<SEC-DOCUMENT>0001213900-25-125820.txt : 20251229
<SEC-HEADER>0001213900-25-125820.hdr.sgml : 20251229
<ACCEPTANCE-DATETIME>20251229081058
ACCESSION NUMBER:		0001213900-25-125820
CONFORMED SUBMISSION TYPE:	20-F
PUBLIC DOCUMENT COUNT:		161
CONFORMED PERIOD OF REPORT:	20250630
FILED AS OF DATE:		20251229
DATE AS OF CHANGE:		20251229

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Moolec Science SA
		CENTRAL INDEX KEY:			0001937737
		STANDARD INDUSTRIAL CLASSIFICATION:	TEXTILE MILL PRODUCTS [2200]
		ORGANIZATION NAME:           	04 Manufacturing
		EIN:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		20-F
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41586
		FILM NUMBER:		251603222

	BUSINESS ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		89 NEXUS WAY, CAMANA BAY
		CITY:			GRAND CAYMAN
		PROVINCE COUNTRY:   	E9
		ZIP:			KY1-9009
		BUSINESS PHONE:		352 26 49 65 65

	MAIL ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		89 NEXUS WAY, CAMANA BAY
		CITY:			GRAND CAYMAN
		PROVINCE COUNTRY:   	E9
		ZIP:			KY1-9009
</SEC-HEADER>
<DOCUMENT>
<TYPE>20-F
<SEQUENCE>1
<FILENAME>ea0270125-20f_moolec.htm
<DESCRIPTION>ANNUAL REPORT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Sun Dec 28 18:19:33 UTC 2025 -->
<html xmlns:compsci="http://compsciresources.com" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:cyd="http://xbrl.sec.gov/cyd/2025" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:dtr="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:dtr1="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:mlec="http://www.moolecscience.com/20250630" xmlns:srt="http://fasb.org/srt/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml">
<head>
     <title> </title>

<meta content="text/html" http-equiv="Content-Type"/>
</head>
<body><div style="font: 10pt Times New Roman, Times, Serif"><div>

</div><p style="margin: 0"></p><div>

</div><!-- Field: Rule-Page --><div style="width: 100%"><div style="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="margin: 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">UNITED STATES</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SECURITIES AND EXCHANGE COMMISSION</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Washington, D.C. 20549</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <ix:nonNumeric contextRef="c0" name="dei:DocumentType" id="ixv-43047">20-F</ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Mark One)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:DocumentRegistrationStatement" id="ixv-43048">&#9744;</ix:nonNumeric> REGISTRATION STATEMENT PURSUANT TO SECTION
12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>OR</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:DocumentAnnualReport" id="ixv-43049">&#9746;</ix:nonNumeric> ANNUAL REPORT PURSUANT TO SECTION 13 OR
15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">For the fiscal year ended <ix:nonNumeric contextRef="c0" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate" id="ixv-43050"><ix:nonNumeric contextRef="c0" format="ixt:date-monthname-day-en" name="dei:CurrentFiscalYearEndDate" id="ixv-43051">June 30</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" name="dei:DocumentFiscalYearFocus" id="ixv-43052">2025</ix:nonNumeric></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>OR</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="ixv-43053">&#9744;</ix:nonNumeric> TRANSITION REPORT PURSUANT TO SECTION 13
OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">For the transition period from ________________
to ________________</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>OR</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:DocumentShellCompanyReport" id="ixv-43054">&#9744;</ix:nonNumeric> SHELL COMPANY REPORT PURSUANT TO SECTION
13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Date of event requiring this shell company
report:</b> __________</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Commission file number: <ix:nonNumeric contextRef="c0" name="dei:EntityFileNumber" id="ixv-43055">001-41586</ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName" id="ixv-85"><b>Moolec Science SA</b></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><i>(Exact name of Registrant as specified in its
charter)</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span style="-sec-ix-hidden: hidden-fact-0">The Cayman Islands</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><i>(Jurisdiction of incorporation)</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>c/o Ogier Global (Cayman) Limited,</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><ix:nonNumeric contextRef="c0" name="dei:EntityAddressAddressLine1" id="ixv-43056">89 Nexus Way, Camana Bay</ix:nonNumeric>,&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><ix:nonNumeric contextRef="c0" name="dei:EntityAddressCityOrTown" id="ixv-43057">Grand Cayman</ix:nonNumeric> <ix:nonNumeric contextRef="c0" name="dei:EntityAddressPostalZipCode" id="ixv-43058">KY1-9009</ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt-sec:countrynameen" name="dei:EntityAddressCountry" id="ixv-113"><b>Cayman Islands</b></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><i>(Address of principal executive offices)</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><ix:nonNumeric contextRef="c1" name="dei:ContactPersonnelName" id="ixv-122"><b>Valeria Falottico</b></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Chief Financial Officer</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><ix:nonNumeric contextRef="c1" name="dei:EntityAddressAddressLine1" id="ixv-43059">Ocampo Bis 210</ix:nonNumeric>, <ix:nonNumeric contextRef="c1" name="dei:EntityAddressCityOrTown" id="ixv-43060">Rosario Sud</ix:nonNumeric>, <ix:nonNumeric contextRef="c1" continuedAt="_EntityAddressAddressLine2-c1_cont_1" name="dei:EntityAddressAddressLine2" id="ixv-43061">Santa Fe</ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><ix:continuation id="_EntityAddressAddressLine2-c1_cont_1">2000</ix:continuation>, <ix:nonNumeric contextRef="c1" format="ixt-sec:countrynameen" name="dei:EntityAddressCountry" id="ixv-43063">Argentina</ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><ix:nonNumeric contextRef="c1" name="dei:ContactPersonnelEmailAddress" id="ixv-135"><b>ir@moolecscience.com</b></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><ix:nonNumeric contextRef="c1" name="dei:CityAreaCode" id="ixv-43064">+54</ix:nonNumeric> <ix:nonNumeric contextRef="c1" name="dei:LocalPhoneNumber" id="ixv-43065">341 486 1100</ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>(Name, Telephone, E-mail and/or Facsimile number
and Address of Company Contact Person)</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Securities registered or to be registered pursuant
to Section 12(b) of the Act:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr> <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title of Each Class</b></span></td> <td style="vertical-align: top; width: 2%"><b>&#160;</b></td> <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading Symbol</b></span></td> <td style="vertical-align: top; width: 2%"><b>&#160;</b></td> <td style="border-bottom: black 1.5pt solid; vertical-align: top; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name of each exchange on which registered</b></span></td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="text-align: center"><ix:nonNumeric contextRef="c2" name="dei:Security12bTitle" id="ixv-168"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary Shares, with nominal value of<br/>
US$0.10 per share</span></ix:nonNumeric></td> <td>&#160;</td> <td style="text-align: center"><ix:nonNumeric contextRef="c2" name="dei:TradingSymbol" id="ixv-173"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MLEC</span></ix:nonNumeric></td> <td>&#160;</td> <td style="text-align: center"><ix:nonNumeric contextRef="c2" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="ixv-177"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq Stock Market LLC</span></ix:nonNumeric></td></tr> <tr style="vertical-align: top; "> <td style="text-align: center"><ix:nonNumeric contextRef="c3" name="dei:Security12bTitle" id="ixv-181"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants, exercisable for ordinary<br/>
shares</span></ix:nonNumeric></td> <td>&#160;</td> <td style="text-align: center"><ix:nonNumeric contextRef="c3" name="dei:TradingSymbol" id="ixv-186"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MLECW</span></ix:nonNumeric></td> <td>&#160;</td> <td style="text-align: center"><ix:nonNumeric contextRef="c3" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="ixv-190"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq Stock Market LLC</span></ix:nonNumeric></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Securities registered or to be registered pursuant
to Section 12(g) of the Act:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>None</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Securities for which there is a reporting obligation
pursuant to Section 15(d) of the Act:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Ordinary Shares</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Warrants</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate the number of outstanding shares of each
of the issuer&#8217;s classes of capital stock or common stock as of the close of business covered by the annual report.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-43066">10,891,761</ix:nonFraction> Ordinary Shares were issued and outstanding
as of June 30, 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark if the registrant is a
well-known seasoned issuer, as defined in Rule 405 of the Securities Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#9744; Yes&#160;&#160; &#9746; <ix:nonNumeric contextRef="c0" name="dei:EntityWellKnownSeasonedIssuer" id="ixv-43067">No</ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this report is an annual or transition report,
indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act
of 1934.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#9744; Yes&#160;&#160; &#9746; <ix:nonNumeric contextRef="c0" name="dei:EntityVoluntaryFilers" id="ixv-43068">No</ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
(1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months
(or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements
for the past 90 days.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#9744; Yes&#160;&#160; &#9746; <ix:nonNumeric contextRef="c0" name="dei:EntityCurrentReportingStatus" id="ixv-43069">No</ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405
of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#9746; <ix:nonNumeric contextRef="c0" name="dei:EntityInteractiveDataCurrent" id="ixv-43070">Yes</ix:nonNumeric>&#160;&#160;&#160; &#9744; No</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth company. See definition of &#8220;large
accelerated filer,&#8221; &#8220;accelerated filer,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 25%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large accelerated filer &#9744;</span></td> <td style="width: 25%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated filer &#9744;</span></td> <td style="width: 25%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="c0" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="ixv-43071">Non-accelerated filer</ix:nonNumeric> &#9746;</span></td> <td style="white-space: nowrap; width: 25%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging growth company <ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="ixv-43072">&#9746;</ix:nonNumeric></span></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company that prepares its
financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition
period for complying with any new or revised financial accounting standards&#8224; provided pursuant to Section 13(a) of the Exchange
Act. <ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:EntityExTransitionPeriod" id="ixv-43073">&#9744;</ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8224;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The term &#8220;new or revised financial accounting standard&#8221; refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial
reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or
issued its audit report. <ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:IcfrAuditorAttestationFlag" id="ixv-43074">&#9744;</ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If securities are registered pursuant to Section
12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction
of an error to previously issued financial statements. <ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:DocumentFinStmtErrorCorrectionFlag" id="ixv-43075">&#9744;</ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether any of those error
corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s
executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b). &#9744;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark which basis of accounting
the registrant has used to prepare the financial statements included in this filing:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 33%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US GAAP &#9744;</span></td> <td style="white-space: nowrap; width: 34%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-1">International Financial Reporting</span><br/>
Standards as issued by the<br/>
International Accounting Standards Board &#9746;</span></td> <td style="width: 33%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other &#9744;</span></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If &#8220;Other&#8221; has been checked in response
to the previous question indicate by check mark which financial statement item the registrant has elected to follow.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#9744; Item 17&#160;&#160; &#9744; Item 18</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this is an annual report, indicate by check
mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#9744; Yes&#160;&#160; <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:EntityShellCompany" id="ixv-43076">&#9746;</ix:nonNumeric> No</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Rule-Page --><div style="width: 100%"><div style="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>


</div><!-- Field: Page; Sequence: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Table of Contents</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="2"><a href="#k_001"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABOUT THIS ANNUAL REPORT</span></a></td>
    <td style="text-align: center">iii</td></tr>
  <tr style="vertical-align: top; ">
    <td style="width: 8%">&#160;</td>
    <td style="width: 84%">&#160;</td>
    <td style="width: 8%; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="2"><a href="#k_002"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PART I</span></a></td>
    <td style="text-align: center">1</td></tr>
  <tr style="vertical-align: top; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="2" style="text-align: justify"><a href="#k_003"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">INTRODUCTORY NOTE AND PRESENTATION OF FINANCIAL AND OTHER INFORMATION</span></a></td>
    <td style="text-align: center">1</td></tr>
  <tr style="vertical-align: top; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 1.</span></td>
    <td><a href="#k_004"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS &#160;</span></a></td>
    <td style="text-align: center">5</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td><a href="#k_005"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors and Senior Management</span></a></td>
    <td style="text-align: center">5</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td><a href="#k_006"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advisors</span></a></td>
    <td style="text-align: center">5</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
    <td><a href="#k_007"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Auditors</span></a></td>
    <td style="text-align: center">5</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 2.</span></td>
    <td><a href="#k_008"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OFFER STATISTICS AND EXPECTED TIMETABLE&#160;</span></a></td>
    <td style="text-align: center">5</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td><a href="#k_009"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offer Statistics</span></a></td>
    <td style="text-align: center">5</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td><a href="#k_010"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Method and Expected Timetable</span></a></td>
    <td style="text-align: center">5</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 3.&#160;</span></td>
    <td><a href="#k_011"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">KEY INFORMATION</span></a></td>
    <td style="text-align: center">5</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td><a href="#k_012"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[RESERVED]</span></a></td>
    <td style="text-align: center">5</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td><a href="#k_013"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalization and Indebtedness</span></a></td>
    <td style="text-align: center">5</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
    <td><a href="#k_014"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reasons for the Offer and Use of Proceeds</span></a></td>
    <td style="text-align: center">5</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td>
    <td><a href="#k_015"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk Factors</span></a></td>
    <td style="text-align: center">5</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 4.</span></td>
    <td><a href="#k_016"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">INFORMATION ON THE COMPANY&#160;</span></a></td>
    <td style="text-align: center">45</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td><a href="#k_017"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">History and Development of the Company</span></a></td>
    <td style="text-align: center">45</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td><a href="#k_018"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Business Overview</span></a></td>
    <td style="text-align: center">53</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
    <td><a href="#k_019"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Organizational Structure</span></a></td>
    <td style="text-align: center">66</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td>
    <td><a href="#k_020"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property, Plant and Equipment</span></a></td>
    <td style="text-align: center">66</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 5.</span></td>
    <td><a href="#k_021"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OPERATING AND FINANCIAL REVIEW AND PROSPECTS &#160;</span></a></td>
    <td style="text-align: center">67</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td><a href="#k_022"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating Results</span></a></td>
    <td style="text-align: center">67</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td><a href="#k_023"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liquidity and Capital Resources</span></a></td>
    <td style="text-align: center">77</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
    <td><a href="#k_024"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research and Development, Patents and Licenses, etc.</span></a></td>
    <td style="text-align: center">81</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td>
    <td><a href="#k_025"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trend Information</span></a></td>
    <td style="text-align: center">81</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.</span></td>
    <td><a href="#k_026"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Critical Accounting Estimates</span></a></td>
    <td style="text-align: center">81</td></tr>
  <tr style="vertical-align: top; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 6.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_027">DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES</a></span></td>
    <td style="text-align: center">81</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td><a href="#k_028"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors and Senior Management</span></a></td>
    <td style="text-align: center">81</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_029">Compensation</a></span></td>
    <td style="text-align: center">83</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
    <td><a href="#k_030"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Board Practices</span></a></td>
    <td style="text-align: center">84</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td>
    <td><a href="#k_031"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employees</span></a></td>
    <td style="text-align: center">86</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.</span></td>
    <td><a href="#k_032"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share Ownership</span></a></td>
    <td style="text-align: center">86</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F.</span></td>
    <td><a href="#k_033"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosure of a Registrant&#8217;s Action to Recover Erroneously Awarded Compensation</span></a></td>
    <td style="text-align: center">87</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: center">&#160;</td>
    <td/>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 7.</span></td>
    <td><a href="#k_034"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS &#160;</span></a></td>
    <td style="text-align: center">87</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td><a href="#k_035"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Major Shareholders</span></a></td>
    <td style="text-align: center">87</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td><a href="#k_036"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Related Party Transactions</span></a></td>
    <td style="text-align: center">87</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
    <td><a href="#k_037"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interests of Experts and Counsel</span></a></td>
    <td style="text-align: center">90</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>


</div><!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 8.</span></td>
    <td style="width: 84%"><a href="#k_038"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FINANCIAL INFORMATION &#160;</span></a></td>
    <td style="text-align: center; width: 8%">90</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td><a href="#k_039"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated Statements and Other Financial Information</span></a></td>
    <td style="text-align: center">90</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td><a href="#k_040"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant Changes</span></a></td>
    <td style="text-align: center">91</td></tr>
  <tr style="vertical-align: top; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 9.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_041">THE OFFER AND LISTING</a></span></td>
    <td style="text-align: center">91</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td><a href="#k_042"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offer and Listing Details</span></a></td>
    <td style="text-align: center">91</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td><a href="#k_043"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plan of Distribution</span></a></td>
    <td style="text-align: center">91</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
    <td><a href="#k_044"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Markets</span></a></td>
    <td style="text-align: center">91</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td>
    <td><a href="#k_045"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling Shareholders</span></a></td>
    <td style="text-align: center">91</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.</span></td>
    <td><a href="#k_046"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dilution</span></a></td>
    <td style="text-align: center">91</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F.</span></td>
    <td><a href="#k_047"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenses of the Issue</span></a></td>
    <td style="text-align: center">91</td></tr>
  <tr style="vertical-align: top; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 10.</span></td>
    <td><a href="#k_048"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ADDITIONAL INFORMATION</span></a></td>
    <td style="text-align: center">91</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td><a href="#k_049"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share Capital</span></a></td>
    <td style="text-align: center">91</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td><a href="#k_050"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Memorandum and Articles of Association</span></a></td>
    <td style="text-align: center">91</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
    <td><a href="#k_090"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Material Contracts</span></a></td>
    <td style="text-align: center">93</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td>
    <td><a href="#k_051"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange Controls</span></a></td>
    <td style="text-align: center">94</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.</span></td>
    <td><a href="#k_052"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taxation</span></a></td>
    <td style="text-align: center">94</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F.</span></td>
    <td><a href="#k_053"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends and Paying Agents</span></a></td>
    <td style="text-align: center">99</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">G.</span></td>
    <td><a href="#k_054"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statement by Experts</span></a></td>
    <td style="text-align: center">99</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">H.</span></td>
    <td><a href="#k_055"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Documents on Display</span></a></td>
    <td style="text-align: center">99</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">I.</span></td>
    <td><a href="#k_056"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsidiary Information</span></a></td>
    <td style="text-align: center">99</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">J.</span></td>
    <td><a href="#k_057"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annual Report to Security Holders</span></a></td>
    <td style="text-align: center">99</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 11.</span></td>
    <td><a href="#k_058"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK &#160;</span></a></td>
    <td style="text-align: center">99</td></tr>
  <tr style="vertical-align: top; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 12.</span></td>
    <td><a href="#k_059"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES</span></a></td>
    <td style="text-align: center">99</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td><a href="#k_060"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debt Securities</span></a></td>
    <td style="text-align: center">99</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td><a href="#k_061"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants and Rights</span></a></td>
    <td style="text-align: center">99</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
    <td><a href="#k_062"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other Securities</span></a></td>
    <td style="text-align: center">99</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td>
    <td><a href="#k_063"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">American Depositary Shares</span></a></td>
    <td style="text-align: center">99</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><a href="#k_064"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PART II</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">100</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 13.</span></td>
    <td><a href="#k_065"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES</span></a></td>
    <td style="text-align: center">100</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td><a href="#k_066"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Defaults</span></a></td>
    <td style="text-align: center">100</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td><a href="#k_067"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Arrears and Delinquencies</span></a></td>
    <td style="text-align: center">100</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 14.</span></td>
    <td><a href="#k_068"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS &#160;</span></a></td>
    <td style="text-align: center">101</td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 15.</span></td>
    <td><a href="#k_069"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONTROLS AND PROCEDURES &#160;</span></a></td>
    <td style="text-align: center">101</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td><a href="#k_070"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosure Controls and Procedures</span></a></td>
    <td style="text-align: center">101</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td><a href="#k_071"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management&#8217;s Annual Report on Internal Control Over Financial Reporting</span></a></td>
    <td style="text-align: center">101</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
    <td><a href="#k_072"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attestation Report of the Registered Public Accounting Firm</span></a></td>
    <td style="text-align: center">102</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td>
    <td><a href="#k_073"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes in Internal Control Over Financial Reporting</span></a></td>
    <td style="text-align: center">102</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 16.&#160;</span></td>
    <td><a href="#k_074"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reserved</span></a></td>
    <td style="text-align: center">102</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td><a href="#k_075"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit Committee Financial Expert</span></a></td>
    <td style="text-align: center">102</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td><a href="#k_076"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Code of Ethics</span></a></td>
    <td style="text-align: center">102</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
    <td><a href="#k_077"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal Accountant Fees and Services</span></a></td>
    <td style="text-align: center">102</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td>
    <td><a href="#k_078"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exemptions from the Listing Standards for Audit Committees</span></a></td>
    <td style="text-align: center">103</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.</span></td>
    <td><a href="#k_079"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchases of Equity Securities by the Issuer and Affiliated Purchasers</span></a></td>
    <td style="text-align: center">103</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F.</span></td>
    <td><a href="#k_080"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in Registrant&#8217;s Certifying Accountant</span></a></td>
    <td style="text-align: center">103</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">G.</span></td>
    <td><a href="#k_081"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate Governance</span></a></td>
    <td style="text-align: center">103</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">H.</span></td>
    <td><a href="#k_082"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mine Safety Disclosure</span></a></td>
    <td style="text-align: center">103</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">I.</span></td>
    <td><a href="#k_083"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</span></a></td>
    <td style="text-align: center">103</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">J.</span></td>
    <td><a href="#k_084"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insider Trading Policies</span></a></td>
    <td style="text-align: center">103</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">K.</span></td>
    <td><a href="#k_085"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cybersecurity</span></a></td>
    <td style="text-align: center">103</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><a href="#k_086"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PART III</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">104</td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 17.</span></td>
    <td><a href="#k_087"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FINANCIAL STATEMENTS&#160;</span></a></td>
    <td style="text-align: center">104</td></tr>
  <tr style="vertical-align: top; ">
    <td colspan="2">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 18.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_088">FINANCIAL STATEMENTS</a></span></td>
    <td style="text-align: center">104</td></tr>
  <tr style="vertical-align: top; ">
    <td colspan="2">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 19.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_089">EXHIBITS</a></span></td>
    <td style="text-align: center">105</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>


</div><!-- Field: Page; Sequence: 4; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="k_001"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ABOUT THIS ANNUAL REPORT</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Unless the context otherwise
requires, &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; &#8220;the Company,&#8221; &#8220;the Group,&#8221; &#8220;Moolec&#8221;
and &#8220;Moolec Science&#8221; refers to Moolec Science SA and its subsidiaries.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SELECTED DEFINITIONS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following terms used
in this annual report are defined below, unless where context otherwise requires:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#8220;Companies Act&#8221;
means the Companies Act (Revised) of the Cayman Islands.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#8220;<i>Articles</i>&#8221;
means the memorandum and articles of association of Moolec, as amended and restated from time to time.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#8220;<i>BIOX</i>&#8221;
or &#8220;Bioceres&#8221; means Bioceres Crop Solutions Corp.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#8220;<i>Bioceres Group</i>&#8221;
means Bioceres Group Limited (formerly, Bioceres Group PLC) and its subsidiaries.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#8220;Business Combination&#8221;
means the business combination entered into by Moolec Science SA, Bioceres Group, Nutrecon LLC, Nordelis Ventures Corp., Union Group Ventures
Limited and Gentle Technologies Corp. dated April 16, 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#8220;<i>Bioceres Group
Business Combination Agreement</i>&#8221; or &#8220;<i>Business Combination Agreement</i>&#8221; means the business combination agreement
dated April 16, 2025 entered into by Moolec Science SA, Bioceres Group, Nutrecon LLC, Nordelis Ventures Corp., Union Group Ventures Limited
and Gentle Technologies Corp.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#8220;<i>Bioceres LLC</i>&#8221;
means Bioceres LLC (formerly, Bioceres Inc.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#8220;<i>BIOX Soy Supply
Agreement</i>&#8221; means the HB4 soy supply agreement entered into by Moolec and BIOX on September 17, 2024.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#8220;<i>Board</i>&#8221;
or &#8220;<i>Board of Directors</i>&#8221; means the board of directors of Moolec.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#8220;<i>BSA</i>&#8221;
means Bioceres S.A.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#8220;<i>Business Combination
Closing</i>&#8221; or &#8220;<i>Closing</i>&#8221; means the consummation of the Business Combination pursuant to the Business Combination
Agreement.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#8220;<i>Business Combination
Closing Date</i>&#8221; or &#8220;<i>Closing Date</i>&#8221; means June 16, 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#8220;<i>Business Combination
Proposal</i>&#8221; means the proposal presented to the Company&#8217;s shareholders to approve the adoption of the Business Combination
Agreement and the transactions contemplated thereby, including the Business Combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#8220;<i>Continental</i>&#8221;
means Continental Stock Transfer &amp; Trust Company, transfer agent and warrant agent of Moolec.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#8220;<i>DGCL</i>&#8221;
means the Delaware General Corporation Law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#8220;<i>Farmers</i>&#8221;
means Don Osvaldo SA; Los Cha&#241;ares Agropecuaria SA; Agropecuaria Don Juan SA; Cintia SA; Daleril S.A.; Agrosudeste S.A; Marcelo
Enrique Juan Tombetta; Ana Claudia Formica; Agustin Tombetta; and Francisco Jos&#233; Tombetta.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#8220;<i>FDA</i>&#8221;
means the U.S. Food and Drug Administration.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 5; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#8220;<i>Gentle Tech</i>&#8221;
means Gentle Technologies Corp. and its subsidiaries.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#8220;<i>GLA</i>&#8221;
means gamma-linoleic acid.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#8220;<i>GM</i>&#8221; means
genetically modified.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#8220;<i>GMOs</i>&#8221;
means genetically modified organisms.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#8220;<i>IFRS</i>&#8221;
means the International Financial Reporting Standards as issued by the International Accounting Standards Board (the &#8220;IASB&#8221;).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#8220;<i>Insud</i>&#8221;
means Invim Corporativo S.L.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#8220;<i>Insud Convertible
Note</i>&#8221; means the convertible note issued by us to Insud pursuant to the note purchase agreement dated October 15, 2023.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#8220;<i>InMet</i>&#8221; means Ingenier&#237;a
Metab&#243;lica S.A., where Bioceres Tech Services LLC, our wholly owned subsidiary, holds a 48% equity interest.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#8220;<i>LightJump</i>&#8221;
means LightJump Acquisition Corporation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#8220;<i>Nasdaq</i>&#8221;
means Nasdaq Stock Market LLC.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#8220;<i>Nomura</i>&#8221;
means Nomura Securities International, Inc.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#8220;<i>Nomura Purchase
Agreement</i>&#8221; means the share purchase agreement, dated as of April 14, 2023, by and between Moolec and Nomura.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#8220;<i>Nomura Registration
Rights Agreement</i>&#8221; means the registration rights agreement, between Moolec and Nomura, dated as of April 14, 2023.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#8220;<i>Nordelis</i>&#8221;
means Nordelis Ventures Corp.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#8220;<i>Nutrecon</i>&#8221;
means Nutrecon LLC and its subsidiary.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#8220;<i>Ordinary Shares</i>&#8221; means the ordinary shares of Moolec,
US$0.10 par value per share of Moolec.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#8220;<i>Piggy Sooy</i><sup>TM</sup>&#8221;
means a brand registered by us, in the U.S. and Argentina.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#8220;<i>Secured Notes</i>&#8221;
means the Note Purchase Agreement dated 5 August 2022 (as amended, restated, supplemented and/or otherwise modified from time to time,
the &#8220;Jasper NPA&#8221;) by and among, <i>inter alios</i>, the Bioceres Crop Solutions Corp and Jasper Lake Ventures One LLC, Redwood
Enhanced Income Corp. and Liminality Partners LP; and (b) Note Purchase Agreement dated 5 August 2022 (as amended, restated, supplemented
and/or otherwise modified from time to time, the &#8220;Solel NPA&#8221;) by and among, <i>inter alios</i>, Bioceres Crop Solutions Corp.
and Solel-Bioceres SPV, L.P.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#8220;<i>Synbio</i>&#8221;
means Synbio Powerlabs OY</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#8220;<i>Theo</i>&#8221;
means THEO I SCSp.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#8220;<i>UGVL</i>&#8221;
means Union Group Ventures Limited.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#8220;<i>USD</i>&#8221;
or &#8220;<i>US$</i>&#8221; means U.S. dollars.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#8220;<i>ValoraSoy</i>&#8221;
or &#8220;<i>ValoraSoy Food Ingredients</i>&#8221; means ValoraSoy S.A., a company incorporated in Argentina.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#8220;<i>ValoraSoy Acquisition</i>&#8221;
means our acquisition of ValoraSoy on April 24, 2023.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 6; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iv<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase"><b>CAUTIONARY
NOTE REGARDING FORWARD-LOOKING STATEMENTS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">This annual report contains
forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 that relate to our current
expectations and views of future events, industry and financial trends affecting our business. We intend such forward-looking statements
to be covered by the safe harbor provisions for forward-looking statements as contained in Section 27A of the Securities Act and Section
21E of the Exchange Act. Forward-looking statements include information concerning our possible or assumed future results of operations,
including descriptions of our business strategy. In some cases, you can identify forward-looking statements by terminology such as &#8220;believe,&#8221;
&#8220;may,&#8221; &#8220;might,&#8221; &#8220;will,&#8221; &#8220;consider,&#8221; &#8220;estimate,&#8221; &#8220;continue,&#8221; &#8220;anticipate,&#8221;
&#8220;intend,&#8221; &#8220;target,&#8221; &#8220;project,&#8221; &#8220;contemplate,&#8221; &#8220;should,&#8221; &#8220;plan,&#8221;
&#8220;expect,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; or the negative of these terms or other similar terms or expressions.
The statements we make regarding the following matters are forward-looking by their nature:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the impact of the ongoing conflict in Israel and Palestine, as well as in Ukraine, and any possible escalation of such conflicts or contagion to neighboring countries or regions;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">general economic, financial, business and political conditions in Latin America;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our financial performance;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our financial position, our need to raise additional capital and to obtain additional capital on acceptable terms, or at all, raises substantial doubt about our ability to continue as a going concern;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to maintain the listing of the Ordinary Shares or warrants on Nasdaq;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes in our strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects and plans;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to develop and launch new products and services;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to successfully and efficiently integrate future expansion plans and opportunities;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the availability of raw materials used in our products and our ability to source such raw materials;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to grow our business in a cost-effective manner;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our product development timeline and expected research and development (&#8220;R&amp;D&#8221;) activities;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to commercialize the products developed in our R&amp;D center acquired through the ValoraSoy acquisition, as well as in our fermentation hub in Finland;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to achieve vertical integration across our business units following the consummation of the Business Combination;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the implementation, market acceptance, and success of our business model;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">developments and projections relating to our competitors and the industry;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our approach to and goals with respect to technology;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our expectations regarding our ability to obtain and maintain intellectual property protection and to avoid infringing on the rights of others;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in"></p><div>

</div><!-- Field: Page; Sequence: 7; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->v<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the impact of any global viral pandemic on our business, including any potential monkeypox (&#8220;Mpox&#8221;) outbreak;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes in applicable laws or regulations;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the outcome of any known and unknown litigation or regulatory proceedings; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">various other factors, including without limitation those described under &#8220;<i>Item 3. Key Information&#8211;D. Risk Factors.</i>&#8221;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The preceding list is not
intended to be an exhaustive list of all of our forward-looking statements. The forward-looking statements are based on our beliefs, assumptions,
and expectations of future performance, taking into account the information currently available to us. These statements are only predictions
based upon our current expectations and projections about future events. There are important factors that could cause our actual results,
levels of activity, performance or achievements to differ materially from the results, levels of activity, performance or achievements
expressed or implied by the forward-looking statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">You should not rely upon
forward-looking statements as predictions of future events. Although we believe that the expectations reflected in the forward-looking
statements are reasonable, we cannot guarantee that future results, levels of activity, performance and events and circumstances reflected
in the forward-looking statements will be achieved or will occur. Except as required by law, we undertake no obligation to update publicly
any forward-looking statements for any reason after the date of this report or to conform these statements to actual results or to changes
in our expectations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>MARKET AND INDUSTRY DATA</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">This annual report on Form
20-F industry data, information and statistics regarding the markets in which we compete as well as our analysis of statistics, data and
other information provided by third parties relating to markets, market sizes, market shares, market positions and other industry data
pertaining to our business and markets (collectively, &#8220;Industry Analysis&#8221;). Such information is supplemented where necessary
with our own internal estimates, taking into account publicly available information about other industry participants and our management
judgment where information is not publicly available.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Industry publications, tailormade
industry reports, research, studies and forecasts generally state that the information they contain has been obtained from sources believed
to be reliable, but that the accuracy and completeness of such information is not guaranteed. Forecasts and other forward-looking&#160;information
obtained from these sources are subject to the same qualifications and uncertainties as the other forward-looking&#160;statements in this
annual report on Form 20-F. These forecasts and forward-looking&#160;information are subject to uncertainty and risk due to a variety
of factors, including those described under &#8220;<i>Risk Factors</i>.&#8221; These and other factors could cause results to differ materially
from those expressed in any forecasts or estimates.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>TRADEMARKS, SERVICE MARKS AND TRADE NAMES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">This annual report on Form
20-F contains references to our trademarks and to trademarks belonging to other entities. Solely for convenience, trademarks and trade
names referred to in this annual report, including logos, artwork and other visual displays may appear without the &#174; or TM symbols,
but such references are not intended to indicate, in any way, that their respective owners will not assert, to the fullest extent under
applicable law, their rights thereto. We do not intend our use or display of other companies&#8217; trade names or trademarks to imply
a relationship with, or endorsement or sponsorship of us by, any other companies.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 8; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->vi<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_002"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PART I</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase"><b>&#160;</b></span></p><div>

</div><div><a id="k_003"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase"><b>INTRODUCTORY
NOTE AND PRESENTATION OF FINANCIAL AND OTHER INFORMATION</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Introductory Note</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>The Bioceres Group Business Combination Agreement.</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Before the end of the fiscal
year, on June 16, 2025, the Company consummated a Business Combination. Prior to such consummation, a series of previous steps had taken
place, as follows:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On May 14, 2025, Moolec Science
(Luxembourg) made effective a reverse stock split of its Ordinary Shares (the &#8220;Reverse Stock Split&#8221;) on the consolidation
ratio of ten-to-one (the &#8220;Consolidation Ratio&#8221;), pursuant to which holders of Ordinary Shares received one Ordinary Share
for every ten Ordinary Shares held.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On May 22, 2025, the Company
changed its jurisdiction by redomiciling Moolec Science (Luxembourg) from the Grand Duchy of Luxembourg to the Cayman Islands as Moolec
Science (Cayman Islands) by way of continuation pursuant to Part XII of the Companies Act (Revised) of the Cayman Islands. On the Effective
Date, all of the shares of Moolec Science (Luxembourg), par value US$0.10 per share by operation of law became shares of Moolec Science
(Cayman Islands), par value $0.10 per share (the &#8220;Ordinary Shares&#8221;).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">After completion of the Reverse
Stock Split, all references to the Ordinary Shares, share data, per share data and related information have been adjusted for the Consolidation
Ratio to reflect the Reverse Stock Split. The Reverse Stock Split has consolidated each ten of the Ordinary Shares into one Ordinary Share,
with a new par value of US$0.10 per Ordinary Share. Upon completion of the Reverse Stock Split, no fractional Ordinary Shares were issued,
and any fractional Ordinary Shares resulting from the Reverse Stock Split were rounded up to the nearest whole Ordinary Share. Except
for the adjustments that resulted from the treatment of fractional shares, the Reverse Stock Split did not have any dilutive effect on
the shareholders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On June 16, 2025, following the consummation of the Business Combination,
the Company initiated integration processes across organizational, operational, and IT functions to support competitiveness and long-term
sustainability. In parallel, management continued to advance the ongoing operations, which remain crucial to maintaining business continuity
and supporting the successful execution of the integration and growth strategy. The consolidated results as of and for the year ended
June 30, 2025 (&#8220;FY2025&#8221;) reflect purchase accounting. The prior period as of and for the year ended June 30, 2024 (&#8220;FY2024&#8221;)
and for the year ended June 30, 2023 reflects the Predecessor on a stand-alone basis and does not include any effects of the Business
Combination. As a result, variances between FY2025 and FY2024 primarily reflect changes in scope and basis of presentation rather than
purely period-over-period operating trends, and therefore the periods are not directly comparable. Effective as of the Closing (i.e.,
June 16, 2025), the Company accounted for the Business Combination under IFRS 3, <i>Business Combinations</i>, using the acquisition method
of accounting and treating the transaction as a reverse acquisition. Under this approach, Bioceres Group (the legal absorbed entity) was
considered the accounting acquirer, and Moolec Science SA (the legal acquirer) was considered the accounting acquiree, together with Gentle
Tech and Nutrecon.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Going Concern</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Business Combination, initially announced on April 17, 2025, in
which the Company, Bioceres Group (formerly, Bioceres Group PLC, one of the main shareholders of the Company), Gentle Tech and Nutrecon
entered into the Bioceres Group Business Combination Agreement, pursuant to which several parties transferred their respective holdings
in Bioceres Group, Nutrecon and Gentle Tech (together, the &#8220;Contributed Entities&#8221;) to the Company, in exchange of a combination
of newly issued Company&#8217;s shares, and warrants, to the shareholders of the Contributed Entities. Following the closing, Moolec became
the legal parent company of the combined group comprising Bioceres Group, Gentle Tech, and Nutrecon. The Business Combination was ratified
by Moolec shareholders at the Extraordinary General Meeting (&#8220;EGM&#8221;) held on June 16, 2025, with 77% of the outstanding shares
present at the meeting, and 98% of the votes cast were in favor of the transaction. From an accounting perspective and based on the guidance
of IFRS 3, Bioceres Group Limited is deemed to be the accounting acquirer. The transaction was subsequently consummated on the same date,
June 16, 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 9; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On June 18, 2025, Bioceres
Crop Solutions Corp. (BIOX), a public company controlled until that date by Bioceres Group Limited, entered into an amendment with the
Secured Notes&#8217; holders by which the holders of the Secured Notes waived the breach of covenants that led to the default of the debt
(specifically, the breach of covenants related to the Consolidated Total Net Leverage Ratio (determined as the ratio of (a) Consolidated
Total Net Debt as of the last day of such Test Period to (b) Consolidated EBITDA of the Issuer and its Subsidiaries for such Test Period)
of 3.75x as of March 31, 2025), retrospectively modifying the required Consolidated Total Net Leverage Ratio to 5x Consolidated Total
Net Leverage Ratio, and extended the maturity of the Secured Notes to August 31, 2027. In accordance with the terms of the amendments,
effective June 24, 2025, Gloria Montaron Estrada, Enrique Lopez Lecube, and Keith McGovern were replaced in Bioceres Crop Solutions Corp.&#8217;s
Board of Directors by Milen Marinov, Noah Kolatch and Scott Crocco, who were nominated by certain holders of the Secured Notes. Bioceres
Crop Solutions Corp. agreed, for so long as the Secured Notes remain outstanding, to continue to nominate Messrs. Marinov, Kolatch and
Crocco (or such other persons as may be nominated as their replacements) for additional terms as directors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The effect of the changes in the terms of the Secured Notes of Bioceres
Crop Solutions, resulted in the loss of de facto control of that subsidiary and consequently, its deconsolidation. The equity method was
applied to account for the investment in such former subsidiary, as well as for other investments in joint ventures and associates (the
&#8220;BIOX deconsolidation&#8221;). Even when there was a deconsolidation of the business, the Company will continue to be affected by
BIOX business due to the HB4 royalty agreement. It is important to note that the effects of the loss of control in BIOX represents substantially
all of the Company&#8217;s business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As a
result of the loss of control over BIOX, access to financing that Bioceres S.A., its wholly owned subsidiary Bioceres LLC, Bioceres Group
Limited and Moolec Science SA had until then, was restricted or limited.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In June 2025, Bioceres S.A., one of the Argentine subsidiaries of Bioceres
Group Limited, defaulted on a portion of its financial debt that was due that month. As a result, Bioceres S.A. had initiated a debt restructuring
process for its financial debt for an aggregate amount of US$36.4 million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In July 2025, Bioceres LLC,
a wholly owned subsidiary of Bioceres S.A., received a notice of default on its financial debt&#160;in the amount of US$69.5 million.
The creditor conducted a public auction for 3,062,500 pledged BIOX shares, pursuant to the New York Uniform Commercial Code. Management
has responded to the creditor, reserving all rights, remedies, and defenses. As of June 30, 2025, the current debt amounts to US$58.0
million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The defaults by Bioceres S.A. and Bioceres LLC do not have implications
in other debts as there are no cross-default clauses on the remaining financial debt of the Group. There are no guarantees granted above
Bioceres S.A. and Bioceres LLC.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As of June 30, 2025, the Group had a negative working capital amounting
to US$204,860,444, and a shareholders&#8217; deficit of US$82,873,602. Additionally, the Group reported recurring operating losses amounting
to US$104,150,129.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company had the financial
support of its main shareholders and considering the aforementioned events that derived in the loss of the financial support that was
previously provided by Bioceres Group (and who is also no longer a shareholder of the Company), and, consequently, raise a material uncertainty
which may cast significant doubt (or raise substantial doubt as contemplated by PCAOB standards) &#160;about the ability of Moolec Science
SA to continue as a going concern, currently, the Group lacks sufficient financial resources to meet its obligations or fully implement
its business plan. Without securing additional capital, the Group will not be able to sustain its operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The uncertainty surrounding
the ability to secure additional funding and the potential for continued operational losses contribute to substantial doubt about the
Group&#8217;s ability to continue as a going concern.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 10; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i style="font-style: normal; font-weight: normal">Management has plans to address
the Group&#8217;s financial situation as follows:</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>Theo I SCSp</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On November 28, 2025, subsequent
to the reporting date, Theo I SCSp received a conditional payment order from district court of&#160; Luxembourg, and therefore the General
Partners engaged Ogier (Luxembourg) SCS represented by its general partner Ogier Luxembourg (GP) S.&#224;.r.l&#160; formally as their
legal advisor to assist with Theo I SCSp&#8217;s declaration of bankruptcy before the Luxembourg District Court. The declaration of bankruptcy
will declare Theo I SCSp bankrupt and appoint a receiver who will take control over the management of the company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The loss of control constitutes
the derecognition event under IFRS 10.25. Accordingly, the Group will derecognize the assets and liabilities of Theo I SCSp and will remeasure
its retained interest at fair value in accordance with IFRS 9 at the date of the derecognition event. This will result in the recognition
of an estimated gain of US$9.5 million in the consolidated statement of profit or loss as of the derecognition date.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Group will continue to
measure its retained interest in Theo at fair value through profit or loss until the liquidation process is formally completed.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>Bioceres S.A. and Bioceres
LLC</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On December 16, 2025, subsequent to the reporting date, the Board of
Directors of Bioceres S.A. formally approved the initiation of voluntary bankruptcy proceedings and instructed management to seek and
appoint a trustee (&#8220;<i>s&#237;ndico</i>&#8221;) to oversee the process. The commencement of the voluntary bankruptcy proceedings
and the transfer of decision-making authority to the trustee will result in the Group losing control over Bioceres S.A. in accordance
with the principles of IFRS 10 Consolidated Financial Statements. As Bioceres LLC is a wholly owned subsidiary of Bioceres S.A., the Group
simultaneously will  lose control over Bioceres LLC as well.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Under IFRS 10.25, the date
on which control is lost constitutes the derecognition event. Accordingly, after December 16, 2025, the Group will derecognize the assets
and liabilities of Bioceres S.A. and Bioceres LLC and will remeasure any retained interest at fair value in accordance with IFRS 9 Financial
Instruments.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The resulting derecognition effects are expected to generate an approximate
gain of US$91.0 million related to the loss of control of Bioceres S.A. and an additional approximate gain of US$5.3 million related to
the loss of control of Bioceres LLC (including the loss of holding in BIOX, therefore it will no longer be an equity method associate).
These amounts will be recognized in the consolidated statement of profit or loss as of the derecognition date.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Group will continue to monitor the progress of the voluntary bankruptcy
and liquidation proceedings and will update the accounting treatment as necessary in accordance with IFRS.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Management expects that certain
shareholders and/or investors will continue or commence to provide new financing lines.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">However, there is no assurance
that investors and shareholders will continue to provide financing, or that the Group&#8217;s future operations will generate profitability.
The uncertainty surrounding the ability to secure additional funding and the potential for continued operational losses contribute to
raise a material uncertainty which may cast significant doubt (or raise substantial doubt as contemplated by PCAOB standards) about the
Group&#8217;s ability to continue as a going concern.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The consolidated financial statements of Moolec
Science SA do not include any adjustments that may be required to address the potential impacts on the recoverability and classification
of assets or the amounts and classifications liabilities, should the Group be unable to continue as a going concern.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Accordingly, the financial
statements of Moolec Science SA for periods prior to the Closing reflect the historical financial information of Bioceres Group. The financial
information as of and for the year ended June 30, 2025 reflects the figures corresponding to Bioceres Group and incorporates the effects
of applying the acquisition method to Moolec Science SA, Gentle Tech and Nutrecon, measured at fair value in accordance with IFRS 3.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 11; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase"><b>PRESENTATION
OF FINANCIAL AND OTHER INFORMATION</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Moolec Science SA, which
we refer to in this annual report as &#8220;Moolec&#8221; was initially incorporated on May 23, 2022, as a public limited liability company
(soci&#233;t&#233; anonyme) governed by the laws of the Grand Duchy of Luxembourg. On May 22, 2025 (the &#8220;Effective Date&#8221;),
the Company effected the Redomiciliation. See &#8220;<i>Introductory Note&#8212;The Bioceres Group Business Combination Agreement.&#8221;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We present in this annual
report the audited consolidated financial statements of Moolec as of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024
and 2023, which were prepared in accordance with IFRS, as issued by the IASB.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Effective as of the Closing
(i.e., June 16, 2025), we accounted for the Business Combination under IFRS 3, <i>Business Combinations</i>, using the acquisition method
of accounting and treating the transaction as a reverse acquisition. Under this approach, Bioceres Group (the legal subsidiary) was considered
the accounting acquirer, and Moolec Science SA (the legal acquirer) was considered the accounting acquiree, together with Gentle Tech
and Nutrecon.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Accordingly, the financial
statements of Moolec Science SA for periods prior to the Closing reflect the historical financial information of Bioceres Group. The financial
information as of and for the year ended June 30, 2025 reflects the figures corresponding to Bioceres Group and incorporates the effects
of applying the acquisition method to Moolec Science SA, Gentle Tech and Nutrecon, measured at fair value in accordance with IFRS 3.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">All references herein to
&#8220;our financial statements,&#8221; &#8220;our audited consolidated financial information,&#8221; and &#8220;our audited consolidated
financial statements&#8221; refer to the audited consolidated financial statements of Moolec included elsewhere in this annual report.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">This financial information
should be read in conjunction with &#8220;<i>Item 5. Operating and Financial Review and Prospects</i>&#8221; and our audited consolidated
financial statements, including the notes thereto, included elsewhere in this annual report.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our fiscal year ends on June
30<sup>th</sup>. References in this annual report to a fiscal year relate to our fiscal year ended June 30, 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 12; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase"><b>INDUSTRY
AND MARKET DATA</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">This report includes industry
and market data that we obtained from industry publications and research, surveys and studies conducted by third parties, as well as estimates
by our management based on such data. All of this information involves a variety of assumptions, limitations, and methodologies and is
inherently subject to uncertainties, and you are cautioned not to give undue weight to such industry and market data.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="k_004"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM&#160;1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="k_005"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><b>A.&#160;Directors and Senior Management</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_006"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><b>B.&#160;Advisors</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_007"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><b>C.&#160;Auditors</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_008"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM&#160;2. OFFER STATISTICS AND EXPECTED TIMETABLE</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="k_009"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><b>A.&#160;Offer Statistics</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_010"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><b>B.&#160;Method and Expected Timetable</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_011"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM&#160;3. KEY INFORMATION</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="k_012"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><b>A.&#160; [RESERVED]</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="k_013"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><b>B.&#160;Capitalization and Indebtedness</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_014"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><b>C.&#160;Reasons for the Offer and Use of Proceeds</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_015"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><b>D.&#160;Risk Factors</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>The following risk factors
apply to our business and operations. The occurrence of one or more of the events or circumstances described in these risk factors, alone
or in combination with other events or circumstances, may have a material adverse effect on our business, projections, cash flows, financial
condition and results of operations. You should carefully consider the following risk factors in addition to the other information included
in this report, including matters addressed in the section titled &#8220;Cautionary Note Regarding Forward-Looking statements.&#8221;
We may face additional risks and uncertainties that are not presently known to us, or that we currently deem immaterial, which may also
impair our business or financial condition. The following discussion should be read in conjunction with the financial statements included
herein.</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Summary Risk Factors</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">You should carefully consider
all of the information in this annual report before making an investment in our ordinary shares. Below is a summary of the principal risks
and uncertainties that we face, organized under relevant headings. These risks are discussed in greater detail below.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks Relating to Our Business and Operations</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We are subject to the following
risks in respect of our business and our strategy:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we may face difficulties implementing our inorganic growth strategy, including in respect of integrating the operations of the business we have acquired or expect to acquire in the future;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 13; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">integration with Bioceres Group, Nutrecon LLC, Nordelis, Union Group Ventures Limited, and Gentle Technologies Corp, may not be successful in achieving their intended benefits, cost savings and synergies and may disrupt current operations;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our financial statements for the year ended June 30, 2025 state that there is substantial doubt about our ability to continue as a going concern;</span></td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we are an early-stage, high-risk company with a history of losses and we may not achieve or maintain profitability;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we have a limited operating history, which makes it difficult to evaluate our current business and prospects and may increase the risk of investment;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">price increases and shortages of raw materials could adversely affect our results of operations;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our failure to accurately forecast and manage inventory could result in unexpected shortfalls or surpluses of products, which could harm our business;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our future revenue depends on the success of our technologies and product developments, including our extrusion, fermentation, molecular farming and other technologies. We have limited data on the performance of such technologies to date, and our product development depends on assumptions that are inherently uncertain;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we may face difficulty servicing our indebtedness, including the convertible notes issued to Insud, Farmers, and BIOX;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">conversion of the convertible notes, preference shares, and warrants would increase the number of ordinary shares and result in dilution to shareholders;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our financial statements have been prepared assuming we will continue as a going concern, however, uncertainty surrounding the ability to secure additional funding and the potential for continued operational losses contribute to raise a material uncertainty which may cast significant doubt on the Group&#8217;s ability to continue as a going concern;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">defaults by BSA and Bioceres LLC, while not triggering cross-default clauses in the Group&#8217;s remaining financial debt, could affect our financial conditions;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we will likely require additional financing to achieve our goals, and failure to obtain necessary capital when needed on acceptable terms, or at all, may force us to delay, limit, reduce or terminate our product manufacturing, development and other operations;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our failure to successfully implement the restructuring process initiated following the business combination with Bioceres Group, among others, could materially and adversely impact the Company&#8217;s performance, operations and financial condition;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we may face difficulties implementing our inorganic growth strategy, including identifying suitable targets and integrating acquired operations;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we may acquire businesses, patents or products, or form strategic alliances, in the future, and we may not realize the benefits of such acquisitions or alliances;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if we fail to effectively utilize or expand our manufacturing and production capacity, or commercialize or license our intellectual property, our business, results of operations and brand reputation could be harmed;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we may face difficulties in collecting payments or royalties, which could have an adverse impact on our business;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our HB4 technology business depends on the success of the exclusive license granted to BIOX;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we operate in a privately owned facility conducting research with third parties under lease and service agreements with private companies and research universities;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in"></p><div>

</div><!-- Field: Page; Sequence: 14; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our current operations depend in part on third-party agreements for supplies required to develop and scale our production and increase our stock of seed, feedstock, biomass and other raw materials;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reliance on third parties to grow our seeds could adversely affect our business;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we are developing a customer base for our fermentation and molecular farming-derived products, and failure to expand that base could adversely affect our sales and profitability;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we face significant competition, and many competitors have substantially greater financial, technical and other resources than we do;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to compete effectively, we must introduce and improve existing and new products that achieve market acceptance and enhance the output of our technology;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">collaboration agreements we may seek to enter into with third parties may not be consummated or may not be successful;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the successful commercialization of our products depends significantly on our ability to produce high-quality products cost-effectively at scale, accurately forecast the demand for them, and to obtain necessary regulatory approvals;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our products require specific storage measures and have limited shelf life, which may not align with operational or market expectations;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">commercialization of our products may face challenges arising from public perceptions of plant and strain engineered products (GMOs) and from ethical, legal, environmental, health and social concerns;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">consumer habits and preferences for our products are difficult to predict and may change rapidly, and if we are unable to respond quickly to new trends, our business may be adversely affected;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our business activities are concentrated in a limited number of locations, making us susceptible to disruptions caused by natural disasters, climatic variations, disease, pests, or vandalism;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if our genetically engineered plants or strains fail to express or produce a sufficient yield of the targeted animal protein, ingredient or function, we may not be able to market our products in a timely manner or compete effectively;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if we are unable to attract, train and retain employees, we may not be able to grow or operate successfully;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">food safety and food-borne illness incidents or advertising or product mislabeling may materially and adversely affect our business by exposing us to lawsuits, product recalls or regulatory enforcement actions, increasing our operating costs and reducing demand for our products;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">defective-products lawsuits determined adversely to us could result in substantial damages for which insurance coverage may not be available;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">limited brand awareness could affect our ability to sell products;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure to develop our technology, products or brand could adversely affect our prospects;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reliance on information-technology systems exposes us to operational risks, and failures or cyber-attacks could impair our business;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we are subject to anti-corruption and anti-money laundering laws, and non-compliance could result in civil or criminal liability;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in"></p><div>

</div><!-- Field: Page; Sequence: 15; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">disruptions in the global economy, including high rates of inflation, the ongoing conflict in Israel and Palestine, the war in Ukraine, and the impact of pandemics, epidemics or disease outbreaks may adversely affect our business, results of operations and financial condition;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Latin America has experienced, and may continue to experience, adverse economic or political conditions, including considerable economic uncertainty that may impact our business, results of operations and financial condition; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">economic and political developments in Argentina, including regulations and restrictions, inflation and government controls may adversely affect the economy and our financial condition and results of operations.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks Relating to Our Industries</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We are subject to the following
risks in respect of our industries:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the overall agricultural, nutraceutical and food ingredient industries are susceptible to commodity price changes, and we are exposed to market risks from changes in commodity prices;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we are subject to industry-specific risks, which could adversely affect our operating results;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">climate change and adverse weather conditions may negatively affect our business and operations; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our crop productivity business is highly seasonal and affected by factors beyond our control, which may cause our sales and operating results to fluctuate significantly.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks Related to Our Intellectual Property</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We are subject to the following
risks in respect of our intellectual property rights:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">agreements with our collaborators and third parties may not adequately prevent disclosure of trade secrets, know-how and other proprietary information, which could lead to a loss of competitive advantage, and adversely affect our technology and business;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we and our customers depend on patents, copyrights, trademarks, know-how, trade secrets, and other forms of intellectual property protections, but these protections may not be adequate;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">biotechnology patents and patent applications involve highly complex legal and factual questions, which, if determined adversely to us, could adversely affect our competitive position;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we will not seek to protect our intellectual property rights in all jurisdictions throughout the world and we may not be able to adequately enforce our intellectual property rights even in the jurisdictions where we have sought protection;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we may be unsuccessful in developing, licensing or acquiring intellectual property rights that may be required to develop and commercialize our future products;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we or our customers may infringe intellectual property unknowingly and unintentionally affecting our reputation and our future plans for our products and competitiveness;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">potential litigation relating to third party intellectual property rights infringement could prevent us from using certain technologies and products; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">requirements to pay royalties to employees who develop inventions commercialized by us may increase our operational costs.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 16; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks Relating to Laws and Regulation</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We are subject to the following
risks in respect of the relevant laws and regulation:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the regulatory environment in the United States for our current and potential future products is evolving and may change in the future, adversely affecting the speed and cost to launch our potential future products;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the regulatory environment outside the United States varies greatly from jurisdiction to jurisdiction and there is less certainty over how our products will be regulated;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">government policies and regulations, particularly those affecting the agricultural sector and related industries, could adversely affect our operations and profitability;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we may use biological materials in our business and are subject to numerous environmental, health and safety laws and regulations. Compliance with such laws and regulations and any claims relating to improper handling, storage or disposal of these materials could be time consuming and costly;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">tax, legislative or regulatory initiatives, new interpretations or developments concerning existing tax laws, or challenges to our tax positions could adversely affect our results of operations and financial condition;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we are subject to governmental export and import controls that could impair our ability to compete in international markets and subject us to liability if we are not in compliance with applicable laws;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure to comply with the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act 2010 and similar laws associated with our activities in other jurisdictions could subject us to penalties and other adverse consequences;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the JOBS Act permits &#8220;emerging growth companies&#8221; like us to take advantage of certain exemptions from various reporting requirements applicable to other public companies that are not emerging growth companies; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we are an early-stage global company, operating in several jurisdictions and we may inadvertently omit any labor or civil registration law due to lack of qualified personnel.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks Relating to the Company</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We are subject to the following
risks in respect of our operating as a public company:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we will incur increased costs as a result of operating as a public company whose shares are listed on the Nasdaq, and its management will devote substantial time to new compliance initiatives;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our management has limited experience in operating a public company;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as we became a publicly traded company by means of consummating a de SPAC business combination, as opposed to an underwritten initial public offering, the process did not use the services of one or more underwriters, which resulted in less diligence being conducted; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the resignation of Nomura as our exclusive financial advisor may indicate that it is unwilling to be associated with the disclosure in SEC filings and the underlying business analysis related to the de SPAC business combination.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in"></p><div>

</div><!-- Field: Page; Sequence: 17; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Additional Risks Relating to Our Securities</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our shareholders are subject
to the following risks:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">sales of a substantial number of our securities in the public market by our existing securityholders, including our major shareholders, management and Nomura (pursuant to the Nomura Purchase Agreement), could cause the price of our Ordinary Shares and warrants to decrease significantly;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">there can be no assurance that we will be able to comply with the continued listing standards of the Nasdaq Global Select Market, which may result in restrictions to our listing and trading volume;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if our Ordinary Shares become subject to the penny stock rules, it may be more difficult to sell our Ordinary Shares;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the price of our securities may be volatile, and their value may decline;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our warrants are exercisable for our Ordinary Shares, which will increase the number of shares eligible for future resale in the public market and result in dilution to our shareholders;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a market for our securities may not continue, which would adversely affect the liquidity and price of our Ordinary Shares and Warrants;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if securities or industry analysts cease publishing research or reports about us, our business, or our market, or if they change their recommendations regarding Ordinary Shares adversely, then the price and trading volume of Ordinary Shares could decline; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we do not intend to pay dividends for the foreseeable future and, as a result, your ability to achieve a return on your investment will depend on appreciation in the price of our Ordinary Shares.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks Relating to Investment in a Cayman Islands
Company and Our Status as a Foreign Private Issuer</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as a &#8220;foreign private issuer,&#8221; we are exempt from a number of U.S. securities laws and rules promulgated thereunder and will be permitted to publicly disclose less information than U.S. public companies must disclose. This may limit the information available to holders of the Ordinary Shares and may pose additional risks and less regulatory protection for our shareholders in comparison to domestic issuers;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we may lose our foreign private issuer status in the future, which could result in significant additional costs and expenses, and this would subject us to GAAP reporting requirements which may be difficult for us to comply with;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">because we are incorporated under the laws of the Cayman Islands you may face difficulties in protecting your interests, and your ability to protect your rights through the U.S. Federal courts may be limited; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the rights of our shareholders may differ from the rights they would have as shareholders of a United States corporation, which could adversely impact trading in Ordinary Shares and our ability to conduct equity financings.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks Relating to U.S. Tax</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt">we believe we likely were a passive foreign investment company for
U.S. federal income tax purposes for our taxable year ending June 30, 2025, and may be a PFIC for our current taxable year or future taxable
years which could subject U.S. holders of the Ordinary Shares to adverse U.S. federal income tax consequences.</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 18; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks Related to Our Business and Operations</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may face difficulties implementing our
inorganic growth strategy, including in respect of integrating the operations of the business we have acquired or expect to acquire in
the future.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">From time to time, we may
acquire businesses, assets, or securities of companies that we believe will provide a strategic fit with our business, such as the Business
Combination with Bioceres Group, Nutrecon LLC, Nordelis, Union Group Ventures Limited, and Gentle Technologies Corp, which closed on June
16, 2025. We integrate acquired businesses with our existing operations, our overall internal control over financial reporting processes,
and our financial, operations, and information systems. If the financial performance of our business, as supplemented by the assets and
businesses acquired, does not meet our expectations, our results of operations may fail to meet market expectations, and we may face difficulties
servicing our debt obligations. We may not be able to effectively assimilate the business or product offerings of acquired companies into
our business or within the anticipated costs or timeframes, retain key customers and suppliers or key employees of acquired businesses,
or successfully implement our business plan for the combined business. In addition, our final determinations and appraisals of the estimated
fair value of assets acquired and liabilities assumed in our acquisitions may vary materially from earlier estimates and we may fail to
realize fully anticipated cost savings, growth opportunities or other potential synergies. We cannot assure that the fair value of acquired
businesses or investments will meet prior expectations or will not decrease.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Integration with Bioceres Group, Nutrecon
LLC, Nordelis, Union Group Ventures Limited, and Gentle Technologies Corp, may not be successful in achieving their intended benefits,
cost savings and synergies and may disrupt current operations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The integration process of
any newly acquired company may be complex, costly and time-consuming. The potential difficulties of integrating the operations of an acquired
business and realizing our expectations for an acquisition, include, among other things:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">failure of the business to perform as planned following the
acquisition or achieve anticipated revenue or profitability targets;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">delays, unexpected costs or difficulties in completing the integration
of acquired companies or assets;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">higher than expected costs, lower than expected cost savings
or synergies and/or a need to allocate resources to manage unexpected operating difficulties;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">difficulties assimilating the operations and personnel of acquired
companies into our operations;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">diversion of the attention and resources of management or other
disruptions to current operations;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">the impact on our or an acquired business&#8217; internal controls
and compliance with legal requirements</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">ineffective or inadequate controls, procedures, or policies
at the acquired company&#894;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">multiple product lines or service offerings, as a result of
our acquisitions, that are offered, priced, and supported differently&#894;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">adverse effects on our existing business relationships with
business partners and customers as a result of the acquisition&#894;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">potential write-offs of acquired assets and potential financial
and credit risks associated with acquired customers&#894;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">inability to maintain relationships with key customers, suppliers,
and partners of the acquired business&#894;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">lack of experience in new markets, products, or technologies&#894;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">diversion of management&#8217;s attention from other business
concerns&#894;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">use of resources that are needed in other parts of our business&#894;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">retaining key customers, suppliers and key personnel;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 19; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">retaining and obtaining required regulatory approvals, licenses
and permits;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">operating risks inherent in the acquired business and our
business;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">lower than anticipated demand for product offerings by us
or our licensees; and</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">unanticipated issues, debt, expenses and liabilities, including
those arising from existing contractual obligations or litigation matters.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our failure to successfully
implement the restructuring process initiated following the Business Combination or to complete the integration of any acquired business
and any adverse consequences associated with future acquisition activities, could have an adverse effect on our business, financial condition
and operating results.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Completed acquisitions may
result in additional goodwill and/or an increase in other intangible assets on our balance sheet. We are required annually, or as facts
and circumstances exist, to assess goodwill and other intangible assets to determine if impairment has occurred. If the testing performed
indicates that impairment has occurred, we are required to record a non-cash impairment charge for the difference between the carrying
value of the goodwill or other intangible assets and the implied fair value of the goodwill or the fair value of other intangible assets
in the period the determination is made. We cannot accurately predict the amount and timing of any potential future impairment of assets.
Should the value of goodwill or other intangible assets become impaired, there could be a material adverse effect on our financial condition
and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our financial statements for the year ended
June 30, 2025 state that there is substantial doubt about our ability to continue as a &#8220;going concern&#8221;.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As of June 30, 2025, we had a working capital deficit of US$204.9 million.
Our financial statements for the year ended June 30, 2025 state that there is substantial doubt about our ability to continue as a going
concern. While management plans to continue to focus on improving operational efficiency and cost reductions to improve our working capital,
there can be no assurances that such plans will be successful. If we are unable to continue as a going concern, we may be required to
liquidate our assets and could receive less than their carrying value as reflected in our financial statements. As a result, investors
may lose all or part of their investment.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We are an early-stage and high-risk company
with a history of losses and we may not achieve or maintain profitability.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our net losses for the year ended June 30, 2025, were US$154.6 million.
As of June 30, 2025, we had an accumulated deficit of US$57.3 million. We will need to generate significant revenues to achieve profitability,
and we may not be able to achieve and maintain profitability in the near future or at all. Our future success will depend, in part, on
our ability to grow revenue associated with further R&amp;D, production partnerships and direct sales to distributors and food producers.
In addition, our growth prospects rely on the successful commercialization and monetization of the HB4 royalties and the fermentation
production platform in Synbio, the latter acquired through the Business Combination. The net losses we incur may fluctuate significantly
from year to year, such that a period-to-period comparison of the results of our operations may not be a good indication of our future
performance. We cannot ensure that we will generate increased revenues, successfully commercialize products or generate revenue from licensing
needed to attain a level of profitable operations, and therefore our business has an inherently high risk of failure. Based on our history
of losses, we do not expect that we will be able to fund our longer-term capital and liquidity needs through our cash balances and operating
cash flow alone. Our current source of capital comes mainly from the issuance of convertible notes to our affiliates and investors. To
fund our longer-term capital and liquidity needs, we expect we will need to secure additional capital. Our business plan and financing
needs are subject to change depending on, among other things, the success of our efforts to increase revenue and our efforts to continue
to effectively manage expenses.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 20; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We have a limited operating history, which
makes it difficult to evaluate our current business and prospects and may increase the risk of investment.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We are an early-stage food-technology
company with a limited operating history that to date has been focused primarily on R&amp;D, conducting scientific research to develop
our products, field trials, pursuing initial commercialization efforts and building our management team in both molecular farming and
fermentation technologies. Investment in food technology development is a highly speculative endeavor. It entails substantial upfront
R&amp;D investment and there is significant risk that we will not be able to insert the genes in a particular plant to express a desired
trait, or, once modified, we will not be able to replicate that trait across entire crops in order to commercialize the product candidate.
Our operations involve investments in fermentation processes that function as biological &#8220;factories&#8221; to produce target proteins,
enzymes, and other biomolecules. However, there is a significant risk that we may not be able to identify, select, or develop the appropriate
microbial or cellular systems required to obtain the desired products at a commercially viable yield, quality, or cost. The complexity
of these biological processes may result in delays, increased development expenses, or the inability to achieve scalable production. Moreover,
the regulatory pathway for our product candidates can be uncertain and could add significant additional cost and time to development and
may ultimately be unsuccessful.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our limited operating history
may make it difficult to evaluate our current business and our prospects. We have encountered, and will continue to encounter, risks and
difficulties frequently experienced by growing companies in rapidly developing and changing industries, including challenges in forecasting
accuracy, determining appropriate investments of our limited resources, gaining market acceptance of the products made using our molecular
farming technology, managing a complex regulatory landscape and developing new product candidates.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In respect to scientific
research to develop our products, we may also face challenges in scaling our supply chain in a cost-effective manner, as we will likely
rely on contracting with third parties to bring our products to market. In addition, there is limited crushing and processing capacity
for our soybean-based and pea-based products which could restrict our ability to scale production of these products. We may be required
to adjust our current operating model in order to efficiently scale our operations. We may not be able to fully implement or execute our
business strategy or realize, in whole or in part within our expected time frames, the anticipated benefits of our growth strategies.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Potential adverse outcome from dispute with
INVIM Corporativo S.L. could have a material adverse effect on our business, results of operations and reputation.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On October 2, 2025, we received
a notice of alleged breach from INVIM Corporativo S.L. asserting that we failed to pay an assignment price of $13 million under an Assignment
and Assumption Agreement dated May 27, 2025. We have rejected INVIM&#8217;s assertion and intend to vigorously defend our position that
no amount is due and payable under the Agreement. Nevertheless, disputes and legal proceedings are inherently uncertain, and if INVIM
were to initiate proceedings and ultimately prevail, we could be required to pay some or all of the claimed amount, as well as interest,
fees, and costs, and we could be subject to other remedies. Any such adverse outcome, or the costs and distractions of defending against
these claims, could have a material adverse effect on our business, financial condition and results of operation. In addition, the dispute
could divert management attention, increase legal and advisory expenses, and create reputational risk. See Item 8 &#8211; <i>Financial
Information &#8211; &#8220;Notice of Alleged breach</i>&#8221;.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Price increases and shortages of raw materials
could adversely affect our results of operations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our results of operations
may be affected by the availability and pricing of raw materials, principally materials needed in our crushing and ingredients development
facility, such as soybean. Factors such as changes in the global or regional levels of supply and demand, weather conditions, seasonal
fluctuations, shortages or interruptions, changes in global climates and government regulations could substantially impact the price of
raw materials. These and other factors could also cause plant shutdowns, reductions in capacity, delays and increased costs with associated
manufacturers. To the extent we are unable to pass on increases in raw materials and energy prices to our customers, a substantial increase
in raw material prices or a continued interruption in supply could have a material adverse effect on our business, financial condition
and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 21; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our failure to accurately forecast and manage
inventory could result in unexpected shortfalls or surpluses of products, which could harm our business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We are required to produce
inventories of certain of our products (mainly seeds) and we monitor our inventory levels based on our own projections of future demand.
Because of the significant time it takes to produce commercial quantities of seeds, production decisions must be made well in advance
of sales. An inaccurate forecast of demand for any seed variety can result in the unavailability of seeds in high demand. Such unavailability
may depress sales volumes and adversely affect customer relationships. Conversely, an inaccurate forecast could also result in an over-supply
of seeds which may increase costs, adversely affect cash flow, reduce the quality of inventory and ultimately result in inventory write-offs,
which could have a material adverse effect on our business, results of operations and financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our future revenue depends on the success
of our technologies portfolio and product developments, including our extrusion, fermentation, molecular farming and other technologies.
We have limited data on the performance of such technologies to date, and our product development depends on assumptions that are are
inherently uncertain.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our technology portfolio
includes GLASO, which is fully approved for cultivation and commercialization in the United States, HB4 technology, which is fully approved
for cultivation and commercialization in the United States for soybeans and wheat, among other jurisdictions; Eternal precision fermentation
technology; and SPC technology, which has approvals for cultivation and commercialization in other jurisdictions, mainly in Argentina.
We have successfully achieved approval for cultivation in US territory for our Piggy Sooy&#8482; and PEEA1 crops through Regulatory Status
Review clearance from USDA-APHIS. While these technologies provide a diversified platform, certain of them remain in the early stages
of development and commercialization, and there can be no assurance that they will achieve the expected market adoption or financial performance.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">To date, we have limited
data on the ability of our technologies, which consist of developing a nuclear stable transformation of a crop to express a nutritional
oil or an animal protein, within the protein bodies of the seed in order to produce a product consisting not only of the target oil/protein
but the plant oil/protein as well, towards which we have devoted substantial resources to date as well as to the development of fungi-based
alternative proteins.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We may not be successful
in developing our technologies and products in a manner sufficient to support our expected scale-ups and future growth, or at all. We
expect that a substantial portion of our efforts and expenditures over the next few years will be devoted to the development of technologies
and products designed to enable us to market industrial-scale manufacturing processes. We cannot guarantee that we will be successful
in developing these technologies and products on the timeline we expect, or at all, and we may not be able to achieve our anticipated
growth, revenues or profitability needed to continue our operations. If we are able to successfully develop our technologies and products,
we cannot ensure that we will obtain regulatory approval or that, following approval, upon commercialization our technologies and products
will achieve market acceptance. Any such delay or failure would materially and adversely affect our financial condition, results of operations
and prospects. See &#8220;<i>Item 4. Information on the Company&#8212;B. Business&#8212;Overview&#8212;Development Timeline and Process</i>.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We have a significant amount of indebtedness
and may face difficulty servicing all of them, including the convertible notes issued to Insud, Farmers, and BIOX.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As of June 30, 2025, we had US$248.0 million of indebtedness, of which
92% is current. Our ability to make scheduled payments of the principal of, to pay interest on, or to refinance our indebtedness depends
on our future performance, which is subject to many factors, including, economic, financial, competitive and other, beyond our control.
We cannot assure you that our business will generate sufficient cash flow from operations, or that future borrowings will be available
to us in an amount sufficient to enable us to pay our indebtedness or to fund our other liquidity needs.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We may elect to make in-kind
interest payments under the notes issued to Insud through its affiliate INVIM Corporativo S.L., and issued to Farmers, and to BIOX, which
will be capitalized. However, if we elect not to convert the Convertible Notes into ordinary shares at maturity, we will be required to
pay the principal thereof in cash. Our ability to refinance the convertible notes will depend on the financial markets and our financial
condition at such time. See <i>&#8220;Item 5. Operating and Financial Review and Prospects&#8212;B. Liquidity and Capital Resources&#8221;</i>
and &#8220;<i>Item 7. Major Shareholders and Related Party Transactions&#8212;B. Related Party Transactions&#8212;Convertible Note issued
to Bioceres Crop Solutions Corp.</i>&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Conversion of the convertible notes, preference
shares and warrants that we have issued, and issuance of shares pursuant to our share option plan would increase the number of ordinary
shares and result in a significant dilution to shareholders.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On October 15, 2023, we issued
to Insud through its affiliate INVIM Corporativo S.L. an aggregate principal amount of US$10 million convertible notes (due 2026), pursuant
to a note purchase agreement among us and Insud, which, in accordance with our ongoing restructuring process, is currently under review.
In addition, on December 4, 2023, we issued to Farmers a convertible note (due 2026) in an aggregate principal amount of US$940,000, while
on September 17, 2024, we issued to BIOX a convertible note (due 2027) in an aggregate principal amount of approximately US$6.6 million
which, in accordance with our ongoing restructuring process, is currently under review.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 22; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On December 9, 2024, Bioceres
Group issued to Agriculture Investment Group Corp preference shares that are convertible into Ordinary Shares of the Company in an aggregate
principal amount of US$15 million. Such preference shares accrue a PIK amount of 9% per annum (the &#8220;PIK Amount&#8221;), which the
holder (along with the base number of preference shares) has a right to convert into Ordinary Shares within two years of the Business
Combination Closing.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On the Business Combination
Closing Date, we issued to Nordelis 500,000 warrants to acquire Ordinary Shares of the Company, exercisable within three years of such
date.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The convertible notes we
have issued to Insud, BIOX, Farmers, alongside the preference shares issued to Agriculture Investment Group Corp, and the warrants issued
to Nordelis may be converted into our ordinary shares. The issuance of a substantial number of additional ordinary shares upon conversion
of the notes, warrants and preference shares that we have issued and expect to issue will result in a significant dilution to the then
existing holders of our ordinary shares and will increase the number of ordinary shares in the public market. Sales of substantial numbers
of such ordinary shares in the public market could adversely affect the market price of our ordinary shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Further, the issuance of
Ordinary Shares pursuant to the Incentive Plan, approved by our Board of Directors on September 20, 2024, may further contribute to the
dilution of the ownership held by our current shareholders, as the vested shares under the Incentive Plan can be substantially sold in
the public market, and lead to an adverse effect on the market price of our Ordinary Shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Defaults by BSA and Bioceres LLC could materially adversely affect
our financial conditions</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In June 2025, Bioceres S.A., one of our Argentine subsidiaries, defaulted
on a portion of its financial debt that was due that month. As a result, Bioceres S.A. has initiated a debt restructuring process for
its financial debt, which amounts to US$36.4 million. In July 2025, Bioceres LLC, a wholly owned subsidiary of Bioceres S.A., received
a notice of default on its financial debt in the amount of US$69.5 million. The creditor of Bioceres LLC conducted a public auction of
3,062,500 pledged BIOX shares pursuant to the New York Uniform Commercial Code and a sale on the open market of the 437,500-remaining
pledged BIOX shares. As of the date of this report, the current debt amounts to US$58.0 million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">There are no cross-default
clauses on the remaining financial debt of the Group. However, defaults by Bioceres S.A. and Bioceres LLC may materially and adversely
affect the Group&#8217;s financial condition, ability to obtain credit, reputation or results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">After June 30, 2025, the Company initiated voluntary bankruptcy proceedings in relation to Theo I SCSp, Bioceres
S.A. and Bioceres LLC <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as follows:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Theo I SCSp</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On November 28, 2025, subsequent
to the reporting date, Theo I SCSp received a conditional payment order from district court of&#160; Luxembourg, and therefore the General
Partners engaged Ogier (Luxembourg) SCS represented by its general partner Ogier Luxembourg (GP) S.&#224;.r.l&#160; formally as their
legal advisor to assist with Theo I SCSp&#8217;s declaration of bankruptcy before the Luxembourg District Court. The declaration of bankruptcy
will declare Theo I SCSp bankrupt and appoint a receiver who will take control over the management of the company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The loss of control constitutes
the derecognition event under IFRS 10.25. This will result in the recognition of an estimated gain of US$9.5 million in the consolidated
statement of profit or loss as of the derecognition date.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Bioceres S.A. and Bioceres LLC</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On December 16, 2025, subsequent
to the reporting date, the Board of Directors of Bioceres S.A. formally approved the initiation of voluntary bankruptcy proceedings and
instructed management to seek and appoint a trustee (&#8220;<i>s&#237;ndico</i>&#8221;) to oversee the process. The commencement of
the voluntary bankruptcy proceedings and the transfer of decision-making authority to the trustee will result in the Group losing control
over Bioceres S.A. in accordance with the principles of IFRS 10. As Bioceres LLC is a wholly owned subsidiary of Bioceres S.A., the Group
simultaneously will lose  control over Bioceres LLC as well.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The loss of control constitutes
the derecognition event under IFRS 10.25. This will result in the recognition of an estimated gain of US$91.0 million and US$5.3 million
in the consolidated statement of profit or loss as of the derecognition date, related to the loss of control of Bioceres S.A. and Bioceres
LLC (including the loss of holding in BIOX, therefore it will no longer be an equity method associate)., respectively.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We will likely require additional financing
to achieve our goals, and failure to obtain necessary capital when needed on acceptable terms, or at all, may force us to delay, limit,
reduce or terminate our product manufacturing, development and other operations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We believe that we will continue
to expend substantial resources for the foreseeable future as we expand into additional markets we may choose to pursue. These expenditures
are expected to include costs associated with R&amp;D, the acquisition or expansion of manufacturing and supply capabilities, as well
as the marketing and selling of new products. In addition, other unanticipated costs may arise.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our operations may change
because of factors that are currently unknown to us, and we may need to seek additional funds sooner than planned, including through public
equity or debt financings or other sources, such as the issuance of convertible notes or strategic collaborations. Such financing may
result in dilution to our existing shareholders, imposition of debt covenants and repayment obligations, or other restrictions that may
adversely affect our business. In addition, we may seek additional capital due to favorable market conditions or strategic considerations
even if we believe we have sufficient funds for our current or future operating plans.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 23; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our future capital requirements
depend on many factors, including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the number and characteristics of any additional products or manufacturing processes we develop or acquire to serve new or existing markets;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the expenses associated with our marketing initiatives;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">investment in manufacturing to expand manufacturing and production capacity;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the costs required to fund domestic and international growth;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the scope, progress, results and costs of researching and developing future products or improvements to existing products or manufacturing processes;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any lawsuits related to our products or team that may be commenced against us;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the expenses needed to attract and retain skilled personnel;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the costs associated with being a public company; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the timing, receipt and number of sales of future products.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Additional funds may not
be available when we need them, on terms that are acceptable to us, or at all. If adequate funds are not available on a timely basis,
we may be required to:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">delay, limit, reduce or terminate our manufacturing, research and development activities or growth and expansion plans; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">delay, limit, reduce or terminate the expansion of sales and marketing capabilities or other activities that may be necessary to generate revenue and increase profitability.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may face difficulties implementing our
inorganic growth strategy, including identifying suitable targets and integrating acquired operations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">From time to time, we may
acquire businesses, assets, or securities of companies that we believe will provide a strategic fit with our business, such as the ValoraSoy
Acquisition. We integrate acquired businesses with our existing operations; our overall internal control over financial reporting processes;
and our financial, operations, and information systems. If the financial performance of our business, as supplemented by the assets and
businesses acquired, does not meet our expectations, our results of operations may fail to meet market expectations. We may not effectively
assimilate the business or product offerings of acquired companies into our business or within the anticipated costs or timeframes. In
addition, we may be unable to retain key customers and suppliers or key employees of acquired businesses or successfully implement our
business plan for the combined business. Further, our final determinations and appraisals of the estimated fair value of assets acquired
and liabilities assumed in our acquisitions may vary materially from earlier estimates and we may fail to realize fully anticipated cost
savings, growth opportunities or other potential synergies. We cannot assure that the fair value of acquired businesses or investments
will meet prior expectations or will not decrease.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may acquire businesses, patents or products,
or form strategic alliances, in the future, and we may not realize the benefits of such acquisitions or alliances.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We plan to selectively partner,
in-license or acquire key enabling technologies, patents and businesses across our value chain that we believe will keep us on the cutting
edge of our industry. We currently have GLA exclusive licensing agreement with Arcadia Biosciences, Inc. for the commercialization of
GLA worldwide. However, we may not be able to identify additional suitable targets or make acquisitions under satisfactory conditions,
in particular on satisfactory price conditions. In addition, we may be unable to obtain the financing for these acquisitions in the context
of existing operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 24; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">If we acquire businesses
within promising markets or which hold promising technologies, we may not be able to realize the benefit of acquiring such businesses
if we are unable to successfully integrate them with our existing operations and company culture. The integration process of any newly
acquired company may be complex, costly and time-consuming, and our failure to successfully complete this process could have an adverse
effect on our business, financial condition and operating results. The potential difficulties of integrating the operations of an acquired
business and realizing our expectations for an acquisition, including the benefits that may be realized, include, among other things:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure of the business to perform as planned following the acquisition or achieve anticipated revenue or profitability targets;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">delays, unexpected costs or difficulties in completing the integration of acquired companies or assets;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">higher than expected costs, lower than expected cost savings or synergies and/or a need to allocate resources to manage unexpected operating difficulties;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">difficulties assimilating the operations and personnel of acquired companies into our operations;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">diversion of the attention and resources of management or other disruptions to current operations;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the impact on our or an acquired business&#8217; internal controls and compliance with legal requirements;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">retaining key customers, suppliers and key personnel;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">retaining and obtaining required regulatory approvals, licenses and permits;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">operating risks inherent in the acquired business and our business;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">lower than anticipated demand for product offerings by us or our licensees; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">unanticipated issues, expenses and liabilities.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We may also encounter numerous
difficulties in developing, manufacturing and marketing any new products resulting from a strategic alliance or acquisition that delay
or prevent us from realizing their expected benefits or enhancing our business. We cannot assure that, following any such acquisition,
we will achieve the expected synergies to justify the transaction, which could have a material adverse effect on our business, financial
conditions, earnings and prospects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If we fail to effectively utilize or expand
our manufacturing and production capacity or the commercialization or license of our intellectual property, our business, results of operations
and brand reputation could be harmed.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">If we do not have sufficient
capacity to meet our customers&#8217; demands and to satisfy increased demand, we will need to expand our operations, supply, and manufacturing
capabilities. However, there is risk in our ability to effectively scale production processes and effectively manage our supply chain
requirements. As we continue to scale our production, we must accurately forecast demand for our products in order to ensure we have adequate
available manufacturing capacity. We currently do not know what impact any current supply chain disruptions, including but not limited
to labor shortages, consumer demand, challenges related to the war in Ukraine, challenges related to the conflict in Israel and Palestine,
or export restrictions will have on our business. Our forecasts are based on multiple assumptions which may cause our estimates to be
inaccurate and affect our ability to obtain adequate manufacturing capacity (whether our own manufacturing capacity or co-manufacturing
capacity) in order to meet the demand for our products, which could prevent us from meeting increased customer demand and harm our brand
and our business and in some cases may result in penalties we must pay customers or distributors if we are unable to fulfill orders placed
by them in a timely manner or at all.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 25; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">However, if we overestimate
our demand and overbuild our capacity, we may have significantly underutilized assets and may experience reduced margins. If we do not
accurately align our manufacturing capabilities with demand, if we experience disruptions or delays in our supply chain, or if we cannot
obtain raw materials of sufficient quantity and quality at reasonable prices and in a timely manner, our business, financial condition
and results of operations may be materially adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may face difficulties in collecting payments
or royalties, which could have an adverse impact on our business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our customers, distributors
and other counterparties may delay or fail to make payments owed to us under sales or service agreements, royalty agreements or licensing
agreements. Counterparty non-payment or late payment may result from a variety of factors, including liquidity constraints among market
participants, volatile commodity prices, crop failures or adverse weather events. Disputes regarding contract interpretation, performance,
quality, or measurement can also delay or reduce our collections.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Any sustained inability to
collect payments or royalties when due could materially adversely affect our liquidity and financial condition. We may also be required
to modify contract terms or extend additional credit, and there can be no assurance that these measures will be successful or that we
will recover amounts owed in full.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our HB4 technology business depends on the
success of the exclusive license granted to BIOX</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">BIOX may delay or fail to
make payments owed to us under the HB4 exclusive license agreement. Counterparty non-payment or late payment may result from a variety
of factors, including liquidity constraints among market participants, volatile commodity prices, crop failures or adverse weather events.
Disputes regarding contract interpretation, performance, quality, or measurement can also delay or reduce our collections. Any sustained
inability to collect payments or royalties when due could materially adversely affect our liquidity and financial condition. We may also
be required to modify contract terms and or termination, and there can be no assurance that these measures will be successful or that
we will recover amounts owed in full.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We operate in a privately owned facility
conducting research with third-parties under lease and service agreements with private companies and research universities.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We conduct our research by
means of lease and service agreements and contracts with universities and private companies. We cannot guarantee that these arrangements
will be successful and yield the expected results, and that the engaged third parties will not make errors in their research activities
or breach their obligations to us, which could result in substantial losses to us.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our current operations depend in part on
third-party agreements for supplies required to develop and scale our production and increase our stock of seed, feedstock, biomass and
other raw materials.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Currently, our operations
require an increase in the stock of our seeds and product development for our safflower platform, as well as R&amp;D of soy and pea platforms
since we have not yet reached the production stage. The seeds that we are developing in R&amp;D stages are the primary raw materials necessary
for the development of our portfolio.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In addition, our current
operations require the use of chemical solvents, equipment, filters, and other research materials in order to increase our stock of viable
seeds. The suppliers of these products manufacture their products at a limited number of facilities. A natural disaster, fire, power interruption,
work stoppage or other calamity affecting any of these facilities, or any interruption in their operations, could adversely affect our
ability to obtain required quantities of plant proteins in a timely manner, or at all, which could materially reduce our net product sales
and have a material adverse effect on our business and financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Further, pursuant to the
BIOX Soy Supply Agreement with Bioceres, we will pay a premium in respect of HB4&#174; soy. We may not be able to translate this cost relating
to higher raw materials into end products, which would adversely affect on our gross margins. Bioceres may be affected by negative weather
factors that may impact their capacity to deliver soy to us. If Bioceres is unable to deliver soy to us pursuant to the BIOX Soy Supply
Agreement, that could adversely affect on our cash position. See &#8220;<i>Item 7. Major Shareholders and Related Party Transactions&#8212;B.
Related Party Transactions&#8212;Convertible Note issued to Bioceres Crop Solutions Corp</i>.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 26; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Reliance on third parties to grow our seeds
could adversely affect our business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We rely on third-party parties
to grow our seeds. If such third parties fail to meet our standards or contractual obligations, or if we are unable to continue to work
with qualified partners on commercially acceptable terms, our business and results of operations could be materially adversely affected.
In addition, potential disputes with or insolvencies or financial distress of our partners could disrupt our supply chain. If we are unable
to successfully manage business risks arising from our reliance on third party growers or replace them in a timely manner and on terms
satisfactory to us, our results of operations could be materially adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We are developing a customer base for our
fermentation and molecular farming-derived products, and our failure to expand that base could adversely affect our sales and profitability.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">If customers do not perceive
our product offerings to be of sufficient value, quality or innovation, or if we fail to offer innovative and relevant product offerings,
and if we fail to develop a suitable pricing strategy, we may not be able to attract customers to purchase our products. We are focused
on engineering plants to produce foreign molecules, such as oils or certain animal proteins. This is a technology that has not been widely
introduced to the markets that we target and will require sufficient education to show the difference between our technology and other
science-based food ingredients. In addition, our products could face difficulties in some jurisdictions due to regulatory requirements.
If producers face challenges in adopting our products, if we are unable to adequately educate our customers and develop commercial relationships
while emphasizing the difference in our technology, our sales and profitability may be adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We face significant competition and many
competitors have substantially greater financial, technical, and other resources than we do.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We face substantial competition
in the development and commercialization of science-based food ingredients, including those derived from molecular farming, precision
fermentation, and texturized plant-based protein technologies. Many of our competitors have significantly greater financial, technical,
regulatory, and commercial resources than we do.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our competitors include other
molecular farming-focused companies (such as AlpineBio, Finally Foods, IngredientWerks Inc., Kyomei, Miruku Limited, Mooza Foods, NewMoo,
PoLoPo Inc.), as well as companies active in the broader alternative protein and synthetic biology sectors (such as Impossible Foods Inc,
Paleo and Ginko Bioworks, among others). Additionally, we compete with established ingredient suppliers such as Givaudan Group, International
Flavors &amp; Fragrances, DSM - Firmenich and Novonesis (Chr. Hansen).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">These companies often have
larger R&amp;D teams, more advanced manufacturing capabilities, and extensive commercial and supply chain networks. As a result, we may
not be able to match their development pace, scale of production, or pricing flexibility. Furthermore, ongoing technological advancements
in areas such as genetic engineering and precision fermentation could render our products less competitive or obsolete.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our ability to compete effectively
depends, in part, on our success in controlling production costs, accelerating product development, improving supply chain efficiency,
and driving customer adoption across our product portfolio &#8211; including our Valora line of soy and legume-based texturized proteins.
Failure to achieve these objectives, or the emergence of superior technologies or business models by competitors, could adversely affect
our business, operating results, and prospects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>To compete effectively, we must introduce
and improve existing and new products that achieve market acceptance and enhance the output of our technology.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">To compete effectively and
generate revenue, we must successfully advance and commercialize products from our molecular farming, precision fermentation, and plant-based
ingredient platforms. This requires us to improve existing products, introduce new ones from our development pipeline, and demonstrate
the technical and economic feasibility of our technologies. Failure to anticipate or respond to technological advances, regulatory changes,
consumer requirements, or shifts in consumer preferences could adversely affect our ability to generate revenue.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 27; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The development of ingredients
and proteins using molecular farming and precision fermentation is inherently complex, costly, and time-consuming, often requiring multiple
years of laboratory, greenhouse, and field trials. Significant investments and commitments - including R&amp;D resources and potential
licensing or milestone payments &#8211; are often required before knowing whether the product will achieve technical success, regulatory
approval, or market acceptance.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Products under
development face several risks, including: &#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Difficulty in scaling agricultural production due to climatic variability or cost overruns;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Low farmer adoption of crops expressing target proteins;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Field performance variability; </span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delays or denials in regulatory approvals in intended markets; </span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Higher-than-expected processing or production costs; </span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rapid shift in consumer preference or regulatory environment affecting demand;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Competition from products with superior taste, functionality, or cost; </span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Challenges in achieving scalable and economical production; </span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inability to secure, maintain, or commercialize relevant intellectual property rights; </span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emergence of superior or equivalent technologies developed by third parties; and </span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exposure to nature or climate-related risks.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Accordingly, if we experience
any significant delays in the development or introduction of new products or if our new products do not achieve market acceptance, our
business, operating results and financial conditions would be adversely affected. See <i>&#8220;Item 4. Information on the Company&#8212;B.
Business Overview&#8212;Development Timeline and Process</i>.<i>&#8221;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Collaboration agreements we may seek to
enter into with third parties may not be accomplished or successful.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We may seek to enter into
collaboration arrangements with third parties for the development or commercialization of our products, such as the Bunge Collaboration
Agreement. We will face, to the extent that we decide to enter into collaboration arrangements, significant competition in seeking appropriate
partners. Moreover, collaboration arrangements are complex and time-consuming to negotiate, document, implement, and maintain. Further,
we cannot guarantee that such collaboration agreements will be renewed on commercially acceptable terms. We may not be successful in our
efforts to establish and implement collaboration, or other alternative arrangements should we so choose to enter into such arrangements.
The terms of any collaborations or other arrangements that we may establish may not be favorable to us. Any collaboration/marketing/wholesale/research
agreements that we may enter into in the future may not be successful, which could adversely affect our ability to develop and commercialize
our product candidates.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 28; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The successful commercialization of our
products significantly depends mainly on our ability to produce high-quality products cost-effectively at scale, accurately forecast
the demand for them, and to obtain the necessary regulatory approvals.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The production of commercial-scale
quantities of seeds and products requires the multiplication of the plants or seeds through a succession of plantings and seed harvests.
The cost-effective production of high-quality, high-volume quantities of any product candidates we successfully develop depends on our
ability to scale our production processes to produce plants and seeds in enough quantity to meet demand. We cannot assure that our existing
or future seed production techniques will enable us to meet our large-scale production goals cost-effectively. Even if we are successful
in developing ways to minimize yield drag and enhance quality, we may not be able to do so cost-effectively or on a timely basis, which
could adversely affect our ability to achieve profitability. If we are unable to maintain or enhance the quality of our plants and seeds
as we increase our production capacity, including through the expected use of third parties to have access to industrial availability
for processing and purification, we may experience reductions in customer or farmer demand, higher costs and increased inventory write-offs.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In addition, because of
the length of time it takes to produce commercial quantities of marketable seeds, we will need to make seed production decisions well
in advance of product sales. The process that we may use to produce oil and concentrate and isolate proteins is based on technologies
currently being used in the industry. We have access to a pilot plant where the wet-concentration process for protein recovery is being
validated. Our ability to accurately forecast supply can be adversely affected by several factors outside of our control, including unexpected
challenges in the process, changes in market conditions, environmental factors, such as pests and diseases, and adverse weather conditions.
A shortfall in the supply of our products may reduce product revenue, damage our reputation in the market, and adversely affect relationships.
Any product surplus we have on hand may adversely affect cash flows, reduce the quality of our inventory, and ultimately result in write-offs
of inventory. While we estimate that the potential size of our target markets for our products is significant, that estimate has not
been independently verified and is based on certain assumptions that may not prove to be accurate. Our ability to accurately forecast
demand is dependent on the timing of customer decisions, qualification cycles, and other factors outside of our control. As a result,
these estimates could differ materially from actual market sizes, which could result in decreased demand for our products and therefore
adversely impact our future business prospects, results of operation and financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our products require specific storage measures
and have a limited shelf life, which may not align with operational or market expectations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our products are subject
to specific measures with regard to their maintenance in storage, particularly GLASO. The final product is stored in sealed plastic bags
to prevent changes in moisture that can lead to the acceleration of oxidation, formation of lumps, and alterations of the characteristics
of the product. Sealed bags also prevent the powder from any contact with insects or odors, and delay oxidation. The temperature should
be kept below a specific temperature to prevent microbial growth and oxidation. Direct sunlight in the storage environment should be
avoided. Brown paper bags with a plastic layer inside are advised since they prevent the isolates from light. A change in any of these
conditions may affect the shelf life and the properties of the product significantly, which may consequently adversely affect our business.
See <i>&#8220;Item 4. Information on the Company&#8212;B. Business Overview &#8211; Moolec&#8217;s Platforms and Key Products.&#8221;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Commercialization of our products may face
challenges from public perceptions of plant and strain engineered products (GMOs) and from ethical, legal, environmental, health and
social concerns.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The successful commercialization
of our products depends, in part, on public acceptance of molecular farming/bio-engineered, and/or molecular biology-derived products.
The majority of our products are GMOs and negative social perception about GMOs, or our technology may adversely affect our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Consumers may not understand
the nature of our technologies, which consist of the nuclear stable transformation of a crop or microorganism to express an oil or an
animal protein within the protein bodies of the seed or microorganism for the product to consist in an ingredient containing not only
the engineered protein but the plant or host protein as well. Consumers may also not understand the scientific distinction between our
molecular farming products and other plant-based protein or science-based food ingredients products. As a result, they may transfer negative
perceptions and attitudes regarding our products. A lack of understanding of our technologies may also make consumers more susceptible
to the influence of negative information provided by opponents of biotechnology. Some opponents of biotechnology actively seek to raise
public concern about genetic engineering or GMOs by claiming that plant or yeast products developed using biotechnology are unsafe for
consumption or their use poses a risk of causing damage to the environment, or creates legal, social and ethical dilemmas. The commercial
success of our products may be adversely affected by such claims, even if unsubstantiated. In addition, opponents of biotechnology have
vandalized the farmers&#8217; fields where biotech seeds were planted, and facilities used by biotechnology companies. Any such acts
of vandalism targeting the fields of our farmers, our field-testing sites or our research, production or other facilities, could adversely
affect our sales and our costs.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><!-- Field: Page; Sequence: 29; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Negative public perception
about molecular farming and GMO products in general can also affect the regulatory environment in the jurisdictions in which we target
the sale of our products and the commercialization of our product candidates. Any increase in such negative perception or any restrictive
government regulations in response thereto, could have a negative effect on our business and may delay or impair the sale of our products
or the development or commercialization of our product candidates. Even in light of compliance with regulatory protocols or following
receipt of confirmation of non-regulated status in a jurisdiction, public pressure may lead to increased regulation of products produced
using biotechnology, further legislation regarding novel trait development technologies, or administrative litigation concerning prior
regulatory determinations, each of which could adversely affect our ability to sell our product or commercialize our product candidates.
In addition, labeling requirements could heighten public concerns and make consumers less likely to purchase food products containing
plant bioengineered/molecular farming and fermented ingredients.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Market perception, habits and preferences
for our products are difficult to predict and may adversely affect our business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">There are currently many
competitors in the plant-based protein market. For our molecular farming products expressing animal proteins, we expect to be the first
to produce and commercialize an ingredient containing both animal and plant proteins coming from a single source for the food market.
There is a risk that our products will not be as in demand as more traditional plant-based proteins or lab grown meat. A change in preferences
for our products could reduce our sales or our market share and could harm our business and financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Consumer habits and preferences for our
products are difficult to predict and may change rapidly, and if we are unable to respond quickly to new trends, our business may be
adversely affected.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our business is focused
on the development, manufacturing, marketing, and distribution of science-based food ingredients. Consumer demand could change based
on a number of factors, including dietary habits and nutritional values, concerns regarding the health effects of ingredients, and shifts
in preference for various product attributes. If consumer demand for our products decreases, our business and financial conditions would
suffer. In addition, sales of science-based ingredients are subject to evolving consumer preferences to which we may not be able to accurately
predict or respond. Consumer trends that we believe favor sales of our products could change based on a number of possible factors, including
economic factors, social trends such as more sustainable and healthy approaches. Views towards healthy eating and plant-based products
are trendy in nature, with constantly changing consumer perceptions; however, utilizing animal proteins within plants has not been introduced
into the market.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our success will depend,
in part, on our ability to anticipate the tastes and dietary habits of consumers and other consumer trends and to offer products that
appeal to their needs and preferences on a timely and affordable basis. A change in consumer discretionary spending, due to economic
downturn or other reasons, may also adversely affect our sales and business, financial condition and results of operations. A significant
shift in consumer demand away from our products could reduce sales or market share and the perception of our brand, which would harm
our business and financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our business activities are concentrated
in a limited number of locations, making us susceptible to disruptions caused by natural disasters, climatic variations, disease, pests,
or vandalism.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We conduct our activities
in geographic regions that are subject to climate disasters or other natural disasters that could negatively affect our business and
the development and increase of our operations. Natural disasters, such as hurricanes, droughts, fires, floods, tornados, earthquakes,
diseases or pests, or intentional or negligent acts, including acts of vandalism, could damage or destroy our equipment, inventory, development
projects, field trials or data, and could cause us to incur significant additional expenses to repair or replace the damaged physical
facilities, which in the case of seed production may be the result of years of development work that is not easily or quickly reproduced,
and increase the time required to development schedule for our pipeline of product candidates. If our early testing of pipeline products
is unsuccessful, we may be unable to complete the development of product candidates on a timely basis or at all. Additionally, field
trials, which may take years to be concluded, are costly, and any field trial failures that we may experience may not be covered by insurance
and, therefore, could result in increased costs, which may adversely affect our business and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><!-- Field: Page; Sequence: 30; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In addition, we rely on
early testing and research, including laboratory research, greenhouse activities, and field trials, to demonstrate the efficacy of product
candidates that we develop and evaluate. Field trials allow us to test product candidates in the field as well as to increase seed production,
and to measure performance across multiple geographies and conditions. Successful completion of early testing is critical to the success
of our product development and scale-up efforts. Field trials for event selection and field trials for gathering regulatory information
in 2024 occurred in three different locations in the United States. If our ongoing or future testing is unsuccessful or produces inconsistent
results or unanticipated adverse effects on the agronomic performance of our crops, or if the testing does not produce reliable data,
our product development efforts could be delayed, subject to additional regulatory review or abandoned entirely. Further, in order to
support our commercialization efforts, it is necessary to collect data across multiple growing seasons and from different geographies.
Even in cases where initial field trials are successful, we cannot be certain that additional field trials conducted on a greater number
of acres or in different geographies will also be successful.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If our genetically engineered plants or
strains fail to express or produce a sufficient yield of the targeted animal protein, ingredient or function, we may not be able to market
our products in a timely manner or compete effectively.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We rely heavily on the research
and development of our products. We are focused on engineering plants to produce foreign molecules within them, such as oils or certain
animal proteins. This process requires significant research and testing in order to produce a sufficient amount of oil or animal protein
in order to be commercially viable. If the tests of our products do not yield a sufficient amount of the oil or animal protein within
the plant, we may be required to begin the research and development process anew for certain products or spend a significant amount of
time and resources in order to achieve the targeted outcome.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our research and testing
to produce the expected result of oil or animal protein yields within our molecular farmed plants can also be affected by laboratory
conditions, adverse climate conditions during planting and harvesting, or other conditions whereby the expected yield of oil or animal
proteins within the plant are not what we would expect. Such conditions may delay our ability to take our products to market or require
additional time within our research and development stage in order to prepare a viable product. Such delays may have an adverse effect
on our business and operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If we are unable to attract, train and
retain employees, we may not be able to grow or operate successfully.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our success depends in part
on our ability to attract, train and retain a sufficient number of employees who understand and appreciate our culture and business model,
and can effectively represent our brand and establish credibility with potential business partners and customers. The ability, expertise,
motivation, judgment and discretion of our employees, including our technical team, are key to the development of our business. In addition,
our ability to manage our anticipated growth depends on our ability to recruit and retain qualified personnel prepared to face major
challenges with regard to technology and innovation. Our ability to retain our employees is influenced by the economic environment and
the fact that our operations are spread in different locations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Food safety and food-borne illness incidents
or advertising or product mislabeling may materially and adversely affect our business by exposing us to lawsuits, product recalls or
regulatory enforcement actions, increasing our operating costs and reducing demand for our products.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Selling food for human consumption
involves inherent legal and other risks, and there is increasing governmental scrutiny of and public awareness regarding food safety.
Unexpected side effects, illness, injury or death related to allergens, food-borne illnesses or other food safety incidents caused by
products we sell, or involving our suppliers, could result in the discontinuance of sales of these products or our relationships with
such suppliers, or otherwise result in increased operating costs, regulatory enforcement actions or harm to our reputation. Shipment
of adulterated or misbranded products, even if inadvertent, can result in criminal or civil liability. Such incidents could also expose
us to product liability and negligence claims or other lawsuits, including consumer class action lawsuits. Any claims brought against
us may exceed or be outside the scope of our future insurance policy coverage or limits. Any judgment against us that is more than our
policy limits or not covered by our policies or not subject to insurance would have to be paid from our cash reserves, which would reduce
our capital resources.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><!-- Field: Page; Sequence: 31; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The occurrence of food-borne
illnesses or other food safety incidents could also adversely affect the price and availability of affected ingredients, resulting in
higher costs, disruptions in supply and a reduction in our sales. Furthermore, any instances of food contamination or regulatory noncompliance,
whether or not caused by our actions, could compel us, our suppliers, our distributors or our customers, depending on the circumstances,
to conduct a recall in accordance with FDA regulations, and comparable state laws. Food recalls could result in significant losses due
to their costs, the destruction of product inventory, lost sales due to the unavailability of the product for a period of time and potential
loss of existing distributors or customers and a potential material adverse effect on our ability to attract new customers due to negative
consumer experiences or because of an adverse impact on our brand and reputation. The costs of a recall could exceed or be outside the
scope of our future insurance policy coverage or limits.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In addition, food companies
have been subject to targeted, large-scale tampering as well as to opportunistic, individual product tampering, and we, like any food
company, could be a target for product tampering. Forms of tampering could include the introduction of foreign material, chemical contaminants,
and pathological organisms into consumer products as well as product substitution. Recently issued FDA regulations will require companies
like us to analyze, prepare and implement mitigation strategies specifically to address tampering designed to inflict widespread public
health harm. If we do not adequately address the possibility, or any actual instance, of product tampering, we could face possible seizure
or recall of our products and the imposition of civil or criminal sanctions, which could materially adversely affect our business, financial
condition and operating results.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Defective products lawsuits determined
adversely to us could result in substantial damages, for which insurance coverage may not be available.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We may be held liable if
any product we develop, or any product that uses or incorporates any of our technologies, is found unsuitable during marketing, sale
or consumption. For example, the detection of an unintended trait in a commercial seed variety, or the crops and products produced may
result in governmental actions such as mandated crop destruction, product recalls or environmental cleanup or monitoring. The costs of
implementing these remedies could exceed or be outside the scope of our existing or future insurance policies. Concerns about seed quality
could also lead to additional regulations being imposed on our business, such as regulations related to testing procedures, mandatory
governmental reviews of biotechnology advances, or additional regulations relating to the integrity of the food supply chain from the
farm to the finished product.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Limited brand awareness could affect our
ability to sell products.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We have not conducted a
dedicated and significant marketing campaign to educate consumers on our brand and it still has limited awareness among the general public.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We will need to dedicate
significant resources in order to effectively plan, coordinate, and execute a marketing campaign and to add additional sales and marketing
staff. Substantial advertising and promotional expenditures may be required to improve our brand&#8217;s market position or to introduce
new products to the market. However, an increase in our marketing and advertising efforts may not enhance our reputation or lead to an
increase in brand awareness.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Further, we compete against
other large, well-capitalized food and ingredients companies who have significantly more resources than we do. Therefore, we may have
limited success, or none at all, in increasing awareness and reputation of our brand.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Failure to develop our technology, products
and brand, could adversely affect our prospects.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We believe our future growth
could be affected by the perception of our brand and its value. Maintaining, promoting and positioning our brand and its reputation will
depend on, among other factors, the success of our science-based technology for the development of food ingredients, food safety, quality
assurance, marketing efforts, and our ability to provide a consistent, high-quality customer experience. Any negative publicity, regardless
of its accuracy, could adversely affect our business. Brand value is based on perceptions of subjective qualities, and any incident that
erodes the loyalty of customers or suppliers, including adverse publicity, product recall or a governmental investigation or litigation,
could significantly reduce the value of our brand and significantly damage our business, financial condition and results of operation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><!-- Field: Page; Sequence: 32; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Reliance on information-technology systems
exposes us to operational risks, and failures or cyber-attacks could impair our business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We are increasingly dependent
upon third-party information technology systems to operate our business. These systems may contain confidential information (including
personal data, trade secrets or other intellectual property, or proprietary business information). The nature of digital systems, both
internally and externally, makes them potentially vulnerable to disruption or damage from human error and/or security breaches, which
include, but are not limited to, ransomware, data theft, denial of service attacks, sabotage, industrial espionage, cyberattacks or cyber-intrusions
and computer viruses. Further, the risk of a security breach or disruption, particularly through cyber-attacks or cyber-intrusion, including
by computer hackers, foreign governments, and cyber terrorists, has generally increased as the number, intensity and sophistication of
attempted attacks and intrusions from around the world have increased. This risk may be further enhanced as the techniques and tools
used in cyber-attacks have evolved rapidly and now use advanced automation and artificial intelligence. Any of such events may be difficult
to detect, and once detected, their impact may be difficult to assess and address. In addition, if any such event were to occur and cause
interruptions in our operations, it could result in a material disruption of our product development programs. To the extent that any
disruption or security breach was to result in a loss of or damage to our data or applications, or inappropriate disclosure of confidential
or proprietary information, we could incur material legal claims and liability, damage to our reputation, the further development of
our product candidates could be delayed, which could adversely affect our business, financial condition, and operating results, and could
adversely affect our share price.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In addition, the information
technology systems we use may be vulnerable to damage or interruption from circumstances beyond our control, including fire, natural
disasters, power outages, systems failures, malware, and viruses. If we are unable to execute our disaster recovery plans or if our plans
prove insufficient for a particular situation or take longer than expected to implement in a crisis situation, it could have a material
adverse effect on our business, financial condition and results of operations, and our business interruption insurance may not adequately
compensate us for losses that may occur.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We are also subject to numerous
laws and regulations designed to protect personal data, such as the European national laws implementing the General Data Protection Regulation
as well as the UK General Data Protection Regulation. These data protection laws introduced more stringent data protection requirements
and significant potential fines, as well as increased our responsibility and potential liability in relation to personal data that we
process. We have put mechanisms in place to ensure compliance with applicable data protection laws, but there can be no guarantee of
their effectiveness.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We are subject to anti-corruption and anti-money
laundering laws and non-compliance could result in civil or criminal liability.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We are subject to the U.S.
Foreign Corrupt Practices Act of 1977, as amended, the U.S. domestic bribery statute contained in 18 U.S.C.&#167;201, the U.S. Travel
Act, the USA PATRIOT Act, Argentine Law No. 27,401, as amended, and possibly other anti-bribery and anti-money laundering laws in countries
in which we conduct activities. Anti-corruption laws are interpreted broadly and prohibit us and our collaborators from authorizing,
offering, or directly or indirectly providing improper payments or benefits to recipients in the public or private sector. We or our
collaborators may have direct and indirect interactions with government agencies and state-affiliated entities and universities in the
course of our business. We may also have certain matters come before public international organizations such as the United Nations. We
use third-party collaborators, joint venture and strategic partners, law firms, and other representatives for regulatory compliance,
patent registration, lobbying, deregulation advocacy, field testing, and other purposes in a variety of countries, including those that
are known to present a high corruption risk such as India, China, and Latin American countries. We can be held liable for the corrupt
or other illegal activities of these third-party collaborators, our employees, representatives, contractors, partners, and agents, even
if we do not explicitly authorize such activities. In addition, although we have implemented policies and procedures to ensure compliance
with anti-corruption and related laws, there can be no assurance that all of our employees, representatives, contractors, partners, or
agents will always comply with these laws. Noncompliance with these laws could subject us to whistleblower complaints, investigations,
sanctions, settlements, prosecution, other or injunctions, suspension and debarment from contracting with certain governments or other
persons, the loss of export licenses, reputational harm, adverse media coverage, and other negative consequences. If any subpoenas or
investigations are launched, or governmental or other sanctions are imposed, or if we do not prevail in any possible civil or criminal
litigation, our business, results of operations, and financial conditions could be materially harmed. In addition, responding to any
action will likely result in a materially significant diversion of management&#8217;s attention and resources and significant defense
costs and other professional fees. Enforcement actions and sanctions could further harm our business, results of operations, and financial
conditions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><!-- Field: Page; Sequence: 33; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Disruptions in the global economy, including
high rates of inflation, the ongoing conflict in Israel and Palestine, the war in Ukraine and the impact of pandemics, epidemics or disease
outbreaks may adversely affect our business, results of operations and financial condition.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The global economy has been
adversely affected by a variety of factors such as global high rates of inflation, economic crises including recessions and uncertainty
regarding protracted U.S. federal debt ceiling negotiations, actual or threatened war, terrorist activity, political unrest, civil strife,
the spread or fear of spread of contagious diseases in locations where our products are sold, man-made or natural disasters, and other
geopolitical uncertainty. These economic conditions can arise suddenly, and the full impact of such conditions can be difficult to predict.
As a result, we may experience price volatility and increases and supply disruptions, among other consequences. In addition, geopolitical
and domestic political developments, such as existing and potential trade wars and other events beyond our control, such as the ongoing
conflict in Israel and Palestine, in addition to the Ukraine, and a possible escalation of such conflicts or contagion to neighboring
regions, can increase levels of political and economic unpredictability globally and increase the volatility of global financial markets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In addition, the outcome of the most recent U.S. presidential elections
may continue to introduce significant uncertainties in the global economy. Political transitions following the elections, including changes
in leadership and implementation of new policy agendas, may result in shifts in regulatory and fiscal policies, trade agreements, and
other economic factors. The period following the election may also be characterized by volatility in financial markets, currency fluctuations,
and broader economic instability as markets react to actual or anticipated policy changes. Any substantial changes in U.S. foreign or
domestic policies, including modifications to trade agreements, tariffs, or international relations, may impact global economies, including
the Argentine economy and contribute to economic uncertainty and volatility. These developments could negatively influence our financial
results and future growth prospects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Further, our Argentine operations
could be affected by any general business restrictions imposed by the government due to its political and economic instability. These
adverse and uncertain economic conditions may impact distributors, retailers, foodservice, and consumer demand for our products. In addition,
our ability to manage normal commercial relationships with our suppliers, distributors, customers and consumers and creditors may suffer.
Consumers may shift purchases to lower-priced or other perceived value offerings during economic downturns as a result of various factors,
including job losses, inflation, higher taxes, reduced access to credit, change in federal economic policy and international trade disputes.
A decrease in consumer discretionary spending may also result in consumers reducing the frequency and amount spent on plant-based food.
Distributors and customers may become more conservative in response to these conditions and seek to reduce their inventories. Our results
of operations depend upon, among other things, our ability to maintain and increase sales volume with our existing and future customers
and our ability to attract new consumers, the financial condition of consumers and our ability to provide products that appeal to consumers
at the right price. Decreases in demand for products without a corresponding decrease in costs would put downward pressure on margins
and would adversely affect our financial results. Prolonged unfavorable economic conditions or uncertainty may adversely affect our sales
and profitability and may result in consumers making changes to their discretionary spending behavior on a more long-lasting or even
permanent basis.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Latin America has experienced, and may
continue to experience, adverse economic or political conditions, including considerable economic uncertainty that may impact our business,
financial condition and results of operations and financial conditions.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">A major portion of our operations
and/or development activities are based in Latin America. Accordingly, our financial condition and results of operations are substantially
dependent on economic conditions in Latin America.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><!-- Field: Page; Sequence: 34; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Latin American countries
have historically experienced uneven periods of economic growth, recessions, periods of high inflation and economic instability. Recently,
the economic growth rates of the economies of many Latin American countries have slowed and some have entered recessions. Additionally,
economic and political developments in Latin America, including future economic changes or crises (such as inflation, currency devaluation
or recession), government deadlock, political instability, civil strife, changes in laws and regulations, restrictions on the repatriation
of dividends or profits, expropriation or nationalization of property, restrictions on currency convertibility, volatility of the foreign
exchange market and exchange controls could impact our operations and/or the market value of the ordinary shares and have a material
adverse effect on our business, financial condition and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Further, in Argentina, the
fluctuation in currency exchange rates, the gap between the official and alternative exchange rates, and high inflation, along with the
measures attempting to control inflation adopted by the Argentine government, caused a deepening recession during the last years. While
the large inflationary spike seen in 2023 has moderated under the current policy mix, inflation remained elevated in 2024 and into 2025
&#8212; and the exchange-rate environment has continued to be volatile: the gap between official and alternative rates narrowed from
the very wide spreads of 2024 but has at times re-widened across 2025 depending on market conditions. Accordingly, the fluctuation of
the peso, multi-rate exchange regime and high (albeit moderating) inflationary pressures continue to present material risks to operating
results and financial condition, including increased input costs, constrained domestic demand, foreign-exchange exposures and higher
rates of business failure among smaller counterparties.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On October 23, 2023, general
presidential elections took place in Argentina. The former Minister of Economy with the political party <i>Union por la Patria</i>, Sergio
Massa, obtained 36.68% of the votes, while the new coalition <i>La Libertad Avanza</i>, led by Javier Milei, and <i>Juntos por el Cambio</i>
received 29.98% and 23.83% of the votes, respectively.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On November 19, 2023, the
second round (ballotage) of the presidential elections in Argentina took place, in which the ruling party <i>Uni&#243;n por la Patria</i>,
with former Minister of Economy Sergio Massa as its candidate, obtained 44.30% of the votes, and, in contrast, the party <i>La Libertad
Avanza</i>, led by Javier Milei, obtained a result of 55.65% of the votes. Hence, on December 10, 2023, Javier Milei took office as the
new President of the Argentine Republic for the next four years.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On December 20, 2023, Emergency
Decree 70/2023 entitled &#8220;Bases for the Reconstruction of the Argentine Economy&#8221; (&#8220;<span style="text-decoration:underline">Decree 70/2023</span>&#8221;) was
published in the Official Gazette, repealing and amending several laws. The most relevant measures contained in the Decree 70/2023 include
the declaration of public emergency in economic, financial, fiscal, administrative, social security, tariff, health and social matters
until December 31, 2025, as well as measures ranging from the repeal of regulations on housing lease contracts, supply of basic necessities,
commercialization of mass consumption products, to the modification of the corporate form of companies in which the State has a stake.
Moreover, Decree 70/2023 contains a labor chapter with 44 sections by means of which changes in the labor regulations in force are ordered.
With respect to the latter, different precautionary measures, contained in actions for injunctive relief, have recently been granted,
temporarily suspending the application of the labor chapter of Decree 70/2023. All these precautionary measures, filed mainly by labor
unions, have been appealed by the National Government of Javier Milei. Currently, it is not possible to confirm what the outcome of these
measures filed against Decree 70/2023 will be. In addition, Decree 70/2023 is still subject to a subsequent legislative control established
in section 99, paragraph 3, of the National Constitution and in Law 26,122. According to the provisions of the latter, Decree 70/2023
will remain in force until it is rejected by both Chambers of Congress. On March 14, 2024, after failing to comply with the deadlines
stipulated by Law 26,122 for the Permanent Bicameral Commission to consider Decree 70/2023, the Senate of the Nation opened special sessions
in which it voted for the rejection of Decree 70/2023. As of the date hereof, Decree 70/2023 continues to be subject to the legislative
review procedure set forth in Section 99, paragraph 3, of the National Constitution and Law No. 26,122. While the Senate of the Nation
voted for its rejection on March 14, 2024, the final legal status of Decree 70/2023 remains uncertain, as its effectiveness ultimately
depends on the outcome of the legislative process as a whole. Accordingly, no assurance can be given as to whether Decree 70/2023 will
remain in force, be partially invalidated, or be repealed in its entirety.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><!-- Field: Page; Sequence: 35; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Furthermore, on December
27, 2023, the Administration of President Javier Milei submitted to Congress an extensive bill entitled &#8220;Law of Bases and Starting
Points for the Freedom of Argentines&#8221; (the &#8220;<span style="text-decoration:underline">Bases Law</span>&#8221;). Among the many issues dealt with in the draft of the
Bases Law is a broad declaration of emergency and the delegation of legislative powers to the executive branch. In addition, the draft
of the Bases Law proposes a general program of deregulation of commerce, services and industry throughout the national territory, as
well as the privatization of companies under State control, such as the national airlines (<i>Aerolineas Argentinas)</i>, the national
train company (<i>Trenes Argentinos)</i>, the national postal service (<i>Correo Argentino)</i> and companies engaged in strategic services
such as banking, energy, water, among others. After six months of legislative work, on June 27, 2024, the Chamber of Deputies of the
National Congress approved the final text of the Bases Law, finally passing the Bases Law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On the same date, the National
Congress approved Law No. 2774 on tax measures, including moratorium and tax amnesty regimes and amendments to the Personal Assets Tax,
Income Tax, and Special Regime for Small Taxpayers, among others (&#8220;<span style="text-decoration:underline">Tax Package</span>&#8221;). The aim of this bill is, among others,
to achieve the voluntary payment of taxes by taxpayers and responsible parties, who, if they join the regime, will obtain different benefits
according to the type of adhesion and the type of debt they have.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On July 8, 2024, the executive
branch issued Decrees No. 592 and 593, whereby it enacted the Bases Law along with the Tax Package.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The executive branch issued
Decree No. 608 and 695 on July 12, 2024, and August 5, 2024, respectively, regulating certain rules of the Tax Package and the following
four chapters of Title II of the Base Law: (i) Administrative Reorganization; (ii) Privatizations; (iii) Administrative Procedure; and
(iv) Public Employment. Finally, on August 12, 2024, the executive branch published Decree No. 713 in the Official Gazette through which
it moved forward with the regulation of Section of the Bases Law related to contracts and transactional agreements (including concessions).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The social, political and
economic impact of the reforms and measures announced by the Argentine government to date, the consequences of the Bases Law and the
Tax Package and the impact of future reforms and measures that may be proposed remain uncertain. The ambitious deregulation plan intended
to be implemented through Decree 70/2023 and the Bases Law could affect our business, results, and financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Argentina&#8217;s political
landscape remains subject to uncertainty following the mid-term legislative elections held on October 27, 2025, in which the ruling party,
La Libertad Avanza, obtained 40.84% of the national vote. While the electoral outcome strengthened the administration&#8217;s political
standing, its ability to advance or sustain its economic, regulatory and fiscal agenda will continue to depend on the evolving composition
and alliances within Congress, as no single party holds an absolute majority. As a result, key legislative initiatives&#8212;particularly
those relating to structural reforms, fiscal consolidation, deregulation and modifications of the existing emergency decree framework&#8212;may
still face negotiation delays, amendments or rejection. Any shifts in congressional support or policy direction could generate renewed
regulatory uncertainty, affecting macroeconomic stability, inflation dynamics, market expectations, and the general business environment.
Such developments could adversely impact our operations, financial conditions and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In Brazil, the economy has
experienced significant volatility in recent decades, characterized by periods of low or negative growth, high and variable levels of
inflation and currency devaluation. Brazil&#8217;s GDP increased 1.8% in 2018 and 1.2% in 2019, followed by a decrease of 3.9% in 2020,
and increases of 4.6% in 2021, 2.9% in 2022, 2.9% in 2023, presenting an increase of 3.7% as of the six-month period ended June 30, 2024.
Historically, Brazil&#8217;s political situation has influenced the performance of the Brazilian economy, and political crisis have affected
the confidence of investors and the general public. As a result, Brazil continues to face uncertainty related to the future developments
in policies and whether and when such policies and regulations may be implemented.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">If the Latin American governments
do not adopt reforms required to address structural changes, then the current economic conditions may be worsened, which could have an
adverse effect on our financial condition and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><!-- Field: Page; Sequence: 36; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Economic and political developments in
Argentina, including regulations and restrictions, inflation and government controls may adversely affect the economy and our financial
condition and results of operations</i></b><i>.</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In recent years, Argentina
has confronted significant market volatility, including numerous periods of low growth or stagnation, inflationary pressures, including
the depreciation of the Argentine Peso, evidenced by significantly higher fuel, energy, and food prices, among other factors. Further,
the Argentine government increased its direct intervention in the economy, including through the implementation of regulation of market
conditions, expropriations or nationalizations and price controls. Therefore, the inflation rate in Argentina and the government&#8217;s
intervention in the economy may adversely affect our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">According to data published by the Argentine
National Institute of Statistics and Census (Instituto Nacional de Estad&#237;stica y Censos) (&#8220;INDEC&#8221;), the Consumer Price
Index (&#8220;CPI&#8221;) increased 27.9% accumulated as of November 2025, 118% in 2024, 211% in 2023, 94.8% in 2022 and 50.9% in 2021.
Nevertheless, if inflation returns to the percentages reached on previous years or continue to rise towards a hyperinflation, Argentina&#8217;s
economy will continue to be negatively impacted, and our results of operations could be materially adversely affected.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Following the October 2023
presidential and federal congressional elections, Javier Milei was elected President of Argentina, officially assuming office on December
10, 2023. Upon taking office, President Milei signed a decree to stabilize Argentina&#8217;s economy through spending cuts, devaluing
the Argentine Peso and temporarily increasing import taxes and export taxes. In December 2023, he also tabled a bill to the Argentine
National Congress that focused on mass privatization, deregulating certain sectors, and easing labor market rules. The economic reforms
implemented when the government took office have already shown results, notwithstanding that uncertainty remains regarding the overall
macro-economic performance, which may adversely affect the Argentine economy, stock market prices, and our business, financial condition,
and operational results. No assurances can be made as to the policies that may be implemented by the new Argentine administration, or
that political developments in Argentina, will not adversely affect the Argentine economy or our business, financial condition or results
of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The social, political
and economic impact of the reforms and measures announced and implemented to the date of this annual report by the Argentine
government, such as the ambitious deregulation plan implemented and continuing to be implemented through Decree 70/2023 and the
Bases Law, the consequences of such law and the Tax Package and the impact of future reforms, measures and policies that may be
proposed by the Milei administration remain uncertain, and could adversely affect the Argentine economy or our business, financial
condition or results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks Related to Our Industries</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The overall agricultural, nutraceutical
and food ingredient industries are susceptible to commodity price changes, and we are exposed to market risks from changes in commodity
prices.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Conditions in the United
States agricultural industry and the Argentine agricultural industry significantly impact our operating results. Changes in the prices
of commodities could result in higher overall costs along the agricultural and commercial supply chains, which may negatively affect
our ability to commercialize our products. We are susceptible to changes in costs in the agricultural industry as a result of factors
beyond our control, such as general economic conditions, seasonal fluctuations, weather conditions, demand, food safety concerns, product
recalls and government regulations. As a result, we may not be able to anticipate or react to changing costs by adjusting our practices,
which could cause our operating results to deteriorate.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We are subject to industry-specific risks,
which could adversely affect our operating results.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We are subject to industry-specific
risks which include, but are not limited to, product safety and quality, launch of new products by other industries that can replace
the functionalities of our production; shifting consumer preferences, federal, state, and local regulations on manufacturing or labeling;
socially acceptable and sustainable farming practices; environmental, health, and safety regulations; and customer product liability
claims. The liability which could result from certain of these risks may not always be covered by, or could exceed the liability cap
of, our insurance for product liability and food safety matters. In addition, we may be unable to procure insurance on commercially reasonable
terms or may decide not to seek insurance for certain risks. Risks to our reputation may exist due to potential negative publicity caused
by product liability, food safety, occupational health and safety, workforce diversity, and environmental matters.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><!-- Field: Page; Sequence: 37; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our products are used as
ingredients in food production. We are subject to risks associated with economic, product quality, food safety, or other factors inherent
to the food industry, which may adversely affect us. In addition, as we increase our investment in the flavors and ingredients businesses,
we are exposed to increased risks related to rapidly changing consumer preferences and the impacts these changes could have on the success
of certain of our customers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Climate change and adverse weather conditions
may negatively affect our business and operations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The ability to grow our
products may be negatively affected by adverse weather conditions, including windstorms, floods, drought and extreme temperature, which
may be influenced and intensified by carbon dioxide and other greenhouse gases in the atmosphere. Unfavorable growing conditions and
natural disasters can reduce both crop size and crop quality, and in extreme cases may cause us to lose entire harvests in some geographic
areas. If such weather conditions and climate change negatively affects agricultural productivity, we may be subject to decreased availability
or less favorable pricing for certain commodities that are necessary for our products, such as our soy and pea plants, among others.
Due to climate change, we may also be subjected to decreased availability of water, deteriorated quality of water, or less favorable
pricing for water, which could adversely impact manufacturing operations. In addition, the ability to grow our products may be negatively
affected by adverse weather conditions, including windstorms, floods, drought, and extreme temperatures. Negative effects on agricultural
productivity caused by climate change in the locations where we operate may lead to adverse long-term impacts on our business and results
of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our crop productivity business is highly
seasonal and affected by factors beyond our control, which may cause our sales and operating results to fluctuate significantly.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The sale of our products
is dependent upon planting and harvest seasons and is expected to result in highly seasonal patterns and substantial fluctuations in
quarterly sales and profitability. As we increase the variety of products sold within our current markets, and expand into new markets
in different geographies, the seasonality of our business may change. Therefore, our business may be more seasonal or experience seasonality
in different periods than anticipated.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Weather conditions and natural
disasters, such as heavy rains, hail, floods, freezing conditions, windstorms, drought or fire, affect decisions by our distributors,
direct customers and end users about the types and amounts of products to use and the timing of harvesting and planting. As a result,
our operating results may vary substantially from year to year and quarter to quarter beyond the regular seasonal patterns&#8217; predictions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Other factors may also contribute
to the unpredictability of our operating results, including the size and timing of significant distributor transactions, the delay or
deferral of use of our commercial technology or products and the fiscal or quarterly budget cycles of our direct customers, distributors,
licensees and end users. Customers may purchase large quantities of our products in a particular quarter to store and use over long periods
of time or time their purchases to manage their inventories, which may cause significant fluctuations in our operating results for a
particular quarter or year.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks Related to Our Intellectual Property</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Agreements with our collaborators and third
parties may not adequately prevent disclosure of trade secrets, know-how and other proprietary information, which could lead to a loss
of competitive advantage, and adversely affect our technology and business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We rely on a combination
of intellectual property laws and agreements with our collaborators and third parties to protect and otherwise seek to control access
to, and distribution of, our proprietary information. These measures may not be sufficient to prevent disclosure, infringement, or misappropriation
of our confidential information. Our confidentiality and nondisclosure agreements or covenants may not be enforceable under applicable
law and, even if they are enforceable, may be breached, and we may not have adequate remedies for such a breach that would effectively
prevent the further dissemination of our confidential information. We also have limited control over the protection of trade secrets
used by our collaborators and could lose future trade secret protection if any unauthorized disclosure of such information occurs. Enforcement
of any claim that a party illegally disclosed confidential information or misappropriated by a trade secret is difficult, expensive,
and time-consuming, and the outcome is unpredictable. In addition, others may independently discover our trade secrets and proprietary
information, and in such cases, we may not be able to assert any trade secret rights against such parties. Laws regarding trade secret
rights in certain markets where we operate may afford little or no protection of our trade secrets. If any of our trade secrets were
to be disclosed to or independently developed by a competitor (for example, by reverse engineering), or if we otherwise were to lose
protection for our trade secrets or proprietary know-how, the value of this information may be greatly reduced, and our business could
be adversely impacted.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><!-- Field: Page; Sequence: 38; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We and our customers depend on patents,
copyrights, trademarks, know-how, trade secrets, and other forms of intellectual property protections, but these protections may not
be adequate.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We rely on a combination
of know-how, trade secrets, patents, copyrights, trademarks, and other intellectual property laws, nondisclosure and other contractual
arrangements, and technical measures to protect many of our products, services and intangible assets. These rights are important to our
ongoing operations. There can be no assurance that these protections will provide a unique or meaningful competitive advantage in our
offerings or otherwise be commercially valuable. In addition, we may not be successful in obtaining additional intellectual property
or enforcing our intellectual property rights against unauthorized users. Our exclusive rights under certain of our products and services
are protected by patents, and when patents covering a product or service expire, loss of exclusivity may occur, which may force us to
compete with third parties, thereby negatively affecting our revenue and profitability.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our proprietary rights may
be invalidated, circumvented, or challenged. We may in the future be subject to proceedings seeking to oppose or limit the scope of our
patent applications or issued patents. In addition, in the future, we may need to take legal actions to enforce our intellectual property
rights, to protect our trade secrets, or to determine the validity or scope of the proprietary rights of others. Legal proceedings are
inherently uncertain, and the outcome of such proceedings may be unfavorable to us. Any legal action regardless of the outcome might
result in substantial costs and diversion of resources and management attention. Although we use reasonable efforts to protect our proprietary
and confidential information, there can be no assurance that our confidentiality and non-disclosure agreements will not be breached,
our trade secrets will not otherwise become known by competitors, or that we will have adequate remedies in the event of unauthorized
use or disclosure of proprietary information. Even if the validity and enforceability of our intellectual property is upheld, an adjudicator
might construe our intellectual property not to cover the alleged infringement. In addition, intellectual property enforcement may be
unavailable or practically ineffective in some countries. There can be no assurance that our competitors will not independently develop
technologies that are substantially equivalent or superior to our technology or that third parties will not design around our intellectual
property claims to produce competitive offerings. The use of our technology or similar technology by others could reduce or eliminate
any competitive advantage we have developed, cause us to lose sales, or otherwise harm our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">While we are not party to
such suits at this time, we may become subject to such litigation in the future. Such cases could also adversely impact public perception
and the demand for science-based food ingredients products, which could subsequently result in decreased demand for our products and
materially adversely affect our business and operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We have patents granted
and patent applications, as owner or as licensee, in the United States, China, India, Canada, Germany, Spain, France, United Kingdom,
Brazil, Mexico, Australia, New Zealand, Japan, Hong Kong, Malaysia, and Argentina and trademarks and service marks in the United States,
Europe, Canada, the United Kingdom and Argentina, some of which have been registered or issued, and also claim common law rights in various
trademarks and service marks. There can be no assurance that third parties will not oppose our future applications to register intellectual
property. It is possible that in some cases we may be unable to obtain the registrations for trademarks, service marks, and patents for
which we have applied, and a failure to obtain trademark and patent registrations in the United States, the United Kingdom, the European
Union, and Argentina or other countries could limit our ability to protect our trademarks and proprietary technologies and our marketing
efforts in those jurisdictions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">License agreements with
third parties limit our rights to use certain patents, software, and information technology systems and proprietary technologies owned
by third parties, some of which are important to our business. Termination of these license agreements, for any reason, could result
in the loss of our rights to this intellectual property, causing an adverse change in our operations or the inability to commercialize
certain offerings.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><!-- Field: Page; Sequence: 39; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Biotechnology patents and patent applications
involve highly complex legal and factual questions, which, if determined adversely to us, could adversely affect our competitive position.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The patent positions of
biotechnology companies and other actors in our fields of business can be highly uncertain and involve complex scientific, legal, and
factual analyses. The interpretation and breadth of claims allowed in some patents covering biological compositions may be uncertain
and difficult to determine and are often affected materially by the facts and circumstances that pertain to the patented compositions
and the related patent claims. The issuance and scope of patents cannot be predicted with certainty. Patents, if issued, may be challenged,
invalidated, narrowed, or circumvented. Challenges to our, or our licensors&#8217; patents and patent applications, if successful, may
result in the denial of our, or our licensors&#8217; patent applications or the loss or reduction in their scope. In addition, defending
against such challenges may be costly and involve the diversion of significant management time and our resources. Accordingly, rights
under any of our patents may not provide us with enough protection against competitive products or processes and any loss, denial or
reduction in scope of any of such patents and patent applications may have a material adverse effect on our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We will not seek to protect our intellectual
property rights in all jurisdictions throughout the world and we may not be able to adequately enforce our intellectual property rights
even in the jurisdictions where we have sought protection.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our commercial success depends,
in part, on our ability to recognize intellectual property rights and protect our trade secrets for the technologies that we develop
and use. However, filing, prosecuting and defending patents in all countries and jurisdictions throughout the world would be prohibitively
expensive. Patent prosecution must be sought on a country-by-country basis, which is an expensive and time-consuming process with uncertain
outcomes. Our intellectual property rights in some countries outside the United States could be less extensive than those in the United
States, assuming that rights are obtained in the United States. In addition, the laws of some foreign countries do not protect intellectual
property rights to the same extent as federal and state laws in the United States. Consequently, we may not be able to prevent third
parties from using our inventions in countries outside the United States, or from selling or importing products made using our inventions
in and into the United States or other jurisdictions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Competitors may use our
technologies in jurisdictions where we or our licensors do not pursue and obtain patent protection. Further, competition may export products
that would otherwise infringe upon our intellectual property rights to territories where we or our licensors have patent protection,
but where the ability to enforce those patent rights is not as strong as in the United States. These products may compete with our products
and our intellectual property rights, and such rights may not prevent such competition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In addition, changes in,
or different interpretations of, patent laws in the United States and other countries may permit others to use our discoveries or to
develop and commercialize our technology and products without providing any notice or compensation to us or may limit the scope of patent
protection that we or our licensors are able to obtain. The laws of certain countries do not protect intellectual property rights to
the same extent as United States laws and those countries may lack adequate rules and procedures for defending our intellectual property
rights.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Furthermore, proceedings
to enforce our patent rights and other intellectual property rights around the world could result in substantial costs and divert our
efforts and attention from other aspects of our business, could put our patents at risk of being invalidated or interpreted narrowly,
could put our or our licensors&#8217; patent applications at risk of not issuing and could provoke third parties to assert claims against
us. We may not prevail in any lawsuits that we initiate, and the damages or other remedies awarded to us, if any, may not be commercially
meaningful, while the damages and other remedies we may be ordered to pay such third parties may be significant. Accordingly, our efforts
to enforce our intellectual property rights around the world may be inadequate to obtain a significant commercial advantage from the
intellectual property that we develop or license.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In addition, there is a
possibility that our technologies may be viewed by competitors as an infringement on their intellectual property rights, even in a case
where we believe they do not. This may lead to litigation that could create a significant cost for us and adversely affect our business
and operations as well as our public perception and goodwill.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><!-- Field: Page; Sequence: 40; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may be unsuccessful in developing, licensing
or acquiring intellectual property rights that may be required to develop and commercialize our future products.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our programs may involve
additional product candidates that may require the use of intellectual property or proprietary rights held by third parties and the growth
of our business may depend in part on our ability to acquire, license or use these intellectual property and proprietary rights.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">However, we may be unable
to acquire or license any third-party intellectual property or proprietary rights that may be key to development. Even if we can acquire
or license such rights, we may be unable to do so on commercially reasonable terms. The licensing and acquisition of third-party intellectual
property and proprietary rights is highly competitive, and several more established companies are also pursuing strategies to license
or acquire third-party intellectual property and proprietary rights that we may consider attractive or necessary. These established companies
may have a competitive advantage over us due to their size, capital resources and agricultural development and commercialization capabilities.
We may also not be able to bypass or achieve &#8220;freedom to operate&#8221; status for the products in our pipeline to avoid liability
to third parties.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In addition, companies that
perceive us to be a competitor may be unwilling to assign or license intellectual property and proprietary rights to us. We also may
be unable to license or acquire third-party intellectual property and proprietary rights on terms that would allow us to make an appropriate
return on our investment or at all. If a program, product or product candidate requires us to acquire or license third-party intellectual
property and proprietary rights or maintain our existing intellectual property and proprietary rights, and we are unable to do so, we
may have to cease development of such program, product or product candidate, which could have a material adverse effect on our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We or our customers may infringe intellectual
property unknowingly and unintentionally affect our reputation and our future plans for our products and competitiveness.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As the agricultural biotech
industry continues to develop, we, our customers, collaborators or licensees may become party to, or be threatened with, litigation or
other proceedings regarding intellectual property or proprietary rights in our technology and processes. Third parties may assert claims
based on existing or future intellectual property rights and the outcome of any proceedings is subject to uncertainties that cannot be
adequately quantified in advance. Any litigation proceedings could be costly and time consuming. A negative outcome from an intellectual
property infringement suit could result in liability for monetary damages, require us to indemnify our licensees for damages arising
from warranties we have made in respect of the intellectual property rights we have licensed, which claims might not be subject to a
cap, or treble damages and attorneys&#8217; fees if we are found to have willfully infringed a patent. There is also no guarantee that
we, our customers, collaborators or licensees, would be able to obtain a license under such infringed intellectual property rights on
commercially reasonable terms or at all. A finding of infringement could prevent us, our customers, collaborators or our licensees from
developing, marketing or selling a product or force us to cease some or all of our business operations. Even if we are successful in
these proceedings, we may incur substantial costs and the time and attention of our management and scientific personnel may be diverted
as a result of these proceedings, which could have a material adverse effect on our operations. In some cases, our agreements with our
collaborators or licensees might oblige us to pay for the enforcement of our licensed intellectual property rights, even though our collaborators
or licensees may be responsible for commercializing the potentially infringing products. Claims that we have misappropriated the confidential
information or trade secrets of third parties could similarly have a material adverse effect on our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If we or one of our collaborators or licensees
are sued for infringing the intellectual property rights of a third party, such litigation could be costly and time consuming and could
prevent us or our collaborators or licensees from developing or commercializing products that incorporate our technology.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our ability to generate
significant revenues from our products depends on our joint ventures&#8217; and licensees&#8217; ability to develop, market and sell
products and utilize our proprietary technologies without infringing the intellectual property rights and other rights of any third parties.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><!-- Field: Page; Sequence: 41; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As the agricultural biotech
industry continues to develop, we, our collaborators or licensees may become party to, or threatened with, litigation or other adverse
proceedings regarding intellectual property or proprietary rights in our technology, processes, developed seed traits or seed treatments.
Third parties may assert claims based on existing or future intellectual property rights, and the outcome of any proceedings is subject
to uncertainties that cannot be adequately quantified in advance. Any litigation proceedings could be costly and time consuming. A negative
outcome from an intellectual property infringement suit could result in liability for monetary damages, require us to indemnify our licensees
for damages arising from warranties we have made in respect of the intellectual property rights we have licensed, which claims might
not be subject to a cap, or treble damages and attorneys&#8217; fees if we are found to have willfully infringed a patent. There is also
no guarantee that we, our collaborators or licensees, would be able to obtain a license under such infringed intellectual property rights
on commercially reasonable terms or at all. A finding of infringement could prevent us, our collaborators or our licensees from developing,
marketing or selling a product or force us to cease some or all of our business operations. Even if we are successful in these proceedings,
we may incur substantial costs and the time and attention of our management and scientific personnel may be diverted as a result of these
proceedings, which could have a material adverse effect on our operations. In some cases, our agreements with our collaborators or licensees
might oblige us to pay for the enforcement of our licensed intellectual property rights, even though our collaborators or licensees may
be responsible for commercializing the potentially infringing products. Claims that we have misappropriated the confidential information
or trade secrets of third parties could similarly have a material adverse effect on our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks Relating to Laws and Regulation</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The regulatory environment in the United
States for our current and potential future products is evolving and may change in the future, adversely affecting the speed and cost
to launch our potential future products.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Changes in applicable regulatory
requirements could result in a substantial increase in the time and costs associated with developing our products and adversely affect
our operating results. While the USDA and FDA currently have petition processes that we have initiated, these processes and the manner
in which the USDA and FDA interpret their regulations may change in the future, adversely affecting the speed and cost with which we
launch our potential future products. We cannot predict whether advocacy groups will challenge existing regulations and USDA or FDA determinations
or whether the USDA or FDA will alter the manner in which it interprets its own regulations or institutes new regulations, or otherwise
modify regulations in a way that will subject our products to more burdensome standards, thereby substantially increasing the time and
costs associated with developing our product candidates. While we do not have any USDA-APHIS petitions pending, we may submit petitions
in the future.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The regulatory environment outside the
United States varies greatly from jurisdiction to jurisdiction and there is less certainty over how our products will be regulated.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The regulatory environment
around genetic engineering of plants, particularly in our case which majorly includes the addition of animal-proteins without the use
of animals, to create food ingredients is greatly uncertain outside of the United States and varies greatly from jurisdiction to jurisdiction.
Each jurisdiction may have its own regulatory framework regarding genetically modified crops and foods, which may include restrictions
and regulations on planting and growing genetically modified plants and in the consumption and labeling of genetically modified foods,
and which may encapsulate our products. To the extent regulatory frameworks outside of the United States are not receptive to our genetic
engineered technologies, this may limit our ability to expand into other global markets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Complying with the regulatory
requirements outside the United States will be costly and time-consuming, and there is no guarantee we will be able to commercialize
our products in other jurisdictions apart from the United States and Argentina.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We cannot predict whether
or when any jurisdiction will change its regulations with respect to our products. Advocacy groups have engaged in publicity campaigns
and filed lawsuits in various countries against companies and regulatory agencies, seeking to halt regulatory approval or clearance activities
or influence public opinion against GMO products. In addition, governmental reaction to negative publicity concerning our products could
result in greater regulation of genetic research and derivative products or regulatory costs that render our products cost prohibitive.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The scale of the commodity
food and agricultural industry may make it difficult to monitor and control the distribution of our products. As a result, our products
may be sold inadvertently within jurisdictions where they are not approved for distribution. Such sales may lead to regulatory challenges
or lawsuits against us, which could result in significant expenses and management attention.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><!-- Field: Page; Sequence: 42; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Government policies and regulations, particularly
those affecting the agricultural sector and related industries, could adversely affect our operations and profitability.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Agricultural production
and trade flows are subject to government policies and regulations. Governmental policies and approvals of technologies affecting the
agricultural industry, such as taxes, tariffs, duties, subsidies, incentives and import and export restrictions on agricultural commodities
and commodity products can influence the planting of certain crops, the location and size of crop production, and the volume and types
of imports and exports. In addition, as we grow our business, we may be required to secure additional permits and licenses. Finally,
future government policies in the United States or in other countries may discourage our customers from using our products or encourage
the use of products that are more advantageous to our competitors, which would put us at a commercial disadvantage and could adversely
affect our future revenues and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may use biological materials in our
business and are subject to numerous environmental, health and safety laws and regulations. Compliance with such laws and regulations
and any claims relating to improper handling, storage or disposal of these materials could be time consuming and costly.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We are subject to numerous
federal, state, local and foreign environmental, health and safety laws and regulations, including those governing laboratory procedures,
the handling, use, storage, treatment, manufacture and disposal of hazardous materials and wastes, discharge of pollutants into the environment
and human health and safety matters. Our R&amp;D processes involve the controlled use of hazardous materials, including biological materials.
We may be sued for any injury or contamination that results from our use or the use by third parties of these materials, or may otherwise
be required to remediate such contamination, and our liability may exceed any insurance coverage and our total assets. Compliance with
environmental, health and safety laws and regulations may be expensive and may impair our R&amp;D efforts. If we fail to comply with
these requirements, we could incur substantial costs and liabilities, including civil or criminal fines and penalties, clean-up costs
or capital expenditures for control equipment or operational changes necessary to achieve and maintain compliance. In addition, we cannot
predict the impact on our business of new or amended environmental, health and safety laws or regulations or any changes in the way existing
and future laws and regulations are interpreted and enforced. These existing or future laws and regulations may impair our research,
development or production efforts or result in increased expense of compliance.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Tax, legislative or regulatory initiatives,
new interpretations or developments concerning existing tax laws, or challenges to our tax positions could adversely affect our results
of operations and financial condition.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We currently have limited
operations; however, we have relationships with multiple jurisdictions throughout the world including the United Kingdom, the Cayman
Islands, the United States, Argentina and the Netherlands. As such, we are subject to the tax laws and regulations of various jurisdictions,
including U.S. federal, state, and local governments and could be potentially subject to additional tax laws and regulations in additional
jurisdictions. From time to time, various legislative initiatives may be proposed that could adversely affect our tax positions, and
existing legislation, such as the 2017 U.S. Tax Cuts and Jobs Act, may be subject to additional regulatory changes or new interpretations.
There can be no assurance that our effective tax rate or tax payments will not be adversely affected by these initiatives.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In addition, the tax laws
of several of the countries in which we operate, including Argentine and U.S. federal, state and local tax laws and regulations, are
extremely complex and subject to varying interpretations. It is possible that the outcomes from examinations or interpretations by taxing
authorities or changes in laws, rules, regulations, or interpretations by taxing authorities could have a material adverse effect on
our financial condition or results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We are subject to governmental export and
import controls that could impair our ability to compete in international markets and subject us to liability if we are not in compliance
with applicable laws.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our products are subject
to Export Control Laws and Import Control Laws and regulations of the jurisdictions in which we operate. Exports of our products must
be made in compliance with these laws and regulations. If we fail to comply with these laws and regulations, we and certain of our employees
could be subject to substantial civil or criminal penalties, including the possible loss of export or import privileges; fines, which
may be imposed on us and responsible employees or managers; and, in extreme cases, the incarceration of responsible employees or managers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><!-- Field: Page; Sequence: 43; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In addition, changes in
our products or changes in applicable export or import laws and regulations may create delays in the introduction, provision, or sale
of our products in international markets, prevent customers from using our products or, in some cases, prevent the export or import of
our products to certain countries, governments or persons altogether. Any limitation on our ability to export, provide, or sell our products
could adversely affect our business, financial condition and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Failure to comply with the U.S. Foreign
Corrupt Practices Act, the U.K. Bribery Act 2010 and similar laws associated with our activities in other jurisdictions could subject
us to penalties and other adverse consequences.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As we expect a substantial
portion of our future revenue to come from jurisdictions other than the United States, we face significant risks if we fail to comply
with the U.S. Foreign Corrupt Practices Act (&#8220;FCPA&#8221;), the U.K. Bribery Act 2010 (the &#8220;Bribery Act&#8221;) and other
laws that prohibit improper payments or offers of payment to governments and their officials and political parties by us and other business
entities for the purpose of obtaining or retaining business. In many countries, particularly in countries with developing economies,
it may be a local custom that businesses operating in such countries engage in business practices that are prohibited by the FCPA, the
Bribery Act or other laws and regulations. Although we have implemented company policy requiring employees and consultants to comply
with the FCPA, the Bribery Act and similar laws, such policy may not be effective at preventing all potential FCPA, Bribery Act or other
violations. In addition, we cannot guarantee the compliance by our partners, resellers, suppliers and agents with applicable laws, including
the FCPA and the Bribery Act. Therefore, there can be no assurance that none of our employees or agents will take actions in violation
of our policies or of applicable laws, for which we may be ultimately held responsible. Any violation of the FCPA or the Bribery Act
and related policies could result in severe criminal or civil sanctions, which could have a material and adverse effect on our reputation,
business, financial condition and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The JOBS Act permits &#8220;emerging growth
companies&#8221; like us to take advantage of certain exemptions from various reporting requirements applicable to other public companies
that are not emerging growth companies.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We currently qualify as
an &#8220;emerging growth company&#8221; as defined in Section 2(a)(19) of the Securities Act, as modified by the Jumpstart Our Business
Startups Act of 2012, which we refer to as the &#8220;JOBS Act.&#8221; As such, we take advantage of certain exemptions from various
reporting requirements applicable to other public companies that are not emerging growth companies for as long as we continue to be an
emerging growth company, including the exemption from the auditor attestation requirements with respect to internal control over financial
reporting under Section 404 of the Sarbanes-Oxley Act. As a result, our shareholders may not have access to certain information they
deem important. We will cease to be an emerging growth company upon the earliest of:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">the last day of the fiscal year during which we have total annual gross
revenues of US$1,235,000,000 (as such amount is indexed for inflation every five years by the Securities and Exchange Commission (the
&#8220;SEC&#8221;)) or more;</span></td>
</tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">the
                                            last day of our fiscal year following the fifth anniversary of the completion of our first
                                            sale of common equity securities pursuant to an effective registration statement under the
                                            Securities Act, which is currently expected to be June 30, 2026, unless we change our fiscal
                                            year;</span></td>
</tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">the
                                            date on which we have, during the previous three-year period, issued more than US$1,000,000,000
                                            in non-convertible debt; or</span></td>
</tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">the
                                            date on which we are deemed to be a &#8220;large accelerated filer&#8221;, as defined in
                                            Rule 12b-2 of the Exchange Act, which would occur in future fiscal years if the market value
                                            of our ordinary shares and ADSs that are held by non-affiliates exceeds US$700,000,000 as
                                            of the last day of our most recently-completed second fiscal quarter.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">If we cease to be an &#8220;emerging
growth company,&#8221; as such term is defined in the JOBS Act, our independent registered public accounting firm must attest to and
report on the effectiveness of our internal control over financial reporting on an annual basis.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We cannot predict if investors
will find Ordinary Shares less attractive because we rely on these exemptions. If some investors find Ordinary Shares less attractive
as a result, there may be a less active trading market and share price for Ordinary Shares may be more volatile. When we no longer qualify
as an emerging growth company, we may incur increased legal, accounting and compliance costs associated with Section 404 of the Sarbanes-Oxley
Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><!-- Field: Page; Sequence: 44; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We are an early-stage global company, operating
in several jurisdictions and we may inadvertently omit any labor or civil registration law due to lack of qualified personnel.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As we are an early-stage
developing company operating in several jurisdictions, we may have difficulties facing compliance, including with respect to labor and
other regulatory matters in these jurisdictions, due to not having qualified personnel to address such issue.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks Relating to the Company</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We will incur increased costs as a result
of operating as a public company whose shares are listed on the Nasdaq, and our management will devote substantial time to new compliance
initiatives.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We expect to incur significant
legal, accounting and other expenses that we did not incur as a private company, and these expenses may increase even more after we are
no longer an emerging growth company, as defined in Section 2(a) of the Securities Act. As a public company, we are subject to the reporting
requirements of the Exchange Act, the Sarbanes-Oxley Act, the Dodd-Frank Wall Street Reform and Consumer Protection Act, as well as rules
adopted, and to be adopted, by the SEC and Nasdaq. Our management and other personnel will need to devote a substantial amount of time
to these compliance initiatives. Moreover, we expect these rules and regulations to substantially increase our legal and financial compliance
costs and to make some activities more time consuming and costly. The increased costs may increase our net loss. For example, these rules
and regulations could make it more difficult and more expensive for us to obtain director and officer liability insurance and as a result,
we may be forced to accept reduced policy limits or incur substantially higher costs to maintain the same or similar coverage. We cannot
predict or estimate the amount or timing of additional costs it may incur to respond to these requirements. The impact of these requirements
could also make it more difficult for us to attract and retain qualified persons to serve on our Board or as executive officers. Furthermore,
due to the increase in our shareholders&#8217; base, costs related to shareholders&#8217; communication will increase as a result of
the listing of our shares on Nasdaq.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our management has limited experience in
operating a public company.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our executive officers have
limited experience in the management of a publicly traded company. Our management team may not successfully or effectively manage our
transition to a public company that will be subject to significant regulatory oversight and reporting obligations under federal securities
laws. Their limited experience in dealing with the increasingly complex laws pertaining to public companies could be a significant disadvantage
in that it is likely that an increasing amount of their time may be devoted to these activities which will result in less time being
devoted to our management and our growth. We may not have adequate personnel with the appropriate level of knowledge, experience, and
training in the accounting policies, practices or internal controls over financial reporting required of public companies in the United
States. The development and implementation of the standards and controls necessary for us to achieve the level of accounting standards
required of a public company in the United States may require costs greater than expected. It is likely that we will be required to expand
our employee base and hire additional employees to support our operations as a public company, which will increase our operating costs
in future periods.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Because we became a public reporting company
by means other than a traditional underwritten initial public offering, our shareholders may face additional risks and uncertainties.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Because we became a public
reporting company by means of consummating a de SPAC business combination rather than by means of a traditional underwritten initial
public offering, there was no independent third-party underwriter involved in the going public process of the combined company, and,
accordingly, our shareholders did not have the benefit of an independent review and investigation of the type normally performed by an
unaffiliated, independent underwriter in an initial public securities offering. Due diligence reviews typically include an independent
investigation of the background of a company, any advisors of the company and their respective affiliates, review of the offering documents
and independent analysis of the plan of business and any underlying financial assumptions. While private investors and management in
our business combination undertook a certain level of due diligence, it was not necessarily the same level of due diligence undertaken
by an underwriter in a traditional initial public offering and, therefore, there could be a heightened risk of an incorrect valuation
of the business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><!-- Field: Page; Sequence: 45; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The resignation of Nomura as our exclusive
financial advisor may indicate that it is unwilling to be associated with the disclosure in SEC filings and the underlying business analysis
related to our initial business combination.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On June 29, 2022, Nomura
resigned from its role as our exclusive financial advisor, effective as of April 27, 2022, and waived its entitlement to the payment
of any fees or expense reimbursements. On March 30, 2022, prior to the resignation of Nomura, the SPAC Rule Proposals relating to, among
other items, disclosures in SEC filings and the treatment of investment banks in connection with business combination transactions involving
special purpose acquisition companies. The uncertainty related to the treatment of investment banks following the SPAC Rule Proposals
was the reason Nomura gave for its resignation. Nomura did not have a role in the negotiation of any materials related to or arising
out of our initial business combination and had no role in any subsequent preparation of the disclosure in SEC filings. Neither Moolec
Science Ltd. nor LightJump (our predecessor entities) relied on Nomura in the preparation and analysis of materials related to the initial
business combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We note that Nomura was
provided with the disclosures in SEC filings pertaining to its roles and resignation, however we did not receive a response from Nomura
whether they agree with either the risks or the conclusions stated therein that are associated with its role and resignation. While Nomura
did not provide any additional detail in its resignation letters either to Moolec or to the SEC, such resignation may be an indication
by Nomura that it does not want to be associated with the disclosure in SEC filings, including any discussion related to reasons for
its withdrawal, or the underlying business analysis related to the initial business combination. Shareholders and investors should not
place any reliance on the fact that Nomura has been previously involved with the Business Combination solely as it was engaged as the
exclusive financial advisor to Moolec.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Additional Risks Relating to Our Securities</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Sales of a substantial number of our securities
in the public market by our existing securityholders, including management, could cause the price of our Ordinary Shares and warrants
to decrease significantly.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Sales of a substantial number
of Ordinary Shares in the public market by our existing securityholders, including management, or the perception that those sales might
occur, could depress the market price of our Ordinary Shares and warrants and could impair our ability to raise capital through the sale
of additional equity securities. We are unable to predict the effect that such sales may have on the prevailing market price of our Ordinary
Shares and warrants.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>There is substantial doubt about whether
we will be able to comply with the continued listing standards of the Nasdaq Capital Market, which may result in restrictions to our
listing and trading volume.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our Ordinary Shares are
currently listed on the Nasdaq Capital Market. Our continued eligibility for listing depends on our ability to satisfy the continued
listing standards of Nasdaq. Those listing standards generally require that we have $500,000 of net income from continuing operations,
or at least $2.5 million in stockholders&#8217; equity or at least $35 million in market capitalization. In addition, we need to maintain
an average stock price per share of at least $1.00 and a &#8220;public float&#8221; (equity held by non-affiliates) of at least $1 million.
There is substantial doubt whether we will be able to company with these continued listing standards.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">If Nasdaq delists our Ordinary
Shares from trading on its exchange for failure to meet the listing standards, our shareholders could face significant material adverse
consequences including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            limited availability of market quotation for our Ordinary Shares;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reduced
                                            liquidity and inability to sell our Ordinary Shares;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            determination that our Ordinary Shares are a &#8220;penny stock&#8221; which will require
                                            brokers trading in our Ordinary Shares to adhere to more stringent rules and possibly result
                                            in a reduced level of trading activity in the secondary trading market for our Ordinary Shares;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            limited amount of news and analyst coverage; and</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            decreased ability to issue additional Ordinary Shares or obtain additional financing in the
                                            future.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><!-- Field: Page; Sequence: 46; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The National Securities
Markets Improvement Act of 1996, which is a federal statute, prevents or preempts the states from regulating the sale of certain securities,
which are referred to as &#8220;covered securities&#8221;. Because our Ordinary Shares are listed on Nasdaq or another national securities
exchange, they are covered securities. If our securities were no longer listed on Nasdaq, they would not be covered securities and we
would be subject to regulation in each state in which we offer securities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may be automatically delisted from the
Nasdaq Capital Market because our Ordinary Shares have been trading at less than $1.00 per share.&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Companies listed on Nasdaq
are subject to delisting for, among other things, failure to maintain a minimum closing bid price of $1.00 per share for 30 consecutive
business days, pursuant to the NASDAQ Listing Rule 5450(a)(1). </p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On November 14, 2025, the
Company received a determination letter (the &#8220;Nasdaq Determination Letter&#8221;) from the Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;)
indicating that the closing bid price of the Company&#8217;s ordinary shares had been below the minimum $1.00 per share requirement for
the last 30 consecutive business days, as set forth in Nasdaq Listing Rule 5550(a)(2), and informing the Company of their view that the
Company would not be afforded an automatic 180-day period to regain compliance with such rule.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-align: justify; text-indent: 20.8pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company has submitted
a timely appeal to a Nasdaq Hearings Panel, through which it will request the granting of a 180- day period to submit and effect a compliance
plan, which includes a potential implementation of a reverse stock split, if determined to be in the best interest of shareholders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-align: justify; text-indent: 20.8pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The submission of the
appeal automatically stays the effect of the Nasdaq Determination Letter until the appeal has been considered, which took place on
December 18, 2025. Accordingly, the Company&#8217;s ordinary shares will continue to trade on The Nasdaq Capital Market under the
symbol &#8220;MLEC&#8221; without interruption pending the appeal decision.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-align: justify; text-indent: 20.8pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-align: justify; text-indent: 20.8pt">On December 16, 2025, the shareholders held an extraordinary general
meeting (&#8220;EGM&#8221;) and approved, among other matters, a reverse stock split on the basis of a ratio to be approved by the board
of directors (the &#8220;Board&#8221;) that is no less than ten-to-one and no more than twenty five-to-one, to be determined by Board
of Directors and to be effective on a date between December 17, 2025 and May 14, 2026, depending on whether our request for a 180 days
extension period is granted. The reverse stock split will cause our ordinary share price to increase by a minimum of ten times on the
date we file the amended and restated articles and memorandum of association (the &#8220;Articles&#8221;). The Board determined on December
19, 2025, the final reverse stock split ratio consolidation of fifteen-to-one, to be effective on or around January 5, 2026.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-align: justify; text-indent: 20.8pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company intends to continue
closely monitoring the closing bid price for its Ordinary Shares and remains committed to evaluating and executing all appropriate actions
to cure the deficiency and regain compliance with Nasdaq Listing Rule 5550(a)(2). The receipt of the Nasdaq Determination Letter does
not affect the Company&#8217;s business, operations or reporting requirements with the Securities and Exchange Commission.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><!-- Field: Page; Sequence: 47; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On November 24, 2025, the
Company received a letter (the &#8220;Letter&#8221;) from the Listing Qualifications Department of Nasdaq stating that the Company is
not in compliance with Nasdaq Listing Rule 5250(c)(1) because it has not yet filed its Annual Report on Form 20-F for the year ended
June 30, 2025 (the &#8220;Form 20-F&#8221;) with the Securities and Exchange Commission (the &#8220;SEC&#8221;).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As the Company stated in
the form 12b-25 filed with the SEC on October 31, 2025, it was unable to file the Form 20-F in a timely manner due to complexities that
arose immediately after the closing of the business combination in mid-June 2025, two weeks prior to Moolec&#8217;s fiscal year end of
June 30. The business combination involves complex accounting, including the imposition of reverse acquisition accounting and valuation
of acquired assets and liabilities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company has requested
a stay of suspension to the Nasdaq Hearings Panel, which automatically stayed the effect of the Letter until the panel hearing, which
    took place on December 18, 2025. Accordingly, the Company&#8217;s ordinary shares will continue to trade on The Nasdaq
Capital Market under the symbol &#8220;MLEC&#8221; without interruption during the time period when the panel decision is pending.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">However, we cannot
ensure you that we will be able to comply with the minimum closing bid price requirements or other requirements for continued
listing on the Nasdaq Capital Market in the future. Further, if our Ordinary Shares are delisted from Nasdaq, our securities would
likely trade in the over-the-counter market.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">If our securities were to
trade on the over-the-counter market, selling our Ordinary Shares could be more difficult because smaller quantities of shares would
likely be bought and sold, transactions could be delayed, and security analysts&#8217; coverage of us may be reduced. In addition, in
the event our Ordinary Shares are delisted, broker-dealers have certain regulatory burdens imposed upon them, which may discourage broker-dealers
from effecting transactions in our Ordinary Shares, further limiting the liquidity of our Ordinary Shares. These factors could result
in lower prices and larger spreads in the bid and ask prices for our Ordinary Shares. Such delisting from the Nasdaq and continued or
further declines in our share price could also greatly impair our ability to raise additional necessary capital through equity or debt
financing and could significantly increase the ownership dilution to shareholders caused by our issuing equity in financing or other
transactions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The price of our securities may be volatile,
and their value may decline.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We cannot predict the prices
at which our securities, which include our Ordinary Shares and warrants, will trade. The market price of our securities may fluctuate
substantially and may be lower than the current market price. In addition, the trading price of our securities is likely to be volatile
and could be subject to fluctuations in response to various factors, some of which are beyond our control. These fluctuations could cause
you to lose all or part of your investment in our securities as you might be unable to sell your securities at or above the price you
paid. Factors that could cause fluctuations in the trading price of our securities include the following:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">actual
                                            or anticipated fluctuations in our financial condition or results of operations;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">variance
                                            in our financial performance from expectations of securities analysts;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                            in the pricing of our solutions;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                            in our projected operating and financial results;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                            in laws or regulations applicable to our business;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements
                                            by us or our competitors of significant business developments, acquisitions or new offerings;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            involvement in litigation;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in"></p><div>

</div><!-- Field: Page; Sequence: 48; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">conditions
                                            or developments affecting the science-based food ingredients industry;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">future
                                            sales of our securities by us or our shareholders, as well as the anticipation of lock-up
                                            releases;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                            in senior management or key personnel;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            trading volume of securities;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                            in the anticipated future size and growth rate of our markets;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">sales
                                            and short-selling of our securities;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">publication
                                            of research reports or news stories about us, our competitors or our industry, or positive
                                            or negative recommendations or withdrawal of research coverage by securities analysts;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">general
                                            economic and market conditions; and</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other
                                            events or factors, including those resulting from war (including the ongoing conflict in
                                            Israel and Palestine and war between Russia and Ukraine), incidents of terrorism, global
                                            pandemics or responses to these events.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Broad market and industry
fluctuations, as well as general economic, political, regulatory and market conditions, may also adversely affect the market price of
our securities. In addition, technology stocks have historically experienced high levels of volatility. In the past, companies who have
experienced volatility in the market price of their securities have been subject to securities class action litigation. We may be the
target of this type of litigation in the future, which could result in substantial expenses and divert our management&#8217;s attention.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our warrants are exercisable for our Ordinary
Shares, which will increase the number of shares eligible for future resale in the public market and result in dilution to our shareholders.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As of June 30, 2025, there
were 1,698,987 warrants outstanding, 1,109,987 entitling the holder to purchase one Ordinary Share for every 10 warrants exercised at
an exercise price of US$115.00 per share and 500,000 at an exercise price of US$20.00. To the extent such warrants are exercised, additional
Ordinary Shares will be issued, which will result in dilution to the holders of our Ordinary Share and increase the number of shares
eligible for resale in the public market. Sales of substantial numbers of such shares in the public market or the fact that such warrants
may be exercised could adversely affect the market price of our Ordinary Shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Assuming the exercise of all outstanding warrants for cash, we would
receive aggregate proceeds of approximately US$137,648,505. However, we will only receive such proceeds if all warrant holders fully exercise
their warrants. The exercise price of our warrants is US$115.00 per share or US$20.00 per share, as applicable, subject to customary adjustments.
We believe that the likelihood that warrant holders determine to exercise their warrants, and therefore the amount of cash proceeds that
we would receive, is dependent upon the market price of our Ordinary Shares. If the market price for our Ordinary Shares is less than
the exercise price of the warrants (on a per share basis), we believe that warrant holders will be very unlikely to exercise any of their
warrants, and accordingly, we will not receive any such proceeds. There is no assurance that the warrants will be &#8220;in the money&#8221;
prior to their expiration or that the warrant holders will exercise their warrants. As of December 26, 2025, the closing price of our
Ordinary Shares was US$0.2403 per share. Warrant holders may exercise the warrants on a cashless basis at our option in accordance with
the Warrant Amendment. To the extent that any warrants are exercised on a cashless basis, the amount of cash we would receive from the
exercise of the warrants will decrease.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>A market for our securities may not continue,
which would adversely affect the liquidity and price of our Ordinary Shares and Warrants.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The price of our securities
may fluctuate significantly due to the market&#8217;s reaction to general market and economic conditions. An active trading market for
our securities may never develop or, if developed, it may not be sustained. In addition, the price of our securities can vary due to
general economic conditions and forecasts, our general business condition and the release of our financial reports. Additionally, if
our securities are delisted from, Nasdaq for any reason, and are quoted on the OTC Bulletin Board, an inter-dealer automated quotation
system for equity securities that is not a national securities exchange, the liquidity and price of our securities may be more limited
than if it were quoted or listed on Nasdaq or another national securities exchange. You may be unable to sell your securities unless
a market can be established or sustained.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><!-- Field: Page; Sequence: 49; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If securities or industry analysts cease
publishing research or reports about us, our business, or our market, or if they change their recommendations regarding Ordinary Shares
adversely, then the price and trading volume of Ordinary Shares could decline.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The trading market for the
Ordinary Shares is influenced by the research and reports that industry or securities analysts may publish about us, our business, our
market, or our competitors. There is currently one publication that covers us. However, if no securities or industry analysts further
cover us, the price and trading volume of our ordinary shares would likely be adversely affected. If any of the analysts who cover us
change their recommendation regarding our Ordinary Shares adversely, or provide more favorable relative recommendations about our competitors,
the price of the Ordinary Shares would likely decline. If any analyst were to cease coverage of us or fail to regularly publish reports
on us, we could lose visibility in the financial markets, which could cause Ordinary Share price or trading volume to decline.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We do not intend to pay dividends for the
foreseeable future and, as a result, your ability to achieve a return on your investment will depend on appreciation in the price of
our Ordinary Shares.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We do not intend to pay
any cash dividends in the foreseeable future, and any determination to pay dividends in the future will be at the discretion of our board
of directors. Accordingly, you may need to rely on sales of our Ordinary Shares after price appreciation, which may never occur, as the
only way to realize any future gains on your investment.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks Relating to Investment in a Cayman Islands
Company and Our Status as a Foreign Private Issuer </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>As a &#8220;foreign private issuer,&#8221;
we are exempt from a number of U.S. securities laws and rules promulgated thereunder and will be permitted to publicly disclose less
information than U.S. public companies must disclose. This may limit the information available to holders of the Ordinary Shares and
may pose additional risks and less regulatory protection for our shareholders in comparison to domestic issuers.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We qualify as a &#8220;foreign
private issuer,&#8221; as defined in the SEC&#8217;s rules and regulations, and, consequently, we are not subject to all of the disclosure
requirements applicable to public companies organized within the United States. For example, we are exempt from certain rules under the
Exchange Act that regulate disclosure obligations and procedural requirements related to the solicitation of proxies, consents or authorizations
applicable to a security registered under the Exchange Act. In addition, our officers and directors are exempt from the reporting and
&#8220;short-swing&#8221; profit recovery provisions of Section 16 of the Exchange Act and related rules with respect to their purchases
and sales of our securities. For example, some of our key executives may sell a significant number of Ordinary Shares and such sales
will not be required to be disclosed as promptly as public companies organized within the United States would have to disclose. Accordingly,
once such sales are eventually disclosed, the price of Ordinary Shares may decline significantly. Moreover, we will not be required to
file periodic reports and financial statements with the SEC as frequently or as promptly as U.S. public companies. We are also not subject
to Regulation FD under the Exchange Act, which would prohibit us from selectively disclosing material nonpublic information to certain
persons without concurrently making a widespread public disclosure of such information. Accordingly, there may be less publicly available
information concerning us than there is for U.S. public companies.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As a &#8220;foreign private
issuer,&#8221; we file an annual report on Form 20-F within four months of the close of each fiscal year ended June 30 and furnish reports
on Form 6-K relating to certain material events promptly after we publicly announce these events. However, because of the above exemptions
for foreign private issuers, which we intend to rely on, our shareholders will not be afforded the same information generally available
to investors holding shares in public companies that are not foreign private issuers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><!-- Field: Page; Sequence: 50; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may lose our foreign private issuer
status in the future, which could result in significant additional costs and expenses. This would subject us to GAAP reporting requirements
which may be difficult for us to comply with.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As a &#8220;foreign private
issuer,&#8221; we are not required to comply with all of the periodic disclosure and current reporting requirements of the Exchange Act
and related rules and regulations. Under those rules, the determination of foreign private issuer status is made annually on the last
business day of an issuer&#8217;s most recently completed second fiscal quarter, and, accordingly, the next determination will be made
with respect to us on December 31, 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In the future, we could
lose our foreign private issuer status if a majority of our Ordinary Shares are held by residents in the United States and we fail to
meet any one of the additional &#8220;business contacts&#8221; requirements. Although we intend to follow certain practices that are
consistent with U.S. regulatory provisions applicable to U.S. companies, our loss of foreign private issuer status would make such provisions
mandatory. The regulatory and compliance costs to us under U.S. securities laws if we are deemed a U.S. domestic issuer may be significantly
higher. If we are not a foreign private issuer, we will be required to file periodic reports and prospectuses on U.S. domestic issuer
forms with the SEC, which are more detailed and extensive than the forms available to a foreign private issuer. For example, we would
become subject to the Regulation FD, aimed at preventing issuers from making selective disclosures of material information. We also may
be required to modify certain policies to comply with good governance practices associated with U.S. domestic issuers. Such conversion
and modifications will involve additional costs.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In addition, we may lose
our ability to rely upon exemptions from certain corporate governance requirements of Nasdaq that are available to foreign private issuers.
For example, Nasdaq&#8217;s corporate governance rules require listed companies to have, among other things, a majority of independent
board members and independent director oversight of executive compensation, nomination of directors, and corporate governance matters.
As a &#8220;foreign private issuer&#8221;, we are permitted to follow home country practice in lieu of the above requirements. As long
as we rely on the foreign private issuer exemption to certain of Nasdaq&#8217;s corporate governance standards, a majority of the directors
on our Board are not required to be independent directors, our compensation committee is not required to be comprised entirely of independent
directors, and we will not be required to have a nominating committee. Also, we would be required to change our basis of accounting from
IFRS as issued by the IASB to GAAP, which may be difficult and costly for us to comply with. If we lose our foreign private issuer status
and fail to comply with U.S. securities laws applicable to U.S. domestic issuers, we may have to de-list from Nasdaq and could be subject
to investigation by the SEC, Nasdaq and other regulators, among other materially adverse consequences.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Because we are incorporated under the laws of the Cayman Islands,
you may face difficulties in protecting your interests, and your ability to protect your rights through the U.S. Federal courts may be
limited.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We are an exempted company
incorporated under the laws of the Cayman Islands. As a result, it may be difficult for investors to effect service of process within
the United States upon our directors or officers, or enforce judgements obtained in the United States courts against our directors or
officers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our corporate affairs are
governed by our Articles, the Companies Act (as the same may be supplemented or amended from time to time) and the common law of the
Cayman Islands. We will also be subject to the federal securities laws of the United States. The rights of shareholders to take action
against the directors, actions by minority shareholders and the fiduciary responsibilities of our directors to us under Cayman Islands
law are to a large extent governed by the common law of the Cayman Islands. The common law of the Cayman Islands is derived in part from
comparatively limited judicial precedent in the Cayman Islands as well as from English common law, the decisions of whose courts are
of persuasive authority, but are not binding on a court in the Cayman Islands.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p><div>

</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The rights of our shareholders and the fiduciary
responsibilities of our directors under Cayman Islands law are different from what they would be under statutes or judicial precedent
in some jurisdictions in the United States. In particular, the Cayman Islands has a different body of securities laws as compared to
the United States, and certain states, such as Delaware, may have more fully developed and judicially interpreted bodies of corporate
law. In addition, Cayman Islands companies may not have standing to initiate a shareholders derivative action in a Federal court of the
United States. &#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Shareholders of Cayman Islands
exempted companies have no general rights under Cayman Islands law to inspect corporate records or to obtain copies of the register of
members of these companies. Our directors have discretion under our Articles to determine whether or not, and under what conditions,
our corporate records may be inspected by our shareholders but are not obliged to make them available to our shareholders. This may make
it more difficult for you to obtain the information needed to establish any facts necessary for a shareholder motion or to solicit proxies
from other shareholders in connection with a proxy contest.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><!-- Field: Page; Sequence: 51; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We have been advised by
Ogier (Cayman) LLP, our Cayman Islands legal counsel, that the courts of the Cayman Islands are unlikely (i) to recognize or enforce
against us judgments of courts of the United States predicated upon the civil liability provisions of the federal securities laws of
the United States or any state; and (ii) in original actions brought in the Cayman Islands, to impose liabilities against us predicated
upon the civil liability provisions of the federal securities laws of the United States or any state, so far as the liabilities imposed
by those provisions are penal in nature. In those circumstances, although there is no statutory enforcement in the Cayman Islands of
judgments obtained in the United States, the courts of the Cayman Islands will recognize and enforce a foreign money judgment of a foreign
court of competent jurisdiction without retrial on the merits based on the principle that a judgment of a competent foreign court imposes
upon the judgment debtor an obligation to pay the sum for which judgment has been given provided certain conditions are met. For a foreign
judgment to be enforced in the Cayman Islands, such judgment must be final and conclusive and for a liquidated sum, and must not be in
respect of taxes or a fine or penalty, inconsistent with a Cayman Islands judgment in respect of the same matter, impeachable on the
grounds of fraud or obtained in a manner, or be of a kind the enforcement of which is, contrary to natural justice or the public policy
of the Cayman Islands (awards of punitive or multiple damages may well be held to be contrary to public policy). A Cayman Islands Court
may stay enforcement proceedings if concurrent proceedings are being brought elsewhere.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As a result of all of the
above, our shareholders may have more difficulty in protecting their interests in the face of actions taken by management, members of
the board of directors or controlling shareholders than they would as public shareholders of a United States company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>U.S. Tax Risk Factors</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We believe we likely were a passive foreign
investment company (&#8220;PFIC&#8221;) for U.S. federal income tax purposes for our taxable year ending June 30, 2025, and may be classified
as a PFIC for our current taxable year or future taxable years which could subject U.S. holders of the Ordinary Shares to adverse U.S.
federal income tax consequences. </i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">A non-U.S. corporation will
be a PFIC for U.S. federal income tax purposes in any taxable year in which, after taking into account the income and assets of the corporation
and certain subsidiaries pursuant to applicable &#8220;look-through rules,&#8221; either (i) at least 75% of the corporation&#8217;s gross
income is &#8220;passive income&#8221; or (ii) at least 50% of the value of the corporation&#8217;s assets (generally based on the quarterly
average of the value of its assets during the taxable year) is attributable to assets, including cash, that produce passive income or
are held for the production of passive income. Passive income generally includes dividends, interest, certain royalties and rents, annuities,
net gains from the sale or exchange of property producing such income and net foreign currency gains.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Based on the composition
of our income, we believe we likely were a PFIC for our taxable year ending June 30, 2025, and may be a PFIC for our current taxable year
or future taxable years. However, since the tests for determining PFIC status are applied annually after the close of the taxable year,
and it is difficult to predict accurately future income and assets relevant to this determination, there can be no assurance with respect
to our PFIC status for our current taxable year or any future taxable year. Further, we provide no assurances that we will make a determination
as to our PFIC status in respect of any taxable year. The fair market value of our assets is expected to depend, in part, upon (a) the
market value of the Ordinary Shares, and (b) the composition of our assets and income. Because we may value our goodwill based on the
market value of the Ordinary Shares, a decrease in the market value of the Ordinary Shares and/or an increase in cash or other passive
assets would increase the relative percentage of our passive assets. The application of the PFIC rules is subject to uncertainty in several
respects and, therefore, no assurances can be provided that the IRS will not assert that we are a PFIC with respect to any taxable year.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">If we are a PFIC in any year
during which a U.S. holder (as defined under &#8220;U.S. Federal Income Tax Considerations&#8221;) owns the Ordinary Shares, subject to
the discussion below regarding the mark-to-market or qualified electing fund elections,, a U.S. holder generally will be subject to special
rules with respect to (i) any &#8220;excess distribution&#8221; (generally, any distributions received by a U.S. holder on its Ordinary
Shares in a taxable year that are greater than 125% of the average annual distributions received by the U.S. holder in the three preceding
taxable years or, if shorter, the U.S. holder&#8217;s holding period for the Ordinary Shares) and (ii) any gain realized on the sale,
exchange, redemption or other taxable disposition of Ordinary Shares. Under these rules (a) the excess distribution or gain will be allocated
ratably over the U.S. holder&#8217;s holding period, (b) the amount allocated to the current taxable year and any taxable year prior to
the first taxable year in which we became a PFIC will be taxed as ordinary income, and (c) the amount allocated to each of the other taxable
years will be subject to tax at the highest rate of tax in effect for the applicable class of taxpayer for that year, and an interest
charge for the deemed deferral benefit will be imposed with respect to the resulting tax attributable to each such other taxable year.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">U.S. holders should consult
their  tax advisors regarding the likely application of the PFIC rules and the consequences to them, including potential reporting
requirements, if we are a PFIC for any taxable year, and should read the discussion below under &#8220;<span style="font-weight: normal">U.S.
Federal Income Tax Considerations&#8211;&#8211;Passive Foreign Investment Company Rules</span>.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><!-- Field: Page; Sequence: 52; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p><div>

</div><div><a id="k_016"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>ITEM 4. INFORMATION ON THE COMPANY</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="k_017"></a></div><p style="margin-left: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>A. History and Development of the Company</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>General Overview</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Moolec is an integrated
ingredient and food-tech platform built on two complementary engines for producing alternative proteins. On one front, the Company advances
its molecular farming programs in crops such as soy and safflower to produce proteins and lipids with animal-like functionality and plant-based
cost structures. On the other front, Moolec is developing a precision fermentation facility in Finland, under the SynBio Powerlabs brand,
which will be dedicated to producing target proteins, enzymes, and other biomolecules using optimized microbial and cellular systems.
Once operational, this facility will provide an industrial pathway to design, ferment, and scale alternative proteins while establishing
commercial channels with leading food companies.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The combination of these
two complementary approaches, farming and fermentation, enables the Company to accelerate time-to-market, diversify technology risks,
and anchor production costs in agricultural scalability, without compromising product functionality or organoleptic properties.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The fermentation capabilities
being developed in Finland expand Moolec&#8217;s scientific base, strengthening the Company&#8217;s original expertise in yeasts and
microorganisms while enabling rapid iteration, precise specification, and controlled protein production. In parallel, Moolec&#8217;s
Molecular Farming programs &#8212; Piggy Sooy (porcine proteins expressed in soybean) and GLASO (safflower-derived GLA oil) &#8212; continue
to advance through agronomic, regulatory and scale-up stages. Both technological platforms converge under a single strategic thesis:
to produce ingredients with animal-like quality and functionality through biological systems that combine scalability, affordability,
and sustainability.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our execution capacity is
underpinned by Agrality, Moolec&#8217;s in-house service platform with operations in Argentina, Brazil, and the United States. Agrality
provides field trials, regulatory testing, crop characterization, analytics and seed production, as well as comprehensive crop and field
monitoring, a capability that is key to ensuring cost efficiency and operational precision. These integrated services enable us to design,
test and iterate in real agricultural conditions while reducing friction in the data packages required for Piggy Sooy, GLASO, and our
future molecular farming pipeline.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Complementing this, InMet
contributes to a synthetic biology and small-scale fermentation platform that includes pilot-plant capabilities, protein engineering,
metabolomics and synthetic strain optimization. InMet bridges the critical gap between discovery and industrial scale-up, allowing us
to design, ferment and characterize molecules at pilot scale, de-risking processes prior to large-scale production and improving the
cost and success profile of commercialization.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our formal equity relationship
with Bioceres Crop Solutions provides access not only to biological inputs that enhance productivity and plant health, but also to the
HB4<sup>&#174;</sup> climate-smart technology platform, which strengthens sustainability and crop yield under stress conditions. These
assets directly support the scalability of our Molecular Farming programs in the field and help mitigate agronomic volatility.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">A further dimension of sustainability
is provided by Gentle Tech, which contributes agricultural-machinery innovations such as harvesting heads and prototypes that are lighter,
consume less fuel, reduce soil compaction, and increase throughput and harvesting speed. These advances improve both the cost and environmental
profile of our farming operations, extending our sustainability logic from laboratory and fermenter to the field and harvest.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In summary, Moolec operates
an integrated platform encompassing R&amp;D, manufacturing, and regulatory capabilities that span from molecular design to validation
in both fermenter and field environments. Moolec&#8217;s multidisciplinary team includes PhDs, food scientists, agronomists and experienced
industry professionals, with operations across the United States, Europe, and South America. On the commercial front, the Company is
building channels for fermentation-derived ingredients with leading food industry partners in Europe, the United States, and Mexico,
while advancing regulatory approvals and supply chain development for its Molecular Farming products.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><!-- Field: Page; Sequence: 53; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Moolec&#8217;s ambition
is to consolidate a portfolio of ingredients that combine animal-like functionality with plant-based cost structures, supported by proprietary
intellectual property, industrial assets, and in-house execution capabilities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">For investors, this represents
a platform with multiple value horizons: near-term revenues from services and fermentation contracts; mid-term opportunities from precision-fermented
proteins; and long-term scalability from validated Molecular Farming traits and ingredients. This strategy is anchored in differentiated,
hard-to-replicate assets, proprietary infrastructure spanning fermentation, pilot, and field scales, strong regulatory and IP capabilities,
access to HB4<sup>&#174;</sup> and other advanced biological inputs, and a continuous learning cycle that connects and enhances both our
fermentation and farming operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our History</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Moolec was incorporated
under the laws of the Grand Duchy of Luxembourg on May 23, 2022, as a public limited liability company (<i>Soci&#233;t&#233; Anonyme</i>)
governed by the laws of the Grand Duchy of Luxembourg, having our registered office at 17, Boulevard F.W. Raiffeisen, L-2411 Luxembourg,
Grand Duchy of Luxembourg and registered with the Luxembourg Trade and Companies&#8217; Register (<i>Registre de Commerce et des Soci&#233;t&#233;s,
Luxembourg</i>) under number B268440. Following the Redomiciliation, our address is at c/o Ogier Global (Cayman) -89 Nexus Way, Camana
Bay, Grand Cayman KY1-9009. Our principal website address is www.moolecscience.com and our Investor Relations website address is ir.moolecscience.com.
The SEC also maintains a website at http://www.sec.gov which contains reports and other information regarding registrants that file electronically
with the SEC. We do not incorporate by reference the information contained on, or accessible through, our websites into this annual report
on form 20-F, and you should not consider such information to be a part of this annual report.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On April 24, 2023, we completed
the acquisition of ValoraSoy Food Ingredients from the sellers pursuant to a share purchase agreement. ValoraSoy Food Ingredients specializes
in the production of textured soy proteins and has a long track record of providing high-quality products and customized solutions to
clients in more than 15 countries across three continents. Its products are manufactured through various extrusion processes to obtain
vegetable proteins with texture and fibrousness similar to those of meat, with applications in hamburgers, sausages, and other plant-based
products. As a result of this acquisition, we acquired all of the issued and outstanding equity securities of ValoraSoy Food Ingredients,
which became our wholly owned subsidiary, for total aggregate consideration of $2.6 million, payable in a combination of cash and equity.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On June 16, 2025, we completed the business combination with Bioceres
Group Limited, Nutrecon LLC and Gentle Technologies Corp. pursuant to the terms of the Business Combination Agreement approved by our
shareholders. Through this transaction, we acquired all the issued and outstanding equity interests of Bioceres Group and Nutrecon and
50% of Gentle Tech, integrating into our company mature agricultural biologicals and seed businesses, nutritional solutions, and emerging
technology ventures. In consideration for the contributed entities, we issued approximately 6.2 million of our ordinary shares to the
shareholders of Bioceres Group, 450,000 of our ordinary shares and 500,000 private warrants with an exercise price of US$20.00 per share
to the shareholders of Nutrecon, and 132,750 to the shareholders of Gentle Tech. Also, Moolec Science SA committed to issue additional
ordinary shares twelve months after the acquisition date, representing the 10% of the total shares to be issued (the &#8220;Holdback&#8221;),
representing approximately 0.7 million of ordinary shares to the shareholders of Bioceres Group, 50,000 of ordinary shares to the shareholders
of Nutrecon, and 14,750 ordinary shares to the shareholders of Gentle Tech. As a result of this combination, Bioceres Group, Nutrecon
and Gentle Tech became subsidiaries of Moolec, and our company evolved into a diversified life sciences and food-tech platform. For more
information see &#8220;<i>&#8212;B. Business Overview&#8212;Significant Transactions&#8212;The Bioceres Group Business Combination Agreement.&#8221;</i></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On June 18, 2025, Bioceres
Crop Solutions Corp. (BIOX), a public company controlled until that date by Bioceres Group Limited, entered into an amendment with the
Secured Notes&#8217; holders by which the holders of the Secured Notes waived the breach of covenants that led to the default of the debt
(specifically, the breach of covenants related to the Consolidated Total Net Leverage Ratio (determined as the ratio of (a) Consolidated
Total Net Debt as of the last day of such Test Period to (b) Consolidated EBITDA of the Issuer and its Subsidiaries for such Test Period)
of 3.75x as of March 31, 2025), retrospectively modifying the required Consolidated Total Net Leverage Ratio to 5x Consolidated Total
Net Leverage Ratio, and extended the maturity of the Secured Notes to August 31, 2027. In accordance with the terms of the amendments,
effective June 24, 2025, Gloria Montaron Estrada, Enrique Lopez Lecube, and Keith McGovern were replaced in Bioceres Crop Solutions Corp.&#8217;s
Board of Directors by Milen Marinov, Noah Kolatch and Scott Crocco, who were nominated by certain holders of the Secured Notes. Bioceres
Crop Solutions Corp. agreed, for so long as the Secured Notes remain outstanding, to continue to nominate Messrs. Marinov, Kolatch and
Crocco (or such other persons as may be nominated as their replacements) for additional terms as directors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The effect of the changes in the terms of the Secured Notes of Bioceres
Crop Solutions, resulted in the loss of de facto control of that subsidiary and consequently, its deconsolidation. The equity method was
applied to account for the investment in such former subsidiary, as well as for other investments in joint ventures and associates (the
&#8220;BIOX deconsolidation&#8221;). Even when there was a deconsolidation of the business, the Company will continue to be affected by
BIOX business due to the HB4 royalty agreement. It is important to note that the effects of the loss of control in BIOX represents substantially
all of the Company&#8217;s business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 54; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Recent developments</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>Support letter and working
capital financing agreement</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On December 17, 2025, the
Company entered into a support letter with its principal shareholder, Union Group Ventures Limited, which has confirmed its intention
to take all reasonable steps and to use commercially reasonable efforts to enable Moolec Science SA to continue its operations and to
meet its liabilities incurred in the ordinary course of business as they become due for a period of twelve (12) months from the submission
of this annual report on Form 20-F. In addition, in November 2025, the Company consummated a loan financing of US$2.5 million, primarily
intended to support working capital and operational needs of Glaso, Synbio Powerlabs Oy, and ValoraSoy S.A.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>GLASO (Plant-Engineered
Safflower Platform) &#8211; AG Biomolecules LLC</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On December 11, 2025, Moolec&#8217;s
GLASO platform achieved a significant operational milestone with the successful completion of its U.S. GLASO safflower campaign, marking
the Company&#8217;s first large-scale expansion of its plant-engineered molecular farming platform. This campaign demonstrates Moolec&#8217;s
ability to execute at commercial scale, transitioning from prior development and smaller pilot cycles into a broader agronomic deployment
using existing U.S. farming infrastructure.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Key achievements include:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">1)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Expanded
Acreage and Yield Performance: The 2025 campaign covered approximately 1,100 acres across the United States, more than doubling prior
acreage, and delivered an average yield of ~2,200 lb/acre, representing a 57% year-over-year increase compared to 2024. This performance
materially exceeded internal forecasts and reinforces confidence in agronomic optimization and operational execution.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">2)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Large-Scale
Value-Chain Validation: These results provide the first evidence that the GLASO platform can operate successfully at commercial-scale
volumes while maintaining traceability, quality, and cost discipline. This operational validation supports continued scale-up planning
and reinforces Moolec&#8217;s ability to manage complex field deployments and harvest logistics.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">3)&#160;&#160;&#160;&#160;&#160;&#160;&#160;High-Growth
Commercial Opportunity: The campaign has uncovered early demand from leading wellness and performance brands in the U.S. nutrition and
supplements market, a segment characterized by robust growth, premium positioning, and stringent quality requirements. This interest positions
GLASO for entry into high-value functional lipid markets, including high-concentration GLA softgel applications, which could unlock differentiated
commercialization pathways and access established distribution channels.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">4)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Strategic
Commercial Focus: Management continues to emphasize disciplined, execution-led platform scaling, aligning capital expenditure with demonstrated
agronomic performance and market pull. The 2025 GLASO campaign represents a foundational step toward repeatable commercial-scale production,
improved inventory availability for customers, and the potential for recurring revenue streams tied to high-value end markets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Overall, GLASO&#8217;s 2025
U.S. campaign reinforces Moolec&#8217;s ability to transform scientific innovation into tangible, operational outcomes by testing and
validating key assumptions related to acreage scalability, crop performance, supply chain execution, and commercial demand. This progress
enhances Moolec&#8217;s operational credibility and supports improved oversight, financial controls, and execution discipline at the subsidiary
level.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In parallel, Moolec&#8217;s
next molecular farming technology, Piggy Sooy (porcine proteins expressed in soybean, technology patented in the United States), continues
to advance through agronomic development, regulatory pathways, and scale-up. Together with GLASO, Piggy Sooy converges under a single
strategic thesis: the production of ingredients with animal-like quality and functionality through biological systems that deliver scalability,
affordability, and sustainability.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>Synbio Powerlabs Oy (Precision
Fermentation Platform)</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Synbio Powerlabs has successfully
completed the construction of a one-of-a-kind precision fermentation pilot facility in Finland, co-financed by the European Union and
Business Finland, reflecting strong institutional validation and public-sector support. The multipurpose facility is now equipped with
state-of-the-art bioreactor infrastructure spanning 50 L, 500 L, 10,000 L, and two 27,000 L units, enabling a unique, fully integrated
scale-up pathway from laboratory to commercial volumes within a single site. The installation of this core equipment has recently been
completed.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In parallel, Synbio Powerlabs
has secured a binding commercial agreement with a cultivated meat company to scale its production process from 400 L to 10,000 L at the
Synbio Powerlabs pilot facility. This engagement represents a significant operational milestone, positioning the facility as an enabling
platform for advanced scale-up in high-value applications, including premium Wagyu and Angus cultivated meat markets. Management views
this agreement as an important validation of the facility&#8217;s technical capabilities, execution readiness, and potential to support
revenue-generating pilot-to-commercial transition activities, while maintaining disciplined cost controls and operational oversight.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 55; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>ValoraSoy (Value-added
Soy Ingredients Platform)</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">ValoraSoy operates as a commercially
active subsidiary focused on the production and international commercialization of value-added, texturized soy ingredients for a broad
range of food applications. The business maintains an established export footprint across multiple international markets and supplies
differentiated solutions tailored to customer specifications, supported by an industrial-scale production platform. ValoraSoy&#8217;s
operations generate recurring commercial activity and provide the Company with near-term operating revenues.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Under the Company&#8217;s
renewed management framework, ValoraSoy is prioritizing operational discipline, cost optimization, and improved working-capital management,
while continuing to leverage its existing manufacturing capabilities and customer relationships. In parallel, management is actively pursuing
new market entry opportunities and customer expansion initiatives, with a focus on geographies and applications that align with the Company&#8217;s
margin and risk objectives. Enhanced internal controls have been implemented around production planning, inventory management, and commercial
contracting to ensure scalability is matched with financial oversight and transparency.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>Agrality Inc. (Agricultural
Biotechnology Platform)</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Agrality operates as a strategic
innovation and integration platform within Moolec&#8217;s portfolio, supported by its own operational and R&amp;D facilities in the United
States, Brazil, and Argentina. This geographic footprint provides Agrality with direct access to key agricultural regions, talent pools,
and partner ecosystems, enabling hands-on development, testing, and validation of agricultural biotechnology initiatives across diverse
regulatory and production environments.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As part of the Company&#8217;s
broader integration and operational optimization strategy, Moolec has relocated its GLASO research and development platform to Agrality&#8217;s
R&amp;D headquarters in Lafayette, United States. This integration consolidates technical capabilities, infrastructure, and personnel
within a single, established facility, strengthening cross-functional collaboration between molecular farming, agronomy, and downstream
application teams.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The relocation has resulted in meaningful operational efficiencies, including reduced overhead, elimination of
duplicative infrastructure, and improved coordination of research, regulatory, and commercial preparation activities. By leveraging Agrality&#8217;s
existing facilities and operational backbone, management has enhanced execution speed while maintaining tighter control over costs, capital
allocation, and project oversight. This integration supports a more disciplined operating model and reinforces the Company&#8217;s focus
on efficiency, scalability, and internal control enhancement across its subsidiaries.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Our Strengths and Competitive Positioning
</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b><i>Environmental Advantages.</i></b>
We believe our platform offers measurable environmental benefits by shifting protein and lipid production away from resource-intensive
animal systems toward biology-based processes that can be scaled either in controlled fermentation environments or through existing agricultural
infrastructure. In Molecular Farming, the expression of functional proteins and oils directly in crops (e.g., Piggy Sooy in soybean and
GLASO in safflower) has the potential to reduce greenhouse gas emissions, land use, and blue-water consumption compared to conventional
animal supply chains, while mitigating downstream impacts associated with intensive livestock production. In precision fermentation,
producing target proteins, enzymes and other biomolecules using optimized microbial and/or cellular systems enables high conversion efficiency,
flexible geographic deployment, and tight control of inputs and utilities, collectively reducing waste and supporting the transition
to cleaner energy sourcing over time.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">A core element of the environmental
profile is traceability-by-design. For field programs, we implement identity-preserved seed lots, to maintain chain-of-custody from seed
increase through harvest and processing. For fermentation, the Finland facility (SynBio Powerlabs) will adopt a traceability-by-design
approach, incorporating batch genealogy, electronic batch records, and analytical release criteria to link every production lot to its
complete materials and utilities history. Together, these systems will enable cradle-to-gate life cycle assessments and support alignment
with emerging deforestation-free and supply chain transparency frameworks across our target markets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><!-- Field: Page; Sequence: 56; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our pipeline is designed
to strengthen environmental performance at the product level. Through GLASO, we valorize safflower oil while utilizing its co-products
&#8212;such as meal streams with established regulatory pathways&#8212; to improve overall material efficiency. Piggy Sooy aims to achieve
animal-like functionality within a crop-based platform, which, if scaled, could replace part of the animal-derived inputs currently used
in the food industry, thereby reducing land use and emission intensity per unit of functionality delivered. In fermentation, our programs
leverage microbial and cellular systems, focusing on fungi-based proteins and complementary yeast platforms to produce high-purity, consistent
outputs with minimal downstream losses. This approach improves yield efficiency and enables localized or regional production close to
demand centers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Through the recent Business
Combination, we have incorporated several enablers that enhance our environmental performance. Access to HB4<sup>&#174;</sup> climate-smart
technologies and other biological inputs through our relationship with Bioceres Crop Solutions is designed to improve water-use efficiency
and yield stability under stress, thereby reducing agronomic volatility and input intensity across our field programs. Gentle Tech&#8217;s
lightweight harvesting heads and prototype machinery are engineered to lower fuel consumption, reduced soil compaction, and increase
harvest throughput, improving both the energy and soil-health footprint of our Molecular Farming operations. At sub-industrial scale,
InMet&#8217;s synthetic-biology and pilot-fermentation capabilities enable us to de-risk processes prior to full scale-up, minimizing
failed large-batch runs and the associated waste.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Overall, by combining field-scale
biology with controlled fermentation and embedding traceability across both systems, we aim to lower unit environmental intensity, minimize
waste through co-product utilization and disciplined process design, and document outcomes with auditable data trails. This integrated
configuration positions our portfolio to meet customer expectations for functionality and cost while supporting credible, data-driven
sustainability claims.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b><i>Shift in Consumer
Preferences.</i></b> Consumers&#8217; increasing focus on health, sustainability, ethical sourcing, animal welfare, and convenience is
driving food producers and retailers to rethink portfolios traditionally dependent on animal-derived inputs. Our dual-engine platform
&#8211; combining molecular farming in crops with precision fermentation in controlled facilities &#8211; is uniquely positioned to meet
this transition, delivering animal-like functionality with plant-based efficiency, scalability, and full traceability. We plan to continue
advancing our brand and product portfolio, while forging partnerships with food companies that seek credible, scalable, and cost-effective
alternatives. Although consumer preferences differ across markets and price segments and may evolve over time, we believe this structural
shift toward sustainable protein sources positions us favorably against conventional suppliers. <i>See Item 4.B&#8212;Business Overview.</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b><i>Industrial Shift.</i></b>
The food and feed industries are undergoing a global ingredient transition. We believe this shift is driven by six structural pillars:
(i) supply-chain resilience, (ii) cost dynamics, (iii) compliance and responsible sourcing, (iv) operational complexity, (v) sustainability,
and (vi) innovation.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Supply-chain
resilience.</b> Recent droughts, livestock disease outbreaks, trade frictions and geopolitical instability, &#8212;combined with growing
demand for locally sourced food&#8212;, have revealed vulnerabilities in cross-border ingredient flows, leading to intermittent shortages
of key animal-derived inputs (such as milk, pork and poultry).</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cost
dynamics. </b>Price volatility and, in many cases, sustained cost inflation in animal-derived proteins and derivatives have prompted
formulators to partially replace these inputs across multi-component products such as processed meats, cheese-containing items, baked
goods, and prepared foods.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compliance
and responsible sourcing. </b>New regulations on due diligence, traceability and deforestation-free supply chains are increasing compliance
costs and reducing tolerance for sourcing from constrained or high-risk categories.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><div>

</div><!-- Field: Page; Sequence: 57; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Operational
complexity and food safety. </b>Stricter regimes regarding cross-contamination and labeling claims (including organic, allergen-free,
cruelty-free, and GMO-free) are encouraging manufacturers to adopt dedicated products lines and tighter raw-material segregation.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sustainability</b>.
Corporate decarbonization goals and biodiversity commitments are accelerating the search for lower impact ingredients that reduce land
use, water consumption, and emissions per unit of functional output.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Innovation</b>.
Growing demand for functional, scalable alternatives is expanding the role of plant-based, microbial, and cellular systems to address
applications where traditional plant proteins have historically underperformed.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We believe our dual-engine
platform&#8212;molecular farming in crops and precision fermentation in controlled facilities&#8212;is designed to address these structural
pillars by enabling localized or regionalized production, identity-preserved and traceable supply chains, and ingredient functionality
with plant-based economics. Traceability is built into both systems: through georeferenced field lots and chain-of-custody protocols
in farming, and batch genealogy with electronic batch records in fermentation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In Molecular Farming, our
programs, including Piggy Sooy and GLASO, aim to deliver animal-like performance while leveraging existing agricultural infrastructure.
In precision fermentation, our Finnish facility focuses on fungi-based proteins with high specification control and flexible geographic
siting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Together with Agrality (field
trials, regulatory testing, and crop characterization), InMet (synthetic biology and pilot-scale fermentation), and our relationship
with Bioceres Crop Solutions (biological inputs and HB4&#174; climate-smart technologies), we believe these capabilities will help mitigate&#8212;though
not fully eliminate&#8212;risks related to supply availability, cost volatility, compliance, and operational constraints, while supporting
our customers&#8217; increasing demands for sustainability and innovation. <i>See Item 3.D&#8212;Risk Factors.</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b><i>Taste and Texture</i></b>.
Alternatives to animal-derived foods are steadily advancing toward parity with their conventional counterparts, supported by a growing
base of consumers who actively choose plant-based products. To achieving a meaningful global impact on sustainability and health, however,
broader adoption is needed. This requires appealing not only to committed vegans but also flexitarian and reducetarian consumers who
seek familiar taste, texture and functionality.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We believe that success
in this space depends on developing products that convincingly replicate the sensory and functional attributes of animal-based products
while offering nutritional, cost, and environmental advantages. If these products can endure across one or two generations, a structural
shift in food systems could begin&#8212;gradually transitioning towards ingredients that are less animal-like but superior in efficiency
and sustainability.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our approach, which includes
expressing animal proteins in plants, aims to enhance the functionality of plant- and seed-based formulations that dominate the alternative
protein sector. These animal-derived proteins confer key properties&#8212;such as texture, binding, and stability&#8212; that are difficult
to replicate with conventional plant ingredients. Combined with advances in flavor development using plant and/or microbial systems,
we believe this can move the industry closer the delivering taste and performance with traditional animal-based products.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We believe our products
resonate with consumers who appreciate the traditional taste and texture of meat but share our values around sustainability and innovation.
One of the main challenges for the science-based food ingredient industry has been replicating the sensory experience of meat &#8211;
particularly its taste and texture. Through our technology, the key proteins responsible for these attributes are produced directly within
the plants themselves. This unique approach positions us at an advantageous position when compared to competitors that rely on external
formulations or processing methods to recreate meat-like qualities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b><i>Nutritional Values</i></b>.
We are a mission-driven company, and nutritional value is central to our priorities. Increasingly, data highlights the link between diet,
general health, and wellbeing. Many foods that are attractive in terms of taste, cost, or convenience may not contribute to a balanced
diet and replacing them while still appealing to mainstream consumers remains a challenge.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><!-- Field: Page; Sequence: 58; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Through molecular farming,
we produce animal proteins directly in plants, maintaining the same amino acid sequences as those naturally consumed by humans throughout
evolution. By incorporating these proteins in crops, we aim to enhance the overall nutritional profile of the products we develop.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">For the health-conscious
consumer, we believe this represents a strong competitive advantage. Our technology is designed to deliver the nutritional benefits of
traditional meat, including specific animal proteins, without relying on less healthy ingredients typically used to recreate meat alternatives.
As discussed above, currently consumers are more health conscious when making decisions related to their food; we are well positioned
to capitalize on this growing trend.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b><i>Scalability and Low
Costs</i></b>. We aim to achieve scalable and competitive unit economics throughout two complementary production engines&#8212;molecular
farming in crops and precision fermentation in controlled facilities&#8212;each designed to leverage existing infrastructure and minimize
downstream complexity.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In molecular farming, the
expression of functional proteins and lipids in soybean and safflower allows post-harvest operations to remain largely aligned with established
oilseed workflows, reducing incremental capital and operating expenditures. Agrality supports seed multiplication and trialing across
Argentina, Brazil, and the United States, accelerating time-to-scale, while ValoraSoy adds soy texturization and downstream processing
to capture margin steps and improve conversion efficiency; co-product valorization (e.g., meal and oil fractions) further enhances overall
material efficiency.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In precision fermentation,
our Finland facility focuses on volumetric productivity, batch consistency, and specification control. This enables modular capacity
expansion close to demand centers and progressive cost-of-goods improvements through strain and process optimization. InMet provides
synthetic-biology and pilot-scale fermentation capabilities, bridging discovery and industrial scale to de-risk process development and
reduce the cost of failures.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Taken together, precision
fermentation offers a controllable cost base and rapid iteration, while molecular farming offers agriculture-scale volumes and plant-based
economics. The combination diversifies cost drivers, expands supply optionality, and supports competitive pricing across applications
in food, pet food, feed and dietary supplements. Although input, agricultural and energy costs may fluctuate, we believe that this dual-engine
configuration, supported by Agrality&#8217;s scale-up services and ValoraSoy&#8217;s processing platform, positions us to achieve lower
unit costs at scale compared to both conventional animal inputs and certain alternative protein technologies. <i>See Item 3.D&#8212;Risk
Factors and Item 5&#8212;Operating and Financial Review and prospects.</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">One of our lead products,
Mycofood&#8482; exemplifies Moolec&#8217;s approach in action. It is a scalable, 100% animal-free protein ingredient obtained through
precision fermentation of fungal biomass. Designed to deliver a neutral taste and versatile texture, it can be seamlessly integrated
into a wide range of food systems&#8212;from meat analogues to protein-enriched formulations&#8212;without altering flavor or mouthfeel.
With a PDCAAS of 0.92, comparable to beef and soy, Mycofood&#8482; provides complete nutritional quality while ensuring consistency and
functionality. Produced under HACCP and GMP standards using traceable, non-GMO inputs, it offers a reliable, sustainable, and label-friendly
alternative for manufacturers seeking high-performance proteins that meet growing consumer demand for taste, texture, and environmental
responsibility.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b><i>Management team and
Industry Expertise</i></b>. We are led by an experienced management team with deep expertise in molecular farming, precision fermentation,
crop science, and agri-food commercialization. Our leadership includes Ph.D. -level scientist and seasoned industry operators with multi-decade
track records across the United States, Europe and Latin America. Following the Business Combination, we strengthened our capabilities
in nutrition and synthetic biology (including pilot- and industrial-scale fermentation) and integrated in-house regulatory, intellectual
property, and field-trial functions through Bioceres, Agrality and InMet. We believe this combination of scientific excellence and operational
experience enables disciplined scale-up, credible customer engagement, and capital-efficient growth. See &#8220;<i>Item 6. Directors,
Senior Management and Employees</i>&#8221;.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><!-- Field: Page; Sequence: 59; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Industry Overview</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The global food, feed, and
ingredient industries are in a period of structural transformation shaped by economic, environmental, and technological forces. Growing
consumer expectations around health, sustainability and transparency, alongside corporate and regulatory commitments to decarbonization
and supply-chain resilience, are driving a shift toward new biological manufacturing models. These trends are accelerating demand for
scalable alternatives to traditional animal-based inputs, opening new market segments for companies operating at the intersection of
agricultural biotechnology, precision fermentation, and food-tech innovation. Within this evolving context, the competitive landscape
is being redefined by platforms capable of delivering cost-effective, traceable, and functional ingredients that can be deployed across
global value chains.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Market Dynamics and Demand Drivers</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The global food and feed
industries are undergoing a structural transition toward science-based proteins and lipids driven by sustained consumer interest in health,
sustainability, animal welfare, and convenience, along with institutional priorities around cost efficiency, reliability, and traceability.
What began as a niche movement has now evolved into mainstream and private-label adoption, where functionality, price and supply assurance
are the key drivers of procurement decisions. While demand patterns have stabilized from the initial &#8220;hype&#8221; phase, structural
tailwinds&#8212;including corporate decarbonization commitments, deforestation-free sourcing mandates, Scope 1&#8211;3 reporting, and
nutritional reformulation initiatives&#8212;continue to reinforce long-term growth and integration of alternative and complementary ingredients
across global value chains.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Supply, Geopolitics and Localized Production</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Commodity and energy price
volatility, climate events, livestock disease cycles, and geopolitical tensions have underscored the fragility of globalized supply chains.
In response, the industry is showing growing interest in localized and regionalized production models, as well as flexible platforms
capable of shifting between field-based and controlled-facility manufacturing. Customers are increasingly adopting multi-sourcing strategies,
demanding auditable chain-of-custody systems, and seeking the ability to reposition production closer to demand centers to enhance supply
resilience and reduce the risk of disruption. <i>See Item 3.D&#8212;Risk Factors.</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Regulatory and Traceability</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Regulatory frameworks continue
to evolve across jurisdictions. In the United States, pathways under USDA and FDA provide precedents for crop traits and feed/food uses;
in the European Union and other markets, novel-food, traceability and deforestation-free rules are tightening, and acceptance of GMOs
and gene editing varies by application. Across regions, identity preservation in agriculture and batch genealogy/electronic batch records
in fermentation have become central to customers&#8217; compliance programs and LCA / Scope 1&#8211;3 disclosures, reinforcing demand
for platforms designed with traceability-by-design.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Technology Landscape</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Two biological manufacturing
modalities have become increasingly relevant: molecular farming, which leverages existing agricultural infrastructure to express functional
proteins and oils in widely grown crops, aiming for plant-based cost structures and agriculture-scale volumes; and precision fermentation,
which enables high-control, specification-tight production of proteins and functional molecules in industrial facilities that can be
sited closer to demand, with modular capacity expansion. A complementary layer of CRO/CDMO-style services&#8212;including field trialing,
regulatory analytics, seed increase and pilot/industrial fermentation&#8212;supports faster de-risking from discovery to scale-up and
is increasingly procured by food, feed and ag-input companies seeking to externalize development steps. <i>See Item 5&#8212;Operating
and Financial Review and Prospects.</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Addressable Markets (industry estimates)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Agricultural
biotechnology solutions (North America): </b>approximately US$20 billion in 2024, projected to exceed US$30 billion by 2030, reflecting
continued investment in trait development, high GM adoption and demand for specialized CRO services (e.g., regulatory testing, GMO field
trials, dossier preparation).</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 60; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;&#160;</b></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Agricultural
biotechnology solutions (South America):</b> approximately US$8 billion in 2024, expected to reach approximately US$14&#8211;15 billion
by 2030, with Brazil and Argentina as core growth markets given their global leadership in biotech crop production.</span></td>
</tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Synthetic
biology (global):</b> approximately US$16.2 billion in 2024, projected to approximately US$42.1 billion by 2030 (CAGR approximately 17.3%
of CAGR), spanning agriculture, food, healthcare and industrial biotech.</span></td>
</tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Precision
fermentation (global): </b>approximately US$3.03 billion in 2024, projected to approximately US$57 billion by 2032 (approximately 44.3%
of CAGR), driven by alternative proteins, enzymes, dairy substitutes and functional ingredients.</span></td>
</tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Cultivated
meat (global):</b> approximately US$1.2 billion in 2025, projected to &gt;US$10.7 billion by 2033 (approximately 16.5% of CAGR); relevant
as a complementary demand vector for enabling inputs and processing know-how.</span></td>
</tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Agricultural
equipment (global):</b> approximately US$193.5 billion in 2024, projected to approximately US$344.7 billion by 2032 (approximately 7.5%
of CAGR), reflecting mechanization, precision farming and autonomous machinery trends which influence the sustainability and efficiency
profile of field operations.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">These markets intersect across
biotechnology services (e.g., field testing, breeding, seed production/processing, regulatory affairs), synthetic biology and fermentation
(R&amp;D, pilot and industrial scale), and sustainable equipment that improves energy use, soil impact and harvest throughput.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Capital Markets and Competitive Landscape</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Financing conditions for alternative-protein
and ag-biotech companies have been cyclical, favoring platforms that combine near-term revenue generation (including services), credible
cost trajectories and disciplined scale-up. Competition includes incumbent animal-protein suppliers, plant-protein providers, fermentation-based
entrants, emerging molecular-farming developers, and diversified ag-input companies. Differentiation increasingly depends on the ability
to deliver functionality at target price, traceable supply, regulatory execution and scalable manufacturing across more than one biological
route. See <i>Item 3.D&#8212;Risk Factors</i>.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Implications for Platform Strategy</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Within this landscape, platforms
that integrate field-scale biology and controlled fermentation&#8212;supported by CRO/CDMO-style capabilities and traceability-by-design&#8212;are
positioned to offer customers supply optionality, cost resilience and auditable ESG data, which are becoming central to procurement decisions
in food, feed and nutrition markets. This configuration aligns with the shift toward localized production, multi-sourcing and outcome-driven
specifications that emphasize unit economics, reliability, and environmental performance over time.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Takeover Offers</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We are not aware of any public
takeover offers by third parties in respect of our securities, and we have not made any public takeover offers in respect of any other
company&#8217;s securities, during the last or current financial year.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p><div>

</div><div><a id="k_018"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>B. Business Overview</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Significant Transactions</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b>&#160;&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The Bioceres Group Business Combination.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Before the end of the fiscal
year, on June 16, 2025, the Company consummated a business combination (the &#8220;Business Combination&#8221;). Prior to such consummation,
a series of previous steps had taken place, as follows:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On May 14, 2025, Moolec Science
(Luxembourg) made effective a reverse stock split of its Ordinary Shares (the &#8220;Reverse Stock Split&#8221;) on the consolidation
ratio of ten-to-one (the &#8220;Consolidation Ratio&#8221;), pursuant to which holders of Ordinary Shares received one Ordinary Share
for every ten Ordinary Shares held.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><!-- Field: Page; Sequence: 61; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On May 22, 2025, the Company
changed its jurisdiction by redomiciling Moolec Science (Luxembourg) from the Grand Duchy of Luxembourg to the Cayman Islands as Moolec
Science (Cayman Islands) by way of continuation pursuant to Part XII of the Companies Act (Revised) of the Cayman Islands. On the Effective
Date, all of the shares of Moolec Science (Luxembourg), par value $0.10 per share by operation of law became shares of Moolec Science
(Cayman Islands), par value $0.10 per share (the &#8220;Ordinary Shares&#8221;).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">After completion of the Reverse
Stock Split, all references to the Ordinary Shares, share data, per share data and related information have been adjusted for the Consolidation
Ratio to reflect the Reverse Stock Split. The Reverse Stock Split has consolidated each ten of the Ordinary Shares into one Ordinary Share,
with a new par value of $0.10 per Ordinary Share. Upon completion of the Reverse Stock Split, no fractional Ordinary Shares were issued,
and any fractional Ordinary Shares resulting from the Reverse Stock Split were rounded up to the nearest whole Ordinary Share. Except
for the adjustments that resulted from the treatment of fractional shares, the Reverse Stock Split did not have any dilutive effect on
the shareholders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On June 16, 2025, following the consummation of the Business Combination,
the Company initiated integration processes across organizational, operational, and IT functions to support competitiveness and long-term
sustainability. In parallel, management continued to advance the ongoing operations, which remain crucial to maintaining business continuity
and supporting the successful execution of the integration and growth strategy. The consolidated results as of and for the year ended
June 30, 2025 (&#8220;FY2025&#8221;) reflect purchase accounting. The prior period as of and for the year ended June 30, 2024 (&#8220;FY2024&#8221;)
and for the year ended June 30, 2023 reflects the Predecessor on a stand-alone basis and does not include any effects of the Business
Combination. As a result, variances between FY2025 and FY2024 primarily reflect changes in scope and basis of presentation rather than
purely period-over-period operating trends, and therefore the periods are not directly comparable. Effective as of the Closing (i.e.,
June 16, 2025), the Company accounted for the Business Combination under IFRS 3, Business Combinations, using the acquisition method of
accounting and treating the transaction as a reverse acquisition. Under this approach, Bioceres Group (the legal subsidiary) was considered
the accounting acquirer, and Moolec Science SA (the legal acquirer) was considered the accounting acquiree, together with Gentle Tech
and Nutrecon.</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>Going Concern</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Business
Combination, initially announced on April 17, 2025, in which the Company, Bioceres Group (formerly, Bioceres Group PLC, one of the
main shareholders of the Company), Gentle Tech and Nutrecon entered into the Bioceres Group Business Combination Agreement, pursuant
to which several parties transferred their respective holdings in Bioceres Group, Nutrecon and Gentle Tech (together, the
&#8220;Contributed Entities&#8221;) to the Company, in exchange of a combination of newly issued Company&#8217;s shares, and
warrants, to the shareholders of the Contributed Entities. Following the closing, Moolec became the legal parent company of the
combined group comprising Bioceres Group, Gentle Tech, and Nutrecon. The Business Combination was ratified by Moolec shareholders at
the Extraordinary General Meeting (&#8220;EGM&#8221;) held on June 16, 2025, with 77% of the outstanding shares present at the
meeting, and 98% of the votes cast were in favor of the transaction. From an accounting perspective and based on the guidance of
IFRS 3, Bioceres Group Limited is deemed to be the accounting acquirer. The transaction was subsequently consummated on the same
date, June 16, 2025 (the &#8220;Closing&#8221;).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On June 18, 2025, Bioceres
Crop Solutions Corp. (BIOX), a public company controlled until that date by Bioceres Group Limited, entered into an amendment with the
Secured Notes&#8217; holders by which the holders of the Secured Notes waived the breach of covenants that led to the default of the debt
(specifically, the breach of covenants related to the Consolidated Total Net Leverage Ratio (determined as the ratio of (a) Consolidated
Total Net Debt as of the last day of such Test Period to (b) Consolidated EBITDA of the Issuer and its Subsidiaries for such Test Period)
of 3.75x as of March 31, 2025), retrospectively modifying the required Consolidated Total Net Leverage Ratio to 5x Consolidated Total
Net Leverage Ratio, and extended the maturity of the Secured Notes to August 31, 2027. In accordance with the terms of the amendments,
effective June 24, 2025, Gloria Montaron Estrada, Enrique Lopez Lecube, and Keith McGovern were replaced in Bioceres Crop Solutions Corp.&#8217;s
Board of Directors by Milen Marinov, Noah Kolatch and Scott Crocco, who were nominated by certain holders of the Secured Notes. Bioceres
Crop Solutions Corp. agreed, for so long as the Secured Notes remain outstanding, to continue to nominate Messrs. Marinov, Kolatch and
Crocco (or such other persons as may be nominated as their replacements) for additional terms as directors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><!-- Field: Page; Sequence: 62; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The effect of the changes
in the terms of the Secured Notes of Bioceres Crop Solutions, resulted in the loss of de facto control of that subsidiary and consequently,
its deconsolidation. The equity method was applied to account for the investment in such former subsidiary, as well as for other investments
in joint ventures and associates (the &#8220;BIOX deconsolidation&#8221;). Even when there was a deconsolidation of the business, the
Company will continue to be affected by BIOX business due to the HB4 royalty agreement. It is important to note that the effects of the
loss of control in BIOX represents substantially all of the Company&#8217;s business.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As a result of the loss of
control over BIOX, access to financing that Bioceres S.A., its wholly owned subsidiary Bioceres LLC, Bioceres Group Limited and Moolec
Science SA had until then, was restricted or limited.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In June 2025, Bioceres S.A.,
one of the Argentine subsidiaries of Bioceres Group Limited, defaulted on a portion of its financial debt that was due that month. As
a result, Bioceres S.A. had initiated a debt restructuring process for its financial debt for an aggregate amount of US$36.4 million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In July 2025, Bioceres
LLC, a wholly owned subsidiary of Bioceres S.A., received a notice of default on its financial debt&#160;in the amount of US$69.5
million. The creditor conducted a public auction for 3,062,500 pledged BIOX shares, pursuant to the New York Uniform Commercial
Code. Management has responded to the creditor, reserving all rights, remedies, and defenses. As of June 30, 2025, the current debt
amounts to US$58.0 million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The defaults by Bioceres S.A. and Bioceres LLC do not have implications in other debts as there are no cross-default
clauses on the remaining financial debt of the Group. <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no guarantees granted above Bioceres S.A. and Bioceres LLC.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As of June 30, 202<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5, the Group had
a negative working capital amounting to US$204,860,444, and a shareholders&#8217; deficit of US$82,873,602. Additionally, the Group reported
recurring operating losses amounting to US$104,150,129.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company had the financial
support of its main shareholders and considering the aforementioned events that derived in the loss of the financial support that was
previously provided by Bioceres Group (and who is also no longer a shareholder of the Company), and, consequently, raise a material uncertainty
which may cast significant doubt (or raise substantial doubt as contemplated by PCAOB standards) &#160;about the ability of Moolec Science
SA to continue as a going concern, currently, the Group lacks sufficient financial resources to meet its obligations or fully implement
its business plan. Without securing additional capital, the Group will not be able to sustain its operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The uncertainty surrounding
the ability to secure additional funding and the potential for continued operational losses contribute to substantial doubt about the
Group&#8217;s ability to continue as a going concern.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Management has plans to address
the Group&#8217;s financial situation as follows:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>Theo I SCSp</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On November 28, 2025, subsequent
to the reporting date, Theo I SCSp received a conditional payment order from district court of&#160; Luxembourg, and therefore the General
Partners engaged Ogier (Luxembourg) SCS represented by its general partner Ogier Luxembourg (GP) S.&#224;.r.l&#160; formally as their
legal advisor to assist with Theo I SCSp&#8217;s declaration of bankruptcy before the Luxembourg District Court. The declaration of bankruptcy
will declare Theo I SCSp bankrupt and appoint a receiver who will take control over the management of the company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The loss of control constitutes
the derecognition event under IFRS 10.25. Accordingly, the Group will derecognize the assets and liabilities of Theo I SCSp and will remeasure
its retained interest at fair value in accordance with IFRS 9 at the date of the derecognition event. This will result in the recognition
of an estimated gain of US$9.5 million in the consolidated statement of profit or loss as of the derecognition date.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Group will continue to measure its retained interest in Theo I SCSp at fair value through profit or loss
until the liquidation process is formally completed.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><!-- Field: Page; Sequence: 63; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>Bioceres S.A. and Bioceres
LLC</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On December 16, 2025, subsequent
to the reporting date, the Board of Directors of Bioceres S.A. formally approved the initiation of voluntary bankruptcy proceedings and
instructed management to seek and appoint a trustee (&#8220;<i>s&#237;ndico</i>&#8221;) to oversee the process. The commencement of
the voluntary bankruptcy proceedings and the transfer of decision-making authority to the trustee will result in the Group losing control
over Bioceres S.A. in accordance with the principles of IFRS 10 Consolidated Financial Statements. As Bioceres LLC is a wholly owned
subsidiary of Bioceres S.A., the Group simultaneously will lose  control over Bioceres LLC as well.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Under IFRS 10.25, the date
on which control is lost constitutes the derecognition event. Accordingly, after December 16, 2025, the Group will derecognize the assets
and liabilities of Bioceres S.A. and Bioceres LLC and will remeasure any retained interest at fair value in accordance with IFRS 9 Financial
Instruments.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The resulting derecognition
effects are expected to generate an approximate gain of US$91.0 million related to the loss of control of Bioceres S.A. and an additional
approximate gain of US$5.3 million related to the loss of control of Bioceres LLC (including the loss of holding in BIOX, therefore it
will no longer be an equity method associate). These amounts will be recognized in the consolidated statement of profit or loss as of
the derecognition date.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Group will continue to monitor the progress of the <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">voluntary
bankruptcy and liquidation proceedings and will update the accounting treatment as necessary in accordance with IFRS.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Management expects that certain
shareholders and/or investors will continue or commence to provide new financing lines.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">However, there is no assurance
that investors and shareholders will continue to provide financing, or that the Group&#8217;s future operations will generate profitability.
The uncertainty surrounding the ability to secure additional funding and the potential for continued operational losses contribute to
raise a material uncertainty which may cast significant doubt (or raise substantial doubt as contemplated by PCAOB standards) about the
Group&#8217;s ability to continue as a going concern.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The consolidated financial
statements of Moolec Science SA do not include any adjustments that may be required to address the potential impacts on the recoverability
and classification of assets or the amounts and classifications liabilities, should the Group be unable to continue as a going concern.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Accordingly, the financial
statements of Moolec Science SA for periods prior to the Closing reflect the historical financial information of Bioceres Group. The financial
information as of and for the year ended June 30, 2025 reflects the figures corresponding to Bioceres Group and incorporates the effects
of applying the acquisition method to Moolec Science SA, Gentle Tech and Nutrecon, measured at fair value in accordance with IFRS 3.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Customers and Contracts </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">ValoraSoy&#8217;s commercial
operations resulted in sales to more than 80 clients, including 25 customers located across 14 countries on three continents. During the
fiscal year ended June 30, 2025, we sold approximately 8,113 tons of products, of which 63% corresponded to textured soy proteins, with
the remainder consisting of soybean oil and other by-products. This volume represents a 5% year-over-year increase.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><!-- Field: Page; Sequence: 64; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Offtake Agreement</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On July 15, 2024, we entered
into an offtake agreement (the &#8220;Offtake Agreement&#8221;) with a leading global consumer packaged goods and pet food company for
the supply and use of our GLA Safflower Oil product (GLASO). The Offtake Agreement has a term of three years and sets forth the commercial
conditions for the delivery of 50 tons of GLASO to the U.S. market in 2025. In connection with the Offtake Agreement, we have established
partnerships with farmers for safflower cultivation and with an industrial partner for downstream processing, ensuring a controlled and
traceable supply chain for GLASO.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Moolec&#8217;s Platforms and Key Products</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><img alt="" src="image_001.jpg"/></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The table below outlines
our product pipeline, which includes both commercialized and development-stage ingredients. Mycofood&#8482; and ValoraSoy products are
already available to food manufacturers as functional protein ingredients. GLASO, a safflower-derived oil rich in functional lipids, is
currently incorporated into formulations for small-animal feed, extending its applicability beyond human food systems. Other programs
remain under research and development and will progress through the discovery, transformation, development, and selection stages prior
to full-scale production and commercialization.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">This balanced mix of revenue-generating
and pipeline-stage projects reflects our dual focus on near-term market presence and long-term innovation across Molecular Farming and
precision fermentation platforms.</p><div>

</div><p style="margin: 0pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="color: White; background-color: black">
    <td style="padding: 5.4pt; border: white 1pt solid; color: White; width: 15%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">PROGRAM</span></td>
    <td style="padding: 5.4pt; border-top: white 1pt solid; border-right: white 1pt solid; border-bottom: white 1pt solid; color: White; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt; color: White">PLATFORM</span></td>
    <td style="padding: 5.4pt; border-top: white 1pt solid; border-right: white 1pt solid; border-bottom: white 1pt solid; color: White; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt; color: White">PROJECT</span></td>
    <td style="padding: 5.4pt; border-top: white 1pt solid; border-right: white 1pt solid; border-bottom: white 1pt solid; color: White; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">DESCRIPTION</span></td>
    <td style="padding: 5.4pt; border-top: white 1pt solid; border-right: white 1pt solid; border-bottom: white 1pt solid; color: White; width: 33%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">MARKET</span></td></tr>
  <tr>
    <td rowspan="2" style="border-right: white 1pt solid; border-left: white 1pt solid; background-color: #F2F2F2; padding-right: 0pt; padding-left: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">NUTRITIONAL
    SUPPLEMENTS &amp; FOOD INGREDIENTS</span></td>
    <td rowspan="2" style="border-right: white 1pt solid; background-color: #00B050; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt; color: White">Safflowers</span></td>
    <td style="border-right: white 1pt solid; border-bottom: white 1pt solid; background-color: #00B050; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt; color: White">GLASO</span></td>
    <td style="border-bottom: #BFBFBF 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Safflower
    oil with a high concentration of gamma-linolenic acid (GLA), representing up to 60% of the total oil content. The technology used
    enables a GLA concentration up to three times higher than other standard sources of GLA, such as borage oil and evening primrose
    oil, which typically contain 20&#8211;22% and 9&#8211;12% GLA, respectively.</span></td>
    <td style="border-bottom: #BFBFBF 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">This
    project targets the high-value specialty oils market, particularly segments focused on nutritional supplements, cosmetics, and functional
    foods. The product&#8217;s elevated gamma-linolenic acid (GLA) concentration positions it as an alternative to traditional sources
    such as borage and evening primrose oils, enabling potential differentiation through formulation efficiency and cost competitiveness.</span></td></tr>
  <tr>
    <td style="border-right: white 1pt solid; border-bottom: white 1pt solid; background-color: #00B050; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt; color: White">SPC</span></td>
    <td style="border-bottom: #BFBFBF 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Plant-based
    chymosin is a key enzyme used in the coagulation step of cheese production. Moolec&#8217;s technology enables the production of chymosin
    in safflower seeds, transforming this semi-arid crop into a scalable host system for the industrial manufacturing of enzymes.</span></td>
    <td style="border-bottom: #BFBFBF 1pt solid; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">This
    project targets the global market for dairy enzymes, particularly rennet substitutes used in cheese manufacturing. Producing chymosin
    through plant molecular farming offers a cost-efficient and sustainable alternative to traditional microbial or fermentation-based
    systems, expanding Moolec&#8217;s presence in the ingredient biotechnology segment and demonstrating the scalability of plant-based
    bioproduction platforms.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 65; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr>
    <td rowspan="4" style="padding-right: 3pt; border-right: white 1pt solid; border-left: white 1pt solid; width: 15%; padding-left: 3pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="padding-right: 3pt; border-right: white 1pt solid; border-bottom: white 1pt solid; background-color: #00B050; text-align: center; width: 10%; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt; color: White">Chickpea</span></td>
    <td style="padding-right: 3pt; border-right: white 1pt solid; border-bottom: white 1pt solid; background-color: #00B050; width: 10%; padding-left: 3pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt; color: White">CHICKPEA</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt; color: White">TVP</span></p></td>
    <td style="padding-right: 3pt; border-bottom: #BFBFBF 1pt solid; width: 32%; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">A
    line of precooked chickpea-based proteins that provide a crunchy texture when dry and acts as a thickening agent when hydrated. These
    products are suitable for a wide range of applications, including bakery, plant-based, and nutritional formulations.</span></td>
    <td style="padding-right: 3pt; border-bottom: #BFBFBF 1pt solid; width: 33%; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Chickpea
    TVP represents an alternative to soy- and pea-based textured vegetable proteins, which are widely used and established in the plant-protein
    segment. Its formulation supports clean-label positioning and broad application potential, offering a non-allergenic protein source
    suitable for brands seeking diversification within their ingredient portfolios.</span></td></tr>
  <tr>
    <td style="padding-right: 3pt; border-right: white 1pt solid; border-bottom: white 1pt solid; background-color: #00B050; text-align: center; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt; color: White">Fungi</span></td>
    <td style="padding-right: 3pt; border-right: white 1pt solid; border-bottom: white 1pt solid; background-color: #00B050; text-align: center; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt; color: White">MYCOFOOD</span></td>
    <td style="padding-right: 3pt; border-bottom: #BFBFBF 1pt solid; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Mycofood&#8482;
    is a fungal-based protein ingredient produced via bioreactor fermentation of fungal biomass. The product is available in wet form
    (approximately 28.5 % solids) or in dry form (approximately ~96 % solids). It offers a complete amino acid profile and a Protein
    Digestibility-Corrected Amino Acid Score (PDCAAS) of 0.92, which compares favorably to beef (0.91), soy (0.91), and wheat gluten.
    The ingredient exhibits a neutral taste and is designed for broad applicability in various food systems, from meat analogues to use
    as a protein additive in processed foods.</span></td>
    <td style="padding-right: 3pt; border-bottom: #BFBFBF 1pt solid; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">This
    project addresses the growing alternative protein market by offering a scalable fungal protein solution with competitive nutritional
    quality and organoleptic neutrality. Because it is 100 % animal-free, it caters to consumer segments and regulatory environments
    favoring sustainable, non-animal, and novel protein sources. The technology is positioned to serve food manufacturers seeking protein
    ingredients that integrate smoothly into existing formulations while meeting demands for sustainability, label-friendliness, and
    product innovation.</span></td></tr>
  <tr>
    <td style="padding-right: 3pt; border-right: white 1pt solid; border-bottom: white 1pt solid; background-color: #00B050; text-align: center; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt; color: White">Soybean</span></td>
    <td style="padding-right: 3pt; border-right: white 1pt solid; border-bottom: white 1pt solid; background-color: #00B050; text-align: center; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt; color: White">VALORA
    2.0</span></td>
    <td style="padding-right: 3pt; border-bottom: #BFBFBF 1pt solid; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">A
    development project focused on enhanced textured vegetable proteins (TVP) designed to deliver improved sensory characteristics, particularly
    in fibrous texture and chewiness, compared to conventional TVP. The products are produced from blends of raw materials such as soybean
    expeller-pressed flour combined with either isolated soy protein or vital wheat gluten, along with food-grade additives, under customized
    process and machining parameters.</span></td>
    <td style="padding-right: 3pt; border-bottom: #BFBFBF 1pt solid; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">VALORA
    2.0 is positioned to address the increasing demand for next-generation textured proteins with enhanced sensory attributes, particularly
    related to fibrous texture and chewiness, supporting use in full meat-replacement applications. The product line is differentiated
    from standard textured soy proteins (TSP), which are commonly used as fillers. Strategically, VALORA 2.0 targets two main market
    segments: (i) meat processors seeking higher-quality extenders for hybrid formulations, and (ii) food manufacturers and plant-based
    brands requiring standalone protein bases for applications such as nuggets, pizza toppings, and taco fillings.</span></td></tr>
  <tr>
    <td style="padding-right: 3pt; border-right: white 1pt solid; border-bottom: white 1pt solid; background-color: #00B050; text-align: center; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt; color: White">Yeast</span></td>
    <td style="padding-right: 3pt; border-right: white 1pt solid; border-bottom: white 1pt solid; background-color: #00B050; text-align: center; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt; color: White">YEEA1</span></td>
    <td style="padding-right: 3pt; border-bottom: #BFBFBF 1pt solid; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Extract
    derived from a novel yeast biomass with defined functional and nutritional properties. This technology enables the replacement of
    certain animal-derived nutritional supplements, addressing markets with dietary, religious, or ethical restrictions. A secondary
    application is under evaluation, where the same extract is utilized as a base for savory flavor development.</span></td>
    <td style="padding-right: 3pt; border-bottom: #BFBFBF 1pt solid; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">This
    project targets the alternative ingredients segment within the nutritional and functional food markets. By providing a non-animal,
    fermentation-based source of bioactive compounds, the platform addresses the growing demand for ethical, sustainable, and label-friendly
    nutrition. The potential flavor-enhancing application also opens opportunities in the seasonings and savory product categories.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr>
    <td rowspan="4" style="width: 15%; background-color: #F2F2F2; padding-right: 5.65pt; padding-left: 5.65pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">MEAT<br/>
    REPLACEMENTS</span></td>
    <td rowspan="4" style="border-top: white 1pt solid; border-right: white 1pt solid; border-left: white 1pt solid; width: 10%; background-color: #002060; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt; color: White">Soybean</span></td>
    <td style="border-top: white 1pt solid; border-right: white 1pt solid; border-bottom: white 1pt solid; width: 10%; background-color: #002060; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt; color: White">VALORA
    TSP</span></td>
    <td style="border-bottom: #BFBFBF 1pt solid; width: 32%; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 9pt">A
    line of soy-based textured proteins designed to replicate the texture and mouthfeel of different types of meat when hydrated. These
    products are primarily used as meat extenders in hybrid formulations. They are available in various formats, including chunks, flour,
    flakes, and granules, each developed to address specific functional properties and application requirements.</span></td>
    <td style="border-bottom: #BFBFBF 1pt solid; width: 33%; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 9pt">Strategically,
    the product line is positioned within the commodity segment of textured soy proteins, while differentiating itself through its range
    of formats and application adaptability. Soy remains the predominant raw material, accounting for the majority of global consumption
    of textured vegetable proteins (TVP). This positioning provides access to a large, established addressable market for VALORA TSP,
    with opportunities for incremental growth through customization and application-specific developments.</span></td></tr>
  <tr>
    <td style="border-right: white 1pt solid; border-bottom: white 1pt solid; background-color: #002060; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt; color: White">SOOY1</span></td>
    <td style="border-bottom: #BFBFBF 1pt solid; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 9pt">Moolec
    Science&#8217;s patented soybean platform has been engineered to produce high levels of porcine myoglobin in soybean seeds, achieving
    expression levels exceeding 20% of total soluble protein. This technology enables the incorporation of functional soy-based protein
    ingredients to enhance organoleptic and nutritional properties in processed meat products, pet food, and animal feed applications,
    providing a more efficient and sustainable alternative to conventional animal protein production.</span></td>
    <td style="border-bottom: #BFBFBF 1pt solid; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 9pt">This
    project targets alternative protein and hybrid meat segments, where heme-containing proteins are key to replicating the color, flavor,
    and aroma of conventional meat. By producing porcine myoglobin directly in soybean seeds, the platform enables a scalable and cost-efficient
    supply of functional heme proteins for use in plant-based and blended meat formulations, as well as in pet food applications. The
    technology positions Moolec within the intersection of plant biotechnology and the cultured protein market, addressing growing demand
    for sustainable and functional ingredients.</span></td></tr>
  <tr>
    <td style="border-right: white 1pt solid; border-bottom: white 1pt solid; background-color: #002060; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt; color: White">SOOY2</span></td>
    <td style="border-bottom: #BFBFBF 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: #BFBFBF 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr>
    <td style="border-right: white 1pt solid; border-bottom: white 1pt solid; background-color: #002060; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt; color: White">SOOY3</span></td>
    <td style="border-bottom: #BFBFBF 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: #BFBFBF 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 66; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr>
    <td style="width: 15%; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border: white 1pt solid; color: White; width: 10%; background-color: #002060; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Pea</span></td>
    <td style="border-top: white 1pt solid; border-right: white 1pt solid; border-bottom: white 1pt solid; color: White; width: 10%; background-color: #002060; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">PEEA1</span></td>
    <td style="border-top: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; width: 32%; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 9pt">Pea
    platform engineered to produce high levels of bovine myoglobin in pea seeds. This technology enhances the nutritional profile of
    the resulting protein ingredients by significantly increasing heme iron content, providing an alternative source of iron-rich proteins
    compared to conventional animal-derived sources.</span></td>
    <td style="border-top: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; width: 33%; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 9pt">This
    project addresses the growing demand for functional plant-based ingredients that deliver nutritional equivalence to animal proteins.
    By expressing bovine myoglobin in pea seeds, the platform targets hybrid and plant-based meat manufacturers seeking natural sources
    of heme iron to improve color, taste, and micronutrient content in their formulations. The technology also positions Moolec to participate
    in the expanding market for bioengineered proteins with enhanced nutritional functionality.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr>
    <td rowspan="4" style="width: 15%; background-color: #F2F2F2; padding-right: 5.65pt; padding-bottom: 8pt; padding-left: 5.65pt; text-align: center"><span style="font-size: 9pt">BY-PRODUCTS</span></td>
    <td rowspan="4" style="border-top: white 1pt solid; border-right: white 1pt solid; width: 10%; background-color: #782170; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt; color: White">Soybean</span></td>
    <td style="border-top: white 1pt solid; border-right: white 1pt solid; border-bottom: white 1pt solid; width: 10%; background-color: #782170; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt; color: White">OIL</span></td>
    <td style="border-bottom: #BFBFBF 1pt solid; width: 32%; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 9pt">Expeller-pressed,
    degummed soybean oil intended for further refining, bleaching, and deodorizing (RBD) for use in food applications or biofuel production.</span></td>
    <td rowspan="4" style="border-bottom: #BFBFBF 1pt solid; width: 33%; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-size: 9pt">Degummed soybean oil can be used in
    multiple applications. In its crude form, it provides an energy source for animal feed, supports fermentation processes in pharmaceutical
    and industrial uses, and serves as a feedstock for biofuel production. Once refined, it is used in food applications such as cooking
    oils, margarines, dressings, and baked goods.&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-size: 9pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-size: 9pt">Soybean hulls serve as a fiber source
    for animal feed and can also be used as a component in fermentation culture media, enabling potential synergies with fermentation
    manufacturers. Gums from the degumming process are used as a raw material for lecithin production, while expeller-pressed soybean
    meal, rich in protein and residual oil, is used in animal nutrition.&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-size: 9pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-size: 9pt">Collectively, these byproducts illustrate
    a circular production approach aimed at maximizing value extraction while minimizing waste.</span></p></td></tr>
  <tr>
    <td style="border-right: white 1pt solid; border-bottom: white 1pt solid; background-color: #782170; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt; color: White">HULLS</span></td>
    <td style="border-bottom: #BFBFBF 1pt solid; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 9pt">Soybean
    hulls are used as a fiber source for feed applications and are suitable for pelleting. Due to their low lignin, high cellulose, and
    moderate to high protein content, soybean hulls can also serve as a component in culture media formulations.</span></td></tr>
  <tr>
    <td style="border-right: white 1pt solid; border-bottom: white 1pt solid; background-color: #782170; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt; color: White">EXPELLER</span></td>
    <td style="border-bottom: #BFBFBF 1pt solid; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 9pt">Expeller-pressed
    soybean meal containing approximately 45% protein and 7% residual oil, suitable for use in feed formulations or as a raw material
    for value-added processing. Anti-nutritional factors are inactivated during the production process.</span></td></tr>
  <tr>
    <td style="border-right: white 1pt solid; background-color: #782170; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt; color: White">GUMS</span></td>
    <td style="border-bottom: #BFBFBF 1pt solid; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 9pt">Byproduct
                                            of the soybean oil degumming process, consisting of hydrated phospholipids (approximately
                                            26%) obtained from expeller-pressed soybean oil. It is used as a raw material for dry lecithin
                                            production.</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 9pt">&#160;</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 9pt">&#160;</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 9pt">&#160;</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 9pt">&#160;</span></p></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr>
    <td style="width: 15%; background-color: #F2F2F2; padding-right: 5.65pt; padding-bottom: 8pt; padding-left: 5.65pt; text-align: center"><span style="font-size: 9pt">CO-PRODUCTS</span></td>
    <td style="border: white 1pt solid; color: White; width: 10%; background-color: #782170; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 9pt">Soybean</span></td>
    <td style="border-top: white 1pt solid; border-right: white 1pt solid; border-bottom: white 1pt solid; color: White; width: 10%; background-color: #782170; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 9pt">SCRAPS</span></td>
    <td style="border-bottom: #BFBFBF 1pt solid; vertical-align: bottom; width: 32%; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 9pt">Refers
    to the value-added products derived from soybean byproducts. Several processing routes are under development to enable applications
    across feed, food, and pharmaceutical sectors, utilizing soybean hulls, gums, and expeller meal as raw materials.</span></td>
    <td style="border-bottom: #BFBFBF 1pt solid; vertical-align: bottom; width: 33%; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 9pt">This
    project focuses on the development of processes to transform byproducts into functional ingredients for feed, food, and pharmaceutical
    applications, supporting circular valorization and the creation of additional value streams.</span></td></tr>
  <tr>
    <td rowspan="2" style="background-color: #F2F2F2; padding-right: 5.65pt; padding-bottom: 8pt; padding-left: 5.65pt; text-align: center"><span style="font-size: 9pt">CO-<br/>
DEVELOPMENTS</span></td>
    <td style="border-right: white 1pt solid; border-bottom: white 1pt solid; border-left: white 1pt solid; color: Black; background-color: #FFC000; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">Lupin</span></td>
    <td style="border-right: white 1pt solid; border-bottom: white 1pt solid; color: Black; background-color: #FFC000; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: Black; text-align: center"><span style="font-size: 9pt">LUPIN</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: Black; text-align: center"><span style="font-size: 9pt">PRODUCTS</span></p></td>
    <td style="border-bottom: #BFBFBF 1pt solid; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 9pt">Texturized
    lupine concentrate produced from lupine seeds or flour, processed to obtain a fibrous, meat-like texture. It is used as a plant-based
    ingredient for meat alternative formulations and as a functional component in snack and health-oriented food products.</span></td>
    <td style="border-bottom: #BFBFBF 1pt solid; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 9pt">LUPIN
    is a next-generation texturized lupine concentrate developed to meet the increasing demand for soy-free and allergen-friendly protein
    ingredients. Produced from lupine seeds or flour and processed to achieve a fibrous, meat-like texture, it is suitable for use in
    meat alternatives as well as in snack, bakery, and health-oriented food applications. The product is positioned to serve the growing
    market interest in high-protein, non-soy, and non-gluten options, supporting clean-label and specialized dietary formulations.</span></td></tr>
  <tr>
    <td style="border-right: white 1pt solid; border-bottom: white 1pt solid; border-left: white 1pt solid; color: Black; background-color: #FFC000; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">Pea</span></td>
    <td style="border-right: white 1pt solid; border-bottom: white 1pt solid; color: Black; background-color: #FFC000; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: Black; text-align: center"><span style="font-size: 9pt">PEA</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: Black; text-align: center"><span style="font-size: 9pt">PRODUCTS</span></p></td>
    <td style="border-bottom: #BFBFBF 1pt solid; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 9pt">Texturized
    pea concentrate produced from yellow peas or pea flour, processed to obtain a fibrous, meat-like texture. It has a high protein content,
    a neutral taste profile, and favorable water- and fat-binding properties.</span></td>
    <td style="border-bottom: #BFBFBF 1pt solid; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 9pt">PEA
    Texturized Concentrate is intended for plant-based meat manufacturers, hybrid meat producers, and food processors seeking a high-protein,
    neutral-tasting ingredient suitable for a wide range of applications. It can be used in plant-based and blended meat products, snacks,
    bakery items, and functional foods, supporting the development of clean-label and texturally consistent formulations.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 67; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr>
    <td rowspan="2" style="width: 15%; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border: white 1pt solid; width: 10%; background-color: #FFC000; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">Ferment.</span></td>
    <td style="border-top: white 1pt solid; border-right: white 1pt solid; border-bottom: white 1pt solid; width: 10%; background-color: #FFC000; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">PHB</span></td>
    <td style="border-top: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; width: 32%; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 9pt">Development
    of a biodegradable biopolymer based on polyhydroxybutyrate (PHB), produced through bacterial fermentation using glycerin and other
    agro-industrial byproducts as feedstocks. The process aims to obtain high-molecular-weight PHB suitable for the production of fully
    compostable materials. Optimization efforts focus on strain performance, fermentation efficiency, and downstream processing to ensure
    material quality and scalability.</span></td>
    <td style="border-top: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; width: 33%; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 9pt">This
    project targets the growing market for sustainable and compostable bioplastics, driven by regulatory and consumer pressure to reduce
    fossil-based plastic waste. By leveraging renewable feedstocks and circular-economy principles, the PHB platform positions Moolec
    within the bio-materials segment, enabling potential applications in packaging, coatings, and agricultural films while offering a
    lower-impact alternative to conventional plastics.</span></td></tr>
  <tr>
    <td style="border-right: white 1pt solid; border-bottom: white 1pt solid; border-left: white 1pt solid; background-color: #FFC000; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">Yeast</span></td>
    <td style="border-right: white 1pt solid; border-bottom: white 1pt solid; background-color: #FFC000; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">LIIP</span></td>
    <td style="border-bottom: #BFBFBF 1pt solid; padding-right: 5.4pt; padding-bottom: 0pt; padding-left: 5.4pt"><span style="font-size: 9pt">Development
    of a recombinant yeast platform designed for the expression of industrial lipase enzymes intended for bakery applications. The project
    focuses on optimizing lipase production and secretion through yeast-based expression systems. This approach aims to deliver a scalable,
    cost-efficient alternative to conventional microbial or animal-derived enzyme production methods.</span></td>
    <td style="border-bottom: #BFBFBF 1pt solid; padding-right: 5.4pt; padding-bottom: 8pt; padding-left: 5.4pt"><span style="font-size: 9pt">This
    project targets the global baking enzyme market, where lipases are widely used to enhance texture, shelf life, and processability
    of dough-based products. By using a yeast expression system, the platform offers potential advantages in production efficiency, regulatory
    acceptance, and sustainability.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Development Timeline and Process</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The projects in our product
portfolio are currently at different stages of development. To bring these products to market, each must progress through multiple phases,
from initial research to full commercialization. This process begins with research and development, where we identify proteins of interest
from traditional animal foods and evaluate their ability to be efficiently and effectively expressed in plants, microorganisms, or cellular
systems. Once target proteins are validated, we proceed to prototype development, followed by further testing and optimization to confirm
that the prototype can be scaled efficiently under industrial conditions. The subsequent stages involve pilot and commercial-scale production,
and ultimately, market launch and commercialization.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The main stages of products
development can be summarized as follows:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Discovery</b>:
The first stage involves the identification of hosts systems, candidate genes, metabolic pathways, or microorganisms with the potential
to enhance desired characteristics or enable an agro-industrial biotech solution. Within our dual engine platform, discovery activities
encompass both crop hosts (for molecular farming) and microbial and cellular systems (including bacteria, fungi, and yeasts for precision
fermentation). This phase also integrates early traceability-by-design principles to ensure transparency and compliance throughout subsequent
development stages.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proof of concept/Transformation:</b> Once validated in model systems (<i>in vitro</i> or <i>in vivo</i>), promising candidates advance from discovery to the proof-of-concept stage. In this stage, targets constructs are introduced into the chosen host&#8212;crops in greenhouse conditions or microbes or cellular systems in small-scale bioreactors (lab scale). The objective is to confirm expression and performance within the targeted organism before progressing scale-up, field validation, or pilot fermentation. At this step, preliminary release specifications and data packages are typically defined to support subsequent regulatory and quality documentation.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Early development/Development:</b> In this
    stage, efficacy field trials (for crops) and pilot-scale fermentation (for microbial and cellular systems) are expanded to assess expression
    levels, phenological traits, and performance across multiple geographies and growing cycles. Additional parameters are evaluated to optimize
    the technology and confirm its robustness under real-world conditions.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Agrality supports seed increase, multi-site trialing
    and crop characterization; Bioceres contributes regulatory analytics and intellectual property strategy; and InMet provides synthetic-biology
    and pilot-scale fermentation to bridge discovery and industrial scale.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The primary objective of this stage is to demonstrate
    technical feasibility by identifying the optimal candidate for scale-up &#8211; whether to expand seed stock and initiate regulatory field
    trials (for crops), or to study organisms&#8217; behavior in production conditions and produce sufficient biomass for downstream prototyping
    and safety assessments (for microbial and cellular systems).</p></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in"></p><div>

</div><!-- Field: Page; Sequence: 68; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Advanced development/Selection:</b> At this
    stage, extensive field evaluations (for genetically modified traits and other crop events) are conducted to fully demonstrate efficacy
    for the intended purpose. For GM traits, regulatory processes are initiated, including multi-site field trials designated to generate
    environmental, compositional, and food safety data required for submission and approval.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For microbial and cellular fermentation solutions,
    industrial-scale (SynBio Powerlabs) production runs are carried out to collect data supporting refined techno-economic assessments, process
    optimization, and the establishment of robust batch genealogy and quality controls for traceability and compliance.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The goal of this phase is to validate the technology
    under operational conditions and prepare comprehensive data packages to support regulatory, quality, and commercial readiness.</p></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Pre-launch/Scale-Up: </b>This phase involves
    finalizing regulatory approvals and preparing product launch and commercialization. Key activities include seed multiplication, pre-commercial
    production, and product or solution testing with selected customers.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For fermentation solutions, accumulated safety
    and quality data are submitted to regulatory agencies, while SynBio Powerlabs and partner facilities plan capacity expansions, validate
    release specifications, and establish cost-of-good-sold (COGS) and supply parameters to ensure reliable and efficient market entry.</p></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Product launch/Downstream:</b> This final stage
    converts novel seeds or microbial/cellular biomass into finished business-to-business (B2B) ingredients through established downstream
    processing pathways. For crops, production leverages existing oilseed workflows, with ValoraSoy contributing soy texturization and downstream
    processing expertise. For microbial or cellular systems, the process validates fermentation, downstream, and purification schemes.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Across both production routes, full chain-of-custody
    (identity preservation for seed lots and detailed batch records for fermentation) ensures compliance with customer requirements for traceability
    and quality.</p></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Sales and Marketing</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As our product and focus
on molecular farming may not be familiar to many potential consumers, we will be required to educate potential customers and consumers
about our products and brand, respond quickly to concerns and consult on food trends. As we develop and grow our brand, we expect to expand
our sales and marketing team in the future by adding dedicated personnel to service new institutional and retail customers. In the future
we may also add sales representatives to expand our sales efforts to the extent necessary.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Competition</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We operate in a highly competitive
and rapidly evolving landscape. For analytical purposes, we view competition across technology clusters; boundaries are fluid, and several
companies may be potential partners, suppliers or customers in specific use cases.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>(i)</b></td><td style="text-align: justify"><b>Molecular farming peers:</b>	Companies developing animal-like
proteins or functional lipids in plants through molecular farming or related plant-expression systems. Examples include AlpineBio, Finally
Foods, IngredientWerks Inc., Kyomei, Miruku Limited, Mooza Foods, NewMoo and PoLoPo Inc., among others. These companies pursue different
host crops, molecular targets, and end-use applications, and compete primarily on expression levels, regulatory advancement, cost of
goods, agronomic performance, supply-chain traceability and IP portfolios.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>(ii)</b></td><td style="text-align: justify"><b>Fungal and microbial alternative proteins (precision fermentation
/ mycoprotein): </b>These are companies developing proteins, lipids, or other functional ingredients through microbial or cellular systems
using precision fermentation or related biotechnological platforms. Illustrative examples include Marlow Foods (Quorn), ENOUGH (ABUNDA),
The Better Meat Co. (Rhiza), Nature&#8217;s Fynd, Meati Foods y MycoTechnology, among others. These companies differ in host selection
(yeasts, fungi, bacteria, or cell cultures), production scale, and target molecules, and compete on expression yields, scalability, and
integration into established food manufacturing workflows.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 69; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(iii)</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Traditional
and diversified ingredient suppliers</b></span>: <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large flavor,
fragrance, enzyme and ingredient companies and broader suppliers that address overlapping functionality spaces and may, in some cases,
be prospective customers or channel partners. Examples include Givaudan Group, International Flavors &amp; Fragrances, DSM-Firmenich
and Novonesis (Chr. Hansen), among others. Competition in this cluster centers on breadth of portfolio, application support, global supply
reliability, regulatory coverage and pricing.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We compete primarily on our
ability to deliver target functionality at competitive price points, with traceable supply chains and credible regulatory execution across
multiple biological routes. We believe that our dual-engine platform&#8212; combining molecular farming in crops with precision fermentation
in controlled environments&#8212; positions us to address customer requirements for performance, cost, reliability and compliance. Nevertheless,
many of our competitors have greater financial and technical resources, longer operating histories, or broader commercial footprints,
which could limit our ability to compete effectively in certain markets. See Item 3.D&#8212;Risk Factors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Intellectual Property</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our business model is focused
on R&amp;D and the development of future IP and patents. Our IP strategy consists of conducting research and testing to rapidly acquire
IP protection for all of our platforms.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The main jurisdictions in
which we seek patent protection, among others, are the United&#160;States, Canada, Brazil, Argentina, Australia, India, China, Hong&#160;Kong,
Japan, Malaysia, New Zealand, Mexico and countries in Europe.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">To date, we have identified
and sought patent protection in our capacity as either title holder or exclusive licensee for a diverse technology portfolio including
food ingredients, nutritional supplements, meat replacements ingredients and biomass, seed traits, among others.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">These technologies are currently
protected through our 64 patents and 54 current patent applications as owner and or as exclusive licensee. In addition, the company possess
150 trademarks and 15 pending trademarks accounting 165 registers related to Moolec&#8217;s business technologies, including the trademarks:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><table cellpadding="0" style="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
<tr style="vertical-align: bottom; text-align: left">
    <td style="width: 0.25in">&#160;</td>
  <td style="vertical-align: bottom; width: 15%; text-align: left"><img alt="" src="image_002.jpg"/></td>
  <td style="vertical-align: bottom; width: 15%; text-align: left"><img alt="" src="image_003.jpg"/>,</td>
  <td style="vertical-align: bottom; width: 15%; text-align: left"><img alt="" src="image_004.jpg" style="width: 99px; height: 17px"/>.</td>
    <td>&#160;</td></tr>
</table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In July 2025, the USPTO issued
a patent for the promising &#8220;Piggy Sooy&#8221; technology. The patent issued grants exclusivity over soybean plants and seed capable
of producing 5-30% of total soluble protein (TSP) of as heme proteins and also covers food applications derived from soybean seed expressing
high levels of heme proteins.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Moolec has also licensed
the HB4<sup>&#174;</sup> technology to Bioceres Crop Solutions Corp. The license includes the HB4<sup>&#174;</sup> soy and HB4<sup>&#174;</sup>
wheat events, which are protected by patents filed in key agricultural markets such as the United States, Canada, Brazil, Argentina, Bolivia,
Paraguay, Uruguay, Mexico, South Africa, Australia, India, China, Ukraine, Russia, and several European countries. HB4<sup>&#174;</sup>
is a proprietary biotechnology trait that enhances crop tolerance to abiotic stress, particularly drought, by modulating the expression
of the HaHB4 transcription factor. This technology was developed through a long-standing collaboration between Bioceres and Argentina&#8217;s
National Scientific and Technical Research Council (CONICET), combining public research excellence with private sector innovation. The
HB4<sup>&#174;</sup> soy and wheat patents are expected to expire in 2039 and 2040, respectively.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On March 28, 2025, <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bioceres Crop Solutions
Corp agreed to transfer all rights, licenses, and materials containing or pertaining to the soy ANF trait and pay US$750,000 to a Arcadia
Biosciences Inc in exchange for (i) RG and OX Wheat Patents and RS exclusive rights; (ii) the cancellation of all royalty payments, which
included 25% of the net wheat technology licensing revenues and 6% of the net HB4 soybean revenues up to US$10 million; and (iii) the
release from any performance benchmark obligations related to the RG, OX, and RS varieties which amounted to US$8.1 million. Therefore,
as of June 30, 2025, in Bioceres Crop Solutions Corp accounting records, payment related to the acquisition of Verdeca and other intangibles
assets was cancelled.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Research and Development</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our R&amp;D activities focus
on the discovery, design, expression, and scale-up of proteins and functional lipids through two complementary routes: Molecular Farming
in crops and precision fermentation in microorganisms (fungi and yeasts). Our workstreams encompass host and trait discovery, construct
and strain engineering, greenhouse and multi-site field trials, pilot and industrial fermentations, downstream processing, and analytical
validation, all executed within a stage-gated development framework and a traceability-by-design approach&#8212;featuring identity preservation
for seed lines and batch genealogy with electronic batch records for fermentation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><!-- Field: Page; Sequence: 70; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We execute R&amp;D through
a combination of in-house capabilities and external collaborations. Internally:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Agrality supports seed multiplication, field trialing, and crop characterization across Argentina, Brazil,
and the United States.</td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">InMet provides synthetic-biology, process-development, and pilot-scale fermentation capabilities bridging
discovery and full-scale production.</td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">SynBio Powerlabs provides end-to-end support for fermentation operations across laboratory, pilot, and
industrial scales and analytical and quality-control activities.</td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Bioceres Crop Solutions contributes regulatory expertise and intellectual-property management.</td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">ValoraSoy brings soybean downstream-processing know-how and application-testing capabilities.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Externally, we collaborate
with universities, contract research organizations (CROs), and technology partners under service and research agreements to augment capacity
in specialized assays&#8212;particularly for regulatory and safety studies. <i>See Item 4.B&#8212;Business Overview; Item 5&#8212;Operating
and Financial Review and Prospects (R&amp;D expenses); and Item 3.D&#8212;Risk Factors.</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Raw Materials and Material Sourcing</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The process of scaling up
our seed inventory and production is carried out in the United States and Argentina. We work with multiple growers in both countries to
outsource production according to agronomic conditions and regional suitability. Currently, we maintain safflower production in American
Falls, Idaho (USA).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The fungal biomass (Mycofood&#8482;)
serves as a core raw material for fungi-based products. It is produced under HACCP and GMP standards through controlled fermentation processes
using traceable, non-GMO ingredients to ensure transparency and quality throughout the value chain. This initiative provides sustainable
and scalable sources of functional proteins and bio-based ingredients, fully aligned with our objectives of traceability, environmental
performance, and circularity.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">For ValoraSoy products, we
utilize soy- and chickpea-based functional proteins specifically designed for human nutrition. These products are manufactured in state-of-the-art
facilities strategically located within Argentina&#8217;s soybean corridor, leveraging advanced processing technologies to produce plant
proteins that offer chewiness, texture, and fibrous structure comparable to meat.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Government Regulation</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We are, and will be, subject
to the laws and regulations in which we operate. This includes laws and regulations governing biotechnology and food companies related
to the development, approval, manufacturing, import, export, marketing and sale of our products. See &#8220;<i>Item 3. Key Information&#8212;D.
Risk Factors&#8212;Risks Relating to Laws and Regulation</i>&#8221;.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In order to manage the seasonability
of our operations, we plan to produce our crops in both Argentina and the United States.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>United States</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our principal market focus
is the United States. In the U.S., the primary agencies responsible for the regulation of plant biotechnology products are the United
States Department of Agriculture (USDA) &#8211; Animal and Plant Health Inspection Service (APHIS), which oversees environmental release,
and the Food and Drug Administration (FDA), which regulates food and feed use.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We are subject to a range
of federal, state and local laws and regulations administered by agencies such as the FDA, the Federal Trade Commission (FTC), the Environmental
Protection Agency (EPA), the Occupational Safety and Health Administration (OSHA), and the USDA. These regulations cover various aspects
of our operations, including future processing, packaging, distribution, marketing, labeling, quality assurance, safety, and transportation
of our products, as well as occupational health and safety practices.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><!-- Field: Page; Sequence: 71; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Facilities in the United
States where our products are grown or produced may be required to register with the FDA and comply with applicable regulatory frameworks,
including the Food Safety Modernization Act (FSMA). In addition, we will be subject to state and local food safety and labeling regulations
in connection with the commercialization of our products. We are also subject to labor and employment laws, advertising and privacy regulations,
workplace safety standards, and other laws governing business operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Consistent with this regulatory
framework, several of our molecular farming products have already received favorable determinations from USDA-APHIS and the FDA.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On September 23, 2024, USDA-APHIS
issued a Regulatory Status Review concluding that our PEEA1 pea meat replacement product poses no greater plant pest risk than non-genetically
engineered pea plants under 7 CFR part 340, thereby exempting it from permits requirements for importation, interstate movement, and environmental
release.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On April 19, 2024, USDA-APHIS
APHIS issued a Regulatory Status Review concluding that our soybean Piggy Sooy&#8482; presents no greater plant pest risk than conventional
soybeans plants under 7 CFR part 340. As a result, we are no longer required to obtain USDA-APHIS permits for the importation, interstate
movement, or environmental release of these genetically engineered soybean plants.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On March 31, 2023, USDA-APHIS
issued a Regulatory Status Review with the conclusion that our GLA safflower plants pose no greater plant pest risk than non-genetically
engineered safflower plants according to regulation 7 CFR part 340. Accordingly, we are no longer required to obtain USDA-APHIS permits
for importation, interstate movement, and environmental release of GE plants. Our GLASO product derived from this crop already received
FDA approvals for use as an ingredient in dietary supplements, nutritional beverages, medical foods, and pet food, as well as for the
use of its seed meal in cattle and poultry feed.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Argentina</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Approvals for the environmental
release of genetically modified plants in Argentina are granted by the Secretariat of Agriculture, Livestock and Fisheries (SAGyP). These
approvals are associated with risk evaluations performed by National Commission of Agricultural Biotechnology (CONABIA) and food/feed
assessment by the National Food Safety and Quality Service (SENASA).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Currently we have permits
from the SAGyP for importation, movement, and environmental release from some of our genetically modified plants. Our chymosin safflower
has been fully approved by MAGP for release and production in Argentina and no further permits are required for its production and consumption.
In addition, on September 2025, SENASA granted the approval for GLA safflower use for food and feed.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Finland</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Under Finnish and EU regulatory
frameworks, our operations in Finland are subject to oversight by the Finnish Food Authority (Ruokavirasto) and the Board for Gene Technology
(GTLK), pursuant to the Gene Technology Act 377/1995 and the accompanying Government Decree on Gene Technology 928/2004.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As an EU Member State, Finland
requires that any genetically modified organisms intended for environmental release or cultivation receive prior authorization pursuant
to Directive 2001/18/EC and related EU regulation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">A precision-fermentation
facility in Finland that utilizes contained microbial and cellular systems under controlled conditions, which fall within the regulated
&#8220;contained use&#8221; classification, does not require the same environmental release authorizations as open-field genetically engineered
crops.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">By operating the Finnish
facility under contained-use protocols and aligning with traceability and data-audit requirements, we remain in compliance with Finnish
and EU biotechnology regulatory standards applicable to our Finland-based operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><!-- Field: Page; Sequence: 72; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Other Regulatory Requirements</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We are also subject to various
federal, state, local, national, and transnational laws, regulations, and requirements in the jurisdictions in which we operate, relating
not only to biotechnology and food and ingredient products but also to other areas of our operations. As we continue to grow, we may become
subject to additional regulations and requirements in these jurisdictions relating, among other things, to safe working conditions, laboratory
and distribution practices, and the transportation and disposal of hazardous or potentially hazardous substances. In addition, applicable
import and export laws will require us to comply with certain standards governing the cross-border transit of finished goods and raw materials.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The costs associated with
our continued compliance with these various federal, state, local, national, and transnational laws and regulations, or with any new requirements
to which we may become subject, could be significant. Failure to comply with such legal obligations could have a material adverse effect
on our results of operations and financial conditions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Employees</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As of June 30, 2025, we had
103 full-time and temporary employees located in Argentina, the United States, the Netherlands, Finland, and the United Kingdom. Our workforce
includes 14 Ph.Ds. and other highly skilled scientists, biotechnologists, and engineers. Our work environment is technology-driven, reflecting
our corporate purpose and innovation-focused culture. We have never experienced a labor-related work stoppage.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As of October 31, 2025, we
had 72 employees, reflecting a decrease attributable to the reorganization process arising from the Business Combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Legal Proceedings</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">From time to time, we may
become involved in legal proceedings arising in the ordinary course of our business. Except as described in Item 8. of this report, we
are not currently involved in any legal proceedings that could reasonably be expected to have a material adverse effect on our business,
results of operations, prospects or financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Notice of Alleged Breach</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On October 2, 2025, the Company received a notice of alleged breach
from INVIM Corporativo S.L., a private limited company incorporated under the laws of Spain (&#8220;INVIM&#8221;), regarding the alleged
failure to pay the assignment price of US$13 million in connection with a certain Assignment and Assumption Agreement dated May 27, 2025
(the &#8220;Agreement&#8221;). The Agreement, in turn, references related instruments, including a Note Purchase Agreement and a Binding
Contribution Memorandum of Understanding, both dated October 15, 2023.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In response, the Company
rejected INVIM&#8217;s assertion that any payment is due or owing, on the grounds that, among other reasons, under the express terms of
the Agreement and related transaction instruments, INVIM failed to satisfy certain conditions precedent, including the valid transfer
of relevant securities and the execution of a required services agreement.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company intends to vigorously
defend its position and enforce its rights under the Agreement, the related transaction instruments, and applicable law. While the Company
believes that INVIM&#8217;s assertions are without merit, if INVIM were ultimately to prevail in any proceedings, such an adverse outcome
could have a material adverse effect on the Company&#8217;s business, results of operations, financial condition, or liquidity.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 73; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="k_019"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>C. Organizational Structure</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The following diagram depicts our current
organizational structure:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="image_005.jpg"/></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Notes:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">1</td><td style="text-align: justify">Includes 3,076,079 (5%) shares that Bioceres LLC has shareholder
rights over pursuant to the Shareholders Agreement, dated as of March 5, 2019, by and between Bioceres LLC, Pedro Enrique Mac Mullen,
Maria Marta Mac Mullen and International Property Services Corp.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">2</td><td style="text-align: justify">For more information about BIOX subsidiaries, please refer
to the latest 20-F filed by BIOX with the SEC.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">3</td><td style="text-align: justify">The shareholding of Bioceres Group in THEO I is planned to
be distributed (spin-off) to Bioceres Group shareholders within 12 months from the signing date of the Business Combination Agreement
with Moolec Science.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">4.</td><td style="text-align: justify">For more information about Bioceres SA, Bioceres LLC and
Theo I, please refer to ITEM 13. DEFAULTS,DIVIDEND ARREARAGES AND DELINQUENCIES</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following table identifies
our main subsidiaries as of the date of this report:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Name</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Jurisdiction of<br/> Incorporation</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Ownership Interest</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Voting Interest</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 50%; text-align: left; padding-left: 0.55pt">Moolec Science Ltd.</td><td style="width: 1%">&#160;</td>
    <td style="width: 25%; text-align: center; padding-left: 0.55pt">United Kingdom</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">100</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">100</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.55pt">AG Biomolecules LLC</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 0.55pt">United States</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ValoraSoy S.A.<sup>1</sup></span></td><td>&#160;</td>
    <td style="text-align: center; padding-left: 0.55pt">Argentina</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.55pt">Nutrecon LLC</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 0.55pt">United States</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.55pt">SynBio Powerlabs</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 0.55pt">Finland</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">90</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">90</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.55pt">Gentle Tech</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 0.55pt">British Virgin Islands</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.55pt">Gentle Farming</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 0.55pt">British Virgin Islands</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">51</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">51</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.55pt">G-FAS</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 0.55pt">Argentina</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">64</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">64</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.55pt">Bioceres S.A.</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 0.55pt">Argentina</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">90</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">90</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0.55pt">Bioceres Tech Services LLC</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 0.55pt">United States</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0.55pt">Bioceres LLC</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 0.55pt">United States</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Notes:-</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">1</td><td style="text-align: justify">Calculated considering the indirect interests held through
Moolec Science Ltd</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="k_020"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>D. Property, Plant and Equipment</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Prior to the closing of the
ValoraSoy Acquisition, our tangible assets primarily consisted of laboratory equipment and other R&amp;D assets, while our principal assets
were intangible, including intellectual property rights. Following the closing of such acquisition, we incorporated a soybean processing
facility located in Argentina&#8217;s soybean corridor, designed to maximize raw-material origination, with an installed crushing capacity
of approximately 10,000 tons of soybean per year. This facility specializes in the production of textured soy proteins, and provides industrial
conditions for specification validation, application testing and downstream know-how that support our commercialization plans in multiple
regions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><!-- Field: Page; Sequence: 74; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In April 2025 we announced
the Business Combination with Bioceres Group Limited, Nutrecon LLC and Gentle Technologies Corp., and, upon closing, our base of property,
plant and equipment expanded to include contributed and integrated assets across biotechnology services, field operations and controlled-facility
manufacturing. These assets include (i) precision-fermentation infrastructure in Finland operated under the Synbio Powerlabs brand, supporting
controlled production of fungi-based proteins and related analytical release activities; (ii) Agrality&#8217;s multi-geography execution
footprint in Argentina, Brazil and the United States, comprising seed increase, nursery and multi-site field-trial capabilities, drying/conditioning
and processing assets, and warehousing and distribution (including an estimated storage capacity of approximately 300,000 square feet
and handling/shipping throughput of up to approximately 1.1 million units), which together enable identity-preserved logistics and regulatory
trialing; and (iii) InMet&#8217;s synthetic-biology and pilot-scale fermentation facilities used for process development, low-scale/plant-pilot
runs and metabolomics, bridging discovery and industrial scale-up. These facilities complement our existing downstream capacity at ValoraSoy
and are intended to reduce scale-up risk and time-to-market across both molecular-farming and fermentation programs.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Future capital expenditures
are expected to relate primarily to scale-up and debottlenecking of fermentation capacity, expansion and modernization of field and seed-processing
assets, and incremental downstream capabilities for our molecular-farming and fermentation programs. See Item 4.C&#8212;Organizational
Structure.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 4A. UNRESOLVED STAFF COMMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">None.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><div><a id="k_021"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM&#160;5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>The following discussion
and analysis provide information which our management believes is relevant to an assessment and understanding of our operating results
and financial condition. This discussion and analysis should be read together with our audited consolidated financial statements and related
notes that are included elsewhere in this annual report. In addition to historical financial information, this discussion and analysis
contains forward-looking statements based upon current expectations that involve risks, uncertainties and assumptions. See the section
entitled &#8220;Cautionary Note&#160;Regarding Forward-Looking Statements.&#8221; Actual results and timing of selected events may differ
materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth under
&#8220;Item 3. Key Information&#8212;D. Risk Factors&#8221; or elsewhere in this annual report.</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>&#160;</i></p><div>

</div><div><a id="k_022"></a></div><p style="margin-left: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>A. Operating Results</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>The Business Combination Agreement</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Before the end of the fiscal
year, on June 16, 2025, the Company consummated a business combination. Prior to that moment, a series of previous steps have taken place,
as follows:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On May 14, 2025, Moolec Science
(Luxembourg) made effective a reverse stock split of its Ordinary Shares (the &#8220;Reverse Stock Split&#8221;) on the consolidation
ratio of ten-to-one (the &#8220;Consolidation Ratio&#8221;), pursuant to which holders of Ordinary Shares received one Ordinary Share
for every ten Ordinary Shares held.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On May 22, 2025 (the &#8220;Effective
Date&#8221;), the Company changed its jurisdiction by Moolec Science (Luxembourg) discontinuing from the Grand Duchy of Luxembourg and
transferring by way of continuation to the Cayman Islands as Moolec Science (Cayman Islands) pursuant to Part XII of the Companies Act
(Revised) of the Cayman Islands (the &#8220;Redomiciliation&#8221;). On the Effective Date, all of the shares of Moolec Science (Luxembourg),
par value $0.10 per share by operation of law became shares of Moolec Science (Cayman Islands), par value $0.10 per share.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">After completion of the Reverse
Stock Split, all references to our Ordinary Shares, share data, per share data and related information have been adjusted for the Consolidation
Ratio to reflect the Reverse Stock Split. The Reverse Stock Split has consolidated each ten of our Ordinary Shares into one Ordinary Share,
with a new par value of $0.10 per Ordinary Share. Upon completion of the Reverse Stock Split, no fractional Ordinary Shares were issued,
and any fractional Ordinary Shares resulting from the Reverse Stock Split were rounded up to the nearest whole Ordinary Share. Except
for the adjustments that resulted from the treatment of fractional shares, the Reverse Stock Split did not have any dilutive effect on
our shareholders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><!-- Field: Page; Sequence: 75; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Business Combination, initially announced on April 17, 2025, in
which the Company, Bioceres Group Limited (formerly, Bioceres Group PLC, one of the main shareholders of the Company), Gentle Technologies
Corp (&#8220;Gentle Tech&#8221;) and Nutrecon LLC (&#8220;Nutrecon&#8221;) entered into the Business Combination Agreement, pursuant to
which several parties transferred their respective holdings in Bioceres Group, Nutrecon and Gentle Tech (together, the &#8220;Contributed
Entities&#8221;) to the Company, in exchange of a combination of newly issued Company&#8217;s shares, and warrants, to the shareholders
of the Contributed Entities. Following the closing, Moolec became the legal parent company of the combined group comprising Bioceres Group,
Gentle Tech, and Nutrecon. was ratified by Moolec shareholders at the Extraordinary General Meeting (&#8220;EGM&#8221;) held on June 16,
2025 with 77% of the outstanding shares present at the meeting, and 98% of the votes cast were in favor of the transaction. From an accounting
perspective and based on the guidance of IFRS 3 Bioceres Group Limited is deemed to be the accounting acquirer. The transaction was subsequently
consummated on the same date, June 16, 2025 (the &#8220;Closing&#8221;).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Through the consummation
of the Business Combination, Moolec Science SA acquired all the issued and outstanding equity interests of Bioceres Group and Nutrecon
and 50% of Gentle Tech, integrating mature agricultural biologicals and seed businesses, nutritional solutions, and emerging technology
ventures. In consideration for the contributed entities, the Company issued approximately 6.2 million of ordinary shares to the shareholders
of Bioceres Group, 450,000 of ordinary shares and 500,000 private warrants with an exercise price of US$20.00 per share to the shareholders
of Nutrecon, and 132,750 ordinary shares to the shareholders of Gentle Tech. Also, Moolec Science SA committed to issue additional ordinary
shares twelve months after the acquisition date, representing the 10% of the total shares to be issued (the &#8220;Holdback&#8221;), representing
approximately 0.7 million of ordinary shares to the shareholders of Bioceres Group, 50,000 of ordinary shares to the shareholders of Nutrecon,
and 14,750 ordinary shares to the shareholders of Gentle Tech.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On June 16, 2025,
following the consummation of the Business Combination, the Company initiated integration processes across organizational,
operational, and IT functions to support competitiveness and long-term sustainability. In parallel, management continued to advance
the ongoing operations, which remain crucial to maintaining business continuity and supporting the successful execution of the
integration and growth strategy. The consolidated results as of and for the year ended June 30, 2025 (&#8220;FY2025&#8221;) reflect
purchase accounting. The prior periods as of and for the year ended June 30, 2024 (&#8220;FY2024&#8221;) and for the year ended June
30, 2023 reflects the Predecessor on a stand-alone basis and does not include any effects of the Business Combination. As a result,
variances between FY2025 and FY2024 primarily reflect changes in scope and basis of presentation rather than purely
period-over-period operating trends, and therefore the periods are not directly comparable. Effective as of the Closing (i.e., June
16, 2025), the Company accounted for the Business Combination under IFRS 3, <i>Business Combinations</i>, using the acquisition
method of accounting and treating the transaction as a reverse acquisition. Under this approach, Bioceres Group (the legal
subsidiary) was considered the accounting acquirer, and Moolec Science SA (the legal acquirer) was considered the accounting
acquiree, together with Gentle Tech and Nutrecon.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Going concern</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Business Combination,
initially announced on April 17, 2025, in which the Company, Bioceres Group (formerly, Bioceres Group PLC, one of the main shareholders
of the Company), Gentle Tech and Nutrecon entered into the Bioceres Group Business Combination Agreement, pursuant to which several parties
transferred their respective holdings in Bioceres Group, Nutrecon and Gentle Tech (together, the &#8220;Contributed Entities&#8221;) to
the Company, in exchange of a combination of newly issued Company&#8217;s shares, and warrants, to the shareholders of the Contributed
Entities. Following the closing, Moolec became the legal parent company of the combined group comprising Bioceres Group, Gentle Tech,
and Nutrecon. The Business Combination was ratified by Moolec shareholders at the Extraordinary General Meeting (&#8220;EGM&#8221;) held
on June 16, 2025, with 77% of the outstanding shares present at the meeting, and 98% of the votes cast were in favor of the transaction.
From an accounting perspective and based on the guidance of IFRS 3, Bioceres Group Limited is deemed to be the accounting acquirer. The
transaction was subsequently consummated on the same date, June 16, 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On June 18, 2025, Bioceres
Crop Solutions Corp. (BIOX), a public company controlled until that date by Bioceres Group Limited, entered into an amendment with the
Secured Notes&#8217; holders by which the holders of the Secured Notes waived the breach of covenants that led to the default of the debt
(specifically, the breach of covenants related to the Consolidated Total Net Leverage Ratio (determined as the ratio of (a) Consolidated
Total Net Debt as of the last day of such Test Period to (b) Consolidated EBITDA of the Issuer and its Subsidiaries for such Test Period)
of 3.75x as of March 31, 2025), retrospectively modifying the required Consolidated Total Net Leverage Ratio to 5x Consolidated Total
Net Leverage Ratio, and extended the maturity of the Secured Notes to August 31, 2027. In accordance with the terms of the amendments,
effective June 24, 2025, Gloria Montaron Estrada, Enrique Lopez Lecube, and Keith McGovern were replaced in Bioceres Crop Solutions Corp.&#8217;s
Board of Directors by Milen Marinov, Noah Kolatch and Scott Crocco, who were nominated by certain holders of the Secured Notes. Bioceres
Crop Solutions Corp. agreed, for so long as the Secured Notes remain outstanding, to continue to nominate Messrs. Marinov, Kolatch and
Crocco (or such other persons as may be nominated as their replacements) for additional terms as directors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 76; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The effect of the changes
in the terms of the Secured Notes of Bioceres Crop Solutions, resulted in the loss of de facto control of that subsidiary and consequently,
its deconsolidation. The equity method was applied to account for the investment in such former subsidiary, as well as for other investments
in joint ventures and associates (the &#8220;BIOX deconsolidation&#8221;). Even when there was a deconsolidation of the business, the
Company will continue to be affected by BIOX business due to the HB4 royalty agreement. It is important to note that the effects of the
loss of control in BIOX represents substantially all of the Company&#8217;s business.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As a result of the loss of
control over BIOX, access to financing that Bioceres S.A., its wholly owned subsidiary Bioceres LLC, Bioceres Group Limited and Moolec
Science SA had until then, was restricted or limited.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In June 2025, Bioceres S.A.,
one of the Argentine subsidiaries of Bioceres Group Limited, defaulted on a portion of its financial debt that was due that month. As
a result, Bioceres S.A. had initiated a debt restructuring process for its financial debt for an aggregate amount of $36.4 million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In July 2025, Bioceres LLC,
a wholly owned subsidiary of Bioceres S.A., received a notice of default on its financial debt&#160;in the amount of $69.5 million. The
creditor conducted a public auction for 3,062,500 pledged BIOX shares, pursuant to the New York Uniform Commercial Code. Management has
responded to the creditor, reserving all rights, remedies, and defenses. As of June 30, 2025, the current debt amounts to US$58.0 million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The defaults by Bioceres
S.A. and Bioceres LLC do not have implications in other debts as there are no cross-default clauses on the remaining financial debt of
the Group. There are no guarantees granted above Bioceres S.A. and Bioceres LLC.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As of June 30, 2025, the
Group had a negative working capital amounting to US$204,860,444, and a shareholders&#8217; deficit of US$82,873,602. Additionally, the
Group reported recurring operating losses amounting to US$104,150,129.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company had the financial
support of its main shareholders and considering the aforementioned events that derived in the loss of the financial support that was
previously provided by Bioceres Group (and who is also no longer a shareholder of the Company), and, consequently, raise a material uncertainty
which may cast significant doubt (or raise substantial doubt as contemplated by PCAOB standards) &#160;about the ability of Moolec Science
SA to continue as a going concern, currently, the Group lacks sufficient financial resources to meet its obligations or fully implement
its business plan. Without securing additional capital, the Group will not be able to sustain its operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The uncertainty surrounding
the ability to secure additional funding and the potential for continued operational losses contribute to substantial doubt about the
Group&#8217;s ability to continue as a going concern.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Management has plans to address
the Group&#8217;s financial situation as follows:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Theo I SCSp</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On November 28, 2025, subsequent
to the reporting date, Theo I SCSp received a conditional payment order from district court of&#160; Luxembourg, and therefore the General
Partners engaged Ogier (Luxembourg) SCS represented by its general partner Ogier Luxembourg (GP) S.&#224;.r.l&#160; formally as their
legal advisor to assist with Theo I SCSp&#8217;s declaration of bankruptcy before the Luxembourg District Court. The declaration of bankruptcy
will declare Theo I SCSp bankrupt and appoint a receiver who will take control over the management of the company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The loss of control constitutes
the derecognition event under IFRS 10.25. Accordingly, the Group will derecognize the assets and liabilities of Theo I SCSp and will remeasure
its retained interest at fair value in accordance with IFRS 9 at the date of the derecognition event. This will result in the recognition
of an estimated gain of US$9.5 million in the consolidated statement of profit or loss as of the derecognition date.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Group will continue to
measure its retained interest in Theo I SCSp at fair value through profit or loss until the liquidation process is formally completed.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i>&#160;</p><div>

</div><!-- Field: Page; Sequence: 77; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Bioceres S.A. and Bioceres LLC</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On December 16, 2025, subsequent
to the reporting date, the Board of Directors of Bioceres S.A. formally approved the initiation of voluntary bankruptcy proceedings and
instructed management to seek and appoint a trustee (&#8220;s&#237;ndico&#8221;) to oversee the process. The commencement of the voluntary
bankruptcy proceedings and the transfer of decision-making authority to the trustee will result in the Group losing control over Bioceres
S.A. in accordance with the principles of IFRS 10 Consolidated Financial Statements. As Bioceres LLC is a wholly owned subsidiary of Bioceres
S.A., the Group simultaneously will lose  control over Bioceres LLC as well.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Under IFRS 10.25, the date
on which control is lost constitutes the derecognition event. Accordingly, after December 16, 2025, the Group will derecognize the assets
and liabilities of Bioceres S.A. and Bioceres LLC and will remeasure any retained interest at fair value in accordance with IFRS 9 Financial
Instruments.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The resulting derecognition
effects are expected to generate an approximate gain of US$91.0 million related to the loss of control of Bioceres S.A. and an additional
approximate gain of US$5.3 million related to the loss of control of Bioceres LLC (including the loss of holding in BIOX, therefore it
will no longer be an equity method associate).These amounts will be recognized in the consolidated statement of profit or loss as of the
derecognition date.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Group will continue to
monitor the progress of the voluntary bankruptcy and liquidation proceedings and will update the accounting treatment as necessary in
accordance with IFRS.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Management expects that certain
shareholders and/or investors will continue or commence to provide new financing lines.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">However, there is no assurance
that investors and shareholders will continue to provide financing, or that the Group&#8217;s future operations will generate profitability.
The uncertainty surrounding the ability to secure additional funding and the potential for continued operational losses contribute to
raise a material uncertainty which may cast significant doubt (or raise substantial doubt as contemplated by PCAOB standards) about the
Group&#8217;s ability to continue as a going concern.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The consolidated financial
statements of Moolec Science SA do not include any adjustments that may be required to address the potential impacts on the recoverability
and classification of assets or the amounts and classifications liabilities, should the Group be unable to continue as a going concern.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Accordingly, the financial statements of Moolec Science SA for periods prior to the Closing reflect the historical
financial information of Bioceres Group. The financial information as of and for the year ended June 30, 2025 <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reflects
the figures corresponding to Bioceres Group and incorporates the effects of applying the acquisition method to Moolec Science SA, Gentle
Tech and Nutrecon, measured at fair value in accordance with IFRS 3.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">For a discussion of the factors
that may affect our results of operations see &#8220;Item 3&#8212;Key Information&#8212;Risk Factors&#8221;.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Factors Affecting our Operating Results</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>BIOX deconsolidation</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our operating results going
forward will be affected by the deconsolidation of BIOX following the loss of de facto control over that entity on June 18, 2025. As a
result of this deconsolidation, the Group no longer consolidates BIOX&#8217;s assets, liabilities, revenues and expenses, and instead
accounts for its investment in BIOX under the equity method. Accordingly, our operating results will reflect only our share of BIOX&#8217;s
net results, rather than BIOX&#8217;s results on a consolidated basis, which may materially reduce reported revenues, operating income
and other key performance indicators compared to prior periods. If the voluntary bankruptcy described above proceeds, BIOX will no longer
be an equity method associate. For a detailed discussion of the events and circumstances that led to the loss of control over BIOX, see
&#8220;Part I &#8211; <i>Introductory note and presentation of financial and other information</i>.&#8221;</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Regulatory environment</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our operating results will
vary depending on the speed at which we are able to obtain regulatory approvals for our products and the cost and expense associated with
gaining such approvals. The degree of regulation to which we are subject varies by activity and country. Our ability to sell our technologies
and products depends on obtaining and maintaining necessary authorizations, permits, and regulatory approvals in the markets in which
we operate.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Product Development</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Moolec has developed a range
of functional proteins and lipids that are already available to food manufacturers and feed producers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">One of our lead products,
Mycofood&#8482;, exemplifies our approach in action. It is a scalable, 100% animal-free protein ingredient produced through precision
fermentation of fungal biomass. Designed to deliver a neutral taste and versatile texture, Mycofood&#8482; can be seamlessly integrated
into a wide range of food systems&#8212;from meat analogues to protein-enriched formulations&#8212;without altering flavor or mouthfeel.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">ValoraSoy products primarily
use soy-based functional proteins, supplemented with chickpea-based proteins, specifically designed for human nutrition. Produced in state-of-the-art
facilities in Argentina&#8217;s soybean corridor, these plant proteins provide chewiness, texture, and fibrous structure comparable to
meat, supporting clean-label and nutritionally rich applications.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">GLASO, a safflower-derived
oil rich in functional lipids, is currently being used in formulations for small-animal feed, demonstrating the versatility of our platform
and its applicability beyond human food systems.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><!-- Field: Page; Sequence: 78; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Other programs remain under
research and development and will advance through discovery, transformation, development, and selection stages prior to full-scale production
and commercialization. This mix of revenue-generating and pipeline projects reflects our dual focus on near-term market presence and long-term
innovation across molecular farming and precision fermentation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We have made significant
progress in the research and development of our products, as well as in acquiring the necessary production facilities to scale-up production:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the Closing of the Business Combination in June 2025, we incorporated a pilot and industrial precision-fermentation facility
under the SynBio Powerlabs brand, designed to produce target proteins, enzymes, and other biomolecules using optimized microbial and
cellular systems &#8211; providing a controlled, scalable pathway from design through fermentation to commercial channels with food-industry
partners. The site runs under the Finnish and EU &#8220;contained use&#8221; framework, overseen by the Finnish Food Authority (Ruokavirasto)
and the Board for Gene Technology (GTLK), which enables compliant, controlled production without open-field authorizations, while aligning
with traceability and data-audit requirements across our Finland-based operations.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 2025, in Argentina, the National Service for Agri-Food Health and Quality (SENASA) granted feed and food approval for Moolec&#8217;s
proprietary Safflower GLASO1&#160;technology.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.4pt; text-align: justify; text-indent: -17.85pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 18, 2024, USDA-APHIS concluded its Regulatory Status Review for our genetically engineered soybean, Piggy Sooy&#8482;. The review
determined that Piggy Sooy&#8482;, which accumulates animal meat protein, does not pose an increased plant pest risk compared to non-engineered
soybeans. Consequently, Piggy Sooy&#8482; is not subject to the APHIS regulation governing the movement of genetically engineered organisms
(7 CFR part 340). This represents the first-ever USDA-APHIS approval for plant-grown animal proteins. See <i>&#8220;Item 4. Information
on the Company&#8212;B. Business Overview&#8212;Government Regulation.&#8221;</i></span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.4pt; text-align: justify; text-indent: -17.85pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 31, 2023, USDA-APHIS issued a Regulatory Status Review with the conclusion that our GLA safflower plants pose no greater plant
pest risk than non-genetically engineered safflower plants according to regulation 7 CFR part 340. We also have FDA approval for use
of the seed meal from GLA safflower plants in food for cattle and poultry. See <i>&#8220;Item 4. Information on the Company&#8212;B.
Business Overview&#8212;Government Regulation.&#8221;</i></span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.4pt; text-align: justify; text-indent: -17.85pt">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the closing of the ValoraSoy Food Ingredients Acquisition in April 2023, we acquired a soy processing plant in Argentina
which specializes in the production of textured soy proteins. Its products are manufactured using various extrusion processes obtaining
vegetable proteins with texture and fibrousness similar to those of meat, with various applications such as hamburgers, sausages, and
other plant-based products.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 39.4pt; text-align: justify; text-indent: -17.85pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We are striving to successfully
complete certain major research, development, and production activities in order to meet our expected production dates.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our team of scientists, technicians
and staff is committed to achieving the milestones to meet our current production and commercialization timelines to enable us to achieve
our expected production dates. Achievement of these milestones are critical to our development timelines, though may be subject to unanticipated
delays outside of our control such as the ability to obtain sufficient capital to support production.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Capital Requirements</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As a result of the closing
of the ValoraSoy Acquisition, we used to generate revenue from our operations from ValoraSoy&#8217;s pre-existing contracts. Starting
in the fiscal year 2025, we initiated the commercialization of GLASO. However, until we can generate sufficient revenue, we are dependent
on our ability to raise sufficient capital from third-party sources. After the Business Combination Closing, we incorporated other sources
of revenues from operations of Bioceres Group and we expect to incorporate other sources from Nutrecon and its subsidiary. We expect to
finance our future capital needs through private placements of our securities, public offerings of equity and/or equity-linked securities,
debt financings, collaborations, and licensing arrangements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><!-- Field: Page; Sequence: 79; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Macroeconomic conditions in Argentina</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We generate a significant
portion of our revenue in Argentina, an emerging market. Therefore, our operating result and financial condition are directly impacted
by macroeconomic and fiscal developments, including fluctuations in currency exchange rates, inflation and interest rate fluctuations,
in Argentina. See &#8220;<i>Item 3. Key Information&#8212;D. Risk Factors&#8212;Risks Relating to our Business and Operations&#8212;Economic
and political developments in Argentina, including inflation and government controls may adversely affect the economy and our financial
condition and results of operations</i>.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Operating Results</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We have based the following
discussion on our audited consolidated financial statements included elsewhere in this report. You should read it along with these financial
statements, and it is qualified in its entirety by reference to them.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Comparison of the Year Ended June&#160;30,
2025, and the Year Ended June 30, 2024</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following table sets
forth our historical operating results for the periods indicated:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Consolidated Statements of Comprehensive Loss</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the<br/> year&#160;ended<br/> June&#160;30,<br/> 2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the<br/> year&#160;ended<br/> June&#160;30,<br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Change</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Variation</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-style: italic">&#160;</td>
    <td colspan="10" style="font-style: italic; text-align: center">(in United States Dollars)</td><td style="font-style: italic">&#160;</td><td style="font-style: italic">&#160;</td>
    <td colspan="2" style="font-style: italic; text-align: center">(%)</td><td style="font-style: italic">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; text-indent: -0.1in; padding-left: 0.1in">Revenues from contracts with customers</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">333,611,248</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">466,376,330</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(132,765,082</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(28</td><td style="width: 1%; text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">Government grants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,412</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">197,519</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(194,107</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(98</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">Initial recognition and changes in the fair value of biological assets at the point of harvest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,764,863</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(45,746</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,810,609</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">n.s.</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.1in; padding-left: 0.1in">Cost of sales</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(203,424,872</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(279,368,328</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">75,943,456</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(27</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">Changes in the net realizable value of agricultural products after harvest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,541,204</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,385,069</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">843,865</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(35</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">Research and development expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(15,138,510</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(17,422,487</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,283,977</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(13</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">Selling, general and administrative expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(125,908,240</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(126,340,822</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">432,582</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">Share of profit or loss of joint ventures and associates</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(36,927,610</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(21,023,150</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(15,904,460</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">76</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.1in; padding-left: 0.1in">Other income or expenses, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(56,589,216</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(703,265</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(55,885,951</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">n.s.</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; text-indent: -0.1in; padding-left: 0.1in">Operating profit</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(104,150,129</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">19,284,982</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(123,435,111</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(640</td><td style="font-weight: bold; text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">Financial costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(41,809,445</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(37,634,153</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,175,292</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">Other financial results</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(24,043,905</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,608,981</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(14,434,924</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">150</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; text-indent: -0.1in; padding-left: 0.1in">(Loss) Profit before income tax</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(170,003,479</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(27,958,152</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(142,045,327</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">508</td><td style="font-weight: bold; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.1in; padding-left: 0.1in">Income tax</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(6,636,121</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,103,152</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(5,532,969</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">502</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; text-indent: -0.1in; padding-left: 0.1in">(Loss) Profit for the year</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(176,639,600</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(29,061,304</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(147,578,296</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">508</td><td style="font-weight: bold; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">Basic and diluted (loss) / profit attributable to ordinary equity holders of the parent</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(17.2461</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5.6146</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(11.6315</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">207</td><td style="text-align: left">%</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Notes:</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8220;n.s.&#8221;: not significant.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>As a result of the deconsolidation of BIOX, the Company expects
significant decreases in revenues from contracts with customers, cost of sales, selling, general and administrative expenses, share of
profit or loss of joint ventures and associates in future periods, as BIOX&#8217;s results will no longer be consolidated. Other operating
line items previously impacted by BIOX&#8217;s operations may also be affected. Following the deconsolidation, the Company will recognize
only its share of BIOX&#8217;s net results under the equity method, which may impact the comparability of operating results across periods.
See &#8220;Item 5. Operating and Financial Review and Prospects&#8212;A. Operating results&#8212;Factors affecting our operating results&#8221;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><!-- Field: Page; Sequence: 80; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Revenues from contracts with customers and
initial recognition and changes in the fair value of biological assets at the point of harvest </i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Total revenues and changes
in the fair value of biological assets at the point of harvest are mainly derived from our former consolidated subsidiary Bioceres Crop
Solutions Corp. (BIOX). Total revenue decreased by US$132.8 million, or 28%, totaling US$333.6 million for the year ended June 30, 2025,
compared to our total revenue of US$466.4 million for the year ended June 30, 2024. Revenue was impacted mainly by severe challenges in
Argentina, one of our key markets, during the year ended June 30, 2025, driven mainly by a combination of factors: (i) extraordinary prior-year
sales linked to local currency devaluation, which led distribution channels to accumulate inventories beyond short-term needs; (ii) deteriorating
on-farm economics; and (iii) constrained financing availability across the agricultural sector.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b>Crop</b>&#160;<b>Protection.</b>&#160;Total
revenue decreased by US$41.6 million, or 19%, to US$181.9 million for the year ended June 30, 2025, compared to our total revenue of US$223.5
million for the year ended June 30, 2024, primarily driven by reduced commercialization of third-party products in Argentina, which accounted
for US$41.9 million of the total decrease. This trend aligns with our strategic shift toward prioritizing higher-margin proprietary technologies.
Meanwhile, bioprotection products saw a US$5.8 million increase, which was nearly offset by a US$5.7 million decline in seed crop protection
products.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b><i>Crop</i></b><i>&#160;<b>Nutrition.</b>&#160;</i>Total
revenue decreased by US$55.3 million, or 38%, to US$89.5 million for the year ended June 30, 2025, compared to our total revenue of US$144.8
million for the year ended June 30, 2024. The decrease was primarily driven by a sharp contraction in micro-beaded fertilizer sales, attributed
to reduced corn acreage in Argentina early in the year. This was further compounded by unfavorable farm economics and elevated channel
inventories, which constrained purchasing behavior throughout the season and led to a 39% drop in sales volume. The expected reduction
of US$15.7 million related to the Syngenta downpayment further weighed on comparisons.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b>Seed
and</b>&#160;<b>Integrated Products.</b>&#160;Total revenue decreased by US$32.7 million, or 34%, to US$63.7 million for
the year ended June 30, 2025, compared to our total revenue of US$96.4 million for the year ended June 30, 2024. The decline
reflects the ongoing transition of the HB4 business model toward strategic partnerships. Reduced volumes from the HB4 business
accounted for US$31.7 million of total segment sales, highlighting the impact of this shift on overall performance.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Gross profit</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Gross profit (defined as
Revenues and changes in the fair value of biological assets at the point of harvest less cost of sales) are mainly derived from our former
consolidated subsidiary Bioceres Crop Solutions Corp. (BIOX). Gross profit decreased by US$54.2 million, or 29%, to US$130.4 million for
the year ended June 30, 2025, from US$184.6 million for the year ended June 30, 2024. The decrease was mainly driven by lower sales across
all segments, including a US$15.7 million year-over-year reduction from the Syngenta agreement that carried a 100% gross margin in the
year ended June 30, 2024. Even in this challenging context, gross profit performance broadly tracked sales, and the full-year gross margin
held stable compared to the prior year. This reflects the relative resilience of the higher-margin proprietary products, where we retained
market share and, in some international markets, achieved modest gains.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b>Crop Nutrition.</b>&#160;The
Syngenta license payment carries a 100% gross margin; therefore, the US$15.7 million decline had a direct and full impact on gross profit,
reducing both the segment&#8217;s total gross profit and average gross margin compared to the prior year. Additionally, as described above,
the segment was negatively affected by lower fertilizer volumes, which were the primary driver of the overall decline. Margin pressure
was further intensified by pricing headwinds in biostimulants and, to a lesser extent, in micro-beaded fertilizers, resulting in segment
margins declining from 53% to 48%.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b>Crop Protection.</b>&#160;The
decline in gross profit was consistent with lower sales, though less pronounced, resulting in an improved gross margin for the segment.
This improvement was mainly driven by a reduction in the commercialization of low-margin third-party products, along with a more favorable
product mix. Notably, bioprotection products contributed an additional US$1.6 million, and adjuvants saw a modest margin improvement,
further supporting the overall margin expansion.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><!-- Field: Page; Sequence: 81; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b>Seed and Integrated Products.</b>&#160;The
decrease in gross profit was consistent with the decline in sales and reflects the planned wind-down of the seed business. This transition
is part of our strategic shift toward partnerships and trait development, while continuing to sell through existing grain and seed inventories.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Research and development expenses</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Research and development
expenses are mainly derived from our former consolidated subsidiary Bioceres Crop Solutions Corp. (BIOX). Research and development expenses,
which include ongoing efforts to maintain and continuously update our existing product portfolio, decreased by US$2.3 million in the year
ended June 30, 2025, compared US$17.4 million for the year ended June 30, 2024. The reduction reflects a refocusing of resources to prioritize
initiatives that balance our long-term growth prospects with nearer-term profitability opportunities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Selling, general and administrative expenses&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Selling, general and administrative
expenses decreased slightly by US$0.4 million, to US$125.9 million for the year ended June 30, 2025, from US$126.3 million for the year
ended June 30, 2024. The figure reflects a US$6.4 million increase in impairment of receivables, mainly associated with non-recurring
events in Bolivia and the HB4 business, and US$3.5 million in one-time workforce streamlining costs, which offset savings achieved through
cost-control initiatives and lower variable costs resulting from reduced sales activity.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Share of profit or loss of joint ventures and
associates</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The result from our share in the profit of joint ventures and associates
declined by US$15.9 million, from a loss of US$21.0 million in the fiscal year ended June 30, 2024, to a loss of US$36.9 million in the
fiscal year ended June 30, 2025. Increase in loss of joint ventures and associates was primarily driven by a higher loss of our participation
in Theo I SCSp for US$7.8 million and lower earnings from participation in Agrality and Synertech by US$4.1 million and US$2.9 million,
respectively.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Other income or expense, net</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Other income or expense, net increased by loss of US$55.9 million to
US$56.6 million in the fiscal year ended June 30, 2025, from a loss of $0.7 million in the fiscal year ended June 30, 2024. The increase
loss was mainly derived from higher expenses related to the recognition of financial guarantees of Theo I SCSp, one of our associates
for US$61.7, and partially offset by the result of exchange of intangible assets amounting US$ 7.6 million and the recognition of US$1.5
million gain on purchase related to the Business Combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Other financial results</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Other financial results
are mainly derived from our former consolidated subsidiary Bioceres Crop Solutions Corp. (BIOX).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Income tax</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Income tax increased to US$6.6 million for the year ended June 30,
2025, from US$1.1 million for the year ended June 30, 2024. The Company&#180;s effective tax is 4.2% and 3.9% for the year ended June
30, 2025 and 2024. For the year ended June 2025, the effective tax is lower than statutory tax rate mainly due to derecognition of deferred
tax assets (US$40.5 million) from Bioceres SA because it initiated voluntary bankruptcy, Share of profit or loss of subsidiaries, joint
ventures and associates (US$8.2 million) and non-deductible expenses (US$4 million). For the year ended June 2024, the effective tax is
lower than statutory tax rate mainly due to Share of profit or loss of subsidiaries, joint ventures and associates (US$5.1 million), non-deductible
expenses (US$1.5 million), tax inflation adjustment (US$4.2 million) and result of inflation effect on monetary items (US$5.1 million).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><!-- Field: Page; Sequence: 82; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Comparison of the Year Ended June&#160;30,
2024, and the Year Ended June 30, 2023</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following table sets
forth our historical operating results for the periods indicated:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="14" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Consolidated Statements of Comprehensive Loss</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the<br/> year&#160;ended<br/> June&#160;30,<br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the<br/> year&#160;ended<br/> June&#160;30,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Change</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Variation</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-style: italic">&#160;</td>
    <td colspan="10" style="font-style: italic; text-align: center">(in United States Dollars)</td><td style="font-style: italic">&#160;</td><td style="font-style: italic">&#160;</td>
    <td colspan="2" style="font-style: italic; text-align: center">(%)</td><td style="font-style: italic">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; text-indent: -0.1in; padding-left: 0.1in">Revenues from contracts with customers</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">466,376,330</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">420,867,429</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">45,508,901</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">11</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">Government grants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">197,519</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">93,509</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">104,010</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">111</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">Initial recognition and changes in the fair value of biological assets at the point of harvest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(45,746</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">610,554</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(656,300</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(107</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.1in; padding-left: 0.1in">Cost of sales</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(279,368,328</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(235,464,072</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(43,904,256</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">Changes in the net realizable value of agricultural products after harvest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,385,069</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,351,433</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,966,364</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(45</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">Research and development expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(17,422,487</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(15,943,987</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,478,500</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">Selling, general and administrative expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(126,340,822</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(116,531,274</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,809,548</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">Share of profit or loss of joint ventures and associates</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(21,023,150</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">47,709,605</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(68,732,755</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(144</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.1in; padding-left: 0.1in">Other income or expenses, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(703,265</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,055,299</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,758,564</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(167</td><td style="padding-bottom: 1.5pt; text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; text-indent: -0.1in; padding-left: 0.1in">Operating profit</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">19,284,982</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">98,045,630</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(78,760,648</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(80</td><td style="font-weight: bold; text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">Financial costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(37,634,153</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(33,576,632</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,057,521</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">Other financial results</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,608,981</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(13,674,756</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,065,775</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(30</td><td style="text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; text-indent: -0.1in; padding-left: 0.1in">(Loss) Profit before income tax</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(27,958,152</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">50,794,242</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(78,752,394</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(155</td><td style="font-weight: bold; text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.1in; padding-left: 0.1in">Income tax</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,103,152</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,328,366</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,431,518</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(147</td><td style="padding-bottom: 1.5pt; text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; text-indent: -0.1in; padding-left: 0.1in">(Loss) Profit for the year</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(29,061,304</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">53,122,608</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(82,183,912</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(155</td><td style="font-weight: bold; text-align: left">)%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">Basic and diluted (loss) / profit attributable to ordinary equity holders of the parent</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5.6146</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8.8034</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(14.4180</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(164</td><td style="text-align: left">)%</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Notes:-</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8220;n.s.&#8221;: not significant.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Revenues from contracts with customers and
initial recognition and changes in the fair value of biological assets at the point of harvest </i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Revenues and changes in
the fair value of biological assets at the point of harvest are mainly derived from our former consolidated subsidiary Bioceres Crop Solutions
Corp. (BIOX). Total revenue increased by US$45.5 million, or 11%, totaling US$466.4 million for the year ended June 30, 2024, compared
to our total revenue of US$420.9 for the year ended June 30, 2023. Revenue from HB4 sales, adjuvants, and other crop protection products
increased as a result of normalized weather conditions in the southern hemisphere and, to a lesser extent, an increase in bio stimulant
sales in Europe.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b><i>Crop Protection.</i></b>
Total revenue increased by US$17.7 million, or 8.6%, to US$223.5 million for the year ended June 30, 2024, from US$205.8 million for the
year ended June 30, 2023. This increase was due to a greater demand for crop protection products in key markets, such as Brazil and Argentina,
as a result of heightened pest pressure - in this segment, adjuvants and seed protection products were the main growth drivers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b><i>Crop Nutrition.</i></b>
Total revenue decreased by US$12.4 million, or 7.9%, to US$144.8 million for the year ended June 30, 2024, compared to US$157.3 million
for the year ended June 30, 2023. The decrease was mainly due to a US$17.2 million decrease in the accrual of the Syngenta license payment
in the amount of US$15.7 million in the year ended June 30, 2024, compared to US$32.9 million in the year ended June 30, 2023. In addition,
softened micro-beaded fertilizers demand in the fourth quarter interrupted the momentum shown by this product category during the first
half of the fiscal year, while bio stimulants were the best performers, increasing by more than 50%, mainly in Europe.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt"><b><i>&#160;</i></b></p><div>

</div><!-- Field: Page; Sequence: 83; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b><i>Seed and Integrated
Products.</i></b> Total revenue increased by US$39.5 million, or 69.3%, to US$96.4 million for the year ended June 30, 2024, compared
to US$56.9 million for the year ended June 30, 2023, as a result of the largest year-on-year increase driven by HB4 sales.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0in; text-align: justify"><i>Gross profit</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Gross profit (defined as
Revenues and changes in the fair value of biological assets at the point of harvest less cost of sales) are mainly derived from our former
consolidated subsidiary Bioceres Crop Solutions Corp. (BIOX). Gross profit remained nearly flat compared to the year before, increasing
by US$2.9 million, or 2%, to US$184.6 million for the year ended June 30, 2024, from US$181.7 million for the year ended June 30, 2023
primarily due to the lower contribution of the Syngenta compensatory payment.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b><i>Crop Nutrition.</i></b>
In addition, the Syngenta license payment entails a 100% gross margin, and the US$17.2 million decline translates directly into gross
profit, lowering Crop Nutrition segment&#8217;s gross profit and average gross margin, compared to last year.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b><i>Crop Protection.</i></b>
Crop Protection saw gross margin improvement on top of top line growth, with margin expansions led by the bio protection portfolio as
well as a more focused approach to third-party products&#8217; commercialization.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b><i>Seed and
Integrated Products.</i></b> In Seed and Integrated Products, HB4 downstream sales &#8212; with a lower gross margin than upstream
sales &#8211; were higher in the year ended June 2024, as a result of grain inventories being drawn down to minimize working capital
requirements and to develop commercial channels for fully traced grain inventories. As a result, gross profit for Seed and
Integrated Products grew less than sales. Overall gross margin decreased 381 bps to 40% for the year ended June 30, 2024, from 44%
in the year ended June 30, 2023.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Research and development expenses</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Research and development
expenses are mainly derived from our former consolidated subsidiary Bioceres Crop Solutions Corp. (BIOX). Research and development expenses,
which include ongoing efforts to maintain and continuously update BIOX existing product portfolio, remained nearly flat at 4% of revenue
in the year ended June 30, 2024, compared to the year ended June 30, 2024, totaling US$17.4 million for the year ended June 30, 2024,
compared to US$15.9 million for the year ended June 30, 2023.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Selling, general and administrative expenses&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Selling, general and administrative
expenses are mainly derived from our former consolidated subsidiary Bioceres Crop Solutions Corp. (BIOX). These expenses increased by
US$9.8 million, or 8%, to US$126.3 million for the year ended June 30, 2024, from US$116.5 million for the year ended June 30, 2023. Total
selling, general and administrative expenses as a percentage of revenues stood flat at 28% in the year ended June 30, 2023, compared to
28% in the year ended June 30, 2023.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Share of profit or loss of joint ventures and
associates</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The result from our share
in the profit of joint ventures and associates declined by US$68.7 million, from an income of US$47.7 million in the fiscal year ended
June 30, 2023, to a loss of US$21.0 million in the fiscal year ended June 30, 2024. This loss was primarily driven by a decline in our
investments like Theo I SCSp.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Other financial results</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Other financial results
are mainly derived from our former consolidated subsidiary Bioceres Crop Solutions Corp. (BIOX).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Financial costs increased
by US$4.1 million, or 12%, to US$37.6 million for the year ended June 30, 2024, from US$33.6 million for the year ended June 30, 2023,
driven mainly by interest expenses.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><!-- Field: Page; Sequence: 84; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Other financial results
decreased by US$4.1 million to a loss of US$9.6 million for the year ended June 30, 2024, compared to a loss of US$13.7 million for the
year ended June 30, 2023, mainly as a result of a gain in exchange differences in the amount of US$12.9 million and net gain of inflation
effect on monetary items in the amount of US$1.3 million offset by changes in fair value of financial assets or liabilities and other
financial results.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><i>Income tax</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Income tax changed to an
expense of US$1.1 million for the year ended June 30, 2024, from a gain of US$2.3 million for the year ended June 30, 2023. The tax on
the Group&#8217;s profit before tax differs from the theoretical amount that would arise using the weighted average tax rate applicable
to profits of the consolidated entities due to share of profit or loss of subsidiaries, joint ventures and associates, share-based incentives
charges, non-deductible expenses, tax inflation adjustment and result of inflation effect on monetary items, among other.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_023"></a></div><p style="margin-left: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>B. Liquidity and Capital Resources</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Overview</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our principal source of liquidity
has been through shareholders funding, which has historically been sufficient to meet our working capital and capital expenditure requirements.
As of June 30, 2025, and June 30,&#160;2024, we had cash and cash equivalents of US$0.8 million and US$53.0 million, respectively.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We will require additional
cash resources in order to meet our expected operational and business needs for the next twelve&#160;months, which may include implementation
of our strategies to expand our business, or other investments or acquisitions we may decide to pursue. If we determine that our cash
requirements exceed the amount of cash and cash equivalents we have on hand at the time, we may seek to issue equity, debt or convertible
securities or obtain credit facilities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i><span style="text-decoration:underline">Going Concern</span></i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Business
Combination, initially announced on April 17, 2025, in which the Company, Bioceres Group (formerly, Bioceres Group PLC, one of the
main shareholders of the Company), Gentle Tech and Nutrecon entered into the Bioceres Group Business Combination Agreement, pursuant
to which several parties transferred their respective holdings in Bioceres Group, Nutrecon and Gentle Tech (together, the
&#8220;Contributed Entities&#8221;) to the Company, in exchange of a combination of newly issued Company&#8217;s shares, and
warrants, to the shareholders of the Contributed Entities. Following the closing, Moolec became the legal parent company of the
combined group comprising Bioceres Group, Gentle Tech, and Nutrecon. The Business Combination was ratified by Moolec shareholders at
the Extraordinary General Meeting (&#8220;EGM&#8221;) held on June 16, 2025, with 77% of the outstanding shares present at the
meeting, and 98% of the votes cast were in favor of the transaction. From an accounting perspective and based on the guidance of
IFRS 3, Bioceres Group Limited is deemed to be the accounting acquirer. The transaction was subsequently consummated on the same
date, June 16, 2025 (the &#8220;Closing&#8221;).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On June 18, 2025, Bioceres
Crop Solutions Corp. (BIOX), a public company controlled until that date by Bioceres Group Limited, entered into an amendment with the
Secured Notes&#8217; holders by which the holders of the Secured Notes waived the breach of covenants that led to the default of the debt
(specifically, the breach of covenants related to the Consolidated Total Net Leverage Ratio (determined as the ratio of (a) Consolidated
Total Net Debt as of the last day of such Test Period to (b) Consolidated EBITDA of the Issuer and its Subsidiaries for such Test Period)
of 3.75x as of March 31, 2025), retrospectively modifying the required Consolidated Total Net Leverage Ratio to 5x Consolidated Total
Net Leverage Ratio, and extended the maturity of the Secured Notes to August 31, 2027. In accordance with the terms of the amendments,
effective June 24, 2025, Gloria Montaron Estrada, Enrique Lopez Lecube, and Keith McGovern were replaced in Bioceres Crop Solutions Corp.&#8217;s
Board of Directors by Milen Marinov, Noah Kolatch and Scott Crocco, who were nominated by certain holders of the Secured Notes. Bioceres
Crop Solutions Corp. agreed, for so long as the Secured Notes remain outstanding, to continue to nominate Messrs. Marinov, Kolatch and
Crocco (or such other persons as may be nominated as their replacements) for additional terms as directors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The effect of the changes in the terms of the Secured Notes of Bioceres
Crop Solutions, resulted in the loss of de facto control of that subsidiary and consequently, its deconsolidation. The equity method was
applied to account for the investment in such former subsidiary, as well as for other investments in joint ventures and associates (the
&#8220;BIOX deconsolidation&#8221;). Even when there was a deconsolidation of the business, the Company will continue to be affected by
BIOX business due to the HB4 royalty agreement. It is important to note that the effects of the loss of control in BIOX represents substantially
all of the Company&#8217;s business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><!-- Field: Page; Sequence: 85; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As a result of the loss of control over BIOX, access to financing that
Bioceres S.A., its wholly owned subsidiary Bioceres LLC, Bioceres Group Limited and Moolec Science SA had until then, was restricted or
limited.</p><div>





</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In June 2025, Bioceres S.A.,
one of the Argentine subsidiaries of Bioceres Group Limited, defaulted on a portion of its financial debt that was due that month. As
a result, Bioceres S.A. had initiated a debt restructuring process for its financial debt for an aggregate amount of US$36.4 million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In July 2025, Bioceres LLC,
a wholly owned subsidiary of Bioceres S.A., received a notice of default on its financial debt&#160;in the amount of US$69.5 million. The
creditor conducted a public auction for 3,062,500 pledged BIOX shares, pursuant to the New York Uniform Commercial Code. Management has
responded to the creditor, reserving all rights, remedies, and defenses. As of June 30, 2025, the current debt amounts to US$58.0 million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The defaults by Bioceres
S.A. and Bioceres LLC do not have implications in other debts as there are no cross-default clauses on the remaining financial debt of
the Group. There are no guarantees granted above Bioceres S.A. and Bioceres LLC.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As of June 30, 2025,
the Group had a negative working capital amounting to <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$204,860,444,
and a shareholders&#8217; deficit of US$82,873,602. Additionally, the Group reported recurring operating losses amounting to </span>US$104,150,129.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company had the financial
support of its main shareholders and considering the aforementioned events that derived in the loss of the financial support that was
previously provided by Bioceres Group (and who is also no longer a shareholder of the Company), and, consequently, raise a material uncertainty
which may cast significant doubt (or raise substantial doubt as contemplated by PCAOB standards) &#160;about the ability of Moolec Science
SA to continue as a going concern, currently, the Group lacks sufficient financial resources to meet its obligations or fully implement
its business plan. Without securing additional capital, the Group will not be able to sustain its operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The uncertainty surrounding
the ability to secure additional funding and the potential for continued operational losses contribute to substantial doubt about the
Group&#8217;s ability to continue as a going concern.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Management has plans to address
the Group&#8217;s financial situation as follows:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Theo I SCSp</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On November 28, 2025, subsequent
to the reporting date, Theo I SCSp received a conditional payment order from district court of&#160; Luxembourg, and therefore the General
Partners engaged Ogier (Luxembourg) SCS represented by its general partner Ogier Luxembourg (GP) S.&#224;.r.l&#160; formally as their
legal advisor to assist with Theo I SCSp&#8217;s declaration of bankruptcy before the Luxembourg District Court. The declaration of bankruptcy
will declare Theo I SCSp bankrupt and appoint a receiver who will take control over the management of the company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The loss of control constitutes
the derecognition event under IFRS 10.25. Accordingly, the Group will derecognize the assets and liabilities of Theo I SCSp and will remeasure
its retained interest at fair value in accordance with IFRS 9 at the date of the derecognition event. This will result in the recognition
of an estimated gain of US$9.5 million in the consolidated statement of profit or loss as of the derecognition date.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Group will continue to measure its retained interest in Theo <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
SCSp at fair value through profit or loss until the liquidation process is formally completed.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>Bioceres S.A. and Bioceres
LLC</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On December 16, 2025,
subsequent to the reporting date, the Board of Directors of Bioceres S.A. formally approved the initiation of voluntary bankruptcy
proceedings and instructed management to seek and appoint a trustee (&#8220;s&#237;ndico&#8221;) to oversee the process. The
commencement of the voluntary bankruptcy proceedings and the transfer of decision-making authority to the trustee will result in the
Group losing control over Bioceres S.A. in accordance with the principles of IFRS 10 Consolidated Financial Statements. As Bioceres
LLC is a wholly owned subsidiary of Bioceres S.A., the Group simultaneously will lose  control over Bioceres LLC as well.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><!-- Field: Page; Sequence: 86; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Under IFRS 10.25, the date
on which control is lost constitutes the derecognition event. Accordingly, after December 16, 2025, the Group will derecognize the assets
and liabilities of Bioceres S.A. and Bioceres LLC and will remeasure any retained interest at fair value in accordance with IFRS 9 Financial
Instruments.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The resulting derecognition effects are expected to generate an approximate
gain of US$91.0 million related to the loss of control of Bioceres S.A. and an additional approximate gain of US$5.3 million related to
the loss of control of Bioceres LLC (including the loss of holding in BIOX, therefore it will no longer be an equity method associate).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">These amounts will be recognized
in the consolidated statement of profit or loss as of the derecognition date.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Group will continue to
monitor the progress of the voluntary bankruptcy and liquidation proceedings and will update the accounting treatment as necessary in
accordance with IFRS.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Management expects that
certain shareholders and/or investors will continue or commence to provide new financing lines.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">However, there is no assurance
that investors and shareholders will continue to provide financing, or that the Group&#8217;s future operations will generate profitability.
These factors may cast significant doubt (or raise substantial doubt as contemplated by PCAOB standards) about the Company&#8217;s ability
to continue as a going concern. The Company does not have sufficient financial resources to repay its obligations, or make any payments
in the form of dividends to its shareholders. Without additional capital, the Company will not be able to remain in business. However,
our management plans to continue to focus on raising the funds necessary to fully implement our business plan. Management believes that
certain shareholders and/or investors will continue to advance the capital required to meet its financial obligations. There is no assurance,
however, that these investors and shareholders will continue to advance capital to the Company or that its business operations will be
profitable. The possibility of failure in obtaining additional funding and the potential inability to achieve profitability raise substantial
doubts about the Company&#8217;s ability to continue as a going concern.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">A decline in the market price
of our Ordinary Shares could adversely affect our ability to issue additional securities and our ability to raise additional capital on
acceptable terms at a time that we deem appropriate or at all in the future. In addition, issuance and sale of additional equity would
result in further dilution to our shareholders. The incurrence of indebtedness would result in increased fixed obligations and could result
in operating covenants that would restrict our operations. We cannot assure you that financing will be available in amounts or on terms
acceptable to us, if at all. See &#8220;<i>Item 3. Key Information&#8212;D.&#160;Risk Factors&#8212;Risks Relating to the Company</i>&#8221;&#160;and
&#8220;<i>Item 4. Information on the Company&#8212;A. History and Development of the Company&#8212;Recent Developments</i>&#8221; for
more details.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Consolidated Statements of Cash Flows</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The table below illustrate
our statement of cash flows for the periods indicated:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the<br/> year&#160;ended<br/> June&#160;30,<br/> 2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the<br/> year&#160;ended<br/> June&#160;30,<br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the<br/> year&#160;ended<br/> June&#160;30,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-style: italic">&#160;</td>
    <td colspan="10" style="font-style: italic; text-align: center">(in United States Dollars)</td><td style="font-style: italic">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Net cash flows generated by / (used in) operating activities</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3,636,413</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">39,557,562</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(41,158,857</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Net cash generated from/(used in) investing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(35,987,608</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(27,400,186</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(25,589,907</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net cash generated from financing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(15,021,036</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,492,443</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">76,223,706</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Net increase in cash and cash equivalents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(47,372,231</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,664,933</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,474,942</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Inflation effects on cash and cash equivalents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,352</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(189,309</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(195,181</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Cash and cash equivalents at the beginning of the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">52,994,865</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">49,265,020</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,851,505</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Effect of exchange rate changes and inflation on cash and equivalents</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(4,851,363</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(6,745,779</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">5,133,754</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Cash and cash equivalents at end of the year</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">767,919</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">52,994,865</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">49,265,020</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Net cash generated by / (used in) operating
activities</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Net cash generated by operating activities amounted to US$3.6 million
for fiscal year ended June 30, 2025, despite a net loss of US$176.6 million for the period. The net loss was primarily adjusted for significant
non-cash items, including financial results of US$65.9 million, share of profit of joint ventures and associates of US$36.9 million, depreciation
and amortization of US$22.3 million, income tax expense of US$6.6 million, and share-based incentive compensation of US$4.4 million, partially
offset by a gain from a bargain purchase of US$1.5 million and a gain on the sale of equipment and intangible assets of US$7.6 million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 87; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In addition, working capital movements contributed positively to operating
cash flows, mainly due to increases in inventories and biological assets of US$34.9 million, trade receivables of US$26.0 million, and
other receivables of US$2.0 million, partially offset by decreases in trade and other payables of US$18.8 million, employee benefits and
social security liabilities, and deferred revenue and advances from customers. As a result, the Company generated positive net cash flows
from operating activities during the period.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Net cash generated by operating
activities amounted to US$39.6 million for fiscal year ended June 30, 2024, despite a net loss of US$29.1 million for the period. The
net loss was primarily adjusted for significant non-cash items, including financial results of US$47.2 million, share of profit of joint
ventures and associates of US$21.0 million, depreciation and amortization of US$21.3 million, income tax expense of US$1.1 million, and
share-based incentive compensation of US$14.2 million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In addition, working capital
movements contributed negatively to operating cash flows, mainly due to, decreases in trade receivables of US$41.3 million, and other
receivables of US$6.3 million, deferred revenue and advances from customers of $21.1 million and decreases in employee benefits and social
security liabilities of US$2.4 million, partially offset by increases in inventories and biological assets of US$15.3 million, trade and
other payables of US$ 16.3million,. As a result, the Company generated positive net cash flows from operating activities during the period.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Net cash used in operating
activities amounted to US$41.2 million for fiscal year ended June 30, 2023, despite a net profit of US$53.1 million for the period. The
net loss was primarily adjusted for significant non-cash items, including depreciation and amortization of US$19.5 million and share-based
incentive compensation of US$3.5 million, partially offset by income tax benefit of US$2.3 million, share of profit of joint ventures
and associates of US$47.7 million and financial results of US$47.3 million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In addition, working capital
movements contributed positively to operating cash flows, mainly due to decreases in inventories and biological assets of US$8.6 million,
trade receivables of US$14.2 million, and other receivables of US$36.7 million, increase in in trade and other payables of US$14.2 million
partially offset by increases in employee benefits and social security liabilities and deferred revenue and advances from customers of
US$21.0 million. As a result, the Company used net cash flows in operating activities during the period.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Net cash used in investing
activities</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Net
cash </span>used in investing activities <span style="font-family: Times New Roman, Times, Serif">amounted to US</span>$36.0 million for
the fiscal year ended June 30, 2025<span style="font-family: Times New Roman, Times, Serif">. Cash outflows were primarily related to
</span>the loss of controlling interest <span style="font-family: Times New Roman, Times, Serif">BIOX</span> of <span style="font-family: Times New Roman, Times, Serif">US</span>$32.7
million<span style="font-family: Times New Roman, Times, Serif">, </span>capitalized development expenditures of <span style="font-family: Times New Roman, Times, Serif">US</span>$8.6
million<span style="font-family: Times New Roman, Times, Serif">, </span>purchases of property, plant and equipment of <span style="font-family: Times New Roman, Times, Serif">US</span>$5.7
million<span style="font-family: Times New Roman, Times, Serif">, and </span>investments in financial assets of <span style="font-family: Times New Roman, Times, Serif">US</span>$11.4
million<span style="font-family: Times New Roman, Times, Serif">. These outflows were partially offset by </span>proceeds from financial
assets of <span style="font-family: Times New Roman, Times, Serif">US</span>$21.7 million<span style="font-family: Times New Roman, Times, Serif">,
</span>net cash received from a business combination of <span style="font-family: Times New Roman, Times, Serif">US</span>$0.6 million<span style="font-family: Times New Roman, Times, Serif">,
and </span>proceeds from the sale of property, plant and equipment of <span style="font-family: Times New Roman, Times, Serif">US</span>$0.4
million<span style="font-family: Times New Roman, Times, Serif">.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Net cash used in investing
activities amounted to US$27.4 million for the fiscal year ended June 30, 2024. Cash outflows were primarily related to investments in
financial assets of US$65.6 million, capitalized development expenditures of US$11.9 million, purchases of property, plant and equipment
of US$9.9 million and intangible assets for US$3.2 million. These outflows were partially offset by proceeds from financial assets of
US$62.8 million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Net <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">cash used in investing activities
amounted to US$25.6 million for the fiscal year ended June 30, 2023. Cash outflows were primarily related to capitalized development expenditures
of US$10.7 million, purchases of property, plant and equipment of US$11.5 million and investments in financial assets of US$8.5 million.
These outflows were partially offset by proceeds from net cash received from business combination of US$4.4 million, proceeds from financial
assets of US$1.3 million and investment in joint ventures and associates of US$1.1 million.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Net cash generated by / (used in) financing
activities</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Net cash used in financing activities amounted to US$15.0 million for
the fiscal year ended June 30, 2025. Cash inflows during the period were primarily derived from proceeds from borrowings of US$403.3 million,
which were largely offset by repayments of borrowings and financed payments totaling US$380.0 million, interest payments of US$28.1 million,
and payments related to lease liabilities of US$5.5 million. Additional cash outflows included other financial payments of US$3.7 million,
the repurchase of the Company&#8217;s own shares of US$0.9 million, and cash dividends distributed to non-controlling interests of US$0.1
million. As a result of these movements, financing activities resulted in a net cash outflow for the fiscal year.</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Net cash used in financing
activities amounted to US$1.5 million for the fiscal year ended June 30, 2024. Cash inflows during the period were primarily derived from
proceeds from borrowings of US$188.0 million, which were largely offset by repayments of borrowings and financed payments totaling US$145.0
million, interest payments of US$36.8 million, and payments related to lease liabilities of US$4.9 million. Additional cash outflows included
other financial payments of US$1.9 million, the repurchase of the Company&#8217;s own shares of US$0.7 million, and cash dividends distributed
to non-controlling interests of US$0.1 million. As a result of these movements, financing activities resulted in a net cash outflow for
the fiscal year.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Net cash generated by financing activities amounted to US$76.2 million for the fiscal year ended June 30, 2023.
Cash inflows during the period were primarily derived from proceeds from borrowings of US$150.6 million, which were partially offset by
repayments of borrowings and financed payments totaling US$38.5 million, interest payments of US$25.6 million, and payments related to
lease liabilities of US$3.9 million. Additional cash outflows included other financial payments of US$3.0 million, the repurchase of the
Company&#8217;s own shares of US$3.0 million, and cash dividends distributed to non-controlling interests of US$0.5 million. As a result
of these movements, financing activities resulted in a net cash inflow for the fiscal year.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Indebtedness</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As of June 30, 2025 and 2024 our total outstanding indebtedness, were
US$248.0 million and US$442.6 million, respectively.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As of June 30, 2025, our
total outstanding borrowings were unsecured.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><!-- Field: Page; Sequence: 88; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Consideration of payment of acquisitions</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Business Combination</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On June 16, 2025, we completed
the Bioceres Group Business Combination. As a result of the transaction, Moolec Science SA (the legal acquirer) obtained all of the issued
and outstanding equity of Bioceres Group, Nutrecon, and Gentle Tech through an equity-for-equity exchange. No cash consideration was paid
in connection with this transaction.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>ValoraSoy Acquisition</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On April 24, 2023, we completed
the acquisition of ValoraSoy from the sellers in accordance with the share purchase agreement. As a result of this acquisition, we acquired
all of the issued and outstanding equity securities of ValoraSoy from the sellers, and ValoraSoy became our wholly owned subsidiary for
total aggregate consideration of US$2.6 million, which we have paid for in a combination of cash and equity.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_024"></a></div><p style="margin-left: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>C. Research and Development, Patents and Licenses, etc.</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">For a discussion of our R&amp;D
policy, see &#8220;<i>Item 4. Information on the Company&#8212;B. Business Overview&#8212;Research and Development</i>&#8221;. For a discussion
of patents and licenses, see &#8220;<i>Item 4. Information on the Company&#8212;B. Business Overview&#8212;Intellectual Property</i>.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_025"></a></div><p style="margin-left: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>D. Trend Information</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">For a discussion of trend
information, see &#8220;<i>Item 5&#8212;A. Operating Results&#8212;Factors affecting our operating results</i>.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_026"></a></div><p style="margin-left: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>E. Critical Accounting Estimates</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our audited consolidated
financial statements are prepared in conformity with IFRS, as issued by the IASB. In preparing our audited consolidated financial statements,
we make judgments, estimates and assumptions about the application of our accounting policies which affect the reported amounts of assets,
liabilities, revenue and expenses. Our critical accounting judgements and sources of estimation uncertainty are described in Note 2 and
Note 4 to our audited consolidated financial statements, which are included elsewhere in this annual report.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="k_027"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM&#160;6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="k_028"></a></div><p style="margin-left: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>A. Directors and Senior Management</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Directors</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As of June 30, 2025, the
following persons (with ages as of the date of this report) are members of our Board of Directors and senior management.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our Executive Officers and Directors</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Name</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Age</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Position</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 30%; text-align: left">Alejandro Antalich</td><td style="width: 1%">&#160;</td>
    <td style="width: 8%; text-align: center">53</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 59%; text-align: left">Chief Executive Officer</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Valeria Falottico</td><td>&#160;</td>
    <td style="text-align: center">43</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">Chief Financial Officer</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Paola Diaz</td><td>&#160;</td>
    <td style="text-align: center">49</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">Chief Technology Officer</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Gloria Montaron Estrada</td><td>&#160;</td>
    <td style="text-align: center">54</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">Chairwoman and Executive Director</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Aimar Dimo</td><td>&#160;</td>
    <td style="text-align: center">60</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">Non Executive Director</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Oscar Leon Bentancor</td><td>&#160;</td>
    <td style="text-align: center">66</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">Non Executive Director</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Diego Abelleyra Llodra</td><td>&#160;</td>
    <td style="text-align: center">55</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">Non Executive Director</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Romualdo Varela</td><td>&#160;</td>
    <td style="text-align: center">69</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">Non Executive Director</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><!-- Field: Page; Sequence: 89; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Biographical information
for each member of our Board of Directors and senior management is set forth below.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Alejandro Antalich. Mr.
Antalich serves as our Chief Executive Officer. Mr. Antalich is an experienced entrepreneur, investor, and executive with a proven history
of building and guiding companies across the biotechnology, food technology, and pharmaceutical industries. He possesses extensive expertise
in operations, manufacturing, product development, organizational restructuring, and the negotiation of strategic and high-value transactions.
Mr. Antalich previously served as Chief Executive Officer of ICC Labs Inc. (TSXV), where he led the company to become the first publicly
traded entity to sell cannabis to a federal government. He played a key role in structuring and executing the company&#8217;s successful
exit, completed through its acquisition by Aurora Cannabis Inc. (TSX) in 2018 for approximately US$300 million, marking one of the most
significant transactions in the regulated cannabis industry. With a focus on initiatives advancing alternative proteins, bio-based materials,
and large-scale precision-fermentation infrastructure, as part of broader efforts to promote sustainable industrial transformation and
organizational optimization, he also oversees the development of novel therapeutics and advanced drug-delivery systems targeting mental
health and neurological disorders.</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b>Valeria Falottico</b>.
Ms. Falottico serves as our Chief Financial Officer. Ms. Falottico joined Moolec Science SA in March 2023 where she held several key leadership
roles in financial and compliance reporting. Prior to Moolec, she served in senior positions at NASDAQ trading public company dLocal and
PayClip and earlier spent 17 years at PricewaterhouseCoopers in Argentina and Mexico, advising clients worldwide. She holds an Accounting
degree and an MBA from IAE Business School. Ms. Falottico brings more than 20 years of experience in consulting, financial services, and
capital markets across the U.S., Asia and Latin America. She has held senior leadership roles in multinational organizations, driving
capital raising, IPOs, M&amp;A, and other strategic transactions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b>Paola Diaz</b>. Dr. Diaz
serves as our Chief Technology Officer as from December 29, 2025. Dr. D&#237;az Dellavalle holds a Ph.D. in Chemistry and Natural Molecules
and brings more than 20 years of experience in the research, development, and management of biotechnology projects. She has specialized
training in intellectual property and competitive intelligence, with deep expertise in patent strategy, technology transfer, and innovation
management, particularly across the chemistry, life sciences, pharmaceutical, and biotechnology sectors. Prior to joining the Company,
Dr. D&#237;az Dellavalle served as Chief Scientific Officer of two organizations: a Canadian life sciences company focused on innovation
in mental health, and an alternative-protein biotechnology enterprise dedicated to developing sustainable food technologies. Throughout
her career, she has led multidisciplinary scientific teams and managed non-clinical study programs and new-molecule development initiatives,
contributing to the advancement of biotechnological innovation and translational research.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b>Gloria Montaron Estrada</b>.
Ms Montaron serves as Executive Director and as our Chairwoman from December 29, 2025. She has served as Legal Director and Chief Intellectual
Property Officer of Bioceres Group Limited since April 2021. Prior to joining Bioceres, she worked for 16 years as an attorney at Marval,
O&#8217;Farrell &amp; Mairal in Buenos Aires, where she focused on intellectual property, corporate and banking matters. Ms. Montaron
also serves as manager of Bioceres LLC (formerly Bioceres Inc.), Bioceres Tech Services LLC and Moolec Science Limited. She holds an
LL.M. in Intellectual Property from the University of Palermo, Buenos Aires, and a Law degree from the University of Buenos Aires, and
she became a registered Intellectual Property Agent in 2013. She is a member of the Bar Association of the City of Buenos Aires. She
has successfully completed two of the three programs of the Harvard Business School Corporate Director Certificate: Making Corporate
Boards More Effective and Audit Committees. An active international lecturer, Ms. Montaron frequently participates in law congresses
and seminars in her field of expertise and teaches at several universities in the area of intellectual property. Under her leadership,
Bioceres&#8217; legal team received the &#8220;Deal of the Year &#8211; Private Equity&#8221; award in 2019. Ms. Montaron has been recognized
in The Legal 500 GC Powerlist (Argentina) and included in the IAM Strategy 300: The World&#8217;s Leading IP Strategists. In 2025, she
was selected as one of the 50 Women Leaders in Argentina by The London School of Economics and Political Science (LSE) and Santander
Bank.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b>Oscar Le&#243;n Betancor.
</b>Mr. Betancor is a highly experienced Certified Public Accountant with a solid background in financial management, accounting, project
finance and risk analysis, with large experience in agriculture, mining and hydropower industries. He has twenty-four years of experience
as a CFO, financial controller and chief accountant for several Uruguayan, Canadian and American Companies. He has served as Chief Financial
Officer of Biomind Labs Inc from July 2021 and Director at Union Group Ventures Limited from July 2020.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p><div>

</div><!-- Field: Page; Sequence: 90; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b>Aimar Dimo. </b>Mr. Dimo
is the vice chairman of Bioceres and the chairman of InMet. He has served as chairman of Ki&#241;ewen SA, an Argentine food producer
and exporter, since it started in 2003. He has also served as the chairman of Santa Angelina SA, Produsem SA, and Agrodim SA. He is the
vice chairman of Agro Matara SA and Kalpachay SA. He is also a full partner of Dimku SRL, an Argentine crop services company. Aimar has
a degree in agronomy from the National University of Rosario.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b>Diego Abelleyra Llodra.
</b>Mr Llodra graduated from the University of Belgrano with a law degree in 1992 and completed a LLM with merit grade in Banking and
Finance Law at the University of London, Queen Mary College in 1997. He is registered before the Solicitors Regulation Authority of England
and Wales to practice as a foreign lawyer and is also a member of the Bar Association of the City of Buenos Aires.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b>Romualdo Varela. </b>Mr.
Varela is former CEO of Uruguay&#8217;s leading agribusiness company, overseeing operations across 181,000 hectares and managing diversified
activities including soy, wheat, rice, dairy, cattle, sheep, logistics, and silo storage. Spent 11 years in South Africa as Managing Director
and Country Manager for ZENDA Leather (formerly Curtiembre Branaa, now part of MARFRIG Group). An international executive with extensive
experience in multinational environments, he is a results-driven, decisive leader and entrepreneur with strong expertise in launching
new business ventures.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_029"></a></div><p style="margin-left: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>B. Compensation</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Remuneration of Directors and Senior Management</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The aggregate compensation,
including benefits in kind, accrued or paid to our senior management with respect to the year ended June 30, 2025, for services in all
capacities was US$0.9&#160;million. In addition, in the year ended June 30, 2025, we granted our directors and senior management options
to purchase 100,000 of our Ordinary Shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>2024 Omnibus Equity Incentive Plan</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On September 20, 2024, our
Board of Directors approved the 2024 Omnibus Equity Incentive Plan (the &#8220;Incentive Plan&#8221;), to attract and retain the best
available personnel, provide additional incentives to employees, directors and consultants and to promote the success of our business.
Under the Incentive Plan, the maximum aggregate number of ordinary shares that may be issued pursuant to all awards is a number of Ordinary
Shares equal to up to 13% of our issued and outstanding capital stock on a fully diluted basis. The Incentive Plan allows us to establish
the terms and conditions of the equity awards granted thereunder. Previously, we had adopted the Moolec Limited Employee Share Plan as
our share option plan, approved by our Board of Directors on December 20, 2023.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Option periods under the
Incentive Plan shall not exceed ten years, unless the option period (other than in the case of an incentive share option) would expire
at a time when trading in the Ordinary Shares is prohibited by our securities trading policy or a self-imposed &#8220;blackout period,&#8221;
in which case options period shall be extended automatically until the 30<sup>th</sup> day following the expiration of such prohibition
(so long as such extension shall not violate Section 409A of the Internal Revenue Code of 1986).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Amount set aside for pension, retirement
or similar benefits</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We have not set aside or
accrued any amount to provide pension, retirement or similar benefits for the fiscal year ended June 30, 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Director Compensation</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our Board of Directors has
established a compensation program for non-executive directors, which consists of an annual retainer, board fees in accordance with their
attendance at board meetings and committee fees for their service as members of a committee. We also reimburse our independent directors
for reasonable out of pocket expenses incurred in connection with the performance of their duties as directors, including, without limitation,
travel expenses in connection with their attendance in person at board and committee meetings.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;&#160;</p><div>

</div><!-- Field: Page; Sequence: 91; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="k_030"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>C.&#160;Board Practices</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our Articles provide that
the Board of Directors must comprise at least five members. Our board currently consists of five directors. Our Articles also provide
that each director will have a mandate that does not exceed one year, but is eligible for re-appointment.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our Board of Directors has
established an audit committee, a compensation committee and a nominating committee, each of which operates pursuant to written charters
adopted by our Board of Directors on December 28, 2022. The Board of Directors may also establish other committees from time to time to
assist our Company and the Board. The composition and functioning of all of our committees comply with all applicable requirements of
the Sarbanes-Oxley Act of 2002, Nasdaq and SEC rules and regulations, if applicable. Each committee&#8217;s written charter is available
on our website at ir.moolecscience.com/corporate-governance. The reference to our website address does not constitute incorporation by
reference of the information contained at or available through our website, and you should not consider it to be part of this annual report.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Audit Committee</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As of the date of this report,
our audit committee consists of Romualdo Varela, Aimar Dimo and Diego Abelleyra Llodra, with Romualdo Varela serving as the chair of the
audit committee. Each of Romualdo Varela, Aimar Dimo and Diego Abelleyra Llodra meets the applicable audit committee independence standards.
In addition, all of the audit committee members meet the requirements for financial literacy under applicable SEC and Nasdaq rules and
at least one of the members qualifies as an &#8220;audit committee financial expert,&#8221; as such term is defined in Item 407(d) of
Regulation S-K.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our audit committee is responsible
for, among other things:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">appointing, compensating, retaining, evaluating, terminating and overseeing our independent registered public accounting firm;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">discussing with our independent registered public accounting firm their independence from management;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing, with our independent registered public accounting firm, the scope and results of their audit;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">approving all audit and permissible non-audit services to be performed by our independent registered public accounting firm;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">overseeing the financial reporting process and discussing with management and our independent registered public accounting firm the annual financial statements that we file with the SEC;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">overseeing our financial and accounting controls and compliance with legal and regulatory requirements;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing our policies on risk assessment and risk management;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing related person transactions; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">establishing procedures for the confidential anonymous submission of concerns regarding questionable accounting, internal controls or auditing matters.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Compensation Committee</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As of the date of this report,
our compensation committee consists of Gloria Montaron Estrada, Aimar Dimo and Romualdo Varela, serving Gloria Montaron Estrada as the
chair of the compensation committee. The members of our compensation committee were designated by our Board of Directors on June 16, 2025,
and each qualifies as an independent director according to the rules and regulations of the SEC and Nasdaq with respect to compensation
committee membership, including the heightened independence standards for members of a compensation committee.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 92; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our compensation committee
is responsible for, among other things:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing and approving the corporate goals and objectives, evaluating the performance of and reviewing and approving, (either alone or, if directed by the Board, in conjunction with a majority of the independent members of the Board) the compensation of our Chief Executive Officer;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">overseeing an evaluation of the performance of and reviewing and setting or making recommendations to our Board regarding the compensation of our other executive officers;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing and approving or making recommendations to our Board regarding our incentive compensation and equity-based plans, policies and programs;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing and approving all employment agreement and severance arrangements for our executive officers;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">making recommendations to our Board regarding the compensation of our directors; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">retaining and overseeing any compensation consultants.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Nominating Committee</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our nominating committee
consists of Oscar Leon Bentancor, Gloria Montaron Estrada and Diego Abelleyra Llodra, serving Diego Abelleyra Llodra as the chair of the
nominating committee. The members of our nominating committee were designated by our Board of Directors on June 16, 2025, and each qualifies
as an independent director according to the rules and regulations of the SEC and Nasdaq with respect to nominating committee membership,
including the heightened independence standards for members of a nominating committee.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our nominating committee
is responsible for, among other things:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">identifying individuals qualified to become members of our Board, consistent with criteria approved by our Board;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">overseeing succession planning for our Chief Executive Officer and other executive officers;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">periodically reviewing our Board&#8217; leadership structure and recommending any proposed changes to our Board;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviews developments in corporate governance practices;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">overseeing an annual evaluation of the effectiveness of our Board and its committees; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">developing and recommending to our Board a set of corporate governance guidelines.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Code of Ethics</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our Board of Directors adopted
a Code of Ethics applicable to our directors, executive officers and team members and such Code of Ethics complies with the rules and
regulations of Nasdaq and the SEC. The Code of Ethics is available on our Investor Relations website and has been signed by all of our
directors, executive officers and team members.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 93; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><div><a id="k_031"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>D. Employees</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The table below shows our
employees by role and location, as of the dates indicated, and does not include employees of our research collaborators or joint venture
partners.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As of June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Management and administrative</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">52</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">14</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">11</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Sales</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">OPEX and downstream</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">23</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Research and development services</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">20</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">103</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">52</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">45</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As of June 30, 2025 and June
30, 2024, 94% and 88%, respectively, of our total employees were located in Argentina, 3% and 6% were located in the United States, 1%
and 2% in the United Kingdom and the remaining 2% and 4% were located in other countries.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As part of the Business Combination,
our total employees decreased to 72 as of October 31, 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_032"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>E.&#160;Share Ownership</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following table sets
forth information regarding the beneficial ownership of the Ordinary Shares as of June 30, 2025:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each person known to by us to be the beneficial owner of more than 5% of the Ordinary Shares;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each of our directors and Executive Officers; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">all of our directors and members of Executive Management as a group.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Beneficial ownership is determined
according to the rules of the SEC, which generally provide that a person has beneficial ownership of a security if he, she or it possesses
sole or shared voting or investment power over that security, and includes shares underlying warrants and awards (including options) issuable
in connection with our Incentive Plan, as applicable, that are currently exercisable or convertible or exercisable or convertible within
60 days. Ordinary Shares that may be acquired within 60 days of the date of this report pursuant to the exercise of warrants and awards
(including options) issuable in connection with our Incentive Plan are deemed to be outstanding for the purpose of computing the percentage
ownership of such holder but are not deemed to be outstanding for computing the percentage ownership of any other person or entity shown
in the table.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Unless otherwise indicated,
we believe that all persons named in the table below have sole voting and investment power with respect to the Ordinary Shares beneficially
owned by them. They have the same voting rights as all other holders of ordinary shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Beneficial owners</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<b>%<br/>
 owned</b> &#160;</span></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Gloria Montaron Estrada <sup>(1)</sup></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">28,639</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span>*</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Aimar Dimo <sup>(1)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">98,045</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> *</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Diego Abelleyra Llodra <sup>(1)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Oscar Leon Bentancor <sup>(1)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Romualdo Varela <sup>(1)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify">Valeria Falottico <sup>(1)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,355</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> *</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Paola Diaz <sup>(1)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Alejandro Antalich <sup>(1)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">All directors and executive officers as a group (7 individuals) </td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">140,039</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"/><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; font-style: italic; text-align: left">Five Percent or More Holders </td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Union Group Ventures Limited <sup>(2)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,153,833</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19.77</td><td style="text-align: left">%</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Notes:-&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less
than 1%.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
business address of Ocampo 210bis, Rosario Argentina</span></td>
</tr></table><div>

</div><p style="margin: 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Through
Union Group Ventures Limited, Nordelis Ventures Corp. and Aversa Corp.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 94; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">For more information on our
ordinary shares and share options owned by individual Directors see &#8220;<i>Item 6. Directors, Senior Management and Employees&#8212;B.
Compensation&#8212;Remuneration of Directors and Senior Management&#8212;2024 Omnibus Equity Incentive Plan</i>.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_033"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>F.&#160;Disclosure of a Registrant&#8217;s
Action to Recover Erroneously Awarded Compensation</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;<b>&#160;</b></p><div>

</div><div><a id="k_034"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>ITEM&#160;7. MAJOR SHAREHOLDERS AND RELATED
PARTY TRANSACTIONS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="k_035"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>A. Major Shareholders</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">See &#8220;<i>Item 6. Directors,
Senior Management and Employees&#8212;E. Share Ownership</i>.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Changes in Ownership</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">See <i>Introductory
Note&#8212;The Bioceres Group Business Combination Agreement.&#8221;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Difference in Voting Rights</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">All of our Ordinary Shares
have the same voting rights and no major shareholder has different voting rights.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Securities Held in the Host Country</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As of June 30, 2025, 10,891,761
Ordinary Shares were issued and outstanding, of which 6,479,422 Ordinary Shares, or 59.489%, were held by one record holder in the United
States, Cede &amp; Co.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Arrangements for Change in Control</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We are not aware of any arrangements
that may, when in force, result in a change in control.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_036"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>B.&#160;Related Party Transactions</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Policy Concerning Related Party Transactions</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our Board of Directors has
adopted a written policy, for the review of any transaction, arrangement or relationship in which it is a participant, if the amount involved
exceeds US$120,000 and one of our executive officers, directors, director nominees or beneficial holders of more than 5% of our total
equity (or their immediate family members), each of whom we refer to as a related person, has a direct or indirect material interest.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">A copy of the related person
transaction approval policy is available on our Investor Relations website.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 95; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Technology Access License Agreement with
Bioceres Crop Solutions Corp.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On June 29, 2024, we entered
into an exclusive technology access license agreement with Bioceres, pursuant to which Bioceres will grant us the right to use its HB4
technology for a period of 5 years in exchange for a license fee of US$1 million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Furthermore, following the
Closing of the Business Combination, new management has decided to early terminate the exclusive technology access license agreement.
Consequently, effective September 5, 2025 the agreement was terminated.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Convertible Note issued to Bioceres Crop
Solutions Corp.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We entered into a note purchase
agreement (the &#8220;Note Purchase Agreement&#8221;) and a HB4<sup>&#174;</sup> soy supply agreement (the &#8220;BIOX Soy Supply Agreement&#8221;)
with BIOX. On September 17, 2024, we issued to Bioceres convertible notes in an aggregate principal amount equal to US$6.6 million, in
relation to the value of the HB4 soy delivered by us (the &#8220;BIOX Convertible Notes&#8221;).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The BIOX Convertible Notes
will mature 36 months after they are issued by us and will include a &#8220;payment-in-kind&#8221; feature. If the trading price of our
ordinary shares exceeds the strike price of US$60.00 per ordinary share for 10 trading days, Bioceres has the option to exercise the early
conversion option pursuant to which the principal amount outstanding under the notes may be converted into our ordinary shares at the
strike price. At maturity, we have the option to convert the principal amount outstanding under the BIOX Convertible Notes into ordinary
shares. In connection with Bioceres&#8217; early conversion option and our optional conversion at maturity, we may deliver ordinary shares,
cash, or a combination of cash and ordinary shares. Notwithstanding the foregoing, in accordance with the restructuring process, the new
management is reviewing the supply agreement and the convertible note issued to BIOX.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Convertible Note issued to INVIM</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On October 15, 2023, we entered into agreements
with INVIM to issue a convertible note for an aggregate principal amount of approximately US$10 million (the &#8220;Invim Convertible
Note&#8221;). The convertible note was issued against a cash payment of US$10 million. In connection with this, we entered into a binding
contribution memorandum of understanding, pursuant to which Insud assumed a binding obligation to contribute to us certain rights under
an industrial services agreement and its interest in Microo Foods Ingredients. See Item 8 &#8211; Financial Information &#8211; <i>&#8220;Notice
of Alleged breach&#8221;.</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>HB4 Technology </i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In 2003, Bioceres SA entered
into an Hahb 4 research and development agreement with CONICET and the National University of the Litoral under which they became equal
owners of the patents derived from their research activity regarding the Hahb 4 gene, which we refer to as the 2003 Hahb 4 patents. Under
this agreement, that was subsequently amended in 2010, Bioceres SA financed the Hahb 4 research activities performed by CONICET and the
National University of the Litoral in exchange for an exclusive license to commercially exploit their rights in the 2003 Hahb 4 patents.
As of today, the 2003 Hahb 4 patents have expired except the US patent and the BR patent which will expire in 2030 and 2026, respectively.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In 2012, Bioceres SA into
a separate agreement with CONICET and the National University of the Litoral for the ownership and licensing rights of additional patents
for development of our modified HB4 gene trait, which we refer to as the 2012 HB4 patents. Pursuant to this agreement, that was subsequently
amended in 2020, Bioceres Group owns 40% of the 2012 HB4 patents, and CONICET and the National University of the Litoral each own 30%.
In addition, CONICET and the National University of the Litoral granted us an exclusive license to commercially exploit their respective
rights in the 2012 HB4 patents. The license related to additional patents under the 2012 agreement will remain in force until the expiration
of the last 2012 HB4 patent in 2033, unless terminated earlier in accordance with the terms of the agreement.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt"></p><div>

</div><!-- Field: Page; Sequence: 96; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In 2019 and in 2020, Bioceres
Group, through its subsidiary Bioceres LLC, filed the 2019 and 2020 HB4 soy and wheat events patents which will expire in 2039 and 2040,
respectively. Bioceres Group owns 100% of the 2019-2020 HB4 soy and wheat events patents.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On March 4, 2022, Bioceres
Group entered into an exclusive license agreement with BCS Holding Inc., a subsidiary of Bioceres Crop Solutions Corp. (BIOX), as amended,
under which Bioceres Group granted BIOX the right to use the HB4 technology in the field of soy and wheat worldwide. In consideration
of the exclusive license, BIOX is required to pay royalties.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b><i>Agrality S.A. Debt
Restructuring</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On August 14, 2025, Agrality
S.A. (the &#8220;Borrower&#8221;) and Bioceres Tech Services LLC (the &#8220;Lender&#8221;) entered into a debt restructuring agreement
for US$ 790,475.18, to be repaid in eight (8) installments between September 2025 and February 2026.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b><i>Rizobacter Argentina
S.A. Loan Agreement</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On August 14, 2019, Rizobacter
Argentina S.A. (the &#8220;Borrower&#8221;) and Bioceres LLC (the &#8220;Lender&#8221;) entered into a Loan Agreement for a principal
amount of US$ 2,089,297, which matured on June 30, 2025. As of today, remains an outstanding balance of US$134,715<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b><i>Office Services Agreement</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Bioceres S.A. entered into
Office Services Agreements with BIOX and Agrality S.A.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="text-decoration:underline">BIOX Term:</span> Two-year
term starting on July 1, 2024.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="text-decoration:underline">Agrality Term:</span> One-year
term starting on August 23, 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="text-decoration:underline">BIOX and Agrality S.A.
Compensation:</span> In consideration for the services provided by Bioceres S.A. during the term, each company will pay a monthly fee.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Other Related Party Transactions</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">From time to time, we may
be involved in other related party transactions with our directors, executive officers and shareholders. Omitted periods below signify
that there were no transactions in such period or the value of such transaction was a de minimis amount.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Indemnification Agreement</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In connection with the consummation
of the business combination, we entered into indemnification agreements with each of our directors and executive officers. These agreements
provide that the director or officer will be indemnified by us to the fullest extent permitted by law against liability and against all
expenses reasonably incurred or paid by him or her in connection with any claim, action, suit or proceeding which he or she becomes involved
as a party or otherwise by virtue of his or her being or having been such a director or officer of and against amounts paid or incurred
by him or her in the resolution thereof. The agreements are subject to certain exceptions, including, among other exceptions, that no
indemnification will be provided to any director or officer against any liability to us or our shareholders (i) by reason of actual fraud,
dishonesty, actual fraudulent conduct, or gross negligence on the part of the director or officer; (ii) by reason of payment made under
an insurance policy or any third party that has no recourse against the indemnitee director or officer; or (iii) if contrary to applicable
law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Holdback Provision under the Business Combination
</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">At the closing of the Business
Combination, Moolec withheld ten percent (10%) of the shares issued at closing to secure potential indemnification obligations, as agreed
under the BCA (the &#8220;Holdback shares&#8221;).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On the first anniversary
of the closing date, and subject to the terms and conditions of the BCA, Moolec shall issue and release the Holdback shares on a pro rata
basis to Bioceres Group shareholders, Nordelis, and Union Group.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 97; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Preference shares</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On December 9, 2024, Bioceres
Group issued to Agriculture Investment Group Corp preference shares that are convertible into Ordinary Shares of the Company in an aggregate
principal amount of US$15 million. Such preference shares accrue a PIK amount of 9% per annum (the &#8220;PIK Amount&#8221;), which the
holder (along with the base number of preference shares) has a right to convert into Ordinary Shares within two years of the Business
Combination Closing.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_037"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>C.&#160;Interests of Experts and
Counsel</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="k_038"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM&#160;8. FINANCIAL INFORMATION</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="k_039"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>A.&#160;Consolidated Statements
and Other Financial Information</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Financial Statements</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our financial statements
are set forth under &#8220;<i>Item 18. Financial Statements</i>.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Legal Proceedings</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">From time to time, we may
become party to litigation or other legal proceedings that we consider to be a part of the ordinary course of our business. Other than
as discussed below, we are not currently involved in any legal proceedings that could reasonably be expected to have a material adverse
effect on our business, prospects, financial condition or results of operations, other than the proceeding described below.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Notice of Alleged breach</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; text-align: justify">On October 2, 2025, the Company received a notice of alleged breach
from INVIM Corporativo S.L., a private limited company incorporated under the laws of Spain (&#8220;INVIM&#8221;), regarding the alleged
failure to pay the assignment price of US$13 million in connection with a certain Assignment and Assumption Agreement dated May 27, 2025
(the &#8220;Agreement&#8221;). The Agreement, in turn, references related instruments, including a Note Purchase Agreement and a Binding
Contribution Memorandum of Understanding, both dated October 15, 2023.</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In response, the Company
rejected INVIM&#8217;s assertion that any payment is due or owing, on the grounds that, among other reasons, under the express terms of
the Agreement and related transaction instruments, INVIM failed to satisfy certain conditions precedent, including the valid transfer
of relevant securities and the execution of a required services agreement.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company intends to vigorously
defend its position and enforce its rights under the Agreement, the related transaction instruments, and applicable law. While the Company
believes that INVIM&#8217;s assertions are without merit, if INVIM were ultimately to prevail in any proceedings, such an adverse outcome
could have a material adverse effect on the Company&#8217;s business, results of operations, financial condition, or liquidity.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Dividend Policy</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We currently intend to retain
any earnings for use in our business and do not intend, as of the date of this report, to pay cash dividends on our ordinary shares for
the foreseeable future. Dividends, if any, on our outstanding ordinary shares will be proposed by our board of directors and subject to
the approval of our shareholders. Even if our shareholders decide to distribute dividends, the form, frequency and amount of such dividends
will depend upon our future operations and earnings, capital requirements and surplus, general financial condition, contractual restrictions
and other factors that our board of directors and shareholders may deem relevant.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 98; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_040"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>B.&#160;Significant Changes</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">No significant change has
occurred other than as described in this annual report on Form 20-F since the date of our most recent audited consolidated financial statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_041"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>ITEM&#160;9. THE OFFER AND LISTING</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="k_042"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>A.&#160;Offer and Listing Details</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><b><i>Stock Exchange Listing</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our Ordinary Shares and warrant are traded on
the NASDAQ under the symbol &#8220;MLEC&#8221; and &#8220;MLECW&#8221;, respectively.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_043"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>B.&#160;Plan of Distribution</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_044"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>C.&#160;Markets</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Nasdaq Global Select
Market.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_045"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>D.&#160;Selling Shareholders</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_046"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>E.&#160;Dilution</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_047"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>F.&#160;Expenses of the Issue</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;<b>&#160;</b></p><div>

</div><div><a id="k_048"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM&#160;10. ADDITIONAL INFORMATION</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="k_049"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>A.&#160;Share Capital</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As of June&#160;30, 2025,
there were 10,891,761 Ordinary Shares issued and outstanding, net of 12,282 of treasury shares. There were also 11,109,987 warrants outstanding,
each entitling the holder to purchase one Ordinary Share for every 10 warrants exercised, at an exercise price of US$115.00 per share
as a result of the RSS and 500,000 additional warrants at an exercise price of US$20. We are authorized to issue five hundred billion
(500,000,000,000) Ordinary Shares, from which the shares already issued under the authorized capital shall be deducted.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_050"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>B.&#160;Memorandum and Articles
of Association</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Registration Number</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our registration number with
the Cayman Islands Registrar of Companies is OC-421988.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Objects</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our Articles state that the
objects of the Company are unrestricted. Pursuant to section 7(4) of the Companies Act, the Company has full power and authority to carry
out any object not prohibited by the laws of the Cayman Islands.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 99; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Directors</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Companies Act and our
Articles allow directors to hold interests in transactions with the Company provided such interests are disclosed in accordance with
our Articles. Directors are permitted to vote and be counted in the quorum on matters in which they are interested unless otherwise provided
by our Articles. There is no mandatory retirement age for our directors, and our directors are not required to hold any of our shares
in order to qualify as directors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="es_001"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Ordinary shares</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Under the Companies Act and
our Articles, our Board has general and unconditional authority to allot, issue, grant options over or otherwise deal with any unissued
Ordinary Shares to such persons, at such times and on such terms and conditions as they may determine. Shares may be issued with or without
preferred, deferred or other special rights or restrictions, whether in respect of dividend, voting, return of capital or otherwise.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company may also issue
rights, options, warrants or other convertible securities conferring the right upon the holders to subscribe for, purchase or receive
Ordinary Shares or other securities of the Company at such times and on such terms as the directors may determine. The Company shall not
issue bearer shares or warrants to bearers. Ordinary shares that the Company purchases, redeems or acquires may be held as treasury shares
or cancelled, as determined by the directors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Unless otherwise provided
in the terms of issue, the rights attaching to a class of shares may only be varied with the consent in writing of holders of not less
than two-thirds of the issued shares of that class or with the sanction of a special resolution passed at a separate meeting of the holders
of that class.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Preferential Subscription Rights</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Under Cayman Islands law
and in accordance with our Articles, shareholders do not have statutory pre-emptive rights to subscribe for additional issues of shares.
Our Articles grant our board of directors general and unconditional authority to issue, allot and dispose of shares, options, warrants,
convertible securities or other rights to acquire shares in the Company on such terms and conditions as they may determine, without requirement
to first offer such securities to existing shareholders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Share Repurchases</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Under Cayman Islands law
and our Articles, the Company may issue shares that are redeemable or liable to be redeemed, at the option of the Company or the holder
of such shares, on such terms and in such manner as determined by our Board prior to the issuance of such shares. In addition, the Company
may repurchase or otherwise acquire any of its own shares of any class, including redeemable shares, on such terms and in such manner
as determined by our Board at the time of such repurchase, subject to the provisions of the Companies Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The purchase or redemption
price may be paid out of capital, out of profits or from the proceeds of a fresh issue of shares, in each case as permitted by the Companies
Act. Upon redemption or repurchase, the relevant shares may, at the discretion of the board of directors, either be cancelled or held
as treasury shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">While held in treasury, such
shares may not be voted or receive dividends or other distributions. Treasury shares may subsequently be cancelled, transferred or otherwise
disposed of by the Company in accordance with Cayman Islands law and our Articles.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Voting and Appointment of Directors</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Voting Power</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Each Ordinary Share entitles
the holder to one vote. Neither Cayman Islands law nor our Articles contain any restrictions on the voting of Ordinary Shares by non-Cayman
Islands residents.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Pre-emptive or Other Rights</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">There are no sinking fund
or redemption provisions applicable to our Ordinary Shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 100; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->92<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>General Meetings</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In accordance with our Articles,
there is no statutory distinction between ordinary and extraordinary general meetings. Unless otherwise provided by our Articles, resolutions
at a duly convened general meeting are adopted by a simple majority of votes cast by shareholders present in person or by proxy. Our Articles
provide that the quorum for a general meeting, where the Company has more than one shareholder, is one or more shareholder&#8217;s holding
shares that represent not less than half of the outstanding shares carrying the right to vote at such general meeting. If a quorum is
not present within fifteen minutes of the time appointed for the meeting, or if at any time during the meeting it becomes inquorate, the
meeting shall be: (i) cancelled, if was requisitioned by shareholders or (ii) adjourned, and at the adjourned meeting the shareholders
present in person or by proxy shall constitute a quorum.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Annual General Meetings</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our Articles provide that
the Company may, but shall not (unless required by the rules of the Nasdaq Global Market or any other applicable Designated Stock Exchange),
be obligated to hold an annual general meeting, which, if held, shall be convened by our Board .</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Extraordinary General Meetings</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Under Cayman Islands law
there is no statutory distinction between ordinary and extraordinary general meetings. However, certain matters must be approved by shareholders
by way of a special resolution under our Articles and the Companies Act . A special resolution requires the approval of not less than
two-thirds of the votes cast by shareholders who, being entitled to do so, vote in person or by proxy at a duly convened general meeting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Matters requiring approval
by special resolution include, among others: (i) amendments to our Articles ; (ii) a change of name or domicile; (iii) reduction of share
capital; (iv) our voluntary liquidation or dissolution; and (v) such other matters as may be specified in the Companies Act or our Articles.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Rights of Non-Resident or Foreign Shareholders</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">There are no limitations
imposed by our Articles on the rights of non-resident or foreign shareholders to hold or exercise voting rights on our shares. In addition,
there are no provisions in our Articles governing the ownership threshold above which shareholder ownership must be disclosed, other than
as may be required by applicable rules of the Nasdaq Global Market, the SEC or other relevant regulatory authorities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_090"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>C.&#160;Material Contracts</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Agreements Relating to the Business Combination</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Business Combination Agreement</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Business Combination
Agreement (the &#8220;Business Combination&#8221; or the &#8220;BCA&#8221;) was initially announced on April 17, 2025, among the Company,
Bioceres Group Limited (formerly Bioceres Group PLC and one of the main shareholders of the Company) (&#8220;Bioceres Group&#8221;), Gentle
Technologies Corp (&#8220;Gentle Tech&#8221;), and Nutrecon LLC (&#8220;Nutrecon&#8221;). Under the BCA, several parties transferred their
respective holdings in Bioceres Group, Nutrecon, and Gentle Tech (together, the &#8220;Contributed Entities&#8221;) to the Company in
exchange for a combination of newly issued Company shares and warrants.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Following the closing, Moolec
became the legal parent company of the combined group comprising the Contributed Entities. The transaction was ratified by Moolec shareholders
at the Extraordinary General Meeting (&#8220;EGM&#8221;) held on June 16, 2025, with 77% of the outstanding shares present and 98% of
the votes cast in favor of the transaction. From an accounting perspective, and based on the guidance of IFRS 3, Bioceres Group is deemed
to be the accounting acquirer. The transaction was consummated on the same date, June 16, 2025. See Introductory Note&#8212;<i>&#8220;The
Bioceres Group Business Combination Agreement.&#8221;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 101; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->93<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="k_051"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>D.&#160;Exchange Controls</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">There are no exchange control
laws or currency regulations in The Cayman Islands that would set out restrictions on our activities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_052"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>E.&#160;Taxation</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following is a summary
of the material Cayman Islands and U.S. tax consequences of acquiring, owning and disposing of securities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Material Cayman Islands Tax Considerations</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; ">The
following is a discussion on certain Cayman Islands income tax consequences of an investment in our securities. The discussion is a general
summary of present law, which is subject to prospective and retroactive change. It is not intended as tax advice, does not consider any
investor&#8217;s particular circumstances, and does not consider tax consequences other than those arising under Cayman Islands law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; ">Under
Existing Cayman Islands Laws</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; ">The
Cayman Islands currently levies no taxes on individuals or corporations based upon profits, income, gains, or appreciation and there is
no taxation in the nature of inheritance tax, gift tax or estate duty. There are no other taxes likely to be material to us levied by
the Government of the Cayman Islands except for stamp duties which may be applicable on instruments executed in, or, after execution,
brought within the jurisdiction of the Cayman Islands. No stamp duty is payable in the Cayman Islands on the issue of shares by, or any
transfers of shares of, Cayman Islands companies (except those which hold interests in land in the Cayman Islands). There are no exchange
control regulations or currency restrictions in the Cayman Islands.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; ">Payments
of dividends and capital in respect of our securities will not be subject to taxation in the Cayman Islands and no withholding will be
required on the payment of a dividend or capital to any holder of the securities, nor will gains derived from the disposal of the securities
be subject to Cayman Islands income or corporate tax. No stamp duty is payable in respect of the issue of our securities. An instrument
of transfer in respect of our securities is stampable if executed or brought into the Cayman Islands.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; ">The
Company has applied for, and received, an undertaking from the Financial Secretary of the Cayman Islands that, in accordance with section
6 of the Tax Concessions Act (As Revised) of the Cayman Islands, for a period of 20&#160;years from the date of the undertaking, no law
which is enacted in the Cayman Islands imposing any tax to be levied on profits, income, gains or appreciations shall apply to the Company
or its operations and, in addition, that no tax to be levied on profits, income, gains or appreciations or which is in the nature of
estate duty or inheritance tax shall be payable (i)&#160;on or in respect of the shares, debentures or other obligations of the Company
or (ii)&#160;by way of the withholding in whole or in part of a payment of dividend or other distribution of income or capital by the
Company to or its shareholders or a payment of principal or interest or other sums due under a debenture or other obligation of the Company</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in"></p><div>

</div><!-- Field: Page; Sequence: 102; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->94<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Material U.S. Federal Income Tax Considerations</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><sup>&#160;</sup></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>General</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following is a summary
of certain U.S.&#160;federal income tax consequences of the ownership and disposition of the Ordinary Shares by a U.S.&#160;holder (as
defined below). This summary only applies to the Ordinary Shares held as capital assets within the meaning of Section 1221 of the Internal
Revenue Code of 1986, as amended (the &#8220;Code&#8221;). The discussion below does not cover all aspects of U.S.&#160;federal income
taxation that may be relevant to, or the actual tax effect that any of the matters described herein will have on, the ownership or disposition
of the Ordinary Shares by particular investors (including consequences under the alternative minimum tax, Medicare tax on net investment
income tax), and does not address state, local, non-U.S.&#160;or other tax laws (such as estate or gift tax laws). This summary also does
not describe all of the tax consequences that may be relevant to holders that own (directly, indirectly or by attribution) 5% or more
of the Ordinary Shares by vote or value, nor does this summary discuss all of the tax considerations that may be relevant to certain types
of holders subject to special rules under the U.S.&#160;federal income tax laws, such as:</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">financial
institutions or financial services entities;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">insurance
companies;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">individual
retirement accounts or other tax-deferred accounts;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulatory
agencies or instrumentalities thereof;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulated
investment companies and real estate investment trusts;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">grantor trusts;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
that have ceased to be U.S.&#160;citizens or lawful permanent residents of the United&#160;States;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.&#160;citizens
or lawful permanent residents living abroad;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
that acquired the Ordinary Shares pursuant to an exercise of employee share options, in connection with employee share incentive plans
or otherwise as compensation;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">dealers
or traders subject to a mark-to-market method of tax accounting with respect to the Ordinary Shares;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
holding the Ordinary Shares as part of a &#8220;straddle,&#8221; constructive sale, hedging transactions, integrated transactions or
similar transactions for U.S.&#160;federal income tax purposes;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.&#160;holders
(as defined below) whose functional currency is not the U.S.&#160;dollar;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">holders
that are controlled foreign corporations or passive foreign investment companies; or</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">tax-exempt
organizations.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">For purposes of this discussion,
the term &#8220;U.S.&#160;holder&#8221; means a beneficial owner of Ordinary Shares that is, for U.S.&#160;federal income tax purposes:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
individual citizen or resident of the United&#160;States;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
corporation created or organized in or under the laws of the United&#160;States, any state thereof or the District of Columbia;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
estate the income of which is subject to U.S.&#160;federal income tax regardless of its source; or;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
trust if (1)&#160;a U.S.&#160;court can exercise primary supervision over the trust&#8217;s administration, and one or more U.S.&#160;persons
are authorized to control all substantial decisions of the trust; or (2)&#160;the trust has a valid election in effect under applicable
Treasury regulations to be treated as a domestic trust for U.S.&#160;federal income tax purposes.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The U.S.&#160;federal income tax treatment of a partner in an entity
or arrangement classified as a partnership for U.S.&#160;federal income tax purposes that holds the Ordinary Shares will depend on the
status of the partner and the activities of the partnership. Holders that are entities or arrangements classified as partnerships for
U.S.&#160;federal income tax purposes should consult their tax advisors concerning the U.S.&#160;federal income tax consequences to them
and their partners of the ownership and disposition of the Ordinary Shares by the partnership.</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">This discussion is based on the tax laws of the United&#160;States,
including the Code, its legislative history, existing, proposed and temporary Treasury regulations thereunder, published administrative
pronouncements and court decisions, all as of the date hereof and all subject to change at any time, possibly with retroactive effect.
No rulings have been requested from the U.S.&#160;Internal Revenue Service (the &#8220;IRS&#8221;) and there can be no guarantee that
the IRS would not challenge, possibly successfully, the treatment described below.</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 103; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->95<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>THE SUMMARY OF U.S.&#160;FEDERAL INCOME TAX
CONSEQUENCES SET OUT BELOW IS FOR GENERAL INFORMATION ONLY.&#160;ALL HOLDERS SHOULD CONSULT THEIR TAX ADVISORS AS TO THE PARTICULAR TAX
CONSEQUENCES TO THEM OF OWNING, AND DISPOSING OF THE ORDINARY SHARES, INCLUDING THE APPLICABILITY AND EFFECT OF STATE, LOCAL,
NON-U.S.&#160;AND OTHER TAX LAWS AND POSSIBLE CHANGES IN TAX LAW.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>U.S. Holders</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Passive Foreign Investment Company Considerations</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">A non-U.S.&#160;corporation
will be a passive foreign investment company (&#8220;PFIC&#8221;) for U.S.&#160;federal income tax purposes in any taxable year in which,
after taking into account the income and assets of the corporation and certain subsidiaries pursuant to applicable &#8220;look-through
rules,&#8221; either (i)&#160;at least 75% of the corporation&#8217;s gross income is &#8220;passive income&#8221; or (ii)&#160;at least
50% of the value of the corporation&#8217;s assets (generally based on the quarterly average of the value of its assets during the taxable
year) is attributable to assets, including cash, that produce passive income or are held for the production of passive income. Passive
income generally includes dividends, interest, certain royalties and rents, annuities, net gains from the sale or exchange of property
producing such income and net foreign currency gains.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Based on the composition of our income, we believe we likely were a
PFIC for our taxable year ending June 30, 2025, and may be a PFIC for our current taxable year or future taxable years. However, since
the tests for determining PFIC status are applied annually after the close of the taxable year, and it is difficult to predict accurately
future income and assets relevant to this determination, there can be no assurance with respect to our PFIC status for our current taxable
year or any future taxable year. Further, we provide no assurances that we will make a determination as to our PFIC status in respect
of any taxable year. The fair market value of our assets is expected to depend, in part, upon (a)&#160;the market value of the Ordinary
Shares, and (b)&#160;the composition of our assets and income. Because we may value our goodwill based on the market value of the Ordinary
Shares, a decrease in the market value of the Ordinary Shares and/or an increase in cash or other passive assets would increase the relative
percentage of our passive assets. The application of the PFIC rules is subject to uncertainty in several respects and, therefore, no assurances
can be provided that the IRS will not assert that we are a PFIC with respect to any taxable year.</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">If we are a PFIC in any year during which a U.S.&#160;holder owns the
Ordinary Shares, subject to the discussion below regarding the mark-to-market&#160;or qualified electing fund (&#8220;QEF&#8221;) elections,
a U.S.&#160;holder generally will be subject to special rules with respect to (i)&#160;any &#8220;excess distribution&#8221; (generally,
any distributions received by a U.S.&#160;holder on its Ordinary Shares in a taxable year that are greater than 125% of the average annual
distributions received by the U.S.&#160;holder in the three preceding taxable&#160;years or, if shorter, the U.S.&#160;holder&#8217;s
holding period for the Ordinary Shares) and (ii)&#160;any gain realized on the sale, exchange, redemption or other taxable disposition
of Ordinary Shares. Under these rules (a)&#160;the excess distribution or gain will be allocated ratably over the U.S.&#160;holder&#8217;s
holding period, (b)&#160;the amount allocated to the current taxable year and any taxable year prior to the first taxable year in which
we became a PFIC will be taxed as ordinary income, and (c)&#160;the amount allocated to each of the other taxable&#160;years will be subject
to tax at the highest rate of tax in effect for the applicable class of taxpayer for that year, and an interest charge for the deemed
deferral benefit will be imposed with respect to the resulting tax attributable to each such other taxable year.</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">If we are a PFIC for any taxable year, to the extent any of our subsidiaries
are also PFICs, a U.S.&#160;holder generally will be deemed to own shares in such lower-tier PFICs that are directly or indirectly owned
by us in the proportion which the value of the Ordinary Shares owned by such U.S.&#160;holder bears to the value of all of our equity
interests, and such U.S.&#160;holder generally will be subject to the tax consequences described above (and the IRS Form&#160;8621 reporting
requirement described below) with respect to the shares of such lower-tier PFIC the U.S.&#160;holder is deemed to own. As a result, if
we receive a distribution from any lower-tier PFIC or sell shares in a lower-tier PFIC, a U.S.&#160;holder generally will be subject to
tax under the excess distribution rules described above in the same manner as if such U.S.&#160;holder had held a proportionate share
of the lower-tier PFIC stock directly, even if such amounts are not distributed to the U.S.&#160;holder. However, if a U.S.&#160;holder
is treated as receiving an excess distribution in respect of a lower-tier PFIC, such holder would increase its tax basis in the Ordinary
Shares by the amount of such distribution. In addition, if we were to distribute such amount to the U.S.&#160;holder with respect to its
Ordinary Shares, such U.S.&#160;holder would not include the distribution in income but would instead reduce its tax basis in the Ordinary
Shares by the amount of the distribution. The application of the PFIC rules to indirect ownership of any lower-tier PFIC held by us is
complex and uncertain, and U.S.&#160;holders should therefore consult their tax advisors regarding the application of such rules to their
ownership of the Ordinary Shares.</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 104; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->96<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">A U.S.&#160;holder may be able to avoid the interest charge and the
other adverse impacts of the PFIC rules described above by making a mark-to-market election with respect to the Ordinary Shares, provided
that the Ordinary Shares are &#8220;marketable.&#8221; PFIC shares generally are marketable if: (i)&#160;they are &#8220;regularly traded&#8221;
on a national securities exchange that is registered with the SEC or on the national market system established under Section&#160;11A
of the Exchange&#160;Act; or (ii)&#160;they are &#8220;regularly traded&#8221; on any exchange or market that the Treasury Department
determines to have rules sufficient to ensure that the market price accurately represents the fair market value of the stock. It is expected
that the Ordinary Shares, which are listed on the Nasdaq, will qualify as marketable shares for purposes of the PFIC rules, but there
can be no assurance that the Ordinary Shares will be &#8220;regularly traded&#8221; for purposes of these rules. Pursuant to the mark-to-market
election, a U.S.&#160;holder would include in each year as ordinary income the excess, if any, of the fair market value of the Ordinary
Shares over their adjusted basis at the end of the taxable year. A U.S.&#160;holder may treat as ordinary loss any excess of the adjusted
basis of the Ordinary Shares over their fair market value at the end of the year, but only to the extent of the net amount previously
included in income as a result of the election in prior&#160;years. A U.S.&#160;holder&#8217;s adjusted tax basis in the PFIC shares will
be increased to reflect any amounts included in income, and decreased to reflect any amounts deducted, as a result of a mark-to-market
election. Any gain recognized on a sale, exchange, redemption or other taxable disposition of the Ordinary Shares will be treated as ordinary
income and any loss will be treated as ordinary loss (but only to the extent of the net amount of income previously included as a result
of a mark-to-market election), and thereafter, as capital loss. A mark-to-market election only applies for the taxable year in which the
election was made, and for each subsequent taxable year, unless the PFIC shares cease to be marketable or the IRS consents to the revocation
of the election. U.S.&#160;holders should also be aware that the Code and the Treasury regulations do not allow a mark-to-market election
with respect to the stock of lower-tier PFICs that is non-marketable. There is also no provision in the Code, Treasury regulations or
other published authority that specifically provides that a mark-to-market election with respect to the stock of a publicly-traded holding
company (such as us) effectively exempts the stock of any lower-tier PFICs from the negative tax consequences arising from the general
PFIC rules and, as a result, a mark-to-market election may not mitigate the adverse implications of the excess distribution regime with
respect to an investment in the Ordinary Shares if we were a PFIC as a result of owning interests in PFIC subsidiaries. U.S.&#160;holders
should consult their tax advisors to determine whether the mark-to-market tax election is available to them and the consequences resulting
from such election.</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In some cases, a shareholder of a PFIC may be subject to alternative
treatment by making a QEF election to be taxed currently on its share of the PFIC&#8217;s undistributed income. To make a QEF election,
we must provide U.S.&#160;holders with certain information compiled according to U.S.&#160;federal income tax principles. There is no
assurance that we will provide such information. There is also no assurance that we will have timely knowledge of our status as a PFIC
in the future or of the required information to be provided. In addition, if we hold an interest in a lower-tier PFIC (including, without
limitation, in any PFIC subsidiaries), U.S.&#160;holders generally will be subject to the PFIC rules described above with respect to any
such lower-tier PFICs. There can be no assurance that a portfolio company or subsidiary in which we hold an interest will not qualify
as a PFIC, or that a PFIC in which we hold an interest will provide the information necessary for a QEF election to be made by a U.S.&#160;holder
(in particular if we do not control that PFIC).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">If we are a PFIC in any year
with respect to which a U.S. holder holds the Ordinary Shares, we generally will continue to be treated as a PFIC with respect to such
U.S. holder in all succeeding years during which the U.S. holder holds the Ordinary Shares (unless a purging election is made), regardless
of whether we continue to meet the tests described above for treatment as a PFIC in such succeeding years. Under one form of purging election,
a &#8220;deemed sale&#8221; election, a U.S. holder may be able to elect to be treated as having disposed of the Ordinary Shares at their
fair market value as of the last day of the last taxable year in which we are a PFIC, triggering gain that would be subject to tax under
the excess distribution regime discussed above but terminating treatment of the Ordinary Shares as stock of a PFIC with respect to such
U.S. holder. As a result of the purging election, the U.S. holder would have a new basis and holding period in the Ordinary Shares for
purposes of the PFIC rules. U.S. holders should discuss the potential availability of a deemed sale election and other purging elections
with their tax advisors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">A U.S.&#160;holder that owns
(or is deemed to own) shares in a PFIC during any taxable year generally is required to file an IRS Form&#160;8621 (whether or not
a QEF or mark-to-market&#160;election is or has been made) with such U.S.&#160;holder&#8217;s U.S.&#160;federal income tax return and
provide such other information as may be required by the U.S.&#160;Treasury Department. Failure to file IRS Form&#160;8621 for each applicable
taxable year may result in substantial penalties and result in the U.S.&#160;holder&#8217;s taxable&#160;years being open to audit by
the IRS until such Forms are properly filed.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">U.S.&#160;holders should
consult their  tax advisors concerning our likely PFIC status and the consequences to them, including potential reporting requirements,
if we are  a PFIC for any taxable year.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 105; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->97<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Dividends</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Subject to the PFIC rules
discussed above under &#8220;&#8212;Passive Foreign Investment Company Considerations,&#8221; the gross amount of distributions of cash
or other property paid by us on our Ordinary Shares out of current or accumulated earnings and profits (as determined for U.S. federal
income tax purposes) generally will be taxable to a U.S. holder as dividend income, and will not be eligible for the dividends-received
deduction allowed to corporations. Distributions in excess of current and accumulated earnings and profits will be treated as a nontaxable
return of capital to the extent of the U.S. holder&#8217;s basis in the Ordinary Shares, and thereafter as capital gain. However, we cannot
provide any assurance that we will maintain calculations of our earnings and profits in accordance with U.S. federal income tax accounting
principles. U.S. holders should therefore assume that any distribution by us with respect to Ordinary Shares may be reported as ordinary
dividend income. U.S. holders should consult their tax advisors with respect to the appropriate U.S. federal income tax treatment of any
distribution received or treated as received from us. Dividends paid by us generally will be taxable to a non-corporate U.S. holder at
the reduced rate normally applicable to long-term capital gains, provided that (i) the Ordinary Shares are readily tradable on an established
securities market in the United States; (ii) certain holding period requirements are satisfied; and (3) we are not a PFIC for our taxable
year during which the dividend is paid or the immediately preceding taxable year.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Sale, Exchange, Redemption or Other Taxable
Disposition</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Subject to the discussion
above under &#8220;&#8212;Passive Foreign Investment Company Considerations,&#8221; a U.S. holder generally will recognize gain or loss
on any sale, exchange, redemption or other taxable disposition of the Ordinary Shares in an amount equal to the difference between (i)
the amount realized on the sale, exchange, redemption or other taxable disposition and (ii) such U.S. holder&#8217;s adjusted tax basis
in the Ordinary Shares. Any gain or loss recognized by a U.S. holder on a sale, exchange, redemption or other taxable disposition of the
Ordinary Shares generally will be capital gain or loss and will be long-term capital gain or loss if the U.S. holder&#8217;s holding period
in such Ordinary Shares exceeds one year at the time of the sale, exchange, redemption or other taxable disposition. Preferential tax
rates may apply to long-term capital gains of non-corporate U.S. holders (including individuals). The deductibility of capital losses
is subject to limitations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Foreign Financial Asset Reporting</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; text-align: justify">U.S. taxpayers that own
certain foreign financial assets, including equity of foreign entities, with an aggregate value in excess of US$50,000 at the end of
the taxable year or US$75,000 at any time during the taxable year (or, for certain individuals living outside the United States and married
individuals filing joint returns, certain higher thresholds) may be required to file an information report with respect to such assets
with their tax returns. The Ordinary Shares are expected to constitute foreign financial assets subject to these requirements unless
such Ordinary Shares are held in an account at a financial institution (in which case the account may be reportable if maintained by
a foreign financial institution). U.S. holders should consult their tax advisors regarding the application of the rules relating to foreign
financial asset reporting.</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Backup Withholding and Information Reporting</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Information reporting requirements may apply to payments of dividends
on, and to the proceeds from the sale, exchange, redemption or other taxable disposition of the Ordinary Shares effected within the United&#160;States
(and, in certain cases, outside the United&#160;States), in each case, other than U.S.&#160;holders that are exempt recipients (such as
corporations).<b><i>&#160;</i></b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 106; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->98<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Backup withholding may apply
to such amounts if the U.S.&#160;holder fails to provide an accurate taxpayer identification number (generally on an IRS Form&#160;W-9&#160;provided
to the paying agent of the U.S.&#160;holder&#8217;s broker) or is otherwise subject to backup withholding.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Backup withholding is not
an additional tax. Any amounts withheld under the backup withholding rules may be allowed as a refund or credit against a U.S.&#160;holder&#8217;s
U.S.&#160;federal income tax liability, if any, provided the required information is timely furnished to the IRS. Holders should consult
their tax advisors regarding these rules and any other reporting obligations that may apply to the ownership or disposition of the Ordinary
Shares, including reporting obligations related to the holding of certain foreign financial assets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_053"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>F.&#160;Dividends and Paying Agents</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_054"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>G.&#160;Statement by Experts</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_055"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>H.&#160;Documents on Display</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We are subject to the information
requirements of the Exchange Act, except that as a foreign issuer, we will not be subject to the proxy rules or the short-swing profit
disclosure rules of the Exchange Act. In accordance with these statutory requirements, we will file or furnish reports and other information
with the SEC, which you may inspect and copy at the Public Reference Room at 100 F Street, N.E., Washington, D.C. 20549. Information on
the operation of the Public Reference Room may be obtained by calling the SEC at 1-800-SEC-0330. In addition, the SEC maintains an Internet
website that contains reports and other information about issuers, like us, that file electronically with the SEC. The address of that
website is www.sec.gov. In addition, our security filings may be accessed at our website, http://www.moolecscience.com. Such filings and
other information on our website are not incorporated by reference in this annual report on Form 20-F.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_056"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>I.&#160;Subsidiary Information</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Please refer to &#8220;<i>Item
4. Information on the Company&#8212;C. Organizational Structure</i>.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_057"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>J.&#160;Annual Report to Security
Holders</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">If we are required to provide
an annual report to security holders in response to the requirements of Form 6-K, we will submit the annual report to security holders
in electronic format in accordance with the EDGAR Filer Manual.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;&#160;</p><div>

</div><div><a id="k_058"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM&#160;11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET
RISK</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We are exposed to market
risks in the ordinary course of our business. These risks primarily include credit risk, liquidity risk, market risk and fair value risk.
For more information about market risks to which we are exposed, see Note 15 to our audited consolidated financial statements included
elsewhere in this annual report.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_059"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM&#160;12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="k_060"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>A.&#160;Debt Securities</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_061"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>B.&#160;Warrants and Rights</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_062"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>C.&#160;Other Securities</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_063"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>D.&#160;American Depositary Shares</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Not applicable.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 107 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->99<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><div><a id="k_064"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PART II</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;&#160;</b></p><div>

</div><div><a id="k_065"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM&#160;13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="k_066"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>A.&#160;Defaults</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On August 11, 2025, the Company
disclosed in a Form 6-K filed with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) that in June 2025, Bioceres S.A.,
one of the Argentine subsidiaries of Bioceres Group Limited, defaulted on a portion of its financial debt that was due that month. As
a result, Bioceres S.A. had initiated a debt restructuring process for its financial debt for an aggregate amount of US$36.4 million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In July 2025, Bioceres LLC,
a wholly owned subsidiary of Bioceres S.A., received a notice of default on its financial debt&#160;in the amount of US$69.5 million.
The creditor conducted a public auction for 3,062,500 pledged BIOX shares, pursuant to the New York Uniform Commercial Code. Management
has responded to the creditor, reserving all rights, remedies, and defenses. As of June 30, 2025, the current debt amounts to US$58.0
million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The defaults by Bioceres
S.A. and Bioceres LLC do not have implications in other debts as there are no cross-default clauses on the remaining financial debt of
the Group. There are no guarantees granted above Bioceres S.A. and Bioceres LLC.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As of June 30, 2025, the
Group had a negative working capital amounting to US$204,860,444, and a shareholders&#8217; deficit of US$82,873,602. Additionally, the
Group reported recurring operating losses amounting to US$104,150,129.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company had the financial
support of its main shareholders and considering the aforementioned events that derived in the loss of the financial support that was
previously provided by Bioceres Group (and who is also no longer a shareholder of the Company), and, consequently, raise a material uncertainty
which may cast significant doubt (or raise substantial doubt as contemplated by PCAOB standards) &#160;about the ability of Moolec Science
SA to continue as a going concern, currently, the Group lacks sufficient financial resources to meet its obligations or fully implement
its business plan. Without securing additional capital, the Group will not be able to sustain its operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The uncertainty surrounding
the ability to secure additional funding and the potential for continued operational losses contribute to substantial doubt about the
Group&#8217;s ability to continue as a going concern.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Management has plans to address
the Group&#8217;s financial situation as follows:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>Theo I SCSp</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On November 28, 2025, subsequent
to the reporting date, Theo I SCSp received a conditional payment order from district court of&#160; Luxembourg, and therefore the General
Partners engaged Ogier (Luxembourg) SCS represented by its general partner Ogier Luxembourg (GP) S.&#224;.r.l&#160; formally as their
legal advisor to assist with Theo I SCSp&#8217;s declaration of bankruptcy before the Luxembourg District Court. The declaration of bankruptcy
will declare Theo I SCSp bankrupt and appoint a receiver who will take control over the management of the company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The loss of control constitutes
the derecognition event under IFRS 10.25. Accordingly, the Group will derecognize the assets and liabilities of Theo I SCSp and will remeasure
its retained interest at fair value in accordance with IFRS 9 at the date of the derecognition event. This will result in the recognition
of an estimated gain of US$9.5 million in the consolidated statement of profit or loss as of the derecognition date.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Group will continue to
measure its retained interest in Theo at fair value through profit or loss until the liquidation process is formally completed.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><i>Bioceres S.A. and Bioceres
LLC</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On December 16, 2025, subsequent
to the reporting date, the Board of Directors of Bioceres S.A. formally approved the initiation of voluntary bankruptcy proceedings and
instructed management to seek and appoint a trustee (&#8220;<i>s&#237;ndico</i>&#8221;) to oversee the process. The commencement of
the voluntary bankruptcy proceedings and the transfer of decision-making authority to the trustee will result in the Group losing control
over Bioceres S.A. in accordance with the principles of IFRS 10 Consolidated Financial Statements. As Bioceres LLC is a wholly owned subsidiary
of Bioceres S.A., the Group simultaneously will lose control over Bioceres LLC as well.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Under IFRS 10.25, the date
on which control is lost constitutes the derecognition event. Accordingly, after December 16, 2025, the Group will derecognize the assets
and liabilities of Bioceres S.A. and Bioceres LLC and will remeasure any retained interest at fair value in accordance with IFRS 9 Financial
Instruments.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The resulting derecognition
effects are expected to generate an approximate gain of US$91.0 million related to the loss of control of Bioceres S.A. and an additional
approximate gain of US$5.3 million related to the loss of control of Bioceres LLC (including the loss of holding in BIOX, therefore it
will no longer be an equity method associate). These amounts will be recognized in the consolidated statement of profit or loss as of
the derecognition date.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Group will continue to monitor the progress
of the voluntary bankruptcy and liquidation proceedings and will update the accounting treatment as necessary in accordance with IFRS.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">For further information,
see the Company&#8217;s Form 6-K furnished to the SEC on August 11, 2025, which is incorporated herein by reference.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As of the date of this Annual
Report, the default remains outstanding.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_067"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>B.&#160;Arrears and Delinquencies</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 108 --><div>
    </div><div style="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->100<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_068"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM&#160;14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS
AND USE OF PROCEEDS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;<b>&#160;</b></p><div>

</div><div><a id="k_069"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM&#160;15. CONTROLS AND PROCEDURES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="k_070"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>A.&#160;Disclosure Controls and
Procedures</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Under the supervision and
with the participation of our management, including our chief executive officer and chief financial officer, we conducted an evaluation
of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e)
under the Exchange Act, as of June 30, 2025. Based on such evaluation, management concluded that the Company&#8217;s disclosure controls
and procedures were not effective as of such date due to the material weakness described below under Item 15B.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">There are inherent limitations
to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention
or overriding of the controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable
assurance of achieving their control objectives.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_071"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>B.&#160;Management&#8217;s Annual
Report on Internal Control Over Financial Reporting</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Management, under the supervision
and with the participation of our Chief Executive Officer and Chief Financial Officer, is responsible for establishing and maintaining
adequate internal control over financial reporting. Internal control over financial reporting is defined in Rule 13a-15(f) and 15d-15(f)
under the Exchange Act as a process designed to provide reasonable assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance with IFRS as adopted by the IASB and includes those policies and
procedures that:</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.55pt; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.55pt; text-align: justify; text-indent: -0.25in"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">pertain
to the maintenance of records that in reasonable detail accurately and fairly reflect the transaction and dispositions of the assets
of the company;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.55pt; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">provide
reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with IFRS
as adopted by the IASB, and that receipts and expenditures of the company are being made only in accordance with authorizations of management
and directors of the company; and</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.55pt; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">provide
reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the company&#8217;s
assets that could have a material effect on the financial statements.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Because of its inherent limitations,
internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness
to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of
compliance with the policies or procedures may deteriorate.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Management assessed the effectiveness
of our internal control over financial reporting (as defined in Rules 13(a)-13(f) and 15(d)-15(f) under the U.S. Securities Exchange Act
of 1934) as of June 30, 2025. In making this assessment, it used the criteria established in Internal Control&#8212;Integrated Framework
(2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Management has excluded
Bioceres Group, Nutrecon and Gentle Tech from its assessment of internal control over financial reporting as of June 30, 2025, because
they were acquired by the Company in June 16, 2025 close to the year ended June 30, 2025. Bioceres Group, Nutrecon and Gentle Tech are
wholly-owned subsidiaries whose total assets and total revenues excluded from management&#8217;s assessment of internal control over
financial reporting represent 100% and 71%, respectively, of the Company&#8217;s consolidated financial statement amounts as of and for
the year ended June 30, 2025.</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">During the fiscal year ended June 30, 2025, management identified a material weakness in the Company&#8217;s
internal control over financial reporting related to the accounting for business combinations, specifically the timely completion of the
purchase price allocation (PPA) in connection with Business Combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The material weakness resulted
from insufficient resources to gather and assess timely the necessary valuation information to complete the PPA within the SEC reporting
deadline. Consequently, the Company was unable to finalize the allocation of the purchase price to the acquired identifiable assets and
liabilities in accordance with IFRS 3 before the SEC reporting deadline.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 109; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->101<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="text-decoration:underline">Remediation Plan:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Management has initiated
remediation actions to address this material weakness, which include:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Providing
                                            additional training to finance and accounting personnel regarding the requirements of IFRS
                                            3 and internal control; and</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">Strenghten the finance team by hiring professionals with expertise in complex accounting transactions, including business combinations
and purchase price allocation under IFRS 3.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><b>&#160;</b></p><div>

</div><div><a id="k_072"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b>C.&#160;Attestation Report
of the Registered Public Accounting Firm</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">This report does not include
an attestation report of internal controls from our independent registered public accounting firm due to our status as an emerging growth
company under the JOBS Act.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p><div>

</div><div><a id="k_073"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>D.&#160;Changes in Internal Control
Over Financial Reporting</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Other than the remediation
activities described above, there were no changes in the Company&#8217;s internal control over financial reporting during the period covered
by this Annual Report that have materially affected, or are reasonably likely to materially affect, the Company&#8217;s internal control
over financial reporting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_074"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM&#160;16. Reserved</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>&#160;&#160;</b></p><div>

</div><div><a id="k_075"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>A.&#160;Audit Committee Financial
Expert</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our board of directors has
determined that Romualdo Varela is an &#8220;audit committee financial expert&#8221; as defined by the SEC item 16A of Form 20-F. All
members of the audit committee are independent directors as defined in the Nasdaq Global Select Market corporate governance standards
and Rule 10A-3 under the Exchange Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_076"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>B.&#160;Code of Ethics</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We have adopted a Code of
Ethics applicable to our directors, executive officers and employees and to all board members, employees and officers of our controlled
companies. The Code of Ethics codifies the business and ethical principles that govern all aspects of our business. A copy of the Code
of Ethics will be filed with the SEC and will be provided without charge upon written request to us in writing at compliance@moolecscience.com.
We intend to disclose any amendments to or waivers of certain provisions of our Code of Ethics in a Current Report on Form 6-K (as required)
or on our website.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_077"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>C.&#160;Principal Accountant Fees
and Services</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Price Waterhouse &amp; Co.
S.R.L. (&#8220;PwC&#8221;) has acted as our principal accountants for the years ended June 30, 2025 and 2024. The following is a summary
of fees paid or to be paid to PwC for services rendered for each of the last two fiscal years.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Audit Fees</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Audit fees consist of fees
billed for standard audit work that needs to be performed each year in order to issue opinions on our consolidated financial statements
and for services that are normally provided by PwC in connection with regulatory filings. The aggregate fees billed by PwC for professional
services rendered for the audit of our annual consolidated financial statements and review of the financial information included in our
required filings with the SEC for the years ended June 30, 2025 and 2024 totaled US$0.4 million and US$0.4 million, respectively.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Audit-Related Fees</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Audit-related fees billed
consist of fees for services such as auditing of non-recurring transactions, consents and comfort letters and any other audit services
required for SEC or other regulatory filings. The aggregate fees billed by PwC for professional services rendered for audit-related services
for the year ended June 30, 2024 totaled US$0.2 million. PwC did not bill us for audit-related fees for the year ended June 30, 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Tax Fees</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Tax services relate to the
aggregated fees for services on tax compliance. PwC did not bill us for tax fees for the years ended June 30, 2025 and 2024.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 110; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->102<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>All Other Fees</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We did not pay PwC for other
services for the years ended June 30, 2025 and 2024.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Pre-approval Policies</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our audit committee approves
all auditing services and permitted non-audit services performed for us by its independent auditor in advance of an engagement. All auditing
services and permitted non-audit services (including the fees and terms thereof) to be performed for us by our independent auditor must
be approved by the audit committee in advance, subject to the de minimis exceptions for non-audit services described in Section 10A(i)(1)(B)
of the Exchange Act which are approved by the committee prior to the completion of the audit.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><div><a id="k_078"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>D.&#160;Exemptions from the Listing
Standards for Audit Committees</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">No exemptions from the listing
standards for our audit committee.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_079"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>E.&#160;Purchases of Equity Securities
by the Issuer and Affiliated Purchasers</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In the year ended June 30,
2025, we did not purchase any of our Ordinary Shares. See <i>&#8220;Item 10 Additional Information&#8212;B. Memorandum and Articles of
Association&#8212;Share Repurchases.&#8221;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_080"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>F.&#160;Change in Registrant&#8217;s
Certifying Accountant</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_081"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>G.&#160;Corporate Governance</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">See &#8220;<i>&#8212;Item
6. Directors, Senior Management and Employees&#8212;C. Board Practices</i>.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p><div>

</div><div><a id="k_082"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>H.&#160;Mine Safety Disclosure</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_083"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>I.&#160;Disclosure Regarding Foreign
Jurisdictions that Prevent Inspections</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_084"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>J.&#160;Insider Trading Policies</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our Board of Directors has
<ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="ecd:InsiderTrdPoliciesProcAdoptedFlag" id="ixv-43077">adopted</ix:nonNumeric> insider trading policies and procedures governing the purchase, sale, and other dispositions of our securities by directors, senior
management, and employees that are reasonably designed to promote compliance with applicable insider trading laws, rules and regulations,
and any listing standards applicable to us. A copy of the Company&#8217;s insider trading policy is filed as Exhibit 11.1 to this report.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_085"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>K.&#160;<ix:nonNumeric contextRef="c0" continuedAt="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_1" escape="true" name="cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" id="ixv-43078">Cybersecurity</ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_2" id="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As of the date of this report
we have not adopted a formal cybersecurity policy, and we have not invested in a comprehensive set of processes for managing cybersecurity
risk due to our relatively small size and limited resources. However, we have taken certain preliminary steps to manage cybersecurity
risks such as utilizing commercially available anti-virus software on company computers, utilizing cloud-based systems and software offered
by major global software and computer systems providers for company records and documents.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><ix:continuation id="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><ix:nonNumeric contextRef="c0" escape="true" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" id="ixv-43079">As of the date of this report
we do not believe, or are not aware, of any existing or previous cybersecurity incident that has materially affected or are <ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" id="ixv-43080">reasonably
likely to materially affect our business</ix:nonNumeric>, strategy, operations, or financial condition.</ix:nonNumeric> However, we may in the future be materially adversely
affected by a cybersecurity incident, such as a computer system failure, a computer system security breach, and as a result may be subject
to ransomware, phishing attacks, or other malicious intrusions.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_CybersecurityRiskBoardOfDirectorsOversightTextBlock-c0_cont_1" escape="true" name="cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock" id="ixv-12525"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b>Cybersecurity Risk Governance</b></p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><ix:continuation continuedAt="_CybersecurityRiskBoardOfDirectorsOversightTextBlock-c0_cont_2" id="_CybersecurityRiskBoardOfDirectorsOversightTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our Compliance Officer is
responsible for assessing and managing material risks from cybersecurity threats. Our Compliance Officer oversees our efforts to monitor
the prevention, detection, mitigation, and remediation of cybersecurity incidents.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><ix:continuation id="_CybersecurityRiskBoardOfDirectorsOversightTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><ix:nonNumeric contextRef="c0" escape="true" name="cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" id="ixv-43081">Our Board of Directors has
specific responsibility for <ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" id="ixv-43082">overseeing</ix:nonNumeric> cybersecurity risk management and evaluation and being informed on risks from cybersecurity threats.</ix:nonNumeric>
Our Compliance Officer reports to the Board of Directors on cybersecurity risk management matters as needed. Any material cybersecurity
incidents would be reported to the <ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" id="ixv-43083">Board of Directors</ix:nonNumeric> by our Compliance Officer. In the case of a material cybersecurity incident, our
board is responsible for ensuring that the proposed action and disclosure of the incident is adequate and that measures are put in place
to prevent further incidents. See Item 3 &#8211; Risk Factors<i>&#8212;&#8220;We rely on information technology systems, and any inadequacy,
failure, interruption or security breaches of those systems may impair our ability to operate our business effectively</i>&#8221; in this
Form 20-F.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 111; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->103<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><div><a id="k_086"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PART III</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><div><a id="k_087"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM&#160;17. FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We have responded to Item
18 in lieu of this item.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="k_088"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM&#160;18. FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Financial Statements are
filed as part of this report, see page F-1.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 112; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->104<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="k_089"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 19. EXHIBITS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="width: 9%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1*</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 90%; text-align: justify"><a href="ea027012501ex1-1_moolec.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended and Restated Memorandum and Articles of Association of the Company, &#160;adopted by special resolution passed on 16 December 2025 effective 5 January 2026.</span></a></td></tr><tr style="vertical-align: top; "><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2**</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1937737/000121390022074033/ff42022a1ex4-1_moolec.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Specimen Ordinary Share Certificate of Moolec Science SA (incorporated by reference to Exhibit 4.1 to the Registration Statement on Form F-4/A filed December 1, 2022 (file no. 333-267912)).</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2**</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1825437/000121390022033124/ea161359ex10-4_lightjump.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Specimen Warrant Certificate of Moolec Science S.A. (included as Exhibit A to Exhibit 2.5).</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3**</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1825437/000121390021002945/ea133526ex4-1_lightjump.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant Agreement, dated January 12, 2021, by and between LightJump Acquisition Corporation and Continental Stock Transfer &amp; Trust Company, as warrant agent (incorporated by reference to Exhibit 4.1 to LightJump Acquisition Corporation&#8217;s Form 8-K, File No. 001-39869, filed with the SEC on January 20, 2021).</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4**</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1825437/000121390021002945/ea133526ex10-3_lightjump.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription Agreement for Private Warrants by LightJump One Founders, LLC (incorporated by reference to Exhibit 10.3 to LightJump Acquisition Corporation&#8217;s Form 8-K, File No. 001-39869, filed with the SEC on January 20, 2021).</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5**</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1825437/000121390022033124/ea161359ex10-4_lightjump.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Assignment, Assumption and Amendment Agreement with respect to the Warrant Agreement between LightJump Acquisition Corporation, Moolec Science SA and Continental Stock Transfer &amp; Trust Company (incorporated by reference to Exhibit 10.4 to LightJump Acquisition Corporation&#8217;s Form 8-K, File No. 001-39869, filed with the SEC on June 15, 2022).</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.6*</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#es_001">Description of Registrant&#8217;s Securities: See &#8220;<i>Item 10. Additional Information&#8212;B. Memorandum and Articles of Association&#8212;Ordinary Shares</i>.&#8221;</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1**#</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1825437/000121390022033124/ea161359ex2-1_lightjump.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Business Combination Agreement, dated as of June 14, 2022, by and among LightJump Acquisition Corporation, Moolec Science Limited, Moolec Science SA and Moolec Acquisition, Inc. (incorporated by reference to Exhibit 2.1 to LightJump Acquisition Corporation&#8217;s Form 8-K, File No. 001-39869, filed with the SEC on June 15, 2022).</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2**#</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1825437/000121390022074207/ea169063ex2-1_lightjump.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">First Amendment to the Business Combination Agreement, by and among LightJump Acquisition Corporation, Moolec Science Limited, Moolec Science SA and Moolec Acquisition, Inc. (incorporated by reference to Exhibit 2.1 to LightJump Acquisition Corporation&#8217;s Form 8-K, File No. 001-39869, filed with the SEC on November 21, 2022).</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3**</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1825437/000121390022033124/ea161359ex10-1_lightjump.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Exchange Agreement (incorporated by reference to Exhibit 10.1 to LightJump Acquisition Corporation&#8217;s Form 8-K, File No. 001-39869, filed with the SEC on June 15, 2022).</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4**</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1825437/000121390022033124/ea161359ex10-3_lightjump.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transaction Support Agreement, dated as of June 14, 2022, by and among LightJump Acquisition Corporation, LightJump One Founders, LLC, Moolec Science Limited, Moolec Science SA and others (incorporated by reference to Exhibit 10.3 to LightJump Acquisition Corporation&#8217;s Form 8-K, File No. 001-39869, filed with the SEC on June 15, 2022).</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5**</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1825437/000121390021002945/ea133526ex10-2_lightjump.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registration Rights Agreement, dated as of January 12, 2021, by and between LightJump Acquisition Corporation and other investors (incorporated by reference to Exhibit 10.2 to LightJump Acquisition Corporation&#8217;s Form 8-K, File No. 001-39869, filed with the SEC on January 20, 2021).</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6**</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1937737/000121390023001441/f20f2022ex4-6_moolecsci.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registration Right and Lock-Up Agreement, dated December 30, 2022, by and among, Moolec Science SA, LightJump One Founders, LLC, BG Farming Technologies Ltd., Union Group Ventures Ltd., Bioceres Crop Solutions Corp., THEO I SCSp, Serenity Traders LTD., UG Holdings, LLC, Robert M. Bennett and Jose L&#243;pez Lecube (incorporated by reference to Exhibit 4.6 to Company&#8217;s Form 20-F, File No. 001-41586, filed with the SEC on January 6, 2023).</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7**</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1825437/000121390022033124/ea161359ex10-2_lightjump.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Backstop Agreement (incorporated by reference to Exhibit 10.2 to LightJump Acquisition Corporation&#8217;s Form 8-K, File No. 001-39869, filed with the SEC on June 15, 2022).</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8**</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1937737/000121390023001441/f20f2022ex4-8_moolecsci.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Memorandum of Understanding on the Backstop Agreement, dated as of December 30, 2022, by and among LightJump Acquisition Corporation, Moolec Science Limited, Moolec Science SA, UG Holdings, LLC, Union Group Ventures Limited, THEO I SCSp and LightJump One Founders, LLC (incorporated by reference to Exhibit 4.8 to Company&#8217;s Form 20-F, File No. 001-41586, filed with the SEC on January 6, 2023).</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9**</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1825437/000121390022033124/ea161359ex10-6_lightjump.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment to Business Combination Marketing Agreement, dated June 14, 2022 between LightJump Acquisition Corporation and EarlyBirdCapital, Inc. (incorporated by reference to Exhibit 10.6 to LightJump Acquisition Corporations&#8217;s Form 8-K, File No. 001-39869, filed with the SEC on June 15, 2022).</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10**</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1937737/000121390025033070/ea023797101ex99-2_moolec.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Business Combination Agreement, dated as of April 17, 2025</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1*</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#k_019">List of subsidiaries of Moolec Science SA, as of June 30, 2025: See &#8220;<i>Item 4. Information on the Company&#8212;C. Organizational Structure</i>.&#8221;</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11**</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1937737/000121390023028710/ea176777ex10-1_moolec.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Acceptance Letter, dated April 9, 2023, and Selling Shareholders Offer Letter, dated April 9, 2023, relating to the ValoraSoy SPA, between the Company and the Sellers (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Form 6-K, File No. 001-41586).</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.1*</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea027012501ex11-1_moolec.htm">Insider Trading Policy</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.1*</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ea027012501ex12-1_moolec.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rule 13a-14(a)/15d-14(a) &#8211; Section 302 - Certification of Chief Executive Officer</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.2*</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ea027012501ex12-2_moolec.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rule 13a-14(a)/15d-14(a) &#8211; Section 302 - Certification of Chief Financial Officer</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.1*</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ea027012501ex13-1_moolec.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18 U.S.C. SECTION 1350 &#8211; Section 906 - Certification of Chief Executive Officer</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.2*</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ea027012501ex13-2_moolec.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18 U.S.C. SECTION 1350 &#8211; Section 906 - Certification of Chief Financial Officer</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.1*</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ea027012501ex15-1_moolec.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Price Waterhouse &amp; Co. S.R.L., independent registered public accounting firm, with respect to Moolec Science SA&#8217;s consolidated financial statements</span></a></td></tr>

<tr style="vertical-align: top; ">
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">15.2*</span></td>
    <td>&#160;</td>
    <td style="font-size: 10pt; text-align: justify"><a href="ea027012501ex15-2_moolec.htm"><span style="font-size: 10pt">Consent of Price Waterhouse &amp; Co. S.R.L., independent registered public accounting firm, with respect to Bioceres Crop Solutions Corp.&#8217;s consolidated financial statements</span></a></td></tr>

<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">97*</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea027012501ex97_moolec.htm">Moolec Clawback Policy</a></span></td></tr>

<tr style="vertical-align: top; ">
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">99.1*</span></td>
    <td>&#160;</td>
    <td style="font-size: 10pt; text-align: justify"><a href="ea027012501ex99-1_moolec.htm"><span style="font-size: 10pt">Consolidated Financial Statements of Bioceres Crop Solutions Corp. as of June 30, 2025 and 2024, and for the years ended June 30, 2025, 2024 and 2023</span></a></td></tr>

<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.1*</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: justify; width: 90%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following financial statements from the Company&#8217;s Annual Report on Form 20-F for the year ended June 30, 2025, formatted in Inline XBRL: (i) Consolidated Statements of Profit or Loss and Other Comprehensive Income, (ii) Consolidated Statement of Financial Position, (iii) Consolidated Statements of Changes in Equity, (iv) Consolidated Statements of Cash Flows, and (v) Notes to Consolidated Financial Statements, tagged as blocks of text and including detailed tags.</span></td></tr>


  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104*</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed herewith.</span></td></tr>
</table><div>

</div><p style="margin: 0"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously filed.</span></td></tr>
</table><div>

</div><p style="margin: 0"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">#</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain schedules, annexes and exhibits have been omitted pursuant to Item 601(b)(2) of Regulation S-K, but will be furnished supplementally to the SEC upon request.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify; text-indent: -0.3in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 113; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->105<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The registrant hereby certifies
that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this
registration statement on its behalf.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: December 29, 2025</span></td>
    <td colspan="3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MOOLEC SCIENCE SA</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="3">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid">/s/ <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alejandro Antalich</span></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 60%">&#160;</td>
    <td style="width: 3%">&#160;</td>
    <td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alejandro Antalich</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 114; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->106<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: center; text-indent: -70.9pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: center; text-indent: -70.9pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: center; text-indent: -70.9pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: center; text-indent: -70.9pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: center; text-indent: -70.9pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="fin_001.jpg"/></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>MOOLEC SCIENCE SA</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Consolidated financial statements as of</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>June 30, 2025 and 2024 and for the years</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>


</div><!-- Field: Page; Sequence: 115 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="text-transform: uppercase"><b>Contents</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-transform: uppercase"><b>&#160;</b></span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; width: 91%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Consolidated financial statements as of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023.</b></span></td> <td style="text-align: center; width: 9%; vertical-align: bottom">&#160;</td></tr> <tr style="vertical-align: top; "> <td style="font-size: 10pt">&#160;</td> <td style="text-align: center; vertical-align: bottom">&#160;</td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company information</span></td> <td style="text-align: center; vertical-align: bottom">&#160;</td></tr> <tr style="vertical-align: top; "> <td style="font-size: 10pt">&#160;</td> <td style="text-align: center; vertical-align: bottom">&#160;</td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="font-size: 10pt"><a href="#fin_001"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Report of Independent Registered Public Accounting Firm PCAOB ID: <ix:nonNumeric contextRef="c0" name="dei:AuditorFirmId" id="ixv-43084">1349</ix:nonNumeric></span></a></td> <td style="text-align: center; vertical-align: bottom">F-2</td></tr> <tr style="vertical-align: top; "> <td style="font-size: 10pt">&#160;</td> <td style="text-align: center; vertical-align: bottom">&#160;</td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="font-size: 10pt"><a href="#fin_002"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated statements of comprehensive income</span></a></td> <td style="text-align: center; vertical-align: bottom">F-4</td></tr> <tr style="vertical-align: top; "> <td style="font-size: 10pt">&#160;</td> <td style="text-align: center; vertical-align: bottom">&#160;</td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="font-size: 10pt"><a href="#fin_003"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated statements of financial position</span></a></td> <td style="text-align: center; vertical-align: bottom">F-5</td></tr> <tr style="vertical-align: top; "> <td style="font-size: 10pt">&#160;</td> <td style="text-align: center; vertical-align: bottom">&#160;</td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="font-size: 10pt"><a href="#fin_004"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated statements of changes in equity </span></a></td> <td style="text-align: center; vertical-align: bottom">F-7</td></tr> <tr style="vertical-align: top; "> <td style="font-size: 10pt">&#160;</td> <td style="text-align: center; vertical-align: bottom">&#160;</td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="font-size: 10pt"><a href="#fin_005"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated statements of cash flows </span></a></td> <td style="text-align: center; vertical-align: bottom">F-10</td></tr> <tr style="vertical-align: top; "> <td style="font-size: 10pt">&#160;</td> <td style="text-align: center; vertical-align: bottom">&#160;</td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="font-size: 10pt"><a href="#fin_006"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes to the consolidated financial statements</span></a></td> <td style="text-align: center; vertical-align: bottom">F-12</td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>


</div><!-- Field: Page; Sequence: 116; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><img alt="" src="fin_002.jpg"/></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="fin_001"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Report of Independent Registered Public Accounting
Firm</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To the board of directors and shareholders of Moolec Science SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_AuditorOpinionTextBlock-c0_cont_1" escape="true" name="dei:AuditorOpinionTextBlock" id="ixv-13123"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Opinion on the Financial Statements</i></b></p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:continuation id="_AuditorOpinionTextBlock-c0_cont_1"><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have audited the accompanying consolidated statements of financial
position of Moolec Science SA and its subsidiaries (the &#8220;Company&#8221;) as of June 30, 2025 and 2024, and the related consolidated
statements of comprehensive income, of changes in shareholders&#8217; deficit / equity and of cash flows for each of the three years in
the period ended June 30, 2025, including the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;).
In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company
as of June 30, 2025 and 2024, and the results of its operations and its cash flows for each of the three years in the period ended June
30, 2025 in conformity with IFRS Accounting Standards as issued by the International Accounting Standards Board.</p></ix:continuation><div>



</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Substantial Doubt about the Company&#8217;s Ability to Continue
as a Going Concern</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">The accompanying consolidated financial statements have been prepared
assuming that the Company will continue as a going concern. As discussed in Note 1.1 to the consolidated financial statements, due to
the loss of financial support from former main shareholders and default events in certain subsidiaries, Moolec&#8217;s financial conditions
deteriorated and its access to financing have been restricted or limited. These events or conditions raise substantial doubt on the Company&#8217;s
ability to continue as a going concern. Management&#8217;s plans in regard to these matters are also described in Note 1.1. The consolidated
financial statements do not include any adjustments that might result from the outcome of this uncertainty.</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Basis for Opinion</i></b></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">These consolidated financial statements are the responsibility of the
Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s consolidated financial statements based
on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and
are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules
and regulations of the Securities and Exchange Commission and the PCAOB.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We conducted our audits of these consolidated financial statements
in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance
about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not
required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we
are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion
on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 50%">www.pwc.com.ar</td>
  <td style="width: 50%">Price Waterhouse &amp; Co. S.R.L.</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>Bouchard 557, 8th floor</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>C1106ABG - Autonomous City of Buenos Aires, Argentina</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>T: +(54.11) 4850.0000</td></tr>
</table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 117; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><img alt="" src="fin_002.jpg"/></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our audits included performing procedures to assess the risks of material
misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those
risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial
statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as
evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for
our opinion.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/<span style="font-size: 10pt">s/ Price Waterhouse&#160;&amp; Co.
S.R.L.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="border-bottom: Black 1.5pt solid; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ <ix:nonNumeric contextRef="c0" name="dei:AuditorName" id="ixv-43085">Sebastian Azagra</ix:nonNumeric></span></td> <td style="width: 60%">&#160;</td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sebastian Azagra</span></td> <td>&#160;</td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Partner</span></td> <td>&#160;</td></tr> <tr style="vertical-align: top"> <td><ix:nonNumeric contextRef="c0" name="dei:AuditorLocation" id="ixv-13219"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rosario, Argentina</span></ix:nonNumeric></td> <td>&#160;</td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 29,</span> 2025</td> <td>&#160;</td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have served as the Company&#8217;s auditor since 2020.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 118; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><div><a id="fin_002"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">CONSOLIDATED SATEMENT OF COMPREHENSIVE INCOME</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>For the years ended June 30, 2025, 2024 and
2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Notes</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 52%; text-align: left">Revenues from contracts with customers</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: center">8.1</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-43086">333,611,248</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-43087">466,376,330</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-43088">420,867,429</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Government grants</td><td>&#160;</td>
    <td style="text-align: center">7.17</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromGovernmentGrants" scale="0" unitRef="usd" id="ixv-43089">3,412</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromGovernmentGrants" scale="0" unitRef="usd" id="ixv-43090">197,519</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromGovernmentGrants" scale="0" unitRef="usd" id="ixv-43091">93,509</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Initial recognition and changes in the fair value of biological assets at the point of harvest</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets" scale="0" sign="-" unitRef="usd" id="ixv-43092">1,764,863</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets" scale="0" unitRef="usd" id="ixv-43093">45,746</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets" scale="0" sign="-" unitRef="usd" id="ixv-43094">610,554</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Cost of sales</td><td>&#160;</td>
    <td style="text-align: center">8.2</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CostOfSales" scale="0" unitRef="usd" id="ixv-43095">203,424,872</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CostOfSales" scale="0" unitRef="usd" id="ixv-43096">279,368,328</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CostOfSales" scale="0" unitRef="usd" id="ixv-43097">235,464,072</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Changes in the net realizable value of agricultural products after harvest</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:ChangeInNetRealizableValueOfAgricultural" scale="0" sign="-" unitRef="usd" id="ixv-43098">1,541,204</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="mlec:ChangeInNetRealizableValueOfAgricultural" scale="0" sign="-" unitRef="usd" id="ixv-43099">2,385,069</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:ChangeInNetRealizableValueOfAgricultural" scale="0" sign="-" unitRef="usd" id="ixv-43100">4,351,433</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Research and development expenses</td><td>&#160;</td>
    <td style="text-align: center">8.3</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="0" unitRef="usd" id="ixv-43101">15,138,510</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="0" unitRef="usd" id="ixv-43102">17,422,487</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="0" unitRef="usd" id="ixv-43103">15,943,987</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Selling, general and administrative expenses</td><td>&#160;</td>
    <td style="text-align: center">8.4</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:SellingGeneralAndAdministrativeExpense" scale="0" unitRef="usd" id="ixv-43104">125,908,240</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:SellingGeneralAndAdministrativeExpense" scale="0" unitRef="usd" id="ixv-43105">126,340,822</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:SellingGeneralAndAdministrativeExpense" scale="0" unitRef="usd" id="ixv-43106">116,531,274</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Share of profit or loss of joint ventures and associates</td><td>&#160;</td>
    <td style="text-align: center">13</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="0" sign="-" unitRef="usd" id="ixv-43107">36,927,610</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="0" sign="-" unitRef="usd" id="ixv-43108">21,023,150</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="0" unitRef="usd" id="ixv-43109">47,709,605</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Other income or expenses, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">8.6</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherOperatingIncomeExpense" scale="0" sign="-" unitRef="usd" id="ixv-43110">56,589,216</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherOperatingIncomeExpense" scale="0" sign="-" unitRef="usd" id="ixv-43111">703,265</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherOperatingIncomeExpense" scale="0" unitRef="usd" id="ixv-43112">1,055,299</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Operating (loss) profit</td><td>&#160;</td>
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossFromOperatingActivities" scale="0" sign="-" unitRef="usd" id="ixv-43113">104,150,129</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossFromOperatingActivities" scale="0" unitRef="usd" id="ixv-43114">19,284,982</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossFromOperatingActivities" scale="0" unitRef="usd" id="ixv-43115">98,045,630</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Financial cost</td><td>&#160;</td>
    <td style="text-align: center">8.5</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinanceIncomeCost" scale="0" sign="-" unitRef="usd" id="ixv-43116">41,809,445</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinanceIncomeCost" scale="0" sign="-" unitRef="usd" id="ixv-43117">37,634,153</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinanceIncomeCost" scale="0" sign="-" unitRef="usd" id="ixv-43118">33,576,632</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Other financial results</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">8.5</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherFinanceIncomeCost" scale="0" sign="-" unitRef="usd" id="ixv-43119">24,043,905</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherFinanceIncomeCost" scale="0" sign="-" unitRef="usd" id="ixv-43120">9,608,981</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherFinanceIncomeCost" scale="0" sign="-" unitRef="usd" id="ixv-43121">13,674,756</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">(Loss) Profit before income tax</td><td>&#160;</td>
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossBeforeTax" scale="0" sign="-" unitRef="usd" id="ixv-43122">170,003,479</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossBeforeTax" scale="0" sign="-" unitRef="usd" id="ixv-43123">27,958,152</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossBeforeTax" scale="0" unitRef="usd" id="ixv-43124">50,794,242</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Income tax</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">9</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="0" unitRef="usd" id="ixv-43125">6,636,121</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="0" unitRef="usd" id="ixv-43126">1,103,152</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="0" sign="-" unitRef="usd" id="ixv-43127">2,328,366</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">(Loss) Profit for the year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" sign="-" unitRef="usd" id="ixv-43128">176,639,600</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" sign="-" unitRef="usd" id="ixv-43129">29,061,304</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" unitRef="usd" id="ixv-43130">53,122,608</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Other comprehensive income</td><td>&#160;</td>
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; font-style: italic; text-align: left; padding-bottom: 1.5pt"><i>Items
    that may be subsequently reclassified to profit and loss</i></td><td style="padding-bottom: 1.5pt"><i>&#160;</i></td>
    <td style="padding-bottom: 1.5pt"><i>&#160;</i></td><td style="font-weight: bold; padding-bottom: 1.5pt"><i>&#160;</i></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><i>&#160;</i></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><i>(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" scale="0" sign="-" unitRef="usd" id="ixv-43131">3,680,709</ix:nonFraction></i></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><i>)</i></td><td style="font-weight: bold; font-style: italic; padding-bottom: 1.5pt"><i>&#160;</i></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: left"><i>&#160;</i></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: right"><i>(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" scale="0" sign="-" unitRef="usd" id="ixv-43132">1,092,833</ix:nonFraction></i></td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic; text-align: left"><i>)</i></td><td style="font-weight: bold; font-style: italic; padding-bottom: 1.5pt"><i>&#160;</i></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: left"><i>&#160;</i></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: right"><i>(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" scale="0" sign="-" unitRef="usd" id="ixv-43133">911,896</ix:nonFraction></i></td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic; text-align: left"><i>)</i></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Foreign exchange differences on translation of foreign operations from joint ventures</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations" scale="0" sign="-" unitRef="usd" id="ixv-43134">802,200</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations" scale="0" unitRef="usd" id="ixv-43135">977,482</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations" scale="0" sign="-" unitRef="usd" id="ixv-43136">46,541</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Foreign exchange differences on translation of foreign operations</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" scale="0" sign="-" unitRef="usd" id="ixv-43137">2,878,509</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" scale="0" sign="-" unitRef="usd" id="ixv-43138">2,070,315</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" scale="0" sign="-" unitRef="usd" id="ixv-43139">865,355</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; font-style: italic; text-align: left; padding-bottom: 1.5pt">Items that will not be subsequently reclassified to loss and profit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; font-style: italic; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: right"><div style="-sec-ix-hidden: hidden-fact-2">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic; text-align: left">&#160;</td><td style="font-weight: bold; font-style: italic; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: right"><div style="-sec-ix-hidden: hidden-fact-3">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic; text-align: left">&#160;</td><td style="font-weight: bold; font-style: italic; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:ItemsThatWillNotBeSubsequentlyReclassifiedToLossAndProfit" scale="0" sign="-" unitRef="usd" id="ixv-43140">1,467,349</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Revaluation of property, plant and equipment, net of tax, of joint ventures and associates</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-4">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-5">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:RevaluationOfPropertyPlantAndEquipmentNetOfTaxOfJointVenturesAndAssociates" scale="0" sign="-" unitRef="usd" id="ixv-43141">184,630</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Revaluation of property, plant and equipment, net of tax</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-6">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-7">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:RevaluationOfPropertyPlantAndEquipmentNetOfTax" scale="0" sign="-" unitRef="usd" id="ixv-43142">1,282,719</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total comprehensive (loss) profit</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="0" sign="-" unitRef="usd" id="ixv-43143">180,320,309</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="0" sign="-" unitRef="usd" id="ixv-43144">30,154,137</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="0" unitRef="usd" id="ixv-43145">50,743,363</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">(Loss) / profit for the year attributable to:</td><td>&#160;</td>
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Equity holders of the parent</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" scale="0" sign="-" unitRef="usd" id="ixv-43146">111,460,708</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" scale="0" sign="-" unitRef="usd" id="ixv-43147">32,685,398</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" scale="0" unitRef="usd" id="ixv-43148">40,435,923</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Non-controlling interests</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: right; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" scale="0" sign="-" unitRef="usd" id="ixv-43149">65,178,892</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" scale="0" unitRef="usd" id="ixv-43150">3,624,094</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" scale="0" unitRef="usd" id="ixv-43151">12,686,685</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" sign="-" unitRef="usd" id="ixv-43152">176,639,600</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" sign="-" unitRef="usd" id="ixv-43153">29,061,304</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" unitRef="usd" id="ixv-43154">53,122,608</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>

<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">(Loss) /Profit per share</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="width: 52%; text-align: left">Basic (loss) / profit attributable to ordinary equity holders of the parent</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: center">10</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c0" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:BasicEarningsLossPerShare" scale="0" sign="-" unitRef="usdPershares" id="ixv-43155">17.2461</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c5" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:BasicEarningsLossPerShare" scale="0" sign="-" unitRef="usdPershares" id="ixv-43156">5.6146</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c6" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:BasicEarningsLossPerShare" scale="0" unitRef="usdPershares" id="ixv-43157">8.8034</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Diluted (loss) / profit attributable to ordinary equity holders of the parent</td><td>&#160;</td>
    <td style="text-align: center">10</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:DilutedEarningsLossPerShare" scale="0" sign="-" unitRef="usdPershares" id="ixv-43158">17.2461</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:DilutedEarningsLossPerShare" scale="0" sign="-" unitRef="usdPershares" id="ixv-43159">5.6146</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:DilutedEarningsLossPerShare" scale="0" unitRef="usdPershares" id="ixv-43160">8.8034</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total comprehensive (loss) / income attributable to:</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Equity holders of the parent</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" scale="0" sign="-" unitRef="usd" id="ixv-43161">114,009,391</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" scale="0" sign="-" unitRef="usd" id="ixv-43162">32,875,350</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" scale="0" unitRef="usd" id="ixv-43163">39,068,323</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Non-controlling interests</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests" scale="0" sign="-" unitRef="usd" id="ixv-43164">66,310,918</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests" scale="0" unitRef="usd" id="ixv-43165">2,721,213</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests" scale="0" unitRef="usd" id="ixv-43166">11,675,040</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="0" sign="-" unitRef="usd" id="ixv-43167">180,320,309</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="0" sign="-" unitRef="usd" id="ixv-43168">30,154,137</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="0" unitRef="usd" id="ixv-43169">50,743,363</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying Notes are an integral part of
these consolidated financial statements. Related parties balances and transactions are disclosed in Note 17.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>


</div><!-- Field: Page; Sequence: 119; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><div><a id="fin_003"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">CONSOLIDATED STATEMENT OF FINANCIAL POSITION</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025 and 2024</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in
US$)</b></p><div>

</div><p style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Notes</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="text-decoration:underline">ASSETS</span></td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">NON-CURRENT ASSETS</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Other financial assets</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: center">7.2</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-8">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentFinancialAssets" scale="0" unitRef="usd" id="ixv-43170">190,517</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Other receivables</td><td>&#160;</td>
    <td style="text-align: center">7.4</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentReceivables" scale="0" unitRef="usd" id="ixv-43171">664,493</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentReceivables" scale="0" unitRef="usd" id="ixv-43172">27,887,034</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Recoverable income tax</td><td>&#160;</td>
    <td style="text-align: center">4.8</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-9">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentTaxAssetsNoncurrent" scale="0" unitRef="usd" id="ixv-43173">10,889</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Deferred tax assets</td><td>&#160;</td>
    <td style="text-align: center">9</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-10">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxAssets" scale="0" unitRef="usd" id="ixv-43174">14,476,230</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Investments in joint ventures and associates</td><td>&#160;</td>
    <td style="text-align: center">13</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="mlec:InvestmentsInJointVenturesAndAssociates" scale="0" unitRef="usd" id="ixv-43175">94,147,971</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="mlec:InvestmentsInJointVenturesAndAssociates" scale="0" unitRef="usd" id="ixv-43176">92,795,851</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Property, plant and equipment</td><td>&#160;</td>
    <td style="text-align: center">7.7</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43177">3,345,170</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43178">74,612,434</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Investment properties</td><td>&#160;</td>
    <td style="text-align: center">7.10</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-11">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InvestmentProperty" scale="0" unitRef="usd" id="ixv-43179">560,783</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Intangible assets</td><td>&#160;</td>
    <td style="text-align: center">7.8</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-43180">75,258,790</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-43181">177,331,280</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Goodwill</td><td>&#160;</td>
    <td style="text-align: center">7.9</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-12">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Goodwill" scale="0" unitRef="usd" id="ixv-43182">112,163,432</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Right of use asset</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">16</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RightofuseAssets" scale="0" unitRef="usd" id="ixv-43183">100,896</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RightofuseAssets" scale="0" unitRef="usd" id="ixv-43184">11,601,752</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total non-current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentAssets" scale="0" unitRef="usd" id="ixv-43185">173,517,320</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentAssets" scale="0" unitRef="usd" id="ixv-43186">511,630,202</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">CURRENT ASSETS</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Cash and cash equivalents</td><td>&#160;</td>
    <td style="text-align: center">7.1</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalents" scale="0" unitRef="usd" id="ixv-43187">767,919</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalents" scale="0" unitRef="usd" id="ixv-43188">52,994,865</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other financial assets</td><td>&#160;</td>
    <td style="text-align: center">7.2</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentFinancialAssets" scale="0" unitRef="usd" id="ixv-43189">8,254,261</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentFinancialAssets" scale="0" unitRef="usd" id="ixv-43190">14,667,607</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Trade receivables</td><td>&#160;</td>
    <td style="text-align: center">7.3</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentTradeReceivables" scale="0" unitRef="usd" id="ixv-43191">6,085,400</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentTradeReceivables" scale="0" unitRef="usd" id="ixv-43192">209,007,195</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other receivables</td><td>&#160;</td>
    <td style="text-align: center">7.4</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentReceivables" scale="0" unitRef="usd" id="ixv-43193">13,849,164</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentReceivables" scale="0" unitRef="usd" id="ixv-43194">34,657,383</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Recoverable income tax</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-13">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentTaxAssetsCurrent" scale="0" unitRef="usd" id="ixv-43195">655,691</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Inventories</td><td>&#160;</td>
    <td style="text-align: center">7.5</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Inventories" scale="0" unitRef="usd" id="ixv-43196">2,235,482</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Inventories" scale="0" unitRef="usd" id="ixv-43197">125,929,768</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Biological assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">7.6</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-14">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentBiologicalAssets" scale="0" unitRef="usd" id="ixv-43198">294,134</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentAssets" scale="0" unitRef="usd" id="ixv-43199">31,192,226</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentAssets" scale="0" unitRef="usd" id="ixv-43200">438,206,643</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Assets" scale="0" unitRef="usd" id="ixv-43201">204,709,546</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Assets" scale="0" unitRef="usd" id="ixv-43202">949,836,845</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The accompanying Notes are an integral part of these Consolidated financial
statements. Related parties balances and transactions are disclosed in Note 17.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 120; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">CONSOLIDATED STATEMENT OF FINANCIAL POSITION</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025 and 2024</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Notes</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="text-decoration:underline">SHAREHOLDERS&#8217; DEFICIT / EQUITY</span></td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Issued capital</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: center">11</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IssuedCapital" scale="0" unitRef="usd" id="ixv-43203">1,089,176</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IssuedCapital" scale="0" unitRef="usd" id="ixv-43204">598,369</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Shared to be issued</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="mlec:ShareToBeIssuedAmount" scale="0" unitRef="usd" id="ixv-43205">77,589</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-15">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Shares premium</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="mlec:SharesPremium" scale="0" unitRef="usd" id="ixv-43206">39,668,135</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="mlec:SharesPremium" scale="0" sign="-" unitRef="usd" id="ixv-43207">5,516,907</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Own shares held</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="mlec:OwnSharesHeld" scale="0" sign="-" unitRef="usd" id="ixv-43208">422,146</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="mlec:OwnSharesHeld" scale="0" sign="-" unitRef="usd" id="ixv-43209">444,473</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock options and share based incentives</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="mlec:StockOptionsAndShareBasedIncentives" scale="0" unitRef="usd" id="ixv-43210">7,271,881</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="mlec:StockOptionsAndShareBasedIncentives" scale="0" unitRef="usd" id="ixv-43211">6,222,175</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Retained earnings / (deficit)</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RetainedEarnings" scale="0" sign="-" unitRef="usd" id="ixv-43212">110,317,946</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RetainedEarnings" scale="0" unitRef="usd" id="ixv-43213">1,142,761</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Revaluation of property, plant and equipment reserve</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="mlec:RevaluationOfPropertyPlantAndEquipmentReserve" scale="0" sign="-" unitRef="usd" id="ixv-43214">1,323,916</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="mlec:RevaluationOfPropertyPlantAndEquipmentReserve" scale="0" sign="-" unitRef="usd" id="ixv-43215">1,323,916</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Foreign currency translation reserve</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" scale="0" sign="-" unitRef="usd" id="ixv-43216">2,013,856</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" scale="0" unitRef="usd" id="ixv-43217">534,827</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Shareholders&#8217; deficit / Equity attributable to owners of the parent</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:EquityAttributableToOwnersOfParent" scale="0" sign="-" unitRef="usd" id="ixv-43218">65,971,083</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:EquityAttributableToOwnersOfParent" scale="0" unitRef="usd" id="ixv-43219">1,212,836</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Non-controlling interest</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncontrollingInterests" scale="0" sign="-" unitRef="usd" id="ixv-43220">16,902,519</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncontrollingInterests" scale="0" unitRef="usd" id="ixv-43221">248,788,534</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total shareholders&#8217; deficit / Equity</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" sign="-" unitRef="usd" id="ixv-43222">82,873,602</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd" id="ixv-43223">250,001,370</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-decoration: underline">LIABILITIES</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">NON-CURRENT LIABILITIES</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Borrowings</td><td>&#160;</td>
    <td style="text-align: center">7.12</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LongtermBorrowings" scale="0" unitRef="usd" id="ixv-43224">1,348,173</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LongtermBorrowings" scale="0" unitRef="usd" id="ixv-43225">127,248,305</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Deferred revenue and advances from customers</td><td>&#160;</td>
    <td style="text-align: center">7.15</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-16">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentContractLiabilities" scale="0" unitRef="usd" id="ixv-43226">1,925,138</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Government grants</td><td>&#160;</td>
    <td style="text-align: center">7.17</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-17">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentGovernmentGrants" scale="0" unitRef="usd" id="ixv-43227">782</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Joint ventures and associates</td><td>&#160;</td>
    <td style="text-align: center">13</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-18">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="mlec:JointVenturesAndAssociatesLiabilities" scale="0" unitRef="usd" id="ixv-43228">296,455</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred tax liabilities</td><td>&#160;</td>
    <td style="text-align: center">9</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxLiabilities" scale="0" unitRef="usd" id="ixv-43229">15,767,275</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxLiabilities" scale="0" unitRef="usd" id="ixv-43230">34,500,445</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Provisions</td><td>&#160;</td>
    <td style="text-align: center">7.16</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentProvisions" scale="0" unitRef="usd" id="ixv-43231">16,154,574</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentProvisions" scale="0" unitRef="usd" id="ixv-43232">17,484,715</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Consideration for acquisition</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-19">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="mlec:ConsiderationForAcquisitionOfAssetsNonCurrent" scale="0" unitRef="usd" id="ixv-43233">2,005,143</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Convertible and non-convertible notes</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="mlec:SecuredDebtNonCurrent" scale="0" unitRef="usd" id="ixv-43234">18,260,456</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="mlec:SecuredDebtNonCurrent" scale="0" unitRef="usd" id="ixv-43235">80,809,686</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Lease liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">16</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-20">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentLeaseLiabilities" scale="0" unitRef="usd" id="ixv-43236">8,161,359</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total non-current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentLiabilities" scale="0" unitRef="usd" id="ixv-43237">51,530,478</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentLiabilities" scale="0" unitRef="usd" id="ixv-43238">272,432,028</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">CURRENT LIABILITIES</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Trade and other payables</td><td>&#160;</td>
    <td style="text-align: center">7.11</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentPayables" scale="0" unitRef="usd" id="ixv-43239">7,323,933</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentPayables" scale="0" unitRef="usd" id="ixv-43240">168,937,536</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Borrowings</td><td>&#160;</td>
    <td style="text-align: center">7.12</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermBorrowings" scale="0" unitRef="usd" id="ixv-43241">227,154,007</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermBorrowings" scale="0" unitRef="usd" id="ixv-43242">234,510,751</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Employee benefits and social security</td><td>&#160;</td>
    <td style="text-align: center">7.14</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentProvisionsForEmployeeBenefits" scale="0" unitRef="usd" id="ixv-43243">243,634</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentProvisionsForEmployeeBenefits" scale="0" unitRef="usd" id="ixv-43244">7,506,831</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Deferred revenue and advances from customers</td><td>&#160;</td>
    <td style="text-align: center">7.15</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentDeferredIncomeIncludingCurrentContractLiabilities" scale="0" unitRef="usd" id="ixv-43245">1,260</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentDeferredIncomeIncludingCurrentContractLiabilities" scale="0" unitRef="usd" id="ixv-43246">3,924,801</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Income tax payable</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-21">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentTaxLiabilitiesCurrent" scale="0" unitRef="usd" id="ixv-43247">4,825,271</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Government grants</td><td>&#160;</td>
    <td style="text-align: center">7.17</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentGovernmentGrants" scale="0" unitRef="usd" id="ixv-43248">1,280</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentGovernmentGrants" scale="0" unitRef="usd" id="ixv-43249">3,655</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrant liabilities</td><td>&#160;</td>
    <td style="text-align: center">7.18</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentWarrantLiability" scale="0" unitRef="usd" id="ixv-43250">1,211,093</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-22">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Consideration for acquisition</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-23">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="mlec:ConsiderationForAcquisitionOfAssetsCurrent" scale="0" unitRef="usd" id="ixv-43251">4,571,824</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Lease liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">16</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentLeaseLiabilities" scale="0" unitRef="usd" id="ixv-43252">117,463</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentLeaseLiabilities" scale="0" unitRef="usd" id="ixv-43253">3,122,778</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentLiabilities" scale="0" unitRef="usd" id="ixv-43254">236,052,670</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentLiabilities" scale="0" unitRef="usd" id="ixv-43255">427,403,447</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Liabilities" scale="0" unitRef="usd" id="ixv-43256">287,583,148</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Liabilities" scale="0" unitRef="usd" id="ixv-43257">699,835,475</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total shareholders&#8217; deficit / equity and liabilities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:EquityAndLiabilities" scale="0" unitRef="usd" id="ixv-43258">204,709,546</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:EquityAndLiabilities" scale="0" unitRef="usd" id="ixv-43259">949,836,845</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying Notes are an integral part of
these Consolidated financial statements. Related parties balances and transactions are disclosed in Note 17.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>


</div><!-- Field: Page; Sequence: 121; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="fin_004"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS&#8217;
DEFICIT / EQUITY</span></b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>For the years ended June 30, 2025, 2024 and
2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="30" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Attributable to the equity holders of
    the parent</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 8pt">Issued<br/>
capital</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 8pt">Shares&#160;to<br/>
 be&#160;issued</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 8pt">Own<br/>
shares&#160;held</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 8pt">Share<br/>

    premium</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 8pt">Stock<br/>
options<br/>
and share<br/>
based<br/>
incentives</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 8pt">Retained<br/>
(deficit)<br/>
earnings</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 8pt">Foreign<br/>
currency<br/>
translation<br/>
reserve</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 8pt">Revaluation<br/>
of PP&amp;E<br/>
and effect<br/>
of tax rate<br/>
change</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 8pt">Attributable<br/>
    to the equity<br/>
holders of<br/>
the parent</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 8pt">Non-controlling<br/>
Interests</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 8pt">Total
    <br/>
shareholders&#8217;<br/>
 deficit / equity</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; width: 17.5%"><span style="font-size: 8pt">06/30/2024</span></td><td style="width: 0.5%; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 6%; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd" id="ixv-43260">598,369</ix:nonFraction></span></td><td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 0.5%; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 6%; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: hidden-fact-24; font-size: 8pt">-</span></td><td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 0.5%; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 6%; font-weight: bold; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-size: 8pt">(<ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" sign="-" unitRef="usd" id="ixv-43261">444,473</ix:nonFraction></span></td><td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td><td style="width: 0.5%; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 6%; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" sign="-" unitRef="usd" id="ixv-43262">5,516,907</ix:nonFraction></span></td><td style="width: 0.5%; font-weight: bold; text-align: left">)<span style="font-size: 8pt">&#160;</span></td><td style="width: 0.5%; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 6%; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd" id="ixv-43263">6,222,175</ix:nonFraction></span></td><td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 0.5%; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 6%; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd" id="ixv-43264">1,142,761</ix:nonFraction></span></td><td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 0.5%; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 6%; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd" id="ixv-43265">534,827</ix:nonFraction></span></td><td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 0.5%; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 6%; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" sign="-" unitRef="usd" id="ixv-43266">1,323,916</ix:nonFraction></span></td><td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td><td style="width: 0.5%; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 6%; font-weight: bold; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-size: 8pt"><ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd" id="ixv-43267">1,212,836</ix:nonFraction></span></td><td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 0.5%; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 6%; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c17" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd" id="ixv-43268">248,788,534</ix:nonFraction></span></td><td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 0.5%; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 6%; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd" id="ixv-43269">250,001,370</ix:nonFraction></span></td><td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 8pt">Increase in capital</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c18" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" scale="0" unitRef="usd" id="ixv-43270">111,345</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-25; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-26; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c21" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" scale="0" unitRef="usd" id="ixv-43271">346,160</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-27; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-28; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-29; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-30; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c26" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" scale="0" unitRef="usd" id="ixv-43272">457,505</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-31; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" scale="0" unitRef="usd" id="ixv-43273">457,505</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 8pt">Changes in ownership interests&#160;in&#160;subsidiaries</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-32; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-33; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" scale="0" unitRef="usd" id="ixv-43274">22,327</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c21" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" scale="0" unitRef="usd" id="ixv-43275">11,791,403</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-34; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-35; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-36; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-37; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c26" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" scale="0" unitRef="usd" id="ixv-43276">11,813,730</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c27" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" scale="0" unitRef="usd" id="ixv-43277">11,416,836</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" scale="0" unitRef="usd" id="ixv-43278">23,230,566</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 8pt">Share-based incentives of subsidiaries</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-38; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-39; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-40; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-41; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c22" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="0" unitRef="usd" id="ixv-43279">1,049,706</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-42; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-43; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-44; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c26" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="0" unitRef="usd" id="ixv-43280">1,049,706</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c27" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="0" unitRef="usd" id="ixv-43281">3,326,658</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="0" unitRef="usd" id="ixv-43282">4,376,364</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 8pt">Business&#160;combination</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c18" decimals="0" format="ixt:num-dot-decimal" name="mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity" scale="0" unitRef="usd" id="ixv-43283">379,462</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c19" decimals="0" format="ixt:num-dot-decimal" name="mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity" scale="0" unitRef="usd" id="ixv-43284">77,589</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-45; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><ix:nonFraction contextRef="c21" decimals="0" format="ixt:num-dot-decimal" name="mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity" scale="0" unitRef="usd" id="ixv-43285">33,047,480</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-46; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-47; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-48; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-49; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c26" decimals="0" format="ixt:num-dot-decimal" name="mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity" scale="0" unitRef="usd" id="ixv-43286">33,504,531</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c27" decimals="0" format="ixt:num-dot-decimal" name="mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity" scale="0" unitRef="usd" id="ixv-43287">6,316,790</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity" scale="0" unitRef="usd" id="ixv-43288">39,821,321</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 8pt">BIOX  deconsolidation</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-50; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-51; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-52; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-53; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-54; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-55; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-56; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-57; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-58; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c27" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughOtherDistributionsToOwners" scale="0" unitRef="usd" id="ixv-43289">220,368,368</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;&#160;&#160;(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughOtherDistributionsToOwners" scale="0" unitRef="usd" id="ixv-43290">220,368,368</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 8pt">Distribution of dividends</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-59; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-60; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-61; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-62; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-63; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-64; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-65; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-66; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-67; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c27" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DividendsPaid" scale="0" unitRef="usd" id="ixv-43291">72,051</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DividendsPaid" scale="0" unitRef="usd" id="ixv-43292">72,051</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 8pt">Loss for the year</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-68; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-69; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-70; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-71; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-72; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c23" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" sign="-" unitRef="usd" id="ixv-43293">111,460,708</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-73; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-74; font-size: 8pt">-</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c26" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" sign="-" unitRef="usd" id="ixv-43294">111,460,708</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c27" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" sign="-" unitRef="usd" id="ixv-43295">65,178,892</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" sign="-" unitRef="usd" id="ixv-43296">176,639,600</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 8pt">Other comprehensive loss</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-75; font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-76; font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-77; font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-78; font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-79; font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-80; font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c24" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeBeforeTax" scale="0" sign="-" unitRef="usd" id="ixv-43297">2,548,683</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-81; font-size: 8pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c26" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeBeforeTax" scale="0" sign="-" unitRef="usd" id="ixv-43298">2,548,683</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c27" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeBeforeTax" scale="0" sign="-" unitRef="usd" id="ixv-43299">1,132,026</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 8pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeBeforeTax" scale="0" sign="-" unitRef="usd" id="ixv-43300">3,680,709</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold"><span style="font-size: 8pt">06/30/2025</span></td><td style="padding-bottom: 2.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c28" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd" id="ixv-43301">1,089,176</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-size: 8pt">&#160;&#160;&#160;&#160;&#160;<ix:nonFraction contextRef="c29" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd" id="ixv-43302">77,589</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c30" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" sign="-" unitRef="usd" id="ixv-43303">422,146</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td><td style="padding-bottom: 2.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c31" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd" id="ixv-43304">39,668,136</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c32" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd" id="ixv-43305">7,271,881</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 2.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c33" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" sign="-" unitRef="usd" id="ixv-43306">110,317,947</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td><td style="padding-bottom: 2.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c34" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" sign="-" unitRef="usd" id="ixv-43307">2,013,856</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td><td style="padding-bottom: 2.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c35" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" sign="-" unitRef="usd" id="ixv-43308">1,323,916</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td><td style="padding-bottom: 2.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c36" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" sign="-" unitRef="usd" id="ixv-43309">65,971,083</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td><td style="padding-bottom: 2.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c37" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" sign="-" unitRef="usd" id="ixv-43310">16,902,519</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td><td style="padding-bottom: 2.5pt; font-weight: bold"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" sign="-" unitRef="usd" id="ixv-43311">82,873,602</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 8pt">)</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying Notes are an integral part of
these consolidated financial statements. Related parties balances and transactions are disclosed in Note 17.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>


</div><!-- Field: Page; Sequence: 122; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS&#8217;
DEFICIT / EQUITY</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>For the years ended June 30, 2025, 2024 and
2023</b></p><div>

</div><div style="padding: 0in; border-bottom: Black 1.5pt solid">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="26" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Attributable
    to the equity holders of the parent</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Issued<br/>
    capital</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Own<br/>
    shares&#160;held</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Share<br/>
    premium</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Stock<br/>
    options<br/>
    and share<br/>
    based<br/>
    incentives</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Retained<br/>
    (deficit) /<br/>
    earnings</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Foreign<br/>
    currency<br/>
    translation<br/>
    reserve</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Revaluation<br/>
    of PP&amp;E<br/>
    and effect<br/>
    of tax rate<br/>
    change</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Attributable<br/>
    to the equity<br/>
    holders of<br/>
    the parent</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Non-controlling<br/>
    Interests</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Total<br/>
    equity</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">06/30/2023</span></td><td style="width: 0.5%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="width: 7%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction contextRef="c38" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd" id="ixv-43312">530,170</ix:nonFraction></span></td><td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="width: 0.5%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="width: 7%; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: hidden-fact-82; font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td><td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="width: 0.5%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="width: 7%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(<ix:nonFraction contextRef="c40" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" sign="-" unitRef="usd" id="ixv-43313">12,021,426</ix:nonFraction></span></td><td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td><td style="width: 0.5%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="width: 7%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction contextRef="c41" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd" id="ixv-43314">1,853,856</ix:nonFraction></span></td><td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="width: 0.5%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="width: 7%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction contextRef="c42" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd" id="ixv-43315">33,828,159</ix:nonFraction></span></td><td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="width: 0.5%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="width: 7%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction contextRef="c43" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd" id="ixv-43316">724,779</ix:nonFraction></span></td><td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="width: 0.5%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="width: 7%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(<ix:nonFraction contextRef="c44" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" sign="-" unitRef="usd" id="ixv-43317">1,323,916</ix:nonFraction></span></td><td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td><td style="width: 0.5%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="width: 7%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction contextRef="c45" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd" id="ixv-43318">23,591,622</ix:nonFraction></span></td><td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="width: 0.5%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="width: 7%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction contextRef="c46" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd" id="ixv-43319">234,978,480</ix:nonFraction></span></td><td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="width: 0.5%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="width: 7%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction contextRef="c47" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd" id="ixv-43320">258,570,102</ix:nonFraction></span></td><td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Increase
    in capital</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction contextRef="c48" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" scale="0" unitRef="usd" id="ixv-43321">68,199</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c49" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" scale="0" sign="-" unitRef="usd" id="ixv-43322">7,319</ix:nonFraction></span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction contextRef="c50" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" scale="0" unitRef="usd" id="ixv-43323">206,720</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-83; font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-84; font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-85; font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-86; font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction contextRef="c55" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" scale="0" unitRef="usd" id="ixv-43324">267,600</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-87; font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" scale="0" unitRef="usd" id="ixv-43325">267,600</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Changes
    in ownership interests in subsidiaries</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-88; font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(<ix:nonFraction contextRef="c49" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" scale="0" sign="-" unitRef="usd" id="ixv-43326">437,154</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction contextRef="c50" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" scale="0" unitRef="usd" id="ixv-43327">6,297,799</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-89; font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-90; font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-91; font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-92; font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction contextRef="c55" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" scale="0" unitRef="usd" id="ixv-43328">5,860,645</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction contextRef="c56" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" scale="0" unitRef="usd" id="ixv-43329">557,267</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" scale="0" unitRef="usd" id="ixv-43330">6,417,912</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Share-based
    incentives of subsidiaries</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-93; font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-94; font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-95; font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction contextRef="c51" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="0" unitRef="usd" id="ixv-43331">4,368,319</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-96; font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-97; font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-98; font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction contextRef="c55" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="0" unitRef="usd" id="ixv-43332">4,368,319</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction contextRef="c56" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="0" unitRef="usd" id="ixv-43333">9,592,291</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="0" unitRef="usd" id="ixv-43334">13,960,610</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Business&#160;combination</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-99; font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-100; font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-101; font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-102; font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-103; font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-104; font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-105; font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-106; font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction contextRef="c56" decimals="0" format="ixt:num-dot-decimal" name="mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity" scale="0" unitRef="usd" id="ixv-43335">1,114,083</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity" scale="0" unitRef="usd" id="ixv-43336">1,114,083</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Distribution
    of dividends</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-107; font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-108; font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-109; font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-110; font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-111; font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-112; font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-113; font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-114; font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(<ix:nonFraction contextRef="c56" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DividendsPaid" scale="0" unitRef="usd" id="ixv-43337">174,800</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DividendsPaid" scale="0" unitRef="usd" id="ixv-43338">174,800</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(Loss)
    / Profit for the year</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-115; font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-116; font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-117; font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-118; font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(<ix:nonFraction contextRef="c52" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" sign="-" unitRef="usd" id="ixv-43339">32,685,398</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-119; font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-120; font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(<ix:nonFraction contextRef="c55" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" sign="-" unitRef="usd" id="ixv-43340">32,685,398</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction contextRef="c56" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" unitRef="usd" id="ixv-43341">3,624,094</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" sign="-" unitRef="usd" id="ixv-43342">29,061,304</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Other
    comprehensive loss</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-121; font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-122; font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-123; font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-124; font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-125; font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(<ix:nonFraction contextRef="c53" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeBeforeTax" scale="0" sign="-" unitRef="usd" id="ixv-43343">189,952</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-126; font-family: Times New Roman, Times, Serif; font-size: 9pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(<ix:nonFraction contextRef="c55" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeBeforeTax" scale="0" sign="-" unitRef="usd" id="ixv-43344">189,952</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(<ix:nonFraction contextRef="c56" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeBeforeTax" scale="0" sign="-" unitRef="usd" id="ixv-43345">902,881</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeBeforeTax" scale="0" sign="-" unitRef="usd" id="ixv-43346">1,092,833</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">06/30/2024</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd" id="ixv-43347">598,369</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(<ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" sign="-" unitRef="usd" id="ixv-43348">444,473</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(<ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" sign="-" unitRef="usd" id="ixv-43349">5,516,907</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd" id="ixv-43350">6,222,175</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd" id="ixv-43351">1,142,761</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd" id="ixv-43352">534,827</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(<ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" sign="-" unitRef="usd" id="ixv-43353">1,323,916</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">)</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd" id="ixv-43354">1,212,836</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction contextRef="c17" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd" id="ixv-43355">248,788,534</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd" id="ixv-43356">250,001,370</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">The accompanying Notes are an integral part of
these consolidated financial statements. Related parties balances and transactions are disclosed in Note 17.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 123; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS&#8217;
DEFICIT / EQUITY</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>For the years ended June 30, 2025, 2024 and
2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in
US$)</b></p><div>

</div><p style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="22" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 9pt">Attributable
    to the equity holders of the parent</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: center"><span style="font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 9pt">Issued<br/>
    capital</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 9pt">Share<br/>
    premium</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 9pt">Stock<br/>
    options<br/>
    and share<br/>
    based<br/>
    incentives</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 9pt">Retained<br/>
    (deficit) /<br/>
    earnings</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 9pt">Foreign<br/>
    currency<br/>
    translation<br/>
    reserve</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 9pt">Revaluation<br/>
    of PP&amp;E<br/>
    and effect<br/>
    of tax rate<br/>
    change</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 9pt">Attributable<br/>
    to the equity<br/>
    holders of<br/>
    the parent</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 9pt">Non-controlling<br/>
    Interests</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 9pt">Total
    <br/>
    equity</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td colspan="2"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 23.5%; font-weight: bold"><span style="font-size: 9pt">06/30/2022</span></td><td style="width: 0.5%; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 7%; font-weight: bold; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c57" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd" id="ixv-43357">326,694</ix:nonFraction></span></td><td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 0.5%; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 7%; font-weight: bold; text-align: right"><span style="font-size: 9pt">(<ix:nonFraction contextRef="c58" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" sign="-" unitRef="usd" id="ixv-43358">7,566,943</ix:nonFraction></span></td><td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-size: 9pt">)</span></td><td style="width: 0.5%; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 7%; font-weight: bold; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c59" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd" id="ixv-43359">777,376</ix:nonFraction></span></td><td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 0.5%; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 7%; font-weight: bold; text-align: right"><span style="font-size: 9pt">(<ix:nonFraction contextRef="c60" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" sign="-" unitRef="usd" id="ixv-43360">6,607,764</ix:nonFraction></span></td><td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-size: 9pt">)</span></td><td style="width: 0.5%; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 7%; font-weight: bold; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c61" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd" id="ixv-43361">1,773,218</ix:nonFraction></span></td><td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 0.5%; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 7%; font-weight: bold; text-align: right"><span style="font-size: 9pt">(<ix:nonFraction contextRef="c62" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" sign="-" unitRef="usd" id="ixv-43362">1,004,755</ix:nonFraction></span></td><td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-size: 9pt">)</span></td><td style="width: 0.5%; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 7%; font-weight: bold; text-align: right"><span style="font-size: 9pt">(<ix:nonFraction contextRef="c63" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" sign="-" unitRef="usd" id="ixv-43363">12,302,174</ix:nonFraction></span></td><td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-size: 9pt">)</span></td><td style="width: 0.5%; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 7%; font-weight: bold; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c64" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd" id="ixv-43364">137,171,291</ix:nonFraction></span></td><td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 0.5%; font-weight: bold"><span style="font-size: 9pt">&#160;</span></td>
    <td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="width: 7%; font-weight: bold; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c65" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd" id="ixv-43365">124,869,117</ix:nonFraction></span></td><td style="width: 0.5%; font-weight: bold; text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-size: 9pt">Increase in capital</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c66" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" scale="0" unitRef="usd" id="ixv-43366">203,476</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c67" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" scale="0" unitRef="usd" id="ixv-43367">555,760</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-127; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-128; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-129; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-130; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c72" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" scale="0" unitRef="usd" id="ixv-43368">759,236</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-131; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" scale="0" unitRef="usd" id="ixv-43369">759,236</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-size: 9pt">Changes in ownership interests
    in subsidiaries</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-132; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">(<ix:nonFraction contextRef="c67" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" scale="0" sign="-" unitRef="usd" id="ixv-43370">29,474,351</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">)</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-133; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-134; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-135; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-136; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;&#160;(<ix:nonFraction contextRef="c72" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" scale="0" sign="-" unitRef="usd" id="ixv-43371">29,474,351</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">)</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">(<ix:nonFraction contextRef="c73" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" scale="0" sign="-" unitRef="usd" id="ixv-43372">46,940,078</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">)</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" scale="0" sign="-" unitRef="usd" id="ixv-43373">76,414,429</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-size: 9pt">Business&#160;combination</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-137; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c67" decimals="0" format="ixt:num-dot-decimal" name="mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity" scale="0" unitRef="usd" id="ixv-43374">24,464,108</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-138; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-139; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-140; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-141; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c72" decimals="0" format="ixt:num-dot-decimal" name="mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity" scale="0" unitRef="usd" id="ixv-43375">24,464,108</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c73" decimals="0" format="ixt:num-dot-decimal" name="mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity" scale="0" unitRef="usd" id="ixv-43376">130,515,236</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity" scale="0" unitRef="usd" id="ixv-43377">154,979,344</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-size: 9pt">Share-based incentives of
    subsidiaries</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-142; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-143; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c68" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="0" unitRef="usd" id="ixv-43378">1,076,480</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-144; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-145; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-146; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c72" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="0" unitRef="usd" id="ixv-43379">1,076,480</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c73" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="0" unitRef="usd" id="ixv-43380">3,009,120</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" scale="0" unitRef="usd" id="ixv-43381">4,085,600</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 9pt">Distribution of dividends</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-147; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-148; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-149; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-150; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-151; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-152; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-153; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">(<ix:nonFraction contextRef="c73" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DividendsPaid" scale="0" unitRef="usd" id="ixv-43382">452,129</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">)</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DividendsPaid" scale="0" unitRef="usd" id="ixv-43383">452,129</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"><span style="font-size: 9pt">Profit for the year</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-154; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-155; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-156; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c69" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" unitRef="usd" id="ixv-43384">40,435,923</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-157; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-158; font-size: 9pt">-</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c72" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" unitRef="usd" id="ixv-43385">40,435,923</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c73" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" unitRef="usd" id="ixv-43386">12,686,685</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" unitRef="usd" id="ixv-43387">53,122,608</ix:nonFraction></span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-size: 9pt">Other&#160;comprehensive&#160;loss</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-159; font-size: 9pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-160; font-size: 9pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-161; font-size: 9pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-162; font-size: 9pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">(<ix:nonFraction contextRef="c70" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeBeforeTax" scale="0" sign="-" unitRef="usd" id="ixv-43388">1,048,439</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">(<ix:nonFraction contextRef="c71" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeBeforeTax" scale="0" sign="-" unitRef="usd" id="ixv-43389">319,161</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">(<ix:nonFraction contextRef="c72" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeBeforeTax" scale="0" sign="-" unitRef="usd" id="ixv-43390">1,367,600</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">(<ix:nonFraction contextRef="c73" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeBeforeTax" scale="0" sign="-" unitRef="usd" id="ixv-43391">1,011,645</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-size: 9pt">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeBeforeTax" scale="0" sign="-" unitRef="usd" id="ixv-43392">2,379,245</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 9pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 9pt">06/30/2023</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c38" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd" id="ixv-43393">530,170</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-size: 9pt">(<ix:nonFraction contextRef="c40" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" sign="-" unitRef="usd" id="ixv-43394">12,021,426</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 9pt">)</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c41" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd" id="ixv-43395">1,853,856</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c42" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd" id="ixv-43396">33,828,159</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c43" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd" id="ixv-43397">724,779</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-size: 9pt">(<ix:nonFraction contextRef="c44" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" sign="-" unitRef="usd" id="ixv-43398">1,323,916</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 9pt">)</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c45" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd" id="ixv-43399">23,591,622</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c46" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd" id="ixv-43400">234,978,480</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><span style="font-size: 9pt">&#160;</span></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="font-size: 9pt"><ix:nonFraction contextRef="c47" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd" id="ixv-43401">258,570,102</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-size: 9pt">&#160;</span></td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">The accompanying Notes are an integral part of
these consolidated financial statements. Related parties balances and transactions are disclosed in Note 17.</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><b>&#160;</b></p><div>


</div><!-- Field: Page; Sequence: 124; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><div><a id="fin_005"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">CONSOLIDATED STATEMENT OF CASH FLOWS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>For the years ended June 30, 2025 2024 and 2023<br/>
(Amounts in US$)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Notes</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="text-decoration:underline">OPERATING ACTIVITIES</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; text-indent: -0.125in; padding-left: 0.125in">(Loss) / profit for the year</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: center">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" sign="-" unitRef="usd" id="ixv-43402">176,639,600</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" sign="-" unitRef="usd" id="ixv-43403">29,061,304</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" unitRef="usd" id="ixv-43404">53,122,608</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Adjustments to reconcile (loss) / profit to net cash flows</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Income tax</td><td>&#160;</td>
    <td style="text-align: center">9</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForIncomeTaxExpense" scale="0" unitRef="usd" id="ixv-43405">6,636,121</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForIncomeTaxExpense" scale="0" unitRef="usd" id="ixv-43406">1,103,152</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForIncomeTaxExpense" scale="0" sign="-" unitRef="usd" id="ixv-43407">2,328,366</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Depreciation of property, plant and equipment</td><td>&#160;</td>
    <td style="text-align: center">7.7</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDepreciationExpense" scale="0" unitRef="usd" id="ixv-43408">6,015,700</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDepreciationExpense" scale="0" unitRef="usd" id="ixv-43409">5,799,998</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDepreciationExpense" scale="0" unitRef="usd" id="ixv-43410">4,938,927</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Amortization of intangible assets</td><td>&#160;</td>
    <td style="text-align: center">7.8</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:AmortizationOfIntangibleAsset" scale="0" unitRef="usd" id="ixv-43411">11,201,048</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="mlec:AmortizationOfIntangibleAsset" scale="0" unitRef="usd" id="ixv-43412">12,113,223</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:AmortizationOfIntangibleAsset" scale="0" unitRef="usd" id="ixv-43413">11,004,584</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Depreciation of leased assets</td><td>&#160;</td>
    <td style="text-align: center">16</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:DepreciationOfLeasedAssets" scale="0" unitRef="usd" id="ixv-43414">5,036,703</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="mlec:DepreciationOfLeasedAssets" scale="0" unitRef="usd" id="ixv-43415">3,418,956</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:DepreciationOfLeasedAssets" scale="0" unitRef="usd" id="ixv-43416">3,565,894</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Gain from a bargain purchase</td><td>&#160;</td>
    <td style="text-align: center">6</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForFairValueGainsLosses" scale="0" sign="-" unitRef="usd" id="ixv-43417">1,473,482</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-163">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-164">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Remeasurement of previously held interest</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:RemeasurementOfPreviouslyHeldInterest" scale="0" unitRef="usd" id="ixv-43418">1,666,680</ix:nonFraction></p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-165">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-166">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Share-based incentive and stock options</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForSharebasedPayments" scale="0" unitRef="usd" id="ixv-43419">4,386,688</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForSharebasedPayments" scale="0" unitRef="usd" id="ixv-43420">14,199,480</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForSharebasedPayments" scale="0" unitRef="usd" id="ixv-43421">3,480,178</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Share of profit or loss of joint ventures and associates</td><td>&#160;</td>
    <td style="text-align: center">13</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="0" sign="-" unitRef="usd" id="ixv-43422">36,927,610</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="0" sign="-" unitRef="usd" id="ixv-43423">21,023,150</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="0" unitRef="usd" id="ixv-43424">47,709,605</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Provisions for contingencies</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:ProvisionsForContingencies" scale="0" unitRef="usd" id="ixv-43425">336,919</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="mlec:ProvisionsForContingencies" scale="0" unitRef="usd" id="ixv-43426">653,574</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:ProvisionsForContingencies" scale="0" unitRef="usd" id="ixv-43427">239,292</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Allowance for impairment of trade debtors</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:AllowanceForImpairmentOfTradeDebtors" scale="0" unitRef="usd" id="ixv-43428">7,123,716</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="mlec:AllowanceForImpairmentOfTradeDebtors" scale="0" unitRef="usd" id="ixv-43429">753,428</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:AllowanceForImpairmentOfTradeDebtors" scale="0" unitRef="usd" id="ixv-43430">1,327,385</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Allowance for obsolescence</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:AllowanceForObsolescences" scale="0" unitRef="usd" id="ixv-43431">1,547,723</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="mlec:AllowanceForObsolescences" scale="0" unitRef="usd" id="ixv-43432">586,515</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:AllowanceForObsolescences" scale="0" unitRef="usd" id="ixv-43433">1,066,777</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Initial recognition and changes in the fair value of biological assets</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets" scale="0" sign="-" unitRef="usd" id="ixv-43434">1,764,863</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets" scale="0" unitRef="usd" id="ixv-43435">45,746</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets" scale="0" sign="-" unitRef="usd" id="ixv-43436">610,554</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Changes in the net realizable value of agricultural products after harvest</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnChangeInFairValueEstimatesOfBiologicalAssetsForCurrentPeriod" scale="0" sign="-" unitRef="usd" id="ixv-43437">1,541,204</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnChangeInFairValueEstimatesOfBiologicalAssetsForCurrentPeriod" scale="0" sign="-" unitRef="usd" id="ixv-43438">2,385,069</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnChangeInFairValueEstimatesOfBiologicalAssetsForCurrentPeriod" scale="0" sign="-" unitRef="usd" id="ixv-43439">4,351,433</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Financial results</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForFinanceCosts" scale="0" unitRef="usd" id="ixv-43440">65,853,350</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForFinanceCosts" scale="0" unitRef="usd" id="ixv-43441">47,243,134</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForFinanceCosts" scale="0" sign="-" unitRef="usd" id="ixv-43442">47,251,388</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Gain on sale of equipment and intangible assets</td><td>&#160;</td>
    <td style="text-align: center">8.6</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" scale="0" sign="-" unitRef="usd" id="ixv-43443">7,649,848</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" scale="0" sign="-" unitRef="usd" id="ixv-43444">125,464</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-167">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Working capital adjustments</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Trade receivables</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" scale="0" unitRef="usd" id="ixv-43445">26,040,164</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" scale="0" sign="-" unitRef="usd" id="ixv-43446">41,256,269</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" scale="0" sign="-" unitRef="usd" id="ixv-43447">14,179,711</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Other receivables</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" scale="0" unitRef="usd" id="ixv-43448">2,039,034</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" scale="0" sign="-" unitRef="usd" id="ixv-43449">6,338,099</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" scale="0" sign="-" unitRef="usd" id="ixv-43450">36,705,492</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Inventories and biological assets</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" scale="0" unitRef="usd" id="ixv-43451">34,880,985</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" scale="0" unitRef="usd" id="ixv-43452">15,285,866</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" scale="0" sign="-" unitRef="usd" id="ixv-43453">8,572,529</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Trade and other payables</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" scale="0" sign="-" unitRef="usd" id="ixv-43454">18,847,998</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" scale="0" unitRef="usd" id="ixv-43455">16,286,414</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" scale="0" unitRef="usd" id="ixv-43456">14,172,818</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Employee benefits and social security</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" scale="0" sign="-" unitRef="usd" id="ixv-43457">1,089,185</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" scale="0" sign="-" unitRef="usd" id="ixv-43458">2,413,413</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" scale="0" unitRef="usd" id="ixv-43459">2,074,795</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Government grants</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:AdjustmentsForDecreaseIncreaseInGovernmentGrants" scale="0" sign="-" unitRef="usd" id="ixv-43460">3,157</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="mlec:AdjustmentsForDecreaseIncreaseInGovernmentGrants" scale="0" sign="-" unitRef="usd" id="ixv-43461">188,518</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:AdjustmentsForDecreaseIncreaseInGovernmentGrants" scale="0" sign="-" unitRef="usd" id="ixv-43462">93,091</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Income tax paid</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-168">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities" scale="0" unitRef="usd" id="ixv-43463">853,299</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities" scale="0" unitRef="usd" id="ixv-43464">4,072,347</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Deferred revenue and advances from customers</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">7.15</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities" scale="0" sign="-" unitRef="usd" id="ixv-43465">129,099</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities" scale="0" sign="-" unitRef="usd" id="ixv-43466">21,103,777</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities" scale="0" unitRef="usd" id="ixv-43467">21,019,535</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Net cash flows generated by / (used in) operating activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" scale="0" unitRef="usd" id="ixv-43468">3,636,413</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" scale="0" unitRef="usd" id="ixv-43469">39,557,562</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" scale="0" sign="-" unitRef="usd" id="ixv-43470">41,158,857</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  </table><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying Notes are an integral part of
these consolidated financial statements. Related parties balances and transactions are disclosed in Note 17.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>


</div><!-- Field: Page; Sequence: 125; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">CONSOLIDATED STATEMENT OF CASH FLOWS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>For the years ended June 30, 2025, 2024 and
2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Notes</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="text-decoration:underline">INVESTMENT ACTIVITIES</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Proceeds from sale of property, plant and equipment</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: center">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="0" unitRef="usd" id="ixv-43471">390,381</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="0" unitRef="usd" id="ixv-43472">336,726</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="0" unitRef="usd" id="ixv-43473">137,357</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Investment in joint ventures and associates</td><td>&#160;</td>
    <td style="text-align: center">13</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-169">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-170">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCashReceiptsFromSalesOfInterestsInJointVenturesClassifiedAsInvestingActivities" scale="0" unitRef="usd" id="ixv-43474">1,085,676</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net cash received from business combination</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" scale="0" unitRef="usd" id="ixv-43475">554,420</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" scale="0" unitRef="usd" id="ixv-43476">37,508</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" scale="0" unitRef="usd" id="ixv-43477">4,373,265</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Loss of controlling interest</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" scale="0" unitRef="usd" id="ixv-43478">32,695,079</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" scale="0" unitRef="usd" id="ixv-43479">18,097</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" scale="0" unitRef="usd" id="ixv-43480">1,081,808</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds from financial assets</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities" scale="0" unitRef="usd" id="ixv-43481">21,731,347</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities" scale="0" unitRef="usd" id="ixv-43482">62,836,432</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities" scale="0" unitRef="usd" id="ixv-43483">1,316,980</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Investment in financial assets</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod" scale="0" unitRef="usd" id="ixv-43484">11,351,880</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod" scale="0" unitRef="usd" id="ixv-43485">65,567,062</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod" scale="0" unitRef="usd" id="ixv-43486">8,488,144</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Purchase of property, plant and equipment</td><td>&#160;</td>
    <td style="text-align: center">7.7</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="0" unitRef="usd" id="ixv-43487">5,651,506</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="0" unitRef="usd" id="ixv-43488">9,936,611</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="0" unitRef="usd" id="ixv-43489">11,491,899</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Capitalized development expenditures</td><td>&#160;</td>
    <td style="text-align: center">8.3</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PaymentsForDevelopmentProjectExpenditure" scale="0" unitRef="usd" id="ixv-43490">8,614,448</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PaymentsForDevelopmentProjectExpenditure" scale="0" unitRef="usd" id="ixv-43491">11,855,766</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PaymentsForDevelopmentProjectExpenditure" scale="0" unitRef="usd" id="ixv-43492">10,753,047</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Purchase of intangible assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">7.8</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" scale="0" unitRef="usd" id="ixv-43493">350,843</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" scale="0" unitRef="usd" id="ixv-43494">3,233,316</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" scale="0" unitRef="usd" id="ixv-43495">688,287</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net cash flows used in investing activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" scale="0" sign="-" unitRef="usd" id="ixv-43496">35,987,608</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" scale="0" sign="-" unitRef="usd" id="ixv-43497">27,400,186</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" scale="0" sign="-" unitRef="usd" id="ixv-43498">25,589,907</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-decoration: underline; text-align: left">FINANCING ACTIVITIES</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds from borrowings</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities" scale="0" unitRef="usd" id="ixv-43499">403,333,190</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities" scale="0" unitRef="usd" id="ixv-43500">187,994,310</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities" scale="0" unitRef="usd" id="ixv-43501">150,631,747</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Repayment of borrowings and financed payments</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities" scale="0" unitRef="usd" id="ixv-43502">380,033,708</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities" scale="0" unitRef="usd" id="ixv-43503">145,044,508</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities" scale="0" unitRef="usd" id="ixv-43504">38,457,281</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Interest payments</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" scale="0" unitRef="usd" id="ixv-43505">28,088,688</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" scale="0" unitRef="usd" id="ixv-43506">36,803,697</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" scale="0" unitRef="usd" id="ixv-43507">25,639,013</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Leased assets payments</td><td>&#160;</td>
    <td style="text-align: center">16</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" scale="0" unitRef="usd" id="ixv-43508">5,501,387</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" scale="0" unitRef="usd" id="ixv-43509">4,879,108</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" scale="0" unitRef="usd" id="ixv-43510">3,855,517</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Cash dividend distributed by non-controlling interest</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities" scale="0" unitRef="usd" id="ixv-43511">72,051</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities" scale="0" unitRef="usd" id="ixv-43512">174,800</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities" scale="0" unitRef="usd" id="ixv-43513">452,129</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Other financial payments</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PaymentsOfOtherEquityInstruments" scale="0" unitRef="usd" id="ixv-43514">3,731,493</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PaymentsOfOtherEquityInstruments" scale="0" unitRef="usd" id="ixv-43515">1,850,252</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PaymentsOfOtherEquityInstruments" scale="0" unitRef="usd" id="ixv-43516">3,007,154</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Purchase of own shares</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:PurchaseOfOwnShares" scale="0" unitRef="usd" id="ixv-43517">926,899</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="mlec:PurchaseOfOwnShares" scale="0" unitRef="usd" id="ixv-43518">734,388</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:PurchaseOfOwnShares" scale="0" unitRef="usd" id="ixv-43519">2,996,947</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net cash flows (used in) / generated by financing activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" scale="0" sign="-" unitRef="usd" id="ixv-43520">15,021,036</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" scale="0" sign="-" unitRef="usd" id="ixv-43521">1,492,443</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" scale="0" unitRef="usd" id="ixv-43522">76,223,706</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net increase / (decrease) in cash and cash equivalents</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" scale="0" sign="-" unitRef="usd" id="ixv-43523">47,372,231</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" scale="0" unitRef="usd" id="ixv-43524">10,664,933</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" scale="0" unitRef="usd" id="ixv-43525">9,474,942</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Inflation effects on cash and cash equivalents</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:InflationEffectsOnCashAndCashEquivalents" scale="0" sign="-" unitRef="usd" id="ixv-43526">3,352</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="mlec:InflationEffectsOnCashAndCashEquivalents" scale="0" sign="-" unitRef="usd" id="ixv-43527">189,309</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:InflationEffectsOnCashAndCashEquivalents" scale="0" sign="-" unitRef="usd" id="ixv-43528">195,181</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">Cash and cash equivalents as of beginning of the year</td><td>&#160;</td>
    <td style="text-align: center">7.1</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition" scale="0" unitRef="usd" id="ixv-43529">52,994,865</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c47" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition" scale="0" unitRef="usd" id="ixv-43530">49,265,020</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c65" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition" scale="0" unitRef="usd" id="ixv-43531">34,851,505</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Effect of exchange rate changes on cash and equivalents</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" scale="0" sign="-" unitRef="usd" id="ixv-43532">4,851,363</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" scale="0" sign="-" unitRef="usd" id="ixv-43533">6,745,779</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" scale="0" unitRef="usd" id="ixv-43534">5,133,754</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Cash and cash equivalents as of the end of the year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">7.1</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition" scale="0" unitRef="usd" id="ixv-43535">767,919</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition" scale="0" unitRef="usd" id="ixv-43536">52,994,865</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c47" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition" scale="0" unitRef="usd" id="ixv-43537">49,265,020</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying Notes are an integral part of
these consolidated financial statements. Related parties balances and transactions are disclosed in Note 17.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 126; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="fin_006"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: center"><b>&#160;</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Index</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top; background-color: rgb(204,238,255)">
<td style="width: 9%">1.</td><td style="width: 82%"><a href="#fs_001">The Group&#8217;s business reorganization and general information.</a></td>
    <td style="text-align: center; width: 9%">F-13</td></tr>
<tr style="vertical-align: top; ">
<td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
<td>2.</td><td><a href="#fs_002">Accounting standards and basis of preparation.</a></td>
    <td style="text-align: center">F-16</td></tr>
<tr style="vertical-align: top; ">
<td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
<td>3.</td><td><a href="#fs_003">New standards, amendments and interpretations issued by the IASB.</a></td>
    <td style="text-align: center">F-19</td></tr>
<tr style="vertical-align: top; ">
<td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
<td>4.</td><td><a href="#fs_004">Summary of significant accounting policies.</a></td>
    <td style="text-align: center">F-20</td></tr>
<tr style="vertical-align: top; ">
<td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
<td>5.</td><td><a href="#fs_005">Critical accounting judgments and estimates.</a></td>
    <td style="text-align: center">F-34</td></tr>
<tr style="vertical-align: top; ">
<td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
<td>6.</td><td><a href="#fs_006">Acquisitions and other significant transactions</a></td>
    <td style="text-align: center">F-35</td></tr>
<tr style="vertical-align: top; ">
<td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
<td>7.</td><td><a href="#fs_007">Information about components of consolidated statement of financial position.</a></td>
    <td style="text-align: center">F-38</td></tr>
<tr style="vertical-align: top; ">
<td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
<td>8.</td><td><a href="#fs_008">Information about components of consolidated statement of comprehensive income.</a></td>
    <td style="text-align: center">F-50</td></tr>
<tr style="vertical-align: top; ">
<td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
<td>9.</td><td><a href="#fs_009">Taxation.</a></td>
    <td style="text-align: center">F-56</td></tr>
<tr style="vertical-align: top; ">
<td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
<td>10.</td><td><a href="#es_002">Earnings per share.</a></td>
    <td style="text-align: center">F-58</td></tr>
<tr style="vertical-align: top; ">
<td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
<td>11.</td><td><a href="#fs_010">Information about components of equity.</a></td>
    <td style="text-align: center">F-59</td></tr>
<tr style="vertical-align: top; ">
<td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
<td>12.</td><td><a href="#fs_011">Cash flow information.</a></td>
    <td style="text-align: center">F-62</td></tr>
<tr style="vertical-align: top; ">
<td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
<td>13.</td><td><a href="#fs_012">Joint ventures and associates.</a></td>
    <td style="text-align: center">F-64</td></tr>
<tr style="vertical-align: top; ">
<td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
<td>14.</td><td><a href="#fs_013">Segment information</a></td>
    <td style="text-align: center">F-65</td></tr>
<tr style="vertical-align: top; ">
<td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
<td>15.</td><td><a href="#fs_014">Financial instruments &#8211; Risk management.</a></td>
    <td style="text-align: center">F-69</td></tr>
<tr style="vertical-align: top; ">
<td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
<td>16.</td><td><a href="#fs_015">Leases.</a></td>
    <td style="text-align: center">F-75</td></tr>
<tr style="vertical-align: top; ">
<td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
<td>17.</td><td><a href="#fs_016">Shareholders and other related parties&#8217; balances and transactions.</a></td>
    <td style="text-align: center">F-77</td></tr>
<tr style="vertical-align: top; ">
<td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
<td>18.</td><td><a href="#fs_017">Key management personnel compensation.</a></td>
    <td style="text-align: center">F-78</td></tr>
<tr style="vertical-align: top; ">
<td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
<td>19.</td><td><a href="#fs_018">Share-based payments.</a></td>
    <td style="text-align: center">F-78</td></tr>
<tr style="vertical-align: top; ">
<td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
<td>20.</td><td><a href="#fs_019">Contingencies, commitments and restrictions on the distribution of profits.</a></td>
    <td style="text-align: center">F-81</td></tr>
<tr style="vertical-align: top; ">
<td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
<td>21.</td><td><a href="#fs_020">Events occurring after the reporting period.</a></td>
    <td style="text-align: center">F-81</td></tr>
                                                                      <tr style="vertical-align: top; ">
<td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
                                                                      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
<td>22.</td><td><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><a href="#note_022">Reverse stock split after the reporting period</a>.</p></td>
    <td style="text-align: center">F-83</td></tr>
                                                                      </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 127; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: center"><b>&#160;</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><div><a id="fs_001"></a></div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" id="ixv-21107"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><b>1.</b></td><td style="text-align: justify"><b><span style="text-decoration:underline">THE GROUP&#8217;S BUSINESS REORGANIZATION AND GENERAL
INFORMATION</span></b></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Moolec Science SA (the &#8220;Company&#8221; or
the &#8220;Group&#8221;) is an exempted company incorporated under the laws of the laws of the Cayman Islands.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The company was previously registered with the
Luxembourg Trade and Companies&#8217; Register (<i>Registre de Commerce et des Soci&#233;t&#233;s, Luxembourg</i>) under number B268440.
On May 22, 2025 (the &#8220;Effective Date&#8221;), the Company changed its jurisdiction by redomiciling Moolec Science (Luxembourg) from
the Grand Duchy of Luxembourg to the Cayman Islands as Moolec Science (Cayman Islands) by way of continuation pursuant to Part XII of
the Companies Act (Revised) of the Cayman Islands (the &#8220;Redomiciliation&#8221;). Following the Redomiciliation, the Company&#8217;s
address is at c/o Ogier Global (Cayman) -89 Nexus Way, Camana Bay, Grand Cayman KY1-9009.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>The Bioceres Group Business Combination Agreement.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Before the end of the fiscal year, on June 16,
2025, the Company consummated a business combination (the &#8220;Business Combination&#8221;). Prior to such consummation, a series of
previous steps had taken place, as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 14, 2025, Moolec Science (Luxembourg) made
effective a reverse stock split of its Ordinary Shares (the &#8220;Reverse Stock Split&#8221;) on the consolidation ratio of <ix:nonNumeric contextRef="c74" name="mlec:ReverseStockSplitConsolidationRatio" id="ixv-43538">ten-to-one</ix:nonNumeric>
(the &#8220;Consolidation Ratio&#8221;), pursuant to which holders of Ordinary Shares received <ix:nonFraction contextRef="c75" decimals="0" format="ixt-sec:numwordsen" name="ifrs-full:NumberOfSharesIssued" scale="0" unitRef="shares" id="ixv-43539">one</ix:nonFraction> Ordinary Share for every <ix:nonFraction contextRef="c76" decimals="0" format="ixt-sec:numwordsen" name="ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" scale="0" unitRef="shares" id="ixv-43540">ten</ix:nonFraction> Ordinary
Shares held.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 22, 2025, the Company changed its jurisdiction
by redomiciling Moolec Science (Luxembourg) from the Grand Duchy of Luxembourg to the Cayman Islands as Moolec Science (Cayman Islands)
by way of continuation pursuant to Part XII of the Companies Act (Revised) of the Cayman Islands. On the Effective Date, all of the shares
of Moolec Science (Luxembourg), par value $<ix:nonFraction contextRef="c77" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ParValuePerShare" scale="0" unitRef="usdPershares" id="ixv-43541">0.10</ix:nonFraction> per share by operation of law became shares of Moolec Science (Cayman Islands), par value
$<ix:nonFraction contextRef="c78" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ParValuePerShare" scale="0" unitRef="usdPershares" id="ixv-43542">0.10</ix:nonFraction> per share (the &#8220;Ordinary Shares&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">After completion of the Reverse Stock Split, all
references to the Ordinary Shares, share data, per share data and related information have been adjusted for the Consolidation Ratio to
reflect the Reverse Stock Split. The Reverse Stock Split has consolidated each <ix:nonFraction contextRef="c78" decimals="0" format="ixt-sec:numwordsen" name="mlec:NumberOfSharesReverseStockSplit" scale="0" unitRef="shares" id="ixv-43543">ten</ix:nonFraction> of the Ordinary Shares into <ix:nonFraction contextRef="c78" decimals="0" format="ixt-sec:numwordsen" name="ifrs-full:NumberOfSharesIssued" scale="0" unitRef="shares" id="ixv-43544">one</ix:nonFraction> Ordinary Share, with
a new par value of $<ix:nonFraction contextRef="c78" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ParValuePerShare" scale="0" unitRef="usdPershares" id="ixv-43545">0.10</ix:nonFraction> per Ordinary Share. Upon completion of the Reverse Stock Split, no fractional Ordinary Shares were issued, and
any fractional Ordinary Shares resulting from the Reverse Stock Split were rounded up to the nearest whole Ordinary Share. Except for
the adjustments that resulted from the treatment of fractional shares, the Reverse Stock Split did not have any dilutive effect on the
shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Through the consummation of the Business Combination, Moolec Science
SA acquired all the issued and outstanding equity interests of Bioceres Group and Nutrecon and <ix:nonFraction contextRef="c78" decimals="2" format="ixt:num-dot-decimal" name="mlec:PercentageOfIssuedAndOutstandingEquityInterests" scale="-2" unitRef="pure" id="ixv-43546">50</ix:nonFraction>% of Gentle Tech, integrating mature
agricultural biologicals and seed businesses, nutritional solutions, and emerging technology ventures. In consideration for the contributed
entities, the Company issued approximately <ix:nonFraction contextRef="c79" decimals="-5" format="ixt:num-dot-decimal" name="mlec:ConsiderationForIssuedOrdinaryShareValue" scale="6" unitRef="shares" id="ixv-43547">6.2</ix:nonFraction> million of ordinary shares to the shareholders of Bioceres Group, <ix:nonFraction contextRef="c79" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesIssued" scale="0" unitRef="shares" id="ixv-43548">450,000</ix:nonFraction> of ordinary shares
and <ix:nonFraction contextRef="c78" decimals="0" format="ixt:num-dot-decimal" name="mlec:PrivateWarrantsShares" scale="0" unitRef="shares" id="ixv-43549">500,000</ix:nonFraction> private warrants with an exercise price of US$<ix:nonFraction contextRef="c80" decimals="2" format="ixt:num-dot-decimal" name="mlec:PrivateWarrantsExercisePrice" scale="0" unitRef="usdPershares" id="ixv-43550">20.00</ix:nonFraction> per share to the shareholders of Nutrecon, and <ix:nonFraction contextRef="c81" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesIssued" scale="0" unitRef="shares" id="ixv-43551">132,750</ix:nonFraction> ordinary shares
to the shareholders of Gentle Tech. Also, Moolec Science SA committed to issue additional ordinary shares <ix:nonNumeric contextRef="c78" format="ixt-sec:durwordsen" name="mlec:AdditionalOrdinarySharesIssue" id="ixv-43552">twelve months</ix:nonNumeric> after the acquisition
date, representing the <ix:nonFraction contextRef="c82" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" scale="-2" unitRef="pure" id="ixv-43553">10</ix:nonFraction>% of the total shares to be issued (the &#8220;Holdback&#8221;), representing approximately <ix:nonFraction contextRef="c83" decimals="-5" format="ixt:num-dot-decimal" name="mlec:ConsiderationForIssuedOrdinaryShareValue" scale="6" unitRef="shares" id="ixv-43554">0.7</ix:nonFraction> million of ordinary
shares to the shareholders of Bioceres Group, <ix:nonFraction contextRef="c83" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesIssued" scale="0" unitRef="shares" id="ixv-43555">50,000</ix:nonFraction> of ordinary shares to the shareholders of Nutrecon, and <ix:nonFraction contextRef="c84" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesIssued" scale="0" unitRef="shares" id="ixv-43556">14,750</ix:nonFraction> ordinary shares to
the shareholders of Gentle Tech.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 16, 2025, following the consummation of the Business Combination,
the Company initiated integration processes across organizational, operational, and IT functions to support competitiveness and long-term
sustainability. In parallel, management continued to advance the ongoing operations, which remain crucial to maintaining business continuity
and supporting the successful execution of the integration and growth strategy. The consolidated results as of and for the year ended
June 30, 2025 (&#8220;FY2025&#8221;) reflect purchase accounting. The prior periods as of and for the year ended June 30, 2024 (&#8220;FY2024&#8221;)
and for the year ended June 30, 2023 reflects the Predecessor on a stand-alone basis and does not include any effects of the Business
Combination. As a result, variances between FY2025 and FY2024 primarily reflect changes in scope and basis of presentation rather than
purely period-over-period operating trends, and therefore the periods are not directly comparable. Effective as of the Closing (i.e.,
June 16, 2025), the Company accounted for the Business Combination under IFRS 3, <i>Business Combinations</i>, using the acquisition method
of accounting and treating the transaction as a reverse acquisition. Under this approach, Bioceres Group (the legal subsidiary) was considered
the accounting acquirer, and Moolec Science SA (the legal acquirer) was considered the accounting acquiree, together with Gentle Tech
and Nutrecon.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">1.1 Going Concern</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Business Combination, initially
announced on April 17, 2025, in which the Company, Bioceres Group (formerly, Bioceres Group PLC, one of the main shareholders of the
Company), Gentle Tech and Nutrecon entered into the Bioceres Group Business Combination Agreement, pursuant to which several parties
transferred their respective holdings in Bioceres Group, Nutrecon and Gentle Tech (together, the &#8220;Contributed Entities&#8221;)
to the Company, in exchange of a combination of newly issued Company&#8217;s shares, and warrants, to the shareholders of the
Contributed Entities. Following the closing, Moolec became the legal parent company of the combined group comprising Bioceres Group,
Gentle Tech, and Nutrecon. The Business Combination was ratified by Moolec shareholders at the Extraordinary General Meeting
(&#8220;EGM&#8221;) held on June 16, 2025, with <ix:nonFraction contextRef="c85" decimals="2" format="ixt:num-dot-decimal" name="mlec:NumberOfSharesOutstandingPercentage" scale="-2" unitRef="pure" id="ixv-43557">77</ix:nonFraction>% of the outstanding shares present at the meeting, and <ix:nonFraction contextRef="c85" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ProportionOfVotingPowerHeldInSubsidiary" scale="-2" unitRef="pure" id="ixv-43558">98</ix:nonFraction>% of the votes cast were
in favor of the transaction. From an accounting perspective and based on the guidance of IFRS 3, Bioceres Group Limited is deemed to
be the accounting acquirer. The transaction was subsequently consummated on the same date, June 16, 2025 (the
&#8220;Closing&#8221;).</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 128; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: center"><b>&#160;</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:continuation continuedAt="_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory-c0_cont_2" id="_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 18, 2025, Bioceres Crop Solutions Corp.
(BIOX), a public company controlled until that date by Bioceres Group Limited, entered into an amendment with the Secured Notes&#8217;
holders by which the holders of the Secured Notes waived the breach of covenants that led to the default of the debt (specifically, the
breach of covenants related to the Consolidated Total Net Leverage Ratio (determined as the ratio of (a) Consolidated Total Net Debt as
of the last day of such Test Period to (b) Consolidated EBITDA of the Issuer and its Subsidiaries for such Test Period) of 3.75x as of
March 31, 2025), retrospectively modifying the required Consolidated Total Net Leverage Ratio to 5x Consolidated Total Net Leverage Ratio,
and extended the maturity of the Secured Notes to August 31, 2027. In accordance with the terms of the amendments, effective June 24,
2025, Gloria Montaron Estrada, Enrique Lopez Lecube, and Keith McGovern were replaced in Bioceres Crop Solutions Corp.&#8217;s Board of
Directors by Milen Marinov, Noah Kolatch and Scott Crocco, who were nominated by certain holders of the Secured Notes. Bioceres Crop Solutions
Corp. agreed, for so long as the Secured Notes remain outstanding, to continue to nominate Messrs. Marinov, Kolatch and Crocco (or such
other persons as may be nominated as their replacements) for additional terms as directors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The effect of the changes in the terms of the Secured Notes of Bioceres
Crop Solutions, resulted in the loss of de facto control of that subsidiary and consequently, its deconsolidation. The equity method was
applied to account for the investment in such former subsidiary, as well as for other investments in joint ventures and associates (the
&#8220;BIOX deconsolidation&#8221;). Even when there was a deconsolidation of the business, the Company will continue to be affected by
BIOX business due to the HB4 royalty agreement. It is important to note that the effects of the loss of control in BIOX represents substantially
all of the Company&#8217;s business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a result of the loss of control over BIOX, access to financing that
Bioceres S.A., its wholly owned subsidiary Bioceres LLC, Bioceres Group Limited and Moolec Science SA had until then, was restricted or
limited.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In June 2025, Bioceres S.A., one of the Argentine
subsidiaries of Bioceres Group Limited, defaulted on a portion of its financial debt that was due that month. As a result, Bioceres S.A.
had initiated a debt restructuring process for its financial debt for an aggregate amount of $<ix:nonFraction contextRef="c86" decimals="-5" format="ixt:num-dot-decimal" name="ifrs-full:Borrowings" scale="6" unitRef="usd" id="ixv-43559">36.4</ix:nonFraction> million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In July 2025, Bioceres LLC, a wholly owned subsidiary
of Bioceres S.A., received a notice of default on its financial debt&#160;in the amount of $<ix:nonFraction contextRef="c87" decimals="-5" format="ixt:num-dot-decimal" name="ifrs-full:FinanceCosts" scale="6" unitRef="usd" id="ixv-43560">69.5</ix:nonFraction> million. The creditor conducted a public
auction for <ix:nonFraction contextRef="c88" decimals="0" format="ixt:num-dot-decimal" name="mlec:NumberOfSharesPledged" scale="0" unitRef="shares" id="ixv-43561">3,062,500</ix:nonFraction> pledged BIOX shares, pursuant to the New York Uniform Commercial Code. Management has responded to the creditor,
reserving all rights, remedies, and defenses. As of June 30, 2025, the current debt amounts to $<ix:nonFraction contextRef="c4" decimals="-5" format="ixt:num-dot-decimal" name="ifrs-full:CurrentDebtInstrumentsIssued" scale="6" unitRef="usd" id="ixv-43562">58.0</ix:nonFraction> million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The defaults by Bioceres S.A. and Bioceres LLC do not have implications
in other debts as there are no cross-default clauses on the remaining financial debt of the Group. There are no guarantees granted above
Bioceres S.A. and Bioceres LLC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of June 30, 2025, the Group had a negative working capital amounting
to $<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="mlec:WorkingCapital" scale="0" sign="-" unitRef="usd" id="ixv-43563">204,860,444</ix:nonFraction>, and a shareholders&#8217; deficit of $<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" sign="-" unitRef="usd" id="ixv-43564">82,873,602</ix:nonFraction>. Additionally, the Group reported recurring operating losses amounting
to $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossFromOperatingActivities" scale="0" sign="-" unitRef="usd" id="ixv-43565">104,150,129</ix:nonFraction>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company had the financial support of its main
shareholders and considering the aforementioned events that derived in the loss of the financial support that was previously provided
by Bioceres Group (and who is also no longer a shareholder of the Company), and, consequently, raise a material uncertainty which may
cast significant doubt (or raise substantial doubt as contemplated by PCAOB standards) &#160;about the ability of Moolec Science SA to
continue as a going concern, currently, the Group lacks sufficient financial resources to meet its obligations or fully implement its
business plan. Without securing additional capital, the Group will not be able to sustain its operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The uncertainty surrounding the ability to secure
additional funding and the potential for continued operational losses contribute to substantial doubt about the Group&#8217;s ability
to continue as a going concern.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 129; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: center"><b>&#160;</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><ix:continuation id="_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management has plans to address the Group&#8217;s
financial situation as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Theo I SCSp</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November 28, 2025, subsequent to the reporting
date, Theo I SCSp received a conditional payment order from district court of&#160; Luxembourg, and therefore the General Partners engaged
Ogier (Luxembourg) SCS represented by its general partner Ogier Luxembourg (GP) S.&#224;.r.l&#160; formally as their legal advisor to
assist with Theo I SCSp&#8217;s declaration of bankruptcy before the Luxembourg District Court. The declaration of bankruptcy will declare
Theo I SCSp bankrupt and appoint a receiver who will take control over the management of the company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The loss of control constitutes the derecognition
event under IFRS 10.25. Accordingly, the Group will derecognize the assets and liabilities of Theo I SCSp and will remeasure its retained
interest at fair value in accordance with IFRS 9 at the date of the derecognition event. This will result in the recognition of an estimated
gain of $<ix:nonFraction contextRef="c0" decimals="-5" format="ixt:num-dot-decimal" name="mlec:GainlossOfRecognitionTransactions" scale="6" unitRef="usd" id="ixv-43566">9.5</ix:nonFraction> million in the consolidated statement of profit or loss as of the derecognition date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group will continue to measure its retained
interest in Theo I SCSp at fair value through profit or loss until the liquidation process is formally completed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Bioceres S.A. and Bioceres LLC</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 16, 2025, subsequent to the reporting date, the Board of
Directors of Bioceres S.A. formally approved the initiation of voluntary bankruptcy proceedings and instructed management to seek and
appoint a trustee (&#8220;<i>s&#237;ndico</i>&#8221;) to oversee the process. The commencement of the voluntary bankruptcy proceedings
and the transfer of decision-making authority to the trustee will result in the Group losing control over Bioceres S.A. in accordance
with the principles of IFRS 10 Consolidated Financial Statements. As Bioceres LLC is a wholly owned subsidiary of Bioceres S.A., the Group
simultaneously will lose control over Bioceres LLC as well.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under IFRS 10.25, the date on which control is
lost constitutes the derecognition event. Accordingly, after December 16, 2025, the Group will derecognize the assets and liabilities
of Bioceres S.A. and Bioceres LLC and will remeasure any retained interest at fair value in accordance with IFRS 9 Financial Instruments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The resulting derecognition effects are expected to generate an approximate
gain of $<ix:nonFraction contextRef="c89" decimals="-5" format="ixt:num-dot-decimal" name="mlec:GainlossOfDerecognitionTransactions" scale="6" unitRef="usd" id="ixv-43567">91.0</ix:nonFraction> million related to the loss of control of Bioceres S.A. and an additional approximate gain of $<ix:nonFraction contextRef="c90" decimals="-5" format="ixt:num-dot-decimal" name="mlec:GainlossOfDerecognitionTransactions" scale="6" unitRef="usd" id="ixv-43568">5.3</ix:nonFraction> million related to the
loss of control of Bioceres LLC (including the loss of holding in BIOX, therefore it will no longer be an equity method associate). These
amounts will be recognized in the consolidated statement of profit or loss as of the derecognition date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group will continue to monitor the progress of the voluntary bankruptcy
and liquidation proceedings and will update the accounting treatment as necessary in accordance with IFRS.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management expects that certain shareholders and/or
investors will continue or commence to provide new financing lines.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">However, there is no assurance that investors
and shareholders will continue to provide financing, or that the Group&#8217;s future operations will generate profitability. The uncertainty
surrounding the ability to secure additional funding and the potential for continued operational losses contribute to raise a material
uncertainty which may cast significant doubt (or raise substantial doubt as contemplated by PCAOB standards) about the Group&#8217;s ability
to continue as a going concern.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consolidated financial statements of Moolec
Science SA do not include any adjustments that may be required to address the potential impacts on the recoverability and classification
of assets or the amounts and classifications liabilities, should the Group be unable to continue as a going concern.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accordingly, the financial statements of Moolec
Science SA for periods prior to the Closing reflect the historical financial information of Bioceres Group. The financial information
as of and for the year ended June 30, 2025 reflects the figures corresponding to Bioceres Group and incorporates the effects of applying
the acquisition method to Moolec Science SA, Gentle Tech and Nutrecon, measured at fair value in accordance with IFRS 3.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 130; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: center"><b>&#160;</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><div><a id="fs_002"></a></div><ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory" id="ixv-21324"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><b>2.</b></td><td style="text-align: justify"><b><span style="text-decoration:underline">ACCOUNTING STANDARDS AND BASIS OF PREPARATION</span></b></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration:underline">Statement of compliance with IFRS as issued by IASB</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These consolidated financial statements of the
Group have been prepared in accordance with IFRS Accounting (&#8220;IFRS&#8221;) as issued by International Accounting Standard Board
(&#8220;IASB&#8221;), and interpretations issued by the IFRS Interpretations Committee (IFRIC), following the accounting policies as set
forth and summarized in Note 4 &#8211; &#8220;Summary of significant accounting policies&#8221;. All IFRS issued by the IASB, effective
at the time of preparing these consolidated financial statements have been applied.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration:underline">Authorization for the issue of the Consolidated financial statements</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These consolidated financial statements of the Group as of June 30,
2025 and 2024 and for the years ended June 30, 2025, and 2024 have been authorized by the Board of Directors of Moolec Science SA on December
29, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration:underline">Basis of measurement</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consolidated financial statements have been
prepared on the historical cost basis, except for items that are required to be accounted for at fair value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The significant accounting policies set out in
Note 4 &#8211; Summary of significant accounting policies have been consistently applied in preparing these consolidated financial statements
to all the periods presented, unless otherwise stated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Due to the activities of the Group, costs and
expenses presented in the statement of operations are classified according to their function. The statement of financial position has
been prepared based on the nature of the transactions, distinguishing: (a) current assets from non-current assets, where current assets
are assets that should be realized, sold or used during the normal operating cycle, or the assets owned with the aim of being sold in
the short-term (within <ix:nonNumeric contextRef="c0" format="ixt-sec:durmonth" name="mlec:ShorttermPeriod" id="ixv-43569">12</ix:nonNumeric> months); (b) current liabilities from non-current liabilities, where current liabilities are liabilities that
should be paid during the normal operating cycle or over the 12-month period subsequent to the reporting date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All other assets and liabilities are classified
as non-current. Current and deferred tax assets and liabilities (income tax credits / liabilities) are presented separately from each
other and from other assets and liabilities, classified as current and non-current, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consolidated financial statements of the Group
have been prepared using:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Accrual basis of accounting:</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accrual basis of accounting (except for cash flows
information). Under this basis of accounting, the effects of transactions and other events are recognized as they occur, even when there
are no cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration:underline">Functional currency and presentation currency</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Functional currency</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Items included in the financial statements of
each of the Group&#8217;s entities are measured using the currency of the primary economic market in which the entity operates (i.e.,
&#8220;the functional currency&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company and the main subsidiaries of the Group
have United States Dollars as functional currency.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Macroeconomic context &#8211; in recent years
Argentina&#8217;s macroeconomic scenario has featured a misalignment between inflation rates and the devaluation of the Argentine peso,
which became more pronounced during the first half of the year ended June 30, 2022. Notwithstanding such misalignment, the Company&#8217;s
Argentine subsidiaries have been able to continue pricing their products in U.S. dollars as the costs of products and services are set
in U.S. dollars. This has also been achievable as the demand for the type of products the Company commercializes is relatively inelastic
when compared to non-essential goods and services. Further, Argentina&#8217;s significant economic volatility has caused materials, and
other costs of providing goods that the Company acquires from the Argentine domestic market, to become increasingly indexed to the U.S.
dollar (i.e., denominated in Argentine Pesos but indexed to the U.S. dollar exchange rate).</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 131; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: center"><b>&#160;</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><ix:continuation continuedAt="_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the years ended June 30, 2025, 2024 and 2023, Argentinian subsidiaries,
that have Argentine Pesos as functional currency, had applied IAS 29 &#8220;Financial reporting in hyperinflationary economies&#8221;
which requires that the financial statements of an entity whose functional currency is the currency of a hyperinflationary economy, whether
these are based on the historical cost method or the current cost method, be stated in terms of the measuring unit current at the closing
date of the reporting period. For such purpose, the inflation produced since the acquisition date or the revaluation date, as applicable,
must be computed in non-monetary items. The standard details a series of factors to be considered for concluding whether an economy is
hyperinflationary, including, but not limited to, a cumulative inflation rate over a three-year period that approaches or exceeds <ix:nonFraction contextRef="c91" decimals="2" format="ixt:num-dot-decimal" name="mlec:CumulativeInflationRate" scale="-2" unitRef="pure" id="ixv-43570">100</ix:nonFraction>%.
Inflation accumulated in <ix:nonNumeric contextRef="c91" format="ixt-sec:durwordsen" name="mlec:InflationOfAccumulatedYears" id="ixv-43571">three years</ix:nonNumeric>, as of June 30, 2018, was over <ix:nonFraction contextRef="c91" decimals="2" format="ixt:num-dot-decimal" name="mlec:PercentageOfInflationAccumulated" scale="-2" unitRef="pure" id="ixv-43572">100</ix:nonFraction>%. It was for this reason that, in accordance with IAS 29, the
Argentine economy had to be considered as hyperinflationary since July 1, 2018. Consequently, the Group has applied IAS 29 to these financial
statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During an inflationary period, any entity that
maintains an excess of monetary assets over monetary liabilities will lose purchasing power, and any entity that maintains an excess of
monetary liabilities over monetary assets will gain purchasing power, provided that such items are not subject to an adjustment mechanism.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Briefly, the restatement mechanism of IAS 29 establishes
that monetary assets and liabilities will not be restated because they are already expressed in a current unit of measurement at the end
of the reporting period. Assets and liabilities subject to adjustments based on specific agreements, will be adjusted according to those
agreements. Non-monetary items measured at their current values at the end of the reporting period, such as the net realizable value or
others, do not need to be restated. The remaining non-monetary assets and liabilities will be restated according to a general price index.
The loss or gain for the net monetary position will be included in the net result of the reporting period, revealing this information
in a separate line item.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The inflation adjustment to the initial balances
was calculated by means of a conversion factor derived from the Argentine price indexes published by the National Institute of Statistics.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Argentine price index as of June 30, 2025,
and 2024 was&#160;<ix:nonFraction contextRef="c0" decimals="4" format="ixt:num-dot-decimal" name="mlec:ArgentinePriceIndexShares" scale="0" unitRef="shares" id="ixv-43573">8,855.5681</ix:nonFraction>&#160;and&#160;<ix:nonFraction contextRef="c5" decimals="4" format="ixt:num-dot-decimal" name="mlec:ArgentinePriceIndexShares" scale="0" unitRef="shares" id="ixv-43574">6,351.7145</ix:nonFraction>, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Presentation currency</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consolidated financial statements of the Group
are presented in US dollars.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration:underline">Foreign currency</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Transactions entered into by Group entities in
a currency other than their functional currency are recorded at the relevant exchange rates as of the date upon which such transactions
occur. Foreign currency monetary assets and liabilities are translated at the prevailing exchanges rates as of the final day of each reporting
period. Exchange differences arising on the retranslation of unsettled monetary assets and liabilities are recognized immediately in profit
or loss, except for foreign currency borrowings qualifying as a hedge of a net investment in a foreign operation for which exchange differences
are recognized in other comprehensive income and accumulated in the foreign exchange reserve along with the exchange differences arising
on the retranslation of the foreign operation. Upon the disposal of a foreign operation, the cumulative exchange differences recognized
in the foreign exchange reserve relating to such operation up to the date of disposal are transferred to the Consolidated statement of
profit or loss and other comprehensive income as part of the profit or loss reorganized upon such disposal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration:underline">Business combination</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 16, 2025, it was completed the business combination with Bioceres
Group Limited, Nutrecon LLC and Gentle Technologies Corp. pursuant to the terms of the Business Combination Agreement approved by Moolec
Science SA&#8217;s shareholders. Through this transaction, Moolec Science SA acquired all the issued and outstanding equity interests
of Bioceres Group and Nutrecon and <ix:nonFraction contextRef="c92" decimals="2" format="ixt:num-dot-decimal" name="mlec:PercentageOfIssuedAndOutstandingEquityInterests" scale="-2" unitRef="pure" id="ixv-43575">50</ix:nonFraction>% of Gentle Tech, integrating mature agricultural biologicals and seed businesses, nutritional solutions,
and emerging technology ventures. In consideration for the contributed entities, the Company issued approximately <ix:nonFraction contextRef="c92" decimals="-5" format="ixt:num-dot-decimal" name="mlec:ConsiderationForIssuedOrdinaryShareValue" scale="6" unitRef="shares" id="ixv-43576">6.2</ix:nonFraction> million of ordinary
shares to the shareholders of Bioceres Group, <ix:nonFraction contextRef="c85" decimals="0" format="ixt:num-dot-decimal" name="mlec:PrivateWarrantShares" scale="0" unitRef="shares" id="ixv-43577">450,000</ix:nonFraction> of ordinary shares and <ix:nonFraction contextRef="c93" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesIssued" scale="0" unitRef="shares" id="ixv-43578">500,000</ix:nonFraction> private warrants with an exercise price of US$<ix:nonFraction contextRef="c85" decimals="2" format="ixt:num-dot-decimal" name="mlec:PrivateWarrantsExercisePrice" scale="0" unitRef="usdPershares" id="ixv-43579">20.00</ix:nonFraction>
per share to the shareholders of Nutrecon, and <ix:nonFraction contextRef="c94" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesIssued" scale="0" unitRef="shares" id="ixv-43580">132,750</ix:nonFraction> ordinary shares to the shareholders of Gentle Tech. Also, Moolec Science SA committed
to issue additional ordinary shares twelve months after the acquisition date, representing the <ix:nonFraction contextRef="c85" decimals="2" format="ixt:num-dot-decimal" name="mlec:PercentageOfShare" scale="-2" unitRef="pure" id="ixv-43581">10</ix:nonFraction>% of the total shares to be issued (the
&#8220;Holdback&#8221;), representing approximately <ix:nonFraction contextRef="c92" decimals="-5" format="ixt:num-dot-decimal" name="ifrs-full:IssuedCapitalOrdinaryShares" scale="6" unitRef="usd" id="ixv-43582">0.7</ix:nonFraction> million of ordinary shares to the shareholders of Bioceres Group, <ix:nonFraction contextRef="c95" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesIssued" scale="0" unitRef="shares" id="ixv-43583">50,000</ix:nonFraction> of ordinary
shares to the shareholders of Nutrecon, and <ix:nonFraction contextRef="c96" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesIssued" scale="0" unitRef="shares" id="ixv-43584">14,750</ix:nonFraction> ordinary shares to the shareholders of Gentle Tech. As a result of this combination,
Bioceres Group, Nutrecon and Gentle Tech became subsidiaries of Moolec, and the Company evolved into a diversified life sciences and food-tech
platform, as more fully described below in Note 1 &#8211; The Group&#8217;s business reorganization and general information - &#8220;<i>The
Bioceres Group Business Combination Agreement&#8221;</i>. This business combination was accounted as reverse acquisition in accordance
with IFRS 3 &#8211; <i>Business Combinations</i>.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 132; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: center"><b>&#160;</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory-c0_cont_3" id="_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration:underline">Subsidiaries</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Where the Group holds a controlling interest in
an entity, such entity is classified as a subsidiary. The Group exercises control over such an entity if all three of the following elements
are present: (i) the Group has the power to direct or cause the direction of the management and policies of the entity; (ii) the Group
is exposed to the variable returns of such entity; and (iii) the Group has power to affect the variability of such returns. Control is
reassessed whenever facts and circumstances indicate that there may be a change in any of these elements of control.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">De-facto control exists in situations where the
Group has the practical ability to direct the relevant activities of an entity without holding the majority of the voting rights. In determining
whether de facto control exists, the Group considers all relevant facts and circumstances, including:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">The relative share of the Group&#8217;s voting rights with
respect both the size and dispersion of other parties who hold voting rights;</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">Substantive potential voting rights held by the Group and
by other parties;</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">Other contractual arrangements; and</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">Historic patterns in voting attendance.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfInterestsInSubsidiariesExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfInterestsInSubsidiariesExplanatory" id="ixv-21532"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The subsidiaries of the Group, all of which have
been included in the consolidated financial statements of the Group, are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: left"><b>Name</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td> <td style="text-align: center; border-bottom: Black 1.5pt solid"><b>Principal activities</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td> <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><b>Country of <br/>incorporation and <br/>principal place of <br/>business</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td> <td style="text-align: center; border-bottom: Black 1.5pt solid"><b>Ref</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>% Equity <br/>interest <br/>06/30/2025</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>% Equity <br/>interest <br/>06/30/2024</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; width: 20%; text-align: left">Moolec Science Limited</td><td style="width: 1%">&#160;</td> <td style="width: 38%; text-align: left"><ix:nonNumeric contextRef="c97" name="ifrs-full:NameOfSubsidiary" id="ixv-43585">Investment in subsidiaries</ix:nonNumeric></td><td style="width: 1%">&#160;</td> <td style="vertical-align: top; width: 15%; text-align: center"><ix:nonNumeric contextRef="c97" name="ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary" id="ixv-43586">United Kingdom</ix:nonNumeric></td><td style="width: 1%">&#160;</td> <td style="width: 6%; text-align: center">b)</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><ix:nonFraction contextRef="c97" decimals="2" format="ixt:num-dot-decimal" id="ix_12_fact" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" unitRef="pure">100</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-171">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-align: left">AG Biomolecules LLC</td><td>&#160;</td> <td style="text-align: left"><ix:nonNumeric contextRef="c99" name="ifrs-full:NameOfSubsidiary" id="ixv-43588">Production and commercialization of agricultural products</ix:nonNumeric></td><td>&#160;</td> <td style="vertical-align: top; text-align: center"><ix:nonNumeric contextRef="c99" name="ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary" id="ixv-43589">United States</ix:nonNumeric></td><td>&#160;</td> <td style="text-align: center">b)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c99" decimals="2" format="ixt:num-dot-decimal" id="ix_13_fact" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" unitRef="pure">100</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-172">-</div></td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left">ValoraSoy S.A.</td><td>&#160;</td> <td style="text-align: left"><ix:nonNumeric contextRef="c101" name="ifrs-full:NameOfSubsidiary" id="ixv-43591">Production and commercialization of agricultural products</ix:nonNumeric></td><td>&#160;</td> <td style="vertical-align: top; text-align: center"><ix:nonNumeric contextRef="c101" name="ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary" id="ixv-43592">Argentina</ix:nonNumeric></td><td>&#160;</td> <td style="text-align: center">b)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c101" decimals="2" format="ixt:num-dot-decimal" id="ix_14_fact" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" unitRef="pure">100</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-173">-</div></td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-align: left">Nutrecon LLC</td><td>&#160;</td> <td style="text-align: left"><ix:nonNumeric contextRef="c103" name="ifrs-full:NameOfSubsidiary" id="ixv-43594">Investment in subsidiaries</ix:nonNumeric></td><td>&#160;</td> <td style="vertical-align: top; text-align: center"><ix:nonNumeric contextRef="c103" name="ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary" id="ixv-43595">United States</ix:nonNumeric></td><td>&#160;</td> <td style="text-align: center">b)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c103" decimals="2" format="ixt:num-dot-decimal" id="ix_15_fact" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" unitRef="pure">100</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-174">-</div></td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left">SynBio Powerlabs</td><td>&#160;</td> <td style="text-align: left"><ix:nonNumeric contextRef="c105" name="ifrs-full:NameOfSubsidiary" id="ixv-43597">Production and commercialization of fermentation products</ix:nonNumeric></td><td>&#160;</td> <td style="vertical-align: top; text-align: center"><ix:nonNumeric contextRef="c105" name="ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary" id="ixv-43598">Finland</ix:nonNumeric></td><td>&#160;</td> <td style="text-align: center">d)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c105" decimals="2" format="ixt:num-dot-decimal" id="ix_20_fact" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" unitRef="pure">90</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-175">-</div></td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-align: left">Gentle Tech</td><td>&#160;</td> <td style="vertical-align: top; text-align: left"><ix:nonNumeric contextRef="c107" name="ifrs-full:NameOfSubsidiary" id="ixv-43600">Investment in subsidiaries</ix:nonNumeric></td><td>&#160;</td> <td style="vertical-align: top; text-align: center"><ix:nonNumeric contextRef="c107" name="ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary" id="ixv-43601">British Virgin Islands</ix:nonNumeric></td><td>&#160;</td> <td style="text-align: center">a),b)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c107" decimals="2" format="ixt:num-dot-decimal" id="ix_0_fact" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" unitRef="pure">100</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c108" decimals="2" format="ixt:num-dot-decimal" id="ix_1_fact" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" unitRef="pure">50</ix:nonFraction></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left">Gentle Farming</td><td>&#160;</td> <td style="vertical-align: top; text-align: left"><ix:nonNumeric contextRef="c109" name="ifrs-full:NameOfSubsidiary" id="ixv-43604">Investment in subsidiaries</ix:nonNumeric></td><td>&#160;</td> <td style="vertical-align: top; text-align: center"><ix:nonNumeric contextRef="c109" name="ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary" id="ixv-43605">British Virgin Islands</ix:nonNumeric></td><td>&#160;</td> <td style="text-align: center">a),b)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c109" decimals="2" format="ixt:num-dot-decimal" id="ix_2_fact" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" unitRef="pure">51</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c110" decimals="2" format="ixt:num-dot-decimal" id="ix_3_fact" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" unitRef="pure">51</ix:nonFraction></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; vertical-align: top">G-FAS</td><td>&#160;</td> <td style="text-align: left"><ix:nonNumeric contextRef="c111" name="ifrs-full:NameOfSubsidiary" id="ixv-43608">Production and commercialization of sustainable agricultural equipment</ix:nonNumeric></td><td>&#160;</td> <td style="vertical-align: top; text-align: center"><ix:nonNumeric contextRef="c111" name="ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary" id="ixv-43609">Argentina</ix:nonNumeric></td><td>&#160;</td> <td style="text-align: center">a),b)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c111" decimals="2" format="ixt:num-dot-decimal" id="ix_4_fact" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" unitRef="pure">64</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c112" decimals="2" format="ixt:num-dot-decimal" id="ix_5_fact" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" unitRef="pure">64</ix:nonFraction></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left">Bioceres Group Limited</td><td>&#160;</td> <td style="text-align: left"><ix:nonNumeric contextRef="c113" name="ifrs-full:NameOfSubsidiary" id="ixv-43612">Investment in subsidiaries</ix:nonNumeric></td><td>&#160;</td> <td style="vertical-align: top; text-align: center"><ix:nonNumeric contextRef="c113" name="ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary" id="ixv-43613">United Kingdom</ix:nonNumeric></td><td>&#160;</td> <td style="text-align: center">b)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c113" decimals="2" format="ixt:num-dot-decimal" id="ix_16_fact" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" unitRef="pure">100</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c114" decimals="2" format="ixt:num-dot-decimal" id="ix_17_fact" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" unitRef="pure">100</ix:nonFraction></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Bioceres Crop Solutions (BIOX)</td><td>&#160;</td> <td style="vertical-align: top; text-align: left"><ix:nonNumeric contextRef="c115" name="ifrs-full:NameOfSubsidiary" id="ixv-43616">Research and development</ix:nonNumeric></td><td>&#160;</td> <td style="vertical-align: top; text-align: center"><ix:nonNumeric contextRef="c115" name="ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary" id="ixv-43617">United States</ix:nonNumeric></td><td>&#160;</td> <td style="text-align: center">c)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c115" decimals="4" format="ixt:num-dot-decimal" id="ix_18_fact" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" unitRef="pure">29.30</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c116" decimals="4" format="ixt:num-dot-decimal" id="ix_19_fact" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" unitRef="pure">28.75</ix:nonFraction></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left">Bioceres LLC</td><td>&#160;</td> <td style="text-align: left"><ix:nonNumeric contextRef="c117" name="ifrs-full:NameOfSubsidiary" id="ixv-43620">Investment in subsidiaries</ix:nonNumeric></td><td>&#160;</td> <td style="vertical-align: top; text-align: center"><ix:nonNumeric contextRef="c117" name="ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary" id="ixv-43621">United States</ix:nonNumeric></td><td>&#160;</td> <td style="text-align: center">a)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c117" decimals="2" format="ixt:num-dot-decimal" id="ix_6_fact" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" unitRef="pure">100</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c118" decimals="2" format="ixt:num-dot-decimal" id="ix_7_fact" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" unitRef="pure">100</ix:nonFraction></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-align: left">Bioceres S.A.</td><td>&#160;</td> <td style="text-align: left"><ix:nonNumeric contextRef="c119" name="ifrs-full:NameOfSubsidiary" id="ixv-43624">Investment in subsidiaries</ix:nonNumeric></td><td>&#160;</td> <td style="vertical-align: top; text-align: center"><ix:nonNumeric contextRef="c119" name="ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary" id="ixv-43625">Argentina</ix:nonNumeric></td><td>&#160;</td> <td style="text-align: center">a)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c119" decimals="4" format="ixt:num-dot-decimal" id="ix_8_fact" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" unitRef="pure">89.93</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c120" decimals="4" format="ixt:num-dot-decimal" id="ix_9_fact" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" unitRef="pure">79.72</ix:nonFraction></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left">Bioceres Tech Services LLC</td><td>&#160;</td> <td style="vertical-align: top; text-align: left"><ix:nonNumeric contextRef="c121" name="ifrs-full:NameOfSubsidiary" id="ixv-43628">Investment in subsidiaries</ix:nonNumeric></td><td>&#160;</td> <td style="vertical-align: top; text-align: center"><ix:nonNumeric contextRef="c121" name="ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary" id="ixv-43629">United States</ix:nonNumeric></td><td>&#160;</td> <td style="text-align: center">a)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c121" decimals="2" format="ixt:num-dot-decimal" id="ix_10_fact" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" unitRef="pure">100</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c122" decimals="2" format="ixt:num-dot-decimal" id="ix_11_fact" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" unitRef="pure">100</ix:nonFraction></td><td style="text-align: left">%</td></tr> </table></ix:nonNumeric></ix:continuation><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 133; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin: 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation id="_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory-c0_cont_3"><ix:continuation id="_DisclosureOfInterestsInSubsidiariesExplanatory-c0_cont_1"><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> a)&#160;<ix:footnote id="ix_0_footnote" xml:lang="en-US">Direct interests held by Bioceres Group Limited.</ix:footnote></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">b)&#160;<ix:footnote id="ix_1_footnote" xml:lang="en-US">Direct
interest held by Moolec Science SA.</ix:footnote></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">c)&#160;<ix:footnote id="ix_2_footnote" xml:lang="en-US">Since
2023, the Group exercises &#8220;de facto control&#8221; over Bioceres Crop Solutions Corp, however, as stated in note Note 1 &#8211;
The Group&#8217;s business reorganization and general information - &#8220;<i>The Bioceres Group Business Combination Agreement&#8221;</i>,
Bioceres Group Limited lost the &#8220;de facto control&#8221; on June 24, 2025. The subsidiary was deconsolidated as of June 30, 2025,
and the investment in it was measured using the equity method. The Group&#8217;s consolidated result includes the results of that entity
up to the date of its deconsolidation. No results related to the loss of control have been recognized. Various notes to the financial
statements show the effect it has had on consolidated assets and liabilities, business segments and CGUs.</ix:footnote></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">d)&#160;<ix:footnote id="ix_3_footnote" xml:lang="en-US">Direct
interest held by Nutrecon LLC.</ix:footnote></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration:underline">Special purpose and structured entities (&#8220;SPE&#8221;)</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A structured entity is an entity that has been
designed so that voting or similar rights are not the dominant factor in deciding who controls the entity and the relevant activities
are directed by means of contractual arrangements. In these cases, the Company considers the purpose and design of the SPE, including
a consideration of the risks the SPE was expected to be exposed to, the risks it was designed to pass on to the parties involved with
the SPE and whether the Company is exposed to some or all of those risks or potential returns. One then considers which activities have
a significant impact on the SPE&#8217;s returns and determines which parties have an ability to direct each of those activities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group controls an SPE when is exposed, or
has rights, to variable returns from its involvement with the SPE and has the ability to affect those returns through its power over the
SPE. Following the BIOX deconsolidation, the Group does not control any SPE.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="fs_003"></a></div><ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" id="ixv-21851"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><b>3.</b></td><td style="text-align: justify"><b><span style="text-decoration:underline">NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS ISSUED
BY THE IASB</span></b></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">New standards and interpretations adopted
by the Group</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">a)</span></td><td style="text-align: justify">The following new standards became applicable for the current
reporting period and adopted by the Group.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">-</span></td><td style="text-align: justify">Amendments to <ix:nonNumeric contextRef="c123" name="ifrs-full:DescriptionWhetherChangeInAccountingPolicyIsMadeInAccordanceWithTransitionalProvisionsOfInitiallyAppliedIFRS" id="ixv-43635"><ix:nonNumeric contextRef="c123" name="ifrs-full:TitleOfInitiallyAppliedIFRS" id="ixv-43636">IFRS 16</ix:nonNumeric> - Lease Liability in a Sale and Leaseback.</ix:nonNumeric></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.3pt; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">-</span></td><td style="text-align: justify">Amendments to <ix:nonNumeric contextRef="c124" name="ifrs-full:DescriptionWhetherChangeInAccountingPolicyIsMadeInAccordanceWithTransitionalProvisionsOfInitiallyAppliedIFRS" id="ixv-43637"><ix:nonNumeric contextRef="c124" name="ifrs-full:TitleOfInitiallyAppliedIFRS" id="ixv-43638">IAS 1</ix:nonNumeric> &#8211; Non-current liabilities with covenants.</ix:nonNumeric></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.3pt; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">-</span></td><td style="text-align: justify">Amendment to IAS 7 and IFRS 7 - Supplier Financing.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.3pt; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">-</span></td><td style="text-align: justify">Amendments to IAS 7 - Statement of Cash Flows &amp; to IFRS 7- Financial Instruments:
                                                                                                                     Disclosures.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.3pt; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These new standards and amendments did not have
any material impact on the Group.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-size: 10pt">b)</span></td><td style="text-align: justify">The following new standards are not yet adopted by the Group.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">-</span></td><td style="text-align: justify"><i>IFRS 19 &#8211; Subsidiaries without Public Accountability. </i>The standard is effective for annual
periods beginning on or after January 1, 2027.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.3pt; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">-</span></td><td style="text-align: justify"><i>Amendments to IFRS 9 and IFRS 7 - Amendments to the Classification and Measurement of Financial Instruments.
</i>The amendments are effective for reporting periods beginning on or after January 1, 2026.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.3pt; text-align: justify; text-indent: -0.25in"><i>&#160;</i></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">-</span></td><td style="text-align: justify"><i>Amendments to IFRS 9 and IFRS 7 &#8211; Contracts Referencing Nature-dependent Electricity. </i>The
amendments are effective for annual periods beginning on or after January 1, 2026.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.3pt; text-align: justify; text-indent: -0.25in"><i>&#160;</i></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">-</span></td><td style="text-align: justify"><i>Annual Improvements to IFRS Accounting Standards&#8212;Volume 11.</i> The amendments are effective
for annual periods beginning on or after January 1, 2026.</td></tr></table></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.3pt; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.3pt; text-align: justify; text-indent: -0.25in"></p><div>

</div><!-- Field: Page; Sequence: 134; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.3pt; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation id="_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations-c0_cont_1"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">-</span></td><td style="text-align: justify"><i>Amendments to IAS 21- The Effects of Changes in Foreign Exchange Rates titled Lack of Exchangeability</i><b>.
</b>The amendments are effective for annual reporting periods beginning on or after January 1, 2025.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.3pt; text-align: justify; text-indent: -0.25in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These amendments are not expected to have material
impact on the Group.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">-</span></td><td style="text-align: justify"><i>IFRS 18 &#8211; Presentation and Disclosure in Financial Statements. </i>This standard introduces new
requirements for the presentation and disclosure of income and expenses in the statement of profit or loss, including the introduction
of new defined subtotals such as Operating Profit and enhanced disaggregation requirements. The standard also includes additional guidance
on aggregation principles and requires disclosures about management-defined performance measures (MPMs) used in public communications
outside the financial statements. It is effective for annual periods beginning on or after January 1, 2027, with retrospective application
in accordance with IAS 8, subject to specific transitional reliefs.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.3pt; text-align: justify; text-indent: -0.25in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group is analyzing the potential impact of
this standard on our financial statements, which is expected to mainly affect the presentation and structure of the primary financial
statements and related disclosures, but not the recognition or measurement of transactions.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="fs_004"></a></div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfMaterialAccountingPolicyInformationExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory" id="ixv-22016"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><b>4.</b></td><td style="text-align: justify"><b><span style="text-decoration:underline">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" id="ixv-22027"><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>4.1.&#160;<span style="text-decoration:underline">Cash and cash
equivalents</span></b></p></ix:nonNumeric>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:continuation id="_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the purposes of the statements of financial
position and statements of cash flows, cash and cash equivalents include cash on hand and in banks and short-term highly liquid investments.
Investments can be readily convertible to known amounts of cash and they are subject to insignificant risk of changes in value. In the
consolidated statements of financial position, bank overdrafts are included in borrowings within current liabilities.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="mlec_DescriptionOfAccountingPolicyForFinancialAssetsAndLiabilitiesPolicyTextBlock-c0_cont_1" escape="true" name="mlec:DescriptionOfAccountingPolicyForFinancialAssetsAndLiabilitiesPolicyTextBlock" id="ixv-22036"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>4.2. &#160;<span style="text-decoration:underline">Financial assets and liabilities</span></b></p></ix:nonNumeric>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify; text-indent: -0.3in"><b>&#160;</b></p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForFinancialAssetsAndLiabilitiesPolicyTextBlock-c0_cont_2" id="mlec_DescriptionOfAccountingPolicyForFinancialAssetsAndLiabilitiesPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group measures its financial assets at initial
recognition at fair value and subsequently at amortized cost using the effective interest method.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForFinancialAssetsAndLiabilitiesPolicyTextBlock-c0_cont_3" id="mlec_DescriptionOfAccountingPolicyForFinancialAssetsAndLiabilitiesPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group has not irrevocably designated a financial
asset as measured at fair value through profit or loss to eliminate or significantly reduce a measurement or recognition inconsistency.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForFinancialAssetsAndLiabilitiesPolicyTextBlock-c0_cont_4" id="mlec_DescriptionOfAccountingPolicyForFinancialAssetsAndLiabilitiesPolicyTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial assets at fair value through profit
or loss are measured at fair value through profit and loss due to the business model used in their negotiation and/or the contractual
characteristics of their cash flows.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForFinancialAssetsAndLiabilitiesPolicyTextBlock-c0_cont_5" id="mlec_DescriptionOfAccountingPolicyForFinancialAssetsAndLiabilitiesPolicyTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Estimates</i></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForFinancialAssetsAndLiabilitiesPolicyTextBlock-c0_cont_6" id="mlec_DescriptionOfAccountingPolicyForFinancialAssetsAndLiabilitiesPolicyTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group makes estimates of uncollectability
of its recorded receivables. Management analyzes trade account receivables in accordance with conventional criteria, adjusting the amount
through a charge of an allowance for bad debts upon recognition of the inability of third parties to afford their financial obligations
to the Group. Management specifically analyzes the accounts receivable, the historical bad debts, solvency of customers, current economic
trends and the changes to the payment conditions of customers to assess the adequate allowance for bad debts.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForFinancialAssetsAndLiabilitiesPolicyTextBlock-c0_cont_7" id="mlec_DescriptionOfAccountingPolicyForFinancialAssetsAndLiabilitiesPolicyTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Offsetting of financial assets with financial
liabilities</i></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<ix:continuation id="mlec_DescriptionOfAccountingPolicyForFinancialAssetsAndLiabilitiesPolicyTextBlock-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial assets and liabilities are offset and
presented for their net amount in the statements of financial position only when the Group has the right, legally enforceable, to compensate
the recognized amounts and has the intention to liquidate for the net amount or to settle the asset and cancel the liability simultaneously.</p></ix:continuation></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 135; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_DisclosureOfMaterialAccountingPolicyInformationExplanatory-c0_cont_2" id="_DisclosureOfMaterialAccountingPolicyInformationExplanatory-c0_cont_1"><ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForMeasuringInventories-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForMeasuringInventories" id="ixv-22110"><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>4.3. <span style="text-decoration:underline">Inventories</span></b></p></ix:nonNumeric>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForMeasuringInventories-c0_cont_2" id="_DescriptionOfAccountingPolicyForMeasuringInventories-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Inventories are recognized at cost initially and
subsequently at the lower of cost and net realizable value. Cost comprises all costs of purchase and conversion as well as other costs
incurred in bringing the inventories to their present location and condition.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForMeasuringInventories-c0_cont_3" id="_DescriptionOfAccountingPolicyForMeasuringInventories-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Weighted average cost is used to determine the
cost of ordinarily interchangeable items.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForMeasuringInventories-c0_cont_4" id="_DescriptionOfAccountingPolicyForMeasuringInventories-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Estimates</i></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForMeasuringInventories-c0_cont_5" id="_DescriptionOfAccountingPolicyForMeasuringInventories-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group assesses the recoverability of inventories
considering their sale price, whether the inventories are damaged and whether they have become obsolete in whole or in part.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForMeasuringInventories-c0_cont_6" id="_DescriptionOfAccountingPolicyForMeasuringInventories-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Net realizable value is the sale price estimated
to be attained in the ordinary course of business, less costs of completion and other selling expenses.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation id="_DescriptionOfAccountingPolicyForMeasuringInventories-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group sets up an allowance for obsolescence
or slow-moving inventories in relation to finished and in-process products. The allowance for obsolescence or slow-moving inventories
is recognized for finished products and in-process products based on an analysis by Management of the aging of inventory stocks.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory" id="ixv-22136"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>4.4. <span style="text-decoration:underline">Biological assets</span></b></p></ix:nonNumeric>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify; text-indent: -0.3in"><b>&#160;</b></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Within current assets, growing crops are included
as biological assets, from the moment of sowing until the moment of harvest (approximately <ix:nonNumeric contextRef="c125" format="ixt-sec:durmonth" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeBiologicalAssetsAtCost" id="ixv-43639">5</ix:nonNumeric> to <ix:nonNumeric contextRef="c126" format="ixt-sec:durmonth" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeBiologicalAssetsAtCost" id="ixv-43640">7</ix:nonNumeric> months depending on the crop). At harvest
time the biological assets are transformed into agricultural products, including seed varieties for resale, and incorporated into the
inventory.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory-c0_cont_3" id="_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Costs are capitalized as biological assets if,
and only if, (a) it is probable that future economic benefits will flow to the entity, and (b) the cost can be measured reliably. The
Group capitalizes costs such as: planting, harvesting, weeding, seedlings, irrigation, agrochemicals, fertilizers and a systematic allocation
of fixed and variable production overheads that are directly attributable to the management of biological assets, among others.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory-c0_cont_4" id="_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Biological assets, both at initial recognition
and at each subsequent reporting date, are measured at fair value less costs to sell, except where fair value cannot be reliably measured.
Cost approximates fair value when little biological transformation has taken place since the costs were originally incurred or the impact
of biological transformation on price is not expected to be material.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory-c0_cont_5" id="_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Gains and losses that arise from measuring biological
assets at fair value less costs to sell and measuring agricultural produce at the point of harvest at fair value less costs to sell are
recognized in the statement of income in the period in which they arise in the line item &#8220;Initial recognition and changes in fair
value of biological assets&#8221;.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory-c0_cont_6" id="_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From the harvest time, agricultural products are
valued at net realizable value because there is a market asset, and the risk of non-sale is non-significant.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory-c0_cont_7" id="_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Generally, the estimation of the fair value of
biological assets is based on models or inputs that are not observable in the market and the use of unobservable inputs is significant
to the overall valuation of the assets. Unobservable inputs are determined based on the best information available. Key assumptions include
future market prices, estimated yields at the point of harvest, estimated production cycle, future cash flows, future costs of harvesting
and other costs, and estimated discount rate.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation id="_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Market prices are generally determined by reference
to observable data in the principal market for the agricultural produce. Harvesting costs and other costs are estimated based on historical
and statistical data. Yields are estimated based on several factors, including the location of the farmland and soil type, environmental
conditions, infrastructure and other restrictions and growth at the time of measurement. Yields are subject to a high degree of uncertainty
and may be affected by several factors out of the Group&#8217;s control including but not limited to extreme or unusual weather conditions,
plagues and other crop diseases, among other factors.</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 136; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_DisclosureOfMaterialAccountingPolicyInformationExplanatory-c0_cont_3" id="_DisclosureOfMaterialAccountingPolicyInformationExplanatory-c0_cont_2"><ix:nonNumeric contextRef="c0" continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_1" escape="true" name="mlec:DescriptionOfAccountingPolicyForBasisOfConsolidation" id="ixv-22207"><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>4.5. <span style="text-decoration:underline">Basis of consolidation</span></b></p></ix:nonNumeric>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_2" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Business combinations</span></b></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_3" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>General</i><b>&#160;</b></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_4" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group applies the acquisition method to account
for business combinations. The acquisition cost is measured as the aggregate of the consideration transferred for the acquisition of a
subsidiary, which is measured at fair value at the acquisition date, and the amount of any non-controlling interest in such subsidiary.
The Group recognizes any non-controlling interest in a subsidiary at the non-controlling interest&#8217;s proportionate share of the recognized
amounts of subsidiary&#8217;s identifiable net assets. The acquisition related costs are expensed as incurred.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_5" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any contingent consideration to be transferred
by the Group is recognized at fair value at the acquisition date. The contingent consideration is classified as an asset or liability
that is a financial instrument under IFRS 9 is measured at fair value through profit or loss.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_6" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Goodwill is initially measured at cost, which
is the excess of the aggregate of the consideration transferred and the amount of the non-controlling interest and any previous interest
carried over the net identifiable assets acquired, and liabilities assumed.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_7" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">After initial recognition, goodwill is measured
at cost less any accumulated impairment losses. For impairment testing, goodwill acquired in a business combination is, as of the acquisition
date, allocated to each of the cash-generating units of the Group that is expected to benefit from the synergies of the combination, without
considering whether other assets or liabilities of the subsidiary are allocated to those units.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_8" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any impairment in the carrying value is recognized
in the consolidated statement of comprehensive income. In the case of acquisitions in stages, prior to the write-off of the previously
held equity interest in the subsidiary, said interest is re-measured at fair value as of the date of acquisition of control over the subsidiary.
The result of the re-measurement at fair value is recognized in profit or loss.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_9" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When a seller in a business combination has contractually
agreed to indemnify the Group for the result of a contingency or uncertainty related to the entirety or a portion of an asset or liability,
the Group recognizes an indemnification asset. The indemnification asset is measured on the same basis as the indemnification item. At
the end of each period, the Group measures the indemnification assets recognized at the acquisition date on the same basis as the indemnified
liability, subject to any contractual limitation on the amount and, for an indemnification asset that is not periodically measured at
fair value, based on Management&#8217;s assessment of the recoverability of the indemnification asset. The Group derecognizes the indemnification
asset when it collects or sells it, or when it loses the right over it.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_10" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Reverse acquisitions</i></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_11" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_10"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In a reverse acquisition, the accounting acquirer
usually issues no consideration for the acquiree. Instead, the accounting acquiree usually issues its equity shares to the owners of the
accounting acquirer. Accordingly, the acquisition-date fair value of the consideration transferred by the accounting acquirer for its
interest in the accounting acquiree is based on the number of equity interests the legal subsidiary would have had to issue to give the
owners of the legal parent the same percentage equity interest in the combined entity that results from the reverse acquisition. The fair
value of the number of equity interests calculated in that way can be u sed as the fair value of consideration transferred in exchange
for the acquiree.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_12" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_11"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Consolidated financial statements prepared following
a reverse acquisition are issued under the name of the legal parent (accounting acquiree) but described in the notes as a continuation
of the financial statements of the legal subsidiary (accounting acquirer), with one adjustment, which is to adjust retroactively the accounting
acquirer&#8217;s legal capital to reflect the legal capital of the accounting acquiree. That adjustment is required to reflect the capital
of the legal parent (the accounting acquiree). Comparative information presented in those consolidated financial statements also is retroactively
adjusted to reflect the legal capital of the legal parent (accounting acquiree).</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_13" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_12"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because the consolidated financial statements
represent the continuation of the financial statements of the legal subsidiary except for its capital structure, the consolidated financial
statements reflect:</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_14" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_13"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-size: 10pt">a.</span></td><td style="text-align: justify">the assets and liabilities of the legal subsidiary (the accounting acquirer) recognized and measured at
their pre-combination carrying amounts.</td></tr></table></ix:continuation>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_15" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_14"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-size: 10pt">b.</span></td><td style="text-align: justify">the assets and liabilities of the legal parent (the accounting acquiree) recognized and measured in accordance
with IFRS 3.</td></tr></table></ix:continuation>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_16" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_15"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-size: 10pt">c.</span></td><td style="text-align: justify">the retained earnings and other equity balances of the legal subsidiary (accounting acquirer) before the
business combination.</td></tr></table></ix:continuation></ix:continuation><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><!-- Field: Page; Sequence: 137; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><ix:continuation continuedAt="_DisclosureOfMaterialAccountingPolicyInformationExplanatory-c0_cont_4" id="_DisclosureOfMaterialAccountingPolicyInformationExplanatory-c0_cont_3"><ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_17" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_16"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-size: 10pt">d.</span></td><td style="text-align: justify">the amount recognized as issued equity interests in the consolidated financial statements determined by
adding the issued equity interest of the legal subsidiary (the accounting acquirer) outstanding immediately before the business combination
to the fair value of the legal parent (accounting acquiree). However, the equity structure (ie. the number and type of equity interests
issued) reflects the equity structure of the legal parent (the accounting acquiree), including the equity interests the legal parent issued
to effect the combination. Accordingly, the equity structure of the legal subsidiary (the accounting acquirer) is restated using the exchange
ratio established in the acquisition agreement to reflect the number of shares of the legal parent (the accounting acquiree) issued in
the reverse acquisition.</td></tr></table></ix:continuation>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_18" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_17"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When a reverse acquisition occurs, in calculating
the weighted average number of ordinary shares outstanding (the denominator of the earnings per share calculation) during the period in
which the reverse acquisition occurs:</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_19" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_18"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-size: 10pt">a.</span></td><td style="text-align: justify">the number of ordinary shares outstanding from the beginning of that period to the acquisition date shall
be computed on the basis of the weighted average number of ordinary shares of the legal acquiree (accounting acquirer) outstanding during
the period multiplied by the exchange ratio established in the merger agreement; and</td></tr></table></ix:continuation>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_20" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_19"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-size: 10pt">b.</span></td><td style="text-align: justify">the number of ordinary shares outstanding from the acquisition date to the end of that period shall be
the actual number of ordinary shares of the legal acquirer (the accounting acquiree) outstanding during that period.</td></tr></table></ix:continuation>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_21" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_20"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The basic earnings per share for each comparative
period before the acquisition date presented in the consolidated financial statements following a reverse acquisition shall be calculated
by dividing:</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_22" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_21"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-size: 10pt">a.</span></td><td style="text-align: justify">the profit or loss of the legal acquiree attributable to ordinary shareholders in each of those periods
by</td></tr></table></ix:continuation>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_23" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_22"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-size: 10pt">b.</span></td><td style="text-align: justify">the legal acquiree&#8217;s historical weighted average number of ordinary shares outstanding multiplied
by the exchange ratio established in the acquisition agreement.</td></tr></table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_24" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_23"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Subsidiaries</span></b></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_25" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_24"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subsidiaries are entities controlled by the Group.
Information about Group accounting policy is included in Note 2 &#8211; &#8220;<i>Accounting standards and Basis of Preparation</i>&#8221;.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_26" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_25"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Non controlling interest</span></b></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_27" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_26"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NCI are measured initially at their proportionate
share of the acquiree&#8217;s identifiable net assets at the date of acquisition.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_28" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_27"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Change in ownership interest in subsidiaries
without change of control </span></b></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_29" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_28"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Transactions with non-controlling interest that
do not result in a loss of control are accounted for as equity transactions - i.e., as transactions with the owners&#160;in their capacity
as owners. The recorded value corresponds to the difference between the fair value of the consideration paid and/or received and the relevant
share acquired and/or transferred of the carrying value of the net assets of the subsidiary.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_30" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_29"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Loss of control</span></b></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_31" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_30"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When the Group loses control over a subsidiary,
it derecognizes the assets and liabilities of the subsidiary, and any related NCI and other components of equity. Any resulting gain or
loss is recognized in profit or loss.</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 138; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_DisclosureOfMaterialAccountingPolicyInformationExplanatory-c0_cont_5" id="_DisclosureOfMaterialAccountingPolicyInformationExplanatory-c0_cont_4"><ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_32" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_31"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Investments for which the Group does not exercise
control, but which are not accounted for under the equity method due to meeting the definition of a financial asset, are measured at fair
value through profit or loss in accordance with IFRS 9 Financial Instruments.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_33" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_32"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When an investee (either a subsidiary or other
investment) enters a liquidation process and the Group no longer retains the ability to direct its relevant activities&#8212;such as through
the formal appointment of a liquidator by the investee&#8217;s Board of Directors&#8212;the Group concludes that control has been lost.
In such cases, the date of the liquidator&#8217;s appointment is considered the derecognition event for purposes of IFRS 10.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_34" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_33"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Associate and joint arrangements </span></b></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_35" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_34"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">An associate is an entity over which the Group
exerts significant influence. Significant influence is the power to participate in financial and operating policy decision-making at such
entity, but it does not involve control or joint control over those policies.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_36" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_35"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group is a party to a joint arrangement when
there is a contractual arrangement that confers joint control over the relevant activities of the arrangement to the Group and at least
one other party. Joint control is assessed under the same principles as control over subsidiaries.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_37" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_36"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group classifies its interests in joint arrangements
as either:</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_38" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_37"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify"><i>Joint ventures</i>: where the group has rights to only
the <i>net assets </i>of the joint arrangement.</td>
</tr></table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: justify; text-indent: -14.2pt"><i>&#160;</i></p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_39" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_38"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify"><i>Joint operations</i>: where the group has both the rights
to the assets and obligations for the liabilities of the joint arrangement.</td>
</tr></table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_40" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_39"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In assessing the classification of interests in
joint arrangements, the Group considers:</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_41" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_40"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">The structure of the joint arrangement;</td>
</tr></table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_42" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_41"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">The legal form of joint arrangements structured through a
separate vehicle;</td>
</tr></table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_43" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_42"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">The contractual terms of the joint arrangement agreement;
and</td>
</tr></table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_44" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_43"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">Any other facts and circumstances (including any other contractual
arrangements).</td>
</tr></table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_45" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_44"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group accounts for its interests in joint
ventures and associates using the equity method, where the Group&#8217;s share of post-acquisition profits and losses and other comprehensive
income is recognized in the Consolidated statement of profit and loss and other comprehensive income.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_46" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_45"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Losses in excess of the Group&#8217;s investment
in the joint venture and associates are recognized only to the extent that the Group has incurred legal or constructive obligations or
made payments on behalf of the joint venture.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_47" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_46"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Profits and losses arising on transactions between
the Group and its joint ventures and associates are recognized only to the extent of unrelated investors&#8217; interests in the joint
venture and/or associates. The Group&#8217;s share in a joint venture and/or associates&#8217; profits and losses resulting from a transaction
is eliminated against the carrying amount of investment in the joint venture and/or associates through the line &#8220;share of profit
(or loss) of joint ventures and associates&#8221; in the Consolidated statements of profit or loss and other comprehensive income.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_48" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_47"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any premium paid for an investment in a joint
venture and/or associates above the fair value of the Group&#8217;s share of the identifiable assets, liabilities and contingent liabilities
acquired is capitalized and included in the carrying amount of the investment in the joint venture and/or associates. Where there is objective
evidence that the investment in a joint venture and/or associates has been impaired, the carrying amount of the investment is tested for
impairment in the same way as other non-financial assets.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_49" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_48"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When the Group loses significant influence in
an associate or joint control over a joint venture, it measures and recognizes any investment held at fair value. Any difference between
the carrying amount of the associate or joint venture when losing significant influence or joint control and the fair value of the held
investment and sale revenue are recognized in profit or loss.</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 139; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_DisclosureOfMaterialAccountingPolicyInformationExplanatory-c0_cont_6" id="_DisclosureOfMaterialAccountingPolicyInformationExplanatory-c0_cont_5"><ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_50" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_49"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group accounts for its interests in joint
operations by recognizing its share of assets, liabilities, revenues and expenses in accordance with its contractually conferred rights
and obligations.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_51" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_50"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For all joint arrangements structured in separate
vehicles the Group must assess the substance of the joint arrangement in determining whether it is classified as a joint venture or joint
operation. This assessment requires the Group to consider whether it has rights to the joint arrangement&#8217;s net assets (in which
case it is classified as a joint venture), or rights to and obligations for specific assets, liabilities, expenses, and revenues (in which
case it is classified as a joint operation).</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_52" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_51"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Paragraph 18 of IAS 28 states when an investment
in an associate or a joint venture is held by, or is held indirectly through, an entity that is a venture capital organization, or a mutual
fund, unit trust and similar entities, the entity may elect to measure that investment al fair value through profit or loss in accordance
with IFRS 9.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_53" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_52"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has elected to measure the investment
in associates held through Theo I SCSp at fair value through profit or loss in accordance with IFRS 9.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_54" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_53"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Estimates</i></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_55" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_54"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There is uncertainty regarding Management&#8217;s
estimates of the Group&#8217;s ability to recover the carrying amounts of the investments in joint ventures, since such estimates depend
on the joint ventures&#8217; ability to generate sufficient funds to complete the development projects, the future outcome of the project
deregulation process and the amounts and timing of the cash flows from projects, among other future events.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_56" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_55"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management assesses whether there are impairment
indicators and, if any, it performs a recoverability analysis.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_57" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_56"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management estimates of the recoverability of
these investments represent the best estimate based on available evidence, the existing facts and circumstances, using reasonable and
provable assumptions in the cash flow projections.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_58" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_57"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Therefore, the consolidated financial statements
do not include adjustments that would be required if the Group were unable to recover the carrying amount of the above-mentioned assets
by generating sufficient economic benefits in the future.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_59" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_58"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Transactions eliminated on consolidation</span></b></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:continuation id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation-c0_cont_59"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Intra-group balances and transactions, and any
unrealized income and expenses (except for foreign currency transaction gains and losses) arising from intra-group transactions, are eliminated.
Unrealized gains arising from transactions with equity-accounted investees are eliminated against the investment to the extent of the
Group&#180;s interest in the investee. Unrealized losses are eliminated in the same way as unrealized gains, but only to the extent that
there is no evidence of impairment.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory" id="ixv-22620"><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>4.6. <span style="text-decoration:underline">Impairment assessment of Goodwill and Intangible assets</span></b></p></ix:nonNumeric>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Impairment tests on goodwill and intangible assets
not yet available for use or with indefinite useful lives, are undertaken annually at the end of the reporting period. Other non-financial
assets are subject to impairment tests whenever events or changes in circumstances indicate that their carrying amount may not be recoverable.
Where the carrying value of an asset exceeds its recoverable amount (i.e. the higher of value in use and fair value less costs to sell),
the asset is written down accordingly.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory-c0_cont_3" id="_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Where it is not possible to estimate the recoverable
amount of an individual asset, the impairment test is carried out on the smallest group of assets to which it belongs for which there
are separately identifiable cash flows (its Cash Generating Unit or CGU). Goodwill is allocated on initial recognition to each of the
Group&#8217;s CGUs that are expected to benefit from a business combination that gives rise to the goodwill.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory-c0_cont_4" id="_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Impairment charges are included in profit or loss,
except to the extent they reverse gains previously recognized in other comprehensive income. An impairment loss recognized for goodwill
is not reversed.</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 140; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_DisclosureOfMaterialAccountingPolicyInformationExplanatory-c0_cont_7" id="_DisclosureOfMaterialAccountingPolicyInformationExplanatory-c0_cont_6"><ix:continuation continuedAt="_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory-c0_cont_5" id="_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Estimates</i></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<ix:continuation id="_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Impairment testing of goodwill and intangible
assets not yet available for use or with indefinite useful lives, requires the use of significant assumptions for the estimation of future
cash flows and the determination of discount rates. The significant assumptions and the determination of discount rates for the impairment
testing of goodwill are further explained in Note 7.9 - Goodwill.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" id="ixv-22689"><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>4.7. <span style="text-decoration:underline">Property, plant and equipment</span></b></p></ix:nonNumeric>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Property, plant and equipment items are initially
recognized at cost. In addition to the purchase price, cost also includes costs directly attributable to such property, plant and equipment
items. There are no unavoidable costs with respect to dismantling and removing items. The cost of property, plant and equipment items
acquired in a business combination is their fair value at the acquisition date.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_3" id="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Depreciation is calculated using the straight-line
method to allocate the property, plant or equipment items&#8217; cost or revalued amounts, net of their residual values, over their estimated
useful lives or, in the case of leasehold improvements and certain leased plant and equipment, the shorter lease term as follows:</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_4" id="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Research instruments: <ix:nonNumeric contextRef="c127" format="ixt-sec:duryear" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" id="ixv-43641">3</ix:nonNumeric> to <ix:nonNumeric contextRef="c128" format="ixt-sec:duryear" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" id="ixv-43642">10</ix:nonNumeric> years</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_5" id="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Office equipment: <ix:nonNumeric contextRef="c129" format="ixt-sec:duryear" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" id="ixv-43643">5</ix:nonNumeric> to <ix:nonNumeric contextRef="c130" format="ixt-sec:duryear" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" id="ixv-43644">10</ix:nonNumeric> years</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_6" id="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Vehicles: <ix:nonNumeric contextRef="c131" format="ixt-sec:duryear" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" id="ixv-43645">5</ix:nonNumeric> years</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_7" id="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Computer equipment and software: <ix:nonNumeric contextRef="c132" format="ixt-sec:duryear" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" id="ixv-43646">3</ix:nonNumeric> years</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_8" id="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Fixture and fittings: <ix:nonNumeric contextRef="c133" format="ixt-sec:duryear" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" id="ixv-43647">10</ix:nonNumeric> years</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_9" id="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Machinery and equipment: <ix:nonNumeric contextRef="c134" format="ixt-sec:duryear" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" id="ixv-43648">5</ix:nonNumeric> to <ix:nonNumeric contextRef="c135" format="ixt-sec:duryear" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" id="ixv-43649">10</ix:nonNumeric> years</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_10" id="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Buildings: <ix:nonNumeric contextRef="c136" format="ixt-sec:duryear" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" id="ixv-43650">50</ix:nonNumeric> years</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_11" id="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_10"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Useful lives and depreciation methods are reviewed
every year as required by IAS 16.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_12" id="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_11"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a result of the business combination completed
on <span style="font-weight: normal">June 16, 2025</span>, and the BIOX deconsolidation, the structure, scale and operations of the Group
changed significantly compared with the former reporting entity. The transaction resulted in a new combined entity whose asset base, operational
model and strategic focus differ materially from those of the pre-combination entity.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_13" id="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_12"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Given these changes, management re-assessed the
appropriateness of the accounting policy applied to property, plant and equipment. Prior to the business combination, the former entity
measured certain classes of property, plant and equipment under the <span style="font-weight: normal">revaluation model</span>. Following
the acquisition, and considering the characteristics of the combined business, management determined that the <span style="font-weight: normal">cost
model</span> provides more reliable and relevant information for users of the financial statements.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_14" id="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_13"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accordingly, beginning on <span style="font-weight: normal">June
16, 2025</span>, the Group <span style="font-weight: normal">discontinued the revaluation model</span> and now measures all property plant
and equipment at <span style="font-weight: normal">cost less accumulated depreciation and impairment losses</span>. The change has been
accounted for prospectively in accordance with applicable IFRS requirements, as it results from management&#8217;s reassessment of the
accounting policies of the newly formed reporting entity rather than from a voluntary change.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_15" id="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_14"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The carrying amounts of property, plant and equipment
previously measured under the revaluation model became their deemed cost at the date the new policy was adopted. No restatement of comparative
periods was required.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_16" id="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_15"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prior to The Bioceres Group Business Combination
Agreement and the BIOX deconsolidation, the assets under items Land and Buildings, were accounted for at fair value arising from the last
revaluation performed, applying the revaluation model indicated by IAS 16. Starting with the fiscal year ended on June&#160;30, 2024,
the Group modified its Property, Plant, and Equipment valuation policy by changing the revaluation frequency for items classified under
Buildings and Land. The revaluation must never exceed five years between each occurrence, in compliance with the maximum periods established
by accounting standards, or whenever there are indications that the carrying amount differs significantly from the amount that could be
determined using fair value at the end of the reporting year.</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 141; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin: 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_DisclosureOfMaterialAccountingPolicyInformationExplanatory-c0_cont_8" id="_DisclosureOfMaterialAccountingPolicyInformationExplanatory-c0_cont_7"><ix:continuation continuedAt="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_17" id="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_16"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To obtain fair values, the existence or not of
an active market it was considered for the assets in their current status. For those assets for which an active market in their current
status existed, the fair values were determined based on their market values. For the remaining cases, the market values of comparable
new assets were analyzed, applying a discount based on the status and wear of each asset and considering the characteristics of each of
the revalued assets (for example, improvements made, maintenance status, level of productivity, use, etc.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_18" id="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_17"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Estimates</i></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_19" id="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_18"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group used to carry certain classes of property,
plant and equipment under the revaluation model under IAS 16. The revaluation model requires that the Group carry property, plant and
equipment at revalued amounts, being fair value at the date of revaluation less any subsequent accumulated depreciation and any subsequent
accumulated impairment losses. IAS 16 requires that the Group carry out these revaluations with sufficient regularity so that the carrying
amounts of its property, plant and equipment do not differ materially from that which would be determined using fair value at the end
of a reporting period. The determination of fair value at the date of revaluation requires judgments, estimates and assumptions based
on market conditions prevailing at the time of any such revaluation. Changes to any of the Group&#8217;s judgments, estimates or assumptions
or to the market conditions subsequent to a revaluation will result in changes to the fair value of property, plant and equipment.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_20" id="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_19"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group used to prepare the corresponding revaluations
on a regular basis taking into account the work of independent appraisers. The Group uses different valuation techniques depending on
the class of property being valued. Generally, the Group determines the fair value of its industrial buildings and warehouses based on
a depreciated replacement cost approach. The Group determines the fair value of its land based on active market prices adjusted, if necessary,
for differences in the nature, location or condition of the specific asset. If this information is not available, the Group may use alternative
valuation methods, such as recent prices in less active markets.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_21" id="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_20"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Property valuation is a significant area of estimation
uncertainty. Fair values used to be prepared regularly by Management, taking into account independent valuations. The determination of
fair value for the different classes of property, plant and equipment is sensitive to the selection of various significant assumptions
and estimates. Changes in those significant assumptions and estimates could materially affect the determination of the revalued amounts
of property, plant and equipment. The Group utilizes historical experience, market information and other internal information to determine
and/or review the appropriate revalued amounts.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_22" id="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_21"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following were the most significant assumptions
used in the preparation of the revalued amounts for its classes of property, plant and equipment:</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_23" id="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_22"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">a)&#160;Land:
The Group generally used to use the market price of a square meter of land for the same or similar location as the most significant assumption
to determine the revalued amount. The Group typically used to use comparable land sales in the same location to assess appropriateness
of the value of its land.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation id="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_23"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">b)&#160;Industrial
buildings and warehouses: The Group generally used to determine the construction cost of a new asset and then the Group adjusts it for
normal wear and tear. Construction prices may include, but are not limited to, construction materials, labor costs, installation and assembly
costs, site preparation, professional fees and applicable taxes. Construction costs may differ significantly from year to year and are
subject to macroeconomic changes in the economy where the Group operates, such as the impact of inflation and foreign exchange rates.
The construction cost of its industrial buildings and warehouses is determined on a US dollar per constructed square meter basis, while
the construction cost of its mills, facilities and grain storage facilities is determined by reference to their total capacity measured
in tons milled or stored, respectively. A <ix:nonFraction contextRef="c137" decimals="2" format="ixt:num-dot-decimal" name="mlec:ValuationSignificantChangePercentageOfConstructionCosts" scale="-2" unitRef="pure" id="ixv-43651">5</ix:nonFraction>% increase or decrease in the construction costs or the estimate of normal wear and tear relating
to such assets could have an impact of $<ix:nonFraction contextRef="c0" decimals="-5" format="ixt:num-dot-decimal" name="mlec:ValuationSignificantChangeInAmountNormalWearAndTearVariationImpactOnRevaluationAmount" scale="6" unitRef="usd" id="ixv-43652">1.2</ix:nonFraction> million on their revalued amounts.</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 142; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin: 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><ix:continuation continuedAt="_DisclosureOfMaterialAccountingPolicyInformationExplanatory-c0_cont_9" id="_DisclosureOfMaterialAccountingPolicyInformationExplanatory-c0_cont_8"><ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForLeasesExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory" id="ixv-22860"><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>4.8. <span style="text-decoration:underline">Leased assets</span></b></p></ix:nonNumeric>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForLeasesExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForLeasesExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Leases are recognized as a right-of-use asset
and corresponding liability at the date of which the leased asset is available for use by the Group. Each lease payment is allocated between
the liability and finance cost. The finance cost is charged to profit or loss over the lease period so as to produce a constant periodic
rate of interest on the remaining balance of the liability for each period. The right-of-use asset is depreciated over the shorter of
the asset&#8217;s useful life and the lease term on a straight-line basis.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForLeasesExplanatory-c0_cont_3" id="_DescriptionOfAccountingPolicyForLeasesExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In determining the lease term, the Company considers
all facts and circumstances that create an economic incentive to exercise an extension option or not exercise a termination option. Extension
options (or periods after termination options) are only included in the lease term if the lease is reasonably certain to be extended (or
not terminated).</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForLeasesExplanatory-c0_cont_4" id="_DescriptionOfAccountingPolicyForLeasesExplanatory-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Short term leases are recognized on a straight-line
basis as an expense in the income statement.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForLeasesExplanatory-c0_cont_5" id="_DescriptionOfAccountingPolicyForLeasesExplanatory-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At initial recognition, the right-of-use asset
is measured considering the value of the initial measurement of the lease liability; any lease payments made at or before the commencement
date, less any lease incentives; and any initial direct costs incurred by the lessee. After initial recognition, the right-of-use assets
are measured at cost, less any accumulated depreciation and/or impairment losses, and adjusted for any re-measurement of the lease liability.
Depreciation of the right-of-use asset is calculated using the straight-line method over the estimated duration of the lease contract.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForLeasesExplanatory-c0_cont_6" id="_DescriptionOfAccountingPolicyForLeasesExplanatory-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The lease liability is initially measured at the
present value of the lease payments that are not paid at such date, including variable lease payments that depend on an index or rate,
initially measured using the index or rate as of the commencement date; amounts expected to be payable by the lessee under residual value
guarantees; the exercise price of a purchase option if the lessee is reasonably certain to exercise that option; payments of penalties
for terminating the lease, if the lease term reflects the lessee exercising an option to terminate the lease; and fixed payments, less
any lease incentives receivable. After the commencement date, the Company measures the lease liability by increasing the carrying amount
to reflect interest on the lease liability; reducing the carrying amount to reflect lease payments made; and re-measuring the carrying
amount to reflect any reassessment or lease modifications.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation id="_DescriptionOfAccountingPolicyForLeasesExplanatory-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The above-mentioned inputs for the valuation of
the right of use assets and lease liabilities including the determination of the contracts within the scope of the standard, the contract
term ant interest rate used in the discounted cash flow involved a management&#8217;s estimations.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory" id="ixv-22884"><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>4.9. <span style="text-decoration:underline">Intangible assets</span></b></p></ix:nonNumeric>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_1"><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>a) Externally acquired intangible assets</b></p></ix:continuation>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_3" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Externally acquired intangible assets are initially
recognized at acquisition date fair value (which is considered as their cost). After initial recognition, those assets are measured at
cost less accumulated amortization and accumulated impairment losses.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_4" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Intangible assets acquired from third parties
have an estimated useful life as follows (in years):</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_5" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Software: <ix:nonNumeric contextRef="c138" format="ixt-sec:duryear" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" id="ixv-43653">3</ix:nonNumeric> years</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_6" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Trademarks and patents: <ix:nonNumeric contextRef="c139" format="ixt-sec:duryear" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" id="ixv-43654">5</ix:nonNumeric> years</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_7" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certification ISO Standards: <ix:nonNumeric contextRef="c140" format="ixt-sec:duryear" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" id="ixv-43655">3</ix:nonNumeric> years</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_8" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Useful lives and amortization methods are reviewed
every year as required by IAS 38.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_9" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Estimates</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_10" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To value acquired intangible assets, valuation
techniques generally accepted in the market are applied, based mainly on the revenue approach (such as excess earnings, relief from royalty,
and with or without), considering the characteristics of the assets to be valued and available information to estimate their acquisition
date fair value. Application of these valuation techniques requires the use of several assumptions related to future cash flows and the
discount rate.</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 143; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><ix:continuation continuedAt="_DisclosureOfMaterialAccountingPolicyInformationExplanatory-c0_cont_10" id="_DisclosureOfMaterialAccountingPolicyInformationExplanatory-c0_cont_9"><ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_11" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_10"><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>b) Internally generated intangible assets (development costs)</b></p></ix:continuation>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_12" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_11"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Expenditure on internally developed products is
capitalized if it can be demonstrated that:</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_13" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_12"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">It is technically feasible to develop the product for it
to be sold;</td>
</tr></table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_14" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_13"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">Adequate resources are available to complete the development;</td>
</tr></table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_15" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_14"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">There is an intention to complete and sell the product;</td>
</tr></table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_16" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_15"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">The Group is able to sell the product;</td>
</tr></table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_17" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_16"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">Sale of the product will generate future economic benefits;
and</td>
</tr></table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_18" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_17"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">Expenditure on the project can be measured reliably.</td>
</tr></table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_19" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_18"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Development expenditure not satisfying the above
criteria and expenditure on the research phase of internal projects are recognized in the consolidated statement of profit or loss and
other comprehensive income as incurred (Note 8.3 - R&amp;D classified by nature).</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_20" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_19"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Capitalized development costs are amortized using
the straight-line method over the periods the Group expects to benefit from selling the products developed (Note 7.8 &#8211; Intangible
assets).</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_21" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_20"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Useful lives and amortization methods are reviewed
every year as required by IAS 38.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_22" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_21"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The research and development process can be divided
into several discrete steps or phases, which generally begin with discovery, validation and development and end with regulatory approval
and commercial launch. The process for developing seed traits is relatively similar for both GM and non-GM traits. However, the two differ
significantly in later phases of development. For example, obtaining regulatory approval for GM seeds is a far more comprehensive and
lengthy process than for non-GM seeds. Although breeding programs and industrial biotechnology solutions may have shorter or simpler phases
than those described below, the Group has used the industry consensus for seed-trait development phases to characterize its technology
portfolios, which is generally divided into the following six phases:</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_23" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_22"><p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify">i) Discovery: The first phase in the technology
development process is the discovery or identification of candidate genes or genetic systems, metabolites, or microorganisms potentially
capable of enhancing specified plant characteristics or enabling an agro-industrial biotech solution.</p></ix:continuation>

<p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_24" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_23"><p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify">ii) Proof of concept: Upon successful validation
of the technologies in model systems (<i>in vitro </i>or <i>in vivo</i>), promising technologies graduate from discovery and are advanced
to the proof of concept phase. The goal of this phase is to validate a technology within the targeted organism before moving forward with
technology escalation activities or extensive field validation.</p></ix:continuation>

<p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_25" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_24"><p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify">iii) Early development: In this phase, field tests
commenced in the proof of concept phase are expanded to evaluate various permutations of a technology in multiple geographies and growing
cycles, as well as other characteristics in order to optimize the technology&#8217;s performance in the targeted organisms. The goal of
the early development phase is to identify the best mode of use of a technology to define its performance concept.</p></ix:continuation>

<p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_26" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_25"><p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify">iv) Advanced development and deregulation: In
this phase, extensive field tests are used to demonstrate the effectiveness of the technology for its intended purpose. In the case of
GM traits, the process of obtaining regulatory approvals from government authorities is also initiated during this phase, and tests are
performed to evaluate the potential environmental impact of modified plants. For solutions involving microbial fermentation, industrial-scale
runs are conducted.</p></ix:continuation>

<p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_27" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_26"><p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify">v) Pre-launch: This phase involves finalizing
the regulatory approval process and preparing for the launch and commercialization of the technology. The range of activities in this
phase includes seed increases, pre-commercial production, and product and solution testing with selected customers. Usually, a more detailed
marketing strategy and preparation of marketing materials occur during this phase.</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 144; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><ix:continuation continuedAt="_DisclosureOfMaterialAccountingPolicyInformationExplanatory-c0_cont_11" id="_DisclosureOfMaterialAccountingPolicyInformationExplanatory-c0_cont_10"><ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_28" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_27"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: 0pt; text-align: justify">vi) Product launch: In general, this phase, which
is the last milestone of the research and development process, is carried out by the Group, the joint ventures and/or the Group&#8217;s
technology licensees. When technology is commercialized through the joint ventures or technology licensees, a successful product launch
will trigger royalty payments to the Group, which are generally calculated as a percentage of the net sales realized by the technology
and captured upon commercialization.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_29" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_28"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Demonstrability of technical feasibility generally
occurs when the project reaches the &#8220;advanced development and deregulation&#8221; phase because at this stage success is considered
to be probable.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_30" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_29"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>c)&#160;Intangible
assets acquired in a business combination</b></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_31" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_30"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Intangible assets acquired in a business combination
and recognized separately from goodwill are initially recognized at acquisition date fair value (which is considered as their cost). After
initial recognition, those assets are measured at cost less accumulated amortization and accumulated impairment losses in the same manner
as intangible assets acquired separately.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_32" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_31"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Intangible assets acquired in a business combination
have an estimated useful life as follows (in years):</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_33" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_32"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Product development: <ix:nonNumeric contextRef="c141" format="ixt-sec:duryear" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" id="ixv-43656">20</ix:nonNumeric> &#8211; <ix:nonNumeric contextRef="c142" format="ixt-sec:duryear" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" id="ixv-43657">25</ix:nonNumeric> years</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_34" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_33"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Trademarks: <ix:nonNumeric contextRef="c143" format="ixt-sec:duryear" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" id="ixv-43658">20</ix:nonNumeric> years</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_35" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_34"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Customer loyalty: <ix:nonNumeric contextRef="c144" format="ixt-sec:duryear" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" id="ixv-43659">14</ix:nonNumeric> - <ix:nonNumeric contextRef="c145" format="ixt-sec:duryear" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" id="ixv-43660">26</ix:nonNumeric> years</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_36" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_35"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Estimates</i></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><ix:continuation id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_36">To value intangible assets acquired from a business
combination, valuation techniques generally accepted in the market were applied, based mainly on the revenue approach (such as excess
earnings, relief from royalty, and with or without), considering the characteristics of the assets to be valued and available information
to estimate their acquisition date fair value.</ix:continuation> Application of these valuation techniques requires the use of several assumptions related
to future cash flows and the discount rate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForInvestmentPropertyExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForInvestmentPropertyExplanatory" id="ixv-23119"><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>4.10. <span style="text-decoration:underline">Investment properties</span></b></p></ix:nonNumeric>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForInvestmentPropertyExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForInvestmentPropertyExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Investment properties shall be measured initially
at its cost. The cost of a purchased investment property comprises its purchase price and any directly attributable expenditure. Directly
attributable expenditure includes, for example, professional fees for legal services, property transfer taxes and other transaction costs.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation id="_DescriptionOfAccountingPolicyForInvestmentPropertyExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the measurement after initial recognition,
the Group has chosen the cost model for all investment properties.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForBorrowingsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForBorrowingsExplanatory" id="ixv-23132"><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>4.11. <span style="text-decoration:underline">Borrowings</span></b></p></ix:nonNumeric>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForBorrowingsExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForBorrowingsExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group measures its borrowings at initial recognition
at fair value and, subsequently, are measured at amortized cost using the effective interest rate method.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForBorrowingsExplanatory-c0_cont_3" id="_DescriptionOfAccountingPolicyForBorrowingsExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Borrowing costs, either generic or specific, attributable
to the acquisition, construction or production of assets that necessarily take a substantial period of time to get ready for their intended
use or sale (qualifying assets) are included in the cost of the assets until the moment that they are substantially ready for use or sale.
Income earned on the temporary investments of funds generated in specific borrowings still pending use in the qualifying assets, are deducted
from the total of financing costs potentially eligible for capitalization.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation id="_DescriptionOfAccountingPolicyForBorrowingsExplanatory-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All other loan costs are recognized under financial
costs, through profit and loss.</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 145; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><ix:continuation continuedAt="_DisclosureOfMaterialAccountingPolicyInformationExplanatory-c0_cont_12" id="_DisclosureOfMaterialAccountingPolicyInformationExplanatory-c0_cont_11"><ix:nonNumeric contextRef="c0" continuedAt="mlec_DescriptionOfAccountingPolicyForConvertibleNotesTextBlock-c0_cont_1" escape="true" name="mlec:DescriptionOfAccountingPolicyForConvertibleNotesTextBlock" id="ixv-23191"><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>4.12. <span style="text-decoration:underline">Convertibles notes</span></b></p></ix:nonNumeric>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation id="mlec_DescriptionOfAccountingPolicyForConvertibleNotesTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial liabilities, like convertible notes
that do not meet the &#8220;fixed for fixed&#8221; condition, are classified at their inception at fair value through profit or loss or
at amortized cost, using the effective interest amortization method.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" id="ixv-23200"><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>4.13. <span style="text-decoration:underline">Employee benefits</span></b></p></ix:nonNumeric>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Employee benefits are expected to be settled wholly
within 12 months after the end of the reporting period and are presented as current liabilities.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation id="_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accounting policies related to incentive payments
based on shares, if any, are detailed in Note 19 &#8211; Share-based payments.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForProvisionsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory" id="ixv-23212"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>4.14.&#160;<span style="text-decoration:underline">Provisions</span></b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:continuation id="_DescriptionOfAccountingPolicyForProvisionsExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group has recognized provisions for liabilities
of uncertain timing or amount. The provision is measured at the best estimate of the expenditure required to settle the obligation at
the end of the reporting period, discounted at a pre-tax rate reflecting current market assessments of the time value of money and risks
specific to the liability.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="mlec_DescriptionOfAccountingPolicyForWarrantLiabilities-c0_cont_1" escape="true" name="mlec:DescriptionOfAccountingPolicyForWarrantLiabilities" id="ixv-23221"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>4.15.&#160;<span style="text-decoration:underline">Warrant
liabilities </span></b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForWarrantLiabilities-c0_cont_2" id="mlec_DescriptionOfAccountingPolicyForWarrantLiabilities-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As part of the business combination, the Group
acquired public warrants and private warrants.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForWarrantLiabilities-c0_cont_3" id="mlec_DescriptionOfAccountingPolicyForWarrantLiabilities-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Public Warrants: These instruments are initially
recognized at fair value on the date the derivative contract is entered into and are subsequently remeasured to fair value at the end
of each reporting period. Gains and losses arising from changes in fair value are recognized in profit or loss.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForWarrantLiabilities-c0_cont_4" id="mlec_DescriptionOfAccountingPolicyForWarrantLiabilities-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These warrants are measured at Level 1 fair value,
based on their quoted market price.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForWarrantLiabilities-c0_cont_5" id="mlec_DescriptionOfAccountingPolicyForWarrantLiabilities-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Private Warrants: These instruments are measured
at fair value using valuation techniques, including the Black-Scholes model.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation id="mlec_DescriptionOfAccountingPolicyForWarrantLiabilities-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These warrants are classified as Level 3 fair
value measurements, as they rely on significant unobservable inputs.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForRecognitionOfRevenue-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue" id="ixv-23242"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>4.16.&#160;<span style="text-decoration:underline">Revenue
recognition</span></b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForRecognitionOfRevenue-c0_cont_2" id="_DescriptionOfAccountingPolicyForRecognitionOfRevenue-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Revenue is recognized when control has been transferred
to the buyer. Transfers of control vary depending on the individual terms of the sales contract. Revenues are recognized when control
of the products has been transferred, which generally means that the products have been delivered to the customer and there is no unfulfilled
obligation that could affect a customer&#8217;s acceptance of the products. Generally, acceptance occurs upon shipment or delivery but
ultimately depends on the terms of the underlying contracts. The customer is then invoiced at the agreed-upon price with the usual payment
terms for each geographical region. Those payment terms do not contain a significant financing component.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForRecognitionOfRevenue-c0_cont_3" id="_DescriptionOfAccountingPolicyForRecognitionOfRevenue-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The timing of performance sometimes differs from
the timing that the associated consideration is received from the customer, thus resulting in the recognition of a contract asset or contract
liability. The Company recognizes a contract liability if the customer&#8217;s payment of consideration is received prior to completion
of the related performance obligation.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForRecognitionOfRevenue-c0_cont_4" id="_DescriptionOfAccountingPolicyForRecognitionOfRevenue-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a part of the Company&#8217;s customary business
practices, the Company offers a number of sales incentives to the customers, including volume discounts, retailer incentives, prepayment
options and other product rebates. For all such contracts that include any variable consideration, the Company estimates the amount of
variable consideration that should be included in the transaction price utilizing either the expected value method or the most likely
amount method, depending on the nature of the variable consideration. Variable consideration is included in the transaction price if,
in the judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur. Although determining
the transaction price for consideration requires significant judgment, the Company has meaningful historical experience with incentives
provided to customers and estimate the expected consideration in view of historical patterns of incentive payouts. These estimates are
reassessed each reporting period.</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 146; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><ix:continuation continuedAt="_DisclosureOfMaterialAccountingPolicyInformationExplanatory-c0_cont_13" id="_DisclosureOfMaterialAccountingPolicyInformationExplanatory-c0_cont_12"><ix:continuation continuedAt="_DescriptionOfAccountingPolicyForRecognitionOfRevenue-c0_cont_5" id="_DescriptionOfAccountingPolicyForRecognitionOfRevenue-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company also offer an assurance warranty,
which gives customers a refund or exchange right in the case the delivered product does not conform to specifications. Replacement products
are accounted for under the warranty guidance if the customer exchanges one product for another of the same type, quality, and price.
The Company has significant experience with historical return patterns and use this experience to include returns in the estimate of transaction
price.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForRecognitionOfRevenue-c0_cont_6" id="_DescriptionOfAccountingPolicyForRecognitionOfRevenue-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With respect to services, the Company mainly provides
R&amp;D and seed treatment services. Revenue associated with services is recognized by reference to the stage of completion of the transaction
at the end of the reporting period. Each of the services to be provided has a detailed work plan in which all activities to be rendered
are listed. The stage of completion for services is determined in accordance with the execution of the performed tasks listed in the respective
work plan. The level of execution of such services is provided by the Company&#8217;s technical experts, who provide information relating
to the transfer of goods or services. The Company has no material revenue for services that cannot be reliably estimated.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForRecognitionOfRevenue-c0_cont_7" id="_DescriptionOfAccountingPolicyForRecognitionOfRevenue-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Revenue for usage-based royalties relating to
licensed intellectual property rights is recognized at the later of when the performance obligation is satisfied and when a sale or use
occurs.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation id="_DescriptionOfAccountingPolicyForRecognitionOfRevenue-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Typically, the Company&#8217;s average payment
terms range from <ix:nonNumeric contextRef="c125" format="ixt-sec:durday" name="mlec:AveragePaymentTermBySales" id="ixv-43662">130</ix:nonNumeric> to <ix:nonNumeric contextRef="c126" format="ixt-sec:durday" name="mlec:AveragePaymentTermBySales" id="ixv-43663">160</ix:nonNumeric> days at a consolidated level. Longer terms may be granted in limited circumstances; however, the effects of
such sales are not material to the consolidated financial statements. Those payment terms do not contain a significant financing component.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForGovernmentGrants-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForGovernmentGrants" id="ixv-23313"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>4.17.&#160;<span style="text-decoration:underline">Government
grants</span></b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForGovernmentGrants-c0_cont_2" id="_DescriptionOfAccountingPolicyForGovernmentGrants-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Government grants are recognized where there is
reasonable assurance that the grant will be received and all attached conditions will be complied with. When the grant relates to an expense
item, it is recognized as income on a systematic basis over the periods that the related costs, for which it is intended to compensate,
are expensed. When the grant relates to an asset, it is recognized as income in equal amounts over the expected useful life of the related
asset. Management elected this accounting policy because the Group determined it better shows the financial effect of government grants
in the consolidated financial statements.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForGovernmentGrants-c0_cont_3" id="_DescriptionOfAccountingPolicyForGovernmentGrants-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When the Group receives grants of non-monetary
assets, the asset and the grant are recorded at nominal amounts and released to profit or loss over the expected useful life of the asset.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation id="_DescriptionOfAccountingPolicyForGovernmentGrants-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The difference between the money obtained under
government loans at subsidized rates and the carrying amount of those loans is treated as a government grant, in accordance with IAS 20.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory" id="ixv-23328"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>4.18.&#160;<span style="text-decoration:underline">Income
tax</span></b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Income tax expense comprises current and deferred
tax. It is recognized in profit or loss except to the extent that it relates to a business combination, or items recognized directly in
equity or in OCI.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_3" id="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group has determined that interest and penalties
related to income taxes, including uncertain tax treatments, do not meet the definition of income taxes, and therefore accounted for them
under IAS 37 <i>Provisions, Contingent Liabilities and Contingent Assets.</i></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_4" id="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group has determined that the global minimum
top-up tax &#8211; which it is required to pay under Pillar Two legislation &#8211; is an income tax in the scope of IAS 12. Pillar Two
legislation is not applicable to Moolec Science SA in accordance with current thresholds.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_5" id="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Current tax</b></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_6" id="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Current tax comprises the expected tax payable
or receivable on the taxable income or loss for the year and any adjustment to the tax payable or receivable in respect of previous years.
The amount of current tax payable or receivable is the best estimate of the tax amount expected to be paid or received that reflects uncertainty
related to income taxes, if any. It is measured using tax rates enacted or substantively enacted at the reporting date. Current tax also
includes any tax arising from dividends.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_7" id="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Current tax assets and liabilities are offset
only if certain criteria are met.</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 147; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_DisclosureOfMaterialAccountingPolicyInformationExplanatory-c0_cont_14" id="_DisclosureOfMaterialAccountingPolicyInformationExplanatory-c0_cont_13"><ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_8" id="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Deferred tax</b></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_9" id="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Deferred tax assets and liabilities are recognized
where the carrying amount of an asset or liability in the Consolidated statement of financial position differs from its tax base, except
for differences arising on:</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_10" id="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_9"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">The initial recognition of goodwill;</td>
</tr></table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_11" id="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_10"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">The initial recognition of an asset or liability in a transaction
which is not a business combination and at the time of the transaction affects neither accounting or taxable profit; and</td>
</tr></table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_12" id="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_11"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">Investments in subsidiaries and jointly controlled entities
where the Group is able to control the timing of the reversal of the difference and it is probable that the difference will not reverse
in the foreseeable future.</td>
</tr></table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_13" id="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_12"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Recognition of deferred tax assets is restricted
to those instances where it is probable that taxable profit will be available against which the difference can be utilized.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_14" id="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_13"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The amount of the asset or liability is determined
using tax rates that have been enacted or substantively enacted by the end of the reporting period and are expected to apply when the
deferred tax liabilities / (assets) are settled / (recovered).</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_15" id="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_14"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Deferred tax assets and liabilities are offset
when the Group has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities
relate to taxes levied by the same tax authority on either:</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_16" id="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_15"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">The same taxable entity within the Group, or</td>
</tr></table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation id="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_16"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">Different entities within the Group which intend either to
settle current tax assets and liabilities on a net basis, or to realize the assets and settle the liabilities simultaneously, in each
future period in which significant amounts of deferred tax assets or liabilities are expected to be settled or recovered.</td>
</tr></table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" id="ixv-23450"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>4.19.&#160;<span style="text-decoration:underline">Share-based
payments</span></b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prior to the Business Combination and the BIOX
deconsolidation, certain executives and directors of the Group were granted incentives in the form of shares and options to purchase shares
as consideration for services.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_3" id="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The cost of these share-based transactions is
determined based on their fair value at the date upon which such incentives are granted using a valuation model that is appropriate in
the circumstances.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_4" id="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This cost is recognized as an expense together
with an increase in equity throughout the period in which the service or performance conditions are satisfied (i.e., the vesting period).
The accumulated expense recorded in connection with these transactions at the end of each year until the vesting date reflects the time
elapsed between the vesting period and Management&#8217;s best estimate of the number of equity instruments that will vest. The charge
to income/loss for the period represents the variation in the accumulated expense recorded between the beginning and the end of the year.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_5" id="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Non-market related service and performance conditions
are not taken into account when determining the grant date fair value of the equity instruments, but the probability that the conditions
are fulfilled is assessed as part of Management&#8217;s best estimate of the number of equity instruments that will vest. Market-related
performance conditions are reflected in the grant date fair value. Any other conditions related to equity-settled share-based payment
transactions but without a service requirement are considered as non-vesting conditions. Non-vesting conditions are reflected in the fair
value of the equity instruments and are charged to income/loss immediately unless there are service and/or performance conditions as well.</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 148; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin: 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation id="_DisclosureOfMaterialAccountingPolicyInformationExplanatory-c0_cont_14"><ix:continuation continuedAt="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_6" id="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No amount is recognized for transactions that
will not vest because non-market related performance conditions and/or service conditions were not satisfied. When transactions include
market-related conditions or non-vesting conditions, the transactions are considered to be vested, irrespective of whether a market-related
condition or the non-vesting condition is satisfied, provided that all the other performance and/or service conditions are met.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_7" id="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When the terms and conditions of an equity-settled
share-based payment transaction are modified, the minimum expense recognized is the grant date fair value, unmodified, provided that the
original terms have been complied with. An additional expense, measured at the date of modification, is recognized for any modification
that increases the total fair value of the share-based payment transaction, or is otherwise beneficial to the employee.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_8" id="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When the transaction is settled by the Group or
by the counterparty, any remainder of the fair value is charged to income immediately.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_9" id="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The dilutive effect of current options is considered
in the calculation of the diluted earnings per share.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_10" id="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Estimates</i></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_11" id="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_10"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The estimate of the fair value of equity-settled share-based payment
transactions requires a determination to be made of the most adequate option pricing model to apply depending on the terms and conditions
of the arrangement. This estimate also requires a determination of those factors most appropriate to the pricing model, including the
expected life of the option and the expected volatility of the share price upon the basis of which assumptions are made. The Group measures
the fair value of these transactions at the grant date applying the Black-Scholes formula adjusted to consider the possible dilutive effect
of the future exercise of the share options granted on their estimated fair value at grant date, as established in paragraph B41 of IFRS
2. The assumptions used for the estimate of the fair value of these transactions are disclosed in Note 19 &#8211; Share-based payment
and will not necessarily take place in the future.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation id="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_11"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of June 30, 2025 no equity awards are outstanding.</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="fs_005"></a></div><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory" id="ixv-23539"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>5.&#160;<span style="text-decoration:underline">CRITICAL ACCOUNTING
JUDGMENTS AND ESTIMATES</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group makes certain estimates and assumptions
regarding the future. Estimates and judgments are continually evaluated based on historical experience and other factors, including expectations
of future events that are believed to be reasonable under the circumstances. In the future, actual experience may differ from these estimates
and assumptions. The estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amounts of
assets and liabilities within the next financial year are listed below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Critical judgements</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">De facto control over BIOX (Note 1 &#8211; The Group&#8217;s
business reorganization and general information and Note 2 &#8211; Accounting standards an basis of presentation).</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration:underline">Critical estimates</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">Impairment of goodwill (Notes 4.6 &#8211; Impairment assessment
of goodwill and intangibles).</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">Impairment testing of intangible assets not yet available
for use or with indefinite useful lives.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">Identification and fair value of identifiable intangible
assets arising in acquisitions.</td>
</tr></table></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 149; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><div><a id="fs_006"></a></div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory" id="ixv-23624"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>6.&#160;<span style="text-decoration:underline">ACQUISITIONS AND
OTHER SIGNIFICANT TRANSACTIONS</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><i>Bioceres Group, Nutrecon,
Gentle Tech and Moolec Science business combination</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">As stated in Note 1 &#8211;
The Group&#8217;s business reorganization and general information - &#8220;<i>The Bioceres Group Business Combination Agreement&#8221;,
</i>on June 16, 2025, it was announced the closing of the Bioceres Group Business Combination.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The combined group now operates an integrated
platform encompassing R&amp;D, manufacturing, and regulatory capabilities that span from molecular design to validation in both fermenter
and field environments. On one front, the Company advances its molecular farming programs in crops such as soy and safflower to produce
proteins and lipids with animal-like functionality and plant-based cost structures. On the other front, Moolec is developing a precision
fermentation facility in Finland, under the SynBio Powerlabs brand, which will be dedicated to producing target proteins, enzymes, and
other biomolecules using optimized microbial and cellular systems. Once operational, this facility will provide an industrial pathway
to design, ferment, and scale alternative proteins while establishing commercial channels with leading food companies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">The combination of these
two complementary approaches, farming and fermentation, will enable the Company to accelerate time-to-market, diversify technology risks,
and anchor production costs in agricultural scalability, without compromising product functionality or organoleptic properties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">The Business Combination
under IFRS 3, <i>Business Combinations</i>, was accounted using the acquisition method of accounting and treating the transaction as a
reverse acquisition. Under this approach, Bioceres Group (the legal subsidiary) was considered the accounting acquirer, and Moolec Science
SA (the legal acquirer) was considered the accounting acquiree, together with Gentle Tech and Nutrecon.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">As a result, the consolidated
financial statements represent a continuation of the financial statements of Bioceres Group, the predecessor, with the net assets of Moolec
Science SA, Gentle Tech and Nutrecon recognized at fair value on the acquisition date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">Because the transaction is accounted for as a reverse acquisition,
the consideration transferred is based on the number of equity instruments that Bioceres Group would have had to issue to give the owners
of Moolec Science SA, Nutrecon and Gentle Tech the same percentage ownership in the combined entity that results from the transaction.
The fair value of the consideration amounted to $<ix:nonFraction contextRef="c146" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" scale="0" unitRef="usd" id="ixv-43664">19,939,162</ix:nonFraction>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="text-decoration:underline">Identifiable Assets
Acquired and Liabilities Assumed (Accounting Acquirees):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">Provisional Purchase
Price Allocation:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">The purchase price allocation (&#8220;PPA&#8221;) related to the business
combinations have been determined on a provisional basis in accordance with IFRS 3.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 150; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory-c0_cont_2" id="_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">Under IFRS 3, the Company
is permitted to adjust the provisional amounts recognized at the acquisition date during the measurement period, which may extend up to
twelve months from the acquisition date, as new information becomes available regarding facts and circumstances that existed at that date.
Consequently, the amounts disclosed in this note are subject to change.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="mlec_ScheduleOfFairValueOfConsiderationOfPaymentTableTextBlock-c0_cont_1" escape="true" name="mlec:ScheduleOfFairValueOfConsiderationOfPaymentTableTextBlock" id="ixv-23700"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Fair value of the consideration of payment</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%">Equity shares</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c150" decimals="0" format="ixt:num-dot-decimal" name="mlec:EquityShares" scale="0" unitRef="usd" id="ixv-43665">33,504,531</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Warrants</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c150" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:WarrantLiability" scale="0" unitRef="usd" id="ixv-43666">1,030,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total consideration</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c150" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" scale="0" unitRef="usd" id="ixv-43667">34,534,531</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consideration of payment was measured at fair value, which was
calculated as the sum of equity shares and warrants. The fair values of the warrants measured were based on Black &amp; Scholes method
and the equity shares measured was determined using the Moolec&#8217;s share quoted price at the transaction date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory" id="ixv-23726"><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;Assets acquired, liabilities assumed, and non-controlling interest
recognized</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-style: normal; border-bottom: Black 1.5pt solid; font-weight: normal; text-align: left"><b>Net assets incorporated</b></td><td style="font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><b>Total</b></td><td style="padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: normal; width: 88%; font-weight: normal; text-align: justify">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCashAndCashEquivalents" scale="0" unitRef="usd" id="ixv-43668">554,420</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-style: normal; font-weight: normal; text-align: justify">Trade and other receivables</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeReceivables" scale="0" unitRef="usd" id="ixv-43669">4,036,558</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: normal; font-weight: normal; text-align: justify">Property, plant and equipment</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" scale="0" unitRef="usd" id="ixv-43670">3,319,313</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-style: normal; font-weight: normal; text-align: justify">Intangible assets</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" scale="0" unitRef="usd" id="ixv-43671">74,841,933</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: normal; font-weight: normal; text-align: justify">Right of use assets</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsToRightofuseAssets" scale="0" unitRef="usd" id="ixv-43672">100,896</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-style: normal; font-weight: normal; text-align: justify">Inventories</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InventoriesTotal" scale="0" unitRef="usd" id="ixv-43673">2,235,482</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: normal; font-weight: normal; text-align: justify">Borrowings / Financial debt</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate" scale="0" unitRef="usd" id="ixv-43674">19,608,629</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-style: normal; font-weight: normal; text-align: justify">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" scale="0" unitRef="usd" id="ixv-43675">5,806,020</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: normal; font-weight: normal; text-align: justify">Lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LeaseLiabilities" scale="0" unitRef="usd" id="ixv-43676">117,463</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-style: normal; font-weight: normal; text-align: justify">Warrant liabilities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:WarrantLiability" scale="0" unitRef="usd" id="ixv-43677">181,093</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: normal; padding-bottom: 1.5pt; font-weight: normal; text-align: justify">Deferred tax liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" scale="0" unitRef="usd" id="ixv-43678">15,767,275</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-style: normal; font-weight: normal; text-align: justify">Total net assets identified</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed" scale="0" unitRef="usd" id="ixv-43679">43,608,122</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: normal; font-weight: normal; text-align: justify">Non-controlling interest</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="mlec:NoncontrollingInterest" scale="0" unitRef="usd" id="ixv-43680">6,316,790</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-style: normal; font-weight: normal; text-align: left">Previously held interest - revalued at FV</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssetsAtFairValue" scale="0" unitRef="usd" id="ixv-43681">1,283,319</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: normal; padding-bottom: 1.5pt; font-weight: normal; text-align: justify">Gain on purchase</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnDisposalsOfInvestments" scale="0" unitRef="usd" id="ixv-43682">1,473,482</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-style: normal; padding-bottom: 2.5pt; font-weight: normal; text-align: justify"><b>Total consideration</b></td><td style="padding-bottom: 2.5pt; font-weight: bold"><b>&#160;</b></td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><b>$</b></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><b><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" scale="0" unitRef="usd" id="ixv-43683">34,534,531</ix:nonFraction></b></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><b>&#160;</b></td></tr>
  </table></ix:nonNumeric>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>Non-controlling
interest (NCI) was measured at the present ownership instruments&#8217; proportionate share in the recognized amounts of the acquiree&#8217;s
identifiable net assets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>In one of the three acquired
businesses, the Group held an equity interest in the acquiree prior to obtaining control. In accordance with IFRS 3, the previously held
interest was remeasured at its acquisition-date fair value, and the resulting gain or loss was recognized in profit or loss. This remeasurement
reflects the change in value of the Group&#8217;s existing investment up to the date control was obtained and forms part of the total
consideration transferred for the business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The fair value of the identifiable
net assets exceeded the consideration transferred (including the fair value of the NCI). As required by IFRS 3, the resulting excess was
recognized as a bargain purchase gain in profit or loss on the acquisition date. The bargain gain primarily reflects overperforming asset
base identified during the purchase price allocation process. The bargain gain on purchase is recognized in the line item &#8220;Other
income or expenses, net&#8221; in the Consolidated Statement of Comprehensive Income.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The amounts of revenue and net profit of the acquirees
since the merger date included in the consolidated statement of comprehensive income for the year ended June 30, 2025, were immaterial
considering that the acquisition date was very close to the end of the fiscal year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Had the reverse acquisition been completed on
<span style="font-weight: normal">July 1 2024</span>, the pro forma revenue and net loss of the combined entity for the year ended June
30, 2025 as though the date for the merger had been as of the beginning of the reporting period amount to $<ix:nonFraction contextRef="c147" decimals="-5" format="ixt:num-dot-decimal" name="ifrs-full:RevenueOfCombinedEntity" scale="6" unitRef="usd" id="ixv-43684">339.8</ix:nonFraction>&#160;million and $<ix:nonFraction contextRef="c147" decimals="-5" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossOfCombinedEntity" scale="6" unitRef="usd" id="ixv-43685">157.4</ix:nonFraction>&#160;million,
respectively.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 151; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><ix:continuation continuedAt="_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory-c0_cont_3" id="_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Natal Agro S.R.L.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 10, 2024, the former subsidiary, BIOX,
acquired a controlling interest in Natal Agro S.R.L (&#8220;Natal&#8221;), an Argentine company that breeds and develops corn varieties.
The interest acquired is represented by a total of <ix:nonFraction contextRef="c148" decimals="0" format="ixt:num-dot-decimal" name="mlec:NumberOfSharesAcquiredInBusinessCombination" scale="0" unitRef="shares" id="ixv-43686">116,225</ix:nonFraction> shares of AR$ <ix:nonFraction contextRef="c148" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:ParValuePerShare" scale="0" unitRef="arsPershares" id="ixv-43687">10</ix:nonFraction> nominal value each, representing <ix:nonFraction contextRef="c148" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" scale="-2" unitRef="pure" id="ixv-43688">51</ix:nonFraction>% of equity and voting
interest.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consideration for the acquisition was $<ix:nonFraction contextRef="c148" decimals="-4" format="ixt:num-dot-decimal" name="ifrs-full:CashTransferred" scale="6" unitRef="usd" id="ixv-43689">0.22</ix:nonFraction>
million in cash and the commitment to carrying out, at BIOX&#8217;s own expense, the regulatory activities for HB4 corn to obtain authorization
for its commercialization in Argentina, and the regulatory activities for HB4 corn in Brazil, once the commercialization strategy of HB4
corn in Brazil has been defined by the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation id="mlec_ScheduleOfFairValueOfConsiderationOfPaymentTableTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Fair value of the consideration of payment</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; width: 88%; text-align: left">Cash payment</td><td style="padding: 0pt; width: 1%">&#160;</td>
    <td style="padding: 0pt; width: 1%; text-align: left">&#160;</td><td style="padding: 0pt; width: 9%; text-align: right"><ix:nonFraction contextRef="c151" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashTransferred" scale="0" unitRef="usd" id="ixv-43690">215,415</ix:nonFraction></td><td style="padding: 0pt; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding: 0pt; text-align: left">Regulatory activities</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="padding: 0pt; border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c151" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:EquityInterestsOfAcquirer" scale="0" unitRef="usd" id="ixv-43691">727,985</ix:nonFraction></td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; font-weight: bold; text-align: left">Total consideration</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="padding: 0pt; border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c151" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" scale="0" unitRef="usd" id="ixv-43692">943,400</ix:nonFraction></td><td style="padding: 0pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consideration of payment was measured at fair
value, which was calculated as the sum of cash paid and the acquisition-date fair values of the regulatory services to be provided. The
fair values measured were based on discounting future cash flow using market discount rates. The difference between fair value and nominal
value of consideration will be recognized as finance cost over the period the consideration will be paid.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Assets acquired, liabilities assumed, and non-controlling
interest recognized </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<ix:continuation id="_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory-c0_cont_1"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left; padding-left: 0pt">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c152" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCashAndCashEquivalents" scale="0" unitRef="usd" id="ixv-43693">252,923</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Other financial assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c152" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherFinancialAssets" scale="0" unitRef="usd" id="ixv-43694">73,950</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Trade receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c152" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeReceivables" scale="0" unitRef="usd" id="ixv-43695">596,463</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Other receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c152" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherReceivables" scale="0" unitRef="usd" id="ixv-43696">288,861</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Income and minimum presumed recoverable income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c152" decimals="0" format="ixt:num-dot-decimal" name="mlec:IncomeAndMinimumPresumedRecoverableIncomeTaxes" scale="0" unitRef="usd" id="ixv-43697">19,998</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Inventories</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c152" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InventoriesTotal" scale="0" unitRef="usd" id="ixv-43698">4,031,412</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Property, plant and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c152" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" scale="0" unitRef="usd" id="ixv-43699">816,576</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Intangible assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c152" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" scale="0" unitRef="usd" id="ixv-43700">2,217,985</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Right of use asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c153" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsToRightofuseAssets" scale="0" unitRef="usd" id="ixv-43701">168,988</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Trade and other payables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c152" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherPayables" scale="0" unitRef="usd" id="ixv-43702">2,302,332</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">Borrowings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c152" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate" scale="0" unitRef="usd" id="ixv-43703">743,279</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Employee benefits and social security</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c153" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:SocialSecurityContributions" scale="0" unitRef="usd" id="ixv-43704">23,346</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Deferred revenue and advances from customers</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c153" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="0" sign="-" unitRef="usd" id="ixv-43705">2,515</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Provisions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c152" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentProvisions" scale="0" unitRef="usd" id="ixv-43706">355,898</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c152" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LeaseLiabilities" scale="0" unitRef="usd" id="ixv-43707">168,988</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Deferred tax liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c152" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" scale="0" unitRef="usd" id="ixv-43708">996,824</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 0pt">Total net assets identified</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c152" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed" scale="0" unitRef="usd" id="ixv-43709">3,873,974</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-left: 0pt">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Non-controlling interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c152" decimals="0" format="ixt:num-dot-decimal" name="mlec:NoncontrollingInterest" scale="0" sign="-" unitRef="usd" id="ixv-43710">1,898,247</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 0pt">Gain from a bargain purchase</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c153" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainRecognisedInBargainPurchaseTransaction" scale="0" unitRef="usd" id="ixv-43711">1,032,327</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Total consideration</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c152" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" scale="0" unitRef="usd" id="ixv-43712">943,400</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:continuation>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The business combination was executed in a context
of financial setbacks faced by the acquired company. To address these, in addition to the initial cash payment, BIOX has committed to
providing a working capital loan of up to $<ix:nonFraction contextRef="c149" decimals="-6" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermBorrowings" scale="6" unitRef="usd" id="ixv-43713">3</ix:nonFraction> million to help alleviate the financial strain.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 152; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><ix:continuation id="_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">BIOX will also provide regulatory services related
to its proprietary technologies, which will enable strategic business development for Natal and create a new product pipeline leveraging
BIOX&#8217; technology. Specifically, BIOX has agreed to grant Natal an exclusive license for certain technologies to be applied to corn, with
Natal committing to pay <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="mlec:PercentageOfCustomerRevenues" scale="-2" unitRef="pure" id="ixv-43714">15</ix:nonFraction>% of the revenues generated from this technology.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="fs_007"></a></div><ix:nonNumeric contextRef="c0" continuedAt="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock-c0_cont_1" escape="true" name="mlec:DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock" id="ixv-24132"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>7.&#160;<span style="text-decoration:underline">INFORMATION ABOUT
COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>7.1 <span style="text-decoration:underline">Cash and cash equivalents</span></b></p>



<ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory" id="ixv-24141"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>06/30/2025</b></span></td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>06/30/2024</b></span></td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0pt">Cash at bank and on hand</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Cash" scale="0" unitRef="usd" id="ixv-43715">767,919</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Cash" scale="0" unitRef="usd" id="ixv-43716">27,210,070</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Mutual funds</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-176">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="mlec:MutualFunds" scale="0" unitRef="usd" id="ixv-43717">25,784,795</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalents" scale="0" unitRef="usd" id="ixv-43718">767,919</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalents" scale="0" unitRef="usd" id="ixv-43719">52,994,865</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>7.2 <span style="text-decoration:underline">Other financial assets</span></b></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="mlec:DisclosureOfOtherFinancialAssetsExplanatory" id="ixv-24192"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 1.5pt">&#160;</td><td style="padding: 0pt 0pt 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-top: 0pt; text-align: center; padding-right: 0pt; padding-left: 0pt"><span style="font-size: 10pt"><b>06/30/2025</b></span></td><td style="padding: 0pt 0pt 1.5pt">&#160;</td><td style="padding: 0pt 0pt 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-top: 0pt; font-weight: bold; text-align: center; padding-right: 0pt; padding-left: 0pt"><span style="font-size: 10pt"><b>06/30/2024</b></span></td><td style="padding: 0pt 0pt 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-top: 0pt; font-weight: bold; padding-right: 0pt; padding-left: 0pt">Current</td><td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt">&#160;</td>
    <td colspan="2" style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt">&#160;</td>
    <td colspan="2" style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0pt; width: 76%; text-align: left; padding-left: 0pt; padding-right: 0pt">Investments at fair value</td><td style="padding-top: 0pt; width: 1%; padding-right: 0pt; padding-left: 0pt">&#160;</td>
    <td style="padding-top: 0pt; width: 1%; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; width: 9%; text-align: right; padding-right: 0pt; padding-left: 0pt"><ix:nonFraction contextRef="c174" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentFinancialAssets" scale="0" unitRef="usd" id="ixv-43720">19,722</ix:nonFraction></td><td style="padding-top: 0pt; width: 1%; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; width: 1%; padding-right: 0pt; padding-left: 0pt">&#160;</td>
    <td style="padding-top: 0pt; width: 1%; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; width: 9%; text-align: right; padding-right: 0pt; padding-left: 0pt"><ix:nonFraction contextRef="c175" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentFinancialAssets" scale="0" unitRef="usd" id="ixv-43721">2,191,286</ix:nonFraction></td><td style="padding-top: 0pt; width: 1%; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-top: 0pt; text-align: left; padding-left: 0pt; padding-right: 0pt">Mutual funds</td><td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt">&#160;</td>
    <td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; text-align: right; padding-right: 0pt; padding-left: 0pt"><div style="-sec-ix-hidden: hidden-fact-177">-</div></td><td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt">&#160;</td>
    <td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; text-align: right; padding-right: 0pt; padding-left: 0pt"><ix:nonFraction contextRef="c177" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentFinancialAssets" scale="0" unitRef="usd" id="ixv-43722">6,658,805</ix:nonFraction></td><td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 1.5pt; text-align: left">Other investments</td><td style="padding: 0pt 0pt 1.5pt">&#160;</td>
    <td style="padding-top: 0pt; border-bottom: Black 1.5pt solid; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; border-bottom: Black 1.5pt solid; text-align: right; padding-right: 0pt; padding-left: 0pt"><ix:nonFraction contextRef="c178" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentFinancialAssets" scale="0" unitRef="usd" id="ixv-43723">8,234,539</ix:nonFraction></td><td style="padding: 0pt 0pt 1.5pt; text-align: left">&#160;</td><td style="padding: 0pt 0pt 1.5pt">&#160;</td>
    <td style="padding-top: 0pt; border-bottom: Black 1.5pt solid; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; border-bottom: Black 1.5pt solid; text-align: right; padding-right: 0pt; padding-left: 0pt"><ix:nonFraction contextRef="c179" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentFinancialAssets" scale="0" unitRef="usd" id="ixv-43724">5,817,516</ix:nonFraction></td><td style="padding: 0pt 0pt 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding: 0pt 0pt 4pt">&#160;</td><td style="padding: 0pt 0pt 4pt">&#160;</td>
    <td style="padding-top: 0pt; border-bottom: Black 4pt double; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; border-bottom: Black 4pt double; text-align: right; padding-right: 0pt; padding-left: 0pt"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentFinancialAssets" scale="0" unitRef="usd" id="ixv-43725">8,254,261</ix:nonFraction></td><td style="padding: 0pt 0pt 4pt; text-align: left">&#160;</td><td style="padding: 0pt 0pt 4pt">&#160;</td>
    <td style="padding-top: 0pt; border-bottom: Black 4pt double; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; border-bottom: Black 4pt double; text-align: right; padding-right: 0pt; padding-left: 0pt"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentFinancialAssets" scale="0" unitRef="usd" id="ixv-43726">14,667,607</ix:nonFraction></td><td style="padding: 0pt 0pt 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0pt; padding-left: 0pt; padding-right: 0pt">&#160;</td><td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt">&#160;</td>
    <td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; text-align: right; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt">&#160;</td>
    <td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; text-align: right; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-top: 0pt; font-weight: bold; padding-left: 0pt; padding-right: 0pt">Non-current</td><td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt">&#160;</td>
    <td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; text-align: right; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt">&#160;</td>
    <td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; text-align: right; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0pt; text-align: left; padding-left: 0pt; padding-right: 0pt">Mutual funds</td><td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt">&#160;</td>
    <td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; text-align: right; padding-right: 0pt; padding-left: 0pt"><div style="-sec-ix-hidden: hidden-fact-178">-</div></td><td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt">&#160;</td>
    <td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; text-align: right; padding-right: 0pt; padding-left: 0pt"><ix:nonFraction contextRef="c177" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentFinancialAssets" scale="0" unitRef="usd" id="ixv-43727">190,080</ix:nonFraction></td><td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding: 0pt 0pt 1.5pt; text-align: left">Investments at fair value</td><td style="padding: 0pt 0pt 1.5pt">&#160;</td>
    <td style="padding-top: 0pt; border-bottom: Black 1.5pt solid; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; border-bottom: Black 1.5pt solid; text-align: right; padding-right: 0pt; padding-left: 0pt"><div style="-sec-ix-hidden: hidden-fact-179">-</div></td><td style="padding: 0pt 0pt 1.5pt; text-align: left">&#160;</td><td style="padding: 0pt 0pt 1.5pt">&#160;</td>
    <td style="padding-top: 0pt; border-bottom: Black 1.5pt solid; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; border-bottom: Black 1.5pt solid; text-align: right; padding-right: 0pt; padding-left: 0pt"><ix:nonFraction contextRef="c175" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentFinancialAssets" scale="0" unitRef="usd" id="ixv-43728">437</ix:nonFraction></td><td style="padding: 0pt 0pt 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 4pt">&#160;</td><td style="padding: 0pt 0pt 4pt">&#160;</td>
    <td style="padding-top: 0pt; border-bottom: Black 4pt double; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; border-bottom: Black 4pt double; text-align: right; padding-right: 0pt; padding-left: 0pt"><div style="-sec-ix-hidden: hidden-fact-180">-</div></td><td style="padding: 0pt 0pt 4pt; text-align: left">&#160;</td><td style="padding: 0pt 0pt 4pt">&#160;</td>
    <td style="padding-top: 0pt; border-bottom: Black 4pt double; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; border-bottom: Black 4pt double; text-align: right; padding-right: 0pt; padding-left: 0pt"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentFinancialAssets" scale="0" unitRef="usd" id="ixv-43729">190,517</ix:nonFraction></td><td style="padding: 0pt 0pt 4pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The book value is reasonably approximate to the
fair value given its short-term nature.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>7.3 <span style="text-decoration:underline">Trade receivables</span></b></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="mlec:DisclosureOfTradeReceivablesTableTextBlock" id="ixv-24315"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt"><b>06/30/2025</b></span></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Current</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0pt">Trade debtors</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c180" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentTradeReceivables" scale="0" unitRef="usd" id="ixv-43730">4,519,487</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c181" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentTradeReceivables" scale="0" unitRef="usd" id="ixv-43731">205,490,518</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Allowance for impairment of trade debtors (Note 7.16)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-181">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c181" decimals="0" format="ixt:num-dot-decimal" name="mlec:CurrentTradeReceivablesAllowanceForImpairmentOfTradeDebtors" scale="0" sign="-" unitRef="usd" id="ixv-43732">7,050,280</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Shareholders and other related parties (Note 17)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-182">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c181" decimals="0" format="ixt:num-dot-decimal" name="mlec:CurrentTradeReceivablesShareholdersAndOtherRelatedParties" scale="0" unitRef="usd" id="ixv-43733">37</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; padding-left: 0pt">Allowance for credit notes to be issued</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-183">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c181" decimals="0" format="ixt:num-dot-decimal" name="mlec:AllowanceForReturnOfGoods" scale="0" sign="-" unitRef="usd" id="ixv-43734">2,905,624</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Trade debtors - Joint ventures and associates (Note 13)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c180" decimals="0" format="ixt:num-dot-decimal" name="mlec:CurrentTradeReceivablesTradeDebtorsJointVenturesAndAssociates" scale="0" unitRef="usd" id="ixv-43735">1,565,913</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c181" decimals="0" format="ixt:num-dot-decimal" name="mlec:CurrentTradeReceivablesTradeDebtorsJointVenturesAndAssociates" scale="0" unitRef="usd" id="ixv-43736">2,176,622</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Deferred checks</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-184">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c181" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherReceivables" scale="0" unitRef="usd" id="ixv-43737">11,295,922</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c180" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentReceivables" scale="0" unitRef="usd" id="ixv-43738">6,085,400</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c181" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentReceivables" scale="0" unitRef="usd" id="ixv-43739">209,007,195</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The book value is reasonably approximate to the fair value given its
short-term nature.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As of June 30, 2025, there is no allowance for impairment of
trade debtors, as the trade debtors mainly was acquired through the Business Combination Agreement consummated in June 16, 2025.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 153; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><ix:continuation continuedAt="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock-c0_cont_2" id="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>7.4 <span style="text-decoration:underline">Other receivables</span></b></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="mlec:DisclosureOfOtherReceivablesTableTextBlock" id="ixv-24462"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt"><b>06/30/2024</b></span></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Current</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; padding-left: 0pt">Taxes</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c182" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentReceivables" scale="0" unitRef="usd" id="ixv-43740">382,957</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c183" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentReceivables" scale="0" unitRef="usd" id="ixv-43741">5,475,685</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Insurance to be accrued</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c184" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentReceivables" scale="0" unitRef="usd" id="ixv-43742">11,835</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c185" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentReceivables" scale="0" unitRef="usd" id="ixv-43743">1,595,319</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Other receivables - Joint ventures and associates (Note 13)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c186" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentReceivables" scale="0" unitRef="usd" id="ixv-43744">10,547,409</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c187" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentReceivables" scale="0" unitRef="usd" id="ixv-43745">12,162,870</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Prepayments to suppliers</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c188" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentReceivables" scale="0" unitRef="usd" id="ixv-43746">114</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c189" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentReceivables" scale="0" unitRef="usd" id="ixv-43747">7,236,905</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Shareholders and other related parties (Note 17)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c190" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentReceivables" scale="0" unitRef="usd" id="ixv-43748">2,313,179</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c191" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentReceivables" scale="0" unitRef="usd" id="ixv-43749">47,348</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Government grants receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-185">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c193" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentReceivables" scale="0" unitRef="usd" id="ixv-43750">608</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Prepaid expenses and other receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c194" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentReceivables" scale="0" unitRef="usd" id="ixv-43751">33,448</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c195" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentReceivables" scale="0" unitRef="usd" id="ixv-43752">3,736,808</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Loans receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-186">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c197" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentReceivables" scale="0" unitRef="usd" id="ixv-43753">1,800,572</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 0pt">Miscellaneous</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c198" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentReceivables" scale="0" unitRef="usd" id="ixv-43754">560,222</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c199" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentReceivables" scale="0" unitRef="usd" id="ixv-43755">2,601,268</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentReceivables" scale="0" unitRef="usd" id="ixv-43756">13,849,164</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentReceivables" scale="0" unitRef="usd" id="ixv-43757">34,657,383</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right; padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-left: 0pt">Non-current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">Taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-187">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c183" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentReceivables" scale="0" unitRef="usd" id="ixv-43758">752,045</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Other receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-188">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c201" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentReceivables" scale="0" unitRef="usd" id="ixv-43759">230,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Reimbursements over exports</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-189">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c203" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentReceivables" scale="0" unitRef="usd" id="ixv-43760">1,461,042</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Other receivables - Joint ventures and associates (Note 13)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c186" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentReceivables" scale="0" unitRef="usd" id="ixv-43761">664,493</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c187" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentReceivables" scale="0" unitRef="usd" id="ixv-43762">25,423,142</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 0pt">Miscellaneous</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-190">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c199" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentReceivables" scale="0" unitRef="usd" id="ixv-43763">20,805</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentReceivables" scale="0" unitRef="usd" id="ixv-43764">664,493</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentReceivables" scale="0" unitRef="usd" id="ixv-43765">27,887,034</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The book value of financial assets is reasonably approximate to the
fair value given its short-term nature.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>7.5 <span style="text-decoration:underline">Inventories</span></b></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfInventoriesExplanatory" id="ixv-24676"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt"/>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>06/30/2025</b></span></td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>06/30/2024</b></span></td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; padding-left: 0pt">Seeds</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c204" decimals="0" format="ixt:num-dot-decimal" name="mlec:InventoriesCurrent" scale="0" unitRef="usd" id="ixv-43766">551,290</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c205" decimals="0" format="ixt:num-dot-decimal" name="mlec:InventoriesCurrent" scale="0" unitRef="usd" id="ixv-43767">5,967,231</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Resale products</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-191">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c207" decimals="0" format="ixt:num-dot-decimal" name="mlec:InventoriesCurrent" scale="0" unitRef="usd" id="ixv-43768">53,788,333</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Manufactured products</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c208" decimals="0" format="ixt:num-dot-decimal" name="mlec:InventoriesCurrent" scale="0" unitRef="usd" id="ixv-43769">994,360</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c209" decimals="0" format="ixt:num-dot-decimal" name="mlec:InventoriesCurrent" scale="0" unitRef="usd" id="ixv-43770">26,081,250</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Goods in transit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-192">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c211" decimals="0" format="ixt:num-dot-decimal" name="mlec:InventoriesCurrent" scale="0" unitRef="usd" id="ixv-43771">5,618,540</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">Supplies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-193">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c213" decimals="0" format="ixt:num-dot-decimal" name="mlec:InventoriesCurrent" scale="0" unitRef="usd" id="ixv-43772">22,546,093</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Agricultural products</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c214" decimals="0" format="ixt:num-dot-decimal" name="mlec:InventoriesCurrent" scale="0" unitRef="usd" id="ixv-43773">689,832</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c215" decimals="0" format="ixt:num-dot-decimal" name="mlec:InventoriesCurrent" scale="0" unitRef="usd" id="ixv-43774">15,015,884</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Allowance for obsolescence (Note 7.16)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-194">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c217" decimals="0" format="ixt:num-dot-decimal" name="mlec:InventoriesCurrent" scale="0" sign="-" unitRef="usd" id="ixv-43775">3,087,563</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="mlec:InventoriesCurrent" scale="0" unitRef="usd" id="ixv-43776">2,235,482</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="mlec:InventoriesCurrent" scale="0" unitRef="usd" id="ixv-43777">125,929,768</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Net of agricultural products</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="mlec:InventoriesExcludingAgriculturalProduce" scale="0" unitRef="usd" id="ixv-43778">1,545,650</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="mlec:InventoriesExcludingAgriculturalProduce" scale="0" unitRef="usd" id="ixv-43779">110,913,884</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The roll-forward of allowance for obsolescence
is in Note 7.16.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 154; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><ix:continuation continuedAt="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock-c0_cont_3" id="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>7.6 <span style="text-decoration:underline">Biological assets</span></b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory" id="ixv-24853"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Changes in Biological assets:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Soybean</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Corn</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Wheat</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Barley</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Sunflower</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left; padding-left: 0pt">Beginning of the year</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-195">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-196">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c220" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:BiologicalAssets" scale="0" unitRef="usd" id="ixv-43780">220,682</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c221" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:BiologicalAssets" scale="0" unitRef="usd" id="ixv-43781">73,452</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-197">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:BiologicalAssets" scale="0" unitRef="usd" id="ixv-43782">294,134</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Initial recognition and changes in the fair value of biological assets at the point of harvest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c223" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets" scale="0" sign="-" unitRef="usd" id="ixv-43783">593,001</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c224" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets" scale="0" sign="-" unitRef="usd" id="ixv-43784">435,725</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c225" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets" scale="0" sign="-" unitRef="usd" id="ixv-43785">579,313</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c226" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets" scale="0" sign="-" unitRef="usd" id="ixv-43786">158,080</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c227" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets" scale="0" unitRef="usd" id="ixv-43787">1,256</ix:nonFraction></td><td style="text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets" scale="0" sign="-" unitRef="usd" id="ixv-43788">1,764,863</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Costs incurred during the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c223" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets" scale="0" unitRef="usd" id="ixv-43789">1,959,381</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c224" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets" scale="0" unitRef="usd" id="ixv-43790">1,814,249</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c225" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets" scale="0" unitRef="usd" id="ixv-43791">444,303</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c226" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets" scale="0" unitRef="usd" id="ixv-43792">162,342</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c227" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets" scale="0" unitRef="usd" id="ixv-43793">55,063</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets" scale="0" unitRef="usd" id="ixv-43794">4,435,338</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Decrease due to harvest/disposals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c223" decimals="0" format="ixt:num-dot-decimal" name="mlec:DecreaseDueToHarvestAndDisposalsBiologicalAssets" scale="0" unitRef="usd" id="ixv-43795">1,275,688</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c224" decimals="0" format="ixt:num-dot-decimal" name="mlec:DecreaseDueToHarvestAndDisposalsBiologicalAssets" scale="0" unitRef="usd" id="ixv-43796">1,148,288</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c225" decimals="0" format="ixt:num-dot-decimal" name="mlec:DecreaseDueToHarvestAndDisposalsBiologicalAssets" scale="0" unitRef="usd" id="ixv-43797">1,244,298</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c226" decimals="0" format="ixt:num-dot-decimal" name="mlec:DecreaseDueToHarvestAndDisposalsBiologicalAssets" scale="0" unitRef="usd" id="ixv-43798">393,874</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c227" decimals="0" format="ixt:num-dot-decimal" name="mlec:DecreaseDueToHarvestAndDisposalsBiologicalAssets" scale="0" unitRef="usd" id="ixv-43799">53,807</ix:nonFraction></td><td style="text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:DecreaseDueToHarvestAndDisposalsBiologicalAssets" scale="0" unitRef="usd" id="ixv-43800">4,115,955</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 0pt">Loss of control</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c223" decimals="0" format="ixt:num-dot-decimal" name="mlec:LossOfControlonBiologicalAssets" scale="0" unitRef="usd" id="ixv-43801">1,276,694</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c224" decimals="0" format="ixt:num-dot-decimal" name="mlec:LossOfControlonBiologicalAssets" scale="0" unitRef="usd" id="ixv-43802">1,101,686</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-198">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-199">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-200">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:LossOfControlonBiologicalAssets" scale="0" unitRef="usd" id="ixv-43803">2,378,380</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 0pt">Year ended June 30, 2025</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-201">-</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-202">-</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-203">-</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-204">-</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-205">-</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-206">-</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Soybean</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Corn</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Wheat</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Barley</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Sunflower</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left; padding-left: 0pt">Beginning of the year</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-207">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-208">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c235" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:BiologicalAssets" scale="0" unitRef="usd" id="ixv-43804">87,785</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c236" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:BiologicalAssets" scale="0" unitRef="usd" id="ixv-43805">59,057</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-209">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c47" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:BiologicalAssets" scale="0" unitRef="usd" id="ixv-43806">146,842</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Initial recognition and changes in the fair value of biological assets at the point of harvest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c238" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets" scale="0" unitRef="usd" id="ixv-43807">352,199</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c239" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets" scale="0" unitRef="usd" id="ixv-43808">32,674</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c240" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets" scale="0" sign="-" unitRef="usd" id="ixv-43809">231,526</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c241" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets" scale="0" sign="-" unitRef="usd" id="ixv-43810">106,605</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c242" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets" scale="0" sign="-" unitRef="usd" id="ixv-43811">996</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets" scale="0" unitRef="usd" id="ixv-43812">45,746</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Costs incurred during the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c238" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets" scale="0" unitRef="usd" id="ixv-43813">1,423,732</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c239" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets" scale="0" unitRef="usd" id="ixv-43814">792,235</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c240" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets" scale="0" unitRef="usd" id="ixv-43815">220,679</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c241" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets" scale="0" unitRef="usd" id="ixv-43816">73,452</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c242" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets" scale="0" unitRef="usd" id="ixv-43817">137,680</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets" scale="0" unitRef="usd" id="ixv-43818">2,647,778</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Decrease due to harvest/disposals</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c238" decimals="0" format="ixt:num-dot-decimal" name="mlec:DecreaseDueToHarvestAndDisposalsBiologicalAssets" scale="0" unitRef="usd" id="ixv-43819">1,071,533</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c239" decimals="0" format="ixt:num-dot-decimal" name="mlec:DecreaseDueToHarvestAndDisposalsBiologicalAssets" scale="0" unitRef="usd" id="ixv-43820">759,561</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c240" decimals="0" format="ixt:num-dot-decimal" name="mlec:DecreaseDueToHarvestAndDisposalsBiologicalAssets" scale="0" unitRef="usd" id="ixv-43821">319,308</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c241" decimals="0" format="ixt:num-dot-decimal" name="mlec:DecreaseDueToHarvestAndDisposalsBiologicalAssets" scale="0" unitRef="usd" id="ixv-43822">165,662</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c242" decimals="0" format="ixt:num-dot-decimal" name="mlec:DecreaseDueToHarvestAndDisposalsBiologicalAssets" scale="0" unitRef="usd" id="ixv-43823">138,676</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="mlec:DecreaseDueToHarvestAndDisposalsBiologicalAssets" scale="0" unitRef="usd" id="ixv-43824">2,454,740</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 0pt">Year ended June 30, 2024</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-210">-</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-211">-</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c220" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:BiologicalAssets" scale="0" unitRef="usd" id="ixv-43825">220,682</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c221" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:BiologicalAssets" scale="0" unitRef="usd" id="ixv-43826">73,452</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-212">-</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:BiologicalAssets" scale="0" unitRef="usd" id="ixv-43827">294,134</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>7.7 <span style="text-decoration:underline">Property, plant and equipment</span></b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" id="ixv-25208"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Property, plant and equipment as of June 30, 2025 and 2024, included
the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid"><b>Class</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Net carrying amount 06/30/2024</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Additions</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Reclassification<br/>
within PPE</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Disposals</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Depreciation of the year</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Foreign currency translation</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Loss of control</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Business combination</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Net&#160;carrying<br/>
amount<br/>
06/30/2025</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 0pt; padding-left: 0pt; width: 19%">Office&#160;equipment</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><ix:nonFraction contextRef="c243" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43828">503,950</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><ix:nonFraction contextRef="c244" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43829">39,611</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-213">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">(<ix:nonFraction contextRef="c244" decimals="0" format="ixt:num-dot-decimal" name="mlec:DisposalsPropertyPlantAndEquipments" scale="0" unitRef="usd" id="ixv-43830">4,791</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">(<ix:nonFraction contextRef="c244" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43831">82,495</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><ix:nonFraction contextRef="c244" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43832">3,947</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">(<ix:nonFraction contextRef="c244" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43833">449,942</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-214">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><ix:nonFraction contextRef="c245" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43834">10,280</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0pt; padding-left: 0pt">Vehicles</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c246" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43835">2,192,627</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c247" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43836">35,915</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-215">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c247" decimals="0" format="ixt:num-dot-decimal" name="mlec:DisposalsPropertyPlantAndEquipments" scale="0" unitRef="usd" id="ixv-43837">17,239</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c247" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43838">882,264</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c247" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43839">1,023</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c247" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43840">1,330,062</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-216">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-217">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Equipment and computer software</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c249" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43841">528,816</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c250" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43842">75,297</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-218">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c250" decimals="0" format="ixt:num-dot-decimal" name="mlec:DisposalsPropertyPlantAndEquipments" scale="0" unitRef="usd" id="ixv-43843">323</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c250" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43844">273,912</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c250" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43845">16,012</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c250" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43846">331,763</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-219">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c251" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43847">14,127</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Fixtures and fittings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c252" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43848">2,805,076</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c253" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43849">9,084</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c253" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43850">225,338</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c253" decimals="0" format="ixt:num-dot-decimal" name="mlec:DisposalsPropertyPlantAndEquipments" scale="0" unitRef="usd" id="ixv-43851">6,789</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c253" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43852">860,822</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c253" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43853">6,350</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c253" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43854">2,178,237</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-220">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-221">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Machinery and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c255" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43855">16,722,642</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c256" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43856">563,352</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c256" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43857">122,653</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c256" decimals="0" format="ixt:num-dot-decimal" name="mlec:DisposalsPropertyPlantAndEquipments" scale="0" unitRef="usd" id="ixv-43858">143,947</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c256" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43859">2,895,031</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c256" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43860">81,204</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c256" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43861">14,449,423</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-222">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c257" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43862">1,450</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Land and buildings</td><td>&#160;</td>
    <td style="text-align: left"/><td style="text-align: right"><ix:nonFraction contextRef="c258" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43863">39,745,067</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"/><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-223">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"/><td style="text-align: right"><ix:nonFraction contextRef="c259" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43864">348,085</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"/><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-224">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"/><td style="text-align: right">(<ix:nonFraction contextRef="c259" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43865">1,021,176</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left"/><td style="text-align: right"><ix:nonFraction contextRef="c259" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43866">71,315</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"/><td style="text-align: right">(<ix:nonFraction contextRef="c259" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43867">39,143,291</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left"/><td style="text-align: right"><ix:nonFraction contextRef="c259" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43868">982,939</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"/><td style="text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction contextRef="c260" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43869">982,939</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Buildings in progress</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;&#160;&#160;&#160;&#160;<ix:nonFraction contextRef="c261" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43870">12,114,256</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c262" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43871">5,264,663</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c262" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" scale="0" sign="-" unitRef="usd" id="ixv-43872">696,076</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-225">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-226">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c262" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43873">9,753</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c262" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43874">16,692,596</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c262" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43875">2,336,374</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c263" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43876">2,336,374</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-indent: 0pt; padding-left: 0pt">Total</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c264" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43877">74,612,434</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c265" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43878">5,987,922</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-227">-</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c265" decimals="0" format="ixt:num-dot-decimal" name="mlec:DisposalsPropertyPlantAndEquipments" scale="0" unitRef="usd" id="ixv-43879">173,089</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c265" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43880">6,015,700</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c265" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43881">189,604</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c265" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43882">74,575,314</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c265" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43883">3,319,313</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c266" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43884">3,345,170</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 155; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><ix:continuation continuedAt="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock-c0_cont_4" id="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock-c0_cont_3"><ix:continuation id="_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory-c0_cont_1"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; border-bottom: Black 1.5pt solid"><b>Class</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Net&#160;carrying amount <br/>06/30/2023</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Additions</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Reclassification from Investment properties</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Disposals</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Depreciation of the year</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Foreign currency translation</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Loss of control</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Net&#160;carrying amount 06/30/2024</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; width: 19%; text-align: left; padding-left: 0.125in">Research&#160;instruments</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><ix:nonFraction contextRef="c267" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43885">66,131</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-228">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-229">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-230">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-231">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-232">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">(<ix:nonFraction contextRef="c268" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43886">66,131</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-233">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Office&#160;equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c270" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43887">360,575</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c271" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43888">238,679</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-234">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-235">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c271" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43889">81,507</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c271" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="0" sign="-" unitRef="usd" id="ixv-43890">13,324</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c271" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43891">473</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c243" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43892">503,950</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Vehicles</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c272" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43893">2,053,263</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c273" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43894">1,077,988</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-236">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c273" decimals="0" format="ixt:num-dot-decimal" name="mlec:DisposalsPropertyPlantAndEquipments" scale="0" unitRef="usd" id="ixv-43895">1,677</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c273" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43896">908,040</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c273" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="0" sign="-" unitRef="usd" id="ixv-43897">775</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c273" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43898">28,132</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c246" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43899">2,192,627</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Equipment and computer software</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c274" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43900">198,364</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c275" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43901">725,706</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-237">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c275" decimals="0" format="ixt:num-dot-decimal" name="mlec:DisposalsPropertyPlantAndEquipments" scale="0" unitRef="usd" id="ixv-43902">8,184</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c275" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43903">354,379</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c275" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="0" sign="-" unitRef="usd" id="ixv-43904">27,650</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c275" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43905">5,041</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c249" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43906">528,816</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Fixtures and fittings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c276" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43907">2,925,032</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c277" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43908">731,699</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-238">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c277" decimals="0" format="ixt:num-dot-decimal" name="mlec:DisposalsPropertyPlantAndEquipments" scale="0" sign="-" unitRef="usd" id="ixv-43909">6,295</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c277" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43910">812,810</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c277" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="0" sign="-" unitRef="usd" id="ixv-43911">1,663</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c277" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43912">43,477</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c252" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43913">2,805,076</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Machinery and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c278" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43914">14,586,768</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c279" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43915">5,460,655</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-239">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c279" decimals="0" format="ixt:num-dot-decimal" name="mlec:DisposalsPropertyPlantAndEquipments" scale="0" unitRef="usd" id="ixv-43916">154,492</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c279" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43917">2,661,097</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c279" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="0" sign="-" unitRef="usd" id="ixv-43918">409,769</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c279" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43919">99,423</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c255" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43920">16,722,642</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Land and buildings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c280" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43921">36,211,957</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c281" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43922">1,835,054</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c281" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43923">3,222,044</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"/><td style="text-align: right"><ix:nonFraction contextRef="c281" decimals="0" format="ixt:num-dot-decimal" name="mlec:DisposalsPropertyPlantAndEquipments" scale="0" sign="-" unitRef="usd" id="ixv-43924">53,217</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c281" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43925">982,165</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c281" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="0" sign="-" unitRef="usd" id="ixv-43926">595,040</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-240">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c258" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43927">39,745,067</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-indent: -0.125in; text-align: left; padding-left: 0.125in">Buildings in progress</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;&#160;&#160;&#160;&#160;<ix:nonFraction contextRef="c282" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43928">11,757,249</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c283" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43929">683,406</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-241">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt"/>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c283" decimals="0" format="ixt:num-dot-decimal" name="mlec:DisposalsPropertyPlantAndEquipments" scale="0" unitRef="usd" id="ixv-43930">106,421</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-242">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c283" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="0" sign="-" unitRef="usd" id="ixv-43931">207,757</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c283" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43932">12,221</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"/><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;&#160;&#160;&#160;&#160;<ix:nonFraction contextRef="c261" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43933">12,114,256</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-indent: -0.125in; font-weight: bold; padding-left: 0.125in">Total</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c284" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43934">68,159,339</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c285" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43935">10,753,187</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold"/>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c285" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43936">3,222,044</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c285" decimals="0" format="ixt:num-dot-decimal" name="mlec:DisposalsPropertyPlantAndEquipments" scale="0" unitRef="usd" id="ixv-43937">211,262</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c285" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43938">5,799,998</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c285" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="0" sign="-" unitRef="usd" id="ixv-43939">1,255,978</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c285" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43940">254,898</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c264" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-43941">74,612,434</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The depreciation charge is included in Notes 8.3 - R&amp;D classified
by nature and Note 8.4 &#8211; Expenses classified by nature and function. The Group has no commitments to purchase property, plant and
equipment items.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Revaluation of property, plant and equipment</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group used to frequently update their assessment
of the fair value of its land and buildings taking into account the most recent independent valuations and market data. Last valuations
were performed as of June 30, 2023. Management determined the property, plant and equipment&#8217;s value within a range of reasonable
fair value estimates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All resulting fair value estimates for properties
are included in level 2 or 3 depending on the methodology used.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="mlec:DisclosureOfDepreciationIfAssetsHadBeenCarriedUnderCostModelTextBlock" id="ixv-26020"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following are the carrying amounts that would
have been recognized if land and building were stated at cost.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Value at cost</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Class of property</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: justify; padding-left: 0pt">Land and buildings</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c286" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets" scale="0" unitRef="usd" id="ixv-43942">27,876,636</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 156; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 6pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><ix:continuation continuedAt="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock-c0_cont_5" id="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-size: 10pt"><b>7.8</b></span> <b><span style="text-decoration:underline">Intangible assets</span></b></p>



<p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 6pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" id="ixv-26095"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Intangible assets as of June 30, 2025 and 2024 included the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 6pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; border-bottom: Black 1.5pt solid"><b>Class</b></td><td style="border-bottom: Black 1.5pt solid"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Net carrying amount 06/30/2024</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Additions</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt"><b>Loss of control) <sup>(*)</sup></b></span></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt"><b>Additions from business
    combinations <sup>(**)</sup></b></span></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Transfers/ Disposals</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Amortization of the year</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Foreign currency translation</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Net carrying amount 06/30/2025</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; font-style: italic"><span style="text-decoration:underline">Seed and
    integrated products</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; text-indent: -0.125in; padding-left: 0.125in; width: 28%; text-align: left">Alfalfa Genuity Har Xstra</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><ix:nonFraction contextRef="c287" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-43943">438,029</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-243">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-244">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-245">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-246">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-247">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">(<ix:nonFraction contextRef="c288" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" scale="0" sign="-" unitRef="usd" id="ixv-43944">21,172</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><ix:nonFraction contextRef="c289" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-43945">416,857</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">HB4 soy and breeding program</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c290" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-43946">35,574,369</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c291" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-43947">3,164,283</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c291" decimals="0" format="ixt:num-dot-decimal" id="ix_21_fact" name="mlec:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets" scale="0" sign="-" unitRef="usd">36,464,169</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-248">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-249">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c291" decimals="0" format="ixt:num-dot-decimal" name="mlec:AmortizationOfTheYear" scale="0" unitRef="usd" id="ixv-43949">2,274,483</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-250">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-251">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Integrated seed products</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c293" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-43950">2,681,826</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-252">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c294" decimals="0" format="ixt:num-dot-decimal" id="ix_22_fact" name="mlec:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets" scale="0" sign="-" unitRef="usd">2,526,410</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-253">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-254">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c294" decimals="0" format="ixt:num-dot-decimal" name="mlec:AmortizationOfTheYear" scale="0" unitRef="usd" id="ixv-43952">194,339</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c294" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-43953">38,923</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-255">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; font-style: italic; text-decoration: underline; text-align: left">Crop nutrition</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Microbiological products</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c296" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-43954">41,187,249</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c297" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-43955">286,665</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c297" decimals="0" format="ixt:num-dot-decimal" id="ix_23_fact" name="mlec:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets" scale="0" sign="-" unitRef="usd">43,570,818</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-256">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c297" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" scale="0" sign="-" unitRef="usd" id="ixv-43957">3,605,198</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c297" decimals="0" format="ixt:num-dot-decimal" name="mlec:AmortizationOfTheYear" scale="0" unitRef="usd" id="ixv-43958">1,511,420</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c297" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-43959">3,126</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-257">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Microbiological products in progress</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c299" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-43960">10,452,861</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c300" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-43961">5,163,500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c300" decimals="0" format="ixt:num-dot-decimal" id="ix_24_fact" name="mlec:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets" scale="0" sign="-" unitRef="usd">11,909,700</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-258">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c300" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-43963">3,706,661</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-259">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-260">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-261">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; font-style: italic; text-decoration: underline; text-align: left">Other intangible assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Trademarks and patents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c302" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-43964">51,316,860</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c303" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-43965">158,557</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c303" decimals="0" format="ixt:num-dot-decimal" id="ix_25_fact" name="mlec:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets" scale="0" sign="-" unitRef="usd">47,394,664</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-262">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-263">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c303" decimals="0" format="ixt:num-dot-decimal" name="mlec:AmortizationOfTheYear" scale="0" unitRef="usd" id="ixv-43967">4,080,753</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-264">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-265">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Trademarks and patents with indefinite useful life</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c305" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-43968">10,045,294</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-266">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c306" decimals="0" format="ixt:num-dot-decimal" id="ix_26_fact" name="mlec:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets" scale="0" sign="-" unitRef="usd">10,045,294</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-267">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-268">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-269">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-270">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-271">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Software</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c308" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-43970">1,119,494</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c309" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-43971">16,222</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c309" decimals="0" format="ixt:num-dot-decimal" id="ix_27_fact" name="mlec:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets" scale="0" sign="-" unitRef="usd">605,341</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-272">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c309" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" scale="0" sign="-" unitRef="usd" id="ixv-43973">146,839</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c309" decimals="0" format="ixt:num-dot-decimal" name="mlec:AmortizationOfTheYear" scale="0" unitRef="usd" id="ixv-43974">723,312</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c309" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-43975">46,098</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-273">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Software in progress</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c311" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-43976">580,728</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c312" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-43977">176,064</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c312" decimals="0" format="ixt:num-dot-decimal" id="ix_28_fact" name="mlec:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets" scale="0" sign="-" unitRef="usd">609,953</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-274">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c312" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-43979">146,839</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-275">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-276">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-277">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Customer loyalty</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c314" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-43980">18,934,570</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-278">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c315" decimals="0" format="ixt:num-dot-decimal" id="ix_29_fact" name="mlec:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets" scale="0" sign="-" unitRef="usd">17,565,911</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-279">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-280">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c315" decimals="0" format="ixt:num-dot-decimal" name="mlec:AmortizationOfTheYear" scale="0" unitRef="usd" id="ixv-43982">1,368,659</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-281">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-282">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">RG/RS/OX Wheat</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c317" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-43983">5,000,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c318" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-43984">6,528,899</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c318" decimals="0" format="ixt:num-dot-decimal" id="ix_30_fact" name="mlec:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets" scale="0" sign="-" unitRef="usd">10,480,817</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-283">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-284">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c318" decimals="0" format="ixt:num-dot-decimal" name="mlec:AmortizationOfTheYear" scale="0" unitRef="usd" id="ixv-43986">1,048,082</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-285">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-286">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Sustainable agricultural equipment technology</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-287">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-288">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-289">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c321" decimals="0" format="ixt:num-dot-decimal" id="ix_35_fact" name="mlec:AdditionsFromBusinessCombinations" scale="0" unitRef="usd">10,719,710</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-290">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-291">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-292">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c322" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-43988">10,719,710</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Fungal Biomass</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-293">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-294">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-295">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c324" decimals="0" format="ixt:num-dot-decimal" id="ix_36_fact" name="mlec:AdditionsFromBusinessCombinations" scale="0" unitRef="usd">10,775,940</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-296">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-297">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-298">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c325" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-43990">10,775,940</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Piggysooy</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-299">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-300">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-301">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c327" decimals="0" format="ixt:num-dot-decimal" id="ix_37_fact" name="mlec:AdditionsFromBusinessCombinations" scale="0" unitRef="usd">16,813,781</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-302">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-303">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-304">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c328" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-43992">16,813,781</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Safflower GLA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-305">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-306">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-307">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c330" decimals="0" format="ixt:num-dot-decimal" id="ix_38_fact" name="mlec:AdditionsFromBusinessCombinations" scale="0" unitRef="usd">27,857,339</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-308">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-309">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-310">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c331" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-43994">27,857,339</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Safflower Chimosin 2.0</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-311">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-312">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-313">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c333" decimals="0" format="ixt:num-dot-decimal" id="ix_39_fact" name="mlec:AdditionsFromBusinessCombinations" scale="0" unitRef="usd">2,600,554</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c334" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-43996">2,600,554</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Other intangibles</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-314">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-315">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-316">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c336" decimals="0" format="ixt:num-dot-decimal" id="ix_40_fact" name="mlec:AdditionsFromBusinessCombinations" scale="0" unitRef="usd">6,074,609</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-317">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-318">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-319">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c337" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-43998">6,074,609</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold">Total</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-43999">177,331,280</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-44000">15,494,190</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" id="ix_31_fact" name="mlec:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets" scale="0" sign="-" unitRef="usd">181,173,077</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" id="ix_41_fact" name="mlec:AdditionsFromBusinessCombinations" scale="0" unitRef="usd">74,841,933</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-44003">101,463</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:AmortizationOfTheYear" scale="0" unitRef="usd" id="ixv-44004">11,201,048</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-44005">66,975</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-44006">75,258,790</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 6pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><sup>(*)</sup></td><td style="text-align: justify"><ix:footnote id="ix_4_footnote" xml:lang="en-US">Correspond to the loss of control of BIOX.</ix:footnote></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><sup>(**)</sup></td><td style="text-align: justify"><ix:footnote id="ix_6_footnote" xml:lang="en-US">Correspond to The Bioceres Group Business Combination Agreement.</ix:footnote></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 6pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left; padding-left: 0in"><b>Class</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Net carrying amount 06/30/2023</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Additions</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Additions
    from business combinations/ (loss of control)<sup>(*)</sup></b></span></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Transfers/ Disposals</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Amortization of the year</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Foreign currency translation</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Net carrying amount 06/30/2024</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; font-style: italic">Seed and integrated products</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 28%; text-align: left">Alfalfa Genuity Har Xstra</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><ix:nonFraction contextRef="c338" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-44009">419,061</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-320">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-321">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-322">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-323">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><ix:nonFraction contextRef="c339" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-44010">18,968</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><ix:nonFraction contextRef="c287" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-44011">438,029</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Bacillus-PHAs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c340" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-44012">1,089,536</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-324">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c341" decimals="0" format="ixt:num-dot-decimal" id="ix_32_fact" name="mlec:AdditionsFromBusinessCombinations" scale="0" sign="-" unitRef="usd">1,089,536</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-325">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-326">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-327">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-328">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">HB4 soy and breeding program</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c343" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-44014">31,679,114</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c344" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-44015">5,987,247</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-329">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-330">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c344" decimals="0" format="ixt:num-dot-decimal" name="mlec:AmortizationOfTheYear" scale="0" unitRef="usd" id="ixv-44016">2,091,992</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-331">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c290" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-44017">35,574,369</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Integrated seed products</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c345" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-44018">2,841,008</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-332">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-333">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-334">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c346" decimals="0" format="ixt:num-dot-decimal" name="mlec:AmortizationOfTheYear" scale="0" unitRef="usd" id="ixv-44019">191,559</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c346" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-44020">32,377</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c293" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-44021">2,681,826</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; font-style: italic; text-decoration: underline; text-align: left">Crop
    nutrition</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Microbiological&#160;products</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c347" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-44022">37,295,460</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-335">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-336">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c348" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" scale="0" sign="-" unitRef="usd" id="ixv-44023">7,610,115</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c348" decimals="0" format="ixt:num-dot-decimal" name="mlec:AmortizationOfTheYear" scale="0" unitRef="usd" id="ixv-44024">3,718,326</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-337">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c296" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-44025">41,187,249</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Microbiological products in progress</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c349" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-44026">12,213,341</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c350" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-44027">5,869,084</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-338">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c350" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-44028">7,610,115</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-339">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c350" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" scale="0" sign="-" unitRef="usd" id="ixv-44029">19,449</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c299" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-44030">10,452,861</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; font-style: italic; text-decoration: underline; text-align: left">Other
    intangible assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Trademarks and patents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c351" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-44031">51,933,444</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c352" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-44032">44,073</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-340">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-341">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c352" decimals="0" format="ixt:num-dot-decimal" name="mlec:AmortizationOfTheYear" scale="0" unitRef="usd" id="ixv-44033">670,514</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c352" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-44034">9,857</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c302" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-44035">51,316,860</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Trademarks and patents with indefinite useful life</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c353" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-44036">7,827,309</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-342">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c354" decimals="0" format="ixt:num-dot-decimal" id="ix_33_fact" name="mlec:AdditionsFromBusinessCombinations" scale="0" unitRef="usd">2,217,985</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-343">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-344">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-345">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c305" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-44038">10,045,294</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Software</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c355" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-44039">1,638,752</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c356" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-44040">585,313</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-346">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c356" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" scale="0" sign="-" unitRef="usd" id="ixv-44041">276,128</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c356" decimals="0" format="ixt:num-dot-decimal" name="mlec:AmortizationOfTheYear" scale="0" unitRef="usd" id="ixv-44042">1,369,379</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c356" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" scale="0" sign="-" unitRef="usd" id="ixv-44043">11,320</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c308" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-44044">1,119,494</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Software in progress</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c357" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-44045">349,171</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c358" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-44046">507,685</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-347">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c358" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-44047">276,128</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-348">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-349">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c311" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-44048">580,728</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Customer loyalty</td><td>&#160;</td>
    <td style="text-align: left"/><td style="text-align: right"><ix:nonFraction contextRef="c359" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-44049">23,006,023</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"/><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-350">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"/><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-351">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"/><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-352">-</div></td><td style="text-align: left">&#160;</td><td/>
    <td style="text-align: left"/><td style="text-align: right">(<ix:nonFraction contextRef="c360" decimals="0" format="ixt:num-dot-decimal" name="mlec:AmortizationOfTheYear" scale="0" unitRef="usd" id="ixv-44050">4,071,453</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left"/><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-353">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"/><td style="text-align: right"><ix:nonFraction contextRef="c314" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-44051">18,934,570</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">RG/RS/OX
    Wheat</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c361" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-44052">5,000,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-354">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-355">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-356">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-357">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-358">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c317" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-44053">5,000,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c47" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-44054">175,292,219</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-44055">12,993,402</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" id="ix_34_fact" name="mlec:AdditionsFromBusinessCombinations" scale="0" unitRef="usd">1,128,449</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-359">-</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="mlec:AmortizationOfTheYear" scale="0" unitRef="usd" id="ixv-44057">12,113,223</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-44058">30,433</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-44059">177,331,280</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 6pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><sup>(*)</sup></td><td style="text-align: justify"><ix:footnote id="ix_5_footnote" xml:lang="en-US">USD <ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryOtherProvisions" scale="0" unitRef="usd" id="ixv-44061">1,089,768</ix:nonFraction> correspond to the loss of control of Inmet
S.A.</ix:footnote></td>
</tr></table></ix:nonNumeric></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 6pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 157; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><ix:continuation continuedAt="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock-c0_cont_6" id="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The amortization charge is included in Notes 8.3 - R&amp;D classified
by nature and Note 8.4 &#8211; Expenses classified by nature and function.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are no intangibles assets whose use has
been restricted or which have been delivered as a guarantee. The Group has not assumed any commitments to acquire new intangibles.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Estimates</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">There is an inherent
material uncertainty related to management&#8217;s estimation of the ability of the Group to recover the carrying amounts of internally
generated intangible assets, because it is dependent upon Group&#8217;s ability to raise sufficient funds to complete the projects development,
the future outcome of the regulatory process, and the timing and amount of the future cash flows generated by the projects, among other
future events.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">Management&#8217;s estimations
about the demonstrability of the recognition criteria for these assets and the subsequent recoverability represent the best estimate that
can be made based on all the available evidence, existing facts and circumstances and using reasonable and supportable assumptions in
cash flow projections. Therefore, the consolidated financial statements do not include any adjustments that would result if the Group
were unable to recover the carrying amount of the above-mentioned assets through the generation of enough future economic benefits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">The Group is required
to perform an annual impairment test for non-depreciating assets, either because they are not available for use, have indefinite useful
lives, or for other intangible assets when events or changes in circumstances indicate that their carrying amount may not be recoverable.
The recoverable amount is determined based on calculations of value in use. This method requires estimating future cash flows and determining
a discount rate to calculate the present value of those cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management has made the estimates considering
the cash flow projections projected by the management. <ix:nonNumeric contextRef="c0" continuedAt="mlec_DisclosureOfIntangibleAssetsAndLiabilitiesAssumedTextBlock-c0_cont_1" escape="true" name="mlec:DisclosureOfIntangibleAssetsAndLiabilitiesAssumedTextBlock" id="ixv-44062">All key assumptions values reflect past experience or, if appropriate, are consistent
with external sources of information.</ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="mlec_DisclosureOfIntangibleAssetsAndLiabilitiesAssumedTextBlock-c0_cont_2" id="mlec_DisclosureOfIntangibleAssetsAndLiabilitiesAssumedTextBlock-c0_cont_1"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="border-bottom: Black 1.5pt solid; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; width: 20%"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><b>Key assumption</b></p></td> <td style="padding-bottom: 1.5pt; width: 1%">&#160;</td> <td style="text-align: center; border-bottom: Black 1.5pt solid; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; width: 79%"><span style="font-size: 10pt"><b>Management&#8217;s approach</b></span></td></tr> <tr> <td style="padding: 0pt"><span style="font-size: 10pt">Discount rate</span></td> <td>&#160;</td> <td style="padding: 0pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">The discount rate applied was either&#160;<ix:nonFraction contextRef="c4" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections" scale="-2" unitRef="pure" id="ixv-44063">16.39</ix:nonFraction>% or&#160;<ix:nonFraction contextRef="c4" decimals="4" format="ixt:num-dot-decimal" name="mlec:PercentageOfWeightedAverageCostOfCapital" scale="-2" unitRef="pure" id="ixv-44064">11.56</ix:nonFraction>%, depending on the target market.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">The weighted average cost of capital (WACC) was estimated using the market capital structure plus&#160;<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="mlec:PercentageOfRiskPremium" scale="-2" unitRef="pure" id="ixv-44065">2</ix:nonFraction>% of risk premium which reflect the higher risk associated with intangible assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">For the cost of equity, the discount rate is estimated based on the Capital Asset Pricing Model (CAPM).</p></td></tr> <tr> <td style="padding: 0pt">&#160;</td> <td>&#160;</td> <td style="padding: 0pt">&#160;</td></tr> <tr> <td style="text-indent: -0.125in; padding: 0pt 0pt 0pt 0.125in"><span style="font-size: 10pt">Market share, product prices and royalties.</span></td> <td>&#160;</td> <td style="padding: 0pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; ">The projected revenue from the products and services of the CGUs has been estimated by the management based on market penetration data for comparable products and technologies and on future expectations of foreseen economic and market conditions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; ">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; ">The prices and royalties estimated in the revenue projections are based on current and projected market prices for the products and services of the CGUs.</p></td></tr> </table></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">A projection horizon
longer than&#160;five years&#160;was adopted, as the GGUs are linked to biological products that require extended development and regulatory
approval timelines across multiple target countries. Due to the nature of these products and the maturity level of the markets involved,
a longer time frame is essential to reasonably capture the expected cash flows and the time needed to reach commercial readiness and registration
milestones. Projected range period used:&#160;<ix:nonNumeric contextRef="c154" format="ixt-sec:duryear" name="mlec:ProjectedPeriodRange" id="ixv-44066">8</ix:nonNumeric>-<ix:nonNumeric contextRef="c155" format="ixt-sec:durwordsen" name="mlec:ProjectedPeriodRange" id="ixv-44067">18&#160;years</ix:nonNumeric>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">Management estimates
that any reasonably possible change in any of these key assumptions would not cause the aggregate carrying amount of the CGU to exceed
its recoverable amount.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "></p><div>

</div><!-- Field: Page; Sequence: 158; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: center"><b>&#160;</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>


</div><ix:continuation continuedAt="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock-c0_cont_7" id="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock-c0_cont_6"><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>7.9 <span style="text-decoration:underline">Goodwill</span></b></p>





<p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfReconciliationOfChangesInGoodwillExplanatory" id="ixv-27676"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Rizobacter Argentina S.A.</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-360">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c366" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Goodwill" scale="0" unitRef="usd" id="ixv-44068">28,080,271</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Bioceres Crops S.A.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-361">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c368" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Goodwill" scale="0" unitRef="usd" id="ixv-44069">7,523,322</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Insumos Agroqu&#237;micos S.A.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-362">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c370" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Goodwill" scale="0" unitRef="usd" id="ixv-44070">470,090</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Pro Farm Group</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-363">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c372" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Goodwill" scale="0" unitRef="usd" id="ixv-44071">76,089,749</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-364">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Goodwill" scale="0" unitRef="usd" id="ixv-44072">112,163,432</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>


<p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group is required to test whether goodwill
has suffered any impairment on an annual basis. The recoverable amount is determined based on value in use calculations. The use of this
method requires the estimation of future cash flows and the determination of a discount rate in order to calculate the present value of
the cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prior to the BIOX deconsolidation, the CGUs were
determined as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Rizobacter CGU. This CGU is composed of all revenues
collected through Rizobacter from the production and sale of proprietary and third-party products, both in the domestic and international
markets. Additionally, Rizobacter generates revenue from the formulation, fragmentation and resale of third-party products.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Bioceres Crops CGU. This CGU is composed of the
expected revenues from the commercialization of intensive R&amp;D products that previously were allocated on the equity participation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Insuagro CGU. This CGU is composed of all revenues
collected through Insuagro from the production and sale of proprietary and third-party products, both in the domestic markets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pro Farm Group Inc CGU. This CGU is composed of
all revenues collected through Pro Farm from the production and sale of proprietary and third-party products, both in the domestic and
international markets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management has made the estimates considering
the cash flow projections projected by the management and third-party valuation reports on the assets, intangible assets and liabilities
assumed. <ix:continuation continuedAt="mlec_DisclosureOfIntangibleAssetsAndLiabilitiesAssumedTextBlock-c0_cont_3" id="mlec_DisclosureOfIntangibleAssetsAndLiabilitiesAssumedTextBlock-c0_cont_2">The key assumptions utilized are the following:</ix:continuation></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation id="mlec_DisclosureOfIntangibleAssetsAndLiabilitiesAssumedTextBlock-c0_cont_3"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="border-bottom: Black 1.5pt solid; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; width: 20%"> <p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><b>Key assumption</b></p></td> <td style="padding-bottom: 1.5pt; width: 2%">&#160;</td> <td style="text-align: center; border-bottom: Black 1.5pt solid; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; width: 78%"><span style="font-size: 10pt"><b>Management&#8217;s approach</b></span></td></tr> <tr> <td style="padding: 0pt"><span style="font-size: 10pt">Discount rate</span></td> <td>&#160;</td> <td style="padding: 0pt"> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify">The discount rate used ranges was&#160;<ix:nonFraction contextRef="c363" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections" scale="-2" unitRef="pure" id="ixv-44074">14.11</ix:nonFraction>%&#160;for Rizobacter UGE and for&#160;Bioceres Crops UGE, and&#160;<ix:nonFraction contextRef="c364" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections" scale="-2" unitRef="pure" id="ixv-44075">9.28</ix:nonFraction>% for Pro Farm UGE due to the target market.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify">&#160;</p> <p style="text-align: justify; text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt">The weighted average cost of capital (&#8220;WACC&#8221;) rate has been estimated based on the market capital structure.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0pt; margin: 0pt">&#160;</p> <p style="text-align: justify; text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt">For the cost of equity, the discount rate is estimated based on the Capital Asset Pricing Model (CAPM).</p></td></tr> <tr> <td style="padding: 0pt">&#160;</td> <td>&#160;</td> <td style="padding: 0pt">&#160;</td></tr> <tr> <td style="text-indent: -0.125in; padding: 0pt 0pt 0pt 0.125in; text-align: justify"><span style="font-size: 10pt">Market share, product prices and royalties.</span></td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify; padding: 0pt"> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify">The projected revenue from the products and services of the CGUs has been estimated by the management based on market penetration data for comparable products and technologies and on future expectations of foreseen economic and market conditions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify">The prices (Rizobacter CGU and Pro Farm CGU) and royalties (Bioceres Crops CGU) estimated in the revenue projections are based on current and projected market prices for the products and services of the CGUs.</p></td></tr> <tr> <td style="text-align: justify; padding: 0pt">&#160;</td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify; padding: 0pt">&#160;</td></tr> <tr> <td style="text-align: justify; padding: 0pt"><span style="font-size: 10pt">Terminal value</span></td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify; padding: 0pt"> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify">Rizobacter CGU and Bioceres Crops CGU: The growth rate used to extrapolate the future cash flow projections to terminal period&#160;is&#160;<ix:nonFraction contextRef="c4" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections" scale="-2" unitRef="pure" id="ixv-44076">2</ix:nonFraction>%.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify">&#160;</p> <p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Pro Farm CGU: EBITDA multiple (10x)</p></td></tr> </table></ix:continuation></ix:continuation><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 159; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: center"><b>&#160;</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;&#160;</b></p><div>

</div><ix:continuation continuedAt="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock-c0_cont_8" id="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock-c0_cont_7"><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>7.10 <span style="text-decoration:underline">Investment properties</span></b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>



<ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfDetailedInformationAboutInvestmentPropertyExplanatory" id="ixv-27851"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Investment properties</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-365">&#160;&#160;&#160;-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InvestmentProperty" scale="0" unitRef="usd" id="ixv-44077">560,783</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-366">-</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InvestmentProperty" scale="0" unitRef="usd" id="ixv-44078">560,783</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The decrease for the year is attributed to loss
of control in BIOX.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The book value of the investment properties does not differ significantly
from its fair value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>7.11&#160; <span style="text-decoration:underline">Trade and other payables</span></b></p>





<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="mlec:DisclosureOfTradeAndOtherPayablesComponentsTableTextBlock" id="ixv-27892"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Current</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0pt">Trade creditors</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers" scale="0" unitRef="usd" id="ixv-44079">6,490,684</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers" scale="0" unitRef="usd" id="ixv-44080">108,922,112</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Shareholders and other related parties (Note 17)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-367">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="mlec:TradeAndOtherPayablesShareholdersAndOtherRelatedParties" scale="0" unitRef="usd" id="ixv-44081">37,985</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Trade creditors - Joint ventures and associates (Note 13)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="mlec:TradeCreditorsJointVenturesAndAssociates" scale="0" unitRef="usd" id="ixv-44082">620,034</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="mlec:TradeCreditorsJointVenturesAndAssociates" scale="0" unitRef="usd" id="ixv-44083">52,778,206</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax" scale="0" unitRef="usd" id="ixv-44084">12,647</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax" scale="0" unitRef="usd" id="ixv-44085">5,877,930</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 0pt">Miscellaneous</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentPayables" scale="0" unitRef="usd" id="ixv-44086">200,568</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentPayables" scale="0" unitRef="usd" id="ixv-44087">1,321,303</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentPayables" scale="0" unitRef="usd" id="ixv-44088">7,323,933</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentPayables" scale="0" unitRef="usd" id="ixv-44089">168,937,536</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The book value of financial liabilities is reasonably approximate to
the fair value given its short-term nature.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><b>&#160;</b></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>7.12&#160; <span style="text-decoration:underline">Borrowings</span></b></p>





<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory" id="ixv-27979"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Current</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0pt">Bank borrowings</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c373" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentPortionOfLongtermBorrowings" scale="0" unitRef="usd" id="ixv-44090">33,383</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c374" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentPortionOfLongtermBorrowings" scale="0" unitRef="usd" id="ixv-44091">94,711,273</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Corporate bonds</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-368">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c376" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentPortionOfLongtermBorrowings" scale="0" unitRef="usd" id="ixv-44092">42,035,925</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Net loans payables- Joint ventures and associates (Note 13)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c377" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentPortionOfLongtermBorrowings" scale="0" unitRef="usd" id="ixv-44093">10,303,098</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c378" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentPortionOfLongtermBorrowings" scale="0" unitRef="usd" id="ixv-44094">1,860,058</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Convertible preference shares (Note 17)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c379" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentPortionOfLongtermBorrowings" scale="0" unitRef="usd" id="ixv-44095">15,739,726</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-369">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Financial borrowings</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c381" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentPortionOfLongtermBorrowings" scale="0" unitRef="usd" id="ixv-44096">201,077,800</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c382" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentPortionOfLongtermBorrowings" scale="0" unitRef="usd" id="ixv-44097">95,903,495</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentPortionOfLongtermBorrowings" scale="0" unitRef="usd" id="ixv-44098">227,154,007</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentPortionOfLongtermBorrowings" scale="0" unitRef="usd" id="ixv-44099">234,510,751</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-left: 0pt">Non-current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Bank borrowings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c373" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherBorrowings" scale="0" unitRef="usd" id="ixv-44100">1,348,173</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c374" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherBorrowings" scale="0" unitRef="usd" id="ixv-44101">17,033,059</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Corporate bonds</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-370">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c376" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherBorrowings" scale="0" unitRef="usd" id="ixv-44102">25,071,823</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Financial borrowings</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-371">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c382" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherBorrowings" scale="0" unitRef="usd" id="ixv-44103">85,143,423</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherBorrowings" scale="0" unitRef="usd" id="ixv-44104">1,348,173</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherBorrowings" scale="0" unitRef="usd" id="ixv-44105">127,248,305</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 160; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: center"><b>&#160;</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>


</div><ix:continuation continuedAt="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock-c0_cont_9" id="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Bioceres S.A. is the guarantor of the stock purchase
agreement signed on October 28, 2022, between Theo I SCSp and DRACO I-LATAM SPC LTD, as well as the subsequent credit line agreement signed
on December 11, 2023, which are included in the investment in Theo I SCSp, as indicated in Note 13 &#8211; Joint ventures and associates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a result of Theo I SCSp&#8217;s default in July 7, 2025, Bioceres
S.A., a subsidiary of Bioceres Group, as guarantor, recognized the financial debt with DRACO I-LATAM SPC LTD as of June 30, 2025. The
amount recognized of $<ix:nonFraction contextRef="c4" decimals="-5" format="ixt:num-dot-decimal" name="ifrs-full:EstimatedFinancialEffectOfContingentAssets" scale="6" unitRef="usd" id="ixv-44106">61.7</ix:nonFraction> million was determined as the difference between the estimated realizable value of Theo I SCSp&#8217;s assets
and the settlement value of its liabilities. Theo I SCSp is an associate of Bioceres Group, a wholly owned subsidiary of the Company.
As of June 30, 2024 and 2023, the fair value of Theo I SCSp&#8217;s assets exceeded the value of its liabilities. Accordingly, the value
of the guarantee recognized by Bioceres S.A. as of June 30, 2024 and 2023 was <ix:nonFraction contextRef="c5" decimals="0" format="ixt:fixed-zero" name="mlec:InventoryRecognizedAsExpense" scale="0" unitRef="usd" id="ixv-44107"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:fixed-zero" name="mlec:InventoryRecognizedAsExpense" scale="0" unitRef="usd" id="ixv-44108">zero</ix:nonFraction></ix:nonFraction>. See note 8.6.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In December 2024, the Company issued <ix:nonFraction contextRef="c156" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesIssued" scale="0" unitRef="shares" id="ixv-44109">2,380,952</ix:nonFraction>
convertible preference shares for total proceeds of $<ix:nonFraction contextRef="c156" decimals="-6" format="ixt:num-dot-decimal" name="ifrs-full:IssuedCapitalPreferenceShares" scale="6" unitRef="usd" id="ixv-44110">15</ix:nonFraction> million. These preference shares accrue a <ix:nonFraction contextRef="c157" decimals="2" format="ixt:num-dot-decimal" name="mlec:PercentageOfPreferenceSharesAccrue" scale="-2" unitRef="pure" id="ixv-44111">9</ix:nonFraction>% per annum payment-in-kind (PIK) return
and grant the holder specific conversion rights, including the option to convert into ordinary shares at predefined terms, mandatory conversion
provisions, and redemption alternatives contingent on the occurrence of certain events. See Note 21 &#8211; Events occurring after the
reporting period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The carrying value of some borrowings as of June
30, 2025 and 2024, are measured at amortized cost differ from their fair value. The following fair values measured are based on discounted
cash flows (Level 3) due to the use of unobservable inputs, including own credit risk.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As stated in Note 1 &#8211; The Group&#8217;s
business reorganization and general information - &#8220;<i>The Bioceres Group Business Combination Agreement&#8221;, </i>in June 2025,
Bioceres S.A., one of the Argentine subsidiaries of Bioceres Group Limited, defaulted on a portion of its financial debt that was due
that month. The aggregate amount is $<ix:nonFraction contextRef="c4" decimals="-5" format="ixt:num-dot-decimal" name="mlec:AggregateAmount" scale="6" unitRef="usd" id="ixv-44112">36.4</ix:nonFraction> million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In July 2025, Bioceres LLC, a wholly owned subsidiary
of Bioceres S.A., received a notice of default on its financial debt&#160;in the amount of $<ix:nonFraction contextRef="c158" decimals="-5" format="ixt:num-dot-decimal" name="ifrs-full:DebtInstrumentsHeldAtAmortisedCost" scale="6" unitRef="usd" id="ixv-44113">69.5</ix:nonFraction> million. <ix:nonNumeric contextRef="c0" continuedAt="mlec_DisclosureOfCarryingValueOfBorrowingsExplanatory-c0_cont_1" escape="true" name="mlec:DisclosureOfCarryingValueOfBorrowingsExplanatory" id="ixv-44114">The creditor conducted a public
auction for <ix:nonFraction contextRef="c158" decimals="0" format="ixt:num-dot-decimal" name="mlec:CreditorsPublicAuctionShares" scale="0" unitRef="shares" id="ixv-44115">3,062,500</ix:nonFraction> pledged BIOX shares, pursuant to the New York Uniform Commercial Code. Management has responded to the creditor,
reserving all rights, remedies, and defenses. As of the date of this report, the current debt amounts to $<ix:nonFraction contextRef="c4" decimals="-5" format="ixt:num-dot-decimal" name="ifrs-full:CurrentDebtInstrumentsIssued" scale="6" unitRef="usd" id="ixv-44116">58.0</ix:nonFraction> million.</ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation id="mlec_DisclosureOfCarryingValueOfBorrowingsExplanatory-c0_cont_1"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amortized Cost</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amortized Cost</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Current</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-left: 0pt">Bank borrowings</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c383" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermBorrowings" scale="0" unitRef="usd" id="ixv-44117">33,383</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c384" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermBorrowings" scale="0" unitRef="usd" id="ixv-44118">33,383</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c385" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermBorrowings" scale="0" unitRef="usd" id="ixv-44119">94,711,273</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c386" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermBorrowings" scale="0" unitRef="usd" id="ixv-44120">93,301,194</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Corporate bonds</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-372">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-373">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c389" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermBorrowings" scale="0" unitRef="usd" id="ixv-44121">42,035,925</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c390" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermBorrowings" scale="0" unitRef="usd" id="ixv-44122">41,492,963</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">Convertible preference shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c391" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermBorrowings" scale="0" unitRef="usd" id="ixv-44123">15,739,726</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c392" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermBorrowings" scale="0" unitRef="usd" id="ixv-44124">14,179,927</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-374">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-375">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Financial borrowings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c395" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermBorrowings" scale="0" unitRef="usd" id="ixv-44125">211,380,898</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c396" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermBorrowings" scale="0" unitRef="usd" id="ixv-44126">205,082,929</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c397" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermBorrowings" scale="0" unitRef="usd" id="ixv-44127">95,903,495</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c398" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermBorrowings" scale="0" unitRef="usd" id="ixv-44128">95,480,681</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-left: 0pt">Non current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Bank borrowings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c383" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LongtermBorrowings" scale="0" unitRef="usd" id="ixv-44129">1,348,173</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c384" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LongtermBorrowings" scale="0" unitRef="usd" id="ixv-44130">1,348,173</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c385" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LongtermBorrowings" scale="0" unitRef="usd" id="ixv-44131">17,033,059</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c386" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LongtermBorrowings" scale="0" unitRef="usd" id="ixv-44132">12,206,794</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Corporate bonds</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-376">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-377">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c389" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LongtermBorrowings" scale="0" unitRef="usd" id="ixv-44133">25,071,823</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c390" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LongtermBorrowings" scale="0" unitRef="usd" id="ixv-44134">23,845,583</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Convertible notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c399" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LongtermBorrowings" scale="0" unitRef="usd" id="ixv-44135">18,260,456</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c400" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LongtermBorrowings" scale="0" unitRef="usd" id="ixv-44136">18,260,456</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-378">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-379">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Financial borrowings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-380">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-381">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c397" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LongtermBorrowings" scale="0" unitRef="usd" id="ixv-44137">85,143,423</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c398" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LongtermBorrowings" scale="0" unitRef="usd" id="ixv-44138">81,120,125</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table></ix:continuation>



<p style="margin: 0">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"> <b>7.13&#160; <span style="text-decoration:underline">Convertible notes</span></b></p>





<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfDebtSecuritiesExplanatory" id="ixv-28413"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="text-decoration:underline">Convertible notes</span></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Non-current</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Convertible notes</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><ix:nonFraction contextRef="c403" decimals="0" format="ixt:num-dot-decimal" name="mlec:SecuredDebtNonCurrent" scale="0" unitRef="usd" id="ixv-44139">18,260,456</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><ix:nonFraction contextRef="c404" decimals="0" format="ixt:num-dot-decimal" name="mlec:SecuredDebtNonCurrent" scale="0" unitRef="usd" id="ixv-44140">80,809,686</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="mlec:SecuredDebtNonCurrent" scale="0" unitRef="usd" id="ixv-44141">18,260,456</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="mlec:SecuredDebtNonCurrent" scale="0" unitRef="usd" id="ixv-44142">80,809,686</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>


</div><p style="margin: 0"></p><div>

</div><!-- Field: Page; Sequence: 161; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: center"><b>&#160;</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><ix:continuation continuedAt="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock-c0_cont_10" id="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Secured Guaranteed Notes </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Secured Guaranteed Notes due 2026 bore interest
at&#160;<ix:nonFraction contextRef="c159" decimals="3" format="ixt:num-dot-decimal" name="ifrs-full:BorrowingsInterestRate" scale="-2" unitRef="pure" id="ixv-44143">9.0</ix:nonFraction>%&#160;from the issue date through 24 months after the issue date,&#160;<ix:nonFraction contextRef="c160" decimals="3" format="ixt:num-dot-decimal" name="ifrs-full:BorrowingsInterestRate" scale="-2" unitRef="pure" id="ixv-44144">13.0</ix:nonFraction>%&#160;from 25 through 36 months after the issue
date, and&#160;<ix:nonFraction contextRef="c161" decimals="3" format="ixt:num-dot-decimal" name="ifrs-full:BorrowingsInterestRate" scale="-2" unitRef="pure" id="ixv-44145">14.0</ix:nonFraction>%&#160;from 37 through <ix:nonNumeric contextRef="c162" format="ixt-sec:durmonth" name="mlec:IfrsDebtInstrumentTerm" id="ixv-44146">48</ix:nonNumeric> months after the issue date. Interest was payable semi-annually.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 18, 2025, BIOX entered into an amendment
to the Secured Guaranteed Notes pursuant to which the aggregate principal amount increases from&#160;$<ix:nonFraction contextRef="c163" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Borrowings" scale="0" unitRef="usd" id="ixv-44147">26,437,485</ix:nonFraction>&#160;to&#160;$<ix:nonFraction contextRef="c164" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Borrowings" scale="0" unitRef="usd" id="ixv-44148">29,081,233</ix:nonFraction>,
with an annual interest rate of&#160;<ix:nonFraction contextRef="c165" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:BorrowingsInterestRate" scale="-2" unitRef="pure" id="ixv-44149">19</ix:nonFraction>%, of which&#160;<ix:nonFraction contextRef="c164" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:BorrowingsInterestRate" scale="-2" unitRef="pure" id="ixv-44150">14</ix:nonFraction>%&#160;is payable in cash and&#160;<ix:nonFraction contextRef="c166" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:BorrowingsInterestRate" scale="-2" unitRef="pure" id="ixv-44151">5</ix:nonFraction>%&#160;in kind. BIOX is required to make
scheduled amortization payments of&#160;$<ix:nonFraction contextRef="c167" decimals="0" format="ixt:num-dot-decimal" name="mlec:AmortizationPayments" scale="0" unitRef="usd" id="ixv-44152">1,000,000</ix:nonFraction>&#160;on the last business day of each calendar month and may only be repurchased in
full. Had BIOX repurchased it on or before August 5, 2025, a&#160;<ix:nonFraction contextRef="c167" decimals="2" format="ixt:num-dot-decimal" name="mlec:PercentageOfPrepaymentPremium" scale="-2" unitRef="pure" id="ixv-44153">5</ix:nonFraction>%&#160;&#8220;Prepayment Premium&#8221; penalty would have applied.
If the repurchase occurred after that date, the penalty increased to&#160;<ix:nonFraction contextRef="c167" decimals="2" format="ixt:num-dot-decimal" name="mlec:PercentageOfPenalty" scale="-2" unitRef="pure" id="ixv-44154">10</ix:nonFraction>%. The Prepayment Premium also applied to payments made following
acceleration.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">The Secured Guaranteed Notes due 2026 had no conversion rights into
BIOX ordinary shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Secured Convertible Guaranteed Notes </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Secured Guaranteed Convertible Notes were
issued for a total principal amount of $<ix:nonFraction contextRef="c168" decimals="-6" format="ixt:num-dot-decimal" name="ifrs-full:NotionalAmount" scale="6" unitRef="usd" id="ixv-44155">55</ix:nonFraction> million. The notes have a <ix:nonNumeric contextRef="c169" format="ixt-sec:duryear" name="mlec:IfrsDebtInstrumentTerm" id="ixv-44156">4</ix:nonNumeric>- year maturity and accrue interest at an annual interest rate of
<ix:nonFraction contextRef="c168" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:BorrowingsInterestRate" scale="-2" unitRef="pure" id="ixv-44157">9</ix:nonFraction>%, of which <ix:nonFraction contextRef="c168" decimals="2" format="ixt:num-dot-decimal" name="mlec:BorrowingInterestRateInCash" scale="-2" unitRef="pure" id="ixv-44158">5</ix:nonFraction>% is payable in cash and <ix:nonFraction contextRef="c168" decimals="2" format="ixt:num-dot-decimal" name="mlec:BorrowingInterestRateInKind" scale="-2" unitRef="pure" id="ixv-44159">4</ix:nonFraction>% in-kind. At any time up to maturity the note holders might opt to convert the outstanding principal
amount into common shares of BIOX at a strike price of $<ix:nonFraction contextRef="c169" decimals="0" format="ixt:num-dot-decimal" name="mlec:StrikePriceForConversionOfDebt" scale="0" unitRef="usdPershares" id="ixv-44160">18</ix:nonFraction> per share. BIOX can repurchase the notes voluntarily <ix:nonNumeric contextRef="c169" format="ixt-sec:durmonth" name="mlec:VoluntaryRepurchaseOfNotesAfterIssueDate" id="ixv-44161">30</ix:nonNumeric> months after the issue
date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 18, 2025, BIOX entered into an amendment to the Secured Convertible
Guaranteed Notes pursuant to which the aggregate principal amount increases from&#160;$<ix:nonFraction contextRef="c166" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Borrowings" scale="0" unitRef="usd" id="ixv-44162">61,652,927</ix:nonFraction>&#160;to&#160;$<ix:nonFraction contextRef="c170" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Borrowings" scale="0" unitRef="usd" id="ixv-44163">67,868,227</ix:nonFraction>, and the maturity
date is extended to <ix:nonNumeric contextRef="c167" name="ifrs-full:BorrowingsMaturity" id="ixv-44164">August 31, 2027</ix:nonNumeric>. The notes carry an annual interest rate of&#160;<ix:nonFraction contextRef="c171" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:BorrowingsInterestRate" scale="-2" unitRef="pure" id="ixv-44165">15</ix:nonFraction>%, of which&#160;<ix:nonFraction contextRef="c166" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:BorrowingsInterestRate" scale="-2" unitRef="pure" id="ixv-44166">5</ix:nonFraction>%&#160;is payable in cash and&#160;<ix:nonFraction contextRef="c170" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:BorrowingsInterestRate" scale="-2" unitRef="pure" id="ixv-44167">10</ix:nonFraction>%&#160;in
kind. Noteholders have now the option to convert the outstanding principal amount of their Convertible Notes into common shares of BIOX
at a reduced strike price of&#160;$<ix:nonFraction contextRef="c167" decimals="0" format="ixt:num-dot-decimal" name="mlec:PricePerSharesOfStrikePrice" scale="0" unitRef="usdPershares" id="ixv-44168">6</ix:nonFraction>&#160;per share. If BIOX raises more than&#160;$<ix:nonFraction contextRef="c167" decimals="0" format="ixt:num-dot-decimal" name="mlec:CommonEquity" scale="0" unitRef="usd" id="ixv-44169">10,000,000</ix:nonFraction>&#160;in common equity, the strike price
resets to the lesser of (1) the then-applicable strike price or (2) the price per share at which the new shares are issued (or the weighted
average price per share, if issued at varying prices). BIOX may voluntarily repurchase the Convertible Notes; however, it must pay either
a &#8220;Prepayment Premium Fee&#8221; or an &#8220;Equity Option Fee.&#8221; If the repurchase occurs on or before August 31, 2025, a&#160;<ix:nonFraction contextRef="c167" decimals="2" format="ixt:num-dot-decimal" name="mlec:PercentageOfPenaltyOfPrepayment" scale="-2" unitRef="pure" id="ixv-44170">5</ix:nonFraction>%&#160;prepayment
penalty applies. If the repurchase had occurred on or before August 31, 2025, a&#160;<ix:nonFraction contextRef="c172" decimals="2" format="ixt:num-dot-decimal" name="mlec:PercentageOfPenaltyOfPrepayment" scale="-2" unitRef="pure" id="ixv-44171">5</ix:nonFraction>%&#160;prepayment penalty would have applied. If
repurchased between September 1 and prior to October 1, 2025, the penalty would have increased to&#160;<ix:nonFraction contextRef="c173" decimals="2" format="ixt:num-dot-decimal" name="mlec:PercentageOfPenalty" scale="-2" unitRef="pure" id="ixv-44172">7</ix:nonFraction>%. For repurchases on or after
October 1, 2025, the applicable fee would be the full Equity Option Fee. Additionally, either the Prepayment Premium Fee or the Equity
Option Fee will apply in the event of payments made following acceleration.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At inception, the fair value of the liability
component of the Secured Convertible Guaranteed Notes was measured using a discount rate of <ix:nonFraction contextRef="c169" decimals="4" format="ixt:num-dot-decimal" name="mlec:DiscountRateForFairValueOfLiabilityComponent" scale="-2" unitRef="pure" id="ixv-44173">13.57</ix:nonFraction>%. Following the BIOX deconsolidation
and as of June 30, 2025, the Secured Convertible Guaranteed Notes are not included within the line item &#8220;Convertible Notes&#8221;
from the Statement of Financial Position.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of June 30, 2025 a total of $<ix:nonFraction contextRef="c169" decimals="-5" format="ixt:num-dot-decimal" name="mlec:PrepaymentPremiumFee" scale="6" unitRef="usd" id="ixv-44174">4.8</ix:nonFraction>&#160;million
was accrued as a Prepayment Premium Fee. (Note 8.5).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="text-align: justify; margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">Following the BIOX deconsolidation and as of June 30, 2025, the Secured
Guaranteed Notes are not included within the line item &#8220;Convertible Notes&#8221; from the Statement of Financial Position</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Convertible Notes</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 15, 2023, Moolec Science has entered
into an agreement to issue a convertible note due 2026 to Invim Corporativo S.L. As of June 30, 2025, the Company has received USD <ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LoansReceived" scale="0" unitRef="usd" id="ixv-44175">10,000,000</ix:nonFraction>
related to such convertible note. Additionally, the Company signed additional convertible notes for USD <ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="mlec:AdditionalConvertibleNotesReceivedAmount" scale="0" unitRef="usd" id="ixv-44176">940,000</ix:nonFraction> between October 2023 and
June 30, 2024 with local farmers and jointly with the convertible note with Invim Corporativo S.L., are referred to as &#8220;the Notes&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Notes have a term of three years with an early
conversion option with a strike price of US $<ix:nonFraction contextRef="c4" decimals="2" format="ixt:num-dot-decimal" name="mlec:ConversionOptionStrikePrice" scale="0" unitRef="usdPershares" id="ixv-44177">60.00</ix:nonFraction>&#160;per share. If the early conversion option is exercised, Moolec Science will have
the option to pay the outstanding amount at that date using shares, cash or a combination of both. Initial interest rate on the notes
is of <ix:nonFraction contextRef="c4" decimals="2" format="ixt:num-dot-decimal" name="mlec:PercentageOfOutstandingAmountInitialInterestRate" scale="-2" unitRef="pure" id="ixv-44178">5</ix:nonFraction>% per annum payable annually in cash in arrears on anniversary of the date of the notes and on the maturity date, however Moolec
Science will have the option at each payment date to capitalize the interest accrued. After the remaining cash payment made during 2024
the interest rate was increased to <ix:nonFraction contextRef="c4" decimals="2" format="ixt:num-dot-decimal" name="mlec:PercentageOfCashPaymentInterestRate" scale="-2" unitRef="pure" id="ixv-44179">10</ix:nonFraction>% per annum. Lastly, as per the convertible note with Invim Corporativo S.L., after the in-kind contribution,
when received, the interest rate will be calculated in accordance with a formula included in the agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At maturity, Moolec Science will hold the option
to deliver ordinary shares, cash, or a combination of cash and ordinary shares. See Note 21 - Events occurring after the reporting period
&#8211; Notice of Alleged Breach.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"></p><div>

</div><!-- Field: Page; Sequence: 162; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: center"><b>&#160;</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>


</div><ix:continuation continuedAt="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock-c0_cont_11" id="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock-c0_cont_10"><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>7.14&#160; <span style="text-decoration:underline">Employee benefits and social security</span></b></p>





<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="mlec:DisclosureOfBenefitsAndSocialSecurityPayablesTableTextBlock" id="ixv-28581"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Current</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0pt">Salaries, accrued incentives, vacations&#160;and social security</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="mlec:SalariesAccruedIncentivesVacationsAndSocialSecurity" scale="0" unitRef="usd" id="ixv-44180">202,014</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="mlec:SalariesAccruedIncentivesVacationsAndSocialSecurity" scale="0" unitRef="usd" id="ixv-44181">7,280,129</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Key management personnel (Note 18)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="mlec:KeyManagementPersonnelBenefitsLiabilityCurrent" scale="0" unitRef="usd" id="ixv-44182">41,620</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="mlec:KeyManagementPersonnelBenefitsLiabilityCurrent" scale="0" unitRef="usd" id="ixv-44183">226,702</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentProvisionsForEmployeeBenefits" scale="0" unitRef="usd" id="ixv-44184">243,634</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentProvisionsForEmployeeBenefits" scale="0" unitRef="usd" id="ixv-44185">7,506,831</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The book value is reasonably approximate to the fair value given its
short-term nature.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>7.15&#160; <span style="text-decoration:underline">Deferred revenue and advances from customers</span></b></p>





<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="mlec:DisclosuresOfDeferredRevenueAndAdvancesFromCustomersTableTextBlock" id="ixv-28636"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Current</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0pt">Advances from customers</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentAdvances" scale="0" unitRef="usd" id="ixv-44186">1,260</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentAdvances" scale="0" unitRef="usd" id="ixv-44187">3,335,740</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Deferred revenue</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-382">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime" scale="0" unitRef="usd" id="ixv-44188">589,061</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentDeferredIncomeIncludingCurrentContractLiabilities" scale="0" unitRef="usd" id="ixv-44189">1,260</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentDeferredIncomeIncludingCurrentContractLiabilities" scale="0" unitRef="usd" id="ixv-44190">3,924,801</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-left: 0pt">Non current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Advances from customers</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-383">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentAdvances" scale="0" unitRef="usd" id="ixv-44191">52,511</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Deferred revenue</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-384">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime" scale="0" unitRef="usd" id="ixv-44192">1,872,627</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-385">-</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentDeferredIncomeIncludingNoncurrentContractLiabilities" scale="0" unitRef="usd" id="ixv-44193">1,925,138</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>7.16&#160; <span style="text-decoration:underline">Changes in allowances and provisions</span></b></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c0" escape="true" name="mlec:DisclosureOfChangesInAllowancesAndProvisionsTableTextBlock" id="ixv-28735"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Item</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Additions</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Uses and </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>reversals</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Currency </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>conversion </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>difference</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Loss of </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>control</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">DEDUCTED FROM ASSETS</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Allowance for impairment of trade debtors</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c405" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherProvisions" scale="0" unitRef="usd" id="ixv-44194">7,050,280</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c406" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionalProvisionsOtherProvisions" scale="0" unitRef="usd" id="ixv-44195">7,123,716</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-386">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c406" decimals="0" format="ixt:num-dot-decimal" name="mlec:AllowancesAndProvisionsUsedAndReversed" scale="0" sign="-" unitRef="usd" id="ixv-44196">50,533</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c406" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" scale="0" sign="-" unitRef="usd" id="ixv-44197">14,123,463</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Allowance for obsolescence</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c407" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherProvisions" scale="0" unitRef="usd" id="ixv-44198">3,087,563</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c408" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionalProvisionsOtherProvisions" scale="0" unitRef="usd" id="ixv-44199">1,547,723</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c408" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions" scale="0" unitRef="usd" id="ixv-44200">1,158,036</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c408" decimals="0" format="ixt:num-dot-decimal" name="mlec:AllowancesAndProvisionsUsedAndReversed" scale="0" unitRef="usd" id="ixv-44201">29,204</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c408" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" scale="0" sign="-" unitRef="usd" id="ixv-44202">3,506,454</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Total deducted from assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c409" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherProvisions" scale="0" unitRef="usd" id="ixv-44203">10,137,843</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c410" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionalProvisionsOtherProvisions" scale="0" unitRef="usd" id="ixv-44204">8,671,439</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c410" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions" scale="0" unitRef="usd" id="ixv-44205">1,158,036</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c410" decimals="0" format="ixt:num-dot-decimal" name="mlec:AllowancesAndProvisionsUsedAndReversed" scale="0" sign="-" unitRef="usd" id="ixv-44206">21,329</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c410" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" scale="0" sign="-" unitRef="usd" id="ixv-44207">17,629,917</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in">INCLUDED IN LIABILITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Provisions for contingencies</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c411" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherProvisions" scale="0" unitRef="usd" id="ixv-44208">17,484,715</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c412" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionalProvisionsOtherProvisions" scale="0" unitRef="usd" id="ixv-44209">336,919</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c412" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions" scale="0" unitRef="usd" id="ixv-44210">309,793</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c412" decimals="0" format="ixt:num-dot-decimal" name="mlec:AllowancesAndProvisionsUsedAndReversed" scale="0" sign="-" unitRef="usd" id="ixv-44211">89,694</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c412" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" scale="0" sign="-" unitRef="usd" id="ixv-44212">1,267,573</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c412" decimals="0" format="ixt:num-dot-decimal" name="mlec:ChangeInAllowanceAndProvisionLossOfControl" scale="0" sign="-" unitRef="usd" id="ixv-44213">16,154,574</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Total included in liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c413" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherProvisions" scale="0" unitRef="usd" id="ixv-44214">17,484,715</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c414" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionalProvisionsOtherProvisions" scale="0" unitRef="usd" id="ixv-44215">336,919</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c414" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions" scale="0" unitRef="usd" id="ixv-44216">309,793</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c414" decimals="0" format="ixt:num-dot-decimal" name="mlec:AllowancesAndProvisionsUsedAndReversed" scale="0" sign="-" unitRef="usd" id="ixv-44217">89,694</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c414" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" scale="0" sign="-" unitRef="usd" id="ixv-44218">1,267,573</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c414" decimals="0" format="ixt:num-dot-decimal" name="mlec:ChangeInAllowanceAndProvisionLossOfControl" scale="0" sign="-" unitRef="usd" id="ixv-44219">16,154,574</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.125in">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherProvisions" scale="0" unitRef="usd" id="ixv-44220">27,622,558</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionalProvisionsOtherProvisions" scale="0" unitRef="usd" id="ixv-44221">9,008,358</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions" scale="0" unitRef="usd" id="ixv-44222">1,467,829</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:AllowancesAndProvisionsUsedAndReversed" scale="0" sign="-" unitRef="usd" id="ixv-44223">111,023</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" scale="0" sign="-" unitRef="usd" id="ixv-44224">18,897,490</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:ChangeInAllowanceAndProvisionLossOfControl" scale="0" sign="-" unitRef="usd" id="ixv-44225">16,154,574</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-indent: -0.25in; padding-left: 0.25in; font-weight: bold">Item</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Additions</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Additions <br/> from <br/> business <br/> combination</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Uses and <br/> reversals</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Currency <br/> conversion <br/> difference</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.25in; padding-left: 0.25in; font-weight: bold">DEDUCTED FROM ASSETS</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left; text-indent: -0.25in; padding-left: 0.25in">Allowance for impairment of trade debtors</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c415" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherProvisions" scale="0" unitRef="usd" id="ixv-44226">7,425,604</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c416" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherProvisions" scale="0" unitRef="usd" id="ixv-44227">753,428</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-387">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c417" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions" scale="0" unitRef="usd" id="ixv-44228">777,558</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c417" decimals="0" format="ixt:num-dot-decimal" name="mlec:AllowancesAndProvisionsUsedAndReversed" scale="0" sign="-" unitRef="usd" id="ixv-44229">351,194</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c417" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" scale="0" unitRef="usd" id="ixv-44230">7,050,280</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.25in; padding-left: 0.25in">Allowance for obsolescence</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c418" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherProvisions" scale="0" unitRef="usd" id="ixv-44231">2,492,499</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c419" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherProvisions" scale="0" unitRef="usd" id="ixv-44232">586,515</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-388">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c420" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions" scale="0" unitRef="usd" id="ixv-44233">69,582</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c420" decimals="0" format="ixt:num-dot-decimal" name="mlec:AllowancesAndProvisionsUsedAndReversed" scale="0" unitRef="usd" id="ixv-44234">78,131</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c420" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" scale="0" unitRef="usd" id="ixv-44235">3,087,563</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -0.25in; padding-left: 0.25in">Total deducted from assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c421" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherProvisions" scale="0" unitRef="usd" id="ixv-44236">9,918,103</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c422" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherProvisions" scale="0" unitRef="usd" id="ixv-44237">1,339,943</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-389">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c423" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions" scale="0" unitRef="usd" id="ixv-44238">847,140</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c423" decimals="0" format="ixt:num-dot-decimal" name="mlec:AllowancesAndProvisionsUsedAndReversed" scale="0" sign="-" unitRef="usd" id="ixv-44239">273,063</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c423" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" scale="0" unitRef="usd" id="ixv-44240">10,137,843</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.25in; padding-left: 0.25in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; text-indent: -0.25in; padding-left: 0.25in">INCLUDED IN LIABILITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.25in; padding-left: 0.25in">Provisions for contingencies</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c424" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherProvisions" scale="0" unitRef="usd" id="ixv-44241">16,901,773</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c425" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherProvisions" scale="0" unitRef="usd" id="ixv-44242">653,574</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c426" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionalProvisionsOtherProvisions" scale="0" unitRef="usd" id="ixv-44243">355,898</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c426" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions" scale="0" unitRef="usd" id="ixv-44244">393,073</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c426" decimals="0" format="ixt:num-dot-decimal" name="mlec:AllowancesAndProvisionsUsedAndReversed" scale="0" sign="-" unitRef="usd" id="ixv-44245">33,457</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c426" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" scale="0" unitRef="usd" id="ixv-44246">17,484,715</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -0.25in; padding-left: 0.25in">Total included in liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c427" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherProvisions" scale="0" unitRef="usd" id="ixv-44247">16,901,773</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c428" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherProvisions" scale="0" unitRef="usd" id="ixv-44248">653,574</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c429" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionalProvisionsOtherProvisions" scale="0" unitRef="usd" id="ixv-44249">355,898</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c429" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions" scale="0" unitRef="usd" id="ixv-44250">393,073</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c429" decimals="0" format="ixt:num-dot-decimal" name="mlec:AllowancesAndProvisionsUsedAndReversed" scale="0" sign="-" unitRef="usd" id="ixv-44251">33,457</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c429" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" scale="0" unitRef="usd" id="ixv-44252">17,484,715</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 2.5pt; text-indent: -0.25in; padding-left: 0.25in">Total</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherProvisions" scale="0" unitRef="usd" id="ixv-44253">26,819,876</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c47" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherProvisions" scale="0" unitRef="usd" id="ixv-44254">1,993,517</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionalProvisionsOtherProvisions" scale="0" unitRef="usd" id="ixv-44255">355,898</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions" scale="0" unitRef="usd" id="ixv-44256">1,240,213</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="mlec:AllowancesAndProvisionsUsedAndReversed" scale="0" sign="-" unitRef="usd" id="ixv-44257">306,520</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" scale="0" unitRef="usd" id="ixv-44258">27,622,558</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 163; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: center"><b>&#160;</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>


</div><ix:continuation continuedAt="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock-c0_cont_12" id="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock-c0_cont_11"><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfProvisionsExplanatory" id="ixv-29305"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="text-decoration:underline">Provisions</span></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0pt">Conditional payment Rizobacter SA</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c430" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentProvisions" scale="0" unitRef="usd" id="ixv-44259">15,916,116</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c431" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentProvisions" scale="0" unitRef="usd" id="ixv-44260">15,916,116</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Provisions for contingencies</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c424" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentProvisions" scale="0" unitRef="usd" id="ixv-44261">238,458</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c411" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentProvisions" scale="0" unitRef="usd" id="ixv-44262">1,568,599</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentProvisions" scale="0" unitRef="usd" id="ixv-44263">16,154,574</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentProvisions" scale="0" unitRef="usd" id="ixv-44264">17,484,715</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group has recorded a provision for probable
administrative, judicial and out-of-court proceedings that could arise in the ordinary course of business, based on a prudent criterion
according to its professional advisors and on Management&#8217;s assessment of the best estimate of the amount of possible claims. These
potential claims are not likely to have a material impact on the results of the Group&#8217;s operations, its cash flow or financial position.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management considers that the objective evidence
is not enough to determine the date of the eventual cash outflow due to a lack of experience in any similar cases. However, the provision
was classified under current or non-current liabilities, applying the best prudent criterion based on Management&#8217;s estimates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are no expected reimbursements related to
the provisions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In order to assess the need for provisions and
disclosures in its consolidated financial statements, Management considers the following factors: (i) nature of the claim and potential
level of damages in the jurisdiction in which the claim has been brought; (ii) the progress of the eventual case; (iii) the opinions or
views of tax and legal advisers; (iv) experience in similar cases; and (v) any decision of the Group&#8217;s management as to how it will respond
to the eventual claim.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Conditional payment Rizobacter S.A.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group agreed with certain sellers of Rizobacter,
a contingent payment of $<ix:nonFraction contextRef="c4" decimals="-5" format="ixt:num-dot-decimal" name="mlec:ContingentPayment" scale="6" unitRef="usd" id="ixv-44265">17.3</ix:nonFraction> million (current value of $<ix:nonFraction contextRef="c4" decimals="-5" format="ixt:num-dot-decimal" name="mlec:ContingentPaymentCurrent" scale="6" unitRef="usd" id="ixv-44266">15.9</ix:nonFraction> million) conditional on obtaining a favorable resolution that totally rejects
the claim of the plaintiff in the nullity trials, file &#8220;Harnan Miguel, Marcos and Martina c/ac Mullen Jorge and others s/ Annulment
Action&#8221;, file No. 76,806 and in the injunction (&#8220;<i>embargo</i>&#8221;), file &#8220;Harnan Miguel, Marcos and Martina c/
Mac Mullen Jorge and others s/ Precautionary Measures&#8221;, file No. 76,745. In said cause, <ix:nonFraction contextRef="c4" decimals="2" format="ixt:num-dot-decimal" name="mlec:PercentageOfCapital" scale="-2" unitRef="pure" id="ixv-44267">44</ix:nonFraction>% of the capital of Rizobacter Argentina
S.A. is seized and <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="mlec:PercentageOfDividendsTaxedShares" scale="-2" unitRef="pure" id="ixv-44268">30</ix:nonFraction>% of the dividends that the taxed shares produce.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If the injunction is lifted, the Group will be
required to pay within 12 months of notification, a contingent purchase price of $<ix:nonFraction contextRef="c4" decimals="-5" format="ixt:num-dot-decimal" name="mlec:ContingentPurchasePrice" scale="6" unitRef="usd" id="ixv-44269">17.3</ix:nonFraction> million to certain selling shareholders of Rizobacter.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of June 30, 2025 there is no allowance for
obsolescence for inventories, as the inventory was acquired through the Business Combination Agreement consummated in June 16, 2025.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><b>&#160;</b></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>7.17&#160; <span style="text-decoration:underline">Government Grants</span></b></p>





<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfGovernmentGrantsExplanatory" id="ixv-29372"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0pt">At the beginning of the year</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c432" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GovernmentGrants" scale="0" unitRef="usd" id="ixv-44270">4,437</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c433" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GovernmentGrants" scale="0" unitRef="usd" id="ixv-44271">349,998</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt"><span style="font-size: 10pt">Loss of control <sup>(*)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-390">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c435" decimals="0" format="ixt:num-dot-decimal" id="ix_42_fact" name="ifrs-full:LossesOnDisposalsOfInvestments" scale="0" unitRef="usd">157,043</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Currency conversion difference</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c434" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" scale="0" unitRef="usd" id="ixv-44273">255</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c435" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" scale="0" unitRef="usd" id="ixv-44274">9,001</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Released to the statement of profit or loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c434" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" scale="0" sign="-" unitRef="usd" id="ixv-44275">3,412</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c435" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" scale="0" sign="-" unitRef="usd" id="ixv-44276">197,519</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">At the end of the year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c436" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GovernmentGrants" scale="0" unitRef="usd" id="ixv-44277">1,280</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c432" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GovernmentGrants" scale="0" unitRef="usd" id="ixv-44278">4,437</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><sup>&#160;</sup></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><sup>(*)</sup></span></td><td style="text-align: justify"><ix:footnote id="ix_7_footnote" xml:lang="en-US"><span style="font-size: 10pt">Correspond to the loss of control
of Inmet S.A. in the year 2024</span></ix:footnote></td>
</tr></table></ix:nonNumeric></ix:continuation><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 164; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: center"><b>&#160;</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>


</div><ix:continuation id="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock-c0_cont_12"><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>7.18&#160; <span style="text-decoration:underline">Warrants</span></b></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>



<ix:nonNumeric contextRef="c0" escape="true" name="mlec:DisclosureOfWarrantsTextBlock" id="ixv-29497"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">At the beginning of the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-391">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-392">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Additions for the year</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:AdditionsWarrantsForTheYear" scale="0" unitRef="usd" id="ixv-44279">1,030,000</ix:nonFraction></p></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right"><p style="-sec-ix-hidden: hidden-fact-393; margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">-</p></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Additions from business combination</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:AdditionsFromBusinessCombination" scale="0" unitRef="usd" id="ixv-44280">181,093</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-394">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">At the end of the year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentWarrantLiability" scale="0" unitRef="usd" id="ixv-44281">1,211,093</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-395">-</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><sup>&#160;</sup></b></p><div>

</div><div><a id="fs_008"></a></div><ix:nonNumeric contextRef="c0" continuedAt="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock-c0_cont_1" escape="true" name="mlec:DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock" id="ixv-29560"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><b>8.</b></td><td style="text-align: justify"><b><span style="text-decoration:underline">INFORMATION ABOUT COMPONENT OF CONSOLIDATED STATEMENTS
OF COMPREHENSIVE INCOME</span></b></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>8.1 <span style="text-decoration:underline">Revenue from contracts with customers</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory" id="ixv-29575"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Sale of goods and services</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromSaleOfGoods" scale="0" unitRef="usd" id="ixv-44282">317,924,355</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromSaleOfGoods" scale="0" unitRef="usd" id="ixv-44283">444,149,141</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromSaleOfGoods" scale="0" unitRef="usd" id="ixv-44284">385,976,753</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Royalties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromRoyalties" scale="0" unitRef="usd" id="ixv-44285">1,414,864</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromRoyalties" scale="0" unitRef="usd" id="ixv-44286">986,602</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromRoyalties" scale="0" unitRef="usd" id="ixv-44287">1,247,567</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Rendering of services with related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromRenderingOfServices" scale="0" unitRef="usd" id="ixv-44288">841,205</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromRenderingOfServices" scale="0" unitRef="usd" id="ixv-44289">952,742</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromRenderingOfServices" scale="0" unitRef="usd" id="ixv-44290">739,651</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Right of use licenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LicenceFeeIncome" scale="0" unitRef="usd" id="ixv-44291">13,430,824</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LicenceFeeIncome" scale="0" unitRef="usd" id="ixv-44292">20,287,845</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LicenceFeeIncome" scale="0" unitRef="usd" id="ixv-44293">32,903,458</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-44294">333,611,248</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-44295">466,376,330</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-44296">420,867,429</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Transactions of sales of goods and services with
joint ventures and with shareholders and other related parties are reported in Note 17.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>8.2 <span style="text-decoration:underline">Cost of sales</span></b></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfCostOfSalesExplanatory" id="ixv-29665"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid"><b>Item</b></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-left: 0pt">Inventories as of the beginning of the year</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="mlec:InventoriesNetOfAgriculturalProducts" scale="0" unitRef="usd" id="ixv-44297">110,913,884</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c47" decimals="0" format="ixt:num-dot-decimal" name="mlec:InventoriesNetOfAgriculturalProducts" scale="0" unitRef="usd" id="ixv-44298">112,000,786</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c65" decimals="0" format="ixt:num-dot-decimal" name="mlec:InventoriesNetOfAgriculturalProducts" scale="0" unitRef="usd" id="ixv-44299">78,775,003</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Loss of control</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:LossOfControl" scale="0" sign="-" unitRef="usd" id="ixv-44300">82,999,205</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-396">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-397">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Additions related to Business combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:InventoriesFromBusinessCombination" scale="0" unitRef="usd" id="ixv-44301">2,235,482</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="mlec:InventoriesFromBusinessCombination" scale="0" unitRef="usd" id="ixv-44302">4,020,771</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:InventoriesFromBusinessCombination" scale="0" unitRef="usd" id="ixv-44303">11,182,602</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Purchases of the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:PurchaseOfInventory" scale="0" unitRef="usd" id="ixv-44304">149,950,181</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="mlec:PurchaseOfInventory" scale="0" unitRef="usd" id="ixv-44305">249,648,267</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:PurchaseOfInventory" scale="0" unitRef="usd" id="ixv-44306">233,465,488</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Production costs (note 8.4)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:InventoryProductionCosts" scale="0" unitRef="usd" id="ixv-44307">25,177,920</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="mlec:InventoryProductionCosts" scale="0" unitRef="usd" id="ixv-44308">25,819,152</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:InventoryProductionCosts" scale="0" unitRef="usd" id="ixv-44309">23,234,862</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Foreign currency translation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:ForeignCurrencyTranslationOnInventory" scale="0" unitRef="usd" id="ixv-44310">382,092</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="mlec:ForeignCurrencyTranslationOnInventory" scale="0" sign="-" unitRef="usd" id="ixv-44311">1,206,764</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:ForeignCurrencyTranslationOnInventory" scale="0" unitRef="usd" id="ixv-44312">806,903</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">Subtotal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:InventoriesBeforeClosingInventory" scale="0" unitRef="usd" id="ixv-44313">205,660,354</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="mlec:InventoriesBeforeClosingInventory" scale="0" unitRef="usd" id="ixv-44314">390,282,212</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:InventoriesBeforeClosingInventory" scale="0" unitRef="usd" id="ixv-44315">347,464,858</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"><span style="font-size: 10pt">Inventories as of the end of
the year</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InventoriesTotal" scale="0" unitRef="usd" id="ixv-44316">2,235,482</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InventoriesTotal" scale="0" unitRef="usd" id="ixv-44317">110,913,884</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c47" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InventoriesTotal" scale="0" unitRef="usd" id="ixv-44318">112,000,786</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 0pt">Cost of sales</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CostOfSales" scale="0" unitRef="usd" id="ixv-44319">203,424,872</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CostOfSales" scale="0" unitRef="usd" id="ixv-44320">279,368,328</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CostOfSales" scale="0" unitRef="usd" id="ixv-44321">235,464,072</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:nonNumeric><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><sup>&#160;</sup></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 165; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: center"><b>&#160;</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>


</div><ix:continuation continuedAt="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock-c0_cont_2" id="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>8.3 <span style="text-decoration:underline">R&amp;D classified by nature</span></b></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory" id="ixv-29861"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Research and development expenses</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid"><b>Item</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>06/30/2025</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>06/30/2024</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>06/30/2023</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Amortization of intangible assets</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-44322">5,079,839</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-44323">5,923,389</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-44324">4,804,768</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Analysis and storage</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-398">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="mlec:AnalysisAndStorage" scale="0" unitRef="usd" id="ixv-44325">5,302</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:AnalysisAndStorage" scale="0" unitRef="usd" id="ixv-44326">52,660</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Commissions and royalties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RoyaltyExpense" scale="0" unitRef="usd" id="ixv-44327">14,179</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-399">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RoyaltyExpense" scale="0" unitRef="usd" id="ixv-44328">16,257</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Import and export expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-400">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-401">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:ImportAndExportExpenses" scale="0" unitRef="usd" id="ixv-44329">855</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Depreciation of leased assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationRightofuseAssets" scale="0" unitRef="usd" id="ixv-44330">54,505</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-402">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationRightofuseAssets" scale="0" unitRef="usd" id="ixv-44331">68,321</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Depreciation of property, plant and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-44332">767,731</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-44333">618,627</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-44334">637,734</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Freight and haulage</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TransportationExpense" scale="0" unitRef="usd" id="ixv-44335">2,025</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TransportationExpense" scale="0" unitRef="usd" id="ixv-44336">30,450</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TransportationExpense" scale="0" unitRef="usd" id="ixv-44337">17,707</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Employee benefits and social securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermEmployeeBenefitsExpense" scale="0" unitRef="usd" id="ixv-44338">4,032,386</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermEmployeeBenefitsExpense" scale="0" unitRef="usd" id="ixv-44339">4,727,340</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermEmployeeBenefitsExpense" scale="0" unitRef="usd" id="ixv-44340">4,781,678</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Insurance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InsuranceExpense" scale="0" unitRef="usd" id="ixv-44341">49,343</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InsuranceExpense" scale="0" unitRef="usd" id="ixv-44342">48,872</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InsuranceExpense" scale="0" unitRef="usd" id="ixv-44343">78,673</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Energy and fuel</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FuelAndEnergyExpense" scale="0" unitRef="usd" id="ixv-44344">5,576</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FuelAndEnergyExpense" scale="0" unitRef="usd" id="ixv-44345">8,101</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FuelAndEnergyExpense" scale="0" unitRef="usd" id="ixv-44346">111,481</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Maintenance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RepairsAndMaintenanceExpense" scale="0" unitRef="usd" id="ixv-44347">236,867</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RepairsAndMaintenanceExpense" scale="0" unitRef="usd" id="ixv-44348">283,895</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RepairsAndMaintenanceExpense" scale="0" unitRef="usd" id="ixv-44349">475,868</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Supplies and materials</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:SuppliesAndMaterials" scale="0" unitRef="usd" id="ixv-44350">2,731,604</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="mlec:SuppliesAndMaterials" scale="0" unitRef="usd" id="ixv-44351">2,361,380</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:SuppliesAndMaterials" scale="0" unitRef="usd" id="ixv-44352">3,078,403</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Licenses &amp; Patents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:LicensesandPatents" scale="0" unitRef="usd" id="ixv-44353">516,591</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="mlec:LicensesandPatents" scale="0" unitRef="usd" id="ixv-44354">67,188</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:LicensesandPatents" scale="0" unitRef="usd" id="ixv-44355">181,264</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Mobility and travel</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TravelExpense" scale="0" unitRef="usd" id="ixv-44356">141,481</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TravelExpense" scale="0" unitRef="usd" id="ixv-44357">205,741</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TravelExpense" scale="0" unitRef="usd" id="ixv-44358">245,875</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Publicity and advertising</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-403">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdvertisingExpense" scale="0" unitRef="usd" id="ixv-44359">23,383</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-404">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Systems expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:SystemExpenses" scale="0" unitRef="usd" id="ixv-44360">40,286</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="mlec:SystemExpenses" scale="0" unitRef="usd" id="ixv-44361">29,026</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:SystemExpenses" scale="0" unitRef="usd" id="ixv-44362">31,410</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Vehicles expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:VehicleExpenses" scale="0" unitRef="usd" id="ixv-44363">16,858</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="mlec:VehicleExpenses" scale="0" unitRef="usd" id="ixv-44364">30,883</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:VehicleExpenses" scale="0" unitRef="usd" id="ixv-44365">8,252</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Share-based incentives</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" scale="0" unitRef="usd" id="ixv-44366">217,494</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" scale="0" unitRef="usd" id="ixv-44367">510,162</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" scale="0" unitRef="usd" id="ixv-44368">136,754</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Surveillance expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-405">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-406">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:SurveillanceExpense" scale="0" unitRef="usd" id="ixv-44369">11,145</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Professional fees and outsourced services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfessionalFeesExpense" scale="0" unitRef="usd" id="ixv-44370">878,973</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfessionalFeesExpense" scale="0" unitRef="usd" id="ixv-44371">1,325,361</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfessionalFeesExpense" scale="0" unitRef="usd" id="ixv-44372">550,585</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Professional fees related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:ProfessionalFeesExpenseRelatedParties" scale="0" unitRef="usd" id="ixv-44373">90,533</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="mlec:ProfessionalFeesExpenseRelatedParties" scale="0" unitRef="usd" id="ixv-44374">256,877</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:ProfessionalFeesExpenseRelatedParties" scale="0" unitRef="usd" id="ixv-44375">542,551</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Office supplies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdministrativeExpense" scale="0" unitRef="usd" id="ixv-44376">261,263</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdministrativeExpense" scale="0" unitRef="usd" id="ixv-44377">696,760</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdministrativeExpense" scale="0" unitRef="usd" id="ixv-44378">111,618</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Miscellaneous</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:MiscellaneousOtherOperatingExpense" scale="0" unitRef="usd" id="ixv-44379">976</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:MiscellaneousOtherOperatingExpense" scale="0" unitRef="usd" id="ixv-44380">269,750</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:MiscellaneousOtherOperatingExpense" scale="0" unitRef="usd" id="ixv-44381">128</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="0" unitRef="usd" id="ixv-44382">15,138,510</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="0" unitRef="usd" id="ixv-44383">17,422,487</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="0" unitRef="usd" id="ixv-44384">15,943,987</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-left: 0pt">R&amp;D capitalized (Note 8.3)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:ResearchAndDevelopmentExpenseCapitalized" scale="0" unitRef="usd" id="ixv-44385">8,614,448</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="mlec:ResearchAndDevelopmentExpenseCapitalized" scale="0" unitRef="usd" id="ixv-44386">11,856,331</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:ResearchAndDevelopmentExpenseCapitalized" scale="0" unitRef="usd" id="ixv-44387">10,753,047</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">R&amp;D profit and loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="0" unitRef="usd" id="ixv-44388">15,138,510</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="0" unitRef="usd" id="ixv-44389">17,422,487</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="0" unitRef="usd" id="ixv-44390">15,943,987</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:TotalResearchAndDevelopmentExpenseIncurred" scale="0" unitRef="usd" id="ixv-44391">23,752,958</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="mlec:TotalResearchAndDevelopmentExpenseIncurred" scale="0" unitRef="usd" id="ixv-44392">29,278,818</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:TotalResearchAndDevelopmentExpenseIncurred" scale="0" unitRef="usd" id="ixv-44393">26,697,034</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"></p><div>

</div><!-- Field: Page; Sequence: 166; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: center"><b>&#160;</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>


</div><ix:continuation continuedAt="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock-c0_cont_3" id="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>8.4 <span style="text-decoration:underline">Expenses classified by nature and function</span></b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfExpensesByNatureExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfExpensesByNatureExplanatory" id="ixv-30345"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>Item</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Production and services costs</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Selling, general and administrative expenses</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><b>Total</b></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><b>06/30/2025</b></p></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-left: 0pt">Amortization of intangible assets</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c441" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForAmortisationExpense" scale="0" unitRef="usd" id="ixv-44394">351,240</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c442" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForAmortisationExpense" scale="0" unitRef="usd" id="ixv-44395">5,769,969</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c443" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForAmortisationExpense" scale="0" unitRef="usd" id="ixv-44396">6,121,209</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Analysis and storage</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-407">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c442" decimals="0" format="ixt:num-dot-decimal" name="mlec:AnalysisAndStorage" scale="0" unitRef="usd" id="ixv-44397">14,744</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c443" decimals="0" format="ixt:num-dot-decimal" name="mlec:AnalysisAndStorage" scale="0" unitRef="usd" id="ixv-44398">14,744</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Commissions and royalties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c441" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RoyaltyExpense" scale="0" unitRef="usd" id="ixv-44399">835,082</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c442" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RoyaltyExpense" scale="0" unitRef="usd" id="ixv-44400">1,989,880</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c443" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RoyaltyExpense" scale="0" unitRef="usd" id="ixv-44401">2,824,962</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Import and export expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-408">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c442" decimals="0" format="ixt:num-dot-decimal" name="mlec:ImportAndExportExpenses" scale="0" unitRef="usd" id="ixv-44402">826,942</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c443" decimals="0" format="ixt:num-dot-decimal" name="mlec:ImportAndExportExpenses" scale="0" unitRef="usd" id="ixv-44403">826,942</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Depreciation of property, plant and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c441" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-44404">2,861,812</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c442" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-44405">2,386,157</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c443" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-44406">5,247,969</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Impairment of receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-409">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c442" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossTradeReceivables" scale="0" unitRef="usd" id="ixv-44407">7,123,716</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c443" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossTradeReceivables" scale="0" unitRef="usd" id="ixv-44408">7,123,716</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Freight and haulage</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c441" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TransportationExpense" scale="0" unitRef="usd" id="ixv-44409">1,003,986</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c442" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TransportationExpense" scale="0" unitRef="usd" id="ixv-44410">11,367,271</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c443" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TransportationExpense" scale="0" unitRef="usd" id="ixv-44411">12,371,257</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Employee benefits and social securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c441" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermEmployeeBenefitsExpense" scale="0" unitRef="usd" id="ixv-44412">9,899,884</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c442" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermEmployeeBenefitsExpense" scale="0" unitRef="usd" id="ixv-44413">44,971,665</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c443" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermEmployeeBenefitsExpense" scale="0" unitRef="usd" id="ixv-44414">54,871,549</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">Taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c441" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentTaxExpenseIncome" scale="0" unitRef="usd" id="ixv-44415">260,091</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c442" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentTaxExpenseIncome" scale="0" unitRef="usd" id="ixv-44416">12,411,799</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c443" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentTaxExpenseIncome" scale="0" unitRef="usd" id="ixv-44417">12,671,890</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Maintenance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c441" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RepairsAndMaintenanceExpense" scale="0" unitRef="usd" id="ixv-44418">2,414,461</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c442" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RepairsAndMaintenanceExpense" scale="0" unitRef="usd" id="ixv-44419">2,216,680</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c443" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RepairsAndMaintenanceExpense" scale="0" unitRef="usd" id="ixv-44420">4,631,141</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Energy and fuel</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c441" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FuelAndEnergyExpense" scale="0" unitRef="usd" id="ixv-44421">658,621</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c442" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FuelAndEnergyExpense" scale="0" unitRef="usd" id="ixv-44422">106,846</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c443" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FuelAndEnergyExpense" scale="0" unitRef="usd" id="ixv-44423">765,467</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Supplies and materials</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c441" decimals="0" format="ixt:num-dot-decimal" name="mlec:SuppliesAndMaterials" scale="0" unitRef="usd" id="ixv-44424">586,696</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c442" decimals="0" format="ixt:num-dot-decimal" name="mlec:SuppliesAndMaterials" scale="0" unitRef="usd" id="ixv-44425">2,678,691</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c443" decimals="0" format="ixt:num-dot-decimal" name="mlec:SuppliesAndMaterials" scale="0" unitRef="usd" id="ixv-44426">3,265,387</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Mobility and travel</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c441" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TravelExpense" scale="0" unitRef="usd" id="ixv-44427">339,447</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c442" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TravelExpense" scale="0" unitRef="usd" id="ixv-44428">4,472,895</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c443" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TravelExpense" scale="0" unitRef="usd" id="ixv-44429">4,812,342</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Allowance&#160;for obsolescence</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c441" decimals="0" format="ixt:num-dot-decimal" name="mlec:AllowanceForObsolescences" scale="0" unitRef="usd" id="ixv-44430">1,547,723</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-410">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c443" decimals="0" format="ixt:num-dot-decimal" name="mlec:AllowanceForObsolescences" scale="0" unitRef="usd" id="ixv-44431">1,547,723</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Publicity and advertising</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-411">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c442" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdvertisingExpense" scale="0" unitRef="usd" id="ixv-44432">4,556,518</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c443" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdvertisingExpense" scale="0" unitRef="usd" id="ixv-44433">4,556,518</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Systems expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c441" decimals="0" format="ixt:num-dot-decimal" name="mlec:SystemExpenses" scale="0" unitRef="usd" id="ixv-44434">39,583</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c442" decimals="0" format="ixt:num-dot-decimal" name="mlec:SystemExpenses" scale="0" unitRef="usd" id="ixv-44435">3,008,347</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c443" decimals="0" format="ixt:num-dot-decimal" name="mlec:SystemExpenses" scale="0" unitRef="usd" id="ixv-44436">3,047,930</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Share-based incentives for employees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c441" decimals="0" format="ixt:num-dot-decimal" name="mlec:SharebasedIncentivesForEmployees" scale="0" unitRef="usd" id="ixv-44437">315,965</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c442" decimals="0" format="ixt:num-dot-decimal" name="mlec:SharebasedIncentivesForEmployees" scale="0" unitRef="usd" id="ixv-44438">3,853,229</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c443" decimals="0" format="ixt:num-dot-decimal" name="mlec:SharebasedIncentivesForEmployees" scale="0" unitRef="usd" id="ixv-44439">4,169,194</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Surveillance expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-412">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c442" decimals="0" format="ixt:num-dot-decimal" name="mlec:SurveillanceExpense" scale="0" unitRef="usd" id="ixv-44440">583,115</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c443" decimals="0" format="ixt:num-dot-decimal" name="mlec:SurveillanceExpense" scale="0" unitRef="usd" id="ixv-44441">583,115</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Professional fees and outsourced services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c441" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfessionalFeesExpense" scale="0" unitRef="usd" id="ixv-44442">201,601</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c442" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfessionalFeesExpense" scale="0" unitRef="usd" id="ixv-44443">9,939,339</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c443" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfessionalFeesExpense" scale="0" unitRef="usd" id="ixv-44444">10,140,940</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Professional fees related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-413">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c442" decimals="0" format="ixt:num-dot-decimal" name="mlec:ProfessionalFeesRelatedParties" scale="0" unitRef="usd" id="ixv-44445">16,353</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c443" decimals="0" format="ixt:num-dot-decimal" name="mlec:ProfessionalFeesRelatedParties" scale="0" unitRef="usd" id="ixv-44446">16,353</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Office supplies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c441" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdministrativeExpense" scale="0" unitRef="usd" id="ixv-44447">93,967</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c442" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdministrativeExpense" scale="0" unitRef="usd" id="ixv-44448">1,373,911</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c443" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdministrativeExpense" scale="0" unitRef="usd" id="ixv-44449">1,467,878</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Insurance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c441" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InsuranceExpense" scale="0" unitRef="usd" id="ixv-44450">181,595</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c442" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InsuranceExpense" scale="0" unitRef="usd" id="ixv-44451">2,850,968</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c443" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InsuranceExpense" scale="0" unitRef="usd" id="ixv-44452">3,032,563</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Depreciation of leased assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c441" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationRightofuseAssets" scale="0" unitRef="usd" id="ixv-44453">2,477,334</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c442" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationRightofuseAssets" scale="0" unitRef="usd" id="ixv-44454">2,504,864</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c443" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationRightofuseAssets" scale="0" unitRef="usd" id="ixv-44455">4,982,198</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Contingencies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c441" decimals="0" format="ixt:num-dot-decimal" name="mlec:Contingencies" scale="0" unitRef="usd" id="ixv-44456">84,567</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c442" decimals="0" format="ixt:num-dot-decimal" name="mlec:Contingencies" scale="0" unitRef="usd" id="ixv-44457">252,352</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c443" decimals="0" format="ixt:num-dot-decimal" name="mlec:Contingencies" scale="0" unitRef="usd" id="ixv-44458">336,919</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Environmental Impact Treatment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c441" decimals="0" format="ixt:num-dot-decimal" name="mlec:EnvironmentalImpactTreatment" scale="0" unitRef="usd" id="ixv-44459">998,303</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c442" decimals="0" format="ixt:num-dot-decimal" name="mlec:EnvironmentalImpactTreatment" scale="0" unitRef="usd" id="ixv-44460">67,510</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c443" decimals="0" format="ixt:num-dot-decimal" name="mlec:EnvironmentalImpactTreatment" scale="0" unitRef="usd" id="ixv-44461">1,065,813</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Licenses &amp; Patents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c441" decimals="0" format="ixt:num-dot-decimal" name="mlec:LicensesandPatents" scale="0" unitRef="usd" id="ixv-44462">75</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c442" decimals="0" format="ixt:num-dot-decimal" name="mlec:LicensesandPatents" scale="0" unitRef="usd" id="ixv-44463">193,773</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c443" decimals="0" format="ixt:num-dot-decimal" name="mlec:LicensesandPatents" scale="0" unitRef="usd" id="ixv-44464">193,848</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 0pt">Miscellaneous</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c441" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:MiscellaneousOtherOperatingExpense" scale="0" unitRef="usd" id="ixv-44465">25,887</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c442" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:MiscellaneousOtherOperatingExpense" scale="0" unitRef="usd" id="ixv-44466">370,706</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c443" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:MiscellaneousOtherOperatingExpense" scale="0" unitRef="usd" id="ixv-44467">396,593</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 0pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c441" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherExpenseByFunction" scale="0" unitRef="usd" id="ixv-44468">25,177,920</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c442" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherExpenseByFunction" scale="0" unitRef="usd" id="ixv-44469">125,908,240</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c443" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherExpenseByFunction" scale="0" unitRef="usd" id="ixv-44470">151,086,160</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 167; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: center"><b>&#160;</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>


</div><ix:continuation continuedAt="_DisclosureOfExpensesByNatureExplanatory-c0_cont_2" id="_DisclosureOfExpensesByNatureExplanatory-c0_cont_1"><ix:continuation continuedAt="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock-c0_cont_4" id="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock-c0_cont_3"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>Item</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Production and services costs</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Selling, general and administrative expenses</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="margin-top: 0; margin-bottom: 0"><b>Total</b></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><b>06/30/2024</b></p></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-left: 0pt">Amortization of intangible assets</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c444" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForAmortisationExpense" scale="0" unitRef="usd" id="ixv-44471">239,545</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c445" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForAmortisationExpense" scale="0" unitRef="usd" id="ixv-44472">5,950,289</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c446" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForAmortisationExpense" scale="0" unitRef="usd" id="ixv-44473">6,189,834</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Analysis and storage</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c444" decimals="0" format="ixt:num-dot-decimal" name="mlec:AnalysisAndStorage" scale="0" unitRef="usd" id="ixv-44474">598</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c445" decimals="0" format="ixt:num-dot-decimal" name="mlec:AnalysisAndStorage" scale="0" unitRef="usd" id="ixv-44475">160,133</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c446" decimals="0" format="ixt:num-dot-decimal" name="mlec:AnalysisAndStorage" scale="0" unitRef="usd" id="ixv-44476">160,731</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Commissions and royalties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c444" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RoyaltyExpense" scale="0" unitRef="usd" id="ixv-44477">217,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c445" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RoyaltyExpense" scale="0" unitRef="usd" id="ixv-44478">1,745,169</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c446" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RoyaltyExpense" scale="0" unitRef="usd" id="ixv-44479">1,962,169</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Import and export expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c444" decimals="0" format="ixt:num-dot-decimal" name="mlec:ImportAndExportExpenses" scale="0" unitRef="usd" id="ixv-44480">147,392</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c445" decimals="0" format="ixt:num-dot-decimal" name="mlec:ImportAndExportExpenses" scale="0" unitRef="usd" id="ixv-44481">734,026</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c446" decimals="0" format="ixt:num-dot-decimal" name="mlec:ImportAndExportExpenses" scale="0" unitRef="usd" id="ixv-44482">881,418</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Depreciation of property, plant and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c444" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-44483">3,018,014</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c445" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-44484">2,163,357</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c446" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-44485">5,181,371</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Impairment of receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-414">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c445" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossTradeReceivables" scale="0" unitRef="usd" id="ixv-44486">753,428</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c446" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossTradeReceivables" scale="0" unitRef="usd" id="ixv-44487">753,428</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Freight and haulage</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c444" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TransportationExpense" scale="0" unitRef="usd" id="ixv-44488">927,910</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c445" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TransportationExpense" scale="0" unitRef="usd" id="ixv-44489">11,831,209</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c446" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TransportationExpense" scale="0" unitRef="usd" id="ixv-44490">12,759,119</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Employee benefits and social securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c444" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermEmployeeBenefitsExpense" scale="0" unitRef="usd" id="ixv-44491">11,162,207</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c445" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermEmployeeBenefitsExpense" scale="0" unitRef="usd" id="ixv-44492">38,799,972</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c446" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermEmployeeBenefitsExpense" scale="0" unitRef="usd" id="ixv-44493">49,962,179</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">Taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c444" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentTaxExpenseIncome" scale="0" unitRef="usd" id="ixv-44494">285,791</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c445" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentTaxExpenseIncome" scale="0" unitRef="usd" id="ixv-44495">14,442,557</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c446" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentTaxExpenseIncome" scale="0" unitRef="usd" id="ixv-44496">14,728,348</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Maintenance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c444" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RepairsAndMaintenanceExpense" scale="0" unitRef="usd" id="ixv-44497">2,074,352</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c445" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RepairsAndMaintenanceExpense" scale="0" unitRef="usd" id="ixv-44498">1,666,524</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c446" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RepairsAndMaintenanceExpense" scale="0" unitRef="usd" id="ixv-44499">3,740,876</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Energy and fuel</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c444" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FuelAndEnergyExpense" scale="0" unitRef="usd" id="ixv-44500">997,066</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c445" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FuelAndEnergyExpense" scale="0" unitRef="usd" id="ixv-44501">514,422</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c446" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FuelAndEnergyExpense" scale="0" unitRef="usd" id="ixv-44502">1,511,488</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Supplies and materials</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c444" decimals="0" format="ixt:num-dot-decimal" name="mlec:SuppliesAndMaterials" scale="0" unitRef="usd" id="ixv-44503">1,031,386</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c445" decimals="0" format="ixt:num-dot-decimal" name="mlec:SuppliesAndMaterials" scale="0" unitRef="usd" id="ixv-44504">3,520,386</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c446" decimals="0" format="ixt:num-dot-decimal" name="mlec:SuppliesAndMaterials" scale="0" unitRef="usd" id="ixv-44505">4,551,772</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Mobility and travel</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c444" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TravelExpense" scale="0" unitRef="usd" id="ixv-44506">202,810</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c445" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TravelExpense" scale="0" unitRef="usd" id="ixv-44507">5,317,138</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c446" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TravelExpense" scale="0" unitRef="usd" id="ixv-44508">5,519,948</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Allowance&#160;for obsolescence</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c444" decimals="0" format="ixt:num-dot-decimal" name="mlec:AllowanceForObsolescences" scale="0" unitRef="usd" id="ixv-44509">581,804</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c445" decimals="0" format="ixt:num-dot-decimal" name="mlec:AllowanceForObsolescences" scale="0" unitRef="usd" id="ixv-44510">4,711</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c446" decimals="0" format="ixt:num-dot-decimal" name="mlec:AllowanceForObsolescences" scale="0" unitRef="usd" id="ixv-44511">586,515</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Publicity and advertising</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c444" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdvertisingExpense" scale="0" unitRef="usd" id="ixv-44512">233</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c445" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdvertisingExpense" scale="0" unitRef="usd" id="ixv-44513">5,065,506</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c446" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdvertisingExpense" scale="0" unitRef="usd" id="ixv-44514">5,065,739</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Systems expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c444" decimals="0" format="ixt:num-dot-decimal" name="mlec:SystemExpenses" scale="0" unitRef="usd" id="ixv-44515">35,526</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c445" decimals="0" format="ixt:num-dot-decimal" name="mlec:SystemExpenses" scale="0" unitRef="usd" id="ixv-44516">3,857,779</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c446" decimals="0" format="ixt:num-dot-decimal" name="mlec:SystemExpenses" scale="0" unitRef="usd" id="ixv-44517">3,893,305</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Share-based incentives for employees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c444" decimals="0" format="ixt:num-dot-decimal" name="mlec:SharebasedIncentivesForEmployees" scale="0" unitRef="usd" id="ixv-44518">1,111,919</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c445" decimals="0" format="ixt:num-dot-decimal" name="mlec:SharebasedIncentivesForEmployees" scale="0" unitRef="usd" id="ixv-44519">12,577,399</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c446" decimals="0" format="ixt:num-dot-decimal" name="mlec:SharebasedIncentivesForEmployees" scale="0" unitRef="usd" id="ixv-44520">13,689,318</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Surveillance expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c444" decimals="0" format="ixt:num-dot-decimal" name="mlec:SurveillanceExpense" scale="0" unitRef="usd" id="ixv-44521">368</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c445" decimals="0" format="ixt:num-dot-decimal" name="mlec:SurveillanceExpense" scale="0" unitRef="usd" id="ixv-44522">468,090</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c446" decimals="0" format="ixt:num-dot-decimal" name="mlec:SurveillanceExpense" scale="0" unitRef="usd" id="ixv-44523">468,458</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Professional fees and outsourced services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c444" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfessionalFeesExpense" scale="0" unitRef="usd" id="ixv-44524">189,090</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c445" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfessionalFeesExpense" scale="0" unitRef="usd" id="ixv-44525">9,131,891</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c446" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfessionalFeesExpense" scale="0" unitRef="usd" id="ixv-44526">9,320,981</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Professional fees related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-415">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c445" decimals="0" format="ixt:num-dot-decimal" name="mlec:ProfessionalFeesRelatedParties" scale="0" unitRef="usd" id="ixv-44527">243,827</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c446" decimals="0" format="ixt:num-dot-decimal" name="mlec:ProfessionalFeesRelatedParties" scale="0" unitRef="usd" id="ixv-44528">243,827</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Office supplies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c444" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdministrativeExpense" scale="0" unitRef="usd" id="ixv-44529">242,790</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c445" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdministrativeExpense" scale="0" unitRef="usd" id="ixv-44530">1,743,957</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c446" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdministrativeExpense" scale="0" unitRef="usd" id="ixv-44531">1,986,747</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Insurance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c444" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InsuranceExpense" scale="0" unitRef="usd" id="ixv-44532">199,109</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c445" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InsuranceExpense" scale="0" unitRef="usd" id="ixv-44533">2,133,572</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c446" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InsuranceExpense" scale="0" unitRef="usd" id="ixv-44534">2,332,681</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Depreciation of leased assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c444" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationRightofuseAssets" scale="0" unitRef="usd" id="ixv-44535">1,312,849</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c445" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationRightofuseAssets" scale="0" unitRef="usd" id="ixv-44536">2,106,107</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c446" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationRightofuseAssets" scale="0" unitRef="usd" id="ixv-44537">3,418,956</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Contingencies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c444" decimals="0" format="ixt:num-dot-decimal" name="mlec:Contingencies" scale="0" unitRef="usd" id="ixv-44538">66,682</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c445" decimals="0" format="ixt:num-dot-decimal" name="mlec:Contingencies" scale="0" unitRef="usd" id="ixv-44539">586,892</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c446" decimals="0" format="ixt:num-dot-decimal" name="mlec:Contingencies" scale="0" unitRef="usd" id="ixv-44540">653,574</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Environmental Impact Treatment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c444" decimals="0" format="ixt:num-dot-decimal" name="mlec:EnvironmentalImpactTreatment" scale="0" unitRef="usd" id="ixv-44541">1,770,857</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c445" decimals="0" format="ixt:num-dot-decimal" name="mlec:EnvironmentalImpactTreatment" scale="0" unitRef="usd" id="ixv-44542">14,208</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c446" decimals="0" format="ixt:num-dot-decimal" name="mlec:EnvironmentalImpactTreatment" scale="0" unitRef="usd" id="ixv-44543">1,785,065</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; padding-left: 0pt">Miscellaneous</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c444" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:MiscellaneousOtherOperatingExpense" scale="0" unitRef="usd" id="ixv-44544">3,854</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c445" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:MiscellaneousOtherOperatingExpense" scale="0" unitRef="usd" id="ixv-44545">808,273</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c446" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:MiscellaneousOtherOperatingExpense" scale="0" unitRef="usd" id="ixv-44546">812,127</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 0pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c444" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherExpenseByFunction" scale="0" unitRef="usd" id="ixv-44547">25,819,152</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c445" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherExpenseByFunction" scale="0" unitRef="usd" id="ixv-44548">126,340,822</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c446" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherExpenseByFunction" scale="0" unitRef="usd" id="ixv-44549">152,159,974</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:continuation></ix:continuation><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 168; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: center"><b>&#160;</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>


</div><ix:continuation id="_DisclosureOfExpensesByNatureExplanatory-c0_cont_2"><ix:continuation continuedAt="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock-c0_cont_5" id="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock-c0_cont_4"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>Item</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Production and services costs</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Selling, general and administrative expenses</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Total <br/>06/30/2023</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-left: 0pt">Amortization of intangible assets</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c447" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForAmortisationExpense" scale="0" unitRef="usd" id="ixv-44550">173,032</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c448" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForAmortisationExpense" scale="0" unitRef="usd" id="ixv-44551">6,026,784</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c449" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForAmortisationExpense" scale="0" unitRef="usd" id="ixv-44552">6,199,816</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Analysis and storage</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c447" decimals="0" format="ixt:num-dot-decimal" name="mlec:AnalysisAndStorage" scale="0" unitRef="usd" id="ixv-44553">4,496</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c448" decimals="0" format="ixt:num-dot-decimal" name="mlec:AnalysisAndStorage" scale="0" unitRef="usd" id="ixv-44554">700,671</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c449" decimals="0" format="ixt:num-dot-decimal" name="mlec:AnalysisAndStorage" scale="0" unitRef="usd" id="ixv-44555">705,167</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Commissions and royalties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c447" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RoyaltyExpense" scale="0" unitRef="usd" id="ixv-44556">127,771</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c448" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RoyaltyExpense" scale="0" unitRef="usd" id="ixv-44557">1,396,750</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c449" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RoyaltyExpense" scale="0" unitRef="usd" id="ixv-44558">1,524,521</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Import and export expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c447" decimals="0" format="ixt:num-dot-decimal" name="mlec:ImportAndExportExpenses" scale="0" unitRef="usd" id="ixv-44559">150,402</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c448" decimals="0" format="ixt:num-dot-decimal" name="mlec:ImportAndExportExpenses" scale="0" unitRef="usd" id="ixv-44560">794,561</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c449" decimals="0" format="ixt:num-dot-decimal" name="mlec:ImportAndExportExpenses" scale="0" unitRef="usd" id="ixv-44561">944,963</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Depreciation of property, plant and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c447" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-44562">2,161,236</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c448" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-44563">2,139,957</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c449" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-44564">4,301,193</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Impairment of receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-416">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c448" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossTradeReceivables" scale="0" unitRef="usd" id="ixv-44565">1,327,385</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c449" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossTradeReceivables" scale="0" unitRef="usd" id="ixv-44566">1,327,385</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Freight and haulage</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c447" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TransportationExpense" scale="0" unitRef="usd" id="ixv-44567">2,427,296</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c448" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TransportationExpense" scale="0" unitRef="usd" id="ixv-44568">9,646,138</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c449" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TransportationExpense" scale="0" unitRef="usd" id="ixv-44569">12,073,434</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Employee benefits and social securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c447" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermEmployeeBenefitsExpense" scale="0" unitRef="usd" id="ixv-44570">10,033,252</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c448" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermEmployeeBenefitsExpense" scale="0" unitRef="usd" id="ixv-44571">39,593,472</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c449" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermEmployeeBenefitsExpense" scale="0" unitRef="usd" id="ixv-44572">49,626,724</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">Taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c447" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentTaxExpenseIncome" scale="0" unitRef="usd" id="ixv-44573">255,227</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c448" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentTaxExpenseIncome" scale="0" unitRef="usd" id="ixv-44574">12,001,149</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c449" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentTaxExpenseIncome" scale="0" unitRef="usd" id="ixv-44575">12,256,376</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Maintenance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c447" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RepairsAndMaintenanceExpense" scale="0" unitRef="usd" id="ixv-44576">1,157,887</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c448" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RepairsAndMaintenanceExpense" scale="0" unitRef="usd" id="ixv-44577">956,916</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c449" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RepairsAndMaintenanceExpense" scale="0" unitRef="usd" id="ixv-44578">2,114,803</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Energy and fuel</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c447" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FuelAndEnergyExpense" scale="0" unitRef="usd" id="ixv-44579">967,412</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c448" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FuelAndEnergyExpense" scale="0" unitRef="usd" id="ixv-44580">397,305</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c449" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FuelAndEnergyExpense" scale="0" unitRef="usd" id="ixv-44581">1,364,717</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Supplies and materials</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c447" decimals="0" format="ixt:num-dot-decimal" name="mlec:SuppliesAndMaterials" scale="0" unitRef="usd" id="ixv-44582">1,075,909</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c448" decimals="0" format="ixt:num-dot-decimal" name="mlec:SuppliesAndMaterials" scale="0" unitRef="usd" id="ixv-44583">1,048,056</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c449" decimals="0" format="ixt:num-dot-decimal" name="mlec:SuppliesAndMaterials" scale="0" unitRef="usd" id="ixv-44584">2,123,965</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Mobility and travel</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c447" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TravelExpense" scale="0" unitRef="usd" id="ixv-44585">128,072</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c448" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TravelExpense" scale="0" unitRef="usd" id="ixv-44586">5,431,323</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c449" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TravelExpense" scale="0" unitRef="usd" id="ixv-44587">5,559,395</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Allowance&#160;for obsolescence</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c447" decimals="0" format="ixt:num-dot-decimal" name="mlec:AllowanceForObsolescences" scale="0" unitRef="usd" id="ixv-44588">1,012,788</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c448" decimals="0" format="ixt:num-dot-decimal" name="mlec:AllowanceForObsolescences" scale="0" unitRef="usd" id="ixv-44589">53,989</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c449" decimals="0" format="ixt:num-dot-decimal" name="mlec:AllowanceForObsolescences" scale="0" unitRef="usd" id="ixv-44590">1,066,777</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Publicity and advertising</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c447" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdvertisingExpense" scale="0" unitRef="usd" id="ixv-44591">2,528</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c448" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdvertisingExpense" scale="0" unitRef="usd" id="ixv-44592">5,775,012</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c449" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdvertisingExpense" scale="0" unitRef="usd" id="ixv-44593">5,777,540</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Systems expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c447" decimals="0" format="ixt:num-dot-decimal" name="mlec:SystemExpenses" scale="0" unitRef="usd" id="ixv-44594">11,556</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c448" decimals="0" format="ixt:num-dot-decimal" name="mlec:SystemExpenses" scale="0" unitRef="usd" id="ixv-44595">3,158,735</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c449" decimals="0" format="ixt:num-dot-decimal" name="mlec:SystemExpenses" scale="0" unitRef="usd" id="ixv-44596">3,170,291</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Share-based incentives for employees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-417">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c448" decimals="0" format="ixt:num-dot-decimal" name="mlec:SharebasedIncentivesForEmployees" scale="0" unitRef="usd" id="ixv-44597">3,393,348</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c449" decimals="0" format="ixt:num-dot-decimal" name="mlec:SharebasedIncentivesForEmployees" scale="0" unitRef="usd" id="ixv-44598">3,393,348</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Surveillance expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c447" decimals="0" format="ixt:num-dot-decimal" name="mlec:SurveillanceExpense" scale="0" unitRef="usd" id="ixv-44599">105,988</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c448" decimals="0" format="ixt:num-dot-decimal" name="mlec:SurveillanceExpense" scale="0" unitRef="usd" id="ixv-44600">392,631</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c449" decimals="0" format="ixt:num-dot-decimal" name="mlec:SurveillanceExpense" scale="0" unitRef="usd" id="ixv-44601">498,619</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Professional fees and outsourced services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c447" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfessionalFeesExpense" scale="0" unitRef="usd" id="ixv-44602">100,308</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c448" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfessionalFeesExpense" scale="0" unitRef="usd" id="ixv-44603">13,807,495</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c449" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfessionalFeesExpense" scale="0" unitRef="usd" id="ixv-44604">13,907,803</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Professional fees related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-418">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c448" decimals="0" format="ixt:num-dot-decimal" name="mlec:ProfessionalFeesRelatedParties" scale="0" unitRef="usd" id="ixv-44605">196,101</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c449" decimals="0" format="ixt:num-dot-decimal" name="mlec:ProfessionalFeesRelatedParties" scale="0" unitRef="usd" id="ixv-44606">196,101</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Office supplies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c447" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdministrativeExpense" scale="0" unitRef="usd" id="ixv-44607">229,500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c448" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdministrativeExpense" scale="0" unitRef="usd" id="ixv-44608">976,350</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c449" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdministrativeExpense" scale="0" unitRef="usd" id="ixv-44609">1,205,850</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Insurance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c447" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InsuranceExpense" scale="0" unitRef="usd" id="ixv-44610">230,388</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c448" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InsuranceExpense" scale="0" unitRef="usd" id="ixv-44611">3,137,598</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c449" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InsuranceExpense" scale="0" unitRef="usd" id="ixv-44612">3,367,986</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Licenses &amp; Patents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-419">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c448" decimals="0" format="ixt:num-dot-decimal" name="mlec:LicensesandPatents" scale="0" unitRef="usd" id="ixv-44613">37,015</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c449" decimals="0" format="ixt:num-dot-decimal" name="mlec:LicensesandPatents" scale="0" unitRef="usd" id="ixv-44614">37,015</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Depreciation of leased assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c447" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationRightofuseAssets" scale="0" unitRef="usd" id="ixv-44615">468,524</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c448" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationRightofuseAssets" scale="0" unitRef="usd" id="ixv-44616">3,029,049</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c449" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationRightofuseAssets" scale="0" unitRef="usd" id="ixv-44617">3,497,573</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">Contingencies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-420">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c448" decimals="0" format="ixt:num-dot-decimal" name="mlec:Contingencies" scale="0" unitRef="usd" id="ixv-44618">239,292</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c449" decimals="0" format="ixt:num-dot-decimal" name="mlec:Contingencies" scale="0" unitRef="usd" id="ixv-44619">239,292</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Environmental Impact Treatment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c447" decimals="0" format="ixt:num-dot-decimal" name="mlec:EnvironmentalImpactTreatment" scale="0" unitRef="usd" id="ixv-44620">2,369,838</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-421">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c449" decimals="0" format="ixt:num-dot-decimal" name="mlec:EnvironmentalImpactTreatment" scale="0" unitRef="usd" id="ixv-44621">2,369,838</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 0pt">Miscellaneous</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c447" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:MiscellaneousOtherOperatingExpense" scale="0" unitRef="usd" id="ixv-44622">41,452</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c448" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:MiscellaneousOtherOperatingExpense" scale="0" unitRef="usd" id="ixv-44623">874,192</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c449" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:MiscellaneousOtherOperatingExpense" scale="0" unitRef="usd" id="ixv-44624">915,644</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 0pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c447" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherExpenseByFunction" scale="0" unitRef="usd" id="ixv-44625">23,234,862</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c448" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherExpenseByFunction" scale="0" unitRef="usd" id="ixv-44626">116,531,274</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c449" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherExpenseByFunction" scale="0" unitRef="usd" id="ixv-44627">139,766,136</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:continuation></ix:continuation><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"></p><div>

</div><!-- Field: Page; Sequence: 169; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: center"><b>&#160;</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>


</div><ix:continuation id="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>8.5 <span style="text-decoration:underline">Finance results</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>



<ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory" id="ixv-31738"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="text-decoration:underline">Financial cost</span></td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-left: 0pt">Interest expenses</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c434" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InterestExpense" scale="0" unitRef="usd" id="ixv-44628">38,077,952</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c435" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InterestExpense" scale="0" unitRef="usd" id="ixv-44629">35,783,901</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c450" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InterestExpense" scale="0" unitRef="usd" id="ixv-44630">30,569,478</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Financial commissions</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c434" decimals="0" format="ixt:num-dot-decimal" name="mlec:FinancialCommissions" scale="0" sign="-" unitRef="usd" id="ixv-44631">3,731,493</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c435" decimals="0" format="ixt:num-dot-decimal" name="mlec:FinancialCommissions" scale="0" sign="-" unitRef="usd" id="ixv-44632">1,850,252</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c450" decimals="0" format="ixt:num-dot-decimal" name="mlec:FinancialCommissions" scale="0" sign="-" unitRef="usd" id="ixv-44633">3,007,154</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c434" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinanceCosts" scale="0" sign="-" unitRef="usd" id="ixv-44634">41,809,445</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c435" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinanceCosts" scale="0" sign="-" unitRef="usd" id="ixv-44635">37,634,153</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c450" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinanceCosts" scale="0" sign="-" unitRef="usd" id="ixv-44636">33,576,632</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-decoration: underline; text-align: left; padding-left: 0pt">Other financial results</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Exchange differences generated by assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c434" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementAssets" scale="0" unitRef="usd" id="ixv-44637">2,183,367</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c435" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementAssets" scale="0" sign="-" unitRef="usd" id="ixv-44638">7,519,875</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c450" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementAssets" scale="0" sign="-" unitRef="usd" id="ixv-44639">19,758,444</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Exchange differences generated by liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c434" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementLiabilities" scale="0" sign="-" unitRef="usd" id="ixv-44640">14,647,580</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c435" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementLiabilities" scale="0" sign="-" unitRef="usd" id="ixv-44641">20,499,620</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c450" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementLiabilities" scale="0" sign="-" unitRef="usd" id="ixv-44642">3,886,408</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Changes in fair value of financial assets or liabilities and other financial results</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c434" decimals="0" format="ixt:num-dot-decimal" name="mlec:ChangeInFairValueOfFinancialAssetsOrLiabilitiesOrOtherFinancialResults" scale="0" sign="-" unitRef="usd" id="ixv-44643">15,603,088</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c435" decimals="0" format="ixt:num-dot-decimal" name="mlec:ChangeInFairValueOfFinancialAssetsOrLiabilitiesOrOtherFinancialResults" scale="0" sign="-" unitRef="usd" id="ixv-44644">10,455,775</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c450" decimals="0" format="ixt:num-dot-decimal" name="mlec:ChangeInFairValueOfFinancialAssetsOrLiabilitiesOrOtherFinancialResults" scale="0" sign="-" unitRef="usd" id="ixv-44645">341,341</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Prepayment premium fee</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c434" decimals="0" format="ixt:num-dot-decimal" name="mlec:PrepaymentPremiumFee" scale="0" sign="-" unitRef="usd" id="ixv-44646">4,870,021</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-422">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-423">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Net gain of inflation effect on monetary items</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c434" decimals="0" format="ixt:num-dot-decimal" name="mlec:NetGainOnInflationEffectOnMonetary" scale="0" unitRef="usd" id="ixv-44647">7,949,231</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c435" decimals="0" format="ixt:num-dot-decimal" name="mlec:NetGainOnInflationEffectOnMonetary" scale="0" unitRef="usd" id="ixv-44648">28,730,804</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c450" decimals="0" format="ixt:num-dot-decimal" name="mlec:NetGainOnInflationEffectOnMonetary" scale="0" unitRef="usd" id="ixv-44649">10,311,437</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Interest accrued with related parties</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c434" decimals="0" format="ixt:num-dot-decimal" name="mlec:InterestAccruedWithRelatedParties" scale="0" unitRef="usd" id="ixv-44650">944,186</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c435" decimals="0" format="ixt:num-dot-decimal" name="mlec:InterestAccruedWithRelatedParties" scale="0" unitRef="usd" id="ixv-44651">135,485</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-424">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c434" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherFinanceIncomeCost" scale="0" sign="-" unitRef="usd" id="ixv-44652">24,043,905</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c435" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherFinanceIncomeCost" scale="0" sign="-" unitRef="usd" id="ixv-44653">9,608,981</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c450" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherFinanceIncomeCost" scale="0" sign="-" unitRef="usd" id="ixv-44654">13,674,756</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-decoration: underline; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Total net financial cost</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c434" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinanceIncomeCost" scale="0" sign="-" unitRef="usd" id="ixv-44655">65,853,350</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c435" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinanceIncomeCost" scale="0" sign="-" unitRef="usd" id="ixv-44656">47,243,134</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c450" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinanceIncomeCost" scale="0" sign="-" unitRef="usd" id="ixv-44657">47,251,388</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table></ix:nonNumeric>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>8.6 <span style="text-decoration:underline">Other income or expenses, net</span></b></p>



<p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory" id="ixv-31955"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">06/30/2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Loss from subsidiary&#8217;s guarantee recognition (Note 7.12)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromSaleOfAgriculturalProduce" scale="0" sign="-" unitRef="usd" id="ixv-44658">61,681,998</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-425">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-426">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Gain on bargain purchase</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:GainOnBargainPurchase" scale="0" unitRef="usd" id="ixv-44659">1,473,482</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="mlec:GainOnBargainPurchase" scale="0" unitRef="usd" id="ixv-44660">1,032,327</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-427">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Remeasurement to fair value of pre-existing interest in an acquiree</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:RemeasurementToFairValueOfPreexistingInterestInAnAcquiree" scale="0" sign="-" unitRef="usd" id="ixv-44661">1,666,680</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-428">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-429">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Net result from commercialization of agricultural products</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:NetResultFromCommercializationOfAgriculturalProducts" scale="0" unitRef="usd" id="ixv-44662">1,890,110</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="mlec:NetResultFromCommercializationOfAgriculturalProducts" scale="0" unitRef="usd" id="ixv-44663">3,560,703</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:NetResultFromCommercializationOfAgriculturalProducts" scale="0" sign="-" unitRef="usd" id="ixv-44664">174,122</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Result of intangible assets (i)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" id="ix_43_fact" name="ifrs-full:AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" scale="0" sign="-" unitRef="usd">7,649,848</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:OtherIncomeOrExpensesNet" scale="0" sign="-" unitRef="usd" id="ixv-44666">473,758</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="mlec:OtherIncomeOrExpensesNet" scale="0" unitRef="usd" id="ixv-44667">1,825,111</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:OtherIncomeOrExpensesNet" scale="0" unitRef="usd" id="ixv-44668">881,177</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherOperatingIncomeExpense" scale="0" sign="-" unitRef="usd" id="ixv-44669">56,589,216</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherOperatingIncomeExpense" scale="0" sign="-" unitRef="usd" id="ixv-44670">703,265</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherOperatingIncomeExpense" scale="0" unitRef="usd" id="ixv-44671">1,055,299</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(i) <ix:footnote id="ix_8_footnote" xml:lang="en-US">On March 28, 2025, BIOX, a former subsidiary,
agreed to transfer all rights, licenses, and materials containing or pertaining to the Soy ANF trait and pay $<ix:nonFraction contextRef="c437" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashTransferred" scale="0" unitRef="usd" id="ixv-44673">750,000</ix:nonFraction>&#160;to a Arcadia
Biosciences Inc in exchange for (i) RG and OX Wheat Patents and RS exclusive rights; (ii) the cancellation of all Royalty Payments, which
included&#160;<ix:nonFraction contextRef="c438" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:PercentageOfEntitysRevenue" scale="-2" unitRef="pure" id="ixv-44674">25</ix:nonFraction>% of the Net Wheat Technology Licensing Revenues and&#160;<ix:nonFraction contextRef="c439" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:PercentageOfEntitysRevenue" scale="-2" unitRef="pure" id="ixv-44675">6</ix:nonFraction>% of the Net HB4 Soybean Revenues up to $<ix:nonFraction contextRef="c440" decimals="-6" format="ixt:num-dot-decimal" name="ifrs-full:RevenueOfAcquiree" scale="6" unitRef="usd" id="ixv-44676">10</ix:nonFraction>&#160;million;
and (iii) the release from any Performance Benchmark Obligations related to the RG, OX, and RS Varieties which amounted to $<ix:nonFraction contextRef="c437" decimals="-5" format="ixt:num-dot-decimal" name="ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations" scale="6" unitRef="usd" id="ixv-44677">8.1</ix:nonFraction>&#160;million.
This transaction resulted in the accounting of a gain from the exchange of intangible assets amounting to $<ix:nonFraction contextRef="c437" decimals="-5" format="ixt:num-dot-decimal" name="ifrs-full:OtherTangibleOrIntangibleAssetsTransferred" scale="6" unitRef="usd" id="ixv-44678">7.5</ix:nonFraction>&#160;million.</ix:footnote>&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 170; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: center"><b>&#160;</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>


</div><div><a id="fs_009"></a></div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfIncomeTaxExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfIncomeTaxExplanatory" id="ixv-32133"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><b>9.</b></td><td style="text-align: justify"><b><span style="text-decoration:underline">TAXATION</span></b></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfDeferredTaxesExplanatory" id="ixv-32144"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The balances of deferred tax assets and liabilities
are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="text-decoration:underline">Deferred tax assets</span></td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0pt">Tax Loss-Carry Forward</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-430">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c452" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" unitRef="usd" id="ixv-44679">26,988,067</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Others financial assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-431">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c454" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" unitRef="usd" id="ixv-44680">813,780</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">Others</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-432">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c456" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" unitRef="usd" id="ixv-44681">2,516,719</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Royalties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-433">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c458" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" unitRef="usd" id="ixv-44682">764,888</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Trade receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-434">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c460" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" unitRef="usd" id="ixv-44683">532,106</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Allowances</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-435">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c462" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" unitRef="usd" id="ixv-44684">942,587</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Government grants</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-436">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c464" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" unitRef="usd" id="ixv-44685">15,090</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Total deferred tax assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-437">-</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c466" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" unitRef="usd" id="ixv-44686">32,573,237</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-decoration: underline; text-align: left; padding-left: 0pt">Deferred tax liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Intangible assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c467" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxLiabilities" scale="0" sign="-" unitRef="usd" id="ixv-44687">15,767,275</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c468" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxLiabilities" scale="0" sign="-" unitRef="usd" id="ixv-44688">28,444,095</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Property, plant and equipment depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-438">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c470" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxLiabilities" scale="0" sign="-" unitRef="usd" id="ixv-44689">14,608,912</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">Inventories</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-439">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c472" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxLiabilities" scale="0" sign="-" unitRef="usd" id="ixv-44690">8,041,220</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Others financial assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-440">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c454" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxLiabilities" scale="0" sign="-" unitRef="usd" id="ixv-44691">464,404</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Right-of-use leased asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-441">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c474" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxLiabilities" scale="0" sign="-" unitRef="usd" id="ixv-44692">190,088</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Inflation tax adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-442">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c476" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxLiabilities" scale="0" sign="-" unitRef="usd" id="ixv-44693">302,456</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 0pt">Others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-443">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c456" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxLiabilities" scale="0" sign="-" unitRef="usd" id="ixv-44694">546,277</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Total deferred tax liabilities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c477" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxLiabilities" scale="0" sign="-" unitRef="usd" id="ixv-44695">15,767,275</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c478" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxLiabilities" scale="0" sign="-" unitRef="usd" id="ixv-44696">52,597,452</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Net deferred tax</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxLiabilityAsset" scale="0" sign="-" unitRef="usd" id="ixv-44697">15,767,275</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxLiabilityAsset" scale="0" sign="-" unitRef="usd" id="ixv-44698">20,024,215</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table></ix:nonNumeric>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="mlec_ScheduleOfRollforwardOfDeferredTaxAssetsAndLiabilitiesTableTextBlock-c0_cont_1" escape="true" name="mlec:ScheduleOfRollforwardOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="ixv-32380"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The roll forward of deferred tax assets and liabilities
as of June 30, 2025 and 2024 are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Balance 06/30/2024</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Business combination / (loss) of control</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Income tax provision</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Conversion difference</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Balance 06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="text-decoration:underline">Deferred tax assets</span></td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left; padding-left: 0pt">Tax Loss-Carry Forward</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c452" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" unitRef="usd" id="ixv-44699">26,988,067</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c479" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" scale="0" sign="-" unitRef="usd" id="ixv-44700">21,525,926</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c479" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="0" sign="-" unitRef="usd" id="ixv-44701">5,579,828</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c479" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="0" unitRef="usd" id="ixv-44702">117,687</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-444">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Others financial assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c480" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" unitRef="usd" id="ixv-44703">813,780</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c481" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" scale="0" sign="-" unitRef="usd" id="ixv-44704">475,554</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c481" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="0" sign="-" unitRef="usd" id="ixv-44705">342,341</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c481" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="0" unitRef="usd" id="ixv-44706">4,115</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-445">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Trade receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c460" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" unitRef="usd" id="ixv-44707">532,106</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c483" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" scale="0" sign="-" unitRef="usd" id="ixv-44708">1,353,889</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c483" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="0" unitRef="usd" id="ixv-44709">822,145</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c483" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="0" sign="-" unitRef="usd" id="ixv-44710">362</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-446">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Royalties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c458" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" unitRef="usd" id="ixv-44711">764,888</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c484" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" scale="0" sign="-" unitRef="usd" id="ixv-44712">744,388</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c484" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="0" sign="-" unitRef="usd" id="ixv-44713">18,311</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c484" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="0" sign="-" unitRef="usd" id="ixv-44714">2,189</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-447">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">Allowances</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c462" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" unitRef="usd" id="ixv-44715">942,587</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c485" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" scale="0" sign="-" unitRef="usd" id="ixv-44716">1,053,605</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c485" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="0" unitRef="usd" id="ixv-44717">98,032</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c485" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="0" unitRef="usd" id="ixv-44718">12,986</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-448">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Government grants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c464" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" unitRef="usd" id="ixv-44719">15,090</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-449">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c486" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="0" sign="-" unitRef="usd" id="ixv-44720">15,596</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c486" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="0" unitRef="usd" id="ixv-44721">506</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-450">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 0pt">Others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c456" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" unitRef="usd" id="ixv-44722">2,516,719</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c487" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" scale="0" unitRef="usd" id="ixv-44723">227,950</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c487" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="0" sign="-" unitRef="usd" id="ixv-44724">2,744,669</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-451">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-452">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Total deferred tax assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c466" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" unitRef="usd" id="ixv-44725">32,573,237</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c488" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" scale="0" sign="-" unitRef="usd" id="ixv-44726">24,925,412</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c488" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="0" sign="-" unitRef="usd" id="ixv-44727">7,780,568</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c488" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="0" unitRef="usd" id="ixv-44728">132,743</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-453">-</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-decoration: underline; text-align: left; padding-left: 0pt">Deferred tax liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Intangible assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c468" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" sign="-" unitRef="usd" id="ixv-44729">28,444,095</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c489" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" scale="0" unitRef="usd" id="ixv-44730">12,428,299</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c489" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="0" unitRef="usd" id="ixv-44731">214,190</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c489" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="0" unitRef="usd" id="ixv-44732">34,331</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c467" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" sign="-" unitRef="usd" id="ixv-44733">15,767,275</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Property, plant and equipment depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c470" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" sign="-" unitRef="usd" id="ixv-44734">14,608,912</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c490" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" scale="0" unitRef="usd" id="ixv-44735">15,315,097</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c490" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="0" sign="-" unitRef="usd" id="ixv-44736">703,102</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c490" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="0" sign="-" unitRef="usd" id="ixv-44737">3,083</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-454">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">Inventories</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c472" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" sign="-" unitRef="usd" id="ixv-44738">8,041,220</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c491" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" scale="0" unitRef="usd" id="ixv-44739">6,611,790</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c491" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="0" unitRef="usd" id="ixv-44740">1,429,430</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-455">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-456">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Biological assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-457">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c493" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" scale="0" unitRef="usd" id="ixv-44741">640,035</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c493" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="0" sign="-" unitRef="usd" id="ixv-44742">640,035</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-458">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-459">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Others financial assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c495" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" sign="-" unitRef="usd" id="ixv-44743">464,404</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c496" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" scale="0" unitRef="usd" id="ixv-44744">28,040</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c496" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="0" unitRef="usd" id="ixv-44745">436,364</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-460">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-461">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Right-of-use leased asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c474" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" sign="-" unitRef="usd" id="ixv-44746">190,088</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c498" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" scale="0" unitRef="usd" id="ixv-44747">180,967</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c498" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="0" unitRef="usd" id="ixv-44748">10,505</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c498" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="0" sign="-" unitRef="usd" id="ixv-44749">1,384</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-462">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Inflation tax adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c476" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" sign="-" unitRef="usd" id="ixv-44750">302,456</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c499" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" scale="0" unitRef="usd" id="ixv-44751">26,801</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c499" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="0" unitRef="usd" id="ixv-44752">218,362</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c499" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="0" unitRef="usd" id="ixv-44753">57,293</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-463">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; padding-left: 0pt">Others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c500" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" sign="-" unitRef="usd" id="ixv-44754">546,277</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c501" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" scale="0" unitRef="usd" id="ixv-44755">541,800</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c501" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="0" unitRef="usd" id="ixv-44756">178,733</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c501" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="0" sign="-" unitRef="usd" id="ixv-44757">174,256</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-464">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Total deferred tax liabilities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c478" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" sign="-" unitRef="usd" id="ixv-44758">52,597,452</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c503" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" scale="0" unitRef="usd" id="ixv-44759">35,772,829</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c503" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="0" unitRef="usd" id="ixv-44760">1,144,447</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c503" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="0" sign="-" unitRef="usd" id="ixv-44761">87,099</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c477" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" sign="-" unitRef="usd" id="ixv-44762">15,767,275</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Net deferred tax</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" sign="-" unitRef="usd" id="ixv-44763">20,024,215</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" scale="0" unitRef="usd" id="ixv-44764">10,847,417</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="0" sign="-" unitRef="usd" id="ixv-44765">6,636,121</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="0" unitRef="usd" id="ixv-44766">45,644</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" sign="-" unitRef="usd" id="ixv-44767">15,767,275</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table></ix:nonNumeric></ix:nonNumeric><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 171; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: center"><b>&#160;</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>


</div><ix:continuation continuedAt="_DisclosureOfIncomeTaxExplanatory-c0_cont_2" id="_DisclosureOfIncomeTaxExplanatory-c0_cont_1"><ix:continuation id="mlec_ScheduleOfRollforwardOfDeferredTaxAssetsAndLiabilitiesTableTextBlock-c0_cont_1"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><b><span style="text-decoration:underline">Deferred tax assets</span></b></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Balance 06/30/2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Business combination / (loss) of control</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Income tax provision</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Conversion difference</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Charge to OCI</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Balance 06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; width: 28%; text-align: left; padding-left: 0.125in">Tax Loss-Carry Forward</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c504" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" unitRef="usd" id="ixv-44768">21,215,789</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c505" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" scale="0" sign="-" unitRef="usd" id="ixv-44769">62,585</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c505" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="0" unitRef="usd" id="ixv-44770">7,752,424</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c505" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="0" sign="-" unitRef="usd" id="ixv-44771">694,718</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c505" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" scale="0" sign="-" unitRef="usd" id="ixv-44772">1,222,843</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c452" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" unitRef="usd" id="ixv-44773">26,988,067</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Others financial assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c506" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" unitRef="usd" id="ixv-44774">1,336,260</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c507" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" scale="0" sign="-" unitRef="usd" id="ixv-44775">2,299</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c507" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="0" sign="-" unitRef="usd" id="ixv-44776">423,116</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c507" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="0" sign="-" unitRef="usd" id="ixv-44777">97,065</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-465">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c480" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" unitRef="usd" id="ixv-44778">813,780</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Trade receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c508" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" unitRef="usd" id="ixv-44779">447,449</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-466">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c509" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="0" unitRef="usd" id="ixv-44780">214,734</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c509" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="0" sign="-" unitRef="usd" id="ixv-44781">130,077</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-467">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c460" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" unitRef="usd" id="ixv-44782">532,106</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Royalties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c510" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" unitRef="usd" id="ixv-44783">723,082</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-468">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c511" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="0" unitRef="usd" id="ixv-44784">48,310</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c511" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="0" sign="-" unitRef="usd" id="ixv-44785">6,504</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-469">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c458" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" unitRef="usd" id="ixv-44786">764,888</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Allowances</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c512" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" unitRef="usd" id="ixv-44787">1,213,899</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-470">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c513" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="0" sign="-" unitRef="usd" id="ixv-44788">221,106</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c513" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="0" sign="-" unitRef="usd" id="ixv-44789">50,206</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-471">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c462" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" unitRef="usd" id="ixv-44790">942,587</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Government grants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c514" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" unitRef="usd" id="ixv-44791">93,996</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c515" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" scale="0" sign="-" unitRef="usd" id="ixv-44792">39,261</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c515" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="0" sign="-" unitRef="usd" id="ixv-44793">42,199</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c515" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="0" unitRef="usd" id="ixv-44794">2,554</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-472">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c464" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" unitRef="usd" id="ixv-44795">15,090</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-bottom: 1.5pt; padding-left: 0.125in">Others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c516" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" unitRef="usd" id="ixv-44796">3,402,846</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c517" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" scale="0" unitRef="usd" id="ixv-44797">765,384</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c517" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="0" sign="-" unitRef="usd" id="ixv-44798">1,651,511</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-473">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-474">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c518" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" unitRef="usd" id="ixv-44799">2,516,719</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0.125in">Total deferred tax assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c519" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" unitRef="usd" id="ixv-44800">28,433,321</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c520" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" scale="0" unitRef="usd" id="ixv-44801">661,239</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c520" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="0" unitRef="usd" id="ixv-44802">5,677,536</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c520" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="0" sign="-" unitRef="usd" id="ixv-44803">976,016</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c520" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" scale="0" sign="-" unitRef="usd" id="ixv-44804">1,222,843</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c466" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" unitRef="usd" id="ixv-44805">32,573,237</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-decoration: underline; font-weight: bold; text-align: left; padding-left: 0.125in">Deferred tax liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Intangible assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c521" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" sign="-" unitRef="usd" id="ixv-44806">29,117,986</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c522" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" scale="0" sign="-" unitRef="usd" id="ixv-44807">301,659</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c522" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="0" unitRef="usd" id="ixv-44808">867,636</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c522" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="0" unitRef="usd" id="ixv-44809">107,914</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-475">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c468" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" sign="-" unitRef="usd" id="ixv-44810">28,444,095</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Property, plant and equipment depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c523" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" sign="-" unitRef="usd" id="ixv-44811">13,678,341</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c524" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" scale="0" sign="-" unitRef="usd" id="ixv-44812">174,228</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c524" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="0" sign="-" unitRef="usd" id="ixv-44813">773,812</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c524" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="0" unitRef="usd" id="ixv-44814">17,469</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-476">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c470" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" sign="-" unitRef="usd" id="ixv-44815">14,608,912</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Inventories</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c525" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" sign="-" unitRef="usd" id="ixv-44816">6,461,576</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c526" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" scale="0" sign="-" unitRef="usd" id="ixv-44817">939,250</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c526" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="0" sign="-" unitRef="usd" id="ixv-44818">640,394</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-477">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-478">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c527" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" sign="-" unitRef="usd" id="ixv-44819">8,041,220</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Others financial assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c528" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" sign="-" unitRef="usd" id="ixv-44820">2,154,504</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-479">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c529" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="0" unitRef="usd" id="ixv-44821">1,690,100</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-480">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-481">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c495" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" sign="-" unitRef="usd" id="ixv-44822">464,404</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Right-of-use leased asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c530" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" sign="-" unitRef="usd" id="ixv-44823">120,442</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c531" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" scale="0" sign="-" unitRef="usd" id="ixv-44824">115,495</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c531" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="0" unitRef="usd" id="ixv-44825">30,998</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c531" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="0" unitRef="usd" id="ixv-44826">14,851</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-482">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c474" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" sign="-" unitRef="usd" id="ixv-44827">190,088</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Inflation tax adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c532" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" sign="-" unitRef="usd" id="ixv-44828">1,131,895</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c533" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" scale="0" unitRef="usd" id="ixv-44829">10,732</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c533" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="0" unitRef="usd" id="ixv-44830">827,211</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c533" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="0" sign="-" unitRef="usd" id="ixv-44831">8,504</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-483">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c476" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" sign="-" unitRef="usd" id="ixv-44832">302,456</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-bottom: 1.5pt; padding-left: 0.125in">Others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c534" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" sign="-" unitRef="usd" id="ixv-44833">607,722</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-484">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c535" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="0" unitRef="usd" id="ixv-44834">111,773</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c535" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="0" sign="-" unitRef="usd" id="ixv-44835">50,328</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-485">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c536" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" sign="-" unitRef="usd" id="ixv-44836">546,277</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0.125in">Total deferred tax liabilities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c537" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" sign="-" unitRef="usd" id="ixv-44837">53,272,466</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c538" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" scale="0" sign="-" unitRef="usd" id="ixv-44838">1,519,900</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c538" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="0" unitRef="usd" id="ixv-44839">2,113,512</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c538" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="0" unitRef="usd" id="ixv-44840">81,402</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-486">-</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c478" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" sign="-" unitRef="usd" id="ixv-44841">52,597,452</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0.125in">Net deferred tax</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c47" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" sign="-" unitRef="usd" id="ixv-44842">24,839,145</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" scale="0" sign="-" unitRef="usd" id="ixv-44843">858,661</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="0" unitRef="usd" id="ixv-44844">7,791,048</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="0" sign="-" unitRef="usd" id="ixv-44845">894,614</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" scale="0" sign="-" unitRef="usd" id="ixv-44846">1,222,843</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxAssets" scale="0" sign="-" unitRef="usd" id="ixv-44847">20,024,215</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table></ix:continuation>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="mlec:EffectiveIncomeTaxRateReconciliationTableTextBlock" id="ixv-33515"><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The tax on the Group&#8217;s profit before tax differs from the theoretical
amount that would arise using the weighted average tax rate applicable to profits of the consolidated entities as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">(Loss) / earnings before income tax-rate</td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossFromDiscontinuedOperations" scale="0" sign="-" unitRef="usd" id="ixv-44848">170,003,479</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossFromDiscontinuedOperations" scale="0" sign="-" unitRef="usd" id="ixv-44849">27,958,152</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossFromDiscontinuedOperations" scale="0" unitRef="usd" id="ixv-44850">50,794,242</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Income tax expense by applying tax rate in force in the respective countries</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TaxExpenseIncomeAtApplicableTaxRate" scale="0" unitRef="usd" id="ixv-44851">45,342,071</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TaxExpenseIncomeAtApplicableTaxRate" scale="0" unitRef="usd" id="ixv-44852">7,224,973</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TaxExpenseIncomeAtApplicableTaxRate" scale="0" sign="-" unitRef="usd" id="ixv-44853">7,628,367</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Share of profit or loss of subsidiaries, joint ventures and associates</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:TaxEffectOfShareOfProfitOrLossOfSubsidiesJointVenturesAndAssociates" scale="0" unitRef="usd" id="ixv-44854">8,232,869</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="mlec:TaxEffectOfShareOfProfitOrLossOfSubsidiesJointVenturesAndAssociates" scale="0" unitRef="usd" id="ixv-44855">5,141,460</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:TaxEffectOfShareOfProfitOrLossOfSubsidiesJointVenturesAndAssociates" scale="0" sign="-" unitRef="usd" id="ixv-44856">12,645,224</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Puttable instruments charge</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-487">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-488">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:PuttableInstrumentsCharge" scale="0" unitRef="usd" id="ixv-44857">3,645</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Stock options charge</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:TaxEffectOfStockOptionCharge" scale="0" unitRef="usd" id="ixv-44858">167,601</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="mlec:TaxEffectOfStockOptionCharge" scale="0" unitRef="usd" id="ixv-44859">1,366,999</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:TaxEffectOfStockOptionCharge" scale="0" unitRef="usd" id="ixv-44860">586,774</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Derecognition of deferred tax assets (i)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" id="ix_44_fact" name="mlec:DerecognitionOfDeferredTaxAssets" scale="0" sign="-" unitRef="usd">40,565,962</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" id="ix_45_fact" name="mlec:DerecognitionOfDeferredTaxAssets" scale="0" sign="-" unitRef="usd">94,189</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" id="ix_46_fact" name="mlec:DerecognitionOfDeferredTaxAssets" scale="0" unitRef="usd">428,530</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Mutual funds adjustments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:MutualFundsAdjustment" scale="0" unitRef="usd" id="ixv-44864">18,471</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="mlec:MutualFundsAdjustment" scale="0" unitRef="usd" id="ixv-44865">27,560</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-489">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Non-deductible expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:TaxEffectOfRevenuesExemptFromTaxationAndExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss" scale="0" unitRef="usd" id="ixv-44866">4,027,734</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="mlec:TaxEffectOfRevenuesExemptFromTaxationAndExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss" scale="0" unitRef="usd" id="ixv-44867">1,469,872</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:TaxEffectOfRevenuesExemptFromTaxationAndExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss" scale="0" unitRef="usd" id="ixv-44868">373,655</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Result of inflation effect on monetary items and other finance results</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:ResultOfInflationEffectOnMonetaryItemsAndOtherFinanceResults" scale="0" sign="-" unitRef="usd" id="ixv-44869">335,680</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="mlec:ResultOfInflationEffectOnMonetaryItemsAndOtherFinanceResults" scale="0" unitRef="usd" id="ixv-44870">5,113,890</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:ResultOfInflationEffectOnMonetaryItemsAndOtherFinanceResults" scale="0" unitRef="usd" id="ixv-44871">7,872,801</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Tax inflation adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:TaxInflationAdjustment" scale="0" sign="-" unitRef="usd" id="ixv-44872">1,633,659</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="mlec:TaxInflationAdjustment" scale="0" sign="-" unitRef="usd" id="ixv-44873">4,278,344</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:TaxInflationAdjustment" scale="0" sign="-" unitRef="usd" id="ixv-44874">5,916,143</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Rate change adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-490">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TaxEffectFromChangeInTaxRate" scale="0" unitRef="usd" id="ixv-44875">118,060</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TaxEffectFromChangeInTaxRate" scale="0" sign="-" unitRef="usd" id="ixv-44876">192,127</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; padding-left: 0pt">Others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" scale="0" unitRef="usd" id="ixv-44877">971,836</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" scale="0" sign="-" unitRef="usd" id="ixv-44878">434,321</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" scale="0" unitRef="usd" id="ixv-44879">4,162</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Income tax expenses</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="0" unitRef="usd" id="ixv-44880">6,636,121</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="0" unitRef="usd" id="ixv-44881">1,103,152</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="0" sign="-" unitRef="usd" id="ixv-44882">2,328,366</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(i)</td><td style="text-align: justify"><ix:nonNumeric contextRef="c0" continuedAt="mlec_ComponentsOfIncomeTaxExpenseBenefitTableTextBlock-c0_cont_1" escape="true" name="mlec:ComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="ixv-44883"><ix:footnote id="ix_9_footnote" xml:lang="en-US">Mainly represent derecognition of deferred tax assets from
Bioceres S.A. because it initiated the voluntary bankruptcy proceeding (Note 21).</ix:footnote></ix:nonNumeric></td>
</tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation id="mlec_ComponentsOfIncomeTaxExpenseBenefitTableTextBlock-c0_cont_1"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">06/30/2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Current tax expense</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-491">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentTaxExpenseIncome" scale="0" unitRef="usd" id="ixv-44885">8,894,200</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentTaxExpenseIncome" scale="0" unitRef="usd" id="ixv-44886">1,311,506</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Deferred tax</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncome" scale="0" unitRef="usd" id="ixv-44887">6,636,121</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncome" scale="0" sign="-" unitRef="usd" id="ixv-44888">7,791,048</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncome" scale="0" sign="-" unitRef="usd" id="ixv-44889">3,639,872</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="0" unitRef="usd" id="ixv-44890">6,636,121</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="0" unitRef="usd" id="ixv-44891">1,103,152</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="0" sign="-" unitRef="usd" id="ixv-44892">2,328,366</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:continuation></ix:continuation><div>



</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><!-- Field: Page; Sequence: 172; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: center"><b>&#160;</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>


</div><ix:continuation id="_DisclosureOfIncomeTaxExplanatory-c0_cont_2"><ix:nonNumeric contextRef="c0" escape="true" name="mlec:IncomeTaxExpenseByApplyingApplicableTaxRateInForceInRespectiveJurisdictionsTableTextBlock" id="ixv-33824"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The income tax expense was calculated by applying
the tax rate in force in the respective countries, as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Tax jurisdiction</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Earnings before income tax-rate</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weight average applicable <br/>
tax rate</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Income <br/>
tax as of <br/>
June 30, <br/>
2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Low or null taxation jurisdictions</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c539" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AccountingProfit" scale="0" sign="-" unitRef="usd" id="ixv-44893">7,247,084</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c539" decimals="3" format="ixt:num-dot-decimal" name="ifrs-full:ApplicableTaxRate" scale="-2" unitRef="pure" id="ixv-44894">0.0</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-492">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Loss-making entities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c540" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AccountingProfit" scale="0" sign="-" unitRef="usd" id="ixv-44895">162,756,395</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right"><ix:nonFraction contextRef="c540" decimals="3" format="ixt:num-dot-decimal" name="ifrs-full:ApplicableTaxRate" scale="-2" unitRef="pure" id="ixv-44896">27.9</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c540" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TaxExpenseIncomeAtApplicableTaxRate" scale="0" unitRef="usd" id="ixv-44897">45,342,071</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AccountingProfit" scale="0" sign="-" unitRef="usd" id="ixv-44898">170,003,479</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TaxExpenseIncomeAtApplicableTaxRate" scale="0" unitRef="usd" id="ixv-44899">45,342,071</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Tax jurisdiction</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Earnings before income tax-rate</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weight average applicable <br/>
tax rate</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Income <br/>
tax as of <br/>
June 30, <br/>
2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Low or null taxation jurisdictions</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c541" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AccountingProfit" scale="0" unitRef="usd" id="ixv-44900">13,131,953</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c541" decimals="3" format="ixt:num-dot-decimal" name="ifrs-full:ApplicableTaxRate" scale="-2" unitRef="pure" id="ixv-44901">0.0</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-493">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Profit-making entities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c542" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AccountingProfit" scale="0" unitRef="usd" id="ixv-44902">32,251,706</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c542" decimals="3" format="ixt:num-dot-decimal" name="ifrs-full:ApplicableTaxRate" scale="-2" unitRef="pure" id="ixv-44903">32.2</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c542" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TaxExpenseIncomeAtApplicableTaxRate" scale="0" sign="-" unitRef="usd" id="ixv-44904">10,370,389</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Loss-making entities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c543" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AccountingProfit" scale="0" sign="-" unitRef="usd" id="ixv-44905">73,341,811</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right"><ix:nonFraction contextRef="c543" decimals="3" format="ixt:num-dot-decimal" name="ifrs-full:ApplicableTaxRate" scale="-2" unitRef="pure" id="ixv-44906">24.0</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c543" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TaxExpenseIncomeAtApplicableTaxRate" scale="0" unitRef="usd" id="ixv-44907">17,595,362</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AccountingProfit" scale="0" sign="-" unitRef="usd" id="ixv-44908">27,958,152</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TaxExpenseIncomeAtApplicableTaxRate" scale="0" unitRef="usd" id="ixv-44909">7,224,973</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Tax jurisdiction</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Earnings before income tax-rate</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weight average applicable <br/>
tax rate</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Income <br/>
tax as of <br/>
June 30, <br/>
2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Low or null taxation jurisdictions</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c544" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AccountingProfit" scale="0" unitRef="usd" id="ixv-44910">30,921,548</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c544" decimals="3" format="ixt:num-dot-decimal" name="ifrs-full:ApplicableTaxRate" scale="-2" unitRef="pure" id="ixv-44911">0.0</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-494">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Profit-making entities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c545" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AccountingProfit" scale="0" unitRef="usd" id="ixv-44912">73,999,737</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c545" decimals="3" format="ixt:num-dot-decimal" name="ifrs-full:ApplicableTaxRate" scale="-2" unitRef="pure" id="ixv-44913">21.5</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c545" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TaxExpenseIncomeAtApplicableTaxRate" scale="0" sign="-" unitRef="usd" id="ixv-44914">15,899,829</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Loss-making entities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c546" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AccountingProfit" scale="0" sign="-" unitRef="usd" id="ixv-44915">54,127,043</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right"><ix:nonFraction contextRef="c546" decimals="3" format="ixt:num-dot-decimal" name="ifrs-full:ApplicableTaxRate" scale="-2" unitRef="pure" id="ixv-44916">15.3</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c546" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TaxExpenseIncomeAtApplicableTaxRate" scale="0" unitRef="usd" id="ixv-44917">8,271,462</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AccountingProfit" scale="0" unitRef="usd" id="ixv-44918">50,794,242</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TaxExpenseIncomeAtApplicableTaxRate" scale="0" sign="-" unitRef="usd" id="ixv-44919">7,628,367</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Estimates</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There is an inherent material uncertainty related
to management&#8217;s estimation of the ability of the Group to use the deferred tax assets (both carryforward of unused tax losses and
deductible temporary differences) and the credit of minimum presumed income tax because their future utilization depends on the generation
of enough future taxable income by the entities within the Group during the periods in which those temporary differences are deductible
or when the unused tax losses can be used.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Based on the projections of future taxable income
for the periods in which the deferred tax assets are deductible, the Group&#8217;s management estimates that it is not probable that the
entities within the Group can utilize those deferred tax assets. Tax-loss Carry unrecognized as of June 30, 2025 amounting to $<ix:nonFraction contextRef="c0" decimals="-5" format="ixt:num-dot-decimal" name="ifrs-full:TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense" scale="6" unitRef="usd" id="ixv-44920">7.6</ix:nonFraction> million.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="es_002"></a></div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfEarningsPerShareExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfEarningsPerShareExplanatory" id="ixv-34046"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>10.&#160;<span style="text-decoration:underline">EARNING PER SHARE</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Basic and diluted EPS for the current period is based on the profit
or loss of the accounting acquirer and the weighted average number of ordinary shares of the legal acquirer outstanding during the period
(net of treasury shares). Comparative EPS has been retrospectively restated to reflect exchange ratio of the Business Combination Agreement
and the Reverse Stock Split ratio.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As part of the consideration transferred in the reverse acquisition
stated in Note 1 - The Group&#8217;s business reorganization and general information &#8211; &#8220;<i>The Bioceres Group Business Combination
Agreement</i>&#8221;, the Company committed to issue the Holdback additional ordinary shares twelve months after the acquisition date.
As this obligation is unconditional and forms part of the purchase consideration under IFRS 3, such shares are included in basic and diluted
EPS from the acquisition date and retrospectively for all comparative periods, in accordance with IAS 33. The deferred issuance date does
not affect their inclusion in the earnings per share calculation.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 173; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>



</div><p style="margin: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0pt">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:EarningsPerShareExplanatory" id="ixv-34099"><ix:continuation id="_DisclosureOfEarningsPerShareExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group&#8217;s basic and diluted loss per ordinary
share are the same because the Group has generated net loss to ordinary shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2023</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Numerator</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Loss/Profit for the year (basic EPS)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c547" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" scale="0" sign="-" unitRef="usd" id="ixv-44921">111,460,708</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c548" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" scale="0" sign="-" unitRef="usd" id="ixv-44922">32,685,398</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c549" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" scale="0" unitRef="usd" id="ixv-44923">40,435,923</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Loss/Profit for the year (diluted EPS)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c547" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" scale="0" sign="-" unitRef="usd" id="ixv-44924">111,460,708</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c548" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" scale="0" sign="-" unitRef="usd" id="ixv-44925">32,685,398</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c549" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" scale="0" unitRef="usd" id="ixv-44926">40,435,923</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Denominator</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Number of shares (basic EPS)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c547" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageShares" scale="0" unitRef="shares" id="ixv-44927">6,462,960</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c548" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageShares" scale="0" unitRef="shares" id="ixv-44928">5,821,519</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c549" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageShares" scale="0" unitRef="shares" id="ixv-44929">4,593,222</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Number of shares (diluted EPS)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c547" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustedWeightedAverageShares" scale="0" unitRef="shares" id="ixv-44930">6,462,960</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c548" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustedWeightedAverageShares" scale="0" unitRef="shares" id="ixv-44931">5,821,519</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c549" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustedWeightedAverageShares" scale="0" unitRef="shares" id="ixv-44932">4,593,222</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Basic (loss)/profit attributable to ordinary equity holders of the parent</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction contextRef="c547" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:BasicEarningsLossPerShare" scale="0" sign="-" unitRef="usdPershares" id="ixv-44933">17.2461</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction contextRef="c548" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:BasicEarningsLossPerShare" scale="0" sign="-" unitRef="usdPershares" id="ixv-44934">5.6146</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c549" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:BasicEarningsLossPerShare" scale="0" unitRef="usdPershares" id="ixv-44935">8.8034</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">Diluted (loss)/profit attributable to ordinary equity holders of the parent</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction contextRef="c547" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:DilutedEarningsLossPerShare" scale="0" sign="-" unitRef="usdPershares" id="ixv-44936">17.2461</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction contextRef="c548" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:DilutedEarningsLossPerShare" scale="0" sign="-" unitRef="usdPershares" id="ixv-44937">5.6146</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c549" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:DilutedEarningsLossPerShare" scale="0" unitRef="usdPershares" id="ixv-44938">8.8034</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table></ix:continuation></ix:nonNumeric><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><div><a id="fs_010"></a></div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" id="ixv-34244"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><b>11.</b></td><td style="text-align: justify"><b><span style="text-decoration:underline">INFORMATION ABOUT COMPONENTS OF EQUITY</span></b></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Capital issued</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As described in Note 1 &#8211; The Group&#8217;s
business reorganization and general information &#8211; &#8220;<i>The Bioceres Group Business Combination Agreement</i>&#8221; and in
note 6 &#8211; Acquisitions and other significant transactions &#8211; &#8220;<i>Bioceres Group, Nutrecon, Gentle Tech and Moolec Science
business combination</i>&#8221;, the Company completed a reverse acquisition on June 16, 2025, whereby Moolec Science SA (&#8220;the Legal
Acquirer&#8221;) legally acquired Bioceres Group, Nutrecon and Gentle Tech (&#8220;the Legal Acquirees&#8221;). For accounting purposes,
however, Bioceres Group was identified as the accounting acquirer in accordance with IFRS 3 Business Combinations. As a result, the consolidated
financial statements represent a continuation of the financial statements of the accounting acquirer, except for the capital structure,
which is that of the legal acquirer. Following the reverse acquisition, <span style="font-weight: normal">Share Capital</span> reflects
the share capital of <span style="font-weight: normal">Moolec Science SA, </span>including the shares issued to the former shareholders
of the accounting acquirer as consideration for the transaction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="mlec:DisclosureOfNumberOfSharesIssuedtextBlock" id="ixv-34266"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The number of shares issued as of June 30, 2025,
2024 and 2023 is the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>Year ended</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="text-align: center; border-bottom: Black 1.5pt solid"><b>Class</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Number of <br/>
Shares</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Nominal Value</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Subscribed capital</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 23%; text-align: left">06/30/2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 22%; text-align: center">Ordinary</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 15%; text-align: right"><ix:nonFraction contextRef="c551" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesIssued" scale="0" unitRef="shares" id="ixv-44939">5,301,700</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c552" decimals="2" format="ixt:num-dot-decimal" name="mlec:NumberOfNominalValue" scale="0" unitRef="usdPershares" id="ixv-44940">0.10</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c552" decimals="0" format="ixt:num-dot-decimal" name="mlec:SubscribedCapitalOfShares" scale="0" unitRef="shares" id="ixv-44941">5,301,700</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c551" decimals="0" format="ixt:num-dot-decimal" name="mlec:SubscribedCapital" scale="0" unitRef="usd" id="ixv-44942">530,170</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">06/30/2024</td><td>&#160;</td>
    <td style="text-align: center">Ordinary</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c553" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesIssued" scale="0" unitRef="shares" id="ixv-44943">5,983,687</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c554" decimals="2" format="ixt:num-dot-decimal" name="mlec:NumberOfNominalValue" scale="0" unitRef="usdPershares" id="ixv-44944">0.10</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c554" decimals="0" format="ixt:num-dot-decimal" name="mlec:SubscribedCapitalOfShares" scale="0" unitRef="shares" id="ixv-44945">5,983,687</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c553" decimals="0" format="ixt:num-dot-decimal" name="mlec:SubscribedCapital" scale="0" unitRef="usd" id="ixv-44946">598,369</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">06/30/2025</td><td>&#160;</td>
    <td style="text-align: center">Ordinary</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c550" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesIssued" scale="0" unitRef="shares" id="ixv-44947">10,891,761</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c555" decimals="2" format="ixt:num-dot-decimal" name="mlec:NumberOfNominalValue" scale="0" unitRef="usdPershares" id="ixv-44948">0.10</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c555" decimals="0" format="ixt:num-dot-decimal" name="mlec:SubscribedCapitalOfShares" scale="0" unitRef="shares" id="ixv-44949">10,891,761</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c550" decimals="0" format="ixt:num-dot-decimal" name="mlec:SubscribedCapital" scale="0" unitRef="usd" id="ixv-44950">1,089,176</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Holders of the ordinary shares are entitled to
<ix:nonFraction contextRef="c550" decimals="INF" format="ixt-sec:numwordsen" name="mlec:VotePerShare" scale="0" unitRef="pure" id="ixv-44951">one</ix:nonFraction> vote for each ordinary share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Reserves</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Foreign currency translation reserve</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The translation reserve comprises all foreign
currency differences arising from the translation of the financial statements of foreign operations.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 174; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">&#160;</p><div>

</div><ix:continuation continuedAt="_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory-c0_cont_2" id="_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Revaluation of PP&amp;E and effect of tax rate
change</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The revaluation reserve relates to the revaluation
of Land and buildings, prior to the BIOX deconsolidation, as mentioned in note 4.8 &#8211; Property, plant and equipment, net of income
tax effect.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Own shares held</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The reserve of the Company&#180;s own shares
held comprises the cost of the Company&#8217;s shares held by the Group. At June 30, 2025, the Group held <ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" scale="0" unitRef="shares" id="ixv-44952">80,370</ix:nonFraction> of the Company&#8217;s
shares. (2024: <ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" scale="0" unitRef="shares" id="ixv-44953">60,083</ix:nonFraction>).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Share premium</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Share premium represents the excess of the consideration
received over the par value of shares issued, net of directly attributable transaction costs, and is presented within equity in accordance
with IAS 32.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Non-controlling interests</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfNoncontrollingInterestsExplanatory" id="ixv-34436"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The subsidiaries whose non-controlling interest
is significant as of June 30, 2025 and 2024 are:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>Name</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>06/30/2025</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>06/30/2024</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Bioceres S.A.</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" scale="-2" unitRef="pure" id="ixv-44954">10.07</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c5" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" scale="-2" unitRef="pure" id="ixv-44955">26.53</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Bioceres Crop Solutions (*)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-495">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" scale="-2" unitRef="pure" id="ixv-44956">72.67</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  </table></ix:nonNumeric>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Below is a detail of the summarized financial
information of Bioceres S.A., prepared in accordance with IFRS, and modified due to fair value adjustments at the acquisition date and
differences in accounting policies. The information is presented prior to eliminations between that subsidiary and other Group companies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left">(*)</td><td style="text-align: justify">Bioceres Crop Solutions ceased to be a subsidiary in June
24, 2025.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Bioceres S.A.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="mlec_ScheduleOfFinancialStatementsTextBlock-c0_cont_1" escape="true" name="mlec:ScheduleOfFinancialStatementsTextBlock" id="ixv-34495"><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="text-decoration:underline">Summary financial statements:</span> &#160; &#160; &#160; &#160; &#160; &#160;</p>



<p style="margin: 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0pt">Current assets</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c86" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentAssets" scale="0" unitRef="usd" id="ixv-44957">19,390,689</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c556" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentAssets" scale="0" unitRef="usd" id="ixv-44958">37,499,373</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Non-current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c86" decimals="0" format="ixt:num-dot-decimal" name="mlec:NoncurrentAsset" scale="0" sign="-" unitRef="usd" id="ixv-44959">12,909,646</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c556" decimals="0" format="ixt:num-dot-decimal" name="mlec:NoncurrentAsset" scale="0" unitRef="usd" id="ixv-44960">78,742,912</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Total assets</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c86" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Assets" scale="0" unitRef="usd" id="ixv-44961">6,481,043</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c556" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Assets" scale="0" unitRef="usd" id="ixv-44962">116,242,285</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c86" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentLiabilities" scale="0" unitRef="usd" id="ixv-44963">97,284,715</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c556" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentLiabilities" scale="0" unitRef="usd" id="ixv-44964">47,526,407</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Non-current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c86" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentLiabilities" scale="0" unitRef="usd" id="ixv-44965">238,458</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c556" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentLiabilities" scale="0" unitRef="usd" id="ixv-44966">14,689,742</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Total liabilities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c86" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Liabilities" scale="0" unitRef="usd" id="ixv-44967">97,523,173</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c556" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Liabilities" scale="0" unitRef="usd" id="ixv-44968">62,216,149</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Total equity</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c86" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" sign="-" unitRef="usd" id="ixv-44969">91,042,130</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c556" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd" id="ixv-44970">54,026,136</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Total liabilities and equity</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c86" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:EquityAndLiabilities" scale="0" unitRef="usd" id="ixv-44971">6,481,043</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c556" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:EquityAndLiabilities" scale="0" unitRef="usd" id="ixv-44972">116,242,285</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 175; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">&#160;</p><div>

</div><ix:continuation continuedAt="_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory-c0_cont_3" id="_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory-c0_cont_2"><ix:continuation id="mlec_ScheduleOfFinancialStatementsTextBlock-c0_cont_1"><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="text-decoration:underline">Summary statements of comprehensive income or loss</span></p>



<p style="margin: 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">06/30/2023</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; padding-left: 0pt">Revenues</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c89" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="0" unitRef="usd" id="ixv-44973">780,952</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c557" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="0" unitRef="usd" id="ixv-44974">1,422,707</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c558" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="0" unitRef="usd" id="ixv-44975">1,074,655</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Government grants</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c89" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromGovernmentGrants" scale="0" unitRef="usd" id="ixv-44976">3,412</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c557" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromGovernmentGrants" scale="0" unitRef="usd" id="ixv-44977">197,519</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c558" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromGovernmentGrants" scale="0" unitRef="usd" id="ixv-44978">49,185</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 0pt">Gross margin</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c89" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GrossProfit" scale="0" unitRef="usd" id="ixv-44979">784,364</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c557" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GrossProfit" scale="0" unitRef="usd" id="ixv-44980">1,620,226</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c558" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GrossProfit" scale="0" unitRef="usd" id="ixv-44981">1,123,840</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Research and development expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c89" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="0" unitRef="usd" id="ixv-44982">223,688</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c557" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="0" unitRef="usd" id="ixv-44983">239,446</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c558" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="0" unitRef="usd" id="ixv-44984">175,737</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Selling, general and administrative expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c89" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:SellingGeneralAndAdministrativeExpense" scale="0" unitRef="usd" id="ixv-44985">2,275,441</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c557" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:SellingGeneralAndAdministrativeExpense" scale="0" unitRef="usd" id="ixv-44986">3,248,643</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c558" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:SellingGeneralAndAdministrativeExpense" scale="0" unitRef="usd" id="ixv-44987">3,287,433</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">Share of profit or loss of subsidiaries</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c89" decimals="0" format="ixt:num-dot-decimal" name="mlec:ShareOfProfitOrLossOfSubsidiaries" scale="0" sign="-" unitRef="usd" id="ixv-44988">33,367,101</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c557" decimals="0" format="ixt:num-dot-decimal" name="mlec:ShareOfProfitOrLossOfSubsidiaries" scale="0" sign="-" unitRef="usd" id="ixv-44989">3,285,724</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c558" decimals="0" format="ixt:num-dot-decimal" name="mlec:ShareOfProfitOrLossOfSubsidiaries" scale="0" unitRef="usd" id="ixv-44990">5,287,879</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Share of profit or loss of joint ventures and associates</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c89" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="0" sign="-" unitRef="usd" id="ixv-44991">285</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c557" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="0" sign="-" unitRef="usd" id="ixv-44992">2,592</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c558" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="0" sign="-" unitRef="usd" id="ixv-44993">3,917</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Other income / (loss), net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c89" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherOperatingIncomeExpense" scale="0" sign="-" unitRef="usd" id="ixv-44994">56,484,792</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c557" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherOperatingIncomeExpense" scale="0" unitRef="usd" id="ixv-44995">11,126</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c558" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherOperatingIncomeExpense" scale="0" unitRef="usd" id="ixv-44996">249,372</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-left: 0pt">Operating loss</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c89" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossFromOperatingActivities" scale="0" sign="-" unitRef="usd" id="ixv-44997">91,566,943</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c557" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossFromOperatingActivities" scale="0" sign="-" unitRef="usd" id="ixv-44998">5,145,053</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c558" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossFromOperatingActivities" scale="0" unitRef="usd" id="ixv-44999">3,194,004</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Financial results</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c89" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinanceIncomeCost" scale="0" unitRef="usd" id="ixv-45000">2,891,781</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c557" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinanceIncomeCost" scale="0" sign="-" unitRef="usd" id="ixv-45001">1,128,752</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c558" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinanceIncomeCost" scale="0" sign="-" unitRef="usd" id="ixv-45002">4,327,324</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Loss before taxes</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c89" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossBeforeTax" scale="0" sign="-" unitRef="usd" id="ixv-45003">88,675,162</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c557" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossBeforeTax" scale="0" sign="-" unitRef="usd" id="ixv-45004">6,273,805</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c558" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossBeforeTax" scale="0" sign="-" unitRef="usd" id="ixv-45005">1,133,320</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Income tax (expense) / benefit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c89" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="0" unitRef="usd" id="ixv-45006">1,653,797</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c557" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="0" sign="-" unitRef="usd" id="ixv-45007">471,416</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c558" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="0" unitRef="usd" id="ixv-45008">463,175</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Result for the year</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c89" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" sign="-" unitRef="usd" id="ixv-45009">90,328,959</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c557" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" sign="-" unitRef="usd" id="ixv-45010">5,802,389</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c558" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" sign="-" unitRef="usd" id="ixv-45011">1,596,495</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-style: italic; text-align: left; padding-left: 0pt">Revaluation of property, plant and equipment, net of tax</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c558" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation" scale="0" sign="-" unitRef="usd" id="ixv-45012">434,390</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Foreign exchange differences on translation of foreign operations</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c89" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" scale="0" sign="-" unitRef="usd" id="ixv-45013">5,467,311</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c557" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" scale="0" sign="-" unitRef="usd" id="ixv-45014">3,865,328</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c558" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" scale="0" sign="-" unitRef="usd" id="ixv-45015">5,182,181</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-style: italic; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Total comprehensive result</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c89" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="0" sign="-" unitRef="usd" id="ixv-45016">95,796,270</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c557" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="0" sign="-" unitRef="usd" id="ixv-45017">9,667,717</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c558" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="0" sign="-" unitRef="usd" id="ixv-45018">7,213,066</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
  </table></ix:continuation>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Bioceres Crop Solutions</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory" id="ixv-34980"><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="text-decoration:underline">Summary financial statements:</span></p>



<p style="margin: 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0pt">Current assets</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-496">&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c560" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentAssets" scale="0" unitRef="usd" id="ixv-45019">408,668,037</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Non-current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-497">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c560" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentAssets" scale="0" unitRef="usd" id="ixv-45020">441,960,310</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Total assets</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-498">-</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c560" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Assets" scale="0" unitRef="usd" id="ixv-45021">850,628,347</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-499">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c560" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentLiabilities" scale="0" unitRef="usd" id="ixv-45022">329,505,846</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Non-current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-500">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c560" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentLiabilities" scale="0" unitRef="usd" id="ixv-45023">171,558,140</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Total liabilities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-501">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c560" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Liabilities" scale="0" unitRef="usd" id="ixv-45024">501,063,986</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Total equity</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-502">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c560" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd" id="ixv-45025">349,564,361</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"/><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Total liabilities and equity</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-503">-</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c560" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:EquityAndLiabilities" scale="0" unitRef="usd" id="ixv-45026">850,628,347</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 176; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">&#160;</p><div>

</div><ix:continuation id="_DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory-c0_cont_1"><ix:continuation id="_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory-c0_cont_3"><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="text-decoration:underline">Summary statements of comprehensive income or loss</span></p>



<p style="margin: 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 64%">Revenues</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c561" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="0" unitRef="usd" id="ixv-45027">333,343,987</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c562" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="0" unitRef="usd" id="ixv-45028">464,828,548</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c563" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="0" unitRef="usd" id="ixv-45029">419,446,439</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Initial recognition and changes in the fair value of biological assets at the point of harvest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c561" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets" scale="0" unitRef="usd" id="ixv-45030">1,764,863</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c562" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets" scale="0" sign="-" unitRef="usd" id="ixv-45031">45,746</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c563" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets" scale="0" unitRef="usd" id="ixv-45032">610,554</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Cost of sales</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c561" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CostOfSales" scale="0" unitRef="usd" id="ixv-45033">203,424,872</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c562" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CostOfSales" scale="0" unitRef="usd" id="ixv-45034">278,221,812</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c563" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CostOfSales" scale="0" unitRef="usd" id="ixv-45035">235,457,053</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Changes in the net realizable value of agricultural products after harvest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c561" decimals="0" format="ixt:num-dot-decimal" name="mlec:ChangeInNetRealizableValueOfAgricultural" scale="0" sign="-" unitRef="usd" id="ixv-45036">1,541,204</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c562" decimals="0" format="ixt:num-dot-decimal" name="mlec:ChangeInNetRealizableValueOfAgricultural" scale="0" sign="-" unitRef="usd" id="ixv-45037">2,385,069</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c563" decimals="0" format="ixt:num-dot-decimal" name="mlec:ChangeInNetRealizableValueOfAgricultural" scale="0" sign="-" unitRef="usd" id="ixv-45038">4,351,433</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Research and development expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c561" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="0" unitRef="usd" id="ixv-45039">14,914,822</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c562" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="0" unitRef="usd" id="ixv-45040">17,183,041</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c563" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="0" unitRef="usd" id="ixv-45041">15,345,315</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Selling, general and administrative expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c561" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:SellingGeneralAndAdministrativeExpense" scale="0" unitRef="usd" id="ixv-45042">123,113,572</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c562" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:SellingGeneralAndAdministrativeExpense" scale="0" unitRef="usd" id="ixv-45043">123,690,910</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c563" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:SellingGeneralAndAdministrativeExpense" scale="0" unitRef="usd" id="ixv-45044">113,002,747</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Share of profit or loss of joint ventures and associates</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c561" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="0" sign="-" unitRef="usd" id="ixv-45045">1,126,312</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c562" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="0" unitRef="usd" id="ixv-45046">4,049,508</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c563" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="0" unitRef="usd" id="ixv-45047">1,198,628</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Other income or expenses, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c561" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherOperatingIncomeExpense" scale="0" unitRef="usd" id="ixv-45048">6,775,970</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c562" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherOperatingIncomeExpense" scale="0" sign="-" unitRef="usd" id="ixv-45049">1,498,555</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c563" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherOperatingIncomeExpense" scale="0" unitRef="usd" id="ixv-45050">1,084,892</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Operating (loss) / profit</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c561" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossFromOperatingActivities" scale="0" sign="-" unitRef="usd" id="ixv-45051">2,235,962</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c562" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossFromOperatingActivities" scale="0" unitRef="usd" id="ixv-45052">45,852,923</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c563" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossFromOperatingActivities" scale="0" unitRef="usd" id="ixv-45053">54,183,965</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Financial results</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c561" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinanceIncomeCost" scale="0" sign="-" unitRef="usd" id="ixv-45054">55,335,675</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c562" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinanceIncomeCost" scale="0" sign="-" unitRef="usd" id="ixv-45055">34,785,325</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c563" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinanceIncomeCost" scale="0" sign="-" unitRef="usd" id="ixv-45056">35,078,018</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">(Loss) / profit before taxes</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c561" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossBeforeTax" scale="0" sign="-" unitRef="usd" id="ixv-45057">57,571,637</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c562" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossBeforeTax" scale="0" unitRef="usd" id="ixv-45058">11,067,598</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c563" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossBeforeTax" scale="0" unitRef="usd" id="ixv-45059">19,105,947</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Income tax</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c561" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="0" unitRef="usd" id="ixv-45060">1,273,616</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c562" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="0" unitRef="usd" id="ixv-45061">3,778,615</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c563" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="0" sign="-" unitRef="usd" id="ixv-45062">1,068,652</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Result for the year</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c561" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" sign="-" unitRef="usd" id="ixv-45063">58,845,253</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c562" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" unitRef="usd" id="ixv-45064">7,288,983</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c563" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" unitRef="usd" id="ixv-45065">20,174,599</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-style: italic; text-align: left">Foreign exchange differences on translation of foreign operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c561" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" scale="0" sign="-" unitRef="usd" id="ixv-45066">714,251</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c562" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" scale="0" sign="-" unitRef="usd" id="ixv-45067">787,354</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c563" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" scale="0" unitRef="usd" id="ixv-45068">631,500</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-style: italic; text-align: left; padding-bottom: 1.5pt">Revaluation of property, plant and equipment, net of tax</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-504">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-505">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c563" decimals="0" format="ixt:num-dot-decimal" name="mlec:RevaluationOfPropertyPlantAndEquipmentNetOfTax" scale="0" sign="-" unitRef="usd" id="ixv-45069">1,467,349</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-style: italic; text-align: left; padding-bottom: 2.5pt">Total comprehensive result</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c561" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="0" sign="-" unitRef="usd" id="ixv-45070">59,559,504</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c562" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="0" unitRef="usd" id="ixv-45071">6,501,629</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c563" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="0" unitRef="usd" id="ixv-45072">19,338,750</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:continuation></ix:continuation><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><div><a id="fs_011"></a></div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfCashFlowStatementExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfCashFlowStatementExplanatory" id="ixv-35478"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><b>12.</b></td><td style="text-align: justify"><b><span style="text-decoration:underline">CASH FLOW INFORMATION</span></b></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c0" escape="true" name="mlec:ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities" id="ixv-35489"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Significant non-cash transactions related to investing
and financing activities are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2023</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold">Investment activities</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; width: 64%; text-align: left; padding-left: 0.125in">Net assets acquisition by business combination (Note 6)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c564" decimals="0" format="ixt:num-dot-decimal" name="mlec:NetAssetsAcquisitionByBusinessCombination" scale="0" sign="-" unitRef="usd" id="ixv-45073">43,053,702</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c565" decimals="0" format="ixt:num-dot-decimal" name="mlec:NetAssetsAcquisitionByBusinessCombination" scale="0" sign="-" unitRef="usd" id="ixv-45074">1,297,882</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c566" decimals="0" format="ixt:num-dot-decimal" name="mlec:NetAssetsAcquisitionByBusinessCombination" scale="0" sign="-" unitRef="usd" id="ixv-45075">152,070,313</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Investment in-kind in other related parties (Note 17)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-506">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c565" decimals="0" format="ixt:num-dot-decimal" name="mlec:InvestmentInKindInOtherRelatedPartiesNonCashTransactionsInvestmentActivities" scale="0" unitRef="usd" id="ixv-45076">2,409,244</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c566" decimals="0" format="ixt:num-dot-decimal" name="mlec:InvestmentInKindInOtherRelatedPartiesNonCashTransactionsInvestmentActivities" scale="0" unitRef="usd" id="ixv-45077">1,163,384</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Issuance of shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c564" decimals="0" format="ixt:num-dot-decimal" name="mlec:IssuanceOfShare" scale="0" unitRef="usd" id="ixv-45078">457,504</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c565" decimals="0" format="ixt:num-dot-decimal" name="mlec:IssuanceOfShare" scale="0" unitRef="usd" id="ixv-45079">267,600</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c566" decimals="0" format="ixt:num-dot-decimal" name="mlec:IssuanceOfShare" scale="0" unitRef="usd" id="ixv-45080">759,236</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Own shares held</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c564" decimals="0" format="ixt:num-dot-decimal" name="mlec:OwnShareHeld" scale="0" sign="-" unitRef="usd" id="ixv-45081">22,327</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c565" decimals="0" format="ixt:num-dot-decimal" name="mlec:OwnShareHeld" scale="0" unitRef="usd" id="ixv-45082">437,154</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-507">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Exchange of intangible assets (Note 8.6)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c564" decimals="0" format="ixt:num-dot-decimal" name="mlec:ExchangeOfIntangibleAssets" scale="0" unitRef="usd" id="ixv-45083">6,427,436</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-508">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-509">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Capitalization of interest on buildings in progress</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c564" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InterestCostsCapitalised" scale="0" unitRef="usd" id="ixv-45084">336,416</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c565" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InterestCostsCapitalised" scale="0" unitRef="usd" id="ixv-45085">124,098</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c566" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InterestCostsCapitalised" scale="0" unitRef="usd" id="ixv-45086">74,710</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Right-of-use leased asset additions through an increase
    in lease liabilities (Note 16)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c564" decimals="0" format="ixt:num-dot-decimal" name="mlec:RightofuseLeasedAssetAdditionsThroughAnIncreaseInLeaseLiabilities" scale="0" sign="-" unitRef="usd" id="ixv-45087">9,569,819</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c565" decimals="0" format="ixt:num-dot-decimal" name="mlec:RightofuseLeasedAssetAdditionsThroughAnIncreaseInLeaseLiabilities" scale="0" sign="-" unitRef="usd" id="ixv-45088">2,585,223</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c566" decimals="0" format="ixt:num-dot-decimal" name="mlec:RightofuseLeasedAssetAdditionsThroughAnIncreaseInLeaseLiabilities" scale="0" sign="-" unitRef="usd" id="ixv-45089">3,154,950</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Reclassification from Investment properties to property, plant and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-510">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-511">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c566" decimals="0" format="ixt:num-dot-decimal" name="mlec:NonMonetaryContributionsInJointVenturesNonCashTransactionsInvestmentActivities" scale="0" unitRef="usd" id="ixv-45090">3,589,749</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">Sale of equity investee (Note 13)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-512">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c565" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod" scale="0" unitRef="usd" id="ixv-45091">900,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c566" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod" scale="0" unitRef="usd" id="ixv-45092">133,079</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-bottom: 2.5pt; padding-left: 0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c564" decimals="0" format="ixt:num-dot-decimal" name="mlec:NonCashInvestingActivities" scale="0" unitRef="usd" id="ixv-45093">59,867,204</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c565" decimals="0" format="ixt:num-dot-decimal" name="mlec:NonCashInvestingActivities" scale="0" unitRef="usd" id="ixv-45094">5,346,893</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c566" decimals="0" format="ixt:num-dot-decimal" name="mlec:NonCashInvestingActivities" scale="0" unitRef="usd" id="ixv-45095">160,679,263</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>

<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Financing activities</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="width: 64%; text-align: left; padding-left: 0pt">Capitalization of convertible notes</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-513">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-514">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c566" decimals="0" format="ixt:num-dot-decimal" name="mlec:CapitalizationOfConvertibleFinancingActivities" scale="0" sign="-" unitRef="usd" id="ixv-45096">12,211,638</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Assignment of receivables with shareholders and other related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c564" decimals="0" format="ixt:num-dot-decimal" name="mlec:AssignmentOfReceivablesWithShareholdersAndOtherRelatedParties" scale="0" unitRef="usd" id="ixv-45097">7,886,442</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-515">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-516">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Compensation payment financed by acquisition of intangible assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c564" decimals="0" format="ixt:num-dot-decimal" name="mlec:CompensationPaymentFinancedByAcquisitionOfIntangibleAssets" scale="0" unitRef="usd" id="ixv-45098">1,781,507</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-517">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-518">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Acquisition of interest in subsidiaries by financed debts</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-519">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c565" decimals="0" format="ixt:num-dot-decimal" name="mlec:IncreaseThroughAcquisitionOfNonControllingInterestInSubsidiaries" scale="0" sign="-" unitRef="usd" id="ixv-45099">6,417,912</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c566" decimals="0" format="ixt:num-dot-decimal" name="mlec:IncreaseThroughAcquisitionOfNonControllingInterestInSubsidiaries" scale="0" sign="-" unitRef="usd" id="ixv-45100">81,965,022</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c564" decimals="0" format="ixt:num-dot-decimal" name="mlec:NonCashFinancingActivities" scale="0" sign="-" unitRef="usd" id="ixv-45101">9,667,949</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c565" decimals="0" format="ixt:num-dot-decimal" name="mlec:NonCashFinancingActivities" scale="0" unitRef="usd" id="ixv-45102">6,417,912</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c566" decimals="0" format="ixt:num-dot-decimal" name="mlec:NonCashFinancingActivities" scale="0" unitRef="usd" id="ixv-45103">94,176,660</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the fiscal year ended on June 30, 2024,
the Group has incorporated the assets and liabilities from Natal Agro S.R.L. mentioned in Note 6 &#8211; Acquisitions and other significant
transactions.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 177; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory" id="ixv-35795"><ix:continuation id="_DisclosureOfCashFlowStatementExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Disclosure of changes in liabilities arising from
financing activities:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; border-bottom: Black 1.5pt solid">Financing activities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Borrowings</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Consideration for acquisition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Convertible notes</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; width: 52%; font-weight: bold; padding-bottom: 2.5pt; padding-left: 0.125in">As of June 30 2022</td><td style="width: 1%; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c567" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="0" unitRef="usd" id="ixv-45104">211,426,056</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c568" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="0" unitRef="usd" id="ixv-45105">12,326,110</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c569" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="0" unitRef="usd" id="ixv-45106">12,559,071</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c65" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="0" unitRef="usd" id="ixv-45107">236,311,237</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Proceeds</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c570" decimals="0" format="ixt:num-dot-decimal" name="mlec:IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities" scale="0" unitRef="usd" id="ixv-45108">200,185,822</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-520">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c572" decimals="0" format="ixt:num-dot-decimal" name="mlec:IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities" scale="0" unitRef="usd" id="ixv-45109">55,000,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities" scale="0" unitRef="usd" id="ixv-45110">255,185,822</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c570" decimals="0" format="ixt:num-dot-decimal" name="mlec:DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities" scale="0" unitRef="usd" id="ixv-45111">35,308,664</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c571" decimals="0" format="ixt:num-dot-decimal" name="mlec:DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities" scale="0" unitRef="usd" id="ixv-45112">3,148,617</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-521">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities" scale="0" unitRef="usd" id="ixv-45113">38,457,281</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Conversion of Convertible Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-522">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-523">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c572" decimals="0" format="ixt:num-dot-decimal" name="mlec:DecreaseThroughCapitalizationOfDebtLiabilitiesArisingFromFinancingActivities" scale="0" unitRef="usd" id="ixv-45114">9,109,516</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:DecreaseThroughCapitalizationOfDebtLiabilitiesArisingFromFinancingActivities" scale="0" unitRef="usd" id="ixv-45115">9,109,516</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Interest payment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c570" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" scale="0" unitRef="usd" id="ixv-45116">20,465,271</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-524">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c572" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" scale="0" unitRef="usd" id="ixv-45117">5,173,742</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" scale="0" unitRef="usd" id="ixv-45118">25,639,013</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">Exchange differences, currency translation differences and other financial results</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c570" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" scale="0" sign="-" unitRef="usd" id="ixv-45119">23,391,636</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c571" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" scale="0" sign="-" unitRef="usd" id="ixv-45120">4,617,570</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c572" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" scale="0" unitRef="usd" id="ixv-45121">21,937,333</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" scale="0" sign="-" unitRef="usd" id="ixv-45122">6,071,873</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; font-weight: bold; padding-bottom: 2.5pt; padding-left: 0.125in">As of June 30 2023</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c573" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="0" unitRef="usd" id="ixv-45123">332,446,307</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c574" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="0" unitRef="usd" id="ixv-45124">4,559,923</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c575" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="0" unitRef="usd" id="ixv-45125">75,213,146</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c47" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="0" unitRef="usd" id="ixv-45126">412,219,376</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Proceeds</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c576" decimals="0" format="ixt:num-dot-decimal" name="mlec:IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities" scale="0" unitRef="usd" id="ixv-45127">187,994,310</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-525">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-526">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="mlec:IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities" scale="0" unitRef="usd" id="ixv-45128">187,994,310</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c576" decimals="0" format="ixt:num-dot-decimal" name="mlec:DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities" scale="0" unitRef="usd" id="ixv-45129">142,866,725</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c577" decimals="0" format="ixt:num-dot-decimal" name="mlec:DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities" scale="0" unitRef="usd" id="ixv-45130">2,912,171</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-527">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="mlec:DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities" scale="0" unitRef="usd" id="ixv-45131">145,778,896</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Financing for assets acquisitions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c576" decimals="0" format="ixt:num-dot-decimal" name="mlec:FinancingForAssetsAcquisitions" scale="0" unitRef="usd" id="ixv-45132">743,279</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c577" decimals="0" format="ixt:num-dot-decimal" name="mlec:FinancingForAssetsAcquisitions" scale="0" unitRef="usd" id="ixv-45133">1,119,975</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-528">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="mlec:FinancingForAssetsAcquisitions" scale="0" unitRef="usd" id="ixv-45134">1,863,254</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Interest payment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c576" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" scale="0" unitRef="usd" id="ixv-45135">32,631,369</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-529">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c578" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" scale="0" unitRef="usd" id="ixv-45136">4,172,328</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" scale="0" unitRef="usd" id="ixv-45137">36,803,697</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">Exchange differences, currency translation differences and other financial results</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c576" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" scale="0" unitRef="usd" id="ixv-45138">16,073,254</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c577" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" scale="0" unitRef="usd" id="ixv-45139">3,809,240</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c578" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" scale="0" unitRef="usd" id="ixv-45140">9,768,868</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" scale="0" unitRef="usd" id="ixv-45141">29,651,362</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; font-weight: bold; padding-bottom: 2.5pt; padding-left: 0.125in">As of June 30 2024</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c579" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="0" unitRef="usd" id="ixv-45142">361,759,056</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c580" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="0" unitRef="usd" id="ixv-45143">6,576,967</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c581" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="0" unitRef="usd" id="ixv-45144">80,809,686</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="0" unitRef="usd" id="ixv-45145">449,145,709</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Proceeds</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c582" decimals="0" format="ixt:num-dot-decimal" name="mlec:IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities" scale="0" unitRef="usd" id="ixv-45146">403,333,190</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-530">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-531">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities" scale="0" unitRef="usd" id="ixv-45147">403,333,190</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c582" decimals="0" format="ixt:num-dot-decimal" name="mlec:DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities" scale="0" unitRef="usd" id="ixv-45148">376,998,320</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c583" decimals="0" format="ixt:num-dot-decimal" name="mlec:DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities" scale="0" unitRef="usd" id="ixv-45149">2,035,388</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c584" decimals="0" format="ixt:num-dot-decimal" name="mlec:DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities" scale="0" unitRef="usd" id="ixv-45150">1,000,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities" scale="0" unitRef="usd" id="ixv-45151">380,033,708</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Prepayment Premium Fee</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-532">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-533">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c584" decimals="0" format="ixt:num-dot-decimal" name="mlec:PrepaymentPremiumFee" scale="0" unitRef="usd" id="ixv-45152">4,870,021</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:PrepaymentPremiumFee" scale="0" unitRef="usd" id="ixv-45153">4,870,021</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Non-cash activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c582" decimals="0" format="ixt:num-dot-decimal" name="mlec:NoncashActivities" scale="0" sign="-" unitRef="usd" id="ixv-45154">7,886,442</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c583" decimals="0" format="ixt:num-dot-decimal" name="mlec:NoncashActivities" scale="0" sign="-" unitRef="usd" id="ixv-45155">1,781,507</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-534">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:NoncashActivities" scale="0" sign="-" unitRef="usd" id="ixv-45156">9,667,949</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Interest payment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c582" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" scale="0" unitRef="usd" id="ixv-45157">21,772,862</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-535">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c584" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" scale="0" unitRef="usd" id="ixv-45158">6,315,826</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" scale="0" unitRef="usd" id="ixv-45159">28,088,688</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Exchange differences, currency translation differences and other financial results</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c582" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" scale="0" unitRef="usd" id="ixv-45160">26,645,537</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c583" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" scale="0" unitRef="usd" id="ixv-45161">138,825</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c584" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" scale="0" unitRef="usd" id="ixv-45162">23,906,564</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" scale="0" unitRef="usd" id="ixv-45163">50,690,926</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Acquisition from business combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c582" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-45164">1,348,173</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-536">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c584" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-45165">18,260,456</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-45166">19,608,629</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">Decrease because of loss of control</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c582" decimals="0" format="ixt:num-dot-decimal" name="mlec:DecreaseBecauseOfLossOfControl" scale="0" sign="-" unitRef="usd" id="ixv-45167">157,926,152</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c583" decimals="0" format="ixt:num-dot-decimal" name="mlec:DecreaseBecauseOfLossOfControl" scale="0" sign="-" unitRef="usd" id="ixv-45168">2,898,897</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c584" decimals="0" format="ixt:num-dot-decimal" name="mlec:DecreaseBecauseOfLossOfControl" scale="0" sign="-" unitRef="usd" id="ixv-45169">102,270,445</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:DecreaseBecauseOfLossOfControl" scale="0" sign="-" unitRef="usd" id="ixv-45170">263,095,494</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; font-weight: bold; padding-bottom: 2.5pt; padding-left: 0.125in">As of June 30 2025</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c585" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="0" unitRef="usd" id="ixv-45171">228,502,180</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-537">-</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c587" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="0" unitRef="usd" id="ixv-45172">18,260,456</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="0" unitRef="usd" id="ixv-45173">246,762,636</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:continuation></ix:nonNumeric><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>


</div><!-- Field: Page; Sequence: 178; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">&#160;</p><div>

</div><div><a id="fs_012"></a></div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfJointVenturesExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfJointVenturesExplanatory" id="ixv-36272"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="padding: 0pt; width: 0"/><td style="padding: 0pt; width: 0.25in"><b>13.</b></td><td style="padding: 0pt"><b><span style="text-decoration:underline">JOINT VENTURES AND ASSOCIATES</span></b></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="mlec:DisclosureOfInvestmentsInJointVenturesAndAffiliatesTableTextBlock" id="ixv-36282"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"/><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">06/30/2025</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">06/30/2024</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"><span style="text-decoration:underline">Assets</span></span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic"><span style="font-family: Times New Roman, Times, Serif">Measured at equity value
    method</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Synertech Industrias
    S.A.</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-538; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c590" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates" scale="0" unitRef="usd" id="ixv-45174">39,749,850</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Bioceres Crops Solutions
    Corp</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c591" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates" scale="0" unitRef="usd" id="ixv-45175">77,741,970</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-539; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Agrality Argentina S.A.</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c593" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates" scale="0" unitRef="usd" id="ixv-45176">7,521,996</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c594" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates" scale="0" unitRef="usd" id="ixv-45177">7,758,886</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Agrality US Inc.</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c595" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates" scale="0" unitRef="usd" id="ixv-45178">3,315,307</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c596" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates" scale="0" unitRef="usd" id="ixv-45179">3,521,791</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Agrality Seeds Inc.</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c597" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates" scale="0" unitRef="usd" id="ixv-45180">5,496,286</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c598" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates" scale="0" unitRef="usd" id="ixv-45181">4,812,389</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">SW Semillas S.A.</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c599" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates" scale="0" unitRef="usd" id="ixv-45182">725</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c600" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates" scale="0" unitRef="usd" id="ixv-45183">955</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Alfalfa Technologies S.R.L.</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-540; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c602" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates" scale="0" unitRef="usd" id="ixv-45184">36,503</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Inmet
    S.A</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c603" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates" scale="0" unitRef="usd" id="ixv-45185">71,687</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c604" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates" scale="0" unitRef="usd" id="ixv-45186">379,876</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates" scale="0" unitRef="usd" id="ixv-45187">94,147,971</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates" scale="0" unitRef="usd" id="ixv-45188">56,260,250</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; font-style: italic; text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Measured
    at Fair value</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Theo
    I SCSp</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-541; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c606" decimals="0" format="ixt:num-dot-decimal" name="mlec:InvestmentsMeasuredAtFairValue" scale="0" unitRef="usd" id="ixv-45189">36,535,601</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-542; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="mlec:InvestmentsMeasuredAtFairValue" scale="0" unitRef="usd" id="ixv-45190">36,535,601</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"/><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>06/30/2025</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>06/30/2024</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="text-decoration:underline">Liabilities</span></td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic; text-align: left">Measured at equity value method</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Trigall Genetics S.A.</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-543">&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c608" decimals="0" format="ixt:num-dot-decimal" name="mlec:DueToJointVenturesAndAssociatesNonCurrent" scale="0" unitRef="usd" id="ixv-45191">296,455</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-544">-</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="mlec:DueToJointVenturesAndAssociatesNonCurrent" scale="0" unitRef="usd" id="ixv-45192">296,455</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="mlec:DisclosureOfChangesInInvestmentInJointVenturesAndAffiliatesTableTextBlock" id="ixv-36611"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Changes in joint ventures investments and affiliates:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; padding-left: 0pt">As of the beginning</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c609" decimals="0" format="ixt:num-dot-decimal" name="mlec:InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity" scale="0" unitRef="usd" id="ixv-45193">92,499,396</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c610" decimals="0" format="ixt:num-dot-decimal" name="mlec:InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity" scale="0" unitRef="usd" id="ixv-45194">117,720,140</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Loss of control</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c611" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LossesOnDisposalsOfInvestments" scale="0" unitRef="usd" id="ixv-45195">38,363,585</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-545">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Changes in equity interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c611" decimals="0" format="ixt:num-dot-decimal" name="mlec:ChangesInEquityInterest" scale="0" unitRef="usd" id="ixv-45196">77,741,970</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c612" decimals="0" format="ixt:num-dot-decimal" name="mlec:ChangesInEquityInterest" scale="0" unitRef="usd" id="ixv-45197">9,958</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Sale of equity investment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-546">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c612" decimals="0" format="ixt:num-dot-decimal" name="mlec:SaleOfEquityInvestment" scale="0" sign="-" unitRef="usd" id="ixv-45198">900,000</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Reclassification of Moolec Science S.A.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-547">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c612" decimals="0" format="ixt:num-dot-decimal" name="mlec:JointVenturesAndAssociatesAccountedForUsingEquityMethodReclassificationChangeInOwnership" scale="0" unitRef="usd" id="ixv-45199">2,560,472</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Share-based incentives</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-548">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c612" decimals="0" format="ixt:num-dot-decimal" name="mlec:EquityMethodInvestmentIncreaseFromShareBasedIncentives" scale="0" unitRef="usd" id="ixv-45200">65,470</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Dividends distribution</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-549">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c612" decimals="0" format="ixt:num-dot-decimal" name="mlec:ChangeinJointVenturesDividendsDistribution" scale="0" sign="-" unitRef="usd" id="ixv-45201">1,790,032</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Foreign currency translation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c611" decimals="0" format="ixt:num-dot-decimal" name="mlec:GainsLossesOnExchangeDifferencesOnTranslationFromJointVentureNetOfTax" scale="0" sign="-" unitRef="usd" id="ixv-45202">802,200</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c612" decimals="0" format="ixt:num-dot-decimal" name="mlec:GainsLossesOnExchangeDifferencesOnTranslationFromJointVentureNetOfTax" scale="0" unitRef="usd" id="ixv-45203">977,482</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Share of profit or loss measured at equity value method</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c611" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="0" sign="-" unitRef="usd" id="ixv-45204">392,009</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c612" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="0" unitRef="usd" id="ixv-45205">7,747,312</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Share of profit or loss measured at fair value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c611" decimals="0" format="ixt:num-dot-decimal" name="mlec:ShareOfProfitOrLossMeasuredAtFairValue" scale="0" sign="-" unitRef="usd" id="ixv-45206">36,535,601</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c612" decimals="0" format="ixt:num-dot-decimal" name="mlec:ShareOfProfitOrLossMeasuredAtFairValue" scale="0" sign="-" unitRef="usd" id="ixv-45207">28,770,462</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">As of the end of the year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c613" decimals="0" format="ixt:num-dot-decimal" name="mlec:InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity" scale="0" unitRef="usd" id="ixv-45208">94,147,971</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c609" decimals="0" format="ixt:num-dot-decimal" name="mlec:InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity" scale="0" unitRef="usd" id="ixv-45209">92,499,396</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 179; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">&#160;</p><div>

</div><ix:continuation id="_DisclosureOfJointVenturesExplanatory-c0_cont_1"><ix:nonNumeric contextRef="c0" continuedAt="mlec_DisclosureOfShareOfProfitOrLossInJointVenturesAndAffiliatesTableTextBlock-c0_cont_1" escape="true" name="mlec:DisclosureOfShareOfProfitOrLossInJointVenturesAndAffiliatesTableTextBlock" id="ixv-36780"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Share of profit or loss of joint ventures and affiliates:</p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration:underline">Profit and losses</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:continuation id="mlec_DisclosureOfShareOfProfitOrLossInJointVenturesAndAffiliatesTableTextBlock-c0_cont_1"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-weight: bold"/><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic">Measured at equity value method</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-left: 0pt">Synertech Industrias S.A.</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c614" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" scale="0" sign="-" unitRef="usd" id="ixv-45210">415,089</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c615" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" scale="0" unitRef="usd" id="ixv-45211">3,723,140</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c616" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" scale="0" unitRef="usd" id="ixv-45212">564,598</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Agrality Argentina S.A.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c617" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" scale="0" unitRef="usd" id="ixv-45213">587,173</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c618" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" scale="0" unitRef="usd" id="ixv-45214">3,519,639</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c619" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" scale="0" unitRef="usd" id="ixv-45215">2,126,492</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Agrality US Inc.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c620" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" scale="0" sign="-" unitRef="usd" id="ixv-45216">206,484</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c621" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" scale="0" sign="-" unitRef="usd" id="ixv-45217">64,322</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c622" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" scale="0" sign="-" unitRef="usd" id="ixv-45218">2,940,435</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Agrality Seeds Inc.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c623" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" scale="0" unitRef="usd" id="ixv-45219">683,897</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c624" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" scale="0" sign="-" unitRef="usd" id="ixv-45220">124,468</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c625" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" scale="0" unitRef="usd" id="ixv-45221">2,187,415</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Indrasa Biotecnolog&#237;a S.A.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-550">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-551">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c628" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" scale="0" unitRef="usd" id="ixv-45222">62,613</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Moolec Science SA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-552">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-553">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c631" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" scale="0" sign="-" unitRef="usd" id="ixv-45223">4,176,703</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">SW Semillas S.A.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c632" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" scale="0" sign="-" unitRef="usd" id="ixv-45224">285</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c633" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" scale="0" sign="-" unitRef="usd" id="ixv-45225">2,592</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c634" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" scale="0" sign="-" unitRef="usd" id="ixv-45226">3,917</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Trigall Genetics</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c635" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" scale="0" sign="-" unitRef="usd" id="ixv-45227">711,223</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c636" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" scale="0" unitRef="usd" id="ixv-45228">326,368</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c637" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" scale="0" unitRef="usd" id="ixv-45229">103,703</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Inmet S.A.</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c638" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" scale="0" sign="-" unitRef="usd" id="ixv-45230">329,998</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c639" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" scale="0" unitRef="usd" id="ixv-45231">369,547</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-554">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" scale="0" sign="-" unitRef="usd" id="ixv-45232">392,009</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" scale="0" unitRef="usd" id="ixv-45233">7,747,312</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" scale="0" sign="-" unitRef="usd" id="ixv-45234">2,076,234</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; font-style: italic; text-align: left; padding-left: 0pt">Measured at Fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Theo I SCSp</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c641" decimals="0" format="ixt:num-dot-decimal" name="mlec:ShareOfProfitOrLossMeasuredAtFairValue" scale="0" sign="-" unitRef="usd" id="ixv-45235">36,535,601</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c642" decimals="0" format="ixt:num-dot-decimal" name="mlec:ShareOfProfitOrLossMeasuredAtFairValue" scale="0" sign="-" unitRef="usd" id="ixv-45236">28,770,462</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c643" decimals="0" format="ixt:num-dot-decimal" name="mlec:ShareOfProfitOrLossMeasuredAtFairValue" scale="0" unitRef="usd" id="ixv-45237">49,785,839</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:ShareOfProfitOrLossMeasuredAtFairValue" scale="0" sign="-" unitRef="usd" id="ixv-45238">36,535,601</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="mlec:ShareOfProfitOrLossMeasuredAtFairValue" scale="0" sign="-" unitRef="usd" id="ixv-45239">28,770,462</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:ShareOfProfitOrLossMeasuredAtFairValue" scale="0" unitRef="usd" id="ixv-45240">49,785,839</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:continuation>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Bioceres Group Limited has elected to measure
the investment in associates held through Theo I SCSp at fair value through profit or loss in accordance&#160;with&#160;IFRS&#160;9.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are no significant restrictions on the ability
of the joint ventures and affiliates to transfer funds to the Group for cash dividends, or to repay loans or advances made by the Group,
except for the legal obligation to establish a legal reserve for <ix:nonFraction contextRef="c588" decimals="2" format="ixt:num-dot-decimal" name="mlec:PercentageOfProfitForObligationToLegalReserve" scale="-2" unitRef="pure" id="ixv-45241">5</ix:nonFraction>% of the profit for the year until reaching <ix:nonFraction contextRef="c588" decimals="2" format="ixt:num-dot-decimal" name="mlec:MaximumPercentageOfCapitalForObligationToLegalReserve" scale="-2" unitRef="pure" id="ixv-45242">20</ix:nonFraction>% of the capital for Argentinian
entities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="mlec:ScheduleOfSignificantJointVenturesTableTextBlock" id="ixv-37028"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Summarized financial information prepared in accordance
with International Financial Reporting Standards (&#8220;IFRS&#8221;) in relation to the significant joint ventures is presented below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Name</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Date</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Current<br/>
    assets</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Non-current<br/>
    assets</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Current<br/>
    liabilities</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Non-<br/>
    current<br/> liabilities</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Equity</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Sales</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Loss)/Profit<br/>
    of the year</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Synertech</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">06/30/2025</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-555; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-556; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-557; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-558; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-559; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-560"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-561"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; width: 16%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Industries</span></td><td style="width: 0.5%"/>
    <td style="width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">06/30/2024</span></td><td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c646" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentAssets" scale="0" unitRef="usd" id="ixv-45243">55,963,591</ix:nonFraction></span></td><td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c646" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentAssets" scale="0" unitRef="usd" id="ixv-45244">11,195,394</ix:nonFraction></span></td><td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c646" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentLiabilities" scale="0" unitRef="usd" id="ixv-45245">27,610,517</ix:nonFraction></span></td><td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c646" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentLiabilities" scale="0" unitRef="usd" id="ixv-45246">3,447,008</ix:nonFraction></span></td><td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c646" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd" id="ixv-45247">36,101,460</ix:nonFraction></span></td><td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c647" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CostOfSales" scale="0" unitRef="usd" id="ixv-45248">61,815,678</ix:nonFraction></span></td><td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c647" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" unitRef="usd" id="ixv-45249">7,236,901</ix:nonFraction></span></td><td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">S.A.</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">06/30/2023</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c648" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentAssets" scale="0" unitRef="usd" id="ixv-45250">50,602,942</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c648" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentAssets" scale="0" unitRef="usd" id="ixv-45251">12,351,672</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c648" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentLiabilities" scale="0" unitRef="usd" id="ixv-45252">30,248,685</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c648" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentLiabilities" scale="0" unitRef="usd" id="ixv-45253">3,841,374</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c648" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd" id="ixv-45254">28,864,555</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c649" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CostOfSales" scale="0" unitRef="usd" id="ixv-45255">62,798,136</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c649" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" unitRef="usd" id="ixv-45256">3,980,995</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"/><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">06/30/2025</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c650" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentAssets" scale="0" unitRef="usd" id="ixv-45257">10,733,702</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c650" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentAssets" scale="0" unitRef="usd" id="ixv-45258">17,174,010</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c650" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentLiabilities" scale="0" unitRef="usd" id="ixv-45259">9,749,928</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c650" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentLiabilities" scale="0" unitRef="usd" id="ixv-45260">8,155,954</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c650" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd" id="ixv-45261">10,001,830</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c651" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CostOfSales" scale="0" unitRef="usd" id="ixv-45262">27,931,724</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c651" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" unitRef="usd" id="ixv-45263">1,409,802</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Agrality S.A.</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">06/30/2024</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c652" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentAssets" scale="0" unitRef="usd" id="ixv-45264">22,098,808</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c652" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentAssets" scale="0" unitRef="usd" id="ixv-45265">20,002,212</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c652" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentLiabilities" scale="0" unitRef="usd" id="ixv-45266">22,984,897</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c652" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentLiabilities" scale="0" unitRef="usd" id="ixv-45267">8,640,513</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c652" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd" id="ixv-45268">10,475,610</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c653" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CostOfSales" scale="0" unitRef="usd" id="ixv-45269">22,757,410</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c653" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" unitRef="usd" id="ixv-45270">3,935,787</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">06/30/2023</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c654" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentAssets" scale="0" unitRef="usd" id="ixv-45271">14,203,372</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c654" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentAssets" scale="0" unitRef="usd" id="ixv-45272">24,832,433</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c654" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentLiabilities" scale="0" unitRef="usd" id="ixv-45273">14,591,700</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c654" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentLiabilities" scale="0" unitRef="usd" id="ixv-45274">19,382,094</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c654" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd" id="ixv-45275">5,062,012</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c655" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CostOfSales" scale="0" unitRef="usd" id="ixv-45276">20,540,979</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c655" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" unitRef="usd" id="ixv-45277">2,071,653</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Theo I SCSp</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">06/30/2025</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-562; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c656" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentAssets" scale="0" unitRef="usd" id="ixv-45278">22,755,817</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c656" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentLiabilities" scale="0" unitRef="usd" id="ixv-45279">10,642,112</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c656" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentLiabilities" scale="0" unitRef="usd" id="ixv-45280">73,674,157</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c656" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" sign="-" unitRef="usd" id="ixv-45281">61,560,452</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-563; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c657" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" sign="-" unitRef="usd" id="ixv-45282">99,549,928</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"/><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">06/30/2024</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-564; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c658" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentAssets" scale="0" unitRef="usd" id="ixv-45283">108,456,044</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c658" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentLiabilities" scale="0" unitRef="usd" id="ixv-45284">13,405,755</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c658" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentLiabilities" scale="0" unitRef="usd" id="ixv-45285">57,060,813</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c658" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd" id="ixv-45286">37,989,476</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-565; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c659" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" sign="-" unitRef="usd" id="ixv-45287">32,213,331</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">06/30/2023</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-566; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c660" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentAssets" scale="0" unitRef="usd" id="ixv-45288">135,533,950</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c660" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentLiabilities" scale="0" unitRef="usd" id="ixv-45289">11,998,548</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c660" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentLiabilities" scale="0" unitRef="usd" id="ixv-45290">55,630,592</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c660" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd" id="ixv-45291">67,904,810</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-567; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c661" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" sign="-" unitRef="usd" id="ixv-45292">10,632,802</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table></ix:nonNumeric></ix:continuation><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="fs_013"></a></div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfEntitysReportableSegmentsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory" id="ixv-37708"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><b>14.</b></td><td style="text-align: justify"><b><span style="text-decoration:underline">SEGMENT INFORMATION</span></b></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">After the BIOX deconsolidation, that took place
in June 24, 2025 the Group is organized under <span>a single operating segment, which is &#8220;science-based
food ingredients&#8221;. Operating segments are defined as components of an enterprise for which separate financial information is regularly
evaluated by the chief operating decision maker, who in the Group&#8217;s case is the Executive Team, in deciding how to allocate resources
and assess performance. The Executive Team is composed of the Chief Executive Officer (&#8220;CEO&#8221;), the Chief Financial Officer
(&#8220;CFO&#8221;) and the Chief Technology Officer (&#8220;CTO&#8221;).</span></p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 180; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">&#160;</p><div>

</div><ix:continuation continuedAt="_DisclosureOfEntitysReportableSegmentsExplanatory-c0_cont_2" id="_DisclosureOfEntitysReportableSegmentsExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>Prior to the BIOX deconsolidation,
the Executive Team evaluates the Group&#8217;s financial information and resources and assess the financial performance of these resources
as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Seed and integrated products</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The seed and integrated products segment focuses
mainly on the development and commercialization of seed technologies and products that increase yield per hectare, with a focus on the
provision of seed technologies integrated with crop protection and crop nutrition products designed to control weeds, insects or diseases,
to increase their quality characteristics, to improve nutritional value and other benefits. The segment focuses on the commercialization
of integrated products that combine <ix:nonFraction contextRef="c4" decimals="INF" format="ixt-sec:numwordsen" name="mlec:NumberOfComplementaryComponents" scale="0" unitRef="pure" id="ixv-45293">three</ix:nonFraction> complementary components biotechnological events, germplasm and seed treatments&#8212;in order
to increase crop productivity and create value for customers. While each component can increase yield independently, through an integrated
technology strategy the segment offers products that complement and integrate with each other to generate higher yields in crops.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Currently the segment generates revenue from ordinary
activities through the sale of seeds, integrated product packs, royalties and licenses charged to third parties, among others.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Crop protection</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The crop protection segment mainly includes the
development, production and marketing of high-tech adjuvants and a full range of pest control molecules and biocontrol products. Adjuvants
are used in mixtures to facilitate the application and effectiveness of active ingredients, such as insecticides, leading to better performance,
reduced usage rates and lower residue levels Insecticides and fungicides are applied to control pests and significantly reduce disease
during the germination period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The segment currently generates revenue from ordinary
activities through the sale of adjuvants, insecticides, fungicides, and baits, among others.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Crop nutrition</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The crop nutrition segment focuses mainly on the
development, production and commercialization of inoculants that allow the biological fixation of nitrogen in the crops, and of fertilizers
including biofertilizers and microgranulated fertilizers that optimize the productivity and yield of the crops.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Currently the segment generates income from ordinary
activities through the sale of inoculants, bio-inductors, biological fertilizers and microgranulated fertilizers, among others.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The measurement principles for the Group&#8217;s
segment reporting structure are based on the IFRS principles adopted in the Consolidated financial statements. Revenue generated by products
and services exchanged between segments and entities within the Group are calculated based on market prices.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Emerging solutions</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The emerging solution segment is based on providing
R&amp;D services, biotechnology capabilities and specialised expertise to facilitate the integration of technologies and product development
efforts within the Group, as well as R&amp;D services to third parties.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 181; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">&#160;</p><div>

</div><ix:continuation continuedAt="_DisclosureOfEntitysReportableSegmentsExplanatory-c0_cont_3" id="_DisclosureOfEntitysReportableSegmentsExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This segment includes revenue sources primarily
related to agro-industrial biotechnology businesses, such as those generated by the production and commercialization of industrial enzymes
and fermentation technology to convert sugars and oils into high-value molecules or compounds.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The measurement principles for the Group&#8217;s
segment reporting structure are based on the IFRS principles adopted in the Consolidated financial statements. Revenue generated by products
and services exchanged between segments and entities within the Group are calculated based on market prices.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfOperatingSegmentsExplanatory" id="ixv-37845"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following tables present information with
respect to the Group&#8217;s reporting segments:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Year ended June 30, 2025</b></p></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Seed and integrated products</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Crop protection</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Crop nutrition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Emerging solutions</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Consolidated</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Revenues from contracts with customers</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">Sale of goods and services</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c662" decimals="0" format="ixt:num-dot-decimal" name="mlec:RevenueFromSaleOfGoodsAndRenderingOfServices" scale="0" unitRef="usd" id="ixv-45294">60,535,026</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c663" decimals="0" format="ixt:num-dot-decimal" name="mlec:RevenueFromSaleOfGoodsAndRenderingOfServices" scale="0" unitRef="usd" id="ixv-45295">181,908,584</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c664" decimals="0" format="ixt:num-dot-decimal" name="mlec:RevenueFromSaleOfGoodsAndRenderingOfServices" scale="0" unitRef="usd" id="ixv-45296">76,054,689</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c665" decimals="0" format="ixt:num-dot-decimal" name="mlec:RevenueFromSaleOfGoodsAndRenderingOfServices" scale="0" unitRef="usd" id="ixv-45297">267,261</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c666" decimals="0" format="ixt:num-dot-decimal" name="mlec:RevenueFromSaleOfGoodsAndRenderingOfServices" scale="0" unitRef="usd" id="ixv-45298">318,765,560</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Royalties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c662" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromRoyalties" scale="0" unitRef="usd" id="ixv-45299">1,414,864</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-568">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-569">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-570">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c666" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromRoyalties" scale="0" unitRef="usd" id="ixv-45300">1,414,864</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Right of use licenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-571">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-572">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c664" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LicenceFeeIncome" scale="0" unitRef="usd" id="ixv-45301">13,430,824</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-573">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c666" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LicenceFeeIncome" scale="0" unitRef="usd" id="ixv-45302">13,430,824</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold">Others</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Initial recognition and changes in the fair value of biological assets at the point of harvest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c662" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets" scale="0" unitRef="usd" id="ixv-45303">1,764,863</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-574">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-575">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-576">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c666" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets" scale="0" unitRef="usd" id="ixv-45304">1,764,863</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Government grants</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-577">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-578">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-579">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c665" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromGovernmentGrants" scale="0" unitRef="usd" id="ixv-45305">3,412</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c666" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromGovernmentGrants" scale="0" unitRef="usd" id="ixv-45306">3,412</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total revenues</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c662" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="0" unitRef="usd" id="ixv-45307">63,714,753</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c663" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="0" unitRef="usd" id="ixv-45308">181,908,584</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c664" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="0" unitRef="usd" id="ixv-45309">89,485,513</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c665" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="0" unitRef="usd" id="ixv-45310">270,673</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c666" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="0" unitRef="usd" id="ixv-45311">335,379,523</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Cost of sales</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c662" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CostOfSales" scale="0" unitRef="usd" id="ixv-45312">44,727,989</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c663" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CostOfSales" scale="0" unitRef="usd" id="ixv-45313">111,888,640</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c664" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CostOfSales" scale="0" unitRef="usd" id="ixv-45314">46,808,243</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-580">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c666" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CostOfSales" scale="0" unitRef="usd" id="ixv-45315">203,424,872</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Gross profit per segment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c662" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GrossProfit" scale="0" unitRef="usd" id="ixv-45316">18,986,764</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c663" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GrossProfit" scale="0" unitRef="usd" id="ixv-45317">70,019,944</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c664" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GrossProfit" scale="0" unitRef="usd" id="ixv-45318">42,677,270</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c665" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GrossProfit" scale="0" unitRef="usd" id="ixv-45319">270,673</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c666" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GrossProfit" scale="0" unitRef="usd" id="ixv-45320">131,954,651</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">% Gross margin</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c667" decimals="2" format="ixt:num-dot-decimal" name="mlec:PercentageGrossMargin" scale="-2" unitRef="pure" id="ixv-45321">30</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c668" decimals="2" format="ixt:num-dot-decimal" name="mlec:PercentageGrossMargin" scale="-2" unitRef="pure" id="ixv-45322">38</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c669" decimals="2" format="ixt:num-dot-decimal" name="mlec:PercentageGrossMargin" scale="-2" unitRef="pure" id="ixv-45323">48</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c670" decimals="2" format="ixt:num-dot-decimal" name="mlec:PercentageGrossMargin" scale="-2" unitRef="pure" id="ixv-45324">100</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c671" decimals="2" format="ixt:num-dot-decimal" name="mlec:PercentageGrossMargin" scale="-2" unitRef="pure" id="ixv-45325">39</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Year ended June 30, 2024</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Seed and integrated products</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Crop protection</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Crop nutrition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Emerging solutions</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Consolidated</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Revenues from contracts with customers</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">Sale of goods and services</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c672" decimals="0" format="ixt:num-dot-decimal" name="mlec:RevenueFromSaleOfGoodsAndRenderingOfServices" scale="0" unitRef="usd" id="ixv-45326">94,457,404</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c673" decimals="0" format="ixt:num-dot-decimal" name="mlec:RevenueFromSaleOfGoodsAndRenderingOfServices" scale="0" unitRef="usd" id="ixv-45327">223,538,317</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c674" decimals="0" format="ixt:num-dot-decimal" name="mlec:RevenueFromSaleOfGoodsAndRenderingOfServices" scale="0" unitRef="usd" id="ixv-45328">125,558,380</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c675" decimals="0" format="ixt:num-dot-decimal" name="mlec:RevenueFromSaleOfGoodsAndRenderingOfServices" scale="0" unitRef="usd" id="ixv-45329">1,547,782</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c676" decimals="0" format="ixt:num-dot-decimal" name="mlec:RevenueFromSaleOfGoodsAndRenderingOfServices" scale="0" unitRef="usd" id="ixv-45330">445,101,883</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Royalties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c672" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromRoyalties" scale="0" unitRef="usd" id="ixv-45331">986,602</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-581">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-582">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-583">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c676" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromRoyalties" scale="0" unitRef="usd" id="ixv-45332">986,602</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Right of use licenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c672" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LicenceFeeIncome" scale="0" unitRef="usd" id="ixv-45333">1,000,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-584">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c674" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LicenceFeeIncome" scale="0" unitRef="usd" id="ixv-45334">19,287,845</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-585">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c676" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LicenceFeeIncome" scale="0" unitRef="usd" id="ixv-45335">20,287,845</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold">Others</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Initial recognition and changes in the fair value of biological assets at the point of harvest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c672" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets" scale="0" sign="-" unitRef="usd" id="ixv-45336">45,746</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-586">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-587">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-588">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c676" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets" scale="0" sign="-" unitRef="usd" id="ixv-45337">45,746</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Government grants</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-589">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-590">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-591">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c675" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromGovernmentGrants" scale="0" unitRef="usd" id="ixv-45338">197,519</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c676" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromGovernmentGrants" scale="0" unitRef="usd" id="ixv-45339">197,519</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total revenues</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c672" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="0" unitRef="usd" id="ixv-45340">96,398,260</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c673" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="0" unitRef="usd" id="ixv-45341">223,538,317</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c674" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="0" unitRef="usd" id="ixv-45342">144,846,225</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c675" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="0" unitRef="usd" id="ixv-45343">1,745,301</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c676" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="0" unitRef="usd" id="ixv-45344">466,528,103</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Cost of sales</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c672" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CostOfSales" scale="0" unitRef="usd" id="ixv-45345">66,306,974</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c673" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CostOfSales" scale="0" unitRef="usd" id="ixv-45346">143,807,301</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c674" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CostOfSales" scale="0" unitRef="usd" id="ixv-45347">68,107,537</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c675" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CostOfSales" scale="0" unitRef="usd" id="ixv-45348">1,146,516</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c676" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CostOfSales" scale="0" unitRef="usd" id="ixv-45349">279,368,328</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Gross profit per segment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c672" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GrossProfit" scale="0" unitRef="usd" id="ixv-45350">30,091,286</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c673" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GrossProfit" scale="0" unitRef="usd" id="ixv-45351">79,731,016</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c674" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GrossProfit" scale="0" unitRef="usd" id="ixv-45352">76,738,688</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c675" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GrossProfit" scale="0" unitRef="usd" id="ixv-45353">598,785</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c676" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GrossProfit" scale="0" unitRef="usd" id="ixv-45354">187,159,775</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">% Gross margin</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c677" decimals="2" format="ixt:num-dot-decimal" name="mlec:PercentageGrossMargin" scale="-2" unitRef="pure" id="ixv-45355">31</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c678" decimals="2" format="ixt:num-dot-decimal" name="mlec:PercentageGrossMargin" scale="-2" unitRef="pure" id="ixv-45356">36</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c679" decimals="2" format="ixt:num-dot-decimal" name="mlec:PercentageGrossMargin" scale="-2" unitRef="pure" id="ixv-45357">53</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c680" decimals="2" format="ixt:num-dot-decimal" name="mlec:PercentageGrossMargin" scale="-2" unitRef="pure" id="ixv-45358">34</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c681" decimals="2" format="ixt:num-dot-decimal" name="mlec:PercentageGrossMargin" scale="-2" unitRef="pure" id="ixv-45359">40</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Year ended June 30, 2023</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Seed and integrated products</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Crop protection</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Crop nutrition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Emerging solutions</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Consolidated</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Revenues from contracts with customers</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">Sale of goods and services</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c682" decimals="0" format="ixt:num-dot-decimal" name="mlec:RevenueFromSaleOfGoodsAndRenderingOfServices" scale="0" unitRef="usd" id="ixv-45360">55,360,397</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c683" decimals="0" format="ixt:num-dot-decimal" name="mlec:RevenueFromSaleOfGoodsAndRenderingOfServices" scale="0" unitRef="usd" id="ixv-45361">205,685,451</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c684" decimals="0" format="ixt:num-dot-decimal" name="mlec:RevenueFromSaleOfGoodsAndRenderingOfServices" scale="0" unitRef="usd" id="ixv-45362">157,153,024</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c685" decimals="0" format="ixt:num-dot-decimal" name="mlec:RevenueFromSaleOfGoodsAndRenderingOfServices" scale="0" unitRef="usd" id="ixv-45363">1,420,990</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c686" decimals="0" format="ixt:num-dot-decimal" name="mlec:RevenueFromSaleOfGoodsAndRenderingOfServices" scale="0" unitRef="usd" id="ixv-45364">419,619,862</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Royalties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c682" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromRoyalties" scale="0" unitRef="usd" id="ixv-45365">1,247,567</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-592">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-593">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-594">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c686" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromRoyalties" scale="0" unitRef="usd" id="ixv-45366">1,247,567</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Others</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Initial recognition and changes in the fair value of biological assets at the point of harvest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c682" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets" scale="0" unitRef="usd" id="ixv-45367">319,428</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c683" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets" scale="0" unitRef="usd" id="ixv-45368">153,460</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c684" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets" scale="0" unitRef="usd" id="ixv-45369">137,666</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-595">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c686" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets" scale="0" unitRef="usd" id="ixv-45370">610,554</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Government grants</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-596">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-597">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-598">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c685" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromGovernmentGrants" scale="0" unitRef="usd" id="ixv-45371">93,509</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c686" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromGovernmentGrants" scale="0" unitRef="usd" id="ixv-45372">93,509</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total revenues</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c682" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="0" unitRef="usd" id="ixv-45373">56,927,392</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c683" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="0" unitRef="usd" id="ixv-45374">205,838,911</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c684" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="0" unitRef="usd" id="ixv-45375">157,290,690</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c685" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="0" unitRef="usd" id="ixv-45376">1,514,499</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c686" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="0" unitRef="usd" id="ixv-45377">421,571,492</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Cost of sales</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c682" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CostOfSales" scale="0" unitRef="usd" id="ixv-45378">31,012,687</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c683" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CostOfSales" scale="0" unitRef="usd" id="ixv-45379">137,529,299</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c684" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CostOfSales" scale="0" unitRef="usd" id="ixv-45380">66,915,067</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c685" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CostOfSales" scale="0" unitRef="usd" id="ixv-45381">7,019</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c686" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CostOfSales" scale="0" unitRef="usd" id="ixv-45382">235,464,072</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Gross profit per segment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c682" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GrossProfit" scale="0" unitRef="usd" id="ixv-45383">25,914,705</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c683" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GrossProfit" scale="0" unitRef="usd" id="ixv-45384">68,309,612</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c684" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GrossProfit" scale="0" unitRef="usd" id="ixv-45385">90,375,623</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c685" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GrossProfit" scale="0" unitRef="usd" id="ixv-45386">1,507,480</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c686" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GrossProfit" scale="0" unitRef="usd" id="ixv-45387">186,107,420</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">% Gross margin</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c687" decimals="2" format="ixt:num-dot-decimal" name="mlec:PercentageGrossMargin" scale="-2" unitRef="pure" id="ixv-45388">46</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c688" decimals="2" format="ixt:num-dot-decimal" name="mlec:PercentageGrossMargin" scale="-2" unitRef="pure" id="ixv-45389">33</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c689" decimals="2" format="ixt:num-dot-decimal" name="mlec:PercentageGrossMargin" scale="-2" unitRef="pure" id="ixv-45390">57</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c690" decimals="2" format="ixt:num-dot-decimal" name="mlec:PercentageGrossMargin" scale="-2" unitRef="pure" id="ixv-45391">100</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c691" decimals="2" format="ixt:num-dot-decimal" name="mlec:PercentageGrossMargin" scale="-2" unitRef="pure" id="ixv-45392">44</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 182; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"></p><div>


</div><ix:continuation continuedAt="_DisclosureOfEntitysReportableSegmentsExplanatory-c0_cont_4" id="_DisclosureOfEntitysReportableSegmentsExplanatory-c0_cont_3"><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfProductsAndServicesExplanatory" id="ixv-38740"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-weight: bold"/><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>06/30/2023</b></span></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><b><span style="text-decoration:underline">Revenue by similar group of products or services</span></b></td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; font-weight: bold; font-style: italic; text-decoration: underline; text-align: left; padding-bottom: 1.5pt">Seed and integrated products</td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c692" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45393">61,949,890</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c693" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45394">96,444,006</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c694" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45395">56,607,954</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Seed Treatments Packs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c695" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45396">28,476,396</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c696" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45397">29,992,052</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c697" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45398">32,563,161</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Seed &amp; Royalties Payments &amp; HB4 Program</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c698" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45399">33,473,494</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c699" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45400">66,451,954</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c700" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45401">24,044,803</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; font-style: italic; text-decoration: underline; text-align: left; padding-bottom: 1.5pt">Crop protection</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c701" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45402">181,908,584</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c702" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45403">223,538,317</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c703" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45404">205,685,451</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Adjuvants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c704" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45405">56,028,937</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c705" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45406">56,634,128</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c706" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45407">52,825,245</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Seed CP Products and Services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c707" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45408">28,890,840</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c708" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45409">34,877,911</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c709" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45410">26,080,587</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Other CP Products and Services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c710" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45411">62,983,430</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c711" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45412">103,092,454</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c712" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45413">94,277,444</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Bioprotection</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c713" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45414">34,005,377</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c714" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45415">28,933,824</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c715" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45416">32,502,175</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; font-style: italic; text-decoration: underline; text-align: left; padding-bottom: 1.5pt">Crop nutrition</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c716" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45417">89,485,513</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c717" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45418">144,846,225</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c718" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45419">157,153,024</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Inoculants &amp; Biofertilizers</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c719" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45420">22,445,093</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c720" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45421">18,315,253</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c721" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45422">23,621,534</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Micro-beaded Fertilizers</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c722" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45423">56,461,771</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c723" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45424">91,786,942</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c724" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45425">90,827,714</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Biostimulants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c725" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45426">10,578,649</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c726" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45427">15,456,185</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c727" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45428">9,800,318</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Syngenta up-front fee</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-599">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c729" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45429">19,287,845</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c730" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45430">32,903,458</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; font-style: italic; text-decoration: underline; text-align: left; padding-bottom: 1.5pt">Emerging solutions</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c731" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45431">270,673</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c732" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45432">1,745,301</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c733" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45433">1,514,499</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Management expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c734" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45434">267,261</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c735" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45435">1,547,782</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c736" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45436">1,420,990</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Government grants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c737" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45437">3,412</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c738" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45438">197,519</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c739" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45439">93,509</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-decoration: underline; text-align: left; padding-bottom: 1.5pt">Total revenues</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c434" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45440">333,614,660</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c435" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45441">466,573,849</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c450" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RevenueFromContractsWithCustomers" scale="0" unitRef="usd" id="ixv-45442">420,960,938</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of the current period, geographical information
is reported by main countries and regions. LATAM refers to Latin America countries, excluding Argentina and Brazil which are reported
separately. North America includes United States of America and Canada. The EMEA region covers Europe, the Middle East and Africa. The
Group has recast the comparative figures accordingly.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfGeographicalAreasExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfGeographicalAreasExplanatory" id="ixv-39066"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Geographical information</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Argentina</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c740" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="0" unitRef="usd" id="ixv-45443">231,823,079</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c741" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="0" unitRef="usd" id="ixv-45444">348,366,339</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c742" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="0" unitRef="usd" id="ixv-45445">289,346,766</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Brazil</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c743" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="0" unitRef="usd" id="ixv-45446">17,673,809</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c744" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="0" unitRef="usd" id="ixv-45447">24,175,116</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c745" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="0" unitRef="usd" id="ixv-45448">23,690,028</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>LATAM</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c746" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="0" unitRef="usd" id="ixv-45449">23,900,621</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c747" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="0" unitRef="usd" id="ixv-45450">21,952,339</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c748" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="0" unitRef="usd" id="ixv-45451">21,044,547</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">North America</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c749" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="0" unitRef="usd" id="ixv-45452">30,107,865</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c750" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="0" unitRef="usd" id="ixv-45453">27,543,558</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c751" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="0" unitRef="usd" id="ixv-45454">30,768,912</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>EMEA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c752" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="0" unitRef="usd" id="ixv-45455">7,920,550</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c753" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="0" unitRef="usd" id="ixv-45456">21,320,535</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c754" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="0" unitRef="usd" id="ixv-45457">22,014,855</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Rest of the world</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c755" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="0" unitRef="usd" id="ixv-45458">22,188,736</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c756" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="0" unitRef="usd" id="ixv-45459">23,215,962</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c757" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="0" unitRef="usd" id="ixv-45460">34,095,830</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total revenues</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c434" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="0" unitRef="usd" id="ixv-45461">333,614,660</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c435" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="0" unitRef="usd" id="ixv-45462">466,573,849</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c450" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="0" unitRef="usd" id="ixv-45463">420,960,938</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 183; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">&#160;</p><div>

</div><ix:continuation id="_DisclosureOfEntitysReportableSegmentsExplanatory-c0_cont_4"><ix:continuation id="_DisclosureOfGeographicalAreasExplanatory-c0_cont_1"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold">Non-current assets</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 76%">Argentina</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c758" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentAssets" scale="0" unitRef="usd" id="ixv-45464">12,493,920</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c759" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentAssets" scale="0" unitRef="usd" id="ixv-45465">139,722,896</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Brazil</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-600">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c761" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentAssets" scale="0" unitRef="usd" id="ixv-45466">7,698,175</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">LATAM</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-601">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c763" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentAssets" scale="0" unitRef="usd" id="ixv-45467">1,162,654</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">North America</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c764" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentAssets" scale="0" unitRef="usd" id="ixv-45468">53,447,180</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c765" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentAssets" scale="0" unitRef="usd" id="ixv-45469">189,199,549</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">EMEA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c766" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentAssets" scale="0" unitRef="usd" id="ixv-45470">12,662,860</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c767" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentAssets" scale="0" unitRef="usd" id="ixv-45471">44,141</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Rest of the world</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-602">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c769" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentAssets" scale="0" unitRef="usd" id="ixv-45472">26,279,731</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; padding-bottom: 4pt">Total</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c436" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentAssets" scale="0" unitRef="usd" id="ixv-45473">78,603,960</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c432" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentAssets" scale="0" unitRef="usd" id="ixv-45474">364,107,146</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Property, plant and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c436" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-45475">3,345,170</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c432" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-45476">74,612,434</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Intangible assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c436" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-45477">75,258,790</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c432" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-45478">177,331,280</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1.5pt">Goodwill</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-603">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c432" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Goodwill" scale="0" unitRef="usd" id="ixv-45479">112,163,432</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Total reportable assets</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c436" decimals="0" format="ixt:num-dot-decimal" name="mlec:TotalReportableAssets" scale="0" unitRef="usd" id="ixv-45480">78,603,960</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c432" decimals="0" format="ixt:num-dot-decimal" name="mlec:TotalReportableAssets" scale="0" unitRef="usd" id="ixv-45481">364,107,146</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Total non-reportable assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c436" decimals="0" format="ixt:num-dot-decimal" name="mlec:TotalNonreportableAssets" scale="0" unitRef="usd" id="ixv-45482">126,105,586</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c432" decimals="0" format="ixt:num-dot-decimal" name="mlec:TotalNonreportableAssets" scale="0" unitRef="usd" id="ixv-45483">585,729,699</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 4pt">Total assets</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c436" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Assets" scale="0" unitRef="usd" id="ixv-45484">204,709,546</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c432" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Assets" scale="0" unitRef="usd" id="ixv-45485">949,836,845</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:continuation>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Following the Business Combination and the BIOX
deconsolidation, the Executive team will evaluate <span>the Group&#8217;s financial information and resources
and assess the financial performance of these resources on a consolidated basis on the basis of Net revenue/loss for the period.</span>&#160;</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><b>&#160;</b></p><div>

</div><div><a id="fs_014"></a></div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfFinancialRiskManagementExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfFinancialRiskManagementExplanatory" id="ixv-39406"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="padding: 0pt; width: 0"/><td style="padding: 0pt; width: 0.25in"><b>15.</b></td><td style="padding: 0pt"><b><span style="text-decoration:underline">FINANCIAL INSTRUMENTS &#8211; RISK MANAGEMENT</span></b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group is exposed to a variety of financial
risks that arise from its activities and from its use of financial instruments. This Note provides information on the Group&#8217;s exposure
to certain main risks, the Group&#8217;s objectives, policies and processes regarding the measurement and management of each risk.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group does not use derivative financial instruments
to hedge any of the above risks.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>General objectives, policies, and processes</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board of Directors has overall responsibility
for establishing and monitoring the Group&#8217;s risk management objectives and policies and, whilst retaining ultimate responsibility
for them, it has delegated the function to design and operate processes that ensure the effective implementation of the objectives and
policies to the management that periodically reports to the Board of Directors on the evolution of the risk management activities and
results. The overall objective of the Board of Directors is to set policies that seek to reduce risk as much as possible without unduly
affecting the Group&#8217;s competitiveness and flexibility.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group&#8217;s risk management policy is established
to identify and analyze the risks facing the Group, to set appropriate risk limits and controls and to monitor risks and adherence to
limits. The risks and methods for managing the risks are reviewed regularly in order to reflect changes in market conditions and the Group&#8217;s
activities. The Group, through training and management standards and procedures, aims to develop a disciplined and constructive control
environment in which all the employees understand their roles and obligations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group seeks to use suitable means of financing
to minimize the Group&#8217;s capital costs and to manage and control the Group&#8217;s financial risks effectively. There have been no
substantive changes in the Group&#8217;s exposure to financial instrument risks, its objectives, policies and processes for managing those risks
or the methods used to measure them from previous periods unless otherwise stated in this Note.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group adopted a code of ethics applicable
to its principal executive, financial and accounting officers and all employees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The principal risks and uncertainties facing the
business, set out below, do not appear in any particular order of potential materiality or probability of occurrence.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>


</div><!-- Field: Page; Sequence: 184; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">&#160;</p><div>


</div><ix:continuation continuedAt="_DisclosureOfFinancialRiskManagementExplanatory-c0_cont_2" id="_DisclosureOfFinancialRiskManagementExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Credit risk</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Credit risk is the risk of financial loss to the
Group if a customer or counterparty fails to meet its contractual obligations, which derives mainly from trade and other receivables,
as well as from cash and deposits in financial institutions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The credit risk to which the Group is exposed
is mainly defined in the Group&#8217;s accounts receivable followed by cash and cash equivalents, with the logical importance of being
able to satisfy the Group&#8217;s needs in the short term.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Trade and other receivables</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Credit risk is the risk of financial loss to the
Group if a customer or counterparty fails to meet its contractual obligations and derives mainly from trade receivables and other receivables
generated by services and product sales. The Group is also exposed to political and economic risk events, which may cause nonpayment of
local and foreign currency obligations to the Group owed by customers, partners, contractors and suppliers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group sells its products to a diverse base
of customers. Customers include multi-national and local agricultural companies, distributors, and farmers who purchase the Group&#8217;s
products. Type and class of customers may differ depending on the Group&#8217;s business segments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group&#8217;s management determines concentrations
of credit risk by periodically monitoring the credit worthiness rating of existing customers and through a monthly review of the trade
receivables&#8217; aging analysis. In monitoring the customers&#8217; credit risk, customers are grouped according to their credit characteristics.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group&#8217;s policy is to manage credit exposure
to counterparties through a process of credit rating. The Group performs credit evaluations of existing and new customers, and every new
customer is examined thoroughly regarding the quality of its credit before offering the customer transaction terms. The examination made
by the Group includes outside credit rating information, if available. Additionally, and even if there is no independent outside rating,
the Group assesses the credit quality of the customer taking into account its financial position, past experience, bank references and
other factors. A credit limit is prescribed for each customer. These limits are examined periodically. Customers that do not meet the
Group&#8217;s criteria for credit quality may do business with the Group on a prepayment basis or by furnishing collateral satisfactory
to the Group. The Group may still seek collateral and guarantees as it may consider appropriate regardless the credit profile of any customer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Cash and deposits in banks </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group is exposed to counterparty credit risk
on cash and cash equivalent balances. The Group holds cash on deposit with a number of financial institutions. The Group manages its credit
risk exposure by limiting individual deposits to clearly defined limits. The Group only deposits with high quality banks and financial
institutions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The maximum exposure to credit risk is represented
by the carrying amount of cash and cash equivalents in the statement of financial position.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Liquidity risk</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Liquidity risk is the risk that the Group will
encounter difficulty in meeting its financial obligations when they come due.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group&#8217;s approach to managing its liquidity
risk is to manage the profile of debt maturities and funding sources, maintaining sufficient cash, and ensuring the availability of funding
from an adequate amount of credit facilities. The Group&#8217;s ability to fund its existing and prospective debt requirements is managed
by maintaining diversified funding sources.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The cash flow forecast is determined at both an
entity level and consolidated level. The forecasts are reviewed by the Board of Directors in advance, enabling the Group&#8217;s cash
requirements to be anticipated. The Group examines the forecasts of its liquidity requirements in order to ascertain that there is sufficient
cash for the operating needs, including the amounts required in order to settle financial liabilities.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 185; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">&#160;</p><div>


</div><ix:continuation continuedAt="_DisclosureOfFinancialRiskManagementExplanatory-c0_cont_3" id="_DisclosureOfFinancialRiskManagementExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As explained in Note 1 &#8211; The Group&#8217;s
business reorganization and general information, in the near term, management plans to continue to focus on raising the funds necessary
to fully implement the Group&#8217;s business plan. Management believes that certain shareholders and/or investors will continue to advance
the capital required to meet the Group&#8217;s financial obligations. There is no assurance, however, that these investors and shareholders
will continue to advance capital to the Group or that the business operations will be profitable. The possibility of failure in obtaining
additional funding and the potential inability to achieve profitability raise substantial doubts about the Group&#8217;s ability to continue
as a going concern.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:MaturityAnalysisForNonderivativeFinancialLiabilities" id="ixv-39560"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table sets out the contractual maturities of financial
liabilities:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid">As of June 30, 2025</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Up to<br/> 3 months</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">3 to 12 months</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Between one and three years</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Trade and other payables</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c770" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherPayables" scale="0" unitRef="usd" id="ixv-45486">7,323,933</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-604">&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-605">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Borrowings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c773" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Borrowings" scale="0" unitRef="usd" id="ixv-45487">227,154,007</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-606">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c775" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Borrowings" scale="0" unitRef="usd" id="ixv-45488">1,348,173</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Convertible notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-607">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-608">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c778" decimals="0" format="ixt:num-dot-decimal" name="mlec:ConvertibleNotes" scale="0" unitRef="usd" id="ixv-45489">18,260,456</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Lease liability</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c779" decimals="0" format="ixt:num-dot-decimal" name="mlec:LeasingLiabilities" scale="0" unitRef="usd" id="ixv-45490">117,463</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-609">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-610">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c782" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilities" scale="0" unitRef="usd" id="ixv-45491">234,595,403</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-611">-</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c784" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilities" scale="0" unitRef="usd" id="ixv-45492">19,608,629</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid">As of June 30, 2024</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Up to <br/>
3 months</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">3 to 12 months</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Between one and three years</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Trade and other payables</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c785" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherPayables" scale="0" unitRef="usd" id="ixv-45493">107,801,065</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c786" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherPayables" scale="0" unitRef="usd" id="ixv-45494">61,136,471</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-612">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Borrowings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c788" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Borrowings" scale="0" unitRef="usd" id="ixv-45495">87,538,816</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c789" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Borrowings" scale="0" unitRef="usd" id="ixv-45496">146,971,935</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c790" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Borrowings" scale="0" unitRef="usd" id="ixv-45497">127,248,305</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Consideration for acquisition of assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-613">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c792" decimals="0" format="ixt:num-dot-decimal" name="mlec:ConsiderationForAcquisitionOfAssets" scale="0" unitRef="usd" id="ixv-45498">4,571,824</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c793" decimals="0" format="ixt:num-dot-decimal" name="mlec:ConsiderationForAcquisitionOfAssets" scale="0" unitRef="usd" id="ixv-45499">2,005,143</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Convertible notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-614">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-615">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c796" decimals="0" format="ixt:num-dot-decimal" name="mlec:ConvertibleNotes" scale="0" unitRef="usd" id="ixv-45500">80,809,686</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Lease liability</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c797" decimals="0" format="ixt:num-dot-decimal" name="mlec:LeasingLiabilities" scale="0" unitRef="usd" id="ixv-45501">738,561</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c798" decimals="0" format="ixt:num-dot-decimal" name="mlec:LeasingLiabilities" scale="0" unitRef="usd" id="ixv-45502">2,384,217</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c799" decimals="0" format="ixt:num-dot-decimal" name="mlec:LeasingLiabilities" scale="0" unitRef="usd" id="ixv-45503">8,161,359</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c800" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilities" scale="0" unitRef="usd" id="ixv-45504">196,078,442</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c801" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilities" scale="0" unitRef="usd" id="ixv-45505">215,064,447</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c802" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilities" scale="0" unitRef="usd" id="ixv-45506">218,224,493</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of June 30, 2025 and 2024, the Group had no
exposure to derivative liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Currency risk</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Foreign currency risk is the risk that the fair
value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rate. Currency on foreign exchange
risk arises when the Group enters into transactions denominated in a currency other than its functional currency.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Part of the Company&#8217;s business activities
is conducted in Argentine pesos. However, some of the subsidiaries using the Argentine peso as their functional currency also have significant
transactions denominated in U.S. dollars, mainly with respect to sales and financing activities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c803" escape="true" name="ifrs-full:DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory" id="ixv-39767"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The table below sets forth the net exposure to
currency risk as of June 30, 2025:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Net foreign currency position</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">Amount expressed in US$</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c436" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic" scale="0" unitRef="usd" id="ixv-45507">206,837,587</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Other currencies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c436" decimals="0" format="ixt:num-dot-decimal" name="mlec:OtherCurrencies" scale="0" unitRef="usd" id="ixv-45508">49,304,636</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  </table></ix:nonNumeric>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The main Argentinian subsidiaries of the Group
have changed their functional currency from Argentine Pesos to US Dollar (Note 2 &#8211; Accounting standards and basis of preparation).</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 186; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">&#160;</p><div>


</div><ix:continuation continuedAt="_DisclosureOfFinancialRiskManagementExplanatory-c0_cont_4" id="_DisclosureOfFinancialRiskManagementExplanatory-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Considering only this net currency exposure as
of June 30, 2025, if an Argentine peso/US dollar revaluation or depreciation in relation to other foreign currencies with the remaining
variables remaining constant, would have a positive or a negative impact on comprehensive income as a result of foreign exchange gains
or losses. <ix:nonNumeric contextRef="c0" continuedAt="mlec_DisclosureOfForeignExchangeRiskSensitivityAnalysistextBlock-c0_cont_1" escape="true" name="mlec:DisclosureOfForeignExchangeRiskSensitivityAnalysistextBlock" id="ixv-45509">The Company estimates that a devaluation or an appreciation of the Argentine peso against the U.S. dollar of <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="mlec:PercentageOfEstimatesThatDevaluationOrAnAppreciation" scale="-2" unitRef="pure" id="ixv-45510">20</ix:nonFraction>% during the
year ended June 30, 2025, would have resulted in the following results:</ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation id="mlec_DisclosureOfForeignExchangeRiskSensitivityAnalysistextBlock-c0_cont_1"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Estimated</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif"><b>Exchange rate variation</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(-)
    20%</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(+)
    20%</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Argentine peso amount expressed
    in US$</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic" scale="0" unitRef="usd" id="ixv-45511">51,228,445</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic" scale="0" unitRef="usd" id="ixv-45512">51,228,445</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table></ix:continuation>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Interest rate risk</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group&#8217;s financing costs may be affected
by interest rate volatility. Borrowings under the Group&#8217;s interest rate management policy may be fixed or floating rate. The Group
maintains adequate committed borrowing facilities and holds most of its financial assets primarily in cash or checks collected from customers
that are readily convertible into known amounts of cash.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group&#8217;s interest rate risk arises from
long-term borrowings. Borrowings issued at floating rates expose the Group to cash flow interest rate risk. Borrowings issued at fixed
rates expose the Group to fair value interest rate risk. The Group has not entered into derivative contracts to hedge this exposure.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group does not use derivative financial instruments
to hedge its interest rate risk exposure.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c804" escape="true" name="ifrs-full:DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory" id="ixv-39895"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group&#8217;s debt composition is set out
below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic"/><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><b><i><span style="text-decoration:underline">Carrying amount</span></i></b></td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Fixed-rate instruments</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Current financial liabilities</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c805" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentFinancialLiabilities" scale="0" unitRef="usd" id="ixv-45513">227,154,007</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c806" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentFinancialLiabilities" scale="0" unitRef="usd" id="ixv-45514">187,141,491</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Non-current financial liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c805" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentFinancialLiabilities" scale="0" unitRef="usd" id="ixv-45515">19,608,629</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c806" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentFinancialLiabilities" scale="0" unitRef="usd" id="ixv-45516">193,681,929</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c805" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="0" unitRef="usd" id="ixv-45517">246,762,636</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c806" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="0" unitRef="usd" id="ixv-45518">380,823,420</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">Variable-rate instruments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Current financial liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-616">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c808" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentFinancialLiabilities" scale="0" unitRef="usd" id="ixv-45519">47,369,260</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Non-current financial liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-617">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c808" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentFinancialLiabilities" scale="0" unitRef="usd" id="ixv-45520">14,376,062</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-618">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c808" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" scale="0" unitRef="usd" id="ixv-45521">61,745,322</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group does not use derivative financial instruments
to hedge its interest rate risk exposure.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Capital risk</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group&#8217;s objectives when managing capital
are to safeguard the Group&#8217;s ability to continue as a going concern, in order to provide returns for shareholders and benefits for
other stakeholders, and to maintain an optimal capital structure to reduce the cost of capital.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group manages its capital structure and makes
adjustments to it in the light of changes in economic conditions and the risk characteristics of the underlying assets. In order to maintain
or adjust the capital structure, the Group may adjust the amount of any dividends it could pay to shareholders, return capital to shareholders,
issue new shares, or sell assets to reduce debt.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Financial instruments by category</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following tables show additional information
required under IFRS 7 on the financial assets and liabilities recorded as of June 30, 2025 and 2024.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 187; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">&#160;</p><div>


</div><ix:continuation continuedAt="_DisclosureOfFinancialRiskManagementExplanatory-c0_cont_5" id="_DisclosureOfFinancialRiskManagementExplanatory-c0_cont_4"><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfFinancialAssetsExplanatory" id="ixv-40059"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Financial assets by category</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amortized cost</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Mandatorily measured at fair value through profit or loss</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>Financial asset</b></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c809" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalents" scale="0" unitRef="usd" id="ixv-45522">767,919</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c810" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalents" scale="0" unitRef="usd" id="ixv-45523">27,210,070</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-619">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c812" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalents" scale="0" unitRef="usd" id="ixv-45524">56,284,573</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Other financial assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c813" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherFinancialAssets" scale="0" unitRef="usd" id="ixv-45525">8,234,539</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-620">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction contextRef="c815" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherFinancialAssets" scale="0" unitRef="usd" id="ixv-45526">19,722</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c816" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherFinancialAssets" scale="0" unitRef="usd" id="ixv-45527">14,858,124</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Trade receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c817" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeReceivables" scale="0" unitRef="usd" id="ixv-45528">6,085,400</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c818" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeReceivables" scale="0" unitRef="usd" id="ixv-45529">209,007,195</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-621">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-622">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-align: left">Other receivables (*)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c821" decimals="0" format="ixt:num-dot-decimal" id="ix_47_fact" name="ifrs-full:OtherCurrentReceivables" scale="0" unitRef="usd">14,085,303</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c822" decimals="0" format="ixt:num-dot-decimal" id="ix_48_fact" name="ifrs-full:OtherCurrentReceivables" scale="0" unitRef="usd">45,342,974</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-623">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-624">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; font-weight: bold">Total</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c825" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentFinancialAssetsAtAmortisedCost" scale="0" unitRef="usd" id="ixv-45532">29,173,161</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c826" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentFinancialAssetsAtAmortisedCost" scale="0" unitRef="usd" id="ixv-45533">281,560,239</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c827" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentFinancialAssetsAtAmortisedCost" scale="0" unitRef="usd" id="ixv-45534">19,722</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c828" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentFinancialAssetsAtAmortisedCost" scale="0" unitRef="usd" id="ixv-45535">21,142,697</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><sup>&#160;</sup></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><sup>(*)</sup></td><td style="text-align: justify"><ix:footnote id="ix_10_footnote" xml:lang="en-US">Advances expenses and tax balances are not included.</ix:footnote></td>
</tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory" id="ixv-40196"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Financial liabilities by category</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amortized cost</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Mandatorily measured at fair value through profit or loss</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Financial liability</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Trade and other payables</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c829" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilities" scale="0" unitRef="usd" id="ixv-45537">7,323,933</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c830" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilities" scale="0" unitRef="usd" id="ixv-45538">156,947,744</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-625">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c832" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilities" scale="0" unitRef="usd" id="ixv-45539">11,989,792</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Borrowings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c833" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilities" scale="0" unitRef="usd" id="ixv-45540">228,502,180</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c834" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilities" scale="0" unitRef="usd" id="ixv-45541">361,759,056</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-626">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-627">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Consideration for acquisition of assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-628">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c838" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilities" scale="0" unitRef="usd" id="ixv-45542">3,852,853</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-629">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c840" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilities" scale="0" unitRef="usd" id="ixv-45543">2,724,114</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Convertible notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c841" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilities" scale="0" unitRef="usd" id="ixv-45544">18,260,456</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c842" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilities" scale="0" unitRef="usd" id="ixv-45545">80,809,686</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-630">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-631">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Lease liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c845" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilities" scale="0" unitRef="usd" id="ixv-45546">117,463</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c846" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilities" scale="0" unitRef="usd" id="ixv-45547">11,284,137</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-632">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-633">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Warrants</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-634">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-635">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonFraction contextRef="c851" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilities" scale="0" unitRef="usd" id="ixv-45548">1,211,093</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-636">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; font-weight: bold">Total</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c853" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilities" scale="0" unitRef="usd" id="ixv-45549">254,204,032</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c854" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilities" scale="0" unitRef="usd" id="ixv-45550">614,653,476</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c855" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilities" scale="0" unitRef="usd" id="ixv-45551">1,211,093</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c856" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilities" scale="0" unitRef="usd" id="ixv-45552">14,713,906</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Financial instruments measured at fair value</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Measurement of fair values</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A number of the Group&#8217;s accounting policies
and disclosures require the measurement of fair values, for both financial and non-financial assets, and financial and non-financial liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group has an established control framework
with respect to the measurement of fair values. This includes a valuation team that has overall responsibility for overseeing all significant
fair value measurements, including Level 3 fair values, and reports directly to the chief financial officer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The valuation team regularly reviews significant
unobservable inputs and valuation adjustments. If third party information, such as broker quotes or pricing services, is used to measure
fair values, then the valuation team assesses the evidence obtained from the third parties to support the conclusion that these valuations
meet the requirements of the Accounting Standards, including the level in the fair value hierarchy in which the valuations should be classified.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Significant valuation issues are reported to the
Group&#8217;s audit committee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Fair value by hierarchy</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">According to the requirements of IFRS 7, the Group
classifies each class of financial instrument valued at fair value into three levels, depending on the relevance of the judgment associated
to the assumptions used for measuring the fair value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 1 comprises financial assets and liabilities
with fair values determined by reference to quoted prices (unadjusted) in active markets for identical assets or liabilities;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 2 comprises inputs other than quoted prices
included within Level 1 that are observable for the asset or liability, either directly (i.e. as prices) or indirectly (i.e. derived from
prices);</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 3 comprises financial instruments with inputs
for estimating fair value that are not based on observable market data.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 188; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">&#160;</p><div>

</div><ix:continuation id="_DisclosureOfFinancialRiskManagementExplanatory-c0_cont_5"><ix:continuation id="_DisclosureOfFairValueOfFinancialInstrumentsExplanatory-c0_cont_1"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-weight: bold"/><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Level
    1</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Level
    2</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Level
    3</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif"><b><span style="text-decoration:underline">Measurement at fair value at 06/30/2025</span></b></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic"><span style="font-family: Times New Roman, Times, Serif">Financial assets at fair
    value</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Investments at fair value</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c857" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssetsAtFairValue" scale="0" unitRef="usd" id="ixv-45553">19,722</ix:nonFraction></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-637; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-638; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; font-style: italic; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Financial
    liabilities valued at fair value</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Warrant liability</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c860" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilitiesAtFairValue" scale="0" unitRef="usd" id="ixv-45554">181,093</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-639; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c862" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilitiesAtFairValue" scale="0" unitRef="usd" id="ixv-45555">1,030,000</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-weight: bold"/><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">Level 1</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">Level 2</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">Level 3</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><b><span style="text-decoration:underline">Measurement at fair value at 06/30/2024</span></b></td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic">Financial assets at fair value</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Mutual funds</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c863" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssetsAtFairValue" scale="0" unitRef="usd" id="ixv-45556">12,943,378</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-640">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-641">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Moolec Science SA shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c866" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssetsAtFairValue" scale="0" unitRef="usd" id="ixv-45557">2,191,286</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-642">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-643">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Investments at fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c869" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssetsAtFairValue" scale="0" unitRef="usd" id="ixv-45558">2,311,604</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-644">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-645">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">US Treasury bills</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c872" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssetsAtFairValue" scale="0" unitRef="usd" id="ixv-45559">1,993,668</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-646">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-647">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other investments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c875" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialAssetsAtFairValue" scale="0" unitRef="usd" id="ixv-45560">1,702,761</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-648">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-649">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; font-style: italic; text-align: left">Financial liabilities valued at fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Trade and other payables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-650">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c879" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilitiesAtFairValue" scale="0" unitRef="usd" id="ixv-45561">11,989,792</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-651">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Consideration for acquisition</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c881" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilitiesAtFairValue" scale="0" unitRef="usd" id="ixv-45562">2,724,114</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-652">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-653">-</div></td><td style="text-align: left">&#160;</td></tr>
  </table></ix:continuation>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Estimation of fair value</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value of marketable securities, mutual
funds and US Treasury Bills is calculated using the market approach using quoted prices in active markets for identical assets. The quoted
marked price used for financial assets held by the Group is the current bid price. These instruments are included in level 1.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group&#8217;s financial liabilities, which
were not traded in an active market, were determined using valuation techniques that maximize the use of available market information
and thus rely as little as possible on specific estimates of the entity specific estimates. If all significant inputs required to fair
value an instrument are observable, the instruments are included in level 2.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If one or more of the significant inputs is not
based on observable market data, the instruments are included in level 3.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group&#8217;s policy is to recognize transfers
between different categories of the fair value hierarchy at the time they occur or when there are changes in the circumstances that cause
the transfer. There were no transfers between levels of the fair value hierarchy. There were no changes in economic or business circumstances
affecting fair value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Financial instruments not measured at fair
value</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The financial instruments not measured at fair
value include cash and cash equivalents, trade accounts receivable, other accounts receivable, trade payables and other debts, borrowings,
financed payments and convertible notes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The carrying value of financial instruments not
measured at fair value does not differ significantly from their fair value, except for borrowings (Note 7.12).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management estimates that the carrying value of
the financial instruments measured at amortized cost approximates their fair value.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 189; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">&#160;</p><div>


</div><div><a id="fs_015"></a></div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfLeasesExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfLeasesExplanatory" id="ixv-40862"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><b>16.</b></td><td style="text-align: justify"><b><span style="text-decoration:underline">LEASES</span></b></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The right-of-use asset was initially measured
at the amount of the lease liability plus initial direct costs incurred, adjusted by pre-payments made in relation to the lease. The right-of-use
asset was measured at cost less accumulated depreciation and accumulated impairment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The lease liability was initially measured at
the present value of the lease payments payable over the lease term, discounted at the rate implicit in the lease if it can be readily
determined. If that rate cannot be readily determined, the Group uses its incremental borrowing rate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" id="ixv-40876"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The information about the right-of-use and liabilities
related with lease assets is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Right-of-use leased asset</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0pt">Book value at the beginning of the year</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c884" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RightofuseAssets" scale="0" unitRef="usd" id="ixv-45563">20,979,597</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c885" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RightofuseAssets" scale="0" unitRef="usd" id="ixv-45564">21,163,192</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Additions of the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c886" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsToRightofuseAssets" scale="0" unitRef="usd" id="ixv-45565">9,569,819</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c887" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsToRightofuseAssets" scale="0" unitRef="usd" id="ixv-45566">2,585,223</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Additions from business combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c886" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsRightofuseAssets" scale="0" unitRef="usd" id="ixv-45567">100,896</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c887" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsRightofuseAssets" scale="0" unitRef="usd" id="ixv-45568">168,988</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Disposals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c886" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DisposalsRightofuseAssets" scale="0" unitRef="usd" id="ixv-45569">680,110</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c887" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DisposalsRightofuseAssets" scale="0" unitRef="usd" id="ixv-45570">1,284,975</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Exchange differences</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c886" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" scale="0" unitRef="usd" id="ixv-45571">273,529</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c887" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" scale="0" sign="-" unitRef="usd" id="ixv-45572">1,652,831</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; padding-left: 0pt">Loss of control</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c886" decimals="0" format="ixt:num-dot-decimal" name="mlec:RightOfUseAssetLossOfControl" scale="0" sign="-" unitRef="usd" id="ixv-45573">30,142,835</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-654">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Book value at the end of the year</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c888" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RightofuseAssets" scale="0" unitRef="usd" id="ixv-45574">100,896</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c884" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RightofuseAssets" scale="0" unitRef="usd" id="ixv-45575">20,979,597</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Depreciation</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0pt">Book value at the beginning of the year/inception</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c889" decimals="0" format="ixt:num-dot-decimal" name="mlec:BookValueAtTheBeginningOfThePeriod" scale="0" unitRef="usd" id="ixv-45576">9,377,845</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c890" decimals="0" format="ixt:num-dot-decimal" name="mlec:BookValueAtTheBeginningOfThePeriod" scale="0" unitRef="usd" id="ixv-45577">7,226,617</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Depreciation of the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c889" decimals="0" format="ixt:num-dot-decimal" name="mlec:DepreciationOfThePeriod" scale="0" unitRef="usd" id="ixv-45578">5,036,703</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c890" decimals="0" format="ixt:num-dot-decimal" name="mlec:DepreciationOfThePeriod" scale="0" unitRef="usd" id="ixv-45579">3,418,956</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">Disposals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c889" decimals="0" format="ixt:num-dot-decimal" name="mlec:DisposalsDepreciation" scale="0" sign="-" unitRef="usd" id="ixv-45580">697,150</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c890" decimals="0" format="ixt:num-dot-decimal" name="mlec:DisposalsDepreciation" scale="0" sign="-" unitRef="usd" id="ixv-45581">1,092,167</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Exchange differences</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c889" decimals="0" format="ixt:num-dot-decimal" name="mlec:ExchangeDifferencesDepreciation" scale="0" unitRef="usd" id="ixv-45582">47,736</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c890" decimals="0" format="ixt:num-dot-decimal" name="mlec:ExchangeDifferencesDepreciation" scale="0" sign="-" unitRef="usd" id="ixv-45583">175,561</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 0pt">Loss of control</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c891" decimals="0" format="ixt:num-dot-decimal" name="mlec:LossOfControlDepreciation" scale="0" sign="-" unitRef="usd" id="ixv-45584">13,765,134</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-655">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Accumulated depreciation at the end of the year</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-656">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c890" decimals="0" format="ixt:num-dot-decimal" name="mlec:AccumulatedDepreciationAtTheEndOfThePeriod" scale="0" unitRef="usd" id="ixv-45585">9,377,845</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 0pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-45586">100,896</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-45587">11,601,752</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:nonNumeric><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>




</div><!-- Field: Page; Sequence: 190; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">&#160;</p><div>

</div><ix:continuation id="_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory-c0_cont_1"><ix:continuation id="_DisclosureOfLeasesExplanatory-c0_cont_1"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Lease Liabilities</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Book value at the beginning of the year/inception</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="mlec:LeaseLiabilityBeginningOfTheYearinception" scale="0" unitRef="usd" id="ixv-45588">11,284,137</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="mlec:LeaseLiabilityBeginningOfTheYearinception" scale="0" unitRef="usd" id="ixv-45589">13,889,223</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Additions of the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="mlec:LeaseLiabiltyAdditionsOfTheYear" scale="0" unitRef="usd" id="ixv-45590">9,569,819</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="mlec:LeaseLiabiltyAdditionsOfTheYear" scale="0" unitRef="usd" id="ixv-45591">2,585,223</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Additions from business combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:AdditionsToLeaseLiabilityFromBusinessCombination" scale="0" unitRef="usd" id="ixv-45592">117,463</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="mlec:AdditionsToLeaseLiabilityFromBusinessCombination" scale="0" unitRef="usd" id="ixv-45593">168,988</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Interest expenses, exchange differences and inflation effects</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:LeaseLiabilitiesInterestExpenseExchangeDifferencesAndInflationEffects" scale="0" unitRef="usd" id="ixv-45594">1,059,412</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="mlec:LeaseLiabilitiesInterestExpenseExchangeDifferencesAndInflationEffects" scale="0" sign="-" unitRef="usd" id="ixv-45595">480,189</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Payments of the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="mlec:PaymentsOfThePeriodLeaseliability" scale="0" sign="-" unitRef="usd" id="ixv-45596">5,501,387</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="mlec:PaymentsOfThePeriodLeaseliability" scale="0" sign="-" unitRef="usd" id="ixv-45597">4,879,108</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Loss of control</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:LossOfControlLeaseLiability" scale="0" sign="-" unitRef="usd" id="ixv-45598">16,411,981</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-657">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:TotalLeaseLiabilities" scale="0" unitRef="usd" id="ixv-45599">117,463</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="mlec:TotalLeaseLiabilities" scale="0" unitRef="usd" id="ixv-45600">11,284,137</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Lease Liabilities</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%">Current</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentLeaseLiabilities" scale="0" unitRef="usd" id="ixv-45601">117,463</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentLeaseLiabilities" scale="0" unitRef="usd" id="ixv-45602">3,122,778</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Non-current</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-658">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentLeaseLiabilities" scale="0" unitRef="usd" id="ixv-45603">8,161,359</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LeaseLiabilities" scale="0" unitRef="usd" id="ixv-45604">117,463</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LeaseLiabilities" scale="0" unitRef="usd" id="ixv-45605">11,284,137</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Machinery and equipment</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-659">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c894" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Machinery" scale="0" unitRef="usd" id="ixv-45606">3,655,741</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Vehicles</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-660">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c896" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Vehicles" scale="0" unitRef="usd" id="ixv-45607">1,272,071</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Equipment and computer software</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-661">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c898" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ComputerSoftware" scale="0" unitRef="usd" id="ixv-45608">1,130,541</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Land and buildings</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c899" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LandAndBuildings" scale="0" unitRef="usd" id="ixv-45609">100,896</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c900" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LandAndBuildings" scale="0" unitRef="usd" id="ixv-45610">14,921,244</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c888" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-45611">100,896</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c884" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd" id="ixv-45612">20,979,597</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:continuation></ix:continuation><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 191; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">&#160;</p><div>


</div><div><a id="fs_016"></a></div><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfRelatedPartyExplanatory" id="ixv-41347"><ix:continuation continuedAt="_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory-c0_cont_2" id="_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory-c0_cont_1"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><b>17.</b></td><td style="text-align: justify"><b><span style="text-decoration:underline">SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND
TRANSACTIONS</span></b></td>
</tr></table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended June 30, 2025, the transactions
between the Group and related parties, and the related balances owed by and to them for the year ended June 30, 2025, 2024 and 2023 are
as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation id="_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory-c0_cont_2"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Value of transactions for the year ended</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid">Party</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Transaction type</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 30%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 33%; text-align: left">Sales of goods and services</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c901" decimals="0" format="ixt:num-dot-decimal" name="mlec:ValueOfTransactionsForThePeriodEnded" scale="0" unitRef="usd" id="ixv-45613">4,033,811</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c902" decimals="0" format="ixt:num-dot-decimal" name="mlec:ValueOfTransactionsForThePeriodEnded" scale="0" unitRef="usd" id="ixv-45614">952,742</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c903" decimals="0" format="ixt:num-dot-decimal" name="mlec:ValueOfTransactionsForThePeriodEnded" scale="0" unitRef="usd" id="ixv-45615">739,651</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Joint ventures and associates</td><td>&#160;</td>
    <td style="text-align: left">Purchases of goods and services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c904" decimals="0" format="ixt:num-dot-decimal" name="mlec:ValueOfTransactionsForThePeriodEnded" scale="0" sign="-" unitRef="usd" id="ixv-45616">24,061,563</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c905" decimals="0" format="ixt:num-dot-decimal" name="mlec:ValueOfTransactionsForThePeriodEnded" scale="0" sign="-" unitRef="usd" id="ixv-45617">500,704</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c906" decimals="0" format="ixt:num-dot-decimal" name="mlec:ValueOfTransactionsForThePeriodEnded" scale="0" sign="-" unitRef="usd" id="ixv-45618">738,652</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">Net loans granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c907" decimals="0" format="ixt:num-dot-decimal" name="mlec:ValueOfTransactionsForThePeriodEnded" scale="0" unitRef="usd" id="ixv-45619">7,645,504</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c908" decimals="0" format="ixt:num-dot-decimal" name="mlec:ValueOfTransactionsForThePeriodEnded" scale="0" unitRef="usd" id="ixv-45620">13,005,841</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c909" decimals="0" format="ixt:num-dot-decimal" name="mlec:ValueOfTransactionsForThePeriodEnded" scale="0" unitRef="usd" id="ixv-45621">7,141,471</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">Interest gain</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c910" decimals="0" format="ixt:num-dot-decimal" name="mlec:ValueOfTransactionsForThePeriodEnded" scale="0" unitRef="usd" id="ixv-45622">944,186</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c911" decimals="0" format="ixt:num-dot-decimal" name="mlec:ValueOfTransactionsForThePeriodEnded" scale="0" unitRef="usd" id="ixv-45623">135,485</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c912" decimals="0" format="ixt:num-dot-decimal" name="mlec:ValueOfTransactionsForThePeriodEnded" scale="0" unitRef="usd" id="ixv-45624">212,407</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">Net loans received</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-662">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c914" decimals="0" format="ixt:num-dot-decimal" name="mlec:ValueOfTransactionsForThePeriodEnded" scale="0" sign="-" unitRef="usd" id="ixv-45625">1,860,058</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c915" decimals="0" format="ixt:num-dot-decimal" name="mlec:ValueOfTransactionsForThePeriodEnded" scale="0" sign="-" unitRef="usd" id="ixv-45626">1,854,680</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">Puttable instruments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-663">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-664">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c918" decimals="0" format="ixt:num-dot-decimal" name="mlec:ValueOfTransactionsForThePeriodEnded" scale="0" unitRef="usd" id="ixv-45627">4,399,631</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">Net loans granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-665">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c920" decimals="0" format="ixt:num-dot-decimal" name="mlec:ValueOfTransactionsForThePeriodEnded" scale="0" unitRef="usd" id="ixv-45628">28,299</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c921" decimals="0" format="ixt:num-dot-decimal" name="mlec:ValueOfTransactionsForThePeriodEnded" scale="0" unitRef="usd" id="ixv-45629">19,049</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">Preference shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c922" decimals="0" format="ixt:num-dot-decimal" name="mlec:ValueOfTransactionsForThePeriodEnded" scale="0" sign="-" unitRef="usd" id="ixv-45630">15,000,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-666">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-667">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">Interest expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-668">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c926" decimals="0" format="ixt:num-dot-decimal" name="mlec:ValueOfTransactionsForThePeriodEnded" scale="0" sign="-" unitRef="usd" id="ixv-45631">2,425,703</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c927" decimals="0" format="ixt:num-dot-decimal" name="mlec:ValueOfTransactionsForThePeriodEnded" scale="0" sign="-" unitRef="usd" id="ixv-45632">956,873</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Shareholders and other related parties</td><td>&#160;</td>
    <td style="text-align: left">Own shares held by subsidiaries</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-669">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c929" decimals="0" format="ixt:num-dot-decimal" name="mlec:ValueOfTransactionsForThePeriodEnded" scale="0" sign="-" unitRef="usd" id="ixv-45633">444,473</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c930" decimals="0" format="ixt:num-dot-decimal" name="mlec:ValueOfTransactionsForThePeriodEnded" scale="0" sign="-" unitRef="usd" id="ixv-45634">133,079</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">In-kind contributions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c931" decimals="0" format="ixt:num-dot-decimal" name="mlec:ValueOfTransactionsForThePeriodEnded" scale="0" unitRef="usd" id="ixv-45635">4,343,549</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c932" decimals="0" format="ixt:num-dot-decimal" name="mlec:ValueOfTransactionsForThePeriodEnded" scale="0" unitRef="usd" id="ixv-45636">2,409,244</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c933" decimals="0" format="ixt:num-dot-decimal" name="mlec:ValueOfTransactionsForThePeriodEnded" scale="0" unitRef="usd" id="ixv-45637">1,163,384</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">Sales of goods and services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c934" decimals="0" format="ixt:num-dot-decimal" name="mlec:ValueOfTransactionsForThePeriodEnded" scale="0" unitRef="usd" id="ixv-45638">3,714,441</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c935" decimals="0" format="ixt:num-dot-decimal" name="mlec:ValueOfTransactionsForThePeriodEnded" scale="0" unitRef="usd" id="ixv-45639">2,911,723</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c936" decimals="0" format="ixt:num-dot-decimal" name="mlec:ValueOfTransactionsForThePeriodEnded" scale="0" unitRef="usd" id="ixv-45640">6,565,027</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">Purchases of goods and services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c937" decimals="0" format="ixt:num-dot-decimal" name="mlec:ValueOfTransactionsForThePeriodEnded" scale="0" sign="-" unitRef="usd" id="ixv-45641">3,517,528</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c938" decimals="0" format="ixt:num-dot-decimal" name="mlec:ValueOfTransactionsForThePeriodEnded" scale="0" sign="-" unitRef="usd" id="ixv-45642">1,998,349</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c939" decimals="0" format="ixt:num-dot-decimal" name="mlec:ValueOfTransactionsForThePeriodEnded" scale="0" sign="-" unitRef="usd" id="ixv-45643">2,334,556</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">Salaries, social security benefits and other benefits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c940" decimals="0" format="ixt:num-dot-decimal" name="mlec:ValueOfTransactionsForThePeriodEnded" scale="0" sign="-" unitRef="usd" id="ixv-45644">2,494,538</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c941" decimals="0" format="ixt:num-dot-decimal" name="mlec:ValueOfTransactionsForThePeriodEnded" scale="0" sign="-" unitRef="usd" id="ixv-45645">2,496,073</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c942" decimals="0" format="ixt:num-dot-decimal" name="mlec:ValueOfTransactionsForThePeriodEnded" scale="0" sign="-" unitRef="usd" id="ixv-45646">1,995,361</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Key management personnel</td><td>&#160;</td>
    <td style="text-align: left">Sales and services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c943" decimals="0" format="ixt:num-dot-decimal" name="mlec:ValueOfTransactionsForThePeriodEnded" scale="0" unitRef="usd" id="ixv-45647">367,928</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-670">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-671">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">Purchases of goods and services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c946" decimals="0" format="ixt:num-dot-decimal" name="mlec:ValueOfTransactionsForThePeriodEnded" scale="0" sign="-" unitRef="usd" id="ixv-45648">3,079,070</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-672">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-673">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left; padding-bottom: 1.5pt">Stock options-based incentives</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c949" decimals="0" format="ixt:num-dot-decimal" name="mlec:ValueOfTransactionsForThePeriodEnded" scale="0" sign="-" unitRef="usd" id="ixv-45649">480,450</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c950" decimals="0" format="ixt:num-dot-decimal" name="mlec:ValueOfTransactionsForThePeriodEnded" scale="0" sign="-" unitRef="usd" id="ixv-45650">8,181,849</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c951" decimals="0" format="ixt:num-dot-decimal" name="mlec:ValueOfTransactionsForThePeriodEnded" scale="0" sign="-" unitRef="usd" id="ixv-45651">1,868,430</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Total</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="mlec:ValueOfTransactionsForThePeriodEnded" scale="0" sign="-" unitRef="usd" id="ixv-45652">27,583,730</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="mlec:ValueOfTransactionsForThePeriodEnded" scale="0" unitRef="usd" id="ixv-45653">1,536,125</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c47" decimals="0" format="ixt:num-dot-decimal" name="mlec:ValueOfTransactionsForThePeriodEnded" scale="0" unitRef="usd" id="ixv-45654">10,358,989</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amounts receivable from<br/>
 related parties</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Party</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Transaction type</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 30%; text-align: left">Joint ventures and associates</td><td style="width: 1%">&#160;</td>
    <td style="width: 45%; text-align: left">Trade debtors</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c952" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherReceivablesDueFromRelatedParties" scale="0" unitRef="usd" id="ixv-45655">1,565,913</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c953" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherReceivablesDueFromRelatedParties" scale="0" unitRef="usd" id="ixv-45656">2,176,622</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">Other receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c954" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherReceivablesDueFromRelatedParties" scale="0" unitRef="usd" id="ixv-45657">11,211,902</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c955" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherReceivablesDueFromRelatedParties" scale="0" unitRef="usd" id="ixv-45658">37,586,012</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Shareholders and other related parties</td><td>&#160;</td>
    <td style="text-align: left">Trade debtors</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-674">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c957" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherReceivablesDueFromRelatedParties" scale="0" unitRef="usd" id="ixv-45659">37</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">Loans receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c958" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherReceivablesDueFromRelatedParties" scale="0" unitRef="usd" id="ixv-45660">2,295,774</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-675">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left; padding-bottom: 1.5pt">Other receivables</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c960" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherReceivablesDueFromRelatedParties" scale="0" unitRef="usd" id="ixv-45661">17,405</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c961" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherReceivablesDueFromRelatedParties" scale="0" unitRef="usd" id="ixv-45662">47,348</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherReceivablesDueFromRelatedParties" scale="0" unitRef="usd" id="ixv-45663">15,090,994</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherReceivablesDueFromRelatedParties" scale="0" unitRef="usd" id="ixv-45664">39,810,019</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 52.5pt">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amounts payable to<br/>
 related parties</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Party</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Transaction type</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 30%; text-align: left">Joint ventures and associates</td><td style="width: 1%">&#160;</td>
    <td style="width: 45%; text-align: left">Trade creditors</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c962" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherPayablesToRelatedParties" scale="0" unitRef="usd" id="ixv-45665">620,034</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c963" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherPayablesToRelatedParties" scale="0" unitRef="usd" id="ixv-45666">52,778,206</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">Convertible notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c964" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherPayablesToRelatedParties" scale="0" unitRef="usd" id="ixv-45667">7,102,028</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-676">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">Net loans payables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c966" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherPayablesToRelatedParties" scale="0" unitRef="usd" id="ixv-45668">10,303,098</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c967" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherPayablesToRelatedParties" scale="0" unitRef="usd" id="ixv-45669">1,860,058</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Shareholders and other related parties</td><td>&#160;</td>
    <td style="text-align: left">Trade creditors</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-677">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c969" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherPayablesToRelatedParties" scale="0" unitRef="usd" id="ixv-45670">37,985</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c970" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherPayablesToRelatedParties" scale="0" unitRef="usd" id="ixv-45671">1,030,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-678">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">Preference shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c972" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherPayablesToRelatedParties" scale="0" unitRef="usd" id="ixv-45672">15,739,726</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-679">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Key management personnel</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left; padding-bottom: 1.5pt">Salaries, social security benefits and other benefits</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c940" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherPayablesToRelatedParties" scale="0" unitRef="usd" id="ixv-45673">41,620</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c941" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherPayablesToRelatedParties" scale="0" unitRef="usd" id="ixv-45674">226,702</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherPayablesToRelatedParties" scale="0" unitRef="usd" id="ixv-45675">34,836,506</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherPayablesToRelatedParties" scale="0" unitRef="usd" id="ixv-45676">54,902,951</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
  </table></ix:continuation></ix:nonNumeric><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 52.5pt"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 52.5pt"></p><div>

</div><!-- Field: Page; Sequence: 192; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">&#160;</p><div>


</div><div><a id="fs_017"></a></div><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory" id="ixv-41943"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><b>18.</b></td><td style="text-align: justify"><b><span style="text-decoration:underline">KEY MANAGEMENT PERSONNEL COMPENSATION</span></b></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Key management personnel are those persons having
authority and responsibility for planning, directing and controlling the activities of the Group.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="mlec:DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock" id="ixv-41956"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The compensation of directors and other members
of key management personnel, including social contributions and other benefits, were as follows for the year ended June 30, 2025, 2024
and 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Short-term employee benefits</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits" scale="0" unitRef="usd" id="ixv-45677">2,494,538</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits" scale="0" unitRef="usd" id="ixv-45678">2,496,073</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits" scale="0" unitRef="usd" id="ixv-45679">1,995,361</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Share based payment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment" scale="0" unitRef="usd" id="ixv-45680">480,450</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment" scale="0" unitRef="usd" id="ixv-45681">8,181,849</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment" scale="0" unitRef="usd" id="ixv-45682">1,868,430</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:KeyManagementPersonnelCompensation" scale="0" unitRef="usd" id="ixv-45683">2,974,988</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:KeyManagementPersonnelCompensation" scale="0" unitRef="usd" id="ixv-45684">10,677,922</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:KeyManagementPersonnelCompensation" scale="0" unitRef="usd" id="ixv-45685">3,863,791</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group entered into indemnification agreements
with each of its directors and executive officers. These agreements generally provide that the relevant director or officer will be indemnified
by the Group to the fullest extent permitted by law against liability and against all expenses reasonably incurred or paid by him or her
in connection with any claim, action, suit or proceeding which he or she becomes involved as a party or otherwise by virtue of his or
her being or having been such a director or officer of the Group and against amounts paid or incurred by him or her in the settlement
thereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The agreements are subject to certain exceptions,
including that no indemnification will be provided to any director or officer against any liability to the Group or its shareholder (i)
by reason of intentional fraudulent conduct, dishonesty, willful misconduct, or gross negligence on the part of the director or officer;
or (ii) by reason of payment made under an insurance policy or any third party that has no recourse against the indemnitee director or
officer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The compensation of key executives is determined
by the Board of Directors of Moolec Science SA, Bioceres Group Limited, Bioceres S.A. and Bioceres Crop Solutions Corp., based on the
performance of individuals and market trends.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Moolec Science SA currently does not pay any compensation
to any of its executive board members.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="fs_018"></a></div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfSharebasedPaymentArrangementsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory" id="ixv-42026"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><b>19.</b></td><td style="text-align: justify"><b><span style="text-decoration:underline">SHARE-BASED PAYMENT</span></b></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>19.1 <span style="text-decoration:underline">Bioceres S.A share based payments</span></b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prior to the Business Combination and the BIOX
deconsolidation, and in accordance with the compensation policy defined previously by the Bioceres Group Limited and its subsidiaries,
certain directors of Bioceres S.A. had the option of choosing to collect the annual incentive in cash or in shares of BIOX. The incentive
was for up to five times the monthly salary of each one and increases by $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:ShareBasedPaymentsIncentiveIncreases" scale="0" unitRef="usd" id="ixv-45686">30,000</ix:nonFraction> in the event that they choose to receive the incentive
in the form of shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of June 30, 2023 <ix:nonFraction contextRef="c974" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" scale="0" unitRef="pure" id="ixv-45687">8,560</ix:nonFraction> of Bioceres Crop Solutions Corp, were assigned
to the beneficiaries, which were granted immediately in recognition of the professional performance demonstrated during the year.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 193; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">&#160;</p><div>


</div><ix:continuation continuedAt="_DisclosureOfSharebasedPaymentArrangementsExplanatory-c0_cont_2" id="_DisclosureOfSharebasedPaymentArrangementsExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Additionally, in January 2024, in compliance with
the resolution in Minute No. 256 of the Board Meeting held in December 2021, it was decided to grant the Bioceres 2021 Award. It consists
of <ix:nonFraction contextRef="c975" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" scale="0" unitRef="pure" id="ixv-45688">10,000</ix:nonFraction> shares of Bioceres Crops Solutions Corp for Dr. L&#237;a Raquel Chan, a researcher at CONICET, in recognition of her leadership
in the early development of HB4 technology.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">After the latest grant in January 2024, no incentives were awarded.
As of June 30, 2025 there is no outstanding annual incentive pending to be granted.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>19.2 <span style="text-decoration:underline">Bioceres Crop Solutions Corp share based payments</span></b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>2023 Omnibus Equity Incentive Plan</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 12, 2023, the board of directors of Bioceres
Crop Solutions Corp approved the 2023 Omnibus Equity Incentive Plan to attract and retain the best available personnel, provide additional
incentives to employees, directors and consultants and to promote the success of the Company&#8217;s business. In addition to introducing
new incentive plans, it comprehensively amends and restates in entirety (i) the Employee Stock Purchase Plan, (ii) the Equity Compensation
Plan, (iii) the Stand-Alone Stock Option Grant, and (iv) the Employee Stock Option Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">-</span></td><td style="text-align: justify">Employee Stock Purchase Plan (&#8220;ESPP&#8221;): incentive
plan for eligible employees with no stock compensation to purchase ordinary shares of BIOX up to a maximum of <ix:nonFraction contextRef="c976" decimals="2" format="ixt:num-dot-decimal" name="mlec:IfrsDefinedContributionPlanEmployerMatchingContributionPercentOfEmployeesGrossPay" scale="-2" unitRef="pure" id="ixv-45689">15</ix:nonFraction>% percent of such employee&#8217;s
monthly compensation. The number of ordinary shares subject to the ESPP shall be <ix:nonFraction contextRef="c977" decimals="INF" format="ixt:num-dot-decimal" name="mlec:SharesSubjectToEmployeeStockPurchasePlan" scale="0" unitRef="shares" id="ixv-45690">200,000</ix:nonFraction> ordinary shares. The purchase price will be
equal to <ix:nonFraction contextRef="c976" decimals="2" format="ixt:num-dot-decimal" name="mlec:PercentageOfClosingPriceOnFirstAndLastBusinessDayToDeterminePurchasePrice" scale="-2" unitRef="pure" id="ixv-45691">85</ix:nonFraction>% of the lower of the closing price of BIOX&#8217;s ordinary shares on the first business day and the last business day of
the relevant offering period. As of the date of these consolidated financial statements the ESSP is not yet implemented.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">-</span></td><td style="text-align: justify">Equity Compensation Plan: annual incentive plan based on
certain financial and operational targets defined by the Board of Directors upon approval of the annual budget.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">-</span></td><td style="text-align: justify">Stand Alone Stock Option Grant: plan granted up to <ix:nonFraction contextRef="c978" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" scale="0" unitRef="pure" id="ixv-45692">1,200,000</ix:nonFraction>
underlying ordinary shares. The options have an exercise price of $<ix:nonFraction contextRef="c979" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ExercisePriceShareOptionsGranted2019" scale="0" unitRef="usdPershares" id="ixv-45693">4.55</ix:nonFraction> and expire on <ix:nonNumeric contextRef="c978" format="ixt:date-monthname-day-year-en" name="mlec:ShareBasedPaymentAwardExpirationDate" id="ixv-45694">October 31, 2029</ix:nonNumeric>. Options can be exercised for
a period of up to <ix:nonNumeric contextRef="c978" format="ixt-sec:durwordsen" name="mlec:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod" id="ixv-45695">three years</ix:nonNumeric>, with 1/3 vesting every 12 months, and on a cashless basis at their volume weighted average price (&#8220;VWAP&#8221;)
of the ordinary shares during a <ix:nonNumeric contextRef="c978" format="ixt-sec:durwordsen" name="mlec:ShareBasedPaymentPeriodOfWeightedAveragePriceVwapOfOrdinarySharesForCashlessBasisExercise" id="ixv-45696">twenty-day</ix:nonNumeric> period to the date of exercise.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">-</span></td><td style="text-align: justify">Employee Stock Option Plan: plan granted up to <ix:nonFraction contextRef="c980" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" scale="0" unitRef="pure" id="ixv-45697">100,000</ix:nonFraction> underlying
ordinary shares to certain key employees. The options have an exercise price of $<ix:nonFraction contextRef="c981" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ExercisePriceShareOptionsGranted2019" scale="0" unitRef="usdPershares" id="ixv-45698">5.55</ix:nonFraction> and expire on <ix:nonNumeric contextRef="c982" format="ixt:date-monthname-day-year-en" name="mlec:ShareBasedPaymentAwardExpirationDate" id="ixv-45699">October 23, 2030</ix:nonNumeric>. Options can be
exercised for a period of up to <ix:nonNumeric contextRef="c980" format="ixt-sec:durwordsen" name="mlec:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod" id="ixv-45700">three years</ix:nonNumeric>, with 1/3 vesting every 12 months, and on a cashless basis at their volume weighted average
price (&#8220;VWAP&#8221;) of the ordinary shares during a <ix:nonNumeric contextRef="c980" format="ixt-sec:durwordsen" name="mlec:ShareBasedPaymentPeriodOfWeightedAveragePriceVwapOfOrdinarySharesForCashlessBasisExercise" id="ixv-45701">twenty-day</ix:nonNumeric> period to the date of exercise.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">-</span></td><td style="text-align: justify"><span style="font-size: 10pt">Past Share Option plan: immediately
vested options with a strike price between $<ix:nonFraction contextRef="c983" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ExercisePriceShareOptionsGranted2019" scale="0" unitRef="usdPershares" id="ixv-45702">11.93</ix:nonFraction> and $<ix:nonFraction contextRef="c984" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ExercisePriceShareOptionsGranted2019" scale="0" unitRef="usdPershares" id="ixv-45703">13.24</ix:nonFraction>.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">-</span></td><td style="text-align: justify"><span style="font-size: 10pt">Base Share Option plan: to
vest and become exercisable in equal installments on June 30, 2023, June 30, 2024, and June 30, 2025, with a strike price between $<ix:nonFraction contextRef="c985" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ExercisePriceShareOptionsGranted2019" scale="0" unitRef="usdPershares" id="ixv-45704"><ix:nonFraction contextRef="c986" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ExercisePriceShareOptionsGranted2019" scale="0" unitRef="usdPershares" id="ixv-45705"><ix:nonFraction contextRef="c987" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ExercisePriceShareOptionsGranted2019" scale="0" unitRef="usdPershares" id="ixv-45706">10.47</ix:nonFraction></ix:nonFraction></ix:nonFraction>
and $<ix:nonFraction contextRef="c988" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ExercisePriceShareOptionsGranted2019" scale="0" unitRef="usdPershares" id="ixv-45707"><ix:nonFraction contextRef="c989" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ExercisePriceShareOptionsGranted2019" scale="0" unitRef="usdPershares" id="ixv-45708"><ix:nonFraction contextRef="c990" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ExercisePriceShareOptionsGranted2019" scale="0" unitRef="usdPershares" id="ixv-45709">10.79</ix:nonFraction></ix:nonFraction></ix:nonFraction>.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">-</span></td><td style="text-align: justify"><span style="font-size: 10pt">Performance Share Option plan:
to vest and become exercisable if the Group&#8217;s fiscal year 2025 EBITDA reaches at least US$<ix:nonFraction contextRef="c991" decimals="-6" format="ixt:num-dot-decimal" name="mlec:ThresholdEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="6" unitRef="usd" id="ixv-45710">120</ix:nonFraction> million, at <ix:nonFraction contextRef="c992" decimals="2" format="ixt:num-dot-decimal" name="mlec:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage" scale="-2" unitRef="pure" id="ixv-45711">0</ix:nonFraction>% of the award, and
linearly thereafter up to <ix:nonFraction contextRef="c993" decimals="2" format="ixt:num-dot-decimal" name="mlec:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage" scale="-2" unitRef="pure" id="ixv-45712">100</ix:nonFraction>% of the awarded options when reaching at least US$<ix:nonFraction contextRef="c994" decimals="-6" format="ixt:num-dot-decimal" name="mlec:ThresholdEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="6" unitRef="usd" id="ixv-45713">150</ix:nonFraction> million. These options have also a strike price of
between $<ix:nonFraction contextRef="c995" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ExercisePriceShareOptionsGranted2019" scale="0" unitRef="usdPershares" id="ixv-45714">10.47</ix:nonFraction> and $<ix:nonFraction contextRef="c996" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ExercisePriceShareOptionsGranted2019" scale="0" unitRef="usdPershares" id="ixv-45715">10.79</ix:nonFraction>.</span></td>
</tr></table></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 194; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">&#160;</p><div>

</div><ix:continuation id="_DisclosureOfSharebasedPaymentArrangementsExplanatory-c0_cont_2"><ix:nonNumeric contextRef="c0" escape="true" name="mlec:DisclosureOfFairValueOfTheStockOptionsAtTheGrantDateTextBlock" id="ixv-42195"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value of the stock options at the grant
date was estimated using the &#8220;Black-Scholes&#8221; model, considering the terms and conditions under which the options on shares were
granted and adjusted to consider the possible dilutive effect of the future exercise of options.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">&#160;</p>


<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid">Factor</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Stand Alone Stock Option Grant</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Employee Stock Option Plan</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Past Share Option plan</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Base Share Option plan</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Performance Share Option plan</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: justify; padding-left: 0pt">Weighted average fair value of shares</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c999" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" scale="0" unitRef="usdPershares" id="ixv-45716">5.42</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c1000" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" scale="0" unitRef="usdPershares" id="ixv-45717">13.98</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c1001" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" scale="0" unitRef="usdPershares" id="ixv-45718">11.45</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c1002" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" scale="0" unitRef="usdPershares" id="ixv-45719">10.80</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c1003" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" scale="0" unitRef="usdPershares" id="ixv-45720">10.79</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; padding-left: 0pt">Weighted average exercise price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c999" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ExercisePriceShareOptionsGranted2019" scale="0" unitRef="usdPershares" id="ixv-45721">4.55</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c1000" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ExercisePriceShareOptionsGranted2019" scale="0" unitRef="usdPershares" id="ixv-45722">5.55</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c1001" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ExercisePriceShareOptionsGranted2019" scale="0" unitRef="usdPershares" id="ixv-45723">12.48</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c1002" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ExercisePriceShareOptionsGranted2019" scale="0" unitRef="usdPershares" id="ixv-45724">10.52</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c1003" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ExercisePriceShareOptionsGranted2019" scale="0" unitRef="usdPershares" id="ixv-45725">10.52</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0pt">Weighted average expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c999" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" scale="-2" unitRef="pure" id="ixv-45726">29.69</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1000" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" scale="-2" unitRef="pure" id="ixv-45727">42.18</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1001" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" scale="-2" unitRef="pure" id="ixv-45728">48.73</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1002" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" scale="-2" unitRef="pure" id="ixv-45729">54.73</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1003" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" scale="-2" unitRef="pure" id="ixv-45730">54.73</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; padding-left: 0pt">Dividend rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c999" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" scale="-2" unitRef="pure" id="ixv-45731">0</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1000" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" scale="-2" unitRef="pure" id="ixv-45732">0</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1001" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" scale="-2" unitRef="pure" id="ixv-45733">0</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1002" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" scale="-2" unitRef="pure" id="ixv-45734">0</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1003" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" scale="-2" unitRef="pure" id="ixv-45735">0</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0pt">Weighted average risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c999" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" scale="-2" unitRef="pure" id="ixv-45736">1.66</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1000" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" scale="-2" unitRef="pure" id="ixv-45737">1.17</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1001" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" scale="-2" unitRef="pure" id="ixv-45738">4.40</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1002" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" scale="-2" unitRef="pure" id="ixv-45739">4.47</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1003" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" scale="-2" unitRef="pure" id="ixv-45740">4.47</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; padding-left: 0pt">Weighted average expected life</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt"><ix:nonFraction contextRef="c999" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" scale="0" unitRef="pure" id="ixv-45741">9.89</ix:nonFraction> years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt"><ix:nonFraction contextRef="c1000" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" scale="0" unitRef="pure" id="ixv-45742">9.22</ix:nonFraction> years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt"><ix:nonFraction contextRef="c1001" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" scale="0" unitRef="pure" id="ixv-45743">4.89</ix:nonFraction> years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt"><ix:nonFraction contextRef="c1002" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" scale="0" unitRef="pure" id="ixv-45744">2.97</ix:nonFraction> year</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt"><ix:nonFraction contextRef="c1003" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" scale="0" unitRef="pure" id="ixv-45745">2.97</ix:nonFraction> year</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: justify; padding-left: 0.125in">Weighted average fair value of stock options at measurement date</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c1004" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" scale="0" unitRef="usd" id="ixv-45746">2.47</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c1005" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" scale="0" unitRef="usd" id="ixv-45747">10.10</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c1006" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" scale="0" unitRef="usd" id="ixv-45748">5.01</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c1007" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" scale="0" unitRef="usd" id="ixv-45749">4.46</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c1008" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" scale="0" unitRef="usd" id="ixv-45750">4.45</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are no market-related performance conditions
or non-vesting conditions that should be considered for determining the fair value of options.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group estimated that nearly <ix:nonFraction contextRef="c997" decimals="2" format="ixt:num-dot-decimal" name="mlec:NumberOfOptionsEstimatedExercisePercent" scale="-2" unitRef="pure" id="ixv-45751">100</ix:nonFraction>% of the share
options will be exercised, based on historical trends of executive retention and option exercise behavior. This estimate is reviewed at
the end of each annual or interim period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>2013 Stock Incentive Plan &#8211; Pro Farm
Group</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As part of the acquisition of Pro Farm Group,
Bioceres Group Limited, through its former subsidiary, BIOX, have incorporated the outstanding &#8220;2013 Stock Incentive Plan&#8221;
from Pro Farm Group. On the merger date the total equity awards outstanding was converted consistent with the terms of the merger agreement
into an aggregate of <ix:nonFraction contextRef="c998" decimals="INF" format="ixt:num-dot-decimal" name="mlec:ShareBasedPaymentArrangementConversionOfEquityAwardsOutstandingToOptionOrRestrictedStockUnits" scale="0" unitRef="shares" id="ixv-45752">1,191,362</ix:nonFraction> option and or restricted stock units which was fully registered with the Securities and Exchange Commission
on July 26, 2022. All equity awards retained their original granted terms. BIOX has not granted any additional awards under this plan
during the year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" id="ixv-42386"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Bioceres Crop Solutions&#8217;s fair value of
the grants was estimated utilizing a Black Scholes option pricing model based on the following range of assumptions which have determined
consistent with BIOX&#8217;s historical methodology for such assumptions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">July
    12, <br/>
    2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">Exercise price</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c1009" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ExercisePriceShareOptionsGranted2019" scale="0" unitRef="usdPershares" id="ixv-45753">7.16</ix:nonFraction> - <ix:nonFraction contextRef="c1010" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ExercisePriceShareOptionsGranted2019" scale="0" unitRef="usdPershares" id="ixv-45754">204.66</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected life (years)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c1009" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" scale="0" unitRef="pure" id="ixv-45755">0.03</ix:nonFraction> - <ix:nonFraction contextRef="c1010" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" scale="0" unitRef="pure" id="ixv-45756">9.83</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Estimated volatility factor</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c1009" decimals="3" format="ixt:num-dot-decimal" name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" scale="-2" unitRef="pure" id="ixv-45757">34.9</ix:nonFraction>% - <ix:nonFraction contextRef="c1010" decimals="3" format="ixt:num-dot-decimal" name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" scale="-2" unitRef="pure" id="ixv-45758">44.4</ix:nonFraction></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; width: 88%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Risk-free
    interest rate</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c1011" decimals="3" format="ixt:num-dot-decimal" name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" scale="-2" unitRef="pure" id="ixv-45759">0.0</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected dividend yield</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-680; font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table></ix:nonNumeric>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory" id="ixv-42456"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table shows the evolution of stock
option and weighted average exercise price for the years ended June 30, 2025, and 2024:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of options</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">W.A. Exercise price</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of options</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">W.A. Exercise price</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-weight: bold; text-align: left">At the beginning of the year</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c1012" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfOutstandingShareOptions" scale="0" unitRef="pure" id="ixv-45760">7,345,795</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c1012" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" unitRef="usdPershares" id="ixv-45761">11.83</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c1013" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfOutstandingShareOptions" scale="0" unitRef="pure" id="ixv-45762">1,791,000</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c1013" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" unitRef="usdPershares" id="ixv-45763">15.79</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Granted during the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-681">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-682">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1015" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" scale="0" unitRef="pure" id="ixv-45764">5,631,894</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1015" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" scale="0" unitRef="usdPershares" id="ixv-45765">10.55</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Cancelled or expired during the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-683">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-684">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c1015" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" scale="0" unitRef="pure" id="ixv-45766">570</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1015" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" scale="0" unitRef="usdPershares" id="ixv-45767">10.07</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Exercised during the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-685">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-686">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c1015" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" scale="0" unitRef="pure" id="ixv-45768">76,529</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1015" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" scale="0" unitRef="usdPershares" id="ixv-45769">10.73</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Loss of control</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c1014" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" scale="0" unitRef="pure" id="ixv-45770">7,345,795</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c1014" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" scale="0" unitRef="usdPershares" id="ixv-45771">11.83</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-687">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-688">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">Effective at the end of the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-689">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-690">-</div></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c1012" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfOutstandingShareOptions" scale="0" unitRef="pure" id="ixv-45772">7,345,795</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c1012" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" unitRef="usdPershares" id="ixv-45773">11.83</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 195; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">&#160;</p><div>


</div><div><a id="fs_019"></a></div><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfCommitmentsExplanatory" id="ixv-42660"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><b>20.</b></td><td style="text-align: justify"><b><span style="text-decoration:underline">CONTINGENCIES, COMMITMENTS AND RESTRICTIONS ON THE
DISTRIBUTION OF PROFITS</span></b></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prior to the BIOX deconsolidation, the Group had
secured guaranteed notes and the convertibles notes which are referenced in Note 7.13 &#8211; Convertible Notes. Such instruments were
secured by substantially all of the assets located in the United States of Pro Farm Group, Inc. and its U.S. subsidiaries and are guaranteed
by BCS Holding Inc., Bioceres Crops do Brasil Ltda., Bioceres Crops S.A., Bioceres Semillas S.A.U., Verdeca LLC, Rasa Holding LLC, Rizobacter
Argentina S.A., Rizobacter del Paraguay S.A., Rizobacter do Brasil Ltda., Rizobacter South Africa, Rizobacter Uruguay, Rizobacter USA,
LLC, Pro Farm Group, Inc., Pro Farm Michigan Manufacturing LLC, Pro Farm, Inc., Pro Farm Technologies Com&#233;rcio de Insumo Agr&#237;colas
do Brasil Ltda., Glinatur S.A. and Pro Farm OU.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="fs_020"></a></div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfEventsAfterReportingPeriodExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory" id="ixv-42677"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><b>21.</b></td><td style="text-align: justify"><b><span style="text-decoration:underline">EVENTS OCCURRING AFTER THE REPORTING PERIOD</span></b></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management has considered subsequent events through
the date these consolidated financial statements were issued.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Notice of Alleged breach</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 2, 2025, the Company received a notice
of alleged breach from INVIM Corporativo S.L., a private limited company incorporated under the laws of Spain (&#8220;INVIM&#8221;), regarding
the alleged failure to pay the assignment price of $<ix:nonFraction contextRef="c1017" decimals="-6" format="ixt:num-dot-decimal" name="ifrs-full:Provisions" scale="6" unitRef="usd" id="ixv-45774">13</ix:nonFraction> million in connection with a certain Assignment and Assumption Agreement dated
May 27, 2025 (the &#8220;Agreement&#8221;). The Agreement, in turn, references related instruments, including a Note Purchase Agreement
and a Binding Contribution Memorandum of Understanding, both dated October 15, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In response, the Company rejected INVIM&#8217;s
assertion that any payment is due or owing, on the grounds that, among other reasons, under the express terms of the Agreement and related
transaction instruments, INVIM failed to satisfy certain conditions precedent, including the valid transfer of relevant securities and
the execution of a required services agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company intends to vigorously defend its position
and enforce its rights under the Agreement, the related transaction instruments, and applicable law. While the Company believes that INVIM&#8217;s
assertions are without merit, if INVIM were ultimately to prevail in any proceedings, such an adverse outcome could have a material adverse
effect on the Company&#8217;s business, results of operations, financial condition, or liquidity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Bioceres S.A. and Bioceres LLC</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As stated in Note 1 &#8211; The Group&#8217;s
business reorganization and general information - &#8220;<i>The Bioceres Group Business Combination Agreement&#8221;, </i>in June 2025,
Bioceres S.A., one of the Argentine subsidiaries of Bioceres Group Limited, defaulted on a portion of its financial debt that was due
that month. As a result, Bioceres S.A. had initiated a debt restructuring process for its financial debt for an aggregate amount of $<ix:nonFraction contextRef="c0" decimals="-5" format="ixt:num-dot-decimal" name="mlec:AmountOfFinancialDebtUnderRestructuring" scale="6" unitRef="usd" id="ixv-45775">36.4</ix:nonFraction>
million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In July 2025, Bioceres LLC, a wholly owned subsidiary
of Bioceres S.A., received a notice of default on its financial debt in the amount of $<ix:nonFraction contextRef="c1018" decimals="-5" format="ixt:num-dot-decimal" name="mlec:AmountOfFinancialDebtUnderRestructuring" scale="6" unitRef="usd" id="ixv-45776">69.5</ix:nonFraction> million. The creditor conducted a public auction
to wit <ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:PledgedOrTransferredSharesQuantity" scale="0" unitRef="shares" id="ixv-45777">3,062,500</ix:nonFraction> pledged BIOX shares, pursuant to the New York Uniform Commercial Code. Management has responded to said creditor, reserving
all rights, remedies, and defenses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The defaults by Bioceres S.A. and Bioceres LLC
do not have implications in other debts as there are no cross-default clauses on the remaining financial debt of the Group. There are no guarantees granted above Bioceres S.A. and Bioceres LLC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company had the financial support of its main
shareholders and considering the aforementioned events that derived in the loss of the financial support that was previously provided
by Bioceres Group (and who is also no longer a shareholder of the Company), and, consequently, raise a material uncertainty which may
cast significant doubt (or raise substantial doubt as contemplated by PCAOB standards) about the ability of Moolec Science SA to continue
as a going concern. The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Currently, the Group lacks sufficient financial resources to meet its obligations or fully implement its business plan. Without securing
additional capital, or achieving a successful financial restructuring process, the Group will not be able to sustain its operations. See
below &#8220;<i>Exercise of convertible preference shares&#8221;</i> and <i>&#8220;Summary of the liquidation and loss of control&#8221;.</i></p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 196; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">&#160;</p><div>


</div><ix:continuation continuedAt="_DisclosureOfEventsAfterReportingPeriodExplanatory-c0_cont_2" id="_DisclosureOfEventsAfterReportingPeriodExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">However, there is no assurance the Group&#8217;s
future operations will generate profitability. The uncertainty surrounding the ability to secure additional funding and the potential
for continued operational losses contribute to raise a material uncertainty which may cast significant doubt (or raise substantial doubt
as contemplated by PCAOB standards) about the Group&#8217;s ability to continue as a going concern.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Exercise of convertible preference shares</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In December 2024, Bioceres Group issued <ix:nonFraction contextRef="c1019" decimals="0" format="ixt:num-dot-decimal" name="mlec:IssuedConvertiblePreferenceShares" scale="0" unitRef="shares" id="ixv-45778">2,380,952</ix:nonFraction>
convertible preference shares for total proceeds of $<ix:nonFraction contextRef="c1019" decimals="-6" format="ixt:num-dot-decimal" name="mlec:ProceedFromIssuedShares" scale="6" unitRef="usd" id="ixv-45779">15</ix:nonFraction> million. These preference shares accrue a <ix:nonFraction contextRef="c1019" decimals="2" format="ixt:num-dot-decimal" name="mlec:PreferenceOfAccruePerAnnum" scale="-2" unitRef="pure" id="ixv-45780">9</ix:nonFraction>% per annum payment-in-kind (PIK) return
and grant the holder specific conversion rights, including the option to convert into ordinary shares or into Moolec Scicence shares if
the business combination closed before September 12, 2025. Upon the consummation of the Business Combination, and subsequent to the reporting
date, on December 10, 2025, the holder undertook to exercise the conversion of all or part of the subscription shares into a number of
Moolec Science shares, at the Company&#8217;s request. If total convertible shares are exercised, it will result in the derecognition
of a financial liability and an increase in equity of approximately $<ix:nonFraction contextRef="c1019" decimals="-6" format="ixt:num-dot-decimal" name="mlec:ProceedsFromIssueOfEquityInstrumentsOnConversionOfDebt" scale="6" unitRef="usd" id="ixv-45781">15</ix:nonFraction> million plus the accumulated PIK up to the moment of exercise.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Financing proceeds</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subsequent to the closing date of the financial
statements, on December 2, 2025, the Company successfully obtained and received financing proceeds for working capital purposes in the
amount of $<ix:nonFraction contextRef="c1020" decimals="-5" format="ixt:num-dot-decimal" name="mlec:WorkingCapital" scale="6" unitRef="usd" id="ixv-45782">2.5</ix:nonFraction> million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Financial support</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of the date of issuance of these financial statements, the Company&#8217;s
principal minority shareholder has committed to provide financial support to the Company for a period of twelve months.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Nasdaq delist letter received &amp; 20-F
delinquency letter</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-align: justify; text-indent: -0.5pt">On November 14,
2025, the Company received a determination letter (the &#8220;Nasdaq Determination Letter&#8221;) from the Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;)
indicating that the closing bid price of the Company&#8217;s ordinary shares had been below the minimum $<ix:nonFraction contextRef="c1021" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ParValuePerShare" scale="0" unitRef="usdPershares" id="ixv-45783">1.00</ix:nonFraction> per share requirement for
the last <ix:nonNumeric contextRef="c1022" format="ixt-sec:durday" name="mlec:ConsecutiveBusinessDays" id="ixv-45784">30</ix:nonNumeric> consecutive business days, as set forth in Nasdaq Listing Rule 5550(a)(2), and informing the Company of their view that the
Company would not be afforded an automatic 180-day period to regain compliance with such rule.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-align: justify; text-indent: -0.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-align: justify; text-indent: -0.5pt">The Company has
submitted a timely appeal to a Nasdaq Hearings Panel, through which it will request the granting of a 180- day period to submit and effect
a compliance plan, which includes a potential implementation of a reverse stock split, if determined to be in the best interest of shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-align: justify; text-indent: -0.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-align: justify; text-indent: -0.5pt">The submission of the appeal automatically stays the effect of the
Nasdaq Determination Letter until the appeal has been considered, which took place on December 18, 2025. Accordingly, the Company&#8217;s
ordinary shares will continue to trade on The Nasdaq Capital Market under the symbol &#8220;MLEC&#8221; without interruption during the
time period when the panel decision is pending.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-align: justify; text-indent: -0.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-align: justify; text-indent: -0.5pt">The Company intends
to continue closely monitoring the closing bid price for its ordinary shares and remains committed to evaluating and executing all appropriate
actions to cure the deficiency and regain compliance with Nasdaq Listing Rule 5550(a)(2). The receipt of the Nasdaq Determination Letter
does not affect the Company&#8217;s business, operations or reporting requirements with the Securities and Exchange Commission.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-align: justify; text-indent: -0.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November 24, 2025, the Company received a letter
(the &#8220;Letter&#8221;) from the Listing Qualifications Department of Nasdaq stating that the Company is not in compliance with Nasdaq
Listing Rule 5250(c)(1) because it has not yet filed its Annual Report on Form 20-F for the year ended June 30, 2025 (the &#8220;Form
20-F&#8221;) with the Securities and Exchange Commission (the &#8220;SEC&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As the Company stated in the form 12b-25 filed
with the SEC on October 31, 2025, it was unable to file the Form 20-F in a timely manner due to complexities that arose immediately after
the closing of the business combination in mid-June 2025, two weeks prior to Moolec&#8217;s fiscal year end of June 30. The business combination
involves complex accounting, including the imposition of reverse acquisition accounting and valuation of acquired assets and liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has requested a stay of suspension
to the Nasdaq Hearings Panel, which automatically stayed the effect of the Letter until the panel hearing, which took
place on December 18, 2025. Accordingly, the Company&#8217;s ordinary shares will continue to trade on The Nasdaq Capital Market under
the symbol &#8220;MLEC&#8221; without interruption during the time period when the panel decision is pending.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 197; Value: 1 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">MOOLEC SCIENCE SA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span style="text-decoration:underline">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>As of June 30, 2025 and 2024 and for the years
ended June 30, 2025, 2024 and 2023</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(Amounts in US$, except otherwise indicated)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">&#160;</p><div>


</div><ix:continuation id="_DisclosureOfEventsAfterReportingPeriodExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Summary of the liquidation and loss of control</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Theo I SCSp</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November 28, 2025, subsequent to the reporting
date, Theo I SCSp received a conditional payment order from district court of&#160; Luxembourg, and therefore the General Partners engaged
Ogier (Luxembourg) SCS represented by its general partner Ogier Luxembourg (GP) S.&#224;.r.l&#160; formally as their legal advisor to
assist with Theo I SCSp&#8217;s declaration of bankruptcy before the Luxembourg District Court. The declaration of bankruptcy will declare
Theo I SCSp bankrupt and appoint a receiver who will take control over the management of the company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The loss of control constitutes the derecognition
event under IFRS 10.25. Accordingly, the Group will derecognize the assets and liabilities of Theo I SCSp and will remeasure its retained
interest at fair value in accordance with IFRS 9 at the date of the derecognition event. This will result in the recognition of an estimated
gain of $<ix:nonFraction contextRef="c0" decimals="-5" format="ixt:num-dot-decimal" name="ifrs-full:GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss" scale="6" unitRef="usd" id="ixv-45785">9.5</ix:nonFraction> million in the consolidated statement of profit or loss as of the derecognition date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group will continue to measure its retained
interest in Theo I SCSp at fair value through profit or loss until the liquidation process is formally completed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Bioceres S.A. and Bioceres LLC</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 16, 2025, subsequent to the
reporting date, the Board of Directors of Bioceres S.A. formally approved the initiation of voluntary bankruptcy proceedings and
instructed management to seek and appoint a trustee (&#8220;<i>s&#237;ndico</i>&#8221;) to oversee the process. The commencement
of the voluntary bankruptcy proceedings and the transfer of decision-making authority to the trustee will result in the Group losing
control over Bioceres S.A. in accordance with the principles of IFRS 10 Consolidated Financial Statements. As Bioceres LLC is a
wholly owned subsidiary of Bioceres S.A., the Group simultaneously will lose control over Bioceres LLC as well.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under IFRS 10.25, the date on which control is
lost constitutes the derecognition event. Accordingly, after December 16, 2025, the Group will derecognize the assets and liabilities
of Bioceres S.A. and Bioceres LLC and will remeasure any retained interest at fair value in accordance with IFRS 9 Financial Instruments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The resulting derecognition effects are expected to generate an approximate
gain of $<ix:nonFraction contextRef="c1023" decimals="-5" format="ixt:num-dot-decimal" name="ifrs-full:GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss" scale="6" unitRef="usd" id="ixv-45786">91.0</ix:nonFraction> million related to the loss of control of Bioceres S.A. and an additional approximate gain of $<ix:nonFraction contextRef="c1024" decimals="-5" format="ixt:num-dot-decimal" name="ifrs-full:GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss" scale="6" unitRef="usd" id="ixv-45787">5.3</ix:nonFraction> million related to the
loss of control of Bioceres LLC (including the loss of holding in BIOX, therefore it will no longer be an equity method associate). These
amounts will be recognized in the consolidated statement of profit or loss as of the derecognition date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group will continue to monitor the
progress of the voluntary bankruptcy and liquidation proceedings and will update the accounting treatment as necessary in accordance
with IFRS.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="note_022"></a></div><ix:nonNumeric contextRef="c0" escape="true" name="mlec:DisclosureOfReverseStockSplitAfterTheReportingPeriod" id="ixv-42880"><table border="0" cellpadding="0" style="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
<tr style="vertical-align: top">
  <td style="width: 0.25in"><b>22.</b></td>
  <td><b><span style="text-decoration:underline">REVERSE STOCK SPLIT AFTER THE REPORTING PERIOD</span></b></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&#160;</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Subsequent to the period end,
the Company&#8217;s shareholders approved a reverse stock split of the Company&#8217;s ordinary shares at a ratio to be determined by
the Board of Directors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&#160;</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On December 20, 2025, the Board of Directors approved a reverse stock
split at a ratio of&#160;<ix:nonNumeric contextRef="c1025" name="mlec:ReverseStockSplit" id="ixv-45788">15-for-1</ix:nonNumeric>, which will be effective on or around January 5, 2026.</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&#160;</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For purposes of comparability, earnings per share (&#8220;EPS&#8221;)
information presented in this note has been retrospectively adjusted to reflect the reverse stock split, as if it had been effective for
all periods presented. <ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" id="ixv-45789">The reverse stock split did not impact the Company&#8217;s consolidated statements of operations, financial position
or cash flows, other than the recast of the weighted average number of ordinary shares outstanding used in the calculation of basic and
diluted EPS.</ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&#160;</p>

<ix:continuation id="_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory-c0_cont_1"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; font-weight: bold; text-indent: -0.125in">Numerator</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; width: 64%; text-align: left; text-indent: -0.125in">Loss/Profit for the year (basic EPS)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c1026" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" scale="0" sign="-" unitRef="usd" id="ixv-45790">111,460,708</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c1027" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" scale="0" sign="-" unitRef="usd" id="ixv-45791">32,685,398</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c1028" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" scale="0" unitRef="usd" id="ixv-45792">40,435,923</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; text-indent: -0.125in">Loss/Profit for the year (diluted EPS)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c1026" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" scale="0" sign="-" unitRef="usd" id="ixv-45793">111,460,708</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c1027" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" scale="0" sign="-" unitRef="usd" id="ixv-45794">32,685,398</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1028" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" scale="0" unitRef="usd" id="ixv-45795">40,435,923</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; font-weight: bold; text-indent: -0.125in">Denominator</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Number of shares (basic EPS)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1026" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageShares" scale="0" unitRef="shares" id="ixv-45796">430,864</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1027" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageShares" scale="0" unitRef="shares" id="ixv-45797">388,101</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1028" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageShares" scale="0" unitRef="shares" id="ixv-45798">306,215</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Number of shares (diluted EPS)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1026" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:AdjustedWeightedAverageShares" scale="0" unitRef="shares" id="ixv-45799">430,864</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1027" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:AdjustedWeightedAverageShares" scale="0" unitRef="shares" id="ixv-45800">388,101</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c1028" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:AdjustedWeightedAverageShares" scale="0" unitRef="shares" id="ixv-45801">306,215</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; font-weight: bold; text-align: left; text-indent: -0.125in">Basic (loss)/profit attributable to ordinary equity holders of the parent</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction contextRef="c1026" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:BasicEarningsLossPerShare" scale="0" sign="-" unitRef="usdPershares" id="ixv-45802">258.6912</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction contextRef="c1027" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:BasicEarningsLossPerShare" scale="0" sign="-" unitRef="usdPershares" id="ixv-45803">84.2188</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c1028" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:BasicEarningsLossPerShare" scale="0" unitRef="usdPershares" id="ixv-45804">132.0508</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; font-weight: bold; text-align: left; text-indent: -0.125in">Diluted (loss)/profit attributable to ordinary equity holders of the parent</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction contextRef="c1026" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:DilutedEarningsLossPerShare" scale="0" sign="-" unitRef="usdPershares" id="ixv-45805">258.6912</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction contextRef="c1027" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:DilutedEarningsLossPerShare" scale="0" sign="-" unitRef="usdPershares" id="ixv-45806">84.2188</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c1028" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:DilutedEarningsLossPerShare" scale="0" unitRef="usdPershares" id="ixv-45807">132.0508</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table></ix:continuation></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 198; Options: Last --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font-size: 10pt; border-spacing: 0px;"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></td></tr></table></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="c0" id="hidden-fact-0" name="dei:EntityIncorporationStateCountryCode">E9</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" id="hidden-fact-1" name="dei:DocumentAccountingStandard">International Financial Reporting Standards</ix:nonNumeric>
<ix:nonFraction contextRef="c0" id="hidden-fact-2" name="mlec:ItemsThatWillNotBeSubsequentlyReclassifiedToLossAndProfit" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-3" name="mlec:ItemsThatWillNotBeSubsequentlyReclassifiedToLossAndProfit" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-4" name="mlec:RevaluationOfPropertyPlantAndEquipmentNetOfTaxOfJointVenturesAndAssociates" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-5" name="mlec:RevaluationOfPropertyPlantAndEquipmentNetOfTaxOfJointVenturesAndAssociates" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-6" name="mlec:RevaluationOfPropertyPlantAndEquipmentNetOfTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-7" name="mlec:RevaluationOfPropertyPlantAndEquipmentNetOfTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-8" name="ifrs-full:OtherNoncurrentFinancialAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-9" name="ifrs-full:CurrentTaxAssetsNoncurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-10" name="ifrs-full:DeferredTaxAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-11" name="ifrs-full:InvestmentProperty" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-12" name="ifrs-full:Goodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-13" name="ifrs-full:CurrentTaxAssetsCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-14" name="ifrs-full:CurrentBiologicalAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-15" name="mlec:ShareToBeIssuedAmount" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-16" name="ifrs-full:NoncurrentContractLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-17" name="ifrs-full:NoncurrentGovernmentGrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-18" name="mlec:JointVenturesAndAssociatesLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-19" name="mlec:ConsiderationForAcquisitionOfAssetsNonCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-20" name="ifrs-full:NoncurrentLeaseLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-21" name="ifrs-full:CurrentTaxLiabilitiesCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-22" name="ifrs-full:CurrentWarrantLiability" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-23" name="mlec:ConsiderationForAcquisitionOfAssetsCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c9" id="hidden-fact-24" name="ifrs-full:Equity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-25" name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c20" id="hidden-fact-26" name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-27" name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c23" id="hidden-fact-28" name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c24" id="hidden-fact-29" name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c25" id="hidden-fact-30" name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c27" id="hidden-fact-31" name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c18" id="hidden-fact-32" name="ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-33" name="ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-34" name="ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c23" id="hidden-fact-35" name="ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c24" id="hidden-fact-36" name="ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c25" id="hidden-fact-37" name="ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c18" id="hidden-fact-38" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-39" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c20" id="hidden-fact-40" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c21" id="hidden-fact-41" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c23" id="hidden-fact-42" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c24" id="hidden-fact-43" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c25" id="hidden-fact-44" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c20" id="hidden-fact-45" name="mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-46" name="mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c23" id="hidden-fact-47" name="mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c24" id="hidden-fact-48" name="mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c25" id="hidden-fact-49" name="mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c18" id="hidden-fact-50" name="ifrs-full:IncreaseDecreaseThroughOtherDistributionsToOwners" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-51" name="ifrs-full:IncreaseDecreaseThroughOtherDistributionsToOwners" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c20" id="hidden-fact-52" name="ifrs-full:IncreaseDecreaseThroughOtherDistributionsToOwners" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c21" id="hidden-fact-53" name="ifrs-full:IncreaseDecreaseThroughOtherDistributionsToOwners" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-54" name="ifrs-full:IncreaseDecreaseThroughOtherDistributionsToOwners" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c23" id="hidden-fact-55" name="ifrs-full:IncreaseDecreaseThroughOtherDistributionsToOwners" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c24" id="hidden-fact-56" name="ifrs-full:IncreaseDecreaseThroughOtherDistributionsToOwners" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c25" id="hidden-fact-57" name="ifrs-full:IncreaseDecreaseThroughOtherDistributionsToOwners" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-58" name="ifrs-full:IncreaseDecreaseThroughOtherDistributionsToOwners" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c18" id="hidden-fact-59" name="ifrs-full:DividendsPaid" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-60" name="ifrs-full:DividendsPaid" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c20" id="hidden-fact-61" name="ifrs-full:DividendsPaid" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c21" id="hidden-fact-62" name="ifrs-full:DividendsPaid" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-63" name="ifrs-full:DividendsPaid" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c23" id="hidden-fact-64" name="ifrs-full:DividendsPaid" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c24" id="hidden-fact-65" name="ifrs-full:DividendsPaid" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c25" id="hidden-fact-66" name="ifrs-full:DividendsPaid" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-67" name="ifrs-full:DividendsPaid" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c18" id="hidden-fact-68" name="ifrs-full:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-69" name="ifrs-full:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c20" id="hidden-fact-70" name="ifrs-full:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c21" id="hidden-fact-71" name="ifrs-full:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-72" name="ifrs-full:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c24" id="hidden-fact-73" name="ifrs-full:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c25" id="hidden-fact-74" name="ifrs-full:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c18" id="hidden-fact-75" name="ifrs-full:OtherComprehensiveIncomeBeforeTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-76" name="ifrs-full:OtherComprehensiveIncomeBeforeTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c20" id="hidden-fact-77" name="ifrs-full:OtherComprehensiveIncomeBeforeTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c21" id="hidden-fact-78" name="ifrs-full:OtherComprehensiveIncomeBeforeTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-79" name="ifrs-full:OtherComprehensiveIncomeBeforeTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c23" id="hidden-fact-80" name="ifrs-full:OtherComprehensiveIncomeBeforeTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c25" id="hidden-fact-81" name="ifrs-full:OtherComprehensiveIncomeBeforeTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c39" id="hidden-fact-82" name="ifrs-full:Equity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c51" id="hidden-fact-83" name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c52" id="hidden-fact-84" name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c53" id="hidden-fact-85" name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c54" id="hidden-fact-86" name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c56" id="hidden-fact-87" name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c48" id="hidden-fact-88" name="ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c51" id="hidden-fact-89" name="ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c52" id="hidden-fact-90" name="ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c53" id="hidden-fact-91" name="ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c54" id="hidden-fact-92" name="ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c48" id="hidden-fact-93" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c49" id="hidden-fact-94" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c50" id="hidden-fact-95" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c52" id="hidden-fact-96" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c53" id="hidden-fact-97" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c54" id="hidden-fact-98" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c48" id="hidden-fact-99" name="mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c49" id="hidden-fact-100" name="mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c50" id="hidden-fact-101" name="mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c51" id="hidden-fact-102" name="mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c52" id="hidden-fact-103" name="mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c53" id="hidden-fact-104" name="mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c54" id="hidden-fact-105" name="mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c55" id="hidden-fact-106" name="mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c48" id="hidden-fact-107" name="ifrs-full:DividendsPaid" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c49" id="hidden-fact-108" name="ifrs-full:DividendsPaid" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c50" id="hidden-fact-109" name="ifrs-full:DividendsPaid" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c51" id="hidden-fact-110" name="ifrs-full:DividendsPaid" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c52" id="hidden-fact-111" name="ifrs-full:DividendsPaid" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c53" id="hidden-fact-112" name="ifrs-full:DividendsPaid" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c54" id="hidden-fact-113" name="ifrs-full:DividendsPaid" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c55" id="hidden-fact-114" name="ifrs-full:DividendsPaid" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c48" id="hidden-fact-115" name="ifrs-full:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c49" id="hidden-fact-116" name="ifrs-full:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c50" id="hidden-fact-117" name="ifrs-full:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c51" id="hidden-fact-118" name="ifrs-full:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c53" id="hidden-fact-119" name="ifrs-full:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c54" id="hidden-fact-120" name="ifrs-full:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c48" id="hidden-fact-121" name="ifrs-full:OtherComprehensiveIncomeBeforeTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c49" id="hidden-fact-122" name="ifrs-full:OtherComprehensiveIncomeBeforeTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c50" id="hidden-fact-123" name="ifrs-full:OtherComprehensiveIncomeBeforeTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c51" id="hidden-fact-124" name="ifrs-full:OtherComprehensiveIncomeBeforeTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c52" id="hidden-fact-125" name="ifrs-full:OtherComprehensiveIncomeBeforeTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c54" id="hidden-fact-126" name="ifrs-full:OtherComprehensiveIncomeBeforeTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c68" id="hidden-fact-127" name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c69" id="hidden-fact-128" name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c70" id="hidden-fact-129" name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c71" id="hidden-fact-130" name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c73" id="hidden-fact-131" name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c66" id="hidden-fact-132" name="ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c68" id="hidden-fact-133" name="ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c69" id="hidden-fact-134" name="ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c70" id="hidden-fact-135" name="ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c71" id="hidden-fact-136" name="ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c66" id="hidden-fact-137" name="mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c68" id="hidden-fact-138" name="mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c69" id="hidden-fact-139" name="mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c70" id="hidden-fact-140" name="mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c71" id="hidden-fact-141" name="mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c66" id="hidden-fact-142" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c67" id="hidden-fact-143" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c69" id="hidden-fact-144" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c70" id="hidden-fact-145" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c71" id="hidden-fact-146" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c66" id="hidden-fact-147" name="ifrs-full:DividendsPaid" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c67" id="hidden-fact-148" name="ifrs-full:DividendsPaid" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c68" id="hidden-fact-149" name="ifrs-full:DividendsPaid" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c69" id="hidden-fact-150" name="ifrs-full:DividendsPaid" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c70" id="hidden-fact-151" name="ifrs-full:DividendsPaid" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c71" id="hidden-fact-152" name="ifrs-full:DividendsPaid" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c72" id="hidden-fact-153" name="ifrs-full:DividendsPaid" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c66" id="hidden-fact-154" name="ifrs-full:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c67" id="hidden-fact-155" name="ifrs-full:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c68" id="hidden-fact-156" name="ifrs-full:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c70" id="hidden-fact-157" name="ifrs-full:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c71" id="hidden-fact-158" name="ifrs-full:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c66" id="hidden-fact-159" name="ifrs-full:OtherComprehensiveIncomeBeforeTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c67" id="hidden-fact-160" name="ifrs-full:OtherComprehensiveIncomeBeforeTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c68" id="hidden-fact-161" name="ifrs-full:OtherComprehensiveIncomeBeforeTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c69" id="hidden-fact-162" name="ifrs-full:OtherComprehensiveIncomeBeforeTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-163" name="ifrs-full:AdjustmentsForFairValueGainsLosses" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-164" name="ifrs-full:AdjustmentsForFairValueGainsLosses" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-165" name="mlec:RemeasurementOfPreviouslyHeldInterest" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-166" name="mlec:RemeasurementOfPreviouslyHeldInterest" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-167" name="ifrs-full:AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-168" name="ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-169" name="ifrs-full:OtherCashReceiptsFromSalesOfInterestsInJointVenturesClassifiedAsInvestingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-170" name="ifrs-full:OtherCashReceiptsFromSalesOfInterestsInJointVenturesClassifiedAsInvestingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c98" id="hidden-fact-171" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c100" id="hidden-fact-172" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c102" id="hidden-fact-173" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c104" id="hidden-fact-174" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c106" id="hidden-fact-175" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-176" name="mlec:MutualFunds" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c176" id="hidden-fact-177" name="ifrs-full:OtherCurrentFinancialAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c176" id="hidden-fact-178" name="ifrs-full:OtherNoncurrentFinancialAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c174" id="hidden-fact-179" name="ifrs-full:OtherNoncurrentFinancialAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-180" name="ifrs-full:OtherNoncurrentFinancialAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c180" id="hidden-fact-181" name="mlec:CurrentTradeReceivablesAllowanceForImpairmentOfTradeDebtors" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c180" id="hidden-fact-182" name="mlec:CurrentTradeReceivablesShareholdersAndOtherRelatedParties" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c180" id="hidden-fact-183" name="mlec:AllowanceForReturnOfGoods" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c180" id="hidden-fact-184" name="ifrs-full:OtherReceivables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c192" id="hidden-fact-185" name="ifrs-full:OtherCurrentReceivables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c196" id="hidden-fact-186" name="ifrs-full:OtherCurrentReceivables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c182" id="hidden-fact-187" name="ifrs-full:OtherNoncurrentReceivables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c200" id="hidden-fact-188" name="ifrs-full:OtherNoncurrentReceivables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c202" id="hidden-fact-189" name="ifrs-full:OtherNoncurrentReceivables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c198" id="hidden-fact-190" name="ifrs-full:OtherNoncurrentReceivables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c206" id="hidden-fact-191" name="mlec:InventoriesCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c210" id="hidden-fact-192" name="mlec:InventoriesCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c212" id="hidden-fact-193" name="mlec:InventoriesCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c216" id="hidden-fact-194" name="mlec:InventoriesCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c218" id="hidden-fact-195" name="ifrs-full:BiologicalAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c219" id="hidden-fact-196" name="ifrs-full:BiologicalAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c222" id="hidden-fact-197" name="ifrs-full:BiologicalAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c225" id="hidden-fact-198" name="mlec:LossOfControlonBiologicalAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c226" id="hidden-fact-199" name="mlec:LossOfControlonBiologicalAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c227" id="hidden-fact-200" name="mlec:LossOfControlonBiologicalAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c228" id="hidden-fact-201" name="ifrs-full:BiologicalAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c229" id="hidden-fact-202" name="ifrs-full:BiologicalAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c230" id="hidden-fact-203" name="ifrs-full:BiologicalAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c231" id="hidden-fact-204" name="ifrs-full:BiologicalAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c232" id="hidden-fact-205" name="ifrs-full:BiologicalAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-206" name="ifrs-full:BiologicalAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c233" id="hidden-fact-207" name="ifrs-full:BiologicalAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c234" id="hidden-fact-208" name="ifrs-full:BiologicalAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c237" id="hidden-fact-209" name="ifrs-full:BiologicalAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c218" id="hidden-fact-210" name="ifrs-full:BiologicalAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c219" id="hidden-fact-211" name="ifrs-full:BiologicalAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c222" id="hidden-fact-212" name="ifrs-full:BiologicalAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c244" id="hidden-fact-213" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c244" id="hidden-fact-214" name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c247" id="hidden-fact-215" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c247" id="hidden-fact-216" name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c248" id="hidden-fact-217" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c250" id="hidden-fact-218" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c250" id="hidden-fact-219" name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c253" id="hidden-fact-220" name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c254" id="hidden-fact-221" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c256" id="hidden-fact-222" name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c259" id="hidden-fact-223" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c259" id="hidden-fact-224" name="mlec:DisposalsPropertyPlantAndEquipments" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c262" id="hidden-fact-225" name="mlec:DisposalsPropertyPlantAndEquipments" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c262" id="hidden-fact-226" name="ifrs-full:DepreciationPropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c265" id="hidden-fact-227" name="ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c268" id="hidden-fact-228" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c268" id="hidden-fact-229" name="ifrs-full:IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c268" id="hidden-fact-230" name="mlec:DisposalsPropertyPlantAndEquipments" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c268" id="hidden-fact-231" name="ifrs-full:DepreciationPropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c268" id="hidden-fact-232" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c269" id="hidden-fact-233" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c271" id="hidden-fact-234" name="ifrs-full:IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c271" id="hidden-fact-235" name="mlec:DisposalsPropertyPlantAndEquipments" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c273" id="hidden-fact-236" name="ifrs-full:IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c275" id="hidden-fact-237" name="ifrs-full:IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c277" id="hidden-fact-238" name="ifrs-full:IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c279" id="hidden-fact-239" name="ifrs-full:IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c281" id="hidden-fact-240" name="ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c283" id="hidden-fact-241" name="ifrs-full:IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c283" id="hidden-fact-242" name="ifrs-full:DepreciationPropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c288" id="hidden-fact-243" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c288" id="hidden-fact-244" name="mlec:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c288" id="hidden-fact-245" name="mlec:AdditionsFromBusinessCombinations" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c288" id="hidden-fact-246" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c288" id="hidden-fact-247" name="mlec:AmortizationOfTheYear" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c291" id="hidden-fact-248" name="mlec:AdditionsFromBusinessCombinations" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c291" id="hidden-fact-249" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c291" id="hidden-fact-250" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c292" id="hidden-fact-251" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c294" id="hidden-fact-252" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c294" id="hidden-fact-253" name="mlec:AdditionsFromBusinessCombinations" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c294" id="hidden-fact-254" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c295" id="hidden-fact-255" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c297" id="hidden-fact-256" name="mlec:AdditionsFromBusinessCombinations" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c298" id="hidden-fact-257" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c300" id="hidden-fact-258" name="mlec:AdditionsFromBusinessCombinations" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c300" id="hidden-fact-259" name="mlec:AmortizationOfTheYear" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c300" id="hidden-fact-260" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c301" id="hidden-fact-261" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c303" id="hidden-fact-262" name="mlec:AdditionsFromBusinessCombinations" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c303" id="hidden-fact-263" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c303" id="hidden-fact-264" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c304" id="hidden-fact-265" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c306" id="hidden-fact-266" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c306" id="hidden-fact-267" name="mlec:AdditionsFromBusinessCombinations" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c306" id="hidden-fact-268" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c306" id="hidden-fact-269" name="mlec:AmortizationOfTheYear" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c306" id="hidden-fact-270" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c307" id="hidden-fact-271" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c309" id="hidden-fact-272" name="mlec:AdditionsFromBusinessCombinations" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c310" id="hidden-fact-273" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c312" id="hidden-fact-274" name="mlec:AdditionsFromBusinessCombinations" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c312" id="hidden-fact-275" name="mlec:AmortizationOfTheYear" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c312" id="hidden-fact-276" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c313" id="hidden-fact-277" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c315" id="hidden-fact-278" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c315" id="hidden-fact-279" name="mlec:AdditionsFromBusinessCombinations" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c315" id="hidden-fact-280" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c315" id="hidden-fact-281" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c316" id="hidden-fact-282" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c318" id="hidden-fact-283" name="mlec:AdditionsFromBusinessCombinations" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c318" id="hidden-fact-284" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c318" id="hidden-fact-285" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c319" id="hidden-fact-286" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c320" id="hidden-fact-287" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c321" id="hidden-fact-288" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c321" id="hidden-fact-289" name="mlec:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c321" id="hidden-fact-290" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c321" id="hidden-fact-291" name="mlec:AmortizationOfTheYear" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c321" id="hidden-fact-292" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c323" id="hidden-fact-293" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c324" id="hidden-fact-294" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c324" id="hidden-fact-295" name="mlec:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c324" id="hidden-fact-296" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c324" id="hidden-fact-297" name="mlec:AmortizationOfTheYear" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c324" id="hidden-fact-298" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c326" id="hidden-fact-299" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c327" id="hidden-fact-300" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c327" id="hidden-fact-301" name="mlec:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c327" id="hidden-fact-302" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c327" id="hidden-fact-303" name="mlec:AmortizationOfTheYear" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c327" id="hidden-fact-304" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c329" id="hidden-fact-305" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c330" id="hidden-fact-306" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c330" id="hidden-fact-307" name="mlec:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c330" id="hidden-fact-308" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c330" id="hidden-fact-309" name="mlec:AmortizationOfTheYear" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c330" id="hidden-fact-310" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c332" id="hidden-fact-311" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c333" id="hidden-fact-312" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c333" id="hidden-fact-313" name="mlec:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c335" id="hidden-fact-314" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c336" id="hidden-fact-315" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c336" id="hidden-fact-316" name="mlec:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c336" id="hidden-fact-317" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c336" id="hidden-fact-318" name="mlec:AmortizationOfTheYear" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c336" id="hidden-fact-319" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c339" id="hidden-fact-320" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c339" id="hidden-fact-321" name="mlec:AdditionsFromBusinessCombinations" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c339" id="hidden-fact-322" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c339" id="hidden-fact-323" name="mlec:AmortizationOfTheYear" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c341" id="hidden-fact-324" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c341" id="hidden-fact-325" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c341" id="hidden-fact-326" name="mlec:AmortizationOfTheYear" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c341" id="hidden-fact-327" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c342" id="hidden-fact-328" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c344" id="hidden-fact-329" name="mlec:AdditionsFromBusinessCombinations" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c344" id="hidden-fact-330" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c344" id="hidden-fact-331" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c346" id="hidden-fact-332" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c346" id="hidden-fact-333" name="mlec:AdditionsFromBusinessCombinations" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c346" id="hidden-fact-334" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c348" id="hidden-fact-335" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c348" id="hidden-fact-336" name="mlec:AdditionsFromBusinessCombinations" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c348" id="hidden-fact-337" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c350" id="hidden-fact-338" name="mlec:AdditionsFromBusinessCombinations" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c350" id="hidden-fact-339" name="mlec:AmortizationOfTheYear" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c352" id="hidden-fact-340" name="mlec:AdditionsFromBusinessCombinations" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c352" id="hidden-fact-341" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c354" id="hidden-fact-342" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c354" id="hidden-fact-343" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c354" id="hidden-fact-344" name="mlec:AmortizationOfTheYear" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c354" id="hidden-fact-345" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c356" id="hidden-fact-346" name="mlec:AdditionsFromBusinessCombinations" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c358" id="hidden-fact-347" name="mlec:AdditionsFromBusinessCombinations" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c358" id="hidden-fact-348" name="mlec:AmortizationOfTheYear" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c358" id="hidden-fact-349" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c360" id="hidden-fact-350" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c360" id="hidden-fact-351" name="mlec:AdditionsFromBusinessCombinations" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c360" id="hidden-fact-352" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c360" id="hidden-fact-353" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c362" id="hidden-fact-354" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c362" id="hidden-fact-355" name="mlec:AdditionsFromBusinessCombinations" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c362" id="hidden-fact-356" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c362" id="hidden-fact-357" name="mlec:AmortizationOfTheYear" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c362" id="hidden-fact-358" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-359" name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c365" id="hidden-fact-360" name="ifrs-full:Goodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c367" id="hidden-fact-361" name="ifrs-full:Goodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c369" id="hidden-fact-362" name="ifrs-full:Goodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c371" id="hidden-fact-363" name="ifrs-full:Goodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-364" name="ifrs-full:Goodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-365" name="ifrs-full:InvestmentProperty" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-366" name="ifrs-full:InvestmentProperty" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-367" name="mlec:TradeAndOtherPayablesShareholdersAndOtherRelatedParties" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c375" id="hidden-fact-368" name="ifrs-full:CurrentPortionOfLongtermBorrowings" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c380" id="hidden-fact-369" name="ifrs-full:CurrentPortionOfLongtermBorrowings" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c375" id="hidden-fact-370" name="ifrs-full:OtherBorrowings" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c381" id="hidden-fact-371" name="ifrs-full:OtherBorrowings" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c387" id="hidden-fact-372" name="ifrs-full:ShorttermBorrowings" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c388" id="hidden-fact-373" name="ifrs-full:ShorttermBorrowings" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c393" id="hidden-fact-374" name="ifrs-full:ShorttermBorrowings" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c394" id="hidden-fact-375" name="ifrs-full:ShorttermBorrowings" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c387" id="hidden-fact-376" name="ifrs-full:LongtermBorrowings" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c388" id="hidden-fact-377" name="ifrs-full:LongtermBorrowings" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c401" id="hidden-fact-378" name="ifrs-full:LongtermBorrowings" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c402" id="hidden-fact-379" name="ifrs-full:LongtermBorrowings" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c395" id="hidden-fact-380" name="ifrs-full:LongtermBorrowings" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c396" id="hidden-fact-381" name="ifrs-full:LongtermBorrowings" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-382" name="ifrs-full:CurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-383" name="ifrs-full:NoncurrentAdvances" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-384" name="ifrs-full:NoncurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-385" name="ifrs-full:NoncurrentDeferredIncomeIncludingNoncurrentContractLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c406" id="hidden-fact-386" name="ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c417" id="hidden-fact-387" name="ifrs-full:AdditionalProvisionsOtherProvisions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c420" id="hidden-fact-388" name="ifrs-full:AdditionalProvisionsOtherProvisions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c423" id="hidden-fact-389" name="ifrs-full:AdditionalProvisionsOtherProvisions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c434" id="hidden-fact-390" name="ifrs-full:LossesOnDisposalsOfInvestments" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-391" name="ifrs-full:CurrentWarrantLiability" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c47" id="hidden-fact-392" name="ifrs-full:CurrentWarrantLiability" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-393" name="mlec:AdditionsWarrantsForTheYear" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-394" name="mlec:AdditionsFromBusinessCombination" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-395" name="ifrs-full:CurrentWarrantLiability" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-396" name="mlec:LossOfControl" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-397" name="mlec:LossOfControl" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-398" name="mlec:AnalysisAndStorage" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-399" name="ifrs-full:RoyaltyExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-400" name="mlec:ImportAndExportExpenses" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-401" name="mlec:ImportAndExportExpenses" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-402" name="ifrs-full:DepreciationRightofuseAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-403" name="ifrs-full:AdvertisingExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-404" name="ifrs-full:AdvertisingExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-405" name="mlec:SurveillanceExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-406" name="mlec:SurveillanceExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c441" id="hidden-fact-407" name="mlec:AnalysisAndStorage" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c441" id="hidden-fact-408" name="mlec:ImportAndExportExpenses" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c441" id="hidden-fact-409" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossTradeReceivables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c442" id="hidden-fact-410" name="mlec:AllowanceForObsolescences" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c441" id="hidden-fact-411" name="ifrs-full:AdvertisingExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c441" id="hidden-fact-412" name="mlec:SurveillanceExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c441" id="hidden-fact-413" name="mlec:ProfessionalFeesRelatedParties" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c444" id="hidden-fact-414" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossTradeReceivables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c444" id="hidden-fact-415" name="mlec:ProfessionalFeesRelatedParties" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c447" id="hidden-fact-416" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossTradeReceivables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c447" id="hidden-fact-417" name="mlec:SharebasedIncentivesForEmployees" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c447" id="hidden-fact-418" name="mlec:ProfessionalFeesRelatedParties" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c447" id="hidden-fact-419" name="mlec:LicensesandPatents" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c447" id="hidden-fact-420" name="mlec:Contingencies" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c448" id="hidden-fact-421" name="mlec:EnvironmentalImpactTreatment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c435" id="hidden-fact-422" name="mlec:PrepaymentPremiumFee" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c450" id="hidden-fact-423" name="mlec:PrepaymentPremiumFee" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c450" id="hidden-fact-424" name="mlec:InterestAccruedWithRelatedParties" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-425" name="ifrs-full:RevenueFromSaleOfAgriculturalProduce" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-426" name="ifrs-full:RevenueFromSaleOfAgriculturalProduce" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-427" name="mlec:GainOnBargainPurchase" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-428" name="mlec:RemeasurementToFairValueOfPreexistingInterestInAnAcquiree" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-429" name="mlec:RemeasurementToFairValueOfPreexistingInterestInAnAcquiree" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c451" id="hidden-fact-430" name="ifrs-full:NetDeferredTaxAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c453" id="hidden-fact-431" name="ifrs-full:NetDeferredTaxAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c455" id="hidden-fact-432" name="ifrs-full:NetDeferredTaxAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c457" id="hidden-fact-433" name="ifrs-full:NetDeferredTaxAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c459" id="hidden-fact-434" name="ifrs-full:NetDeferredTaxAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c461" id="hidden-fact-435" name="ifrs-full:NetDeferredTaxAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c463" id="hidden-fact-436" name="ifrs-full:NetDeferredTaxAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c465" id="hidden-fact-437" name="ifrs-full:NetDeferredTaxAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c469" id="hidden-fact-438" name="ifrs-full:NetDeferredTaxLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c471" id="hidden-fact-439" name="ifrs-full:NetDeferredTaxLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c453" id="hidden-fact-440" name="ifrs-full:NetDeferredTaxLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c473" id="hidden-fact-441" name="ifrs-full:NetDeferredTaxLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c475" id="hidden-fact-442" name="ifrs-full:NetDeferredTaxLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c455" id="hidden-fact-443" name="ifrs-full:NetDeferredTaxLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c451" id="hidden-fact-444" name="ifrs-full:NetDeferredTaxAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c482" id="hidden-fact-445" name="ifrs-full:NetDeferredTaxAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c459" id="hidden-fact-446" name="ifrs-full:NetDeferredTaxAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c457" id="hidden-fact-447" name="ifrs-full:NetDeferredTaxAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c461" id="hidden-fact-448" name="ifrs-full:NetDeferredTaxAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c486" id="hidden-fact-449" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c463" id="hidden-fact-450" name="ifrs-full:NetDeferredTaxAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c487" id="hidden-fact-451" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c455" id="hidden-fact-452" name="ifrs-full:NetDeferredTaxAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c465" id="hidden-fact-453" name="ifrs-full:NetDeferredTaxAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c469" id="hidden-fact-454" name="ifrs-full:NetDeferredTaxAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c491" id="hidden-fact-455" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c471" id="hidden-fact-456" name="ifrs-full:NetDeferredTaxAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c492" id="hidden-fact-457" name="ifrs-full:NetDeferredTaxAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c493" id="hidden-fact-458" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c494" id="hidden-fact-459" name="ifrs-full:NetDeferredTaxAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c496" id="hidden-fact-460" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c497" id="hidden-fact-461" name="ifrs-full:NetDeferredTaxAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c473" id="hidden-fact-462" name="ifrs-full:NetDeferredTaxAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c475" id="hidden-fact-463" name="ifrs-full:NetDeferredTaxAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c502" id="hidden-fact-464" name="ifrs-full:NetDeferredTaxAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c507" id="hidden-fact-465" name="ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c509" id="hidden-fact-466" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c509" id="hidden-fact-467" name="ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c511" id="hidden-fact-468" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c511" id="hidden-fact-469" name="ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c513" id="hidden-fact-470" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c513" id="hidden-fact-471" name="ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c515" id="hidden-fact-472" name="ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c517" id="hidden-fact-473" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c517" id="hidden-fact-474" name="ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c522" id="hidden-fact-475" name="ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c524" id="hidden-fact-476" name="ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c526" id="hidden-fact-477" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c526" id="hidden-fact-478" name="ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c529" id="hidden-fact-479" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c529" id="hidden-fact-480" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c529" id="hidden-fact-481" name="ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c531" id="hidden-fact-482" name="ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c533" id="hidden-fact-483" name="ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c535" id="hidden-fact-484" name="ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c535" id="hidden-fact-485" name="ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c538" id="hidden-fact-486" name="ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-487" name="mlec:PuttableInstrumentsCharge" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-488" name="mlec:PuttableInstrumentsCharge" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-489" name="mlec:MutualFundsAdjustment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-490" name="ifrs-full:TaxEffectFromChangeInTaxRate" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-491" name="ifrs-full:CurrentTaxExpenseIncome" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c539" id="hidden-fact-492" name="ifrs-full:TaxExpenseIncomeAtApplicableTaxRate" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c541" id="hidden-fact-493" name="ifrs-full:TaxExpenseIncomeAtApplicableTaxRate" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c544" id="hidden-fact-494" name="ifrs-full:TaxExpenseIncomeAtApplicableTaxRate" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-495" name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c559" id="hidden-fact-496" name="ifrs-full:CurrentAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c559" id="hidden-fact-497" name="ifrs-full:NoncurrentAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c559" id="hidden-fact-498" name="ifrs-full:Assets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c559" id="hidden-fact-499" name="ifrs-full:CurrentLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c559" id="hidden-fact-500" name="ifrs-full:NoncurrentLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c559" id="hidden-fact-501" name="ifrs-full:Liabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c559" id="hidden-fact-502" name="ifrs-full:Equity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c559" id="hidden-fact-503" name="ifrs-full:EquityAndLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c561" id="hidden-fact-504" name="mlec:RevaluationOfPropertyPlantAndEquipmentNetOfTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c562" id="hidden-fact-505" name="mlec:RevaluationOfPropertyPlantAndEquipmentNetOfTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c564" id="hidden-fact-506" name="mlec:InvestmentInKindInOtherRelatedPartiesNonCashTransactionsInvestmentActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c566" id="hidden-fact-507" name="mlec:OwnShareHeld" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c565" id="hidden-fact-508" name="mlec:ExchangeOfIntangibleAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c566" id="hidden-fact-509" name="mlec:ExchangeOfIntangibleAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c564" id="hidden-fact-510" name="mlec:NonMonetaryContributionsInJointVenturesNonCashTransactionsInvestmentActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c565" id="hidden-fact-511" name="mlec:NonMonetaryContributionsInJointVenturesNonCashTransactionsInvestmentActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c564" id="hidden-fact-512" name="ifrs-full:ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c564" id="hidden-fact-513" name="mlec:CapitalizationOfConvertibleFinancingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c565" id="hidden-fact-514" name="mlec:CapitalizationOfConvertibleFinancingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c565" id="hidden-fact-515" name="mlec:AssignmentOfReceivablesWithShareholdersAndOtherRelatedParties" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c566" id="hidden-fact-516" name="mlec:AssignmentOfReceivablesWithShareholdersAndOtherRelatedParties" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c565" id="hidden-fact-517" name="mlec:CompensationPaymentFinancedByAcquisitionOfIntangibleAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c566" id="hidden-fact-518" name="mlec:CompensationPaymentFinancedByAcquisitionOfIntangibleAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c564" id="hidden-fact-519" name="mlec:IncreaseThroughAcquisitionOfNonControllingInterestInSubsidiaries" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c571" id="hidden-fact-520" name="mlec:IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c572" id="hidden-fact-521" name="mlec:DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c570" id="hidden-fact-522" name="mlec:DecreaseThroughCapitalizationOfDebtLiabilitiesArisingFromFinancingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c571" id="hidden-fact-523" name="mlec:DecreaseThroughCapitalizationOfDebtLiabilitiesArisingFromFinancingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c571" id="hidden-fact-524" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c577" id="hidden-fact-525" name="mlec:IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c578" id="hidden-fact-526" name="mlec:IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c578" id="hidden-fact-527" name="mlec:DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c578" id="hidden-fact-528" name="mlec:FinancingForAssetsAcquisitions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c577" id="hidden-fact-529" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c583" id="hidden-fact-530" name="mlec:IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c584" id="hidden-fact-531" name="mlec:IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c582" id="hidden-fact-532" name="mlec:PrepaymentPremiumFee" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c583" id="hidden-fact-533" name="mlec:PrepaymentPremiumFee" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c584" id="hidden-fact-534" name="mlec:NoncashActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c583" id="hidden-fact-535" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c583" id="hidden-fact-536" name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c586" id="hidden-fact-537" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c589" id="hidden-fact-538" name="ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c592" id="hidden-fact-539" name="ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c601" id="hidden-fact-540" name="ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c605" id="hidden-fact-541" name="mlec:InvestmentsMeasuredAtFairValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-542" name="mlec:InvestmentsMeasuredAtFairValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c607" id="hidden-fact-543" name="mlec:DueToJointVenturesAndAssociatesNonCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-544" name="mlec:DueToJointVenturesAndAssociatesNonCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c612" id="hidden-fact-545" name="ifrs-full:LossesOnDisposalsOfInvestments" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c611" id="hidden-fact-546" name="mlec:SaleOfEquityInvestment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c611" id="hidden-fact-547" name="mlec:JointVenturesAndAssociatesAccountedForUsingEquityMethodReclassificationChangeInOwnership" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c611" id="hidden-fact-548" name="mlec:EquityMethodInvestmentIncreaseFromShareBasedIncentives" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c611" id="hidden-fact-549" name="mlec:ChangeinJointVenturesDividendsDistribution" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c626" id="hidden-fact-550" name="ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c627" id="hidden-fact-551" name="ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c629" id="hidden-fact-552" name="ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c630" id="hidden-fact-553" name="ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c640" id="hidden-fact-554" name="ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c644" id="hidden-fact-555" name="ifrs-full:CurrentAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c644" id="hidden-fact-556" name="ifrs-full:NoncurrentAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c644" id="hidden-fact-557" name="ifrs-full:CurrentLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c644" id="hidden-fact-558" name="ifrs-full:NoncurrentLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c644" id="hidden-fact-559" name="ifrs-full:Equity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c645" id="hidden-fact-560" name="ifrs-full:CostOfSales" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c645" id="hidden-fact-561" name="ifrs-full:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c656" id="hidden-fact-562" name="ifrs-full:CurrentAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c657" id="hidden-fact-563" name="ifrs-full:CostOfSales" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c658" id="hidden-fact-564" name="ifrs-full:CurrentAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c659" id="hidden-fact-565" name="ifrs-full:CostOfSales" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c660" id="hidden-fact-566" name="ifrs-full:CurrentAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c661" id="hidden-fact-567" name="ifrs-full:CostOfSales" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c663" id="hidden-fact-568" name="ifrs-full:RevenueFromRoyalties" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c664" id="hidden-fact-569" name="ifrs-full:RevenueFromRoyalties" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c665" id="hidden-fact-570" name="ifrs-full:RevenueFromRoyalties" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c662" id="hidden-fact-571" name="ifrs-full:LicenceFeeIncome" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c663" id="hidden-fact-572" name="ifrs-full:LicenceFeeIncome" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c665" id="hidden-fact-573" name="ifrs-full:LicenceFeeIncome" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c663" id="hidden-fact-574" name="ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c664" id="hidden-fact-575" name="ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c665" id="hidden-fact-576" name="ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c662" id="hidden-fact-577" name="ifrs-full:RevenueFromGovernmentGrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c663" id="hidden-fact-578" name="ifrs-full:RevenueFromGovernmentGrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c664" id="hidden-fact-579" name="ifrs-full:RevenueFromGovernmentGrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c665" id="hidden-fact-580" name="ifrs-full:CostOfSales" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c673" id="hidden-fact-581" name="ifrs-full:RevenueFromRoyalties" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c674" id="hidden-fact-582" name="ifrs-full:RevenueFromRoyalties" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c675" id="hidden-fact-583" name="ifrs-full:RevenueFromRoyalties" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c673" id="hidden-fact-584" name="ifrs-full:LicenceFeeIncome" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c675" id="hidden-fact-585" name="ifrs-full:LicenceFeeIncome" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c673" id="hidden-fact-586" name="ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c674" id="hidden-fact-587" name="ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c675" id="hidden-fact-588" name="ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c672" id="hidden-fact-589" name="ifrs-full:RevenueFromGovernmentGrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c673" id="hidden-fact-590" name="ifrs-full:RevenueFromGovernmentGrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c674" id="hidden-fact-591" name="ifrs-full:RevenueFromGovernmentGrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c683" id="hidden-fact-592" name="ifrs-full:RevenueFromRoyalties" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c684" id="hidden-fact-593" name="ifrs-full:RevenueFromRoyalties" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c685" id="hidden-fact-594" name="ifrs-full:RevenueFromRoyalties" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c685" id="hidden-fact-595" name="ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c682" id="hidden-fact-596" name="ifrs-full:RevenueFromGovernmentGrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c683" id="hidden-fact-597" name="ifrs-full:RevenueFromGovernmentGrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c684" id="hidden-fact-598" name="ifrs-full:RevenueFromGovernmentGrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c728" id="hidden-fact-599" name="ifrs-full:RevenueFromContractsWithCustomers" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c760" id="hidden-fact-600" name="ifrs-full:NoncurrentAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c762" id="hidden-fact-601" name="ifrs-full:NoncurrentAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c768" id="hidden-fact-602" name="ifrs-full:NoncurrentAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c436" id="hidden-fact-603" name="ifrs-full:Goodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c771" id="hidden-fact-604" name="ifrs-full:TradeAndOtherPayables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c772" id="hidden-fact-605" name="ifrs-full:TradeAndOtherPayables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c774" id="hidden-fact-606" name="ifrs-full:Borrowings" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c776" id="hidden-fact-607" name="mlec:ConvertibleNotes" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c777" id="hidden-fact-608" name="mlec:ConvertibleNotes" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c780" id="hidden-fact-609" name="mlec:LeasingLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c781" id="hidden-fact-610" name="mlec:LeasingLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c783" id="hidden-fact-611" name="ifrs-full:FinancialLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c787" id="hidden-fact-612" name="ifrs-full:TradeAndOtherPayables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c791" id="hidden-fact-613" name="mlec:ConsiderationForAcquisitionOfAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c794" id="hidden-fact-614" name="mlec:ConvertibleNotes" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c795" id="hidden-fact-615" name="mlec:ConvertibleNotes" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c807" id="hidden-fact-616" name="ifrs-full:CurrentFinancialLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c807" id="hidden-fact-617" name="ifrs-full:NoncurrentFinancialLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c807" id="hidden-fact-618" name="ifrs-full:LiabilitiesArisingFromFinancingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c811" id="hidden-fact-619" name="ifrs-full:CashAndCashEquivalents" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c814" id="hidden-fact-620" name="ifrs-full:OtherFinancialAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c819" id="hidden-fact-621" name="ifrs-full:TradeReceivables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c820" id="hidden-fact-622" name="ifrs-full:TradeReceivables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c823" id="hidden-fact-623" name="ifrs-full:OtherCurrentReceivables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c824" id="hidden-fact-624" name="ifrs-full:OtherCurrentReceivables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c831" id="hidden-fact-625" name="ifrs-full:FinancialLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c835" id="hidden-fact-626" name="ifrs-full:FinancialLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c836" id="hidden-fact-627" name="ifrs-full:FinancialLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c837" id="hidden-fact-628" name="ifrs-full:FinancialLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c839" id="hidden-fact-629" name="ifrs-full:FinancialLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c843" id="hidden-fact-630" name="ifrs-full:FinancialLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c844" id="hidden-fact-631" name="ifrs-full:FinancialLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c847" id="hidden-fact-632" name="ifrs-full:FinancialLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c848" id="hidden-fact-633" name="ifrs-full:FinancialLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c849" id="hidden-fact-634" name="ifrs-full:FinancialLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c850" id="hidden-fact-635" name="ifrs-full:FinancialLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c852" id="hidden-fact-636" name="ifrs-full:FinancialLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfFairValueOfFinancialInstrumentsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfFairValueOfFinancialInstrumentsExplanatory" id="ixv-46447">Level 3 comprises financial instruments with inputs for estimating fair value that are not based on observable market data.</ix:nonNumeric><!--Text not found in tagged paragraph preceding Schedule of Fair Value by Hierarchy-->
<ix:nonFraction contextRef="c858" id="hidden-fact-637" name="ifrs-full:FinancialAssetsAtFairValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c859" id="hidden-fact-638" name="ifrs-full:FinancialAssetsAtFairValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c861" id="hidden-fact-639" name="ifrs-full:FinancialLiabilitiesAtFairValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c864" id="hidden-fact-640" name="ifrs-full:FinancialAssetsAtFairValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c865" id="hidden-fact-641" name="ifrs-full:FinancialAssetsAtFairValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c867" id="hidden-fact-642" name="ifrs-full:FinancialAssetsAtFairValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c868" id="hidden-fact-643" name="ifrs-full:FinancialAssetsAtFairValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c870" id="hidden-fact-644" name="ifrs-full:FinancialAssetsAtFairValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c871" id="hidden-fact-645" name="ifrs-full:FinancialAssetsAtFairValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c873" id="hidden-fact-646" name="ifrs-full:FinancialAssetsAtFairValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c874" id="hidden-fact-647" name="ifrs-full:FinancialAssetsAtFairValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c876" id="hidden-fact-648" name="ifrs-full:FinancialAssetsAtFairValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c877" id="hidden-fact-649" name="ifrs-full:FinancialAssetsAtFairValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c878" id="hidden-fact-650" name="ifrs-full:FinancialLiabilitiesAtFairValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c880" id="hidden-fact-651" name="ifrs-full:FinancialLiabilitiesAtFairValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c882" id="hidden-fact-652" name="ifrs-full:FinancialLiabilitiesAtFairValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c883" id="hidden-fact-653" name="ifrs-full:FinancialLiabilitiesAtFairValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c887" id="hidden-fact-654" name="mlec:RightOfUseAssetLossOfControl" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c892" id="hidden-fact-655" name="mlec:LossOfControlDepreciation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c889" id="hidden-fact-656" name="mlec:AccumulatedDepreciationAtTheEndOfThePeriod" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-657" name="mlec:LossOfControlLeaseLiability" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-658" name="ifrs-full:NoncurrentLeaseLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c893" id="hidden-fact-659" name="ifrs-full:Machinery" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c895" id="hidden-fact-660" name="ifrs-full:Vehicles" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c897" id="hidden-fact-661" name="ifrs-full:ComputerSoftware" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" id="ixv-46473">During the year ended June 30, 2025, the transactions between the Group and related parties, and the related balances owed by and to them for the year ended June 30, 2025, 2024 and 2023 are as follows:</ix:nonNumeric><!--Text not found in tagged paragraph preceding Schedule of Transactions Between the Group and Related Parties-->
<ix:nonFraction contextRef="c913" id="hidden-fact-662" name="mlec:ValueOfTransactionsForThePeriodEnded" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c916" id="hidden-fact-663" name="mlec:ValueOfTransactionsForThePeriodEnded" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c917" id="hidden-fact-664" name="mlec:ValueOfTransactionsForThePeriodEnded" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c919" id="hidden-fact-665" name="mlec:ValueOfTransactionsForThePeriodEnded" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c923" id="hidden-fact-666" name="mlec:ValueOfTransactionsForThePeriodEnded" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c924" id="hidden-fact-667" name="mlec:ValueOfTransactionsForThePeriodEnded" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c925" id="hidden-fact-668" name="mlec:ValueOfTransactionsForThePeriodEnded" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c928" id="hidden-fact-669" name="mlec:ValueOfTransactionsForThePeriodEnded" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c944" id="hidden-fact-670" name="mlec:ValueOfTransactionsForThePeriodEnded" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c945" id="hidden-fact-671" name="mlec:ValueOfTransactionsForThePeriodEnded" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c947" id="hidden-fact-672" name="mlec:ValueOfTransactionsForThePeriodEnded" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c948" id="hidden-fact-673" name="mlec:ValueOfTransactionsForThePeriodEnded" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c956" id="hidden-fact-674" name="ifrs-full:TradeAndOtherReceivablesDueFromRelatedParties" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c959" id="hidden-fact-675" name="ifrs-full:TradeAndOtherReceivablesDueFromRelatedParties" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c965" id="hidden-fact-676" name="ifrs-full:TradeAndOtherPayablesToRelatedParties" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c968" id="hidden-fact-677" name="ifrs-full:TradeAndOtherPayablesToRelatedParties" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c971" id="hidden-fact-678" name="ifrs-full:TradeAndOtherPayablesToRelatedParties" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c973" id="hidden-fact-679" name="ifrs-full:TradeAndOtherPayablesToRelatedParties" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c1011" id="hidden-fact-680" name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c1014" id="hidden-fact-681" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c1014" id="hidden-fact-682" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c1014" id="hidden-fact-683" name="ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c1014" id="hidden-fact-684" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c1014" id="hidden-fact-685" name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c1014" id="hidden-fact-686" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c1015" id="hidden-fact-687" name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c1015" id="hidden-fact-688" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c1016" id="hidden-fact-689" name="ifrs-full:NumberOfOutstandingShareOptions" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c1016" id="hidden-fact-690" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey" id="ixv-46503">0001937737</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:AmendmentFlag" id="ixv-46504">false</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:DocumentFiscalPeriodFocus" id="ixv-46505">FY</ix:nonNumeric>
<ix:nonNumeric contextRef="c1" name="dei:EntityAddressPostalZipCode" id="ixv-46506">KY1-9009</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="mlec-20250630.xsd" xlink:type="simple"/></ix:references>
<ix:resources xmlns="http://www.xbrl.org/2003/instance"><ix:relationship xmlns="" fromRefs="ix_0_fact ix_1_fact ix_2_fact ix_3_fact ix_4_fact ix_5_fact ix_6_fact ix_7_fact ix_8_fact ix_9_fact ix_10_fact ix_11_fact" toRefs="ix_0_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_12_fact hidden-fact-171 ix_13_fact hidden-fact-172 ix_14_fact hidden-fact-173 ix_15_fact hidden-fact-174 ix_0_fact ix_1_fact ix_2_fact ix_3_fact ix_4_fact ix_5_fact ix_16_fact ix_17_fact" toRefs="ix_1_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_18_fact ix_19_fact" toRefs="ix_2_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_20_fact hidden-fact-175" toRefs="ix_3_footnote"/>
<ix:relationship xmlns="" fromRefs="hidden-fact-244 ix_21_fact ix_22_fact ix_23_fact ix_24_fact ix_25_fact ix_26_fact ix_27_fact ix_28_fact ix_29_fact ix_30_fact hidden-fact-289 hidden-fact-295 hidden-fact-301 hidden-fact-307 hidden-fact-313 hidden-fact-316 ix_31_fact" toRefs="ix_4_footnote"/>
<ix:relationship xmlns="" fromRefs="hidden-fact-321 ix_32_fact hidden-fact-329 hidden-fact-333 hidden-fact-336 hidden-fact-338 hidden-fact-340 ix_33_fact hidden-fact-346 hidden-fact-347 hidden-fact-351 hidden-fact-355 ix_34_fact" toRefs="ix_5_footnote"/>
<ix:relationship xmlns="" fromRefs="hidden-fact-245 hidden-fact-248 hidden-fact-253 hidden-fact-256 hidden-fact-258 hidden-fact-262 hidden-fact-267 hidden-fact-272 hidden-fact-274 hidden-fact-279 hidden-fact-283 ix_35_fact ix_36_fact ix_37_fact ix_38_fact ix_39_fact ix_40_fact ix_41_fact" toRefs="ix_6_footnote"/>
<ix:relationship xmlns="" fromRefs="hidden-fact-390 ix_42_fact" toRefs="ix_7_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_43_fact" toRefs="ix_8_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_44_fact ix_45_fact ix_46_fact" toRefs="ix_9_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_47_fact ix_48_fact hidden-fact-623 hidden-fact-624" toRefs="ix_10_footnote"/>
<xbrli:context xmlns="" id="c0">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c1">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c2">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mlec:OrdinarySharesWithNominalValueOfUS010PerShareMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c3">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mlec:WarrantsExercisableForOrdinarySharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c4">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c5">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c6">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c7">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c8">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c9">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:SharesIssuedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c10">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:OwnSharesHeldMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c11">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c12">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c13">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c14">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c15">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:RevaluationOfPropertyPlantEquipmentAndEffectOfTaxRateChangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c16">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c17">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c18">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c19">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:SharesIssuedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c20">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:OwnSharesHeldMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c21">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c22">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c23">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c24">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c25">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:RevaluationOfPropertyPlantEquipmentAndEffectOfTaxRateChangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c26">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c27">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c28">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c29">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:SharesIssuedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c30">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:OwnSharesHeldMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c31">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c32">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c33">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c34">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c35">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:RevaluationOfPropertyPlantEquipmentAndEffectOfTaxRateChangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c36">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c37">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c38">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c39">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:OwnSharesHeldMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c40">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c41">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c42">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c43">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c44">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:RevaluationOfPropertyPlantEquipmentAndEffectOfTaxRateChangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c45">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c46">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c47">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c48">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c49">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:OwnSharesHeldMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c50">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c51">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c52">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c53">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c54">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:RevaluationOfPropertyPlantEquipmentAndEffectOfTaxRateChangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c55">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c56">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c57">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c58">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c59">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c60">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c61">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c62">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:RevaluationOfPropertyPlantEquipmentAndEffectOfTaxRateChangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c63">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c64">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c65">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c66">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c67">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c68">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c69">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c70">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c71">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:RevaluationOfPropertyPlantEquipmentAndEffectOfTaxRateChangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c72">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c73">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c74">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">mlec:MoolecScienceLuxembourgMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-05-14</xbrli:startDate>
    <xbrli:endDate>2025-05-14</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c75">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">mlec:MoolecScienceLuxembourgMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-05-14</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c76">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-05-14</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c77">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">mlec:MoolecScienceCaymanIslandsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-05-22</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c78">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-05-22</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c79">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresGroupLimitedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-05-22</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c80">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-05-22</xbrli:startDate>
    <xbrli:endDate>2025-05-22</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c81">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:GentleTechMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-05-22</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c82">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">mlec:HoldbackMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-05-22</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c83">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresGroupLimitedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">mlec:OrdinarySharesOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-05-22</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c84">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:GentleTechMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">mlec:OrdinarySharesOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-05-22</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c85">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-06-16</xbrli:startDate>
    <xbrli:endDate>2025-06-16</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c86">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">mlec:BioceresSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c87">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">mlec:SubsequentEventsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">mlec:BioceresSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-07-01</xbrli:startDate>
    <xbrli:endDate>2025-07-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c88">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">mlec:SubsequentEventsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">mlec:BioceresSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-07-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c89">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">mlec:BioceresSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c90">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">mlec:BioceresLLCMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c91">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2018-06-30</xbrli:startDate>
    <xbrli:endDate>2018-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c92">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-16</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c93">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresGroupLimitedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-16</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c94">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BusinessCombinationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-16</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c95">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-16</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c96">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BusinessCombinationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-16</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c97">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:MoolecScienceLimitedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c98">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:MoolecScienceLimitedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c99">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:AGBiomoleculesLLCMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c100">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:AGBiomoleculesLLCMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c101">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:ValoraSoySAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c102">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:ValoraSoySAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c103">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:NutreconLLCMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c104">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:NutreconLLCMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c105">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:SynBioPowerlabsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c106">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:SynBioPowerlabsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c107">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:GentleTechMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c108">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:GentleTechMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c109">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:GentleFarmingMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c110">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:GentleFarmingMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c111">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:GFASMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c112">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:GFASMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c113">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresGroupLimitedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c114">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresGroupLimitedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c115">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsBIOXMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c116">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsBIOXMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c117">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresLLCMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c118">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresLLCMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c119">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c120">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c121">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresTechServicesLLCMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c122">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresTechServicesLLCMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c123">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:InitiallyAppliedIFRSsAxis">ifrs-full:LeaseLiabilityInASaleAndLeasebackMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c124">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:InitiallyAppliedIFRSsAxis">ifrs-full:NoncurrentLiabilitiesWithCovenantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c125">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c126">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c127">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c128">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c129">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c130">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c131">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c132">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c133">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c134">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:IfrsFull_machineryAndEquipmentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c135">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:IfrsFull_machineryAndEquipmentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c136">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c137">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c138">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c139">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c140">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c141">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c142">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c143">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c144">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c145">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c146">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresGroupLimitedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c147">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">mlec:ProFarmGroupIncMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c148">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">mlec:NatalAgroSRLMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-10</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c149">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">mlec:NatalAgroSRLMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c150">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis">mlec:ProFarmGroupIncMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c151">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis">mlec:NatalAgroSRLMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c152">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis">mlec:MoolecScienceSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c153">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis">mlec:MoolecScienceSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c154">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c155">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c156">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresGroupMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c157">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c158">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">mlec:SubsequentEventsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-07-01</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c159">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:SecuredGuaranteedNotesDue2026Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">mlec:FortyEightMonthsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c160">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:SecuredGuaranteedNotesDue2026Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c161">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:SecuredGuaranteedNotesDue2026Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c162">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:SecuredGuaranteedNotesDue2026Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c163">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:SecuredConvertibleGuaranteedNotesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-18</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c164">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:SecuredConvertibleGuaranteedNotesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-18</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c165">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:SecuredConvertibleGuaranteedNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-18</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c166">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-18</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c167">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-06-18</xbrli:startDate>
    <xbrli:endDate>2025-06-18</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c168">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:SecuredConvertibleGuaranteedNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c169">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:SecuredConvertibleGuaranteedNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c170">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-18</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c171">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-18</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c172">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-06-18</xbrli:startDate>
    <xbrli:endDate>2025-06-18</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c173">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-06-18</xbrli:startDate>
    <xbrli:endDate>2025-06-18</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c174">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:InvestmentsInSharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c175">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:InvestmentsInSharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c176">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:MutualFundsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c177">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:MutualFundsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c178">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:OtherInvestmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c179">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:OtherInvestmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c180">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="mlec:IfrsBalanceSheetLocationAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c181">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="mlec:IfrsBalanceSheetLocationAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c182">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:TaxesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c183">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:TaxesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c184">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:InsuranceToBeAccruedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c185">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:InsuranceToBeAccruedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c186">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:OtherReceivablesJointVenturesAndAssociatesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c187">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:OtherReceivablesJointVenturesAndAssociatesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c188">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PrepaymentsToSuppliersMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c189">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PrepaymentsToSuppliersMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c190">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:ShareholdersAndOtherRelatedPartiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c191">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:ShareholdersAndOtherRelatedPartiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c192">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:GovernmentsGrantsReceivableMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c193">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:GovernmentsGrantsReceivableMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c194">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PrepaidExpensesAndOtherReceivablesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c195">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PrepaidExpensesAndOtherReceivablesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c196">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:LoansReceivablesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c197">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:LoansReceivablesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c198">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:MiscellaneousMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c199">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:MiscellaneousMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c200">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:OtherReceivableMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c201">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:OtherReceivableMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c202">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:ReimbursementsOverExportsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c203">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:ReimbursementsOverExportsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c204">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:SeedsAndGrainsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c205">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:SeedsAndGrainsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c206">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:MicrobiologicalResaleProductsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c207">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:MicrobiologicalResaleProductsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c208">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:MicrobiologicalProductsProducedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c209">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:MicrobiologicalProductsProducedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c210">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:GoodsInTransitMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c211">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:GoodsInTransitMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c212">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:SuppliesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c213">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:SuppliesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c214">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:AgriculturalProductsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c215">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:AgriculturalProductsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c216">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:AllowanceForObsolescenceMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c217">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:AllowanceForObsolescenceMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c218">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:BiologicalAssetsSoybeanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c219">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:BiologicalAssetsCornMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c220">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:BiologicalAssetsWheatMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c221">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:BiologicalAssetsBarleyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c222">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:SunflowerMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c223">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:BiologicalAssetsSoybeanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c224">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:BiologicalAssetsCornMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c225">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:BiologicalAssetsWheatMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c226">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:BiologicalAssetsBarleyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c227">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:SunflowerMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c228">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:BiologicalAssetsSoybeanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c229">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:BiologicalAssetsCornMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c230">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:BiologicalAssetsWheatMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c231">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:BiologicalAssetsBarleyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c232">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:SunflowerMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c233">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:BiologicalAssetsSoybeanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c234">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:BiologicalAssetsCornMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c235">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:BiologicalAssetsWheatMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c236">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:BiologicalAssetsBarleyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c237">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:SunflowerMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c238">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:BiologicalAssetsSoybeanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c239">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:BiologicalAssetsCornMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c240">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:BiologicalAssetsWheatMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c241">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:BiologicalAssetsBarleyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c242">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:SunflowerMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c243">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c244">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c245">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c246">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c247">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c248">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c249">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c250">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c251">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c252">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c253">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c254">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c255">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:MachineryAndEquipmentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c256">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:MachineryAndEquipmentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c257">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:MachineryAndEquipmentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c258">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c259">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c260">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c261">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c262">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c263">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c264">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c265">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c266">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c267">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:ResearchInstrumentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c268">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:ResearchInstrumentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c269">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:ResearchInstrumentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c270">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c271">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c272">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c273">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c274">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c275">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c276">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c277">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c278">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:MachineryAndEquipmentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c279">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:MachineryAndEquipmentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c280">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c281">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c282">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c283">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c284">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c285">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c286">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c287">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:AlfalfaGenuityHarXstraMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c288">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:AlfalfaGenuityHarXstraMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c289">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:AlfalfaGenuityHarXstraMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c290">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:HB4SoyAndBreedingProgramMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c291">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:HB4SoyAndBreedingProgramMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c292">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:HB4SoyAndBreedingProgramMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c293">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:IntegratedSeedProductsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c294">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:IntegratedSeedProductsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c295">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:IntegratedSeedProductsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c296">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:MicrobiologicalProductsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c297">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:MicrobiologicalProductsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c298">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:MicrobiologicalProductsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c299">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:MicrobiologicalProductsInProgressMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c300">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:MicrobiologicalProductsInProgressMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c301">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:MicrobiologicalProductsInProgressMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c302">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:TrademarksAndPatentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c303">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:TrademarksAndPatentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c304">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:TrademarksAndPatentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c305">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:TrademarksAndPatentsWithIndefiniteUsefulLifeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c306">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:TrademarksAndPatentsWithIndefiniteUsefulLifeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c307">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:TrademarksAndPatentsWithIndefiniteUsefulLifeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c308">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:SoftwareMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c309">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:SoftwareMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c310">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:SoftwareMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c311">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:SoftwareInProgressMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c312">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:SoftwareInProgressMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c313">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:SoftwareInProgressMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c314">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:CustomerLoyaltyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c315">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:CustomerLoyaltyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c316">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:CustomerLoyaltyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c317">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:RGRSOXWheatMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c318">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:RGRSOXWheatMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c319">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:RGRSOXWheatMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c320">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:SustainableAgriculturalEquipmentTechnologyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c321">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:SustainableAgriculturalEquipmentTechnologyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c322">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:SustainableAgriculturalEquipmentTechnologyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c323">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:FungalBiomassMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c324">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:FungalBiomassMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c325">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:FungalBiomassMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c326">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:PiggysooyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c327">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:PiggysooyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c328">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:PiggysooyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c329">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:SafflowerGLAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c330">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:SafflowerGLAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c331">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:SafflowerGLAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c332">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:SafflowerChimosin20Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c333">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:SafflowerChimosin20Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c334">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:SafflowerChimosin20Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c335">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c336">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c337">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c338">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:AlfalfaGenuityHarXstraMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c339">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:AlfalfaGenuityHarXstraMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c340">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:BacillusPHAsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c341">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:BacillusPHAsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c342">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:BacillusPHAsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c343">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:HB4SoyAndBreedingProgramMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c344">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:HB4SoyAndBreedingProgramMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c345">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:IntegratedSeedProductsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c346">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:IntegratedSeedProductsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c347">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:MicrobiologicalProductsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c348">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:MicrobiologicalProductsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c349">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:MicrobiologicalProductsInProgressMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c350">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:MicrobiologicalProductsInProgressMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c351">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:TrademarksAndPatentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c352">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:TrademarksAndPatentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c353">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:TrademarksAndPatentsWithIndefiniteUsefulLifeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c354">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:TrademarksAndPatentsWithIndefiniteUsefulLifeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c355">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:SoftwareMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c356">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:SoftwareMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c357">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:SoftwareInProgressMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c358">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:SoftwareInProgressMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c359">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:CustomerLoyaltyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c360">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:CustomerLoyaltyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c361">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:RGRSOXWheatMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c362">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:RGRSOXWheatMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c363">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:RizobacterUGEMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c364">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:ProFarmUGEMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c365">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">mlec:RizobacterArgentinaSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c366">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">mlec:RizobacterArgentinaSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c367">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">mlec:BioceresCropsSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c368">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">mlec:BioceresCropsSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c369">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">mlec:InsumosAgroqumicosSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c370">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">mlec:InsumosAgroqumicosSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c371">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">mlec:ProFarmGroupMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c372">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">mlec:ProFarmGroupMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c373">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BankBorrowingMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c374">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BankBorrowingMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c375">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:CorporateBondsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c376">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:CorporateBondsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c377">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:NetLoansPayablesJointVenturesAndAssociatesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c378">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:NetLoansPayablesJointVenturesAndAssociatesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c379">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:ConvertiblePreferenceSharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c380">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:ConvertiblePreferenceSharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c381">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:FinancialBorrowingsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c382">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:FinancialBorrowingsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c383">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BankBorrowingMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c384">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BankBorrowingMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c385">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BankBorrowingMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c386">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BankBorrowingMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c387">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:CorporateBondsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c388">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:CorporateBondsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c389">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:CorporateBondsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c390">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:CorporateBondsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c391">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:ConvertiblePreferenceSharesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c392">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:ConvertiblePreferenceSharesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c393">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:ConvertiblePreferenceSharesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c394">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:ConvertiblePreferenceSharesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c395">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:FinancialBorrowingsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c396">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:FinancialBorrowingsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c397">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:FinancialBorrowingsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c398">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:FinancialBorrowingsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c399">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:ConvertibleNotesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c400">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:ConvertibleNotesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c401">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:ConvertibleNotesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c402">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:ConvertibleNotesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c403">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:ConvertibleNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c404">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:ConvertibleNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c405">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:AllowanceForImpairmentOfTradeDebtorsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c406">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:AllowanceForImpairmentOfTradeDebtorsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c407">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:AllowanceForObsolescenceMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c408">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:AllowanceForObsolescenceMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c409">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:deductedFromAssetsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c410">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:deductedFromAssetsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c411">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:ProvisionForContingenciesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c412">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:ProvisionForContingenciesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c413">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:LiabilitiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c414">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:LiabilitiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c415">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:AllowanceForImpairmentOfTradeDebtorsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c416">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:AllowanceForImpairmentOfTradeDebtorsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c417">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:AllowanceForImpairmentOfTradeDebtorsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c418">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:AllowanceForObsolescenceMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c419">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:AllowanceForObsolescenceMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c420">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:AllowanceForObsolescenceMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c421">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:deductedFromAssetsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c422">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:deductedFromAssetsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c423">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:deductedFromAssetsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c424">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:ProvisionForContingenciesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c425">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:ProvisionForContingenciesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c426">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:ProvisionForContingenciesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c427">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:LiabilitiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c428">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:LiabilitiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c429">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:LiabilitiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c430">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:ConditionalPaymentRizobacterSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c431">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:ConditionalPaymentRizobacterSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c432">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c433">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c434">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c435">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c436">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c437">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-03-28</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c438">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">mlec:NetWheatTechnologyLicensingMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-03-28</xbrli:startDate>
    <xbrli:endDate>2025-03-28</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c439">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">mlec:NetHB4SoybeanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-03-28</xbrli:startDate>
    <xbrli:endDate>2025-03-28</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c440">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-03-28</xbrli:startDate>
    <xbrli:endDate>2025-03-28</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c441">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">ifrs-full:CostOfSalesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c442">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">ifrs-full:SellingGeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c443">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">mlec:ExpensesClassifiedByNatureAndFunctionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c444">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">ifrs-full:CostOfSalesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c445">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">ifrs-full:SellingGeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c446">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">mlec:ExpensesClassifiedByNatureAndFunctionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c447">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">ifrs-full:CostOfSalesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c448">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">ifrs-full:SellingGeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c449">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">mlec:ExpensesClassifiedByNatureAndFunctionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c450">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c451">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:CarryForwardOfTaxLossMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c452">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:CarryForwardOfTaxLossMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c453">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:OthersFinancialAssetMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c454">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:OthersFinancialAssetMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c455">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:OthersOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c456">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:OthersOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c457">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:RoyaltiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c458">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:RoyaltiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c459">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:TradeReceivableMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c460">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:TradeReceivableMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c461">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:AllowancesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c462">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:AllowancesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c463">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:GovernmentGrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c464">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:GovernmentGrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c465">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:DeferredTaxAssetMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c466">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:DeferredTaxAssetMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c467">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:IntangiblesTaxLiabilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c468">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:IntangiblesTaxLiabilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c469">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:PropertyPlantAndEquipmentDepreciationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c470">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:PropertyPlantAndEquipmentDepreciationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c471">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:InventoriesTaxLiabilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c472">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:InventoriesTaxLiabilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c473">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:RightOfUseLeasedAssetTaxLiabilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c474">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:RightOfUseLeasedAssetTaxLiabilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c475">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:InflationTaxAdjustmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c476">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:InflationTaxAdjustmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c477">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:DeferredTaxLiabilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c478">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:DeferredTaxLiabilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c479">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:CarryForwardOfTaxLossMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c480">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:OthersFinancialAssetsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c481">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:OthersFinancialAssetsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c482">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:OthersFinancialAssetsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c483">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:TradeReceivableMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c484">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:RoyaltiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c485">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:AllowancesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c486">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:GovernmentGrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c487">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:OthersOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c488">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:DeferredTaxAssetMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c489">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:IntangiblesTaxLiabilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c490">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:PropertyPlantAndEquipmentDepreciationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c491">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:InventoriesTaxLiabilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c492">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:BiologicalAssetsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c493">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:BiologicalAssetsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c494">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:BiologicalAssetsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c495">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:OthersFinancialAssetsOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c496">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:OthersFinancialAssetsOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c497">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:OthersFinancialAssetsOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c498">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:RightOfUseLeasedAssetTaxLiabilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c499">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:InflationTaxAdjustmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c500">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:OthersTaxAssetsTwoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c501">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:OthersTaxAssetsTwoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c502">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:OthersTaxAssetsTwoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c503">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:DeferredTaxLiabilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c504">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:CarryForwardOfTaxLossMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c505">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:CarryForwardOfTaxLossMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c506">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:OthersFinancialAssetsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c507">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:OthersFinancialAssetsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c508">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:TradeReceivableMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c509">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:TradeReceivableMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c510">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:RoyaltiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c511">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:RoyaltiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c512">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:AllowancesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c513">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:AllowancesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c514">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:GovernmentGrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c515">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:GovernmentGrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c516">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:OtherTaxAssetMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c517">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:OtherTaxAssetMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c518">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:OtherTaxAssetMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c519">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:DeferredTaxAssetMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c520">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:DeferredTaxAssetMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c521">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:IntangiblesTaxLiabilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c522">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:IntangiblesTaxLiabilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c523">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:PropertyPlantAndEquipmentDepreciationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c524">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:PropertyPlantAndEquipmentDepreciationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c525">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:InventoryMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c526">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:InventoryMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c527">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:InventoryMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c528">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:OthersFinancialAssetsOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c529">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:OthersFinancialAssetsOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c530">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:RightOfUseLeasedAssetTaxLiabilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c531">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:RightOfUseLeasedAssetTaxLiabilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c532">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:InflationTaxAdjustmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c533">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:InflationTaxAdjustmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c534">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:OtherLiabilitiesOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c535">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:OtherLiabilitiesOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c536">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:OtherLiabilitiesOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c537">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:DeferredTaxLiabilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c538">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:DeferredTaxLiabilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c539">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="mlec:TaxJurisdictionAxis">mlec:LowOrNullTaxationJurisdictionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c540">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="mlec:TaxJurisdictionAxis">mlec:LossMakingEntitiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c541">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="mlec:TaxJurisdictionAxis">mlec:LowOrNullTaxationJurisdictionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c542">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="mlec:TaxJurisdictionAxis">mlec:ProfitMakingEntitiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c543">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="mlec:TaxJurisdictionAxis">mlec:LossMakingEntitiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c544">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="mlec:TaxJurisdictionAxis">mlec:LowOrNullTaxationJurisdictionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c545">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="mlec:TaxJurisdictionAxis">mlec:ProfitMakingEntitiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c546">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="mlec:TaxJurisdictionAxis">mlec:LossMakingEntitiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c547">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:UnderlyingEquityInstrumentAndDepositaryReceiptsAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c548">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:UnderlyingEquityInstrumentAndDepositaryReceiptsAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c549">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:UnderlyingEquityInstrumentAndDepositaryReceiptsAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c550">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c551">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c552">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-06-30</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c553">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c554">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-06-30</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c555">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-06-30</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c556">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">mlec:BioceresSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c557">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">mlec:BioceresSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c558">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">mlec:BioceresSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c559">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">mlec:BioceresCropSolutionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c560">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">mlec:BioceresCropSolutionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c561">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">mlec:BioceresCropSolutionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c562">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">mlec:BioceresCropSolutionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c563">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">mlec:BioceresCropSolutionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c564">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c565">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c566">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c567">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">mlec:BorrowingMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c568">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">mlec:FinancedPaymentAcquisitionOfBusinessMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c569">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">mlec:IfrsConvertibleNotesPayableMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c570">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">mlec:BorrowingMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c571">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">mlec:FinancedPaymentAcquisitionOfBusinessMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c572">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">mlec:IfrsConvertibleNotesPayableMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c573">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">mlec:BorrowingMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c574">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">mlec:FinancedPaymentAcquisitionOfBusinessMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c575">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">mlec:IfrsConvertibleNotesPayableMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c576">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">mlec:BorrowingMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c577">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">mlec:FinancedPaymentAcquisitionOfBusinessMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c578">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">mlec:IfrsConvertibleNotesPayableMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c579">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">mlec:BorrowingMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c580">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">mlec:FinancedPaymentAcquisitionOfBusinessMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c581">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">mlec:IfrsConvertibleNotesPayableMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c582">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">mlec:BorrowingMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c583">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">mlec:FinancedPaymentAcquisitionOfBusinessMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c584">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">mlec:IfrsConvertibleNotesPayableMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c585">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">mlec:BorrowingMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c586">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">mlec:FinancedPaymentAcquisitionOfBusinessMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c587">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">mlec:IfrsConvertibleNotesPayableMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c588">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AR</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c589">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:SynertechIndustriasSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c590">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:SynertechIndustriasSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c591">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c592">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c593">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:AgralityArgentinaSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c594">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:AgralityArgentinaSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c595">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:AgralityUSIncMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c596">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:AgralityUSIncMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c597">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:AgralitySeedsIncMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c598">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:AgralitySeedsIncMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c599">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:SWSemillasSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c600">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:SWSemillasSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c601">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:AlfalfaTechnologiesSRlMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c602">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:AlfalfaTechnologiesSRlMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c603">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:InmetSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c604">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:InmetSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c605">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:TheoISCSpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c606">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:TheoISCSpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c607">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:TrigallGeneticsSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c608">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:TrigallGeneticsSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c609">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:JointVenturesInvestmentsAndAffiliatesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c610">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:JointVenturesInvestmentsAndAffiliatesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c611">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:JointVenturesInvestmentsAndAffiliatesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c612">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:JointVenturesInvestmentsAndAffiliatesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c613">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:JointVenturesInvestmentsAndAffiliatesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c614">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:SynertechIndustriasSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c615">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:SynertechIndustriasSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c616">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:SynertechIndustriasSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c617">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:AgralityArgentinaSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c618">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:AgralityArgentinaSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c619">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:AgralityArgentinaSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c620">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:AgralityUSIncMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c621">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:AgralityUSIncMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c622">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:AgralityUSIncMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c623">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:AgralitySeedsIncMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c624">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:AgralitySeedsIncMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c625">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:AgralitySeedsIncMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c626">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:IndrasaBiotecnologaSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c627">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:IndrasaBiotecnologaSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c628">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:IndrasaBiotecnologaSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c629">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:MoolecScienceSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c630">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:MoolecScienceSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c631">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:MoolecScienceSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c632">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:SWSemillasSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c633">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:SWSemillasSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c634">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:SWSemillasSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c635">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:TrigallGeneticsSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c636">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:TrigallGeneticsSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c637">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:TrigallGeneticsSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c638">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:InmetSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c639">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:InmetSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c640">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:InmetSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c641">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:TheoISCSpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c642">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:TheoISCSpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c643">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:TheoISCSpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c644">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mlec:SynertechIndustriasSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c645">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mlec:SynertechIndustriasSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c646">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mlec:SynertechIndustriasSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c647">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mlec:SynertechIndustriasSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c648">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mlec:SynertechIndustriasSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c649">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mlec:SynertechIndustriasSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c650">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mlec:AgralitySAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c651">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mlec:AgralitySAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c652">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mlec:AgralitySAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c653">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mlec:AgralitySAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c654">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mlec:AgralitySAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c655">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mlec:AgralitySAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c656">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mlec:TheoISCSpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c657">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mlec:TheoISCSpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c658">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mlec:TheoISCSpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c659">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mlec:TheoISCSpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c660">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mlec:TheoISCSpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c661">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mlec:TheoISCSpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c662">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:SeedAndIntegratedProductsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c663">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropProtectionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c664">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropNutritionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c665">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:EmergingSolutionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c666">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:ConsolidatedEntitieMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c667">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:SeedAndIntegratedProductsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c668">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropProtectionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c669">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropNutritionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c670">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:EmergingSolutionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c671">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:ConsolidatedEntitieMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c672">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:SeedAndIntegratedProductsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c673">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropProtectionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c674">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropNutritionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c675">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:EmergingSolutionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c676">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:ConsolidatedEntitieMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c677">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:SeedAndIntegratedProductsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c678">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropProtectionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c679">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropNutritionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c680">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:EmergingSolutionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c681">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:ConsolidatedEntitieMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c682">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:SeedAndIntegratedProductsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c683">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropProtectionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c684">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropNutritionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c685">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:EmergingSolutionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c686">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:ConsolidatedEntitieMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c687">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:SeedAndIntegratedProductsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c688">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropProtectionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c689">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropNutritionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c690">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:EmergingSolutionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c691">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:ConsolidatedEntitieMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c692">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:SeedAndIntegratedProductsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c693">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:SeedAndIntegratedProductsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c694">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:SeedAndIntegratedProductsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c695">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:SeedTreatmentsPacksMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:SeedAndIntegratedProductsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c696">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:SeedTreatmentsPacksMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:SeedAndIntegratedProductsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c697">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:SeedTreatmentsPacksMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:SeedAndIntegratedProductsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c698">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:SeedRoyaltiesPaymentsHB4ProgramMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:SeedAndIntegratedProductsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c699">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:SeedRoyaltiesPaymentsHB4ProgramMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:SeedAndIntegratedProductsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c700">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:SeedRoyaltiesPaymentsHB4ProgramMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:SeedAndIntegratedProductsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c701">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropProtectionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c702">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropProtectionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c703">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropProtectionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c704">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:AdjuvantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropProtectionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c705">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:AdjuvantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropProtectionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c706">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:AdjuvantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropProtectionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c707">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:SeedCpProductsAndServicesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropProtectionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c708">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:SeedCpProductsAndServicesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropProtectionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c709">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:SeedCpProductsAndServicesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropProtectionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c710">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:OtherCpProductsAndServicesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropProtectionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c711">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:OtherCpProductsAndServicesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropProtectionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c712">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:OtherCpProductsAndServicesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropProtectionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c713">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:BioprotectionMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropProtectionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c714">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:BioprotectionMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropProtectionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c715">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:BioprotectionMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropProtectionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c716">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropNutritionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c717">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropNutritionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c718">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropNutritionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c719">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:InoculantsBiofertilizersMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropNutritionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c720">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:InoculantsBiofertilizersMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropNutritionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c721">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:InoculantsBiofertilizersMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropNutritionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c722">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:MicroBeadedFertilizersMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropNutritionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c723">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:MicroBeadedFertilizersMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropNutritionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c724">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:MicroBeadedFertilizersMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropNutritionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c725">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:BiostimulantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropNutritionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c726">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:BiostimulantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropNutritionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c727">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:BiostimulantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropNutritionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c728">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:SyngentaUpfrontFeeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropNutritionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c729">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:SyngentaUpfrontFeeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropNutritionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c730">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:SyngentaUpfrontFeeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropNutritionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c731">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:EmergingSolutionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c732">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:EmergingSolutionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c733">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:EmergingSolutionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c734">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:ManagementExpensesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:EmergingSolutionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c735">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:ManagementExpensesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:EmergingSolutionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c736">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:ManagementExpensesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:EmergingSolutionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c737">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:GovernmentGrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:EmergingSolutionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c738">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:GovernmentGrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:EmergingSolutionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c739">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:GovernmentGrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:EmergingSolutionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c740">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:AR</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c741">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:AR</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c742">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:AR</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c743">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:BR</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c744">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:BR</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c745">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:BR</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c746">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c747">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c748">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c749">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c750">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c751">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c752">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">mlec:EuropeMiddleEastAndAfricaMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c753">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">mlec:EuropeMiddleEastAndAfricaMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c754">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">mlec:EuropeMiddleEastAndAfricaMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c755">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">mlec:OtherRegionsOrCountriesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c756">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">mlec:OtherRegionsOrCountriesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c757">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">mlec:OtherRegionsOrCountriesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c758">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:AR</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c759">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:AR</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c760">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:BR</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c761">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:BR</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c762">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c763">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c764">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c765">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c766">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">mlec:EuropeMiddleEastAndAfricaMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c767">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">mlec:EuropeMiddleEastAndAfricaMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c768">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">mlec:OtherRegionsOrCountriesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c769">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">mlec:OtherRegionsOrCountriesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c770">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:TradeAndOtherPayablesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanThreeMonthsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c771">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:TradeAndOtherPayablesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c772">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:TradeAndOtherPayablesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c773">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:BorrowingMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanThreeMonthsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c774">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:BorrowingMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c775">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:BorrowingMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c776">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:IfrsConvertibleNotesPayableMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanThreeMonthsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c777">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:IfrsConvertibleNotesPayableMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c778">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:IfrsConvertibleNotesPayableMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c779">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanThreeMonthsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c780">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c781">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c782">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanThreeMonthsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c783">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c784">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c785">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:TradeAndOtherPayablesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanThreeMonthsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c786">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:TradeAndOtherPayablesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c787">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:TradeAndOtherPayablesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c788">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:BorrowingMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanThreeMonthsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c789">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:BorrowingMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c790">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:BorrowingMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c791">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:ConsiderationForAcquisitionOfAssetsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanThreeMonthsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c792">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:ConsiderationForAcquisitionOfAssetsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c793">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:ConsiderationForAcquisitionOfAssetsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c794">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:IfrsConvertibleNotesPayableMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanThreeMonthsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c795">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:IfrsConvertibleNotesPayableMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c796">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:IfrsConvertibleNotesPayableMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c797">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanThreeMonthsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c798">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c799">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c800">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanThreeMonthsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c801">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c802">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c803">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c804">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c805">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:FixedRateBorrowingsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c806">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:FixedRateBorrowingsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c807">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:VariableRateBorrowingsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c808">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:VariableRateBorrowingsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c809">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:CashAndEquivalentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c810">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:CashAndEquivalentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c811">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:CashAndEquivalentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">mlec:MandatorilyMeasuredAtFairValueThroughProfitOrLossMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c812">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:CashAndEquivalentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">mlec:MandatorilyMeasuredAtFairValueThroughProfitOrLossMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c813">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:OtherFinancialAssetsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c814">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:OtherFinancialAssetsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c815">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:OtherFinancialAssetsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">mlec:MandatorilyMeasuredAtFairValueThroughProfitOrLossMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c816">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:OtherFinancialAssetsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">mlec:MandatorilyMeasuredAtFairValueThroughProfitOrLossMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c817">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c818">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c819">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">mlec:MandatorilyMeasuredAtFairValueThroughProfitOrLossMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c820">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">mlec:MandatorilyMeasuredAtFairValueThroughProfitOrLossMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c821">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:OtherReceivablesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c822">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:OtherReceivablesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c823">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:OtherReceivablesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">mlec:MandatorilyMeasuredAtFairValueThroughProfitOrLossMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c824">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:OtherReceivablesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">mlec:MandatorilyMeasuredAtFairValueThroughProfitOrLossMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c825">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c826">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c827">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">mlec:MandatorilyMeasuredAtFairValueThroughProfitOrLossMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c828">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">mlec:MandatorilyMeasuredAtFairValueThroughProfitOrLossMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c829">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:TradeAndOtherPayablesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">mlec:AtAmortizedCostMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c830">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:TradeAndOtherPayablesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">mlec:AtAmortizedCostMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c831">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:TradeAndOtherPayablesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c832">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:TradeAndOtherPayablesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c833">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:BorrowingMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">mlec:AtAmortizedCostMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c834">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:BorrowingMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">mlec:AtAmortizedCostMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c835">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:BorrowingMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c836">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:BorrowingMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c837">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:ConsiderationForAcquisitionOfAssetsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">mlec:AtAmortizedCostMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c838">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:ConsiderationForAcquisitionOfAssetsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">mlec:AtAmortizedCostMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c839">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:ConsiderationForAcquisitionOfAssetsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c840">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:ConsiderationForAcquisitionOfAssetsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c841">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:ConvertibleNotesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">mlec:AtAmortizedCostMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c842">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:ConvertibleNotesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">mlec:AtAmortizedCostMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c843">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:ConvertibleNotesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c844">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:ConvertibleNotesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c845">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">mlec:AtAmortizedCostMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c846">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">mlec:AtAmortizedCostMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c847">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c848">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c849">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:WarrantLiabilityMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">mlec:AtAmortizedCostMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c850">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:WarrantLiabilityMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">mlec:AtAmortizedCostMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c851">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:WarrantLiabilityMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c852">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:WarrantLiabilityMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c853">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">mlec:AtAmortizedCostMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c854">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">mlec:AtAmortizedCostMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c855">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c856">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c857">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:InvestmentsAtFairValueMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c858">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:InvestmentsAtFairValueMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c859">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:InvestmentsAtFairValueMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c860">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:WarrantLiabilityMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c861">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:WarrantLiabilityMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c862">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:WarrantLiabilityMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c863">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:MutualFundsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c864">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:MutualFundsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c865">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:MutualFundsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c866">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:MoolecScienceSASharesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c867">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:MoolecScienceSASharesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c868">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:MoolecScienceSASharesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c869">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:InvestmentsAtFairValueMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c870">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:InvestmentsAtFairValueMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c871">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:InvestmentsAtFairValueMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c872">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:UsTreasuryBillsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c873">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:UsTreasuryBillsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c874">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:UsTreasuryBillsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c875">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:OtherInvestmentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c876">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:OtherInvestmentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c877">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:OtherInvestmentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c878">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:TradeAndOtherPayablesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c879">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:TradeAndOtherPayablesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c880">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:TradeAndOtherPayablesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c881">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:ConsiderationForAcquisitionMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c882">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:ConsiderationForAcquisitionMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c883">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:ConsiderationForAcquisitionMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c884">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c885">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c886">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c887">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c888">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c889">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c890">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c891">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c892">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c893">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c894">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c895">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c896">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c897">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c898">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c899">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c900">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c901">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:SalesOfGoodsAndServicesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c902">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:SalesOfGoodsAndServicesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c903">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:SalesOfGoodsAndServicesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c904">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:PurchasesOfGoodsAndServicesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c905">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:PurchasesOfGoodsAndServicesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c906">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:PurchasesOfGoodsAndServicesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c907">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:NetLoansGrantedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c908">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:NetLoansGrantedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c909">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:NetLoansGrantedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c910">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:InterestGainMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c911">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:InterestGainMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c912">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:InterestGainMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c913">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:NetLoansReceivedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c914">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:NetLoansReceivedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c915">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:NetLoansReceivedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c916">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:PuttableInstrumentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c917">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:PuttableInstrumentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c918">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:PuttableInstrumentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c919">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:NetLoansGrantedOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c920">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:NetLoansGrantedOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c921">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:NetLoansGrantedOneMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c922">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:PreferenceShareMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c923">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:PreferenceShareMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c924">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:PreferenceShareMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c925">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:InterestExpensesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c926">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:InterestExpensesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c927">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:InterestExpensesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c928">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:OwnSharesHeldBySubsidiariesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c929">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:OwnSharesHeldBySubsidiariesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c930">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:OwnSharesHeldBySubsidiariesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c931">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:InKindContributionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c932">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:InKindContributionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c933">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:InKindContributionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c934">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:SalesOfGoodsAndServicesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c935">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:SalesOfGoodsAndServicesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c936">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:SalesOfGoodsAndServicesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c937">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:PurchasesOfGoodsAndServicesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c938">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:PurchasesOfGoodsAndServicesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c939">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:PurchasesOfGoodsAndServicesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c940">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:SalariesSocialSecurityBenefitsAndOtherBenefitsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c941">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:SalariesSocialSecurityBenefitsAndOtherBenefitsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c942">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:SalariesSocialSecurityBenefitsAndOtherBenefitsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c943">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:SalesAndServicesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c944">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:SalesAndServicesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c945">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:SalesAndServicesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c946">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:PurchasesOfGoodsAndServicesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c947">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:PurchasesOfGoodsAndServicesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c948">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:PurchasesOfGoodsAndServicesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c949">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:StockOptionsAndShareBasedIncentivesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c950">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:StockOptionsAndShareBasedIncentivesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c951">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:StockOptionsAndShareBasedIncentivesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c952">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:TradeDebtorsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c953">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:TradeDebtorsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c954">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:OtherReceivablesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c955">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:OtherReceivablesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c956">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:TradeDebtorsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c957">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:TradeDebtorsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c958">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:LoansReceivablesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c959">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:LoansReceivablesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c960">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:OtherReceivablesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c961">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:OtherReceivablesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c962">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:TradeCreditorsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c963">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:TradeCreditorsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c964">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:ConvertibleNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c965">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:ConvertibleNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c966">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:NetLoansPayablesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c967">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:NetLoansPayablesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c968">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:TradeCreditorsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c969">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:TradeCreditorsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c970">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:WarrantesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c971">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:WarrantesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c972">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:PreferenceShareMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c973">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:PreferenceShareMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c974">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c975">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-01-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c976">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-05-12</xbrli:startDate>
    <xbrli:endDate>2023-05-12</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c977">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-05-12</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c978">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:StandAloneStockOptionGrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-05-12</xbrli:startDate>
    <xbrli:endDate>2023-05-12</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c979">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:VolumeWeightedAveragePriceMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:StandAloneStockOptionGrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-05-12</xbrli:startDate>
    <xbrli:endDate>2023-05-12</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c980">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:EmployeeStockOptionPlanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-05-12</xbrli:startDate>
    <xbrli:endDate>2023-05-12</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c981">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:VolumeWeightedAveragePriceMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:EmployeeStockOptionPlanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-05-12</xbrli:startDate>
    <xbrli:endDate>2023-05-12</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c982">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-05-12</xbrli:startDate>
    <xbrli:endDate>2023-05-12</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c983">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:PastShareOptionPlanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-05-12</xbrli:startDate>
    <xbrli:endDate>2023-05-12</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c984">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:PastShareOptionPlanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-05-12</xbrli:startDate>
    <xbrli:endDate>2023-05-12</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c985">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c986">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c987">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c988">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c989">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c990">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c991">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">mlec:EBITDAMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:PerformanceShareOptionPlanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-05-12</xbrli:startDate>
    <xbrli:endDate>2023-05-12</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c992">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">mlec:EBITDAMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:PerformanceShareOptionPlanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-05-12</xbrli:startDate>
    <xbrli:endDate>2023-05-12</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c993">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">mlec:EBITDAMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:PerformanceShareOptionPlanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-05-12</xbrli:startDate>
    <xbrli:endDate>2023-05-12</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c994">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:PerformanceShareOptionPlanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-05-12</xbrli:startDate>
    <xbrli:endDate>2023-05-12</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c995">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:PerformanceShareOptionPlanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-05-12</xbrli:startDate>
    <xbrli:endDate>2023-05-12</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c996">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:PerformanceShareOptionPlanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-05-12</xbrli:startDate>
    <xbrli:endDate>2023-05-12</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c997">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-05-12</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c998">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">mlec:ProFarmGroupIncMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:StockIncentivePlan2013Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-26</xbrli:startDate>
    <xbrli:endDate>2022-07-26</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c999">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:StandAloneStockOptionGrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c1000">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:EmployeeStockOptionPlanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c1001">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:PastShareOptionPlanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c1002">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c1003">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:PerformanceShareOptionPlanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c1004">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:StandAloneStockOptionGrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c1005">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:EmployeeStockOptionPlanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c1006">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:PastShareOptionPlanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c1007">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c1008">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:PerformanceShareOptionPlanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c1009">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-12</xbrli:startDate>
    <xbrli:endDate>2022-07-12</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c1010">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-12</xbrli:startDate>
    <xbrli:endDate>2022-07-12</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c1011">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-12</xbrli:startDate>
    <xbrli:endDate>2022-07-12</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c1012">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:OptionsIncentivePlanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c1013">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:OptionsIncentivePlanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c1014">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:OptionsIncentivePlanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c1015">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:OptionsIncentivePlanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c1016">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:OptionsIncentivePlanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c1017">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-10-02</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c1018">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">mlec:SubsequentEventsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-07-01</xbrli:startDate>
    <xbrli:endDate>2025-07-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c1019">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-12-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c1020">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">ifrs-full:MajorBusinessCombinationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-02</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c1021">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-11-14</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c1022">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-11-14</xbrli:startDate>
    <xbrli:endDate>2024-11-14</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c1023">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c1024">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresLLCMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c1025">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-12-20</xbrli:startDate>
    <xbrli:endDate>2025-12-20</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c1026">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mlec:ReverseStockSplitMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-07-01</xbrli:startDate>
    <xbrli:endDate>2025-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c1027">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mlec:ReverseStockSplitMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2024-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c1028">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mlec:ReverseStockSplitMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:unit xmlns="" id="shares">
  <xbrli:measure>xbrli:shares</xbrli:measure>
</xbrli:unit><xbrli:unit xmlns="" id="usd">
  <xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unit><xbrli:unit xmlns="" id="usdPershares">
  <xbrli:divide>
    <xbrli:unitNumerator>
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unitNumerator>
    <xbrli:unitDenominator>
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unitDenominator>
  </xbrli:divide>
</xbrli:unit><xbrli:unit xmlns="" id="pure">
  <xbrli:measure>xbrli:pure</xbrli:measure>
</xbrli:unit><xbrli:unit xmlns="" id="arsPershares">
  <xbrli:divide>
    <xbrli:unitNumerator>
      <xbrli:measure>iso4217:ARS</xbrli:measure>
    </xbrli:unitNumerator>
<!-- [WMV6][nHFRrgaihFC12HA+WXatjhRuVm00bgTWKyIVrmFHi8StMf4jnDNTszjta2jkerixMtZ26PpI1fdF71tk2lgrgPwinRZSrvV0dwhKiP04HlNFfigR6AvF5KTMlyIQLo0JXRY+HMlWjACGdpErPgDIXnftQ4KJ/JNMLvWgWvwKpWHt2yjM5hVnJ6f2cnFMWniXv4f+wGt405tw9CREJRapuTh7HVhhL5r4IDTxcqEN5V2LmYJkKZk3VG7vFlrG/wbVwTqB11C0OUoLjJNWkovkhPNA4GEbbK/4Ug1oaBLS2iwB7ERyx8mbmT1WSgGT8CalMbYw7mDp7AyAPDipy8CfwIYZsWq92EDASh+58v2bdHCt4Q6thHnVTbiu1wECTR0r0hzTiWc=] CSR-->
    <xbrli:unitDenominator>
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unitDenominator>
  </xbrli:divide>
</xbrli:unit></ix:resources></ix:header>
</div></div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ea027012501ex1-1_moolec.htm
<DESCRIPTION>AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION OF THE COMPANY, ADOPTED BY SPECIAL RESOLUTION PASSED ON 16 DECEMBER 2025 EFFECTIVE 5 JANUARY 2026
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 1.1</B></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>



<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>Companies Act (Revised)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>Company Limited by Shares</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 60%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>AMENDED AND RESTATED
MEMORANDUM OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>ASSOCIATION<BR> OF<BR>
MOOLEC SCIENCE SA <BR> <FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: none">(Adopted by special resolution
passed on 16 December 2025 effective 5 January 2026)</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 60%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Companies Act (Revised)</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Company Limited by Shares</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Amended and Restated Memorandum of Association</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">of</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Moolec Science SA</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-variant: small-caps"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-variant: small-caps"><B>(A</B></FONT><B>dopted
by special resolution </B><FONT STYLE="font-family: Times New Roman, Times, Serif">passed </FONT><B>on 16 December 2025 effective 5 January
2026<FONT STYLE="font-variant: small-caps">)</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">1</FONT></TD><TD STYLE="text-align: justify">The name of the Company is Moolec Science SA.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">2</FONT></TD><TD STYLE="text-align: justify">The Company&rsquo;s registered office will be situated at the office of Ogier Global (Cayman) Limited at 89
Nexus Way, Camana Bay, Grand Cayman KY1-9009, Cayman Islands or at such other place in the Cayman Islands as the directors may at any
time decide.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">3</FONT></TD><TD STYLE="text-align: justify">The Company&rsquo;s objects are unrestricted. As provided by section 7(4) of the Companies Act (Revised), the
Company has full power and authority to carry out any object not prohibited by any law of the Cayman Islands.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">4</FONT></TD><TD STYLE="text-align: justify">The Company has unrestricted corporate capacity. Without limitation to the foregoing, as provided by section
27(2) of the Companies Act (Revised), the Company has and is capable of exercising all the functions of a natural person of full capacity
irrespective of any question of corporate benefit.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">5</FONT></TD><TD STYLE="text-align: justify">Nothing in any of the preceding paragraphs permits the Company to carry on any of the following businesses
without being duly licensed, namely:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">the business of a bank or trust company without being licensed in that behalf under the Banks and Trust
Companies Act (Revised); or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">insurance business from within the Cayman Islands or the business of an insurance manager, agent, sub-agent
or broker without being licensed in that behalf under the Insurance Act (Revised); or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">the business of company management without being licensed in that behalf under the Companies Management
Act (Revised).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">6</FONT></TD><TD STYLE="text-align: justify">Unless licensed to do so, the Company will not trade in the Cayman Islands with any person, firm or corporation
except in furtherance of its business carried on outside the Cayman Islands. Despite this, the Company may effect and conclude contracts
in the Cayman Islands and exercise in the Cayman Islands any of its powers necessary for the carrying on of its business outside the Cayman
Islands.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">7</FONT></TD><TD STYLE="text-align: justify">The Company is a company limited by shares and accordingly the liability of each member is limited to
the amount (if any) unpaid on that member&rsquo;s shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">8</FONT></TD><TD STYLE="text-align: justify">The share capital of the Company is US$5,000,000,000 divided into 3,333,333 ordinary shares of par value
US$1.50 each. However, subject to the Companies Act (Revised) and the Company&rsquo;s articles of association, the Company has power to do any
one or more of the following:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">to redeem or repurchase any of its shares; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">to increase or reduce its capital; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">to issue any part of its capital (whether original, redeemed, increased or reduced):</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.3pt; text-align: justify; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 35.4pt">(i)</TD><TD STYLE="text-align: justify">with or without any preferential, deferred, qualified or special rights, privileges or conditions; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.3pt; text-align: justify; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 35.4pt">(ii)</TD><TD STYLE="text-align: justify">subject to any limitations or restrictions</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">and unless the condition of issue expressly
declares otherwise, every issue of shares (whether declared to be ordinary, preference or otherwise) is subject to this power; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">to alter any of those rights, privileges, conditions, limitations or restrictions.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">9</FONT></TD><TD STYLE="text-align: justify">The Company has power to register by way of continuation as a body corporate limited by shares under the
laws of any jurisdiction outside the Cayman Islands and to be deregistered in the Cayman Islands.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>Companies Act (Revised)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>Company Limited By Shares &nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 60%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>AMENDED AND
RESTATED ARTICLES OF ASSOCIATION<BR> OF<BR> MOOLEC SCIENCE SA</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>(Adopted by Special Resolution
passed on 16 December 2025 effective 5 January 2026)</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 60%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;<IMG SRC="ex1-1_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;&nbsp;</P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">Contents</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1</B></FONT></TD>
    <TD STYLE="width: 85%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Definitions, interpretation and exclusion of Table A</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 10%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitions</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interpretation</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exclusion of Table A Articles</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shares</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power to issue Shares and options, with or without special rights</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power to issue fractions of a Share</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power to pay commissions and brokerage fees</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trusts not recognised</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security interests</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power to vary class rights</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect of new Share issue on existing class rights</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No bearer Shares or warrants</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Treasury Shares</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rights attaching to Treasury Shares and related matters</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Register of Members</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annual Return</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Share certificates</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue of share certificates</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Renewal of lost or damaged share certificates</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lien on Shares</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nature and scope of lien</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company may sell Shares to satisfy lien</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authority to execute instrument of transfer</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consequences of sale of Shares to satisfy lien</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Application of proceeds of sale</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Calls on Shares and forfeiture</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>11</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power to make calls and effect of calls</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Time when call made</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liability of joint holders</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest on unpaid calls</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deemed calls</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power to accept early payment</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power to make different arrangements at time of issue of Shares</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notice of default</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeiture or surrender of Shares</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disposal of forfeited or surrendered Share and power to cancel forfeiture or surrender</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect of forfeiture or surrender on former Member</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evidence of forfeiture or surrender</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sale of forfeited or surrendered Shares</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Transfer of Shares</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>14</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of transfer</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power to refuse registration</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notice of refusal to register</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power to suspend registration</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company may retain instrument of transfer</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7</B></FONT></TD>
    <TD STYLE="width: 85%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Transmission of Shares</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>15</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Persons entitled on death of a Member</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registration of transfer of a Share following death or bankruptcy</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indemnity</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rights of person entitled to a Share following death or bankruptcy</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Alteration of capital</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>16</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increasing, consolidating, converting, dividing and cancelling share capital</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dealing with fractions resulting from consolidation of Shares</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reducing share capital</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Redemption and purchase of own Shares</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>17</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power to issue redeemable Shares and to purchase own Shares</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power to pay for redemption or purchase in cash or in specie</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect of redemption or purchase of a Share</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Meetings of Members</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>18</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annual and extraordinary general meetings</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power to call meetings</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Content of notice</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Period of notice</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Record date and persons entitled to receive notice</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accidental omission to give notice or non-receipt of notice</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>11</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proceedings at meetings of Members</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>21</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quorum</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lack of quorum</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right of a Director to attend and speak</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accommodation of Members attending meeting virtually</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjournment, postponement and cancellation</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Method of voting</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman&rsquo;s casting vote</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written resolutions</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sole-Member Company</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>12</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Voting rights of Members</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>24</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right to vote</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rights of joint holders</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Representation of corporate Members</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Member with mental disorder</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Objections to admissibility of votes</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of proxy</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">How and when proxy is to be delivered</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Voting by proxy</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>13</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number of Directors</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>28</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>14</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Appointment, disqualification and removal of Directors</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>28</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No age limit</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate Directors</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No shareholding qualification</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Appointment of Directors</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Term of appointment</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eligibility</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Removal of Directors</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Resignation of Directors</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Termination of the office of Director</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>15</B></FONT></TD>
    <TD STYLE="width: 85%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Alternate Directors</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>30</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Appointment and removal</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notices</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rights of alternate Director</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Appointment ceases when the appointor ceases to be a Director</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Status of alternate Director</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Status of the Director making the appointment</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>16</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Powers of Directors</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>32</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Powers of Directors</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors below the minimum number</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Appointments to office</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provisions for employees</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise of voting rights</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remuneration</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosure of information</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>17</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delegation of powers</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>34</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power to delegate any of the Directors&rsquo; powers to a committee</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Local boards</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power to appoint an agent of the Company</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power to appoint an attorney or authorised signatory of the Company</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowing Powers</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate Governance</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>18</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Meetings of Directors</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><B>36</B></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regulation of Directors&rsquo; meetings</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Calling meetings</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notice of meetings</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use of technology</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quorum</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman or deputy to preside</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Voting</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recording of dissent</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written resolutions</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Validity of acts of Directors in spite of formal defect</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>19</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Permissible Directors&rsquo; interests and disclosure</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>38</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Permissible interests subject to disclosure</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notification of interests</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Voting where a Director is interested in a matter</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>20</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Minutes</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>39</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>21</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Accounts and audit</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>40</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Auditors</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>22</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Record dates</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>40</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>23</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dividends</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>41</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Source of dividends</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Declaration of dividends by Members</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment of interim dividends and declaration of final dividends by Directors</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Apportionment of dividends</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">42</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right of set off</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">42</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power to pay other than in cash</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">42</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">How payments may be made</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">42</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends or other monies not to bear interest in absence of special rights</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">43</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends unable to be paid or unclaimed</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">43</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>24</B></FONT></TD>
    <TD STYLE="width: 85%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Capitalisation of profits</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>43</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalisation of profits or of any share premium account or capital redemption reserve</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">43</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Applying an amount for the benefit of Members</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>25</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Share Premium Account</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>44</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors to maintain share premium account</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debits to share premium account</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>26</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Seal</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>45</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company seal</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Duplicate seal</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">When and how seal is to be used</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If no seal is adopted or used</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power to allow non-manual signatures and facsimile printing of seal</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Validity of execution</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>27</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Indemnity</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>46</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Release</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insurance</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>28</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notices</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>47</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of notices</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Electronic communications</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Persons entitled to notices</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">48</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Persons authorised to give notices</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delivery of written notices</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joint holders</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signatures</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Giving notice to a deceased or bankrupt Member</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date of giving notices</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Saving provision</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>29</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Authentication of Electronic Records</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>50</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Application of Articles</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authentication of documents sent by Members by Electronic means</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authentication of document sent by the Secretary or Officers of the Company by Electronic means</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manner of signing</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Saving provision</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>30</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Transfer by way of continuation</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>52</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>31</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Winding up</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>52</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Distribution of assets in specie</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">52</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No obligation to accept liability</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">52</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>32</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amendment of Memorandum and Articles</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>53</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power to change name or amend Memorandum</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power to amend these Articles</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</FONT></TD></TR>
  </TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iv<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Companies Act (Revised)</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Company Limited by Shares</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Amended and Restated Articles of Association</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">of</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Moolec Science SA</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Adopted by Special Resolution on 16 December
2025 effective 5 January 2026)</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1</TD><TD STYLE="text-align: justify">Definitions, interpretation and exclusion of Table A</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Definitions</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.1</TD><TD STYLE="text-align: justify">In these Articles, the following definitions apply:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>Act </B>means the Companies Act
(Revised) of the Cayman Islands, including any statutory modification or re-enactment thereof for the time being in force;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>ADS</B> means an American depository
share representing an Share;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>Articles </B>means, as appropriate:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">these articles of association as amended from time to time: or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">two or more particular articles of these Articles;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">and <B>Article</B> refers to a particular
article of these Articles;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>Auditors</B> means the auditor
or auditors for the time being of the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>Board</B> means the board of Directors
from time to time;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>Business Day</B> means a day when
banks in Grand Cayman, the Cayman Islands are open for the transaction of normal banking business and for the avoidance of doubt, shall
not include a Saturday, Sunday or public holiday in the Cayman Islands;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>Cayman Islands</B> means the British
Overseas Territory of the Cayman Islands;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>Clear Days</B>, in relation to
a period of notice, means that period excluding:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">the day when the notice is given or deemed to be given; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">the day for which it is given or on which it is to take effect;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 9; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>Commission</B> means Securities
and Exchange Commission of the United States of America or other federal agency for the time being administering the U.S. Securities Act;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>Company</B> means the above-named
company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>Default Rate</B> means ten per
cent per annum;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>Designated Stock Exchanges</B>
means Nasdaq Global Market in the United States of America for so long as the Company&rsquo;s Shares or ADSs are there listed and any
other stock exchange on which the Company&rsquo;s Shares or ADSs are listed for trading;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>Designated Stock Exchange Rules</B>
means the relevant code, rules and regulations, as amended, from time to time, applicable as a result of the original and continued listing
of any Shares or ADSs on the Designated Stock Exchanges;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>Directors</B> means the directors
for the time being of the Company and the expression Director shall be construed accordingly;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>Electronic</B> has the meaning
given to that term in the Electronic Transactions Act (Revised) of the Cayman Islands<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>Electronic Record</B> has the meaning
given to that term in the Electronic Transactions Act (Revised) of the Cayman Islands;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>Electronic Signature</B> has the
meaning given to that term in the Electronic Transactions Act (Revised) of the Cayman Islands;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>Fully Paid Up</B> means:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">in relation to a Share with par value, means that the par value for that Share and any premium payable
in respect of the issue of that Share, has been fully paid or credited as paid in money or money&rsquo;s worth; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">in relation to a Share without par value, means that the agreed issue price for that Share has been fully
paid or credited as paid in money or money&rsquo;s worth;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>General Meeting</B> means a general
meeting of the Company duly constituted in accordance with the Articles;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>Independent Director</B> means
a Director who is an independent director as defined in the Designated Stock Exchange Rules as determined by the Board;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>Member</B> means any person or
persons entered on the register of Members from time to time as the holder of a Share;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>Memorandum</B> means the memorandum
of association of the Company as amended from time to time;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>month</B> means a calendar month;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>Officer</B> means a person appointed
to hold an office in the Company including a Director, alternate Director or liquidator and excluding the Secretary;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>Ordinary Resolution</B> means a
resolution of a General Meeting passed by a simple majority of votes cast by Members who (being entitled to do so) vote in person or by
proxy at that meeting. The expression includes a unanimous written resolution;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: 0in"><B>Partly Paid Up</B>
means:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">in relation to a Share with par value, that the par value for that Share and any premium payable in respect
of the issue of that Share, has not been fully paid or credited as paid in money or money&rsquo;s worth; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">in relation to a Share without par value, means that the agreed issue price for that Share has not been
fully paid or credited as paid in money or money&rsquo;s worth;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>Register of Members </B>means the
register of Members maintained in accordance with the Act and includes (except where otherwise stated) any branch or duplicate register
of Members;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>SEC</B> means the United States
Securities and Exchange Commission;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>Secretary</B> means a person appointed
to perform the duties of the secretary of the Company, including a joint, assistant or deputy secretary;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>Share</B> means a share in the
capital of the Company and the expression:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">includes stock (except where a distinction between shares and stock is expressed or implied); and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">where the context permits, also includes a fraction of a Share;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>Special Resolution</B> means a
resolution of a General Meeting or a resolution of a meeting of the holders of any class of Shares in a class meeting duly constituted
in accordance with the Articles in each case passed by a majority of votes not less than two-thirds of votes cast by Members who (being
entitled to do so) vote in person or by proxy at that meeting. The expression includes a written resolution passed in accordance with
the Act;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>Treasury Shares</B> means Shares
held in treasury pursuant to the Act and Article 2.14; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>U.S. Securities Act</B> means the
Securities Act of 1933 of the United States of America, as amended, or any similar federal statute and the rules and regulations of the
Commission thereunder, all as the same shall be in effect at the time.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Interpretation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.2</TD><TD STYLE="text-align: justify">In the interpretation of these Articles, the following provisions apply unless the context otherwise requires:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">A reference in these Articles to a statute is a reference to a statute of the Cayman Islands as known
by its short title, and includes:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.3pt; text-align: justify; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 35.4pt">(i)</TD><TD STYLE="text-align: justify">any statutory modification, amendment or re-enactment; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.3pt; text-align: justify; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 35.4pt">(ii)</TD><TD STYLE="text-align: justify">any subordinate legislation or regulations issued under that statute.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">Without limitation to the preceding
sentence, a reference to a revised Act of the Cayman Islands is taken to be a reference to the revision of that Act in force from time
to time as amended from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">Headings are inserted for convenience only and do not affect the interpretation of these Articles, unless
there is ambiguity.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">Unless otherwise specified in these Articles, if a day on which any act, matter or thing is to be done
under these Articles is not a Business Day, the act, matter or thing must be done on the next Business Day.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">A word which denotes the singular also denotes the plural, a word which denotes the plural also denotes
the singular, and a reference to any gender also denotes the other genders.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">A reference to a <B>person</B> includes, as appropriate, a company, trust, partnership, joint venture,
association, body corporate or government agency.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify">Where a word or phrase is given a defined meaning another part of speech or grammatical form in respect
to that word or phrase has a corresponding meaning.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(g)</TD><TD STYLE="text-align: justify">All references to time are to be calculated by reference to time in the place where the Company&rsquo;s
registered office is located.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(h)</TD><TD STYLE="text-align: justify">The words <B>written</B> and <B>in writing</B> include all modes of representing or reproducing words
in a visible form, but do not include an Electronic Record where the distinction between a document in writing and an Electronic Record
is expressed or implied.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">The words <B>including</B>, <B>include</B> and <B>in particular</B> or any similar expression are to be
construed without limitation.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.3</TD><TD STYLE="text-align: justify">The headings in these Articles are intended for convenience only and shall not affect the interpretation
of these Articles.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Exclusion of Table A Articles</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.4</TD><TD STYLE="text-align: justify">The regulations contained in Table A in the First Schedule of the Act and any other regulations contained
in any statute or subordinate legislation are expressly excluded and do not apply to the Company.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2</TD><TD STYLE="text-align: justify">Shares</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Power to issue Shares and options, with or
without special rights</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.1</TD><TD STYLE="text-align: justify">Subject to the provisions of the Act and these Articles about the redemption and purchase of the Shares,
and, where applicable, the rules and regulations of the Designated Stock Exchange and/or the SEC the Directors have general and unconditional
authority to allot (with or without confirming rights of renunciation), grant options over or otherwise deal with any unissued Shares
to such persons, at such times and on such terms and conditions as they may decide. No Share may be issued at a discount except in accordance
with the provisions of the Act.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.2</TD><TD STYLE="text-align: justify">Without limitation to the preceding Article, the Directors may so deal with the unissued Shares:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">either at a premium or at par; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">with or without preferred, deferred or other special rights or restrictions, whether in regard to dividend,
voting, return of capital or otherwise.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.3</TD><TD STYLE="text-align: justify">Without limitation to the two preceding Articles, the Directors may refuse to accept any application for
Shares, and may accept any application in whole or in part, for any reason or for no reason.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.4</TD><TD STYLE="text-align: justify">The Company may issue rights, options, warrants or convertible securities or securities of similar nature
conferring the right upon the holders thereof to subscribe for, purchase or receive any class of Shares or other securities in the Company
at such times and on such terms and conditions as the Directors may decide.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Power to issue fractions of a Share</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.5</TD><TD STYLE="text-align: justify">Subject to the Act, the Company may issue fractions of a Share of any class. A fraction of a Share shall
be subject to and carry the corresponding fraction of liabilities (whether with respect to calls or otherwise), limitations, preferences,
privileges, qualifications, restrictions, rights and other attributes of a Share of that class of Shares.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Power to pay commissions and brokerage fees</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.6</TD><TD STYLE="text-align: justify">The Company may pay a commission to any person in consideration of that person:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">subscribing or agreeing to subscribe, whether absolutely or conditionally; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">procuring or agreeing to procure subscriptions, whether absolute or conditional,</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">for any Shares. That commission may
be satisfied by the payment of cash or the allotment of Fully Paid Up or Partly Paid Up Shares or partly in one way and partly in another.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.7</TD><TD STYLE="text-align: justify">The Company may employ a broker in the issue of its capital and pay him any proper commission or brokerage.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Trusts not recognised</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.8</TD><TD STYLE="text-align: justify">Except as required by Law:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">no person shall be recognised by the Company as holding any Share on any trust; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">no person other than the Member shall be recognised by the Company as having any right in a Share.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Security interests</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.9</TD><TD STYLE="text-align: justify">Notwithstanding the preceding Article, the Company may (but shall not be obliged to) recognise a security
interest of which it has actual notice over shares. The Company shall not be treated as having recognised any such security interest unless
it has so agreed in writing with the secured party.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Power to vary class rights</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.10</TD><TD STYLE="text-align: justify">If the share capital is divided into different classes of Shares then, unless the terms on which a class
of Shares was issued state otherwise, the rights attaching to a class of Shares may only be varied if one of the following applies:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">the Members holding not less than two-thirds of the issued Shares of that class consent in writing to
the variation; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">the variation is made with the sanction of a Special Resolution passed at a separate general meeting of
the Members holding the issued Shares of that class.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.11</TD><TD STYLE="text-align: justify">For the purpose of Article 2.10(b), all the provisions of these Articles relating to general meetings
apply, mutatis mutandis, to every such separate meeting except that:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">the necessary quorum shall be one or more persons holding, or representing by proxy, not less than one
third of the issued Shares of the class; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">any Member holding issued Shares of the class, present in person or by proxy or, in the case of a corporate
Member, by its duly authorised representative, may demand a poll.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effect of new Share issue on existing class
rights</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.12</TD><TD STYLE="text-align: justify">Unless the terms on which a class of Shares was issued state otherwise, the rights conferred on the Member
holding Shares of any class shall not be deemed to be varied by the creation or issue of further Shares ranking <I>pari passu</I> with
the existing Shares of that class.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No bearer Shares or warrants</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.13</TD><TD STYLE="text-align: justify">The Company shall not issue Shares or warrants to bearers.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Treasury Shares</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.14</TD><TD STYLE="text-align: justify">Shares that the Company purchases, redeems or acquires by way of surrender in accordance with the Act
shall be held as Treasury Shares and not treated as cancelled if:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">the Directors so determine prior to the purchase, redemption or surrender of those shares; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">the relevant provisions of the Memorandum and Articles and the Act are otherwise complied with.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Rights attaching to Treasury Shares and related
matters</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.15</TD><TD STYLE="text-align: justify">No dividend may be declared or paid, and no other distribution (whether in cash or otherwise) of the Company&rsquo;s
assets (including any distribution of assets to Members on a winding up) may be made to the Company in respect of a Treasury Share.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.16</TD><TD STYLE="text-align: justify">The Company shall be entered in the register of Members as the holder of the Treasury Shares. However:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">the Company shall not be treated as a Member for any purpose and shall not exercise any right in respect
of the Treasury Shares, and any purported exercise of such a right shall be void; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">a Treasury Share shall not be voted, directly or indirectly, at any meeting of the Company and shall not
be counted in determining the total number of issued shares at any given time, whether for the purposes of these Articles or the Act.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.17</TD><TD STYLE="text-align: justify">Nothing in Article 2.16 prevents an allotment of Shares as Fully Paid Up bonus shares in respect of a
Treasury Share and Shares allotted as Fully Paid Up bonus shares in respect of a Treasury Share shall be treated as Treasury Shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.18</TD><TD STYLE="text-align: justify">Treasury Shares may be disposed of by the Company in accordance with the Act and otherwise on such terms
and conditions as the Directors determine.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Register of Members</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.19</TD><TD STYLE="text-align: justify">The Company shall maintain or cause to be maintained the Register of Members in accordance with the Act.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.20</TD><TD STYLE="text-align: justify">The Directors may determine that the Company shall maintain one or more branch registers of Members in
accordance with the Act. The Directors may also determine which Register of Members shall constitute the principal register and which
shall constitute the branch register or registers, and to vary such determination from time to time.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.21</TD><TD STYLE="text-align: justify">The title to Shares may be evidenced and transferred in accordance with the laws applicable to the rules
and regulations of the Designated Stock Exchange and, for these purposes, the Register of Members may be maintained in accordance with
Article 40B of the Act.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Annual Return</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.22</TD><TD STYLE="text-align: justify">The Directors in each calendar year shall prepare or cause to be prepared an annual return and declaration
setting forth the particulars required by the Act and shall deliver a copy thereof to the registrar of companies for the Cayman Islands.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3</TD><TD STYLE="text-align: justify">Share certificates</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Issue of share certificates</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.1</TD><TD STYLE="text-align: justify">A Member shall only be entitled to a share certificate if the Directors resolve that share certificates
shall be issued. Share certificates representing Shares, if any, shall be in such form as the Directors may determine. If the Directors
resolve that share certificates shall be issued, upon being entered in the register of Members as the holder of a Share, the Directors
may issue to any Member:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">without payment, one certificate for all the Shares of each class held by that Member (and, upon transferring
a part of the Member&rsquo;s holding of Shares of any class, to a certificate for the balance of that holding); and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">upon payment of such reasonable sum as the Directors may determine for every certificate after the first,
several certificates each for one or more of that Member&rsquo;s Shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.2</TD><TD STYLE="text-align: justify">Every certificate shall specify the number, class and distinguishing numbers (if any) of the Shares to
which it relates and whether they are Fully Paid Up or Partly Paid Up. A certificate may be executed under seal or executed in such other
manner as the Directors determine.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.3</TD><TD STYLE="text-align: justify">Every certificate shall bear legends required under the applicable laws, including the U.S. Securities
Act.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.4</TD><TD STYLE="text-align: justify">The Company shall not be bound to issue more than one certificate for Shares held jointly by several persons
and delivery of a certificate for a Share to one joint holder shall be a sufficient delivery to all of them.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Renewal of lost or damaged share certificates</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.5</TD><TD STYLE="text-align: justify">If a share certificate is defaced, worn-out, lost or destroyed, it may be renewed on such terms (if any)
as to:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">evidence;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">indemnity;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">payment of the expenses reasonably incurred by the Company in investigating the evidence; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">payment of a reasonable fee, if any for issuing a replacement share certificate,</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">as the Directors may determine, and
(in the case of defacement or wearing-out) on delivery to the Company of the old certificate.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4</TD><TD STYLE="text-align: justify">Lien on Shares</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nature and scope of lien</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.1</TD><TD STYLE="text-align: justify">The Company has a first and paramount lien on all Shares (whether Fully Paid Up or not) registered in
the name of a Member (whether solely or jointly with others). The lien is for all monies payable to the Company by the Member or the Member&rsquo;s
estate:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">either alone or jointly with any other person, whether or not that other person is a Member; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">whether or not those monies are presently payable.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.2</TD><TD STYLE="text-align: justify">At any time the Board may declare any Share to be wholly or partly exempt from the provisions of this
Article.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Company may sell Shares to satisfy lien</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.3</TD><TD STYLE="text-align: justify">The Company may sell any Shares over which it has a lien if all of the following conditions are met:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">the sum in respect of which the lien exists is presently payable;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">the Company gives notice to the Member holding the Share (or to the person entitled to it in consequence
of the death or bankruptcy of that Member) demanding payment and stating that if the notice is not complied with the Shares may be sold;
and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">that sum is not paid within 14 Clear Days after that notice is deemed to be given under these Articles,</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">and Shares to which this Article 4.3
applies shall be referred to as Lien Default Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.4</TD><TD STYLE="text-align: justify">The Lien Default Shares may be sold in such manner as the Board determines.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.5</TD><TD STYLE="text-align: justify">To the maximum extent permitted by law, the Directors shall incur no personal liability to the Member
concerned in respect of the sale.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Authority to execute instrument of transfer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.6</TD><TD STYLE="text-align: justify">To give effect to a sale, the Directors may authorise any person to execute an instrument of transfer
of the Lien Default Shares sold to, or in accordance with the directions of, the purchaser.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.7</TD><TD STYLE="text-align: justify">The title of the transferee of the Lien Default Shares shall not be affected by any irregularity or invalidity
in the proceedings in respect of the sale.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Consequences of sale of Shares to satisfy
lien</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.8</TD><TD STYLE="text-align: justify">On a sale pursuant to the preceding Articles:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">the name of the Member concerned shall be removed from the register of Members as the holder of those
Lien Default Shares; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">that person shall deliver to the Company for cancellation the certificate (if any) for those Lien Default
Shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.9</TD><TD STYLE="text-align: justify">Notwithstanding the provisions of Article 4.8, such person shall remain liable to the Company for all
monies which, at the date of sale, were presently payable by him to the Company in respect of those Lien Default Shares. That person shall
also be liable to pay interest on those monies from the date of sale until payment at the rate at which interest was payable before that
sale or, failing that, at the Default Rate. The Board may waive payment wholly or in part or enforce payment without any allowance for
the value of the Lien Default Shares at the time of sale or for any consideration received on their disposal.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Application of proceeds of sale</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.10</TD><TD STYLE="text-align: justify">The net proceeds of the sale, after payment of the costs, shall be applied in payment of so much of the
sum for which the lien exists as is presently payable. Any residue shall be paid to the person whose Lien Default Shares have been sold:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">if no certificate for the Lien Default Shares was issued, at the date of the sale; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">if a certificate for the Lien Default Shares was issued, upon surrender to the Company of that certificate
for cancellation</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">but, in either case, subject to the
Company retaining a like lien for all sums not presently payable as existed on the Lien Default Shares before the sale.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5</TD><TD STYLE="text-align: justify">Calls on Shares and forfeiture</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Power to make calls and effect of calls</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.1</TD><TD STYLE="text-align: justify">Subject to the terms of allotment, the Board may make calls on the Members in respect of any monies unpaid
on their Shares including any premium. The call may provide for payment to be by instalments. Subject to receiving at least 14 Clear Days&rsquo;
notice specifying when and where payment is to be made, each Member shall pay to the Company the amount called on his Shares as required
by the notice.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.2</TD><TD STYLE="text-align: justify">Before receipt by the Company of any sum due under a call, that call may be revoked in whole or in part
and payment of a call may be postponed in whole or in part. Where a call is to be paid in instalments, the Company may revoke the call
in respect of all or any remaining instalments in whole or in part and may postpone payment of all or any of the remaining instalments
in whole or in part.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.3</TD><TD STYLE="text-align: justify">A Member on whom a call is made shall remain liable for that call notwithstanding the subsequent transfer
of the Shares in respect of which the call was made. He shall not be liable for calls made after he is no longer registered as Member
in respect of those Shares.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Time when call made</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.4</TD><TD STYLE="text-align: justify">A call shall be deemed to have been made at the time when the resolution of the Directors authorising
the call was passed.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Liability of joint holders</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.5</TD><TD STYLE="text-align: justify">Members registered as the joint holders of a Share shall be jointly and severally liable to pay all calls
in respect of the Share.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Interest on unpaid calls</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.6</TD><TD STYLE="text-align: justify">If a call remains unpaid after it has become due and payable the person from whom it is due and payable
shall pay interest on the amount unpaid from the day it became due and payable until it is paid:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">at the rate fixed by the terms of allotment of the Share or in the notice of the call; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">if no rate is fixed, at the Default Rate.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">The Directors may waive payment of
the interest wholly or in part.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Deemed calls</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.7</TD><TD STYLE="text-align: justify">Any amount payable in respect of a Share, whether on allotment or on a fixed date or otherwise, shall
be deemed to be payable as a call. If the amount is not paid when due the provisions of these Articles shall apply as if the amount had
become due and payable by virtue of a call.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Power to accept early payment</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.8</TD><TD STYLE="text-align: justify">The Company may accept from a Member the whole or a part of the amount remaining unpaid on Shares held
by him although no part of that amount has been called up.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Power to make different arrangements at time
of issue of Shares</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.9</TD><TD STYLE="text-align: justify">Subject to the terms of allotment, the Directors may make arrangements on the issue of Shares to distinguish
between Members in the amounts and times of payment of calls on their Shares.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Notice of default</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.10</TD><TD STYLE="text-align: justify">If a call remains unpaid after it has become due and payable the Directors may give to the person from
whom it is due not less than 14 Clear Days&rsquo; notice requiring payment of:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">the amount unpaid;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">any interest which may have accrued;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">any expenses which have been incurred by the Company due to that person&rsquo;s default.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.11</TD><TD STYLE="text-align: justify">The notice shall state the following:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">the place where payment is to be made; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">a warning that if the notice is not complied with the Shares in respect of which the call is made will
be liable to be forfeited.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Forfeiture or surrender of Shares</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.12</TD><TD STYLE="text-align: justify">If the notice given pursuant to Article 5.10 is not complied with, the Directors may, before the payment
required by the notice has been received, resolve that any Share the subject of that notice be forfeited. The forfeiture shall include
all dividends or other monies payable in respect of the forfeited Share and not paid before the forfeiture. Despite the foregoing, the
Board may determine that any Share the subject of that notice be accepted by the Company as surrendered by the Member holding that Share
in lieu of forfeiture.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Disposal of forfeited or surrendered Share
and power to cancel forfeiture or surrender</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.13</TD><TD STYLE="text-align: justify">A forfeited or surrendered Share may be sold, re-allotted or otherwise disposed of on such terms and in
such manner as the Board determine either to the former Member who held that Share or to any other person. The forfeiture or surrender
may be cancelled on such terms as the Directors think fit at any time before a sale, re-allotment or other disposition. Where, for the
purposes of its disposal, a forfeited or surrendered Share is to be transferred to any person, the Directors may authorise some person
to execute an instrument of transfer of the Share to the transferee.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effect of forfeiture or surrender on former
Member</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.14</TD><TD STYLE="text-align: justify">On forfeiture or surrender:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">the name of the Member concerned shall be removed from the register of Members as the holder of those
Shares and that person shall cease to be a Member in respect of those Shares; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">that person shall surrender to the Company for cancellation the certificate (if any) for the forfeited
or surrendered Shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.15</TD><TD STYLE="text-align: justify">Despite the forfeiture or surrender of his Shares, that person shall remain liable to the Company for
all monies which at the date of forfeiture or surrender were presently payable by him to the Company in respect of those Shares together
with:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">all expenses; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">interest from the date of forfeiture or surrender until payment:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.3pt; text-align: justify; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 35.4pt">(i)</TD><TD STYLE="text-align: justify">at the rate of which interest was payable on those monies before forfeiture; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.3pt; text-align: justify; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 35.4pt">(ii)</TD><TD STYLE="text-align: justify">if no interest was so payable, at the Default Rate.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">The Directors, however, may waive
payment wholly or in part.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Evidence of forfeiture or surrender</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.16</TD><TD STYLE="text-align: justify">A declaration, whether statutory or under oath, made by a Director or the Secretary shall be conclusive
evidence of the following matters stated in it as against all persons claiming to be entitled to forfeited Shares:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">that the person making the declaration is a Director or Secretary of the Company, and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">that the particular Shares have been forfeited or surrendered on a particular date.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">Subject to the execution of an instrument
of transfer, if necessary, the declaration shall constitute good title to the Shares.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Sale of forfeited or surrendered Shares</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.17</TD><TD STYLE="text-align: justify">Any person to whom the forfeited or surrendered Shares are disposed of shall not be bound to see to the
application of the consideration, if any, of those Shares nor shall his title to the Shares be affected by any irregularity in, or invalidity
of the proceedings in respect of, the forfeiture, surrender or disposal of those Shares.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6</TD><TD STYLE="text-align: justify">Transfer of Shares</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Form of transfer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.1</TD><TD STYLE="text-align: justify">Subject to the following Articles about the transfer of Shares, and provided that such transfer complies
with applicable rules of the SEC, the Designated Stock Exchange and federal and state securities laws of the United States, a Member may
transfer Shares to another person by completing an instrument of transfer in a common form or in a form prescribed by the Designated Stock
Exchange or in any other form approved by the Directors, executed:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">where the Shares are Fully Paid Up, by or on behalf of that Member; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">where the Shares are partly paid, by or on behalf of that Member and the transferee.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.2</TD><TD STYLE="text-align: justify">The transferor shall be deemed to remain the holder of a Share until the name of the transferee is entered
into the Register of Members.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Power to refuse registration</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.3</TD><TD STYLE="text-align: justify">The Directors may refuse to register any transfer of Shares at their discretion.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.4</TD><TD STYLE="text-align: justify">If the Shares in question were issued in conjunction with rights, options or warrants issued pursuant
to Article 2.4 on terms that one cannot be transferred without the other, the Directors shall refuse to register the transfer of any such
Share without evidence satisfactory to them of the like transfer of such option or warrant.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Notice of refusal to register</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.5</TD><TD STYLE="text-align: justify">If the Directors refuse to register a transfer of any Shares, they shall within two months after the date
on which the instrument of transfer was lodged with the Company send to each of the transferor and the transferee notice of the refusal.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Power to suspend registration</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.6</TD><TD STYLE="text-align: justify">The Directors may suspend registration of the transfer of Shares at such times and for such periods, not
exceeding 45 days in any calendar year, as they determine.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Company may retain instrument of transfer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.7</TD><TD STYLE="text-align: justify">The Company shall be entitled to retain any instrument of transfer which is registered; but an instrument
of transfer which the Directors refuse to register shall be returned to the person lodging it when notice of the refusal is given.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7</TD><TD STYLE="text-align: justify">Transmission of Shares</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Persons entitled on death of a Member</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7.1</TD><TD STYLE="text-align: justify">If a Member dies, the only persons recognised by the Company as having any title to the deceased Members&rsquo;
interest are the following:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">where the deceased Member was a joint holder, the survivor or survivors; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">where the deceased Member was a sole holder, that Member&rsquo;s personal representative or representatives.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7.2</TD><TD STYLE="text-align: justify">Nothing in these Articles shall release the deceased Member&rsquo;s estate from any liability in respect
of any Share, whether the deceased was a sole holder or a joint holder.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Registration of transfer of a Share following
death or bankruptcy</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7.3</TD><TD STYLE="text-align: justify">A person becoming entitled to a Share in consequence of the death or bankruptcy of a Member may elect
to do either of the following:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">to become the holder of the Share; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">to transfer the Share to another person.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7.4</TD><TD STYLE="text-align: justify">That person must produce such evidence of his entitlement as the Directors may properly require.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7.5</TD><TD STYLE="text-align: justify">If the person elects to become the holder of the Share, he must give notice to the Company to that effect.
For the purposes of these Articles, that notice shall be treated as though it were an executed instrument of transfer.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7.6</TD><TD STYLE="text-align: justify">If the person elects to transfer the Share to another person then:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">if the Share is Fully Paid Up, the transferor must execute an instrument of transfer; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">if the Share is nil or Partly Paid Up, the transferor and the transferee must execute an instrument of
transfer.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7.7</TD><TD STYLE="text-align: justify">All the Articles relating to the transfer of Shares shall apply to the notice or, as appropriate, the
instrument of transfer.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indemnity</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7.8</TD><TD STYLE="text-align: justify">A person registered as a Member by reason of the death or bankruptcy of another Member shall indemnify
the Company and the Directors against any loss or damage suffered by the Company or the Directors as a result of that registration.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Rights of person entitled to a Share following
death or bankruptcy</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7.9</TD><TD STYLE="text-align: justify">A person becoming entitled to a Share by reason of the death or bankruptcy of a Member shall have the
rights to which he would be entitled if he were registered as the holder of the Share. But, until he is registered as Member in respect
of the Share, he shall not be entitled to attend or vote at any meeting of the Company or at any separate meeting of the holders of that
class of Shares.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">8</TD><TD STYLE="text-align: justify">Alteration of capital</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Increasing, consolidating, converting, dividing
and cancelling share capital</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">8.1</TD><TD STYLE="text-align: justify">To the fullest extent permitted by the Act, the Company may by Ordinary Resolution do any of the following
and amend its Memorandum for that purpose:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">increase its share capital by new Shares of the amount fixed by that Ordinary Resolution and with the
attached rights, priorities and privileges set out in that Ordinary Resolution;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">consolidate and divide all or any of its share capital into Shares of larger amount than its existing
Shares;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">convert all or any of its Paid Up Shares into stock, and reconvert that stock into Paid Up Shares of any
denomination;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">sub-divide its Shares or any of them into Shares of an amount smaller than that fixed by the Memorandum,
so, however, that in the sub-division, the proportion between the amount paid and the amount, if any, unpaid on each reduced Share shall
be the same as it was in case of the Share from which the reduced Share is derived; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">cancel Shares which, at the date of the passing of that Ordinary Resolution, have not been taken or agreed
to be taken by any person, and diminish the amount of its share capital by the amount of the Shares so cancelled or, in the case of Shares
without nominal par value, diminish the number of Shares into which its capital is divided.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dealing with fractions resulting from consolidation
of Shares</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">8.2</TD><TD STYLE="text-align: justify">Whenever, as a result of a consolidation of Shares, any Members would become entitled to fractions of
a Share the Directors may on behalf of those Members deal with the fractions as it thinks fit, including (without limitation):</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">sell the Shares representing the fractions for the best price reasonably obtainable to any person (including,
subject to the provisions of the Act, the Company); and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">distribute the net proceeds in due proportion among those Members.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">8.3</TD><TD STYLE="text-align: justify">For the purposes of Article 8.2, the Directors may authorise some person to execute an instrument of transfer
of the Shares to, in accordance with the directions of, the purchaser. The transferee shall not be bound to see to the application of
the purchase money nor shall the transferee&rsquo;s title to the Shares be affected by any irregularity in, or invalidity of, the proceedings
in respect of the sale.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Reducing share capital</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">8.4</TD><TD STYLE="text-align: justify">Subject to the Act and to any rights for the time being conferred on the Members holding a particular
class of Shares, the Company may, by Special Resolution, reduce its share capital in any way.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">9</TD><TD STYLE="text-align: justify">Redemption and purchase of own Shares</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Power to issue redeemable Shares and to purchase
own Shares</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">9.1</TD><TD STYLE="text-align: justify">Subject to the Act, and, where applicable, the rules and regulations of the Designated Stock Exchange
and/or the SEC, and to any rights for the time being conferred on the Members holding a particular class of Shares, the Company may by
its Directors:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">issue Shares that are to be redeemed or liable to be redeemed, at the option of the Company or the Member
holding those redeemable Shares, on the terms and in the manner its Directors determine before the issue of those Shares;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">with the consent by Special Resolution of the Members holding Shares of a particular class, vary the rights
attaching to that class of Shares so as to provide that those Shares are to be redeemed or are liable to be redeemed at the option of
the Company on the terms and in the manner which the Directors determine at the time of such variation; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">purchase all or any of its own Shares of any class including any redeemable Shares on the terms and in
the manner which the Directors determine at the time of such purchase.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">The Company may make a payment in
respect of the redemption or purchase of its own Shares in any manner authorised by the Act, including out of any combination of the following:
capital, its profits and the proceeds of a fresh issue of Shares.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Power to pay for redemption or purchase in
cash or in specie</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">9.2</TD><TD STYLE="text-align: justify">When making a payment in respect of the redemption or purchase of Shares, the Directors may make the payment
in cash or <I>in specie</I> (or partly in one and partly in the other) if so authorised by the terms of the allotment of those Shares
or by the terms applying to those Shares in accordance with Article 9.1, or otherwise by agreement with the Member holding those Shares.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effect of redemption or purchase of a Share</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">9.3</TD><TD STYLE="text-align: justify">Upon the date of redemption or purchase of a Share:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">the Member holding that Share shall cease to be entitled to any rights in respect of the Share other than
the right to receive:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.3pt; text-align: justify; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 35.4pt">(i)</TD><TD STYLE="text-align: justify">the price for the Share; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.3pt; text-align: justify; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 35.4pt">(ii)</TD><TD STYLE="text-align: justify">any dividend declared in respect of the Share prior to the date of redemption or purchase;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">the Member&rsquo;s name shall be removed from the register of Members with respect to the Share; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">the Share shall be cancelled or held as a Treasury Share, as the Directors may determine.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">9.4</TD><TD STYLE="text-align: justify">For the purpose of Article 9.3, the date of redemption or purchase is the date when the Member&rsquo;s name
is removed from the register of Members with respect to the Shares the subject of the redemption or purchase.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10</TD><TD STYLE="text-align: justify">Meetings of Members</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Annual and extraordinary general meetings</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10.1</TD><TD STYLE="text-align: justify">The Company may, but shall not (unless required by the Designated Stock Exchange Rules) be obligated to,
in each year hold a general meeting as an annual general meeting, which, if held, shall be convened by the Board, in accordance with these
Articles.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10.2</TD><TD STYLE="text-align: justify">All general meetings other than annual general meetings shall be called extraordinary general meetings.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Power to call meetings</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10.3</TD><TD STYLE="text-align: justify">The Directors may call a general meeting at any time.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10.4</TD><TD STYLE="text-align: justify">If there are insufficient Directors to constitute a quorum and the remaining Directors are unable to agree
on the appointment of additional Directors, the Directors must call a general meeting for the purpose of appointing additional Directors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10.5</TD><TD STYLE="text-align: justify">The Directors must also call a general meeting if requisitioned in the manner set out in the next two
Articles.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10.6</TD><TD STYLE="text-align: justify">The requisition must be in writing and given by one or more Members who together hold at least ten per
cent of the rights to vote at such general meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10.7</TD><TD STYLE="text-align: justify">The requisition must also:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">specify the purpose of the meeting;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">be signed by or on behalf of each requisitioner (and for this purpose each joint holder shall be obliged
to sign). The requisition may consist of several documents in like form signed by one or more of the requisitioners; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">be delivered in accordance with the notice provisions.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10.8</TD><TD STYLE="text-align: justify">Should the Directors fail to call a general meeting within 21 Clear Days from the date of receipt of a
requisition, the requisitioners or any of them may call a general meeting within three months after the end of that period.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10.9</TD><TD STYLE="text-align: justify">Without limitation to the foregoing, if there are insufficient Directors to constitute a quorum and the
remaining Directors are unable to agree on the appointment of additional Directors, any one or more Members who together hold at least
five per cent of the rights to vote at a general meeting may call a general meeting for the purpose of considering the business specified
in the notice of meeting which shall include as an item of business the appointment of additional Directors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10.10</TD><TD STYLE="text-align: justify">If the Members call a meeting under the above provisions, the Company shall reimburse their reasonable
expenses.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Content of notice</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10.11</TD><TD STYLE="text-align: justify">Notice of a general meeting shall specify each of the following:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">the date and the hour of the meeting;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">whether the meeting will be held virtually, at a physical place or both;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">if the meeting is to be held in any part at a physical place, the address of such place;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">if the meeting is to be held in two or more places or in any part virtually, the technology that will
be used to facilitate the meeting;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">subject to paragraph (f) and the requirements of (to the extent applicable) the Designated Stock Exchange
Rules, the general nature of the business to be transacted; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify">if a resolution is proposed as a Special Resolution, the text of that resolution.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10.12</TD><TD STYLE="text-align: justify">In each notice there shall appear with reasonable prominence the following statements:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">that a Member who is entitled to attend and vote is entitled to appoint one or more proxies to attend
and vote instead of that Member; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">that a proxyholder need not be a Member.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Period of notice</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10.13</TD><TD STYLE="text-align: justify">At least seven Clear Days&rsquo; notice of any general meeting must be given to Members.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10.14</TD><TD STYLE="text-align: justify">Subject to the Act, a meeting may be convened on shorter notice, subject to the Act with the consent of
the Member or Members who, individually or collectively, hold at least ninety per cent of the voting rights of all those who have a right
to vote at that meeting.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Record date and persons entitled to receive
notice</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10.15</TD><TD STYLE="text-align: justify">Subject to the provisions of these Articles and to any restrictions imposed on any Shares, the notice
shall be given to the following people:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">the Members</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">persons entitled to a Share in consequence of the death or bankruptcy of a Member;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">the Directors; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">the Auditors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10.16</TD><TD STYLE="text-align: justify">The Board may determine that the Members entitled to receive notice of and vote at a meeting are those
persons entered on the register of Members at the close of business on a day determined by the Board.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accidental omission to give notice or non-receipt
of notice</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10.17</TD><TD STYLE="text-align: justify">Proceedings at a meeting shall not be invalidated by the following:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">an accidental failure to give notice of the meeting to any person entitled to notice; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">non-receipt of notice of the meeting by any person entitled to notice.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10.18</TD><TD STYLE="text-align: justify">In addition, where a notice of meeting is published on a website proceedings at the meeting shall not
be invalidated merely because it is accidentally published:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">in a different place on the website; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">for part only of the period from the date of the notification until the conclusion of the meeting to which
the notice relates.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">11</TD><TD STYLE="text-align: justify">Proceedings at meetings of Members</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Quorum</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">11.1</TD><TD STYLE="text-align: justify">Save as provided in the following Article, no business shall be transacted at any meeting unless a quorum
is present in person or by proxy. A quorum is as follows:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">if the Company has only one Member: that Member;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">if the Company has more than one Member: one or more Members holding Shares that represent not less than
half of the outstanding Shares carrying the right to vote at such general meeting.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Lack of quorum</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">11.2</TD><TD STYLE="text-align: justify">If a quorum is not present within fifteen minutes of the time appointed for the meeting, or if at any
time during the meeting it becomes inquorate, then the following provisions apply:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">If the meeting was requisitioned by Members, it shall be cancelled.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">In any other case, the meeting shall stand adjourned to the same time and manner (including whether the
meeting will be held virtually, at a physical place or both) seven days hence, or to such other time or manner as is determined by the
Directors. If a quorum is not present within fifteen minutes of the time appointed for the adjourned meeting, then the Members present
in person or by proxy shall constitute a quorum.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Chairman</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">11.3</TD><TD STYLE="text-align: justify">The chairman of a general meeting shall be the chairman of the Board or such other person as the Directors
may determine. Absent any such person being present within fifteen minutes of the time appointed for the meeting, the Directors present
shall elect one of their number to chair the meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">11.4</TD><TD STYLE="text-align: justify">If no Director is present within fifteen minutes of the time appointed for the meeting, or if no Director
is willing to act as chairman, the Members present in person or by proxy and entitled to vote shall choose one of their number to chair
the meeting.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Right of a Director to attend and speak</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">11.5</TD><TD STYLE="text-align: justify">Even if a Director is not a Member, he shall be entitled to attend and speak at any general meeting and
at any separate meeting of Members holding a particular class of Shares.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accommodation of Members attending meeting
virtually</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">11.6</TD><TD STYLE="text-align: justify">A Member entitled to receive notice and attend a meeting will be deemed to be in attendance at such meeting
despite their attendance being virtual if adequate facilities are available to ensure that the Member is able to:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">participate in the business for which the meeting has been convened; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">hear all that happens at the meeting.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Security</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">11.7</TD><TD STYLE="text-align: justify">In addition to any measures which the Board may be required to take due to the location or venue of the
meeting, the Board may make any arrangement and impose any restriction it considers appropriate and reasonable in the circumstances to
ensure the security of a meeting including, without limitation, the searching of any person attending the meeting and the imposing of
restrictions on the items of personal property that may be taken into the meeting place. The Board may refuse entry to, or eject from,
a meeting a person who refuses to comply with any such arrangements or restrictions.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Adjournment, postponement and cancellation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">11.8</TD><TD STYLE="text-align: justify">A meeting may be:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">postponed or cancelled prior to the meeting at the discretion of the Directors by written notice provided
to all persons entitled to attend the meeting, unless the meeting was requisitioned by Members or otherwise called by Members pursuant
to Article 10.8; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">adjourned, with or without an appointed date for resumption, at any time during the meeting at the discretion
of the chairman with the consent of the Members constituting a quorum.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">11.9</TD><TD STYLE="text-align: justify">The chairman must adjourn a meeting if so directed by Members constituting a quorum at the meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">11.10</TD><TD STYLE="text-align: justify">No business can be transacted at an adjourned meeting other than business which might properly have been
transacted at the original meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">11.11</TD><TD STYLE="text-align: justify">Should a meeting be adjourned or postponed for more than seven Clear Days, whether (in respect of a meeting
that has been adjourned) because of a lack of quorum or otherwise, Members shall be given at least seven Clear Days&rsquo; notice of the adjourned
or postponed meeting in accordance with Article 10.11. Otherwise it shall not be necessary to give any notice of the adjournment or postponement.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Method of voting</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">11.12</TD><TD STYLE="text-align: justify">A resolution put to the vote of the meeting shall be decided on a poll.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"></P>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Chairman&rsquo;s casting vote</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">11.13</TD><TD STYLE="text-align: justify">In the case of an equality of votes the chairman of the meeting at which the poll is demanded shall not
be entitled to a second or casting vote.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Written resolutions</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">11.14</TD><TD STYLE="text-align: justify">Members may pass a resolution in writing without holding a meeting if the following conditions are met:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">all Members entitled to vote are given notice of the resolution as if the same were being proposed at
a meeting of Members;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">all Members entitled so to vote;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.3pt; text-align: justify; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 35.4pt">(i)</TD><TD STYLE="text-align: justify">sign a document; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.3pt; text-align: justify; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 35.4pt">(ii)</TD><TD STYLE="text-align: justify">sign several documents in the like form each signed by one or more of those Members; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">the signed document or documents is or are delivered to the Company, including, if the Company so nominates,
by delivery of an Electronic Record by Electronic means to the address specified for that purpose.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">Such written resolution shall be as effective as if it had been passed at a meeting of the Members entitled
to vote duly convened and held.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">11.15</TD><TD STYLE="text-align: justify">If a written resolution is described as a Special Resolution or as an Ordinary Resolution, it has effect
accordingly.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">11.16</TD><TD STYLE="text-align: justify">The Directors may determine the manner in which written resolutions shall be put to Members. In particular,
they may provide, in the form of any written resolution, for each Member to indicate, out of the number of votes the Member would have
been entitled to cast at a meeting to consider the resolution, how many votes he wishes to cast in favour of the resolution and how many
against the resolution or to be treated as abstentions. The result of any such written resolution shall be determined on the same basis
as on a poll.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Sole-Member Company</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">11.17</TD><TD STYLE="text-align: justify">If the Company has only one Member, and the Member records in writing his decision on a question, that
record shall constitute both the passing of a resolution and the minute of it.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"></P>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">12</TD><TD STYLE="text-align: justify">Voting rights of Members</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Right to vote</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">12.1</TD><TD STYLE="text-align: justify">Unless their Shares carry no right to vote, or unless a call or other amount presently payable has not
been paid, all Members are entitled to vote at a general meeting, and all Members holding Shares of a particular class of Shares are entitled
to vote at a meeting of the holders of that class of Shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">12.2</TD><TD STYLE="text-align: justify">Members may vote in person or by proxy.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">12.3</TD><TD STYLE="text-align: justify">On a poll a Member shall have one vote for each Share he holds, unless any Share carries special voting
rights. For the avoidance of doubt, an individual who represents two or more Members, including a Member in that individual&rsquo;s own
right, that individual shall be entitled to a separate vote for each Member.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">12.4</TD><TD STYLE="text-align: justify">No Member is bound to vote on his Shares or any of them; nor is he bound to vote each of his Shares in
the same way.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Rights of joint holders</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">12.5</TD><TD STYLE="text-align: justify">If Shares are held jointly, only one of the joint holders may vote. If more than one of the joint holders
tenders a vote, the vote of the holder whose name in respect of those Shares appears first in the register of Members shall be accepted
to the exclusion of the votes of the other joint holder.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Representation of corporate Members</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">12.6</TD><TD STYLE="text-align: justify">Save where otherwise provided, a corporate Member must act by a duly authorised representative.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">12.7</TD><TD STYLE="text-align: justify">A corporate Member wishing to act by a duly authorised representative must identify that person to the
Company by notice in writing.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">12.8</TD><TD STYLE="text-align: justify">The authorisation may be for any period of time, and must be delivered to the Company before the commencement
of the meeting at which it is first used.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">12.9</TD><TD STYLE="text-align: justify">The Directors of the Company may require the production of any evidence which they consider necessary
to determine the validity of the notice.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">12.10</TD><TD STYLE="text-align: justify">Where a duly authorised representative is present at a meeting that Member is deemed to be present in
person; and the acts of the duly authorised representative are personal acts of that Member.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">12.11</TD><TD STYLE="text-align: justify">A corporate Member may revoke the appointment of a duly authorised representative at any time by notice
to the Company; but such revocation will not affect the validity of any acts carried out by the duly authorised representative before
the Directors of the Company had actual notice of the revocation.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Member with mental disorder</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">12.12</TD><TD STYLE="text-align: justify">A Member in respect of whom an order has been made by any court having jurisdiction (whether in the Cayman
Islands or elsewhere) in matters concerning mental disorder may vote, by that Member&rsquo;s receiver, <I>curator bonis</I> or other person
authorised in that behalf appointed by that court.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">12.13</TD><TD STYLE="text-align: justify">For the purpose of the preceding Article, evidence to the satisfaction of the Directors of the authority
of the person claiming to exercise the right to vote must be received on a Business Day not less than 24 hours before holding the relevant
meeting, the postponed meeting or the adjourned meeting in any manner specified for the delivery of forms of appointment of a proxy, whether
in writing or by Electronic means. In default, the right to vote shall not be exercisable.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Objections to admissibility of votes</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">12.14</TD><TD STYLE="text-align: justify">An objection to the validity of a person&rsquo;s vote may only be raised at the meeting or at the adjourned
meeting at which the vote is sought to be tendered. Any objection duly made shall be referred to the chairman whose decision shall be
final and conclusive.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Form of proxy</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">12.15</TD><TD STYLE="text-align: justify">An instrument appointing a proxy shall be in any common form or in any other form approved by the Directors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">12.16</TD><TD STYLE="text-align: justify">The instrument must be in writing and signed in one of the following ways:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">by the Member; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">by the Member&rsquo;s authorised attorney; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">if the Member is a corporation or other body corporate, under seal or signed by an authorised officer,
secretary or attorney.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">If the Directors so resolve, the Company
may accept an Electronic Record of that instrument delivered in the manner specified below and otherwise satisfying the Articles about
authentication of Electronic Records.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">12.17</TD><TD STYLE="text-align: justify">The Directors may require the production of any evidence which they consider necessary to determine the
validity of any appointment of a proxy.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">12.18</TD><TD STYLE="text-align: justify">A Member may revoke the appointment of a proxy at any time by notice to the Company duly signed in accordance
with Article 12.16.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"></P>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">12.19</TD><TD STYLE="text-align: justify">No revocation by a Member of the appointment of a proxy made in accordance with Article 12.18 will affect
the validity of any acts carried out by the relevant proxy before the Directors of the Company had actual notice of the revocation.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">How and when proxy is to be delivered</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">12.20</TD><TD STYLE="text-align: justify">Subject to the following Articles, the Directors may, in the notice convening any meeting or adjourned
meeting, or in an instrument of proxy sent out by the Company, specify the manner by which the instrument appointing a proxy shall be
deposited and the place and/or electronic address and the time (being not later than the time appointed for the commencement of the meeting
or adjourned meeting to which the proxy relates) at which the instrument appointing a proxy shall be deposited. In the absence of any
such direction from the Directors in the notice convening any meeting or adjourned meeting or in an instrument of proxy sent out by the
Company, the form of appointment of a proxy and any authority under which it is signed (or a copy of the authority certified notarially
or in any other way approved by the Directors) must be delivered so that it is received by the Company before the time for holding the
meeting or adjourned meeting at which the person named in the form of appointment of proxy proposes to vote. They must be delivered in
either of the following ways:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">In the case of an instrument in writing, it must be left at or sent by post:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.3pt; text-align: justify; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 35.4pt">(i)</TD><TD STYLE="text-align: justify">to the registered office of the Company; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.3pt; text-align: justify; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 35.4pt">(ii)</TD><TD STYLE="text-align: justify">to such other place within the Cayman Islands specified in the notice convening the meeting or in any
form of appointment of proxy sent out by the Company in relation to the meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">If, pursuant to the notice provisions, a notice may be given to the Company in an Electronic Record, an
Electronic Record of an appointment of a proxy must be sent to the address specified pursuant to those provisions unless another address
for that purpose is specified:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.3pt; text-align: justify; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 35.4pt">(i)</TD><TD STYLE="text-align: justify">in the notice convening the meeting; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.3pt; text-align: justify; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 35.4pt">(ii)</TD><TD STYLE="text-align: justify">in any form of appointment of a proxy sent out by the Company in relation to the meeting; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.3pt; text-align: justify; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 35.4pt">(iii)</TD><TD STYLE="text-align: justify">in any invitation to appoint a proxy issued by the Company in relation to the meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">Notwithstanding Article 12.20(a) and Article 12.20(b), the chairman of the Company may, in any event at
his discretion, direct that an instrument of proxy shall be deemed to have been duly deposited.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">12.21</TD><TD STYLE="text-align: justify">Where a poll is taken:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">if it is taken more than seven Clear Days after it is demanded, the form of appointment of a proxy and
any accompanying authority (or an Electronic Record of the same) must be delivered in accordance with Article 12.20 before the time appointed
for the taking of the poll;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">if it is to be taken within seven Clear Days after it was demanded, the form of appointment of a proxy
and any accompanying authority (or an Electronic Record of the same) must be delivered in accordance with Article 12.20 before the time
appointed for the taking of the poll.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"></P>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">12.22</TD><TD STYLE="text-align: justify">If the form of appointment of proxy is not delivered on time, it is invalid.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">12.23</TD><TD STYLE="text-align: justify">When two or more valid but differing appointments of proxy are delivered or received in respect of the
same Share for use at the same meeting and in respect of the same matter, the one which is last validly delivered or received (regardless
of its date or of the date of its execution) shall be treated as replacing and revoking the other or others as regards that Share. lf
the Company is unable to determine which appointment was last validly delivered or received, none of them shall be treated as valid in
respect of that Share.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">12.24</TD><TD STYLE="text-align: justify">The Board may at the expense of the Company send forms of appointment of proxy to the Members by post
(that is to say, pre-paying and posting a letter), or by Electronic communication or otherwise (with or without provision for their return
by pre-paid post) for use at any general meeting or at any separate meeting of the holders of any class of Shares, either blank or nominating
as proxy in the alternative any one or more of the Directors or any other person. lf for the purpose of any meeting invitations to appoint
as proxy a person or one of a number of persons specified in the invitations are issued at the Company&rsquo;s expense, they shall be
issued to all (and not to some only) of the Members entitled to be sent notice of the meeting and to vote at it. The accidental omission
to send such a form of appointment or to give such an invitation to, or the non-receipt of such form of appointment by, any Member entitled
to attend and vote at a meeting shall not invalidate the proceedings at that meeting</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Voting by proxy</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">12.25</TD><TD STYLE="text-align: justify">A proxy shall have the same voting rights at a meeting, postponed meeting or adjourned meeting as the
Member would have had except to the extent that the instrument appointing him limits those rights. Notwithstanding the appointment of
a proxy, a Member may attend and vote at a meeting, postponed meeting or adjourned meeting. If a Member votes on any resolution a vote
by his proxy on the same resolution, unless in respect of different Shares, shall be invalid.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">12.26</TD><TD STYLE="text-align: justify">The instrument appointing a proxy to vote at a meeting shall be deemed also to confer authority to demand
or join in demanding a poll and, for the purposes of Article 11.13, a demand by a person as proxy for a Member shall be the same as a
demand by a Member. Such appointment shall not confer any further right to speak at the meeting, except with the permission of the chairman
of the meeting.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"></P>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">13</TD><TD STYLE="text-align: justify">Number of Directors</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">13.1</TD><TD STYLE="text-align: justify">Subject to Article 13.2, there shall be a Board consisting of not less than five person provided however
that the Company may by Ordinary Resolution increase or reduce the limits in the number of Directors. Unless fixed by Ordinary Resolution,
the maximum number of Directors shall be unlimited.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">13.2</TD><TD STYLE="text-align: justify">If the Company only has one member, the Board may comprise of one (1) person only.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">14</TD><TD STYLE="text-align: justify">Appointment, disqualification and removal of Directors</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No age limit</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">14.1</TD><TD STYLE="text-align: justify">There is no age limit for Directors save that they must be at least eighteen years of age.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Corporate Directors</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">14.2</TD><TD STYLE="text-align: justify">Unless prohibited by law, a body corporate may be a Director. If a body corporate is a Director, the Articles
about representation of corporate Members at general meetings apply, mutatis mutandis, to the Articles about Directors&rsquo; meetings.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No shareholding qualification</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">14.3</TD><TD STYLE="text-align: justify">Unless a shareholding qualification for Directors is fixed by Ordinary Resolution, no Director shall be
required to own Shares as a condition of his appointment.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Appointment of Directors</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">14.4</TD><TD STYLE="text-align: justify">A Director may be appointed by Ordinary Resolution or by the Directors. Any appointment may be to fill
a vacancy or as an additional Director.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">14.5</TD><TD STYLE="text-align: justify">A remaining Director may appoint a Director even though there is not a quorum of Directors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">14.6</TD><TD STYLE="text-align: justify">No appointment can cause the number of Directors to exceed the maximum (if one is set); and any such appointment
shall be invalid.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">14.7</TD><TD STYLE="text-align: justify">For so long as Shares or ADSs are listed on a Designated Stock Exchange, the Directors shall include at
least such number of Independent Directors as applicable law, rules or regulations or the Designated Stock Exchange Rules require as determined
by the Board.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Term of appointment</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">14.8</TD><TD STYLE="text-align: justify">Each Director appointed shall be appointed for a term expiring at the conclusion of the next-following
annual general meeting of the Company (unless re-elected at such annual general meeting).</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Eligibility</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">14.9</TD><TD STYLE="text-align: justify">No person (other than a Director retiring in accordance with these Articles) shall be appointed or re-appointed
a Director at any general meeting unless:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">he is recommended by the Board; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">not less than seven nor more than 42 Clear Days before the date appointed for the meeting, a Member (other
than the person to be proposed) entitled to vote at the meeting has given to the Company notice of his intention to propose a resolution
for the appointment of that person, stating the particulars which would, if he were so appointed, be required to be included in the Company&rsquo;s
register of Directors and a notice executed by that person of his willingness to be appointed.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Removal of Directors</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">14.10</TD><TD STYLE="text-align: justify">A Director may be removed by Ordinary Resolution.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Resignation of Directors</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">14.11</TD><TD STYLE="text-align: justify">A Director may at any time resign office by giving to the Company notice in writing or, if permitted pursuant
to the notice provisions, in an Electronic Record delivered in either case in accordance with those provisions.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">14.12</TD><TD STYLE="text-align: justify">Unless the notice specifies a different date, the Director shall be deemed to have resigned on the date
that the notice is delivered to the Company.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Termination of the office of Director</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">14.13</TD><TD STYLE="text-align: justify">A Director may retire from office as a Director by giving notice in writing to that effect to the Company
at the registered office, which notice shall be effective upon such date as may be specified in the notice, failing which upon delivery
to the registered office.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">14.14</TD><TD STYLE="text-align: justify">Without prejudice to the provisions in these Articles for retirement (by rotation or otherwise), a Director&rsquo;s
office shall be terminated forthwith if:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">he is prohibited by the law of the Cayman Islands from acting as a Director; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">he is made bankrupt or makes an arrangement or composition with his creditors generally; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">he resigns his office by notice to the Company; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">he only held office as a Director for a fixed term and such term expires; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">in the opinion of a registered medical practitioner by whom he is being treated he becomes physically
or mentally incapable of acting as a Director; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt"></P>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify">he is given notice by the majority of the other Directors (not being less than two in number) to vacate
office (without prejudice to any claim for damages for breach of any agreement relating to the provision of the services of such Director);
or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(g)</TD><TD STYLE="text-align: justify">he dies or he is made subject to any law relating to mental health or incompetence, whether by court order
or otherwise; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(h)</TD><TD STYLE="text-align: justify">without the consent of the other Directors, he is absent from meetings of Directors for a continuous period
of six months.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">15</TD><TD STYLE="text-align: justify">Alternate Directors</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Appointment and removal</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">15.1</TD><TD STYLE="text-align: justify">Any Director may appoint any other person, including another Director, to act in his place as an alternate
Director. No appointment shall take effect until the Director has given notice of the appointment to the Board.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">15.2</TD><TD STYLE="text-align: justify">A Director may revoke his appointment of an alternate at any time. No revocation shall take effect until
the Director has given notice of the revocation to the Board.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">15.3</TD><TD STYLE="text-align: justify">A notice of appointment or removal of an alternate Director shall be effective only if given to the Company
by one or more of the following methods:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">by notice in writing in accordance with the notice provisions contained in these Articles;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">if the Company has a facsimile address for the time being, by sending by facsimile transmission to that
facsimile address a facsimile copy or, otherwise, by sending by facsimile transmission to the facsimile address of the Company&rsquo;s registered
office a facsimile copy (in either case, the facsimile copy being deemed to be the notice unless Article 29.7 applies), in which event
notice shall be taken to be given on the date of an error-free transmission report from the sender&rsquo;s fax machine;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">if the Company has an email address for the time being, by emailing to that email address a scanned copy
of the notice as a PDF attachment or, otherwise, by emailing to the email address provided by the Company&rsquo;s registered office a scanned
copy of the notice as a PDF attachment (in either case, the PDF version being deemed to be the notice unless Article 29.7 applies), in
which event notice shall be taken to be given on the date of receipt by the Company or the Company&rsquo;s registered office (as appropriate)
in readable form; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">if permitted pursuant to the notice provisions, in some other form of approved Electronic Record delivered
in accordance with those provisions in writing.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Notices</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">15.4</TD><TD STYLE="text-align: justify">All notices of meetings of Directors shall continue to be given to the appointing Director and not to
the alternate.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Rights of alternate Director</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">15.5</TD><TD STYLE="text-align: justify">An alternate Director shall be entitled to attend and vote at any Board meeting or meeting of a committee
of the Directors at which the appointing Director is not personally present, and generally to perform all the functions of the appointing
Director in his absence. An alternate Director, however, is not entitled to receive any remuneration from the Company for services rendered
as an alternate Director.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Appointment ceases when the appointor ceases
to be a Director</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">15.6</TD><TD STYLE="text-align: justify">An alternate Director shall cease to be an alternate Director if:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">the Director who appointed him ceases to be a Director; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">the Director who appointed him revokes his appointment by notice delivered to the Board or to the registered
office of the Company or in any other manner approved by the Board; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">in any event happens in relation to him which, if he were a Director of the Company, would cause his office
as Director to be vacated.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Status of alternate Director</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">15.7</TD><TD STYLE="text-align: justify">An alternate Director shall carry out all functions of the Director who made the appointment.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">15.8</TD><TD STYLE="text-align: justify">Save where otherwise expressed, an alternate Director shall be treated as a Director under these Articles.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">15.9</TD><TD STYLE="text-align: justify">An alternate Director is not the agent of the Director appointing him.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">15.10</TD><TD STYLE="text-align: justify">An alternate Director is not entitled to any remuneration for acting as alternate Director.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Status of the Director making the appointment</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">15.11</TD><TD STYLE="text-align: justify">A Director who has appointed an alternate is not thereby relieved from the duties which he owes the Company.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"></P>

<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16</TD><TD STYLE="text-align: justify">Powers of Directors</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Powers of Directors</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.1</TD><TD STYLE="text-align: justify">Subject to the provisions of the Act, the Memorandum and these Articles the business of the Company shall
be managed by the Directors who may for that purpose exercise all the powers of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.2</TD><TD STYLE="text-align: justify">No prior act of the Directors shall be invalidated by any subsequent alteration of the Memorandum or these
Articles. However, to the extent allowed by the Act, Members may, by Special Resolution, validate any prior or future act of the Directors
which would otherwise be in breach of their duties.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Directors below the minimum number</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.3</TD><TD STYLE="text-align: justify">lf the number of Directors is less than the minimum prescribed in accordance with these Articles, the
remaining Director or Directors shall act only for the purposes of appointing an additional Director or Directors to make up such minimum
or of convening a general meeting of the Company for the purpose of making such appointment. lf there are no Director or Directors able
or willing to act, any two Members may summon a general meeting for the purpose of appointing Directors. Any additional Director so appointed
shall hold office (subject to these Articles) only until the dissolution of the annual general meeting next following such appointment
unless he is re-elected during such meeting.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Appointments to office</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.4</TD><TD STYLE="text-align: justify">The Directors may appoint a Director:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">as chairman of the Board;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">as managing Director;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">to any other executive office,</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">for such period, and on such terms,
including as to remuneration as they think fit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.5</TD><TD STYLE="text-align: justify">The appointee must consent in writing to holding that office.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.6</TD><TD STYLE="text-align: justify">Where a chairman is appointed he shall, unless unable to do so, preside at every meeting of Directors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.7</TD><TD STYLE="text-align: justify">If there is no chairman, or if the chairman is unable to preside at a meeting, that meeting may select
its own chairman; or the Directors may nominate one of their number to act in place of the chairman should he ever not be available.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.8</TD><TD STYLE="text-align: justify">Subject to the provisions of the Act, the Directors may also appoint and remove any person, who need not
be a Director:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">as Secretary; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">to any office that may be required</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">for such period and on such terms,
including as to remuneration, as they think fit. In the case of an Officer, that Officer may be given any title the Directors decide.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"></P>

<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.9</TD><TD STYLE="text-align: justify">The Secretary or Officer must consent in writing to holding that office.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.10</TD><TD STYLE="text-align: justify">A Director, Secretary or other Officer of the Company may not the hold the office, or perform the services,
of auditor.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Provisions for employees</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.11</TD><TD STYLE="text-align: justify">The Board may make provision for the benefit of any persons employed or formerly employed by the Company
or any of its subsidiary undertakings (or any member of his family or any person who is dependent on him) in connection with the cessation
or the transfer to any person of the whole or part of the undertaking of the Company or any of its subsidiary undertakings.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Exercise of voting rights</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.12</TD><TD STYLE="text-align: justify">The Board may exercise the voting power conferred by the Shares in any body corporate held or owned by
the Company in such manner in all respects as it thinks fit (including, without limitation, the exercise of that power in favour of any
resolution appointing any Director as a Director of such body corporate, or voting or providing for the payment of remuneration to the
Directors of such body corporate).</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Remuneration</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.13</TD><TD STYLE="text-align: justify">Every Director may be remunerated by the Company for the services he provides for the benefit of the Company,
whether as Director, employee or otherwise, and shall be entitled to be paid for the expenses incurred in the Company&rsquo;s business
including attendance at Directors&rsquo; meetings.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.14</TD><TD STYLE="text-align: justify">Until otherwise determined by the Company by Ordinary Resolution, the Directors (other than alternate
Directors) shall be entitled to such remuneration by way of fees for their services in the office of Director as the Directors may determine.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.15</TD><TD STYLE="text-align: justify">Remuneration may take any form and may include arrangements to pay pensions, health insurance, death or
sickness benefits, whether to the Director or to any other person connected to or related to him.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.16</TD><TD STYLE="text-align: justify">Unless his fellow Directors determine otherwise, a Director is not accountable to the Company for remuneration
or other benefits received from any other company which is in the same group as the Company or which has common shareholdings.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 41; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Disclosure of information</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.17</TD><TD STYLE="text-align: justify">The Directors may release or disclose to a third party any information regarding the affairs of the Company,
including any information contained in the register of Members relating to a Member, (and they may authorise any Director, Officer or
other authorised agent of the Company to release or disclose to a third party any such information in his possession) if:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">the Company or that person, as the case may be, is lawfully required to do so under the laws of any jurisdiction
to which the Company is subject; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">such disclosure is in compliance with the Designated Stock Exchange Rules; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">such disclosure is in accordance with any contract entered into by the Company; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">the Directors are of the opinion such disclosure would assist or facilitate the Company&rsquo;s operations.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">17</TD><TD STYLE="text-align: justify">Delegation of powers</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Power to delegate any of the Directors&rsquo;
powers to a committee</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">17.1</TD><TD STYLE="text-align: justify">The Directors may delegate any of their powers to any committee consisting of one or more persons who
need not be Members. Persons on the committee may include non-Directors so long as the majority of those persons are Directors. Any such
committee shall be made up of such number of Independent Directors as required from time to time by the Designated Stock Exchange Rules
or otherwise required by applicable law.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">17.2</TD><TD STYLE="text-align: justify">The delegation may be collateral with, or to the exclusion of, the Directors&rsquo; own powers.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">17.3</TD><TD STYLE="text-align: justify">The delegation may be on such terms as the Directors think fit, including provision for the committee
itself to delegate to a sub-committee; save that any delegation must be capable of being revoked or altered by the Directors at will.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">17.4</TD><TD STYLE="text-align: justify">Unless otherwise permitted by the Directors, a committee must follow the procedures prescribed for the
taking of decisions by Directors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">17.5</TD><TD STYLE="text-align: justify">The Board shall establish an audit committee, a compensation committee and a nominating and corporate
governance committee. Each of these committees shall be empowered to do all things necessary to exercise the rights of such committee
set forth in these Articles. Each of the audit committee, compensation committee and nominating and corporate governance committee shall
consist of at least three Directors (or such larger minimum number as may be required from time to time by the Designated Stock Exchange
Rules). The majority of the committee members on each of the compensation committee and nominating and corporate governance committee
shall be Independent Directors. The audit committee shall be made up of such number of Independent Directors as required from time to
time by the Designated Stock Exchange Rules or otherwise required by applicable law.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 42; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Local boards</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">17.6</TD><TD STYLE="text-align: justify">The Board may establish any local or divisional board or agency for managing any of the affairs of the
Company whether in the Cayman Islands or elsewhere and may appoint any persons to be members of a local or divisional Board, or to be
managers or agents, and may fix their remuneration.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">17.7</TD><TD STYLE="text-align: justify">The Board may delegate to any local or divisional board, manager or agent any of its powers and authorities
(with power to sub-delegate) and may authorise the members of any local or divisional board or any of them to fill any vacancies and to
act notwithstanding vacancies.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">17.8</TD><TD STYLE="text-align: justify">Any appointment or delegation under Article 17.6 and 17.7 may be made on such terms and subject to such
conditions as the Board thinks fit and the Board may remove any person so appointed, and may revoke or vary any delegation.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Power to appoint an agent of the Company</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">17.9</TD><TD STYLE="text-align: justify">The Directors may appoint any person, either generally or in respect of any specific matter, to be the
agent of the Company with or without authority for that person to delegate all or any of that person&rsquo;s powers. The Directors may
make that appointment:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">by causing the Company to enter into a power of attorney or agreement; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">in any other manner they determine.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Power to appoint an attorney or authorised
signatory of the Company</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">17.10</TD><TD STYLE="text-align: justify">The Directors may appoint any person, whether nominated directly or indirectly by the Directors, to be
the attorney or the authorised signatory of the Company. The appointment may be:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">for any purpose;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">with the powers, authorities and discretions;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">for the period; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">subject to such conditions,</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">as they think fit. The powers, authorities
and discretions, however, must not exceed those vested in, or exercisable, by the Directors under these Articles. The Directors may do
so by power of attorney or any other manner they think fit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">17.11</TD><TD STYLE="text-align: justify">Any power of attorney or other appointment may contain such provision for the protection and convenience
for persons dealing with the attorney or authorised signatory as the Directors think fit. Any power of attorney or other appointment may
also authorise the attorney or authorised signatory to delegate all or any of the powers, authorities and discretions vested in that person.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"></P>

<!-- Field: Page; Sequence: 43; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">17.12</TD><TD STYLE="text-align: justify">The Board may remove any person appointed under Article 17.10 and may revoke or vary the delegation.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Borrowing Powers</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">17.13</TD><TD STYLE="text-align: justify">The Directors may exercise all the powers of the Company to borrow money and to mortgage or charge its
undertaking, property and assets both present and future and uncalled capital, or any part thereof, and to issue debentures and other
securities, whether outright or as collateral security for any debt, liability or obligation of the Company or its parent undertaking
(if any) or any subsidiary undertaking of the Company or of any third party.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Corporate Governance</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">17.14</TD><TD STYLE="text-align: justify">The Board may, from time to time, and except as required by applicable law or the Designated Stock Exchange
Rules, adopt, institute, amend, modify or revoke the corporate governance policies or initiatives of the Company, which shall be intended
to set forth the guiding principles and policies of the Company and the Board on various corporate governance related matters as the Board
shall determine by resolution from time to time.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">18</TD><TD STYLE="text-align: justify">Meetings of Directors</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Regulation of Directors&rsquo; meetings</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">18.1</TD><TD STYLE="text-align: justify">Subject to the provisions of these Articles, the Directors may regulate their proceedings as they think
fit.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Calling meetings</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">18.2</TD><TD STYLE="text-align: justify">Any Director may call a meeting of Directors at any time. The Secretary must call a meeting of the Directors
if requested to do so by a Director.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Notice of meetings</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">18.3</TD><TD STYLE="text-align: justify">Except in the case of urgency or with the consent of all those entitled to attend, at least 48 hours notice
of a Board meeting must be given to all Director in writing or by Electronic communications at such address as he may from time to time
specify for this purpose (or, if he does not specify an address, at his last known address). A Director may waive his right to receive
notice of any meeting either prospectively or retrospectively.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Use of technology</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">18.4</TD><TD STYLE="text-align: justify">A Director may participate in a meeting of Directors through the medium of conference telephone, video
or any other form of communications equipment providing all persons participating in the meeting are able to hear and speak to each other
throughout the meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">18.5</TD><TD STYLE="text-align: justify">A Director participating in this way is deemed to be present in person at the meeting.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 44; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Quorum</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">18.6</TD><TD STYLE="text-align: justify">Unless otherwise necessary to comply with the Designated Stock Exchange Rules, the quorum for the transaction
of business at a meeting of Directors shall be at least half (1/2) of all Directors.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Chairman or deputy to preside</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">18.7</TD><TD STYLE="text-align: justify">The Board may appoint a chairman and one or more deputy chairman or chairmen and may at any time revoke
any such appointment.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">18.8</TD><TD STYLE="text-align: justify">The chairman, or failing him any deputy chairman (the longest in office taking precedence if more than
one is present), shall preside at all Board meetings. If no chairman or deputy chairman has been appointed, or if he is not present within
five minutes after the time fixed for holding the meeting, or is unwilling to act as chairman of the meeting, the Directors present shall
choose one of their number to act as chairman of the meeting.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Voting</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">18.9</TD><TD STYLE="text-align: justify">A question which arises at a Board meeting shall be decided by a majority of votes. If votes are equal
the chairman shall not have a casting vote.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Recording of dissent</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">18.10</TD><TD STYLE="text-align: justify">A Director present at a meeting of Directors shall be presumed to have assented to any action taken at
that meeting unless:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">his dissent is entered in the minutes of the meeting; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">he has filed with the meeting before it is concluded signed dissent from that action; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">he has forwarded to the Company as soon as practical following the conclusion of that meeting signed dissent.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">A Director who votes in favour of
an action is not entitled to record his dissent to it.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Written resolutions</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">18.11</TD><TD STYLE="text-align: justify">The Directors may pass a resolution in writing without holding a meeting if all Directors sign a document
or sign several documents in the like form each signed by one or more of those Directors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">18.12</TD><TD STYLE="text-align: justify">A written resolution signed by a validly appointed alternate Director need not also be signed by the appointing
Director.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">18.13</TD><TD STYLE="text-align: justify">A written resolution signed personally by the appointing Director need not also be signed by his alternate.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"></P>

<!-- Field: Page; Sequence: 45; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">18.14</TD><TD STYLE="text-align: justify">A resolution in writing passed pursuant to Article 18.11, Article 18.12 and/or Article 18.13 shall be
as effective as if it had been passed at a meeting of the Directors duly convened and held; and it shall be treated as having been passed
on the day and at the time that the last Director signs (and for the avoidance of doubt, such day may or may not be a Business Day).</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Validity of acts of Directors in spite of
formal defect</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">18.15</TD><TD STYLE="text-align: justify">All acts done by a meeting of the Board, or of a committee of the Board, or by any person acting as a
Director or an alternate Director, shall, notwithstanding that it is afterwards discovered that there was some defect in the appointment
of any Director or alternate Director or member of the committee, or that any of them were disqualified or had vacated office or were
not entitled to vote, be as valid as if every such person had been duly appointed and qualified and had continued to be a Director or
alternate Director and had been entitled to vote.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">19</TD><TD STYLE="text-align: justify">Permissible Directors&rsquo; interests and disclosure</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Permissible interests subject to disclosure</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">19.1</TD><TD STYLE="text-align: justify">Save as expressly permitted by these Articles or as set out below, a Director may not have a direct or
indirect interest or duty which conflicts or may possibly conflict with the interests of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">19.2</TD><TD STYLE="text-align: justify">If, notwithstanding the prohibition in the preceding Article, a Director discloses to their fellow Directors
the nature and extent of any material interest or duty in accordance with the next Article, he may:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">be a party to, or otherwise interested in, any transaction or arrangement with the Company or in which
the Company is or may otherwise be interested; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">be interested in another body corporate promoted by the Company or in which the Company is otherwise interested.
In particular, the Director may be a Director, secretary or officer of, or employed by, or be a party to any transaction or arrangement
with, or otherwise interested in, that other body corporate.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">19.3</TD><TD STYLE="text-align: justify">Such disclosure may be made at a meeting of the board or otherwise (and, if otherwise, it must be made
in writing). The Director must disclose the nature and extent of his direct or indirect interest in or duty in relation to a transaction
or arrangement or series of transactions or arrangements with the Company or in which the Company has any material interest.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">19.4</TD><TD STYLE="text-align: justify">If a Director has made disclosure in accordance with the preceding Article, then they shall not, by reason
only of their office, be accountable to the Company for any benefit that he derives from any such transaction or arrangement or from any
such office or employment or from any interest in any such body corporate, and no such transaction or arrangement shall be liable to be
avoided on the ground of any such interest or benefit.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 46; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Notification of interests</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">19.5</TD><TD STYLE="text-align: justify">For the purposes of the preceding Articles:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">a general notice that a Director gives to the other directors that he is to be regarded as having an interest
of the nature and extent specified in the notice in any transaction or arrangement in which a specified person or class of persons is
interested shall be deemed to be a disclosure that he has an interest in or duty in relation to any such transaction of the nature and
extent so specified; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">an interest of which a director has no knowledge and of which it is unreasonable to expect him to have
knowledge shall not be treated as an interest of his.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">19.6</TD><TD STYLE="text-align: justify">A Director shall not be treated as having an interest in a transaction or arrangement if he has no knowledge
of that interest and it is unreasonable to expect the director to have that knowledge.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Voting where a Director is interested in
a matter</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">19.7</TD><TD STYLE="text-align: justify">A Director may vote at a meeting of directors on any resolution concerning a matter in which that Director
has an interest or duty, whether directly or indirectly, so long as that director discloses any material interest pursuant to these Articles.
The Director shall be counted towards a quorum of those present at the meeting. If the Director votes on the resolution, his vote shall
be counted.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">19.8</TD><TD STYLE="text-align: justify">Where proposals are under consideration concerning the appointment of two or more Directors to offices
or employment with the Company or any body corporate in which the Company is interested, the proposals may be divided and considered in
relation to each Director separately and each of the directors concerned shall be entitled to vote and be counted in the quorum in respect
of each resolution except that concerning his or her own appointment.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">20</TD><TD STYLE="text-align: justify">Minutes</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">20.1</TD><TD STYLE="text-align: justify">The Company shall cause minutes to be made in books of:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">all appointments of Officers and committees made by the Board and of any such Officer&rsquo;s remuneration;
and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">the names of Directors present at every meeting of the Directors, a committee of the Board, the Company
or the holders of any class of shares or debentures, and all orders, resolutions and proceedings of such meetings.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">20.2</TD><TD STYLE="text-align: justify">Any such minutes, if purporting to be signed by the chairman of the meeting at which the proceedings were
held or by the chairman of the next succeeding meeting or the Secretary, shall be prima facie evidence of the matters stated in them.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"></P>

<!-- Field: Page; Sequence: 47; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">21</TD><TD STYLE="text-align: justify">Accounts and audit</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">21.1</TD><TD STYLE="text-align: justify">The Directors must ensure that proper accounting and other records are kept, and that accounts and associated
reports are distributed in accordance with the requirements of the Act.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">21.2</TD><TD STYLE="text-align: justify">The books of account shall be kept at the registered office of the Company and shall always be open to
inspection by the Directors. No Member (other than a Director) shall have any right of inspecting any account or book or document of the
Company except as conferred by the Act or as authorised by the Directors or by Ordinary Resolution.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">21.3</TD><TD STYLE="text-align: justify">Unless the Directors otherwise prescribe, the financial year of the Company shall end on 30 June in each
year and begin on 1 July in each year.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Auditors</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">21.4</TD><TD STYLE="text-align: justify">The Directors may appoint an Auditor of the Company who shall hold office on such terms as the Directors
determine.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">21.5</TD><TD STYLE="text-align: justify">At any general meeting convened and held at any time in accordance with these Articles, the Members may,
by Ordinary Resolution, remove the Auditor before the expiration of his term of office. If they do so, the Members shall, by Ordinary
Resolution, at that meeting appoint another Auditor in his stead for the remainder of his term.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">21.6</TD><TD STYLE="text-align: justify">The Auditors shall examine such books, accounts and vouchers; as may be necessary for the performance
of their duties.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">21.7</TD><TD STYLE="text-align: justify">The Auditors shall, if so requested by the Directors, make a report on the accounts of the Company during
their tenure of office at the next annual general meeting following their appointment, and at any time during their term of office, upon
request of the Directors or any general meeting of the Company.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22</TD><TD STYLE="text-align: justify">Record dates</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.1</TD><TD STYLE="text-align: justify">Except to the extent of any conflicting rights attached to Shares, the resolution declaring a dividend
on Shares of any class, whether it be an Ordinary Resolution of the Members or a Director&rsquo;s resolution, may specify that the dividend
is payable or distributable to the persons registered as the holders of those Shares at the close of business on a particular date, notwithstanding
that the date may be a date prior to that on which the resolution is passed.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.2</TD><TD STYLE="text-align: justify">If the resolution does so specify, the dividend shall be payable or distributable to the persons registered
as the holders of those Shares at the close of business on the specified date in accordance with their respective holdings so registered,
but without prejudice to the rights <I>inter se</I> in respect of the dividend of transferors and transferees of any of those Shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.3</TD><TD STYLE="text-align: justify">The provisions of this Article apply, <I>mutatis mutandis</I>, to bonuses, capitalisation issues, distributions
of realised capital profits or offers or grants made by the Company to the Members.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"></P>

<!-- Field: Page; Sequence: 48; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">23</TD><TD STYLE="text-align: justify">Dividends</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Source of dividends</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">23.1</TD><TD STYLE="text-align: justify">Dividends may be declared and paid out of any funds of the Company lawfully available for distribution.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">23.2</TD><TD STYLE="text-align: justify">Subject to the requirements of the Act regarding the application of a company&rsquo;s Share premium account
and with the sanction of an Ordinary Resolution, dividends may also be declared and paid out of any share premium account.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Declaration of dividends by Members</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">23.3</TD><TD STYLE="text-align: justify">Subject to the provisions of the Act, the Company may by Ordinary Resolution declare dividends in accordance
with the respective rights of the Members but no dividend shall exceed the amount recommended by the Directors.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Payment of interim dividends and declaration
of final dividends by Directors</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">23.4</TD><TD STYLE="text-align: justify">The Directors may declare and pay interim dividends or recommend final dividends in accordance with the
respective rights of the Members if it appears to them that they are justified by the financial position of the Company and that such
dividends may lawfully be paid.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">23.5</TD><TD STYLE="text-align: justify">Subject to the provisions of the Act, in relation to the distinction between interim dividends and final
dividends, the following applies:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">Upon determination to pay a dividend or dividends described as interim by the Directors in the dividend
resolution, no debt shall be created by the declaration until such time as payment is made.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">Upon declaration of a dividend or dividends described as final by the Directors in the dividend resolution,
a debt shall be created immediately following the declaration, the due date to be the date the dividend is stated to be payable in the
resolution.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">If the resolution fails to specify
whether a dividend is final or interim, it shall be assumed to be interim.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">23.6</TD><TD STYLE="text-align: justify">In relation to Shares carrying differing rights to dividends or rights to dividends at a fixed rate, the
following applies:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">If the share capital is divided into different classes, the Directors may pay dividends on Shares which
confer deferred or non-preferred rights with regard to dividends as well as on Shares which confer preferential rights with regard to
dividends but no dividend shall be paid on Shares carrying deferred or non-preferred rights if, at the time of payment, any preferential
dividend is in arrears.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt"></P>

<!-- Field: Page; Sequence: 49; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">The Directors may also pay, at intervals settled by them, any dividend payable at a fixed rate if it appears
to them that there are sufficient funds of the Company lawfully available for distribution to justify the payment.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">If the Directors act in good faith, they shall not incur any liability to the Members holding Shares conferring
preferred rights for any loss those Members may suffer by the lawful payment of the dividend on any Shares having deferred or non-preferred
rights.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Apportionment of dividends</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">23.7</TD><TD STYLE="text-align: justify">Except as otherwise provided by the rights attached to Shares all dividends shall be declared and paid
according to the amounts Paid Up on the Shares on which the dividend is paid. All dividends shall be apportioned and paid proportionately
to the amount Paid Up on the Shares during the time or part of the time in respect of which the dividend is paid. But if a Share is issued
on terms providing that it shall rank for dividend as from a particular date, that Share shall rank for dividend accordingly.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Right of set off</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">23.8</TD><TD STYLE="text-align: justify">The Directors may deduct from a dividend or any other amount payable to a person in respect of a Share
any amount due by that person to the Company on a call or otherwise in relation to a Share.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Power to pay other than in cash</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">23.9</TD><TD STYLE="text-align: justify">If the Directors so determine, any resolution declaring a dividend may direct that it shall be satisfied
wholly or partly by the distribution of assets. If a difficulty arises in relation to the distribution, the Directors may settle that
difficulty in any way they consider appropriate. For example, they may do any one or more of the following:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">issue fractional Shares;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">fix the value of assets for distribution and make cash payments to some Members on the footing of the
value so fixed in order to adjust the rights of Members; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">vest some assets in trustees.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">How payments may be made</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">23.10</TD><TD STYLE="text-align: justify">A dividend or other monies payable on or in respect of a Share may be paid in any of the following ways:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">if the Member holding that Share or other person entitled to that Share nominates a bank account for that
purpose - by wire transfer to that bank account; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">by cheque or warrant sent by post to the registered address of the Member holding that Share or other
person entitled to that Share.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"></P>

<!-- Field: Page; Sequence: 50; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">23.11</TD><TD STYLE="text-align: justify">For the purposes of Article 23.10(a), the nomination may be in writing or in an Electronic Record and
the bank account nominated may be the bank account of another person. For the purposes of Article 23.10(b), subject to any applicable
law or regulation, the cheque or warrant shall be made to the order of the Member holding that Share or other person entitled to the Share
or to his nominee, whether nominated in writing or in an Electronic Record, and payment of the cheque or warrant shall be a good discharge
to the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">23.12</TD><TD STYLE="text-align: justify">If two or more persons are registered as the holders of the Share or are jointly entitled to it by reason
of the death or bankruptcy of the registered holder (<B>Joint Holders</B>), a dividend (or other amount) payable on or in respect of that
Share may be paid as follows:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">to the registered address of the Joint Holder of the Share who is named first on the register of Members
or to the registered address of the deceased or bankrupt holder, as the case may be; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">to the address or bank account of another person nominated by the Joint Holders, whether that nomination
is in writing or in an Electronic Record.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">23.13</TD><TD STYLE="text-align: justify">Any Joint Holder of a Share may give a valid receipt for a dividend (or other amount) payable in respect
of that Share.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dividends or other monies not to bear interest
in absence of special rights</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">23.14</TD><TD STYLE="text-align: justify">Unless provided for by the rights attached to a Share, no dividend or other monies payable by the Company
in respect of a Share shall bear interest.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dividends unable to be paid or unclaimed</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">23.15</TD><TD STYLE="text-align: justify">If a dividend cannot be paid to a Member or remains unclaimed within six weeks after it was declared or
both, the Directors may pay it into a separate account in the Company&rsquo;s name. If a dividend is paid into a separate account, the
Company shall not be constituted trustee in respect of that account and the dividend shall remain a debt due to the Member.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">23.16</TD><TD STYLE="text-align: justify">A dividend that remains unclaimed for a period of six years after it became due for payment shall be forfeited
to, and shall cease to remain owing by, the Company.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">24</TD><TD STYLE="text-align: justify">Capitalisation of profits</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Capitalisation of profits or of any share
premium account or capital redemption reserve</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">24.1</TD><TD STYLE="text-align: justify">The Directors may resolve to capitalise:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">any part of the Company&rsquo;s profits not required for paying any preferential dividend (whether or
not those profits are available for distribution); or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">any sum standing to the credit of the Company&rsquo;s share premium account or capital redemption reserve, if
any.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"></P>

<!-- Field: Page; Sequence: 51; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">24.2</TD><TD STYLE="text-align: justify">The amount resolved to be capitalised must be appropriated to the Members who would have been entitled
to it had it been distributed by way of dividend and in the same proportions. The benefit to each Member so entitled must be given in
either or both of the following ways::</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">by paying up the amounts unpaid on that Member&rsquo;s Shares;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">by issuing Fully Paid Up Shares, debentures or other securities of the Company to that Member or as that
Member directs. The Directors may resolve that any Shares issued to the Member in respect of Partly Paid Up Shares (<B>Original Shares</B>)
rank for dividend only to the extent that the Original Shares rank for dividend while those Original Shares remain Partly Paid Up.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Applying an amount for the benefit of Members</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">24.3</TD><TD STYLE="text-align: justify">The amount capitalised must be applied to the benefit of Members in the proportions to which the Members
would have been entitled to dividends if the amount capitalised had been distributed as a dividend.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">24.4</TD><TD STYLE="text-align: justify">Subject to the Act, if a fraction of a Share, a debenture or other security is allocated to a Member,
the Directors may issue a fractional certificate to that Member or pay him the cash equivalent of the fraction.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">25</TD><TD STYLE="text-align: justify">Share Premium Account</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Directors to maintain share premium account</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">25.1</TD><TD STYLE="text-align: justify">The Directors shall establish a share premium account in accordance with the Act. They shall carry to
the credit of that account from time to time an amount equal to the amount or value of the premium paid on the issue of any Share or capital
contributed or such other amounts required by the Act.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Debits to share premium account</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">25.2</TD><TD STYLE="text-align: justify">The following amounts shall be debited to any share premium account:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">on the redemption or purchase of a Share, the difference between the nominal value of that Share and the
redemption or purchase price; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">any other amount paid out of a share premium account as permitted by the Act.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">25.3</TD><TD STYLE="text-align: justify">Notwithstanding the preceding Article, on the redemption or purchase of a Share, the Directors may pay
the difference between the nominal value of that Share and the redemption purchase price out of the profits of the Company or, as permitted
by the Act, out of capital.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"></P>

<!-- Field: Page; Sequence: 52; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">26</TD><TD STYLE="text-align: justify">Seal</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Company seal</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">26.1</TD><TD STYLE="text-align: justify">The Company may have a seal if the Directors so determine.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Duplicate seal</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">26.2</TD><TD STYLE="text-align: justify">Subject to the provisions of the Act, the Company may also have a duplicate seal or seals for use in any
place or places outside the Cayman Islands. Each duplicate seal shall be a facsimile of the original seal of the Company. However, if
the Directors so determine, a duplicate seal shall have added on its face the name of the place where it is to be used.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When and how seal is to be used</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">26.3</TD><TD STYLE="text-align: justify">A seal may only be used by the authority of the Directors. Unless the Directors otherwise determine, a
document to which a seal is affixed must be signed in one of the following ways:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">by a Director (or his alternate) and the Secretary; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">by a single Director (or his alternate).</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If no seal is adopted or used</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">26.4</TD><TD STYLE="text-align: justify">If the Directors do not adopt a seal, or a seal is not used, a document may be executed in the following
manner:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">by a Director (or his alternate) and the Secretary; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">by a single Director (or his alternate); or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">in any other manner permitted by the Act.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Power to allow non-manual signatures and
facsimile printing of seal</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">26.5</TD><TD STYLE="text-align: justify">The Directors may determine that either or both of the following applies:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">that the seal or a duplicate seal need not be affixed manually but may be affixed by some other method
or system of reproduction;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">that a signature required by these Articles need not be manual but may be a mechanical or Electronic Signature.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Validity of execution</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">26.6</TD><TD STYLE="text-align: justify">If a document is duly executed and delivered by or on behalf of the Company, it shall not be regarded
as invalid merely because, at the date of the delivery, the Secretary, or the Director, or other Officer or person who signed the document
or affixed the seal for and on behalf of the Company ceased to be the Secretary or hold that office and authority on behalf of the Company.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"></P>

<!-- Field: Page; Sequence: 53; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">27</TD><TD STYLE="text-align: justify">Indemnity</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">27.1</TD><TD STYLE="text-align: justify">To the extent permitted by law, the Company shall indemnify each existing or former Director (including
alternate Director), Secretary and other Officer of the Company (including an investment adviser or an administrator or liquidator) and
their personal representatives against:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">all actions, proceedings, costs, charges, expenses, losses, damages or liabilities incurred or sustained
by the existing or former Director (including alternate Director), Secretary or Officer in or about the conduct of the Company&rsquo;s business
or affairs or in the execution or discharge of the existing or former Director&rsquo;s (including alternate Director&rsquo;s), Secretary&rsquo;s or
Officer&rsquo;s duties, powers, authorities or discretions; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">without limitation to paragraph (a), all costs, expenses, losses or liabilities incurred by the existing
or former Director (including alternate Director), Secretary or Officer in defending (whether successfully or otherwise) any civil, criminal,
administrative or investigative proceedings (whether threatened, pending or completed) concerning the Company or its affairs in any court
or tribunal, whether in the Cayman Islands or elsewhere.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">No such existing or former Director
(including alternate Director), Secretary or Officer, however, shall be indemnified (i) against any liability by reason of willful misfeasance,
bad faith, gross negligence or reckless disregard of the duties involved in the conduct of his or her office, (ii) with respect to any
matter as to which he or she shall have been finally adjudicated to have acted in bad faith and not in the interest of the Company or
(iii) in the event of a settlement, unless the settlement has been approved by a court of competent jurisdiction or by the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">27.2</TD><TD STYLE="text-align: justify">To the extent permitted by Act, the Company may make a payment, or agree to make a payment, whether by
way of advance, loan or otherwise, for any legal costs incurred by an existing or former Director (including alternate Director), Secretary
or Officer of the Company in respect of any matter identified in Article 27.1 on condition that the Director (including alternate Director),
Secretary or Officer must repay the amount paid by the Company to the extent that it is ultimately found not liable to indemnify the Director
(including alternate Director), Secretary or that Officer for those legal costs.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Release</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">27.3</TD><TD STYLE="text-align: justify">To the extent permitted by Act, the Company may by Special Resolution release any existing or former Director
(including alternate Director), Secretary or other Officer of the Company from liability for any loss or damage or right to compensation
which may arise out of or in connection with the execution or discharge of the duties, powers, authorities or discretions of his office;
but there may be no release from liability arising out of or in connection with that person&rsquo;s own dishonesty.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 54; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Insurance</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">27.4</TD><TD STYLE="text-align: justify">To the extent permitted by Act, the Company may pay, or agree to pay, a premium in respect of a contract
insuring each of the following persons against risks determined by the Directors, other than liability arising out of that person&rsquo;s
own dishonesty:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">an existing or former Director (including alternate Director), Secretary or Officer or auditor of:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.3pt; text-align: justify; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 35.4pt">(i)</TD><TD STYLE="text-align: justify">the Company;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.3pt; text-align: justify; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 35.4pt">(ii)</TD><TD STYLE="text-align: justify">a company which is or was a subsidiary of the Company;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.3pt; text-align: justify; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 35.4pt">(iii)</TD><TD STYLE="text-align: justify">a company in which the Company has or had an interest (whether direct or indirect); and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">a trustee of an employee or retirement benefits scheme or other trust in which any of the persons referred
to in paragraph (a) is or was interested.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">28</TD><TD STYLE="text-align: justify">Notices</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Form of notices</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">28.1</TD><TD STYLE="text-align: justify">Save where these Articles provide otherwise, and subject to the Designated Stock Exchange Rules, any notice
to be given to or by any person pursuant to these Articles shall be:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">in writing signed by or on behalf of the giver in the manner set out below for written notices; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">subject to the next Article, in an Electronic Record signed by or on behalf of the giver by Electronic
Signature and authenticated in accordance with Articles about authentication of Electronic Records; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">where these Articles expressly permit, by the Company by means of a website.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Electronic communications</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">28.2</TD><TD STYLE="text-align: justify">A notice may only be given to the Company in an Electronic Record if:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">the Directors so resolve or otherwise accept the notice; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">any Director or Officer provides the giver of the notice an electronic address to which the notice may
be sent and a notice is sent to that address within a reasonable period of time.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"></P>

<!-- Field: Page; Sequence: 55; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">28.3</TD><TD STYLE="text-align: justify">A notice may not be given by Electronic Record to a person other than the Company unless the recipient
has provided the giver of the notice an electronic address to which notice may be sent.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">28.4</TD><TD STYLE="text-align: justify">Subject to the Act, the Designated Stock Exchange Rules and to any other rules which the Company is bound
to follow, the Company may also send any notice or other document pursuant to these Articles to a Member by publishing that notice or
other document on a website where:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">the Company and the Member have agreed to his having access to the notice or document on a website (instead
of it being sent to him);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">the notice or document is one to which that agreement applies;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">the Member is notified (in accordance with any requirements laid down by the Act and, in a manner for
the time being agreed between him and the Company for the purpose) of:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.3pt; text-align: justify; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 35.4pt">(i)</TD><TD STYLE="text-align: justify">the publication of the notice or document on a website;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.3pt; text-align: justify; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 35.4pt">(ii)</TD><TD STYLE="text-align: justify">the address of that website; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.3pt; text-align: justify; text-indent: -35.4pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.9pt"></TD><TD STYLE="width: 35.4pt">(iii)</TD><TD STYLE="text-align: justify">the place on that website where the notice or document may be accessed, and how it may be accessed; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">the notice or document is published on that website throughout the publication period, provided that,
if the notice or document is published on that website for a part, but not all of, the publication period, the notice or document shall
be treated as being published throughout that period if the failure to publish that notice of document throughout that period is wholly
attributable to circumstances which it would not be reasonable to have expected the Company to prevent or avoid. For the purposes of this
Article 28.4 &ldquo;publication period&rdquo; means a period of not less than twenty-one days, beginning on the day on which the notification
referred to in Article 28.4(c) is deemed sent.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Persons entitled to notices</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">28.5</TD><TD STYLE="text-align: justify">Any notice or other document to be given to a Member may be given by reference to the register of Members
as it stands at any time within the period of twenty-one days before the day that the notice is given or (where and as applicable) within
any other period permitted by, or in accordance with the requirements of, (to the extent applicable) the Designated Stock Exchange Rules
and/or the Designated Stock Exchanges. No change in the register of Members after that time shall invalidate the giving of such notice
or document or require the Company to give such item to any other person.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 56; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Persons authorised to give notices</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">28.6</TD><TD STYLE="text-align: justify">A notice by either the Company or a Member pursuant to these Articles may be given on behalf of the Company
or a Member by a Director or company secretary of the Company or a Member.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Delivery of written notices</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">28.7</TD><TD STYLE="text-align: justify">Save where these Articles provide otherwise, a notice in writing may be given personally to the recipient,
or left at (as appropriate) the Member&rsquo;s or Director&rsquo;s registered address or the Company&rsquo;s registered office, or posted
to that registered address or registered office.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Joint holders</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">28.8</TD><TD STYLE="text-align: justify">Where Members are joint holders of a Share, all notices shall be given to the Member whose name first
appears in the register of Members.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Signatures</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">28.9</TD><TD STYLE="text-align: justify">A written notice shall be signed when it is autographed by or on behalf of the giver, or is marked in
such a way as to indicate its execution or adoption by the giver.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">28.10</TD><TD STYLE="text-align: justify">An Electronic Record may be signed by an Electronic Signature.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Evidence of transmission</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">28.11</TD><TD STYLE="text-align: justify">A notice given by Electronic Record shall be deemed sent if an Electronic Record is kept demonstrating
the time, date and content of the transmission, and if no notification of failure to transmit is received by the giver.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">28.12</TD><TD STYLE="text-align: justify">A notice given in writing shall be deemed sent if the giver can provide proof that the envelope containing
the notice was properly addressed, pre-paid and posted, or that the written notice was otherwise properly transmitted to the recipient.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">28.13</TD><TD STYLE="text-align: justify">A Member present, either in person or by proxy, at any meeting of the Company or of the holders of any
class of Shares shall be deemed to have received due notice of the meeting and, where requisite, of the purposes for which it was called.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Giving notice to a deceased or bankrupt Member</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">28.14</TD><TD STYLE="text-align: justify">A notice may be given by the Company to the persons entitled to a Share in consequence of the death or
bankruptcy of a Member by sending or delivering it, in any manner authorised by these Articles for the giving of notice to a Member, addressed
to them by name, or by the title of representatives of the deceased, or trustee of the bankrupt or by any like description, at the address,
if any, supplied for that purpose by the persons claiming to be so entitled.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">28.15</TD><TD STYLE="text-align: justify">Until such an address has been supplied, a notice may be given in any manner in which it might have been
given if the death or bankruptcy had not occurred.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 57; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date of giving notices</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">28.16</TD><TD STYLE="text-align: justify">A notice is given on the date identified in the following table</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Method for giving notices</B></P></TD>
    <TD STYLE="width: 50%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt"><B>When taken to be given</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">(A) Personally</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">At the time and date of delivery</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">(B) By leaving it at the Member&rsquo;s registered address</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">At the time and date it was left</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">(C) By posting it by prepaid post to the street or postal address of that recipient</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">48 hours after the date it was posted</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">(D) By Electronic Record (other than publication on a website), to recipient&rsquo;s Electronic address</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">48 hours after the date it was sent</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">(E) By publication on a website</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">24 hours after the date on which the Member is deemed to have been notified of the publication of the notice or document on the website</FONT></TD></TR>
  </TABLE>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Saving provision</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">28.17</TD><TD STYLE="text-align: justify">None of the preceding notice provisions shall derogate from the Articles about the delivery of written
resolutions of Directors and written resolutions of Members.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">29</TD><TD STYLE="text-align: justify">Authentication of Electronic Records</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Application of Articles</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">29.1</TD><TD STYLE="text-align: justify">Without limitation to any other provision of these Articles, any notice, written resolution or other document
under these Articles that is sent by Electronic means by a Member, or by the Secretary, or by a Director or other Officer of the Company,
shall be deemed to be authentic if either Article 29.2 or Article 29.4 applies.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Authentication of documents sent by Members
by Electronic means</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">29.2</TD><TD STYLE="text-align: justify">An Electronic Record of a notice, written resolution or other document sent by Electronic means by or
on behalf of one or more Members shall be deemed to be authentic if the following conditions are satisfied:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">the Member or each Member, as the case may be, signed the original document, and for this purpose <B>Original
Document</B> includes several documents in like form signed by one or more of those Members; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">the Electronic Record of the Original Document was sent by Electronic means by, or at the direction of,
that Member to an address specified in accordance with these Articles for the purpose for which it was sent; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">Article 29.7 does not apply.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"></P>

<!-- Field: Page; Sequence: 58; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">29.3</TD><TD STYLE="text-align: justify">For example, where a sole Member signs a resolution and sends the Electronic Record of the original resolution,
or causes it to be sent, by facsimile transmission to the address in these Articles specified for that purpose, the facsimile copy shall
be deemed to be the written resolution of that Member unless Article 28.7 applies.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Authentication of document sent by the Secretary
or Officers of the Company by Electronic means</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">29.4</TD><TD STYLE="text-align: justify">An Electronic Record of a notice, written resolution or other document sent by or on behalf of the Secretary
or an Officer or Officers of the Company shall be deemed to be authentic if the following conditions are satisfied:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">the Secretary or the Officer or each Officer, as the case may be, signed the original document, and for
this purpose <B>Original Document</B> includes several documents in like form signed by the Secretary or one or more of those Officers;
and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">the Electronic Record of the Original Document was sent by Electronic means by, or at the direction of,
the Secretary or that Officer to an address specified in accordance with these Articles for the purpose for which it was sent; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">Article 29.7 does not apply.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">This Article 29.4 applies whether
the document is sent by or on behalf of the Secretary or Officer in his own right or as a representative of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">29.5</TD><TD STYLE="text-align: justify">For example, where a sole Director signs a resolution and scans the resolution, or causes it to be scanned,
as a PDF version which is attached to an email sent to the address in these Articles specified for that purpose, the PDF version shall
be deemed to be the written resolution of that Director unless Article 29.7 applies.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Manner of signing</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">29.6</TD><TD STYLE="text-align: justify">For the purposes of these Articles about the authentication of Electronic Records, a document will be
taken to be signed if it is signed manually or in any other manner permitted by these Articles.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Saving provision</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">29.7</TD><TD STYLE="text-align: justify">A notice, written resolution or other document under these Articles will not be deemed to be authentic
if the recipient, acting reasonably:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">believes that the signature of the signatory has been altered after the signatory had signed the original
document; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt"></P>

<!-- Field: Page; Sequence: 59; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">believes that the original document, or the Electronic Record of it, was altered, without the approval
of the signatory, after the signatory signed the original document; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">otherwise doubts the authenticity of the Electronic Record of the document</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">and the recipient promptly gives notice
to the sender setting the grounds of its objection. If the recipient invokes this Article, the sender may seek to establish the authenticity
of the Electronic Record in any way the sender thinks fit.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">30</TD><TD STYLE="text-align: justify">Transfer by way of continuation</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">30.1</TD><TD STYLE="text-align: justify">The Company may, by Special Resolution, resolve to be registered by way of continuation in a jurisdiction
outside:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">the Cayman Islands; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">such other jurisdiction in which it is, for the time being, incorporated, registered or existing.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">30.2</TD><TD STYLE="text-align: justify">To give effect to any resolution made pursuant to the preceding Article, the Directors may cause the following:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">an application be made to the Registrar of Companies of the Cayman Islands to deregister the Company in
the Cayman Islands or in the other jurisdiction in which it is for the time being incorporated, registered or existing; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">all such further steps as they consider appropriate to be taken to effect the transfer by way of continuation
of the Company.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">31</TD><TD STYLE="text-align: justify">Winding up</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Distribution of assets in specie</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">31.1</TD><TD STYLE="text-align: justify">If the Company is wound up the Members may, subject to these Articles and any other sanction required
by the Act, pass a Special Resolution allowing the liquidator to do either or both of the following:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">to divide in specie among the Members the whole or any part of the assets of the Company and, for that
purpose, to value any assets and to determine how the division shall be carried out as between the Members or different classes of Members;
and/or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">to vest the whole or any part of the assets in trustees for the benefit of Members and those liable to
contribute to the winding up.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No obligation to accept liability</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">31.2</TD><TD STYLE="text-align: justify">No Member shall be compelled to accept any assets if an obligation attaches to them.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt"></P>

<!-- Field: Page; Sequence: 60; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">31.3</TD><TD STYLE="text-align: justify">The Directors are authorised to present a winding up petition.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">31.4</TD><TD STYLE="text-align: justify">The Directors have the authority to present a petition for the winding up of the Company to the Grand
Court of the Cayman Islands on behalf of the Company without the sanction of a resolution passed at a general meeting.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">32</TD><TD STYLE="text-align: justify">Amendment of Memorandum and Articles</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Power to change name or amend Memorandum</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">32.1</TD><TD STYLE="text-align: justify">Subject to the Act, the Company may, by Special Resolution:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">change its name; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">change the provisions of its Memorandum with respect to its objects, powers or any other matter specified
in the Memorandum.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Power to amend these Articles</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">32.2</TD><TD STYLE="text-align: justify">Subject to the Act and as provided in these Articles, the Company may, by Special Resolution, amend these
Articles in whole or in part.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 61; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-11.1
<SEQUENCE>3
<FILENAME>ea027012501ex11-1_moolec.htm
<DESCRIPTION>INSIDER TRADING POLICY
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 356.45pt"><B>Exhibit 11.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 356.45pt; text-align: right"><IMG SRC="ex11-1_001.jpg" ALT=""></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">INSIDER TRADING POLICY</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-variant: small-caps">(Last update:
December, 2025) </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">PURPOSE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">It is illegal for any employee,
contractor, officer or director of Moolec Science SA (the &ldquo;<FONT STYLE="text-decoration: underline solid"><B>Company</B></FONT>,&rdquo;
or &ldquo;<FONT STYLE="text-decoration: underline solid"><B>our</B></FONT>&rdquo;), a company incorporated in Cayman Islands, with registered
office at 89 Nexus Way, Camana Bay, Grand Cayman KY1-9009, Cayman Islands to trade in the securities of the Company while in the possession
of material nonpublic information about the Company. For that reason, there are some rules you&rsquo;ll need to know and follow so that
you don&rsquo;t accidentally commit insider trading, which is both a civil wrong and a crime in the United States that carries serious
legal penalties, including potentially millions of dollars in fines or jail time of up to 20 years. Insider trading can result in the
termination of your employment with the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Insider trading happens when
someone with knowledge of material nonpublic information (&ldquo;<FONT STYLE="text-decoration: underline solid"><B>MNPI</B></FONT>&rdquo;)
about the Company uses that MNPI, or tips off someone else to use the MNPI, to gain profits or avoid losses in the stock market. Because
we are committed to upholding high standards of honest and ethical business conduct, we have adopted this Insider Trading Policy (this
&ldquo;<FONT STYLE="text-decoration: underline solid"><B>Policy</B></FONT>&rdquo;) to take an active role in preventing insider trading
violations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">If you are considering trading our Moolec securities, please
keep these three key points in mind:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">1.</TD><TD STYLE="text-align: justify">Never buy or sell our Moolec securities based on MNPI.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">2.</TD><TD>Keep all MNPI confidential, including from your family and friends.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">3.</TD><TD>When in doubt about whether you have MNPI, ask before trading or transacting in any of our securities.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="ex11-1_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We trust our employees, officers, directors,
and contractors and write our policies with that trust in mind. You are responsible for understanding and following this Policy and
for the consequences of any actions you may take. Our Chief Financial Officer will assist with implementing, interpreting and
enforcing this Policy, pre-clearing trading activities of certain people and pre-approving any Rule 10b5-1 plans (plans that permit
insiders to sell Company Moolec securities on a predetermined schedule that the insider doesn&rsquo;t control, discussed more fully
later in this Policy).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">PERSONS COVERED BY THIS POLICY</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Policy applies to our
employees, officers, directors and contractors, as well as to their immediate family members, people sharing their households, and anyone
subject to their influence or control. It applies as well to entities such as venture capital funds, partnerships, trusts and corporations
with which our employees and directors are associated or affiliated. We will refer to all these individuals and entities in this Policy
collectively as &ldquo;<FONT STYLE="text-decoration: underline solid"><B>Insiders</B></FONT>.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain Insiders who have
regular access to MNPI in the normal course of their job are known as our &ldquo;<FONT STYLE="text-decoration: underline solid"><B>Designated
Insiders</B></FONT>&rdquo; and are listed on <FONT STYLE="text-decoration: underline solid">Exhibit A</FONT> to this Policy. Designated
Insiders also must get pre-approval of any trades in our Moolec securities. The list of Designated Insiders may be amended by our Chief
Financial Officer without the approval of the board of directors of the Company (the &ldquo;<FONT STYLE="text-decoration: underline solid"><B>Board</B></FONT>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If you are aware of MNPI when
your employment or service relationship ends, you still may not trade our Moolec securities until that MNPI has become public or is no
longer material.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">WHAT THIS POLICY COVERS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The primary purpose of this
Policy is to prevent people with MNPI from profiting from that MNPI before it is made publicly available, thus allowing all our shareholders
to benefit from the information at the same time. More specifically, federal securities laws prohibit a person from using MNPI to make
decisions about trading our Moolec securities, including tipping off someone else with that information so that they can trade our Moolec
securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="ex11-1_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="text-decoration: underline solid"><B>Material
Information</B></FONT>&rdquo; is information about the Company, positive or negative, that a reasonable shareholder would consider useful
when buying or selling our Moolec securities. Some examples of MNPI include not-yet-announced financial or company performance information,
significant regulatory communications, timing and achievement of significant goals, entry into a new commercial agreement or termination
of an existing commercial agreement, mergers or acquisitions, development and launch of new products, significant cybersecurity incidents
or data breaches, and changes in senior executive management or our Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<FONT STYLE="text-decoration: underline solid"><B>Nonpublic</B></FONT>&rdquo;
means that the confidential information has not yet been shared broadly outside the company. Please remember that we may possess confidential
information relating to or belonging to our clients, partners or other third parties, and that it is equally important that we treat this
information with the same care with which we treat our own information. If you are not sure whether information is considered public,
you should either consult with the Chief Financial Officer or assume that the information is nonpublic and treat it as confidential.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Policy applies to all
transactions involving our Moolec securities, including our ordinary Moolec securities, restricted ordinary Moolec securities and warrants
and any other type of securities we may issue, such as convertible notes and exchange traded options or other derivative securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">PROHIBITED ACTIVITIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Insiders are prohibited from carrying out the following activities:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>trading our Moolec securities while in possession of any MNPI;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>trading our Moolec securities outside of our Trading Window (as defined below) or during any Blackout Period (as defined below);</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>making a gift, charitable contribution or other transfer without consideration of our Moolec securities during a period when you cannot
trade;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0pt 0"><IMG SRC="ex11-1_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">sharing MNPI with any outside person unless required by your job and such person is under a non-disclosure agreement previously approved
by our legal department, or as authorized by our legal department;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.5in"></TD><TD STYLE="text-align: justify; width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">giving trading advice based on MNPI to anyone unless the advice is to tell someone not to trade our Moolec securities because the
trade would violate this Policy or the law;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.5in"></TD><TD STYLE="text-align: justify; width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">engaging in transactions involving options or other derivative securities on our Moolec securities, such as puts and calls, whether
on an exchange or in any other market unless you limit the transaction solely to exercising a compensatory equity grant issued by us;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.5in"></TD><TD STYLE="text-align: justify; width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">engaging in hedging or monetization transactions involving our Moolec securities, such as zero cost collars and forward sale contracts,
or contributing our Moolec securities to exchange funds in a manner that could be interpreted as hedging in our Moolec securities;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.5in"></TD><TD STYLE="text-align: justify; width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">engaging in short sales of our Moolec securities, including short sales &ldquo;against the box;&rdquo;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.5in"></TD><TD STYLE="text-align: justify; width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">using or pledging our Moolec securities as collateral in a margin account or as collateral for a loan unless the pledge has been approved
by the Legal Department at least two weeks prior to the proposed execution of documents for the pledge;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.5in"></TD><TD STYLE="text-align: justify; width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">distributing our Moolec securities to limited partners, general partners, or shareholders of any entity unless those limited partners,
general partners or shareholders have agreed in writing to hold the Moolec securities until the next open Trading Window; and</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.5in"></TD><TD STYLE="text-align: justify; width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">engaging in any of the above activities for Moolec securities you own in any other public company if you have MNPI about that company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57pt; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">EXCEPTIONS TO PROHIBITED ACTIVITIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The trading restrictions of
this Policy do not apply to exercising stock options granted under equity incentive plans adopted by the Company for cash or the delivery
of previously owned Company Moolec securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">WHEN TRADING IS ALLOWED</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">When you have access to MNPI,
you need to take special care in planning when you might trade our Moolec securities. We&rsquo;ve provided some guidelines below to help
you plan your trading in a way that is consistent with this Policy and the law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Six-Month Window and Blackout Periods</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Six-Month Window. <FONT STYLE="font-weight: normal">To
comply with the U.S. federal securities regulations and this Policy, the Insiders may not buy or sell Moolec securities within a six-month
window, except for the securities that may be granted under any stock incentive plans. If you buy Moolec securities, you must wait six
(6) months before selling them. Likewise, if you sell Moolec securities, you must wait six months before buying more securities. The securities
you buy do not have to be the same ones you sell: if you buy one group of securities, you must wait six months before selling that group
or another group of securities. This waiting period prevents corporate insiders from making short-term profits at the Company&rsquo;s
expense.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">If you
violate this rule, then you have violated U.S. law and this Policy. As a result, you may face a lawsuit or government enforcement action,and
will be subject to corporate disciplinary action and may be terminated. In addition, the Company can take the earnings you made on the
trade. In taking these earnings, the Company can pair any purchase with any sale within the six-month window to maximize the amount it
gets</FONT>.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Blackout Period. <FONT STYLE="font-weight: normal">Outside
the six-month window, buying, selling, and shorting Moolec securities remains restricted for the Insiders, from seven days before the
last calendar day of each quarter until the financial statements are publicly disclosed by the submission with the controlling authority,
or by the issuance of a press release by the Company including the results of the financial statements, whatever occurs first. If you
wish to trade Moolec securities within the six-month window or blackout period, you must first get permission from the Chief Financial
Officer. If you are given permission, you must buy or sell the securities within 72 hours of getting permission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal"></FONT></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><IMG SRC="ex11-1_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Trading Permission for Insiders. </I><FONT STYLE="font-weight: normal">Whether
or not the six-month window or blackout period applies, if you are an Insiders want to buy or sell Moolec securities, you must first get
permission from the Company&rsquo;s Chief Financial Officer. This includes securities granted under any stock incentive plans. If you
are given permission, you must buy or sell the securities within 72 hours of getting permission. Permission is not needed to buy or sell
securities based on a Rule 10b5-1 plan (see below).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal"><I>&nbsp;</I></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>No trading during open windows while in
the possession of MNPI</I>. <FONT STYLE="font-weight: normal">Even if you would allow you to trade Moolec securities is open, you still
may not trade our Moolec securities if you possess MNPI at that time. An Insider who possesses MNPI during an open window may trade Moolec
securities only after the close of trading on the next full trading day following our widespread public release of that MNPI.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Permitted Trades Under fi0b5-fi Plans</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A 10b5-1 Plan is a plan written
in advance that allows an Insider with MNPI to trade a predetermined number of Moolec securities at a predetermined time based on terms
put in place before the Insider had any MNPI; these trades occur in accordance with the 10b5-1 Plan and without any action or influence
by the Insider. We encourage all our Designated Insiders to establish a 10b5-1 Plan. If you are interested in setting up a 10b5-1 Plan,
you should consult with our Legal Department and make sure that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the 10b5-1 Plan complies with the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the &ldquo;<FONT STYLE="text-decoration: underline solid"><B>Exchange
Act</B></FONT>&rdquo;), and the Policy;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.5in"></TD><TD STYLE="text-align: justify; width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">you have certified to our Legal Department in writing, no earlier than two business days prior to the date that the 10b5-1 Plan is
formally established, that (i) you do not know any MNPI, (ii) all trades to be made pursuant to the 10b5 1 Plan will be in accordance
with the trading restrictions of Rule 144 of the Securities Act of 1933, as amended (the &ldquo;<FONT STYLE="text-decoration: underline solid"><B>Securities
Act</B></FONT>&rdquo;), to the extent such restrictions are applicable, and (iii) the 10b5-1 Plan complies with the requirements of Rule
10b5-1 (this certification may be made by email to our Legal Department);</TD></TR></TABLE>


<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: right; margin-top: 0; margin-bottom: 0"><IMG SRC="ex11-1_001.jpg" ALT=""></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the 10b5-1 Plan is approved in writing by our Legal Department at least 60 days in advance of the first trade under such plan;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.5in"></TD><TD STYLE="text-align: justify; width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the 10b5-1 Plan is put in place during an open window and not during any regular quarterly or specially declared Blackout Period;
and</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.5in"></TD><TD STYLE="text-align: justify; width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">your first trade under the 10b5-1 Plan does not occur until the opening of the next open window following our Legal Department&rsquo;s
approval of the 10b5-1 Plan.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Once you have an approved 10b5-1 Plan in place,
you will need approval from our Legal Department if you want to make any changes to it. We may limit your ability to modify your 10b5-1
Plan because making frequent changes to a 10b5-1 Plan may give the appearance that you are trading on MNPI under the guise of that plan.
Any changes to your 10b5-1 Plan will be subject to a &ldquo;cooling off&rdquo; period, meaning that the change will take effect no sooner
than 60 days after it is made. The first trade under the modified 10b5-1 Plan must occur during an open window.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">CONSE&#490;UENCES OF VIOLATING THIS POLICY</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may impose sanctions on
anyone violating this Policy and may issue stop transfer orders to our transfer agent to forestall any attempted trades that would violate
the Policy. Sanctions may include disciplinary action, including termination of your employment. Executive Officers and Designated Insiders
may be required to certify compliance with this Policy on an annual basis. Notifications and approvals required under this Policy may
be provided by email.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The trading prohibitions of
this Policy are not the only stock-trading rules and regulations you need to follow. You should be aware of additional prohibitions and
restrictions set by contract or by federal and state securities laws and regulations (e.g., contractual restrictions on the resale of
securities, compliance with Rule 144 under the Securities Act and others). Any Insider who is uncertain whether other prohibitions or
restrictions apply should ask our Legal Department.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">REPORTING VIOLATIONS; &#490;UESTIONS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any Insider who violates this
Policy or any federal or state laws governing insider trading or tipping, or who knows of any such violation by any other Insider, must
report the violation immediately to our Legal Department.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Please direct all questions
about this Policy to our Chief Financial Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-variant: small-caps">EXHIBIT
A</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-variant: small-caps">Designated
Insiders</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>Alejandro Antalich, CEO</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>Valeria Falottico, CFO</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>Paola D&iacute;az, CTO</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>Gloria Montaron Estrada, Executive Director</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>Romualdo Varela, Director</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>Diego Abelleyra Llodra, Director</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>Aimar Dimo, Director</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>Oscar Le&oacute;n Betancor, Director</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.95pt; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.95pt; text-align: left; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 7; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.95pt; text-align: left; text-indent: 0in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.1
<SEQUENCE>4
<FILENAME>ea027012501ex12-1_moolec.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 12.1</B></P>

<P STYLE="margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION PURSUANT TO RULES 13a-14(a) AND
15d-14(a)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNDER THE SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY
ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I, Alejandro Antalich, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">1.</TD><TD STYLE="text-align: justify">I have reviewed this annual report on Form 20-F of Moolec
Science SA;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">2.</TD><TD STYLE="text-align: justify">Based on my knowledge, this report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under
which such statements were made, not misleading with respect to the period covered by this report;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">3.</TD><TD STYLE="text-align: justify">Based on my knowledge, the financial statements, and other
financial information included in this report, fairly present in all material respects the financial condition, results of operations
and cash flows of the company as of, and for, the periods presented in this report;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">4.</TD><TD STYLE="text-align: justify">The company&rsquo;s other certifying officer and I are responsible
for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal
control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: justify">Designed such disclosure controls and procedures, or caused
such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company,
including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which
this report is being prepared;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: justify">Designed such internal control over financial reporting,
or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding
the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally
accepted accounting principles;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(c)</TD><TD STYLE="text-align: justify">Evaluated the effectiveness of the company&rsquo;s disclosure
controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures,
as of the end of the period covered by this report based on such evaluation; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(d)</TD><TD STYLE="text-align: justify">Disclosed in this report any change in the company&rsquo;s
internal control over financial reporting that occurred during the period covered by the annual report that has materially affected,
or is reasonably likely to materially affect, the company&rsquo;s internal control over financial reporting; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">5.</TD><TD STYLE="text-align: justify">The company&rsquo;s other certifying officer and I have disclosed,
based on our most recent evaluation of internal control over financial reporting, to the company&rsquo;s auditors and the audit committee
of the company&rsquo;s board of directors (or persons performing the equivalent functions):</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: justify">All significant deficiencies and material weaknesses in the
design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company&rsquo;s
ability to record, process, summarize and report financial information; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: justify">Any fraud, whether or not material, that involves management
or other employees who have a significant role in the company&rsquo;s internal control over financial reporting.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>[Signature page as follows]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>&nbsp;</I></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 40%">Date: December 29, 2025</TD>
  <TD STYLE="width: 60%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="border-bottom: Black 1.5pt solid">/s/ Alejandro Antalich</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>Alejandro Antalich, Chief Executive Officer</TD>
  <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.2
<SEQUENCE>5
<FILENAME>ea027012501ex12-2_moolec.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 12.2</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION PURSUANT TO RULES 13a-14(a) AND
15d-14(a)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNDER THE SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY
ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I, Valeria Falottico, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">1.</TD><TD STYLE="text-align: justify">I have reviewed this annual report on Form 20-F of Moolec
Science SA;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">2.</TD><TD STYLE="text-align: justify">Based on my knowledge, this report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under
which such statements were made, not misleading with respect to the period covered by this report;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">3.</TD><TD STYLE="text-align: justify">Based on my knowledge, the financial statements, and other
financial information included in this report, fairly present in all material respects the financial condition, results of operations
and cash flows of the company as of, and for, the periods presented in this report;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">4.</TD><TD STYLE="text-align: justify">The company&rsquo;s other certifying officer and I are responsible
for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal
control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: justify">Designed such disclosure controls and procedures, or caused
such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company,
including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which
this report is being prepared;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: justify">Designed such internal control over financial reporting,
or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding
the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally
accepted accounting principles;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(c)</TD><TD STYLE="text-align: justify">Evaluated the effectiveness of the company&rsquo;s disclosure
controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures,
as of the end of the period covered by this report based on such evaluation; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(d)</TD><TD STYLE="text-align: justify">Disclosed in this report any change in the company&rsquo;s
internal control over financial reporting that occurred during the period covered by the annual report that has materially affected,
or is reasonably likely to materially affect, the company&rsquo;s internal control over financial reporting; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">5.</TD><TD STYLE="text-align: justify">The company&rsquo;s other certifying officer and I have disclosed,
based on our most recent evaluation of internal control over financial reporting, to the company&rsquo;s auditors and the audit committee
of the company&rsquo;s board of directors (or persons performing the equivalent functions):</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: justify">All significant deficiencies and material weaknesses in the
design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company&rsquo;s
ability to record, process, summarize and report financial information; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: justify">Any fraud, whether or not material, that involves management
or other employees who have a significant role in the company&rsquo;s internal control over financial reporting.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>[Signature page as follows]&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 40%">Date: December 29, 2025</TD>
  <TD STYLE="width: 60%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="border-bottom: Black 1.5pt solid">/s/ Valeria Falottico</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>Valeria Falottico, Chief Financial Officer</TD>
  <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.1
<SEQUENCE>6
<FILENAME>ea027012501ex13-1_moolec.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 13.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION PURSUANT TO<BR>
18 U.S.C. SECTION 1350,<BR>
AS ADOPTED PURSUANT TO<BR>
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the Annual Report of Moolec
Science SA (the &ldquo;Company&rdquo;) on Form 20-F for the year ended June 30, 2025, as filed with the Securities and Exchange Commission
on the date hereof (the &ldquo;Report&rdquo;), the undersigned hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of our knowledge:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">1)</TD><TD STYLE="text-align: justify">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act
of 1934; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">2)</TD><TD STYLE="text-align: justify">The information contained in the Report fairly presents, in all material respects, the financial condition
and results of operations of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="3">Date: December 29, 2025</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 5%"></TD>
  <TD STYLE="width: 35%"></TD>
  <TD STYLE="width: 60%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>By:</TD>
  <TD STYLE="border-bottom: Black 1.5pt solid">/s/ Alejandro Antalich</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
  <TD>Alejandro Antalich</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
  <TD>Chief Executive Officer</TD>
  <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.2
<SEQUENCE>7
<FILENAME>ea027012501ex13-2_moolec.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 13.2</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION PURSUANT TO<BR>
18 U.S.C. SECTION 1350,<BR>
AS ADOPTED PURSUANT TO<BR>
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the Annual Report of Moolec
Science SA (the &ldquo;Company&rdquo;) on Form 20-F for the year ended June 30, 2025, as filed with the Securities and Exchange Commission
on the date hereof (the &ldquo;Report&rdquo;), the undersigned hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of our knowledge:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">1)</TD><TD STYLE="text-align: justify">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act
of 1934; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">2)</TD><TD STYLE="text-align: justify">The information contained in the Report fairly presents, in all material respects, the financial condition
and results of operations of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD COLSPAN="2">Date: December 29, 2025</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 5%">&nbsp;</TD>
  <TD STYLE="width: 35%">&nbsp;</TD>
  <TD STYLE="width: 60%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>By:</TD>
  <TD STYLE="border-bottom: Black 1.5pt solid">/s/ Valeria Falottico</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>Valeria Falottico</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>Chief Financial Officer</TD>
  <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-15.1
<SEQUENCE>8
<FILENAME>ea027012501ex15-1_moolec.htm
<DESCRIPTION>CONSENT OF PRICE WATERHOUSE & CO. S.R.L., INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM, WITH RESPECT TO MOOLEC SCIENCE SA'S CONSOLIDATED FINANCIAL STATEMENTS
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 15.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We hereby consent to the incorporation by reference
in the Registration Statement on Form&nbsp;S-8 (No. 333-282263) of Moolec Science SA of our report dated December&nbsp;29, 2025 relating
to the consolidated financial statements, which appears in this Form&nbsp;20-F.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">/s/ Price Waterhouse&nbsp;&amp; Co S.R.L.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">/s/ Sebastian Azagra</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Sebastian Azagra</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Partner</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Rosario, Argentina</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">December 29, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-15.2
<SEQUENCE>9
<FILENAME>ea027012501ex15-2_moolec.htm
<DESCRIPTION>CONSENT OF PRICE WATERHOUSE & CO. S.R.L., INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM, WITH RESPECT TO BIOCERES CROP SOLUTIONS CORP.'S CONSOLIDATED FINANCIAL STATEMENTS
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 15.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We hereby consent to the incorporation by reference in the Registration
Statement on Form&nbsp;S-8 (No. 333-282263) of Moolec Science SA of our report dated November 10, 2025 relating to the consolidated financial
statements of Bioceres Crop Solutions Corp., which appears in this Form 20-F.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 40%">/s/ Price Waterhouse &amp; Co. S.R.L.</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">/s/ Guillermo Miguel Bosio</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>Guillermo Miguel Bosio</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>Partner</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>Rosario, Argentina</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>December&nbsp;29, 2025</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-97
<SEQUENCE>10
<FILENAME>ea027012501ex97_moolec.htm
<DESCRIPTION>MOOLEC CLAWBACK POLICY
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 97</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NASDAQ EXECUTIVE REMUNERATION CLAWBACK POLICY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PURPOSE</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.1</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The purpose of this policy (this &ldquo;<B>Nasdaq Clawback Policy</B>&rdquo;) is to set out the basis for the mandatory recovery of erroneously awarded Incentive-Based Compensation (as defined below) from Executives (as defined below) of Moolec Science SA (the &ldquo;<B>Company</B>&rdquo;, together with its subsidiaries, the &ldquo;<B>Group</B>&rdquo;) in the event of a Restatement (as defined below).</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.2</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Board of Directors of the Company (the &ldquo;<B>Board</B>&rdquo;) has adopted this Nasdaq Clawback Policy in accordance with the requirements of Nasdaq Stock Market LLC (&ldquo;<B>Nasdaq</B>&rdquo;) Listing Rule 5608, which was mandated by Rule 10D-1 of themole Securities Exchange Act of 1934 (the &ldquo;<B>Exchange Act</B>&rdquo;).</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.3</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Nasdaq Clawback Policy may be amended from time to time by the Compensation Committee of the Board (the &ldquo;<B>Compensation Committee</B>&rdquo;) pursuant to any laws, regulations or rules of the US Securities and Exchange Commission, Nasdaq, any other stock exchange on which the Company&rsquo;s securities are listed or other regulatory authority applicable to the Group or the Executive (&ldquo;<B>Applicable Law</B>&rdquo;). Applicable Law includes Section 304 of the US Sarbanes-Oxley Act of 2002. Executives will be notified of any significant amendments to this Nasdaq Clawback Policy and how such amendments may impact their remuneration.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APPLICABILITY</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.1</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Nasdaq Clawback Policy applies to any current and former executive officers, as the Company may determine from time to time in accordance with the definition of &ldquo;executive officer&rdquo; as defined in Nasdaq Listing Rule 5608(d) (each an &ldquo;<B>Executive</B>&rdquo;). Executives of the Company&rsquo;s parent(s) or subsidiaries are deemed to be Executives of the Company if they perform such policy making functions for the Company. Individuals will be notified as soon as practicable after becoming or being determined to be an Executive.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.2</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remuneration shall be subject to recovery pursuant to this Nasdaq Clawback Policy where: (i) the Compensation Committee determines that such remuneration constitutes Incentive-Based Compensation; and (ii) the remuneration was Received (as defined below) by an Executive:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.05pt; text-align: justify; text-indent: -34.05pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.2.1</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">after beginning their services as an Executive;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.05pt; text-align: justify; text-indent: -34.05pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.2.2</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">who served as an Executive at any time during the performance period for that Incentive-Based Compensation;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.05pt; text-align: justify; text-indent: -34.05pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.2.3</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">while the Company has a class of securities listed on Nasdaq, another national securities exchange or a national securities association in the United States; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.05pt; text-align: justify; text-indent: -34.05pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.2.4</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">during the Recovery Period (as defined below);</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify">provided that this Nasdaq Clawback Policy
shall only apply to Incentive-Based Compensation Received on or after October 2, 2023 (the &ldquo;<B>Effective Date</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.3</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the avoidance of doubt, this Nasdaq Clawback Policy continues to apply to an Executive following any termination of their office or employment.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.4</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Nasdaq Clawback Policy will be notified to Executives through any means determined by the Compensation Committee.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RECOVERY OF ERRONEOUSLY AWARDED INCENTIVE-BASED COMPENSATION</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.1</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the event that the Company is required to prepare an accounting restatement due to the material noncompliance of the Company with any financial reporting requirement under the securities laws (as used in Section 303A.14 of the NYSE Listed Company Manual) (a &ldquo;<B>Restatement</B>&rdquo;), including any required accounting restatement to correct an error in previously issued financial statements that is material to the previously issued financial statements, or that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period,<SUP>1</SUP>&nbsp;the Compensation Committee shall reasonably promptly recover the amount of Incentive-Based Compensation Received by an Executive in the Recovery Period that exceeds the amount of Incentive-Based Compensation that otherwise would have been Received by the Executive had such remuneration been determined based on the restated amounts, computed without regard to any taxes/duties/contributions/levies (&ldquo;<B>Taxes</B>&rdquo;) paid or payable (&ldquo;<B>Recoverable Amount</B>&rdquo;). The Recoverable Amount shall not exceed the differential between the amount of Incentive-Based Compensation paid to such Executive in connection with the Restatement and the amount of Incentive-Based Compensation that would have been paid to such Executive had the Restatement not occurred (in each case without regard to any Taxes paid or payable). Where Incentive-Based Compensation is based only in part on the achievement of a Financial Reporting Measure performance goal, the Compensation Committee shall first determine the portion of the original Incentive-Based Compensation based on or derived from the Financial Reporting Measure that was restated. The Compensation Committee shall then recalculate the affected portion based on the Financial Reporting Measure as restated, and recover the difference between the greater amount based on the original financial statements and the lesser amount that would have been received based on the restatement. In calculating the Recoverable Amount, the Compensation Committee may, at its sole and absolute discretion, consult with legal advisers and any experts it retains to assist in such calculations.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.2</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Whether a Restatement has occurred for the purposes of this Nasdaq Clawback Policy shall be confirmed by the Compensation Committee, which shall rely on any decision in this respect of the Audit Committee.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.3</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Recovery Period shall mean the period of three full financial years of the Company preceding the Restatement Date (as defined below) and any transition period that results from a change in the Company&rsquo;s financial year within or immediately following such period.<SUP>2</SUP></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.4</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For Incentive-Based Compensation based on share price or total shareholder return, where the Recoverable Amount is not subject to mathematical recalculation directly from the information in the Restatement, the Recoverable Amount will be determined by the Compensation Committee based on the Compensation Committee&rsquo;s reasonable estimate of the effect of the Restatement on the share price or total shareholder return upon which the Incentive-Based Compensation was received. The Company must maintain documentation of the determination of that reasonable estimate and provide such documentation to Nasdaq.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.5</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the event that the Company is required to prepare a Restatement, the Compensation Committee shall:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.05pt; text-align: justify; text-indent: -34.05pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.5.1</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">determine the Recoverable Amount in accordance with Section 3.1 of this Nasdaq Clawback Policy; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.05pt; text-align: justify; text-indent: -34.05pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.5.2</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to the extent the Recoverable Amount has been Received by an Executive, instruct the Company to recover reasonably promptly the full Recoverable Amount in accordance with Section 3.6 of this Nasdaq Clawback Policy; or</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.05pt; text-align: justify; text-indent: -34.05pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.5.3</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to the extent the Recoverable Amount has not been Received, but is otherwise owed to an Executive, cancel the right of such Executive to receive the Recoverable Amount reasonably promptly.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B></B></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.6</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To the extent permitted by Applicable Law, the Compensation Committee may seek to recoup Recoverable Amounts by all legal means available, including but not limited to, by requiring any affected Executive to repay such amount to the Company, by set-off, by reducing future remuneration of such affected Executive, or by such other means or combination of means as the Compensation Committee, in its sole and absolute discretion, determines to be appropriate.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.7</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recoupment of the Recoverable Amount under this Nasdaq Clawback Policy will be initiated by the Company as soon as practicable following the written resolution of the Compensation Committee.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.8</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All amounts recoverable pursuant to this Nasdaq Clawback Policy shall be payable by the Executive to the Company (or as the Company directs) and shall be payable immediately on demand.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.9</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For purposes of this Nasdaq Clawback Policy:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.05pt; text-align: justify; text-indent: -34.05pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.9.1</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Incentive-Based Compensation</B>&rdquo; means any remuneration that is granted, earned, or vested/released based wholly or in part upon the attainment of a Financial Reporting Measure (as defined below). Incentive-Based Compensation is based in part upon the attainment of a Financial Reporting Measure if such compensation is subject to multiple conditions one or more, but not all, of which are Financial Reporting Measures. Examples of Incentive-Based Compensation include, but are not limited to: (i) non-equity incentive plan awards that are earned based wholly or in part on satisfying a Financial Reporting Measure performance goal; (ii) bonuses paid from a &ldquo;bonus pool&rdquo;, the size of which is determined based wholly or in part on satisfying a Financial Reporting Measure performance goal; (iii) other cash awards based wholly or in part on satisfying a Financial Reporting Measure performance goal; (iv) restricted shares, restricted share units, performance share units, stock options and stock appreciation rights that are granted or become vested/released based wholly or in part on satisfying a Financial Reporting Measure performance goal; and (v) proceeds received upon the sale of shares acquired through an incentive plan that were granted or vested/released based wholly or in part on satisfying a Financial Reporting Measure performance goal.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 102.05pt; text-align: justify; text-indent: -34pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 91px">&nbsp;</TD>
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incentive-Based Compensation includes any compensation that vests, accrues or is granted based in whole or variable remuneration structures operated by the Group from time to time under which awards are wholly or in part based upon the attainment of a Financial Reporting Measure.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 91px">&nbsp;</TD>
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Examples of compensation that is not Incentive-Based Compensation for this purpose include, but are not limited to: (i) an Executive&rsquo;s salary;<SUP>3</SUP>&nbsp;(ii) bonuses paid solely at the discretion of the Compensation Committee or the Board that are not paid from a &ldquo;bonus pool&rdquo; that is determined by satisfying a Financial Reporting Measure performance goal; (iii) bonuses paid solely upon satisfying one or more subjective standards (e.g. demonstrated leadership) and/or completion of a specified employment period); (iv) non-equity incentive plan awards earned solely upon satisfying one or more strategic measures (e.g., consummating a merger or divestiture), or operational measures (e.g., completion of a project, increase in market share); and (v) equity awards for which the grant is not contingent upon achieving any Financial Reporting Measure performance goal and vesting/release is contingent solely upon completion of a specified employment period and/or attaining one or more nonfinancial reporting measures.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.05pt; text-align: justify; text-indent: -34.05pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.9.2</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Financial Reporting Measure</B>&rdquo; means any measure that is determined and presented in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board (&ldquo;<B>IFRS</B>&rdquo;) (or any other accounting principles used to prepare the Group&rsquo;s financial statements from time to time), and any measure derived wholly or in part from such measure, including non-IFRS financial measures (as well as other measures, metrics and ratios that are non-IFRS measures). The term Financial Reporting Measure includes stock price and total shareholder return. Financial Reporting Measures may be presented outside the Company&rsquo;s financial statements.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.05pt; text-align: justify; text-indent: -34.05pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.05pt; text-align: justify; text-indent: -34.05pt"><B></B></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.05pt; text-align: justify; text-indent: -34.05pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.9.3</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Received</B>&rdquo;: Incentive-Based Compensation is deemed Received in the Company&rsquo;s financial period during which the Financial Reporting Measure specified in the Incentive-Based Compensation award is attained, even if the payment or grant occurs after the end of the financial period in which the Financial Reporting Measure is attained. For the avoidance of doubt, an Executive receives the Incentive-Based Compensation even when the Executive has established only a contingent right to payment at that time. Ministerial acts or other conditions necessary to effect issuance or payment, such as calculating the amount earned or obtaining Compensation Committee approval of payment do not affect the determination of the date Received. In the case of awards subject to multiple conditions, not all conditions must be satisfied for the Incentive-Based Compensation to be deemed Received. The Compensation Committee shall have the discretion to determine when the Incentive-Based Compensation was Received, and such determination need not be uniform across the type of Incentive-Based Compensation or for all Executives.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.05pt; text-align: justify; text-indent: -34.05pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.9.4</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Restatement Date</B>&rdquo; means the date on which the Company is required to prepare a Restatement, which is the earlier to occur of: (i) the date on which the Board, or the Audit Committee concludes, or reasonably should have concluded, that the Company is required to prepare a Restatement; or (ii) the date a court, regulator or other legal authorised body directs the Company to prepare a Restatement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.05pt; text-align: justify; text-indent: -34.05pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Impracticability Exception to Recovery Obligation</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.1</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company must recover the Recoverable Amount in compliance with this Nasdaq Clawback Policy except to the extent that the conditions set out in 4.2.1, 4.2.2 or 4.2.3 of this Nasdaq Clawback Policy are met and the Compensation Committee determines, in its sole and absolute discretion, that recovery would be impracticable.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B>&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.2</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Compensation Committee may determine that a recovery is impracticable only if:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.05pt; text-align: justify; text-indent: -34.05pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.2.1</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">following a reasonable attempt to recover the Recoverable Amount, the Compensation Committee determines, in its sole discretion, that the direct expense that would need to be paid to a third party to assist in enforcing this Nasdaq Clawback Policy would exceed the Recoverable Amount. The Company must document such reasonable attempt(s) to recover and provide that documentation to Nasdaq;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.05pt; text-align: justify; text-indent: -34.05pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.2.2</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">recovery would violate a law of the Grand Duchy of Luxembourg (&ldquo;<B>Luxembourg</B>&rdquo;), where such law was adopted prior to November 28, 2022. Before concluding that it would be impracticable to recover any Recoverable Amount based on a violation of the law of Luxembourg, the Company must obtain an opinion of a law firm in Luxembourg, acceptable to Nasdaq that recovery would result in such a violation and provide such opinion to Nasdaq; or</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.05pt; text-align: justify; text-indent: -34.05pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.2.3</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if applicable, the Compensation Committee determines that recovery would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly available to employees of the Company, to fail to meet the requirements of 26 U.S.C. 401(a)(13) or 26 U.S.C. 411(a) and regulations thereunder.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.3</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In determining whether a recovery would be impracticable due to costs in accordance with 4.2.1 above, the only criteria that the Compensation Committee may consider is whether the direct costs, such as reasonable legal expense and consulting fees, amongst others, paid to a third party to assist in enforcing recovery would exceed the Recoverable Amount. Indirect costs, such as reputational concerns or the effect on hiring of new Executives, amongst others, may not be considered when determining whether recovery is impracticable.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>5</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>INDEMNIFICATION AND INSURANCE</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.1</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group is prohibited from insuring or indemnifying any Executive against the loss of erroneously awarded remuneration as set forth in this Nasdaq Clawback Policy. If an Executive purchases a third-party insurance policy to fund potential recovery obligations, the Company is prohibited from paying or reimbursing the Executive for premiums for such an insurance policy.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>6</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>OTHER RECOVERY RIGHTS</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.1</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any right of recovery under this Nasdaq Clawback Policy applies in addition to (and without limiting) any other remedies and/or rights to reduce, cancel or recover any elements of remuneration (or similar) that may be available to any member of the Group pursuant to any remuneration policy (including any further malus and clawback policies) operated by any member of the Group, the terms of any incentive plans or awards operated by any member of the Group, any employment agreement, any other terms and conditions and/or Applicable Law applicable to any Executive, in each case from time to time in force, and/or pursuant to any other legal remedies available to any member of the Group. Recovery (or similar) may be applied pursuant to both this Nasdaq Clawback Policy and any such other policies, plans, awards, agreements, terms, conditions, Applicable Laws or similar in respect of the same award of remuneration, provided that there shall be no duplication of recovery.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>7</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>DISCLOSURE</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.1</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the event of any Restatement, the Company shall disclose certain information in its annual report on Form 20-F, as required by Form 20-F. This information shall include, without limitation:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.05pt; text-align: justify; text-indent: -34.05pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0in">&nbsp;</TD>
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.1.1</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the date on which the Company was required to prepare the Restatement;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.05pt; text-align: justify; text-indent: -34.05pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0in">&nbsp;</TD>
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.1.2</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the aggregate Recoverable Amount (in US dollars), including an analysis of how the Recoverable Amount was calculated, or, if not determined, an explanation of the reasons;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.05pt; text-align: justify; text-indent: -34.05pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0in">&nbsp;</TD>
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.1.3</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any estimates used to determine the Recoverable Amount for Financial Reporting Measures related to share price or total shareholder return and an explanation of the methodology used for such estimates;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68.05pt; text-align: justify; text-indent: -34.05pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0in">&nbsp;</TD>
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.1.4</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any required details of Recoverable Amounts that remain outstanding (on an aggregate, individual, group or other basis, as required) and for which recovery has been forgone due to impracticability and the reasons why, for the relevant annual report on Form 20-F and otherwise pursuant to the requirements of any other annual report or statement it is obligated to prepare and file under the Exchange Act.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.2</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Nasdaq Clawback Policy shall be filed as an exhibit to the first annual report on Form 20-F that the Company is required to file under the Exchange Act after the adoption of this Nasdaq Clawback Policy. If this Nasdaq Clawback Policy is amended, the amended policy shall be filed as an exhibit to the first annual report on Form 20-F that the Company is required to file under the Exchange Act after such amendment.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ADMINISTRATION AND OPERATION</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.1</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Compensation Committee has the exclusive power and full and final authority to: (i) administer this Nasdaq Clawback Policy, including, without limitation, the right and power to interpret the provisions of this Nasdaq Clawback Policy; (ii) make all determinations deemed necessary or advisable in applying this Nasdaq Clawback Policy (which in every case shall be made at the Compensation Committee&rsquo;s absolute discretion, without this being limited by references in certain clauses but not others to a discretion being absolute), including, without limitation, determinations as to: (a) what constitutes Incentive-Based Compensation, a Recoverable Amount or other remuneration; (b) that a Restatement has occurred (in reliance on any decision in this respect of the Audit Committee); and (c) whether a recovery is impracticable; and (iii) delegate any power or discretion under this Nasdaq Clawback Policy to such person or persons as it may determine (and in which case this Nasdaq Clawback Policy shall be applied accordingly). The Compensation Committee may delegate ministerial administrative duties with respect to this Nasdaq Clawback Policy to one or more officers or employees of the Company.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.2</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any action, interpretation or determination taken or made by the Compensation Committee pursuant to this Nasdaq Clawback Policy will be final, conclusive and binding.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.3</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From and after the adoption of this Nasdaq Clawback Policy, each award agreement or other document setting forth the terms and conditions of any annual incentive or other performance-based award granted to an Executive shall include a provision incorporating the requirements of this Nasdaq Clawback Policy.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GENERAL</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.1</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any provision in this Nasdaq Clawback Policy can apply even if the Executive was not responsible for the Restatement in question or if it took place before the grant and/or vesting/release of any remuneration which is subject to recovery.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.2</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The means of recovery can be different for different Executives in relation to the same or different events depending on the particular facts and circumstances of the Executive and their compensation.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.3</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An Executive will not be entitled to any remuneration or compensation from the Group in respect of any application of this Nasdaq Clawback Policy.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.4</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The remedy specified in this Nasdaq Clawback Policy shall not be exclusive and shall be in addition to every other right or remedy at law or in equity that may be available to the Company or a member of the Group.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.5</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The terms of this Nasdaq Clawback Policy shall apply regardless of any agreement, undertaking or suggestion (or similar), whether or not contractual, that any remuneration shall not be subject to recovery.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.6</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The invalidity or unenforceability of any provision of this Nasdaq Clawback Policy shall not affect the validity or enforceability of any other provision.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.7</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New York law governs this Nasdaq Clawback Policy and its construction. The New York City courts have non-exclusive jurisdiction in respect of disputes arising under or in connection with this Nasdaq Clawback Policy.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.8</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">References in this Nasdaq Clawback Policy to the phrase &ldquo;including&rdquo; (or similar) shall not limit or prejudice the generality of the following words (without this being limited by such references in some clauses but not others).</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">6</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>11
<FILENAME>ea027012501ex99-1_moolec.htm
<DESCRIPTION>CONSOLIDATED FINANCIAL STATEMENTS BIOCERES CROP SOLUTIONS CORP. AS OF JUNE 30, 2025 AND 2024 AND FOR THE YEARS ENDED JUNE 30, 2025, 2024 AND 2023
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin-top: 0; margin-bottom: 0"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex99-1_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>BIOCERES CROP SOLUTIONS
CORP.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>Consolidated financial statements as of June 30, 2025 and 2024 <BR>
and for the years ended June 30, 2025, 2024 and 2023.  &nbsp; <FONT STYLE="text-transform: uppercase">&nbsp;</FONT></B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><IMG SRC="ex99-1_002.jpg" ALT=""></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify">INDEX</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Consolidated financial statements as of June
30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 90%; text-align: justify; font-size: 10pt"><A HREF="#fin_001">Report of independent registered public accounting firm <FONT STYLE="font-size: 10pt">(PCAOB ID 1349)</FONT></A></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 9%; font-size: 10pt; text-align: center">F-3</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; font-size: 10pt"><A HREF="#fin_002">Consolidated statements of financial position</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: center">F-6</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; font-size: 10pt"><A HREF="#fin_003">Consolidated statements of comprehensive income</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: center">F-8</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; font-size: 10pt"><A HREF="#fin_004">Consolidated statements of changes in equity</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: center">F-10</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; font-size: 10pt"><A HREF="#fin_005">Consolidated statements of cash flows</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: center">F-11</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><A HREF="#fin_006">Notes to the consolidated financial statements</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: center">F-13</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="fin_001"></A>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><IMG SRC="ex99-1_003.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Report of Independent Registered Public Accounting
Firm</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the board of directors and shareholders of
Bioceres Crop Solutions Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Opinion on the Financial Statements</I></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have audited the accompanying consolidated statements of financial
position of Bioceres Crop Solutions Corp. and its subsidiaries (the &ldquo;Company&rdquo;) as of June 30, 2025 and 2024, and the related
consolidated statements of comprehensive income, of changes in equity and of cash flows for each of the three years in the period ended
June 30, 2025, including the related notes (collectively referred to as the &ldquo;consolidated financial statements&rdquo;). In our opinion,
the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of June 30, 2025
and 2024, and the results of its operations and its cash flows for each of the three years in the period ended June 30, 2025 in conformity
with International Financial Reporting Standards as issued by the International Accounting Standards Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Substantial Doubt about the Company&rsquo;s
Ability to Continue as a Going Concern</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying consolidated financial statements have been prepared
assuming that the Company will continue as a going concern. As discussed in Note 2 to the consolidated financial statements, the Company&rsquo;s
current economic and financial situation indicate the existence of material uncertainty that raise substantial doubt on the Company&rsquo;s
ability to continue as a going concern. Management&rsquo;s plans in regard to these matters are also described in Note 2. The consolidated
financial statements do not include any adjustments that might result from the outcome of this uncertainty.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Basis for Opinion</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These consolidated financial statements are the responsibility of the
Company&rsquo;s management. Our responsibility is to express an opinion on the Company&rsquo;s consolidated financial statements based
on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and
are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules
and regulations of the Securities and Exchange Commission and the PCAOB.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We conducted our audits of these consolidated financial statements
in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance
about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our audits included performing procedures to assess the risks of material
misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those
risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial
statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as
evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for
our opinion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 65%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 35%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Price Waterhouse &amp; Co. S.R.L.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Bouchard 557, piso 8&deg; </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">C1106ABG - Ciudad Aut&oacute;noma de Buenos Aires, Argentina</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">T: +(54.11) 4850.0000</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>www.pwc.com.ar</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><IMG SRC="ex99-1_003.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;<B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Critical Audit Matters</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The critical audit matter communicated below is a matter arising from
the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee
and that (i) relates to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially
challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the
consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate
opinion on the critical audit matter or on the accounts or disclosures to which it relates.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Impairment Tests on Goodwill (Pro Farm Group, Inc., Rizobacter S.A.
and Bioceres Crops S.A. Cash Generating Units), intangible assets not yet available for use,</I>&nbsp;<I>which have indefinite useful
lives and intangible assets with definite useful lives for which events or changes in circumstances indicate that their carrying amount
may not be recoverable. (Bioceres Crops S.A. Cash Generating Unit).</I></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><I>&nbsp;</I><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As described in Notes 4.6, 7.8 and 7.9 to the consolidated financial
statements, the Company&rsquo;s goodwill associated with the Pro Farm Group, Inc. Rizobacter S.A. and Bioceres Crop S.A. cash generating
units (&ldquo;CGU&rdquo;), intangible assets not yet available for use, which have indefinite useful lives and intangible assets with
definite useful lives for which events or changes in circumstances indicate that their carrying amount may not be recoverable (Bioceres
Crops S.A. CGU) amounted to $76.1 million, $28.1 million, $7.5 million and $60.9 million, respectively, as of June 30, 2025. Impairment
tests on goodwill and intangible assets not yet available for use or with indefinite useful lives are undertaken annually at the end of
the reporting period or for other intangible assets when events or changes in circumstances indicate that their carrying amount may not
be recoverable. Where the carrying value of an asset exceeds its recoverable amount (i.e. the higher of value in use and fair value less
costs to sell), the asset is written down to its recoverable amount. In each case, management determined the recoverable amount based
on value in use calculations prepared by management. The determination of the recoverable amount of the CGU&rsquo;s, intangible assets
not yet available for use, which have indefinite useful lives and intangible assets with definite useful lives for which events or changes
in circumstances indicate that their carrying amount may not be recoverable (Bioceres Crops S.A. CGU) includes significant and numerous
judgments and assumptions that are subject to various risks and uncertainties. The key assumptions used in management&rsquo;s models consisted
of (i) market shares (ii) product prices (iii) royalties (iv) terminal value (growth rates used to extrapolate the future cash flow projections
to the terminal period or EBITDA multiple) and (v) discount rates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><IMG SRC="ex99-1_003.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The principal considerations for our
                                                                                             determination that performing procedures relating to impairment tests on goodwill (Pro Farm Group, Inc., Rizobacter S.A. and
                                                                                             Bioceres Crops S.A. cash generating units), intangible assets not yet available for use, which have indefinite useful lives and
                                                                                             intangible assets with definite useful lives for which events or changes in circumstances indicate that their carrying amount may
                                                                                             not be recoverable (Bioceres Crops S.A. CGU) is a critical audit matter are (i) the significant judgment by management when
                                                                                             developing the recoverable amount of the CGUs, intangible assets not yet available, which have indefinite useful lives and
                                                                                             intangible assets with definite useful lives for which events or changes in circumstances indicate that their carrying amount may
                                                                                             not be recoverable; (ii) a high degree of auditor judgment, subjectivity and effort in performing procedures and evaluating
                                                                                             management&rsquo;s significant assumptions used in the models related to the (i) market shares (ii) product prices, (iii) royalties
                                                                                             (iv) terminal value (v) discount rates; and (vi) the audit effort involved the use of professionals with specialized skill and
                                                                                             knowledge.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Addressing the matter involved performing procedures and evaluating
audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing
the effectiveness of controls relating to management&rsquo;s impairment tests on goodwill&nbsp;(Pro Farm Group, Inc., Rizobacter S.A.
and Bioceres Crops S.A. Cash Generating Units), intangible assets not yet available for use, which have indefinite useful lives and intangible
assets with definite useful lives for which events or changes in circumstances indicate that their carrying amount may not be recoverable
(Bioceres Crops S.A. CGU), including controls over the valuation of the CGUs, intangible assets not yet available for use, which have
indefinite useful lives and intangible assets with definite useful lives for which events or changes in circumstances indicate that their
carrying amount may not be recoverable (Bioceres Crops S.A. CGU). These procedures also included, among others (i) testing management&rsquo;s
process for developing the recoverable amounts of CGUs, intangible assets not yet available for use, which have indefinite useful lives
and intangible assets with definite for which events or changes in circumstances indicate that their carrying amount may not be recoverable
(Bioceres Crops S.A. CGU); (ii) evaluating the appropriateness of the models used; (iii) testing the completeness and accuracy of underlying
data used in the models; (iv) evaluating the reasonableness of the significant assumptions used by management in the models related to
market shares, product prices, royalties, terminal value and discount rates. Evaluating management&rsquo;s assumptions used in the models
related to market shares, product prices, royalties, terminal value and discount rates involved evaluating whether the assumptions used
by management were reasonable considering (i) the current and past performance of the CGUs and the Company&rsquo;s business; (ii) the
consistency with external market and industry data; and (iii) whether these assumptions were consistent with evidence obtained in other
areas of the audit. Professionals with specialized skill and knowledge were used to assist in the evaluation of the Company&rsquo;s discounted
cash flow model and the discount rate assumptions.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">/s/ Price Waterhouse&nbsp;&amp; Co. S.R.L.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">/s/
    Guillermo Miguel Bosio</FONT></TD>
    <TD STYLE="width: 60%; font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Guillermo Miguel Bosio <BR>
Partner <BR>
Rosario, Argentina <BR>
November 10, 2025</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have served as the Company&rsquo;s auditor
since 2018.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="fin_002"></A>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="ex99-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>CONSOLIDATED STATEMENTS OF FINANCIAL POSITION</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in
US$)</B></P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Notes</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: justify"><U>ASSETS</U></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify">CURRENT ASSETS</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 66%; text-align: justify">Cash and cash equivalents</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: center">7.1</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">32,695,079</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">44,473,270</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Other financial assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">7.2</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,040,038</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,695,528</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Trade receivables</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">7.3</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">165,859,933</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">207,320,974</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Other receivables</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">7.4</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15,861,981</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18,298,672</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Recoverable income tax</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,864,817</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">655,691</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Inventories</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">7.5</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">87,611,269</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">125,929,768</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Biological assets</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">7.6</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,378,380</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">294,134</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Total current assets</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">308,311,497</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">408,668,037</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify">NON-CURRENT ASSETS</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Other financial assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">7.2</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">58</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">634,553</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Trade receivables</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">7.3</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,506,834</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Other receivables</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">7.4</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23,660,530</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17,957,121</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Recoverable income tax</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17,995</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,889</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Deferred tax assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">9</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,916,980</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,698,860</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Investments in joint ventures and associates</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">13</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">39,371,264</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">39,786,353</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Investment properties</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">7.10</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">570,324</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">560,783</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Property, plant and equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">7.7</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">74,575,386</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">74,573,278</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Intangible assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">7.8</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">181,173,079</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">176,893,136</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Goodwill</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">7.9</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">112,163,432</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">112,163,432</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Right of use asset</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">16</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">16,377,701</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">11,601,752</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Total non-current assets</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">455,333,583</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">443,880,157</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 4pt">Total assets</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">763,645,080</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">852,548,194</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying Notes are an integral part of
these Consolidated financial statements. Related parties&rsquo; balances and transactions are disclosed in Note 17.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="ex99-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>CONSOLIDATED STATEMENTS OF FINANCIAL POSITION</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: justify">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Notes</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify"><U>LIABILITIES</U></TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify">CURRENT LIABILITIES</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 66%; text-align: justify">Trade and other payables</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: center">7.11</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">96,432,604</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">168,732,469</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Borrowings</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">7.12</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">119,728,126</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">136,747,198</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Employee benefits and social security</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">7.14</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,174,012</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,340,958</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Deferred revenue and advances from customers</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">7.15</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,282,668</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,923,140</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Income tax payable</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">452,800</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,825,271</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Consideration for acquisition</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,761,274</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,617,281</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Secured notes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">7.13</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">102,270,445</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Lease liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">16</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">6,884,042</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">3,122,778</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Total current liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">337,985,971</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">329,309,095</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify">NON-CURRENT LIABILITIES</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Trade and other payables</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">7.11</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">48,481,726</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Borrowings</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">7.12</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">38,198,026</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">42,104,882</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Deferred revenue and advances from customers</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">7.15</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,436,912</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,925,138</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Joint ventures and associates</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">13</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,007,678</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">296,455</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Deferred tax liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">9</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">30,122,920</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">34,995,791</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Provisions</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">7.16</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,267,572</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,255,702</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Consideration for acquisition</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">397,774</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,309,234</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Secured notes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">7.13</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">80,809,686</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Lease liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">16</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">9,527,939</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">8,161,359</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Total non-current liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">130,440,547</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">171,858,247</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Total liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">468,426,518</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">501,167,342</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-decoration: underline; text-align: justify">EQUITY</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify">Equity attributable to owners of the parent</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">265,444,568</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">315,041,257</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Non-controlling interest</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">29,773,994</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">36,339,595</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Total equity</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">295,218,562</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">351,380,852</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 4pt">Total equity and liabilities</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">763,645,080</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">852,548,194</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying Notes are an integral part of
these Consolidated financial statements. Related parties&rsquo; balances and transactions are disclosed in Note 17.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="fin_003"></A>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="ex99-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><U>CONSOLIDATED STATEMENTS OF COMPREHENSIVE
INCOME</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>For the years ended June 30, 2025,
2024 and 2023</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>(Amounts in
US$)</B></P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Notes</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; width: 54%; text-align: left">Revenues from contracts with customers</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: center">8.1</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">333,343,987</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">464,828,548</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">419,446,439</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Initial recognition and changes in the fair value of biological assets at the point of harvest</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,764,863</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(45,746</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">610,554</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Cost of sales</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">8.2</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(203,424,872</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(278,221,812</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(235,457,053</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Changes in the net realizable value of agricultural products after harvest</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,541,204</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,385,069</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,351,433</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Research and development expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">8.3</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(14,914,822</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(17,183,041</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(15,345,315</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Selling, general and administrative expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">8.4</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(123,113,572</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(123,690,910</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(113,002,747</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Share of profit or loss of joint ventures and associates</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">13</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,126,312</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,049,508</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,198,628</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Other income or expenses, net</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">8.5</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">6,775,970</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,498,555</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,084,892</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Operating (loss)/ profit</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">(2,235,962</TD><TD STYLE="font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">45,852,923</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">54,183,965</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Financial cost</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">8.6</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(28,838,818</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(26,871,698</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(23,788,085</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Other financial results</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">8.6</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(26,496,857</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(7,913,627</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(11,289,933</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">(Loss)/ Profit before income tax</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">(57,571,637</TD><TD STYLE="font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">11,067,598</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">19,105,947</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Income tax</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">9</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,273,616</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(3,778,615</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,068,652</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 4pt">(Loss)/ Profit for the year</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(58,845,253</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">7,288,983</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">20,174,599</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>

<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">(Loss) / Profit for the year attributable to:</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 54%; text-align: justify">Equity holders of the parent</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: center">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">(55,416,054</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">4,275,688</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">18,779,876</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Non-controlling interests</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(3,429,199</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">3,013,295</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,394,723</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(58,845,253</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">7,288,983</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">20,174,599</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>

<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">(Loss)/Profit per share</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 54%; text-align: left">Basic loss attributable to ordinary equity holders of the parent</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: center">10</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">(0.8764</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">0.0680</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">0.3022</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Diluted loss attributable to ordinary equity holders of the parent</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">10</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(0.8764</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.0673</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.2972</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying Notes are an integral part of
these consolidated financial statements. Related parties&rsquo; balances and transactions are disclosed in Note 17.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="ex99-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><U>CONSOLIDATED STATEMENTS OF COMPREHENSIVE
INCOME</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>For the years ended June 30, 2025, 2024 and
2023</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>(Amounts in
US$)</B></P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2023</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; font-weight: bold; text-align: left; padding-bottom: 4pt">(Loss)/ Profit for the year</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 4pt double; font-weight: bold; text-align: right">(58,845,253</TD><TD STYLE="width: 1%; padding-bottom: 4pt; font-weight: bold; text-align: left">)</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 4pt double; font-weight: bold; text-align: right">7,288,983</TD><TD STYLE="width: 1%; padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 4pt double; font-weight: bold; text-align: right">20,174,599</TD><TD STYLE="width: 1%; padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Other comprehensive (loss)</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(714,251</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(787,354</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(835,849</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; font-style: italic; text-align: left; padding-bottom: 1.5pt">Items that may be subsequently reclassified to (loss)/ profit</TD><TD STYLE="font-weight: bold; font-style: italic; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: right">(714,251</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-style: italic; text-align: left">)</TD><TD STYLE="font-weight: bold; font-style: italic; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: right">(787,354</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-style: italic; text-align: left">)</TD><TD STYLE="font-weight: bold; font-style: italic; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: right">631,500</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-style: italic; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Foreign exchange differences on translation of foreign operations from joint ventures</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(238</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(46,901</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Foreign exchange differences on translation of foreign operations</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(714,251</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(787,116</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">678,401</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; font-style: italic; text-align: left; padding-bottom: 1.5pt">Items that will not be subsequently reclassified to loss and profit</TD><TD STYLE="font-weight: bold; font-style: italic; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-style: italic; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; font-style: italic; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-style: italic; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; font-style: italic; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: right">(1,467,349</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-style: italic; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Revaluation of property, plant and equipment, net of tax, of joint ventures and associates <SUP>1</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(184,630</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Revaluation of property, plant and equipment, net of tax <SUP>2</SUP></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,282,719</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 4pt">Total comprehensive (loss)/ profit</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(59,559,504</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">6,501,629</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">19,338,750</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Total comprehensive (loss)/ profit attributable to:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Equity holders of the parent</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(55,957,731</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,787,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17,924,877</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Non-controlling interests</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(3,601,773</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,714,129</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,413,873</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 4pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(59,559,504</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">6,501,629</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">19,338,750</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(1)</TD><TD STYLE="text-align: justify">The tax effect of the revaluation of property, plant and equipment
of joint ventures and associates was $99,415 for the year ended June 30, 2023.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: -21.3pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(2)</TD><TD STYLE="text-align: justify">The tax effect of the revaluation of property, plant and equipment
was $ 703,087 for the year ended June 30,2023.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: -21.3pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying Notes are an integral part of
these Consolidated financial statements. Related parties&rsquo; balances and transactions are disclosed in Note 17.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="fin_004"></A>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="ex99-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>For the years ended June 30, 2025, 2024 and
2023</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="42" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Attributable
    to the equity holders of the parent</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Description</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Issued
    capital</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Share
    premium</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Changes
    in non-controlling interests</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Own
    shares trading premium</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Stock
    options and share based incentives</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Convertible
    instruments</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Cost
    of own shares held</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Retained
    deficit</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Foreign
    currency translation reserve</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Revaluation
    of PP&amp;E and effect of tax rate change</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Equity
    / (deficit) attributable to owners of the parent</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Non-controlling
    Interests</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Total
    equity</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; width: 10%; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">06/30/2022</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 4%; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">4,637</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 4%; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">158,819,506</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 4%; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(255,893</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 4%; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(916,202</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 4%; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">3,767,925</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 4%; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">175,745</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 4%; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(3,530,926</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 4%; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(32,682,893</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 4%; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">969,402</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 4%; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,007,272</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 4%; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">127,358,573</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 4%; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">30,940,275</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 4%; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">158,298,848</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Share-based
    incentives</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">63</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,640,004</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">135,361</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,257,377</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">4,032,805</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">4,032,805</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Business
    combination</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,640</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">153,357,564</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,620,140</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">154,979,344</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">154,979,344</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Capitalization
    of convertible notes</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">153</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">12,211,485</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">12,211,638</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">12,211,638</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Purchase
    of own shares</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(27,022,665</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(27,022,665</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(27,022,665</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Issuance
    of convertible notes</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">9,109,516</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">9,109,516</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">9,109,516</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Distribution
    of dividends by subsidiary</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(452,129</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(452,129</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Profit
    for the year</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">18,779,876</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">18,779,876</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,394,723</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">20,174,599</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Other
    comprehensive income or (loss)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">312,975</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,167,974</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(854,999</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">19,150</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(835,849</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">06/30/2023</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">6,493</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">327,028,559</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(255,893</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(780,841</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">6,645,442</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">9,285,261</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(30,553,591</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(13,903,017</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,282,377</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(160,702</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">298,594,088</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">31,902,019</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">330,496,107</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Share-based
    incentives</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">7</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">612,117</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">12,781,933</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">13,394,057</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">13,394,057</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Purchase
    of own shares</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(734,388</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(734,388</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(734,388</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Business
    combination (Note 6)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,898,247</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,898,247</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Distribution
    of dividends by subsidiary</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(174,800</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(174,800</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Profit
    for the year</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">4,275,688</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">4,275,688</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">3,013,295</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">7,288,983</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Other
    comprehensive loss</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(488,188</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(488,188</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(299,166</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(787,354</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">06/30/2024</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">6,500</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">327,640,676</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(255,893</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(780,841</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">19,427,375</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">9,285,261</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(31,287,979</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(9,627,329</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">794,189</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(160,702</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">315,041,257</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">36,339,595</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">351,380,852</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Share-based
    incentives</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,359,832</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,036,332</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">4,396,164</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">4,396,164</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Purchase
    of own shares</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(926,899</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(926,899</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(926,899</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Business
    combination (Note 2- Subsidiaries)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,891,777</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,891,777</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2,891,777</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Distribution
    of dividends by subsidiary</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(72,051</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(72,051</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Loss
    for the year</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(55,416,054</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(55,416,054</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(3,429,199</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(58,845,253</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Other
    comprehensive loss</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(541,677</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(541,677</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(172,574</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(714,251</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">06/30/2025</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">6,500</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">330,000,508</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,635,884</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(780,841</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">21,463,707</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">9,285,261</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(32,214,878</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(65,043,383</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">252,512</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(160,702</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">265,444,568</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">29,773,994</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">295,218,562</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The accompanying Notes are an integral part of
these consolidated financial statements. Related parties&rsquo; balances and transactions are disclosed in Note 17.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="fin_005"></A>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="ex99-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>CONSOLIDATED STATEMENTS OF CASH FLOWS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>For the
years ended June 30, 2025, 2024 and 2023</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>(Amounts in US$)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Notes</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><U>OPERATING ACTIVITIES</U></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; width: 54%; text-align: left">(Loss)/ Profit for the year</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 9%">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">(58,845,253</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">7,288,983</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">20,174,599</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Adjustments to reconcile profit to net cash flows</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Income tax</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">9</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,273,616</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,778,615</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,068,652</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Financial results</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">55,335,675</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">34,785,325</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">35,078,018</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Depreciation of property, plant and equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">7.7</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,990,809</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,763,249</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,833,274</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Amortization of intangible assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">7.8</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,154,731</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,113,107</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,991,433</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Depreciation of leased assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">16</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,036,703</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,418,956</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,565,894</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Transactional expenses</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,992,662</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,119,525</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,183,916</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Share-based incentive and stock options</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,386,688</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,134,885</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,415,108</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Share of profit or loss of joint ventures and associates</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">13</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,126,312</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,049,508</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,198,628</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Loss of participation in joint ventures and associates</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">133,079</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Gain from a bargain purchase</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">8.5</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,032,327</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Provisions for contingencies</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">335,773</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">367,126</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">221,008</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Allowance for impairment of trade debtors</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,123,716</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">753,428</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,327,385</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Allowance for obsolescence</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,547,723</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">586,515</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,066,777</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Initial recognition and changes in the fair value of biological assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,764,863</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">45,746</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(610,554</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Changes in the net realizable value of agricultural products after harvest</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,541,204</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,385,069</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,351,433</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Gain on sale of equipment and intangible assets</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(7,751,311</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(125,464</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(74,593</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Working capital adjustments</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Trade receivables</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,499,217</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(46,681,153</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(56,867,123</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Other receivables</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(916,362</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,967,150</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(11,475,717</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Income and minimum presumed income taxes</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(6,997,089</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,782,508</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(16,154,083</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Inventories and biological assets</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">34,910,189</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,176,656</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(11,066,489</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Trade and other payables</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(32,039,367</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,234,092</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,501,398</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Employee benefits and social security</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,166,946</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,289,095</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,258,673</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Deferred revenue and advances from customers</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(128,698</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(21,087,704</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,322,769</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Income taxes paid</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(853,299</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,072,347</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Interest collected</TD><TD>&nbsp;</TD>
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">120,568</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,747,398</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,378,413</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Inflation effects on working capital adjustments</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">139,914</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">321,103</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">376,597</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net cash flows generated by operating activities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">49,905,611</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">41,716,586</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">2,588,792</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying Notes are an integral part of
these consolidated financial statements. Related parties&rsquo; balances and transactions are disclosed in Note 17.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="ex99-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>CONSOLIDATED STATEMENTS OF CASH FLOWS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>For the years ended June 30, 2025, 2024 and
2023</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in
US$)</B></P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Notes</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1.5pt; font-weight: bold; text-align: justify"><U>INVESTMENT ACTIVITIES</U></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; width: 54%; text-align: justify">Proceeds from sale of property, plant and equipment</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: center">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">390,381</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">336,726</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">137,357</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: justify">Net cash received from business combination</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">37,508</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,373,265</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: justify">Proceeds from financial assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19,270,288</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">888,140</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,316,980</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: justify">Investment in financial assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(11,182,107</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(7,208,218</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(8,990,083</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: justify">Purchase of property, plant and equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">7.7</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(5,642,162</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(9,789,574</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(11,360,469</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: justify">Capitalized development expenditures</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">7.8</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(8,614,448</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(11,855,766</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(10,753,047</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: justify; padding-bottom: 1.5pt">Purchase of intangible assets</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">7.8</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(350,843</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,137,071</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(449,673</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Net cash flows used by investing activities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(6,128,891</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(28,728,255</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(25,725,670</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-decoration: underline; text-align: justify">FINANCING ACTIVITIES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: justify">Proceeds from borrowings</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">266,390,032</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">135,818,247</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">79,817,888</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: justify">Repayment of borrowings and financed payments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(288,454,302</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(112,614,437</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(16,744,956</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: justify">Interest payments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(18,932,563</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(24,724,436</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(18,046,961</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: justify">Other financial payments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,208,933</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,746,945</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,767,378</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: justify">Purchase of own shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(926,899</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(734,388</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,996,947</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: justify">Leased assets payments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">16</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(5,501,387</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,879,108</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,855,517</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: justify; padding-bottom: 1.5pt">Cash dividend distributed by subsidiary</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(72,051</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(174,800</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(452,129</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Net cash flows (used by)/ generated by financing activities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(50,706,103</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(10,055,867</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">32,954,000</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: justify; padding-bottom: 4pt">Net (decrease)/ increase in cash and cash equivalents</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 4pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(6,929,383</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">2,932,464</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">9,817,122</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: justify; padding-bottom: 1.5pt">Inflation effects on cash and cash equivalents</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,557</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(31,918</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(101,767</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: justify">Cash and cash equivalents as of beginning of the year</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">7.1</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">44,473,270</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">48,129,194</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">33,475,266</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: justify; padding-bottom: 1.5pt">Effect of exchange rate changes on cash and equivalents</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(4,851,365</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(6,556,470</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">4,938,573</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: justify; padding-bottom: 4pt">Cash and cash equivalents as of the end of the year</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; padding-bottom: 4pt">7.1</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">32,695,079</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">44,473,270</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">48,129,194</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying Notes are an integral part of
these Consolidated financial statements. Related parties&rsquo; balances and transactions are disclosed in Note 17.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>




<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><A NAME="fin_006"></A><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>Index</B></FONT> </P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; text-align: justify"><FONT STYLE="font-size: 10pt">1.</FONT></TD>
    <TD STYLE="width: 1%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 94%; text-align: justify"><FONT STYLE="font-size: 10pt">General information.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">2.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Accounting standards and basis of preparation.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">3.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">New standards, amendments and interpretations issued by the IASB.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">4.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Summary of significant accounting policies.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">5.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Critical accounting judgments and estimates.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">6.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Acquisitions and other significant transactions.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">7.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Information about components of consolidated statements of financial position.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">8.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Information about components of consolidated statements of comprehensive income.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">9.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Taxation.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">10.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Earnings per share.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">11.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Information about components of equity.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">12.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Cash flow information.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">13.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Joint ventures and associates.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">14.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Segment information.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">15.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Financial instruments &ndash; Risk management.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">16.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Leases.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">17.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Shareholders and other related parties&rsquo; balances and transactions.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">18.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Key management personnel compensation.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">19.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Share-based payments.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">20.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Contingencies, commitments and restrictions on the distribution of profits.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">21.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Events occurring after the reporting period.</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <B>1.</B> <B><U>GENERAL INFORMATION</U></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Bioceres Crop Solutions Corp. (NASDAQ:BIOX) is
a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making
crops more resilient to climate change. To do this, Bioceres&rsquo; products create economic incentives for farmers and other stakeholders
to adopt environmentally friendly production practices. Bioceres has a unique biotech platform with high impact, patented technologies
for seeds and microbial ag inputs, as well as next generation crop nutrition and protection solutions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Bioceres is a global company with an extensive
geographic footprint. The Group&rsquo;s agricultural inputs are marketed across more than 45 countries, primarily in South America, the
United States and Europe.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless the context otherwise requires, &ldquo;we&rdquo;,
&ldquo;us&rdquo;, &ldquo;our&rdquo;, &ldquo;Bioceres&rdquo;, &ldquo;BIOX&rdquo;, &ldquo;the Group&rdquo;, and &ldquo;Bioceres Crop Solutions&rdquo;
will refer to Bioceres Crop Solutions Corp. and its subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <B>2.</B> <B><U>ACCOUNTING STANDARDS AND BASIS OF PREPARATION</U></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Statement of compliance with IFRS as issued
by IASB</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consolidated financial statements of the Group
have been prepared in accordance with International Financial Reporting Standards (&ldquo;IFRS&rdquo;) as issued by International Accounting
Standard Board (&ldquo;IASB&rdquo;) following the accounting policies as set forth and summarized in Note 4. All IFRS issued by the IASB,
effective at the time of preparing these consolidated financial statements have been applied.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Authorization for the issue of the consolidated
financial statements</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These consolidated financial statements of the
Group as of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023 have been authorized by the Board of Directors
of Bioceres Crop Solutions on November 10, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Basis of measurement</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consolidated financial statements of the Group
have been prepared using:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">Accrual basis of accounting (except for cash flows information).
Under this basis of accounting, the effects of transactions and other events are recognized as they occur, even when there are no cash
flows.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">Going concern basis of accounting, considering the conclusion
of the assessment made by the Group&rsquo;s Management in accordance with the requirements of paragraph 25 of IAS 1, &ldquo;Presentation
of Financial Statements&rdquo; as described below.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the current period, we experienced a setback
due to challenges in the Argentine market&mdash;most notably, the deterioration in farmer economics driven by declining commodity prices
and weak yield forecasts. These external pressures significantly impacted per-hectare income for Argentine farmers, leading to reduced
investment in key inputs such as fertilizers and crop protection products.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This reduction in demand, combined with a well-supplied
ag-inputs market resulting from aggressive purchasing in prior years, has led to increased price pressure and lower adoption of high-value
technologies like ours.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Additionally, in June 2025, Bioceres S.A.&mdash;a
wholly owned subsidiary of Bioceres Group Limited, formerly our ultimate controlling parent&mdash;defaulted on a portion of its financial
debt. This created a context of uncertainty in our financial partnership with local banks in Argentina. As a result, by the end of August
2025, these banks suspended access to previously available credit lines, requiring us to rely on cash generated from operating activities
to meet financial obligations. Moreover, due to the adverse market conditions described above, our performance metrics were negatively
impacted, resulting in a breach of the ratio thresholds stipulated in the Secured Notes (see Note 7.13). As of the date of issuance of
this financial statement, the Company has not received any acceleration notice. However, as of June 30, 2025, we were unable to demonstrate
an unconditional right to defer settlement of the liability for at least twelve months. Accordingly, the liability was reclassified as
current for this reporting period, and a total of $4.8 million was accrued as a Prepayment Premium Fee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are actively pursuing several alternatives
to address this financial situation. Notably, we have made substantial progress in optimizing our working capital and realigning our cost
structure to reflect current market conditions. While discussions remain open regarding a new long-term facility or assets disposal, we
are also engaging with local Argentine banks to refinance current debt and restore confidence in our business. However, there is no guarantee
that financing will become available on acceptable terms or at all.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">It is important to highlight that, despite the
adverse impact of financial difficulties faced by agricultural producers, we were able to maintain our market share in key product families
and the outlook for upcoming campaigns remains positive in Argentina. This optimism is grounded in expectations of a more favorable macroeconomic
environment in the country and the normalization of climatic conditions affecting the agricultural sector.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The generation of cash flows over the next twelve
months depends on the success of these initiatives, which cannot be guaranteed as they rely on factors not entirely within the Group&rsquo;s
control. The uncertainty surrounding our ability to secure additional financing contributes to a material uncertainty that raise substantial
doubt regarding the Group&rsquo;s ability to continue as a going concern.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying consolidated financial statements
do not include any adjustments that may be required to address potential impacts on the recoverability and classification of assets, or
on the amounts and classifications of liabilities, should the Group be unable to continue as a going concern.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Functional currency and presentation currency</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <B>a)</B> <B>Functional currency</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Items included in the financial statements of
each of the Group&rsquo;s entities are measured using the currency of the primary economic market in which the entity operates (i.e.,
&ldquo;the functional currency&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the years ended June 30, 2022, our Argentine
subsidiaries applied IAS 29 &ldquo;Financial reporting in hyperinflationary economies,&rdquo; which requires that the financial statements
of an entity whose functional currency is the currency of a hyperinflationary economy be stated in terms of the measuring unit current
at the closing date of the reporting period. For such purpose, the inflation produced since the acquisition date or the revaluation date,
as applicable, must be computed for non-monetary items. The standard details a series of factors to be considered for concluding whether
an economy is hyperinflationary, including, but not limited to, a cumulative inflation rate over a three-year period that approaches or
exceeds 100%. As of June 30, 2018, the cumulative inflation in Argentina exceeded 100%. Therefore, as of July 1, 2018, the Argentine economy
was considered hyperinflationary, in accordance with IAS 29.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During an inflationary period, any entity that
maintains an excess of monetary assets over monetary liabilities will lose purchasing power, and any entity that maintains an excess of
monetary liabilities over monetary assets will gain purchasing power, provided that such items are not subject to an adjustment mechanism.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In short, the restatement mechanism of IAS 29
establishes that monetary assets and liabilities will not be restated because they are already expressed in a current unit of measurement
at the end of the reporting period. Assets and liabilities subject to adjustments based on specific agreements will be adjusted according
to those agreements. Non-monetary items measured at their current values at the end of the reporting period, such as fair value or others,
do not need to be restated. The remaining non-monetary assets and liabilities will be restated according to a general price index. The
loss or gain for the net monetary position will be included in the net result of the reporting period, presented in a separate line item.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From July 1, 2022, our main Argentine subsidiaries
changed their functional currency from the Argentine Peso to the U.S. dollar as a result of changes in events and conditions that are
relevant to their business operations, which include a hyper inflationary macroeconomic context and the depreciation of the Argentine
Peso, in addition to the effects on our business of certain business combination transactions, as discussed below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Macroeconomic context &ndash; in recent years
Argentina&rsquo;s macroeconomic scenario has featured a misalignment between inflation rates and the devaluation of the Argentine peso,
which became more pronounced during the first half of the year ended June 30, 2022. Notwithstanding such misalignment, our Argentine subsidiaries
have been able to continue pricing their products in U.S. dollars as the costs of products and services are set in U.S. dollars. This
has also been achievable as the demand for the type of products we commercialize is relatively inelastic when compared to non-essential
goods and services. Further, Argentina&rsquo;s significant economic volatility has caused materials, and other costs of providing goods
that we acquire from the Argentine domestic market, to become increasingly indexed to the U.S. dollar (i.e., denominated in Argentine
Pesos but indexed to the U.S. dollar exchange rate).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Business effects &ndash; following the merger
with Pro Farm, which closed at the beginning of the fiscal year ended June 30, 2023, in addition to other business combination transactions,
we established a global commercial strategy with a view to unifying pricing policies for the commercialization of our products.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In accordance with IAS 21, we have considered
the following primary factors to determine the functional currency of our main Argentine subsidiaries: (i) the sales prices for goods
and services, which are mainly influenced and determined by the U.S. dollar; and (ii) the increasing influence of transactions indexed
to the U.S. dollar related to labor, materials, and other costs of providing goods.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Taking into account the analysis of the primary
factors provided by IAS 21 in determining the functional currency of our main Argentine subsidiaries (in particular the increased influence
of exchange rates on their costs of operations, which are indexed to the U.S. dollar), we identified that there is strong evidence that
their functional currency had changed to the U.S. dollar.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As discussed above, we assessed primary indicators
and determined that they were conclusive for the analyzed period; however, consideration was also given to secondary indicators. The result
of such analysis also leads to the conclusion that the U.S. dollar is the relevant currency for cash generation from operating and financing
activities of our main Argentine subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In accordance with IAS 21, the effects of the
change in functional currency were recorded prospectively. Accordingly, from July 1, 2022, there are no longer significant effects of
inflation adjustments in our financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <B>b)</B> <B>Presentation currency</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consolidated financial statements of the Group
are presented in US dollars.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <B>c)</B> <B>Foreign currency</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Transactions entered into by Group entities in
a currency other than their functional currency are recorded at the relevant exchange rates as of the date upon which such transactions
occur. Foreign currency monetary assets and liabilities are translated at the prevailing exchanges rates as of the final day of each reporting
period. Exchange differences arising from the retranslation of unsettled monetary assets and liabilities are recognized immediately in
profit or loss, except for foreign currency borrowings qualifying as a hedge of a net investment in a foreign operation for which exchange
differences are recognized in other comprehensive income and accumulated in the foreign exchange reserve along with the exchange differences
arising from the retranslation of the foreign operation. Upon the disposal of a foreign operation, the cumulative exchange differences
recognized in the foreign exchange reserve relating to such operation up to the date of disposal are transferred to the consolidated statement
of profit or loss and other comprehensive income as part of the gain or loss recognized upon such disposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Subsidiaries</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Where the Group holds a controlling interest in
an entity, such entity is classified as a subsidiary. The Group exercises control over such an entity if all three of the following elements
are present: (i) the Group has the power to direct or cause the direction of the management and policies of the entity; (ii) the Group
is exposed to the variable returns of such entity; and (iii) the Group has power to affect the variability of such returns. Control is
reassessed whenever facts and circumstances indicate that there may be a change in any of these elements of control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">De-facto control exists in situations where the
Group has the practical ability to direct the relevant activities of an entity without holding the majority of the voting rights. In determining
whether de facto control exists, the Group considers all relevant facts and circumstances, including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: justify; text-indent: -14.2pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">-</TD><TD STYLE="text-align: justify">The relative share of the Group&rsquo;s voting rights with respect
both the size and dispersion of other parties who hold voting rights;</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">-</TD><TD STYLE="text-align: justify">Substantive potential voting rights held by the Group and by
other parties;</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">-</TD><TD STYLE="text-align: justify">Other contractual arrangements; and</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">-</TD><TD STYLE="text-align: justify">Historic patterns in voting attendance.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The subsidiaries of the Group, all of which have
been included in the consolidated financial statements of the Group, are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group holds a majority share of the voting
rights in all of its subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="vertical-align: bottom; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; vertical-align: bottom">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">% Equity interest</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: left; font-weight: bold">Name</TD><TD STYLE="text-align: center; font-weight: bold; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-weight: bold">Principal activities</TD><TD STYLE="text-align: center; font-weight: bold; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; font-weight: bold">Country</TD><TD STYLE="text-align: center; font-weight: bold; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Ref</TD><TD STYLE="text-align: center; font-weight: bold; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">06/30/2025</TD><TD STYLE="text-align: center; font-weight: bold; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">06/30/2024</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; width: 28%; text-align: left; padding-bottom: 1.5pt">RASA Holding, LLC</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 28%; text-align: left; padding-bottom: 1.5pt">Holding company</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 12%; text-align: center; padding-bottom: 1.5pt">USA</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 7%; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 10%; text-align: center; padding-bottom: 1.5pt">100%</TD><TD STYLE="text-align: center; width: 1%; padding-bottom: 1.5pt; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 10%; text-align: center; padding-bottom: 1.5pt">100%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Rizobacter Argentina S.A.</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Biological business</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">Argentina</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">80%</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">80%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Rizobacter do Brasil Ltda.</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Biological business</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">Brazil</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">a</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">80%</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">80%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Rizobacter del Paraguay S.A.</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Biological business</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">Paraguay</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">a</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">80%</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">80%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Rizobacter Uruguay</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Biological business</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">Uruguay</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">a</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">80%</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">80%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Rizobacter South Africa</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Biological business</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">South Africa</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">a</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">76%</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">76%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Comer. Agrop. Rizobacter de Bolivia S.A.</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Biological business</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">Bolivia</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">a</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">80%</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">80%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Rizobacter USA, LLC</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Biological business</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">USA</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">a</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">80%</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">80%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Rizobacter Colombia SAS</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Biological business</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">Colombia</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">a</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">80%</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">80%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Rizobacter France SAS</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Biological business</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">France</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">a</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">80%</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">80%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Bioceres Crops S.A.</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Biological business</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">Argentina</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">90%</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">90%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">BCS Holding Inc</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Holding Company</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">USA</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">100%</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">100%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Bioceres Semillas S.A.U.</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Production and commercialization of seeds</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">Argentina</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">a/b</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">80%</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">100%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Verdeca LLC</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Research and development</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">USA</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">100%</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">100%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Insumos Agroqu&iacute;micos S.A.</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Selling of agricultural inputs</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">Argentina</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">61.32%</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">61.32%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Bioceres Crops Do Brasil Ltda.</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Production and commercialization of seeds</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">Brazil</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">100%</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">100%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Pro Farm Group Inc.</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Biological business</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">USA</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">100%</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">100%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Pro Farm International, O&Uuml; </TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Biological business</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">Finland</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">100%</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">100%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Pro Farm Michigan Manufacturing LLC</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Biological business</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">USA</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">100%</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">100%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Pro Farm Russia, LLC</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Biological business</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">Russia</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">100%</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">100%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Pro Farm Technologies Com&eacute;rcio de Insumo Agr&iacute;colas do Brasil Ltda</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Biological business</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">Brazil</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">99%</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">99%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Pro Farm Technologies, O&Uuml;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Biological business</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">Finland</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">100%</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">100%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Glinatur S.A.</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Biological business</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">Uruguay</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">100%</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">100%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Pro Farm, Inc.</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Biological business</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">USA</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">100%</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">100%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Rifarm Mexico S.R.L.de C.V.</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Biological business</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">Mexico</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">100%</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">-</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Natal Agro S.R.L.</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Development and breeding of seeds</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">Argentina</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">c</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">51%</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1.5pt">51%</TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left">a)</TD><TD STYLE="text-align: justify">Indirect interests held through Rizobacter. The indirect equity
interest participation included in this table was the 80% of the direct equity interest participation that Rizobacter owns in each entity.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left">b)</TD><TD STYLE="text-align: justify">In June 2025, Rizobacter Argentina S.A. entered into a share
purchase agreement with Bioceres Crop Solutions Corp., acquiring 100% of the share capital of Bioceres Semillas S.A.U. In line with the
Group&rsquo;s accounting policies, the transaction was accounted using the predecessor value method.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left">c)</TD><TD STYLE="text-align: justify">On June 10, 2024 we acquired a controlling interest in Natal
Agro S.R.L (&ldquo;Natal&rdquo;). See Note 6</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Special purpose and structured entities
(&ldquo;SPE&rdquo;)</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A structured entity is an entity that has been
designed so that voting or similar rights are not the dominant factor in deciding who controls the entity and the relevant activities
are directed by means of contractual arrangements. In these cases, we consider the purpose and design of the SPE, including a consideration
of the risks the SPE was expected to be exposed to, the risks it was designed to pass on to the parties involved with the SPE and whether
we are exposed to some or all of those risks or potential returns. One then considers which activities have a significant impact on the
SPE&rsquo;s returns and determines which parties have an ability to direct each of those activities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group controls an SPE when is exposed, or
has rights, to variable returns from its involvement with the SPE and has the ability to affect those returns through its power over the
SPE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>3. <U>NEW
STANDARDS, AMENDMENTS AND INTERPRETATIONS ISSUED BY THE IASB</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">a) The following new standards, amendments and
interpretations became applicable for the current reporting period and adopted by the Group.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: -14.2pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left">-</TD><TD STYLE="text-align: justify"><I>Amendments to IFRS 16 - Lease Liability in a Sale and Leaseback.</I></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">-</TD><TD STYLE="text-align: justify"><I>Amendments to IAS1 - Non-current liabilities with covenants. </I></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">-</TD><TD STYLE="text-align: justify"><I>Amendments to IAS 7- Statement of Cash Flows &amp; to IFRS 7- Financial Instruments: Disclosures. </I></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">-</TD><TD STYLE="text-align: justify"><I>Amendment to IAS 7 and IFRS 7 - Supplier Financing. </I></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These new standards and amendments did not have
any material impact on the Group.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">b) The following new standards are not yet adopted
by the Group.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: -14.2pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">-</TD><TD STYLE="text-align: justify"><I>Amendments to IAS 21- The Effects of Changes in Foreign Exchange Ratestitled Lack of Exchangeability.
</I>The amendments are effective for annual reporting periods beginning on or after 1 January 2025.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">-</TD><TD STYLE="text-align: justify"><I>Amendment to IFRS 9 and IFRS 7 &ndash; Classification and measurement of financial instruments. </I>The
amendments are effective for annual periods beginning on or after January 1, 2026.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">-</TD><TD STYLE="text-align: justify"><I>IFRS 19 - Subsidiaries without Public Accountability: Disclosures-</I> The amendments are effective
for annual periods beginning on or after January 1, 2027.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I></I></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top"><TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">-</TD><TD STYLE="text-align: justify"><I>Annual Improvements to IFRS Accounting Standards&mdash;Volume 11.</I> The amendments are effective
for annual periods beginning on or after January 1, 2026.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">-</TD><TD STYLE="text-align: justify"><I>Amendments to IFRS 9 and IFRS 7 &ndash; Contracts Referencing Nature-dependent Electricity.</I> The
amendments are effective for annual periods beginning on or after January 1, 2026.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The above amendments are not expected to have
material impact on the Group.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">-</TD><TD STYLE="text-align: justify"><I>IFRS 18 &ndash; Presentation and Disclosure in Financial Statements. </I>This standard introduces new
requirements for the presentation and disclosure of income and expenses in the statement of profit or loss, including the introduction
of new defined subtotals such as Operating Profit and enhanced disaggregation requirements. The standard also includes additional guidance
on aggregation principles and requires disclosures about management-defined performance measures (MPMs) used in public communications
outside the financial statements. It is effective for annual periods beginning on or after January 1, 2027.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group is analyzing the potential impact of
this standard on our financial statements, which is expected to mainly affect the presentation and structure of the primary financial
statements and related disclosures, but not the recognition or measurement of transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>4. <U>SUMMARY
OF SIGNIFICANT ACCOUNTING POLICIES </U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>4.1. <U>Cash
and cash equivalents</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the purposes of the statements of financial
position and statements of cash flows, cash and cash equivalents include cash on hand and in banks and short-term highly liquid investments.
Investments can be readily convertible to known amounts of cash and they are subject to insignificant risk of changes in value. In the
consolidated statements of financial position, bank overdrafts are included in borrowings within current liabilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>4.2. <U>Inventories</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Inventories are recognized at cost initially and
subsequently at the lower of cost and net realizable value. Cost comprises all costs of purchase and conversion as well as other costs
incurred in bringing the inventories to their present location and condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Weighted average cost is used to determine the
cost of ordinarily interchangeable items.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group assesses the recoverability of inventories
considering their sale price, whether the inventories are damaged and whether they have become obsolete in whole or in part.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Net realizable value is the sale price estimated
to be attained in the ordinary course of business, less costs of completion and other selling expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group sets up an allowance for obsolescence
or slow-moving inventories in relation to finished and in-process products. The allowance for obsolescence or slow-moving inventories
is recognized for finished products and in-process products based on an analysis by Management of the aging of inventory stocks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>4.3. <U>Biological
assets</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Within current assets, growing crops are included
as biological assets from the moment of sowing until the moment of harvest (approximately 5 to 7 months depending on the crop). At harvest
time the biological assets are transformed into agricultural products, including seed varieties for resale, and incorporated into the
inventory.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Costs are capitalized as biological assets if,
and only if, (a) it is probable that future economic benefits will flow to the entity, and (b) the cost can be measured reliably. The
Group capitalizes costs such as: planting, harvesting, weeding, seedlings, irrigation, agrochemicals, fertilizers and a systematic allocation
of fixed and variable production overheads that are directly attributable to the management of biological assets, among others.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Biological assets, both at initial recognition
and at each subsequent reporting date, are measured at fair value less costs to sell, except where fair value cannot be reliably measured.
Cost approximates fair value when little biological transformation has taken place since the costs were originally incurred or the impact
of biological transformation on price is not expected to be material.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Gains and losses that arise from measuring biological
assets at fair value less costs to sell and measuring agricultural produce at the point of harvest at fair value less costs to sell are
recognized in the statement of income in the period in which they arise in the line item &ldquo;Initial recognition and changes in fair
value of biological assets&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From the harvest time, agricultural products are
valued at net realizable value because there is a market asset, and the risk of non-sale is non-significant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Generally, the estimation of the fair value of
biological assets is based on models or inputs that are not observable in the market and the use of unobservable inputs is significant
to the overall valuation of the assets. Unobservable inputs are determined based on the best information available. Key assumptions include
future market prices, estimated yields at the point of harvest, estimated production cycle, future cash flows, future costs of harvesting
and other costs, and estimated discount rate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Market prices are generally determined by reference
to observable data in the principal market for the agricultural produce. Harvesting costs and other costs are estimated based on historical
and statistical data. Yields are estimated based on several factors, including the location of the farmland and soil type, environmental
conditions, infrastructure and other restrictions and growth at the time of measurement. Yields are subject to a high degree of uncertainty
and may be affected by several factors out of the Group&rsquo;s control including but not limited to extreme or unusual weather conditions,
plagues and other crop diseases, among other factors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>4.4. <U>Business
combinations</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group applies the acquisition method to account
for business combinations. The acquisition cost is measured as the aggregate of the consideration transferred for the acquisition of a
subsidiary, which is measured at fair value at the acquisition date, and the amount of any non-controlling interest in such subsidiary.
The Group recognizes any non-controlling interest in a subsidiary at the non-controlling interest&rsquo;s proportionate share of the recognized
amounts of subsidiary&rsquo;s identifiable net assets. The acquisition related costs are expensed as incurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any contingent consideration to be transferred
by the Group is recognized at fair value at the acquisition date. The contingent consideration is classified as an asset or liability
that is a financial instrument under IFRS 9 is measured at fair value through profit or loss.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Goodwill is initially measured at cost, which
is the excess of the aggregate of the consideration transferred and the amount of the non-controlling interest and any previous interest
carried over the net identifiable assets acquired, and liabilities assumed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">After initial recognition, goodwill is measured
at cost less any accumulated impairment losses. For impairment testing, goodwill acquired in a business combination is, as of the acquisition
date, allocated to each of the cash-generating units of the Group that is expected to benefit from the synergies of the combination, without
considering whether other assets or liabilities of the subsidiary are allocated to those units.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any impairment in the carrying value is recognized
in the consolidated statement of comprehensive income. In the case of acquisitions in stages, prior to the write-off of the previously
held equity interest in the subsidiary, said interest is re-measured at fair value as of the date of acquisition of control over the subsidiary.
The result of the re-measurement at fair value is recognized in profit or loss.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When a seller in a business combination has contractually
agreed to indemnify the Group for the result of a contingency or uncertainty related to the entirety or a portion of an asset or liability,
the Group recognizes an indemnification asset. The indemnification asset is measured on the same basis as the indemnification item. At
the end of each period, the Group measures the indemnification assets recognized at the acquisition date on the same basis as the indemnified
liability, subject to any contractual limitation on the amount and, for an indemnification asset that is not periodically measured at
fair value, based on Management&rsquo;s assessment of the recoverability of the indemnification asset. The Group derecognizes the indemnification
asset when it collects or sells it, or when it loses the right over it.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>4.5. <U>Business
combination under common control</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Common control of business combination is excluded
from the scope of IFRS 3. There is no other specific guidance on this topic elsewhere in IFRS.&nbsp;Therefore, management needs to use
judgement to develop an accounting policy that provides relevant and reliable information in accordance with IAS 8. Management accounting
police choice for business combination under common control is &ldquo;Predecessor value method&rdquo;. A Predecessor value method involves
accounting for the assets and liabilities of the acquired business using existing carrying values. Differences between the carrying value
and the amount payable should be accounted as an equity contribution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management&rsquo;s accounting policy choice is
to use a prospective presentation method.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>4.6. <U>Impairment
of non-financial assets (excluding inventories and deferred tax assets)</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Impairment tests on goodwill and intangible assets
not yet available for use, or with indefinite useful lives, are undertaken annually at the end of the reporting period. Other non-financial
assets are subject to impairment tests whenever events or changes in circumstances indicate that their carrying amount may not be recoverable.
Where the carrying value of an asset exceeds its recoverable amount (i.e., the higher of value in use and fair value less costs to sell),
the asset is written down accordingly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Where it is not possible to estimate the recoverable
amount of an individual asset, the impairment test is carried out on the smallest group of assets to which it belongs for which there
are separately identifiable cash flows (its Cash Generating Unit or CGU). Goodwill is allocated on initial recognition to each of the
Group&rsquo;s CGUs that are expected to benefit from a business combination that gives rise to the goodwill.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Impairment charges are included in profit or loss,
except to the extent they reverse gains previously recognized in other comprehensive income. An impairment loss recognized for goodwill
is not reversed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Impairment testing of goodwill and intangible
assets not yet available for use, with indefinite useful lives or whenever events or changes in circumstances indicate that their carrying
amount may not be recoverable, requires the use of significant assumptions for the estimation of future cash flows and the determination
of discount rates. The significant assumptions and the determination of discount rates for the impairment testing of intangibles and goodwill
are further explained in Notes 7.8 and 7.9.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>4.7. <U>Joint
arrangements </U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">An associate is an entity over which the Group
exerts significant influence. Significant influence is the power to participate in financial and operating policy decision-making at such
entity, but it does not involve control or joint control over those policies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group is a party to a joint arrangement when
there is a contractual arrangement that confers joint control over the relevant activities of the arrangement to the Group and at least
one other party. Joint control is assessed under the same principles as control over subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group classifies its interests in joint arrangements
as either:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left">-</TD><TD STYLE="text-align: justify"><I>Joint ventures</I>: where the group has rights to only
the <I>net assets </I>of the joint arrangement.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left">-</TD><TD STYLE="text-align: justify"><I>Joint operations</I>: where the group has both the rights
to the assets and obligations for the liabilities of the joint arrangement.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In assessing the classification of interests in
joint arrangements, the Group considers:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left">-</TD><TD STYLE="text-align: justify">The structure of the joint arrangement;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left">-</TD><TD STYLE="text-align: justify">The legal form of joint arrangements structured through a
separate vehicle;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left">-</TD><TD STYLE="text-align: justify">The contractual terms of the joint arrangement agreement;
and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left">-</TD><TD STYLE="text-align: justify">Any other facts and circumstances (including any other contractual
arrangements).</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group accounts for its interests in joint
ventures using the equity method, where the Group&rsquo;s share of post-acquisition profits and losses and other comprehensive income
is recognized in the Consolidated statement of profit and loss and other comprehensive income.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Losses in excess of the Group&rsquo;s investment
in the joint venture are recognized only to the extent that the Group has incurred legal or constructive obligations or made payments
on behalf of the joint venture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Profits and losses arising on transactions between
the Group and its joint ventures are recognized only to the extent of unrelated investors&rsquo; interests in the joint venture. The Group&rsquo;s
share in a joint venture&rsquo;s profits and losses resulting from a transaction is eliminated against the carrying amount of investment
in the joint venture through the line &ldquo;share of profit (or loss) of joint ventures&rdquo; in the Consolidated statements of profit
or loss and other comprehensive income.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any premium paid for an investment in a joint
venture above the fair value of the Group&rsquo;s share of the identifiable assets, liabilities and contingent liabilities acquired is
capitalized and included in the carrying amount of the investment in the joint venture. Where there is objective evidence that the investment
in a joint venture has been impaired, the carrying amount of the investment is tested for impairment in the same way as other non-financial
assets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When the Group loses significant influence in
an associate or joint control over a joint venture, it measures and recognizes any investment held at fair value. Any difference between
the carrying amount of the associate or joint venture when losing significant influence or joint control and the fair value of the held
investment and sale revenue are recognized in profit or loss.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group accounts for its interests in joint
operations by recognizing its share of assets, liabilities, revenues and expenses in accordance with its contractually conferred rights
and obligations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For all joint arrangements structured in separate
vehicles the Group must assess the substance of the joint arrangement in determining whether it is classified as a joint venture or joint
operation. This assessment requires the Group to consider whether it has rights to the joint arrangement&rsquo;s net assets (in which
case it is classified as a joint venture), or rights to and obligations for specific assets, liabilities, expenses, and revenues (in which
case it is classified as a joint operation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There is uncertainty regarding Management&rsquo;s
estimates of the Group&rsquo;s ability to recover the carrying amounts of the investments in joint ventures, since such estimates depend
on the joint ventures&rsquo; ability to generate sufficient funds to complete the development projects, the future outcome of the project
deregulation process and the amounts and timing of the cash flows from projects, among other future events.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management assesses whether there are impairment
indicators and, if any, it performs a recoverability analysis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management estimates of the recoverability of
these investments represent the best estimate based on available evidence, the existing facts and circumstances, using reasonable and
provable assumptions in the cash flow projections.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Therefore, the consolidated financial statements
do not include adjustments that would be required if the Group were unable to recover the carrying amount of the above-mentioned assets
by generating sufficient economic benefits in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>4.8. <U>Property,
plant and equipment</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Property, plant and equipment items are initially
recognized at cost. In addition to the purchase price, cost also includes costs directly attributable to such property, plant and equipment
items. There are no unavoidable costs with respect to dismantling and removing items. The cost of property, plant and equipment items
acquired in a business combination is their fair value at the acquisition date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Depreciation is calculated using the straight-line
method to allocate the property, plant or equipment items&rsquo; cost or revalued amounts, net of their residual values, over their estimated
useful lives or, in the case of leasehold improvements and certain leased plant and equipment, the shorter lease term as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Research instruments: 3 to 10 years</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Office equipment: 5 to 10 years</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Vehicles: 5 years</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Computer equipment and software: 3 years</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Fixture and fittings: 10 years</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Machinery and equipment: 5 to 10 years</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Buildings: 50 years</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">However, for certain assets whose use is directly
linked to the level of production, depreciation is determined using the units-of-production method, so that the depreciation expense reflects
the actual pattern of consumption of the asset&rsquo;s future economic benefits.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Useful lives and depreciation methods are reviewed
every year as required by IAS 16.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Assets under items Land and Buildings, are accounted
for at fair value arising from the last revaluation performed, applying the revaluation model indicated by IAS 16.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Starting with the fiscal year ended on June 30,
2024, the Group modified its Property, Plant, and Equipment valuation policy by changing the revaluation frequency for items classified
under Buildings and Land. The revaluation must never exceed five years between each occurrence, in compliance with the maximum periods
established by accounting standards, or whenever there are indications that the carrying amount differs significantly from the amount
that could be determined using fair value at the end of the reporting year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To obtain fair values, the existence or not of
an active market is considered for the assets in their current status. For those assets for which an active market in their current status
exists, the fair values were determined based on their market values. For the remaining cases, the market values of comparable new assets
are analyzed, applying a discount based on the status and wear of each asset and considering the characteristics of each of the revalued
assets (for example, improvements made, maintenance status, level of productivity, use, etc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group carries certain classes of property,
plant and equipment under the revaluation model under IAS 16. The revaluation model requires that the Group carry property, plant and
equipment at revalued amounts, being fair value at the date of revaluation less any subsequent accumulated depreciation and any subsequent
accumulated impairment losses. IAS 16 requires that the Group carry out these revaluations with sufficient regularity so that the carrying
amounts of its property, plant and equipment do not differ materially from that which would be determined using fair value at the end
of a reporting period. The determination of fair value at the date of revaluation requires judgments, estimates and assumptions based
on market conditions prevailing at the time of any such revaluation. Changes to any of the Group&rsquo;s judgments, estimates or assumptions
or to the market conditions subsequent to a revaluation will result in changes to the fair value of property, plant and equipment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group prepares the corresponding revaluations
on a regular basis taking into account the work of independent appraisers. The Group uses different valuation techniques depending on
the class of property being valued. Generally, the Group determines the fair value of its industrial buildings and warehouses based on
a depreciated replacement cost approach. The Group determines the fair value of its land based on active market prices adjusted, if necessary,
for differences in the nature, location or condition of the specific asset. If this information is not available, the Group may use alternative
valuation methods, such as recent prices in less active markets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Property valuation is a significant area of estimation
uncertainty. Fair values are prepared regularly by Management, taking into account independent valuations. The determination of fair value
for the different classes of property, plant and equipment is sensitive to the selection of various significant assumptions and estimates.
Changes in those significant assumptions and estimates could materially affect the determination of the revalued amounts of property,
plant and equipment. The Group utilizes historical experience, market information and other internal information to determine and/or review
the appropriate revalued amounts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following are the most significant assumptions
used in the preparation of the revalued amounts for its classes of property, plant and equipment:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">a) Land:
The Group generally uses the market price of a square meter of land for the same or similar location as the most significant assumption
to determine the revalued amount. The Group typically uses comparable land sales in the same location to assess appropriateness of the
value of its land.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">b) Industrial
buildings and warehouses: The Group generally determines the construction cost of a new asset and then the Group adjusts it for normal
wear and tear. Construction prices may include, but are not limited to, construction materials, labor costs, installation and assembly
costs, site preparation, professional fees and applicable taxes. Construction costs may differ significantly from year to year and are
subject to macroeconomic changes in the economy where the Group operates, such as the impact of inflation and foreign exchange rates.
The construction cost of its industrial buildings and warehouses is determined on a US dollar per constructed square meter basis, while
the construction cost of its mills, facilities and grain storage facilities is determined by reference to their total capacity measured
in tons milled or stored, respectively. A 5% increase or decrease in the construction costs or the estimate of normal wear and tear relating
to such assets could have an impact of $ 1.2 million on their revalued amounts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Increases in the carrying amounts arising on revaluation
of land and buildings are recognized, net of tax, in other comprehensive income and accumulated in reserves in shareholders&rsquo; equity.
To the extent that the increase reverses a decrease previously recognized in profit or loss, the increase is first recognized in profit
or loss. Decreases that reverse previous increases of the same asset are first recognized in other comprehensive income to the extent
of the remaining surplus attributable to the asset; all other decreases are charged to profit or loss.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>4.9. <U>Leases</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Leases are recognized as a right-of-use asset
and corresponding liability at the date of which the leased asset is available for use by the Group. Each lease payment is allocated between
the liability and finance cost. The finance cost is charged to profit or loss over the lease period so as to produce a constant periodic
rate of interest on the remaining balance of the liability for each period. The right-of-use asset is depreciated over the shorter of
the asset&rsquo;s useful life and the lease term on a straight-line basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In determining the lease term, we consider all
facts and circumstances that create an economic incentive to exercise an extension option, or not exercise a termination option. Extension
options (or periods after termination options) are only included in the lease term if the lease is reasonably certain to be extended (or
not terminated).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Short term leases are recognized on a straight-line
basis as an expense in the income statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At initial recognition, the right-of-use asset
is measured considering the value of the initial measurement of the lease liability; any lease payments made at or before the commencement
date, less any lease incentives; and any initial direct costs incurred by the lessee. After initial recognition, the right-of-use assets
are measured at cost, less any accumulated depreciation and/or impairment losses, and adjusted for any re-measurement of the lease liability.
Depreciation of the right-of-use asset is calculated using the straight-line method over the estimated duration of the lease contract.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The lease liability is initially measured at the
present value of the lease payments that are not paid at such date, including variable lease payments that depend on an index or rate,
initially measured using the index or rate as of the commencement date; amounts expected to be payable by the lessee under residual value
guarantees; the exercise price of a purchase option if the lessee is reasonably certain to exercise that option; payments of penalties
for terminating the lease, if the lease term reflects the lessee exercising an option to terminate the lease; and fixed payments, less
any lease incentives receivable. After the commencement date, we measure the lease liability by increasing the carrying amount to reflect
interest on the lease liability; reducing the carrying amount to reflect lease payments made; and re-measuring the carrying amount to
reflect any reassessment or lease modifications.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The above-mentioned inputs for the valuation of
the right of use assets and lease liabilities including the determination of the contracts within the scope of the standard, the contract
term ant interest rate used in the discounted cash flow involved a management&rsquo;s estimations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>4.10. <U>Intangible
assets</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>a) Externally
acquired intangible assets</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Externally acquired intangible assets are initially
recognized at acquisition date fair value (which is considered as their cost). After initial recognition, those assets are measured at
cost less accumulated amortization and accumulated impairment losses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Intangible assets acquired from third parties
have an estimated useful life as follows (in years):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Software: 3 years</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Trademarks and patents: 5 years</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certification ISO Standards: 3 years</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Useful lives and amortization methods are reviewed
every year as required by IAS 38.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To value acquired intangible assets, valuation
techniques generally accepted in the market are applied, based mainly on the revenue approach (such as excess earnings, relief from royalty,
and with or without), considering the characteristics of the assets to be valued and available information to estimate their acquisition
date fair value. Application of these valuation techniques requires the use of several assumptions related to future cash flows and the
discount rate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>b) Internally
generated intangible assets (development costs)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Expenditure on internally developed products is
capitalized if it can be demonstrated that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left">-</TD><TD STYLE="text-align: justify">It is technically feasible to develop the product for it to
be sold;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left">-</TD><TD STYLE="text-align: justify">Adequate resources are available to complete the development;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left">-</TD><TD STYLE="text-align: justify">There is an intention to complete and sell the product;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left">-</TD><TD STYLE="text-align: justify">The Group is able to sell the product;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left">-</TD><TD STYLE="text-align: justify">Sale of the product will generate future economic benefits;
and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left">-</TD><TD STYLE="text-align: justify">Expenditure on the project can be measured reliably.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Development expenditure not satisfying the above
criteria and expenditure on the research phase of internal projects are recognized in the consolidated statement of profit or loss and
other comprehensive income as incurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Capitalized development costs are amortized using
the straight-line method over the periods the Group expects to benefit from selling the products developed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Useful lives and amortization methods are reviewed
every year as required by IAS 38.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The research and development process can be divided
into several discrete steps or phases, which generally begin with discovery, validation and development and end with regulatory approval
and commercial launch. The process for developing seed traits is relatively similar for both GM and non-GM traits. However, the two differ
significantly in later phases of development. For example, obtaining regulatory approval for GM seeds is a far more comprehensive and
lengthy process than for non-GM seeds. Although breeding programs and industrial biotechnology solutions may have shorter or simpler phases
than those described below, the Group has used the industry consensus for seed-trait development phases to characterize its technology
portfolios, which is generally divided into the following six phases:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">i) Discovery: The first phase in the technology
development process is the discovery or identification of candidate genes or genetic systems, metabolites, or microorganisms potentially
capable of enhancing specified plant characteristics or enabling an agro-industrial biotech solution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ii) Proof of concept: Upon successful validation
of the technologies in model systems (<I>in vitro </I>or <I>in vivo</I>), promising technologies graduate from discovery and are advanced
to the proof-of-concept phase. The goal of this phase is to validate a technology within the targeted organism before moving forward with
technology escalation activities or extensive field validation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">iii) Early development: In this phase, field tests
commenced in the proof-of-concept phase are expanded to evaluate various permutations of a technology in multiple geographies and growing
cycles, as well as other characteristics in order to optimize the technology&rsquo;s performance in the targeted organisms. The goal of
the early development phase is to identify the best mode of use of a technology to define its performance concept.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">iv) Advanced development and deregulation: In
this phase, extensive field tests are used to demonstrate the effectiveness of the technology for its intended purpose. In the case of
GM traits, the process of obtaining regulatory approvals from government authorities is also initiated during this phase, and tests are
performed to evaluate the potential environmental impact of modified plants. For solutions involving microbial fermentation, industrial-scale
runs are conducted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">v) Pre-launch: This phase involves finalizing
the regulatory approval process and preparing for the launch and commercialization of the technology. The range of activities in this
phase includes seed increases, pre-commercial production, and product and solution testing with selected customers. Usually, a more detailed
marketing strategy and preparation of marketing materials occur during this phase.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">vi) Product launch:
In general, this phase, which is the last milestone of the research and development process, is carried out by the Group, the joint ventures
and/or the Group</FONT>&rsquo;<FONT STYLE="font-size: 10pt">s technology licensees. When technology is commercialized through the joint
ventures or technology licensees, a successful product launch will trigger royalty payments to the Group, which are generally calculated
as a percentage of the net sales realized by the technology and captured upon commercialization. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Demonstrability of technical feasibility generally
occurs when the project reaches the &ldquo;advanced development and deregulation&rdquo; phase because at this stage success is considered
to be probable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>c) Intangible
assets acquired in a business combination</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Intangible assets acquired in a business combination
and recognized separately from goodwill are initially recognized at acquisition date fair value (which is considered as their cost). After
initial recognition, those assets are measured at cost less accumulated amortization and accumulated impairment losses in the same manner
as intangible assets acquired separately.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Intangible assets acquired in a business combination
have an estimated useful life as follows (in years):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Product development: 5 - 15 years</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Trademarks: 20 years</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Customer loyalty: 14 - 26 years</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To value intangible assets acquired from a business
combination, valuation techniques generally accepted in the market were applied, based mainly on the revenue approach (such as excess
earnings, relief from royalty, and with or without), considering the characteristics of the assets to be valued and available information
to estimate their acquisition date fair value. Application of these valuation techniques requires the use of several assumptions related
to future cash flows and the discount rate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>4.11. <U>Investment
properties</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Investment properties shall be measured initially
at its cost. The cost of a purchased investment property comprises its purchase price and any directly attributable expenditure. Directly
attributable expenditure includes, for example, professional fees for legal services, property transfer taxes and other transaction costs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the measurement after initial recognition,
the Group has chosen the cost model for all investment property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>4.12. <U>Financial
assets and liabilities</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">The Group measures
its financial assets and liabilities at initial recognition at fair value a</FONT>nd subsequently at amortized cost using the effective
interest method.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group has not irrevocably designated a financial
asset or liability as measured at fair value through profit or loss to eliminate or significantly reduce a measurement or recognition
inconsistency.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial assets or liabilities at fair value
through profit or loss are measured at fair value through profit and loss due to the business model used in their negotiation and/or the
contractual characteristics of their cash flows.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group makes estimates of collectability of
its recorded receivables. Management analyzes trade account receivables in accordance with conventional criteria, adjusting the amount
through a charge of an allowance for bad debts upon recognition of the inability of third parties to afford their financial obligations
to the Group. Management specifically analyzes the accounts receivable, the historical bad debts, solvency of customers, current economic
trends and the changes to the payment conditions of customers to assess the adequate allowance for bad debts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>4.13. <U>Borrowings</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group measures its borrowings at initial recognition
at fair value and, subsequently, are measured at amortized cost using the effective interest rate method.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Borrowing costs, either generic or specific, attributable
to the acquisition, construction or production of assets that necessarily take a substantial period of time to get ready for their intended
use or sale (qualifying assets) are included in the cost of the assets until the moment that they are substantially ready for use or sale.
Income earned on the temporary investments of funds generated in specific borrowings still pending use in the qualifying assets, are deducted
from the total of financing costs potentially eligible for capitalization.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All other loan costs are recognized under financial
costs, through profit and loss.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>4.14. <U>Convertible
notes</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The convertible notes were classified as compound
instruments, a non-derivative financial instrument that contains both a liability and an equity component. The equity component was measured
as the residual amount that results from deducting the fair value of the liability component from the initial carrying amount of the instrument.
The fair value of the consideration of the liability component was measured first at the fair value of a similar liability (including
any embedded non-equity derivative features, such as an issuer&rsquo;s call option to redeem the bond early) that does not have any associated
equity conversion option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group considers that if the instrument meets
the &lsquo;fixed for fixed&rsquo; condition, as the strike price is pre-determined at inception and only varies over time, and it is therefore
classified as equity. As regards to the mandatory conversion feature, as it is a contingent settlement provision, the Group decided to
measure the liability component at initial recognition, based on its best estimate of the present value of the redemption amount and allocated
the residual to the equity component.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>4.15. <U>Employee
benefits</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Employee benefits are expected to be settled wholly
within 12 months after the end of the reporting period and are presented as current liabilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accounting policies related to incentive payments
based on shares are detailed in Note 4.20.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>4.16. <U>Provisions</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group has recognized provisions for liabilities
of uncertain timing or amount. The provision is measured at the best estimate of the expenditure required to settle the obligation at
the end of the reporting period, discounted at a pre-tax rate reflecting current market assessments of the time value of money and risks
specific to the liability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>4.17. <U>Change
in ownership interest in subsidiaries without change of control </U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Transactions with non-controlling interest that
do not result in a loss of control are accounted for as equity transactions - ie., as transactions with the owners in their capacity as
owners. The recorded value corresponds to the difference between the fair value of the consideration paid and/or received and the relevant
share acquired and/or transferred of the carrying value of the net assets of the subsidiary.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>4.18. <U>Revenue
recognition</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Revenue is recognized when control has been transferred
to the buyer. Transfers of control vary depending on the individual terms of the sales contract. Revenues are recognized when control
of the products has been transferred, which generally means that the products have been delivered to the customer and there is no unfulfilled
obligation that could affect a customer&rsquo;s acceptance of the products. Generally, acceptance occurs upon shipment or delivery, but
ultimately depends on the terms of the underlying contracts. The customer is then invoiced at the agreed-upon price with the usual payment
terms for each geographical region. Those payment terms do not contain a significant financing component.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The timing of performance sometimes differs from
the timing that the associated consideration is received from the customer, thus resulting in the recognition of a contract asset or contract
liability. We recognize a contract liability if the customer&rsquo;s payment of consideration is received prior to completion of our related
performance obligation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a part of our customary business practices,
we offer a number of sales incentives to our customers, including volume discounts, retailer incentives, prepayment options and other
product rebates. For all such contracts that include any variable consideration, we estimate the amount of variable consideration that
should be included in the transaction price utilizing either the expected value method or the most likely amount method, depending on
the nature of the variable consideration. Variable consideration is included in the transaction price if, in our judgment, it is probable
that a significant future reversal of cumulative revenue under the contract will not occur. Although determining the transaction price
for consideration requires significant judgment, we have meaningful historical experience with incentives provided to customers and estimate
the expected consideration in view of historical patterns of incentive payouts. These estimates are reassessed each reporting period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We also offer an assurance warranty, which gives
customers a refund or exchange right in the case the delivered product does not conform to specifications. Replacement products are accounted
for under the warranty guidance if the customer exchanges one product for another of the same type, quality, and price. We have significant
experience with historical return patterns and use this experience to include returns in the estimate of transaction price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With respect to services, we mainly provide R&amp;D
and seed treatment services. Revenue associated with services is recognized by reference to the stage of completion of the transaction
at the end of the reporting period. Each of the services to be provided has a detailed work plan in which all activities to be rendered
are listed. The stage of completion for services is determined in accordance with the execution of the performed tasks listed in the respective
work plan. The level of execution of such services is provided by our technical experts, who provide information relating to the transfer
of goods or services. We have no material revenue for services that cannot be reliably estimated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Revenue for usage-based royalties relating to
licensed intellectual property rights is recognized at the later of when the performance obligation is satisfied and when a sale or use
occurs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Typically, our average payment terms range from
130 to 160 days at a consolidated level. Longer terms may be granted in limited circumstances; however, the effects of such sales are
not material to our consolidated financial statements. Those payment terms do not contain a significant financing component.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>4.19. <U>Current
and deferred income tax</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Deferred tax assets and liabilities are recognized
where the carrying amount of an asset or liability in the Consolidated statement of financial position differs from its tax base, except
for differences arising on:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left">-</TD><TD STYLE="text-align: justify">The initial recognition of goodwill;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left">-</TD><TD STYLE="text-align: justify">The initial recognition of an asset or liability in a transaction
which is not a business combination and at the time of the transaction affects neither accounting or taxable profit; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left">-</TD><TD STYLE="text-align: justify">Investments in subsidiaries and jointly controlled entities
where the Group is able to control the timing of the reversal of the difference and it is probable that the difference will not reverse
in the foreseeable future.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Recognition of deferred tax assets is restricted
to those instances where it is probable that taxable profit will be available against which the difference can be utilized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The amount of the asset or liability is determined
using tax rates that have been enacted or substantively enacted by the end of the reporting period and are expected to apply when the
deferred tax liabilities / (assets) are settled / (recovered).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Deferred tax assets and liabilities are offset
when the Group has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities
relate to taxes levied by the same tax authority on either:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left">-</TD><TD STYLE="text-align: justify">The same taxable entity within the Group, or</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left">-</TD><TD STYLE="text-align: justify">Different entities within the Group which intend either to
settle current tax assets and liabilities on a net basis, or to realize the assets and settle the liabilities simultaneously, in each
future period in which significant amounts of deferred tax assets or liabilities are expected to be settled or recovered.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>4.20. <U>Share-based
payments</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain executives and directors of the Group
were granted incentives in the form of shares and options to purchase Bioceres Crop Solutions shares as consideration for services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The cost of these share-based transactions is
determined based on their fair value at the date upon which such incentives are granted using a valuation model that is appropriate in
the circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This cost is recognized as an expense together
with an increase in equity throughout the period in which the service or performance conditions are satisfied (i.e., the vesting period).
The accumulated expense recorded in connection with these transactions at the end of each year until the vesting date reflects the time
elapsed between the vesting period and Management&rsquo;s best estimate of the number of equity instruments that will vest. The charge
to income/loss for the period represents the variation in the accumulated expense recorded between the beginning and the end of the year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Non-market related service and performance conditions
are not taken into account when determining the grant date fair value of the equity instruments, but the probability that the conditions
are fulfilled is assessed as part of Management&rsquo;s best estimate of the number of equity instruments that will vest. Market-related
performance conditions are reflected in the grant date fair value. Any other conditions related to equity-settled share-based payment
transactions but without a service requirement are considered as non-vesting conditions. Non-vesting conditions are reflected in the fair
value of the equity instruments and are charged to income/loss immediately unless there are service and/or performance conditions as well.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No amount is recognized for transactions that
will not vest because non-market related performance conditions and/or service conditions were not satisfied. When transactions include
market-related conditions or non-vesting conditions, the transactions are considered to be vested, irrespective of whether a market-related
condition or the non-vesting condition is satisfied, provided that all the other performance and/or service conditions are met.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When the terms and conditions of an equity-settled
share-based payment transaction are modified, the minimum expense recognized is the grant date fair value, unmodified, provided that the
original terms have been complied with. An additional expense, measured at the date of modification, is recognized for any modification
that increases the total fair value of the share-based payment transaction, or is otherwise beneficial to the employee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When the transaction is settled by the Bioceres
Crop Solutions or by the counterparty, any remainder of the fair value is charged to income immediately.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The dilutive effect of current options is considered
in the calculation of the diluted earnings per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The estimate of the fair value of equity-settled
share-based payment transactions requires a determination to be made of the most adequate option pricing model to apply depending on the
terms and conditions of the arrangement. This estimate also requires a determination of those factors most appropriate to the pricing
model, including the expected life of the option and the expected volatility of the share price upon the basis of which hypotheses are
made. The Group measures the fair value of these transactions at the grant date applying the Black-Scholes formula adjusted to consider
the possible dilutive effect of the future exercise of the share options granted on their estimated fair value at grant date, as established
in paragraph B41 of IFRS 2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>5. <U>CRITICAL
ACCOUNTING JUDGMENTS AND ESTIMATES</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group makes certain estimates and assumptions
regarding the future. Estimates and judgments are continually evaluated based on historical experience and other factors, including expectations
of future events that are believed to be reasonable under the circumstances. In the future, actual experience may differ from these estimates
and assumptions. The estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amounts of
assets and liabilities within the next financial year are listed below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Critical estimates</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: -21.3pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left">-</TD><TD STYLE="text-align: justify">Impairment testing of intangible assets not yet available
for use, with indefinite useful lives or whenever events or changes in circumstances indicate that their carrying amount may not be recoverable
(Note 4.6).</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">-</TD><TD STYLE="text-align: justify">Impairment of goodwill (Notes 4.6).</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in">-</TD><TD STYLE="text-align: justify">Identification and fair value of identifiable intangible assets arising in acquisitions (Note 4.10 c).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>6. <U>ACQUISITIONS
AND OTHER SIGNIFICANT TRANSACTIONS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Natal Agro S.R.L.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 10, 2024, we acquired a controlling interest
in Natal Agro S.R.L (&ldquo;Natal&rdquo;), an Argentine company that breeds and develops corn varieties. The interest acquired is represented
by a total of 116,225 shares of AR$ 10 nominal value each, representing 51% of equity and voting interest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consideration for the acquisition was $0.22
million in cash and the commitment to carrying out, at our own expense, the regulatory activities for HB4 corn to obtain authorization
for its commercialization in Argentina, and the regulatory activities for HB4 corn in Brazil, once the commercialization strategy of HB4
corn in Brazil has been defined by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Fair value of the consideration of payment</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; text-align: left">Cash payment</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">215,415</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Regulatory activities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">727,985</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 4pt">Total consideration</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">943,400</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consideration of payment was measured at fair
value, which was calculated as the sum of cash paid and the acquisition-date fair values of the regulatory services to be provided. The
fair values measured were based on discounting future cash flow using market discount rates. The difference between fair value and nominal
value of consideration will be recognized as finance cost over the period the consideration will be paid.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Assets acquired, liabilities assumed, and non-controlling
interest recognized </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; text-align: justify">Cash and cash equivalents</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">252,923</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Other financial assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">73,950</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Trade receivables</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">596,463</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Other receivables</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">288,861</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Income and minimum presumed recoverable income taxes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19,998</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Inventories</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,031,412</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Property, plant and equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">816,576</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Intangible assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,217,985</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Right of use asset</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">168,988</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Trade and other payables</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,302,332</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Borrowings</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(743,279</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Employee benefits and social security</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(23,346</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Deferred revenue and advances from customers</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,515</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Provisions</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(355,898</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Lease liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(168,988</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Deferred tax liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(996,824</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify">Total net assets identified</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">3,873,974</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Non-controlling interest</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,898,247</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; text-align: justify">Gain from a bargain purchase</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,032,327</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 4pt">Total consideration</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">943,400</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The business combination was executed in a context
of financial setbacks faced by the acquired company. To address these, in addition to the initial cash payment, Bioceres has committed
to providing a working capital loan of up to $3 million to help alleviate the financial strain.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Bioceres will also provide regulatory services
related to its proprietary technologies, which will enable strategic business development for Natal and create a new product pipeline
leveraging Bioceres&rsquo; technology. Specifically, Bioceres has agreed to grant Natal an exclusive license for certain technologies
to be applied to corn, with Natal committing to pay 15% of the revenues generated from this technology.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Since the issuance of the annual financial statements
for the period ending June 30, 2024, we have revisited the fair value of the services we committed to providing in exchange for payment
and have concluded in the identification and valuation of specific intangible assets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As required by the standards, measurement period
adjustments are incorporated into the business combination accounting. The effect of the adjustment corresponds to the identification
of an intangible asset for an amount of $0.8 million (net of deferred income tax liability and non-controlling interest of $0.5 million
and $0.8 million, respectively) and a change in the fair value of the consideration by $0.4 million, generating a bargain purchase gain
of $1.0 million as opposed to the $0.2 million goodwill recognized as of June 30, 2024. Comparative prior period information in the financial
statements has been updated to reflect these adjustments, as if the business combination had been fully accounted for on the acquisition
date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Non-controlling interest was measured at the present
ownership instruments&rsquo; proportionate share in the recognized amounts of the acquiree&rsquo;s identifiable net assets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>7. <U>INFORMATION
ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>7.1. <U>Cash
and cash equivalents</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">Cash at bank and on hand</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">19,488,145</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">24,973,048</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Mutual funds</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">13,206,934</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">19,500,222</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">32,695,079</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">44,473,270</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>7.2. <U>Other
financial assets</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify">Current</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">US Treasury bills</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">1,993,668</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Mutual funds</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">144,606</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,658,805</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Shares of Moolec Science S.A.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">976,425</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,530,375</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Other investments</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">919,007</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,512,680</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">2,040,038</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">11,695,528</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify">Non-current</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">Shares of Bioceres Group PLC.</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">444,473</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Other investments</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">58</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">190,080</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">58</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">634,553</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 16, 2025, Bioceres Group Limited (formerly
Bioceres Group PLC), Moolec Science SA (&ldquo;Moolec&rdquo;), and other companies completed a Business Combination, resulting in an expanded
corporate structure with Moolec as the parent company. As part of this transaction, the 57,600 shares we previously held in Bioceres Group
PLC were converted into Moolec shares at a conversion ratio of 0.315, net of taxes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Following the merger, Moolec&mdash;through its
stake in Bioceres Group Limited&mdash;initially acquired approximately 35% of our shares. However, as of September 18, 2025, Bioceres
Group Limited reported a reduced ownership interest of 14.9%.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>7.3. <U>Trade
receivables</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify">Current</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">Trade debtors</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">171,840,254</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">205,057,590</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Allowance for impairment of trade debtors</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(13,847,745</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(7,050,280</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Shareholders and other related parties (Note 17)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">122</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">141,224</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Allowance for credit notes to be issued</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(711,663</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,905,624</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Trade debtors - Joint ventures and associates (Note 17)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,179</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">782,142</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Deferred checks</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">8,574,786</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">11,295,922</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">165,859,933</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">207,320,974</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify">Non-current</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">Trade debtors</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">2,123,463</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Allowance for impairment of trade debtors</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(275,718</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Shareholders and other related parties (Note 17)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">249,579</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Trade debtors - Joint ventures and associates (Note 17)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">409,510</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">2,506,834</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The book value is reasonably approximate to the
fair value given its short-term nature.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Variations in the allowance for uncollectible
trade receivables are reported in Note 7.17.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>7.4. <U>Other
receivables</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify">Current</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">Taxes</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">8,884,305</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">5,019,659</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Shareholders and other related parties (Note 17)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">77,045</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Other receivables - Joint ventures and associates (Note 17)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">200,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">207,449</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Prepayments to suppliers</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,834,158</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,242,075</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Prepaid expenses and other receivables</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">251,590</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,594,152</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Miscellaneous</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">614,883</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,235,337</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">15,861,981</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">18,298,672</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: right; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: right; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify">Non-current</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">Taxes</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">576,538</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">752,045</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Shareholders and other related parties (Note 17)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,698,047</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Other receivables - Joint ventures and associates (Note 17)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18,947,793</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15,495,543</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Reimbursements over exports</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,204,269</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,461,038</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Loans receivables</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">230,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">230,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Miscellaneous</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">3,883</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">18,495</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">23,660,530</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">17,957,121</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In June 2024, we supplied Moolec Science SA (&ldquo;Moolec&rdquo;)
with an amount of HB4 soy equivalent to US$6.6 million, pursuant to a binding memorandum of understanding dated 15 October 2023. In September
2024, we subsequently entered into a HB4 Soy Supply Agreement and a note purchase agreement (the &ldquo;Note Purchase Agreement&rdquo;)
with Moolec and Moolec issued convertibles notes to us in an aggregate principal amount of $6.6 million (the &ldquo;Moolec Convertible
Notes&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Moolec Convertible Notes will mature 36 months
after and include a &ldquo;payment-in-kind&rdquo; feature. If the trading price of Moolec&rsquo;s ordinary shares exceeds the strike price
of $6.00 per ordinary share for 10 trading days, we have the option to exercise the early conversion option pursuant to which the principal
amount outstanding under the Moolec Convertible Notes may be converted into ordinary shares of Moolec at the strike price. At maturity,
Moolec has the option to convert the principal amount outstanding under the Moolec Convertible Notes into ordinary shares. In connection
with our early conversion option and Moolec&rsquo;s optional conversion at maturity, Moolec may deliver ordinary shares, cash, or a combination
of cash and ordinary shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>7.5. <U>Inventories</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">Seeds</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">5,317,730</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">5,967,231</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Resale products</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">42,228,777</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">53,788,333</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Manufactured products</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,648,705</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">26,081,250</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Goods in transit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,024,201</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,618,540</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Supplies</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19,286,246</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,546,093</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Agricultural products</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,612,064</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15,015,884</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Allowance for obsolescence</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(3,506,454</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(3,087,563</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">87,611,269</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">125,929,768</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 4pt">Net of agricultural products</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">82,999,205</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">110,913,884</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The roll-forward of allowance for obsolescence
is in Note 7.17. Inventories recognized as an expense during the years ended June 30, 2025, 2024 and 2023 amounted to $1,548, $0,587 and
$1.066 million, respectively. Those expenses were included in cost of sales.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>7.6. <U>Biological
assets</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Changes in Biological assets:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Soybean</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Corn</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Wheat</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Barley</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Sunflower</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; width: 28%; text-align: left">Beginning of the year</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">220,682</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">73,452</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; font-weight: bold; text-align: right">294,134</TD><TD STYLE="width: 1%; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Initial recognition and changes in the fair value of biological assets at the point of harvest</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">593,001</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">435,725</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">579,313</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">158,080</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,256</TD><TD STYLE="text-align: left">)</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">1,764,863</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Costs incurred during the year</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,959,381</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,814,249</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">444,303</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">162,342</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">55,063</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">4,435,338</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Decrease due to harvest/disposals</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,275,688</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,148,288</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,244,298</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(393,874</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(53,807</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(4,115,955</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 4pt">Year ended June 30, 2025</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,276,694</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,101,686</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">-</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">-</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">-</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">2,378,380</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Soybean</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Corn</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Wheat</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Barley</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Sunflower</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 28%; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Beginning of the year</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">87,785</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">59,057</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; font-weight: bold; text-align: right">146,842</TD><TD STYLE="width: 1%; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Initial recognition and changes in the fair value of biological assets at the point of harvest</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(352,199</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(32,674</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">231,526</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">106,605</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">996</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">(45,746</TD><TD STYLE="font-weight: bold; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Costs incurred during the year</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,423,732</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">792,235</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">220,679</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">73,452</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">137,680</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">2,647,778</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Decrease due to harvest/disposals</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,071,533</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(759,561</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(319,308</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(165,662</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(138,676</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(2,454,740</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in">Year ended June 30, 2024</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">-</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">-</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">220,682</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">73,452</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">-</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">294,134</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>7.7. <U>Property, plant and equipment</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: -0.5in; margin: 0pt 0 0pt 0.5in; text-align: justify">Property, plant and equipment as of
June 30, 2025 and 2024, included the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><B>Class</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>Net carrying amount 06/30/2024</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>Additions</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>Transfers</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>Disposals</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>Depreciation of the year</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>Foreign currency translation</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>Net carrying amount 06/30/2025</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 16%; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Office equipment</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">410,338</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">39,611</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">(4,791</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">(78,901</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">3,194</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">369,451</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Vehicles</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,200,349</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">35,915</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(17,239</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(882,264</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,023</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,337,784</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Equipment and computer software</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">507,469</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">65,953</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(323</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(256,198</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,862</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">331,763</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Fixtures and fittings</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,786,470</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,084</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">225,338</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(6,789</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(860,822</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,350</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,159,631</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Machinery and equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,710,328</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">563,352</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">122,653</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(143,947</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,891,448</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">80,931</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,441,869</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Land and buildings</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">39,677,902</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">348,085</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,021,176</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">71,315</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">39,076,126</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Buildings in progress</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">12,280,422</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">5,264,663</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(696,076</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">9,753</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">16,858,762</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in">Total</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">74,573,278</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">5,978,578</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(173,089</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(5,990,809</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">187,428</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">74,575,386</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left; border-bottom: Black 1.5pt solid"><B>Class</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>Net carrying amount 06/30/2023</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>Additions</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>Additions from business combination</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>Reclassification from Investment properties</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>Disposals</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>Depreciation of the year</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>Foreign currency translation</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>Net carrying amount 06/30/2024</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; width: 12%; text-align: left">Office equipment</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">263,892</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">235,900</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">2,242</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">&nbsp;-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">(77,639</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">(14,057</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 8%; text-align: right">410,338</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Vehicles</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,032,853</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">904,798</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">173,190</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,677</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(908,040</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(775</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,200,349</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Equipment and computer software</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">174,399</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">702,842</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">462</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(8,184</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(333,521</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(28,529</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">507,469</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Fixtures and fittings</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,862,949</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">703,027</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">28,672</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,295</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(812,810</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,663</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,786,470</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Machinery and equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,463,756</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,459,571</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,084</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(154,492</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,649,074</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(410,517</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,710,328</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Land and buildings</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">36,144,792</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,835,054</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,222,044</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">53,217</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(982,165</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(595,040</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">39,677,902</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Buildings in progress</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">11,911,194</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">72,480</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">610,926</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(106,421</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(207,757</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">12,280,422</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 4pt">Total</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">67,853,835</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">9,913,672</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">816,576</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">3,222,044</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(211,262</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(5,763,249</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(1,258,338</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">74,573,278</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The depreciation charge is included in Notes 8.3
and 8.4. The Group has no commitments to purchase property, plant and equipment items.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A detail of restricted assets is provided in Note
20.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Revaluation of property, plant and equipment</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group updates frequently their assessment
of the fair value of its land and buildings taking into account the most recent independent valuations and market data. Last valuations
were performed as of June 30, 2023. Management determined the property, plant and equipment&rsquo;s value within a range of reasonable
fair value estimates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All resulting fair value estimates for properties
are included in level 2 or 3 depending on the methodology used.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following are the carrying amounts that would
have been recognized if land and building were stated at cost.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid">Class of property</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">Land and buildings</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">28,304,611</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">27,876,636</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>7.8. <U>Intangible
assets</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Intangible assets as of June 30, 2025 and 2024
included the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><B>Class</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Net carrying amount 06/30/2024</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Additions</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Transfers/<BR>
    Disposals</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Amortization of the year</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Foreign currency translation</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Net carrying amount 06/30/2025</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1.5pt; font-weight: bold; font-style: italic; text-align: left"><U>Seed and integrated products</U></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; width: 28%; text-align: left">HB4 technology and breeding program&nbsp;&nbsp;(*)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">35,574,371</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">3,164,283</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">(2,274,483</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">36,464,171</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&nbsp;Integrated seed products (*)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,681,826</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(194,339</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">38,923</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,526,410</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-decoration: underline; font-weight: bold; font-style: italic; text-align: left">Crop nutrition</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Microbiological products</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">41,187,249</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">286,665</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,605,198</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,511,420</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,126</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">43,570,818</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Microbiological products in progress</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,452,861</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,163,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,706,661</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,909,700</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-decoration: underline; font-weight: bold; font-style: italic; text-align: left">Other intangible assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Trademarks and patents</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">48,028,369</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">158,557</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(122,305</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,080,753</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">43,983,868</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Trademarks and patents with indefinite useful lives</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,922,989</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">122,305</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,045,294</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Software</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,827,983</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,222</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">146,839</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(676,995</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(102</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,313,947</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Software in progress</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">580,728</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">176,064</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(146,839</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">609,953</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Customer loyalty</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">21,636,760</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,368,659</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,268,101</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">RG/RS/OX Wheat in progress</TD><TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">5,000,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">6,528,899</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,048,082</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">10,480,817</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 4pt">Total</TD><TD STYLE="border-bottom: Black 4pt double">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">176,893,136</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">15,494,190</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(101,463</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="border-bottom: Black 4pt double">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(11,154,731</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="border-bottom: Black 4pt double">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">41,947</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">181,173,079</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(*)</FONT></TD><TD STYLE="text-align: justify">Intangible assets with definite useful lives included in the
Bioceres Crops CGU were tested for impairment following events or changes in circumstances indicating that their carrying amount may
not be recoverable. The triggering event was a change in the business model for HB4, shifting toward expanding and reinforcing the standard
licensing-based commercial model. The impairment test concluded that the estimated recoverable amount of the Bioceres Crops CGU exceeded
its carrying amount. For further details, see Note 7.9.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><B>Class</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>Net carrying amount 06/30/2023</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>Additions</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>Additions from business combination</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>Transfers</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>Amortization of the year</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>Foreign currency translation</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>Net carrying amount 06/30/2024</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1.5pt; font-weight: bold; font-style: italic; text-align: left"><U>Seed and integrated products</U></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 16%; text-align: left; text-indent: -0.125in; padding-left: 0.125in">HB4 technology and breeding program</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">31,679,681</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">5,986,682</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">(2,091,992</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">35,574,371</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Integrated seed products</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,841,008</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(191,559</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">32,377</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,681,826</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; font-style: italic; text-decoration: underline; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Crop nutrition</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Microbiological products</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">37,295,460</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,610,115</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,718,326</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">41,187,249</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Microbiological products in progress</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,213,341</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,869,084</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(7,610,115</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(19,449</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,452,861</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; font-style: italic; text-decoration: underline; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Other intangible assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Trademarks and patents</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">51,933,444</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">44,073</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">122,305</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,071,453</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">48,028,369</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Trademarks and patents with indefinite useful lives</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,827,309</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,095,680</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,922,989</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Software</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,638,519</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">585,313</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">276,128</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(670,514</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,463</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,827,983</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Software in progress</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">349,171</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">507,685</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(276,128</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">580,728</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Customer loyalty</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23,006,023</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,369,263</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">21,636,760</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">RG/RS/OX Wheat in progress</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">5,000,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">5,000,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in">Total</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">173,783,956</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">12,992,837</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">2,217,985</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(12,113,107</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">11,465</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">176,893,136</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">T<FONT STYLE="font-size: 10pt">he amortization
charge is included in Notes 8.3 and 8.4.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are no intangibles assets whose use has
been restricted or which have been delivered as a guarantee. The Group has not assumed any commitments to acquire new intangibles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There is an inherent material uncertainty related
to management&rsquo;s estimation of the ability of the Group to recover the carrying amounts of internally generated intangible assets,
because it is dependent upon Group`s ability to raise sufficient funds to complete the projects development, the future outcome of the
regulatory process, and the timing and amount of the future cash flows generated by the projects, among other future events.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management&rsquo;s estimations about the demonstrability
of the recognition criteria for these assets and the subsequent recoverability represent the best estimate that can be made based on all
the available evidence, existing facts and circumstances and using reasonable and supportable assumptions in cash flow projections. Therefore,
the Consolidated financial statements do not include any adjustments that would result if the Group were unable to recover the carrying
amount of the above-mentioned assets through the generation of enough future economic benefits.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group is required to perform an annual impairment
test for non-depreciating assets, either because they are not available for use, have indefinite useful lives, or for other intangible
assets when events or changes in circumstances indicate that their carrying amount may not be recoverable. The recoverable amount is determined
based on calculations of value in use. This method requires estimating future cash flows and determining a discount rate to calculate
the present value of those cash flows.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management has made the estimates considering
the cash flow projections projected by the management. All key assumptions values reflect past experience or, if appropriate, are consistent
with external sources of information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 3pt; width: 18%; border: black 1pt solid"><B>Key assumption</B></TD>
    <TD STYLE="padding: 3pt; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 82%; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Management&rsquo;s approach</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: middle; padding: 3pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: left"><FONT STYLE="font-size: 10pt">Discount rate</FONT></TD>
    <TD STYLE="padding: 3pt; text-align: justify; border-right: black 1pt solid; border-bottom: black 1pt solid">The discount rate applied was either 16.39% or 11.56%, depending on the target market. <BR>
<BR>
The weighted average cost of capital (WACC) was estimated using the market capital structure plus 2% of risk premium which reflect the higher risk associated with intangible assets. <BR>
<BR>
For the cost of equity, the discount rate is estimated based on the Capital Asset Pricing Model (CAPM).</TD></TR>
  <TR>
    <TD STYLE="vertical-align: middle; padding: 3pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: left"><FONT STYLE="font-size: 10pt">Market share, product prices and royalties.</FONT></TD>
    <TD STYLE="padding: 3pt; text-align: justify; border-right: black 1pt solid; border-bottom: black 1pt solid">The projected revenue from the products and services of the CGUs has been estimated by the management based on market penetration data for comparable products and technologies and on future expectations of foreseen economic and market conditions. <BR>
<BR>
The prices and royalties estimated in the revenue projections are based on current and projected market prices for the products and services of the CGUs.</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A projection horizon longer than five years was
adopted, as the GGUs are linked to biological products that require extended development and regulatory approval timelines across multiple
target countries. Due to the nature of these products and the maturity level of the markets involved, a longer time frame is essential
to reasonably capture the expected cash flows and the time needed to reach commercial readiness and registration milestones. Projected
range period used: 8-18 years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management estimates that any reasonably possible
change in any of these key assumptions would not cause the aggregate carrying amount of the CGU to exceed its recoverable amount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>7.9. <U>Goodwill</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">Rizobacter Argentina S.A.</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">28,080,271</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">28,080,271</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Bioceres Crops S.A.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,523,322</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,523,322</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Pro farm Group, Inc.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">76,089,749</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">76,089,749</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Insumos Agroqu&iacute;micos S.A.</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">470,090</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">470,090</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">112,163,432</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">112,163,432</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group is required to test whether goodwill
has suffered any impairment on an annual basis. The recoverable amount is determined based on value in use calculations. The use of this
method requires the estimation of future cash flows and the determination of a discount rate in order to calculate the present value of
the cash flows.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There is an inherent material uncertainty related
to management&rsquo;s estimation of the ability of the Group to recover the carrying amounts of goodwill, because it is dependent upon
Group`s ability to raise sufficient funds to complete the projects development, the future outcome of the regulatory process, and the
timing and amount of the future cash flows generated by the projects, among other future events.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Rizobacter CGU. This CGU is composed of all revenues
collected through Rizobacter from the production and sale of proprietary and third-party products, both in the domestic and international
markets. Additionally, Rizobacter generates revenue from the formulation, fragmentation and resale of third-party products.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Bioceres Crops CGU. This CGU is composed of the
expected revenues from the commercialization of intensive R&amp;D products associated to HB4.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Insuagro CGU. This CGU is composed of all revenues
collected through Insuagro from the production and sale of proprietary and third-party products in the domestic markets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pro Farm CGU. This CGU is composed of all revenues
collected through Pro Farm from the production and sale of proprietary and third-party products, both in the domestic and international
markets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management has made the estimates considering
the cash flow projections projected by the management and third-party valuation reports on the assets, intangible assets and liabilities
assumed. All key assumptions values reflect past experience or, if appropriate, are consistent with external sources of information. The
key assumptions utilized are the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 3pt; width: 18%; border: Black 1pt solid"><B>Key assumption</B></TD>
    <TD STYLE="padding: 3pt; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 82%; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Management&rsquo;s approach</B></FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 3pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-size: 10pt">Discount rate</FONT></TD>
    <TD STYLE="padding: 3pt; text-align: justify; border-right: Black 1pt solid; border-bottom: Black 1pt solid">The discount rate used ranges was 14.11 % for Rizobacter UGE and for Bioceres Crops UGE, and 9.28 % for Pro Farm UGE due to the target market. <BR>
<BR>
The weighted average cost of capital (&ldquo;WACC&rdquo;) rate has been estimated based on the market capital structure. <BR>
<BR>
For the cost of equity, the discount rate is estimated based on the Capital Asset Pricing Model (CAPM).</TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; padding: 3pt; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: left"><FONT STYLE="font-size: 10pt">Market share, product prices and royalties.</FONT></TD>
    <TD STYLE="padding: 3pt; text-align: justify; border-right: Black 1pt solid; border-bottom: Black 1pt solid">The projected revenue from the products and services of the CGUs has been estimated by the management based on market penetration data for comparable products and technologies and on future expectations of foreseen economic and market conditions. <BR>
<BR>
The prices (Rizobacter CGU and Pro Farm CGU) and royalties (Bioceres Crops CGU) estimated in the revenue projections are based on current and projected market prices for the products and services of the CGUs.</TD></TR>
  <TR>
    <TD STYLE="padding: 3pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: justify"><FONT STYLE="font-size: 10pt">Terminal value</FONT></TD>
    <TD STYLE="padding: 3pt; text-align: justify; border-right: Black 1pt solid; border-bottom: Black 1pt solid">Rizobacter CGU and Bioceres Crops CGU: The growth rate used to extrapolate the future cash flow projections to terminal period is 2%. <BR>
<BR>
Pro Farm CGU: EBITDA multiple (10x)</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 39; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The period used for projection was 5 years, except
those GGUs that are linked to biological products that require extended development and regulatory approval timelines across multiple
target countries. Due to the nature of these products and the maturity level of the markets involved, a longer time frame is essential
to reasonably capture the expected cash flows and the time needed to reach commercial readiness and registration milestones. Projected
range period used: 8-18 years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Rizobacter CGU: </I>If, as of June 30, 2025,
the market share used in the value-in-use calculation for Rizobacter&rsquo;s CGU had been 5% lower, the post-tax discount rate applied
to the cash flow projections had been 2% higher, and the terminal growth rate had been 0.5% lower than management&rsquo;s estimates, the
Group would have been required to recognize an impairment loss of $24.7 million against the carrying amount of goodwill.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Bioceres Crops CGU: </I>had the market share
used in the value-in-use calculation as of June 30, 2025 been 5% lower, and the post-tax discount rate 2% higher than management&rsquo;s
estimates, the Group would have been required to recognize an impairment loss of $3.5 million against the carrying amount of goodwill.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Pro Farm CGU: </I>If the market share used
in the value-in-use calculation for Pro Farm&rsquo;s CGU had been 5% lower, and the post-tax discount rate applied to the cash flow projections
had been 1% higher than management&rsquo;s estimates as of June 30, 2025, the Group would have recognized an impairment loss of $34.4
million against the carrying amount of goodwill.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>7.10. <U>Investment
properties</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify; padding-bottom: 1.5pt">Investment properties</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">570,324</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">560,783</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">570,324</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">560,783</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The book value of the investment property does
not differ significantly from its fair value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 40; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<!-- Field: Split-Segment; Name: 1 -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <B>7.11.</B> <B><U>Trade and other payables</U></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">Trade creditors</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">87,073,151</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">108,307,192</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Shareholders and other related parties (Note 17)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">286,172</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">37,985</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Trade creditors - Parent company (Note 17)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">878,874</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">729,171</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Trade creditors - Joint ventures and associates (Note 17)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,625,406</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">52,888,732</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Taxes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,283,856</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,647,550</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Miscellaneous</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,285,145</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,121,839</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">96,432,604</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">168,732,469</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify">Non-current</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Trade creditors</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,785,300</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Trade creditors - Joint ventures and associates (Note 17)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">43,696,426</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">48,481,726</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The trade and other payables include debts with
grain producers. These debts represent payment obligations contracted by purchase contracts, which give the producer the right to set
the price at any time between the delivery date and a future date. Those debts that are not fixed at closing are valued at their fair
value and debts with a price set by the producer at their amortized cost.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <B>7.12.</B> <B><U>Borrowings</U></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify">Current</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">Bank borrowings</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">93,752,214</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">91,816,134</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Corporate bonds</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,265,276</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">42,035,925</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Trust debt securities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">710,636</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,895,139</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">119,728,126</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">136,747,198</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify">Non-current</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Bank borrowings</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,271,490</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15,316,612</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Corporate bonds</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,926,536</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,071,823</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Trust debt securities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,716,447</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">38,198,026</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">42,104,882</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group has a pre-approved financing program
authorized by the Argentine National Securities Commission (Comisi&oacute;n Nacional de Valores &ndash; CNV), which allows for the issuance
of public corporate bonds for up to $200 million. As of June 30, 2025, the Group had utilized $51 million under this program, with $149
million remaining available for future use. The facility remains fully discretionary and may be utilized as needed by the Group.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In January 2025, we completed a $20 million financing
agreement with Co&ouml;peratieve Rabobank U.A. (&ldquo;Rabobank&rdquo;) The capital will be repaid in seven semi-annual installments between
June 15, 2026, and June 15, 2029. The annual interest rate is Term SOFR plus a margin ranging from 5.15% to 6.15%, with interest payable
semi-annually at the end of each interest period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a result of market conditions described in
Note 2, our performance indicators were affected, leading us to exceed the thresholds established in Rabobank&rsquo;s agreement for both
the Net Financial Debt to EBITDA ratio and the Current Liquidity ratio. However, on September 5, 2025, we reached a waiver and amendment
agreement under which Rabobank agreed to waive the breach of these ratios for the fiscal year ended June 30, 2025. Nevertheless, since
the waiver was granted after the closing date of these financial statements, we are unable to demonstrate, as of June 30, 2025, an unconditional
right to defer settlement of the liability for at least twelve months. Accordingly, we have reclassified the loan as a current liability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 41; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition to the waiver, the amendment sets
forth the following key financial provisions that our subsidiary, Rizobacter, is required to comply with: (i) new progressive limits for
the Net Financial Debt to EBITDA ratio, starting at 6.00x as of September 30, 2025, and gradually decreasing to 2.75x by September 30,
2027; (ii) a maximum gross financial debt cap, ranging between USD 105 million and USD 130 million on a quarterly basis; (iii) a restriction
on granting new intercompany loans (financial or commercial) that exceed the amounts in effect at the time of signing the agreement, unless
funds are provided by the parent company; and (iv) for the fiscal years ending in June 2026 and 2027, capital investments will be limited
to maintenance purposes only.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The carrying value of some borrowings as of June
30, 2025 are measured at amortized cost differ from their fair value. The following fair values measured are based on discounted cash
flows (Level 3) due to the use of unobservable inputs, including own credit risk.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amortized&nbsp;cost</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fair value</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amortized&nbsp;cost</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fair value</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify">Current</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: justify">Bank borrowings</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">93,752,214</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">83,183,234</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">91,816,134</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">89,874,010</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Corporate Bonds</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,265,276</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,529,823</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">42,035,925</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">41,492,963</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify">Non-current</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Bank borrowings</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,271,490</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,402,501</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15,316,612</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,850,783</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Corporate Bonds</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,926,536</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18,732,545</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,071,823</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23,845,583</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <B>7.13.</B> <B><U>Secured Notes</U></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Secured Guaranteed Notes</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Secured Guaranteed Notes due 2026 bore interest
at 9.0% from the issue date through 24 months after the issue date, 13.0% from 25 through 36 months after the issue date, and 14.0% from
37 through 48 months after the issue date. Interest was payable semi-annually.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 18, 2025, we entered into an amendment
to the Secured Guaranteed Notes pursuant to which the aggregate principal amount increases from $26,437,485 to $29,081,233, with an annual
interest rate of 19%, of which 14% is payable in cash and 5% in kind. The Company is required to make scheduled amortization payments
of $1,000,000 on the last business day of each calendar month and may only be repurchased in full. Had the Company repurchased it on or
before August 5, 2025, a 5% &ldquo;Prepayment Premium&rdquo; penalty would have applied. If the repurchase occurred after that date, the
penalty increased to 10%. The Prepayment Premium also applied to payments made following acceleration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Secured Guaranteed Notes due 2026 had no conversion
rights into our ordinary shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The carrying value the Secured Guaranteed Notes
as of June 30, 2025, are measured at amortized cost. Its fair value does not differ significantly from the carrying amount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 42; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Secured Convertible Guaranteed Notes </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Secured Guaranteed Convertible Notes were
issued for a total principal amount of $55 million. The notes had a 4-year maturity and accrued interest at an annual rate of 9%, of which
5% was payable in cash and 4% in-kind. Up to maturity, the note holders could opt to convert the outstanding principal amount into common
shares of Bioceres at a strike price of $18 per share. The Company had the option to repurchase the notes voluntarily 30 months after
the issue date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 18, 2025, we entered into an amendment
to the Secured Convertible Guaranteed Notes pursuant to which the aggregate principal amount increases from $61,652,927 to $67,868,227,
and the maturity date is extended to August 31, 2027. The notes carry an annual interest rate of 15%, of which 5% is payable in cash and
10% in kind. Noteholders have now the option to convert the outstanding principal amount of their Convertible Notes into common shares
of the Company at a reduced strike price of $6 per share. If the Company raises more than $10,000,000 in common equity, the strike price
resets to the lesser of (1) the then-applicable strike price or (2) the price per share at which the new shares are issued (or the weighted
average price per share, if issued at varying prices). The Company may voluntarily repurchase the Convertible Notes; however, it must
pay either a &ldquo;Prepayment Premium Fee&rdquo; or an &ldquo;Equity Option Fee.&rdquo; If the repurchase occurs on or before August
31, 2025, a 5% prepayment penalty applies. If the repurchase had occurred on or before August 31, 2025, a 5% prepayment penalty would
have applied. If repurchased between September 1 and prior to October 1, 2025, the penalty would have increased to 7%. For repurchases
on or after October 1, 2025, the applicable fee would be the full Equity Option Fee. Additionally, either the Prepayment Premium Fee or
the Equity Option Fee will apply in the event of payments made following acceleration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In accordance with the terms of the amendments,
certain members of the Board of Directors were nominated by the noteholders of the Secured Convertible Guaranteed Notes. For as long as
the Notes remain outstanding, they will have the right to nominate members to the Board of Directors. Accordingly, as of June 30, 2025,
the outstanding balance is reported as amounts payable to related parties (see Note 17). Subsequently, both directors nominated by the
noteholders resigned from the Company&rsquo;s Board in connection with the delivery of a reservation of rights letter sent by Jasper Lake
through its legal counsel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The carrying value the Secured Guaranteed Notes
as of June 30, 2025, are measured at amortized cost. Its fair value does not differ significantly from the carrying amount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Furthermore, the Group&rsquo;s financial covenants
in both Secured Notes are being amended to reset the Consolidated Total Net Leverage Ratio and Interest Coverage Ratio to the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Consolidated Total Net Leverage Ratio</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Fiscal Quarters ended March 31, 2025 and June
30, 2025: 5.00x</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Fiscal Quarters ended September 30, 2025 and December
31, 2025: 4.33x</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Fiscal Quarters ended March 31, 2026 through the
Maturity Date: 3.75x</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Interest Coverage Ratio</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Fiscal Quarter ended March 31, 2025 and June 30,
2025: 1.50x</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Fiscal Quarters ended September 30, 2025 and December
31, 2025: 1.75x</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Fiscal Quarters ended March 31, 2026 through the
Maturity Date: 2.00x</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Although the financial covenants of the Notes
were amended to reflect the market conditions described in Note 2, as of the end of this fiscal year, the updated ratios in the amendment
have been exceeded. This is mainly due to profitability falling short of expectations, as well as the recognition of exceptional charges
arising in response to the aforementioned market conditions&mdash;such as employee severance payments, higher bad debt expenses and inventory
obsolescence primary due to our shift in our seed business strategy, among others. As of the date of issuance of this financial statement,
the Company has not received any acceleration notice. However, as of June 30, 2025, we were unable to demonstrate an unconditional right
to defer settlement of the liability for at least twelve months. Accordingly, the liability was reclassified as current for this reporting
period, and a total of $4.8 million was accrued as a Prepayment Premium Fee, see Note 8.6, as described above. Discussions with the holders
of the Convertible Notes are ongoing, and the Company is actively evaluating potential solutions to address this matter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 43; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <B>7.14.</B> <B><U>Employee benefits and social security</U></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: justify">Salaries, accrued incentives, vacations&nbsp;and social security</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">6,108,130</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">7,192,492</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: justify; padding-bottom: 1.5pt">Key management personnel (Note 17)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">65,882</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">148,466</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">6,174,012</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">7,340,958</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <B>7.15.</B> <B><U>Deferred revenue and advances from customers</U></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify">Current</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">Advances from customers</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">4,282,668</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">3,335,740</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Deferred revenue</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">587,400</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">4,282,668</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">3,923,140</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Non-current</B></P></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Advances from customers</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">52,511</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Deferred revenue</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,436,912</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,872,627</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">1,436,912</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">1,925,138</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <B>7.16.</B> <B><U>Provisions</U></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify; padding-bottom: 1.5pt">Provisions for contingencies</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">1,267,572</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">1,255,702</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">1,267,572</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">1,255,702</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group has recognized a provision for probable
administrative, judicial, and out-of-court proceedings that may arise in the ordinary course of business. This provision is based on a
prudent approach, informed by professional legal advice and Management&rsquo;s best estimate of the amount of these claims. These claims
are not expected to have a material impact on the Group&rsquo;s operating results, cash flows, or financial position.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are no expected reimbursements related to
the provisions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The roll forward of the provision is in Note 7.17.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In order to assess the need for provisions and
disclosures in its consolidated financial statements, Management considers the following factors: (i) nature of the claim and potential
level of damages in the jurisdiction in which the claim has been brought; (ii) the progress of the eventual case; (iii) the opinions or
views of tax and legal advisers; (iv) experience in similar cases; and (v) any decision of the Group`s management as to how it will respond
to the eventual claim.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Due to the lack of precedent in similar cases,
Management believes there is insufficient objective evidence to reliably determine the timing of any potential cash outflows. Nevertheless,
the provision has been classified under current or non-current liabilities, applying a prudent criterion based on Management&rsquo;s judgment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 44; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <B>7.17.</B> <B><U>Changes in allowances and provisions</U></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><B>Item</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>06/30/2024</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Additions</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Uses and<BR>
 reversals</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Currency<BR>
 conversion<BR>
 difference</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>06/30/2025</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify">DEDUCTED FROM ASSETS</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; text-align: justify">Allowance for impairment of trade debtors</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">(7,050,280</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">(7,123,716</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">50,533</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">(14,123,463</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Allowance for obsolescence</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(3,087,563</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,547,723</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,158,036</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(29,204</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(3,506,454</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Total deducted from assets</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(10,137,843</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(8,671,439</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,158,036</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">21,329</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(17,629,917</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify">INCLUDED IN LIABILITIES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Provisions for contingencies</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,255,702</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(335,773</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">309,793</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">14,110</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,267,572</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Total included in liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,255,702</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(335,773</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">309,793</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">14,110</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,267,572</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 4pt">Total</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(11,393,545</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(9,007,212</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,467,829</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">35,439</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(18,897,489</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><B>Item</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>06/30/2023</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Additions</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Additions<BR>
 from<BR>
 business<BR>
 combination</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Uses and<BR>
 reversals</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Currency<BR>
 conversion<BR>
 difference</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>06/30/2024</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify">DEDUCTED FROM ASSETS</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 28%; text-align: justify">Allowance for impairment of trade debtors</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">(7,425,604</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">(753,428</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">777,558</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">351,194</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">(7,050,280</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Allowance for obsolescence</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(2,492,499</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(586,515</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">69,582</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(78,131</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(3,087,563</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Total deducted from assets</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(9,918,103</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,339,943</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">847,140</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">273,063</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(10,137,843</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify">INCLUDED IN LIABILITIES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Provisions for contingencies</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(891,769</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(367,126</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(355,898</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">393,073</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(33,982</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,255,702</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Total included in liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(891,769</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(367,126</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(355,898</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">393,073</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(33,982</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,255,702</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 4pt">Total</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(10,809,872</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(1,707,069</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(355,898</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,240,213</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">239,081</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(11,393,545</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD></TR>
  </TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 45; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <B>8.</B> <B><U>INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</U></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <B>8.1.</B> <B><U>Revenue from contracts with customers</U></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: justify">Sale of goods and services</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">318,498,299</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">443,554,101</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">385,295,414</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Royalties</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,414,864</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">986,602</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,247,567</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Right of use licenses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">13,430,824</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">20,287,845</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">32,903,458</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">333,343,987</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">464,828,548</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">419,446,439</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Transactions of sales of goods and services with
joint ventures and with shareholders and other related parties are reported in Note 17.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <B>8.2.</B> <B><U>Cost of sales</U></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify"><B>Item</B></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold; text-align: center">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold; text-align: center">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold; text-align: center">06/30/2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: justify">Inventories as of the beginning of the year</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">110,913,884</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">111,990,145</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">78,759,610</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Business combination</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,031,412</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,182,602</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Purchases of the year</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">149,950,181</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">249,648,267</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">233,471,036</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Production costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,177,920</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">24,672,636</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23,227,844</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Foreign currency translation</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">382,092</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,206,764</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">806,106</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Subtotal</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">286,424,077</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">389,135,696</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">347,447,198</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Inventories as of the end of the year (*)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(82,999,205</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(110,913,884</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(111,990,145</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 4pt">Cost of sales</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">203,424,872</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">278,221,812</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">235,457,053</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left">(*)</TD><TD STYLE="text-align: justify">Net of agricultural products.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 46; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <B>8.3.</B> <B><U>R&amp;D classified by nature</U></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><B>Item</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Research and development expenses 06/30/2025</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Research and development expenses 06/30/2024</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>Research and development expenses 06/30/2023</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: justify">Amortization of intangible assets</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">5,079,962</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">5,923,389</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">4,804,768</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Analysis and storage</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,302</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">52,660</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Commissions and royalties</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,179</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,257</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Import and export expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">855</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Depreciation of property, plant and equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">767,731</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">618,627</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">577,785</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Freight and haulage</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,025</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">30,450</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17,429</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Employee benefits and social securities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,032,386</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,727,340</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,530,533</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Maintenance</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">253,581</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">314,721</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">452,449</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Energy and fuel</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,576</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,101</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">111,481</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Supplies and materials</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,589,371</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,256,748</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,924,994</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Mobility and travel</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">141,271</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">205,572</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">243,865</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Share-based incentives</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">217,494</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">510,162</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">136,754</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Publicity and advertising</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23,383</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Professional fees and outsourced services</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,328,301</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,265,765</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">660,887</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Professional fees related parties</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">90,533</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">256,877</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">542,551</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Office supplies</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">247,425</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">688,969</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">93,623</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Information technology expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">40,286</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">29,013</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">31,356</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Insurance</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">49,343</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">48,872</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">78,673</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Depreciation of leased assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">54,505</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">68,321</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Miscellaneous</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">853</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">269,750</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">74</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 4pt">Total</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">14,914,822</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">17,183,041</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">15,345,315</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2023</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: justify">R&amp;D capitalized (Note 7.8)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">8,614,448</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">11,855,766</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">10,753,047</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">R&amp;D profit and loss</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">14,914,822</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">17,183,041</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">15,345,315</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 4pt">Total</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">23,529,270</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">29,038,807</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">26,098,362</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 47; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <B>8.4.</B> <B><U>Expenses classified by nature and function</U></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><B>Item</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Production costs</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Selling, general and administrative expenses</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Total 06/30/2025</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: justify">Amortization of intangible assets</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">351,240</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">5,723,529</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">6,074,769</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Analysis and storage</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,744</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,744</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Commissions and royalties</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">835,082</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,989,880</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,824,962</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Import and export expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">826,942</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">826,942</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Depreciation of property, plant and equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,861,812</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,361,266</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,223,078</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Depreciation of leased assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,477,334</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,504,864</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,982,198</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Impairment of receivables</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,123,716</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,123,716</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Freight and haulage</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,003,986</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,367,204</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,371,190</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Employee benefits and social securities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,899,884</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">43,439,612</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">53,339,496</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Maintenance</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,640,232</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,793,293</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,433,525</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Energy and fuel</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">658,621</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">106,846</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">765,467</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Supplies and materials</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">586,696</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,678,691</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,265,387</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Mobility and travel</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">113,676</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,775,315</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,888,991</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Publicity and advertising</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,509,183</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,509,183</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Contingencies</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">84,567</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">251,206</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">335,773</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Share-based incentives</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">315,965</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,853,229</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,169,194</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Professional fees and outsourced services</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,199,979</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,142,925</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,342,904</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Professional fees related parties</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,102</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,102</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Office supplies and registrations fees</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">93,967</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,232,477</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,326,444</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Insurance</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">181,595</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,846,208</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,027,803</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Information technology expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">39,583</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,931,502</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,971,085</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Obsolescence</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,547,723</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,547,723</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Taxes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">260,091</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,271,870</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,531,961</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Miscellaneous</TD><TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">25,887</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">367,968</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">393,855</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Total</TD><TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">25,177,920</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">123,113,572</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">148,291,492</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 48; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><B>Item</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Production costs</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Selling, general and administrative expenses</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Total 06/30/2024</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: justify">Amortization of intangible assets</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">239,545</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">5,950,173</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">6,189,718</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Analysis and storage</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">598</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">160,133</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">160,731</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Commissions and royalties</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">217,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,745,169</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,962,169</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Import and export expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">147,392</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">734,026</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">881,418</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Depreciation of property, plant and equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,018,014</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,126,608</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,144,622</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Depreciation of leased assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,312,849</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,106,107</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,418,956</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Impairment of receivables</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">753,428</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">753,428</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Freight and haulage</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">927,910</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,831,050</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,758,960</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Employee benefits and social securities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,015,691</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">38,253,407</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">48,269,098</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Maintenance</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,134,116</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,558,352</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,692,468</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Energy and fuel</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">997,066</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">514,422</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,511,488</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Supplies and materials</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,031,386</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,520,386</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,551,772</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Mobility and travel</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">143,046</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,250,764</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,393,810</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Publicity and advertising</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">233</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,985,955</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,986,188</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Contingencies</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">66,682</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">300,444</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">367,126</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Share-based incentives</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,111,919</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,512,804</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,624,723</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Professional fees and outsourced services</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,960,315</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,759,807</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,720,122</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Professional fees related parties</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">225,950</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">225,950</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Office supplies and registrations fees</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">242,790</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,601,554</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,844,344</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Insurance</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">199,109</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,117,158</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,316,267</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Information technology expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">35,526</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,692,227</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,727,753</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Obsolescence</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">581,804</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,711</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">586,515</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Taxes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">285,791</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,184,503</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,470,294</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Miscellaneous</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">3,854</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">801,772</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">805,626</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 4pt">Total</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">24,672,636</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">123,690,910</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">148,363,546</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 49; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><B>Item</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Production costs</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Selling, general and administrative expenses</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Total 06/30/2023</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><B>&nbsp;</B></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: justify">Amortization of intangible assets</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">173,032</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">6,013,633</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">6,186,665</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Analysis and storage</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,496</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">700,671</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">705,167</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Commissions and royalties</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">127,771</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,396,750</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,524,521</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Import and export expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">150,402</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">794,561</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">944,963</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Depreciation of property, plant and equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,161,236</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,094,253</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,255,489</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Depreciation of leased assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">468,524</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,029,049</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,497,573</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Impairment of receivables</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,327,385</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,327,385</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Freight and haulage</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,427,296</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,645,962</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,073,258</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Employee benefits and social securities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,973,301</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">38,030,033</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">48,003,334</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Maintenance</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,195,111</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,067,672</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,262,783</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Energy and fuel</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">967,412</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">397,305</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,364,717</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Supplies and materials</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,075,319</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,047,720</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,123,039</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Mobility and travel</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">90,848</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,140,153</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,231,001</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Publicity and advertising</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,528</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,668,569</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,671,097</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Contingencies</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">221,008</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">221,008</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Share-based incentives</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,278,354</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,278,354</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Professional fees and outsourced services</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,629,567</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,498,757</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,128,324</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Professional fees related parties</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">277,137</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">277,137</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Office supplies and registrations fees</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">229,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">833,430</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,062,930</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Insurance</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">230,388</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,006,387</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,236,775</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Information technology expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,556</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,087,945</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,099,501</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Obsolescence</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,012,788</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">53,989</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,066,777</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Taxes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">255,227</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,533,391</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,788,618</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Miscellaneous</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">41,542</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">858,633</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">900,175</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 4pt">Total</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">23,227,844</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">113,002,747</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">136,230,591</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <B>8.5.</B> <B><U>Other income or expenses, net</U></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: justify">Net result from commercialization of agricultural products</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">(1,890,110</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">(3,560,703</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">174,122</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Expenses recovery</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,808</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">336,815</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">79,274</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Result of intangible sales</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,751,311</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Gain from a bargain purchase (Note 6)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,032,327</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Others</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">907,961</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">693,006</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">831,496</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">6,775,970</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(1,498,555</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">1,084,892</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 28, 2025, we agree to transfer all rights,
licenses, and materials containing or pertaining to the Soy ANF trait and pay $750,000 to a Arcadia Biosciences Inc in exchange for (i)
RG and OX Wheat Patents and RS exclusive rights; (ii) the cancellation of all Royalty Payments, which included 25% of the Net Wheat Technology
Licensing Revenues and 6% of the Net HB4 Soybean Revenues up to $10 million; and (iii) the release from any Performance Benchmark Obligations
related to the RG, OX, and RS Varieties which amounted to $8.1 million. This transaction resulted in the accounting of a gain from the
exchange of intangible assets amounting to $7.5 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 50; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <B>8.6.</B> <B><U>Finance results</U></B></P>



<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-decoration: underline; text-align: justify">Financial costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: justify">Interest expenses with the Parent (Note 17)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">(45,852</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">(462,575</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Interest expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(25,629,885</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(24,078,901</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(20,767,168</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Financial commissions</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(3,208,933</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(2,746,945</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(2,558,342</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(28,838,818</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(26,871,698</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(23,788,085</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-decoration: underline; text-align: justify">Other financial results</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Exchange differences generated by assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(11,137,132</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(15,750,105</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(20,410,188</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Exchange differences generated by liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,083,222</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19,166,100</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,890,789</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Changes in fair value of financial assets or liabilities and other financial results</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(14,982,282</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(13,026,967</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,209,036</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Prepayment premium fee</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,870,021</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Net gain of inflation effect on monetary items</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">409,356</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,697,345</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">438,502</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(26,496,857</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(7,913,627</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(11,289,933</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <B>9.</B> <B><U>TAXATION</U></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The balances of income tax and minimum presumed
income tax recoverable and payable are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify">Current assets</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify; padding-bottom: 1.5pt">Income tax</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">1,864,817</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">655,691</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">1,864,817</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">655,691</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify">Non-current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Income tax</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">17,995</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">10,889</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">17,995</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">10,889</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify">Liabilities</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify; padding-bottom: 1.5pt">Income tax</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">452,800</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">4,825,271</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">452,800</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">4,825,271</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The roll forward of net deferred tax as of June
30, 2025 and 2024 is as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">Beginning of the period deferred tax</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">(25,296,931</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">(28,472,383</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Additions for business combination</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(996,824</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Charge for the period</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">134,770</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,115,586</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Conversion difference</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(43,779</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(943,310</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 4pt">Total net deferred tax</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(25,205,940</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(25,296,931</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 51; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The roll forward of deferred tax assets and liabilities
as of June 30, 2025 and 2024 are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Balance<BR> &nbsp;06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Income tax<BR> provision</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Conversion<BR> difference</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Balance<BR> 30/06/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: justify"><U>Deferred tax assets</U></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: justify">Tax Loss-Carry Forward</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">21,582,404</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">31,609</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">(88,088</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">21,525,925</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Changes in fair value of financial assets or liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">875</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(211</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">664</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Trade receivables</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">437,352</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">572,129</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(362</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,009,119</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Allowances</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">447,526</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">463,297</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,729</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">917,552</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Royalties</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">764,891</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(18,311</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,189</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">744,391</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Others</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,750,935</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(2,201,952</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(63,039</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">485,944</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Total deferred tax assets</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">25,983,983</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(1,153,228</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(147,160</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">24,683,595</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>




<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance<BR>
    &nbsp;06/30/2024</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
    tax<BR>
    provision</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversion<BR>
    difference</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance<BR>
    30/06/2025</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Deferred
    tax liabilities</U></FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(28,312,803)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">62,914</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41,870</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(28,208,019)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 52%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property, plant
    and equipment depreciation</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14,609,276</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(703,042</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,410</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(15,314,728</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inflation tax adjustment</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(162,915</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">70,804</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">65,303</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(26,808</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7,560,403</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,429,429</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,130,974</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Others financial assets</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(460,306</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">436,364</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(23,942</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right-of-use leased asset</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(190,086</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,505</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,382</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(180,963</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Others</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,875</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(18,976</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,101</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    deferred tax liabilities</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(51,280,914</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,287,998</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">103,381</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(49,889,535</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    deferred tax</FONT></TD><TD STYLE="padding-bottom: 4pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(25,296,931</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding-bottom: 4pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">134,770</FONT></TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 4pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(43,779</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding-bottom: 4pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(25,205,940</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1.5pt; font-weight: bold; text-align: justify">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Balance<BR>
&nbsp;06/30/2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Additions<BR>
 for business<BR>
 combination</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Income tax<BR>
 provision</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Conversion<BR>
 difference</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Balance<BR>
 30/06/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: justify"><U>Deferred tax assets</U></TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; width: 40%; text-align: justify">Tax Loss-Carry Forward</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">16,701,783</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">5,655,758</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">(775,137</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">21,582,404</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Changes in fair value of financial assets or liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,107</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,232</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">875</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: justify">Trade receivables</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">354,741</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">212,688</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(130,077</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">437,352</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: justify">Allowances</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">796,606</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(297,513</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(51,567</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">447,526</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: justify">Royalties</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">723,083</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">48,310</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(6,502</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">764,891</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: justify; padding-bottom: 1.5pt">Others</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">4,210,435</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">765,384</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(2,094,736</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(130,148</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,750,935</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Total deferred tax assets</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">22,789,755</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">765,384</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,524,507</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(1,095,663</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">25,983,983</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 52; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: justify">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Balance<BR> &nbsp;06/30/2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Additions<BR> for business<BR> combination</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Income tax<BR> provision</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Conversion<BR> difference</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Balance<BR> 30/06/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify"><U>Deferred tax liabilities</U></TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; text-align: justify">Intangible assets</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">(28,798,967</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">(495,346</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">867,747</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">113,763</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">(28,312,803</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Property, plant and equipment depreciation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(13,620,151</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(211,136</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(784,369</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,380</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(14,609,276</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Inflation tax adjustment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(566,759</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">386,486</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17,358</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(162,915</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Inventories</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(5,979,778</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(940,231</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(640,394</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(7,560,403</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Others financial assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,150,406</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,690,100</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(460,306</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Right-of-use leased asset</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(120,440</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(115,495</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">30,997</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,852</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(190,086</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Others</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(25,637</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">40,512</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">14,875</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Total deferred tax liabilities</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(51,262,138</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(1,762,208</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,591,079</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">152,353</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(51,280,914</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 4pt">Net deferred tax</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(28,472,383</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(996,824</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">5,115,586</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(943,310</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(25,296,931</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Principal statutory taxes rates in the countries
where the Group operates for all of the years presented are:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: right; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: justify">Current tax expense</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">(1,408,386</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">(8,894,201</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">(1,311,505</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Deferred tax</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">134,770</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">5,115,586</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,380,157</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 4pt">Total</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(1,273,616</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(3,778,615</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,068,652</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The tax on the Group&rsquo;s profit before tax
differs from the theoretical amount that would arise using the weighted average tax rate applicable to profits of the consolidated entities
as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: justify; padding-bottom: 1.5pt">Earning before income tax-rate</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(57,571,637</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">11,067,598</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">19,105,947</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Income tax expense by applying tax rate in force in the respective countries</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,417,515</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,532,953</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,331,544</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Share of profit or loss of subsidiaries, joint ventures and associates</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(294,638</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,371,636</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">241,301</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Stock options charge</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(167,601</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,351,831</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(558,026</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Non-deductible expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,027,734</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,468,643</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(371,316</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Tax inflation adjustment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,211,529</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,788,533</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,920,895</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Result of inflation effect on monetary items and other finance results</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,391,617</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(8,999,710</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(8,120,822</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Derecognition of tax loss carryforwards</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(10,935,018</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Others</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,086,052</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">414,353</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">625,076</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 4pt">Income tax expenses</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(1,273,616</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(3,778,615</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,068,652</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Derecognition of tax loss carryforwards totaling
$10.9 million across BCS Holding Inc. ($2.4M), RASA Holding LLC ($1.5M), Bioceres Crops S.A. ($0.4M), Bioceres Semillas ($4.5M), and Bioceres
Crops do Brasil Ltda. ($2.2M), primarily due to a shift in the HB4 program&rsquo;s business model affecting the allocation of taxable
profits.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 53; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The income tax expense was calculated by applying
the tax rate in force in the respective countries, as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">June 30, 2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify">Tax jurisdiction</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Earnings&nbsp;before<BR>
 income tax-rate</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weight&nbsp;average<BR>
 applicable tax&nbsp;rate</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Income tax</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: justify">Low or null taxation jurisdictions</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">(9,187,121</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">0.0</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Profit-making entities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Loss-making entities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(48,384,516</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">27.8</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">13,417,515</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(57,571,637</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">13,417,515</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">June 30, 2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify">Tax jurisdiction</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Earnings&nbsp;before<BR>
 income tax-rate</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weight&nbsp;average<BR>
 applicable tax&nbsp;rate</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Income tax</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: justify">Low or null taxation jurisdictions</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">10,464,257</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">0.0</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Profit-making entities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">30,435,214</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">34.7</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(10,560,379</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Loss-making entities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(29,831,873</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">26.9</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">8,027,426</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">11,067,598</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(2,532,953</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">June 30, 2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify">Tax jurisdiction</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Earnings&nbsp;before<BR>
 income tax-rate</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weight&nbsp;average<BR>
 applicable tax&nbsp;rate</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Income tax</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: justify">Low or null taxation jurisdictions</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">29,696,082</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">0.0</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Profit-making entities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,484,562</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">34.1</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,577,918</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Loss-making entities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(21,074,697</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">23.3</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">4,909,462</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">19,105,947</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,331,544</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The charge for income tax charged directly to
profit or loss and the amount and expiry date of carry forward tax losses as of June 30, 2025 are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify"><B>Tax jurisdiction</B></TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Tax-Loss&nbsp;Carry<BR> forward</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Tax-Loss&nbsp;Carry<BR> forward&nbsp;applying<BR> tax rate in force<BR> in the respective<BR> countries</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Expiration</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: justify">United States of America</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right">69,459,595</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right">14,586,515</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right">-</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Brazil</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">13,624,448</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">4,632,313</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">-</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Argentina</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">213,252</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">53,313</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">2029</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Argentina</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">6,467,278</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">2,033,203</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">2030</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">France</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">882,319</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">220,581</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: right">-</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 4pt">Total</TD>
    <TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">90,646,892</TD>
    <TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD>
    <TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">21,525,925</TD>
    <TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt; text-align: right">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The amount of tax losses for the fiscal year ended
on June 30, 2025 is an estimate of the amount to be presented in the tax return. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 54; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">There is an inherent
material uncertainty related to management</FONT>&rsquo;<FONT STYLE="font-size: 10pt">s estimation of the ability of the Group to use
the deferred tax assets (both carryforward of unused tax losses and deductible temporary differences) and the credit of minimum presumed
income tax because their future utilization depends on the generation of enough future taxable income by the entities within the Group
during the periods in which those temporary differences are deductible or when the unused tax losses can be used. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">Based on the projections
of future taxable income for the periods in which the deferred tax assets are deductible, the Group</FONT>&rsquo;<FONT STYLE="font-size: 10pt">s
management estimates that, except for the part of deferred tax asset that were unrecognized (tax loss carry forward for USD 10,9 million
as of June 30, 2025), it is probable that the entities within the Group can utilize those deferred tax assets, which depends, among other
factors, on the success of the current projects of agricultural biotechnology, the future market price of commodities and the market share
of the entities within the Group. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The estimates of management about the demonstrability
of the recognition criteria for these deferred tax assets and their subsequent recoverability represent the best estimate that can be
made based on all the available evidence, existing facts and circumstances and the use of reasonable and supportable assumptions in the
projections of future taxable income. Therefore, the Consolidated financial statements do not include adjustments that could result if
the entities within the Group would not be able to recover the deferred tax assets through the generation of enough future taxable income.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <B>10.</B> <B><U>EARNING PER SHARE</U></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: justify">Numerator</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: justify">Profit/(Loss) for the year (basic EPS)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">(55,416,054</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">4,275,688</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">18,779,876</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: justify">Profit/(Loss) for the year (diluted EPS)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(55,416,054</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,275,688</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18,779,876</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: justify">Denominator</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: justify">Weighted average number of shares (basic EPS)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">63,228,240</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">62,840,129</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">62,146,082</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: justify">Weighted average number of shares (diluted EPS)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">63,228,240</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">63,485,432</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">63,185,508</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: justify">Basic profit/(loss) attributable to ordinary equity holders of the parent</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(0.8764</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.0680</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.3022</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: justify">Diluted profit/(loss) attributable to ordinary equity holders of the parent</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(0.8764</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.0673</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.2972</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the year ended June 30, 2025, diluted earnings
per share have not been presented, as the Group reported a net loss and the inclusion of potential dilutive shares would have resulted
in an anti-dilutive effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the year ended June 30, 2024 and 2023, diluted
earnings per share was calculated by adjusting the weighted average number of shares outstanding to assume conversion of all dilutive
potential shares. The Group had two categories of dilutive potential shares, share-based incentives and convertible notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The stock options were included in the diluted
EPS calculation for the year ended June 30, 2024 and 2023 only for the tranches in which the average market price of ordinary shares during
the periods was higher than the assumed proceeds per option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Convertible notes outstanding were not included
in the diluted EPS calculations for the year ended June 30, 2024 and 2023 because the interest (net of tax and other changes in income
or expense) per ordinary share obtainable on conversion exceeds basic earnings per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <B>11.</B> <B><U>INFORMATION ABOUT COMPONENTS OF EQUITY</U></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Capital issued</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of June 30, 2025, we had, (i) 100,000,000 ordinary
shares ($0.0001 par value) authorized, (ii) 63,228,239 ordinary shares issued and outstanding, (iii) 1,000,000 preference shares ($0.0001
par value) authorized, (iv) no preference shares issued and outstanding, (v) 3,402,744 ordinary shares reserved for our equity compensation
plans. Of the total issued shares, we have repurchased 2,402,692 shares of our own.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Holders of the ordinary shares are entitled to
one vote for each ordinary share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 55; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Convertible notes</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Convertibles notes were classified as compound
instruments, a non-derivative financial instrument that contains both a liability and an equity component. The equity consideration was
included in the &ldquo;Convertible instruments&rdquo; column. See Note 7.13.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Non-controlling interests</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The subsidiaries whose non-controlling interest
is significant as of June 30, 2025 and 2024 is:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid"><B>Name</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>06/30/2025</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>06/30/2024</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left">Rizobacter Argentina S.A.</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">20</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">20</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Insumos Agroquimicos S.A.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">38.68</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">38.68</TD><TD STYLE="text-align: left">%</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Below is a detail of the summarized financial
information of Rizobacter and Insuagro, prepared in accordance with IFRS, and modified due to fair value adjustments at the acquisition
date and differences in accounting policies. The information is presented prior to eliminations between that subsidiary and other Group
companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Rizobacter</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Summary financial statements:</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U></U></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">Current assets</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">198,279,028</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">345,561,483</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Non-current assets</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">197,805,099</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">98,157,355</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 4pt">Total assets</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">396,084,127</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">443,718,838</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Current liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">182,516,237</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">258,332,709</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Non-current liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">121,291,077</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">69,831,217</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 4pt">Total liabilities</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">303,807,314</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">328,163,926</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Equity attributable to controlling interest</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">92,276,497</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">115,554,674</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Equity attributable to non-controlling interest</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">316</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">238</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 4pt">Total equity</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">92,276,813</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">115,554,912</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 4pt">Total liabilities and equity</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">396,084,127</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">443,718,838</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 56; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Summary statements of comprehensive income
or loss</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: justify">Revenues</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">197,827,605</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">303,870,411</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">288,880,411</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: justify">Initial recognition and changes in the fair value of biological assets at the point of harvest</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">26,388</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,468,693</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,199,885</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: justify; padding-bottom: 1.5pt">Cost of sales</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(123,358,412</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(194,869,433</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(178,970,954</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: justify">Gross margin</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">74,495,581</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">106,532,285</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">106,709,572</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: justify">Research and development expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,123,919</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,341,318</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,851,144</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: justify">Selling, general and administrative expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(64,711,783</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(65,215,877</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(68,580,834</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: justify">Share of profit or loss of joint ventures and associates</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,807,263</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">716,168</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">222,364</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: justify; padding-bottom: 1.5pt">Other income</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(759,008</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(947,068</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">361,639</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: justify">Operating profit</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">4,093,608</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">37,744,190</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">34,861,597</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: justify; padding-bottom: 1.5pt">Financial results</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(14,078,506</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(14,275,961</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(25,356,667</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: justify; padding-bottom: 4pt">Profit before taxes</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(9,984,898</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">23,468,229</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">9,504,930</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: justify; padding-bottom: 1.5pt">Income tax expense</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,145,775</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(8,216,712</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(3,064,006</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: justify; padding-bottom: 4pt">Result for the year</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(8,839,123</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">15,251,517</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">6,440,924</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; font-style: italic; text-align: justify">Foreign exchange differences on translation of foreign operations</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(517,387</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,495,976</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,075,805</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; font-style: italic; text-align: justify; padding-bottom: 1.5pt">Revaluation of property, plant and equipment, net of tax</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,435,739</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; font-style: italic; text-align: justify; padding-bottom: 4pt">Total comprehensive result</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(9,356,510</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">13,755,541</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">6,080,990</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There were no dividends paid to Rizobacter non-controlling
interest (NCI) in the years ended June 30, 2025, 2024 and 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Insuagro</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Summary financial statements: </U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">Current assets</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">44,995,363</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">48,088,212</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Non-current assets</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">4,982,874</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">5,253,148</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 4pt">Total assets</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">49,978,237</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">53,341,360</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Current liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">43,934,269</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">45,049,873</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Non-current liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">98,071</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">293,858</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Total liabilities</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">44,032,340</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">45,343,731</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Total equity</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">5,945,897</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">7,997,629</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 4pt">Total liabilities and equity</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">49,978,237</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">53,341,360</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 57; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Summary statements of comprehensive income
or loss</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: justify">Revenues</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">40,926,498</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">57,959,538</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">55,710,643</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Cost of sales</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(31,554,081</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(44,575,216</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(42,765,656</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify">Gross margin</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">9,372,417</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">13,384,322</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">12,944,987</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Selling, general and administrative expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(9,517,827</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(9,360,140</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(7,931,425</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Other income or expenses, net</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">16,314</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(9,723</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">9,833</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify">Operating profit</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">(129,096</TD><TD STYLE="font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">4,014,459</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">5,023,395</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Financial results</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(3,055,433</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(3,223,411</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(2,403,656</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 4pt">Profit/(loss) before tax</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(3,184,529</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">791,048</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">2,619,739</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Income tax</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,319,072</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(85,586</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,053,372</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 4pt">Profit/(loss) for the year</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(1,865,457</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">705,462</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,566,367</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-style: italic; text-align: justify">Exchange differences on translation of foreign operations</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-style: italic; text-align: justify; padding-bottom: 1.5pt">Revaluation of property, plant and equipment, net of tax</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(31,610</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-style: italic; text-align: justify; padding-bottom: 4pt">Total comprehensive result</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(1,865,457</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">705,462</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,534,757</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <B>12.</B> <B><U>CASH FLOW INFORMATION</U></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Significant non-cash transactions related to investing
and financing activities are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify">Investment activities</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: justify">Net assets acquisition by business combination</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">905,892</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">152,070,313</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Exchange of intangible assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,528,899</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Investment in-kind in other related parties (Note 17)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,343,549</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,409,244</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,163,384</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Capitalization of interest on buildings in progress</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">336,416</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">124,098</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">74,710</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Reclasification from Investment properties to property, plant and equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,589,749</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Sale of Moolec Science S.A. equity investment (Note 13)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(900,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(133,079</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">11,208,864</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">2,539,234</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">156,765,077</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify">Financing activities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: justify">Assignment of receivables with shareholders and other related parties</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">(7,886,442</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Compensation payment financed by acquisition of intangible assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,781,507</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Capitalization of convertible notes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,211,638</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Purchase of own shares</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(24,025,718</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(9,667,949</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(11,814,080</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group has incorporated the assets and liabilities
from Natal Agro S.R.L. mentioned in Note 6 and Pro Farm Group for year ended June 30, 2024 and 2023, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 58; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Disclosure of changes in liabilities arising from
financing activities:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="14" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Financing activities</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Borrowings</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Consideration for acquisition</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Convertible notes</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: justify; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">As of June 30, 2022</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">145,478,637</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">12,902,790</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">12,559,071</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">170,940,498</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; text-indent: -0.125in; padding-left: 0.125in">Proceeds</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">24,817,888</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">55,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">79,817,888</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; text-indent: -0.125in; padding-left: 0.125in">Payments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(13,596,339</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,148,617</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(16,744,956</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; text-indent: -0.125in; padding-left: 0.125in">Interest payment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(12,873,219</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(5,173,742</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(18,046,961</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; text-indent: -0.125in; padding-left: 0.125in">Conversion of convertible notes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(9,109,516</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(9,109,516</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Exchange differences, currency translation differences and other financial results</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">24,483,638</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(4,760,917</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">21,937,333</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">41,660,054</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in">As of June 30, 2023</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">168,310,605</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">4,993,256</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">75,213,146</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">248,517,007</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="14" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Financing activities</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Borrowings</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Consideration for acquisition</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Convertible notes</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: justify; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">As of June 30, 2023</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">168,310,605</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">4,993,256</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">75,213,146</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">248,517,007</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; text-indent: -0.125in; padding-left: 0.125in">Proceeds</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">135,818,247</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">135,818,247</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; text-indent: -0.125in; padding-left: 0.125in">Payments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(109,702,266</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,912,171</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(112,614,437</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; text-indent: -0.125in; padding-left: 0.125in">Financing for assets acquisitions</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">743,279</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">727,985</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,471,264</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; text-indent: -0.125in; padding-left: 0.125in">Interest payment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(20,552,108</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,172,328</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(24,724,436</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Exchange differences, currency translation differences and other financial results</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">4,234,323</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">4,117,445</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">9,768,868</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">18,120,636</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in">As of June 30, 2024</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">178,852,080</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">6,926,515</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">80,809,686</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">266,588,281</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="14" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Financing activities</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Borrowings</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Consideration for acquisition</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Convertible notes</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: justify; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">As of June 30, 2024</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">178,852,080</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">6,926,515</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">80,809,686</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">266,588,281</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; text-indent: -0.125in; padding-left: 0.125in">Proceeds</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">266,390,032</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">266,390,032</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; text-indent: -0.125in; padding-left: 0.125in">Payments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(285,418,914</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,035,388</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,000,000</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(288,454,302</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; text-indent: -0.125in; padding-left: 0.125in">Interest payment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(12,616,737</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(6,315,826</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(18,932,563</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; text-indent: -0.125in; padding-left: 0.125in">Non-cash activities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(6,797,045</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,870,904</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(9,667,949</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; text-indent: -0.125in; padding-left: 0.125in">Prepayment Premium Fee</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,870,021</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,870,021</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Exchange differences, currency translation differences and other financial results</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">17,516,736</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">138,825</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">23,906,564</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">41,562,125</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in">As of June 30, 2025</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">157,926,152</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">2,159,048</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">102,270,445</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">262,355,645</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 59; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <B>13.</B> <B><U>JOINT VENTURES AND ASSOCIATES</U></B></P>



<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: justify"><U>Assets</U></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">Synertech Industrias S.A.</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">39,334,762</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">39,749,851</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Alfalfa Technologies S.R.L.</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">36,502</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">36,502</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">39,371,264</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">39,786,353</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: justify"><U>Liabilities</U></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify; padding-bottom: 1.5pt">Trigall Genetics S.A.(i)</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">1,007,678</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">296,455</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">1,007,678</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">296,455</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">(i)&nbsp;The
investment in Trigall has a negative balance because the company intends to make additional contributions or cover the losses of the investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Changes in joint ventures investments and affiliates:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">As of the beginning of the year</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">39,489,898</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">38,673,987</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Share-based incentives</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">65,470</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Sale of equity investment -&nbsp;Moolec Science S.A.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(900,000</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Reclassification of Moolec Sciense S.A.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,398,829</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Foreign currency translation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(238</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Share of profit or loss</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,126,312</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">4,049,508</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 4pt">As of the end of the year</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">38,363,586</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">39,489,898</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Moolec Science S.A. ownership was reclassified
as a marked-to-market asset (NASDAQ:MLEC). As of June 30, 2025, we own 155,364 ordinary shares, representing less than 5% of the company&rsquo;s
equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Share of profit or loss of joint ventures and
affiliates:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: justify">Trigall Genetics S.A.</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">(711,223</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">326,368</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">103,703</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Synertech Industrias S.A.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(415,089</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,723,140</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">564,598</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Moolec Science S.A.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">467,714</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Indrasa Biotecnolog&iacute;a S.A.</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">62,613</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(1,126,312</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">4,049,508</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">1,198,628</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are no significant restrictions on the ability
of the joint ventures and affiliates to transfer funds to the Group for cash dividends, or to repay loans or advances made by the Group,
except for the Argentinian legal obligation to establish a legal reserve for 5% of the profit for the year until reaching 20% of the capital
for Argentinian entities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 60; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Summarized financial information prepared in accordance
with International Financial Reporting Standards (&ldquo;IFRS&rdquo;) in relation to the joint ventures is presented below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Trigall Genetics</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify"><B>Summarized balance sheet</B></TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: justify"><U>Current assets</U></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">Cash and cash equivalents</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">331,201</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">450,687</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Other current assets</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">5,278,565</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">6,429,065</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify">Total current assets</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">5,609,766</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">6,879,752</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-decoration: underline; font-weight: bold; text-align: justify">Non-current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Intangible assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19,019,926</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17,122,954</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Investments in joint ventures and associates</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">3,935,124</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">3,623,325</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify">Total non-current assets</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">22,955,050</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">20,746,279</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-decoration: underline; font-weight: bold; text-align: justify">Current liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Other current liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,677,894</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,832,719</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify">Total current liabilities</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">1,677,894</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">1,832,719</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-decoration: underline; font-weight: bold; text-align: justify">Non-current liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Financial liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">24,363,613</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,318,949</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Other non- current liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,229,668</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">653,604</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Total non-current liabilities</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">25,593,281</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">22,972,553</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify">Net assets</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">1,293,641</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">2,820,759</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="10" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Trigall Genetics</B></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><B>&nbsp;</B></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><B>Summarized balance sheet</B></TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2023</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: justify">Revenue</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">1,910,914</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">2,525,061</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">2,010,229</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Finance income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19,011</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Finance expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(580,115</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(24,435</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(718,388</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Depreciation and amortization</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(507,860</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(507,860</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(507,860</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Profit of the year</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(61,964</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">674,059</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">207,410</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Other comprehensive income</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(17,156</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Total comprehensive income</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(61,964</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">674,059</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">190,254</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Synertech</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Summarized balance sheet</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: justify"><U>Current assets</U></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">Cash and cash equivalents</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">1,346,714</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">3,086</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Other current assets</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">9,081,341</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">55,960,505</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify">Total current assets</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">10,428,055</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">55,963,591</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-decoration: underline; font-weight: bold; text-align: justify">Non-current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Property, plan and equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,065,936</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,195,394</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Other non- current assets</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">43,632,401</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify">Total non-current assets</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">53,698,337</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">11,195,394</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-decoration: underline; font-weight: bold; text-align: justify">Current liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Financial liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">21,927,582</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19,015,285</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Other current liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">6,667,724</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">8,595,232</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify">Total current liabilities</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">28,595,306</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">27,610,517</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-decoration: underline; font-weight: bold; text-align: justify">Non-current liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Financial liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Other non- current liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,246,318</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">3,447,008</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Total non-current liabilities</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,246,318</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,447,008</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify">Net assets</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">34,284,768</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">36,101,460</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 61; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="10" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Synertech</B></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><B>Summarized statements of comprehensive income</B></TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2023</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>

<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: justify">Revenue</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">24,430,024</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">61,815,678</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">62,798,136</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Finance income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,467,883</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,608,329</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">633,741</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Finance expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(5,136,285</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(7,385,027</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(6,768,810</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Depreciation and amortization</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,543,069</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,554,452</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(2,032,809</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">(Loss)/Profit of the year</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,816,693</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">7,236,901</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">3,980,995</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Other comprehensive (loss)/income</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(369,259</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Total comprehensive (loss)/income</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,816,693</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">7,236,901</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">3,611,736</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>14.&nbsp;<U>SEGMENT
INFORMATION</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group is organized into three main operating
segments:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Seed and integrated products</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The seed and integrated products segment focuses
mainly on the development and commercialization of seed technologies and products that increase yield per hectare, with a focus on the
provision of seed technologies integrated with crop protection and crop nutrition products designed to control weeds, insects or diseases,
to increase their quality characteristics, to improve nutritional value and other benefits. The segment focuses on the commercialization
of integrated products that combine three complementary components biotechnological events, germplasm and seed treatments&mdash;in order
to increase crop productivity and create value for customers. While each component can increase yield independently, through an integrated
technology strategy the segment offers products that complement and integrate with each other to generate higher yields in crops.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Currently the segment generates revenue from ordinary
activities through the sale of seeds, integrated product packs, royalties and licenses charged to third parties, among others.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Crop protection</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The crop protection segment mainly includes the
development, production and marketing of high-tech adjuvants and a full range of pest control molecules and biocontrol products. Adjuvants
are used in mixtures to facilitate the application and effectiveness of active ingredients, such as insecticides, leading to better performance,
reduced usage rates and lower residue levels Insecticides and fungicides are applied to control pests and significantly reduce disease
during the germination period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The segment currently generates revenue from ordinary
activities through the sale of adjuvants, insecticides, fungicides and baits, among others.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 62; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Crop nutrition</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The crop nutrition segment focuses mainly on the
development, production and commercialization of inoculants that allow the biological fixation of nitrogen in the crops, and of fertilizers
including biofertilizers and microgranulated fertilizers that optimize the productivity and yield of the crops.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Currently the segment generates income from ordinary
activities through the sale of inoculants, bio-inductors, biological fertilizers and microgranulated fertilizers, among others.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The measurement principles for the Group&rsquo;s
segment reporting structure are based on the IFRS principles adopted in the Consolidated financial statements. Revenue generated by products
and services exchanged between segments and entities within the Group are calculated based on market prices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following tables present information with
respect to the Group&acute;s reporting segments:&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: left">Year ended June 30, 2025</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Seed and integrated products</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Crop protection</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Crop nutrition</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Consolidated</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="vertical-align: top; font-weight: bold; text-align: left">Revenues from contracts with customers</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; width: 52%; text-align: left">Sale of goods and services</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">60,535,026</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">181,908,584</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">76,054,689</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">318,498,299</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">Royalties</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,414,864</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,414,864</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">Right of use licenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,430,824</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,430,824</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; font-weight: bold; text-align: left">Others</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Initial recognition and changes in the fair value of biological assets at the point of harvest</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,764,863</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,764,863</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">63,714,753</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">181,908,584</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">89,485,513</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">335,108,850</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Cost of sales</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(44,727,989</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(111,888,640</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(46,808,243</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(203,424,872</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Gross profit per segment</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">18,986,764</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">70,019,944</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">42,677,270</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">131,683,978</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; font-weight: bold; text-align: left">% Gross margin</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">30</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">38</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">48</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">39</TD><TD STYLE="text-align: left">%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify">Year ended June 30, 2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Seed and integrated products</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Crop protection</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Crop nutrition</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Consolidated</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify">Revenues from contracts with customers</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: justify">Sale of goods and services</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">94,457,404</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">223,538,317</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">125,558,380</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">443,554,101</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Royalties</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">986,602</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">986,602</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Right of use licenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19,287,845</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,287,845</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify">Others</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: justify; padding-bottom: 1.5pt">Initial recognition and changes in the fair value of biological assets at the point of harvest</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(45,746</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(45,746</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Total</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">96,398,260</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">223,538,317</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">144,846,225</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">464,782,802</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Cost of sales</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(66,306,974</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(143,807,301</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(68,107,537</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(278,221,812</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Gross profit per segment</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">30,091,286</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">79,731,016</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">76,738,688</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">186,560,990</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify">% Gross margin</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">31</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">36</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">53</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">40</TD><TD STYLE="text-align: left">%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 63; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify">Year ended June 30, 2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Seed and integrated products</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Crop protection</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Crop nutrition</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Consolidated</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify">Revenues from contracts with customers</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: justify">Sale of goods and services</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">55,360,397</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">205,685,451</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">124,249,566</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">385,295,414</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Royalties</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,247,567</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,247,567</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Right of use licenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">32,903,458</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">32,903,458</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify">Others</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: justify; padding-bottom: 1.5pt">Initial recognition and changes in the fair value of biological assets at the point of harvest</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">319,428</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">153,460</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">137,666</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">610,554</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Total</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">56,927,392</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">205,838,911</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">157,290,690</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">420,056,993</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Cost of sales</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(31,012,687</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(137,529,299</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(66,915,067</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(235,457,053</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Gross profit per segment</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">25,914,705</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">68,309,612</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">90,375,623</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">184,599,940</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify">% Gross margin</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">46</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">33</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">57</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">44</TD><TD STYLE="text-align: left">%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of the current period, changes in the net realizable
value of agricultural products after harvest have been excluded from segment information since those results depend on market fluctuations
which are beyond the Group&rsquo;s operating control. The Group has recast the comparative figures accordingly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Revenue by similar group of products or
services</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-decoration: underline; width: 64%; font-weight: bold; font-style: italic; text-align: justify; padding-bottom: 1.5pt">Seed and integrated products</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">61,949,890</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">96,444,006</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">56,607,964</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Seed Treatments Packs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">28,476,396</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">30,037,798</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">32,469,652</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Seeds &amp; HB4 Program</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">33,473,494</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">66,406,208</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">24,138,312</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-decoration: underline; font-weight: bold; font-style: italic; text-align: justify; padding-bottom: 1.5pt">Crop protection</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">181,908,584</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">223,538,317</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">205,685,451</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Adjuvants</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">56,028,937</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">56,634,128</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">52,978,705</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Seed CP Products and Services</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">28,890,840</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">34,877,911</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">26,080,587</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Other CP Products and Services</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">62,983,430</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">106,720,670</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">94,123,984</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Bioprotection</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">34,005,377</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,305,608</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">32,502,175</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-decoration: underline; font-weight: bold; font-style: italic; text-align: justify; padding-bottom: 1.5pt">Crop nutrition</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">89,485,513</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">144,846,225</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">157,153,024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Inoculants &amp; Biofertilizers</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,445,093</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">21,943,468</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23,621,534</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Micro-beaded Fertilizers</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">56,461,771</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">88,158,727</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">90,827,714</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Biostimulants</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,578,649</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19,084,400</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,800,318</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; text-align: justify">Syngenta up-front fee</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">15,659,630</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">32,903,458</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-decoration: underline; font-weight: bold; text-align: justify; padding-bottom: 4pt">Total revenues</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">333,343,987</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">464,828,548</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">419,446,439</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 64; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Geographical information</U></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: justify">Argentina</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">231,552,406</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">346,794,376</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">288,228,267</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Brazil</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17,673,809</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">24,175,116</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23,690,028</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">LATAM</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23,900,621</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">21,952,339</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">21,044,547</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">North America</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">30,107,865</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">27,370,220</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">30,372,912</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">EMEA</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,920,550</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">21,320,535</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,014,855</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">ROW</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">22,188,736</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">23,215,962</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">34,095,830</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 4pt">Total revenues</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">333,343,987</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">464,828,548</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">419,446,439</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid">Non-current assets</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">Argentina</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">142,743,386</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">139,245,596</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Brazil</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,448,724</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,698,175</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">LATAM</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">856,329</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,162,654</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">North America</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">185,817,356</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">189,199,549</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">EMEA</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">537,302</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">44,141</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">ROW</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">30,508,800</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">26,279,731</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify">Total non-current assets</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">367,911,897</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">363,629,846</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Property, plant and equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">74,575,386</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">74,573,278</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Intangible assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">181,173,079</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">176,893,136</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Goodwill</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">112,163,432</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">112,163,432</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify">Total reportable assets</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">367,911,897</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">363,629,846</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Total non-reportable assets</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">395,733,183</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">488,918,348</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 4pt">Total assets</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">763,645,080</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">852,548,194</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of the current period, geographical information
is reported by main countries and regions. LATAM refers to Latin America countries, excluding Argentina and Brazil which are reported
separately. North America includes United States of America and Canada. The EMEA region covers Europe, the Middle East and Africa. The
Group has recast the comparative figures accordingly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>15.&nbsp;<U>FINANCIAL
INSTRUMENTS &ndash; RISK MANAGEMENT</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group is exposed to a variety of financial
risks that arise from its activities and from its use of financial instruments. This Note provides information on the Group&rsquo;s exposure
to certain main risks, the Group&rsquo;s objectives, policies and processes regarding the measurement and management of each risk.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group does not use derivative financial instruments
to hedge any of the above risks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>General objectives, policies and processes</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board of Directors has overall responsibility
for establishing and monitoring the Group&rsquo;s risk management objectives and policies and, whilst retaining ultimate responsibility
for them, it has delegated the function to design and operate processes that ensure the effective implementation of the objectives and
policies to the management that periodically reports to the Board of Directors on the evolution of the risk management activities and
results. The overall objective of the Board of Directors is to set policies that seek to reduce risk as much as possible without unduly
affecting the Group&rsquo;s competitiveness and flexibility.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 65; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group&rsquo;s risk management policy is established
to identify and analyze the risks facing the Group, to set appropriate risk limits and controls and to monitor risks and adherence to
limits. The risks and methods for managing the risks are reviewed regularly in order to reflect changes in market conditions and the Group&rsquo;s
activities. The Group, through training and management standards and procedures, aims to develop a disciplined and constructive control
environment in which all the employees understand their roles and obligations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group seeks to use suitable means of financing
to minimize the Group&rsquo;s capital costs and to manage and control the Group&rsquo;s financial risks effectively. There have been no
substantive changes in the Group&rsquo;s exposure to financial instrument risks, its objectives, policies and processes for managing those
risks or the methods used to measure them from previous periods unless otherwise stated in this Note.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group adopted a code of ethics applicable
to its principal executive, financial and accounting officers and all employees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The principal risks and uncertainties facing the
business, set out below, do not appear in any particular order of potential materiality or probability of occurrence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Credit risk</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Credit risk is the risk of financial loss to the
Group if a customer or counterparty fails to meet its contractual obligations, which derives mainly from trade and other receivables,
as well as from cash and deposits in financial institutions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The credit risk to which the Group is exposed
is mainly defined in the Group&rsquo;s accounts receivable followed by cash and cash equivalents, with the logical importance of being
able to satisfy the Group&rsquo;s needs in the short term.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Trade and other receivables</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Credit risk is the risk of financial loss to the
Group if a customer or counterparty fails to meet its contractual obligations and derives mainly from trade receivables and other receivables
generated by services and product sales. The Group is also exposed to political and economic risk events, which may cause nonpayment of
local and foreign currency obligations to the Group owed by customers, partners, contractors and suppliers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group sells its products to a diverse base
of customers. Customers include multi-national and local agricultural companies, distributors, and farmers who purchase the Group&rsquo;s
products. Type and class of customers may differ depending on the Group&rsquo;s business segments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group&rsquo;s management determines concentrations
of credit risk by periodically monitoring the credit worthiness rating of existing customers and through a monthly review of the trade
receivables&rsquo; aging analysis. In monitoring the customers&rsquo; credit risk, customers are grouped according to their credit characteristics.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group&rsquo;s policy is to manage credit exposure
to counterparties through a process of credit rating. The Group performs credit evaluations of existing and new customers, and every new
customer is examined thoroughly regarding the quality of its credit before offering the customer transaction terms. The examination made
by the Group includes outside credit rating information, if available. Additionally, and even if there is no independent outside rating,
the Group assesses the credit quality of the customer taking into account its financial position, past experience, bank references and
other factors. A credit limit is prescribed for each customer. These limits are examined periodically. Customers that do not meet the
Group&rsquo;s criteria for credit quality may do business with the Group on a prepayment basis or by furnishing collateral satisfactory
to the Group. The Group may still seek collateral and guarantees as it may consider appropriate regardless the credit profile of any customer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 66; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To cover trade receivables, the Group has a credit
insurance for main subsidiaries, which periodically analyzes its customer portfolio.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The financial statements contain specific provisions
for doubtful debts, which properly reflect, in Management&rsquo;s estimate, the loss embedded in debts, the collection of which is doubtful.
The maximum exposure to credit risk is represented by the carrying amount of each financial asset in the statement of financial position
after deducting any impairment allowance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On that basis, the loss allowance as of June 30,
2025 was determined as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Gross carrying amount-trade receivables</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Expected Loss rate</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Loss allowance</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: justify">Current</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">125,583,929</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 11%; text-align: center">0.39%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">489,540</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">More than 15 days past due</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,142,922</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">0.03%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,206</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">More than 30 days past due</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,990,398</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">0.10%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,155</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">More than 60 days past due</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,581,056</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">1.01%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,047</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">More than 90 days past due</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,362,450</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">0.34%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,449</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">More than 120 days past due</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">722,431</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">0.04%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">302</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">More than 180 days past due</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,729,503</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">24.90%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,165,044</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">More than 365 days past due</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">11,851,028</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">79.60%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">9,433,720</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify">Total 06/30/2025</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">173,963,717</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">14,123,463</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Cash and deposits in banks </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group is exposed to counterparty credit risk
on cash and cash equivalent balances. The Group holds cash on deposit with a number of financial institutions. The Group manages its credit
risk exposure by limiting individual deposits to clearly defined limits. The Group only deposits with high quality banks and financial
institutions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The maximum exposure to credit risk is represented
by the carrying amount of cash and cash equivalents in the statement of financial position.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Liquidity risk</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Liquidity risk is the risk that the Group will
encounter difficulty in meeting its financial obligations when they come due.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group&rsquo;s approach to managing its liquidity
risk is to manage the profile of debt maturities and funding sources, maintaining sufficient cash, and ensuring the availability of funding
from an adequate amount of committed credit facilities. The Group&rsquo;s ability to fund its existing and prospective debt requirements
is managed by maintaining diversified funding sources with adequate committed funding lines from high quality lenders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The cash flow forecast is determined at both an
entity level and consolidated level. The forecasts are reviewed by the Board of Directors in advance, enabling the Group&rsquo;s cash
requirements to be anticipated. The Group examines the forecasts of its liquidity requirements in order to ascertain that there is sufficient
cash for the operating needs, including the amounts required in order to settle financial liabilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The generation of cash flows over the next twelve
months depends on the success of the initiatives mentioned in Note 2, which cannot be guaranteed as they rely on factors not entirely
within the Group&rsquo;s control. The uncertainty surrounding our ability to secure additional financing contributes to a material uncertainty
that raise substantial doubt regarding the Group&rsquo;s ability to continue as a going concern.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 67; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets out the contractual maturities
of financial liabilities:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid">As of June 30, 2025</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Up to 3 months</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">3 to 12 months</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Between one and three years</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: justify">Trade and other payables</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">35,989,362</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">60,443,242</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">48,481,726</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Borrowings</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">78,084,912</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">41,643,214</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">38,198,026</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Convertible notes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">102,270,445</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Leasing liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,010,540</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,873,502</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,527,939</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Consideration for acquisition</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,761,274</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">397,774</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-style: italic; text-align: justify; padding-bottom: 4pt">Total</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">217,355,259</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">109,721,232</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">96,605,465</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a result of the market conditions described
in Note 2, our performance metrics were impacted, leading us to classify a portion of the outstanding borrowings (see Note 7.12) and the
full amount of the Secured Notes (see Note 7.13) as current liabilities since, as of June 30, 2025, we were unable to demonstrate an unconditional
right to defer settlement of those liabilities for at least twelve months.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid">As of June 30, 2024</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Up to 3 months</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">3 to 12 months</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Between one and three years</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: justify">Trade and other payables</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">107,801,065</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">60,931,404</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Borrowings</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">73,706,045</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">63,041,153</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">42,104,882</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Convertible notes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">80,809,686</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Consideration for acquisition</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,617,281</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,309,234</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Leasing liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">738,561</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,384,217</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">8,161,359</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-style: italic; text-align: justify; padding-bottom: 4pt">Total</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">182,245,671</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">130,974,055</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">133,385,161</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of June 30, 2025, and 2024 the Group had no
exposure to derivative liabilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Currency risk</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Foreign currency risk is the risk that the fair
value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rate. Currency on foreign exchange
risk arises when the Group enters into transactions denominated in a currency other than its functional currency.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The table below sets forth our net exposure to
currency risk as of June 30, 2025:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify">Net foreign currency position</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold; text-align: center">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; text-align: justify">Amount expressed in US$</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">(3,805,325</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Considering only this net currency exposure as
of June 30, 2025 if an US Dollar revaluation or depreciation in relation to other foreign currencies with the remaining variables remaining
constant, would have a positive or a negative impact on comprehensive income as a result of foreign exchange gains or losses. We estimate
that a devaluation or an appreciation of the US Dollar other currencies of 10% during the year ended June 30, 2025 would have resulted
in a net pre-tax loss or gain of approximately $0.4 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 68; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Interest rate risk</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group&rsquo;s financing costs may be affected
by interest rate volatility. Borrowings under the Group&rsquo;s interest rate management policy may be fixed or floating rate. The Group
maintains adequate committed borrowing facilities and holds most of its financial assets primarily in cash or checks collected from customers
that are readily convertible into known amounts of cash.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group&rsquo;s interest rate risk arises from
long-term borrowings. Borrowings issued at floating rates expose the Group to cash flow interest rate risk. Borrowings issued at fixed
rates expose the Group to fair value interest rate risk. The Group has not entered into derivative contracts to hedge this exposure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group&rsquo;s debt composition is set out
below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Carrying amount</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Carrying amount</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify">Fixed-rate instruments</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">Current financial liabilities</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">211,497,698</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">142,986,250</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Non-current financial liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">48,123,739</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">133,385,161</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify">Variable-rate instruments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Current financial liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19,146,189</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,501,007</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company does not use derivative financial
instruments to hedge its interest rate risk exposure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Capital risk</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group&rsquo;s objectives when managing capital
are to safeguard the Group&rsquo;s ability to continue as a going concern, in order to provide returns for shareholders and benefits for
other stakeholders, and to maintain an optimal capital structure to reduce the cost of capital.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group manages its capital structure and makes
adjustments to it in the light of changes in economic conditions and the risk characteristics of the underlying assets. In order to maintain
or adjust the capital structure, the Group may adjust the amount of any dividends it could pay to shareholders, return capital to shareholders,
issue new shares, or sell assets to reduce debt.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Financial instruments by category</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following tables show additional information
required under IFRS 7 on the financial assets and liabilities recorded as of June 30, 2025, and 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Financial assets by category</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>Amortized cost</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>Mandatorily measured at fair value through profit
    or loss</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid">Financial asset</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: justify">Cash and cash equivalents</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">19,488,145</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">24,973,048</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">13,206,934</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">19,500,222</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Other financial assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">58</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">634,553</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,040,038</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,695,528</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Trade receivables</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">168,366,767</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">207,320,974</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Other receivables (*)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">23,975,920</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">18,647,862</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 4pt">Total</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">211,830,890</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">251,576,437</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">15,246,972</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">31,195,750</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>(*) Advances expenses and tax balances are
not included.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>


<!-- Field: Page; Sequence: 69; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Financial liabilities by category</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amortized cost</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Mandatorily measured at fair value through profit or loss</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid">Financial liability</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: justify">Trade and other payables</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">141,779,322</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">156,742,677</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">3,135,008</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">11,989,792</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Borrowings</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">157,926,152</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">178,852,080</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Secured notes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">102,270,445</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">80,809,686</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Lease liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,411,981</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,284,137</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Consideration for acquisition</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,075,234</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">4,202,401</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,083,814</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,724,114</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 4pt">Total</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">419,463,134</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">431,890,981</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">4,218,822</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">14,713,906</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Financial instruments measured at fair value</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Fair value by hierarchy</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">According to the requirements of IFRS 7, the Group
classifies each class of financial instrument valued at fair value into three levels, depending on the relevance of the judgment associated
to the assumptions used for measuring the fair value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 1 comprises financial assets and liabilities
with fair values determined by reference to quoted prices (unadjusted) in active markets for identical assets or liabilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 2 comprises inputs other than quoted prices
included within Level 1 that are observable for the asset or liability, either directly (i.e. as prices) or indirectly (i.e. derived from
prices).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 3 comprises financial instruments with inputs
for estimating fair value that are not based on observable market data.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid">Measurement at fair value at 06/30/2025</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level 1</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level 2</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Level 3</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; font-style: italic; text-align: justify">Financial assets at fair value</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: justify">Mutual funds</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">144,606</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Moolec Science S.A. shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">976,425</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Other investments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">919,007</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Other receivables - Joint ventures and associates</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; font-style: italic; text-align: justify">Financial liability at fair value</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Trade and other payables</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,135,008</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Consideration for acquisition</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,083,814</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>

<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify">Measurement at fair value at 06/30/2024</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 1</TD><TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 2</TD><TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 3</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; font-style: italic; text-align: justify">Financial assets at fair value</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: justify">Mutual funds</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">6,658,805</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">US Treasury bills</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,993,668</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Moolec Science S.A. shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,530,375</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Other investments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,512,680</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; font-style: italic; text-align: justify">Financial liability at fair value</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Trade and other payables</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,989,792</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Consideration for acquisition</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,724,114</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 70; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Estimation of fair value</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value of marketable securities, mutual
funds, shares and US Treasury Bills is calculated using the market approach using quoted prices in active markets for identical assets.
The quoted marked price used for financial assets held by the Group is the current bid price. These instruments are included in level
1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group&rsquo;s financial liabilities, which
were not traded in an active market, were determined using valuation techniques that maximize the use of available market information,
and thus rely as little as possible on specific estimates of the entity specific estimates. If all significant inputs required to fair
value an instrument are observable, the instruments are included in level 2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If one or more of the significant inputs is not
based on observable market data, the instruments are included in level 3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group&rsquo;s policy is to recognize transfers
between different categories of the fair value hierarchy at the time they occur or when there are changes in the circumstances that cause
the transfer. There were no transfers between levels of the fair value hierarchy. There were no changes in economic or business circumstances
affecting fair value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Financial instruments not measured at fair
value</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The financial instruments not measured at fair
value include cash and cash equivalents, trade accounts receivable, other accounts receivable, trade payables and other debts, borrowings,
financed payments and convertible notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The carrying value of financial instruments not
measured at fair value does not differ significantly from their fair value, except for borrowings (Note 7.12).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management estimates that the carrying value of
the financial instruments measured at amortized cost approximates their fair value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>16.&nbsp;<U>LEASES</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The right-of-use asset was initially measured
at the amount of the lease liability plus initial direct costs incurred, adjusted by pre-payments made in relation to the lease. The right-of-use
asset was measured at cost less accumulated depreciation and accumulated impairment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The lease liability was initially measured at
the present value of the lease payments payable over the lease term, discounted at the rate implicit in the lease if it can be readily
determined. If that rate cannot be readily determined, the Group uses its incremental borrowing rate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The information about the right-of-use and liabilities
related with lease assets is as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid">Right-of-use leased asset</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">Book value at the beginning of the year</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">20,979,597</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">21,163,192</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Additions of the year</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,569,819</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,585,223</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Additions from business combination</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">168,988</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Disposals</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(680,110</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,284,975</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Exchange differences</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">273,529</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,652,831</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Book value at the end of the year</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">30,142,835</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">20,979,597</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 71; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid">Depreciation</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">Book value at the beginning of the year</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">9,377,845</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">7,226,617</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Depreciation of the year</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,036,703</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,418,956</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Disposals</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(697,150</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,092,167</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Exchange differences</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">47,736</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(175,561</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Accumulated depreciation at the end of the year</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">13,765,134</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">9,377,845</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Total</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">16,377,701</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">11,601,752</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid">Lease liability</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">Book value at the beginning of the year</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">11,284,137</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">13,889,223</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Additions of the year</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,569,819</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,585,223</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Additions from business combination</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">168,988</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Interest expenses, exchange differences and inflation effects</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,059,412</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(480,189</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Payments of the year</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(5,501,387</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(4,879,108</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Total</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">16,411,981</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">11,284,137</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid">Lease Liabilities</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">Non-current</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">9,527,939</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">8,161,359</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Current</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">6,884,042</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">3,122,778</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Total</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">16,411,981</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">11,284,137</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">Machinery and equipment</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">3,655,741</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">3,655,741</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Vehicles</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,214,933</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,272,071</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Equipment and computer software</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,347,568</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,130,541</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Land and buildings</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">23,924,593</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">14,921,244</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">30,142,835</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">20,979,597</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The incremental borrowing rate used was 4.48 %
in dollars and 18.55% in reais.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 72; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>17.&nbsp;<U>SHAREHOLDERS
AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended June 30, 2025, 2024 and
2023, the transactions between the Group and related parties, are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1.5pt; text-align: left"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="10" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Value of transactions for the year ended</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Party</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Transaction type</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 33%; text-align: left">Joint ventures and associates</TD><TD STYLE="text-align: left; width: 1%; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 30%; text-align: left">Sales and services</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">4,874,027</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">32,036,547</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">27,945,312</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Joint ventures and associates</TD><TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">Purchases of goods and services</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(24,076,814</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(61,946,096</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(60,847,857</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Key management personnel</TD><TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">Salaries, social security benefits and other benefits</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,656,077</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(10,209,376</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(5,002,881</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Key management personnel</TD><TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">Sales and services</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">367,928</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Key management personnel</TD><TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">Purchases of goods and services</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,079,070</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Shareholders and other related parties</TD><TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">Sales of goods and services</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,714,441</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,911,723</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,381,641</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Shareholders and other related parties</TD><TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">Purchases of goods and services</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,517,528</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,998,349</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,249,940</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Shareholders and other related parties</TD><TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">In-kind contributions</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,343,549</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,409,244</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,163,384</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Shareholders and other related parties</TD><TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">Interest expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,753</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left; padding-bottom: 1.5pt">Parent company and related parties to Parent</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Interest expenses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(45,852</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(462,575</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left; padding-bottom: 4pt">Total</TD><TD STYLE="text-align: left; padding-bottom: 4pt; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(20,029,544</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(36,842,159</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(33,067,163</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The related balances owed by and to them as of
June 30, 2025 and 2024 are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; text-align: center"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center"><B>&nbsp;</B></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center"><B>&nbsp;</B></TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>Amounts receivable from related parties</B></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center"><B>&nbsp;</B></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Party</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Transaction type</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold; text-align: center">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold; text-align: center">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; width: 38%; text-align: left">Shareholders and other related parties</TD><TD STYLE="text-align: left; width: 1%; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 37%; text-align: left">Trade debtors</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">249,701</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">141,224</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">Shareholders and other related parties</TD><TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">Other receivables</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,775,092</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">Joint ventures and associates</TD><TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">Trade debtors</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">413,689</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">782,142</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Joint ventures and associates</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Other receivables</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">19,147,793</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">15,702,992</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 4pt">Total</TD><TD STYLE="text-align: left; padding-bottom: 4pt; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">22,586,275</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">16,626,358</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>Amounts payable to related parties</B></TD><TD STYLE="padding-bottom: 1.5pt"><B>&nbsp;</B></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify">Party</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify">Transaction type</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; width: 38%; text-align: left">Shareholders and other related parties</TD><TD STYLE="text-align: left; width: 1%; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 37%; text-align: left">Trade creditors</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">(878,874</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">(729,171</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">Key management personnel</TD><TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">Salaries, social security benefits and other benefits</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(65,882</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(148,466</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">Shareholders and other related parties</TD><TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">Trade and other payables</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(286,172</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(37,985</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">Joint ventures and associates</TD><TD STYLE="text-align: left; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">Trade creditors</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(47,321,832</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(52,888,732</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Other related parties</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Secured notes</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(102,270,445</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 4pt">Total</TD><TD STYLE="text-align: left; padding-bottom: 4pt; vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(150,823,205</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(53,804,354</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 73; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>18.&nbsp;<U>KEY
MANAGEMENT PERSONNEL COMPENSATION</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Key management personnel are those persons having
authority and responsibility for planning, directing, and controlling the activities of the Group.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The compensation of directors and other members
of key management personnel, including social contributions and other benefits, were as follows for the year ended June 30, 2025, 2024
and 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: justify">Salaries, social security and other benefits</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">2,175,627</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">2,092,122</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">1,587,773</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Share-based incentives</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">480,450</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">8,117,254</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">3,415,108</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 4pt">Total</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">2,656,077</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">10,209,376</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">5,002,881</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company entered into indemnification agreements
with each of its directors and executive officers. These agreements generally provide that the relevant director or officer will be indemnified
by the Company to the fullest extent permitted by law against liability and against all expenses reasonably incurred or paid by him or
her in connection with any claim, action, suit or proceeding which he or she becomes involved as a party or otherwise by virtue of his
or her being or having been such a director or officer of the Company and against amounts paid or incurred by him or her in the settlement
thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The agreements are subject to certain exceptions,
including that no indemnification will be provided to any director or officer against any liability to the Group or its shareholder (i)
by reason of intentional fraudulent conduct, dishonesty, willful misconduct, or gross negligence on the part of the director or officer;
or (ii) by reason of payment made under an insurance policy or any third party that has no recourse against the indemnitee director or
officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The compensation of key executives is determined
by the Compensation Committee based on the performance of individuals and market trends.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>19.&nbsp;<U>SHARE-BASED
PAYMENT</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>2023 Omnibus Equity Incentive Plan</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 12, 2023, the board of directors of the
Company approved the 2023 Omnibus Equity Incentive Plan to attract and retain the best available personnel, provide additional incentives
to employees, directors and consultants and to promote the success of our business. In addition to introducing new incentive plans, it
comprehensively amends and restates in entirety (i) the Employee Stock Purchase Plan, (ii) the Equity Compensation Plan, (iii) the Stand-alone
Stock Option Grant, and (iv) the Employee Stock Option Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">-</TD><TD STYLE="text-align: justify">Employee Stock Purchase Plan (&ldquo;ESPP&rdquo;): incentive
plan for eligible employees with no stock compensation to purchase ordinary shares of the Company up to a maximum of 15% percent of such
employee&rsquo;s monthly compensation. The number of ordinary shares subject to the ESPP shall be 200,000 ordinary shares. The purchase
price will be equal to 85% of the lower of the closing price of the Company&rsquo;s ordinary shares on the first business day and the
last business day of the relevant offering period. As of the date of these consolidated financial statements the ESSP is not yet implemented.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">-</TD><TD STYLE="text-align: justify">Equity Compensation Plan: annual incentive plan based on
certain financial and operational targets defined by the Board of Directors upon approval of the annual budget.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">-</TD><TD STYLE="text-align: justify">Stand Alone Stock Option Grant: plan granted up to 1,200,000
underlying ordinary shares. The options have an exercise price of $4.55 and expire on October 31, 2029. Options can be exercised for
a period of up to three years, with 1/3 vesting every 12 months, and on a cashless basis at their volume weighted average price (&ldquo;VWAP&rdquo;)
of the ordinary shares during a twenty-day period to the date of exercise.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 74; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">-</TD><TD STYLE="text-align: justify">Employee Stock Option Plan: plan granted up to 100,000 underlying
ordinary shares to certain key employees. The options have an exercise price of $5.55 and expire on October 23, 2030. Options can be
exercised for a period of up to three years, with 1/3 vesting every 12 months, and on a cashless basis at their volume weighted average
price (&ldquo;VWAP&rdquo;) of the ordinary shares during a twenty-day period to the date of exercise.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">-</TD><TD STYLE="text-align: justify">Past Share Option plan: immediately vested options with a
strike price between $11.93 and $13.24.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">-</TD><TD STYLE="text-align: justify">Base Share Option plan: to vest and become exercisable in
equal installments on June 30, 2023, June 30, 2024, and June 30, 2025, with a strike price between $10.47 and $10.79.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">-</TD><TD STYLE="text-align: justify">Performance Share Option plan: to vest and become exercisable
if the Group&rsquo;s fiscal year 2025 EBITDA reaches at least US$120 million, at 0% of the award, and linearly thereafter up to 100%
of the awarded options when reaching at least US$150 million. These options have also a strike price of between $10.47 and $10.79.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value of the stock options at the grant
date was estimated using the &ldquo;Black-Scholes&rdquo; model, considering the terms and conditions under which the options on shares
were granted and adjusted to consider the possible dilutive effect of the future exercise of options.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Factor&#8239;&#8239;&#8239;&#8239;&#8239;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Stand Alone Stock Option Grant</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Employee Stock Option Plan</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Past Share Option plan</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Base Share Option plan</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Performance Share Option plan</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; width: 40%; text-align: left; padding-bottom: 1.5pt">Weighted average fair value of shares</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; width: 9%; text-align: right">5.42</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; width: 9%; text-align: right">13.98</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; width: 9%; text-align: right">11.45</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; width: 9%; text-align: right">10.80</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; width: 9%; text-align: right">10.79</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Weighted average exercise price</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">4.55</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">5.55</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">12.48</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">10.52</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">10.52</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Weighted average expected volatility</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">29.69</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">42.18</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">48.73</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">54.73</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">54.73</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Dividend rate</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">0</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">0</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">0</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">0</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">0</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Weighted average risk-free interest rate</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">1.66</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">1.17</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">4.40</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">4.47</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">4.47</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Weighted average expected life</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">9.89 years</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">9.22 years</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">4.89 years</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">2.97 year</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">2.97 year</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Weighted average fair value of stock options at measurement date</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">2.47</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">10.10</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">5.01</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">4.46</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">4.45</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are no market-related performance conditions
or non-vesting conditions that should be considered for determining the fair value of options.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group estimated that nearly 100% of the share
options will be exercised, based on historical trends of executive retention and option exercise behavior. This estimate is reviewed at
the end of each annual or interim period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>2013 Stock Incentive Plan</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As part of the merger described in Note 6, we
have assumed the outstanding &ldquo;2013 Stock Incentive Plan&rdquo; from Pro Farm Group. On the merger date the total equity awards outstanding
was converted consistent with the terms of the merger agreement into an aggregate of 1,191,362 option and or restricted stock units which
was fully registered with the Securities and Exchange Commission on July 26, 2022. All equity awards retained their original granted terms.
The company has not granted any additional awards under this plan during the year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 75; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As of June 30, 2025 and 2024 and for the years ended June 30, 2025, 2024 and 2023</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Amounts in US$, except otherwise indicated)</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P><!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s fair value of the grants was
estimated utilizing a Black Scholes option pricing model based on the following range of assumptions which have determined consistent
with the Company&rsquo;s historical methodology for such assumptions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="vertical-align: top; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">July 12, 2022</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">Exercise price</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$7.16 - 204.66</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">Expected life (years)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">0.03 - 9.83</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">Estimated volatility factor</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">34.9%&nbsp;-&nbsp;44.4%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; width: 88%; text-align: left">Risk-free interest rate</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 11%; text-align: center">0.0%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left">Expected dividend yield</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&mdash;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table shows the evolution of stock
option and weighted average exercise price for the years ended June 30, 2025 and 2024:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><B>06/30/2024</B></TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of options</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">W.A. Exercise price</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of options</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">W.A. Exercise price</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: left">At the beginning of the year</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">7,345,795</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">11.83</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">1,791,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">15.79</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Granted during the year</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,631,894</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10.55</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Cancelled or expired during the year</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(221,444</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">58.27</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(570</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10.07</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Forfeited during the year</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,115,000</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10.52</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Exercised during the year</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(76,529</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10.73</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Effective at the end of the year</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,009,351</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10.14</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,345,795</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11.83</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>20.&nbsp;<U>CONTINGENCIES,
COMMITMENTS AND RESTRICTIONS ON THE DISTRIBUTION OF PROFITS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The secured notes referenced in Note 7.13 are
secured by substantially all of the assets located in the United States of Pro Farm Group, Inc. and its U.S. subsidiaries and are guaranteed
by BCS Holding Inc., Bioceres Crops do Brasil Ltda., Bioceres Crops S.A., Bioceres Semillas S.A.U., Verdeca LLC, Rasa Holding LLC, Rizobacter
Argentina S.A., Rizobacter del Paraguay S.A., Rizobacter do Brasil Ltda., Rizobacter South Africa, Rizobacter Uruguay, Rizobacter USA,
LLC, Pro Farm Group, Inc., Pro Farm Michigan Manufacturing LLC, Pro Farm, Inc., Pro Farm Technologies Com&eacute;rcio de Insumo Agr&iacute;colas
do Brasil Ltda., Glinatur S.A. and Pro Farm OU.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>21.&nbsp;<U>EVENTS
OCCURRING AFTER THE REPORTING PERIOD</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subsequent to June 30, 2025, there have been no
other situations or circumstances that may require significant adjustments or further disclosure in these consolidated financial statements&nbsp;that
were not mentioned above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 76; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></FONT></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $7 G # 2(  A$! Q$!_\0
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M1H$AMK>/$<2*.$49+-DGXG_X>I_\%&?^CR?CO_X6MY_\31_P53_Y2,_MD_\
M9=_&O_I8M? % 'W_ /\ #U/_ (*,_P#1Y/QW_P#"UO/_ (FC_AZG_P %&?\
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M%@D=88=T:AC^95 'W_\ \/4_^"C/_1Y/QW_\+6\_^)H_X>I_\%&?^CR?CO\
M^%K>?_$U\ 44 ?OS_P $N/\ @HO^W3\3OV_OV9/ GC_]J?XQ^+?!WB3QU=V6
MO>'-;\5W5[I6K6:>%_$%T+:]M9%V31?:+>&7:>CQJPP0#7Q/XO\ ^"I/_!1*
MQ\6^*;*U_;%^.L-M:>(]<MX(D\9W:)'##JEU'&B(J!5554 *H"@#    J?\
MX(^_\I*_V2?^RB7W_J'^)J^ ?'7_ "._C+_L:O$/_IWO* /M4?\ !5/_ (*-
M$X'[9/QW)/  \:7N2?3[M7[C_@I]_P %+;1%DNOVM_VAK:-O+VO<>*=5A1O-
MYBVM)"JGS!S'@_/_  YKX$T6Y@LM9TF\N@6M;34["YN5""0M!!=12S 1D@.3
M&C (2 WW2>:_HM\8_P#!27]BC]HBV\5_#?XSZ?XX\'?"?PE\<?A1\6?ASJ&C
M_#[1_$OC;QUH?@[3[F+Q/\/M8U"WFTIO"'A6]N[;3_[ TQ3J"Z=#>7K2S3L=
MJ@'YJQ_\%-/^"F\HD,7[5W[1T@AF-O*8_$>LN(K@ $P2%;<A)@&!,38< @E<
M$5'_ ,/.?^"F119!^UE^T48WN?L2/_PDNK[&O#TM%;R-K7)_YX F7_8K]3IO
M^"P_[/MEXB^//C7P5H7COP=;?&6P\'>/H/A>?#OAW5=%\/\ QG@M+[2O&5Q9
M:U+:AH+"_LK70IX[N&%8991*HM4,99N3^#O_  5 _9HT#4OA#\1OB->^.-1C
M\-R^')?&/[.5K\/=$O/":_$?2HM:_M#]H6Q\;N\3WOC&^DN[$+HC6,=J"K2.
MK")$ !^;;_\ !3O_ (*8)*L#_M:_M$).\WV=(7\3ZLLKW!!80+&8 [3$ GR@
MI? )VX%9Y_X*I?\ !1I25;]LCX\!@2"#XTO000<$$%<@@\$'D&OV0\'_ /!:
MC]E#PCXF^'?B#4?@/'\0)=2U./Q?XOU/Q9X0T:;Q5\*/B#:6GB&PTGQ1X;U:
M-4M_&T]G%JD,FI6UQ;:?;:HCA=D<EG&)?YAO$%^FJZ]K>IQDM'J6KZE?QL8U
MA+)>7LUPA,2_+$2L@)C7Y4/RC@"@#]4?V<O^"G'_  4%\2?'KX0:#K?[7OQO
MU'2-6^(/ABPU*PNO&%S/;7ME<:I;QW-K<0R(R20SQ,T4BL#E&.,'!'I7[=O_
M  4G_;V\"_MA?M"^$?"/[6/QI\/^&M!^)&L6&C:+IGBVYM;#3;&)+8Q6MI;Q
MH$BAB#$(H'3DDDDG\R_V5?\ DY+X'_\ 93/"7_IVMZ]7_P""C7_)\O[3G_94
M]:_]%6M '5?\/4_^"C/_ $>3\=__  M;S_XFC_AZG_P49_Z/)^.__A:WG_Q-
M? %% 'W_ /\ #U/_ (*,_P#1Y/QW_P#"UO/_ (FM9?\ @IK_ ,%-G2.1/VK_
M -HUTFB:>)U\1ZPR2P*,M-&PMR'B4<M(I* <D@5^=T3*LL;-]U9$9N,_*&!/
M'?@'CO7],_PB_P""T/[/O@;3?A)X)UWX:>)[_P '?"WP%H?AAK]=)\/SZOKM
M]J6BZI8>,;4F2S#V_A>">:R:UTJ62:>]4,PN82@R ?E%_P //_\ @I9Y,%S_
M ,-<?M#?9[I_+MI_^$IU3R;B3)'EP2^3LF?((VQLS9!&.#4Z?\%-?^"FTDB1
M1_M7_M&R2RQO-%&GB/6'DDAC&9)41;<L\<8Y>1054?>(K]"O"G[??[&6F^"/
MAI8Z_P"*/'^IVGP_U#X6^)="^$A^$6C'PUX7U_P%J/BNZ\1C2_$/VX7-U_PG
M<6OV0U">Y62.(Z<BF$#;75^,?^"D?[+?BXW-MX6^,WQ8^$.L:EIFB'1_B'HO
MP5T#5M6^&VEZ3!JP\1?#30],%]"NI:-\07OK2+5-8F</9?8HG,4D9>)P#\P;
MG_@J#_P4KLXH9[S]KG]H2T@N03;S7/BK5((IP"03#)+"B2@$$$HS8(.>E4O^
M'J?_  49_P"CR?CO_P"%K>?_ !-9W[5G[52?'3X7? SX>6?B/Q%JUI\*K;Q-
M9O::QI&F:;:0KJ%^DMA/9RV4*3W#2P^=+,EQ(_V=YVC4D#(^$: /O_\ X>I_
M\%&?^CR?CO\ ^%K>?_$T?\/4_P#@HS_T>3\=_P#PM;S_ .)KX HH _HA^+W_
M  4+_;>T?_@F!^QM\3-,_:B^+]CX_P#&'[07[3>A>)O%5OXJN(]:US1O#L'@
M0Z%IVH7@3S;BTTE[V\:SC8[8FNYNNY=OYN_\/4_^"C/_ $>3\=__  M;S_XF
MOO?PY\:/A/\ !W_@DC^QS/\ %/\ 9]\)_'NWUO\ :7_:E_LFW\57L]G'X=-I
M:> TN/LA@CE:0WS2QR294!?('.2 ?EG_ (;>_9!_Z1T?!_\ \'FH?_(E 'EW
M_#U/_@HS_P!'D_'?_P +6\_^)H_X>I_\%&?^CR?CO_X6MY_\37VQ\.O&?PX^
M+/@#7/B9\/O^"6GPD\1>%]!N);>Y^S>*)%U6\:U>W34)-*TV5([C4(]--U U
M\($:2-)%*(_.*%WX_P# =GJ<FDM_P21\'W-U'J^K:$'LIM9N;675="@CN=8M
M8;F.Q:%SIT$T4EV_F".%7'F,IXH ^-O^'J?_  49_P"CR?CO_P"%K>?_ !-'
M_#U/_@HS_P!'D_'?_P +6\_^)KZED^-GPDCTSP]K3_\ !)WP@-*\5WT.F^&[
M\?V^UMK5_</-'!:Z?(NG$3S3/;S+&J_?,;;2<5>N_BS\-=/MO$-Y??\ !(_P
MU9VWA/2M-USQ++=0^(K<:+I&KR-#I=_?K+IBO#;W\JLELQ7,I!V@XH ^3/\
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MPQJFI>([.=-%MK*[UVW6XTJTNE%[H<.HV1U6T?;-:FYCW(RL&/#^&OB1\/\
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M//"&D_$?0(_%/@74M4U._CLO$V@22- -0TVXC@ECD1)T>&6-RDT;J=T04JS
M'RS_ ,/4_P#@HS_T>3\=_P#PM;S_ .)K]'O^"0/_  4._;?^+?\ P4__ &&/
MAK\3/VH?B_XU\ ^-/VB_A_H'BSPGX@\575]HOB#1;_4?+O=*U.TD79<6EW'^
MZEC)!*M\I5L$?&7_  V]^R#_ -(Z/@__ .#S4/\ Y$K]%?\ @D5^UO\ LR>,
M_P#@IW^PQX8\)?L,_##P!XBUK]HKP'IVD^,=(U>]FU+P]>W5Z\4&JVD4MO'&
M\UE(PG1689*8&2<$ _6?]KS_ (-+OVI?VD?VG/CC\>=(^/\ \*?#^E?%?XAZ
M]XTT_1=3BN)-0TRUUBX\Z.SNWCNHD::#!1B$7( )^;<:^<_^(,']K;_HY?X-
M_P#@-=__ ";7^BS=_P"O?ZM_Z&U5J /\Z_\ X@P?VMO^CE_@W_X#7?\ \FT?
M\08/[6W_ $<O\&__  &N_P#Y-K_10HH _P Z_P#X@P?VMO\ HY?X-_\ @-=_
M_)M'_$&#^UM_T<O\&_\ P&N__DVO]%"B@#_.O_X@P?VMO^CE_@W_ . UW_\
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M_P 537TF/%U;\(Y4]&K?ZO9^M6M'I)WL];;/9V0?Z]\2?]"W#O?_ )@\8O\
MV[H?F5I/[#G[0'AKQ5XZ\<Z#\6?A!J'C'QWI]Q87WB/QO?67B348DO\ 2#I-
MU;NPLK:&?3=-CQ+X5MC#]HT0M,/M$QDROA'B_P#X)2?'KQK^RC8?L[Z]^T;\
M&[[Q#HTWP[L/#GCV:P4ZGX=\-^"]4UC5O$>G6MUG[1(GQ#N=1L3K41DV1_V-
M:*59"4;]K/\ A6GC[_H3-:_\!%_^*H_X5IX^_P"A,UK_ ,!%_P#BJ7_$S'B]
M_P!$EE7_ (CN?_\ R8?Z]\2_]"[#_P#A%C/_ )(_*[1OV$?VG_"'CJZ\1^ _
MC?\  _PKX;G/C7Q!;Z/&L-_XCM/B/X]TK2M,U[Q0GB.^2Y7^QG_L>UGB\/+;
M+&I!3>>M:6F?L<?MHV'A[6-''[07[.MG>ZSX-TCPWJ>H:#H%AI4'B+7(GO1X
MH\:>+K412'6-<\607-M%=30O:O ;*)DV@D5^G_\ PK3Q]_T)FM?^ B__ !5'
M_"M/'W_0F:U_X"+_ /%4?\3,>+W_ $265?\ B.Y__P#)A_KWQ+_T+L/_ .$6
M+_\ DC\ROAO^P1\7_!NH^%KK5OB;\'-0L/ _PA\=_#C0[#3KJWLY[G5O%OV=
M['6;B\^SNT-EIL\<TEW98S>I(L9D4+D\UX)_8?\ VT_!_C#X5^*W_:2^ >JP
M?"NZ\?76E:!)HUDFF3R>/3:^;+% \;Q076BK:)_9D[B3[/(\DD2KO85^K7_"
MM/'W_0F:U_X"+_\ %4?\*T\??]"9K7_@(O\ \51_Q,QXO?\ 1)95_P"([G__
M ,F'^O?$O_0NP_\ X18O_P"2/R(UW_@GI^U?XD;XD:=J_P"T?\'+GPS\4_'-
MAXM\36NV*#7A;P2%[NSMM9LX[<Q7=Z2AN+R*)$DCA2-XCUKGO$__  2?^-O@
M[]IZ3]I'X&?M+_!:V\1R_L[V'P.M3XOT9M3ATB.:-(=;U2WA\Z%FOFMX_L]E
M=QO'+&)[ABS*^!^S'_"M/'W_ $)FM?\ @(O_ ,53A\,?B&>5\">(F!Z,NFNR
MGW##((]P<52^DQXO6:_U1RMO2S7#O$+LEOHFT[Z:NUK:;A_KWQ+_ -"W#]-L
M%C/R3>Y^87C7]B?]IWQ+I%II.B?%7]G#PY!:> ?$WA"TL9=,M]0T+0M?U]+.
M.R\?>%=)(2+1?$GA](]2_LVZ!E96U6=V#L*^1_A3_P $8/BU\&_"VNZ)X/\
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MK*;3+NXTZ.!=.L[C2FB\UKZ)X3)=:@ERBW1D(:/@$?M/_P *P^(O_0A>)/\
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M%6E?M4_"^UU3X'^&/$.B:[=75A.;6^FU>[M;F&6S"7$<@6(6YCPTKY#DL68
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MXS!^(N%G5PU>+E1Q%.&(A0E.A6BG*E6A&5*I%-PG)*YXW_POKXR?]%+\5_\
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M5_\ P+KM_P#A9/@G_HD?AW_OX?\ &C_A9/@G_HD?AW_OX?\ &OS?3_HX;_\
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M+KM_^%D^"?\ HD?AW_OX?\:/^%D^"?\ HD?AW_OX?\:-/^CAO_P#B[_Y(/\
MNM_AF)Q'_"Q/&_\ T-VK_P#@71_PL3QO_P!#=J__ (%UV_\ PLGP3_T2/P[_
M -_#_C1_PLGP3_T2/P[_ -_#_C1I_P!'#?\ X!Q=_P#)!_W6_P ,Q.(_X6)X
MW_Z&[5__  +H_P"%B>-_^ANU?_P+KM_^%D^"?^B1^'?^_A_QH_X63X)_Z)'X
M=_[^'_&C3_HX;_\  .+O_D@_[K?X9B<1_P +$\;_ /0W:O\ ^!='_"Q/&_\
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MMH?Z_P#Q='_#PGXD?]"MH?Z__%T?\3,^$G_0QS7_ ,1_&?\ R0?Z^<.?\_\
M$?\ A'5_S/U]\B#_ )XQ?]^T_P */(@_YXQ?]^T_PK\@O^'A/Q(_Z%;0_P!?
M_BZ/^'A/Q(_Z%;0_U_\ BZ/^)F?"3_H8YK_XC^,_^2#_ %\X<_Y_XC_PCJ_Y
MGZ^^1!_SQB_[]I_A1Y$'_/&+_OVG^%?D%_P\)^)'_0K:'^O_ ,71_P /"?B1
M_P!"MH?Z_P#Q='_$S/A)_P!#'-?_ !'\9_\ )!_KYPY_S_Q'_A'5_P S]??(
M@_YXQ?\ ?M/\*/(@_P">,7_?M/\ "OR"_P"'A/Q(_P"A6T/]?_BZ/^'A/Q(_
MZ%;0_P!?_BZ/^)F?"3_H8YK_ .(_C/\ Y(/]?.'/^?\ B/\ PCJ_YGZ^^1!_
MSQB_[]I_A1Y$'_/&+_OVG^%?D%_P\)^)'_0K:'^O_P 71_P\)^)'_0K:'^O_
M ,71_P 3,^$G_0QS7_Q'\9_\D'^OG#G_ #_Q'_A'5_S/U]\B#_GC%_W[3_"C
MR(/^>,7_ '[3_"OR"_X>$_$C_H5M#_7_ .+H_P"'A/Q(_P"A6T/]?_BZ/^)F
M?"3_ *&.:_\ B/XS_P"2#_7SAS_G_B/_  CJ_P"9^OOD0?\ /&+_ +]I_A1Y
M$'_/&+_OVG^%?D%_P\)^)'_0K:'^O_Q='_#PGXD?]"MH?Z__ !='_$S/A)_T
M,<U_\1_&?_)!_KYPY_S_ ,1_X1U?\S]??(@_YXQ?]^T_PH\B#_GC%_W[3_"O
MR"_X>$_$C_H5M#_7_P"+H_X>$_$C_H5M#_7_ .+H_P")F?"3_H8YK_XC^,_^
M2#_7SAS_ )_XC_PCJ_YGZ^^1!_SQB_[]I_A1Y$'_ #QB_P"_:?X5^07_  \)
M^)'_ $*VA_K_ /%T?\/"?B1_T*VA_K_\71_Q,SX2?]#'-?\ Q'\9_P#)!_KY
MPY_S_P 1_P"$=7_,_7WR(/\ GC%_W[3_  I1#$I!6*,$<@A%!!]00,BOR!_X
M>$_$C_H5M#_7_P"+H_X>$_$C_H5M#_7_ .+I_P#$S/A)_P!#+-?_  P8S_Y(
M/]?.'/\ G_B/_".K_F?9/[0OPGT_X\?!OXH?!;5;R+3M,^)OA>Z\+7U_-;->
M1V=M<WEO</.;5'C>9D^S#R@LBE)=DF3LP?S?\/?\$PO%GA+PEKG@#1/VB8+S
MPCXOO?'NE^,?^$D\&7&L>(M3^'?C"UTJ'3?#EEK+WB&SU_09-,W2^('BD6^@
ME2$0+Y63^O=V/WS=.K=Q_?;WJM@^WYC_ !K^@C[,_)#7_P#@E=8ZOI^BVL'Q
MK_L9M!T_X1:7:P0^&+:VT.[B^&$^HRRWFHV2/!)<:MK*7T<=G=)<1_8FBD:X
MCN?-4)W^L?\ !.IK_5!KVG?%32M.U;3Y_B)J>G,_A&&2P_M7QS_8AT]_$MM%
M-$=8T?1CI#FYTZZ<)J(NDV,@C.[W/]K?X7?%GXKV?PHT#X6^)U\*)9?$+3M6
M\7ZG- ][8-H=E'<2?9[ZSAG@DFBDN?LYR)0(P"Q5AD#X9UGX:_M?'6=%>RN_
MBTVE>'=>U!_VKUAUN-(?BMX>)=-&A^ UMY6^:.*(0EK&!XWMR'W2/CD [+6/
M^"6NH:]J'C;QA=?':TTGXH>./$#Z]=^*O"WA232=/TRPU*W@A\3^&--\/Q7K
MPV_A?7WLK":2SC0) ]J#%*I=L[GP3_X)N^._@)\9/#?Q:\(?M(_V];Q^%?$>
ME>/_  SXW\)3:Y%XJ\6>-($@\8>*]%NDO;?^P3K,5KIL0LW6>1(K-T+N)./-
MOA9\-OVNK7]H;2=4O+KXKV?AJ2\^%NH^'KCQ'K"-X=TSX+Z='KG_  FG@WQI
M<LGEWGQ$F\[31);B..:<JBB0>6<T=1^%'_!0G3?VC;OQOX8\4:]?_"O5_BOX
M&T[5_!FK:["EA8^#([7Q MWXMT(-$3;PZ-,]@=7TS+MJCRV[B2/[.0P!UFH_
M\$POB)=7?B6;3OVCO"6@Z7XB\%>+OAQ'X4TWX;"W\*>'?#GC6]MKS7SH%@-1
M$UIK=TUK 3=7%U<2J_F/L^< =;H7_!*CX76.N>'=9\0?$;7O$%U#\/\ Q1\/
M?B% 6M;0>.]&UFTM[;P_HDJ[2^F^&?#\D+W!TT?\3&^9P%OQM.?F+6O@#^WM
MXS\"ZQX>\)^,O'G@[Q!!XB\ WMUKWBN_^T->>)=%UW4;KQU=:5$"AN+'5-+>
MPAM?$BE+:^ ")9Q^0=VG:_#W]IIM7^)]WXRL?CUJJ:E^T/%J^EV?AG2)]-U>
MS\#'3[6VT633_%INY+?6-)AU.*:YO4CL8!IML["3SA)P >OV/_!,3XA#P]XB
M\)>)OVC_  ?JGA_Q#\&?#_P+%A;?#%=/F@\)^&=0N;K29DFN=0FF?4X[>Y-L
M\\#(\DD<<S [:U!_P2KT7P9XJT[7?@W\8%\$V5E::9'<V'C+1/\ A,]2U?4;
M:PELM7U2^O[ZZ43W&IF17B*Q*+2.-(U'!)\?O?A/^W%%XY^"3?$;Q%XVU.*R
M3XP6OBV]\,::_BS3IM7UJ"SC\ W=Q=6MQ9)H(L("Q@UN6.YBL[N*4M;ONP':
M1^SS^V_J^C6V@?$[Q#XQUF[\$>*?@_IOA+Q1I/BY;;5O$?P[LCXEG\9ZCXCN
M8X=DOB69;G3H]75H@;E+:UA783NH ]N\ _\ !+_3_A]K&C76F_%JVU'PWI\_
M@[7KOPK?^&!J.EW?C70SK+>*/$5K]IGN([.'Q@VI6RS:?'\EG'8E%P9<C ^)
M/_!+[Q5\2O@/\4?@5=_'_1_#>A_$#Q;X.\3:+:>&OA^^G>%?!EOX3N[Z_DTR
MPT-+LW,XUF[N;6>[FDO)")++.0LFT?57["/A_P"+'A?X+ZSH?Q=E\3W>LVWQ
M'\6R:!J7C& Z?KU]X6DND_LEI-)DDEDTVS1 ZVL;S2F15,N0) !]GX/M^8_Q
MH \E^#7@KQO\._@3X(^'7Q*^(2?%3Q]X/^&\OA?Q3\3GTO\ L&/QAJ-GI=[:
M)KTND^9-_9D2V;6T,L/F2>7':M(6.:_D3U+]DII=4U64_M'_ ++L9EU74Y/+
M?XJQ!T#W]PP20#2SMD4$"1,DHX9"<BO[/=0'_$JUSH<Z#KH !!))TF\   R2
M22  !DDX%?P0:MX7\0MJ^L%/#6M[3K.K8QHM_C U&Y'&+;%?G/'LJ<9Y5[3#
M^WO'&V?MJ]%0UPU_X-.?-S:?%:W+[M[NW^;G[0/$97AZGA9_:7#5;B+GI<6^
MQ5+-\XRKZK:MD?M')95@<9[?VMXV=9T_9\CY.=3ER_2A_9%R"/\ AI+]EL9!
M'_)58O\ Y55]A^'=.TWPX?A7KEM\6OV>?^$Z^%UGX0TFTUB#]H&WB\.W^D^$
M/MP@V^&WT-[>'6+P7S!]2DWLNPEE;=BOR9_X17Q'_P!"UKG_ ()=0_\ D:K%
MGX7UU;RS:X\,ZV;=;RT:X!T34&4P+<1F8,OV;YE\H/E>XR.]?"4<9##N4J6!
M492Y+MXK%R:<*BG"4>;#OEE"?O*2UWT:V_S]R+C++N'Z]2IE'A]B,'4Q,L'[
M2K4XFXIK^SJ8+&TL=@L13=?(FZ%?"8NG'$4J])J<&IJTXS:7[':UXA36]+\>
M6=Y\3OV;M/O?'.H:?J[:IIOQPTNQF6XL;D7,MK?"7PRRWFDZD5"ZA:V?V8R[
M4(D7;7N6I?&_PC<W?A#Q;%XN_9>N_$.GZCJ3:SX'NOC/HTG@?[,;6TMK&YMH
M#X<:>ZN(_)>;3(&G9M(D><R&<2J%^ ]9C^ ?Q)\3>/IM3\*ZWX9TOPQ<>&#X
M*CFTV]6RUO2;:%4\1P:3;1:=&UHURZHUM8RR2ORY$F2:^AO WPM_9.O])^(/
MQ2TOPE8QZ7X?T^TTR/PYK>CZDL]I_H4ZS^(]%>6#]UK-O<F(PV+1S?VH78J8
MS$<_14,1B9SG[&6":;?OSQ.(4G&A4JSE64'A=.2:FU?^)&K&3C433C_2V0\1
M<08K&8RCE.+X/J4INM/ZUB^*,[=>6'R7'9IF>(S:EA*O#,6GA,72Q=10KQF\
M7A<SIU)83,*4>?#YGQ;DT/XG?"/QE\,K/QQ^RIX;O_&'Q2B^)+^*!\:=,N)-
M/CBW;M$CMH?#\4K"7=AYDD6+:JCRAC-?$G_#(W_5R7[+?_AUHO\ Y55\PW/A
M?7FN;IH/#6N"!KJY:#.B7ZGR&GD:$[1;87,94X'3I4/_  BOB/\ Z%K7/_!+
MJ'_R-7SV(QL,5-5*V"4IQ@J::Q6*A[D95)135/#13=ZDWS--OFWLD?S;Q)QO
M@>*L=1QV?>']?&XK"82&74:U'B+B/!P6$H8C'8BG#V>!X<P]*H_;YAC*GMIP
ME6FJT5.;C3IQA]N?#/\ 91-A\0_!5X/VB?V9+PVWB/3)C:67Q1BGO+@)<*3%
M:PG3%\V=^%CC# L37V9\1]#T/3?B9K]SJ?Q)^ [>*?"_BW6CHSR?'5- L8],
MU"WM$6U\0>$ET>99=7@,>Z2\>9F=2I..M?DS\)O"^OI\3O +2>&]:"#Q5I!+
M/HM^%7%RIW$FVP N,EC]W&3@#-?I=\1OB!\#O#VI?%KP[K_P/&M?%BVN_'<&
M@^/9/#]]-;P2ZZFB;XM7LQ:NNJ:E:P6TT?AN_1U73!+<DK*9!CT,OJ4/JU9J
MC3PJ6)C)RK8C&5(U)0PTI1C#_9W)5+Q7)=<BE:\DV?I'A]F'#ZX4S:=+(\!P
MG3I\04:WM,[S_C''4<9B,-P_B<7AZ&%C3X?K589C*>'C_9\IPIX:.(LZV(I<
MZOTMMXLU&?PZ_A_6_BA^RU?QW7BBSUK5+S2_C-;:;(VCVBSI+IMBT>BM_9^I
M,LP$>L9S 5)QS6GX#\3Z-X TH>$M)\=?L[ZAX/76(O$=C:ZG^T&MYXE;6M.6
M[&D&?Q!_8?G7FDQ/>S_VIIZKMU"/RT=D\L5\]ZCXI^$GB!=97PAX!\.?#J"U
MMO#+:U;ZSX!U#68->T>VMY!XAM](@\F-Y]0OI"OGV*.DET^UHY4$1!V-.\6?
M W0="\6ZG?\ @:VUL2^#KH_!K1=%\'WNF>(_"UTH*:C8ZYJ#VDZVNK7\CB:P
MN9HY]D:E%!QFNV.(M-256A:%.25:5;$/W(J4I12E0YW&3BHM2I\TJTJ22<7S
MK[+"\2.GBZ.(AFN0MX/!UZ%+-J^=<25(O!4H8JI7P\7B,B6-J8?$5,-##3I5
M\M]KB,VK9;!1EA>;&T_8-'\9:G#HG@&'Q7\4/V7?$/B+X8>,M6\5>"KE?C:M
MCX3L8[N3S=.\.WWAV32':_TW2I'E8PS7+2S&7EQ@9Y1;K48_&?B?QW%\5OV6
M;/4_&'CWP-\0_%6FV7QE-OX>NM:\*-?G5;5-+.EF"VT[Q"E[&@M9BPMS 2YD
MW+CS;0O$/P1GT?P-J'B'P39G3&C\(K>:#/X)O[SQ#IOCFU351XH\0:Y-';Q?
M;=$N9YM-:<@)'J0B#(D0A*ML2:O\'TL[Y=4T'PU?M;:+H$/Q'6R\#WV[QG=0
M?VG]NC\)*MNIDU';+IOF:E$\28A93'\A8RJW/&#]K2:@H3@Y8G$<Z:H\JG*3
MH*;:I6@Y/7V,)Q=-2A"G/%YU+&8?".IFF3RCA5@L5AY3XEXC6(5:CE$,)A\5
MB*SR:&(JU:.6<N#]I4;F\JP>+I5,#"OA\)@,9L_&N/Q)\7/#M[X-TWXW_LI>
M#O"FH>);WQ#<Z=#\7HKR=HIBC:?H\<PTL11:=I;>>T,<4*$F;(?@@_)7_#(W
M_5R7[+?_ (=:+_Y55\PW/A?77N;E[?PQKJ6[W-P]NC:+J&Y+=IG:!&_T;JD1
M13[BH?\ A%?$?_0M:Y_X)=0_^1J\*MC(8FHZM;!N<VE&[QF-244Y6C&,</&,
M8W;:22WOZ?@N?\8X#B7,9YCGO F89EC%!8>->?%G%E.$*%*=:5.EAZ-'A^C1
MHT(RK59PITJ4(KVE[7LH_4G_  R-_P!7)?LM_P#AUHO_ )54?\,C?]7)?LM_
M^'6B_P#E57RW_P (KXC_ .A:US_P2ZA_\C4?\(KXC_Z%K7/_  2ZA_\ (U9>
MTP__ $ ?^7N._P#E!XG]H\+?]&TQ?_B7<8?_ #D/J3_AD;_JY+]EO_PZT7_R
MJH_X9&_ZN2_9;_\ #K1?_*JOEO\ X17Q'_T+6N?^"74/_D:C_A%?$?\ T+6N
M?^"74/\ Y&H]IA_^@#_R]QW_ ,H#^T>%O^C:8O\ \2[C#_YR']!7[.WP-?1O
MV4/ OAW_ (6S\&-4-I\3OB)?G6M'\;1WV@7(O$TL"TM-1%F@FOK;R]UY;^4#
M )(P6.37=?\ "F'_ .BI_"/_ ,*Y/_D2OE[]E_1-2B_8R^'<,NC:A'*OQ<^)
MSM"^FW*2JK1Z. S1M"&4-M*AB,,5*@G:<>B?V-?_ /0%O_\ P6W'_P 9K^2/
M%S%95#CO,XU^%:F,J+ Y#S8A9WGN'4D\EPKC%4L/EU6E'V<6H74W*5N::C)M
M+_7#PMK8&?ACX=RHY)4PU&7!>0NEAI9EF5>6&INCC>6A*M6P=.K6=-)IU*M.
M%25_>@K*_KO_  IA_P#HJ?PC_P#"N3_Y$H_X4P__ $5/X1_^%<G_ ,B5Y%_8
MU_\ ] 6__P#!;<?_ !FC^QK_ /Z M_\ ^"VX_P#C-?FOUW)?^B+J_P#B0\1_
M_.H^Z]IA?^A5/_PMQW_S,>N_\*8?_HJ?PC_\*Y/_ )$H_P"%,/\ ]%3^$?\
MX5R?_(E>1?V-?_\ 0%O_ /P6W'_QFC^QK_\ Z M__P""VX_^,T?7<E_Z(NK_
M .)#Q'_\Z@]IA?\ H53_ /"W'?\ S,>N_P#"F'_Z*G\(_P#PKD_^1*/^%,/_
M -%3^$?_ (5R?_(E>1?V-?\ _0%O_P#P6W'_ ,9H_L:__P"@+?\ _@MN/_C-
M'UW)?^B+J_\ B0\1_P#SJ#VF%_Z%4_\ PMQW_P S'KO_  IA_P#HJ?PC_P#"
MN3_Y$H_X4P__ $5/X1_^%<G_ ,B5Y%_8U_\ ] 6__P#!;<?_ !FC^QK_ /Z
MM_\ ^"VX_P#C-'UW)?\ HBZO_B0\1_\ SJ#VF%_Z%4__  MQW_S,>N_\*8?_
M **G\(__  KD_P#D2C_A3#_]%3^$?_A7)_\ (E>1?V-?_P#0%O\ _P %MQ_\
M9H_L:_\ ^@+?_P#@MN/_ (S1]=R7_HBZO_B0\1__ #J#VF%_Z%4__"W'?_,Q
MZ[_PIA_^BI_"/_PKD_\ D2C_ (4P_P#T5/X1_P#A7)_\B5Y%_8U__P! 6_\
M_!;<?_&:/[&O_P#H"W__ (+;C_XS1]=R7_HBZO\ XD/$?_SJ#VF%_P"A5/\
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M/_T5/X1_^%<G_P B5Y%_8U__ - 6_P#_  6W'_QFC^QK_P#Z M__ ."VX_\
MC-'UW)?^B+J_^)#Q'_\ .H/:87_H53_\+<=_\S'KO_"F'_Z*G\(__"N3_P"1
M*/\ A3#_ /14_A'_ .%<G_R)7D7]C7__ $!;_P#\%MQ_\9H_L:__ .@+?_\
M@MN/_C-'UW)?^B+J_P#B0\1__.H/:87_ *%4_P#PMQW_ ,S'KO\ PIA_^BI_
M"/\ \*Y/_D2C_A3#_P#14_A'_P"%<G_R)7D7]C7_ /T!;_\ \%MQ_P#&:/[&
MO_\ H"W_ /X+;C_XS1]=R7_HBZO_ (D/$?\ \Z@]IA?^A5/_ ,+<=_\ ,QZ[
M_P *8?\ Z*G\(_\ PKD_^1*/^%,/_P!%3^$?_A7)_P#(E>1?V-?_ /0%O_\
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M$H_X4P__ $5/X1_^%<G_ ,B5Y%_8U_\ ] 6__P#!;<?_ !FC^QK_ /Z M_\
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MZ _CK_P;I_\ (U'UCB;_ *.3AO\ Q,<^_P#F</:8_P#Z'D/_  YXS_Y J_\
M"]?C%_T4'6/^_&F?_(-'_"]?C%_T4'6/^_&F?_(-66NO@(JECH_CHA021_:Z
M<X&<?\>]?=WP\_8B^$WQ!\$>&?&MMK/BVQM_$NDV^JPVCWJ.]NEP"1&S%%RR
MXY( 'IQ7T_"W"OB9QKC,3@.%^,X9OB\'A8XS$T:/&N;4I4L-*O'#1JMXB%&+
M3KRC3M&4I7=VK:GH9?E^?9K4J4<OS18FI2IJK4A'-<3%QIN:IJ5YJ*:YVEHV
M_(^"/^%Z_&+_ **#K'_?C3/_ )!H_P"%Z_&+_HH.L?\ ?C3/_D&OTI_X=X_"
MS_H9/%?_ (%1_P#Q-'_#O'X6?]#)XK_\"H__ (FON/\ B!GT@O\ H:U?_$\Q
M?_RT]7_5/C/_ *")_P#AXJ?_ "9^:W_"]?C%_P!%!UC_ +\:9_\ (-'_  O7
MXQ?]%!UC_OQIG_R#7Z4_\.\?A9_T,GBO_P "H_\ XFC_ (=X_"S_ *&3Q7_X
M%1__ !-'_$#/I!?]#6K_ .)YB_\ Y:'^J?&?_01/_P /%3_Y,_-;_A>OQB_Z
M*#K'_?C3/_D&C_A>OQB_Z*#K'_?C3/\ Y!K]*?\ AWC\+/\ H9/%?_@5'_\
M$T?\.\?A9_T,GBO_ ,"H_P#XFC_B!GT@O^AK5_\ $\Q?_P M#_5/C/\ Z")_
M^'BI_P#)GYK?\+U^,7_10=8_[\:9_P#(-'_"]?C%_P!%!UC_ +\:9_\ (-?I
M3_P[Q^%G_0R>*_\ P*C_ /B:/^'>/PL_Z&3Q7_X%1_\ Q-'_ ! SZ07_ $-:
MO_B>8O\ ^6A_JGQG_P!!$_\ P\5/_DS\UO\ A>OQB_Z*#K'_ 'XTS_Y!H_X7
MK\8O^B@ZQ_WXTS_Y!K]*?^'>/PL_Z&3Q7_X%1_\ Q-'_  [Q^%G_ $,GBO\
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MR1BH?P]W/_!-C]MBYNKJY_X41XL7[3<W%QM,<;%//F>8(6# ,4W[2P !(R
M:@_X=I?ML?\ 1"?%?_?J/_XJO[BZ*\W_ %!RS_H,Q_WX?S?_ #Z\S\OE^SR\
M*Y2E*7&7'KE*3E)\_#RNY-MNRRZVK;?S/XJ?AO\ \$YOVS-#\?\ @W5]1^!W
MBF#3]-\1:;>7L[PH5AMH+A7ED8!LD*H)/\C7Z/7?[+G[<ND^)]?LM+^%-KXB
M^'M]XW\6^*%MO^$]M=#U#5;;Q':64.FQR%[26>PDT0P2F&,RM&IE8(BU_1Q1
M79AN#L!A8RC2QF/7/451R4Z*;M#DY7:DTX-)-IK5K>S:/M>%_H6< \)X/$8/
M+.,>/::Q&.ACI5Z>+R3#UFXX18.>&JJ.55Z.(PE:G&FZM&K2]Z4+<WLYSA+^
M<RR_9N_;6T#5M"\3^&?V:M"'BCPQX,NO!N@7'BGXGVVO:+:0W3L&U:XTO[+"
M;C4X[>2>**Y#K(K2!]V%Q7@OQB_X)W_M;_$OP5X3\)Z#\!;?PG-X8\5^,/$4
M=U>_$^QUC319>+'LYVT33=.2PA:R@L+JWFECD>67>LY7J,U_5;16U7A3!5Z<
MJ53%8V5.::<>;#1W=)MQ<<,I1DW1I7DF](122UO[&9_1%X%SC 8G*\QXJXXQ
M& Q=.I3K8?V_#-%6K2RV5:=*I1X:IUJ-:M_8^5PJUH5I3E3P5"FHTXJ3J?QA
M?\.@?VXO^A"\/?\ A4VO_P 8H_X= _MQ?]"%X>_\*FU_^,5_9[17#_J'D_\
MS_S'_P **?\ \SGP_P#Q3]\%/^AMQ[_X>\N_^<A_&%_PZ!_;B_Z$+P]_X5-K
M_P#&*/\ AT#^W%_T(7A[_P *FU_^,5_9[11_J'D__/\ S'_PHI__ #.'_%/W
MP4_Z&W'O_A[R[_YR'\87_#H']N+_ *$+P]_X5-K_ /&*/^'0/[<7_0A>'O\
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M8'_$.\C_ .?V8?\ A13_ /E!^%?_  Q5^T%_T+FE_P#@VC_^-T?\,5?M!?\
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M,.*__#IA/_G8'_$.\C_Y_9A_X44__E!^%?\ PQ5^T%_T+FE_^#:/_P"-T?\
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M\)#+'A<3B,.YO$<[H5JM+FM*G;F]G.'-;I>]NEC]:/\ A_-_P58_Z.N\9?\
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M. ?^C-O_ ,0;AS_YX!_KGXN?])+O_P 6IQK_ /.P[+_AX7^UY_T5_7/RA_\
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M^0#_ (E;^GW_ -' S;_Q=69?_+S\<O\ AX7^UY_T5_7/RA_^-4?\/"_VO/\
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M.?+..CY%&?2-2%W)?F>#GA85KXRG.I1<)Q:INTTW%I2C=I73LUS72W:=DC[
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ME+QY_P!#M\&__#BZ?_\ &*/^&4O'G_0[?!O_ ,.+I_\ \8KYL\J\_P">-_\
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MC_Q(LM_^AX_DS_X=7?MD_P#0F>&__"IL_P#XW1_PZN_;)_Z$SPW_ .%39_\
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M"^#_ /Y24?\ #U;]MC_HHVA_^$+X/_\ E)5O_A)/^"3W_1(/VM__  [.@_\
MRCH_X23_ ()/?]$@_:W_ /#LZ#_\HZ/JV3?]$=BO_#/@?_GB+VF+_P"A_2_\
M*<5_\I*G_#U;]MC_ **-H?\ X0O@_P#^4E'_  ]6_;8_Z*-H?_A"^#__ )25
M;_X23_@D]_T2#]K?_P .SH/_ ,HZ/^$D_P""3W_1(/VM_P#P[.@__*.CZMDW
M_1'8K_PSX'_YXA[3%_\ 0_I?^%.*_P#E)4_X>K?ML?\ 11M#_P#"%\'_ /RD
MH_X>K?ML?]%&T/\ \(7P?_\ *2K?_"2?\$GO^B0?M;_^'9T'_P"4='_"2?\
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MH_M?]D#_ *$GXQ_^%=IG_P K:/J'"G_1J\R_\1;)_P#Y^A_:G'G_ $?S)/\
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M$_\ D"OV7_X)%?&'Q]\5+[XW)XUU2WU)=(C\(-8>3I]C8F$W0U,3@_8[>#S
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M73_HD?PT_P##JZ-_\CT?\0RO_!73_HD?PT_\.KHW_P CU_J(T5[?_$>.,_\
MH%R'_P (*_\ \W'%_P 0_P B_FQG_@Z'_P K/\N[_B&5_P""NG_1(_AI_P"'
M5T;_ .1Z/^(97_@KI_T2/X:?^'5T;_Y'K_41HH_XCQQG_P! N0_^$%?_ .;@
M_P"(?Y%_-C/_  =#_P"5G^7=_P 0RO\ P5T_Z)'\-/\ PZNC?_(]'_$,K_P5
MT_Z)'\-/_#JZ-_\ (]?ZB-%'_$>.,_\ H%R'_P (*_\ \W!_Q#_(OYL9_P"#
MH?\ RL_R[O\ B&5_X*Z?]$C^&G_AU=&_^1Z/^(97_@KI_P!$C^&G_AU=&_\
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M:_K)HH_XG(\5?^@#@[_PSXS_ .>X?\4U/H__ /0V\2/_ !),M_\ H=/Y-O\
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M<VI+RHQ!W@;1BO'/^'QO_!2?_HZ/QQ_WU8__ "'7?>.?''[.OQ>T?P%9>/\
MX/?MR^-=$T!?^$/^'7V[Q]X6\NWV>=*/#VDW=KX:@N+R5-L[K;W,LS(%D*D
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M[ZL?_D.C_A\;_P %)_\ HZ/QQ_WU8_\ R'7FO_"0?\$U/^B2?M4?^':\/_\
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M -'1^./^^K'_ .0Z/^'QO_!2?_HZ/QQ_WU8__(=>:_\ "0?\$U/^B2?M4?\
MAVO#_P#\HZ/^$@_X)J?]$D_:H_\ #M>'_P#Y1UV_4<F_Z)?_ ,P^7_\ R\]+
M^R^&O^B"_P#-;R;_ .;#TK_A\;_P4G_Z.C\<?]]6/_R'1_P^-_X*3_\ 1T?C
MC_OJQ_\ D.O-?^$@_P"":G_1)/VJ/_#M>'__ )1T?\)!_P $U/\ HDG[5'_A
MVO#_ /\ *.CZCDW_ $2__F'R_P#^7A_9?#7_ $07_FMY-_\ -AZ5_P /C?\
M@I/_ -'1^./^^K'_ .0Z/^'QO_!2?_HZ/QQ_WU8__(=>:_\ "0?\$U/^B2?M
M4?\ AVO#_P#\HZ/^$@_X)J?]$D_:H_\ #M>'_P#Y1T?4<F_Z)?\ \P^7_P#R
M\/[+X:_Z(+_S6\F_^;#TK_A\;_P4G_Z.C\<?]]6/_P AT?\ #XW_ (*3_P#1
MT?CC_OJQ_P#D.O-?^$@_X)J?]$D_:H_\.UX?_P#E'1_PD'_!-3_HDG[5'_AV
MO#__ ,HZ/J.3?]$O_P"8?+__ )>']E\-?]$%_P":WDW_ ,V'I7_#XW_@I/\
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M[5'_ (=KP_\ _*.C_A(/^":G_1)/VJ/_  [7A_\ ^4='U')O^B7_ /,/E_\
M\O#^R^&O^B"_\UO)O_FP]*_X?&_\%)_^CH_''_?5C_\ (='_  ^-_P""D_\
MT='XX_[ZL?\ Y#KS7_A(/^":G_1)/VJ/_#M>'_\ Y1T?\)!_P34_Z))^U1_X
M=KP__P#*.CZCDW_1+_\ F'R__P"7A_9?#7_1!?\ FMY-_P#-AZ5_P^-_X*3_
M /1T?CC_ +ZL?_D.C_A\;_P4G_Z.C\<?]]6/_P AUYK_ ,)!_P $U/\ HDG[
M5'_AVO#_ /\ *.C_ (2#_@FI_P!$D_:H_P##M>'_ /Y1T?4<F_Z)?_S#Y?\
M_+P_LOAK_H@O_-;R;_YL/2O^'QO_  4G_P"CH_''_?5C_P#(='_#XW_@I/\
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M))^U1_X=KP__ /*.C_A(/^":G_1)/VJ/_#M>'_\ Y1T?4<F_Z)?_ ,P^7_\
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MZRJN?LU.<G"I!P<5/P?_ (=Z_%TXQ\7OV33GI_QD'X:Y^G^BTO\ P[S^+_\
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M]6SK_H<X3_PR87_YYGWC_P .\_B__P!%=_9._P#$@?#?_P B4?\ #O/XO_\
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MJ7_@#J7_ ,9H\A_^?/4O_ '4O_C-'L<Q_P"AE0_\-N'_ /FT/JV=?]#G"?\
MADPO_P \S[Q_X=Y_%_\ Z*[^R=_XD#X;_P#D2C_AWG\7_P#HKO[)W_B0/AO_
M .1*^#O(?_GSU+_P!U+_ .,T>0__ #YZE_X ZE_\9H]CF/\ T,J'_AMP_P#\
MVA]6SK_H<X3_ ,,F%_\ GF?>/_#O/XO_ /17?V3O_$@?#?\ \B4?\.\_B_\
M]%=_9._\2!\-_P#R)7P=Y#_\^>I?^ .I?_&:/(?_ )\]2_\  '4O_C-'L<Q_
MZ&5#_P -N'_^;0^K9U_T.<)_X9,+_P#/,^\?^'>?Q?\ ^BN_LG?^) ^&_P#Y
M$H_X=Y_%_P#Z*[^R=_XD#X;_ /D2O@[R'_Y\]2_\ =2_^,T>0_\ SYZE_P"
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M ZE_\9H]CF/_ $,J'_AMP_\ \VA]6SK_ *'.$_\ #)A?_GF?>/\ P[S^+_\
MT5W]D[_Q('PW_P#(E'_#O/XO_P#17?V3O_$@?#?_ ,B5\'>0_P#SYZE_X ZE
M_P#&:/(?_GSU+_P!U+_XS1[',?\ H94/_#;A_P#YM#ZMG7_0YPG_ (9,+_\
M/,^\?^'>?Q?_ .BN_LG?^) ^&_\ Y$H_X=Y_%_\ Z*[^R=_XD#X;_P#D2O@[
MR'_Y\]2_\ =2_P#C-'D/_P ^>I?^ .I?_&:/8YC_ -#*A_X;</\ _-H?5LZ_
MZ'.$_P##)A?_ )YGWC_P[S^+_P#T5W]D[_Q('PW_ /(E'_#O/XO_ /17?V3O
M_$@?#?\ \B5\'>0__/GJ7_@#J7_QFCR'_P"?/4O_  !U+_XS1[',?^AE0_\
M#;A__FT/JV=?]#G"?^&3"_\ SS/O'_AWG\7_ /HKO[)W_B0/AO\ ^1*/^'>?
MQ?\ ^BN_LG?^) ^&_P#Y$KX.\A_^?/4O_ '4O_C-'D/_ ,^>I?\ @#J7_P 9
MH]CF/_0RH?\ AMP__P VA]6SK_H<X3_PR87_ .>9]X_\.\_B_P#]%=_9._\
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M;K^JW_B&-_8A_P"BF_M!?^%=IG_RIH_XAC?V(?\ HIO[07_A7:9_\J:/]=.
M?^@5_P#AE_\ NH?\1-\(_P#H7R_\1>/_ ,O/Y4O^'E/[9O\ T52R_P#"'\"_
M_,W1_P /*?VS?^BJ67_A#^!?_F;K^JW_ (AC?V(?^BF_M!?^%=IG_P J:/\
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MX>4_MF_]%4LO_"'\"_\ S-T?\/*?VS?^BJ67_A#^!?\ YFZ_JM_XAC?V(?\
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MQ\KBOWI_XAC?V(?^BF_M!?\ A7:9_P#*FO6O@)_P;W?LB?L\_&[X5_'?P?\
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M+,9AZ$<SXAJTJV&=63H8?+J]6-1XM8>+E!TTHT(J[J3492@WSRM2A-O^QO\
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M17^>5\2(;;_AW%^R5NMF7_C(']I3A[2:-_O^'N=KQ*^"<X)&#V.*^%/)M/\
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M (E]R3_HHLW_ /"/+O\ Y(_U(/\ AX/^Q!_T=1\$?_"]T3_Y(H_X>#_L0?\
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M_HKW27CM0N]$EEO'EVWHDK</W;;=DE>[=K.Y]I_Q"KQN6O\ 9>?K_NX<.O\
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MU\(/^B4_#;_PAO"__P JZ^4?^&ZM%_Z)]J__ (-K/_XQ1_PW5HO_ $3[5_\
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M;JT7_HGVK_\ @VL__C%'_#=6B_\ 1/M7_P#!M9__ !BC_BH?]%;_ */MA_\
MPV\=_P#T/A_Q"GQM_P"A5GW_ (D.'_\ G\=7_P .\/V(O^C9?A3_ .$^/_CU
M'_#O#]B+_HV7X4_^$^/_ (]7*?\ #=6B_P#1/M7_ /!M9_\ QBC_ (;JT7_H
MGVK_ /@VL_\ XQ1_Q4/^BM_T?;#_ /AMX[_^A\/^(4^-O_0JS[_Q(</_ //X
MZO\ X=X?L1?]&R_"G_PGQ_\ 'J/^'>'[$7_1LOPI_P#"?'_QZN4_X;JT7_HG
MVK_^#:S_ /C%'_#=6B_]$^U?_P &UG_\8H_XJ'_16_Z/MA__  V\=_\ T/A_
MQ"GQM_Z%6??^)#A__G\=7_P[P_8B_P"C9?A3_P"$^/\ X]1_P[P_8B_Z-E^%
M/_A/C_X]7*?\-U:+_P!$^U?_ ,&UG_\ &*/^&ZM%_P"B?:O_ .#:S_\ C%'_
M !4/^BM_T?;#_P#AMX[_ /H?#_B%/C;_ -"K/O\ Q(</_P#/XZIO^"=_[$#*
M5;]F3X4E6!4@^'Q@@C!!_?\ <5]4^#_!_ACX?^&-$\%^"]$L/#?A3PW80Z7H
M.@Z7#Y&G:5IUOGR;.SARWE01;CL3)QFOBL_MUZ, 3_PK[5^ 3_R%[/\ ^1Z^
MR_ GBE/&_A#P_P"+8[1["+7].AU*.RDD662V2?.V*250%D=<<LJJ#G@"OTOP
MP^E!X.>.N;9EP_X;>(M/C/,\ERZ&=9C@J>$XCP_U/+ZF,IY;#%RGG66X&A+F
MQ=6&'4:,ZE:\KN"IIR7R?%W!GB!PU@L)BN+\'F6&P6(Q<L/A)8W-*6.A+%JA
M*M*,*<,RQKA-8>,I.;A!./N\[;Y3K:***_;#\_"BBB@ HHHH **** "BBB@
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M*5;J!BB#5I;"]CL0PS.]M,JCY#0!](T5PWP[^)7@CXL>'!XM^'VO6OB/P_\
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M2?X0:^\DCCQ)\.E#R2.%_P"$VTH[0[LP7(('R@XX&..*;_PI[Q!_T,WPZ_\
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M);))))?HJP/$227^L6$T27_)-8%[)+=YS=Z):O5[O5L]:_X4]X@_Z&;X=?\
MA:Z5_P#%4?\ "GO$'_0S?#K_ ,+72O\ XJO)=J_\\S_WZ;_XFC:O_/,_]^F_
M^)J?]8/##_HU6<_^+2X@_P#H-#ZEQ%_T46#_ /$9P/\ \^3ZAU;X7:W+\+?!
M6FKX@\"++9^(_%4\D[^+=/6RD6Y%F$2WNC^ZGFC\L^?&I!BRN<YKSC_A3WB#
M_H9OAU_X6NE?_%5%K:K_ ,*<\ #RS_R-7C+(\INN+#)^[W]>]>5;5_YYG_OT
MW_Q-?H?B3GOAQ#-N'%B?#/-L5-^''AM.G.'B7GN'5.A/A.G*AAG&'"%13EAZ
M?[J5>4HSKO\ >3A3D^5>)D.#S]X?,.3/\+!+B'B)24N',%-RFLUDIU$WF\>5
M5)>\H)-07NQE):GK7_"GO$'_ $,WPZ_\+72O_BJ/^%/>(/\ H9OAU_X6NE?_
M !5>2[5_YYG_ +]-_P#$T;5_YYG_ +]-_P#$U^>?ZP>&'_1JLY_\6EQ!_P#0
M:>W]2XB_Z*+!_P#B,X'_ .?)ZU_PI[Q!_P!#-\.O_"UTK_XJC_A3WB#_ *&;
MX=?^%KI7_P 57DNU?^>9_P"_3?\ Q-&U?^>9_P"_3?\ Q-'^L'AA_P!&JSG_
M ,6EQ!_]!H?4N(O^BBP?_B,X'_Y\GK7_  I[Q!_T,WPZ_P#"UTK_ .*H_P"%
M/>(/^AF^'7_A:Z5_\57DNU?^>9_[]-_\31M7_GF?^_3?_$T?ZP>&'_1JLY_\
M6EQ!_P#0:'U+B+_HHL'_ .(S@?\ Y\GK7_"GO$'_ $,WPZ_\+72O_BJ/^%/>
M(/\ H9OAU_X6NE?_ !5>2[5_YYG_ +]-_P#$T;5_YYG_ +]-_P#$T?ZP>&'_
M $:K.?\ Q:7$'_T&A]2XB_Z*+!_^(S@?_GR>M?\ "GO$'_0S?#K_ ,+72O\
MXJC_ (4]X@_Z&;X=?^%KI7_Q5>2[5_YYG_OTW_Q-&U?^>9_[]-_\31_K!X8?
M]&JSG_Q:7$'_ -!H?4N(O^BBP?\ XC.!_P#GR>M?\*>\0?\ 0S?#K_PM=*_^
M*H_X4]X@_P"AF^'7_A:Z5_\ %5Y+M7_GF?\ OTW_ ,31M7_GF?\ OTW_ ,31
M_K!X8?\ 1JLY_P#%I<0?_0:'U+B+_HHL'_XC.!_^?)ZU_P *>\0?]#-\.O\
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M,W/%S>"K9=POD,:=/#04H3HU.3.G%U85HVDO:59P<9PJ3YERQB_X71\2^/\
MBHTXY'_$ET'@GJ1_Q+.]'_"Z?B9S_P 5(G/)_P")+H/)]3_Q+.:E_M#X(?\
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M(?\ 0K_$C_PI-(_^5]']H?!#_H5_B1_X4FD?_*^C^VO$S_I*#(__ !:?'/\
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M?^%)I'_ROKX/^VO$S_I*#(__ !:?'/\ ]!A[7U+A_P#Z-UC/_$9R/_Y]#?\
MA=GQ/_Z&?_RCZ%_\K:/^%V?$_P#Z&?\ \H^A?_*VG?VA\$/^A7^)'_A2:1_\
MKZ/[0^"'_0K_ !(_\*32/_E?1_;7B9_TE!D?_BT^.?\ Z# ^I</_ /1NL9_X
MC.1__/H;_P +L^)__0S_ /E'T+_Y6T?\+L^)_P#T,_\ Y1]"_P#E;3O[0^"'
M_0K_ !(_\*32/_E?1_:'P0_Z%?XD?^%)I'_ROH_MKQ,_Z2@R/_Q:?'/_ -!@
M?4N'_P#HW6,_\1G(_P#Y]#?^%V?$_P#Z&?\ \H^A?_*VC_A=GQ/_ .AG_P#*
M/H7_ ,K:=_:'P0_Z%?XD?^%)I'_ROH_M#X(?]"O\2/\ PI-(_P#E?1_;7B9_
MTE!D?_BT^.?_ *# ^I</_P#1NL9_XC.1_P#SZ&_\+L^)_P#T,_\ Y1]"_P#E
M;1_PNSXG_P#0S_\ E'T+_P"5M._M#X(?]"O\2/\ PI-(_P#E?1_:'P0_Z%?X
MD?\ A2:1_P#*^C^VO$S_ *2@R/\ \6GQS_\ 08'U+A__ *-UC/\ Q&<C_P#G
MT-_X79\3_P#H9_\ RCZ%_P#*VC_A=GQ/_P"AG_\ */H7_P K:=_:'P0_Z%?X
MD?\ A2:1_P#*^C^T/@A_T*_Q(_\ "DTC_P"5]']M>)G_ $E!D?\ XM/CG_Z#
M ^I</_\ 1NL9_P"(SD?_ ,^AO_"[/B?_ -#/_P"4?0O_ )6T?\+L^)__ $,_
M_E'T+_Y6T[^T/@A_T*_Q(_\ "DTC_P"5]']H?!#_ *%?XD?^%)I'_P KZ/[:
M\3/^DH,C_P#%I\<__08'U+A__HW6,_\ $9R/_P"?0W_A=GQ/_P"AG_\ */H7
M_P K:/\ A=GQ/_Z&?_RCZ%_\K:=_:'P0_P"A7^)'_A2:1_\ *^C^T/@A_P!"
MO\2/_"DTC_Y7T?VUXF?])09'_P"+3XY_^@P/J7#_ /T;K&?^(SD?_P ^AO\
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MQY(17*H<G,G+EYI2YOF^3]DOXW/)))_8FBCS))),?\)%IQ(WNS8)WKDC.#@
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M_H":+_X4.G?_ !RBBC_BE?\ 1I_Z&GBK_P")?E?_ -"0?\3*^(/_ $!\+_\
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M-W_0$T7_ ,*'3O\ XY111_Q2O^C3_P!#3Q5_\2_*_P#Z$@_XF5\0?^@/A?\
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MR[!5L-5=:>&GA&JDZF-Q2E3]E-M14(OGM+FM[K]$HHHK^MS\L"BBB@ HHHH
B**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  = &D# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^[WQY\1/!
M/PM\+:QX\^(WBG2/!?@W0(8IM:\2^(;R*PT?3(IYEBB>ZNYB(XE-Q,EN"3DN
MR#OQY-\+OVN_V8/CA?ZWI/PC^.GPX^(6I>&].DUG6].\,>(K34;S3M)B4M/>
MSP(XE-LBHSR/&K[55CP 37XT?\'3E]?Z?_P1I^/[Z7?76GR2^+_A;;W#VEP]
MO)/9S>++=I[>1XR&>&<*K2(3AMOJH(_FW\$>"?V8[O\ :E_X)IZI_P $B/AK
M^T9X4^+/AS6=/UO]K/Q-XHTGQ)I'PSU+X>V?P^M=1\00:]/<N-.U6UU#48]7
M:&*ZW6]Q%+&\4*AD* '^@1\#?V@?@U^TOX,;XC_ GX@:!\2_!,6N:OX>?Q'X
M;N&N=-CU_17AAU/3I)72-A=V?G0O)'MP(KB,\$D#V-R592%.,DDD<!@1R<?W
MLD<<9 K_ #S?V*O^"GG[3</[-/[!_P"Q)^Q5I?@CX*_%S]MK]L;]JS3#\0M2
MLK*U\/\ A/PMX.UKP_J5XUO;.%MKW6[V'Q-<O:K_ *Z6?1=-TI3NNXU/VA\1
M/^"R7_!0;]A#]JS]M[]GG]I+Q+X+^-,?[)O[$>J_%;PIJGAZPM+*/QIXWU;5
MO"5KX-\0>(5M!G2Y8HO%+2:GITJEXTLHTD4^< 0#^V,QX!!W.Q'WCP.HV@_[
MI.1CW[4PQL?+#,7V!!\PY=@"?FQ_>(5F]"AK^'+X]?\ !1#_ (+#_L9?LQ?L
M*_M1_$[XW_"_XA>'/VXOBG\,;>X\/:7IVF-=_#W3O&+6_B&T\/Z--&=^KV.H
M^&Y3#JMS&6CTN\:.WDPQ KZ!\2?\%R/VB?@!^RW_ ,%9? 'QRFTQ?VZOV3_V
ME].^$/[.WAL:>J7/CCPU\>/$4%A\%M4T_2A\^I&TT.SUW62T,<OFQQ6$0&;A
M0 #^PY4887+EEW%GXPY).0?8'VS@=*Q?$.MZ+X3T+6O%'B?4[31/#7AO3-1U
M_6M8U"=+>RT?2-*M);O4KZ\G<[(K2TLH;BYFD))6,.<%ABOYQO\ @JC^U!_P
M43_9M_X)[?L4:]X%G\26'Q6^(>O?#WPU^UY\6/ G@J;QGK?PLT[4O!=OJOB'
MQ3I_A&S5I+F&+5Y+B&ZC12L MRK#M7Y ?MH?MK_M&?&/_@E[\-?V9O#7[8-A
M^T/XT_;E_;N^&_['NE_%30](B\'^*M#^&&O:;'?:Y9^)]'M&2ZTK4M8UX6^B
MS6MQB672TO$'RYH _2;XG?\ !8']MW]OKXH>(_@S_P $;/@E;>*/AAX2U:X\
M*^+_ -KOXBQW>F>!I?%5A-<>?9>"[S?'::C8" 0O->C>V\8214D9*QC^R[_P
M<YZ99VGB.']K#X*:QK<;K=7WA*?4YQICQH6E:RMYBWE.S +%DL5;/RY->!?L
MJ#]O3XV>,/VI_P!D7_@E5XW\#?LE?LK?\$Q?$-Q^SUX:2]T>RU/7OCY\>_ =
ME-;>*5\87$P$]FOC#7-.EO+S7KGB%)@DKYCP+A_X+U?M<_&']A#]D;P?\(_!
M?AK1?^"@W[3/[8&N_L0ZCJ=]-;KX-T#Q;X(U&"PUWQK:2N!:,-3DOM-ACMP0
MMJ999U8_)@ ^TOV4?^"T_P ;?@U\;/"W['O_  5W^#/_  SC\4/'-^FA?!_X
MY:;%<-\)?BE>VLR6-U!=:W,SV]EK5Q-=:6L$2,JR).I9'9BR_P!,7F+Y?G(R
MR1G8ZF(AQ)Y@5A(K#*L"K!E*DJ5.>1@G^&/]OWP%^UQXA^*NE?\ !*#_ (*+
M>//#7[2J_M-_ SXR_&[]B?\ :/T+2(/#?CKX7?M#_ _P)K7Q"DT^*.V7[99Z
M*\>A_P!@2R92.^2:"7YTMP1U'_!/;_@L=^U!I^H?\$=/&_[07C*TB_97_:%^
M'/QE_9"^+6J:NL,$6F_M'_ SQ'J>AZ+XTU[796)A?6/#NG:+>E7.V?[7>9(,
M2D ']O,9D/,BA3@YVD%2"Q*$<DY"]<]S4M?A9_P18_:__:/_ &[;[]NS]I+X
ME7T0_9PU3]I[6?AU^Q_I"6Z)Y/P^^&BZCH'B368;E<M?66O:D=+O+>Y)93,+
MM%.$ '[F[V]?T'^% 'Y^_P#!3?\ 82T'_@H_^Q[\0/V4]?\ $]QX-MO&FJ>$
M]9M_$-NLCFSNO"^OVNJ(LD<89WCN+=+JV"!6VR2QLPVH2/ICP!\"_A[\//AO
M9_#CPMX8T;0K2W\":;X#N]3TS3K2UOKNST[PU'X;6>:YAB6:2;[/$&+-(=S,
M78DG->U^4-V[)VXX3L&R26'OSC'3@4XQC! )7)ZCKUSCGM^OO0!_$I^V5_P2
M&TK]B']CC]F/X(^"?V>OC=^U9JOP\_:&^./QFTSXW_ OQ&GA/XA?!>Z\97^@
MWVA:997UPHNPFJ_V?I+%HAL^V:%<RME95!^>?V&_^"='[1GC?XE?\%#/VT_B
MY^RA\9O$7P]\6?L:W7P-\"_ [XS>)K?7OB_\<?%>N0:'::Y=:EKTRB(WVE2:
M#'K-G<RX1-]HBX9,'^^]H48,K*KQOC=&ZAXR02V2K9!.[:?JHQ[(L"*%50J(
MI)V1JL:'., JH XQ^(X- '^;#X'_ ."</[3/[7?Q"_8__9L\&?LS?M;?"3X:
M?!O]H'P9XQ\6>)?VA_'L?BKP)\*?AAX7NG?5]*\ :8%!L!<7<QE$41=Y(T6*
M,<C'ZIZW^Q7\2_\ @IO_ ,%\O!/[2'CW]D?QQ^SA\"_V9-MU\9==\9W\%YHG
M[17C7X'^)-?TSX'^(=.M+6**"4W%K?:9>6LMPDDD&EZ2D;M(Y9V_M(2"&)V\
MN&&,N")&CB1&?//S%0"?Q)YYS3EBB60E8XU+%2650K-M4[=Y !?!8D;LXR?K
M0!^=?[?'[%7Q"_:SM/AGKGPN^/\ XP^"'CCX2ZIK.L:58Z9<N_@3QM+J]DED
M=,^(.BQQ3'6-)MX5D\J (2AE;&,YK^;K]N3_ ((&^-/V6/V!+KXI_LD:A<_$
MK]K/X,_MH^"_V_M:TO2XYXM+\3ZYX8:^M-8T3P?I4ZE["QT6TU:;Q##9(BM/
M%I;0(BL4+?VNA,!?F)*YR>[9SU_.HY(D975T61'0HZ.H9)$DW*RR*1M=2A*E
M6!4@D$4 ?PW_  *\,_ []N/QW\2/VE/V"/V__P#A@;XP_M@V4U_^V[^S%\3=
M1?P]J'A[X@ZM;0V_C35?"EG?3VYLO&#:K_:<EMJXC56^VL5/S9'ZB>-?^"*/
M[",_["'P;_98\ _M%:3X \;? +XG7?QZ^&7[0MK\2/#L7BZS^-^I2&YU?Q=J
M.J)J/FSQ7]Z(7F16:4K:6Y*[@5'U[^UW_P $)_\ @G]^U]XUU+XF>)/AF?AY
M\3M9F:77_'/PWNKKPUJ>MB6%XF%]!IUS9VID+'S3-&B,TG+ DYKX+C_X-5OV
M.28;:\^._P"T3?:+;RB6+19O%^JK;*P.!F0:Z7/R?+R"#U(S0!^6G[3.N_#S
M]C_Q;XQ^.'Q#_:T'_!1__@J_KGPK\7_LR_LD_#[X7&?Q!X4^%T?Q5TL>!;SQ
MJEM9/=1:;JUAINKZI/K&IR(L<PNI,N!DCFOVM_\ @GW^T=\+/^"1_P"Q=_P2
M:\+?LD?$'XL_'#QI?:)^T9=?M#^'M3MK?P]\%?CGXZ^(&L7_ (T\*:N5@.H(
M^FZ'K4EO?R0W44-Q9);H(_,A1T_JR_8O_P""/?[#'["VKGQE\(_A+INH?$Z:
M&XMKGXF^+FF\0>*Y+>X*M)##<:E-=Q6@+@/YD"K.' *RKC%?J%Y,3%9&C1Y
MP<.Z*S*V ,H2,J0H !7'2@#Y"_8%_93\,?L3?L??L]_LO^&(HC!\(_AKH7A_
M6;V-5_XF_BZ:!-0\9:U*X ,TFJ^)KG4[I9'+.('AC+$(*^PL#T'Y"D"X).23
,C'/89)_K^E.H __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  B %L# 2(  A$! Q$!_\0
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)110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  1 &,# 2(  A$! Q$!_\0
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I]X?^@R444 17W_'C)](O_9*?)U/_ %T/_H2T44 .B_U2?[HHHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>image_005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $E G # 2(  A$! Q$!_\0
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M]*F6SUFX\+?!SQ#HMA)H>ORW<%U$VG>-/$WBJQ\.SB6UN=.UN11)!\>?#/\
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MA']I+6O'&FV$/Q!^+&D:'%<66K:E97OB;4[75K;7[_5_$^HV^OZ1';_V _\
M!D?\+OB'X?\ V:?VU/BUK>GZG8?#;XD?%WX9^&/ =Q>0S0V.N:[\.?#'BB7Q
MQJ.E><%2YM[(>,_#6DW%]:B2"6_M;NP>7[3I4T40!_<!1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Y[\2OBKX"^$&@VGB7X
MA:[_ &#I&H:U8^'=/E33-8UF[U'7-32YEL-*T_2]!T_4]4O;VYBL[J2.&ULY
M6*6\K' 6O0J^4/VIR1>_LPX./^,K_AB/P.@>.01^(X/M7/BJDZ.'J5*?+SQ4
M%'G3E%.=6A3O**E%M)56[*4;M)72;/G>+<TQF3<.YGF67_5OKV'A@H85XNE4
MKX6%7&YQD65JI7H4J^&J5H48YO4K>RAB*#J2HTX.K",IR+?_  V;^SW_ -#-
MXN_\,_\ &3_Y@:/^&S?V>_\ H9O%W_AG_C)_\P-?4E%1R8W_ *"<-_X1S_\
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M(1C/_HU/E'_AMG]G+_H:_%W_ (9SXT?_ #OJ/^&V?V<O^AK\7?\ AG/C1_\
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M_P"C8^3/^&W_ -G'_H:?&/\ X9OXS_\ SOZ/^&W_ -G'_H:?&/\ X9OXS_\
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M1M;#QDK2:)IK>)=/U*+2H+Y9$N=,U*[U/1K'3]!U.QO+7Q#<:;-"Z5]<0?\
M!$;]F$?#_0?A5;^ K+5]>U^?PQI,OQ&M_'-T/B3H.O\ C'1D\1:!J&OZA)]F
M\.Z7:7.E"?46C@T:]\*PVMC?VMQ(\UM+N_JUA_X)W_MB2:E::UK>L_L^ZWK6
MGW.HW%CJZZQXT\.WL<>I:O-KEQI5X/"?A;0[76- FU*[OI[S1-7M;VTU+[=.
M-0^T$1,E%?\ @F[^UK:"YFTB_P#V==)U/4-(TW2M3U6+4O&5_+>G1_"Q\&:9
M>+8:OX6O]&LI+3P]<:I:):66FPZ8TNJW-S)9/)!IWV+\8RG$_1TR:>/GA/\
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M2Z?X/D.JZ#H?C27PY##\+]8\9ZAXAT'3)=(L[&5_&4FAS:?#+-<:]+9V8O+
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M]_9A_P"SK_AC_P"F'QS7U?7RA^U/_P ?O[,/_9U_PQ_],/CFN3'?[I5]:/\
MZE8,^-\0/^20S?\ Z^9'_P"M;P6?5]%%%=9]D%%%% !7ROX!_P"3O_VD/^R1
M_LV?^G7XZ5]45\K^ ?\ D[_]I#_LD?[-G_IU^.E<F)_B8'_L-C_ZC8P^0XH_
MY&/ G_9:X?\ ]9?C4^J****ZSZ\**** "OEC]C/_ )(19_\ 94?VA/\ UH#X
MG5]3U\L?L9_\D(L_^RH_M"?^M ?$ZN2I_ON&_P"P?&_^E8,^0S#_ )+GA/\
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MZ$\?C32?$WB7X%^-_BA<^+?AEHWA2[^,?C/Q3\/OACHYLXM,NV\-_LT>"?\
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MCE1=6I"FI-<<<4R:CS-<S4=6E>RU=D?=U%?GS_P]-_88_P"BQ:Y_X9+X_?\
MSK:/^'IO[#'_ $6+7/\ PR7Q^_\ G6UZ_P#8.=_]"?,__"'$?_(GU']HY?\
M]!V$_P#"BE_F?H-17Y\_\/3?V&/^BQ:Y_P"&2^/W_P ZVC_AZ;^PQ_T6+7/_
M  R7Q^_^=;1_8.=_]"?,_P#PAQ'_ ,B']HY?_P!!V$_\**7^9^@U9VKV;ZCI
M.J:?$Z1RWVG7MG&\F?+1[JVE@1WV@ML5G!;:"< X!-?!7_#TW]AC_HL6N?\
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M^EZ7>6OE3:=:-#5_X>S_ + ?_1;]6_\ #)?M ?\ SJZ/^'L_[ ?_ $6_5O\
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M%O<6_P %OCW/;W$$R++#/!/%\+WBF@FB99(9HG:.6-EDC9D8$R?\/3?V&/\
MHL6N?^&2^/W_ ,ZVE_8.>?\ 0GS/_P (<1_\@']HY?\ ]!V$_P#"BE_\D>Y?
M\**^(/\ T=)\;O\ P"^$_P#\[>C_ (45\0?^CI/C=_X!?"?_ .=O7AO_  ]-
M_88_Z+%KG_ADOC]_\ZVC_AZ;^PQ_T6+7/_#)?'[_ .=;1_8.=_\ 0GS/_P (
M<1_\B']HY?\ ]!V$_P#"BE_F>Y?\**^(/_1TGQN_\ OA/_\ .WH_X45\0?\
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MH_X>F_L,?]%BUS_PR7Q^_P#G6T?V#G?_ $)\S_\ "'$?_(A_:.7_ /0=A/\
MPHI?YGN7_"BOB#_T=)\;O_ +X3__ #MZ/^%%?$'_ *.D^-W_ (!?"?\ ^=O7
M@MW_ ,%6?V"-.MIK[5?CI<:-IMLHDO=6UOX2_&_1='TZ NL9NM4UC5?AM9Z9
MIEE&SKY]]J%W;6ENIWSSQH"P_0Q'61%=&#(ZJZ,IRK*P!5@1U!!!![@UR8K+
M\=@53>-P6*PBJN2I/$X>K151PY7-0=2*4W!3@Y*+;BI1;24DWM1Q.'Q'-["O
M1K<EN=4JD*CCS7Y>91;:4N5V;23L[-V:7S;_ ,**^(/_ $=)\;O_  "^$_\
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M)SJ?A71+K4K76_!6BZMXFT3Q-9BYM/&6F:3J%SX8U+6WL+A8MCVS]<Z*\O\
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M5K?P(\+>.?#GB&TOK_PY;3:/XGU*WU70;C2/#EAJMIXXT6WTV_O]4TU6L[<
M[R#X)?"?2/%%UJ5]^VA\()?B5_PEO[/OBO33J6C>!;K3XO%_@+X7VWPV\ VV
MI?#F_P#B7=:%K6E^-_ "-?V&F06FG^()=9FM?$NEZ_<65E86$7ZGVEO)9VEI
M:32)--:6MM:S316D6GQ2S6\$<,LL5A 6@L(I)$9X[&!FALT9;>)FCB4G\_\
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MVL-*TO5[_1-(MKC3=!U;1/"4^H^'-6TKQKJ>H6?B! #]2--_X.4O^"4'P_\
MB)X0_9\\):M\8KOX9>'[+0?!.F?&W3OA^Q^%NAV6G6UMI.GO<6^N:Y9?$V^T
M>P@AC74=<7P9+,^U[R*TNXFDF7^B73=2TW6M-TW6M&U"RU?1M9TZQU?1]6TV
MYCO--U72=4M8;[3=3T^[A+0W=AJ%E<07=G<Q,T=Q;312QDHX-?Y__P"V!_P2
M>_X*B_M#?$.'X'Z/_P $YO@C\';"[^*ECXM'QK^!'B/PEI_P'.C3^$+#PNS:
MYXDNH;36VTS1/LTEY;F>UT[6[:V9],F\(ZQK#Q:M<_UCI\8M9_8M^!?P_P#V
M>/ 'AV+XE+^R=\-_@9\&?B7\1/B$GBOPM87WB"74/A;X$L[KP/ ]I:0>-=(N
M;3Q%K<FH:E::Z9?#FIV.F:<^G7MFEY?1[T\/5JT,=B8QBL/EN#JX_&UISA3I
MT</2M%)RG)*5;$57'#8.A&]3%8J4,/2<:DXN7K</Y)F/$_$&1\,9-16)SGB+
M-,'D^5X>4U2A4Q>-K1HPG6JRC.-#"8?F5?'8J4*E/!813Q=:E*A2K2I?TK>!
M_P#D2_"'_8K^'_\ TTVE?GB_^LD_ZZ2?^AM7M'[&_P"TA>_&SPOK/@[QEX"O
M/AE\5?A2FEZ1XQ\(!]8U;0H=-O'U&W\*ZAHOBR_T?2['6+C4-&TJ"_UO2+.6
M^O?"]S?6MAJTWG7$#R^*NZ>9)\R_ZR3^(?WV]ZTQ^!Q&6XJK@\5&"JTN5\U*
MK"O0K4JD54H8C#5Z3=/$87$T90KX;$4[4Z]"I3K0C&%2"?BTJL:T%.*G!IN%
M2E5C[.M0K0Y56PV(I.4W1Q.&J2=#%4'.I+#XFG7P\YRJT*W)^5__  4P^-P\
M#K\&/A3J1U9? /Q \0?\)#\88="U.XT35]=^&^@ZQI-EJ?A>RUBS4W5@-1CO
M+R[N7@#F8V5K!*C0M+'+YSX*_P"":'P:O?B?^U1X.\6Z[KUCX73Q/X4^&W[&
MFJQ:S.+?Q)XR^*/PYUOXJ^ )M<OX+1;?7M/M?#D&C6.I&XC@M;B6YE5C%>RI
MY7TC_P %!OV6=;_:-^'V@:UX"CMKSXC?#B;5)]+T6>>*W'BKP]J\<!UC0;:X
MF9((=42>TM;_ $H3O'!<RI/9R2H\\3#\Y-4_;3_;>L=&_9]^$>D^"_&7@W7?
M@#%IVB/%I?A/Q._B'XIIHM]X;;0;#Q[!-I\WVF'2K#PMIFC6W]E/"\M@]R5N
MQ'.$'\F^(M.A@N.<UQO&638[-LJK0RJIPK4P^78G'T*]"6 EE&8Y*ZE&2I8>
M6&J8S%9[&C.5.K/-,+@\13AB95*:?^KOT<,1F&=>!'"N1^#'&N0\(\5X.MQ9
MAO%?#YCQ'EN08_ 8^EGU+B_AOC6.'QD)8G,J>9X;)LJX#GC*-.OA:'"V:9UE
MV(KY=3P^)E'W/_@E#\6_&*:W\1/V>O%,][-I?AS29O%'A[3[]Y))?"FK:9K,
M>A^*M MO,):VT^XGGBNA8J5@M;^UN6@13=R"OW:\ _\ ([^$O^QATK_TKCK\
MX?V/O@3XMTSX@?&']I7XE^#-(^''Q(_:%UZ34+/X7Z+=2W=IX#TO6=336=5M
MY99VDEM[_P 1^(7&HMI>^1M(M5CLW*R2-!%]):]\3OCOX+\=6/\ PAG[-OC#
M6].T;6T2QU7Q'I?B&PG\2W>GS;Y'T:RLHXDBLI?*>2R\X7UW-;[+J:*)'-NG
M[YX)\)<28C@_ 97BJM&%7!2S"IAJF>X_"9+.CDM7,:T<DHXC^U\5AZE'$UL+
MRU*67R4\3A:>)I8:K"A[*,(?PS],+CS@7,/&OB7B+AO#TUA,SPW#M/.8<+X:
MIG^7XGC6AP_@_P#73$9=B<BPM?"9A@J&<NIA*V=X9QP.;XG+<3F>&K8M8N6(
MQ/ZE?&/_ ))OXE_W-+_]/>FU\*5]4ZGXWO\ X@_ &^\4:OX/\1> M5O(=.CU
M/PMXILIK+4]+OH-=TQ)XU,\4!N[-V^>SODB1+B(@E(Y%DC3Y4WI_>7_OH?XU
M]CB,/5PN(K8:O&,:V'JSHU8QJ4JL54IR<9*-6C4K4:D;J\:E*K4ISBXRA.49
M)GX-AZ]+%4*.)HR<J->G"K2E*%2E)PJ14HN5.M3I5:<K.TH5:5.I"2E&<(RB
MT.HIN]/[R_\ ?0_QHWI_>7_OH?XUB;#J][_9Z_Y&O6_^Q>/_ *<K.OF3Q7XH
MT;P5X3\5^-O$$\L/A_P7X8U_Q?KLMM&D]TNC^&M*NM8U 6=NTD0N+V6VM'@L
M;8R)]IO)8+<.ID!'Y[?LX_\ !7RS'C[Q3<Z[\,?A7X/\%2ZGIVE:;J'CS]H?
M0_ASXNL/"DWB'5[*_P!6FT?Q1HLVG^-=1M[72+749X?#S:#965S))I#3SM-#
M>U[%'(<TK\/9UQ7##6R#A^ME^&S3,*E6E3A1Q6:5XT,'AJ5.4E5Q%:;FJM2-
M*/+0P_[ZM4BG&$^G(<'BN)^,,DX"R&C/,>+>(L)G&.RC)Z*:K8K"9#@*V99E
M6]HZ56E35+#T*D:,)J57%XGDPV'@ZDU./]#_ ,5O^2>>*?\ L'I_Z5V]?FG\
M3-6\.^'_ (:?$;Q!XPT)O%'A'P_X!\8Z]XJ\,)IT.KMXD\-Z-X=U'4M;T!=)
MN UOJ9UC3;6YTX6%PK6]U]H\F=3$[BOT;^(&KZ9KWPFU;7M%O[;4]&UKP]I^
MKZ3J=G*LUGJ&F:DUE>6%]:SJ2DMM=VLT5Q!*I*R12(ZG!%?#(D4'(9.X()4@
M@C!5E.0RL"0RL"K*2&!!(KRJ51TZE*K&4DZ=2E5C*E4E3FG"I3J1E3JP:G3F
MN12IU824Z<_9U824J<&L9QJT:DX252A7HSG"2E&=.K1KTIR@U*$E3J4ZM&M2
M:E"2IU(5*4HM0G!J'\X7A*\_X)JOK7B&?XJ?LY:7X<G^)VF>%+>/X#?!O6M5
M^)/PL^'^G>.O 7@KQY!\</#6GR^'? ]Q\)?B5X?\.^*O#6C:]K_PNO-0TCQ(
MR27OA<:U80720WM1\6_L(:'I_@VZ^'G[/_Q;\?\ C7P3X3^(/B[Q%XE^(^H^
M&O#-O\<_ _A_P9JGQ$T>7]HH&76+?XO^&/%MQILFGZ?J>HZ(/&FB3Z%:ZK<Q
M%_LD[_LMX@_9A^'LDV@)\/?#WPI^&NC:7KMMXAU+P_IWP0^&>L:7J6M07CW*
M^)+.&\TFW&E>+K:"22QTS75%VNG6[E$L98_W5<_J?[,MW/<Z++;^(_A9J=EI
MWB+3;JZTGQ'^SO\ "Z6&7PK;W&KVE_H.G7MA8K/IU[)X2UB[\)65_%;^1#IU
MYJ;36LCWQ,7ZAB/$/-,PC#Z[Q'Q/B*?)&,L-CN(,PKPY:6'GA*=.=Z5>51RP
MK]G4G5QE>IB)+#XC%8C$8W#8?'8/W<%X@>)>614,OXTX@PG+!4XSPV85H2<?
MJE7!R;G*KSROA\1.,I27/*I3P^*<GC\%EV98'SK]B#XF?LX>(=2^,'PY_9P;
MXNZ;X6\*:U_PD\'A/QS#.OPZT2QU7Q%XC\(W5Q\'3?R7>J:;X<O/%/@[Q##-
MH%Y=PI:"U@OK?3+6.]5I/UR_9]_Y';4O^Q6O_P#T[:%7RC;>'/A9\,X_&_CF
MQ\.^"/A_;7=KJ?BWXA^*M*T#1M#GO;'1K:\UC4M8\2:AIUI;7&I"QMUO[\F[
MED'VB6ZG7;<74\DGXX7W_!?^7X'7VL_$%OV1_B+I/@*RO$\.I>^,9K1-7U>P
MU;5HO[("/I.MS6=MK6OPZ9!?6%II>G:Y!I]C>+<7,NI6RQW<GRV7Y#F?%^8U
MXY'AU5JSE0@J>8YMEE#%8G%5*5O949XW%X">/Q-:5*I45+"T<35A32G7<%+V
MD_+S[/\ /,XKYCQ-Q+B<VSW'.,,1G>>K+,?CW"G0H4,+3QN=8W+\JJ4:$OJ^
M'PU.MF.:UJ%?&U*?M\3C<PQ<L1BZW]@5%?.'[(W[4/PY_;-_9U^%_P"TI\*C
MJ,7@[XGZ!_:MMI>M0"UUWP]JEG=W.E:_X:UVU!/V?5M UNQO],NP,1S&W6Z@
MS;W$+-]'U\YB<-7P>(KX3%4IT,3A:U7#XBC424Z5>A4G2JTYI2DN:%2$HMQE
M*+LI1G.,HSEP4ZE.M3IU:4XU*56$:E.<7>,X3BI1E%]5*+37XV::11116!84
M444 %%%% 'YZ_M/_ /)[G_!,G_LHG[4?_K+7CNOT*K\]?VG_ /D]S_@F3_V4
M3]J/_P!9:\=U^A5>OF/^Y9#_ -BS$_\ JZS(XL-_O&8_]A5+_P!0,*%?+G[1
MO_'SX0_ZX:]_Z,T>OJ.OEO\ :-(%SX/R0/W&O=2!_P M-']:\@[3Y?U'3[;5
M=/O=,O/-^RZA;36DYMY6@N$CF0KYMM.GSP74#;9K:=/F@N(XY5^9!7QU\4[;
MXN>+;J3X5>(=*TWQSI6B^&HO$-\-'71Y-<^)NC:AJ=]H.G7UWIOB"UEAT&^T
M"ZM;<>(M/TJY)U.>^?5=&NHA!#I@^S]Z?WE_[Z'^-<OJ_A_[9K6E>)])O(-.
M\2:1I^K:-#>S1&YMKG1]8\B>>SO+='1IQ9:G9:?K&GC<%2\M7AD(@O)V7PL^
MRIYGA?91JXJFIRIT<7#"U(1>+R^52<J^'G2K1E0KN$G3K4J=7V:GR5\/.K[#
M$U:<O-S/!/&4>2,ZT%)PIUXT913KX5RDZM*5.HG2JM-PJ0C/D4E&K1E/V5:<
M'Y'\*+WQGXY\/^$X]8AN-"\'>" NAWMMJ#0IXF\>>,/!LSZ)>7>J6-E+<V.@
M^%=)UFPFFM[(7EYJ?B&^M;>XOC964)MKKZ&Z]:P?#6A:=X5T'3/#^FN[VFF0
M-&)[B17NKRYGGEO+_4+MQ@/=ZC?W%U?73* IN+B3: N )O$MQXLTSPY<ZUX/
M^'?BGXEZFEY%I]MHGABUEE6.XEADN&N]9O8HISI^FP11_,8XGN;J:2*WMQ'F
M2>+U.'LHQ<H8#+E46(S+$QPU&K5Q.*P]&E[6G0C2C3>(Q%3#83#87"T:2A&4
MJE.DE3K5YSK5L3*528SAE.6RQ&-J5IO#X>G/%5(4ZV*JOV5.%.-*A0PM&K5J
M*"Y*-&C0HRE.7/4;E*K4JQ^[_@7_ ,D_M/\ L)ZM_P"E35[#7PE^R-\8/B=X
MD67P;X^^!GB+P'8 :AJ&C>+[1-0OO"]W.LSO>:;?W5Z97L;Q&5X[>1;J:&>9
M#;&*&;!;[MKV<SRS$Y3BGA,5/!U*GLZ=6%7 8_!9GA*M*JFX5*.,R_$XK#58
MOEDFHU%*,HM2@M'+7+<RPV:X98K"QQ4*?/.E*GC<%C,OQ5.I3:4X5<+CL/AL
M13:YHM-P<91:<9RU42OG']HK_D%^&?\ L)7O_I(*^CJ^</VBR!I?AC) _P")
ME>]2!_RZ#UKSSO/E.6**>*6">-9H)XI()X7&4EAF1HY8G'7;)&S(V,'!."#S
M7R5\1[7XLM<:5\(8KBT\4>%+O2=>\06-P+JQ3QAXQ\,>'[WP_8S_  _U2'7[
M.XT4:MI5CK;WD>N+*(_%-GIUK::E#87+WLEW];;T_O+_ -]#_&N=US0;?5KS
M0-7AEBMM<\+ZA/?Z+>R*9(@M_9R:=JVFWD:,KRZ=JUC+Y5U&C+(LT%G<QL)+
M90WCYUELLQPKITZN)HS;A3J_5:WLIXC!3K4WC,+-24J555*2=2G"HHIU:7L_
M:PIXK$1J^?F.$>+H.$*E:G*\83]C4Y)5<-*I!XBA)-.$U."YH1FDG.'+SQA6
MJJ?@/P>C\;^(?"VF>!+ZRN_"/@SX<:M<>&O$L.H7,3>(_$M_I4L.JV7@W3;6
MPN+JUT?P9H=EJ&DZ=?ZI<WLVL:_;60TV*TTZUENW/U&2223U))/U/-<[X:T&
MS\,Z6=.@N'NY[B_U+6-5U"XV+<ZIK6LWDNH:IJ$ZH=J&>YF9885)6VM(K>U0
MLD*D^<_M ?&_PW^SO\)_$?Q8\2Z;?Z]9Z+<Z-H^F^'])GAMK[7?$GB2^&FZ#
MIOVR:.XCT^R>Y+W.J:D;6[:QTZUN9H[6>;RHV]#A3A_,*\LJR3!T\1F6<8^>
M#R[#4'.G*I4J-RP^!P5&SI8:C3P]!4X2<7"C[2GC,55JS34X<\:F&R/*:N-S
M+$^RP^ P;KXS%5Y.4</A<)3ERQ2I1:4*%'V4%"C3DZM>4Y1]I.K#E_2?]GO_
M )$[5?\ L9KS_P!-FD5[Q7X/_L!_\%0]/^)FM>$_AQ\0_"_P:^'DWCWQ3JUC
M9WEG\?-&;Q<NMW<%I#X9T@?"#7=//BPR:HZ6NFI>+K;K=R2)JUO8Q6DQMH?W
M@KTLQP=;*\US7)L7[..89+F.*RK,:5*K"M"CC<'4]E7IQJP]RK",[J%6"5.H
MDY0O%7/K<;D>;Y;E?"V<X_ 8C"9;QIPWEW%O#6)K0E&&99#FD7/"8NG^ZA&%
M1I)8C"RJ5:^$G4I0Q#C*K34BBBBN4\H**** "BBB@#Q_XK_\P#_N*_\ N.KP
MS7+^72=#UO58(?M$^EZ/J>I06^"?/FL;*>YBB(')$DD2J0.N<=Z]S^*__, _
M[BO_ +CJ\>95=61U5T=61T895T=2KHP/564E6'<$BOLLIM]2P[:;C>;DE=-Q
M5:7,D[.S:ND];-I]#Y+-DY8G$QC/DE*"C&:LW"4J'+&:3T;A*49I/1N*3T;/
M8O@3X:TWPY\+?"$EFRW=_P"(]%TWQ9XBUM@KW?B#Q#XBLH-4U35;RXY>=I9[
MDPVB.S)9Z?!:6%N([:UAC3L/'.G6E]X=OY;A$,UA"UY:3, 'AFCP2$<\@3IF
M&1,[7# ,"0I'S]X!\2ZY\.=+M_"]I96_B+PG8-(FBPSZ@;#6="LI)#(FE)--
M#/:ZEIMD7>.P$C6MS:VPCM2\\44(3K/$WCNZ\06HL(;3^S[-RCW"-,)IYV0A
MEC=T58UB5P&*INWLJDOM&T_-87"5\9C<1%Y?C\)2PF8U(J68X=4E4IT,2ZM#
M$X:K&MB*6+IU81I5*->A.+YW)5*>'JPJ4UZ-"K@L'D^#PT94)*&!I8>.'A-5
M)QJ4J,*4W5BTI1<JJJ5Y5:C<JDJLJO/.K.<C@Z]^^&?_ "+C_P#82NO_ $5;
M5\@?%?Q=XJ\ _#KQ1XP\$?"WQE\:/%6CVUNNA?#CP);K-KOB#4[^X6UM$EN)
M%>+2]'M79KO6-5DCG:TLH9!;VUS=2P0O\O?LC_MB?MYZO\3M*\!_M#?L#>,_
MA]\.?%&J-:VWCWPII>O,G@FZNQBWO/%D.NZC>KJ&A*8HH+V_L#8W-B)6O?LM
MS#$;>M.).(,NP-;#Y17^NRQF+G0J1>'RW'XG#482J3A!XK%T,-4P^&]I)^ZI
MSDU']Y55&FU-_I7A]X-<:<:<,<0\>9-5X/I9%PS#&T\50SOC_@GAWB',ZF$P
MD,;C:?#G#&><0Y?GF?RPF&]^H\#@Z4*U;_8LOJ9GCT\$OVBHHHKSCY$****
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M2[#1O$-S9:9'-#8_9-+NX(9YS<RP_;]-M;QXFG95:0)),RJQ4': .U96A_\
M(5LO^NI_]%O0!^C=%%% !7Q7\<+NXMO'UX\=Q<QK%I&G2A8;B6+!CAGDRFQ@
M%8E?O  YYSFOM2OB;XY_\E NO^P5I?\ Z+EH _G0T/\ X*H_M.:SX/\ "7VC
MP+X/TWQQX>\$?&+Q3\>K^?3_ !R/"K:K)\'/'OQF_9=_X5Y'-KBR/;^-/"'@
M]_$'CQ;[4-6FTP07.B6LNGWM[:S)Z+\3?V_/VC])^&.O^.?AYK_PU\3_ !#;
MXX^/OAO'^S/H_@S5O$GQ9^$_AGX?0_&JZ-_X[MM0^+OA.76K_P :V'PNT;7K
MJX-AX7@L-'\1R7/@N#QE,FG6]_\ IQ\:?'-M\(_@[\4/BBGAFT\1GX<> ?%'
MC.'PXL<%I_;<GAS1+N\AT=)XK&\DM_MRQ?V>CPV=U*D$[PP6TV\0/\4>)/VZ
M+GP9XBUFPUWX0>";/7XM6_X0O4H+KQ;+X<\:Z+XWTWP[X U8>,/BCX?USP?;
MZ_X*^!%O;_$6VTFU^(FMR7.K6K:9?(VB16^H6\: 'A?BG_@I)\:='TK5/&6@
M7WP;\5RSZQ\2_#,OP5T>R\:7_BWX5^%_!7@;P]XCT;]ISQIXCMO$*ZQK/P8U
MBYUA/$=Q;OX)\,P7_@77?#"^'O$DVNQZMG]"?V8?C+XP^*=C\7K37_&W@SXF
MV/PR^+=Y\/O"_P 9OA=9WNB^ ?BQHD?@_P )^)I]9T73F\2^+K!+SPWJ_B'4
M/!^N3Z%XGUG1;C4=&9[>>WO!?65MX;\'?VT+;XB_%_2OAW)\-? .FW>LZQJ'
MPWO]<\'^-K'Q)K-_?^'M/^(NHMXKT"P'AG3+CQ1^SU=0_#R[M-%\9->P+:W>
MO:+!/HRK*^?T M;2TL+:&RT^SL]/LK9#';6.GVEO8V5M&69REO:6D<-O A=F
M<K%$BEV9R"S$D _1CP22W@SPBS$LS>&- +,Q+,Q.E6A)8G)))Y))))Y-?G_>
MW=V+V]_TNZXO;O\ Y>9O^?B7C[_0=AVZ5]_^!_\ D2_"'_8K^'__ $TVE?ST
M^,/V_+30/C)\5?A,WPHU"*]\#_%UOAG9>,-=\3IH7@>Y%Y)Y2^,_%6MOHEVG
MA/PAI6H2!M?U%UOS8:/_ ,3&)+@I(@ /N[Q=XUTWP)X2\5>.?%.KW&G>&/!7
MAK7?%OB*^:ZD7[)HGAS2[K5]3F4O(%,HL[.401YS+.T42 NZJ?QUT+_@JM\1
M-5\"Z5J'B/2?!WP>\8>&-*^*7C/XM0>+=#^)-\L/A_PAJ/P[U7PEX6^'7@;7
M-=^&WBO6?%FM_#'XGZ)XW\6W=U?S3:9IWAKQ/>>$/#'C"!;>&'U63_@I9H>I
MV5WIU_\ LZ>.;B66[ECOM.U*\LKCP[+X(;P3#JX\;W^J7&B26#>&KGQP\_@Q
MK6:UDNAH-I-X\F@&ER6]A+T^L?MF?#WQ#;A/$7P1\+>+=?L?BSX9\+7EC]JT
M#QK9ZH;7P?\ $S7;'XI^!K^Z\-M=>)O#Q7X;7?AOX=>(S96!U6ZU_2K2&[T]
M!);N ?I;#JE[-!;3I?WNR:VAGB/VJZ&([J%9AM#NKJ'63+*RJ_)#KNR*ZOP1
M>WC>,_"2->7;(_B/1$=&N9V1D&H081E+E64?W2"/:OS,F_;VT#3M"T[5=8\(
M:/+>:E:> =>2U\-?$&Q\0V%OX2\;6WB"ZU77[K5CHNGI&/AK)H]GHOQ&B-N+
M;P_XCU--+N+U#'&\_K_[//[7EK\1OV@?A=X"/@N+2-,\5_$+XH:#HGB2/Q&N
MK2SWOPA\3_8;>*;1;/3/M-I'XMTBQO?%&GZS>2VWAL::+;3[35K_ %F>*RE
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MSM\6:QID,8:%;P6WI?PX_:>?Q]XX\->!KGX/^+?#D_BV]^)=OH^OG6_#^O\
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MI-&&B4VEM91>3%!:.1<27EROVEOI_P#X6#XY_P"AKUK_ ,"__L:/^%@^./\
MH:]:_P# K_[&@"U\1P1XJF!!!&D>'00000?["L."#R#[&N:T/_D*V7_74_\
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MEO97D\9T#3QYD%K<3)D7FIY&^.-ER.XSD<9'-?)WQ#^$I\;/I%[-X7OM0O\
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M?CK^T_$%KHLT$EIJ>EZY]OFTOQ#INNV4MY?FPUS3=2TR33]0L4NI(;5K6..
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MDLT86V&Y0,<:;IPR,D$KD,H894LKJ#N1@/KZB@#\ZO\ A'-;_P"@?/\ D/\
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MM_\ 5C@#FQO^YXS_ +!,7_ZBXD]T^"__ "1WX3_]DT\"?^HMI5>EUYI\%_\
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M9-WP]!UE&SM:356GRM[I:W6I7_:L_P"4@G_!*K_L;_VQ1^'_  S#KAQ^8!_
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M@ 239W(  )))A?  '))[ <FL30_,^/\ U<?^XO\ Z"*_&W_@LS\6_%EM\'/
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MM*M/Z!HHHIGH!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110!Y[\5O^2>>*?^P>G_I7;U\$
MU^D^K:38:YIUWI.J0?:M/OH_*NK<2SP&6,.KA?.MI89X_F13F.1&XQG!(/ ?
M\*9^&W_0N-_X.O$/_P MJ /A>BONC_A3/PV_Z%QO_!UXA_\ EM1_PIGX;?\
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MRK_L:9;_ .K' '-C?]SQG_8)B_\ U%Q)^;IUNU^,OA'X>:Y\4?\ @EE^WO\
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MDYJU&:FDOLRBBBLSU0HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!BP>T6(I):[1AY7; E=CD>6D9P%8;0^&([C5C_U<?^XO_H(IS*K JRAE/56
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.%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>fin_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fin_001.jpg
M_]C_X  02D9)1@ ! 0$       #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" "* 5X# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBBB@ H
MHKYY_:5_:K_9]_9!^%^O_&;]I'XH>'OA/\./#;P07OB'Q ]W+-?:C=[$M-$\
M-Z#I5KJ/B/Q;XAO#,AL]!\,:1J^J7 W/':,L4I1-I)MNR6K] WT6[/H*201
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M0+R?PKJ$0^7Y<FQ^]\^T\(?X^J*GVU3NO_ 5_F/V-/M+_P "_P" ?W6?"_\
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MZ$G\\?\ P<B(H_:8_9WDPN]O@/JB,Q4%BD?Q U*2-0Y!8".2[N60 X07$ZJ
M)6K^=>OZ*O\ @Y$_Y.5_9V_[(3J__J?75?SQZ3I.L>(=6TO0/#NDZEK^O:YJ
M5EH^BZ+H]G/J&J:KJVHW$5K8:=86-K'-=7EY>W,T5M;V]M#+,\LT16)TW WA
M_P"%&_XOU H9'7MSSV&.#D]!@\')ZT9YQWY.W!W8'4[>O&1GCO7]:G[$O_!O
MKX!T;1='\>?MQZAJ'C+Q7J"I?R? GP?XCU+P_P"$O#EO+:KY&C>./&_A74-.
M\2>(=>M9V:?4H/!.MZ+H4-S'%96^M:_9)=2WGZVV_P#P2V_X)T6VF#2(_P!C
M;X'R6:!5$ESX?U"]U-5"A5!UZYU:772VWI,^I><2-[2.Y9RGBH)M*/,D[7UW
MZK1]/U+C3E)75K>J7X'^=_G_ #@CIUZ^G?T[T5_95^V+_P $!/V=_B'X;UKQ
M+^R&EU\"?BA:Z>USI/@?4/$?B#Q+\(O%NH6D<L@T^[E\6:EK_BCP/>ZM$J:?
M;:II&L7WAO39H[)I/"L-H;NX7^/WQQX&\9_#'QIXJ^'7Q$\.:KX1\<>"==U'
MPWXI\-ZU:/9W^DZSI5PUM=VSHQ9+BW9E$]CJ%K)-8:GI\MKJ6GW-S8WEM.^E
M.I&HFU96W5_DK7NWW^\F47%V>^GXG+TF1G'4XS@<G'K@<X]^E36]M=7MU:V-
MC:W%]?7UQ!96-A9P375Y?7MW-';VEG9VMNDMQ<W5S<21P6]O!')-/-)'%%&\
MCJI_J$_8:_X-^;/7O#NB_$K]N76]<TNYU>#3=8TS]G[P1J$VB:KI5E(DD\]A
M\5?&L:R7ECK$T1@%SX9\$G3KO2$,UM=>+IM6<V&C.=2,+<SWVMJ_N'&+D[+<
M_ETW+ZCGOVZXQGIG) QGJ0.XI<@]"#]*_P!#W1_^"6/_  3GT*P&FV7['?P8
MG@$"VQFU_2=7\7:K)&B"+]]KGB[6==UNXG(.)+F74)+IG.1,K!=OSE^T!_P0
MU_8)^,/A^\A^'WP^N_V=?&XBN&TKQ=\+];\1W6DK<M"QMX-9\ ^*=>U?PM>:
M8+C9++'HD'AK4R/E75DMT6%85>+Z6726MWZIO_AK?>W3DK[:>9_"A17T[^V#
M^R7\3_V*?CAK_P #?BI+I>I:IIUGIVN>'?%6@+<GPYXW\(ZRDQTCQ-HXN@+N
MQ^TRVUU:W^C7P-]HVI66HZ?/+="SCN[KYBK5--)K9DM6=NP4444Q!1110 UP
M&1E8 JRL"#T((((/L1Q7^J+_ ,&\G[15S^T;_P $I?V<K_6-<_M[Q9\';;7O
MV>O%<\SP-J%G-\)K\:1X0L=32!5V7"?#&Y\"7-HTX^U7>CW6F:A<-))>-(_^
M5X>A_KT_&O[Q?^#.CQ]=77P+_;A^%GFO);>&?C7\,?B5;6S.J[9_B/X U#PG
M?31HYW,QMOA'H\<\@&P 6T8(V@5K1;4TKZ-._P M5_5S*LDX-]8M6^>C_3[C
M^5[_ (+&7T^H_P#!5;]OVYN2#(G[2WCRQ7:CHH@TMM/TVU 5V9L_9K2(NVXJ
MTA=D"(5C3\VZ_6'_ (+I^&)O"?\ P5R_;ELIU*MJOQ7L/%29  :'Q5X$\'ZW
M"P^1,AH[M>3N.[(W'%?D]43^.?K_ )FD/X=/_"_S84445(PHHHH 0]/Q7^8K
M^\?_ ((:?\HU_@Q_V-7Q?_\ 5CZW7\'!Z?BO\Q7]X_\ P0T_Y1K_  8_[&KX
MO_\ JQ];K#%?[NO^O\?_ $AFE+XX>LO_ $EGT7^U9^VMX1_9)^-O[(/@WXEF
MVT_X:_M,ZY\6/AWJWBZ8,O\ PA/C71G^$:_#G6M0G4G[/X7OK_Q?K?A[Q+<.
MAMM-CU?3O$5_)!IV@W<E?2/QT^"W@7]H7X2_$3X'_$_2SJ/@SXB>'=0\-ZU#
MM9+[3IYT)TSQ!I4P,<MMK7AK4TM-<T2X1Q$+VU@:5+BVD:-_YU/^#F50WA']
MB=6&5?Q)^TFC#GE6T'X(@@X(.""01GYAE3\K,&^PO^")/[>\G[4?P+3X%?$/
M5UO?CO\ L_:':65S=W?EQZCX_P#A/'>II?A3Q:JK(9+[6/#GGV/A'Q9<-;1/
M/<KHNN3^?=:]>2+SJ$O94YPLFN:[V=^9VZ.^UC23_>N+NXVUCT^&_EL]3Z*_
MX)??\$]-._8 ^#?B30->U;0_%_QE^(OB2ZU7XC>.=!6_32+S0-"U'4[3X=>'
M-(@U&.WGMK;2O#T\>L:XK6XW>,=;UZ.WNKW3+6QN[CO_ (G?ML^'/#G[<G[/
M/[#7A![;5/'OCJW\5>._C!=-&LR^"O ^D?#;Q1XB\&Z /,!$'B?QEJ\6F:YN
MB=)=-\)6"M<12KXHTZ6V]F_:U_:;\"_L>_ +Q[\??B"OVO3O"&G&'P]X<2[2
MRO?''CO4$FB\(^!].EDBN/*FU_4H62\OE@N%T?2;74M3E@N%M1$?X^_^"4OQ
M9\=_'C_@K[\/OC)\3M7_ +=\>_$:[^,GB3Q)J(C6"$W4WPK\0VUII]A;Q_N[
M72-$TRUL=$T.RC^2RT;3K"T4LL.YDHSJ2G*5Y.,6N9[)V5K/KII_PPIN$=(I
MJ2:U2L[==;ONNFY_=#I0QJFG'UOK7U[2KZDG]:_RM$8+"&)P%#$GC@ M_>*J
M.<9). ,G!Q@_ZIFE_P#(3TW_ *_K;_T:M?Y5%X'.F78BQYAM+H1ACA3(8I1&
M"2K 9<J 2K#)&0:,%?\ >MZM7;^5O+T,6VW=ZM[L_O*_X(K_ +(FB_LU_L=^
M$?'NHZ?:/\6?VD=,TGXH^-=<7SVNK?PCJEI%>?#/P;%Y^$MM/T3P]=MK5PEJ
M@:\U[Q+J\MS))!:6"Q7?^"HW_!4GPY^P)H?A[P-X0\/V'C[]HOXA:%<>(_#/
MAO5I9!X0\&>#7N]1T2T\<^-WLKJUU2\^UZ[I6I6>@>$[ VT^N/I>HSW6K6%A
M:I+>_I=\'[CP]=_"'X27?A Y\(W/PJ^&UQX3;" 'PO-X(T*3PZ5\O,13^QFL
MMIB9H\<(S* Q_BG_ ."^MMK5M_P4=\52ZK)(++4_@U\%[WPO&[;2_AN'0=0T
MV62*,LVZT'C+3/&4$4JA4%Y!J48 F2=445[2NWNN;K_+?9]EM_F;2]RG%K1R
M23:W>E[??J2>'?\ @OI_P42TKQ+:ZQKOB?X1^+_#L=[YUWX$O_@YX5T/0[FS
M:53-966J^&%TSQ=ILK1@K;W?_"1W\D,OS7!O86G,O]77[!7[<OPY_;V^"W_"
MTO!-A>>&/$WAW4HO"WQ3^'^I2I>7?@GQD]A;ZFMM::K'Y2:YX;UBQF_M+PWK
M?V:UEOK;[3:7MK::GI6H0#_.EK^F?_@VI@\8GXC_ +6EU;BZ'P[3P!\+[75\
M%_L#>/'\3>()O"SR*5V?;E\.)XZCA^<,ML)2$*R,4Z*\+4Y<B47&^W2VFFYE
MS2WN_P"OD?0__!PO^R+H_B?X3>%OVR?"FCQVWC;X9ZAH/@#XJ7UG'!"NO?#W
MQ-J,>D>$M8US;$C75]X4\77MAHMCJ,DBR0Z7XI?3)_-M[+34LORD_P""(7[(
M&B?M/_M7S>-_'NA'Q!\+?V<-+T/XB:YI-U#!+HNO^.=7O[ZU^%^@:Y;7*O'?
M:<^HZ-K?B:;2IHS::BGA8VVH![%YK>X_J)_X*[R64?\ P31_; ;4#&+8_#SP
MQ$/.4O$;VY^+'P[M](WJ/XO[:DTX6[$$"\:V 4LRU^5G_!M'+I[?#C]LJ.-C
M_::>/_@8VH$A0W]ER^&/B@-"\QN74-=0^(VC)8*3YZQDD2BLX5)2P[ES2YE;
M5[ZZ"ZZG]'/Q*^(OA'X3?#_QU\6/B-K7]B^"/AWX4\1>.O&&MS(UR]EH?AS3
M;K5]3D@MU*RWVHW,5N\&F:=&ZSZKJ]Q::=;'[7?1A_XX_CY_P<#_ +8/C#X@
M:U=?L\KX*^"_PNMM1E3PGINK?#_PMXY\>W^E032+:ZAXPUGQ4FO:3#JE_#Y=
MS<:3X?L++3M-=OL"WFJ);B^F_?G_ (+8VFMW?_!-3]H4Z/'++!93_#2_\1A-
MQ"^&[?XE^%3>SS!< PV^HR:7<.74PQM$DLAC6/=7\#X/3\<=\X)4X/?# @]\
MCGM1A:<)1E)Q33M:ZUZ^9K4?+;D]VZUMI?1/S/ZY/^"9'_!;SQA\>/BOX:_9
MS_:UTOP?9>*_']\='^&?Q<\'Z5!X1TC5/%D\L:Z3X)\8^&(IWTFSOO$CRBR\
M.Z[H0TVUFUS[%H5QH"_VDNJV_P#0/\8_A%X!^/?PL\=_!OXH:1%KO@/XA^'M
M0\,^(;!SY4L$5TFVVU?3;A8YWL=;T&_AM]7T34X89I=/U*R@N88I0K12?YJ7
MPFCUF;XN_"2#PUYA\37'Q6^&</AE803.WB63QSX?B\/BV4*S&Z_MJ;3EMBBF
M0W+PHFYF5#_J!W;1B_NS&I9%U"X"(%4,-MW(/*"Q+L!5PT*K$I4[0JJ22#.(
MA&$X2BE%\KLUO\2\_(</?C)R]YJ]F^GNMZ;==3_,3^-OPA\3_ #XT?$SX(^,
M]C>)_A7XY\0^"M5GC<217IT?4+F*PU.*141&AU;2FL=4A* KY5X@W%@V/[\/
M^"7'_*.O]CC_ +(;X6_]&7U?QQ_\%@'LI/\ @II^UBU@Z20KXP\#0S&,'8-0
MM_@Y\.K?50&).]SJD5V\[C&;EYEV@J:_L<_X)<?\HZ_V./\ LAOA;_T9?55=
MMX9-ZMK5LP/YY?\ @Y$_Y.5_9V_[(3J__J?750_\&[?[-N@?$#X[?%+]I#Q/
MI$>I#X!Z+HN@_#J:X:8P:5\1O'Z:B+SQ## I2"?4M&\):7JEIILTAF%A<>(K
MF]2&.^M])OXYO^#D3_DY7]G;_LA.K_\ J?75?H%_P;A2Z*W[''QIAMS'_P )
M'#^U)XADUH*ZM)_8ES\)/A)'X7:2,?.B?;;+Q<(68!6<W$<9/D/5;82+6C;D
MGYJZ+@DYQ3U3?^9^JG[<'[6/A3]BC]F_QO\ 'SQ5I\OB&XT>;3/#?@SPO$RP
MMXN^(GBB::U\+Z%<W?VBT-EIIEAO-9\17UO+]KL?#FDZO=6%M<WD=M:S?Q=:
MQ_P6E_X*.:M\0#\0X/VC3H$JS[[7P+H?@GX>0?#"QM,SE=-'@F^\/7]GJ,:I
M<21R:KK,^H>)YV6&YFUUKVVM;B#^YKXW0? !_"%H_P"TA_PJ!?A_'XBT]K&7
MXVR>#8?!\?BZ2RU*+2OLL_CEH]&3Q!)IK:S'8+'(+Y[(:DL ,/VK/RC]C_X)
M--@AO^">.#AAB^_9WQZC&;H\<]!BL*2I)*]&I+5MN$N57:[)/6^[OV+FW"5E
M[JT=EMU[WU[C?^"9?[=6G_M]?LY1?$:_T[3]"^)_@775\!?&#0-(69-%@\5Q
MZ9:ZK8Z_H"7-Q<W$6@^+-*N%U*SMVN+K^SM0AUG17N9'TD23?C-_P<8?LQ:/
M93?!O]KKPW86>FZKK=S-\&OBJUO#(DNNWL-M-KWP[\479C2.*6[L+"V\2^&+
M^X=7N[FQB\+6@E-GI<26W[S^ ?BY_P $_?A3!J=K\+_BU^QU\.;;6IK:YUBV
M\#?$3X,^%+?5;BSCDBLY]1AT36K..]FM(IIHK::Z6::"*62.)U21U;\2_P#@
MO?\ ME?L[_$+]GSP/^SU\,OB;X/^)WC[6/BAH?C_ %&3P!K&G^+]#\+>&?"N
MDZ]9E]<\2:-=W>BVNHZS?ZY9C3-'AN+F\N+2UGOI_LUO%$]]=&+55-0G&+;^
M)W=DG:\K*_DK::;DN47#6[G_ #-=+]_3R/C;_@WU_9AT'XN_M*^/OCWXPT<:
MII7[,6B^&;_P:EPTWV6V^+OCRXU^U\,:L+<&.WU&Z\,>'_#?BO5+'S_M$6DZ
MY)H&LBW6_M],N;?^MS]H#XZ?#O\ 9E^#GCWXY_%74+G3? WP]T9]5U4Z=;"[
MU74[NYN+;3=#\/Z'9EXH[K6]?UJ\L='TRWEFM[<7%Y%+=W-K90S74'XA?\&W
M4^CM^RG^T%';-#_;2?M(F?5(]RF[&D7/PH^'R>'991]\6<L]OX@CLV8!'N8-
M2*882A?:_P#@X"@\1S?\$^[V31W*Z-:_&KX73>+T16\Q],D.O6VCEW5<I:KX
MFGTI9][!%\P':[,(RJVM9IZV<5\FE=+U+24:2DM)7WZZMI_>D?A[\4_^"_\
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MX(/J#U!'9AAAV(YHHH  6!)#R!CD%O,?<P/4.V[<X/<,32 8&!T'X?D!P!Z
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MXHT2=YHGA%W;VNIP3+IVJ6Z2S?8]8T\V^JV+R/)97=O*2]>O44 ?R(?MB?\
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8DELDON,VVVVW=MW?J%%%%,04444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>fin_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fin_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  W &0# 2(  A$! Q$!_\0
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M \$_$GPO<.\=OXD\ ^*M"\8Z#.\;O'(D.L>'K_4=/E=)(Y(W5+ABKQNA 96
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$* /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>ex1-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex1-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  ^ )(# 2(  A$! Q$!_\0
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MVU:>8\=%'J:P+;QE&5/VFW8-G@H:Z6XMH;N$Q3QAT/8USMSX2LS(3'-*@],
MT] ,;6]>?5=L4:&.%3G'<FM_PKIKVEH]Q*NUYN@/85+I_AJPM7$I#3..A?H/
<PK<Z47 ****0!1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>ex11-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex11-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !6 (L# 2(  A$! Q$!_\0
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M+Q_HFG^#/#_@1_#HTG1OLM_=7C>#? 7B7QQ\1/">E/8W=M?^)&NY4LKV5&B
M!_,)^UK_ ,$,?^"IG[$7PXN/C!^T+^RCXIT#X7:;##/XA\=>$O$?@CXF:#X1
MAG=8UN/&,OP[\2>)KGPM8)*Z0S:OK=M9Z-%*\<;Z@'EB#_!W[/7[+_[0/[6/
MQ/T;X,?LW?"CQA\9OB?KL5Q<V'A#P-ICZK?1V%FJ->ZOJMUNBTO0M"L1)']N
MU[6[_3]&LM\8NKZ$R1[O[=_^#4C]LS_@H1^V%\?_ -JCX,?M4^/OBC^TW^R1
M>_!/Q!??$#5OCMJ.I^.]&\(_$;5_$6A:/:>$+/7O%*WKK'X\\*ZQXQC\0^!F
MO&T^;3M*_M5M,M6LY)IO0_\ @B-X;T/X!_\ !-C_ (+K?&;_ ()Y:-I7C?\
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K#&B)'HWAN#6+VRFU&#0-(1=,T>.Y6PL56V@C4>ET44 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>ex99-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !V (L# 2(  A$! Q$!_\0
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MOP,SZOIL6FPRS2VEO%(MJ_B'Q']G6: "X%P+9H+K?I]K;7+6.9C/=37/W!\
M/VBM ^,6G+I=Z]MI/CO3[<-J.CA]L.IQ1J ^J:-O8M);D_-<V9+7%BYPQEMS
M'</_ "[X8_2[\,_%#Q&S[P\RZEFN33H8J=#@?B+.Z7U/)?$JE@U*AFU3ARI6
MHX>="OA,PI5J>!P.-F\5G& IK'854,2Y9+'\^R'Q/X8X@SK$9+A:\Z-1SE#*
ML5B5['#9VJ+<,0\!.I&G>=.K&<:5*;=3$4X^TIJ-2^&7TI1117]5'Z*%%%%
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M2F\1BLMC2E"O4E1G4HRQ$J-3V6*G1J3I5<1AYXBG*4<0VRBBBOT<_8@HHHH
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M<H\E.,I)>(/A#X#<6<687.?$+*N'ZO%V?X7!9/@9YCQ9F&19CG.&RR-7#X/
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/ **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>ex99-1_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  > 40# 2(  A$! Q$!_\0
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M^F>)=+MM6LK/Q#X?U%$OM&UBWM[I(K_3;M%GM+E9(9!N0U_(Q^TK\1/VD?\
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M3^T3_P $.O\ @H9^W?\ '_XS?LB_&']J/]C+]M_QQX8^)UI^U)^S[HD?Q/\
MB7\&I]$TE],F\(?$KPY.VD7FC^&K.2662\>^U#3-%>UM/#UQH>M:Y?6=YI$'
MZ-_LX>-_^"57_!6C]JOX-_\ !0+]FCXY:KK'[2_[*G@[Q/X<N/"WAR\7X7>.
M(O"'C5X=-U/3_C1\/_$GA.T\<>*O#-F[3Z-I>IV6JR^#[9]6U'3K34[F349(
MW[JF%IQPRJ+#57!TU)8ZG7]O3]HU?DJT:<'&@F_<Y*CIU82LY2DFT9*HW4<?
M:1O?^"X*,K=XSDTY6WNDT]4K:'[J55O;D65E=WA0R"TM;BY,88*9!!$\I0,0
M0I;9M#$$ G)!K^9CP)\>_P#@I%_P5[_:/_:FL_V1/VJ[;_@GK^Q-^R;\4M9^
M NB>/M)^!?@SXQ_&3]H;XO\ A2:YL?&]U<Q?$&8>'_"?@WPCK%H]ND&C7\-]
M=VTFEO<1ZQ%XBEE\+>]?\$\_VU/VO-._:M_:?_X):?\ !0G5O"GQ'_: ^!_P
MLL?C5\(/VE/!GAK0_ .D?M#? O7KMM M]<\0>!-+OUL_#GCBTU5Y8Y],T'2H
M=/,&D^(#.\D>G6&L>(.26&Y::G[>A*:493H1E+VL(SV;;BJ4VE9SA3J3G!2B
MY+XN313O*W)-+5*;MRMJW9N2WT<HI.S\K_<__!-;]OZP_P""BOPB^+GQ7T[X
M6WOPFA^%/[3GQC_9NET.^\70>,IM;N/A'<Z';R^+EO[?P[X;CT^+7?[:5DT0
MVM\VG&V93JU\)0R?HA7\97_!.?XU?$W]G'_@A-_P6.^.OP9\3'P;\5?A5^V%
M_P %%O&W@'Q4-(T+7VT#Q/H-AX1OM*U1=&\3Z9K/A_4FM+J*.46FL:3J.GS%
M=ES:31ED/[[6'[0_QAD_X(]Z'^U))XM67X[7?[!7AWXSW'CA]"\/!9OB5??!
M:P\677B1_#D6EQ>%E\W7YY+]M)AT:+1%+&VATZ*S"VZY.'/4Y8\L7*KR1BN:
MT;R44[MRTNU?5RW>UD5>RUN[1NWI=V5WVU^Y'W;\9_C=\(OV=OAUKOQ<^.GQ
M$\*?"KX9>&#8+X@\<^-M6MM#\-Z0VJZA;:5IJWVI7;+! U]J5Y:V-LK',MS<
M11("S@5XC^U3^VQ\)?V4/V3/$?[9>O:1X_\ BW\)-!\.>$O%EC;_  )\-P?$
M'Q3XL\/^.+W1K/P[K/AC33JFD:==Z-<0Z[8:Q=ZU>ZO8:3IN@?:-9OKV&QMI
M9!_(1^WCX_\ VX_VTO\ @VN^#7[9WQ,_;%":1K7PPNY?VC_A#'\ OA84_:#\
M3S_M00>&/ ?B-O'>DP:#>_"IO VFZ!"'TSP+X>AL?$\DI_M1(@'9_P!&_C'\
M3_V\O^">'_!OEKWQ^M/VS1\5OC18_#?]E_Q5\#O'4O[/GPE\$CX,?#/QC9?!
MSPY:?"E?#*6?BGPQ\03H6E7VKVZ>./%FE/K>IF_6YNK2*YMHGKN6!IQC1<JU
M.=26-EAITDZL4XP:YFI^Q;C=7DY>\U"4>6,JBE Q=:3E.*@TE1512?*_>=U9
MKF5[.W9-IZI-,_IG^&WCK2_BC\.O /Q,T33O$&D:+\1?!7A7QUI&D^+=&N?#
MOBK2]+\7:%8>(-/T[Q-X?O?],T+Q!96FH16VLZ-=_P"DZ7J,5S93_O8'KM:_
MG>_;;_X*8?M1?##X ?\ !,;]G_\ 9>L/!OBC_@H%_P %,_#'PRTGP=X_^(^C
M79^&OPQL)? /@?6_C+\<O$'A[PWI-W:W[>%[SQAIEU9>'(]/.D:9#JEWXCFT
M3Q+IGA>;P;KWS_\ M7?$;_@K7_P1@\(^!?VSOC5^W!I__!2/]E#3O'?@'PA^
MUM\,/%G[//PH^!?C;P!HGC[Q+I_A&V^(OP4UOP3J]M)?W">)M=TK1K7PKK%Z
MVFV<MW87%_I]YIDVI:KX<PC@W*+;KT*<G*K&E1G*HZE7V4I1ERN-.4()RBXP
M=6<'.2LHQT;OVNJ2A.2M%RDE&T>9)JZ<DV[.[Y4TEU[?U0T5_-5_P4;_ &U/
MV^[/_@J%_P $[/V0_P!@3XS?#+POX4_;#^!'QN\27=S\2/ ^@>+O <*Z/X5N
M?$MG\7_/&C'QKJVI^ /!=KJOC'P5X,TGQ/X>\.^-/$MCH^A>+C)H>HWCP\%!
M\;?^"DW_  3._P""H/[!/[-7[4W[<=I^WW^SG_P4/E^*7@877B7]GSX??!GQ
M[\)OB?X%TSP]<6.L^'(OAU<I9+HNJZ_XL\*VYMKO5M6T:'PU/XMLU\)Z?K6G
M:!XCNR.$<J?-[>BJCI2JQH-5O:RC#FYUI1=.,DH.5IS2:35XM,'4M*W))QYN
M5SO!15[6>LE)IMV]U-WZ']25%?R]?M-?MF?M@?M1?\%?/BK_ ,$P?A!^VCX*
M_P""8_PS_9^^#G@?Q]%\0M4^'/@CX@?&G]KCQGX]TGPQK[:;\+A\6)]*\*V7
M@CPC9^)TTFYC\(2R^+(O$/@WQ@;N3Q1I>JR6WPW_ $1_X)N:A_P5,\"_%#]I
M3]FW_@H>FB?''P#\+KOPCJ7[,O[=GACPYX ^'<?Q_P#"^M:<)_$&@>-_A?X3
M\027'A7QAX3FN=,M"T?A.PLIK^S\66\OB#Q1:6OA[Q-XA53".G1C5E6H\\J<
M*JH?O%4]E-M1DI2IQHS>B<H4ZDYP4E>[YHQ:J7FXJ$K)N//[O+S+I92<UY-Q
M2=G;35_KI1117(:'GOQ<\ 6?Q8^%'Q.^%FHRB#3_ (E?#WQIX OIV4NL-GXR
M\-ZEX=NI612&<1P:D[E5(+!< @G-?Q?_ !*^ O@']GC_ (*?_L"_ 7XL7>E^
M-?V>_P#@A%_P1#\3_MX:SX'T#0+>RTGQW\<_A9JFHZ'X[^(&C:<(4DM/%OBO
MQ5HWPQ^,=I<7SB=_%_@73[Z[:>>\NQ=_W!5\4?M3_P#!/_\ 9N_:UTWXN7?C
MSPF?#?Q1^,7[+_Q#_8^U[XZ>!Q9:3\5M/^!7Q)U73?$6M^#;35[VSU/2-3TZ
MT\3Z18^(=%M?$NBZY;:-?R:PNF16EMXD\10ZIO1K.G=7:BU.]E=WG#V;3UNH
MR@W%N-IQNY0:=U*)13UMKHODG>_:Z>JOH]GW7\0_P_\ B_\ ''X)?!KX'?M8
MQ>,?AGH/_!8G_@NWXU^*GQ8U#]KSX_ZAX,TGP5^P/^P?\/[8WEQXA\*:U\3/
M%FI:=X&\)S_";3],\4>"$ALV6\\!Z.OPSTK2]5\1_#'X7:;?:G_!"+]GC7OV
MQ/\ @M[XQ_;.\%?&[]I+]I;]FW]B;PSKFD:;^U9^TAJ6HZGXO^-?Q9\:?#K4
M_AH;&QM?%%\/$/ASP=XH?QE\6_BIX,\#21ZEXA^%_@!_AYHGQ&DB\4>*$O\
M5/WX_:)_X-H/V4?VJM6_8PA^,WQS^/=YX"_8P_8^^$7[(7AOP5X1F\%>&9_'
M_A[X1/JWV+Q9XJ\27'AO7+K3=2\3V^I06OB*P\-6.EL(M/MVT?5-+F9I!^Y7
M[-?[,/P#_8_^$7AGX$?LU_##PW\)?A7X2BD72?"_AR*ZD\Z[N"K7VM:[K6J7
M6H>(/%/B7595%QK7BCQ-JNK^(=9NB;K5-3N[AC(?4J9A1A@Y0I3=3$8JG*%=
M.A!4Z,&^50C5FI5*G)2IPA2A35&E34YS:G5:<>=49RJIRBHPIRYH-3?-)O76
M$;):N[<G.3LDK)7?\Q__  >6V5YJ7_!-SX%6-A:W%Y=W'[87A2.&WMH9)I9'
M/P9^-AVJL:L<X!8_[*LW16(\J_;;_P"#C/\ 8N_:E_8@^-G[)?P!_9G_ &J/
MV@?C3\=O@UK7P7\&> =8^!MA_84'B7Q9X?.@6'B^Y6VUSQ?K=Y>^"-0EB\6>
M%+3P[X1UK7+[Q=HN@6]F-%\UO$6D_P!G;QQR "2-) #D!U5@#C&0&!P<$C/H
M:1(8HR3'%'&2,$HBJ2.N"5 )&>QKBH8C"TZ<(U\+4KSIU)SA*.+GAXKGY'RR
MC3I2FTG!-N-6$M6HN.C6DZ=5R<J=6,%)14DZ2FWRW6C<DEHWO&6NKOL?Y]_[
M=O[*OQQ_9#_X-+_V?O@7\>O#%WX:^*NF_M":5XTUOP7F2^U'P?I_Q)\<_&CX
MA:'X?UQ(;2)M/UO1]#\2:?:>(M/=KB#2-;6\TR&]N(8(';Z2_P""J7[/GQS^
M'7PW_P"")?\ P5<^#?PQ\5_&'1/V+/AW\(K'X]^!?"VE76K>(M)^&UO9Z!XE
MB\0V.C6\;7"6UQ8:EXYT75=>O/L^F>%=4D\*7NJE]/NKM[7^W]XTD7;(B2+G
M.UU#+D=#A@1D>M. "@*H  &     .@ '  ]!6L<RDN1NE>2Q&*K5??:C5ABE
M:I2LXRE'1NTG*>T-/=U?L59I2LN6$8Z:Q<%9/=)Z=++=ZZZ?P8_\%</^"D?P
M_P#^"_\ \-/V=/\ @G!_P32^&OQ>^)OCWQ_\:?!7Q0^+/CCQ-X'U7POX1^!>
MA:#HWB#PY+_PFLYM]2WZ;I(\9:EK7B?Q##-;:):PZ!IND>&M0\5>(/$MII-O
M[O\ \%,?A?X\_P""5?\ P5C_ &&?^"IL_P -/'OQ._9*\-_!#P[\ _VAO$/@
M#0YO%6I_#J_\/>%+OP,NH74.^R@TO2Y]-C\)Z_IFK:W<V$6M&R\3Z+8QMJMO
M:17/]HNFZ)HNCFY.D:1I>E&\F-Q>'3;"TL3=7#?>GN3:Q1>?,W>67<Y[M6A+
M%'-')#-&DL,J/%+%*BR1RQR*5>.1&!5T=25=&!5E)!!!(H6/I0G2C1P\X86%
M.M3G1GB)3J55B/XS=;V<8Q=U!TU&E:+@I2YI.3$J4W&3E4BZC<6IQARQ7+\*
MY>9M]5+WKM.RMH?S<?L__P#!=3QY_P %"OV\OA7\!_\ @FU^SYJ/Q3_9$TK1
M)]<_:H_:J^*_@KQGX.TSX?L(=1FMM$\&;]<TC3CJ]Q,-#TRQT_Q#;3^(M;U"
MZUVZT?PM<^'/#=WK\W\RVJ?LD_L+?\$SO^"C/[6OPW_X+-?LF?$SXF?LS?%W
MQIJOCK]E7]IKPZWQ9M="@TS4=8U35I+34?\ A6'CCPS::S)JNG7]A!JVDV0U
MW7_"&OV%W;7MLUA=Q7$/^E+IVEZ9H]JECI&G6.EV4;.T=GIUI;V-JC2,7D9+
M>VCBA5I'8NY5 68EF)))HU'3--U>U>QU;3['5+*0JTEGJ-I;WMJ[(<HSV]S'
M+$Q4\J60E3R,5=',J>'J36'P]6AAZE&-*I"EBYPQ,Y1FYQK/$QIJU1-VM&DJ
M?)[CB[N1,J$JD+5)PG-2YDY4DZ:T2Y53<OAZ_%?FUOT/XW_V$?"__!,OXA?
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M6I!>\XQ3E[M*,^;6:<$[J/+:5]+<TKM-)[6C%[7>FO\ &+_P3W^$'Q ^.O\
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M"Q7[,>D?\$U?^"7M[XG_ &JOCA^U3X[^$+>+=8T7X?\ Q.\&^"?V=_AKX/\
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4.:=I03NTG&^RNK:R4445YYN?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>ex99-1_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  X ' # 2(  A$! Q$!_\0
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MXY;3)G01W,/A>VTSP=;7LL3-&+K7Q;JS36UTD/NW@C_@S]^*7QU^.M]\=O\
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I]KL9)&M;G82GG1/M)7%:=%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>24
<FILENAME>mlec-20250630.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Sun Dec 28 18:19:32 UTC 2025 -->
<xs:schema elementFormDefault="qualified" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:mlec="http://www.moolecscience.com/20250630" targetNamespace="http://www.moolecscience.com/20250630" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dtr1="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dtr="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="mlec-20250630_lab.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="mlec-20250630_pre.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="mlec-20250630_def.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="mlec-20250630_cal.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef"/>
      <link:roleType roleURI="http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome" id="mlec_r_ConsolidatedComprehensiveIncome">
        <link:definition>995301 - Statement - Consolidated Statement of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ConsolidatedComprehensiveIncomeAlt0" id="mlec_r_ConsolidatedComprehensiveIncomeAlt0">
        <link:definition>995301 - Statement - Consolidated Statement of Comprehensive Income Alternate 0</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ConsolidatedBalanceSheet" id="mlec_r_ConsolidatedBalanceSheet">
        <link:definition>995302 - Statement - Consolidated Statement of Financial Position</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ShareholdersEquityType2or3" id="mlec_r_ShareholdersEquityType2or3">
        <link:definition>995303 - Statement - Consolidated Statement of Changes in Shareholders&#8217; Deficit / Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ConsolidatedCashFlow" id="mlec_r_ConsolidatedCashFlow">
        <link:definition>995304 - Statement - Consolidated Statement of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformation" id="mlec_r_TheGroupsBusinessReorganizationandGeneralInformation">
        <link:definition>995305 - Disclosure - The Group&#8217;s Business Reorganization and General Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparation" id="mlec_r_AccountingStandardsandBasisofPreparation">
        <link:definition>995306 - Disclosure - Accounting Standards and Basis of Preparation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/NewStandardsAmendmentsandInterpretationsIssuedbytheIASB" id="mlec_r_NewStandardsAmendmentsandInterpretationsIssuedbytheIASB">
        <link:definition>995307 - Disclosure - New Standards, Amendments and Interpretations Issued by the IASB</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/SummaryofSignificantAccountingPolicies" id="mlec_r_SummaryofSignificantAccountingPolicies">
        <link:definition>995308 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/CriticalAccountingJudgmentsandEstimates" id="mlec_r_CriticalAccountingJudgmentsandEstimates">
        <link:definition>995309 - Disclosure - Critical Accounting Judgments and Estimates</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/AcquisitionsandOtherSignificantTransactions" id="mlec_r_AcquisitionsandOtherSignificantTransactions">
        <link:definition>995310 - Disclosure - Acquisitions and Other Significant Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPosition" id="mlec_r_InformationAboutComponentsofConsolidatedStatementsofFinancialPosition">
        <link:definition>995311 - Disclosure - Information About Components of Consolidated Statements of Financial Position</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/InformationaboutComponentofConsolidatedStatementsofComprehensiveIncome" id="mlec_r_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncome">
        <link:definition>995312 - Disclosure - Information about Component of Consolidated Statements of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/Taxation" id="mlec_r_Taxation">
        <link:definition>995313 - Disclosure - Taxation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/EarningPerShare" id="mlec_r_EarningPerShare">
        <link:definition>995314 - Disclosure - Earning Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/InformationaboutComponentsofEquity" id="mlec_r_InformationaboutComponentsofEquity">
        <link:definition>995315 - Disclosure - Information about Components of Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/CashFlowInformation" id="mlec_r_CashFlowInformation">
        <link:definition>995316 - Disclosure - Cash Flow Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/JointVenturesandAssociates" id="mlec_r_JointVenturesandAssociates">
        <link:definition>995317 - Disclosure - Joint Ventures and Associates</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/SegmentInformation" id="mlec_r_SegmentInformation">
        <link:definition>995318 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/FinancialInstrumentsRiskManagement" id="mlec_r_FinancialInstrumentsRiskManagement">
        <link:definition>995319 - Disclosure - Financial Instruments &#8211; Risk Management</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/Leases" id="mlec_r_Leases">
        <link:definition>995320 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ShareholdersandOtherRelatedPartiesBalancesandTransactions" id="mlec_r_ShareholdersandOtherRelatedPartiesBalancesandTransactions">
        <link:definition>995321 - Disclosure - Shareholders and Other Related Parties Balances and Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/KeyManagementPersonnelCompensation" id="mlec_r_KeyManagementPersonnelCompensation">
        <link:definition>995322 - Disclosure - Key Management Personnel Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ShareBasedPayment" id="mlec_r_ShareBasedPayment">
        <link:definition>995323 - Disclosure - Share-Based Payment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ContingenciesCommitmentsandRestrictionsontheDistributionofProfits" id="mlec_r_ContingenciesCommitmentsandRestrictionsontheDistributionofProfits">
        <link:definition>995324 - Disclosure - Contingencies, Commitments and Restrictions on the Distribution of Profits</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/EventsOccurringAftertheReportingPeriod" id="mlec_r_EventsOccurringAftertheReportingPeriod">
        <link:definition>995325 - Disclosure - Events Occurring After the Reporting Period</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ReverseStockSplitAftertheReportingPeriod" id="mlec_r_ReverseStockSplitAftertheReportingPeriod">
        <link:definition>995326 - Disclosure - Reverse Stock Split After the Reporting Period</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/AccountingPoliciesByPolicy" id="mlec_r_AccountingPoliciesByPolicy">
        <link:definition>996000 - Disclosure - Accounting Policies, by Policy (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationTables" id="mlec_r_AccountingStandardsandBasisofPreparationTables">
        <link:definition>996001 - Disclosure - Accounting Standards and Basis of Preparation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/AcquisitionsandOtherSignificantTransactionsTables" id="mlec_r_AcquisitionsandOtherSignificantTransactionsTables">
        <link:definition>996002 - Disclosure - Acquisitions and Other Significant Transactions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionTables" id="mlec_r_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionTables">
        <link:definition>996003 - Disclosure - Information About Components of Consolidated Statements of Financial Position (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeTables" id="mlec_r_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeTables">
        <link:definition>996004 - Disclosure - Information about Component of Consolidated Statements of Comprehensive Income (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/TaxationTables" id="mlec_r_TaxationTables">
        <link:definition>996005 - Disclosure - Taxation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/EarningPerShareTables" id="mlec_r_EarningPerShareTables">
        <link:definition>996006 - Disclosure - Earning Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/InformationaboutComponentsofEquityTables" id="mlec_r_InformationaboutComponentsofEquityTables">
        <link:definition>996007 - Disclosure - Information about Components of Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/CashFlowInformationTables" id="mlec_r_CashFlowInformationTables">
        <link:definition>996008 - Disclosure - Cash Flow Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/JointVenturesandAssociatesTables" id="mlec_r_JointVenturesandAssociatesTables">
        <link:definition>996009 - Disclosure - Joint Ventures and Associates (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/SegmentInformationTables" id="mlec_r_SegmentInformationTables">
        <link:definition>996010 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/FinancialInstrumentsRiskManagementTables" id="mlec_r_FinancialInstrumentsRiskManagementTables">
        <link:definition>996011 - Disclosure - Financial Instruments &#8211; Risk Management (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/LeasesTables" id="mlec_r_LeasesTables">
        <link:definition>996012 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ShareholdersandOtherRelatedPartiesBalancesandTransactionsTables" id="mlec_r_ShareholdersandOtherRelatedPartiesBalancesandTransactionsTables">
        <link:definition>996013 - Disclosure - Shareholders and Other Related Parties Balances and Transactions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/KeyManagementPersonnelCompensationTables" id="mlec_r_KeyManagementPersonnelCompensationTables">
        <link:definition>996014 - Disclosure - Key Management Personnel Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ShareBasedPaymentTables" id="mlec_r_ShareBasedPaymentTables">
        <link:definition>996015 - Disclosure - Share-Based Payment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ReverseStockSplitAftertheReportingPeriodTables" id="mlec_r_ReverseStockSplitAftertheReportingPeriodTables">
        <link:definition>996016 - Disclosure - Reverse Stock Split After the Reporting Period (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails" id="mlec_r_TheGroupsBusinessReorganizationandGeneralInformationDetails">
        <link:definition>996017 - Disclosure - The Group&#8217;s Business Reorganization and General Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationDetails" id="mlec_r_AccountingStandardsandBasisofPreparationDetails">
        <link:definition>996018 - Disclosure - Accounting Standards and Basis of Preparation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofInformationrelatedtoCompanysShareofVotingRightsinitsSubsidiariesTable" id="mlec_r_ScheduleofInformationrelatedtoCompanysShareofVotingRightsinitsSubsidiariesTable">
        <link:definition>996019 - Disclosure - Accounting Standards and Basis of Preparation - Schedule of Information related to Company&#8217;s Share of Voting Rights in its Subsidiaries (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/NewStandardsAmendmentsandInterpretationsIssuedbytheIASBDetails" id="mlec_r_NewStandardsAmendmentsandInterpretationsIssuedbytheIASBDetails">
        <link:definition>996020 - Disclosure - New Standards, Amendments and Interpretations Issued by the IASB (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails" id="mlec_r_SummaryofSignificantAccountingPoliciesDetails">
        <link:definition>996021 - Disclosure - Summary of Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/AcquisitionsandOtherSignificantTransactionsDetails" id="mlec_r_AcquisitionsandOtherSignificantTransactionsDetails">
        <link:definition>996022 - Disclosure - Acquisitions and Other Significant Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofFairValueoftheConsiderationofPaymentTable" id="mlec_r_ScheduleofFairValueoftheConsiderationofPaymentTable">
        <link:definition>996023 - Disclosure - Acquisitions and Other Significant Transactions - Schedule of Fair Value of the Consideration of Payment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofAssetsAcquiredandLiabilitiesAssumedTable" id="mlec_r_ScheduleofAssetsAcquiredandLiabilitiesAssumedTable">
        <link:definition>996024 - Disclosure - Acquisitions and Other Significant Transactions - Schedule of Assets Acquired and Liabilities Assumed (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails" id="mlec_r_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails">
        <link:definition>996025 - Disclosure - Information About Components of Consolidated Statements of Financial Position (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofCashandCashEquivalentsTable" id="mlec_r_ScheduleofCashandCashEquivalentsTable">
        <link:definition>996026 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Cash and Cash Equivalents (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofOtherFinancialAssetsTable" id="mlec_r_ScheduleofOtherFinancialAssetsTable">
        <link:definition>996027 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Other Financial Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofTradeReceivablesTable" id="mlec_r_ScheduleofTradeReceivablesTable">
        <link:definition>996028 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Trade Receivables (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofOtherReceivablesTable" id="mlec_r_ScheduleofOtherReceivablesTable">
        <link:definition>996029 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Other Receivables (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofInventoriesTable" id="mlec_r_ScheduleofInventoriesTable">
        <link:definition>996030 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofChangesinBiologicalAssetsTable" id="mlec_r_ScheduleofChangesinBiologicalAssetsTable">
        <link:definition>996031 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Changes in Biological Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofPropertyPlantandEquipmentTable" id="mlec_r_ScheduleofPropertyPlantandEquipmentTable">
        <link:definition>996032 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Property, Plant and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofCarryingAmountsthatWouldHaveBeenRecognizedTable" id="mlec_r_ScheduleofCarryingAmountsthatWouldHaveBeenRecognizedTable">
        <link:definition>996033 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Carrying Amounts that Would Have Been Recognized (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable" id="mlec_r_ScheduleofIntangibleAssetsTable">
        <link:definition>996034 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of&#8203; Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsScheduleofIntangibleAssetsandLiabilitiesAssumed" id="mlec_r_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsScheduleofIntangibleAssetsandLiabilitiesAssumed">
        <link:definition>996035 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Intangible Assets and Liabilities Assumed (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofGoodwillTable" id="mlec_r_ScheduleofGoodwillTable">
        <link:definition>996036 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofInvestmentPropertiesTable" id="mlec_r_ScheduleofInvestmentPropertiesTable">
        <link:definition>996037 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Investment Properties (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofTradeandOtherPayablesTable" id="mlec_r_ScheduleofTradeandOtherPayablesTable">
        <link:definition>996038 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Trade and Other Payables (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofBorrowingsTable" id="mlec_r_ScheduleofBorrowingsTable">
        <link:definition>996039 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Borrowings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofBorrowingsCarryingAmountTable" id="mlec_r_ScheduleofBorrowingsCarryingAmountTable">
        <link:definition>996040 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Borrowings, Carrying Amount (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofConvertibleNotesTable" id="mlec_r_ScheduleofConvertibleNotesTable">
        <link:definition>996041 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Convertible Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofEmployeeBenefitsandSocialSecurityTable" id="mlec_r_ScheduleofEmployeeBenefitsandSocialSecurityTable">
        <link:definition>996042 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Employee Benefits and Social Security (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofDeferredRevenueandAdvancesfromCustomersTable" id="mlec_r_ScheduleofDeferredRevenueandAdvancesfromCustomersTable">
        <link:definition>996043 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Deferred Revenue and Advances from Customers (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofChangesinAllowancesandProvisionsTable" id="mlec_r_ScheduleofChangesinAllowancesandProvisionsTable">
        <link:definition>996044 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Changes in Allowances and Provisions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofProvisionsTable" id="mlec_r_ScheduleofProvisionsTable">
        <link:definition>996045 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Provisions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofGovernmentGrantsTable" id="mlec_r_ScheduleofGovernmentGrantsTable">
        <link:definition>996046 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Government Grants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofWarrantsTable" id="mlec_r_ScheduleofWarrantsTable">
        <link:definition>996047 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Warrants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeDetails" id="mlec_r_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeDetails">
        <link:definition>996048 - Disclosure - Information about Component of Consolidated Statements of Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofRevenuefromContractswithCustomersTable" id="mlec_r_ScheduleofRevenuefromContractswithCustomersTable">
        <link:definition>996049 - Disclosure - Information about Component of Consolidated Statements of Comprehensive Income - Schedule of Revenue from Contracts with Customers (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofCostofSalesTable" id="mlec_r_ScheduleofCostofSalesTable">
        <link:definition>996050 - Disclosure - Information about Component of Consolidated Statements of Comprehensive Income - Schedule of Cost of Sales (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable" id="mlec_r_ScheduleofRDClassifiedbyNatureTable">
        <link:definition>996051 - Disclosure - Information about Component of Consolidated Statements of Comprehensive Income - Schedule of R&amp;D Classified by Nature (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTableAlt0" id="mlec_r_ScheduleofRDClassifiedbyNatureTableAlt0">
        <link:definition>996051 - Disclosure - Information about Component of Consolidated Statements of Comprehensive Income - Schedule of R&amp;D Classified by Nature (Details) Alternate 0</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofExpensesClassifiedbyNatureandFunctionTable" id="mlec_r_ScheduleofExpensesClassifiedbyNatureandFunctionTable">
        <link:definition>996052 - Disclosure - Information about Component of Consolidated Statements of Comprehensive Income - Schedule of Expenses Classified by Nature and Function (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofFinanceResultsTable" id="mlec_r_ScheduleofFinanceResultsTable">
        <link:definition>996053 - Disclosure - Information about Component of Consolidated Statements of Comprehensive Income - Schedule of Finance Results (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofOtherIncomeorExpensesNetTable" id="mlec_r_ScheduleofOtherIncomeorExpensesNetTable">
        <link:definition>996054 - Disclosure - Information about Component of Consolidated Statements of Comprehensive Income - Schedule of Other Income or Expenses, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/TaxationDetails" id="mlec_r_TaxationDetails">
        <link:definition>996055 - Disclosure - Taxation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" id="mlec_r_ScheduleofDeferredTaxAssetsandLiabilitiesTable">
        <link:definition>996056 - Disclosure - Taxation - Schedule of Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesTable" id="mlec_r_ScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesTable">
        <link:definition>996057 - Disclosure - Taxation - Schedule of Roll Forward of Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofWeightedAverageTaxRateTable" id="mlec_r_ScheduleofWeightedAverageTaxRateTable">
        <link:definition>996058 - Disclosure - Taxation - Schedule of Weighted Average Tax Rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofPrincipalStatutoryTaxesRatesandCurrentTaxTable" id="mlec_r_ScheduleofPrincipalStatutoryTaxesRatesandCurrentTaxTable">
        <link:definition>996059 - Disclosure - Taxation - Schedule of Principal Statutory Taxes Rates and Current Tax (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceTable" id="mlec_r_ScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceTable">
        <link:definition>996060 - Disclosure - Taxation - Schedule of Income Tax Expense Calculated by Applying Tax Rate in Force (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofEarningPerShareTable" id="mlec_r_ScheduleofEarningPerShareTable">
        <link:definition>996061 - Disclosure - Earning Per Share - Schedule of Earning Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/InformationaboutComponentsofEquityDetails" id="mlec_r_InformationaboutComponentsofEquityDetails">
        <link:definition>996062 - Disclosure - Information about Components of Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofNumberofSharesIssuedTable" id="mlec_r_ScheduleofNumberofSharesIssuedTable">
        <link:definition>996063 - Disclosure - Information about Components of Equity - Schedule of Number of Shares Issued (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofSubsidiariesNonControllingInterestTable" id="mlec_r_ScheduleofSubsidiariesNonControllingInterestTable">
        <link:definition>996064 - Disclosure - Information about Components of Equity - Schedule of Subsidiaries Non-Controlling Interest (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable" id="mlec_r_ScheduleofFinancialStatementsTable">
        <link:definition>996065 - Disclosure - Information about Components of Equity - Schedule of Financial Statements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable" id="mlec_r_ScheduleofBioceresSAandBioceresCropSolutionsTable">
        <link:definition>996066 - Disclosure - Information about Components of Equity - Schedule of Bioceres SA and Bioceres Crop Solutions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesTable" id="mlec_r_ScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesTable">
        <link:definition>996067 - Disclosure - Cash Flow Information - Schedule of Significant Non-Cash Transactions Related to Investing and Financing Activities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable" id="mlec_r_ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable">
        <link:definition>996068 - Disclosure - Cash Flow Information - Schedule of Changes in Liabilities Arising from Financing Activities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/JointVenturesandAssociatesDetails" id="mlec_r_JointVenturesandAssociatesDetails">
        <link:definition>996069 - Disclosure - Joint Ventures and Associates (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofJointVenturesAssetsTable" id="mlec_r_ScheduleofJointVenturesAssetsTable">
        <link:definition>996070 - Disclosure - Joint Ventures and Associates - Schedule of Joint Ventures Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofChangesinJointVenturesInvestmentsandAffiliatesTable" id="mlec_r_ScheduleofChangesinJointVenturesInvestmentsandAffiliatesTable">
        <link:definition>996071 - Disclosure - Joint Ventures and Associates - Schedule of Changes in Joint Ventures Investments and Affiliates (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofShareofProfitorLossofJointVenturesandAffiliatesTable" id="mlec_r_ScheduleofShareofProfitorLossofJointVenturesandAffiliatesTable">
        <link:definition>996072 - Disclosure - Joint Ventures and Associates - Schedule of Share of Profit or Loss of Joint Ventures and Affiliates (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofSignificantJointVenturesTable" id="mlec_r_ScheduleofSignificantJointVenturesTable">
        <link:definition>996073 - Disclosure - Joint Ventures and Associates - Schedule of Significant Joint Ventures (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/SegmentInformationDetails" id="mlec_r_SegmentInformationDetails">
        <link:definition>996074 - Disclosure - Segment Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofOperatingResultsGroupsReportingSegmentsTable" id="mlec_r_ScheduleofOperatingResultsGroupsReportingSegmentsTable">
        <link:definition>996075 - Disclosure - Segment Information - Schedule of Operating Results Group's Reporting Segments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofRevenuebySimilarGroupofProductsorServicesTable" id="mlec_r_ScheduleofRevenuebySimilarGroupofProductsorServicesTable">
        <link:definition>996076 - Disclosure - Segment Information - Schedule of Revenue by Similar Group of Products or Services (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofGeographicalInformationTable" id="mlec_r_ScheduleofGeographicalInformationTable">
        <link:definition>996077 - Disclosure - Segment Information - Schedule of Geographical Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/FinancialInstrumentsRiskManagementDetails" id="mlec_r_FinancialInstrumentsRiskManagementDetails">
        <link:definition>996078 - Disclosure - Financial Instruments &#8211; Risk Management (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofLiquidityRiskTable" id="mlec_r_ScheduleofLiquidityRiskTable">
        <link:definition>996079 - Disclosure - Financial Instruments &#8211; Risk Management - Schedule of Liquidity Risk (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofCurrencyRiskTable" id="mlec_r_ScheduleofCurrencyRiskTable">
        <link:definition>996080 - Disclosure - Financial Instruments &#8211; Risk Management - Schedule of Currency Risk (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofOtherForiegnCurrencieswithVariablesRemainingConstantTable" id="mlec_r_ScheduleofOtherForiegnCurrencieswithVariablesRemainingConstantTable">
        <link:definition>996081 - Disclosure - Financial Instruments &#8211; Risk Management - Schedule of Other Foriegn Currencies with Variables Remaining Constant (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofInterestRateRiskTable" id="mlec_r_ScheduleofInterestRateRiskTable">
        <link:definition>996082 - Disclosure - Financial Instruments &#8211; Risk Management - Schedule of Interest Rate Risk (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofFinancialAssetsbyCategoryTable" id="mlec_r_ScheduleofFinancialAssetsbyCategoryTable">
        <link:definition>996083 - Disclosure - Financial Instruments &#8211; Risk Management - Schedule of Financial Assets by Category (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofFinancialLiabilitiesbyCategoryTable" id="mlec_r_ScheduleofFinancialLiabilitiesbyCategoryTable">
        <link:definition>996084 - Disclosure - Financial Instruments &#8211; Risk Management - Schedule of Financial Liabilities by Category (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofFairValuebyHierarchyTable" id="mlec_r_ScheduleofFairValuebyHierarchyTable">
        <link:definition>996085 - Disclosure - Financial Instruments &#8211; Risk Management - Schedule of Fair Value by Hierarchy (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable" id="mlec_r_ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable">
        <link:definition>996086 - Disclosure - Leases - Schedule of Right-of-Use and Liabilities Related with Lease Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofTransactionsBetweentheGroupandRelatedPartiesTable" id="mlec_r_ScheduleofTransactionsBetweentheGroupandRelatedPartiesTable">
        <link:definition>996087 - Disclosure - Shareholders and Other Related Parties Balances and Transactions - Schedule of Transactions Between the Group and Related Parties (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofCompensationofKeyManagementPersonnelCompensationTable" id="mlec_r_ScheduleofCompensationofKeyManagementPersonnelCompensationTable">
        <link:definition>996088 - Disclosure - Key Management Personnel Compensation - Schedule of Compensation of Key Management Personnel Compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ShareBasedPaymentDetails" id="mlec_r_ShareBasedPaymentDetails">
        <link:definition>996089 - Disclosure - Share-Based Payment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofFairValueoftheStockOptionsattheGrantDateTable" id="mlec_r_ScheduleofFairValueoftheStockOptionsattheGrantDateTable">
        <link:definition>996090 - Disclosure - Share-Based Payment - Schedule of Fair Value of the Stock Options at the Grant Date (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofRangeofAssumptionswhichhaveDeterminedTable" id="mlec_r_ScheduleofRangeofAssumptionswhichhaveDeterminedTable">
        <link:definition>996091 - Disclosure - Share-Based Payment - Schedule of Range of Assumptions which have Determined (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofOptionActivityandWeightedAverageExercisePriceTable" id="mlec_r_ScheduleofOptionActivityandWeightedAverageExercisePriceTable">
        <link:definition>996092 - Disclosure - Share-Based Payment - Schedule of Option Activity and Weighted Average Exercise Price (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/EventsOccurringAftertheReportingPeriodDetails" id="mlec_r_EventsOccurringAftertheReportingPeriodDetails">
        <link:definition>996093 - Disclosure - Events Occurring After the Reporting Period (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ReverseStockSplitAftertheReportingPeriodDetails" id="mlec_r_ReverseStockSplitAftertheReportingPeriodDetails">
        <link:definition>996094 - Disclosure - Reverse Stock Split After the Reporting Period (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofWeightedAverageNumberofOrdinarySharesOutstandingTable" id="mlec_r_ScheduleofWeightedAverageNumberofOrdinarySharesOutstandingTable">
        <link:definition>996095 - Disclosure - Reverse Stock Split After the Reporting Period - Schedule of Weighted Average Number of Ordinary Shares Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/sic/2025" schemaLocation="https://xbrl.sec.gov/sic/2025/sic-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/cyd-af/2025" schemaLocation="https://xbrl.sec.gov/cyd/2025/cyd-af-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2025" schemaLocation="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd-sub/2025" schemaLocation="https://xbrl.sec.gov/ecd/2025/ecd-sub-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei-sub/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-sub-2025.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:element name="ConsolidatedStatementOfChangesInShareholdersDeficitEquityAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ConsolidatedStatementOfChangesInShareholdersDeficitEquityAbstract"/>
  <xs:element name="ScheduleOfInformationRelatedToCompanySShareOfVotingRightsInItsSubsidiariesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfInformationRelatedToCompanySShareOfVotingRightsInItsSubsidiariesAbstract"/>
  <xs:element name="ScheduleOfFairValueOfTheConsiderationOfPaymentAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfFairValueOfTheConsiderationOfPaymentAbstract"/>
  <xs:element name="ScheduleOfAssetsAcquiredAndLiabilitiesAssumedAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfAssetsAcquiredAndLiabilitiesAssumedAbstract"/>
  <xs:element name="DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract"/>
  <xs:element name="ScheduleOfOtherFinancialAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfOtherFinancialAssetsAbstract"/>
  <xs:element name="ScheduleOfOtherReceivablesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfOtherReceivablesAbstract"/>
  <xs:element name="ScheduleOfInventoriesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfInventoriesAbstract"/>
  <xs:element name="ScheduleOfChangesInBiologicalAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfChangesInBiologicalAssetsAbstract"/>
  <xs:element name="ScheduleOfPropertyPlantAndEquipmentAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfPropertyPlantAndEquipmentAbstract"/>
  <xs:element name="ScheduleOfCarryingAmountsThatWouldHaveBeenRecognizedAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfCarryingAmountsThatWouldHaveBeenRecognizedAbstract"/>
  <xs:element name="ScheduleOfIntangibleAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfIntangibleAssetsAbstract"/>
  <xs:element name="ScheduleOfGoodwillAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfGoodwillAbstract"/>
  <xs:element name="ScheduleOfBorrowingsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfBorrowingsAbstract"/>
  <xs:element name="ScheduleOfBorrowingsCarryingAmountAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfBorrowingsCarryingAmountAbstract"/>
  <xs:element name="ScheduleOfConvertibleNotesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfConvertibleNotesAbstract"/>
  <xs:element name="ScheduleOfEmployeeBenefitsAndSocialSecurityAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfEmployeeBenefitsAndSocialSecurityAbstract"/>
  <xs:element name="ScheduleOfDeferredRevenueAndAdvancesFromCustomersAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfDeferredRevenueAndAdvancesFromCustomersAbstract"/>
  <xs:element name="ScheduleOfChangesInAllowancesAndProvisionsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfChangesInAllowancesAndProvisionsAbstract"/>
  <xs:element name="ScheduleOfProvisionsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfProvisionsAbstract"/>
  <xs:element name="ScheduleOfGovernmentGrantsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfGovernmentGrantsAbstract"/>
  <xs:element name="ScheduleOfWarrantsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfWarrantsAbstract"/>
  <xs:element name="ScheduleOfExpensesClassifiedByNatureAndFunctionAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionAbstract"/>
  <xs:element name="ScheduleOfFinanceResultsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfFinanceResultsAbstract"/>
  <xs:element name="ScheduleOfOtherIncomeOrExpensesNetAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfOtherIncomeOrExpensesNetAbstract"/>
  <xs:element name="ScheduleOfRollForwardOfDeferredTaxAssetsAndLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfRollForwardOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
  <xs:element name="ScheduleOfEarningPerShareAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfEarningPerShareAbstract"/>
  <xs:element name="ScheduleOfNumberOfSharesIssuedAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfNumberOfSharesIssuedAbstract"/>
  <xs:element name="ScheduleOfSubsidiariesNonControllingInterestAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfSubsidiariesNonControllingInterestAbstract"/>
  <xs:element name="ScheduleOfFinancialStatementsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfFinancialStatementsAbstract"/>
  <xs:element name="ScheduleOfBioceresSaAndBioceresCropSolutionsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfBioceresSaAndBioceresCropSolutionsAbstract"/>
  <xs:element name="ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivitiesAbstract"/>
  <xs:element name="ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesAbstract"/>
  <xs:element name="ScheduleOfJointVenturesAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfJointVenturesAssetsAbstract"/>
  <xs:element name="ScheduleOfChangesInJointVenturesInvestmentsAndAffiliatesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfChangesInJointVenturesInvestmentsAndAffiliatesAbstract"/>
  <xs:element name="ScheduleOfSignificantJointVenturesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfSignificantJointVenturesAbstract"/>
  <xs:element name="ScheduleOfOperatingResultsGroupsReportingSegmentsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfOperatingResultsGroupsReportingSegmentsAbstract"/>
  <xs:element name="ScheduleOfRevenueBySimilarGroupOfProductsOrServicesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfRevenueBySimilarGroupOfProductsOrServicesAbstract"/>
  <xs:element name="ScheduleOfGeographicalInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfGeographicalInformationAbstract"/>
  <xs:element name="ScheduleOfLiquidityRiskAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfLiquidityRiskAbstract"/>
  <xs:element name="ScheduleOfInterestRateRiskAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfInterestRateRiskAbstract"/>
  <xs:element name="ScheduleOfFinancialAssetsByCategoryAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfFinancialAssetsByCategoryAbstract"/>
  <xs:element name="ScheduleOfFinancialLiabilitiesByCategoryAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfFinancialLiabilitiesByCategoryAbstract"/>
  <xs:element name="ScheduleOfFairValueByHierarchyAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfFairValueByHierarchyAbstract"/>
  <xs:element name="ScheduleOfRightOfUseAndLiabilitiesRelatedWithLeaseAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfRightOfUseAndLiabilitiesRelatedWithLeaseAssetsAbstract"/>
  <xs:element name="ScheduleOfTransactionsBetweenTheGroupAndRelatedPartiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfTransactionsBetweenTheGroupAndRelatedPartiesAbstract"/>
  <xs:element name="ScheduleOfFairValueOfTheStockOptionsAtTheGrantDateAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfFairValueOfTheStockOptionsAtTheGrantDateAbstract"/>
  <xs:element name="ScheduleOfRangeOfAssumptionsWhichHaveDeterminedAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfRangeOfAssumptionsWhichHaveDeterminedAbstract"/>
  <xs:element name="ScheduleOfOptionActivityAndWeightedAverageExercisePriceAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfOptionActivityAndWeightedAverageExercisePriceAbstract"/>
  <xs:element name="DisclosureOfReverseStockSplitAfterTheReportingPeriodAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DisclosureOfReverseStockSplitAfterTheReportingPeriodAbstract"/>
  <xs:element name="ScheduleOfWeightedAverageNumberOfOrdinarySharesOutstandingAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfWeightedAverageNumberOfOrdinarySharesOutstandingAbstract"/>
  <xs:element name="CurrentAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_CurrentAbstract"/>
  <xs:element name="UnlabeledAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_UnlabeledAbstract"/>
  <xs:element name="NonCurrentAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_NonCurrentAbstract"/>
  <xs:element name="CurrentAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_CurrentAbstract0"/>
  <xs:element name="CurrentAbstract1" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_CurrentAbstract1"/>
  <xs:element name="NonCurrentAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_NonCurrentAbstract0"/>
  <xs:element name="UnlabeledAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_UnlabeledAbstract0"/>
  <xs:element name="SeedAndIntegratedProductsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_SeedAndIntegratedProductsAbstract"/>
  <xs:element name="CropNutritionAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_CropNutritionAbstract"/>
  <xs:element name="OtherIntangibleAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_OtherIntangibleAssetsAbstract"/>
  <xs:element name="SeedAndIntegratedProductsAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_SeedAndIntegratedProductsAbstract0"/>
  <xs:element name="CropNutritionAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_CropNutritionAbstract0"/>
  <xs:element name="OtherIntangibleAssetsAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_OtherIntangibleAssetsAbstract0"/>
  <xs:element name="UnlabeledAbstract1" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_UnlabeledAbstract1"/>
  <xs:element name="CurrentAbstract2" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_CurrentAbstract2"/>
  <xs:element name="CurrentAbstract3" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_CurrentAbstract3"/>
  <xs:element name="NonCurrentAbstract1" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_NonCurrentAbstract1"/>
  <xs:element name="DeductedFromAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DeductedFromAssetsAbstract"/>
  <xs:element name="IncludedInLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_IncludedInLiabilitiesAbstract"/>
  <xs:element name="DeductedFromAssetsAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DeductedFromAssetsAbstract0"/>
  <xs:element name="IncludedInLiabilitiesAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_IncludedInLiabilitiesAbstract0"/>
  <xs:element name="FinancialCostAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_FinancialCostAbstract"/>
  <xs:element name="OtherFinancialResultsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_OtherFinancialResultsAbstract"/>
  <xs:element name="DeferredTaxAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DeferredTaxAssetsAbstract"/>
  <xs:element name="DeferredTaxAssetsAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DeferredTaxAssetsAbstract0"/>
  <xs:element name="DeferredTaxLiabilitiesAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DeferredTaxLiabilitiesAbstract0"/>
  <xs:element name="UnlabeledAbstract2" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_UnlabeledAbstract2"/>
  <xs:element name="AssetsAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_AssetsAbstract0"/>
  <xs:element name="MeasuredAtEquityValueMethodAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_MeasuredAtEquityValueMethodAbstract"/>
  <xs:element name="MeasuredAtFairValueAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_MeasuredAtFairValueAbstract"/>
  <xs:element name="LiabilitiesAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_LiabilitiesAbstract0"/>
  <xs:element name="MeasuredAtEquityValueMethodAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_MeasuredAtEquityValueMethodAbstract0"/>
  <xs:element name="MeasuredAtEquityValueMethodAbstract1" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_MeasuredAtEquityValueMethodAbstract1"/>
  <xs:element name="MeasuredAtFairValueAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_MeasuredAtFairValueAbstract0"/>
  <xs:element name="RevenuesFromContractsWithCustomersAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_RevenuesFromContractsWithCustomersAbstract"/>
  <xs:element name="OthersAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_OthersAbstract"/>
  <xs:element name="RevenuesFromContractsWithCustomersAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_RevenuesFromContractsWithCustomersAbstract0"/>
  <xs:element name="OthersAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_OthersAbstract0"/>
  <xs:element name="RevenuesFromContractsWithCustomersAbstract1" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_RevenuesFromContractsWithCustomersAbstract1"/>
  <xs:element name="OthersAbstract1" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_OthersAbstract1"/>
  <xs:element name="RevenueBySimilarGroupOfProductsOrServicesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_RevenueBySimilarGroupOfProductsOrServicesAbstract"/>
  <xs:element name="UnlabeledAbstract3" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_UnlabeledAbstract3"/>
  <xs:element name="UnlabeledAbstract4" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_UnlabeledAbstract4"/>
  <xs:element name="UnlabeledAbstract5" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_UnlabeledAbstract5"/>
  <xs:element name="NonCurrentAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_NonCurrentAssetsAbstract"/>
  <xs:element name="UnlabeledAbstract6" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_UnlabeledAbstract6"/>
  <xs:element name="CarryingAmountAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_CarryingAmountAbstract"/>
  <xs:element name="FixedRateInstrumentsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_FixedRateInstrumentsAbstract"/>
  <xs:element name="VariableRateInstrumentsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_VariableRateInstrumentsAbstract"/>
  <xs:element name="MeasurementAtFairValueAt06302025Abstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_MeasurementAtFairValueAt06302025Abstract"/>
  <xs:element name="FinancialAssetsAtFairValueAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_FinancialAssetsAtFairValueAbstract"/>
  <xs:element name="FinancialLiabilitiesValuedAtFairValueAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_FinancialLiabilitiesValuedAtFairValueAbstract"/>
  <xs:element name="MeasurementAtFairValueAt06302024Abstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_MeasurementAtFairValueAt06302024Abstract"/>
  <xs:element name="FinancialAssetsAtFairValueAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_FinancialAssetsAtFairValueAbstract0"/>
  <xs:element name="FinancialLiabilitiesValuedAtFairValueAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_FinancialLiabilitiesValuedAtFairValueAbstract0"/>
  <xs:element name="NumeratorAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_NumeratorAbstract"/>
  <xs:element name="DenominatorAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DenominatorAbstract"/>
  <xs:element name="ChangeInNetRealizableValueOfAgricultural" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ChangeInNetRealizableValueOfAgricultural"/>
  <xs:element name="ItemsThatWillNotBeSubsequentlyReclassifiedToLossAndProfit" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ItemsThatWillNotBeSubsequentlyReclassifiedToLossAndProfit"/>
  <xs:element name="RevaluationOfPropertyPlantAndEquipmentNetOfTaxOfJointVenturesAndAssociates" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTaxOfJointVenturesAndAssociates"/>
  <xs:element name="RevaluationOfPropertyPlantAndEquipmentNetOfTax" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTax"/>
  <xs:element name="InvestmentsInJointVenturesAndAssociates" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_InvestmentsInJointVenturesAndAssociates"/>
  <xs:element name="ShareToBeIssuedAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ShareToBeIssuedAmount"/>
  <xs:element name="SharesPremium" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_SharesPremium"/>
  <xs:element name="OwnSharesHeld" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_OwnSharesHeld"/>
  <xs:element name="StockOptionsAndShareBasedIncentives" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_StockOptionsAndShareBasedIncentives"/>
  <xs:element name="RevaluationOfPropertyPlantAndEquipmentReserve" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_RevaluationOfPropertyPlantAndEquipmentReserve"/>
  <xs:element name="JointVenturesAndAssociatesLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_JointVenturesAndAssociatesLiabilities"/>
  <xs:element name="ConsiderationForAcquisitionOfAssetsNonCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ConsiderationForAcquisitionOfAssetsNonCurrent"/>
  <xs:element name="SecuredDebtNonCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_SecuredDebtNonCurrent"/>
  <xs:element name="ConsiderationForAcquisitionOfAssetsCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ConsiderationForAcquisitionOfAssetsCurrent"/>
  <xs:element name="IncreaseDecreaseThroughChangesInBusinessCombinationEquity" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_IncreaseDecreaseThroughChangesInBusinessCombinationEquity"/>
  <xs:element name="AmortizationOfIntangibleAsset" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_AmortizationOfIntangibleAsset"/>
  <xs:element name="DepreciationOfLeasedAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_DepreciationOfLeasedAssets"/>
  <xs:element name="RemeasurementOfPreviouslyHeldInterest" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_RemeasurementOfPreviouslyHeldInterest"/>
  <xs:element name="ProvisionsForContingencies" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ProvisionsForContingencies"/>
  <xs:element name="AllowanceForImpairmentOfTradeDebtors" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_AllowanceForImpairmentOfTradeDebtors"/>
  <xs:element name="AllowanceForObsolescences" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_AllowanceForObsolescences"/>
  <xs:element name="AdjustmentsForDecreaseIncreaseInGovernmentGrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_AdjustmentsForDecreaseIncreaseInGovernmentGrants"/>
  <xs:element name="PurchaseOfOwnShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_PurchaseOfOwnShares"/>
  <xs:element name="InflationEffectsOnCashAndCashEquivalents" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_InflationEffectsOnCashAndCashEquivalents"/>
  <xs:element name="DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock"/>
  <xs:element name="DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock"/>
  <xs:element name="DisclosureOfReverseStockSplitAfterTheReportingPeriod" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DisclosureOfReverseStockSplitAfterTheReportingPeriod"/>
  <xs:element name="DescriptionOfAccountingPolicyForFinancialAssetsAndLiabilitiesPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DescriptionOfAccountingPolicyForFinancialAssetsAndLiabilitiesPolicyTextBlock"/>
  <xs:element name="DescriptionOfAccountingPolicyForBasisOfConsolidation" type="dtr1:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation"/>
  <xs:element name="DescriptionOfAccountingPolicyForConvertibleNotesTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DescriptionOfAccountingPolicyForConvertibleNotesTextBlock"/>
  <xs:element name="DescriptionOfAccountingPolicyForWarrantLiabilities" type="dtr1:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DescriptionOfAccountingPolicyForWarrantLiabilities"/>
  <xs:element name="ScheduleOfFairValueOfConsiderationOfPaymentTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfFairValueOfConsiderationOfPaymentTableTextBlock"/>
  <xs:element name="DisclosureOfOtherFinancialAssetsExplanatory" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DisclosureOfOtherFinancialAssetsExplanatory"/>
  <xs:element name="DisclosureOfTradeReceivablesTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DisclosureOfTradeReceivablesTableTextBlock"/>
  <xs:element name="DisclosureOfOtherReceivablesTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DisclosureOfOtherReceivablesTableTextBlock"/>
  <xs:element name="DisclosureOfDepreciationIfAssetsHadBeenCarriedUnderCostModelTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DisclosureOfDepreciationIfAssetsHadBeenCarriedUnderCostModelTextBlock"/>
  <xs:element name="DisclosureOfIntangibleAssetsAndLiabilitiesAssumedTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DisclosureOfIntangibleAssetsAndLiabilitiesAssumedTextBlock"/>
  <xs:element name="DisclosureOfTradeAndOtherPayablesComponentsTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DisclosureOfTradeAndOtherPayablesComponentsTableTextBlock"/>
  <xs:element name="DisclosureOfCarryingValueOfBorrowingsExplanatory" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DisclosureOfCarryingValueOfBorrowingsExplanatory"/>
  <xs:element name="DisclosureOfBenefitsAndSocialSecurityPayablesTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DisclosureOfBenefitsAndSocialSecurityPayablesTableTextBlock"/>
  <xs:element name="DisclosuresOfDeferredRevenueAndAdvancesFromCustomersTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DisclosuresOfDeferredRevenueAndAdvancesFromCustomersTableTextBlock"/>
  <xs:element name="DisclosureOfChangesInAllowancesAndProvisionsTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DisclosureOfChangesInAllowancesAndProvisionsTableTextBlock"/>
  <xs:element name="DisclosureOfWarrantsTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DisclosureOfWarrantsTextBlock"/>
  <xs:element name="ScheduleOfRollforwardOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfRollforwardOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
  <xs:element name="EffectiveIncomeTaxRateReconciliationTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_EffectiveIncomeTaxRateReconciliationTableTextBlock"/>
  <xs:element name="ComponentsOfIncomeTaxExpenseBenefitTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
  <xs:element name="IncomeTaxExpenseByApplyingApplicableTaxRateInForceInRespectiveJurisdictionsTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_IncomeTaxExpenseByApplyingApplicableTaxRateInForceInRespectiveJurisdictionsTableTextBlock"/>
  <xs:element name="DisclosureOfNumberOfSharesIssuedtextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DisclosureOfNumberOfSharesIssuedtextBlock"/>
  <xs:element name="ScheduleOfFinancialStatementsTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfFinancialStatementsTextBlock"/>
  <xs:element name="ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities"/>
  <xs:element name="DisclosureOfInvestmentsInJointVenturesAndAffiliatesTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DisclosureOfInvestmentsInJointVenturesAndAffiliatesTableTextBlock"/>
  <xs:element name="DisclosureOfChangesInInvestmentInJointVenturesAndAffiliatesTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DisclosureOfChangesInInvestmentInJointVenturesAndAffiliatesTableTextBlock"/>
  <xs:element name="DisclosureOfShareOfProfitOrLossInJointVenturesAndAffiliatesTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DisclosureOfShareOfProfitOrLossInJointVenturesAndAffiliatesTableTextBlock"/>
  <xs:element name="ScheduleOfSignificantJointVenturesTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfSignificantJointVenturesTableTextBlock"/>
  <xs:element name="DisclosureOfForeignExchangeRiskSensitivityAnalysistextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DisclosureOfForeignExchangeRiskSensitivityAnalysistextBlock"/>
  <xs:element name="DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock"/>
  <xs:element name="DisclosureOfFairValueOfTheStockOptionsAtTheGrantDateTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DisclosureOfFairValueOfTheStockOptionsAtTheGrantDateTextBlock"/>
  <xs:element name="AccountingStandardsandBasisofPreparationScheduleofInformationrelatedtoCompanysShareofVotingRightsinitsSubsidiariesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_AccountingStandardsandBasisofPreparationScheduleofInformationrelatedtoCompanysShareofVotingRightsinitsSubsidiariesDetailsTable"/>
  <xs:element name="AcquisitionsandOtherSignificantTransactionsScheduleofFairValueoftheConsiderationofPaymentDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofFairValueoftheConsiderationofPaymentDetailsTable"/>
  <xs:element name="AcquisitionsandOtherSignificantTransactionsScheduleofFairValueoftheConsiderationofPaymentDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofFairValueoftheConsiderationofPaymentDetailsLineItems"/>
  <xs:element name="EquityShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_EquityShares"/>
  <xs:element name="AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsTable"/>
  <xs:element name="AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems"/>
  <xs:element name="NoncontrollingInterest" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_NoncontrollingInterest"/>
  <xs:element name="IncomeAndMinimumPresumedRecoverableIncomeTaxes" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_IncomeAndMinimumPresumedRecoverableIncomeTaxes"/>
  <xs:element name="MutualFunds" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_MutualFunds"/>
  <xs:element name="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofOtherFinancialAssetsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofOtherFinancialAssetsDetailsTable"/>
  <xs:element name="IfrsBalanceSheetLocationDomainDomain" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_IfrsBalanceSheetLocationDomainDomain"/>
  <xs:element name="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofTradeReceivablesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofTradeReceivablesDetailsTable"/>
  <xs:element name="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofTradeReceivablesDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofTradeReceivablesDetailsLineItems"/>
  <xs:element name="CurrentTradeReceivablesAllowanceForImpairmentOfTradeDebtors" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_CurrentTradeReceivablesAllowanceForImpairmentOfTradeDebtors"/>
  <xs:element name="CurrentTradeReceivablesShareholdersAndOtherRelatedParties" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_CurrentTradeReceivablesShareholdersAndOtherRelatedParties"/>
  <xs:element name="AllowanceForReturnOfGoods" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_AllowanceForReturnOfGoods"/>
  <xs:element name="CurrentTradeReceivablesTradeDebtorsJointVenturesAndAssociates" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_CurrentTradeReceivablesTradeDebtorsJointVenturesAndAssociates"/>
  <xs:element name="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofOtherReceivablesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofOtherReceivablesDetailsTable"/>
  <xs:element name="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofInventoriesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofInventoriesDetailsTable"/>
  <xs:element name="InventoriesCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_InventoriesCurrent"/>
  <xs:element name="InventoriesExcludingAgriculturalProduce" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_InventoriesExcludingAgriculturalProduce"/>
  <xs:element name="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinBiologicalAssetsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinBiologicalAssetsDetailsTable"/>
  <xs:element name="DecreaseDueToHarvestAndDisposalsBiologicalAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_DecreaseDueToHarvestAndDisposalsBiologicalAssets"/>
  <xs:element name="LossOfControlonBiologicalAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_LossOfControlonBiologicalAssets"/>
  <xs:element name="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofPropertyPlantandEquipmentDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofPropertyPlantandEquipmentDetailsTable"/>
  <xs:element name="DisposalsPropertyPlantAndEquipments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_DisposalsPropertyPlantAndEquipments"/>
  <xs:element name="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofIntangibleAssetsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofIntangibleAssetsDetailsTable"/>
  <xs:element name="DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets"/>
  <xs:element name="AdditionsFromBusinessCombinations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_AdditionsFromBusinessCombinations"/>
  <xs:element name="AmortizationOfTheYear" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_AmortizationOfTheYear"/>
  <xs:element name="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGoodwillDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGoodwillDetailsTable"/>
  <xs:element name="TradeAndOtherPayablesShareholdersAndOtherRelatedParties" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_TradeAndOtherPayablesShareholdersAndOtherRelatedParties"/>
  <xs:element name="TradeCreditorsJointVenturesAndAssociates" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_TradeCreditorsJointVenturesAndAssociates"/>
  <xs:element name="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofBorrowingsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofBorrowingsDetailsTable"/>
  <xs:element name="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofBorrowingsCarryingAmountDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofBorrowingsCarryingAmountDetailsTable"/>
  <xs:element name="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofConvertibleNotesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofConvertibleNotesDetailsTable"/>
  <xs:element name="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofConvertibleNotesDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofConvertibleNotesDetailsLineItems"/>
  <xs:element name="SalariesAccruedIncentivesVacationsAndSocialSecurity" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_SalariesAccruedIncentivesVacationsAndSocialSecurity"/>
  <xs:element name="KeyManagementPersonnelBenefitsLiabilityCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_KeyManagementPersonnelBenefitsLiabilityCurrent"/>
  <xs:element name="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsTable"/>
  <xs:element name="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsLineItems"/>
  <xs:element name="AllowancesAndProvisionsUsedAndReversed" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_AllowancesAndProvisionsUsedAndReversed"/>
  <xs:element name="ChangeInAllowanceAndProvisionLossOfControl" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ChangeInAllowanceAndProvisionLossOfControl"/>
  <xs:element name="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofProvisionsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofProvisionsDetailsTable"/>
  <xs:element name="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofProvisionsDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofProvisionsDetailsLineItems"/>
  <xs:element name="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGovernmentGrantsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGovernmentGrantsDetailsTable"/>
  <xs:element name="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGovernmentGrantsDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGovernmentGrantsDetailsLineItems"/>
  <xs:element name="AdditionsWarrantsForTheYear" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_AdditionsWarrantsForTheYear"/>
  <xs:element name="AdditionsFromBusinessCombination" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_AdditionsFromBusinessCombination"/>
  <xs:element name="InventoriesNetOfAgriculturalProducts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_InventoriesNetOfAgriculturalProducts"/>
  <xs:element name="LossOfControl" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_LossOfControl"/>
  <xs:element name="InventoriesFromBusinessCombination" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_InventoriesFromBusinessCombination"/>
  <xs:element name="PurchaseOfInventory" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_PurchaseOfInventory"/>
  <xs:element name="InventoryProductionCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_InventoryProductionCosts"/>
  <xs:element name="ForeignCurrencyTranslationOnInventory" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ForeignCurrencyTranslationOnInventory"/>
  <xs:element name="InventoriesBeforeClosingInventory" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_InventoriesBeforeClosingInventory"/>
  <xs:element name="AnalysisAndStorage" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_AnalysisAndStorage"/>
  <xs:element name="ImportAndExportExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ImportAndExportExpenses"/>
  <xs:element name="SuppliesAndMaterials" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_SuppliesAndMaterials"/>
  <xs:element name="LicensesandPatents" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_LicensesandPatents"/>
  <xs:element name="SystemExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_SystemExpenses"/>
  <xs:element name="VehicleExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_VehicleExpenses"/>
  <xs:element name="SurveillanceExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_SurveillanceExpense"/>
  <xs:element name="ProfessionalFeesExpenseRelatedParties" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ProfessionalFeesExpenseRelatedParties"/>
  <xs:element name="ResearchAndDevelopmentExpenseCapitalized" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ResearchAndDevelopmentExpenseCapitalized"/>
  <xs:element name="TotalResearchAndDevelopmentExpenseIncurred" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_TotalResearchAndDevelopmentExpenseIncurred"/>
  <xs:element name="InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofExpensesClassifiedbyNatureandFunctionDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofExpensesClassifiedbyNatureandFunctionDetailsTable"/>
  <xs:element name="SharebasedIncentivesForEmployees" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_SharebasedIncentivesForEmployees"/>
  <xs:element name="ProfessionalFeesRelatedParties" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ProfessionalFeesRelatedParties"/>
  <xs:element name="Contingencies" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_Contingencies"/>
  <xs:element name="EnvironmentalImpactTreatment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_EnvironmentalImpactTreatment"/>
  <xs:element name="InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofFinanceResultsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofFinanceResultsDetailsTable"/>
  <xs:element name="InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofFinanceResultsDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofFinanceResultsDetailsLineItems"/>
  <xs:element name="FinancialCommissions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_FinancialCommissions"/>
  <xs:element name="ChangeInFairValueOfFinancialAssetsOrLiabilitiesOrOtherFinancialResults" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ChangeInFairValueOfFinancialAssetsOrLiabilitiesOrOtherFinancialResults"/>
  <xs:element name="PrepaymentPremiumFee" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_PrepaymentPremiumFee"/>
  <xs:element name="NetGainOnInflationEffectOnMonetary" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_NetGainOnInflationEffectOnMonetary"/>
  <xs:element name="InterestAccruedWithRelatedParties" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_InterestAccruedWithRelatedParties"/>
  <xs:element name="GainOnBargainPurchase" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_GainOnBargainPurchase"/>
  <xs:element name="RemeasurementToFairValueOfPreexistingInterestInAnAcquiree" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_RemeasurementToFairValueOfPreexistingInterestInAnAcquiree"/>
  <xs:element name="NetResultFromCommercializationOfAgriculturalProducts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_NetResultFromCommercializationOfAgriculturalProducts"/>
  <xs:element name="OtherIncomeOrExpensesNet" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_OtherIncomeOrExpensesNet"/>
  <xs:element name="TaxationScheduleofDeferredTaxAssetsandLiabilitiesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_TaxationScheduleofDeferredTaxAssetsandLiabilitiesDetailsTable"/>
  <xs:element name="TaxationScheduleofDeferredTaxAssetsandLiabilitiesDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_TaxationScheduleofDeferredTaxAssetsandLiabilitiesDetailsLineItems"/>
  <xs:element name="TaxationScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_TaxationScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesDetailsTable"/>
  <xs:element name="TaxEffectOfShareOfProfitOrLossOfSubsidiesJointVenturesAndAssociates" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_TaxEffectOfShareOfProfitOrLossOfSubsidiesJointVenturesAndAssociates"/>
  <xs:element name="PuttableInstrumentsCharge" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_PuttableInstrumentsCharge"/>
  <xs:element name="TaxEffectOfStockOptionCharge" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_TaxEffectOfStockOptionCharge"/>
  <xs:element name="DerecognitionOfDeferredTaxAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_DerecognitionOfDeferredTaxAssets"/>
  <xs:element name="MutualFundsAdjustment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_MutualFundsAdjustment"/>
  <xs:element name="TaxEffectOfRevenuesExemptFromTaxationAndExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_TaxEffectOfRevenuesExemptFromTaxationAndExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss"/>
  <xs:element name="ResultOfInflationEffectOnMonetaryItemsAndOtherFinanceResults" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ResultOfInflationEffectOnMonetaryItemsAndOtherFinanceResults"/>
  <xs:element name="TaxInflationAdjustment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_TaxInflationAdjustment"/>
  <xs:element name="TaxJurisdictionDomainDomain" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_TaxJurisdictionDomainDomain"/>
  <xs:element name="TaxationScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_TaxationScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceDetailsTable"/>
  <xs:element name="TaxationScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_TaxationScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceDetailsLineItems"/>
  <xs:element name="EarningPerShareScheduleofEarningPerShareDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_EarningPerShareScheduleofEarningPerShareDetailsTable"/>
  <xs:element name="InformationaboutComponentsofEquityScheduleofNumberofSharesIssuedDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_InformationaboutComponentsofEquityScheduleofNumberofSharesIssuedDetailsTable"/>
  <xs:element name="NumberOfNominalValue" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_NumberOfNominalValue"/>
  <xs:element name="SubscribedCapitalOfShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_SubscribedCapitalOfShares"/>
  <xs:element name="SubscribedCapital" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_SubscribedCapital"/>
  <xs:element name="InformationaboutComponentsofEquityScheduleofSubsidiariesNonControllingInterestDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_InformationaboutComponentsofEquityScheduleofSubsidiariesNonControllingInterestDetailsTable"/>
  <xs:element name="InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsTable"/>
  <xs:element name="InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems"/>
  <xs:element name="NoncurrentAsset" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_NoncurrentAsset"/>
  <xs:element name="ShareOfProfitOrLossOfSubsidiaries" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ShareOfProfitOrLossOfSubsidiaries"/>
  <xs:element name="InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsTable"/>
  <xs:element name="InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems"/>
  <xs:element name="CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsTable"/>
  <xs:element name="CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsLineItems"/>
  <xs:element name="NetAssetsAcquisitionByBusinessCombination" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_NetAssetsAcquisitionByBusinessCombination"/>
  <xs:element name="InvestmentInKindInOtherRelatedPartiesNonCashTransactionsInvestmentActivities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_InvestmentInKindInOtherRelatedPartiesNonCashTransactionsInvestmentActivities"/>
  <xs:element name="IssuanceOfShare" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_IssuanceOfShare"/>
  <xs:element name="OwnShareHeld" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_OwnShareHeld"/>
  <xs:element name="ExchangeOfIntangibleAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ExchangeOfIntangibleAssets"/>
  <xs:element name="RightofuseLeasedAssetAdditionsThroughAnIncreaseInLeaseLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_RightofuseLeasedAssetAdditionsThroughAnIncreaseInLeaseLiabilities"/>
  <xs:element name="NonMonetaryContributionsInJointVenturesNonCashTransactionsInvestmentActivities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_NonMonetaryContributionsInJointVenturesNonCashTransactionsInvestmentActivities"/>
  <xs:element name="NonCashInvestingActivities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_NonCashInvestingActivities"/>
  <xs:element name="CapitalizationOfConvertibleFinancingActivities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_CapitalizationOfConvertibleFinancingActivities"/>
  <xs:element name="AssignmentOfReceivablesWithShareholdersAndOtherRelatedParties" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_AssignmentOfReceivablesWithShareholdersAndOtherRelatedParties"/>
  <xs:element name="CompensationPaymentFinancedByAcquisitionOfIntangibleAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_CompensationPaymentFinancedByAcquisitionOfIntangibleAssets"/>
  <xs:element name="IncreaseThroughAcquisitionOfNonControllingInterestInSubsidiaries" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_IncreaseThroughAcquisitionOfNonControllingInterestInSubsidiaries"/>
  <xs:element name="NonCashFinancingActivities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_NonCashFinancingActivities"/>
  <xs:element name="CashFlowInformationScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_CashFlowInformationScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesDetailsTable"/>
  <xs:element name="IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities"/>
  <xs:element name="FinancingForAssetsAcquisitions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_FinancingForAssetsAcquisitions"/>
  <xs:element name="NoncashActivities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_NoncashActivities"/>
  <xs:element name="DecreaseBecauseOfLossOfControl" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_DecreaseBecauseOfLossOfControl"/>
  <xs:element name="DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities"/>
  <xs:element name="DecreaseThroughCapitalizationOfDebtLiabilitiesArisingFromFinancingActivities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_DecreaseThroughCapitalizationOfDebtLiabilitiesArisingFromFinancingActivities"/>
  <xs:element name="JointVenturesandAssociatesScheduleofJointVenturesAssetsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_JointVenturesandAssociatesScheduleofJointVenturesAssetsDetailsTable"/>
  <xs:element name="JointVenturesandAssociatesScheduleofJointVenturesAssetsDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_JointVenturesandAssociatesScheduleofJointVenturesAssetsDetailsLineItems"/>
  <xs:element name="InvestmentsMeasuredAtFairValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_InvestmentsMeasuredAtFairValue"/>
  <xs:element name="DueToJointVenturesAndAssociatesNonCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_DueToJointVenturesAndAssociatesNonCurrent"/>
  <xs:element name="JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsTable"/>
  <xs:element name="JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsLineItems"/>
  <xs:element name="InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity"/>
  <xs:element name="ChangesInEquityInterest" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ChangesInEquityInterest"/>
  <xs:element name="SaleOfEquityInvestment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_SaleOfEquityInvestment"/>
  <xs:element name="JointVenturesAndAssociatesAccountedForUsingEquityMethodReclassificationChangeInOwnership" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_JointVenturesAndAssociatesAccountedForUsingEquityMethodReclassificationChangeInOwnership"/>
  <xs:element name="EquityMethodInvestmentIncreaseFromShareBasedIncentives" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_EquityMethodInvestmentIncreaseFromShareBasedIncentives"/>
  <xs:element name="ChangeinJointVenturesDividendsDistribution" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ChangeinJointVenturesDividendsDistribution"/>
  <xs:element name="GainsLossesOnExchangeDifferencesOnTranslationFromJointVentureNetOfTax" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_GainsLossesOnExchangeDifferencesOnTranslationFromJointVentureNetOfTax"/>
  <xs:element name="ShareOfProfitOrLossMeasuredAtFairValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ShareOfProfitOrLossMeasuredAtFairValue"/>
  <xs:element name="JointVenturesandAssociatesScheduleofSignificantJointVenturesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_JointVenturesandAssociatesScheduleofSignificantJointVenturesDetailsTable"/>
  <xs:element name="SegmentInformationScheduleofOperatingResultsGroupsReportingSegmentsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_SegmentInformationScheduleofOperatingResultsGroupsReportingSegmentsDetailsTable"/>
  <xs:element name="RevenueFromSaleOfGoodsAndRenderingOfServices" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_RevenueFromSaleOfGoodsAndRenderingOfServices"/>
  <xs:element name="PercentageGrossMargin" type="dtr1:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="mlec_PercentageGrossMargin"/>
  <xs:element name="SegmentInformationScheduleofRevenuebySimilarGroupofProductsorServicesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_SegmentInformationScheduleofRevenuebySimilarGroupofProductsorServicesDetailsTable"/>
  <xs:element name="SegmentInformationScheduleofGeographicalInformationDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_SegmentInformationScheduleofGeographicalInformationDetailsTable"/>
  <xs:element name="TotalReportableAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_TotalReportableAssets"/>
  <xs:element name="TotalNonreportableAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_TotalNonreportableAssets"/>
  <xs:element name="FinancialInstrumentsRiskManagementScheduleofLiquidityRiskDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_FinancialInstrumentsRiskManagementScheduleofLiquidityRiskDetailsTable"/>
  <xs:element name="ConvertibleNotes" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ConvertibleNotes"/>
  <xs:element name="LeasingLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_LeasingLiabilities"/>
  <xs:element name="ConsiderationForAcquisitionOfAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ConsiderationForAcquisitionOfAssets"/>
  <xs:element name="FinancialInstrumentsRiskManagementScheduleofCurrencyRiskDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_FinancialInstrumentsRiskManagementScheduleofCurrencyRiskDetailsTable"/>
  <xs:element name="FinancialInstrumentsRiskManagementScheduleofCurrencyRiskDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_FinancialInstrumentsRiskManagementScheduleofCurrencyRiskDetailsLineItems"/>
  <xs:element name="OtherCurrencies" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_OtherCurrencies"/>
  <xs:element name="FinancialInstrumentsRiskManagementScheduleofInterestRateRiskDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_FinancialInstrumentsRiskManagementScheduleofInterestRateRiskDetailsTable"/>
  <xs:element name="FinancialInstrumentsRiskManagementScheduleofFinancialAssetsbyCategoryDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_FinancialInstrumentsRiskManagementScheduleofFinancialAssetsbyCategoryDetailsTable"/>
  <xs:element name="FinancialInstrumentsRiskManagementScheduleofFinancialLiabilitiesbyCategoryDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_FinancialInstrumentsRiskManagementScheduleofFinancialLiabilitiesbyCategoryDetailsTable"/>
  <xs:element name="FinancialInstrumentsRiskManagementScheduleofFairValuebyHierarchyDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_FinancialInstrumentsRiskManagementScheduleofFairValuebyHierarchyDetailsTable"/>
  <xs:element name="LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsTable"/>
  <xs:element name="LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems"/>
  <xs:element name="RightOfUseAssetLossOfControl" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_RightOfUseAssetLossOfControl"/>
  <xs:element name="BookValueAtTheBeginningOfThePeriod" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_BookValueAtTheBeginningOfThePeriod"/>
  <xs:element name="DepreciationOfThePeriod" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_DepreciationOfThePeriod"/>
  <xs:element name="DisposalsDepreciation" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_DisposalsDepreciation"/>
  <xs:element name="ExchangeDifferencesDepreciation" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ExchangeDifferencesDepreciation"/>
  <xs:element name="LossOfControlDepreciation" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_LossOfControlDepreciation"/>
  <xs:element name="AccumulatedDepreciationAtTheEndOfThePeriod" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_AccumulatedDepreciationAtTheEndOfThePeriod"/>
  <xs:element name="LeaseLiabilityBeginningOfTheYearinception" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_LeaseLiabilityBeginningOfTheYearinception"/>
  <xs:element name="LeaseLiabiltyAdditionsOfTheYear" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_LeaseLiabiltyAdditionsOfTheYear"/>
  <xs:element name="AdditionsToLeaseLiabilityFromBusinessCombination" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_AdditionsToLeaseLiabilityFromBusinessCombination"/>
  <xs:element name="LeaseLiabilitiesInterestExpenseExchangeDifferencesAndInflationEffects" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_LeaseLiabilitiesInterestExpenseExchangeDifferencesAndInflationEffects"/>
  <xs:element name="PaymentsOfThePeriodLeaseliability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_PaymentsOfThePeriodLeaseliability"/>
  <xs:element name="LossOfControlLeaseLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_LossOfControlLeaseLiability"/>
  <xs:element name="TotalLeaseLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_TotalLeaseLiabilities"/>
  <xs:element name="ShareholdersandOtherRelatedPartiesBalancesandTransactionsScheduleofTransactionsBetweentheGroupandRelatedPartiesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_ShareholdersandOtherRelatedPartiesBalancesandTransactionsScheduleofTransactionsBetweentheGroupandRelatedPartiesDetailsTable"/>
  <xs:element name="ValueOfTransactionsForThePeriodEnded" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ValueOfTransactionsForThePeriodEnded"/>
  <xs:element name="ShareBasedPaymentScheduleofFairValueoftheStockOptionsattheGrantDateDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_ShareBasedPaymentScheduleofFairValueoftheStockOptionsattheGrantDateDetailsTable"/>
  <xs:element name="ShareBasedPaymentScheduleofRangeofAssumptionswhichhaveDeterminedDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_ShareBasedPaymentScheduleofRangeofAssumptionswhichhaveDeterminedDetailsTable"/>
  <xs:element name="ShareBasedPaymentScheduleofOptionActivityandWeightedAverageExercisePriceDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_ShareBasedPaymentScheduleofOptionActivityandWeightedAverageExercisePriceDetailsTable"/>
  <xs:element name="ReverseStockSplitAftertheReportingPeriodScheduleofWeightedAverageNumberofOrdinarySharesOutstandingDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_ReverseStockSplitAftertheReportingPeriodScheduleofWeightedAverageNumberofOrdinarySharesOutstandingDetailsTable"/>
  <xs:element name="ReverseStockSplitAftertheReportingPeriodScheduleofWeightedAverageNumberofOrdinarySharesOutstandingDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ReverseStockSplitAftertheReportingPeriodScheduleofWeightedAverageNumberofOrdinarySharesOutstandingDetailsLineItems"/>
  <xs:element name="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofIntangibleAssetsandLiabilitiesAssumedDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofIntangibleAssetsandLiabilitiesAssumedDetailsTable"/>
  <xs:element name="PercentageOfWeightedAverageCostOfCapital" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="mlec_PercentageOfWeightedAverageCostOfCapital"/>
  <xs:element name="PercentageOfRiskPremium" type="dtr1:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_PercentageOfRiskPremium"/>
  <xs:element name="TheGroupsBusinessReorganizationandGeneralInformationDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_TheGroupsBusinessReorganizationandGeneralInformationDetailsTable"/>
  <xs:element name="ReverseStockSplitConsolidationRatio" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ReverseStockSplitConsolidationRatio"/>
  <xs:element name="NumberOfSharesReverseStockSplit" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="mlec_NumberOfSharesReverseStockSplit"/>
  <xs:element name="PercentageOfIssuedAndOutstandingEquityInterests" type="dtr1:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="mlec_PercentageOfIssuedAndOutstandingEquityInterests"/>
  <xs:element name="ConsiderationForIssuedOrdinaryShareValue" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="mlec_ConsiderationForIssuedOrdinaryShareValue"/>
  <xs:element name="PrivateWarrantsShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="mlec_PrivateWarrantsShares"/>
  <xs:element name="PrivateWarrantsExercisePrice" type="dtr1:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_PrivateWarrantsExercisePrice"/>
  <xs:element name="AdditionalOrdinarySharesIssue" type="xbrli:durationItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="mlec_AdditionalOrdinarySharesIssue"/>
  <xs:element name="NumberOfSharesOutstandingPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_NumberOfSharesOutstandingPercentage"/>
  <xs:element name="NumberOfSharesPledged" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="mlec_NumberOfSharesPledged"/>
  <xs:element name="WorkingCapital" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_WorkingCapital"/>
  <xs:element name="GainlossOfRecognitionTransactions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_GainlossOfRecognitionTransactions"/>
  <xs:element name="GainlossOfDerecognitionTransactions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_GainlossOfDerecognitionTransactions"/>
  <xs:element name="AccountingStandardsandBasisofPreparationDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_AccountingStandardsandBasisofPreparationDetailsTable"/>
  <xs:element name="AccountingStandardsandBasisofPreparationDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_AccountingStandardsandBasisofPreparationDetailsLineItems"/>
  <xs:element name="ShorttermPeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ShorttermPeriod"/>
  <xs:element name="CumulativeInflationRate" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_CumulativeInflationRate"/>
  <xs:element name="InflationOfAccumulatedYears" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_InflationOfAccumulatedYears"/>
  <xs:element name="PercentageOfInflationAccumulated" type="dtr1:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_PercentageOfInflationAccumulated"/>
  <xs:element name="ArgentinePriceIndexShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ArgentinePriceIndexShares"/>
  <xs:element name="PrivateWarrantShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_PrivateWarrantShares"/>
  <xs:element name="PercentageOfShare" type="dtr1:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_PercentageOfShare"/>
  <xs:element name="NewStandardsAmendmentsandInterpretationsIssuedbytheIASBDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_NewStandardsAmendmentsandInterpretationsIssuedbytheIASBDetailsTable"/>
  <xs:element name="SummaryofSignificantAccountingPoliciesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_SummaryofSignificantAccountingPoliciesDetailsTable"/>
  <xs:element name="ValuationSignificantChangePercentageOfConstructionCosts" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="mlec_ValuationSignificantChangePercentageOfConstructionCosts"/>
  <xs:element name="ValuationSignificantChangeInAmountNormalWearAndTearVariationImpactOnRevaluationAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ValuationSignificantChangeInAmountNormalWearAndTearVariationImpactOnRevaluationAmount"/>
  <xs:element name="AveragePaymentTermBySales" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_AveragePaymentTermBySales"/>
  <xs:element name="AcquisitionsandOtherSignificantTransactionsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_AcquisitionsandOtherSignificantTransactionsDetailsTable"/>
  <xs:element name="NumberOfSharesAcquiredInBusinessCombination" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="mlec_NumberOfSharesAcquiredInBusinessCombination"/>
  <xs:element name="PercentageOfCustomerRevenues" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_PercentageOfCustomerRevenues"/>
  <xs:element name="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsTable"/>
  <xs:element name="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems"/>
  <xs:element name="ProjectedPeriodRange" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ProjectedPeriodRange"/>
  <xs:element name="InventoryRecognizedAsExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_InventoryRecognizedAsExpense"/>
  <xs:element name="PercentageOfPreferenceSharesAccrue" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="mlec_PercentageOfPreferenceSharesAccrue"/>
  <xs:element name="AggregateAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_AggregateAmount"/>
  <xs:element name="CreditorsPublicAuctionShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="mlec_CreditorsPublicAuctionShares"/>
  <xs:element name="IfrsDebtInstrumentTerm" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_IfrsDebtInstrumentTerm"/>
  <xs:element name="AmortizationPayments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_AmortizationPayments"/>
  <xs:element name="PercentageOfPrepaymentPremium" type="dtr1:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_PercentageOfPrepaymentPremium"/>
  <xs:element name="PercentageOfPenalty" type="dtr1:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_PercentageOfPenalty"/>
  <xs:element name="BorrowingInterestRateInCash" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="mlec_BorrowingInterestRateInCash"/>
  <xs:element name="BorrowingInterestRateInKind" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="mlec_BorrowingInterestRateInKind"/>
  <xs:element name="StrikePriceForConversionOfDebt" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_StrikePriceForConversionOfDebt"/>
  <xs:element name="VoluntaryRepurchaseOfNotesAfterIssueDate" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_VoluntaryRepurchaseOfNotesAfterIssueDate"/>
  <xs:element name="PricePerSharesOfStrikePrice" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_PricePerSharesOfStrikePrice"/>
  <xs:element name="CommonEquity" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_CommonEquity"/>
  <xs:element name="PercentageOfPenaltyOfPrepayment" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_PercentageOfPenaltyOfPrepayment"/>
  <xs:element name="DiscountRateForFairValueOfLiabilityComponent" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DiscountRateForFairValueOfLiabilityComponent"/>
  <xs:element name="AdditionalConvertibleNotesReceivedAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_AdditionalConvertibleNotesReceivedAmount"/>
  <xs:element name="ConversionOptionStrikePrice" type="dtr:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="mlec_ConversionOptionStrikePrice"/>
  <xs:element name="PercentageOfOutstandingAmountInitialInterestRate" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="mlec_PercentageOfOutstandingAmountInitialInterestRate"/>
  <xs:element name="PercentageOfCashPaymentInterestRate" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="mlec_PercentageOfCashPaymentInterestRate"/>
  <xs:element name="ContingentPayment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ContingentPayment"/>
  <xs:element name="ContingentPaymentCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ContingentPaymentCurrent"/>
  <xs:element name="PercentageOfCapital" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="mlec_PercentageOfCapital"/>
  <xs:element name="PercentageOfDividendsTaxedShares" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_PercentageOfDividendsTaxedShares"/>
  <xs:element name="ContingentPurchasePrice" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ContingentPurchasePrice"/>
  <xs:element name="InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeDetailsTable"/>
  <xs:element name="InformationaboutComponentsofEquityDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_InformationaboutComponentsofEquityDetailsTable"/>
  <xs:element name="InformationaboutComponentsofEquityDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_InformationaboutComponentsofEquityDetailsLineItems"/>
  <xs:element name="VotePerShare" type="xbrli:integerItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="mlec_VotePerShare"/>
  <xs:element name="JointVenturesandAssociatesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_JointVenturesandAssociatesDetailsTable"/>
  <xs:element name="PercentageOfProfitForObligationToLegalReserve" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_PercentageOfProfitForObligationToLegalReserve"/>
  <xs:element name="MaximumPercentageOfCapitalForObligationToLegalReserve" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_MaximumPercentageOfCapitalForObligationToLegalReserve"/>
  <xs:element name="NumberOfComplementaryComponents" type="xbrli:integerItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="mlec_NumberOfComplementaryComponents"/>
  <xs:element name="PercentageOfEstimatesThatDevaluationOrAnAppreciation" type="dtr1:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_PercentageOfEstimatesThatDevaluationOrAnAppreciation"/>
  <xs:element name="ShareBasedPaymentDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_ShareBasedPaymentDetailsTable"/>
  <xs:element name="ShareBasedPaymentsIncentiveIncreases" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ShareBasedPaymentsIncentiveIncreases"/>
  <xs:element name="IfrsDefinedContributionPlanEmployerMatchingContributionPercentOfEmployeesGrossPay" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_IfrsDefinedContributionPlanEmployerMatchingContributionPercentOfEmployeesGrossPay"/>
  <xs:element name="SharesSubjectToEmployeeStockPurchasePlan" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="mlec_SharesSubjectToEmployeeStockPurchasePlan"/>
  <xs:element name="PercentageOfClosingPriceOnFirstAndLastBusinessDayToDeterminePurchasePrice" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_PercentageOfClosingPriceOnFirstAndLastBusinessDayToDeterminePurchasePrice"/>
  <xs:element name="ShareBasedPaymentAwardExpirationDate" type="xbrli:dateItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ShareBasedPaymentAwardExpirationDate"/>
  <xs:element name="IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod"/>
  <xs:element name="ShareBasedPaymentPeriodOfWeightedAveragePriceVwapOfOrdinarySharesForCashlessBasisExercise" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ShareBasedPaymentPeriodOfWeightedAveragePriceVwapOfOrdinarySharesForCashlessBasisExercise"/>
  <xs:element name="ThresholdEarningsBeforeInterestTaxesDepreciationAndAmortization" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ThresholdEarningsBeforeInterestTaxesDepreciationAndAmortization"/>
  <xs:element name="IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage"/>
  <xs:element name="NumberOfOptionsEstimatedExercisePercent" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="mlec_NumberOfOptionsEstimatedExercisePercent"/>
  <xs:element name="ShareBasedPaymentArrangementConversionOfEquityAwardsOutstandingToOptionOrRestrictedStockUnits" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ShareBasedPaymentArrangementConversionOfEquityAwardsOutstandingToOptionOrRestrictedStockUnits"/>
  <xs:element name="EventsOccurringAftertheReportingPeriodDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_EventsOccurringAftertheReportingPeriodDetailsTable"/>
  <xs:element name="EventsOccurringAftertheReportingPeriodDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_EventsOccurringAftertheReportingPeriodDetailsLineItems"/>
  <xs:element name="AmountOfFinancialDebtUnderRestructuring" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_AmountOfFinancialDebtUnderRestructuring"/>
  <xs:element name="PledgedOrTransferredSharesQuantity" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_PledgedOrTransferredSharesQuantity"/>
  <xs:element name="IssuedConvertiblePreferenceShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_IssuedConvertiblePreferenceShares"/>
  <xs:element name="ProceedFromIssuedShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ProceedFromIssuedShares"/>
  <xs:element name="PreferenceOfAccruePerAnnum" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_PreferenceOfAccruePerAnnum"/>
  <xs:element name="ProceedsFromIssueOfEquityInstrumentsOnConversionOfDebt" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ProceedsFromIssueOfEquityInstrumentsOnConversionOfDebt"/>
  <xs:element name="ConsecutiveBusinessDays" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ConsecutiveBusinessDays"/>
  <xs:element name="ReverseStockSplitAftertheReportingPeriodDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_ReverseStockSplitAftertheReportingPeriodDetailsTable"/>
  <xs:element name="ReverseStockSplitAftertheReportingPeriodDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ReverseStockSplitAftertheReportingPeriodDetailsLineItems"/>
  <xs:element name="ReverseStockSplit" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ReverseStockSplit"/>
  <xs:element name="IfrsBalanceSheetLocationAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:dimensionItem" id="mlec_IfrsBalanceSheetLocationAxis"/>
  <xs:element name="TaxJurisdictionAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:dimensionItem" id="mlec_TaxJurisdictionAxis"/>
  <xs:element name="AGBiomoleculesLLCMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_AGBiomoleculesLLCMember"/>
  <xs:element name="AdjuvantsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_AdjuvantsMember"/>
  <xs:element name="AgralityArgentinaSAMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_AgralityArgentinaSAMember"/>
  <xs:element name="AgralitySAMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_AgralitySAMember"/>
  <xs:element name="AgralitySeedsIncMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_AgralitySeedsIncMember"/>
  <xs:element name="AgralityUSIncMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_AgralityUSIncMember"/>
  <xs:element name="AgriculturalProductsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_AgriculturalProductsMember"/>
  <xs:element name="AlfalfaGenuityHarXstraMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_AlfalfaGenuityHarXstraMember"/>
  <xs:element name="AlfalfaTechnologiesSRlMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_AlfalfaTechnologiesSRlMember"/>
  <xs:element name="AllowanceForImpairmentOfTradeDebtorsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_AllowanceForImpairmentOfTradeDebtorsMember"/>
  <xs:element name="AllowanceForObsolescenceMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_AllowanceForObsolescenceMember"/>
  <xs:element name="AllowancesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_AllowancesMember"/>
  <xs:element name="AtAmortizedCostMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_AtAmortizedCostMember"/>
  <xs:element name="BacillusPHAsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_BacillusPHAsMember"/>
  <xs:element name="BankBorrowingMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_BankBorrowingMember"/>
  <xs:element name="BioceresCropSolutionsBIOXMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_BioceresCropSolutionsBIOXMember"/>
  <xs:element name="BioceresCropSolutionsCorpMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_BioceresCropSolutionsCorpMember"/>
  <xs:element name="BioceresCropSolutionsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_BioceresCropSolutionsMember"/>
  <xs:element name="BioceresCropsSAMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_BioceresCropsSAMember"/>
  <xs:element name="BioceresGroupLimitedMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_BioceresGroupLimitedMember"/>
  <xs:element name="BioceresGroupMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_BioceresGroupMember"/>
  <xs:element name="BioceresLLCMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_BioceresLLCMember"/>
  <xs:element name="BioceresSAMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_BioceresSAMember"/>
  <xs:element name="BioceresTechServicesLLCMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_BioceresTechServicesLLCMember"/>
  <xs:element name="BiologicalAssetsBarleyMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_BiologicalAssetsBarleyMember"/>
  <xs:element name="BiologicalAssetsCornMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_BiologicalAssetsCornMember"/>
  <xs:element name="BiologicalAssetsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_BiologicalAssetsMember"/>
  <xs:element name="BiologicalAssetsSoybeanMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_BiologicalAssetsSoybeanMember"/>
  <xs:element name="BiologicalAssetsWheatMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_BiologicalAssetsWheatMember"/>
  <xs:element name="BioprotectionMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_BioprotectionMember"/>
  <xs:element name="BiostimulantsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_BiostimulantsMember"/>
  <xs:element name="BorrowingMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_BorrowingMember"/>
  <xs:element name="BusinessCombinationMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_BusinessCombinationMember"/>
  <xs:element name="CarryForwardOfTaxLossMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_CarryForwardOfTaxLossMember"/>
  <xs:element name="CashAndEquivalentsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_CashAndEquivalentsMember"/>
  <xs:element name="ConditionalPaymentRizobacterSAMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ConditionalPaymentRizobacterSAMember"/>
  <xs:element name="ConsiderationForAcquisitionMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ConsiderationForAcquisitionMember"/>
  <xs:element name="ConsiderationForAcquisitionOfAssetsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ConsiderationForAcquisitionOfAssetsMember"/>
  <xs:element name="ConsolidatedEntitieMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ConsolidatedEntitieMember"/>
  <xs:element name="ConvertibleNotesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ConvertibleNotesMember"/>
  <xs:element name="ConvertiblePreferenceSharesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ConvertiblePreferenceSharesMember"/>
  <xs:element name="CorporateBondsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_CorporateBondsMember"/>
  <xs:element name="CropNutritionMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_CropNutritionMember"/>
  <xs:element name="CropProtectionMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_CropProtectionMember"/>
  <xs:element name="CustomerLoyaltyMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_CustomerLoyaltyMember"/>
  <xs:element name="DeferredTaxAssetMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DeferredTaxAssetMember"/>
  <xs:element name="DeferredTaxLiabilityMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DeferredTaxLiabilityMember"/>
  <xs:element name="EBITDAMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_EBITDAMember"/>
  <xs:element name="EmergingSolutionsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_EmergingSolutionsMember"/>
  <xs:element name="EmployeeStockOptionPlanMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_EmployeeStockOptionPlanMember"/>
  <xs:element name="EmployeeStockPurchasePlanMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_EmployeeStockPurchasePlanMember"/>
  <xs:element name="EuropeMiddleEastAndAfricaMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_EuropeMiddleEastAndAfricaMember"/>
  <xs:element name="ExpensesClassifiedByNatureAndFunctionMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ExpensesClassifiedByNatureAndFunctionMember"/>
  <xs:element name="FinancedPaymentAcquisitionOfBusinessMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_FinancedPaymentAcquisitionOfBusinessMember"/>
  <xs:element name="FinancialBorrowingsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_FinancialBorrowingsMember"/>
  <xs:element name="FixedRateBorrowingsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_FixedRateBorrowingsMember"/>
  <xs:element name="FortyEightMonthsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_FortyEightMonthsMember"/>
  <xs:element name="FungalBiomassMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_FungalBiomassMember"/>
  <xs:element name="GFASMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_GFASMember"/>
  <xs:element name="GentleFarmingMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_GentleFarmingMember"/>
  <xs:element name="GentleTechMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_GentleTechMember"/>
  <xs:element name="GoodsInTransitMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_GoodsInTransitMember"/>
  <xs:element name="GovernmentGrantsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_GovernmentGrantsMember"/>
  <xs:element name="GovernmentsGrantsReceivableMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_GovernmentsGrantsReceivableMember"/>
  <xs:element name="HB4SoyAndBreedingProgramMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_HB4SoyAndBreedingProgramMember"/>
  <xs:element name="HoldbackMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_HoldbackMember"/>
  <xs:element name="IfrsConvertibleNotesPayableMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_IfrsConvertibleNotesPayableMember"/>
  <xs:element name="IfrsFull_machineryAndEquipmentMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_IfrsFull_machineryAndEquipmentMember"/>
  <xs:element name="InKindContributionsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_InKindContributionsMember"/>
  <xs:element name="IndrasaBiotecnologaSAMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_IndrasaBiotecnologaSAMember"/>
  <xs:element name="InflationTaxAdjustmentMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_InflationTaxAdjustmentMember"/>
  <xs:element name="InmetSAMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_InmetSAMember"/>
  <xs:element name="InoculantsBiofertilizersMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_InoculantsBiofertilizersMember"/>
  <xs:element name="InsumosAgroqumicosSAMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_InsumosAgroqumicosSAMember"/>
  <xs:element name="InsuranceToBeAccruedMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_InsuranceToBeAccruedMember"/>
  <xs:element name="IntangiblesTaxLiabilityMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_IntangiblesTaxLiabilityMember"/>
  <xs:element name="IntegratedSeedProductsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_IntegratedSeedProductsMember"/>
  <xs:element name="InterestExpensesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_InterestExpensesMember"/>
  <xs:element name="InterestGainMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_InterestGainMember"/>
  <xs:element name="InventoriesTaxLiabilityMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_InventoriesTaxLiabilityMember"/>
  <xs:element name="InventoryMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_InventoryMember"/>
  <xs:element name="InvestmentsAtFairValueMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_InvestmentsAtFairValueMember"/>
  <xs:element name="InvestmentsInSharesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_InvestmentsInSharesMember"/>
  <xs:element name="JointVenturesInvestmentsAndAffiliatesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_JointVenturesInvestmentsAndAffiliatesMember"/>
  <xs:element name="LiabilitiesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_LiabilitiesMember"/>
  <xs:element name="LoansReceivablesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_LoansReceivablesMember"/>
  <xs:element name="LossMakingEntitiesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_LossMakingEntitiesMember"/>
  <xs:element name="LowOrNullTaxationJurisdictionsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_LowOrNullTaxationJurisdictionsMember"/>
  <xs:element name="MachineryAndEquipmentsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_MachineryAndEquipmentsMember"/>
  <xs:element name="ManagementExpensesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ManagementExpensesMember"/>
  <xs:element name="MandatorilyMeasuredAtFairValueThroughProfitOrLossMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_MandatorilyMeasuredAtFairValueThroughProfitOrLossMember"/>
  <xs:element name="MicroBeadedFertilizersMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_MicroBeadedFertilizersMember"/>
  <xs:element name="MicrobiologicalProductsInProgressMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_MicrobiologicalProductsInProgressMember"/>
  <xs:element name="MicrobiologicalProductsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_MicrobiologicalProductsMember"/>
  <xs:element name="MicrobiologicalProductsProducedMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_MicrobiologicalProductsProducedMember"/>
  <xs:element name="MicrobiologicalResaleProductsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_MicrobiologicalResaleProductsMember"/>
  <xs:element name="MiscellaneousMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_MiscellaneousMember"/>
  <xs:element name="MoolecScienceCaymanIslandsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_MoolecScienceCaymanIslandsMember"/>
  <xs:element name="MoolecScienceLimitedMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_MoolecScienceLimitedMember"/>
  <xs:element name="MoolecScienceLuxembourgMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_MoolecScienceLuxembourgMember"/>
  <xs:element name="MoolecScienceSAMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_MoolecScienceSAMember"/>
  <xs:element name="MoolecScienceSASharesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_MoolecScienceSASharesMember"/>
  <xs:element name="MutualFundsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_MutualFundsMember"/>
  <xs:element name="NatalAgroSRLMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_NatalAgroSRLMember"/>
  <xs:element name="NetHB4SoybeanMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_NetHB4SoybeanMember"/>
  <xs:element name="NetLoansGrantedMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_NetLoansGrantedMember"/>
  <xs:element name="NetLoansGrantedOneMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_NetLoansGrantedOneMember"/>
  <xs:element name="NetLoansPayablesJointVenturesAndAssociatesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_NetLoansPayablesJointVenturesAndAssociatesMember"/>
  <xs:element name="NetLoansPayablesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_NetLoansPayablesMember"/>
  <xs:element name="NetLoansReceivedMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_NetLoansReceivedMember"/>
  <xs:element name="NetWheatTechnologyLicensingMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_NetWheatTechnologyLicensingMember"/>
  <xs:element name="NutreconLLCMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_NutreconLLCMember"/>
  <xs:element name="OptionsIncentivePlanMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_OptionsIncentivePlanMember"/>
  <xs:element name="OrdinarySharesOneMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_OrdinarySharesOneMember"/>
  <xs:element name="OrdinarySharesWithNominalValueOfUS010PerShareMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_OrdinarySharesWithNominalValueOfUS010PerShareMember"/>
  <xs:element name="OtherCpProductsAndServicesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_OtherCpProductsAndServicesMember"/>
  <xs:element name="OtherFinancialAssetsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_OtherFinancialAssetsMember"/>
  <xs:element name="OtherInvestmentMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_OtherInvestmentMember"/>
  <xs:element name="OtherLiabilitiesOneMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_OtherLiabilitiesOneMember"/>
  <xs:element name="OtherReceivableMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_OtherReceivableMember"/>
  <xs:element name="OtherReceivablesJointVenturesAndAssociatesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_OtherReceivablesJointVenturesAndAssociatesMember"/>
  <xs:element name="OtherReceivablesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_OtherReceivablesMember"/>
  <xs:element name="OtherRegionsOrCountriesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_OtherRegionsOrCountriesMember"/>
  <xs:element name="OtherTaxAssetMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_OtherTaxAssetMember"/>
  <xs:element name="OthersFinancialAssetMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_OthersFinancialAssetMember"/>
  <xs:element name="OthersFinancialAssetsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_OthersFinancialAssetsMember"/>
  <xs:element name="OthersFinancialAssetsOneMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_OthersFinancialAssetsOneMember"/>
  <xs:element name="OthersOneMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_OthersOneMember"/>
  <xs:element name="OthersTaxAssetsTwoMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_OthersTaxAssetsTwoMember"/>
  <xs:element name="OwnSharesHeldBySubsidiariesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_OwnSharesHeldBySubsidiariesMember"/>
  <xs:element name="OwnSharesHeldMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_OwnSharesHeldMember"/>
  <xs:element name="PastShareOptionPlanMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_PastShareOptionPlanMember"/>
  <xs:element name="PerformanceShareOptionPlanMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_PerformanceShareOptionPlanMember"/>
  <xs:element name="PiggysooyMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_PiggysooyMember"/>
  <xs:element name="PreferenceShareMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_PreferenceShareMember"/>
  <xs:element name="PrepaidExpensesAndOtherReceivablesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_PrepaidExpensesAndOtherReceivablesMember"/>
  <xs:element name="PrepaymentsToSuppliersMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_PrepaymentsToSuppliersMember"/>
  <xs:element name="ProFarmGroupIncMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ProFarmGroupIncMember"/>
  <xs:element name="ProFarmGroupMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ProFarmGroupMember"/>
  <xs:element name="ProFarmUGEMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ProFarmUGEMember"/>
  <xs:element name="ProfitMakingEntitiesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ProfitMakingEntitiesMember"/>
  <xs:element name="PropertyPlantAndEquipmentDepreciationMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_PropertyPlantAndEquipmentDepreciationMember"/>
  <xs:element name="PropertyPlantAndEquipmentsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_PropertyPlantAndEquipmentsMember"/>
  <xs:element name="ProvisionForContingenciesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ProvisionForContingenciesMember"/>
  <xs:element name="PurchasesOfGoodsAndServicesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_PurchasesOfGoodsAndServicesMember"/>
  <xs:element name="PuttableInstrumentsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_PuttableInstrumentsMember"/>
  <xs:element name="RGRSOXWheatMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_RGRSOXWheatMember"/>
  <xs:element name="ReimbursementsOverExportsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ReimbursementsOverExportsMember"/>
  <xs:element name="ResearchInstrumentsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ResearchInstrumentsMember"/>
  <xs:element name="RevaluationOfPropertyPlantEquipmentAndEffectOfTaxRateChangeMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_RevaluationOfPropertyPlantEquipmentAndEffectOfTaxRateChangeMember"/>
  <xs:element name="ReverseStockSplitMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ReverseStockSplitMember"/>
  <xs:element name="RightOfUseLeasedAssetTaxLiabilityMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_RightOfUseLeasedAssetTaxLiabilityMember"/>
  <xs:element name="RizobacterArgentinaSAMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_RizobacterArgentinaSAMember"/>
  <xs:element name="RizobacterUGEMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_RizobacterUGEMember"/>
  <xs:element name="RoyaltiesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_RoyaltiesMember"/>
  <xs:element name="SWSemillasSAMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_SWSemillasSAMember"/>
  <xs:element name="SafflowerChimosin20Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_SafflowerChimosin20Member"/>
  <xs:element name="SafflowerGLAMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_SafflowerGLAMember"/>
  <xs:element name="SalariesSocialSecurityBenefitsAndOtherBenefitsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_SalariesSocialSecurityBenefitsAndOtherBenefitsMember"/>
  <xs:element name="SalesAndServicesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_SalesAndServicesMember"/>
  <xs:element name="SalesOfGoodsAndServicesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_SalesOfGoodsAndServicesMember"/>
  <xs:element name="SecuredConvertibleGuaranteedNotesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_SecuredConvertibleGuaranteedNotesMember"/>
  <xs:element name="SecuredGuaranteedNotesDue2026Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_SecuredGuaranteedNotesDue2026Member"/>
  <xs:element name="SeedAndIntegratedProductsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_SeedAndIntegratedProductsMember"/>
  <xs:element name="SeedCpProductsAndServicesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_SeedCpProductsAndServicesMember"/>
  <xs:element name="SeedRoyaltiesPaymentsHB4ProgramMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_SeedRoyaltiesPaymentsHB4ProgramMember"/>
  <xs:element name="SeedTreatmentsPacksMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_SeedTreatmentsPacksMember"/>
  <xs:element name="SeedsAndGrainsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_SeedsAndGrainsMember"/>
  <xs:element name="ShareholdersAndOtherRelatedPartiesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ShareholdersAndOtherRelatedPartiesMember"/>
  <xs:element name="SharesIssuedMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_SharesIssuedMember"/>
  <xs:element name="SoftwareInProgressMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_SoftwareInProgressMember"/>
  <xs:element name="SoftwareMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_SoftwareMember"/>
  <xs:element name="StandAloneStockOptionGrantMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_StandAloneStockOptionGrantMember"/>
  <xs:element name="StockIncentivePlan2013Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_StockIncentivePlan2013Member"/>
  <xs:element name="StockOptionsAndShareBasedIncentivesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_StockOptionsAndShareBasedIncentivesMember"/>
  <xs:element name="SubsequentEventsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_SubsequentEventsMember"/>
  <xs:element name="SunflowerMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_SunflowerMember"/>
  <xs:element name="SuppliesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_SuppliesMember"/>
  <xs:element name="SustainableAgriculturalEquipmentTechnologyMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_SustainableAgriculturalEquipmentTechnologyMember"/>
  <xs:element name="SynBioPowerlabsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_SynBioPowerlabsMember"/>
  <xs:element name="SynertechIndustriasSAMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_SynertechIndustriasSAMember"/>
  <xs:element name="SyngentaUpfrontFeeMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_SyngentaUpfrontFeeMember"/>
  <xs:element name="TaxesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_TaxesMember"/>
  <xs:element name="TheoISCSpMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_TheoISCSpMember"/>
  <xs:element name="TradeAndOtherPayablesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_TradeAndOtherPayablesMember"/>
  <xs:element name="TradeCreditorsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_TradeCreditorsMember"/>
  <xs:element name="TradeDebtorsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_TradeDebtorsMember"/>
  <xs:element name="TradeReceivableMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_TradeReceivableMember"/>
  <xs:element name="TrademarksAndPatentsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_TrademarksAndPatentsMember"/>
  <xs:element name="TrademarksAndPatentsWithIndefiniteUsefulLifeMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_TrademarksAndPatentsWithIndefiniteUsefulLifeMember"/>
  <xs:element name="TrigallGeneticsSAMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_TrigallGeneticsSAMember"/>
  <xs:element name="UsTreasuryBillsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_UsTreasuryBillsMember"/>
  <xs:element name="ValoraSoySAMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ValoraSoySAMember"/>
  <xs:element name="VariableRateBorrowingsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_VariableRateBorrowingsMember"/>
  <xs:element name="VolumeWeightedAveragePriceMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_VolumeWeightedAveragePriceMember"/>
  <xs:element name="WarrantLiabilityMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_WarrantLiabilityMember"/>
  <xs:element name="WarrantesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_WarrantesMember"/>
  <xs:element name="WarrantsExercisableForOrdinarySharesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_WarrantsExercisableForOrdinarySharesMember"/>
  <xs:element name="deductedFromAssetsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_deductedFromAssetsMember"/>
  <xs:element name="AccountingStandardsAndBasiofPreparationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_AccountingStandardsAndBasiofPreparationAbstract"/>
  <xs:element name="CriticalAccountingJudgmentsAndEstimatesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_CriticalAccountingJudgmentsAndEstimatesAbstract"/>
  <xs:element name="FinancialInstrumentsRiskManagementAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_FinancialInstrumentsRiskManagementAbstract"/>
  <xs:element name="InformationAboutComponentOfConsolidatedStatementsOfComprehensiveIncomeLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_InformationAboutComponentOfConsolidatedStatementsOfComprehensiveIncomeLineItems"/>
  <xs:element name="InformationAboutComponentsOfEquityAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_InformationAboutComponentsOfEquityAbstract"/>
  <xs:element name="InventoriesScheduleOfInventoriesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_InventoriesScheduleOfInventoriesLineItems"/>
  <xs:element name="KeyManagementPersonnelCompensationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_KeyManagementPersonnelCompensationAbstract"/>
  <xs:element name="NewStandardsAmendmentsAndInterpretationsIssuedByTheIASBAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_NewStandardsAmendmentsAndInterpretationsIssuedByTheIASBAbstract"/>
  <xs:element name="ResearchAndDevelopmentsExpenseAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ResearchAndDevelopmentsExpenseAbstract"/>
  <xs:element name="ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesLineItems"/>
  <xs:element name="ScheduleOfCompensationOfKeyManagementPersonnelCompensationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfCompensationOfKeyManagementPersonnelCompensationAbstract"/>
  <xs:element name="ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems"/>
  <xs:element name="ScheduleOfGeographicalInformationLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfGeographicalInformationLineItems"/>
  <xs:element name="ScheduleOfIntangibleAssetsAndLiabilitiesAssumedLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfIntangibleAssetsAndLiabilitiesAssumedLineItems"/>
  <xs:element name="ScheduleOfNumberOfSharesIssuedLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfNumberOfSharesIssuedLineItems"/>
  <xs:element name="ScheduleOfOtherReceivablesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfOtherReceivablesLineItems"/>
  <xs:element name="ScheduleOfWeightedAverageTaxRateAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfWeightedAverageTaxRateAbstract"/>
  <xs:element name="WorkingCapitalAdjustmentsOperatingActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_WorkingCapitalAdjustmentsOperatingActivitiesAbstract"/>
<!-- [WMV6][iAPnbhixU+IF2SON8yPIxUOHeBtUN455J/BSmtPeNs2w8s0HiFGlB4UILOBHjNRlN3pA/4BXm9s2PYt8lUuaFFtYy5DqB/9rlRzrOJrJz4inMIK8ufOs1XsFGV6I7U6zzxpUvDHkjWTkCUEjF3Guiflz/SyYhIs/P6L1YBr4zN8hPbroAvokOD37N+uWwq+o0334wabqK273pysG6/vlJeAzwn6hyeivA8WMWWnm+4TnUdqvO9Oev0BWF1qbvKtHY4Zp5G9E5YsAkWL79LRukfi4ps2MA6mU8RD4CFZodVu8EZivP7suehmPHrwtTWI2K4AlE9tsb8o1jXV/Q6ctnx/rQJk52aeXxpzl3CUcfRj/k/IPwtsb/4crQfeqECtapJTWrQo=] CSR-->
  <xs:element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DocumentAndEntityInformationAbstract"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>25
<FILENAME>mlec-20250630_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Sun Dec 28 18:19:32 UTC 2025 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ConsolidatedComprehensiveIncome" roleURI="http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ConsolidatedComprehensiveIncomeAlt0" roleURI="http://www.moolecscience.com/role/ConsolidatedComprehensiveIncomeAlt0"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ConsolidatedBalanceSheet" roleURI="http://www.moolecscience.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ConsolidatedCashFlow" roleURI="http://www.moolecscience.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofCashandCashEquivalentsTable" roleURI="http://www.moolecscience.com/role/ScheduleofCashandCashEquivalentsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofTradeReceivablesTable" roleURI="http://www.moolecscience.com/role/ScheduleofTradeReceivablesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofTradeandOtherPayablesTable" roleURI="http://www.moolecscience.com/role/ScheduleofTradeandOtherPayablesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofEmployeeBenefitsandSocialSecurityTable" roleURI="http://www.moolecscience.com/role/ScheduleofEmployeeBenefitsandSocialSecurityTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofDeferredRevenueandAdvancesfromCustomersTable" roleURI="http://www.moolecscience.com/role/ScheduleofDeferredRevenueandAdvancesfromCustomersTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofRevenuefromContractswithCustomersTable" roleURI="http://www.moolecscience.com/role/ScheduleofRevenuefromContractswithCustomersTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofRDClassifiedbyNatureTable" roleURI="http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofOtherIncomeorExpensesNetTable" roleURI="http://www.moolecscience.com/role/ScheduleofOtherIncomeorExpensesNetTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofPrincipalStatutoryTaxesRatesandCurrentTaxTable" roleURI="http://www.moolecscience.com/role/ScheduleofPrincipalStatutoryTaxesRatesandCurrentTaxTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofFinancialStatementsTable" roleURI="http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofBioceresSAandBioceresCropSolutionsTable" roleURI="http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesTable" roleURI="http://www.moolecscience.com/role/ScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofOperatingResultsGroupsReportingSegmentsTable" roleURI="http://www.moolecscience.com/role/ScheduleofOperatingResultsGroupsReportingSegmentsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofCompensationofKeyManagementPersonnelCompensationTable" roleURI="http://www.moolecscience.com/role/ScheduleofCompensationofKeyManagementPersonnelCompensationTable"/>
  <calculationLink xlink:role="http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossFromOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromContractsWithCustomers" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromContractsWithCustomers"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_RevenueFromContractsWithCustomers" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromGovernmentGrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromGovernmentGrants"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_RevenueFromGovernmentGrants" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_ChangeInNetRealizableValueOfAgricultural" xlink:href="mlec-20250630.xsd#mlec_ChangeInNetRealizableValueOfAgricultural"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="mlec_ChangeInNetRealizableValueOfAgricultural" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherOperatingIncomeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherOperatingIncomeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_OtherOperatingIncomeExpense" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets" order="6" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CostOfSales" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CostOfSales"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_CostOfSales" order="7" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_ResearchAndDevelopmentExpense" order="8" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_SellingGeneralAndAdministrativeExpense" order="9" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossBeforeTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_ProfitLossFromOperatingActivities" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinanceIncomeCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceIncomeCost"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_FinanceIncomeCost" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherFinanceIncomeCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherFinanceIncomeCost"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_OtherFinanceIncomeCost" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_ProfitLossBeforeTax" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:to="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_ItemsThatWillNotBeSubsequentlyReclassifiedToLossAndProfit" xlink:href="mlec-20250630.xsd#mlec_ItemsThatWillNotBeSubsequentlyReclassifiedToLossAndProfit"/>
    <loc xlink:type="locator" xlink:label="mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTaxOfJointVenturesAndAssociates" xlink:href="mlec-20250630.xsd#mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTaxOfJointVenturesAndAssociates"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="mlec_ItemsThatWillNotBeSubsequentlyReclassifiedToLossAndProfit" xlink:to="mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTaxOfJointVenturesAndAssociates" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTax" xlink:href="mlec-20250630.xsd#mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTax"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="mlec_ItemsThatWillNotBeSubsequentlyReclassifiedToLossAndProfit" xlink:to="mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTax" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncome"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ComprehensiveIncome" xlink:to="ifrs-full_ProfitLoss" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ComprehensiveIncome" xlink:to="ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" order="2" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ComprehensiveIncome" xlink:to="mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTaxOfJointVenturesAndAssociates" order="3" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ComprehensiveIncome" xlink:to="mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTax" order="4" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.moolecscience.com/role/ConsolidatedComprehensiveIncomeAlt0" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_ProfitLossAttributableToOwnersOfParent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_ProfitLossAttributableToNoncontrollingInterests" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncome"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ComprehensiveIncome" xlink:to="ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ComprehensiveIncome" xlink:to="ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.moolecscience.com/role/ConsolidatedBalanceSheet" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssets"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentFinancialAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_OtherNoncurrentFinancialAssets" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentReceivables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_OtherNoncurrentReceivables" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentTaxAssetsNoncurrent" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxAssetsNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_CurrentTaxAssetsNoncurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_DeferredTaxAssets" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_InvestmentsInJointVenturesAndAssociates" xlink:href="mlec-20250630.xsd#mlec_InvestmentsInJointVenturesAndAssociates"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="mlec_InvestmentsInJointVenturesAndAssociates" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_PropertyPlantAndEquipment" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InvestmentProperty" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InvestmentProperty"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_InvestmentProperty" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill" order="8" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Goodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Goodwill"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_Goodwill" order="9" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RightofuseAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_RightofuseAssets" order="10" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAssets"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_CashAndCashEquivalents" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherCurrentFinancialAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_OtherCurrentFinancialAssets" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentTradeReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTradeReceivables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_CurrentTradeReceivables" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherCurrentReceivables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_OtherCurrentReceivables" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentTaxAssetsCurrent" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxAssetsCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_CurrentTaxAssetsCurrent" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Inventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Inventories"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_Inventories" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentBiologicalAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentBiologicalAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_CurrentBiologicalAssets" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Assets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Assets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Assets" xlink:to="ifrs-full_NoncurrentAssets" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Assets" xlink:to="ifrs-full_CurrentAssets" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityAttributableToOwnersOfParent" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAttributableToOwnersOfParent"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuedCapital" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapital"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_EquityAttributableToOwnersOfParent" xlink:to="ifrs-full_IssuedCapital" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareToBeIssuedAmount" xlink:href="mlec-20250630.xsd#mlec_ShareToBeIssuedAmount"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_EquityAttributableToOwnersOfParent" xlink:to="mlec_ShareToBeIssuedAmount" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_SharesPremium" xlink:href="mlec-20250630.xsd#mlec_SharesPremium"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_EquityAttributableToOwnersOfParent" xlink:to="mlec_SharesPremium" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_OwnSharesHeld" xlink:href="mlec-20250630.xsd#mlec_OwnSharesHeld"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_EquityAttributableToOwnersOfParent" xlink:to="mlec_OwnSharesHeld" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_StockOptionsAndShareBasedIncentives" xlink:href="mlec-20250630.xsd#mlec_StockOptionsAndShareBasedIncentives"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_EquityAttributableToOwnersOfParent" xlink:to="mlec_StockOptionsAndShareBasedIncentives" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RetainedEarnings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RetainedEarnings"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_EquityAttributableToOwnersOfParent" xlink:to="ifrs-full_RetainedEarnings" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_RevaluationOfPropertyPlantAndEquipmentReserve" xlink:href="mlec-20250630.xsd#mlec_RevaluationOfPropertyPlantAndEquipmentReserve"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_EquityAttributableToOwnersOfParent" xlink:to="mlec_RevaluationOfPropertyPlantAndEquipmentReserve" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslation"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_EquityAttributableToOwnersOfParent" xlink:to="ifrs-full_ReserveOfExchangeDifferencesOnTranslation" order="8" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_EquityAttributableToOwnersOfParent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncontrollingInterests" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncontrollingInterests"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_NoncontrollingInterests" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLiabilities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LongtermBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LongtermBorrowings"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentLiabilities" xlink:to="ifrs-full_LongtermBorrowings" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentContractLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentContractLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentLiabilities" xlink:to="ifrs-full_NoncurrentContractLiabilities" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentGovernmentGrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentGovernmentGrants"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentLiabilities" xlink:to="ifrs-full_NoncurrentGovernmentGrants" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_JointVenturesAndAssociatesLiabilities" xlink:href="mlec-20250630.xsd#mlec_JointVenturesAndAssociatesLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentLiabilities" xlink:to="mlec_JointVenturesAndAssociatesLiabilities" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentLiabilities" xlink:to="ifrs-full_DeferredTaxLiabilities" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentProvisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentProvisions"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentLiabilities" xlink:to="ifrs-full_NoncurrentProvisions" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_ConsiderationForAcquisitionOfAssetsNonCurrent" xlink:href="mlec-20250630.xsd#mlec_ConsiderationForAcquisitionOfAssetsNonCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentLiabilities" xlink:to="mlec_ConsiderationForAcquisitionOfAssetsNonCurrent" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_SecuredDebtNonCurrent" xlink:href="mlec-20250630.xsd#mlec_SecuredDebtNonCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentLiabilities" xlink:to="mlec_SecuredDebtNonCurrent" order="8" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentLiabilities" xlink:to="ifrs-full_NoncurrentLeaseLiabilities" order="9" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLiabilities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_TradeAndOtherCurrentPayables" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShorttermBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShorttermBorrowings"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_ShorttermBorrowings" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentProvisionsForEmployeeBenefits" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentProvisionsForEmployeeBenefits"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_CurrentProvisionsForEmployeeBenefits" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_CurrentTaxLiabilitiesCurrent" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentGovernmentGrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentGovernmentGrants"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_CurrentGovernmentGrants" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentWarrantLiability" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentWarrantLiability"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_CurrentWarrantLiability" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_ConsiderationForAcquisitionOfAssetsCurrent" xlink:href="mlec-20250630.xsd#mlec_ConsiderationForAcquisitionOfAssetsCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="mlec_ConsiderationForAcquisitionOfAssetsCurrent" order="8" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLeaseLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_CurrentLeaseLiabilities" order="9" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Liabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Liabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Liabilities" xlink:to="ifrs-full_NoncurrentLiabilities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Liabilities" xlink:to="ifrs-full_CurrentLiabilities" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityAndLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAndLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_EquityAndLiabilities" xlink:to="ifrs-full_Equity" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_EquityAndLiabilities" xlink:to="ifrs-full_Liabilities" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.moolecscience.com/role/ConsolidatedCashFlow" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_ProfitLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncomeTaxExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForIncomeTaxExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_AdjustmentsForIncomeTaxExpense" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDepreciationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDepreciationExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_AdjustmentsForDepreciationExpense" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_AmortizationOfIntangibleAsset" xlink:href="mlec-20250630.xsd#mlec_AmortizationOfIntangibleAsset"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="mlec_AmortizationOfIntangibleAsset" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_DepreciationOfLeasedAssets" xlink:href="mlec-20250630.xsd#mlec_DepreciationOfLeasedAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="mlec_DepreciationOfLeasedAssets" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForFairValueGainsLosses" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForFairValueGainsLosses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_AdjustmentsForFairValueGainsLosses" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_RemeasurementOfPreviouslyHeldInterest" xlink:href="mlec-20250630.xsd#mlec_RemeasurementOfPreviouslyHeldInterest"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="mlec_RemeasurementOfPreviouslyHeldInterest" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_AdjustmentsForSharebasedPayments" order="8" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_ProvisionsForContingencies" xlink:href="mlec-20250630.xsd#mlec_ProvisionsForContingencies"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="mlec_ProvisionsForContingencies" order="9" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_AllowanceForImpairmentOfTradeDebtors" xlink:href="mlec-20250630.xsd#mlec_AllowanceForImpairmentOfTradeDebtors"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="mlec_AllowanceForImpairmentOfTradeDebtors" order="10" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_AllowanceForObsolescences" xlink:href="mlec-20250630.xsd#mlec_AllowanceForObsolescences"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="mlec_AllowanceForObsolescences" order="11" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets" order="12" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForFinanceCosts" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForFinanceCosts"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_AdjustmentsForFinanceCosts" order="13" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" order="14" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" order="15" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" order="16" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" order="17" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" order="18" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" order="19" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_AdjustmentsForDecreaseIncreaseInGovernmentGrants" xlink:href="mlec-20250630.xsd#mlec_AdjustmentsForDecreaseIncreaseInGovernmentGrants"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="mlec_AdjustmentsForDecreaseIncreaseInGovernmentGrants" order="20" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities" order="21" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" order="22" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnChangeInFairValueEstimatesOfBiologicalAssetsForCurrentPeriod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnChangeInFairValueEstimatesOfBiologicalAssetsForCurrentPeriod"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_GainsLossesOnChangeInFairValueEstimatesOfBiologicalAssetsForCurrentPeriod" order="23" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" order="24" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCashReceiptsFromSalesOfInterestsInJointVenturesClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherCashReceiptsFromSalesOfInterestsInJointVenturesClassifiedAsInvestingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="ifrs-full_OtherCashReceiptsFromSalesOfInterestsInJointVenturesClassifiedAsInvestingActivities" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="ifrs-full_ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" order="5" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod" order="6" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" order="7" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PaymentsForDevelopmentProjectExpenditure" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PaymentsForDevelopmentProjectExpenditure"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="ifrs-full_PaymentsForDevelopmentProjectExpenditure" order="8" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" order="9" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_InterestPaidClassifiedAsFinancingActivities" order="3" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" order="4" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities" order="5" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PaymentsOfOtherEquityInstruments" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PaymentsOfOtherEquityInstruments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_PaymentsOfOtherEquityInstruments" order="6" weight="-1"/>
    <loc xlink:type="locator" xlink:label="mlec_PurchaseOfOwnShares" xlink:href="mlec-20250630.xsd#mlec_PurchaseOfOwnShares"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="mlec_PurchaseOfOwnShares" order="7" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivities" order="2" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivities" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.moolecscience.com/role/ScheduleofCashandCashEquivalentsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Cash" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Cash"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashAndCashEquivalents" xlink:to="ifrs-full_Cash" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_MutualFunds" xlink:href="mlec-20250630.xsd#mlec_MutualFunds"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashAndCashEquivalents" xlink:to="mlec_MutualFunds" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.moolecscience.com/role/ScheduleofTradeReceivablesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivables"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentTradeReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTradeReceivables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_TradeAndOtherCurrentReceivables" xlink:to="ifrs-full_CurrentTradeReceivables" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_CurrentTradeReceivablesAllowanceForImpairmentOfTradeDebtors" xlink:href="mlec-20250630.xsd#mlec_CurrentTradeReceivablesAllowanceForImpairmentOfTradeDebtors"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_TradeAndOtherCurrentReceivables" xlink:to="mlec_CurrentTradeReceivablesAllowanceForImpairmentOfTradeDebtors" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_CurrentTradeReceivablesShareholdersAndOtherRelatedParties" xlink:href="mlec-20250630.xsd#mlec_CurrentTradeReceivablesShareholdersAndOtherRelatedParties"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_TradeAndOtherCurrentReceivables" xlink:to="mlec_CurrentTradeReceivablesShareholdersAndOtherRelatedParties" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_AllowanceForReturnOfGoods" xlink:href="mlec-20250630.xsd#mlec_AllowanceForReturnOfGoods"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_TradeAndOtherCurrentReceivables" xlink:to="mlec_AllowanceForReturnOfGoods" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_CurrentTradeReceivablesTradeDebtorsJointVenturesAndAssociates" xlink:href="mlec-20250630.xsd#mlec_CurrentTradeReceivablesTradeDebtorsJointVenturesAndAssociates"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_TradeAndOtherCurrentReceivables" xlink:to="mlec_CurrentTradeReceivablesTradeDebtorsJointVenturesAndAssociates" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherReceivables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_TradeAndOtherCurrentReceivables" xlink:to="ifrs-full_OtherReceivables" order="6" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.moolecscience.com/role/ScheduleofTradeandOtherPayablesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_TradeAndOtherCurrentPayables" xlink:to="ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_TradeAndOtherPayablesShareholdersAndOtherRelatedParties" xlink:href="mlec-20250630.xsd#mlec_TradeAndOtherPayablesShareholdersAndOtherRelatedParties"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_TradeAndOtherCurrentPayables" xlink:to="mlec_TradeAndOtherPayablesShareholdersAndOtherRelatedParties" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_TradeCreditorsJointVenturesAndAssociates" xlink:href="mlec-20250630.xsd#mlec_TradeCreditorsJointVenturesAndAssociates"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_TradeAndOtherCurrentPayables" xlink:to="mlec_TradeCreditorsJointVenturesAndAssociates" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_TradeAndOtherCurrentPayables" xlink:to="ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherCurrentPayables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_TradeAndOtherCurrentPayables" xlink:to="ifrs-full_OtherCurrentPayables" order="5" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.moolecscience.com/role/ScheduleofEmployeeBenefitsandSocialSecurityTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentProvisionsForEmployeeBenefits" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentProvisionsForEmployeeBenefits"/>
    <loc xlink:type="locator" xlink:label="mlec_SalariesAccruedIncentivesVacationsAndSocialSecurity" xlink:href="mlec-20250630.xsd#mlec_SalariesAccruedIncentivesVacationsAndSocialSecurity"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentProvisionsForEmployeeBenefits" xlink:to="mlec_SalariesAccruedIncentivesVacationsAndSocialSecurity" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_KeyManagementPersonnelBenefitsLiabilityCurrent" xlink:href="mlec-20250630.xsd#mlec_KeyManagementPersonnelBenefitsLiabilityCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentProvisionsForEmployeeBenefits" xlink:to="mlec_KeyManagementPersonnelBenefitsLiabilityCurrent" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.moolecscience.com/role/ScheduleofDeferredRevenueandAdvancesfromCustomersTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAdvances" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAdvances"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities" xlink:to="ifrs-full_CurrentAdvances" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities" xlink:to="ifrs-full_CurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentDeferredIncomeIncludingNoncurrentContractLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentDeferredIncomeIncludingNoncurrentContractLiabilities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAdvances" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAdvances"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentDeferredIncomeIncludingNoncurrentContractLiabilities" xlink:to="ifrs-full_NoncurrentAdvances" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentDeferredIncomeIncludingNoncurrentContractLiabilities" xlink:to="ifrs-full_NoncurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.moolecscience.com/role/ScheduleofRevenuefromContractswithCustomersTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromContractsWithCustomers" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromContractsWithCustomers"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromSaleOfGoods" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromSaleOfGoods"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_RevenueFromContractsWithCustomers" xlink:to="ifrs-full_RevenueFromSaleOfGoods" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromRoyalties" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromRoyalties"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_RevenueFromContractsWithCustomers" xlink:to="ifrs-full_RevenueFromRoyalties" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromRenderingOfServices" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromRenderingOfServices"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_RevenueFromContractsWithCustomers" xlink:to="ifrs-full_RevenueFromRenderingOfServices" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LicenceFeeIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LicenceFeeIncome"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_RevenueFromContractsWithCustomers" xlink:to="ifrs-full_LicenceFeeIncome" order="4" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ResearchAndDevelopmentExpense" xlink:to="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_AnalysisAndStorage" xlink:href="mlec-20250630.xsd#mlec_AnalysisAndStorage"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ResearchAndDevelopmentExpense" xlink:to="mlec_AnalysisAndStorage" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RoyaltyExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RoyaltyExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ResearchAndDevelopmentExpense" xlink:to="ifrs-full_RoyaltyExpense" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_ImportAndExportExpenses" xlink:href="mlec-20250630.xsd#mlec_ImportAndExportExpenses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ResearchAndDevelopmentExpense" xlink:to="mlec_ImportAndExportExpenses" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepreciationRightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DepreciationRightofuseAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ResearchAndDevelopmentExpense" xlink:to="ifrs-full_DepreciationRightofuseAssets" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ResearchAndDevelopmentExpense" xlink:to="ifrs-full_DepreciationPropertyPlantAndEquipment" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TransportationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TransportationExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ResearchAndDevelopmentExpense" xlink:to="ifrs-full_TransportationExpense" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShorttermEmployeeBenefitsExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShorttermEmployeeBenefitsExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ResearchAndDevelopmentExpense" xlink:to="ifrs-full_ShorttermEmployeeBenefitsExpense" order="8" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InsuranceExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InsuranceExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ResearchAndDevelopmentExpense" xlink:to="ifrs-full_InsuranceExpense" order="9" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FuelAndEnergyExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FuelAndEnergyExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ResearchAndDevelopmentExpense" xlink:to="ifrs-full_FuelAndEnergyExpense" order="10" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RepairsAndMaintenanceExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RepairsAndMaintenanceExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ResearchAndDevelopmentExpense" xlink:to="ifrs-full_RepairsAndMaintenanceExpense" order="11" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_SuppliesAndMaterials" xlink:href="mlec-20250630.xsd#mlec_SuppliesAndMaterials"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ResearchAndDevelopmentExpense" xlink:to="mlec_SuppliesAndMaterials" order="12" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_LicensesandPatents" xlink:href="mlec-20250630.xsd#mlec_LicensesandPatents"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ResearchAndDevelopmentExpense" xlink:to="mlec_LicensesandPatents" order="13" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TravelExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TravelExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ResearchAndDevelopmentExpense" xlink:to="ifrs-full_TravelExpense" order="14" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdvertisingExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdvertisingExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ResearchAndDevelopmentExpense" xlink:to="ifrs-full_AdvertisingExpense" order="15" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_SystemExpenses" xlink:href="mlec-20250630.xsd#mlec_SystemExpenses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ResearchAndDevelopmentExpense" xlink:to="mlec_SystemExpenses" order="16" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_VehicleExpenses" xlink:href="mlec-20250630.xsd#mlec_VehicleExpenses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ResearchAndDevelopmentExpense" xlink:to="mlec_VehicleExpenses" order="17" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ResearchAndDevelopmentExpense" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" order="18" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_SurveillanceExpense" xlink:href="mlec-20250630.xsd#mlec_SurveillanceExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ResearchAndDevelopmentExpense" xlink:to="mlec_SurveillanceExpense" order="19" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfessionalFeesExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfessionalFeesExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ResearchAndDevelopmentExpense" xlink:to="ifrs-full_ProfessionalFeesExpense" order="20" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_ProfessionalFeesExpenseRelatedParties" xlink:href="mlec-20250630.xsd#mlec_ProfessionalFeesExpenseRelatedParties"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ResearchAndDevelopmentExpense" xlink:to="mlec_ProfessionalFeesExpenseRelatedParties" order="21" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdministrativeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ResearchAndDevelopmentExpense" xlink:to="ifrs-full_AdministrativeExpense" order="22" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MiscellaneousOtherOperatingExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MiscellaneousOtherOperatingExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ResearchAndDevelopmentExpense" xlink:to="ifrs-full_MiscellaneousOtherOperatingExpense" order="23" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_TotalResearchAndDevelopmentExpenseIncurred" xlink:href="mlec-20250630.xsd#mlec_TotalResearchAndDevelopmentExpenseIncurred"/>
    <loc xlink:type="locator" xlink:label="mlec_ResearchAndDevelopmentExpenseCapitalized" xlink:href="mlec-20250630.xsd#mlec_ResearchAndDevelopmentExpenseCapitalized"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="mlec_TotalResearchAndDevelopmentExpenseIncurred" xlink:to="mlec_ResearchAndDevelopmentExpenseCapitalized" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="mlec_TotalResearchAndDevelopmentExpenseIncurred" xlink:to="ifrs-full_ResearchAndDevelopmentExpense" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.moolecscience.com/role/ScheduleofOtherIncomeorExpensesNetTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherOperatingIncomeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherOperatingIncomeExpense"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromSaleOfAgriculturalProduce" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromSaleOfAgriculturalProduce"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="ifrs-full_RevenueFromSaleOfAgriculturalProduce" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_GainOnBargainPurchase" xlink:href="mlec-20250630.xsd#mlec_GainOnBargainPurchase"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="mlec_GainOnBargainPurchase" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_RemeasurementToFairValueOfPreexistingInterestInAnAcquiree" xlink:href="mlec-20250630.xsd#mlec_RemeasurementToFairValueOfPreexistingInterestInAnAcquiree"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="mlec_RemeasurementToFairValueOfPreexistingInterestInAnAcquiree" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherIncomeOrExpensesNet" xlink:href="mlec-20250630.xsd#mlec_OtherIncomeOrExpensesNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="mlec_OtherIncomeOrExpensesNet" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_NetResultFromCommercializationOfAgriculturalProducts" xlink:href="mlec-20250630.xsd#mlec_NetResultFromCommercializationOfAgriculturalProducts"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="mlec_NetResultFromCommercializationOfAgriculturalProducts" order="5" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" order="6" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.moolecscience.com/role/ScheduleofPrincipalStatutoryTaxesRatesandCurrentTaxTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentTaxExpenseIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxExpenseIncome"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="ifrs-full_CurrentTaxExpenseIncome" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxExpenseIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxExpenseIncome"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="ifrs-full_DeferredTaxExpenseIncome" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_Assets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Assets"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Assets" xlink:to="ifrs-full_CurrentAssets" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_NoncurrentAsset" xlink:href="mlec-20250630.xsd#mlec_NoncurrentAsset"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Assets" xlink:to="mlec_NoncurrentAsset" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Liabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Liabilities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Liabilities" xlink:to="ifrs-full_CurrentLiabilities" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Liabilities" xlink:to="ifrs-full_NoncurrentLiabilities" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityAndLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAndLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_EquityAndLiabilities" xlink:to="ifrs-full_Liabilities" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_EquityAndLiabilities" xlink:to="ifrs-full_Equity" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GrossProfit" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossProfit"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Revenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Revenue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_GrossProfit" xlink:to="ifrs-full_Revenue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromGovernmentGrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromGovernmentGrants"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_GrossProfit" xlink:to="ifrs-full_RevenueFromGovernmentGrants" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossFromOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_GrossProfit" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareOfProfitOrLossOfSubsidiaries" xlink:href="mlec-20250630.xsd#mlec_ShareOfProfitOrLossOfSubsidiaries"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="mlec_ShareOfProfitOrLossOfSubsidiaries" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherOperatingIncomeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherOperatingIncomeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_OtherOperatingIncomeExpense" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_ResearchAndDevelopmentExpense" order="5" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_SellingGeneralAndAdministrativeExpense" order="6" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossBeforeTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_ProfitLossFromOperatingActivities" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinanceIncomeCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceIncomeCost"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_FinanceIncomeCost" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_ProfitLossBeforeTax" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations" order="2" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_Assets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Assets"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Assets" xlink:to="ifrs-full_CurrentAssets" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Assets" xlink:to="ifrs-full_NoncurrentAssets" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Liabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Liabilities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Liabilities" xlink:to="ifrs-full_CurrentLiabilities" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Liabilities" xlink:to="ifrs-full_NoncurrentLiabilities" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityAndLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAndLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_EquityAndLiabilities" xlink:to="ifrs-full_Liabilities" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_EquityAndLiabilities" xlink:to="ifrs-full_Equity" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossFromOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Revenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Revenue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_Revenue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_ChangeInNetRealizableValueOfAgricultural" xlink:href="mlec-20250630.xsd#mlec_ChangeInNetRealizableValueOfAgricultural"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="mlec_ChangeInNetRealizableValueOfAgricultural" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherOperatingIncomeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherOperatingIncomeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_OtherOperatingIncomeExpense" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CostOfSales" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CostOfSales"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_CostOfSales" order="6" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_ResearchAndDevelopmentExpense" order="7" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_SellingGeneralAndAdministrativeExpense" order="8" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossBeforeTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_ProfitLossFromOperatingActivities" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinanceIncomeCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceIncomeCost"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_FinanceIncomeCost" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_ProfitLossBeforeTax" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations" order="2" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.moolecscience.com/role/ScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_NonCashInvestingActivities" xlink:href="mlec-20250630.xsd#mlec_NonCashInvestingActivities"/>
    <loc xlink:type="locator" xlink:label="mlec_InvestmentInKindInOtherRelatedPartiesNonCashTransactionsInvestmentActivities" xlink:href="mlec-20250630.xsd#mlec_InvestmentInKindInOtherRelatedPartiesNonCashTransactionsInvestmentActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="mlec_NonCashInvestingActivities" xlink:to="mlec_InvestmentInKindInOtherRelatedPartiesNonCashTransactionsInvestmentActivities" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_IssuanceOfShare" xlink:href="mlec-20250630.xsd#mlec_IssuanceOfShare"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="mlec_NonCashInvestingActivities" xlink:to="mlec_IssuanceOfShare" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_ExchangeOfIntangibleAssets" xlink:href="mlec-20250630.xsd#mlec_ExchangeOfIntangibleAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="mlec_NonCashInvestingActivities" xlink:to="mlec_ExchangeOfIntangibleAssets" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestCostsCapitalised" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestCostsCapitalised"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="mlec_NonCashInvestingActivities" xlink:to="ifrs-full_InterestCostsCapitalised" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_NonMonetaryContributionsInJointVenturesNonCashTransactionsInvestmentActivities" xlink:href="mlec-20250630.xsd#mlec_NonMonetaryContributionsInJointVenturesNonCashTransactionsInvestmentActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="mlec_NonCashInvestingActivities" xlink:to="mlec_NonMonetaryContributionsInJointVenturesNonCashTransactionsInvestmentActivities" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_NetAssetsAcquisitionByBusinessCombination" xlink:href="mlec-20250630.xsd#mlec_NetAssetsAcquisitionByBusinessCombination"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="mlec_NonCashInvestingActivities" xlink:to="mlec_NetAssetsAcquisitionByBusinessCombination" order="6" weight="-1"/>
    <loc xlink:type="locator" xlink:label="mlec_OwnShareHeld" xlink:href="mlec-20250630.xsd#mlec_OwnShareHeld"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="mlec_NonCashInvestingActivities" xlink:to="mlec_OwnShareHeld" order="7" weight="-1"/>
    <loc xlink:type="locator" xlink:label="mlec_RightofuseLeasedAssetAdditionsThroughAnIncreaseInLeaseLiabilities" xlink:href="mlec-20250630.xsd#mlec_RightofuseLeasedAssetAdditionsThroughAnIncreaseInLeaseLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="mlec_NonCashInvestingActivities" xlink:to="mlec_RightofuseLeasedAssetAdditionsThroughAnIncreaseInLeaseLiabilities" order="8" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="mlec_NonCashInvestingActivities" xlink:to="ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod" order="9" weight="-1"/>
    <loc xlink:type="locator" xlink:label="mlec_NonCashFinancingActivities" xlink:href="mlec-20250630.xsd#mlec_NonCashFinancingActivities"/>
    <loc xlink:type="locator" xlink:label="mlec_CapitalizationOfConvertibleFinancingActivities" xlink:href="mlec-20250630.xsd#mlec_CapitalizationOfConvertibleFinancingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="mlec_NonCashFinancingActivities" xlink:to="mlec_CapitalizationOfConvertibleFinancingActivities" order="1" weight="-1"/>
    <loc xlink:type="locator" xlink:label="mlec_AssignmentOfReceivablesWithShareholdersAndOtherRelatedParties" xlink:href="mlec-20250630.xsd#mlec_AssignmentOfReceivablesWithShareholdersAndOtherRelatedParties"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="mlec_NonCashFinancingActivities" xlink:to="mlec_AssignmentOfReceivablesWithShareholdersAndOtherRelatedParties" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="mlec_CompensationPaymentFinancedByAcquisitionOfIntangibleAssets" xlink:href="mlec-20250630.xsd#mlec_CompensationPaymentFinancedByAcquisitionOfIntangibleAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="mlec_NonCashFinancingActivities" xlink:to="mlec_CompensationPaymentFinancedByAcquisitionOfIntangibleAssets" order="3" weight="-1"/>
    <loc xlink:type="locator" xlink:label="mlec_IncreaseThroughAcquisitionOfNonControllingInterestInSubsidiaries" xlink:href="mlec-20250630.xsd#mlec_IncreaseThroughAcquisitionOfNonControllingInterestInSubsidiaries"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="mlec_NonCashFinancingActivities" xlink:to="mlec_IncreaseThroughAcquisitionOfNonControllingInterestInSubsidiaries" order="4" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.moolecscience.com/role/ScheduleofOperatingResultsGroupsReportingSegmentsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_Revenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Revenue"/>
    <loc xlink:type="locator" xlink:label="mlec_RevenueFromSaleOfGoodsAndRenderingOfServices" xlink:href="mlec-20250630.xsd#mlec_RevenueFromSaleOfGoodsAndRenderingOfServices"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Revenue" xlink:to="mlec_RevenueFromSaleOfGoodsAndRenderingOfServices" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromRoyalties" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromRoyalties"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Revenue" xlink:to="ifrs-full_RevenueFromRoyalties" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LicenceFeeIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LicenceFeeIncome"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Revenue" xlink:to="ifrs-full_LicenceFeeIncome" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Revenue" xlink:to="ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromGovernmentGrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromGovernmentGrants"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Revenue" xlink:to="ifrs-full_RevenueFromGovernmentGrants" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GrossProfit" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossProfit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_GrossProfit" xlink:to="ifrs-full_Revenue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CostOfSales" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CostOfSales"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_GrossProfit" xlink:to="ifrs-full_CostOfSales" order="2" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:role="http://www.moolecscience.com/role/ScheduleofCompensationofKeyManagementPersonnelCompensationTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_KeyManagementPersonnelCompensation" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensation"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_KeyManagementPersonnelCompensation" xlink:to="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment"/>
<!-- [WMV6][bFkXl3vEQilowtVrjiDWg6G8FgRN7LsOMpHX+AyHT/OpBCtUbrcBGkMUZXZNztLJ8qncQyAW4lHKXLGarwGyeKtuUkjzUp2/QUwY94MvNMx6Dy2EBUTgXmbbxYxYjOOajEN+/9SU2n/bHi+8y3I/bL9XKVu/MhmjGH9EcJaO4PWDtc0eON7pakJwa1RjVtdfbX1mjsEE1FF7I6WL0jKpMkFH8QbvO2l7ehX6u95npjaRvOIHA+l8JthkZFyK02r7RoKQidKkB6mcCDF8CM90kgYJJ4VJKEVJ6eA4u0UqOWt91I+UwbnChUYqpi3DJCQV82TV+ydojDtZgDR7eJb4V2UNwstKdND5+ChAR4Cf2ZWyTEk0TZVu1iKeik1zICH42zeE8Lo=] CSR-->
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_KeyManagementPersonnelCompensation" xlink:to="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" order="2" weight="1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>26
<FILENAME>mlec-20250630_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Sun Dec 28 18:19:32 UTC 2025 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ConsolidatedComprehensiveIncome" roleURI="http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ConsolidatedBalanceSheet" roleURI="http://www.moolecscience.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ShareholdersEquityType2or3" roleURI="http://www.moolecscience.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ConsolidatedCashFlow" roleURI="http://www.moolecscience.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_TheGroupsBusinessReorganizationandGeneralInformation" roleURI="http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformation"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_AccountingStandardsandBasisofPreparation" roleURI="http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparation"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_NewStandardsAmendmentsandInterpretationsIssuedbytheIASB" roleURI="http://www.moolecscience.com/role/NewStandardsAmendmentsandInterpretationsIssuedbytheIASB"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_SummaryofSignificantAccountingPolicies" roleURI="http://www.moolecscience.com/role/SummaryofSignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_CriticalAccountingJudgmentsandEstimates" roleURI="http://www.moolecscience.com/role/CriticalAccountingJudgmentsandEstimates"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_AcquisitionsandOtherSignificantTransactions" roleURI="http://www.moolecscience.com/role/AcquisitionsandOtherSignificantTransactions"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_InformationAboutComponentsofConsolidatedStatementsofFinancialPosition" roleURI="http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPosition"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncome" roleURI="http://www.moolecscience.com/role/InformationaboutComponentofConsolidatedStatementsofComprehensiveIncome"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_Taxation" roleURI="http://www.moolecscience.com/role/Taxation"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_EarningPerShare" roleURI="http://www.moolecscience.com/role/EarningPerShare"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_InformationaboutComponentsofEquity" roleURI="http://www.moolecscience.com/role/InformationaboutComponentsofEquity"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_CashFlowInformation" roleURI="http://www.moolecscience.com/role/CashFlowInformation"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_JointVenturesandAssociates" roleURI="http://www.moolecscience.com/role/JointVenturesandAssociates"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_SegmentInformation" roleURI="http://www.moolecscience.com/role/SegmentInformation"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_FinancialInstrumentsRiskManagement" roleURI="http://www.moolecscience.com/role/FinancialInstrumentsRiskManagement"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_Leases" roleURI="http://www.moolecscience.com/role/Leases"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ShareholdersandOtherRelatedPartiesBalancesandTransactions" roleURI="http://www.moolecscience.com/role/ShareholdersandOtherRelatedPartiesBalancesandTransactions"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_KeyManagementPersonnelCompensation" roleURI="http://www.moolecscience.com/role/KeyManagementPersonnelCompensation"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ShareBasedPayment" roleURI="http://www.moolecscience.com/role/ShareBasedPayment"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ContingenciesCommitmentsandRestrictionsontheDistributionofProfits" roleURI="http://www.moolecscience.com/role/ContingenciesCommitmentsandRestrictionsontheDistributionofProfits"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_EventsOccurringAftertheReportingPeriod" roleURI="http://www.moolecscience.com/role/EventsOccurringAftertheReportingPeriod"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ReverseStockSplitAftertheReportingPeriod" roleURI="http://www.moolecscience.com/role/ReverseStockSplitAftertheReportingPeriod"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_AccountingPoliciesByPolicy" roleURI="http://www.moolecscience.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_AccountingStandardsandBasisofPreparationTables" roleURI="http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_AcquisitionsandOtherSignificantTransactionsTables" roleURI="http://www.moolecscience.com/role/AcquisitionsandOtherSignificantTransactionsTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionTables" roleURI="http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeTables" roleURI="http://www.moolecscience.com/role/InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_TaxationTables" roleURI="http://www.moolecscience.com/role/TaxationTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_EarningPerShareTables" roleURI="http://www.moolecscience.com/role/EarningPerShareTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_InformationaboutComponentsofEquityTables" roleURI="http://www.moolecscience.com/role/InformationaboutComponentsofEquityTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_CashFlowInformationTables" roleURI="http://www.moolecscience.com/role/CashFlowInformationTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_JointVenturesandAssociatesTables" roleURI="http://www.moolecscience.com/role/JointVenturesandAssociatesTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_SegmentInformationTables" roleURI="http://www.moolecscience.com/role/SegmentInformationTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_FinancialInstrumentsRiskManagementTables" roleURI="http://www.moolecscience.com/role/FinancialInstrumentsRiskManagementTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_LeasesTables" roleURI="http://www.moolecscience.com/role/LeasesTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ShareholdersandOtherRelatedPartiesBalancesandTransactionsTables" roleURI="http://www.moolecscience.com/role/ShareholdersandOtherRelatedPartiesBalancesandTransactionsTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_KeyManagementPersonnelCompensationTables" roleURI="http://www.moolecscience.com/role/KeyManagementPersonnelCompensationTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ShareBasedPaymentTables" roleURI="http://www.moolecscience.com/role/ShareBasedPaymentTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ReverseStockSplitAftertheReportingPeriodTables" roleURI="http://www.moolecscience.com/role/ReverseStockSplitAftertheReportingPeriodTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofInformationrelatedtoCompanysShareofVotingRightsinitsSubsidiariesTable" roleURI="http://www.moolecscience.com/role/ScheduleofInformationrelatedtoCompanysShareofVotingRightsinitsSubsidiariesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofFairValueoftheConsiderationofPaymentTable" roleURI="http://www.moolecscience.com/role/ScheduleofFairValueoftheConsiderationofPaymentTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofAssetsAcquiredandLiabilitiesAssumedTable" roleURI="http://www.moolecscience.com/role/ScheduleofAssetsAcquiredandLiabilitiesAssumedTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofCashandCashEquivalentsTable" roleURI="http://www.moolecscience.com/role/ScheduleofCashandCashEquivalentsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofOtherFinancialAssetsTable" roleURI="http://www.moolecscience.com/role/ScheduleofOtherFinancialAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofTradeReceivablesTable" roleURI="http://www.moolecscience.com/role/ScheduleofTradeReceivablesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofOtherReceivablesTable" roleURI="http://www.moolecscience.com/role/ScheduleofOtherReceivablesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofInventoriesTable" roleURI="http://www.moolecscience.com/role/ScheduleofInventoriesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofChangesinBiologicalAssetsTable" roleURI="http://www.moolecscience.com/role/ScheduleofChangesinBiologicalAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofPropertyPlantandEquipmentTable" roleURI="http://www.moolecscience.com/role/ScheduleofPropertyPlantandEquipmentTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofCarryingAmountsthatWouldHaveBeenRecognizedTable" roleURI="http://www.moolecscience.com/role/ScheduleofCarryingAmountsthatWouldHaveBeenRecognizedTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofIntangibleAssetsTable" roleURI="http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofGoodwillTable" roleURI="http://www.moolecscience.com/role/ScheduleofGoodwillTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofInvestmentPropertiesTable" roleURI="http://www.moolecscience.com/role/ScheduleofInvestmentPropertiesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofTradeandOtherPayablesTable" roleURI="http://www.moolecscience.com/role/ScheduleofTradeandOtherPayablesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofBorrowingsTable" roleURI="http://www.moolecscience.com/role/ScheduleofBorrowingsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofBorrowingsCarryingAmountTable" roleURI="http://www.moolecscience.com/role/ScheduleofBorrowingsCarryingAmountTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofConvertibleNotesTable" roleURI="http://www.moolecscience.com/role/ScheduleofConvertibleNotesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofEmployeeBenefitsandSocialSecurityTable" roleURI="http://www.moolecscience.com/role/ScheduleofEmployeeBenefitsandSocialSecurityTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofDeferredRevenueandAdvancesfromCustomersTable" roleURI="http://www.moolecscience.com/role/ScheduleofDeferredRevenueandAdvancesfromCustomersTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofChangesinAllowancesandProvisionsTable" roleURI="http://www.moolecscience.com/role/ScheduleofChangesinAllowancesandProvisionsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofProvisionsTable" roleURI="http://www.moolecscience.com/role/ScheduleofProvisionsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofGovernmentGrantsTable" roleURI="http://www.moolecscience.com/role/ScheduleofGovernmentGrantsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofWarrantsTable" roleURI="http://www.moolecscience.com/role/ScheduleofWarrantsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofRevenuefromContractswithCustomersTable" roleURI="http://www.moolecscience.com/role/ScheduleofRevenuefromContractswithCustomersTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofCostofSalesTable" roleURI="http://www.moolecscience.com/role/ScheduleofCostofSalesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofRDClassifiedbyNatureTable" roleURI="http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofExpensesClassifiedbyNatureandFunctionTable" roleURI="http://www.moolecscience.com/role/ScheduleofExpensesClassifiedbyNatureandFunctionTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofFinanceResultsTable" roleURI="http://www.moolecscience.com/role/ScheduleofFinanceResultsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofOtherIncomeorExpensesNetTable" roleURI="http://www.moolecscience.com/role/ScheduleofOtherIncomeorExpensesNetTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofDeferredTaxAssetsandLiabilitiesTable" roleURI="http://www.moolecscience.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesTable" roleURI="http://www.moolecscience.com/role/ScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofWeightedAverageTaxRateTable" roleURI="http://www.moolecscience.com/role/ScheduleofWeightedAverageTaxRateTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofPrincipalStatutoryTaxesRatesandCurrentTaxTable" roleURI="http://www.moolecscience.com/role/ScheduleofPrincipalStatutoryTaxesRatesandCurrentTaxTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceTable" roleURI="http://www.moolecscience.com/role/ScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofEarningPerShareTable" roleURI="http://www.moolecscience.com/role/ScheduleofEarningPerShareTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofNumberofSharesIssuedTable" roleURI="http://www.moolecscience.com/role/ScheduleofNumberofSharesIssuedTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofSubsidiariesNonControllingInterestTable" roleURI="http://www.moolecscience.com/role/ScheduleofSubsidiariesNonControllingInterestTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofFinancialStatementsTable" roleURI="http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofBioceresSAandBioceresCropSolutionsTable" roleURI="http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesTable" roleURI="http://www.moolecscience.com/role/ScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable" roleURI="http://www.moolecscience.com/role/ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofJointVenturesAssetsTable" roleURI="http://www.moolecscience.com/role/ScheduleofJointVenturesAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofChangesinJointVenturesInvestmentsandAffiliatesTable" roleURI="http://www.moolecscience.com/role/ScheduleofChangesinJointVenturesInvestmentsandAffiliatesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofShareofProfitorLossofJointVenturesandAffiliatesTable" roleURI="http://www.moolecscience.com/role/ScheduleofShareofProfitorLossofJointVenturesandAffiliatesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofSignificantJointVenturesTable" roleURI="http://www.moolecscience.com/role/ScheduleofSignificantJointVenturesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofOperatingResultsGroupsReportingSegmentsTable" roleURI="http://www.moolecscience.com/role/ScheduleofOperatingResultsGroupsReportingSegmentsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofRevenuebySimilarGroupofProductsorServicesTable" roleURI="http://www.moolecscience.com/role/ScheduleofRevenuebySimilarGroupofProductsorServicesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofGeographicalInformationTable" roleURI="http://www.moolecscience.com/role/ScheduleofGeographicalInformationTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofLiquidityRiskTable" roleURI="http://www.moolecscience.com/role/ScheduleofLiquidityRiskTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofCurrencyRiskTable" roleURI="http://www.moolecscience.com/role/ScheduleofCurrencyRiskTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofOtherForiegnCurrencieswithVariablesRemainingConstantTable" roleURI="http://www.moolecscience.com/role/ScheduleofOtherForiegnCurrencieswithVariablesRemainingConstantTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofInterestRateRiskTable" roleURI="http://www.moolecscience.com/role/ScheduleofInterestRateRiskTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofFinancialAssetsbyCategoryTable" roleURI="http://www.moolecscience.com/role/ScheduleofFinancialAssetsbyCategoryTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofFinancialLiabilitiesbyCategoryTable" roleURI="http://www.moolecscience.com/role/ScheduleofFinancialLiabilitiesbyCategoryTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofFairValuebyHierarchyTable" roleURI="http://www.moolecscience.com/role/ScheduleofFairValuebyHierarchyTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable" roleURI="http://www.moolecscience.com/role/ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofTransactionsBetweentheGroupandRelatedPartiesTable" roleURI="http://www.moolecscience.com/role/ScheduleofTransactionsBetweentheGroupandRelatedPartiesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofCompensationofKeyManagementPersonnelCompensationTable" roleURI="http://www.moolecscience.com/role/ScheduleofCompensationofKeyManagementPersonnelCompensationTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofFairValueoftheStockOptionsattheGrantDateTable" roleURI="http://www.moolecscience.com/role/ScheduleofFairValueoftheStockOptionsattheGrantDateTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofRangeofAssumptionswhichhaveDeterminedTable" roleURI="http://www.moolecscience.com/role/ScheduleofRangeofAssumptionswhichhaveDeterminedTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofOptionActivityandWeightedAverageExercisePriceTable" roleURI="http://www.moolecscience.com/role/ScheduleofOptionActivityandWeightedAverageExercisePriceTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofWeightedAverageNumberofOrdinarySharesOutstandingTable" roleURI="http://www.moolecscience.com/role/ScheduleofWeightedAverageNumberofOrdinarySharesOutstandingTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsScheduleofIntangibleAssetsandLiabilitiesAssumed" roleURI="http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsScheduleofIntangibleAssetsandLiabilitiesAssumed"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_TheGroupsBusinessReorganizationandGeneralInformationDetails" roleURI="http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_AccountingStandardsandBasisofPreparationDetails" roleURI="http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_NewStandardsAmendmentsandInterpretationsIssuedbytheIASBDetails" roleURI="http://www.moolecscience.com/role/NewStandardsAmendmentsandInterpretationsIssuedbytheIASBDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_SummaryofSignificantAccountingPoliciesDetails" roleURI="http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_AcquisitionsandOtherSignificantTransactionsDetails" roleURI="http://www.moolecscience.com/role/AcquisitionsandOtherSignificantTransactionsDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails" roleURI="http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeDetails" roleURI="http://www.moolecscience.com/role/InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_TaxationDetails" roleURI="http://www.moolecscience.com/role/TaxationDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_InformationaboutComponentsofEquityDetails" roleURI="http://www.moolecscience.com/role/InformationaboutComponentsofEquityDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_JointVenturesandAssociatesDetails" roleURI="http://www.moolecscience.com/role/JointVenturesandAssociatesDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_SegmentInformationDetails" roleURI="http://www.moolecscience.com/role/SegmentInformationDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_FinancialInstrumentsRiskManagementDetails" roleURI="http://www.moolecscience.com/role/FinancialInstrumentsRiskManagementDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ShareBasedPaymentDetails" roleURI="http://www.moolecscience.com/role/ShareBasedPaymentDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_EventsOccurringAftertheReportingPeriodDetails" roleURI="http://www.moolecscience.com/role/EventsOccurringAftertheReportingPeriodDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ReverseStockSplitAftertheReportingPeriodDetails" roleURI="http://www.moolecscience.com/role/ReverseStockSplitAftertheReportingPeriodDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#DocumentAndEntityInformation" roleURI="http://www.moolecscience.com/role/DocumentAndEntityInformation"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeStatementAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromContractsWithCustomers" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromContractsWithCustomers"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_RevenueFromContractsWithCustomers" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromGovernmentGrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromGovernmentGrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_RevenueFromGovernmentGrants" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CostOfSales" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CostOfSales"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_CostOfSales" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ChangeInNetRealizableValueOfAgricultural" xlink:href="mlec-20250630.xsd#mlec_ChangeInNetRealizableValueOfAgricultural"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="mlec_ChangeInNetRealizableValueOfAgricultural" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_ResearchAndDevelopmentExpense" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_SellingGeneralAndAdministrativeExpense" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherOperatingIncomeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherOperatingIncomeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_OtherOperatingIncomeExpense" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossFromOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_ProfitLossFromOperatingActivities" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinanceIncomeCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceIncomeCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_FinanceIncomeCost" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherFinanceIncomeCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherFinanceIncomeCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_OtherFinanceIncomeCost" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossBeforeTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_ProfitLossBeforeTax" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_ProfitLoss" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ItemsThatWillNotBeSubsequentlyReclassifiedToLossAndProfit" xlink:href="mlec-20250630.xsd#mlec_ItemsThatWillNotBeSubsequentlyReclassifiedToLossAndProfit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="mlec_ItemsThatWillNotBeSubsequentlyReclassifiedToLossAndProfit" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTaxOfJointVenturesAndAssociates" xlink:href="mlec-20250630.xsd#mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTaxOfJointVenturesAndAssociates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTaxOfJointVenturesAndAssociates" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTax" xlink:href="mlec-20250630.xsd#mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTax" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_ComprehensiveIncome" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_ProfitLossAttributableToOwnersOfParent" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_ProfitLossAttributableToNoncontrollingInterests" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BasicEarningsLossPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BasicEarningsLossPerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_BasicEarningsLossPerShare" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DilutedEarningsLossPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DilutedEarningsLossPerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_DilutedEarningsLossPerShare" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" order="27" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ConsolidatedBalanceSheet" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentFinancialAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_OtherNoncurrentFinancialAssets" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_OtherNoncurrentReceivables" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentTaxAssetsNoncurrent" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxAssetsNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_CurrentTaxAssetsNoncurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_DeferredTaxAssets" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_InvestmentsInJointVenturesAndAssociates" xlink:href="mlec-20250630.xsd#mlec_InvestmentsInJointVenturesAndAssociates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="mlec_InvestmentsInJointVenturesAndAssociates" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_PropertyPlantAndEquipment" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InvestmentProperty" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InvestmentProperty"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_InvestmentProperty" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Goodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Goodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_Goodwill" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RightofuseAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_RightofuseAssets" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_NoncurrentAssets" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_CashAndCashEquivalents" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherCurrentFinancialAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_OtherCurrentFinancialAssets" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentTradeReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTradeReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_CurrentTradeReceivables" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherCurrentReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_OtherCurrentReceivables" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentTaxAssetsCurrent" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxAssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_CurrentTaxAssetsCurrent" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Inventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Inventories"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_Inventories" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentBiologicalAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentBiologicalAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_CurrentBiologicalAssets" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_CurrentAssets" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Assets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Assets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_Assets" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuedCapital" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_IssuedCapital" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareToBeIssuedAmount" xlink:href="mlec-20250630.xsd#mlec_ShareToBeIssuedAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="mlec_ShareToBeIssuedAmount" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SharesPremium" xlink:href="mlec-20250630.xsd#mlec_SharesPremium"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="mlec_SharesPremium" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_OwnSharesHeld" xlink:href="mlec-20250630.xsd#mlec_OwnSharesHeld"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="mlec_OwnSharesHeld" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_StockOptionsAndShareBasedIncentives" xlink:href="mlec-20250630.xsd#mlec_StockOptionsAndShareBasedIncentives"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="mlec_StockOptionsAndShareBasedIncentives" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RetainedEarnings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RetainedEarnings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_RetainedEarnings" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_RevaluationOfPropertyPlantAndEquipmentReserve" xlink:href="mlec-20250630.xsd#mlec_RevaluationOfPropertyPlantAndEquipmentReserve"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="mlec_RevaluationOfPropertyPlantAndEquipmentReserve" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_ReserveOfExchangeDifferencesOnTranslation" order="27" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityAttributableToOwnersOfParent" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAttributableToOwnersOfParent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_EquityAttributableToOwnersOfParent" order="28" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncontrollingInterests" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncontrollingInterests"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_NoncontrollingInterests" order="29" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_Equity" order="30" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LongtermBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LongtermBorrowings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_LongtermBorrowings" order="31" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentContractLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentContractLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_NoncurrentContractLiabilities" order="32" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentGovernmentGrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentGovernmentGrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_NoncurrentGovernmentGrants" order="33" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_JointVenturesAndAssociatesLiabilities" xlink:href="mlec-20250630.xsd#mlec_JointVenturesAndAssociatesLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="mlec_JointVenturesAndAssociatesLiabilities" order="34" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_DeferredTaxLiabilities" order="35" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentProvisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentProvisions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_NoncurrentProvisions" order="36" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ConsiderationForAcquisitionOfAssetsNonCurrent" xlink:href="mlec-20250630.xsd#mlec_ConsiderationForAcquisitionOfAssetsNonCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="mlec_ConsiderationForAcquisitionOfAssetsNonCurrent" order="37" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SecuredDebtNonCurrent" xlink:href="mlec-20250630.xsd#mlec_SecuredDebtNonCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="mlec_SecuredDebtNonCurrent" order="38" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_NoncurrentLeaseLiabilities" order="39" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_NoncurrentLiabilities" order="40" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_TradeAndOtherCurrentPayables" order="41" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShorttermBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShorttermBorrowings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_ShorttermBorrowings" order="42" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentProvisionsForEmployeeBenefits" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentProvisionsForEmployeeBenefits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_CurrentProvisionsForEmployeeBenefits" order="43" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities" order="44" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_CurrentTaxLiabilitiesCurrent" order="45" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentGovernmentGrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentGovernmentGrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_CurrentGovernmentGrants" order="46" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentWarrantLiability" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentWarrantLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_CurrentWarrantLiability" order="47" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ConsiderationForAcquisitionOfAssetsCurrent" xlink:href="mlec-20250630.xsd#mlec_ConsiderationForAcquisitionOfAssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="mlec_ConsiderationForAcquisitionOfAssetsCurrent" order="48" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLeaseLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_CurrentLeaseLiabilities" order="49" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_CurrentLiabilities" order="50" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Liabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Liabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_Liabilities" order="51" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityAndLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAndLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_EquityAndLiabilities" order="52" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ShareholdersEquityType2or3" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfChangesInEquityLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfChangesInEquityLineItems"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfChangesInEquityTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_StatementOfChangesInEquityTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComponentsOfEquityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ifrs-full_StatementOfChangesInEquityTable" xlink:to="ifrs-full_ComponentsOfEquityAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComponentsOfEquityDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_ComponentsOfEquityDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComponentsOfEquityDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_ComponentsOfEquityDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuedCapitalMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapitalMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ComponentsOfEquityDomain" xlink:to="ifrs-full_IssuedCapitalMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SharesIssuedMember" xlink:href="mlec-20250630.xsd#mlec_SharesIssuedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ComponentsOfEquityDomain" xlink:to="mlec_SharesIssuedMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_OwnSharesHeldMember" xlink:href="mlec-20250630.xsd#mlec_OwnSharesHeldMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ComponentsOfEquityDomain" xlink:to="mlec_OwnSharesHeldMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharePremiumMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SharePremiumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ComponentsOfEquityDomain" xlink:to="ifrs-full_SharePremiumMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReserveOfSharebasedPaymentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ComponentsOfEquityDomain" xlink:to="ifrs-full_ReserveOfSharebasedPaymentsMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RetainedEarningsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RetainedEarningsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ComponentsOfEquityDomain" xlink:to="ifrs-full_RetainedEarningsMember" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ComponentsOfEquityDomain" xlink:to="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_RevaluationOfPropertyPlantEquipmentAndEffectOfTaxRateChangeMember" xlink:href="mlec-20250630.xsd#mlec_RevaluationOfPropertyPlantEquipmentAndEffectOfTaxRateChangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ComponentsOfEquityDomain" xlink:to="mlec_RevaluationOfPropertyPlantEquipmentAndEffectOfTaxRateChangeMember" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAttributableToOwnersOfParentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ComponentsOfEquityDomain" xlink:to="ifrs-full_EquityAttributableToOwnersOfParentMember" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncontrollingInterestsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncontrollingInterestsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ComponentsOfEquityDomain" xlink:to="ifrs-full_NoncontrollingInterestsMember" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_Equity" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_IncreaseDecreaseThroughChangesInBusinessCombinationEquity" xlink:href="mlec-20250630.xsd#mlec_IncreaseDecreaseThroughChangesInBusinessCombinationEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="mlec_IncreaseDecreaseThroughChangesInBusinessCombinationEquity" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughOtherDistributionsToOwners" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughOtherDistributionsToOwners"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_IncreaseDecreaseThroughOtherDistributionsToOwners" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DividendsPaid" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DividendsPaid"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_DividendsPaid" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_ProfitLoss" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeBeforeTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeBeforeTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_OtherComprehensiveIncomeBeforeTax" order="8" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ConsolidatedCashFlow" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_ProfitLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncomeTaxExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForIncomeTaxExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_AdjustmentsForIncomeTaxExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDepreciationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDepreciationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_AdjustmentsForDepreciationExpense" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AmortizationOfIntangibleAsset" xlink:href="mlec-20250630.xsd#mlec_AmortizationOfIntangibleAsset"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="mlec_AmortizationOfIntangibleAsset" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DepreciationOfLeasedAssets" xlink:href="mlec-20250630.xsd#mlec_DepreciationOfLeasedAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="mlec_DepreciationOfLeasedAssets" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForFairValueGainsLosses" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForFairValueGainsLosses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_AdjustmentsForFairValueGainsLosses" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_RemeasurementOfPreviouslyHeldInterest" xlink:href="mlec-20250630.xsd#mlec_RemeasurementOfPreviouslyHeldInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="mlec_RemeasurementOfPreviouslyHeldInterest" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_AdjustmentsForSharebasedPayments" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ProvisionsForContingencies" xlink:href="mlec-20250630.xsd#mlec_ProvisionsForContingencies"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="mlec_ProvisionsForContingencies" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AllowanceForImpairmentOfTradeDebtors" xlink:href="mlec-20250630.xsd#mlec_AllowanceForImpairmentOfTradeDebtors"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="mlec_AllowanceForImpairmentOfTradeDebtors" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AllowanceForObsolescences" xlink:href="mlec-20250630.xsd#mlec_AllowanceForObsolescences"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="mlec_AllowanceForObsolescences" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnChangeInFairValueEstimatesOfBiologicalAssetsForCurrentPeriod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnChangeInFairValueEstimatesOfBiologicalAssetsForCurrentPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_GainsLossesOnChangeInFairValueEstimatesOfBiologicalAssetsForCurrentPeriod" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForFinanceCosts" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForFinanceCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_AdjustmentsForFinanceCosts" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AdjustmentsForDecreaseIncreaseInGovernmentGrants" xlink:href="mlec-20250630.xsd#mlec_AdjustmentsForDecreaseIncreaseInGovernmentGrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="mlec_AdjustmentsForDecreaseIncreaseInGovernmentGrants" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCashReceiptsFromSalesOfInterestsInJointVenturesClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherCashReceiptsFromSalesOfInterestsInJointVenturesClassifiedAsInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_OtherCashReceiptsFromSalesOfInterestsInJointVenturesClassifiedAsInvestingActivities" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" order="27" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" order="28" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities" order="29" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod" order="30" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" order="31" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PaymentsForDevelopmentProjectExpenditure" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PaymentsForDevelopmentProjectExpenditure"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_PaymentsForDevelopmentProjectExpenditure" order="32" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" order="33" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivities" order="34" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" order="35" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" order="36" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_InterestPaidClassifiedAsFinancingActivities" order="37" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" order="38" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities" order="39" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PaymentsOfOtherEquityInstruments" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PaymentsOfOtherEquityInstruments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_PaymentsOfOtherEquityInstruments" order="40" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PurchaseOfOwnShares" xlink:href="mlec-20250630.xsd#mlec_PurchaseOfOwnShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="mlec_PurchaseOfOwnShares" order="41" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivities" order="42" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" order="43" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_InflationEffectsOnCashAndCashEquivalents" xlink:href="mlec-20250630.xsd#mlec_InflationEffectsOnCashAndCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="mlec_InflationEffectsOnCashAndCashEquivalents" order="44" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition" order="45" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" order="46" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformation" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:to="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparation" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_AccountingStandardsAndBasiofPreparationAbstract" xlink:href="mlec-20250630.xsd#mlec_AccountingStandardsAndBasiofPreparationAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_AccountingStandardsAndBasiofPreparationAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/NewStandardsAmendmentsandInterpretationsIssuedbytheIASB" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_NewStandardsAmendmentsAndInterpretationsIssuedByTheIASBAbstract" xlink:href="mlec-20250630.xsd#mlec_NewStandardsAmendmentsAndInterpretationsIssuedByTheIASBAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_NewStandardsAmendmentsAndInterpretationsIssuedByTheIASBAbstract" xlink:to="ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/CriticalAccountingJudgmentsandEstimates" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_CriticalAccountingJudgmentsAndEstimatesAbstract" xlink:href="mlec-20250630.xsd#mlec_CriticalAccountingJudgmentsAndEstimatesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_CriticalAccountingJudgmentsAndEstimatesAbstract" xlink:to="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/AcquisitionsandOtherSignificantTransactions" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:to="ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPosition" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:to="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/InformationaboutComponentofConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfComprehensiveIncomeAbstract"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:to="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/Taxation" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="ifrs-full_DisclosureOfIncomeTaxExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/EarningPerShare" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_EarningsPerShareAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EarningsPerShareAbstract" xlink:to="ifrs-full_DisclosureOfEarningsPerShareExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/InformationaboutComponentsofEquity" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_InformationAboutComponentsOfEquityAbstract" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsOfEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsOfEquityAbstract" xlink:to="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/CashFlowInformation" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfCashFlowStatementExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfCashFlowStatementExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:to="ifrs-full_DisclosureOfCashFlowStatementExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/JointVenturesandAssociates" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfJointVenturesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfJointVenturesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfJointVenturesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfJointVenturesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfJointVenturesAbstract" xlink:to="ifrs-full_DisclosureOfJointVenturesExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/SegmentInformation" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:to="ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/FinancialInstrumentsRiskManagement" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_FinancialInstrumentsRiskManagementAbstract" xlink:href="mlec-20250630.xsd#mlec_FinancialInstrumentsRiskManagementAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialRiskManagementExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_FinancialInstrumentsRiskManagementAbstract" xlink:to="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/Leases" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PresentationOfLeasesForLesseeAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfLeasesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfLeasesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:to="ifrs-full_DisclosureOfLeasesExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ShareholdersandOtherRelatedPartiesBalancesandTransactions" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:to="ifrs-full_DisclosureOfRelatedPartyExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/KeyManagementPersonnelCompensation" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_KeyManagementPersonnelCompensationAbstract" xlink:href="mlec-20250630.xsd#mlec_KeyManagementPersonnelCompensationAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_KeyManagementPersonnelCompensationAbstract" xlink:to="ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ShareBasedPayment" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ContingenciesCommitmentsandRestrictionsontheDistributionofProfits" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_CapitalCommitmentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CapitalCommitmentsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfCommitmentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfCommitmentsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CapitalCommitmentsAbstract" xlink:to="ifrs-full_DisclosureOfCommitmentsExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/EventsOccurringAftertheReportingPeriod" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:to="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ReverseStockSplitAftertheReportingPeriod" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfReverseStockSplitAfterTheReportingPeriodAbstract" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfReverseStockSplitAfterTheReportingPeriodAbstract"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfReverseStockSplitAfterTheReportingPeriod" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfReverseStockSplitAfterTheReportingPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_DisclosureOfReverseStockSplitAfterTheReportingPeriodAbstract" xlink:to="mlec_DisclosureOfReverseStockSplitAfterTheReportingPeriod" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/AccountingPoliciesByPolicy" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DescriptionOfAccountingPolicyForFinancialAssetsAndLiabilitiesPolicyTextBlock" xlink:href="mlec-20250630.xsd#mlec_DescriptionOfAccountingPolicyForFinancialAssetsAndLiabilitiesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="mlec_DescriptionOfAccountingPolicyForFinancialAssetsAndLiabilitiesPolicyTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation" xlink:href="mlec-20250630.xsd#mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForInvestmentPropertyExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForInvestmentPropertyExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForInvestmentPropertyExplanatory" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DescriptionOfAccountingPolicyForConvertibleNotesTextBlock" xlink:href="mlec-20250630.xsd#mlec_DescriptionOfAccountingPolicyForConvertibleNotesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="mlec_DescriptionOfAccountingPolicyForConvertibleNotesTextBlock" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DescriptionOfAccountingPolicyForWarrantLiabilities" xlink:href="mlec-20250630.xsd#mlec_DescriptionOfAccountingPolicyForWarrantLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="mlec_DescriptionOfAccountingPolicyForWarrantLiabilities" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" order="18" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_AccountingStandardsAndBasiofPreparationAbstract" xlink:href="mlec-20250630.xsd#mlec_AccountingStandardsAndBasiofPreparationAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_AccountingStandardsAndBasiofPreparationAbstract" xlink:to="ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/AcquisitionsandOtherSignificantTransactionsTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsAbstract"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfFairValueOfConsiderationOfPaymentTableTextBlock" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfFairValueOfConsiderationOfPaymentTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:to="mlec_ScheduleOfFairValueOfConsiderationOfPaymentTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:to="ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfOtherFinancialAssetsExplanatory" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfOtherFinancialAssetsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:to="mlec_DisclosureOfOtherFinancialAssetsExplanatory" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfTradeReceivablesTableTextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfTradeReceivablesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:to="mlec_DisclosureOfTradeReceivablesTableTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfOtherReceivablesTableTextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfOtherReceivablesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:to="mlec_DisclosureOfOtherReceivablesTableTextBlock" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfInventoriesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInventoriesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:to="ifrs-full_DisclosureOfInventoriesExplanatory" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:to="ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfDepreciationIfAssetsHadBeenCarriedUnderCostModelTextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfDepreciationIfAssetsHadBeenCarriedUnderCostModelTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:to="mlec_DisclosureOfDepreciationIfAssetsHadBeenCarriedUnderCostModelTextBlock" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfIntangibleAssetsAndLiabilitiesAssumedTextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfIntangibleAssetsAndLiabilitiesAssumedTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:to="mlec_DisclosureOfIntangibleAssetsAndLiabilitiesAssumedTextBlock" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:to="ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutInvestmentPropertyExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutInvestmentPropertyExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutInvestmentPropertyExplanatory" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfTradeAndOtherPayablesComponentsTableTextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfTradeAndOtherPayablesComponentsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:to="mlec_DisclosureOfTradeAndOtherPayablesComponentsTableTextBlock" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfCarryingValueOfBorrowingsExplanatory" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfCarryingValueOfBorrowingsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:to="mlec_DisclosureOfCarryingValueOfBorrowingsExplanatory" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDebtSecuritiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDebtSecuritiesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:to="ifrs-full_DisclosureOfDebtSecuritiesExplanatory" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfBenefitsAndSocialSecurityPayablesTableTextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfBenefitsAndSocialSecurityPayablesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:to="mlec_DisclosureOfBenefitsAndSocialSecurityPayablesTableTextBlock" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosuresOfDeferredRevenueAndAdvancesFromCustomersTableTextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosuresOfDeferredRevenueAndAdvancesFromCustomersTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:to="mlec_DisclosuresOfDeferredRevenueAndAdvancesFromCustomersTableTextBlock" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfChangesInAllowancesAndProvisionsTableTextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfChangesInAllowancesAndProvisionsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:to="mlec_DisclosureOfChangesInAllowancesAndProvisionsTableTextBlock" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfProvisionsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfProvisionsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:to="ifrs-full_DisclosureOfProvisionsExplanatory" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfGovernmentGrantsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfGovernmentGrantsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:to="ifrs-full_DisclosureOfGovernmentGrantsExplanatory" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfWarrantsTextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfWarrantsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:to="mlec_DisclosureOfWarrantsTextBlock" order="21" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfComprehensiveIncomeAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfCostOfSalesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfCostOfSalesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:to="ifrs-full_DisclosureOfCostOfSalesExplanatory" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:to="ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfExpensesByNatureExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfExpensesByNatureExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:to="ifrs-full_DisclosureOfExpensesByNatureExplanatory" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:to="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:to="ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/TaxationTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDeferredTaxesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDeferredTaxesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="ifrs-full_DisclosureOfDeferredTaxesExplanatory" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfRollforwardOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfRollforwardOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="mlec_ScheduleOfRollforwardOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_EffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="mlec-20250630.xsd#mlec_EffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="mlec_EffectiveIncomeTaxRateReconciliationTableTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="mlec-20250630.xsd#mlec_ComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="mlec_ComponentsOfIncomeTaxExpenseBenefitTableTextBlock" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_IncomeTaxExpenseByApplyingApplicableTaxRateInForceInRespectiveJurisdictionsTableTextBlock" xlink:href="mlec-20250630.xsd#mlec_IncomeTaxExpenseByApplyingApplicableTaxRateInForceInRespectiveJurisdictionsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="mlec_IncomeTaxExpenseByApplyingApplicableTaxRateInForceInRespectiveJurisdictionsTableTextBlock" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/EarningPerShareTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_EarningsPerShareAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EarningsPerShareExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EarningsPerShareExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EarningsPerShareAbstract" xlink:to="ifrs-full_EarningsPerShareExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/InformationaboutComponentsofEquityTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_InformationAboutComponentsOfEquityAbstract" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsOfEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfNumberOfSharesIssuedtextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfNumberOfSharesIssuedtextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsOfEquityAbstract" xlink:to="mlec_DisclosureOfNumberOfSharesIssuedtextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsOfEquityAbstract" xlink:to="ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfFinancialStatementsTextBlock" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfFinancialStatementsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsOfEquityAbstract" xlink:to="mlec_ScheduleOfFinancialStatementsTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsOfEquityAbstract" xlink:to="ifrs-full_DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/CashFlowInformationTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:to="mlec_ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:to="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/JointVenturesandAssociatesTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfJointVenturesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfJointVenturesAbstract"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfInvestmentsInJointVenturesAndAffiliatesTableTextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfInvestmentsInJointVenturesAndAffiliatesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfJointVenturesAbstract" xlink:to="mlec_DisclosureOfInvestmentsInJointVenturesAndAffiliatesTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfChangesInInvestmentInJointVenturesAndAffiliatesTableTextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfChangesInInvestmentInJointVenturesAndAffiliatesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfJointVenturesAbstract" xlink:to="mlec_DisclosureOfChangesInInvestmentInJointVenturesAndAffiliatesTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfShareOfProfitOrLossInJointVenturesAndAffiliatesTableTextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfShareOfProfitOrLossInJointVenturesAndAffiliatesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfJointVenturesAbstract" xlink:to="mlec_DisclosureOfShareOfProfitOrLossInJointVenturesAndAffiliatesTableTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfSignificantJointVenturesTableTextBlock" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfSignificantJointVenturesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfJointVenturesAbstract" xlink:to="mlec_ScheduleOfSignificantJointVenturesTableTextBlock" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/SegmentInformationTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:to="ifrs-full_DisclosureOfOperatingSegmentsExplanatory" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfProductsAndServicesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfProductsAndServicesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:to="ifrs-full_DisclosureOfProductsAndServicesExplanatory" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfGeographicalAreasExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfGeographicalAreasExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:to="ifrs-full_DisclosureOfGeographicalAreasExplanatory" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/FinancialInstrumentsRiskManagementTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingLineItems"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingLineItems" xlink:to="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfRisksAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfRisksAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable" xlink:to="ifrs-full_TypesOfRisksAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfRisksDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfRisksDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_TypesOfRisksAxis" xlink:to="ifrs-full_TypesOfRisksDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfRisksDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfRisksDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_TypesOfRisksAxis" xlink:to="ifrs-full_TypesOfRisksDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrencyRiskMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrencyRiskMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TypesOfRisksDomain" xlink:to="ifrs-full_CurrencyRiskMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestRateRiskMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestRateRiskMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TypesOfRisksDomain" xlink:to="ifrs-full_InterestRateRiskMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingLineItems" xlink:to="ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingLineItems" xlink:to="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfForeignExchangeRiskSensitivityAnalysistextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfForeignExchangeRiskSensitivityAnalysistextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingLineItems" xlink:to="mlec_DisclosureOfForeignExchangeRiskSensitivityAnalysistextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingLineItems" xlink:to="ifrs-full_DisclosureOfFinancialAssetsExplanatory" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingLineItems" xlink:to="ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingLineItems" xlink:to="ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/LeasesTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PresentationOfLeasesForLesseeAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ShareholdersandOtherRelatedPartiesBalancesandTransactionsTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:to="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/KeyManagementPersonnelCompensationTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_KeyManagementPersonnelCompensationAbstract" xlink:href="mlec-20250630.xsd#mlec_KeyManagementPersonnelCompensationAbstract"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_KeyManagementPersonnelCompensationAbstract" xlink:to="mlec_DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ShareBasedPaymentTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfFairValueOfTheStockOptionsAtTheGrantDateTextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfFairValueOfTheStockOptionsAtTheGrantDateTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="mlec_DisclosureOfFairValueOfTheStockOptionsAtTheGrantDateTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ReverseStockSplitAftertheReportingPeriodTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfReverseStockSplitAfterTheReportingPeriodAbstract" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfReverseStockSplitAfterTheReportingPeriodAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_DisclosureOfReverseStockSplitAfterTheReportingPeriodAbstract" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofInformationrelatedtoCompanysShareofVotingRightsinitsSubsidiariesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_AccountingStandardsandBasisofPreparationScheduleofInformationrelatedtoCompanysShareofVotingRightsinitsSubsidiariesDetailsTable" xlink:href="mlec-20250630.xsd#mlec_AccountingStandardsandBasisofPreparationScheduleofInformationrelatedtoCompanysShareofVotingRightsinitsSubsidiariesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="mlec_AccountingStandardsandBasisofPreparationScheduleofInformationrelatedtoCompanysShareofVotingRightsinitsSubsidiariesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ConsolidatedStructuredEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_AccountingStandardsandBasisofPreparationScheduleofInformationrelatedtoCompanysShareofVotingRightsinitsSubsidiariesDetailsTable" xlink:to="ifrs-full_ConsolidatedStructuredEntitiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ConsolidatedStructuredEntitiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ConsolidatedStructuredEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:to="ifrs-full_ConsolidatedStructuredEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ConsolidatedStructuredEntitiesDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ConsolidatedStructuredEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:to="ifrs-full_ConsolidatedStructuredEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_MoolecScienceLimitedMember" xlink:href="mlec-20250630.xsd#mlec_MoolecScienceLimitedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesDomain" xlink:to="mlec_MoolecScienceLimitedMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AGBiomoleculesLLCMember" xlink:href="mlec-20250630.xsd#mlec_AGBiomoleculesLLCMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesDomain" xlink:to="mlec_AGBiomoleculesLLCMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ValoraSoySAMember" xlink:href="mlec-20250630.xsd#mlec_ValoraSoySAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesDomain" xlink:to="mlec_ValoraSoySAMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_NutreconLLCMember" xlink:href="mlec-20250630.xsd#mlec_NutreconLLCMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesDomain" xlink:to="mlec_NutreconLLCMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SynBioPowerlabsMember" xlink:href="mlec-20250630.xsd#mlec_SynBioPowerlabsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesDomain" xlink:to="mlec_SynBioPowerlabsMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_GentleTechMember" xlink:href="mlec-20250630.xsd#mlec_GentleTechMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesDomain" xlink:to="mlec_GentleTechMember" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_GentleFarmingMember" xlink:href="mlec-20250630.xsd#mlec_GentleFarmingMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesDomain" xlink:to="mlec_GentleFarmingMember" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_GFASMember" xlink:href="mlec-20250630.xsd#mlec_GFASMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesDomain" xlink:to="mlec_GFASMember" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresGroupLimitedMember" xlink:href="mlec-20250630.xsd#mlec_BioceresGroupLimitedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesDomain" xlink:to="mlec_BioceresGroupLimitedMember" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresCropSolutionsBIOXMember" xlink:href="mlec-20250630.xsd#mlec_BioceresCropSolutionsBIOXMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesDomain" xlink:to="mlec_BioceresCropSolutionsBIOXMember" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresLLCMember" xlink:href="mlec-20250630.xsd#mlec_BioceresLLCMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesDomain" xlink:to="mlec_BioceresLLCMember" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresSAMember" xlink:href="mlec-20250630.xsd#mlec_BioceresSAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesDomain" xlink:to="mlec_BioceresSAMember" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresTechServicesLLCMember" xlink:href="mlec-20250630.xsd#mlec_BioceresTechServicesLLCMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesDomain" xlink:to="mlec_BioceresTechServicesLLCMember" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NameOfSubsidiary" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NameOfSubsidiary"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_NameOfSubsidiary" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_ProportionOfOwnershipInterestInSubsidiary" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofFairValueoftheConsiderationofPaymentTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofFairValueoftheConsiderationofPaymentDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_AcquisitionsandOtherSignificantTransactionsScheduleofFairValueoftheConsiderationofPaymentDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofFairValueoftheConsiderationofPaymentDetailsTable" xlink:href="mlec-20250630.xsd#mlec_AcquisitionsandOtherSignificantTransactionsScheduleofFairValueoftheConsiderationofPaymentDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofFairValueoftheConsiderationofPaymentDetailsLineItems" xlink:to="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofFairValueoftheConsiderationofPaymentDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofFairValueoftheConsiderationofPaymentDetailsTable" xlink:to="ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis" xlink:to="ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis" xlink:to="ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ProFarmGroupIncMember" xlink:href="mlec-20250630.xsd#mlec_ProFarmGroupIncMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain" xlink:to="mlec_ProFarmGroupIncMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_NatalAgroSRLMember" xlink:href="mlec-20250630.xsd#mlec_NatalAgroSRLMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain" xlink:to="mlec_NatalAgroSRLMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_EquityShares" xlink:href="mlec-20250630.xsd#mlec_EquityShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofFairValueoftheConsiderationofPaymentDetailsLineItems" xlink:to="mlec_EquityShares" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WarrantLiability" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WarrantLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofFairValueoftheConsiderationofPaymentDetailsLineItems" xlink:to="ifrs-full_WarrantLiability" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofFairValueoftheConsiderationofPaymentDetailsLineItems" xlink:to="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashTransferred" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashTransferred"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofFairValueoftheConsiderationofPaymentDetailsLineItems" xlink:to="ifrs-full_CashTransferred" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityInterestsOfAcquirer" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityInterestsOfAcquirer"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofFairValueoftheConsiderationofPaymentDetailsLineItems" xlink:to="ifrs-full_EquityInterestsOfAcquirer" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofAssetsAcquiredandLiabilitiesAssumedTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsTable" xlink:href="mlec-20250630.xsd#mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsTable" xlink:to="ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis" xlink:to="ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis" xlink:to="ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_MoolecScienceSAMember" xlink:href="mlec-20250630.xsd#mlec_MoolecScienceSAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain" xlink:to="mlec_MoolecScienceSAMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherCashAndCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="ifrs-full_OtherCashAndCashEquivalents" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="ifrs-full_TradeReceivables" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdditionsToRightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdditionsToRightofuseAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="ifrs-full_AdditionsToRightofuseAssets" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InventoriesTotal" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InventoriesTotal"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="ifrs-full_InventoriesTotal" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="ifrs-full_LeaseLiabilities" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WarrantLiability" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WarrantLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="ifrs-full_WarrantLiability" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_NoncontrollingInterest" xlink:href="mlec-20250630.xsd#mlec_NoncontrollingInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="mlec_NoncontrollingInterest" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialAssetsAtFairValue" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssetsAtFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="ifrs-full_FinancialAssetsAtFairValue" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnDisposalsOfInvestments" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnDisposalsOfInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="ifrs-full_GainsLossesOnDisposalsOfInvestments" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherFinancialAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="ifrs-full_OtherFinancialAssets" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="ifrs-full_OtherReceivables" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_IncomeAndMinimumPresumedRecoverableIncomeTaxes" xlink:href="mlec-20250630.xsd#mlec_IncomeAndMinimumPresumedRecoverableIncomeTaxes"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="mlec_IncomeAndMinimumPresumedRecoverableIncomeTaxes" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherPayables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="ifrs-full_TradeAndOtherPayables" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SocialSecurityContributions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SocialSecurityContributions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="ifrs-full_SocialSecurityContributions" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentProvisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentProvisions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="ifrs-full_CurrentProvisions" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainRecognisedInBargainPurchaseTransaction" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainRecognisedInBargainPurchaseTransaction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="ifrs-full_GainRecognisedInBargainPurchaseTransaction" order="23" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofCashandCashEquivalentsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalentsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Cash" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Cash"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CashAndCashEquivalentsAbstract" xlink:to="ifrs-full_Cash" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_MutualFunds" xlink:href="mlec-20250630.xsd#mlec_MutualFunds"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CashAndCashEquivalentsAbstract" xlink:to="mlec_MutualFunds" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CashAndCashEquivalentsAbstract" xlink:to="ifrs-full_CashAndCashEquivalents" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofOtherFinancialAssetsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofOtherFinancialAssetsDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofOtherFinancialAssetsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems" xlink:to="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofOtherFinancialAssetsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofOtherFinancialAssetsDetailsTable" xlink:to="ifrs-full_ClassesOfAssetsAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfAssetsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="ifrs-full_ClassesOfAssetsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfAssetsDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="ifrs-full_ClassesOfAssetsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_InvestmentsInSharesMember" xlink:href="mlec-20250630.xsd#mlec_InvestmentsInSharesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfAssetsDomain" xlink:to="mlec_InvestmentsInSharesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_MutualFundsMember" xlink:href="mlec-20250630.xsd#mlec_MutualFundsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfAssetsDomain" xlink:to="mlec_MutualFundsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherInvestmentMember" xlink:href="mlec-20250630.xsd#mlec_OtherInvestmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfAssetsDomain" xlink:to="mlec_OtherInvestmentMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherCurrentFinancialAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems" xlink:to="ifrs-full_OtherCurrentFinancialAssets" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentFinancialAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems" xlink:to="ifrs-full_OtherNoncurrentFinancialAssets" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofTradeReceivablesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofTradeReceivablesDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofTradeReceivablesDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofTradeReceivablesDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofTradeReceivablesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofTradeReceivablesDetailsLineItems" xlink:to="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofTradeReceivablesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_IfrsBalanceSheetLocationAxis" xlink:href="mlec-20250630.xsd#mlec_IfrsBalanceSheetLocationAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofTradeReceivablesDetailsTable" xlink:to="mlec_IfrsBalanceSheetLocationAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_IfrsBalanceSheetLocationDomainDomain" xlink:href="mlec-20250630.xsd#mlec_IfrsBalanceSheetLocationDomainDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="mlec_IfrsBalanceSheetLocationAxis" xlink:to="mlec_IfrsBalanceSheetLocationDomainDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_IfrsBalanceSheetLocationDomainDomain_0" xlink:href="mlec-20250630.xsd#mlec_IfrsBalanceSheetLocationDomainDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="mlec_IfrsBalanceSheetLocationAxis" xlink:to="mlec_IfrsBalanceSheetLocationDomainDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeReceivablesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeReceivablesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_IfrsBalanceSheetLocationDomainDomain" xlink:to="ifrs-full_TradeReceivablesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentTradeReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTradeReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofTradeReceivablesDetailsLineItems" xlink:to="ifrs-full_CurrentTradeReceivables" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_CurrentTradeReceivablesAllowanceForImpairmentOfTradeDebtors" xlink:href="mlec-20250630.xsd#mlec_CurrentTradeReceivablesAllowanceForImpairmentOfTradeDebtors"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofTradeReceivablesDetailsLineItems" xlink:to="mlec_CurrentTradeReceivablesAllowanceForImpairmentOfTradeDebtors" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_CurrentTradeReceivablesShareholdersAndOtherRelatedParties" xlink:href="mlec-20250630.xsd#mlec_CurrentTradeReceivablesShareholdersAndOtherRelatedParties"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofTradeReceivablesDetailsLineItems" xlink:to="mlec_CurrentTradeReceivablesShareholdersAndOtherRelatedParties" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AllowanceForReturnOfGoods" xlink:href="mlec-20250630.xsd#mlec_AllowanceForReturnOfGoods"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofTradeReceivablesDetailsLineItems" xlink:to="mlec_AllowanceForReturnOfGoods" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_CurrentTradeReceivablesTradeDebtorsJointVenturesAndAssociates" xlink:href="mlec-20250630.xsd#mlec_CurrentTradeReceivablesTradeDebtorsJointVenturesAndAssociates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofTradeReceivablesDetailsLineItems" xlink:to="mlec_CurrentTradeReceivablesTradeDebtorsJointVenturesAndAssociates" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofTradeReceivablesDetailsLineItems" xlink:to="ifrs-full_OtherReceivables" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofTradeReceivablesDetailsLineItems" xlink:to="ifrs-full_TradeAndOtherCurrentReceivables" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofOtherReceivablesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfOtherReceivablesLineItems" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfOtherReceivablesLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofOtherReceivablesDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofOtherReceivablesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_ScheduleOfOtherReceivablesLineItems" xlink:to="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofOtherReceivablesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofOtherReceivablesDetailsTable" xlink:to="ifrs-full_ClassesOfAssetsAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfAssetsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="ifrs-full_ClassesOfAssetsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfAssetsDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="ifrs-full_ClassesOfAssetsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_TaxesMember" xlink:href="mlec-20250630.xsd#mlec_TaxesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfAssetsDomain" xlink:to="mlec_TaxesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_InsuranceToBeAccruedMember" xlink:href="mlec-20250630.xsd#mlec_InsuranceToBeAccruedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfAssetsDomain" xlink:to="mlec_InsuranceToBeAccruedMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherReceivablesJointVenturesAndAssociatesMember" xlink:href="mlec-20250630.xsd#mlec_OtherReceivablesJointVenturesAndAssociatesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfAssetsDomain" xlink:to="mlec_OtherReceivablesJointVenturesAndAssociatesMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PrepaymentsToSuppliersMember" xlink:href="mlec-20250630.xsd#mlec_PrepaymentsToSuppliersMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfAssetsDomain" xlink:to="mlec_PrepaymentsToSuppliersMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareholdersAndOtherRelatedPartiesMember" xlink:href="mlec-20250630.xsd#mlec_ShareholdersAndOtherRelatedPartiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfAssetsDomain" xlink:to="mlec_ShareholdersAndOtherRelatedPartiesMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_GovernmentsGrantsReceivableMember" xlink:href="mlec-20250630.xsd#mlec_GovernmentsGrantsReceivableMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfAssetsDomain" xlink:to="mlec_GovernmentsGrantsReceivableMember" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PrepaidExpensesAndOtherReceivablesMember" xlink:href="mlec-20250630.xsd#mlec_PrepaidExpensesAndOtherReceivablesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfAssetsDomain" xlink:to="mlec_PrepaidExpensesAndOtherReceivablesMember" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_LoansReceivablesMember" xlink:href="mlec-20250630.xsd#mlec_LoansReceivablesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfAssetsDomain" xlink:to="mlec_LoansReceivablesMember" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_MiscellaneousMember" xlink:href="mlec-20250630.xsd#mlec_MiscellaneousMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfAssetsDomain" xlink:to="mlec_MiscellaneousMember" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherReceivableMember" xlink:href="mlec-20250630.xsd#mlec_OtherReceivableMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfAssetsDomain" xlink:to="mlec_OtherReceivableMember" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ReimbursementsOverExportsMember" xlink:href="mlec-20250630.xsd#mlec_ReimbursementsOverExportsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfAssetsDomain" xlink:to="mlec_ReimbursementsOverExportsMember" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherCurrentReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfOtherReceivablesLineItems" xlink:to="ifrs-full_OtherCurrentReceivables" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfOtherReceivablesLineItems" xlink:to="ifrs-full_OtherNoncurrentReceivables" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofInventoriesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_InventoriesScheduleOfInventoriesLineItems" xlink:href="mlec-20250630.xsd#mlec_InventoriesScheduleOfInventoriesLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofInventoriesDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofInventoriesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_InventoriesScheduleOfInventoriesLineItems" xlink:to="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofInventoriesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BiologicalAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BiologicalAssetsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofInventoriesDetailsTable" xlink:to="ifrs-full_BiologicalAssetsAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BiologicalAssetsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BiologicalAssetsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_BiologicalAssetsAxis" xlink:to="ifrs-full_BiologicalAssetsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BiologicalAssetsDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BiologicalAssetsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_BiologicalAssetsAxis" xlink:to="ifrs-full_BiologicalAssetsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SeedsAndGrainsMember" xlink:href="mlec-20250630.xsd#mlec_SeedsAndGrainsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BiologicalAssetsDomain" xlink:to="mlec_SeedsAndGrainsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_MicrobiologicalResaleProductsMember" xlink:href="mlec-20250630.xsd#mlec_MicrobiologicalResaleProductsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BiologicalAssetsDomain" xlink:to="mlec_MicrobiologicalResaleProductsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_MicrobiologicalProductsProducedMember" xlink:href="mlec-20250630.xsd#mlec_MicrobiologicalProductsProducedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BiologicalAssetsDomain" xlink:to="mlec_MicrobiologicalProductsProducedMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_GoodsInTransitMember" xlink:href="mlec-20250630.xsd#mlec_GoodsInTransitMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BiologicalAssetsDomain" xlink:to="mlec_GoodsInTransitMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SuppliesMember" xlink:href="mlec-20250630.xsd#mlec_SuppliesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BiologicalAssetsDomain" xlink:to="mlec_SuppliesMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AgriculturalProductsMember" xlink:href="mlec-20250630.xsd#mlec_AgriculturalProductsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BiologicalAssetsDomain" xlink:to="mlec_AgriculturalProductsMember" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AllowanceForObsolescenceMember" xlink:href="mlec-20250630.xsd#mlec_AllowanceForObsolescenceMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BiologicalAssetsDomain" xlink:to="mlec_AllowanceForObsolescenceMember" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_InventoriesCurrent" xlink:href="mlec-20250630.xsd#mlec_InventoriesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InventoriesScheduleOfInventoriesLineItems" xlink:to="mlec_InventoriesCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_InventoriesExcludingAgriculturalProduce" xlink:href="mlec-20250630.xsd#mlec_InventoriesExcludingAgriculturalProduce"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InventoriesScheduleOfInventoriesLineItems" xlink:to="mlec_InventoriesExcludingAgriculturalProduce" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofChangesinBiologicalAssetsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinBiologicalAssetsDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinBiologicalAssetsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems" xlink:to="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinBiologicalAssetsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BiologicalAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BiologicalAssetsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinBiologicalAssetsDetailsTable" xlink:to="ifrs-full_BiologicalAssetsAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BiologicalAssetsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BiologicalAssetsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_BiologicalAssetsAxis" xlink:to="ifrs-full_BiologicalAssetsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BiologicalAssetsDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BiologicalAssetsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_BiologicalAssetsAxis" xlink:to="ifrs-full_BiologicalAssetsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BiologicalAssetsSoybeanMember" xlink:href="mlec-20250630.xsd#mlec_BiologicalAssetsSoybeanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BiologicalAssetsDomain" xlink:to="mlec_BiologicalAssetsSoybeanMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BiologicalAssetsCornMember" xlink:href="mlec-20250630.xsd#mlec_BiologicalAssetsCornMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BiologicalAssetsDomain" xlink:to="mlec_BiologicalAssetsCornMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BiologicalAssetsWheatMember" xlink:href="mlec-20250630.xsd#mlec_BiologicalAssetsWheatMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BiologicalAssetsDomain" xlink:to="mlec_BiologicalAssetsWheatMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BiologicalAssetsBarleyMember" xlink:href="mlec-20250630.xsd#mlec_BiologicalAssetsBarleyMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BiologicalAssetsDomain" xlink:to="mlec_BiologicalAssetsBarleyMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SunflowerMember" xlink:href="mlec-20250630.xsd#mlec_SunflowerMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BiologicalAssetsDomain" xlink:to="mlec_SunflowerMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BiologicalAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BiologicalAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems" xlink:to="ifrs-full_BiologicalAssets" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems" xlink:to="ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DecreaseDueToHarvestAndDisposalsBiologicalAssets" xlink:href="mlec-20250630.xsd#mlec_DecreaseDueToHarvestAndDisposalsBiologicalAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems" xlink:to="mlec_DecreaseDueToHarvestAndDisposalsBiologicalAssets" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_LossOfControlonBiologicalAssets" xlink:href="mlec-20250630.xsd#mlec_LossOfControlonBiologicalAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems" xlink:to="mlec_LossOfControlonBiologicalAssets" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofPropertyPlantandEquipmentTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofPropertyPlantandEquipmentDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofPropertyPlantandEquipmentDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofPropertyPlantandEquipmentDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofPropertyPlantandEquipmentDetailsTable" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofPropertyPlantandEquipmentDetailsTable" xlink:to="ifrs-full_ClassesOfAssetsAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfAssetsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="ifrs-full_ClassesOfAssetsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfAssetsDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="ifrs-full_ClassesOfAssetsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OfficeEquipmentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OfficeEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:to="ifrs-full_OfficeEquipmentMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_VehiclesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_VehiclesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:to="ifrs-full_VehiclesMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComputerEquipmentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComputerEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:to="ifrs-full_ComputerEquipmentMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FixturesAndFittingsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FixturesAndFittingsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:to="ifrs-full_FixturesAndFittingsMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_MachineryAndEquipmentsMember" xlink:href="mlec-20250630.xsd#mlec_MachineryAndEquipmentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:to="mlec_MachineryAndEquipmentsMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LandAndBuildingsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LandAndBuildingsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:to="ifrs-full_LandAndBuildingsMember" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ConstructionInProgressMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ConstructionInProgressMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:to="ifrs-full_ConstructionInProgressMember" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ResearchInstrumentsMember" xlink:href="mlec-20250630.xsd#mlec_ResearchInstrumentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:to="mlec_ResearchInstrumentsMember" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PropertyPlantAndEquipmentsMember" xlink:href="mlec-20250630.xsd#mlec_PropertyPlantAndEquipmentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfAssetsDomain" xlink:to="mlec_PropertyPlantAndEquipmentsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="ifrs-full_PropertyPlantAndEquipment" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DisposalsPropertyPlantAndEquipments" xlink:href="mlec-20250630.xsd#mlec_DisposalsPropertyPlantAndEquipments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="mlec_DisposalsPropertyPlantAndEquipments" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="ifrs-full_DepreciationPropertyPlantAndEquipment" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="ifrs-full_IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment" order="8" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofCarryingAmountsthatWouldHaveBeenRecognizedTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LandAndBuildingsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LandAndBuildingsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:to="ifrs-full_LandAndBuildingsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofIntangibleAssetsDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofIntangibleAssetsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems" xlink:to="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofIntangibleAssetsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofIntangibleAssetsDetailsTable" xlink:to="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AlfalfaGenuityHarXstraMember" xlink:href="mlec-20250630.xsd#mlec_AlfalfaGenuityHarXstraMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="mlec_AlfalfaGenuityHarXstraMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_HB4SoyAndBreedingProgramMember" xlink:href="mlec-20250630.xsd#mlec_HB4SoyAndBreedingProgramMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="mlec_HB4SoyAndBreedingProgramMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_IntegratedSeedProductsMember" xlink:href="mlec-20250630.xsd#mlec_IntegratedSeedProductsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="mlec_IntegratedSeedProductsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_MicrobiologicalProductsMember" xlink:href="mlec-20250630.xsd#mlec_MicrobiologicalProductsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="mlec_MicrobiologicalProductsMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_MicrobiologicalProductsInProgressMember" xlink:href="mlec-20250630.xsd#mlec_MicrobiologicalProductsInProgressMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="mlec_MicrobiologicalProductsInProgressMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_TrademarksAndPatentsMember" xlink:href="mlec-20250630.xsd#mlec_TrademarksAndPatentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="mlec_TrademarksAndPatentsMember" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_TrademarksAndPatentsWithIndefiniteUsefulLifeMember" xlink:href="mlec-20250630.xsd#mlec_TrademarksAndPatentsWithIndefiniteUsefulLifeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="mlec_TrademarksAndPatentsWithIndefiniteUsefulLifeMember" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SoftwareMember" xlink:href="mlec-20250630.xsd#mlec_SoftwareMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="mlec_SoftwareMember" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SoftwareInProgressMember" xlink:href="mlec-20250630.xsd#mlec_SoftwareInProgressMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="mlec_SoftwareInProgressMember" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_CustomerLoyaltyMember" xlink:href="mlec-20250630.xsd#mlec_CustomerLoyaltyMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="mlec_CustomerLoyaltyMember" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_RGRSOXWheatMember" xlink:href="mlec-20250630.xsd#mlec_RGRSOXWheatMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="mlec_RGRSOXWheatMember" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SustainableAgriculturalEquipmentTechnologyMember" xlink:href="mlec-20250630.xsd#mlec_SustainableAgriculturalEquipmentTechnologyMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="mlec_SustainableAgriculturalEquipmentTechnologyMember" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_FungalBiomassMember" xlink:href="mlec-20250630.xsd#mlec_FungalBiomassMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="mlec_FungalBiomassMember" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PiggysooyMember" xlink:href="mlec-20250630.xsd#mlec_PiggysooyMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="mlec_PiggysooyMember" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SafflowerGLAMember" xlink:href="mlec-20250630.xsd#mlec_SafflowerGLAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="mlec_SafflowerGLAMember" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SafflowerChimosin20Member" xlink:href="mlec-20250630.xsd#mlec_SafflowerChimosin20Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="mlec_SafflowerChimosin20Member" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherIntangibleAssetsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherIntangibleAssetsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="ifrs-full_OtherIntangibleAssetsMember" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BacillusPHAsMember" xlink:href="mlec-20250630.xsd#mlec_BacillusPHAsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="mlec_BacillusPHAsMember" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets" xlink:href="mlec-20250630.xsd#mlec_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems" xlink:to="mlec_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AdditionsFromBusinessCombinations" xlink:href="mlec-20250630.xsd#mlec_AdditionsFromBusinessCombinations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems" xlink:to="mlec_AdditionsFromBusinessCombinations" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems" xlink:to="ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AmortizationOfTheYear" xlink:href="mlec-20250630.xsd#mlec_AmortizationOfTheYear"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems" xlink:to="mlec_AmortizationOfTheYear" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems" xlink:to="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofGoodwillTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGoodwillDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGoodwillDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems" xlink:to="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGoodwillDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGoodwillDetailsTable" xlink:to="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:to="ifrs-full_SignificantInvestmentsInSubsidiariesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:to="ifrs-full_SignificantInvestmentsInSubsidiariesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_RizobacterArgentinaSAMember" xlink:href="mlec-20250630.xsd#mlec_RizobacterArgentinaSAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:to="mlec_RizobacterArgentinaSAMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresCropsSAMember" xlink:href="mlec-20250630.xsd#mlec_BioceresCropsSAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:to="mlec_BioceresCropsSAMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_InsumosAgroqumicosSAMember" xlink:href="mlec-20250630.xsd#mlec_InsumosAgroqumicosSAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:to="mlec_InsumosAgroqumicosSAMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ProFarmGroupMember" xlink:href="mlec-20250630.xsd#mlec_ProFarmGroupMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:to="mlec_ProFarmGroupMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Goodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Goodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems" xlink:to="ifrs-full_Goodwill" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofInvestmentPropertiesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnDisposalsOfInvestmentPropertiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnDisposalsOfInvestmentPropertiesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InvestmentProperty" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InvestmentProperty"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_GainsLossesOnDisposalsOfInvestmentPropertiesAbstract" xlink:to="ifrs-full_InvestmentProperty" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofTradeandOtherPayablesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherPayablesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherPayablesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TradeAndOtherPayablesAbstract" xlink:to="ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_TradeAndOtherPayablesShareholdersAndOtherRelatedParties" xlink:href="mlec-20250630.xsd#mlec_TradeAndOtherPayablesShareholdersAndOtherRelatedParties"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TradeAndOtherPayablesAbstract" xlink:to="mlec_TradeAndOtherPayablesShareholdersAndOtherRelatedParties" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_TradeCreditorsJointVenturesAndAssociates" xlink:href="mlec-20250630.xsd#mlec_TradeCreditorsJointVenturesAndAssociates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TradeAndOtherPayablesAbstract" xlink:to="mlec_TradeCreditorsJointVenturesAndAssociates" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TradeAndOtherPayablesAbstract" xlink:to="ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherCurrentPayables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TradeAndOtherPayablesAbstract" xlink:to="ifrs-full_OtherCurrentPayables" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TradeAndOtherPayablesAbstract" xlink:to="ifrs-full_TradeAndOtherCurrentPayables" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofBorrowingsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofBorrowingsDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofBorrowingsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofBorrowingsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofBorrowingsDetailsTable" xlink:to="ifrs-full_BorrowingsByNameAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="ifrs-full_BorrowingsByNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="ifrs-full_BorrowingsByNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BankBorrowingMember" xlink:href="mlec-20250630.xsd#mlec_BankBorrowingMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BorrowingsByNameDomain" xlink:to="mlec_BankBorrowingMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_CorporateBondsMember" xlink:href="mlec-20250630.xsd#mlec_CorporateBondsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BorrowingsByNameDomain" xlink:to="mlec_CorporateBondsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_NetLoansPayablesJointVenturesAndAssociatesMember" xlink:href="mlec-20250630.xsd#mlec_NetLoansPayablesJointVenturesAndAssociatesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BorrowingsByNameDomain" xlink:to="mlec_NetLoansPayablesJointVenturesAndAssociatesMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ConvertiblePreferenceSharesMember" xlink:href="mlec-20250630.xsd#mlec_ConvertiblePreferenceSharesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BorrowingsByNameDomain" xlink:to="mlec_ConvertiblePreferenceSharesMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialBorrowingsMember" xlink:href="mlec-20250630.xsd#mlec_FinancialBorrowingsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BorrowingsByNameDomain" xlink:to="mlec_FinancialBorrowingsMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentPortionOfLongtermBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentPortionOfLongtermBorrowings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="ifrs-full_CurrentPortionOfLongtermBorrowings" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherBorrowings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="ifrs-full_OtherBorrowings" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofBorrowingsCarryingAmountTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofBorrowingsCarryingAmountDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofBorrowingsCarryingAmountDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofBorrowingsCarryingAmountDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MeasurementAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofBorrowingsCarryingAmountDetailsTable" xlink:to="ifrs-full_MeasurementAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MeasurementDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_MeasurementAxis" xlink:to="ifrs-full_MeasurementDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MeasurementDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_MeasurementAxis" xlink:to="ifrs-full_MeasurementDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofBorrowingsCarryingAmountDetailsTable" xlink:to="ifrs-full_BorrowingsByNameAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="ifrs-full_BorrowingsByNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="ifrs-full_BorrowingsByNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BankBorrowingMember" xlink:href="mlec-20250630.xsd#mlec_BankBorrowingMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BorrowingsByNameDomain" xlink:to="mlec_BankBorrowingMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_CorporateBondsMember" xlink:href="mlec-20250630.xsd#mlec_CorporateBondsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BorrowingsByNameDomain" xlink:to="mlec_CorporateBondsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ConvertiblePreferenceSharesMember" xlink:href="mlec-20250630.xsd#mlec_ConvertiblePreferenceSharesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BorrowingsByNameDomain" xlink:to="mlec_ConvertiblePreferenceSharesMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialBorrowingsMember" xlink:href="mlec-20250630.xsd#mlec_FinancialBorrowingsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BorrowingsByNameDomain" xlink:to="mlec_FinancialBorrowingsMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ConvertibleNotesMember" xlink:href="mlec-20250630.xsd#mlec_ConvertibleNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BorrowingsByNameDomain" xlink:to="mlec_ConvertibleNotesMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_MeasurementDomain" xlink:to="ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AtFairValueMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AtFairValueMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_MeasurementDomain" xlink:to="ifrs-full_AtFairValueMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShorttermBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShorttermBorrowings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="ifrs-full_ShorttermBorrowings" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LongtermBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LongtermBorrowings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="ifrs-full_LongtermBorrowings" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofConvertibleNotesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofConvertibleNotesDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofConvertibleNotesDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofConvertibleNotesDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofConvertibleNotesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofConvertibleNotesDetailsLineItems" xlink:to="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofConvertibleNotesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofConvertibleNotesDetailsTable" xlink:to="ifrs-full_BorrowingsByNameAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="ifrs-full_BorrowingsByNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="ifrs-full_BorrowingsByNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ConvertibleNotesMember" xlink:href="mlec-20250630.xsd#mlec_ConvertibleNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BorrowingsByNameDomain" xlink:to="mlec_ConvertibleNotesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SecuredDebtNonCurrent" xlink:href="mlec-20250630.xsd#mlec_SecuredDebtNonCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofConvertibleNotesDetailsLineItems" xlink:to="mlec_SecuredDebtNonCurrent" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofEmployeeBenefitsandSocialSecurityTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfEmployeeBenefitsAndSocialSecurityAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfEmployeeBenefitsAndSocialSecurityAbstract"/>
    <loc xlink:type="locator" xlink:label="mlec_SalariesAccruedIncentivesVacationsAndSocialSecurity" xlink:href="mlec-20250630.xsd#mlec_SalariesAccruedIncentivesVacationsAndSocialSecurity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfEmployeeBenefitsAndSocialSecurityAbstract" xlink:to="mlec_SalariesAccruedIncentivesVacationsAndSocialSecurity" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_KeyManagementPersonnelBenefitsLiabilityCurrent" xlink:href="mlec-20250630.xsd#mlec_KeyManagementPersonnelBenefitsLiabilityCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfEmployeeBenefitsAndSocialSecurityAbstract" xlink:to="mlec_KeyManagementPersonnelBenefitsLiabilityCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentProvisionsForEmployeeBenefits" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentProvisionsForEmployeeBenefits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfEmployeeBenefitsAndSocialSecurityAbstract" xlink:to="ifrs-full_CurrentProvisionsForEmployeeBenefits" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofDeferredRevenueandAdvancesfromCustomersTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfDeferredRevenueAndAdvancesFromCustomersAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfDeferredRevenueAndAdvancesFromCustomersAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAdvances" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAdvances"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfDeferredRevenueAndAdvancesFromCustomersAbstract" xlink:to="ifrs-full_CurrentAdvances" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfDeferredRevenueAndAdvancesFromCustomersAbstract" xlink:to="ifrs-full_CurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfDeferredRevenueAndAdvancesFromCustomersAbstract" xlink:to="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAdvances" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAdvances"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfDeferredRevenueAndAdvancesFromCustomersAbstract" xlink:to="ifrs-full_NoncurrentAdvances" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfDeferredRevenueAndAdvancesFromCustomersAbstract" xlink:to="ifrs-full_NoncurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentDeferredIncomeIncludingNoncurrentContractLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentDeferredIncomeIncludingNoncurrentContractLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfDeferredRevenueAndAdvancesFromCustomersAbstract" xlink:to="ifrs-full_NoncurrentDeferredIncomeIncludingNoncurrentContractLiabilities" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofChangesinAllowancesandProvisionsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsLineItems" xlink:to="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfProvisionsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfProvisionsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsTable" xlink:to="ifrs-full_ClassesOfProvisionsAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfOtherProvisionsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfOtherProvisionsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfProvisionsAxis" xlink:to="ifrs-full_ClassesOfOtherProvisionsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfOtherProvisionsDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfOtherProvisionsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfProvisionsAxis" xlink:to="ifrs-full_ClassesOfOtherProvisionsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AllowanceForImpairmentOfTradeDebtorsMember" xlink:href="mlec-20250630.xsd#mlec_AllowanceForImpairmentOfTradeDebtorsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfOtherProvisionsDomain" xlink:to="mlec_AllowanceForImpairmentOfTradeDebtorsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AllowanceForObsolescenceMember" xlink:href="mlec-20250630.xsd#mlec_AllowanceForObsolescenceMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfOtherProvisionsDomain" xlink:to="mlec_AllowanceForObsolescenceMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_deductedFromAssetsMember" xlink:href="mlec-20250630.xsd#mlec_deductedFromAssetsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfOtherProvisionsDomain" xlink:to="mlec_deductedFromAssetsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ProvisionForContingenciesMember" xlink:href="mlec-20250630.xsd#mlec_ProvisionForContingenciesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfOtherProvisionsDomain" xlink:to="mlec_ProvisionForContingenciesMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_LiabilitiesMember" xlink:href="mlec-20250630.xsd#mlec_LiabilitiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfOtherProvisionsDomain" xlink:to="mlec_LiabilitiesMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherProvisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherProvisions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsLineItems" xlink:to="ifrs-full_OtherProvisions" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdditionalProvisionsOtherProvisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdditionalProvisionsOtherProvisions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsLineItems" xlink:to="ifrs-full_AdditionalProvisionsOtherProvisions" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsLineItems" xlink:to="ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AllowancesAndProvisionsUsedAndReversed" xlink:href="mlec-20250630.xsd#mlec_AllowancesAndProvisionsUsedAndReversed"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsLineItems" xlink:to="mlec_AllowancesAndProvisionsUsedAndReversed" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsLineItems" xlink:to="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ChangeInAllowanceAndProvisionLossOfControl" xlink:href="mlec-20250630.xsd#mlec_ChangeInAllowanceAndProvisionLossOfControl"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsLineItems" xlink:to="mlec_ChangeInAllowanceAndProvisionLossOfControl" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofProvisionsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofProvisionsDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofProvisionsDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofProvisionsDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofProvisionsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofProvisionsDetailsLineItems" xlink:to="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofProvisionsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfProvisionsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfProvisionsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofProvisionsDetailsTable" xlink:to="ifrs-full_ClassesOfProvisionsAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfOtherProvisionsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfOtherProvisionsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfProvisionsAxis" xlink:to="ifrs-full_ClassesOfOtherProvisionsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfOtherProvisionsDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfOtherProvisionsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfProvisionsAxis" xlink:to="ifrs-full_ClassesOfOtherProvisionsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ConditionalPaymentRizobacterSAMember" xlink:href="mlec-20250630.xsd#mlec_ConditionalPaymentRizobacterSAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfOtherProvisionsDomain" xlink:to="mlec_ConditionalPaymentRizobacterSAMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ProvisionForContingenciesMember" xlink:href="mlec-20250630.xsd#mlec_ProvisionForContingenciesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfOtherProvisionsDomain" xlink:to="mlec_ProvisionForContingenciesMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentProvisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentProvisions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofProvisionsDetailsLineItems" xlink:to="ifrs-full_NoncurrentProvisions" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofGovernmentGrantsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGovernmentGrantsDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGovernmentGrantsDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGovernmentGrantsDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGovernmentGrantsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGovernmentGrantsDetailsLineItems" xlink:to="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGovernmentGrantsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ConsolidatedStructuredEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGovernmentGrantsDetailsTable" xlink:to="ifrs-full_ConsolidatedStructuredEntitiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ConsolidatedStructuredEntitiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ConsolidatedStructuredEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:to="ifrs-full_ConsolidatedStructuredEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ConsolidatedStructuredEntitiesDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ConsolidatedStructuredEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:to="ifrs-full_ConsolidatedStructuredEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresCropSolutionsCorpMember" xlink:href="mlec-20250630.xsd#mlec_BioceresCropSolutionsCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesDomain" xlink:to="mlec_BioceresCropSolutionsCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GovernmentGrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GovernmentGrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGovernmentGrantsDetailsLineItems" xlink:to="ifrs-full_GovernmentGrants" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LossesOnDisposalsOfInvestments" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LossesOnDisposalsOfInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGovernmentGrantsDetailsLineItems" xlink:to="ifrs-full_LossesOnDisposalsOfInvestments" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGovernmentGrantsDetailsLineItems" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGovernmentGrantsDetailsLineItems" xlink:to="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofWarrantsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfWarrantsAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfWarrantsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentWarrantLiability" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentWarrantLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfWarrantsAbstract" xlink:to="ifrs-full_CurrentWarrantLiability" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AdditionsWarrantsForTheYear" xlink:href="mlec-20250630.xsd#mlec_AdditionsWarrantsForTheYear"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfWarrantsAbstract" xlink:to="mlec_AdditionsWarrantsForTheYear" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AdditionsFromBusinessCombination" xlink:href="mlec-20250630.xsd#mlec_AdditionsFromBusinessCombination"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfWarrantsAbstract" xlink:to="mlec_AdditionsFromBusinessCombination" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofRevenuefromContractswithCustomersTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromSaleOfGoods" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromSaleOfGoods"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_RevenueFromSaleOfGoods" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromRoyalties" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromRoyalties"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_RevenueFromRoyalties" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromRenderingOfServices" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromRenderingOfServices"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_RevenueFromRenderingOfServices" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LicenceFeeIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LicenceFeeIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_LicenceFeeIncome" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromContractsWithCustomers" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromContractsWithCustomers"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_RevenueFromContractsWithCustomers" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofCostofSalesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_CostOfSalesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CostOfSalesMember"/>
    <loc xlink:type="locator" xlink:label="mlec_InventoriesNetOfAgriculturalProducts" xlink:href="mlec-20250630.xsd#mlec_InventoriesNetOfAgriculturalProducts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CostOfSalesMember" xlink:to="mlec_InventoriesNetOfAgriculturalProducts" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_LossOfControl" xlink:href="mlec-20250630.xsd#mlec_LossOfControl"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CostOfSalesMember" xlink:to="mlec_LossOfControl" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_InventoriesFromBusinessCombination" xlink:href="mlec-20250630.xsd#mlec_InventoriesFromBusinessCombination"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CostOfSalesMember" xlink:to="mlec_InventoriesFromBusinessCombination" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PurchaseOfInventory" xlink:href="mlec-20250630.xsd#mlec_PurchaseOfInventory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CostOfSalesMember" xlink:to="mlec_PurchaseOfInventory" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_InventoryProductionCosts" xlink:href="mlec-20250630.xsd#mlec_InventoryProductionCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CostOfSalesMember" xlink:to="mlec_InventoryProductionCosts" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ForeignCurrencyTranslationOnInventory" xlink:href="mlec-20250630.xsd#mlec_ForeignCurrencyTranslationOnInventory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CostOfSalesMember" xlink:to="mlec_ForeignCurrencyTranslationOnInventory" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_InventoriesBeforeClosingInventory" xlink:href="mlec-20250630.xsd#mlec_InventoriesBeforeClosingInventory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CostOfSalesMember" xlink:to="mlec_InventoriesBeforeClosingInventory" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InventoriesTotal" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InventoriesTotal"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CostOfSalesMember" xlink:to="ifrs-full_InventoriesTotal" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CostOfSales" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CostOfSales"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CostOfSalesMember" xlink:to="ifrs-full_CostOfSales" order="8" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_ResearchAndDevelopmentsExpenseAbstract" xlink:href="mlec-20250630.xsd#mlec_ResearchAndDevelopmentsExpenseAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ResearchAndDevelopmentsExpenseAbstract" xlink:to="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AnalysisAndStorage" xlink:href="mlec-20250630.xsd#mlec_AnalysisAndStorage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ResearchAndDevelopmentsExpenseAbstract" xlink:to="mlec_AnalysisAndStorage" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RoyaltyExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RoyaltyExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ResearchAndDevelopmentsExpenseAbstract" xlink:to="ifrs-full_RoyaltyExpense" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ImportAndExportExpenses" xlink:href="mlec-20250630.xsd#mlec_ImportAndExportExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ResearchAndDevelopmentsExpenseAbstract" xlink:to="mlec_ImportAndExportExpenses" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepreciationRightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DepreciationRightofuseAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ResearchAndDevelopmentsExpenseAbstract" xlink:to="ifrs-full_DepreciationRightofuseAssets" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ResearchAndDevelopmentsExpenseAbstract" xlink:to="ifrs-full_DepreciationPropertyPlantAndEquipment" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TransportationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TransportationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ResearchAndDevelopmentsExpenseAbstract" xlink:to="ifrs-full_TransportationExpense" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShorttermEmployeeBenefitsExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShorttermEmployeeBenefitsExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ResearchAndDevelopmentsExpenseAbstract" xlink:to="ifrs-full_ShorttermEmployeeBenefitsExpense" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InsuranceExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InsuranceExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ResearchAndDevelopmentsExpenseAbstract" xlink:to="ifrs-full_InsuranceExpense" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FuelAndEnergyExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FuelAndEnergyExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ResearchAndDevelopmentsExpenseAbstract" xlink:to="ifrs-full_FuelAndEnergyExpense" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RepairsAndMaintenanceExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RepairsAndMaintenanceExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ResearchAndDevelopmentsExpenseAbstract" xlink:to="ifrs-full_RepairsAndMaintenanceExpense" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SuppliesAndMaterials" xlink:href="mlec-20250630.xsd#mlec_SuppliesAndMaterials"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ResearchAndDevelopmentsExpenseAbstract" xlink:to="mlec_SuppliesAndMaterials" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_LicensesandPatents" xlink:href="mlec-20250630.xsd#mlec_LicensesandPatents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ResearchAndDevelopmentsExpenseAbstract" xlink:to="mlec_LicensesandPatents" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TravelExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TravelExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ResearchAndDevelopmentsExpenseAbstract" xlink:to="ifrs-full_TravelExpense" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdvertisingExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdvertisingExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ResearchAndDevelopmentsExpenseAbstract" xlink:to="ifrs-full_AdvertisingExpense" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SystemExpenses" xlink:href="mlec-20250630.xsd#mlec_SystemExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ResearchAndDevelopmentsExpenseAbstract" xlink:to="mlec_SystemExpenses" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_VehicleExpenses" xlink:href="mlec-20250630.xsd#mlec_VehicleExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ResearchAndDevelopmentsExpenseAbstract" xlink:to="mlec_VehicleExpenses" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ResearchAndDevelopmentsExpenseAbstract" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SurveillanceExpense" xlink:href="mlec-20250630.xsd#mlec_SurveillanceExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ResearchAndDevelopmentsExpenseAbstract" xlink:to="mlec_SurveillanceExpense" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfessionalFeesExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfessionalFeesExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ResearchAndDevelopmentsExpenseAbstract" xlink:to="ifrs-full_ProfessionalFeesExpense" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ProfessionalFeesExpenseRelatedParties" xlink:href="mlec-20250630.xsd#mlec_ProfessionalFeesExpenseRelatedParties"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ResearchAndDevelopmentsExpenseAbstract" xlink:to="mlec_ProfessionalFeesExpenseRelatedParties" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ResearchAndDevelopmentsExpenseAbstract" xlink:to="ifrs-full_AdministrativeExpense" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MiscellaneousOtherOperatingExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MiscellaneousOtherOperatingExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ResearchAndDevelopmentsExpenseAbstract" xlink:to="ifrs-full_MiscellaneousOtherOperatingExpense" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ResearchAndDevelopmentsExpenseAbstract" xlink:to="ifrs-full_ResearchAndDevelopmentExpense" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ResearchAndDevelopmentExpenseCapitalized" xlink:href="mlec-20250630.xsd#mlec_ResearchAndDevelopmentExpenseCapitalized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ResearchAndDevelopmentsExpenseAbstract" xlink:to="mlec_ResearchAndDevelopmentExpenseCapitalized" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_TotalResearchAndDevelopmentExpenseIncurred" xlink:href="mlec-20250630.xsd#mlec_TotalResearchAndDevelopmentExpenseIncurred"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ResearchAndDevelopmentsExpenseAbstract" xlink:to="mlec_TotalResearchAndDevelopmentExpenseIncurred" order="25" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofExpensesClassifiedbyNatureandFunctionTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofExpensesClassifiedbyNatureandFunctionDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofExpensesClassifiedbyNatureandFunctionDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofExpensesClassifiedbyNatureandFunctionDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofExpensesClassifiedbyNatureandFunctionDetailsTable" xlink:to="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:to="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:to="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CostOfSalesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CostOfSalesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain" xlink:to="ifrs-full_CostOfSalesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpenseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain" xlink:to="ifrs-full_SellingGeneralAndAdministrativeExpenseMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ExpensesClassifiedByNatureAndFunctionMember" xlink:href="mlec-20250630.xsd#mlec_ExpensesClassifiedByNatureAndFunctionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain" xlink:to="mlec_ExpensesClassifiedByNatureAndFunctionMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForAmortisationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForAmortisationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="ifrs-full_AdjustmentsForAmortisationExpense" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AnalysisAndStorage" xlink:href="mlec-20250630.xsd#mlec_AnalysisAndStorage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="mlec_AnalysisAndStorage" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RoyaltyExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RoyaltyExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="ifrs-full_RoyaltyExpense" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ImportAndExportExpenses" xlink:href="mlec-20250630.xsd#mlec_ImportAndExportExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="mlec_ImportAndExportExpenses" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="ifrs-full_DepreciationPropertyPlantAndEquipment" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TransportationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TransportationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="ifrs-full_TransportationExpense" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShorttermEmployeeBenefitsExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShorttermEmployeeBenefitsExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="ifrs-full_ShorttermEmployeeBenefitsExpense" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentTaxExpenseIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxExpenseIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="ifrs-full_CurrentTaxExpenseIncome" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RepairsAndMaintenanceExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RepairsAndMaintenanceExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="ifrs-full_RepairsAndMaintenanceExpense" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FuelAndEnergyExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FuelAndEnergyExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="ifrs-full_FuelAndEnergyExpense" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SuppliesAndMaterials" xlink:href="mlec-20250630.xsd#mlec_SuppliesAndMaterials"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="mlec_SuppliesAndMaterials" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TravelExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TravelExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="ifrs-full_TravelExpense" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AllowanceForObsolescences" xlink:href="mlec-20250630.xsd#mlec_AllowanceForObsolescences"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="mlec_AllowanceForObsolescences" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdvertisingExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdvertisingExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="ifrs-full_AdvertisingExpense" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SystemExpenses" xlink:href="mlec-20250630.xsd#mlec_SystemExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="mlec_SystemExpenses" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SharebasedIncentivesForEmployees" xlink:href="mlec-20250630.xsd#mlec_SharebasedIncentivesForEmployees"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="mlec_SharebasedIncentivesForEmployees" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SurveillanceExpense" xlink:href="mlec-20250630.xsd#mlec_SurveillanceExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="mlec_SurveillanceExpense" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfessionalFeesExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfessionalFeesExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="ifrs-full_ProfessionalFeesExpense" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ProfessionalFeesRelatedParties" xlink:href="mlec-20250630.xsd#mlec_ProfessionalFeesRelatedParties"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="mlec_ProfessionalFeesRelatedParties" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="ifrs-full_AdministrativeExpense" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InsuranceExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InsuranceExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="ifrs-full_InsuranceExpense" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepreciationRightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DepreciationRightofuseAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="ifrs-full_DepreciationRightofuseAssets" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_Contingencies" xlink:href="mlec-20250630.xsd#mlec_Contingencies"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="mlec_Contingencies" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_EnvironmentalImpactTreatment" xlink:href="mlec-20250630.xsd#mlec_EnvironmentalImpactTreatment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="mlec_EnvironmentalImpactTreatment" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_LicensesandPatents" xlink:href="mlec-20250630.xsd#mlec_LicensesandPatents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="mlec_LicensesandPatents" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MiscellaneousOtherOperatingExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MiscellaneousOtherOperatingExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="ifrs-full_MiscellaneousOtherOperatingExpense" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherExpenseByFunction" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherExpenseByFunction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="ifrs-full_OtherExpenseByFunction" order="27" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofFinanceResultsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofFinanceResultsDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofFinanceResultsDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofFinanceResultsDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofFinanceResultsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofFinanceResultsDetailsLineItems" xlink:to="mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofFinanceResultsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ConsolidatedStructuredEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofFinanceResultsDetailsTable" xlink:to="ifrs-full_ConsolidatedStructuredEntitiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ConsolidatedStructuredEntitiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ConsolidatedStructuredEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:to="ifrs-full_ConsolidatedStructuredEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ConsolidatedStructuredEntitiesDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ConsolidatedStructuredEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:to="ifrs-full_ConsolidatedStructuredEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresCropSolutionsCorpMember" xlink:href="mlec-20250630.xsd#mlec_BioceresCropSolutionsCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesDomain" xlink:to="mlec_BioceresCropSolutionsCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofFinanceResultsDetailsLineItems" xlink:to="ifrs-full_InterestExpense" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialCommissions" xlink:href="mlec-20250630.xsd#mlec_FinancialCommissions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofFinanceResultsDetailsLineItems" xlink:to="mlec_FinancialCommissions" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinanceCosts" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofFinanceResultsDetailsLineItems" xlink:to="ifrs-full_FinanceCosts" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofFinanceResultsDetailsLineItems" xlink:to="ifrs-full_GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementAssets" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofFinanceResultsDetailsLineItems" xlink:to="ifrs-full_GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementLiabilities" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ChangeInFairValueOfFinancialAssetsOrLiabilitiesOrOtherFinancialResults" xlink:href="mlec-20250630.xsd#mlec_ChangeInFairValueOfFinancialAssetsOrLiabilitiesOrOtherFinancialResults"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofFinanceResultsDetailsLineItems" xlink:to="mlec_ChangeInFairValueOfFinancialAssetsOrLiabilitiesOrOtherFinancialResults" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PrepaymentPremiumFee" xlink:href="mlec-20250630.xsd#mlec_PrepaymentPremiumFee"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofFinanceResultsDetailsLineItems" xlink:to="mlec_PrepaymentPremiumFee" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_NetGainOnInflationEffectOnMonetary" xlink:href="mlec-20250630.xsd#mlec_NetGainOnInflationEffectOnMonetary"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofFinanceResultsDetailsLineItems" xlink:to="mlec_NetGainOnInflationEffectOnMonetary" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_InterestAccruedWithRelatedParties" xlink:href="mlec-20250630.xsd#mlec_InterestAccruedWithRelatedParties"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofFinanceResultsDetailsLineItems" xlink:to="mlec_InterestAccruedWithRelatedParties" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherFinanceIncomeCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherFinanceIncomeCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofFinanceResultsDetailsLineItems" xlink:to="ifrs-full_OtherFinanceIncomeCost" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinanceIncomeCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceIncomeCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofFinanceResultsDetailsLineItems" xlink:to="ifrs-full_FinanceIncomeCost" order="10" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofOtherIncomeorExpensesNetTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfOtherIncomeOrExpensesNetAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfOtherIncomeOrExpensesNetAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromSaleOfAgriculturalProduce" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromSaleOfAgriculturalProduce"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfOtherIncomeOrExpensesNetAbstract" xlink:to="ifrs-full_RevenueFromSaleOfAgriculturalProduce" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_GainOnBargainPurchase" xlink:href="mlec-20250630.xsd#mlec_GainOnBargainPurchase"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfOtherIncomeOrExpensesNetAbstract" xlink:to="mlec_GainOnBargainPurchase" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_RemeasurementToFairValueOfPreexistingInterestInAnAcquiree" xlink:href="mlec-20250630.xsd#mlec_RemeasurementToFairValueOfPreexistingInterestInAnAcquiree"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfOtherIncomeOrExpensesNetAbstract" xlink:to="mlec_RemeasurementToFairValueOfPreexistingInterestInAnAcquiree" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_NetResultFromCommercializationOfAgriculturalProducts" xlink:href="mlec-20250630.xsd#mlec_NetResultFromCommercializationOfAgriculturalProducts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfOtherIncomeOrExpensesNetAbstract" xlink:to="mlec_NetResultFromCommercializationOfAgriculturalProducts" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfOtherIncomeOrExpensesNetAbstract" xlink:to="ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherIncomeOrExpensesNet" xlink:href="mlec-20250630.xsd#mlec_OtherIncomeOrExpensesNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfOtherIncomeOrExpensesNetAbstract" xlink:to="mlec_OtherIncomeOrExpensesNet" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherOperatingIncomeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherOperatingIncomeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfOtherIncomeOrExpensesNetAbstract" xlink:to="ifrs-full_OtherOperatingIncomeExpense" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_TaxationScheduleofDeferredTaxAssetsandLiabilitiesDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_TaxationScheduleofDeferredTaxAssetsandLiabilitiesDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_TaxationScheduleofDeferredTaxAssetsandLiabilitiesDetailsTable" xlink:href="mlec-20250630.xsd#mlec_TaxationScheduleofDeferredTaxAssetsandLiabilitiesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_TaxationScheduleofDeferredTaxAssetsandLiabilitiesDetailsLineItems" xlink:to="mlec_TaxationScheduleofDeferredTaxAssetsandLiabilitiesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_TaxationScheduleofDeferredTaxAssetsandLiabilitiesDetailsTable" xlink:to="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_CarryForwardOfTaxLossMember" xlink:href="mlec-20250630.xsd#mlec_CarryForwardOfTaxLossMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:to="mlec_CarryForwardOfTaxLossMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_OthersFinancialAssetMember" xlink:href="mlec-20250630.xsd#mlec_OthersFinancialAssetMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:to="mlec_OthersFinancialAssetMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_OthersOneMember" xlink:href="mlec-20250630.xsd#mlec_OthersOneMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:to="mlec_OthersOneMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_RoyaltiesMember" xlink:href="mlec-20250630.xsd#mlec_RoyaltiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:to="mlec_RoyaltiesMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_TradeReceivableMember" xlink:href="mlec-20250630.xsd#mlec_TradeReceivableMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:to="mlec_TradeReceivableMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AllowancesMember" xlink:href="mlec-20250630.xsd#mlec_AllowancesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:to="mlec_AllowancesMember" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_GovernmentGrantsMember" xlink:href="mlec-20250630.xsd#mlec_GovernmentGrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:to="mlec_GovernmentGrantsMember" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DeferredTaxAssetMember" xlink:href="mlec-20250630.xsd#mlec_DeferredTaxAssetMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:to="mlec_DeferredTaxAssetMember" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_IntangiblesTaxLiabilityMember" xlink:href="mlec-20250630.xsd#mlec_IntangiblesTaxLiabilityMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:to="mlec_IntangiblesTaxLiabilityMember" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PropertyPlantAndEquipmentDepreciationMember" xlink:href="mlec-20250630.xsd#mlec_PropertyPlantAndEquipmentDepreciationMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:to="mlec_PropertyPlantAndEquipmentDepreciationMember" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_InventoriesTaxLiabilityMember" xlink:href="mlec-20250630.xsd#mlec_InventoriesTaxLiabilityMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:to="mlec_InventoriesTaxLiabilityMember" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_RightOfUseLeasedAssetTaxLiabilityMember" xlink:href="mlec-20250630.xsd#mlec_RightOfUseLeasedAssetTaxLiabilityMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:to="mlec_RightOfUseLeasedAssetTaxLiabilityMember" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_InflationTaxAdjustmentMember" xlink:href="mlec-20250630.xsd#mlec_InflationTaxAdjustmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:to="mlec_InflationTaxAdjustmentMember" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DeferredTaxLiabilityMember" xlink:href="mlec-20250630.xsd#mlec_DeferredTaxLiabilityMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:to="mlec_DeferredTaxLiabilityMember" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetDeferredTaxAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetDeferredTaxAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_TaxationScheduleofDeferredTaxAssetsandLiabilitiesDetailsLineItems" xlink:to="ifrs-full_NetDeferredTaxAssets" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetDeferredTaxLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetDeferredTaxLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_TaxationScheduleofDeferredTaxAssetsandLiabilitiesDetailsLineItems" xlink:to="ifrs-full_NetDeferredTaxLiabilities" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxLiabilityAsset" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxLiabilityAsset"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_TaxationScheduleofDeferredTaxAssetsandLiabilitiesDetailsLineItems" xlink:to="ifrs-full_DeferredTaxLiabilityAsset" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_TaxationScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesDetailsTable" xlink:href="mlec-20250630.xsd#mlec_TaxationScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="mlec_TaxationScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_TaxationScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesDetailsTable" xlink:to="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_CarryForwardOfTaxLossMember" xlink:href="mlec-20250630.xsd#mlec_CarryForwardOfTaxLossMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:to="mlec_CarryForwardOfTaxLossMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_OthersFinancialAssetsMember" xlink:href="mlec-20250630.xsd#mlec_OthersFinancialAssetsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:to="mlec_OthersFinancialAssetsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_TradeReceivableMember" xlink:href="mlec-20250630.xsd#mlec_TradeReceivableMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:to="mlec_TradeReceivableMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_RoyaltiesMember" xlink:href="mlec-20250630.xsd#mlec_RoyaltiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:to="mlec_RoyaltiesMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AllowancesMember" xlink:href="mlec-20250630.xsd#mlec_AllowancesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:to="mlec_AllowancesMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_GovernmentGrantsMember" xlink:href="mlec-20250630.xsd#mlec_GovernmentGrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:to="mlec_GovernmentGrantsMember" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_OthersOneMember" xlink:href="mlec-20250630.xsd#mlec_OthersOneMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:to="mlec_OthersOneMember" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DeferredTaxAssetMember" xlink:href="mlec-20250630.xsd#mlec_DeferredTaxAssetMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:to="mlec_DeferredTaxAssetMember" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_IntangiblesTaxLiabilityMember" xlink:href="mlec-20250630.xsd#mlec_IntangiblesTaxLiabilityMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:to="mlec_IntangiblesTaxLiabilityMember" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PropertyPlantAndEquipmentDepreciationMember" xlink:href="mlec-20250630.xsd#mlec_PropertyPlantAndEquipmentDepreciationMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:to="mlec_PropertyPlantAndEquipmentDepreciationMember" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_InventoriesTaxLiabilityMember" xlink:href="mlec-20250630.xsd#mlec_InventoriesTaxLiabilityMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:to="mlec_InventoriesTaxLiabilityMember" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BiologicalAssetsMember" xlink:href="mlec-20250630.xsd#mlec_BiologicalAssetsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:to="mlec_BiologicalAssetsMember" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_OthersFinancialAssetsOneMember" xlink:href="mlec-20250630.xsd#mlec_OthersFinancialAssetsOneMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:to="mlec_OthersFinancialAssetsOneMember" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_RightOfUseLeasedAssetTaxLiabilityMember" xlink:href="mlec-20250630.xsd#mlec_RightOfUseLeasedAssetTaxLiabilityMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:to="mlec_RightOfUseLeasedAssetTaxLiabilityMember" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_InflationTaxAdjustmentMember" xlink:href="mlec-20250630.xsd#mlec_InflationTaxAdjustmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:to="mlec_InflationTaxAdjustmentMember" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_OthersTaxAssetsTwoMember" xlink:href="mlec-20250630.xsd#mlec_OthersTaxAssetsTwoMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:to="mlec_OthersTaxAssetsTwoMember" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DeferredTaxLiabilityMember" xlink:href="mlec-20250630.xsd#mlec_DeferredTaxLiabilityMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:to="mlec_DeferredTaxLiabilityMember" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherTaxAssetMember" xlink:href="mlec-20250630.xsd#mlec_OtherTaxAssetMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:to="mlec_OtherTaxAssetMember" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_InventoryMember" xlink:href="mlec-20250630.xsd#mlec_InventoryMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:to="mlec_InventoryMember" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherLiabilitiesOneMember" xlink:href="mlec-20250630.xsd#mlec_OtherLiabilitiesOneMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:to="mlec_OtherLiabilitiesOneMember" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetDeferredTaxAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetDeferredTaxAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_NetDeferredTaxAssets" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofWeightedAverageTaxRateTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfWeightedAverageTaxRateAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfWeightedAverageTaxRateAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfWeightedAverageTaxRateAbstract" xlink:to="ifrs-full_ProfitLossFromDiscontinuedOperations" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TaxExpenseIncomeAtApplicableTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfWeightedAverageTaxRateAbstract" xlink:to="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_TaxEffectOfShareOfProfitOrLossOfSubsidiesJointVenturesAndAssociates" xlink:href="mlec-20250630.xsd#mlec_TaxEffectOfShareOfProfitOrLossOfSubsidiesJointVenturesAndAssociates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfWeightedAverageTaxRateAbstract" xlink:to="mlec_TaxEffectOfShareOfProfitOrLossOfSubsidiesJointVenturesAndAssociates" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PuttableInstrumentsCharge" xlink:href="mlec-20250630.xsd#mlec_PuttableInstrumentsCharge"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfWeightedAverageTaxRateAbstract" xlink:to="mlec_PuttableInstrumentsCharge" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_TaxEffectOfStockOptionCharge" xlink:href="mlec-20250630.xsd#mlec_TaxEffectOfStockOptionCharge"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfWeightedAverageTaxRateAbstract" xlink:to="mlec_TaxEffectOfStockOptionCharge" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DerecognitionOfDeferredTaxAssets" xlink:href="mlec-20250630.xsd#mlec_DerecognitionOfDeferredTaxAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfWeightedAverageTaxRateAbstract" xlink:to="mlec_DerecognitionOfDeferredTaxAssets" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_MutualFundsAdjustment" xlink:href="mlec-20250630.xsd#mlec_MutualFundsAdjustment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfWeightedAverageTaxRateAbstract" xlink:to="mlec_MutualFundsAdjustment" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_TaxEffectOfRevenuesExemptFromTaxationAndExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:href="mlec-20250630.xsd#mlec_TaxEffectOfRevenuesExemptFromTaxationAndExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfWeightedAverageTaxRateAbstract" xlink:to="mlec_TaxEffectOfRevenuesExemptFromTaxationAndExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ResultOfInflationEffectOnMonetaryItemsAndOtherFinanceResults" xlink:href="mlec-20250630.xsd#mlec_ResultOfInflationEffectOnMonetaryItemsAndOtherFinanceResults"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfWeightedAverageTaxRateAbstract" xlink:to="mlec_ResultOfInflationEffectOnMonetaryItemsAndOtherFinanceResults" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_TaxInflationAdjustment" xlink:href="mlec-20250630.xsd#mlec_TaxInflationAdjustment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfWeightedAverageTaxRateAbstract" xlink:to="mlec_TaxInflationAdjustment" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TaxEffectFromChangeInTaxRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TaxEffectFromChangeInTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfWeightedAverageTaxRateAbstract" xlink:to="ifrs-full_TaxEffectFromChangeInTaxRate" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfWeightedAverageTaxRateAbstract" xlink:to="ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfWeightedAverageTaxRateAbstract" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations" order="12" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofPrincipalStatutoryTaxesRatesandCurrentTaxTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentTaxExpenseIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxExpenseIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="ifrs-full_CurrentTaxExpenseIncome" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxExpenseIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxExpenseIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="ifrs-full_DeferredTaxExpenseIncome" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_TaxationScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_TaxationScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_TaxationScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceDetailsTable" xlink:href="mlec-20250630.xsd#mlec_TaxationScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_TaxationScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceDetailsLineItems" xlink:to="mlec_TaxationScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_TaxJurisdictionAxis" xlink:href="mlec-20250630.xsd#mlec_TaxJurisdictionAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_TaxationScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceDetailsTable" xlink:to="mlec_TaxJurisdictionAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_TaxJurisdictionDomainDomain" xlink:href="mlec-20250630.xsd#mlec_TaxJurisdictionDomainDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="mlec_TaxJurisdictionAxis" xlink:to="mlec_TaxJurisdictionDomainDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_TaxJurisdictionDomainDomain_0" xlink:href="mlec-20250630.xsd#mlec_TaxJurisdictionDomainDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="mlec_TaxJurisdictionAxis" xlink:to="mlec_TaxJurisdictionDomainDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_LowOrNullTaxationJurisdictionsMember" xlink:href="mlec-20250630.xsd#mlec_LowOrNullTaxationJurisdictionsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_TaxJurisdictionDomainDomain" xlink:to="mlec_LowOrNullTaxationJurisdictionsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_LossMakingEntitiesMember" xlink:href="mlec-20250630.xsd#mlec_LossMakingEntitiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_TaxJurisdictionDomainDomain" xlink:to="mlec_LossMakingEntitiesMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ProfitMakingEntitiesMember" xlink:href="mlec-20250630.xsd#mlec_ProfitMakingEntitiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_TaxJurisdictionDomainDomain" xlink:to="mlec_ProfitMakingEntitiesMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AccountingProfit" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AccountingProfit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_TaxationScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceDetailsLineItems" xlink:to="ifrs-full_AccountingProfit" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ApplicableTaxRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ApplicableTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_TaxationScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceDetailsLineItems" xlink:to="ifrs-full_ApplicableTaxRate" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TaxExpenseIncomeAtApplicableTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_TaxationScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceDetailsLineItems" xlink:to="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofEarningPerShareTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_EarningsPerShareLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EarningsPerShareLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_EarningPerShareScheduleofEarningPerShareDetailsTable" xlink:href="mlec-20250630.xsd#mlec_EarningPerShareScheduleofEarningPerShareDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_EarningsPerShareLineItems" xlink:to="mlec_EarningPerShareScheduleofEarningPerShareDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_EarningPerShareScheduleofEarningPerShareDetailsTable" xlink:to="ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsAxis" xlink:to="ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsAxis" xlink:to="ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresCropSolutionsCorpMember" xlink:href="mlec-20250630.xsd#mlec_BioceresCropSolutionsCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsDomain" xlink:to="mlec_BioceresCropSolutionsCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EarningsPerShareLineItems" xlink:to="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EarningsPerShareLineItems" xlink:to="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EarningsPerShareLineItems" xlink:to="ifrs-full_WeightedAverageShares" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustedWeightedAverageShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustedWeightedAverageShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EarningsPerShareLineItems" xlink:to="ifrs-full_AdjustedWeightedAverageShares" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BasicEarningsLossPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BasicEarningsLossPerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EarningsPerShareLineItems" xlink:to="ifrs-full_BasicEarningsLossPerShare" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DilutedEarningsLossPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DilutedEarningsLossPerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EarningsPerShareLineItems" xlink:to="ifrs-full_DilutedEarningsLossPerShare" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofNumberofSharesIssuedTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfNumberOfSharesIssuedLineItems" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfNumberOfSharesIssuedLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationaboutComponentsofEquityScheduleofNumberofSharesIssuedDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationaboutComponentsofEquityScheduleofNumberofSharesIssuedDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_ScheduleOfNumberOfSharesIssuedLineItems" xlink:to="mlec_InformationaboutComponentsofEquityScheduleofNumberofSharesIssuedDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofNumberofSharesIssuedDetailsTable" xlink:to="ifrs-full_ClassesOfShareCapitalAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OrdinarySharesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OrdinarySharesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfShareCapitalDomain" xlink:to="ifrs-full_OrdinarySharesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfNumberOfSharesIssuedLineItems" xlink:to="ifrs-full_NumberOfSharesIssued" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_NumberOfNominalValue" xlink:href="mlec-20250630.xsd#mlec_NumberOfNominalValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfNumberOfSharesIssuedLineItems" xlink:to="mlec_NumberOfNominalValue" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SubscribedCapitalOfShares" xlink:href="mlec-20250630.xsd#mlec_SubscribedCapitalOfShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfNumberOfSharesIssuedLineItems" xlink:to="mlec_SubscribedCapitalOfShares" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SubscribedCapital" xlink:href="mlec-20250630.xsd#mlec_SubscribedCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfNumberOfSharesIssuedLineItems" xlink:to="mlec_SubscribedCapital" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofSubsidiariesNonControllingInterestTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationaboutComponentsofEquityScheduleofSubsidiariesNonControllingInterestDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationaboutComponentsofEquityScheduleofSubsidiariesNonControllingInterestDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="mlec_InformationaboutComponentsofEquityScheduleofSubsidiariesNonControllingInterestDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofSubsidiariesNonControllingInterestDetailsTable" xlink:to="ifrs-full_SegmentsAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_ProportionOfOwnershipInterestInSubsidiary" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsTable" xlink:to="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:to="ifrs-full_SignificantInvestmentsInSubsidiariesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:to="ifrs-full_SignificantInvestmentsInSubsidiariesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresSAMember" xlink:href="mlec-20250630.xsd#mlec_BioceresSAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:to="mlec_BioceresSAMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="ifrs-full_CurrentAssets" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_NoncurrentAsset" xlink:href="mlec-20250630.xsd#mlec_NoncurrentAsset"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="mlec_NoncurrentAsset" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Assets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Assets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="ifrs-full_Assets" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="ifrs-full_CurrentLiabilities" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="ifrs-full_NoncurrentLiabilities" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Liabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Liabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="ifrs-full_Liabilities" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="ifrs-full_Equity" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityAndLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAndLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="ifrs-full_EquityAndLiabilities" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Revenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Revenue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="ifrs-full_Revenue" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromGovernmentGrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromGovernmentGrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="ifrs-full_RevenueFromGovernmentGrants" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GrossProfit" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossProfit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="ifrs-full_GrossProfit" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="ifrs-full_ResearchAndDevelopmentExpense" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="ifrs-full_SellingGeneralAndAdministrativeExpense" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareOfProfitOrLossOfSubsidiaries" xlink:href="mlec-20250630.xsd#mlec_ShareOfProfitOrLossOfSubsidiaries"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="mlec_ShareOfProfitOrLossOfSubsidiaries" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherOperatingIncomeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherOperatingIncomeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="ifrs-full_OtherOperatingIncomeExpense" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossFromOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="ifrs-full_ProfitLossFromOperatingActivities" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinanceIncomeCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceIncomeCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="ifrs-full_FinanceIncomeCost" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossBeforeTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="ifrs-full_ProfitLossBeforeTax" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="ifrs-full_ProfitLoss" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="ifrs-full_ComprehensiveIncome" order="23" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsTable" xlink:to="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:to="ifrs-full_SignificantInvestmentsInSubsidiariesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:to="ifrs-full_SignificantInvestmentsInSubsidiariesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresCropSolutionsMember" xlink:href="mlec-20250630.xsd#mlec_BioceresCropSolutionsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:to="mlec_BioceresCropSolutionsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="ifrs-full_CurrentAssets" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="ifrs-full_NoncurrentAssets" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Assets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Assets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="ifrs-full_Assets" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="ifrs-full_CurrentLiabilities" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="ifrs-full_NoncurrentLiabilities" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Liabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Liabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="ifrs-full_Liabilities" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="ifrs-full_Equity" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityAndLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAndLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="ifrs-full_EquityAndLiabilities" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Revenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Revenue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="ifrs-full_Revenue" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CostOfSales" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CostOfSales"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="ifrs-full_CostOfSales" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ChangeInNetRealizableValueOfAgricultural" xlink:href="mlec-20250630.xsd#mlec_ChangeInNetRealizableValueOfAgricultural"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="mlec_ChangeInNetRealizableValueOfAgricultural" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="ifrs-full_ResearchAndDevelopmentExpense" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="ifrs-full_SellingGeneralAndAdministrativeExpense" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherOperatingIncomeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherOperatingIncomeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="ifrs-full_OtherOperatingIncomeExpense" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossFromOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="ifrs-full_ProfitLossFromOperatingActivities" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinanceIncomeCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceIncomeCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="ifrs-full_FinanceIncomeCost" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossBeforeTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="ifrs-full_ProfitLossBeforeTax" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="ifrs-full_ProfitLoss" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTax" xlink:href="mlec-20250630.xsd#mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTax" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="ifrs-full_ComprehensiveIncome" order="23" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsTable" xlink:href="mlec-20250630.xsd#mlec_CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsLineItems" xlink:to="mlec_CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresCropSolutionsCorpMember" xlink:href="mlec-20250630.xsd#mlec_BioceresCropSolutionsCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="mlec_BioceresCropSolutionsCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_NetAssetsAcquisitionByBusinessCombination" xlink:href="mlec-20250630.xsd#mlec_NetAssetsAcquisitionByBusinessCombination"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsLineItems" xlink:to="mlec_NetAssetsAcquisitionByBusinessCombination" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_InvestmentInKindInOtherRelatedPartiesNonCashTransactionsInvestmentActivities" xlink:href="mlec-20250630.xsd#mlec_InvestmentInKindInOtherRelatedPartiesNonCashTransactionsInvestmentActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsLineItems" xlink:to="mlec_InvestmentInKindInOtherRelatedPartiesNonCashTransactionsInvestmentActivities" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_IssuanceOfShare" xlink:href="mlec-20250630.xsd#mlec_IssuanceOfShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsLineItems" xlink:to="mlec_IssuanceOfShare" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_OwnShareHeld" xlink:href="mlec-20250630.xsd#mlec_OwnShareHeld"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsLineItems" xlink:to="mlec_OwnShareHeld" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ExchangeOfIntangibleAssets" xlink:href="mlec-20250630.xsd#mlec_ExchangeOfIntangibleAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsLineItems" xlink:to="mlec_ExchangeOfIntangibleAssets" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestCostsCapitalised" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestCostsCapitalised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsLineItems" xlink:to="ifrs-full_InterestCostsCapitalised" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_RightofuseLeasedAssetAdditionsThroughAnIncreaseInLeaseLiabilities" xlink:href="mlec-20250630.xsd#mlec_RightofuseLeasedAssetAdditionsThroughAnIncreaseInLeaseLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsLineItems" xlink:to="mlec_RightofuseLeasedAssetAdditionsThroughAnIncreaseInLeaseLiabilities" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_NonMonetaryContributionsInJointVenturesNonCashTransactionsInvestmentActivities" xlink:href="mlec-20250630.xsd#mlec_NonMonetaryContributionsInJointVenturesNonCashTransactionsInvestmentActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsLineItems" xlink:to="mlec_NonMonetaryContributionsInJointVenturesNonCashTransactionsInvestmentActivities" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsLineItems" xlink:to="ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_NonCashInvestingActivities" xlink:href="mlec-20250630.xsd#mlec_NonCashInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsLineItems" xlink:to="mlec_NonCashInvestingActivities" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_CapitalizationOfConvertibleFinancingActivities" xlink:href="mlec-20250630.xsd#mlec_CapitalizationOfConvertibleFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsLineItems" xlink:to="mlec_CapitalizationOfConvertibleFinancingActivities" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AssignmentOfReceivablesWithShareholdersAndOtherRelatedParties" xlink:href="mlec-20250630.xsd#mlec_AssignmentOfReceivablesWithShareholdersAndOtherRelatedParties"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsLineItems" xlink:to="mlec_AssignmentOfReceivablesWithShareholdersAndOtherRelatedParties" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_CompensationPaymentFinancedByAcquisitionOfIntangibleAssets" xlink:href="mlec-20250630.xsd#mlec_CompensationPaymentFinancedByAcquisitionOfIntangibleAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsLineItems" xlink:to="mlec_CompensationPaymentFinancedByAcquisitionOfIntangibleAssets" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_IncreaseThroughAcquisitionOfNonControllingInterestInSubsidiaries" xlink:href="mlec-20250630.xsd#mlec_IncreaseThroughAcquisitionOfNonControllingInterestInSubsidiaries"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsLineItems" xlink:to="mlec_IncreaseThroughAcquisitionOfNonControllingInterestInSubsidiaries" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_NonCashFinancingActivities" xlink:href="mlec-20250630.xsd#mlec_NonCashFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsLineItems" xlink:to="mlec_NonCashFinancingActivities" order="14" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_CashFlowInformationScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesDetailsTable" xlink:href="mlec-20250630.xsd#mlec_CashFlowInformationScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:to="mlec_CashFlowInformationScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_CashFlowInformationScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesDetailsTable" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BorrowingMember" xlink:href="mlec-20250630.xsd#mlec_BorrowingMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain" xlink:to="mlec_BorrowingMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancedPaymentAcquisitionOfBusinessMember" xlink:href="mlec-20250630.xsd#mlec_FinancedPaymentAcquisitionOfBusinessMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain" xlink:to="mlec_FinancedPaymentAcquisitionOfBusinessMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_IfrsConvertibleNotesPayableMember" xlink:href="mlec-20250630.xsd#mlec_IfrsConvertibleNotesPayableMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain" xlink:to="mlec_IfrsConvertibleNotesPayableMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivities" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities" xlink:href="mlec-20250630.xsd#mlec_IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:to="mlec_IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities" xlink:href="mlec-20250630.xsd#mlec_DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:to="mlec_DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DecreaseThroughCapitalizationOfDebtLiabilitiesArisingFromFinancingActivities" xlink:href="mlec-20250630.xsd#mlec_DecreaseThroughCapitalizationOfDebtLiabilitiesArisingFromFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:to="mlec_DecreaseThroughCapitalizationOfDebtLiabilitiesArisingFromFinancingActivities" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:to="ifrs-full_InterestPaidClassifiedAsFinancingActivities" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:to="ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancingForAssetsAcquisitions" xlink:href="mlec-20250630.xsd#mlec_FinancingForAssetsAcquisitions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:to="mlec_FinancingForAssetsAcquisitions" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PrepaymentPremiumFee" xlink:href="mlec-20250630.xsd#mlec_PrepaymentPremiumFee"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:to="mlec_PrepaymentPremiumFee" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_NoncashActivities" xlink:href="mlec-20250630.xsd#mlec_NoncashActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:to="mlec_NoncashActivities" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:to="ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DecreaseBecauseOfLossOfControl" xlink:href="mlec-20250630.xsd#mlec_DecreaseBecauseOfLossOfControl"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:to="mlec_DecreaseBecauseOfLossOfControl" order="10" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofJointVenturesAssetsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_JointVenturesandAssociatesScheduleofJointVenturesAssetsDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_JointVenturesandAssociatesScheduleofJointVenturesAssetsDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_JointVenturesandAssociatesScheduleofJointVenturesAssetsDetailsTable" xlink:href="mlec-20250630.xsd#mlec_JointVenturesandAssociatesScheduleofJointVenturesAssetsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_JointVenturesandAssociatesScheduleofJointVenturesAssetsDetailsLineItems" xlink:to="mlec_JointVenturesandAssociatesScheduleofJointVenturesAssetsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_JointVenturesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_JointVenturesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_JointVenturesandAssociatesScheduleofJointVenturesAssetsDetailsTable" xlink:to="ifrs-full_JointVenturesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_JointVenturesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_JointVenturesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_JointVenturesAxis" xlink:to="ifrs-full_JointVenturesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_JointVenturesDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_JointVenturesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_JointVenturesAxis" xlink:to="ifrs-full_JointVenturesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SynertechIndustriasSAMember" xlink:href="mlec-20250630.xsd#mlec_SynertechIndustriasSAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_JointVenturesDomain" xlink:to="mlec_SynertechIndustriasSAMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresCropSolutionsCorpMember" xlink:href="mlec-20250630.xsd#mlec_BioceresCropSolutionsCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_JointVenturesDomain" xlink:to="mlec_BioceresCropSolutionsCorpMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AgralityArgentinaSAMember" xlink:href="mlec-20250630.xsd#mlec_AgralityArgentinaSAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_JointVenturesDomain" xlink:to="mlec_AgralityArgentinaSAMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AgralityUSIncMember" xlink:href="mlec-20250630.xsd#mlec_AgralityUSIncMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_JointVenturesDomain" xlink:to="mlec_AgralityUSIncMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AgralitySeedsIncMember" xlink:href="mlec-20250630.xsd#mlec_AgralitySeedsIncMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_JointVenturesDomain" xlink:to="mlec_AgralitySeedsIncMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SWSemillasSAMember" xlink:href="mlec-20250630.xsd#mlec_SWSemillasSAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_JointVenturesDomain" xlink:to="mlec_SWSemillasSAMember" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AlfalfaTechnologiesSRlMember" xlink:href="mlec-20250630.xsd#mlec_AlfalfaTechnologiesSRlMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_JointVenturesDomain" xlink:to="mlec_AlfalfaTechnologiesSRlMember" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_InmetSAMember" xlink:href="mlec-20250630.xsd#mlec_InmetSAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_JointVenturesDomain" xlink:to="mlec_InmetSAMember" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_TheoISCSpMember" xlink:href="mlec-20250630.xsd#mlec_TheoISCSpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_JointVenturesDomain" xlink:to="mlec_TheoISCSpMember" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_TrigallGeneticsSAMember" xlink:href="mlec-20250630.xsd#mlec_TrigallGeneticsSAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_JointVenturesDomain" xlink:to="mlec_TrigallGeneticsSAMember" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_JointVenturesandAssociatesScheduleofJointVenturesAssetsDetailsLineItems" xlink:to="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_InvestmentsMeasuredAtFairValue" xlink:href="mlec-20250630.xsd#mlec_InvestmentsMeasuredAtFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_JointVenturesandAssociatesScheduleofJointVenturesAssetsDetailsLineItems" xlink:to="mlec_InvestmentsMeasuredAtFairValue" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DueToJointVenturesAndAssociatesNonCurrent" xlink:href="mlec-20250630.xsd#mlec_DueToJointVenturesAndAssociatesNonCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_JointVenturesandAssociatesScheduleofJointVenturesAssetsDetailsLineItems" xlink:to="mlec_DueToJointVenturesAndAssociatesNonCurrent" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofChangesinJointVenturesInvestmentsandAffiliatesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsTable" xlink:href="mlec-20250630.xsd#mlec_JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsLineItems" xlink:to="mlec_JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_JointVenturesInvestmentsAndAffiliatesMember" xlink:href="mlec-20250630.xsd#mlec_JointVenturesInvestmentsAndAffiliatesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:to="mlec_JointVenturesInvestmentsAndAffiliatesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity" xlink:href="mlec-20250630.xsd#mlec_InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsLineItems" xlink:to="mlec_InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LossesOnDisposalsOfInvestments" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LossesOnDisposalsOfInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsLineItems" xlink:to="ifrs-full_LossesOnDisposalsOfInvestments" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ChangesInEquityInterest" xlink:href="mlec-20250630.xsd#mlec_ChangesInEquityInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsLineItems" xlink:to="mlec_ChangesInEquityInterest" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SaleOfEquityInvestment" xlink:href="mlec-20250630.xsd#mlec_SaleOfEquityInvestment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsLineItems" xlink:to="mlec_SaleOfEquityInvestment" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_JointVenturesAndAssociatesAccountedForUsingEquityMethodReclassificationChangeInOwnership" xlink:href="mlec-20250630.xsd#mlec_JointVenturesAndAssociatesAccountedForUsingEquityMethodReclassificationChangeInOwnership"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsLineItems" xlink:to="mlec_JointVenturesAndAssociatesAccountedForUsingEquityMethodReclassificationChangeInOwnership" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_EquityMethodInvestmentIncreaseFromShareBasedIncentives" xlink:href="mlec-20250630.xsd#mlec_EquityMethodInvestmentIncreaseFromShareBasedIncentives"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsLineItems" xlink:to="mlec_EquityMethodInvestmentIncreaseFromShareBasedIncentives" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ChangeinJointVenturesDividendsDistribution" xlink:href="mlec-20250630.xsd#mlec_ChangeinJointVenturesDividendsDistribution"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsLineItems" xlink:to="mlec_ChangeinJointVenturesDividendsDistribution" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_GainsLossesOnExchangeDifferencesOnTranslationFromJointVentureNetOfTax" xlink:href="mlec-20250630.xsd#mlec_GainsLossesOnExchangeDifferencesOnTranslationFromJointVentureNetOfTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsLineItems" xlink:to="mlec_GainsLossesOnExchangeDifferencesOnTranslationFromJointVentureNetOfTax" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsLineItems" xlink:to="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareOfProfitOrLossMeasuredAtFairValue" xlink:href="mlec-20250630.xsd#mlec_ShareOfProfitOrLossMeasuredAtFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsLineItems" xlink:to="mlec_ShareOfProfitOrLossMeasuredAtFairValue" order="9" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofShareofProfitorLossofJointVenturesandAffiliatesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfJointVenturesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfJointVenturesLineItems"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfJointVenturesTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfJointVenturesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfJointVenturesLineItems" xlink:to="ifrs-full_DisclosureOfJointVenturesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_JointVenturesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_JointVenturesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ifrs-full_DisclosureOfJointVenturesTable" xlink:to="ifrs-full_JointVenturesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_JointVenturesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_JointVenturesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_JointVenturesAxis" xlink:to="ifrs-full_JointVenturesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_JointVenturesDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_JointVenturesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_JointVenturesAxis" xlink:to="ifrs-full_JointVenturesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SynertechIndustriasSAMember" xlink:href="mlec-20250630.xsd#mlec_SynertechIndustriasSAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_JointVenturesDomain" xlink:to="mlec_SynertechIndustriasSAMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AgralityArgentinaSAMember" xlink:href="mlec-20250630.xsd#mlec_AgralityArgentinaSAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_JointVenturesDomain" xlink:to="mlec_AgralityArgentinaSAMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AgralityUSIncMember" xlink:href="mlec-20250630.xsd#mlec_AgralityUSIncMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_JointVenturesDomain" xlink:to="mlec_AgralityUSIncMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AgralitySeedsIncMember" xlink:href="mlec-20250630.xsd#mlec_AgralitySeedsIncMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_JointVenturesDomain" xlink:to="mlec_AgralitySeedsIncMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_IndrasaBiotecnologaSAMember" xlink:href="mlec-20250630.xsd#mlec_IndrasaBiotecnologaSAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_JointVenturesDomain" xlink:to="mlec_IndrasaBiotecnologaSAMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_MoolecScienceSAMember" xlink:href="mlec-20250630.xsd#mlec_MoolecScienceSAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_JointVenturesDomain" xlink:to="mlec_MoolecScienceSAMember" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SWSemillasSAMember" xlink:href="mlec-20250630.xsd#mlec_SWSemillasSAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_JointVenturesDomain" xlink:to="mlec_SWSemillasSAMember" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_TrigallGeneticsSAMember" xlink:href="mlec-20250630.xsd#mlec_TrigallGeneticsSAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_JointVenturesDomain" xlink:to="mlec_TrigallGeneticsSAMember" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_InmetSAMember" xlink:href="mlec-20250630.xsd#mlec_InmetSAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_JointVenturesDomain" xlink:to="mlec_InmetSAMember" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_TheoISCSpMember" xlink:href="mlec-20250630.xsd#mlec_TheoISCSpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_JointVenturesDomain" xlink:to="mlec_TheoISCSpMember" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfJointVenturesLineItems" xlink:to="ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareOfProfitOrLossMeasuredAtFairValue" xlink:href="mlec-20250630.xsd#mlec_ShareOfProfitOrLossMeasuredAtFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfJointVenturesLineItems" xlink:to="mlec_ShareOfProfitOrLossMeasuredAtFairValue" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofSignificantJointVenturesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfJointVenturesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfJointVenturesLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_JointVenturesandAssociatesScheduleofSignificantJointVenturesDetailsTable" xlink:href="mlec-20250630.xsd#mlec_JointVenturesandAssociatesScheduleofSignificantJointVenturesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfJointVenturesLineItems" xlink:to="mlec_JointVenturesandAssociatesScheduleofSignificantJointVenturesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_JointVenturesandAssociatesScheduleofSignificantJointVenturesDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SynertechIndustriasSAMember" xlink:href="mlec-20250630.xsd#mlec_SynertechIndustriasSAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mlec_SynertechIndustriasSAMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AgralitySAMember" xlink:href="mlec-20250630.xsd#mlec_AgralitySAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mlec_AgralitySAMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_TheoISCSpMember" xlink:href="mlec-20250630.xsd#mlec_TheoISCSpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="mlec_TheoISCSpMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfJointVenturesLineItems" xlink:to="ifrs-full_CurrentAssets" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfJointVenturesLineItems" xlink:to="ifrs-full_NoncurrentAssets" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfJointVenturesLineItems" xlink:to="ifrs-full_CurrentLiabilities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfJointVenturesLineItems" xlink:to="ifrs-full_NoncurrentLiabilities" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfJointVenturesLineItems" xlink:to="ifrs-full_Equity" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CostOfSales" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CostOfSales"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfJointVenturesLineItems" xlink:to="ifrs-full_CostOfSales" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfJointVenturesLineItems" xlink:to="ifrs-full_ProfitLoss" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofOperatingResultsGroupsReportingSegmentsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_SegmentInformationScheduleofOperatingResultsGroupsReportingSegmentsDetailsTable" xlink:href="mlec-20250630.xsd#mlec_SegmentInformationScheduleofOperatingResultsGroupsReportingSegmentsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:to="mlec_SegmentInformationScheduleofOperatingResultsGroupsReportingSegmentsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_SegmentInformationScheduleofOperatingResultsGroupsReportingSegmentsDetailsTable" xlink:to="ifrs-full_SegmentsAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SeedAndIntegratedProductsMember" xlink:href="mlec-20250630.xsd#mlec_SeedAndIntegratedProductsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_SegmentsDomain" xlink:to="mlec_SeedAndIntegratedProductsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_CropProtectionMember" xlink:href="mlec-20250630.xsd#mlec_CropProtectionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_SegmentsDomain" xlink:to="mlec_CropProtectionMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_CropNutritionMember" xlink:href="mlec-20250630.xsd#mlec_CropNutritionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_SegmentsDomain" xlink:to="mlec_CropNutritionMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_EmergingSolutionsMember" xlink:href="mlec-20250630.xsd#mlec_EmergingSolutionsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_SegmentsDomain" xlink:to="mlec_EmergingSolutionsMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ConsolidatedEntitieMember" xlink:href="mlec-20250630.xsd#mlec_ConsolidatedEntitieMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_SegmentsDomain" xlink:to="mlec_ConsolidatedEntitieMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_RevenueFromSaleOfGoodsAndRenderingOfServices" xlink:href="mlec-20250630.xsd#mlec_RevenueFromSaleOfGoodsAndRenderingOfServices"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:to="mlec_RevenueFromSaleOfGoodsAndRenderingOfServices" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromRoyalties" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromRoyalties"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:to="ifrs-full_RevenueFromRoyalties" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LicenceFeeIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LicenceFeeIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:to="ifrs-full_LicenceFeeIncome" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:to="ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromGovernmentGrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromGovernmentGrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:to="ifrs-full_RevenueFromGovernmentGrants" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Revenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Revenue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:to="ifrs-full_Revenue" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CostOfSales" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CostOfSales"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:to="ifrs-full_CostOfSales" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GrossProfit" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossProfit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:to="ifrs-full_GrossProfit" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PercentageGrossMargin" xlink:href="mlec-20250630.xsd#mlec_PercentageGrossMargin"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:to="mlec_PercentageGrossMargin" order="8" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofRevenuebySimilarGroupofProductsorServicesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfProductsAndServicesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfProductsAndServicesLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_SegmentInformationScheduleofRevenuebySimilarGroupofProductsorServicesDetailsTable" xlink:href="mlec-20250630.xsd#mlec_SegmentInformationScheduleofRevenuebySimilarGroupofProductsorServicesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfProductsAndServicesLineItems" xlink:to="mlec_SegmentInformationScheduleofRevenuebySimilarGroupofProductsorServicesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ConsolidatedStructuredEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_SegmentInformationScheduleofRevenuebySimilarGroupofProductsorServicesDetailsTable" xlink:to="ifrs-full_ConsolidatedStructuredEntitiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ConsolidatedStructuredEntitiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ConsolidatedStructuredEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:to="ifrs-full_ConsolidatedStructuredEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ConsolidatedStructuredEntitiesDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ConsolidatedStructuredEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:to="ifrs-full_ConsolidatedStructuredEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_SegmentInformationScheduleofRevenuebySimilarGroupofProductsorServicesDetailsTable" xlink:to="ifrs-full_SegmentsAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProductsAndServicesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProductsAndServicesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_SegmentInformationScheduleofRevenuebySimilarGroupofProductsorServicesDetailsTable" xlink:to="ifrs-full_ProductsAndServicesAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProductsAndServicesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProductsAndServicesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="ifrs-full_ProductsAndServicesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProductsAndServicesDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProductsAndServicesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="ifrs-full_ProductsAndServicesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SeedTreatmentsPacksMember" xlink:href="mlec-20250630.xsd#mlec_SeedTreatmentsPacksMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ProductsAndServicesDomain" xlink:to="mlec_SeedTreatmentsPacksMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SeedRoyaltiesPaymentsHB4ProgramMember" xlink:href="mlec-20250630.xsd#mlec_SeedRoyaltiesPaymentsHB4ProgramMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ProductsAndServicesDomain" xlink:to="mlec_SeedRoyaltiesPaymentsHB4ProgramMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AdjuvantsMember" xlink:href="mlec-20250630.xsd#mlec_AdjuvantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ProductsAndServicesDomain" xlink:to="mlec_AdjuvantsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SeedCpProductsAndServicesMember" xlink:href="mlec-20250630.xsd#mlec_SeedCpProductsAndServicesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ProductsAndServicesDomain" xlink:to="mlec_SeedCpProductsAndServicesMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherCpProductsAndServicesMember" xlink:href="mlec-20250630.xsd#mlec_OtherCpProductsAndServicesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ProductsAndServicesDomain" xlink:to="mlec_OtherCpProductsAndServicesMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BioprotectionMember" xlink:href="mlec-20250630.xsd#mlec_BioprotectionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ProductsAndServicesDomain" xlink:to="mlec_BioprotectionMember" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_InoculantsBiofertilizersMember" xlink:href="mlec-20250630.xsd#mlec_InoculantsBiofertilizersMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ProductsAndServicesDomain" xlink:to="mlec_InoculantsBiofertilizersMember" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_MicroBeadedFertilizersMember" xlink:href="mlec-20250630.xsd#mlec_MicroBeadedFertilizersMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ProductsAndServicesDomain" xlink:to="mlec_MicroBeadedFertilizersMember" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BiostimulantsMember" xlink:href="mlec-20250630.xsd#mlec_BiostimulantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ProductsAndServicesDomain" xlink:to="mlec_BiostimulantsMember" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SyngentaUpfrontFeeMember" xlink:href="mlec-20250630.xsd#mlec_SyngentaUpfrontFeeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ProductsAndServicesDomain" xlink:to="mlec_SyngentaUpfrontFeeMember" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ManagementExpensesMember" xlink:href="mlec-20250630.xsd#mlec_ManagementExpensesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ProductsAndServicesDomain" xlink:to="mlec_ManagementExpensesMember" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_GovernmentGrantsMember" xlink:href="mlec-20250630.xsd#mlec_GovernmentGrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ProductsAndServicesDomain" xlink:to="mlec_GovernmentGrantsMember" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresCropSolutionsCorpMember" xlink:href="mlec-20250630.xsd#mlec_BioceresCropSolutionsCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesDomain" xlink:to="mlec_BioceresCropSolutionsCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SeedAndIntegratedProductsMember" xlink:href="mlec-20250630.xsd#mlec_SeedAndIntegratedProductsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_SegmentsDomain" xlink:to="mlec_SeedAndIntegratedProductsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_CropProtectionMember" xlink:href="mlec-20250630.xsd#mlec_CropProtectionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_SegmentsDomain" xlink:to="mlec_CropProtectionMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_CropNutritionMember" xlink:href="mlec-20250630.xsd#mlec_CropNutritionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_SegmentsDomain" xlink:to="mlec_CropNutritionMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_EmergingSolutionsMember" xlink:href="mlec-20250630.xsd#mlec_EmergingSolutionsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_SegmentsDomain" xlink:to="mlec_EmergingSolutionsMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromContractsWithCustomers" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromContractsWithCustomers"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfProductsAndServicesLineItems" xlink:to="ifrs-full_RevenueFromContractsWithCustomers" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofGeographicalInformationTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfGeographicalInformationLineItems" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfGeographicalInformationLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_SegmentInformationScheduleofGeographicalInformationDetailsTable" xlink:href="mlec-20250630.xsd#mlec_SegmentInformationScheduleofGeographicalInformationDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_ScheduleOfGeographicalInformationLineItems" xlink:to="mlec_SegmentInformationScheduleofGeographicalInformationDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ConsolidatedStructuredEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_SegmentInformationScheduleofGeographicalInformationDetailsTable" xlink:to="ifrs-full_ConsolidatedStructuredEntitiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ConsolidatedStructuredEntitiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ConsolidatedStructuredEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:to="ifrs-full_ConsolidatedStructuredEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ConsolidatedStructuredEntitiesDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ConsolidatedStructuredEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:to="ifrs-full_ConsolidatedStructuredEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeographicalAreasAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_SegmentInformationScheduleofGeographicalInformationDetailsTable" xlink:to="ifrs-full_GeographicalAreasAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeographicalAreasDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="ifrs-full_GeographicalAreasDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeographicalAreasDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="ifrs-full_GeographicalAreasDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresCropSolutionsCorpMember" xlink:href="mlec-20250630.xsd#mlec_BioceresCropSolutionsCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesDomain" xlink:to="mlec_BioceresCropSolutionsCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_AR" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_AR"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_GeographicalAreasDomain" xlink:to="country_AR" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_BR" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_BR"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_GeographicalAreasDomain" xlink:to="country_BR" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_LatinAmericaMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_LatinAmericaMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_GeographicalAreasDomain" xlink:to="srt_LatinAmericaMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_NorthAmericaMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_NorthAmericaMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_GeographicalAreasDomain" xlink:to="srt_NorthAmericaMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_EuropeMiddleEastAndAfricaMember" xlink:href="mlec-20250630.xsd#mlec_EuropeMiddleEastAndAfricaMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_GeographicalAreasDomain" xlink:to="mlec_EuropeMiddleEastAndAfricaMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherRegionsOrCountriesMember" xlink:href="mlec-20250630.xsd#mlec_OtherRegionsOrCountriesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_GeographicalAreasDomain" xlink:to="mlec_OtherRegionsOrCountriesMember" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Revenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Revenue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfGeographicalInformationLineItems" xlink:to="ifrs-full_Revenue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfGeographicalInformationLineItems" xlink:to="ifrs-full_NoncurrentAssets" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfGeographicalInformationLineItems" xlink:to="ifrs-full_PropertyPlantAndEquipment" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfGeographicalInformationLineItems" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Goodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Goodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfGeographicalInformationLineItems" xlink:to="ifrs-full_Goodwill" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_TotalReportableAssets" xlink:href="mlec-20250630.xsd#mlec_TotalReportableAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfGeographicalInformationLineItems" xlink:to="mlec_TotalReportableAssets" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_TotalNonreportableAssets" xlink:href="mlec-20250630.xsd#mlec_TotalNonreportableAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfGeographicalInformationLineItems" xlink:to="mlec_TotalNonreportableAssets" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Assets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Assets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfGeographicalInformationLineItems" xlink:to="ifrs-full_Assets" order="7" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofLiquidityRiskTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialInstrumentsRiskManagementScheduleofLiquidityRiskDetailsTable" xlink:href="mlec-20250630.xsd#mlec_FinancialInstrumentsRiskManagementScheduleofLiquidityRiskDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:to="mlec_FinancialInstrumentsRiskManagementScheduleofLiquidityRiskDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_FinancialInstrumentsRiskManagementScheduleofLiquidityRiskDetailsTable" xlink:to="ifrs-full_ClassesOfFinancialLiabilitiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:to="ifrs-full_ClassesOfFinancialLiabilitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialLiabilitiesDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:to="ifrs-full_ClassesOfFinancialLiabilitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfRisksAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfRisksAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_FinancialInstrumentsRiskManagementScheduleofLiquidityRiskDetailsTable" xlink:to="ifrs-full_TypesOfRisksAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfRisksDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfRisksDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_TypesOfRisksAxis" xlink:to="ifrs-full_TypesOfRisksDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfRisksDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfRisksDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_TypesOfRisksAxis" xlink:to="ifrs-full_TypesOfRisksDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MaturityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_FinancialInstrumentsRiskManagementScheduleofLiquidityRiskDetailsTable" xlink:to="ifrs-full_MaturityAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MaturityDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_MaturityDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MaturityDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_MaturityDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiquidityRiskMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LiquidityRiskMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TypesOfRisksDomain" xlink:to="ifrs-full_LiquidityRiskMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NotLaterThanThreeMonthsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NotLaterThanThreeMonthsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_MaturityDomain" xlink:to="ifrs-full_NotLaterThanThreeMonthsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LaterThanThreeMonthsAndNotLaterThanOneYearMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanThreeMonthsAndNotLaterThanOneYearMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_MaturityDomain" xlink:to="ifrs-full_LaterThanThreeMonthsAndNotLaterThanOneYearMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_MaturityDomain" xlink:to="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_TradeAndOtherPayablesMember" xlink:href="mlec-20250630.xsd#mlec_TradeAndOtherPayablesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:to="mlec_TradeAndOtherPayablesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BorrowingMember" xlink:href="mlec-20250630.xsd#mlec_BorrowingMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:to="mlec_BorrowingMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_IfrsConvertibleNotesPayableMember" xlink:href="mlec-20250630.xsd#mlec_IfrsConvertibleNotesPayableMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:to="mlec_IfrsConvertibleNotesPayableMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LeaseLiabilitiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseLiabilitiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:to="ifrs-full_LeaseLiabilitiesMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ConsiderationForAcquisitionOfAssetsMember" xlink:href="mlec-20250630.xsd#mlec_ConsiderationForAcquisitionOfAssetsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:to="mlec_ConsiderationForAcquisitionOfAssetsMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherPayables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:to="ifrs-full_TradeAndOtherPayables" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Borrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Borrowings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:to="ifrs-full_Borrowings" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ConvertibleNotes" xlink:href="mlec-20250630.xsd#mlec_ConvertibleNotes"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:to="mlec_ConvertibleNotes" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_LeasingLiabilities" xlink:href="mlec-20250630.xsd#mlec_LeasingLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:to="mlec_LeasingLiabilities" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:to="ifrs-full_FinancialLiabilities" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ConsiderationForAcquisitionOfAssets" xlink:href="mlec-20250630.xsd#mlec_ConsiderationForAcquisitionOfAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:to="mlec_ConsiderationForAcquisitionOfAssets" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofCurrencyRiskTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_FinancialInstrumentsRiskManagementScheduleofCurrencyRiskDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_FinancialInstrumentsRiskManagementScheduleofCurrencyRiskDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialInstrumentsRiskManagementScheduleofCurrencyRiskDetailsTable" xlink:href="mlec-20250630.xsd#mlec_FinancialInstrumentsRiskManagementScheduleofCurrencyRiskDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_FinancialInstrumentsRiskManagementScheduleofCurrencyRiskDetailsLineItems" xlink:to="mlec_FinancialInstrumentsRiskManagementScheduleofCurrencyRiskDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ConsolidatedStructuredEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_FinancialInstrumentsRiskManagementScheduleofCurrencyRiskDetailsTable" xlink:to="ifrs-full_ConsolidatedStructuredEntitiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ConsolidatedStructuredEntitiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ConsolidatedStructuredEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:to="ifrs-full_ConsolidatedStructuredEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ConsolidatedStructuredEntitiesDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ConsolidatedStructuredEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:to="ifrs-full_ConsolidatedStructuredEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresCropSolutionsCorpMember" xlink:href="mlec-20250630.xsd#mlec_BioceresCropSolutionsCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesDomain" xlink:to="mlec_BioceresCropSolutionsCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_FinancialInstrumentsRiskManagementScheduleofCurrencyRiskDetailsLineItems" xlink:to="ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherCurrencies" xlink:href="mlec-20250630.xsd#mlec_OtherCurrencies"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_FinancialInstrumentsRiskManagementScheduleofCurrencyRiskDetailsLineItems" xlink:to="mlec_OtherCurrencies" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofOtherForiegnCurrencieswithVariablesRemainingConstantTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract" xlink:to="ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofInterestRateRiskTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialInstrumentsRiskManagementScheduleofInterestRateRiskDetailsTable" xlink:href="mlec-20250630.xsd#mlec_FinancialInstrumentsRiskManagementScheduleofInterestRateRiskDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems" xlink:to="mlec_FinancialInstrumentsRiskManagementScheduleofInterestRateRiskDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfRisksAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfRisksAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_FinancialInstrumentsRiskManagementScheduleofInterestRateRiskDetailsTable" xlink:to="ifrs-full_TypesOfRisksAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfRisksDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfRisksDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_TypesOfRisksAxis" xlink:to="ifrs-full_TypesOfRisksDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfRisksDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfRisksDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_TypesOfRisksAxis" xlink:to="ifrs-full_TypesOfRisksDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_FinancialInstrumentsRiskManagementScheduleofInterestRateRiskDetailsTable" xlink:to="ifrs-full_BorrowingsByNameAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="ifrs-full_BorrowingsByNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="ifrs-full_BorrowingsByNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestRateRiskMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestRateRiskMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TypesOfRisksDomain" xlink:to="ifrs-full_InterestRateRiskMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_FixedRateBorrowingsMember" xlink:href="mlec-20250630.xsd#mlec_FixedRateBorrowingsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BorrowingsByNameDomain" xlink:to="mlec_FixedRateBorrowingsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_VariableRateBorrowingsMember" xlink:href="mlec-20250630.xsd#mlec_VariableRateBorrowingsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BorrowingsByNameDomain" xlink:to="mlec_VariableRateBorrowingsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentFinancialLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems" xlink:to="ifrs-full_CurrentFinancialLiabilities" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentFinancialLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems" xlink:to="ifrs-full_NoncurrentFinancialLiabilities" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivities" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofFinancialAssetsbyCategoryTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialAssetsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialInstrumentsRiskManagementScheduleofFinancialAssetsbyCategoryDetailsTable" xlink:href="mlec-20250630.xsd#mlec_FinancialInstrumentsRiskManagementScheduleofFinancialAssetsbyCategoryDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfFinancialAssetsLineItems" xlink:to="mlec_FinancialInstrumentsRiskManagementScheduleofFinancialAssetsbyCategoryDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_FinancialInstrumentsRiskManagementScheduleofFinancialAssetsbyCategoryDetailsTable" xlink:to="ifrs-full_ClassesOfFinancialAssetsAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialAssetsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="ifrs-full_ClassesOfFinancialAssetsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialAssetsDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="ifrs-full_ClassesOfFinancialAssetsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MeasurementAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_FinancialInstrumentsRiskManagementScheduleofFinancialAssetsbyCategoryDetailsTable" xlink:to="ifrs-full_MeasurementAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MeasurementDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_MeasurementAxis" xlink:to="ifrs-full_MeasurementDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MeasurementDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_MeasurementAxis" xlink:to="ifrs-full_MeasurementDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_CashAndEquivalentsMember" xlink:href="mlec-20250630.xsd#mlec_CashAndEquivalentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialAssetsDomain" xlink:to="mlec_CashAndEquivalentsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherFinancialAssetsMember" xlink:href="mlec-20250630.xsd#mlec_OtherFinancialAssetsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialAssetsDomain" xlink:to="mlec_OtherFinancialAssetsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeReceivablesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeReceivablesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialAssetsDomain" xlink:to="ifrs-full_TradeReceivablesMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherReceivablesMember" xlink:href="mlec-20250630.xsd#mlec_OtherReceivablesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialAssetsDomain" xlink:to="mlec_OtherReceivablesMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_MeasurementDomain" xlink:to="ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_MandatorilyMeasuredAtFairValueThroughProfitOrLossMember" xlink:href="mlec-20250630.xsd#mlec_MandatorilyMeasuredAtFairValueThroughProfitOrLossMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_MeasurementDomain" xlink:to="mlec_MandatorilyMeasuredAtFairValueThroughProfitOrLossMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfFinancialAssetsLineItems" xlink:to="ifrs-full_CashAndCashEquivalents" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherFinancialAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfFinancialAssetsLineItems" xlink:to="ifrs-full_OtherFinancialAssets" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfFinancialAssetsLineItems" xlink:to="ifrs-full_TradeReceivables" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherCurrentReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfFinancialAssetsLineItems" xlink:to="ifrs-full_OtherCurrentReceivables" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentFinancialAssetsAtAmortisedCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentFinancialAssetsAtAmortisedCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfFinancialAssetsLineItems" xlink:to="ifrs-full_CurrentFinancialAssetsAtAmortisedCost" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofFinancialLiabilitiesbyCategoryTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialLiabilitiesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialInstrumentsRiskManagementScheduleofFinancialLiabilitiesbyCategoryDetailsTable" xlink:href="mlec-20250630.xsd#mlec_FinancialInstrumentsRiskManagementScheduleofFinancialLiabilitiesbyCategoryDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesLineItems" xlink:to="mlec_FinancialInstrumentsRiskManagementScheduleofFinancialLiabilitiesbyCategoryDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MeasurementAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_FinancialInstrumentsRiskManagementScheduleofFinancialLiabilitiesbyCategoryDetailsTable" xlink:to="ifrs-full_MeasurementAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MeasurementDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_MeasurementAxis" xlink:to="ifrs-full_MeasurementDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MeasurementDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_MeasurementAxis" xlink:to="ifrs-full_MeasurementDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_FinancialInstrumentsRiskManagementScheduleofFinancialLiabilitiesbyCategoryDetailsTable" xlink:to="ifrs-full_ClassesOfFinancialLiabilitiesAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:to="ifrs-full_ClassesOfFinancialLiabilitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialLiabilitiesDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:to="ifrs-full_ClassesOfFinancialLiabilitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AtAmortizedCostMember" xlink:href="mlec-20250630.xsd#mlec_AtAmortizedCostMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_MeasurementDomain" xlink:to="mlec_AtAmortizedCostMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AtFairValueMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AtFairValueMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_MeasurementDomain" xlink:to="ifrs-full_AtFairValueMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_TradeAndOtherPayablesMember" xlink:href="mlec-20250630.xsd#mlec_TradeAndOtherPayablesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:to="mlec_TradeAndOtherPayablesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BorrowingMember" xlink:href="mlec-20250630.xsd#mlec_BorrowingMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:to="mlec_BorrowingMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ConsiderationForAcquisitionOfAssetsMember" xlink:href="mlec-20250630.xsd#mlec_ConsiderationForAcquisitionOfAssetsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:to="mlec_ConsiderationForAcquisitionOfAssetsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ConvertibleNotesMember" xlink:href="mlec-20250630.xsd#mlec_ConvertibleNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:to="mlec_ConvertibleNotesMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LeaseLiabilitiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseLiabilitiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:to="ifrs-full_LeaseLiabilitiesMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_WarrantLiabilityMember" xlink:href="mlec-20250630.xsd#mlec_WarrantLiabilityMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:to="mlec_WarrantLiabilityMember" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesLineItems" xlink:to="ifrs-full_FinancialLiabilities" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofFairValuebyHierarchyTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialInstrumentsRiskManagementScheduleofFairValuebyHierarchyDetailsTable" xlink:href="mlec-20250630.xsd#mlec_FinancialInstrumentsRiskManagementScheduleofFairValuebyHierarchyDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems" xlink:to="mlec_FinancialInstrumentsRiskManagementScheduleofFairValuebyHierarchyDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_FinancialInstrumentsRiskManagementScheduleofFairValuebyHierarchyDetailsTable" xlink:to="ifrs-full_ClassesOfFinancialAssetsAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialAssetsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="ifrs-full_ClassesOfFinancialAssetsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialAssetsDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="ifrs-full_ClassesOfFinancialAssetsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_FinancialInstrumentsRiskManagementScheduleofFairValuebyHierarchyDetailsTable" xlink:to="ifrs-full_ClassesOfFinancialLiabilitiesAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:to="ifrs-full_ClassesOfFinancialLiabilitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialLiabilitiesDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:to="ifrs-full_ClassesOfFinancialLiabilitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_FinancialInstrumentsRiskManagementScheduleofFairValuebyHierarchyDetailsTable" xlink:to="ifrs-full_LevelsOfFairValueHierarchyAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LevelsOfFairValueHierarchyDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:to="ifrs-full_LevelsOfFairValueHierarchyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LevelsOfFairValueHierarchyDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:to="ifrs-full_LevelsOfFairValueHierarchyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_InvestmentsAtFairValueMember" xlink:href="mlec-20250630.xsd#mlec_InvestmentsAtFairValueMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialAssetsDomain" xlink:to="mlec_InvestmentsAtFairValueMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_WarrantLiabilityMember" xlink:href="mlec-20250630.xsd#mlec_WarrantLiabilityMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialAssetsDomain" xlink:to="mlec_WarrantLiabilityMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_MutualFundsMember" xlink:href="mlec-20250630.xsd#mlec_MutualFundsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialAssetsDomain" xlink:to="mlec_MutualFundsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_MoolecScienceSASharesMember" xlink:href="mlec-20250630.xsd#mlec_MoolecScienceSASharesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialAssetsDomain" xlink:to="mlec_MoolecScienceSASharesMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_UsTreasuryBillsMember" xlink:href="mlec-20250630.xsd#mlec_UsTreasuryBillsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialAssetsDomain" xlink:to="mlec_UsTreasuryBillsMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherInvestmentMember" xlink:href="mlec-20250630.xsd#mlec_OtherInvestmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialAssetsDomain" xlink:to="mlec_OtherInvestmentMember" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Level1OfFairValueHierarchyMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Level1OfFairValueHierarchyMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_LevelsOfFairValueHierarchyDomain" xlink:to="ifrs-full_Level1OfFairValueHierarchyMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Level2OfFairValueHierarchyMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Level2OfFairValueHierarchyMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_LevelsOfFairValueHierarchyDomain" xlink:to="ifrs-full_Level2OfFairValueHierarchyMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Level3OfFairValueHierarchyMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Level3OfFairValueHierarchyMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_LevelsOfFairValueHierarchyDomain" xlink:to="ifrs-full_Level3OfFairValueHierarchyMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_TradeAndOtherPayablesMember" xlink:href="mlec-20250630.xsd#mlec_TradeAndOtherPayablesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:to="mlec_TradeAndOtherPayablesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ConsiderationForAcquisitionMember" xlink:href="mlec-20250630.xsd#mlec_ConsiderationForAcquisitionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:to="mlec_ConsiderationForAcquisitionMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialAssetsAtFairValue" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssetsAtFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems" xlink:to="ifrs-full_FinancialAssetsAtFairValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialLiabilitiesAtFairValue" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems" xlink:to="ifrs-full_FinancialLiabilitiesAtFairValue" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsTable" xlink:href="mlec-20250630.xsd#mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:to="mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsTable" xlink:to="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CarryingAmountMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="ifrs-full_CarryingAmountMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CarryingAmountMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="ifrs-full_CarryingAmountMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsTable" xlink:to="ifrs-full_ClassesOfAssetsAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfAssetsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="ifrs-full_ClassesOfAssetsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfAssetsDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="ifrs-full_ClassesOfAssetsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GrossCarryingAmountMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossCarryingAmountMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CarryingAmountMember" xlink:to="ifrs-full_GrossCarryingAmountMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CarryingAmountMember" xlink:to="ifrs-full_AccumulatedDepreciationAndAmortisationMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MachineryMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MachineryMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfAssetsDomain" xlink:to="ifrs-full_MachineryMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_VehiclesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_VehiclesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfAssetsDomain" xlink:to="ifrs-full_VehiclesMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComputerSoftwareMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComputerSoftwareMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfAssetsDomain" xlink:to="ifrs-full_ComputerSoftwareMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LandAndBuildingsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LandAndBuildingsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfAssetsDomain" xlink:to="ifrs-full_LandAndBuildingsMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RightofuseAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:to="ifrs-full_RightofuseAssets" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdditionsToRightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdditionsToRightofuseAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:to="ifrs-full_AdditionsToRightofuseAssets" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsRightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsRightofuseAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsRightofuseAssets" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisposalsRightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisposalsRightofuseAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:to="ifrs-full_DisposalsRightofuseAssets" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:to="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_RightOfUseAssetLossOfControl" xlink:href="mlec-20250630.xsd#mlec_RightOfUseAssetLossOfControl"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:to="mlec_RightOfUseAssetLossOfControl" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BookValueAtTheBeginningOfThePeriod" xlink:href="mlec-20250630.xsd#mlec_BookValueAtTheBeginningOfThePeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:to="mlec_BookValueAtTheBeginningOfThePeriod" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DepreciationOfThePeriod" xlink:href="mlec-20250630.xsd#mlec_DepreciationOfThePeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:to="mlec_DepreciationOfThePeriod" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DisposalsDepreciation" xlink:href="mlec-20250630.xsd#mlec_DisposalsDepreciation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:to="mlec_DisposalsDepreciation" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ExchangeDifferencesDepreciation" xlink:href="mlec-20250630.xsd#mlec_ExchangeDifferencesDepreciation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:to="mlec_ExchangeDifferencesDepreciation" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_LossOfControlDepreciation" xlink:href="mlec-20250630.xsd#mlec_LossOfControlDepreciation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:to="mlec_LossOfControlDepreciation" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AccumulatedDepreciationAtTheEndOfThePeriod" xlink:href="mlec-20250630.xsd#mlec_AccumulatedDepreciationAtTheEndOfThePeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:to="mlec_AccumulatedDepreciationAtTheEndOfThePeriod" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:to="ifrs-full_OtherPropertyPlantAndEquipment" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_LeaseLiabilityBeginningOfTheYearinception" xlink:href="mlec-20250630.xsd#mlec_LeaseLiabilityBeginningOfTheYearinception"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:to="mlec_LeaseLiabilityBeginningOfTheYearinception" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_LeaseLiabiltyAdditionsOfTheYear" xlink:href="mlec-20250630.xsd#mlec_LeaseLiabiltyAdditionsOfTheYear"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:to="mlec_LeaseLiabiltyAdditionsOfTheYear" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AdditionsToLeaseLiabilityFromBusinessCombination" xlink:href="mlec-20250630.xsd#mlec_AdditionsToLeaseLiabilityFromBusinessCombination"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:to="mlec_AdditionsToLeaseLiabilityFromBusinessCombination" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_LeaseLiabilitiesInterestExpenseExchangeDifferencesAndInflationEffects" xlink:href="mlec-20250630.xsd#mlec_LeaseLiabilitiesInterestExpenseExchangeDifferencesAndInflationEffects"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:to="mlec_LeaseLiabilitiesInterestExpenseExchangeDifferencesAndInflationEffects" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PaymentsOfThePeriodLeaseliability" xlink:href="mlec-20250630.xsd#mlec_PaymentsOfThePeriodLeaseliability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:to="mlec_PaymentsOfThePeriodLeaseliability" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_LossOfControlLeaseLiability" xlink:href="mlec-20250630.xsd#mlec_LossOfControlLeaseLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:to="mlec_LossOfControlLeaseLiability" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_TotalLeaseLiabilities" xlink:href="mlec-20250630.xsd#mlec_TotalLeaseLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:to="mlec_TotalLeaseLiabilities" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLeaseLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:to="ifrs-full_CurrentLeaseLiabilities" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:to="ifrs-full_NoncurrentLeaseLiabilities" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:to="ifrs-full_LeaseLiabilities" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Machinery" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Machinery"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:to="ifrs-full_Machinery" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Vehicles" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Vehicles"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:to="ifrs-full_Vehicles" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComputerSoftware" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComputerSoftware"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:to="ifrs-full_ComputerSoftware" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LandAndBuildings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LandAndBuildings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:to="ifrs-full_LandAndBuildings" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill" order="27" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofTransactionsBetweentheGroupandRelatedPartiesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareholdersandOtherRelatedPartiesBalancesandTransactionsScheduleofTransactionsBetweentheGroupandRelatedPartiesDetailsTable" xlink:href="mlec-20250630.xsd#mlec_ShareholdersandOtherRelatedPartiesBalancesandTransactionsScheduleofTransactionsBetweentheGroupandRelatedPartiesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="mlec_ShareholdersandOtherRelatedPartiesBalancesandTransactionsScheduleofTransactionsBetweentheGroupandRelatedPartiesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_ShareholdersandOtherRelatedPartiesBalancesandTransactionsScheduleofTransactionsBetweentheGroupandRelatedPartiesDetailsTable" xlink:to="ifrs-full_ClassesOfFinancialInstrumentsAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="ifrs-full_ClassesOfFinancialInstrumentsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="ifrs-full_ClassesOfFinancialInstrumentsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_ShareholdersandOtherRelatedPartiesBalancesandTransactionsScheduleofTransactionsBetweentheGroupandRelatedPartiesDetailsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SalesOfGoodsAndServicesMember" xlink:href="mlec-20250630.xsd#mlec_SalesOfGoodsAndServicesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:to="mlec_SalesOfGoodsAndServicesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PurchasesOfGoodsAndServicesMember" xlink:href="mlec-20250630.xsd#mlec_PurchasesOfGoodsAndServicesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:to="mlec_PurchasesOfGoodsAndServicesMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_NetLoansGrantedMember" xlink:href="mlec-20250630.xsd#mlec_NetLoansGrantedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:to="mlec_NetLoansGrantedMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_InterestGainMember" xlink:href="mlec-20250630.xsd#mlec_InterestGainMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:to="mlec_InterestGainMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_NetLoansReceivedMember" xlink:href="mlec-20250630.xsd#mlec_NetLoansReceivedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:to="mlec_NetLoansReceivedMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PuttableInstrumentsMember" xlink:href="mlec-20250630.xsd#mlec_PuttableInstrumentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:to="mlec_PuttableInstrumentsMember" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_NetLoansGrantedOneMember" xlink:href="mlec-20250630.xsd#mlec_NetLoansGrantedOneMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:to="mlec_NetLoansGrantedOneMember" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PreferenceShareMember" xlink:href="mlec-20250630.xsd#mlec_PreferenceShareMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:to="mlec_PreferenceShareMember" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_InterestExpensesMember" xlink:href="mlec-20250630.xsd#mlec_InterestExpensesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:to="mlec_InterestExpensesMember" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_OwnSharesHeldBySubsidiariesMember" xlink:href="mlec-20250630.xsd#mlec_OwnSharesHeldBySubsidiariesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:to="mlec_OwnSharesHeldBySubsidiariesMember" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_InKindContributionsMember" xlink:href="mlec-20250630.xsd#mlec_InKindContributionsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:to="mlec_InKindContributionsMember" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SalariesSocialSecurityBenefitsAndOtherBenefitsMember" xlink:href="mlec-20250630.xsd#mlec_SalariesSocialSecurityBenefitsAndOtherBenefitsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:to="mlec_SalariesSocialSecurityBenefitsAndOtherBenefitsMember" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SalesAndServicesMember" xlink:href="mlec-20250630.xsd#mlec_SalesAndServicesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:to="mlec_SalesAndServicesMember" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_StockOptionsAndShareBasedIncentivesMember" xlink:href="mlec-20250630.xsd#mlec_StockOptionsAndShareBasedIncentivesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:to="mlec_StockOptionsAndShareBasedIncentivesMember" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_TradeDebtorsMember" xlink:href="mlec-20250630.xsd#mlec_TradeDebtorsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:to="mlec_TradeDebtorsMember" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherReceivablesMember" xlink:href="mlec-20250630.xsd#mlec_OtherReceivablesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:to="mlec_OtherReceivablesMember" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_LoansReceivablesMember" xlink:href="mlec-20250630.xsd#mlec_LoansReceivablesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:to="mlec_LoansReceivablesMember" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_TradeCreditorsMember" xlink:href="mlec-20250630.xsd#mlec_TradeCreditorsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:to="mlec_TradeCreditorsMember" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ConvertibleNotesMember" xlink:href="mlec-20250630.xsd#mlec_ConvertibleNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:to="mlec_ConvertibleNotesMember" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_NetLoansPayablesMember" xlink:href="mlec-20250630.xsd#mlec_NetLoansPayablesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:to="mlec_NetLoansPayablesMember" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_WarrantesMember" xlink:href="mlec-20250630.xsd#mlec_WarrantesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:to="mlec_WarrantesMember" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_JointVenturesWhereEntityIsVenturerMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_JointVenturesWhereEntityIsVenturerMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:to="ifrs-full_JointVenturesWhereEntityIsVenturerMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherRelatedPartiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherRelatedPartiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:to="ifrs-full_OtherRelatedPartiesMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_KeyManagementPersonnelOfEntityOrParentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:to="ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ValueOfTransactionsForThePeriodEnded" xlink:href="mlec-20250630.xsd#mlec_ValueOfTransactionsForThePeriodEnded"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="mlec_ValueOfTransactionsForThePeriodEnded" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherReceivablesDueFromRelatedParties" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherReceivablesDueFromRelatedParties"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="ifrs-full_TradeAndOtherReceivablesDueFromRelatedParties" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherPayablesToRelatedParties" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherPayablesToRelatedParties"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="ifrs-full_TradeAndOtherPayablesToRelatedParties" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofCompensationofKeyManagementPersonnelCompensationTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfCompensationOfKeyManagementPersonnelCompensationAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfCompensationOfKeyManagementPersonnelCompensationAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfCompensationOfKeyManagementPersonnelCompensationAbstract" xlink:to="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfCompensationOfKeyManagementPersonnelCompensationAbstract" xlink:to="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_KeyManagementPersonnelCompensation" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfCompensationOfKeyManagementPersonnelCompensationAbstract" xlink:to="ifrs-full_KeyManagementPersonnelCompensation" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofFairValueoftheStockOptionsattheGrantDateTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareBasedPaymentScheduleofFairValueoftheStockOptionsattheGrantDateDetailsTable" xlink:href="mlec-20250630.xsd#mlec_ShareBasedPaymentScheduleofFairValueoftheStockOptionsattheGrantDateDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="mlec_ShareBasedPaymentScheduleofFairValueoftheStockOptionsattheGrantDateDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_ShareBasedPaymentScheduleofFairValueoftheStockOptionsattheGrantDateDetailsTable" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_StandAloneStockOptionGrantMember" xlink:href="mlec-20250630.xsd#mlec_StandAloneStockOptionGrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:to="mlec_StandAloneStockOptionGrantMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_EmployeeStockOptionPlanMember" xlink:href="mlec-20250630.xsd#mlec_EmployeeStockOptionPlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:to="mlec_EmployeeStockOptionPlanMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PastShareOptionPlanMember" xlink:href="mlec-20250630.xsd#mlec_PastShareOptionPlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:to="mlec_PastShareOptionPlanMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShareOptionsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShareOptionsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:to="ifrs-full_ShareOptionsMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PerformanceShareOptionPlanMember" xlink:href="mlec-20250630.xsd#mlec_PerformanceShareOptionPlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:to="mlec_PerformanceShareOptionPlanMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_ExercisePriceShareOptionsGranted2019" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofRangeofAssumptionswhichhaveDeterminedTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareBasedPaymentScheduleofRangeofAssumptionswhichhaveDeterminedDetailsTable" xlink:href="mlec-20250630.xsd#mlec_ShareBasedPaymentScheduleofRangeofAssumptionswhichhaveDeterminedDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems" xlink:to="mlec_ShareBasedPaymentScheduleofRangeofAssumptionswhichhaveDeterminedDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_ShareBasedPaymentScheduleofRangeofAssumptionswhichhaveDeterminedDetailsTable" xlink:to="ifrs-full_RangeAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangeDomain" xlink:to="ifrs-full_BottomOfRangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangeDomain" xlink:to="ifrs-full_TopOfRangeMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems" xlink:to="ifrs-full_ExercisePriceShareOptionsGranted2019" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems" xlink:to="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems" xlink:to="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems" xlink:to="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems" xlink:to="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofOptionActivityandWeightedAverageExercisePriceTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareBasedPaymentScheduleofOptionActivityandWeightedAverageExercisePriceDetailsTable" xlink:href="mlec-20250630.xsd#mlec_ShareBasedPaymentScheduleofOptionActivityandWeightedAverageExercisePriceDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:to="mlec_ShareBasedPaymentScheduleofOptionActivityandWeightedAverageExercisePriceDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_ShareBasedPaymentScheduleofOptionActivityandWeightedAverageExercisePriceDetailsTable" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_OptionsIncentivePlanMember" xlink:href="mlec-20250630.xsd#mlec_OptionsIncentivePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:to="mlec_OptionsIncentivePlanMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfOutstandingShareOptions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:to="ifrs-full_NumberOfOutstandingShareOptions" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:to="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:to="ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:to="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:to="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" order="9" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ScheduleofWeightedAverageNumberofOrdinarySharesOutstandingTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_ReverseStockSplitAftertheReportingPeriodScheduleofWeightedAverageNumberofOrdinarySharesOutstandingDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_ReverseStockSplitAftertheReportingPeriodScheduleofWeightedAverageNumberofOrdinarySharesOutstandingDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_ReverseStockSplitAftertheReportingPeriodScheduleofWeightedAverageNumberofOrdinarySharesOutstandingDetailsTable" xlink:href="mlec-20250630.xsd#mlec_ReverseStockSplitAftertheReportingPeriodScheduleofWeightedAverageNumberofOrdinarySharesOutstandingDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_ReverseStockSplitAftertheReportingPeriodScheduleofWeightedAverageNumberofOrdinarySharesOutstandingDetailsLineItems" xlink:to="mlec_ReverseStockSplitAftertheReportingPeriodScheduleofWeightedAverageNumberofOrdinarySharesOutstandingDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_ReverseStockSplitAftertheReportingPeriodScheduleofWeightedAverageNumberofOrdinarySharesOutstandingDetailsTable" xlink:to="ifrs-full_ClassesOfShareCapitalAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ReverseStockSplitMember" xlink:href="mlec-20250630.xsd#mlec_ReverseStockSplitMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfShareCapitalDomain" xlink:to="mlec_ReverseStockSplitMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ReverseStockSplitAftertheReportingPeriodScheduleofWeightedAverageNumberofOrdinarySharesOutstandingDetailsLineItems" xlink:to="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ReverseStockSplitAftertheReportingPeriodScheduleofWeightedAverageNumberofOrdinarySharesOutstandingDetailsLineItems" xlink:to="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ReverseStockSplitAftertheReportingPeriodScheduleofWeightedAverageNumberofOrdinarySharesOutstandingDetailsLineItems" xlink:to="ifrs-full_WeightedAverageShares" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustedWeightedAverageShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustedWeightedAverageShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ReverseStockSplitAftertheReportingPeriodScheduleofWeightedAverageNumberofOrdinarySharesOutstandingDetailsLineItems" xlink:to="ifrs-full_AdjustedWeightedAverageShares" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BasicEarningsLossPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BasicEarningsLossPerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ReverseStockSplitAftertheReportingPeriodScheduleofWeightedAverageNumberofOrdinarySharesOutstandingDetailsLineItems" xlink:to="ifrs-full_BasicEarningsLossPerShare" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DilutedEarningsLossPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DilutedEarningsLossPerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ReverseStockSplitAftertheReportingPeriodScheduleofWeightedAverageNumberofOrdinarySharesOutstandingDetailsLineItems" xlink:to="ifrs-full_DilutedEarningsLossPerShare" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsScheduleofIntangibleAssetsandLiabilitiesAssumed" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfIntangibleAssetsAndLiabilitiesAssumedLineItems" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfIntangibleAssetsAndLiabilitiesAssumedLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofIntangibleAssetsandLiabilitiesAssumedDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofIntangibleAssetsandLiabilitiesAssumedDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_ScheduleOfIntangibleAssetsAndLiabilitiesAssumedLineItems" xlink:to="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofIntangibleAssetsandLiabilitiesAssumedDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofIntangibleAssetsandLiabilitiesAssumedDetailsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_RizobacterUGEMember" xlink:href="mlec-20250630.xsd#mlec_RizobacterUGEMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:to="mlec_RizobacterUGEMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ProFarmUGEMember" xlink:href="mlec-20250630.xsd#mlec_ProFarmUGEMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:to="mlec_ProFarmUGEMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfIntangibleAssetsAndLiabilitiesAssumedLineItems" xlink:to="ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PercentageOfWeightedAverageCostOfCapital" xlink:href="mlec-20250630.xsd#mlec_PercentageOfWeightedAverageCostOfCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfIntangibleAssetsAndLiabilitiesAssumedLineItems" xlink:to="mlec_PercentageOfWeightedAverageCostOfCapital" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PercentageOfRiskPremium" xlink:href="mlec-20250630.xsd#mlec_PercentageOfRiskPremium"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfIntangibleAssetsAndLiabilitiesAssumedLineItems" xlink:to="mlec_PercentageOfRiskPremium" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfIntangibleAssetsAndLiabilitiesAssumedLineItems" xlink:to="ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_TheGroupsBusinessReorganizationandGeneralInformationDetailsTable" xlink:href="mlec-20250630.xsd#mlec_TheGroupsBusinessReorganizationandGeneralInformationDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="mlec_TheGroupsBusinessReorganizationandGeneralInformationDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BusinessCombinationsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_TheGroupsBusinessReorganizationandGeneralInformationDetailsTable" xlink:to="ifrs-full_BusinessCombinationsAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BusinessCombinationsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_BusinessCombinationsAxis" xlink:to="ifrs-full_BusinessCombinationsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BusinessCombinationsDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_BusinessCombinationsAxis" xlink:to="ifrs-full_BusinessCombinationsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_TheGroupsBusinessReorganizationandGeneralInformationDetailsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfOrdinarySharesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfOrdinarySharesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_TheGroupsBusinessReorganizationandGeneralInformationDetailsTable" xlink:to="ifrs-full_ClassesOfOrdinarySharesAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfOrdinarySharesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfOrdinarySharesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfOrdinarySharesAxis" xlink:to="ifrs-full_ClassesOfOrdinarySharesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfOrdinarySharesDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfOrdinarySharesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfOrdinarySharesAxis" xlink:to="ifrs-full_ClassesOfOrdinarySharesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_TheGroupsBusinessReorganizationandGeneralInformationDetailsTable" xlink:to="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:to="ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:to="ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_TheGroupsBusinessReorganizationandGeneralInformationDetailsTable" xlink:to="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:to="ifrs-full_SignificantInvestmentsInSubsidiariesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:to="ifrs-full_SignificantInvestmentsInSubsidiariesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_TheGroupsBusinessReorganizationandGeneralInformationDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_OrdinarySharesOneMember" xlink:href="mlec-20250630.xsd#mlec_OrdinarySharesOneMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfOrdinarySharesDomain" xlink:to="mlec_OrdinarySharesOneMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_HoldbackMember" xlink:href="mlec-20250630.xsd#mlec_HoldbackMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BusinessCombinationsDomain" xlink:to="mlec_HoldbackMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SubsequentEventsMember" xlink:href="mlec-20250630.xsd#mlec_SubsequentEventsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:to="mlec_SubsequentEventsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresSAMember" xlink:href="mlec-20250630.xsd#mlec_BioceresSAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:to="mlec_BioceresSAMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresLLCMember" xlink:href="mlec-20250630.xsd#mlec_BioceresLLCMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:to="mlec_BioceresLLCMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresGroupLimitedMember" xlink:href="mlec-20250630.xsd#mlec_BioceresGroupLimitedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:to="mlec_BioceresGroupLimitedMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_GentleTechMember" xlink:href="mlec-20250630.xsd#mlec_GentleTechMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:to="mlec_GentleTechMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_MoolecScienceLuxembourgMember" xlink:href="mlec-20250630.xsd#mlec_MoolecScienceLuxembourgMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="mlec_MoolecScienceLuxembourgMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_MoolecScienceCaymanIslandsMember" xlink:href="mlec-20250630.xsd#mlec_MoolecScienceCaymanIslandsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="mlec_MoolecScienceCaymanIslandsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ReverseStockSplitConsolidationRatio" xlink:href="mlec-20250630.xsd#mlec_ReverseStockSplitConsolidationRatio"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="mlec_ReverseStockSplitConsolidationRatio" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_NumberOfSharesIssued" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ParValuePerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ParValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_ParValuePerShare" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_NumberOfSharesReverseStockSplit" xlink:href="mlec-20250630.xsd#mlec_NumberOfSharesReverseStockSplit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="mlec_NumberOfSharesReverseStockSplit" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PercentageOfIssuedAndOutstandingEquityInterests" xlink:href="mlec-20250630.xsd#mlec_PercentageOfIssuedAndOutstandingEquityInterests"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="mlec_PercentageOfIssuedAndOutstandingEquityInterests" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ConsiderationForIssuedOrdinaryShareValue" xlink:href="mlec-20250630.xsd#mlec_ConsiderationForIssuedOrdinaryShareValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="mlec_ConsiderationForIssuedOrdinaryShareValue" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PrivateWarrantsShares" xlink:href="mlec-20250630.xsd#mlec_PrivateWarrantsShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="mlec_PrivateWarrantsShares" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PrivateWarrantsExercisePrice" xlink:href="mlec-20250630.xsd#mlec_PrivateWarrantsExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="mlec_PrivateWarrantsExercisePrice" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AdditionalOrdinarySharesIssue" xlink:href="mlec-20250630.xsd#mlec_AdditionalOrdinarySharesIssue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="mlec_AdditionalOrdinarySharesIssue" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_PercentageOfVotingEquityInterestsAcquired" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_NumberOfSharesOutstandingPercentage" xlink:href="mlec-20250630.xsd#mlec_NumberOfSharesOutstandingPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="mlec_NumberOfSharesOutstandingPercentage" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProportionOfVotingPowerHeldInSubsidiary" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProportionOfVotingPowerHeldInSubsidiary"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_ProportionOfVotingPowerHeldInSubsidiary" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Borrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Borrowings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_Borrowings" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinanceCosts" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_FinanceCosts" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_NumberOfSharesPledged" xlink:href="mlec-20250630.xsd#mlec_NumberOfSharesPledged"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="mlec_NumberOfSharesPledged" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentDebtInstrumentsIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentDebtInstrumentsIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_CurrentDebtInstrumentsIssued" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_WorkingCapital" xlink:href="mlec-20250630.xsd#mlec_WorkingCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="mlec_WorkingCapital" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_Equity" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossFromOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_ProfitLossFromOperatingActivities" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_GainlossOfRecognitionTransactions" xlink:href="mlec-20250630.xsd#mlec_GainlossOfRecognitionTransactions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="mlec_GainlossOfRecognitionTransactions" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_GainlossOfDerecognitionTransactions" xlink:href="mlec-20250630.xsd#mlec_GainlossOfDerecognitionTransactions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="mlec_GainlossOfDerecognitionTransactions" order="21" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_AccountingStandardsandBasisofPreparationDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_AccountingStandardsandBasisofPreparationDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_AccountingStandardsandBasisofPreparationDetailsTable" xlink:href="mlec-20250630.xsd#mlec_AccountingStandardsandBasisofPreparationDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_AccountingStandardsandBasisofPreparationDetailsLineItems" xlink:to="mlec_AccountingStandardsandBasisofPreparationDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_AccountingStandardsandBasisofPreparationDetailsTable" xlink:to="ifrs-full_ClassesOfShareCapitalAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_AccountingStandardsandBasisofPreparationDetailsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_AccountingStandardsandBasisofPreparationDetailsTable" xlink:to="ifrs-full_RangeAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresGroupLimitedMember" xlink:href="mlec-20250630.xsd#mlec_BioceresGroupLimitedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:to="mlec_BioceresGroupLimitedMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BusinessCombinationMember" xlink:href="mlec-20250630.xsd#mlec_BusinessCombinationMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:to="mlec_BusinessCombinationMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangeDomain" xlink:to="ifrs-full_TopOfRangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangeDomain" xlink:to="ifrs-full_BottomOfRangeMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OrdinarySharesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OrdinarySharesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfShareCapitalDomain" xlink:to="ifrs-full_OrdinarySharesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ShorttermPeriod" xlink:href="mlec-20250630.xsd#mlec_ShorttermPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_AccountingStandardsandBasisofPreparationDetailsLineItems" xlink:to="mlec_ShorttermPeriod" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_CumulativeInflationRate" xlink:href="mlec-20250630.xsd#mlec_CumulativeInflationRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_AccountingStandardsandBasisofPreparationDetailsLineItems" xlink:to="mlec_CumulativeInflationRate" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_InflationOfAccumulatedYears" xlink:href="mlec-20250630.xsd#mlec_InflationOfAccumulatedYears"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_AccountingStandardsandBasisofPreparationDetailsLineItems" xlink:to="mlec_InflationOfAccumulatedYears" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PercentageOfInflationAccumulated" xlink:href="mlec-20250630.xsd#mlec_PercentageOfInflationAccumulated"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_AccountingStandardsandBasisofPreparationDetailsLineItems" xlink:to="mlec_PercentageOfInflationAccumulated" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ArgentinePriceIndexShares" xlink:href="mlec-20250630.xsd#mlec_ArgentinePriceIndexShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_AccountingStandardsandBasisofPreparationDetailsLineItems" xlink:to="mlec_ArgentinePriceIndexShares" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PercentageOfIssuedAndOutstandingEquityInterests" xlink:href="mlec-20250630.xsd#mlec_PercentageOfIssuedAndOutstandingEquityInterests"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_AccountingStandardsandBasisofPreparationDetailsLineItems" xlink:to="mlec_PercentageOfIssuedAndOutstandingEquityInterests" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ConsiderationForIssuedOrdinaryShareValue" xlink:href="mlec-20250630.xsd#mlec_ConsiderationForIssuedOrdinaryShareValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_AccountingStandardsandBasisofPreparationDetailsLineItems" xlink:to="mlec_ConsiderationForIssuedOrdinaryShareValue" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PrivateWarrantShares" xlink:href="mlec-20250630.xsd#mlec_PrivateWarrantShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_AccountingStandardsandBasisofPreparationDetailsLineItems" xlink:to="mlec_PrivateWarrantShares" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_AccountingStandardsandBasisofPreparationDetailsLineItems" xlink:to="ifrs-full_NumberOfSharesIssued" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PrivateWarrantsExercisePrice" xlink:href="mlec-20250630.xsd#mlec_PrivateWarrantsExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_AccountingStandardsandBasisofPreparationDetailsLineItems" xlink:to="mlec_PrivateWarrantsExercisePrice" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PercentageOfShare" xlink:href="mlec-20250630.xsd#mlec_PercentageOfShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_AccountingStandardsandBasisofPreparationDetailsLineItems" xlink:to="mlec_PercentageOfShare" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuedCapitalOrdinaryShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapitalOrdinaryShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_AccountingStandardsandBasisofPreparationDetailsLineItems" xlink:to="ifrs-full_IssuedCapitalOrdinaryShares" order="11" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/NewStandardsAmendmentsandInterpretationsIssuedbytheIASBDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_NewStandardsAmendmentsandInterpretationsIssuedbytheIASBDetailsTable" xlink:href="mlec-20250630.xsd#mlec_NewStandardsAmendmentsandInterpretationsIssuedbytheIASBDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems" xlink:to="mlec_NewStandardsAmendmentsandInterpretationsIssuedbytheIASBDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InitiallyAppliedIFRSsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InitiallyAppliedIFRSsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_NewStandardsAmendmentsandInterpretationsIssuedbytheIASBDetailsTable" xlink:to="ifrs-full_InitiallyAppliedIFRSsAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InitiallyAppliedIFRSsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InitiallyAppliedIFRSsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_InitiallyAppliedIFRSsAxis" xlink:to="ifrs-full_InitiallyAppliedIFRSsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InitiallyAppliedIFRSsDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InitiallyAppliedIFRSsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_InitiallyAppliedIFRSsAxis" xlink:to="ifrs-full_InitiallyAppliedIFRSsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LeaseLiabilityInASaleAndLeasebackMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseLiabilityInASaleAndLeasebackMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_InitiallyAppliedIFRSsDomain" xlink:to="ifrs-full_LeaseLiabilityInASaleAndLeasebackMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLiabilitiesWithCovenantsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLiabilitiesWithCovenantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_InitiallyAppliedIFRSsDomain" xlink:to="ifrs-full_NoncurrentLiabilitiesWithCovenantsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionWhetherChangeInAccountingPolicyIsMadeInAccordanceWithTransitionalProvisionsOfInitiallyAppliedIFRS" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionWhetherChangeInAccountingPolicyIsMadeInAccordanceWithTransitionalProvisionsOfInitiallyAppliedIFRS"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems" xlink:to="ifrs-full_DescriptionWhetherChangeInAccountingPolicyIsMadeInAccordanceWithTransitionalProvisionsOfInitiallyAppliedIFRS" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TitleOfInitiallyAppliedIFRS" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TitleOfInitiallyAppliedIFRS"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems" xlink:to="ifrs-full_TitleOfInitiallyAppliedIFRS" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:href="mlec-20250630.xsd#mlec_SummaryofSignificantAccountingPoliciesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="mlec_SummaryofSignificantAccountingPoliciesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="srt_RangeAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="ifrs-full_RangeAxis" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherPropertyPlantAndEquipmentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherPropertyPlantAndEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:to="ifrs-full_OtherPropertyPlantAndEquipmentMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OfficeEquipmentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OfficeEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:to="ifrs-full_OfficeEquipmentMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_VehiclesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_VehiclesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:to="ifrs-full_VehiclesMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComputerEquipmentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComputerEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:to="ifrs-full_ComputerEquipmentMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FixturesAndFittingsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FixturesAndFittingsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:to="ifrs-full_FixturesAndFittingsMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_IfrsFull_machineryAndEquipmentMember" xlink:href="mlec-20250630.xsd#mlec_IfrsFull_machineryAndEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:to="mlec_IfrsFull_machineryAndEquipmentMember" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BuildingsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BuildingsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:to="ifrs-full_BuildingsMember" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangeDomain" xlink:to="ifrs-full_BottomOfRangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangeDomain" xlink:to="ifrs-full_TopOfRangeMember" order="1" xbrldt:closed="true"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="ifrs-full_BottomOfRangeMember" order="0" xbrldt:closed="true"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="ifrs-full_TopOfRangeMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComputerSoftwareMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComputerSoftwareMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="ifrs-full_ComputerSoftwareMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LicencesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LicencesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="ifrs-full_LicencesMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherIntangibleAssetsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherIntangibleAssetsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="ifrs-full_OtherIntangibleAssetsMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BrandNamesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BrandNamesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="ifrs-full_BrandNamesMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CustomerrelatedIntangibleAssetsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CustomerrelatedIntangibleAssetsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="ifrs-full_CustomerrelatedIntangibleAssetsMember" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeBiologicalAssetsAtCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeBiologicalAssetsAtCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeBiologicalAssetsAtCost" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ValuationSignificantChangePercentageOfConstructionCosts" xlink:href="mlec-20250630.xsd#mlec_ValuationSignificantChangePercentageOfConstructionCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="mlec_ValuationSignificantChangePercentageOfConstructionCosts" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ValuationSignificantChangeInAmountNormalWearAndTearVariationImpactOnRevaluationAmount" xlink:href="mlec-20250630.xsd#mlec_ValuationSignificantChangeInAmountNormalWearAndTearVariationImpactOnRevaluationAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="mlec_ValuationSignificantChangeInAmountNormalWearAndTearVariationImpactOnRevaluationAmount" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AveragePaymentTermBySales" xlink:href="mlec-20250630.xsd#mlec_AveragePaymentTermBySales"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="mlec_AveragePaymentTermBySales" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/AcquisitionsandOtherSignificantTransactionsDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_AcquisitionsandOtherSignificantTransactionsDetailsTable" xlink:href="mlec-20250630.xsd#mlec_AcquisitionsandOtherSignificantTransactionsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:to="mlec_AcquisitionsandOtherSignificantTransactionsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_AcquisitionsandOtherSignificantTransactionsDetailsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BusinessCombinationsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_AcquisitionsandOtherSignificantTransactionsDetailsTable" xlink:to="ifrs-full_BusinessCombinationsAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BusinessCombinationsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_BusinessCombinationsAxis" xlink:to="ifrs-full_BusinessCombinationsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BusinessCombinationsDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_BusinessCombinationsAxis" xlink:to="ifrs-full_BusinessCombinationsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ProFarmGroupIncMember" xlink:href="mlec-20250630.xsd#mlec_ProFarmGroupIncMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BusinessCombinationsDomain" xlink:to="mlec_ProFarmGroupIncMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_NatalAgroSRLMember" xlink:href="mlec-20250630.xsd#mlec_NatalAgroSRLMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BusinessCombinationsDomain" xlink:to="mlec_NatalAgroSRLMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresGroupLimitedMember" xlink:href="mlec-20250630.xsd#mlec_BioceresGroupLimitedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:to="mlec_BioceresGroupLimitedMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:to="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueOfCombinedEntity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueOfCombinedEntity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:to="ifrs-full_RevenueOfCombinedEntity" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossOfCombinedEntity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossOfCombinedEntity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:to="ifrs-full_ProfitLossOfCombinedEntity" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_NumberOfSharesAcquiredInBusinessCombination" xlink:href="mlec-20250630.xsd#mlec_NumberOfSharesAcquiredInBusinessCombination"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:to="mlec_NumberOfSharesAcquiredInBusinessCombination" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ParValuePerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ParValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:to="ifrs-full_ParValuePerShare" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:to="ifrs-full_PercentageOfVotingEquityInterestsAcquired" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashTransferred" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashTransferred"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:to="ifrs-full_CashTransferred" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShorttermBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShorttermBorrowings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:to="ifrs-full_ShorttermBorrowings" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PercentageOfCustomerRevenues" xlink:href="mlec-20250630.xsd#mlec_PercentageOfCustomerRevenues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:to="mlec_PercentageOfCustomerRevenues" order="8" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsTable" xlink:to="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:to="ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:to="ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MaturityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsTable" xlink:to="ifrs-full_MaturityAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MaturityDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_MaturityDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MaturityDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_MaturityDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsTable" xlink:to="ifrs-full_RangeAxis" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsTable" xlink:to="ifrs-full_BorrowingsByNameAxis" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="ifrs-full_BorrowingsByNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="ifrs-full_BorrowingsByNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresGroupMember" xlink:href="mlec-20250630.xsd#mlec_BioceresGroupMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:to="mlec_BioceresGroupMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangeDomain" xlink:to="ifrs-full_BottomOfRangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangeDomain" xlink:to="ifrs-full_TopOfRangeMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_FortyEightMonthsMember" xlink:href="mlec-20250630.xsd#mlec_FortyEightMonthsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_MaturityDomain" xlink:to="mlec_FortyEightMonthsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_MaturityDomain" xlink:to="ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_MaturityDomain" xlink:to="ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SecuredGuaranteedNotesDue2026Member" xlink:href="mlec-20250630.xsd#mlec_SecuredGuaranteedNotesDue2026Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BorrowingsByNameDomain" xlink:to="mlec_SecuredGuaranteedNotesDue2026Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SecuredConvertibleGuaranteedNotesMember" xlink:href="mlec-20250630.xsd#mlec_SecuredConvertibleGuaranteedNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BorrowingsByNameDomain" xlink:to="mlec_SecuredConvertibleGuaranteedNotesMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SubsequentEventsMember" xlink:href="mlec-20250630.xsd#mlec_SubsequentEventsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:to="mlec_SubsequentEventsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryOtherProvisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryOtherProvisions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryOtherProvisions" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ProjectedPeriodRange" xlink:href="mlec-20250630.xsd#mlec_ProjectedPeriodRange"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="mlec_ProjectedPeriodRange" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EstimatedFinancialEffectOfContingentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EstimatedFinancialEffectOfContingentAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="ifrs-full_EstimatedFinancialEffectOfContingentAssets" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_InventoryRecognizedAsExpense" xlink:href="mlec-20250630.xsd#mlec_InventoryRecognizedAsExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="mlec_InventoryRecognizedAsExpense" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="ifrs-full_NumberOfSharesIssued" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuedCapitalPreferenceShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapitalPreferenceShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="ifrs-full_IssuedCapitalPreferenceShares" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PercentageOfPreferenceSharesAccrue" xlink:href="mlec-20250630.xsd#mlec_PercentageOfPreferenceSharesAccrue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="mlec_PercentageOfPreferenceSharesAccrue" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AggregateAmount" xlink:href="mlec-20250630.xsd#mlec_AggregateAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="mlec_AggregateAmount" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DebtInstrumentsHeldAtAmortisedCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DebtInstrumentsHeldAtAmortisedCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="ifrs-full_DebtInstrumentsHeldAtAmortisedCost" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_CreditorsPublicAuctionShares" xlink:href="mlec-20250630.xsd#mlec_CreditorsPublicAuctionShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="mlec_CreditorsPublicAuctionShares" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentDebtInstrumentsIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentDebtInstrumentsIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="ifrs-full_CurrentDebtInstrumentsIssued" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsInterestRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsInterestRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="ifrs-full_BorrowingsInterestRate" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_IfrsDebtInstrumentTerm" xlink:href="mlec-20250630.xsd#mlec_IfrsDebtInstrumentTerm"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="mlec_IfrsDebtInstrumentTerm" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Borrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Borrowings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="ifrs-full_Borrowings" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AmortizationPayments" xlink:href="mlec-20250630.xsd#mlec_AmortizationPayments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="mlec_AmortizationPayments" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PercentageOfPrepaymentPremium" xlink:href="mlec-20250630.xsd#mlec_PercentageOfPrepaymentPremium"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="mlec_PercentageOfPrepaymentPremium" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PercentageOfPenalty" xlink:href="mlec-20250630.xsd#mlec_PercentageOfPenalty"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="mlec_PercentageOfPenalty" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NotionalAmount" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NotionalAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="ifrs-full_NotionalAmount" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BorrowingInterestRateInCash" xlink:href="mlec-20250630.xsd#mlec_BorrowingInterestRateInCash"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="mlec_BorrowingInterestRateInCash" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BorrowingInterestRateInKind" xlink:href="mlec-20250630.xsd#mlec_BorrowingInterestRateInKind"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="mlec_BorrowingInterestRateInKind" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_StrikePriceForConversionOfDebt" xlink:href="mlec-20250630.xsd#mlec_StrikePriceForConversionOfDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="mlec_StrikePriceForConversionOfDebt" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_VoluntaryRepurchaseOfNotesAfterIssueDate" xlink:href="mlec-20250630.xsd#mlec_VoluntaryRepurchaseOfNotesAfterIssueDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="mlec_VoluntaryRepurchaseOfNotesAfterIssueDate" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsMaturity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsMaturity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="ifrs-full_BorrowingsMaturity" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PricePerSharesOfStrikePrice" xlink:href="mlec-20250630.xsd#mlec_PricePerSharesOfStrikePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="mlec_PricePerSharesOfStrikePrice" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_CommonEquity" xlink:href="mlec-20250630.xsd#mlec_CommonEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="mlec_CommonEquity" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PercentageOfPenaltyOfPrepayment" xlink:href="mlec-20250630.xsd#mlec_PercentageOfPenaltyOfPrepayment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="mlec_PercentageOfPenaltyOfPrepayment" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DiscountRateForFairValueOfLiabilityComponent" xlink:href="mlec-20250630.xsd#mlec_DiscountRateForFairValueOfLiabilityComponent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="mlec_DiscountRateForFairValueOfLiabilityComponent" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PrepaymentPremiumFee" xlink:href="mlec-20250630.xsd#mlec_PrepaymentPremiumFee"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="mlec_PrepaymentPremiumFee" order="27" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LoansReceived" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LoansReceived"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="ifrs-full_LoansReceived" order="28" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AdditionalConvertibleNotesReceivedAmount" xlink:href="mlec-20250630.xsd#mlec_AdditionalConvertibleNotesReceivedAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="mlec_AdditionalConvertibleNotesReceivedAmount" order="29" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ConversionOptionStrikePrice" xlink:href="mlec-20250630.xsd#mlec_ConversionOptionStrikePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="mlec_ConversionOptionStrikePrice" order="30" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PercentageOfOutstandingAmountInitialInterestRate" xlink:href="mlec-20250630.xsd#mlec_PercentageOfOutstandingAmountInitialInterestRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="mlec_PercentageOfOutstandingAmountInitialInterestRate" order="31" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PercentageOfCashPaymentInterestRate" xlink:href="mlec-20250630.xsd#mlec_PercentageOfCashPaymentInterestRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="mlec_PercentageOfCashPaymentInterestRate" order="32" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ContingentPayment" xlink:href="mlec-20250630.xsd#mlec_ContingentPayment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="mlec_ContingentPayment" order="33" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ContingentPaymentCurrent" xlink:href="mlec-20250630.xsd#mlec_ContingentPaymentCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="mlec_ContingentPaymentCurrent" order="34" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PercentageOfCapital" xlink:href="mlec-20250630.xsd#mlec_PercentageOfCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="mlec_PercentageOfCapital" order="35" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PercentageOfDividendsTaxedShares" xlink:href="mlec-20250630.xsd#mlec_PercentageOfDividendsTaxedShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="mlec_PercentageOfDividendsTaxedShares" order="36" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ContingentPurchasePrice" xlink:href="mlec-20250630.xsd#mlec_ContingentPurchasePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="mlec_ContingentPurchasePrice" order="37" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_InformationAboutComponentOfConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentOfConsolidatedStatementsOfComprehensiveIncomeLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_InformationAboutComponentOfConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeDetailsTable" xlink:to="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:to="ifrs-full_SignificantInvestmentsInSubsidiariesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:to="ifrs-full_SignificantInvestmentsInSubsidiariesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_NetWheatTechnologyLicensingMember" xlink:href="mlec-20250630.xsd#mlec_NetWheatTechnologyLicensingMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:to="mlec_NetWheatTechnologyLicensingMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_NetHB4SoybeanMember" xlink:href="mlec-20250630.xsd#mlec_NetHB4SoybeanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:to="mlec_NetHB4SoybeanMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashTransferred" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashTransferred"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentOfConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="ifrs-full_CashTransferred" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PercentageOfEntitysRevenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PercentageOfEntitysRevenue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentOfConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="ifrs-full_PercentageOfEntitysRevenue" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueOfAcquiree" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueOfAcquiree"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentOfConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="ifrs-full_RevenueOfAcquiree" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentOfConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherTangibleOrIntangibleAssetsTransferred" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherTangibleOrIntangibleAssetsTransferred"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationAboutComponentOfConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="ifrs-full_OtherTangibleOrIntangibleAssetsTransferred" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/TaxationDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="ifrs-full_TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/InformationaboutComponentsofEquityDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_InformationaboutComponentsofEquityDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_InformationaboutComponentsofEquityDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationaboutComponentsofEquityDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationaboutComponentsofEquityDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_InformationaboutComponentsofEquityDetailsLineItems" xlink:to="mlec_InformationaboutComponentsofEquityDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_InformationaboutComponentsofEquityDetailsTable" xlink:to="ifrs-full_ClassesOfShareCapitalAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OrdinarySharesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OrdinarySharesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfShareCapitalDomain" xlink:to="ifrs-full_OrdinarySharesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_VotePerShare" xlink:href="mlec-20250630.xsd#mlec_VotePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityDetailsLineItems" xlink:to="mlec_VotePerShare" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_InformationaboutComponentsofEquityDetailsLineItems" xlink:to="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/JointVenturesandAssociatesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfJointVenturesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfJointVenturesLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_JointVenturesandAssociatesDetailsTable" xlink:href="mlec-20250630.xsd#mlec_JointVenturesandAssociatesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfJointVenturesLineItems" xlink:to="mlec_JointVenturesandAssociatesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_JointVenturesandAssociatesDetailsTable" xlink:to="srt_StatementGeographicalAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_AR" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_AR"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_AR" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PercentageOfProfitForObligationToLegalReserve" xlink:href="mlec-20250630.xsd#mlec_PercentageOfProfitForObligationToLegalReserve"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfJointVenturesLineItems" xlink:to="mlec_PercentageOfProfitForObligationToLegalReserve" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_MaximumPercentageOfCapitalForObligationToLegalReserve" xlink:href="mlec-20250630.xsd#mlec_MaximumPercentageOfCapitalForObligationToLegalReserve"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfJointVenturesLineItems" xlink:to="mlec_MaximumPercentageOfCapitalForObligationToLegalReserve" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/SegmentInformationDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract"/>
    <loc xlink:type="locator" xlink:label="mlec_NumberOfComplementaryComponents" xlink:href="mlec-20250630.xsd#mlec_NumberOfComplementaryComponents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:to="mlec_NumberOfComplementaryComponents" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/FinancialInstrumentsRiskManagementDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_FinancialInstrumentsRiskManagementAbstract" xlink:href="mlec-20250630.xsd#mlec_FinancialInstrumentsRiskManagementAbstract"/>
    <loc xlink:type="locator" xlink:label="mlec_PercentageOfEstimatesThatDevaluationOrAnAppreciation" xlink:href="mlec-20250630.xsd#mlec_PercentageOfEstimatesThatDevaluationOrAnAppreciation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_FinancialInstrumentsRiskManagementAbstract" xlink:to="mlec_PercentageOfEstimatesThatDevaluationOrAnAppreciation" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ShareBasedPaymentDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareBasedPaymentDetailsTable" xlink:href="mlec-20250630.xsd#mlec_ShareBasedPaymentDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="mlec_ShareBasedPaymentDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_ShareBasedPaymentDetailsTable" xlink:to="ifrs-full_ClassesOfFinancialInstrumentsAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="ifrs-full_ClassesOfFinancialInstrumentsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="ifrs-full_ClassesOfFinancialInstrumentsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BusinessCombinationsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_ShareBasedPaymentDetailsTable" xlink:to="ifrs-full_BusinessCombinationsAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BusinessCombinationsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_BusinessCombinationsAxis" xlink:to="ifrs-full_BusinessCombinationsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BusinessCombinationsDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_BusinessCombinationsAxis" xlink:to="ifrs-full_BusinessCombinationsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_ShareBasedPaymentDetailsTable" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_ShareBasedPaymentDetailsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_ShareBasedPaymentDetailsTable" xlink:to="ifrs-full_RangeAxis" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_ShareBasedPaymentDetailsTable" xlink:to="srt_StatementScenarioAxis" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_VolumeWeightedAveragePriceMember" xlink:href="mlec-20250630.xsd#mlec_VolumeWeightedAveragePriceMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:to="mlec_VolumeWeightedAveragePriceMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_EmployeeStockPurchasePlanMember" xlink:href="mlec-20250630.xsd#mlec_EmployeeStockPurchasePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:to="mlec_EmployeeStockPurchasePlanMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_StandAloneStockOptionGrantMember" xlink:href="mlec-20250630.xsd#mlec_StandAloneStockOptionGrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:to="mlec_StandAloneStockOptionGrantMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_EmployeeStockOptionPlanMember" xlink:href="mlec-20250630.xsd#mlec_EmployeeStockOptionPlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:to="mlec_EmployeeStockOptionPlanMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PastShareOptionPlanMember" xlink:href="mlec-20250630.xsd#mlec_PastShareOptionPlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:to="mlec_PastShareOptionPlanMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShareOptionsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShareOptionsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:to="ifrs-full_ShareOptionsMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PerformanceShareOptionPlanMember" xlink:href="mlec-20250630.xsd#mlec_PerformanceShareOptionPlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:to="mlec_PerformanceShareOptionPlanMember" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_StockIncentivePlan2013Member" xlink:href="mlec-20250630.xsd#mlec_StockIncentivePlan2013Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:to="mlec_StockIncentivePlan2013Member" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangeDomain" xlink:to="ifrs-full_BottomOfRangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangeDomain" xlink:to="ifrs-full_TopOfRangeMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ProFarmGroupIncMember" xlink:href="mlec-20250630.xsd#mlec_ProFarmGroupIncMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BusinessCombinationsDomain" xlink:to="mlec_ProFarmGroupIncMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresCropSolutionsCorpMember" xlink:href="mlec-20250630.xsd#mlec_BioceresCropSolutionsCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:to="mlec_BioceresCropSolutionsCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_EBITDAMember" xlink:href="mlec-20250630.xsd#mlec_EBITDAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="mlec_EBITDAMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareBasedPaymentsIncentiveIncreases" xlink:href="mlec-20250630.xsd#mlec_ShareBasedPaymentsIncentiveIncreases"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="mlec_ShareBasedPaymentsIncentiveIncreases" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_IfrsDefinedContributionPlanEmployerMatchingContributionPercentOfEmployeesGrossPay" xlink:href="mlec-20250630.xsd#mlec_IfrsDefinedContributionPlanEmployerMatchingContributionPercentOfEmployeesGrossPay"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="mlec_IfrsDefinedContributionPlanEmployerMatchingContributionPercentOfEmployeesGrossPay" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SharesSubjectToEmployeeStockPurchasePlan" xlink:href="mlec-20250630.xsd#mlec_SharesSubjectToEmployeeStockPurchasePlan"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="mlec_SharesSubjectToEmployeeStockPurchasePlan" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PercentageOfClosingPriceOnFirstAndLastBusinessDayToDeterminePurchasePrice" xlink:href="mlec-20250630.xsd#mlec_PercentageOfClosingPriceOnFirstAndLastBusinessDayToDeterminePurchasePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="mlec_PercentageOfClosingPriceOnFirstAndLastBusinessDayToDeterminePurchasePrice" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_ExercisePriceShareOptionsGranted2019" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareBasedPaymentAwardExpirationDate" xlink:href="mlec-20250630.xsd#mlec_ShareBasedPaymentAwardExpirationDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="mlec_ShareBasedPaymentAwardExpirationDate" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod" xlink:href="mlec-20250630.xsd#mlec_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="mlec_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareBasedPaymentPeriodOfWeightedAveragePriceVwapOfOrdinarySharesForCashlessBasisExercise" xlink:href="mlec-20250630.xsd#mlec_ShareBasedPaymentPeriodOfWeightedAveragePriceVwapOfOrdinarySharesForCashlessBasisExercise"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="mlec_ShareBasedPaymentPeriodOfWeightedAveragePriceVwapOfOrdinarySharesForCashlessBasisExercise" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ThresholdEarningsBeforeInterestTaxesDepreciationAndAmortization" xlink:href="mlec-20250630.xsd#mlec_ThresholdEarningsBeforeInterestTaxesDepreciationAndAmortization"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="mlec_ThresholdEarningsBeforeInterestTaxesDepreciationAndAmortization" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage" xlink:href="mlec-20250630.xsd#mlec_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="mlec_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_NumberOfOptionsEstimatedExercisePercent" xlink:href="mlec-20250630.xsd#mlec_NumberOfOptionsEstimatedExercisePercent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="mlec_NumberOfOptionsEstimatedExercisePercent" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareBasedPaymentArrangementConversionOfEquityAwardsOutstandingToOptionOrRestrictedStockUnits" xlink:href="mlec-20250630.xsd#mlec_ShareBasedPaymentArrangementConversionOfEquityAwardsOutstandingToOptionOrRestrictedStockUnits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="mlec_ShareBasedPaymentArrangementConversionOfEquityAwardsOutstandingToOptionOrRestrictedStockUnits" order="12" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/EventsOccurringAftertheReportingPeriodDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_EventsOccurringAftertheReportingPeriodDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_EventsOccurringAftertheReportingPeriodDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_EventsOccurringAftertheReportingPeriodDetailsTable" xlink:href="mlec-20250630.xsd#mlec_EventsOccurringAftertheReportingPeriodDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_EventsOccurringAftertheReportingPeriodDetailsLineItems" xlink:to="mlec_EventsOccurringAftertheReportingPeriodDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_EventsOccurringAftertheReportingPeriodDetailsTable" xlink:to="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:to="ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:to="ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_EventsOccurringAftertheReportingPeriodDetailsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresSAMember" xlink:href="mlec-20250630.xsd#mlec_BioceresSAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:to="mlec_BioceresSAMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresLLCMember" xlink:href="mlec-20250630.xsd#mlec_BioceresLLCMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:to="mlec_BioceresLLCMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SubsequentEventsMember" xlink:href="mlec-20250630.xsd#mlec_SubsequentEventsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:to="mlec_SubsequentEventsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MajorBusinessCombinationMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorBusinessCombinationMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:to="ifrs-full_MajorBusinessCombinationMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Provisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Provisions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_EventsOccurringAftertheReportingPeriodDetailsLineItems" xlink:to="ifrs-full_Provisions" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AmountOfFinancialDebtUnderRestructuring" xlink:href="mlec-20250630.xsd#mlec_AmountOfFinancialDebtUnderRestructuring"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_EventsOccurringAftertheReportingPeriodDetailsLineItems" xlink:to="mlec_AmountOfFinancialDebtUnderRestructuring" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PledgedOrTransferredSharesQuantity" xlink:href="mlec-20250630.xsd#mlec_PledgedOrTransferredSharesQuantity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_EventsOccurringAftertheReportingPeriodDetailsLineItems" xlink:to="mlec_PledgedOrTransferredSharesQuantity" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_IssuedConvertiblePreferenceShares" xlink:href="mlec-20250630.xsd#mlec_IssuedConvertiblePreferenceShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_EventsOccurringAftertheReportingPeriodDetailsLineItems" xlink:to="mlec_IssuedConvertiblePreferenceShares" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ProceedFromIssuedShares" xlink:href="mlec-20250630.xsd#mlec_ProceedFromIssuedShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_EventsOccurringAftertheReportingPeriodDetailsLineItems" xlink:to="mlec_ProceedFromIssuedShares" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PreferenceOfAccruePerAnnum" xlink:href="mlec-20250630.xsd#mlec_PreferenceOfAccruePerAnnum"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_EventsOccurringAftertheReportingPeriodDetailsLineItems" xlink:to="mlec_PreferenceOfAccruePerAnnum" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ProceedsFromIssueOfEquityInstrumentsOnConversionOfDebt" xlink:href="mlec-20250630.xsd#mlec_ProceedsFromIssueOfEquityInstrumentsOnConversionOfDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_EventsOccurringAftertheReportingPeriodDetailsLineItems" xlink:to="mlec_ProceedsFromIssueOfEquityInstrumentsOnConversionOfDebt" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_WorkingCapital" xlink:href="mlec-20250630.xsd#mlec_WorkingCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_EventsOccurringAftertheReportingPeriodDetailsLineItems" xlink:to="mlec_WorkingCapital" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ParValuePerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ParValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_EventsOccurringAftertheReportingPeriodDetailsLineItems" xlink:to="ifrs-full_ParValuePerShare" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ConsecutiveBusinessDays" xlink:href="mlec-20250630.xsd#mlec_ConsecutiveBusinessDays"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_EventsOccurringAftertheReportingPeriodDetailsLineItems" xlink:to="mlec_ConsecutiveBusinessDays" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_EventsOccurringAftertheReportingPeriodDetailsLineItems" xlink:to="ifrs-full_GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss" order="10" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/ReverseStockSplitAftertheReportingPeriodDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="mlec_ReverseStockSplitAftertheReportingPeriodDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_ReverseStockSplitAftertheReportingPeriodDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_ReverseStockSplitAftertheReportingPeriodDetailsTable" xlink:href="mlec-20250630.xsd#mlec_ReverseStockSplitAftertheReportingPeriodDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_ReverseStockSplitAftertheReportingPeriodDetailsLineItems" xlink:to="mlec_ReverseStockSplitAftertheReportingPeriodDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_ReverseStockSplitAftertheReportingPeriodDetailsTable" xlink:to="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:to="ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:to="ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioForecastMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:to="srt_ScenarioForecastMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ReverseStockSplit" xlink:href="mlec-20250630.xsd#mlec_ReverseStockSplit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ReverseStockSplitAftertheReportingPeriodDetailsLineItems" xlink:to="mlec_ReverseStockSplit" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://www.moolecscience.com/role/DocumentAndEntityInformation" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationLineItems"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressesAddressTypeAxis" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_EntityAddressesAddressTypeAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AddressTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AddressTypeDomain_0" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AddressTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="ifrs-full_ClassesOfShareCapitalAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalDomain_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_BusinessContactMember" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_BusinessContactMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_AddressTypeDomain" xlink:to="dei_BusinessContactMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_OrdinarySharesWithNominalValueOfUS010PerShareMember" xlink:href="mlec-20250630.xsd#mlec_OrdinarySharesWithNominalValueOfUS010PerShareMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfShareCapitalDomain" xlink:to="mlec_OrdinarySharesWithNominalValueOfUS010PerShareMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_WarrantsExercisableForOrdinarySharesMember" xlink:href="mlec-20250630.xsd#mlec_WarrantsExercisableForOrdinarySharesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfShareCapitalDomain" xlink:to="mlec_WarrantsExercisableForOrdinarySharesMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentRegistrationStatement" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentRegistrationStatement" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAnnualReport" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentTransitionReport" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentShellCompanyReport" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentShellCompanyReport" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCountry" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCountry" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_ContactPersonnelName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_ContactPersonnelName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_ContactPersonnelName" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_ContactPersonnelEmailAddress" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_ContactPersonnelEmailAddress"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_ContactPersonnelEmailAddress" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" order="27" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="28" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="29" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="30" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_IcfrAuditorAttestationFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_IcfrAuditorAttestationFlag" order="31" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag" order="32" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAccountingStandard" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAccountingStandard" order="33" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" order="34" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorFirmId"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorFirmId" order="35" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorOpinionTextBlock" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorOpinionTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorOpinionTextBlock" order="36" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorName" order="37" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorLocation"/>
<!-- [WMV6][hi+59iH1OxGCjE3h3cvKln6LB1MV/UfIVPsF+XWsxR34DM3T2MDmgsM4jZQwGhxv9AE9fUZ9YCiSl60gj9YDTTqOe6LdnRzuNpHBHqEKchT24EC5dVkOj5ET1m9IlDtqNQHgfpF4uioFYaHySqvf5C/EkL/LrVcwGWKr8/Et+HlAGpLjtgGQj/XydPeLcdnyoTS0WVCnfXtx2NJZ5F+UKIhiGHJK/RUkz0eVWHxHgSnvzUrszP/QXMHE3Bh6b9ej0JAKZVVBslYVH4c88KkW4wpGoY33L7YiKTtRu/MBaFdGC7VIwZfv5fx4jYLWHOH+jiKJxtNKE1D+K4F7DA1kqTAscfYZ0ZuwCwxmtpaEGHQttjj1NH+ATDiH33LUoEBJhTkW] CSR-->
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorLocation" order="38" xbrldt:closed="true"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>27
<FILENAME>mlec-20250630_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Sun Dec 28 18:19:32 UTC 2025 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/>
  <labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfShareCapitalAxis_lbl" xml:lang="en-US">Classes of share capital [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossFromOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_ProfitLossFromOperatingActivities_lbl" xml:lang="en-US">Operating (loss) profit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_ProfitLossFromOperatingActivities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProfitLossFromOperatingActivities_lbl0" xml:lang="en-US">Operating loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_ProfitLossFromOperatingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ProfitLossFromOperatingActivities_lbl1" xml:lang="en-US">Operating (loss) / profit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_ProfitLossFromOperatingActivities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="ifrs-full_ProfitLossFromOperatingActivities_lbl2" xml:lang="en-US">Operating loss (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_ProfitLossFromOperatingActivities_lbl2"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossBeforeTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_ProfitLossBeforeTax_lbl" xml:lang="en-US">(Loss) Profit before income tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_ProfitLossBeforeTax_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProfitLossBeforeTax_lbl0" xml:lang="en-US">Loss before taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_ProfitLossBeforeTax_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ProfitLossBeforeTax_lbl1" xml:lang="en-US">(Loss) / profit before taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_ProfitLossBeforeTax_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_ProfitLoss_lbl" xml:lang="en-US">(Loss) Profit for the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_ProfitLoss_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProfitLoss_lbl0" xml:lang="en-US">(Loss) / Profit for the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_ProfitLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ProfitLoss_lbl1" xml:lang="en-US">(Loss) / profit for the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_ProfitLoss_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="ifrs-full_ProfitLoss_lbl2" xml:lang="en-US">(Loss)/Profit of the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_ProfitLoss_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLoss_lbl3" xml:lang="en-US">Result for the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_ProfitLoss_lbl3"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncome"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_ComprehensiveIncome_lbl" xml:lang="en-US">Total comprehensive (loss) profit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComprehensiveIncome" xlink:to="ifrs-full_ComprehensiveIncome_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ComprehensiveIncome_lbl0" xml:lang="en-US">Total comprehensive (loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComprehensiveIncome" xlink:to="ifrs-full_ComprehensiveIncome_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ComprehensiveIncome_lbl1" xml:lang="en-US">Total comprehensive result</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComprehensiveIncome" xlink:to="ifrs-full_ComprehensiveIncome_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_NoncurrentAssets_lbl" xml:lang="en-US">Total non-current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_NoncurrentAssets_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncurrentAssets_lbl0" xml:lang="en-US">Non-current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_NoncurrentAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NoncurrentAssets_lbl1" xml:lang="en-US">Total non-current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_NoncurrentAssets_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CurrentAssets_lbl" xml:lang="en-US">Total current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_CurrentAssets_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentAssets_lbl0" xml:lang="en-US">Current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_CurrentAssets_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_NoncurrentLiabilities_lbl" xml:lang="en-US">Total non-current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLiabilities" xlink:to="ifrs-full_NoncurrentLiabilities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncurrentLiabilities_lbl0" xml:lang="en-US">Non-current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLiabilities" xlink:to="ifrs-full_NoncurrentLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NoncurrentLiabilities_lbl1" xml:lang="en-US">Non- current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLiabilities" xlink:to="ifrs-full_NoncurrentLiabilities_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CurrentLiabilities_lbl" xml:lang="en-US">Total current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_CurrentLiabilities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentLiabilities_lbl0" xml:lang="en-US">Current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_CurrentLiabilities_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Liabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Liabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_Liabilities_lbl" xml:lang="en-US">Total liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Liabilities" xlink:to="ifrs-full_Liabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityAndLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAndLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_EquityAndLiabilities_lbl" xml:lang="en-US">Total shareholders&#8217; deficit / equity and liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAndLiabilities" xlink:to="ifrs-full_EquityAndLiabilities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_EquityAndLiabilities_lbl0" xml:lang="en-US">Total liabilities and equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAndLiabilities" xlink:to="ifrs-full_EquityAndLiabilities_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_Equity_lbl" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_Equity_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_Equity_lbl0" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_Equity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_Equity_lbl1" xml:lang="en-US">Total equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_Equity_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_Equity_lbl2" xml:lang="en-US">Total shareholders&#8217; deficit / Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_Equity_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_Equity_lbl3" xml:lang="en-US">Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_Equity_lbl3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="ifrs-full_Equity_lbl4" xml:lang="en-US">Shareholders&apos; deficit (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_Equity_lbl4"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComponentsOfEquityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComponentsOfEquityAxis_lbl" xml:lang="en-US">Components of equity [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_ComponentsOfEquityAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash flows generated by / (used in) operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash flows used in investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash flows (used in) / generated by financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_lbl" xml:lang="en-US">Net increase / (decrease) in cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InflationEffectsOnCashAndCashEquivalents" xlink:href="mlec-20250630.xsd#mlec_InflationEffectsOnCashAndCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="mlec_InflationEffectsOnCashAndCashEquivalents_lbl" xml:lang="en-US">Inflation effects on cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InflationEffectsOnCashAndCashEquivalents" xlink:to="mlec_InflationEffectsOnCashAndCashEquivalents_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition_lbl" xml:lang="en-US">Cash and cash equivalents as of beginning of the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition" xlink:to="ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition_lbl0" xml:lang="en-US">Cash and cash equivalents as of the end of the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition" xlink:to="ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NotesAndOtherExplanatoryInformationAbstract_lbl" xml:lang="en-US">The Group&#8217;s Business Reorganization and General Information [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:to="ifrs-full_NotesAndOtherExplanatoryInformationAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AccountingStandardsAndBasiofPreparationAbstract" xlink:href="mlec-20250630.xsd#mlec_AccountingStandardsAndBasiofPreparationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AccountingStandardsAndBasiofPreparationAbstract_lbl" xml:lang="en-US">Accounting Standards and Basis of Preparation [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AccountingStandardsAndBasiofPreparationAbstract" xlink:to="mlec_AccountingStandardsAndBasiofPreparationAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ConsolidatedStructuredEntitiesAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ConsolidatedStructuredEntitiesAxis_lbl" xml:lang="en-US">Consolidated structured entities [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:to="ifrs-full_ConsolidatedStructuredEntitiesAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NewStandardsAmendmentsAndInterpretationsIssuedByTheIASBAbstract" xlink:href="mlec-20250630.xsd#mlec_NewStandardsAmendmentsAndInterpretationsIssuedByTheIASBAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NewStandardsAmendmentsAndInterpretationsIssuedByTheIASBAbstract_lbl" xml:lang="en-US">New Standards, Amendments and Interpretations Issued by the IASB [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NewStandardsAmendmentsAndInterpretationsIssuedByTheIASBAbstract" xlink:to="mlec_NewStandardsAmendmentsAndInterpretationsIssuedByTheIASBAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Summary of Significant Accounting Policies [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_CriticalAccountingJudgmentsAndEstimatesAbstract" xlink:href="mlec-20250630.xsd#mlec_CriticalAccountingJudgmentsAndEstimatesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_CriticalAccountingJudgmentsAndEstimatesAbstract_lbl" xml:lang="en-US">Critical Accounting Judgments and Estimates [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CriticalAccountingJudgmentsAndEstimatesAbstract" xlink:to="mlec_CriticalAccountingJudgmentsAndEstimatesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfBusinessCombinationsAbstract_lbl" xml:lang="en-US">Acquisitions and Other Significant Transactions [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:to="ifrs-full_DisclosureOfBusinessCombinationsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_lbl" xml:lang="en-US">Transactions recognised separately from acquisition of assets and assumption of liabilities in business combination [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis" xlink:to="ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_lbl" xml:lang="en-US">Total net assets identified</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:to="ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_lbl" xml:lang="en-US">Total consideration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:to="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_lbl0" xml:lang="en-US">Total consideration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:to="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_lbl1" xml:lang="en-US">Fair value of consideration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:to="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract_lbl" xml:lang="en-US">Information About Components of Consolidated Statements of Financial Position [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:to="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashAndCashEquivalentsAbstract_lbl" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalentsAbstract" xlink:to="ifrs-full_CashAndCashEquivalentsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CashAndCashEquivalents_lbl" xml:lang="en-US">Cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalents" xlink:to="ifrs-full_CashAndCashEquivalents_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CashAndCashEquivalents_lbl0" xml:lang="en-US">Cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalents" xlink:to="ifrs-full_CashAndCashEquivalents_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfAssetsAxis_lbl" xml:lang="en-US">Classes of assets [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="ifrs-full_ClassesOfAssetsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherReceivablesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherReceivablesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherReceivablesAbstract_lbl" xml:lang="en-US">Schedule of Trade Receivables [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherReceivablesAbstract" xlink:to="ifrs-full_TradeAndOtherReceivablesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_TradeAndOtherCurrentReceivables_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentReceivables" xlink:to="ifrs-full_TradeAndOtherCurrentReceivables_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_IfrsBalanceSheetLocationAxis" xlink:href="mlec-20250630.xsd#mlec_IfrsBalanceSheetLocationAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_IfrsBalanceSheetLocationAxis_lbl" xml:lang="en-US">IFRS Balance Sheet Location [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IfrsBalanceSheetLocationAxis" xlink:to="mlec_IfrsBalanceSheetLocationAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BiologicalAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BiologicalAssetsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BiologicalAssetsAxis_lbl" xml:lang="en-US">Biological assets [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BiologicalAssetsAxis" xlink:to="ifrs-full_BiologicalAssetsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BiologicalAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BiologicalAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_BiologicalAssets_lbl" xml:lang="en-US">Beginning of the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BiologicalAssets" xlink:to="ifrs-full_BiologicalAssets_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_BiologicalAssets_lbl0" xml:lang="en-US">Ending of the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BiologicalAssets" xlink:to="ifrs-full_BiologicalAssets_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_lbl" xml:lang="en-US">Classes of property, plant and equipment [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_PropertyPlantAndEquipment_lbl" xml:lang="en-US">Net carrying amount beginning</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipment" xlink:to="ifrs-full_PropertyPlantAndEquipment_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_PropertyPlantAndEquipment_lbl0" xml:lang="en-US">Net carrying amount ending</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipment" xlink:to="ifrs-full_PropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_PropertyPlantAndEquipment_lbl1" xml:lang="en-US">Property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipment" xlink:to="ifrs-full_PropertyPlantAndEquipment_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_lbl" xml:lang="en-US">Classes of intangible assets other than goodwill [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US">Net carrying amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl0" xml:lang="en-US">Net carrying amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl1" xml:lang="en-US">Intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl2" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl2"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesAxis_lbl" xml:lang="en-US">Subsidiaries [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:to="ifrs-full_SignificantInvestmentsInSubsidiariesAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnDisposalsOfInvestmentPropertiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnDisposalsOfInvestmentPropertiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GainsLossesOnDisposalsOfInvestmentPropertiesAbstract_lbl" xml:lang="en-US">Schedule of Investment Properties [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsLossesOnDisposalsOfInvestmentPropertiesAbstract" xlink:to="ifrs-full_GainsLossesOnDisposalsOfInvestmentPropertiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherPayablesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherPayablesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherPayablesAbstract_lbl" xml:lang="en-US">Schedule of Trade and Other Payables [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherPayablesAbstract" xlink:to="ifrs-full_TradeAndOtherPayablesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_TradeAndOtherCurrentPayables_lbl" xml:lang="en-US">Trade and Other Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentPayables" xlink:to="ifrs-full_TradeAndOtherCurrentPayables_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TradeAndOtherCurrentPayables_lbl0" xml:lang="en-US">Trade and other payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentPayables" xlink:to="ifrs-full_TradeAndOtherCurrentPayables_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BorrowingsByNameAxis_lbl" xml:lang="en-US">Borrowings by name [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="ifrs-full_BorrowingsByNameAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MeasurementAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MeasurementAxis_lbl" xml:lang="en-US">Measurement [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MeasurementAxis" xlink:to="ifrs-full_MeasurementAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentProvisionsForEmployeeBenefits" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentProvisionsForEmployeeBenefits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CurrentProvisionsForEmployeeBenefits_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentProvisionsForEmployeeBenefits" xlink:to="ifrs-full_CurrentProvisionsForEmployeeBenefits_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentProvisionsForEmployeeBenefits_lbl0" xml:lang="en-US">Employee benefits and social security</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentProvisionsForEmployeeBenefits" xlink:to="ifrs-full_CurrentProvisionsForEmployeeBenefits_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities_lbl" xml:lang="en-US">Total current deferred revenue and advances from customers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities" xlink:to="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities_lbl0" xml:lang="en-US">Deferred revenue and advances from customers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities" xlink:to="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentDeferredIncomeIncludingNoncurrentContractLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentDeferredIncomeIncludingNoncurrentContractLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_NoncurrentDeferredIncomeIncludingNoncurrentContractLiabilities_lbl" xml:lang="en-US">Total non current deferred revenue and advances from customers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentDeferredIncomeIncludingNoncurrentContractLiabilities" xlink:to="ifrs-full_NoncurrentDeferredIncomeIncludingNoncurrentContractLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfProvisionsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfProvisionsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfProvisionsAxis_lbl" xml:lang="en-US">Classes of other provisions [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfProvisionsAxis" xlink:to="ifrs-full_ClassesOfProvisionsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherProvisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherProvisions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_OtherProvisions_lbl" xml:lang="en-US">Beginning</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherProvisions" xlink:to="ifrs-full_OtherProvisions_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_OtherProvisions_lbl0" xml:lang="en-US">Ending</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherProvisions" xlink:to="ifrs-full_OtherProvisions_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GovernmentGrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GovernmentGrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_GovernmentGrants_lbl" xml:lang="en-US">At the beginning of the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GovernmentGrants" xlink:to="ifrs-full_GovernmentGrants_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_GovernmentGrants_lbl0" xml:lang="en-US">At the end of the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GovernmentGrants" xlink:to="ifrs-full_GovernmentGrants_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfWarrantsAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfWarrantsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfWarrantsAbstract_lbl" xml:lang="en-US">Schedule of Warrants [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfWarrantsAbstract" xlink:to="mlec_ScheduleOfWarrantsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentWarrantLiability" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentWarrantLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_CurrentWarrantLiability_lbl" xml:lang="en-US">At the beginning of the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentWarrantLiability" xlink:to="ifrs-full_CurrentWarrantLiability_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_CurrentWarrantLiability_lbl0" xml:lang="en-US">At the end of the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentWarrantLiability" xlink:to="ifrs-full_CurrentWarrantLiability_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentWarrantLiability_lbl1" xml:lang="en-US">Warrant liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentWarrantLiability" xlink:to="ifrs-full_CurrentWarrantLiability_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfComprehensiveIncomeAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfComprehensiveIncomeAbstract_lbl" xml:lang="en-US">Information about Component of Consolidated Statements of Comprehensive Income [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:to="ifrs-full_StatementOfComprehensiveIncomeAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_lbl" xml:lang="en-US">Schedule of Revenue from Contracts with Customers [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromContractsWithCustomers" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromContractsWithCustomers"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_RevenueFromContractsWithCustomers_lbl" xml:lang="en-US">Revenue from contracts with customers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueFromContractsWithCustomers" xlink:to="ifrs-full_RevenueFromContractsWithCustomers_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RevenueFromContractsWithCustomers_lbl0" xml:lang="en-US">Revenues from contracts with customers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueFromContractsWithCustomers" xlink:to="ifrs-full_RevenueFromContractsWithCustomers_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_RevenueFromContractsWithCustomers_lbl1" xml:lang="en-US">Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueFromContractsWithCustomers" xlink:to="ifrs-full_RevenueFromContractsWithCustomers_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CostOfSalesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CostOfSalesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CostOfSalesMember_lbl" xml:lang="en-US">Schedule of Cost of Sales [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CostOfSalesMember" xlink:to="ifrs-full_CostOfSalesMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CostOfSalesMember_lbl0" xml:lang="en-US">Production and services costs [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CostOfSalesMember" xlink:to="ifrs-full_CostOfSalesMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_InventoriesNetOfAgriculturalProducts" xlink:href="mlec-20250630.xsd#mlec_InventoriesNetOfAgriculturalProducts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="mlec_InventoriesNetOfAgriculturalProducts_lbl" xml:lang="en-US">Inventories as of the beginning of the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InventoriesNetOfAgriculturalProducts" xlink:to="mlec_InventoriesNetOfAgriculturalProducts_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InventoriesTotal" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InventoriesTotal"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:label="ifrs-full_InventoriesTotal_lbl" xml:lang="en-US">Inventories as of the end of the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InventoriesTotal" xlink:to="ifrs-full_InventoriesTotal_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_InventoriesTotal_lbl0" xml:lang="en-US">Inventories</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InventoriesTotal" xlink:to="ifrs-full_InventoriesTotal_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ResearchAndDevelopmentExpense" xlink:to="ifrs-full_ResearchAndDevelopmentExpense_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_ResearchAndDevelopmentExpense_lbl0" xml:lang="en-US">Research and development expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ResearchAndDevelopmentExpense" xlink:to="ifrs-full_ResearchAndDevelopmentExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ResearchAndDevelopmentExpense_lbl1" xml:lang="en-US">R&amp;D profit and loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ResearchAndDevelopmentExpense" xlink:to="ifrs-full_ResearchAndDevelopmentExpense_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="ifrs-full_ResearchAndDevelopmentExpense_lbl2" xml:lang="en-US">Research and development expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ResearchAndDevelopmentExpense" xlink:to="ifrs-full_ResearchAndDevelopmentExpense_lbl2"/>
    <loc xlink:type="locator" xlink:label="mlec_TotalResearchAndDevelopmentExpenseIncurred" xlink:href="mlec-20250630.xsd#mlec_TotalResearchAndDevelopmentExpenseIncurred"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="mlec_TotalResearchAndDevelopmentExpenseIncurred_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TotalResearchAndDevelopmentExpenseIncurred" xlink:to="mlec_TotalResearchAndDevelopmentExpenseIncurred_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherExpenseByFunction" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherExpenseByFunction"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_OtherExpenseByFunction_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherExpenseByFunction" xlink:to="ifrs-full_OtherExpenseByFunction_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_lbl" xml:lang="en-US">Attribution of expenses by nature to their function [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:to="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfFinanceResultsAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfFinanceResultsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfFinanceResultsAbstract_lbl" xml:lang="en-US">Schedule of Finance Results [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfFinanceResultsAbstract" xlink:to="mlec_ScheduleOfFinanceResultsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinanceIncomeCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceIncomeCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_FinanceIncomeCost_lbl" xml:lang="en-US">Total net financial cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceIncomeCost" xlink:to="ifrs-full_FinanceIncomeCost_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_FinanceIncomeCost_lbl0" xml:lang="en-US">Financial cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceIncomeCost" xlink:to="ifrs-full_FinanceIncomeCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_FinanceIncomeCost_lbl1" xml:lang="en-US">Financial results</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceIncomeCost" xlink:to="ifrs-full_FinanceIncomeCost_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfOtherIncomeOrExpensesNetAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfOtherIncomeOrExpensesNetAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfOtherIncomeOrExpensesNetAbstract_lbl" xml:lang="en-US">Schedule of Other Income or Expenses, Net [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfOtherIncomeOrExpensesNetAbstract" xlink:to="mlec_ScheduleOfOtherIncomeOrExpensesNetAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherOperatingIncomeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherOperatingIncomeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_OtherOperatingIncomeExpense_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="ifrs-full_OtherOperatingIncomeExpense_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherOperatingIncomeExpense_lbl0" xml:lang="en-US">Other income or expenses, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="ifrs-full_OtherOperatingIncomeExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherOperatingIncomeExpense_lbl1" xml:lang="en-US">Other income / (loss), net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="ifrs-full_OtherOperatingIncomeExpense_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_lbl" xml:lang="en-US">Taxation [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetDeferredTaxAssetsAndLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetDeferredTaxAssetsAndLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NetDeferredTaxAssetsAndLiabilitiesAbstract_lbl" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="ifrs-full_NetDeferredTaxAssetsAndLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_lbl" xml:lang="en-US">Temporary difference, unused tax losses and unused tax credits [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetDeferredTaxAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetDeferredTaxAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_NetDeferredTaxAssets_lbl" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetDeferredTaxAssets" xlink:to="ifrs-full_NetDeferredTaxAssets_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_NetDeferredTaxAssets_lbl0" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetDeferredTaxAssets" xlink:to="ifrs-full_NetDeferredTaxAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NetDeferredTaxAssets_lbl1" xml:lang="en-US">Total deferred tax assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetDeferredTaxAssets" xlink:to="ifrs-full_NetDeferredTaxAssets_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfWeightedAverageTaxRateAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfWeightedAverageTaxRateAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfWeightedAverageTaxRateAbstract_lbl" xml:lang="en-US">Schedule of Weighted Average Tax Rate [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfWeightedAverageTaxRateAbstract" xlink:to="mlec_ScheduleOfWeightedAverageTaxRateAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TaxExpenseIncomeAtApplicableTaxRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_lbl" xml:lang="en-US">Income tax expense by applying tax rate in force in the respective countries</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:to="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_lbl0" xml:lang="en-US">Income tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:to="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations_lbl" xml:lang="en-US">Income tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations_lbl0" xml:lang="en-US">Income tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations_lbl1" xml:lang="en-US">Income tax expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations_lbl2" xml:lang="en-US">Income tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations_lbl2"/>
    <loc xlink:type="locator" xlink:label="mlec_TaxJurisdictionAxis" xlink:href="mlec-20250630.xsd#mlec_TaxJurisdictionAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_TaxJurisdictionAxis_lbl" xml:lang="en-US">Tax Jurisdiction [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TaxJurisdictionAxis" xlink:to="mlec_TaxJurisdictionAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EarningsPerShareAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EarningsPerShareAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EarningsPerShareAbstract_lbl" xml:lang="en-US">Earning Per Share [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EarningsPerShareAbstract" xlink:to="ifrs-full_EarningsPerShareAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_EarningsPerShareAbstract_lbl0" xml:lang="en-US">(Loss) /Profit per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EarningsPerShareAbstract" xlink:to="ifrs-full_EarningsPerShareAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_EarningsPerShareAbstract_lbl1" xml:lang="en-US">Numerator</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EarningsPerShareAbstract" xlink:to="ifrs-full_EarningsPerShareAbstract_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsAxis_lbl" xml:lang="en-US">Underlying equity instrument and depositary receipts [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsAxis" xlink:to="ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationAboutComponentsOfEquityAbstract" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsOfEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InformationAboutComponentsOfEquityAbstract_lbl" xml:lang="en-US">Information about Components of Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InformationAboutComponentsOfEquityAbstract" xlink:to="mlec_InformationAboutComponentsOfEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Assets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Assets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_Assets_lbl" xml:lang="en-US">Total assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Assets" xlink:to="ifrs-full_Assets_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_Assets_lbl0" xml:lang="en-US">Total assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Assets" xlink:to="ifrs-full_Assets_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_NonCashInvestingActivities" xlink:href="mlec-20250630.xsd#mlec_NonCashInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="mlec_NonCashInvestingActivities_lbl" xml:lang="en-US">Total Investment Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NonCashInvestingActivities" xlink:to="mlec_NonCashInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NonCashFinancingActivities" xlink:href="mlec-20250630.xsd#mlec_NonCashFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="mlec_NonCashFinancingActivities_lbl" xml:lang="en-US">Total Financing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NonCashFinancingActivities" xlink:to="mlec_NonCashFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ConsolidatedEntitiesAxis_lbl" xml:lang="en-US">Consolidated Entities [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivities_lbl" xml:lang="en-US">Beginning balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivities_lbl0" xml:lang="en-US">Ending balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivities_lbl1" xml:lang="en-US">Liabilities arising from financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivities_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_lbl" xml:lang="en-US">Liabilities arising from financing activities [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfJointVenturesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfJointVenturesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfJointVenturesAbstract_lbl" xml:lang="en-US">Joint Ventures and Associates [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfJointVenturesAbstract" xlink:to="ifrs-full_DisclosureOfJointVenturesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_JointVenturesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_JointVenturesAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_JointVenturesAxis_lbl" xml:lang="en-US">Joint ventures [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_JointVenturesAxis" xlink:to="ifrs-full_JointVenturesAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity" xlink:href="mlec-20250630.xsd#mlec_InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="mlec_InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity_lbl" xml:lang="en-US">As of the beginning</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity" xlink:to="mlec_InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="mlec_InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity_lbl0" xml:lang="en-US">As of the end of the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity" xlink:to="mlec_InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis_lbl" xml:lang="en-US">Categories of related parties [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related and Nonrelated Parties [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsAbstract_lbl" xml:lang="en-US">Segment Information [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:to="ifrs-full_DisclosureOfOperatingSegmentsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Revenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Revenue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_Revenue_lbl" xml:lang="en-US">Total revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Revenue" xlink:to="ifrs-full_Revenue_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_Revenue_lbl0" xml:lang="en-US">Revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Revenue" xlink:to="ifrs-full_Revenue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_Revenue_lbl1" xml:lang="en-US">Total revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Revenue" xlink:to="ifrs-full_Revenue_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GrossProfit" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossProfit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_GrossProfit_lbl" xml:lang="en-US">Gross profit per segment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GrossProfit" xlink:to="ifrs-full_GrossProfit_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_GrossProfit_lbl0" xml:lang="en-US">Gross margin</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GrossProfit" xlink:to="ifrs-full_GrossProfit_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SegmentsAxis_lbl" xml:lang="en-US">Segments [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProductsAndServicesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProductsAndServicesAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProductsAndServicesAxis_lbl" xml:lang="en-US">Products and services [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="ifrs-full_ProductsAndServicesAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeographicalAreasAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GeographicalAreasAxis_lbl" xml:lang="en-US">Geographical areas [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="ifrs-full_GeographicalAreasAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialInstrumentsRiskManagementAbstract" xlink:href="mlec-20250630.xsd#mlec_FinancialInstrumentsRiskManagementAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FinancialInstrumentsRiskManagementAbstract_lbl" xml:lang="en-US">Financial Instruments &#8211; Risk Management [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialInstrumentsRiskManagementAbstract" xlink:to="mlec_FinancialInstrumentsRiskManagementAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfFinancialLiabilitiesAxis_lbl" xml:lang="en-US">Classes of financial liabilities [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:to="ifrs-full_ClassesOfFinancialLiabilitiesAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_FinancialLiabilities_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilities" xlink:to="ifrs-full_FinancialLiabilities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_FinancialLiabilities_lbl0" xml:lang="en-US">Financial liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilities" xlink:to="ifrs-full_FinancialLiabilities_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MaturityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MaturityAxis_lbl" xml:lang="en-US">Maturity [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_MaturityAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfRisksAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfRisksAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TypesOfRisksAxis_lbl" xml:lang="en-US">Types of risks [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TypesOfRisksAxis" xlink:to="ifrs-full_TypesOfRisksAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfFinancialAssetsAxis_lbl" xml:lang="en-US">Classes of financial assets [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="ifrs-full_ClassesOfFinancialAssetsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentFinancialAssetsAtAmortisedCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentFinancialAssetsAtAmortisedCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CurrentFinancialAssetsAtAmortisedCost_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentFinancialAssetsAtAmortisedCost" xlink:to="ifrs-full_CurrentFinancialAssetsAtAmortisedCost_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LevelsOfFairValueHierarchyAxis_lbl" xml:lang="en-US">Levels of fair value hierarchy [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:to="ifrs-full_LevelsOfFairValueHierarchyAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PresentationOfLeasesForLesseeAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PresentationOfLeasesForLesseeAbstract_lbl" xml:lang="en-US">Leases [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:to="ifrs-full_PresentationOfLeasesForLesseeAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_lbl" xml:lang="en-US">Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RightofuseAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_RightofuseAssets_lbl" xml:lang="en-US">Book value at the beginning of the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RightofuseAssets" xlink:to="ifrs-full_RightofuseAssets_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_RightofuseAssets_lbl0" xml:lang="en-US">Book value at the end of the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RightofuseAssets" xlink:to="ifrs-full_RightofuseAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RightofuseAssets_lbl1" xml:lang="en-US">Right of use asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RightofuseAssets" xlink:to="ifrs-full_RightofuseAssets_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_OtherPropertyPlantAndEquipment_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherPropertyPlantAndEquipment" xlink:to="ifrs-full_OtherPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_TotalLeaseLiabilities" xlink:href="mlec-20250630.xsd#mlec_TotalLeaseLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="mlec_TotalLeaseLiabilities_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TotalLeaseLiabilities" xlink:to="mlec_TotalLeaseLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_lbl" xml:lang="en-US">Shareholders and Other Related Parties Balances and Transactions [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:to="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsAxis_lbl" xml:lang="en-US">Classes of financial instruments [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="ifrs-full_ClassesOfFinancialInstrumentsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherReceivablesDueFromRelatedParties" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherReceivablesDueFromRelatedParties"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_TradeAndOtherReceivablesDueFromRelatedParties_lbl" xml:lang="en-US">Amounts receivable from related parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherReceivablesDueFromRelatedParties" xlink:to="ifrs-full_TradeAndOtherReceivablesDueFromRelatedParties_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherPayablesToRelatedParties" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherPayablesToRelatedParties"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="ifrs-full_TradeAndOtherPayablesToRelatedParties_lbl" xml:lang="en-US">Amounts payable to related parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherPayablesToRelatedParties" xlink:to="ifrs-full_TradeAndOtherPayablesToRelatedParties_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_KeyManagementPersonnelCompensationAbstract" xlink:href="mlec-20250630.xsd#mlec_KeyManagementPersonnelCompensationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_KeyManagementPersonnelCompensationAbstract_lbl" xml:lang="en-US">Key Management Personnel Compensation [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_KeyManagementPersonnelCompensationAbstract" xlink:to="mlec_KeyManagementPersonnelCompensationAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfCompensationOfKeyManagementPersonnelCompensationAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfCompensationOfKeyManagementPersonnelCompensationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfCompensationOfKeyManagementPersonnelCompensationAbstract_lbl" xml:lang="en-US">Schedule of Compensation of Key Management Personnel Compensation [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfCompensationOfKeyManagementPersonnelCompensationAbstract" xlink:to="mlec_ScheduleOfCompensationOfKeyManagementPersonnelCompensationAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_KeyManagementPersonnelCompensation" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_KeyManagementPersonnelCompensation_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_KeyManagementPersonnelCompensation" xlink:to="ifrs-full_KeyManagementPersonnelCompensation_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_lbl" xml:lang="en-US">Share-Based Payment [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_lbl" xml:lang="en-US">Types of share-based payment arrangements [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RangeAxis_lbl" xml:lang="en-US">Range [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfOutstandingShareOptions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_NumberOfOutstandingShareOptions_lbl" xml:lang="en-US">Number of options, At the beginning of the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfOutstandingShareOptions" xlink:to="ifrs-full_NumberOfOutstandingShareOptions_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_NumberOfOutstandingShareOptions_lbl0" xml:lang="en-US">Number of options, Effective at the end of the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfOutstandingShareOptions" xlink:to="ifrs-full_NumberOfOutstandingShareOptions_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US">W.A. Exercise price, At the beginning of the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_lbl0" xml:lang="en-US">W.A. Exercise price, Effective at the end of the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CapitalCommitmentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CapitalCommitmentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CapitalCommitmentsAbstract_lbl" xml:lang="en-US">Contingencies, Commitments and Restrictions on the Distribution of Profits [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CapitalCommitmentsAbstract" xlink:to="ifrs-full_CapitalCommitmentsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_lbl" xml:lang="en-US">Events Occurring After the Reporting Period [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:to="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfReverseStockSplitAfterTheReportingPeriodAbstract" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfReverseStockSplitAfterTheReportingPeriodAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DisclosureOfReverseStockSplitAfterTheReportingPeriodAbstract_lbl" xml:lang="en-US">Reverse Stock Split After the Reporting Period [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfReverseStockSplitAfterTheReportingPeriodAbstract" xlink:to="mlec_DisclosureOfReverseStockSplitAfterTheReportingPeriodAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromGovernmentGrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromGovernmentGrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RevenueFromGovernmentGrants_lbl" xml:lang="en-US">Government grants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueFromGovernmentGrants" xlink:to="ifrs-full_RevenueFromGovernmentGrants_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ChangeInNetRealizableValueOfAgricultural" xlink:href="mlec-20250630.xsd#mlec_ChangeInNetRealizableValueOfAgricultural"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ChangeInNetRealizableValueOfAgricultural_lbl" xml:lang="en-US">Changes in the net realizable value of agricultural products after harvest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ChangeInNetRealizableValueOfAgricultural" xlink:to="mlec_ChangeInNetRealizableValueOfAgricultural_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_lbl" xml:lang="en-US">Share of profit or loss of joint ventures and associates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:to="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_lbl0" xml:lang="en-US">Share of profit or loss of joint ventures and associates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:to="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_lbl1" xml:lang="en-US">Share of profit or loss measured at equity value method</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:to="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherFinanceIncomeCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherFinanceIncomeCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherFinanceIncomeCost_lbl" xml:lang="en-US">Other financial results</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherFinanceIncomeCost" xlink:to="ifrs-full_OtherFinanceIncomeCost_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherFinanceIncomeCost_lbl0" xml:lang="en-US">Other finance results</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherFinanceIncomeCost" xlink:to="ifrs-full_OtherFinanceIncomeCost_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherComprehensiveIncomeAbstract_lbl" xml:lang="en-US">Other comprehensive income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncomeAbstract" xlink:to="ifrs-full_OtherComprehensiveIncomeAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherComprehensiveIncomeAbstract_lbl0" xml:lang="en-US">Total comprehensive (loss) / income attributable to:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncomeAbstract" xlink:to="ifrs-full_OtherComprehensiveIncomeAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_lbl" xml:lang="en-US">Items that may be subsequently reclassified to profit and loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:to="ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations_lbl" xml:lang="en-US">Foreign exchange differences on translation of foreign operations from joint ventures</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax_lbl" xml:lang="en-US">Foreign exchange differences on translation of foreign operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" xlink:to="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ItemsThatWillNotBeSubsequentlyReclassifiedToLossAndProfit" xlink:href="mlec-20250630.xsd#mlec_ItemsThatWillNotBeSubsequentlyReclassifiedToLossAndProfit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="mlec_ItemsThatWillNotBeSubsequentlyReclassifiedToLossAndProfit_lbl" xml:lang="en-US">Items that will not be subsequently reclassified to loss and profit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ItemsThatWillNotBeSubsequentlyReclassifiedToLossAndProfit" xlink:to="mlec_ItemsThatWillNotBeSubsequentlyReclassifiedToLossAndProfit_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTaxOfJointVenturesAndAssociates" xlink:href="mlec-20250630.xsd#mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTaxOfJointVenturesAndAssociates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTaxOfJointVenturesAndAssociates_lbl" xml:lang="en-US">Revaluation of property, plant and equipment, net of tax, of joint ventures and associates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTaxOfJointVenturesAndAssociates" xlink:to="mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTaxOfJointVenturesAndAssociates_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTax" xlink:href="mlec-20250630.xsd#mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTax_lbl" xml:lang="en-US">Revaluation of property, plant and equipment, net of tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTax" xlink:to="mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTax_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossAttributableToAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProfitLossAttributableToAbstract_lbl" xml:lang="en-US">(Loss) / profit for the year attributable to:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossAttributableToAbstract" xlink:to="ifrs-full_ProfitLossAttributableToAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProfitLossAttributableToOwnersOfParent_lbl" xml:lang="en-US">Equity holders of the parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:to="ifrs-full_ProfitLossAttributableToOwnersOfParent_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProfitLossAttributableToNoncontrollingInterests_lbl" xml:lang="en-US">Non-controlling interests</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:to="ifrs-full_ProfitLossAttributableToNoncontrollingInterests_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BasicEarningsLossPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BasicEarningsLossPerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_BasicEarningsLossPerShare_lbl" xml:lang="en-US">Basic (loss) / profit attributable to ordinary equity holders of the parent (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BasicEarningsLossPerShare" xlink:to="ifrs-full_BasicEarningsLossPerShare_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_BasicEarningsLossPerShare_lbl0" xml:lang="en-US">Basic (loss)/profit attributable to ordinary equity holders of the parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BasicEarningsLossPerShare" xlink:to="ifrs-full_BasicEarningsLossPerShare_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DilutedEarningsLossPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DilutedEarningsLossPerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DilutedEarningsLossPerShare_lbl" xml:lang="en-US">Diluted (loss) / profit attributable to ordinary equity holders of the parent (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DilutedEarningsLossPerShare" xlink:to="ifrs-full_DilutedEarningsLossPerShare_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DilutedEarningsLossPerShare_lbl0" xml:lang="en-US">Diluted (loss)/profit attributable to ordinary equity holders of the parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DilutedEarningsLossPerShare" xlink:to="ifrs-full_DilutedEarningsLossPerShare_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_lbl" xml:lang="en-US">Equity holders of the parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:to="ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests_lbl" xml:lang="en-US">Non-controlling interests</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:to="ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AssetsAbstract" xlink:to="ifrs-full_AssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncurrentAssetsAbstract_lbl" xml:lang="en-US">NON-CURRENT ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentAssetsAbstract" xlink:to="ifrs-full_NoncurrentAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentFinancialAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherNoncurrentFinancialAssets_lbl" xml:lang="en-US">Other financial assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentFinancialAssets" xlink:to="ifrs-full_OtherNoncurrentFinancialAssets_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherNoncurrentFinancialAssets_lbl0" xml:lang="en-US">Investments at fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentFinancialAssets" xlink:to="ifrs-full_OtherNoncurrentFinancialAssets_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherNoncurrentReceivables_lbl" xml:lang="en-US">Other receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentReceivables" xlink:to="ifrs-full_OtherNoncurrentReceivables_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherNoncurrentReceivables_lbl0" xml:lang="en-US">Other receivables, Non-current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentReceivables" xlink:to="ifrs-full_OtherNoncurrentReceivables_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentTaxAssetsNoncurrent" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxAssetsNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentTaxAssetsNoncurrent_lbl" xml:lang="en-US">Recoverable income tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentTaxAssetsNoncurrent" xlink:to="ifrs-full_CurrentTaxAssetsNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DeferredTaxAssets_lbl" xml:lang="en-US">Deferred tax assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxAssets" xlink:to="ifrs-full_DeferredTaxAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InvestmentsInJointVenturesAndAssociates" xlink:href="mlec-20250630.xsd#mlec_InvestmentsInJointVenturesAndAssociates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_InvestmentsInJointVenturesAndAssociates_lbl" xml:lang="en-US">Investments in joint ventures and associates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InvestmentsInJointVenturesAndAssociates" xlink:to="mlec_InvestmentsInJointVenturesAndAssociates_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InvestmentProperty" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InvestmentProperty"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_InvestmentProperty_lbl" xml:lang="en-US">Investment properties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InvestmentProperty" xlink:to="ifrs-full_InvestmentProperty_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_InvestmentProperty_lbl0" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InvestmentProperty" xlink:to="ifrs-full_InvestmentProperty_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Goodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Goodwill"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_Goodwill_lbl" xml:lang="en-US">Goodwill</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Goodwill" xlink:to="ifrs-full_Goodwill_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentAssetsAbstract_lbl" xml:lang="en-US">CURRENT ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_CurrentAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherCurrentFinancialAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherCurrentFinancialAssets_lbl" xml:lang="en-US">Other financial assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCurrentFinancialAssets" xlink:to="ifrs-full_OtherCurrentFinancialAssets_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherCurrentFinancialAssets_lbl0" xml:lang="en-US">Investments at fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCurrentFinancialAssets" xlink:to="ifrs-full_OtherCurrentFinancialAssets_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentTradeReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTradeReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentTradeReceivables_lbl" xml:lang="en-US">Trade receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentTradeReceivables" xlink:to="ifrs-full_CurrentTradeReceivables_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CurrentTradeReceivables_lbl0" xml:lang="en-US">Trade debtors</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentTradeReceivables" xlink:to="ifrs-full_CurrentTradeReceivables_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherCurrentReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherCurrentReceivables_lbl" xml:lang="en-US">Other receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCurrentReceivables" xlink:to="ifrs-full_OtherCurrentReceivables_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherCurrentReceivables_lbl0" xml:lang="en-US">Other receivables, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCurrentReceivables" xlink:to="ifrs-full_OtherCurrentReceivables_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentTaxAssetsCurrent" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxAssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentTaxAssetsCurrent_lbl" xml:lang="en-US">Recoverable income tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentTaxAssetsCurrent" xlink:to="ifrs-full_CurrentTaxAssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Inventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Inventories"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_Inventories_lbl" xml:lang="en-US">Inventories</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Inventories" xlink:to="ifrs-full_Inventories_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentBiologicalAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentBiologicalAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentBiologicalAssets_lbl" xml:lang="en-US">Biological assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentBiologicalAssets" xlink:to="ifrs-full_CurrentBiologicalAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_EquityAbstract_lbl" xml:lang="en-US">SHAREHOLDERS&#8217; DEFICIT / EQUITY</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAbstract" xlink:to="ifrs-full_EquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuedCapital" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapital"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IssuedCapital_lbl" xml:lang="en-US">Issued capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssuedCapital" xlink:to="ifrs-full_IssuedCapital_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareToBeIssuedAmount" xlink:href="mlec-20250630.xsd#mlec_ShareToBeIssuedAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ShareToBeIssuedAmount_lbl" xml:lang="en-US">Shared to be issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareToBeIssuedAmount" xlink:to="mlec_ShareToBeIssuedAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SharesPremium" xlink:href="mlec-20250630.xsd#mlec_SharesPremium"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SharesPremium_lbl" xml:lang="en-US">Shares premium</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SharesPremium" xlink:to="mlec_SharesPremium_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_OwnSharesHeld" xlink:href="mlec-20250630.xsd#mlec_OwnSharesHeld"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_OwnSharesHeld_lbl" xml:lang="en-US">Own shares held</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OwnSharesHeld" xlink:to="mlec_OwnSharesHeld_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_StockOptionsAndShareBasedIncentives" xlink:href="mlec-20250630.xsd#mlec_StockOptionsAndShareBasedIncentives"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_StockOptionsAndShareBasedIncentives_lbl" xml:lang="en-US">Stock options and share based incentives</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_StockOptionsAndShareBasedIncentives" xlink:to="mlec_StockOptionsAndShareBasedIncentives_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RetainedEarnings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RetainedEarnings"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RetainedEarnings_lbl" xml:lang="en-US">Retained earnings / (deficit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RetainedEarnings" xlink:to="ifrs-full_RetainedEarnings_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_RevaluationOfPropertyPlantAndEquipmentReserve" xlink:href="mlec-20250630.xsd#mlec_RevaluationOfPropertyPlantAndEquipmentReserve"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_RevaluationOfPropertyPlantAndEquipmentReserve_lbl" xml:lang="en-US">Revaluation of property, plant and equipment reserve</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RevaluationOfPropertyPlantAndEquipmentReserve" xlink:to="mlec_RevaluationOfPropertyPlantAndEquipmentReserve_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslation_lbl" xml:lang="en-US">Foreign currency translation reserve</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:to="ifrs-full_ReserveOfExchangeDifferencesOnTranslation_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityAttributableToOwnersOfParent" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAttributableToOwnersOfParent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_EquityAttributableToOwnersOfParent_lbl" xml:lang="en-US">Shareholders&#8217; deficit / Equity attributable to owners of the parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAttributableToOwnersOfParent" xlink:to="ifrs-full_EquityAttributableToOwnersOfParent_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncontrollingInterests" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncontrollingInterests"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncontrollingInterests_lbl" xml:lang="en-US">Non-controlling interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncontrollingInterests" xlink:to="ifrs-full_NoncontrollingInterests_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_LiabilitiesAbstract_lbl" xml:lang="en-US">LIABILITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiabilitiesAbstract" xlink:to="ifrs-full_LiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncurrentLiabilitiesAbstract_lbl" xml:lang="en-US">NON-CURRENT LIABILITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLiabilitiesAbstract" xlink:to="ifrs-full_NoncurrentLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LongtermBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LongtermBorrowings"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_LongtermBorrowings_lbl" xml:lang="en-US">Borrowings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LongtermBorrowings" xlink:to="ifrs-full_LongtermBorrowings_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_LongtermBorrowings_lbl0" xml:lang="en-US">Non current borrowing</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LongtermBorrowings" xlink:to="ifrs-full_LongtermBorrowings_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentContractLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentContractLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncurrentContractLiabilities_lbl" xml:lang="en-US">Deferred revenue and advances from customers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentContractLiabilities" xlink:to="ifrs-full_NoncurrentContractLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentGovernmentGrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentGovernmentGrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncurrentGovernmentGrants_lbl" xml:lang="en-US">Government grants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentGovernmentGrants" xlink:to="ifrs-full_NoncurrentGovernmentGrants_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_JointVenturesAndAssociatesLiabilities" xlink:href="mlec-20250630.xsd#mlec_JointVenturesAndAssociatesLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_JointVenturesAndAssociatesLiabilities_lbl" xml:lang="en-US">Joint ventures and associates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_JointVenturesAndAssociatesLiabilities" xlink:to="mlec_JointVenturesAndAssociatesLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DeferredTaxLiabilities_lbl" xml:lang="en-US">Deferred tax liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxLiabilities" xlink:to="ifrs-full_DeferredTaxLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentProvisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentProvisions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncurrentProvisions_lbl" xml:lang="en-US">Provisions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentProvisions" xlink:to="ifrs-full_NoncurrentProvisions_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ConsiderationForAcquisitionOfAssetsNonCurrent" xlink:href="mlec-20250630.xsd#mlec_ConsiderationForAcquisitionOfAssetsNonCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ConsiderationForAcquisitionOfAssetsNonCurrent_lbl" xml:lang="en-US">Consideration for acquisition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ConsiderationForAcquisitionOfAssetsNonCurrent" xlink:to="mlec_ConsiderationForAcquisitionOfAssetsNonCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SecuredDebtNonCurrent" xlink:href="mlec-20250630.xsd#mlec_SecuredDebtNonCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SecuredDebtNonCurrent_lbl" xml:lang="en-US">Convertible and non-convertible notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SecuredDebtNonCurrent" xlink:to="mlec_SecuredDebtNonCurrent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="mlec_SecuredDebtNonCurrent_lbl0" xml:lang="en-US">Convertible notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SecuredDebtNonCurrent" xlink:to="mlec_SecuredDebtNonCurrent_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncurrentLeaseLiabilities_lbl" xml:lang="en-US">Lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLeaseLiabilities" xlink:to="ifrs-full_NoncurrentLeaseLiabilities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NoncurrentLeaseLiabilities_lbl0" xml:lang="en-US">Non-current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLeaseLiabilities" xlink:to="ifrs-full_NoncurrentLeaseLiabilities_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentLiabilitiesAbstract_lbl" xml:lang="en-US">CURRENT LIABILITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_CurrentLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShorttermBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShorttermBorrowings"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ShorttermBorrowings_lbl" xml:lang="en-US">Borrowings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShorttermBorrowings" xlink:to="ifrs-full_ShorttermBorrowings_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ShorttermBorrowings_lbl0" xml:lang="en-US">Current borrowing</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShorttermBorrowings" xlink:to="ifrs-full_ShorttermBorrowings_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="ifrs-full_ShorttermBorrowings_lbl1" xml:lang="en-US">Working capital loan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShorttermBorrowings" xlink:to="ifrs-full_ShorttermBorrowings_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentTaxLiabilitiesCurrent_lbl" xml:lang="en-US">Income tax payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:to="ifrs-full_CurrentTaxLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentGovernmentGrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentGovernmentGrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentGovernmentGrants_lbl" xml:lang="en-US">Government grants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentGovernmentGrants" xlink:to="ifrs-full_CurrentGovernmentGrants_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ConsiderationForAcquisitionOfAssetsCurrent" xlink:href="mlec-20250630.xsd#mlec_ConsiderationForAcquisitionOfAssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ConsiderationForAcquisitionOfAssetsCurrent_lbl" xml:lang="en-US">Consideration for acquisition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ConsiderationForAcquisitionOfAssetsCurrent" xlink:to="mlec_ConsiderationForAcquisitionOfAssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLeaseLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentLeaseLiabilities_lbl" xml:lang="en-US">Lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLeaseLiabilities" xlink:to="ifrs-full_CurrentLeaseLiabilities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CurrentLeaseLiabilities_lbl0" xml:lang="en-US">Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLeaseLiabilities" xlink:to="ifrs-full_CurrentLeaseLiabilities_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners_lbl" xml:lang="en-US">Increase in capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners" xlink:to="ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl_lbl" xml:lang="en-US">Changes in ownership interests in subsidiaries</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" xlink:to="ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_lbl" xml:lang="en-US">Share-based incentives of subsidiaries</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:to="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_IncreaseDecreaseThroughChangesInBusinessCombinationEquity" xlink:href="mlec-20250630.xsd#mlec_IncreaseDecreaseThroughChangesInBusinessCombinationEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_IncreaseDecreaseThroughChangesInBusinessCombinationEquity_lbl" xml:lang="en-US">Business combination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IncreaseDecreaseThroughChangesInBusinessCombinationEquity" xlink:to="mlec_IncreaseDecreaseThroughChangesInBusinessCombinationEquity_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeBeforeTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeBeforeTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherComprehensiveIncomeBeforeTax_lbl" xml:lang="en-US">Other comprehensive loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncomeBeforeTax" xlink:to="ifrs-full_OtherComprehensiveIncomeBeforeTax_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">OPERATING ACTIVITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfCashPaymentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfCashPaymentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ClassesOfCashPaymentsAbstract_lbl" xml:lang="en-US">Adjustments to reconcile (loss) / profit to net cash flows</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfCashPaymentsAbstract" xlink:to="ifrs-full_ClassesOfCashPaymentsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncomeTaxExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForIncomeTaxExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForIncomeTaxExpense_lbl" xml:lang="en-US">Income tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncomeTaxExpense" xlink:to="ifrs-full_AdjustmentsForIncomeTaxExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDepreciationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDepreciationExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForDepreciationExpense_lbl" xml:lang="en-US">Depreciation of property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDepreciationExpense" xlink:to="ifrs-full_AdjustmentsForDepreciationExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AmortizationOfIntangibleAsset" xlink:href="mlec-20250630.xsd#mlec_AmortizationOfIntangibleAsset"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AmortizationOfIntangibleAsset_lbl" xml:lang="en-US">Amortization of intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AmortizationOfIntangibleAsset" xlink:to="mlec_AmortizationOfIntangibleAsset_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DepreciationOfLeasedAssets" xlink:href="mlec-20250630.xsd#mlec_DepreciationOfLeasedAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DepreciationOfLeasedAssets_lbl" xml:lang="en-US">Depreciation of leased assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DepreciationOfLeasedAssets" xlink:to="mlec_DepreciationOfLeasedAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForFairValueGainsLosses" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForFairValueGainsLosses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForFairValueGainsLosses_lbl" xml:lang="en-US">Gain from a bargain purchase</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForFairValueGainsLosses" xlink:to="ifrs-full_AdjustmentsForFairValueGainsLosses_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_RemeasurementOfPreviouslyHeldInterest" xlink:href="mlec-20250630.xsd#mlec_RemeasurementOfPreviouslyHeldInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_RemeasurementOfPreviouslyHeldInterest_lbl" xml:lang="en-US">Remeasurement of previously held interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RemeasurementOfPreviouslyHeldInterest" xlink:to="mlec_RemeasurementOfPreviouslyHeldInterest_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments_lbl" xml:lang="en-US">Share-based incentive and stock options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForSharebasedPayments" xlink:to="ifrs-full_AdjustmentsForSharebasedPayments_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ProvisionsForContingencies" xlink:href="mlec-20250630.xsd#mlec_ProvisionsForContingencies"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ProvisionsForContingencies_lbl" xml:lang="en-US">Provisions for contingencies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ProvisionsForContingencies" xlink:to="mlec_ProvisionsForContingencies_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AllowanceForImpairmentOfTradeDebtors" xlink:href="mlec-20250630.xsd#mlec_AllowanceForImpairmentOfTradeDebtors"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AllowanceForImpairmentOfTradeDebtors_lbl" xml:lang="en-US">Allowance for impairment of trade debtors</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AllowanceForImpairmentOfTradeDebtors" xlink:to="mlec_AllowanceForImpairmentOfTradeDebtors_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AllowanceForObsolescences" xlink:href="mlec-20250630.xsd#mlec_AllowanceForObsolescences"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AllowanceForObsolescences_lbl" xml:lang="en-US">Allowance for obsolescence</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AllowanceForObsolescences" xlink:to="mlec_AllowanceForObsolescences_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets_lbl" xml:lang="en-US">Initial recognition and changes in the fair value of biological assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets" xlink:to="ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForFinanceCosts" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForFinanceCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForFinanceCosts_lbl" xml:lang="en-US">Financial results</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForFinanceCosts" xlink:to="ifrs-full_AdjustmentsForFinanceCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets_lbl" xml:lang="en-US">Gain on sale of equipment and intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" xlink:to="ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets_lbl0" xml:lang="en-US">Result of intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" xlink:to="ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_WorkingCapitalAdjustmentsOperatingActivitiesAbstract" xlink:href="mlec-20250630.xsd#mlec_WorkingCapitalAdjustmentsOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_WorkingCapitalAdjustmentsOperatingActivitiesAbstract_lbl" xml:lang="en-US">Working capital adjustments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_WorkingCapitalAdjustmentsOperatingActivitiesAbstract" xlink:to="mlec_WorkingCapitalAdjustmentsOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_lbl" xml:lang="en-US">Trade receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_lbl" xml:lang="en-US">Other receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_lbl" xml:lang="en-US">Inventories and biological assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_lbl" xml:lang="en-US">Trade and other payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_lbl" xml:lang="en-US">Employee benefits and social security</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AdjustmentsForDecreaseIncreaseInGovernmentGrants" xlink:href="mlec-20250630.xsd#mlec_AdjustmentsForDecreaseIncreaseInGovernmentGrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AdjustmentsForDecreaseIncreaseInGovernmentGrants_lbl" xml:lang="en-US">Government grants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AdjustmentsForDecreaseIncreaseInGovernmentGrants" xlink:to="mlec_AdjustmentsForDecreaseIncreaseInGovernmentGrants_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities_lbl" xml:lang="en-US">Deferred revenue and advances from customers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">INVESTMENT ACTIVITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_lbl0" xml:lang="en-US">Investment activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl" xml:lang="en-US">Proceeds from sale of property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:to="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCashReceiptsFromSalesOfInterestsInJointVenturesClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherCashReceiptsFromSalesOfInterestsInJointVenturesClassifiedAsInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherCashReceiptsFromSalesOfInterestsInJointVenturesClassifiedAsInvestingActivities_lbl" xml:lang="en-US">Investment in joint ventures and associates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCashReceiptsFromSalesOfInterestsInJointVenturesClassifiedAsInvestingActivities" xlink:to="ifrs-full_OtherCashReceiptsFromSalesOfInterestsInJointVenturesClassifiedAsInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_lbl" xml:lang="en-US">Net cash received from business combination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:to="ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities_lbl" xml:lang="en-US">Proceeds from financial assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:to="ifrs-full_ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">FINANCING ACTIVITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_lbl0" xml:lang="en-US">Financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_lbl" xml:lang="en-US">Proceeds from borrowings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:to="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_lbl" xml:lang="en-US">Effect of exchange rate changes on cash and equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:to="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_lbl" xml:lang="en-US">Initial recognition and changes in the fair value of biological assets at the point of harvest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets" xlink:to="ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_lbl0" xml:lang="en-US">Initial recognition and changes in the fair value of biological assets at the point of harvest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets" xlink:to="ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_lbl1" xml:lang="en-US">Initial recognition and changes in the fair value of biological assets at the point of harvest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets" xlink:to="ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CostOfSales" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CostOfSales"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_CostOfSales_lbl" xml:lang="en-US">Cost of sales</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CostOfSales" xlink:to="ifrs-full_CostOfSales_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CostOfSales_lbl0" xml:lang="en-US">Cost of sales</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CostOfSales" xlink:to="ifrs-full_CostOfSales_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CostOfSales_lbl1" xml:lang="en-US">Sales</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CostOfSales" xlink:to="ifrs-full_CostOfSales_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="ifrs-full_CostOfSales_lbl2" xml:lang="en-US">Cost of sales</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CostOfSales" xlink:to="ifrs-full_CostOfSales_lbl2"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Selling, general and administrative expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:to="ifrs-full_SellingGeneralAndAdministrativeExpense_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpense_lbl0" xml:lang="en-US">Selling, general and administrative expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:to="ifrs-full_SellingGeneralAndAdministrativeExpense_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughOtherDistributionsToOwners" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughOtherDistributionsToOwners"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_IncreaseDecreaseThroughOtherDistributionsToOwners_lbl" xml:lang="en-US">BIOX of deconsolidation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughOtherDistributionsToOwners" xlink:to="ifrs-full_IncreaseDecreaseThroughOtherDistributionsToOwners_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DividendsPaid" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DividendsPaid"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_DividendsPaid_lbl" xml:lang="en-US">Distribution of dividends</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DividendsPaid" xlink:to="ifrs-full_DividendsPaid_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnChangeInFairValueEstimatesOfBiologicalAssetsForCurrentPeriod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnChangeInFairValueEstimatesOfBiologicalAssetsForCurrentPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_GainsLossesOnChangeInFairValueEstimatesOfBiologicalAssetsForCurrentPeriod_lbl" xml:lang="en-US">Changes in the net realizable value of agricultural products after harvest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsLossesOnChangeInFairValueEstimatesOfBiologicalAssetsForCurrentPeriod" xlink:to="ifrs-full_GainsLossesOnChangeInFairValueEstimatesOfBiologicalAssetsForCurrentPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_lbl" xml:lang="en-US">Income tax paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:to="ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_lbl" xml:lang="en-US">Loss of controlling interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:to="ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod_lbl" xml:lang="en-US">Investment in financial assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod" xlink:to="ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl" xml:lang="en-US">Purchase of property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:to="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PaymentsForDevelopmentProjectExpenditure" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PaymentsForDevelopmentProjectExpenditure"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_PaymentsForDevelopmentProjectExpenditure_lbl" xml:lang="en-US">Capitalized development expenditures</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PaymentsForDevelopmentProjectExpenditure" xlink:to="ifrs-full_PaymentsForDevelopmentProjectExpenditure_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_lbl" xml:lang="en-US">Purchase of intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:to="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_lbl" xml:lang="en-US">Repayment of borrowings and financed payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:to="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_InterestPaidClassifiedAsFinancingActivities_lbl" xml:lang="en-US">Interest payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:to="ifrs-full_InterestPaidClassifiedAsFinancingActivities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="ifrs-full_InterestPaidClassifiedAsFinancingActivities_lbl0" xml:lang="en-US">Interest payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:to="ifrs-full_InterestPaidClassifiedAsFinancingActivities_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_lbl" xml:lang="en-US">Leased assets payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:to="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities_lbl" xml:lang="en-US">Cash dividend distributed by non-controlling interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities" xlink:to="ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PaymentsOfOtherEquityInstruments" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PaymentsOfOtherEquityInstruments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_PaymentsOfOtherEquityInstruments_lbl" xml:lang="en-US">Other financial payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PaymentsOfOtherEquityInstruments" xlink:to="ifrs-full_PaymentsOfOtherEquityInstruments_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PurchaseOfOwnShares" xlink:href="mlec-20250630.xsd#mlec_PurchaseOfOwnShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mlec_PurchaseOfOwnShares_lbl" xml:lang="en-US">Purchase of own shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PurchaseOfOwnShares" xlink:to="mlec_PurchaseOfOwnShares_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_BusinessContactMember" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_BusinessContactMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_BusinessContactMember_lbl" xml:lang="en-US">Business Contact</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_BusinessContactMember" xlink:to="dei_BusinessContactMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_OrdinarySharesWithNominalValueOfUS010PerShareMember" xlink:href="mlec-20250630.xsd#mlec_OrdinarySharesWithNominalValueOfUS010PerShareMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_OrdinarySharesWithNominalValueOfUS010PerShareMember_lbl" xml:lang="en-US">Ordinary Shares, with nominal value of US$0.10 per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OrdinarySharesWithNominalValueOfUS010PerShareMember" xlink:to="mlec_OrdinarySharesWithNominalValueOfUS010PerShareMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_WarrantsExercisableForOrdinarySharesMember" xlink:href="mlec-20250630.xsd#mlec_WarrantsExercisableForOrdinarySharesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_WarrantsExercisableForOrdinarySharesMember_lbl" xml:lang="en-US">Warrants, exercisable for ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_WarrantsExercisableForOrdinarySharesMember" xlink:to="mlec_WarrantsExercisableForOrdinarySharesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuedCapitalMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapitalMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IssuedCapitalMember_lbl" xml:lang="en-US">Issued capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssuedCapitalMember" xlink:to="ifrs-full_IssuedCapitalMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SharesIssuedMember" xlink:href="mlec-20250630.xsd#mlec_SharesIssuedMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SharesIssuedMember_lbl" xml:lang="en-US">Shares to be issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SharesIssuedMember" xlink:to="mlec_SharesIssuedMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_OwnSharesHeldMember" xlink:href="mlec-20250630.xsd#mlec_OwnSharesHeldMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_OwnSharesHeldMember_lbl" xml:lang="en-US">Own shares held</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OwnSharesHeldMember" xlink:to="mlec_OwnSharesHeldMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharePremiumMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SharePremiumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_SharePremiumMember_lbl" xml:lang="en-US">Share premium</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SharePremiumMember" xlink:to="ifrs-full_SharePremiumMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReserveOfSharebasedPaymentsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ReserveOfSharebasedPaymentsMember_lbl" xml:lang="en-US">Stock options and share based incentives</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:to="ifrs-full_ReserveOfSharebasedPaymentsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RetainedEarningsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RetainedEarningsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RetainedEarningsMember_lbl" xml:lang="en-US">Retained (deficit) earnings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RetainedEarningsMember" xlink:to="ifrs-full_RetainedEarningsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_lbl" xml:lang="en-US">Foreign currency translation reserve</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:to="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_RevaluationOfPropertyPlantEquipmentAndEffectOfTaxRateChangeMember" xlink:href="mlec-20250630.xsd#mlec_RevaluationOfPropertyPlantEquipmentAndEffectOfTaxRateChangeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_RevaluationOfPropertyPlantEquipmentAndEffectOfTaxRateChangeMember_lbl" xml:lang="en-US">Revaluation of PP&amp;E and effect of tax rate change</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RevaluationOfPropertyPlantEquipmentAndEffectOfTaxRateChangeMember" xlink:to="mlec_RevaluationOfPropertyPlantEquipmentAndEffectOfTaxRateChangeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAttributableToOwnersOfParentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_EquityAttributableToOwnersOfParentMember_lbl" xml:lang="en-US">Attributable to the equity holders of the parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:to="ifrs-full_EquityAttributableToOwnersOfParentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncontrollingInterestsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncontrollingInterestsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncontrollingInterestsMember_lbl" xml:lang="en-US">Non-controlling Interests</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncontrollingInterestsMember" xlink:to="ifrs-full_NoncontrollingInterestsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_lbl" xml:lang="en-US">The Group&#8217;s Business Reorganization and General Information</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xlink:to="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory_lbl" xml:lang="en-US">ACCOUNTING STANDARDS AND BASIS OF PREPARATION</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory_lbl" xml:lang="en-US">Schedule of Information related to Company&#8217;s Share of Voting Rights in its Subsidiaries</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory" xlink:to="ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NameOfSubsidiary" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NameOfSubsidiary"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NameOfSubsidiary_lbl" xml:lang="en-US">Principal activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NameOfSubsidiary" xlink:to="ifrs-full_NameOfSubsidiary_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary_lbl" xml:lang="en-US">Country of incorporation and principal place of business</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary" xlink:to="ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProportionOfOwnershipInterestInSubsidiary_lbl" xml:lang="en-US">Equity interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:to="ifrs-full_ProportionOfOwnershipInterestInSubsidiary_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ProportionOfOwnershipInterestInSubsidiary_lbl0" xml:lang="en-US">Bioceres Crop Solutions (*)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:to="ifrs-full_ProportionOfOwnershipInterestInSubsidiary_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_lbl" xml:lang="en-US">NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS ISSUED BY THE IASB</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" xlink:to="ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory_lbl" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory" xlink:to="ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_lbl" xml:lang="en-US">CRITICAL ACCOUNTING JUDGMENTS AND ESTIMATES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:to="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory_lbl" xml:lang="en-US">ACQUISITIONS AND OTHER SIGNIFICANT TRANSACTIONS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory" xlink:to="ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfFairValueOfConsiderationOfPaymentTableTextBlock" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfFairValueOfConsiderationOfPaymentTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ScheduleOfFairValueOfConsiderationOfPaymentTableTextBlock_lbl" xml:lang="en-US">Schedule of Fair Value of the Consideration of Payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfFairValueOfConsiderationOfPaymentTableTextBlock" xlink:to="mlec_ScheduleOfFairValueOfConsiderationOfPaymentTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_EquityShares" xlink:href="mlec-20250630.xsd#mlec_EquityShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_EquityShares_lbl" xml:lang="en-US">Equity shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_EquityShares" xlink:to="mlec_EquityShares_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WarrantLiability" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WarrantLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WarrantLiability_lbl" xml:lang="en-US">Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WarrantLiability" xlink:to="ifrs-full_WarrantLiability_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_WarrantLiability_lbl0" xml:lang="en-US">Warrant liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WarrantLiability" xlink:to="ifrs-full_WarrantLiability_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashTransferred" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashTransferred"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CashTransferred_lbl" xml:lang="en-US">Cash payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashTransferred" xlink:to="ifrs-full_CashTransferred_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CashTransferred_lbl0" xml:lang="en-US">Transfer all rights, licenses, and materials</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashTransferred" xlink:to="ifrs-full_CashTransferred_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityInterestsOfAcquirer" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityInterestsOfAcquirer"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_EquityInterestsOfAcquirer_lbl" xml:lang="en-US">Regulatory activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityInterestsOfAcquirer" xlink:to="ifrs-full_EquityInterestsOfAcquirer_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_lbl" xml:lang="en-US">Schedule of Fair Value of the Consideration of Payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherCashAndCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherCashAndCashEquivalents_lbl" xml:lang="en-US">Cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCashAndCashEquivalents" xlink:to="ifrs-full_OtherCashAndCashEquivalents_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TradeReceivables_lbl" xml:lang="en-US">Trade and other receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeReceivables" xlink:to="ifrs-full_TradeReceivables_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_TradeReceivables_lbl0" xml:lang="en-US">Trade receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeReceivables" xlink:to="ifrs-full_TradeReceivables_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_lbl" xml:lang="en-US">Property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_lbl" xml:lang="en-US">Intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdditionsToRightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdditionsToRightofuseAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdditionsToRightofuseAssets_lbl" xml:lang="en-US">Right of use assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionsToRightofuseAssets" xlink:to="ifrs-full_AdditionsToRightofuseAssets_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdditionsToRightofuseAssets_lbl0" xml:lang="en-US">Additions of the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionsToRightofuseAssets" xlink:to="ifrs-full_AdditionsToRightofuseAssets_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_NoncontrollingInterest" xlink:href="mlec-20250630.xsd#mlec_NoncontrollingInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NoncontrollingInterest_lbl" xml:lang="en-US">Non-controlling interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NoncontrollingInterest" xlink:to="mlec_NoncontrollingInterest_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialAssetsAtFairValue" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssetsAtFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_FinancialAssetsAtFairValue_lbl" xml:lang="en-US">Previously held interest - revalued at FV</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialAssetsAtFairValue" xlink:to="ifrs-full_FinancialAssetsAtFairValue_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_FinancialAssetsAtFairValue_lbl0" xml:lang="en-US">Financial assets at fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialAssetsAtFairValue" xlink:to="ifrs-full_FinancialAssetsAtFairValue_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnDisposalsOfInvestments" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnDisposalsOfInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_GainsLossesOnDisposalsOfInvestments_lbl" xml:lang="en-US">Gain on purchase</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsLossesOnDisposalsOfInvestments" xlink:to="ifrs-full_GainsLossesOnDisposalsOfInvestments_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherFinancialAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherFinancialAssets_lbl" xml:lang="en-US">Other financial assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherFinancialAssets" xlink:to="ifrs-full_OtherFinancialAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherReceivables_lbl" xml:lang="en-US">Other receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherReceivables" xlink:to="ifrs-full_OtherReceivables_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherReceivables_lbl0" xml:lang="en-US">Deferred checks</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherReceivables" xlink:to="ifrs-full_OtherReceivables_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_IncomeAndMinimumPresumedRecoverableIncomeTaxes" xlink:href="mlec-20250630.xsd#mlec_IncomeAndMinimumPresumedRecoverableIncomeTaxes"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_IncomeAndMinimumPresumedRecoverableIncomeTaxes_lbl" xml:lang="en-US">Income and minimum presumed recoverable income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IncomeAndMinimumPresumedRecoverableIncomeTaxes" xlink:to="mlec_IncomeAndMinimumPresumedRecoverableIncomeTaxes_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_lbl" xml:lang="en-US">Deferred revenue and advances from customers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:to="ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_lbl0" xml:lang="en-US">Income tax provision</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:to="ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock_lbl" xml:lang="en-US">INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock" xlink:to="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_lbl" xml:lang="en-US">Schedule of Cash and Cash Equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" xlink:to="ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Cash" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Cash"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_Cash_lbl" xml:lang="en-US">Cash at bank and on hand</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Cash" xlink:to="ifrs-full_Cash_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_MutualFunds" xlink:href="mlec-20250630.xsd#mlec_MutualFunds"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_MutualFunds_lbl" xml:lang="en-US">Mutual funds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MutualFunds" xlink:to="mlec_MutualFunds_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfOtherFinancialAssetsExplanatory" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfOtherFinancialAssetsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DisclosureOfOtherFinancialAssetsExplanatory_lbl" xml:lang="en-US">Schedule of Other Financial Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfOtherFinancialAssetsExplanatory" xlink:to="mlec_DisclosureOfOtherFinancialAssetsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_CurrentAbstract" xlink:href="mlec-20250630.xsd#mlec_CurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_CurrentAbstract_lbl" xml:lang="en-US">Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CurrentAbstract" xlink:to="mlec_CurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_UnlabeledAbstract" xlink:href="mlec-20250630.xsd#mlec_UnlabeledAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_UnlabeledAbstract_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract" xlink:to="mlec_UnlabeledAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NonCurrentAbstract" xlink:href="mlec-20250630.xsd#mlec_NonCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NonCurrentAbstract_lbl" xml:lang="en-US">Non-current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NonCurrentAbstract" xlink:to="mlec_NonCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfTradeReceivablesTableTextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfTradeReceivablesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DisclosureOfTradeReceivablesTableTextBlock_lbl" xml:lang="en-US">Schedule of Trade Receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfTradeReceivablesTableTextBlock" xlink:to="mlec_DisclosureOfTradeReceivablesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_CurrentAbstract0" xlink:href="mlec-20250630.xsd#mlec_CurrentAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_CurrentAbstract0_lbl" xml:lang="en-US">Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CurrentAbstract0" xlink:to="mlec_CurrentAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_CurrentTradeReceivablesAllowanceForImpairmentOfTradeDebtors" xlink:href="mlec-20250630.xsd#mlec_CurrentTradeReceivablesAllowanceForImpairmentOfTradeDebtors"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_CurrentTradeReceivablesAllowanceForImpairmentOfTradeDebtors_lbl" xml:lang="en-US">Allowance for impairment of trade debtors</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CurrentTradeReceivablesAllowanceForImpairmentOfTradeDebtors" xlink:to="mlec_CurrentTradeReceivablesAllowanceForImpairmentOfTradeDebtors_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_CurrentTradeReceivablesShareholdersAndOtherRelatedParties" xlink:href="mlec-20250630.xsd#mlec_CurrentTradeReceivablesShareholdersAndOtherRelatedParties"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_CurrentTradeReceivablesShareholdersAndOtherRelatedParties_lbl" xml:lang="en-US">Shareholders and other related parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CurrentTradeReceivablesShareholdersAndOtherRelatedParties" xlink:to="mlec_CurrentTradeReceivablesShareholdersAndOtherRelatedParties_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AllowanceForReturnOfGoods" xlink:href="mlec-20250630.xsd#mlec_AllowanceForReturnOfGoods"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AllowanceForReturnOfGoods_lbl" xml:lang="en-US">Allowance for credit notes to be issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AllowanceForReturnOfGoods" xlink:to="mlec_AllowanceForReturnOfGoods_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_CurrentTradeReceivablesTradeDebtorsJointVenturesAndAssociates" xlink:href="mlec-20250630.xsd#mlec_CurrentTradeReceivablesTradeDebtorsJointVenturesAndAssociates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_CurrentTradeReceivablesTradeDebtorsJointVenturesAndAssociates_lbl" xml:lang="en-US">Trade debtors - Joint ventures and associates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CurrentTradeReceivablesTradeDebtorsJointVenturesAndAssociates" xlink:to="mlec_CurrentTradeReceivablesTradeDebtorsJointVenturesAndAssociates_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfOtherReceivablesTableTextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfOtherReceivablesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DisclosureOfOtherReceivablesTableTextBlock_lbl" xml:lang="en-US">Schedule of Other Receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfOtherReceivablesTableTextBlock" xlink:to="mlec_DisclosureOfOtherReceivablesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_CurrentAbstract1" xlink:href="mlec-20250630.xsd#mlec_CurrentAbstract1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_CurrentAbstract1_lbl" xml:lang="en-US">Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CurrentAbstract1" xlink:to="mlec_CurrentAbstract1_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NonCurrentAbstract0" xlink:href="mlec-20250630.xsd#mlec_NonCurrentAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NonCurrentAbstract0_lbl" xml:lang="en-US">Non-current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NonCurrentAbstract0" xlink:to="mlec_NonCurrentAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfInventoriesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInventoriesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfInventoriesExplanatory_lbl" xml:lang="en-US">Schedule of Inventories</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfInventoriesExplanatory" xlink:to="ifrs-full_DisclosureOfInventoriesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InventoriesCurrent" xlink:href="mlec-20250630.xsd#mlec_InventoriesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_InventoriesCurrent_lbl" xml:lang="en-US">Inventories</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InventoriesCurrent" xlink:to="mlec_InventoriesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_UnlabeledAbstract0" xlink:href="mlec-20250630.xsd#mlec_UnlabeledAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_UnlabeledAbstract0_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract0" xlink:to="mlec_UnlabeledAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InventoriesExcludingAgriculturalProduce" xlink:href="mlec-20250630.xsd#mlec_InventoriesExcludingAgriculturalProduce"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_InventoriesExcludingAgriculturalProduce_lbl" xml:lang="en-US">Net of agricultural products</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InventoriesExcludingAgriculturalProduce" xlink:to="mlec_InventoriesExcludingAgriculturalProduce_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory_lbl" xml:lang="en-US">Schedule of Changes in Biological Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets_lbl" xml:lang="en-US">Costs incurred during the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_lbl" xml:lang="en-US">Schedule of Property, Plant and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_lbl" xml:lang="en-US">Additions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_lbl" xml:lang="en-US">Reclassification within PPE</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" xlink:to="ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_lbl" xml:lang="en-US">Foreign currency translation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" xlink:to="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_lbl" xml:lang="en-US">Business combination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:to="ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_lbl0" xml:lang="en-US">Acquisition from business combination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:to="ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment_lbl" xml:lang="en-US">Reclassification from Investment properties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment" xlink:to="ifrs-full_IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfDepreciationIfAssetsHadBeenCarriedUnderCostModelTextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfDepreciationIfAssetsHadBeenCarriedUnderCostModelTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DisclosureOfDepreciationIfAssetsHadBeenCarriedUnderCostModelTextBlock_lbl" xml:lang="en-US">Schedule of Carrying Amounts that Would Have Been Recognized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfDepreciationIfAssetsHadBeenCarriedUnderCostModelTextBlock" xlink:to="mlec_DisclosureOfDepreciationIfAssetsHadBeenCarriedUnderCostModelTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets_lbl" xml:lang="en-US">Land and buildings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets" xlink:to="ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_lbl" xml:lang="en-US">Schedule of&#8203; Intangible Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SeedAndIntegratedProductsAbstract" xlink:href="mlec-20250630.xsd#mlec_SeedAndIntegratedProductsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SeedAndIntegratedProductsAbstract_lbl" xml:lang="en-US">Seed and integrated products</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SeedAndIntegratedProductsAbstract" xlink:to="mlec_SeedAndIntegratedProductsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US">Additions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets" xlink:href="mlec-20250630.xsd#mlec_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets_lbl" xml:lang="en-US">Loss of control</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets" xlink:to="mlec_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AdditionsFromBusinessCombinations" xlink:href="mlec-20250630.xsd#mlec_AdditionsFromBusinessCombinations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AdditionsFromBusinessCombinations_lbl" xml:lang="en-US">Additions from business combinations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AdditionsFromBusinessCombinations" xlink:to="mlec_AdditionsFromBusinessCombinations_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US">Foreign currency translation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_CropNutritionAbstract" xlink:href="mlec-20250630.xsd#mlec_CropNutritionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_CropNutritionAbstract_lbl" xml:lang="en-US">Crop nutrition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CropNutritionAbstract" xlink:to="mlec_CropNutritionAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherIntangibleAssetsAbstract" xlink:href="mlec-20250630.xsd#mlec_OtherIntangibleAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_OtherIntangibleAssetsAbstract_lbl" xml:lang="en-US">Other intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherIntangibleAssetsAbstract" xlink:to="mlec_OtherIntangibleAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SeedAndIntegratedProductsAbstract0" xlink:href="mlec-20250630.xsd#mlec_SeedAndIntegratedProductsAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SeedAndIntegratedProductsAbstract0_lbl" xml:lang="en-US">Seed and integrated products</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SeedAndIntegratedProductsAbstract0" xlink:to="mlec_SeedAndIntegratedProductsAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_CropNutritionAbstract0" xlink:href="mlec-20250630.xsd#mlec_CropNutritionAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_CropNutritionAbstract0_lbl" xml:lang="en-US">Crop nutrition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CropNutritionAbstract0" xlink:to="mlec_CropNutritionAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherIntangibleAssetsAbstract0" xlink:href="mlec-20250630.xsd#mlec_OtherIntangibleAssetsAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_OtherIntangibleAssetsAbstract0_lbl" xml:lang="en-US">Other intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherIntangibleAssetsAbstract0" xlink:to="mlec_OtherIntangibleAssetsAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfIntangibleAssetsAndLiabilitiesAssumedTextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfIntangibleAssetsAndLiabilitiesAssumedTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DisclosureOfIntangibleAssetsAndLiabilitiesAssumedTextBlock_lbl" xml:lang="en-US">Schedule of Intangible Assets and Liabilities Assumed</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfIntangibleAssetsAndLiabilitiesAssumedTextBlock" xlink:to="mlec_DisclosureOfIntangibleAssetsAndLiabilitiesAssumedTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory_lbl" xml:lang="en-US">Schedule of Goodwill</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory" xlink:to="ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutInvestmentPropertyExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutInvestmentPropertyExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutInvestmentPropertyExplanatory_lbl" xml:lang="en-US">Schedule of Investment Properties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutInvestmentPropertyExplanatory" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutInvestmentPropertyExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfTradeAndOtherPayablesComponentsTableTextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfTradeAndOtherPayablesComponentsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DisclosureOfTradeAndOtherPayablesComponentsTableTextBlock_lbl" xml:lang="en-US">Schedule of Trade and Other Payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfTradeAndOtherPayablesComponentsTableTextBlock" xlink:to="mlec_DisclosureOfTradeAndOtherPayablesComponentsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesAbstract_lbl" xml:lang="en-US">Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:to="ifrs-full_TradeAndOtherCurrentPayablesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_lbl" xml:lang="en-US">Trade creditors</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:to="ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_TradeAndOtherPayablesShareholdersAndOtherRelatedParties" xlink:href="mlec-20250630.xsd#mlec_TradeAndOtherPayablesShareholdersAndOtherRelatedParties"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_TradeAndOtherPayablesShareholdersAndOtherRelatedParties_lbl" xml:lang="en-US">Shareholders and other related parties (Note 17)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TradeAndOtherPayablesShareholdersAndOtherRelatedParties" xlink:to="mlec_TradeAndOtherPayablesShareholdersAndOtherRelatedParties_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_TradeCreditorsJointVenturesAndAssociates" xlink:href="mlec-20250630.xsd#mlec_TradeCreditorsJointVenturesAndAssociates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_TradeCreditorsJointVenturesAndAssociates_lbl" xml:lang="en-US">Trade creditors - Joint ventures and associates (Note 13)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TradeCreditorsJointVenturesAndAssociates" xlink:to="mlec_TradeCreditorsJointVenturesAndAssociates_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_lbl" xml:lang="en-US">Taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax" xlink:to="ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherCurrentPayables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherCurrentPayables_lbl" xml:lang="en-US">Miscellaneous</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCurrentPayables" xlink:to="ifrs-full_OtherCurrentPayables_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_lbl" xml:lang="en-US">Schedule of Borrowings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowingsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowingsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowingsAbstract_lbl" xml:lang="en-US">Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowingsAbstract" xlink:to="ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowingsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentPortionOfLongtermBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentPortionOfLongtermBorrowings"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentPortionOfLongtermBorrowings_lbl" xml:lang="en-US">Current Bank borrowings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentPortionOfLongtermBorrowings" xlink:to="ifrs-full_CurrentPortionOfLongtermBorrowings_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentPortionOfNoncurrentBorrowingsByTypeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentPortionOfNoncurrentBorrowingsByTypeAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncurrentPortionOfNoncurrentBorrowingsByTypeAbstract_lbl" xml:lang="en-US">Non-current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentPortionOfNoncurrentBorrowingsByTypeAbstract" xlink:to="ifrs-full_NoncurrentPortionOfNoncurrentBorrowingsByTypeAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NoncurrentPortionOfNoncurrentBorrowingsByTypeAbstract_lbl0" xml:lang="en-US">Non current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentPortionOfNoncurrentBorrowingsByTypeAbstract" xlink:to="ifrs-full_NoncurrentPortionOfNoncurrentBorrowingsByTypeAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherBorrowings"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherBorrowings_lbl" xml:lang="en-US">Non-current Bank borrowings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherBorrowings" xlink:to="ifrs-full_OtherBorrowings_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfCarryingValueOfBorrowingsExplanatory" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfCarryingValueOfBorrowingsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DisclosureOfCarryingValueOfBorrowingsExplanatory_lbl" xml:lang="en-US">Schedule of Borrowings, Carrying Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfCarryingValueOfBorrowingsExplanatory" xlink:to="mlec_DisclosureOfCarryingValueOfBorrowingsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_UnlabeledAbstract1" xlink:href="mlec-20250630.xsd#mlec_UnlabeledAbstract1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_UnlabeledAbstract1_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract1" xlink:to="mlec_UnlabeledAbstract1_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDebtSecuritiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDebtSecuritiesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfDebtSecuritiesExplanatory_lbl" xml:lang="en-US">Schedule of Convertible Notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDebtSecuritiesExplanatory" xlink:to="ifrs-full_DisclosureOfDebtSecuritiesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfBenefitsAndSocialSecurityPayablesTableTextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfBenefitsAndSocialSecurityPayablesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DisclosureOfBenefitsAndSocialSecurityPayablesTableTextBlock_lbl" xml:lang="en-US">Schedule of Employee Benefits and Social Security</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfBenefitsAndSocialSecurityPayablesTableTextBlock" xlink:to="mlec_DisclosureOfBenefitsAndSocialSecurityPayablesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_CurrentAbstract2" xlink:href="mlec-20250630.xsd#mlec_CurrentAbstract2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_CurrentAbstract2_lbl" xml:lang="en-US">Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CurrentAbstract2" xlink:to="mlec_CurrentAbstract2_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SalariesAccruedIncentivesVacationsAndSocialSecurity" xlink:href="mlec-20250630.xsd#mlec_SalariesAccruedIncentivesVacationsAndSocialSecurity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SalariesAccruedIncentivesVacationsAndSocialSecurity_lbl" xml:lang="en-US">Salaries, accrued incentives, vacations and social security</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SalariesAccruedIncentivesVacationsAndSocialSecurity" xlink:to="mlec_SalariesAccruedIncentivesVacationsAndSocialSecurity_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_KeyManagementPersonnelBenefitsLiabilityCurrent" xlink:href="mlec-20250630.xsd#mlec_KeyManagementPersonnelBenefitsLiabilityCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_KeyManagementPersonnelBenefitsLiabilityCurrent_lbl" xml:lang="en-US">Key management personnel (Note 18)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_KeyManagementPersonnelBenefitsLiabilityCurrent" xlink:to="mlec_KeyManagementPersonnelBenefitsLiabilityCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosuresOfDeferredRevenueAndAdvancesFromCustomersTableTextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosuresOfDeferredRevenueAndAdvancesFromCustomersTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DisclosuresOfDeferredRevenueAndAdvancesFromCustomersTableTextBlock_lbl" xml:lang="en-US">Schedule of Deferred Revenue and Advances from Customers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosuresOfDeferredRevenueAndAdvancesFromCustomersTableTextBlock" xlink:to="mlec_DisclosuresOfDeferredRevenueAndAdvancesFromCustomersTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_CurrentAbstract3" xlink:href="mlec-20250630.xsd#mlec_CurrentAbstract3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_CurrentAbstract3_lbl" xml:lang="en-US">Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CurrentAbstract3" xlink:to="mlec_CurrentAbstract3_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAdvances" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAdvances"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentAdvances_lbl" xml:lang="en-US">Advances from customers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAdvances" xlink:to="ifrs-full_CurrentAdvances_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime_lbl" xml:lang="en-US">Deferred revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime" xlink:to="ifrs-full_CurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NonCurrentAbstract1" xlink:href="mlec-20250630.xsd#mlec_NonCurrentAbstract1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NonCurrentAbstract1_lbl" xml:lang="en-US">Non current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NonCurrentAbstract1" xlink:to="mlec_NonCurrentAbstract1_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAdvances" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAdvances"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncurrentAdvances_lbl" xml:lang="en-US">Advances from customers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentAdvances" xlink:to="ifrs-full_NoncurrentAdvances_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime_lbl" xml:lang="en-US">Deferred revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime" xlink:to="ifrs-full_NoncurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfChangesInAllowancesAndProvisionsTableTextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfChangesInAllowancesAndProvisionsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DisclosureOfChangesInAllowancesAndProvisionsTableTextBlock_lbl" xml:lang="en-US">Schedule of Changes in Allowances and Provisions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfChangesInAllowancesAndProvisionsTableTextBlock" xlink:to="mlec_DisclosureOfChangesInAllowancesAndProvisionsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DeductedFromAssetsAbstract" xlink:href="mlec-20250630.xsd#mlec_DeductedFromAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DeductedFromAssetsAbstract_lbl" xml:lang="en-US">DEDUCTED FROM ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DeductedFromAssetsAbstract" xlink:to="mlec_DeductedFromAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdditionalProvisionsOtherProvisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdditionalProvisionsOtherProvisions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdditionalProvisionsOtherProvisions_lbl" xml:lang="en-US">Additions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionalProvisionsOtherProvisions" xlink:to="ifrs-full_AdditionalProvisionsOtherProvisions_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AllowancesAndProvisionsUsedAndReversed" xlink:href="mlec-20250630.xsd#mlec_AllowancesAndProvisionsUsedAndReversed"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AllowancesAndProvisionsUsedAndReversed_lbl" xml:lang="en-US">Uses and reversals</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AllowancesAndProvisionsUsedAndReversed" xlink:to="mlec_AllowancesAndProvisionsUsedAndReversed_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_lbl" xml:lang="en-US">Currency conversion difference</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" xlink:to="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_lbl0" xml:lang="en-US">Exchange differences</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" xlink:to="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_IncludedInLiabilitiesAbstract" xlink:href="mlec-20250630.xsd#mlec_IncludedInLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_IncludedInLiabilitiesAbstract_lbl" xml:lang="en-US">INCLUDED IN LIABILITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IncludedInLiabilitiesAbstract" xlink:to="mlec_IncludedInLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DeductedFromAssetsAbstract0" xlink:href="mlec-20250630.xsd#mlec_DeductedFromAssetsAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DeductedFromAssetsAbstract0_lbl" xml:lang="en-US">DEDUCTED FROM ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DeductedFromAssetsAbstract0" xlink:to="mlec_DeductedFromAssetsAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_IncludedInLiabilitiesAbstract0" xlink:href="mlec-20250630.xsd#mlec_IncludedInLiabilitiesAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_IncludedInLiabilitiesAbstract0_lbl" xml:lang="en-US">INCLUDED IN LIABILITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IncludedInLiabilitiesAbstract0" xlink:to="mlec_IncludedInLiabilitiesAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfProvisionsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfProvisionsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfProvisionsExplanatory_lbl" xml:lang="en-US">Schedule of Provisions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfProvisionsExplanatory" xlink:to="ifrs-full_DisclosureOfProvisionsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfGovernmentGrantsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfGovernmentGrantsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfGovernmentGrantsExplanatory_lbl" xml:lang="en-US">Schedule of Government Grants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfGovernmentGrantsExplanatory" xlink:to="ifrs-full_DisclosureOfGovernmentGrantsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_lbl" xml:lang="en-US">Currency conversion difference</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_lbl" xml:lang="en-US">Released to the statement of profit or loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" xlink:to="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_lbl0" xml:lang="en-US">Loss/Profit for the year (basic EPS)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" xlink:to="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfWarrantsTextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfWarrantsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DisclosureOfWarrantsTextBlock_lbl" xml:lang="en-US">Schedule of Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfWarrantsTextBlock" xlink:to="mlec_DisclosureOfWarrantsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AdditionsWarrantsForTheYear" xlink:href="mlec-20250630.xsd#mlec_AdditionsWarrantsForTheYear"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AdditionsWarrantsForTheYear_lbl" xml:lang="en-US">Additions for the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AdditionsWarrantsForTheYear" xlink:to="mlec_AdditionsWarrantsForTheYear_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AdditionsFromBusinessCombination" xlink:href="mlec-20250630.xsd#mlec_AdditionsFromBusinessCombination"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AdditionsFromBusinessCombination_lbl" xml:lang="en-US">Additions from business combination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AdditionsFromBusinessCombination" xlink:to="mlec_AdditionsFromBusinessCombination_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock_lbl" xml:lang="en-US">INFORMATION ABOUT COMPONENT OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock" xlink:to="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory_lbl" xml:lang="en-US">Schedule of Revenue from Contracts with Customers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromSaleOfGoods" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromSaleOfGoods"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RevenueFromSaleOfGoods_lbl" xml:lang="en-US">Sale of goods and services</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueFromSaleOfGoods" xlink:to="ifrs-full_RevenueFromSaleOfGoods_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromRoyalties" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromRoyalties"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RevenueFromRoyalties_lbl" xml:lang="en-US">Royalties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueFromRoyalties" xlink:to="ifrs-full_RevenueFromRoyalties_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromRenderingOfServices" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromRenderingOfServices"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RevenueFromRenderingOfServices_lbl" xml:lang="en-US">Rendering of services with related parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueFromRenderingOfServices" xlink:to="ifrs-full_RevenueFromRenderingOfServices_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LicenceFeeIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LicenceFeeIncome"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_LicenceFeeIncome_lbl" xml:lang="en-US">Right of use licenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LicenceFeeIncome" xlink:to="ifrs-full_LicenceFeeIncome_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfCostOfSalesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfCostOfSalesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfCostOfSalesExplanatory_lbl" xml:lang="en-US">Schedule of cost of sales</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfCostOfSalesExplanatory" xlink:to="ifrs-full_DisclosureOfCostOfSalesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_LossOfControl" xlink:href="mlec-20250630.xsd#mlec_LossOfControl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_LossOfControl_lbl" xml:lang="en-US">Loss of control</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LossOfControl" xlink:to="mlec_LossOfControl_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InventoriesFromBusinessCombination" xlink:href="mlec-20250630.xsd#mlec_InventoriesFromBusinessCombination"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_InventoriesFromBusinessCombination_lbl" xml:lang="en-US">Additions related to Business combination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InventoriesFromBusinessCombination" xlink:to="mlec_InventoriesFromBusinessCombination_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PurchaseOfInventory" xlink:href="mlec-20250630.xsd#mlec_PurchaseOfInventory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_PurchaseOfInventory_lbl" xml:lang="en-US">Purchases of the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PurchaseOfInventory" xlink:to="mlec_PurchaseOfInventory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InventoryProductionCosts" xlink:href="mlec-20250630.xsd#mlec_InventoryProductionCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_InventoryProductionCosts_lbl" xml:lang="en-US">Production costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InventoryProductionCosts" xlink:to="mlec_InventoryProductionCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ForeignCurrencyTranslationOnInventory" xlink:href="mlec-20250630.xsd#mlec_ForeignCurrencyTranslationOnInventory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ForeignCurrencyTranslationOnInventory_lbl" xml:lang="en-US">Foreign currency translation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ForeignCurrencyTranslationOnInventory" xlink:to="mlec_ForeignCurrencyTranslationOnInventory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InventoriesBeforeClosingInventory" xlink:href="mlec-20250630.xsd#mlec_InventoriesBeforeClosingInventory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_InventoriesBeforeClosingInventory_lbl" xml:lang="en-US">Subtotal</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InventoriesBeforeClosingInventory" xlink:to="mlec_InventoriesBeforeClosingInventory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory_lbl" xml:lang="en-US">Schedule of R&amp;D Classified by Nature</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory" xlink:to="ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US">Amortization of intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AnalysisAndStorage" xlink:href="mlec-20250630.xsd#mlec_AnalysisAndStorage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AnalysisAndStorage_lbl" xml:lang="en-US">Analysis and storage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AnalysisAndStorage" xlink:to="mlec_AnalysisAndStorage_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RoyaltyExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RoyaltyExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RoyaltyExpense_lbl" xml:lang="en-US">Commissions and royalties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RoyaltyExpense" xlink:to="ifrs-full_RoyaltyExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ImportAndExportExpenses" xlink:href="mlec-20250630.xsd#mlec_ImportAndExportExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ImportAndExportExpenses_lbl" xml:lang="en-US">Import and export expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ImportAndExportExpenses" xlink:to="mlec_ImportAndExportExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepreciationRightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DepreciationRightofuseAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DepreciationRightofuseAssets_lbl" xml:lang="en-US">Depreciation of leased assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationRightofuseAssets" xlink:to="ifrs-full_DepreciationRightofuseAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DepreciationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Depreciation of property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:to="ifrs-full_DepreciationPropertyPlantAndEquipment_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_DepreciationPropertyPlantAndEquipment_lbl0" xml:lang="en-US">Depreciation of the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:to="ifrs-full_DepreciationPropertyPlantAndEquipment_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TransportationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TransportationExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TransportationExpense_lbl" xml:lang="en-US">Freight and haulage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TransportationExpense" xlink:to="ifrs-full_TransportationExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShorttermEmployeeBenefitsExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShorttermEmployeeBenefitsExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ShorttermEmployeeBenefitsExpense_lbl" xml:lang="en-US">Employee benefits and social securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShorttermEmployeeBenefitsExpense" xlink:to="ifrs-full_ShorttermEmployeeBenefitsExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InsuranceExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InsuranceExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_InsuranceExpense_lbl" xml:lang="en-US">Insurance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InsuranceExpense" xlink:to="ifrs-full_InsuranceExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FuelAndEnergyExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FuelAndEnergyExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_FuelAndEnergyExpense_lbl" xml:lang="en-US">Energy and fuel</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FuelAndEnergyExpense" xlink:to="ifrs-full_FuelAndEnergyExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RepairsAndMaintenanceExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RepairsAndMaintenanceExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RepairsAndMaintenanceExpense_lbl" xml:lang="en-US">Maintenance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RepairsAndMaintenanceExpense" xlink:to="ifrs-full_RepairsAndMaintenanceExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SuppliesAndMaterials" xlink:href="mlec-20250630.xsd#mlec_SuppliesAndMaterials"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SuppliesAndMaterials_lbl" xml:lang="en-US">Supplies and materials</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SuppliesAndMaterials" xlink:to="mlec_SuppliesAndMaterials_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_LicensesandPatents" xlink:href="mlec-20250630.xsd#mlec_LicensesandPatents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_LicensesandPatents_lbl" xml:lang="en-US">Licenses &amp; Patents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LicensesandPatents" xlink:to="mlec_LicensesandPatents_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TravelExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TravelExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TravelExpense_lbl" xml:lang="en-US">Mobility and travel</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TravelExpense" xlink:to="ifrs-full_TravelExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdvertisingExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdvertisingExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdvertisingExpense_lbl" xml:lang="en-US">Publicity and advertising</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdvertisingExpense" xlink:to="ifrs-full_AdvertisingExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SystemExpenses" xlink:href="mlec-20250630.xsd#mlec_SystemExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SystemExpenses_lbl" xml:lang="en-US">Systems expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SystemExpenses" xlink:to="mlec_SystemExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_VehicleExpenses" xlink:href="mlec-20250630.xsd#mlec_VehicleExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_VehicleExpenses_lbl" xml:lang="en-US">Vehicles expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_VehicleExpenses" xlink:to="mlec_VehicleExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_lbl" xml:lang="en-US">Share-based incentives</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SurveillanceExpense" xlink:href="mlec-20250630.xsd#mlec_SurveillanceExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SurveillanceExpense_lbl" xml:lang="en-US">Surveillance expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SurveillanceExpense" xlink:to="mlec_SurveillanceExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfessionalFeesExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfessionalFeesExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProfessionalFeesExpense_lbl" xml:lang="en-US">Professional fees and outsourced services</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfessionalFeesExpense" xlink:to="ifrs-full_ProfessionalFeesExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ProfessionalFeesExpenseRelatedParties" xlink:href="mlec-20250630.xsd#mlec_ProfessionalFeesExpenseRelatedParties"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ProfessionalFeesExpenseRelatedParties_lbl" xml:lang="en-US">Professional fees related parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ProfessionalFeesExpenseRelatedParties" xlink:to="mlec_ProfessionalFeesExpenseRelatedParties_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdministrativeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdministrativeExpense_lbl" xml:lang="en-US">Office supplies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdministrativeExpense" xlink:to="ifrs-full_AdministrativeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MiscellaneousOtherOperatingExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MiscellaneousOtherOperatingExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_MiscellaneousOtherOperatingExpense_lbl" xml:lang="en-US">Miscellaneous</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MiscellaneousOtherOperatingExpense" xlink:to="ifrs-full_MiscellaneousOtherOperatingExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ResearchAndDevelopmentExpenseCapitalized" xlink:href="mlec-20250630.xsd#mlec_ResearchAndDevelopmentExpenseCapitalized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ResearchAndDevelopmentExpenseCapitalized_lbl" xml:lang="en-US">R&amp;D capitalized (Note 8.3)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ResearchAndDevelopmentExpenseCapitalized" xlink:to="mlec_ResearchAndDevelopmentExpenseCapitalized_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfExpensesByNatureExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfExpensesByNatureExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfExpensesByNatureExplanatory_lbl" xml:lang="en-US">Schedule of Expenses Classified by Nature and Function</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfExpensesByNatureExplanatory" xlink:to="ifrs-full_DisclosureOfExpensesByNatureExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForAmortisationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForAmortisationExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForAmortisationExpense_lbl" xml:lang="en-US">Amortization of intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForAmortisationExpense" xlink:to="ifrs-full_AdjustmentsForAmortisationExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables_lbl" xml:lang="en-US">Impairment of receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables" xlink:to="ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentTaxExpenseIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxExpenseIncome"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentTaxExpenseIncome_lbl" xml:lang="en-US">Taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentTaxExpenseIncome" xlink:to="ifrs-full_CurrentTaxExpenseIncome_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_CurrentTaxExpenseIncome_lbl0" xml:lang="en-US">Current tax expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentTaxExpenseIncome" xlink:to="ifrs-full_CurrentTaxExpenseIncome_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_SharebasedIncentivesForEmployees" xlink:href="mlec-20250630.xsd#mlec_SharebasedIncentivesForEmployees"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SharebasedIncentivesForEmployees_lbl" xml:lang="en-US">Share-based incentives for employees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SharebasedIncentivesForEmployees" xlink:to="mlec_SharebasedIncentivesForEmployees_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ProfessionalFeesRelatedParties" xlink:href="mlec-20250630.xsd#mlec_ProfessionalFeesRelatedParties"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ProfessionalFeesRelatedParties_lbl" xml:lang="en-US">Professional fees related parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ProfessionalFeesRelatedParties" xlink:to="mlec_ProfessionalFeesRelatedParties_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_Contingencies" xlink:href="mlec-20250630.xsd#mlec_Contingencies"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_Contingencies_lbl" xml:lang="en-US">Contingencies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_Contingencies" xlink:to="mlec_Contingencies_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_EnvironmentalImpactTreatment" xlink:href="mlec-20250630.xsd#mlec_EnvironmentalImpactTreatment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_EnvironmentalImpactTreatment_lbl" xml:lang="en-US">Environmental Impact Treatment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_EnvironmentalImpactTreatment" xlink:to="mlec_EnvironmentalImpactTreatment_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_lbl" xml:lang="en-US">Schedule of Finance Results</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:to="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialCostAbstract" xlink:href="mlec-20250630.xsd#mlec_FinancialCostAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_FinancialCostAbstract_lbl" xml:lang="en-US">Financial cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialCostAbstract" xlink:to="mlec_FinancialCostAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialCommissions" xlink:href="mlec-20250630.xsd#mlec_FinancialCommissions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_FinancialCommissions_lbl" xml:lang="en-US">Financial commissions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialCommissions" xlink:to="mlec_FinancialCommissions_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinanceCosts" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_FinanceCosts_lbl" xml:lang="en-US">Finance Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceCosts" xlink:to="ifrs-full_FinanceCosts_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_FinanceCosts_lbl0" xml:lang="en-US">Finance debt (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceCosts" xlink:to="ifrs-full_FinanceCosts_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherFinancialResultsAbstract" xlink:href="mlec-20250630.xsd#mlec_OtherFinancialResultsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_OtherFinancialResultsAbstract_lbl" xml:lang="en-US">Other financial results</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherFinancialResultsAbstract" xlink:to="mlec_OtherFinancialResultsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementAssets_lbl" xml:lang="en-US">Exchange differences generated by assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementAssets" xlink:to="ifrs-full_GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementLiabilities_lbl" xml:lang="en-US">Exchange differences generated by liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementLiabilities" xlink:to="ifrs-full_GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ChangeInFairValueOfFinancialAssetsOrLiabilitiesOrOtherFinancialResults" xlink:href="mlec-20250630.xsd#mlec_ChangeInFairValueOfFinancialAssetsOrLiabilitiesOrOtherFinancialResults"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ChangeInFairValueOfFinancialAssetsOrLiabilitiesOrOtherFinancialResults_lbl" xml:lang="en-US">Changes in fair value of financial assets or liabilities and other financial results</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ChangeInFairValueOfFinancialAssetsOrLiabilitiesOrOtherFinancialResults" xlink:to="mlec_ChangeInFairValueOfFinancialAssetsOrLiabilitiesOrOtherFinancialResults_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PrepaymentPremiumFee" xlink:href="mlec-20250630.xsd#mlec_PrepaymentPremiumFee"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_PrepaymentPremiumFee_lbl" xml:lang="en-US">Prepayment premium fee</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PrepaymentPremiumFee" xlink:to="mlec_PrepaymentPremiumFee_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="mlec_PrepaymentPremiumFee_lbl0" xml:lang="en-US">Prepayment Premium Fee</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PrepaymentPremiumFee" xlink:to="mlec_PrepaymentPremiumFee_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="mlec_PrepaymentPremiumFee_lbl1" xml:lang="en-US">Prepayment Premium Fee (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PrepaymentPremiumFee" xlink:to="mlec_PrepaymentPremiumFee_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_NetGainOnInflationEffectOnMonetary" xlink:href="mlec-20250630.xsd#mlec_NetGainOnInflationEffectOnMonetary"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NetGainOnInflationEffectOnMonetary_lbl" xml:lang="en-US">Net gain of inflation effect on monetary items</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NetGainOnInflationEffectOnMonetary" xlink:to="mlec_NetGainOnInflationEffectOnMonetary_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InterestAccruedWithRelatedParties" xlink:href="mlec-20250630.xsd#mlec_InterestAccruedWithRelatedParties"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_InterestAccruedWithRelatedParties_lbl" xml:lang="en-US">Interest accrued with related parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InterestAccruedWithRelatedParties" xlink:to="mlec_InterestAccruedWithRelatedParties_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory_lbl" xml:lang="en-US">Schedule of Other Income or Expenses, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory" xlink:to="ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromSaleOfAgriculturalProduce" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromSaleOfAgriculturalProduce"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RevenueFromSaleOfAgriculturalProduce_lbl" xml:lang="en-US">Loss from subsidiary&#8217;s guarantee recognition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueFromSaleOfAgriculturalProduce" xlink:to="ifrs-full_RevenueFromSaleOfAgriculturalProduce_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_GainOnBargainPurchase" xlink:href="mlec-20250630.xsd#mlec_GainOnBargainPurchase"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_GainOnBargainPurchase_lbl" xml:lang="en-US">Gain on bargain purchase</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_GainOnBargainPurchase" xlink:to="mlec_GainOnBargainPurchase_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_RemeasurementToFairValueOfPreexistingInterestInAnAcquiree" xlink:href="mlec-20250630.xsd#mlec_RemeasurementToFairValueOfPreexistingInterestInAnAcquiree"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_RemeasurementToFairValueOfPreexistingInterestInAnAcquiree_lbl" xml:lang="en-US">Remeasurement to fair value of pre-existing interest in an acquiree</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RemeasurementToFairValueOfPreexistingInterestInAnAcquiree" xlink:to="mlec_RemeasurementToFairValueOfPreexistingInterestInAnAcquiree_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherIncomeOrExpensesNet" xlink:href="mlec-20250630.xsd#mlec_OtherIncomeOrExpensesNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_OtherIncomeOrExpensesNet_lbl" xml:lang="en-US">Others</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherIncomeOrExpensesNet" xlink:to="mlec_OtherIncomeOrExpensesNet_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfIncomeTaxExplanatory_lbl" xml:lang="en-US">TAXATION</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:to="ifrs-full_DisclosureOfIncomeTaxExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDeferredTaxesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDeferredTaxesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfDeferredTaxesExplanatory_lbl" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDeferredTaxesExplanatory" xlink:to="ifrs-full_DisclosureOfDeferredTaxesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DeferredTaxAssetsAbstract" xlink:href="mlec-20250630.xsd#mlec_DeferredTaxAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DeferredTaxAssetsAbstract_lbl" xml:lang="en-US">Deferred tax assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DeferredTaxAssetsAbstract" xlink:to="mlec_DeferredTaxAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract_lbl" xml:lang="en-US">Deferred tax liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetDeferredTaxLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetDeferredTaxLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NetDeferredTaxLiabilities_lbl" xml:lang="en-US">Total deferred tax liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetDeferredTaxLiabilities" xlink:to="ifrs-full_NetDeferredTaxLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxLiabilityAsset" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxLiabilityAsset"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DeferredTaxLiabilityAsset_lbl" xml:lang="en-US">Net deferred tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxLiabilityAsset" xlink:to="ifrs-full_DeferredTaxLiabilityAsset_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfRollforwardOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfRollforwardOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ScheduleOfRollforwardOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Roll Forward of Deferred Tax Assets and Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfRollforwardOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="mlec_ScheduleOfRollforwardOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DeferredTaxAssetsAbstract0" xlink:href="mlec-20250630.xsd#mlec_DeferredTaxAssetsAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DeferredTaxAssetsAbstract0_lbl" xml:lang="en-US">Deferred tax assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DeferredTaxAssetsAbstract0" xlink:to="mlec_DeferredTaxAssetsAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset_lbl" xml:lang="en-US">Business combination / (loss) of control</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" xlink:to="ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset_lbl" xml:lang="en-US">Conversion difference</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" xlink:to="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract_lbl" xml:lang="en-US">Deferred tax liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome_lbl" xml:lang="en-US">Charge to OCI</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" xlink:to="ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DeferredTaxLiabilitiesAbstract0" xlink:href="mlec-20250630.xsd#mlec_DeferredTaxLiabilitiesAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DeferredTaxLiabilitiesAbstract0_lbl" xml:lang="en-US">Deferred tax liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DeferredTaxLiabilitiesAbstract0" xlink:to="mlec_DeferredTaxLiabilitiesAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_EffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="mlec-20250630.xsd#mlec_EffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_EffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">Schedule of Weighted Average Tax Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_EffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="mlec_EffectiveIncomeTaxRateReconciliationTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProfitLossFromDiscontinuedOperations_lbl" xml:lang="en-US">(Loss) / earnings before income tax-rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:to="ifrs-full_ProfitLossFromDiscontinuedOperations_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DerecognitionOfDeferredTaxAssets" xlink:href="mlec-20250630.xsd#mlec_DerecognitionOfDeferredTaxAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DerecognitionOfDeferredTaxAssets_lbl" xml:lang="en-US">Derecognition of deferred tax assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DerecognitionOfDeferredTaxAssets" xlink:to="mlec_DerecognitionOfDeferredTaxAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_MutualFundsAdjustment" xlink:href="mlec-20250630.xsd#mlec_MutualFundsAdjustment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_MutualFundsAdjustment_lbl" xml:lang="en-US">Mutual funds adjustments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MutualFundsAdjustment" xlink:to="mlec_MutualFundsAdjustment_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TaxEffectFromChangeInTaxRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TaxEffectFromChangeInTaxRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TaxEffectFromChangeInTaxRate_lbl" xml:lang="en-US">Rate change adjustment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TaxEffectFromChangeInTaxRate" xlink:to="ifrs-full_TaxEffectFromChangeInTaxRate_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="mlec-20250630.xsd#mlec_ComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US">Schedule of Principal Statutory Taxes Rates and Current Tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="mlec_ComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_IncomeTaxExpenseByApplyingApplicableTaxRateInForceInRespectiveJurisdictionsTableTextBlock" xlink:href="mlec-20250630.xsd#mlec_IncomeTaxExpenseByApplyingApplicableTaxRateInForceInRespectiveJurisdictionsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_IncomeTaxExpenseByApplyingApplicableTaxRateInForceInRespectiveJurisdictionsTableTextBlock_lbl" xml:lang="en-US">Schedule of Income Tax Expense Calculated by Applying Tax Rate in Force</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IncomeTaxExpenseByApplyingApplicableTaxRateInForceInRespectiveJurisdictionsTableTextBlock" xlink:to="mlec_IncomeTaxExpenseByApplyingApplicableTaxRateInForceInRespectiveJurisdictionsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AccountingProfit" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AccountingProfit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AccountingProfit_lbl" xml:lang="en-US">Earnings before income tax-rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AccountingProfit" xlink:to="ifrs-full_AccountingProfit_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ApplicableTaxRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ApplicableTaxRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ApplicableTaxRate_lbl" xml:lang="en-US">Weight average applicable tax rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ApplicableTaxRate" xlink:to="ifrs-full_ApplicableTaxRate_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfEarningsPerShareExplanatory_lbl" xml:lang="en-US">EARNING PER SHARE</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:to="ifrs-full_DisclosureOfEarningsPerShareExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EarningsPerShareExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EarningsPerShareExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_EarningsPerShareExplanatory_lbl" xml:lang="en-US">Schedule of Earning Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EarningsPerShareExplanatory" xlink:to="ifrs-full_EarningsPerShareExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_lbl" xml:lang="en-US">Loss/Profit for the year (diluted EPS)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" xlink:to="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract_lbl" xml:lang="en-US">Denominator</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract" xlink:to="ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WeightedAverageShares_lbl" xml:lang="en-US">Number of shares (basic EPS)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageShares" xlink:to="ifrs-full_WeightedAverageShares_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustedWeightedAverageShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustedWeightedAverageShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustedWeightedAverageShares_lbl" xml:lang="en-US">Number of shares (diluted EPS)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustedWeightedAverageShares" xlink:to="ifrs-full_AdjustedWeightedAverageShares_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_UnlabeledAbstract2" xlink:href="mlec-20250630.xsd#mlec_UnlabeledAbstract2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_UnlabeledAbstract2_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract2" xlink:to="mlec_UnlabeledAbstract2_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_lbl" xml:lang="en-US">INFORMATION ABOUT COMPONENTS OF EQUITY</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:to="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfNumberOfSharesIssuedtextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfNumberOfSharesIssuedtextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DisclosureOfNumberOfSharesIssuedtextBlock_lbl" xml:lang="en-US">Schedule of Number of Shares Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfNumberOfSharesIssuedtextBlock" xlink:to="mlec_DisclosureOfNumberOfSharesIssuedtextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NumberOfSharesIssued_lbl" xml:lang="en-US">Number of Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesIssued" xlink:to="ifrs-full_NumberOfSharesIssued_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NumberOfSharesIssued_lbl0" xml:lang="en-US">Shares received</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesIssued" xlink:to="ifrs-full_NumberOfSharesIssued_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="ifrs-full_NumberOfSharesIssued_lbl1" xml:lang="en-US">Ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesIssued" xlink:to="ifrs-full_NumberOfSharesIssued_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfSharesIssued_lbl2" xml:lang="en-US">Issued convertible preference shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesIssued" xlink:to="ifrs-full_NumberOfSharesIssued_lbl2"/>
    <loc xlink:type="locator" xlink:label="mlec_NumberOfNominalValue" xlink:href="mlec-20250630.xsd#mlec_NumberOfNominalValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NumberOfNominalValue_lbl" xml:lang="en-US">Nominal Value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfNominalValue" xlink:to="mlec_NumberOfNominalValue_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SubscribedCapitalOfShares" xlink:href="mlec-20250630.xsd#mlec_SubscribedCapitalOfShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SubscribedCapitalOfShares_lbl" xml:lang="en-US">Subscribed capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SubscribedCapitalOfShares" xlink:to="mlec_SubscribedCapitalOfShares_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SubscribedCapital" xlink:href="mlec-20250630.xsd#mlec_SubscribedCapital"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SubscribedCapital_lbl" xml:lang="en-US">Subscribed capital amount (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SubscribedCapital" xlink:to="mlec_SubscribedCapital_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory_lbl" xml:lang="en-US">Schedule of Subsidiaries Non-Controlling Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory" xlink:to="ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_lbl" xml:lang="en-US">Bioceres S.A.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:to="ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfFinancialStatementsTextBlock" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfFinancialStatementsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ScheduleOfFinancialStatementsTextBlock_lbl" xml:lang="en-US">Schedule of Financial Statements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfFinancialStatementsTextBlock" xlink:to="mlec_ScheduleOfFinancialStatementsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NoncurrentAsset" xlink:href="mlec-20250630.xsd#mlec_NoncurrentAsset"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NoncurrentAsset_lbl" xml:lang="en-US">Non-current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NoncurrentAsset" xlink:to="mlec_NoncurrentAsset_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareOfProfitOrLossOfSubsidiaries" xlink:href="mlec-20250630.xsd#mlec_ShareOfProfitOrLossOfSubsidiaries"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ShareOfProfitOrLossOfSubsidiaries_lbl" xml:lang="en-US">Share of profit or loss of subsidiaries</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareOfProfitOrLossOfSubsidiaries" xlink:to="mlec_ShareOfProfitOrLossOfSubsidiaries_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_lbl" xml:lang="en-US">Revaluation of property, plant and equipment, net of tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory_lbl" xml:lang="en-US">Schedule of Bioceres SA and Bioceres Crop Solutions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory" xlink:to="ifrs-full_DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfCashFlowStatementExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfCashFlowStatementExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfCashFlowStatementExplanatory_lbl" xml:lang="en-US">CASH FLOW INFORMATION</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfCashFlowStatementExplanatory" xlink:to="ifrs-full_DisclosureOfCashFlowStatementExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities_lbl" xml:lang="en-US">Schedule of Significant Non-Cash Transactions Related to Investing and Financing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities" xlink:to="mlec_ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InvestmentInKindInOtherRelatedPartiesNonCashTransactionsInvestmentActivities" xlink:href="mlec-20250630.xsd#mlec_InvestmentInKindInOtherRelatedPartiesNonCashTransactionsInvestmentActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_InvestmentInKindInOtherRelatedPartiesNonCashTransactionsInvestmentActivities_lbl" xml:lang="en-US">Investment in-kind in other related parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InvestmentInKindInOtherRelatedPartiesNonCashTransactionsInvestmentActivities" xlink:to="mlec_InvestmentInKindInOtherRelatedPartiesNonCashTransactionsInvestmentActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_IssuanceOfShare" xlink:href="mlec-20250630.xsd#mlec_IssuanceOfShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_IssuanceOfShare_lbl" xml:lang="en-US">Issuance of shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IssuanceOfShare" xlink:to="mlec_IssuanceOfShare_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ExchangeOfIntangibleAssets" xlink:href="mlec-20250630.xsd#mlec_ExchangeOfIntangibleAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ExchangeOfIntangibleAssets_lbl" xml:lang="en-US">Exchange of intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ExchangeOfIntangibleAssets" xlink:to="mlec_ExchangeOfIntangibleAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestCostsCapitalised" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestCostsCapitalised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_InterestCostsCapitalised_lbl" xml:lang="en-US">Capitalization of interest on buildings in progress</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestCostsCapitalised" xlink:to="ifrs-full_InterestCostsCapitalised_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NonMonetaryContributionsInJointVenturesNonCashTransactionsInvestmentActivities" xlink:href="mlec-20250630.xsd#mlec_NonMonetaryContributionsInJointVenturesNonCashTransactionsInvestmentActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NonMonetaryContributionsInJointVenturesNonCashTransactionsInvestmentActivities_lbl" xml:lang="en-US">Reclassification from Investment properties to property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NonMonetaryContributionsInJointVenturesNonCashTransactionsInvestmentActivities" xlink:to="mlec_NonMonetaryContributionsInJointVenturesNonCashTransactionsInvestmentActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory_lbl" xml:lang="en-US">Schedule of Changes in Liabilities Arising from Financing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory" xlink:to="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities" xlink:href="mlec-20250630.xsd#mlec_IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities_lbl" xml:lang="en-US">Proceeds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities" xlink:to="mlec_IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_lbl" xml:lang="en-US">Exchange differences, currency translation differences and other financial results</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" xlink:to="ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancingForAssetsAcquisitions" xlink:href="mlec-20250630.xsd#mlec_FinancingForAssetsAcquisitions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_FinancingForAssetsAcquisitions_lbl" xml:lang="en-US">Financing for assets acquisitions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancingForAssetsAcquisitions" xlink:to="mlec_FinancingForAssetsAcquisitions_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NoncashActivities" xlink:href="mlec-20250630.xsd#mlec_NoncashActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NoncashActivities_lbl" xml:lang="en-US">Non-cash activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NoncashActivities" xlink:to="mlec_NoncashActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DecreaseBecauseOfLossOfControl" xlink:href="mlec-20250630.xsd#mlec_DecreaseBecauseOfLossOfControl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DecreaseBecauseOfLossOfControl_lbl" xml:lang="en-US">Decrease because of loss of control</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DecreaseBecauseOfLossOfControl" xlink:to="mlec_DecreaseBecauseOfLossOfControl_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfJointVenturesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfJointVenturesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfJointVenturesExplanatory_lbl" xml:lang="en-US">JOINT VENTURES AND ASSOCIATES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfJointVenturesExplanatory" xlink:to="ifrs-full_DisclosureOfJointVenturesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfInvestmentsInJointVenturesAndAffiliatesTableTextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfInvestmentsInJointVenturesAndAffiliatesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DisclosureOfInvestmentsInJointVenturesAndAffiliatesTableTextBlock_lbl" xml:lang="en-US">Schedule of Joint Ventures Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfInvestmentsInJointVenturesAndAffiliatesTableTextBlock" xlink:to="mlec_DisclosureOfInvestmentsInJointVenturesAndAffiliatesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AssetsAbstract0" xlink:href="mlec-20250630.xsd#mlec_AssetsAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AssetsAbstract0_lbl" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AssetsAbstract0" xlink:to="mlec_AssetsAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_MeasuredAtEquityValueMethodAbstract" xlink:href="mlec-20250630.xsd#mlec_MeasuredAtEquityValueMethodAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_MeasuredAtEquityValueMethodAbstract_lbl" xml:lang="en-US">Measured at equity value method</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MeasuredAtEquityValueMethodAbstract" xlink:to="mlec_MeasuredAtEquityValueMethodAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates_lbl" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:to="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_MeasuredAtFairValueAbstract" xlink:href="mlec-20250630.xsd#mlec_MeasuredAtFairValueAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_MeasuredAtFairValueAbstract_lbl" xml:lang="en-US">Measured at Fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MeasuredAtFairValueAbstract" xlink:to="mlec_MeasuredAtFairValueAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InvestmentsMeasuredAtFairValue" xlink:href="mlec-20250630.xsd#mlec_InvestmentsMeasuredAtFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_InvestmentsMeasuredAtFairValue_lbl" xml:lang="en-US">Measured at Fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InvestmentsMeasuredAtFairValue" xlink:to="mlec_InvestmentsMeasuredAtFairValue_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_LiabilitiesAbstract0" xlink:href="mlec-20250630.xsd#mlec_LiabilitiesAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_LiabilitiesAbstract0_lbl" xml:lang="en-US">Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LiabilitiesAbstract0" xlink:to="mlec_LiabilitiesAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_MeasuredAtEquityValueMethodAbstract0" xlink:href="mlec-20250630.xsd#mlec_MeasuredAtEquityValueMethodAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_MeasuredAtEquityValueMethodAbstract0_lbl" xml:lang="en-US">Measured at equity value method</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MeasuredAtEquityValueMethodAbstract0" xlink:to="mlec_MeasuredAtEquityValueMethodAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DueToJointVenturesAndAssociatesNonCurrent" xlink:href="mlec-20250630.xsd#mlec_DueToJointVenturesAndAssociatesNonCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DueToJointVenturesAndAssociatesNonCurrent_lbl" xml:lang="en-US">Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DueToJointVenturesAndAssociatesNonCurrent" xlink:to="mlec_DueToJointVenturesAndAssociatesNonCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfChangesInInvestmentInJointVenturesAndAffiliatesTableTextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfChangesInInvestmentInJointVenturesAndAffiliatesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DisclosureOfChangesInInvestmentInJointVenturesAndAffiliatesTableTextBlock_lbl" xml:lang="en-US">Schedule of Changes in Joint Ventures Investments and Affiliates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfChangesInInvestmentInJointVenturesAndAffiliatesTableTextBlock" xlink:to="mlec_DisclosureOfChangesInInvestmentInJointVenturesAndAffiliatesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ChangesInEquityInterest" xlink:href="mlec-20250630.xsd#mlec_ChangesInEquityInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ChangesInEquityInterest_lbl" xml:lang="en-US">Changes in equity interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ChangesInEquityInterest" xlink:to="mlec_ChangesInEquityInterest_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SaleOfEquityInvestment" xlink:href="mlec-20250630.xsd#mlec_SaleOfEquityInvestment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SaleOfEquityInvestment_lbl" xml:lang="en-US">Sale of equity investment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SaleOfEquityInvestment" xlink:to="mlec_SaleOfEquityInvestment_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_EquityMethodInvestmentIncreaseFromShareBasedIncentives" xlink:href="mlec-20250630.xsd#mlec_EquityMethodInvestmentIncreaseFromShareBasedIncentives"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_EquityMethodInvestmentIncreaseFromShareBasedIncentives_lbl" xml:lang="en-US">Share-based incentives</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_EquityMethodInvestmentIncreaseFromShareBasedIncentives" xlink:to="mlec_EquityMethodInvestmentIncreaseFromShareBasedIncentives_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ChangeinJointVenturesDividendsDistribution" xlink:href="mlec-20250630.xsd#mlec_ChangeinJointVenturesDividendsDistribution"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ChangeinJointVenturesDividendsDistribution_lbl" xml:lang="en-US">Dividends distribution</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ChangeinJointVenturesDividendsDistribution" xlink:to="mlec_ChangeinJointVenturesDividendsDistribution_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_GainsLossesOnExchangeDifferencesOnTranslationFromJointVentureNetOfTax" xlink:href="mlec-20250630.xsd#mlec_GainsLossesOnExchangeDifferencesOnTranslationFromJointVentureNetOfTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_GainsLossesOnExchangeDifferencesOnTranslationFromJointVentureNetOfTax_lbl" xml:lang="en-US">Foreign currency translation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_GainsLossesOnExchangeDifferencesOnTranslationFromJointVentureNetOfTax" xlink:to="mlec_GainsLossesOnExchangeDifferencesOnTranslationFromJointVentureNetOfTax_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareOfProfitOrLossMeasuredAtFairValue" xlink:href="mlec-20250630.xsd#mlec_ShareOfProfitOrLossMeasuredAtFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ShareOfProfitOrLossMeasuredAtFairValue_lbl" xml:lang="en-US">Share of profit or loss measured at fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareOfProfitOrLossMeasuredAtFairValue" xlink:to="mlec_ShareOfProfitOrLossMeasuredAtFairValue_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="mlec_ShareOfProfitOrLossMeasuredAtFairValue_lbl0" xml:lang="en-US">Share of profit or loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareOfProfitOrLossMeasuredAtFairValue" xlink:to="mlec_ShareOfProfitOrLossMeasuredAtFairValue_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfShareOfProfitOrLossInJointVenturesAndAffiliatesTableTextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfShareOfProfitOrLossInJointVenturesAndAffiliatesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DisclosureOfShareOfProfitOrLossInJointVenturesAndAffiliatesTableTextBlock_lbl" xml:lang="en-US">Schedule of Share of Profit or Loss of Joint Ventures and Affiliates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfShareOfProfitOrLossInJointVenturesAndAffiliatesTableTextBlock" xlink:to="mlec_DisclosureOfShareOfProfitOrLossInJointVenturesAndAffiliatesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_MeasuredAtEquityValueMethodAbstract1" xlink:href="mlec-20250630.xsd#mlec_MeasuredAtEquityValueMethodAbstract1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_MeasuredAtEquityValueMethodAbstract1_lbl" xml:lang="en-US">Measured at equity value method</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MeasuredAtEquityValueMethodAbstract1" xlink:to="mlec_MeasuredAtEquityValueMethodAbstract1_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod_lbl" xml:lang="en-US">Share of profit or loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" xlink:to="ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_MeasuredAtFairValueAbstract0" xlink:href="mlec-20250630.xsd#mlec_MeasuredAtFairValueAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_MeasuredAtFairValueAbstract0_lbl" xml:lang="en-US">Measured at Fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MeasuredAtFairValueAbstract0" xlink:to="mlec_MeasuredAtFairValueAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfSignificantJointVenturesTableTextBlock" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfSignificantJointVenturesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ScheduleOfSignificantJointVenturesTableTextBlock_lbl" xml:lang="en-US">Schedule of Significant Joint Ventures</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfSignificantJointVenturesTableTextBlock" xlink:to="mlec_ScheduleOfSignificantJointVenturesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_lbl" xml:lang="en-US">SEGMENT INFORMATION</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:to="ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsExplanatory_lbl" xml:lang="en-US">Schedule of Operating Results Group&apos;s Reporting Segments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsExplanatory" xlink:to="ifrs-full_DisclosureOfOperatingSegmentsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_RevenuesFromContractsWithCustomersAbstract" xlink:href="mlec-20250630.xsd#mlec_RevenuesFromContractsWithCustomersAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_RevenuesFromContractsWithCustomersAbstract_lbl" xml:lang="en-US">Revenues from contracts with customers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RevenuesFromContractsWithCustomersAbstract" xlink:to="mlec_RevenuesFromContractsWithCustomersAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_RevenueFromSaleOfGoodsAndRenderingOfServices" xlink:href="mlec-20250630.xsd#mlec_RevenueFromSaleOfGoodsAndRenderingOfServices"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_RevenueFromSaleOfGoodsAndRenderingOfServices_lbl" xml:lang="en-US">Sale of goods and services</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RevenueFromSaleOfGoodsAndRenderingOfServices" xlink:to="mlec_RevenueFromSaleOfGoodsAndRenderingOfServices_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_OthersAbstract" xlink:href="mlec-20250630.xsd#mlec_OthersAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_OthersAbstract_lbl" xml:lang="en-US">Others</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OthersAbstract" xlink:to="mlec_OthersAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PercentageGrossMargin" xlink:href="mlec-20250630.xsd#mlec_PercentageGrossMargin"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_PercentageGrossMargin_lbl" xml:lang="en-US">% Gross margin</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageGrossMargin" xlink:to="mlec_PercentageGrossMargin_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_RevenuesFromContractsWithCustomersAbstract0" xlink:href="mlec-20250630.xsd#mlec_RevenuesFromContractsWithCustomersAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_RevenuesFromContractsWithCustomersAbstract0_lbl" xml:lang="en-US">Revenues from contracts with customers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RevenuesFromContractsWithCustomersAbstract0" xlink:to="mlec_RevenuesFromContractsWithCustomersAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_OthersAbstract0" xlink:href="mlec-20250630.xsd#mlec_OthersAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_OthersAbstract0_lbl" xml:lang="en-US">Others</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OthersAbstract0" xlink:to="mlec_OthersAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_RevenuesFromContractsWithCustomersAbstract1" xlink:href="mlec-20250630.xsd#mlec_RevenuesFromContractsWithCustomersAbstract1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_RevenuesFromContractsWithCustomersAbstract1_lbl" xml:lang="en-US">Revenues from contracts with customers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RevenuesFromContractsWithCustomersAbstract1" xlink:to="mlec_RevenuesFromContractsWithCustomersAbstract1_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_OthersAbstract1" xlink:href="mlec-20250630.xsd#mlec_OthersAbstract1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_OthersAbstract1_lbl" xml:lang="en-US">Others</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OthersAbstract1" xlink:to="mlec_OthersAbstract1_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfProductsAndServicesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfProductsAndServicesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfProductsAndServicesExplanatory_lbl" xml:lang="en-US">Schedule of Revenue by Similar Group of Products or Services</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfProductsAndServicesExplanatory" xlink:to="ifrs-full_DisclosureOfProductsAndServicesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_RevenueBySimilarGroupOfProductsOrServicesAbstract" xlink:href="mlec-20250630.xsd#mlec_RevenueBySimilarGroupOfProductsOrServicesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_RevenueBySimilarGroupOfProductsOrServicesAbstract_lbl" xml:lang="en-US">Revenue by similar group of products or services</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RevenueBySimilarGroupOfProductsOrServicesAbstract" xlink:to="mlec_RevenueBySimilarGroupOfProductsOrServicesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_UnlabeledAbstract3" xlink:href="mlec-20250630.xsd#mlec_UnlabeledAbstract3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_UnlabeledAbstract3_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract3" xlink:to="mlec_UnlabeledAbstract3_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_UnlabeledAbstract4" xlink:href="mlec-20250630.xsd#mlec_UnlabeledAbstract4"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_UnlabeledAbstract4_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract4" xlink:to="mlec_UnlabeledAbstract4_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_UnlabeledAbstract5" xlink:href="mlec-20250630.xsd#mlec_UnlabeledAbstract5"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_UnlabeledAbstract5_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract5" xlink:to="mlec_UnlabeledAbstract5_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfGeographicalAreasExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfGeographicalAreasExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfGeographicalAreasExplanatory_lbl" xml:lang="en-US">Schedule of Geographical Information</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfGeographicalAreasExplanatory" xlink:to="ifrs-full_DisclosureOfGeographicalAreasExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NonCurrentAssetsAbstract" xlink:href="mlec-20250630.xsd#mlec_NonCurrentAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NonCurrentAssetsAbstract_lbl" xml:lang="en-US">Non-current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NonCurrentAssetsAbstract" xlink:to="mlec_NonCurrentAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_UnlabeledAbstract6" xlink:href="mlec-20250630.xsd#mlec_UnlabeledAbstract6"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_UnlabeledAbstract6_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract6" xlink:to="mlec_UnlabeledAbstract6_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_TotalReportableAssets" xlink:href="mlec-20250630.xsd#mlec_TotalReportableAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_TotalReportableAssets_lbl" xml:lang="en-US">Total reportable assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TotalReportableAssets" xlink:to="mlec_TotalReportableAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_TotalNonreportableAssets" xlink:href="mlec-20250630.xsd#mlec_TotalNonreportableAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_TotalNonreportableAssets_lbl" xml:lang="en-US">Total non-reportable assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TotalNonreportableAssets" xlink:to="mlec_TotalNonreportableAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialRiskManagementExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory_lbl" xml:lang="en-US">FINANCIAL INSTRUMENTS &#8211; RISK MANAGEMENT</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory" xlink:to="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities_lbl" xml:lang="en-US">Schedule of Liquidity Risk</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities" xlink:to="ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherPayables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TradeAndOtherPayables_lbl" xml:lang="en-US">Trade and other payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherPayables" xlink:to="ifrs-full_TradeAndOtherPayables_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_TradeAndOtherPayables_lbl0" xml:lang="en-US">Trade and other payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherPayables" xlink:to="ifrs-full_TradeAndOtherPayables_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Borrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Borrowings"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_Borrowings_lbl" xml:lang="en-US">Borrowings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Borrowings" xlink:to="ifrs-full_Borrowings_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_Borrowings_lbl0" xml:lang="en-US">Borrowings (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Borrowings" xlink:to="ifrs-full_Borrowings_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="ifrs-full_Borrowings_lbl1" xml:lang="en-US">Principal amount (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Borrowings" xlink:to="ifrs-full_Borrowings_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_ConvertibleNotes" xlink:href="mlec-20250630.xsd#mlec_ConvertibleNotes"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ConvertibleNotes_lbl" xml:lang="en-US">Convertible notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ConvertibleNotes" xlink:to="mlec_ConvertibleNotes_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_LeasingLiabilities" xlink:href="mlec-20250630.xsd#mlec_LeasingLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_LeasingLiabilities_lbl" xml:lang="en-US">Leasing liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LeasingLiabilities" xlink:to="mlec_LeasingLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ConsiderationForAcquisitionOfAssets" xlink:href="mlec-20250630.xsd#mlec_ConsiderationForAcquisitionOfAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ConsiderationForAcquisitionOfAssets_lbl" xml:lang="en-US">Consideration for acquisition of assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ConsiderationForAcquisitionOfAssets" xlink:to="mlec_ConsiderationForAcquisitionOfAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory_lbl" xml:lang="en-US">Schedule of Interest Rate Risk</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory" xlink:to="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfForeignExchangeRiskSensitivityAnalysistextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfForeignExchangeRiskSensitivityAnalysistextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DisclosureOfForeignExchangeRiskSensitivityAnalysistextBlock_lbl" xml:lang="en-US">Schedule of Other Foriegn Currencies with Variables Remaining Constant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfForeignExchangeRiskSensitivityAnalysistextBlock" xlink:to="mlec_DisclosureOfForeignExchangeRiskSensitivityAnalysistextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic_lbl" xml:lang="en-US">Argentine peso amount expressed</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic" xlink:to="ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic_lbl0" xml:lang="en-US">Amount expressed in US$</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic" xlink:to="ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic_lbl1" xml:lang="en-US">Argentine peso amount expressed</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic" xlink:to="ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_CarryingAmountAbstract" xlink:href="mlec-20250630.xsd#mlec_CarryingAmountAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_CarryingAmountAbstract_lbl" xml:lang="en-US">Carrying amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CarryingAmountAbstract" xlink:to="mlec_CarryingAmountAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FixedRateInstrumentsAbstract" xlink:href="mlec-20250630.xsd#mlec_FixedRateInstrumentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_FixedRateInstrumentsAbstract_lbl" xml:lang="en-US">Fixed-rate instruments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FixedRateInstrumentsAbstract" xlink:to="mlec_FixedRateInstrumentsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentFinancialLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentFinancialLiabilities_lbl" xml:lang="en-US">Current financial liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentFinancialLiabilities" xlink:to="ifrs-full_CurrentFinancialLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentFinancialLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncurrentFinancialLiabilities_lbl" xml:lang="en-US">Non-current financial liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentFinancialLiabilities" xlink:to="ifrs-full_NoncurrentFinancialLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_VariableRateInstrumentsAbstract" xlink:href="mlec-20250630.xsd#mlec_VariableRateInstrumentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_VariableRateInstrumentsAbstract_lbl" xml:lang="en-US">Variable-rate instruments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_VariableRateInstrumentsAbstract" xlink:to="mlec_VariableRateInstrumentsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfFinancialAssetsExplanatory_lbl" xml:lang="en-US">Schedule of Financial Assets by Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfFinancialAssetsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory_lbl" xml:lang="en-US">Schedule of Financial Liabilities by Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory" xlink:to="ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory_lbl" xml:lang="en-US">Schedule of Fair Value by Hierarchy</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory" xlink:to="ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_MeasurementAtFairValueAt06302025Abstract" xlink:href="mlec-20250630.xsd#mlec_MeasurementAtFairValueAt06302025Abstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_MeasurementAtFairValueAt06302025Abstract_lbl" xml:lang="en-US">Measurement at fair value at 06/30/2025</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MeasurementAtFairValueAt06302025Abstract" xlink:to="mlec_MeasurementAtFairValueAt06302025Abstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialAssetsAtFairValueAbstract" xlink:href="mlec-20250630.xsd#mlec_FinancialAssetsAtFairValueAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_FinancialAssetsAtFairValueAbstract_lbl" xml:lang="en-US">Financial assets at fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialAssetsAtFairValueAbstract" xlink:to="mlec_FinancialAssetsAtFairValueAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialLiabilitiesValuedAtFairValueAbstract" xlink:href="mlec-20250630.xsd#mlec_FinancialLiabilitiesValuedAtFairValueAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_FinancialLiabilitiesValuedAtFairValueAbstract_lbl" xml:lang="en-US">Financial liabilities valued at fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialLiabilitiesValuedAtFairValueAbstract" xlink:to="mlec_FinancialLiabilitiesValuedAtFairValueAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialLiabilitiesAtFairValue" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_FinancialLiabilitiesAtFairValue_lbl" xml:lang="en-US">Financial liabilities at fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilitiesAtFairValue" xlink:to="ifrs-full_FinancialLiabilitiesAtFairValue_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_MeasurementAtFairValueAt06302024Abstract" xlink:href="mlec-20250630.xsd#mlec_MeasurementAtFairValueAt06302024Abstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_MeasurementAtFairValueAt06302024Abstract_lbl" xml:lang="en-US">Measurement at fair value at 06/30/2024</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MeasurementAtFairValueAt06302024Abstract" xlink:to="mlec_MeasurementAtFairValueAt06302024Abstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialAssetsAtFairValueAbstract0" xlink:href="mlec-20250630.xsd#mlec_FinancialAssetsAtFairValueAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_FinancialAssetsAtFairValueAbstract0_lbl" xml:lang="en-US">Financial assets at fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialAssetsAtFairValueAbstract0" xlink:to="mlec_FinancialAssetsAtFairValueAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialLiabilitiesValuedAtFairValueAbstract0" xlink:href="mlec-20250630.xsd#mlec_FinancialLiabilitiesValuedAtFairValueAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_FinancialLiabilitiesValuedAtFairValueAbstract0_lbl" xml:lang="en-US">Financial liabilities valued at fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialLiabilitiesValuedAtFairValueAbstract0" xlink:to="mlec_FinancialLiabilitiesValuedAtFairValueAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfLeasesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfLeasesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfLeasesExplanatory_lbl" xml:lang="en-US">LEASES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfLeasesExplanatory" xlink:to="ifrs-full_DisclosureOfLeasesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_lbl" xml:lang="en-US">Schedule of Right-of-Use and Liabilities Related with Lease Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_lbl" xml:lang="en-US">Right-of-use leased asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsRightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsRightofuseAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsRightofuseAssets_lbl" xml:lang="en-US">Additions from business combination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsRightofuseAssets" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsRightofuseAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_RightOfUseAssetLossOfControl" xlink:href="mlec-20250630.xsd#mlec_RightOfUseAssetLossOfControl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_RightOfUseAssetLossOfControl_lbl" xml:lang="en-US">Loss of control</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RightOfUseAssetLossOfControl" xlink:to="mlec_RightOfUseAssetLossOfControl_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DepreciationAbstract_lbl" xml:lang="en-US">Depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAbstract" xlink:to="us-gaap_DepreciationAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_BookValueAtTheBeginningOfThePeriod" xlink:href="mlec-20250630.xsd#mlec_BookValueAtTheBeginningOfThePeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_BookValueAtTheBeginningOfThePeriod_lbl" xml:lang="en-US">Book value at the beginning of the year/inception</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BookValueAtTheBeginningOfThePeriod" xlink:to="mlec_BookValueAtTheBeginningOfThePeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DepreciationOfThePeriod" xlink:href="mlec-20250630.xsd#mlec_DepreciationOfThePeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DepreciationOfThePeriod_lbl" xml:lang="en-US">Depreciation of the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DepreciationOfThePeriod" xlink:to="mlec_DepreciationOfThePeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DisposalsDepreciation" xlink:href="mlec-20250630.xsd#mlec_DisposalsDepreciation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DisposalsDepreciation_lbl" xml:lang="en-US">Disposals</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisposalsDepreciation" xlink:to="mlec_DisposalsDepreciation_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ExchangeDifferencesDepreciation" xlink:href="mlec-20250630.xsd#mlec_ExchangeDifferencesDepreciation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ExchangeDifferencesDepreciation_lbl" xml:lang="en-US">Exchange differences</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ExchangeDifferencesDepreciation" xlink:to="mlec_ExchangeDifferencesDepreciation_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_LossOfControlDepreciation" xlink:href="mlec-20250630.xsd#mlec_LossOfControlDepreciation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_LossOfControlDepreciation_lbl" xml:lang="en-US">Loss of control</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LossOfControlDepreciation" xlink:to="mlec_LossOfControlDepreciation_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AccumulatedDepreciationAtTheEndOfThePeriod" xlink:href="mlec-20250630.xsd#mlec_AccumulatedDepreciationAtTheEndOfThePeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AccumulatedDepreciationAtTheEndOfThePeriod_lbl" xml:lang="en-US">Accumulated depreciation at the end of the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AccumulatedDepreciationAtTheEndOfThePeriod" xlink:to="mlec_AccumulatedDepreciationAtTheEndOfThePeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LeaseLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_LeaseLiabilitiesAbstract_lbl" xml:lang="en-US">Lease Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LeaseLiabilitiesAbstract" xlink:to="ifrs-full_LeaseLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_LeaseLiabilityBeginningOfTheYearinception" xlink:href="mlec-20250630.xsd#mlec_LeaseLiabilityBeginningOfTheYearinception"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_LeaseLiabilityBeginningOfTheYearinception_lbl" xml:lang="en-US">Book value at the beginning of the year/inception</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LeaseLiabilityBeginningOfTheYearinception" xlink:to="mlec_LeaseLiabilityBeginningOfTheYearinception_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_LeaseLiabiltyAdditionsOfTheYear" xlink:href="mlec-20250630.xsd#mlec_LeaseLiabiltyAdditionsOfTheYear"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_LeaseLiabiltyAdditionsOfTheYear_lbl" xml:lang="en-US">Additions of the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LeaseLiabiltyAdditionsOfTheYear" xlink:to="mlec_LeaseLiabiltyAdditionsOfTheYear_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AdditionsToLeaseLiabilityFromBusinessCombination" xlink:href="mlec-20250630.xsd#mlec_AdditionsToLeaseLiabilityFromBusinessCombination"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AdditionsToLeaseLiabilityFromBusinessCombination_lbl" xml:lang="en-US">Additions from business combination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AdditionsToLeaseLiabilityFromBusinessCombination" xlink:to="mlec_AdditionsToLeaseLiabilityFromBusinessCombination_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_LeaseLiabilitiesInterestExpenseExchangeDifferencesAndInflationEffects" xlink:href="mlec-20250630.xsd#mlec_LeaseLiabilitiesInterestExpenseExchangeDifferencesAndInflationEffects"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_LeaseLiabilitiesInterestExpenseExchangeDifferencesAndInflationEffects_lbl" xml:lang="en-US">Interest expenses, exchange differences and inflation effects</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LeaseLiabilitiesInterestExpenseExchangeDifferencesAndInflationEffects" xlink:to="mlec_LeaseLiabilitiesInterestExpenseExchangeDifferencesAndInflationEffects_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PaymentsOfThePeriodLeaseliability" xlink:href="mlec-20250630.xsd#mlec_PaymentsOfThePeriodLeaseliability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_PaymentsOfThePeriodLeaseliability_lbl" xml:lang="en-US">Payments of the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PaymentsOfThePeriodLeaseliability" xlink:to="mlec_PaymentsOfThePeriodLeaseliability_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_LossOfControlLeaseLiability" xlink:href="mlec-20250630.xsd#mlec_LossOfControlLeaseLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_LossOfControlLeaseLiability_lbl" xml:lang="en-US">Loss of control</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LossOfControlLeaseLiability" xlink:to="mlec_LossOfControlLeaseLiability_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_LeaseLiabilities_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LeaseLiabilities" xlink:to="ifrs-full_LeaseLiabilities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_LeaseLiabilities_lbl0" xml:lang="en-US">Lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LeaseLiabilities" xlink:to="ifrs-full_LeaseLiabilities_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Machinery" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Machinery"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_Machinery_lbl" xml:lang="en-US">Machinery and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Machinery" xlink:to="ifrs-full_Machinery_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Vehicles" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Vehicles"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_Vehicles_lbl" xml:lang="en-US">Vehicles</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Vehicles" xlink:to="ifrs-full_Vehicles_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComputerSoftware" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComputerSoftware"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ComputerSoftware_lbl" xml:lang="en-US">Equipment and computer software</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComputerSoftware" xlink:to="ifrs-full_ComputerSoftware_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LandAndBuildings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LandAndBuildings"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_LandAndBuildings_lbl" xml:lang="en-US">Land and buildings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LandAndBuildings" xlink:to="ifrs-full_LandAndBuildings_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfRelatedPartyExplanatory_lbl" xml:lang="en-US">SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:to="ifrs-full_DisclosureOfRelatedPartyExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_lbl" xml:lang="en-US">Schedule of Transactions Between the Group and Related Parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" xlink:to="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ValueOfTransactionsForThePeriodEnded" xlink:href="mlec-20250630.xsd#mlec_ValueOfTransactionsForThePeriodEnded"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ValueOfTransactionsForThePeriodEnded_lbl" xml:lang="en-US">Value of transactions for the period ended</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ValueOfTransactionsForThePeriodEnded" xlink:to="mlec_ValueOfTransactionsForThePeriodEnded_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_lbl" xml:lang="en-US">KEY MANAGEMENT PERSONNEL COMPENSATION</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory" xlink:to="ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock_lbl" xml:lang="en-US">Schedule of Compensation of Key Management Personnel Compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock" xlink:to="mlec_DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_lbl" xml:lang="en-US">Short-term employee benefits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:to="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_lbl" xml:lang="en-US">Share based payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:to="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_lbl" xml:lang="en-US">SHARE-BASED PAYMENT</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:to="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfFairValueOfTheStockOptionsAtTheGrantDateTextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfFairValueOfTheStockOptionsAtTheGrantDateTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DisclosureOfFairValueOfTheStockOptionsAtTheGrantDateTextBlock_lbl" xml:lang="en-US">Schedule of Fair Value of the Stock Options at the Grant Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfFairValueOfTheStockOptionsAtTheGrantDateTextBlock" xlink:to="mlec_DisclosureOfFairValueOfTheStockOptionsAtTheGrantDateTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_lbl" xml:lang="en-US">Weighted average fair value of shares (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:to="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ExercisePriceShareOptionsGranted2019_lbl" xml:lang="en-US">Weighted average exercise price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:to="ifrs-full_ExercisePriceShareOptionsGranted2019_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ExercisePriceShareOptionsGranted2019_lbl0" xml:lang="en-US">Exercise price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:to="ifrs-full_ExercisePriceShareOptionsGranted2019_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="ifrs-full_ExercisePriceShareOptionsGranted2019_lbl1" xml:lang="en-US">Options exercise price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:to="ifrs-full_ExercisePriceShareOptionsGranted2019_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_lbl" xml:lang="en-US">Weighted average expected volatility</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:to="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_lbl0" xml:lang="en-US">Estimated volatility factor</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:to="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_lbl" xml:lang="en-US">Dividend rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:to="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_lbl0" xml:lang="en-US">Expected dividend yield</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:to="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_lbl" xml:lang="en-US">Weighted average risk-free interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:to="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_lbl0" xml:lang="en-US">Risk-free interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:to="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_lbl" xml:lang="en-US">Weighted average expected life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:to="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_lbl0" xml:lang="en-US">Expected life (years)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:to="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_lbl" xml:lang="en-US">Weighted average fair value of stock options at measurement date (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" xlink:to="ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_lbl" xml:lang="en-US">Schedule of Range of Assumptions which have Determined</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:to="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_lbl" xml:lang="en-US">Schedule of Option Activity and Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_lbl" xml:lang="en-US">Number of options, Granted during the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_lbl0" xml:lang="en-US">Number of options, granted during the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US">W.A. Exercise price, Granted during the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US">W.A. Exercise price, Cancelled or expired during the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US">W.A. Exercise price, Exercised during the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US">W.A. Exercise price, Loss of control</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfCommitmentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfCommitmentsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfCommitmentsExplanatory_lbl" xml:lang="en-US">CONTINGENCIES, COMMITMENTS AND RESTRICTIONS ON THE DISTRIBUTION OF PROFITS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfCommitmentsExplanatory" xlink:to="ifrs-full_DisclosureOfCommitmentsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_lbl" xml:lang="en-US">EVENTS OCCURRING AFTER THE REPORTING PERIOD</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:to="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfReverseStockSplitAfterTheReportingPeriod" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfReverseStockSplitAfterTheReportingPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DisclosureOfReverseStockSplitAfterTheReportingPeriod_lbl" xml:lang="en-US">REVERSE STOCK SPLIT AFTER THE REPORTING PERIOD</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfReverseStockSplitAfterTheReportingPeriod" xlink:to="mlec_DisclosureOfReverseStockSplitAfterTheReportingPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_lbl" xml:lang="en-US">Schedule of Weighted Average Number of Ordinary Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NumeratorAbstract" xlink:href="mlec-20250630.xsd#mlec_NumeratorAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NumeratorAbstract_lbl" xml:lang="en-US">Numerator</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumeratorAbstract" xlink:to="mlec_NumeratorAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DenominatorAbstract" xlink:href="mlec-20250630.xsd#mlec_DenominatorAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DenominatorAbstract_lbl" xml:lang="en-US">Denominator</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DenominatorAbstract" xlink:to="mlec_DenominatorAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_lbl" xml:lang="en-US">Borrowings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_lbl" xml:lang="en-US">Accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_lbl" xml:lang="en-US">Deferred tax liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SocialSecurityContributions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SocialSecurityContributions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_SocialSecurityContributions_lbl" xml:lang="en-US">Employee benefits and social security</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SocialSecurityContributions" xlink:to="ifrs-full_SocialSecurityContributions_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentProvisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentProvisions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_CurrentProvisions_lbl" xml:lang="en-US">Provisions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentProvisions" xlink:to="ifrs-full_CurrentProvisions_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainRecognisedInBargainPurchaseTransaction" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainRecognisedInBargainPurchaseTransaction"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_GainRecognisedInBargainPurchaseTransaction_lbl" xml:lang="en-US">Gain from a bargain purchase</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainRecognisedInBargainPurchaseTransaction" xlink:to="ifrs-full_GainRecognisedInBargainPurchaseTransaction_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DecreaseDueToHarvestAndDisposalsBiologicalAssets" xlink:href="mlec-20250630.xsd#mlec_DecreaseDueToHarvestAndDisposalsBiologicalAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mlec_DecreaseDueToHarvestAndDisposalsBiologicalAssets_lbl" xml:lang="en-US">Decrease due to harvest/disposals</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DecreaseDueToHarvestAndDisposalsBiologicalAssets" xlink:to="mlec_DecreaseDueToHarvestAndDisposalsBiologicalAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_LossOfControlonBiologicalAssets" xlink:href="mlec-20250630.xsd#mlec_LossOfControlonBiologicalAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mlec_LossOfControlonBiologicalAssets_lbl" xml:lang="en-US">Loss of control</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LossOfControlonBiologicalAssets" xlink:to="mlec_LossOfControlonBiologicalAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DisposalsPropertyPlantAndEquipments" xlink:href="mlec-20250630.xsd#mlec_DisposalsPropertyPlantAndEquipments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mlec_DisposalsPropertyPlantAndEquipments_lbl" xml:lang="en-US">Disposals</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisposalsPropertyPlantAndEquipments" xlink:to="mlec_DisposalsPropertyPlantAndEquipments_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment_lbl" xml:lang="en-US">Loss of control</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment" xlink:to="ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US">Transfers/ Disposals</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AmortizationOfTheYear" xlink:href="mlec-20250630.xsd#mlec_AmortizationOfTheYear"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mlec_AmortizationOfTheYear_lbl" xml:lang="en-US">Amortization of the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AmortizationOfTheYear" xlink:to="mlec_AmortizationOfTheYear_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions_lbl" xml:lang="en-US">Additions from business combination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions" xlink:to="ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ChangeInAllowanceAndProvisionLossOfControl" xlink:href="mlec-20250630.xsd#mlec_ChangeInAllowanceAndProvisionLossOfControl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mlec_ChangeInAllowanceAndProvisionLossOfControl_lbl" xml:lang="en-US">Loss of control</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ChangeInAllowanceAndProvisionLossOfControl" xlink:to="mlec_ChangeInAllowanceAndProvisionLossOfControl_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LossesOnDisposalsOfInvestments" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LossesOnDisposalsOfInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_LossesOnDisposalsOfInvestments_lbl" xml:lang="en-US">Loss of control</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LossesOnDisposalsOfInvestments" xlink:to="ifrs-full_LossesOnDisposalsOfInvestments_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_InterestExpense_lbl" xml:lang="en-US">Interest expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestExpense" xlink:to="ifrs-full_InterestExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NetResultFromCommercializationOfAgriculturalProducts" xlink:href="mlec-20250630.xsd#mlec_NetResultFromCommercializationOfAgriculturalProducts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mlec_NetResultFromCommercializationOfAgriculturalProducts_lbl" xml:lang="en-US">Net result from commercialization of agricultural products</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NetResultFromCommercializationOfAgriculturalProducts" xlink:to="mlec_NetResultFromCommercializationOfAgriculturalProducts_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_TaxEffectOfShareOfProfitOrLossOfSubsidiesJointVenturesAndAssociates" xlink:href="mlec-20250630.xsd#mlec_TaxEffectOfShareOfProfitOrLossOfSubsidiesJointVenturesAndAssociates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mlec_TaxEffectOfShareOfProfitOrLossOfSubsidiesJointVenturesAndAssociates_lbl" xml:lang="en-US">Share of profit or loss of subsidiaries, joint ventures and associates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TaxEffectOfShareOfProfitOrLossOfSubsidiesJointVenturesAndAssociates" xlink:to="mlec_TaxEffectOfShareOfProfitOrLossOfSubsidiesJointVenturesAndAssociates_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PuttableInstrumentsCharge" xlink:href="mlec-20250630.xsd#mlec_PuttableInstrumentsCharge"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mlec_PuttableInstrumentsCharge_lbl" xml:lang="en-US">Puttable instruments charge</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PuttableInstrumentsCharge" xlink:to="mlec_PuttableInstrumentsCharge_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_TaxEffectOfStockOptionCharge" xlink:href="mlec-20250630.xsd#mlec_TaxEffectOfStockOptionCharge"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mlec_TaxEffectOfStockOptionCharge_lbl" xml:lang="en-US">Stock options charge</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TaxEffectOfStockOptionCharge" xlink:to="mlec_TaxEffectOfStockOptionCharge_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_TaxEffectOfRevenuesExemptFromTaxationAndExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:href="mlec-20250630.xsd#mlec_TaxEffectOfRevenuesExemptFromTaxationAndExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mlec_TaxEffectOfRevenuesExemptFromTaxationAndExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss_lbl" xml:lang="en-US">Non-deductible expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TaxEffectOfRevenuesExemptFromTaxationAndExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:to="mlec_TaxEffectOfRevenuesExemptFromTaxationAndExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ResultOfInflationEffectOnMonetaryItemsAndOtherFinanceResults" xlink:href="mlec-20250630.xsd#mlec_ResultOfInflationEffectOnMonetaryItemsAndOtherFinanceResults"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mlec_ResultOfInflationEffectOnMonetaryItemsAndOtherFinanceResults_lbl" xml:lang="en-US">Result of inflation effect on monetary items and other finance results</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ResultOfInflationEffectOnMonetaryItemsAndOtherFinanceResults" xlink:to="mlec_ResultOfInflationEffectOnMonetaryItemsAndOtherFinanceResults_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_TaxInflationAdjustment" xlink:href="mlec-20250630.xsd#mlec_TaxInflationAdjustment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mlec_TaxInflationAdjustment_lbl" xml:lang="en-US">Tax inflation adjustment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TaxInflationAdjustment" xlink:to="mlec_TaxInflationAdjustment_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_lbl" xml:lang="en-US">Others</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:to="ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxExpenseIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxExpenseIncome"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_DeferredTaxExpenseIncome_lbl" xml:lang="en-US">Deferred tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxExpenseIncome" xlink:to="ifrs-full_DeferredTaxExpenseIncome_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NetAssetsAcquisitionByBusinessCombination" xlink:href="mlec-20250630.xsd#mlec_NetAssetsAcquisitionByBusinessCombination"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mlec_NetAssetsAcquisitionByBusinessCombination_lbl" xml:lang="en-US">Net assets acquisition by business combination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NetAssetsAcquisitionByBusinessCombination" xlink:to="mlec_NetAssetsAcquisitionByBusinessCombination_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_OwnShareHeld" xlink:href="mlec-20250630.xsd#mlec_OwnShareHeld"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mlec_OwnShareHeld_lbl" xml:lang="en-US">Own shares held</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OwnShareHeld" xlink:to="mlec_OwnShareHeld_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_RightofuseLeasedAssetAdditionsThroughAnIncreaseInLeaseLiabilities" xlink:href="mlec-20250630.xsd#mlec_RightofuseLeasedAssetAdditionsThroughAnIncreaseInLeaseLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mlec_RightofuseLeasedAssetAdditionsThroughAnIncreaseInLeaseLiabilities_lbl" xml:lang="en-US">Right-of-use leased asset additions through an increase in lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RightofuseLeasedAssetAdditionsThroughAnIncreaseInLeaseLiabilities" xlink:to="mlec_RightofuseLeasedAssetAdditionsThroughAnIncreaseInLeaseLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod_lbl" xml:lang="en-US">Sale of equity investee</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod" xlink:to="ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_CapitalizationOfConvertibleFinancingActivities" xlink:href="mlec-20250630.xsd#mlec_CapitalizationOfConvertibleFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mlec_CapitalizationOfConvertibleFinancingActivities_lbl" xml:lang="en-US">Capitalization of convertible notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CapitalizationOfConvertibleFinancingActivities" xlink:to="mlec_CapitalizationOfConvertibleFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AssignmentOfReceivablesWithShareholdersAndOtherRelatedParties" xlink:href="mlec-20250630.xsd#mlec_AssignmentOfReceivablesWithShareholdersAndOtherRelatedParties"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mlec_AssignmentOfReceivablesWithShareholdersAndOtherRelatedParties_lbl" xml:lang="en-US">Assignment of receivables with shareholders and other related parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AssignmentOfReceivablesWithShareholdersAndOtherRelatedParties" xlink:to="mlec_AssignmentOfReceivablesWithShareholdersAndOtherRelatedParties_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_CompensationPaymentFinancedByAcquisitionOfIntangibleAssets" xlink:href="mlec-20250630.xsd#mlec_CompensationPaymentFinancedByAcquisitionOfIntangibleAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mlec_CompensationPaymentFinancedByAcquisitionOfIntangibleAssets_lbl" xml:lang="en-US">Compensation payment financed by acquisition of intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CompensationPaymentFinancedByAcquisitionOfIntangibleAssets" xlink:to="mlec_CompensationPaymentFinancedByAcquisitionOfIntangibleAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_IncreaseThroughAcquisitionOfNonControllingInterestInSubsidiaries" xlink:href="mlec-20250630.xsd#mlec_IncreaseThroughAcquisitionOfNonControllingInterestInSubsidiaries"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mlec_IncreaseThroughAcquisitionOfNonControllingInterestInSubsidiaries_lbl" xml:lang="en-US">Acquisition of interest in subsidiaries by financed debts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IncreaseThroughAcquisitionOfNonControllingInterestInSubsidiaries" xlink:to="mlec_IncreaseThroughAcquisitionOfNonControllingInterestInSubsidiaries_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities" xlink:href="mlec-20250630.xsd#mlec_DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mlec_DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities_lbl" xml:lang="en-US">Payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities" xlink:to="mlec_DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DecreaseThroughCapitalizationOfDebtLiabilitiesArisingFromFinancingActivities" xlink:href="mlec-20250630.xsd#mlec_DecreaseThroughCapitalizationOfDebtLiabilitiesArisingFromFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mlec_DecreaseThroughCapitalizationOfDebtLiabilitiesArisingFromFinancingActivities_lbl" xml:lang="en-US">Conversion of Convertible Notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DecreaseThroughCapitalizationOfDebtLiabilitiesArisingFromFinancingActivities" xlink:to="mlec_DecreaseThroughCapitalizationOfDebtLiabilitiesArisingFromFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_JointVenturesAndAssociatesAccountedForUsingEquityMethodReclassificationChangeInOwnership" xlink:href="mlec-20250630.xsd#mlec_JointVenturesAndAssociatesAccountedForUsingEquityMethodReclassificationChangeInOwnership"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mlec_JointVenturesAndAssociatesAccountedForUsingEquityMethodReclassificationChangeInOwnership_lbl" xml:lang="en-US">Reclassification of Moolec Science S.A.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_JointVenturesAndAssociatesAccountedForUsingEquityMethodReclassificationChangeInOwnership" xlink:to="mlec_JointVenturesAndAssociatesAccountedForUsingEquityMethodReclassificationChangeInOwnership_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherCurrencies" xlink:href="mlec-20250630.xsd#mlec_OtherCurrencies"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mlec_OtherCurrencies_lbl" xml:lang="en-US">Other currencies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherCurrencies" xlink:to="mlec_OtherCurrencies_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisposalsRightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisposalsRightofuseAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_DisposalsRightofuseAssets_lbl" xml:lang="en-US">Disposals</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisposalsRightofuseAssets" xlink:to="ifrs-full_DisposalsRightofuseAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_lbl" xml:lang="en-US">Number of options, Cancelled or expired during the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_lbl" xml:lang="en-US">Number of options, Exercised during the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_lbl" xml:lang="en-US">Number of options, Loss of control</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_MoolecScienceLimitedMember" xlink:href="mlec-20250630.xsd#mlec_MoolecScienceLimitedMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_MoolecScienceLimitedMember_lbl" xml:lang="en-US">Moolec Science Limited [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MoolecScienceLimitedMember" xlink:to="mlec_MoolecScienceLimitedMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AGBiomoleculesLLCMember" xlink:href="mlec-20250630.xsd#mlec_AGBiomoleculesLLCMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AGBiomoleculesLLCMember_lbl" xml:lang="en-US">AG Biomolecules LLC [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AGBiomoleculesLLCMember" xlink:to="mlec_AGBiomoleculesLLCMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ValoraSoySAMember" xlink:href="mlec-20250630.xsd#mlec_ValoraSoySAMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ValoraSoySAMember_lbl" xml:lang="en-US">ValoraSoy S.A.[Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ValoraSoySAMember" xlink:to="mlec_ValoraSoySAMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NutreconLLCMember" xlink:href="mlec-20250630.xsd#mlec_NutreconLLCMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NutreconLLCMember_lbl" xml:lang="en-US">Nutrecon LLC [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NutreconLLCMember" xlink:to="mlec_NutreconLLCMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SynBioPowerlabsMember" xlink:href="mlec-20250630.xsd#mlec_SynBioPowerlabsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SynBioPowerlabsMember_lbl" xml:lang="en-US">SynBio Powerlabs [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SynBioPowerlabsMember" xlink:to="mlec_SynBioPowerlabsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_GentleTechMember" xlink:href="mlec-20250630.xsd#mlec_GentleTechMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_GentleTechMember_lbl" xml:lang="en-US">Gentle Tech [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_GentleTechMember" xlink:to="mlec_GentleTechMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_GentleFarmingMember" xlink:href="mlec-20250630.xsd#mlec_GentleFarmingMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_GentleFarmingMember_lbl" xml:lang="en-US">Gentle Farming [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_GentleFarmingMember" xlink:to="mlec_GentleFarmingMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_GFASMember" xlink:href="mlec-20250630.xsd#mlec_GFASMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_GFASMember_lbl" xml:lang="en-US">G-FAS [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_GFASMember" xlink:to="mlec_GFASMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresGroupLimitedMember" xlink:href="mlec-20250630.xsd#mlec_BioceresGroupLimitedMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_BioceresGroupLimitedMember_lbl" xml:lang="en-US">Bioceres Group Limited [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BioceresGroupLimitedMember" xlink:to="mlec_BioceresGroupLimitedMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresCropSolutionsBIOXMember" xlink:href="mlec-20250630.xsd#mlec_BioceresCropSolutionsBIOXMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_BioceresCropSolutionsBIOXMember_lbl" xml:lang="en-US">Bioceres Crop Solutions (BIOX) [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BioceresCropSolutionsBIOXMember" xlink:to="mlec_BioceresCropSolutionsBIOXMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresLLCMember" xlink:href="mlec-20250630.xsd#mlec_BioceresLLCMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_BioceresLLCMember_lbl" xml:lang="en-US">Bioceres LLC [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BioceresLLCMember" xlink:to="mlec_BioceresLLCMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresSAMember" xlink:href="mlec-20250630.xsd#mlec_BioceresSAMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_BioceresSAMember_lbl" xml:lang="en-US">Bioceres S.A [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BioceresSAMember" xlink:to="mlec_BioceresSAMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="mlec_BioceresSAMember_lbl0" xml:lang="en-US">Bioceres S.A. [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BioceresSAMember" xlink:to="mlec_BioceresSAMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresTechServicesLLCMember" xlink:href="mlec-20250630.xsd#mlec_BioceresTechServicesLLCMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_BioceresTechServicesLLCMember_lbl" xml:lang="en-US">Bioceres Tech Services LLC [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BioceresTechServicesLLCMember" xlink:to="mlec_BioceresTechServicesLLCMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ProFarmGroupIncMember" xlink:href="mlec-20250630.xsd#mlec_ProFarmGroupIncMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ProFarmGroupIncMember_lbl" xml:lang="en-US">Pro Farm Group Inc [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ProFarmGroupIncMember" xlink:to="mlec_ProFarmGroupIncMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NatalAgroSRLMember" xlink:href="mlec-20250630.xsd#mlec_NatalAgroSRLMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NatalAgroSRLMember_lbl" xml:lang="en-US">Natal Agro S. R. L. [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NatalAgroSRLMember" xlink:to="mlec_NatalAgroSRLMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_MoolecScienceSAMember" xlink:href="mlec-20250630.xsd#mlec_MoolecScienceSAMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_MoolecScienceSAMember_lbl" xml:lang="en-US">Moolec Science SA [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MoolecScienceSAMember" xlink:to="mlec_MoolecScienceSAMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InvestmentsInSharesMember" xlink:href="mlec-20250630.xsd#mlec_InvestmentsInSharesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_InvestmentsInSharesMember_lbl" xml:lang="en-US">Investments at fair value [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InvestmentsInSharesMember" xlink:to="mlec_InvestmentsInSharesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_MutualFundsMember" xlink:href="mlec-20250630.xsd#mlec_MutualFundsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_MutualFundsMember_lbl" xml:lang="en-US">Mutual funds [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MutualFundsMember" xlink:to="mlec_MutualFundsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherInvestmentMember" xlink:href="mlec-20250630.xsd#mlec_OtherInvestmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_OtherInvestmentMember_lbl" xml:lang="en-US">Other investments [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherInvestmentMember" xlink:to="mlec_OtherInvestmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeReceivablesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeReceivablesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TradeReceivablesMember_lbl" xml:lang="en-US">Trade receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeReceivablesMember" xlink:to="ifrs-full_TradeReceivablesMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_TradeReceivablesMember_lbl0" xml:lang="en-US">Trade receivables [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeReceivablesMember" xlink:to="ifrs-full_TradeReceivablesMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_TaxesMember" xlink:href="mlec-20250630.xsd#mlec_TaxesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_TaxesMember_lbl" xml:lang="en-US">Taxes [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TaxesMember" xlink:to="mlec_TaxesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InsuranceToBeAccruedMember" xlink:href="mlec-20250630.xsd#mlec_InsuranceToBeAccruedMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_InsuranceToBeAccruedMember_lbl" xml:lang="en-US">Insurance to be accrued [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InsuranceToBeAccruedMember" xlink:to="mlec_InsuranceToBeAccruedMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherReceivablesJointVenturesAndAssociatesMember" xlink:href="mlec-20250630.xsd#mlec_OtherReceivablesJointVenturesAndAssociatesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_OtherReceivablesJointVenturesAndAssociatesMember_lbl" xml:lang="en-US">Other receivables - Joint ventures and associates (Note 13) [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherReceivablesJointVenturesAndAssociatesMember" xlink:to="mlec_OtherReceivablesJointVenturesAndAssociatesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PrepaymentsToSuppliersMember" xlink:href="mlec-20250630.xsd#mlec_PrepaymentsToSuppliersMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_PrepaymentsToSuppliersMember_lbl" xml:lang="en-US">Prepayments to suppliers [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PrepaymentsToSuppliersMember" xlink:to="mlec_PrepaymentsToSuppliersMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareholdersAndOtherRelatedPartiesMember" xlink:href="mlec-20250630.xsd#mlec_ShareholdersAndOtherRelatedPartiesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ShareholdersAndOtherRelatedPartiesMember_lbl" xml:lang="en-US">Shareholders and other related parties (Note 17) [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareholdersAndOtherRelatedPartiesMember" xlink:to="mlec_ShareholdersAndOtherRelatedPartiesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_GovernmentsGrantsReceivableMember" xlink:href="mlec-20250630.xsd#mlec_GovernmentsGrantsReceivableMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_GovernmentsGrantsReceivableMember_lbl" xml:lang="en-US">Governments grants receivable [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_GovernmentsGrantsReceivableMember" xlink:to="mlec_GovernmentsGrantsReceivableMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PrepaidExpensesAndOtherReceivablesMember" xlink:href="mlec-20250630.xsd#mlec_PrepaidExpensesAndOtherReceivablesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_PrepaidExpensesAndOtherReceivablesMember_lbl" xml:lang="en-US">Prepaid expenses and other receivables [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PrepaidExpensesAndOtherReceivablesMember" xlink:to="mlec_PrepaidExpensesAndOtherReceivablesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_LoansReceivablesMember" xlink:href="mlec-20250630.xsd#mlec_LoansReceivablesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_LoansReceivablesMember_lbl" xml:lang="en-US">Loans receivables [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LoansReceivablesMember" xlink:to="mlec_LoansReceivablesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_MiscellaneousMember" xlink:href="mlec-20250630.xsd#mlec_MiscellaneousMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_MiscellaneousMember_lbl" xml:lang="en-US">Miscellaneous	[Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MiscellaneousMember" xlink:to="mlec_MiscellaneousMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherReceivableMember" xlink:href="mlec-20250630.xsd#mlec_OtherReceivableMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_OtherReceivableMember_lbl" xml:lang="en-US">Other receivables [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherReceivableMember" xlink:to="mlec_OtherReceivableMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ReimbursementsOverExportsMember" xlink:href="mlec-20250630.xsd#mlec_ReimbursementsOverExportsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ReimbursementsOverExportsMember_lbl" xml:lang="en-US">Reimbursements over exports [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ReimbursementsOverExportsMember" xlink:to="mlec_ReimbursementsOverExportsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SeedsAndGrainsMember" xlink:href="mlec-20250630.xsd#mlec_SeedsAndGrainsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SeedsAndGrainsMember_lbl" xml:lang="en-US">Seeds [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SeedsAndGrainsMember" xlink:to="mlec_SeedsAndGrainsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_MicrobiologicalResaleProductsMember" xlink:href="mlec-20250630.xsd#mlec_MicrobiologicalResaleProductsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_MicrobiologicalResaleProductsMember_lbl" xml:lang="en-US">Resale products [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MicrobiologicalResaleProductsMember" xlink:to="mlec_MicrobiologicalResaleProductsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_MicrobiologicalProductsProducedMember" xlink:href="mlec-20250630.xsd#mlec_MicrobiologicalProductsProducedMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_MicrobiologicalProductsProducedMember_lbl" xml:lang="en-US">Manufactured products [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MicrobiologicalProductsProducedMember" xlink:to="mlec_MicrobiologicalProductsProducedMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_GoodsInTransitMember" xlink:href="mlec-20250630.xsd#mlec_GoodsInTransitMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_GoodsInTransitMember_lbl" xml:lang="en-US">Goods in transit [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_GoodsInTransitMember" xlink:to="mlec_GoodsInTransitMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SuppliesMember" xlink:href="mlec-20250630.xsd#mlec_SuppliesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SuppliesMember_lbl" xml:lang="en-US">Supplies [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SuppliesMember" xlink:to="mlec_SuppliesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AgriculturalProductsMember" xlink:href="mlec-20250630.xsd#mlec_AgriculturalProductsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AgriculturalProductsMember_lbl" xml:lang="en-US">Agricultural products [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AgriculturalProductsMember" xlink:to="mlec_AgriculturalProductsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AllowanceForObsolescenceMember" xlink:href="mlec-20250630.xsd#mlec_AllowanceForObsolescenceMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AllowanceForObsolescenceMember_lbl" xml:lang="en-US">Allowance for obsolescence [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AllowanceForObsolescenceMember" xlink:to="mlec_AllowanceForObsolescenceMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_BiologicalAssetsSoybeanMember" xlink:href="mlec-20250630.xsd#mlec_BiologicalAssetsSoybeanMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_BiologicalAssetsSoybeanMember_lbl" xml:lang="en-US">Soybean [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BiologicalAssetsSoybeanMember" xlink:to="mlec_BiologicalAssetsSoybeanMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_BiologicalAssetsCornMember" xlink:href="mlec-20250630.xsd#mlec_BiologicalAssetsCornMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_BiologicalAssetsCornMember_lbl" xml:lang="en-US">Corn [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BiologicalAssetsCornMember" xlink:to="mlec_BiologicalAssetsCornMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_BiologicalAssetsWheatMember" xlink:href="mlec-20250630.xsd#mlec_BiologicalAssetsWheatMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_BiologicalAssetsWheatMember_lbl" xml:lang="en-US">Wheat [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BiologicalAssetsWheatMember" xlink:to="mlec_BiologicalAssetsWheatMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_BiologicalAssetsBarleyMember" xlink:href="mlec-20250630.xsd#mlec_BiologicalAssetsBarleyMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_BiologicalAssetsBarleyMember_lbl" xml:lang="en-US">Barley [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BiologicalAssetsBarleyMember" xlink:to="mlec_BiologicalAssetsBarleyMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SunflowerMember" xlink:href="mlec-20250630.xsd#mlec_SunflowerMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SunflowerMember_lbl" xml:lang="en-US">Sunflower [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SunflowerMember" xlink:to="mlec_SunflowerMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OfficeEquipmentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OfficeEquipmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OfficeEquipmentMember_lbl" xml:lang="en-US">Office equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OfficeEquipmentMember" xlink:to="ifrs-full_OfficeEquipmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_VehiclesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_VehiclesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_VehiclesMember_lbl" xml:lang="en-US">Vehicles [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_VehiclesMember" xlink:to="ifrs-full_VehiclesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComputerEquipmentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComputerEquipmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ComputerEquipmentMember_lbl" xml:lang="en-US">Equipment and computer software [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComputerEquipmentMember" xlink:to="ifrs-full_ComputerEquipmentMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ComputerEquipmentMember_lbl0" xml:lang="en-US">Computer equipment and software [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComputerEquipmentMember" xlink:to="ifrs-full_ComputerEquipmentMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FixturesAndFittingsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FixturesAndFittingsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_FixturesAndFittingsMember_lbl" xml:lang="en-US">Fixtures and fittings [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FixturesAndFittingsMember" xlink:to="ifrs-full_FixturesAndFittingsMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_FixturesAndFittingsMember_lbl0" xml:lang="en-US">Fixture and fittings [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FixturesAndFittingsMember" xlink:to="ifrs-full_FixturesAndFittingsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_MachineryAndEquipmentsMember" xlink:href="mlec-20250630.xsd#mlec_MachineryAndEquipmentsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_MachineryAndEquipmentsMember_lbl" xml:lang="en-US">Machinery and Equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MachineryAndEquipmentsMember" xlink:to="mlec_MachineryAndEquipmentsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LandAndBuildingsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LandAndBuildingsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_LandAndBuildingsMember_lbl" xml:lang="en-US">Land and buildings [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LandAndBuildingsMember" xlink:to="ifrs-full_LandAndBuildingsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ConstructionInProgressMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ConstructionInProgressMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ConstructionInProgressMember_lbl" xml:lang="en-US">Buildings in progress [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ConstructionInProgressMember" xlink:to="ifrs-full_ConstructionInProgressMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ResearchInstrumentsMember" xlink:href="mlec-20250630.xsd#mlec_ResearchInstrumentsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ResearchInstrumentsMember_lbl" xml:lang="en-US">Research Instruments [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ResearchInstrumentsMember" xlink:to="mlec_ResearchInstrumentsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PropertyPlantAndEquipmentsMember" xlink:href="mlec-20250630.xsd#mlec_PropertyPlantAndEquipmentsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_PropertyPlantAndEquipmentsMember_lbl" xml:lang="en-US">Property Plant And Equipments [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PropertyPlantAndEquipmentsMember" xlink:to="mlec_PropertyPlantAndEquipmentsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AlfalfaGenuityHarXstraMember" xlink:href="mlec-20250630.xsd#mlec_AlfalfaGenuityHarXstraMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AlfalfaGenuityHarXstraMember_lbl" xml:lang="en-US">Alfalfa Genuity Har Xstra [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AlfalfaGenuityHarXstraMember" xlink:to="mlec_AlfalfaGenuityHarXstraMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_HB4SoyAndBreedingProgramMember" xlink:href="mlec-20250630.xsd#mlec_HB4SoyAndBreedingProgramMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_HB4SoyAndBreedingProgramMember_lbl" xml:lang="en-US">HB4 soy and breeding program [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_HB4SoyAndBreedingProgramMember" xlink:to="mlec_HB4SoyAndBreedingProgramMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_IntegratedSeedProductsMember" xlink:href="mlec-20250630.xsd#mlec_IntegratedSeedProductsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_IntegratedSeedProductsMember_lbl" xml:lang="en-US">Integrated seed products [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IntegratedSeedProductsMember" xlink:to="mlec_IntegratedSeedProductsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_MicrobiologicalProductsMember" xlink:href="mlec-20250630.xsd#mlec_MicrobiologicalProductsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_MicrobiologicalProductsMember_lbl" xml:lang="en-US">Microbiological products [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MicrobiologicalProductsMember" xlink:to="mlec_MicrobiologicalProductsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_MicrobiologicalProductsInProgressMember" xlink:href="mlec-20250630.xsd#mlec_MicrobiologicalProductsInProgressMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_MicrobiologicalProductsInProgressMember_lbl" xml:lang="en-US">Microbiological products in progress [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MicrobiologicalProductsInProgressMember" xlink:to="mlec_MicrobiologicalProductsInProgressMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_TrademarksAndPatentsMember" xlink:href="mlec-20250630.xsd#mlec_TrademarksAndPatentsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_TrademarksAndPatentsMember_lbl" xml:lang="en-US">Trademarks and patents [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TrademarksAndPatentsMember" xlink:to="mlec_TrademarksAndPatentsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_TrademarksAndPatentsWithIndefiniteUsefulLifeMember" xlink:href="mlec-20250630.xsd#mlec_TrademarksAndPatentsWithIndefiniteUsefulLifeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_TrademarksAndPatentsWithIndefiniteUsefulLifeMember_lbl" xml:lang="en-US">Trademarks and patents with indefinite useful life [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TrademarksAndPatentsWithIndefiniteUsefulLifeMember" xlink:to="mlec_TrademarksAndPatentsWithIndefiniteUsefulLifeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SoftwareMember" xlink:href="mlec-20250630.xsd#mlec_SoftwareMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SoftwareMember_lbl" xml:lang="en-US">Software [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SoftwareMember" xlink:to="mlec_SoftwareMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SoftwareInProgressMember" xlink:href="mlec-20250630.xsd#mlec_SoftwareInProgressMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SoftwareInProgressMember_lbl" xml:lang="en-US">Software in progress [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SoftwareInProgressMember" xlink:to="mlec_SoftwareInProgressMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_CustomerLoyaltyMember" xlink:href="mlec-20250630.xsd#mlec_CustomerLoyaltyMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_CustomerLoyaltyMember_lbl" xml:lang="en-US">Customer loyalty [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CustomerLoyaltyMember" xlink:to="mlec_CustomerLoyaltyMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_RGRSOXWheatMember" xlink:href="mlec-20250630.xsd#mlec_RGRSOXWheatMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_RGRSOXWheatMember_lbl" xml:lang="en-US">RG/RS/OX Wheat [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RGRSOXWheatMember" xlink:to="mlec_RGRSOXWheatMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SustainableAgriculturalEquipmentTechnologyMember" xlink:href="mlec-20250630.xsd#mlec_SustainableAgriculturalEquipmentTechnologyMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SustainableAgriculturalEquipmentTechnologyMember_lbl" xml:lang="en-US">Sustainable agricultural equipment technology [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SustainableAgriculturalEquipmentTechnologyMember" xlink:to="mlec_SustainableAgriculturalEquipmentTechnologyMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FungalBiomassMember" xlink:href="mlec-20250630.xsd#mlec_FungalBiomassMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_FungalBiomassMember_lbl" xml:lang="en-US">Fungal Biomass [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FungalBiomassMember" xlink:to="mlec_FungalBiomassMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PiggysooyMember" xlink:href="mlec-20250630.xsd#mlec_PiggysooyMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_PiggysooyMember_lbl" xml:lang="en-US">Piggysooy [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PiggysooyMember" xlink:to="mlec_PiggysooyMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SafflowerGLAMember" xlink:href="mlec-20250630.xsd#mlec_SafflowerGLAMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SafflowerGLAMember_lbl" xml:lang="en-US">Safflower GLA [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SafflowerGLAMember" xlink:to="mlec_SafflowerGLAMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SafflowerChimosin20Member" xlink:href="mlec-20250630.xsd#mlec_SafflowerChimosin20Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SafflowerChimosin20Member_lbl" xml:lang="en-US">Safflower Chimosin 2.0 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SafflowerChimosin20Member" xlink:to="mlec_SafflowerChimosin20Member_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherIntangibleAssetsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherIntangibleAssetsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherIntangibleAssetsMember_lbl" xml:lang="en-US">Other Intangibles [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherIntangibleAssetsMember" xlink:to="ifrs-full_OtherIntangibleAssetsMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherIntangibleAssetsMember_lbl0" xml:lang="en-US">Product development [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherIntangibleAssetsMember" xlink:to="ifrs-full_OtherIntangibleAssetsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_BacillusPHAsMember" xlink:href="mlec-20250630.xsd#mlec_BacillusPHAsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_BacillusPHAsMember_lbl" xml:lang="en-US">Bacillus-PHAs [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BacillusPHAsMember" xlink:to="mlec_BacillusPHAsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_RizobacterArgentinaSAMember" xlink:href="mlec-20250630.xsd#mlec_RizobacterArgentinaSAMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_RizobacterArgentinaSAMember_lbl" xml:lang="en-US">Rizobacter Argentina S.A. [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RizobacterArgentinaSAMember" xlink:to="mlec_RizobacterArgentinaSAMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresCropsSAMember" xlink:href="mlec-20250630.xsd#mlec_BioceresCropsSAMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_BioceresCropsSAMember_lbl" xml:lang="en-US">Bioceres Crops S.A. [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BioceresCropsSAMember" xlink:to="mlec_BioceresCropsSAMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InsumosAgroqumicosSAMember" xlink:href="mlec-20250630.xsd#mlec_InsumosAgroqumicosSAMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_InsumosAgroqumicosSAMember_lbl" xml:lang="en-US">Insumos Agroqu&#237;micos S.A. [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InsumosAgroqumicosSAMember" xlink:to="mlec_InsumosAgroqumicosSAMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ProFarmGroupMember" xlink:href="mlec-20250630.xsd#mlec_ProFarmGroupMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ProFarmGroupMember_lbl" xml:lang="en-US">Pro Farm Group [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ProFarmGroupMember" xlink:to="mlec_ProFarmGroupMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_BankBorrowingMember" xlink:href="mlec-20250630.xsd#mlec_BankBorrowingMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_BankBorrowingMember_lbl" xml:lang="en-US">Bank borrowings [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BankBorrowingMember" xlink:to="mlec_BankBorrowingMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_CorporateBondsMember" xlink:href="mlec-20250630.xsd#mlec_CorporateBondsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_CorporateBondsMember_lbl" xml:lang="en-US">Corporate bonds [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CorporateBondsMember" xlink:to="mlec_CorporateBondsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NetLoansPayablesJointVenturesAndAssociatesMember" xlink:href="mlec-20250630.xsd#mlec_NetLoansPayablesJointVenturesAndAssociatesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NetLoansPayablesJointVenturesAndAssociatesMember_lbl" xml:lang="en-US">Net loans payables- Joint ventures and associates [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NetLoansPayablesJointVenturesAndAssociatesMember" xlink:to="mlec_NetLoansPayablesJointVenturesAndAssociatesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ConvertiblePreferenceSharesMember" xlink:href="mlec-20250630.xsd#mlec_ConvertiblePreferenceSharesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ConvertiblePreferenceSharesMember_lbl" xml:lang="en-US">Convertible preference shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ConvertiblePreferenceSharesMember" xlink:to="mlec_ConvertiblePreferenceSharesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialBorrowingsMember" xlink:href="mlec-20250630.xsd#mlec_FinancialBorrowingsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_FinancialBorrowingsMember_lbl" xml:lang="en-US">Financial borrowings [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialBorrowingsMember" xlink:to="mlec_FinancialBorrowingsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ConvertibleNotesMember" xlink:href="mlec-20250630.xsd#mlec_ConvertibleNotesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ConvertibleNotesMember_lbl" xml:lang="en-US">Convertible notes [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ConvertibleNotesMember" xlink:to="mlec_ConvertibleNotesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_FinancialLiabilitiesAtAmortisedCostMember_lbl" xml:lang="en-US">Amortized cost [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" xlink:to="ifrs-full_FinancialLiabilitiesAtAmortisedCostMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AtFairValueMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AtFairValueMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AtFairValueMember_lbl" xml:lang="en-US">Fair value [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AtFairValueMember" xlink:to="ifrs-full_AtFairValueMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AtFairValueMember_lbl0" xml:lang="en-US">Mandatorily measured at fair value through profit or loss [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AtFairValueMember" xlink:to="ifrs-full_AtFairValueMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_AllowanceForImpairmentOfTradeDebtorsMember" xlink:href="mlec-20250630.xsd#mlec_AllowanceForImpairmentOfTradeDebtorsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AllowanceForImpairmentOfTradeDebtorsMember_lbl" xml:lang="en-US">Allowance for impairment of trade debtors [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AllowanceForImpairmentOfTradeDebtorsMember" xlink:to="mlec_AllowanceForImpairmentOfTradeDebtorsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_deductedFromAssetsMember" xlink:href="mlec-20250630.xsd#mlec_deductedFromAssetsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_deductedFromAssetsMember_lbl" xml:lang="en-US">Total deducted from assets [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_deductedFromAssetsMember" xlink:to="mlec_deductedFromAssetsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ProvisionForContingenciesMember" xlink:href="mlec-20250630.xsd#mlec_ProvisionForContingenciesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ProvisionForContingenciesMember_lbl" xml:lang="en-US">Provisions for contingencies [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ProvisionForContingenciesMember" xlink:to="mlec_ProvisionForContingenciesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_LiabilitiesMember" xlink:href="mlec-20250630.xsd#mlec_LiabilitiesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_LiabilitiesMember_lbl" xml:lang="en-US">Liabilities [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LiabilitiesMember" xlink:to="mlec_LiabilitiesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ConditionalPaymentRizobacterSAMember" xlink:href="mlec-20250630.xsd#mlec_ConditionalPaymentRizobacterSAMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ConditionalPaymentRizobacterSAMember_lbl" xml:lang="en-US">Conditional payment Rizobacter SA [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ConditionalPaymentRizobacterSAMember" xlink:to="mlec_ConditionalPaymentRizobacterSAMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresCropSolutionsCorpMember" xlink:href="mlec-20250630.xsd#mlec_BioceresCropSolutionsCorpMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_BioceresCropSolutionsCorpMember_lbl" xml:lang="en-US">Bioceres Crop Solutions Corp. [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BioceresCropSolutionsCorpMember" xlink:to="mlec_BioceresCropSolutionsCorpMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="mlec_BioceresCropSolutionsCorpMember_lbl0" xml:lang="en-US">Bioceres Crops Solutions Corp [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BioceresCropSolutionsCorpMember" xlink:to="mlec_BioceresCropSolutionsCorpMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpenseMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpenseMember_lbl" xml:lang="en-US">Selling, general and administrative expenses [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SellingGeneralAndAdministrativeExpenseMember" xlink:to="ifrs-full_SellingGeneralAndAdministrativeExpenseMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ExpensesClassifiedByNatureAndFunctionMember" xlink:href="mlec-20250630.xsd#mlec_ExpensesClassifiedByNatureAndFunctionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ExpensesClassifiedByNatureAndFunctionMember_lbl" xml:lang="en-US">Total [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ExpensesClassifiedByNatureAndFunctionMember" xlink:to="mlec_ExpensesClassifiedByNatureAndFunctionMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_CarryForwardOfTaxLossMember" xlink:href="mlec-20250630.xsd#mlec_CarryForwardOfTaxLossMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_CarryForwardOfTaxLossMember_lbl" xml:lang="en-US">Tax Loss-Carry Forward [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CarryForwardOfTaxLossMember" xlink:to="mlec_CarryForwardOfTaxLossMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_OthersFinancialAssetMember" xlink:href="mlec-20250630.xsd#mlec_OthersFinancialAssetMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_OthersFinancialAssetMember_lbl" xml:lang="en-US">Others financial assets [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OthersFinancialAssetMember" xlink:to="mlec_OthersFinancialAssetMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_OthersOneMember" xlink:href="mlec-20250630.xsd#mlec_OthersOneMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_OthersOneMember_lbl" xml:lang="en-US">Others [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OthersOneMember" xlink:to="mlec_OthersOneMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_RoyaltiesMember" xlink:href="mlec-20250630.xsd#mlec_RoyaltiesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_RoyaltiesMember_lbl" xml:lang="en-US">Royalties [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RoyaltiesMember" xlink:to="mlec_RoyaltiesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_TradeReceivableMember" xlink:href="mlec-20250630.xsd#mlec_TradeReceivableMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_TradeReceivableMember_lbl" xml:lang="en-US">Trade receivables [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TradeReceivableMember" xlink:to="mlec_TradeReceivableMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AllowancesMember" xlink:href="mlec-20250630.xsd#mlec_AllowancesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AllowancesMember_lbl" xml:lang="en-US">Allowances [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AllowancesMember" xlink:to="mlec_AllowancesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_GovernmentGrantsMember" xlink:href="mlec-20250630.xsd#mlec_GovernmentGrantsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_GovernmentGrantsMember_lbl" xml:lang="en-US">Government grants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_GovernmentGrantsMember" xlink:to="mlec_GovernmentGrantsMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="mlec_GovernmentGrantsMember_lbl0" xml:lang="en-US">Government Grants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_GovernmentGrantsMember" xlink:to="mlec_GovernmentGrantsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_DeferredTaxAssetMember" xlink:href="mlec-20250630.xsd#mlec_DeferredTaxAssetMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DeferredTaxAssetMember_lbl" xml:lang="en-US">Total deferred tax assets [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DeferredTaxAssetMember" xlink:to="mlec_DeferredTaxAssetMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_IntangiblesTaxLiabilityMember" xlink:href="mlec-20250630.xsd#mlec_IntangiblesTaxLiabilityMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_IntangiblesTaxLiabilityMember_lbl" xml:lang="en-US">Intangible assets [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IntangiblesTaxLiabilityMember" xlink:to="mlec_IntangiblesTaxLiabilityMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PropertyPlantAndEquipmentDepreciationMember" xlink:href="mlec-20250630.xsd#mlec_PropertyPlantAndEquipmentDepreciationMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_PropertyPlantAndEquipmentDepreciationMember_lbl" xml:lang="en-US">Property, plant and equipment depreciation [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PropertyPlantAndEquipmentDepreciationMember" xlink:to="mlec_PropertyPlantAndEquipmentDepreciationMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InventoriesTaxLiabilityMember" xlink:href="mlec-20250630.xsd#mlec_InventoriesTaxLiabilityMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_InventoriesTaxLiabilityMember_lbl" xml:lang="en-US">Inventories [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InventoriesTaxLiabilityMember" xlink:to="mlec_InventoriesTaxLiabilityMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_RightOfUseLeasedAssetTaxLiabilityMember" xlink:href="mlec-20250630.xsd#mlec_RightOfUseLeasedAssetTaxLiabilityMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_RightOfUseLeasedAssetTaxLiabilityMember_lbl" xml:lang="en-US">Right-of-use leased asset [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RightOfUseLeasedAssetTaxLiabilityMember" xlink:to="mlec_RightOfUseLeasedAssetTaxLiabilityMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InflationTaxAdjustmentMember" xlink:href="mlec-20250630.xsd#mlec_InflationTaxAdjustmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_InflationTaxAdjustmentMember_lbl" xml:lang="en-US">Inflation tax adjustment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InflationTaxAdjustmentMember" xlink:to="mlec_InflationTaxAdjustmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DeferredTaxLiabilityMember" xlink:href="mlec-20250630.xsd#mlec_DeferredTaxLiabilityMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DeferredTaxLiabilityMember_lbl" xml:lang="en-US">Total deferred tax liabilities [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DeferredTaxLiabilityMember" xlink:to="mlec_DeferredTaxLiabilityMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_OthersFinancialAssetsMember" xlink:href="mlec-20250630.xsd#mlec_OthersFinancialAssetsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_OthersFinancialAssetsMember_lbl" xml:lang="en-US">Others financial assets [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OthersFinancialAssetsMember" xlink:to="mlec_OthersFinancialAssetsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_BiologicalAssetsMember" xlink:href="mlec-20250630.xsd#mlec_BiologicalAssetsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_BiologicalAssetsMember_lbl" xml:lang="en-US">Biological assets [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BiologicalAssetsMember" xlink:to="mlec_BiologicalAssetsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_OthersFinancialAssetsOneMember" xlink:href="mlec-20250630.xsd#mlec_OthersFinancialAssetsOneMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_OthersFinancialAssetsOneMember_lbl" xml:lang="en-US">Others financial assets [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OthersFinancialAssetsOneMember" xlink:to="mlec_OthersFinancialAssetsOneMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_OthersTaxAssetsTwoMember" xlink:href="mlec-20250630.xsd#mlec_OthersTaxAssetsTwoMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_OthersTaxAssetsTwoMember_lbl" xml:lang="en-US">Others [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OthersTaxAssetsTwoMember" xlink:to="mlec_OthersTaxAssetsTwoMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherTaxAssetMember" xlink:href="mlec-20250630.xsd#mlec_OtherTaxAssetMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_OtherTaxAssetMember_lbl" xml:lang="en-US">Others [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherTaxAssetMember" xlink:to="mlec_OtherTaxAssetMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InventoryMember" xlink:href="mlec-20250630.xsd#mlec_InventoryMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_InventoryMember_lbl" xml:lang="en-US">Inventories [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InventoryMember" xlink:to="mlec_InventoryMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherLiabilitiesOneMember" xlink:href="mlec-20250630.xsd#mlec_OtherLiabilitiesOneMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_OtherLiabilitiesOneMember_lbl" xml:lang="en-US">Others [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherLiabilitiesOneMember" xlink:to="mlec_OtherLiabilitiesOneMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_LowOrNullTaxationJurisdictionsMember" xlink:href="mlec-20250630.xsd#mlec_LowOrNullTaxationJurisdictionsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_LowOrNullTaxationJurisdictionsMember_lbl" xml:lang="en-US">Low or null taxation jurisdictions [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LowOrNullTaxationJurisdictionsMember" xlink:to="mlec_LowOrNullTaxationJurisdictionsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_LossMakingEntitiesMember" xlink:href="mlec-20250630.xsd#mlec_LossMakingEntitiesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_LossMakingEntitiesMember_lbl" xml:lang="en-US">Loss-making entities [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LossMakingEntitiesMember" xlink:to="mlec_LossMakingEntitiesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ProfitMakingEntitiesMember" xlink:href="mlec-20250630.xsd#mlec_ProfitMakingEntitiesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ProfitMakingEntitiesMember_lbl" xml:lang="en-US">Profit-making entities [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ProfitMakingEntitiesMember" xlink:to="mlec_ProfitMakingEntitiesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OrdinarySharesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OrdinarySharesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OrdinarySharesMember_lbl" xml:lang="en-US">Ordinary [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OrdinarySharesMember" xlink:to="ifrs-full_OrdinarySharesMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OrdinarySharesMember_lbl0" xml:lang="en-US">Ordinary shares [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OrdinarySharesMember" xlink:to="ifrs-full_OrdinarySharesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="ifrs-full_OrdinarySharesMember_lbl1" xml:lang="en-US">Ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OrdinarySharesMember" xlink:to="ifrs-full_OrdinarySharesMember_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresCropSolutionsMember" xlink:href="mlec-20250630.xsd#mlec_BioceresCropSolutionsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_BioceresCropSolutionsMember_lbl" xml:lang="en-US">Bioceres Crop Solutions [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BioceresCropSolutionsMember" xlink:to="mlec_BioceresCropSolutionsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_BorrowingMember" xlink:href="mlec-20250630.xsd#mlec_BorrowingMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_BorrowingMember_lbl" xml:lang="en-US">Borrowings [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BorrowingMember" xlink:to="mlec_BorrowingMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancedPaymentAcquisitionOfBusinessMember" xlink:href="mlec-20250630.xsd#mlec_FinancedPaymentAcquisitionOfBusinessMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_FinancedPaymentAcquisitionOfBusinessMember_lbl" xml:lang="en-US">Consideration for acquisition [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancedPaymentAcquisitionOfBusinessMember" xlink:to="mlec_FinancedPaymentAcquisitionOfBusinessMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_IfrsConvertibleNotesPayableMember" xlink:href="mlec-20250630.xsd#mlec_IfrsConvertibleNotesPayableMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_IfrsConvertibleNotesPayableMember_lbl" xml:lang="en-US">Convertible notes [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IfrsConvertibleNotesPayableMember" xlink:to="mlec_IfrsConvertibleNotesPayableMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SynertechIndustriasSAMember" xlink:href="mlec-20250630.xsd#mlec_SynertechIndustriasSAMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SynertechIndustriasSAMember_lbl" xml:lang="en-US">Synertech Industrias S.A.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SynertechIndustriasSAMember" xlink:to="mlec_SynertechIndustriasSAMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AgralityArgentinaSAMember" xlink:href="mlec-20250630.xsd#mlec_AgralityArgentinaSAMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AgralityArgentinaSAMember_lbl" xml:lang="en-US">Agrality Argentina S.A. [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AgralityArgentinaSAMember" xlink:to="mlec_AgralityArgentinaSAMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AgralityUSIncMember" xlink:href="mlec-20250630.xsd#mlec_AgralityUSIncMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AgralityUSIncMember_lbl" xml:lang="en-US">Agrality US Inc. [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AgralityUSIncMember" xlink:to="mlec_AgralityUSIncMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AgralitySeedsIncMember" xlink:href="mlec-20250630.xsd#mlec_AgralitySeedsIncMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AgralitySeedsIncMember_lbl" xml:lang="en-US">Agrality Seeds Inc. [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AgralitySeedsIncMember" xlink:to="mlec_AgralitySeedsIncMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SWSemillasSAMember" xlink:href="mlec-20250630.xsd#mlec_SWSemillasSAMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SWSemillasSAMember_lbl" xml:lang="en-US">SW Semillas S.A. [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SWSemillasSAMember" xlink:to="mlec_SWSemillasSAMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AlfalfaTechnologiesSRlMember" xlink:href="mlec-20250630.xsd#mlec_AlfalfaTechnologiesSRlMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AlfalfaTechnologiesSRlMember_lbl" xml:lang="en-US">Alfalfa Technologies S.R.L.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AlfalfaTechnologiesSRlMember" xlink:to="mlec_AlfalfaTechnologiesSRlMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InmetSAMember" xlink:href="mlec-20250630.xsd#mlec_InmetSAMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_InmetSAMember_lbl" xml:lang="en-US">Inmet S.A [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InmetSAMember" xlink:to="mlec_InmetSAMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="mlec_InmetSAMember_lbl0" xml:lang="en-US">Inmet S.A. [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InmetSAMember" xlink:to="mlec_InmetSAMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_TheoISCSpMember" xlink:href="mlec-20250630.xsd#mlec_TheoISCSpMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_TheoISCSpMember_lbl" xml:lang="en-US">Theo I SCSp [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TheoISCSpMember" xlink:to="mlec_TheoISCSpMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_TrigallGeneticsSAMember" xlink:href="mlec-20250630.xsd#mlec_TrigallGeneticsSAMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_TrigallGeneticsSAMember_lbl" xml:lang="en-US">Trigall Genetics S.A.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TrigallGeneticsSAMember" xlink:to="mlec_TrigallGeneticsSAMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_JointVenturesInvestmentsAndAffiliatesMember" xlink:href="mlec-20250630.xsd#mlec_JointVenturesInvestmentsAndAffiliatesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_JointVenturesInvestmentsAndAffiliatesMember_lbl" xml:lang="en-US">Joint Ventures Investments and Affiliates [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_JointVenturesInvestmentsAndAffiliatesMember" xlink:to="mlec_JointVenturesInvestmentsAndAffiliatesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_IndrasaBiotecnologaSAMember" xlink:href="mlec-20250630.xsd#mlec_IndrasaBiotecnologaSAMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_IndrasaBiotecnologaSAMember_lbl" xml:lang="en-US">Indrasa Biotecnologia S.A.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IndrasaBiotecnologaSAMember" xlink:to="mlec_IndrasaBiotecnologaSAMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AgralitySAMember" xlink:href="mlec-20250630.xsd#mlec_AgralitySAMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AgralitySAMember_lbl" xml:lang="en-US">Agrality S.A. [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AgralitySAMember" xlink:to="mlec_AgralitySAMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SeedAndIntegratedProductsMember" xlink:href="mlec-20250630.xsd#mlec_SeedAndIntegratedProductsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SeedAndIntegratedProductsMember_lbl" xml:lang="en-US">Seed and Integrated Products [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SeedAndIntegratedProductsMember" xlink:to="mlec_SeedAndIntegratedProductsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_CropProtectionMember" xlink:href="mlec-20250630.xsd#mlec_CropProtectionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_CropProtectionMember_lbl" xml:lang="en-US">Crop Protection [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CropProtectionMember" xlink:to="mlec_CropProtectionMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_CropNutritionMember" xlink:href="mlec-20250630.xsd#mlec_CropNutritionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_CropNutritionMember_lbl" xml:lang="en-US">Crop Nutrition [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CropNutritionMember" xlink:to="mlec_CropNutritionMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_EmergingSolutionsMember" xlink:href="mlec-20250630.xsd#mlec_EmergingSolutionsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_EmergingSolutionsMember_lbl" xml:lang="en-US">Emerging Solutions [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_EmergingSolutionsMember" xlink:to="mlec_EmergingSolutionsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ConsolidatedEntitieMember" xlink:href="mlec-20250630.xsd#mlec_ConsolidatedEntitieMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ConsolidatedEntitieMember_lbl" xml:lang="en-US">Consolidated [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ConsolidatedEntitieMember" xlink:to="mlec_ConsolidatedEntitieMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SeedTreatmentsPacksMember" xlink:href="mlec-20250630.xsd#mlec_SeedTreatmentsPacksMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SeedTreatmentsPacksMember_lbl" xml:lang="en-US">Seed Treatments Packs [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SeedTreatmentsPacksMember" xlink:to="mlec_SeedTreatmentsPacksMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SeedRoyaltiesPaymentsHB4ProgramMember" xlink:href="mlec-20250630.xsd#mlec_SeedRoyaltiesPaymentsHB4ProgramMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SeedRoyaltiesPaymentsHB4ProgramMember_lbl" xml:lang="en-US">Seed &amp; Royalties Payments &amp; HB4 Program [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SeedRoyaltiesPaymentsHB4ProgramMember" xlink:to="mlec_SeedRoyaltiesPaymentsHB4ProgramMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AdjuvantsMember" xlink:href="mlec-20250630.xsd#mlec_AdjuvantsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AdjuvantsMember_lbl" xml:lang="en-US">Adjuvants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AdjuvantsMember" xlink:to="mlec_AdjuvantsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SeedCpProductsAndServicesMember" xlink:href="mlec-20250630.xsd#mlec_SeedCpProductsAndServicesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SeedCpProductsAndServicesMember_lbl" xml:lang="en-US">Seed CP Products and Services [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SeedCpProductsAndServicesMember" xlink:to="mlec_SeedCpProductsAndServicesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherCpProductsAndServicesMember" xlink:href="mlec-20250630.xsd#mlec_OtherCpProductsAndServicesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_OtherCpProductsAndServicesMember_lbl" xml:lang="en-US">Other CP Products and Services [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherCpProductsAndServicesMember" xlink:to="mlec_OtherCpProductsAndServicesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_BioprotectionMember" xlink:href="mlec-20250630.xsd#mlec_BioprotectionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_BioprotectionMember_lbl" xml:lang="en-US">Bioprotection [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BioprotectionMember" xlink:to="mlec_BioprotectionMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InoculantsBiofertilizersMember" xlink:href="mlec-20250630.xsd#mlec_InoculantsBiofertilizersMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_InoculantsBiofertilizersMember_lbl" xml:lang="en-US">Inoculants &amp; Biofertilizers []Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InoculantsBiofertilizersMember" xlink:to="mlec_InoculantsBiofertilizersMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_MicroBeadedFertilizersMember" xlink:href="mlec-20250630.xsd#mlec_MicroBeadedFertilizersMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_MicroBeadedFertilizersMember_lbl" xml:lang="en-US">Micro-Beaded Fertilizers [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MicroBeadedFertilizersMember" xlink:to="mlec_MicroBeadedFertilizersMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_BiostimulantsMember" xlink:href="mlec-20250630.xsd#mlec_BiostimulantsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_BiostimulantsMember_lbl" xml:lang="en-US">Biostimulants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BiostimulantsMember" xlink:to="mlec_BiostimulantsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SyngentaUpfrontFeeMember" xlink:href="mlec-20250630.xsd#mlec_SyngentaUpfrontFeeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SyngentaUpfrontFeeMember_lbl" xml:lang="en-US">Syngenta Up-Front Fee [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SyngentaUpfrontFeeMember" xlink:to="mlec_SyngentaUpfrontFeeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ManagementExpensesMember" xlink:href="mlec-20250630.xsd#mlec_ManagementExpensesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ManagementExpensesMember_lbl" xml:lang="en-US">Management Expenses [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ManagementExpensesMember" xlink:to="mlec_ManagementExpensesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="country_AR" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_AR"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="country_AR_lbl" xml:lang="en-US">Argentina [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_AR" xlink:to="country_AR_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="country_AR_lbl0" xml:lang="en-US">Argentina</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_AR" xlink:to="country_AR_lbl0"/>
    <loc xlink:type="locator" xlink:label="country_BR" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_BR"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="country_BR_lbl" xml:lang="en-US">Brazil [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_BR" xlink:to="country_BR_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_LatinAmericaMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_LatinAmericaMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_LatinAmericaMember_lbl" xml:lang="en-US">LATAM [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_LatinAmericaMember" xlink:to="srt_LatinAmericaMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_NorthAmericaMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_NorthAmericaMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_NorthAmericaMember_lbl" xml:lang="en-US">North America [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_NorthAmericaMember" xlink:to="srt_NorthAmericaMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_EuropeMiddleEastAndAfricaMember" xlink:href="mlec-20250630.xsd#mlec_EuropeMiddleEastAndAfricaMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_EuropeMiddleEastAndAfricaMember_lbl" xml:lang="en-US">EMEA [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_EuropeMiddleEastAndAfricaMember" xlink:to="mlec_EuropeMiddleEastAndAfricaMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherRegionsOrCountriesMember" xlink:href="mlec-20250630.xsd#mlec_OtherRegionsOrCountriesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_OtherRegionsOrCountriesMember_lbl" xml:lang="en-US">Rest of the world [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherRegionsOrCountriesMember" xlink:to="mlec_OtherRegionsOrCountriesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_TradeAndOtherPayablesMember" xlink:href="mlec-20250630.xsd#mlec_TradeAndOtherPayablesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_TradeAndOtherPayablesMember_lbl" xml:lang="en-US">Trade and other payables [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TradeAndOtherPayablesMember" xlink:to="mlec_TradeAndOtherPayablesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LeaseLiabilitiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseLiabilitiesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_LeaseLiabilitiesMember_lbl" xml:lang="en-US">Lease liability [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LeaseLiabilitiesMember" xlink:to="ifrs-full_LeaseLiabilitiesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ConsiderationForAcquisitionOfAssetsMember" xlink:href="mlec-20250630.xsd#mlec_ConsiderationForAcquisitionOfAssetsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ConsiderationForAcquisitionOfAssetsMember_lbl" xml:lang="en-US">Consideration for acquisition of assets [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ConsiderationForAcquisitionOfAssetsMember" xlink:to="mlec_ConsiderationForAcquisitionOfAssetsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NotLaterThanThreeMonthsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NotLaterThanThreeMonthsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NotLaterThanThreeMonthsMember_lbl" xml:lang="en-US">Up to 3 months [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NotLaterThanThreeMonthsMember" xlink:to="ifrs-full_NotLaterThanThreeMonthsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiquidityRiskMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LiquidityRiskMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_LiquidityRiskMember_lbl" xml:lang="en-US">Liquidity risk [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiquidityRiskMember" xlink:to="ifrs-full_LiquidityRiskMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LaterThanThreeMonthsAndNotLaterThanOneYearMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanThreeMonthsAndNotLaterThanOneYearMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_LaterThanThreeMonthsAndNotLaterThanOneYearMember_lbl" xml:lang="en-US">3 to 12 months [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LaterThanThreeMonthsAndNotLaterThanOneYearMember" xlink:to="ifrs-full_LaterThanThreeMonthsAndNotLaterThanOneYearMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_lbl" xml:lang="en-US">Between one and three years [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:to="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrencyRiskMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrencyRiskMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrencyRiskMember_lbl" xml:lang="en-US">Currency Risk</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrencyRiskMember" xlink:to="ifrs-full_CurrencyRiskMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestRateRiskMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestRateRiskMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_InterestRateRiskMember_lbl" xml:lang="en-US">Interest Rate Risk</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestRateRiskMember" xlink:to="ifrs-full_InterestRateRiskMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_InterestRateRiskMember_lbl0" xml:lang="en-US">Interest Rate Risk [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestRateRiskMember" xlink:to="ifrs-full_InterestRateRiskMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_FixedRateBorrowingsMember" xlink:href="mlec-20250630.xsd#mlec_FixedRateBorrowingsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_FixedRateBorrowingsMember_lbl" xml:lang="en-US">Fixed-rate instruments [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FixedRateBorrowingsMember" xlink:to="mlec_FixedRateBorrowingsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_VariableRateBorrowingsMember" xlink:href="mlec-20250630.xsd#mlec_VariableRateBorrowingsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_VariableRateBorrowingsMember_lbl" xml:lang="en-US">Variable-rate instruments [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_VariableRateBorrowingsMember" xlink:to="mlec_VariableRateBorrowingsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_CashAndEquivalentsMember" xlink:href="mlec-20250630.xsd#mlec_CashAndEquivalentsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_CashAndEquivalentsMember_lbl" xml:lang="en-US">Cash and cash equivalents [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CashAndEquivalentsMember" xlink:to="mlec_CashAndEquivalentsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherFinancialAssetsMember" xlink:href="mlec-20250630.xsd#mlec_OtherFinancialAssetsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_OtherFinancialAssetsMember_lbl" xml:lang="en-US">Other financial assets [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherFinancialAssetsMember" xlink:to="mlec_OtherFinancialAssetsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherReceivablesMember" xlink:href="mlec-20250630.xsd#mlec_OtherReceivablesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_OtherReceivablesMember_lbl" xml:lang="en-US">Other receivables [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherReceivablesMember" xlink:to="mlec_OtherReceivablesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_MandatorilyMeasuredAtFairValueThroughProfitOrLossMember" xlink:href="mlec-20250630.xsd#mlec_MandatorilyMeasuredAtFairValueThroughProfitOrLossMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_MandatorilyMeasuredAtFairValueThroughProfitOrLossMember_lbl" xml:lang="en-US">Mandatorily measured at fair value through profit or loss [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MandatorilyMeasuredAtFairValueThroughProfitOrLossMember" xlink:to="mlec_MandatorilyMeasuredAtFairValueThroughProfitOrLossMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_WarrantLiabilityMember" xlink:href="mlec-20250630.xsd#mlec_WarrantLiabilityMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_WarrantLiabilityMember_lbl" xml:lang="en-US">Warrants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_WarrantLiabilityMember" xlink:to="mlec_WarrantLiabilityMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="mlec_WarrantLiabilityMember_lbl0" xml:lang="en-US">Warrant liability [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_WarrantLiabilityMember" xlink:to="mlec_WarrantLiabilityMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_AtAmortizedCostMember" xlink:href="mlec-20250630.xsd#mlec_AtAmortizedCostMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AtAmortizedCostMember_lbl" xml:lang="en-US">Amortized cost [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AtAmortizedCostMember" xlink:to="mlec_AtAmortizedCostMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InvestmentsAtFairValueMember" xlink:href="mlec-20250630.xsd#mlec_InvestmentsAtFairValueMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_InvestmentsAtFairValueMember_lbl" xml:lang="en-US">Investments at fair value [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InvestmentsAtFairValueMember" xlink:to="mlec_InvestmentsAtFairValueMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_MoolecScienceSASharesMember" xlink:href="mlec-20250630.xsd#mlec_MoolecScienceSASharesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_MoolecScienceSASharesMember_lbl" xml:lang="en-US">Moolec Science SA shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MoolecScienceSASharesMember" xlink:to="mlec_MoolecScienceSASharesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_UsTreasuryBillsMember" xlink:href="mlec-20250630.xsd#mlec_UsTreasuryBillsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_UsTreasuryBillsMember_lbl" xml:lang="en-US">US Treasury bills [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UsTreasuryBillsMember" xlink:to="mlec_UsTreasuryBillsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ConsiderationForAcquisitionMember" xlink:href="mlec-20250630.xsd#mlec_ConsiderationForAcquisitionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ConsiderationForAcquisitionMember_lbl" xml:lang="en-US">Consideration for acquisition [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ConsiderationForAcquisitionMember" xlink:to="mlec_ConsiderationForAcquisitionMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Level1OfFairValueHierarchyMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Level1OfFairValueHierarchyMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_Level1OfFairValueHierarchyMember_lbl" xml:lang="en-US">Level 1 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Level1OfFairValueHierarchyMember" xlink:to="ifrs-full_Level1OfFairValueHierarchyMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Level2OfFairValueHierarchyMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Level2OfFairValueHierarchyMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_Level2OfFairValueHierarchyMember_lbl" xml:lang="en-US">Level 2 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Level2OfFairValueHierarchyMember" xlink:to="ifrs-full_Level2OfFairValueHierarchyMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Level3OfFairValueHierarchyMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Level3OfFairValueHierarchyMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_Level3OfFairValueHierarchyMember_lbl" xml:lang="en-US">Level 3 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Level3OfFairValueHierarchyMember" xlink:to="ifrs-full_Level3OfFairValueHierarchyMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GrossCarryingAmountMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossCarryingAmountMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_GrossCarryingAmountMember_lbl" xml:lang="en-US">Gross carrying amount [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GrossCarryingAmountMember" xlink:to="ifrs-full_GrossCarryingAmountMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AccumulatedDepreciationAndAmortisationMember_lbl" xml:lang="en-US">Accumulated depreciation and amortisation [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:to="ifrs-full_AccumulatedDepreciationAndAmortisationMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MachineryMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MachineryMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_MachineryMember_lbl" xml:lang="en-US">Machinery and equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MachineryMember" xlink:to="ifrs-full_MachineryMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComputerSoftwareMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComputerSoftwareMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ComputerSoftwareMember_lbl" xml:lang="en-US">Equipment and computer software	[Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComputerSoftwareMember" xlink:to="ifrs-full_ComputerSoftwareMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ComputerSoftwareMember_lbl0" xml:lang="en-US">Software [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComputerSoftwareMember" xlink:to="ifrs-full_ComputerSoftwareMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_JointVenturesWhereEntityIsVenturerMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_JointVenturesWhereEntityIsVenturerMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_JointVenturesWhereEntityIsVenturerMember_lbl" xml:lang="en-US">Joint ventures and associates [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_JointVenturesWhereEntityIsVenturerMember" xlink:to="ifrs-full_JointVenturesWhereEntityIsVenturerMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SalesOfGoodsAndServicesMember" xlink:href="mlec-20250630.xsd#mlec_SalesOfGoodsAndServicesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SalesOfGoodsAndServicesMember_lbl" xml:lang="en-US">Sales of goods and services [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SalesOfGoodsAndServicesMember" xlink:to="mlec_SalesOfGoodsAndServicesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PurchasesOfGoodsAndServicesMember" xlink:href="mlec-20250630.xsd#mlec_PurchasesOfGoodsAndServicesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_PurchasesOfGoodsAndServicesMember_lbl" xml:lang="en-US">Purchases of goods and services [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PurchasesOfGoodsAndServicesMember" xlink:to="mlec_PurchasesOfGoodsAndServicesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NetLoansGrantedMember" xlink:href="mlec-20250630.xsd#mlec_NetLoansGrantedMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NetLoansGrantedMember_lbl" xml:lang="en-US">Net loans granted [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NetLoansGrantedMember" xlink:to="mlec_NetLoansGrantedMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InterestGainMember" xlink:href="mlec-20250630.xsd#mlec_InterestGainMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_InterestGainMember_lbl" xml:lang="en-US">Interest gain [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InterestGainMember" xlink:to="mlec_InterestGainMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NetLoansReceivedMember" xlink:href="mlec-20250630.xsd#mlec_NetLoansReceivedMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NetLoansReceivedMember_lbl" xml:lang="en-US">Net loans received [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NetLoansReceivedMember" xlink:to="mlec_NetLoansReceivedMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PuttableInstrumentsMember" xlink:href="mlec-20250630.xsd#mlec_PuttableInstrumentsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_PuttableInstrumentsMember_lbl" xml:lang="en-US">Puttable instruments [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PuttableInstrumentsMember" xlink:to="mlec_PuttableInstrumentsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NetLoansGrantedOneMember" xlink:href="mlec-20250630.xsd#mlec_NetLoansGrantedOneMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NetLoansGrantedOneMember_lbl" xml:lang="en-US">Net Loans Granted One [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NetLoansGrantedOneMember" xlink:to="mlec_NetLoansGrantedOneMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PreferenceShareMember" xlink:href="mlec-20250630.xsd#mlec_PreferenceShareMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_PreferenceShareMember_lbl" xml:lang="en-US">Preference shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PreferenceShareMember" xlink:to="mlec_PreferenceShareMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InterestExpensesMember" xlink:href="mlec-20250630.xsd#mlec_InterestExpensesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_InterestExpensesMember_lbl" xml:lang="en-US">Interest expenses [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InterestExpensesMember" xlink:to="mlec_InterestExpensesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherRelatedPartiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherRelatedPartiesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherRelatedPartiesMember_lbl" xml:lang="en-US">Shareholders and other related parties [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherRelatedPartiesMember" xlink:to="ifrs-full_OtherRelatedPartiesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_OwnSharesHeldBySubsidiariesMember" xlink:href="mlec-20250630.xsd#mlec_OwnSharesHeldBySubsidiariesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_OwnSharesHeldBySubsidiariesMember_lbl" xml:lang="en-US">Own shares held by subsidiaries [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OwnSharesHeldBySubsidiariesMember" xlink:to="mlec_OwnSharesHeldBySubsidiariesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InKindContributionsMember" xlink:href="mlec-20250630.xsd#mlec_InKindContributionsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_InKindContributionsMember_lbl" xml:lang="en-US">In-kind contributions [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InKindContributionsMember" xlink:to="mlec_InKindContributionsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_KeyManagementPersonnelOfEntityOrParentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_lbl" xml:lang="en-US">Shareholders and other related parties [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:to="ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_lbl0" xml:lang="en-US">Key management personnel [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:to="ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_SalariesSocialSecurityBenefitsAndOtherBenefitsMember" xlink:href="mlec-20250630.xsd#mlec_SalariesSocialSecurityBenefitsAndOtherBenefitsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SalariesSocialSecurityBenefitsAndOtherBenefitsMember_lbl" xml:lang="en-US">Salaries, social security benefits and other benefits [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SalariesSocialSecurityBenefitsAndOtherBenefitsMember" xlink:to="mlec_SalariesSocialSecurityBenefitsAndOtherBenefitsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SalesAndServicesMember" xlink:href="mlec-20250630.xsd#mlec_SalesAndServicesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SalesAndServicesMember_lbl" xml:lang="en-US">Sales and services [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SalesAndServicesMember" xlink:to="mlec_SalesAndServicesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_StockOptionsAndShareBasedIncentivesMember" xlink:href="mlec-20250630.xsd#mlec_StockOptionsAndShareBasedIncentivesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_StockOptionsAndShareBasedIncentivesMember_lbl" xml:lang="en-US">Stock options-based incentives [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_StockOptionsAndShareBasedIncentivesMember" xlink:to="mlec_StockOptionsAndShareBasedIncentivesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_TradeDebtorsMember" xlink:href="mlec-20250630.xsd#mlec_TradeDebtorsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_TradeDebtorsMember_lbl" xml:lang="en-US">Trade debtors [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TradeDebtorsMember" xlink:to="mlec_TradeDebtorsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_TradeCreditorsMember" xlink:href="mlec-20250630.xsd#mlec_TradeCreditorsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_TradeCreditorsMember_lbl" xml:lang="en-US">Trade creditors [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TradeCreditorsMember" xlink:to="mlec_TradeCreditorsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NetLoansPayablesMember" xlink:href="mlec-20250630.xsd#mlec_NetLoansPayablesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NetLoansPayablesMember_lbl" xml:lang="en-US">Net loans payables [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NetLoansPayablesMember" xlink:to="mlec_NetLoansPayablesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_WarrantesMember" xlink:href="mlec-20250630.xsd#mlec_WarrantesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_WarrantesMember_lbl" xml:lang="en-US">Warrants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_WarrantesMember" xlink:to="mlec_WarrantesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_StandAloneStockOptionGrantMember" xlink:href="mlec-20250630.xsd#mlec_StandAloneStockOptionGrantMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_StandAloneStockOptionGrantMember_lbl" xml:lang="en-US">Stand Alone Stock Option Grant [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_StandAloneStockOptionGrantMember" xlink:to="mlec_StandAloneStockOptionGrantMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="mlec_StandAloneStockOptionGrantMember_lbl0" xml:lang="en-US">Stand Alone Stock Option Grant [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_StandAloneStockOptionGrantMember" xlink:to="mlec_StandAloneStockOptionGrantMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_EmployeeStockOptionPlanMember" xlink:href="mlec-20250630.xsd#mlec_EmployeeStockOptionPlanMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_EmployeeStockOptionPlanMember_lbl" xml:lang="en-US">Employee Stock Option Plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_EmployeeStockOptionPlanMember" xlink:to="mlec_EmployeeStockOptionPlanMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="mlec_EmployeeStockOptionPlanMember_lbl0" xml:lang="en-US">Employee Stock Option Plan [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_EmployeeStockOptionPlanMember" xlink:to="mlec_EmployeeStockOptionPlanMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_PastShareOptionPlanMember" xlink:href="mlec-20250630.xsd#mlec_PastShareOptionPlanMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_PastShareOptionPlanMember_lbl" xml:lang="en-US">Past Share Option plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PastShareOptionPlanMember" xlink:to="mlec_PastShareOptionPlanMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="mlec_PastShareOptionPlanMember_lbl0" xml:lang="en-US">Past Share Option plan [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PastShareOptionPlanMember" xlink:to="mlec_PastShareOptionPlanMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShareOptionsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShareOptionsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ShareOptionsMember_lbl" xml:lang="en-US">Base Share Option plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShareOptionsMember" xlink:to="ifrs-full_ShareOptionsMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ShareOptionsMember_lbl0" xml:lang="en-US">Base Share Option plan [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShareOptionsMember" xlink:to="ifrs-full_ShareOptionsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_PerformanceShareOptionPlanMember" xlink:href="mlec-20250630.xsd#mlec_PerformanceShareOptionPlanMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_PerformanceShareOptionPlanMember_lbl" xml:lang="en-US">Performance Share Option plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PerformanceShareOptionPlanMember" xlink:to="mlec_PerformanceShareOptionPlanMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="mlec_PerformanceShareOptionPlanMember_lbl0" xml:lang="en-US">Performance Share Option Plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PerformanceShareOptionPlanMember" xlink:to="mlec_PerformanceShareOptionPlanMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_BottomOfRangeMember_lbl" xml:lang="en-US">Bottom of Range [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BottomOfRangeMember" xlink:to="ifrs-full_BottomOfRangeMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_BottomOfRangeMember_lbl0" xml:lang="en-US">Bottom of range [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BottomOfRangeMember" xlink:to="ifrs-full_BottomOfRangeMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="ifrs-full_BottomOfRangeMember_lbl1" xml:lang="en-US">Bottom of range [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BottomOfRangeMember" xlink:to="ifrs-full_BottomOfRangeMember_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TopOfRangeMember_lbl" xml:lang="en-US">Top of Range [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TopOfRangeMember" xlink:to="ifrs-full_TopOfRangeMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_TopOfRangeMember_lbl0" xml:lang="en-US">Top of range [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TopOfRangeMember" xlink:to="ifrs-full_TopOfRangeMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="ifrs-full_TopOfRangeMember_lbl1" xml:lang="en-US">Top of range [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TopOfRangeMember" xlink:to="ifrs-full_TopOfRangeMember_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_OptionsIncentivePlanMember" xlink:href="mlec-20250630.xsd#mlec_OptionsIncentivePlanMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_OptionsIncentivePlanMember_lbl" xml:lang="en-US">Options incentive Plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OptionsIncentivePlanMember" xlink:to="mlec_OptionsIncentivePlanMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ReverseStockSplitMember" xlink:href="mlec-20250630.xsd#mlec_ReverseStockSplitMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ReverseStockSplitMember_lbl" xml:lang="en-US">Reverse Stock Split [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ReverseStockSplitMember" xlink:to="mlec_ReverseStockSplitMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BusinessCombinationsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BusinessCombinationsAxis_lbl" xml:lang="en-US">Business combinations [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BusinessCombinationsAxis" xlink:to="ifrs-full_BusinessCombinationsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfOrdinarySharesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfOrdinarySharesAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfOrdinarySharesAxis_lbl" xml:lang="en-US">Classes of ordinary shares [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfOrdinarySharesAxis" xlink:to="ifrs-full_ClassesOfOrdinarySharesAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_lbl" xml:lang="en-US">Non-adjusting events after reporting period [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:to="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InitiallyAppliedIFRSsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InitiallyAppliedIFRSsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InitiallyAppliedIFRSsAxis_lbl" xml:lang="en-US">Initially applied IFRSs [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InitiallyAppliedIFRSsAxis" xlink:to="ifrs-full_InitiallyAppliedIFRSsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementGeographicalAxis_lbl" xml:lang="en-US">Geographical [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementScenarioAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementScenarioAxis_lbl" xml:lang="en-US">Scenario [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections_lbl" xml:lang="en-US">Discount rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections" xlink:to="ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PercentageOfWeightedAverageCostOfCapital" xlink:href="mlec-20250630.xsd#mlec_PercentageOfWeightedAverageCostOfCapital"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_PercentageOfWeightedAverageCostOfCapital_lbl" xml:lang="en-US">Discount rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfWeightedAverageCostOfCapital" xlink:to="mlec_PercentageOfWeightedAverageCostOfCapital_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PercentageOfRiskPremium" xlink:href="mlec-20250630.xsd#mlec_PercentageOfRiskPremium"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_PercentageOfRiskPremium_lbl" xml:lang="en-US">Percentage of risk premium</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfRiskPremium" xlink:to="mlec_PercentageOfRiskPremium_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections_lbl" xml:lang="en-US">Growth rate used to extrapolate future cash flow projections to terminal period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections" xlink:to="ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl" xml:lang="en-US">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Board of Directors Oversight [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_lbl" xml:lang="en-US">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:to="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_lbl" xml:lang="en-US">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ReverseStockSplitConsolidationRatio" xlink:href="mlec-20250630.xsd#mlec_ReverseStockSplitConsolidationRatio"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ReverseStockSplitConsolidationRatio_lbl" xml:lang="en-US">Consolidation ratio</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ReverseStockSplitConsolidationRatio" xlink:to="mlec_ReverseStockSplitConsolidationRatio_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates_lbl" xml:lang="en-US">Shares held</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" xlink:to="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates_lbl0" xml:lang="en-US">Held own shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" xlink:to="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ParValuePerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ParValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ParValuePerShare_lbl" xml:lang="en-US">Par value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ParValuePerShare" xlink:to="ifrs-full_ParValuePerShare_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ParValuePerShare_lbl0" xml:lang="en-US">Par value per share (in Pesos per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ParValuePerShare" xlink:to="ifrs-full_ParValuePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="ifrs-full_ParValuePerShare_lbl1" xml:lang="en-US">Minimum per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ParValuePerShare" xlink:to="ifrs-full_ParValuePerShare_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_NumberOfSharesReverseStockSplit" xlink:href="mlec-20250630.xsd#mlec_NumberOfSharesReverseStockSplit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NumberOfSharesReverseStockSplit_lbl" xml:lang="en-US">Number of shares reverse stock split</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfSharesReverseStockSplit" xlink:to="mlec_NumberOfSharesReverseStockSplit_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PercentageOfIssuedAndOutstandingEquityInterests" xlink:href="mlec-20250630.xsd#mlec_PercentageOfIssuedAndOutstandingEquityInterests"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_PercentageOfIssuedAndOutstandingEquityInterests_lbl" xml:lang="en-US">Percentage of issued and outstanding equity interests</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfIssuedAndOutstandingEquityInterests" xlink:to="mlec_PercentageOfIssuedAndOutstandingEquityInterests_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ConsiderationForIssuedOrdinaryShareValue" xlink:href="mlec-20250630.xsd#mlec_ConsiderationForIssuedOrdinaryShareValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ConsiderationForIssuedOrdinaryShareValue_lbl" xml:lang="en-US">Consideration for issued ordinary shares value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ConsiderationForIssuedOrdinaryShareValue" xlink:to="mlec_ConsiderationForIssuedOrdinaryShareValue_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PrivateWarrantsShares" xlink:href="mlec-20250630.xsd#mlec_PrivateWarrantsShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_PrivateWarrantsShares_lbl" xml:lang="en-US">Private warrant shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PrivateWarrantsShares" xlink:to="mlec_PrivateWarrantsShares_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PrivateWarrantsExercisePrice" xlink:href="mlec-20250630.xsd#mlec_PrivateWarrantsExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_PrivateWarrantsExercisePrice_lbl" xml:lang="en-US">Private warrants exercise price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PrivateWarrantsExercisePrice" xlink:to="mlec_PrivateWarrantsExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AdditionalOrdinarySharesIssue" xlink:href="mlec-20250630.xsd#mlec_AdditionalOrdinarySharesIssue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AdditionalOrdinarySharesIssue_lbl" xml:lang="en-US">Additional ordinary shares issue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AdditionalOrdinarySharesIssue" xlink:to="mlec_AdditionalOrdinarySharesIssue_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_PercentageOfVotingEquityInterestsAcquired_lbl" xml:lang="en-US">Percentage of equity and voting interest acquired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:to="ifrs-full_PercentageOfVotingEquityInterestsAcquired_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NumberOfSharesOutstandingPercentage" xlink:href="mlec-20250630.xsd#mlec_NumberOfSharesOutstandingPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NumberOfSharesOutstandingPercentage_lbl" xml:lang="en-US">Shares outstanding, percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfSharesOutstandingPercentage" xlink:to="mlec_NumberOfSharesOutstandingPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProportionOfVotingPowerHeldInSubsidiary" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProportionOfVotingPowerHeldInSubsidiary"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProportionOfVotingPowerHeldInSubsidiary_lbl" xml:lang="en-US">Voting interest percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProportionOfVotingPowerHeldInSubsidiary" xlink:to="ifrs-full_ProportionOfVotingPowerHeldInSubsidiary_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NumberOfSharesPledged" xlink:href="mlec-20250630.xsd#mlec_NumberOfSharesPledged"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NumberOfSharesPledged_lbl" xml:lang="en-US">Shares pledged</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfSharesPledged" xlink:to="mlec_NumberOfSharesPledged_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentDebtInstrumentsIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentDebtInstrumentsIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentDebtInstrumentsIssued_lbl" xml:lang="en-US">Current debt (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentDebtInstrumentsIssued" xlink:to="ifrs-full_CurrentDebtInstrumentsIssued_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CurrentDebtInstrumentsIssued_lbl0" xml:lang="en-US">Current debt amounts (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentDebtInstrumentsIssued" xlink:to="ifrs-full_CurrentDebtInstrumentsIssued_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_WorkingCapital" xlink:href="mlec-20250630.xsd#mlec_WorkingCapital"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_WorkingCapital_lbl" xml:lang="en-US">Working capital (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_WorkingCapital" xlink:to="mlec_WorkingCapital_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="mlec_WorkingCapital_lbl0" xml:lang="en-US">Working capital amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_WorkingCapital" xlink:to="mlec_WorkingCapital_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_GainlossOfRecognitionTransactions" xlink:href="mlec-20250630.xsd#mlec_GainlossOfRecognitionTransactions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_GainlossOfRecognitionTransactions_lbl" xml:lang="en-US">Estimated gain (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_GainlossOfRecognitionTransactions" xlink:to="mlec_GainlossOfRecognitionTransactions_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_GainlossOfDerecognitionTransactions" xlink:href="mlec-20250630.xsd#mlec_GainlossOfDerecognitionTransactions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_GainlossOfDerecognitionTransactions_lbl" xml:lang="en-US">Approximate gain (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_GainlossOfDerecognitionTransactions" xlink:to="mlec_GainlossOfDerecognitionTransactions_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ShorttermPeriod" xlink:href="mlec-20250630.xsd#mlec_ShorttermPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ShorttermPeriod_lbl" xml:lang="en-US">Short-term period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShorttermPeriod" xlink:to="mlec_ShorttermPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_CumulativeInflationRate" xlink:href="mlec-20250630.xsd#mlec_CumulativeInflationRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_CumulativeInflationRate_lbl" xml:lang="en-US">Cumulative inflation rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CumulativeInflationRate" xlink:to="mlec_CumulativeInflationRate_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InflationOfAccumulatedYears" xlink:href="mlec-20250630.xsd#mlec_InflationOfAccumulatedYears"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_InflationOfAccumulatedYears_lbl" xml:lang="en-US">Inflation of accumulated</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InflationOfAccumulatedYears" xlink:to="mlec_InflationOfAccumulatedYears_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PercentageOfInflationAccumulated" xlink:href="mlec-20250630.xsd#mlec_PercentageOfInflationAccumulated"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_PercentageOfInflationAccumulated_lbl" xml:lang="en-US">Percentage of Inflation accumulated</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfInflationAccumulated" xlink:to="mlec_PercentageOfInflationAccumulated_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ArgentinePriceIndexShares" xlink:href="mlec-20250630.xsd#mlec_ArgentinePriceIndexShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ArgentinePriceIndexShares_lbl" xml:lang="en-US">Argentine price index shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ArgentinePriceIndexShares" xlink:to="mlec_ArgentinePriceIndexShares_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PrivateWarrantShares" xlink:href="mlec-20250630.xsd#mlec_PrivateWarrantShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_PrivateWarrantShares_lbl" xml:lang="en-US">Private warrant shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PrivateWarrantShares" xlink:to="mlec_PrivateWarrantShares_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PercentageOfShare" xlink:href="mlec-20250630.xsd#mlec_PercentageOfShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_PercentageOfShare_lbl" xml:lang="en-US">Percentage of share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfShare" xlink:to="mlec_PercentageOfShare_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuedCapitalOrdinaryShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapitalOrdinaryShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IssuedCapitalOrdinaryShares_lbl" xml:lang="en-US">Ordinary shares (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssuedCapitalOrdinaryShares" xlink:to="ifrs-full_IssuedCapitalOrdinaryShares_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionWhetherChangeInAccountingPolicyIsMadeInAccordanceWithTransitionalProvisionsOfInitiallyAppliedIFRS" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionWhetherChangeInAccountingPolicyIsMadeInAccordanceWithTransitionalProvisionsOfInitiallyAppliedIFRS"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionWhetherChangeInAccountingPolicyIsMadeInAccordanceWithTransitionalProvisionsOfInitiallyAppliedIFRS_lbl" xml:lang="en-US">Description of nature</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionWhetherChangeInAccountingPolicyIsMadeInAccordanceWithTransitionalProvisionsOfInitiallyAppliedIFRS" xlink:to="ifrs-full_DescriptionWhetherChangeInAccountingPolicyIsMadeInAccordanceWithTransitionalProvisionsOfInitiallyAppliedIFRS_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TitleOfInitiallyAppliedIFRS" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TitleOfInitiallyAppliedIFRS"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TitleOfInitiallyAppliedIFRS_lbl" xml:lang="en-US">Title of initially applied</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TitleOfInitiallyAppliedIFRS" xlink:to="ifrs-full_TitleOfInitiallyAppliedIFRS_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeBiologicalAssetsAtCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeBiologicalAssetsAtCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeBiologicalAssetsAtCost_lbl" xml:lang="en-US">Period from moment of sowing until the moment of harvest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeBiologicalAssetsAtCost" xlink:to="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeBiologicalAssetsAtCost_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_lbl" xml:lang="en-US">Useful lives</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:to="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ValuationSignificantChangePercentageOfConstructionCosts" xlink:href="mlec-20250630.xsd#mlec_ValuationSignificantChangePercentageOfConstructionCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ValuationSignificantChangePercentageOfConstructionCosts_lbl" xml:lang="en-US">Change in construction costs that impacts valuation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ValuationSignificantChangePercentageOfConstructionCosts" xlink:to="mlec_ValuationSignificantChangePercentageOfConstructionCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ValuationSignificantChangeInAmountNormalWearAndTearVariationImpactOnRevaluationAmount" xlink:href="mlec-20250630.xsd#mlec_ValuationSignificantChangeInAmountNormalWearAndTearVariationImpactOnRevaluationAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ValuationSignificantChangeInAmountNormalWearAndTearVariationImpactOnRevaluationAmount_lbl" xml:lang="en-US">Impact on revaluation amount (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ValuationSignificantChangeInAmountNormalWearAndTearVariationImpactOnRevaluationAmount" xlink:to="mlec_ValuationSignificantChangeInAmountNormalWearAndTearVariationImpactOnRevaluationAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US">Useful life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AveragePaymentTermBySales" xlink:href="mlec-20250630.xsd#mlec_AveragePaymentTermBySales"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AveragePaymentTermBySales_lbl" xml:lang="en-US">Average payment terms</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AveragePaymentTermBySales" xlink:to="mlec_AveragePaymentTermBySales_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueOfCombinedEntity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueOfCombinedEntity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RevenueOfCombinedEntity_lbl" xml:lang="en-US">Revenue of the combined entity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueOfCombinedEntity" xlink:to="ifrs-full_RevenueOfCombinedEntity_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossOfCombinedEntity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossOfCombinedEntity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProfitLossOfCombinedEntity_lbl" xml:lang="en-US">Profit or loss of the combined entity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossOfCombinedEntity" xlink:to="ifrs-full_ProfitLossOfCombinedEntity_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NumberOfSharesAcquiredInBusinessCombination" xlink:href="mlec-20250630.xsd#mlec_NumberOfSharesAcquiredInBusinessCombination"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NumberOfSharesAcquiredInBusinessCombination_lbl" xml:lang="en-US">Number of shares acquired (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfSharesAcquiredInBusinessCombination" xlink:to="mlec_NumberOfSharesAcquiredInBusinessCombination_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PercentageOfCustomerRevenues" xlink:href="mlec-20250630.xsd#mlec_PercentageOfCustomerRevenues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_PercentageOfCustomerRevenues_lbl" xml:lang="en-US">Percentage of customer revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfCustomerRevenues" xlink:to="mlec_PercentageOfCustomerRevenues_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryOtherProvisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryOtherProvisions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryOtherProvisions_lbl" xml:lang="en-US">Loss of control (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryOtherProvisions" xlink:to="ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryOtherProvisions_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ProjectedPeriodRange" xlink:href="mlec-20250630.xsd#mlec_ProjectedPeriodRange"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ProjectedPeriodRange_lbl" xml:lang="en-US">Projected period range</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ProjectedPeriodRange" xlink:to="mlec_ProjectedPeriodRange_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EstimatedFinancialEffectOfContingentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EstimatedFinancialEffectOfContingentAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_EstimatedFinancialEffectOfContingentAssets_lbl" xml:lang="en-US">Estimated value (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EstimatedFinancialEffectOfContingentAssets" xlink:to="ifrs-full_EstimatedFinancialEffectOfContingentAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InventoryRecognizedAsExpense" xlink:href="mlec-20250630.xsd#mlec_InventoryRecognizedAsExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_InventoryRecognizedAsExpense_lbl" xml:lang="en-US">Inventory recognized as expense (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InventoryRecognizedAsExpense" xlink:to="mlec_InventoryRecognizedAsExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuedCapitalPreferenceShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapitalPreferenceShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IssuedCapitalPreferenceShares_lbl" xml:lang="en-US">Total proceeds (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssuedCapitalPreferenceShares" xlink:to="ifrs-full_IssuedCapitalPreferenceShares_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PercentageOfPreferenceSharesAccrue" xlink:href="mlec-20250630.xsd#mlec_PercentageOfPreferenceSharesAccrue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_PercentageOfPreferenceSharesAccrue_lbl" xml:lang="en-US">Percentage of preference shares accrue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfPreferenceSharesAccrue" xlink:to="mlec_PercentageOfPreferenceSharesAccrue_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AggregateAmount" xlink:href="mlec-20250630.xsd#mlec_AggregateAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AggregateAmount_lbl" xml:lang="en-US">Aggregate amount (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AggregateAmount" xlink:to="mlec_AggregateAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DebtInstrumentsHeldAtAmortisedCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DebtInstrumentsHeldAtAmortisedCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DebtInstrumentsHeldAtAmortisedCost_lbl" xml:lang="en-US">Financial debt (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DebtInstrumentsHeldAtAmortisedCost" xlink:to="ifrs-full_DebtInstrumentsHeldAtAmortisedCost_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_CreditorsPublicAuctionShares" xlink:href="mlec-20250630.xsd#mlec_CreditorsPublicAuctionShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_CreditorsPublicAuctionShares_lbl" xml:lang="en-US">Creditor public auction shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CreditorsPublicAuctionShares" xlink:to="mlec_CreditorsPublicAuctionShares_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsInterestRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsInterestRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_BorrowingsInterestRate_lbl" xml:lang="en-US">Interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BorrowingsInterestRate" xlink:to="ifrs-full_BorrowingsInterestRate_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_IfrsDebtInstrumentTerm" xlink:href="mlec-20250630.xsd#mlec_IfrsDebtInstrumentTerm"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_IfrsDebtInstrumentTerm_lbl" xml:lang="en-US">Maturity period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IfrsDebtInstrumentTerm" xlink:to="mlec_IfrsDebtInstrumentTerm_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AmortizationPayments" xlink:href="mlec-20250630.xsd#mlec_AmortizationPayments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AmortizationPayments_lbl" xml:lang="en-US">Amortization payments (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AmortizationPayments" xlink:to="mlec_AmortizationPayments_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PercentageOfPrepaymentPremium" xlink:href="mlec-20250630.xsd#mlec_PercentageOfPrepaymentPremium"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_PercentageOfPrepaymentPremium_lbl" xml:lang="en-US">Prepayment premium</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfPrepaymentPremium" xlink:to="mlec_PercentageOfPrepaymentPremium_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PercentageOfPenalty" xlink:href="mlec-20250630.xsd#mlec_PercentageOfPenalty"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_PercentageOfPenalty_lbl" xml:lang="en-US">Percentage of penalty</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfPenalty" xlink:to="mlec_PercentageOfPenalty_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NotionalAmount" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NotionalAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NotionalAmount_lbl" xml:lang="en-US">Nominal value (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NotionalAmount" xlink:to="ifrs-full_NotionalAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_BorrowingInterestRateInCash" xlink:href="mlec-20250630.xsd#mlec_BorrowingInterestRateInCash"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_BorrowingInterestRateInCash_lbl" xml:lang="en-US">Interest payable in cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BorrowingInterestRateInCash" xlink:to="mlec_BorrowingInterestRateInCash_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_BorrowingInterestRateInKind" xlink:href="mlec-20250630.xsd#mlec_BorrowingInterestRateInKind"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_BorrowingInterestRateInKind_lbl" xml:lang="en-US">Interest payable in kind</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BorrowingInterestRateInKind" xlink:to="mlec_BorrowingInterestRateInKind_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_StrikePriceForConversionOfDebt" xlink:href="mlec-20250630.xsd#mlec_StrikePriceForConversionOfDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_StrikePriceForConversionOfDebt_lbl" xml:lang="en-US">Strike price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_StrikePriceForConversionOfDebt" xlink:to="mlec_StrikePriceForConversionOfDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_VoluntaryRepurchaseOfNotesAfterIssueDate" xlink:href="mlec-20250630.xsd#mlec_VoluntaryRepurchaseOfNotesAfterIssueDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_VoluntaryRepurchaseOfNotesAfterIssueDate_lbl" xml:lang="en-US">Voluntary repurchase of notes after the issue date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_VoluntaryRepurchaseOfNotesAfterIssueDate" xlink:to="mlec_VoluntaryRepurchaseOfNotesAfterIssueDate_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsMaturity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsMaturity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_BorrowingsMaturity_lbl" xml:lang="en-US">Maturity date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BorrowingsMaturity" xlink:to="ifrs-full_BorrowingsMaturity_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PricePerSharesOfStrikePrice" xlink:href="mlec-20250630.xsd#mlec_PricePerSharesOfStrikePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_PricePerSharesOfStrikePrice_lbl" xml:lang="en-US">Price per shares of strike price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PricePerSharesOfStrikePrice" xlink:to="mlec_PricePerSharesOfStrikePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_CommonEquity" xlink:href="mlec-20250630.xsd#mlec_CommonEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_CommonEquity_lbl" xml:lang="en-US">Common equity (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CommonEquity" xlink:to="mlec_CommonEquity_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PercentageOfPenaltyOfPrepayment" xlink:href="mlec-20250630.xsd#mlec_PercentageOfPenaltyOfPrepayment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_PercentageOfPenaltyOfPrepayment_lbl" xml:lang="en-US">Percentage of Penalty of Prepayment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfPenaltyOfPrepayment" xlink:to="mlec_PercentageOfPenaltyOfPrepayment_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DiscountRateForFairValueOfLiabilityComponent" xlink:href="mlec-20250630.xsd#mlec_DiscountRateForFairValueOfLiabilityComponent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DiscountRateForFairValueOfLiabilityComponent_lbl" xml:lang="en-US">Discount rate for fair value of the liability component</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DiscountRateForFairValueOfLiabilityComponent" xlink:to="mlec_DiscountRateForFairValueOfLiabilityComponent_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LoansReceived" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LoansReceived"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_LoansReceived_lbl" xml:lang="en-US">Convertible note received (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LoansReceived" xlink:to="ifrs-full_LoansReceived_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AdditionalConvertibleNotesReceivedAmount" xlink:href="mlec-20250630.xsd#mlec_AdditionalConvertibleNotesReceivedAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AdditionalConvertibleNotesReceivedAmount_lbl" xml:lang="en-US">Additional convertible notes received (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AdditionalConvertibleNotesReceivedAmount" xlink:to="mlec_AdditionalConvertibleNotesReceivedAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ConversionOptionStrikePrice" xlink:href="mlec-20250630.xsd#mlec_ConversionOptionStrikePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ConversionOptionStrikePrice_lbl" xml:lang="en-US">Conversion option strike price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ConversionOptionStrikePrice" xlink:to="mlec_ConversionOptionStrikePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PercentageOfOutstandingAmountInitialInterestRate" xlink:href="mlec-20250630.xsd#mlec_PercentageOfOutstandingAmountInitialInterestRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_PercentageOfOutstandingAmountInitialInterestRate_lbl" xml:lang="en-US">Initial interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfOutstandingAmountInitialInterestRate" xlink:to="mlec_PercentageOfOutstandingAmountInitialInterestRate_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PercentageOfCashPaymentInterestRate" xlink:href="mlec-20250630.xsd#mlec_PercentageOfCashPaymentInterestRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_PercentageOfCashPaymentInterestRate_lbl" xml:lang="en-US">Percentage of cash payment interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfCashPaymentInterestRate" xlink:to="mlec_PercentageOfCashPaymentInterestRate_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ContingentPayment" xlink:href="mlec-20250630.xsd#mlec_ContingentPayment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ContingentPayment_lbl" xml:lang="en-US">Contingent payment (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ContingentPayment" xlink:to="mlec_ContingentPayment_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ContingentPaymentCurrent" xlink:href="mlec-20250630.xsd#mlec_ContingentPaymentCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ContingentPaymentCurrent_lbl" xml:lang="en-US">Contingent payment current value (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ContingentPaymentCurrent" xlink:to="mlec_ContingentPaymentCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PercentageOfCapital" xlink:href="mlec-20250630.xsd#mlec_PercentageOfCapital"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_PercentageOfCapital_lbl" xml:lang="en-US">Percentage of capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfCapital" xlink:to="mlec_PercentageOfCapital_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PercentageOfDividendsTaxedShares" xlink:href="mlec-20250630.xsd#mlec_PercentageOfDividendsTaxedShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_PercentageOfDividendsTaxedShares_lbl" xml:lang="en-US">Percentage of taxed dividend shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfDividendsTaxedShares" xlink:to="mlec_PercentageOfDividendsTaxedShares_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ContingentPurchasePrice" xlink:href="mlec-20250630.xsd#mlec_ContingentPurchasePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ContingentPurchasePrice_lbl" xml:lang="en-US">Contingent purchase price (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ContingentPurchasePrice" xlink:to="mlec_ContingentPurchasePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PercentageOfEntitysRevenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PercentageOfEntitysRevenue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_PercentageOfEntitysRevenue_lbl" xml:lang="en-US">Percentage of revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PercentageOfEntitysRevenue" xlink:to="ifrs-full_PercentageOfEntitysRevenue_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueOfAcquiree" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueOfAcquiree"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RevenueOfAcquiree_lbl" xml:lang="en-US">Royalty payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueOfAcquiree" xlink:to="ifrs-full_RevenueOfAcquiree_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations_lbl" xml:lang="en-US">Performance benchmark obligations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" xlink:to="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherTangibleOrIntangibleAssetsTransferred" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherTangibleOrIntangibleAssetsTransferred"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherTangibleOrIntangibleAssetsTransferred_lbl" xml:lang="en-US">Gain from exchange of intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherTangibleOrIntangibleAssetsTransferred" xlink:to="ifrs-full_OtherTangibleOrIntangibleAssetsTransferred_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense_lbl" xml:lang="en-US">Unrecognized tax-loss carry</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense" xlink:to="ifrs-full_TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_VotePerShare" xlink:href="mlec-20250630.xsd#mlec_VotePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_VotePerShare_lbl" xml:lang="en-US">Vote per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_VotePerShare" xlink:to="mlec_VotePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PercentageOfProfitForObligationToLegalReserve" xlink:href="mlec-20250630.xsd#mlec_PercentageOfProfitForObligationToLegalReserve"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_PercentageOfProfitForObligationToLegalReserve_lbl" xml:lang="en-US">Annual legal reserve required, as percent of profit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfProfitForObligationToLegalReserve" xlink:to="mlec_PercentageOfProfitForObligationToLegalReserve_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_MaximumPercentageOfCapitalForObligationToLegalReserve" xlink:href="mlec-20250630.xsd#mlec_MaximumPercentageOfCapitalForObligationToLegalReserve"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_MaximumPercentageOfCapitalForObligationToLegalReserve_lbl" xml:lang="en-US">Legal reserve required, as percent of capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MaximumPercentageOfCapitalForObligationToLegalReserve" xlink:to="mlec_MaximumPercentageOfCapitalForObligationToLegalReserve_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NumberOfComplementaryComponents" xlink:href="mlec-20250630.xsd#mlec_NumberOfComplementaryComponents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NumberOfComplementaryComponents_lbl" xml:lang="en-US">Number of complementary components</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfComplementaryComponents" xlink:to="mlec_NumberOfComplementaryComponents_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PercentageOfEstimatesThatDevaluationOrAnAppreciation" xlink:href="mlec-20250630.xsd#mlec_PercentageOfEstimatesThatDevaluationOrAnAppreciation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_PercentageOfEstimatesThatDevaluationOrAnAppreciation_lbl" xml:lang="en-US">Percentage of estimates that devaluation or an appreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfEstimatesThatDevaluationOrAnAppreciation" xlink:to="mlec_PercentageOfEstimatesThatDevaluationOrAnAppreciation_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareBasedPaymentsIncentiveIncreases" xlink:href="mlec-20250630.xsd#mlec_ShareBasedPaymentsIncentiveIncreases"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ShareBasedPaymentsIncentiveIncreases_lbl" xml:lang="en-US">Incentive increases (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareBasedPaymentsIncentiveIncreases" xlink:to="mlec_ShareBasedPaymentsIncentiveIncreases_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_IfrsDefinedContributionPlanEmployerMatchingContributionPercentOfEmployeesGrossPay" xlink:href="mlec-20250630.xsd#mlec_IfrsDefinedContributionPlanEmployerMatchingContributionPercentOfEmployeesGrossPay"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_IfrsDefinedContributionPlanEmployerMatchingContributionPercentOfEmployeesGrossPay_lbl" xml:lang="en-US">Maximum percentage of employee&apos;s monthly compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IfrsDefinedContributionPlanEmployerMatchingContributionPercentOfEmployeesGrossPay" xlink:to="mlec_IfrsDefinedContributionPlanEmployerMatchingContributionPercentOfEmployeesGrossPay_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SharesSubjectToEmployeeStockPurchasePlan" xlink:href="mlec-20250630.xsd#mlec_SharesSubjectToEmployeeStockPurchasePlan"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SharesSubjectToEmployeeStockPurchasePlan_lbl" xml:lang="en-US">Number of ordinary shares subject to the ESPP (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SharesSubjectToEmployeeStockPurchasePlan" xlink:to="mlec_SharesSubjectToEmployeeStockPurchasePlan_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PercentageOfClosingPriceOnFirstAndLastBusinessDayToDeterminePurchasePrice" xlink:href="mlec-20250630.xsd#mlec_PercentageOfClosingPriceOnFirstAndLastBusinessDayToDeterminePurchasePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_PercentageOfClosingPriceOnFirstAndLastBusinessDayToDeterminePurchasePrice_lbl" xml:lang="en-US">Percentage of closing price of the Company&apos;s ordinary shares on the first business day and the last business day to determine purchase price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfClosingPriceOnFirstAndLastBusinessDayToDeterminePurchasePrice" xlink:to="mlec_PercentageOfClosingPriceOnFirstAndLastBusinessDayToDeterminePurchasePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareBasedPaymentAwardExpirationDate" xlink:href="mlec-20250630.xsd#mlec_ShareBasedPaymentAwardExpirationDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ShareBasedPaymentAwardExpirationDate_lbl" xml:lang="en-US">Expire date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareBasedPaymentAwardExpirationDate" xlink:to="mlec_ShareBasedPaymentAwardExpirationDate_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod" xlink:href="mlec-20250630.xsd#mlec_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod_lbl" xml:lang="en-US">Vesting period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod" xlink:to="mlec_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareBasedPaymentPeriodOfWeightedAveragePriceVwapOfOrdinarySharesForCashlessBasisExercise" xlink:href="mlec-20250630.xsd#mlec_ShareBasedPaymentPeriodOfWeightedAveragePriceVwapOfOrdinarySharesForCashlessBasisExercise"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ShareBasedPaymentPeriodOfWeightedAveragePriceVwapOfOrdinarySharesForCashlessBasisExercise_lbl" xml:lang="en-US">Period of weighted average price (&quot;VWAP&quot;) of the ordinary shares for cashless basis exercise</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareBasedPaymentPeriodOfWeightedAveragePriceVwapOfOrdinarySharesForCashlessBasisExercise" xlink:to="mlec_ShareBasedPaymentPeriodOfWeightedAveragePriceVwapOfOrdinarySharesForCashlessBasisExercise_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ThresholdEarningsBeforeInterestTaxesDepreciationAndAmortization" xlink:href="mlec-20250630.xsd#mlec_ThresholdEarningsBeforeInterestTaxesDepreciationAndAmortization"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ThresholdEarningsBeforeInterestTaxesDepreciationAndAmortization_lbl" xml:lang="en-US">Threshold earnings before interest (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ThresholdEarningsBeforeInterestTaxesDepreciationAndAmortization" xlink:to="mlec_ThresholdEarningsBeforeInterestTaxesDepreciationAndAmortization_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage" xlink:href="mlec-20250630.xsd#mlec_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage_lbl" xml:lang="en-US">Vesting percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage" xlink:to="mlec_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NumberOfOptionsEstimatedExercisePercent" xlink:href="mlec-20250630.xsd#mlec_NumberOfOptionsEstimatedExercisePercent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NumberOfOptionsEstimatedExercisePercent_lbl" xml:lang="en-US">Estimates of options that will be exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfOptionsEstimatedExercisePercent" xlink:to="mlec_NumberOfOptionsEstimatedExercisePercent_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareBasedPaymentArrangementConversionOfEquityAwardsOutstandingToOptionOrRestrictedStockUnits" xlink:href="mlec-20250630.xsd#mlec_ShareBasedPaymentArrangementConversionOfEquityAwardsOutstandingToOptionOrRestrictedStockUnits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ShareBasedPaymentArrangementConversionOfEquityAwardsOutstandingToOptionOrRestrictedStockUnits_lbl" xml:lang="en-US">Number of total equity awards outstanding converted into option or restricted stock (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareBasedPaymentArrangementConversionOfEquityAwardsOutstandingToOptionOrRestrictedStockUnits" xlink:to="mlec_ShareBasedPaymentArrangementConversionOfEquityAwardsOutstandingToOptionOrRestrictedStockUnits_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Provisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Provisions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_Provisions_lbl" xml:lang="en-US">Assignment price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Provisions" xlink:to="ifrs-full_Provisions_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AmountOfFinancialDebtUnderRestructuring" xlink:href="mlec-20250630.xsd#mlec_AmountOfFinancialDebtUnderRestructuring"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AmountOfFinancialDebtUnderRestructuring_lbl" xml:lang="en-US">Financial debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AmountOfFinancialDebtUnderRestructuring" xlink:to="mlec_AmountOfFinancialDebtUnderRestructuring_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PledgedOrTransferredSharesQuantity" xlink:href="mlec-20250630.xsd#mlec_PledgedOrTransferredSharesQuantity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_PledgedOrTransferredSharesQuantity_lbl" xml:lang="en-US">Pledged shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PledgedOrTransferredSharesQuantity" xlink:to="mlec_PledgedOrTransferredSharesQuantity_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_IssuedConvertiblePreferenceShares" xlink:href="mlec-20250630.xsd#mlec_IssuedConvertiblePreferenceShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_IssuedConvertiblePreferenceShares_lbl" xml:lang="en-US">Issued convertible preference shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IssuedConvertiblePreferenceShares" xlink:to="mlec_IssuedConvertiblePreferenceShares_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ProceedFromIssuedShares" xlink:href="mlec-20250630.xsd#mlec_ProceedFromIssuedShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ProceedFromIssuedShares_lbl" xml:lang="en-US">Total proceeds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ProceedFromIssuedShares" xlink:to="mlec_ProceedFromIssuedShares_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PreferenceOfAccruePerAnnum" xlink:href="mlec-20250630.xsd#mlec_PreferenceOfAccruePerAnnum"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_PreferenceOfAccruePerAnnum_lbl" xml:lang="en-US">Perference of accrue per annum</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PreferenceOfAccruePerAnnum" xlink:to="mlec_PreferenceOfAccruePerAnnum_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ProceedsFromIssueOfEquityInstrumentsOnConversionOfDebt" xlink:href="mlec-20250630.xsd#mlec_ProceedsFromIssueOfEquityInstrumentsOnConversionOfDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ProceedsFromIssueOfEquityInstrumentsOnConversionOfDebt_lbl" xml:lang="en-US">Financial liability and increase in equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ProceedsFromIssueOfEquityInstrumentsOnConversionOfDebt" xlink:to="mlec_ProceedsFromIssueOfEquityInstrumentsOnConversionOfDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ConsecutiveBusinessDays" xlink:href="mlec-20250630.xsd#mlec_ConsecutiveBusinessDays"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ConsecutiveBusinessDays_lbl" xml:lang="en-US">Consecutive business days</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ConsecutiveBusinessDays" xlink:to="mlec_ConsecutiveBusinessDays_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss_lbl" xml:lang="en-US">Estimated gain loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss" xlink:to="ifrs-full_GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ReverseStockSplit" xlink:href="mlec-20250630.xsd#mlec_ReverseStockSplit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ReverseStockSplit_lbl" xml:lang="en-US">Reverse stock split.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ReverseStockSplit" xlink:to="mlec_ReverseStockSplit_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_lbl" xml:lang="en-US">Cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:to="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DescriptionOfAccountingPolicyForFinancialAssetsAndLiabilitiesPolicyTextBlock" xlink:href="mlec-20250630.xsd#mlec_DescriptionOfAccountingPolicyForFinancialAssetsAndLiabilitiesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DescriptionOfAccountingPolicyForFinancialAssetsAndLiabilitiesPolicyTextBlock_lbl" xml:lang="en-US">Financial assets and liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DescriptionOfAccountingPolicyForFinancialAssetsAndLiabilitiesPolicyTextBlock" xlink:to="mlec_DescriptionOfAccountingPolicyForFinancialAssetsAndLiabilitiesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_lbl" xml:lang="en-US">Inventories</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory_lbl" xml:lang="en-US">Biological assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation" xlink:href="mlec-20250630.xsd#mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation_lbl" xml:lang="en-US">Basis of consolidation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation" xlink:to="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_lbl" xml:lang="en-US">Impairment assessment of Goodwill and Intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_lbl" xml:lang="en-US">Property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_lbl" xml:lang="en-US">Leased assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory_lbl" xml:lang="en-US">Intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForInvestmentPropertyExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForInvestmentPropertyExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForInvestmentPropertyExplanatory_lbl" xml:lang="en-US">Investment properties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForInvestmentPropertyExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForInvestmentPropertyExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory_lbl" xml:lang="en-US">Borrowings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DescriptionOfAccountingPolicyForConvertibleNotesTextBlock" xlink:href="mlec-20250630.xsd#mlec_DescriptionOfAccountingPolicyForConvertibleNotesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DescriptionOfAccountingPolicyForConvertibleNotesTextBlock_lbl" xml:lang="en-US">Convertibles notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DescriptionOfAccountingPolicyForConvertibleNotesTextBlock" xlink:to="mlec_DescriptionOfAccountingPolicyForConvertibleNotesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_lbl" xml:lang="en-US">Employee benefits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_lbl" xml:lang="en-US">Provisions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DescriptionOfAccountingPolicyForWarrantLiabilities" xlink:href="mlec-20250630.xsd#mlec_DescriptionOfAccountingPolicyForWarrantLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DescriptionOfAccountingPolicyForWarrantLiabilities_lbl" xml:lang="en-US">Warrant liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DescriptionOfAccountingPolicyForWarrantLiabilities" xlink:to="mlec_DescriptionOfAccountingPolicyForWarrantLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_lbl" xml:lang="en-US">Revenue recognition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_lbl" xml:lang="en-US">Government grants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_lbl" xml:lang="en-US">Income tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_lbl" xml:lang="en-US">Share-based payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_RizobacterUGEMember" xlink:href="mlec-20250630.xsd#mlec_RizobacterUGEMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_RizobacterUGEMember_lbl" xml:lang="en-US">Rizobacter UGE [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RizobacterUGEMember" xlink:to="mlec_RizobacterUGEMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ProFarmUGEMember" xlink:href="mlec-20250630.xsd#mlec_ProFarmUGEMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ProFarmUGEMember_lbl" xml:lang="en-US">Pro Farm UGE [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ProFarmUGEMember" xlink:to="mlec_ProFarmUGEMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_MoolecScienceLuxembourgMember" xlink:href="mlec-20250630.xsd#mlec_MoolecScienceLuxembourgMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_MoolecScienceLuxembourgMember_lbl" xml:lang="en-US">Moolec Science (Luxembourg) [Member[</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MoolecScienceLuxembourgMember" xlink:to="mlec_MoolecScienceLuxembourgMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_MoolecScienceCaymanIslandsMember" xlink:href="mlec-20250630.xsd#mlec_MoolecScienceCaymanIslandsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_MoolecScienceCaymanIslandsMember_lbl" xml:lang="en-US">Moolec Science (Cayman Islands) [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MoolecScienceCaymanIslandsMember" xlink:to="mlec_MoolecScienceCaymanIslandsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_HoldbackMember" xlink:href="mlec-20250630.xsd#mlec_HoldbackMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_HoldbackMember_lbl" xml:lang="en-US">Holdback [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_HoldbackMember" xlink:to="mlec_HoldbackMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_OrdinarySharesOneMember" xlink:href="mlec-20250630.xsd#mlec_OrdinarySharesOneMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_OrdinarySharesOneMember_lbl" xml:lang="en-US">Ordinary Shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OrdinarySharesOneMember" xlink:to="mlec_OrdinarySharesOneMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SubsequentEventsMember" xlink:href="mlec-20250630.xsd#mlec_SubsequentEventsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SubsequentEventsMember_lbl" xml:lang="en-US">Subsequent Events [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SubsequentEventsMember" xlink:to="mlec_SubsequentEventsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_BusinessCombinationMember" xlink:href="mlec-20250630.xsd#mlec_BusinessCombinationMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_BusinessCombinationMember_lbl" xml:lang="en-US">Business Combination [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BusinessCombinationMember" xlink:to="mlec_BusinessCombinationMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LeaseLiabilityInASaleAndLeasebackMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseLiabilityInASaleAndLeasebackMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_LeaseLiabilityInASaleAndLeasebackMember_lbl" xml:lang="en-US">Lease Liability in a Sale and Leaseback [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LeaseLiabilityInASaleAndLeasebackMember" xlink:to="ifrs-full_LeaseLiabilityInASaleAndLeasebackMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLiabilitiesWithCovenantsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLiabilitiesWithCovenantsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncurrentLiabilitiesWithCovenantsMember_lbl" xml:lang="en-US">Non-current Liabilities with Covenants [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLiabilitiesWithCovenantsMember" xlink:to="ifrs-full_NoncurrentLiabilitiesWithCovenantsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherPropertyPlantAndEquipmentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherPropertyPlantAndEquipmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherPropertyPlantAndEquipmentMember_lbl" xml:lang="en-US">Research instruments [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherPropertyPlantAndEquipmentMember" xlink:to="ifrs-full_OtherPropertyPlantAndEquipmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_IfrsFull_machineryAndEquipmentMember" xlink:href="mlec-20250630.xsd#mlec_IfrsFull_machineryAndEquipmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_IfrsFull_machineryAndEquipmentMember_lbl" xml:lang="en-US">Machinery and equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IfrsFull_machineryAndEquipmentMember" xlink:to="mlec_IfrsFull_machineryAndEquipmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BuildingsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BuildingsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_BuildingsMember_lbl" xml:lang="en-US">Buildings [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BuildingsMember" xlink:to="ifrs-full_BuildingsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_lbl" xml:lang="en-US">Trademarks and patents [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" xlink:to="ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LicencesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LicencesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_LicencesMember_lbl" xml:lang="en-US">Certification ISO Standards [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LicencesMember" xlink:to="ifrs-full_LicencesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BrandNamesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BrandNamesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_BrandNamesMember_lbl" xml:lang="en-US">Trademarks [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BrandNamesMember" xlink:to="ifrs-full_BrandNamesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CustomerrelatedIntangibleAssetsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CustomerrelatedIntangibleAssetsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CustomerrelatedIntangibleAssetsMember_lbl" xml:lang="en-US">Customer loyalty [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CustomerrelatedIntangibleAssetsMember" xlink:to="ifrs-full_CustomerrelatedIntangibleAssetsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresGroupMember" xlink:href="mlec-20250630.xsd#mlec_BioceresGroupMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_BioceresGroupMember_lbl" xml:lang="en-US">Bioceres Group [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BioceresGroupMember" xlink:to="mlec_BioceresGroupMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SecuredGuaranteedNotesDue2026Member" xlink:href="mlec-20250630.xsd#mlec_SecuredGuaranteedNotesDue2026Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SecuredGuaranteedNotesDue2026Member_lbl" xml:lang="en-US">Secured Guaranteed Notes due 2026 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SecuredGuaranteedNotesDue2026Member" xlink:to="mlec_SecuredGuaranteedNotesDue2026Member_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FortyEightMonthsMember" xlink:href="mlec-20250630.xsd#mlec_FortyEightMonthsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_FortyEightMonthsMember_lbl" xml:lang="en-US">48 Months [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FortyEightMonthsMember" xlink:to="mlec_FortyEightMonthsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_lbl" xml:lang="en-US">25 through 36 months [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:to="ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_lbl" xml:lang="en-US">37 through 48 months [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:to="ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SecuredConvertibleGuaranteedNotesMember" xlink:href="mlec-20250630.xsd#mlec_SecuredConvertibleGuaranteedNotesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SecuredConvertibleGuaranteedNotesMember_lbl" xml:lang="en-US">Secured Convertible Guaranteed Notes [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SecuredConvertibleGuaranteedNotesMember" xlink:to="mlec_SecuredConvertibleGuaranteedNotesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NetWheatTechnologyLicensingMember" xlink:href="mlec-20250630.xsd#mlec_NetWheatTechnologyLicensingMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NetWheatTechnologyLicensingMember_lbl" xml:lang="en-US">Net Wheat Technology Licensing [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NetWheatTechnologyLicensingMember" xlink:to="mlec_NetWheatTechnologyLicensingMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NetHB4SoybeanMember" xlink:href="mlec-20250630.xsd#mlec_NetHB4SoybeanMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NetHB4SoybeanMember_lbl" xml:lang="en-US">Net HB4 Soybean [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NetHB4SoybeanMember" xlink:to="mlec_NetHB4SoybeanMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_EmployeeStockPurchasePlanMember" xlink:href="mlec-20250630.xsd#mlec_EmployeeStockPurchasePlanMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_EmployeeStockPurchasePlanMember_lbl" xml:lang="en-US">Employee Stock Purchase Plan [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_EmployeeStockPurchasePlanMember" xlink:to="mlec_EmployeeStockPurchasePlanMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_VolumeWeightedAveragePriceMember" xlink:href="mlec-20250630.xsd#mlec_VolumeWeightedAveragePriceMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_VolumeWeightedAveragePriceMember_lbl" xml:lang="en-US">Volume Weighted Average Price [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_VolumeWeightedAveragePriceMember" xlink:to="mlec_VolumeWeightedAveragePriceMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_EBITDAMember" xlink:href="mlec-20250630.xsd#mlec_EBITDAMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_EBITDAMember_lbl" xml:lang="en-US">EBITDA [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_EBITDAMember" xlink:to="mlec_EBITDAMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_StockIncentivePlan2013Member" xlink:href="mlec-20250630.xsd#mlec_StockIncentivePlan2013Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_StockIncentivePlan2013Member_lbl" xml:lang="en-US">Stock Incentive Plan 2013 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_StockIncentivePlan2013Member" xlink:to="mlec_StockIncentivePlan2013Member_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MajorBusinessCombinationMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorBusinessCombinationMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_MajorBusinessCombinationMember_lbl" xml:lang="en-US">Forecast [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MajorBusinessCombinationMember" xlink:to="ifrs-full_MajorBusinessCombinationMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioForecastMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_ScenarioForecastMember_lbl" xml:lang="en-US">Forecast [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioForecastMember" xlink:to="srt_ScenarioForecastMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComponentsOfEquityDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComponentsOfEquityDomain_lbl" xml:lang="en-US">Components of equity [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComponentsOfEquityDomain" xlink:to="ifrs-full_ComponentsOfEquityDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfChangesInEquityTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfChangesInEquityTable_lbl" xml:lang="en-US">Statement of changes in equity [table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfChangesInEquityTable" xlink:to="ifrs-full_StatementOfChangesInEquityTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfChangesInEquityLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfChangesInEquityLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfChangesInEquityLineItems_lbl" xml:lang="en-US">Statement of changes in equity [line items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_StatementOfChangesInEquityLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfRisksDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfRisksDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TypesOfRisksDomain_lbl" xml:lang="en-US">Types of risks [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TypesOfRisksDomain" xlink:to="ifrs-full_TypesOfRisksDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable_lbl" xml:lang="en-US">Disclosure of risk management strategy related to hedge accounting [table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable" xlink:to="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingLineItems_lbl" xml:lang="en-US">FINANCIAL INSTRUMENTS - RISK MANAGEMENT</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingLineItems" xlink:to="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ConsolidatedStructuredEntitiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ConsolidatedStructuredEntitiesDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ConsolidatedStructuredEntitiesDomain_lbl" xml:lang="en-US">Consolidated structured entities [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesDomain" xlink:to="ifrs-full_ConsolidatedStructuredEntitiesDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AccountingStandardsandBasisofPreparationScheduleofInformationrelatedtoCompanysShareofVotingRightsinitsSubsidiariesDetailsTable" xlink:href="mlec-20250630.xsd#mlec_AccountingStandardsandBasisofPreparationScheduleofInformationrelatedtoCompanysShareofVotingRightsinitsSubsidiariesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AccountingStandardsandBasisofPreparationScheduleofInformationrelatedtoCompanysShareofVotingRightsinitsSubsidiariesDetailsTable_lbl" xml:lang="en-US">Accounting Standards and Basis of Preparation - Schedule of Information related to Company&#8217;s Share of Voting Rights in its Subsidiaries (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AccountingStandardsandBasisofPreparationScheduleofInformationrelatedtoCompanysShareofVotingRightsinitsSubsidiariesDetailsTable" xlink:to="mlec_AccountingStandardsandBasisofPreparationScheduleofInformationrelatedtoCompanysShareofVotingRightsinitsSubsidiariesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_lbl" xml:lang="en-US">Schedule of Information related to Company&#8217;s Share of Voting Rights in its Subsidiaries [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain_lbl" xml:lang="en-US">Transactions recognised separately from acquisition of assets and assumption of liabilities in business combination [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain" xlink:to="ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofFairValueoftheConsiderationofPaymentDetailsTable" xlink:href="mlec-20250630.xsd#mlec_AcquisitionsandOtherSignificantTransactionsScheduleofFairValueoftheConsiderationofPaymentDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofFairValueoftheConsiderationofPaymentDetailsTable_lbl" xml:lang="en-US">Acquisitions and Other Significant Transactions - Schedule of Fair Value of the Consideration of Payment (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofFairValueoftheConsiderationofPaymentDetailsTable" xlink:to="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofFairValueoftheConsiderationofPaymentDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofFairValueoftheConsiderationofPaymentDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_AcquisitionsandOtherSignificantTransactionsScheduleofFairValueoftheConsiderationofPaymentDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofFairValueoftheConsiderationofPaymentDetailsLineItems_lbl" xml:lang="en-US">Disclosure of detailed information about business combination [line items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofFairValueoftheConsiderationofPaymentDetailsLineItems" xlink:to="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofFairValueoftheConsiderationofPaymentDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsTable" xlink:href="mlec-20250630.xsd#mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsTable_lbl" xml:lang="en-US">Acquisitions and Other Significant Transactions - Schedule of Assets Acquired and Liabilities Assumed (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsTable" xlink:to="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems_lbl" xml:lang="en-US">Disclosure of detailed information about business combination [line items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfAssetsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfAssetsDomain_lbl" xml:lang="en-US">Classes of assets [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfAssetsDomain" xlink:to="ifrs-full_ClassesOfAssetsDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofOtherFinancialAssetsDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofOtherFinancialAssetsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofOtherFinancialAssetsDetailsTable_lbl" xml:lang="en-US">Information About Components of Consolidated Statements of Financial Position - Schedule of Other Financial Assets (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofOtherFinancialAssetsDetailsTable" xlink:to="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofOtherFinancialAssetsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems_lbl" xml:lang="en-US">Disclosure of fair value measurement of assets [line items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems" xlink:to="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_IfrsBalanceSheetLocationDomainDomain" xlink:href="mlec-20250630.xsd#mlec_IfrsBalanceSheetLocationDomainDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_IfrsBalanceSheetLocationDomainDomain_lbl" xml:lang="en-US">IfrsBalanceSheetLocationDomain [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IfrsBalanceSheetLocationDomainDomain" xlink:to="mlec_IfrsBalanceSheetLocationDomainDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofTradeReceivablesDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofTradeReceivablesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofTradeReceivablesDetailsTable_lbl" xml:lang="en-US">Information About Components of Consolidated Statements of Financial Position - Schedule of Trade Receivables (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofTradeReceivablesDetailsTable" xlink:to="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofTradeReceivablesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofTradeReceivablesDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofTradeReceivablesDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofTradeReceivablesDetailsLineItems_lbl" xml:lang="en-US">Information About Components of Consolidated Statements of Financial Position - Schedule of Trade Receivables (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofTradeReceivablesDetailsLineItems" xlink:to="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofTradeReceivablesDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofOtherReceivablesDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofOtherReceivablesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofOtherReceivablesDetailsTable_lbl" xml:lang="en-US">Information About Components of Consolidated Statements of Financial Position - Schedule of Other Receivables (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofOtherReceivablesDetailsTable" xlink:to="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofOtherReceivablesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfOtherReceivablesLineItems" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfOtherReceivablesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfOtherReceivablesLineItems_lbl" xml:lang="en-US">Schedule of Other Receivables [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfOtherReceivablesLineItems" xlink:to="mlec_ScheduleOfOtherReceivablesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BiologicalAssetsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BiologicalAssetsDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BiologicalAssetsDomain_lbl" xml:lang="en-US">Biological assets [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BiologicalAssetsDomain" xlink:to="ifrs-full_BiologicalAssetsDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofInventoriesDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofInventoriesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofInventoriesDetailsTable_lbl" xml:lang="en-US">Information About Components of Consolidated Statements of Financial Position - Schedule of Inventories (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofInventoriesDetailsTable" xlink:to="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofInventoriesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InventoriesScheduleOfInventoriesLineItems" xlink:href="mlec-20250630.xsd#mlec_InventoriesScheduleOfInventoriesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InventoriesScheduleOfInventoriesLineItems_lbl" xml:lang="en-US">InventoriesSchedule of Inventories [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InventoriesScheduleOfInventoriesLineItems" xlink:to="mlec_InventoriesScheduleOfInventoriesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinBiologicalAssetsDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinBiologicalAssetsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinBiologicalAssetsDetailsTable_lbl" xml:lang="en-US">Information About Components of Consolidated Statements of Financial Position - Schedule of Changes in Biological Assets (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinBiologicalAssetsDetailsTable" xlink:to="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinBiologicalAssetsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems_lbl" xml:lang="en-US">Schedule of Changes in Biological Assets [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_lbl" xml:lang="en-US">Classes of property, plant and equipment [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofPropertyPlantandEquipmentDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofPropertyPlantandEquipmentDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofPropertyPlantandEquipmentDetailsTable_lbl" xml:lang="en-US">Information About Components of Consolidated Statements of Financial Position - Schedule of Property, Plant and Equipment (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofPropertyPlantandEquipmentDetailsTable" xlink:to="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofPropertyPlantandEquipmentDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Schedule of Property, Plant and Equipment [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_lbl0" xml:lang="en-US">Schedule of Carrying Amounts that Would Have Been Recognized [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_lbl" xml:lang="en-US">Classes of intangible assets other than goodwill [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofIntangibleAssetsDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofIntangibleAssetsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofIntangibleAssetsDetailsTable_lbl" xml:lang="en-US">Information About Components of Consolidated Statements of Financial Position - Schedule of&#8203; Intangible Assets (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofIntangibleAssetsDetailsTable" xlink:to="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofIntangibleAssetsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems_lbl" xml:lang="en-US">Schedule of&#8203; Intangible Assets [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesDomain_lbl" xml:lang="en-US">Subsidiaries [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:to="ifrs-full_SignificantInvestmentsInSubsidiariesDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGoodwillDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGoodwillDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGoodwillDetailsTable_lbl" xml:lang="en-US">Information About Components of Consolidated Statements of Financial Position - Schedule of Goodwill (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGoodwillDetailsTable" xlink:to="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGoodwillDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_lbl" xml:lang="en-US">Schedule of Goodwill [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems" xlink:to="ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BorrowingsByNameDomain_lbl" xml:lang="en-US">Borrowings by name [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BorrowingsByNameDomain" xlink:to="ifrs-full_BorrowingsByNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofBorrowingsDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofBorrowingsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofBorrowingsDetailsTable_lbl" xml:lang="en-US">Information About Components of Consolidated Statements of Financial Position - Schedule of Borrowings (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofBorrowingsDetailsTable" xlink:to="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofBorrowingsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_lbl" xml:lang="en-US">Schedule of Borrowings [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MeasurementDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MeasurementDomain_lbl" xml:lang="en-US">Measurement [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MeasurementDomain" xlink:to="ifrs-full_MeasurementDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofBorrowingsCarryingAmountDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofBorrowingsCarryingAmountDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofBorrowingsCarryingAmountDetailsTable_lbl" xml:lang="en-US">Information About Components of Consolidated Statements of Financial Position - Schedule of Borrowings, Carrying Amount (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofBorrowingsCarryingAmountDetailsTable" xlink:to="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofBorrowingsCarryingAmountDetailsTable_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_lbl0" xml:lang="en-US">Schedule of Borrowings, Carrying Amount [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofConvertibleNotesDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofConvertibleNotesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofConvertibleNotesDetailsTable_lbl" xml:lang="en-US">Information About Components of Consolidated Statements of Financial Position - Schedule of Convertible Notes (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofConvertibleNotesDetailsTable" xlink:to="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofConvertibleNotesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofConvertibleNotesDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofConvertibleNotesDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofConvertibleNotesDetailsLineItems_lbl" xml:lang="en-US">Information About Components of Consolidated Statements of Financial Position - Schedule of Convertible Notes (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofConvertibleNotesDetailsLineItems" xlink:to="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofConvertibleNotesDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfOtherProvisionsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfOtherProvisionsDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfOtherProvisionsDomain_lbl" xml:lang="en-US">Classes of other provisions [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfOtherProvisionsDomain" xlink:to="ifrs-full_ClassesOfOtherProvisionsDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsTable_lbl" xml:lang="en-US">Information About Components of Consolidated Statements of Financial Position - Schedule of Changes in Allowances and Provisions (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsTable" xlink:to="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsLineItems_lbl" xml:lang="en-US">Schedule of Changes in Allowances and Provisions [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsLineItems" xlink:to="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofProvisionsDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofProvisionsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofProvisionsDetailsTable_lbl" xml:lang="en-US">Information About Components of Consolidated Statements of Financial Position - Schedule of Provisions (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofProvisionsDetailsTable" xlink:to="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofProvisionsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofProvisionsDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofProvisionsDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofProvisionsDetailsLineItems_lbl" xml:lang="en-US">Information About Components of Consolidated Statements of Financial Position - Schedule of Provisions (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofProvisionsDetailsLineItems" xlink:to="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofProvisionsDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGovernmentGrantsDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGovernmentGrantsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGovernmentGrantsDetailsTable_lbl" xml:lang="en-US">Information About Components of Consolidated Statements of Financial Position - Schedule of Government Grants (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGovernmentGrantsDetailsTable" xlink:to="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGovernmentGrantsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGovernmentGrantsDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGovernmentGrantsDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGovernmentGrantsDetailsLineItems_lbl" xml:lang="en-US">Information About Components of Consolidated Statements of Financial Position - Schedule of Government Grants (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGovernmentGrantsDetailsLineItems" xlink:to="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGovernmentGrantsDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_lbl" xml:lang="en-US">Attribution of expenses by nature to their function [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain" xlink:to="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofExpensesClassifiedbyNatureandFunctionDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofExpensesClassifiedbyNatureandFunctionDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofExpensesClassifiedbyNatureandFunctionDetailsTable_lbl" xml:lang="en-US">Information about Component of Consolidated Statements of Comprehensive Income - Schedule of Expenses Classified by Nature and Function (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofExpensesClassifiedbyNatureandFunctionDetailsTable" xlink:to="mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofExpensesClassifiedbyNatureandFunctionDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems_lbl" xml:lang="en-US">Schedule of Expenses Classified by Nature and Function [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofFinanceResultsDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofFinanceResultsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofFinanceResultsDetailsTable_lbl" xml:lang="en-US">Information about Component of Consolidated Statements of Comprehensive Income - Schedule of Finance Results (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofFinanceResultsDetailsTable" xlink:to="mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofFinanceResultsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofFinanceResultsDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofFinanceResultsDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofFinanceResultsDetailsLineItems_lbl" xml:lang="en-US">Information about Component of Consolidated Statements of Comprehensive Income - Schedule of Finance Results (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofFinanceResultsDetailsLineItems" xlink:to="mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofFinanceResultsDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_lbl" xml:lang="en-US">Temporary difference, unused tax losses and unused tax credits [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:to="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_TaxationScheduleofDeferredTaxAssetsandLiabilitiesDetailsTable" xlink:href="mlec-20250630.xsd#mlec_TaxationScheduleofDeferredTaxAssetsandLiabilitiesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_TaxationScheduleofDeferredTaxAssetsandLiabilitiesDetailsTable_lbl" xml:lang="en-US">Taxation - Schedule of Deferred Tax Assets and Liabilities (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TaxationScheduleofDeferredTaxAssetsandLiabilitiesDetailsTable" xlink:to="mlec_TaxationScheduleofDeferredTaxAssetsandLiabilitiesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_TaxationScheduleofDeferredTaxAssetsandLiabilitiesDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_TaxationScheduleofDeferredTaxAssetsandLiabilitiesDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_TaxationScheduleofDeferredTaxAssetsandLiabilitiesDetailsLineItems_lbl" xml:lang="en-US">Taxation - Schedule of Deferred Tax Assets and Liabilities (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TaxationScheduleofDeferredTaxAssetsandLiabilitiesDetailsLineItems" xlink:to="mlec_TaxationScheduleofDeferredTaxAssetsandLiabilitiesDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_TaxationScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesDetailsTable" xlink:href="mlec-20250630.xsd#mlec_TaxationScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_TaxationScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesDetailsTable_lbl" xml:lang="en-US">Taxation - Schedule of Roll Forward of Deferred Tax Assets and Liabilities (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TaxationScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesDetailsTable" xlink:to="mlec_TaxationScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_lbl" xml:lang="en-US">Taxation [LIne Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_TaxJurisdictionDomainDomain" xlink:href="mlec-20250630.xsd#mlec_TaxJurisdictionDomainDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_TaxJurisdictionDomainDomain_lbl" xml:lang="en-US">TaxJurisdictionDomain [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TaxJurisdictionDomainDomain" xlink:to="mlec_TaxJurisdictionDomainDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_TaxationScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceDetailsTable" xlink:href="mlec-20250630.xsd#mlec_TaxationScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_TaxationScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceDetailsTable_lbl" xml:lang="en-US">Taxation - Schedule of Income Tax Expense Calculated by Applying Tax Rate in Force (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TaxationScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceDetailsTable" xlink:to="mlec_TaxationScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_TaxationScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_TaxationScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_TaxationScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceDetailsLineItems_lbl" xml:lang="en-US">Taxation - Schedule of Income Tax Expense Calculated by Applying Tax Rate in Force (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TaxationScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceDetailsLineItems" xlink:to="mlec_TaxationScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsDomain_lbl" xml:lang="en-US">Underlying equity instrument and depositary receipts [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsDomain" xlink:to="ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_EarningPerShareScheduleofEarningPerShareDetailsTable" xlink:href="mlec-20250630.xsd#mlec_EarningPerShareScheduleofEarningPerShareDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_EarningPerShareScheduleofEarningPerShareDetailsTable_lbl" xml:lang="en-US">Earning Per Share - Schedule of Earning Per Share (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_EarningPerShareScheduleofEarningPerShareDetailsTable" xlink:to="mlec_EarningPerShareScheduleofEarningPerShareDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EarningsPerShareLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EarningsPerShareLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EarningsPerShareLineItems_lbl" xml:lang="en-US">Schedule of Earning Per Share [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EarningsPerShareLineItems" xlink:to="ifrs-full_EarningsPerShareLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfShareCapitalDomain_lbl" xml:lang="en-US">Classes of share capital [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfShareCapitalDomain" xlink:to="ifrs-full_ClassesOfShareCapitalDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationaboutComponentsofEquityScheduleofNumberofSharesIssuedDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationaboutComponentsofEquityScheduleofNumberofSharesIssuedDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InformationaboutComponentsofEquityScheduleofNumberofSharesIssuedDetailsTable_lbl" xml:lang="en-US">Information about Components of Equity - Schedule of Number of Shares Issued (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofNumberofSharesIssuedDetailsTable" xlink:to="mlec_InformationaboutComponentsofEquityScheduleofNumberofSharesIssuedDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfNumberOfSharesIssuedLineItems" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfNumberOfSharesIssuedLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfNumberOfSharesIssuedLineItems_lbl" xml:lang="en-US">Schedule of Number of Shares Issued [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfNumberOfSharesIssuedLineItems" xlink:to="mlec_ScheduleOfNumberOfSharesIssuedLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationaboutComponentsofEquityScheduleofSubsidiariesNonControllingInterestDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationaboutComponentsofEquityScheduleofSubsidiariesNonControllingInterestDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InformationaboutComponentsofEquityScheduleofSubsidiariesNonControllingInterestDetailsTable_lbl" xml:lang="en-US">Information about Components of Equity - Schedule of Subsidiaries Non-Controlling Interest (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofSubsidiariesNonControllingInterestDetailsTable" xlink:to="mlec_InformationaboutComponentsofEquityScheduleofSubsidiariesNonControllingInterestDetailsTable_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_lbl0" xml:lang="en-US">Summarized financial information [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsTable_lbl" xml:lang="en-US">Information about Components of Equity - Schedule of Financial Statements (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsTable" xlink:to="mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems_lbl" xml:lang="en-US">Information about Components of Equity - Schedule of Financial Statements (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsTable_lbl" xml:lang="en-US">Information about Components of Equity - Schedule of Bioceres SA and Bioceres Crop Solutions (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsTable" xlink:to="mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems_lbl" xml:lang="en-US">Information about Components of Equity - Schedule of Bioceres SA and Bioceres Crop Solutions (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ConsolidatedEntitiesDomain_lbl" xml:lang="en-US">Consolidated Entities [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="srt_ConsolidatedEntitiesDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsTable" xlink:href="mlec-20250630.xsd#mlec_CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsTable_lbl" xml:lang="en-US">Cash Flow Information - Schedule of Significant Non-Cash Transactions Related to Investing and Financing Activities (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsTable" xlink:to="mlec_CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsLineItems_lbl" xml:lang="en-US">Schedule of Significant Non-Cash Transactions Related to Investing and Financing Activities [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsLineItems" xlink:to="mlec_CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_lbl" xml:lang="en-US">Liabilities arising from financing activities [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_CashFlowInformationScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesDetailsTable" xlink:href="mlec-20250630.xsd#mlec_CashFlowInformationScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_CashFlowInformationScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesDetailsTable_lbl" xml:lang="en-US">Cash Flow Information - Schedule of Changes in Liabilities Arising from Financing Activities (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CashFlowInformationScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesDetailsTable" xlink:to="mlec_CashFlowInformationScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesLineItems_lbl" xml:lang="en-US">Schedule of Changes in Liabilities Arising from Financing Activities [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:to="mlec_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_JointVenturesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_JointVenturesDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_JointVenturesDomain_lbl" xml:lang="en-US">Joint ventures [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_JointVenturesDomain" xlink:to="ifrs-full_JointVenturesDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_JointVenturesandAssociatesScheduleofJointVenturesAssetsDetailsTable" xlink:href="mlec-20250630.xsd#mlec_JointVenturesandAssociatesScheduleofJointVenturesAssetsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_JointVenturesandAssociatesScheduleofJointVenturesAssetsDetailsTable_lbl" xml:lang="en-US">Joint Ventures and Associates - Schedule of Joint Ventures Assets (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_JointVenturesandAssociatesScheduleofJointVenturesAssetsDetailsTable" xlink:to="mlec_JointVenturesandAssociatesScheduleofJointVenturesAssetsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_JointVenturesandAssociatesScheduleofJointVenturesAssetsDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_JointVenturesandAssociatesScheduleofJointVenturesAssetsDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_JointVenturesandAssociatesScheduleofJointVenturesAssetsDetailsLineItems_lbl" xml:lang="en-US">Joint Ventures and Associates - Schedule of Joint Ventures Assets (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_JointVenturesandAssociatesScheduleofJointVenturesAssetsDetailsLineItems" xlink:to="mlec_JointVenturesandAssociatesScheduleofJointVenturesAssetsDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain_lbl" xml:lang="en-US">Categories of related parties [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsTable" xlink:href="mlec-20250630.xsd#mlec_JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsTable_lbl" xml:lang="en-US">Joint Ventures and Associates - Schedule of Changes in Joint Ventures Investments and Affiliates (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsTable" xlink:to="mlec_JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsLineItems_lbl" xml:lang="en-US">Schedule of Changes in Joint Ventures Investments and Affiliates [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsLineItems" xlink:to="mlec_JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfJointVenturesTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfJointVenturesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfJointVenturesTable_lbl" xml:lang="en-US">Disclosure of joint ventures [table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfJointVenturesTable" xlink:to="ifrs-full_DisclosureOfJointVenturesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfJointVenturesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfJointVenturesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfJointVenturesLineItems_lbl" xml:lang="en-US">Schedule of Joint Ventures Assets [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfJointVenturesLineItems" xlink:to="ifrs-full_DisclosureOfJointVenturesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyDomain_lbl" xml:lang="en-US">Related and Nonrelated Parties [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_JointVenturesandAssociatesScheduleofSignificantJointVenturesDetailsTable" xlink:href="mlec-20250630.xsd#mlec_JointVenturesandAssociatesScheduleofSignificantJointVenturesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_JointVenturesandAssociatesScheduleofSignificantJointVenturesDetailsTable_lbl" xml:lang="en-US">Joint Ventures and Associates - Schedule of Significant Joint Ventures (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_JointVenturesandAssociatesScheduleofSignificantJointVenturesDetailsTable" xlink:to="mlec_JointVenturesandAssociatesScheduleofSignificantJointVenturesDetailsTable_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfJointVenturesLineItems_lbl0" xml:lang="en-US">Schedule of Significant Joint Ventures [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfJointVenturesLineItems" xlink:to="ifrs-full_DisclosureOfJointVenturesLineItems_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SegmentsDomain_lbl" xml:lang="en-US">Segments [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SegmentsDomain" xlink:to="ifrs-full_SegmentsDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SegmentInformationScheduleofOperatingResultsGroupsReportingSegmentsDetailsTable" xlink:href="mlec-20250630.xsd#mlec_SegmentInformationScheduleofOperatingResultsGroupsReportingSegmentsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SegmentInformationScheduleofOperatingResultsGroupsReportingSegmentsDetailsTable_lbl" xml:lang="en-US">Segment Information - Schedule of Operating Results Group&apos;s Reporting Segments (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SegmentInformationScheduleofOperatingResultsGroupsReportingSegmentsDetailsTable" xlink:to="mlec_SegmentInformationScheduleofOperatingResultsGroupsReportingSegmentsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsLineItems_lbl" xml:lang="en-US">Schedule of Reporting Segments [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:to="ifrs-full_DisclosureOfOperatingSegmentsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProductsAndServicesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProductsAndServicesDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProductsAndServicesDomain_lbl" xml:lang="en-US">Products and services [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProductsAndServicesDomain" xlink:to="ifrs-full_ProductsAndServicesDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SegmentInformationScheduleofRevenuebySimilarGroupofProductsorServicesDetailsTable" xlink:href="mlec-20250630.xsd#mlec_SegmentInformationScheduleofRevenuebySimilarGroupofProductsorServicesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SegmentInformationScheduleofRevenuebySimilarGroupofProductsorServicesDetailsTable_lbl" xml:lang="en-US">Segment Information - Schedule of Revenue by Similar Group of Products or Services (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SegmentInformationScheduleofRevenuebySimilarGroupofProductsorServicesDetailsTable" xlink:to="mlec_SegmentInformationScheduleofRevenuebySimilarGroupofProductsorServicesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfProductsAndServicesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfProductsAndServicesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfProductsAndServicesLineItems_lbl" xml:lang="en-US">Schedule of Revenue by Similar Group of Products or Services [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfProductsAndServicesLineItems" xlink:to="ifrs-full_DisclosureOfProductsAndServicesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeographicalAreasDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GeographicalAreasDomain_lbl" xml:lang="en-US">Geographical areas [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GeographicalAreasDomain" xlink:to="ifrs-full_GeographicalAreasDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SegmentInformationScheduleofGeographicalInformationDetailsTable" xlink:href="mlec-20250630.xsd#mlec_SegmentInformationScheduleofGeographicalInformationDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SegmentInformationScheduleofGeographicalInformationDetailsTable_lbl" xml:lang="en-US">Segment Information - Schedule of Geographical Information (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SegmentInformationScheduleofGeographicalInformationDetailsTable" xlink:to="mlec_SegmentInformationScheduleofGeographicalInformationDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfGeographicalInformationLineItems" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfGeographicalInformationLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfGeographicalInformationLineItems_lbl" xml:lang="en-US">Schedule of Geographical Information [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfGeographicalInformationLineItems" xlink:to="mlec_ScheduleOfGeographicalInformationLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfFinancialLiabilitiesDomain_lbl" xml:lang="en-US">Classes of financial liabilities [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:to="ifrs-full_ClassesOfFinancialLiabilitiesDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MaturityDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MaturityDomain_lbl" xml:lang="en-US">Maturity [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MaturityDomain" xlink:to="ifrs-full_MaturityDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialInstrumentsRiskManagementScheduleofLiquidityRiskDetailsTable" xlink:href="mlec-20250630.xsd#mlec_FinancialInstrumentsRiskManagementScheduleofLiquidityRiskDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FinancialInstrumentsRiskManagementScheduleofLiquidityRiskDetailsTable_lbl" xml:lang="en-US">Financial Instruments &#8211; Risk Management - Schedule of Liquidity Risk (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialInstrumentsRiskManagementScheduleofLiquidityRiskDetailsTable" xlink:to="mlec_FinancialInstrumentsRiskManagementScheduleofLiquidityRiskDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems_lbl" xml:lang="en-US">Schedule of Liquidity Risk [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:to="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialInstrumentsRiskManagementScheduleofCurrencyRiskDetailsTable" xlink:href="mlec-20250630.xsd#mlec_FinancialInstrumentsRiskManagementScheduleofCurrencyRiskDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FinancialInstrumentsRiskManagementScheduleofCurrencyRiskDetailsTable_lbl" xml:lang="en-US">Financial Instruments &#8211; Risk Management - Schedule of Currency Risk (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialInstrumentsRiskManagementScheduleofCurrencyRiskDetailsTable" xlink:to="mlec_FinancialInstrumentsRiskManagementScheduleofCurrencyRiskDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialInstrumentsRiskManagementScheduleofCurrencyRiskDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_FinancialInstrumentsRiskManagementScheduleofCurrencyRiskDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FinancialInstrumentsRiskManagementScheduleofCurrencyRiskDetailsLineItems_lbl" xml:lang="en-US">Financial Instruments &#8211; Risk Management - Schedule of Currency Risk (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialInstrumentsRiskManagementScheduleofCurrencyRiskDetailsLineItems" xlink:to="mlec_FinancialInstrumentsRiskManagementScheduleofCurrencyRiskDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialInstrumentsRiskManagementScheduleofInterestRateRiskDetailsTable" xlink:href="mlec-20250630.xsd#mlec_FinancialInstrumentsRiskManagementScheduleofInterestRateRiskDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FinancialInstrumentsRiskManagementScheduleofInterestRateRiskDetailsTable_lbl" xml:lang="en-US">Financial Instruments &#8211; Risk Management - Schedule of Interest Rate Risk (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialInstrumentsRiskManagementScheduleofInterestRateRiskDetailsTable" xlink:to="mlec_FinancialInstrumentsRiskManagementScheduleofInterestRateRiskDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems_lbl" xml:lang="en-US">Schedule of Interest Rate Risk [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems" xlink:to="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialAssetsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfFinancialAssetsDomain_lbl" xml:lang="en-US">Classes of financial assets [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfFinancialAssetsDomain" xlink:to="ifrs-full_ClassesOfFinancialAssetsDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialInstrumentsRiskManagementScheduleofFinancialAssetsbyCategoryDetailsTable" xlink:href="mlec-20250630.xsd#mlec_FinancialInstrumentsRiskManagementScheduleofFinancialAssetsbyCategoryDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FinancialInstrumentsRiskManagementScheduleofFinancialAssetsbyCategoryDetailsTable_lbl" xml:lang="en-US">Financial Instruments &#8211; Risk Management - Schedule of Financial Assets by Category (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialInstrumentsRiskManagementScheduleofFinancialAssetsbyCategoryDetailsTable" xlink:to="mlec_FinancialInstrumentsRiskManagementScheduleofFinancialAssetsbyCategoryDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialAssetsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinancialAssetsLineItems_lbl" xml:lang="en-US">Schedule of Financial Assets by Category [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialAssetsLineItems" xlink:to="ifrs-full_DisclosureOfFinancialAssetsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialInstrumentsRiskManagementScheduleofFinancialLiabilitiesbyCategoryDetailsTable" xlink:href="mlec-20250630.xsd#mlec_FinancialInstrumentsRiskManagementScheduleofFinancialLiabilitiesbyCategoryDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FinancialInstrumentsRiskManagementScheduleofFinancialLiabilitiesbyCategoryDetailsTable_lbl" xml:lang="en-US">Financial Instruments &#8211; Risk Management - Schedule of Financial Liabilities by Category (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialInstrumentsRiskManagementScheduleofFinancialLiabilitiesbyCategoryDetailsTable" xlink:to="mlec_FinancialInstrumentsRiskManagementScheduleofFinancialLiabilitiesbyCategoryDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialLiabilitiesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_lbl" xml:lang="en-US">Schedule of Financial Liabilities by Category [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesLineItems" xlink:to="ifrs-full_DisclosureOfFinancialLiabilitiesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LevelsOfFairValueHierarchyDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LevelsOfFairValueHierarchyDomain_lbl" xml:lang="en-US">Levels of fair value hierarchy [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LevelsOfFairValueHierarchyDomain" xlink:to="ifrs-full_LevelsOfFairValueHierarchyDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialInstrumentsRiskManagementScheduleofFairValuebyHierarchyDetailsTable" xlink:href="mlec-20250630.xsd#mlec_FinancialInstrumentsRiskManagementScheduleofFairValuebyHierarchyDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FinancialInstrumentsRiskManagementScheduleofFairValuebyHierarchyDetailsTable_lbl" xml:lang="en-US">Financial Instruments &#8211; Risk Management - Schedule of Fair Value by Hierarchy (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialInstrumentsRiskManagementScheduleofFairValuebyHierarchyDetailsTable" xlink:to="mlec_FinancialInstrumentsRiskManagementScheduleofFairValuebyHierarchyDetailsTable_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems_lbl0" xml:lang="en-US">Schedule of Fair Value by Hierarchy [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems" xlink:to="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CarryingAmountMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CarryingAmountMember_lbl" xml:lang="en-US">Carrying amount [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CarryingAmountMember" xlink:to="ifrs-full_CarryingAmountMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsTable" xlink:href="mlec-20250630.xsd#mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsTable_lbl" xml:lang="en-US">Leases - Schedule of Right-of-Use and Liabilities Related with Lease Assets (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsTable" xlink:to="mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems_lbl" xml:lang="en-US">Leases - Schedule of Right-of-Use and Liabilities Related with Lease Assets (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:to="mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsDomain_lbl" xml:lang="en-US">Classes of financial instruments [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:to="ifrs-full_ClassesOfFinancialInstrumentsDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareholdersandOtherRelatedPartiesBalancesandTransactionsScheduleofTransactionsBetweentheGroupandRelatedPartiesDetailsTable" xlink:href="mlec-20250630.xsd#mlec_ShareholdersandOtherRelatedPartiesBalancesandTransactionsScheduleofTransactionsBetweentheGroupandRelatedPartiesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ShareholdersandOtherRelatedPartiesBalancesandTransactionsScheduleofTransactionsBetweentheGroupandRelatedPartiesDetailsTable_lbl" xml:lang="en-US">Shareholders and Other Related Parties Balances and Transactions - Schedule of Transactions Between the Group and Related Parties (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareholdersandOtherRelatedPartiesBalancesandTransactionsScheduleofTransactionsBetweentheGroupandRelatedPartiesDetailsTable" xlink:to="mlec_ShareholdersandOtherRelatedPartiesBalancesandTransactionsScheduleofTransactionsBetweentheGroupandRelatedPartiesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_lbl" xml:lang="en-US">Schedule of Transactions Between the Group and Related Parties [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_lbl" xml:lang="en-US">Types of share-based payment arrangements [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareBasedPaymentScheduleofFairValueoftheStockOptionsattheGrantDateDetailsTable" xlink:href="mlec-20250630.xsd#mlec_ShareBasedPaymentScheduleofFairValueoftheStockOptionsattheGrantDateDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ShareBasedPaymentScheduleofFairValueoftheStockOptionsattheGrantDateDetailsTable_lbl" xml:lang="en-US">Share-Based Payment - Schedule of Fair Value of the Stock Options at the Grant Date (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareBasedPaymentScheduleofFairValueoftheStockOptionsattheGrantDateDetailsTable" xlink:to="mlec_ShareBasedPaymentScheduleofFairValueoftheStockOptionsattheGrantDateDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_lbl" xml:lang="en-US">Schedule of Fair Value of the Stock Options at the Grant Date [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RangeDomain_lbl" xml:lang="en-US">Range [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RangeDomain" xlink:to="ifrs-full_RangeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareBasedPaymentScheduleofRangeofAssumptionswhichhaveDeterminedDetailsTable" xlink:href="mlec-20250630.xsd#mlec_ShareBasedPaymentScheduleofRangeofAssumptionswhichhaveDeterminedDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ShareBasedPaymentScheduleofRangeofAssumptionswhichhaveDeterminedDetailsTable_lbl" xml:lang="en-US">Share-Based Payment - Schedule of Range of Assumptions which have Determined (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareBasedPaymentScheduleofRangeofAssumptionswhichhaveDeterminedDetailsTable" xlink:to="mlec_ShareBasedPaymentScheduleofRangeofAssumptionswhichhaveDeterminedDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems_lbl" xml:lang="en-US">Schedule of Range of Assumptions which have Determined [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems" xlink:to="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareBasedPaymentScheduleofOptionActivityandWeightedAverageExercisePriceDetailsTable" xlink:href="mlec-20250630.xsd#mlec_ShareBasedPaymentScheduleofOptionActivityandWeightedAverageExercisePriceDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ShareBasedPaymentScheduleofOptionActivityandWeightedAverageExercisePriceDetailsTable_lbl" xml:lang="en-US">Share-Based Payment - Schedule of Option Activity and Weighted Average Exercise Price (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareBasedPaymentScheduleofOptionActivityandWeightedAverageExercisePriceDetailsTable" xlink:to="mlec_ShareBasedPaymentScheduleofOptionActivityandWeightedAverageExercisePriceDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_lbl" xml:lang="en-US">Schedule of Option Activity and Weighted Average Exercise Price [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ReverseStockSplitAftertheReportingPeriodScheduleofWeightedAverageNumberofOrdinarySharesOutstandingDetailsTable" xlink:href="mlec-20250630.xsd#mlec_ReverseStockSplitAftertheReportingPeriodScheduleofWeightedAverageNumberofOrdinarySharesOutstandingDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ReverseStockSplitAftertheReportingPeriodScheduleofWeightedAverageNumberofOrdinarySharesOutstandingDetailsTable_lbl" xml:lang="en-US">Reverse Stock Split After the Reporting Period - Schedule of Weighted Average Number of Ordinary Shares Outstanding (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ReverseStockSplitAftertheReportingPeriodScheduleofWeightedAverageNumberofOrdinarySharesOutstandingDetailsTable" xlink:to="mlec_ReverseStockSplitAftertheReportingPeriodScheduleofWeightedAverageNumberofOrdinarySharesOutstandingDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ReverseStockSplitAftertheReportingPeriodScheduleofWeightedAverageNumberofOrdinarySharesOutstandingDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_ReverseStockSplitAftertheReportingPeriodScheduleofWeightedAverageNumberofOrdinarySharesOutstandingDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ReverseStockSplitAftertheReportingPeriodScheduleofWeightedAverageNumberofOrdinarySharesOutstandingDetailsLineItems_lbl" xml:lang="en-US">Reverse Stock Split After the Reporting Period - Schedule of Weighted Average Number of Ordinary Shares Outstanding (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ReverseStockSplitAftertheReportingPeriodScheduleofWeightedAverageNumberofOrdinarySharesOutstandingDetailsLineItems" xlink:to="mlec_ReverseStockSplitAftertheReportingPeriodScheduleofWeightedAverageNumberofOrdinarySharesOutstandingDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofIntangibleAssetsandLiabilitiesAssumedDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofIntangibleAssetsandLiabilitiesAssumedDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofIntangibleAssetsandLiabilitiesAssumedDetailsTable_lbl" xml:lang="en-US">Information About Components of Consolidated Statements of Financial Position - Schedule of Intangible Assets and Liabilities Assumed (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofIntangibleAssetsandLiabilitiesAssumedDetailsTable" xlink:to="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofIntangibleAssetsandLiabilitiesAssumedDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfIntangibleAssetsAndLiabilitiesAssumedLineItems" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfIntangibleAssetsAndLiabilitiesAssumedLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfIntangibleAssetsAndLiabilitiesAssumedLineItems_lbl" xml:lang="en-US">Schedule of Intangible Assets and Liabilities Assumed [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfIntangibleAssetsAndLiabilitiesAssumedLineItems" xlink:to="mlec_ScheduleOfIntangibleAssetsAndLiabilitiesAssumedLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable_lbl" xml:lang="en-US">Cybersecurity Risk Management, Strategy, and Governance [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems_lbl" xml:lang="en-US">Cybersecurity Risk Management, Strategy, and Governance [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BusinessCombinationsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BusinessCombinationsDomain_lbl" xml:lang="en-US">Business combinations [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BusinessCombinationsDomain" xlink:to="ifrs-full_BusinessCombinationsDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfOrdinarySharesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfOrdinarySharesDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfOrdinarySharesDomain_lbl" xml:lang="en-US">Classes of ordinary shares [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfOrdinarySharesDomain" xlink:to="ifrs-full_ClassesOfOrdinarySharesDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_lbl" xml:lang="en-US">Non-adjusting events after reporting period [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:to="ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_TheGroupsBusinessReorganizationandGeneralInformationDetailsTable" xlink:href="mlec-20250630.xsd#mlec_TheGroupsBusinessReorganizationandGeneralInformationDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_TheGroupsBusinessReorganizationandGeneralInformationDetailsTable_lbl" xml:lang="en-US">The Group&#8217;s Business Reorganization and General Information (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TheGroupsBusinessReorganizationandGeneralInformationDetailsTable" xlink:to="mlec_TheGroupsBusinessReorganizationandGeneralInformationDetailsTable_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_lbl1" xml:lang="en-US">The Group&#8217;s Business Reorganization and General Information [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_AccountingStandardsandBasisofPreparationDetailsTable" xlink:href="mlec-20250630.xsd#mlec_AccountingStandardsandBasisofPreparationDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AccountingStandardsandBasisofPreparationDetailsTable_lbl" xml:lang="en-US">Accounting Standards and Basis of Preparation (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AccountingStandardsandBasisofPreparationDetailsTable" xlink:to="mlec_AccountingStandardsandBasisofPreparationDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AccountingStandardsandBasisofPreparationDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_AccountingStandardsandBasisofPreparationDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AccountingStandardsandBasisofPreparationDetailsLineItems_lbl" xml:lang="en-US">Accounting Standards and Basis of Preparation [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AccountingStandardsandBasisofPreparationDetailsLineItems" xlink:to="mlec_AccountingStandardsandBasisofPreparationDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InitiallyAppliedIFRSsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InitiallyAppliedIFRSsDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InitiallyAppliedIFRSsDomain_lbl" xml:lang="en-US">Initially applied IFRSs [domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InitiallyAppliedIFRSsDomain" xlink:to="ifrs-full_InitiallyAppliedIFRSsDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NewStandardsAmendmentsandInterpretationsIssuedbytheIASBDetailsTable" xlink:href="mlec-20250630.xsd#mlec_NewStandardsAmendmentsandInterpretationsIssuedbytheIASBDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NewStandardsAmendmentsandInterpretationsIssuedbytheIASBDetailsTable_lbl" xml:lang="en-US">New Standards, Amendments and Interpretations Issued by the IASB (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NewStandardsAmendmentsandInterpretationsIssuedbytheIASBDetailsTable" xlink:to="mlec_NewStandardsAmendmentsandInterpretationsIssuedbytheIASBDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems_lbl" xml:lang="en-US">New Standards, Amendments and Interpretations Issued by the IASB [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems" xlink:to="ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeMember_lbl" xml:lang="en-US">Statistical Measurement [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:href="mlec-20250630.xsd#mlec_SummaryofSignificantAccountingPoliciesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SummaryofSignificantAccountingPoliciesDetailsTable_lbl" xml:lang="en-US">Summary of Significant Accounting Policies (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="mlec_SummaryofSignificantAccountingPoliciesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_lbl" xml:lang="en-US">Summary of Significant Accounting Policies [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AcquisitionsandOtherSignificantTransactionsDetailsTable" xlink:href="mlec-20250630.xsd#mlec_AcquisitionsandOtherSignificantTransactionsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AcquisitionsandOtherSignificantTransactionsDetailsTable_lbl" xml:lang="en-US">Acquisitions and Other Significant Transactions (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AcquisitionsandOtherSignificantTransactionsDetailsTable" xlink:to="mlec_AcquisitionsandOtherSignificantTransactionsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfBusinessCombinationsLineItems_lbl" xml:lang="en-US">Disclosure of detailed information about business combination [line items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:to="ifrs-full_DisclosureOfBusinessCombinationsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsTable_lbl" xml:lang="en-US">Information About Components of Consolidated Statements of Financial Position (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsTable" xlink:to="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems_lbl" xml:lang="en-US">Information About Components of Consolidated Statements of Financial Position [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeDetailsTable_lbl" xml:lang="en-US">Information about Component of Consolidated Statements of Comprehensive Income (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeDetailsTable" xlink:to="mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationAboutComponentOfConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentOfConsolidatedStatementsOfComprehensiveIncomeLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InformationAboutComponentOfConsolidatedStatementsOfComprehensiveIncomeLineItems_lbl" xml:lang="en-US">Information about Component of Consolidated Statements of Comprehensive Income [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InformationAboutComponentOfConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="mlec_InformationAboutComponentOfConsolidatedStatementsOfComprehensiveIncomeLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationaboutComponentsofEquityDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationaboutComponentsofEquityDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InformationaboutComponentsofEquityDetailsTable_lbl" xml:lang="en-US">Information about Components of Equity (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InformationaboutComponentsofEquityDetailsTable" xlink:to="mlec_InformationaboutComponentsofEquityDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InformationaboutComponentsofEquityDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_InformationaboutComponentsofEquityDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InformationaboutComponentsofEquityDetailsLineItems_lbl" xml:lang="en-US">Information about Components of Equity (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InformationaboutComponentsofEquityDetailsLineItems" xlink:to="mlec_InformationaboutComponentsofEquityDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_SegmentGeographicalDomain_lbl" xml:lang="en-US">Geographical [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_SegmentGeographicalDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_JointVenturesandAssociatesDetailsTable" xlink:href="mlec-20250630.xsd#mlec_JointVenturesandAssociatesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_JointVenturesandAssociatesDetailsTable_lbl" xml:lang="en-US">Joint Ventures and Associates (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_JointVenturesandAssociatesDetailsTable" xlink:to="mlec_JointVenturesandAssociatesDetailsTable_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfJointVenturesLineItems_lbl1" xml:lang="en-US">Joint Ventures and Associates [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfJointVenturesLineItems" xlink:to="ifrs-full_DisclosureOfJointVenturesLineItems_lbl1"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioUnspecifiedDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioUnspecifiedDomain_lbl" xml:lang="en-US">Scenario [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioUnspecifiedDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareBasedPaymentDetailsTable" xlink:href="mlec-20250630.xsd#mlec_ShareBasedPaymentDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ShareBasedPaymentDetailsTable_lbl" xml:lang="en-US">Share-Based Payment (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareBasedPaymentDetailsTable" xlink:to="mlec_ShareBasedPaymentDetailsTable_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_lbl0" xml:lang="en-US">Share-Based Payment [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_EventsOccurringAftertheReportingPeriodDetailsTable" xlink:href="mlec-20250630.xsd#mlec_EventsOccurringAftertheReportingPeriodDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_EventsOccurringAftertheReportingPeriodDetailsTable_lbl" xml:lang="en-US">Events Occurring After the Reporting Period (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_EventsOccurringAftertheReportingPeriodDetailsTable" xlink:to="mlec_EventsOccurringAftertheReportingPeriodDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_EventsOccurringAftertheReportingPeriodDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_EventsOccurringAftertheReportingPeriodDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_EventsOccurringAftertheReportingPeriodDetailsLineItems_lbl" xml:lang="en-US">Events Occurring After the Reporting Period [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_EventsOccurringAftertheReportingPeriodDetailsLineItems" xlink:to="mlec_EventsOccurringAftertheReportingPeriodDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ReverseStockSplitAftertheReportingPeriodDetailsTable" xlink:href="mlec-20250630.xsd#mlec_ReverseStockSplitAftertheReportingPeriodDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ReverseStockSplitAftertheReportingPeriodDetailsTable_lbl" xml:lang="en-US">Reverse Stock Split After the Reporting Period (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ReverseStockSplitAftertheReportingPeriodDetailsTable" xlink:to="mlec_ReverseStockSplitAftertheReportingPeriodDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ReverseStockSplitAftertheReportingPeriodDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_ReverseStockSplitAftertheReportingPeriodDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ReverseStockSplitAftertheReportingPeriodDetailsLineItems_lbl" xml:lang="en-US">Reverse Stock Split After the Reporting Period (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ReverseStockSplitAftertheReportingPeriodDetailsLineItems" xlink:to="mlec_ReverseStockSplitAftertheReportingPeriodDetailsLineItems_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_AccumulatedDepreciationAtTheEndOfThePeriod_lbl0" xml:lang="en-US">Accumulated depreciation at the end of the year.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AccumulatedDepreciationAtTheEndOfThePeriod" xlink:to="mlec_AccumulatedDepreciationAtTheEndOfThePeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_AdditionalConvertibleNotesReceivedAmount_lbl0" xml:lang="en-US">Additional convertible notes received amount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AdditionalConvertibleNotesReceivedAmount" xlink:to="mlec_AdditionalConvertibleNotesReceivedAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_AdditionalOrdinarySharesIssue_lbl0" xml:lang="en-US">Additional ordinary shares issue.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AdditionalOrdinarySharesIssue" xlink:to="mlec_AdditionalOrdinarySharesIssue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_AdditionsFromBusinessCombination_lbl0" xml:lang="en-US">Additions from business combination.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AdditionsFromBusinessCombination" xlink:to="mlec_AdditionsFromBusinessCombination_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_AdditionsFromBusinessCombinations_lbl0" xml:lang="en-US">The amount of additions from business combinations.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AdditionsFromBusinessCombinations" xlink:to="mlec_AdditionsFromBusinessCombinations_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_AdditionsToLeaseLiabilityFromBusinessCombination_lbl0" xml:lang="en-US">Additions from business combination.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AdditionsToLeaseLiabilityFromBusinessCombination" xlink:to="mlec_AdditionsToLeaseLiabilityFromBusinessCombination_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_AdditionsWarrantsForTheYear_lbl0" xml:lang="en-US">Amount of additions of warrants for the year.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AdditionsWarrantsForTheYear" xlink:to="mlec_AdditionsWarrantsForTheYear_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_AdjustmentsForDecreaseIncreaseInGovernmentGrants_lbl0" xml:lang="en-US">Adjustments for decrease (increase) in government grants to reconcile profit (loss) to net cash flow from (used in) operating activities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AdjustmentsForDecreaseIncreaseInGovernmentGrants" xlink:to="mlec_AdjustmentsForDecreaseIncreaseInGovernmentGrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_AggregateAmount_lbl0" xml:lang="en-US">Aggregate amount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AggregateAmount" xlink:to="mlec_AggregateAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_AllowanceForImpairmentOfTradeDebtors_lbl0" xml:lang="en-US">Allowance for impairment of trade debtors.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AllowanceForImpairmentOfTradeDebtors" xlink:to="mlec_AllowanceForImpairmentOfTradeDebtors_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_AllowanceForObsolescences_lbl0" xml:lang="en-US">Allowance for obsolescence.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AllowanceForObsolescences" xlink:to="mlec_AllowanceForObsolescences_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_AllowanceForReturnOfGoods_lbl0" xml:lang="en-US">The amount of allowance for return of goods.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AllowanceForReturnOfGoods" xlink:to="mlec_AllowanceForReturnOfGoods_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_AllowancesAndProvisionsUsedAndReversed_lbl0" xml:lang="en-US">The amount used and reversed (i.e. incurrent and charged against the provision) for allowances and provisions.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AllowancesAndProvisionsUsedAndReversed" xlink:to="mlec_AllowancesAndProvisionsUsedAndReversed_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_AmortizationOfIntangibleAsset_lbl0" xml:lang="en-US">Amortization of intangible assets.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AmortizationOfIntangibleAsset" xlink:to="mlec_AmortizationOfIntangibleAsset_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_AmortizationOfTheYear_lbl0" xml:lang="en-US">Amortization of the year.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AmortizationOfTheYear" xlink:to="mlec_AmortizationOfTheYear_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_AmortizationPayments_lbl0" xml:lang="en-US">The amount of amortization payments.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AmortizationPayments" xlink:to="mlec_AmortizationPayments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_AmountOfFinancialDebtUnderRestructuring_lbl0" xml:lang="en-US">Represent the amount of financial debt under restructuring.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AmountOfFinancialDebtUnderRestructuring" xlink:to="mlec_AmountOfFinancialDebtUnderRestructuring_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_AnalysisAndStorage_lbl0" xml:lang="en-US">Amount of analysis and storage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AnalysisAndStorage" xlink:to="mlec_AnalysisAndStorage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ArgentinePriceIndexShares_lbl0" xml:lang="en-US">Argentine price index shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ArgentinePriceIndexShares" xlink:to="mlec_ArgentinePriceIndexShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_AssignmentOfReceivablesWithShareholdersAndOtherRelatedParties_lbl0" xml:lang="en-US">Assignment of receivables with shareholders and other related parties.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AssignmentOfReceivablesWithShareholdersAndOtherRelatedParties" xlink:to="mlec_AssignmentOfReceivablesWithShareholdersAndOtherRelatedParties_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_AveragePaymentTermBySales_lbl0" xml:lang="en-US">Average payment terms range at consolidate level from sale of materials.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AveragePaymentTermBySales" xlink:to="mlec_AveragePaymentTermBySales_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_BookValueAtTheBeginningOfThePeriod_lbl0" xml:lang="en-US">Book value at the beginning of the year.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BookValueAtTheBeginningOfThePeriod" xlink:to="mlec_BookValueAtTheBeginningOfThePeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_BorrowingInterestRateInCash_lbl0" xml:lang="en-US">The interest rate on borrowings payable in cash.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BorrowingInterestRateInCash" xlink:to="mlec_BorrowingInterestRateInCash_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_BorrowingInterestRateInKind_lbl0" xml:lang="en-US">The interest rate on borrowings payable in kind.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BorrowingInterestRateInKind" xlink:to="mlec_BorrowingInterestRateInKind_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_CapitalizationOfConvertibleFinancingActivities_lbl0" xml:lang="en-US">The cash inflow effect of capitalization of convertible notes.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CapitalizationOfConvertibleFinancingActivities" xlink:to="mlec_CapitalizationOfConvertibleFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ChangeInAllowanceAndProvisionLossOfControl_lbl0" xml:lang="en-US">Represents the amount of change in allowance and provisions of loss of control.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ChangeInAllowanceAndProvisionLossOfControl" xlink:to="mlec_ChangeInAllowanceAndProvisionLossOfControl_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ChangeInFairValueOfFinancialAssetsOrLiabilitiesOrOtherFinancialResults_lbl0" xml:lang="en-US">Changes in fair value of financial assets or liabilities and other financial results.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ChangeInFairValueOfFinancialAssetsOrLiabilitiesOrOtherFinancialResults" xlink:to="mlec_ChangeInFairValueOfFinancialAssetsOrLiabilitiesOrOtherFinancialResults_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ChangeInNetRealizableValueOfAgricultural_lbl0" xml:lang="en-US">Change in the net realizable value of agricultural products after harvest.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ChangeInNetRealizableValueOfAgricultural" xlink:to="mlec_ChangeInNetRealizableValueOfAgricultural_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ChangeinJointVenturesDividendsDistribution_lbl0" xml:lang="en-US">The amount of Dividends distribution.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ChangeinJointVenturesDividendsDistribution" xlink:to="mlec_ChangeinJointVenturesDividendsDistribution_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ChangesInEquityInterest_lbl0" xml:lang="en-US">The amount of Changes in equity interest.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ChangesInEquityInterest" xlink:to="mlec_ChangesInEquityInterest_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_CommonEquity_lbl0" xml:lang="en-US">The amoun of common equity.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CommonEquity" xlink:to="mlec_CommonEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_CompensationPaymentFinancedByAcquisitionOfIntangibleAssets_lbl0" xml:lang="en-US">Compensation payment financed by acquisition of intangible assets.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CompensationPaymentFinancedByAcquisitionOfIntangibleAssets" xlink:to="mlec_CompensationPaymentFinancedByAcquisitionOfIntangibleAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl0" xml:lang="en-US">Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="mlec_ComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ConsecutiveBusinessDays_lbl0" xml:lang="en-US">Consecutive business days.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ConsecutiveBusinessDays" xlink:to="mlec_ConsecutiveBusinessDays_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ConsiderationForAcquisitionOfAssets_lbl0" xml:lang="en-US">Repersent the amount of consideration for acquisition of assets.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ConsiderationForAcquisitionOfAssets" xlink:to="mlec_ConsiderationForAcquisitionOfAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ConsiderationForAcquisitionOfAssetsCurrent_lbl0" xml:lang="en-US">The amount of consideration for acquisition of assets recognised as of balance sheet date, classified as current.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ConsiderationForAcquisitionOfAssetsCurrent" xlink:to="mlec_ConsiderationForAcquisitionOfAssetsCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ConsiderationForAcquisitionOfAssetsNonCurrent_lbl0" xml:lang="en-US">The amount of consideration for acquisition of assets recognised as of balance sheet date, classified as non-current.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ConsiderationForAcquisitionOfAssetsNonCurrent" xlink:to="mlec_ConsiderationForAcquisitionOfAssetsNonCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ConsiderationForIssuedOrdinaryShareValue_lbl0" xml:lang="en-US">The number of shares in consideration for issued ordinary share value.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ConsiderationForIssuedOrdinaryShareValue" xlink:to="mlec_ConsiderationForIssuedOrdinaryShareValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_Contingencies_lbl0" xml:lang="en-US">The amount of contingencies.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_Contingencies" xlink:to="mlec_Contingencies_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ContingentPayment_lbl0" xml:lang="en-US">Contingent payment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ContingentPayment" xlink:to="mlec_ContingentPayment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ContingentPaymentCurrent_lbl0" xml:lang="en-US">Contingent payment current.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ContingentPaymentCurrent" xlink:to="mlec_ContingentPaymentCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ContingentPurchasePrice_lbl0" xml:lang="en-US">Contingent purchase price.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ContingentPurchasePrice" xlink:to="mlec_ContingentPurchasePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ConversionOptionStrikePrice_lbl0" xml:lang="en-US">Conversion option strike price.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ConversionOptionStrikePrice" xlink:to="mlec_ConversionOptionStrikePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ConvertibleNotes_lbl0" xml:lang="en-US">Convertible notes.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ConvertibleNotes" xlink:to="mlec_ConvertibleNotes_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_CreditorsPublicAuctionShares_lbl0" xml:lang="en-US">Credit public auction shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CreditorsPublicAuctionShares" xlink:to="mlec_CreditorsPublicAuctionShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_CumulativeInflationRate_lbl0" xml:lang="en-US">CumulativeInflation rate.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CumulativeInflationRate" xlink:to="mlec_CumulativeInflationRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_CurrentTradeReceivablesAllowanceForImpairmentOfTradeDebtors_lbl0" xml:lang="en-US">Represents the amount of current trade receivables of allowance for impairment of trade debtors.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CurrentTradeReceivablesAllowanceForImpairmentOfTradeDebtors" xlink:to="mlec_CurrentTradeReceivablesAllowanceForImpairmentOfTradeDebtors_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_CurrentTradeReceivablesShareholdersAndOtherRelatedParties_lbl0" xml:lang="en-US">Represents the amount of current trade receivables of shareholders and other related parties.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CurrentTradeReceivablesShareholdersAndOtherRelatedParties" xlink:to="mlec_CurrentTradeReceivablesShareholdersAndOtherRelatedParties_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_CurrentTradeReceivablesTradeDebtorsJointVenturesAndAssociates_lbl0" xml:lang="en-US">Represents the amount of trade debtors - joint ventures and associates.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CurrentTradeReceivablesTradeDebtorsJointVenturesAndAssociates" xlink:to="mlec_CurrentTradeReceivablesTradeDebtorsJointVenturesAndAssociates_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DecreaseBecauseOfLossOfControl_lbl0" xml:lang="en-US">Decrease because of loss of control.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DecreaseBecauseOfLossOfControl" xlink:to="mlec_DecreaseBecauseOfLossOfControl_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DecreaseDueToHarvestAndDisposalsBiologicalAssets_lbl0" xml:lang="en-US">The decrease in biological assets due to the detachment of produce from the assets or the cessation of the assets&apos; life processes and disposals.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DecreaseDueToHarvestAndDisposalsBiologicalAssets" xlink:to="mlec_DecreaseDueToHarvestAndDisposalsBiologicalAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DecreaseThroughCapitalizationOfDebtLiabilitiesArisingFromFinancingActivities_lbl0" xml:lang="en-US">The decrease in liabilities arising from financing activities resulting from capitalization of debt.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DecreaseThroughCapitalizationOfDebtLiabilitiesArisingFromFinancingActivities" xlink:to="mlec_DecreaseThroughCapitalizationOfDebtLiabilitiesArisingFromFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets_lbl0" xml:lang="en-US">he decrease in intangible assets resulting from the loss of control of a subsidiary.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets" xlink:to="mlec_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities_lbl0" xml:lang="en-US">The decrease in liabilities arising from financing activities resulting from payments.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities" xlink:to="mlec_DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DepreciationOfLeasedAssets_lbl0" xml:lang="en-US">The amount of depreciation of leased assets.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DepreciationOfLeasedAssets" xlink:to="mlec_DepreciationOfLeasedAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DepreciationOfThePeriod_lbl0" xml:lang="en-US">Depreciation of the year.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DepreciationOfThePeriod" xlink:to="mlec_DepreciationOfThePeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DerecognitionOfDeferredTaxAssets_lbl0" xml:lang="en-US">Derecognition of deferred tax assets.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DerecognitionOfDeferredTaxAssets" xlink:to="mlec_DerecognitionOfDeferredTaxAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation_lbl0" xml:lang="en-US">The description of accounting policy for basis of consolidation.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation" xlink:to="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DescriptionOfAccountingPolicyForConvertibleNotesTextBlock_lbl0" xml:lang="en-US">The description of the entity&apos;s accounting policy for convertible notes.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DescriptionOfAccountingPolicyForConvertibleNotesTextBlock" xlink:to="mlec_DescriptionOfAccountingPolicyForConvertibleNotesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DescriptionOfAccountingPolicyForFinancialAssetsAndLiabilitiesPolicyTextBlock_lbl0" xml:lang="en-US">The description of the entity&apos;s material accounting policy information for financial assets and liabilities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DescriptionOfAccountingPolicyForFinancialAssetsAndLiabilitiesPolicyTextBlock" xlink:to="mlec_DescriptionOfAccountingPolicyForFinancialAssetsAndLiabilitiesPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DescriptionOfAccountingPolicyForWarrantLiabilities_lbl0" xml:lang="en-US">Description of accounting policy for warrant liabilities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DescriptionOfAccountingPolicyForWarrantLiabilities" xlink:to="mlec_DescriptionOfAccountingPolicyForWarrantLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DisclosureOfBenefitsAndSocialSecurityPayablesTableTextBlock_lbl0" xml:lang="en-US">The tabular disclosure of salaries and social security payables.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfBenefitsAndSocialSecurityPayablesTableTextBlock" xlink:to="mlec_DisclosureOfBenefitsAndSocialSecurityPayablesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DisclosureOfCarryingValueOfBorrowingsExplanatory_lbl0" xml:lang="en-US">The disclosure of detailed information about carrying value of borrowings.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfCarryingValueOfBorrowingsExplanatory" xlink:to="mlec_DisclosureOfCarryingValueOfBorrowingsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DisclosureOfChangesInAllowancesAndProvisionsTableTextBlock_lbl0" xml:lang="en-US">The tabular disclosure of changes in allowances and provisions.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfChangesInAllowancesAndProvisionsTableTextBlock" xlink:to="mlec_DisclosureOfChangesInAllowancesAndProvisionsTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DisclosureOfChangesInInvestmentInJointVenturesAndAffiliatesTableTextBlock_lbl0" xml:lang="en-US">The disclosure of investments in joint ventures and affiliates.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfChangesInInvestmentInJointVenturesAndAffiliatesTableTextBlock" xlink:to="mlec_DisclosureOfChangesInInvestmentInJointVenturesAndAffiliatesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock_lbl0" xml:lang="en-US">The tabular disclosure of compensation of directors and other members of key management personnel.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock" xlink:to="mlec_DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DisclosureOfDepreciationIfAssetsHadBeenCarriedUnderCostModelTextBlock_lbl0" xml:lang="en-US">The disclosure of depreciation if the assets had ben carried under the cost model.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfDepreciationIfAssetsHadBeenCarriedUnderCostModelTextBlock" xlink:to="mlec_DisclosureOfDepreciationIfAssetsHadBeenCarriedUnderCostModelTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DisclosureOfFairValueOfTheStockOptionsAtTheGrantDateTextBlock_lbl0" xml:lang="en-US">Disclosure of fair value of the stock options at the grant date.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfFairValueOfTheStockOptionsAtTheGrantDateTextBlock" xlink:to="mlec_DisclosureOfFairValueOfTheStockOptionsAtTheGrantDateTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DisclosureOfForeignExchangeRiskSensitivityAnalysistextBlock_lbl0" xml:lang="en-US">Disclosure of foreign exchange risk sensitivity analysis.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfForeignExchangeRiskSensitivityAnalysistextBlock" xlink:to="mlec_DisclosureOfForeignExchangeRiskSensitivityAnalysistextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock_lbl0" xml:lang="en-US">The entire disclosure of information about components of consolidated statement of comprehensive income.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock" xlink:to="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock_lbl0" xml:lang="en-US">The disclosure of component of consolidated statement of financial positions.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock" xlink:to="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DisclosureOfIntangibleAssetsAndLiabilitiesAssumedTextBlock_lbl0" xml:lang="en-US">The disclosure of intangible assets and lianilities assumed.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfIntangibleAssetsAndLiabilitiesAssumedTextBlock" xlink:to="mlec_DisclosureOfIntangibleAssetsAndLiabilitiesAssumedTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DisclosureOfInvestmentsInJointVenturesAndAffiliatesTableTextBlock_lbl0" xml:lang="en-US">Information pertains to disclosure of investments in associates and joint ventures.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfInvestmentsInJointVenturesAndAffiliatesTableTextBlock" xlink:to="mlec_DisclosureOfInvestmentsInJointVenturesAndAffiliatesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DisclosureOfNumberOfSharesIssuedtextBlock_lbl0" xml:lang="en-US">The Disclosure of number of shares issued.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfNumberOfSharesIssuedtextBlock" xlink:to="mlec_DisclosureOfNumberOfSharesIssuedtextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DisclosureOfOtherFinancialAssetsExplanatory_lbl0" xml:lang="en-US">The disclosure of other financial assets.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfOtherFinancialAssetsExplanatory" xlink:to="mlec_DisclosureOfOtherFinancialAssetsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DisclosureOfOtherReceivablesTableTextBlock_lbl0" xml:lang="en-US">The disclosure of detailed information about other receivables.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfOtherReceivablesTableTextBlock" xlink:to="mlec_DisclosureOfOtherReceivablesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DisclosureOfShareOfProfitOrLossInJointVenturesAndAffiliatesTableTextBlock_lbl0" xml:lang="en-US">The disclosure of share of profit / (loss) joint ventures and affiliates.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfShareOfProfitOrLossInJointVenturesAndAffiliatesTableTextBlock" xlink:to="mlec_DisclosureOfShareOfProfitOrLossInJointVenturesAndAffiliatesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DisclosureOfTradeAndOtherPayablesComponentsTableTextBlock_lbl0" xml:lang="en-US">Definition: Tabular disclosure of components of trade and other payables.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfTradeAndOtherPayablesComponentsTableTextBlock" xlink:to="mlec_DisclosureOfTradeAndOtherPayablesComponentsTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DisclosureOfTradeReceivablesTableTextBlock_lbl0" xml:lang="en-US">The tabular disclosure of current and non-current trade receivables.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfTradeReceivablesTableTextBlock" xlink:to="mlec_DisclosureOfTradeReceivablesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DisclosureOfWarrantsTextBlock_lbl0" xml:lang="en-US">The entire disclosure of warrants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfWarrantsTextBlock" xlink:to="mlec_DisclosureOfWarrantsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DisclosuresOfDeferredRevenueAndAdvancesFromCustomersTableTextBlock_lbl0" xml:lang="en-US">The tabular disclosure of deferred revenue and advances from customers.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosuresOfDeferredRevenueAndAdvancesFromCustomersTableTextBlock" xlink:to="mlec_DisclosuresOfDeferredRevenueAndAdvancesFromCustomersTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DiscountRateForFairValueOfLiabilityComponent_lbl0" xml:lang="en-US">The discount rate used to measure the fair value of the liability component of an instrument.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DiscountRateForFairValueOfLiabilityComponent" xlink:to="mlec_DiscountRateForFairValueOfLiabilityComponent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DisposalsDepreciation_lbl0" xml:lang="en-US">Disposals.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisposalsDepreciation" xlink:to="mlec_DisposalsDepreciation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DisposalsPropertyPlantAndEquipments_lbl0" xml:lang="en-US">The decrease in property, plant and equipment resulting from disposals. [Refer: Property, plant and equipment]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisposalsPropertyPlantAndEquipments" xlink:to="mlec_DisposalsPropertyPlantAndEquipments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DueToJointVenturesAndAssociatesNonCurrent_lbl0" xml:lang="en-US">The non-current amount due to joint ventures and associates.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DueToJointVenturesAndAssociatesNonCurrent" xlink:to="mlec_DueToJointVenturesAndAssociatesNonCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_EffectiveIncomeTaxRateReconciliationTableTextBlock_lbl0" xml:lang="en-US">Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_EffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="mlec_EffectiveIncomeTaxRateReconciliationTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_EnvironmentalImpactTreatment_lbl0" xml:lang="en-US">Environmental Impact Treatment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_EnvironmentalImpactTreatment" xlink:to="mlec_EnvironmentalImpactTreatment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_EquityMethodInvestmentIncreaseFromShareBasedIncentives_lbl0" xml:lang="en-US">The increase in the amount of investment accounted under equity method related to share-based incentives.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_EquityMethodInvestmentIncreaseFromShareBasedIncentives" xlink:to="mlec_EquityMethodInvestmentIncreaseFromShareBasedIncentives_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_EquityShares_lbl0" xml:lang="en-US">Equity shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_EquityShares" xlink:to="mlec_EquityShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ExchangeDifferencesDepreciation_lbl0" xml:lang="en-US">Exchange differences.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ExchangeDifferencesDepreciation" xlink:to="mlec_ExchangeDifferencesDepreciation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ExchangeOfIntangibleAssets_lbl0" xml:lang="en-US">The amount of exchange of intangible assets.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ExchangeOfIntangibleAssets" xlink:to="mlec_ExchangeOfIntangibleAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_FinancialCommissions_lbl0" xml:lang="en-US">Financial commissions.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialCommissions" xlink:to="mlec_FinancialCommissions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_FinancingForAssetsAcquisitions_lbl0" xml:lang="en-US">Increase decrease of Financing for assets acquisitions in financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancingForAssetsAcquisitions" xlink:to="mlec_FinancingForAssetsAcquisitions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ForeignCurrencyTranslationOnInventory_lbl0" xml:lang="en-US">Amount of foreign currency translation on inventory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ForeignCurrencyTranslationOnInventory" xlink:to="mlec_ForeignCurrencyTranslationOnInventory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_GainOnBargainPurchase_lbl0" xml:lang="en-US">Gain on bargain purchase.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_GainOnBargainPurchase" xlink:to="mlec_GainOnBargainPurchase_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_GainlossOfDerecognitionTransactions_lbl0" xml:lang="en-US">Amount of gain (loss) on derecognition transactions.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_GainlossOfDerecognitionTransactions" xlink:to="mlec_GainlossOfDerecognitionTransactions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_GainlossOfRecognitionTransactions_lbl0" xml:lang="en-US">Amount of gain (loss) on recognition transactions.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_GainlossOfRecognitionTransactions" xlink:to="mlec_GainlossOfRecognitionTransactions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_GainsLossesOnExchangeDifferencesOnTranslationFromJointVentureNetOfTax_lbl0" xml:lang="en-US">The gains (losses) recognised in other comprehensive income on exchange differences on the translation from joint venture of financial statements of foreign operations, net of tax.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_GainsLossesOnExchangeDifferencesOnTranslationFromJointVentureNetOfTax" xlink:to="mlec_GainsLossesOnExchangeDifferencesOnTranslationFromJointVentureNetOfTax_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_IfrsDebtInstrumentTerm_lbl0" xml:lang="en-US">Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS&apos; format, for example, &apos;P1Y5M13D&apos; represents the reported fact of one year, five months, and thirteen days.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IfrsDebtInstrumentTerm" xlink:to="mlec_IfrsDebtInstrumentTerm_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_IfrsDefinedContributionPlanEmployerMatchingContributionPercentOfEmployeesGrossPay_lbl0" xml:lang="en-US">Maximum percentage of employee&apos;s monthly compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IfrsDefinedContributionPlanEmployerMatchingContributionPercentOfEmployeesGrossPay" xlink:to="mlec_IfrsDefinedContributionPlanEmployerMatchingContributionPercentOfEmployeesGrossPay_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod_lbl0" xml:lang="en-US">Period over which grantee&apos;s right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in &apos;PnYnMnDTnHnMnS&apos; format, for example, &apos;P1Y5M13D&apos; represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod" xlink:to="mlec_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage_lbl0" xml:lang="en-US">Percentage of vesting of award under share-based payment arrangement.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage" xlink:to="mlec_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ImportAndExportExpenses_lbl0" xml:lang="en-US">Amount of import and export expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ImportAndExportExpenses" xlink:to="mlec_ImportAndExportExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_IncomeAndMinimumPresumedRecoverableIncomeTaxes_lbl0" xml:lang="en-US">The amount of income and minimum presumed recoverable income taxes.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IncomeAndMinimumPresumedRecoverableIncomeTaxes" xlink:to="mlec_IncomeAndMinimumPresumedRecoverableIncomeTaxes_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_IncomeTaxExpenseByApplyingApplicableTaxRateInForceInRespectiveJurisdictionsTableTextBlock_lbl0" xml:lang="en-US">Tabular disclosure of income tax expense was calculated by applying the tax rate in force in the respective jurisdictions and entities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IncomeTaxExpenseByApplyingApplicableTaxRateInForceInRespectiveJurisdictionsTableTextBlock" xlink:to="mlec_IncomeTaxExpenseByApplyingApplicableTaxRateInForceInRespectiveJurisdictionsTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_IncreaseDecreaseThroughChangesInBusinessCombinationEquity_lbl0" xml:lang="en-US">The increase (decrease) in equity through changes in business combination, equity.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IncreaseDecreaseThroughChangesInBusinessCombinationEquity" xlink:to="mlec_IncreaseDecreaseThroughChangesInBusinessCombinationEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_IncreaseThroughAcquisitionOfNonControllingInterestInSubsidiaries_lbl0" xml:lang="en-US">Acquisition of interest in subsidiaries by financed debts.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IncreaseThroughAcquisitionOfNonControllingInterestInSubsidiaries" xlink:to="mlec_IncreaseThroughAcquisitionOfNonControllingInterestInSubsidiaries_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities_lbl0" xml:lang="en-US">The increase in liabilities arising from financing activities resulting from new borrowings.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities" xlink:to="mlec_IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_InflationEffectsOnCashAndCashEquivalents_lbl0" xml:lang="en-US">The effect of inflation effects on cash and cash equivalents.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InflationEffectsOnCashAndCashEquivalents" xlink:to="mlec_InflationEffectsOnCashAndCashEquivalents_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_InflationOfAccumulatedYears_lbl0" xml:lang="en-US">The years of inflation accumulated.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InflationOfAccumulatedYears" xlink:to="mlec_InflationOfAccumulatedYears_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_InterestAccruedWithRelatedParties_lbl0" xml:lang="en-US">Interest accrued with related parties.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InterestAccruedWithRelatedParties" xlink:to="mlec_InterestAccruedWithRelatedParties_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_InventoriesBeforeClosingInventory_lbl0" xml:lang="en-US">Amount of inventory before closing inventory (i.e. Opening inventory plus purchases).</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InventoriesBeforeClosingInventory" xlink:to="mlec_InventoriesBeforeClosingInventory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_InventoriesCurrent_lbl0" xml:lang="en-US">Inventories.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InventoriesCurrent" xlink:to="mlec_InventoriesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_InventoriesExcludingAgriculturalProduce_lbl0" xml:lang="en-US">The amount of current inventories excluding agricultural produce.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InventoriesExcludingAgriculturalProduce" xlink:to="mlec_InventoriesExcludingAgriculturalProduce_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_InventoriesFromBusinessCombination_lbl0" xml:lang="en-US">Additions to inventories as results of business combination.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InventoriesFromBusinessCombination" xlink:to="mlec_InventoriesFromBusinessCombination_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_InventoriesNetOfAgriculturalProducts_lbl0" xml:lang="en-US">Represent the amount of inventories net of agricultural products.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InventoriesNetOfAgriculturalProducts" xlink:to="mlec_InventoriesNetOfAgriculturalProducts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_InventoryProductionCosts_lbl0" xml:lang="en-US">The amount of manufacturing costs capitalized to inventory during the period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InventoryProductionCosts" xlink:to="mlec_InventoryProductionCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_InventoryRecognizedAsExpense_lbl0" xml:lang="en-US">The total amount of inventory recognized as expense.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InventoryRecognizedAsExpense" xlink:to="mlec_InventoryRecognizedAsExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity_lbl1" xml:lang="en-US">The amount of investments accounted for using the equity method, including an investee with negative equity.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity" xlink:to="mlec_InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_InvestmentInKindInOtherRelatedPartiesNonCashTransactionsInvestmentActivities_lbl0" xml:lang="en-US">The amount of investment in kind in other related parties, non cash transactions investment activities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InvestmentInKindInOtherRelatedPartiesNonCashTransactionsInvestmentActivities" xlink:to="mlec_InvestmentInKindInOtherRelatedPartiesNonCashTransactionsInvestmentActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_InvestmentsInJointVenturesAndAssociates_lbl0" xml:lang="en-US">The amount of investments accounted for using the equity method, asset position.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InvestmentsInJointVenturesAndAssociates" xlink:to="mlec_InvestmentsInJointVenturesAndAssociates_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_InvestmentsMeasuredAtFairValue_lbl0" xml:lang="en-US">Investments measured at fair value.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InvestmentsMeasuredAtFairValue" xlink:to="mlec_InvestmentsMeasuredAtFairValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_IssuanceOfShare_lbl0" xml:lang="en-US">The amount of issuance of shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IssuanceOfShare" xlink:to="mlec_IssuanceOfShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_IssuedConvertiblePreferenceShares_lbl0" xml:lang="en-US">The number of issued convertible preference shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IssuedConvertiblePreferenceShares" xlink:to="mlec_IssuedConvertiblePreferenceShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ItemsThatWillNotBeSubsequentlyReclassifiedToLossAndProfit_lbl0" xml:lang="en-US">Items that will not be subsequently reclassified to loss and profit.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ItemsThatWillNotBeSubsequentlyReclassifiedToLossAndProfit" xlink:to="mlec_ItemsThatWillNotBeSubsequentlyReclassifiedToLossAndProfit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_JointVenturesAndAssociatesAccountedForUsingEquityMethodReclassificationChangeInOwnership_lbl0" xml:lang="en-US">The amount of associates and joint ventures accounted for using equity method reclassified from equity method due to change in ownership.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_JointVenturesAndAssociatesAccountedForUsingEquityMethodReclassificationChangeInOwnership" xlink:to="mlec_JointVenturesAndAssociatesAccountedForUsingEquityMethodReclassificationChangeInOwnership_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_JointVenturesAndAssociatesLiabilities_lbl0" xml:lang="en-US">Represent the amount of joint ventures and associates.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_JointVenturesAndAssociatesLiabilities" xlink:to="mlec_JointVenturesAndAssociatesLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_KeyManagementPersonnelBenefitsLiabilityCurrent_lbl0" xml:lang="en-US">The amount of current liability related to key management personnel.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_KeyManagementPersonnelBenefitsLiabilityCurrent" xlink:to="mlec_KeyManagementPersonnelBenefitsLiabilityCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_LeaseLiabilitiesInterestExpenseExchangeDifferencesAndInflationEffects_lbl0" xml:lang="en-US">Lease liabilities additions from interest expense, exchange differences and inflation effects.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LeaseLiabilitiesInterestExpenseExchangeDifferencesAndInflationEffects" xlink:to="mlec_LeaseLiabilitiesInterestExpenseExchangeDifferencesAndInflationEffects_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_LeaseLiabilityBeginningOfTheYearinception_lbl0" xml:lang="en-US">The amount of lease liability beginning of the year/inception.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LeaseLiabilityBeginningOfTheYearinception" xlink:to="mlec_LeaseLiabilityBeginningOfTheYearinception_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_LeaseLiabiltyAdditionsOfTheYear_lbl0" xml:lang="en-US">The amount of addition of the lease liablity.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LeaseLiabiltyAdditionsOfTheYear" xlink:to="mlec_LeaseLiabiltyAdditionsOfTheYear_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_LeasingLiabilities_lbl0" xml:lang="en-US">Leasing liabilities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LeasingLiabilities" xlink:to="mlec_LeasingLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_LicensesandPatents_lbl0" xml:lang="en-US">Licenses &amp; Patents.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LicensesandPatents" xlink:to="mlec_LicensesandPatents_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_LossOfControl_lbl0" xml:lang="en-US">The amount of loss of control.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LossOfControl" xlink:to="mlec_LossOfControl_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_LossOfControlDepreciation_lbl0" xml:lang="en-US">Loss of control.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LossOfControlDepreciation" xlink:to="mlec_LossOfControlDepreciation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_LossOfControlLeaseLiability_lbl0" xml:lang="en-US">Loss of control.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LossOfControlLeaseLiability" xlink:to="mlec_LossOfControlLeaseLiability_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_LossOfControlonBiologicalAssets_lbl0" xml:lang="en-US">The amount of loss of control on biological assets.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LossOfControlonBiologicalAssets" xlink:to="mlec_LossOfControlonBiologicalAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_MaximumPercentageOfCapitalForObligationToLegalReserve_lbl0" xml:lang="en-US">The maximum percentage of capital establish an obligation to legal reserve on ability of the joint venture to transfer funds to the Group in the form of cash dividends, or to repay loans or advances made by the Group.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MaximumPercentageOfCapitalForObligationToLegalReserve" xlink:to="mlec_MaximumPercentageOfCapitalForObligationToLegalReserve_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_MutualFunds_lbl0" xml:lang="en-US">Mutual funds.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MutualFunds" xlink:to="mlec_MutualFunds_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_MutualFundsAdjustment_lbl0" xml:lang="en-US">Represent the amount of mutual funds adjustments.&#xd;
.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MutualFundsAdjustment" xlink:to="mlec_MutualFundsAdjustment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_NetAssetsAcquisitionByBusinessCombination_lbl0" xml:lang="en-US">The amount recognised as of the acquisition date for net assets acquired or liabilities assumed in a business combination.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NetAssetsAcquisitionByBusinessCombination" xlink:to="mlec_NetAssetsAcquisitionByBusinessCombination_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_NetGainOnInflationEffectOnMonetary_lbl0" xml:lang="en-US">Net gain of inflation effect on monetary items.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NetGainOnInflationEffectOnMonetary" xlink:to="mlec_NetGainOnInflationEffectOnMonetary_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_NetResultFromCommercializationOfAgriculturalProducts_lbl0" xml:lang="en-US">The amount of net result from commercialization of agricultural products.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NetResultFromCommercializationOfAgriculturalProducts" xlink:to="mlec_NetResultFromCommercializationOfAgriculturalProducts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_NonCashFinancingActivities_lbl0" xml:lang="en-US">The amount of non cash financing activities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NonCashFinancingActivities" xlink:to="mlec_NonCashFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_NonCashInvestingActivities_lbl0" xml:lang="en-US">The amount of non cash investing activities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NonCashInvestingActivities" xlink:to="mlec_NonCashInvestingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_NonMonetaryContributionsInJointVenturesNonCashTransactionsInvestmentActivities_lbl0" xml:lang="en-US">The amount of non-monetary contributions in joint ventures, non cash transactions investment activities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NonMonetaryContributionsInJointVenturesNonCashTransactionsInvestmentActivities" xlink:to="mlec_NonMonetaryContributionsInJointVenturesNonCashTransactionsInvestmentActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_NoncashActivities_lbl0" xml:lang="en-US">Non-cash activities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NoncashActivities" xlink:to="mlec_NoncashActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_NoncontrollingInterest_lbl0" xml:lang="en-US">The amount of non-controlling interest information components.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NoncontrollingInterest" xlink:to="mlec_NoncontrollingInterest_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_NoncurrentAsset_lbl0" xml:lang="en-US">Non-current assets.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NoncurrentAsset" xlink:to="mlec_NoncurrentAsset_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_NumberOfComplementaryComponents_lbl0" xml:lang="en-US">The number of complementary components of the segments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfComplementaryComponents" xlink:to="mlec_NumberOfComplementaryComponents_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_NumberOfNominalValue_lbl0" xml:lang="en-US">The per share of nominal value.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfNominalValue" xlink:to="mlec_NumberOfNominalValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_NumberOfOptionsEstimatedExercisePercent_lbl0" xml:lang="en-US">The estimate of share options that will be exercise, as a percent.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfOptionsEstimatedExercisePercent" xlink:to="mlec_NumberOfOptionsEstimatedExercisePercent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_NumberOfSharesAcquiredInBusinessCombination_lbl0" xml:lang="en-US">Represents the number of shares acquired in business combination.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfSharesAcquiredInBusinessCombination" xlink:to="mlec_NumberOfSharesAcquiredInBusinessCombination_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_NumberOfSharesOutstandingPercentage_lbl0" xml:lang="en-US">Percentage of number of shares outstanding.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfSharesOutstandingPercentage" xlink:to="mlec_NumberOfSharesOutstandingPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_NumberOfSharesPledged_lbl0" xml:lang="en-US">Total number of shares pledged.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfSharesPledged" xlink:to="mlec_NumberOfSharesPledged_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_NumberOfSharesReverseStockSplit_lbl0" xml:lang="en-US">Number of shares under reverse stock split.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfSharesReverseStockSplit" xlink:to="mlec_NumberOfSharesReverseStockSplit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_OtherCurrencies_lbl0" xml:lang="en-US">Represents the value of other currencies.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherCurrencies" xlink:to="mlec_OtherCurrencies_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_OtherIncomeOrExpensesNet_lbl0" xml:lang="en-US">Other income or expenses net.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherIncomeOrExpensesNet" xlink:to="mlec_OtherIncomeOrExpensesNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_OwnShareHeld_lbl0" xml:lang="en-US">Own shares held.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OwnShareHeld" xlink:to="mlec_OwnShareHeld_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_OwnSharesHeld_lbl0" xml:lang="en-US">Cost of own shares held.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OwnSharesHeld" xlink:to="mlec_OwnSharesHeld_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_PaymentsOfThePeriodLeaseliability_lbl0" xml:lang="en-US">Payments of the year.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PaymentsOfThePeriodLeaseliability" xlink:to="mlec_PaymentsOfThePeriodLeaseliability_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_PercentageGrossMargin_lbl0" xml:lang="en-US">Represents the value of gross margin.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageGrossMargin" xlink:to="mlec_PercentageGrossMargin_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_PercentageOfCapital_lbl0" xml:lang="en-US">Percentage of capital.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfCapital" xlink:to="mlec_PercentageOfCapital_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_PercentageOfCashPaymentInterestRate_lbl0" xml:lang="en-US">Percentage of cash payment interest rate.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfCashPaymentInterestRate" xlink:to="mlec_PercentageOfCashPaymentInterestRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_PercentageOfClosingPriceOnFirstAndLastBusinessDayToDeterminePurchasePrice_lbl0" xml:lang="en-US">Percentage of closing price of the Company&apos;s ordinary shares on the first business day and the last business day to determine purchase price.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfClosingPriceOnFirstAndLastBusinessDayToDeterminePurchasePrice" xlink:to="mlec_PercentageOfClosingPriceOnFirstAndLastBusinessDayToDeterminePurchasePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_PercentageOfCustomerRevenues_lbl0" xml:lang="en-US">The percentage of customer revenues.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfCustomerRevenues" xlink:to="mlec_PercentageOfCustomerRevenues_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_PercentageOfDividendsTaxedShares_lbl0" xml:lang="en-US">Percentage of dividends taxed shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfDividendsTaxedShares" xlink:to="mlec_PercentageOfDividendsTaxedShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_PercentageOfEstimatesThatDevaluationOrAnAppreciation_lbl0" xml:lang="en-US">Percentage of estimates that devaluation or an appreciation.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfEstimatesThatDevaluationOrAnAppreciation" xlink:to="mlec_PercentageOfEstimatesThatDevaluationOrAnAppreciation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_PercentageOfInflationAccumulated_lbl0" xml:lang="en-US">Percentage of Inflation accumulated.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfInflationAccumulated" xlink:to="mlec_PercentageOfInflationAccumulated_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_PercentageOfIssuedAndOutstandingEquityInterests_lbl0" xml:lang="en-US">Percentage of issued and outstanding equity interests.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfIssuedAndOutstandingEquityInterests" xlink:to="mlec_PercentageOfIssuedAndOutstandingEquityInterests_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_PercentageOfOutstandingAmountInitialInterestRate_lbl0" xml:lang="en-US">Percentage of outstanding amount initial interest rate.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfOutstandingAmountInitialInterestRate" xlink:to="mlec_PercentageOfOutstandingAmountInitialInterestRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_PercentageOfPenalty_lbl0" xml:lang="en-US">Percentage of penalty.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfPenalty" xlink:to="mlec_PercentageOfPenalty_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_PercentageOfPenaltyOfPrepayment_lbl0" xml:lang="en-US">Percentage of penalty of prepayment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfPenaltyOfPrepayment" xlink:to="mlec_PercentageOfPenaltyOfPrepayment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_PercentageOfPreferenceSharesAccrue_lbl0" xml:lang="en-US">Percentage of preference shares accrue.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfPreferenceSharesAccrue" xlink:to="mlec_PercentageOfPreferenceSharesAccrue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_PercentageOfPrepaymentPremium_lbl0" xml:lang="en-US">Percentage of prepayment premium.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfPrepaymentPremium" xlink:to="mlec_PercentageOfPrepaymentPremium_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_PercentageOfProfitForObligationToLegalReserve_lbl0" xml:lang="en-US">The percentage of profit to establish an obligation to legal reserve on ability of the joint venture to transfer funds to the Group in the form of cash dividends, or to repay loans or advances made by the Group.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfProfitForObligationToLegalReserve" xlink:to="mlec_PercentageOfProfitForObligationToLegalReserve_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_PercentageOfRiskPremium_lbl0" xml:lang="en-US">Percentage of risk premium.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfRiskPremium" xlink:to="mlec_PercentageOfRiskPremium_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_PercentageOfShare_lbl0" xml:lang="en-US">Percentage of share.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfShare" xlink:to="mlec_PercentageOfShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_PercentageOfWeightedAverageCostOfCapital_lbl0" xml:lang="en-US">Percentage of weighted average cost of capital.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfWeightedAverageCostOfCapital" xlink:to="mlec_PercentageOfWeightedAverageCostOfCapital_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_PledgedOrTransferredSharesQuantity_lbl0" xml:lang="en-US">The number of pledged or transferred shares quantity.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PledgedOrTransferredSharesQuantity" xlink:to="mlec_PledgedOrTransferredSharesQuantity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_PreferenceOfAccruePerAnnum_lbl0" xml:lang="en-US">The percentage of perference of accrue per annum.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PreferenceOfAccruePerAnnum" xlink:to="mlec_PreferenceOfAccruePerAnnum_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_PrepaymentPremiumFee_lbl2" xml:lang="en-US">Prepayment Premium Fee.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PrepaymentPremiumFee" xlink:to="mlec_PrepaymentPremiumFee_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_PricePerSharesOfStrikePrice_lbl0" xml:lang="en-US">Price per shares of strike price.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PricePerSharesOfStrikePrice" xlink:to="mlec_PricePerSharesOfStrikePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_PrivateWarrantShares_lbl0" xml:lang="en-US">Private warrant shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PrivateWarrantShares" xlink:to="mlec_PrivateWarrantShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_PrivateWarrantsExercisePrice_lbl0" xml:lang="en-US">Private warrants exercise price.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PrivateWarrantsExercisePrice" xlink:to="mlec_PrivateWarrantsExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_PrivateWarrantsShares_lbl0" xml:lang="en-US">Private warrants shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PrivateWarrantsShares" xlink:to="mlec_PrivateWarrantsShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ProceedFromIssuedShares_lbl0" xml:lang="en-US">Represent the amount of issued shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ProceedFromIssuedShares" xlink:to="mlec_ProceedFromIssuedShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ProceedsFromIssueOfEquityInstrumentsOnConversionOfDebt_lbl0" xml:lang="en-US">Represent the amount of financial liability and increase in equity.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ProceedsFromIssueOfEquityInstrumentsOnConversionOfDebt" xlink:to="mlec_ProceedsFromIssueOfEquityInstrumentsOnConversionOfDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ProfessionalFeesExpenseRelatedParties_lbl0" xml:lang="en-US">Amount of professional fee expense with related parties.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ProfessionalFeesExpenseRelatedParties" xlink:to="mlec_ProfessionalFeesExpenseRelatedParties_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ProfessionalFeesRelatedParties_lbl0" xml:lang="en-US">Represent the amount of professional fees related parties.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ProfessionalFeesRelatedParties" xlink:to="mlec_ProfessionalFeesRelatedParties_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ProjectedPeriodRange_lbl0" xml:lang="en-US">Represents the projected period range.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ProjectedPeriodRange" xlink:to="mlec_ProjectedPeriodRange_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ProvisionsForContingencies_lbl0" xml:lang="en-US">Represent the amount of provisions for contingencies.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ProvisionsForContingencies" xlink:to="mlec_ProvisionsForContingencies_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_PurchaseOfInventory_lbl0" xml:lang="en-US">Amount of inventory purchased during the year.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PurchaseOfInventory" xlink:to="mlec_PurchaseOfInventory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_PurchaseOfOwnShares_lbl0" xml:lang="en-US">Represent the payment of own shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PurchaseOfOwnShares" xlink:to="mlec_PurchaseOfOwnShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_PuttableInstrumentsCharge_lbl0" xml:lang="en-US">Represent the amount of puttable instruments charge.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PuttableInstrumentsCharge" xlink:to="mlec_PuttableInstrumentsCharge_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_RemeasurementOfPreviouslyHeldInterest_lbl0" xml:lang="en-US">Remeasurement of previously held interest.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RemeasurementOfPreviouslyHeldInterest" xlink:to="mlec_RemeasurementOfPreviouslyHeldInterest_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_RemeasurementToFairValueOfPreexistingInterestInAnAcquiree_lbl0" xml:lang="en-US">Remeasurement to fair value of pre-existing interest in an acquiree.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RemeasurementToFairValueOfPreexistingInterestInAnAcquiree" xlink:to="mlec_RemeasurementToFairValueOfPreexistingInterestInAnAcquiree_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ResearchAndDevelopmentExpenseCapitalized_lbl0" xml:lang="en-US">Amount of research and development expense capitalized.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ResearchAndDevelopmentExpenseCapitalized" xlink:to="mlec_ResearchAndDevelopmentExpenseCapitalized_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ResultOfInflationEffectOnMonetaryItemsAndOtherFinanceResults_lbl0" xml:lang="en-US">Result of inflation effect on monetary items and other finance results</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ResultOfInflationEffectOnMonetaryItemsAndOtherFinanceResults" xlink:to="mlec_ResultOfInflationEffectOnMonetaryItemsAndOtherFinanceResults_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTax_lbl0" xml:lang="en-US">Revaluation of property, plant and equipment, net of tax.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTax" xlink:to="mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTax_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTaxOfJointVenturesAndAssociates_lbl0" xml:lang="en-US">Revaluation of property, plant and equipment, net of tax, of joint ventures and associates.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTaxOfJointVenturesAndAssociates" xlink:to="mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTaxOfJointVenturesAndAssociates_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_RevaluationOfPropertyPlantAndEquipmentReserve_lbl0" xml:lang="en-US">Represent the amount of revaluation of property plant and equipment reserve.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RevaluationOfPropertyPlantAndEquipmentReserve" xlink:to="mlec_RevaluationOfPropertyPlantAndEquipmentReserve_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_RevenueFromSaleOfGoodsAndRenderingOfServices_lbl0" xml:lang="en-US">The amount of revenue arising from the sale of goods and rendering of services.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RevenueFromSaleOfGoodsAndRenderingOfServices" xlink:to="mlec_RevenueFromSaleOfGoodsAndRenderingOfServices_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ReverseStockSplit_lbl0" xml:lang="en-US">Reverse stock split.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ReverseStockSplit" xlink:to="mlec_ReverseStockSplit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ReverseStockSplitConsolidationRatio_lbl0" xml:lang="en-US">Description of reverse stock split consolidation ratio.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ReverseStockSplitConsolidationRatio" xlink:to="mlec_ReverseStockSplitConsolidationRatio_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_RightOfUseAssetLossOfControl_lbl0" xml:lang="en-US">The amount of loss of control.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RightOfUseAssetLossOfControl" xlink:to="mlec_RightOfUseAssetLossOfControl_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_RightofuseLeasedAssetAdditionsThroughAnIncreaseInLeaseLiabilities_lbl0" xml:lang="en-US">Represent the amount of right-of-use leased asset additions through an increase in lease liabilities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RightofuseLeasedAssetAdditionsThroughAnIncreaseInLeaseLiabilities" xlink:to="mlec_RightofuseLeasedAssetAdditionsThroughAnIncreaseInLeaseLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_SalariesAccruedIncentivesVacationsAndSocialSecurity_lbl0" xml:lang="en-US">The amount of current provisions for employee salaries, accrued incentives, vacations and social security.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SalariesAccruedIncentivesVacationsAndSocialSecurity" xlink:to="mlec_SalariesAccruedIncentivesVacationsAndSocialSecurity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_SaleOfEquityInvestment_lbl0" xml:lang="en-US">The carrying amount of the equity investment sold during the period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SaleOfEquityInvestment" xlink:to="mlec_SaleOfEquityInvestment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ScheduleOfFairValueOfConsiderationOfPaymentTableTextBlock_lbl0" xml:lang="en-US">The disclosure of detailed information about the fair value of the consideration of payment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfFairValueOfConsiderationOfPaymentTableTextBlock" xlink:to="mlec_ScheduleOfFairValueOfConsiderationOfPaymentTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ScheduleOfFinancialStatementsTextBlock_lbl0" xml:lang="en-US">Disclosure of financial statements.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfFinancialStatementsTextBlock" xlink:to="mlec_ScheduleOfFinancialStatementsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ScheduleOfRollforwardOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl0" xml:lang="en-US">The disclosure of deferred taxes.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfRollforwardOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="mlec_ScheduleOfRollforwardOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ScheduleOfSignificantJointVenturesTableTextBlock_lbl0" xml:lang="en-US">Tabular Disclosure is for schedule of significant joint ventures.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfSignificantJointVenturesTableTextBlock" xlink:to="mlec_ScheduleOfSignificantJointVenturesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities_lbl0" xml:lang="en-US">The tabular disclosure of significant non-cash transactions related to investing and financing activities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities" xlink:to="mlec_ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_SecuredDebtNonCurrent_lbl1" xml:lang="en-US">Amount of secured debt, non-current.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SecuredDebtNonCurrent" xlink:to="mlec_SecuredDebtNonCurrent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ShareBasedPaymentArrangementConversionOfEquityAwardsOutstandingToOptionOrRestrictedStockUnits_lbl0" xml:lang="en-US">The number of shares converted into options or restricted shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareBasedPaymentArrangementConversionOfEquityAwardsOutstandingToOptionOrRestrictedStockUnits" xlink:to="mlec_ShareBasedPaymentArrangementConversionOfEquityAwardsOutstandingToOptionOrRestrictedStockUnits_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ShareBasedPaymentAwardExpirationDate_lbl0" xml:lang="en-US">Share based payment award expiration date.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareBasedPaymentAwardExpirationDate" xlink:to="mlec_ShareBasedPaymentAwardExpirationDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ShareBasedPaymentPeriodOfWeightedAveragePriceVwapOfOrdinarySharesForCashlessBasisExercise_lbl0" xml:lang="en-US">Period of weighted average price (&quot;VWAP&quot;) of the ordinary shares during to the date of exercise for cashless basis of exercise options in share-based payment arrangement.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareBasedPaymentPeriodOfWeightedAveragePriceVwapOfOrdinarySharesForCashlessBasisExercise" xlink:to="mlec_ShareBasedPaymentPeriodOfWeightedAveragePriceVwapOfOrdinarySharesForCashlessBasisExercise_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ShareBasedPaymentsIncentiveIncreases_lbl0" xml:lang="en-US">Represents the amount of share based payments incentive increases.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareBasedPaymentsIncentiveIncreases" xlink:to="mlec_ShareBasedPaymentsIncentiveIncreases_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ShareOfProfitOrLossMeasuredAtFairValue_lbl1" xml:lang="en-US">Share of profit or loss measured at fair value.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareOfProfitOrLossMeasuredAtFairValue" xlink:to="mlec_ShareOfProfitOrLossMeasuredAtFairValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ShareOfProfitOrLossOfSubsidiaries_lbl0" xml:lang="en-US">Represents the vaue of share of profit or loss of subsidiaries.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareOfProfitOrLossOfSubsidiaries" xlink:to="mlec_ShareOfProfitOrLossOfSubsidiaries_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ShareToBeIssuedAmount_lbl0" xml:lang="en-US">The amount of shares to be issued.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareToBeIssuedAmount" xlink:to="mlec_ShareToBeIssuedAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_SharebasedIncentivesForEmployees_lbl0" xml:lang="en-US">Share-based incentives for employees.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SharebasedIncentivesForEmployees" xlink:to="mlec_SharebasedIncentivesForEmployees_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_SharesPremium_lbl0" xml:lang="en-US">The amount received or receivable from the issuance of the entity&apos;s shares in excess of nominal value.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SharesPremium" xlink:to="mlec_SharesPremium_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_SharesSubjectToEmployeeStockPurchasePlan_lbl0" xml:lang="en-US">The number of shares subject to employee stock purchase plan.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SharesSubjectToEmployeeStockPurchasePlan" xlink:to="mlec_SharesSubjectToEmployeeStockPurchasePlan_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ShorttermPeriod_lbl0" xml:lang="en-US">Short-term period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShorttermPeriod" xlink:to="mlec_ShorttermPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_StockOptionsAndShareBasedIncentives_lbl0" xml:lang="en-US">Amount of stock options and share based incentives.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_StockOptionsAndShareBasedIncentives" xlink:to="mlec_StockOptionsAndShareBasedIncentives_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_StrikePriceForConversionOfDebt_lbl0" xml:lang="en-US">The strike price per share for conversion of debt.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_StrikePriceForConversionOfDebt" xlink:to="mlec_StrikePriceForConversionOfDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_SubscribedCapital_lbl0" xml:lang="en-US">Represent the amount of subscribed capital.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SubscribedCapital" xlink:to="mlec_SubscribedCapital_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_SubscribedCapitalOfShares_lbl0" xml:lang="en-US">Number of subscribed capital.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SubscribedCapitalOfShares" xlink:to="mlec_SubscribedCapitalOfShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_SuppliesAndMaterials_lbl0" xml:lang="en-US">The amount of current supplies and materials purchased for production.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SuppliesAndMaterials" xlink:to="mlec_SuppliesAndMaterials_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_SurveillanceExpense_lbl0" xml:lang="en-US">Surveillance expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SurveillanceExpense" xlink:to="mlec_SurveillanceExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_SystemExpenses_lbl0" xml:lang="en-US">Systems expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SystemExpenses" xlink:to="mlec_SystemExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_TaxEffectOfRevenuesExemptFromTaxationAndExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss_lbl0" xml:lang="en-US">The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to expenses not deductible and revenues that are exempt from taxation in determining taxable profit (tax loss).</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TaxEffectOfRevenuesExemptFromTaxationAndExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:to="mlec_TaxEffectOfRevenuesExemptFromTaxationAndExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_TaxEffectOfShareOfProfitOrLossOfSubsidiesJointVenturesAndAssociates_lbl0" xml:lang="en-US">The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to share of profit or loss of subsidies, joint ventures and associates.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TaxEffectOfShareOfProfitOrLossOfSubsidiesJointVenturesAndAssociates" xlink:to="mlec_TaxEffectOfShareOfProfitOrLossOfSubsidiesJointVenturesAndAssociates_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_TaxEffectOfStockOptionCharge_lbl0" xml:lang="en-US">The amount representing the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to stock option charge.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TaxEffectOfStockOptionCharge" xlink:to="mlec_TaxEffectOfStockOptionCharge_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_TaxInflationAdjustment_lbl0" xml:lang="en-US">Tax Inflation Adjustment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TaxInflationAdjustment" xlink:to="mlec_TaxInflationAdjustment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ThresholdEarningsBeforeInterestTaxesDepreciationAndAmortization_lbl0" xml:lang="en-US">The exercise price of share options granted.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ThresholdEarningsBeforeInterestTaxesDepreciationAndAmortization" xlink:to="mlec_ThresholdEarningsBeforeInterestTaxesDepreciationAndAmortization_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_TotalLeaseLiabilities_lbl0" xml:lang="en-US">The amount of lease liabilities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TotalLeaseLiabilities" xlink:to="mlec_TotalLeaseLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_TotalNonreportableAssets_lbl0" xml:lang="en-US">Total non-reportable assets.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TotalNonreportableAssets" xlink:to="mlec_TotalNonreportableAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_TotalReportableAssets_lbl0" xml:lang="en-US">Reportable assets.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TotalReportableAssets" xlink:to="mlec_TotalReportableAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_TotalResearchAndDevelopmentExpenseIncurred_lbl0" xml:lang="en-US">The amount of research and development costs that an entity incurs.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TotalResearchAndDevelopmentExpenseIncurred" xlink:to="mlec_TotalResearchAndDevelopmentExpenseIncurred_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_TradeAndOtherPayablesShareholdersAndOtherRelatedParties_lbl0" xml:lang="en-US">Represents the amount of trade and other payables in shareholders and other related parties.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TradeAndOtherPayablesShareholdersAndOtherRelatedParties" xlink:to="mlec_TradeAndOtherPayablesShareholdersAndOtherRelatedParties_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_TradeCreditorsJointVenturesAndAssociates_lbl0" xml:lang="en-US">Represents the amount of trade creditors - Joint ventures and associates.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TradeCreditorsJointVenturesAndAssociates" xlink:to="mlec_TradeCreditorsJointVenturesAndAssociates_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ValuationSignificantChangeInAmountNormalWearAndTearVariationImpactOnRevaluationAmount_lbl0" xml:lang="en-US">The amount of increase (decrease) in the amount of normal wear and tear variation impact on revaluation of land.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ValuationSignificantChangeInAmountNormalWearAndTearVariationImpactOnRevaluationAmount" xlink:to="mlec_ValuationSignificantChangeInAmountNormalWearAndTearVariationImpactOnRevaluationAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ValuationSignificantChangePercentageOfConstructionCosts_lbl0" xml:lang="en-US">Percentage of construction costs change that could have significant impact on valuation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ValuationSignificantChangePercentageOfConstructionCosts" xlink:to="mlec_ValuationSignificantChangePercentageOfConstructionCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ValueOfTransactionsForThePeriodEnded_lbl0" xml:lang="en-US">Value of transactions for the period ended.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ValueOfTransactionsForThePeriodEnded" xlink:to="mlec_ValueOfTransactionsForThePeriodEnded_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_VehicleExpenses_lbl0" xml:lang="en-US">Vehicles expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_VehicleExpenses" xlink:to="mlec_VehicleExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_VoluntaryRepurchaseOfNotesAfterIssueDate_lbl0" xml:lang="en-US">The voluntary repurchase of notes after the issue date.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_VoluntaryRepurchaseOfNotesAfterIssueDate" xlink:to="mlec_VoluntaryRepurchaseOfNotesAfterIssueDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_VotePerShare_lbl0" xml:lang="en-US">The number of vote for each share.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_VotePerShare" xlink:to="mlec_VotePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_WorkingCapital_lbl1" xml:lang="en-US">Amount of working capital.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_WorkingCapital" xlink:to="mlec_WorkingCapital_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_IfrsBalanceSheetLocationAxis_lbl0" xml:lang="en-US">Information by location on balance sheet (statement of financial position).</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IfrsBalanceSheetLocationAxis" xlink:to="mlec_IfrsBalanceSheetLocationAxis_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_TaxJurisdictionAxis_lbl0" xml:lang="en-US">The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TaxJurisdictionAxis" xlink:to="mlec_TaxJurisdictionAxis_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_AdjuvantsMember_lbl0" xml:lang="en-US">This member stands for the adjuvants .</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AdjuvantsMember" xlink:to="mlec_AdjuvantsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_AlfalfaTechnologiesSRlMember_lbl0" xml:lang="en-US">This member stands for Alfalfa Technologies S.R.L.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AlfalfaTechnologiesSRlMember" xlink:to="mlec_AlfalfaTechnologiesSRlMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_AllowanceForImpairmentOfTradeDebtorsMember_lbl0" xml:lang="en-US">This member stands for allowance for impairment of trade debtors.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AllowanceForImpairmentOfTradeDebtorsMember" xlink:to="mlec_AllowanceForImpairmentOfTradeDebtorsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_AllowanceForObsolescenceMember_lbl0" xml:lang="en-US">This member stands for allowance for obsolescence.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AllowanceForObsolescenceMember" xlink:to="mlec_AllowanceForObsolescenceMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_AtAmortizedCostMember_lbl0" xml:lang="en-US">This member stands for amortized cost.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AtAmortizedCostMember" xlink:to="mlec_AtAmortizedCostMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_BiologicalAssetsBarleyMember_lbl0" xml:lang="en-US">This member stands for barley biological assets.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BiologicalAssetsBarleyMember" xlink:to="mlec_BiologicalAssetsBarleyMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_BiologicalAssetsCornMember_lbl0" xml:lang="en-US">This member stands for corn biological assets.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BiologicalAssetsCornMember" xlink:to="mlec_BiologicalAssetsCornMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_BiologicalAssetsSoybeanMember_lbl0" xml:lang="en-US">This member stands for soybean biological assets.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BiologicalAssetsSoybeanMember" xlink:to="mlec_BiologicalAssetsSoybeanMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_BiologicalAssetsWheatMember_lbl0" xml:lang="en-US">This member stands for wheat biological assets.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BiologicalAssetsWheatMember" xlink:to="mlec_BiologicalAssetsWheatMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_BioprotectionMember_lbl0" xml:lang="en-US">This member stands for Bioprotection.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BioprotectionMember" xlink:to="mlec_BioprotectionMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_BiostimulantsMember_lbl0" xml:lang="en-US">This member stands for Biostimulants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BiostimulantsMember" xlink:to="mlec_BiostimulantsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_BorrowingMember_lbl0" xml:lang="en-US">Represents information pertaining to borrowings.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BorrowingMember" xlink:to="mlec_BorrowingMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_CarryForwardOfTaxLossMember_lbl0" xml:lang="en-US">This member stands for carry forward of tax loses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CarryForwardOfTaxLossMember" xlink:to="mlec_CarryForwardOfTaxLossMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_CashAndEquivalentsMember_lbl0" xml:lang="en-US">This member stands for cash and cash equivalents.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CashAndEquivalentsMember" xlink:to="mlec_CashAndEquivalentsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ConsiderationForAcquisitionMember_lbl0" xml:lang="en-US">This member stands for consideration for acquisition.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ConsiderationForAcquisitionMember" xlink:to="mlec_ConsiderationForAcquisitionMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_CropNutritionMember_lbl0" xml:lang="en-US">This member stands for Crop nutrition.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CropNutritionMember" xlink:to="mlec_CropNutritionMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_CropProtectionMember_lbl0" xml:lang="en-US">This member stands for Crop protection.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CropProtectionMember" xlink:to="mlec_CropProtectionMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DeferredTaxAssetMember_lbl0" xml:lang="en-US">This member standards for deferred tax assets related differences between the carrying amount of accounts in the statement of financial position and its tax base.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DeferredTaxAssetMember" xlink:to="mlec_DeferredTaxAssetMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DeferredTaxLiabilityMember_lbl0" xml:lang="en-US">This member standards for deferred tax liability related differences between the carrying amount of accounts in the statement of financial position and its tax base.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DeferredTaxLiabilityMember" xlink:to="mlec_DeferredTaxLiabilityMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_EmployeeStockOptionPlanMember_lbl1" xml:lang="en-US">This member stands for employee stock option plan.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_EmployeeStockOptionPlanMember" xlink:to="mlec_EmployeeStockOptionPlanMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_EmployeeStockPurchasePlanMember_lbl0" xml:lang="en-US">n/a</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_EmployeeStockPurchasePlanMember" xlink:to="mlec_EmployeeStockPurchasePlanMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_EuropeMiddleEastAndAfricaMember_lbl0" xml:lang="en-US">This member stands for regions of Europe, Middle East and Africa.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_EuropeMiddleEastAndAfricaMember" xlink:to="mlec_EuropeMiddleEastAndAfricaMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_FinancedPaymentAcquisitionOfBusinessMember_lbl0" xml:lang="en-US">Represents information pertaining to financed payment acquisition of business.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancedPaymentAcquisitionOfBusinessMember" xlink:to="mlec_FinancedPaymentAcquisitionOfBusinessMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_FixedRateBorrowingsMember_lbl0" xml:lang="en-US">This member stands for loans that have fixed interest rate.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FixedRateBorrowingsMember" xlink:to="mlec_FixedRateBorrowingsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_IfrsConvertibleNotesPayableMember_lbl0" xml:lang="en-US">Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IfrsConvertibleNotesPayableMember" xlink:to="mlec_IfrsConvertibleNotesPayableMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_IfrsFull_machineryAndEquipmentMember_lbl0" xml:lang="en-US">This member stands for machinery and equipment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IfrsFull_machineryAndEquipmentMember" xlink:to="mlec_IfrsFull_machineryAndEquipmentMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_IndrasaBiotecnologaSAMember_lbl0" xml:lang="en-US">This member stands for Indrasa Biotecnologia S.A.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IndrasaBiotecnologaSAMember" xlink:to="mlec_IndrasaBiotecnologaSAMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_InflationTaxAdjustmentMember_lbl0" xml:lang="en-US">This member stands for inflation tax adjustments.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InflationTaxAdjustmentMember" xlink:to="mlec_InflationTaxAdjustmentMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_InoculantsBiofertilizersMember_lbl0" xml:lang="en-US">This member stands for inoculants &amp; biofertilizers.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InoculantsBiofertilizersMember" xlink:to="mlec_InoculantsBiofertilizersMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_IntangiblesTaxLiabilityMember_lbl0" xml:lang="en-US">This member standards for deferred liabilities related differences between the carrying amount of intangibles in the statement of financial position and its tax base.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IntangiblesTaxLiabilityMember" xlink:to="mlec_IntangiblesTaxLiabilityMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_InventoriesTaxLiabilityMember_lbl0" xml:lang="en-US">This member standards for deferred liabilities related differences between the carrying amount of inventories in the statement of financial position and its tax base.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InventoriesTaxLiabilityMember" xlink:to="mlec_InventoriesTaxLiabilityMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_InvestmentsInSharesMember_lbl0" xml:lang="en-US">This member stands for investments in shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InvestmentsInSharesMember" xlink:to="mlec_InvestmentsInSharesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_LossMakingEntitiesMember_lbl0" xml:lang="en-US">This member stands for loss-making entities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LossMakingEntitiesMember" xlink:to="mlec_LossMakingEntitiesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_LowOrNullTaxationJurisdictionsMember_lbl0" xml:lang="en-US">This member stands for low or null taxation jurisdictions.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LowOrNullTaxationJurisdictionsMember" xlink:to="mlec_LowOrNullTaxationJurisdictionsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_MicroBeadedFertilizersMember_lbl0" xml:lang="en-US">This member stands for micro-beaded fertilizers.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MicroBeadedFertilizersMember" xlink:to="mlec_MicroBeadedFertilizersMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_MicrobiologicalProductsProducedMember_lbl0" xml:lang="en-US">This member stands for information pertaining to microbiological products produced.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MicrobiologicalProductsProducedMember" xlink:to="mlec_MicrobiologicalProductsProducedMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_MicrobiologicalResaleProductsMember_lbl0" xml:lang="en-US">This member stands for information pertaining to Microbiological resale products.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MicrobiologicalResaleProductsMember" xlink:to="mlec_MicrobiologicalResaleProductsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_MutualFundsMember_lbl0" xml:lang="en-US">The member stands for mutual funds.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MutualFundsMember" xlink:to="mlec_MutualFundsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_NatalAgroSRLMember_lbl0" xml:lang="en-US">This member stands for Natal Agro S.R.L.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NatalAgroSRLMember" xlink:to="mlec_NatalAgroSRLMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_OptionsIncentivePlanMember_lbl0" xml:lang="en-US">This member stands for the option incentive plan.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OptionsIncentivePlanMember" xlink:to="mlec_OptionsIncentivePlanMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_OtherCpProductsAndServicesMember_lbl0" xml:lang="en-US">This member stands for Other CP products and services.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherCpProductsAndServicesMember" xlink:to="mlec_OtherCpProductsAndServicesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_OtherFinancialAssetsMember_lbl0" xml:lang="en-US">This member stands for financial assets that the entity does not separately disclose in the same statement or note.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherFinancialAssetsMember" xlink:to="mlec_OtherFinancialAssetsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_OtherInvestmentMember_lbl0" xml:lang="en-US">This member stands for other investments.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherInvestmentMember" xlink:to="mlec_OtherInvestmentMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_OtherReceivablesMember_lbl0" xml:lang="en-US">This member stands for receivables that the entity does not separately disclose in the same statement or note.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherReceivablesMember" xlink:to="mlec_OtherReceivablesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_OtherRegionsOrCountriesMember_lbl0" xml:lang="en-US">This member stands for other countries and region not specifically identified in the note disclosures.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherRegionsOrCountriesMember" xlink:to="mlec_OtherRegionsOrCountriesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_OtherTaxAssetMember_lbl0" xml:lang="en-US">This member standards for deferred tax asset related differences between the carrying amount of certain accounts in the statement of financial position and its tax base, classified as other.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherTaxAssetMember" xlink:to="mlec_OtherTaxAssetMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_OthersFinancialAssetsMember_lbl0" xml:lang="en-US">This member stands for others financial assets.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OthersFinancialAssetsMember" xlink:to="mlec_OthersFinancialAssetsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_PastShareOptionPlanMember_lbl1" xml:lang="en-US">This member stands for the past share option plan.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PastShareOptionPlanMember" xlink:to="mlec_PastShareOptionPlanMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_PerformanceShareOptionPlanMember_lbl1" xml:lang="en-US">This member stands for the performance share option plan.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PerformanceShareOptionPlanMember" xlink:to="mlec_PerformanceShareOptionPlanMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ProFarmGroupIncMember_lbl0" xml:lang="en-US">The member stands for dilutive effect of the future exercise of options of Pro farm group inc.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ProFarmGroupIncMember" xlink:to="mlec_ProFarmGroupIncMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ProfitMakingEntitiesMember_lbl0" xml:lang="en-US">This member stands for profit-making entities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ProfitMakingEntitiesMember" xlink:to="mlec_ProfitMakingEntitiesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ProvisionForContingenciesMember_lbl0" xml:lang="en-US">This member stands for provision for contingencies.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ProvisionForContingenciesMember" xlink:to="mlec_ProvisionForContingenciesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_RightOfUseLeasedAssetTaxLiabilityMember_lbl0" xml:lang="en-US">Right-of-use Leased Asset Tax Liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RightOfUseLeasedAssetTaxLiabilityMember" xlink:to="mlec_RightOfUseLeasedAssetTaxLiabilityMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_RoyaltiesMember_lbl0" xml:lang="en-US">This member stands for royalties.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RoyaltiesMember" xlink:to="mlec_RoyaltiesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_SecuredConvertibleGuaranteedNotesMember_lbl0" xml:lang="en-US">This member stands for Secured Convertible Guaranteed Notes.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SecuredConvertibleGuaranteedNotesMember" xlink:to="mlec_SecuredConvertibleGuaranteedNotesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_SecuredGuaranteedNotesDue2026Member_lbl0" xml:lang="en-US">This member stands for Secured Guaranteed Notes due 2026.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SecuredGuaranteedNotesDue2026Member" xlink:to="mlec_SecuredGuaranteedNotesDue2026Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_SeedAndIntegratedProductsMember_lbl0" xml:lang="en-US">This member stands for Seed and integrated products.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SeedAndIntegratedProductsMember" xlink:to="mlec_SeedAndIntegratedProductsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_SeedCpProductsAndServicesMember_lbl0" xml:lang="en-US">This member stands for Seeds, CP products and services.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SeedCpProductsAndServicesMember" xlink:to="mlec_SeedCpProductsAndServicesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_SeedTreatmentsPacksMember_lbl0" xml:lang="en-US">This member stands for seed treatments packs.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SeedTreatmentsPacksMember" xlink:to="mlec_SeedTreatmentsPacksMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_SeedsAndGrainsMember_lbl0" xml:lang="en-US">This member stands for information pertaining to seeds and grains.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SeedsAndGrainsMember" xlink:to="mlec_SeedsAndGrainsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_StandAloneStockOptionGrantMember_lbl1" xml:lang="en-US">This member stands for stand alone stock option grant.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_StandAloneStockOptionGrantMember" xlink:to="mlec_StandAloneStockOptionGrantMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_StockIncentivePlan2013Member_lbl0" xml:lang="en-US">This member stands for stock incentive plan 2013.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_StockIncentivePlan2013Member" xlink:to="mlec_StockIncentivePlan2013Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_StockOptionsAndShareBasedIncentivesMember_lbl0" xml:lang="en-US">This member stands for stock options and share based incentives.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_StockOptionsAndShareBasedIncentivesMember" xlink:to="mlec_StockOptionsAndShareBasedIncentivesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_SunflowerMember_lbl0" xml:lang="en-US">This member stands for Sunflower biological assets.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SunflowerMember" xlink:to="mlec_SunflowerMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_SynertechIndustriasSAMember_lbl0" xml:lang="en-US">This member stands for Synertech Industrias S.A.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SynertechIndustriasSAMember" xlink:to="mlec_SynertechIndustriasSAMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_TradeAndOtherPayablesMember_lbl0" xml:lang="en-US">This member stands for trade and other payables.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TradeAndOtherPayablesMember" xlink:to="mlec_TradeAndOtherPayablesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_TrigallGeneticsSAMember_lbl0" xml:lang="en-US">This member stands for Trigall Genetics S.A.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TrigallGeneticsSAMember" xlink:to="mlec_TrigallGeneticsSAMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_UsTreasuryBillsMember_lbl0" xml:lang="en-US">Represents the information pertaining to US Treasury Bills.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UsTreasuryBillsMember" xlink:to="mlec_UsTreasuryBillsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_VariableRateBorrowingsMember_lbl0" xml:lang="en-US">This member stands for loans that have variable interest rate.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_VariableRateBorrowingsMember" xlink:to="mlec_VariableRateBorrowingsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_KeyManagementPersonnelCompensationAbstract_lbl0" xml:lang="en-US">No definition available.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_KeyManagementPersonnelCompensationAbstract" xlink:to="mlec_KeyManagementPersonnelCompensationAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_WorkingCapitalAdjustmentsOperatingActivitiesAbstract_lbl0" xml:lang="en-US">No definition available.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_WorkingCapitalAdjustmentsOperatingActivitiesAbstract" xlink:to="mlec_WorkingCapitalAdjustmentsOperatingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AdditionsFromBusinessCombination_lbl1" xml:lang="en-US">Additions From Business Combination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AdditionsFromBusinessCombination" xlink:to="mlec_AdditionsFromBusinessCombination_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_lbl0" xml:lang="en-US">Disclosure of share capital, reserves and other equity interest [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:to="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SunflowerMember_lbl1" xml:lang="en-US">Sunflower Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SunflowerMember" xlink:to="mlec_SunflowerMember_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesAbstract_lbl" xml:lang="en-US">Schedule Of Changes In Liabilities Arising From Financing Activities Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesAbstract" xlink:to="mlec_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NetAssetsAcquisitionByBusinessCombination_lbl1" xml:lang="en-US">Net Assets Acquisition By Business Combination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NetAssetsAcquisitionByBusinessCombination" xlink:to="mlec_NetAssetsAcquisitionByBusinessCombination_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_lbl0" xml:lang="en-US">Borrowings recognised as of acquisition date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfRangeOfAssumptionsWhichHaveDeterminedAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfRangeOfAssumptionsWhichHaveDeterminedAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfRangeOfAssumptionsWhichHaveDeterminedAbstract_lbl" xml:lang="en-US">Schedule Of Range Of Assumptions Which Have Determined Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfRangeOfAssumptionsWhichHaveDeterminedAbstract" xlink:to="mlec_ScheduleOfRangeOfAssumptionsWhichHaveDeterminedAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivities_lbl2" xml:lang="en-US">Liabilities arising from financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivities_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ManagementExpensesMember_lbl0" xml:lang="en-US">Management Expenses Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ManagementExpensesMember" xlink:to="mlec_ManagementExpensesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComprehensiveIncome_lbl2" xml:lang="en-US">Comprehensive income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComprehensiveIncome" xlink:to="ifrs-full_ComprehensiveIncome_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentDeferredIncomeIncludingNoncurrentContractLiabilities_lbl0" xml:lang="en-US">Non-current deferred income including non-current contract liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentDeferredIncomeIncludingNoncurrentContractLiabilities" xlink:to="ifrs-full_NoncurrentDeferredIncomeIncludingNoncurrentContractLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory_lbl0" xml:lang="en-US">Disclosure of non-controlling interests [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory" xlink:to="ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DisposalsDepreciation_lbl1" xml:lang="en-US">Disposals Depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisposalsDepreciation" xlink:to="mlec_DisposalsDepreciation_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_CashAndEquivalentsMember_lbl1" xml:lang="en-US">Cash And Equivalents Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CashAndEquivalentsMember" xlink:to="mlec_CashAndEquivalentsMember_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfGovernmentGrantsAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfGovernmentGrantsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfGovernmentGrantsAbstract_lbl" xml:lang="en-US">Schedule Of Government Grants Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfGovernmentGrantsAbstract" xlink:to="mlec_ScheduleOfGovernmentGrantsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AccumulatedDepreciationAndAmortisationMember_lbl0" xml:lang="en-US">Accumulated depreciation and amortisation [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:to="ifrs-full_AccumulatedDepreciationAndAmortisationMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod_lbl0" xml:lang="en-US">Share of profit (loss) of joint ventures accounted for using equity method</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" xlink:to="ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForInvestmentPropertyExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for investment property [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForInvestmentPropertyExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForInvestmentPropertyExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation_lbl1" xml:lang="en-US">Description Of Accounting Policy For Basis Of Consolidation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation" xlink:to="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InvestmentProperty_lbl1" xml:lang="en-US">Investment property</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InvestmentProperty" xlink:to="ifrs-full_InvestmentProperty_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NatalAgroSRLMember_lbl1" xml:lang="en-US">Natal Agro SRLMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NatalAgroSRLMember" xlink:to="mlec_NatalAgroSRLMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_VariableRateInstrumentsAbstract_lbl0" xml:lang="en-US">Variable Rate Instruments Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_VariableRateInstrumentsAbstract" xlink:to="mlec_VariableRateInstrumentsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners_lbl0" xml:lang="en-US">Increase through other contributions by owners, equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners" xlink:to="ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_LossOfControlDepreciation_lbl1" xml:lang="en-US">Loss Of Control Depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LossOfControlDepreciation" xlink:to="mlec_LossOfControlDepreciation_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LeaseLiabilitiesAbstract_lbl0" xml:lang="en-US">Lease liabilities [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LeaseLiabilitiesAbstract" xlink:to="ifrs-full_LeaseLiabilitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GainsLossesOnChangeInFairValueEstimatesOfBiologicalAssetsForCurrentPeriod_lbl0" xml:lang="en-US">Gains (losses) on change in fair value less costs to sell of biological assets for current period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsLossesOnChangeInFairValueEstimatesOfBiologicalAssetsForCurrentPeriod" xlink:to="ifrs-full_GainsLossesOnChangeInFairValueEstimatesOfBiologicalAssetsForCurrentPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FixedRateBorrowingsMember_lbl1" xml:lang="en-US">Fixed Rate Borrowings Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FixedRateBorrowingsMember" xlink:to="mlec_FixedRateBorrowingsMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_lbl0" xml:lang="en-US">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:to="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RetainedEarnings_lbl0" xml:lang="en-US">Retained earnings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RetainedEarnings" xlink:to="ifrs-full_RetainedEarnings_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDepreciationExpense_lbl0" xml:lang="en-US">Adjustments for depreciation expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDepreciationExpense" xlink:to="ifrs-full_AdjustmentsForDepreciationExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl0" xml:lang="en-US">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PricePerSharesOfStrikePrice_lbl1" xml:lang="en-US">Price Per Shares Of Strike Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PricePerSharesOfStrikePrice" xlink:to="mlec_PricePerSharesOfStrikePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_BankBorrowingMember_lbl0" xml:lang="en-US">Bank Borrowing Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BankBorrowingMember" xlink:to="mlec_BankBorrowingMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PaymentsForDevelopmentProjectExpenditure_lbl0" xml:lang="en-US">Payments for development project expenditure</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PaymentsForDevelopmentProjectExpenditure" xlink:to="ifrs-full_PaymentsForDevelopmentProjectExpenditure_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PurchaseOfInventory_lbl1" xml:lang="en-US">Purchase Of Inventory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PurchaseOfInventory" xlink:to="mlec_PurchaseOfInventory_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FixedRateInstrumentsAbstract_lbl0" xml:lang="en-US">Fixed Rate Instruments Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FixedRateInstrumentsAbstract" xlink:to="mlec_FixedRateInstrumentsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SalariesAccruedIncentivesVacationsAndSocialSecurity_lbl1" xml:lang="en-US">Salaries Accrued Incentives Vacations And Social Security</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SalariesAccruedIncentivesVacationsAndSocialSecurity" xlink:to="mlec_SalariesAccruedIncentivesVacationsAndSocialSecurity_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DeferredTaxLiabilitiesAbstract0_lbl0" xml:lang="en-US">Deferred Tax Liabilities Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DeferredTaxLiabilitiesAbstract0" xlink:to="mlec_DeferredTaxLiabilitiesAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AmortizationOfTheYear_lbl1" xml:lang="en-US">Amortization Of The Year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AmortizationOfTheYear" xlink:to="mlec_AmortizationOfTheYear_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_CropNutritionMember_lbl1" xml:lang="en-US">Crop Nutrition Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CropNutritionMember" xlink:to="mlec_CropNutritionMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_IssuedConvertiblePreferenceShares_lbl1" xml:lang="en-US">Issued Convertible Preference Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IssuedConvertiblePreferenceShares" xlink:to="mlec_IssuedConvertiblePreferenceShares_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfRightOfUseAndLiabilitiesRelatedWithLeaseAssetsAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfRightOfUseAndLiabilitiesRelatedWithLeaseAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfRightOfUseAndLiabilitiesRelatedWithLeaseAssetsAbstract_lbl" xml:lang="en-US">Schedule Of Right Of Use And Liabilities Related With Lease Assets Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfRightOfUseAndLiabilitiesRelatedWithLeaseAssetsAbstract" xlink:to="mlec_ScheduleOfRightOfUseAndLiabilitiesRelatedWithLeaseAssetsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DiscountRateForFairValueOfLiabilityComponent_lbl1" xml:lang="en-US">Discount Rate For Fair Value Of Liability Component</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DiscountRateForFairValueOfLiabilityComponent" xlink:to="mlec_DiscountRateForFairValueOfLiabilityComponent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_OtherCpProductsAndServicesMember_lbl1" xml:lang="en-US">Other Cp Products And Services Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherCpProductsAndServicesMember" xlink:to="mlec_OtherCpProductsAndServicesMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PaymentsOfOtherEquityInstruments_lbl0" xml:lang="en-US">Payments of other equity instruments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PaymentsOfOtherEquityInstruments" xlink:to="ifrs-full_PaymentsOfOtherEquityInstruments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NotLaterThanThreeMonthsMember_lbl0" xml:lang="en-US">Not later than three months [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NotLaterThanThreeMonthsMember" xlink:to="ifrs-full_NotLaterThanThreeMonthsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NetDeferredTaxLiabilities_lbl0" xml:lang="en-US">Net deferred tax liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetDeferredTaxLiabilities" xlink:to="ifrs-full_NetDeferredTaxLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ContingentPaymentCurrent_lbl1" xml:lang="en-US">Contingent Payment Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ContingentPaymentCurrent" xlink:to="mlec_ContingentPaymentCurrent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_TaxInflationAdjustment_lbl1" xml:lang="en-US">Tax Inflation Adjustment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TaxInflationAdjustment" xlink:to="mlec_TaxInflationAdjustment_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfProvisionsAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfProvisionsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfProvisionsAbstract_lbl" xml:lang="en-US">Schedule Of Provisions Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfProvisionsAbstract" xlink:to="mlec_ScheduleOfProvisionsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_LeasingLiabilities_lbl1" xml:lang="en-US">Leasing Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LeasingLiabilities" xlink:to="mlec_LeasingLiabilities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_EffectiveIncomeTaxRateReconciliationTableTextBlock_lbl1" xml:lang="en-US">Effective Income Tax Rate Reconciliation Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_EffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="mlec_EffectiveIncomeTaxRateReconciliationTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_LoansReceivablesMember_lbl0" xml:lang="en-US">Loans Receivables Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LoansReceivablesMember" xlink:to="mlec_LoansReceivablesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherOperatingIncomeExpense_lbl2" xml:lang="en-US">Other operating income (expense)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="ifrs-full_OtherOperatingIncomeExpense_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NumberOfNominalValue_lbl1" xml:lang="en-US">Number Of Nominal Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfNominalValue" xlink:to="mlec_NumberOfNominalValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_StockOptionsAndShareBasedIncentivesMember_lbl1" xml:lang="en-US">Stock Options And Share Based Incentives Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_StockOptionsAndShareBasedIncentivesMember" xlink:to="mlec_StockOptionsAndShareBasedIncentivesMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NetDeferredTaxAssets_lbl2" xml:lang="en-US">Net deferred tax assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetDeferredTaxAssets" xlink:to="ifrs-full_NetDeferredTaxAssets_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_GFASMember_lbl0" xml:lang="en-US">GFASMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_GFASMember" xlink:to="mlec_GFASMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InventoriesBeforeClosingInventory_lbl1" xml:lang="en-US">Inventories Before Closing Inventory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InventoriesBeforeClosingInventory" xlink:to="mlec_InventoriesBeforeClosingInventory_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DeferredTaxAssetsAbstract0_lbl0" xml:lang="en-US">Deferred Tax Assets Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DeferredTaxAssetsAbstract0" xlink:to="mlec_DeferredTaxAssetsAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_RightofuseLeasedAssetAdditionsThroughAnIncreaseInLeaseLiabilities_lbl1" xml:lang="en-US">Rightofuse Leased Asset Additions Through An Increase In Lease Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RightofuseLeasedAssetAdditionsThroughAnIncreaseInLeaseLiabilities" xlink:to="mlec_RightofuseLeasedAssetAdditionsThroughAnIncreaseInLeaseLiabilities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PercentageOfWeightedAverageCostOfCapital_lbl1" xml:lang="en-US">Percentage Of Weighted Average Cost Of Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfWeightedAverageCostOfCapital" xlink:to="mlec_PercentageOfWeightedAverageCostOfCapital_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_TradeAndOtherPayablesMember_lbl1" xml:lang="en-US">Trade And Other Payables Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TradeAndOtherPayablesMember" xlink:to="mlec_TradeAndOtherPayablesMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_EBITDAMember_lbl0" xml:lang="en-US">EBITDAMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_EBITDAMember" xlink:to="mlec_EBITDAMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InKindContributionsMember_lbl0" xml:lang="en-US">In Kind Contributions Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InKindContributionsMember" xlink:to="mlec_InKindContributionsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GrossCarryingAmountMember_lbl0" xml:lang="en-US">Gross carrying amount [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GrossCarryingAmountMember" xlink:to="ifrs-full_GrossCarryingAmountMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_LossOfControlLeaseLiability_lbl1" xml:lang="en-US">Loss Of Control Lease Liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LossOfControlLeaseLiability" xlink:to="mlec_LossOfControlLeaseLiability_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_lbl0" xml:lang="en-US">Increase (decrease) through transfers, property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" xlink:to="ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_lbl0" xml:lang="en-US">Weighted average share price, share options granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:to="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NumberOfSharesPledged_lbl1" xml:lang="en-US">Number Of Shares Pledged</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfSharesPledged" xlink:to="mlec_NumberOfSharesPledged_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DeductedFromAssetsAbstract_lbl0" xml:lang="en-US">Deducted From Assets Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DeductedFromAssetsAbstract" xlink:to="mlec_DeductedFromAssetsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_BioceresCropSolutionsMember_lbl0" xml:lang="en-US">Bioceres Crop Solutions Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BioceresCropSolutionsMember" xlink:to="mlec_BioceresCropSolutionsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentContractLiabilities_lbl0" xml:lang="en-US">Non-current contract liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentContractLiabilities" xlink:to="ifrs-full_NoncurrentContractLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DisclosureOfTradeReceivablesTableTextBlock_lbl1" xml:lang="en-US">Disclosure Of Trade Receivables Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfTradeReceivablesTableTextBlock" xlink:to="mlec_DisclosureOfTradeReceivablesTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LossesOnDisposalsOfInvestments_lbl0" xml:lang="en-US">Losses on disposals of investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LossesOnDisposalsOfInvestments" xlink:to="ifrs-full_LossesOnDisposalsOfInvestments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities_lbl1" xml:lang="en-US">Decrease Through Payments Liabilities Arising From Financing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities" xlink:to="mlec_DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_lbl0" xml:lang="en-US">Adjustments for increase (decrease) in employee benefit liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for leases [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_CurrentAbstract0_lbl0" xml:lang="en-US">Current Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CurrentAbstract0" xlink:to="mlec_CurrentAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_CurrentAbstract2_lbl0" xml:lang="en-US">Current Abstract2</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CurrentAbstract2" xlink:to="mlec_CurrentAbstract2_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_CurrentAbstract1_lbl0" xml:lang="en-US">Current Abstract1</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CurrentAbstract1" xlink:to="mlec_CurrentAbstract1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_CurrentAbstract3_lbl0" xml:lang="en-US">Current Abstract3</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CurrentAbstract3" xlink:to="mlec_CurrentAbstract3_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AtFairValueMember_lbl1" xml:lang="en-US">At fair value [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AtFairValueMember" xlink:to="ifrs-full_AtFairValueMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ConsiderationForAcquisitionMember_lbl1" xml:lang="en-US">Consideration For Acquisition Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ConsiderationForAcquisitionMember" xlink:to="mlec_ConsiderationForAcquisitionMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SoftwareInProgressMember_lbl0" xml:lang="en-US">Software In Progress Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SoftwareInProgressMember" xlink:to="mlec_SoftwareInProgressMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_WorkingCapitalAdjustmentsOperatingActivitiesAbstract_lbl1" xml:lang="en-US">Working Capital Adjustments Operating Activities Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_WorkingCapitalAdjustmentsOperatingActivitiesAbstract" xlink:to="mlec_WorkingCapitalAdjustmentsOperatingActivitiesAbstract_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivitiesAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivitiesAbstract_lbl" xml:lang="en-US">Schedule Of Significant Non Cash Transactions Related To Investing And Financing Activities Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivitiesAbstract" xlink:to="mlec_ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivitiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_lbl0" xml:lang="en-US">Adjustments for decrease (increase) in trade accounts receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PaymentsOfThePeriodLeaseliability_lbl1" xml:lang="en-US">Payments Of The Period Leaseliability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PaymentsOfThePeriodLeaseliability" xlink:to="mlec_PaymentsOfThePeriodLeaseliability_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PercentageOfDividendsTaxedShares_lbl1" xml:lang="en-US">Percentage Of Dividends Taxed Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfDividendsTaxedShares" xlink:to="mlec_PercentageOfDividendsTaxedShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BottomOfRangeMember_lbl2" xml:lang="en-US">Bottom of range [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BottomOfRangeMember" xlink:to="ifrs-full_BottomOfRangeMember_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_RightOfUseLeasedAssetTaxLiabilityMember_lbl1" xml:lang="en-US">Right Of Use Leased Asset Tax Liability Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RightOfUseLeasedAssetTaxLiabilityMember" xlink:to="mlec_RightOfUseLeasedAssetTaxLiabilityMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PrivateWarrantsShares_lbl1" xml:lang="en-US">Private Warrants Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PrivateWarrantsShares" xlink:to="mlec_PrivateWarrantsShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment_lbl0" xml:lang="en-US">Increase (decrease) through transfers from (to) investment property, property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment" xlink:to="ifrs-full_IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_StrikePriceForConversionOfDebt_lbl1" xml:lang="en-US">Strike Price For Conversion Of Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_StrikePriceForConversionOfDebt" xlink:to="mlec_StrikePriceForConversionOfDebt_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract_lbl0" xml:lang="en-US">Weighted average ordinary shares used in calculating basic and diluted earnings per share [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract" xlink:to="ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfChangesInAllowancesAndProvisionsAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfChangesInAllowancesAndProvisionsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfChangesInAllowancesAndProvisionsAbstract_lbl" xml:lang="en-US">Schedule Of Changes In Allowances And Provisions Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfChangesInAllowancesAndProvisionsAbstract" xlink:to="mlec_ScheduleOfChangesInAllowancesAndProvisionsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_lbl0" xml:lang="en-US">Key management personnel compensation, short-term employee benefits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:to="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_OtherIntangibleAssetsAbstract0_lbl0" xml:lang="en-US">Other Intangible Assets Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherIntangibleAssetsAbstract0" xlink:to="mlec_OtherIntangibleAssetsAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossFromDiscontinuedOperations_lbl0" xml:lang="en-US">Profit (loss) from discontinued operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:to="ifrs-full_ProfitLossFromDiscontinuedOperations_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ConsiderationForIssuedOrdinaryShareValue_lbl1" xml:lang="en-US">Consideration For Issued Ordinary Share Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ConsiderationForIssuedOrdinaryShareValue" xlink:to="mlec_ConsiderationForIssuedOrdinaryShareValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TravelExpense_lbl0" xml:lang="en-US">Travel expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TravelExpense" xlink:to="ifrs-full_TravelExpense_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_ConsolidatedStatementOfChangesInShareholdersDeficitEquityAbstract" xlink:href="mlec-20250630.xsd#mlec_ConsolidatedStatementOfChangesInShareholdersDeficitEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ConsolidatedStatementOfChangesInShareholdersDeficitEquityAbstract_lbl" xml:lang="en-US">Consolidated Statement Of Changes In Shareholders Deficit Equity Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ConsolidatedStatementOfChangesInShareholdersDeficitEquityAbstract" xlink:to="mlec_ConsolidatedStatementOfChangesInShareholdersDeficitEquityAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdditionalProvisionsOtherProvisions_lbl0" xml:lang="en-US">Additional provisions, other provisions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionalProvisionsOtherProvisions" xlink:to="ifrs-full_AdditionalProvisionsOtherProvisions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfGovernmentGrantsExplanatory_lbl0" xml:lang="en-US">Disclosure of government grants [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfGovernmentGrantsExplanatory" xlink:to="ifrs-full_DisclosureOfGovernmentGrantsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SalesOfGoodsAndServicesMember_lbl0" xml:lang="en-US">Sales Of Goods And Services Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SalesOfGoodsAndServicesMember" xlink:to="mlec_SalesOfGoodsAndServicesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory_lbl0" xml:lang="en-US">Disclosure of reconciliation of changes in goodwill [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory" xlink:to="ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_MutualFundsMember_lbl1" xml:lang="en-US">Mutual Funds Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MutualFundsMember" xlink:to="mlec_MutualFundsMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_lbl0" xml:lang="en-US">Description of accounting policy for recognition of revenue [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ValuationSignificantChangeInAmountNormalWearAndTearVariationImpactOnRevaluationAmount_lbl1" xml:lang="en-US">Valuation Significant Change In Amount Normal Wear And Tear Variation Impact On Revaluation Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ValuationSignificantChangeInAmountNormalWearAndTearVariationImpactOnRevaluationAmount" xlink:to="mlec_ValuationSignificantChangeInAmountNormalWearAndTearVariationImpactOnRevaluationAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TaxEffectFromChangeInTaxRate_lbl0" xml:lang="en-US">Tax effect from change in tax rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TaxEffectFromChangeInTaxRate" xlink:to="ifrs-full_TaxEffectFromChangeInTaxRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AmortizationPayments_lbl1" xml:lang="en-US">Amortization Payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AmortizationPayments" xlink:to="mlec_AmortizationPayments_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_lbl1" xml:lang="en-US">Cash flows from (used in) financing activities [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InventoriesCurrent_lbl1" xml:lang="en-US">Inventories Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InventoriesCurrent" xlink:to="mlec_InventoriesCurrent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DenominatorAbstract_lbl0" xml:lang="en-US">Denominator Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DenominatorAbstract" xlink:to="mlec_DenominatorAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_IncomeAndMinimumPresumedRecoverableIncomeTaxes_lbl1" xml:lang="en-US">Income And Minimum Presumed Recoverable Income Taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IncomeAndMinimumPresumedRecoverableIncomeTaxes" xlink:to="mlec_IncomeAndMinimumPresumedRecoverableIncomeTaxes_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_GovernmentsGrantsReceivableMember_lbl0" xml:lang="en-US">Governments Grants Receivable Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_GovernmentsGrantsReceivableMember" xlink:to="mlec_GovernmentsGrantsReceivableMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_TradeDebtorsMember_lbl0" xml:lang="en-US">Trade Debtors Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TradeDebtorsMember" xlink:to="mlec_TradeDebtorsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InvestmentsInJointVenturesAndAssociates_lbl1" xml:lang="en-US">Investments In Joint Ventures And Associates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InvestmentsInJointVenturesAndAssociates" xlink:to="mlec_InvestmentsInJointVenturesAndAssociates_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Goodwill_lbl0" xml:lang="en-US">Goodwill</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Goodwill" xlink:to="ifrs-full_Goodwill_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_lbl0" xml:lang="en-US">Number of share options exercised in share-based payment arrangement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations_lbl0" xml:lang="en-US">Other comprehensive income, net of tax, exchange differences on translation, other than translation of foreign operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossAttributableToOwnersOfParent_lbl0" xml:lang="en-US">Profit (loss), attributable to owners of parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:to="ifrs-full_ProfitLossAttributableToOwnersOfParent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_lbl1" xml:lang="en-US">Deferred tax expense (income) recognised in profit or loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:to="ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_lbl0" xml:lang="en-US">Disclosure of transactions between related parties [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" xlink:to="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfLiquidityRiskAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfLiquidityRiskAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfLiquidityRiskAbstract_lbl" xml:lang="en-US">Schedule Of Liquidity Risk Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfLiquidityRiskAbstract" xlink:to="mlec_ScheduleOfLiquidityRiskAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ParValuePerShare_lbl2" xml:lang="en-US">Par value per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ParValuePerShare" xlink:to="ifrs-full_ParValuePerShare_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SharesSubjectToEmployeeStockPurchasePlan_lbl1" xml:lang="en-US">Shares Subject To Employee Stock Purchase Plan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SharesSubjectToEmployeeStockPurchasePlan" xlink:to="mlec_SharesSubjectToEmployeeStockPurchasePlan_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DisclosureOfCarryingValueOfBorrowingsExplanatory_lbl1" xml:lang="en-US">Disclosure Of Carrying Value Of Borrowings Explanatory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfCarryingValueOfBorrowingsExplanatory" xlink:to="mlec_DisclosureOfCarryingValueOfBorrowingsExplanatory_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SubscribedCapitalOfShares_lbl1" xml:lang="en-US">Subscribed Capital Of Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SubscribedCapitalOfShares" xlink:to="mlec_SubscribedCapitalOfShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PrepaymentPremiumFee_lbl3" xml:lang="en-US">Prepayment Premium Fee</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PrepaymentPremiumFee" xlink:to="mlec_PrepaymentPremiumFee_lbl3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TransportationExpense_lbl0" xml:lang="en-US">Transportation expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TransportationExpense" xlink:to="ifrs-full_TransportationExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NumberOfComplementaryComponents_lbl1" xml:lang="en-US">Number Of Complementary Components</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfComplementaryComponents" xlink:to="mlec_NumberOfComplementaryComponents_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for impairment of assets [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_MicrobiologicalResaleProductsMember_lbl1" xml:lang="en-US">Microbiological Resale Products Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MicrobiologicalResaleProductsMember" xlink:to="mlec_MicrobiologicalResaleProductsMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_lbl0" xml:lang="en-US">Purchase of intangible assets, classified as investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:to="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition_lbl1" xml:lang="en-US">Cash and cash equivalents if different from statement of financial position</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition" xlink:to="ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AllowanceForReturnOfGoods_lbl1" xml:lang="en-US">Allowance For Return Of Goods</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AllowanceForReturnOfGoods" xlink:to="mlec_AllowanceForReturnOfGoods_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_RevenueFromSaleOfGoodsAndRenderingOfServices_lbl1" xml:lang="en-US">Revenue From Sale Of Goods And Rendering Of Services</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RevenueFromSaleOfGoodsAndRenderingOfServices" xlink:to="mlec_RevenueFromSaleOfGoodsAndRenderingOfServices_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Cash flows from (used in) operating activities [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DeferredTaxAssetMember_lbl1" xml:lang="en-US">Deferred Tax Asset Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DeferredTaxAssetMember" xlink:to="mlec_DeferredTaxAssetMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ArgentinePriceIndexShares_lbl1" xml:lang="en-US">Argentine Price Index Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ArgentinePriceIndexShares" xlink:to="mlec_ArgentinePriceIndexShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DeferredTaxAssets_lbl0" xml:lang="en-US">Deferred tax assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxAssets" xlink:to="ifrs-full_DeferredTaxAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_lbl0" xml:lang="en-US">Weighted average exercise price of share options granted in share-based payment arrangement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset_lbl0" xml:lang="en-US">Increase (decrease) through business combinations, deferred tax liability (asset)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" xlink:to="ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MachineryMember_lbl0" xml:lang="en-US">Machinery [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MachineryMember" xlink:to="ifrs-full_MachineryMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MajorBusinessCombinationMember_lbl0" xml:lang="en-US">Major business combination [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MajorBusinessCombinationMember" xlink:to="ifrs-full_MajorBusinessCombinationMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SuppliesMember_lbl0" xml:lang="en-US">Supplies Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SuppliesMember" xlink:to="mlec_SuppliesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ProceedFromIssuedShares_lbl1" xml:lang="en-US">Proceed From Issued Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ProceedFromIssuedShares" xlink:to="mlec_ProceedFromIssuedShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IssuedCapitalPreferenceShares_lbl0" xml:lang="en-US">Issued capital, preference shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssuedCapitalPreferenceShares" xlink:to="ifrs-full_IssuedCapitalPreferenceShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_CompensationPaymentFinancedByAcquisitionOfIntangibleAssets_lbl1" xml:lang="en-US">Compensation Payment Financed By Acquisition Of Intangible Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CompensationPaymentFinancedByAcquisitionOfIntangibleAssets" xlink:to="mlec_CompensationPaymentFinancedByAcquisitionOfIntangibleAssets_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForAmortisationExpense_lbl0" xml:lang="en-US">Adjustments for amortisation expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForAmortisationExpense" xlink:to="ifrs-full_AdjustmentsForAmortisationExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_IncomeTaxExpenseByApplyingApplicableTaxRateInForceInRespectiveJurisdictionsTableTextBlock_lbl1" xml:lang="en-US">Income Tax Expense By Applying Applicable Tax Rate In Force In Respective Jurisdictions Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IncomeTaxExpenseByApplyingApplicableTaxRateInForceInRespectiveJurisdictionsTableTextBlock" xlink:to="mlec_IncomeTaxExpenseByApplyingApplicableTaxRateInForceInRespectiveJurisdictionsTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DeferredTaxLiabilityMember_lbl1" xml:lang="en-US">Deferred Tax Liability Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DeferredTaxLiabilityMember" xlink:to="mlec_DeferredTaxLiabilityMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FortyEightMonthsMember_lbl0" xml:lang="en-US">Forty Eight Months Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FortyEightMonthsMember" xlink:to="mlec_FortyEightMonthsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ShareBasedPaymentsIncentiveIncreases_lbl1" xml:lang="en-US">Share Based Payments Incentive Increases</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareBasedPaymentsIncentiveIncreases" xlink:to="mlec_ShareBasedPaymentsIncentiveIncreases_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OfficeEquipmentMember_lbl0" xml:lang="en-US">Office equipment [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OfficeEquipmentMember" xlink:to="ifrs-full_OfficeEquipmentMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentLiabilitiesAbstract_lbl0" xml:lang="en-US">Current liabilities [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_CurrentLiabilitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfEarningsPerShareExplanatory_lbl0" xml:lang="en-US">Disclosure of earnings per share [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:to="ifrs-full_DisclosureOfEarningsPerShareExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Provisions_lbl0" xml:lang="en-US">Provisions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Provisions" xlink:to="ifrs-full_Provisions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_IntegratedSeedProductsMember_lbl0" xml:lang="en-US">Integrated Seed Products Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IntegratedSeedProductsMember" xlink:to="mlec_IntegratedSeedProductsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_BioceresGroupLimitedMember_lbl0" xml:lang="en-US">Bioceres Group Limited Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BioceresGroupLimitedMember" xlink:to="mlec_BioceresGroupLimitedMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfExpensesByNatureExplanatory_lbl0" xml:lang="en-US">Disclosure of expenses by nature [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfExpensesByNatureExplanatory" xlink:to="ifrs-full_DisclosureOfExpensesByNatureExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections_lbl0" xml:lang="en-US">Discount rate applied to cash flow projections</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections" xlink:to="ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_lbl0" xml:lang="en-US">Disclosure of entity&apos;s operating segments [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:to="ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_lbl1" xml:lang="en-US">Profit (loss), attributable to ordinary equity holders of parent entity, used in calculating basic earnings per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" xlink:to="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_IfrsConvertibleNotesPayableMember_lbl1" xml:lang="en-US">Ifrs Convertible Notes Payable Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IfrsConvertibleNotesPayableMember" xlink:to="mlec_IfrsConvertibleNotesPayableMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FinancialCostAbstract_lbl0" xml:lang="en-US">Financial Cost Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialCostAbstract" xlink:to="mlec_FinancialCostAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_BioceresCropsSAMember_lbl0" xml:lang="en-US">Bioceres Crops SAMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BioceresCropsSAMember" xlink:to="mlec_BioceresCropsSAMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DisclosureOfBenefitsAndSocialSecurityPayablesTableTextBlock_lbl1" xml:lang="en-US">Disclosure Of Benefits And Social Security Payables Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfBenefitsAndSocialSecurityPayablesTableTextBlock" xlink:to="mlec_DisclosureOfBenefitsAndSocialSecurityPayablesTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_lbl0" xml:lang="en-US">Disclosure of number and weighted average exercise prices of share options [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherNoncurrentFinancialAssets_lbl1" xml:lang="en-US">Other non-current financial assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentFinancialAssets" xlink:to="ifrs-full_OtherNoncurrentFinancialAssets_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_TaxEffectOfShareOfProfitOrLossOfSubsidiesJointVenturesAndAssociates_lbl1" xml:lang="en-US">Tax Effect Of Share Of Profit Or Loss Of Subsidies Joint Ventures And Associates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TaxEffectOfShareOfProfitOrLossOfSubsidiesJointVenturesAndAssociates" xlink:to="mlec_TaxEffectOfShareOfProfitOrLossOfSubsidiesJointVenturesAndAssociates_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_MicroBeadedFertilizersMember_lbl1" xml:lang="en-US">Micro Beaded Fertilizers Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MicroBeadedFertilizersMember" xlink:to="mlec_MicroBeadedFertilizersMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Inventories_lbl0" xml:lang="en-US">Current inventories</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Inventories" xlink:to="ifrs-full_Inventories_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfFinancialStatementsTextBlock_lbl1" xml:lang="en-US">Schedule Of Financial Statements Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfFinancialStatementsTextBlock" xlink:to="mlec_ScheduleOfFinancialStatementsTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NumberOfSharesOutstandingPercentage_lbl1" xml:lang="en-US">Number Of Shares Outstanding Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfSharesOutstandingPercentage" xlink:to="mlec_NumberOfSharesOutstandingPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Machinery_lbl0" xml:lang="en-US">Machinery</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Machinery" xlink:to="ifrs-full_Machinery_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ProvisionForContingenciesMember_lbl1" xml:lang="en-US">Provision For Contingencies Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ProvisionForContingenciesMember" xlink:to="mlec_ProvisionForContingenciesMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_TrigallGeneticsSAMember_lbl1" xml:lang="en-US">Trigall Genetics SAMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TrigallGeneticsSAMember" xlink:to="mlec_TrigallGeneticsSAMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfInventoriesExplanatory_lbl0" xml:lang="en-US">Disclosure of inventories [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfInventoriesExplanatory" xlink:to="ifrs-full_DisclosureOfInventoriesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PiggysooyMember_lbl0" xml:lang="en-US">Piggysooy Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PiggysooyMember" xlink:to="mlec_PiggysooyMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfGeographicalAreasExplanatory_lbl0" xml:lang="en-US">Disclosure of geographical areas [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfGeographicalAreasExplanatory" xlink:to="ifrs-full_DisclosureOfGeographicalAreasExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForFinanceCosts_lbl0" xml:lang="en-US">Adjustments for finance costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForFinanceCosts" xlink:to="ifrs-full_AdjustmentsForFinanceCosts_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfFairValueOfTheStockOptionsAtTheGrantDateAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfFairValueOfTheStockOptionsAtTheGrantDateAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfFairValueOfTheStockOptionsAtTheGrantDateAbstract_lbl" xml:lang="en-US">Schedule Of Fair Value Of The Stock Options At The Grant Date Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfFairValueOfTheStockOptionsAtTheGrantDateAbstract" xlink:to="mlec_ScheduleOfFairValueOfTheStockOptionsAtTheGrantDateAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LeaseLiabilities_lbl1" xml:lang="en-US">Lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LeaseLiabilities" xlink:to="ifrs-full_LeaseLiabilities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AllowancesMember_lbl0" xml:lang="en-US">Allowances Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AllowancesMember" xlink:to="mlec_AllowancesMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_ResearchAndDevelopmentsExpenseAbstract" xlink:href="mlec-20250630.xsd#mlec_ResearchAndDevelopmentsExpenseAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ResearchAndDevelopmentsExpenseAbstract_lbl" xml:lang="en-US">Research And Developments Expense Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ResearchAndDevelopmentsExpenseAbstract" xlink:to="mlec_ResearchAndDevelopmentsExpenseAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_lbl0" xml:lang="en-US">Deferred tax liabilities recognised as of acquisition date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfIntangibleAssetsAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfIntangibleAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfIntangibleAssetsAbstract_lbl" xml:lang="en-US">Schedule Of Intangible Assets Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfIntangibleAssetsAbstract" xlink:to="mlec_ScheduleOfIntangibleAssetsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ConsolidatedEntitieMember_lbl0" xml:lang="en-US">Consolidated Entitie Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ConsolidatedEntitieMember" xlink:to="mlec_ConsolidatedEntitieMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_lbl0" xml:lang="en-US">Later than one year and not later than three years [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:to="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_CapitalizationOfConvertibleFinancingActivities_lbl1" xml:lang="en-US">Capitalization Of Convertible Financing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CapitalizationOfConvertibleFinancingActivities" xlink:to="mlec_CapitalizationOfConvertibleFinancingActivities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory_lbl0" xml:lang="en-US">Disclosure of material accounting policy information [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory" xlink:to="ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_KeyManagementPersonnelCompensation_lbl0" xml:lang="en-US">Key management personnel compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_KeyManagementPersonnelCompensation" xlink:to="ifrs-full_KeyManagementPersonnelCompensation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NetLoansReceivedMember_lbl0" xml:lang="en-US">Net Loans Received Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NetLoansReceivedMember" xlink:to="mlec_NetLoansReceivedMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_RemeasurementToFairValueOfPreexistingInterestInAnAcquiree_lbl1" xml:lang="en-US">Remeasurement To Fair Value Of Preexisting Interest In An Acquiree</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RemeasurementToFairValueOfPreexistingInterestInAnAcquiree" xlink:to="mlec_RemeasurementToFairValueOfPreexistingInterestInAnAcquiree_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NotionalAmount_lbl0" xml:lang="en-US">Notional amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NotionalAmount" xlink:to="ifrs-full_NotionalAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_MeasurementAtFairValueAt06302024Abstract_lbl0" xml:lang="en-US">Measurement At Fair Value At06302024 Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MeasurementAtFairValueAt06302024Abstract" xlink:to="mlec_MeasurementAtFairValueAt06302024Abstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AdditionalConvertibleNotesReceivedAmount_lbl1" xml:lang="en-US">Additional Convertible Notes Received Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AdditionalConvertibleNotesReceivedAmount" xlink:to="mlec_AdditionalConvertibleNotesReceivedAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherPayables_lbl1" xml:lang="en-US">Trade and other payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherPayables" xlink:to="ifrs-full_TradeAndOtherPayables_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_MeasuredAtFairValueAbstract0_lbl0" xml:lang="en-US">Measured At Fair Value Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MeasuredAtFairValueAbstract0" xlink:to="mlec_MeasuredAtFairValueAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Level1OfFairValueHierarchyMember_lbl0" xml:lang="en-US">Level 1 of fair value hierarchy [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Level1OfFairValueHierarchyMember" xlink:to="ifrs-full_Level1OfFairValueHierarchyMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_LatinAmericaMember_lbl0" xml:lang="en-US">Latin America [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_LatinAmericaMember" xlink:to="srt_LatinAmericaMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherCurrentReceivables_lbl0" xml:lang="en-US">Trade and other current receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentReceivables" xlink:to="ifrs-full_TradeAndOtherCurrentReceivables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ProceedsFromIssueOfEquityInstrumentsOnConversionOfDebt_lbl1" xml:lang="en-US">Proceeds From Issue Of Equity Instruments On Conversion Of Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ProceedsFromIssueOfEquityInstrumentsOnConversionOfDebt" xlink:to="mlec_ProceedsFromIssueOfEquityInstrumentsOnConversionOfDebt_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialAssetsAtFairValue_lbl1" xml:lang="en-US">Financial assets, at fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialAssetsAtFairValue" xlink:to="ifrs-full_FinancialAssetsAtFairValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SeedsAndGrainsMember_lbl1" xml:lang="en-US">Seeds And Grains Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SeedsAndGrainsMember" xlink:to="mlec_SeedsAndGrainsMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EquityAbstract_lbl0" xml:lang="en-US">Equity [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAbstract" xlink:to="ifrs-full_EquityAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IssuedCapitalMember_lbl0" xml:lang="en-US">Issued capital [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssuedCapitalMember" xlink:to="ifrs-full_IssuedCapitalMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory_lbl0" xml:lang="en-US">Disclosure of reconciliation of liabilities arising from financing activities [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory" xlink:to="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_CropProtectionMember_lbl1" xml:lang="en-US">Crop Protection Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CropProtectionMember" xlink:to="mlec_CropProtectionMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_HB4SoyAndBreedingProgramMember_lbl0" xml:lang="en-US">HB4 Soy And Breeding Program Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_HB4SoyAndBreedingProgramMember" xlink:to="mlec_HB4SoyAndBreedingProgramMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DeferredTaxAssetsAbstract_lbl0" xml:lang="en-US">Deferred Tax Assets Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DeferredTaxAssetsAbstract" xlink:to="mlec_DeferredTaxAssetsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DisclosureOfFairValueOfTheStockOptionsAtTheGrantDateTextBlock_lbl1" xml:lang="en-US">Disclosure Of Fair Value Of The Stock Options At The Grant Date Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfFairValueOfTheStockOptionsAtTheGrantDateTextBlock" xlink:to="mlec_DisclosureOfFairValueOfTheStockOptionsAtTheGrantDateTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SubscribedCapital_lbl1" xml:lang="en-US">Subscribed Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SubscribedCapital" xlink:to="mlec_SubscribedCapital_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DecreaseDueToHarvestAndDisposalsBiologicalAssets_lbl1" xml:lang="en-US">Decrease Due To Harvest And Disposals Biological Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DecreaseDueToHarvestAndDisposalsBiologicalAssets" xlink:to="mlec_DecreaseDueToHarvestAndDisposalsBiologicalAssets_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax_lbl0" xml:lang="en-US">Gains (losses) on exchange differences on translation of foreign operations, net of tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" xlink:to="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_MoolecScienceLimitedMember_lbl0" xml:lang="en-US">Moolec Science Limited Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MoolecScienceLimitedMember" xlink:to="mlec_MoolecScienceLimitedMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AveragePaymentTermBySales_lbl1" xml:lang="en-US">Average Payment Term By Sales</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AveragePaymentTermBySales" xlink:to="mlec_AveragePaymentTermBySales_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LiabilitiesAbstract_lbl0" xml:lang="en-US">Liabilities [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiabilitiesAbstract" xlink:to="ifrs-full_LiabilitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_MandatorilyMeasuredAtFairValueThroughProfitOrLossMember_lbl0" xml:lang="en-US">Mandatorily Measured At Fair Value Through Profit Or Loss Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MandatorilyMeasuredAtFairValueThroughProfitOrLossMember" xlink:to="mlec_MandatorilyMeasuredAtFairValueThroughProfitOrLossMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OrdinarySharesMember_lbl2" xml:lang="en-US">Ordinary shares [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OrdinarySharesMember" xlink:to="ifrs-full_OrdinarySharesMember_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NumeratorAbstract_lbl0" xml:lang="en-US">Numerator Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumeratorAbstract" xlink:to="mlec_NumeratorAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PerformanceShareOptionPlanMember_lbl2" xml:lang="en-US">Performance Share Option Plan Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PerformanceShareOptionPlanMember" xlink:to="mlec_PerformanceShareOptionPlanMember_lbl2"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfEmployeeBenefitsAndSocialSecurityAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfEmployeeBenefitsAndSocialSecurityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfEmployeeBenefitsAndSocialSecurityAbstract_lbl" xml:lang="en-US">Schedule Of Employee Benefits And Social Security Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfEmployeeBenefitsAndSocialSecurityAbstract" xlink:to="mlec_ScheduleOfEmployeeBenefitsAndSocialSecurityAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities_lbl0" xml:lang="en-US">Dividends paid to non-controlling interests, classified as financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities" xlink:to="ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_MutualFundsAdjustment_lbl1" xml:lang="en-US">Mutual Funds Adjustment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MutualFundsAdjustment" xlink:to="mlec_MutualFundsAdjustment_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_BookValueAtTheBeginningOfThePeriod_lbl1" xml:lang="en-US">Book Value At The Beginning Of The Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BookValueAtTheBeginningOfThePeriod" xlink:to="mlec_BookValueAtTheBeginningOfThePeriod_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic_lbl2" xml:lang="en-US">Risk exposure associated with instruments sharing characteristic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic" xlink:to="ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_OwnShareHeld_lbl1" xml:lang="en-US">Own Share Held</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OwnShareHeld" xlink:to="mlec_OwnShareHeld_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_BorrowingMember_lbl1" xml:lang="en-US">Borrowing Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BorrowingMember" xlink:to="mlec_BorrowingMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities_lbl0" xml:lang="en-US">Cash flows from (used in) operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossBeforeTax_lbl2" xml:lang="en-US">Profit (loss) before tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_ProfitLossBeforeTax_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AtAmortizedCostMember_lbl1" xml:lang="en-US">At Amortized Cost Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AtAmortizedCostMember" xlink:to="mlec_AtAmortizedCostMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_TradeCreditorsJointVenturesAndAssociates_lbl1" xml:lang="en-US">Trade Creditors Joint Ventures And Associates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TradeCreditorsJointVenturesAndAssociates" xlink:to="mlec_TradeCreditorsJointVenturesAndAssociates_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AccountingProfit_lbl0" xml:lang="en-US">Accounting profit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AccountingProfit" xlink:to="ifrs-full_AccountingProfit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions_lbl0" xml:lang="en-US">Acquisitions through business combinations, other provisions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions" xlink:to="ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ContingentPurchasePrice_lbl1" xml:lang="en-US">Contingent Purchase Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ContingentPurchasePrice" xlink:to="mlec_ContingentPurchasePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_lbl0" xml:lang="en-US">Increase (decrease) through share-based payment transactions, equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:to="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ForeignCurrencyTranslationOnInventory_lbl1" xml:lang="en-US">Foreign Currency Translation On Inventory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ForeignCurrencyTranslationOnInventory" xlink:to="mlec_ForeignCurrencyTranslationOnInventory_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_GentleTechMember_lbl0" xml:lang="en-US">Gentle Tech Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_GentleTechMember" xlink:to="mlec_GentleTechMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_EmployeeStockOptionPlanMember_lbl2" xml:lang="en-US">Employee Stock Option Plan Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_EmployeeStockOptionPlanMember" xlink:to="mlec_EmployeeStockOptionPlanMember_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory_lbl0" xml:lang="en-US">Disclosure of interests in subsidiaries [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory" xlink:to="ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NonCashInvestingActivities_lbl1" xml:lang="en-US">Non Cash Investing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NonCashInvestingActivities" xlink:to="mlec_NonCashInvestingActivities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory_lbl0" xml:lang="en-US">Disclosure of transactions recognised separately from acquisition of assets and assumption of liabilities in business combination [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory" xlink:to="ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherReceivables_lbl1" xml:lang="en-US">Other receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherReceivables" xlink:to="ifrs-full_OtherReceivables_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LicencesMember_lbl0" xml:lang="en-US">Licences [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LicencesMember" xlink:to="ifrs-full_LicencesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ShareOptionsMember_lbl1" xml:lang="en-US">Share options [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShareOptionsMember" xlink:to="ifrs-full_ShareOptionsMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NonCurrentAbstract0_lbl0" xml:lang="en-US">Non Current Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NonCurrentAbstract0" xlink:to="mlec_NonCurrentAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NonCurrentAbstract1_lbl0" xml:lang="en-US">Non Current Abstract1</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NonCurrentAbstract1" xlink:to="mlec_NonCurrentAbstract1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Level2OfFairValueHierarchyMember_lbl0" xml:lang="en-US">Level 2 of fair value hierarchy [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Level2OfFairValueHierarchyMember" xlink:to="ifrs-full_Level2OfFairValueHierarchyMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherReceivablesDueFromRelatedParties_lbl0" xml:lang="en-US">Receivables due from related parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherReceivablesDueFromRelatedParties" xlink:to="ifrs-full_TradeAndOtherReceivablesDueFromRelatedParties_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_TaxEffectOfStockOptionCharge_lbl1" xml:lang="en-US">Tax Effect Of Stock Option Charge</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TaxEffectOfStockOptionCharge" xlink:to="mlec_TaxEffectOfStockOptionCharge_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_lbl0" xml:lang="en-US">Expense from share-based payment transactions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfRollforwardOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl1" xml:lang="en-US">Schedule Of Rollforward Of Deferred Tax Assets And Liabilities Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfRollforwardOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="mlec_ScheduleOfRollforwardOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AgralityUSIncMember_lbl0" xml:lang="en-US">Agrality USInc Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AgralityUSIncMember" xlink:to="mlec_AgralityUSIncMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_lbl0" xml:lang="en-US">Disclosure of expected impact of initial application of new standards or interpretations [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" xlink:to="ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ExpensesClassifiedByNatureAndFunctionMember_lbl0" xml:lang="en-US">Expenses Classified By Nature And Function Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ExpensesClassifiedByNatureAndFunctionMember" xlink:to="mlec_ExpensesClassifiedByNatureAndFunctionMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SeedCpProductsAndServicesMember_lbl1" xml:lang="en-US">Seed Cp Products And Services Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SeedCpProductsAndServicesMember" xlink:to="mlec_SeedCpProductsAndServicesMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PercentageOfPrepaymentPremium_lbl1" xml:lang="en-US">Percentage Of Prepayment Premium</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfPrepaymentPremium" xlink:to="mlec_PercentageOfPrepaymentPremium_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_lbl2" xml:lang="en-US">Consideration transferred, acquisition-date fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:to="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables_lbl0" xml:lang="en-US">Impairment loss recognised in profit or loss, trade receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables" xlink:to="ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_TrademarksAndPatentsMember_lbl0" xml:lang="en-US">Trademarks And Patents Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TrademarksAndPatentsMember" xlink:to="mlec_TrademarksAndPatentsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinanceIncomeCost_lbl2" xml:lang="en-US">Finance income (cost)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceIncomeCost" xlink:to="ifrs-full_FinanceIncomeCost_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ConsiderationForAcquisitionOfAssets_lbl1" xml:lang="en-US">Consideration For Acquisition Of Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ConsiderationForAcquisitionOfAssets" xlink:to="mlec_ConsiderationForAcquisitionOfAssets_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory_lbl0" xml:lang="en-US">Disclosure of financial liabilities [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory" xlink:to="ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ShareOfProfitOrLossOfSubsidiaries_lbl1" xml:lang="en-US">Share Of Profit Or Loss Of Subsidiaries</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareOfProfitOrLossOfSubsidiaries" xlink:to="mlec_ShareOfProfitOrLossOfSubsidiaries_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_VariableRateBorrowingsMember_lbl1" xml:lang="en-US">Variable Rate Borrowings Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_VariableRateBorrowingsMember" xlink:to="mlec_VariableRateBorrowingsMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_LeaseLiabiltyAdditionsOfTheYear_lbl1" xml:lang="en-US">Lease Liabilty Additions Of The Year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LeaseLiabiltyAdditionsOfTheYear" xlink:to="mlec_LeaseLiabiltyAdditionsOfTheYear_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialLiabilitiesAtAmortisedCostMember_lbl0" xml:lang="en-US">Financial liabilities at amortised cost, class [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" xlink:to="ifrs-full_FinancialLiabilitiesAtAmortisedCostMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinancialAssetsExplanatory_lbl0" xml:lang="en-US">Disclosure of financial assets [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfFinancialAssetsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ConversionOptionStrikePrice_lbl1" xml:lang="en-US">Conversion Option Strike Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ConversionOptionStrikePrice" xlink:to="mlec_ConversionOptionStrikePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_BusinessCombinationMember_lbl0" xml:lang="en-US">Business Combination Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BusinessCombinationMember" xlink:to="mlec_BusinessCombinationMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_lbl1" xml:lang="en-US">Key management personnel of entity or parent [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:to="ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_lbl0" xml:lang="en-US">Disclosure of detailed information about borrowings [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeStatementAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeStatementAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncomeStatementAbstract_lbl" xml:lang="en-US">Profit or loss [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_IncomeStatementAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentPortionOfLongtermBorrowings_lbl0" xml:lang="en-US">Current portion of non-current borrowings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentPortionOfLongtermBorrowings" xlink:to="ifrs-full_CurrentPortionOfLongtermBorrowings_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_IncludedInLiabilitiesAbstract_lbl0" xml:lang="en-US">Included In Liabilities Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IncludedInLiabilitiesAbstract" xlink:to="mlec_IncludedInLiabilitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LaterThanThreeMonthsAndNotLaterThanOneYearMember_lbl0" xml:lang="en-US">Later than three months and not later than one year [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LaterThanThreeMonthsAndNotLaterThanOneYearMember" xlink:to="ifrs-full_LaterThanThreeMonthsAndNotLaterThanOneYearMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_MicrobiologicalProductsInProgressMember_lbl0" xml:lang="en-US">Microbiological Products In Progress Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MicrobiologicalProductsInProgressMember" xlink:to="mlec_MicrobiologicalProductsInProgressMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates_lbl0" xml:lang="en-US">Investments in subsidiaries, joint ventures and associates reported in separate financial statements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:to="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NoncurrentAsset_lbl1" xml:lang="en-US">Noncurrent Asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NoncurrentAsset" xlink:to="mlec_NoncurrentAsset_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfPropertyPlantAndEquipmentAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfPropertyPlantAndEquipmentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfPropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Schedule Of Property Plant And Equipment Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfPropertyPlantAndEquipmentAbstract" xlink:to="mlec_ScheduleOfPropertyPlantAndEquipmentAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DecreaseBecauseOfLossOfControl_lbl1" xml:lang="en-US">Decrease Because Of Loss Of Control</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DecreaseBecauseOfLossOfControl" xlink:to="mlec_DecreaseBecauseOfLossOfControl_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CostOfSales_lbl3" xml:lang="en-US">Cost of sales</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CostOfSales" xlink:to="ifrs-full_CostOfSales_lbl3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_MoolecScienceSAMember_lbl0" xml:lang="en-US">Moolec Science SAMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MoolecScienceSAMember" xlink:to="mlec_MoolecScienceSAMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ResearchAndDevelopmentExpense_lbl3" xml:lang="en-US">Research and development expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ResearchAndDevelopmentExpense" xlink:to="ifrs-full_ResearchAndDevelopmentExpense_lbl3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_lbl2" xml:lang="en-US">Share of profit (loss) of associates and joint ventures accounted for using equity method</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:to="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_CurrentTradeReceivablesTradeDebtorsJointVenturesAndAssociates_lbl1" xml:lang="en-US">Current Trade Receivables Trade Debtors Joint Ventures And Associates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CurrentTradeReceivablesTradeDebtorsJointVenturesAndAssociates" xlink:to="mlec_CurrentTradeReceivablesTradeDebtorsJointVenturesAndAssociates_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_lbl0" xml:lang="en-US">Number of share options forfeited in share-based payment arrangement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime_lbl0" xml:lang="en-US">Current contract liabilities for performance obligations satisfied over time</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime" xlink:to="ifrs-full_CurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod_lbl1" xml:lang="en-US">Ifrs Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod" xlink:to="mlec_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DisclosureOfIntangibleAssetsAndLiabilitiesAssumedTextBlock_lbl1" xml:lang="en-US">Disclosure Of Intangible Assets And Liabilities Assumed Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfIntangibleAssetsAndLiabilitiesAssumedTextBlock" xlink:to="mlec_DisclosureOfIntangibleAssetsAndLiabilitiesAssumedTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SharebasedIncentivesForEmployees_lbl1" xml:lang="en-US">Sharebased Incentives For Employees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SharebasedIncentivesForEmployees" xlink:to="mlec_SharebasedIncentivesForEmployees_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentProvisionsForEmployeeBenefits_lbl1" xml:lang="en-US">Current provisions for employee benefits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentProvisionsForEmployeeBenefits" xlink:to="ifrs-full_CurrentProvisionsForEmployeeBenefits_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DisclosureOfShareOfProfitOrLossInJointVenturesAndAffiliatesTableTextBlock_lbl1" xml:lang="en-US">Disclosure Of Share Of Profit Or Loss In Joint Ventures And Affiliates Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfShareOfProfitOrLossInJointVenturesAndAffiliatesTableTextBlock" xlink:to="mlec_DisclosureOfShareOfProfitOrLossInJointVenturesAndAffiliatesTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NonCurrentAbstract_lbl0" xml:lang="en-US">Non Current Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NonCurrentAbstract" xlink:to="mlec_NonCurrentAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_lbl0" xml:lang="en-US">Disclosure of detailed information about intangible assets [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDebtSecuritiesExplanatory_lbl0" xml:lang="en-US">Disclosure of debt instruments [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDebtSecuritiesExplanatory" xlink:to="ifrs-full_DisclosureOfDebtSecuritiesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Equity_lbl5" xml:lang="en-US">Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_Equity_lbl5"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_OtherCurrencies_lbl1" xml:lang="en-US">Other Currencies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherCurrencies" xlink:to="mlec_OtherCurrencies_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_lbl0" xml:lang="en-US">Proportion of ownership interests held by non-controlling interests</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:to="ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_IfrsDefinedContributionPlanEmployerMatchingContributionPercentOfEmployeesGrossPay_lbl1" xml:lang="en-US">Ifrs Defined Contribution Plan Employer Matching Contribution Percent Of Employees Gross Pay</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IfrsDefinedContributionPlanEmployerMatchingContributionPercentOfEmployeesGrossPay" xlink:to="mlec_IfrsDefinedContributionPlanEmployerMatchingContributionPercentOfEmployeesGrossPay_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl_lbl0" xml:lang="en-US">Increase (decrease) through changes in ownership interests in subsidiaries that do not result in loss of control, equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" xlink:to="ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InvestmentsInSharesMember_lbl1" xml:lang="en-US">Investments In Shares Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InvestmentsInSharesMember" xlink:to="mlec_InvestmentsInSharesMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashAndCashEquivalents_lbl1" xml:lang="en-US">Cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalents" xlink:to="ifrs-full_CashAndCashEquivalents_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RevenueFromGovernmentGrants_lbl0" xml:lang="en-US">Income from government grants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueFromGovernmentGrants" xlink:to="ifrs-full_RevenueFromGovernmentGrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DilutedEarningsLossPerShare_lbl1" xml:lang="en-US">Diluted earnings (loss) per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DilutedEarningsLossPerShare" xlink:to="ifrs-full_DilutedEarningsLossPerShare_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfInformationRelatedToCompanySShareOfVotingRightsInItsSubsidiariesAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfInformationRelatedToCompanySShareOfVotingRightsInItsSubsidiariesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfInformationRelatedToCompanySShareOfVotingRightsInItsSubsidiariesAbstract_lbl" xml:lang="en-US">Schedule Of Information Related To Company SShare Of Voting Rights In Its Subsidiaries Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfInformationRelatedToCompanySShareOfVotingRightsInItsSubsidiariesAbstract" xlink:to="mlec_ScheduleOfInformationRelatedToCompanySShareOfVotingRightsInItsSubsidiariesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory_lbl0" xml:lang="en-US">Disclosure of nature and extent of risks arising from financial instruments [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory" xlink:to="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_OtherIntangibleAssetsAbstract_lbl0" xml:lang="en-US">Other Intangible Assets Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherIntangibleAssetsAbstract" xlink:to="mlec_OtherIntangibleAssetsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FinancialAssetsAtFairValueAbstract0_lbl0" xml:lang="en-US">Financial Assets At Fair Value Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialAssetsAtFairValueAbstract0" xlink:to="mlec_FinancialAssetsAtFairValueAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_OtherReceivablesJointVenturesAndAssociatesMember_lbl0" xml:lang="en-US">Other Receivables Joint Ventures And Associates Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherReceivablesJointVenturesAndAssociatesMember" xlink:to="mlec_OtherReceivablesJointVenturesAndAssociatesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary_lbl0" xml:lang="en-US">Country of incorporation of subsidiary</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary" xlink:to="ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SurveillanceExpense_lbl1" xml:lang="en-US">Surveillance Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SurveillanceExpense" xlink:to="mlec_SurveillanceExpense_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComputerSoftware_lbl0" xml:lang="en-US">Computer software</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComputerSoftware" xlink:to="ifrs-full_ComputerSoftware_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_MicrobiologicalProductsProducedMember_lbl1" xml:lang="en-US">Microbiological Products Produced Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MicrobiologicalProductsProducedMember" xlink:to="mlec_MicrobiologicalProductsProducedMember_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfOtherFinancialAssetsAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfOtherFinancialAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfOtherFinancialAssetsAbstract_lbl" xml:lang="en-US">Schedule Of Other Financial Assets Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfOtherFinancialAssetsAbstract" xlink:to="mlec_ScheduleOfOtherFinancialAssetsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PercentageOfEntitysRevenue_lbl0" xml:lang="en-US">Percentage of entity&apos;s revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PercentageOfEntitysRevenue" xlink:to="ifrs-full_PercentageOfEntitysRevenue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_lbl0" xml:lang="en-US">Disclosure of detailed information about business combination [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AdjustmentsForDecreaseIncreaseInGovernmentGrants_lbl1" xml:lang="en-US">Adjustments For Decrease Increase In Government Grants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AdjustmentsForDecreaseIncreaseInGovernmentGrants" xlink:to="mlec_AdjustmentsForDecreaseIncreaseInGovernmentGrants_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for derivative financial instruments and hedging [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_lbl0" xml:lang="en-US">Proceeds from borrowings, classified as financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:to="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_lbl0" xml:lang="en-US">Additions other than through business combinations, intangible assets other than goodwill</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_LossOfControl_lbl1" xml:lang="en-US">Loss Of Control</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LossOfControl" xlink:to="mlec_LossOfControl_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets_lbl0" xml:lang="en-US">Additions other than through business combinations, biological assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ConvertibleNotesMember_lbl0" xml:lang="en-US">Convertible Notes Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ConvertibleNotesMember" xlink:to="mlec_ConvertibleNotesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AdditionalOrdinarySharesIssue_lbl1" xml:lang="en-US">Additional Ordinary Shares Issue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AdditionalOrdinarySharesIssue" xlink:to="mlec_AdditionalOrdinarySharesIssue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ProjectedPeriodRange_lbl1" xml:lang="en-US">Projected Period Range</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ProjectedPeriodRange" xlink:to="mlec_ProjectedPeriodRange_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock_lbl1" xml:lang="en-US">Disclosure Of Information About Components Of Consolidated Statements Of Comprehensive Income Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock" xlink:to="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RevenueFromRenderingOfServices_lbl0" xml:lang="en-US">Revenue from rendering of services</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueFromRenderingOfServices" xlink:to="ifrs-full_RevenueFromRenderingOfServices_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ProFarmUGEMember_lbl0" xml:lang="en-US">Pro Farm UGEMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ProFarmUGEMember" xlink:to="mlec_ProFarmUGEMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InterestGainMember_lbl0" xml:lang="en-US">Interest Gain Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InterestGainMember" xlink:to="mlec_InterestGainMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_lbl1" xml:lang="en-US">Weighted average exercise price of share options outstanding in share-based payment arrangement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InoculantsBiofertilizersMember_lbl1" xml:lang="en-US">Inoculants Biofertilizers Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InoculantsBiofertilizersMember" xlink:to="mlec_InoculantsBiofertilizersMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FinancedPaymentAcquisitionOfBusinessMember_lbl1" xml:lang="en-US">Financed Payment Acquisition Of Business Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancedPaymentAcquisitionOfBusinessMember" xlink:to="mlec_FinancedPaymentAcquisitionOfBusinessMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTaxOfJointVenturesAndAssociates_lbl1" xml:lang="en-US">Revaluation Of Property Plant And Equipment Net Of Tax Of Joint Ventures And Associates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTaxOfJointVenturesAndAssociates" xlink:to="mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTaxOfJointVenturesAndAssociates_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SafflowerGLAMember_lbl0" xml:lang="en-US">Safflower GLAMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SafflowerGLAMember" xlink:to="mlec_SafflowerGLAMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_OthersAbstract_lbl0" xml:lang="en-US">Others Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OthersAbstract" xlink:to="mlec_OthersAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PercentageOfPreferenceSharesAccrue_lbl1" xml:lang="en-US">Percentage Of Preference Shares Accrue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfPreferenceSharesAccrue" xlink:to="mlec_PercentageOfPreferenceSharesAccrue_lbl1"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract_lbl" xml:lang="en-US">Cybersecurity Risk Management, Strategy, and Governance [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughOtherDistributionsToOwners_lbl0" xml:lang="en-US">Decrease through other distributions to owners, equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughOtherDistributionsToOwners" xlink:to="ifrs-full_IncreaseDecreaseThroughOtherDistributionsToOwners_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ReimbursementsOverExportsMember_lbl0" xml:lang="en-US">Reimbursements Over Exports Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ReimbursementsOverExportsMember" xlink:to="mlec_ReimbursementsOverExportsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FinancialLiabilitiesValuedAtFairValueAbstract0_lbl0" xml:lang="en-US">Financial Liabilities Valued At Fair Value Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialLiabilitiesValuedAtFairValueAbstract0" xlink:to="mlec_FinancialLiabilitiesValuedAtFairValueAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NameOfSubsidiary_lbl0" xml:lang="en-US">Name of subsidiary</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NameOfSubsidiary" xlink:to="ifrs-full_NameOfSubsidiary_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_MeasuredAtEquityValueMethodAbstract1_lbl0" xml:lang="en-US">Measured At Equity Value Method Abstract1</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MeasuredAtEquityValueMethodAbstract1" xlink:to="mlec_MeasuredAtEquityValueMethodAbstract1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_MeasuredAtEquityValueMethodAbstract0_lbl0" xml:lang="en-US">Measured At Equity Value Method Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MeasuredAtEquityValueMethodAbstract0" xlink:to="mlec_MeasuredAtEquityValueMethodAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IssuedCapital_lbl0" xml:lang="en-US">Issued capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssuedCapital" xlink:to="ifrs-full_IssuedCapital_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime_lbl0" xml:lang="en-US">Non-current contract liabilities for performance obligations satisfied over time</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime" xlink:to="ifrs-full_NoncurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_lbl0" xml:lang="en-US">Description of accounting policy for government grants [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity_lbl2" xml:lang="en-US">Investment Accounted For Using Equity Method Including Negative Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity" xlink:to="mlec_InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity_lbl2"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfChangesInBiologicalAssetsAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfChangesInBiologicalAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfChangesInBiologicalAssetsAbstract_lbl" xml:lang="en-US">Schedule Of Changes In Biological Assets Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfChangesInBiologicalAssetsAbstract" xlink:to="mlec_ScheduleOfChangesInBiologicalAssetsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DisclosureOfTradeAndOtherPayablesComponentsTableTextBlock_lbl1" xml:lang="en-US">Disclosure Of Trade And Other Payables Components Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfTradeAndOtherPayablesComponentsTableTextBlock" xlink:to="mlec_DisclosureOfTradeAndOtherPayablesComponentsTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NonCurrentAssetsAbstract_lbl0" xml:lang="en-US">Non Current Assets Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NonCurrentAssetsAbstract" xlink:to="mlec_NonCurrentAssetsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DisposalsPropertyPlantAndEquipments_lbl1" xml:lang="en-US">Disposals Property Plant And Equipments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisposalsPropertyPlantAndEquipments" xlink:to="mlec_DisposalsPropertyPlantAndEquipments_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ConvertibleNotes_lbl1" xml:lang="en-US">Convertible Notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ConvertibleNotes" xlink:to="mlec_ConvertibleNotes_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InventoriesFromBusinessCombination_lbl1" xml:lang="en-US">Inventories From Business Combination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InventoriesFromBusinessCombination" xlink:to="mlec_InventoriesFromBusinessCombination_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for share-based payment transactions [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_LiabilitiesAbstract0_lbl0" xml:lang="en-US">Liabilities Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LiabilitiesAbstract0" xlink:to="mlec_LiabilitiesAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_GentleFarmingMember_lbl0" xml:lang="en-US">Gentle Farming Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_GentleFarmingMember" xlink:to="mlec_GentleFarmingMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AgralitySeedsIncMember_lbl0" xml:lang="en-US">Agrality Seeds Inc Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AgralitySeedsIncMember" xlink:to="mlec_AgralitySeedsIncMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_CurrentAbstract_lbl0" xml:lang="en-US">Current Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CurrentAbstract" xlink:to="mlec_CurrentAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfCashFlowStatementExplanatory_lbl0" xml:lang="en-US">Disclosure of cash flow statement [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfCashFlowStatementExplanatory" xlink:to="ifrs-full_DisclosureOfCashFlowStatementExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EquityAttributableToOwnersOfParentMember_lbl0" xml:lang="en-US">Equity attributable to owners of parent [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:to="ifrs-full_EquityAttributableToOwnersOfParentMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfJointVenturesExplanatory_lbl0" xml:lang="en-US">Disclosure of joint ventures [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfJointVenturesExplanatory" xlink:to="ifrs-full_DisclosureOfJointVenturesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_KeyManagementPersonnelBenefitsLiabilityCurrent_lbl1" xml:lang="en-US">Key Management Personnel Benefits Liability Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_KeyManagementPersonnelBenefitsLiabilityCurrent" xlink:to="mlec_KeyManagementPersonnelBenefitsLiabilityCurrent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentLiabilities_lbl1" xml:lang="en-US">Current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_CurrentLiabilities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_lbl0" xml:lang="en-US">Increase (decrease) through net exchange differences, intangible assets other than goodwill</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BorrowingsInterestRate_lbl0" xml:lang="en-US">Borrowings, interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BorrowingsInterestRate" xlink:to="ifrs-full_BorrowingsInterestRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod_lbl0" xml:lang="en-US">Proceeds from sales of investments accounted for using equity method</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod" xlink:to="ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_TotalLeaseLiabilities_lbl1" xml:lang="en-US">Total Lease Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TotalLeaseLiabilities" xlink:to="mlec_TotalLeaseLiabilities_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfCashFlowsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of cash flows [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_StatementOfCashFlowsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PercentageGrossMargin_lbl1" xml:lang="en-US">Percentage Gross Margin</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageGrossMargin" xlink:to="mlec_PercentageGrossMargin_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestExpense_lbl0" xml:lang="en-US">Interest expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestExpense" xlink:to="ifrs-full_InterestExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_OtherRegionsOrCountriesMember_lbl1" xml:lang="en-US">Other Regions Or Countries Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherRegionsOrCountriesMember" xlink:to="mlec_OtherRegionsOrCountriesMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates_lbl1" xml:lang="en-US">Number of shares in entity held by entity or by its subsidiaries or associates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" xlink:to="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DescriptionOfAccountingPolicyForConvertibleNotesTextBlock_lbl1" xml:lang="en-US">Description Of Accounting Policy For Convertible Notes Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DescriptionOfAccountingPolicyForConvertibleNotesTextBlock" xlink:to="mlec_DescriptionOfAccountingPolicyForConvertibleNotesTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PropertyPlantAndEquipment_lbl2" xml:lang="en-US">Property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipment" xlink:to="ifrs-full_PropertyPlantAndEquipment_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_lbl0" xml:lang="en-US">Adjustments for decrease (increase) in trade and other receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ResearchAndDevelopmentExpenseCapitalized_lbl1" xml:lang="en-US">Research And Development Expense Capitalized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ResearchAndDevelopmentExpenseCapitalized" xlink:to="mlec_ResearchAndDevelopmentExpenseCapitalized_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SocialSecurityContributions_lbl0" xml:lang="en-US">Social security contributions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SocialSecurityContributions" xlink:to="ifrs-full_SocialSecurityContributions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentGovernmentGrants_lbl0" xml:lang="en-US">Current government grants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentGovernmentGrants" xlink:to="ifrs-full_CurrentGovernmentGrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpense_lbl1" xml:lang="en-US">Selling, general and administrative expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:to="ifrs-full_SellingGeneralAndAdministrativeExpense_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations_lbl0" xml:lang="en-US">Transaction price allocated to remaining performance obligations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" xlink:to="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_OrdinarySharesWithNominalValueOfUS010PerShareMember_lbl0" xml:lang="en-US">Ordinary Shares With Nominal Value Of US010 Per Share Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OrdinarySharesWithNominalValueOfUS010PerShareMember" xlink:to="mlec_OrdinarySharesWithNominalValueOfUS010PerShareMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RepairsAndMaintenanceExpense_lbl0" xml:lang="en-US">Repairs and maintenance expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RepairsAndMaintenanceExpense" xlink:to="ifrs-full_RepairsAndMaintenanceExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AssignmentOfReceivablesWithShareholdersAndOtherRelatedParties_lbl1" xml:lang="en-US">Assignment Of Receivables With Shareholders And Other Related Parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AssignmentOfReceivablesWithShareholdersAndOtherRelatedParties" xlink:to="mlec_AssignmentOfReceivablesWithShareholdersAndOtherRelatedParties_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_lbl2" xml:lang="en-US">Gains (losses) on fair value adjustment, biological assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets" xlink:to="ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustedWeightedAverageShares_lbl0" xml:lang="en-US">Weighted average number of ordinary shares used in calculating diluted earnings per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustedWeightedAverageShares" xlink:to="ifrs-full_AdjustedWeightedAverageShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_RightOfUseAssetLossOfControl_lbl1" xml:lang="en-US">Right Of Use Asset Loss Of Control</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RightOfUseAssetLossOfControl" xlink:to="mlec_RightOfUseAssetLossOfControl_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SharePremiumMember_lbl0" xml:lang="en-US">Share premium [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SharePremiumMember" xlink:to="ifrs-full_SharePremiumMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DerecognitionOfDeferredTaxAssets_lbl1" xml:lang="en-US">Derecognition Of Deferred Tax Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DerecognitionOfDeferredTaxAssets" xlink:to="mlec_DerecognitionOfDeferredTaxAssets_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ConvertiblePreferenceSharesMember_lbl0" xml:lang="en-US">Convertible Preference Shares Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ConvertiblePreferenceSharesMember" xlink:to="mlec_ConvertiblePreferenceSharesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_IfrsFull_machineryAndEquipmentMember_lbl1" xml:lang="en-US">Ifrs Full_machinery And Equipment Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IfrsFull_machineryAndEquipmentMember" xlink:to="mlec_IfrsFull_machineryAndEquipmentMember_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionAbstract_lbl" xml:lang="en-US">Schedule Of Expenses Classified By Nature And Function Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionAbstract" xlink:to="mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SystemExpenses_lbl1" xml:lang="en-US">System Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SystemExpenses" xlink:to="mlec_SystemExpenses_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_RoyaltiesMember_lbl1" xml:lang="en-US">Royalties Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RoyaltiesMember" xlink:to="mlec_RoyaltiesMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DepreciationOfLeasedAssets_lbl1" xml:lang="en-US">Depreciation Of Leased Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DepreciationOfLeasedAssets" xlink:to="mlec_DepreciationOfLeasedAssets_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowingsAbstract_lbl0" xml:lang="en-US">Current borrowings and current portion of non-current borrowings [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowingsAbstract" xlink:to="ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowingsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PrivateWarrantShares_lbl1" xml:lang="en-US">Private Warrant Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PrivateWarrantShares" xlink:to="mlec_PrivateWarrantShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdvertisingExpense_lbl0" xml:lang="en-US">Advertising expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdvertisingExpense" xlink:to="ifrs-full_AdvertisingExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LeaseLiabilitiesMember_lbl0" xml:lang="en-US">Lease liabilities [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LeaseLiabilitiesMember" xlink:to="ifrs-full_LeaseLiabilitiesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities_lbl0" xml:lang="en-US">Disclosure of maturity analysis for non-derivative financial liabilities [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities" xlink:to="ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RevenueOfAcquiree_lbl0" xml:lang="en-US">Revenue of acquiree since acquisition date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueOfAcquiree" xlink:to="ifrs-full_RevenueOfAcquiree_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_lbl1" xml:lang="en-US">Increase (decrease) through net exchange differences, other provisions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" xlink:to="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PercentageOfCashPaymentInterestRate_lbl1" xml:lang="en-US">Percentage Of Cash Payment Interest Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfCashPaymentInterestRate" xlink:to="mlec_PercentageOfCashPaymentInterestRate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PercentageOfRiskPremium_lbl1" xml:lang="en-US">Percentage Of Risk Premium</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfRiskPremium" xlink:to="mlec_PercentageOfRiskPremium_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InflationOfAccumulatedYears_lbl1" xml:lang="en-US">Inflation Of Accumulated Years</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InflationOfAccumulatedYears" xlink:to="mlec_InflationOfAccumulatedYears_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BuildingsMember_lbl0" xml:lang="en-US">Buildings [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BuildingsMember" xlink:to="ifrs-full_BuildingsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PropertyPlantAndEquipmentsMember_lbl0" xml:lang="en-US">Property Plant And Equipments Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PropertyPlantAndEquipmentsMember" xlink:to="mlec_PropertyPlantAndEquipmentsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SeedAndIntegratedProductsMember_lbl1" xml:lang="en-US">Seed And Integrated Products Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SeedAndIntegratedProductsMember" xlink:to="mlec_SeedAndIntegratedProductsMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ReverseStockSplitMember_lbl0" xml:lang="en-US">Reverse Stock Split Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ReverseStockSplitMember" xlink:to="mlec_ReverseStockSplitMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for biological assets [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NetWheatTechnologyLicensingMember_lbl0" xml:lang="en-US">Net Wheat Technology Licensing Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NetWheatTechnologyLicensingMember" xlink:to="mlec_NetWheatTechnologyLicensingMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AdditionsFromBusinessCombinations_lbl1" xml:lang="en-US">Additions From Business Combinations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AdditionsFromBusinessCombinations" xlink:to="mlec_AdditionsFromBusinessCombinations_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComputerEquipmentMember_lbl1" xml:lang="en-US">Computer equipment [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComputerEquipmentMember" xlink:to="ifrs-full_ComputerEquipmentMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_lbl0" xml:lang="en-US">Profit (loss), attributable to ordinary equity holders of parent entity, used in calculating diluted earnings per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" xlink:to="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for property, plant and equipment [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentTradeReceivables_lbl1" xml:lang="en-US">Current trade receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentTradeReceivables" xlink:to="ifrs-full_CurrentTradeReceivables_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SaleOfEquityInvestment_lbl1" xml:lang="en-US">Sale Of Equity Investment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SaleOfEquityInvestment" xlink:to="mlec_SaleOfEquityInvestment_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IssuedCapitalOrdinaryShares_lbl0" xml:lang="en-US">Issued capital, ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssuedCapitalOrdinaryShares" xlink:to="ifrs-full_IssuedCapitalOrdinaryShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PreferenceShareMember_lbl0" xml:lang="en-US">Preference Share Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PreferenceShareMember" xlink:to="mlec_PreferenceShareMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ShareBasedPaymentPeriodOfWeightedAveragePriceVwapOfOrdinarySharesForCashlessBasisExercise_lbl1" xml:lang="en-US">Share Based Payment Period Of Weighted Average Price Vwap Of Ordinary Shares For Cashless Basis Exercise</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareBasedPaymentPeriodOfWeightedAveragePriceVwapOfOrdinarySharesForCashlessBasisExercise" xlink:to="mlec_ShareBasedPaymentPeriodOfWeightedAveragePriceVwapOfOrdinarySharesForCashlessBasisExercise_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_RGRSOXWheatMember_lbl0" xml:lang="en-US">RGRSOXWheat Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RGRSOXWheatMember" xlink:to="mlec_RGRSOXWheatMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_lbl0" xml:lang="en-US">Other comprehensive income that will be reclassified to profit or loss, net of tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:to="ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_lbl0" xml:lang="en-US">Identifiable intangible assets recognised as of acquisition date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_lbl0" xml:lang="en-US">Comprehensive income, attributable to owners of parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:to="ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_BioceresSAMember_lbl1" xml:lang="en-US">Bioceres SAMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BioceresSAMember" xlink:to="mlec_BioceresSAMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ShareToBeIssuedAmount_lbl1" xml:lang="en-US">Share To Be Issued Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareToBeIssuedAmount" xlink:to="mlec_ShareToBeIssuedAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_LossOfControlonBiologicalAssets_lbl1" xml:lang="en-US">Loss Of Controlon Biological Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LossOfControlonBiologicalAssets" xlink:to="mlec_LossOfControlonBiologicalAssets_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl0" xml:lang="en-US">Cybersecurity Risk Board of Directors Oversight [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EquityAndLiabilities_lbl1" xml:lang="en-US">Equity and liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAndLiabilities" xlink:to="ifrs-full_EquityAndLiabilities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherCurrentReceivables_lbl1" xml:lang="en-US">Other current receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCurrentReceivables" xlink:to="ifrs-full_OtherCurrentReceivables_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SecuredDebtNonCurrent_lbl2" xml:lang="en-US">Secured Debt Non Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SecuredDebtNonCurrent" xlink:to="mlec_SecuredDebtNonCurrent_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_MachineryAndEquipmentsMember_lbl0" xml:lang="en-US">Machinery And Equipments Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MachineryAndEquipmentsMember" xlink:to="mlec_MachineryAndEquipmentsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for borrowings [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_RemeasurementOfPreviouslyHeldInterest_lbl1" xml:lang="en-US">Remeasurement Of Previously Held Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RemeasurementOfPreviouslyHeldInterest" xlink:to="mlec_RemeasurementOfPreviouslyHeldInterest_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_OtherIncomeOrExpensesNet_lbl1" xml:lang="en-US">Other Income Or Expenses Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherIncomeOrExpensesNet" xlink:to="mlec_OtherIncomeOrExpensesNet_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossFromOperatingActivities_lbl3" xml:lang="en-US">Profit (loss) from operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_ProfitLossFromOperatingActivities_lbl3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod_lbl0" xml:lang="en-US">Purchase of interests in investments accounted for using equity method</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod" xlink:to="ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ProfitMakingEntitiesMember_lbl1" xml:lang="en-US">Profit Making Entities Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ProfitMakingEntitiesMember" xlink:to="mlec_ProfitMakingEntitiesMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Revenue_lbl2" xml:lang="en-US">Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Revenue" xlink:to="ifrs-full_Revenue_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InterestExpensesMember_lbl0" xml:lang="en-US">Interest Expenses Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InterestExpensesMember" xlink:to="mlec_InterestExpensesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ChangeInFairValueOfFinancialAssetsOrLiabilitiesOrOtherFinancialResults_lbl1" xml:lang="en-US">Change In Fair Value Of Financial Assets Or Liabilities Or Other Financial Results</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ChangeInFairValueOfFinancialAssetsOrLiabilitiesOrOtherFinancialResults" xlink:to="mlec_ChangeInFairValueOfFinancialAssetsOrLiabilitiesOrOtherFinancialResults_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_VoluntaryRepurchaseOfNotesAfterIssueDate_lbl1" xml:lang="en-US">Voluntary Repurchase Of Notes After Issue Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_VoluntaryRepurchaseOfNotesAfterIssueDate" xlink:to="mlec_VoluntaryRepurchaseOfNotesAfterIssueDate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NetGainOnInflationEffectOnMonetary_lbl1" xml:lang="en-US">Net Gain On Inflation Effect On Monetary</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NetGainOnInflationEffectOnMonetary" xlink:to="mlec_NetGainOnInflationEffectOnMonetary_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PercentageOfIssuedAndOutstandingEquityInterests_lbl1" xml:lang="en-US">Percentage Of Issued And Outstanding Equity Interests</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfIssuedAndOutstandingEquityInterests" xlink:to="mlec_PercentageOfIssuedAndOutstandingEquityInterests_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GrossProfit_lbl1" xml:lang="en-US">Gross profit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GrossProfit" xlink:to="ifrs-full_GrossProfit_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTax_lbl1" xml:lang="en-US">Revaluation Of Property Plant And Equipment Net Of Tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTax" xlink:to="mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTax_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_GainlossOfRecognitionTransactions_lbl1" xml:lang="en-US">Gainloss Of Recognition Transactions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_GainlossOfRecognitionTransactions" xlink:to="mlec_GainlossOfRecognitionTransactions_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_BioceresCropSolutionsCorpMember_lbl1" xml:lang="en-US">Bioceres Crop Solutions Corp Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BioceresCropSolutionsCorpMember" xlink:to="mlec_BioceresCropSolutionsCorpMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BorrowingsMaturity_lbl0" xml:lang="en-US">Borrowings, maturity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BorrowingsMaturity" xlink:to="ifrs-full_BorrowingsMaturity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets_lbl1" xml:lang="en-US">Decrease Through Loss Of Control Of Subsidiary Intangible Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets" xlink:to="mlec_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_CropNutritionAbstract_lbl0" xml:lang="en-US">Crop Nutrition Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CropNutritionAbstract" xlink:to="mlec_CropNutritionAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RevenueFromSaleOfAgriculturalProduce_lbl0" xml:lang="en-US">Revenue from sale of agricultural produce</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueFromSaleOfAgriculturalProduce" xlink:to="ifrs-full_RevenueFromSaleOfAgriculturalProduce_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ApplicableTaxRate_lbl0" xml:lang="en-US">Applicable tax rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ApplicableTaxRate" xlink:to="ifrs-full_ApplicableTaxRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_lbl1" xml:lang="en-US">Cash flows from (used in) investing activities [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementAssets_lbl0" xml:lang="en-US">Gains (losses) recognised in profit or loss on exchange differences, fair value measurement, assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementAssets" xlink:to="ifrs-full_GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ResultOfInflationEffectOnMonetaryItemsAndOtherFinanceResults_lbl1" xml:lang="en-US">Result Of Inflation Effect On Monetary Items And Other Finance Results</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ResultOfInflationEffectOnMonetaryItemsAndOtherFinanceResults" xlink:to="mlec_ResultOfInflationEffectOnMonetaryItemsAndOtherFinanceResults_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfProductsAndServicesExplanatory_lbl0" xml:lang="en-US">Disclosure of products and services [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfProductsAndServicesExplanatory" xlink:to="ifrs-full_DisclosureOfProductsAndServicesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_TradeAndOtherPayablesShareholdersAndOtherRelatedParties_lbl1" xml:lang="en-US">Trade And Other Payables Shareholders And Other Related Parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TradeAndOtherPayablesShareholdersAndOtherRelatedParties" xlink:to="mlec_TradeAndOtherPayablesShareholdersAndOtherRelatedParties_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_lbl0" xml:lang="en-US">Later than two years and not later than three years [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:to="ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SeedAndIntegratedProductsAbstract_lbl0" xml:lang="en-US">Seed And Integrated Products Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SeedAndIntegratedProductsAbstract" xlink:to="mlec_SeedAndIntegratedProductsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentLeaseLiabilities_lbl1" xml:lang="en-US">Non-current lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLeaseLiabilities" xlink:to="ifrs-full_NoncurrentLeaseLiabilities_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfFairValueByHierarchyAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfFairValueByHierarchyAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfFairValueByHierarchyAbstract_lbl" xml:lang="en-US">Schedule Of Fair Value By Hierarchy Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfFairValueByHierarchyAbstract" xlink:to="mlec_ScheduleOfFairValueByHierarchyAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeReceivablesMember_lbl1" xml:lang="en-US">Trade receivables [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeReceivablesMember" xlink:to="ifrs-full_TradeReceivablesMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for income tax [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_VotePerShare_lbl1" xml:lang="en-US">Vote Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_VotePerShare" xlink:to="mlec_VotePerShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ChangesInEquityInterest_lbl1" xml:lang="en-US">Changes In Equity Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ChangesInEquityInterest" xlink:to="mlec_ChangesInEquityInterest_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Cash_lbl0" xml:lang="en-US">Cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Cash" xlink:to="ifrs-full_Cash_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfLeasesExplanatory_lbl0" xml:lang="en-US">Disclosure of leases [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfLeasesExplanatory" xlink:to="ifrs-full_DisclosureOfLeasesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FinancialLiabilitiesValuedAtFairValueAbstract_lbl0" xml:lang="en-US">Financial Liabilities Valued At Fair Value Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialLiabilitiesValuedAtFairValueAbstract" xlink:to="mlec_FinancialLiabilitiesValuedAtFairValueAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_lbl0" xml:lang="en-US">Adjustments for increase (decrease) in trade and other payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments_lbl0" xml:lang="en-US">Adjustments for share-based payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForSharebasedPayments" xlink:to="ifrs-full_AdjustmentsForSharebasedPayments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems_lbl0" xml:lang="en-US">Acquisitionsand Other Significant Transactions Scheduleof Assets Acquiredand Liabilities Assumed Details Line Items</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InventoriesNetOfAgriculturalProducts_lbl1" xml:lang="en-US">Inventories Net Of Agricultural Products</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InventoriesNetOfAgriculturalProducts" xlink:to="mlec_InventoriesNetOfAgriculturalProducts_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory_lbl0" xml:lang="en-US">Disclosure of fair value of financial instruments [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory" xlink:to="ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ShareOfProfitOrLossMeasuredAtFairValue_lbl2" xml:lang="en-US">Share Of Profit Or Loss Measured At Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareOfProfitOrLossMeasuredAtFairValue" xlink:to="mlec_ShareOfProfitOrLossMeasuredAtFairValue_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AlfalfaTechnologiesSRlMember_lbl1" xml:lang="en-US">Alfalfa Technologies SRl Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AlfalfaTechnologiesSRlMember" xlink:to="mlec_AlfalfaTechnologiesSRlMember_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfWeightedAverageNumberOfOrdinarySharesOutstandingAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfWeightedAverageNumberOfOrdinarySharesOutstandingAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfWeightedAverageNumberOfOrdinarySharesOutstandingAbstract_lbl" xml:lang="en-US">Schedule Of Weighted Average Number Of Ordinary Shares Outstanding Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfWeightedAverageNumberOfOrdinarySharesOutstandingAbstract" xlink:to="mlec_ScheduleOfWeightedAverageNumberOfOrdinarySharesOutstandingAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities_lbl0" xml:lang="en-US">Cash flows from (used in) financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LandAndBuildings_lbl0" xml:lang="en-US">Land and buildings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LandAndBuildings" xlink:to="ifrs-full_LandAndBuildings_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfOtherReceivablesAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfOtherReceivablesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfOtherReceivablesAbstract_lbl" xml:lang="en-US">Schedule Of Other Receivables Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfOtherReceivablesAbstract" xlink:to="mlec_ScheduleOfOtherReceivablesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestCostsCapitalised_lbl0" xml:lang="en-US">Interest costs capitalised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestCostsCapitalised" xlink:to="ifrs-full_InterestCostsCapitalised_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ProvisionsForContingencies_lbl1" xml:lang="en-US">Provisions For Contingencies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ProvisionsForContingencies" xlink:to="mlec_ProvisionsForContingencies_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WarrantLiability_lbl1" xml:lang="en-US">Warrant liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WarrantLiability" xlink:to="ifrs-full_WarrantLiability_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PurchasesOfGoodsAndServicesMember_lbl0" xml:lang="en-US">Purchases Of Goods And Services Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PurchasesOfGoodsAndServicesMember" xlink:to="mlec_PurchasesOfGoodsAndServicesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DisclosureOfDepreciationIfAssetsHadBeenCarriedUnderCostModelTextBlock_lbl1" xml:lang="en-US">Disclosure Of Depreciation If Assets Had Been Carried Under Cost Model Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfDepreciationIfAssetsHadBeenCarriedUnderCostModelTextBlock" xlink:to="mlec_DisclosureOfDepreciationIfAssetsHadBeenCarriedUnderCostModelTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RevenueOfCombinedEntity_lbl0" xml:lang="en-US">Revenue of combined entity as if combination occurred at beginning of period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueOfCombinedEntity" xlink:to="ifrs-full_RevenueOfCombinedEntity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfProvisionsExplanatory_lbl0" xml:lang="en-US">Disclosure of provisions [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfProvisionsExplanatory" xlink:to="ifrs-full_DisclosureOfProvisionsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_lbl1" xml:lang="en-US">Acquisitions through business combinations, property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:to="ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EstimatedFinancialEffectOfContingentAssets_lbl0" xml:lang="en-US">Estimated financial effect of contingent assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EstimatedFinancialEffectOfContingentAssets" xlink:to="ifrs-full_EstimatedFinancialEffectOfContingentAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DueToJointVenturesAndAssociatesNonCurrent_lbl1" xml:lang="en-US">Due To Joint Ventures And Associates Non Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DueToJointVenturesAndAssociatesNonCurrent" xlink:to="mlec_DueToJointVenturesAndAssociatesNonCurrent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ShareBasedPaymentAwardExpirationDate_lbl1" xml:lang="en-US">Share Based Payment Award Expiration Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareBasedPaymentAwardExpirationDate" xlink:to="mlec_ShareBasedPaymentAwardExpirationDate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProportionOfVotingPowerHeldInSubsidiary_lbl0" xml:lang="en-US">Proportion of voting rights held in subsidiary</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProportionOfVotingPowerHeldInSubsidiary" xlink:to="ifrs-full_ProportionOfVotingPowerHeldInSubsidiary_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_lbl0" xml:lang="en-US">Property, plant and equipment recognised as of acquisition date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinanceCosts_lbl1" xml:lang="en-US">Finance costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceCosts" xlink:to="ifrs-full_FinanceCosts_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfBioceresSaAndBioceresCropSolutionsAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfBioceresSaAndBioceresCropSolutionsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfBioceresSaAndBioceresCropSolutionsAbstract_lbl" xml:lang="en-US">Schedule Of Bioceres Sa And Bioceres Crop Solutions Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfBioceresSaAndBioceresCropSolutionsAbstract" xlink:to="mlec_ScheduleOfBioceresSaAndBioceresCropSolutionsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfOptionActivityAndWeightedAverageExercisePriceAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfOptionActivityAndWeightedAverageExercisePriceAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfOptionActivityAndWeightedAverageExercisePriceAbstract_lbl" xml:lang="en-US">Schedule Of Option Activity And Weighted Average Exercise Price Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfOptionActivityAndWeightedAverageExercisePriceAbstract" xlink:to="mlec_ScheduleOfOptionActivityAndWeightedAverageExercisePriceAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FinancialAssetsAtFairValueAbstract_lbl0" xml:lang="en-US">Financial Assets At Fair Value Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialAssetsAtFairValueAbstract" xlink:to="mlec_FinancialAssetsAtFairValueAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ChangeInAllowanceAndProvisionLossOfControl_lbl1" xml:lang="en-US">Change In Allowance And Provision Loss Of Control</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ChangeInAllowanceAndProvisionLossOfControl" xlink:to="mlec_ChangeInAllowanceAndProvisionLossOfControl_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_lbl0" xml:lang="en-US">Description of accounting policy for measuring inventories [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_lbl0" xml:lang="en-US">Additions other than through business combinations, property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentTaxAssetsCurrent_lbl0" xml:lang="en-US">Current tax assets, current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentTaxAssetsCurrent" xlink:to="ifrs-full_CurrentTaxAssetsCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_lbl0" xml:lang="en-US">Identifiable assets acquired (liabilities assumed)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:to="ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BasicEarningsLossPerShare_lbl1" xml:lang="en-US">Basic earnings (loss) per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BasicEarningsLossPerShare" xlink:to="ifrs-full_BasicEarningsLossPerShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_RevaluationOfPropertyPlantAndEquipmentReserve_lbl1" xml:lang="en-US">Revaluation Of Property Plant And Equipment Reserve</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RevaluationOfPropertyPlantAndEquipmentReserve" xlink:to="mlec_RevaluationOfPropertyPlantAndEquipmentReserve_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfBusinessCombinationsLineItems_lbl0" xml:lang="en-US">Disclosure of detailed information about business combination [line items] [Standard Label]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:to="ifrs-full_DisclosureOfBusinessCombinationsLineItems_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AssetsAbstract_lbl0" xml:lang="en-US">Assets [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AssetsAbstract" xlink:to="ifrs-full_AssetsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DeferredTaxLiabilities_lbl0" xml:lang="en-US">Deferred tax liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxLiabilities" xlink:to="ifrs-full_DeferredTaxLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AllowanceForObsolescences_lbl1" xml:lang="en-US">Allowance For Obsolescences</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AllowanceForObsolescences" xlink:to="mlec_AllowanceForObsolescences_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentAdvances_lbl0" xml:lang="en-US">Current advances received, representing current contract liabilities for performance obligations satisfied at point in time</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAdvances" xlink:to="ifrs-full_CurrentAdvances_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_lbl0" xml:lang="en-US">Weighted average exercise price of share options exercised in share-based payment arrangement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RetainedEarningsMember_lbl0" xml:lang="en-US">Retained earnings [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RetainedEarningsMember" xlink:to="ifrs-full_RetainedEarningsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NetHB4SoybeanMember_lbl0" xml:lang="en-US">Net HB4 Soybean Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NetHB4SoybeanMember" xlink:to="mlec_NetHB4SoybeanMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentAssets_lbl1" xml:lang="en-US">Current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_CurrentAssets_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FinancingForAssetsAcquisitions_lbl1" xml:lang="en-US">Financing For Assets Acquisitions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancingForAssetsAcquisitions" xlink:to="mlec_FinancingForAssetsAcquisitions_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfChangesInJointVenturesInvestmentsAndAffiliatesAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfChangesInJointVenturesInvestmentsAndAffiliatesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfChangesInJointVenturesInvestmentsAndAffiliatesAbstract_lbl" xml:lang="en-US">Schedule Of Changes In Joint Ventures Investments And Affiliates Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfChangesInJointVenturesInvestmentsAndAffiliatesAbstract" xlink:to="mlec_ScheduleOfChangesInJointVenturesInvestmentsAndAffiliatesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ConsiderationForAcquisitionOfAssetsMember_lbl0" xml:lang="en-US">Consideration For Acquisition Of Assets Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ConsiderationForAcquisitionOfAssetsMember" xlink:to="mlec_ConsiderationForAcquisitionOfAssetsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TitleOfInitiallyAppliedIFRS_lbl0" xml:lang="en-US">Title of initially applied IFRS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TitleOfInitiallyAppliedIFRS" xlink:to="ifrs-full_TitleOfInitiallyAppliedIFRS_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ProfessionalFeesRelatedParties_lbl1" xml:lang="en-US">Professional Fees Related Parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ProfessionalFeesRelatedParties" xlink:to="mlec_ProfessionalFeesRelatedParties_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfCommitmentsExplanatory_lbl0" xml:lang="en-US">Disclosure of commitments [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfCommitmentsExplanatory" xlink:to="ifrs-full_DisclosureOfCommitmentsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_CommonEquity_lbl1" xml:lang="en-US">Common Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CommonEquity" xlink:to="mlec_CommonEquity_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherPayablesToRelatedParties_lbl0" xml:lang="en-US">Payables to related parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherPayablesToRelatedParties" xlink:to="ifrs-full_TradeAndOtherPayablesToRelatedParties_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_JointVenturesWhereEntityIsVenturerMember_lbl0" xml:lang="en-US">Joint ventures where entity is venturer [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_JointVenturesWhereEntityIsVenturerMember" xlink:to="ifrs-full_JointVenturesWhereEntityIsVenturerMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_EquityShares_lbl1" xml:lang="en-US">Equity Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_EquityShares" xlink:to="mlec_EquityShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl0" xml:lang="en-US">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfIncomeTaxExplanatory_lbl0" xml:lang="en-US">Disclosure of income tax [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:to="ifrs-full_DisclosureOfIncomeTaxExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_MoolecScienceCaymanIslandsMember_lbl0" xml:lang="en-US">Moolec Science Cayman Islands Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MoolecScienceCaymanIslandsMember" xlink:to="mlec_MoolecScienceCaymanIslandsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_OtherInvestmentMember_lbl1" xml:lang="en-US">Other Investment Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherInvestmentMember" xlink:to="mlec_OtherInvestmentMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities_lbl1" xml:lang="en-US">Schedule Of Significant Non Cash Transactions Related To Investing And Financing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities" xlink:to="mlec_ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_CorporateBondsMember_lbl0" xml:lang="en-US">Corporate Bonds Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CorporateBondsMember" xlink:to="mlec_CorporateBondsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ReverseStockSplitConsolidationRatio_lbl1" xml:lang="en-US">Reverse Stock Split Consolidation Ratio</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ReverseStockSplitConsolidationRatio" xlink:to="mlec_ReverseStockSplitConsolidationRatio_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_lbl0" xml:lang="en-US">Amortisation, intangible assets other than goodwill</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_MoolecScienceSASharesMember_lbl0" xml:lang="en-US">Moolec Science SAShares Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MoolecScienceSASharesMember" xlink:to="mlec_MoolecScienceSASharesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ShorttermPeriod_lbl1" xml:lang="en-US">Shortterm Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShorttermPeriod" xlink:to="mlec_ShorttermPeriod_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_HoldbackMember_lbl0" xml:lang="en-US">Holdback Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_HoldbackMember" xlink:to="mlec_HoldbackMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_OtherLiabilitiesOneMember_lbl0" xml:lang="en-US">Other Liabilities One Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherLiabilitiesOneMember" xlink:to="mlec_OtherLiabilitiesOneMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ConsecutiveBusinessDays_lbl1" xml:lang="en-US">Consecutive Business Days</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ConsecutiveBusinessDays" xlink:to="mlec_ConsecutiveBusinessDays_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_EuropeMiddleEastAndAfricaMember_lbl1" xml:lang="en-US">Europe Middle East And Africa Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_EuropeMiddleEastAndAfricaMember" xlink:to="mlec_EuropeMiddleEastAndAfricaMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities_lbl0" xml:lang="en-US">Proceeds from sales of other long-term assets, classified as investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:to="ifrs-full_ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_LeaseLiabilityBeginningOfTheYearinception_lbl1" xml:lang="en-US">Lease Liability Beginning Of The Yearinception</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LeaseLiabilityBeginningOfTheYearinception" xlink:to="mlec_LeaseLiabilityBeginningOfTheYearinception_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets_lbl1" xml:lang="en-US">Adjustments for losses (gains) on disposal of non-current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" xlink:to="ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TopOfRangeMember_lbl2" xml:lang="en-US">Top of range [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TopOfRangeMember" xlink:to="ifrs-full_TopOfRangeMember_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_BiologicalAssetsCornMember_lbl1" xml:lang="en-US">Biological Assets Corn Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BiologicalAssetsCornMember" xlink:to="mlec_BiologicalAssetsCornMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ProfessionalFeesExpenseRelatedParties_lbl1" xml:lang="en-US">Professional Fees Expense Related Parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ProfessionalFeesExpenseRelatedParties" xlink:to="mlec_ProfessionalFeesExpenseRelatedParties_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AGBiomoleculesLLCMember_lbl0" xml:lang="en-US">AGBiomolecules LLCMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AGBiomoleculesLLCMember" xlink:to="mlec_AGBiomoleculesLLCMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_lbl0" xml:lang="en-US">Increase (decrease) through transfers, intangible assets other than goodwill</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_lbl0" xml:lang="en-US">Later than three years and not later than four years [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:to="ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncontrollingInterests_lbl0" xml:lang="en-US">Non-controlling interests</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncontrollingInterests" xlink:to="ifrs-full_NoncontrollingInterests_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestRateRiskMember_lbl1" xml:lang="en-US">Interest rate risk [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestRateRiskMember" xlink:to="ifrs-full_InterestRateRiskMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_MutualFunds_lbl1" xml:lang="en-US">Mutual Funds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MutualFunds" xlink:to="mlec_MutualFunds_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PercentageOfCapital_lbl1" xml:lang="en-US">Percentage Of Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfCapital" xlink:to="mlec_PercentageOfCapital_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfRevenueBySimilarGroupOfProductsOrServicesAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfRevenueBySimilarGroupOfProductsOrServicesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfRevenueBySimilarGroupOfProductsOrServicesAbstract_lbl" xml:lang="en-US">Schedule Of Revenue By Similar Group Of Products Or Services Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfRevenueBySimilarGroupOfProductsOrServicesAbstract" xlink:to="mlec_ScheduleOfRevenueBySimilarGroupOfProductsOrServicesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AllowancesAndProvisionsUsedAndReversed_lbl1" xml:lang="en-US">Allowances And Provisions Used And Reversed</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AllowancesAndProvisionsUsedAndReversed" xlink:to="mlec_AllowancesAndProvisionsUsedAndReversed_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_WorkingCapital_lbl2" xml:lang="en-US">Working Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_WorkingCapital" xlink:to="mlec_WorkingCapital_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DepreciationPropertyPlantAndEquipment_lbl1" xml:lang="en-US">Depreciation, property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:to="ifrs-full_DepreciationPropertyPlantAndEquipment_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_lbl1" xml:lang="en-US">Option life, share options granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:to="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_lbl0" xml:lang="en-US">Increase (decrease) in cash and cash equivalents after effect of exchange rate changes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MiscellaneousOtherOperatingExpense_lbl0" xml:lang="en-US">Miscellaneous other operating expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MiscellaneousOtherOperatingExpense" xlink:to="ifrs-full_MiscellaneousOtherOperatingExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioForecastMember_lbl0" xml:lang="en-US">Forecast [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioForecastMember" xlink:to="srt_ScenarioForecastMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ContingentPayment_lbl1" xml:lang="en-US">Contingent Payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ContingentPayment" xlink:to="mlec_ContingentPayment_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_BioceresGroupMember_lbl0" xml:lang="en-US">Bioceres Group Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BioceresGroupMember" xlink:to="mlec_BioceresGroupMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ConstructionInProgressMember_lbl0" xml:lang="en-US">Construction in progress [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ConstructionInProgressMember" xlink:to="ifrs-full_ConstructionInProgressMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DescriptionOfAccountingPolicyForFinancialAssetsAndLiabilitiesPolicyTextBlock_lbl1" xml:lang="en-US">Description Of Accounting Policy For Financial Assets And Liabilities Policy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DescriptionOfAccountingPolicyForFinancialAssetsAndLiabilitiesPolicyTextBlock" xlink:to="mlec_DescriptionOfAccountingPolicyForFinancialAssetsAndLiabilitiesPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_lbl1" xml:lang="en-US">Expected volatility, share options granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:to="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentAssetsAbstract_lbl0" xml:lang="en-US">Non-current assets [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentAssetsAbstract" xlink:to="ifrs-full_NoncurrentAssetsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentAdvances_lbl0" xml:lang="en-US">Non-current advances received, representing non-current contract liabilities for performance obligations satisfied at point in time</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentAdvances" xlink:to="ifrs-full_NoncurrentAdvances_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsExplanatory_lbl0" xml:lang="en-US">Disclosure of operating segments [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsExplanatory" xlink:to="ifrs-full_DisclosureOfOperatingSegmentsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherCurrentPayables_lbl0" xml:lang="en-US">Other current payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCurrentPayables" xlink:to="ifrs-full_OtherCurrentPayables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_lbl0" xml:lang="en-US">Disclosure of number and weighted average exercise prices of other equity instruments [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SeedTreatmentsPacksMember_lbl1" xml:lang="en-US">Seed Treatments Packs Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SeedTreatmentsPacksMember" xlink:to="mlec_SeedTreatmentsPacksMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_EmployeeStockPurchasePlanMember_lbl1" xml:lang="en-US">Employee Stock Purchase Plan Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_EmployeeStockPurchasePlanMember" xlink:to="mlec_EmployeeStockPurchasePlanMember_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfBorrowingsCarryingAmountAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfBorrowingsCarryingAmountAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfBorrowingsCarryingAmountAbstract_lbl" xml:lang="en-US">Schedule Of Borrowings Carrying Amount Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfBorrowingsCarryingAmountAbstract" xlink:to="mlec_ScheduleOfBorrowingsCarryingAmountAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SeedAndIntegratedProductsAbstract0_lbl0" xml:lang="en-US">Seed And Integrated Products Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SeedAndIntegratedProductsAbstract0" xlink:to="mlec_SeedAndIntegratedProductsAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_WarrantesMember_lbl0" xml:lang="en-US">Warrantes Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_WarrantesMember" xlink:to="mlec_WarrantesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SecuredGuaranteedNotesDue2026Member_lbl1" xml:lang="en-US">Secured Guaranteed Notes Due2026 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SecuredGuaranteedNotesDue2026Member" xlink:to="mlec_SecuredGuaranteedNotesDue2026Member_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl0" xml:lang="en-US">Proceeds from sales of property, plant and equipment, classified as investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:to="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_lbl0" xml:lang="en-US">Weighted average exercise price of share options expired in share-based payment arrangement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_TaxEffectOfRevenuesExemptFromTaxationAndExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss_lbl1" xml:lang="en-US">Tax Effect Of Revenues Exempt From Taxation And Expenses Not Deductible In Determining Taxable Profit Tax Loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TaxEffectOfRevenuesExemptFromTaxationAndExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:to="mlec_TaxEffectOfRevenuesExemptFromTaxationAndExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PastShareOptionPlanMember_lbl2" xml:lang="en-US">Past Share Option Plan Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PastShareOptionPlanMember" xlink:to="mlec_PastShareOptionPlanMember_lbl2"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfConvertibleNotesAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfConvertibleNotesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfConvertibleNotesAbstract_lbl" xml:lang="en-US">Schedule Of Convertible Notes Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfConvertibleNotesAbstract" xlink:to="mlec_ScheduleOfConvertibleNotesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RevenueFromContractsWithCustomers_lbl2" xml:lang="en-US">Revenue from contracts with customers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueFromContractsWithCustomers" xlink:to="ifrs-full_RevenueFromContractsWithCustomers_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_Contingencies_lbl1" xml:lang="en-US">Contingencies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_Contingencies" xlink:to="mlec_Contingencies_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory_lbl0" xml:lang="en-US">Disclosure of other operating income (expense) [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory" xlink:to="ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AmortizationOfIntangibleAsset_lbl1" xml:lang="en-US">Amortization Of Intangible Asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AmortizationOfIntangibleAsset" xlink:to="mlec_AmortizationOfIntangibleAsset_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentWarrantLiability_lbl2" xml:lang="en-US">Current warrant liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentWarrantLiability" xlink:to="ifrs-full_CurrentWarrantLiability_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InventoriesTotal_lbl1" xml:lang="en-US">Inventories</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InventoriesTotal" xlink:to="ifrs-full_InventoriesTotal_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PuttableInstrumentsMember_lbl0" xml:lang="en-US">Puttable Instruments Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PuttableInstrumentsMember" xlink:to="mlec_PuttableInstrumentsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfOperatingResultsGroupsReportingSegmentsAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfOperatingResultsGroupsReportingSegmentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfOperatingResultsGroupsReportingSegmentsAbstract_lbl" xml:lang="en-US">Schedule Of Operating Results Groups Reporting Segments Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfOperatingResultsGroupsReportingSegmentsAbstract" xlink:to="mlec_ScheduleOfOperatingResultsGroupsReportingSegmentsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossAttributableToNoncontrollingInterests_lbl0" xml:lang="en-US">Profit (loss), attributable to non-controlling interests</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:to="ifrs-full_ProfitLossAttributableToNoncontrollingInterests_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DisclosureOfChangesInAllowancesAndProvisionsTableTextBlock_lbl1" xml:lang="en-US">Disclosure Of Changes In Allowances And Provisions Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfChangesInAllowancesAndProvisionsTableTextBlock" xlink:to="mlec_DisclosureOfChangesInAllowancesAndProvisionsTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_CarryForwardOfTaxLossMember_lbl1" xml:lang="en-US">Carry Forward Of Tax Loss Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CarryForwardOfTaxLossMember" xlink:to="mlec_CarryForwardOfTaxLossMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_CropNutritionAbstract0_lbl0" xml:lang="en-US">Crop Nutrition Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CropNutritionAbstract0" xlink:to="mlec_CropNutritionAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory_lbl0" xml:lang="en-US">Disclosure of disaggregation of revenue from contracts with customers [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_OthersOneMember_lbl0" xml:lang="en-US">Others One Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OthersOneMember" xlink:to="mlec_OthersOneMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_lbl0" xml:lang="en-US">Disclosure of finance income (cost) [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:to="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DisclosureOfNumberOfSharesIssuedtextBlock_lbl1" xml:lang="en-US">Disclosure Of Number Of Shares Issuedtext Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfNumberOfSharesIssuedtextBlock" xlink:to="mlec_DisclosureOfNumberOfSharesIssuedtextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_BiologicalAssetsBarleyMember_lbl1" xml:lang="en-US">Biological Assets Barley Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BiologicalAssetsBarleyMember" xlink:to="mlec_BiologicalAssetsBarleyMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_VolumeWeightedAveragePriceMember_lbl0" xml:lang="en-US">Volume Weighted Average Price Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_VolumeWeightedAveragePriceMember" xlink:to="mlec_VolumeWeightedAveragePriceMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense_lbl0" xml:lang="en-US">Tax benefit arising from previously unrecognised tax loss, tax credit or temporary difference of prior period used to reduce deferred tax expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense" xlink:to="ifrs-full_TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PercentageOfShare_lbl1" xml:lang="en-US">Percentage Of Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfShare" xlink:to="mlec_PercentageOfShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_deductedFromAssetsMember_lbl0" xml:lang="en-US">deducted From Assets Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_deductedFromAssetsMember" xlink:to="mlec_deductedFromAssetsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherPropertyPlantAndEquipment_lbl0" xml:lang="en-US">Other property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherPropertyPlantAndEquipment" xlink:to="ifrs-full_OtherPropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GainsLossesOnDisposalsOfInvestments_lbl0" xml:lang="en-US">Gains (losses) on disposals of investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsLossesOnDisposalsOfInvestments" xlink:to="ifrs-full_GainsLossesOnDisposalsOfInvestments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InsumosAgroqumicosSAMember_lbl0" xml:lang="en-US">Insumos Agroqumicos SAMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InsumosAgroqumicosSAMember" xlink:to="mlec_InsumosAgroqumicosSAMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialLiabilitiesAtFairValue_lbl0" xml:lang="en-US">Financial liabilities, at fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilitiesAtFairValue" xlink:to="ifrs-full_FinancialLiabilitiesAtFairValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ProFarmGroupMember_lbl0" xml:lang="en-US">Pro Farm Group Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ProFarmGroupMember" xlink:to="mlec_ProFarmGroupMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss_lbl0" xml:lang="en-US">Gain (loss) on hedge ineffectiveness recognised in profit or loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss" xlink:to="ifrs-full_GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DisclosureOfForeignExchangeRiskSensitivityAnalysistextBlock_lbl1" xml:lang="en-US">Disclosure Of Foreign Exchange Risk Sensitivity Analysistext Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfForeignExchangeRiskSensitivityAnalysistextBlock" xlink:to="mlec_DisclosureOfForeignExchangeRiskSensitivityAnalysistextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentLiabilitiesAbstract_lbl0" xml:lang="en-US">Non-current liabilities [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLiabilitiesAbstract" xlink:to="ifrs-full_NoncurrentLiabilitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PercentageOfCustomerRevenues_lbl1" xml:lang="en-US">Percentage Of Customer Revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfCustomerRevenues" xlink:to="mlec_PercentageOfCustomerRevenues_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FinancialCommissions_lbl1" xml:lang="en-US">Financial Commissions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialCommissions" xlink:to="mlec_FinancialCommissions_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NutreconLLCMember_lbl0" xml:lang="en-US">Nutrecon LLCMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NutreconLLCMember" xlink:to="mlec_NutreconLLCMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PercentageOfProfitForObligationToLegalReserve_lbl1" xml:lang="en-US">Percentage Of Profit For Obligation To Legal Reserve</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfProfitForObligationToLegalReserve" xlink:to="mlec_PercentageOfProfitForObligationToLegalReserve_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_MeasurementAtFairValueAt06302025Abstract_lbl0" xml:lang="en-US">Measurement At Fair Value At06302025 Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MeasurementAtFairValueAt06302025Abstract" xlink:to="mlec_MeasurementAtFairValueAt06302025Abstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_OtherReceivableMember_lbl0" xml:lang="en-US">Other Receivable Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherReceivableMember" xlink:to="mlec_OtherReceivableMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_EnvironmentalImpactTreatment_lbl1" xml:lang="en-US">Environmental Impact Treatment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_EnvironmentalImpactTreatment" xlink:to="mlec_EnvironmentalImpactTreatment_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_lbl0" xml:lang="en-US">Weighted average exercise price of share options forfeited in share-based payment arrangement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SyngentaUpfrontFeeMember_lbl0" xml:lang="en-US">Syngenta Upfront Fee Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SyngentaUpfrontFeeMember" xlink:to="mlec_SyngentaUpfrontFeeMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_OtherFinancialResultsAbstract_lbl0" xml:lang="en-US">Other Financial Results Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherFinancialResultsAbstract" xlink:to="mlec_OtherFinancialResultsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BiologicalAssets_lbl1" xml:lang="en-US">Biological assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BiologicalAssets" xlink:to="ifrs-full_BiologicalAssets_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentProvisions_lbl0" xml:lang="en-US">Current provisions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentProvisions" xlink:to="ifrs-full_CurrentProvisions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InventoryMember_lbl0" xml:lang="en-US">Inventory Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InventoryMember" xlink:to="mlec_InventoryMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentAssets_lbl2" xml:lang="en-US">Non-current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_NoncurrentAssets_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_BioprotectionMember_lbl1" xml:lang="en-US">Bioprotection Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BioprotectionMember" xlink:to="mlec_BioprotectionMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_CurrentTradeReceivablesShareholdersAndOtherRelatedParties_lbl1" xml:lang="en-US">Current Trade Receivables Shareholders And Other Related Parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CurrentTradeReceivablesShareholdersAndOtherRelatedParties" xlink:to="mlec_CurrentTradeReceivablesShareholdersAndOtherRelatedParties_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_IfrsBalanceSheetLocationAxis_lbl1" xml:lang="en-US">Ifrs Balance Sheet Location Axis</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IfrsBalanceSheetLocationAxis" xlink:to="mlec_IfrsBalanceSheetLocationAxis_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EarningsPerShareExplanatory_lbl0" xml:lang="en-US">Earnings per share [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EarningsPerShareExplanatory" xlink:to="ifrs-full_EarningsPerShareExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_IntangiblesTaxLiabilityMember_lbl1" xml:lang="en-US">Intangibles Tax Liability Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IntangiblesTaxLiabilityMember" xlink:to="mlec_IntangiblesTaxLiabilityMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_lbl0" xml:lang="en-US">Repayments of borrowings, classified as financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:to="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LongtermBorrowings_lbl1" xml:lang="en-US">Non-current portion of non-current borrowings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LongtermBorrowings" xlink:to="ifrs-full_LongtermBorrowings_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherExpenseByFunction_lbl0" xml:lang="en-US">Other expense, by function</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherExpenseByFunction" xlink:to="ifrs-full_OtherExpenseByFunction_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DisclosureOfChangesInInvestmentInJointVenturesAndAffiliatesTableTextBlock_lbl1" xml:lang="en-US">Disclosure Of Changes In Investment In Joint Ventures And Affiliates Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfChangesInInvestmentInJointVenturesAndAffiliatesTableTextBlock" xlink:to="mlec_DisclosureOfChangesInInvestmentInJointVenturesAndAffiliatesTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AdditionsWarrantsForTheYear_lbl1" xml:lang="en-US">Additions Warrants For The Year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AdditionsWarrantsForTheYear" xlink:to="mlec_AdditionsWarrantsForTheYear_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestPaidClassifiedAsFinancingActivities_lbl1" xml:lang="en-US">Interest paid, classified as financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:to="ifrs-full_InterestPaidClassifiedAsFinancingActivities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_lbl0" xml:lang="en-US">Current payables on social security and taxes other than income tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax" xlink:to="ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_GoodsInTransitMember_lbl0" xml:lang="en-US">Goods In Transit Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_GoodsInTransitMember" xlink:to="mlec_GoodsInTransitMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherCashAndCashEquivalents_lbl0" xml:lang="en-US">Other cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCashAndCashEquivalents" xlink:to="ifrs-full_OtherCashAndCashEquivalents_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_UnlabeledAbstract3_lbl0" xml:lang="en-US">Unlabeled Abstract3</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract3" xlink:to="mlec_UnlabeledAbstract3_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_UnlabeledAbstract2_lbl0" xml:lang="en-US">Unlabeled Abstract2</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract2" xlink:to="mlec_UnlabeledAbstract2_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_UnlabeledAbstract5_lbl0" xml:lang="en-US">Unlabeled Abstract5</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract5" xlink:to="mlec_UnlabeledAbstract5_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NetLoansGrantedOneMember_lbl0" xml:lang="en-US">Net Loans Granted One Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NetLoansGrantedOneMember" xlink:to="mlec_NetLoansGrantedOneMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_UnlabeledAbstract4_lbl0" xml:lang="en-US">Unlabeled Abstract4</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract4" xlink:to="mlec_UnlabeledAbstract4_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_BioceresLLCMember_lbl0" xml:lang="en-US">Bioceres LLCMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BioceresLLCMember" xlink:to="mlec_BioceresLLCMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_UnlabeledAbstract1_lbl0" xml:lang="en-US">Unlabeled Abstract1</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract1" xlink:to="mlec_UnlabeledAbstract1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_UnlabeledAbstract0_lbl0" xml:lang="en-US">Unlabeled Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract0" xlink:to="mlec_UnlabeledAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_RevenueBySimilarGroupOfProductsOrServicesAbstract_lbl0" xml:lang="en-US">Revenue By Similar Group Of Products Or Services Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RevenueBySimilarGroupOfProductsOrServicesAbstract" xlink:to="mlec_RevenueBySimilarGroupOfProductsOrServicesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_VehiclesMember_lbl0" xml:lang="en-US">Vehicles [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_VehiclesMember" xlink:to="ifrs-full_VehiclesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_lbl0" xml:lang="en-US">Trade and other payables recognised as of acquisition date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfNumberOfSharesIssuedAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfNumberOfSharesIssuedAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfNumberOfSharesIssuedAbstract_lbl" xml:lang="en-US">Schedule Of Number Of Shares Issued Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfNumberOfSharesIssuedAbstract" xlink:to="mlec_ScheduleOfNumberOfSharesIssuedAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_UnlabeledAbstract6_lbl0" xml:lang="en-US">Unlabeled Abstract6</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract6" xlink:to="mlec_UnlabeledAbstract6_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_OthersFinancialAssetMember_lbl0" xml:lang="en-US">Others Financial Asset Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OthersFinancialAssetMember" xlink:to="mlec_OthersFinancialAssetMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_lbl0" xml:lang="en-US">Current trade payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:to="ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncontrollingInterestsMember_lbl0" xml:lang="en-US">Non-controlling interests [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncontrollingInterestsMember" xlink:to="ifrs-full_NoncontrollingInterestsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory_lbl0" xml:lang="en-US">Disclosure of information about separate financial statements [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory" xlink:to="ifrs-full_DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherComprehensiveIncomeAbstract_lbl1" xml:lang="en-US">Other comprehensive income [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncomeAbstract" xlink:to="ifrs-full_OtherComprehensiveIncomeAbstract_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CustomerrelatedIntangibleAssetsMember_lbl0" xml:lang="en-US">Customer-related intangible assets [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CustomerrelatedIntangibleAssetsMember" xlink:to="ifrs-full_CustomerrelatedIntangibleAssetsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherCashReceiptsFromSalesOfInterestsInJointVenturesClassifiedAsInvestingActivities_lbl0" xml:lang="en-US">Other cash receipts from sales of interests in joint ventures, classified as investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCashReceiptsFromSalesOfInterestsInJointVenturesClassifiedAsInvestingActivities" xlink:to="ifrs-full_OtherCashReceiptsFromSalesOfInterestsInJointVenturesClassifiedAsInvestingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_RevenuesFromContractsWithCustomersAbstract1_lbl0" xml:lang="en-US">Revenues From Contracts With Customers Abstract1</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RevenuesFromContractsWithCustomersAbstract1" xlink:to="mlec_RevenuesFromContractsWithCustomersAbstract1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_RevenuesFromContractsWithCustomersAbstract0_lbl0" xml:lang="en-US">Revenues From Contracts With Customers Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RevenuesFromContractsWithCustomersAbstract0" xlink:to="mlec_RevenuesFromContractsWithCustomersAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_TrademarksAndPatentsWithIndefiniteUsefulLifeMember_lbl0" xml:lang="en-US">Trademarks And Patents With Indefinite Useful Life Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TrademarksAndPatentsWithIndefiniteUsefulLifeMember" xlink:to="mlec_TrademarksAndPatentsWithIndefiniteUsefulLifeMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InventoryRecognizedAsExpense_lbl1" xml:lang="en-US">Inventory Recognized As Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InventoryRecognizedAsExpense" xlink:to="mlec_InventoryRecognizedAsExpense_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SharesIssuedMember_lbl0" xml:lang="en-US">Shares Issued Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SharesIssuedMember" xlink:to="mlec_SharesIssuedMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DisclosureOfOtherReceivablesTableTextBlock_lbl1" xml:lang="en-US">Disclosure Of Other Receivables Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfOtherReceivablesTableTextBlock" xlink:to="mlec_DisclosureOfOtherReceivablesTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl0" xml:lang="en-US">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_JointVenturesAndAssociatesLiabilities_lbl1" xml:lang="en-US">Joint Ventures And Associates Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_JointVenturesAndAssociatesLiabilities" xlink:to="mlec_JointVenturesAndAssociatesLiabilities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_JointVenturesInvestmentsAndAffiliatesMember_lbl0" xml:lang="en-US">Joint Ventures Investments And Affiliates Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_JointVenturesInvestmentsAndAffiliatesMember" xlink:to="mlec_JointVenturesInvestmentsAndAffiliatesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_MeasuredAtFairValueAbstract_lbl0" xml:lang="en-US">Measured At Fair Value Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MeasuredAtFairValueAbstract" xlink:to="mlec_MeasuredAtFairValueAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfFinancialLiabilitiesByCategoryAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfFinancialLiabilitiesByCategoryAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfFinancialLiabilitiesByCategoryAbstract_lbl" xml:lang="en-US">Schedule Of Financial Liabilities By Category Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfFinancialLiabilitiesByCategoryAbstract" xlink:to="mlec_ScheduleOfFinancialLiabilitiesByCategoryAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionWhetherChangeInAccountingPolicyIsMadeInAccordanceWithTransitionalProvisionsOfInitiallyAppliedIFRS_lbl0" xml:lang="en-US">Description whether change in accounting policy is made in accordance with transitional provisions of initially applied IFRS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionWhetherChangeInAccountingPolicyIsMadeInAccordanceWithTransitionalProvisionsOfInitiallyAppliedIFRS" xlink:to="ifrs-full_DescriptionWhetherChangeInAccountingPolicyIsMadeInAccordanceWithTransitionalProvisionsOfInitiallyAppliedIFRS_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_lbl0" xml:lang="en-US">Increase (decrease) through net exchange differences, property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" xlink:to="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_IncludedInLiabilitiesAbstract0_lbl0" xml:lang="en-US">Included In Liabilities Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IncludedInLiabilitiesAbstract0" xlink:to="mlec_IncludedInLiabilitiesAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ConsiderationForAcquisitionOfAssetsNonCurrent_lbl1" xml:lang="en-US">Consideration For Acquisition Of Assets Non Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ConsiderationForAcquisitionOfAssetsNonCurrent" xlink:to="mlec_ConsiderationForAcquisitionOfAssetsNonCurrent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DescriptionOfAccountingPolicyForWarrantLiabilities_lbl1" xml:lang="en-US">Description Of Accounting Policy For Warrant Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DescriptionOfAccountingPolicyForWarrantLiabilities" xlink:to="mlec_DescriptionOfAccountingPolicyForWarrantLiabilities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_IncreaseDecreaseThroughChangesInBusinessCombinationEquity_lbl1" xml:lang="en-US">Increase Decrease Through Changes In Business Combination Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IncreaseDecreaseThroughChangesInBusinessCombinationEquity" xlink:to="mlec_IncreaseDecreaseThroughChangesInBusinessCombinationEquity_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities_lbl1" xml:lang="en-US">Increase Through Borrowings Liabilities Arising From Financing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities" xlink:to="mlec_IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfSignificantJointVenturesTableTextBlock_lbl1" xml:lang="en-US">Schedule Of Significant Joint Ventures Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfSignificantJointVenturesTableTextBlock" xlink:to="mlec_ScheduleOfSignificantJointVenturesTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_OwnSharesHeldMember_lbl0" xml:lang="en-US">Own Shares Held Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OwnSharesHeldMember" xlink:to="mlec_OwnSharesHeldMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ExchangeOfIntangibleAssets_lbl1" xml:lang="en-US">Exchange Of Intangible Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ExchangeOfIntangibleAssets" xlink:to="mlec_ExchangeOfIntangibleAssets_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_lbl0" xml:lang="en-US">Description of accounting policy for determining components of cash and cash equivalents [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:to="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GainRecognisedInBargainPurchaseTransaction_lbl0" xml:lang="en-US">Gain recognised in bargain purchase transaction</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainRecognisedInBargainPurchaseTransaction" xlink:to="ifrs-full_GainRecognisedInBargainPurchaseTransaction_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LoansReceived_lbl0" xml:lang="en-US">Loans received</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LoansReceived" xlink:to="ifrs-full_LoansReceived_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentFinancialLiabilities_lbl0" xml:lang="en-US">Current financial liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentFinancialLiabilities" xlink:to="ifrs-full_CurrentFinancialLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LicenceFeeIncome_lbl0" xml:lang="en-US">Licence fee income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LicenceFeeIncome" xlink:to="ifrs-full_LicenceFeeIncome_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfCostOfSalesExplanatory_lbl0" xml:lang="en-US">Disclosure of cost of sales [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfCostOfSalesExplanatory" xlink:to="ifrs-full_DisclosureOfCostOfSalesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_BiologicalAssetsWheatMember_lbl1" xml:lang="en-US">Biological Assets Wheat Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BiologicalAssetsWheatMember" xlink:to="mlec_BiologicalAssetsWheatMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_lbl0" xml:lang="en-US">Reserve of exchange differences on translation [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:to="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Borrowings_lbl2" xml:lang="en-US">Borrowings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Borrowings" xlink:to="ifrs-full_Borrowings_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment_lbl0" xml:lang="en-US">Decrease through loss of control of subsidiary, property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment" xlink:to="ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ConditionalPaymentRizobacterSAMember_lbl0" xml:lang="en-US">Conditional Payment Rizobacter SAMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ConditionalPaymentRizobacterSAMember" xlink:to="mlec_ConditionalPaymentRizobacterSAMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentLiabilitiesWithCovenantsMember_lbl0" xml:lang="en-US">Non-current Liabilities with Covenants [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLiabilitiesWithCovenantsMember" xlink:to="ifrs-full_NoncurrentLiabilitiesWithCovenantsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AmountOfFinancialDebtUnderRestructuring_lbl1" xml:lang="en-US">Amount Of Financial Debt Under Restructuring</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AmountOfFinancialDebtUnderRestructuring" xlink:to="mlec_AmountOfFinancialDebtUnderRestructuring_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_CarryingAmountAbstract_lbl0" xml:lang="en-US">Carrying Amount Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CarryingAmountAbstract" xlink:to="mlec_CarryingAmountAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_lbl1" xml:lang="en-US">Expected dividend as percentage, share options granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:to="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DepreciationRightofuseAssets_lbl0" xml:lang="en-US">Depreciation, right-of-use assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationRightofuseAssets" xlink:to="ifrs-full_DepreciationRightofuseAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SynBioPowerlabsMember_lbl0" xml:lang="en-US">Syn Bio Powerlabs Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SynBioPowerlabsMember" xlink:to="mlec_SynBioPowerlabsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_UnlabeledAbstract_lbl0" xml:lang="en-US">Unlabeled Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract" xlink:to="mlec_UnlabeledAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DisclosureOfWarrantsTextBlock_lbl1" xml:lang="en-US">Disclosure Of Warrants Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfWarrantsTextBlock" xlink:to="mlec_DisclosureOfWarrantsTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentLeaseLiabilities_lbl1" xml:lang="en-US">Current lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLeaseLiabilities" xlink:to="ifrs-full_CurrentLeaseLiabilities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SubsequentEventsMember_lbl0" xml:lang="en-US">Subsequent Events Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SubsequentEventsMember" xlink:to="mlec_SubsequentEventsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset_lbl0" xml:lang="en-US">Increase (decrease) through net exchange differences, deferred tax liability (asset)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" xlink:to="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AgralityArgentinaSAMember_lbl0" xml:lang="en-US">Agrality Argentina SAMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AgralityArgentinaSAMember" xlink:to="mlec_AgralityArgentinaSAMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities_lbl0" xml:lang="en-US">Cash flows from (used in) investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RevenueFromRoyalties_lbl0" xml:lang="en-US">Royalty income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueFromRoyalties" xlink:to="ifrs-full_RevenueFromRoyalties_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ProFarmGroupIncMember_lbl1" xml:lang="en-US">Pro Farm Group Inc Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ProFarmGroupIncMember" xlink:to="mlec_ProFarmGroupIncMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherComprehensiveIncomeBeforeTax_lbl0" xml:lang="en-US">Other comprehensive income, before tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncomeBeforeTax" xlink:to="ifrs-full_OtherComprehensiveIncomeBeforeTax_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_OthersAbstract0_lbl0" xml:lang="en-US">Others Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OthersAbstract0" xlink:to="mlec_OthersAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ResearchInstrumentsMember_lbl0" xml:lang="en-US">Research Instruments Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ResearchInstrumentsMember" xlink:to="mlec_ResearchInstrumentsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherTangibleOrIntangibleAssetsTransferred_lbl0" xml:lang="en-US">Other tangible or intangible assets transferred</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherTangibleOrIntangibleAssetsTransferred" xlink:to="ifrs-full_OtherTangibleOrIntangibleAssetsTransferred_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_OthersAbstract1_lbl0" xml:lang="en-US">Others Abstract1</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OthersAbstract1" xlink:to="mlec_OthersAbstract1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_CumulativeInflationRate_lbl1" xml:lang="en-US">Cumulative Inflation Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CumulativeInflationRate" xlink:to="mlec_CumulativeInflationRate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryOtherProvisions_lbl0" xml:lang="en-US">Decrease through loss of control of subsidiary, other provisions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryOtherProvisions" xlink:to="ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryOtherProvisions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_LiabilitiesMember_lbl0" xml:lang="en-US">Liabilities Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LiabilitiesMember" xlink:to="mlec_LiabilitiesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LeaseLiabilityInASaleAndLeasebackMember_lbl0" xml:lang="en-US">Lease Liability in a Sale and Leaseback [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LeaseLiabilityInASaleAndLeasebackMember" xlink:to="ifrs-full_LeaseLiabilityInASaleAndLeasebackMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_TotalNonreportableAssets_lbl1" xml:lang="en-US">Total Nonreportable Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TotalNonreportableAssets" xlink:to="mlec_TotalNonreportableAssets_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections_lbl0" xml:lang="en-US">Growth rate used to extrapolate cash flow projections</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections" xlink:to="ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PercentageOfPenalty_lbl1" xml:lang="en-US">Percentage Of Penalty</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfPenalty" xlink:to="mlec_PercentageOfPenalty_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ReverseStockSplit_lbl1" xml:lang="en-US">Reverse Stock Split</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ReverseStockSplit" xlink:to="mlec_ReverseStockSplit_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentAssetsAbstract_lbl0" xml:lang="en-US">Current assets [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_CurrentAssetsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_BioceresTechServicesLLCMember_lbl0" xml:lang="en-US">Bioceres Tech Services LLCMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BioceresTechServicesLLCMember" xlink:to="mlec_BioceresTechServicesLLCMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrencyRiskMember_lbl0" xml:lang="en-US">Currency risk [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrencyRiskMember" xlink:to="ifrs-full_CurrencyRiskMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SuppliesAndMaterials_lbl1" xml:lang="en-US">Supplies And Materials</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SuppliesAndMaterials" xlink:to="mlec_SuppliesAndMaterials_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfFairValueOfTheConsiderationOfPaymentAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfFairValueOfTheConsiderationOfPaymentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfFairValueOfTheConsiderationOfPaymentAbstract_lbl" xml:lang="en-US">Schedule Of Fair Value Of The Consideration Of Payment Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfFairValueOfTheConsiderationOfPaymentAbstract" xlink:to="mlec_ScheduleOfFairValueOfTheConsiderationOfPaymentAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossOfCombinedEntity_lbl0" xml:lang="en-US">Profit (loss) of combined entity as if combination occurred at beginning of period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossOfCombinedEntity" xlink:to="ifrs-full_ProfitLossOfCombinedEntity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfCashPaymentsAbstract_lbl0" xml:lang="en-US">Classes of cash payments from operating activities [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfCashPaymentsAbstract" xlink:to="ifrs-full_ClassesOfCashPaymentsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_MiscellaneousMember_lbl0" xml:lang="en-US">Miscellaneous Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MiscellaneousMember" xlink:to="mlec_MiscellaneousMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherFinanceIncomeCost_lbl1" xml:lang="en-US">Other finance income (cost)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherFinanceIncomeCost" xlink:to="ifrs-full_OtherFinanceIncomeCost_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfFinancialPositionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of financial position [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_StatementOfFinancialPositionAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfRollForwardOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfRollForwardOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfRollForwardOfDeferredTaxAssetsAndLiabilitiesAbstract_lbl" xml:lang="en-US">Schedule Of Roll Forward Of Deferred Tax Assets And Liabilities Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfRollForwardOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="mlec_ScheduleOfRollForwardOfDeferredTaxAssetsAndLiabilitiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ThresholdEarningsBeforeInterestTaxesDepreciationAndAmortization_lbl1" xml:lang="en-US">Threshold Earnings Before Interest Taxes Depreciation And Amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ThresholdEarningsBeforeInterestTaxesDepreciationAndAmortization" xlink:to="mlec_ThresholdEarningsBeforeInterestTaxesDepreciationAndAmortization_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Vehicles_lbl0" xml:lang="en-US">Vehicles</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Vehicles" xlink:to="ifrs-full_Vehicles_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ChangeInNetRealizableValueOfAgricultural_lbl1" xml:lang="en-US">Change In Net Realizable Value Of Agricultural</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ChangeInNetRealizableValueOfAgricultural" xlink:to="mlec_ChangeInNetRealizableValueOfAgricultural_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_BacillusPHAsMember_lbl0" xml:lang="en-US">Bacillus PHAs Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BacillusPHAsMember" xlink:to="mlec_BacillusPHAsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_GainlossOfDerecognitionTransactions_lbl1" xml:lang="en-US">Gainloss Of Derecognition Transactions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_GainlossOfDerecognitionTransactions" xlink:to="mlec_GainlossOfDerecognitionTransactions_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentProvisions_lbl0" xml:lang="en-US">Non-current provisions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentProvisions" xlink:to="ifrs-full_NoncurrentProvisions_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract_lbl" xml:lang="en-US">Reconciliation of accounting profit multiplied by applicable tax rates [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:to="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PledgedOrTransferredSharesQuantity_lbl1" xml:lang="en-US">Pledged Or Transferred Shares Quantity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PledgedOrTransferredSharesQuantity" xlink:to="mlec_PledgedOrTransferredSharesQuantity_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DeductedFromAssetsAbstract0_lbl0" xml:lang="en-US">Deducted From Assets Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DeductedFromAssetsAbstract0" xlink:to="mlec_DeductedFromAssetsAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_LeaseLiabilitiesInterestExpenseExchangeDifferencesAndInflationEffects_lbl1" xml:lang="en-US">Lease Liabilities Interest Expense Exchange Differences And Inflation Effects</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LeaseLiabilitiesInterestExpenseExchangeDifferencesAndInflationEffects" xlink:to="mlec_LeaseLiabilitiesInterestExpenseExchangeDifferencesAndInflationEffects_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SalariesSocialSecurityBenefitsAndOtherBenefitsMember_lbl0" xml:lang="en-US">Salaries Social Security Benefits And Other Benefits Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SalariesSocialSecurityBenefitsAndOtherBenefitsMember" xlink:to="mlec_SalariesSocialSecurityBenefitsAndOtherBenefitsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ValueOfTransactionsForThePeriodEnded_lbl1" xml:lang="en-US">Value Of Transactions For The Period Ended</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ValueOfTransactionsForThePeriodEnded" xlink:to="mlec_ValueOfTransactionsForThePeriodEnded_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LandAndBuildingsMember_lbl0" xml:lang="en-US">Land and buildings [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LandAndBuildingsMember" xlink:to="ifrs-full_LandAndBuildingsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdministrativeExpense_lbl0" xml:lang="en-US">Administrative expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdministrativeExpense" xlink:to="ifrs-full_AdministrativeExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AllowanceForObsolescenceMember_lbl1" xml:lang="en-US">Allowance For Obsolescence Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AllowanceForObsolescenceMember" xlink:to="mlec_AllowanceForObsolescenceMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_NorthAmericaMember_lbl0" xml:lang="en-US">North America [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_NorthAmericaMember" xlink:to="srt_NorthAmericaMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_CreditorsPublicAuctionShares_lbl1" xml:lang="en-US">Creditors Public Auction Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CreditorsPublicAuctionShares" xlink:to="mlec_CreditorsPublicAuctionShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RevenueFromSaleOfGoods_lbl0" xml:lang="en-US">Revenue from sale of goods</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueFromSaleOfGoods" xlink:to="ifrs-full_RevenueFromSaleOfGoods_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PercentageOfVotingEquityInterestsAcquired_lbl0" xml:lang="en-US">Percentage of voting equity interests acquired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:to="ifrs-full_PercentageOfVotingEquityInterestsAcquired_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities_lbl1" xml:lang="en-US">Current deferred income including current contract liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities" xlink:to="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForIncomeTaxExpense_lbl0" xml:lang="en-US">Adjustments for income tax expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncomeTaxExpense" xlink:to="ifrs-full_AdjustmentsForIncomeTaxExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_MeasuredAtEquityValueMethodAbstract_lbl0" xml:lang="en-US">Measured At Equity Value Method Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MeasuredAtEquityValueMethodAbstract" xlink:to="mlec_MeasuredAtEquityValueMethodAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashTransferred_lbl1" xml:lang="en-US">Cash transferred</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashTransferred" xlink:to="ifrs-full_CashTransferred_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory_lbl0" xml:lang="en-US">Disclosure of reconciliation of changes in biological assets [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PrepaymentsToSuppliersMember_lbl0" xml:lang="en-US">Prepayments To Suppliers Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PrepaymentsToSuppliersMember" xlink:to="mlec_PrepaymentsToSuppliersMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_RizobacterArgentinaSAMember_lbl0" xml:lang="en-US">Rizobacter Argentina SAMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RizobacterArgentinaSAMember" xlink:to="mlec_RizobacterArgentinaSAMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InventoryProductionCosts_lbl1" xml:lang="en-US">Inventory Production Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InventoryProductionCosts" xlink:to="mlec_InventoryProductionCosts_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SalesAndServicesMember_lbl0" xml:lang="en-US">Sales And Services Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SalesAndServicesMember" xlink:to="mlec_SalesAndServicesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForFairValueGainsLosses_lbl0" xml:lang="en-US">Adjustments for fair value losses (gains)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForFairValueGainsLosses" xlink:to="ifrs-full_AdjustmentsForFairValueGainsLosses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_lbl0" xml:lang="en-US">Cash flows from losing control of subsidiaries or other businesses, classified as investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:to="ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for employee benefits [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DeferredTaxLiabilityAsset_lbl0" xml:lang="en-US">Deferred tax liability (asset)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxLiabilityAsset" xlink:to="ifrs-full_DeferredTaxLiabilityAsset_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ShorttermEmployeeBenefitsExpense_lbl0" xml:lang="en-US">Short-term employee benefits expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShorttermEmployeeBenefitsExpense" xlink:to="ifrs-full_ShorttermEmployeeBenefitsExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExercisePriceShareOptionsGranted2019_lbl2" xml:lang="en-US">Exercise price, share options granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:to="ifrs-full_ExercisePriceShareOptionsGranted2019_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NonMonetaryContributionsInJointVenturesNonCashTransactionsInvestmentActivities_lbl1" xml:lang="en-US">Non Monetary Contributions In Joint Ventures Non Cash Transactions Investment Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NonMonetaryContributionsInJointVenturesNonCashTransactionsInvestmentActivities" xlink:to="mlec_NonMonetaryContributionsInJointVenturesNonCashTransactionsInvestmentActivities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SharesPremium_lbl1" xml:lang="en-US">Shares Premium</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SharesPremium" xlink:to="mlec_SharesPremium_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets_lbl0" xml:lang="en-US">Property, plant and equipment, revalued assets, at cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets" xlink:to="ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InventoriesTaxLiabilityMember_lbl1" xml:lang="en-US">Inventories Tax Liability Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InventoriesTaxLiabilityMember" xlink:to="mlec_InventoriesTaxLiabilityMember_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfFinancialAssetsByCategoryAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfFinancialAssetsByCategoryAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfFinancialAssetsByCategoryAbstract_lbl" xml:lang="en-US">Schedule Of Financial Assets By Category Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfFinancialAssetsByCategoryAbstract" xlink:to="mlec_ScheduleOfFinancialAssetsByCategoryAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PercentageOfInflationAccumulated_lbl1" xml:lang="en-US">Percentage Of Inflation Accumulated</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfInflationAccumulated" xlink:to="mlec_PercentageOfInflationAccumulated_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PrivateWarrantsExercisePrice_lbl1" xml:lang="en-US">Private Warrants Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PrivateWarrantsExercisePrice" xlink:to="mlec_PrivateWarrantsExercisePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisposalsRightofuseAssets_lbl0" xml:lang="en-US">Disposals, right-of-use assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisposalsRightofuseAssets" xlink:to="ifrs-full_DisposalsRightofuseAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SustainableAgriculturalEquipmentTechnologyMember_lbl0" xml:lang="en-US">Sustainable Agricultural Equipment Technology Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SustainableAgriculturalEquipmentTechnologyMember" xlink:to="mlec_SustainableAgriculturalEquipmentTechnologyMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_lbl0" xml:lang="en-US">Disclosure of accounting judgements and estimates [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:to="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentBiologicalAssets_lbl0" xml:lang="en-US">Current biological assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentBiologicalAssets" xlink:to="ifrs-full_CurrentBiologicalAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_CurrentTradeReceivablesAllowanceForImpairmentOfTradeDebtors_lbl1" xml:lang="en-US">Current Trade Receivables Allowance For Impairment Of Trade Debtors</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CurrentTradeReceivablesAllowanceForImpairmentOfTradeDebtors" xlink:to="mlec_CurrentTradeReceivablesAllowanceForImpairmentOfTradeDebtors_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_CustomerLoyaltyMember_lbl0" xml:lang="en-US">Customer Loyalty Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CustomerLoyaltyMember" xlink:to="mlec_CustomerLoyaltyMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_lbl0" xml:lang="en-US">Other comprehensive income, net of tax, gains (losses) on revaluation of property, plant and equipment, right-of-use assets and intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DisclosureOfOtherFinancialAssetsExplanatory_lbl1" xml:lang="en-US">Disclosure Of Other Financial Assets Explanatory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfOtherFinancialAssetsExplanatory" xlink:to="mlec_DisclosureOfOtherFinancialAssetsExplanatory_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DisclosureOfInvestmentsInJointVenturesAndAffiliatesTableTextBlock_lbl1" xml:lang="en-US">Disclosure Of Investments In Joint Ventures And Affiliates Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfInvestmentsInJointVenturesAndAffiliatesTableTextBlock" xlink:to="mlec_DisclosureOfInvestmentsInJointVenturesAndAffiliatesTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentDebtInstrumentsIssued_lbl1" xml:lang="en-US">Current debt instruments issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentDebtInstrumentsIssued" xlink:to="ifrs-full_CurrentDebtInstrumentsIssued_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_StockOptionsAndShareBasedIncentives_lbl1" xml:lang="en-US">Stock Options And Share Based Incentives</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_StockOptionsAndShareBasedIncentives" xlink:to="mlec_StockOptionsAndShareBasedIncentives_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_OthersFinancialAssetsMember_lbl1" xml:lang="en-US">Others Financial Assets Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OthersFinancialAssetsMember" xlink:to="mlec_OthersFinancialAssetsMember_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfDeferredRevenueAndAdvancesFromCustomersAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfDeferredRevenueAndAdvancesFromCustomersAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfDeferredRevenueAndAdvancesFromCustomersAbstract_lbl" xml:lang="en-US">Schedule Of Deferred Revenue And Advances From Customers Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfDeferredRevenueAndAdvancesFromCustomersAbstract" xlink:to="mlec_ScheduleOfDeferredRevenueAndAdvancesFromCustomersAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SeedRoyaltiesPaymentsHB4ProgramMember_lbl0" xml:lang="en-US">Seed Royalties Payments HB4 Program Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SeedRoyaltiesPaymentsHB4ProgramMember" xlink:to="mlec_SeedRoyaltiesPaymentsHB4ProgramMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_lbl0" xml:lang="en-US">Disclosure of information about key management personnel [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory" xlink:to="ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_TradeCreditorsMember_lbl0" xml:lang="en-US">Trade Creditors Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TradeCreditorsMember" xlink:to="mlec_TradeCreditorsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NoncontrollingInterest_lbl1" xml:lang="en-US">Noncontrolling Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NoncontrollingInterest" xlink:to="mlec_NoncontrollingInterest_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets_lbl0" xml:lang="en-US">Gains (losses) on fair value adjustment attributable to price changes, biological assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets" xlink:to="ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_IssuanceOfShare_lbl1" xml:lang="en-US">Issuance Of Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IssuanceOfShare" xlink:to="mlec_IssuanceOfShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_lbl0" xml:lang="en-US">Useful life measured as period of time, property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:to="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AllowanceForImpairmentOfTradeDebtors_lbl1" xml:lang="en-US">Allowance For Impairment Of Trade Debtors</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AllowanceForImpairmentOfTradeDebtors" xlink:to="mlec_AllowanceForImpairmentOfTradeDebtors_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NumberOfOptionsEstimatedExercisePercent_lbl1" xml:lang="en-US">Number Of Options Estimated Exercise Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfOptionsEstimatedExercisePercent" xlink:to="mlec_NumberOfOptionsEstimatedExercisePercent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ShareBasedPaymentArrangementConversionOfEquityAwardsOutstandingToOptionOrRestrictedStockUnits_lbl1" xml:lang="en-US">Share Based Payment Arrangement Conversion Of Equity Awards Outstanding To Option Or Restricted Stock Units</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareBasedPaymentArrangementConversionOfEquityAwardsOutstandingToOptionOrRestrictedStockUnits" xlink:to="mlec_ShareBasedPaymentArrangementConversionOfEquityAwardsOutstandingToOptionOrRestrictedStockUnits_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_StandAloneStockOptionGrantMember_lbl2" xml:lang="en-US">Stand Alone Stock Option Grant Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_StandAloneStockOptionGrantMember" xlink:to="mlec_StandAloneStockOptionGrantMember_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_lbl1" xml:lang="en-US">Number of share options granted in share-based payment arrangement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_EmergingSolutionsMember_lbl0" xml:lang="en-US">Emerging Solutions Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_EmergingSolutionsMember" xlink:to="mlec_EmergingSolutionsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InsuranceToBeAccruedMember_lbl0" xml:lang="en-US">Insurance To Be Accrued Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InsuranceToBeAccruedMember" xlink:to="mlec_InsuranceToBeAccruedMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SynertechIndustriasSAMember_lbl1" xml:lang="en-US">Synertech Industrias SAMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SynertechIndustriasSAMember" xlink:to="mlec_SynertechIndustriasSAMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for provisions [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_GovernmentGrantsMember_lbl1" xml:lang="en-US">Government Grants Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_GovernmentGrantsMember" xlink:to="mlec_GovernmentGrantsMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_lbl0" xml:lang="en-US">Disclosure of events after reporting period [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:to="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EquityAttributableToOwnersOfParent_lbl0" xml:lang="en-US">Equity attributable to owners of parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAttributableToOwnersOfParent" xlink:to="ifrs-full_EquityAttributableToOwnersOfParent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for intangible assets and goodwill [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfSubsidiariesNonControllingInterestAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfSubsidiariesNonControllingInterestAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfSubsidiariesNonControllingInterestAbstract_lbl" xml:lang="en-US">Schedule Of Subsidiaries Non Controlling Interest Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfSubsidiariesNonControllingInterestAbstract" xlink:to="mlec_ScheduleOfSubsidiariesNonControllingInterestAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_BiostimulantsMember_lbl1" xml:lang="en-US">Biostimulants Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BiostimulantsMember" xlink:to="mlec_BiostimulantsMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_GainsLossesOnExchangeDifferencesOnTranslationFromJointVentureNetOfTax_lbl1" xml:lang="en-US">Gains Losses On Exchange Differences On Translation From Joint Venture Net Of Tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_GainsLossesOnExchangeDifferencesOnTranslationFromJointVentureNetOfTax" xlink:to="mlec_GainsLossesOnExchangeDifferencesOnTranslationFromJointVentureNetOfTax_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DebtInstrumentsHeldAtAmortisedCost_lbl0" xml:lang="en-US">Debt instruments held at amortised cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DebtInstrumentsHeldAtAmortisedCost" xlink:to="ifrs-full_DebtInstrumentsHeldAtAmortisedCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Level3OfFairValueHierarchyMember_lbl0" xml:lang="en-US">Level 3 of fair value hierarchy [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Level3OfFairValueHierarchyMember" xlink:to="ifrs-full_Level3OfFairValueHierarchyMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PercentageOfPenaltyOfPrepayment_lbl1" xml:lang="en-US">Percentage Of Penalty Of Prepayment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfPenaltyOfPrepayment" xlink:to="mlec_PercentageOfPenaltyOfPrepayment_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NetLoansPayablesMember_lbl0" xml:lang="en-US">Net Loans Payables Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NetLoansPayablesMember" xlink:to="mlec_NetLoansPayablesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome_lbl0" xml:lang="en-US">Income tax relating to components of other comprehensive income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" xlink:to="ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_LossMakingEntitiesMember_lbl1" xml:lang="en-US">Loss Making Entities Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LossMakingEntitiesMember" xlink:to="mlec_LossMakingEntitiesMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PrepaidExpensesAndOtherReceivablesMember_lbl0" xml:lang="en-US">Prepaid Expenses And Other Receivables Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PrepaidExpensesAndOtherReceivablesMember" xlink:to="mlec_PrepaidExpensesAndOtherReceivablesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ShorttermBorrowings_lbl2" xml:lang="en-US">Current borrowings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShorttermBorrowings" xlink:to="ifrs-full_ShorttermBorrowings_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_lbl0" xml:lang="en-US">Disclosure of quantitative information about right-of-use assets [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SecuredConvertibleGuaranteedNotesMember_lbl1" xml:lang="en-US">Secured Convertible Guaranteed Notes Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SecuredConvertibleGuaranteedNotesMember" xlink:to="mlec_SecuredConvertibleGuaranteedNotesMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Liabilities_lbl0" xml:lang="en-US">Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Liabilities" xlink:to="ifrs-full_Liabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Assets_lbl1" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Assets" xlink:to="ifrs-full_Assets_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfAssetsAcquiredAndLiabilitiesAssumedAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfAssetsAcquiredAndLiabilitiesAssumedAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfAssetsAcquiredAndLiabilitiesAssumedAbstract_lbl" xml:lang="en-US">Schedule Of Assets Acquired And Liabilities Assumed Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfAssetsAcquiredAndLiabilitiesAssumedAbstract" xlink:to="mlec_ScheduleOfAssetsAcquiredAndLiabilitiesAssumedAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeBiologicalAssetsAtCost_lbl0" xml:lang="en-US">Useful life measured as period of time, biological assets, at cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeBiologicalAssetsAtCost" xlink:to="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeBiologicalAssetsAtCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock_lbl1" xml:lang="en-US">Disclosure Of Information About Components Of Consolidated Statements Of Financial Position Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock" xlink:to="mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDeferredTaxesExplanatory_lbl0" xml:lang="en-US">Disclosure of deferred taxes [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDeferredTaxesExplanatory" xlink:to="ifrs-full_DisclosureOfDeferredTaxesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ImportAndExportExpenses_lbl1" xml:lang="en-US">Import And Export Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ImportAndExportExpenses" xlink:to="mlec_ImportAndExportExpenses_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfTransactionsBetweenTheGroupAndRelatedPartiesAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfTransactionsBetweenTheGroupAndRelatedPartiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfTransactionsBetweenTheGroupAndRelatedPartiesAbstract_lbl" xml:lang="en-US">Schedule Of Transactions Between The Group And Related Parties Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfTransactionsBetweenTheGroupAndRelatedPartiesAbstract" xlink:to="mlec_ScheduleOfTransactionsBetweenTheGroupAndRelatedPartiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RoyaltyExpense_lbl0" xml:lang="en-US">Royalty expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RoyaltyExpense" xlink:to="ifrs-full_RoyaltyExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_lbl1" xml:lang="en-US">Tax expense (income) at applicable tax rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:to="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_lbl0" xml:lang="en-US">Income taxes paid (refund), classified as operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:to="ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_GainOnBargainPurchase_lbl1" xml:lang="en-US">Gain On Bargain Purchase</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_GainOnBargainPurchase" xlink:to="mlec_GainOnBargainPurchase_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BrandNamesMember_lbl0" xml:lang="en-US">Brand names [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BrandNamesMember" xlink:to="ifrs-full_BrandNamesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DisclosuresOfDeferredRevenueAndAdvancesFromCustomersTableTextBlock_lbl1" xml:lang="en-US">Disclosures Of Deferred Revenue And Advances From Customers Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosuresOfDeferredRevenueAndAdvancesFromCustomersTableTextBlock" xlink:to="mlec_DisclosuresOfDeferredRevenueAndAdvancesFromCustomersTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_JointVenturesAndAssociatesAccountedForUsingEquityMethodReclassificationChangeInOwnership_lbl1" xml:lang="en-US">Joint Ventures And Associates Accounted For Using Equity Method Reclassification Change In Ownership</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_JointVenturesAndAssociatesAccountedForUsingEquityMethodReclassificationChangeInOwnership" xlink:to="mlec_JointVenturesAndAssociatesAccountedForUsingEquityMethodReclassificationChangeInOwnership_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_RizobacterUGEMember_lbl0" xml:lang="en-US">Rizobacter UGEMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RizobacterUGEMember" xlink:to="mlec_RizobacterUGEMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_lbl0" xml:lang="en-US">Useful life measured as period of time, intangible assets other than goodwill</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherProvisions_lbl1" xml:lang="en-US">Other provisions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherProvisions" xlink:to="ifrs-full_OtherProvisions_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_BorrowingInterestRateInCash_lbl1" xml:lang="en-US">Borrowing Interest Rate In Cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BorrowingInterestRateInCash" xlink:to="mlec_BorrowingInterestRateInCash_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_OthersFinancialAssetsOneMember_lbl0" xml:lang="en-US">Others Financial Assets One Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OthersFinancialAssetsOneMember" xlink:to="mlec_OthersFinancialAssetsOneMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_lbl0" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:to="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ItemsThatWillNotBeSubsequentlyReclassifiedToLossAndProfit_lbl1" xml:lang="en-US">Items That Will Not Be Subsequently Reclassified To Loss And Profit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ItemsThatWillNotBeSubsequentlyReclassifiedToLossAndProfit" xlink:to="mlec_ItemsThatWillNotBeSubsequentlyReclassifiedToLossAndProfit_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdditionsToRightofuseAssets_lbl1" xml:lang="en-US">Additions to right-of-use assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionsToRightofuseAssets" xlink:to="ifrs-full_AdditionsToRightofuseAssets_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InmetSAMember_lbl1" xml:lang="en-US">Inmet SAMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InmetSAMember" xlink:to="mlec_InmetSAMember_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfFinancialStatementsAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfFinancialStatementsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Schedule Of Financial Statements Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfFinancialStatementsAbstract" xlink:to="mlec_ScheduleOfFinancialStatementsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract_lbl" xml:lang="en-US">Disclosure of risk management strategy related to hedge accounting [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract" xlink:to="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialLiabilities_lbl1" xml:lang="en-US">Financial liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilities" xlink:to="ifrs-full_FinancialLiabilities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_BR_lbl0" xml:lang="en-US">BRAZIL</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_BR" xlink:to="country_BR_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PreferenceOfAccruePerAnnum_lbl1" xml:lang="en-US">Preference Of Accrue Per Annum</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PreferenceOfAccruePerAnnum" xlink:to="mlec_PreferenceOfAccruePerAnnum_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_lbl0" xml:lang="en-US">Weighted average fair value at measurement date, share options granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" xlink:to="ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_lbl0" xml:lang="en-US">Number of share options expired in share-based payment arrangement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_TotalReportableAssets_lbl1" xml:lang="en-US">Total Reportable Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TotalReportableAssets" xlink:to="mlec_TotalReportableAssets_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FinancialBorrowingsMember_lbl0" xml:lang="en-US">Financial Borrowings Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialBorrowingsMember" xlink:to="mlec_FinancialBorrowingsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DeferredTaxExpenseIncome_lbl0" xml:lang="en-US">Deferred tax expense (income)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxExpenseIncome" xlink:to="ifrs-full_DeferredTaxExpenseIncome_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_lbl0" xml:lang="en-US">Increase (decrease) through effect of changes in foreign exchange rates, liabilities arising from financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" xlink:to="ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InflationEffectsOnCashAndCashEquivalents_lbl1" xml:lang="en-US">Inflation Effects On Cash And Cash Equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InflationEffectsOnCashAndCashEquivalents" xlink:to="mlec_InflationEffectsOnCashAndCashEquivalents_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_lbl0" xml:lang="en-US">Key management personnel compensation, share-based payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:to="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_BiologicalAssetsMember_lbl0" xml:lang="en-US">Biological Assets Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BiologicalAssetsMember" xlink:to="mlec_BiologicalAssetsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfEarningPerShareAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfEarningPerShareAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfEarningPerShareAbstract_lbl" xml:lang="en-US">Schedule Of Earning Per Share Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfEarningPerShareAbstract" xlink:to="mlec_ScheduleOfEarningPerShareAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_TheoISCSpMember_lbl0" xml:lang="en-US">Theo ISCSp Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TheoISCSpMember" xlink:to="mlec_TheoISCSpMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_LowOrNullTaxationJurisdictionsMember_lbl1" xml:lang="en-US">Low Or Null Taxation Jurisdictions Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LowOrNullTaxationJurisdictionsMember" xlink:to="mlec_LowOrNullTaxationJurisdictionsMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities_lbl0" xml:lang="en-US">Adjustments for increase (decrease) in deferred income including contract liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InsuranceExpense_lbl0" xml:lang="en-US">Insurance expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InsuranceExpense" xlink:to="ifrs-full_InsuranceExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_lbl0" xml:lang="en-US">Disclosure of indirect measurement of fair value of goods or services received, share options granted during period [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:to="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentTaxLiabilitiesCurrent_lbl0" xml:lang="en-US">Current tax liabilities, current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:to="ifrs-full_CurrentTaxLiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_VehicleExpenses_lbl1" xml:lang="en-US">Vehicle Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_VehicleExpenses" xlink:to="mlec_VehicleExpenses_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl3" xml:lang="en-US">Intangible assets other than goodwill</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AlfalfaGenuityHarXstraMember_lbl0" xml:lang="en-US">Alfalfa Genuity Har Xstra Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AlfalfaGenuityHarXstraMember" xlink:to="mlec_AlfalfaGenuityHarXstraMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SWSemillasSAMember_lbl0" xml:lang="en-US">SWSemillas SAMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SWSemillasSAMember" xlink:to="mlec_SWSemillasSAMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_AR_lbl1" xml:lang="en-US">ARGENTINA</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_AR" xlink:to="country_AR_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_TotalResearchAndDevelopmentExpenseIncurred_lbl1" xml:lang="en-US">Total Research And Development Expense Incurred</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TotalResearchAndDevelopmentExpenseIncurred" xlink:to="mlec_TotalResearchAndDevelopmentExpenseIncurred_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_OptionsIncentivePlanMember_lbl1" xml:lang="en-US">Options Incentive Plan Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OptionsIncentivePlanMember" xlink:to="mlec_OptionsIncentivePlanMember_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfGeographicalInformationAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfGeographicalInformationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfGeographicalInformationAbstract_lbl" xml:lang="en-US">Schedule Of Geographical Information Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfGeographicalInformationAbstract" xlink:to="mlec_ScheduleOfGeographicalInformationAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentGovernmentGrants_lbl0" xml:lang="en-US">Non-current government grants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentGovernmentGrants" xlink:to="ifrs-full_NoncurrentGovernmentGrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentPortionOfNoncurrentBorrowingsByTypeAbstract_lbl1" xml:lang="en-US">Non-current portion of non-current borrowings, by type [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentPortionOfNoncurrentBorrowingsByTypeAbstract" xlink:to="ifrs-full_NoncurrentPortionOfNoncurrentBorrowingsByTypeAbstract_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_RevaluationOfPropertyPlantEquipmentAndEffectOfTaxRateChangeMember_lbl0" xml:lang="en-US">Revaluation Of Property Plant Equipment And Effect Of Tax Rate Change Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RevaluationOfPropertyPlantEquipmentAndEffectOfTaxRateChangeMember" xlink:to="mlec_RevaluationOfPropertyPlantEquipmentAndEffectOfTaxRateChangeMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_WarrantLiabilityMember_lbl1" xml:lang="en-US">Warrant Liability Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_WarrantLiabilityMember" xlink:to="mlec_WarrantLiabilityMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_lbl0" xml:lang="en-US">Disclosure of share-based payment arrangements [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:to="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossAttributableToAbstract_lbl0" xml:lang="en-US">Profit (loss), attributable to [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossAttributableToAbstract" xlink:to="ifrs-full_ProfitLossAttributableToAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract_lbl0" xml:lang="en-US">Deferred tax assets and liabilities [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_OtherFinancialAssetsMember_lbl1" xml:lang="en-US">Other Financial Assets Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherFinancialAssetsMember" xlink:to="mlec_OtherFinancialAssetsMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_BorrowingInterestRateInKind_lbl1" xml:lang="en-US">Borrowing Interest Rate In Kind</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BorrowingInterestRateInKind" xlink:to="mlec_BorrowingInterestRateInKind_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProportionOfOwnershipInterestInSubsidiary_lbl1" xml:lang="en-US">Proportion of ownership interest in subsidiary</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:to="ifrs-full_ProportionOfOwnershipInterestInSubsidiary_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherNoncurrentReceivables_lbl1" xml:lang="en-US">Other non-current receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentReceivables" xlink:to="ifrs-full_OtherNoncurrentReceivables_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslation_lbl0" xml:lang="en-US">Reserve of exchange differences on translation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:to="ifrs-full_ReserveOfExchangeDifferencesOnTranslation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PropertyPlantAndEquipmentDepreciationMember_lbl0" xml:lang="en-US">Property Plant And Equipment Depreciation Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PropertyPlantAndEquipmentDepreciationMember" xlink:to="mlec_PropertyPlantAndEquipmentDepreciationMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_lbl0" xml:lang="en-US">Adjustments for decrease (increase) in inventories</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_TaxesMember_lbl0" xml:lang="en-US">Taxes Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TaxesMember" xlink:to="mlec_TaxesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract_lbl0" xml:lang="en-US">Deferred Tax Liabilities, Gross [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AllowanceForImpairmentOfTradeDebtorsMember_lbl1" xml:lang="en-US">Allowance For Impairment Of Trade Debtors Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AllowanceForImpairmentOfTradeDebtorsMember" xlink:to="mlec_AllowanceForImpairmentOfTradeDebtorsMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_OwnSharesHeldBySubsidiariesMember_lbl0" xml:lang="en-US">Own Shares Held By Subsidiaries Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OwnSharesHeldBySubsidiariesMember" xlink:to="mlec_OwnSharesHeldBySubsidiariesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NoncashActivities_lbl1" xml:lang="en-US">Noncash Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NoncashActivities" xlink:to="mlec_NoncashActivities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AccumulatedDepreciationAtTheEndOfThePeriod_lbl1" xml:lang="en-US">Accumulated Depreciation At The End Of The Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AccumulatedDepreciationAtTheEndOfThePeriod" xlink:to="mlec_AccumulatedDepreciationAtTheEndOfThePeriod_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_OtherReceivablesMember_lbl1" xml:lang="en-US">Other Receivables Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherReceivablesMember" xlink:to="mlec_OtherReceivablesMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfOutstandingShareOptions_lbl1" xml:lang="en-US">Number of share options outstanding in share-based payment arrangement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfOutstandingShareOptions" xlink:to="ifrs-full_NumberOfOutstandingShareOptions_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SoftwareMember_lbl0" xml:lang="en-US">Software Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SoftwareMember" xlink:to="mlec_SoftwareMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfessionalFeesExpense_lbl0" xml:lang="en-US">Professional fees expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfessionalFeesExpense" xlink:to="ifrs-full_ProfessionalFeesExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PercentageOfEstimatesThatDevaluationOrAnAppreciation_lbl1" xml:lang="en-US">Percentage Of Estimates That Devaluation Or An Appreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfEstimatesThatDevaluationOrAnAppreciation" xlink:to="mlec_PercentageOfEstimatesThatDevaluationOrAnAppreciation_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RightofuseAssets_lbl2" xml:lang="en-US">Right-of-use assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RightofuseAssets" xlink:to="ifrs-full_RightofuseAssets_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ChangeinJointVenturesDividendsDistribution_lbl1" xml:lang="en-US">Changein Joint Ventures Dividends Distribution</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ChangeinJointVenturesDividendsDistribution" xlink:to="mlec_ChangeinJointVenturesDividendsDistribution_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherRelatedPartiesMember_lbl0" xml:lang="en-US">Other related parties [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherRelatedPartiesMember" xlink:to="ifrs-full_OtherRelatedPartiesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfFairValueOfConsiderationOfPaymentTableTextBlock_lbl1" xml:lang="en-US">Schedule Of Fair Value Of Consideration Of Payment Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfFairValueOfConsiderationOfPaymentTableTextBlock" xlink:to="mlec_ScheduleOfFairValueOfConsiderationOfPaymentTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_TaxJurisdictionAxis_lbl1" xml:lang="en-US">Tax Jurisdiction Axis</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TaxJurisdictionAxis" xlink:to="mlec_TaxJurisdictionAxis_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_IfrsDebtInstrumentTerm_lbl1" xml:lang="en-US">Ifrs Debt Instrument Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IfrsDebtInstrumentTerm" xlink:to="mlec_IfrsDebtInstrumentTerm_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_IndrasaBiotecnologaSAMember_lbl1" xml:lang="en-US">Indrasa Biotecnologa SAMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IndrasaBiotecnologaSAMember" xlink:to="mlec_IndrasaBiotecnologaSAMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_lbl1" xml:lang="en-US">Risk free interest rate, share options granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:to="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DepreciationOfThePeriod_lbl1" xml:lang="en-US">Depreciation Of The Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DepreciationOfThePeriod" xlink:to="mlec_DepreciationOfThePeriod_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ReserveOfSharebasedPaymentsMember_lbl0" xml:lang="en-US">Reserve of share-based payments [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:to="ifrs-full_ReserveOfSharebasedPaymentsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FixturesAndFittingsMember_lbl1" xml:lang="en-US">Fixtures and fittings [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FixturesAndFittingsMember" xlink:to="ifrs-full_FixturesAndFittingsMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LiquidityRiskMember_lbl0" xml:lang="en-US">Liquidity risk [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiquidityRiskMember" xlink:to="ifrs-full_LiquidityRiskMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_lbl0" xml:lang="en-US">Other comprehensive income, net of tax, exchange differences on translation of foreign operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AdditionsToLeaseLiabilityFromBusinessCombination_lbl1" xml:lang="en-US">Additions To Lease Liability From Business Combination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AdditionsToLeaseLiabilityFromBusinessCombination" xlink:to="mlec_AdditionsToLeaseLiabilityFromBusinessCombination_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherPropertyPlantAndEquipmentMember_lbl0" xml:lang="en-US">Other property, plant and equipment [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherPropertyPlantAndEquipmentMember" xlink:to="ifrs-full_OtherPropertyPlantAndEquipmentMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NetResultFromCommercializationOfAgriculturalProducts_lbl1" xml:lang="en-US">Net Result From Commercialization Of Agricultural Products</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NetResultFromCommercializationOfAgriculturalProducts" xlink:to="mlec_NetResultFromCommercializationOfAgriculturalProducts_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ExchangeDifferencesDepreciation_lbl1" xml:lang="en-US">Exchange Differences Depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ExchangeDifferencesDepreciation" xlink:to="mlec_ExchangeDifferencesDepreciation_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DisclosureOfReverseStockSplitAfterTheReportingPeriod_lbl0" xml:lang="en-US">Disclosure Of Reverse Stock Split After The Reporting Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfReverseStockSplitAfterTheReportingPeriod" xlink:to="mlec_DisclosureOfReverseStockSplitAfterTheReportingPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationAbstract_lbl0" xml:lang="en-US">Depreciation [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAbstract" xlink:to="us-gaap_DepreciationAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherFinancialAssets_lbl0" xml:lang="en-US">Other financial assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherFinancialAssets" xlink:to="ifrs-full_OtherFinancialAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_lbl0" xml:lang="en-US">Copyrights, patents and other industrial property rights, service and operating rights [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" xlink:to="ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage_lbl1" xml:lang="en-US">Ifrs Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage" xlink:to="mlec_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentLiabilities_lbl2" xml:lang="en-US">Non-current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLiabilities" xlink:to="ifrs-full_NoncurrentLiabilities_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_MaximumPercentageOfCapitalForObligationToLegalReserve_lbl1" xml:lang="en-US">Maximum Percentage Of Capital For Obligation To Legal Reserve</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MaximumPercentageOfCapitalForObligationToLegalReserve" xlink:to="mlec_MaximumPercentageOfCapitalForObligationToLegalReserve_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests_lbl0" xml:lang="en-US">Comprehensive income, attributable to non-controlling interests</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:to="ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl0" xml:lang="en-US">Purchase of property, plant and equipment, classified as investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:to="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NumberOfSharesReverseStockSplit_lbl1" xml:lang="en-US">Number Of Shares Reverse Stock Split</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfSharesReverseStockSplit" xlink:to="mlec_NumberOfSharesReverseStockSplit_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfInterestRateRiskAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfInterestRateRiskAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfInterestRateRiskAbstract_lbl" xml:lang="en-US">Schedule Of Interest Rate Risk Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfInterestRateRiskAbstract" xlink:to="mlec_ScheduleOfInterestRateRiskAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherCurrentPayables_lbl1" xml:lang="en-US">Trade and other current payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentPayables" xlink:to="ifrs-full_TradeAndOtherCurrentPayables_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ConsiderationForAcquisitionOfAssetsCurrent_lbl1" xml:lang="en-US">Consideration For Acquisition Of Assets Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ConsiderationForAcquisitionOfAssetsCurrent" xlink:to="mlec_ConsiderationForAcquisitionOfAssetsCurrent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock_lbl0" xml:lang="en-US">Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_lbl0" xml:lang="en-US">Disclosure of cash and cash equivalents [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" xlink:to="ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_lbl0" xml:lang="en-US">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AgralitySAMember_lbl0" xml:lang="en-US">Agrality SAMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AgralitySAMember" xlink:to="mlec_AgralitySAMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_OrdinarySharesOneMember_lbl0" xml:lang="en-US">Ordinary Shares One Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OrdinarySharesOneMember" xlink:to="mlec_OrdinarySharesOneMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ValoraSoySAMember_lbl0" xml:lang="en-US">Valora Soy SAMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ValoraSoySAMember" xlink:to="mlec_ValoraSoySAMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherBorrowings_lbl0" xml:lang="en-US">Other borrowings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherBorrowings" xlink:to="ifrs-full_OtherBorrowings_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesAbstract_lbl0" xml:lang="en-US">Trade and other current payables [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentPayablesAbstract" xlink:to="ifrs-full_TradeAndOtherCurrentPayablesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_LicensesandPatents_lbl1" xml:lang="en-US">Licensesand Patents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LicensesandPatents" xlink:to="mlec_LicensesandPatents_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EquityInterestsOfAcquirer_lbl0" xml:lang="en-US">Equity interests of acquirer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityInterestsOfAcquirer" xlink:to="ifrs-full_EquityInterestsOfAcquirer_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PercentageOfClosingPriceOnFirstAndLastBusinessDayToDeterminePurchasePrice_lbl1" xml:lang="en-US">Percentage Of Closing Price On First And Last Business Day To Determine Purchase Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfClosingPriceOnFirstAndLastBusinessDayToDeterminePurchasePrice" xlink:to="mlec_PercentageOfClosingPriceOnFirstAndLastBusinessDayToDeterminePurchasePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_WarrantsExercisableForOrdinarySharesMember_lbl0" xml:lang="en-US">Warrants Exercisable For Ordinary Shares Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_WarrantsExercisableForOrdinarySharesMember" xlink:to="mlec_WarrantsExercisableForOrdinarySharesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InventoriesExcludingAgriculturalProduce_lbl1" xml:lang="en-US">Inventories Excluding Agricultural Produce</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InventoriesExcludingAgriculturalProduce" xlink:to="mlec_InventoriesExcludingAgriculturalProduce_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_lbl0" xml:lang="en-US">Payments of lease liabilities, classified as financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:to="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory_lbl0" xml:lang="en-US">Disclosure of research and development expense [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory" xlink:to="ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfCarryingAmountsThatWouldHaveBeenRecognizedAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfCarryingAmountsThatWouldHaveBeenRecognizedAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfCarryingAmountsThatWouldHaveBeenRecognizedAbstract_lbl" xml:lang="en-US">Schedule Of Carrying Amounts That Would Have Been Recognized Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfCarryingAmountsThatWouldHaveBeenRecognizedAbstract" xlink:to="mlec_ScheduleOfCarryingAmountsThatWouldHaveBeenRecognizedAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfGoodwillAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfGoodwillAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfGoodwillAbstract_lbl" xml:lang="en-US">Schedule Of Goodwill Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfGoodwillAbstract" xlink:to="mlec_ScheduleOfGoodwillAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_OthersTaxAssetsTwoMember_lbl0" xml:lang="en-US">Others Tax Assets Two Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OthersTaxAssetsTwoMember" xlink:to="mlec_OthersTaxAssetsTwoMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AggregateAmount_lbl1" xml:lang="en-US">Aggregate Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AggregateAmount" xlink:to="mlec_AggregateAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InvestmentsMeasuredAtFairValue_lbl1" xml:lang="en-US">Investments Measured At Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InvestmentsMeasuredAtFairValue" xlink:to="mlec_InvestmentsMeasuredAtFairValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherIntangibleAssetsMember_lbl1" xml:lang="en-US">Other intangible assets [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherIntangibleAssetsMember" xlink:to="ifrs-full_OtherIntangibleAssetsMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InflationTaxAdjustmentMember_lbl1" xml:lang="en-US">Inflation Tax Adjustment Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InflationTaxAdjustmentMember" xlink:to="mlec_InflationTaxAdjustmentMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsRightofuseAssets_lbl0" xml:lang="en-US">Additions other than through business combinations, right-of-use assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsRightofuseAssets" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsRightofuseAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_MicrobiologicalProductsMember_lbl0" xml:lang="en-US">Microbiological Products Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MicrobiologicalProductsMember" xlink:to="mlec_MicrobiologicalProductsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AssetsAbstract0_lbl0" xml:lang="en-US">Assets Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AssetsAbstract0" xlink:to="mlec_AssetsAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NetLoansGrantedMember_lbl0" xml:lang="en-US">Net Loans Granted Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NetLoansGrantedMember" xlink:to="mlec_NetLoansGrantedMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentTaxAssetsNoncurrent_lbl0" xml:lang="en-US">Current tax assets, non-current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentTaxAssetsNoncurrent" xlink:to="ifrs-full_CurrentTaxAssetsNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DividendsPaid_lbl0" xml:lang="en-US">Dividends recognised as distributions to owners</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DividendsPaid" xlink:to="ifrs-full_DividendsPaid_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GovernmentGrants_lbl1" xml:lang="en-US">Government grants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GovernmentGrants" xlink:to="ifrs-full_GovernmentGrants_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfRelatedPartyExplanatory_lbl0" xml:lang="en-US">Disclosure of related party [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:to="ifrs-full_DisclosureOfRelatedPartyExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_MoolecScienceLuxembourgMember_lbl0" xml:lang="en-US">Moolec Science Luxembourg Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MoolecScienceLuxembourgMember" xlink:to="mlec_MoolecScienceLuxembourgMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ValuationSignificantChangePercentageOfConstructionCosts_lbl1" xml:lang="en-US">Valuation Significant Change Percentage Of Construction Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ValuationSignificantChangePercentageOfConstructionCosts" xlink:to="mlec_ValuationSignificantChangePercentageOfConstructionCosts_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfInventoriesAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfInventoriesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfInventoriesAbstract_lbl" xml:lang="en-US">Schedule Of Inventories Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfInventoriesAbstract" xlink:to="mlec_ScheduleOfInventoriesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FuelAndEnergyExpense_lbl0" xml:lang="en-US">Fuel and energy expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FuelAndEnergyExpense" xlink:to="ifrs-full_FuelAndEnergyExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NetLoansPayablesJointVenturesAndAssociatesMember_lbl0" xml:lang="en-US">Net Loans Payables Joint Ventures And Associates Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NetLoansPayablesJointVenturesAndAssociatesMember" xlink:to="mlec_NetLoansPayablesJointVenturesAndAssociatesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_OwnSharesHeld_lbl1" xml:lang="en-US">Own Shares Held</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OwnSharesHeld" xlink:to="mlec_OwnSharesHeld_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock_lbl1" xml:lang="en-US">Disclosure Of Compensation Of Directors And Other Members Of Key Management Personnel Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock" xlink:to="mlec_DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ShareholdersAndOtherRelatedPartiesMember_lbl0" xml:lang="en-US">Shareholders And Other Related Parties Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareholdersAndOtherRelatedPartiesMember" xlink:to="mlec_ShareholdersAndOtherRelatedPartiesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpenseMember_lbl0" xml:lang="en-US">Selling, general and administrative expense [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SellingGeneralAndAdministrativeExpenseMember" xlink:to="ifrs-full_SellingGeneralAndAdministrativeExpenseMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_UsTreasuryBillsMember_lbl1" xml:lang="en-US">Us Treasury Bills Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UsTreasuryBillsMember" xlink:to="mlec_UsTreasuryBillsMember_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfSignificantJointVenturesAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfSignificantJointVenturesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfSignificantJointVenturesAbstract_lbl" xml:lang="en-US">Schedule Of Significant Joint Ventures Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfSignificantJointVenturesAbstract" xlink:to="mlec_ScheduleOfSignificantJointVenturesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_OtherTaxAssetMember_lbl1" xml:lang="en-US">Other Tax Asset Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherTaxAssetMember" xlink:to="mlec_OtherTaxAssetMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_BioceresCropSolutionsBIOXMember_lbl0" xml:lang="en-US">Bioceres Crop Solutions BIOXMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BioceresCropSolutionsBIOXMember" xlink:to="mlec_BioceresCropSolutionsBIOXMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_lbl0" xml:lang="en-US">Other tax effects for reconciliation between accounting profit and tax expense (income)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:to="ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentFinancialAssetsAtAmortisedCost_lbl0" xml:lang="en-US">Current financial assets at amortised cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentFinancialAssetsAtAmortisedCost" xlink:to="ifrs-full_CurrentFinancialAssetsAtAmortisedCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PuttableInstrumentsCharge_lbl1" xml:lang="en-US">Puttable Instruments Charge</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PuttableInstrumentsCharge" xlink:to="mlec_PuttableInstrumentsCharge_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PercentageOfOutstandingAmountInitialInterestRate_lbl1" xml:lang="en-US">Percentage Of Outstanding Amount Initial Interest Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfOutstandingAmountInitialInterestRate" xlink:to="mlec_PercentageOfOutstandingAmountInitialInterestRate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_TradeReceivableMember_lbl0" xml:lang="en-US">Trade Receivable Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TradeReceivableMember" xlink:to="mlec_TradeReceivableMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementLiabilities_lbl0" xml:lang="en-US">Gains (losses) recognised in profit or loss on exchange differences, fair value measurement, liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementLiabilities" xlink:to="ifrs-full_GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InvestmentInKindInOtherRelatedPartiesNonCashTransactionsInvestmentActivities_lbl1" xml:lang="en-US">Investment In Kind In Other Related Parties Non Cash Transactions Investment Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InvestmentInKindInOtherRelatedPartiesNonCashTransactionsInvestmentActivities" xlink:to="mlec_InvestmentInKindInOtherRelatedPartiesNonCashTransactionsInvestmentActivities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AgriculturalProductsMember_lbl0" xml:lang="en-US">Agricultural Products Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AgriculturalProductsMember" xlink:to="mlec_AgriculturalProductsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NonCashFinancingActivities_lbl1" xml:lang="en-US">Non Cash Financing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NonCashFinancingActivities" xlink:to="mlec_NonCashFinancingActivities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComputerSoftwareMember_lbl1" xml:lang="en-US">Computer software [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComputerSoftwareMember" xlink:to="ifrs-full_ComputerSoftwareMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NumberOfSharesAcquiredInBusinessCombination_lbl1" xml:lang="en-US">Number Of Shares Acquired In Business Combination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfSharesAcquiredInBusinessCombination" xlink:to="mlec_NumberOfSharesAcquiredInBusinessCombination_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherCurrentFinancialAssets_lbl1" xml:lang="en-US">Other current financial assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCurrentFinancialAssets" xlink:to="ifrs-full_OtherCurrentFinancialAssets_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfBorrowingsAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfBorrowingsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfBorrowingsAbstract_lbl" xml:lang="en-US">Schedule Of Borrowings Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfBorrowingsAbstract" xlink:to="mlec_ScheduleOfBorrowingsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentFinancialLiabilities_lbl0" xml:lang="en-US">Non-current financial liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentFinancialLiabilities" xlink:to="ifrs-full_NoncurrentFinancialLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_EquityMethodInvestmentIncreaseFromShareBasedIncentives_lbl1" xml:lang="en-US">Equity Method Investment Increase From Share Based Incentives</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_EquityMethodInvestmentIncreaseFromShareBasedIncentives" xlink:to="mlec_EquityMethodInvestmentIncreaseFromShareBasedIncentives_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_lbl0" xml:lang="en-US">Disclosure of quantitative information about right-of-use assets [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SafflowerChimosin20Member_lbl0" xml:lang="en-US">Safflower Chimosin20 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SafflowerChimosin20Member" xlink:to="mlec_SafflowerChimosin20Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_BiologicalAssetsSoybeanMember_lbl1" xml:lang="en-US">Biological Assets Soybean Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BiologicalAssetsSoybeanMember" xlink:to="mlec_BiologicalAssetsSoybeanMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DecreaseThroughCapitalizationOfDebtLiabilitiesArisingFromFinancingActivities_lbl1" xml:lang="en-US">Decrease Through Capitalization Of Debt Liabilities Arising From Financing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DecreaseThroughCapitalizationOfDebtLiabilitiesArisingFromFinancingActivities" xlink:to="mlec_DecreaseThroughCapitalizationOfDebtLiabilitiesArisingFromFinancingActivities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory_lbl0" xml:lang="en-US">Disclosure of financial risk management [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory" xlink:to="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FungalBiomassMember_lbl0" xml:lang="en-US">Fungal Biomass Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FungalBiomassMember" xlink:to="mlec_FungalBiomassMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AdjuvantsMember_lbl1" xml:lang="en-US">Adjuvants Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AdjuvantsMember" xlink:to="mlec_AdjuvantsMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InvestmentsAtFairValueMember_lbl0" xml:lang="en-US">Investments At Fair Value Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InvestmentsAtFairValueMember" xlink:to="mlec_InvestmentsAtFairValueMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfJointVenturesAssetsAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfJointVenturesAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfJointVenturesAssetsAbstract_lbl" xml:lang="en-US">Schedule Of Joint Ventures Assets Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfJointVenturesAssetsAbstract" xlink:to="mlec_ScheduleOfJointVenturesAssetsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PurchaseOfOwnShares_lbl1" xml:lang="en-US">Purchase Of Own Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PurchaseOfOwnShares" xlink:to="mlec_PurchaseOfOwnShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_lbl0" xml:lang="en-US">Cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:to="ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutInvestmentPropertyExplanatory_lbl0" xml:lang="en-US">Disclosure of detailed information about investment property [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutInvestmentPropertyExplanatory" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutInvestmentPropertyExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_RevenuesFromContractsWithCustomersAbstract_lbl0" xml:lang="en-US">Revenues From Contracts With Customers Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RevenuesFromContractsWithCustomersAbstract" xlink:to="mlec_RevenuesFromContractsWithCustomersAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_StockIncentivePlan2013Member_lbl1" xml:lang="en-US">Stock Incentive Plan2013 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_StockIncentivePlan2013Member" xlink:to="mlec_StockIncentivePlan2013Member_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InterestAccruedWithRelatedParties_lbl1" xml:lang="en-US">Interest Accrued With Related Parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InterestAccruedWithRelatedParties" xlink:to="mlec_InterestAccruedWithRelatedParties_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_lbl0" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AnalysisAndStorage_lbl1" xml:lang="en-US">Analysis And Storage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AnalysisAndStorage" xlink:to="mlec_AnalysisAndStorage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations_lbl3" xml:lang="en-US">Tax expense (income)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations_lbl3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentTaxExpenseIncome_lbl1" xml:lang="en-US">Current tax expense (income)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentTaxExpenseIncome" xlink:to="ifrs-full_CurrentTaxExpenseIncome_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl1" xml:lang="en-US">Components Of Income Tax Expense Benefit Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="mlec_ComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_IncreaseThroughAcquisitionOfNonControllingInterestInSubsidiaries_lbl1" xml:lang="en-US">Increase Through Acquisition Of Non Controlling Interest In Subsidiaries</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IncreaseThroughAcquisitionOfNonControllingInterestInSubsidiaries" xlink:to="mlec_IncreaseThroughAcquisitionOfNonControllingInterestInSubsidiaries_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_lbl0" xml:lang="en-US">Disclosure of general information about financial statements [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xlink:to="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeReceivables_lbl1" xml:lang="en-US">Trade receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeReceivables" xlink:to="ifrs-full_TradeReceivables_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageShares_lbl0" xml:lang="en-US">Weighted average number of ordinary shares used in calculating basic earnings per share</label>
<!-- [WMV6][iVTmkzu+QaAU3uvlziU7AabKuqDquXRojGWmlqOvy5pIOsqOnwCfZcc/DKgmIQ30W2tUeJjRp6TyG8XoiIerLyss50gzmb5rP3xYaSAx2mmVLCTRJcQxhhbUX9JKt59tgKAw9H1IGt/EKMCg2fZXH0TQ0oN43ozOWcsKNIxwZVWrKSZCblbmDB8bCOnhFsae1kPjEZ1nGt5/Y/lb0NBEnjimAtdWRGEeWBKzA2dbjReUHc1Egdxv7BzWFU+NL986pzD57hUuKvuFkScuN6wAp0DmCXnUgEDHrixAtagde5Xq+IYHFDGK7xXmKswUmpa1fnvkYF+mT0Xo2CjHFXr+SmQDXa63Ogl0QJtpVRzOLvjfKiBszPIXDCa5jflLnMHJ7kpblA==] CSR-->
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageShares" xlink:to="ifrs-full_WeightedAverageShares_lbl0"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>28
<FILENAME>mlec-20250630_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Sun Dec 28 18:19:32 UTC 2025 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ConsolidatedComprehensiveIncome" roleURI="http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ConsolidatedBalanceSheet" roleURI="http://www.moolecscience.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ShareholdersEquityType2or3" roleURI="http://www.moolecscience.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ConsolidatedCashFlow" roleURI="http://www.moolecscience.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_TheGroupsBusinessReorganizationandGeneralInformation" roleURI="http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformation"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_AccountingStandardsandBasisofPreparation" roleURI="http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparation"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_NewStandardsAmendmentsandInterpretationsIssuedbytheIASB" roleURI="http://www.moolecscience.com/role/NewStandardsAmendmentsandInterpretationsIssuedbytheIASB"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_SummaryofSignificantAccountingPolicies" roleURI="http://www.moolecscience.com/role/SummaryofSignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_CriticalAccountingJudgmentsandEstimates" roleURI="http://www.moolecscience.com/role/CriticalAccountingJudgmentsandEstimates"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_AcquisitionsandOtherSignificantTransactions" roleURI="http://www.moolecscience.com/role/AcquisitionsandOtherSignificantTransactions"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_InformationAboutComponentsofConsolidatedStatementsofFinancialPosition" roleURI="http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPosition"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncome" roleURI="http://www.moolecscience.com/role/InformationaboutComponentofConsolidatedStatementsofComprehensiveIncome"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_Taxation" roleURI="http://www.moolecscience.com/role/Taxation"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_EarningPerShare" roleURI="http://www.moolecscience.com/role/EarningPerShare"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_InformationaboutComponentsofEquity" roleURI="http://www.moolecscience.com/role/InformationaboutComponentsofEquity"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_CashFlowInformation" roleURI="http://www.moolecscience.com/role/CashFlowInformation"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_JointVenturesandAssociates" roleURI="http://www.moolecscience.com/role/JointVenturesandAssociates"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_SegmentInformation" roleURI="http://www.moolecscience.com/role/SegmentInformation"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_FinancialInstrumentsRiskManagement" roleURI="http://www.moolecscience.com/role/FinancialInstrumentsRiskManagement"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_Leases" roleURI="http://www.moolecscience.com/role/Leases"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ShareholdersandOtherRelatedPartiesBalancesandTransactions" roleURI="http://www.moolecscience.com/role/ShareholdersandOtherRelatedPartiesBalancesandTransactions"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_KeyManagementPersonnelCompensation" roleURI="http://www.moolecscience.com/role/KeyManagementPersonnelCompensation"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ShareBasedPayment" roleURI="http://www.moolecscience.com/role/ShareBasedPayment"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ContingenciesCommitmentsandRestrictionsontheDistributionofProfits" roleURI="http://www.moolecscience.com/role/ContingenciesCommitmentsandRestrictionsontheDistributionofProfits"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_EventsOccurringAftertheReportingPeriod" roleURI="http://www.moolecscience.com/role/EventsOccurringAftertheReportingPeriod"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ReverseStockSplitAftertheReportingPeriod" roleURI="http://www.moolecscience.com/role/ReverseStockSplitAftertheReportingPeriod"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_AccountingPoliciesByPolicy" roleURI="http://www.moolecscience.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_AccountingStandardsandBasisofPreparationTables" roleURI="http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_AcquisitionsandOtherSignificantTransactionsTables" roleURI="http://www.moolecscience.com/role/AcquisitionsandOtherSignificantTransactionsTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionTables" roleURI="http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeTables" roleURI="http://www.moolecscience.com/role/InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_TaxationTables" roleURI="http://www.moolecscience.com/role/TaxationTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_EarningPerShareTables" roleURI="http://www.moolecscience.com/role/EarningPerShareTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_InformationaboutComponentsofEquityTables" roleURI="http://www.moolecscience.com/role/InformationaboutComponentsofEquityTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_CashFlowInformationTables" roleURI="http://www.moolecscience.com/role/CashFlowInformationTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_JointVenturesandAssociatesTables" roleURI="http://www.moolecscience.com/role/JointVenturesandAssociatesTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_SegmentInformationTables" roleURI="http://www.moolecscience.com/role/SegmentInformationTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_FinancialInstrumentsRiskManagementTables" roleURI="http://www.moolecscience.com/role/FinancialInstrumentsRiskManagementTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_LeasesTables" roleURI="http://www.moolecscience.com/role/LeasesTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ShareholdersandOtherRelatedPartiesBalancesandTransactionsTables" roleURI="http://www.moolecscience.com/role/ShareholdersandOtherRelatedPartiesBalancesandTransactionsTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_KeyManagementPersonnelCompensationTables" roleURI="http://www.moolecscience.com/role/KeyManagementPersonnelCompensationTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ShareBasedPaymentTables" roleURI="http://www.moolecscience.com/role/ShareBasedPaymentTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ReverseStockSplitAftertheReportingPeriodTables" roleURI="http://www.moolecscience.com/role/ReverseStockSplitAftertheReportingPeriodTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofInformationrelatedtoCompanysShareofVotingRightsinitsSubsidiariesTable" roleURI="http://www.moolecscience.com/role/ScheduleofInformationrelatedtoCompanysShareofVotingRightsinitsSubsidiariesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofFairValueoftheConsiderationofPaymentTable" roleURI="http://www.moolecscience.com/role/ScheduleofFairValueoftheConsiderationofPaymentTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofAssetsAcquiredandLiabilitiesAssumedTable" roleURI="http://www.moolecscience.com/role/ScheduleofAssetsAcquiredandLiabilitiesAssumedTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofCashandCashEquivalentsTable" roleURI="http://www.moolecscience.com/role/ScheduleofCashandCashEquivalentsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofOtherFinancialAssetsTable" roleURI="http://www.moolecscience.com/role/ScheduleofOtherFinancialAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofTradeReceivablesTable" roleURI="http://www.moolecscience.com/role/ScheduleofTradeReceivablesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofOtherReceivablesTable" roleURI="http://www.moolecscience.com/role/ScheduleofOtherReceivablesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofInventoriesTable" roleURI="http://www.moolecscience.com/role/ScheduleofInventoriesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofChangesinBiologicalAssetsTable" roleURI="http://www.moolecscience.com/role/ScheduleofChangesinBiologicalAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofPropertyPlantandEquipmentTable" roleURI="http://www.moolecscience.com/role/ScheduleofPropertyPlantandEquipmentTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofCarryingAmountsthatWouldHaveBeenRecognizedTable" roleURI="http://www.moolecscience.com/role/ScheduleofCarryingAmountsthatWouldHaveBeenRecognizedTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofIntangibleAssetsTable" roleURI="http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofGoodwillTable" roleURI="http://www.moolecscience.com/role/ScheduleofGoodwillTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofInvestmentPropertiesTable" roleURI="http://www.moolecscience.com/role/ScheduleofInvestmentPropertiesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofTradeandOtherPayablesTable" roleURI="http://www.moolecscience.com/role/ScheduleofTradeandOtherPayablesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofBorrowingsTable" roleURI="http://www.moolecscience.com/role/ScheduleofBorrowingsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofBorrowingsCarryingAmountTable" roleURI="http://www.moolecscience.com/role/ScheduleofBorrowingsCarryingAmountTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofConvertibleNotesTable" roleURI="http://www.moolecscience.com/role/ScheduleofConvertibleNotesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofEmployeeBenefitsandSocialSecurityTable" roleURI="http://www.moolecscience.com/role/ScheduleofEmployeeBenefitsandSocialSecurityTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofDeferredRevenueandAdvancesfromCustomersTable" roleURI="http://www.moolecscience.com/role/ScheduleofDeferredRevenueandAdvancesfromCustomersTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofChangesinAllowancesandProvisionsTable" roleURI="http://www.moolecscience.com/role/ScheduleofChangesinAllowancesandProvisionsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofProvisionsTable" roleURI="http://www.moolecscience.com/role/ScheduleofProvisionsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofGovernmentGrantsTable" roleURI="http://www.moolecscience.com/role/ScheduleofGovernmentGrantsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofWarrantsTable" roleURI="http://www.moolecscience.com/role/ScheduleofWarrantsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofRevenuefromContractswithCustomersTable" roleURI="http://www.moolecscience.com/role/ScheduleofRevenuefromContractswithCustomersTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofCostofSalesTable" roleURI="http://www.moolecscience.com/role/ScheduleofCostofSalesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofRDClassifiedbyNatureTable" roleURI="http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofExpensesClassifiedbyNatureandFunctionTable" roleURI="http://www.moolecscience.com/role/ScheduleofExpensesClassifiedbyNatureandFunctionTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofFinanceResultsTable" roleURI="http://www.moolecscience.com/role/ScheduleofFinanceResultsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofOtherIncomeorExpensesNetTable" roleURI="http://www.moolecscience.com/role/ScheduleofOtherIncomeorExpensesNetTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofDeferredTaxAssetsandLiabilitiesTable" roleURI="http://www.moolecscience.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesTable" roleURI="http://www.moolecscience.com/role/ScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofWeightedAverageTaxRateTable" roleURI="http://www.moolecscience.com/role/ScheduleofWeightedAverageTaxRateTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofPrincipalStatutoryTaxesRatesandCurrentTaxTable" roleURI="http://www.moolecscience.com/role/ScheduleofPrincipalStatutoryTaxesRatesandCurrentTaxTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceTable" roleURI="http://www.moolecscience.com/role/ScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofEarningPerShareTable" roleURI="http://www.moolecscience.com/role/ScheduleofEarningPerShareTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofNumberofSharesIssuedTable" roleURI="http://www.moolecscience.com/role/ScheduleofNumberofSharesIssuedTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofSubsidiariesNonControllingInterestTable" roleURI="http://www.moolecscience.com/role/ScheduleofSubsidiariesNonControllingInterestTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofFinancialStatementsTable" roleURI="http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofBioceresSAandBioceresCropSolutionsTable" roleURI="http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesTable" roleURI="http://www.moolecscience.com/role/ScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable" roleURI="http://www.moolecscience.com/role/ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofJointVenturesAssetsTable" roleURI="http://www.moolecscience.com/role/ScheduleofJointVenturesAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofChangesinJointVenturesInvestmentsandAffiliatesTable" roleURI="http://www.moolecscience.com/role/ScheduleofChangesinJointVenturesInvestmentsandAffiliatesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofShareofProfitorLossofJointVenturesandAffiliatesTable" roleURI="http://www.moolecscience.com/role/ScheduleofShareofProfitorLossofJointVenturesandAffiliatesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofSignificantJointVenturesTable" roleURI="http://www.moolecscience.com/role/ScheduleofSignificantJointVenturesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofOperatingResultsGroupsReportingSegmentsTable" roleURI="http://www.moolecscience.com/role/ScheduleofOperatingResultsGroupsReportingSegmentsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofRevenuebySimilarGroupofProductsorServicesTable" roleURI="http://www.moolecscience.com/role/ScheduleofRevenuebySimilarGroupofProductsorServicesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofGeographicalInformationTable" roleURI="http://www.moolecscience.com/role/ScheduleofGeographicalInformationTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofLiquidityRiskTable" roleURI="http://www.moolecscience.com/role/ScheduleofLiquidityRiskTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofCurrencyRiskTable" roleURI="http://www.moolecscience.com/role/ScheduleofCurrencyRiskTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofOtherForiegnCurrencieswithVariablesRemainingConstantTable" roleURI="http://www.moolecscience.com/role/ScheduleofOtherForiegnCurrencieswithVariablesRemainingConstantTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofInterestRateRiskTable" roleURI="http://www.moolecscience.com/role/ScheduleofInterestRateRiskTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofFinancialAssetsbyCategoryTable" roleURI="http://www.moolecscience.com/role/ScheduleofFinancialAssetsbyCategoryTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofFinancialLiabilitiesbyCategoryTable" roleURI="http://www.moolecscience.com/role/ScheduleofFinancialLiabilitiesbyCategoryTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofFairValuebyHierarchyTable" roleURI="http://www.moolecscience.com/role/ScheduleofFairValuebyHierarchyTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable" roleURI="http://www.moolecscience.com/role/ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofTransactionsBetweentheGroupandRelatedPartiesTable" roleURI="http://www.moolecscience.com/role/ScheduleofTransactionsBetweentheGroupandRelatedPartiesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofCompensationofKeyManagementPersonnelCompensationTable" roleURI="http://www.moolecscience.com/role/ScheduleofCompensationofKeyManagementPersonnelCompensationTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofFairValueoftheStockOptionsattheGrantDateTable" roleURI="http://www.moolecscience.com/role/ScheduleofFairValueoftheStockOptionsattheGrantDateTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofRangeofAssumptionswhichhaveDeterminedTable" roleURI="http://www.moolecscience.com/role/ScheduleofRangeofAssumptionswhichhaveDeterminedTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofOptionActivityandWeightedAverageExercisePriceTable" roleURI="http://www.moolecscience.com/role/ScheduleofOptionActivityandWeightedAverageExercisePriceTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ScheduleofWeightedAverageNumberofOrdinarySharesOutstandingTable" roleURI="http://www.moolecscience.com/role/ScheduleofWeightedAverageNumberofOrdinarySharesOutstandingTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsScheduleofIntangibleAssetsandLiabilitiesAssumed" roleURI="http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsScheduleofIntangibleAssetsandLiabilitiesAssumed"/>
  <roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#CybersecurityRiskManagementAndStrategyDisclosure" roleURI="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_TheGroupsBusinessReorganizationandGeneralInformationDetails" roleURI="http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_AccountingStandardsandBasisofPreparationDetails" roleURI="http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_NewStandardsAmendmentsandInterpretationsIssuedbytheIASBDetails" roleURI="http://www.moolecscience.com/role/NewStandardsAmendmentsandInterpretationsIssuedbytheIASBDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_SummaryofSignificantAccountingPoliciesDetails" roleURI="http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_AcquisitionsandOtherSignificantTransactionsDetails" roleURI="http://www.moolecscience.com/role/AcquisitionsandOtherSignificantTransactionsDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails" roleURI="http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeDetails" roleURI="http://www.moolecscience.com/role/InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_TaxationDetails" roleURI="http://www.moolecscience.com/role/TaxationDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_InformationaboutComponentsofEquityDetails" roleURI="http://www.moolecscience.com/role/InformationaboutComponentsofEquityDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_JointVenturesandAssociatesDetails" roleURI="http://www.moolecscience.com/role/JointVenturesandAssociatesDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_SegmentInformationDetails" roleURI="http://www.moolecscience.com/role/SegmentInformationDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_FinancialInstrumentsRiskManagementDetails" roleURI="http://www.moolecscience.com/role/FinancialInstrumentsRiskManagementDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ShareBasedPaymentDetails" roleURI="http://www.moolecscience.com/role/ShareBasedPaymentDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_EventsOccurringAftertheReportingPeriodDetails" roleURI="http://www.moolecscience.com/role/EventsOccurringAftertheReportingPeriodDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20250630.xsd#mlec_r_ReverseStockSplitAftertheReportingPeriodDetails" roleURI="http://www.moolecscience.com/role/ReverseStockSplitAftertheReportingPeriodDetails"/>
  <roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#cover" roleURI="http://xbrl.sec.gov/dei/role/document/Cover"/>
  <roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#ai" roleURI="http://xbrl.sec.gov/dei/role/document/AuditInformation"/>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeStatementAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromContractsWithCustomers" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromContractsWithCustomers"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_RevenueFromContractsWithCustomers" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromGovernmentGrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromGovernmentGrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_RevenueFromGovernmentGrants" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CostOfSales" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CostOfSales"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_CostOfSales" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ChangeInNetRealizableValueOfAgricultural" xlink:href="mlec-20250630.xsd#mlec_ChangeInNetRealizableValueOfAgricultural"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ChangeInNetRealizableValueOfAgricultural" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_ResearchAndDevelopmentExpense" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_SellingGeneralAndAdministrativeExpense" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherOperatingIncomeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherOperatingIncomeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_OtherOperatingIncomeExpense" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossFromOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_ProfitLossFromOperatingActivities" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinanceIncomeCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceIncomeCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_FinanceIncomeCost" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherFinanceIncomeCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherFinanceIncomeCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_OtherFinanceIncomeCost" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossBeforeTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_ProfitLossBeforeTax" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations" order="13.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_ProfitLoss" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_OtherComprehensiveIncomeAbstract" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_OtherComprehensiveIncomeAbstract" xlink:to="ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_OtherComprehensiveIncomeAbstract" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_OtherComprehensiveIncomeAbstract" xlink:to="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ItemsThatWillNotBeSubsequentlyReclassifiedToLossAndProfit" xlink:href="mlec-20250630.xsd#mlec_ItemsThatWillNotBeSubsequentlyReclassifiedToLossAndProfit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_OtherComprehensiveIncomeAbstract" xlink:to="ItemsThatWillNotBeSubsequentlyReclassifiedToLossAndProfit" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="RevaluationOfPropertyPlantAndEquipmentNetOfTaxOfJointVenturesAndAssociates" xlink:href="mlec-20250630.xsd#mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTaxOfJointVenturesAndAssociates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_OtherComprehensiveIncomeAbstract" xlink:to="RevaluationOfPropertyPlantAndEquipmentNetOfTaxOfJointVenturesAndAssociates" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RevaluationOfPropertyPlantAndEquipmentNetOfTax" xlink:href="mlec-20250630.xsd#mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_OtherComprehensiveIncomeAbstract" xlink:to="RevaluationOfPropertyPlantAndEquipmentNetOfTax" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_OtherComprehensiveIncomeAbstract" xlink:to="ifrs-full_ComprehensiveIncome" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossAttributableToAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_ProfitLossAttributableToAbstract" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProfitLossAttributableToAbstract" xlink:to="ifrs-full_ProfitLossAttributableToOwnersOfParent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProfitLossAttributableToAbstract" xlink:to="ifrs-full_ProfitLossAttributableToNoncontrollingInterests" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProfitLossAttributableToAbstract" xlink:to="ifrs-full_ProfitLoss_0" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EarningsPerShareAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EarningsPerShareAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_EarningsPerShareAbstract" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BasicEarningsLossPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BasicEarningsLossPerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EarningsPerShareAbstract" xlink:to="ifrs-full_BasicEarningsLossPerShare" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DilutedEarningsLossPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DilutedEarningsLossPerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EarningsPerShareAbstract" xlink:to="ifrs-full_DilutedEarningsLossPerShare" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeAbstract_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_OtherComprehensiveIncomeAbstract_0" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_OtherComprehensiveIncomeAbstract_0" xlink:to="ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" order="0.01" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_OtherComprehensiveIncomeAbstract_0" xlink:to="ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" order="1.01" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncome_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_OtherComprehensiveIncomeAbstract_0" xlink:to="ifrs-full_ComprehensiveIncome_0" order="2.01" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ConsolidatedBalanceSheet" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_NoncurrentAssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentFinancialAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentAssetsAbstract" xlink:to="ifrs-full_OtherNoncurrentFinancialAssets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentAssetsAbstract" xlink:to="ifrs-full_OtherNoncurrentReceivables" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentTaxAssetsNoncurrent" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxAssetsNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentAssetsAbstract" xlink:to="ifrs-full_CurrentTaxAssetsNoncurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentAssetsAbstract" xlink:to="ifrs-full_DeferredTaxAssets" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InvestmentsInJointVenturesAndAssociates" xlink:href="mlec-20250630.xsd#mlec_InvestmentsInJointVenturesAndAssociates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentAssetsAbstract" xlink:to="InvestmentsInJointVenturesAndAssociates" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentAssetsAbstract" xlink:to="ifrs-full_PropertyPlantAndEquipment" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InvestmentProperty" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InvestmentProperty"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentAssetsAbstract" xlink:to="ifrs-full_InvestmentProperty" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentAssetsAbstract" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Goodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Goodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentAssetsAbstract" xlink:to="ifrs-full_Goodwill" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RightofuseAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentAssetsAbstract" xlink:to="ifrs-full_RightofuseAssets" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_NoncurrentAssets" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_CurrentAssetsAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_CashAndCashEquivalents" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherCurrentFinancialAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_OtherCurrentFinancialAssets" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentTradeReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTradeReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_CurrentTradeReceivables" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherCurrentReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_OtherCurrentReceivables" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentTaxAssetsCurrent" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxAssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_CurrentTaxAssetsCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Inventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Inventories"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_Inventories" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentBiologicalAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentBiologicalAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_CurrentBiologicalAssets" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_CurrentAssets" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Assets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Assets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_Assets" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_EquityAbstract" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuedCapital" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAbstract" xlink:to="ifrs-full_IssuedCapital" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareToBeIssuedAmount" xlink:href="mlec-20250630.xsd#mlec_ShareToBeIssuedAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAbstract" xlink:to="ShareToBeIssuedAmount" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SharesPremium" xlink:href="mlec-20250630.xsd#mlec_SharesPremium"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAbstract" xlink:to="SharesPremium" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OwnSharesHeld" xlink:href="mlec-20250630.xsd#mlec_OwnSharesHeld"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAbstract" xlink:to="OwnSharesHeld" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockOptionsAndShareBasedIncentives" xlink:href="mlec-20250630.xsd#mlec_StockOptionsAndShareBasedIncentives"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAbstract" xlink:to="StockOptionsAndShareBasedIncentives" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RetainedEarnings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RetainedEarnings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAbstract" xlink:to="ifrs-full_RetainedEarnings" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RevaluationOfPropertyPlantAndEquipmentReserve" xlink:href="mlec-20250630.xsd#mlec_RevaluationOfPropertyPlantAndEquipmentReserve"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAbstract" xlink:to="RevaluationOfPropertyPlantAndEquipmentReserve" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAbstract" xlink:to="ifrs-full_ReserveOfExchangeDifferencesOnTranslation" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityAttributableToOwnersOfParent" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAttributableToOwnersOfParent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_EquityAttributableToOwnersOfParent" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncontrollingInterests" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncontrollingInterests"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_NoncontrollingInterests" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_Equity" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLiabilitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_NoncurrentLiabilitiesAbstract" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LongtermBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LongtermBorrowings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentLiabilitiesAbstract" xlink:to="ifrs-full_LongtermBorrowings" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentContractLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentContractLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentLiabilitiesAbstract" xlink:to="ifrs-full_NoncurrentContractLiabilities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentGovernmentGrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentGovernmentGrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentLiabilitiesAbstract" xlink:to="ifrs-full_NoncurrentGovernmentGrants" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="JointVenturesAndAssociatesLiabilities" xlink:href="mlec-20250630.xsd#mlec_JointVenturesAndAssociatesLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentLiabilitiesAbstract" xlink:to="JointVenturesAndAssociatesLiabilities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentLiabilitiesAbstract" xlink:to="ifrs-full_DeferredTaxLiabilities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentProvisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentProvisions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentLiabilitiesAbstract" xlink:to="ifrs-full_NoncurrentProvisions" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConsiderationForAcquisitionOfAssetsNonCurrent" xlink:href="mlec-20250630.xsd#mlec_ConsiderationForAcquisitionOfAssetsNonCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentLiabilitiesAbstract" xlink:to="ConsiderationForAcquisitionOfAssetsNonCurrent" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SecuredDebtNonCurrent" xlink:href="mlec-20250630.xsd#mlec_SecuredDebtNonCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentLiabilitiesAbstract" xlink:to="SecuredDebtNonCurrent" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentLiabilitiesAbstract" xlink:to="ifrs-full_NoncurrentLeaseLiabilities" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_NoncurrentLiabilities" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLiabilitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_CurrentLiabilitiesAbstract" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_TradeAndOtherCurrentPayables" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShorttermBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShorttermBorrowings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_ShorttermBorrowings" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentProvisionsForEmployeeBenefits" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentProvisionsForEmployeeBenefits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_CurrentProvisionsForEmployeeBenefits" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_CurrentTaxLiabilitiesCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentGovernmentGrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentGovernmentGrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_CurrentGovernmentGrants" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentWarrantLiability" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentWarrantLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_CurrentWarrantLiability" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConsiderationForAcquisitionOfAssetsCurrent" xlink:href="mlec-20250630.xsd#mlec_ConsiderationForAcquisitionOfAssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ConsiderationForAcquisitionOfAssetsCurrent" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLeaseLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_CurrentLeaseLiabilities" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_CurrentLiabilities" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Liabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Liabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_Liabilities" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityAndLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAndLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_EquityAndLiabilities" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ShareholdersEquityType2or3" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ConsolidatedStatementOfChangesInShareholdersDeficitEquityAbstract" xlink:href="mlec-20250630.xsd#mlec_ConsolidatedStatementOfChangesInShareholdersDeficitEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfChangesInEquityTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfChangesInEquityLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfChangesInEquityLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidatedStatementOfChangesInShareholdersDeficitEquityAbstract" xlink:to="ifrs-full_StatementOfChangesInEquityTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComponentsOfEquityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityTable" xlink:to="ifrs-full_ComponentsOfEquityAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuedCapitalMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapitalMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_IssuedCapitalMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SharesIssuedMember" xlink:href="mlec-20250630.xsd#mlec_SharesIssuedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="SharesIssuedMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OwnSharesHeldMember" xlink:href="mlec-20250630.xsd#mlec_OwnSharesHeldMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="OwnSharesHeldMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharePremiumMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SharePremiumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_SharePremiumMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReserveOfSharebasedPaymentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_ReserveOfSharebasedPaymentsMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RetainedEarningsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RetainedEarningsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_RetainedEarningsMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RevaluationOfPropertyPlantEquipmentAndEffectOfTaxRateChangeMember" xlink:href="mlec-20250630.xsd#mlec_RevaluationOfPropertyPlantEquipmentAndEffectOfTaxRateChangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="RevaluationOfPropertyPlantEquipmentAndEffectOfTaxRateChangeMember" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAttributableToOwnersOfParentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_EquityAttributableToOwnersOfParentMember" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncontrollingInterestsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncontrollingInterestsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_NoncontrollingInterestsMember" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComponentsOfEquityDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_ComponentsOfEquityDomain" order="10.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityTable" xlink:to="ifrs-full_StatementOfChangesInEquityLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_Equity" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IncreaseDecreaseThroughChangesInBusinessCombinationEquity" xlink:href="mlec-20250630.xsd#mlec_IncreaseDecreaseThroughChangesInBusinessCombinationEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="IncreaseDecreaseThroughChangesInBusinessCombinationEquity" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughOtherDistributionsToOwners" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughOtherDistributionsToOwners"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_IncreaseDecreaseThroughOtherDistributionsToOwners" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DividendsPaid" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DividendsPaid"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_DividendsPaid" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_ProfitLoss" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeBeforeTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeBeforeTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_OtherComprehensiveIncomeBeforeTax" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_Equity_0" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ConsolidatedCashFlow" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:to="ifrs-full_ProfitLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfCashPaymentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfCashPaymentsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_ClassesOfCashPaymentsAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncomeTaxExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForIncomeTaxExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfCashPaymentsAbstract" xlink:to="ifrs-full_AdjustmentsForIncomeTaxExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDepreciationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDepreciationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfCashPaymentsAbstract" xlink:to="ifrs-full_AdjustmentsForDepreciationExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AmortizationOfIntangibleAsset" xlink:href="mlec-20250630.xsd#mlec_AmortizationOfIntangibleAsset"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfCashPaymentsAbstract" xlink:to="AmortizationOfIntangibleAsset" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DepreciationOfLeasedAssets" xlink:href="mlec-20250630.xsd#mlec_DepreciationOfLeasedAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfCashPaymentsAbstract" xlink:to="DepreciationOfLeasedAssets" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForFairValueGainsLosses" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForFairValueGainsLosses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfCashPaymentsAbstract" xlink:to="ifrs-full_AdjustmentsForFairValueGainsLosses" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RemeasurementOfPreviouslyHeldInterest" xlink:href="mlec-20250630.xsd#mlec_RemeasurementOfPreviouslyHeldInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfCashPaymentsAbstract" xlink:to="RemeasurementOfPreviouslyHeldInterest" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfCashPaymentsAbstract" xlink:to="ifrs-full_AdjustmentsForSharebasedPayments" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfCashPaymentsAbstract" xlink:to="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ProvisionsForContingencies" xlink:href="mlec-20250630.xsd#mlec_ProvisionsForContingencies"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfCashPaymentsAbstract" xlink:to="ProvisionsForContingencies" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AllowanceForImpairmentOfTradeDebtors" xlink:href="mlec-20250630.xsd#mlec_AllowanceForImpairmentOfTradeDebtors"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfCashPaymentsAbstract" xlink:to="AllowanceForImpairmentOfTradeDebtors" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AllowanceForObsolescences" xlink:href="mlec-20250630.xsd#mlec_AllowanceForObsolescences"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfCashPaymentsAbstract" xlink:to="AllowanceForObsolescences" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfCashPaymentsAbstract" xlink:to="ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnChangeInFairValueEstimatesOfBiologicalAssetsForCurrentPeriod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnChangeInFairValueEstimatesOfBiologicalAssetsForCurrentPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfCashPaymentsAbstract" xlink:to="ifrs-full_GainsLossesOnChangeInFairValueEstimatesOfBiologicalAssetsForCurrentPeriod" order="12.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForFinanceCosts" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForFinanceCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfCashPaymentsAbstract" xlink:to="ifrs-full_AdjustmentsForFinanceCosts" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfCashPaymentsAbstract" xlink:to="ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WorkingCapitalAdjustmentsOperatingActivitiesAbstract" xlink:href="mlec-20250630.xsd#mlec_WorkingCapitalAdjustmentsOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="WorkingCapitalAdjustmentsOperatingActivitiesAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WorkingCapitalAdjustmentsOperatingActivitiesAbstract" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WorkingCapitalAdjustmentsOperatingActivitiesAbstract" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WorkingCapitalAdjustmentsOperatingActivitiesAbstract" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WorkingCapitalAdjustmentsOperatingActivitiesAbstract" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WorkingCapitalAdjustmentsOperatingActivitiesAbstract" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AdjustmentsForDecreaseIncreaseInGovernmentGrants" xlink:href="mlec-20250630.xsd#mlec_AdjustmentsForDecreaseIncreaseInGovernmentGrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WorkingCapitalAdjustmentsOperatingActivitiesAbstract" xlink:to="AdjustmentsForDecreaseIncreaseInGovernmentGrants" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WorkingCapitalAdjustmentsOperatingActivitiesAbstract" xlink:to="ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WorkingCapitalAdjustmentsOperatingActivitiesAbstract" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WorkingCapitalAdjustmentsOperatingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCashReceiptsFromSalesOfInterestsInJointVenturesClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherCashReceiptsFromSalesOfInterestsInJointVenturesClassifiedAsInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_OtherCashReceiptsFromSalesOfInterestsInJointVenturesClassifiedAsInvestingActivities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PaymentsForDevelopmentProjectExpenditure" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PaymentsForDevelopmentProjectExpenditure"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_PaymentsForDevelopmentProjectExpenditure" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" order="8.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivities" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_InterestPaidClassifiedAsFinancingActivities" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PaymentsOfOtherEquityInstruments" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PaymentsOfOtherEquityInstruments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_PaymentsOfOtherEquityInstruments" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="PurchaseOfOwnShares" xlink:href="mlec-20250630.xsd#mlec_PurchaseOfOwnShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="PurchaseOfOwnShares" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivities" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="InflationEffectsOnCashAndCashEquivalents" xlink:href="mlec-20250630.xsd#mlec_InflationEffectsOnCashAndCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="InflationEffectsOnCashAndCashEquivalents" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition_0" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformation" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:to="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparation" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="AccountingStandardsAndBasiofPreparationAbstract" xlink:href="mlec-20250630.xsd#mlec_AccountingStandardsAndBasiofPreparationAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingStandardsAndBasiofPreparationAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/NewStandardsAmendmentsandInterpretationsIssuedbytheIASB" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="NewStandardsAmendmentsAndInterpretationsIssuedByTheIASBAbstract" xlink:href="mlec-20250630.xsd#mlec_NewStandardsAmendmentsAndInterpretationsIssuedByTheIASBAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NewStandardsAmendmentsAndInterpretationsIssuedByTheIASBAbstract" xlink:to="ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/CriticalAccountingJudgmentsandEstimates" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="CriticalAccountingJudgmentsAndEstimatesAbstract" xlink:href="mlec-20250630.xsd#mlec_CriticalAccountingJudgmentsAndEstimatesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CriticalAccountingJudgmentsAndEstimatesAbstract" xlink:to="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/AcquisitionsandOtherSignificantTransactions" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:to="ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPosition" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:to="DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/InformationaboutComponentofConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfComprehensiveIncomeAbstract"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:to="DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/Taxation" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="ifrs-full_DisclosureOfIncomeTaxExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/EarningPerShare" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_EarningsPerShareAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EarningsPerShareAbstract" xlink:to="ifrs-full_DisclosureOfEarningsPerShareExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/InformationaboutComponentsofEquity" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="InformationAboutComponentsOfEquityAbstract" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsOfEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsOfEquityAbstract" xlink:to="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/CashFlowInformation" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfCashFlowStatementExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfCashFlowStatementExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:to="ifrs-full_DisclosureOfCashFlowStatementExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/JointVenturesandAssociates" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfJointVenturesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfJointVenturesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfJointVenturesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfJointVenturesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfJointVenturesAbstract" xlink:to="ifrs-full_DisclosureOfJointVenturesExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/SegmentInformation" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:to="ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/FinancialInstrumentsRiskManagement" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="FinancialInstrumentsRiskManagementAbstract" xlink:href="mlec-20250630.xsd#mlec_FinancialInstrumentsRiskManagementAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialRiskManagementExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialInstrumentsRiskManagementAbstract" xlink:to="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/Leases" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PresentationOfLeasesForLesseeAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfLeasesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfLeasesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:to="ifrs-full_DisclosureOfLeasesExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ShareholdersandOtherRelatedPartiesBalancesandTransactions" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:to="ifrs-full_DisclosureOfRelatedPartyExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/KeyManagementPersonnelCompensation" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="KeyManagementPersonnelCompensationAbstract" xlink:href="mlec-20250630.xsd#mlec_KeyManagementPersonnelCompensationAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="KeyManagementPersonnelCompensationAbstract" xlink:to="ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ShareBasedPayment" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ContingenciesCommitmentsandRestrictionsontheDistributionofProfits" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_CapitalCommitmentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CapitalCommitmentsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfCommitmentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfCommitmentsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CapitalCommitmentsAbstract" xlink:to="ifrs-full_DisclosureOfCommitmentsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/EventsOccurringAftertheReportingPeriod" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:to="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ReverseStockSplitAftertheReportingPeriod" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="DisclosureOfReverseStockSplitAfterTheReportingPeriodAbstract" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfReverseStockSplitAfterTheReportingPeriodAbstract"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfReverseStockSplitAfterTheReportingPeriod" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfReverseStockSplitAfterTheReportingPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfReverseStockSplitAfterTheReportingPeriodAbstract" xlink:to="DisclosureOfReverseStockSplitAfterTheReportingPeriod" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/AccountingPoliciesByPolicy" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DescriptionOfAccountingPolicyForFinancialAssetsAndLiabilitiesPolicyTextBlock" xlink:href="mlec-20250630.xsd#mlec_DescriptionOfAccountingPolicyForFinancialAssetsAndLiabilitiesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="DescriptionOfAccountingPolicyForFinancialAssetsAndLiabilitiesPolicyTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DescriptionOfAccountingPolicyForBasisOfConsolidation" xlink:href="mlec-20250630.xsd#mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="DescriptionOfAccountingPolicyForBasisOfConsolidation" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForInvestmentPropertyExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForInvestmentPropertyExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForInvestmentPropertyExplanatory" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DescriptionOfAccountingPolicyForConvertibleNotesTextBlock" xlink:href="mlec-20250630.xsd#mlec_DescriptionOfAccountingPolicyForConvertibleNotesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="DescriptionOfAccountingPolicyForConvertibleNotesTextBlock" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DescriptionOfAccountingPolicyForWarrantLiabilities" xlink:href="mlec-20250630.xsd#mlec_DescriptionOfAccountingPolicyForWarrantLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="DescriptionOfAccountingPolicyForWarrantLiabilities" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="AccountingStandardsAndBasiofPreparationAbstract" xlink:href="mlec-20250630.xsd#mlec_AccountingStandardsAndBasiofPreparationAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingStandardsAndBasiofPreparationAbstract" xlink:to="ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/AcquisitionsandOtherSignificantTransactionsTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsAbstract"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfFairValueOfConsiderationOfPaymentTableTextBlock" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfFairValueOfConsiderationOfPaymentTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:to="ScheduleOfFairValueOfConsiderationOfPaymentTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:to="ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfOtherFinancialAssetsExplanatory" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfOtherFinancialAssetsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:to="DisclosureOfOtherFinancialAssetsExplanatory" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfTradeReceivablesTableTextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfTradeReceivablesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:to="DisclosureOfTradeReceivablesTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfOtherReceivablesTableTextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfOtherReceivablesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:to="DisclosureOfOtherReceivablesTableTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfInventoriesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInventoriesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:to="ifrs-full_DisclosureOfInventoriesExplanatory" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:to="ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfDepreciationIfAssetsHadBeenCarriedUnderCostModelTextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfDepreciationIfAssetsHadBeenCarriedUnderCostModelTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:to="DisclosureOfDepreciationIfAssetsHadBeenCarriedUnderCostModelTextBlock" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfIntangibleAssetsAndLiabilitiesAssumedTextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfIntangibleAssetsAndLiabilitiesAssumedTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:to="DisclosureOfIntangibleAssetsAndLiabilitiesAssumedTextBlock" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:to="ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutInvestmentPropertyExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutInvestmentPropertyExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutInvestmentPropertyExplanatory" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfTradeAndOtherPayablesComponentsTableTextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfTradeAndOtherPayablesComponentsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:to="DisclosureOfTradeAndOtherPayablesComponentsTableTextBlock" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfCarryingValueOfBorrowingsExplanatory" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfCarryingValueOfBorrowingsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:to="DisclosureOfCarryingValueOfBorrowingsExplanatory" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDebtSecuritiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDebtSecuritiesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:to="ifrs-full_DisclosureOfDebtSecuritiesExplanatory" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfBenefitsAndSocialSecurityPayablesTableTextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfBenefitsAndSocialSecurityPayablesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:to="DisclosureOfBenefitsAndSocialSecurityPayablesTableTextBlock" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DisclosuresOfDeferredRevenueAndAdvancesFromCustomersTableTextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosuresOfDeferredRevenueAndAdvancesFromCustomersTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:to="DisclosuresOfDeferredRevenueAndAdvancesFromCustomersTableTextBlock" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfChangesInAllowancesAndProvisionsTableTextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfChangesInAllowancesAndProvisionsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:to="DisclosureOfChangesInAllowancesAndProvisionsTableTextBlock" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfProvisionsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfProvisionsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:to="ifrs-full_DisclosureOfProvisionsExplanatory" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfGovernmentGrantsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfGovernmentGrantsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:to="ifrs-full_DisclosureOfGovernmentGrantsExplanatory" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfWarrantsTextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfWarrantsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:to="DisclosureOfWarrantsTextBlock" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfComprehensiveIncomeAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfCostOfSalesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfCostOfSalesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:to="ifrs-full_DisclosureOfCostOfSalesExplanatory" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:to="ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfExpensesByNatureExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfExpensesByNatureExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:to="ifrs-full_DisclosureOfExpensesByNatureExplanatory" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:to="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:to="ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/TaxationTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDeferredTaxesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDeferredTaxesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="ifrs-full_DisclosureOfDeferredTaxesExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfRollforwardOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfRollforwardOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="ScheduleOfRollforwardOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="EffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="mlec-20250630.xsd#mlec_EffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="EffectiveIncomeTaxRateReconciliationTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="mlec-20250630.xsd#mlec_ComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="ComponentsOfIncomeTaxExpenseBenefitTableTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IncomeTaxExpenseByApplyingApplicableTaxRateInForceInRespectiveJurisdictionsTableTextBlock" xlink:href="mlec-20250630.xsd#mlec_IncomeTaxExpenseByApplyingApplicableTaxRateInForceInRespectiveJurisdictionsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="IncomeTaxExpenseByApplyingApplicableTaxRateInForceInRespectiveJurisdictionsTableTextBlock" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/EarningPerShareTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_EarningsPerShareAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EarningsPerShareExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EarningsPerShareExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EarningsPerShareAbstract" xlink:to="ifrs-full_EarningsPerShareExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/InformationaboutComponentsofEquityTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="InformationAboutComponentsOfEquityAbstract" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsOfEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfNumberOfSharesIssuedtextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfNumberOfSharesIssuedtextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsOfEquityAbstract" xlink:to="DisclosureOfNumberOfSharesIssuedtextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsOfEquityAbstract" xlink:to="ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfFinancialStatementsTextBlock" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfFinancialStatementsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsOfEquityAbstract" xlink:to="ScheduleOfFinancialStatementsTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsOfEquityAbstract" xlink:to="ifrs-full_DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/CashFlowInformationTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:to="ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:to="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/JointVenturesandAssociatesTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfJointVenturesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfJointVenturesAbstract"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfInvestmentsInJointVenturesAndAffiliatesTableTextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfInvestmentsInJointVenturesAndAffiliatesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfJointVenturesAbstract" xlink:to="DisclosureOfInvestmentsInJointVenturesAndAffiliatesTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfChangesInInvestmentInJointVenturesAndAffiliatesTableTextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfChangesInInvestmentInJointVenturesAndAffiliatesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfJointVenturesAbstract" xlink:to="DisclosureOfChangesInInvestmentInJointVenturesAndAffiliatesTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfShareOfProfitOrLossInJointVenturesAndAffiliatesTableTextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfShareOfProfitOrLossInJointVenturesAndAffiliatesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfJointVenturesAbstract" xlink:to="DisclosureOfShareOfProfitOrLossInJointVenturesAndAffiliatesTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfSignificantJointVenturesTableTextBlock" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfSignificantJointVenturesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfJointVenturesAbstract" xlink:to="ScheduleOfSignificantJointVenturesTableTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/SegmentInformationTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:to="ifrs-full_DisclosureOfOperatingSegmentsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfProductsAndServicesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfProductsAndServicesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:to="ifrs-full_DisclosureOfProductsAndServicesExplanatory" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfGeographicalAreasExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfGeographicalAreasExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:to="ifrs-full_DisclosureOfGeographicalAreasExplanatory" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/FinancialInstrumentsRiskManagementTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract" xlink:to="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfRisksAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfRisksAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable" xlink:to="ifrs-full_TypesOfRisksAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfRisksDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfRisksDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfRisksAxis" xlink:to="ifrs-full_TypesOfRisksDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrencyRiskMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrencyRiskMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfRisksAxis" xlink:to="ifrs-full_CurrencyRiskMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestRateRiskMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestRateRiskMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfRisksAxis" xlink:to="ifrs-full_InterestRateRiskMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable" xlink:to="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingLineItems" xlink:to="ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingLineItems" xlink:to="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfForeignExchangeRiskSensitivityAnalysistextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfForeignExchangeRiskSensitivityAnalysistextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingLineItems" xlink:to="DisclosureOfForeignExchangeRiskSensitivityAnalysistextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingLineItems" xlink:to="ifrs-full_DisclosureOfFinancialAssetsExplanatory" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingLineItems" xlink:to="ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingLineItems" xlink:to="ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/LeasesTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PresentationOfLeasesForLesseeAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ShareholdersandOtherRelatedPartiesBalancesandTransactionsTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:to="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/KeyManagementPersonnelCompensationTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="KeyManagementPersonnelCompensationAbstract" xlink:href="mlec-20250630.xsd#mlec_KeyManagementPersonnelCompensationAbstract"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="KeyManagementPersonnelCompensationAbstract" xlink:to="DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ShareBasedPaymentTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfFairValueOfTheStockOptionsAtTheGrantDateTextBlock" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfFairValueOfTheStockOptionsAtTheGrantDateTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="DisclosureOfFairValueOfTheStockOptionsAtTheGrantDateTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ReverseStockSplitAftertheReportingPeriodTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="DisclosureOfReverseStockSplitAfterTheReportingPeriodAbstract" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfReverseStockSplitAfterTheReportingPeriodAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfReverseStockSplitAfterTheReportingPeriodAbstract" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofInformationrelatedtoCompanysShareofVotingRightsinitsSubsidiariesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfInformationRelatedToCompanySShareOfVotingRightsInItsSubsidiariesAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfInformationRelatedToCompanySShareOfVotingRightsInItsSubsidiariesAbstract"/>
    <loc xlink:type="locator" xlink:label="AccountingStandardsandBasisofPreparationScheduleofInformationrelatedtoCompanysShareofVotingRightsinitsSubsidiariesDetailsTable" xlink:href="mlec-20250630.xsd#mlec_AccountingStandardsandBasisofPreparationScheduleofInformationrelatedtoCompanysShareofVotingRightsinitsSubsidiariesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfInformationRelatedToCompanySShareOfVotingRightsInItsSubsidiariesAbstract" xlink:to="AccountingStandardsandBasisofPreparationScheduleofInformationrelatedtoCompanysShareofVotingRightsinitsSubsidiariesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ConsolidatedStructuredEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingStandardsandBasisofPreparationScheduleofInformationrelatedtoCompanysShareofVotingRightsinitsSubsidiariesDetailsTable" xlink:to="ifrs-full_ConsolidatedStructuredEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="MoolecScienceLimitedMember" xlink:href="mlec-20250630.xsd#mlec_MoolecScienceLimitedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:to="MoolecScienceLimitedMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AGBiomoleculesLLCMember" xlink:href="mlec-20250630.xsd#mlec_AGBiomoleculesLLCMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:to="AGBiomoleculesLLCMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ValoraSoySAMember" xlink:href="mlec-20250630.xsd#mlec_ValoraSoySAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:to="ValoraSoySAMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NutreconLLCMember" xlink:href="mlec-20250630.xsd#mlec_NutreconLLCMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:to="NutreconLLCMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SynBioPowerlabsMember" xlink:href="mlec-20250630.xsd#mlec_SynBioPowerlabsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:to="SynBioPowerlabsMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GentleTechMember" xlink:href="mlec-20250630.xsd#mlec_GentleTechMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:to="GentleTechMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GentleFarmingMember" xlink:href="mlec-20250630.xsd#mlec_GentleFarmingMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:to="GentleFarmingMember" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GFASMember" xlink:href="mlec-20250630.xsd#mlec_GFASMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:to="GFASMember" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BioceresGroupLimitedMember" xlink:href="mlec-20250630.xsd#mlec_BioceresGroupLimitedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:to="BioceresGroupLimitedMember" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BioceresCropSolutionsBIOXMember" xlink:href="mlec-20250630.xsd#mlec_BioceresCropSolutionsBIOXMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:to="BioceresCropSolutionsBIOXMember" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BioceresLLCMember" xlink:href="mlec-20250630.xsd#mlec_BioceresLLCMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:to="BioceresLLCMember" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BioceresSAMember" xlink:href="mlec-20250630.xsd#mlec_BioceresSAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:to="BioceresSAMember" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BioceresTechServicesLLCMember" xlink:href="mlec-20250630.xsd#mlec_BioceresTechServicesLLCMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:to="BioceresTechServicesLLCMember" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingStandardsandBasisofPreparationScheduleofInformationrelatedtoCompanysShareofVotingRightsinitsSubsidiariesDetailsTable" xlink:to="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NameOfSubsidiary" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NameOfSubsidiary"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_NameOfSubsidiary" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_ProportionOfOwnershipInterestInSubsidiary" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofFairValueoftheConsiderationofPaymentTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfFairValueOfTheConsiderationOfPaymentAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfFairValueOfTheConsiderationOfPaymentAbstract"/>
    <loc xlink:type="locator" xlink:label="AcquisitionsandOtherSignificantTransactionsScheduleofFairValueoftheConsiderationofPaymentDetailsTable" xlink:href="mlec-20250630.xsd#mlec_AcquisitionsandOtherSignificantTransactionsScheduleofFairValueoftheConsiderationofPaymentDetailsTable"/>
    <loc xlink:type="locator" xlink:label="AcquisitionsandOtherSignificantTransactionsScheduleofFairValueoftheConsiderationofPaymentDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_AcquisitionsandOtherSignificantTransactionsScheduleofFairValueoftheConsiderationofPaymentDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFairValueOfTheConsiderationOfPaymentAbstract" xlink:to="AcquisitionsandOtherSignificantTransactionsScheduleofFairValueoftheConsiderationofPaymentDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AcquisitionsandOtherSignificantTransactionsScheduleofFairValueoftheConsiderationofPaymentDetailsTable" xlink:to="ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ProFarmGroupIncMember" xlink:href="mlec-20250630.xsd#mlec_ProFarmGroupIncMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis" xlink:to="ProFarmGroupIncMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NatalAgroSRLMember" xlink:href="mlec-20250630.xsd#mlec_NatalAgroSRLMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis" xlink:to="NatalAgroSRLMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AcquisitionsandOtherSignificantTransactionsScheduleofFairValueoftheConsiderationofPaymentDetailsTable" xlink:to="AcquisitionsandOtherSignificantTransactionsScheduleofFairValueoftheConsiderationofPaymentDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="EquityShares" xlink:href="mlec-20250630.xsd#mlec_EquityShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AcquisitionsandOtherSignificantTransactionsScheduleofFairValueoftheConsiderationofPaymentDetailsLineItems" xlink:to="EquityShares" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WarrantLiability" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WarrantLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AcquisitionsandOtherSignificantTransactionsScheduleofFairValueoftheConsiderationofPaymentDetailsLineItems" xlink:to="ifrs-full_WarrantLiability" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AcquisitionsandOtherSignificantTransactionsScheduleofFairValueoftheConsiderationofPaymentDetailsLineItems" xlink:to="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashTransferred" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashTransferred"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AcquisitionsandOtherSignificantTransactionsScheduleofFairValueoftheConsiderationofPaymentDetailsLineItems" xlink:to="ifrs-full_CashTransferred" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityInterestsOfAcquirer" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityInterestsOfAcquirer"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AcquisitionsandOtherSignificantTransactionsScheduleofFairValueoftheConsiderationofPaymentDetailsLineItems" xlink:to="ifrs-full_EquityInterestsOfAcquirer" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofAssetsAcquiredandLiabilitiesAssumedTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfAssetsAcquiredAndLiabilitiesAssumedAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfAssetsAcquiredAndLiabilitiesAssumedAbstract"/>
    <loc xlink:type="locator" xlink:label="AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsTable" xlink:href="mlec-20250630.xsd#mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsTable"/>
    <loc xlink:type="locator" xlink:label="AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAssetsAcquiredAndLiabilitiesAssumedAbstract" xlink:to="AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsTable" xlink:to="ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis" xlink:to="ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="MoolecScienceSAMember" xlink:href="mlec-20250630.xsd#mlec_MoolecScienceSAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis" xlink:to="MoolecScienceSAMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsTable" xlink:to="AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherCashAndCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="ifrs-full_OtherCashAndCashEquivalents" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherFinancialAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="ifrs-full_OtherFinancialAssets" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="ifrs-full_TradeReceivables" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="ifrs-full_OtherReceivables" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IncomeAndMinimumPresumedRecoverableIncomeTaxes" xlink:href="mlec-20250630.xsd#mlec_IncomeAndMinimumPresumedRecoverableIncomeTaxes"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="IncomeAndMinimumPresumedRecoverableIncomeTaxes" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdditionsToRightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdditionsToRightofuseAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="ifrs-full_AdditionsToRightofuseAssets" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherPayables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="ifrs-full_TradeAndOtherPayables" order="8.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InventoriesTotal" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InventoriesTotal"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="ifrs-full_InventoriesTotal" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate" order="10.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SocialSecurityContributions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SocialSecurityContributions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="ifrs-full_SocialSecurityContributions" order="11.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentProvisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentProvisions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="ifrs-full_CurrentProvisions" order="13.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" order="14.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="ifrs-full_LeaseLiabilities" order="15.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WarrantLiability" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WarrantLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="ifrs-full_WarrantLiability" order="16.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" order="17.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="NoncontrollingInterest" xlink:href="mlec-20250630.xsd#mlec_NoncontrollingInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="NoncontrollingInterest" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainRecognisedInBargainPurchaseTransaction" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainRecognisedInBargainPurchaseTransaction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="ifrs-full_GainRecognisedInBargainPurchaseTransaction" order="20.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialAssetsAtFairValue" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssetsAtFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="ifrs-full_FinancialAssetsAtFairValue" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnDisposalsOfInvestments" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnDisposalsOfInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="ifrs-full_GainsLossesOnDisposalsOfInvestments" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems" xlink:to="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofCashandCashEquivalentsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalentsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Cash" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Cash"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashAndCashEquivalentsAbstract" xlink:to="ifrs-full_Cash" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MutualFunds" xlink:href="mlec-20250630.xsd#mlec_MutualFunds"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashAndCashEquivalentsAbstract" xlink:to="MutualFunds" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashAndCashEquivalentsAbstract" xlink:to="ifrs-full_CashAndCashEquivalents" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofOtherFinancialAssetsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfOtherFinancialAssetsAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfOtherFinancialAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofOtherFinancialAssetsDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofOtherFinancialAssetsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherFinancialAssetsAbstract" xlink:to="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofOtherFinancialAssetsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofOtherFinancialAssetsDetailsTable" xlink:to="ifrs-full_ClassesOfAssetsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfAssetsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="ifrs-full_ClassesOfAssetsDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="InvestmentsInSharesMember" xlink:href="mlec-20250630.xsd#mlec_InvestmentsInSharesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="InvestmentsInSharesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MutualFundsMember" xlink:href="mlec-20250630.xsd#mlec_MutualFundsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="MutualFundsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OtherInvestmentMember" xlink:href="mlec-20250630.xsd#mlec_OtherInvestmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="OtherInvestmentMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofOtherFinancialAssetsDetailsTable" xlink:to="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="CurrentAbstract" xlink:href="mlec-20250630.xsd#mlec_CurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems" xlink:to="CurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherCurrentFinancialAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentAbstract" xlink:to="ifrs-full_OtherCurrentFinancialAssets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="NonCurrentAbstract" xlink:href="mlec-20250630.xsd#mlec_NonCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems" xlink:to="NonCurrentAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentFinancialAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentAbstract" xlink:to="ifrs-full_OtherNoncurrentFinancialAssets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofTradeReceivablesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherReceivablesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherReceivablesAbstract"/>
    <loc xlink:type="locator" xlink:label="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofTradeReceivablesDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofTradeReceivablesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofTradeReceivablesDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofTradeReceivablesDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TradeAndOtherReceivablesAbstract" xlink:to="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofTradeReceivablesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="IfrsBalanceSheetLocationAxis" xlink:href="mlec-20250630.xsd#mlec_IfrsBalanceSheetLocationAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofTradeReceivablesDetailsTable" xlink:to="IfrsBalanceSheetLocationAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeReceivablesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeReceivablesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IfrsBalanceSheetLocationAxis" xlink:to="ifrs-full_TradeReceivablesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofTradeReceivablesDetailsTable" xlink:to="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofTradeReceivablesDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="CurrentAbstract0" xlink:href="mlec-20250630.xsd#mlec_CurrentAbstract0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofTradeReceivablesDetailsLineItems" xlink:to="CurrentAbstract0" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentTradeReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTradeReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentAbstract0" xlink:to="ifrs-full_CurrentTradeReceivables" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="CurrentTradeReceivablesAllowanceForImpairmentOfTradeDebtors" xlink:href="mlec-20250630.xsd#mlec_CurrentTradeReceivablesAllowanceForImpairmentOfTradeDebtors"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentAbstract0" xlink:to="CurrentTradeReceivablesAllowanceForImpairmentOfTradeDebtors" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CurrentTradeReceivablesShareholdersAndOtherRelatedParties" xlink:href="mlec-20250630.xsd#mlec_CurrentTradeReceivablesShareholdersAndOtherRelatedParties"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentAbstract0" xlink:to="CurrentTradeReceivablesShareholdersAndOtherRelatedParties" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AllowanceForReturnOfGoods" xlink:href="mlec-20250630.xsd#mlec_AllowanceForReturnOfGoods"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentAbstract0" xlink:to="AllowanceForReturnOfGoods" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CurrentTradeReceivablesTradeDebtorsJointVenturesAndAssociates" xlink:href="mlec-20250630.xsd#mlec_CurrentTradeReceivablesTradeDebtorsJointVenturesAndAssociates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentAbstract0" xlink:to="CurrentTradeReceivablesTradeDebtorsJointVenturesAndAssociates" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentAbstract0" xlink:to="ifrs-full_OtherReceivables" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentAbstract0" xlink:to="ifrs-full_TradeAndOtherCurrentReceivables" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofOtherReceivablesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfOtherReceivablesAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfOtherReceivablesAbstract"/>
    <loc xlink:type="locator" xlink:label="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofOtherReceivablesDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofOtherReceivablesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfOtherReceivablesLineItems" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfOtherReceivablesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherReceivablesAbstract" xlink:to="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofOtherReceivablesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofOtherReceivablesDetailsTable" xlink:to="ifrs-full_ClassesOfAssetsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfAssetsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="ifrs-full_ClassesOfAssetsDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="TaxesMember" xlink:href="mlec-20250630.xsd#mlec_TaxesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="TaxesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InsuranceToBeAccruedMember" xlink:href="mlec-20250630.xsd#mlec_InsuranceToBeAccruedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="InsuranceToBeAccruedMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OtherReceivablesJointVenturesAndAssociatesMember" xlink:href="mlec-20250630.xsd#mlec_OtherReceivablesJointVenturesAndAssociatesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="OtherReceivablesJointVenturesAndAssociatesMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PrepaymentsToSuppliersMember" xlink:href="mlec-20250630.xsd#mlec_PrepaymentsToSuppliersMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="PrepaymentsToSuppliersMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareholdersAndOtherRelatedPartiesMember" xlink:href="mlec-20250630.xsd#mlec_ShareholdersAndOtherRelatedPartiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="ShareholdersAndOtherRelatedPartiesMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GovernmentsGrantsReceivableMember" xlink:href="mlec-20250630.xsd#mlec_GovernmentsGrantsReceivableMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="GovernmentsGrantsReceivableMember" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PrepaidExpensesAndOtherReceivablesMember" xlink:href="mlec-20250630.xsd#mlec_PrepaidExpensesAndOtherReceivablesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="PrepaidExpensesAndOtherReceivablesMember" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LoansReceivablesMember" xlink:href="mlec-20250630.xsd#mlec_LoansReceivablesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="LoansReceivablesMember" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MiscellaneousMember" xlink:href="mlec-20250630.xsd#mlec_MiscellaneousMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="MiscellaneousMember" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OtherReceivableMember" xlink:href="mlec-20250630.xsd#mlec_OtherReceivableMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="OtherReceivableMember" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ReimbursementsOverExportsMember" xlink:href="mlec-20250630.xsd#mlec_ReimbursementsOverExportsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="ReimbursementsOverExportsMember" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofOtherReceivablesDetailsTable" xlink:to="ScheduleOfOtherReceivablesLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="CurrentAbstract1" xlink:href="mlec-20250630.xsd#mlec_CurrentAbstract1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherReceivablesLineItems" xlink:to="CurrentAbstract1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherCurrentReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentAbstract1" xlink:to="ifrs-full_OtherCurrentReceivables" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="NonCurrentAbstract0" xlink:href="mlec-20250630.xsd#mlec_NonCurrentAbstract0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherReceivablesLineItems" xlink:to="NonCurrentAbstract0" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentAbstract0" xlink:to="ifrs-full_OtherNoncurrentReceivables" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofInventoriesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfInventoriesAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfInventoriesAbstract"/>
    <loc xlink:type="locator" xlink:label="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofInventoriesDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofInventoriesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="InventoriesScheduleOfInventoriesLineItems" xlink:href="mlec-20250630.xsd#mlec_InventoriesScheduleOfInventoriesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfInventoriesAbstract" xlink:to="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofInventoriesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BiologicalAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BiologicalAssetsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofInventoriesDetailsTable" xlink:to="ifrs-full_BiologicalAssetsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BiologicalAssetsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BiologicalAssetsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BiologicalAssetsAxis" xlink:to="ifrs-full_BiologicalAssetsDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="SeedsAndGrainsMember" xlink:href="mlec-20250630.xsd#mlec_SeedsAndGrainsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BiologicalAssetsAxis" xlink:to="SeedsAndGrainsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MicrobiologicalResaleProductsMember" xlink:href="mlec-20250630.xsd#mlec_MicrobiologicalResaleProductsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BiologicalAssetsAxis" xlink:to="MicrobiologicalResaleProductsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MicrobiologicalProductsProducedMember" xlink:href="mlec-20250630.xsd#mlec_MicrobiologicalProductsProducedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BiologicalAssetsAxis" xlink:to="MicrobiologicalProductsProducedMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GoodsInTransitMember" xlink:href="mlec-20250630.xsd#mlec_GoodsInTransitMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BiologicalAssetsAxis" xlink:to="GoodsInTransitMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SuppliesMember" xlink:href="mlec-20250630.xsd#mlec_SuppliesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BiologicalAssetsAxis" xlink:to="SuppliesMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AgriculturalProductsMember" xlink:href="mlec-20250630.xsd#mlec_AgriculturalProductsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BiologicalAssetsAxis" xlink:to="AgriculturalProductsMember" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AllowanceForObsolescenceMember" xlink:href="mlec-20250630.xsd#mlec_AllowanceForObsolescenceMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BiologicalAssetsAxis" xlink:to="AllowanceForObsolescenceMember" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofInventoriesDetailsTable" xlink:to="InventoriesScheduleOfInventoriesLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="InventoriesCurrent" xlink:href="mlec-20250630.xsd#mlec_InventoriesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InventoriesScheduleOfInventoriesLineItems" xlink:to="InventoriesCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InventoriesExcludingAgriculturalProduce" xlink:href="mlec-20250630.xsd#mlec_InventoriesExcludingAgriculturalProduce"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InventoriesScheduleOfInventoriesLineItems" xlink:to="InventoriesExcludingAgriculturalProduce" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofChangesinBiologicalAssetsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfChangesInBiologicalAssetsAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfChangesInBiologicalAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinBiologicalAssetsDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinBiologicalAssetsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfChangesInBiologicalAssetsAbstract" xlink:to="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinBiologicalAssetsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BiologicalAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BiologicalAssetsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinBiologicalAssetsDetailsTable" xlink:to="ifrs-full_BiologicalAssetsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BiologicalAssetsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BiologicalAssetsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BiologicalAssetsAxis" xlink:to="ifrs-full_BiologicalAssetsDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="BiologicalAssetsSoybeanMember" xlink:href="mlec-20250630.xsd#mlec_BiologicalAssetsSoybeanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BiologicalAssetsAxis" xlink:to="BiologicalAssetsSoybeanMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BiologicalAssetsCornMember" xlink:href="mlec-20250630.xsd#mlec_BiologicalAssetsCornMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BiologicalAssetsAxis" xlink:to="BiologicalAssetsCornMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BiologicalAssetsWheatMember" xlink:href="mlec-20250630.xsd#mlec_BiologicalAssetsWheatMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BiologicalAssetsAxis" xlink:to="BiologicalAssetsWheatMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BiologicalAssetsBarleyMember" xlink:href="mlec-20250630.xsd#mlec_BiologicalAssetsBarleyMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BiologicalAssetsAxis" xlink:to="BiologicalAssetsBarleyMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SunflowerMember" xlink:href="mlec-20250630.xsd#mlec_SunflowerMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BiologicalAssetsAxis" xlink:to="SunflowerMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinBiologicalAssetsDetailsTable" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BiologicalAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BiologicalAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems" xlink:to="ifrs-full_BiologicalAssets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems" xlink:to="ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DecreaseDueToHarvestAndDisposalsBiologicalAssets" xlink:href="mlec-20250630.xsd#mlec_DecreaseDueToHarvestAndDisposalsBiologicalAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems" xlink:to="DecreaseDueToHarvestAndDisposalsBiologicalAssets" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="LossOfControlonBiologicalAssets" xlink:href="mlec-20250630.xsd#mlec_LossOfControlonBiologicalAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems" xlink:to="LossOfControlonBiologicalAssets" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BiologicalAssets_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BiologicalAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems" xlink:to="ifrs-full_BiologicalAssets_0" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofPropertyPlantandEquipmentTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfPropertyPlantAndEquipmentAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfPropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofPropertyPlantandEquipmentDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofPropertyPlantandEquipmentDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPropertyPlantAndEquipmentAbstract" xlink:to="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofPropertyPlantandEquipmentDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofPropertyPlantandEquipmentDetailsTable" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OfficeEquipmentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OfficeEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_OfficeEquipmentMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_VehiclesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_VehiclesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_VehiclesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComputerEquipmentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComputerEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_ComputerEquipmentMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FixturesAndFittingsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FixturesAndFittingsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_FixturesAndFittingsMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MachineryAndEquipmentsMember" xlink:href="mlec-20250630.xsd#mlec_MachineryAndEquipmentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="MachineryAndEquipmentsMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LandAndBuildingsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LandAndBuildingsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_LandAndBuildingsMember" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ConstructionInProgressMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ConstructionInProgressMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_ConstructionInProgressMember" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ResearchInstrumentsMember" xlink:href="mlec-20250630.xsd#mlec_ResearchInstrumentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ResearchInstrumentsMember" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofPropertyPlantandEquipmentDetailsTable" xlink:to="ifrs-full_ClassesOfAssetsAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="PropertyPlantAndEquipmentsMember" xlink:href="mlec-20250630.xsd#mlec_PropertyPlantAndEquipmentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="PropertyPlantAndEquipmentsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofPropertyPlantandEquipmentDetailsTable" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="ifrs-full_PropertyPlantAndEquipment" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DisposalsPropertyPlantAndEquipments" xlink:href="mlec-20250630.xsd#mlec_DisposalsPropertyPlantAndEquipments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="DisposalsPropertyPlantAndEquipments" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="ifrs-full_DepreciationPropertyPlantAndEquipment" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipment_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="ifrs-full_PropertyPlantAndEquipment_0" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="ifrs-full_IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofCarryingAmountsthatWouldHaveBeenRecognizedTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfCarryingAmountsThatWouldHaveBeenRecognizedAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfCarryingAmountsThatWouldHaveBeenRecognizedAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCarryingAmountsThatWouldHaveBeenRecognizedAbstract" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LandAndBuildingsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LandAndBuildingsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_LandAndBuildingsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfIntangibleAssetsAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfIntangibleAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofIntangibleAssetsDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofIntangibleAssetsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIntangibleAssetsAbstract" xlink:to="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofIntangibleAssetsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofIntangibleAssetsDetailsTable" xlink:to="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="AlfalfaGenuityHarXstraMember" xlink:href="mlec-20250630.xsd#mlec_AlfalfaGenuityHarXstraMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="AlfalfaGenuityHarXstraMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="HB4SoyAndBreedingProgramMember" xlink:href="mlec-20250630.xsd#mlec_HB4SoyAndBreedingProgramMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="HB4SoyAndBreedingProgramMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IntegratedSeedProductsMember" xlink:href="mlec-20250630.xsd#mlec_IntegratedSeedProductsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="IntegratedSeedProductsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MicrobiologicalProductsMember" xlink:href="mlec-20250630.xsd#mlec_MicrobiologicalProductsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="MicrobiologicalProductsMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MicrobiologicalProductsInProgressMember" xlink:href="mlec-20250630.xsd#mlec_MicrobiologicalProductsInProgressMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="MicrobiologicalProductsInProgressMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TrademarksAndPatentsMember" xlink:href="mlec-20250630.xsd#mlec_TrademarksAndPatentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="TrademarksAndPatentsMember" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TrademarksAndPatentsWithIndefiniteUsefulLifeMember" xlink:href="mlec-20250630.xsd#mlec_TrademarksAndPatentsWithIndefiniteUsefulLifeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="TrademarksAndPatentsWithIndefiniteUsefulLifeMember" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SoftwareMember" xlink:href="mlec-20250630.xsd#mlec_SoftwareMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="SoftwareMember" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SoftwareInProgressMember" xlink:href="mlec-20250630.xsd#mlec_SoftwareInProgressMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="SoftwareInProgressMember" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CustomerLoyaltyMember" xlink:href="mlec-20250630.xsd#mlec_CustomerLoyaltyMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="CustomerLoyaltyMember" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RGRSOXWheatMember" xlink:href="mlec-20250630.xsd#mlec_RGRSOXWheatMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="RGRSOXWheatMember" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SustainableAgriculturalEquipmentTechnologyMember" xlink:href="mlec-20250630.xsd#mlec_SustainableAgriculturalEquipmentTechnologyMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="SustainableAgriculturalEquipmentTechnologyMember" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FungalBiomassMember" xlink:href="mlec-20250630.xsd#mlec_FungalBiomassMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="FungalBiomassMember" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PiggysooyMember" xlink:href="mlec-20250630.xsd#mlec_PiggysooyMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="PiggysooyMember" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SafflowerGLAMember" xlink:href="mlec-20250630.xsd#mlec_SafflowerGLAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="SafflowerGLAMember" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SafflowerChimosin20Member" xlink:href="mlec-20250630.xsd#mlec_SafflowerChimosin20Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="SafflowerChimosin20Member" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherIntangibleAssetsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherIntangibleAssetsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="ifrs-full_OtherIntangibleAssetsMember" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BacillusPHAsMember" xlink:href="mlec-20250630.xsd#mlec_BacillusPHAsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="BacillusPHAsMember" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofIntangibleAssetsDetailsTable" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets" xlink:href="mlec-20250630.xsd#mlec_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems" xlink:to="DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AdditionsFromBusinessCombinations" xlink:href="mlec-20250630.xsd#mlec_AdditionsFromBusinessCombinations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems" xlink:to="AdditionsFromBusinessCombinations" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems" xlink:to="ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="AmortizationOfTheYear" xlink:href="mlec-20250630.xsd#mlec_AmortizationOfTheYear"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems" xlink:to="AmortizationOfTheYear" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems" xlink:to="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill_0" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofGoodwillTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfGoodwillAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfGoodwillAbstract"/>
    <loc xlink:type="locator" xlink:label="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGoodwillDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGoodwillDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfGoodwillAbstract" xlink:to="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGoodwillDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGoodwillDetailsTable" xlink:to="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:to="ifrs-full_SignificantInvestmentsInSubsidiariesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="RizobacterArgentinaSAMember" xlink:href="mlec-20250630.xsd#mlec_RizobacterArgentinaSAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:to="RizobacterArgentinaSAMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BioceresCropsSAMember" xlink:href="mlec-20250630.xsd#mlec_BioceresCropsSAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:to="BioceresCropsSAMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InsumosAgroqumicosSAMember" xlink:href="mlec-20250630.xsd#mlec_InsumosAgroqumicosSAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:to="InsumosAgroqumicosSAMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ProFarmGroupMember" xlink:href="mlec-20250630.xsd#mlec_ProFarmGroupMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:to="ProFarmGroupMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGoodwillDetailsTable" xlink:to="ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Goodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Goodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems" xlink:to="ifrs-full_Goodwill" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofInvestmentPropertiesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnDisposalsOfInvestmentPropertiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnDisposalsOfInvestmentPropertiesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InvestmentProperty" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InvestmentProperty"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GainsLossesOnDisposalsOfInvestmentPropertiesAbstract" xlink:to="ifrs-full_InvestmentProperty" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InvestmentProperty_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InvestmentProperty"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GainsLossesOnDisposalsOfInvestmentPropertiesAbstract" xlink:to="ifrs-full_InvestmentProperty_0" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofTradeandOtherPayablesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherPayablesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherPayablesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TradeAndOtherPayablesAbstract" xlink:to="ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TradeAndOtherPayablesShareholdersAndOtherRelatedParties" xlink:href="mlec-20250630.xsd#mlec_TradeAndOtherPayablesShareholdersAndOtherRelatedParties"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TradeAndOtherPayablesAbstract" xlink:to="TradeAndOtherPayablesShareholdersAndOtherRelatedParties" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TradeCreditorsJointVenturesAndAssociates" xlink:href="mlec-20250630.xsd#mlec_TradeCreditorsJointVenturesAndAssociates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TradeAndOtherPayablesAbstract" xlink:to="TradeCreditorsJointVenturesAndAssociates" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TradeAndOtherPayablesAbstract" xlink:to="ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherCurrentPayables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TradeAndOtherPayablesAbstract" xlink:to="ifrs-full_OtherCurrentPayables" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TradeAndOtherPayablesAbstract" xlink:to="ifrs-full_TradeAndOtherCurrentPayables" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofBorrowingsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfBorrowingsAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfBorrowingsAbstract"/>
    <loc xlink:type="locator" xlink:label="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofBorrowingsDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofBorrowingsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBorrowingsAbstract" xlink:to="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofBorrowingsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofBorrowingsDetailsTable" xlink:to="ifrs-full_BorrowingsByNameAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="ifrs-full_BorrowingsByNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="BankBorrowingMember" xlink:href="mlec-20250630.xsd#mlec_BankBorrowingMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="BankBorrowingMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CorporateBondsMember" xlink:href="mlec-20250630.xsd#mlec_CorporateBondsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="CorporateBondsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NetLoansPayablesJointVenturesAndAssociatesMember" xlink:href="mlec-20250630.xsd#mlec_NetLoansPayablesJointVenturesAndAssociatesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="NetLoansPayablesJointVenturesAndAssociatesMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertiblePreferenceSharesMember" xlink:href="mlec-20250630.xsd#mlec_ConvertiblePreferenceSharesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="ConvertiblePreferenceSharesMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FinancialBorrowingsMember" xlink:href="mlec-20250630.xsd#mlec_FinancialBorrowingsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="FinancialBorrowingsMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofBorrowingsDetailsTable" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowingsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowingsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowingsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentPortionOfLongtermBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentPortionOfLongtermBorrowings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowingsAbstract" xlink:to="ifrs-full_CurrentPortionOfLongtermBorrowings" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentPortionOfNoncurrentBorrowingsByTypeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentPortionOfNoncurrentBorrowingsByTypeAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="ifrs-full_NoncurrentPortionOfNoncurrentBorrowingsByTypeAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherBorrowings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentPortionOfNoncurrentBorrowingsByTypeAbstract" xlink:to="ifrs-full_OtherBorrowings" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofBorrowingsCarryingAmountTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfBorrowingsCarryingAmountAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfBorrowingsCarryingAmountAbstract"/>
    <loc xlink:type="locator" xlink:label="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofBorrowingsCarryingAmountDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofBorrowingsCarryingAmountDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBorrowingsCarryingAmountAbstract" xlink:to="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofBorrowingsCarryingAmountDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MeasurementAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofBorrowingsCarryingAmountDetailsTable" xlink:to="ifrs-full_MeasurementAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MeasurementAxis" xlink:to="ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AtFairValueMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AtFairValueMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MeasurementAxis" xlink:to="ifrs-full_AtFairValueMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofBorrowingsCarryingAmountDetailsTable" xlink:to="ifrs-full_BorrowingsByNameAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="BankBorrowingMember" xlink:href="mlec-20250630.xsd#mlec_BankBorrowingMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="BankBorrowingMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CorporateBondsMember" xlink:href="mlec-20250630.xsd#mlec_CorporateBondsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="CorporateBondsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertiblePreferenceSharesMember" xlink:href="mlec-20250630.xsd#mlec_ConvertiblePreferenceSharesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="ConvertiblePreferenceSharesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FinancialBorrowingsMember" xlink:href="mlec-20250630.xsd#mlec_FinancialBorrowingsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="FinancialBorrowingsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertibleNotesMember" xlink:href="mlec-20250630.xsd#mlec_ConvertibleNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="ConvertibleNotesMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofBorrowingsCarryingAmountDetailsTable" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowingsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowingsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowingsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShorttermBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShorttermBorrowings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowingsAbstract" xlink:to="ifrs-full_ShorttermBorrowings" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentPortionOfNoncurrentBorrowingsByTypeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentPortionOfNoncurrentBorrowingsByTypeAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="ifrs-full_NoncurrentPortionOfNoncurrentBorrowingsByTypeAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LongtermBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LongtermBorrowings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentPortionOfNoncurrentBorrowingsByTypeAbstract" xlink:to="ifrs-full_LongtermBorrowings" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofConvertibleNotesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfConvertibleNotesAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfConvertibleNotesAbstract"/>
    <loc xlink:type="locator" xlink:label="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofConvertibleNotesDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofConvertibleNotesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofConvertibleNotesDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofConvertibleNotesDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfConvertibleNotesAbstract" xlink:to="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofConvertibleNotesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofConvertibleNotesDetailsTable" xlink:to="ifrs-full_BorrowingsByNameAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="ifrs-full_BorrowingsByNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ConvertibleNotesMember" xlink:href="mlec-20250630.xsd#mlec_ConvertibleNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="ConvertibleNotesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofConvertibleNotesDetailsTable" xlink:to="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofConvertibleNotesDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="SecuredDebtNonCurrent" xlink:href="mlec-20250630.xsd#mlec_SecuredDebtNonCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofConvertibleNotesDetailsLineItems" xlink:to="SecuredDebtNonCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofEmployeeBenefitsandSocialSecurityTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfEmployeeBenefitsAndSocialSecurityAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfEmployeeBenefitsAndSocialSecurityAbstract"/>
    <loc xlink:type="locator" xlink:label="CurrentAbstract2" xlink:href="mlec-20250630.xsd#mlec_CurrentAbstract2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEmployeeBenefitsAndSocialSecurityAbstract" xlink:to="CurrentAbstract2" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SalariesAccruedIncentivesVacationsAndSocialSecurity" xlink:href="mlec-20250630.xsd#mlec_SalariesAccruedIncentivesVacationsAndSocialSecurity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentAbstract2" xlink:to="SalariesAccruedIncentivesVacationsAndSocialSecurity" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="KeyManagementPersonnelBenefitsLiabilityCurrent" xlink:href="mlec-20250630.xsd#mlec_KeyManagementPersonnelBenefitsLiabilityCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentAbstract2" xlink:to="KeyManagementPersonnelBenefitsLiabilityCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentProvisionsForEmployeeBenefits" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentProvisionsForEmployeeBenefits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentAbstract2" xlink:to="ifrs-full_CurrentProvisionsForEmployeeBenefits" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofDeferredRevenueandAdvancesfromCustomersTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfDeferredRevenueAndAdvancesFromCustomersAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfDeferredRevenueAndAdvancesFromCustomersAbstract"/>
    <loc xlink:type="locator" xlink:label="CurrentAbstract3" xlink:href="mlec-20250630.xsd#mlec_CurrentAbstract3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredRevenueAndAdvancesFromCustomersAbstract" xlink:to="CurrentAbstract3" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAdvances" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAdvances"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentAbstract3" xlink:to="ifrs-full_CurrentAdvances" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentAbstract3" xlink:to="ifrs-full_CurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentAbstract3" xlink:to="ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="NonCurrentAbstract1" xlink:href="mlec-20250630.xsd#mlec_NonCurrentAbstract1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredRevenueAndAdvancesFromCustomersAbstract" xlink:to="NonCurrentAbstract1" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAdvances" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAdvances"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentAbstract1" xlink:to="ifrs-full_NoncurrentAdvances" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentAbstract1" xlink:to="ifrs-full_NoncurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentDeferredIncomeIncludingNoncurrentContractLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentDeferredIncomeIncludingNoncurrentContractLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentAbstract1" xlink:to="ifrs-full_NoncurrentDeferredIncomeIncludingNoncurrentContractLiabilities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofChangesinAllowancesandProvisionsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfChangesInAllowancesAndProvisionsAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfChangesInAllowancesAndProvisionsAbstract"/>
    <loc xlink:type="locator" xlink:label="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfChangesInAllowancesAndProvisionsAbstract" xlink:to="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfProvisionsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfProvisionsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsTable" xlink:to="ifrs-full_ClassesOfProvisionsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfOtherProvisionsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfOtherProvisionsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfProvisionsAxis" xlink:to="ifrs-full_ClassesOfOtherProvisionsDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="AllowanceForImpairmentOfTradeDebtorsMember" xlink:href="mlec-20250630.xsd#mlec_AllowanceForImpairmentOfTradeDebtorsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfProvisionsAxis" xlink:to="AllowanceForImpairmentOfTradeDebtorsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AllowanceForObsolescenceMember" xlink:href="mlec-20250630.xsd#mlec_AllowanceForObsolescenceMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfProvisionsAxis" xlink:to="AllowanceForObsolescenceMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="deductedFromAssetsMember" xlink:href="mlec-20250630.xsd#mlec_deductedFromAssetsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfProvisionsAxis" xlink:to="deductedFromAssetsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ProvisionForContingenciesMember" xlink:href="mlec-20250630.xsd#mlec_ProvisionForContingenciesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfProvisionsAxis" xlink:to="ProvisionForContingenciesMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LiabilitiesMember" xlink:href="mlec-20250630.xsd#mlec_LiabilitiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfProvisionsAxis" xlink:to="LiabilitiesMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsTable" xlink:to="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherProvisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherProvisions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsLineItems" xlink:to="ifrs-full_OtherProvisions" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdditionalProvisionsOtherProvisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdditionalProvisionsOtherProvisions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsLineItems" xlink:to="ifrs-full_AdditionalProvisionsOtherProvisions" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsLineItems" xlink:to="ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="AllowancesAndProvisionsUsedAndReversed" xlink:href="mlec-20250630.xsd#mlec_AllowancesAndProvisionsUsedAndReversed"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsLineItems" xlink:to="AllowancesAndProvisionsUsedAndReversed" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsLineItems" xlink:to="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ChangeInAllowanceAndProvisionLossOfControl" xlink:href="mlec-20250630.xsd#mlec_ChangeInAllowanceAndProvisionLossOfControl"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsLineItems" xlink:to="ChangeInAllowanceAndProvisionLossOfControl" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherProvisions_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherProvisions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsLineItems" xlink:to="ifrs-full_OtherProvisions_0" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofProvisionsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfProvisionsAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfProvisionsAbstract"/>
    <loc xlink:type="locator" xlink:label="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofProvisionsDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofProvisionsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofProvisionsDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofProvisionsDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfProvisionsAbstract" xlink:to="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofProvisionsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfProvisionsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfProvisionsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofProvisionsDetailsTable" xlink:to="ifrs-full_ClassesOfProvisionsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfOtherProvisionsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfOtherProvisionsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfProvisionsAxis" xlink:to="ifrs-full_ClassesOfOtherProvisionsDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ConditionalPaymentRizobacterSAMember" xlink:href="mlec-20250630.xsd#mlec_ConditionalPaymentRizobacterSAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfProvisionsAxis" xlink:to="ConditionalPaymentRizobacterSAMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ProvisionForContingenciesMember" xlink:href="mlec-20250630.xsd#mlec_ProvisionForContingenciesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfProvisionsAxis" xlink:to="ProvisionForContingenciesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofProvisionsDetailsTable" xlink:to="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofProvisionsDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentProvisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentProvisions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofProvisionsDetailsLineItems" xlink:to="ifrs-full_NoncurrentProvisions" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofGovernmentGrantsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfGovernmentGrantsAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfGovernmentGrantsAbstract"/>
    <loc xlink:type="locator" xlink:label="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGovernmentGrantsDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGovernmentGrantsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGovernmentGrantsDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGovernmentGrantsDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfGovernmentGrantsAbstract" xlink:to="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGovernmentGrantsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ConsolidatedStructuredEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGovernmentGrantsDetailsTable" xlink:to="ifrs-full_ConsolidatedStructuredEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="BioceresCropSolutionsCorpMember" xlink:href="mlec-20250630.xsd#mlec_BioceresCropSolutionsCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:to="BioceresCropSolutionsCorpMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGovernmentGrantsDetailsTable" xlink:to="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGovernmentGrantsDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GovernmentGrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GovernmentGrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGovernmentGrantsDetailsLineItems" xlink:to="ifrs-full_GovernmentGrants" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LossesOnDisposalsOfInvestments" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LossesOnDisposalsOfInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGovernmentGrantsDetailsLineItems" xlink:to="ifrs-full_LossesOnDisposalsOfInvestments" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGovernmentGrantsDetailsLineItems" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGovernmentGrantsDetailsLineItems" xlink:to="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GovernmentGrants_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GovernmentGrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGovernmentGrantsDetailsLineItems" xlink:to="ifrs-full_GovernmentGrants_0" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofWarrantsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfWarrantsAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfWarrantsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentWarrantLiability" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentWarrantLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfWarrantsAbstract" xlink:to="ifrs-full_CurrentWarrantLiability" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="AdditionsWarrantsForTheYear" xlink:href="mlec-20250630.xsd#mlec_AdditionsWarrantsForTheYear"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfWarrantsAbstract" xlink:to="AdditionsWarrantsForTheYear" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AdditionsFromBusinessCombination" xlink:href="mlec-20250630.xsd#mlec_AdditionsFromBusinessCombination"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfWarrantsAbstract" xlink:to="AdditionsFromBusinessCombination" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentWarrantLiability_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentWarrantLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfWarrantsAbstract" xlink:to="ifrs-full_CurrentWarrantLiability_0" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofRevenuefromContractswithCustomersTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromSaleOfGoods" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromSaleOfGoods"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_RevenueFromSaleOfGoods" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromRoyalties" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromRoyalties"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_RevenueFromRoyalties" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromRenderingOfServices" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromRenderingOfServices"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_RevenueFromRenderingOfServices" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LicenceFeeIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LicenceFeeIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_LicenceFeeIncome" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromContractsWithCustomers" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromContractsWithCustomers"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract" xlink:to="ifrs-full_RevenueFromContractsWithCustomers" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofCostofSalesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_CostOfSalesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CostOfSalesMember"/>
    <loc xlink:type="locator" xlink:label="InventoriesNetOfAgriculturalProducts" xlink:href="mlec-20250630.xsd#mlec_InventoriesNetOfAgriculturalProducts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CostOfSalesMember" xlink:to="InventoriesNetOfAgriculturalProducts" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="LossOfControl" xlink:href="mlec-20250630.xsd#mlec_LossOfControl"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CostOfSalesMember" xlink:to="LossOfControl" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InventoriesFromBusinessCombination" xlink:href="mlec-20250630.xsd#mlec_InventoriesFromBusinessCombination"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CostOfSalesMember" xlink:to="InventoriesFromBusinessCombination" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PurchaseOfInventory" xlink:href="mlec-20250630.xsd#mlec_PurchaseOfInventory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CostOfSalesMember" xlink:to="PurchaseOfInventory" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InventoryProductionCosts" xlink:href="mlec-20250630.xsd#mlec_InventoryProductionCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CostOfSalesMember" xlink:to="InventoryProductionCosts" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ForeignCurrencyTranslationOnInventory" xlink:href="mlec-20250630.xsd#mlec_ForeignCurrencyTranslationOnInventory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CostOfSalesMember" xlink:to="ForeignCurrencyTranslationOnInventory" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InventoriesBeforeClosingInventory" xlink:href="mlec-20250630.xsd#mlec_InventoriesBeforeClosingInventory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CostOfSalesMember" xlink:to="InventoriesBeforeClosingInventory" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InventoriesTotal" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InventoriesTotal"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CostOfSalesMember" xlink:to="ifrs-full_InventoriesTotal" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CostOfSales" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CostOfSales"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CostOfSalesMember" xlink:to="ifrs-full_CostOfSales" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ResearchAndDevelopmentsExpenseAbstract" xlink:href="mlec-20250630.xsd#mlec_ResearchAndDevelopmentsExpenseAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchAndDevelopmentsExpenseAbstract" xlink:to="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AnalysisAndStorage" xlink:href="mlec-20250630.xsd#mlec_AnalysisAndStorage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchAndDevelopmentsExpenseAbstract" xlink:to="AnalysisAndStorage" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RoyaltyExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RoyaltyExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchAndDevelopmentsExpenseAbstract" xlink:to="ifrs-full_RoyaltyExpense" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ImportAndExportExpenses" xlink:href="mlec-20250630.xsd#mlec_ImportAndExportExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchAndDevelopmentsExpenseAbstract" xlink:to="ImportAndExportExpenses" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepreciationRightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DepreciationRightofuseAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchAndDevelopmentsExpenseAbstract" xlink:to="ifrs-full_DepreciationRightofuseAssets" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchAndDevelopmentsExpenseAbstract" xlink:to="ifrs-full_DepreciationPropertyPlantAndEquipment" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TransportationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TransportationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchAndDevelopmentsExpenseAbstract" xlink:to="ifrs-full_TransportationExpense" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShorttermEmployeeBenefitsExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShorttermEmployeeBenefitsExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchAndDevelopmentsExpenseAbstract" xlink:to="ifrs-full_ShorttermEmployeeBenefitsExpense" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InsuranceExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InsuranceExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchAndDevelopmentsExpenseAbstract" xlink:to="ifrs-full_InsuranceExpense" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FuelAndEnergyExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FuelAndEnergyExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchAndDevelopmentsExpenseAbstract" xlink:to="ifrs-full_FuelAndEnergyExpense" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RepairsAndMaintenanceExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RepairsAndMaintenanceExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchAndDevelopmentsExpenseAbstract" xlink:to="ifrs-full_RepairsAndMaintenanceExpense" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SuppliesAndMaterials" xlink:href="mlec-20250630.xsd#mlec_SuppliesAndMaterials"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchAndDevelopmentsExpenseAbstract" xlink:to="SuppliesAndMaterials" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LicensesandPatents" xlink:href="mlec-20250630.xsd#mlec_LicensesandPatents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchAndDevelopmentsExpenseAbstract" xlink:to="LicensesandPatents" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TravelExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TravelExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchAndDevelopmentsExpenseAbstract" xlink:to="ifrs-full_TravelExpense" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdvertisingExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdvertisingExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchAndDevelopmentsExpenseAbstract" xlink:to="ifrs-full_AdvertisingExpense" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SystemExpenses" xlink:href="mlec-20250630.xsd#mlec_SystemExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchAndDevelopmentsExpenseAbstract" xlink:to="SystemExpenses" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="VehicleExpenses" xlink:href="mlec-20250630.xsd#mlec_VehicleExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchAndDevelopmentsExpenseAbstract" xlink:to="VehicleExpenses" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchAndDevelopmentsExpenseAbstract" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SurveillanceExpense" xlink:href="mlec-20250630.xsd#mlec_SurveillanceExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchAndDevelopmentsExpenseAbstract" xlink:to="SurveillanceExpense" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfessionalFeesExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfessionalFeesExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchAndDevelopmentsExpenseAbstract" xlink:to="ifrs-full_ProfessionalFeesExpense" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ProfessionalFeesExpenseRelatedParties" xlink:href="mlec-20250630.xsd#mlec_ProfessionalFeesExpenseRelatedParties"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchAndDevelopmentsExpenseAbstract" xlink:to="ProfessionalFeesExpenseRelatedParties" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchAndDevelopmentsExpenseAbstract" xlink:to="ifrs-full_AdministrativeExpense" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MiscellaneousOtherOperatingExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MiscellaneousOtherOperatingExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchAndDevelopmentsExpenseAbstract" xlink:to="ifrs-full_MiscellaneousOtherOperatingExpense" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchAndDevelopmentsExpenseAbstract" xlink:to="ifrs-full_ResearchAndDevelopmentExpense" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ResearchAndDevelopmentExpenseCapitalized" xlink:href="mlec-20250630.xsd#mlec_ResearchAndDevelopmentExpenseCapitalized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchAndDevelopmentsExpenseAbstract" xlink:to="ResearchAndDevelopmentExpenseCapitalized" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ResearchAndDevelopmentExpense_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchAndDevelopmentsExpenseAbstract" xlink:to="ifrs-full_ResearchAndDevelopmentExpense_0" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TotalResearchAndDevelopmentExpenseIncurred" xlink:href="mlec-20250630.xsd#mlec_TotalResearchAndDevelopmentExpenseIncurred"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchAndDevelopmentsExpenseAbstract" xlink:to="TotalResearchAndDevelopmentExpenseIncurred" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofExpensesClassifiedbyNatureandFunctionTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfExpensesClassifiedByNatureAndFunctionAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionAbstract"/>
    <loc xlink:type="locator" xlink:label="InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofExpensesClassifiedbyNatureandFunctionDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofExpensesClassifiedbyNatureandFunctionDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfExpensesClassifiedByNatureAndFunctionAbstract" xlink:to="InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofExpensesClassifiedbyNatureandFunctionDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofExpensesClassifiedbyNatureandFunctionDetailsTable" xlink:to="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CostOfSalesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CostOfSalesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:to="ifrs-full_CostOfSalesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpenseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:to="ifrs-full_SellingGeneralAndAdministrativeExpenseMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExpensesClassifiedByNatureAndFunctionMember" xlink:href="mlec-20250630.xsd#mlec_ExpensesClassifiedByNatureAndFunctionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:to="ExpensesClassifiedByNatureAndFunctionMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofExpensesClassifiedbyNatureandFunctionDetailsTable" xlink:to="ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForAmortisationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForAmortisationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="ifrs-full_AdjustmentsForAmortisationExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AnalysisAndStorage" xlink:href="mlec-20250630.xsd#mlec_AnalysisAndStorage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="AnalysisAndStorage" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RoyaltyExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RoyaltyExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="ifrs-full_RoyaltyExpense" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ImportAndExportExpenses" xlink:href="mlec-20250630.xsd#mlec_ImportAndExportExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="ImportAndExportExpenses" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="ifrs-full_DepreciationPropertyPlantAndEquipment" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TransportationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TransportationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="ifrs-full_TransportationExpense" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShorttermEmployeeBenefitsExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShorttermEmployeeBenefitsExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="ifrs-full_ShorttermEmployeeBenefitsExpense" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentTaxExpenseIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxExpenseIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="ifrs-full_CurrentTaxExpenseIncome" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RepairsAndMaintenanceExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RepairsAndMaintenanceExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="ifrs-full_RepairsAndMaintenanceExpense" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FuelAndEnergyExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FuelAndEnergyExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="ifrs-full_FuelAndEnergyExpense" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SuppliesAndMaterials" xlink:href="mlec-20250630.xsd#mlec_SuppliesAndMaterials"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="SuppliesAndMaterials" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TravelExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TravelExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="ifrs-full_TravelExpense" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AllowanceForObsolescences" xlink:href="mlec-20250630.xsd#mlec_AllowanceForObsolescences"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="AllowanceForObsolescences" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdvertisingExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdvertisingExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="ifrs-full_AdvertisingExpense" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SystemExpenses" xlink:href="mlec-20250630.xsd#mlec_SystemExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="SystemExpenses" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SharebasedIncentivesForEmployees" xlink:href="mlec-20250630.xsd#mlec_SharebasedIncentivesForEmployees"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="SharebasedIncentivesForEmployees" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SurveillanceExpense" xlink:href="mlec-20250630.xsd#mlec_SurveillanceExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="SurveillanceExpense" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfessionalFeesExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfessionalFeesExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="ifrs-full_ProfessionalFeesExpense" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ProfessionalFeesRelatedParties" xlink:href="mlec-20250630.xsd#mlec_ProfessionalFeesRelatedParties"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="ProfessionalFeesRelatedParties" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="ifrs-full_AdministrativeExpense" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InsuranceExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InsuranceExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="ifrs-full_InsuranceExpense" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepreciationRightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DepreciationRightofuseAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="ifrs-full_DepreciationRightofuseAssets" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Contingencies" xlink:href="mlec-20250630.xsd#mlec_Contingencies"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="Contingencies" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="EnvironmentalImpactTreatment" xlink:href="mlec-20250630.xsd#mlec_EnvironmentalImpactTreatment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="EnvironmentalImpactTreatment" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LicensesandPatents" xlink:href="mlec-20250630.xsd#mlec_LicensesandPatents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="LicensesandPatents" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MiscellaneousOtherOperatingExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MiscellaneousOtherOperatingExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="ifrs-full_MiscellaneousOtherOperatingExpense" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherExpenseByFunction" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherExpenseByFunction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems" xlink:to="ifrs-full_OtherExpenseByFunction" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofFinanceResultsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfFinanceResultsAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfFinanceResultsAbstract"/>
    <loc xlink:type="locator" xlink:label="InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofFinanceResultsDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofFinanceResultsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofFinanceResultsDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofFinanceResultsDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFinanceResultsAbstract" xlink:to="InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofFinanceResultsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ConsolidatedStructuredEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofFinanceResultsDetailsTable" xlink:to="ifrs-full_ConsolidatedStructuredEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="BioceresCropSolutionsCorpMember" xlink:href="mlec-20250630.xsd#mlec_BioceresCropSolutionsCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:to="BioceresCropSolutionsCorpMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofFinanceResultsDetailsTable" xlink:to="InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofFinanceResultsDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="FinancialCostAbstract" xlink:href="mlec-20250630.xsd#mlec_FinancialCostAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofFinanceResultsDetailsLineItems" xlink:to="FinancialCostAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialCostAbstract" xlink:to="ifrs-full_InterestExpense" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="FinancialCommissions" xlink:href="mlec-20250630.xsd#mlec_FinancialCommissions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialCostAbstract" xlink:to="FinancialCommissions" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinanceCosts" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialCostAbstract" xlink:to="ifrs-full_FinanceCosts" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OtherFinancialResultsAbstract" xlink:href="mlec-20250630.xsd#mlec_OtherFinancialResultsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofFinanceResultsDetailsLineItems" xlink:to="OtherFinancialResultsAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherFinancialResultsAbstract" xlink:to="ifrs-full_GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementAssets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherFinancialResultsAbstract" xlink:to="ifrs-full_GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementLiabilities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ChangeInFairValueOfFinancialAssetsOrLiabilitiesOrOtherFinancialResults" xlink:href="mlec-20250630.xsd#mlec_ChangeInFairValueOfFinancialAssetsOrLiabilitiesOrOtherFinancialResults"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherFinancialResultsAbstract" xlink:to="ChangeInFairValueOfFinancialAssetsOrLiabilitiesOrOtherFinancialResults" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PrepaymentPremiumFee" xlink:href="mlec-20250630.xsd#mlec_PrepaymentPremiumFee"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherFinancialResultsAbstract" xlink:to="PrepaymentPremiumFee" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NetGainOnInflationEffectOnMonetary" xlink:href="mlec-20250630.xsd#mlec_NetGainOnInflationEffectOnMonetary"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherFinancialResultsAbstract" xlink:to="NetGainOnInflationEffectOnMonetary" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InterestAccruedWithRelatedParties" xlink:href="mlec-20250630.xsd#mlec_InterestAccruedWithRelatedParties"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherFinancialResultsAbstract" xlink:to="InterestAccruedWithRelatedParties" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherFinanceIncomeCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherFinanceIncomeCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherFinancialResultsAbstract" xlink:to="ifrs-full_OtherFinanceIncomeCost" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinanceIncomeCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceIncomeCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofFinanceResultsDetailsLineItems" xlink:to="ifrs-full_FinanceIncomeCost" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofOtherIncomeorExpensesNetTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfOtherIncomeOrExpensesNetAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfOtherIncomeOrExpensesNetAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromSaleOfAgriculturalProduce" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromSaleOfAgriculturalProduce"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherIncomeOrExpensesNetAbstract" xlink:to="ifrs-full_RevenueFromSaleOfAgriculturalProduce" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GainOnBargainPurchase" xlink:href="mlec-20250630.xsd#mlec_GainOnBargainPurchase"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherIncomeOrExpensesNetAbstract" xlink:to="GainOnBargainPurchase" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RemeasurementToFairValueOfPreexistingInterestInAnAcquiree" xlink:href="mlec-20250630.xsd#mlec_RemeasurementToFairValueOfPreexistingInterestInAnAcquiree"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherIncomeOrExpensesNetAbstract" xlink:to="RemeasurementToFairValueOfPreexistingInterestInAnAcquiree" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NetResultFromCommercializationOfAgriculturalProducts" xlink:href="mlec-20250630.xsd#mlec_NetResultFromCommercializationOfAgriculturalProducts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherIncomeOrExpensesNetAbstract" xlink:to="NetResultFromCommercializationOfAgriculturalProducts" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherIncomeOrExpensesNetAbstract" xlink:to="ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="OtherIncomeOrExpensesNet" xlink:href="mlec-20250630.xsd#mlec_OtherIncomeOrExpensesNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherIncomeOrExpensesNetAbstract" xlink:to="OtherIncomeOrExpensesNet" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherOperatingIncomeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherOperatingIncomeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherIncomeOrExpensesNetAbstract" xlink:to="ifrs-full_OtherOperatingIncomeExpense" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_NetDeferredTaxAssetsAndLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetDeferredTaxAssetsAndLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="TaxationScheduleofDeferredTaxAssetsandLiabilitiesDetailsTable" xlink:href="mlec-20250630.xsd#mlec_TaxationScheduleofDeferredTaxAssetsandLiabilitiesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="TaxationScheduleofDeferredTaxAssetsandLiabilitiesDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_TaxationScheduleofDeferredTaxAssetsandLiabilitiesDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NetDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="TaxationScheduleofDeferredTaxAssetsandLiabilitiesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TaxationScheduleofDeferredTaxAssetsandLiabilitiesDetailsTable" xlink:to="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="CarryForwardOfTaxLossMember" xlink:href="mlec-20250630.xsd#mlec_CarryForwardOfTaxLossMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="CarryForwardOfTaxLossMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OthersFinancialAssetMember" xlink:href="mlec-20250630.xsd#mlec_OthersFinancialAssetMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="OthersFinancialAssetMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OthersOneMember" xlink:href="mlec-20250630.xsd#mlec_OthersOneMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="OthersOneMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RoyaltiesMember" xlink:href="mlec-20250630.xsd#mlec_RoyaltiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="RoyaltiesMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TradeReceivableMember" xlink:href="mlec-20250630.xsd#mlec_TradeReceivableMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="TradeReceivableMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AllowancesMember" xlink:href="mlec-20250630.xsd#mlec_AllowancesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="AllowancesMember" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GovernmentGrantsMember" xlink:href="mlec-20250630.xsd#mlec_GovernmentGrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="GovernmentGrantsMember" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxAssetMember" xlink:href="mlec-20250630.xsd#mlec_DeferredTaxAssetMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="DeferredTaxAssetMember" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IntangiblesTaxLiabilityMember" xlink:href="mlec-20250630.xsd#mlec_IntangiblesTaxLiabilityMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="IntangiblesTaxLiabilityMember" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PropertyPlantAndEquipmentDepreciationMember" xlink:href="mlec-20250630.xsd#mlec_PropertyPlantAndEquipmentDepreciationMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="PropertyPlantAndEquipmentDepreciationMember" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InventoriesTaxLiabilityMember" xlink:href="mlec-20250630.xsd#mlec_InventoriesTaxLiabilityMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="InventoriesTaxLiabilityMember" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RightOfUseLeasedAssetTaxLiabilityMember" xlink:href="mlec-20250630.xsd#mlec_RightOfUseLeasedAssetTaxLiabilityMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="RightOfUseLeasedAssetTaxLiabilityMember" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InflationTaxAdjustmentMember" xlink:href="mlec-20250630.xsd#mlec_InflationTaxAdjustmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="InflationTaxAdjustmentMember" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxLiabilityMember" xlink:href="mlec-20250630.xsd#mlec_DeferredTaxLiabilityMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="DeferredTaxLiabilityMember" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TaxationScheduleofDeferredTaxAssetsandLiabilitiesDetailsTable" xlink:to="TaxationScheduleofDeferredTaxAssetsandLiabilitiesDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxAssetsAbstract" xlink:href="mlec-20250630.xsd#mlec_DeferredTaxAssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TaxationScheduleofDeferredTaxAssetsandLiabilitiesDetailsLineItems" xlink:to="DeferredTaxAssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetDeferredTaxAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetDeferredTaxAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsAbstract" xlink:to="ifrs-full_NetDeferredTaxAssets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TaxationScheduleofDeferredTaxAssetsandLiabilitiesDetailsLineItems" xlink:to="ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetDeferredTaxLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetDeferredTaxLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="ifrs-full_NetDeferredTaxLiabilities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxLiabilityAsset" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxLiabilityAsset"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TaxationScheduleofDeferredTaxAssetsandLiabilitiesDetailsLineItems" xlink:to="ifrs-full_DeferredTaxLiabilityAsset" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfRollForwardOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfRollForwardOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="TaxationScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesDetailsTable" xlink:href="mlec-20250630.xsd#mlec_TaxationScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfRollForwardOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="TaxationScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TaxationScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesDetailsTable" xlink:to="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="CarryForwardOfTaxLossMember" xlink:href="mlec-20250630.xsd#mlec_CarryForwardOfTaxLossMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="CarryForwardOfTaxLossMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OthersFinancialAssetsMember" xlink:href="mlec-20250630.xsd#mlec_OthersFinancialAssetsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="OthersFinancialAssetsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TradeReceivableMember" xlink:href="mlec-20250630.xsd#mlec_TradeReceivableMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="TradeReceivableMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RoyaltiesMember" xlink:href="mlec-20250630.xsd#mlec_RoyaltiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="RoyaltiesMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AllowancesMember" xlink:href="mlec-20250630.xsd#mlec_AllowancesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="AllowancesMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GovernmentGrantsMember" xlink:href="mlec-20250630.xsd#mlec_GovernmentGrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="GovernmentGrantsMember" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OthersOneMember" xlink:href="mlec-20250630.xsd#mlec_OthersOneMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="OthersOneMember" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxAssetMember" xlink:href="mlec-20250630.xsd#mlec_DeferredTaxAssetMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="DeferredTaxAssetMember" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IntangiblesTaxLiabilityMember" xlink:href="mlec-20250630.xsd#mlec_IntangiblesTaxLiabilityMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="IntangiblesTaxLiabilityMember" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PropertyPlantAndEquipmentDepreciationMember" xlink:href="mlec-20250630.xsd#mlec_PropertyPlantAndEquipmentDepreciationMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="PropertyPlantAndEquipmentDepreciationMember" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InventoriesTaxLiabilityMember" xlink:href="mlec-20250630.xsd#mlec_InventoriesTaxLiabilityMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="InventoriesTaxLiabilityMember" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BiologicalAssetsMember" xlink:href="mlec-20250630.xsd#mlec_BiologicalAssetsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="BiologicalAssetsMember" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OthersFinancialAssetsOneMember" xlink:href="mlec-20250630.xsd#mlec_OthersFinancialAssetsOneMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="OthersFinancialAssetsOneMember" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RightOfUseLeasedAssetTaxLiabilityMember" xlink:href="mlec-20250630.xsd#mlec_RightOfUseLeasedAssetTaxLiabilityMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="RightOfUseLeasedAssetTaxLiabilityMember" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InflationTaxAdjustmentMember" xlink:href="mlec-20250630.xsd#mlec_InflationTaxAdjustmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="InflationTaxAdjustmentMember" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OthersTaxAssetsTwoMember" xlink:href="mlec-20250630.xsd#mlec_OthersTaxAssetsTwoMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="OthersTaxAssetsTwoMember" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxLiabilityMember" xlink:href="mlec-20250630.xsd#mlec_DeferredTaxLiabilityMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="DeferredTaxLiabilityMember" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OtherTaxAssetMember" xlink:href="mlec-20250630.xsd#mlec_OtherTaxAssetMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="OtherTaxAssetMember" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InventoryMember" xlink:href="mlec-20250630.xsd#mlec_InventoryMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="InventoryMember" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OtherLiabilitiesOneMember" xlink:href="mlec-20250630.xsd#mlec_OtherLiabilitiesOneMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="OtherLiabilitiesOneMember" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TaxationScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesDetailsTable" xlink:to="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetDeferredTaxAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetDeferredTaxAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_NetDeferredTaxAssets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetDeferredTaxAssets_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetDeferredTaxAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_NetDeferredTaxAssets_0" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofWeightedAverageTaxRateTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfWeightedAverageTaxRateAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfWeightedAverageTaxRateAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfWeightedAverageTaxRateAbstract" xlink:to="ifrs-full_ProfitLossFromDiscontinuedOperations" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TaxExpenseIncomeAtApplicableTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfWeightedAverageTaxRateAbstract" xlink:to="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="TaxEffectOfShareOfProfitOrLossOfSubsidiesJointVenturesAndAssociates" xlink:href="mlec-20250630.xsd#mlec_TaxEffectOfShareOfProfitOrLossOfSubsidiesJointVenturesAndAssociates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfWeightedAverageTaxRateAbstract" xlink:to="TaxEffectOfShareOfProfitOrLossOfSubsidiesJointVenturesAndAssociates" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="PuttableInstrumentsCharge" xlink:href="mlec-20250630.xsd#mlec_PuttableInstrumentsCharge"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfWeightedAverageTaxRateAbstract" xlink:to="PuttableInstrumentsCharge" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="TaxEffectOfStockOptionCharge" xlink:href="mlec-20250630.xsd#mlec_TaxEffectOfStockOptionCharge"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfWeightedAverageTaxRateAbstract" xlink:to="TaxEffectOfStockOptionCharge" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="DerecognitionOfDeferredTaxAssets" xlink:href="mlec-20250630.xsd#mlec_DerecognitionOfDeferredTaxAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfWeightedAverageTaxRateAbstract" xlink:to="DerecognitionOfDeferredTaxAssets" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MutualFundsAdjustment" xlink:href="mlec-20250630.xsd#mlec_MutualFundsAdjustment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfWeightedAverageTaxRateAbstract" xlink:to="MutualFundsAdjustment" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TaxEffectOfRevenuesExemptFromTaxationAndExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:href="mlec-20250630.xsd#mlec_TaxEffectOfRevenuesExemptFromTaxationAndExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfWeightedAverageTaxRateAbstract" xlink:to="TaxEffectOfRevenuesExemptFromTaxationAndExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ResultOfInflationEffectOnMonetaryItemsAndOtherFinanceResults" xlink:href="mlec-20250630.xsd#mlec_ResultOfInflationEffectOnMonetaryItemsAndOtherFinanceResults"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfWeightedAverageTaxRateAbstract" xlink:to="ResultOfInflationEffectOnMonetaryItemsAndOtherFinanceResults" order="8.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="TaxInflationAdjustment" xlink:href="mlec-20250630.xsd#mlec_TaxInflationAdjustment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfWeightedAverageTaxRateAbstract" xlink:to="TaxInflationAdjustment" order="9.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TaxEffectFromChangeInTaxRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TaxEffectFromChangeInTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfWeightedAverageTaxRateAbstract" xlink:to="ifrs-full_TaxEffectFromChangeInTaxRate" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfWeightedAverageTaxRateAbstract" xlink:to="ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" order="11.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfWeightedAverageTaxRateAbstract" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations" order="12.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofPrincipalStatutoryTaxesRatesandCurrentTaxTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentTaxExpenseIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxExpenseIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="ifrs-full_CurrentTaxExpenseIncome" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxExpenseIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxExpenseIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="ifrs-full_DeferredTaxExpenseIncome" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract"/>
    <loc xlink:type="locator" xlink:label="TaxationScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceDetailsTable" xlink:href="mlec-20250630.xsd#mlec_TaxationScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceDetailsTable"/>
    <loc xlink:type="locator" xlink:label="TaxationScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_TaxationScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract" xlink:to="TaxationScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="TaxJurisdictionAxis" xlink:href="mlec-20250630.xsd#mlec_TaxJurisdictionAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TaxationScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceDetailsTable" xlink:to="TaxJurisdictionAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TaxJurisdictionDomainDomain" xlink:href="mlec-20250630.xsd#mlec_TaxJurisdictionDomainDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TaxJurisdictionAxis" xlink:to="TaxJurisdictionDomainDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="LowOrNullTaxationJurisdictionsMember" xlink:href="mlec-20250630.xsd#mlec_LowOrNullTaxationJurisdictionsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TaxJurisdictionAxis" xlink:to="LowOrNullTaxationJurisdictionsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LossMakingEntitiesMember" xlink:href="mlec-20250630.xsd#mlec_LossMakingEntitiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TaxJurisdictionAxis" xlink:to="LossMakingEntitiesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ProfitMakingEntitiesMember" xlink:href="mlec-20250630.xsd#mlec_ProfitMakingEntitiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TaxJurisdictionAxis" xlink:to="ProfitMakingEntitiesMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TaxationScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceDetailsTable" xlink:to="TaxationScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AccountingProfit" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AccountingProfit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TaxationScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceDetailsLineItems" xlink:to="ifrs-full_AccountingProfit" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ApplicableTaxRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ApplicableTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TaxationScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceDetailsLineItems" xlink:to="ifrs-full_ApplicableTaxRate" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TaxExpenseIncomeAtApplicableTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TaxationScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceDetailsLineItems" xlink:to="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofEarningPerShareTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfEarningPerShareAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfEarningPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="EarningPerShareScheduleofEarningPerShareDetailsTable" xlink:href="mlec-20250630.xsd#mlec_EarningPerShareScheduleofEarningPerShareDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EarningsPerShareLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EarningsPerShareLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEarningPerShareAbstract" xlink:to="EarningPerShareScheduleofEarningPerShareDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningPerShareScheduleofEarningPerShareDetailsTable" xlink:to="ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="BioceresCropSolutionsCorpMember" xlink:href="mlec-20250630.xsd#mlec_BioceresCropSolutionsCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsAxis" xlink:to="BioceresCropSolutionsCorpMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningPerShareScheduleofEarningPerShareDetailsTable" xlink:to="ifrs-full_EarningsPerShareLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EarningsPerShareAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EarningsPerShareAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EarningsPerShareLineItems" xlink:to="ifrs-full_EarningsPerShareAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EarningsPerShareAbstract" xlink:to="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EarningsPerShareAbstract" xlink:to="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EarningsPerShareLineItems" xlink:to="ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract" xlink:to="ifrs-full_WeightedAverageShares" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustedWeightedAverageShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustedWeightedAverageShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract" xlink:to="ifrs-full_AdjustedWeightedAverageShares" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BasicEarningsLossPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BasicEarningsLossPerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EarningsPerShareLineItems" xlink:to="ifrs-full_BasicEarningsLossPerShare" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DilutedEarningsLossPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DilutedEarningsLossPerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EarningsPerShareLineItems" xlink:to="ifrs-full_DilutedEarningsLossPerShare" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofNumberofSharesIssuedTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfNumberOfSharesIssuedAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfNumberOfSharesIssuedAbstract"/>
    <loc xlink:type="locator" xlink:label="InformationaboutComponentsofEquityScheduleofNumberofSharesIssuedDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationaboutComponentsofEquityScheduleofNumberofSharesIssuedDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfNumberOfSharesIssuedLineItems" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfNumberOfSharesIssuedLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfNumberOfSharesIssuedAbstract" xlink:to="InformationaboutComponentsofEquityScheduleofNumberofSharesIssuedDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofNumberofSharesIssuedDetailsTable" xlink:to="ifrs-full_ClassesOfShareCapitalAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OrdinarySharesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OrdinarySharesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_OrdinarySharesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofNumberofSharesIssuedDetailsTable" xlink:to="ScheduleOfNumberOfSharesIssuedLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfNumberOfSharesIssuedLineItems" xlink:to="ifrs-full_NumberOfSharesIssued" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfNominalValue" xlink:href="mlec-20250630.xsd#mlec_NumberOfNominalValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfNumberOfSharesIssuedLineItems" xlink:to="NumberOfNominalValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SubscribedCapitalOfShares" xlink:href="mlec-20250630.xsd#mlec_SubscribedCapitalOfShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfNumberOfSharesIssuedLineItems" xlink:to="SubscribedCapitalOfShares" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SubscribedCapital" xlink:href="mlec-20250630.xsd#mlec_SubscribedCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfNumberOfSharesIssuedLineItems" xlink:to="SubscribedCapital" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofSubsidiariesNonControllingInterestTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfSubsidiariesNonControllingInterestAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfSubsidiariesNonControllingInterestAbstract"/>
    <loc xlink:type="locator" xlink:label="InformationaboutComponentsofEquityScheduleofSubsidiariesNonControllingInterestDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationaboutComponentsofEquityScheduleofSubsidiariesNonControllingInterestDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfSubsidiariesNonControllingInterestAbstract" xlink:to="InformationaboutComponentsofEquityScheduleofSubsidiariesNonControllingInterestDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofSubsidiariesNonControllingInterestDetailsTable" xlink:to="ifrs-full_SegmentsAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofSubsidiariesNonControllingInterestDetailsTable" xlink:to="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_ProportionOfOwnershipInterestInSubsidiary" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfFinancialStatementsAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfFinancialStatementsAbstract"/>
    <loc xlink:type="locator" xlink:label="InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFinancialStatementsAbstract" xlink:to="InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsTable" xlink:to="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="BioceresSAMember" xlink:href="mlec-20250630.xsd#mlec_BioceresSAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:to="BioceresSAMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsTable" xlink:to="InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="ifrs-full_CurrentAssets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NoncurrentAsset" xlink:href="mlec-20250630.xsd#mlec_NoncurrentAsset"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="NoncurrentAsset" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Assets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Assets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="ifrs-full_Assets" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="ifrs-full_CurrentLiabilities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="ifrs-full_NoncurrentLiabilities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Liabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Liabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="ifrs-full_Liabilities" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="ifrs-full_Equity" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityAndLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAndLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="ifrs-full_EquityAndLiabilities" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Revenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Revenue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="ifrs-full_Revenue" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromGovernmentGrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromGovernmentGrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="ifrs-full_RevenueFromGovernmentGrants" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GrossProfit" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossProfit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="ifrs-full_GrossProfit" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="ifrs-full_ResearchAndDevelopmentExpense" order="11.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="ifrs-full_SellingGeneralAndAdministrativeExpense" order="12.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareOfProfitOrLossOfSubsidiaries" xlink:href="mlec-20250630.xsd#mlec_ShareOfProfitOrLossOfSubsidiaries"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="ShareOfProfitOrLossOfSubsidiaries" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherOperatingIncomeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherOperatingIncomeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="ifrs-full_OtherOperatingIncomeExpense" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossFromOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="ifrs-full_ProfitLossFromOperatingActivities" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinanceIncomeCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceIncomeCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="ifrs-full_FinanceIncomeCost" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossBeforeTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="ifrs-full_ProfitLossBeforeTax" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations" order="19.0" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="ifrs-full_ProfitLoss" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems" xlink:to="ifrs-full_ComprehensiveIncome" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfBioceresSaAndBioceresCropSolutionsAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfBioceresSaAndBioceresCropSolutionsAbstract"/>
    <loc xlink:type="locator" xlink:label="InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBioceresSaAndBioceresCropSolutionsAbstract" xlink:to="InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsTable" xlink:to="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="BioceresCropSolutionsMember" xlink:href="mlec-20250630.xsd#mlec_BioceresCropSolutionsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:to="BioceresCropSolutionsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsTable" xlink:to="InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="ifrs-full_CurrentAssets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="ifrs-full_NoncurrentAssets" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Assets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Assets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="ifrs-full_Assets" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="ifrs-full_CurrentLiabilities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="ifrs-full_NoncurrentLiabilities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Liabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Liabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="ifrs-full_Liabilities" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="ifrs-full_Equity" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityAndLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAndLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="ifrs-full_EquityAndLiabilities" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Revenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Revenue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="ifrs-full_Revenue" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CostOfSales" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CostOfSales"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="ifrs-full_CostOfSales" order="10.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <loc xlink:type="locator" xlink:label="ChangeInNetRealizableValueOfAgricultural" xlink:href="mlec-20250630.xsd#mlec_ChangeInNetRealizableValueOfAgricultural"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="ChangeInNetRealizableValueOfAgricultural" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="ifrs-full_ResearchAndDevelopmentExpense" order="12.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="ifrs-full_SellingGeneralAndAdministrativeExpense" order="13.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherOperatingIncomeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherOperatingIncomeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="ifrs-full_OtherOperatingIncomeExpense" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossFromOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="ifrs-full_ProfitLossFromOperatingActivities" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinanceIncomeCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceIncomeCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="ifrs-full_FinanceIncomeCost" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossBeforeTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="ifrs-full_ProfitLossBeforeTax" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations" order="19.0" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="ifrs-full_ProfitLoss" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RevaluationOfPropertyPlantAndEquipmentNetOfTax" xlink:href="mlec-20250630.xsd#mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="RevaluationOfPropertyPlantAndEquipmentNetOfTax" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems" xlink:to="ifrs-full_ComprehensiveIncome" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivitiesAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsTable" xlink:href="mlec-20250630.xsd#mlec_CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivitiesAbstract" xlink:to="CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="BioceresCropSolutionsCorpMember" xlink:href="mlec-20250630.xsd#mlec_BioceresCropSolutionsCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="BioceresCropSolutionsCorpMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsTable" xlink:to="CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsLineItems" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="NetAssetsAcquisitionByBusinessCombination" xlink:href="mlec-20250630.xsd#mlec_NetAssetsAcquisitionByBusinessCombination"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="NetAssetsAcquisitionByBusinessCombination" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="InvestmentInKindInOtherRelatedPartiesNonCashTransactionsInvestmentActivities" xlink:href="mlec-20250630.xsd#mlec_InvestmentInKindInOtherRelatedPartiesNonCashTransactionsInvestmentActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="InvestmentInKindInOtherRelatedPartiesNonCashTransactionsInvestmentActivities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IssuanceOfShare" xlink:href="mlec-20250630.xsd#mlec_IssuanceOfShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="IssuanceOfShare" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OwnShareHeld" xlink:href="mlec-20250630.xsd#mlec_OwnShareHeld"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="OwnShareHeld" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ExchangeOfIntangibleAssets" xlink:href="mlec-20250630.xsd#mlec_ExchangeOfIntangibleAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ExchangeOfIntangibleAssets" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestCostsCapitalised" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestCostsCapitalised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_InterestCostsCapitalised" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RightofuseLeasedAssetAdditionsThroughAnIncreaseInLeaseLiabilities" xlink:href="mlec-20250630.xsd#mlec_RightofuseLeasedAssetAdditionsThroughAnIncreaseInLeaseLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="RightofuseLeasedAssetAdditionsThroughAnIncreaseInLeaseLiabilities" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="NonMonetaryContributionsInJointVenturesNonCashTransactionsInvestmentActivities" xlink:href="mlec-20250630.xsd#mlec_NonMonetaryContributionsInJointVenturesNonCashTransactionsInvestmentActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="NonMonetaryContributionsInJointVenturesNonCashTransactionsInvestmentActivities" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod" order="8.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="NonCashInvestingActivities" xlink:href="mlec-20250630.xsd#mlec_NonCashInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="NonCashInvestingActivities" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsLineItems" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="CapitalizationOfConvertibleFinancingActivities" xlink:href="mlec-20250630.xsd#mlec_CapitalizationOfConvertibleFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="CapitalizationOfConvertibleFinancingActivities" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="AssignmentOfReceivablesWithShareholdersAndOtherRelatedParties" xlink:href="mlec-20250630.xsd#mlec_AssignmentOfReceivablesWithShareholdersAndOtherRelatedParties"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="AssignmentOfReceivablesWithShareholdersAndOtherRelatedParties" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="CompensationPaymentFinancedByAcquisitionOfIntangibleAssets" xlink:href="mlec-20250630.xsd#mlec_CompensationPaymentFinancedByAcquisitionOfIntangibleAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="CompensationPaymentFinancedByAcquisitionOfIntangibleAssets" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="IncreaseThroughAcquisitionOfNonControllingInterestInSubsidiaries" xlink:href="mlec-20250630.xsd#mlec_IncreaseThroughAcquisitionOfNonControllingInterestInSubsidiaries"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="IncreaseThroughAcquisitionOfNonControllingInterestInSubsidiaries" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="NonCashFinancingActivities" xlink:href="mlec-20250630.xsd#mlec_NonCashFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="NonCashFinancingActivities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="CashFlowInformationScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesDetailsTable" xlink:href="mlec-20250630.xsd#mlec_CashFlowInformationScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesAbstract" xlink:to="CashFlowInformationScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowInformationScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesDetailsTable" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="BorrowingMember" xlink:href="mlec-20250630.xsd#mlec_BorrowingMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:to="BorrowingMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FinancedPaymentAcquisitionOfBusinessMember" xlink:href="mlec-20250630.xsd#mlec_FinancedPaymentAcquisitionOfBusinessMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:to="FinancedPaymentAcquisitionOfBusinessMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IfrsConvertibleNotesPayableMember" xlink:href="mlec-20250630.xsd#mlec_IfrsConvertibleNotesPayableMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:to="IfrsConvertibleNotesPayableMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashFlowInformationScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesDetailsTable" xlink:to="ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities" xlink:href="mlec-20250630.xsd#mlec_IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:to="IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FinancingForAssetsAcquisitions" xlink:href="mlec-20250630.xsd#mlec_FinancingForAssetsAcquisitions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities" xlink:to="FinancingForAssetsAcquisitions" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PrepaymentPremiumFee" xlink:href="mlec-20250630.xsd#mlec_PrepaymentPremiumFee"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities" xlink:to="PrepaymentPremiumFee" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="NoncashActivities" xlink:href="mlec-20250630.xsd#mlec_NoncashActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities" xlink:to="NoncashActivities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities" xlink:to="ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="DecreaseBecauseOfLossOfControl" xlink:href="mlec-20250630.xsd#mlec_DecreaseBecauseOfLossOfControl"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities" xlink:to="DecreaseBecauseOfLossOfControl" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities" xlink:href="mlec-20250630.xsd#mlec_DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:to="DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="DecreaseThroughCapitalizationOfDebtLiabilitiesArisingFromFinancingActivities" xlink:href="mlec-20250630.xsd#mlec_DecreaseThroughCapitalizationOfDebtLiabilitiesArisingFromFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:to="DecreaseThroughCapitalizationOfDebtLiabilitiesArisingFromFinancingActivities" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:to="ifrs-full_InterestPaidClassifiedAsFinancingActivities" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:to="ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivities_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesLineItems" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivities_0" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofJointVenturesAssetsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfJointVenturesAssetsAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfJointVenturesAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="JointVenturesandAssociatesScheduleofJointVenturesAssetsDetailsTable" xlink:href="mlec-20250630.xsd#mlec_JointVenturesandAssociatesScheduleofJointVenturesAssetsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="JointVenturesandAssociatesScheduleofJointVenturesAssetsDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_JointVenturesandAssociatesScheduleofJointVenturesAssetsDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfJointVenturesAssetsAbstract" xlink:to="JointVenturesandAssociatesScheduleofJointVenturesAssetsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_JointVenturesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_JointVenturesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="JointVenturesandAssociatesScheduleofJointVenturesAssetsDetailsTable" xlink:to="ifrs-full_JointVenturesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_JointVenturesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_JointVenturesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_JointVenturesAxis" xlink:to="ifrs-full_JointVenturesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="SynertechIndustriasSAMember" xlink:href="mlec-20250630.xsd#mlec_SynertechIndustriasSAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_JointVenturesAxis" xlink:to="SynertechIndustriasSAMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BioceresCropSolutionsCorpMember" xlink:href="mlec-20250630.xsd#mlec_BioceresCropSolutionsCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_JointVenturesAxis" xlink:to="BioceresCropSolutionsCorpMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="AgralityArgentinaSAMember" xlink:href="mlec-20250630.xsd#mlec_AgralityArgentinaSAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_JointVenturesAxis" xlink:to="AgralityArgentinaSAMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AgralityUSIncMember" xlink:href="mlec-20250630.xsd#mlec_AgralityUSIncMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_JointVenturesAxis" xlink:to="AgralityUSIncMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AgralitySeedsIncMember" xlink:href="mlec-20250630.xsd#mlec_AgralitySeedsIncMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_JointVenturesAxis" xlink:to="AgralitySeedsIncMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SWSemillasSAMember" xlink:href="mlec-20250630.xsd#mlec_SWSemillasSAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_JointVenturesAxis" xlink:to="SWSemillasSAMember" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AlfalfaTechnologiesSRlMember" xlink:href="mlec-20250630.xsd#mlec_AlfalfaTechnologiesSRlMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_JointVenturesAxis" xlink:to="AlfalfaTechnologiesSRlMember" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InmetSAMember" xlink:href="mlec-20250630.xsd#mlec_InmetSAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_JointVenturesAxis" xlink:to="InmetSAMember" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TheoISCSpMember" xlink:href="mlec-20250630.xsd#mlec_TheoISCSpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_JointVenturesAxis" xlink:to="TheoISCSpMember" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TrigallGeneticsSAMember" xlink:href="mlec-20250630.xsd#mlec_TrigallGeneticsSAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_JointVenturesAxis" xlink:to="TrigallGeneticsSAMember" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="JointVenturesandAssociatesScheduleofJointVenturesAssetsDetailsTable" xlink:to="JointVenturesandAssociatesScheduleofJointVenturesAssetsDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="MeasuredAtEquityValueMethodAbstract" xlink:href="mlec-20250630.xsd#mlec_MeasuredAtEquityValueMethodAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="JointVenturesandAssociatesScheduleofJointVenturesAssetsDetailsLineItems" xlink:to="MeasuredAtEquityValueMethodAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MeasuredAtEquityValueMethodAbstract" xlink:to="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MeasuredAtFairValueAbstract" xlink:href="mlec-20250630.xsd#mlec_MeasuredAtFairValueAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="JointVenturesandAssociatesScheduleofJointVenturesAssetsDetailsLineItems" xlink:to="MeasuredAtFairValueAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InvestmentsMeasuredAtFairValue" xlink:href="mlec-20250630.xsd#mlec_InvestmentsMeasuredAtFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MeasuredAtFairValueAbstract" xlink:to="InvestmentsMeasuredAtFairValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MeasuredAtEquityValueMethodAbstract0" xlink:href="mlec-20250630.xsd#mlec_MeasuredAtEquityValueMethodAbstract0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="JointVenturesandAssociatesScheduleofJointVenturesAssetsDetailsLineItems" xlink:to="MeasuredAtEquityValueMethodAbstract0" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DueToJointVenturesAndAssociatesNonCurrent" xlink:href="mlec-20250630.xsd#mlec_DueToJointVenturesAndAssociatesNonCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MeasuredAtEquityValueMethodAbstract0" xlink:to="DueToJointVenturesAndAssociatesNonCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofChangesinJointVenturesInvestmentsandAffiliatesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfChangesInJointVenturesInvestmentsAndAffiliatesAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfChangesInJointVenturesInvestmentsAndAffiliatesAbstract"/>
    <loc xlink:type="locator" xlink:label="JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsTable" xlink:href="mlec-20250630.xsd#mlec_JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfChangesInJointVenturesInvestmentsAndAffiliatesAbstract" xlink:to="JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="JointVenturesInvestmentsAndAffiliatesMember" xlink:href="mlec-20250630.xsd#mlec_JointVenturesInvestmentsAndAffiliatesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="JointVenturesInvestmentsAndAffiliatesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsTable" xlink:to="JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity" xlink:href="mlec-20250630.xsd#mlec_InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsLineItems" xlink:to="InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LossesOnDisposalsOfInvestments" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LossesOnDisposalsOfInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsLineItems" xlink:to="ifrs-full_LossesOnDisposalsOfInvestments" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ChangesInEquityInterest" xlink:href="mlec-20250630.xsd#mlec_ChangesInEquityInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsLineItems" xlink:to="ChangesInEquityInterest" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SaleOfEquityInvestment" xlink:href="mlec-20250630.xsd#mlec_SaleOfEquityInvestment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsLineItems" xlink:to="SaleOfEquityInvestment" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="JointVenturesAndAssociatesAccountedForUsingEquityMethodReclassificationChangeInOwnership" xlink:href="mlec-20250630.xsd#mlec_JointVenturesAndAssociatesAccountedForUsingEquityMethodReclassificationChangeInOwnership"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsLineItems" xlink:to="JointVenturesAndAssociatesAccountedForUsingEquityMethodReclassificationChangeInOwnership" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="EquityMethodInvestmentIncreaseFromShareBasedIncentives" xlink:href="mlec-20250630.xsd#mlec_EquityMethodInvestmentIncreaseFromShareBasedIncentives"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsLineItems" xlink:to="EquityMethodInvestmentIncreaseFromShareBasedIncentives" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ChangeinJointVenturesDividendsDistribution" xlink:href="mlec-20250630.xsd#mlec_ChangeinJointVenturesDividendsDistribution"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsLineItems" xlink:to="ChangeinJointVenturesDividendsDistribution" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GainsLossesOnExchangeDifferencesOnTranslationFromJointVentureNetOfTax" xlink:href="mlec-20250630.xsd#mlec_GainsLossesOnExchangeDifferencesOnTranslationFromJointVentureNetOfTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsLineItems" xlink:to="GainsLossesOnExchangeDifferencesOnTranslationFromJointVentureNetOfTax" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsLineItems" xlink:to="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareOfProfitOrLossMeasuredAtFairValue" xlink:href="mlec-20250630.xsd#mlec_ShareOfProfitOrLossMeasuredAtFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsLineItems" xlink:to="ShareOfProfitOrLossMeasuredAtFairValue" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity_0" xlink:href="mlec-20250630.xsd#mlec_InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsLineItems" xlink:to="InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity_0" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofShareofProfitorLossofJointVenturesandAffiliatesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfJointVenturesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfJointVenturesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfJointVenturesTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfJointVenturesTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfJointVenturesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfJointVenturesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfJointVenturesAbstract" xlink:to="ifrs-full_DisclosureOfJointVenturesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_JointVenturesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_JointVenturesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfJointVenturesTable" xlink:to="ifrs-full_JointVenturesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_JointVenturesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_JointVenturesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_JointVenturesAxis" xlink:to="ifrs-full_JointVenturesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="SynertechIndustriasSAMember" xlink:href="mlec-20250630.xsd#mlec_SynertechIndustriasSAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_JointVenturesAxis" xlink:to="SynertechIndustriasSAMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AgralityArgentinaSAMember" xlink:href="mlec-20250630.xsd#mlec_AgralityArgentinaSAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_JointVenturesAxis" xlink:to="AgralityArgentinaSAMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AgralityUSIncMember" xlink:href="mlec-20250630.xsd#mlec_AgralityUSIncMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_JointVenturesAxis" xlink:to="AgralityUSIncMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AgralitySeedsIncMember" xlink:href="mlec-20250630.xsd#mlec_AgralitySeedsIncMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_JointVenturesAxis" xlink:to="AgralitySeedsIncMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IndrasaBiotecnologaSAMember" xlink:href="mlec-20250630.xsd#mlec_IndrasaBiotecnologaSAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_JointVenturesAxis" xlink:to="IndrasaBiotecnologaSAMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MoolecScienceSAMember" xlink:href="mlec-20250630.xsd#mlec_MoolecScienceSAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_JointVenturesAxis" xlink:to="MoolecScienceSAMember" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SWSemillasSAMember" xlink:href="mlec-20250630.xsd#mlec_SWSemillasSAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_JointVenturesAxis" xlink:to="SWSemillasSAMember" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TrigallGeneticsSAMember" xlink:href="mlec-20250630.xsd#mlec_TrigallGeneticsSAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_JointVenturesAxis" xlink:to="TrigallGeneticsSAMember" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InmetSAMember" xlink:href="mlec-20250630.xsd#mlec_InmetSAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_JointVenturesAxis" xlink:to="InmetSAMember" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="TheoISCSpMember" xlink:href="mlec-20250630.xsd#mlec_TheoISCSpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_JointVenturesAxis" xlink:to="TheoISCSpMember" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfJointVenturesTable" xlink:to="ifrs-full_DisclosureOfJointVenturesLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="MeasuredAtEquityValueMethodAbstract1" xlink:href="mlec-20250630.xsd#mlec_MeasuredAtEquityValueMethodAbstract1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfJointVenturesLineItems" xlink:to="MeasuredAtEquityValueMethodAbstract1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MeasuredAtEquityValueMethodAbstract1" xlink:to="ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MeasuredAtFairValueAbstract0" xlink:href="mlec-20250630.xsd#mlec_MeasuredAtFairValueAbstract0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfJointVenturesLineItems" xlink:to="MeasuredAtFairValueAbstract0" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareOfProfitOrLossMeasuredAtFairValue" xlink:href="mlec-20250630.xsd#mlec_ShareOfProfitOrLossMeasuredAtFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="MeasuredAtFairValueAbstract0" xlink:to="ShareOfProfitOrLossMeasuredAtFairValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofSignificantJointVenturesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfSignificantJointVenturesAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfSignificantJointVenturesAbstract"/>
    <loc xlink:type="locator" xlink:label="JointVenturesandAssociatesScheduleofSignificantJointVenturesDetailsTable" xlink:href="mlec-20250630.xsd#mlec_JointVenturesandAssociatesScheduleofSignificantJointVenturesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfJointVenturesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfJointVenturesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfSignificantJointVenturesAbstract" xlink:to="JointVenturesandAssociatesScheduleofSignificantJointVenturesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="JointVenturesandAssociatesScheduleofSignificantJointVenturesDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="SynertechIndustriasSAMember" xlink:href="mlec-20250630.xsd#mlec_SynertechIndustriasSAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="SynertechIndustriasSAMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AgralitySAMember" xlink:href="mlec-20250630.xsd#mlec_AgralitySAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="AgralitySAMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TheoISCSpMember" xlink:href="mlec-20250630.xsd#mlec_TheoISCSpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="TheoISCSpMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="JointVenturesandAssociatesScheduleofSignificantJointVenturesDetailsTable" xlink:to="ifrs-full_DisclosureOfJointVenturesLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfJointVenturesLineItems" xlink:to="ifrs-full_CurrentAssets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfJointVenturesLineItems" xlink:to="ifrs-full_NoncurrentAssets" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfJointVenturesLineItems" xlink:to="ifrs-full_CurrentLiabilities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfJointVenturesLineItems" xlink:to="ifrs-full_NoncurrentLiabilities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfJointVenturesLineItems" xlink:to="ifrs-full_Equity" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CostOfSales" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CostOfSales"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfJointVenturesLineItems" xlink:to="ifrs-full_CostOfSales" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfJointVenturesLineItems" xlink:to="ifrs-full_ProfitLoss" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofOperatingResultsGroupsReportingSegmentsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfOperatingResultsGroupsReportingSegmentsAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfOperatingResultsGroupsReportingSegmentsAbstract"/>
    <loc xlink:type="locator" xlink:label="SegmentInformationScheduleofOperatingResultsGroupsReportingSegmentsDetailsTable" xlink:href="mlec-20250630.xsd#mlec_SegmentInformationScheduleofOperatingResultsGroupsReportingSegmentsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOperatingResultsGroupsReportingSegmentsAbstract" xlink:to="SegmentInformationScheduleofOperatingResultsGroupsReportingSegmentsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentInformationScheduleofOperatingResultsGroupsReportingSegmentsDetailsTable" xlink:to="ifrs-full_SegmentsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="SeedAndIntegratedProductsMember" xlink:href="mlec-20250630.xsd#mlec_SeedAndIntegratedProductsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SegmentsAxis" xlink:to="SeedAndIntegratedProductsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CropProtectionMember" xlink:href="mlec-20250630.xsd#mlec_CropProtectionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SegmentsAxis" xlink:to="CropProtectionMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CropNutritionMember" xlink:href="mlec-20250630.xsd#mlec_CropNutritionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SegmentsAxis" xlink:to="CropNutritionMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="EmergingSolutionsMember" xlink:href="mlec-20250630.xsd#mlec_EmergingSolutionsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SegmentsAxis" xlink:to="EmergingSolutionsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConsolidatedEntitieMember" xlink:href="mlec-20250630.xsd#mlec_ConsolidatedEntitieMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ConsolidatedEntitieMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentInformationScheduleofOperatingResultsGroupsReportingSegmentsDetailsTable" xlink:to="ifrs-full_DisclosureOfOperatingSegmentsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="RevenuesFromContractsWithCustomersAbstract" xlink:href="mlec-20250630.xsd#mlec_RevenuesFromContractsWithCustomersAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:to="RevenuesFromContractsWithCustomersAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RevenueFromSaleOfGoodsAndRenderingOfServices" xlink:href="mlec-20250630.xsd#mlec_RevenueFromSaleOfGoodsAndRenderingOfServices"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenuesFromContractsWithCustomersAbstract" xlink:to="RevenueFromSaleOfGoodsAndRenderingOfServices" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromRoyalties" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromRoyalties"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenuesFromContractsWithCustomersAbstract" xlink:to="ifrs-full_RevenueFromRoyalties" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LicenceFeeIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LicenceFeeIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenuesFromContractsWithCustomersAbstract" xlink:to="ifrs-full_LicenceFeeIncome" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OthersAbstract" xlink:href="mlec-20250630.xsd#mlec_OthersAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:to="OthersAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OthersAbstract" xlink:to="ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromGovernmentGrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromGovernmentGrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OthersAbstract" xlink:to="ifrs-full_RevenueFromGovernmentGrants" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Revenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Revenue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OthersAbstract" xlink:to="ifrs-full_Revenue" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CostOfSales" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CostOfSales"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:to="ifrs-full_CostOfSales" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GrossProfit" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossProfit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:to="ifrs-full_GrossProfit" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageGrossMargin" xlink:href="mlec-20250630.xsd#mlec_PercentageGrossMargin"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:to="PercentageGrossMargin" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofRevenuebySimilarGroupofProductsorServicesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfRevenueBySimilarGroupOfProductsOrServicesAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfRevenueBySimilarGroupOfProductsOrServicesAbstract"/>
    <loc xlink:type="locator" xlink:label="SegmentInformationScheduleofRevenuebySimilarGroupofProductsorServicesDetailsTable" xlink:href="mlec-20250630.xsd#mlec_SegmentInformationScheduleofRevenuebySimilarGroupofProductsorServicesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfProductsAndServicesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfProductsAndServicesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfRevenueBySimilarGroupOfProductsOrServicesAbstract" xlink:to="SegmentInformationScheduleofRevenuebySimilarGroupofProductsorServicesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ConsolidatedStructuredEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentInformationScheduleofRevenuebySimilarGroupofProductsorServicesDetailsTable" xlink:to="ifrs-full_ConsolidatedStructuredEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="BioceresCropSolutionsCorpMember" xlink:href="mlec-20250630.xsd#mlec_BioceresCropSolutionsCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:to="BioceresCropSolutionsCorpMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentInformationScheduleofRevenuebySimilarGroupofProductsorServicesDetailsTable" xlink:to="ifrs-full_SegmentsAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="SeedAndIntegratedProductsMember" xlink:href="mlec-20250630.xsd#mlec_SeedAndIntegratedProductsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SegmentsAxis" xlink:to="SeedAndIntegratedProductsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CropProtectionMember" xlink:href="mlec-20250630.xsd#mlec_CropProtectionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SegmentsAxis" xlink:to="CropProtectionMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CropNutritionMember" xlink:href="mlec-20250630.xsd#mlec_CropNutritionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SegmentsAxis" xlink:to="CropNutritionMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="EmergingSolutionsMember" xlink:href="mlec-20250630.xsd#mlec_EmergingSolutionsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SegmentsAxis" xlink:to="EmergingSolutionsMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProductsAndServicesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProductsAndServicesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentInformationScheduleofRevenuebySimilarGroupofProductsorServicesDetailsTable" xlink:to="ifrs-full_ProductsAndServicesAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProductsAndServicesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProductsAndServicesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="ifrs-full_ProductsAndServicesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="SeedTreatmentsPacksMember" xlink:href="mlec-20250630.xsd#mlec_SeedTreatmentsPacksMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="SeedTreatmentsPacksMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SeedRoyaltiesPaymentsHB4ProgramMember" xlink:href="mlec-20250630.xsd#mlec_SeedRoyaltiesPaymentsHB4ProgramMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="SeedRoyaltiesPaymentsHB4ProgramMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AdjuvantsMember" xlink:href="mlec-20250630.xsd#mlec_AdjuvantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="AdjuvantsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SeedCpProductsAndServicesMember" xlink:href="mlec-20250630.xsd#mlec_SeedCpProductsAndServicesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="SeedCpProductsAndServicesMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OtherCpProductsAndServicesMember" xlink:href="mlec-20250630.xsd#mlec_OtherCpProductsAndServicesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="OtherCpProductsAndServicesMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BioprotectionMember" xlink:href="mlec-20250630.xsd#mlec_BioprotectionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="BioprotectionMember" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InoculantsBiofertilizersMember" xlink:href="mlec-20250630.xsd#mlec_InoculantsBiofertilizersMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="InoculantsBiofertilizersMember" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MicroBeadedFertilizersMember" xlink:href="mlec-20250630.xsd#mlec_MicroBeadedFertilizersMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="MicroBeadedFertilizersMember" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BiostimulantsMember" xlink:href="mlec-20250630.xsd#mlec_BiostimulantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="BiostimulantsMember" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SyngentaUpfrontFeeMember" xlink:href="mlec-20250630.xsd#mlec_SyngentaUpfrontFeeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="SyngentaUpfrontFeeMember" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ManagementExpensesMember" xlink:href="mlec-20250630.xsd#mlec_ManagementExpensesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="ManagementExpensesMember" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GovernmentGrantsMember" xlink:href="mlec-20250630.xsd#mlec_GovernmentGrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="GovernmentGrantsMember" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentInformationScheduleofRevenuebySimilarGroupofProductsorServicesDetailsTable" xlink:to="ifrs-full_DisclosureOfProductsAndServicesLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueFromContractsWithCustomers" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromContractsWithCustomers"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfProductsAndServicesLineItems" xlink:to="ifrs-full_RevenueFromContractsWithCustomers" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofGeographicalInformationTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfGeographicalInformationAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfGeographicalInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="SegmentInformationScheduleofGeographicalInformationDetailsTable" xlink:href="mlec-20250630.xsd#mlec_SegmentInformationScheduleofGeographicalInformationDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfGeographicalInformationLineItems" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfGeographicalInformationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfGeographicalInformationAbstract" xlink:to="SegmentInformationScheduleofGeographicalInformationDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ConsolidatedStructuredEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentInformationScheduleofGeographicalInformationDetailsTable" xlink:to="ifrs-full_ConsolidatedStructuredEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="BioceresCropSolutionsCorpMember" xlink:href="mlec-20250630.xsd#mlec_BioceresCropSolutionsCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:to="BioceresCropSolutionsCorpMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeographicalAreasAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentInformationScheduleofGeographicalInformationDetailsTable" xlink:to="ifrs-full_GeographicalAreasAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeographicalAreasDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="ifrs-full_GeographicalAreasDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="country_AR" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_AR"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="country_AR" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="country_BR" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_BR"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="country_BR" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_LatinAmericaMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_LatinAmericaMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="srt_LatinAmericaMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_NorthAmericaMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_NorthAmericaMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="srt_NorthAmericaMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="EuropeMiddleEastAndAfricaMember" xlink:href="mlec-20250630.xsd#mlec_EuropeMiddleEastAndAfricaMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="EuropeMiddleEastAndAfricaMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OtherRegionsOrCountriesMember" xlink:href="mlec-20250630.xsd#mlec_OtherRegionsOrCountriesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="OtherRegionsOrCountriesMember" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SegmentInformationScheduleofGeographicalInformationDetailsTable" xlink:to="ScheduleOfGeographicalInformationLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Revenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Revenue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfGeographicalInformationLineItems" xlink:to="ifrs-full_Revenue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="NonCurrentAssetsAbstract" xlink:href="mlec-20250630.xsd#mlec_NonCurrentAssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfGeographicalInformationLineItems" xlink:to="NonCurrentAssetsAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentAssetsAbstract" xlink:to="ifrs-full_NoncurrentAssets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfGeographicalInformationLineItems" xlink:to="ifrs-full_PropertyPlantAndEquipment" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfGeographicalInformationLineItems" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Goodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Goodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfGeographicalInformationLineItems" xlink:to="ifrs-full_Goodwill" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TotalReportableAssets" xlink:href="mlec-20250630.xsd#mlec_TotalReportableAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfGeographicalInformationLineItems" xlink:to="TotalReportableAssets" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TotalNonreportableAssets" xlink:href="mlec-20250630.xsd#mlec_TotalNonreportableAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfGeographicalInformationLineItems" xlink:to="TotalNonreportableAssets" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Assets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Assets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfGeographicalInformationLineItems" xlink:to="ifrs-full_Assets" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofLiquidityRiskTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfLiquidityRiskAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfLiquidityRiskAbstract"/>
    <loc xlink:type="locator" xlink:label="FinancialInstrumentsRiskManagementScheduleofLiquidityRiskDetailsTable" xlink:href="mlec-20250630.xsd#mlec_FinancialInstrumentsRiskManagementScheduleofLiquidityRiskDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfLiquidityRiskAbstract" xlink:to="FinancialInstrumentsRiskManagementScheduleofLiquidityRiskDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialInstrumentsRiskManagementScheduleofLiquidityRiskDetailsTable" xlink:to="ifrs-full_ClassesOfFinancialLiabilitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:to="ifrs-full_ClassesOfFinancialLiabilitiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="TradeAndOtherPayablesMember" xlink:href="mlec-20250630.xsd#mlec_TradeAndOtherPayablesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:to="TradeAndOtherPayablesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BorrowingMember" xlink:href="mlec-20250630.xsd#mlec_BorrowingMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:to="BorrowingMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IfrsConvertibleNotesPayableMember" xlink:href="mlec-20250630.xsd#mlec_IfrsConvertibleNotesPayableMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:to="IfrsConvertibleNotesPayableMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LeaseLiabilitiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseLiabilitiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:to="ifrs-full_LeaseLiabilitiesMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConsiderationForAcquisitionOfAssetsMember" xlink:href="mlec-20250630.xsd#mlec_ConsiderationForAcquisitionOfAssetsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:to="ConsiderationForAcquisitionOfAssetsMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfRisksAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfRisksAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialInstrumentsRiskManagementScheduleofLiquidityRiskDetailsTable" xlink:to="ifrs-full_TypesOfRisksAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiquidityRiskMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LiquidityRiskMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfRisksAxis" xlink:to="ifrs-full_LiquidityRiskMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MaturityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialInstrumentsRiskManagementScheduleofLiquidityRiskDetailsTable" xlink:to="ifrs-full_MaturityAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NotLaterThanThreeMonthsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NotLaterThanThreeMonthsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_NotLaterThanThreeMonthsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LaterThanThreeMonthsAndNotLaterThanOneYearMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanThreeMonthsAndNotLaterThanOneYearMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_LaterThanThreeMonthsAndNotLaterThanOneYearMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialInstrumentsRiskManagementScheduleofLiquidityRiskDetailsTable" xlink:to="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherPayables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:to="ifrs-full_TradeAndOtherPayables" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Borrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Borrowings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:to="ifrs-full_Borrowings" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConsiderationForAcquisitionOfAssets" xlink:href="mlec-20250630.xsd#mlec_ConsiderationForAcquisitionOfAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:to="ConsiderationForAcquisitionOfAssets" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertibleNotes" xlink:href="mlec-20250630.xsd#mlec_ConvertibleNotes"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:to="ConvertibleNotes" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LeasingLiabilities" xlink:href="mlec-20250630.xsd#mlec_LeasingLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:to="LeasingLiabilities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems" xlink:to="ifrs-full_FinancialLiabilities" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofCurrencyRiskTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract"/>
    <loc xlink:type="locator" xlink:label="FinancialInstrumentsRiskManagementScheduleofCurrencyRiskDetailsTable" xlink:href="mlec-20250630.xsd#mlec_FinancialInstrumentsRiskManagementScheduleofCurrencyRiskDetailsTable"/>
    <loc xlink:type="locator" xlink:label="FinancialInstrumentsRiskManagementScheduleofCurrencyRiskDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_FinancialInstrumentsRiskManagementScheduleofCurrencyRiskDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract" xlink:to="FinancialInstrumentsRiskManagementScheduleofCurrencyRiskDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ConsolidatedStructuredEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialInstrumentsRiskManagementScheduleofCurrencyRiskDetailsTable" xlink:to="ifrs-full_ConsolidatedStructuredEntitiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="BioceresCropSolutionsCorpMember" xlink:href="mlec-20250630.xsd#mlec_BioceresCropSolutionsCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ConsolidatedStructuredEntitiesAxis" xlink:to="BioceresCropSolutionsCorpMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialInstrumentsRiskManagementScheduleofCurrencyRiskDetailsTable" xlink:to="FinancialInstrumentsRiskManagementScheduleofCurrencyRiskDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialInstrumentsRiskManagementScheduleofCurrencyRiskDetailsLineItems" xlink:to="ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="OtherCurrencies" xlink:href="mlec-20250630.xsd#mlec_OtherCurrencies"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialInstrumentsRiskManagementScheduleofCurrencyRiskDetailsLineItems" xlink:to="OtherCurrencies" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofOtherForiegnCurrencieswithVariablesRemainingConstantTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract" xlink:to="ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract" xlink:to="ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic_0" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofInterestRateRiskTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfInterestRateRiskAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfInterestRateRiskAbstract"/>
    <loc xlink:type="locator" xlink:label="FinancialInstrumentsRiskManagementScheduleofInterestRateRiskDetailsTable" xlink:href="mlec-20250630.xsd#mlec_FinancialInstrumentsRiskManagementScheduleofInterestRateRiskDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfInterestRateRiskAbstract" xlink:to="FinancialInstrumentsRiskManagementScheduleofInterestRateRiskDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfRisksAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfRisksAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialInstrumentsRiskManagementScheduleofInterestRateRiskDetailsTable" xlink:to="ifrs-full_TypesOfRisksAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestRateRiskMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestRateRiskMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfRisksAxis" xlink:to="ifrs-full_InterestRateRiskMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialInstrumentsRiskManagementScheduleofInterestRateRiskDetailsTable" xlink:to="ifrs-full_BorrowingsByNameAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="FixedRateBorrowingsMember" xlink:href="mlec-20250630.xsd#mlec_FixedRateBorrowingsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="FixedRateBorrowingsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="VariableRateBorrowingsMember" xlink:href="mlec-20250630.xsd#mlec_VariableRateBorrowingsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="VariableRateBorrowingsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialInstrumentsRiskManagementScheduleofInterestRateRiskDetailsTable" xlink:to="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="FixedRateInstrumentsAbstract" xlink:href="mlec-20250630.xsd#mlec_FixedRateInstrumentsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems" xlink:to="FixedRateInstrumentsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentFinancialLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FixedRateInstrumentsAbstract" xlink:to="ifrs-full_CurrentFinancialLiabilities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentFinancialLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FixedRateInstrumentsAbstract" xlink:to="ifrs-full_NoncurrentFinancialLiabilities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FixedRateInstrumentsAbstract" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofFinancialAssetsbyCategoryTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfFinancialAssetsByCategoryAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfFinancialAssetsByCategoryAbstract"/>
    <loc xlink:type="locator" xlink:label="FinancialInstrumentsRiskManagementScheduleofFinancialAssetsbyCategoryDetailsTable" xlink:href="mlec-20250630.xsd#mlec_FinancialInstrumentsRiskManagementScheduleofFinancialAssetsbyCategoryDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialAssetsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFinancialAssetsByCategoryAbstract" xlink:to="FinancialInstrumentsRiskManagementScheduleofFinancialAssetsbyCategoryDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialInstrumentsRiskManagementScheduleofFinancialAssetsbyCategoryDetailsTable" xlink:to="ifrs-full_ClassesOfFinancialAssetsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialAssetsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="ifrs-full_ClassesOfFinancialAssetsDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="CashAndEquivalentsMember" xlink:href="mlec-20250630.xsd#mlec_CashAndEquivalentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="CashAndEquivalentsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OtherFinancialAssetsMember" xlink:href="mlec-20250630.xsd#mlec_OtherFinancialAssetsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="OtherFinancialAssetsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeReceivablesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeReceivablesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="ifrs-full_TradeReceivablesMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="OtherReceivablesMember" xlink:href="mlec-20250630.xsd#mlec_OtherReceivablesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="OtherReceivablesMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MeasurementAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialInstrumentsRiskManagementScheduleofFinancialAssetsbyCategoryDetailsTable" xlink:to="ifrs-full_MeasurementAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MeasurementAxis" xlink:to="ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MandatorilyMeasuredAtFairValueThroughProfitOrLossMember" xlink:href="mlec-20250630.xsd#mlec_MandatorilyMeasuredAtFairValueThroughProfitOrLossMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MeasurementAxis" xlink:to="MandatorilyMeasuredAtFairValueThroughProfitOrLossMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialInstrumentsRiskManagementScheduleofFinancialAssetsbyCategoryDetailsTable" xlink:to="ifrs-full_DisclosureOfFinancialAssetsLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialAssetsLineItems" xlink:to="ifrs-full_CashAndCashEquivalents" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherFinancialAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialAssetsLineItems" xlink:to="ifrs-full_OtherFinancialAssets" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialAssetsLineItems" xlink:to="ifrs-full_TradeReceivables" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherCurrentReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialAssetsLineItems" xlink:to="ifrs-full_OtherCurrentReceivables" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentFinancialAssetsAtAmortisedCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentFinancialAssetsAtAmortisedCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialAssetsLineItems" xlink:to="ifrs-full_CurrentFinancialAssetsAtAmortisedCost" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofFinancialLiabilitiesbyCategoryTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfFinancialLiabilitiesByCategoryAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfFinancialLiabilitiesByCategoryAbstract"/>
    <loc xlink:type="locator" xlink:label="FinancialInstrumentsRiskManagementScheduleofFinancialLiabilitiesbyCategoryDetailsTable" xlink:href="mlec-20250630.xsd#mlec_FinancialInstrumentsRiskManagementScheduleofFinancialLiabilitiesbyCategoryDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialLiabilitiesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFinancialLiabilitiesByCategoryAbstract" xlink:to="FinancialInstrumentsRiskManagementScheduleofFinancialLiabilitiesbyCategoryDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MeasurementAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialInstrumentsRiskManagementScheduleofFinancialLiabilitiesbyCategoryDetailsTable" xlink:to="ifrs-full_MeasurementAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="AtAmortizedCostMember" xlink:href="mlec-20250630.xsd#mlec_AtAmortizedCostMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MeasurementAxis" xlink:to="AtAmortizedCostMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AtFairValueMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AtFairValueMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MeasurementAxis" xlink:to="ifrs-full_AtFairValueMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialInstrumentsRiskManagementScheduleofFinancialLiabilitiesbyCategoryDetailsTable" xlink:to="ifrs-full_ClassesOfFinancialLiabilitiesAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:to="ifrs-full_ClassesOfFinancialLiabilitiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="TradeAndOtherPayablesMember" xlink:href="mlec-20250630.xsd#mlec_TradeAndOtherPayablesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:to="TradeAndOtherPayablesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BorrowingMember" xlink:href="mlec-20250630.xsd#mlec_BorrowingMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:to="BorrowingMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConsiderationForAcquisitionOfAssetsMember" xlink:href="mlec-20250630.xsd#mlec_ConsiderationForAcquisitionOfAssetsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:to="ConsiderationForAcquisitionOfAssetsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertibleNotesMember" xlink:href="mlec-20250630.xsd#mlec_ConvertibleNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:to="ConvertibleNotesMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LeaseLiabilitiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseLiabilitiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:to="ifrs-full_LeaseLiabilitiesMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantLiabilityMember" xlink:href="mlec-20250630.xsd#mlec_WarrantLiabilityMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:to="WarrantLiabilityMember" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialInstrumentsRiskManagementScheduleofFinancialLiabilitiesbyCategoryDetailsTable" xlink:to="ifrs-full_DisclosureOfFinancialLiabilitiesLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesLineItems" xlink:to="ifrs-full_FinancialLiabilities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofFairValuebyHierarchyTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfFairValueByHierarchyAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfFairValueByHierarchyAbstract"/>
    <loc xlink:type="locator" xlink:label="FinancialInstrumentsRiskManagementScheduleofFairValuebyHierarchyDetailsTable" xlink:href="mlec-20250630.xsd#mlec_FinancialInstrumentsRiskManagementScheduleofFairValuebyHierarchyDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFairValueByHierarchyAbstract" xlink:to="FinancialInstrumentsRiskManagementScheduleofFairValuebyHierarchyDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialInstrumentsRiskManagementScheduleofFairValuebyHierarchyDetailsTable" xlink:to="ifrs-full_ClassesOfFinancialAssetsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialAssetsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="ifrs-full_ClassesOfFinancialAssetsDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="InvestmentsAtFairValueMember" xlink:href="mlec-20250630.xsd#mlec_InvestmentsAtFairValueMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="InvestmentsAtFairValueMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantLiabilityMember" xlink:href="mlec-20250630.xsd#mlec_WarrantLiabilityMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="WarrantLiabilityMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="MutualFundsMember" xlink:href="mlec-20250630.xsd#mlec_MutualFundsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="MutualFundsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MoolecScienceSASharesMember" xlink:href="mlec-20250630.xsd#mlec_MoolecScienceSASharesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="MoolecScienceSASharesMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UsTreasuryBillsMember" xlink:href="mlec-20250630.xsd#mlec_UsTreasuryBillsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="UsTreasuryBillsMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OtherInvestmentMember" xlink:href="mlec-20250630.xsd#mlec_OtherInvestmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="OtherInvestmentMember" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialInstrumentsRiskManagementScheduleofFairValuebyHierarchyDetailsTable" xlink:to="ifrs-full_ClassesOfFinancialLiabilitiesAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialLiabilitiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:to="ifrs-full_ClassesOfFinancialLiabilitiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="TradeAndOtherPayablesMember" xlink:href="mlec-20250630.xsd#mlec_TradeAndOtherPayablesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:to="TradeAndOtherPayablesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConsiderationForAcquisitionMember" xlink:href="mlec-20250630.xsd#mlec_ConsiderationForAcquisitionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:to="ConsiderationForAcquisitionMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialInstrumentsRiskManagementScheduleofFairValuebyHierarchyDetailsTable" xlink:to="ifrs-full_LevelsOfFairValueHierarchyAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Level1OfFairValueHierarchyMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Level1OfFairValueHierarchyMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:to="ifrs-full_Level1OfFairValueHierarchyMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Level2OfFairValueHierarchyMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Level2OfFairValueHierarchyMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:to="ifrs-full_Level2OfFairValueHierarchyMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Level3OfFairValueHierarchyMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Level3OfFairValueHierarchyMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:to="ifrs-full_Level3OfFairValueHierarchyMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialInstrumentsRiskManagementScheduleofFairValuebyHierarchyDetailsTable" xlink:to="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FinancialAssetsAtFairValueAbstract" xlink:href="mlec-20250630.xsd#mlec_FinancialAssetsAtFairValueAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems" xlink:to="FinancialAssetsAtFairValueAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialAssetsAtFairValue" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssetsAtFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialAssetsAtFairValueAbstract" xlink:to="ifrs-full_FinancialAssetsAtFairValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="FinancialLiabilitiesValuedAtFairValueAbstract" xlink:href="mlec-20250630.xsd#mlec_FinancialLiabilitiesValuedAtFairValueAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems" xlink:to="FinancialLiabilitiesValuedAtFairValueAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialLiabilitiesAtFairValue" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialLiabilitiesValuedAtFairValueAbstract" xlink:to="ifrs-full_FinancialLiabilitiesAtFairValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfRightOfUseAndLiabilitiesRelatedWithLeaseAssetsAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfRightOfUseAndLiabilitiesRelatedWithLeaseAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsTable" xlink:href="mlec-20250630.xsd#mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfRightOfUseAndLiabilitiesRelatedWithLeaseAssetsAbstract" xlink:to="LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsTable" xlink:to="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CarryingAmountMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="ifrs-full_CarryingAmountMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GrossCarryingAmountMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossCarryingAmountMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="ifrs-full_GrossCarryingAmountMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="ifrs-full_AccumulatedDepreciationAndAmortisationMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsTable" xlink:to="ifrs-full_ClassesOfAssetsAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfAssetsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="ifrs-full_ClassesOfAssetsDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MachineryMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MachineryMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="ifrs-full_MachineryMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_VehiclesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_VehiclesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="ifrs-full_VehiclesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComputerSoftwareMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComputerSoftwareMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="ifrs-full_ComputerSoftwareMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LandAndBuildingsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LandAndBuildingsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="ifrs-full_LandAndBuildingsMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsTable" xlink:to="LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RightofuseAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:to="ifrs-full_RightofuseAssets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="BookValueAtTheBeginningOfThePeriod" xlink:href="mlec-20250630.xsd#mlec_BookValueAtTheBeginningOfThePeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:to="BookValueAtTheBeginningOfThePeriod" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DepreciationOfThePeriod" xlink:href="mlec-20250630.xsd#mlec_DepreciationOfThePeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BookValueAtTheBeginningOfThePeriod" xlink:to="DepreciationOfThePeriod" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DisposalsDepreciation" xlink:href="mlec-20250630.xsd#mlec_DisposalsDepreciation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BookValueAtTheBeginningOfThePeriod" xlink:to="DisposalsDepreciation" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExchangeDifferencesDepreciation" xlink:href="mlec-20250630.xsd#mlec_ExchangeDifferencesDepreciation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BookValueAtTheBeginningOfThePeriod" xlink:to="ExchangeDifferencesDepreciation" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LossOfControlDepreciation" xlink:href="mlec-20250630.xsd#mlec_LossOfControlDepreciation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BookValueAtTheBeginningOfThePeriod" xlink:to="LossOfControlDepreciation" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AccumulatedDepreciationAtTheEndOfThePeriod" xlink:href="mlec-20250630.xsd#mlec_AccumulatedDepreciationAtTheEndOfThePeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BookValueAtTheBeginningOfThePeriod" xlink:to="AccumulatedDepreciationAtTheEndOfThePeriod" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:to="ifrs-full_OtherPropertyPlantAndEquipment" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="LeaseLiabilityBeginningOfTheYearinception" xlink:href="mlec-20250630.xsd#mlec_LeaseLiabilityBeginningOfTheYearinception"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:to="LeaseLiabilityBeginningOfTheYearinception" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LeaseLiabiltyAdditionsOfTheYear" xlink:href="mlec-20250630.xsd#mlec_LeaseLiabiltyAdditionsOfTheYear"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeaseLiabilityBeginningOfTheYearinception" xlink:to="LeaseLiabiltyAdditionsOfTheYear" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AdditionsToLeaseLiabilityFromBusinessCombination" xlink:href="mlec-20250630.xsd#mlec_AdditionsToLeaseLiabilityFromBusinessCombination"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeaseLiabilityBeginningOfTheYearinception" xlink:to="AdditionsToLeaseLiabilityFromBusinessCombination" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LeaseLiabilitiesInterestExpenseExchangeDifferencesAndInflationEffects" xlink:href="mlec-20250630.xsd#mlec_LeaseLiabilitiesInterestExpenseExchangeDifferencesAndInflationEffects"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeaseLiabilityBeginningOfTheYearinception" xlink:to="LeaseLiabilitiesInterestExpenseExchangeDifferencesAndInflationEffects" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PaymentsOfThePeriodLeaseliability" xlink:href="mlec-20250630.xsd#mlec_PaymentsOfThePeriodLeaseliability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeaseLiabilityBeginningOfTheYearinception" xlink:to="PaymentsOfThePeriodLeaseliability" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LossOfControlLeaseLiability" xlink:href="mlec-20250630.xsd#mlec_LossOfControlLeaseLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeaseLiabilityBeginningOfTheYearinception" xlink:to="LossOfControlLeaseLiability" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TotalLeaseLiabilities" xlink:href="mlec-20250630.xsd#mlec_TotalLeaseLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:to="TotalLeaseLiabilities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LeaseLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseLiabilitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:to="ifrs-full_LeaseLiabilitiesAbstract" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLeaseLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_LeaseLiabilitiesAbstract" xlink:to="ifrs-full_CurrentLeaseLiabilities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_LeaseLiabilitiesAbstract" xlink:to="ifrs-full_NoncurrentLeaseLiabilities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_LeaseLiabilitiesAbstract" xlink:to="ifrs-full_LeaseLiabilities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Machinery" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Machinery"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:to="ifrs-full_Machinery" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Vehicles" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Vehicles"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:to="ifrs-full_Vehicles" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComputerSoftware" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComputerSoftware"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:to="ifrs-full_ComputerSoftware" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LandAndBuildings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LandAndBuildings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:to="ifrs-full_LandAndBuildings" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdditionsToRightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdditionsToRightofuseAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:to="ifrs-full_AdditionsToRightofuseAssets" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsRightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsRightofuseAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsRightofuseAssets" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisposalsRightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisposalsRightofuseAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:to="ifrs-full_DisposalsRightofuseAssets" order="13.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:to="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="RightOfUseAssetLossOfControl" xlink:href="mlec-20250630.xsd#mlec_RightOfUseAssetLossOfControl"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:to="RightOfUseAssetLossOfControl" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RightofuseAssets_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RightofuseAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems" xlink:to="ifrs-full_RightofuseAssets_0" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofTransactionsBetweentheGroupandRelatedPartiesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfTransactionsBetweenTheGroupAndRelatedPartiesAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfTransactionsBetweenTheGroupAndRelatedPartiesAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareholdersandOtherRelatedPartiesBalancesandTransactionsScheduleofTransactionsBetweentheGroupandRelatedPartiesDetailsTable" xlink:href="mlec-20250630.xsd#mlec_ShareholdersandOtherRelatedPartiesBalancesandTransactionsScheduleofTransactionsBetweentheGroupandRelatedPartiesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTransactionsBetweenTheGroupAndRelatedPartiesAbstract" xlink:to="ShareholdersandOtherRelatedPartiesBalancesandTransactionsScheduleofTransactionsBetweentheGroupandRelatedPartiesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersandOtherRelatedPartiesBalancesandTransactionsScheduleofTransactionsBetweentheGroupandRelatedPartiesDetailsTable" xlink:to="ifrs-full_ClassesOfFinancialInstrumentsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="ifrs-full_ClassesOfFinancialInstrumentsDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="SalesOfGoodsAndServicesMember" xlink:href="mlec-20250630.xsd#mlec_SalesOfGoodsAndServicesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="SalesOfGoodsAndServicesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PurchasesOfGoodsAndServicesMember" xlink:href="mlec-20250630.xsd#mlec_PurchasesOfGoodsAndServicesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="PurchasesOfGoodsAndServicesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NetLoansGrantedMember" xlink:href="mlec-20250630.xsd#mlec_NetLoansGrantedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="NetLoansGrantedMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InterestGainMember" xlink:href="mlec-20250630.xsd#mlec_InterestGainMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="InterestGainMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NetLoansReceivedMember" xlink:href="mlec-20250630.xsd#mlec_NetLoansReceivedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="NetLoansReceivedMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PuttableInstrumentsMember" xlink:href="mlec-20250630.xsd#mlec_PuttableInstrumentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="PuttableInstrumentsMember" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NetLoansGrantedOneMember" xlink:href="mlec-20250630.xsd#mlec_NetLoansGrantedOneMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="NetLoansGrantedOneMember" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PreferenceShareMember" xlink:href="mlec-20250630.xsd#mlec_PreferenceShareMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="PreferenceShareMember" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InterestExpensesMember" xlink:href="mlec-20250630.xsd#mlec_InterestExpensesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="InterestExpensesMember" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OwnSharesHeldBySubsidiariesMember" xlink:href="mlec-20250630.xsd#mlec_OwnSharesHeldBySubsidiariesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="OwnSharesHeldBySubsidiariesMember" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InKindContributionsMember" xlink:href="mlec-20250630.xsd#mlec_InKindContributionsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="InKindContributionsMember" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SalariesSocialSecurityBenefitsAndOtherBenefitsMember" xlink:href="mlec-20250630.xsd#mlec_SalariesSocialSecurityBenefitsAndOtherBenefitsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="SalariesSocialSecurityBenefitsAndOtherBenefitsMember" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SalesAndServicesMember" xlink:href="mlec-20250630.xsd#mlec_SalesAndServicesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="SalesAndServicesMember" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockOptionsAndShareBasedIncentivesMember" xlink:href="mlec-20250630.xsd#mlec_StockOptionsAndShareBasedIncentivesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="StockOptionsAndShareBasedIncentivesMember" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TradeDebtorsMember" xlink:href="mlec-20250630.xsd#mlec_TradeDebtorsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="TradeDebtorsMember" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OtherReceivablesMember" xlink:href="mlec-20250630.xsd#mlec_OtherReceivablesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="OtherReceivablesMember" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LoansReceivablesMember" xlink:href="mlec-20250630.xsd#mlec_LoansReceivablesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="LoansReceivablesMember" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TradeCreditorsMember" xlink:href="mlec-20250630.xsd#mlec_TradeCreditorsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="TradeCreditorsMember" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertibleNotesMember" xlink:href="mlec-20250630.xsd#mlec_ConvertibleNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="ConvertibleNotesMember" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NetLoansPayablesMember" xlink:href="mlec-20250630.xsd#mlec_NetLoansPayablesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="NetLoansPayablesMember" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantesMember" xlink:href="mlec-20250630.xsd#mlec_WarrantesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="WarrantesMember" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersandOtherRelatedPartiesBalancesandTransactionsScheduleofTransactionsBetweentheGroupandRelatedPartiesDetailsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_JointVenturesWhereEntityIsVenturerMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_JointVenturesWhereEntityIsVenturerMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_JointVenturesWhereEntityIsVenturerMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherRelatedPartiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherRelatedPartiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_OtherRelatedPartiesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_KeyManagementPersonnelOfEntityOrParentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareholdersandOtherRelatedPartiesBalancesandTransactionsScheduleofTransactionsBetweentheGroupandRelatedPartiesDetailsTable" xlink:to="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ValueOfTransactionsForThePeriodEnded" xlink:href="mlec-20250630.xsd#mlec_ValueOfTransactionsForThePeriodEnded"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="ValueOfTransactionsForThePeriodEnded" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherReceivablesDueFromRelatedParties" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherReceivablesDueFromRelatedParties"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="ifrs-full_TradeAndOtherReceivablesDueFromRelatedParties" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherPayablesToRelatedParties" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherPayablesToRelatedParties"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="ifrs-full_TradeAndOtherPayablesToRelatedParties" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofCompensationofKeyManagementPersonnelCompensationTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfCompensationOfKeyManagementPersonnelCompensationAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfCompensationOfKeyManagementPersonnelCompensationAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCompensationOfKeyManagementPersonnelCompensationAbstract" xlink:to="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCompensationOfKeyManagementPersonnelCompensationAbstract" xlink:to="ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_KeyManagementPersonnelCompensation" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCompensationOfKeyManagementPersonnelCompensationAbstract" xlink:to="ifrs-full_KeyManagementPersonnelCompensation" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofFairValueoftheStockOptionsattheGrantDateTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfFairValueOfTheStockOptionsAtTheGrantDateAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfFairValueOfTheStockOptionsAtTheGrantDateAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareBasedPaymentScheduleofFairValueoftheStockOptionsattheGrantDateDetailsTable" xlink:href="mlec-20250630.xsd#mlec_ShareBasedPaymentScheduleofFairValueoftheStockOptionsattheGrantDateDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFairValueOfTheStockOptionsAtTheGrantDateAbstract" xlink:to="ShareBasedPaymentScheduleofFairValueoftheStockOptionsattheGrantDateDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentScheduleofFairValueoftheStockOptionsattheGrantDateDetailsTable" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="StandAloneStockOptionGrantMember" xlink:href="mlec-20250630.xsd#mlec_StandAloneStockOptionGrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="StandAloneStockOptionGrantMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="EmployeeStockOptionPlanMember" xlink:href="mlec-20250630.xsd#mlec_EmployeeStockOptionPlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="EmployeeStockOptionPlanMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PastShareOptionPlanMember" xlink:href="mlec-20250630.xsd#mlec_PastShareOptionPlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="PastShareOptionPlanMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShareOptionsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShareOptionsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_ShareOptionsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PerformanceShareOptionPlanMember" xlink:href="mlec-20250630.xsd#mlec_PerformanceShareOptionPlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="PerformanceShareOptionPlanMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentScheduleofFairValueoftheStockOptionsattheGrantDateDetailsTable" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_ExercisePriceShareOptionsGranted2019" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofRangeofAssumptionswhichhaveDeterminedTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfRangeOfAssumptionsWhichHaveDeterminedAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfRangeOfAssumptionsWhichHaveDeterminedAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareBasedPaymentScheduleofRangeofAssumptionswhichhaveDeterminedDetailsTable" xlink:href="mlec-20250630.xsd#mlec_ShareBasedPaymentScheduleofRangeofAssumptionswhichhaveDeterminedDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfRangeOfAssumptionsWhichHaveDeterminedAbstract" xlink:to="ShareBasedPaymentScheduleofRangeofAssumptionswhichhaveDeterminedDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentScheduleofRangeofAssumptionswhichhaveDeterminedDetailsTable" xlink:to="ifrs-full_RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_BottomOfRangeMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_TopOfRangeMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentScheduleofRangeofAssumptionswhichhaveDeterminedDetailsTable" xlink:to="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems" xlink:to="ifrs-full_ExercisePriceShareOptionsGranted2019" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems" xlink:to="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems" xlink:to="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems" xlink:to="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems" xlink:to="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofOptionActivityandWeightedAverageExercisePriceTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfOptionActivityAndWeightedAverageExercisePriceAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfOptionActivityAndWeightedAverageExercisePriceAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareBasedPaymentScheduleofOptionActivityandWeightedAverageExercisePriceDetailsTable" xlink:href="mlec-20250630.xsd#mlec_ShareBasedPaymentScheduleofOptionActivityandWeightedAverageExercisePriceDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOptionActivityAndWeightedAverageExercisePriceAbstract" xlink:to="ShareBasedPaymentScheduleofOptionActivityandWeightedAverageExercisePriceDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentScheduleofOptionActivityandWeightedAverageExercisePriceDetailsTable" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="OptionsIncentivePlanMember" xlink:href="mlec-20250630.xsd#mlec_OptionsIncentivePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="OptionsIncentivePlanMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentScheduleofOptionActivityandWeightedAverageExercisePriceDetailsTable" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfOutstandingShareOptions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:to="ifrs-full_NumberOfOutstandingShareOptions" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:to="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:to="ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:to="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:to="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" order="8.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfOutstandingShareOptions_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:to="ifrs-full_NumberOfOutstandingShareOptions_0" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_0" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ScheduleofWeightedAverageNumberofOrdinarySharesOutstandingTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfWeightedAverageNumberOfOrdinarySharesOutstandingAbstract" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfWeightedAverageNumberOfOrdinarySharesOutstandingAbstract"/>
    <loc xlink:type="locator" xlink:label="ReverseStockSplitAftertheReportingPeriodScheduleofWeightedAverageNumberofOrdinarySharesOutstandingDetailsTable" xlink:href="mlec-20250630.xsd#mlec_ReverseStockSplitAftertheReportingPeriodScheduleofWeightedAverageNumberofOrdinarySharesOutstandingDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ReverseStockSplitAftertheReportingPeriodScheduleofWeightedAverageNumberofOrdinarySharesOutstandingDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_ReverseStockSplitAftertheReportingPeriodScheduleofWeightedAverageNumberofOrdinarySharesOutstandingDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfWeightedAverageNumberOfOrdinarySharesOutstandingAbstract" xlink:to="ReverseStockSplitAftertheReportingPeriodScheduleofWeightedAverageNumberofOrdinarySharesOutstandingDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReverseStockSplitAftertheReportingPeriodScheduleofWeightedAverageNumberofOrdinarySharesOutstandingDetailsTable" xlink:to="ifrs-full_ClassesOfShareCapitalAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ReverseStockSplitMember" xlink:href="mlec-20250630.xsd#mlec_ReverseStockSplitMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ReverseStockSplitMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReverseStockSplitAftertheReportingPeriodScheduleofWeightedAverageNumberofOrdinarySharesOutstandingDetailsTable" xlink:to="ReverseStockSplitAftertheReportingPeriodScheduleofWeightedAverageNumberofOrdinarySharesOutstandingDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="NumeratorAbstract" xlink:href="mlec-20250630.xsd#mlec_NumeratorAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReverseStockSplitAftertheReportingPeriodScheduleofWeightedAverageNumberofOrdinarySharesOutstandingDetailsLineItems" xlink:to="NumeratorAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NumeratorAbstract" xlink:to="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NumeratorAbstract" xlink:to="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DenominatorAbstract" xlink:href="mlec-20250630.xsd#mlec_DenominatorAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReverseStockSplitAftertheReportingPeriodScheduleofWeightedAverageNumberofOrdinarySharesOutstandingDetailsLineItems" xlink:to="DenominatorAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DenominatorAbstract" xlink:to="ifrs-full_WeightedAverageShares" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustedWeightedAverageShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustedWeightedAverageShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DenominatorAbstract" xlink:to="ifrs-full_AdjustedWeightedAverageShares" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BasicEarningsLossPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BasicEarningsLossPerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReverseStockSplitAftertheReportingPeriodScheduleofWeightedAverageNumberofOrdinarySharesOutstandingDetailsLineItems" xlink:to="ifrs-full_BasicEarningsLossPerShare" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DilutedEarningsLossPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DilutedEarningsLossPerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReverseStockSplitAftertheReportingPeriodScheduleofWeightedAverageNumberofOrdinarySharesOutstandingDetailsLineItems" xlink:to="ifrs-full_DilutedEarningsLossPerShare" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsScheduleofIntangibleAssetsandLiabilitiesAssumed" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofIntangibleAssetsandLiabilitiesAssumedDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofIntangibleAssetsandLiabilitiesAssumedDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfIntangibleAssetsAndLiabilitiesAssumedLineItems" xlink:href="mlec-20250630.xsd#mlec_ScheduleOfIntangibleAssetsAndLiabilitiesAssumedLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:to="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofIntangibleAssetsandLiabilitiesAssumedDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofIntangibleAssetsandLiabilitiesAssumedDetailsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="RizobacterUGEMember" xlink:href="mlec-20250630.xsd#mlec_RizobacterUGEMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="RizobacterUGEMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ProFarmUGEMember" xlink:href="mlec-20250630.xsd#mlec_ProFarmUGEMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ProFarmUGEMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofIntangibleAssetsandLiabilitiesAssumedDetailsTable" xlink:to="ScheduleOfIntangibleAssetsAndLiabilitiesAssumedLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIntangibleAssetsAndLiabilitiesAssumedLineItems" xlink:to="ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfWeightedAverageCostOfCapital" xlink:href="mlec-20250630.xsd#mlec_PercentageOfWeightedAverageCostOfCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIntangibleAssetsAndLiabilitiesAssumedLineItems" xlink:to="PercentageOfWeightedAverageCostOfCapital" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfRiskPremium" xlink:href="mlec-20250630.xsd#mlec_PercentageOfRiskPremium"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIntangibleAssetsAndLiabilitiesAssumedLineItems" xlink:to="PercentageOfRiskPremium" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIntangibleAssetsAndLiabilitiesAssumedLineItems" xlink:to="ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceTable"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="TheGroupsBusinessReorganizationandGeneralInformationDetailsTable" xlink:href="mlec-20250630.xsd#mlec_TheGroupsBusinessReorganizationandGeneralInformationDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:to="TheGroupsBusinessReorganizationandGeneralInformationDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BusinessCombinationsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TheGroupsBusinessReorganizationandGeneralInformationDetailsTable" xlink:to="ifrs-full_BusinessCombinationsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BusinessCombinationsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BusinessCombinationsAxis" xlink:to="ifrs-full_BusinessCombinationsDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="HoldbackMember" xlink:href="mlec-20250630.xsd#mlec_HoldbackMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BusinessCombinationsAxis" xlink:to="HoldbackMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TheGroupsBusinessReorganizationandGeneralInformationDetailsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="BioceresGroupLimitedMember" xlink:href="mlec-20250630.xsd#mlec_BioceresGroupLimitedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="BioceresGroupLimitedMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GentleTechMember" xlink:href="mlec-20250630.xsd#mlec_GentleTechMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="GentleTechMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfOrdinarySharesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfOrdinarySharesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TheGroupsBusinessReorganizationandGeneralInformationDetailsTable" xlink:to="ifrs-full_ClassesOfOrdinarySharesAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfOrdinarySharesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfOrdinarySharesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfOrdinarySharesAxis" xlink:to="ifrs-full_ClassesOfOrdinarySharesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="OrdinarySharesOneMember" xlink:href="mlec-20250630.xsd#mlec_OrdinarySharesOneMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfOrdinarySharesAxis" xlink:to="OrdinarySharesOneMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TheGroupsBusinessReorganizationandGeneralInformationDetailsTable" xlink:to="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:to="ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="SubsequentEventsMember" xlink:href="mlec-20250630.xsd#mlec_SubsequentEventsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:to="SubsequentEventsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TheGroupsBusinessReorganizationandGeneralInformationDetailsTable" xlink:to="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:to="ifrs-full_SignificantInvestmentsInSubsidiariesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="BioceresSAMember" xlink:href="mlec-20250630.xsd#mlec_BioceresSAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:to="BioceresSAMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BioceresLLCMember" xlink:href="mlec-20250630.xsd#mlec_BioceresLLCMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:to="BioceresLLCMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TheGroupsBusinessReorganizationandGeneralInformationDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ConsolidatedEntitiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="MoolecScienceLuxembourgMember" xlink:href="mlec-20250630.xsd#mlec_MoolecScienceLuxembourgMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="MoolecScienceLuxembourgMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MoolecScienceCaymanIslandsMember" xlink:href="mlec-20250630.xsd#mlec_MoolecScienceCaymanIslandsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="MoolecScienceCaymanIslandsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TheGroupsBusinessReorganizationandGeneralInformationDetailsTable" xlink:to="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ReverseStockSplitConsolidationRatio" xlink:href="mlec-20250630.xsd#mlec_ReverseStockSplitConsolidationRatio"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ReverseStockSplitConsolidationRatio" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_NumberOfSharesIssued" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ParValuePerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ParValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_ParValuePerShare" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfSharesReverseStockSplit" xlink:href="mlec-20250630.xsd#mlec_NumberOfSharesReverseStockSplit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="NumberOfSharesReverseStockSplit" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfIssuedAndOutstandingEquityInterests" xlink:href="mlec-20250630.xsd#mlec_PercentageOfIssuedAndOutstandingEquityInterests"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="PercentageOfIssuedAndOutstandingEquityInterests" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConsiderationForIssuedOrdinaryShareValue" xlink:href="mlec-20250630.xsd#mlec_ConsiderationForIssuedOrdinaryShareValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ConsiderationForIssuedOrdinaryShareValue" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PrivateWarrantsShares" xlink:href="mlec-20250630.xsd#mlec_PrivateWarrantsShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="PrivateWarrantsShares" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PrivateWarrantsExercisePrice" xlink:href="mlec-20250630.xsd#mlec_PrivateWarrantsExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="PrivateWarrantsExercisePrice" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AdditionalOrdinarySharesIssue" xlink:href="mlec-20250630.xsd#mlec_AdditionalOrdinarySharesIssue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="AdditionalOrdinarySharesIssue" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_PercentageOfVotingEquityInterestsAcquired" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfSharesOutstandingPercentage" xlink:href="mlec-20250630.xsd#mlec_NumberOfSharesOutstandingPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="NumberOfSharesOutstandingPercentage" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProportionOfVotingPowerHeldInSubsidiary" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProportionOfVotingPowerHeldInSubsidiary"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_ProportionOfVotingPowerHeldInSubsidiary" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Borrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Borrowings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_Borrowings" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinanceCosts" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_FinanceCosts" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfSharesPledged" xlink:href="mlec-20250630.xsd#mlec_NumberOfSharesPledged"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="NumberOfSharesPledged" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentDebtInstrumentsIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentDebtInstrumentsIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_CurrentDebtInstrumentsIssued" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WorkingCapital" xlink:href="mlec-20250630.xsd#mlec_WorkingCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="WorkingCapital" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_Equity" order="18.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossFromOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="ifrs-full_ProfitLossFromOperatingActivities" order="19.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="GainlossOfRecognitionTransactions" xlink:href="mlec-20250630.xsd#mlec_GainlossOfRecognitionTransactions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="GainlossOfRecognitionTransactions" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GainlossOfDerecognitionTransactions" xlink:href="mlec-20250630.xsd#mlec_GainlossOfDerecognitionTransactions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="GainlossOfDerecognitionTransactions" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="AccountingStandardsAndBasiofPreparationAbstract" xlink:href="mlec-20250630.xsd#mlec_AccountingStandardsAndBasiofPreparationAbstract"/>
    <loc xlink:type="locator" xlink:label="AccountingStandardsandBasisofPreparationDetailsTable" xlink:href="mlec-20250630.xsd#mlec_AccountingStandardsandBasisofPreparationDetailsTable"/>
    <loc xlink:type="locator" xlink:label="AccountingStandardsandBasisofPreparationDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_AccountingStandardsandBasisofPreparationDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingStandardsAndBasiofPreparationAbstract" xlink:to="AccountingStandardsandBasisofPreparationDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingStandardsandBasisofPreparationDetailsTable" xlink:to="ifrs-full_ClassesOfShareCapitalAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OrdinarySharesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OrdinarySharesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_OrdinarySharesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingStandardsandBasisofPreparationDetailsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="BioceresGroupLimitedMember" xlink:href="mlec-20250630.xsd#mlec_BioceresGroupLimitedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="BioceresGroupLimitedMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BusinessCombinationMember" xlink:href="mlec-20250630.xsd#mlec_BusinessCombinationMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="BusinessCombinationMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingStandardsandBasisofPreparationDetailsTable" xlink:to="ifrs-full_RangeAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_TopOfRangeMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_BottomOfRangeMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingStandardsandBasisofPreparationDetailsTable" xlink:to="AccountingStandardsandBasisofPreparationDetailsLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ShorttermPeriod" xlink:href="mlec-20250630.xsd#mlec_ShorttermPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingStandardsandBasisofPreparationDetailsLineItems" xlink:to="ShorttermPeriod" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CumulativeInflationRate" xlink:href="mlec-20250630.xsd#mlec_CumulativeInflationRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingStandardsandBasisofPreparationDetailsLineItems" xlink:to="CumulativeInflationRate" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InflationOfAccumulatedYears" xlink:href="mlec-20250630.xsd#mlec_InflationOfAccumulatedYears"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingStandardsandBasisofPreparationDetailsLineItems" xlink:to="InflationOfAccumulatedYears" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfInflationAccumulated" xlink:href="mlec-20250630.xsd#mlec_PercentageOfInflationAccumulated"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingStandardsandBasisofPreparationDetailsLineItems" xlink:to="PercentageOfInflationAccumulated" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ArgentinePriceIndexShares" xlink:href="mlec-20250630.xsd#mlec_ArgentinePriceIndexShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingStandardsandBasisofPreparationDetailsLineItems" xlink:to="ArgentinePriceIndexShares" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfIssuedAndOutstandingEquityInterests" xlink:href="mlec-20250630.xsd#mlec_PercentageOfIssuedAndOutstandingEquityInterests"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingStandardsandBasisofPreparationDetailsLineItems" xlink:to="PercentageOfIssuedAndOutstandingEquityInterests" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConsiderationForIssuedOrdinaryShareValue" xlink:href="mlec-20250630.xsd#mlec_ConsiderationForIssuedOrdinaryShareValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingStandardsandBasisofPreparationDetailsLineItems" xlink:to="ConsiderationForIssuedOrdinaryShareValue" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PrivateWarrantShares" xlink:href="mlec-20250630.xsd#mlec_PrivateWarrantShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingStandardsandBasisofPreparationDetailsLineItems" xlink:to="PrivateWarrantShares" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingStandardsandBasisofPreparationDetailsLineItems" xlink:to="ifrs-full_NumberOfSharesIssued" order="8.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="PrivateWarrantsExercisePrice" xlink:href="mlec-20250630.xsd#mlec_PrivateWarrantsExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingStandardsandBasisofPreparationDetailsLineItems" xlink:to="PrivateWarrantsExercisePrice" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfShare" xlink:href="mlec-20250630.xsd#mlec_PercentageOfShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingStandardsandBasisofPreparationDetailsLineItems" xlink:to="PercentageOfShare" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuedCapitalOrdinaryShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapitalOrdinaryShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingStandardsandBasisofPreparationDetailsLineItems" xlink:to="ifrs-full_IssuedCapitalOrdinaryShares" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/NewStandardsAmendmentsandInterpretationsIssuedbytheIASBDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="NewStandardsAmendmentsAndInterpretationsIssuedByTheIASBAbstract" xlink:href="mlec-20250630.xsd#mlec_NewStandardsAmendmentsAndInterpretationsIssuedByTheIASBAbstract"/>
    <loc xlink:type="locator" xlink:label="NewStandardsAmendmentsandInterpretationsIssuedbytheIASBDetailsTable" xlink:href="mlec-20250630.xsd#mlec_NewStandardsAmendmentsandInterpretationsIssuedbytheIASBDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NewStandardsAmendmentsAndInterpretationsIssuedByTheIASBAbstract" xlink:to="NewStandardsAmendmentsandInterpretationsIssuedbytheIASBDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InitiallyAppliedIFRSsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InitiallyAppliedIFRSsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NewStandardsAmendmentsandInterpretationsIssuedbytheIASBDetailsTable" xlink:to="ifrs-full_InitiallyAppliedIFRSsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LeaseLiabilityInASaleAndLeasebackMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseLiabilityInASaleAndLeasebackMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_InitiallyAppliedIFRSsAxis" xlink:to="ifrs-full_LeaseLiabilityInASaleAndLeasebackMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLiabilitiesWithCovenantsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLiabilitiesWithCovenantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_InitiallyAppliedIFRSsAxis" xlink:to="ifrs-full_NoncurrentLiabilitiesWithCovenantsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NewStandardsAmendmentsandInterpretationsIssuedbytheIASBDetailsTable" xlink:to="ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionWhetherChangeInAccountingPolicyIsMadeInAccordanceWithTransitionalProvisionsOfInitiallyAppliedIFRS" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionWhetherChangeInAccountingPolicyIsMadeInAccordanceWithTransitionalProvisionsOfInitiallyAppliedIFRS"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems" xlink:to="ifrs-full_DescriptionWhetherChangeInAccountingPolicyIsMadeInAccordanceWithTransitionalProvisionsOfInitiallyAppliedIFRS" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TitleOfInitiallyAppliedIFRS" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TitleOfInitiallyAppliedIFRS"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems" xlink:to="ifrs-full_TitleOfInitiallyAppliedIFRS" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="SummaryofSignificantAccountingPoliciesDetailsTable" xlink:href="mlec-20250630.xsd#mlec_SummaryofSignificantAccountingPoliciesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="SummaryofSignificantAccountingPoliciesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="srt_RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="ifrs-full_BottomOfRangeMember" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="ifrs-full_TopOfRangeMember" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherPropertyPlantAndEquipmentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherPropertyPlantAndEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_OtherPropertyPlantAndEquipmentMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OfficeEquipmentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OfficeEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_OfficeEquipmentMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_VehiclesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_VehiclesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_VehiclesMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComputerEquipmentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComputerEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_ComputerEquipmentMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FixturesAndFittingsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FixturesAndFittingsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_FixturesAndFittingsMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="IfrsFull_machineryAndEquipmentMember" xlink:href="mlec-20250630.xsd#mlec_IfrsFull_machineryAndEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="IfrsFull_machineryAndEquipmentMember" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BuildingsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BuildingsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_BuildingsMember" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComputerSoftwareMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComputerSoftwareMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="ifrs-full_ComputerSoftwareMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LicencesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LicencesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="ifrs-full_LicencesMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherIntangibleAssetsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherIntangibleAssetsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="ifrs-full_OtherIntangibleAssetsMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BrandNamesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BrandNamesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="ifrs-full_BrandNamesMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CustomerrelatedIntangibleAssetsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CustomerrelatedIntangibleAssetsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="ifrs-full_CustomerrelatedIntangibleAssetsMember" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="ifrs-full_RangeAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_BottomOfRangeMember_0" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_TopOfRangeMember_0" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeBiologicalAssetsAtCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeBiologicalAssetsAtCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeBiologicalAssetsAtCost" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ValuationSignificantChangePercentageOfConstructionCosts" xlink:href="mlec-20250630.xsd#mlec_ValuationSignificantChangePercentageOfConstructionCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="ValuationSignificantChangePercentageOfConstructionCosts" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ValuationSignificantChangeInAmountNormalWearAndTearVariationImpactOnRevaluationAmount" xlink:href="mlec-20250630.xsd#mlec_ValuationSignificantChangeInAmountNormalWearAndTearVariationImpactOnRevaluationAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="ValuationSignificantChangeInAmountNormalWearAndTearVariationImpactOnRevaluationAmount" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AveragePaymentTermBySales" xlink:href="mlec-20250630.xsd#mlec_AveragePaymentTermBySales"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="AveragePaymentTermBySales" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/AcquisitionsandOtherSignificantTransactionsDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsAbstract"/>
    <loc xlink:type="locator" xlink:label="AcquisitionsandOtherSignificantTransactionsDetailsTable" xlink:href="mlec-20250630.xsd#mlec_AcquisitionsandOtherSignificantTransactionsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:to="AcquisitionsandOtherSignificantTransactionsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AcquisitionsandOtherSignificantTransactionsDetailsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="BioceresGroupLimitedMember" xlink:href="mlec-20250630.xsd#mlec_BioceresGroupLimitedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="BioceresGroupLimitedMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BusinessCombinationsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AcquisitionsandOtherSignificantTransactionsDetailsTable" xlink:to="ifrs-full_BusinessCombinationsAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BusinessCombinationsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BusinessCombinationsAxis" xlink:to="ifrs-full_BusinessCombinationsDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ProFarmGroupIncMember" xlink:href="mlec-20250630.xsd#mlec_ProFarmGroupIncMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BusinessCombinationsAxis" xlink:to="ProFarmGroupIncMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NatalAgroSRLMember" xlink:href="mlec-20250630.xsd#mlec_NatalAgroSRLMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BusinessCombinationsAxis" xlink:to="NatalAgroSRLMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AcquisitionsandOtherSignificantTransactionsDetailsTable" xlink:to="ifrs-full_DisclosureOfBusinessCombinationsLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:to="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueOfCombinedEntity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueOfCombinedEntity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:to="ifrs-full_RevenueOfCombinedEntity" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossOfCombinedEntity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossOfCombinedEntity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:to="ifrs-full_ProfitLossOfCombinedEntity" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfSharesAcquiredInBusinessCombination" xlink:href="mlec-20250630.xsd#mlec_NumberOfSharesAcquiredInBusinessCombination"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:to="NumberOfSharesAcquiredInBusinessCombination" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ParValuePerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ParValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:to="ifrs-full_ParValuePerShare" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:to="ifrs-full_PercentageOfVotingEquityInterestsAcquired" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashTransferred" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashTransferred"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:to="ifrs-full_CashTransferred" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShorttermBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShorttermBorrowings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:to="ifrs-full_ShorttermBorrowings" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfCustomerRevenues" xlink:href="mlec-20250630.xsd#mlec_PercentageOfCustomerRevenues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:to="PercentageOfCustomerRevenues" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsTable"/>
    <loc xlink:type="locator" xlink:label="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract" xlink:to="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsTable" xlink:to="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:to="ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="SubsequentEventsMember" xlink:href="mlec-20250630.xsd#mlec_SubsequentEventsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:to="SubsequentEventsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="BioceresGroupMember" xlink:href="mlec-20250630.xsd#mlec_BioceresGroupMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="BioceresGroupMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MaturityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsTable" xlink:to="ifrs-full_MaturityAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MaturityDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_MaturityDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="FortyEightMonthsMember" xlink:href="mlec-20250630.xsd#mlec_FortyEightMonthsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MaturityAxis" xlink:to="FortyEightMonthsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsTable" xlink:to="ifrs-full_RangeAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_BottomOfRangeMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_TopOfRangeMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsTable" xlink:to="ifrs-full_BorrowingsByNameAxis" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="ifrs-full_BorrowingsByNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="SecuredGuaranteedNotesDue2026Member" xlink:href="mlec-20250630.xsd#mlec_SecuredGuaranteedNotesDue2026Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="SecuredGuaranteedNotesDue2026Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SecuredConvertibleGuaranteedNotesMember" xlink:href="mlec-20250630.xsd#mlec_SecuredConvertibleGuaranteedNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="SecuredConvertibleGuaranteedNotesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsTable" xlink:to="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryOtherProvisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryOtherProvisions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryOtherProvisions" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ProjectedPeriodRange" xlink:href="mlec-20250630.xsd#mlec_ProjectedPeriodRange"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="ProjectedPeriodRange" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EstimatedFinancialEffectOfContingentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EstimatedFinancialEffectOfContingentAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="ifrs-full_EstimatedFinancialEffectOfContingentAssets" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InventoryRecognizedAsExpense" xlink:href="mlec-20250630.xsd#mlec_InventoryRecognizedAsExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="InventoryRecognizedAsExpense" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="ifrs-full_NumberOfSharesIssued" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuedCapitalPreferenceShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapitalPreferenceShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="ifrs-full_IssuedCapitalPreferenceShares" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfPreferenceSharesAccrue" xlink:href="mlec-20250630.xsd#mlec_PercentageOfPreferenceSharesAccrue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="PercentageOfPreferenceSharesAccrue" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AggregateAmount" xlink:href="mlec-20250630.xsd#mlec_AggregateAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="AggregateAmount" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DebtInstrumentsHeldAtAmortisedCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DebtInstrumentsHeldAtAmortisedCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="ifrs-full_DebtInstrumentsHeldAtAmortisedCost" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CreditorsPublicAuctionShares" xlink:href="mlec-20250630.xsd#mlec_CreditorsPublicAuctionShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="CreditorsPublicAuctionShares" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentDebtInstrumentsIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentDebtInstrumentsIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="ifrs-full_CurrentDebtInstrumentsIssued" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsInterestRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsInterestRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="ifrs-full_BorrowingsInterestRate" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IfrsDebtInstrumentTerm" xlink:href="mlec-20250630.xsd#mlec_IfrsDebtInstrumentTerm"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="IfrsDebtInstrumentTerm" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Borrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Borrowings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="ifrs-full_Borrowings" order="13.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="AmortizationPayments" xlink:href="mlec-20250630.xsd#mlec_AmortizationPayments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="AmortizationPayments" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfPrepaymentPremium" xlink:href="mlec-20250630.xsd#mlec_PercentageOfPrepaymentPremium"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="PercentageOfPrepaymentPremium" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfPenalty" xlink:href="mlec-20250630.xsd#mlec_PercentageOfPenalty"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="PercentageOfPenalty" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NotionalAmount" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NotionalAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="ifrs-full_NotionalAmount" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BorrowingInterestRateInCash" xlink:href="mlec-20250630.xsd#mlec_BorrowingInterestRateInCash"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="BorrowingInterestRateInCash" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BorrowingInterestRateInKind" xlink:href="mlec-20250630.xsd#mlec_BorrowingInterestRateInKind"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="BorrowingInterestRateInKind" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StrikePriceForConversionOfDebt" xlink:href="mlec-20250630.xsd#mlec_StrikePriceForConversionOfDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="StrikePriceForConversionOfDebt" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="VoluntaryRepurchaseOfNotesAfterIssueDate" xlink:href="mlec-20250630.xsd#mlec_VoluntaryRepurchaseOfNotesAfterIssueDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="VoluntaryRepurchaseOfNotesAfterIssueDate" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsMaturity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsMaturity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="ifrs-full_BorrowingsMaturity" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PricePerSharesOfStrikePrice" xlink:href="mlec-20250630.xsd#mlec_PricePerSharesOfStrikePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="PricePerSharesOfStrikePrice" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CommonEquity" xlink:href="mlec-20250630.xsd#mlec_CommonEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="CommonEquity" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfPenaltyOfPrepayment" xlink:href="mlec-20250630.xsd#mlec_PercentageOfPenaltyOfPrepayment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="PercentageOfPenaltyOfPrepayment" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DiscountRateForFairValueOfLiabilityComponent" xlink:href="mlec-20250630.xsd#mlec_DiscountRateForFairValueOfLiabilityComponent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="DiscountRateForFairValueOfLiabilityComponent" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PrepaymentPremiumFee" xlink:href="mlec-20250630.xsd#mlec_PrepaymentPremiumFee"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="PrepaymentPremiumFee" order="27.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LoansReceived" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LoansReceived"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="ifrs-full_LoansReceived" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AdditionalConvertibleNotesReceivedAmount" xlink:href="mlec-20250630.xsd#mlec_AdditionalConvertibleNotesReceivedAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="AdditionalConvertibleNotesReceivedAmount" order="29.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConversionOptionStrikePrice" xlink:href="mlec-20250630.xsd#mlec_ConversionOptionStrikePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="ConversionOptionStrikePrice" order="30.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfOutstandingAmountInitialInterestRate" xlink:href="mlec-20250630.xsd#mlec_PercentageOfOutstandingAmountInitialInterestRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="PercentageOfOutstandingAmountInitialInterestRate" order="31.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfCashPaymentInterestRate" xlink:href="mlec-20250630.xsd#mlec_PercentageOfCashPaymentInterestRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="PercentageOfCashPaymentInterestRate" order="32.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ContingentPayment" xlink:href="mlec-20250630.xsd#mlec_ContingentPayment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="ContingentPayment" order="33.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ContingentPaymentCurrent" xlink:href="mlec-20250630.xsd#mlec_ContingentPaymentCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="ContingentPaymentCurrent" order="34.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfCapital" xlink:href="mlec-20250630.xsd#mlec_PercentageOfCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="PercentageOfCapital" order="35.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfDividendsTaxedShares" xlink:href="mlec-20250630.xsd#mlec_PercentageOfDividendsTaxedShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="PercentageOfDividendsTaxedShares" order="36.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ContingentPurchasePrice" xlink:href="mlec-20250630.xsd#mlec_ContingentPurchasePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems" xlink:to="ContingentPurchasePrice" order="37.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfComprehensiveIncomeAbstract"/>
    <loc xlink:type="locator" xlink:label="InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeDetailsTable"/>
    <loc xlink:type="locator" xlink:label="InformationAboutComponentOfConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentOfConsolidatedStatementsOfComprehensiveIncomeLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:to="InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeDetailsTable" xlink:to="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:to="ifrs-full_SignificantInvestmentsInSubsidiariesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="NetWheatTechnologyLicensingMember" xlink:href="mlec-20250630.xsd#mlec_NetWheatTechnologyLicensingMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:to="NetWheatTechnologyLicensingMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NetHB4SoybeanMember" xlink:href="mlec-20250630.xsd#mlec_NetHB4SoybeanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:to="NetHB4SoybeanMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeDetailsTable" xlink:to="InformationAboutComponentOfConsolidatedStatementsOfComprehensiveIncomeLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashTransferred" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashTransferred"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentOfConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="ifrs-full_CashTransferred" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PercentageOfEntitysRevenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PercentageOfEntitysRevenue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentOfConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="ifrs-full_PercentageOfEntitysRevenue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueOfAcquiree" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueOfAcquiree"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentOfConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="ifrs-full_RevenueOfAcquiree" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentOfConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherTangibleOrIntangibleAssetsTransferred" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherTangibleOrIntangibleAssetsTransferred"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentOfConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="ifrs-full_OtherTangibleOrIntangibleAssetsTransferred" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/TaxationDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="ifrs-full_TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/InformationaboutComponentsofEquityDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="InformationAboutComponentsOfEquityAbstract" xlink:href="mlec-20250630.xsd#mlec_InformationAboutComponentsOfEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="InformationaboutComponentsofEquityDetailsTable" xlink:href="mlec-20250630.xsd#mlec_InformationaboutComponentsofEquityDetailsTable"/>
    <loc xlink:type="locator" xlink:label="InformationaboutComponentsofEquityDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_InformationaboutComponentsofEquityDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationAboutComponentsOfEquityAbstract" xlink:to="InformationaboutComponentsofEquityDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityDetailsTable" xlink:to="ifrs-full_ClassesOfShareCapitalAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OrdinarySharesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OrdinarySharesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_OrdinarySharesMember" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityDetailsTable" xlink:to="InformationaboutComponentsofEquityDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="VotePerShare" xlink:href="mlec-20250630.xsd#mlec_VotePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityDetailsLineItems" xlink:to="VotePerShare" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InformationaboutComponentsofEquityDetailsLineItems" xlink:to="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/JointVenturesandAssociatesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfJointVenturesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfJointVenturesAbstract"/>
    <loc xlink:type="locator" xlink:label="JointVenturesandAssociatesDetailsTable" xlink:href="mlec-20250630.xsd#mlec_JointVenturesandAssociatesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfJointVenturesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfJointVenturesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfJointVenturesAbstract" xlink:to="JointVenturesandAssociatesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="JointVenturesandAssociatesDetailsTable" xlink:to="srt_StatementGeographicalAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="country_AR" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_AR"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="country_AR" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="JointVenturesandAssociatesDetailsTable" xlink:to="ifrs-full_DisclosureOfJointVenturesLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfProfitForObligationToLegalReserve" xlink:href="mlec-20250630.xsd#mlec_PercentageOfProfitForObligationToLegalReserve"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfJointVenturesLineItems" xlink:to="PercentageOfProfitForObligationToLegalReserve" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MaximumPercentageOfCapitalForObligationToLegalReserve" xlink:href="mlec-20250630.xsd#mlec_MaximumPercentageOfCapitalForObligationToLegalReserve"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfJointVenturesLineItems" xlink:to="MaximumPercentageOfCapitalForObligationToLegalReserve" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/SegmentInformationDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract"/>
    <loc xlink:type="locator" xlink:label="NumberOfComplementaryComponents" xlink:href="mlec-20250630.xsd#mlec_NumberOfComplementaryComponents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:to="NumberOfComplementaryComponents" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/FinancialInstrumentsRiskManagementDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="FinancialInstrumentsRiskManagementAbstract" xlink:href="mlec-20250630.xsd#mlec_FinancialInstrumentsRiskManagementAbstract"/>
    <loc xlink:type="locator" xlink:label="PercentageOfEstimatesThatDevaluationOrAnAppreciation" xlink:href="mlec-20250630.xsd#mlec_PercentageOfEstimatesThatDevaluationOrAnAppreciation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialInstrumentsRiskManagementAbstract" xlink:to="PercentageOfEstimatesThatDevaluationOrAnAppreciation" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ShareBasedPaymentDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareBasedPaymentDetailsTable" xlink:href="mlec-20250630.xsd#mlec_ShareBasedPaymentDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="ShareBasedPaymentDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentDetailsTable" xlink:to="ifrs-full_ClassesOfFinancialInstrumentsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="ifrs-full_ClassesOfFinancialInstrumentsDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="VolumeWeightedAveragePriceMember" xlink:href="mlec-20250630.xsd#mlec_VolumeWeightedAveragePriceMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="VolumeWeightedAveragePriceMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BusinessCombinationsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentDetailsTable" xlink:to="ifrs-full_BusinessCombinationsAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BusinessCombinationsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BusinessCombinationsAxis" xlink:to="ifrs-full_BusinessCombinationsDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ProFarmGroupIncMember" xlink:href="mlec-20250630.xsd#mlec_ProFarmGroupIncMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BusinessCombinationsAxis" xlink:to="ProFarmGroupIncMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentDetailsTable" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="EmployeeStockPurchasePlanMember" xlink:href="mlec-20250630.xsd#mlec_EmployeeStockPurchasePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="EmployeeStockPurchasePlanMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StandAloneStockOptionGrantMember" xlink:href="mlec-20250630.xsd#mlec_StandAloneStockOptionGrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="StandAloneStockOptionGrantMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="EmployeeStockOptionPlanMember" xlink:href="mlec-20250630.xsd#mlec_EmployeeStockOptionPlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="EmployeeStockOptionPlanMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="PastShareOptionPlanMember" xlink:href="mlec-20250630.xsd#mlec_PastShareOptionPlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="PastShareOptionPlanMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShareOptionsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShareOptionsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_ShareOptionsMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="PerformanceShareOptionPlanMember" xlink:href="mlec-20250630.xsd#mlec_PerformanceShareOptionPlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="PerformanceShareOptionPlanMember" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="StockIncentivePlan2013Member" xlink:href="mlec-20250630.xsd#mlec_StockIncentivePlan2013Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="StockIncentivePlan2013Member" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentDetailsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="BioceresCropSolutionsCorpMember" xlink:href="mlec-20250630.xsd#mlec_BioceresCropSolutionsCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="BioceresCropSolutionsCorpMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentDetailsTable" xlink:to="ifrs-full_RangeAxis" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_BottomOfRangeMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_TopOfRangeMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentDetailsTable" xlink:to="srt_StatementScenarioAxis" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="EBITDAMember" xlink:href="mlec-20250630.xsd#mlec_EBITDAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="EBITDAMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentDetailsTable" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedPaymentsIncentiveIncreases" xlink:href="mlec-20250630.xsd#mlec_ShareBasedPaymentsIncentiveIncreases"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ShareBasedPaymentsIncentiveIncreases" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="IfrsDefinedContributionPlanEmployerMatchingContributionPercentOfEmployeesGrossPay" xlink:href="mlec-20250630.xsd#mlec_IfrsDefinedContributionPlanEmployerMatchingContributionPercentOfEmployeesGrossPay"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="IfrsDefinedContributionPlanEmployerMatchingContributionPercentOfEmployeesGrossPay" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SharesSubjectToEmployeeStockPurchasePlan" xlink:href="mlec-20250630.xsd#mlec_SharesSubjectToEmployeeStockPurchasePlan"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="SharesSubjectToEmployeeStockPurchasePlan" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfClosingPriceOnFirstAndLastBusinessDayToDeterminePurchasePrice" xlink:href="mlec-20250630.xsd#mlec_PercentageOfClosingPriceOnFirstAndLastBusinessDayToDeterminePurchasePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="PercentageOfClosingPriceOnFirstAndLastBusinessDayToDeterminePurchasePrice" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ifrs-full_ExercisePriceShareOptionsGranted2019" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedPaymentAwardExpirationDate" xlink:href="mlec-20250630.xsd#mlec_ShareBasedPaymentAwardExpirationDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ShareBasedPaymentAwardExpirationDate" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod" xlink:href="mlec-20250630.xsd#mlec_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedPaymentPeriodOfWeightedAveragePriceVwapOfOrdinarySharesForCashlessBasisExercise" xlink:href="mlec-20250630.xsd#mlec_ShareBasedPaymentPeriodOfWeightedAveragePriceVwapOfOrdinarySharesForCashlessBasisExercise"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ShareBasedPaymentPeriodOfWeightedAveragePriceVwapOfOrdinarySharesForCashlessBasisExercise" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ThresholdEarningsBeforeInterestTaxesDepreciationAndAmortization" xlink:href="mlec-20250630.xsd#mlec_ThresholdEarningsBeforeInterestTaxesDepreciationAndAmortization"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ThresholdEarningsBeforeInterestTaxesDepreciationAndAmortization" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage" xlink:href="mlec-20250630.xsd#mlec_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfOptionsEstimatedExercisePercent" xlink:href="mlec-20250630.xsd#mlec_NumberOfOptionsEstimatedExercisePercent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="NumberOfOptionsEstimatedExercisePercent" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedPaymentArrangementConversionOfEquityAwardsOutstandingToOptionOrRestrictedStockUnits" xlink:href="mlec-20250630.xsd#mlec_ShareBasedPaymentArrangementConversionOfEquityAwardsOutstandingToOptionOrRestrictedStockUnits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="ShareBasedPaymentArrangementConversionOfEquityAwardsOutstandingToOptionOrRestrictedStockUnits" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/EventsOccurringAftertheReportingPeriodDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract"/>
    <loc xlink:type="locator" xlink:label="EventsOccurringAftertheReportingPeriodDetailsTable" xlink:href="mlec-20250630.xsd#mlec_EventsOccurringAftertheReportingPeriodDetailsTable"/>
    <loc xlink:type="locator" xlink:label="EventsOccurringAftertheReportingPeriodDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_EventsOccurringAftertheReportingPeriodDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:to="EventsOccurringAftertheReportingPeriodDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsOccurringAftertheReportingPeriodDetailsTable" xlink:to="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:to="ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="SubsequentEventsMember" xlink:href="mlec-20250630.xsd#mlec_SubsequentEventsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:to="SubsequentEventsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MajorBusinessCombinationMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorBusinessCombinationMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:to="ifrs-full_MajorBusinessCombinationMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsOccurringAftertheReportingPeriodDetailsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="BioceresSAMember" xlink:href="mlec-20250630.xsd#mlec_BioceresSAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="BioceresSAMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="BioceresLLCMember" xlink:href="mlec-20250630.xsd#mlec_BioceresLLCMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="BioceresLLCMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsOccurringAftertheReportingPeriodDetailsTable" xlink:to="EventsOccurringAftertheReportingPeriodDetailsLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Provisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Provisions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsOccurringAftertheReportingPeriodDetailsLineItems" xlink:to="ifrs-full_Provisions" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AmountOfFinancialDebtUnderRestructuring" xlink:href="mlec-20250630.xsd#mlec_AmountOfFinancialDebtUnderRestructuring"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsOccurringAftertheReportingPeriodDetailsLineItems" xlink:to="AmountOfFinancialDebtUnderRestructuring" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PledgedOrTransferredSharesQuantity" xlink:href="mlec-20250630.xsd#mlec_PledgedOrTransferredSharesQuantity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsOccurringAftertheReportingPeriodDetailsLineItems" xlink:to="PledgedOrTransferredSharesQuantity" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IssuedConvertiblePreferenceShares" xlink:href="mlec-20250630.xsd#mlec_IssuedConvertiblePreferenceShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsOccurringAftertheReportingPeriodDetailsLineItems" xlink:to="IssuedConvertiblePreferenceShares" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ProceedFromIssuedShares" xlink:href="mlec-20250630.xsd#mlec_ProceedFromIssuedShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsOccurringAftertheReportingPeriodDetailsLineItems" xlink:to="ProceedFromIssuedShares" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PreferenceOfAccruePerAnnum" xlink:href="mlec-20250630.xsd#mlec_PreferenceOfAccruePerAnnum"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsOccurringAftertheReportingPeriodDetailsLineItems" xlink:to="PreferenceOfAccruePerAnnum" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ProceedsFromIssueOfEquityInstrumentsOnConversionOfDebt" xlink:href="mlec-20250630.xsd#mlec_ProceedsFromIssueOfEquityInstrumentsOnConversionOfDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsOccurringAftertheReportingPeriodDetailsLineItems" xlink:to="ProceedsFromIssueOfEquityInstrumentsOnConversionOfDebt" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WorkingCapital" xlink:href="mlec-20250630.xsd#mlec_WorkingCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsOccurringAftertheReportingPeriodDetailsLineItems" xlink:to="WorkingCapital" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ParValuePerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ParValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsOccurringAftertheReportingPeriodDetailsLineItems" xlink:to="ifrs-full_ParValuePerShare" order="8.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="ConsecutiveBusinessDays" xlink:href="mlec-20250630.xsd#mlec_ConsecutiveBusinessDays"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsOccurringAftertheReportingPeriodDetailsLineItems" xlink:to="ConsecutiveBusinessDays" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsOccurringAftertheReportingPeriodDetailsLineItems" xlink:to="ifrs-full_GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://www.moolecscience.com/role/ReverseStockSplitAftertheReportingPeriodDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="DisclosureOfReverseStockSplitAfterTheReportingPeriodAbstract" xlink:href="mlec-20250630.xsd#mlec_DisclosureOfReverseStockSplitAfterTheReportingPeriodAbstract"/>
    <loc xlink:type="locator" xlink:label="ReverseStockSplitAftertheReportingPeriodDetailsTable" xlink:href="mlec-20250630.xsd#mlec_ReverseStockSplitAftertheReportingPeriodDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ReverseStockSplitAftertheReportingPeriodDetailsLineItems" xlink:href="mlec-20250630.xsd#mlec_ReverseStockSplitAftertheReportingPeriodDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfReverseStockSplitAfterTheReportingPeriodAbstract" xlink:to="ReverseStockSplitAftertheReportingPeriodDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReverseStockSplitAftertheReportingPeriodDetailsTable" xlink:to="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioForecastMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:to="srt_ScenarioForecastMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReverseStockSplitAftertheReportingPeriodDetailsTable" xlink:to="ReverseStockSplitAftertheReportingPeriodDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ReverseStockSplit" xlink:href="mlec-20250630.xsd#mlec_ReverseStockSplit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ReverseStockSplitAftertheReportingPeriodDetailsLineItems" xlink:to="ReverseStockSplit" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://xbrl.sec.gov/dei/role/document/Cover" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AddressTypeDomain"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="ifrs-full_ClassesOfShareCapitalAxis" order="10.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitiesTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntitiesTable" xlink:to="ifrs-full_ClassesOfShareCapitalAxis" order="11.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressesTable" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressesTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesTable" xlink:to="ifrs-full_ClassesOfShareCapitalAxis" order="12.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityListingsTable" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityListingsTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsTable" xlink:to="ifrs-full_ClassesOfShareCapitalAxis" order="13.0"/>
    <loc xlink:type="locator" xlink:label="dei_NameChangeEventTable" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NameChangeEventTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_NameChangeEventTable" xlink:to="ifrs-full_ClassesOfShareCapitalAxis" order="14.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="OrdinarySharesWithNominalValueOfUS010PerShareMember" xlink:href="mlec-20250630.xsd#mlec_OrdinarySharesWithNominalValueOfUS010PerShareMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="OrdinarySharesWithNominalValueOfUS010PerShareMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantsExercisableForOrdinarySharesMember" xlink:href="mlec-20250630.xsd#mlec_WarrantsExercisableForOrdinarySharesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="WarrantsExercisableForOrdinarySharesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://xbrl.sec.gov/dei/role/document/AuditInformation" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="dei_EntityAddressesAddressTypeAxis" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorTable" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_AuditorTable" xlink:to="dei_EntityAddressesAddressTypeAxis" order="10.0"/>
    <loc xlink:type="locator" xlink:label="dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AddressTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="dei_BusinessContactMember" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_BusinessContactMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_BusinessContactMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorTable_0" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_AuditorTable_0" xlink:to="ifrs-full_ClassesOfShareCapitalAxis" order="11.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="OrdinarySharesWithNominalValueOfUS010PerShareMember" xlink:href="mlec-20250630.xsd#mlec_OrdinarySharesWithNominalValueOfUS010PerShareMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="OrdinarySharesWithNominalValueOfUS010PerShareMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantsExercisableForOrdinarySharesMember" xlink:href="mlec-20250630.xsd#mlec_WarrantsExercisableForOrdinarySharesMember"/>
<!-- [WMV6][TVdBuBQwbXwcE9+cN0ToQhbXUg93AfBVsaMsMRPGg93NQDlur0mtvhg78+4pgJ7yRmIR01mGEtt1qlHdWREC33yBomX6WCnclWbSzARfsU2gcQfmvhFCVYYonqNKEolumgXklklq2C0g3TRd4VRNcYV6wobRDPHF1j5XA5uOj94MtDh4mDTpzIuM85fRJR6606E4Ls9sg81x/SXGKov41+d2tJfhrqn1VbHiJ49duDGRqDvn5RLHg2uIC1R1EBFECVa/2qhJvx9ZAGRO1d2+ulSJu/b7AI5Ak0qHua4SK0WvWYnxttTqAbvkiT/1Q3tOaROJfjX+y6s7JYrtPtwSKP0hd+j+awQdUtdqNHArvXCdmhvoEOnFthP0IdL49Sy6cK+jqm/p] CSR-->
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="WarrantsExercisableForOrdinarySharesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2025 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">20-F<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentRegistrationStatement', window );">Document Registration Statement</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentShellCompanyReport', window );">Document Shell Company Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAccountingStandard', window );">Document Accounting Standard</a></td>
<td class="text">International Financial Reporting Standards<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Moolec Science SA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001937737<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41586<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">E9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--06-30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityContactPersonnelLineItems', window );"><strong>Entity Contact Personnel [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">89 Nexus Way, Camana Bay<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Grand Cayman<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">KY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">KY1-9009<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="nump">10,891,761<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=mlec_OrdinarySharesWithNominalValueOfUS010PerShareMember', window );">Ordinary Shares, with nominal value of US$0.10 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary Shares, with nominal value of
US$0.10 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MLEC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=mlec_WarrantsExercisableForOrdinarySharesMember', window );">Warrants, exercisable for ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Warrants, exercisable for ordinary
shares<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MLECW<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityContactPersonnelLineItems', window );"><strong>Entity Contact Personnel [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">Valeria Falottico<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelEmailAddress', window );">Contact Personnel Email Address</a></td>
<td class="text">ir@moolecscience.com<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">Ocampo Bis 210<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Santa Fe2000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Rosario Sud<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">AR<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">KY1-9009<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPhoneFaxNumbersLineItems', window );"><strong>Entity Phone Fax Numbers [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">+54<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">341 486 1100<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelEmailAddress">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Email address of contact personnel.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelEmailAddress</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAccountingStandard">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAccountingStandard</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:accountingStandardItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentRegistrationStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a registration statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentRegistrationStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentShellCompanyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentShellCompanyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityContactPersonnelLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityContactPersonnelLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPhoneFaxNumbersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPhoneFaxNumbersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=mlec_OrdinarySharesWithNominalValueOfUS010PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=mlec_OrdinarySharesWithNominalValueOfUS010PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=mlec_WarrantsExercisableForOrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=mlec_WarrantsExercisableForOrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorTable', window );"><strong>Auditor [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Sebastian Azagra<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">1349<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Rosario, Argentina<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorOpinionTextBlock', window );">Auditor Opinion [Text Block]</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Opinion on the Financial Statements</i></b></p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have audited the accompanying consolidated statements of financial
position of Moolec Science SA and its subsidiaries (the &#8220;Company&#8221;) as of June 30, 2025 and 2024, and the related consolidated
statements of comprehensive income, of changes in shareholders&#8217; deficit / equity and of cash flows for each of the three years in
the period ended June 30, 2025, including the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;).
In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company
as of June 30, 2025 and 2024, and the results of its operations and its cash flows for each of the three years in the period ended June
30, 2025 in conformity with IFRS Accounting Standards as issued by the International Accounting Standards Board.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorOpinionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X<br> -Number 210<br> -Section 2<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorOpinionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statement of Comprehensive Income - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeStatementAbstract', window );"><strong>Profit or loss [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenues from contracts with customers</a></td>
<td class="nump">$ 333,611,248<span></span>
</td>
<td class="nump">$ 466,376,330<span></span>
</td>
<td class="nump">$ 420,867,429<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromGovernmentGrants', window );">Government grants</a></td>
<td class="nump">3,412<span></span>
</td>
<td class="nump">197,519<span></span>
</td>
<td class="nump">93,509<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets', window );">Initial recognition and changes in the fair value of biological assets at the point of harvest</a></td>
<td class="nump">1,764,863<span></span>
</td>
<td class="num">(45,746)<span></span>
</td>
<td class="nump">610,554<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of sales</a></td>
<td class="num">(203,424,872)<span></span>
</td>
<td class="num">(279,368,328)<span></span>
</td>
<td class="num">(235,464,072)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ChangeInNetRealizableValueOfAgricultural', window );">Changes in the net realizable value of agricultural products after harvest</a></td>
<td class="num">(1,541,204)<span></span>
</td>
<td class="num">(2,385,069)<span></span>
</td>
<td class="num">(4,351,433)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="num">(15,138,510)<span></span>
</td>
<td class="num">(17,422,487)<span></span>
</td>
<td class="num">(15,943,987)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="num">(125,908,240)<span></span>
</td>
<td class="num">(126,340,822)<span></span>
</td>
<td class="num">(116,531,274)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Share of profit or loss of joint ventures and associates</a></td>
<td class="num">(36,927,610)<span></span>
</td>
<td class="num">(21,023,150)<span></span>
</td>
<td class="nump">47,709,605<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherOperatingIncomeExpense', window );">Other income or expenses, net</a></td>
<td class="num">(56,589,216)<span></span>
</td>
<td class="num">(703,265)<span></span>
</td>
<td class="nump">1,055,299<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Operating (loss) profit</a></td>
<td class="num">(104,150,129)<span></span>
</td>
<td class="nump">19,284,982<span></span>
</td>
<td class="nump">98,045,630<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceIncomeCost', window );">Financial cost</a></td>
<td class="num">(41,809,445)<span></span>
</td>
<td class="num">(37,634,153)<span></span>
</td>
<td class="num">(33,576,632)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherFinanceIncomeCost', window );">Other financial results</a></td>
<td class="num">(24,043,905)<span></span>
</td>
<td class="num">(9,608,981)<span></span>
</td>
<td class="num">(13,674,756)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">(Loss) Profit before income tax</a></td>
<td class="num">(170,003,479)<span></span>
</td>
<td class="num">(27,958,152)<span></span>
</td>
<td class="nump">50,794,242<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income tax</a></td>
<td class="num">(6,636,121)<span></span>
</td>
<td class="num">(1,103,152)<span></span>
</td>
<td class="nump">2,328,366<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">(Loss) Profit for the year</a></td>
<td class="num">(176,639,600)<span></span>
</td>
<td class="num">(29,061,304)<span></span>
</td>
<td class="nump">53,122,608<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax', window );">Items that may be subsequently reclassified to profit and loss</a></td>
<td class="num">(3,680,709)<span></span>
</td>
<td class="num">(1,092,833)<span></span>
</td>
<td class="num">(911,896)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent', window );">Equity holders of the parent</a></td>
<td class="num">(114,009,391)<span></span>
</td>
<td class="num">(32,875,350)<span></span>
</td>
<td class="nump">39,068,323<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations', window );">Foreign exchange differences on translation of foreign operations from joint ventures</a></td>
<td class="num">(802,200)<span></span>
</td>
<td class="nump">977,482<span></span>
</td>
<td class="num">(46,541)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests', window );">Non-controlling interests</a></td>
<td class="num">(66,310,918)<span></span>
</td>
<td class="nump">2,721,213<span></span>
</td>
<td class="nump">11,675,040<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax', window );">Foreign exchange differences on translation of foreign operations</a></td>
<td class="num">(2,878,509)<span></span>
</td>
<td class="num">(2,070,315)<span></span>
</td>
<td class="num">(865,355)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive (loss)</a></td>
<td class="num">(180,320,309)<span></span>
</td>
<td class="num">(30,154,137)<span></span>
</td>
<td class="nump">50,743,363<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ItemsThatWillNotBeSubsequentlyReclassifiedToLossAndProfit', window );">Items that will not be subsequently reclassified to loss and profit</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,467,349)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTaxOfJointVenturesAndAssociates', window );">Revaluation of property, plant and equipment, net of tax, of joint ventures and associates</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(184,630)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTax', window );">Revaluation of property, plant and equipment, net of tax</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,282,719)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive (loss) profit</a></td>
<td class="num">(180,320,309)<span></span>
</td>
<td class="num">(30,154,137)<span></span>
</td>
<td class="nump">50,743,363<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToAbstract', window );"><strong>(Loss) / profit for the year attributable to:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOwnersOfParent', window );">Equity holders of the parent</a></td>
<td class="num">(111,460,708)<span></span>
</td>
<td class="num">(32,685,398)<span></span>
</td>
<td class="nump">40,435,923<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests', window );">Non-controlling interests</a></td>
<td class="num">(65,178,892)<span></span>
</td>
<td class="nump">3,624,094<span></span>
</td>
<td class="nump">12,686,685<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">(Loss) Profit for the year</a></td>
<td class="num">$ (176,639,600)<span></span>
</td>
<td class="num">$ (29,061,304)<span></span>
</td>
<td class="nump">$ 53,122,608<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EarningsPerShareAbstract', window );"><strong>(Loss) /Profit per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShare', window );">Basic (loss) / profit attributable to ordinary equity holders of the parent (in Dollars per share)</a></td>
<td class="num">$ (17.2461)<span></span>
</td>
<td class="num">$ (5.6146)<span></span>
</td>
<td class="nump">$ 8.8034<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DilutedEarningsLossPerShare', window );">Diluted (loss) / profit attributable to ordinary equity holders of the parent (in Dollars per share)</a></td>
<td class="num">$ (17.2461)<span></span>
</td>
<td class="num">$ (5.6146)<span></span>
</td>
<td class="nump">$ 8.8034<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeAbstract', window );"><strong>Total comprehensive (loss) / income attributable to:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax', window );">Items that may be subsequently reclassified to profit and loss</a></td>
<td class="num">$ (3,680,709)<span></span>
</td>
<td class="num">$ (1,092,833)<span></span>
</td>
<td class="num">$ (911,896)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent', window );">Equity holders of the parent</a></td>
<td class="num">(114,009,391)<span></span>
</td>
<td class="num">(32,875,350)<span></span>
</td>
<td class="nump">39,068,323<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations', window );">Foreign exchange differences on translation of foreign operations from joint ventures</a></td>
<td class="num">(802,200)<span></span>
</td>
<td class="nump">977,482<span></span>
</td>
<td class="num">(46,541)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests', window );">Non-controlling interests</a></td>
<td class="num">(66,310,918)<span></span>
</td>
<td class="nump">2,721,213<span></span>
</td>
<td class="nump">11,675,040<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax', window );">Foreign exchange differences on translation of foreign operations</a></td>
<td class="num">(2,878,509)<span></span>
</td>
<td class="num">(2,070,315)<span></span>
</td>
<td class="num">(865,355)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive (loss)</a></td>
<td class="num">(180,320,309)<span></span>
</td>
<td class="num">(30,154,137)<span></span>
</td>
<td class="nump">50,743,363<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ItemsThatWillNotBeSubsequentlyReclassifiedToLossAndProfit', window );">Items that will not be subsequently reclassified to loss and profit</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,467,349)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTaxOfJointVenturesAndAssociates', window );">Revaluation of property, plant and equipment, net of tax, of joint ventures and associates</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(184,630)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTax', window );">Revaluation of property, plant and equipment, net of tax</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,282,719)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive (loss) profit</a></td>
<td class="num">$ (180,320,309)<span></span>
</td>
<td class="num">$ (30,154,137)<span></span>
</td>
<td class="nump">$ 50,743,363<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81A<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of comprehensive income attributable to non-controlling interests. [Refer: Comprehensive income; Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81B<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81B_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of comprehensive income attributable to owners of the parent. [Refer: Comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81B<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81B_b_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutedEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutedEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncomeCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncomeCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gains (losses) recognised in other comprehensive income on exchange differences on the translation of financial statements of foreign operations, net of tax, before reclassification adjustments. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 41<br> -IssueDate 2025-01-01<br> -Paragraph 50<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=41&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_50_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 273<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_273_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 273<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_273_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 79<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 192<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_192&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 192<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_192&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, related to exchange differences on translation of the financial statements of a parent company or a stand-alone entity to a different presentation currency. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income that will be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph IG6<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_IG6&amp;doctype=Implementation%20Guidance<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 82A<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_82A&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherFinanceIncomeCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherFinanceIncomeCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherOperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherOperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 17<br> -IssueDate 2025-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing and discontinued operations attributable to non-controlling interests. [Refer: Profit (loss); Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 12<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_12_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81B<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81B_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81B<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81B_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2025-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2025-01-01<br> -Paragraph IE33<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_IE33&amp;doctype=Illustrative%20Examples<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 126<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_126&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 266<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_266&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 266<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_266&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromContractsWithCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2025-01-01<br> -Paragraph 114<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_114&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2025-01-01<br> -Paragraph 113<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_113_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromContractsWithCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromGovernmentGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 20<br> -IssueDate 2025-01-01<br> -Paragraph 39<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=20&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_39_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromGovernmentGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23_g&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 82<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_82_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ChangeInNetRealizableValueOfAgricultural">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in the net realizable value of agricultural products after harvest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ChangeInNetRealizableValueOfAgricultural</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ItemsThatWillNotBeSubsequentlyReclassifiedToLossAndProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Items that will not be subsequently reclassified to loss and profit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ItemsThatWillNotBeSubsequentlyReclassifiedToLossAndProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revaluation of property, plant and equipment, net of tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTaxOfJointVenturesAndAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revaluation of property, plant and equipment, net of tax, of joint ventures and associates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTaxOfJointVenturesAndAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statement of Financial Position - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsAbstract', window );"><strong>NON-CURRENT ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentFinancialAssets', window );">Other financial assets</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 190,517<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentReceivables', window );">Other receivables</a></td>
<td class="nump">664,493<span></span>
</td>
<td class="nump">27,887,034<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTaxAssetsNoncurrent', window );">Recoverable income tax</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">10,889<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">14,476,230<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InvestmentsInJointVenturesAndAssociates', window );">Investments in joint ventures and associates</a></td>
<td class="nump">94,147,971<span></span>
</td>
<td class="nump">92,795,851<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="nump">3,345,170<span></span>
</td>
<td class="nump">74,612,434<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentProperty', window );">Investment properties</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">560,783<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="nump">75,258,790<span></span>
</td>
<td class="nump">177,331,280<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">112,163,432<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right of use asset</a></td>
<td class="nump">100,896<span></span>
</td>
<td class="nump">11,601,752<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Total non-current assets</a></td>
<td class="nump">173,517,320<span></span>
</td>
<td class="nump">511,630,202<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssetsAbstract', window );"><strong>CURRENT ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">767,919<span></span>
</td>
<td class="nump">52,994,865<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentFinancialAssets', window );">Other financial assets</a></td>
<td class="nump">8,254,261<span></span>
</td>
<td class="nump">14,667,607<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Trade receivables</a></td>
<td class="nump">6,085,400<span></span>
</td>
<td class="nump">209,007,195<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentReceivables', window );">Other receivables</a></td>
<td class="nump">13,849,164<span></span>
</td>
<td class="nump">34,657,383<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTaxAssetsCurrent', window );">Recoverable income tax</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">655,691<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventories</a></td>
<td class="nump">2,235,482<span></span>
</td>
<td class="nump">125,929,768<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentBiologicalAssets', window );">Biological assets</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">294,134<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Total current assets</a></td>
<td class="nump">31,192,226<span></span>
</td>
<td class="nump">438,206,643<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="nump">204,709,546<span></span>
</td>
<td class="nump">949,836,845<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>SHAREHOLDERS&#8217; DEFICIT / EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Issued capital</a></td>
<td class="nump">1,089,176<span></span>
</td>
<td class="nump">598,369<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ShareToBeIssuedAmount', window );">Shared to be issued</a></td>
<td class="nump">77,589<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SharesPremium', window );">Shares premium</a></td>
<td class="nump">39,668,135<span></span>
</td>
<td class="num">(5,516,907)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_OwnSharesHeld', window );">Own shares held</a></td>
<td class="num">(422,146)<span></span>
</td>
<td class="num">(444,473)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_StockOptionsAndShareBasedIncentives', window );">Stock options and share based incentives</a></td>
<td class="nump">7,271,881<span></span>
</td>
<td class="nump">6,222,175<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RetainedEarnings', window );">Retained earnings / (deficit)</a></td>
<td class="num">(110,317,946)<span></span>
</td>
<td class="nump">1,142,761<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_RevaluationOfPropertyPlantAndEquipmentReserve', window );">Revaluation of property, plant and equipment reserve</a></td>
<td class="num">(1,323,916)<span></span>
</td>
<td class="num">(1,323,916)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReserveOfExchangeDifferencesOnTranslation', window );">Foreign currency translation reserve</a></td>
<td class="num">(2,013,856)<span></span>
</td>
<td class="nump">534,827<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAttributableToOwnersOfParent', window );">Shareholders&#8217; deficit / Equity attributable to owners of the parent</a></td>
<td class="num">(65,971,083)<span></span>
</td>
<td class="nump">1,212,836<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncontrollingInterests', window );">Non-controlling interest</a></td>
<td class="num">(16,902,519)<span></span>
</td>
<td class="nump">248,788,534<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Total shareholders&#8217; deficit / Equity</a></td>
<td class="num">(82,873,602)<span></span>
</td>
<td class="nump">250,001,370<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilitiesAbstract', window );"><strong>NON-CURRENT LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Borrowings</a></td>
<td class="nump">1,348,173<span></span>
</td>
<td class="nump">127,248,305<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentContractLiabilities', window );">Deferred revenue and advances from customers</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,925,138<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentGovernmentGrants', window );">Government grants</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">782<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_JointVenturesAndAssociatesLiabilities', window );">Joint ventures and associates</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">296,455<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="nump">15,767,275<span></span>
</td>
<td class="nump">34,500,445<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentProvisions', window );">Provisions</a></td>
<td class="nump">16,154,574<span></span>
</td>
<td class="nump">17,484,715<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ConsiderationForAcquisitionOfAssetsNonCurrent', window );">Consideration for acquisition</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,005,143<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SecuredDebtNonCurrent', window );">Convertible and non-convertible notes</a></td>
<td class="nump">18,260,456<span></span>
</td>
<td class="nump">80,809,686<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">8,161,359<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Total non-current liabilities</a></td>
<td class="nump">51,530,478<span></span>
</td>
<td class="nump">272,432,028<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilitiesAbstract', window );"><strong>CURRENT LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayables', window );">Trade and other payables</a></td>
<td class="nump">7,323,933<span></span>
</td>
<td class="nump">168,937,536<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermBorrowings', window );">Borrowings</a></td>
<td class="nump">227,154,007<span></span>
</td>
<td class="nump">234,510,751<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentProvisionsForEmployeeBenefits', window );">Employee benefits and social security</a></td>
<td class="nump">243,634<span></span>
</td>
<td class="nump">7,506,831<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities', window );">Deferred revenue and advances from customers</a></td>
<td class="nump">1,260<span></span>
</td>
<td class="nump">3,924,801<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTaxLiabilitiesCurrent', window );">Income tax payable</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">4,825,271<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentGovernmentGrants', window );">Government grants</a></td>
<td class="nump">1,280<span></span>
</td>
<td class="nump">3,655<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentWarrantLiability', window );">Warrant liabilities</a></td>
<td class="nump">1,211,093<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ConsiderationForAcquisitionOfAssetsCurrent', window );">Consideration for acquisition</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">4,571,824<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">117,463<span></span>
</td>
<td class="nump">3,122,778<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Total current liabilities</a></td>
<td class="nump">236,052,670<span></span>
</td>
<td class="nump">427,403,447<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Liabilities', window );">Total liabilities</a></td>
<td class="nump">287,583,148<span></span>
</td>
<td class="nump">699,835,475<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Total shareholders&#8217; deficit / equity and liabilities</a></td>
<td class="nump">$ 204,709,546<span></span>
</td>
<td class="nump">$ 949,836,845<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 169<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_169&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 169<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_169&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentBiologicalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current biological assets. [Refer: Biological assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_f&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentBiologicalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current deferred income including current contract liabilities. [Refer: Deferred income including contract liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentGovernmentGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current government grants recognised in the statement of financial position as deferred income. [Refer: Government [member]; Government grants]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentGovernmentGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 69<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentProvisionsForEmployeeBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current provisions for employee benefits. [Refer: Provisions for employee benefits]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_e&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentProvisionsForEmployeeBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTaxAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current amount of current tax assets. [Refer: Current tax assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph n<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_n&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTaxAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTaxAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The non-current amount of current tax assets. [Refer: Current tax assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph n<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_n&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTaxAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTaxLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current amount of current tax liabilities. [Refer: Current tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph n<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_n&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTaxLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables. [Refer: Trade receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 68<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentWarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current warrant liabilities. [Refer: Warrant liability]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentWarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph f<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_f_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph f<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_f_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 56<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph f<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_f_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph f<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_f_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 56<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of equity attributable to the owners of the parent. This specifically excludes non-controlling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph r<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_r&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2025-01-01<br> -Paragraph 134<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_134_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2025-01-01<br> -Paragraph 135<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_135_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2025-01-01<br> -Paragraph B67<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B67_d&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 254<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_254_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 255<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_255_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 254<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_254_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 255<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_255_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 37<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 37<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Inventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current inventories. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 36<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_36_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 164<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_164_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 164<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_164_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_g&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 68<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Inventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property (land or a building - or part of a building - or both) held (by the owner or by the lessee as a right-of-use asset) to earn rentals or for capital appreciation or both, rather than for: (a) use in the production or supply of goods or services or for administrative purposes; or (b) sale in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 40<br> -IssueDate 2025-01-01<br> -Paragraph 76<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=40&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_76&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 40<br> -IssueDate 2025-01-01<br> -Paragraph 79<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=40&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_79_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 269<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_269&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 271<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_271_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 269<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_269&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 271<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_271_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssuedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value of capital issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssuedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LongtermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The non-current portion of non-current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LongtermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of equity in a subsidiary not attributable, directly or indirectly, to a parent. [Refer: Total for all subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 10<br> -IssueDate 2025-01-01<br> -Paragraph 22<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=10&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_22&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 12<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_12_f&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph q<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_q&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that do not meet the definition of current assets. [Refer: Current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentContractLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current contract liabilities. [Refer: Contract liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2025-01-01<br> -Paragraph 105<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_105&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentContractLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentGovernmentGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current government grants recognised on the statement of financial position as deferred income. [Refer: Government [member]; Government grants]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentGovernmentGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 69<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current provisions, including provisions for employee benefits. [Refer: Provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph l<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_l&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current financial assets that the entity does not separately disclose in the same statement or note. [Refer: Other financial assets; Current financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current other receivables. [Refer: Other receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current financial assets that the entity does not separately disclose in the same statement or note. [Refer: Other financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current other receivables. [Refer: Other receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReserveOfExchangeDifferencesOnTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing exchange differences on translation of financial statements recognised in other comprehensive income and accumulated in equity. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2025-01-01<br> -Paragraph 52<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_52_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 218<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_218_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 218<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_218_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReserveOfExchangeDifferencesOnTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetainedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing the entity's cumulative undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph IG6<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_IG6&amp;doctype=Implementation%20Guidance<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetainedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 53<br> -Subparagraph j<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShorttermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShorttermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph k<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_k&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ConsiderationForAcquisitionOfAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of consideration for acquisition of assets recognised as of balance sheet date, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ConsiderationForAcquisitionOfAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ConsiderationForAcquisitionOfAssetsNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of consideration for acquisition of assets recognised as of balance sheet date, classified as non-current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ConsiderationForAcquisitionOfAssetsNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_InvestmentsInJointVenturesAndAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of investments accounted for using the equity method, asset position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_InvestmentsInJointVenturesAndAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_JointVenturesAndAssociatesLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of joint ventures and associates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_JointVenturesAndAssociatesLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_OwnSharesHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of own shares held.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_OwnSharesHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_RevaluationOfPropertyPlantAndEquipmentReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of revaluation of property plant and equipment reserve.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_RevaluationOfPropertyPlantAndEquipmentReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_SecuredDebtNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of secured debt, non-current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_SecuredDebtNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ShareToBeIssuedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of shares to be issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ShareToBeIssuedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_SharesPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount received or receivable from the issuance of the entity's shares in excess of nominal value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_SharesPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_StockOptionsAndShareBasedIncentives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock options and share based incentives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_StockOptionsAndShareBasedIncentives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statement of Changes in Shareholders&#8217; Deficit / Equity - USD ($)<br></strong></div></th>
<th class="th"><div>Issued capital</div></th>
<th class="th"><div>Shares to be issued</div></th>
<th class="th"><div>Own shares held</div></th>
<th class="th"><div>Share premium</div></th>
<th class="th"><div>Stock options and share based incentives</div></th>
<th class="th"><div>Retained (deficit) earnings</div></th>
<th class="th"><div>Foreign currency translation reserve</div></th>
<th class="th"><div>Revaluation of PP&amp;E and effect of tax rate change</div></th>
<th class="th"><div>Attributable to the equity holders of the parent</div></th>
<th class="th"><div>Non-controlling Interests</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance at Jun. 30, 2022</a></td>
<td class="nump">$ 326,694<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (7,566,943)<span></span>
</td>
<td class="nump">$ 777,376<span></span>
</td>
<td class="num">$ (6,607,764)<span></span>
</td>
<td class="nump">$ 1,773,218<span></span>
</td>
<td class="num">$ (1,004,755)<span></span>
</td>
<td class="num">$ (12,302,174)<span></span>
</td>
<td class="nump">$ 137,171,291<span></span>
</td>
<td class="nump">$ 124,869,117<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners', window );">Increase in capital</a></td>
<td class="nump">203,476<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">555,760<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">759,236<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">759,236<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl', window );">Changes in ownership interests in subsidiaries</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(29,474,351)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(29,474,351)<span></span>
</td>
<td class="num">(46,940,078)<span></span>
</td>
<td class="num">(76,414,429)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share-based incentives of subsidiaries</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,076,480<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,076,480<span></span>
</td>
<td class="nump">3,009,120<span></span>
</td>
<td class="nump">4,085,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_IncreaseDecreaseThroughChangesInBusinessCombinationEquity', window );">Business combination</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,464,108<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">24,464,108<span></span>
</td>
<td class="nump">130,515,236<span></span>
</td>
<td class="nump">154,979,344<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DividendsPaid', window );">Distribution of dividends</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(452,129)<span></span>
</td>
<td class="num">(452,129)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">(Loss) / Profit for the year</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">40,435,923<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">40,435,923<span></span>
</td>
<td class="nump">12,686,685<span></span>
</td>
<td class="nump">53,122,608<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeBeforeTax', window );">Other comprehensive loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,048,439)<span></span>
</td>
<td class="num">(319,161)<span></span>
</td>
<td class="num">(1,367,600)<span></span>
</td>
<td class="num">(1,011,645)<span></span>
</td>
<td class="num">(2,379,245)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance at Jun. 30, 2023</a></td>
<td class="nump">530,170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(12,021,426)<span></span>
</td>
<td class="nump">1,853,856<span></span>
</td>
<td class="nump">33,828,159<span></span>
</td>
<td class="nump">724,779<span></span>
</td>
<td class="num">(1,323,916)<span></span>
</td>
<td class="nump">23,591,622<span></span>
</td>
<td class="nump">234,978,480<span></span>
</td>
<td class="nump">258,570,102<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners', window );">Increase in capital</a></td>
<td class="nump">68,199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,319)<span></span>
</td>
<td class="nump">206,720<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">267,600<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">267,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl', window );">Changes in ownership interests in subsidiaries</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(437,154)<span></span>
</td>
<td class="nump">6,297,799<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">5,860,645<span></span>
</td>
<td class="nump">557,267<span></span>
</td>
<td class="nump">6,417,912<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share-based incentives of subsidiaries</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">4,368,319<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">4,368,319<span></span>
</td>
<td class="nump">9,592,291<span></span>
</td>
<td class="nump">13,960,610<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_IncreaseDecreaseThroughChangesInBusinessCombinationEquity', window );">Business combination</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,114,083<span></span>
</td>
<td class="nump">1,114,083<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DividendsPaid', window );">Distribution of dividends</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(174,800)<span></span>
</td>
<td class="num">(174,800)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">(Loss) / Profit for the year</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(32,685,398)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(32,685,398)<span></span>
</td>
<td class="nump">3,624,094<span></span>
</td>
<td class="num">(29,061,304)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeBeforeTax', window );">Other comprehensive loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(189,952)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(189,952)<span></span>
</td>
<td class="num">(902,881)<span></span>
</td>
<td class="num">(1,092,833)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance at Jun. 30, 2024</a></td>
<td class="nump">598,369<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(444,473)<span></span>
</td>
<td class="num">(5,516,907)<span></span>
</td>
<td class="nump">6,222,175<span></span>
</td>
<td class="nump">1,142,761<span></span>
</td>
<td class="nump">534,827<span></span>
</td>
<td class="num">(1,323,916)<span></span>
</td>
<td class="nump">1,212,836<span></span>
</td>
<td class="nump">248,788,534<span></span>
</td>
<td class="nump">250,001,370<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners', window );">Increase in capital</a></td>
<td class="nump">111,345<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">346,160<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">457,505<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">457,505<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl', window );">Changes in ownership interests in subsidiaries</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">22,327<span></span>
</td>
<td class="nump">11,791,403<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">11,813,730<span></span>
</td>
<td class="nump">11,416,836<span></span>
</td>
<td class="nump">23,230,566<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share-based incentives of subsidiaries</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,049,706<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,049,706<span></span>
</td>
<td class="nump">3,326,658<span></span>
</td>
<td class="nump">4,376,364<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_IncreaseDecreaseThroughChangesInBusinessCombinationEquity', window );">Business combination</a></td>
<td class="nump">379,462<span></span>
</td>
<td class="nump">77,589<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">33,047,480<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">33,504,531<span></span>
</td>
<td class="nump">6,316,790<span></span>
</td>
<td class="nump">39,821,321<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughOtherDistributionsToOwners', window );">BIOX of deconsolidation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(220,368,368)<span></span>
</td>
<td class="num">(220,368,368)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DividendsPaid', window );">Distribution of dividends</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(72,051)<span></span>
</td>
<td class="num">(72,051)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">(Loss) / Profit for the year</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(111,460,708)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(111,460,708)<span></span>
</td>
<td class="num">(65,178,892)<span></span>
</td>
<td class="num">(176,639,600)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeBeforeTax', window );">Other comprehensive loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,548,683)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,548,683)<span></span>
</td>
<td class="num">(1,132,026)<span></span>
</td>
<td class="num">(3,680,709)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance at Jun. 30, 2025</a></td>
<td class="nump">$ 1,089,176<span></span>
</td>
<td class="nump">$ 77,589<span></span>
</td>
<td class="num">$ (422,146)<span></span>
</td>
<td class="nump">$ 39,668,136<span></span>
</td>
<td class="nump">$ 7,271,881<span></span>
</td>
<td class="num">$ (110,317,947)<span></span>
</td>
<td class="num">$ (2,013,856)<span></span>
</td>
<td class="num">$ (1,323,916)<span></span>
</td>
<td class="num">$ (65,971,083)<span></span>
</td>
<td class="num">$ (16,902,519)<span></span>
</td>
<td class="num">$ (82,873,602)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DividendsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of dividends recognised as distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 138<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_138&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 107<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_107&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DividendsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity through changes in ownership interests in subsidiaries that do not result in loss of control. [Refer: Total for all subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in equity through other contributions by owners that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughOtherDistributionsToOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease in equity through distributions to owners that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughOtherDistributionsToOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, before tax. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 91<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_91_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 17<br> -IssueDate 2025-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_IncreaseDecreaseThroughChangesInBusinessCombinationEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity through changes in business combination, equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_IncreaseDecreaseThroughChangesInBusinessCombinationEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statement of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th" colspan="2"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract', window );"><strong>OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">(Loss) / profit for the year</a></td>
<td class="num">$ (176,639,600)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (29,061,304)<span></span>
</td>
<td class="nump">$ 53,122,608<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfCashPaymentsAbstract', window );"><strong>Adjustments to reconcile (loss) / profit to net cash flows</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncomeTaxExpense', window );">Income tax</a></td>
<td class="nump">6,636,121<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,103,152<span></span>
</td>
<td class="num">(2,328,366)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDepreciationExpense', window );">Depreciation of property, plant and equipment</a></td>
<td class="nump">6,015,700<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,799,998<span></span>
</td>
<td class="nump">4,938,927<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AmortizationOfIntangibleAsset', window );">Amortization of intangible assets</a></td>
<td class="nump">11,201,048<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">12,113,223<span></span>
</td>
<td class="nump">11,004,584<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DepreciationOfLeasedAssets', window );">Depreciation of leased assets</a></td>
<td class="nump">5,036,703<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,418,956<span></span>
</td>
<td class="nump">3,565,894<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForFairValueGainsLosses', window );">Gain from a bargain purchase</a></td>
<td class="num">(1,473,482)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_RemeasurementOfPreviouslyHeldInterest', window );">Remeasurement of previously held interest</a></td>
<td class="nump">1,666,680<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForSharebasedPayments', window );">Share-based incentive and stock options</a></td>
<td class="nump">4,386,688<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">14,199,480<span></span>
</td>
<td class="nump">3,480,178<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Share of profit or loss of joint ventures and associates</a></td>
<td class="nump">36,927,610<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">21,023,150<span></span>
</td>
<td class="num">(47,709,605)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ProvisionsForContingencies', window );">Provisions for contingencies</a></td>
<td class="nump">336,919<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">653,574<span></span>
</td>
<td class="nump">239,292<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AllowanceForImpairmentOfTradeDebtors', window );">Allowance for impairment of trade debtors</a></td>
<td class="nump">7,123,716<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">753,428<span></span>
</td>
<td class="nump">1,327,385<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AllowanceForObsolescences', window );">Allowance for obsolescence</a></td>
<td class="nump">1,547,723<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">586,515<span></span>
</td>
<td class="nump">1,066,777<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets', window );">Initial recognition and changes in the fair value of biological assets</a></td>
<td class="num">(1,764,863)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">45,746<span></span>
</td>
<td class="num">(610,554)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnChangeInFairValueEstimatesOfBiologicalAssetsForCurrentPeriod', window );">Changes in the net realizable value of agricultural products after harvest</a></td>
<td class="nump">1,541,204<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,385,069<span></span>
</td>
<td class="nump">4,351,433<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForFinanceCosts', window );">Financial results</a></td>
<td class="nump">65,853,350<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">47,243,134<span></span>
</td>
<td class="num">(47,251,388)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets', window );">Gain on sale of equipment and intangible assets</a></td>
<td class="num">(7,649,848)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(125,464)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_WorkingCapitalAdjustmentsOperatingActivitiesAbstract', window );"><strong>Working capital adjustments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable', window );">Trade receivables</a></td>
<td class="nump">26,040,164<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(41,256,269)<span></span>
</td>
<td class="num">(14,179,711)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables', window );">Other receivables</a></td>
<td class="nump">2,039,034<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(6,338,099)<span></span>
</td>
<td class="num">(36,705,492)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories', window );">Inventories and biological assets</a></td>
<td class="nump">34,880,985<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">15,285,866<span></span>
</td>
<td class="num">(8,572,529)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables', window );">Trade and other payables</a></td>
<td class="num">(18,847,998)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">16,286,414<span></span>
</td>
<td class="nump">14,172,818<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities', window );">Employee benefits and social security</a></td>
<td class="num">(1,089,185)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,413,413)<span></span>
</td>
<td class="nump">2,074,795<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AdjustmentsForDecreaseIncreaseInGovernmentGrants', window );">Government grants</a></td>
<td class="num">(3,157)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(188,518)<span></span>
</td>
<td class="num">(93,091)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities', window );">Income tax paid</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(853,299)<span></span>
</td>
<td class="num">(4,072,347)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities', window );">Deferred revenue and advances from customers</a></td>
<td class="num">(129,099)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(21,103,777)<span></span>
</td>
<td class="nump">21,019,535<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivities', window );">Net cash flows generated by / (used in) operating activities</a></td>
<td class="nump">3,636,413<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">39,557,562<span></span>
</td>
<td class="num">(41,158,857)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract', window );"><strong>INVESTMENT ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities', window );">Proceeds from sale of property, plant and equipment</a></td>
<td class="nump">390,381<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">336,726<span></span>
</td>
<td class="nump">137,357<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCashReceiptsFromSalesOfInterestsInJointVenturesClassifiedAsInvestingActivities', window );">Investment in joint ventures and associates</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,085,676<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities', window );">Net cash received from business combination</a></td>
<td class="nump">554,420<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">37,508<span></span>
</td>
<td class="nump">4,373,265<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities', window );">Loss of controlling interest</a></td>
<td class="num">(32,695,079)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(18,097)<span></span>
</td>
<td class="num">(1,081,808)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities', window );">Proceeds from financial assets</a></td>
<td class="nump">21,731,347<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">62,836,432<span></span>
</td>
<td class="nump">1,316,980<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod', window );">Investment in financial assets</a></td>
<td class="num">(11,351,880)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(65,567,062)<span></span>
</td>
<td class="num">(8,488,144)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities', window );">Purchase of property, plant and equipment</a></td>
<td class="num">(5,651,506)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(9,936,611)<span></span>
</td>
<td class="num">(11,491,899)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsForDevelopmentProjectExpenditure', window );">Capitalized development expenditures</a></td>
<td class="num">(8,614,448)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(11,855,766)<span></span>
</td>
<td class="num">(10,753,047)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities', window );">Purchase of intangible assets</a></td>
<td class="num">(350,843)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3,233,316)<span></span>
</td>
<td class="num">(688,287)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivities', window );">Net cash flows used in investing activities</a></td>
<td class="num">(35,987,608)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(27,400,186)<span></span>
</td>
<td class="num">(25,589,907)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract', window );"><strong>FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities', window );">Proceeds from borrowings</a></td>
<td class="nump">403,333,190<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">187,994,310<span></span>
</td>
<td class="nump">150,631,747<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities', window );">Repayment of borrowings and financed payments</a></td>
<td class="num">(380,033,708)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(145,044,508)<span></span>
</td>
<td class="num">(38,457,281)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestPaidClassifiedAsFinancingActivities', window );">Interest payments</a></td>
<td class="num">(28,088,688)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(36,803,697)<span></span>
</td>
<td class="num">(25,639,013)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities', window );">Leased assets payments</a></td>
<td class="num">(5,501,387)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(4,879,108)<span></span>
</td>
<td class="num">(3,855,517)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities', window );">Cash dividend distributed by non-controlling interest</a></td>
<td class="num">(72,051)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(174,800)<span></span>
</td>
<td class="num">(452,129)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsOfOtherEquityInstruments', window );">Other financial payments</a></td>
<td class="num">(3,731,493)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,850,252)<span></span>
</td>
<td class="num">(3,007,154)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PurchaseOfOwnShares', window );">Purchase of own shares</a></td>
<td class="num">(926,899)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(734,388)<span></span>
</td>
<td class="num">(2,996,947)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivities', window );">Net cash flows (used in) / generated by financing activities</a></td>
<td class="num">(15,021,036)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,492,443)<span></span>
</td>
<td class="nump">76,223,706<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents', window );">Net increase / (decrease) in cash and cash equivalents</a></td>
<td class="num">(47,372,231)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">10,664,933<span></span>
</td>
<td class="nump">9,474,942<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InflationEffectsOnCashAndCashEquivalents', window );">Inflation effects on cash and cash equivalents</a></td>
<td class="num">(3,352)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(189,309)<span></span>
</td>
<td class="num">(195,181)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition', window );">Cash and cash equivalents as of beginning of the year</a></td>
<td class="nump">52,994,865<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">49,265,020<span></span>
</td>
<td class="nump">34,851,505<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents', window );">Effect of exchange rate changes on cash and equivalents</a></td>
<td class="num">(4,851,363)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(6,745,779)<span></span>
</td>
<td class="nump">5,133,754<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition', window );">Cash and cash equivalents as of the end of the year</a></td>
<td class="nump">$ 767,919<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 52,994,865<span></span>
</td>
<td class="nump">$ 49,265,020<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">On March 28, 2025, BIOX, a former subsidiary,
agreed to transfer all rights, licenses, and materials containing or pertaining to the Soy ANF trait and pay $750,000&#160;to a Arcadia
Biosciences Inc in exchange for (i) RG and OX Wheat Patents and RS exclusive rights; (ii) the cancellation of all Royalty Payments, which
included&#160;25% of the Net Wheat Technology Licensing Revenues and&#160;6% of the Net HB4 Soybean Revenues up to $10&#160;million;
and (iii) the release from any Performance Benchmark Obligations related to the RG, OX, and RS Varieties which amounted to $8.1&#160;million.
This transaction resulted in the accounting of a gain from the exchange of intangible assets amounting to $7.5&#160;million.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in trade and other receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other receivables; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDepreciationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for depreciation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDepreciationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForFairValueGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForFairValueGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForFinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForFinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncomeTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncomeTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for the increase (decrease) in deferred income including contract liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Deferred income including contract liabilities; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in employee benefit liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in trade and other payables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other payables; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 14<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_14&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForSharebasedPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForSharebasedPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash and cash equivalents in the statement of cash flows when different from the amount of cash and cash equivalents in the statement of financial position. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cash flows arising from losing control of subsidiaries or other businesses, classified as investing activities. [Refer: Total for all subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 39<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_39&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity, from continuing and discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents, from continuing and discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities. [Refer: Total for all subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 39<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_39&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfCashPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfCashPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for dividends paid to non-controlling interests, classified as financing activities. [Refer: Non-controlling interests; Dividends paid to non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnChangeInFairValueEstimatesOfBiologicalAssetsForCurrentPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 41<br> -IssueDate 2025-01-01<br> -Paragraph 40<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=41&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_40&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnChangeInFairValueEstimatesOfBiologicalAssetsForCurrentPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 41<br> -IssueDate 2025-01-01<br> -Paragraph 51<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=41&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_51&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 41<br> -IssueDate 2025-01-01<br> -Section Example 1 XYZ Dairy Ltd<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=41&amp;code=ifrs-tx-2025-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS41_IE_ex1_TI<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from income taxes paid or refunded, classified as operating activities. [Refer: Income taxes paid (refund)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 14<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_14_f&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 169<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_169&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 169<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_169&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestPaidClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for interest paid, classified as financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestPaidClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCashReceiptsFromSalesOfInterestsInJointVenturesClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of interests in joint ventures (other than receipts for those instruments considered to be cash equivalents and those held for dealing or trading purposes), classified as investing activities. [Refer: Total for all joint ventures [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 16<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_16_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCashReceiptsFromSalesOfInterestsInJointVenturesClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsForDevelopmentProjectExpenditure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for expenditure related to development projects.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 16<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsForDevelopmentProjectExpenditure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsOfOtherEquityInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for payments for equity instruments that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsOfOtherEquityInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from borrowings obtained. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of long-term assets that the entity does not separately disclose in the same statement or note, classified as investing activities. [Refer: Assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_16_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_16_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 17<br> -IssueDate 2025-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of intangible assets, classified as investing activities. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchase of interests in investments accounted for using the equity method. [Refer: Investments accounted for using equity method]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 16<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to settle borrowings, classified as financing activities. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23_g&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 82<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_82_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_AdjustmentsForDecreaseIncreaseInGovernmentGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in government grants to reconcile profit (loss) to net cash flow from (used in) operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_AdjustmentsForDecreaseIncreaseInGovernmentGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_AllowanceForImpairmentOfTradeDebtors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Allowance for impairment of trade debtors.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_AllowanceForImpairmentOfTradeDebtors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_AllowanceForObsolescences">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Allowance for obsolescence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_AllowanceForObsolescences</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_AmortizationOfIntangibleAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization of intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_AmortizationOfIntangibleAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DepreciationOfLeasedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation of leased assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DepreciationOfLeasedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_InflationEffectsOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effect of inflation effects on cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_InflationEffectsOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ProvisionsForContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of provisions for contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ProvisionsForContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_PurchaseOfOwnShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the payment of own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_PurchaseOfOwnShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_RemeasurementOfPreviouslyHeldInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remeasurement of previously held interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_RemeasurementOfPreviouslyHeldInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_WorkingCapitalAdjustmentsOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_WorkingCapitalAdjustmentsOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The Group&#8217;s Business Reorganization and General Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>The Group&#8217;s Business Reorganization and General Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory', window );">The Group&#8217;s Business Reorganization and General Information</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><b>1.</b></td><td style="text-align: justify"><b><span style="text-decoration:underline">THE GROUP&#8217;S BUSINESS REORGANIZATION AND GENERAL
INFORMATION</span></b></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Moolec Science SA (the &#8220;Company&#8221; or
the &#8220;Group&#8221;) is an exempted company incorporated under the laws of the laws of the Cayman Islands.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The company was previously registered with the
Luxembourg Trade and Companies&#8217; Register (<i>Registre de Commerce et des Soci&#233;t&#233;s, Luxembourg</i>) under number B268440.
On May 22, 2025 (the &#8220;Effective Date&#8221;), the Company changed its jurisdiction by redomiciling Moolec Science (Luxembourg) from
the Grand Duchy of Luxembourg to the Cayman Islands as Moolec Science (Cayman Islands) by way of continuation pursuant to Part XII of
the Companies Act (Revised) of the Cayman Islands (the &#8220;Redomiciliation&#8221;). Following the Redomiciliation, the Company&#8217;s
address is at c/o Ogier Global (Cayman) -89 Nexus Way, Camana Bay, Grand Cayman KY1-9009.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>The Bioceres Group Business Combination Agreement.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Before the end of the fiscal year, on June 16,
2025, the Company consummated a business combination (the &#8220;Business Combination&#8221;). Prior to such consummation, a series of
previous steps had taken place, as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 14, 2025, Moolec Science (Luxembourg) made
effective a reverse stock split of its Ordinary Shares (the &#8220;Reverse Stock Split&#8221;) on the consolidation ratio of ten-to-one
(the &#8220;Consolidation Ratio&#8221;), pursuant to which holders of Ordinary Shares received one Ordinary Share for every ten Ordinary
Shares held.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 22, 2025, the Company changed its jurisdiction
by redomiciling Moolec Science (Luxembourg) from the Grand Duchy of Luxembourg to the Cayman Islands as Moolec Science (Cayman Islands)
by way of continuation pursuant to Part XII of the Companies Act (Revised) of the Cayman Islands. On the Effective Date, all of the shares
of Moolec Science (Luxembourg), par value $0.10 per share by operation of law became shares of Moolec Science (Cayman Islands), par value
$0.10 per share (the &#8220;Ordinary Shares&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">After completion of the Reverse Stock Split, all
references to the Ordinary Shares, share data, per share data and related information have been adjusted for the Consolidation Ratio to
reflect the Reverse Stock Split. The Reverse Stock Split has consolidated each ten of the Ordinary Shares into one Ordinary Share, with
a new par value of $0.10 per Ordinary Share. Upon completion of the Reverse Stock Split, no fractional Ordinary Shares were issued, and
any fractional Ordinary Shares resulting from the Reverse Stock Split were rounded up to the nearest whole Ordinary Share. Except for
the adjustments that resulted from the treatment of fractional shares, the Reverse Stock Split did not have any dilutive effect on the
shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Through the consummation of the Business Combination, Moolec Science
SA acquired all the issued and outstanding equity interests of Bioceres Group and Nutrecon and 50% of Gentle Tech, integrating mature
agricultural biologicals and seed businesses, nutritional solutions, and emerging technology ventures. In consideration for the contributed
entities, the Company issued approximately 6.2 million of ordinary shares to the shareholders of Bioceres Group, 450,000 of ordinary shares
and 500,000 private warrants with an exercise price of US$20.00 per share to the shareholders of Nutrecon, and 132,750 ordinary shares
to the shareholders of Gentle Tech. Also, Moolec Science SA committed to issue additional ordinary shares twelve months after the acquisition
date, representing the 10% of the total shares to be issued (the &#8220;Holdback&#8221;), representing approximately 0.7 million of ordinary
shares to the shareholders of Bioceres Group, 50,000 of ordinary shares to the shareholders of Nutrecon, and 14,750 ordinary shares to
the shareholders of Gentle Tech.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 16, 2025, following the consummation of the Business Combination,
the Company initiated integration processes across organizational, operational, and IT functions to support competitiveness and long-term
sustainability. In parallel, management continued to advance the ongoing operations, which remain crucial to maintaining business continuity
and supporting the successful execution of the integration and growth strategy. The consolidated results as of and for the year ended
June 30, 2025 (&#8220;FY2025&#8221;) reflect purchase accounting. The prior periods as of and for the year ended June 30, 2024 (&#8220;FY2024&#8221;)
and for the year ended June 30, 2023 reflects the Predecessor on a stand-alone basis and does not include any effects of the Business
Combination. As a result, variances between FY2025 and FY2024 primarily reflect changes in scope and basis of presentation rather than
purely period-over-period operating trends, and therefore the periods are not directly comparable. Effective as of the Closing (i.e.,
June 16, 2025), the Company accounted for the Business Combination under IFRS 3, <i>Business Combinations</i>, using the acquisition method
of accounting and treating the transaction as a reverse acquisition. Under this approach, Bioceres Group (the legal subsidiary) was considered
the accounting acquirer, and Moolec Science SA (the legal acquirer) was considered the accounting acquiree, together with Gentle Tech
and Nutrecon.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">1.1 Going Concern</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Business Combination, initially
announced on April 17, 2025, in which the Company, Bioceres Group (formerly, Bioceres Group PLC, one of the main shareholders of the
Company), Gentle Tech and Nutrecon entered into the Bioceres Group Business Combination Agreement, pursuant to which several parties
transferred their respective holdings in Bioceres Group, Nutrecon and Gentle Tech (together, the &#8220;Contributed Entities&#8221;)
to the Company, in exchange of a combination of newly issued Company&#8217;s shares, and warrants, to the shareholders of the
Contributed Entities. Following the closing, Moolec became the legal parent company of the combined group comprising Bioceres Group,
Gentle Tech, and Nutrecon. The Business Combination was ratified by Moolec shareholders at the Extraordinary General Meeting
(&#8220;EGM&#8221;) held on June 16, 2025, with 77% of the outstanding shares present at the meeting, and 98% of the votes cast were
in favor of the transaction. From an accounting perspective and based on the guidance of IFRS 3, Bioceres Group Limited is deemed to
be the accounting acquirer. The transaction was subsequently consummated on the same date, June 16, 2025 (the
&#8220;Closing&#8221;).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 18, 2025, Bioceres Crop Solutions Corp.
(BIOX), a public company controlled until that date by Bioceres Group Limited, entered into an amendment with the Secured Notes&#8217;
holders by which the holders of the Secured Notes waived the breach of covenants that led to the default of the debt (specifically, the
breach of covenants related to the Consolidated Total Net Leverage Ratio (determined as the ratio of (a) Consolidated Total Net Debt as
of the last day of such Test Period to (b) Consolidated EBITDA of the Issuer and its Subsidiaries for such Test Period) of 3.75x as of
March 31, 2025), retrospectively modifying the required Consolidated Total Net Leverage Ratio to 5x Consolidated Total Net Leverage Ratio,
and extended the maturity of the Secured Notes to August 31, 2027. In accordance with the terms of the amendments, effective June 24,
2025, Gloria Montaron Estrada, Enrique Lopez Lecube, and Keith McGovern were replaced in Bioceres Crop Solutions Corp.&#8217;s Board of
Directors by Milen Marinov, Noah Kolatch and Scott Crocco, who were nominated by certain holders of the Secured Notes. Bioceres Crop Solutions
Corp. agreed, for so long as the Secured Notes remain outstanding, to continue to nominate Messrs. Marinov, Kolatch and Crocco (or such
other persons as may be nominated as their replacements) for additional terms as directors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The effect of the changes in the terms of the Secured Notes of Bioceres
Crop Solutions, resulted in the loss of de facto control of that subsidiary and consequently, its deconsolidation. The equity method was
applied to account for the investment in such former subsidiary, as well as for other investments in joint ventures and associates (the
&#8220;BIOX deconsolidation&#8221;). Even when there was a deconsolidation of the business, the Company will continue to be affected by
BIOX business due to the HB4 royalty agreement. It is important to note that the effects of the loss of control in BIOX represents substantially
all of the Company&#8217;s business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a result of the loss of control over BIOX, access to financing that
Bioceres S.A., its wholly owned subsidiary Bioceres LLC, Bioceres Group Limited and Moolec Science SA had until then, was restricted or
limited.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In June 2025, Bioceres S.A., one of the Argentine
subsidiaries of Bioceres Group Limited, defaulted on a portion of its financial debt that was due that month. As a result, Bioceres S.A.
had initiated a debt restructuring process for its financial debt for an aggregate amount of $36.4 million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In July 2025, Bioceres LLC, a wholly owned subsidiary
of Bioceres S.A., received a notice of default on its financial debt&#160;in the amount of $69.5 million. The creditor conducted a public
auction for 3,062,500 pledged BIOX shares, pursuant to the New York Uniform Commercial Code. Management has responded to the creditor,
reserving all rights, remedies, and defenses. As of June 30, 2025, the current debt amounts to $58.0 million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The defaults by Bioceres S.A. and Bioceres LLC do not have implications
in other debts as there are no cross-default clauses on the remaining financial debt of the Group. There are no guarantees granted above
Bioceres S.A. and Bioceres LLC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of June 30, 2025, the Group had a negative working capital amounting
to $204,860,444, and a shareholders&#8217; deficit of $82,873,602. Additionally, the Group reported recurring operating losses amounting
to $104,150,129.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company had the financial support of its main
shareholders and considering the aforementioned events that derived in the loss of the financial support that was previously provided
by Bioceres Group (and who is also no longer a shareholder of the Company), and, consequently, raise a material uncertainty which may
cast significant doubt (or raise substantial doubt as contemplated by PCAOB standards) &#160;about the ability of Moolec Science SA to
continue as a going concern, currently, the Group lacks sufficient financial resources to meet its obligations or fully implement its
business plan. Without securing additional capital, the Group will not be able to sustain its operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The uncertainty surrounding the ability to secure
additional funding and the potential for continued operational losses contribute to substantial doubt about the Group&#8217;s ability
to continue as a going concern.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management has plans to address the Group&#8217;s
financial situation as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Theo I SCSp</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November 28, 2025, subsequent to the reporting
date, Theo I SCSp received a conditional payment order from district court of&#160; Luxembourg, and therefore the General Partners engaged
Ogier (Luxembourg) SCS represented by its general partner Ogier Luxembourg (GP) S.&#224;.r.l&#160; formally as their legal advisor to
assist with Theo I SCSp&#8217;s declaration of bankruptcy before the Luxembourg District Court. The declaration of bankruptcy will declare
Theo I SCSp bankrupt and appoint a receiver who will take control over the management of the company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The loss of control constitutes the derecognition
event under IFRS 10.25. Accordingly, the Group will derecognize the assets and liabilities of Theo I SCSp and will remeasure its retained
interest at fair value in accordance with IFRS 9 at the date of the derecognition event. This will result in the recognition of an estimated
gain of $9.5 million in the consolidated statement of profit or loss as of the derecognition date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group will continue to measure its retained
interest in Theo I SCSp at fair value through profit or loss until the liquidation process is formally completed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Bioceres S.A. and Bioceres LLC</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 16, 2025, subsequent to the reporting date, the Board of
Directors of Bioceres S.A. formally approved the initiation of voluntary bankruptcy proceedings and instructed management to seek and
appoint a trustee (&#8220;<i>s&#237;ndico</i>&#8221;) to oversee the process. The commencement of the voluntary bankruptcy proceedings
and the transfer of decision-making authority to the trustee will result in the Group losing control over Bioceres S.A. in accordance
with the principles of IFRS 10 Consolidated Financial Statements. As Bioceres LLC is a wholly owned subsidiary of Bioceres S.A., the Group
simultaneously will lose control over Bioceres LLC as well.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under IFRS 10.25, the date on which control is
lost constitutes the derecognition event. Accordingly, after December 16, 2025, the Group will derecognize the assets and liabilities
of Bioceres S.A. and Bioceres LLC and will remeasure any retained interest at fair value in accordance with IFRS 9 Financial Instruments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The resulting derecognition effects are expected to generate an approximate
gain of $91.0 million related to the loss of control of Bioceres S.A. and an additional approximate gain of $5.3 million related to the
loss of control of Bioceres LLC (including the loss of holding in BIOX, therefore it will no longer be an equity method associate). These
amounts will be recognized in the consolidated statement of profit or loss as of the derecognition date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group will continue to monitor the progress of the voluntary bankruptcy
and liquidation proceedings and will update the accounting treatment as necessary in accordance with IFRS.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management expects that certain shareholders and/or
investors will continue or commence to provide new financing lines.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">However, there is no assurance that investors
and shareholders will continue to provide financing, or that the Group&#8217;s future operations will generate profitability. The uncertainty
surrounding the ability to secure additional funding and the potential for continued operational losses contribute to raise a material
uncertainty which may cast significant doubt (or raise substantial doubt as contemplated by PCAOB standards) about the Group&#8217;s ability
to continue as a going concern.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consolidated financial statements of Moolec
Science SA do not include any adjustments that may be required to address the potential impacts on the recoverability and classification
of assets or the amounts and classifications liabilities, should the Group be unable to continue as a going concern.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accordingly, the financial statements of Moolec
Science SA for periods prior to the Closing reflect the historical financial information of Bioceres Group. The financial information
as of and for the year ended June 30, 2025 reflects the figures corresponding to Bioceres Group and incorporates the effects of applying
the acquisition method to Moolec Science SA, Gentle Tech and Nutrecon, measured at fair value in accordance with IFRS 3.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for general information about financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 128<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_128&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 51<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_51&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting Standards and Basis of Preparation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AccountingStandardsAndBasiofPreparationAbstract', window );"><strong>Accounting Standards and Basis of Preparation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory', window );">ACCOUNTING STANDARDS AND BASIS OF PREPARATION</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><b>2.</b></td><td style="text-align: justify"><b><span style="text-decoration:underline">ACCOUNTING STANDARDS AND BASIS OF PREPARATION</span></b></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration:underline">Statement of compliance with IFRS as issued by IASB</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These consolidated financial statements of the
Group have been prepared in accordance with IFRS Accounting (&#8220;IFRS&#8221;) as issued by International Accounting Standard Board
(&#8220;IASB&#8221;), and interpretations issued by the IFRS Interpretations Committee (IFRIC), following the accounting policies as set
forth and summarized in Note 4 &#8211; &#8220;Summary of significant accounting policies&#8221;. All IFRS issued by the IASB, effective
at the time of preparing these consolidated financial statements have been applied.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration:underline">Authorization for the issue of the Consolidated financial statements</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These consolidated financial statements of the Group as of June 30,
2025 and 2024 and for the years ended June 30, 2025, and 2024 have been authorized by the Board of Directors of Moolec Science SA on December
29, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration:underline">Basis of measurement</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consolidated financial statements have been
prepared on the historical cost basis, except for items that are required to be accounted for at fair value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The significant accounting policies set out in
Note 4 &#8211; Summary of significant accounting policies have been consistently applied in preparing these consolidated financial statements
to all the periods presented, unless otherwise stated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Due to the activities of the Group, costs and
expenses presented in the statement of operations are classified according to their function. The statement of financial position has
been prepared based on the nature of the transactions, distinguishing: (a) current assets from non-current assets, where current assets
are assets that should be realized, sold or used during the normal operating cycle, or the assets owned with the aim of being sold in
the short-term (within 12 months); (b) current liabilities from non-current liabilities, where current liabilities are liabilities that
should be paid during the normal operating cycle or over the 12-month period subsequent to the reporting date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All other assets and liabilities are classified
as non-current. Current and deferred tax assets and liabilities (income tax credits / liabilities) are presented separately from each
other and from other assets and liabilities, classified as current and non-current, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consolidated financial statements of the Group
have been prepared using:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Accrual basis of accounting:</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accrual basis of accounting (except for cash flows
information). Under this basis of accounting, the effects of transactions and other events are recognized as they occur, even when there
are no cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration:underline">Functional currency and presentation currency</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Functional currency</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Items included in the financial statements of
each of the Group&#8217;s entities are measured using the currency of the primary economic market in which the entity operates (i.e.,
&#8220;the functional currency&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company and the main subsidiaries of the Group
have United States Dollars as functional currency.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Macroeconomic context &#8211; in recent years
Argentina&#8217;s macroeconomic scenario has featured a misalignment between inflation rates and the devaluation of the Argentine peso,
which became more pronounced during the first half of the year ended June 30, 2022. Notwithstanding such misalignment, the Company&#8217;s
Argentine subsidiaries have been able to continue pricing their products in U.S. dollars as the costs of products and services are set
in U.S. dollars. This has also been achievable as the demand for the type of products the Company commercializes is relatively inelastic
when compared to non-essential goods and services. Further, Argentina&#8217;s significant economic volatility has caused materials, and
other costs of providing goods that the Company acquires from the Argentine domestic market, to become increasingly indexed to the U.S.
dollar (i.e., denominated in Argentine Pesos but indexed to the U.S. dollar exchange rate).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the years ended June 30, 2025, 2024 and 2023, Argentinian subsidiaries,
that have Argentine Pesos as functional currency, had applied IAS 29 &#8220;Financial reporting in hyperinflationary economies&#8221;
which requires that the financial statements of an entity whose functional currency is the currency of a hyperinflationary economy, whether
these are based on the historical cost method or the current cost method, be stated in terms of the measuring unit current at the closing
date of the reporting period. For such purpose, the inflation produced since the acquisition date or the revaluation date, as applicable,
must be computed in non-monetary items. The standard details a series of factors to be considered for concluding whether an economy is
hyperinflationary, including, but not limited to, a cumulative inflation rate over a three-year period that approaches or exceeds 100%.
Inflation accumulated in three years, as of June 30, 2018, was over 100%. It was for this reason that, in accordance with IAS 29, the
Argentine economy had to be considered as hyperinflationary since July 1, 2018. Consequently, the Group has applied IAS 29 to these financial
statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During an inflationary period, any entity that
maintains an excess of monetary assets over monetary liabilities will lose purchasing power, and any entity that maintains an excess of
monetary liabilities over monetary assets will gain purchasing power, provided that such items are not subject to an adjustment mechanism.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Briefly, the restatement mechanism of IAS 29 establishes
that monetary assets and liabilities will not be restated because they are already expressed in a current unit of measurement at the end
of the reporting period. Assets and liabilities subject to adjustments based on specific agreements, will be adjusted according to those
agreements. Non-monetary items measured at their current values at the end of the reporting period, such as the net realizable value or
others, do not need to be restated. The remaining non-monetary assets and liabilities will be restated according to a general price index.
The loss or gain for the net monetary position will be included in the net result of the reporting period, revealing this information
in a separate line item.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The inflation adjustment to the initial balances
was calculated by means of a conversion factor derived from the Argentine price indexes published by the National Institute of Statistics.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Argentine price index as of June 30, 2025,
and 2024 was&#160;8,855.5681&#160;and&#160;6,351.7145, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Presentation currency</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consolidated financial statements of the Group
are presented in US dollars.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration:underline">Foreign currency</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Transactions entered into by Group entities in
a currency other than their functional currency are recorded at the relevant exchange rates as of the date upon which such transactions
occur. Foreign currency monetary assets and liabilities are translated at the prevailing exchanges rates as of the final day of each reporting
period. Exchange differences arising on the retranslation of unsettled monetary assets and liabilities are recognized immediately in profit
or loss, except for foreign currency borrowings qualifying as a hedge of a net investment in a foreign operation for which exchange differences
are recognized in other comprehensive income and accumulated in the foreign exchange reserve along with the exchange differences arising
on the retranslation of the foreign operation. Upon the disposal of a foreign operation, the cumulative exchange differences recognized
in the foreign exchange reserve relating to such operation up to the date of disposal are transferred to the Consolidated statement of
profit or loss and other comprehensive income as part of the profit or loss reorganized upon such disposal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration:underline">Business combination</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 16, 2025, it was completed the business combination with Bioceres
Group Limited, Nutrecon LLC and Gentle Technologies Corp. pursuant to the terms of the Business Combination Agreement approved by Moolec
Science SA&#8217;s shareholders. Through this transaction, Moolec Science SA acquired all the issued and outstanding equity interests
of Bioceres Group and Nutrecon and 50% of Gentle Tech, integrating mature agricultural biologicals and seed businesses, nutritional solutions,
and emerging technology ventures. In consideration for the contributed entities, the Company issued approximately 6.2 million of ordinary
shares to the shareholders of Bioceres Group, 450,000 of ordinary shares and 500,000 private warrants with an exercise price of US$20.00
per share to the shareholders of Nutrecon, and 132,750 ordinary shares to the shareholders of Gentle Tech. Also, Moolec Science SA committed
to issue additional ordinary shares twelve months after the acquisition date, representing the 10% of the total shares to be issued (the
&#8220;Holdback&#8221;), representing approximately 0.7 million of ordinary shares to the shareholders of Bioceres Group, 50,000 of ordinary
shares to the shareholders of Nutrecon, and 14,750 ordinary shares to the shareholders of Gentle Tech. As a result of this combination,
Bioceres Group, Nutrecon and Gentle Tech became subsidiaries of Moolec, and the Company evolved into a diversified life sciences and food-tech
platform, as more fully described below in Note 1 &#8211; The Group&#8217;s business reorganization and general information - &#8220;<i>The
Bioceres Group Business Combination Agreement&#8221;</i>. This business combination was accounted as reverse acquisition in accordance
with IFRS 3 &#8211; <i>Business Combinations</i>.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration:underline">Subsidiaries</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Where the Group holds a controlling interest in
an entity, such entity is classified as a subsidiary. The Group exercises control over such an entity if all three of the following elements
are present: (i) the Group has the power to direct or cause the direction of the management and policies of the entity; (ii) the Group
is exposed to the variable returns of such entity; and (iii) the Group has power to affect the variability of such returns. Control is
reassessed whenever facts and circumstances indicate that there may be a change in any of these elements of control.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">De-facto control exists in situations where the
Group has the practical ability to direct the relevant activities of an entity without holding the majority of the voting rights. In determining
whether de facto control exists, the Group considers all relevant facts and circumstances, including:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">The relative share of the Group&#8217;s voting rights with
respect both the size and dispersion of other parties who hold voting rights;</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">Substantive potential voting rights held by the Group and
by other parties;</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">Other contractual arrangements; and</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">Historic patterns in voting attendance.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The subsidiaries of the Group, all of which have
been included in the consolidated financial statements of the Group, are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: left"><b>Name</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td> <td style="text-align: center; border-bottom: Black 1.5pt solid"><b>Principal activities</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td> <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><b>Country of <br/>incorporation and <br/>principal place of <br/>business</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td> <td style="text-align: center; border-bottom: Black 1.5pt solid"><b>Ref</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>% Equity <br/>interest <br/>06/30/2025</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>% Equity <br/>interest <br/>06/30/2024</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; width: 20%; text-align: left">Moolec Science Limited</td><td style="width: 1%">&#160;</td> <td style="width: 38%; text-align: left">Investment in subsidiaries</td><td style="width: 1%">&#160;</td> <td style="vertical-align: top; width: 15%; text-align: center">United Kingdom</td><td style="width: 1%">&#160;</td> <td style="width: 6%; text-align: center">b)</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">100</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-171">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-align: left">AG Biomolecules LLC</td><td>&#160;</td> <td style="text-align: left">Production and commercialization of agricultural products</td><td>&#160;</td> <td style="vertical-align: top; text-align: center">United States</td><td>&#160;</td> <td style="text-align: center">b)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-172">-</div></td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left">ValoraSoy S.A.</td><td>&#160;</td> <td style="text-align: left">Production and commercialization of agricultural products</td><td>&#160;</td> <td style="vertical-align: top; text-align: center">Argentina</td><td>&#160;</td> <td style="text-align: center">b)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-173">-</div></td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-align: left">Nutrecon LLC</td><td>&#160;</td> <td style="text-align: left">Investment in subsidiaries</td><td>&#160;</td> <td style="vertical-align: top; text-align: center">United States</td><td>&#160;</td> <td style="text-align: center">b)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-174">-</div></td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left">SynBio Powerlabs</td><td>&#160;</td> <td style="text-align: left">Production and commercialization of fermentation products</td><td>&#160;</td> <td style="vertical-align: top; text-align: center">Finland</td><td>&#160;</td> <td style="text-align: center">d)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">90</td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-175">-</div></td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-align: left">Gentle Tech</td><td>&#160;</td> <td style="vertical-align: top; text-align: left">Investment in subsidiaries</td><td>&#160;</td> <td style="vertical-align: top; text-align: center">British Virgin Islands</td><td>&#160;</td> <td style="text-align: center">a),b)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">50</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left">Gentle Farming</td><td>&#160;</td> <td style="vertical-align: top; text-align: left">Investment in subsidiaries</td><td>&#160;</td> <td style="vertical-align: top; text-align: center">British Virgin Islands</td><td>&#160;</td> <td style="text-align: center">a),b)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">51</td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">51</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; vertical-align: top">G-FAS</td><td>&#160;</td> <td style="text-align: left">Production and commercialization of sustainable agricultural equipment</td><td>&#160;</td> <td style="vertical-align: top; text-align: center">Argentina</td><td>&#160;</td> <td style="text-align: center">a),b)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">64</td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">64</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left">Bioceres Group Limited</td><td>&#160;</td> <td style="text-align: left">Investment in subsidiaries</td><td>&#160;</td> <td style="vertical-align: top; text-align: center">United Kingdom</td><td>&#160;</td> <td style="text-align: center">b)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Bioceres Crop Solutions (BIOX)</td><td>&#160;</td> <td style="vertical-align: top; text-align: left">Research and development</td><td>&#160;</td> <td style="vertical-align: top; text-align: center">United States</td><td>&#160;</td> <td style="text-align: center">c)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">29.30</td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">28.75</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left">Bioceres LLC</td><td>&#160;</td> <td style="text-align: left">Investment in subsidiaries</td><td>&#160;</td> <td style="vertical-align: top; text-align: center">United States</td><td>&#160;</td> <td style="text-align: center">a)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-align: left">Bioceres S.A.</td><td>&#160;</td> <td style="text-align: left">Investment in subsidiaries</td><td>&#160;</td> <td style="vertical-align: top; text-align: center">Argentina</td><td>&#160;</td> <td style="text-align: center">a)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">89.93</td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">79.72</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left">Bioceres Tech Services LLC</td><td>&#160;</td> <td style="vertical-align: top; text-align: left">Investment in subsidiaries</td><td>&#160;</td> <td style="vertical-align: top; text-align: center">United States</td><td>&#160;</td> <td style="text-align: center">a)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr> </table><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> a)&#160;Direct interests held by Bioceres Group Limited.</p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">b)&#160;Direct
interest held by Moolec Science SA.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">c)&#160;Since
2023, the Group exercises &#8220;de facto control&#8221; over Bioceres Crop Solutions Corp, however, as stated in note Note 1 &#8211;
The Group&#8217;s business reorganization and general information - &#8220;<i>The Bioceres Group Business Combination Agreement&#8221;</i>,
Bioceres Group Limited lost the &#8220;de facto control&#8221; on June 24, 2025. The subsidiary was deconsolidated as of June 30, 2025,
and the investment in it was measured using the equity method. The Group&#8217;s consolidated result includes the results of that entity
up to the date of its deconsolidation. No results related to the loss of control have been recognized. Various notes to the financial
statements show the effect it has had on consolidated assets and liabilities, business segments and CGUs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">d)&#160;Direct
interest held by Nutrecon LLC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration:underline">Special purpose and structured entities (&#8220;SPE&#8221;)</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A structured entity is an entity that has been
designed so that voting or similar rights are not the dominant factor in deciding who controls the entity and the relevant activities
are directed by means of contractual arrangements. In these cases, the Company considers the purpose and design of the SPE, including
a consideration of the risks the SPE was expected to be exposed to, the risks it was designed to pass on to the parties involved with
the SPE and whether the Company is exposed to some or all of those risks or potential returns. One then considers which activities have
a significant impact on the SPE&#8217;s returns and determines which parties have an ability to direct each of those activities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group controls an SPE when is exposed, or
has rights, to variable returns from its involvement with the SPE and has the ability to affect those returns through its power over the
SPE. Following the BIOX deconsolidation, the Group does not control any SPE.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for derivative financial instruments and hedging. [Refer: Classes of financial instruments [domain]; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_AccountingStandardsAndBasiofPreparationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_AccountingStandardsAndBasiofPreparationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>New Standards, Amendments and Interpretations Issued by the IASB<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NewStandardsAmendmentsAndInterpretationsIssuedByTheIASBAbstract', window );"><strong>New Standards, Amendments and Interpretations Issued by the IASB [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations', window );">NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS ISSUED BY THE IASB</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><b>3.</b></td><td style="text-align: justify"><b><span style="text-decoration:underline">NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS ISSUED
BY THE IASB</span></b></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">New standards and interpretations adopted
by the Group</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">a)</span></td><td style="text-align: justify">The following new standards became applicable for the current
reporting period and adopted by the Group.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">-</span></td><td style="text-align: justify">Amendments to IFRS 16 - Lease Liability in a Sale and Leaseback.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.3pt; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">-</span></td><td style="text-align: justify">Amendments to IAS 1 &#8211; Non-current liabilities with covenants.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.3pt; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">-</span></td><td style="text-align: justify">Amendment to IAS 7 and IFRS 7 - Supplier Financing.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.3pt; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">-</span></td><td style="text-align: justify">Amendments to IAS 7 - Statement of Cash Flows &amp; to IFRS 7- Financial Instruments:
                                                                                                                     Disclosures.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.3pt; text-align: justify; text-indent: -0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These new standards and amendments did not have
any material impact on the Group.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-size: 10pt">b)</span></td><td style="text-align: justify">The following new standards are not yet adopted by the Group.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-size: 10pt">-</span></td><td style="text-align: justify"><i>IFRS 19 &#8211; Subsidiaries without Public Accountability. </i>The standard is effective for annual
periods beginning on or after January 1, 2027.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.3pt; text-align: justify; text-indent: -0.25in">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-size: 10pt">-</span></td><td style="text-align: justify"><i>Amendments to IFRS 9 and IFRS 7 - Amendments to the Classification and Measurement of Financial Instruments.
</i>The amendments are effective for reporting periods beginning on or after January 1, 2026.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.3pt; text-align: justify; text-indent: -0.25in"><i>&#160;</i></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-size: 10pt">-</span></td><td style="text-align: justify"><i>Amendments to IFRS 9 and IFRS 7 &#8211; Contracts Referencing Nature-dependent Electricity. </i>The
amendments are effective for annual periods beginning on or after January 1, 2026.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.3pt; text-align: justify; text-indent: -0.25in"><i>&#160;</i></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-size: 10pt">-</span></td><td style="text-align: justify"><i>Annual Improvements to IFRS Accounting Standards&#8212;Volume 11.</i> The amendments are effective
for annual periods beginning on or after January 1, 2026.</td></tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-size: 10pt">-</span></td><td style="text-align: justify"><i>Amendments to IAS 21- The Effects of Changes in Foreign Exchange Rates titled Lack of Exchangeability</i><b>.
</b>The amendments are effective for annual reporting periods beginning on or after January 1, 2025.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.3pt; text-align: justify; text-indent: -0.25in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These amendments are not expected to have material
impact on the Group.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-size: 10pt">-</span></td><td style="text-align: justify"><i>IFRS 18 &#8211; Presentation and Disclosure in Financial Statements. </i>This standard introduces new
requirements for the presentation and disclosure of income and expenses in the statement of profit or loss, including the introduction
of new defined subtotals such as Operating Profit and enhanced disaggregation requirements. The standard also includes additional guidance
on aggregation principles and requires disclosures about management-defined performance measures (MPMs) used in public communications
outside the financial statements. It is effective for annual periods beginning on or after January 1, 2027, with retrospective application
in accordance with IAS 8, subject to specific transitional reliefs.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.3pt; text-align: justify; text-indent: -0.25in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group is analyzing the potential impact of
this standard on our financial statements, which is expected to mainly affect the presentation and structure of the primary financial
statements and related disclosures, but not the recognition or measurement of transactions.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 30<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_30_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 180<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_180_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 180<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_180_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_NewStandardsAmendmentsAndInterpretationsIssuedByTheIASBAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_NewStandardsAmendmentsAndInterpretationsIssuedByTheIASBAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><b>4.</b></td><td style="text-align: justify"><b><span style="text-decoration:underline">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>4.1.&#160;<span style="text-decoration:underline">Cash and cash
equivalents</span></b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the purposes of the statements of financial
position and statements of cash flows, cash and cash equivalents include cash on hand and in banks and short-term highly liquid investments.
Investments can be readily convertible to known amounts of cash and they are subject to insignificant risk of changes in value. In the
consolidated statements of financial position, bank overdrafts are included in borrowings within current liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>4.2. &#160;<span style="text-decoration:underline">Financial assets and liabilities</span></b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify; text-indent: -0.3in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group measures its financial assets at initial
recognition at fair value and subsequently at amortized cost using the effective interest method.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group has not irrevocably designated a financial
asset as measured at fair value through profit or loss to eliminate or significantly reduce a measurement or recognition inconsistency.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial assets at fair value through profit
or loss are measured at fair value through profit and loss due to the business model used in their negotiation and/or the contractual
characteristics of their cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Estimates</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group makes estimates of uncollectability
of its recorded receivables. Management analyzes trade account receivables in accordance with conventional criteria, adjusting the amount
through a charge of an allowance for bad debts upon recognition of the inability of third parties to afford their financial obligations
to the Group. Management specifically analyzes the accounts receivable, the historical bad debts, solvency of customers, current economic
trends and the changes to the payment conditions of customers to assess the adequate allowance for bad debts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Offsetting of financial assets with financial
liabilities</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial assets and liabilities are offset and
presented for their net amount in the statements of financial position only when the Group has the right, legally enforceable, to compensate
the recognized amounts and has the intention to liquidate for the net amount or to settle the asset and cancel the liability simultaneously.</p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>4.3. <span style="text-decoration:underline">Inventories</span></b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Inventories are recognized at cost initially and
subsequently at the lower of cost and net realizable value. Cost comprises all costs of purchase and conversion as well as other costs
incurred in bringing the inventories to their present location and condition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Weighted average cost is used to determine the
cost of ordinarily interchangeable items.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Estimates</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group assesses the recoverability of inventories
considering their sale price, whether the inventories are damaged and whether they have become obsolete in whole or in part.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Net realizable value is the sale price estimated
to be attained in the ordinary course of business, less costs of completion and other selling expenses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group sets up an allowance for obsolescence
or slow-moving inventories in relation to finished and in-process products. The allowance for obsolescence or slow-moving inventories
is recognized for finished products and in-process products based on an analysis by Management of the aging of inventory stocks.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>4.4. <span style="text-decoration:underline">Biological assets</span></b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify; text-indent: -0.3in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Within current assets, growing crops are included
as biological assets, from the moment of sowing until the moment of harvest (approximately 5 to 7 months depending on the crop). At harvest
time the biological assets are transformed into agricultural products, including seed varieties for resale, and incorporated into the
inventory.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Costs are capitalized as biological assets if,
and only if, (a) it is probable that future economic benefits will flow to the entity, and (b) the cost can be measured reliably. The
Group capitalizes costs such as: planting, harvesting, weeding, seedlings, irrigation, agrochemicals, fertilizers and a systematic allocation
of fixed and variable production overheads that are directly attributable to the management of biological assets, among others.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Biological assets, both at initial recognition
and at each subsequent reporting date, are measured at fair value less costs to sell, except where fair value cannot be reliably measured.
Cost approximates fair value when little biological transformation has taken place since the costs were originally incurred or the impact
of biological transformation on price is not expected to be material.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Gains and losses that arise from measuring biological
assets at fair value less costs to sell and measuring agricultural produce at the point of harvest at fair value less costs to sell are
recognized in the statement of income in the period in which they arise in the line item &#8220;Initial recognition and changes in fair
value of biological assets&#8221;.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From the harvest time, agricultural products are
valued at net realizable value because there is a market asset, and the risk of non-sale is non-significant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Generally, the estimation of the fair value of
biological assets is based on models or inputs that are not observable in the market and the use of unobservable inputs is significant
to the overall valuation of the assets. Unobservable inputs are determined based on the best information available. Key assumptions include
future market prices, estimated yields at the point of harvest, estimated production cycle, future cash flows, future costs of harvesting
and other costs, and estimated discount rate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Market prices are generally determined by reference
to observable data in the principal market for the agricultural produce. Harvesting costs and other costs are estimated based on historical
and statistical data. Yields are estimated based on several factors, including the location of the farmland and soil type, environmental
conditions, infrastructure and other restrictions and growth at the time of measurement. Yields are subject to a high degree of uncertainty
and may be affected by several factors out of the Group&#8217;s control including but not limited to extreme or unusual weather conditions,
plagues and other crop diseases, among other factors.</p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>4.5. <span style="text-decoration:underline">Basis of consolidation</span></b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Business combinations</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>General</i><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group applies the acquisition method to account
for business combinations. The acquisition cost is measured as the aggregate of the consideration transferred for the acquisition of a
subsidiary, which is measured at fair value at the acquisition date, and the amount of any non-controlling interest in such subsidiary.
The Group recognizes any non-controlling interest in a subsidiary at the non-controlling interest&#8217;s proportionate share of the recognized
amounts of subsidiary&#8217;s identifiable net assets. The acquisition related costs are expensed as incurred.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any contingent consideration to be transferred
by the Group is recognized at fair value at the acquisition date. The contingent consideration is classified as an asset or liability
that is a financial instrument under IFRS 9 is measured at fair value through profit or loss.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Goodwill is initially measured at cost, which
is the excess of the aggregate of the consideration transferred and the amount of the non-controlling interest and any previous interest
carried over the net identifiable assets acquired, and liabilities assumed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">After initial recognition, goodwill is measured
at cost less any accumulated impairment losses. For impairment testing, goodwill acquired in a business combination is, as of the acquisition
date, allocated to each of the cash-generating units of the Group that is expected to benefit from the synergies of the combination, without
considering whether other assets or liabilities of the subsidiary are allocated to those units.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any impairment in the carrying value is recognized
in the consolidated statement of comprehensive income. In the case of acquisitions in stages, prior to the write-off of the previously
held equity interest in the subsidiary, said interest is re-measured at fair value as of the date of acquisition of control over the subsidiary.
The result of the re-measurement at fair value is recognized in profit or loss.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When a seller in a business combination has contractually
agreed to indemnify the Group for the result of a contingency or uncertainty related to the entirety or a portion of an asset or liability,
the Group recognizes an indemnification asset. The indemnification asset is measured on the same basis as the indemnification item. At
the end of each period, the Group measures the indemnification assets recognized at the acquisition date on the same basis as the indemnified
liability, subject to any contractual limitation on the amount and, for an indemnification asset that is not periodically measured at
fair value, based on Management&#8217;s assessment of the recoverability of the indemnification asset. The Group derecognizes the indemnification
asset when it collects or sells it, or when it loses the right over it.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Reverse acquisitions</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In a reverse acquisition, the accounting acquirer
usually issues no consideration for the acquiree. Instead, the accounting acquiree usually issues its equity shares to the owners of the
accounting acquirer. Accordingly, the acquisition-date fair value of the consideration transferred by the accounting acquirer for its
interest in the accounting acquiree is based on the number of equity interests the legal subsidiary would have had to issue to give the
owners of the legal parent the same percentage equity interest in the combined entity that results from the reverse acquisition. The fair
value of the number of equity interests calculated in that way can be u sed as the fair value of consideration transferred in exchange
for the acquiree.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Consolidated financial statements prepared following
a reverse acquisition are issued under the name of the legal parent (accounting acquiree) but described in the notes as a continuation
of the financial statements of the legal subsidiary (accounting acquirer), with one adjustment, which is to adjust retroactively the accounting
acquirer&#8217;s legal capital to reflect the legal capital of the accounting acquiree. That adjustment is required to reflect the capital
of the legal parent (the accounting acquiree). Comparative information presented in those consolidated financial statements also is retroactively
adjusted to reflect the legal capital of the legal parent (accounting acquiree).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because the consolidated financial statements
represent the continuation of the financial statements of the legal subsidiary except for its capital structure, the consolidated financial
statements reflect:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-size: 10pt">a.</span></td><td style="text-align: justify">the assets and liabilities of the legal subsidiary (the accounting acquirer) recognized and measured at
their pre-combination carrying amounts.</td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-size: 10pt">b.</span></td><td style="text-align: justify">the assets and liabilities of the legal parent (the accounting acquiree) recognized and measured in accordance
with IFRS 3.</td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-size: 10pt">c.</span></td><td style="text-align: justify">the retained earnings and other equity balances of the legal subsidiary (accounting acquirer) before the
business combination.</td></tr></table><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-size: 10pt">d.</span></td><td style="text-align: justify">the amount recognized as issued equity interests in the consolidated financial statements determined by
adding the issued equity interest of the legal subsidiary (the accounting acquirer) outstanding immediately before the business combination
to the fair value of the legal parent (accounting acquiree). However, the equity structure (ie. the number and type of equity interests
issued) reflects the equity structure of the legal parent (the accounting acquiree), including the equity interests the legal parent issued
to effect the combination. Accordingly, the equity structure of the legal subsidiary (the accounting acquirer) is restated using the exchange
ratio established in the acquisition agreement to reflect the number of shares of the legal parent (the accounting acquiree) issued in
the reverse acquisition.</td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When a reverse acquisition occurs, in calculating
the weighted average number of ordinary shares outstanding (the denominator of the earnings per share calculation) during the period in
which the reverse acquisition occurs:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-size: 10pt">a.</span></td><td style="text-align: justify">the number of ordinary shares outstanding from the beginning of that period to the acquisition date shall
be computed on the basis of the weighted average number of ordinary shares of the legal acquiree (accounting acquirer) outstanding during
the period multiplied by the exchange ratio established in the merger agreement; and</td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-size: 10pt">b.</span></td><td style="text-align: justify">the number of ordinary shares outstanding from the acquisition date to the end of that period shall be
the actual number of ordinary shares of the legal acquirer (the accounting acquiree) outstanding during that period.</td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The basic earnings per share for each comparative
period before the acquisition date presented in the consolidated financial statements following a reverse acquisition shall be calculated
by dividing:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-size: 10pt">a.</span></td><td style="text-align: justify">the profit or loss of the legal acquiree attributable to ordinary shareholders in each of those periods
by</td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-size: 10pt">b.</span></td><td style="text-align: justify">the legal acquiree&#8217;s historical weighted average number of ordinary shares outstanding multiplied
by the exchange ratio established in the acquisition agreement.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Subsidiaries</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subsidiaries are entities controlled by the Group.
Information about Group accounting policy is included in Note 2 &#8211; &#8220;<i>Accounting standards and Basis of Preparation</i>&#8221;.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Non controlling interest</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NCI are measured initially at their proportionate
share of the acquiree&#8217;s identifiable net assets at the date of acquisition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Change in ownership interest in subsidiaries
without change of control </span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Transactions with non-controlling interest that
do not result in a loss of control are accounted for as equity transactions - i.e., as transactions with the owners&#160;in their capacity
as owners. The recorded value corresponds to the difference between the fair value of the consideration paid and/or received and the relevant
share acquired and/or transferred of the carrying value of the net assets of the subsidiary.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Loss of control</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When the Group loses control over a subsidiary,
it derecognizes the assets and liabilities of the subsidiary, and any related NCI and other components of equity. Any resulting gain or
loss is recognized in profit or loss.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Investments for which the Group does not exercise
control, but which are not accounted for under the equity method due to meeting the definition of a financial asset, are measured at fair
value through profit or loss in accordance with IFRS 9 Financial Instruments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When an investee (either a subsidiary or other
investment) enters a liquidation process and the Group no longer retains the ability to direct its relevant activities&#8212;such as through
the formal appointment of a liquidator by the investee&#8217;s Board of Directors&#8212;the Group concludes that control has been lost.
In such cases, the date of the liquidator&#8217;s appointment is considered the derecognition event for purposes of IFRS 10.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Associate and joint arrangements </span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">An associate is an entity over which the Group
exerts significant influence. Significant influence is the power to participate in financial and operating policy decision-making at such
entity, but it does not involve control or joint control over those policies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group is a party to a joint arrangement when
there is a contractual arrangement that confers joint control over the relevant activities of the arrangement to the Group and at least
one other party. Joint control is assessed under the same principles as control over subsidiaries.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group classifies its interests in joint arrangements
as either:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify"><i>Joint ventures</i>: where the group has rights to only
the <i>net assets </i>of the joint arrangement.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: justify; text-indent: -14.2pt"><i>&#160;</i></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify"><i>Joint operations</i>: where the group has both the rights
to the assets and obligations for the liabilities of the joint arrangement.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In assessing the classification of interests in
joint arrangements, the Group considers:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">The structure of the joint arrangement;</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">The legal form of joint arrangements structured through a
separate vehicle;</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">The contractual terms of the joint arrangement agreement;
and</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">Any other facts and circumstances (including any other contractual
arrangements).</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group accounts for its interests in joint
ventures and associates using the equity method, where the Group&#8217;s share of post-acquisition profits and losses and other comprehensive
income is recognized in the Consolidated statement of profit and loss and other comprehensive income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Losses in excess of the Group&#8217;s investment
in the joint venture and associates are recognized only to the extent that the Group has incurred legal or constructive obligations or
made payments on behalf of the joint venture.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Profits and losses arising on transactions between
the Group and its joint ventures and associates are recognized only to the extent of unrelated investors&#8217; interests in the joint
venture and/or associates. The Group&#8217;s share in a joint venture and/or associates&#8217; profits and losses resulting from a transaction
is eliminated against the carrying amount of investment in the joint venture and/or associates through the line &#8220;share of profit
(or loss) of joint ventures and associates&#8221; in the Consolidated statements of profit or loss and other comprehensive income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any premium paid for an investment in a joint
venture and/or associates above the fair value of the Group&#8217;s share of the identifiable assets, liabilities and contingent liabilities
acquired is capitalized and included in the carrying amount of the investment in the joint venture and/or associates. Where there is objective
evidence that the investment in a joint venture and/or associates has been impaired, the carrying amount of the investment is tested for
impairment in the same way as other non-financial assets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When the Group loses significant influence in
an associate or joint control over a joint venture, it measures and recognizes any investment held at fair value. Any difference between
the carrying amount of the associate or joint venture when losing significant influence or joint control and the fair value of the held
investment and sale revenue are recognized in profit or loss.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group accounts for its interests in joint
operations by recognizing its share of assets, liabilities, revenues and expenses in accordance with its contractually conferred rights
and obligations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For all joint arrangements structured in separate
vehicles the Group must assess the substance of the joint arrangement in determining whether it is classified as a joint venture or joint
operation. This assessment requires the Group to consider whether it has rights to the joint arrangement&#8217;s net assets (in which
case it is classified as a joint venture), or rights to and obligations for specific assets, liabilities, expenses, and revenues (in which
case it is classified as a joint operation).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Paragraph 18 of IAS 28 states when an investment
in an associate or a joint venture is held by, or is held indirectly through, an entity that is a venture capital organization, or a mutual
fund, unit trust and similar entities, the entity may elect to measure that investment al fair value through profit or loss in accordance
with IFRS 9.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has elected to measure the investment
in associates held through Theo I SCSp at fair value through profit or loss in accordance with IFRS 9.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Estimates</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There is uncertainty regarding Management&#8217;s
estimates of the Group&#8217;s ability to recover the carrying amounts of the investments in joint ventures, since such estimates depend
on the joint ventures&#8217; ability to generate sufficient funds to complete the development projects, the future outcome of the project
deregulation process and the amounts and timing of the cash flows from projects, among other future events.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management assesses whether there are impairment
indicators and, if any, it performs a recoverability analysis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management estimates of the recoverability of
these investments represent the best estimate based on available evidence, the existing facts and circumstances, using reasonable and
provable assumptions in the cash flow projections.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Therefore, the consolidated financial statements
do not include adjustments that would be required if the Group were unable to recover the carrying amount of the above-mentioned assets
by generating sufficient economic benefits in the future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Transactions eliminated on consolidation</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Intra-group balances and transactions, and any
unrealized income and expenses (except for foreign currency transaction gains and losses) arising from intra-group transactions, are eliminated.
Unrealized gains arising from transactions with equity-accounted investees are eliminated against the investment to the extent of the
Group&#180;s interest in the investee. Unrealized losses are eliminated in the same way as unrealized gains, but only to the extent that
there is no evidence of impairment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>4.6. <span style="text-decoration:underline">Impairment assessment of Goodwill and Intangible assets</span></b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Impairment tests on goodwill and intangible assets
not yet available for use or with indefinite useful lives, are undertaken annually at the end of the reporting period. Other non-financial
assets are subject to impairment tests whenever events or changes in circumstances indicate that their carrying amount may not be recoverable.
Where the carrying value of an asset exceeds its recoverable amount (i.e. the higher of value in use and fair value less costs to sell),
the asset is written down accordingly.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Where it is not possible to estimate the recoverable
amount of an individual asset, the impairment test is carried out on the smallest group of assets to which it belongs for which there
are separately identifiable cash flows (its Cash Generating Unit or CGU). Goodwill is allocated on initial recognition to each of the
Group&#8217;s CGUs that are expected to benefit from a business combination that gives rise to the goodwill.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Impairment charges are included in profit or loss,
except to the extent they reverse gains previously recognized in other comprehensive income. An impairment loss recognized for goodwill
is not reversed.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Estimates</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Impairment testing of goodwill and intangible
assets not yet available for use or with indefinite useful lives, requires the use of significant assumptions for the estimation of future
cash flows and the determination of discount rates. The significant assumptions and the determination of discount rates for the impairment
testing of goodwill are further explained in Note 7.9 - Goodwill.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>4.7. <span style="text-decoration:underline">Property, plant and equipment</span></b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Property, plant and equipment items are initially
recognized at cost. In addition to the purchase price, cost also includes costs directly attributable to such property, plant and equipment
items. There are no unavoidable costs with respect to dismantling and removing items. The cost of property, plant and equipment items
acquired in a business combination is their fair value at the acquisition date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Depreciation is calculated using the straight-line
method to allocate the property, plant or equipment items&#8217; cost or revalued amounts, net of their residual values, over their estimated
useful lives or, in the case of leasehold improvements and certain leased plant and equipment, the shorter lease term as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Research instruments: 3 to 10 years</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Office equipment: 5 to 10 years</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Vehicles: 5 years</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Computer equipment and software: 3 years</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Fixture and fittings: 10 years</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Machinery and equipment: 5 to 10 years</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Buildings: 50 years</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Useful lives and depreciation methods are reviewed
every year as required by IAS 16.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a result of the business combination completed
on <span style="font-weight: normal">June 16, 2025</span>, and the BIOX deconsolidation, the structure, scale and operations of the Group
changed significantly compared with the former reporting entity. The transaction resulted in a new combined entity whose asset base, operational
model and strategic focus differ materially from those of the pre-combination entity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Given these changes, management re-assessed the
appropriateness of the accounting policy applied to property, plant and equipment. Prior to the business combination, the former entity
measured certain classes of property, plant and equipment under the <span style="font-weight: normal">revaluation model</span>. Following
the acquisition, and considering the characteristics of the combined business, management determined that the <span style="font-weight: normal">cost
model</span> provides more reliable and relevant information for users of the financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accordingly, beginning on <span style="font-weight: normal">June
16, 2025</span>, the Group <span style="font-weight: normal">discontinued the revaluation model</span> and now measures all property plant
and equipment at <span style="font-weight: normal">cost less accumulated depreciation and impairment losses</span>. The change has been
accounted for prospectively in accordance with applicable IFRS requirements, as it results from management&#8217;s reassessment of the
accounting policies of the newly formed reporting entity rather than from a voluntary change.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The carrying amounts of property, plant and equipment
previously measured under the revaluation model became their deemed cost at the date the new policy was adopted. No restatement of comparative
periods was required.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prior to The Bioceres Group Business Combination
Agreement and the BIOX deconsolidation, the assets under items Land and Buildings, were accounted for at fair value arising from the last
revaluation performed, applying the revaluation model indicated by IAS 16. Starting with the fiscal year ended on June&#160;30, 2024,
the Group modified its Property, Plant, and Equipment valuation policy by changing the revaluation frequency for items classified under
Buildings and Land. The revaluation must never exceed five years between each occurrence, in compliance with the maximum periods established
by accounting standards, or whenever there are indications that the carrying amount differs significantly from the amount that could be
determined using fair value at the end of the reporting year.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To obtain fair values, the existence or not of
an active market it was considered for the assets in their current status. For those assets for which an active market in their current
status existed, the fair values were determined based on their market values. For the remaining cases, the market values of comparable
new assets were analyzed, applying a discount based on the status and wear of each asset and considering the characteristics of each of
the revalued assets (for example, improvements made, maintenance status, level of productivity, use, etc.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Estimates</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group used to carry certain classes of property,
plant and equipment under the revaluation model under IAS 16. The revaluation model requires that the Group carry property, plant and
equipment at revalued amounts, being fair value at the date of revaluation less any subsequent accumulated depreciation and any subsequent
accumulated impairment losses. IAS 16 requires that the Group carry out these revaluations with sufficient regularity so that the carrying
amounts of its property, plant and equipment do not differ materially from that which would be determined using fair value at the end
of a reporting period. The determination of fair value at the date of revaluation requires judgments, estimates and assumptions based
on market conditions prevailing at the time of any such revaluation. Changes to any of the Group&#8217;s judgments, estimates or assumptions
or to the market conditions subsequent to a revaluation will result in changes to the fair value of property, plant and equipment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group used to prepare the corresponding revaluations
on a regular basis taking into account the work of independent appraisers. The Group uses different valuation techniques depending on
the class of property being valued. Generally, the Group determines the fair value of its industrial buildings and warehouses based on
a depreciated replacement cost approach. The Group determines the fair value of its land based on active market prices adjusted, if necessary,
for differences in the nature, location or condition of the specific asset. If this information is not available, the Group may use alternative
valuation methods, such as recent prices in less active markets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Property valuation is a significant area of estimation
uncertainty. Fair values used to be prepared regularly by Management, taking into account independent valuations. The determination of
fair value for the different classes of property, plant and equipment is sensitive to the selection of various significant assumptions
and estimates. Changes in those significant assumptions and estimates could materially affect the determination of the revalued amounts
of property, plant and equipment. The Group utilizes historical experience, market information and other internal information to determine
and/or review the appropriate revalued amounts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following were the most significant assumptions
used in the preparation of the revalued amounts for its classes of property, plant and equipment:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">a)&#160;Land:
The Group generally used to use the market price of a square meter of land for the same or similar location as the most significant assumption
to determine the revalued amount. The Group typically used to use comparable land sales in the same location to assess appropriateness
of the value of its land.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">b)&#160;Industrial
buildings and warehouses: The Group generally used to determine the construction cost of a new asset and then the Group adjusts it for
normal wear and tear. Construction prices may include, but are not limited to, construction materials, labor costs, installation and assembly
costs, site preparation, professional fees and applicable taxes. Construction costs may differ significantly from year to year and are
subject to macroeconomic changes in the economy where the Group operates, such as the impact of inflation and foreign exchange rates.
The construction cost of its industrial buildings and warehouses is determined on a US dollar per constructed square meter basis, while
the construction cost of its mills, facilities and grain storage facilities is determined by reference to their total capacity measured
in tons milled or stored, respectively. A 5% increase or decrease in the construction costs or the estimate of normal wear and tear relating
to such assets could have an impact of $1.2 million on their revalued amounts.</p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>4.8. <span style="text-decoration:underline">Leased assets</span></b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Leases are recognized as a right-of-use asset
and corresponding liability at the date of which the leased asset is available for use by the Group. Each lease payment is allocated between
the liability and finance cost. The finance cost is charged to profit or loss over the lease period so as to produce a constant periodic
rate of interest on the remaining balance of the liability for each period. The right-of-use asset is depreciated over the shorter of
the asset&#8217;s useful life and the lease term on a straight-line basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In determining the lease term, the Company considers
all facts and circumstances that create an economic incentive to exercise an extension option or not exercise a termination option. Extension
options (or periods after termination options) are only included in the lease term if the lease is reasonably certain to be extended (or
not terminated).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Short term leases are recognized on a straight-line
basis as an expense in the income statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At initial recognition, the right-of-use asset
is measured considering the value of the initial measurement of the lease liability; any lease payments made at or before the commencement
date, less any lease incentives; and any initial direct costs incurred by the lessee. After initial recognition, the right-of-use assets
are measured at cost, less any accumulated depreciation and/or impairment losses, and adjusted for any re-measurement of the lease liability.
Depreciation of the right-of-use asset is calculated using the straight-line method over the estimated duration of the lease contract.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The lease liability is initially measured at the
present value of the lease payments that are not paid at such date, including variable lease payments that depend on an index or rate,
initially measured using the index or rate as of the commencement date; amounts expected to be payable by the lessee under residual value
guarantees; the exercise price of a purchase option if the lessee is reasonably certain to exercise that option; payments of penalties
for terminating the lease, if the lease term reflects the lessee exercising an option to terminate the lease; and fixed payments, less
any lease incentives receivable. After the commencement date, the Company measures the lease liability by increasing the carrying amount
to reflect interest on the lease liability; reducing the carrying amount to reflect lease payments made; and re-measuring the carrying
amount to reflect any reassessment or lease modifications.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The above-mentioned inputs for the valuation of
the right of use assets and lease liabilities including the determination of the contracts within the scope of the standard, the contract
term ant interest rate used in the discounted cash flow involved a management&#8217;s estimations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>4.9. <span style="text-decoration:underline">Intangible assets</span></b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>a) Externally acquired intangible assets</b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Externally acquired intangible assets are initially
recognized at acquisition date fair value (which is considered as their cost). After initial recognition, those assets are measured at
cost less accumulated amortization and accumulated impairment losses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Intangible assets acquired from third parties
have an estimated useful life as follows (in years):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Software: 3 years</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Trademarks and patents: 5 years</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certification ISO Standards: 3 years</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Useful lives and amortization methods are reviewed
every year as required by IAS 38.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Estimates</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To value acquired intangible assets, valuation
techniques generally accepted in the market are applied, based mainly on the revenue approach (such as excess earnings, relief from royalty,
and with or without), considering the characteristics of the assets to be valued and available information to estimate their acquisition
date fair value. Application of these valuation techniques requires the use of several assumptions related to future cash flows and the
discount rate.</p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>b) Internally generated intangible assets (development costs)</b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Expenditure on internally developed products is
capitalized if it can be demonstrated that:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">It is technically feasible to develop the product for it
to be sold;</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">Adequate resources are available to complete the development;</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">There is an intention to complete and sell the product;</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">The Group is able to sell the product;</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">Sale of the product will generate future economic benefits;
and</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">Expenditure on the project can be measured reliably.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Development expenditure not satisfying the above
criteria and expenditure on the research phase of internal projects are recognized in the consolidated statement of profit or loss and
other comprehensive income as incurred (Note 8.3 - R&amp;D classified by nature).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Capitalized development costs are amortized using
the straight-line method over the periods the Group expects to benefit from selling the products developed (Note 7.8 &#8211; Intangible
assets).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Useful lives and amortization methods are reviewed
every year as required by IAS 38.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The research and development process can be divided
into several discrete steps or phases, which generally begin with discovery, validation and development and end with regulatory approval
and commercial launch. The process for developing seed traits is relatively similar for both GM and non-GM traits. However, the two differ
significantly in later phases of development. For example, obtaining regulatory approval for GM seeds is a far more comprehensive and
lengthy process than for non-GM seeds. Although breeding programs and industrial biotechnology solutions may have shorter or simpler phases
than those described below, the Group has used the industry consensus for seed-trait development phases to characterize its technology
portfolios, which is generally divided into the following six phases:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify">i) Discovery: The first phase in the technology
development process is the discovery or identification of candidate genes or genetic systems, metabolites, or microorganisms potentially
capable of enhancing specified plant characteristics or enabling an agro-industrial biotech solution.</p>

<p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify">&#160;</p>

<p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify">ii) Proof of concept: Upon successful validation
of the technologies in model systems (<i>in vitro </i>or <i>in vivo</i>), promising technologies graduate from discovery and are advanced
to the proof of concept phase. The goal of this phase is to validate a technology within the targeted organism before moving forward with
technology escalation activities or extensive field validation.</p>

<p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify">&#160;</p>

<p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify">iii) Early development: In this phase, field tests
commenced in the proof of concept phase are expanded to evaluate various permutations of a technology in multiple geographies and growing
cycles, as well as other characteristics in order to optimize the technology&#8217;s performance in the targeted organisms. The goal of
the early development phase is to identify the best mode of use of a technology to define its performance concept.</p>

<p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify">&#160;</p>

<p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify">iv) Advanced development and deregulation: In
this phase, extensive field tests are used to demonstrate the effectiveness of the technology for its intended purpose. In the case of
GM traits, the process of obtaining regulatory approvals from government authorities is also initiated during this phase, and tests are
performed to evaluate the potential environmental impact of modified plants. For solutions involving microbial fermentation, industrial-scale
runs are conducted.</p>

<p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify">&#160;</p>

<p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify">v) Pre-launch: This phase involves finalizing
the regulatory approval process and preparing for the launch and commercialization of the technology. The range of activities in this
phase includes seed increases, pre-commercial production, and product and solution testing with selected customers. Usually, a more detailed
marketing strategy and preparation of marketing materials occur during this phase.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: 0pt; text-align: justify">vi) Product launch: In general, this phase, which
is the last milestone of the research and development process, is carried out by the Group, the joint ventures and/or the Group&#8217;s
technology licensees. When technology is commercialized through the joint ventures or technology licensees, a successful product launch
will trigger royalty payments to the Group, which are generally calculated as a percentage of the net sales realized by the technology
and captured upon commercialization.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Demonstrability of technical feasibility generally
occurs when the project reaches the &#8220;advanced development and deregulation&#8221; phase because at this stage success is considered
to be probable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>c)&#160;Intangible
assets acquired in a business combination</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Intangible assets acquired in a business combination
and recognized separately from goodwill are initially recognized at acquisition date fair value (which is considered as their cost). After
initial recognition, those assets are measured at cost less accumulated amortization and accumulated impairment losses in the same manner
as intangible assets acquired separately.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Intangible assets acquired in a business combination
have an estimated useful life as follows (in years):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Product development: 20 &#8211; 25 years</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Trademarks: 20 years</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Customer loyalty: 14 - 26 years</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Estimates</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To value intangible assets acquired from a business
combination, valuation techniques generally accepted in the market were applied, based mainly on the revenue approach (such as excess
earnings, relief from royalty, and with or without), considering the characteristics of the assets to be valued and available information
to estimate their acquisition date fair value. Application of these valuation techniques requires the use of several assumptions related
to future cash flows and the discount rate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>4.10. <span style="text-decoration:underline">Investment properties</span></b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Investment properties shall be measured initially
at its cost. The cost of a purchased investment property comprises its purchase price and any directly attributable expenditure. Directly
attributable expenditure includes, for example, professional fees for legal services, property transfer taxes and other transaction costs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the measurement after initial recognition,
the Group has chosen the cost model for all investment properties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>4.11. <span style="text-decoration:underline">Borrowings</span></b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group measures its borrowings at initial recognition
at fair value and, subsequently, are measured at amortized cost using the effective interest rate method.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Borrowing costs, either generic or specific, attributable
to the acquisition, construction or production of assets that necessarily take a substantial period of time to get ready for their intended
use or sale (qualifying assets) are included in the cost of the assets until the moment that they are substantially ready for use or sale.
Income earned on the temporary investments of funds generated in specific borrowings still pending use in the qualifying assets, are deducted
from the total of financing costs potentially eligible for capitalization.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All other loan costs are recognized under financial
costs, through profit and loss.</p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>4.12. <span style="text-decoration:underline">Convertibles notes</span></b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial liabilities, like convertible notes
that do not meet the &#8220;fixed for fixed&#8221; condition, are classified at their inception at fair value through profit or loss or
at amortized cost, using the effective interest amortization method.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>4.13. <span style="text-decoration:underline">Employee benefits</span></b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Employee benefits are expected to be settled wholly
within 12 months after the end of the reporting period and are presented as current liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accounting policies related to incentive payments
based on shares, if any, are detailed in Note 19 &#8211; Share-based payments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>4.14.&#160;<span style="text-decoration:underline">Provisions</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group has recognized provisions for liabilities
of uncertain timing or amount. The provision is measured at the best estimate of the expenditure required to settle the obligation at
the end of the reporting period, discounted at a pre-tax rate reflecting current market assessments of the time value of money and risks
specific to the liability.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>4.15.&#160;<span style="text-decoration:underline">Warrant
liabilities </span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As part of the business combination, the Group
acquired public warrants and private warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Public Warrants: These instruments are initially
recognized at fair value on the date the derivative contract is entered into and are subsequently remeasured to fair value at the end
of each reporting period. Gains and losses arising from changes in fair value are recognized in profit or loss.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These warrants are measured at Level 1 fair value,
based on their quoted market price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Private Warrants: These instruments are measured
at fair value using valuation techniques, including the Black-Scholes model.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These warrants are classified as Level 3 fair
value measurements, as they rely on significant unobservable inputs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>4.16.&#160;<span style="text-decoration:underline">Revenue
recognition</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Revenue is recognized when control has been transferred
to the buyer. Transfers of control vary depending on the individual terms of the sales contract. Revenues are recognized when control
of the products has been transferred, which generally means that the products have been delivered to the customer and there is no unfulfilled
obligation that could affect a customer&#8217;s acceptance of the products. Generally, acceptance occurs upon shipment or delivery but
ultimately depends on the terms of the underlying contracts. The customer is then invoiced at the agreed-upon price with the usual payment
terms for each geographical region. Those payment terms do not contain a significant financing component.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The timing of performance sometimes differs from
the timing that the associated consideration is received from the customer, thus resulting in the recognition of a contract asset or contract
liability. The Company recognizes a contract liability if the customer&#8217;s payment of consideration is received prior to completion
of the related performance obligation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a part of the Company&#8217;s customary business
practices, the Company offers a number of sales incentives to the customers, including volume discounts, retailer incentives, prepayment
options and other product rebates. For all such contracts that include any variable consideration, the Company estimates the amount of
variable consideration that should be included in the transaction price utilizing either the expected value method or the most likely
amount method, depending on the nature of the variable consideration. Variable consideration is included in the transaction price if,
in the judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur. Although determining
the transaction price for consideration requires significant judgment, the Company has meaningful historical experience with incentives
provided to customers and estimate the expected consideration in view of historical patterns of incentive payouts. These estimates are
reassessed each reporting period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company also offer an assurance warranty,
which gives customers a refund or exchange right in the case the delivered product does not conform to specifications. Replacement products
are accounted for under the warranty guidance if the customer exchanges one product for another of the same type, quality, and price.
The Company has significant experience with historical return patterns and use this experience to include returns in the estimate of transaction
price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With respect to services, the Company mainly provides
R&amp;D and seed treatment services. Revenue associated with services is recognized by reference to the stage of completion of the transaction
at the end of the reporting period. Each of the services to be provided has a detailed work plan in which all activities to be rendered
are listed. The stage of completion for services is determined in accordance with the execution of the performed tasks listed in the respective
work plan. The level of execution of such services is provided by the Company&#8217;s technical experts, who provide information relating
to the transfer of goods or services. The Company has no material revenue for services that cannot be reliably estimated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Revenue for usage-based royalties relating to
licensed intellectual property rights is recognized at the later of when the performance obligation is satisfied and when a sale or use
occurs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Typically, the Company&#8217;s average payment
terms range from 130 to 160 days at a consolidated level. Longer terms may be granted in limited circumstances; however, the effects of
such sales are not material to the consolidated financial statements. Those payment terms do not contain a significant financing component.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>4.17.&#160;<span style="text-decoration:underline">Government
grants</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Government grants are recognized where there is
reasonable assurance that the grant will be received and all attached conditions will be complied with. When the grant relates to an expense
item, it is recognized as income on a systematic basis over the periods that the related costs, for which it is intended to compensate,
are expensed. When the grant relates to an asset, it is recognized as income in equal amounts over the expected useful life of the related
asset. Management elected this accounting policy because the Group determined it better shows the financial effect of government grants
in the consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When the Group receives grants of non-monetary
assets, the asset and the grant are recorded at nominal amounts and released to profit or loss over the expected useful life of the asset.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The difference between the money obtained under
government loans at subsidized rates and the carrying amount of those loans is treated as a government grant, in accordance with IAS 20.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>4.18.&#160;<span style="text-decoration:underline">Income
tax</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Income tax expense comprises current and deferred
tax. It is recognized in profit or loss except to the extent that it relates to a business combination, or items recognized directly in
equity or in OCI.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group has determined that interest and penalties
related to income taxes, including uncertain tax treatments, do not meet the definition of income taxes, and therefore accounted for them
under IAS 37 <i>Provisions, Contingent Liabilities and Contingent Assets.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group has determined that the global minimum
top-up tax &#8211; which it is required to pay under Pillar Two legislation &#8211; is an income tax in the scope of IAS 12. Pillar Two
legislation is not applicable to Moolec Science SA in accordance with current thresholds.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Current tax</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Current tax comprises the expected tax payable
or receivable on the taxable income or loss for the year and any adjustment to the tax payable or receivable in respect of previous years.
The amount of current tax payable or receivable is the best estimate of the tax amount expected to be paid or received that reflects uncertainty
related to income taxes, if any. It is measured using tax rates enacted or substantively enacted at the reporting date. Current tax also
includes any tax arising from dividends.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Current tax assets and liabilities are offset
only if certain criteria are met.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Deferred tax</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Deferred tax assets and liabilities are recognized
where the carrying amount of an asset or liability in the Consolidated statement of financial position differs from its tax base, except
for differences arising on:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">The initial recognition of goodwill;</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">The initial recognition of an asset or liability in a transaction
which is not a business combination and at the time of the transaction affects neither accounting or taxable profit; and</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">Investments in subsidiaries and jointly controlled entities
where the Group is able to control the timing of the reversal of the difference and it is probable that the difference will not reverse
in the foreseeable future.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Recognition of deferred tax assets is restricted
to those instances where it is probable that taxable profit will be available against which the difference can be utilized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The amount of the asset or liability is determined
using tax rates that have been enacted or substantively enacted by the end of the reporting period and are expected to apply when the
deferred tax liabilities / (assets) are settled / (recovered).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Deferred tax assets and liabilities are offset
when the Group has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities
relate to taxes levied by the same tax authority on either:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">The same taxable entity within the Group, or</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">Different entities within the Group which intend either to
settle current tax assets and liabilities on a net basis, or to realize the assets and settle the liabilities simultaneously, in each
future period in which significant amounts of deferred tax assets or liabilities are expected to be settled or recovered.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>4.19.&#160;<span style="text-decoration:underline">Share-based
payments</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prior to the Business Combination and the BIOX
deconsolidation, certain executives and directors of the Group were granted incentives in the form of shares and options to purchase shares
as consideration for services.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The cost of these share-based transactions is
determined based on their fair value at the date upon which such incentives are granted using a valuation model that is appropriate in
the circumstances.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This cost is recognized as an expense together
with an increase in equity throughout the period in which the service or performance conditions are satisfied (i.e., the vesting period).
The accumulated expense recorded in connection with these transactions at the end of each year until the vesting date reflects the time
elapsed between the vesting period and Management&#8217;s best estimate of the number of equity instruments that will vest. The charge
to income/loss for the period represents the variation in the accumulated expense recorded between the beginning and the end of the year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Non-market related service and performance conditions
are not taken into account when determining the grant date fair value of the equity instruments, but the probability that the conditions
are fulfilled is assessed as part of Management&#8217;s best estimate of the number of equity instruments that will vest. Market-related
performance conditions are reflected in the grant date fair value. Any other conditions related to equity-settled share-based payment
transactions but without a service requirement are considered as non-vesting conditions. Non-vesting conditions are reflected in the fair
value of the equity instruments and are charged to income/loss immediately unless there are service and/or performance conditions as well.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No amount is recognized for transactions that
will not vest because non-market related performance conditions and/or service conditions were not satisfied. When transactions include
market-related conditions or non-vesting conditions, the transactions are considered to be vested, irrespective of whether a market-related
condition or the non-vesting condition is satisfied, provided that all the other performance and/or service conditions are met.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When the terms and conditions of an equity-settled
share-based payment transaction are modified, the minimum expense recognized is the grant date fair value, unmodified, provided that the
original terms have been complied with. An additional expense, measured at the date of modification, is recognized for any modification
that increases the total fair value of the share-based payment transaction, or is otherwise beneficial to the employee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When the transaction is settled by the Group or
by the counterparty, any remainder of the fair value is charged to income immediately.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The dilutive effect of current options is considered
in the calculation of the diluted earnings per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Estimates</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The estimate of the fair value of equity-settled share-based payment
transactions requires a determination to be made of the most adequate option pricing model to apply depending on the terms and conditions
of the arrangement. This estimate also requires a determination of those factors most appropriate to the pricing model, including the
expected life of the option and the expected volatility of the share price upon the basis of which assumptions are made. The Group measures
the fair value of these transactions at the grant date applying the Black-Scholes formula adjusted to consider the possible dilutive effect
of the future exercise of the share options granted on their estimated fair value at grant date, as established in paragraph B41 of IFRS
2. The assumptions used for the estimate of the fair value of these transactions are disclosed in Note 19 &#8211; Share-based payment
and will not necessarily take place in the future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of June 30, 2025 no equity awards are outstanding.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of material accounting policy information applied by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 176<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_176&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B13<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B13&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Critical Accounting Judgments and Estimates<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_CriticalAccountingJudgmentsAndEstimatesAbstract', window );"><strong>Critical Accounting Judgments and Estimates [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory', window );">CRITICAL ACCOUNTING JUDGMENTS AND ESTIMATES</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>5.&#160;<span style="text-decoration:underline">CRITICAL ACCOUNTING
JUDGMENTS AND ESTIMATES</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group makes certain estimates and assumptions
regarding the future. Estimates and judgments are continually evaluated based on historical experience and other factors, including expectations
of future events that are believed to be reasonable under the circumstances. In the future, actual experience may differ from these estimates
and assumptions. The estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amounts of
assets and liabilities within the next financial year are listed below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Critical judgements</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">De facto control over BIOX (Note 1 &#8211; The Group&#8217;s
business reorganization and general information and Note 2 &#8211; Accounting standards an basis of presentation).</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration:underline">Critical estimates</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">Impairment of goodwill (Notes 4.6 &#8211; Impairment assessment
of goodwill and intangibles).</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">Impairment testing of intangible assets not yet available
for use or with indefinite useful lives.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">Identification and fair value of identifiable intangible
assets arising in acquisitions.</td>
</tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of judgements that management has made in the process of applying the entity's accounting policies that have the most significant effect on amounts recognised in the financial statements along with information about the assumptions that the entity makes about the future, and other major sources of estimation uncertainty at the end of the reporting period, that have a significant risk of resulting in a material adjustment to the carrying amounts of assets and liabilities within the next year. [Refer: Carrying amount [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_CriticalAccountingJudgmentsAndEstimatesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_CriticalAccountingJudgmentsAndEstimatesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Other Significant Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsAbstract', window );"><strong>Acquisitions and Other Significant Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory', window );">ACQUISITIONS AND OTHER SIGNIFICANT TRANSACTIONS</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>6.&#160;<span style="text-decoration:underline">ACQUISITIONS AND
OTHER SIGNIFICANT TRANSACTIONS</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><i>Bioceres Group, Nutrecon,
Gentle Tech and Moolec Science business combination</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">As stated in Note 1 &#8211;
The Group&#8217;s business reorganization and general information - &#8220;<i>The Bioceres Group Business Combination Agreement&#8221;,
</i>on June 16, 2025, it was announced the closing of the Bioceres Group Business Combination.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The combined group now operates an integrated
platform encompassing R&amp;D, manufacturing, and regulatory capabilities that span from molecular design to validation in both fermenter
and field environments. On one front, the Company advances its molecular farming programs in crops such as soy and safflower to produce
proteins and lipids with animal-like functionality and plant-based cost structures. On the other front, Moolec is developing a precision
fermentation facility in Finland, under the SynBio Powerlabs brand, which will be dedicated to producing target proteins, enzymes, and
other biomolecules using optimized microbial and cellular systems. Once operational, this facility will provide an industrial pathway
to design, ferment, and scale alternative proteins while establishing commercial channels with leading food companies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">The combination of these
two complementary approaches, farming and fermentation, will enable the Company to accelerate time-to-market, diversify technology risks,
and anchor production costs in agricultural scalability, without compromising product functionality or organoleptic properties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">The Business Combination
under IFRS 3, <i>Business Combinations</i>, was accounted using the acquisition method of accounting and treating the transaction as a
reverse acquisition. Under this approach, Bioceres Group (the legal subsidiary) was considered the accounting acquirer, and Moolec Science
SA (the legal acquirer) was considered the accounting acquiree, together with Gentle Tech and Nutrecon.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">As a result, the consolidated
financial statements represent a continuation of the financial statements of Bioceres Group, the predecessor, with the net assets of Moolec
Science SA, Gentle Tech and Nutrecon recognized at fair value on the acquisition date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">Because the transaction is accounted for as a reverse acquisition,
the consideration transferred is based on the number of equity instruments that Bioceres Group would have had to issue to give the owners
of Moolec Science SA, Nutrecon and Gentle Tech the same percentage ownership in the combined entity that results from the transaction.
The fair value of the consideration amounted to $19,939,162.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="text-decoration:underline">Identifiable Assets
Acquired and Liabilities Assumed (Accounting Acquirees):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">Provisional Purchase
Price Allocation:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">The purchase price allocation (&#8220;PPA&#8221;) related to the business
combinations have been determined on a provisional basis in accordance with IFRS 3.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">Under IFRS 3, the Company
is permitted to adjust the provisional amounts recognized at the acquisition date during the measurement period, which may extend up to
twelve months from the acquisition date, as new information becomes available regarding facts and circumstances that existed at that date.
Consequently, the amounts disclosed in this note are subject to change.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Fair value of the consideration of payment</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%">Equity shares</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">33,504,531</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Warrants</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,030,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total consideration</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">34,534,531</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consideration of payment was measured at fair value, which was
calculated as the sum of equity shares and warrants. The fair values of the warrants measured were based on Black &amp; Scholes method
and the equity shares measured was determined using the Moolec&#8217;s share quoted price at the transaction date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;Assets acquired, liabilities assumed, and non-controlling interest
recognized</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-style: normal; border-bottom: Black 1.5pt solid; font-weight: normal; text-align: left"><b>Net assets incorporated</b></td><td style="font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><b>Total</b></td><td style="padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: normal; width: 88%; font-weight: normal; text-align: justify">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">554,420</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-style: normal; font-weight: normal; text-align: justify">Trade and other receivables</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,036,558</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: normal; font-weight: normal; text-align: justify">Property, plant and equipment</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,319,313</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-style: normal; font-weight: normal; text-align: justify">Intangible assets</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">74,841,933</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: normal; font-weight: normal; text-align: justify">Right of use assets</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">100,896</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-style: normal; font-weight: normal; text-align: justify">Inventories</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,235,482</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: normal; font-weight: normal; text-align: justify">Borrowings / Financial debt</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(19,608,629</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-style: normal; font-weight: normal; text-align: justify">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(5,806,020</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: normal; font-weight: normal; text-align: justify">Lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(117,463</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-style: normal; font-weight: normal; text-align: justify">Warrant liabilities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(181,093</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: normal; padding-bottom: 1.5pt; font-weight: normal; text-align: justify">Deferred tax liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(15,767,275</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-style: normal; font-weight: normal; text-align: justify">Total net assets identified</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">43,608,122</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: normal; font-weight: normal; text-align: justify">Non-controlling interest</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">6,316,790</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-style: normal; font-weight: normal; text-align: left">Previously held interest - revalued at FV</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,283,319</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: normal; padding-bottom: 1.5pt; font-weight: normal; text-align: justify">Gain on purchase</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,473,482</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-style: normal; padding-bottom: 2.5pt; font-weight: normal; text-align: justify"><b>Total consideration</b></td><td style="padding-bottom: 2.5pt; font-weight: bold"><b>&#160;</b></td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><b>$</b></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><b>34,534,531</b></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><b>&#160;</b></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>Non-controlling
interest (NCI) was measured at the present ownership instruments&#8217; proportionate share in the recognized amounts of the acquiree&#8217;s
identifiable net assets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>In one of the three acquired
businesses, the Group held an equity interest in the acquiree prior to obtaining control. In accordance with IFRS 3, the previously held
interest was remeasured at its acquisition-date fair value, and the resulting gain or loss was recognized in profit or loss. This remeasurement
reflects the change in value of the Group&#8217;s existing investment up to the date control was obtained and forms part of the total
consideration transferred for the business combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The fair value of the identifiable
net assets exceeded the consideration transferred (including the fair value of the NCI). As required by IFRS 3, the resulting excess was
recognized as a bargain purchase gain in profit or loss on the acquisition date. The bargain gain primarily reflects overperforming asset
base identified during the purchase price allocation process. The bargain gain on purchase is recognized in the line item &#8220;Other
income or expenses, net&#8221; in the Consolidated Statement of Comprehensive Income.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The amounts of revenue and net profit of the acquirees
since the merger date included in the consolidated statement of comprehensive income for the year ended June 30, 2025, were immaterial
considering that the acquisition date was very close to the end of the fiscal year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Had the reverse acquisition been completed on
<span style="font-weight: normal">July 1 2024</span>, the pro forma revenue and net loss of the combined entity for the year ended June
30, 2025 as though the date for the merger had been as of the beginning of the reporting period amount to $339.8&#160;million and $157.4&#160;million,
respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Natal Agro S.R.L.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 10, 2024, the former subsidiary, BIOX,
acquired a controlling interest in Natal Agro S.R.L (&#8220;Natal&#8221;), an Argentine company that breeds and develops corn varieties.
The interest acquired is represented by a total of 116,225 shares of AR$ 10 nominal value each, representing 51% of equity and voting
interest.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consideration for the acquisition was $0.22
million in cash and the commitment to carrying out, at BIOX&#8217;s own expense, the regulatory activities for HB4 corn to obtain authorization
for its commercialization in Argentina, and the regulatory activities for HB4 corn in Brazil, once the commercialization strategy of HB4
corn in Brazil has been defined by the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Fair value of the consideration of payment</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; width: 88%; text-align: left">Cash payment</td><td style="padding: 0pt; width: 1%">&#160;</td>
    <td style="padding: 0pt; width: 1%; text-align: left">&#160;</td><td style="padding: 0pt; width: 9%; text-align: right">215,415</td><td style="padding: 0pt; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding: 0pt; text-align: left">Regulatory activities</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="padding: 0pt; border-bottom: Black 1.5pt solid; text-align: right">727,985</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; font-weight: bold; text-align: left">Total consideration</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="padding: 0pt; border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; border-bottom: Black 4pt double; font-weight: bold; text-align: right">943,400</td><td style="padding: 0pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consideration of payment was measured at fair
value, which was calculated as the sum of cash paid and the acquisition-date fair values of the regulatory services to be provided. The
fair values measured were based on discounting future cash flow using market discount rates. The difference between fair value and nominal
value of consideration will be recognized as finance cost over the period the consideration will be paid.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Assets acquired, liabilities assumed, and non-controlling
interest recognized </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left; padding-left: 0pt">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">252,923</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Other financial assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">73,950</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Trade receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">596,463</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Other receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">288,861</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Income and minimum presumed recoverable income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19,998</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Inventories</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,031,412</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Property, plant and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">816,576</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Intangible assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,217,985</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Right of use asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">168,988</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Trade and other payables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,302,332</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">Borrowings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(743,279</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Employee benefits and social security</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(23,346</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Deferred revenue and advances from customers</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,515</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Provisions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(355,898</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(168,988</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Deferred tax liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(996,824</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 0pt">Total net assets identified</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">3,873,974</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-left: 0pt">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Non-controlling interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,898,247</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 0pt">Gain from a bargain purchase</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,032,327</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Total consideration</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">943,400</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The business combination was executed in a context
of financial setbacks faced by the acquired company. To address these, in addition to the initial cash payment, BIOX has committed to
providing a working capital loan of up to $3 million to help alleviate the financial strain.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">BIOX will also provide regulatory services related
to its proprietary technologies, which will enable strategic business development for Natal and create a new product pipeline leveraging
BIOX&#8217; technology. Specifically, BIOX has agreed to grant Natal an exclusive license for certain technologies to be applied to corn, with
Natal committing to pay 15% of the revenues generated from this technology.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of transactions recognised separately from acquisition of assets and assumption of liabilities in a business combination. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2025-01-01<br> -Paragraph B64<br> -Subparagraph l<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B64_l&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Information About Components of Consolidated Statements of Financial Position<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract', window );"><strong>Information About Components of Consolidated Statements of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock', window );">INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>7.&#160;<span style="text-decoration:underline">INFORMATION ABOUT
COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>7.1 <span style="text-decoration:underline">Cash and cash equivalents</span></b></p>



<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>06/30/2025</b></span></td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>06/30/2024</b></span></td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0pt">Cash at bank and on hand</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">767,919</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">27,210,070</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Mutual funds</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-176">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">25,784,795</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">767,919</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">52,994,865</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>7.2 <span style="text-decoration:underline">Other financial assets</span></b></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 1.5pt">&#160;</td><td style="padding: 0pt 0pt 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-top: 0pt; text-align: center; padding-right: 0pt; padding-left: 0pt"><span style="font-size: 10pt"><b>06/30/2025</b></span></td><td style="padding: 0pt 0pt 1.5pt">&#160;</td><td style="padding: 0pt 0pt 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-top: 0pt; font-weight: bold; text-align: center; padding-right: 0pt; padding-left: 0pt"><span style="font-size: 10pt"><b>06/30/2024</b></span></td><td style="padding: 0pt 0pt 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-top: 0pt; font-weight: bold; padding-right: 0pt; padding-left: 0pt">Current</td><td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt">&#160;</td>
    <td colspan="2" style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt">&#160;</td>
    <td colspan="2" style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0pt; width: 76%; text-align: left; padding-left: 0pt; padding-right: 0pt">Investments at fair value</td><td style="padding-top: 0pt; width: 1%; padding-right: 0pt; padding-left: 0pt">&#160;</td>
    <td style="padding-top: 0pt; width: 1%; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; width: 9%; text-align: right; padding-right: 0pt; padding-left: 0pt">19,722</td><td style="padding-top: 0pt; width: 1%; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; width: 1%; padding-right: 0pt; padding-left: 0pt">&#160;</td>
    <td style="padding-top: 0pt; width: 1%; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; width: 9%; text-align: right; padding-right: 0pt; padding-left: 0pt">2,191,286</td><td style="padding-top: 0pt; width: 1%; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-top: 0pt; text-align: left; padding-left: 0pt; padding-right: 0pt">Mutual funds</td><td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt">&#160;</td>
    <td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; text-align: right; padding-right: 0pt; padding-left: 0pt"><div style="-sec-ix-hidden: hidden-fact-177">-</div></td><td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt">&#160;</td>
    <td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; text-align: right; padding-right: 0pt; padding-left: 0pt">6,658,805</td><td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 1.5pt; text-align: left">Other investments</td><td style="padding: 0pt 0pt 1.5pt">&#160;</td>
    <td style="padding-top: 0pt; border-bottom: Black 1.5pt solid; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; border-bottom: Black 1.5pt solid; text-align: right; padding-right: 0pt; padding-left: 0pt">8,234,539</td><td style="padding: 0pt 0pt 1.5pt; text-align: left">&#160;</td><td style="padding: 0pt 0pt 1.5pt">&#160;</td>
    <td style="padding-top: 0pt; border-bottom: Black 1.5pt solid; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; border-bottom: Black 1.5pt solid; text-align: right; padding-right: 0pt; padding-left: 0pt">5,817,516</td><td style="padding: 0pt 0pt 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding: 0pt 0pt 4pt">&#160;</td><td style="padding: 0pt 0pt 4pt">&#160;</td>
    <td style="padding-top: 0pt; border-bottom: Black 4pt double; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; border-bottom: Black 4pt double; text-align: right; padding-right: 0pt; padding-left: 0pt">8,254,261</td><td style="padding: 0pt 0pt 4pt; text-align: left">&#160;</td><td style="padding: 0pt 0pt 4pt">&#160;</td>
    <td style="padding-top: 0pt; border-bottom: Black 4pt double; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; border-bottom: Black 4pt double; text-align: right; padding-right: 0pt; padding-left: 0pt">14,667,607</td><td style="padding: 0pt 0pt 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0pt; padding-left: 0pt; padding-right: 0pt">&#160;</td><td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt">&#160;</td>
    <td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; text-align: right; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt">&#160;</td>
    <td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; text-align: right; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-top: 0pt; font-weight: bold; padding-left: 0pt; padding-right: 0pt">Non-current</td><td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt">&#160;</td>
    <td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; text-align: right; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt">&#160;</td>
    <td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; text-align: right; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0pt; text-align: left; padding-left: 0pt; padding-right: 0pt">Mutual funds</td><td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt">&#160;</td>
    <td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; text-align: right; padding-right: 0pt; padding-left: 0pt"><div style="-sec-ix-hidden: hidden-fact-178">-</div></td><td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt">&#160;</td>
    <td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; text-align: right; padding-right: 0pt; padding-left: 0pt">190,080</td><td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding: 0pt 0pt 1.5pt; text-align: left">Investments at fair value</td><td style="padding: 0pt 0pt 1.5pt">&#160;</td>
    <td style="padding-top: 0pt; border-bottom: Black 1.5pt solid; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; border-bottom: Black 1.5pt solid; text-align: right; padding-right: 0pt; padding-left: 0pt"><div style="-sec-ix-hidden: hidden-fact-179">-</div></td><td style="padding: 0pt 0pt 1.5pt; text-align: left">&#160;</td><td style="padding: 0pt 0pt 1.5pt">&#160;</td>
    <td style="padding-top: 0pt; border-bottom: Black 1.5pt solid; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; border-bottom: Black 1.5pt solid; text-align: right; padding-right: 0pt; padding-left: 0pt">437</td><td style="padding: 0pt 0pt 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 4pt">&#160;</td><td style="padding: 0pt 0pt 4pt">&#160;</td>
    <td style="padding-top: 0pt; border-bottom: Black 4pt double; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; border-bottom: Black 4pt double; text-align: right; padding-right: 0pt; padding-left: 0pt"><div style="-sec-ix-hidden: hidden-fact-180">-</div></td><td style="padding: 0pt 0pt 4pt; text-align: left">&#160;</td><td style="padding: 0pt 0pt 4pt">&#160;</td>
    <td style="padding-top: 0pt; border-bottom: Black 4pt double; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; border-bottom: Black 4pt double; text-align: right; padding-right: 0pt; padding-left: 0pt">190,517</td><td style="padding: 0pt 0pt 4pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The book value is reasonably approximate to the
fair value given its short-term nature.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>7.3 <span style="text-decoration:underline">Trade receivables</span></b></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt"><b>06/30/2025</b></span></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Current</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0pt">Trade debtors</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">4,519,487</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">205,490,518</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Allowance for impairment of trade debtors (Note 7.16)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-181">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(7,050,280</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Shareholders and other related parties (Note 17)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-182">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">37</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; padding-left: 0pt">Allowance for credit notes to be issued</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-183">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,905,624</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Trade debtors - Joint ventures and associates (Note 13)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,565,913</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,176,622</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Deferred checks</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-184">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,295,922</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">6,085,400</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">209,007,195</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The book value is reasonably approximate to the fair value given its
short-term nature.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As of June 30, 2025, there is no allowance for impairment of
trade debtors, as the trade debtors mainly was acquired through the Business Combination Agreement consummated in June 16, 2025.</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>7.4 <span style="text-decoration:underline">Other receivables</span></b></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt"><b>06/30/2024</b></span></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Current</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; padding-left: 0pt">Taxes</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">382,957</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">5,475,685</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Insurance to be accrued</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,835</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,595,319</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Other receivables - Joint ventures and associates (Note 13)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,547,409</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,162,870</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Prepayments to suppliers</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">114</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,236,905</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Shareholders and other related parties (Note 17)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,313,179</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">47,348</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Government grants receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-185">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">608</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Prepaid expenses and other receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33,448</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,736,808</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Loans receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-186">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,800,572</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 0pt">Miscellaneous</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">560,222</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,601,268</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">13,849,164</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">34,657,383</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right; padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-left: 0pt">Non-current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">Taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-187">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">752,045</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Other receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-188">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">230,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Reimbursements over exports</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-189">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,461,042</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Other receivables - Joint ventures and associates (Note 13)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">664,493</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,423,142</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 0pt">Miscellaneous</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-190">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">20,805</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">664,493</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">27,887,034</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The book value of financial assets is reasonably approximate to the
fair value given its short-term nature.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>7.5 <span style="text-decoration:underline">Inventories</span></b></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt"></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>06/30/2025</b></span></td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>06/30/2024</b></span></td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; padding-left: 0pt">Seeds</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">551,290</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">5,967,231</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Resale products</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-191">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">53,788,333</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Manufactured products</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">994,360</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26,081,250</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Goods in transit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-192">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,618,540</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">Supplies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-193">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,546,093</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Agricultural products</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">689,832</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,015,884</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Allowance for obsolescence (Note 7.16)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-194">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,087,563</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">2,235,482</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">125,929,768</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Net of agricultural products</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">1,545,650</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">110,913,884</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The roll-forward of allowance for obsolescence
is in Note 7.16.</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>7.6 <span style="text-decoration:underline">Biological assets</span></b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Changes in Biological assets:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Soybean</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Corn</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Wheat</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Barley</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Sunflower</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left; padding-left: 0pt">Beginning of the year</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-195">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-196">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">220,682</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">73,452</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-197">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right">294,134</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Initial recognition and changes in the fair value of biological assets at the point of harvest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">593,001</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">435,725</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">579,313</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">158,080</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,256</td><td style="text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">1,764,863</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Costs incurred during the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,959,381</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,814,249</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">444,303</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">162,342</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">55,063</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">4,435,338</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Decrease due to harvest/disposals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,275,688</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,148,288</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,244,298</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(393,874</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(53,807</td><td style="text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(4,115,955</td><td style="font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 0pt">Loss of control</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,276,694</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,101,686</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-198">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-199">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-200">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(2,378,380</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 0pt">Year ended June 30, 2025</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-201">-</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-202">-</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-203">-</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-204">-</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-205">-</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-206">-</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Soybean</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Corn</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Wheat</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Barley</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Sunflower</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left; padding-left: 0pt">Beginning of the year</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-207">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-208">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">87,785</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">59,057</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-209">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right">146,842</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Initial recognition and changes in the fair value of biological assets at the point of harvest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(352,199</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(32,674</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">231,526</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">106,605</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">996</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(45,746</td><td style="font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Costs incurred during the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,423,732</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">792,235</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">220,679</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">73,452</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">137,680</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">2,647,778</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Decrease due to harvest/disposals</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,071,533</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(759,561</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(319,308</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(165,662</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(138,676</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(2,454,740</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 0pt">Year ended June 30, 2024</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-210">-</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-211">-</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">220,682</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">73,452</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-212">-</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">294,134</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>7.7 <span style="text-decoration:underline">Property, plant and equipment</span></b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Property, plant and equipment as of June 30, 2025 and 2024, included
the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid"><b>Class</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Net carrying amount 06/30/2024</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Additions</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Reclassification<br/>
within PPE</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Disposals</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Depreciation of the year</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Foreign currency translation</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Loss of control</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Business combination</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Net&#160;carrying<br/>
amount<br/>
06/30/2025</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 0pt; padding-left: 0pt; width: 19%">Office&#160;equipment</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">503,950</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">39,611</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-213">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">(4,791</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">(82,495</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">3,947</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">(449,942</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-214">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">10,280</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0pt; padding-left: 0pt">Vehicles</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,192,627</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35,915</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-215">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(17,239</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(882,264</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,330,062</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-216">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-217">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Equipment and computer software</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">528,816</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">75,297</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-218">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(323</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(273,912</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,012</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(331,763</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-219">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,127</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Fixtures and fittings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,805,076</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,084</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">225,338</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(6,789</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(860,822</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,350</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,178,237</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-220">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-221">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Machinery and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,722,642</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">563,352</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">122,653</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(143,947</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,895,031</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">81,204</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(14,449,423</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-222">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,450</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Land and buildings</td><td>&#160;</td>
    <td style="text-align: left"></td><td style="text-align: right">39,745,067</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-223">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"></td><td style="text-align: right">348,085</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-224">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"></td><td style="text-align: right">(1,021,176</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left"></td><td style="text-align: right">71,315</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"></td><td style="text-align: right">(39,143,291</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left"></td><td style="text-align: right">982,939</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"></td><td style="text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;982,939</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Buildings in progress</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;&#160;&#160;&#160;&#160;12,114,256</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,264,663</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(696,076</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-225">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-226">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,753</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(16,692,596</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,336,374</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,336,374</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-indent: 0pt; padding-left: 0pt">Total</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">74,612,434</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">5,987,922</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-227">-</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(173,089</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(6,015,700</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">189,604</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(74,575,314</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">3,319,313</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">3,345,170</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; border-bottom: Black 1.5pt solid"><b>Class</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Net&#160;carrying amount <br/>06/30/2023</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Additions</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Reclassification from Investment properties</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Disposals</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Depreciation of the year</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Foreign currency translation</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Loss of control</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Net&#160;carrying amount 06/30/2024</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; width: 19%; text-align: left; padding-left: 0.125in">Research&#160;instruments</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">66,131</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-228">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-229">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-230">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-231">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-232">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">(66,131</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-233">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Office&#160;equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">360,575</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">238,679</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-234">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-235">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(81,507</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(13,324</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(473</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">503,950</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Vehicles</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,053,263</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,077,988</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-236">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,677</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(908,040</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(775</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(28,132</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,192,627</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Equipment and computer software</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">198,364</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">725,706</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-237">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(8,184</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(354,379</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(27,650</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5,041</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">528,816</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Fixtures and fittings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,925,032</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">731,699</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-238">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,295</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(812,810</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,663</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(43,477</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,805,076</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Machinery and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,586,768</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,460,655</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-239">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(154,492</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,661,097</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(409,769</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(99,423</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,722,642</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Land and buildings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">36,211,957</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,835,054</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,222,044</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"></td><td style="text-align: right">53,217</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(982,165</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(595,040</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-240">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">39,745,067</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-indent: -0.125in; text-align: left; padding-left: 0.125in">Buildings in progress</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;&#160;&#160;&#160;&#160;11,757,249</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; text-align: right">683,406</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-241">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt"></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; text-align: right">(106,421</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-242">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; text-align: right">(207,757</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; text-align: right">(12,221</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;&#160;&#160;&#160;&#160;12,114,256</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-indent: -0.125in; font-weight: bold; padding-left: 0.125in">Total</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">68,159,339</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">10,753,187</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold"></td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">3,222,044</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(211,262</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(5,799,998</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(1,255,978</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(254,898</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">74,612,434</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The depreciation charge is included in Notes 8.3 - R&amp;D classified
by nature and Note 8.4 &#8211; Expenses classified by nature and function. The Group has no commitments to purchase property, plant and
equipment items.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Revaluation of property, plant and equipment</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group used to frequently update their assessment
of the fair value of its land and buildings taking into account the most recent independent valuations and market data. Last valuations
were performed as of June 30, 2023. Management determined the property, plant and equipment&#8217;s value within a range of reasonable
fair value estimates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All resulting fair value estimates for properties
are included in level 2 or 3 depending on the methodology used.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following are the carrying amounts that would
have been recognized if land and building were stated at cost.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Value at cost</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Class of property</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: justify; padding-left: 0pt">Land and buildings</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">27,876,636</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-size: 10pt"><b>7.8</b></span> <b><span style="text-decoration:underline">Intangible assets</span></b></p>



<p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 6pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Intangible assets as of June 30, 2025 and 2024 included the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 6pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; border-bottom: Black 1.5pt solid"><b>Class</b></td><td style="border-bottom: Black 1.5pt solid"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Net carrying amount 06/30/2024</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Additions</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt"><b>Loss of control) <sup>(*)</sup></b></span></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt"><b>Additions from business
    combinations <sup>(**)</sup></b></span></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Transfers/ Disposals</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Amortization of the year</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Foreign currency translation</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Net carrying amount 06/30/2025</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; font-style: italic"><span style="text-decoration:underline">Seed and
    integrated products</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; text-indent: -0.125in; padding-left: 0.125in; width: 28%; text-align: left">Alfalfa Genuity Har Xstra</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">438,029</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-243">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-244">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-245">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-246">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-247">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">(21,172</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">416,857</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">HB4 soy and breeding program</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35,574,369</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,164,283</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(36,464,169</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-248">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-249">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,274,483</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-250">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-251">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Integrated seed products</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,681,826</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-252">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,526,410</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-253">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-254">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(194,339</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">38,923</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-255">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; font-style: italic; text-decoration: underline; text-align: left">Crop nutrition</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Microbiological products</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">41,187,249</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">286,665</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(43,570,818</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-256">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,605,198</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,511,420</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,126</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-257">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Microbiological products in progress</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,452,861</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,163,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(11,909,700</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-258">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,706,661</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-259">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-260">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-261">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; font-style: italic; text-decoration: underline; text-align: left">Other intangible assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Trademarks and patents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">51,316,860</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">158,557</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(47,394,664</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-262">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-263">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,080,753</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-264">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-265">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Trademarks and patents with indefinite useful life</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,045,294</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-266">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(10,045,294</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-267">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-268">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-269">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-270">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-271">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Software</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,119,494</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,222</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(605,341</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-272">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">146,839</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(723,312</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">46,098</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-273">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Software in progress</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">580,728</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">176,064</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(609,953</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-274">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(146,839</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-275">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-276">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-277">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Customer loyalty</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,934,570</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-278">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(17,565,911</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-279">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-280">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,368,659</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-281">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-282">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">RG/RS/OX Wheat</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,000,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,528,899</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(10,480,817</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-283">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-284">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,048,082</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-285">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-286">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Sustainable agricultural equipment technology</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-287">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-288">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-289">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,719,710</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-290">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-291">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-292">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,719,710</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Fungal Biomass</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-293">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-294">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-295">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,775,940</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-296">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-297">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-298">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,775,940</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Piggysooy</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-299">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-300">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-301">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,813,781</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-302">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-303">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-304">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,813,781</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Safflower GLA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-305">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-306">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-307">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27,857,339</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-308">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-309">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-310">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27,857,339</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Safflower Chimosin 2.0</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-311">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-312">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-313">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,600,554</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,600,554</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Other intangibles</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-314">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-315">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-316">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,074,609</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-317">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-318">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-319">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,074,609</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold">Total</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">177,331,280</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">15,494,190</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(181,173,077</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">74,841,933</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(101,463</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(11,201,048</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">66,975</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">75,258,790</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 6pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><sup>(*)</sup></td><td style="text-align: justify">Correspond to the loss of control of BIOX.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><sup>(**)</sup></td><td style="text-align: justify">Correspond to The Bioceres Group Business Combination Agreement.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 6pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left; padding-left: 0in"><b>Class</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Net carrying amount 06/30/2023</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Additions</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Additions
    from business combinations/ (loss of control)<sup>(*)</sup></b></span></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Transfers/ Disposals</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Amortization of the year</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Foreign currency translation</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Net carrying amount 06/30/2024</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; font-style: italic">Seed and integrated products</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 28%; text-align: left">Alfalfa Genuity Har Xstra</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">419,061</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-320">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-321">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-322">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-323">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">18,968</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">438,029</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Bacillus-PHAs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,089,536</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-324">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,089,536</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-325">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-326">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-327">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-328">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">HB4 soy and breeding program</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,679,114</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,987,247</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-329">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-330">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,091,992</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-331">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35,574,369</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Integrated seed products</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,841,008</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-332">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-333">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-334">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(191,559</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">32,377</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,681,826</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; font-style: italic; text-decoration: underline; text-align: left">Crop
    nutrition</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Microbiological&#160;products</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">37,295,460</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-335">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-336">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,610,115</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,718,326</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-337">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">41,187,249</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Microbiological products in progress</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,213,341</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,869,084</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-338">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(7,610,115</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-339">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(19,449</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,452,861</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; font-style: italic; text-decoration: underline; text-align: left">Other
    intangible assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Trademarks and patents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">51,933,444</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">44,073</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-340">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-341">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(670,514</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,857</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">51,316,860</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Trademarks and patents with indefinite useful life</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,827,309</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-342">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,217,985</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-343">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-344">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-345">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,045,294</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Software</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,638,752</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">585,313</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-346">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">276,128</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,369,379</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(11,320</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,119,494</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Software in progress</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">349,171</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">507,685</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-347">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(276,128</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-348">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-349">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">580,728</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Customer loyalty</td><td>&#160;</td>
    <td style="text-align: left"></td><td style="text-align: right">23,006,023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-350">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-351">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-352">-</div></td><td style="text-align: left">&#160;</td><td></td>
    <td style="text-align: left"></td><td style="text-align: right">(4,071,453</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left"></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-353">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"></td><td style="text-align: right">18,934,570</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">RG/RS/OX
    Wheat</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,000,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-354">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-355">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-356">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-357">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-358">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,000,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">175,292,219</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">12,993,402</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,128,449</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-359">-</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(12,113,223</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">30,433</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">177,331,280</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 6pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><sup>(*)</sup></td><td style="text-align: justify">USD 1,089,768 correspond to the loss of control of Inmet
S.A.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The amortization charge is included in Notes 8.3 - R&amp;D classified
by nature and Note 8.4 &#8211; Expenses classified by nature and function.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are no intangibles assets whose use has
been restricted or which have been delivered as a guarantee. The Group has not assumed any commitments to acquire new intangibles.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Estimates</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">There is an inherent
material uncertainty related to management&#8217;s estimation of the ability of the Group to recover the carrying amounts of internally
generated intangible assets, because it is dependent upon Group&#8217;s ability to raise sufficient funds to complete the projects development,
the future outcome of the regulatory process, and the timing and amount of the future cash flows generated by the projects, among other
future events.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">Management&#8217;s estimations
about the demonstrability of the recognition criteria for these assets and the subsequent recoverability represent the best estimate that
can be made based on all the available evidence, existing facts and circumstances and using reasonable and supportable assumptions in
cash flow projections. Therefore, the consolidated financial statements do not include any adjustments that would result if the Group
were unable to recover the carrying amount of the above-mentioned assets through the generation of enough future economic benefits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">The Group is required
to perform an annual impairment test for non-depreciating assets, either because they are not available for use, have indefinite useful
lives, or for other intangible assets when events or changes in circumstances indicate that their carrying amount may not be recoverable.
The recoverable amount is determined based on calculations of value in use. This method requires estimating future cash flows and determining
a discount rate to calculate the present value of those cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management has made the estimates considering
the cash flow projections projected by the management. All key assumptions values reflect past experience or, if appropriate, are consistent
with external sources of information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="border-bottom: Black 1.5pt solid; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; width: 20%"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><b>Key assumption</b></p></td> <td style="padding-bottom: 1.5pt; width: 1%">&#160;</td> <td style="text-align: center; border-bottom: Black 1.5pt solid; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; width: 79%"><span style="font-size: 10pt"><b>Management&#8217;s approach</b></span></td></tr> <tr> <td style="padding: 0pt"><span style="font-size: 10pt">Discount rate</span></td> <td>&#160;</td> <td style="padding: 0pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">The discount rate applied was either&#160;16.39% or&#160;11.56%, depending on the target market.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">The weighted average cost of capital (WACC) was estimated using the market capital structure plus&#160;2% of risk premium which reflect the higher risk associated with intangible assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">For the cost of equity, the discount rate is estimated based on the Capital Asset Pricing Model (CAPM).</p></td></tr> <tr> <td style="padding: 0pt">&#160;</td> <td>&#160;</td> <td style="padding: 0pt">&#160;</td></tr> <tr> <td style="text-indent: -0.125in; padding: 0pt 0pt 0pt 0.125in"><span style="font-size: 10pt">Market share, product prices and royalties.</span></td> <td>&#160;</td> <td style="padding: 0pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; ">The projected revenue from the products and services of the CGUs has been estimated by the management based on market penetration data for comparable products and technologies and on future expectations of foreseen economic and market conditions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; ">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; ">The prices and royalties estimated in the revenue projections are based on current and projected market prices for the products and services of the CGUs.</p></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">A projection horizon
longer than&#160;five years&#160;was adopted, as the GGUs are linked to biological products that require extended development and regulatory
approval timelines across multiple target countries. Due to the nature of these products and the maturity level of the markets involved,
a longer time frame is essential to reasonably capture the expected cash flows and the time needed to reach commercial readiness and registration
milestones. Projected range period used:&#160;8-18&#160;years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">Management estimates
that any reasonably possible change in any of these key assumptions would not cause the aggregate carrying amount of the CGU to exceed
its recoverable amount.</p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>7.9 <span style="text-decoration:underline">Goodwill</span></b></p>





<p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Rizobacter Argentina S.A.</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-360">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">28,080,271</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Bioceres Crops S.A.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-361">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,523,322</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Insumos Agroqu&#237;micos S.A.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-362">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">470,090</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Pro Farm Group</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-363">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">76,089,749</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-364">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">112,163,432</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group is required to test whether goodwill
has suffered any impairment on an annual basis. The recoverable amount is determined based on value in use calculations. The use of this
method requires the estimation of future cash flows and the determination of a discount rate in order to calculate the present value of
the cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prior to the BIOX deconsolidation, the CGUs were
determined as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Rizobacter CGU. This CGU is composed of all revenues
collected through Rizobacter from the production and sale of proprietary and third-party products, both in the domestic and international
markets. Additionally, Rizobacter generates revenue from the formulation, fragmentation and resale of third-party products.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Bioceres Crops CGU. This CGU is composed of the
expected revenues from the commercialization of intensive R&amp;D products that previously were allocated on the equity participation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Insuagro CGU. This CGU is composed of all revenues
collected through Insuagro from the production and sale of proprietary and third-party products, both in the domestic markets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pro Farm Group Inc CGU. This CGU is composed of
all revenues collected through Pro Farm from the production and sale of proprietary and third-party products, both in the domestic and
international markets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management has made the estimates considering
the cash flow projections projected by the management and third-party valuation reports on the assets, intangible assets and liabilities
assumed. The key assumptions utilized are the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="border-bottom: Black 1.5pt solid; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; width: 20%"> <p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><b>Key assumption</b></p></td> <td style="padding-bottom: 1.5pt; width: 2%">&#160;</td> <td style="text-align: center; border-bottom: Black 1.5pt solid; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; width: 78%"><span style="font-size: 10pt"><b>Management&#8217;s approach</b></span></td></tr> <tr> <td style="padding: 0pt"><span style="font-size: 10pt">Discount rate</span></td> <td>&#160;</td> <td style="padding: 0pt"> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify">The discount rate used ranges was&#160;14.11%&#160;for Rizobacter UGE and for&#160;Bioceres Crops UGE, and&#160;9.28% for Pro Farm UGE due to the target market.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify">&#160;</p> <p style="text-align: justify; text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt">The weighted average cost of capital (&#8220;WACC&#8221;) rate has been estimated based on the market capital structure.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0pt; margin: 0pt">&#160;</p> <p style="text-align: justify; text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt">For the cost of equity, the discount rate is estimated based on the Capital Asset Pricing Model (CAPM).</p></td></tr> <tr> <td style="padding: 0pt">&#160;</td> <td>&#160;</td> <td style="padding: 0pt">&#160;</td></tr> <tr> <td style="text-indent: -0.125in; padding: 0pt 0pt 0pt 0.125in; text-align: justify"><span style="font-size: 10pt">Market share, product prices and royalties.</span></td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify; padding: 0pt"> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify">The projected revenue from the products and services of the CGUs has been estimated by the management based on market penetration data for comparable products and technologies and on future expectations of foreseen economic and market conditions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify">The prices (Rizobacter CGU and Pro Farm CGU) and royalties (Bioceres Crops CGU) estimated in the revenue projections are based on current and projected market prices for the products and services of the CGUs.</p></td></tr> <tr> <td style="text-align: justify; padding: 0pt">&#160;</td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify; padding: 0pt">&#160;</td></tr> <tr> <td style="text-align: justify; padding: 0pt"><span style="font-size: 10pt">Terminal value</span></td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify; padding: 0pt"> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify">Rizobacter CGU and Bioceres Crops CGU: The growth rate used to extrapolate the future cash flow projections to terminal period&#160;is&#160;2%.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify">&#160;</p> <p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Pro Farm CGU: EBITDA multiple (10x)</p></td></tr> </table><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>7.10 <span style="text-decoration:underline">Investment properties</span></b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>



<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Investment properties</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-365">&#160;&#160;&#160;-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">560,783</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-366">-</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">560,783</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The decrease for the year is attributed to loss
of control in BIOX.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The book value of the investment properties does not differ significantly
from its fair value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>7.11&#160; <span style="text-decoration:underline">Trade and other payables</span></b></p>





<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Current</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0pt">Trade creditors</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">6,490,684</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">108,922,112</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Shareholders and other related parties (Note 17)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-367">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">37,985</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Trade creditors - Joint ventures and associates (Note 13)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">620,034</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">52,778,206</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,647</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,877,930</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 0pt">Miscellaneous</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">200,568</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,321,303</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">7,323,933</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">168,937,536</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The book value of financial liabilities is reasonably approximate to
the fair value given its short-term nature.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><b>&#160;</b></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>7.12&#160; <span style="text-decoration:underline">Borrowings</span></b></p>





<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Current</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0pt">Bank borrowings</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">33,383</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">94,711,273</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Corporate bonds</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-368">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">42,035,925</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Net loans payables- Joint ventures and associates (Note 13)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,303,098</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,860,058</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Convertible preference shares (Note 17)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,739,726</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-369">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Financial borrowings</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">201,077,800</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">95,903,495</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">227,154,007</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">234,510,751</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-left: 0pt">Non-current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Bank borrowings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,348,173</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,033,059</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Corporate bonds</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-370">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,071,823</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Financial borrowings</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-371">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">85,143,423</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">1,348,173</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">127,248,305</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Bioceres S.A. is the guarantor of the stock purchase
agreement signed on October 28, 2022, between Theo I SCSp and DRACO I-LATAM SPC LTD, as well as the subsequent credit line agreement signed
on December 11, 2023, which are included in the investment in Theo I SCSp, as indicated in Note 13 &#8211; Joint ventures and associates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a result of Theo I SCSp&#8217;s default in July 7, 2025, Bioceres
S.A., a subsidiary of Bioceres Group, as guarantor, recognized the financial debt with DRACO I-LATAM SPC LTD as of June 30, 2025. The
amount recognized of $61.7 million was determined as the difference between the estimated realizable value of Theo I SCSp&#8217;s assets
and the settlement value of its liabilities. Theo I SCSp is an associate of Bioceres Group, a wholly owned subsidiary of the Company.
As of June 30, 2024 and 2023, the fair value of Theo I SCSp&#8217;s assets exceeded the value of its liabilities. Accordingly, the value
of the guarantee recognized by Bioceres S.A. as of June 30, 2024 and 2023 was zero. See note 8.6.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In December 2024, the Company issued 2,380,952
convertible preference shares for total proceeds of $15 million. These preference shares accrue a 9% per annum payment-in-kind (PIK) return
and grant the holder specific conversion rights, including the option to convert into ordinary shares at predefined terms, mandatory conversion
provisions, and redemption alternatives contingent on the occurrence of certain events. See Note 21 &#8211; Events occurring after the
reporting period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The carrying value of some borrowings as of June
30, 2025 and 2024, are measured at amortized cost differ from their fair value. The following fair values measured are based on discounted
cash flows (Level 3) due to the use of unobservable inputs, including own credit risk.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As stated in Note 1 &#8211; The Group&#8217;s
business reorganization and general information - &#8220;<i>The Bioceres Group Business Combination Agreement&#8221;, </i>in June 2025,
Bioceres S.A., one of the Argentine subsidiaries of Bioceres Group Limited, defaulted on a portion of its financial debt that was due
that month. The aggregate amount is $36.4 million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In July 2025, Bioceres LLC, a wholly owned subsidiary
of Bioceres S.A., received a notice of default on its financial debt&#160;in the amount of $69.5 million. The creditor conducted a public
auction for 3,062,500 pledged BIOX shares, pursuant to the New York Uniform Commercial Code. Management has responded to the creditor,
reserving all rights, remedies, and defenses. As of the date of this report, the current debt amounts to $58.0 million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amortized Cost</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amortized Cost</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Current</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-left: 0pt">Bank borrowings</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">33,383</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">33,383</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">94,711,273</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">93,301,194</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Corporate bonds</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-372">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-373">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">42,035,925</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">41,492,963</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">Convertible preference shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,739,726</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,179,927</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-374">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-375">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Financial borrowings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">211,380,898</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">205,082,929</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">95,903,495</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">95,480,681</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-left: 0pt">Non current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Bank borrowings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,348,173</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,348,173</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,033,059</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,206,794</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Corporate bonds</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-376">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-377">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,071,823</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">23,845,583</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Convertible notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,260,456</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,260,456</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-378">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-379">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Financial borrowings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-380">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-381">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">85,143,423</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">81,120,125</td><td style="text-align: left">&#160;</td></tr>
  </table>



<p style="margin: 0">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"> <b>7.13&#160; <span style="text-decoration:underline">Convertible notes</span></b></p>





<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="text-decoration:underline">Convertible notes</span></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Non-current</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Convertible notes</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">18,260,456</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">80,809,686</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">18,260,456</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">80,809,686</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Secured Guaranteed Notes </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Secured Guaranteed Notes due 2026 bore interest
at&#160;9.0%&#160;from the issue date through 24 months after the issue date,&#160;13.0%&#160;from 25 through 36 months after the issue
date, and&#160;14.0%&#160;from 37 through 48 months after the issue date. Interest was payable semi-annually.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 18, 2025, BIOX entered into an amendment
to the Secured Guaranteed Notes pursuant to which the aggregate principal amount increases from&#160;$26,437,485&#160;to&#160;$29,081,233,
with an annual interest rate of&#160;19%, of which&#160;14%&#160;is payable in cash and&#160;5%&#160;in kind. BIOX is required to make
scheduled amortization payments of&#160;$1,000,000&#160;on the last business day of each calendar month and may only be repurchased in
full. Had BIOX repurchased it on or before August 5, 2025, a&#160;5%&#160;&#8220;Prepayment Premium&#8221; penalty would have applied.
If the repurchase occurred after that date, the penalty increased to&#160;10%. The Prepayment Premium also applied to payments made following
acceleration.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">The Secured Guaranteed Notes due 2026 had no conversion rights into
BIOX ordinary shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Secured Convertible Guaranteed Notes </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Secured Guaranteed Convertible Notes were
issued for a total principal amount of $55 million. The notes have a 4- year maturity and accrue interest at an annual interest rate of
9%, of which 5% is payable in cash and 4% in-kind. At any time up to maturity the note holders might opt to convert the outstanding principal
amount into common shares of BIOX at a strike price of $18 per share. BIOX can repurchase the notes voluntarily 30 months after the issue
date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 18, 2025, BIOX entered into an amendment to the Secured Convertible
Guaranteed Notes pursuant to which the aggregate principal amount increases from&#160;$61,652,927&#160;to&#160;$67,868,227, and the maturity
date is extended to August 31, 2027. The notes carry an annual interest rate of&#160;15%, of which&#160;5%&#160;is payable in cash and&#160;10%&#160;in
kind. Noteholders have now the option to convert the outstanding principal amount of their Convertible Notes into common shares of BIOX
at a reduced strike price of&#160;$6&#160;per share. If BIOX raises more than&#160;$10,000,000&#160;in common equity, the strike price
resets to the lesser of (1) the then-applicable strike price or (2) the price per share at which the new shares are issued (or the weighted
average price per share, if issued at varying prices). BIOX may voluntarily repurchase the Convertible Notes; however, it must pay either
a &#8220;Prepayment Premium Fee&#8221; or an &#8220;Equity Option Fee.&#8221; If the repurchase occurs on or before August 31, 2025, a&#160;5%&#160;prepayment
penalty applies. If the repurchase had occurred on or before August 31, 2025, a&#160;5%&#160;prepayment penalty would have applied. If
repurchased between September 1 and prior to October 1, 2025, the penalty would have increased to&#160;7%. For repurchases on or after
October 1, 2025, the applicable fee would be the full Equity Option Fee. Additionally, either the Prepayment Premium Fee or the Equity
Option Fee will apply in the event of payments made following acceleration.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At inception, the fair value of the liability
component of the Secured Convertible Guaranteed Notes was measured using a discount rate of 13.57%. Following the BIOX deconsolidation
and as of June 30, 2025, the Secured Convertible Guaranteed Notes are not included within the line item &#8220;Convertible Notes&#8221;
from the Statement of Financial Position.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of June 30, 2025 a total of $4.8&#160;million
was accrued as a Prepayment Premium Fee. (Note 8.5).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="text-align: justify; margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">Following the BIOX deconsolidation and as of June 30, 2025, the Secured
Guaranteed Notes are not included within the line item &#8220;Convertible Notes&#8221; from the Statement of Financial Position</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Convertible Notes</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 15, 2023, Moolec Science has entered
into an agreement to issue a convertible note due 2026 to Invim Corporativo S.L. As of June 30, 2025, the Company has received USD 10,000,000
related to such convertible note. Additionally, the Company signed additional convertible notes for USD 940,000 between October 2023 and
June 30, 2024 with local farmers and jointly with the convertible note with Invim Corporativo S.L., are referred to as &#8220;the Notes&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Notes have a term of three years with an early
conversion option with a strike price of US $60.00&#160;per share. If the early conversion option is exercised, Moolec Science will have
the option to pay the outstanding amount at that date using shares, cash or a combination of both. Initial interest rate on the notes
is of 5% per annum payable annually in cash in arrears on anniversary of the date of the notes and on the maturity date, however Moolec
Science will have the option at each payment date to capitalize the interest accrued. After the remaining cash payment made during 2024
the interest rate was increased to 10% per annum. Lastly, as per the convertible note with Invim Corporativo S.L., after the in-kind contribution,
when received, the interest rate will be calculated in accordance with a formula included in the agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At maturity, Moolec Science will hold the option
to deliver ordinary shares, cash, or a combination of cash and ordinary shares. See Note 21 - Events occurring after the reporting period
&#8211; Notice of Alleged Breach.</p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>7.14&#160; <span style="text-decoration:underline">Employee benefits and social security</span></b></p>





<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Current</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0pt">Salaries, accrued incentives, vacations&#160;and social security</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">202,014</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">7,280,129</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Key management personnel (Note 18)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">41,620</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">226,702</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">243,634</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">7,506,831</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The book value is reasonably approximate to the fair value given its
short-term nature.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>7.15&#160; <span style="text-decoration:underline">Deferred revenue and advances from customers</span></b></p>





<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Current</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0pt">Advances from customers</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,260</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3,335,740</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Deferred revenue</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-382">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">589,061</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">1,260</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">3,924,801</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-left: 0pt">Non current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Advances from customers</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-383">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">52,511</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Deferred revenue</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-384">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,872,627</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-385">-</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">1,925,138</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>7.16&#160; <span style="text-decoration:underline">Changes in allowances and provisions</span></b></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Item</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Additions</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Uses and </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>reversals</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Currency </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>conversion </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>difference</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Loss of </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>control</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">DEDUCTED FROM ASSETS</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Allowance for impairment of trade debtors</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">7,050,280</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">7,123,716</td><td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-386">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(50,533</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(14,123,463</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Allowance for obsolescence</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,087,563</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,547,723</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,158,036</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">29,204</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,506,454</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Total deducted from assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,137,843</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,671,439</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,158,036</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(21,329</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(17,629,917</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in">INCLUDED IN LIABILITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Provisions for contingencies</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,484,715</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">336,919</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(309,793</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(89,694</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,267,573</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">16,154,574</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Total included in liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,484,715</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">336,919</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(309,793</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(89,694</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,267,573</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">16,154,574</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.125in">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">27,622,558</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">9,008,358</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(1,467,829</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(111,023</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(18,897,490</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">16,154,574</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-indent: -0.25in; padding-left: 0.25in; font-weight: bold">Item</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Additions</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Additions <br/> from <br/> business <br/> combination</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Uses and <br/> reversals</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Currency <br/> conversion <br/> difference</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.25in; padding-left: 0.25in; font-weight: bold">DEDUCTED FROM ASSETS</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left; text-indent: -0.25in; padding-left: 0.25in">Allowance for impairment of trade debtors</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">7,425,604</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">753,428</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-387">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(777,558</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(351,194</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">7,050,280</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.25in; padding-left: 0.25in">Allowance for obsolescence</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,492,499</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">586,515</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-388">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(69,582</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">78,131</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,087,563</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -0.25in; padding-left: 0.25in">Total deducted from assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,918,103</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,339,943</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-389">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(847,140</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(273,063</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,137,843</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.25in; padding-left: 0.25in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; text-indent: -0.25in; padding-left: 0.25in">INCLUDED IN LIABILITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.25in; padding-left: 0.25in">Provisions for contingencies</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">16,901,773</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">653,574</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">355,898</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(393,073</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(33,457</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,484,715</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -0.25in; padding-left: 0.25in">Total included in liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">16,901,773</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">653,574</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">355,898</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(393,073</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(33,457</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,484,715</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 2.5pt; text-indent: -0.25in; padding-left: 0.25in">Total</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">26,819,876</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,993,517</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">355,898</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(1,240,213</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(306,520</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">27,622,558</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="text-decoration:underline">Provisions</span></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0pt">Conditional payment Rizobacter SA</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">15,916,116</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">15,916,116</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Provisions for contingencies</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">238,458</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,568,599</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">16,154,574</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">17,484,715</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group has recorded a provision for probable
administrative, judicial and out-of-court proceedings that could arise in the ordinary course of business, based on a prudent criterion
according to its professional advisors and on Management&#8217;s assessment of the best estimate of the amount of possible claims. These
potential claims are not likely to have a material impact on the results of the Group&#8217;s operations, its cash flow or financial position.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management considers that the objective evidence
is not enough to determine the date of the eventual cash outflow due to a lack of experience in any similar cases. However, the provision
was classified under current or non-current liabilities, applying the best prudent criterion based on Management&#8217;s estimates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are no expected reimbursements related to
the provisions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In order to assess the need for provisions and
disclosures in its consolidated financial statements, Management considers the following factors: (i) nature of the claim and potential
level of damages in the jurisdiction in which the claim has been brought; (ii) the progress of the eventual case; (iii) the opinions or
views of tax and legal advisers; (iv) experience in similar cases; and (v) any decision of the Group&#8217;s management as to how it will respond
to the eventual claim.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Conditional payment Rizobacter S.A.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group agreed with certain sellers of Rizobacter,
a contingent payment of $17.3 million (current value of $15.9 million) conditional on obtaining a favorable resolution that totally rejects
the claim of the plaintiff in the nullity trials, file &#8220;Harnan Miguel, Marcos and Martina c/ac Mullen Jorge and others s/ Annulment
Action&#8221;, file No. 76,806 and in the injunction (&#8220;<i>embargo</i>&#8221;), file &#8220;Harnan Miguel, Marcos and Martina c/
Mac Mullen Jorge and others s/ Precautionary Measures&#8221;, file No. 76,745. In said cause, 44% of the capital of Rizobacter Argentina
S.A. is seized and 30% of the dividends that the taxed shares produce.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If the injunction is lifted, the Group will be
required to pay within 12 months of notification, a contingent purchase price of $17.3 million to certain selling shareholders of Rizobacter.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of June 30, 2025 there is no allowance for
obsolescence for inventories, as the inventory was acquired through the Business Combination Agreement consummated in June 16, 2025.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><b>&#160;</b></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>7.17&#160; <span style="text-decoration:underline">Government Grants</span></b></p>





<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0pt">At the beginning of the year</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">4,437</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">349,998</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt"><span style="font-size: 10pt">Loss of control <sup>(*)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-390">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(157,043</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Currency conversion difference</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">255</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,001</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Released to the statement of profit or loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,412</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(197,519</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">At the end of the year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">1,280</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">4,437</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><sup>&#160;</sup></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><sup>(*)</sup></span></td><td style="text-align: justify"><span style="font-size: 10pt">Correspond to the loss of control
of Inmet S.A. in the year 2024</span></td>
</tr></table><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>7.18&#160; <span style="text-decoration:underline">Warrants</span></b></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>



<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">At the beginning of the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-391">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-392">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Additions for the year</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">1,030,000</p></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right"><p style="-sec-ix-hidden: hidden-fact-393; margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">-</p></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Additions from business combination</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">181,093</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-394">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">At the end of the year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">1,211,093</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-395">-</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of component of consolidated statement of financial positions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Information about Component of Consolidated Statements of Comprehensive Income<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_StatementOfComprehensiveIncomeAbstract', window );"><strong>Information about Component of Consolidated Statements of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock', window );">INFORMATION ABOUT COMPONENT OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><b>8.</b></td><td style="text-align: justify"><b><span style="text-decoration:underline">INFORMATION ABOUT COMPONENT OF CONSOLIDATED STATEMENTS
OF COMPREHENSIVE INCOME</span></b></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>8.1 <span style="text-decoration:underline">Revenue from contracts with customers</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Sale of goods and services</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">317,924,355</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">444,149,141</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">385,976,753</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Royalties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,414,864</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">986,602</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,247,567</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Rendering of services with related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">841,205</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">952,742</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">739,651</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Right of use licenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">13,430,824</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">20,287,845</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">32,903,458</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">333,611,248</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">466,376,330</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">420,867,429</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Transactions of sales of goods and services with
joint ventures and with shareholders and other related parties are reported in Note 17.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>8.2 <span style="text-decoration:underline">Cost of sales</span></b></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid"><b>Item</b></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-left: 0pt">Inventories as of the beginning of the year</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">110,913,884</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">112,000,786</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">78,775,003</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Loss of control</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(82,999,205</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-396">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-397">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Additions related to Business combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,235,482</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,020,771</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,182,602</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Purchases of the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">149,950,181</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">249,648,267</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">233,465,488</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Production costs (note 8.4)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,177,920</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,819,152</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">23,234,862</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Foreign currency translation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">382,092</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,206,764</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">806,903</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">Subtotal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">205,660,354</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">390,282,212</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">347,464,858</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"><span style="font-size: 10pt">Inventories as of the end of
the year</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,235,482</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(110,913,884</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(112,000,786</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 0pt">Cost of sales</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">203,424,872</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">279,368,328</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">235,464,072</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>8.3 <span style="text-decoration:underline">R&amp;D classified by nature</span></b></p>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Research and development expenses</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid"><b>Item</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>06/30/2025</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>06/30/2024</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>06/30/2023</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Amortization of intangible assets</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">5,079,839</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">5,923,389</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">4,804,768</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Analysis and storage</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-398">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,302</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">52,660</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Commissions and royalties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,179</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-399">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,257</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Import and export expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-400">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-401">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">855</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Depreciation of leased assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">54,505</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-402">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">68,321</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Depreciation of property, plant and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">767,731</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">618,627</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">637,734</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Freight and haulage</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,025</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30,450</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,707</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Employee benefits and social securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,032,386</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,727,340</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,781,678</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Insurance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">49,343</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48,872</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">78,673</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Energy and fuel</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,576</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,101</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">111,481</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Maintenance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">236,867</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">283,895</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">475,868</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Supplies and materials</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,731,604</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,361,380</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,078,403</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Licenses &amp; Patents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">516,591</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">67,188</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">181,264</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Mobility and travel</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">141,481</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">205,741</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">245,875</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Publicity and advertising</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-403">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">23,383</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-404">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Systems expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">40,286</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">29,026</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,410</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Vehicles expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,858</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30,883</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,252</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Share-based incentives</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">217,494</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">510,162</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">136,754</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Surveillance expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-405">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-406">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,145</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Professional fees and outsourced services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">878,973</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,325,361</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">550,585</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Professional fees related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">90,533</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">256,877</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">542,551</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Office supplies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">261,263</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">696,760</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">111,618</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Miscellaneous</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">976</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">269,750</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">128</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">15,138,510</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">17,422,487</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">15,943,987</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-left: 0pt">R&amp;D capitalized (Note 8.3)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">8,614,448</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">11,856,331</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">10,753,047</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">R&amp;D profit and loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">15,138,510</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,422,487</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">15,943,987</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">23,752,958</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">29,278,818</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">26,697,034</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>8.4 <span style="text-decoration:underline">Expenses classified by nature and function</span></b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>Item</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Production and services costs</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Selling, general and administrative expenses</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><b>Total</b></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><b>06/30/2025</b></p></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-left: 0pt">Amortization of intangible assets</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">351,240</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">5,769,969</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">6,121,209</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Analysis and storage</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-407">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,744</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,744</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Commissions and royalties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">835,082</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,989,880</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,824,962</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Import and export expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-408">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">826,942</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">826,942</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Depreciation of property, plant and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,861,812</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,386,157</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,247,969</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Impairment of receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-409">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,123,716</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,123,716</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Freight and haulage</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,003,986</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,367,271</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,371,257</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Employee benefits and social securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,899,884</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">44,971,665</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">54,871,549</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">Taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">260,091</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,411,799</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,671,890</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Maintenance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,414,461</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,216,680</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,631,141</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Energy and fuel</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">658,621</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">106,846</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">765,467</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Supplies and materials</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">586,696</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,678,691</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,265,387</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Mobility and travel</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">339,447</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,472,895</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,812,342</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Allowance&#160;for obsolescence</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,547,723</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-410">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,547,723</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Publicity and advertising</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-411">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,556,518</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,556,518</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Systems expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">39,583</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,008,347</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,047,930</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Share-based incentives for employees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">315,965</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,853,229</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,169,194</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Surveillance expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-412">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">583,115</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">583,115</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Professional fees and outsourced services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">201,601</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,939,339</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,140,940</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Professional fees related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-413">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,353</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,353</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Office supplies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">93,967</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,373,911</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,467,878</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Insurance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">181,595</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,850,968</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,032,563</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Depreciation of leased assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,477,334</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,504,864</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,982,198</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Contingencies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">84,567</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">252,352</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">336,919</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Environmental Impact Treatment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">998,303</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">67,510</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,065,813</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Licenses &amp; Patents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">75</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">193,773</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">193,848</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 0pt">Miscellaneous</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">25,887</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">370,706</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">396,593</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 0pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">25,177,920</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">125,908,240</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">151,086,160</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>Item</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Production and services costs</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Selling, general and administrative expenses</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="margin-top: 0; margin-bottom: 0"><b>Total</b></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><b>06/30/2024</b></p></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-left: 0pt">Amortization of intangible assets</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">239,545</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">5,950,289</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">6,189,834</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Analysis and storage</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">598</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">160,133</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">160,731</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Commissions and royalties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">217,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,745,169</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,962,169</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Import and export expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">147,392</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">734,026</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">881,418</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Depreciation of property, plant and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,018,014</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,163,357</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,181,371</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Impairment of receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-414">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">753,428</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">753,428</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Freight and haulage</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">927,910</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,831,209</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,759,119</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Employee benefits and social securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,162,207</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">38,799,972</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">49,962,179</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">Taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">285,791</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,442,557</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,728,348</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Maintenance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,074,352</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,666,524</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,740,876</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Energy and fuel</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">997,066</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">514,422</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,511,488</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Supplies and materials</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,031,386</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,520,386</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,551,772</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Mobility and travel</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">202,810</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,317,138</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,519,948</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Allowance&#160;for obsolescence</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">581,804</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,711</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">586,515</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Publicity and advertising</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">233</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,065,506</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,065,739</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Systems expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35,526</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,857,779</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,893,305</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Share-based incentives for employees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,111,919</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,577,399</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,689,318</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Surveillance expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">368</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">468,090</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">468,458</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Professional fees and outsourced services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">189,090</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,131,891</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,320,981</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Professional fees related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-415">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">243,827</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">243,827</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Office supplies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">242,790</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,743,957</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,986,747</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Insurance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">199,109</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,133,572</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,332,681</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Depreciation of leased assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,312,849</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,106,107</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,418,956</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Contingencies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">66,682</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">586,892</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">653,574</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Environmental Impact Treatment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,770,857</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,208</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,785,065</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; padding-left: 0pt">Miscellaneous</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,854</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">808,273</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">812,127</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 0pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">25,819,152</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">126,340,822</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">152,159,974</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>Item</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Production and services costs</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Selling, general and administrative expenses</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Total <br/>06/30/2023</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-left: 0pt">Amortization of intangible assets</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">173,032</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">6,026,784</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">6,199,816</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Analysis and storage</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,496</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">700,671</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">705,167</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Commissions and royalties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">127,771</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,396,750</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,524,521</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Import and export expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">150,402</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">794,561</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">944,963</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Depreciation of property, plant and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,161,236</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,139,957</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,301,193</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Impairment of receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-416">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,327,385</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,327,385</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Freight and haulage</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,427,296</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,646,138</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,073,434</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Employee benefits and social securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,033,252</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">39,593,472</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">49,626,724</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">Taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">255,227</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,001,149</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,256,376</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Maintenance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,157,887</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">956,916</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,114,803</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Energy and fuel</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">967,412</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">397,305</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,364,717</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Supplies and materials</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,075,909</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,048,056</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,123,965</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Mobility and travel</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">128,072</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,431,323</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,559,395</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Allowance&#160;for obsolescence</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,012,788</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">53,989</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,066,777</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Publicity and advertising</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,528</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,775,012</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,777,540</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Systems expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,556</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,158,735</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,170,291</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Share-based incentives for employees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-417">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,393,348</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,393,348</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Surveillance expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">105,988</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">392,631</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">498,619</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Professional fees and outsourced services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100,308</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,807,495</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,907,803</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Professional fees related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-418">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">196,101</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">196,101</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Office supplies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">229,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">976,350</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,205,850</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Insurance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">230,388</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,137,598</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,367,986</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Licenses &amp; Patents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-419">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">37,015</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">37,015</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Depreciation of leased assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">468,524</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,029,049</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,497,573</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">Contingencies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-420">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">239,292</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">239,292</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Environmental Impact Treatment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,369,838</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-421">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,369,838</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 0pt">Miscellaneous</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">41,452</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">874,192</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">915,644</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 0pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">23,234,862</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">116,531,274</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">139,766,136</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>8.5 <span style="text-decoration:underline">Finance results</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>



<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="text-decoration:underline">Financial cost</span></td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-left: 0pt">Interest expenses</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(38,077,952</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(35,783,901</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(30,569,478</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Financial commissions</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,731,493</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,850,252</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,007,154</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(41,809,445</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(37,634,153</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(33,576,632</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-decoration: underline; text-align: left; padding-left: 0pt">Other financial results</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Exchange differences generated by assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,183,367</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(7,519,875</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(19,758,444</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Exchange differences generated by liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(14,647,580</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(20,499,620</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,886,408</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Changes in fair value of financial assets or liabilities and other financial results</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(15,603,088</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(10,455,775</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(341,341</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Prepayment premium fee</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,870,021</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-422">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-423">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Net gain of inflation effect on monetary items</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,949,231</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,730,804</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,311,437</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Interest accrued with related parties</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">944,186</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">135,485</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-424">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(24,043,905</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(9,608,981</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(13,674,756</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-decoration: underline; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Total net financial cost</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(65,853,350</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(47,243,134</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(47,251,388</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>8.6 <span style="text-decoration:underline">Other income or expenses, net</span></b></p>



<p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">06/30/2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Loss from subsidiary&#8217;s guarantee recognition (Note 7.12)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(61,681,998</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-425">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-426">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Gain on bargain purchase</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,473,482</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,032,327</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-427">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Remeasurement to fair value of pre-existing interest in an acquiree</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,666,680</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-428">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-429">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Net result from commercialization of agricultural products</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,890,110</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,560,703</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">174,122</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Result of intangible assets (i)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,649,848</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(473,758</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,825,111</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">881,177</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(56,589,216</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(703,265</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">1,055,299</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(i) On March 28, 2025, BIOX, a former subsidiary,
agreed to transfer all rights, licenses, and materials containing or pertaining to the Soy ANF trait and pay $750,000&#160;to a Arcadia
Biosciences Inc in exchange for (i) RG and OX Wheat Patents and RS exclusive rights; (ii) the cancellation of all Royalty Payments, which
included&#160;25% of the Net Wheat Technology Licensing Revenues and&#160;6% of the Net HB4 Soybean Revenues up to $10&#160;million;
and (iii) the release from any Performance Benchmark Obligations related to the RG, OX, and RS Varieties which amounted to $8.1&#160;million.
This transaction resulted in the accounting of a gain from the exchange of intangible assets amounting to $7.5&#160;million.&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_StatementOfComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_StatementOfComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of information about components of consolidated statement of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Taxation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract', window );"><strong>Taxation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIncomeTaxExplanatory', window );">TAXATION</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><b>9.</b></td><td style="text-align: justify"><b><span style="text-decoration:underline">TAXATION</span></b></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The balances of deferred tax assets and liabilities
are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="text-decoration:underline">Deferred tax assets</span></td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0pt">Tax Loss-Carry Forward</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-430">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">26,988,067</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Others financial assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-431">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">813,780</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">Others</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-432">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,516,719</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Royalties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-433">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">764,888</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Trade receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-434">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">532,106</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Allowances</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-435">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">942,587</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Government grants</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-436">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">15,090</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Total deferred tax assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-437">-</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">32,573,237</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-decoration: underline; text-align: left; padding-left: 0pt">Deferred tax liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Intangible assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(15,767,275</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(28,444,095</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Property, plant and equipment depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-438">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(14,608,912</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">Inventories</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-439">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(8,041,220</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Others financial assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-440">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(464,404</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Right-of-use leased asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-441">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(190,088</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Inflation tax adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-442">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(302,456</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 0pt">Others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-443">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(546,277</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Total deferred tax liabilities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(15,767,275</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(52,597,452</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Net deferred tax</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(15,767,275</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(20,024,215</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The roll forward of deferred tax assets and liabilities
as of June 30, 2025 and 2024 are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Balance 06/30/2024</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Business combination / (loss) of control</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Income tax provision</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Conversion difference</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Balance 06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="text-decoration:underline">Deferred tax assets</span></td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left; padding-left: 0pt">Tax Loss-Carry Forward</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">26,988,067</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(21,525,926</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(5,579,828</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">117,687</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-444">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Others financial assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">813,780</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(475,554</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(342,341</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,115</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-445">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Trade receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">532,106</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,353,889</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">822,145</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(362</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-446">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Royalties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">764,888</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(744,388</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(18,311</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,189</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-447">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">Allowances</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">942,587</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,053,605</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">98,032</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,986</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-448">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Government grants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,090</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-449">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(15,596</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">506</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-450">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 0pt">Others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,516,719</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">227,950</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,744,669</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-451">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-452">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Total deferred tax assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">32,573,237</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(24,925,412</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(7,780,568</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">132,743</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-453">-</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-decoration: underline; text-align: left; padding-left: 0pt">Deferred tax liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Intangible assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(28,444,095</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,428,299</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">214,190</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,331</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(15,767,275</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Property, plant and equipment depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(14,608,912</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,315,097</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(703,102</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,083</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-454">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">Inventories</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(8,041,220</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,611,790</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,429,430</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-455">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-456">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Biological assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-457">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">640,035</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(640,035</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-458">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-459">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Others financial assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(464,404</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,040</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">436,364</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-460">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-461">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Right-of-use leased asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(190,088</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">180,967</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,505</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,384</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-462">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Inflation tax adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(302,456</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26,801</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">218,362</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">57,293</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-463">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; padding-left: 0pt">Others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(546,277</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">541,800</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">178,733</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(174,256</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-464">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Total deferred tax liabilities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(52,597,452</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">35,772,829</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">1,144,447</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(87,099</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(15,767,275</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Net deferred tax</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(20,024,215</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">10,847,417</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(6,636,121</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">45,644</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(15,767,275</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><b><span style="text-decoration:underline">Deferred tax assets</span></b></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Balance 06/30/2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Business combination / (loss) of control</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Income tax provision</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Conversion difference</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Charge to OCI</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Balance 06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; width: 28%; text-align: left; padding-left: 0.125in">Tax Loss-Carry Forward</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">21,215,789</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(62,585</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">7,752,424</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(694,718</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(1,222,843</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">26,988,067</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Others financial assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,336,260</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,299</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(423,116</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(97,065</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-465">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">813,780</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Trade receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">447,449</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-466">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">214,734</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(130,077</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-467">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">532,106</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Royalties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">723,082</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-468">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48,310</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(6,504</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-469">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">764,888</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Allowances</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,213,899</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-470">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(221,106</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(50,206</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-471">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">942,587</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Government grants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">93,996</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(39,261</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(42,199</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,554</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-472">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,090</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-bottom: 1.5pt; padding-left: 0.125in">Others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,402,846</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">765,384</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,651,511</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-473">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-474">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,516,719</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0.125in">Total deferred tax assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">28,433,321</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">661,239</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">5,677,536</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(976,016</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(1,222,843</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">32,573,237</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-decoration: underline; font-weight: bold; text-align: left; padding-left: 0.125in">Deferred tax liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Intangible assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(29,117,986</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(301,659</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">867,636</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">107,914</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-475">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(28,444,095</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Property, plant and equipment depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(13,678,341</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(174,228</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(773,812</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,469</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-476">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(14,608,912</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Inventories</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(6,461,576</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(939,250</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(640,394</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-477">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-478">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(8,041,220</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Others financial assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,154,504</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-479">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,690,100</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-480">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-481">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(464,404</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Right-of-use leased asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(120,442</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(115,495</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30,998</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,851</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-482">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(190,088</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Inflation tax adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,131,895</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,732</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">827,211</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(8,504</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-483">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(302,456</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-bottom: 1.5pt; padding-left: 0.125in">Others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(607,722</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-484">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">111,773</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(50,328</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-485">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(546,277</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0.125in">Total deferred tax liabilities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(53,272,466</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(1,519,900</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">2,113,512</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">81,402</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-486">-</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(52,597,452</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0.125in">Net deferred tax</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(24,839,145</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(858,661</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">7,791,048</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(894,614</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(1,222,843</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(20,024,215</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The tax on the Group&#8217;s profit before tax differs from the theoretical
amount that would arise using the weighted average tax rate applicable to profits of the consolidated entities as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">(Loss) / earnings before income tax-rate</td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(170,003,479</td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(27,958,152</td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">50,794,242</td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Income tax expense by applying tax rate in force in the respective countries</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">45,342,071</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,224,973</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(7,628,367</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Share of profit or loss of subsidiaries, joint ventures and associates</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(8,232,869</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5,141,460</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,645,224</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Puttable instruments charge</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-487">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-488">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,645</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Stock options charge</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(167,601</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,366,999</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(586,774</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Derecognition of deferred tax assets (i)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(40,565,962</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(94,189</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">428,530</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Mutual funds adjustments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,471</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27,560</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-489">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Non-deductible expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,027,734</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,469,872</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(373,655</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Result of inflation effect on monetary items and other finance results</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">335,680</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5,113,890</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(7,872,801</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Tax inflation adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,633,659</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,278,344</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,916,143</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Rate change adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-490">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">118,060</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(192,127</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; padding-left: 0pt">Others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(971,836</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">434,321</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,162</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Income tax expenses</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(6,636,121</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(1,103,152</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">2,328,366</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(i)</td><td style="text-align: justify">Mainly represent derecognition of deferred tax assets from
Bioceres S.A. because it initiated the voluntary bankruptcy proceeding (Note 21).</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">06/30/2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Current tax expense</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-491">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(8,894,200</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(1,311,506</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Deferred tax</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(6,636,121</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,791,048</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,639,872</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(6,636,121</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(1,103,152</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">2,328,366</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The income tax expense was calculated by applying
the tax rate in force in the respective countries, as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Tax jurisdiction</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Earnings before income tax-rate</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weight average applicable <br/>
tax rate</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Income <br/>
tax as of <br/>
June 30, <br/>
2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Low or null taxation jurisdictions</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(7,247,084</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">0.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-492">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Loss-making entities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(162,756,395</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">27.9</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">45,342,071</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(170,003,479</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">45,342,071</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Tax jurisdiction</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Earnings before income tax-rate</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weight average applicable <br/>
tax rate</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Income <br/>
tax as of <br/>
June 30, <br/>
2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Low or null taxation jurisdictions</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">13,131,953</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">0.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-493">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Profit-making entities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">32,251,706</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">32.2</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(10,370,389</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Loss-making entities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(73,341,811</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">24.0</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,595,362</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(27,958,152</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">7,224,973</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Tax jurisdiction</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Earnings before income tax-rate</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weight average applicable <br/>
tax rate</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Income <br/>
tax as of <br/>
June 30, <br/>
2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Low or null taxation jurisdictions</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">30,921,548</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">0.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-494">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Profit-making entities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">73,999,737</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">21.5</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(15,899,829</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Loss-making entities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(54,127,043</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">15.3</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,271,462</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">50,794,242</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(7,628,367</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Estimates</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There is an inherent material uncertainty related
to management&#8217;s estimation of the ability of the Group to use the deferred tax assets (both carryforward of unused tax losses and
deductible temporary differences) and the credit of minimum presumed income tax because their future utilization depends on the generation
of enough future taxable income by the entities within the Group during the periods in which those temporary differences are deductible
or when the unused tax losses can be used.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Based on the projections of future taxable income
for the periods in which the deferred tax assets are deductible, the Group&#8217;s management estimates that it is not probable that the
entities within the Group can utilize those deferred tax assets. Tax-loss Carry unrecognized as of June 30, 2025 amounting to $7.6 million.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIncomeTaxExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;doctype=Standard&amp;dita_xref=IAS12_g79-88_TI<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIncomeTaxExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earning Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EarningsPerShareAbstract', window );"><strong>Earning Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfEarningsPerShareExplanatory', window );">EARNING PER SHARE</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>10.&#160;<span style="text-decoration:underline">EARNING PER SHARE</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Basic and diluted EPS for the current period is based on the profit
or loss of the accounting acquirer and the weighted average number of ordinary shares of the legal acquirer outstanding during the period
(net of treasury shares). Comparative EPS has been retrospectively restated to reflect exchange ratio of the Business Combination Agreement
and the Reverse Stock Split ratio.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As part of the consideration transferred in the reverse acquisition
stated in Note 1 - The Group&#8217;s business reorganization and general information &#8211; &#8220;<i>The Bioceres Group Business Combination
Agreement</i>&#8221;, the Company committed to issue the Holdback additional ordinary shares twelve months after the acquisition date.
As this obligation is unconditional and forms part of the purchase consideration under IFRS 3, such shares are included in basic and diluted
EPS from the acquisition date and retrospectively for all comparative periods, in accordance with IAS 33. The deferred issuance date does
not affect their inclusion in the earnings per share calculation.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group&#8217;s basic and diluted loss per ordinary
share are the same because the Group has generated net loss to ordinary shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2023</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Numerator</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Loss/Profit for the year (basic EPS)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(111,460,708</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(32,685,398</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">40,435,923</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Loss/Profit for the year (diluted EPS)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(111,460,708</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(32,685,398</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">40,435,923</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Denominator</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Number of shares (basic EPS)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,462,960</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,821,519</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,593,222</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Number of shares (diluted EPS)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,462,960</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,821,519</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,593,222</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Basic (loss)/profit attributable to ordinary equity holders of the parent</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(17.2461</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(5.6146</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">8.8034</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">Diluted (loss)/profit attributable to ordinary equity holders of the parent</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(17.2461</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(5.6146</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">8.8034</td><td style="text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEarningsPerShareExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;doctype=Standard&amp;dita_xref=IAS33_g70-73A_TI<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEarningsPerShareExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Information about Components of Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InformationAboutComponentsOfEquityAbstract', window );"><strong>Information about Components of Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory', window );">INFORMATION ABOUT COMPONENTS OF EQUITY</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><b>11.</b></td><td style="text-align: justify"><b><span style="text-decoration:underline">INFORMATION ABOUT COMPONENTS OF EQUITY</span></b></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Capital issued</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As described in Note 1 &#8211; The Group&#8217;s
business reorganization and general information &#8211; &#8220;<i>The Bioceres Group Business Combination Agreement</i>&#8221; and in
note 6 &#8211; Acquisitions and other significant transactions &#8211; &#8220;<i>Bioceres Group, Nutrecon, Gentle Tech and Moolec Science
business combination</i>&#8221;, the Company completed a reverse acquisition on June 16, 2025, whereby Moolec Science SA (&#8220;the Legal
Acquirer&#8221;) legally acquired Bioceres Group, Nutrecon and Gentle Tech (&#8220;the Legal Acquirees&#8221;). For accounting purposes,
however, Bioceres Group was identified as the accounting acquirer in accordance with IFRS 3 Business Combinations. As a result, the consolidated
financial statements represent a continuation of the financial statements of the accounting acquirer, except for the capital structure,
which is that of the legal acquirer. Following the reverse acquisition, <span style="font-weight: normal">Share Capital</span> reflects
the share capital of <span style="font-weight: normal">Moolec Science SA, </span>including the shares issued to the former shareholders
of the accounting acquirer as consideration for the transaction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The number of shares issued as of June 30, 2025,
2024 and 2023 is the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>Year ended</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="text-align: center; border-bottom: Black 1.5pt solid"><b>Class</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Number of <br/>
Shares</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Nominal Value</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Subscribed capital</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 23%; text-align: left">06/30/2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 22%; text-align: center">Ordinary</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 15%; text-align: right">5,301,700</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.10</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">5,301,700</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">530,170</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">06/30/2024</td><td>&#160;</td>
    <td style="text-align: center">Ordinary</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,983,687</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.10</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,983,687</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">598,369</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">06/30/2025</td><td>&#160;</td>
    <td style="text-align: center">Ordinary</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,891,761</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.10</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,891,761</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,089,176</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Holders of the ordinary shares are entitled to
one vote for each ordinary share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Reserves</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Foreign currency translation reserve</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The translation reserve comprises all foreign
currency differences arising from the translation of the financial statements of foreign operations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Revaluation of PP&amp;E and effect of tax rate
change</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The revaluation reserve relates to the revaluation
of Land and buildings, prior to the BIOX deconsolidation, as mentioned in note 4.8 &#8211; Property, plant and equipment, net of income
tax effect.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Own shares held</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The reserve of the Company&#180;s own shares
held comprises the cost of the Company&#8217;s shares held by the Group. At June 30, 2025, the Group held 80,370 of the Company&#8217;s
shares. (2024: 60,083).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Share premium</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Share premium represents the excess of the consideration
received over the par value of shares issued, net of directly attributable transaction costs, and is presented within equity in accordance
with IAS 32.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Non-controlling interests</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The subsidiaries whose non-controlling interest
is significant as of June 30, 2025 and 2024 are:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>Name</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>06/30/2025</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>06/30/2024</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Bioceres S.A.</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">10.07</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">26.53</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Bioceres Crop Solutions (*)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-495">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">72.67</td><td style="text-align: left">%</td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Below is a detail of the summarized financial
information of Bioceres S.A., prepared in accordance with IFRS, and modified due to fair value adjustments at the acquisition date and
differences in accounting policies. The information is presented prior to eliminations between that subsidiary and other Group companies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(*)</td><td style="text-align: justify">Bioceres Crop Solutions ceased to be a subsidiary in June
24, 2025.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Bioceres S.A.</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="text-decoration:underline">Summary financial statements:</span> &#160; &#160; &#160; &#160; &#160; &#160;</p>



<p style="margin: 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0pt">Current assets</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">19,390,689</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">37,499,373</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Non-current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(12,909,646</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">78,742,912</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Total assets</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">6,481,043</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">116,242,285</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">97,284,715</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">47,526,407</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Non-current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">238,458</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">14,689,742</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Total liabilities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">97,523,173</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">62,216,149</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Total equity</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(91,042,130</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">54,026,136</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Total liabilities and equity</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">6,481,043</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">116,242,285</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="text-decoration:underline">Summary statements of comprehensive income or loss</span></p>



<p style="margin: 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">06/30/2023</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; padding-left: 0pt">Revenues</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">780,952</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,422,707</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,074,655</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Government grants</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,412</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">197,519</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">49,185</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 0pt">Gross margin</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">784,364</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">1,620,226</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">1,123,840</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Research and development expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(223,688</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(239,446</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(175,737</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Selling, general and administrative expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,275,441</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,248,643</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,287,433</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">Share of profit or loss of subsidiaries</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(33,367,101</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,285,724</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,287,879</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Share of profit or loss of joint ventures and associates</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(285</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,592</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,917</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Other income / (loss), net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(56,484,792</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,126</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">249,372</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-left: 0pt">Operating loss</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(91,566,943</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(5,145,053</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">3,194,004</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Financial results</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,891,781</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,128,752</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,327,324</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Loss before taxes</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(88,675,162</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(6,273,805</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(1,133,320</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Income tax (expense) / benefit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,653,797</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">471,416</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(463,175</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Result for the year</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(90,328,959</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(5,802,389</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(1,596,495</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-style: italic; text-align: left; padding-left: 0pt">Revaluation of property, plant and equipment, net of tax</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(434,390</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Foreign exchange differences on translation of foreign operations</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(5,467,311</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,865,328</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(5,182,181</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-style: italic; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Total comprehensive result</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(95,796,270</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(9,667,717</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(7,213,066</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Bioceres Crop Solutions</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="text-decoration:underline">Summary financial statements:</span></p>



<p style="margin: 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0pt">Current assets</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-496">&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">408,668,037</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Non-current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-497">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">441,960,310</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Total assets</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-498">-</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">850,628,347</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-499">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">329,505,846</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Non-current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-500">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">171,558,140</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Total liabilities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-501">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">501,063,986</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Total equity</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-502">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">349,564,361</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Total liabilities and equity</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-503">-</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">850,628,347</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="text-decoration:underline">Summary statements of comprehensive income or loss</span></p>



<p style="margin: 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 64%">Revenues</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">333,343,987</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">464,828,548</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">419,446,439</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Initial recognition and changes in the fair value of biological assets at the point of harvest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,764,863</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(45,746</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">610,554</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Cost of sales</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(203,424,872</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(278,221,812</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(235,457,053</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Changes in the net realizable value of agricultural products after harvest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,541,204</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,385,069</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,351,433</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Research and development expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(14,914,822</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(17,183,041</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(15,345,315</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Selling, general and administrative expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(123,113,572</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(123,690,910</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(113,002,747</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Share of profit or loss of joint ventures and associates</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,126,312</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,049,508</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,198,628</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Other income or expenses, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,775,970</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,498,555</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,084,892</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Operating (loss) / profit</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(2,235,962</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">45,852,923</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">54,183,965</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Financial results</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(55,335,675</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(34,785,325</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(35,078,018</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">(Loss) / profit before taxes</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(57,571,637</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">11,067,598</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">19,105,947</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Income tax</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,273,616</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,778,615</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,068,652</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Result for the year</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(58,845,253</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">7,288,983</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">20,174,599</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-style: italic; text-align: left">Foreign exchange differences on translation of foreign operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(714,251</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(787,354</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">631,500</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-style: italic; text-align: left; padding-bottom: 1.5pt">Revaluation of property, plant and equipment, net of tax</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-504">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-505">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,467,349</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-style: italic; text-align: left; padding-bottom: 2.5pt">Total comprehensive result</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(59,559,504</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">6,501,629</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">19,338,750</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share capital, reserves and other equity interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 160<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_160&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 79<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_InformationAboutComponentsOfEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_InformationAboutComponentsOfEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash Flow Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>The Group&#8217;s Business Reorganization and General Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCashFlowStatementExplanatory', window );">CASH FLOW INFORMATION</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><b>12.</b></td><td style="text-align: justify"><b><span style="text-decoration:underline">CASH FLOW INFORMATION</span></b></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Significant non-cash transactions related to investing
and financing activities are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2023</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold">Investment activities</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; width: 64%; text-align: left; padding-left: 0.125in">Net assets acquisition by business combination (Note 6)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">43,053,702</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,297,882</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">152,070,313</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Investment in-kind in other related parties (Note 17)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-506">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,409,244</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,163,384</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Issuance of shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">457,504</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">267,600</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">759,236</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Own shares held</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,327</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(437,154</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-507">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Exchange of intangible assets (Note 8.6)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,427,436</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-508">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-509">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Capitalization of interest on buildings in progress</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">336,416</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">124,098</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">74,710</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Right-of-use leased asset additions through an increase
    in lease liabilities (Note 16)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,569,819</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,585,223</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,154,950</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Reclassification from Investment properties to property, plant and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-510">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-511">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,589,749</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">Sale of equity investee (Note 13)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-512">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(900,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(133,079</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-bottom: 2.5pt; padding-left: 0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">59,867,204</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">5,346,893</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">160,679,263</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>

<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Financing activities</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="width: 64%; text-align: left; padding-left: 0pt">Capitalization of convertible notes</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-513">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-514">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">12,211,638</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Assignment of receivables with shareholders and other related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(7,886,442</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-515">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-516">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Compensation payment financed by acquisition of intangible assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,781,507</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-517">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-518">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Acquisition of interest in subsidiaries by financed debts</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-519">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,417,912</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">81,965,022</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(9,667,949</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">6,417,912</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">94,176,660</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the fiscal year ended on June 30, 2024,
the Group has incorporated the assets and liabilities from Natal Agro S.R.L. mentioned in Note 6 &#8211; Acquisitions and other significant
transactions.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Disclosure of changes in liabilities arising from
financing activities:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; border-bottom: Black 1.5pt solid">Financing activities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Borrowings</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Consideration for acquisition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Convertible notes</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; width: 52%; font-weight: bold; padding-bottom: 2.5pt; padding-left: 0.125in">As of June 30 2022</td><td style="width: 1%; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 4pt double; font-weight: bold; text-align: right">211,426,056</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 4pt double; font-weight: bold; text-align: right">12,326,110</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 4pt double; font-weight: bold; text-align: right">12,559,071</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 4pt double; font-weight: bold; text-align: right">236,311,237</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Proceeds</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">200,185,822</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-520">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">55,000,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">255,185,822</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(35,308,664</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,148,617</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-521">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(38,457,281</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Conversion of Convertible Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-522">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-523">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,109,516</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,109,516</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Interest payment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(20,465,271</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-524">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5,173,742</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(25,639,013</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">Exchange differences, currency translation differences and other financial results</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(23,391,636</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,617,570</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">21,937,333</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(6,071,873</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; font-weight: bold; padding-bottom: 2.5pt; padding-left: 0.125in">As of June 30 2023</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">332,446,307</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">4,559,923</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">75,213,146</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">412,219,376</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Proceeds</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">187,994,310</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-525">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-526">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">187,994,310</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(142,866,725</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,912,171</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-527">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(145,778,896</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Financing for assets acquisitions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">743,279</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,119,975</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-528">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,863,254</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Interest payment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(32,631,369</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-529">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,172,328</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(36,803,697</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">Exchange differences, currency translation differences and other financial results</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">16,073,254</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,809,240</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,768,868</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">29,651,362</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; font-weight: bold; padding-bottom: 2.5pt; padding-left: 0.125in">As of June 30 2024</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">361,759,056</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">6,576,967</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">80,809,686</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">449,145,709</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Proceeds</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">403,333,190</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-530">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-531">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">403,333,190</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(376,998,320</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,035,388</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,000,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(380,033,708</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Prepayment Premium Fee</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-532">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-533">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,870,021</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,870,021</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Non-cash activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(7,886,442</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,781,507</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-534">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,667,949</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Interest payment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(21,772,862</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-535">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(6,315,826</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(28,088,688</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Exchange differences, currency translation differences and other financial results</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26,645,537</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">138,825</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">23,906,564</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50,690,926</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Acquisition from business combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,348,173</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-536">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,260,456</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19,608,629</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">Decrease because of loss of control</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(157,926,152</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,898,897</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(102,270,445</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(263,095,494</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; font-weight: bold; padding-bottom: 2.5pt; padding-left: 0.125in">As of June 30 2025</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">228,502,180</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-537">-</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">18,260,456</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">246,762,636</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCashFlowStatementExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a statement of cash flows.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Section Presentation of a statement of cash flows<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;doctype=Standard&amp;dita_xref=IAS07_g10-17_TI<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCashFlowStatementExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Joint Ventures and Associates<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfJointVenturesAbstract', window );"><strong>Joint Ventures and Associates [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfJointVenturesExplanatory', window );">JOINT VENTURES AND ASSOCIATES</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="padding: 0pt; width: 0"></td><td style="padding: 0pt; width: 0.25in"><b>13.</b></td><td style="padding: 0pt"><b><span style="text-decoration:underline">JOINT VENTURES AND ASSOCIATES</span></b></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">06/30/2025</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">06/30/2024</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"><span style="text-decoration:underline">Assets</span></span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic"><span style="font-family: Times New Roman, Times, Serif">Measured at equity value
    method</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Synertech Industrias
    S.A.</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-538; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">39,749,850</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Bioceres Crops Solutions
    Corp</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">77,741,970</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-539; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Agrality Argentina S.A.</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,521,996</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,758,886</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Agrality US Inc.</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,315,307</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,521,791</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Agrality Seeds Inc.</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,496,286</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,812,389</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">SW Semillas S.A.</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">725</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">955</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Alfalfa Technologies S.R.L.</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-540; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">36,503</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Inmet
    S.A</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">71,687</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">379,876</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">94,147,971</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">56,260,250</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; font-style: italic; text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Measured
    at Fair value</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Theo
    I SCSp</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-541; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">36,535,601</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-542; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">36,535,601</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>06/30/2025</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>06/30/2024</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="text-decoration:underline">Liabilities</span></td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic; text-align: left">Measured at equity value method</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Trigall Genetics S.A.</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-543">&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">296,455</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-544">-</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">296,455</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Changes in joint ventures investments and affiliates:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; padding-left: 0pt">As of the beginning</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">92,499,396</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">117,720,140</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Loss of control</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(38,363,585</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-545">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Changes in equity interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">77,741,970</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,958</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Sale of equity investment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-546">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(900,000</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Reclassification of Moolec Science S.A.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-547">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,560,472</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Share-based incentives</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-548">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">65,470</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Dividends distribution</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-549">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,790,032</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Foreign currency translation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(802,200</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">977,482</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Share of profit or loss measured at equity value method</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(392,009</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,747,312</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Share of profit or loss measured at fair value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(36,535,601</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(28,770,462</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">As of the end of the year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">94,147,971</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">92,499,396</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Share of profit or loss of joint ventures and affiliates:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration:underline">Profit and losses</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-weight: bold"></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic">Measured at equity value method</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-left: 0pt">Synertech Industrias S.A.</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(415,089</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3,723,140</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">564,598</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Agrality Argentina S.A.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">587,173</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,519,639</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,126,492</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Agrality US Inc.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(206,484</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(64,322</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,940,435</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Agrality Seeds Inc.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">683,897</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(124,468</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,187,415</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Indrasa Biotecnolog&#237;a S.A.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-550">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-551">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">62,613</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Moolec Science SA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-552">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-553">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,176,703</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">SW Semillas S.A.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(285</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,592</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,917</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Trigall Genetics</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(711,223</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">326,368</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">103,703</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Inmet S.A.</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(329,998</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">369,547</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-554">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(392,009</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">7,747,312</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(2,076,234</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; font-style: italic; text-align: left; padding-left: 0pt">Measured at Fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Theo I SCSp</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(36,535,601</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(28,770,462</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">49,785,839</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(36,535,601</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(28,770,462</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">49,785,839</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Bioceres Group Limited has elected to measure
the investment in associates held through Theo I SCSp at fair value through profit or loss in accordance&#160;with&#160;IFRS&#160;9.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are no significant restrictions on the ability
of the joint ventures and affiliates to transfer funds to the Group for cash dividends, or to repay loans or advances made by the Group,
except for the legal obligation to establish a legal reserve for 5% of the profit for the year until reaching 20% of the capital for Argentinian
entities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Summarized financial information prepared in accordance
with International Financial Reporting Standards (&#8220;IFRS&#8221;) in relation to the significant joint ventures is presented below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Name</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Date</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Current<br/>
    assets</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Non-current<br/>
    assets</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Current<br/>
    liabilities</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Non-<br/>
    current<br/> liabilities</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Equity</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Sales</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Loss)/Profit<br/>
    of the year</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Synertech</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">06/30/2025</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-555; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-556; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-557; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-558; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-559; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-560"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-561"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; width: 16%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Industries</span></td><td style="width: 0.5%"></td>
    <td style="width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">06/30/2024</span></td><td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">55,963,591</span></td><td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,195,394</span></td><td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">27,610,517</span></td><td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,447,008</span></td><td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">36,101,460</span></td><td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">61,815,678</span></td><td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,236,901</span></td><td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">S.A.</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">06/30/2023</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">50,602,942</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">12,351,672</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">30,248,685</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,841,374</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">28,864,555</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">62,798,136</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,980,995</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">06/30/2025</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,733,702</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">17,174,010</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,749,928</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,155,954</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,001,830</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">27,931,724</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,409,802</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Agrality S.A.</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">06/30/2024</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">22,098,808</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">20,002,212</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">22,984,897</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,640,513</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,475,610</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">22,757,410</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,935,787</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">06/30/2023</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">14,203,372</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">24,832,433</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">14,591,700</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">19,382,094</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,062,012</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">20,540,979</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,071,653</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Theo I SCSp</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">06/30/2025</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-562; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">22,755,817</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,642,112</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">73,674,157</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(61,560,452</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-563; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(99,549,928</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">06/30/2024</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-564; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">108,456,044</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">13,405,755</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">57,060,813</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">37,989,476</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-565; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(32,213,331</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">06/30/2023</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-566; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">135,533,950</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,998,548</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">55,630,592</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">67,904,810</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-567; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(10,632,802</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfJointVenturesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of joint ventures. [Refer: Total for all joint ventures [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2025-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_16_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B4<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B4_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 75<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_75_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 75<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_75_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfJointVenturesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract', window );"><strong>Segment Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory', window );">SEGMENT INFORMATION</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><b>14.</b></td><td style="text-align: justify"><b><span style="text-decoration:underline">SEGMENT INFORMATION</span></b></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">After the BIOX deconsolidation, that took place
in June 24, 2025 the Group is organized under <span>a single operating segment, which is &#8220;science-based
food ingredients&#8221;. Operating segments are defined as components of an enterprise for which separate financial information is regularly
evaluated by the chief operating decision maker, who in the Group&#8217;s case is the Executive Team, in deciding how to allocate resources
and assess performance. The Executive Team is composed of the Chief Executive Officer (&#8220;CEO&#8221;), the Chief Financial Officer
(&#8220;CFO&#8221;) and the Chief Technology Officer (&#8220;CTO&#8221;).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>Prior to the BIOX deconsolidation,
the Executive Team evaluates the Group&#8217;s financial information and resources and assess the financial performance of these resources
as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Seed and integrated products</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The seed and integrated products segment focuses
mainly on the development and commercialization of seed technologies and products that increase yield per hectare, with a focus on the
provision of seed technologies integrated with crop protection and crop nutrition products designed to control weeds, insects or diseases,
to increase their quality characteristics, to improve nutritional value and other benefits. The segment focuses on the commercialization
of integrated products that combine three complementary components biotechnological events, germplasm and seed treatments&#8212;in order
to increase crop productivity and create value for customers. While each component can increase yield independently, through an integrated
technology strategy the segment offers products that complement and integrate with each other to generate higher yields in crops.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Currently the segment generates revenue from ordinary
activities through the sale of seeds, integrated product packs, royalties and licenses charged to third parties, among others.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Crop protection</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The crop protection segment mainly includes the
development, production and marketing of high-tech adjuvants and a full range of pest control molecules and biocontrol products. Adjuvants
are used in mixtures to facilitate the application and effectiveness of active ingredients, such as insecticides, leading to better performance,
reduced usage rates and lower residue levels Insecticides and fungicides are applied to control pests and significantly reduce disease
during the germination period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The segment currently generates revenue from ordinary
activities through the sale of adjuvants, insecticides, fungicides, and baits, among others.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Crop nutrition</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The crop nutrition segment focuses mainly on the
development, production and commercialization of inoculants that allow the biological fixation of nitrogen in the crops, and of fertilizers
including biofertilizers and microgranulated fertilizers that optimize the productivity and yield of the crops.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Currently the segment generates income from ordinary
activities through the sale of inoculants, bio-inductors, biological fertilizers and microgranulated fertilizers, among others.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The measurement principles for the Group&#8217;s
segment reporting structure are based on the IFRS principles adopted in the Consolidated financial statements. Revenue generated by products
and services exchanged between segments and entities within the Group are calculated based on market prices.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Emerging solutions</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The emerging solution segment is based on providing
R&amp;D services, biotechnology capabilities and specialised expertise to facilitate the integration of technologies and product development
efforts within the Group, as well as R&amp;D services to third parties.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This segment includes revenue sources primarily
related to agro-industrial biotechnology businesses, such as those generated by the production and commercialization of industrial enzymes
and fermentation technology to convert sugars and oils into high-value molecules or compounds.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The measurement principles for the Group&#8217;s
segment reporting structure are based on the IFRS principles adopted in the Consolidated financial statements. Revenue generated by products
and services exchanged between segments and entities within the Group are calculated based on market prices.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following tables present information with
respect to the Group&#8217;s reporting segments:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Year ended June 30, 2025</b></p></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Seed and integrated products</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Crop protection</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Crop nutrition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Emerging solutions</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Consolidated</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Revenues from contracts with customers</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">Sale of goods and services</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">60,535,026</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">181,908,584</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">76,054,689</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">267,261</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">318,765,560</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Royalties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,414,864</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-568">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-569">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-570">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,414,864</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Right of use licenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-571">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-572">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,430,824</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-573">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,430,824</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold">Others</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Initial recognition and changes in the fair value of biological assets at the point of harvest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,764,863</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-574">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-575">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-576">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,764,863</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Government grants</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-577">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-578">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-579">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,412</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,412</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total revenues</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">63,714,753</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">181,908,584</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">89,485,513</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">270,673</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">335,379,523</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Cost of sales</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(44,727,989</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(111,888,640</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(46,808,243</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-580">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(203,424,872</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Gross profit per segment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">18,986,764</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">70,019,944</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">42,677,270</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">270,673</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">131,954,651</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">% Gross margin</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">38</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">39</td><td style="text-align: left">%</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Year ended June 30, 2024</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Seed and integrated products</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Crop protection</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Crop nutrition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Emerging solutions</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Consolidated</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Revenues from contracts with customers</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">Sale of goods and services</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">94,457,404</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">223,538,317</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">125,558,380</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,547,782</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">445,101,883</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Royalties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">986,602</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-581">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-582">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-583">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">986,602</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Right of use licenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,000,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-584">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19,287,845</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-585">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20,287,845</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold">Others</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Initial recognition and changes in the fair value of biological assets at the point of harvest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(45,746</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-586">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-587">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-588">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(45,746</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Government grants</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-589">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-590">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-591">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">197,519</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">197,519</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total revenues</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">96,398,260</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">223,538,317</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">144,846,225</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,745,301</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">466,528,103</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Cost of sales</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(66,306,974</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(143,807,301</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(68,107,537</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,146,516</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(279,368,328</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Gross profit per segment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">30,091,286</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">79,731,016</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">76,738,688</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">598,785</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">187,159,775</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">% Gross margin</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">36</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">53</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">40</td><td style="text-align: left">%</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Year ended June 30, 2023</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Seed and integrated products</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Crop protection</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Crop nutrition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Emerging solutions</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Consolidated</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Revenues from contracts with customers</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">Sale of goods and services</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">55,360,397</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">205,685,451</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">157,153,024</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,420,990</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">419,619,862</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Royalties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,247,567</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-592">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-593">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-594">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,247,567</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Others</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Initial recognition and changes in the fair value of biological assets at the point of harvest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">319,428</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">153,460</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">137,666</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-595">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">610,554</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Government grants</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-596">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-597">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-598">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">93,509</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">93,509</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total revenues</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">56,927,392</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">205,838,911</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">157,290,690</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,514,499</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">421,571,492</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Cost of sales</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(31,012,687</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(137,529,299</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(66,915,067</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(7,019</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(235,464,072</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Gross profit per segment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">25,914,705</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">68,309,612</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">90,375,623</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,507,480</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">186,107,420</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">% Gross margin</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">46</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">57</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">44</td><td style="text-align: left">%</td></tr>
  </table><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-weight: bold"></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>06/30/2023</b></span></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><b><span style="text-decoration:underline">Revenue by similar group of products or services</span></b></td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; font-weight: bold; font-style: italic; text-decoration: underline; text-align: left; padding-bottom: 1.5pt">Seed and integrated products</td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">61,949,890</td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">96,444,006</td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">56,607,954</td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Seed Treatments Packs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,476,396</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">29,992,052</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">32,563,161</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Seed &amp; Royalties Payments &amp; HB4 Program</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33,473,494</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">66,451,954</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">24,044,803</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; font-style: italic; text-decoration: underline; text-align: left; padding-bottom: 1.5pt">Crop protection</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">181,908,584</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">223,538,317</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">205,685,451</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Adjuvants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">56,028,937</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">56,634,128</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">52,825,245</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Seed CP Products and Services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,890,840</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,877,911</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26,080,587</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Other CP Products and Services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">62,983,430</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">103,092,454</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">94,277,444</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Bioprotection</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,005,377</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,933,824</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">32,502,175</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; font-style: italic; text-decoration: underline; text-align: left; padding-bottom: 1.5pt">Crop nutrition</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">89,485,513</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">144,846,225</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">157,153,024</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Inoculants &amp; Biofertilizers</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,445,093</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,315,253</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">23,621,534</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Micro-beaded Fertilizers</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">56,461,771</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">91,786,942</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">90,827,714</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Biostimulants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,578,649</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,456,185</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,800,318</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Syngenta up-front fee</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-599">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19,287,845</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">32,903,458</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; font-style: italic; text-decoration: underline; text-align: left; padding-bottom: 1.5pt">Emerging solutions</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">270,673</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,745,301</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,514,499</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Management expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">267,261</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,547,782</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,420,990</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Government grants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,412</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">197,519</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">93,509</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-decoration: underline; text-align: left; padding-bottom: 1.5pt">Total revenues</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">333,614,660</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">466,573,849</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">420,960,938</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of the current period, geographical information
is reported by main countries and regions. LATAM refers to Latin America countries, excluding Argentina and Brazil which are reported
separately. North America includes United States of America and Canada. The EMEA region covers Europe, the Middle East and Africa. The
Group has recast the comparative figures accordingly.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Geographical information</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Argentina</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">231,823,079</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">348,366,339</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">289,346,766</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Brazil</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,673,809</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">24,175,116</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">23,690,028</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>LATAM</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">23,900,621</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">21,952,339</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">21,044,547</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">North America</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30,107,865</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27,543,558</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30,768,912</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>EMEA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,920,550</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">21,320,535</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,014,855</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Rest of the world</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">22,188,736</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">23,215,962</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">34,095,830</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total revenues</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">333,614,660</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">466,573,849</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">420,960,938</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold">Non-current assets</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 76%">Argentina</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">12,493,920</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">139,722,896</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Brazil</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-600">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,698,175</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">LATAM</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-601">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,162,654</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">North America</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">53,447,180</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">189,199,549</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">EMEA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,662,860</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">44,141</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Rest of the world</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-602">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">26,279,731</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; padding-bottom: 4pt">Total</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">78,603,960</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">364,107,146</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Property, plant and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,345,170</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">74,612,434</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Intangible assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">75,258,790</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">177,331,280</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1.5pt">Goodwill</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-603">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">112,163,432</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Total reportable assets</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">78,603,960</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">364,107,146</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Total non-reportable assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">126,105,586</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">585,729,699</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 4pt">Total assets</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">204,709,546</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">949,836,845</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Following the Business Combination and the BIOX
deconsolidation, the Executive team will evaluate <span>the Group&#8217;s financial information and resources
and assess the financial performance of these resources on a consolidated basis on the basis of Net revenue/loss for the period.</span>&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;doctype=Standard&amp;dita_xref=IFRS08_g20-24_TI<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments &#8211; Risk Management<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialInstrumentsRiskManagementAbstract', window );"><strong>Financial Instruments &#8211; Risk Management [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialRiskManagementExplanatory', window );">FINANCIAL INSTRUMENTS &#8211; RISK MANAGEMENT</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="padding: 0pt; width: 0"></td><td style="padding: 0pt; width: 0.25in"><b>15.</b></td><td style="padding: 0pt"><b><span style="text-decoration:underline">FINANCIAL INSTRUMENTS &#8211; RISK MANAGEMENT</span></b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group is exposed to a variety of financial
risks that arise from its activities and from its use of financial instruments. This Note provides information on the Group&#8217;s exposure
to certain main risks, the Group&#8217;s objectives, policies and processes regarding the measurement and management of each risk.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group does not use derivative financial instruments
to hedge any of the above risks.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>General objectives, policies, and processes</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board of Directors has overall responsibility
for establishing and monitoring the Group&#8217;s risk management objectives and policies and, whilst retaining ultimate responsibility
for them, it has delegated the function to design and operate processes that ensure the effective implementation of the objectives and
policies to the management that periodically reports to the Board of Directors on the evolution of the risk management activities and
results. The overall objective of the Board of Directors is to set policies that seek to reduce risk as much as possible without unduly
affecting the Group&#8217;s competitiveness and flexibility.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group&#8217;s risk management policy is established
to identify and analyze the risks facing the Group, to set appropriate risk limits and controls and to monitor risks and adherence to
limits. The risks and methods for managing the risks are reviewed regularly in order to reflect changes in market conditions and the Group&#8217;s
activities. The Group, through training and management standards and procedures, aims to develop a disciplined and constructive control
environment in which all the employees understand their roles and obligations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group seeks to use suitable means of financing
to minimize the Group&#8217;s capital costs and to manage and control the Group&#8217;s financial risks effectively. There have been no
substantive changes in the Group&#8217;s exposure to financial instrument risks, its objectives, policies and processes for managing those risks
or the methods used to measure them from previous periods unless otherwise stated in this Note.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group adopted a code of ethics applicable
to its principal executive, financial and accounting officers and all employees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The principal risks and uncertainties facing the
business, set out below, do not appear in any particular order of potential materiality or probability of occurrence.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Credit risk</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Credit risk is the risk of financial loss to the
Group if a customer or counterparty fails to meet its contractual obligations, which derives mainly from trade and other receivables,
as well as from cash and deposits in financial institutions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The credit risk to which the Group is exposed
is mainly defined in the Group&#8217;s accounts receivable followed by cash and cash equivalents, with the logical importance of being
able to satisfy the Group&#8217;s needs in the short term.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Trade and other receivables</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Credit risk is the risk of financial loss to the
Group if a customer or counterparty fails to meet its contractual obligations and derives mainly from trade receivables and other receivables
generated by services and product sales. The Group is also exposed to political and economic risk events, which may cause nonpayment of
local and foreign currency obligations to the Group owed by customers, partners, contractors and suppliers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group sells its products to a diverse base
of customers. Customers include multi-national and local agricultural companies, distributors, and farmers who purchase the Group&#8217;s
products. Type and class of customers may differ depending on the Group&#8217;s business segments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group&#8217;s management determines concentrations
of credit risk by periodically monitoring the credit worthiness rating of existing customers and through a monthly review of the trade
receivables&#8217; aging analysis. In monitoring the customers&#8217; credit risk, customers are grouped according to their credit characteristics.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group&#8217;s policy is to manage credit exposure
to counterparties through a process of credit rating. The Group performs credit evaluations of existing and new customers, and every new
customer is examined thoroughly regarding the quality of its credit before offering the customer transaction terms. The examination made
by the Group includes outside credit rating information, if available. Additionally, and even if there is no independent outside rating,
the Group assesses the credit quality of the customer taking into account its financial position, past experience, bank references and
other factors. A credit limit is prescribed for each customer. These limits are examined periodically. Customers that do not meet the
Group&#8217;s criteria for credit quality may do business with the Group on a prepayment basis or by furnishing collateral satisfactory
to the Group. The Group may still seek collateral and guarantees as it may consider appropriate regardless the credit profile of any customer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Cash and deposits in banks </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group is exposed to counterparty credit risk
on cash and cash equivalent balances. The Group holds cash on deposit with a number of financial institutions. The Group manages its credit
risk exposure by limiting individual deposits to clearly defined limits. The Group only deposits with high quality banks and financial
institutions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The maximum exposure to credit risk is represented
by the carrying amount of cash and cash equivalents in the statement of financial position.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Liquidity risk</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Liquidity risk is the risk that the Group will
encounter difficulty in meeting its financial obligations when they come due.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group&#8217;s approach to managing its liquidity
risk is to manage the profile of debt maturities and funding sources, maintaining sufficient cash, and ensuring the availability of funding
from an adequate amount of credit facilities. The Group&#8217;s ability to fund its existing and prospective debt requirements is managed
by maintaining diversified funding sources.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The cash flow forecast is determined at both an
entity level and consolidated level. The forecasts are reviewed by the Board of Directors in advance, enabling the Group&#8217;s cash
requirements to be anticipated. The Group examines the forecasts of its liquidity requirements in order to ascertain that there is sufficient
cash for the operating needs, including the amounts required in order to settle financial liabilities.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As explained in Note 1 &#8211; The Group&#8217;s
business reorganization and general information, in the near term, management plans to continue to focus on raising the funds necessary
to fully implement the Group&#8217;s business plan. Management believes that certain shareholders and/or investors will continue to advance
the capital required to meet the Group&#8217;s financial obligations. There is no assurance, however, that these investors and shareholders
will continue to advance capital to the Group or that the business operations will be profitable. The possibility of failure in obtaining
additional funding and the potential inability to achieve profitability raise substantial doubts about the Group&#8217;s ability to continue
as a going concern.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table sets out the contractual maturities of financial
liabilities:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid">As of June 30, 2025</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Up to<br/> 3 months</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">3 to 12 months</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Between one and three years</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Trade and other payables</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">7,323,933</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-604">&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-605">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Borrowings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">227,154,007</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-606">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,348,173</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Convertible notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-607">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-608">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,260,456</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Lease liability</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">117,463</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-609">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-610">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">234,595,403</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-611">-</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">19,608,629</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid">As of June 30, 2024</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Up to <br/>
3 months</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">3 to 12 months</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Between one and three years</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Trade and other payables</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">107,801,065</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">61,136,471</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-612">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Borrowings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">87,538,816</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">146,971,935</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">127,248,305</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Consideration for acquisition of assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-613">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,571,824</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,005,143</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Convertible notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-614">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-615">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">80,809,686</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Lease liability</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">738,561</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,384,217</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,161,359</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">196,078,442</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">215,064,447</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">218,224,493</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of June 30, 2025 and 2024, the Group had no
exposure to derivative liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Currency risk</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Foreign currency risk is the risk that the fair
value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rate. Currency on foreign exchange
risk arises when the Group enters into transactions denominated in a currency other than its functional currency.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Part of the Company&#8217;s business activities
is conducted in Argentine pesos. However, some of the subsidiaries using the Argentine peso as their functional currency also have significant
transactions denominated in U.S. dollars, mainly with respect to sales and financing activities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The table below sets forth the net exposure to
currency risk as of June 30, 2025:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Net foreign currency position</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">Amount expressed in US$</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(206,837,587</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Other currencies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(49,304,636</td><td style="text-align: left">)</td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The main Argentinian subsidiaries of the Group
have changed their functional currency from Argentine Pesos to US Dollar (Note 2 &#8211; Accounting standards and basis of preparation).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Considering only this net currency exposure as
of June 30, 2025, if an Argentine peso/US dollar revaluation or depreciation in relation to other foreign currencies with the remaining
variables remaining constant, would have a positive or a negative impact on comprehensive income as a result of foreign exchange gains
or losses. The Company estimates that a devaluation or an appreciation of the Argentine peso against the U.S. dollar of 20% during the
year ended June 30, 2025, would have resulted in the following results:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Estimated</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif"><b>Exchange rate variation</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(-)
    20%</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(+)
    20%</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Argentine peso amount expressed
    in US$</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(51,228,445</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">51,228,445</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Interest rate risk</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group&#8217;s financing costs may be affected
by interest rate volatility. Borrowings under the Group&#8217;s interest rate management policy may be fixed or floating rate. The Group
maintains adequate committed borrowing facilities and holds most of its financial assets primarily in cash or checks collected from customers
that are readily convertible into known amounts of cash.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group&#8217;s interest rate risk arises from
long-term borrowings. Borrowings issued at floating rates expose the Group to cash flow interest rate risk. Borrowings issued at fixed
rates expose the Group to fair value interest rate risk. The Group has not entered into derivative contracts to hedge this exposure.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group does not use derivative financial instruments
to hedge its interest rate risk exposure.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group&#8217;s debt composition is set out
below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic"></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><b><i><span style="text-decoration:underline">Carrying amount</span></i></b></td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Fixed-rate instruments</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Current financial liabilities</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">227,154,007</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">187,141,491</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Non-current financial liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">19,608,629</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">193,681,929</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">246,762,636</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">380,823,420</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">Variable-rate instruments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Current financial liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-616">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">47,369,260</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Non-current financial liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-617">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">14,376,062</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-618">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">61,745,322</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group does not use derivative financial instruments
to hedge its interest rate risk exposure.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Capital risk</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group&#8217;s objectives when managing capital
are to safeguard the Group&#8217;s ability to continue as a going concern, in order to provide returns for shareholders and benefits for
other stakeholders, and to maintain an optimal capital structure to reduce the cost of capital.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group manages its capital structure and makes
adjustments to it in the light of changes in economic conditions and the risk characteristics of the underlying assets. In order to maintain
or adjust the capital structure, the Group may adjust the amount of any dividends it could pay to shareholders, return capital to shareholders,
issue new shares, or sell assets to reduce debt.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Financial instruments by category</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following tables show additional information
required under IFRS 7 on the financial assets and liabilities recorded as of June 30, 2025 and 2024.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Financial assets by category</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amortized cost</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Mandatorily measured at fair value through profit or loss</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>Financial asset</b></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">767,919</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">27,210,070</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-619">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">56,284,573</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Other financial assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,234,539</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-620">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;19,722</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,858,124</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Trade receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,085,400</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">209,007,195</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-621">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-622">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-align: left">Other receivables (*)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">14,085,303</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">45,342,974</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-623">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-624">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; font-weight: bold">Total</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">29,173,161</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">281,560,239</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">19,722</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">21,142,697</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><sup>&#160;</sup></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><sup>(*)</sup></td><td style="text-align: justify">Advances expenses and tax balances are not included.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Financial liabilities by category</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amortized cost</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Mandatorily measured at fair value through profit or loss</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Financial liability</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Trade and other payables</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">7,323,933</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">156,947,744</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-625">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">11,989,792</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Borrowings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">228,502,180</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">361,759,056</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-626">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-627">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Consideration for acquisition of assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-628">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,852,853</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-629">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,724,114</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Convertible notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,260,456</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">80,809,686</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-630">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-631">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Lease liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">117,463</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,284,137</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-632">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-633">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Warrants</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-634">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-635">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,211,093</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-636">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; font-weight: bold">Total</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">254,204,032</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">614,653,476</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,211,093</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">14,713,906</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Financial instruments measured at fair value</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Measurement of fair values</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A number of the Group&#8217;s accounting policies
and disclosures require the measurement of fair values, for both financial and non-financial assets, and financial and non-financial liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group has an established control framework
with respect to the measurement of fair values. This includes a valuation team that has overall responsibility for overseeing all significant
fair value measurements, including Level 3 fair values, and reports directly to the chief financial officer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The valuation team regularly reviews significant
unobservable inputs and valuation adjustments. If third party information, such as broker quotes or pricing services, is used to measure
fair values, then the valuation team assesses the evidence obtained from the third parties to support the conclusion that these valuations
meet the requirements of the Accounting Standards, including the level in the fair value hierarchy in which the valuations should be classified.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Significant valuation issues are reported to the
Group&#8217;s audit committee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Fair value by hierarchy</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">According to the requirements of IFRS 7, the Group
classifies each class of financial instrument valued at fair value into three levels, depending on the relevance of the judgment associated
to the assumptions used for measuring the fair value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 1 comprises financial assets and liabilities
with fair values determined by reference to quoted prices (unadjusted) in active markets for identical assets or liabilities;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 2 comprises inputs other than quoted prices
included within Level 1 that are observable for the asset or liability, either directly (i.e. as prices) or indirectly (i.e. derived from
prices);</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 3 comprises financial instruments with inputs
for estimating fair value that are not based on observable market data.</p><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-weight: bold"></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Level
    1</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Level
    2</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Level
    3</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif"><b><span style="text-decoration:underline">Measurement at fair value at 06/30/2025</span></b></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic"><span style="font-family: Times New Roman, Times, Serif">Financial assets at fair
    value</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Investments at fair value</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right">19,722</td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-637; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-638; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; font-style: italic; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Financial
    liabilities valued at fair value</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Warrant liability</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">181,093</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-639; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,030,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-weight: bold"></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">Level 1</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">Level 2</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">Level 3</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><b><span style="text-decoration:underline">Measurement at fair value at 06/30/2024</span></b></td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic">Financial assets at fair value</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Mutual funds</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">12,943,378</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-640">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-641">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Moolec Science SA shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,191,286</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-642">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-643">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Investments at fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,311,604</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-644">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-645">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">US Treasury bills</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,993,668</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-646">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-647">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other investments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,702,761</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-648">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-649">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; font-style: italic; text-align: left">Financial liabilities valued at fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Trade and other payables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-650">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,989,792</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-651">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Consideration for acquisition</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,724,114</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-652">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-653">-</div></td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Estimation of fair value</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value of marketable securities, mutual
funds and US Treasury Bills is calculated using the market approach using quoted prices in active markets for identical assets. The quoted
marked price used for financial assets held by the Group is the current bid price. These instruments are included in level 1.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group&#8217;s financial liabilities, which
were not traded in an active market, were determined using valuation techniques that maximize the use of available market information
and thus rely as little as possible on specific estimates of the entity specific estimates. If all significant inputs required to fair
value an instrument are observable, the instruments are included in level 2.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If one or more of the significant inputs is not
based on observable market data, the instruments are included in level 3.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group&#8217;s policy is to recognize transfers
between different categories of the fair value hierarchy at the time they occur or when there are changes in the circumstances that cause
the transfer. There were no transfers between levels of the fair value hierarchy. There were no changes in economic or business circumstances
affecting fair value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Financial instruments not measured at fair
value</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The financial instruments not measured at fair
value include cash and cash equivalents, trade accounts receivable, other accounts receivable, trade payables and other debts, borrowings,
financed payments and convertible notes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The carrying value of financial instruments not
measured at fair value does not differ significantly from their fair value, except for borrowings (Note 7.12).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management estimates that the carrying value of
the financial instruments measured at amortized cost approximates their fair value.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialRiskManagementExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the entity's financial risk management practices and policies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialRiskManagementExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_FinancialInstrumentsRiskManagementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_FinancialInstrumentsRiskManagementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PresentationOfLeasesForLesseeAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfLeasesExplanatory', window );">LEASES</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><b>16.</b></td><td style="text-align: justify"><b><span style="text-decoration:underline">LEASES</span></b></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The right-of-use asset was initially measured
at the amount of the lease liability plus initial direct costs incurred, adjusted by pre-payments made in relation to the lease. The right-of-use
asset was measured at cost less accumulated depreciation and accumulated impairment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The lease liability was initially measured at
the present value of the lease payments payable over the lease term, discounted at the rate implicit in the lease if it can be readily
determined. If that rate cannot be readily determined, the Group uses its incremental borrowing rate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The information about the right-of-use and liabilities
related with lease assets is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Right-of-use leased asset</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0pt">Book value at the beginning of the year</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">20,979,597</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">21,163,192</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Additions of the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,569,819</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,585,223</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Additions from business combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100,896</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">168,988</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Disposals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(680,110</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,284,975</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Exchange differences</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">273,529</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,652,831</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; padding-left: 0pt">Loss of control</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(30,142,835</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-654">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Book value at the end of the year</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">100,896</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">20,979,597</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Depreciation</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0pt">Book value at the beginning of the year/inception</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">9,377,845</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">7,226,617</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Depreciation of the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,036,703</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,418,956</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">Disposals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(697,150</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,092,167</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Exchange differences</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">47,736</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(175,561</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 0pt">Loss of control</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(13,765,134</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-655">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Accumulated depreciation at the end of the year</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-656">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,377,845</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 0pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">100,896</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">11,601,752</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Lease Liabilities</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Book value at the beginning of the year/inception</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">11,284,137</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">13,889,223</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Additions of the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,569,819</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,585,223</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Additions from business combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">117,463</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">168,988</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Interest expenses, exchange differences and inflation effects</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,059,412</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(480,189</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Payments of the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5,501,387</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,879,108</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Loss of control</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(16,411,981</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-657">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">117,463</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">11,284,137</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Lease Liabilities</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%">Current</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">117,463</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3,122,778</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Non-current</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-658">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,161,359</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">117,463</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">11,284,137</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Machinery and equipment</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-659">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3,655,741</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Vehicles</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-660">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,272,071</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Equipment and computer software</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-661">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,130,541</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Land and buildings</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">100,896</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">14,921,244</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">100,896</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">20,979,597</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfLeasesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Section Presentation<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;doctype=Standard&amp;dita_xref=IFRS16_g47-50_TI<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;doctype=Standard&amp;dita_xref=IFRS16_g51-60_TI<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfLeasesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PresentationOfLeasesForLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PresentationOfLeasesForLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders and Other Related Parties Balances and Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract', window );"><strong>Shareholders and Other Related Parties Balances and Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfRelatedPartyExplanatory', window );">SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><b>17.</b></td><td style="text-align: justify"><b><span style="text-decoration:underline">SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND
TRANSACTIONS</span></b></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended June 30, 2025, the transactions
between the Group and related parties, and the related balances owed by and to them for the year ended June 30, 2025, 2024 and 2023 are
as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Value of transactions for the year ended</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid">Party</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Transaction type</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 30%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 33%; text-align: left">Sales of goods and services</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">4,033,811</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">952,742</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">739,651</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Joint ventures and associates</td><td>&#160;</td>
    <td style="text-align: left">Purchases of goods and services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(24,061,563</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(500,704</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(738,652</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">Net loans granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,645,504</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,005,841</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,141,471</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">Interest gain</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">944,186</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">135,485</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">212,407</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">Net loans received</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-662">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,860,058</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,854,680</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">Puttable instruments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-663">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-664">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,399,631</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">Net loans granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-665">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,299</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19,049</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">Preference shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(15,000,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-666">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-667">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">Interest expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-668">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,425,703</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(956,873</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Shareholders and other related parties</td><td>&#160;</td>
    <td style="text-align: left">Own shares held by subsidiaries</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-669">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(444,473</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(133,079</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">In-kind contributions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,343,549</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,409,244</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,163,384</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">Sales of goods and services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,714,441</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,911,723</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,565,027</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">Purchases of goods and services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,517,528</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,998,349</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,334,556</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">Salaries, social security benefits and other benefits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,494,538</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,496,073</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,995,361</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Key management personnel</td><td>&#160;</td>
    <td style="text-align: left">Sales and services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">367,928</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-670">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-671">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">Purchases of goods and services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,079,070</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-672">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-673">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left; padding-bottom: 1.5pt">Stock options-based incentives</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(480,450</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(8,181,849</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,868,430</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Total</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(27,583,730</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,536,125</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">10,358,989</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amounts receivable from<br/>
 related parties</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Party</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Transaction type</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 30%; text-align: left">Joint ventures and associates</td><td style="width: 1%">&#160;</td>
    <td style="width: 45%; text-align: left">Trade debtors</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,565,913</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">2,176,622</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">Other receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,211,902</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">37,586,012</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Shareholders and other related parties</td><td>&#160;</td>
    <td style="text-align: left">Trade debtors</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-674">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">37</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">Loans receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,295,774</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-675">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left; padding-bottom: 1.5pt">Other receivables</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,405</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">47,348</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">15,090,994</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">39,810,019</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 52.5pt">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amounts payable to<br/>
 related parties</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Party</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Transaction type</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 30%; text-align: left">Joint ventures and associates</td><td style="width: 1%">&#160;</td>
    <td style="width: 45%; text-align: left">Trade creditors</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(620,034</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(52,778,206</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">Convertible notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(7,102,028</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-676">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">Net loans payables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(10,303,098</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,860,058</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Shareholders and other related parties</td><td>&#160;</td>
    <td style="text-align: left">Trade creditors</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-677">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(37,985</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,030,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-678">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">Preference shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(15,739,726</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-679">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Key management personnel</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left; padding-bottom: 1.5pt">Salaries, social security benefits and other benefits</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(41,620</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(226,702</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(34,836,506</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(54,902,951</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRelatedPartyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2025-01-01<br> -Section Disclosures<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2025-en-r&amp;doctype=Standard&amp;dita_xref=IAS24_g13-24_TI<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRelatedPartyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Key Management Personnel Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_KeyManagementPersonnelCompensationAbstract', window );"><strong>Key Management Personnel Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory', window );">KEY MANAGEMENT PERSONNEL COMPENSATION</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><b>18.</b></td><td style="text-align: justify"><b><span style="text-decoration:underline">KEY MANAGEMENT PERSONNEL COMPENSATION</span></b></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Key management personnel are those persons having
authority and responsibility for planning, directing and controlling the activities of the Group.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The compensation of directors and other members
of key management personnel, including social contributions and other benefits, were as follows for the year ended June 30, 2025, 2024
and 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Short-term employee benefits</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">2,494,538</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">2,496,073</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,995,361</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Share based payment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">480,450</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,181,849</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,868,430</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">2,974,988</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">10,677,922</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">3,863,791</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group entered into indemnification agreements
with each of its directors and executive officers. These agreements generally provide that the relevant director or officer will be indemnified
by the Group to the fullest extent permitted by law against liability and against all expenses reasonably incurred or paid by him or her
in connection with any claim, action, suit or proceeding which he or she becomes involved as a party or otherwise by virtue of his or
her being or having been such a director or officer of the Group and against amounts paid or incurred by him or her in the settlement
thereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The agreements are subject to certain exceptions,
including that no indemnification will be provided to any director or officer against any liability to the Group or its shareholder (i)
by reason of intentional fraudulent conduct, dishonesty, willful misconduct, or gross negligence on the part of the director or officer;
or (ii) by reason of payment made under an insurance policy or any third party that has no recourse against the indemnitee director or
officer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The compensation of key executives is determined
by the Board of Directors of Moolec Science SA, Bioceres Group Limited, Bioceres S.A. and Bioceres Crop Solutions Corp., based on the
performance of individuals and market trends.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Moolec Science SA currently does not pay any compensation
to any of its executive board members.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of information about key management personnel. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_KeyManagementPersonnelCompensationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_KeyManagementPersonnelCompensationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Payment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract', window );"><strong>Share-Based Payment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory', window );">SHARE-BASED PAYMENT</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><b>19.</b></td><td style="text-align: justify"><b><span style="text-decoration:underline">SHARE-BASED PAYMENT</span></b></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>19.1 <span style="text-decoration:underline">Bioceres S.A share based payments</span></b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prior to the Business Combination and the BIOX
deconsolidation, and in accordance with the compensation policy defined previously by the Bioceres Group Limited and its subsidiaries,
certain directors of Bioceres S.A. had the option of choosing to collect the annual incentive in cash or in shares of BIOX. The incentive
was for up to five times the monthly salary of each one and increases by $30,000 in the event that they choose to receive the incentive
in the form of shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of June 30, 2023 8,560 of Bioceres Crop Solutions Corp, were assigned
to the beneficiaries, which were granted immediately in recognition of the professional performance demonstrated during the year.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Additionally, in January 2024, in compliance with
the resolution in Minute No. 256 of the Board Meeting held in December 2021, it was decided to grant the Bioceres 2021 Award. It consists
of 10,000 shares of Bioceres Crops Solutions Corp for Dr. L&#237;a Raquel Chan, a researcher at CONICET, in recognition of her leadership
in the early development of HB4 technology.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">After the latest grant in January 2024, no incentives were awarded.
As of June 30, 2025 there is no outstanding annual incentive pending to be granted.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>19.2 <span style="text-decoration:underline">Bioceres Crop Solutions Corp share based payments</span></b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>2023 Omnibus Equity Incentive Plan</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 12, 2023, the board of directors of Bioceres
Crop Solutions Corp approved the 2023 Omnibus Equity Incentive Plan to attract and retain the best available personnel, provide additional
incentives to employees, directors and consultants and to promote the success of the Company&#8217;s business. In addition to introducing
new incentive plans, it comprehensively amends and restates in entirety (i) the Employee Stock Purchase Plan, (ii) the Equity Compensation
Plan, (iii) the Stand-Alone Stock Option Grant, and (iv) the Employee Stock Option Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">-</span></td><td style="text-align: justify">Employee Stock Purchase Plan (&#8220;ESPP&#8221;): incentive
plan for eligible employees with no stock compensation to purchase ordinary shares of BIOX up to a maximum of 15% percent of such employee&#8217;s
monthly compensation. The number of ordinary shares subject to the ESPP shall be 200,000 ordinary shares. The purchase price will be
equal to 85% of the lower of the closing price of BIOX&#8217;s ordinary shares on the first business day and the last business day of
the relevant offering period. As of the date of these consolidated financial statements the ESSP is not yet implemented.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">-</span></td><td style="text-align: justify">Equity Compensation Plan: annual incentive plan based on
certain financial and operational targets defined by the Board of Directors upon approval of the annual budget.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">-</span></td><td style="text-align: justify">Stand Alone Stock Option Grant: plan granted up to 1,200,000
underlying ordinary shares. The options have an exercise price of $4.55 and expire on October 31, 2029. Options can be exercised for
a period of up to three years, with 1/3 vesting every 12 months, and on a cashless basis at their volume weighted average price (&#8220;VWAP&#8221;)
of the ordinary shares during a twenty-day period to the date of exercise.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">-</span></td><td style="text-align: justify">Employee Stock Option Plan: plan granted up to 100,000 underlying
ordinary shares to certain key employees. The options have an exercise price of $5.55 and expire on October 23, 2030. Options can be
exercised for a period of up to three years, with 1/3 vesting every 12 months, and on a cashless basis at their volume weighted average
price (&#8220;VWAP&#8221;) of the ordinary shares during a twenty-day period to the date of exercise.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">-</span></td><td style="text-align: justify"><span style="font-size: 10pt">Past Share Option plan: immediately
vested options with a strike price between $11.93 and $13.24.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">-</span></td><td style="text-align: justify"><span style="font-size: 10pt">Base Share Option plan: to
vest and become exercisable in equal installments on June 30, 2023, June 30, 2024, and June 30, 2025, with a strike price between $10.47
and $10.79.</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">-</span></td><td style="text-align: justify"><span style="font-size: 10pt">Performance Share Option plan:
to vest and become exercisable if the Group&#8217;s fiscal year 2025 EBITDA reaches at least US$120 million, at 0% of the award, and
linearly thereafter up to 100% of the awarded options when reaching at least US$150 million. These options have also a strike price of
between $10.47 and $10.79.</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value of the stock options at the grant
date was estimated using the &#8220;Black-Scholes&#8221; model, considering the terms and conditions under which the options on shares were
granted and adjusted to consider the possible dilutive effect of the future exercise of options.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">&#160;</p>


<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid">Factor</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Stand Alone Stock Option Grant</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Employee Stock Option Plan</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Past Share Option plan</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Base Share Option plan</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Performance Share Option plan</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: justify; padding-left: 0pt">Weighted average fair value of shares</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">5.42</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">13.98</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">11.45</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">10.80</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">10.79</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; padding-left: 0pt">Weighted average exercise price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4.55</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5.55</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.48</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">10.52</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">10.52</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0pt">Weighted average expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">29.69</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">42.18</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48.73</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">54.73</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">54.73</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; padding-left: 0pt">Dividend rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0pt">Weighted average risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.66</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.17</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.40</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.47</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.47</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; padding-left: 0pt">Weighted average expected life</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">9.89 years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">9.22 years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">4.89 years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">2.97 year</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">2.97 year</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: justify; padding-left: 0.125in">Weighted average fair value of stock options at measurement date</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2.47</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">10.10</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5.01</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4.46</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4.45</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are no market-related performance conditions
or non-vesting conditions that should be considered for determining the fair value of options.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group estimated that nearly 100% of the share
options will be exercised, based on historical trends of executive retention and option exercise behavior. This estimate is reviewed at
the end of each annual or interim period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>2013 Stock Incentive Plan &#8211; Pro Farm
Group</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As part of the acquisition of Pro Farm Group,
Bioceres Group Limited, through its former subsidiary, BIOX, have incorporated the outstanding &#8220;2013 Stock Incentive Plan&#8221;
from Pro Farm Group. On the merger date the total equity awards outstanding was converted consistent with the terms of the merger agreement
into an aggregate of 1,191,362 option and or restricted stock units which was fully registered with the Securities and Exchange Commission
on July 26, 2022. All equity awards retained their original granted terms. BIOX has not granted any additional awards under this plan
during the year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Bioceres Crop Solutions&#8217;s fair value of
the grants was estimated utilizing a Black Scholes option pricing model based on the following range of assumptions which have determined
consistent with BIOX&#8217;s historical methodology for such assumptions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">July
    12, <br/>
    2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">Exercise price</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.16 - 204.66</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected life (years)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.03 - 9.83</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Estimated volatility factor</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34.9% - 44.4</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; width: 88%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Risk-free
    interest rate</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.0</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected dividend yield</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-680; font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table shows the evolution of stock
option and weighted average exercise price for the years ended June 30, 2025, and 2024:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of options</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">W.A. Exercise price</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of options</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">W.A. Exercise price</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-weight: bold; text-align: left">At the beginning of the year</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right">7,345,795</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right">11.83</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right">1,791,000</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right">15.79</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Granted during the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-681">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-682">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,631,894</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10.55</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Cancelled or expired during the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-683">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-684">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(570</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10.07</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Exercised during the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-685">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-686">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(76,529</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10.73</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Loss of control</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(7,345,795</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">11.83</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-687">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-688">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">Effective at the end of the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-689">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-690">-</div></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">7,345,795</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">11.83</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 44<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_44&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies, Commitments and Restrictions on the Distribution of Profits<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CapitalCommitmentsAbstract', window );"><strong>Contingencies, Commitments and Restrictions on the Distribution of Profits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCommitmentsExplanatory', window );">CONTINGENCIES, COMMITMENTS AND RESTRICTIONS ON THE DISTRIBUTION OF PROFITS</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><b>20.</b></td><td style="text-align: justify"><b><span style="text-decoration:underline">CONTINGENCIES, COMMITMENTS AND RESTRICTIONS ON THE
DISTRIBUTION OF PROFITS</span></b></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prior to the BIOX deconsolidation, the Group had
secured guaranteed notes and the convertibles notes which are referenced in Note 7.13 &#8211; Convertible Notes. Such instruments were
secured by substantially all of the assets located in the United States of Pro Farm Group, Inc. and its U.S. subsidiaries and are guaranteed
by BCS Holding Inc., Bioceres Crops do Brasil Ltda., Bioceres Crops S.A., Bioceres Semillas S.A.U., Verdeca LLC, Rasa Holding LLC, Rizobacter
Argentina S.A., Rizobacter del Paraguay S.A., Rizobacter do Brasil Ltda., Rizobacter South Africa, Rizobacter Uruguay, Rizobacter USA,
LLC, Pro Farm Group, Inc., Pro Farm Michigan Manufacturing LLC, Pro Farm, Inc., Pro Farm Technologies Com&#233;rcio de Insumo Agr&#237;colas
do Brasil Ltda., Glinatur S.A. and Pro Farm OU.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CapitalCommitmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CapitalCommitmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCommitmentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of commitments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCommitmentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Events Occurring After the Reporting Period<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract', window );"><strong>Events Occurring After the Reporting Period [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory', window );">EVENTS OCCURRING AFTER THE REPORTING PERIOD</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><b>21.</b></td><td style="text-align: justify"><b><span style="text-decoration:underline">EVENTS OCCURRING AFTER THE REPORTING PERIOD</span></b></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management has considered subsequent events through
the date these consolidated financial statements were issued.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Notice of Alleged breach</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 2, 2025, the Company received a notice
of alleged breach from INVIM Corporativo S.L., a private limited company incorporated under the laws of Spain (&#8220;INVIM&#8221;), regarding
the alleged failure to pay the assignment price of $13 million in connection with a certain Assignment and Assumption Agreement dated
May 27, 2025 (the &#8220;Agreement&#8221;). The Agreement, in turn, references related instruments, including a Note Purchase Agreement
and a Binding Contribution Memorandum of Understanding, both dated October 15, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In response, the Company rejected INVIM&#8217;s
assertion that any payment is due or owing, on the grounds that, among other reasons, under the express terms of the Agreement and related
transaction instruments, INVIM failed to satisfy certain conditions precedent, including the valid transfer of relevant securities and
the execution of a required services agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company intends to vigorously defend its position
and enforce its rights under the Agreement, the related transaction instruments, and applicable law. While the Company believes that INVIM&#8217;s
assertions are without merit, if INVIM were ultimately to prevail in any proceedings, such an adverse outcome could have a material adverse
effect on the Company&#8217;s business, results of operations, financial condition, or liquidity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Bioceres S.A. and Bioceres LLC</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As stated in Note 1 &#8211; The Group&#8217;s
business reorganization and general information - &#8220;<i>The Bioceres Group Business Combination Agreement&#8221;, </i>in June 2025,
Bioceres S.A., one of the Argentine subsidiaries of Bioceres Group Limited, defaulted on a portion of its financial debt that was due
that month. As a result, Bioceres S.A. had initiated a debt restructuring process for its financial debt for an aggregate amount of $36.4
million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In July 2025, Bioceres LLC, a wholly owned subsidiary
of Bioceres S.A., received a notice of default on its financial debt in the amount of $69.5 million. The creditor conducted a public auction
to wit 3,062,500 pledged BIOX shares, pursuant to the New York Uniform Commercial Code. Management has responded to said creditor, reserving
all rights, remedies, and defenses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The defaults by Bioceres S.A. and Bioceres LLC
do not have implications in other debts as there are no cross-default clauses on the remaining financial debt of the Group. There are no guarantees granted above Bioceres S.A. and Bioceres LLC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company had the financial support of its main
shareholders and considering the aforementioned events that derived in the loss of the financial support that was previously provided
by Bioceres Group (and who is also no longer a shareholder of the Company), and, consequently, raise a material uncertainty which may
cast significant doubt (or raise substantial doubt as contemplated by PCAOB standards) about the ability of Moolec Science SA to continue
as a going concern. The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Currently, the Group lacks sufficient financial resources to meet its obligations or fully implement its business plan. Without securing
additional capital, or achieving a successful financial restructuring process, the Group will not be able to sustain its operations. See
below &#8220;<i>Exercise of convertible preference shares&#8221;</i> and <i>&#8220;Summary of the liquidation and loss of control&#8221;.</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">However, there is no assurance the Group&#8217;s
future operations will generate profitability. The uncertainty surrounding the ability to secure additional funding and the potential
for continued operational losses contribute to raise a material uncertainty which may cast significant doubt (or raise substantial doubt
as contemplated by PCAOB standards) about the Group&#8217;s ability to continue as a going concern.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Exercise of convertible preference shares</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In December 2024, Bioceres Group issued 2,380,952
convertible preference shares for total proceeds of $15 million. These preference shares accrue a 9% per annum payment-in-kind (PIK) return
and grant the holder specific conversion rights, including the option to convert into ordinary shares or into Moolec Scicence shares if
the business combination closed before September 12, 2025. Upon the consummation of the Business Combination, and subsequent to the reporting
date, on December 10, 2025, the holder undertook to exercise the conversion of all or part of the subscription shares into a number of
Moolec Science shares, at the Company&#8217;s request. If total convertible shares are exercised, it will result in the derecognition
of a financial liability and an increase in equity of approximately $15 million plus the accumulated PIK up to the moment of exercise.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Financing proceeds</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subsequent to the closing date of the financial
statements, on December 2, 2025, the Company successfully obtained and received financing proceeds for working capital purposes in the
amount of $2.5 million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Financial support</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of the date of issuance of these financial statements, the Company&#8217;s
principal minority shareholder has committed to provide financial support to the Company for a period of twelve months.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Nasdaq delist letter received &amp; 20-F
delinquency letter</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-align: justify; text-indent: -0.5pt">On November 14,
2025, the Company received a determination letter (the &#8220;Nasdaq Determination Letter&#8221;) from the Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;)
indicating that the closing bid price of the Company&#8217;s ordinary shares had been below the minimum $1.00 per share requirement for
the last 30 consecutive business days, as set forth in Nasdaq Listing Rule 5550(a)(2), and informing the Company of their view that the
Company would not be afforded an automatic 180-day period to regain compliance with such rule.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-align: justify; text-indent: -0.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-align: justify; text-indent: -0.5pt">The Company has
submitted a timely appeal to a Nasdaq Hearings Panel, through which it will request the granting of a 180- day period to submit and effect
a compliance plan, which includes a potential implementation of a reverse stock split, if determined to be in the best interest of shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-align: justify; text-indent: -0.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-align: justify; text-indent: -0.5pt">The submission of the appeal automatically stays the effect of the
Nasdaq Determination Letter until the appeal has been considered, which took place on December 18, 2025. Accordingly, the Company&#8217;s
ordinary shares will continue to trade on The Nasdaq Capital Market under the symbol &#8220;MLEC&#8221; without interruption during the
time period when the panel decision is pending.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-align: justify; text-indent: -0.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-align: justify; text-indent: -0.5pt">The Company intends
to continue closely monitoring the closing bid price for its ordinary shares and remains committed to evaluating and executing all appropriate
actions to cure the deficiency and regain compliance with Nasdaq Listing Rule 5550(a)(2). The receipt of the Nasdaq Determination Letter
does not affect the Company&#8217;s business, operations or reporting requirements with the Securities and Exchange Commission.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-align: justify; text-indent: -0.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November 24, 2025, the Company received a letter
(the &#8220;Letter&#8221;) from the Listing Qualifications Department of Nasdaq stating that the Company is not in compliance with Nasdaq
Listing Rule 5250(c)(1) because it has not yet filed its Annual Report on Form 20-F for the year ended June 30, 2025 (the &#8220;Form
20-F&#8221;) with the Securities and Exchange Commission (the &#8220;SEC&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As the Company stated in the form 12b-25 filed
with the SEC on October 31, 2025, it was unable to file the Form 20-F in a timely manner due to complexities that arose immediately after
the closing of the business combination in mid-June 2025, two weeks prior to Moolec&#8217;s fiscal year end of June 30. The business combination
involves complex accounting, including the imposition of reverse acquisition accounting and valuation of acquired assets and liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has requested a stay of suspension
to the Nasdaq Hearings Panel, which automatically stayed the effect of the Letter until the panel hearing, which took
place on December 18, 2025. Accordingly, the Company&#8217;s ordinary shares will continue to trade on The Nasdaq Capital Market under
the symbol &#8220;MLEC&#8221; without interruption during the time period when the panel decision is pending.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Summary of the liquidation and loss of control</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Theo I SCSp</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November 28, 2025, subsequent to the reporting
date, Theo I SCSp received a conditional payment order from district court of&#160; Luxembourg, and therefore the General Partners engaged
Ogier (Luxembourg) SCS represented by its general partner Ogier Luxembourg (GP) S.&#224;.r.l&#160; formally as their legal advisor to
assist with Theo I SCSp&#8217;s declaration of bankruptcy before the Luxembourg District Court. The declaration of bankruptcy will declare
Theo I SCSp bankrupt and appoint a receiver who will take control over the management of the company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The loss of control constitutes the derecognition
event under IFRS 10.25. Accordingly, the Group will derecognize the assets and liabilities of Theo I SCSp and will remeasure its retained
interest at fair value in accordance with IFRS 9 at the date of the derecognition event. This will result in the recognition of an estimated
gain of $9.5 million in the consolidated statement of profit or loss as of the derecognition date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group will continue to measure its retained
interest in Theo I SCSp at fair value through profit or loss until the liquidation process is formally completed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Bioceres S.A. and Bioceres LLC</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 16, 2025, subsequent to the
reporting date, the Board of Directors of Bioceres S.A. formally approved the initiation of voluntary bankruptcy proceedings and
instructed management to seek and appoint a trustee (&#8220;<i>s&#237;ndico</i>&#8221;) to oversee the process. The commencement
of the voluntary bankruptcy proceedings and the transfer of decision-making authority to the trustee will result in the Group losing
control over Bioceres S.A. in accordance with the principles of IFRS 10 Consolidated Financial Statements. As Bioceres LLC is a
wholly owned subsidiary of Bioceres S.A., the Group simultaneously will lose control over Bioceres LLC as well.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under IFRS 10.25, the date on which control is
lost constitutes the derecognition event. Accordingly, after December 16, 2025, the Group will derecognize the assets and liabilities
of Bioceres S.A. and Bioceres LLC and will remeasure any retained interest at fair value in accordance with IFRS 9 Financial Instruments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The resulting derecognition effects are expected to generate an approximate
gain of $91.0 million related to the loss of control of Bioceres S.A. and an additional approximate gain of $5.3 million related to the
loss of control of Bioceres LLC (including the loss of holding in BIOX, therefore it will no longer be an equity method associate). These
amounts will be recognized in the consolidated statement of profit or loss as of the derecognition date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group will continue to monitor the
progress of the voluntary bankruptcy and liquidation proceedings and will update the accounting treatment as necessary in accordance
with IFRS.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for events after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 10<br> -IssueDate 2025-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=10&amp;code=ifrs-tx-2025-en-r&amp;doctype=Standard&amp;dita_xref=IAS10_g17-22_TI<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Reverse Stock Split After the Reporting Period<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DisclosureOfReverseStockSplitAfterTheReportingPeriodAbstract', window );"><strong>Reverse Stock Split After the Reporting Period [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DisclosureOfReverseStockSplitAfterTheReportingPeriod', window );">REVERSE STOCK SPLIT AFTER THE REPORTING PERIOD</a></td>
<td class="text"><table border="0" cellpadding="0" style="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
<tr style="vertical-align: top">
  <td style="width: 0.25in"><b>22.</b></td>
  <td><b><span style="text-decoration:underline">REVERSE STOCK SPLIT AFTER THE REPORTING PERIOD</span></b></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&#160;</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Subsequent to the period end,
the Company&#8217;s shareholders approved a reverse stock split of the Company&#8217;s ordinary shares at a ratio to be determined by
the Board of Directors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&#160;</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On December 20, 2025, the Board of Directors approved a reverse stock
split at a ratio of&#160;15-for-1, which will be effective on or around January 5, 2026.</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&#160;</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For purposes of comparability, earnings per share (&#8220;EPS&#8221;)
information presented in this note has been retrospectively adjusted to reflect the reverse stock split, as if it had been effective for
all periods presented. The reverse stock split did not impact the Company&#8217;s consolidated statements of operations, financial position
or cash flows, other than the recast of the weighted average number of ordinary shares outstanding used in the calculation of basic and
diluted EPS.</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; font-weight: bold; text-indent: -0.125in">Numerator</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; width: 64%; text-align: left; text-indent: -0.125in">Loss/Profit for the year (basic EPS)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(111,460,708</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(32,685,398</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">40,435,923</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; text-indent: -0.125in">Loss/Profit for the year (diluted EPS)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(111,460,708</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(32,685,398</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">40,435,923</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; font-weight: bold; text-indent: -0.125in">Denominator</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Number of shares (basic EPS)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">430,864</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">388,101</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">306,215</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Number of shares (diluted EPS)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">430,864</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">388,101</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">306,215</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; font-weight: bold; text-align: left; text-indent: -0.125in">Basic (loss)/profit attributable to ordinary equity holders of the parent</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(258.6912</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(84.2188</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">132.0508</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; font-weight: bold; text-align: left; text-indent: -0.125in">Diluted (loss)/profit attributable to ordinary equity holders of the parent</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(258.6912</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(84.2188</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">132.0508</td><td style="text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DisclosureOfReverseStockSplitAfterTheReportingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DisclosureOfReverseStockSplitAfterTheReportingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DisclosureOfReverseStockSplitAfterTheReportingPeriodAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DisclosureOfReverseStockSplitAfterTheReportingPeriodAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cybersecurity Risk Management and Strategy Disclosure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems', window );"><strong>Cybersecurity Risk Management, Strategy, and Governance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock', window );">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</a></td>
<td class="text">Cybersecurity<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As of the date of this report
we have not adopted a formal cybersecurity policy, and we have not invested in a comprehensive set of processes for managing cybersecurity
risk due to our relatively small size and limited resources. However, we have taken certain preliminary steps to manage cybersecurity
risks such as utilizing commercially available anti-virus software on company computers, utilizing cloud-based systems and software offered
by major global software and computer systems providers for company records and documents.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As of the date of this report
we do not believe, or are not aware, of any existing or previous cybersecurity incident that has materially affected or are reasonably
likely to materially affect our business, strategy, operations, or financial condition. However, we may in the future be materially adversely
affected by a cybersecurity incident, such as a computer system failure, a computer system security breach, and as a result may be subject
to ransomware, phishing attacks, or other malicious intrusions.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]</a></td>
<td class="text">As of the date of this report
we do not believe, or are not aware, of any existing or previous cybersecurity incident that has materially affected or are reasonably
likely to materially affect our business, strategy, operations, or financial condition.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock', window );">Cybersecurity Risk Board of Directors Oversight [Text Block]</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b>Cybersecurity Risk Governance</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our Compliance Officer is
responsible for assessing and managing material risks from cybersecurity threats. Our Compliance Officer oversees our efforts to monitor
the prevention, detection, mitigation, and remediation of cybersecurity incidents.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our Board of Directors has
specific responsibility for overseeing cybersecurity risk management and evaluation and being informed on risks from cybersecurity threats.
Our Compliance Officer reports to the Board of Directors on cybersecurity risk management matters as needed. Any material cybersecurity
incidents would be reported to the Board of Directors by our Compliance Officer. In the case of a material cybersecurity incident, our
board is responsible for ensuring that the proposed action and disclosure of the incident is adequate and that measures are put in place
to prevent further incidents. See Item 3 &#8211; Risk Factors<i>&#8212;&#8220;We rely on information technology systems, and any inadequacy,
failure, interruption or security breaches of those systems may impair our ability to operate our business effectively</i>&#8221; in this
Form 20-F.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]</a></td>
<td class="text">Our Board of Directors has
specific responsibility for overseeing cybersecurity risk management and evaluation and being informed on risks from cybersecurity threats.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag', window );">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting Policies, by Policy (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text"><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>4.1.&#160;<span style="text-decoration:underline">Cash and cash
equivalents</span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the purposes of the statements of financial
position and statements of cash flows, cash and cash equivalents include cash on hand and in banks and short-term highly liquid investments.
Investments can be readily convertible to known amounts of cash and they are subject to insignificant risk of changes in value. In the
consolidated statements of financial position, bank overdrafts are included in borrowings within current liabilities.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DescriptionOfAccountingPolicyForFinancialAssetsAndLiabilitiesPolicyTextBlock', window );">Financial assets and liabilities</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>4.2. &#160;<span style="text-decoration:underline">Financial assets and liabilities</span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group measures its financial assets at initial
recognition at fair value and subsequently at amortized cost using the effective interest method.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group has not irrevocably designated a financial
asset as measured at fair value through profit or loss to eliminate or significantly reduce a measurement or recognition inconsistency.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial assets at fair value through profit
or loss are measured at fair value through profit and loss due to the business model used in their negotiation and/or the contractual
characteristics of their cash flows.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Estimates</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group makes estimates of uncollectability
of its recorded receivables. Management analyzes trade account receivables in accordance with conventional criteria, adjusting the amount
through a charge of an allowance for bad debts upon recognition of the inability of third parties to afford their financial obligations
to the Group. Management specifically analyzes the accounts receivable, the historical bad debts, solvency of customers, current economic
trends and the changes to the payment conditions of customers to assess the adequate allowance for bad debts.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Offsetting of financial assets with financial
liabilities</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial assets and liabilities are offset and
presented for their net amount in the statements of financial position only when the Group has the right, legally enforceable, to compensate
the recognized amounts and has the intention to liquidate for the net amount or to settle the asset and cancel the liability simultaneously.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories', window );">Inventories</a></td>
<td class="text"><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>4.3. <span style="text-decoration:underline">Inventories</span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Inventories are recognized at cost initially and
subsequently at the lower of cost and net realizable value. Cost comprises all costs of purchase and conversion as well as other costs
incurred in bringing the inventories to their present location and condition.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Weighted average cost is used to determine the
cost of ordinarily interchangeable items.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Estimates</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group assesses the recoverability of inventories
considering their sale price, whether the inventories are damaged and whether they have become obsolete in whole or in part.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Net realizable value is the sale price estimated
to be attained in the ordinary course of business, less costs of completion and other selling expenses.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group sets up an allowance for obsolescence
or slow-moving inventories in relation to finished and in-process products. The allowance for obsolescence or slow-moving inventories
is recognized for finished products and in-process products based on an analysis by Management of the aging of inventory stocks.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory', window );">Biological assets</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>4.4. <span style="text-decoration:underline">Biological assets</span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Within current assets, growing crops are included
as biological assets, from the moment of sowing until the moment of harvest (approximately 5 to 7 months depending on the crop). At harvest
time the biological assets are transformed into agricultural products, including seed varieties for resale, and incorporated into the
inventory.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Costs are capitalized as biological assets if,
and only if, (a) it is probable that future economic benefits will flow to the entity, and (b) the cost can be measured reliably. The
Group capitalizes costs such as: planting, harvesting, weeding, seedlings, irrigation, agrochemicals, fertilizers and a systematic allocation
of fixed and variable production overheads that are directly attributable to the management of biological assets, among others.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Biological assets, both at initial recognition
and at each subsequent reporting date, are measured at fair value less costs to sell, except where fair value cannot be reliably measured.
Cost approximates fair value when little biological transformation has taken place since the costs were originally incurred or the impact
of biological transformation on price is not expected to be material.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Gains and losses that arise from measuring biological
assets at fair value less costs to sell and measuring agricultural produce at the point of harvest at fair value less costs to sell are
recognized in the statement of income in the period in which they arise in the line item &#8220;Initial recognition and changes in fair
value of biological assets&#8221;.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From the harvest time, agricultural products are
valued at net realizable value because there is a market asset, and the risk of non-sale is non-significant.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Generally, the estimation of the fair value of
biological assets is based on models or inputs that are not observable in the market and the use of unobservable inputs is significant
to the overall valuation of the assets. Unobservable inputs are determined based on the best information available. Key assumptions include
future market prices, estimated yields at the point of harvest, estimated production cycle, future cash flows, future costs of harvesting
and other costs, and estimated discount rate.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Market prices are generally determined by reference
to observable data in the principal market for the agricultural produce. Harvesting costs and other costs are estimated based on historical
and statistical data. Yields are estimated based on several factors, including the location of the farmland and soil type, environmental
conditions, infrastructure and other restrictions and growth at the time of measurement. Yields are subject to a high degree of uncertainty
and may be affected by several factors out of the Group&#8217;s control including but not limited to extreme or unusual weather conditions,
plagues and other crop diseases, among other factors.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation', window );">Basis of consolidation</a></td>
<td class="text"><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>4.5. <span style="text-decoration:underline">Basis of consolidation</span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Business combinations</span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>General</i><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group applies the acquisition method to account
for business combinations. The acquisition cost is measured as the aggregate of the consideration transferred for the acquisition of a
subsidiary, which is measured at fair value at the acquisition date, and the amount of any non-controlling interest in such subsidiary.
The Group recognizes any non-controlling interest in a subsidiary at the non-controlling interest&#8217;s proportionate share of the recognized
amounts of subsidiary&#8217;s identifiable net assets. The acquisition related costs are expensed as incurred.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any contingent consideration to be transferred
by the Group is recognized at fair value at the acquisition date. The contingent consideration is classified as an asset or liability
that is a financial instrument under IFRS 9 is measured at fair value through profit or loss.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Goodwill is initially measured at cost, which
is the excess of the aggregate of the consideration transferred and the amount of the non-controlling interest and any previous interest
carried over the net identifiable assets acquired, and liabilities assumed.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">After initial recognition, goodwill is measured
at cost less any accumulated impairment losses. For impairment testing, goodwill acquired in a business combination is, as of the acquisition
date, allocated to each of the cash-generating units of the Group that is expected to benefit from the synergies of the combination, without
considering whether other assets or liabilities of the subsidiary are allocated to those units.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any impairment in the carrying value is recognized
in the consolidated statement of comprehensive income. In the case of acquisitions in stages, prior to the write-off of the previously
held equity interest in the subsidiary, said interest is re-measured at fair value as of the date of acquisition of control over the subsidiary.
The result of the re-measurement at fair value is recognized in profit or loss.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When a seller in a business combination has contractually
agreed to indemnify the Group for the result of a contingency or uncertainty related to the entirety or a portion of an asset or liability,
the Group recognizes an indemnification asset. The indemnification asset is measured on the same basis as the indemnification item. At
the end of each period, the Group measures the indemnification assets recognized at the acquisition date on the same basis as the indemnified
liability, subject to any contractual limitation on the amount and, for an indemnification asset that is not periodically measured at
fair value, based on Management&#8217;s assessment of the recoverability of the indemnification asset. The Group derecognizes the indemnification
asset when it collects or sells it, or when it loses the right over it.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Reverse acquisitions</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In a reverse acquisition, the accounting acquirer
usually issues no consideration for the acquiree. Instead, the accounting acquiree usually issues its equity shares to the owners of the
accounting acquirer. Accordingly, the acquisition-date fair value of the consideration transferred by the accounting acquirer for its
interest in the accounting acquiree is based on the number of equity interests the legal subsidiary would have had to issue to give the
owners of the legal parent the same percentage equity interest in the combined entity that results from the reverse acquisition. The fair
value of the number of equity interests calculated in that way can be u sed as the fair value of consideration transferred in exchange
for the acquiree.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Consolidated financial statements prepared following
a reverse acquisition are issued under the name of the legal parent (accounting acquiree) but described in the notes as a continuation
of the financial statements of the legal subsidiary (accounting acquirer), with one adjustment, which is to adjust retroactively the accounting
acquirer&#8217;s legal capital to reflect the legal capital of the accounting acquiree. That adjustment is required to reflect the capital
of the legal parent (the accounting acquiree). Comparative information presented in those consolidated financial statements also is retroactively
adjusted to reflect the legal capital of the legal parent (accounting acquiree).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because the consolidated financial statements
represent the continuation of the financial statements of the legal subsidiary except for its capital structure, the consolidated financial
statements reflect:</p><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-size: 10pt">a.</span></td><td style="text-align: justify">the assets and liabilities of the legal subsidiary (the accounting acquirer) recognized and measured at
their pre-combination carrying amounts.</td></tr></table><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-size: 10pt">b.</span></td><td style="text-align: justify">the assets and liabilities of the legal parent (the accounting acquiree) recognized and measured in accordance
with IFRS 3.</td></tr></table><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-size: 10pt">c.</span></td><td style="text-align: justify">the retained earnings and other equity balances of the legal subsidiary (accounting acquirer) before the
business combination.</td></tr></table><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-size: 10pt">d.</span></td><td style="text-align: justify">the amount recognized as issued equity interests in the consolidated financial statements determined by
adding the issued equity interest of the legal subsidiary (the accounting acquirer) outstanding immediately before the business combination
to the fair value of the legal parent (accounting acquiree). However, the equity structure (ie. the number and type of equity interests
issued) reflects the equity structure of the legal parent (the accounting acquiree), including the equity interests the legal parent issued
to effect the combination. Accordingly, the equity structure of the legal subsidiary (the accounting acquirer) is restated using the exchange
ratio established in the acquisition agreement to reflect the number of shares of the legal parent (the accounting acquiree) issued in
the reverse acquisition.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When a reverse acquisition occurs, in calculating
the weighted average number of ordinary shares outstanding (the denominator of the earnings per share calculation) during the period in
which the reverse acquisition occurs:</p><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-size: 10pt">a.</span></td><td style="text-align: justify">the number of ordinary shares outstanding from the beginning of that period to the acquisition date shall
be computed on the basis of the weighted average number of ordinary shares of the legal acquiree (accounting acquirer) outstanding during
the period multiplied by the exchange ratio established in the merger agreement; and</td></tr></table><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-size: 10pt">b.</span></td><td style="text-align: justify">the number of ordinary shares outstanding from the acquisition date to the end of that period shall be
the actual number of ordinary shares of the legal acquirer (the accounting acquiree) outstanding during that period.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The basic earnings per share for each comparative
period before the acquisition date presented in the consolidated financial statements following a reverse acquisition shall be calculated
by dividing:</p><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-size: 10pt">a.</span></td><td style="text-align: justify">the profit or loss of the legal acquiree attributable to ordinary shareholders in each of those periods
by</td></tr></table><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-size: 10pt">b.</span></td><td style="text-align: justify">the legal acquiree&#8217;s historical weighted average number of ordinary shares outstanding multiplied
by the exchange ratio established in the acquisition agreement.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Subsidiaries</span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subsidiaries are entities controlled by the Group.
Information about Group accounting policy is included in Note 2 &#8211; &#8220;<i>Accounting standards and Basis of Preparation</i>&#8221;.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Non controlling interest</span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NCI are measured initially at their proportionate
share of the acquiree&#8217;s identifiable net assets at the date of acquisition.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Change in ownership interest in subsidiaries
without change of control </span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Transactions with non-controlling interest that
do not result in a loss of control are accounted for as equity transactions - i.e., as transactions with the owners&#160;in their capacity
as owners. The recorded value corresponds to the difference between the fair value of the consideration paid and/or received and the relevant
share acquired and/or transferred of the carrying value of the net assets of the subsidiary.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Loss of control</span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When the Group loses control over a subsidiary,
it derecognizes the assets and liabilities of the subsidiary, and any related NCI and other components of equity. Any resulting gain or
loss is recognized in profit or loss.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Investments for which the Group does not exercise
control, but which are not accounted for under the equity method due to meeting the definition of a financial asset, are measured at fair
value through profit or loss in accordance with IFRS 9 Financial Instruments.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When an investee (either a subsidiary or other
investment) enters a liquidation process and the Group no longer retains the ability to direct its relevant activities&#8212;such as through
the formal appointment of a liquidator by the investee&#8217;s Board of Directors&#8212;the Group concludes that control has been lost.
In such cases, the date of the liquidator&#8217;s appointment is considered the derecognition event for purposes of IFRS 10.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Associate and joint arrangements </span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">An associate is an entity over which the Group
exerts significant influence. Significant influence is the power to participate in financial and operating policy decision-making at such
entity, but it does not involve control or joint control over those policies.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group is a party to a joint arrangement when
there is a contractual arrangement that confers joint control over the relevant activities of the arrangement to the Group and at least
one other party. Joint control is assessed under the same principles as control over subsidiaries.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group classifies its interests in joint arrangements
as either:</p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify"><i>Joint ventures</i>: where the group has rights to only
the <i>net assets </i>of the joint arrangement.</td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify"><i>Joint operations</i>: where the group has both the rights
to the assets and obligations for the liabilities of the joint arrangement.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In assessing the classification of interests in
joint arrangements, the Group considers:</p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">The structure of the joint arrangement;</td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">The legal form of joint arrangements structured through a
separate vehicle;</td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">The contractual terms of the joint arrangement agreement;
and</td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">Any other facts and circumstances (including any other contractual
arrangements).</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group accounts for its interests in joint
ventures and associates using the equity method, where the Group&#8217;s share of post-acquisition profits and losses and other comprehensive
income is recognized in the Consolidated statement of profit and loss and other comprehensive income.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Losses in excess of the Group&#8217;s investment
in the joint venture and associates are recognized only to the extent that the Group has incurred legal or constructive obligations or
made payments on behalf of the joint venture.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Profits and losses arising on transactions between
the Group and its joint ventures and associates are recognized only to the extent of unrelated investors&#8217; interests in the joint
venture and/or associates. The Group&#8217;s share in a joint venture and/or associates&#8217; profits and losses resulting from a transaction
is eliminated against the carrying amount of investment in the joint venture and/or associates through the line &#8220;share of profit
(or loss) of joint ventures and associates&#8221; in the Consolidated statements of profit or loss and other comprehensive income.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any premium paid for an investment in a joint
venture and/or associates above the fair value of the Group&#8217;s share of the identifiable assets, liabilities and contingent liabilities
acquired is capitalized and included in the carrying amount of the investment in the joint venture and/or associates. Where there is objective
evidence that the investment in a joint venture and/or associates has been impaired, the carrying amount of the investment is tested for
impairment in the same way as other non-financial assets.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When the Group loses significant influence in
an associate or joint control over a joint venture, it measures and recognizes any investment held at fair value. Any difference between
the carrying amount of the associate or joint venture when losing significant influence or joint control and the fair value of the held
investment and sale revenue are recognized in profit or loss.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group accounts for its interests in joint
operations by recognizing its share of assets, liabilities, revenues and expenses in accordance with its contractually conferred rights
and obligations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For all joint arrangements structured in separate
vehicles the Group must assess the substance of the joint arrangement in determining whether it is classified as a joint venture or joint
operation. This assessment requires the Group to consider whether it has rights to the joint arrangement&#8217;s net assets (in which
case it is classified as a joint venture), or rights to and obligations for specific assets, liabilities, expenses, and revenues (in which
case it is classified as a joint operation).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Paragraph 18 of IAS 28 states when an investment
in an associate or a joint venture is held by, or is held indirectly through, an entity that is a venture capital organization, or a mutual
fund, unit trust and similar entities, the entity may elect to measure that investment al fair value through profit or loss in accordance
with IFRS 9.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has elected to measure the investment
in associates held through Theo I SCSp at fair value through profit or loss in accordance with IFRS 9.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Estimates</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There is uncertainty regarding Management&#8217;s
estimates of the Group&#8217;s ability to recover the carrying amounts of the investments in joint ventures, since such estimates depend
on the joint ventures&#8217; ability to generate sufficient funds to complete the development projects, the future outcome of the project
deregulation process and the amounts and timing of the cash flows from projects, among other future events.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management assesses whether there are impairment
indicators and, if any, it performs a recoverability analysis.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management estimates of the recoverability of
these investments represent the best estimate based on available evidence, the existing facts and circumstances, using reasonable and
provable assumptions in the cash flow projections.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Therefore, the consolidated financial statements
do not include adjustments that would be required if the Group were unable to recover the carrying amount of the above-mentioned assets
by generating sufficient economic benefits in the future.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Transactions eliminated on consolidation</span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Intra-group balances and transactions, and any
unrealized income and expenses (except for foreign currency transaction gains and losses) arising from intra-group transactions, are eliminated.
Unrealized gains arising from transactions with equity-accounted investees are eliminated against the investment to the extent of the
Group&#180;s interest in the investee. Unrealized losses are eliminated in the same way as unrealized gains, but only to the extent that
there is no evidence of impairment.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory', window );">Impairment assessment of Goodwill and Intangible assets</a></td>
<td class="text"><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>4.6. <span style="text-decoration:underline">Impairment assessment of Goodwill and Intangible assets</span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Impairment tests on goodwill and intangible assets
not yet available for use or with indefinite useful lives, are undertaken annually at the end of the reporting period. Other non-financial
assets are subject to impairment tests whenever events or changes in circumstances indicate that their carrying amount may not be recoverable.
Where the carrying value of an asset exceeds its recoverable amount (i.e. the higher of value in use and fair value less costs to sell),
the asset is written down accordingly.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Where it is not possible to estimate the recoverable
amount of an individual asset, the impairment test is carried out on the smallest group of assets to which it belongs for which there
are separately identifiable cash flows (its Cash Generating Unit or CGU). Goodwill is allocated on initial recognition to each of the
Group&#8217;s CGUs that are expected to benefit from a business combination that gives rise to the goodwill.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Impairment charges are included in profit or loss,
except to the extent they reverse gains previously recognized in other comprehensive income. An impairment loss recognized for goodwill
is not reversed.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Estimates</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Impairment testing of goodwill and intangible
assets not yet available for use or with indefinite useful lives, requires the use of significant assumptions for the estimation of future
cash flows and the determination of discount rates. The significant assumptions and the determination of discount rates for the impairment
testing of goodwill are further explained in Note 7.9 - Goodwill.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory', window );">Property, plant and equipment</a></td>
<td class="text"><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>4.7. <span style="text-decoration:underline">Property, plant and equipment</span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Property, plant and equipment items are initially
recognized at cost. In addition to the purchase price, cost also includes costs directly attributable to such property, plant and equipment
items. There are no unavoidable costs with respect to dismantling and removing items. The cost of property, plant and equipment items
acquired in a business combination is their fair value at the acquisition date.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Depreciation is calculated using the straight-line
method to allocate the property, plant or equipment items&#8217; cost or revalued amounts, net of their residual values, over their estimated
useful lives or, in the case of leasehold improvements and certain leased plant and equipment, the shorter lease term as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Research instruments: 3 to 10 years</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Office equipment: 5 to 10 years</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Vehicles: 5 years</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Computer equipment and software: 3 years</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Fixture and fittings: 10 years</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Machinery and equipment: 5 to 10 years</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Buildings: 50 years</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Useful lives and depreciation methods are reviewed
every year as required by IAS 16.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a result of the business combination completed
on <span style="font-weight: normal">June 16, 2025</span>, and the BIOX deconsolidation, the structure, scale and operations of the Group
changed significantly compared with the former reporting entity. The transaction resulted in a new combined entity whose asset base, operational
model and strategic focus differ materially from those of the pre-combination entity.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Given these changes, management re-assessed the
appropriateness of the accounting policy applied to property, plant and equipment. Prior to the business combination, the former entity
measured certain classes of property, plant and equipment under the <span style="font-weight: normal">revaluation model</span>. Following
the acquisition, and considering the characteristics of the combined business, management determined that the <span style="font-weight: normal">cost
model</span> provides more reliable and relevant information for users of the financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accordingly, beginning on <span style="font-weight: normal">June
16, 2025</span>, the Group <span style="font-weight: normal">discontinued the revaluation model</span> and now measures all property plant
and equipment at <span style="font-weight: normal">cost less accumulated depreciation and impairment losses</span>. The change has been
accounted for prospectively in accordance with applicable IFRS requirements, as it results from management&#8217;s reassessment of the
accounting policies of the newly formed reporting entity rather than from a voluntary change.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The carrying amounts of property, plant and equipment
previously measured under the revaluation model became their deemed cost at the date the new policy was adopted. No restatement of comparative
periods was required.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prior to The Bioceres Group Business Combination
Agreement and the BIOX deconsolidation, the assets under items Land and Buildings, were accounted for at fair value arising from the last
revaluation performed, applying the revaluation model indicated by IAS 16. Starting with the fiscal year ended on June&#160;30, 2024,
the Group modified its Property, Plant, and Equipment valuation policy by changing the revaluation frequency for items classified under
Buildings and Land. The revaluation must never exceed five years between each occurrence, in compliance with the maximum periods established
by accounting standards, or whenever there are indications that the carrying amount differs significantly from the amount that could be
determined using fair value at the end of the reporting year.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To obtain fair values, the existence or not of
an active market it was considered for the assets in their current status. For those assets for which an active market in their current
status existed, the fair values were determined based on their market values. For the remaining cases, the market values of comparable
new assets were analyzed, applying a discount based on the status and wear of each asset and considering the characteristics of each of
the revalued assets (for example, improvements made, maintenance status, level of productivity, use, etc.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Estimates</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group used to carry certain classes of property,
plant and equipment under the revaluation model under IAS 16. The revaluation model requires that the Group carry property, plant and
equipment at revalued amounts, being fair value at the date of revaluation less any subsequent accumulated depreciation and any subsequent
accumulated impairment losses. IAS 16 requires that the Group carry out these revaluations with sufficient regularity so that the carrying
amounts of its property, plant and equipment do not differ materially from that which would be determined using fair value at the end
of a reporting period. The determination of fair value at the date of revaluation requires judgments, estimates and assumptions based
on market conditions prevailing at the time of any such revaluation. Changes to any of the Group&#8217;s judgments, estimates or assumptions
or to the market conditions subsequent to a revaluation will result in changes to the fair value of property, plant and equipment.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group used to prepare the corresponding revaluations
on a regular basis taking into account the work of independent appraisers. The Group uses different valuation techniques depending on
the class of property being valued. Generally, the Group determines the fair value of its industrial buildings and warehouses based on
a depreciated replacement cost approach. The Group determines the fair value of its land based on active market prices adjusted, if necessary,
for differences in the nature, location or condition of the specific asset. If this information is not available, the Group may use alternative
valuation methods, such as recent prices in less active markets.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Property valuation is a significant area of estimation
uncertainty. Fair values used to be prepared regularly by Management, taking into account independent valuations. The determination of
fair value for the different classes of property, plant and equipment is sensitive to the selection of various significant assumptions
and estimates. Changes in those significant assumptions and estimates could materially affect the determination of the revalued amounts
of property, plant and equipment. The Group utilizes historical experience, market information and other internal information to determine
and/or review the appropriate revalued amounts.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following were the most significant assumptions
used in the preparation of the revalued amounts for its classes of property, plant and equipment:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">a)&#160;Land:
The Group generally used to use the market price of a square meter of land for the same or similar location as the most significant assumption
to determine the revalued amount. The Group typically used to use comparable land sales in the same location to assess appropriateness
of the value of its land.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">b)&#160;Industrial
buildings and warehouses: The Group generally used to determine the construction cost of a new asset and then the Group adjusts it for
normal wear and tear. Construction prices may include, but are not limited to, construction materials, labor costs, installation and assembly
costs, site preparation, professional fees and applicable taxes. Construction costs may differ significantly from year to year and are
subject to macroeconomic changes in the economy where the Group operates, such as the impact of inflation and foreign exchange rates.
The construction cost of its industrial buildings and warehouses is determined on a US dollar per constructed square meter basis, while
the construction cost of its mills, facilities and grain storage facilities is determined by reference to their total capacity measured
in tons milled or stored, respectively. A 5% increase or decrease in the construction costs or the estimate of normal wear and tear relating
to such assets could have an impact of $1.2 million on their revalued amounts.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory', window );">Leased assets</a></td>
<td class="text"><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>4.8. <span style="text-decoration:underline">Leased assets</span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Leases are recognized as a right-of-use asset
and corresponding liability at the date of which the leased asset is available for use by the Group. Each lease payment is allocated between
the liability and finance cost. The finance cost is charged to profit or loss over the lease period so as to produce a constant periodic
rate of interest on the remaining balance of the liability for each period. The right-of-use asset is depreciated over the shorter of
the asset&#8217;s useful life and the lease term on a straight-line basis.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In determining the lease term, the Company considers
all facts and circumstances that create an economic incentive to exercise an extension option or not exercise a termination option. Extension
options (or periods after termination options) are only included in the lease term if the lease is reasonably certain to be extended (or
not terminated).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Short term leases are recognized on a straight-line
basis as an expense in the income statement.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At initial recognition, the right-of-use asset
is measured considering the value of the initial measurement of the lease liability; any lease payments made at or before the commencement
date, less any lease incentives; and any initial direct costs incurred by the lessee. After initial recognition, the right-of-use assets
are measured at cost, less any accumulated depreciation and/or impairment losses, and adjusted for any re-measurement of the lease liability.
Depreciation of the right-of-use asset is calculated using the straight-line method over the estimated duration of the lease contract.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The lease liability is initially measured at the
present value of the lease payments that are not paid at such date, including variable lease payments that depend on an index or rate,
initially measured using the index or rate as of the commencement date; amounts expected to be payable by the lessee under residual value
guarantees; the exercise price of a purchase option if the lessee is reasonably certain to exercise that option; payments of penalties
for terminating the lease, if the lease term reflects the lessee exercising an option to terminate the lease; and fixed payments, less
any lease incentives receivable. After the commencement date, the Company measures the lease liability by increasing the carrying amount
to reflect interest on the lease liability; reducing the carrying amount to reflect lease payments made; and re-measuring the carrying
amount to reflect any reassessment or lease modifications.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The above-mentioned inputs for the valuation of
the right of use assets and lease liabilities including the determination of the contracts within the scope of the standard, the contract
term ant interest rate used in the discounted cash flow involved a management&#8217;s estimations.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory', window );">Intangible assets</a></td>
<td class="text"><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>4.9. <span style="text-decoration:underline">Intangible assets</span></b></p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>a) Externally acquired intangible assets</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Externally acquired intangible assets are initially
recognized at acquisition date fair value (which is considered as their cost). After initial recognition, those assets are measured at
cost less accumulated amortization and accumulated impairment losses.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Intangible assets acquired from third parties
have an estimated useful life as follows (in years):</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Software: 3 years</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Trademarks and patents: 5 years</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certification ISO Standards: 3 years</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Useful lives and amortization methods are reviewed
every year as required by IAS 38.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Estimates</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To value acquired intangible assets, valuation
techniques generally accepted in the market are applied, based mainly on the revenue approach (such as excess earnings, relief from royalty,
and with or without), considering the characteristics of the assets to be valued and available information to estimate their acquisition
date fair value. Application of these valuation techniques requires the use of several assumptions related to future cash flows and the
discount rate.</p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>b) Internally generated intangible assets (development costs)</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Expenditure on internally developed products is
capitalized if it can be demonstrated that:</p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">It is technically feasible to develop the product for it
to be sold;</td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">Adequate resources are available to complete the development;</td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">There is an intention to complete and sell the product;</td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">The Group is able to sell the product;</td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">Sale of the product will generate future economic benefits;
and</td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">Expenditure on the project can be measured reliably.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Development expenditure not satisfying the above
criteria and expenditure on the research phase of internal projects are recognized in the consolidated statement of profit or loss and
other comprehensive income as incurred (Note 8.3 - R&amp;D classified by nature).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Capitalized development costs are amortized using
the straight-line method over the periods the Group expects to benefit from selling the products developed (Note 7.8 &#8211; Intangible
assets).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Useful lives and amortization methods are reviewed
every year as required by IAS 38.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The research and development process can be divided
into several discrete steps or phases, which generally begin with discovery, validation and development and end with regulatory approval
and commercial launch. The process for developing seed traits is relatively similar for both GM and non-GM traits. However, the two differ
significantly in later phases of development. For example, obtaining regulatory approval for GM seeds is a far more comprehensive and
lengthy process than for non-GM seeds. Although breeding programs and industrial biotechnology solutions may have shorter or simpler phases
than those described below, the Group has used the industry consensus for seed-trait development phases to characterize its technology
portfolios, which is generally divided into the following six phases:</p><p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify">i) Discovery: The first phase in the technology
development process is the discovery or identification of candidate genes or genetic systems, metabolites, or microorganisms potentially
capable of enhancing specified plant characteristics or enabling an agro-industrial biotech solution.</p><p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify">ii) Proof of concept: Upon successful validation
of the technologies in model systems (<i>in vitro </i>or <i>in vivo</i>), promising technologies graduate from discovery and are advanced
to the proof of concept phase. The goal of this phase is to validate a technology within the targeted organism before moving forward with
technology escalation activities or extensive field validation.</p><p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify">iii) Early development: In this phase, field tests
commenced in the proof of concept phase are expanded to evaluate various permutations of a technology in multiple geographies and growing
cycles, as well as other characteristics in order to optimize the technology&#8217;s performance in the targeted organisms. The goal of
the early development phase is to identify the best mode of use of a technology to define its performance concept.</p><p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify">iv) Advanced development and deregulation: In
this phase, extensive field tests are used to demonstrate the effectiveness of the technology for its intended purpose. In the case of
GM traits, the process of obtaining regulatory approvals from government authorities is also initiated during this phase, and tests are
performed to evaluate the potential environmental impact of modified plants. For solutions involving microbial fermentation, industrial-scale
runs are conducted.</p><p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify">v) Pre-launch: This phase involves finalizing
the regulatory approval process and preparing for the launch and commercialization of the technology. The range of activities in this
phase includes seed increases, pre-commercial production, and product and solution testing with selected customers. Usually, a more detailed
marketing strategy and preparation of marketing materials occur during this phase.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: 0pt; text-align: justify">vi) Product launch: In general, this phase, which
is the last milestone of the research and development process, is carried out by the Group, the joint ventures and/or the Group&#8217;s
technology licensees. When technology is commercialized through the joint ventures or technology licensees, a successful product launch
will trigger royalty payments to the Group, which are generally calculated as a percentage of the net sales realized by the technology
and captured upon commercialization.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Demonstrability of technical feasibility generally
occurs when the project reaches the &#8220;advanced development and deregulation&#8221; phase because at this stage success is considered
to be probable.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>c)&#160;Intangible
assets acquired in a business combination</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Intangible assets acquired in a business combination
and recognized separately from goodwill are initially recognized at acquisition date fair value (which is considered as their cost). After
initial recognition, those assets are measured at cost less accumulated amortization and accumulated impairment losses in the same manner
as intangible assets acquired separately.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Intangible assets acquired in a business combination
have an estimated useful life as follows (in years):</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Product development: 20 &#8211; 25 years</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Trademarks: 20 years</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Customer loyalty: 14 - 26 years</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Estimates</i></p>To value intangible assets acquired from a business
combination, valuation techniques generally accepted in the market were applied, based mainly on the revenue approach (such as excess
earnings, relief from royalty, and with or without), considering the characteristics of the assets to be valued and available information
to estimate their acquisition date fair value.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForInvestmentPropertyExplanatory', window );">Investment properties</a></td>
<td class="text"><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>4.10. <span style="text-decoration:underline">Investment properties</span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Investment properties shall be measured initially
at its cost. The cost of a purchased investment property comprises its purchase price and any directly attributable expenditure. Directly
attributable expenditure includes, for example, professional fees for legal services, property transfer taxes and other transaction costs.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the measurement after initial recognition,
the Group has chosen the cost model for all investment properties.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory', window );">Borrowings</a></td>
<td class="text"><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>4.11. <span style="text-decoration:underline">Borrowings</span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group measures its borrowings at initial recognition
at fair value and, subsequently, are measured at amortized cost using the effective interest rate method.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Borrowing costs, either generic or specific, attributable
to the acquisition, construction or production of assets that necessarily take a substantial period of time to get ready for their intended
use or sale (qualifying assets) are included in the cost of the assets until the moment that they are substantially ready for use or sale.
Income earned on the temporary investments of funds generated in specific borrowings still pending use in the qualifying assets, are deducted
from the total of financing costs potentially eligible for capitalization.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All other loan costs are recognized under financial
costs, through profit and loss.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DescriptionOfAccountingPolicyForConvertibleNotesTextBlock', window );">Convertibles notes</a></td>
<td class="text"><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>4.12. <span style="text-decoration:underline">Convertibles notes</span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial liabilities, like convertible notes
that do not meet the &#8220;fixed for fixed&#8221; condition, are classified at their inception at fair value through profit or loss or
at amortized cost, using the effective interest amortization method.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory', window );">Employee benefits</a></td>
<td class="text"><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>4.13. <span style="text-decoration:underline">Employee benefits</span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Employee benefits are expected to be settled wholly
within 12 months after the end of the reporting period and are presented as current liabilities.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accounting policies related to incentive payments
based on shares, if any, are detailed in Note 19 &#8211; Share-based payments.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory', window );">Provisions</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>4.14.&#160;<span style="text-decoration:underline">Provisions</span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group has recognized provisions for liabilities
of uncertain timing or amount. The provision is measured at the best estimate of the expenditure required to settle the obligation at
the end of the reporting period, discounted at a pre-tax rate reflecting current market assessments of the time value of money and risks
specific to the liability.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DescriptionOfAccountingPolicyForWarrantLiabilities', window );">Warrant liabilities</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>4.15.&#160;<span style="text-decoration:underline">Warrant
liabilities </span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As part of the business combination, the Group
acquired public warrants and private warrants.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Public Warrants: These instruments are initially
recognized at fair value on the date the derivative contract is entered into and are subsequently remeasured to fair value at the end
of each reporting period. Gains and losses arising from changes in fair value are recognized in profit or loss.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These warrants are measured at Level 1 fair value,
based on their quoted market price.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Private Warrants: These instruments are measured
at fair value using valuation techniques, including the Black-Scholes model.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These warrants are classified as Level 3 fair
value measurements, as they rely on significant unobservable inputs.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue', window );">Revenue recognition</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>4.16.&#160;<span style="text-decoration:underline">Revenue
recognition</span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Revenue is recognized when control has been transferred
to the buyer. Transfers of control vary depending on the individual terms of the sales contract. Revenues are recognized when control
of the products has been transferred, which generally means that the products have been delivered to the customer and there is no unfulfilled
obligation that could affect a customer&#8217;s acceptance of the products. Generally, acceptance occurs upon shipment or delivery but
ultimately depends on the terms of the underlying contracts. The customer is then invoiced at the agreed-upon price with the usual payment
terms for each geographical region. Those payment terms do not contain a significant financing component.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The timing of performance sometimes differs from
the timing that the associated consideration is received from the customer, thus resulting in the recognition of a contract asset or contract
liability. The Company recognizes a contract liability if the customer&#8217;s payment of consideration is received prior to completion
of the related performance obligation.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a part of the Company&#8217;s customary business
practices, the Company offers a number of sales incentives to the customers, including volume discounts, retailer incentives, prepayment
options and other product rebates. For all such contracts that include any variable consideration, the Company estimates the amount of
variable consideration that should be included in the transaction price utilizing either the expected value method or the most likely
amount method, depending on the nature of the variable consideration. Variable consideration is included in the transaction price if,
in the judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur. Although determining
the transaction price for consideration requires significant judgment, the Company has meaningful historical experience with incentives
provided to customers and estimate the expected consideration in view of historical patterns of incentive payouts. These estimates are
reassessed each reporting period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company also offer an assurance warranty,
which gives customers a refund or exchange right in the case the delivered product does not conform to specifications. Replacement products
are accounted for under the warranty guidance if the customer exchanges one product for another of the same type, quality, and price.
The Company has significant experience with historical return patterns and use this experience to include returns in the estimate of transaction
price.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With respect to services, the Company mainly provides
R&amp;D and seed treatment services. Revenue associated with services is recognized by reference to the stage of completion of the transaction
at the end of the reporting period. Each of the services to be provided has a detailed work plan in which all activities to be rendered
are listed. The stage of completion for services is determined in accordance with the execution of the performed tasks listed in the respective
work plan. The level of execution of such services is provided by the Company&#8217;s technical experts, who provide information relating
to the transfer of goods or services. The Company has no material revenue for services that cannot be reliably estimated.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Revenue for usage-based royalties relating to
licensed intellectual property rights is recognized at the later of when the performance obligation is satisfied and when a sale or use
occurs.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Typically, the Company&#8217;s average payment
terms range from 130 to 160 days at a consolidated level. Longer terms may be granted in limited circumstances; however, the effects of
such sales are not material to the consolidated financial statements. Those payment terms do not contain a significant financing component.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants', window );">Government grants</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>4.17.&#160;<span style="text-decoration:underline">Government
grants</span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Government grants are recognized where there is
reasonable assurance that the grant will be received and all attached conditions will be complied with. When the grant relates to an expense
item, it is recognized as income on a systematic basis over the periods that the related costs, for which it is intended to compensate,
are expensed. When the grant relates to an asset, it is recognized as income in equal amounts over the expected useful life of the related
asset. Management elected this accounting policy because the Group determined it better shows the financial effect of government grants
in the consolidated financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When the Group receives grants of non-monetary
assets, the asset and the grant are recorded at nominal amounts and released to profit or loss over the expected useful life of the asset.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The difference between the money obtained under
government loans at subsidized rates and the carrying amount of those loans is treated as a government grant, in accordance with IAS 20.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory', window );">Income tax</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>4.18.&#160;<span style="text-decoration:underline">Income
tax</span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Income tax expense comprises current and deferred
tax. It is recognized in profit or loss except to the extent that it relates to a business combination, or items recognized directly in
equity or in OCI.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group has determined that interest and penalties
related to income taxes, including uncertain tax treatments, do not meet the definition of income taxes, and therefore accounted for them
under IAS 37 <i>Provisions, Contingent Liabilities and Contingent Assets.</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group has determined that the global minimum
top-up tax &#8211; which it is required to pay under Pillar Two legislation &#8211; is an income tax in the scope of IAS 12. Pillar Two
legislation is not applicable to Moolec Science SA in accordance with current thresholds.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Current tax</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Current tax comprises the expected tax payable
or receivable on the taxable income or loss for the year and any adjustment to the tax payable or receivable in respect of previous years.
The amount of current tax payable or receivable is the best estimate of the tax amount expected to be paid or received that reflects uncertainty
related to income taxes, if any. It is measured using tax rates enacted or substantively enacted at the reporting date. Current tax also
includes any tax arising from dividends.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Current tax assets and liabilities are offset
only if certain criteria are met.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Deferred tax</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Deferred tax assets and liabilities are recognized
where the carrying amount of an asset or liability in the Consolidated statement of financial position differs from its tax base, except
for differences arising on:</p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">The initial recognition of goodwill;</td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">The initial recognition of an asset or liability in a transaction
which is not a business combination and at the time of the transaction affects neither accounting or taxable profit; and</td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">Investments in subsidiaries and jointly controlled entities
where the Group is able to control the timing of the reversal of the difference and it is probable that the difference will not reverse
in the foreseeable future.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Recognition of deferred tax assets is restricted
to those instances where it is probable that taxable profit will be available against which the difference can be utilized.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The amount of the asset or liability is determined
using tax rates that have been enacted or substantively enacted by the end of the reporting period and are expected to apply when the
deferred tax liabilities / (assets) are settled / (recovered).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Deferred tax assets and liabilities are offset
when the Group has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities
relate to taxes levied by the same tax authority on either:</p><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">The same taxable entity within the Group, or</td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">Different entities within the Group which intend either to
settle current tax assets and liabilities on a net basis, or to realize the assets and settle the liabilities simultaneously, in each
future period in which significant amounts of deferred tax assets or liabilities are expected to be settled or recovered.</td>
</tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory', window );">Share-based payments</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>4.19.&#160;<span style="text-decoration:underline">Share-based
payments</span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prior to the Business Combination and the BIOX
deconsolidation, certain executives and directors of the Group were granted incentives in the form of shares and options to purchase shares
as consideration for services.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The cost of these share-based transactions is
determined based on their fair value at the date upon which such incentives are granted using a valuation model that is appropriate in
the circumstances.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This cost is recognized as an expense together
with an increase in equity throughout the period in which the service or performance conditions are satisfied (i.e., the vesting period).
The accumulated expense recorded in connection with these transactions at the end of each year until the vesting date reflects the time
elapsed between the vesting period and Management&#8217;s best estimate of the number of equity instruments that will vest. The charge
to income/loss for the period represents the variation in the accumulated expense recorded between the beginning and the end of the year.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Non-market related service and performance conditions
are not taken into account when determining the grant date fair value of the equity instruments, but the probability that the conditions
are fulfilled is assessed as part of Management&#8217;s best estimate of the number of equity instruments that will vest. Market-related
performance conditions are reflected in the grant date fair value. Any other conditions related to equity-settled share-based payment
transactions but without a service requirement are considered as non-vesting conditions. Non-vesting conditions are reflected in the fair
value of the equity instruments and are charged to income/loss immediately unless there are service and/or performance conditions as well.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No amount is recognized for transactions that
will not vest because non-market related performance conditions and/or service conditions were not satisfied. When transactions include
market-related conditions or non-vesting conditions, the transactions are considered to be vested, irrespective of whether a market-related
condition or the non-vesting condition is satisfied, provided that all the other performance and/or service conditions are met.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When the terms and conditions of an equity-settled
share-based payment transaction are modified, the minimum expense recognized is the grant date fair value, unmodified, provided that the
original terms have been complied with. An additional expense, measured at the date of modification, is recognized for any modification
that increases the total fair value of the share-based payment transaction, or is otherwise beneficial to the employee.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When the transaction is settled by the Group or
by the counterparty, any remainder of the fair value is charged to income immediately.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The dilutive effect of current options is considered
in the calculation of the diluted earnings per share.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Estimates</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The estimate of the fair value of equity-settled share-based payment
transactions requires a determination to be made of the most adequate option pricing model to apply depending on the terms and conditions
of the arrangement. This estimate also requires a determination of those factors most appropriate to the pricing model, including the
expected life of the option and the expected volatility of the share price upon the basis of which assumptions are made. The Group measures
the fair value of these transactions at the grant date applying the Black-Scholes formula adjusted to consider the possible dilutive effect
of the future exercise of the share options granted on their estimated fair value at grant date, as established in paragraph B41 of IFRS
2. The assumptions used for the estimate of the fair value of these transactions are disclosed in Note 19 &#8211; Share-based payment
and will not necessarily take place in the future.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of June 30, 2025 no equity awards are outstanding.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for biological assets. [Refer: Biological assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for employee benefits. Employee benefits are all forms of consideration given by an entity in exchange for services rendered by employees or for the termination of employment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for government grants, including the methods of presentation adopted in the financial statements. [Refer: Government [member]; Government grants]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 20<br> -IssueDate 2025-01-01<br> -Paragraph 39<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=20&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_39_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 216<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_216_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 216<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_216_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for the impairment of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for intangible assets and goodwill. [Refer: Intangible assets and goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForInvestmentPropertyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for investment property. [Refer: Investment property]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForInvestmentPropertyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for measuring inventories. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 36<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_36_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 164<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_164_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 164<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_164_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for provisions. [Refer: Provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Types of share-based payment arrangements [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy used to determine the components of cash and cash equivalents. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 46<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_46&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 170<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_170&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 170<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_170&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of accounting policy for basis of consolidation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DescriptionOfAccountingPolicyForConvertibleNotesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for convertible notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DescriptionOfAccountingPolicyForConvertibleNotesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DescriptionOfAccountingPolicyForFinancialAssetsAndLiabilitiesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for financial assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DescriptionOfAccountingPolicyForFinancialAssetsAndLiabilitiesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DescriptionOfAccountingPolicyForWarrantLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of accounting policy for warrant liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DescriptionOfAccountingPolicyForWarrantLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting Standards and Basis of Preparation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AccountingStandardsAndBasiofPreparationAbstract', window );"><strong>Accounting Standards and Basis of Preparation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory', window );">Schedule of Information related to Company&#8217;s Share of Voting Rights in its Subsidiaries</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The subsidiaries of the Group, all of which have
been included in the consolidated financial statements of the Group, are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: left"><b>Name</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td> <td style="text-align: center; border-bottom: Black 1.5pt solid"><b>Principal activities</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td> <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><b>Country of <br/>incorporation and <br/>principal place of <br/>business</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td> <td style="text-align: center; border-bottom: Black 1.5pt solid"><b>Ref</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>% Equity <br/>interest <br/>06/30/2025</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>% Equity <br/>interest <br/>06/30/2024</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; width: 20%; text-align: left">Moolec Science Limited</td><td style="width: 1%">&#160;</td> <td style="width: 38%; text-align: left">Investment in subsidiaries</td><td style="width: 1%">&#160;</td> <td style="vertical-align: top; width: 15%; text-align: center">United Kingdom</td><td style="width: 1%">&#160;</td> <td style="width: 6%; text-align: center">b)</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">100</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-171">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-align: left">AG Biomolecules LLC</td><td>&#160;</td> <td style="text-align: left">Production and commercialization of agricultural products</td><td>&#160;</td> <td style="vertical-align: top; text-align: center">United States</td><td>&#160;</td> <td style="text-align: center">b)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-172">-</div></td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left">ValoraSoy S.A.</td><td>&#160;</td> <td style="text-align: left">Production and commercialization of agricultural products</td><td>&#160;</td> <td style="vertical-align: top; text-align: center">Argentina</td><td>&#160;</td> <td style="text-align: center">b)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-173">-</div></td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-align: left">Nutrecon LLC</td><td>&#160;</td> <td style="text-align: left">Investment in subsidiaries</td><td>&#160;</td> <td style="vertical-align: top; text-align: center">United States</td><td>&#160;</td> <td style="text-align: center">b)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-174">-</div></td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left">SynBio Powerlabs</td><td>&#160;</td> <td style="text-align: left">Production and commercialization of fermentation products</td><td>&#160;</td> <td style="vertical-align: top; text-align: center">Finland</td><td>&#160;</td> <td style="text-align: center">d)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">90</td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-175">-</div></td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-align: left">Gentle Tech</td><td>&#160;</td> <td style="vertical-align: top; text-align: left">Investment in subsidiaries</td><td>&#160;</td> <td style="vertical-align: top; text-align: center">British Virgin Islands</td><td>&#160;</td> <td style="text-align: center">a),b)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">50</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left">Gentle Farming</td><td>&#160;</td> <td style="vertical-align: top; text-align: left">Investment in subsidiaries</td><td>&#160;</td> <td style="vertical-align: top; text-align: center">British Virgin Islands</td><td>&#160;</td> <td style="text-align: center">a),b)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">51</td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">51</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; vertical-align: top">G-FAS</td><td>&#160;</td> <td style="text-align: left">Production and commercialization of sustainable agricultural equipment</td><td>&#160;</td> <td style="vertical-align: top; text-align: center">Argentina</td><td>&#160;</td> <td style="text-align: center">a),b)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">64</td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">64</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left">Bioceres Group Limited</td><td>&#160;</td> <td style="text-align: left">Investment in subsidiaries</td><td>&#160;</td> <td style="vertical-align: top; text-align: center">United Kingdom</td><td>&#160;</td> <td style="text-align: center">b)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Bioceres Crop Solutions (BIOX)</td><td>&#160;</td> <td style="vertical-align: top; text-align: left">Research and development</td><td>&#160;</td> <td style="vertical-align: top; text-align: center">United States</td><td>&#160;</td> <td style="text-align: center">c)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">29.30</td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">28.75</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left">Bioceres LLC</td><td>&#160;</td> <td style="text-align: left">Investment in subsidiaries</td><td>&#160;</td> <td style="vertical-align: top; text-align: center">United States</td><td>&#160;</td> <td style="text-align: center">a)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-align: left">Bioceres S.A.</td><td>&#160;</td> <td style="text-align: left">Investment in subsidiaries</td><td>&#160;</td> <td style="vertical-align: top; text-align: center">Argentina</td><td>&#160;</td> <td style="text-align: center">a)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">89.93</td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">79.72</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left">Bioceres Tech Services LLC</td><td>&#160;</td> <td style="vertical-align: top; text-align: left">Investment in subsidiaries</td><td>&#160;</td> <td style="vertical-align: top; text-align: center">United States</td><td>&#160;</td> <td style="text-align: center">a)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr> </table><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> a)&#160;Direct interests held by Bioceres Group Limited.</p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">b)&#160;Direct
interest held by Moolec Science SA.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">c)&#160;Since
2023, the Group exercises &#8220;de facto control&#8221; over Bioceres Crop Solutions Corp, however, as stated in note Note 1 &#8211;
The Group&#8217;s business reorganization and general information - &#8220;<i>The Bioceres Group Business Combination Agreement&#8221;</i>,
Bioceres Group Limited lost the &#8220;de facto control&#8221; on June 24, 2025. The subsidiary was deconsolidated as of June 30, 2025,
and the investment in it was measured using the equity method. The Group&#8217;s consolidated result includes the results of that entity
up to the date of its deconsolidation. No results related to the loss of control have been recognized. Various notes to the financial
statements show the effect it has had on consolidated assets and liabilities, business segments and CGUs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">d)&#160;Direct
interest held by Nutrecon LLC.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of interests in subsidiaries. [Refer: Total for all subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 2<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_2_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_AccountingStandardsAndBasiofPreparationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_AccountingStandardsAndBasiofPreparationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Other Significant Transactions (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsAbstract', window );"><strong>Acquisitions and Other Significant Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfFairValueOfConsiderationOfPaymentTableTextBlock', window );">Schedule of Fair Value of the Consideration of Payment</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Fair value of the consideration of payment</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%">Equity shares</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">33,504,531</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Warrants</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,030,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total consideration</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">34,534,531</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Fair value of the consideration of payment</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; width: 88%; text-align: left">Cash payment</td><td style="padding: 0pt; width: 1%">&#160;</td>
    <td style="padding: 0pt; width: 1%; text-align: left">&#160;</td><td style="padding: 0pt; width: 9%; text-align: right">215,415</td><td style="padding: 0pt; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding: 0pt; text-align: left">Regulatory activities</td><td style="padding: 0pt">&#160;</td>
    <td style="padding: 0pt; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="padding: 0pt; border-bottom: Black 1.5pt solid; text-align: right">727,985</td><td style="padding: 0pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; font-weight: bold; text-align: left">Total consideration</td><td style="padding: 0pt; font-weight: bold">&#160;</td>
    <td style="padding: 0pt; border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="padding: 0pt; border-bottom: Black 4pt double; font-weight: bold; text-align: right">943,400</td><td style="padding: 0pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory', window );">Schedule of Fair Value of the Consideration of Payment</a></td>
<td class="text"><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;Assets acquired, liabilities assumed, and non-controlling interest
recognized</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-style: normal; border-bottom: Black 1.5pt solid; font-weight: normal; text-align: left"><b>Net assets incorporated</b></td><td style="font-weight: bold; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><b>Total</b></td><td style="padding-bottom: 1.5pt; font-weight: bold"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: normal; width: 88%; font-weight: normal; text-align: justify">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">554,420</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-style: normal; font-weight: normal; text-align: justify">Trade and other receivables</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,036,558</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: normal; font-weight: normal; text-align: justify">Property, plant and equipment</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,319,313</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-style: normal; font-weight: normal; text-align: justify">Intangible assets</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">74,841,933</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: normal; font-weight: normal; text-align: justify">Right of use assets</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">100,896</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-style: normal; font-weight: normal; text-align: justify">Inventories</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,235,482</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: normal; font-weight: normal; text-align: justify">Borrowings / Financial debt</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(19,608,629</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-style: normal; font-weight: normal; text-align: justify">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(5,806,020</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: normal; font-weight: normal; text-align: justify">Lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(117,463</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-style: normal; font-weight: normal; text-align: justify">Warrant liabilities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(181,093</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: normal; padding-bottom: 1.5pt; font-weight: normal; text-align: justify">Deferred tax liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(15,767,275</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-style: normal; font-weight: normal; text-align: justify">Total net assets identified</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">43,608,122</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: normal; font-weight: normal; text-align: justify">Non-controlling interest</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">6,316,790</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-style: normal; font-weight: normal; text-align: left">Previously held interest - revalued at FV</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,283,319</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: normal; padding-bottom: 1.5pt; font-weight: normal; text-align: justify">Gain on purchase</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,473,482</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-style: normal; padding-bottom: 2.5pt; font-weight: normal; text-align: justify"><b>Total consideration</b></td><td style="padding-bottom: 2.5pt; font-weight: bold"><b>&#160;</b></td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"><b>$</b></td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><b>34,534,531</b></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><b>&#160;</b></td></tr>
  </table><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left; padding-left: 0pt">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">252,923</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Other financial assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">73,950</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Trade receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">596,463</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Other receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">288,861</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Income and minimum presumed recoverable income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19,998</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Inventories</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,031,412</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Property, plant and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">816,576</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Intangible assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,217,985</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Right of use asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">168,988</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Trade and other payables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,302,332</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">Borrowings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(743,279</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Employee benefits and social security</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(23,346</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Deferred revenue and advances from customers</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,515</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Provisions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(355,898</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(168,988</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Deferred tax liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(996,824</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 0pt">Total net assets identified</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">3,873,974</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-left: 0pt">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Non-controlling interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,898,247</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 0pt">Gain from a bargain purchase</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,032,327</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Total consideration</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">943,400</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about business combinations. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2025-01-01<br> -Section Disclosures application of paragraphs 59 and 61<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2025-en-r&amp;doctype=Appendix&amp;subtype=B&amp;dita_xref=IFRS03_gB64-B67_TI<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ScheduleOfFairValueOfConsiderationOfPaymentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about the fair value of the consideration of payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ScheduleOfFairValueOfConsiderationOfPaymentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Information About Components of Consolidated Statements of Financial Position (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract', window );"><strong>Information About Components of Consolidated Statements of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory', window );">Schedule of Cash and Cash Equivalents</a></td>
<td class="text"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>06/30/2025</b></span></td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>06/30/2024</b></span></td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0pt">Cash at bank and on hand</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">767,919</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">27,210,070</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Mutual funds</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-176">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">25,784,795</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">767,919</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">52,994,865</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DisclosureOfOtherFinancialAssetsExplanatory', window );">Schedule of Other Financial Assets</a></td>
<td class="text"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 1.5pt">&#160;</td><td style="padding: 0pt 0pt 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-top: 0pt; text-align: center; padding-right: 0pt; padding-left: 0pt"><span style="font-size: 10pt"><b>06/30/2025</b></span></td><td style="padding: 0pt 0pt 1.5pt">&#160;</td><td style="padding: 0pt 0pt 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; padding-top: 0pt; font-weight: bold; text-align: center; padding-right: 0pt; padding-left: 0pt"><span style="font-size: 10pt"><b>06/30/2024</b></span></td><td style="padding: 0pt 0pt 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-top: 0pt; font-weight: bold; padding-right: 0pt; padding-left: 0pt">Current</td><td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt">&#160;</td>
    <td colspan="2" style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt">&#160;</td>
    <td colspan="2" style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0pt; width: 76%; text-align: left; padding-left: 0pt; padding-right: 0pt">Investments at fair value</td><td style="padding-top: 0pt; width: 1%; padding-right: 0pt; padding-left: 0pt">&#160;</td>
    <td style="padding-top: 0pt; width: 1%; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; width: 9%; text-align: right; padding-right: 0pt; padding-left: 0pt">19,722</td><td style="padding-top: 0pt; width: 1%; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; width: 1%; padding-right: 0pt; padding-left: 0pt">&#160;</td>
    <td style="padding-top: 0pt; width: 1%; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; width: 9%; text-align: right; padding-right: 0pt; padding-left: 0pt">2,191,286</td><td style="padding-top: 0pt; width: 1%; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-top: 0pt; text-align: left; padding-left: 0pt; padding-right: 0pt">Mutual funds</td><td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt">&#160;</td>
    <td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; text-align: right; padding-right: 0pt; padding-left: 0pt"><div style="-sec-ix-hidden: hidden-fact-177">-</div></td><td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt">&#160;</td>
    <td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; text-align: right; padding-right: 0pt; padding-left: 0pt">6,658,805</td><td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 1.5pt; text-align: left">Other investments</td><td style="padding: 0pt 0pt 1.5pt">&#160;</td>
    <td style="padding-top: 0pt; border-bottom: Black 1.5pt solid; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; border-bottom: Black 1.5pt solid; text-align: right; padding-right: 0pt; padding-left: 0pt">8,234,539</td><td style="padding: 0pt 0pt 1.5pt; text-align: left">&#160;</td><td style="padding: 0pt 0pt 1.5pt">&#160;</td>
    <td style="padding-top: 0pt; border-bottom: Black 1.5pt solid; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; border-bottom: Black 1.5pt solid; text-align: right; padding-right: 0pt; padding-left: 0pt">5,817,516</td><td style="padding: 0pt 0pt 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding: 0pt 0pt 4pt">&#160;</td><td style="padding: 0pt 0pt 4pt">&#160;</td>
    <td style="padding-top: 0pt; border-bottom: Black 4pt double; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; border-bottom: Black 4pt double; text-align: right; padding-right: 0pt; padding-left: 0pt">8,254,261</td><td style="padding: 0pt 0pt 4pt; text-align: left">&#160;</td><td style="padding: 0pt 0pt 4pt">&#160;</td>
    <td style="padding-top: 0pt; border-bottom: Black 4pt double; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; border-bottom: Black 4pt double; text-align: right; padding-right: 0pt; padding-left: 0pt">14,667,607</td><td style="padding: 0pt 0pt 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0pt; padding-left: 0pt; padding-right: 0pt">&#160;</td><td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt">&#160;</td>
    <td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; text-align: right; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt">&#160;</td>
    <td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; text-align: right; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-top: 0pt; font-weight: bold; padding-left: 0pt; padding-right: 0pt">Non-current</td><td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt">&#160;</td>
    <td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; text-align: right; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt">&#160;</td>
    <td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; text-align: right; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0pt; text-align: left; padding-left: 0pt; padding-right: 0pt">Mutual funds</td><td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt">&#160;</td>
    <td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; text-align: right; padding-right: 0pt; padding-left: 0pt"><div style="-sec-ix-hidden: hidden-fact-178">-</div></td><td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt">&#160;</td>
    <td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; text-align: right; padding-right: 0pt; padding-left: 0pt">190,080</td><td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding: 0pt 0pt 1.5pt; text-align: left">Investments at fair value</td><td style="padding: 0pt 0pt 1.5pt">&#160;</td>
    <td style="padding-top: 0pt; border-bottom: Black 1.5pt solid; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; border-bottom: Black 1.5pt solid; text-align: right; padding-right: 0pt; padding-left: 0pt"><div style="-sec-ix-hidden: hidden-fact-179">-</div></td><td style="padding: 0pt 0pt 1.5pt; text-align: left">&#160;</td><td style="padding: 0pt 0pt 1.5pt">&#160;</td>
    <td style="padding-top: 0pt; border-bottom: Black 1.5pt solid; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; border-bottom: Black 1.5pt solid; text-align: right; padding-right: 0pt; padding-left: 0pt">437</td><td style="padding: 0pt 0pt 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 4pt">&#160;</td><td style="padding: 0pt 0pt 4pt">&#160;</td>
    <td style="padding-top: 0pt; border-bottom: Black 4pt double; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; border-bottom: Black 4pt double; text-align: right; padding-right: 0pt; padding-left: 0pt"><div style="-sec-ix-hidden: hidden-fact-180">-</div></td><td style="padding: 0pt 0pt 4pt; text-align: left">&#160;</td><td style="padding: 0pt 0pt 4pt">&#160;</td>
    <td style="padding-top: 0pt; border-bottom: Black 4pt double; text-align: left; padding-right: 0pt; padding-left: 0pt">&#160;</td><td style="padding-top: 0pt; border-bottom: Black 4pt double; text-align: right; padding-right: 0pt; padding-left: 0pt">190,517</td><td style="padding: 0pt 0pt 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DisclosureOfTradeReceivablesTableTextBlock', window );">Schedule of Trade Receivables</a></td>
<td class="text"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt"><b>06/30/2025</b></span></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Current</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0pt">Trade debtors</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">4,519,487</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">205,490,518</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Allowance for impairment of trade debtors (Note 7.16)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-181">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(7,050,280</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Shareholders and other related parties (Note 17)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-182">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">37</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; padding-left: 0pt">Allowance for credit notes to be issued</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-183">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,905,624</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Trade debtors - Joint ventures and associates (Note 13)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,565,913</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,176,622</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Deferred checks</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-184">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,295,922</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">6,085,400</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">209,007,195</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DisclosureOfOtherReceivablesTableTextBlock', window );">Schedule of Other Receivables</a></td>
<td class="text"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt"><b>06/30/2024</b></span></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Current</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; padding-left: 0pt">Taxes</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">382,957</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">5,475,685</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Insurance to be accrued</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,835</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,595,319</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Other receivables - Joint ventures and associates (Note 13)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,547,409</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,162,870</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Prepayments to suppliers</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">114</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,236,905</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Shareholders and other related parties (Note 17)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,313,179</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">47,348</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Government grants receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-185">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">608</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Prepaid expenses and other receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33,448</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,736,808</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Loans receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-186">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,800,572</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 0pt">Miscellaneous</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">560,222</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,601,268</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">13,849,164</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">34,657,383</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right; padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-left: 0pt">Non-current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">Taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-187">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">752,045</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Other receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-188">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">230,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Reimbursements over exports</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-189">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,461,042</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Other receivables - Joint ventures and associates (Note 13)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">664,493</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,423,142</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 0pt">Miscellaneous</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-190">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">20,805</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">664,493</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">27,887,034</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInventoriesExplanatory', window );">Schedule of Inventories</a></td>
<td class="text"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt"></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>06/30/2025</b></span></td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>06/30/2024</b></span></td><td style="text-align: center; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; padding-left: 0pt">Seeds</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">551,290</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">5,967,231</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Resale products</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-191">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">53,788,333</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Manufactured products</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">994,360</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26,081,250</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Goods in transit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-192">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,618,540</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">Supplies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-193">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,546,093</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Agricultural products</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">689,832</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,015,884</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Allowance for obsolescence (Note 7.16)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-194">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,087,563</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">2,235,482</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">125,929,768</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Net of agricultural products</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">1,545,650</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">110,913,884</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory', window );">Schedule of Changes in Biological Assets</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Changes in Biological assets:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Soybean</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Corn</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Wheat</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Barley</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Sunflower</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left; padding-left: 0pt">Beginning of the year</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-195">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-196">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">220,682</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">73,452</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-197">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right">294,134</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Initial recognition and changes in the fair value of biological assets at the point of harvest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">593,001</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">435,725</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">579,313</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">158,080</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,256</td><td style="text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">1,764,863</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Costs incurred during the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,959,381</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,814,249</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">444,303</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">162,342</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">55,063</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">4,435,338</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Decrease due to harvest/disposals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,275,688</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,148,288</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,244,298</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(393,874</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(53,807</td><td style="text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(4,115,955</td><td style="font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 0pt">Loss of control</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,276,694</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,101,686</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-198">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-199">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-200">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(2,378,380</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 0pt">Year ended June 30, 2025</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-201">-</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-202">-</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-203">-</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-204">-</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-205">-</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-206">-</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Soybean</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Corn</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Wheat</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Barley</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Sunflower</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left; padding-left: 0pt">Beginning of the year</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-207">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-208">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">87,785</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">59,057</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-209">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right">146,842</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Initial recognition and changes in the fair value of biological assets at the point of harvest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(352,199</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(32,674</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">231,526</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">106,605</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">996</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(45,746</td><td style="font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Costs incurred during the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,423,732</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">792,235</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">220,679</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">73,452</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">137,680</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">2,647,778</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Decrease due to harvest/disposals</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,071,533</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(759,561</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(319,308</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(165,662</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(138,676</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(2,454,740</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 0pt">Year ended June 30, 2024</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-210">-</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-211">-</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">220,682</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">73,452</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-212">-</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">294,134</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory', window );">Schedule of Property, Plant and Equipment</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Property, plant and equipment as of June 30, 2025 and 2024, included
the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid"><b>Class</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Net carrying amount 06/30/2024</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Additions</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Reclassification<br/>
within PPE</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Disposals</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Depreciation of the year</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Foreign currency translation</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Loss of control</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Business combination</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Net&#160;carrying<br/>
amount<br/>
06/30/2025</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: 0pt; padding-left: 0pt; width: 19%">Office&#160;equipment</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">503,950</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">39,611</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-213">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">(4,791</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">(82,495</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">3,947</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">(449,942</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-214">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">10,280</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: 0pt; padding-left: 0pt">Vehicles</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,192,627</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35,915</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-215">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(17,239</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(882,264</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,330,062</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-216">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-217">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Equipment and computer software</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">528,816</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">75,297</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-218">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(323</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(273,912</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,012</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(331,763</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-219">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,127</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Fixtures and fittings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,805,076</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,084</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">225,338</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(6,789</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(860,822</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,350</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,178,237</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-220">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-221">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Machinery and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,722,642</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">563,352</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">122,653</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(143,947</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,895,031</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">81,204</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(14,449,423</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-222">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,450</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Land and buildings</td><td>&#160;</td>
    <td style="text-align: left"></td><td style="text-align: right">39,745,067</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-223">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"></td><td style="text-align: right">348,085</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-224">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"></td><td style="text-align: right">(1,021,176</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left"></td><td style="text-align: right">71,315</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"></td><td style="text-align: right">(39,143,291</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left"></td><td style="text-align: right">982,939</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"></td><td style="text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;982,939</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Buildings in progress</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;&#160;&#160;&#160;&#160;12,114,256</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,264,663</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(696,076</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-225">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-226">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,753</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(16,692,596</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,336,374</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,336,374</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-indent: 0pt; padding-left: 0pt">Total</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">74,612,434</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">5,987,922</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-227">-</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(173,089</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(6,015,700</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">189,604</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(74,575,314</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">3,319,313</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">3,345,170</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; border-bottom: Black 1.5pt solid"><b>Class</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Net&#160;carrying amount <br/>06/30/2023</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Additions</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Reclassification from Investment properties</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Disposals</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Depreciation of the year</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Foreign currency translation</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Loss of control</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Net&#160;carrying amount 06/30/2024</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; width: 19%; text-align: left; padding-left: 0.125in">Research&#160;instruments</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">66,131</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-228">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-229">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-230">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-231">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-232">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">(66,131</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-233">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Office&#160;equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">360,575</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">238,679</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-234">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-235">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(81,507</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(13,324</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(473</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">503,950</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Vehicles</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,053,263</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,077,988</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-236">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,677</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(908,040</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(775</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(28,132</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,192,627</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Equipment and computer software</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">198,364</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">725,706</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-237">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(8,184</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(354,379</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(27,650</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5,041</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">528,816</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Fixtures and fittings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,925,032</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">731,699</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-238">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,295</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(812,810</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,663</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(43,477</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,805,076</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Machinery and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,586,768</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,460,655</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-239">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(154,492</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,661,097</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(409,769</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(99,423</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,722,642</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Land and buildings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">36,211,957</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,835,054</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,222,044</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"></td><td style="text-align: right">53,217</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(982,165</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(595,040</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-240">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">39,745,067</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-indent: -0.125in; text-align: left; padding-left: 0.125in">Buildings in progress</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;&#160;&#160;&#160;&#160;11,757,249</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; text-align: right">683,406</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-241">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt"></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; text-align: right">(106,421</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-242">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; text-align: right">(207,757</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; text-align: right">(12,221</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"></td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;&#160;&#160;&#160;&#160;12,114,256</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-indent: -0.125in; font-weight: bold; padding-left: 0.125in">Total</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">68,159,339</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">10,753,187</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold"></td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">3,222,044</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(211,262</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(5,799,998</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(1,255,978</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(254,898</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">74,612,434</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DisclosureOfDepreciationIfAssetsHadBeenCarriedUnderCostModelTextBlock', window );">Schedule of Carrying Amounts that Would Have Been Recognized</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following are the carrying amounts that would
have been recognized if land and building were stated at cost.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Value at cost</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Class of property</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: justify; padding-left: 0pt">Land and buildings</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">27,876,636</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory', window );">Schedule of&#8203; Intangible Assets</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Intangible assets as of June 30, 2025 and 2024 included the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 6pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; border-bottom: Black 1.5pt solid"><b>Class</b></td><td style="border-bottom: Black 1.5pt solid"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Net carrying amount 06/30/2024</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Additions</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt"><b>Loss of control) <sup>(*)</sup></b></span></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt"><b>Additions from business
    combinations <sup>(**)</sup></b></span></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Transfers/ Disposals</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Amortization of the year</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Foreign currency translation</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Net carrying amount 06/30/2025</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; font-style: italic"><span style="text-decoration:underline">Seed and
    integrated products</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="white-space: nowrap; text-indent: -0.125in; padding-left: 0.125in; width: 28%; text-align: left">Alfalfa Genuity Har Xstra</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">438,029</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-243">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-244">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-245">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-246">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-247">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">(21,172</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">416,857</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">HB4 soy and breeding program</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35,574,369</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,164,283</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(36,464,169</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-248">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-249">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,274,483</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-250">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-251">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Integrated seed products</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,681,826</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-252">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,526,410</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-253">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-254">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(194,339</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">38,923</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-255">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; font-style: italic; text-decoration: underline; text-align: left">Crop nutrition</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Microbiological products</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">41,187,249</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">286,665</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(43,570,818</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-256">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,605,198</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,511,420</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,126</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-257">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Microbiological products in progress</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,452,861</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,163,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(11,909,700</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-258">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,706,661</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-259">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-260">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-261">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; font-style: italic; text-decoration: underline; text-align: left">Other intangible assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Trademarks and patents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">51,316,860</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">158,557</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(47,394,664</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-262">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-263">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,080,753</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-264">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-265">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Trademarks and patents with indefinite useful life</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,045,294</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-266">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(10,045,294</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-267">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-268">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-269">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-270">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-271">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Software</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,119,494</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,222</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(605,341</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-272">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">146,839</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(723,312</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">46,098</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-273">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Software in progress</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">580,728</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">176,064</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(609,953</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-274">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(146,839</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-275">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-276">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-277">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Customer loyalty</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,934,570</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-278">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(17,565,911</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-279">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-280">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,368,659</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-281">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-282">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">RG/RS/OX Wheat</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,000,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,528,899</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(10,480,817</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-283">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-284">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,048,082</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-285">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-286">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Sustainable agricultural equipment technology</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-287">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-288">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-289">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,719,710</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-290">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-291">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-292">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,719,710</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Fungal Biomass</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-293">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-294">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-295">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,775,940</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-296">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-297">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-298">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,775,940</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Piggysooy</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-299">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-300">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-301">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,813,781</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-302">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-303">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-304">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,813,781</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Safflower GLA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-305">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-306">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-307">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27,857,339</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-308">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-309">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-310">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27,857,339</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Safflower Chimosin 2.0</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-311">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-312">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-313">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,600,554</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,600,554</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Other intangibles</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-314">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-315">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-316">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,074,609</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-317">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-318">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-319">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,074,609</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold">Total</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">177,331,280</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">15,494,190</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(181,173,077</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">74,841,933</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(101,463</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(11,201,048</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">66,975</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">75,258,790</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 6pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><sup>(*)</sup></td><td style="text-align: justify">Correspond to the loss of control of BIOX.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><sup>(**)</sup></td><td style="text-align: justify">Correspond to The Bioceres Group Business Combination Agreement.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 6pt">&#160;</span></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left; padding-left: 0in"><b>Class</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Net carrying amount 06/30/2023</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Additions</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Additions
    from business combinations/ (loss of control)<sup>(*)</sup></b></span></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Transfers/ Disposals</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Amortization of the year</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Foreign currency translation</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Net carrying amount 06/30/2024</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; font-style: italic">Seed and integrated products</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 28%; text-align: left">Alfalfa Genuity Har Xstra</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">419,061</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-320">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-321">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-322">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-323">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">18,968</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">438,029</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Bacillus-PHAs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,089,536</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-324">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,089,536</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-325">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-326">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-327">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-328">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">HB4 soy and breeding program</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,679,114</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,987,247</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-329">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-330">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,091,992</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-331">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35,574,369</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Integrated seed products</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,841,008</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-332">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-333">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-334">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(191,559</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">32,377</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,681,826</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; font-style: italic; text-decoration: underline; text-align: left">Crop
    nutrition</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Microbiological&#160;products</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">37,295,460</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-335">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-336">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,610,115</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,718,326</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-337">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">41,187,249</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Microbiological products in progress</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,213,341</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,869,084</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-338">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(7,610,115</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-339">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(19,449</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,452,861</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; font-style: italic; text-decoration: underline; text-align: left">Other
    intangible assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Trademarks and patents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">51,933,444</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">44,073</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-340">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-341">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(670,514</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,857</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">51,316,860</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Trademarks and patents with indefinite useful life</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,827,309</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-342">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,217,985</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-343">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-344">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-345">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,045,294</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Software</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,638,752</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">585,313</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-346">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">276,128</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,369,379</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(11,320</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,119,494</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Software in progress</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">349,171</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">507,685</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-347">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(276,128</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-348">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-349">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">580,728</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Customer loyalty</td><td>&#160;</td>
    <td style="text-align: left"></td><td style="text-align: right">23,006,023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-350">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-351">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-352">-</div></td><td style="text-align: left">&#160;</td><td></td>
    <td style="text-align: left"></td><td style="text-align: right">(4,071,453</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left"></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-353">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"></td><td style="text-align: right">18,934,570</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">RG/RS/OX
    Wheat</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,000,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-354">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-355">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-356">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-357">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-358">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,000,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">175,292,219</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">12,993,402</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,128,449</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-359">-</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(12,113,223</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">30,433</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">177,331,280</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 6pt">&#160;</span></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><sup>(*)</sup></td><td style="text-align: justify">USD 1,089,768 correspond to the loss of control of Inmet
S.A.</td>
</tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DisclosureOfIntangibleAssetsAndLiabilitiesAssumedTextBlock', window );">Schedule of Intangible Assets and Liabilities Assumed</a></td>
<td class="text">All key assumptions values reflect past experience or, if appropriate, are consistent
with external sources of information.<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="border-bottom: Black 1.5pt solid; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; width: 20%"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><b>Key assumption</b></p></td> <td style="padding-bottom: 1.5pt; width: 1%">&#160;</td> <td style="text-align: center; border-bottom: Black 1.5pt solid; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; width: 79%"><span style="font-size: 10pt"><b>Management&#8217;s approach</b></span></td></tr> <tr> <td style="padding: 0pt"><span style="font-size: 10pt">Discount rate</span></td> <td>&#160;</td> <td style="padding: 0pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">The discount rate applied was either&#160;16.39% or&#160;11.56%, depending on the target market.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">The weighted average cost of capital (WACC) was estimated using the market capital structure plus&#160;2% of risk premium which reflect the higher risk associated with intangible assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">For the cost of equity, the discount rate is estimated based on the Capital Asset Pricing Model (CAPM).</p></td></tr> <tr> <td style="padding: 0pt">&#160;</td> <td>&#160;</td> <td style="padding: 0pt">&#160;</td></tr> <tr> <td style="text-indent: -0.125in; padding: 0pt 0pt 0pt 0.125in"><span style="font-size: 10pt">Market share, product prices and royalties.</span></td> <td>&#160;</td> <td style="padding: 0pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; ">The projected revenue from the products and services of the CGUs has been estimated by the management based on market penetration data for comparable products and technologies and on future expectations of foreseen economic and market conditions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; ">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; ">The prices and royalties estimated in the revenue projections are based on current and projected market prices for the products and services of the CGUs.</p></td></tr> </table>The key assumptions utilized are the following:<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="border-bottom: Black 1.5pt solid; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; width: 20%"> <p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><b>Key assumption</b></p></td> <td style="padding-bottom: 1.5pt; width: 2%">&#160;</td> <td style="text-align: center; border-bottom: Black 1.5pt solid; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; width: 78%"><span style="font-size: 10pt"><b>Management&#8217;s approach</b></span></td></tr> <tr> <td style="padding: 0pt"><span style="font-size: 10pt">Discount rate</span></td> <td>&#160;</td> <td style="padding: 0pt"> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify">The discount rate used ranges was&#160;14.11%&#160;for Rizobacter UGE and for&#160;Bioceres Crops UGE, and&#160;9.28% for Pro Farm UGE due to the target market.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify">&#160;</p> <p style="text-align: justify; text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt">The weighted average cost of capital (&#8220;WACC&#8221;) rate has been estimated based on the market capital structure.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0pt; margin: 0pt">&#160;</p> <p style="text-align: justify; text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt">For the cost of equity, the discount rate is estimated based on the Capital Asset Pricing Model (CAPM).</p></td></tr> <tr> <td style="padding: 0pt">&#160;</td> <td>&#160;</td> <td style="padding: 0pt">&#160;</td></tr> <tr> <td style="text-indent: -0.125in; padding: 0pt 0pt 0pt 0.125in; text-align: justify"><span style="font-size: 10pt">Market share, product prices and royalties.</span></td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify; padding: 0pt"> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify">The projected revenue from the products and services of the CGUs has been estimated by the management based on market penetration data for comparable products and technologies and on future expectations of foreseen economic and market conditions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify">The prices (Rizobacter CGU and Pro Farm CGU) and royalties (Bioceres Crops CGU) estimated in the revenue projections are based on current and projected market prices for the products and services of the CGUs.</p></td></tr> <tr> <td style="text-align: justify; padding: 0pt">&#160;</td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify; padding: 0pt">&#160;</td></tr> <tr> <td style="text-align: justify; padding: 0pt"><span style="font-size: 10pt">Terminal value</span></td> <td style="text-align: justify">&#160;</td> <td style="text-align: justify; padding: 0pt"> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify">Rizobacter CGU and Bioceres Crops CGU: The growth rate used to extrapolate the future cash flow projections to terminal period&#160;is&#160;2%.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify">&#160;</p> <p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Pro Farm CGU: EBITDA multiple (10x)</p></td></tr> </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory', window );">Schedule of Goodwill</a></td>
<td class="text"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Rizobacter Argentina S.A.</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-360">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">28,080,271</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Bioceres Crops S.A.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-361">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,523,322</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Insumos Agroqu&#237;micos S.A.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-362">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">470,090</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Pro Farm Group</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-363">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">76,089,749</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-364">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">112,163,432</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutInvestmentPropertyExplanatory', window );">Schedule of Investment Properties</a></td>
<td class="text"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Investment properties</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-365">&#160;&#160;&#160;-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">560,783</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-366">-</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">560,783</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DisclosureOfTradeAndOtherPayablesComponentsTableTextBlock', window );">Schedule of Trade and Other Payables</a></td>
<td class="text"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Current</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0pt">Trade creditors</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">6,490,684</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">108,922,112</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Shareholders and other related parties (Note 17)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-367">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">37,985</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Trade creditors - Joint ventures and associates (Note 13)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">620,034</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">52,778,206</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,647</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,877,930</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 0pt">Miscellaneous</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">200,568</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,321,303</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">7,323,933</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">168,937,536</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory', window );">Schedule of Borrowings</a></td>
<td class="text"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Current</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0pt">Bank borrowings</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">33,383</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">94,711,273</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Corporate bonds</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-368">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">42,035,925</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Net loans payables- Joint ventures and associates (Note 13)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,303,098</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,860,058</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Convertible preference shares (Note 17)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,739,726</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-369">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Financial borrowings</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">201,077,800</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">95,903,495</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">227,154,007</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">234,510,751</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-left: 0pt">Non-current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Bank borrowings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,348,173</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,033,059</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Corporate bonds</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-370">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,071,823</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Financial borrowings</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-371">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">85,143,423</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">1,348,173</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">127,248,305</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DisclosureOfCarryingValueOfBorrowingsExplanatory', window );">Schedule of Borrowings, Carrying Amount</a></td>
<td class="text">The creditor conducted a public
auction for 3,062,500 pledged BIOX shares, pursuant to the New York Uniform Commercial Code. Management has responded to the creditor,
reserving all rights, remedies, and defenses. As of the date of this report, the current debt amounts to $58.0 million.<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amortized Cost</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amortized Cost</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Current</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-left: 0pt">Bank borrowings</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">33,383</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">33,383</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">94,711,273</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">93,301,194</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Corporate bonds</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-372">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-373">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">42,035,925</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">41,492,963</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">Convertible preference shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,739,726</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,179,927</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-374">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-375">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Financial borrowings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">211,380,898</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">205,082,929</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">95,903,495</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">95,480,681</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-left: 0pt">Non current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Bank borrowings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,348,173</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,348,173</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,033,059</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,206,794</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Corporate bonds</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-376">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-377">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,071,823</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">23,845,583</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Convertible notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,260,456</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,260,456</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-378">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-379">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Financial borrowings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-380">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-381">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">85,143,423</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">81,120,125</td><td style="text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDebtSecuritiesExplanatory', window );">Schedule of Convertible Notes</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="text-decoration:underline">Convertible notes</span></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Non-current</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Convertible notes</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">18,260,456</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">80,809,686</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">18,260,456</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">80,809,686</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DisclosureOfBenefitsAndSocialSecurityPayablesTableTextBlock', window );">Schedule of Employee Benefits and Social Security</a></td>
<td class="text"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Current</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0pt">Salaries, accrued incentives, vacations&#160;and social security</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">202,014</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">7,280,129</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Key management personnel (Note 18)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">41,620</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">226,702</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">243,634</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">7,506,831</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DisclosuresOfDeferredRevenueAndAdvancesFromCustomersTableTextBlock', window );">Schedule of Deferred Revenue and Advances from Customers</a></td>
<td class="text"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Current</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0pt">Advances from customers</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,260</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3,335,740</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Deferred revenue</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-382">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">589,061</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">1,260</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">3,924,801</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-left: 0pt">Non current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Advances from customers</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-383">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">52,511</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Deferred revenue</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-384">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,872,627</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-385">-</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">1,925,138</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DisclosureOfChangesInAllowancesAndProvisionsTableTextBlock', window );">Schedule of Changes in Allowances and Provisions</a></td>
<td class="text"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Item</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Additions</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Uses and </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>reversals</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Currency </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>conversion </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>difference</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Loss of </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>control</b></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">DEDUCTED FROM ASSETS</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Allowance for impairment of trade debtors</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">7,050,280</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">7,123,716</td><td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-386">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(50,533</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(14,123,463</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Allowance for obsolescence</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,087,563</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,547,723</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,158,036</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">29,204</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,506,454</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Total deducted from assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,137,843</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,671,439</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,158,036</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(21,329</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(17,629,917</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in">INCLUDED IN LIABILITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Provisions for contingencies</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,484,715</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">336,919</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(309,793</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(89,694</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,267,573</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">16,154,574</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Total included in liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,484,715</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">336,919</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(309,793</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(89,694</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,267,573</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">16,154,574</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.125in">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">27,622,558</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">9,008,358</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(1,467,829</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(111,023</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(18,897,490</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">16,154,574</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-indent: -0.25in; padding-left: 0.25in; font-weight: bold">Item</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Additions</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Additions <br/> from <br/> business <br/> combination</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Uses and <br/> reversals</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Currency <br/> conversion <br/> difference</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.25in; padding-left: 0.25in; font-weight: bold">DEDUCTED FROM ASSETS</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 28%; text-align: left; text-indent: -0.25in; padding-left: 0.25in">Allowance for impairment of trade debtors</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">7,425,604</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">753,428</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-387">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(777,558</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(351,194</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">7,050,280</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.25in; padding-left: 0.25in">Allowance for obsolescence</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,492,499</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">586,515</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-388">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(69,582</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">78,131</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,087,563</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -0.25in; padding-left: 0.25in">Total deducted from assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,918,103</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,339,943</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-389">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(847,140</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(273,063</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,137,843</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.25in; padding-left: 0.25in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; text-indent: -0.25in; padding-left: 0.25in">INCLUDED IN LIABILITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.25in; padding-left: 0.25in">Provisions for contingencies</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">16,901,773</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">653,574</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">355,898</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(393,073</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(33,457</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,484,715</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -0.25in; padding-left: 0.25in">Total included in liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">16,901,773</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">653,574</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">355,898</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(393,073</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(33,457</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,484,715</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 2.5pt; text-indent: -0.25in; padding-left: 0.25in">Total</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">26,819,876</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,993,517</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">355,898</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(1,240,213</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(306,520</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">27,622,558</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionsExplanatory', window );">Schedule of Provisions</a></td>
<td class="text"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-weight: bold"><span style="text-decoration:underline">Provisions</span></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0pt">Conditional payment Rizobacter SA</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">15,916,116</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">15,916,116</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Provisions for contingencies</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">238,458</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,568,599</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">16,154,574</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">17,484,715</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGovernmentGrantsExplanatory', window );">Schedule of Government Grants</a></td>
<td class="text"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0pt">At the beginning of the year</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">4,437</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">349,998</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt"><span style="font-size: 10pt">Loss of control <sup>(*)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-390">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(157,043</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Currency conversion difference</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">255</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,001</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Released to the statement of profit or loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,412</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(197,519</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">At the end of the year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">1,280</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">4,437</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><sup>&#160;</sup></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><sup>(*)</sup></span></td><td style="text-align: justify"><span style="font-size: 10pt">Correspond to the loss of control
of Inmet S.A. in the year 2024</span></td>
</tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DisclosureOfWarrantsTextBlock', window );">Schedule of Warrants</a></td>
<td class="text"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">At the beginning of the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-391">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-392">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Additions for the year</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">1,030,000</p></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right"><p style="-sec-ix-hidden: hidden-fact-393; margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">-</p></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Additions from business combination</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">181,093</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-394">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">At the end of the year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">1,211,093</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-395">-</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of cash and cash equivalents. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDebtSecuritiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of debt instruments. [Refer: Debt instruments issued; Debt instruments held]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDebtSecuritiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about intangible assets. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 118<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_118&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutInvestmentPropertyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about investment property. [Refer: Investment property]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 40<br> -IssueDate 2025-01-01<br> -Paragraph 32A<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=40&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32A&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutInvestmentPropertyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 73<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_73&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfGovernmentGrantsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for government grants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 20<br> -IssueDate 2025-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=20&amp;code=ifrs-tx-2025-en-r&amp;doctype=Standard&amp;dita_xref=IAS20_g39-39_TI<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfGovernmentGrantsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInventoriesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventories.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;doctype=Standard&amp;dita_xref=IAS02_g36-39_TI<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInventoriesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfProvisionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of provisions. [Refer: Provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfProvisionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the reconciliation of changes in biological assets. [Refer: Biological assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 41<br> -IssueDate 2025-01-01<br> -Paragraph 50<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=41&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_50&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 273<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_273&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 273<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_273&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the reconciliation of changes in goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2025-01-01<br> -Paragraph B67<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B67_d&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 37<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 37<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DisclosureOfBenefitsAndSocialSecurityPayablesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The tabular disclosure of salaries and social security payables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DisclosureOfBenefitsAndSocialSecurityPayablesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DisclosureOfCarryingValueOfBorrowingsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about carrying value of borrowings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DisclosureOfCarryingValueOfBorrowingsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DisclosureOfChangesInAllowancesAndProvisionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The tabular disclosure of changes in allowances and provisions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DisclosureOfChangesInAllowancesAndProvisionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DisclosureOfDepreciationIfAssetsHadBeenCarriedUnderCostModelTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of depreciation if the assets had ben carried under the cost model.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DisclosureOfDepreciationIfAssetsHadBeenCarriedUnderCostModelTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DisclosureOfIntangibleAssetsAndLiabilitiesAssumedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of intangible assets and lianilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DisclosureOfIntangibleAssetsAndLiabilitiesAssumedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DisclosureOfOtherFinancialAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of other financial assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DisclosureOfOtherFinancialAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DisclosureOfOtherReceivablesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about other receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DisclosureOfOtherReceivablesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DisclosureOfTradeAndOtherPayablesComponentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Definition: Tabular disclosure of components of trade and other payables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DisclosureOfTradeAndOtherPayablesComponentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DisclosureOfTradeReceivablesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The tabular disclosure of current and non-current trade receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DisclosureOfTradeReceivablesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DisclosureOfWarrantsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DisclosureOfWarrantsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DisclosuresOfDeferredRevenueAndAdvancesFromCustomersTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The tabular disclosure of deferred revenue and advances from customers.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DisclosuresOfDeferredRevenueAndAdvancesFromCustomersTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Information about Component of Consolidated Statements of Comprehensive Income (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_StatementOfComprehensiveIncomeAbstract', window );"><strong>Information about Component of Consolidated Statements of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory', window );">Schedule of Revenue from Contracts with Customers</a></td>
<td class="text"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Sale of goods and services</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">317,924,355</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">444,149,141</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">385,976,753</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Royalties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,414,864</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">986,602</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,247,567</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Rendering of services with related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">841,205</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">952,742</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">739,651</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Right of use licenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">13,430,824</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">20,287,845</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">32,903,458</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">333,611,248</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">466,376,330</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">420,867,429</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCostOfSalesExplanatory', window );">Schedule of cost of sales</a></td>
<td class="text"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid"><b>Item</b></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-left: 0pt">Inventories as of the beginning of the year</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">110,913,884</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">112,000,786</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">78,775,003</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Loss of control</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(82,999,205</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-396">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-397">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Additions related to Business combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,235,482</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,020,771</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,182,602</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Purchases of the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">149,950,181</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">249,648,267</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">233,465,488</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Production costs (note 8.4)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,177,920</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,819,152</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">23,234,862</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Foreign currency translation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">382,092</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,206,764</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">806,903</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">Subtotal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">205,660,354</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">390,282,212</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">347,464,858</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"><span style="font-size: 10pt">Inventories as of the end of
the year</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,235,482</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(110,913,884</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(112,000,786</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 0pt">Cost of sales</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">203,424,872</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">279,368,328</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">235,464,072</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory', window );">Schedule of R&amp;D Classified by Nature</a></td>
<td class="text"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Research and development expenses</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid"><b>Item</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>06/30/2025</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>06/30/2024</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>06/30/2023</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Amortization of intangible assets</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">5,079,839</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">5,923,389</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">4,804,768</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Analysis and storage</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-398">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,302</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">52,660</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Commissions and royalties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,179</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-399">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,257</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Import and export expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-400">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-401">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">855</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Depreciation of leased assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">54,505</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-402">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">68,321</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Depreciation of property, plant and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">767,731</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">618,627</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">637,734</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Freight and haulage</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,025</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30,450</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,707</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Employee benefits and social securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,032,386</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,727,340</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,781,678</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Insurance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">49,343</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48,872</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">78,673</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Energy and fuel</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,576</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,101</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">111,481</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Maintenance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">236,867</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">283,895</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">475,868</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Supplies and materials</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,731,604</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,361,380</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,078,403</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Licenses &amp; Patents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">516,591</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">67,188</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">181,264</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Mobility and travel</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">141,481</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">205,741</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">245,875</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Publicity and advertising</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-403">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">23,383</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-404">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Systems expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">40,286</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">29,026</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,410</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Vehicles expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,858</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30,883</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,252</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Share-based incentives</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">217,494</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">510,162</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">136,754</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Surveillance expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-405">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-406">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,145</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Professional fees and outsourced services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">878,973</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,325,361</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">550,585</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Professional fees related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">90,533</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">256,877</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">542,551</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Office supplies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">261,263</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">696,760</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">111,618</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Miscellaneous</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">976</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">269,750</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">128</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">15,138,510</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">17,422,487</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">15,943,987</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-left: 0pt">R&amp;D capitalized (Note 8.3)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">8,614,448</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">11,856,331</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">10,753,047</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">R&amp;D profit and loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">15,138,510</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,422,487</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">15,943,987</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">23,752,958</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">29,278,818</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">26,697,034</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfExpensesByNatureExplanatory', window );">Schedule of Expenses Classified by Nature and Function</a></td>
<td class="text"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>Item</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Production and services costs</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Selling, general and administrative expenses</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><b>Total</b></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><b>06/30/2025</b></p></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-left: 0pt">Amortization of intangible assets</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">351,240</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">5,769,969</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">6,121,209</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Analysis and storage</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-407">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,744</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,744</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Commissions and royalties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">835,082</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,989,880</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,824,962</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Import and export expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-408">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">826,942</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">826,942</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Depreciation of property, plant and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,861,812</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,386,157</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,247,969</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Impairment of receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-409">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,123,716</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,123,716</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Freight and haulage</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,003,986</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,367,271</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,371,257</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Employee benefits and social securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,899,884</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">44,971,665</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">54,871,549</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">Taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">260,091</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,411,799</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,671,890</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Maintenance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,414,461</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,216,680</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,631,141</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Energy and fuel</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">658,621</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">106,846</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">765,467</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Supplies and materials</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">586,696</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,678,691</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,265,387</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Mobility and travel</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">339,447</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,472,895</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,812,342</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Allowance&#160;for obsolescence</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,547,723</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-410">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,547,723</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Publicity and advertising</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-411">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,556,518</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,556,518</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Systems expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">39,583</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,008,347</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,047,930</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Share-based incentives for employees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">315,965</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,853,229</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,169,194</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Surveillance expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-412">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">583,115</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">583,115</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Professional fees and outsourced services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">201,601</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,939,339</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,140,940</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Professional fees related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-413">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,353</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,353</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Office supplies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">93,967</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,373,911</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,467,878</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Insurance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">181,595</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,850,968</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,032,563</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Depreciation of leased assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,477,334</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,504,864</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,982,198</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Contingencies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">84,567</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">252,352</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">336,919</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Environmental Impact Treatment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">998,303</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">67,510</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,065,813</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Licenses &amp; Patents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">75</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">193,773</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">193,848</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 0pt">Miscellaneous</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">25,887</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">370,706</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">396,593</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 0pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">25,177,920</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">125,908,240</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">151,086,160</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>Item</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Production and services costs</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Selling, general and administrative expenses</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="margin-top: 0; margin-bottom: 0"><b>Total</b></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><b>06/30/2024</b></p></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-left: 0pt">Amortization of intangible assets</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">239,545</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">5,950,289</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">6,189,834</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Analysis and storage</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">598</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">160,133</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">160,731</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Commissions and royalties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">217,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,745,169</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,962,169</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Import and export expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">147,392</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">734,026</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">881,418</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Depreciation of property, plant and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,018,014</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,163,357</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,181,371</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Impairment of receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-414">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">753,428</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">753,428</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Freight and haulage</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">927,910</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,831,209</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,759,119</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Employee benefits and social securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,162,207</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">38,799,972</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">49,962,179</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">Taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">285,791</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,442,557</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,728,348</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Maintenance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,074,352</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,666,524</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,740,876</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Energy and fuel</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">997,066</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">514,422</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,511,488</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Supplies and materials</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,031,386</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,520,386</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,551,772</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Mobility and travel</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">202,810</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,317,138</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,519,948</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Allowance&#160;for obsolescence</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">581,804</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,711</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">586,515</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Publicity and advertising</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">233</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,065,506</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,065,739</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Systems expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35,526</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,857,779</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,893,305</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Share-based incentives for employees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,111,919</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,577,399</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,689,318</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Surveillance expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">368</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">468,090</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">468,458</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Professional fees and outsourced services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">189,090</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,131,891</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,320,981</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Professional fees related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-415">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">243,827</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">243,827</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Office supplies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">242,790</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,743,957</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,986,747</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Insurance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">199,109</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,133,572</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,332,681</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Depreciation of leased assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,312,849</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,106,107</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,418,956</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Contingencies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">66,682</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">586,892</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">653,574</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Environmental Impact Treatment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,770,857</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,208</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,785,065</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; padding-left: 0pt">Miscellaneous</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,854</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">808,273</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">812,127</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 0pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">25,819,152</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">126,340,822</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">152,159,974</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>Item</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Production and services costs</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Selling, general and administrative expenses</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Total <br/>06/30/2023</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-left: 0pt">Amortization of intangible assets</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">173,032</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">6,026,784</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">6,199,816</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Analysis and storage</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,496</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">700,671</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">705,167</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Commissions and royalties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">127,771</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,396,750</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,524,521</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Import and export expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">150,402</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">794,561</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">944,963</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Depreciation of property, plant and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,161,236</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,139,957</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,301,193</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Impairment of receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-416">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,327,385</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,327,385</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Freight and haulage</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,427,296</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,646,138</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,073,434</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Employee benefits and social securities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,033,252</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">39,593,472</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">49,626,724</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">Taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">255,227</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,001,149</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,256,376</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Maintenance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,157,887</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">956,916</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,114,803</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Energy and fuel</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">967,412</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">397,305</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,364,717</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Supplies and materials</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,075,909</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,048,056</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,123,965</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Mobility and travel</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">128,072</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,431,323</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,559,395</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Allowance&#160;for obsolescence</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,012,788</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">53,989</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,066,777</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Publicity and advertising</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,528</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,775,012</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,777,540</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Systems expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,556</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,158,735</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,170,291</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Share-based incentives for employees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-417">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,393,348</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,393,348</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Surveillance expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">105,988</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">392,631</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">498,619</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Professional fees and outsourced services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100,308</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,807,495</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,907,803</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Professional fees related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-418">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">196,101</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">196,101</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Office supplies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">229,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">976,350</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,205,850</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Insurance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">230,388</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,137,598</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,367,986</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Licenses &amp; Patents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-419">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">37,015</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">37,015</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Depreciation of leased assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">468,524</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,029,049</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,497,573</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">Contingencies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-420">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">239,292</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">239,292</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Environmental Impact Treatment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,369,838</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-421">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,369,838</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 0pt">Miscellaneous</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">41,452</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">874,192</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">915,644</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 0pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">23,234,862</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">116,531,274</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">139,766,136</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory', window );">Schedule of Finance Results</a></td>
<td class="text"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="text-decoration:underline">Financial cost</span></td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-left: 0pt">Interest expenses</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(38,077,952</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(35,783,901</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(30,569,478</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Financial commissions</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,731,493</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,850,252</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,007,154</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(41,809,445</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(37,634,153</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(33,576,632</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-decoration: underline; text-align: left; padding-left: 0pt">Other financial results</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Exchange differences generated by assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,183,367</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(7,519,875</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(19,758,444</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Exchange differences generated by liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(14,647,580</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(20,499,620</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,886,408</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Changes in fair value of financial assets or liabilities and other financial results</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(15,603,088</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(10,455,775</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(341,341</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Prepayment premium fee</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,870,021</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-422">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-423">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Net gain of inflation effect on monetary items</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,949,231</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,730,804</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,311,437</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Interest accrued with related parties</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">944,186</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">135,485</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-424">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(24,043,905</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(9,608,981</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(13,674,756</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-decoration: underline; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Total net financial cost</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(65,853,350</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(47,243,134</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(47,251,388</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory', window );">Schedule of Other Income or Expenses, Net</a></td>
<td class="text"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">06/30/2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Loss from subsidiary&#8217;s guarantee recognition (Note 7.12)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(61,681,998</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-425">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-426">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Gain on bargain purchase</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,473,482</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,032,327</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-427">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Remeasurement to fair value of pre-existing interest in an acquiree</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,666,680</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-428">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-429">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Net result from commercialization of agricultural products</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,890,110</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,560,703</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">174,122</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Result of intangible assets (i)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,649,848</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(473,758</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,825,111</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">881,177</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(56,589,216</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(703,265</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">1,055,299</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(i) On March 28, 2025, BIOX, a former subsidiary,
agreed to transfer all rights, licenses, and materials containing or pertaining to the Soy ANF trait and pay $750,000&#160;to a Arcadia
Biosciences Inc in exchange for (i) RG and OX Wheat Patents and RS exclusive rights; (ii) the cancellation of all Royalty Payments, which
included&#160;25% of the Net Wheat Technology Licensing Revenues and&#160;6% of the Net HB4 Soybean Revenues up to $10&#160;million;
and (iii) the release from any Performance Benchmark Obligations related to the RG, OX, and RS Varieties which amounted to $8.1&#160;million.
This transaction resulted in the accounting of a gain from the exchange of intangible assets amounting to $7.5&#160;million.&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCostOfSalesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCostOfSalesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2025-01-01<br> -Paragraph 114<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_114&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfExpensesByNatureExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfExpensesByNatureExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_StatementOfComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_StatementOfComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Taxation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract', window );"><strong>Taxation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDeferredTaxesExplanatory', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The balances of deferred tax assets and liabilities
are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="text-decoration:underline">Deferred tax assets</span></td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0pt">Tax Loss-Carry Forward</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-430">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">26,988,067</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Others financial assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-431">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">813,780</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">Others</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-432">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,516,719</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Royalties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-433">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">764,888</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Trade receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-434">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">532,106</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Allowances</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-435">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">942,587</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Government grants</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-436">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">15,090</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Total deferred tax assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-437">-</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">32,573,237</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-decoration: underline; text-align: left; padding-left: 0pt">Deferred tax liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Intangible assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(15,767,275</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(28,444,095</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Property, plant and equipment depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-438">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(14,608,912</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">Inventories</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-439">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(8,041,220</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Others financial assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-440">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(464,404</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Right-of-use leased asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-441">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(190,088</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Inflation tax adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-442">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(302,456</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 0pt">Others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-443">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(546,277</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Total deferred tax liabilities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(15,767,275</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(52,597,452</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Net deferred tax</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(15,767,275</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(20,024,215</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfRollforwardOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Roll Forward of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The roll forward of deferred tax assets and liabilities
as of June 30, 2025 and 2024 are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Balance 06/30/2024</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Business combination / (loss) of control</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Income tax provision</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Conversion difference</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Balance 06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="text-decoration:underline">Deferred tax assets</span></td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left; padding-left: 0pt">Tax Loss-Carry Forward</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">26,988,067</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(21,525,926</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(5,579,828</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">117,687</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-444">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Others financial assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">813,780</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(475,554</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(342,341</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,115</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-445">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Trade receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">532,106</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,353,889</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">822,145</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(362</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-446">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Royalties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">764,888</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(744,388</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(18,311</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,189</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-447">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">Allowances</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">942,587</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,053,605</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">98,032</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,986</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-448">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Government grants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,090</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-449">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(15,596</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">506</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-450">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 0pt">Others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,516,719</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">227,950</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,744,669</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-451">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-452">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Total deferred tax assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">32,573,237</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(24,925,412</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(7,780,568</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">132,743</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-453">-</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-decoration: underline; text-align: left; padding-left: 0pt">Deferred tax liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Intangible assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(28,444,095</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,428,299</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">214,190</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,331</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(15,767,275</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Property, plant and equipment depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(14,608,912</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,315,097</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(703,102</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,083</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-454">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">Inventories</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(8,041,220</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,611,790</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,429,430</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-455">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-456">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Biological assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-457">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">640,035</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(640,035</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-458">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-459">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Others financial assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(464,404</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,040</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">436,364</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-460">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-461">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Right-of-use leased asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(190,088</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">180,967</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,505</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,384</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-462">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Inflation tax adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(302,456</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26,801</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">218,362</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">57,293</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-463">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; padding-left: 0pt">Others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(546,277</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">541,800</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">178,733</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(174,256</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-464">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Total deferred tax liabilities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(52,597,452</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">35,772,829</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">1,144,447</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(87,099</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(15,767,275</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Net deferred tax</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(20,024,215</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">10,847,417</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(6,636,121</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">45,644</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(15,767,275</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in"><b><span style="text-decoration:underline">Deferred tax assets</span></b></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Balance 06/30/2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Business combination / (loss) of control</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Income tax provision</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Conversion difference</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Charge to OCI</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Balance 06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; width: 28%; text-align: left; padding-left: 0.125in">Tax Loss-Carry Forward</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">21,215,789</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(62,585</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">7,752,424</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(694,718</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(1,222,843</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">26,988,067</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Others financial assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,336,260</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,299</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(423,116</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(97,065</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-465">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">813,780</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Trade receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">447,449</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-466">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">214,734</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(130,077</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-467">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">532,106</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Royalties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">723,082</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-468">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48,310</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(6,504</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-469">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">764,888</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Allowances</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,213,899</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-470">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(221,106</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(50,206</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-471">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">942,587</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Government grants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">93,996</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(39,261</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(42,199</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,554</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-472">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,090</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-bottom: 1.5pt; padding-left: 0.125in">Others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,402,846</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">765,384</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,651,511</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-473">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-474">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,516,719</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0.125in">Total deferred tax assets</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">28,433,321</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">661,239</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">5,677,536</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(976,016</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(1,222,843</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">32,573,237</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-decoration: underline; font-weight: bold; text-align: left; padding-left: 0.125in">Deferred tax liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Intangible assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(29,117,986</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(301,659</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">867,636</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">107,914</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-475">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(28,444,095</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Property, plant and equipment depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(13,678,341</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(174,228</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(773,812</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,469</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-476">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(14,608,912</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Inventories</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(6,461,576</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(939,250</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(640,394</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-477">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-478">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(8,041,220</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Others financial assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,154,504</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-479">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,690,100</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-480">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-481">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(464,404</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Right-of-use leased asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(120,442</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(115,495</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30,998</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,851</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-482">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(190,088</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Inflation tax adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,131,895</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,732</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">827,211</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(8,504</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-483">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(302,456</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-bottom: 1.5pt; padding-left: 0.125in">Others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(607,722</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-484">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">111,773</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(50,328</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-485">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(546,277</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0.125in">Total deferred tax liabilities</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(53,272,466</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(1,519,900</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">2,113,512</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">81,402</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-486">-</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(52,597,452</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0.125in">Net deferred tax</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(24,839,145</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(858,661</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">7,791,048</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(894,614</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(1,222,843</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(20,024,215</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_EffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Weighted Average Tax Rate</a></td>
<td class="text"><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The tax on the Group&#8217;s profit before tax differs from the theoretical
amount that would arise using the weighted average tax rate applicable to profits of the consolidated entities as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">(Loss) / earnings before income tax-rate</td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(170,003,479</td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(27,958,152</td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">50,794,242</td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Income tax expense by applying tax rate in force in the respective countries</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">45,342,071</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,224,973</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(7,628,367</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Share of profit or loss of subsidiaries, joint ventures and associates</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(8,232,869</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5,141,460</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,645,224</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Puttable instruments charge</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-487">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-488">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,645</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Stock options charge</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(167,601</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,366,999</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(586,774</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Derecognition of deferred tax assets (i)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(40,565,962</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(94,189</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">428,530</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Mutual funds adjustments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,471</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27,560</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-489">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Non-deductible expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,027,734</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,469,872</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(373,655</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Result of inflation effect on monetary items and other finance results</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">335,680</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5,113,890</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(7,872,801</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Tax inflation adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,633,659</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,278,344</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,916,143</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Rate change adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-490">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">118,060</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(192,127</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; padding-left: 0pt">Others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(971,836</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">434,321</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,162</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Income tax expenses</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(6,636,121</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(1,103,152</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">2,328,366</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(i)</td><td style="text-align: justify">Mainly represent derecognition of deferred tax assets from
Bioceres S.A. because it initiated the voluntary bankruptcy proceeding (Note 21).</td>
</tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Principal Statutory Taxes Rates and Current Tax</a></td>
<td class="text">Mainly represent derecognition of deferred tax assets from
Bioceres S.A. because it initiated the voluntary bankruptcy proceeding (Note 21).<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">06/30/2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Current tax expense</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-491">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(8,894,200</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(1,311,506</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Deferred tax</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(6,636,121</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,791,048</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,639,872</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(6,636,121</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(1,103,152</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">2,328,366</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_IncomeTaxExpenseByApplyingApplicableTaxRateInForceInRespectiveJurisdictionsTableTextBlock', window );">Schedule of Income Tax Expense Calculated by Applying Tax Rate in Force</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The income tax expense was calculated by applying
the tax rate in force in the respective countries, as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Tax jurisdiction</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Earnings before income tax-rate</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weight average applicable <br/>
tax rate</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Income <br/>
tax as of <br/>
June 30, <br/>
2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Low or null taxation jurisdictions</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(7,247,084</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">0.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-492">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Loss-making entities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(162,756,395</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">27.9</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">45,342,071</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(170,003,479</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">45,342,071</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Tax jurisdiction</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Earnings before income tax-rate</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weight average applicable <br/>
tax rate</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Income <br/>
tax as of <br/>
June 30, <br/>
2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Low or null taxation jurisdictions</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">13,131,953</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">0.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-493">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Profit-making entities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">32,251,706</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">32.2</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(10,370,389</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Loss-making entities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(73,341,811</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">24.0</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,595,362</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(27,958,152</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">7,224,973</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Tax jurisdiction</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Earnings before income tax-rate</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weight average applicable <br/>
tax rate</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Income <br/>
tax as of <br/>
June 30, <br/>
2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Low or null taxation jurisdictions</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">30,921,548</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">0.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-494">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Profit-making entities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">73,999,737</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">21.5</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(15,899,829</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Loss-making entities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(54,127,043</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">15.3</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,271,462</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">50,794,242</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(7,628,367</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDeferredTaxesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of deferred taxes. [Refer: Deferred tax liabilities; Deferred tax assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDeferredTaxesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_EffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_EffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_IncomeTaxExpenseByApplyingApplicableTaxRateInForceInRespectiveJurisdictionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income tax expense was calculated by applying the tax rate in force in the respective jurisdictions and entities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_IncomeTaxExpenseByApplyingApplicableTaxRateInForceInRespectiveJurisdictionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ScheduleOfRollforwardOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of deferred taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ScheduleOfRollforwardOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earning Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EarningsPerShareAbstract', window );"><strong>Earning Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EarningsPerShareExplanatory', window );">Schedule of Earning Per Share</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group&#8217;s basic and diluted loss per ordinary
share are the same because the Group has generated net loss to ordinary shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2023</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Numerator</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Loss/Profit for the year (basic EPS)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(111,460,708</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(32,685,398</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">40,435,923</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Loss/Profit for the year (diluted EPS)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(111,460,708</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(32,685,398</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">40,435,923</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Denominator</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Number of shares (basic EPS)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,462,960</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,821,519</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,593,222</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Number of shares (diluted EPS)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,462,960</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,821,519</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,593,222</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Basic (loss)/profit attributable to ordinary equity holders of the parent</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(17.2461</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(5.6146</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">8.8034</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">Diluted (loss)/profit attributable to ordinary equity holders of the parent</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(17.2461</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(5.6146</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">8.8034</td><td style="text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Information about Components of Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InformationAboutComponentsOfEquityAbstract', window );"><strong>Information about Components of Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DisclosureOfNumberOfSharesIssuedtextBlock', window );">Schedule of Number of Shares Issued</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The number of shares issued as of June 30, 2025,
2024 and 2023 is the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>Year ended</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="text-align: center; border-bottom: Black 1.5pt solid"><b>Class</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Number of <br/>
Shares</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Nominal Value</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid"><b>Subscribed capital</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 23%; text-align: left">06/30/2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 22%; text-align: center">Ordinary</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 15%; text-align: right">5,301,700</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.10</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">5,301,700</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">530,170</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">06/30/2024</td><td>&#160;</td>
    <td style="text-align: center">Ordinary</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,983,687</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.10</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,983,687</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">598,369</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">06/30/2025</td><td>&#160;</td>
    <td style="text-align: center">Ordinary</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,891,761</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.10</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,891,761</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,089,176</td><td style="text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory', window );">Schedule of Subsidiaries Non-Controlling Interest</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The subsidiaries whose non-controlling interest
is significant as of June 30, 2025 and 2024 are:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>Name</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>06/30/2025</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>06/30/2024</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Bioceres S.A.</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">10.07</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">26.53</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Bioceres Crop Solutions (*)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-495">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">72.67</td><td style="text-align: left">%</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfFinancialStatementsTextBlock', window );">Schedule of Financial Statements</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="text-decoration:underline">Summary financial statements:</span> &#160; &#160; &#160; &#160; &#160; &#160;</p>



<p style="margin: 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0pt">Current assets</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">19,390,689</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">37,499,373</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Non-current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(12,909,646</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">78,742,912</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Total assets</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">6,481,043</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">116,242,285</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">97,284,715</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">47,526,407</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Non-current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">238,458</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">14,689,742</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Total liabilities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">97,523,173</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">62,216,149</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Total equity</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(91,042,130</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">54,026,136</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Total liabilities and equity</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">6,481,043</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">116,242,285</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="text-decoration:underline">Summary statements of comprehensive income or loss</span></p>



<p style="margin: 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">06/30/2023</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; padding-left: 0pt">Revenues</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">780,952</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,422,707</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,074,655</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Government grants</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,412</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">197,519</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">49,185</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 0pt">Gross margin</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">784,364</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">1,620,226</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">1,123,840</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Research and development expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(223,688</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(239,446</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(175,737</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Selling, general and administrative expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,275,441</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,248,643</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,287,433</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">Share of profit or loss of subsidiaries</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(33,367,101</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,285,724</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,287,879</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Share of profit or loss of joint ventures and associates</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(285</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,592</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,917</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Other income / (loss), net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(56,484,792</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,126</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">249,372</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-left: 0pt">Operating loss</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(91,566,943</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(5,145,053</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">3,194,004</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Financial results</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,891,781</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,128,752</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,327,324</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Loss before taxes</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(88,675,162</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(6,273,805</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(1,133,320</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Income tax (expense) / benefit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,653,797</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">471,416</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(463,175</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Result for the year</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(90,328,959</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(5,802,389</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(1,596,495</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-style: italic; text-align: left; padding-left: 0pt">Revaluation of property, plant and equipment, net of tax</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(434,390</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Foreign exchange differences on translation of foreign operations</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(5,467,311</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,865,328</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(5,182,181</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-style: italic; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Total comprehensive result</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(95,796,270</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(9,667,717</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(7,213,066</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory', window );">Schedule of Bioceres SA and Bioceres Crop Solutions</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="text-decoration:underline">Summary financial statements:</span></p>



<p style="margin: 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0pt">Current assets</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-496">&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">408,668,037</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Non-current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-497">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">441,960,310</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Total assets</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-498">-</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">850,628,347</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-499">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">329,505,846</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Non-current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-500">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">171,558,140</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Total liabilities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-501">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">501,063,986</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Total equity</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-502">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">349,564,361</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt">Total liabilities and equity</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-503">-</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">850,628,347</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="text-decoration:underline">Summary statements of comprehensive income or loss</span></p>



<p style="margin: 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 64%">Revenues</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">333,343,987</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">464,828,548</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">419,446,439</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Initial recognition and changes in the fair value of biological assets at the point of harvest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,764,863</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(45,746</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">610,554</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Cost of sales</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(203,424,872</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(278,221,812</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(235,457,053</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Changes in the net realizable value of agricultural products after harvest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,541,204</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,385,069</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,351,433</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Research and development expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(14,914,822</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(17,183,041</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(15,345,315</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Selling, general and administrative expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(123,113,572</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(123,690,910</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(113,002,747</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Share of profit or loss of joint ventures and associates</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,126,312</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,049,508</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,198,628</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Other income or expenses, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,775,970</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,498,555</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,084,892</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Operating (loss) / profit</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(2,235,962</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">45,852,923</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">54,183,965</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Financial results</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(55,335,675</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(34,785,325</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(35,078,018</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">(Loss) / profit before taxes</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(57,571,637</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">11,067,598</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">19,105,947</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Income tax</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,273,616</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,778,615</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,068,652</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Result for the year</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(58,845,253</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">7,288,983</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">20,174,599</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-style: italic; text-align: left">Foreign exchange differences on translation of foreign operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(714,251</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(787,354</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">631,500</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-style: italic; text-align: left; padding-bottom: 1.5pt">Revaluation of property, plant and equipment, net of tax</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-504">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-505">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,467,349</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-style: italic; text-align: left; padding-bottom: 2.5pt">Total comprehensive result</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(59,559,504</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">6,501,629</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">19,338,750</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of information about separate financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2025-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2025-en-r&amp;doctype=Standard&amp;dita_xref=IAS27_g15-17_TI<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Section Objective<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;doctype=Standard&amp;dita_xref=IFRS12_g1-4_TI<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of non-controlling interests. [Refer: Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DisclosureOfNumberOfSharesIssuedtextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Disclosure of number of shares issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DisclosureOfNumberOfSharesIssuedtextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_InformationAboutComponentsOfEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_InformationAboutComponentsOfEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ScheduleOfFinancialStatementsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ScheduleOfFinancialStatementsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash Flow Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>The Group&#8217;s Business Reorganization and General Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities', window );">Schedule of Significant Non-Cash Transactions Related to Investing and Financing Activities</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Significant non-cash transactions related to investing
and financing activities are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2023</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold">Investment activities</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; width: 64%; text-align: left; padding-left: 0.125in">Net assets acquisition by business combination (Note 6)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">43,053,702</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,297,882</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">152,070,313</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Investment in-kind in other related parties (Note 17)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-506">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,409,244</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,163,384</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Issuance of shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">457,504</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">267,600</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">759,236</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Own shares held</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,327</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(437,154</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-507">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Exchange of intangible assets (Note 8.6)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,427,436</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-508">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-509">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Capitalization of interest on buildings in progress</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">336,416</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">124,098</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">74,710</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Right-of-use leased asset additions through an increase
    in lease liabilities (Note 16)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,569,819</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,585,223</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,154,950</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Reclassification from Investment properties to property, plant and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-510">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-511">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,589,749</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">Sale of equity investee (Note 13)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-512">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(900,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(133,079</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-bottom: 2.5pt; padding-left: 0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">59,867,204</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">5,346,893</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">160,679,263</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>

<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Financing activities</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="width: 64%; text-align: left; padding-left: 0pt">Capitalization of convertible notes</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-513">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-514">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">12,211,638</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Assignment of receivables with shareholders and other related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(7,886,442</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-515">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-516">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Compensation payment financed by acquisition of intangible assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,781,507</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-517">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-518">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Acquisition of interest in subsidiaries by financed debts</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-519">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,417,912</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">81,965,022</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(9,667,949</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">6,417,912</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">94,176,660</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory', window );">Schedule of Changes in Liabilities Arising from Financing Activities</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Disclosure of changes in liabilities arising from
financing activities:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; border-bottom: Black 1.5pt solid">Financing activities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Borrowings</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Consideration for acquisition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Convertible notes</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; width: 52%; font-weight: bold; padding-bottom: 2.5pt; padding-left: 0.125in">As of June 30 2022</td><td style="width: 1%; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 4pt double; font-weight: bold; text-align: right">211,426,056</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 4pt double; font-weight: bold; text-align: right">12,326,110</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 4pt double; font-weight: bold; text-align: right">12,559,071</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 4pt double; font-weight: bold; text-align: right">236,311,237</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Proceeds</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">200,185,822</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-520">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">55,000,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">255,185,822</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(35,308,664</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,148,617</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-521">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(38,457,281</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Conversion of Convertible Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-522">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-523">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,109,516</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,109,516</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Interest payment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(20,465,271</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-524">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5,173,742</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(25,639,013</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">Exchange differences, currency translation differences and other financial results</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(23,391,636</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,617,570</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">21,937,333</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(6,071,873</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; font-weight: bold; padding-bottom: 2.5pt; padding-left: 0.125in">As of June 30 2023</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">332,446,307</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">4,559,923</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">75,213,146</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">412,219,376</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Proceeds</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">187,994,310</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-525">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-526">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">187,994,310</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(142,866,725</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,912,171</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-527">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(145,778,896</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Financing for assets acquisitions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">743,279</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,119,975</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-528">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,863,254</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Interest payment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(32,631,369</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-529">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,172,328</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(36,803,697</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">Exchange differences, currency translation differences and other financial results</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">16,073,254</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,809,240</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,768,868</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">29,651,362</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; font-weight: bold; padding-bottom: 2.5pt; padding-left: 0.125in">As of June 30 2024</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">361,759,056</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">6,576,967</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">80,809,686</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">449,145,709</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Proceeds</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">403,333,190</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-530">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-531">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">403,333,190</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(376,998,320</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,035,388</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,000,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(380,033,708</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Prepayment Premium Fee</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-532">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-533">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,870,021</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,870,021</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Non-cash activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(7,886,442</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,781,507</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-534">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9,667,949</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Interest payment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(21,772,862</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-535">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(6,315,826</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(28,088,688</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Exchange differences, currency translation differences and other financial results</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26,645,537</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">138,825</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">23,906,564</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50,690,926</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Acquisition from business combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,348,173</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-536">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,260,456</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19,608,629</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">Decrease because of loss of control</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(157,926,152</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,898,897</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(102,270,445</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(263,095,494</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; font-weight: bold; padding-bottom: 2.5pt; padding-left: 0.125in">As of June 30 2025</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">228,502,180</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-537">-</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">18,260,456</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">246,762,636</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the reconciliation of liabilities arising from financing activities. [Refer: Liabilities arising from financing activities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 44D<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_44D&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 166<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_166&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 166<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_166&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The tabular disclosure of significant non-cash transactions related to investing and financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Joint Ventures and Associates (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfJointVenturesAbstract', window );"><strong>Joint Ventures and Associates [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DisclosureOfInvestmentsInJointVenturesAndAffiliatesTableTextBlock', window );">Schedule of Joint Ventures Assets</a></td>
<td class="text"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">06/30/2025</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">06/30/2024</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"><span style="text-decoration:underline">Assets</span></span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic"><span style="font-family: Times New Roman, Times, Serif">Measured at equity value
    method</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Synertech Industrias
    S.A.</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-538; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">39,749,850</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Bioceres Crops Solutions
    Corp</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">77,741,970</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-539; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Agrality Argentina S.A.</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,521,996</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,758,886</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Agrality US Inc.</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,315,307</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,521,791</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Agrality Seeds Inc.</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,496,286</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,812,389</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">SW Semillas S.A.</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">725</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">955</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Alfalfa Technologies S.R.L.</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-540; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">36,503</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Inmet
    S.A</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">71,687</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">379,876</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">94,147,971</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">56,260,250</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; font-style: italic; text-align: left; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Measured
    at Fair value</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">Theo
    I SCSp</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-541; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">36,535,601</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-542; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">36,535,601</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>06/30/2025</b></span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>06/30/2024</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="text-decoration:underline">Liabilities</span></td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic; text-align: left">Measured at equity value method</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Trigall Genetics S.A.</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-543">&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">296,455</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-544">-</div></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">296,455</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DisclosureOfChangesInInvestmentInJointVenturesAndAffiliatesTableTextBlock', window );">Schedule of Changes in Joint Ventures Investments and Affiliates</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Changes in joint ventures investments and affiliates:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; padding-left: 0pt">As of the beginning</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">92,499,396</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">117,720,140</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Loss of control</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(38,363,585</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-545">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Changes in equity interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">77,741,970</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,958</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Sale of equity investment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-546">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(900,000</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Reclassification of Moolec Science S.A.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-547">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,560,472</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Share-based incentives</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-548">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">65,470</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Dividends distribution</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-549">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,790,032</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Foreign currency translation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(802,200</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">977,482</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Share of profit or loss measured at equity value method</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(392,009</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,747,312</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Share of profit or loss measured at fair value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(36,535,601</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(28,770,462</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">As of the end of the year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">94,147,971</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">92,499,396</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DisclosureOfShareOfProfitOrLossInJointVenturesAndAffiliatesTableTextBlock', window );">Schedule of Share of Profit or Loss of Joint Ventures and Affiliates</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Share of profit or loss of joint ventures and affiliates:</p><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-weight: bold"></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic">Measured at equity value method</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-left: 0pt">Synertech Industrias S.A.</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(415,089</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3,723,140</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">564,598</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Agrality Argentina S.A.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">587,173</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,519,639</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,126,492</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Agrality US Inc.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(206,484</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(64,322</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,940,435</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Agrality Seeds Inc.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">683,897</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(124,468</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,187,415</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Indrasa Biotecnolog&#237;a S.A.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-550">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-551">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">62,613</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Moolec Science SA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-552">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-553">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,176,703</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">SW Semillas S.A.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(285</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,592</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,917</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Trigall Genetics</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(711,223</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">326,368</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">103,703</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Inmet S.A.</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(329,998</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">369,547</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-554">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(392,009</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">7,747,312</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(2,076,234</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; font-style: italic; text-align: left; padding-left: 0pt">Measured at Fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Theo I SCSp</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(36,535,601</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(28,770,462</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">49,785,839</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 2.5pt; padding-left: 0pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(36,535,601</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(28,770,462</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">49,785,839</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfSignificantJointVenturesTableTextBlock', window );">Schedule of Significant Joint Ventures</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Summarized financial information prepared in accordance
with International Financial Reporting Standards (&#8220;IFRS&#8221;) in relation to the significant joint ventures is presented below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Name</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Date</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Current<br/>
    assets</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Non-current<br/>
    assets</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Current<br/>
    liabilities</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Non-<br/>
    current<br/> liabilities</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Equity</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Sales</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Loss)/Profit<br/>
    of the year</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Synertech</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">06/30/2025</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-555; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-556; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-557; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-558; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-559; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-560"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-561"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; width: 16%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Industries</span></td><td style="width: 0.5%"></td>
    <td style="width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">06/30/2024</span></td><td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">55,963,591</span></td><td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,195,394</span></td><td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">27,610,517</span></td><td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,447,008</span></td><td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">36,101,460</span></td><td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">61,815,678</span></td><td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,236,901</span></td><td style="width: 0.5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">S.A.</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">06/30/2023</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">50,602,942</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">12,351,672</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">30,248,685</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,841,374</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">28,864,555</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">62,798,136</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,980,995</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">06/30/2025</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,733,702</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">17,174,010</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,749,928</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,155,954</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,001,830</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">27,931,724</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,409,802</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Agrality S.A.</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">06/30/2024</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">22,098,808</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">20,002,212</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">22,984,897</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,640,513</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,475,610</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">22,757,410</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,935,787</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">06/30/2023</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">14,203,372</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">24,832,433</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">14,591,700</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">19,382,094</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,062,012</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">20,540,979</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,071,653</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Theo I SCSp</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">06/30/2025</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-562; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">22,755,817</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,642,112</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">73,674,157</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(61,560,452</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-563; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(99,549,928</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">06/30/2024</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-564; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">108,456,044</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">13,405,755</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">57,060,813</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">37,989,476</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-565; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(32,213,331</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">06/30/2023</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-566; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">135,533,950</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,998,548</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">55,630,592</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">67,904,810</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-567; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(10,632,802</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DisclosureOfChangesInInvestmentInJointVenturesAndAffiliatesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of investments in joint ventures and affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DisclosureOfChangesInInvestmentInJointVenturesAndAffiliatesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DisclosureOfInvestmentsInJointVenturesAndAffiliatesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Information pertains to disclosure of investments in associates and joint ventures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DisclosureOfInvestmentsInJointVenturesAndAffiliatesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DisclosureOfShareOfProfitOrLossInJointVenturesAndAffiliatesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of share of profit / (loss) joint ventures and affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DisclosureOfShareOfProfitOrLossInJointVenturesAndAffiliatesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ScheduleOfSignificantJointVenturesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular Disclosure is for schedule of significant joint ventures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ScheduleOfSignificantJointVenturesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract', window );"><strong>Segment Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsExplanatory', window );">Schedule of Operating Results Group's Reporting Segments</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following tables present information with
respect to the Group&#8217;s reporting segments:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Year ended June 30, 2025</b></p></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Seed and integrated products</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Crop protection</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Crop nutrition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Emerging solutions</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Consolidated</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Revenues from contracts with customers</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">Sale of goods and services</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">60,535,026</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">181,908,584</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">76,054,689</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">267,261</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">318,765,560</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Royalties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,414,864</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-568">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-569">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-570">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,414,864</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Right of use licenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-571">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-572">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,430,824</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-573">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,430,824</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold">Others</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Initial recognition and changes in the fair value of biological assets at the point of harvest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,764,863</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-574">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-575">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-576">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,764,863</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Government grants</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-577">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-578">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-579">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,412</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,412</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total revenues</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">63,714,753</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">181,908,584</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">89,485,513</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">270,673</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">335,379,523</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Cost of sales</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(44,727,989</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(111,888,640</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(46,808,243</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-580">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(203,424,872</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Gross profit per segment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">18,986,764</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">70,019,944</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">42,677,270</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">270,673</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">131,954,651</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">% Gross margin</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">38</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">39</td><td style="text-align: left">%</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Year ended June 30, 2024</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Seed and integrated products</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Crop protection</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Crop nutrition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Emerging solutions</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Consolidated</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Revenues from contracts with customers</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">Sale of goods and services</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">94,457,404</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">223,538,317</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">125,558,380</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,547,782</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">445,101,883</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Royalties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">986,602</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-581">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-582">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-583">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">986,602</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Right of use licenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,000,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-584">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19,287,845</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-585">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20,287,845</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold">Others</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Initial recognition and changes in the fair value of biological assets at the point of harvest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(45,746</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-586">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-587">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-588">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(45,746</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Government grants</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-589">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-590">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-591">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">197,519</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">197,519</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total revenues</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">96,398,260</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">223,538,317</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">144,846,225</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,745,301</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">466,528,103</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Cost of sales</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(66,306,974</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(143,807,301</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(68,107,537</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,146,516</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(279,368,328</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Gross profit per segment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">30,091,286</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">79,731,016</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">76,738,688</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">598,785</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">187,159,775</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">% Gross margin</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">36</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">53</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">40</td><td style="text-align: left">%</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Year ended June 30, 2023</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Seed and integrated products</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Crop protection</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Crop nutrition</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Emerging solutions</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Consolidated</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Revenues from contracts with customers</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">Sale of goods and services</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">55,360,397</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">205,685,451</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">157,153,024</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,420,990</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">419,619,862</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Royalties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,247,567</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-592">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-593">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-594">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,247,567</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Others</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Initial recognition and changes in the fair value of biological assets at the point of harvest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">319,428</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">153,460</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">137,666</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-595">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">610,554</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Government grants</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-596">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-597">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-598">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">93,509</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">93,509</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total revenues</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">56,927,392</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">205,838,911</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">157,290,690</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,514,499</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">421,571,492</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Cost of sales</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(31,012,687</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(137,529,299</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(66,915,067</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(7,019</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(235,464,072</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Gross profit per segment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">25,914,705</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">68,309,612</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">90,375,623</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,507,480</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">186,107,420</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">% Gross margin</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">46</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">57</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">44</td><td style="text-align: left">%</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfProductsAndServicesExplanatory', window );">Schedule of Revenue by Similar Group of Products or Services</a></td>
<td class="text"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-weight: bold"></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>06/30/2023</b></span></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><b><span style="text-decoration:underline">Revenue by similar group of products or services</span></b></td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; font-weight: bold; font-style: italic; text-decoration: underline; text-align: left; padding-bottom: 1.5pt">Seed and integrated products</td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">61,949,890</td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">96,444,006</td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">56,607,954</td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Seed Treatments Packs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,476,396</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">29,992,052</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">32,563,161</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Seed &amp; Royalties Payments &amp; HB4 Program</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33,473,494</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">66,451,954</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">24,044,803</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; font-style: italic; text-decoration: underline; text-align: left; padding-bottom: 1.5pt">Crop protection</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">181,908,584</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">223,538,317</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">205,685,451</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Adjuvants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">56,028,937</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">56,634,128</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">52,825,245</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Seed CP Products and Services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,890,840</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,877,911</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26,080,587</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Other CP Products and Services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">62,983,430</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">103,092,454</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">94,277,444</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Bioprotection</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,005,377</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,933,824</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">32,502,175</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; font-style: italic; text-decoration: underline; text-align: left; padding-bottom: 1.5pt">Crop nutrition</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">89,485,513</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">144,846,225</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">157,153,024</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Inoculants &amp; Biofertilizers</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,445,093</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,315,253</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">23,621,534</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Micro-beaded Fertilizers</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">56,461,771</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">91,786,942</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">90,827,714</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Biostimulants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,578,649</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,456,185</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,800,318</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Syngenta up-front fee</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-599">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19,287,845</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">32,903,458</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; font-style: italic; text-decoration: underline; text-align: left; padding-bottom: 1.5pt">Emerging solutions</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">270,673</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,745,301</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,514,499</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Management expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">267,261</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,547,782</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,420,990</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Government grants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,412</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">197,519</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">93,509</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-decoration: underline; text-align: left; padding-bottom: 1.5pt">Total revenues</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">333,614,660</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">466,573,849</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">420,960,938</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasExplanatory', window );">Schedule of Geographical Information</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Geographical information</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Argentina</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">231,823,079</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">348,366,339</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">289,346,766</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Brazil</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,673,809</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">24,175,116</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">23,690,028</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>LATAM</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">23,900,621</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">21,952,339</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">21,044,547</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">North America</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30,107,865</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27,543,558</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30,768,912</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>EMEA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,920,550</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">21,320,535</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,014,855</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Rest of the world</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">22,188,736</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">23,215,962</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">34,095,830</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total revenues</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">333,614,660</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">466,573,849</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">420,960,938</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold">Non-current assets</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 76%">Argentina</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">12,493,920</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">139,722,896</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Brazil</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-600">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,698,175</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">LATAM</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-601">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,162,654</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">North America</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">53,447,180</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">189,199,549</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">EMEA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,662,860</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">44,141</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Rest of the world</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-602">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">26,279,731</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; padding-bottom: 4pt">Total</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">78,603,960</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">364,107,146</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Property, plant and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,345,170</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">74,612,434</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Intangible assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">75,258,790</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">177,331,280</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1.5pt">Goodwill</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-603">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">112,163,432</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Total reportable assets</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">78,603,960</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">364,107,146</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Total non-reportable assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">126,105,586</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">585,729,699</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 4pt">Total assets</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">204,709,546</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">949,836,845</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfGeographicalAreasExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of geographical information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 33<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_33&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfGeographicalAreasExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of operating segments. [Refer: Operating segments [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfProductsAndServicesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the entity's products and services. [Refer: Products and services [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfProductsAndServicesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments &#8211; Risk Management (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingLineItems', window );"><strong>FINANCIAL INSTRUMENTS - RISK MANAGEMENT</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities', window );">Schedule of Liquidity Risk</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table sets out the contractual maturities of financial
liabilities:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid">As of June 30, 2025</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Up to<br/> 3 months</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">3 to 12 months</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Between one and three years</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Trade and other payables</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">7,323,933</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-604">&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-605">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Borrowings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">227,154,007</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-606">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,348,173</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Convertible notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-607">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-608">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,260,456</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Lease liability</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">117,463</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-609">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-610">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">234,595,403</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-611">-</div></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">19,608,629</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid">As of June 30, 2024</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Up to <br/>
3 months</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">3 to 12 months</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Between one and three years</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Trade and other payables</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">107,801,065</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">61,136,471</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-612">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Borrowings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">87,538,816</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">146,971,935</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">127,248,305</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Consideration for acquisition of assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-613">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,571,824</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,005,143</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Convertible notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-614">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-615">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">80,809,686</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Lease liability</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">738,561</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,384,217</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,161,359</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">196,078,442</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">215,064,447</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">218,224,493</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DisclosureOfForeignExchangeRiskSensitivityAnalysistextBlock', window );">Schedule of Other Foriegn Currencies with Variables Remaining Constant</a></td>
<td class="text">The Company estimates that a devaluation or an appreciation of the Argentine peso against the U.S. dollar of 20% during the
year ended June 30, 2025, would have resulted in the following results:<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Estimated</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif"><b>Exchange rate variation</b></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(-)
    20%</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(+)
    20%</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Argentine peso amount expressed
    in US$</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(51,228,445</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">51,228,445</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsExplanatory', window );">Schedule of Financial Assets by Category</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Financial assets by category</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amortized cost</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Mandatorily measured at fair value through profit or loss</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>Financial asset</b></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">767,919</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">27,210,070</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-619">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">56,284,573</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Other financial assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,234,539</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-620">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;19,722</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,858,124</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Trade receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,085,400</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">209,007,195</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-621">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-622">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-align: left">Other receivables (*)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">14,085,303</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">45,342,974</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-623">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-624">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; font-weight: bold">Total</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">29,173,161</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">281,560,239</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">19,722</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">21,142,697</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><sup>&#160;</sup></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><sup>(*)</sup></td><td style="text-align: justify">Advances expenses and tax balances are not included.</td>
</tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory', window );">Schedule of Financial Liabilities by Category</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Financial liabilities by category</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amortized cost</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Mandatorily measured at fair value through profit or loss</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Financial liability</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Trade and other payables</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">7,323,933</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">156,947,744</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-625">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">11,989,792</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Borrowings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">228,502,180</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">361,759,056</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-626">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-627">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Consideration for acquisition of assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-628">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,852,853</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-629">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,724,114</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Convertible notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,260,456</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">80,809,686</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-630">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-631">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Lease liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">117,463</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,284,137</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-632">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-633">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Warrants</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-634">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-635">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,211,093</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-636">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; font-weight: bold">Total</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">254,204,032</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">614,653,476</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,211,093</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">14,713,906</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory', window );">Schedule of Fair Value by Hierarchy</a></td>
<td class="text">Level 3 comprises financial instruments with inputs for estimating fair value that are not based on observable market data.<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-weight: bold"></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Level
    1</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Level
    2</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">Level
    3</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif"><b><span style="text-decoration:underline">Measurement at fair value at 06/30/2025</span></b></span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic"><span style="font-family: Times New Roman, Times, Serif">Financial assets at fair
    value</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Investments at fair value</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right">19,722</td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-637; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-638; font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; font-style: italic; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Financial
    liabilities valued at fair value</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Warrant liability</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">181,093</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-639; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,030,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-weight: bold"></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">Level 1</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">Level 2</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">Level 3</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><b><span style="text-decoration:underline">Measurement at fair value at 06/30/2024</span></b></td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic">Financial assets at fair value</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Mutual funds</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">12,943,378</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-640">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-641">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Moolec Science SA shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,191,286</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-642">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-643">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Investments at fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,311,604</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-644">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-645">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">US Treasury bills</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,993,668</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-646">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-647">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other investments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,702,761</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-648">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-649">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; font-style: italic; text-align: left">Financial liabilities valued at fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Trade and other payables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-650">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,989,792</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-651">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Consideration for acquisition</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,724,114</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-652">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-653">-</div></td><td style="text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember', window );">Currency Risk</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingLineItems', window );"><strong>FINANCIAL INSTRUMENTS - RISK MANAGEMENT</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory', window );">Schedule of Interest Rate Risk</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The table below sets forth the net exposure to
currency risk as of June 30, 2025:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Net foreign currency position</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">Amount expressed in US$</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(206,837,587</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Other currencies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(49,304,636</td><td style="text-align: left">)</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember', window );">Interest Rate Risk</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingLineItems', window );"><strong>FINANCIAL INSTRUMENTS - RISK MANAGEMENT</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory', window );">Schedule of Interest Rate Risk</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group&#8217;s debt composition is set out
below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic"></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><b><i><span style="text-decoration:underline">Carrying amount</span></i></b></td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Fixed-rate instruments</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Current financial liabilities</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">227,154,007</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">187,141,491</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Non-current financial liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">19,608,629</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">193,681,929</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">246,762,636</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">380,823,420</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">Variable-rate instruments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Current financial liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-616">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">47,369,260</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Non-current financial liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-617">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">14,376,062</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-618">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">61,745,322</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the fair value of financial instruments. [Refer: Classes of financial instruments [domain]; At fair value [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of financial assets. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 43<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_43&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 43<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_43&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of financial liabilities. [Refer: Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 43<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_43&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 43<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_43&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of information that enables users of financial statements to evaluate the nature and extent of risks arising from financial instruments to which the entity is exposed. [Refer: Classes of financial instruments [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of a maturity analysis for non-derivative financial liabilities (including issued financial guarantee contracts) that shows the remaining contractual maturities. [Refer: Derivative financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 72<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_72_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 39<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_39_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 72<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_72_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DisclosureOfForeignExchangeRiskSensitivityAnalysistextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of foreign exchange risk sensitivity analysis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DisclosureOfForeignExchangeRiskSensitivityAnalysistextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PresentationOfLeasesForLesseeAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory', window );">Schedule of Right-of-Use and Liabilities Related with Lease Assets</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The information about the right-of-use and liabilities
related with lease assets is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Right-of-use leased asset</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0pt">Book value at the beginning of the year</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">20,979,597</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">21,163,192</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Additions of the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,569,819</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,585,223</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Additions from business combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100,896</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">168,988</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0pt">Disposals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(680,110</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,284,975</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 0pt">Exchange differences</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">273,529</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,652,831</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; padding-left: 0pt">Loss of control</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(30,142,835</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-654">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Book value at the end of the year</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">100,896</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">20,979,597</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Depreciation</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-left: 0pt">Book value at the beginning of the year/inception</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">9,377,845</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">7,226,617</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Depreciation of the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,036,703</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,418,956</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt">Disposals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(697,150</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,092,167</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 0pt">Exchange differences</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">47,736</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(175,561</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 0pt">Loss of control</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(13,765,134</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-655">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Accumulated depreciation at the end of the year</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-656">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,377,845</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 0pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">100,896</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">11,601,752</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Lease Liabilities</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Book value at the beginning of the year/inception</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">11,284,137</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">13,889,223</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Additions of the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,569,819</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,585,223</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Additions from business combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">117,463</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">168,988</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Interest expenses, exchange differences and inflation effects</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,059,412</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(480,189</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Payments of the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5,501,387</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,879,108</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Loss of control</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(16,411,981</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-657">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">117,463</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">11,284,137</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Lease Liabilities</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%">Current</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">117,463</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3,122,778</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Non-current</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-658">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,161,359</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">117,463</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">11,284,137</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Machinery and equipment</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-659">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3,655,741</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Vehicles</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-660">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,272,071</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Equipment and computer software</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-661">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,130,541</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Land and buildings</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">100,896</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">14,921,244</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">100,896</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">20,979,597</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of quantitative information about right-of-use assets. [Refer: Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 53<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_53&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PresentationOfLeasesForLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PresentationOfLeasesForLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders and Other Related Parties Balances and Transactions (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract', window );"><strong>Shareholders and Other Related Parties Balances and Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory', window );">Schedule of Transactions Between the Group and Related Parties</a></td>
<td class="text">During the year ended June 30, 2025, the transactions between the Group and related parties, and the related balances owed by and to them for the year ended June 30, 2025, 2024 and 2023 are as follows:<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><b>17.</b></td><td style="text-align: justify"><b><span style="text-decoration:underline">SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND
TRANSACTIONS</span></b></td>
</tr></table><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Value of transactions for the year ended</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid">Party</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Transaction type</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 30%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 33%; text-align: left">Sales of goods and services</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">4,033,811</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">952,742</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">739,651</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Joint ventures and associates</td><td>&#160;</td>
    <td style="text-align: left">Purchases of goods and services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(24,061,563</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(500,704</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(738,652</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">Net loans granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,645,504</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,005,841</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,141,471</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">Interest gain</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">944,186</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">135,485</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">212,407</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">Net loans received</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-662">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,860,058</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,854,680</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">Puttable instruments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-663">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-664">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,399,631</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">Net loans granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-665">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,299</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19,049</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">Preference shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(15,000,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-666">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-667">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">Interest expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-668">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,425,703</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(956,873</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Shareholders and other related parties</td><td>&#160;</td>
    <td style="text-align: left">Own shares held by subsidiaries</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-669">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(444,473</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(133,079</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">In-kind contributions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,343,549</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,409,244</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,163,384</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">Sales of goods and services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,714,441</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,911,723</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,565,027</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">Purchases of goods and services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,517,528</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,998,349</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,334,556</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">Salaries, social security benefits and other benefits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,494,538</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,496,073</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,995,361</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Key management personnel</td><td>&#160;</td>
    <td style="text-align: left">Sales and services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">367,928</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-670">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-671">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">Purchases of goods and services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,079,070</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-672">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-673">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left; padding-bottom: 1.5pt">Stock options-based incentives</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(480,450</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(8,181,849</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,868,430</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Total</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(27,583,730</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,536,125</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">10,358,989</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amounts receivable from<br/>
 related parties</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Party</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Transaction type</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 30%; text-align: left">Joint ventures and associates</td><td style="width: 1%">&#160;</td>
    <td style="width: 45%; text-align: left">Trade debtors</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,565,913</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">2,176,622</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">Other receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,211,902</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">37,586,012</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Shareholders and other related parties</td><td>&#160;</td>
    <td style="text-align: left">Trade debtors</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-674">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">37</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">Loans receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,295,774</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-675">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left; padding-bottom: 1.5pt">Other receivables</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,405</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">47,348</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">15,090,994</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">39,810,019</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 52.5pt">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amounts payable to<br/>
 related parties</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Party</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Transaction type</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 30%; text-align: left">Joint ventures and associates</td><td style="width: 1%">&#160;</td>
    <td style="width: 45%; text-align: left">Trade creditors</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(620,034</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(52,778,206</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">Convertible notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(7,102,028</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-676">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">Net loans payables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(10,303,098</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,860,058</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Shareholders and other related parties</td><td>&#160;</td>
    <td style="text-align: left">Trade creditors</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-677">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(37,985</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,030,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-678">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">Preference shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(15,739,726</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-679">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Key management personnel</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left; padding-bottom: 1.5pt">Salaries, social security benefits and other benefits</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(41,620</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(226,702</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(34,836,506</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(54,902,951</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of transactions between the entity and its related parties. [Refer: Total for all related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2025-01-01<br> -Paragraph 18<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_18&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 230<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_230&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 230<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_230&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Key Management Personnel Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_KeyManagementPersonnelCompensationAbstract', window );"><strong>Key Management Personnel Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock', window );">Schedule of Compensation of Key Management Personnel Compensation</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The compensation of directors and other members
of key management personnel, including social contributions and other benefits, were as follows for the year ended June 30, 2025, 2024
and 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Short-term employee benefits</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">2,494,538</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">2,496,073</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,995,361</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Share based payment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">480,450</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,181,849</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,868,430</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">2,974,988</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">10,677,922</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">3,863,791</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The tabular disclosure of compensation of directors and other members of key management personnel.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_KeyManagementPersonnelCompensationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_KeyManagementPersonnelCompensationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Payment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract', window );"><strong>Share-Based Payment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DisclosureOfFairValueOfTheStockOptionsAtTheGrantDateTextBlock', window );">Schedule of Fair Value of the Stock Options at the Grant Date</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value of the stock options at the grant
date was estimated using the &#8220;Black-Scholes&#8221; model, considering the terms and conditions under which the options on shares were
granted and adjusted to consider the possible dilutive effect of the future exercise of options.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">&#160;</p>


<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid">Factor</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Stand Alone Stock Option Grant</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Employee Stock Option Plan</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Past Share Option plan</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Base Share Option plan</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Performance Share Option plan</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: justify; padding-left: 0pt">Weighted average fair value of shares</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">5.42</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">13.98</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">11.45</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">10.80</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">10.79</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; padding-left: 0pt">Weighted average exercise price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4.55</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5.55</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.48</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">10.52</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">10.52</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0pt">Weighted average expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">29.69</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">42.18</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">48.73</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">54.73</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">54.73</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; padding-left: 0pt">Dividend rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 0pt">Weighted average risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.66</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.17</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.40</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.47</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.47</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: justify; padding-left: 0pt">Weighted average expected life</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">9.89 years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">9.22 years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">4.89 years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">2.97 year</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">2.97 year</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; text-align: justify; padding-left: 0.125in">Weighted average fair value of stock options at measurement date</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2.47</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">10.10</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5.01</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4.46</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4.45</td><td style="text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory', window );">Schedule of Range of Assumptions which have Determined</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Bioceres Crop Solutions&#8217;s fair value of
the grants was estimated utilizing a Black Scholes option pricing model based on the following range of assumptions which have determined
consistent with BIOX&#8217;s historical methodology for such assumptions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">July
    12, <br/>
    2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif">Exercise price</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.16 - 204.66</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected life (years)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.03 - 9.83</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Estimated volatility factor</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34.9% - 44.4</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; width: 88%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Risk-free
    interest rate</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.0</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected dividend yield</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-680; font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory', window );">Schedule of Option Activity and Weighted Average Exercise Price</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table shows the evolution of stock
option and weighted average exercise price for the years ended June 30, 2025, and 2024:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">06/30/2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of options</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">W.A. Exercise price</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of options</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">W.A. Exercise price</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-weight: bold; text-align: left">At the beginning of the year</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right">7,345,795</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right">11.83</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right">1,791,000</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right">15.79</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Granted during the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-681">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-682">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,631,894</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10.55</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Cancelled or expired during the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-683">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-684">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(570</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10.07</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Exercised during the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-685">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-686">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(76,529</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10.73</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Loss of control</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(7,345,795</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">11.83</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-687">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-688">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">Effective at the end of the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-689">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-690">-</div></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">7,345,795</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">11.83</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of information about indirect, by reference to the fair value of the equity instruments granted, measurement of the fair value of goods or services received as consideration for the entity's share options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the number and weighted average exercise prices of other equity instruments (ie other than share options).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DisclosureOfFairValueOfTheStockOptionsAtTheGrantDateTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of fair value of the stock options at the grant date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DisclosureOfFairValueOfTheStockOptionsAtTheGrantDateTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Reverse Stock Split After the Reporting Period (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DisclosureOfReverseStockSplitAfterTheReportingPeriodAbstract', window );"><strong>Reverse Stock Split After the Reporting Period [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory', window );">Schedule of Weighted Average Number of Ordinary Shares Outstanding</a></td>
<td class="text">The reverse stock split did not impact the Company&#8217;s consolidated statements of operations, financial position
or cash flows, other than the recast of the weighted average number of ordinary shares outstanding used in the calculation of basic and
diluted EPS.<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2025</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2024</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">06/30/2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; font-weight: bold; text-indent: -0.125in">Numerator</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; width: 64%; text-align: left; text-indent: -0.125in">Loss/Profit for the year (basic EPS)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(111,460,708</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(32,685,398</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">40,435,923</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-align: left; text-indent: -0.125in">Loss/Profit for the year (diluted EPS)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(111,460,708</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(32,685,398</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">40,435,923</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; font-weight: bold; text-indent: -0.125in">Denominator</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Number of shares (basic EPS)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">430,864</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">388,101</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">306,215</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Number of shares (diluted EPS)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">430,864</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">388,101</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">306,215</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; font-weight: bold; text-align: left; text-indent: -0.125in">Basic (loss)/profit attributable to ordinary equity holders of the parent</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(258.6912</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(84.2188</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">132.0508</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; font-weight: bold; text-align: left; text-indent: -0.125in">Diluted (loss)/profit attributable to ordinary equity holders of the parent</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(258.6912</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(84.2188</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">132.0508</td><td style="text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DisclosureOfReverseStockSplitAfterTheReportingPeriodAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DisclosureOfReverseStockSplitAfterTheReportingPeriodAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The Group&#8217;s Business Reorganization and General Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 16, 2025</div></th>
<th class="th"><div>May 22, 2025</div></th>
<th class="th"><div>May 14, 2025</div></th>
<th class="th"><div>Jul. 31, 2025</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Nov. 14, 2025</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>The Group&#8217;s Business Reorganization and General Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Shares received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates', window );">Shares held</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,370<span></span>
</td>
<td class="nump">60,083<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Par value (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NumberOfSharesReverseStockSplit', window );">Number of shares reverse stock split</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PercentageOfIssuedAndOutstandingEquityInterests', window );">Percentage of issued and outstanding equity interests</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ConsiderationForIssuedOrdinaryShareValue', window );">Consideration for issued ordinary shares value</a></td>
<td class="nump">6,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PrivateWarrantsShares', window );">Private warrant shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PrivateWarrantsExercisePrice', window );">Private warrants exercise price (in Dollars per share)</a></td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AdditionalOrdinarySharesIssue', window );">Additional ordinary shares issue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NumberOfSharesOutstandingPercentage', window );">Shares outstanding, percentage</a></td>
<td class="nump">77.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Voting interest percentage</a></td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentDebtInstrumentsIssued', window );">Current debt (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 58,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_WorkingCapital', window );">Working capital (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(204,860,444)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Shareholders' deficit (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(82,873,602)<span></span>
</td>
<td class="nump">$ 250,001,370<span></span>
</td>
<td class="nump">$ 258,570,102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 124,869,117<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Operating loss (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(104,150,129)<span></span>
</td>
<td class="nump">19,284,982<span></span>
</td>
<td class="nump">98,045,630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_GainlossOfRecognitionTransactions', window );">Estimated gain (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=mlec_MoolecScienceLuxembourgMember', window );">Moolec Science (Luxembourg) [Member[</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>The Group&#8217;s Business Reorganization and General Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ReverseStockSplitConsolidationRatio', window );">Consolidation ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">ten-to-one<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Shares received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=mlec_MoolecScienceCaymanIslandsMember', window );">Moolec Science (Cayman Islands) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>The Group&#8217;s Business Reorganization and General Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Par value (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=mlec_BioceresSAMember', window );">Bioceres S.A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>The Group&#8217;s Business Reorganization and General Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Shareholders' deficit (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(91,042,130)<span></span>
</td>
<td class="nump">54,026,136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Operating loss (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(91,566,943)<span></span>
</td>
<td class="num">$ (5,145,053)<span></span>
</td>
<td class="nump">$ 3,194,004<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_GainlossOfDerecognitionTransactions', window );">Approximate gain (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=mlec_BioceresLLCMember', window );">Bioceres LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>The Group&#8217;s Business Reorganization and General Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_GainlossOfDerecognitionTransactions', window );">Approximate gain (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=mlec_SubsequentEventsMember', window );">Subsequent Events [Member] | Bioceres S.A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>The Group&#8217;s Business Reorganization and General Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceCosts', window );">Finance debt (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NumberOfSharesPledged', window );">Shares pledged</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,062,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresGroupLimitedMember', window );">Bioceres Group Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>The Group&#8217;s Business Reorganization and General Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Shares received</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">450,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ConsiderationForIssuedOrdinaryShareValue', window );">Consideration for issued ordinary shares value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresGroupLimitedMember', window );">Bioceres Group Limited [Member] | Ordinary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>The Group&#8217;s Business Reorganization and General Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Shares received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ConsiderationForIssuedOrdinaryShareValue', window );">Consideration for issued ordinary shares value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_GentleTechMember', window );">Gentle Tech [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>The Group&#8217;s Business Reorganization and General Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Shares received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_GentleTechMember', window );">Gentle Tech [Member] | Ordinary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>The Group&#8217;s Business Reorganization and General Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Shares received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=mlec_HoldbackMember', window );">Holdback [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>The Group&#8217;s Business Reorganization and General Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Percentage of equity and voting interest acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Borrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of outstanding funds that the entity is obligated to repay.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Borrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentDebtInstrumentsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current debt instruments issued. [Refer: Debt instruments issued]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentDebtInstrumentsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 82<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_82_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_a_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 160<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_160_a_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of voting equity interests acquired in a business combination. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2025-01-01<br> -Paragraph B64<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B64_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfVotingEquityInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2025-01-01<br> -Paragraph IE33<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_IE33&amp;doctype=Illustrative%20Examples<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The proportion of the voting rights in a subsidiary held by the entity. [Refer: Total for all subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17_b_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2025-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_16_b_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 19B<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_19B_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfVotingPowerHeldInSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares in the entity held by the entity or by its subsidiaries or associates. [Refer: Total for all associates [member]; Total for all subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 160<br> -Subparagraph a<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_160_a_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph a<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_a_vi&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_79_a_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_AdditionalOrdinarySharesIssue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional ordinary shares issue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_AdditionalOrdinarySharesIssue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ConsiderationForIssuedOrdinaryShareValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares in consideration for issued ordinary share value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ConsiderationForIssuedOrdinaryShareValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_GainlossOfDerecognitionTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on derecognition transactions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_GainlossOfDerecognitionTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_GainlossOfRecognitionTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on recognition transactions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_GainlossOfRecognitionTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_NumberOfSharesOutstandingPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of number of shares outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_NumberOfSharesOutstandingPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_NumberOfSharesPledged">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of shares pledged.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_NumberOfSharesPledged</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_NumberOfSharesReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares under reverse stock split.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_NumberOfSharesReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_PercentageOfIssuedAndOutstandingEquityInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of issued and outstanding equity interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_PercentageOfIssuedAndOutstandingEquityInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_PrivateWarrantsExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Private warrants exercise price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_PrivateWarrantsExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_PrivateWarrantsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Private warrants shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_PrivateWarrantsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ReverseStockSplitConsolidationRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of reverse stock split consolidation ratio.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ReverseStockSplitConsolidationRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_WorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of working capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_WorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=mlec_MoolecScienceLuxembourgMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=mlec_MoolecScienceLuxembourgMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=mlec_MoolecScienceCaymanIslandsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=mlec_MoolecScienceCaymanIslandsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=mlec_BioceresSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=mlec_BioceresSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=mlec_BioceresLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=mlec_BioceresLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=mlec_SubsequentEventsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=mlec_SubsequentEventsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresGroupLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresGroupLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfOrdinarySharesAxis=mlec_OrdinarySharesOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfOrdinarySharesAxis=mlec_OrdinarySharesOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_GentleTechMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_GentleTechMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=mlec_HoldbackMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=mlec_HoldbackMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting Standards and Basis of Preparation (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 16, 2025</div></th>
<th class="th"><div>May 22, 2025</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AccountingStandardsandBasisofPreparationDetailsLineItems', window );"><strong>Accounting Standards and Basis of Preparation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ShorttermPeriod', window );">Short-term period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_CumulativeInflationRate', window );">Cumulative inflation rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InflationOfAccumulatedYears', window );">Inflation of accumulated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PercentageOfInflationAccumulated', window );">Percentage of Inflation accumulated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ArgentinePriceIndexShares', window );">Argentine price index shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,855.5681<span></span>
</td>
<td class="nump">6,351.7145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PercentageOfIssuedAndOutstandingEquityInterests', window );">Percentage of issued and outstanding equity interests</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ConsiderationForIssuedOrdinaryShareValue', window );">Consideration for issued ordinary shares value</a></td>
<td class="nump">6,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PrivateWarrantShares', window );">Private warrant shares</a></td>
<td class="nump">450,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PrivateWarrantsExercisePrice', window );">Private warrants exercise price (in Dollars per share)</a></td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PercentageOfShare', window );">Percentage of share</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssuedCapitalOrdinaryShares', window );">Ordinary shares (in Dollars)</a></td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresGroupLimitedMember', window );">Bioceres Group Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AccountingStandardsandBasisofPreparationDetailsLineItems', window );"><strong>Accounting Standards and Basis of Preparation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ConsiderationForIssuedOrdinaryShareValue', window );">Consideration for issued ordinary shares value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Ordinary shares</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">450,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BusinessCombinationMember', window );">Business Combination [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AccountingStandardsandBasisofPreparationDetailsLineItems', window );"><strong>Accounting Standards and Basis of Preparation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Ordinary shares</a></td>
<td class="nump">132,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BusinessCombinationMember', window );">Business Combination [Member] | Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AccountingStandardsandBasisofPreparationDetailsLineItems', window );"><strong>Accounting Standards and Basis of Preparation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Ordinary shares</a></td>
<td class="nump">14,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember', window );">Ordinary shares [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AccountingStandardsandBasisofPreparationDetailsLineItems', window );"><strong>Accounting Standards and Basis of Preparation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,891,761<span></span>
</td>
<td class="nump">5,983,687<span></span>
</td>
<td class="nump">5,301,700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember', window );">Ordinary shares [member] | Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AccountingStandardsandBasisofPreparationDetailsLineItems', window );"><strong>Accounting Standards and Basis of Preparation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Ordinary shares</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssuedCapitalOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value of capital arising from issuing ordinary shares. [Refer: Issued capital]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssuedCapitalOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_AccountingStandardsandBasisofPreparationDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_AccountingStandardsandBasisofPreparationDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ArgentinePriceIndexShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Argentine price index shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ArgentinePriceIndexShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ConsiderationForIssuedOrdinaryShareValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares in consideration for issued ordinary share value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ConsiderationForIssuedOrdinaryShareValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_CumulativeInflationRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>CumulativeInflation rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_CumulativeInflationRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_InflationOfAccumulatedYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The years of inflation accumulated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_InflationOfAccumulatedYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_PercentageOfInflationAccumulated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of Inflation accumulated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_PercentageOfInflationAccumulated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_PercentageOfIssuedAndOutstandingEquityInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of issued and outstanding equity interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_PercentageOfIssuedAndOutstandingEquityInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_PercentageOfShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_PercentageOfShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_PrivateWarrantShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Private warrant shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_PrivateWarrantShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_PrivateWarrantsExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Private warrants exercise price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_PrivateWarrantsExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ShorttermPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Short-term period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ShorttermPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresGroupLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresGroupLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BusinessCombinationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BusinessCombinationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Accounting Standards and Basis of Preparation - Schedule of Information related to Company&#8217;s Share of Voting Rights in its Subsidiaries (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_MoolecScienceLimitedMember', window );">Moolec Science Limited [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Schedule of Information related to Company&#8217;s Share of Voting Rights in its Subsidiaries [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Principal activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Investment in subsidiaries<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation and principal place of business</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">United Kingdom<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Equity interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_AGBiomoleculesLLCMember', window );">AG Biomolecules LLC [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Schedule of Information related to Company&#8217;s Share of Voting Rights in its Subsidiaries [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Principal activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Production and commercialization of agricultural products<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation and principal place of business</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">United States<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Equity interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_ValoraSoySAMember', window );">ValoraSoy S.A.[Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Schedule of Information related to Company&#8217;s Share of Voting Rights in its Subsidiaries [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Principal activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Production and commercialization of agricultural products<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation and principal place of business</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Argentina<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Equity interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_NutreconLLCMember', window );">Nutrecon LLC [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Schedule of Information related to Company&#8217;s Share of Voting Rights in its Subsidiaries [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Principal activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Investment in subsidiaries<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation and principal place of business</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">United States<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Equity interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_SynBioPowerlabsMember', window );">SynBio Powerlabs [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Schedule of Information related to Company&#8217;s Share of Voting Rights in its Subsidiaries [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Principal activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Production and commercialization of fermentation products<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation and principal place of business</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Finland<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Equity interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">90.00%<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_GentleTechMember', window );">Gentle Tech [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Schedule of Information related to Company&#8217;s Share of Voting Rights in its Subsidiaries [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Principal activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Investment in subsidiaries<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation and principal place of business</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">British Virgin Islands<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Equity interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[3]</sup></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_GentleFarmingMember', window );">Gentle Farming [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Schedule of Information related to Company&#8217;s Share of Voting Rights in its Subsidiaries [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Principal activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Investment in subsidiaries<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation and principal place of business</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">British Virgin Islands<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Equity interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[3]</sup></td>
<td class="nump">51.00%<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_GFASMember', window );">G-FAS [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Schedule of Information related to Company&#8217;s Share of Voting Rights in its Subsidiaries [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Principal activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Production and commercialization of sustainable agricultural equipment<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation and principal place of business</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Argentina<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Equity interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[3]</sup></td>
<td class="nump">64.00%<span></span>
</td>
<td class="nump">64.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresGroupLimitedMember', window );">Bioceres Group Limited [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Schedule of Information related to Company&#8217;s Share of Voting Rights in its Subsidiaries [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Principal activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Investment in subsidiaries<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation and principal place of business</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">United Kingdom<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Equity interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresCropSolutionsBIOXMember', window );">Bioceres Crop Solutions (BIOX) [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Schedule of Information related to Company&#8217;s Share of Voting Rights in its Subsidiaries [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Principal activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Research and development<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation and principal place of business</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">United States<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Equity interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">29.30%<span></span>
</td>
<td class="nump">28.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresLLCMember', window );">Bioceres LLC [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Schedule of Information related to Company&#8217;s Share of Voting Rights in its Subsidiaries [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Principal activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Investment in subsidiaries<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation and principal place of business</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">United States<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Equity interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresSAMember', window );">Bioceres S.A [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Schedule of Information related to Company&#8217;s Share of Voting Rights in its Subsidiaries [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Principal activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Investment in subsidiaries<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation and principal place of business</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Argentina<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Equity interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">89.93%<span></span>
</td>
<td class="nump">79.72%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresTechServicesLLCMember', window );">Bioceres Tech Services LLC [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Schedule of Information related to Company&#8217;s Share of Voting Rights in its Subsidiaries [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Principal activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Investment in subsidiaries<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation and principal place of business</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">United States<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Equity interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Direct
interest held by Moolec Science SA.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Direct
interest held by Nutrecon LLC.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Direct interests held by Bioceres Group Limited.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">Since
2023, the Group exercises &#8220;de facto control&#8221; over Bioceres Crop Solutions Corp, however, as stated in note Note 1 &#8211;
The Group&#8217;s business reorganization and general information - &#8220;<i>The Bioceres Group Business Combination Agreement&#8221;</i>,
Bioceres Group Limited lost the &#8220;de facto control&#8221; on June 24, 2025. The subsidiary was deconsolidated as of June 30, 2025,
and the investment in it was measured using the equity method. The Group&#8217;s consolidated result includes the results of that entity
up to the date of its deconsolidation. No results related to the loss of control have been recognized. Various notes to the financial
statements show the effect it has had on consolidated assets and liabilities, business segments and CGUs.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The country in which a subsidiary of the entity is incorporated. [Refer: Total for all subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2025-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_16_b_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17_b_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 12<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_12_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 19B<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_19B_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NameOfSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The name of a subsidiary. [Refer: Total for all subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 12<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_12_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2025-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_16_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 19B<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_19B_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NameOfSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Total for all subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17_b_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2025-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_16_b_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 19B<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_19B_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfOwnershipInterestInSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_MoolecScienceLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_MoolecScienceLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_AGBiomoleculesLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_AGBiomoleculesLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_ValoraSoySAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_ValoraSoySAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_NutreconLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_NutreconLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_SynBioPowerlabsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_SynBioPowerlabsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_GentleTechMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_GentleTechMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_GentleFarmingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_GentleFarmingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_GFASMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_GFASMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresGroupLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresGroupLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresCropSolutionsBIOXMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresCropSolutionsBIOXMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresTechServicesLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresTechServicesLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>New Standards, Amendments and Interpretations Issued by the IASB (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InitiallyAppliedIFRSsAxis=ifrs-full_LeaseLiabilityInASaleAndLeasebackMember', window );">Lease Liability in a Sale and Leaseback [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems', window );"><strong>New Standards, Amendments and Interpretations Issued by the IASB [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionWhetherChangeInAccountingPolicyIsMadeInAccordanceWithTransitionalProvisionsOfInitiallyAppliedIFRS', window );">Description of nature</a></td>
<td class="text">IFRS 16 - Lease Liability in a Sale and Leaseback.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TitleOfInitiallyAppliedIFRS', window );">Title of initially applied</a></td>
<td class="text">IFRS 16<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InitiallyAppliedIFRSsAxis=ifrs-full_NoncurrentLiabilitiesWithCovenantsMember', window );">Non-current Liabilities with Covenants [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems', window );"><strong>New Standards, Amendments and Interpretations Issued by the IASB [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionWhetherChangeInAccountingPolicyIsMadeInAccordanceWithTransitionalProvisionsOfInitiallyAppliedIFRS', window );">Description of nature</a></td>
<td class="text">IAS 1 &#8211; Non-current liabilities with covenants.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TitleOfInitiallyAppliedIFRS', window );">Title of initially applied</a></td>
<td class="text">IAS 1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionWhetherChangeInAccountingPolicyIsMadeInAccordanceWithTransitionalProvisionsOfInitiallyAppliedIFRS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 178<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_178_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 178<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_178_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionWhetherChangeInAccountingPolicyIsMadeInAccordanceWithTransitionalProvisionsOfInitiallyAppliedIFRS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TitleOfInitiallyAppliedIFRS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 178<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_178_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 178<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_178_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TitleOfInitiallyAppliedIFRS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InitiallyAppliedIFRSsAxis=ifrs-full_LeaseLiabilityInASaleAndLeasebackMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InitiallyAppliedIFRSsAxis=ifrs-full_LeaseLiabilityInASaleAndLeasebackMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InitiallyAppliedIFRSsAxis=ifrs-full_NoncurrentLiabilitiesWithCovenantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InitiallyAppliedIFRSsAxis=ifrs-full_NoncurrentLiabilitiesWithCovenantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2025 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ValuationSignificantChangeInAmountNormalWearAndTearVariationImpactOnRevaluationAmount', window );">Impact on revaluation amount (in Dollars)</a></td>
<td class="nump">$ 1.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_ComputerSoftwareMember', window );">Software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember', window );">Trademarks and patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_LicencesMember', window );">Certification ISO Standards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember', window );">Product development [Member] | Bottom of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Useful life</a></td>
<td class="text">20 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember', window );">Product development [Member] | Top of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Useful life</a></td>
<td class="text">25 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_BrandNamesMember', window );">Trademarks [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Useful life</a></td>
<td class="text">20 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember', window );">Customer loyalty [Member] | Bottom of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Useful life</a></td>
<td class="text">14 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember', window );">Customer loyalty [Member] | Top of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Useful life</a></td>
<td class="text">26 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OtherPropertyPlantAndEquipmentMember', window );">Research instruments [Member] | Bottom of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful lives</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OtherPropertyPlantAndEquipmentMember', window );">Research instruments [Member] | Top of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful lives</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OfficeEquipmentMember', window );">Office equipment [Member] | Bottom of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful lives</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OfficeEquipmentMember', window );">Office equipment [Member] | Top of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful lives</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_VehiclesMember', window );">Vehicles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful lives</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember', window );">Computer equipment and software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful lives</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember', window );">Fixture and fittings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful lives</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=mlec_IfrsFull_machineryAndEquipmentMember', window );">Machinery and equipment [Member] | Bottom of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful lives</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=mlec_IfrsFull_machineryAndEquipmentMember', window );">Machinery and equipment [Member] | Top of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful lives</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember', window );">Buildings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful lives</a></td>
<td class="text">50 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ValuationSignificantChangePercentageOfConstructionCosts', window );">Change in construction costs that impacts valuation</a></td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeBiologicalAssetsAtCost', window );">Period from moment of sowing until the moment of harvest</a></td>
<td class="text">5 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AveragePaymentTermBySales', window );">Average payment terms</a></td>
<td class="text">130 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeBiologicalAssetsAtCost', window );">Period from moment of sowing until the moment of harvest</a></td>
<td class="text">7 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AveragePaymentTermBySales', window );">Average payment terms</a></td>
<td class="text">160 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeBiologicalAssetsAtCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The useful life, measured as period of time, used for biological assets. [Refer: Biological assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 41<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=41&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_54_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 274<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_274_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 274<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_274_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeBiologicalAssetsAtCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The useful life, measured as period of time, used for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 118<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_118_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The useful life, measured as period of time, used for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 73<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_73_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_AveragePaymentTermBySales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Average payment terms range at consolidate level from sale of materials.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_AveragePaymentTermBySales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ValuationSignificantChangeInAmountNormalWearAndTearVariationImpactOnRevaluationAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of increase (decrease) in the amount of normal wear and tear variation impact on revaluation of land.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ValuationSignificantChangeInAmountNormalWearAndTearVariationImpactOnRevaluationAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ValuationSignificantChangePercentageOfConstructionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of construction costs change that could have significant impact on valuation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ValuationSignificantChangePercentageOfConstructionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_ComputerSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_ComputerSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_LicencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_LicencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_BrandNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_BrandNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OtherPropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OtherPropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=mlec_IfrsFull_machineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=mlec_IfrsFull_machineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Other Significant Transactions (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 14, 2025 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>May 22, 2025 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 28, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 10, 2024 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 10, 2024 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Fair value of consideration</a></td>
<td class="nump">$ 34,534,531<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Par value per share (in Pesos per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermBorrowings', window );">Working capital loan</a></td>
<td class="nump">$ 227,154,007<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 234,510,751<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PercentageOfCustomerRevenues', window );">Percentage of customer revenues</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=mlec_ProFarmGroupIncMember', window );">Pro Farm Group Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueOfCombinedEntity', window );">Revenue of the combined entity</a></td>
<td class="nump">$ 339,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossOfCombinedEntity', window );">Profit or loss of the combined entity</a></td>
<td class="nump">157,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=mlec_NatalAgroSRLMember', window );">Natal Agro S. R. L. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NumberOfSharesAcquiredInBusinessCombination', window );">Number of shares acquired (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">116,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Par value per share (in Pesos per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Percentage of equity and voting interest acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 220,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermBorrowings', window );">Working capital loan</a></td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresGroupLimitedMember', window );">Bioceres Group Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Fair value of consideration</a></td>
<td class="nump">$ 19,939,162<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2025-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B64_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value, at acquisition date, of cash transferred as consideration in a business combination. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2025-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B64_f_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_e_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_e_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBusinessCombinationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_a_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 160<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_160_a_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of voting equity interests acquired in a business combination. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2025-01-01<br> -Paragraph B64<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B64_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfVotingEquityInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossOfCombinedEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) of the combined entity as though the acquisition date for all business combinations that occurred during the year had been as of the beginning of the annual reporting period. [Refer: Total for all business combinations [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2025-01-01<br> -Paragraph B64<br> -Subparagraph q<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B64_q_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossOfCombinedEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueOfCombinedEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2025-01-01<br> -Paragraph B64<br> -Subparagraph q<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B64_q_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueOfCombinedEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShorttermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShorttermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_NumberOfSharesAcquiredInBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the number of shares acquired in business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_NumberOfSharesAcquiredInBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_PercentageOfCustomerRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of customer revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_PercentageOfCustomerRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=mlec_ProFarmGroupIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=mlec_ProFarmGroupIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=mlec_NatalAgroSRLMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=mlec_NatalAgroSRLMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresGroupLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresGroupLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisitions and Other Significant Transactions - Schedule of Fair Value of the Consideration of Payment (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis=mlec_ProFarmGroupIncMember', window );">Pro Farm Group Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AcquisitionsandOtherSignificantTransactionsScheduleofFairValueoftheConsiderationofPaymentDetailsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_EquityShares', window );">Equity shares</a></td>
<td class="nump">$ 33,504,531<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WarrantLiability', window );">Warrants</a></td>
<td class="nump">1,030,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Total consideration</a></td>
<td class="nump">34,534,531<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis=mlec_NatalAgroSRLMember', window );">Natal Agro S. R. L. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AcquisitionsandOtherSignificantTransactionsScheduleofFairValueoftheConsiderationofPaymentDetailsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Total consideration</a></td>
<td class="nump">943,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash payment</a></td>
<td class="nump">215,415<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityInterestsOfAcquirer', window );">Regulatory activities</a></td>
<td class="nump">$ 727,985<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2025-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B64_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value, at acquisition date, of cash transferred as consideration in a business combination. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2025-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B64_f_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_e_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_e_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityInterestsOfAcquirer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value, at the acquisition date, of equity interests of the acquirer transferred as consideration in a business combination. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2025-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B64_f_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph e<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_e_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph e<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_e_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityInterestsOfAcquirer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of warrant liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_AcquisitionsandOtherSignificantTransactionsScheduleofFairValueoftheConsiderationofPaymentDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_AcquisitionsandOtherSignificantTransactionsScheduleofFairValueoftheConsiderationofPaymentDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_EquityShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_EquityShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis=mlec_ProFarmGroupIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis=mlec_ProFarmGroupIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis=mlec_NatalAgroSRLMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis=mlec_NatalAgroSRLMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and Other Significant Transactions - Schedule of Assets Acquired and Liabilities Assumed (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 554,420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeReceivables', window );">Trade and other receivables</a></td>
<td class="nump">4,036,558<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate', window );">Property, plant and equipment</a></td>
<td class="nump">3,319,313<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Intangible assets</a></td>
<td class="nump">74,841,933<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsToRightofuseAssets', window );">Right of use assets</a></td>
<td class="nump">100,896<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InventoriesTotal', window );">Inventories</a></td>
<td class="nump">2,235,482<span></span>
</td>
<td class="nump">$ 110,913,884<span></span>
</td>
<td class="nump">$ 112,000,786<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate', window );">Borrowings</a></td>
<td class="num">(19,608,629)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Deferred revenue and advances from customers</a></td>
<td class="num">(6,636,121)<span></span>
</td>
<td class="nump">7,791,048<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate', window );">Accounts payable</a></td>
<td class="num">(5,806,020)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="num">(117,463)<span></span>
</td>
<td class="num">$ (11,284,137)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WarrantLiability', window );">Warrant liabilities</a></td>
<td class="num">(181,093)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate', window );">Deferred tax liabilities</a></td>
<td class="num">(15,767,275)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed', window );">Total net assets identified</a></td>
<td class="nump">43,608,122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NoncontrollingInterest', window );">Non-controlling interest</a></td>
<td class="nump">6,316,790<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Previously held interest - revalued at FV</a></td>
<td class="nump">1,283,319<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnDisposalsOfInvestments', window );">Gain on purchase</a></td>
<td class="nump">1,473,482<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Total consideration</a></td>
<td class="nump">34,534,531<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis=mlec_MoolecScienceSAMember', window );">Moolec Science SA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">252,923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherFinancialAssets', window );">Other financial assets</a></td>
<td class="nump">73,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeReceivables', window );">Trade and other receivables</a></td>
<td class="nump">596,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherReceivables', window );">Other receivables</a></td>
<td class="nump">288,861<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_IncomeAndMinimumPresumedRecoverableIncomeTaxes', window );">Income and minimum presumed recoverable income taxes</a></td>
<td class="nump">19,998<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate', window );">Property, plant and equipment</a></td>
<td class="nump">816,576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Intangible assets</a></td>
<td class="nump">2,217,985<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsToRightofuseAssets', window );">Right of use assets</a></td>
<td class="nump">168,988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayables', window );">Trade and other payables</a></td>
<td class="num">(2,302,332)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InventoriesTotal', window );">Inventories</a></td>
<td class="nump">4,031,412<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate', window );">Borrowings</a></td>
<td class="num">(743,279)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SocialSecurityContributions', window );">Employee benefits and social security</a></td>
<td class="num">(23,346)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Deferred revenue and advances from customers</a></td>
<td class="num">(2,515)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentProvisions', window );">Provisions</a></td>
<td class="num">(355,898)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="num">(168,988)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate', window );">Deferred tax liabilities</a></td>
<td class="num">(996,824)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed', window );">Total net assets identified</a></td>
<td class="nump">3,873,974<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NoncontrollingInterest', window );">Non-controlling interest</a></td>
<td class="num">(1,898,247)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainRecognisedInBargainPurchaseTransaction', window );">Gain from a bargain purchase</a></td>
<td class="num">(1,032,327)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Total consideration</a></td>
<td class="nump">$ 943,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2025-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B64_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsToRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to right-of-use assets. [Refer: Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 53<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_53_h&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115_g&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115_g&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsToRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for borrowings assumed in a business combination. [Refer: Borrowings; Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2025-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current provisions, including provisions for employee benefits. [Refer: Provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph l<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_l&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_g_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph f<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_f_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph f<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_f_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for deferred tax liabilities assumed in a business combination. [Refer: Deferred tax liabilities; Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2025-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of financial assets. [Refer: At fair value [member]; Financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainRecognisedInBargainPurchaseTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2025-01-01<br> -Paragraph B64<br> -Subparagraph n<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B64_n_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainRecognisedInBargainPurchaseTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnDisposalsOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gains (losses) on disposals of investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 98<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_98_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnDisposalsOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for net identifiable assets acquired or liabilities assumed in a business combination. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2025-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2025-01-01<br> -Paragraph IE72<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_g&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_g&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for identifiable intangible assets acquired in a business combination. [Refer: Intangible assets other than goodwill; Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2025-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2025-01-01<br> -Paragraph IE72<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_g&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_g&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InventoriesTotal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets: (a) held for sale in the ordinary course of business; (b) in the process of production for such sale; or (c) in the form of materials or supplies to be consumed in the production process or in the rendering of services. Inventories encompass goods purchased and held for resale including, for example, merchandise purchased by a retailer and held for resale, or land and other property held for resale. Inventories also encompass finished goods produced, or work in progress being produced, by the entity and include materials and supplies awaiting use in the production process. [Refer: Current finished goods; Current merchandise; Current work in progress; Land]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_g&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InventoriesTotal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash and cash equivalents that the entity does not separately disclose in the same statement or note. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of financial assets that the entity does not separately disclose in the same statement or note. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount receivable by the entity that it does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for plant, property and equipment acquired in a business combination. [Refer: Property, plant and equipment; Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2025-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2025-01-01<br> -Paragraph IE72<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_g&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_g&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SocialSecurityContributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 9<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_9&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SocialSecurityContributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of trade payables and other payables. [Refer: Trade payables; Other payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph k<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_k&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for trade and other payables assumed in a business combination. [Refer: Trade and other payables; Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2025-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount due from customers for goods and services sold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of warrant liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_IncomeAndMinimumPresumedRecoverableIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income and minimum presumed recoverable income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_IncomeAndMinimumPresumedRecoverableIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_NoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-controlling interest information components.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_NoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis=mlec_MoolecScienceSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis=mlec_MoolecScienceSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Information About Components of Consolidated Statements of Financial Position (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 18, 2025</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jul. 01, 2025</div></th>
<th class="th"><div>May 22, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems', window );"><strong>Information About Components of Consolidated Statements of Financial Position [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryOtherProvisions', window );">Loss of control (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,089,768<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EstimatedFinancialEffectOfContingentAssets', window );">Estimated value (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InventoryRecognizedAsExpense', window );">Inventory recognized as expense (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Issued convertible preference shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PercentageOfPreferenceSharesAccrue', window );">Percentage of preference shares accrue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AggregateAmount', window );">Aggregate amount (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentDebtInstrumentsIssued', window );">Current debt amounts (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Interest rate</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AmortizationPayments', window );">Amortization payments (in Dollars)</a></td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PercentageOfPrepaymentPremium', window );">Prepayment premium</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PercentageOfPenalty', window );">Percentage of penalty</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Maturity date</a></td>
<td class="text">August 31, 2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PricePerSharesOfStrikePrice', window );">Price per shares of strike price (in Dollars per share)</a></td>
<td class="nump">$ 6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_CommonEquity', window );">Common equity (in Dollars)</a></td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PercentageOfPenaltyOfPrepayment', window );">Percentage of Penalty of Prepayment</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PrepaymentPremiumFee', window );">Prepayment Premium Fee (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,870,021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LoansReceived', window );">Convertible note received (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AdditionalConvertibleNotesReceivedAmount', window );">Additional convertible notes received (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 940,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ConversionOptionStrikePrice', window );">Conversion option strike price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PercentageOfOutstandingAmountInitialInterestRate', window );">Initial interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PercentageOfCashPaymentInterestRate', window );">Percentage of cash payment interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ContingentPayment', window );">Contingent payment (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ContingentPaymentCurrent', window );">Contingent payment current value (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PercentageOfCapital', window );">Percentage of capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PercentageOfDividendsTaxedShares', window );">Percentage of taxed dividend shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ContingentPurchasePrice', window );">Contingent purchase price (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=mlec_SecuredGuaranteedNotesDue2026Member', window );">Secured Guaranteed Notes due 2026 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems', window );"><strong>Information About Components of Consolidated Statements of Financial Position [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_IfrsDebtInstrumentTerm', window );">Maturity period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">48 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=mlec_SecuredConvertibleGuaranteedNotesMember', window );">Secured Convertible Guaranteed Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems', window );"><strong>Information About Components of Consolidated Statements of Financial Position [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Interest rate</a></td>
<td class="nump">19.00%<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_IfrsDebtInstrumentTerm', window );">Maturity period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Nominal value (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_BorrowingInterestRateInCash', window );">Interest payable in cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_BorrowingInterestRateInKind', window );">Interest payable in kind</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_StrikePriceForConversionOfDebt', window );">Strike price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_VoluntaryRepurchaseOfNotesAfterIssueDate', window );">Voluntary repurchase of notes after the issue date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DiscountRateForFairValueOfLiabilityComponent', window );">Discount rate for fair value of the liability component</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.57%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PrepaymentPremiumFee', window );">Prepayment Premium Fee (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems', window );"><strong>Information About Components of Consolidated Statements of Financial Position [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ProjectedPeriodRange', window );">Projected period range</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Interest rate</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Principal amount (in Dollars)</a></td>
<td class="nump">$ 61,652,927<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PercentageOfPenaltyOfPrepayment', window );">Percentage of Penalty of Prepayment</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range [member] | Secured Convertible Guaranteed Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems', window );"><strong>Information About Components of Consolidated Statements of Financial Position [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Principal amount (in Dollars)</a></td>
<td class="nump">$ 26,437,485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems', window );"><strong>Information About Components of Consolidated Statements of Financial Position [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ProjectedPeriodRange', window );">Projected period range</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Interest rate</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Principal amount (in Dollars)</a></td>
<td class="nump">$ 67,868,227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PercentageOfPenalty', window );">Percentage of penalty</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range [member] | Secured Convertible Guaranteed Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems', window );"><strong>Information About Components of Consolidated Statements of Financial Position [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Interest rate</a></td>
<td class="nump">14.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Principal amount (in Dollars)</a></td>
<td class="nump">$ 29,081,233<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=mlec_FortyEightMonthsMember', window );">48 Months [Member] | Secured Guaranteed Notes due 2026 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems', window );"><strong>Information About Components of Consolidated Statements of Financial Position [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember', window );">25 through 36 months [Member] | Secured Guaranteed Notes due 2026 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems', window );"><strong>Information About Components of Consolidated Statements of Financial Position [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember', window );">37 through 48 months [Member] | Secured Guaranteed Notes due 2026 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems', window );"><strong>Information About Components of Consolidated Statements of Financial Position [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresGroupMember', window );">Bioceres Group [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems', window );"><strong>Information About Components of Consolidated Statements of Financial Position [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Issued convertible preference shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,380,952<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssuedCapitalPreferenceShares', window );">Total proceeds (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=mlec_SubsequentEventsMember', window );">Subsequent Events [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems', window );"><strong>Information About Components of Consolidated Statements of Financial Position [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DebtInstrumentsHeldAtAmortisedCost', window );">Financial debt (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_CreditorsPublicAuctionShares', window );">Creditor public auction shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,062,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Borrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of outstanding funds that the entity is obligated to repay.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Borrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The interest rate on borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsMaturity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maturity of borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsMaturity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentDebtInstrumentsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current debt instruments issued. [Refer: Debt instruments issued]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentDebtInstrumentsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DebtInstrumentsHeldAtAmortisedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of instruments representing indebtedness held by the entity at amortised cost. [Refer: Debt instruments held; Financial assets at amortised cost]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DebtInstrumentsHeldAtAmortisedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease in other provisions resulting from the loss of control of a subsidiary. [Refer: Other provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2025-01-01<br> -Paragraph 84<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_84&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EstimatedFinancialEffectOfContingentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the estimated financial effect of possible assets that arise from past events and whose existence will be confirmed only by the occurrence or non-occurrence of one or more uncertain future events not wholly within control of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2025-01-01<br> -Paragraph 89<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_89&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 260<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_260&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 260<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_260&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EstimatedFinancialEffectOfContingentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssuedCapitalPreferenceShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value of capital arising from issuing preference shares. [Refer: Issued capital]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssuedCapitalPreferenceShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LoansReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of loans received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LoansReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal or face amount of a financial instrument, used to calculate payments made on that instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_AdditionalConvertibleNotesReceivedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional convertible notes received amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_AdditionalConvertibleNotesReceivedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_AggregateAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_AggregateAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_AmortizationPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of amortization payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_AmortizationPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_BorrowingInterestRateInCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The interest rate on borrowings payable in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_BorrowingInterestRateInCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_BorrowingInterestRateInKind">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The interest rate on borrowings payable in kind.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_BorrowingInterestRateInKind</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_CommonEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amoun of common equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_CommonEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ContingentPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ContingentPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ContingentPaymentCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent payment current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ContingentPaymentCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ContingentPurchasePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent purchase price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ContingentPurchasePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ConversionOptionStrikePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Conversion option strike price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ConversionOptionStrikePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_CreditorsPublicAuctionShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Credit public auction shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_CreditorsPublicAuctionShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DiscountRateForFairValueOfLiabilityComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The discount rate used to measure the fair value of the liability component of an instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DiscountRateForFairValueOfLiabilityComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_IfrsDebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_IfrsDebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_InventoryRecognizedAsExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of inventory recognized as expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_InventoryRecognizedAsExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_PercentageOfCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_PercentageOfCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_PercentageOfCashPaymentInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of cash payment interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_PercentageOfCashPaymentInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_PercentageOfDividendsTaxedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of dividends taxed shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_PercentageOfDividendsTaxedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_PercentageOfOutstandingAmountInitialInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of outstanding amount initial interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_PercentageOfOutstandingAmountInitialInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_PercentageOfPenalty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of penalty.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_PercentageOfPenalty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_PercentageOfPenaltyOfPrepayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of penalty of prepayment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_PercentageOfPenaltyOfPrepayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_PercentageOfPreferenceSharesAccrue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of preference shares accrue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_PercentageOfPreferenceSharesAccrue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_PercentageOfPrepaymentPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of prepayment premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_PercentageOfPrepaymentPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_PrepaymentPremiumFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepayment Premium Fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_PrepaymentPremiumFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_PricePerSharesOfStrikePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price per shares of strike price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_PricePerSharesOfStrikePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ProjectedPeriodRange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the projected period range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ProjectedPeriodRange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_StrikePriceForConversionOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The strike price per share for conversion of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_StrikePriceForConversionOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_VoluntaryRepurchaseOfNotesAfterIssueDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The voluntary repurchase of notes after the issue date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_VoluntaryRepurchaseOfNotesAfterIssueDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=mlec_SecuredGuaranteedNotesDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=mlec_SecuredGuaranteedNotesDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=mlec_SecuredConvertibleGuaranteedNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=mlec_SecuredConvertibleGuaranteedNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=mlec_FortyEightMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=mlec_FortyEightMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=mlec_SubsequentEventsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=mlec_SubsequentEventsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Information About Components of Consolidated Statements of Financial Position - Schedule of Cash and Cash Equivalents (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsAbstract', window );"><strong>Schedule of Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Cash', window );">Cash at bank and on hand</a></td>
<td class="nump">$ 767,919<span></span>
</td>
<td class="nump">$ 27,210,070<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_MutualFunds', window );">Mutual funds</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">25,784,795<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 767,919<span></span>
</td>
<td class="nump">$ 52,994,865<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits. [Refer: Cash on hand]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 169<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_169&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 169<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_169&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_MutualFunds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Mutual funds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_MutualFunds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Information About Components of Consolidated Statements of Financial Position - Schedule of Other Financial Assets (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_CurrentAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentFinancialAssets', window );">Investments at fair value</a></td>
<td class="nump">$ 8,254,261<span></span>
</td>
<td class="nump">$ 14,667,607<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NonCurrentAbstract', window );"><strong>Non-current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentFinancialAssets', window );">Investments at fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">190,517<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=mlec_InvestmentsInSharesMember', window );">Investments at fair value [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_CurrentAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentFinancialAssets', window );">Investments at fair value</a></td>
<td class="nump">19,722<span></span>
</td>
<td class="nump">2,191,286<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NonCurrentAbstract', window );"><strong>Non-current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentFinancialAssets', window );">Investments at fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">437<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=mlec_MutualFundsMember', window );">Mutual funds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_CurrentAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentFinancialAssets', window );">Investments at fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">6,658,805<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NonCurrentAbstract', window );"><strong>Non-current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentFinancialAssets', window );">Investments at fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">190,080<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=mlec_OtherInvestmentMember', window );">Other investments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_CurrentAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentFinancialAssets', window );">Investments at fair value</a></td>
<td class="nump">$ 8,234,539<span></span>
</td>
<td class="nump">$ 5,817,516<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current financial assets that the entity does not separately disclose in the same statement or note. [Refer: Other financial assets; Current financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current financial assets that the entity does not separately disclose in the same statement or note. [Refer: Other financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_CurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_CurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_NonCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_NonCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=mlec_InvestmentsInSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=mlec_InvestmentsInSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=mlec_MutualFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=mlec_MutualFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=mlec_OtherInvestmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=mlec_OtherInvestmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Information About Components of Consolidated Statements of Financial Position - Schedule of Trade Receivables (Details) - Trade receivables - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_CurrentAbstract0', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Trade debtors</a></td>
<td class="nump">$ 4,519,487<span></span>
</td>
<td class="nump">$ 205,490,518<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_CurrentTradeReceivablesAllowanceForImpairmentOfTradeDebtors', window );">Allowance for impairment of trade debtors</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(7,050,280)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_CurrentTradeReceivablesShareholdersAndOtherRelatedParties', window );">Shareholders and other related parties</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AllowanceForReturnOfGoods', window );">Allowance for credit notes to be issued</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(2,905,624)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_CurrentTradeReceivablesTradeDebtorsJointVenturesAndAssociates', window );">Trade debtors - Joint ventures and associates</a></td>
<td class="nump">1,565,913<span></span>
</td>
<td class="nump">2,176,622<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherReceivables', window );">Deferred checks</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">11,295,922<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentReceivables', window );">Total</a></td>
<td class="nump">$ 6,085,400<span></span>
</td>
<td class="nump">$ 209,007,195<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables. [Refer: Trade receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 68<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount receivable by the entity that it does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables and current other receivables. [Refer: Current trade receivables; Other current receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_h&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_AllowanceForReturnOfGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of allowance for return of goods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_AllowanceForReturnOfGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_CurrentAbstract0">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_CurrentAbstract0</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_CurrentTradeReceivablesAllowanceForImpairmentOfTradeDebtors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of current trade receivables of allowance for impairment of trade debtors.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_CurrentTradeReceivablesAllowanceForImpairmentOfTradeDebtors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_CurrentTradeReceivablesShareholdersAndOtherRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of current trade receivables of shareholders and other related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_CurrentTradeReceivablesShareholdersAndOtherRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_CurrentTradeReceivablesTradeDebtorsJointVenturesAndAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of trade debtors - joint ventures and associates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_CurrentTradeReceivablesTradeDebtorsJointVenturesAndAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_IfrsBalanceSheetLocationAxis=ifrs-full_TradeReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_IfrsBalanceSheetLocationAxis=ifrs-full_TradeReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Information About Components of Consolidated Statements of Financial Position - Schedule of Other Receivables (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_CurrentAbstract1', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentReceivables', window );">Other receivables, Current</a></td>
<td class="nump">$ 13,849,164<span></span>
</td>
<td class="nump">$ 34,657,383<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NonCurrentAbstract0', window );"><strong>Non-current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentReceivables', window );">Other receivables, Non-current</a></td>
<td class="nump">664,493<span></span>
</td>
<td class="nump">27,887,034<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=mlec_TaxesMember', window );">Taxes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_CurrentAbstract1', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentReceivables', window );">Other receivables, Current</a></td>
<td class="nump">382,957<span></span>
</td>
<td class="nump">5,475,685<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NonCurrentAbstract0', window );"><strong>Non-current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentReceivables', window );">Other receivables, Non-current</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">752,045<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=mlec_InsuranceToBeAccruedMember', window );">Insurance to be accrued [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_CurrentAbstract1', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentReceivables', window );">Other receivables, Current</a></td>
<td class="nump">11,835<span></span>
</td>
<td class="nump">1,595,319<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=mlec_OtherReceivablesJointVenturesAndAssociatesMember', window );">Other receivables - Joint ventures and associates (Note 13) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_CurrentAbstract1', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentReceivables', window );">Other receivables, Current</a></td>
<td class="nump">10,547,409<span></span>
</td>
<td class="nump">12,162,870<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NonCurrentAbstract0', window );"><strong>Non-current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentReceivables', window );">Other receivables, Non-current</a></td>
<td class="nump">664,493<span></span>
</td>
<td class="nump">25,423,142<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=mlec_PrepaymentsToSuppliersMember', window );">Prepayments to suppliers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_CurrentAbstract1', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentReceivables', window );">Other receivables, Current</a></td>
<td class="nump">114<span></span>
</td>
<td class="nump">7,236,905<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=mlec_ShareholdersAndOtherRelatedPartiesMember', window );">Shareholders and other related parties (Note 17) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_CurrentAbstract1', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentReceivables', window );">Other receivables, Current</a></td>
<td class="nump">2,313,179<span></span>
</td>
<td class="nump">47,348<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=mlec_GovernmentsGrantsReceivableMember', window );">Governments grants receivable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_CurrentAbstract1', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentReceivables', window );">Other receivables, Current</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">608<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=mlec_PrepaidExpensesAndOtherReceivablesMember', window );">Prepaid expenses and other receivables [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_CurrentAbstract1', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentReceivables', window );">Other receivables, Current</a></td>
<td class="nump">33,448<span></span>
</td>
<td class="nump">3,736,808<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=mlec_LoansReceivablesMember', window );">Loans receivables [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_CurrentAbstract1', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentReceivables', window );">Other receivables, Current</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,800,572<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=mlec_MiscellaneousMember', window );">Miscellaneous [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_CurrentAbstract1', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentReceivables', window );">Other receivables, Current</a></td>
<td class="nump">560,222<span></span>
</td>
<td class="nump">2,601,268<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NonCurrentAbstract0', window );"><strong>Non-current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentReceivables', window );">Other receivables, Non-current</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">20,805<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=mlec_OtherReceivableMember', window );">Other receivables [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NonCurrentAbstract0', window );"><strong>Non-current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentReceivables', window );">Other receivables, Non-current</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">230,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=mlec_ReimbursementsOverExportsMember', window );">Reimbursements over exports [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NonCurrentAbstract0', window );"><strong>Non-current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentReceivables', window );">Other receivables, Non-current</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,461,042<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current other receivables. [Refer: Other receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current other receivables. [Refer: Other receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_CurrentAbstract1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_CurrentAbstract1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_NonCurrentAbstract0">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_NonCurrentAbstract0</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=mlec_TaxesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=mlec_TaxesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=mlec_InsuranceToBeAccruedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=mlec_InsuranceToBeAccruedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=mlec_OtherReceivablesJointVenturesAndAssociatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=mlec_OtherReceivablesJointVenturesAndAssociatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=mlec_PrepaymentsToSuppliersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=mlec_PrepaymentsToSuppliersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=mlec_ShareholdersAndOtherRelatedPartiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=mlec_ShareholdersAndOtherRelatedPartiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=mlec_GovernmentsGrantsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=mlec_GovernmentsGrantsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=mlec_PrepaidExpensesAndOtherReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=mlec_PrepaidExpensesAndOtherReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=mlec_LoansReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=mlec_LoansReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=mlec_MiscellaneousMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=mlec_MiscellaneousMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=mlec_OtherReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=mlec_OtherReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=mlec_ReimbursementsOverExportsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=mlec_ReimbursementsOverExportsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Information About Components of Consolidated Statements of Financial Position - Schedule of Inventories (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InventoriesScheduleOfInventoriesLineItems', window );"><strong>InventoriesSchedule of Inventories [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InventoriesCurrent', window );">Inventories</a></td>
<td class="nump">$ 2,235,482<span></span>
</td>
<td class="nump">$ 125,929,768<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InventoriesExcludingAgriculturalProduce', window );">Net of agricultural products</a></td>
<td class="nump">1,545,650<span></span>
</td>
<td class="nump">110,913,884<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BiologicalAssetsAxis=mlec_SeedsAndGrainsMember', window );">Seeds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InventoriesScheduleOfInventoriesLineItems', window );"><strong>InventoriesSchedule of Inventories [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InventoriesCurrent', window );">Inventories</a></td>
<td class="nump">551,290<span></span>
</td>
<td class="nump">5,967,231<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BiologicalAssetsAxis=mlec_MicrobiologicalResaleProductsMember', window );">Resale products [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InventoriesScheduleOfInventoriesLineItems', window );"><strong>InventoriesSchedule of Inventories [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InventoriesCurrent', window );">Inventories</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">53,788,333<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BiologicalAssetsAxis=mlec_MicrobiologicalProductsProducedMember', window );">Manufactured products [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InventoriesScheduleOfInventoriesLineItems', window );"><strong>InventoriesSchedule of Inventories [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InventoriesCurrent', window );">Inventories</a></td>
<td class="nump">994,360<span></span>
</td>
<td class="nump">26,081,250<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BiologicalAssetsAxis=mlec_GoodsInTransitMember', window );">Goods in transit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InventoriesScheduleOfInventoriesLineItems', window );"><strong>InventoriesSchedule of Inventories [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InventoriesCurrent', window );">Inventories</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">5,618,540<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BiologicalAssetsAxis=mlec_SuppliesMember', window );">Supplies [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InventoriesScheduleOfInventoriesLineItems', window );"><strong>InventoriesSchedule of Inventories [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InventoriesCurrent', window );">Inventories</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">22,546,093<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BiologicalAssetsAxis=mlec_AgriculturalProductsMember', window );">Agricultural products [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InventoriesScheduleOfInventoriesLineItems', window );"><strong>InventoriesSchedule of Inventories [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InventoriesCurrent', window );">Inventories</a></td>
<td class="nump">689,832<span></span>
</td>
<td class="nump">15,015,884<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BiologicalAssetsAxis=mlec_AllowanceForObsolescenceMember', window );">Allowance for obsolescence [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InventoriesScheduleOfInventoriesLineItems', window );"><strong>InventoriesSchedule of Inventories [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InventoriesCurrent', window );">Inventories</a></td>
<td class="text"> <span></span>
</td>
<td class="num">$ (3,087,563)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_InventoriesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Inventories.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_InventoriesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_InventoriesExcludingAgriculturalProduce">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current inventories excluding agricultural produce.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_InventoriesExcludingAgriculturalProduce</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_InventoriesScheduleOfInventoriesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_InventoriesScheduleOfInventoriesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BiologicalAssetsAxis=mlec_SeedsAndGrainsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BiologicalAssetsAxis=mlec_SeedsAndGrainsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BiologicalAssetsAxis=mlec_MicrobiologicalResaleProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BiologicalAssetsAxis=mlec_MicrobiologicalResaleProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BiologicalAssetsAxis=mlec_MicrobiologicalProductsProducedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BiologicalAssetsAxis=mlec_MicrobiologicalProductsProducedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BiologicalAssetsAxis=mlec_GoodsInTransitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BiologicalAssetsAxis=mlec_GoodsInTransitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BiologicalAssetsAxis=mlec_SuppliesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BiologicalAssetsAxis=mlec_SuppliesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BiologicalAssetsAxis=mlec_AgriculturalProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BiologicalAssetsAxis=mlec_AgriculturalProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BiologicalAssetsAxis=mlec_AllowanceForObsolescenceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BiologicalAssetsAxis=mlec_AllowanceForObsolescenceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Information About Components of Consolidated Statements of Financial Position - Schedule of Changes in Biological Assets (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems', window );"><strong>Schedule of Changes in Biological Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BiologicalAssets', window );">Beginning of the year</a></td>
<td class="nump">$ 294,134<span></span>
</td>
<td class="nump">$ 146,842<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets', window );">Initial recognition and changes in the fair value of biological assets at the point of harvest</a></td>
<td class="nump">1,764,863<span></span>
</td>
<td class="num">(45,746)<span></span>
</td>
<td class="nump">$ 610,554<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets', window );">Costs incurred during the year</a></td>
<td class="nump">4,435,338<span></span>
</td>
<td class="nump">2,647,778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DecreaseDueToHarvestAndDisposalsBiologicalAssets', window );">Decrease due to harvest/disposals</a></td>
<td class="num">(4,115,955)<span></span>
</td>
<td class="num">(2,454,740)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_LossOfControlonBiologicalAssets', window );">Loss of control</a></td>
<td class="num">(2,378,380)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BiologicalAssets', window );">Ending of the year</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">294,134<span></span>
</td>
<td class="nump">146,842<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BiologicalAssetsAxis=mlec_BiologicalAssetsSoybeanMember', window );">Soybean [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems', window );"><strong>Schedule of Changes in Biological Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BiologicalAssets', window );">Beginning of the year</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets', window );">Initial recognition and changes in the fair value of biological assets at the point of harvest</a></td>
<td class="nump">593,001<span></span>
</td>
<td class="num">(352,199)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets', window );">Costs incurred during the year</a></td>
<td class="nump">1,959,381<span></span>
</td>
<td class="nump">1,423,732<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DecreaseDueToHarvestAndDisposalsBiologicalAssets', window );">Decrease due to harvest/disposals</a></td>
<td class="num">(1,275,688)<span></span>
</td>
<td class="num">(1,071,533)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_LossOfControlonBiologicalAssets', window );">Loss of control</a></td>
<td class="num">(1,276,694)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BiologicalAssets', window );">Ending of the year</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BiologicalAssetsAxis=mlec_BiologicalAssetsCornMember', window );">Corn [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems', window );"><strong>Schedule of Changes in Biological Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BiologicalAssets', window );">Beginning of the year</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets', window );">Initial recognition and changes in the fair value of biological assets at the point of harvest</a></td>
<td class="nump">435,725<span></span>
</td>
<td class="num">(32,674)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets', window );">Costs incurred during the year</a></td>
<td class="nump">1,814,249<span></span>
</td>
<td class="nump">792,235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DecreaseDueToHarvestAndDisposalsBiologicalAssets', window );">Decrease due to harvest/disposals</a></td>
<td class="num">(1,148,288)<span></span>
</td>
<td class="num">(759,561)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_LossOfControlonBiologicalAssets', window );">Loss of control</a></td>
<td class="num">(1,101,686)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BiologicalAssets', window );">Ending of the year</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BiologicalAssetsAxis=mlec_BiologicalAssetsWheatMember', window );">Wheat [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems', window );"><strong>Schedule of Changes in Biological Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BiologicalAssets', window );">Beginning of the year</a></td>
<td class="nump">220,682<span></span>
</td>
<td class="nump">87,785<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets', window );">Initial recognition and changes in the fair value of biological assets at the point of harvest</a></td>
<td class="nump">579,313<span></span>
</td>
<td class="nump">231,526<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets', window );">Costs incurred during the year</a></td>
<td class="nump">444,303<span></span>
</td>
<td class="nump">220,679<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DecreaseDueToHarvestAndDisposalsBiologicalAssets', window );">Decrease due to harvest/disposals</a></td>
<td class="num">(1,244,298)<span></span>
</td>
<td class="num">(319,308)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_LossOfControlonBiologicalAssets', window );">Loss of control</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BiologicalAssets', window );">Ending of the year</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">220,682<span></span>
</td>
<td class="nump">87,785<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BiologicalAssetsAxis=mlec_BiologicalAssetsBarleyMember', window );">Barley [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems', window );"><strong>Schedule of Changes in Biological Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BiologicalAssets', window );">Beginning of the year</a></td>
<td class="nump">73,452<span></span>
</td>
<td class="nump">59,057<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets', window );">Initial recognition and changes in the fair value of biological assets at the point of harvest</a></td>
<td class="nump">158,080<span></span>
</td>
<td class="nump">106,605<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets', window );">Costs incurred during the year</a></td>
<td class="nump">162,342<span></span>
</td>
<td class="nump">73,452<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DecreaseDueToHarvestAndDisposalsBiologicalAssets', window );">Decrease due to harvest/disposals</a></td>
<td class="num">(393,874)<span></span>
</td>
<td class="num">(165,662)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_LossOfControlonBiologicalAssets', window );">Loss of control</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BiologicalAssets', window );">Ending of the year</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">73,452<span></span>
</td>
<td class="nump">59,057<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BiologicalAssetsAxis=mlec_SunflowerMember', window );">Sunflower [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems', window );"><strong>Schedule of Changes in Biological Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BiologicalAssets', window );">Beginning of the year</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets', window );">Initial recognition and changes in the fair value of biological assets at the point of harvest</a></td>
<td class="num">(1,256)<span></span>
</td>
<td class="nump">996<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets', window );">Costs incurred during the year</a></td>
<td class="nump">55,063<span></span>
</td>
<td class="nump">137,680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DecreaseDueToHarvestAndDisposalsBiologicalAssets', window );">Decrease due to harvest/disposals</a></td>
<td class="num">(53,807)<span></span>
</td>
<td class="num">(138,676)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_LossOfControlonBiologicalAssets', window );">Loss of control</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BiologicalAssets', window );">Ending of the year</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to biological assets, other than those acquired through business combinations. [Refer: Total for all business combinations [member]; Biological assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 41<br> -IssueDate 2025-01-01<br> -Paragraph 50<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=41&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_50&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BiologicalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of living animals or plants recognised as assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 41<br> -IssueDate 2025-01-01<br> -Paragraph 43<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=41&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_43&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 41<br> -IssueDate 2025-01-01<br> -Paragraph 50<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=41&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_50&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 273<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_273&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 273<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_273&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_f&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BiologicalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 41<br> -IssueDate 2025-01-01<br> -Paragraph 50<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=41&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_50_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 273<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_273_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 273<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_273_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DecreaseDueToHarvestAndDisposalsBiologicalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease in biological assets due to the detachment of produce from the assets or the cessation of the assets' life processes and disposals.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DecreaseDueToHarvestAndDisposalsBiologicalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_LossOfControlonBiologicalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of loss of control on biological assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_LossOfControlonBiologicalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BiologicalAssetsAxis=mlec_BiologicalAssetsSoybeanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BiologicalAssetsAxis=mlec_BiologicalAssetsSoybeanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BiologicalAssetsAxis=mlec_BiologicalAssetsCornMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BiologicalAssetsAxis=mlec_BiologicalAssetsCornMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BiologicalAssetsAxis=mlec_BiologicalAssetsWheatMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BiologicalAssetsAxis=mlec_BiologicalAssetsWheatMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BiologicalAssetsAxis=mlec_BiologicalAssetsBarleyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BiologicalAssetsAxis=mlec_BiologicalAssetsBarleyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BiologicalAssetsAxis=mlec_SunflowerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BiologicalAssetsAxis=mlec_SunflowerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Information About Components of Consolidated Statements of Financial Position - Schedule of Property, Plant and Equipment (Details) - Property Plant And Equipments [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net carrying amount beginning</a></td>
<td class="nump">$ 74,612,434<span></span>
</td>
<td class="nump">$ 68,159,339<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">5,987,922<span></span>
</td>
<td class="nump">10,753,187<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Reclassification within PPE</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DisposalsPropertyPlantAndEquipments', window );">Disposals</a></td>
<td class="num">(173,089)<span></span>
</td>
<td class="num">(211,262)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation of the year</a></td>
<td class="num">(6,015,700)<span></span>
</td>
<td class="num">(5,799,998)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Foreign currency translation</a></td>
<td class="nump">189,604<span></span>
</td>
<td class="num">(1,255,978)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment', window );">Loss of control</a></td>
<td class="num">(74,575,314)<span></span>
</td>
<td class="num">(254,898)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Business combination</a></td>
<td class="nump">3,319,313<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net carrying amount ending</a></td>
<td class="nump">3,345,170<span></span>
</td>
<td class="nump">74,612,434<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment', window );">Reclassification from Investment properties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,222,044<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OfficeEquipmentMember', window );">Office equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net carrying amount beginning</a></td>
<td class="nump">503,950<span></span>
</td>
<td class="nump">360,575<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">39,611<span></span>
</td>
<td class="nump">238,679<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Reclassification within PPE</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DisposalsPropertyPlantAndEquipments', window );">Disposals</a></td>
<td class="num">(4,791)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation of the year</a></td>
<td class="num">(82,495)<span></span>
</td>
<td class="num">(81,507)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Foreign currency translation</a></td>
<td class="nump">3,947<span></span>
</td>
<td class="num">(13,324)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment', window );">Loss of control</a></td>
<td class="num">(449,942)<span></span>
</td>
<td class="num">(473)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Business combination</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net carrying amount ending</a></td>
<td class="nump">10,280<span></span>
</td>
<td class="nump">503,950<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment', window );">Reclassification from Investment properties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_VehiclesMember', window );">Vehicles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net carrying amount beginning</a></td>
<td class="nump">2,192,627<span></span>
</td>
<td class="nump">2,053,263<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">35,915<span></span>
</td>
<td class="nump">1,077,988<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Reclassification within PPE</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DisposalsPropertyPlantAndEquipments', window );">Disposals</a></td>
<td class="num">(17,239)<span></span>
</td>
<td class="num">(1,677)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation of the year</a></td>
<td class="num">(882,264)<span></span>
</td>
<td class="num">(908,040)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Foreign currency translation</a></td>
<td class="nump">1,023<span></span>
</td>
<td class="num">(775)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment', window );">Loss of control</a></td>
<td class="num">(1,330,062)<span></span>
</td>
<td class="num">(28,132)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Business combination</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net carrying amount ending</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,192,627<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment', window );">Reclassification from Investment properties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember', window );">Equipment and computer software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net carrying amount beginning</a></td>
<td class="nump">528,816<span></span>
</td>
<td class="nump">198,364<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">75,297<span></span>
</td>
<td class="nump">725,706<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Reclassification within PPE</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DisposalsPropertyPlantAndEquipments', window );">Disposals</a></td>
<td class="num">(323)<span></span>
</td>
<td class="num">(8,184)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation of the year</a></td>
<td class="num">(273,912)<span></span>
</td>
<td class="num">(354,379)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Foreign currency translation</a></td>
<td class="nump">16,012<span></span>
</td>
<td class="num">(27,650)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment', window );">Loss of control</a></td>
<td class="num">(331,763)<span></span>
</td>
<td class="num">(5,041)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Business combination</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net carrying amount ending</a></td>
<td class="nump">14,127<span></span>
</td>
<td class="nump">528,816<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment', window );">Reclassification from Investment properties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember', window );">Fixtures and fittings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net carrying amount beginning</a></td>
<td class="nump">2,805,076<span></span>
</td>
<td class="nump">2,925,032<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">9,084<span></span>
</td>
<td class="nump">731,699<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Reclassification within PPE</a></td>
<td class="nump">225,338<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DisposalsPropertyPlantAndEquipments', window );">Disposals</a></td>
<td class="num">(6,789)<span></span>
</td>
<td class="nump">6,295<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation of the year</a></td>
<td class="num">(860,822)<span></span>
</td>
<td class="num">(812,810)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Foreign currency translation</a></td>
<td class="nump">6,350<span></span>
</td>
<td class="num">(1,663)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment', window );">Loss of control</a></td>
<td class="num">(2,178,237)<span></span>
</td>
<td class="num">(43,477)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Business combination</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net carrying amount ending</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,805,076<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment', window );">Reclassification from Investment properties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=mlec_MachineryAndEquipmentsMember', window );">Machinery and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net carrying amount beginning</a></td>
<td class="nump">16,722,642<span></span>
</td>
<td class="nump">14,586,768<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">563,352<span></span>
</td>
<td class="nump">5,460,655<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Reclassification within PPE</a></td>
<td class="nump">122,653<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DisposalsPropertyPlantAndEquipments', window );">Disposals</a></td>
<td class="num">(143,947)<span></span>
</td>
<td class="num">(154,492)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation of the year</a></td>
<td class="num">(2,895,031)<span></span>
</td>
<td class="num">(2,661,097)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Foreign currency translation</a></td>
<td class="nump">81,204<span></span>
</td>
<td class="num">(409,769)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment', window );">Loss of control</a></td>
<td class="num">(14,449,423)<span></span>
</td>
<td class="num">(99,423)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Business combination</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net carrying amount ending</a></td>
<td class="nump">1,450<span></span>
</td>
<td class="nump">16,722,642<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment', window );">Reclassification from Investment properties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandAndBuildingsMember', window );">Land and buildings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net carrying amount beginning</a></td>
<td class="nump">39,745,067<span></span>
</td>
<td class="nump">36,211,957<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,835,054<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Reclassification within PPE</a></td>
<td class="nump">348,085<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DisposalsPropertyPlantAndEquipments', window );">Disposals</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">53,217<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation of the year</a></td>
<td class="num">(1,021,176)<span></span>
</td>
<td class="num">(982,165)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Foreign currency translation</a></td>
<td class="nump">71,315<span></span>
</td>
<td class="num">(595,040)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment', window );">Loss of control</a></td>
<td class="num">(39,143,291)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Business combination</a></td>
<td class="nump">982,939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net carrying amount ending</a></td>
<td class="nump">982,939<span></span>
</td>
<td class="nump">39,745,067<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment', window );">Reclassification from Investment properties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,222,044<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ConstructionInProgressMember', window );">Buildings in progress [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net carrying amount beginning</a></td>
<td class="nump">12,114,256<span></span>
</td>
<td class="nump">11,757,249<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">5,264,663<span></span>
</td>
<td class="nump">683,406<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment', window );">Reclassification within PPE</a></td>
<td class="num">(696,076)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DisposalsPropertyPlantAndEquipments', window );">Disposals</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(106,421)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation of the year</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Foreign currency translation</a></td>
<td class="nump">9,753<span></span>
</td>
<td class="num">(207,757)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment', window );">Loss of control</a></td>
<td class="num">(16,692,596)<span></span>
</td>
<td class="num">(12,221)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Business combination</a></td>
<td class="nump">2,336,374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net carrying amount ending</a></td>
<td class="nump">2,336,374<span></span>
</td>
<td class="nump">12,114,256<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment', window );">Reclassification from Investment properties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=mlec_ResearchInstrumentsMember', window );">Research Instruments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net carrying amount beginning</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">66,131<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DisposalsPropertyPlantAndEquipments', window );">Disposals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation of the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Foreign currency translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment', window );">Loss of control</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(66,131)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net carrying amount ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment', window );">Reclassification from Investment properties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in property, plant and equipment resulting from acquisitions through business combinations. [Refer: Total for all business combinations [member]; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_73_e_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -Subparagraph e<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200_e_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -Subparagraph e<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200_e_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Total for all business combinations [member]; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_73_e_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200_e_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200_e_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease in property, plant and equipment resulting from the loss of control of a subsidiary. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_73_e_vii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 75<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_75_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -Subparagraph e<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200_e_vii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -Subparagraph e<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200_e_vii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in property, plant and equipment resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_73_e_viii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in property, plant and equipment resulting from transfers from (to) investment property. [Refer: Property, plant and equipment; Investment property]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in property, plant and equipment resulting from transfers. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DisposalsPropertyPlantAndEquipments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease in property, plant and equipment resulting from disposals. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DisposalsPropertyPlantAndEquipments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=mlec_PropertyPlantAndEquipmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=mlec_PropertyPlantAndEquipmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=mlec_MachineryAndEquipmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=mlec_MachineryAndEquipmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandAndBuildingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandAndBuildingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=mlec_ResearchInstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=mlec_ResearchInstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Information About Components of Consolidated Statements of Financial Position - Schedule of Carrying Amounts that Would Have Been Recognized (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandAndBuildingsMember', window );">Land and buildings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Carrying Amounts that Would Have Been Recognized [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets', window );">Land and buildings</a></td>
<td class="nump">$ 27,876,636<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant and equipment that would have been recognised had the revalued assets been carried under the cost model. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 77<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_77_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 202<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_202_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 202<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_202_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandAndBuildingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandAndBuildingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Information About Components of Consolidated Statements of Financial Position - Schedule of&#8203; Intangible Assets (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th" colspan="2"><div>Jun. 30, 2025</div></th>
<th class="th" colspan="2"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems', window );"><strong>Schedule of&#8203; Intangible Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Net carrying amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 177,331,280<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 175,292,219<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">15,494,190<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">12,993,402<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets', window );">Loss of control</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(181,173,077)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AdditionsFromBusinessCombinations', window );">Additions from business combinations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">74,841,933<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">1,128,449<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill', window );">Transfers/ Disposals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(101,463)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AmortizationOfTheYear', window );">Amortization of the year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(11,201,048)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(12,113,223)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Foreign currency translation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">66,975<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">30,433<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Net carrying amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">75,258,790<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">177,331,280<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_AlfalfaGenuityHarXstraMember', window );">Alfalfa Genuity Har Xstra [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems', window );"><strong>Schedule of&#8203; Intangible Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Net carrying amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">438,029<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">419,061<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets', window );">Loss of control</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AdditionsFromBusinessCombinations', window );">Additions from business combinations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill', window );">Transfers/ Disposals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AmortizationOfTheYear', window );">Amortization of the year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Foreign currency translation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(21,172)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">18,968<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Net carrying amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">416,857<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">438,029<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_HB4SoyAndBreedingProgramMember', window );">HB4 soy and breeding program [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems', window );"><strong>Schedule of&#8203; Intangible Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Net carrying amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">35,574,369<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">31,679,114<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,164,283<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,987,247<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets', window );">Loss of control</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(36,464,169)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AdditionsFromBusinessCombinations', window );">Additions from business combinations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill', window );">Transfers/ Disposals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AmortizationOfTheYear', window );">Amortization of the year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,274,483)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,091,992)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Foreign currency translation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Net carrying amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">35,574,369<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_IntegratedSeedProductsMember', window );">Integrated seed products [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems', window );"><strong>Schedule of&#8203; Intangible Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Net carrying amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,681,826<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,841,008<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets', window );">Loss of control</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(2,526,410)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AdditionsFromBusinessCombinations', window );">Additions from business combinations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill', window );">Transfers/ Disposals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AmortizationOfTheYear', window );">Amortization of the year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(194,339)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(191,559)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Foreign currency translation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">38,923<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">32,377<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Net carrying amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,681,826<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_MicrobiologicalProductsMember', window );">Microbiological products [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems', window );"><strong>Schedule of&#8203; Intangible Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Net carrying amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">41,187,249<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">37,295,460<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">286,665<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets', window );">Loss of control</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(43,570,818)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AdditionsFromBusinessCombinations', window );">Additions from business combinations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill', window );">Transfers/ Disposals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,605,198<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7,610,115<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AmortizationOfTheYear', window );">Amortization of the year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,511,420)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3,718,326)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Foreign currency translation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,126<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Net carrying amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">41,187,249<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_MicrobiologicalProductsInProgressMember', window );">Microbiological products in progress [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems', window );"><strong>Schedule of&#8203; Intangible Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Net carrying amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10,452,861<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">12,213,341<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,163,500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,869,084<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets', window );">Loss of control</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(11,909,700)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AdditionsFromBusinessCombinations', window );">Additions from business combinations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill', window );">Transfers/ Disposals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3,706,661)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(7,610,115)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AmortizationOfTheYear', window );">Amortization of the year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Foreign currency translation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(19,449)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Net carrying amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">10,452,861<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_TrademarksAndPatentsMember', window );">Trademarks and patents [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems', window );"><strong>Schedule of&#8203; Intangible Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Net carrying amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">51,316,860<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">51,933,444<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">158,557<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">44,073<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets', window );">Loss of control</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(47,394,664)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AdditionsFromBusinessCombinations', window );">Additions from business combinations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill', window );">Transfers/ Disposals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AmortizationOfTheYear', window );">Amortization of the year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(4,080,753)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(670,514)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Foreign currency translation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">9,857<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Net carrying amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">51,316,860<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_TrademarksAndPatentsWithIndefiniteUsefulLifeMember', window );">Trademarks and patents with indefinite useful life [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems', window );"><strong>Schedule of&#8203; Intangible Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Net carrying amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10,045,294<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7,827,309<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets', window );">Loss of control</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(10,045,294)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AdditionsFromBusinessCombinations', window );">Additions from business combinations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">2,217,985<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill', window );">Transfers/ Disposals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AmortizationOfTheYear', window );">Amortization of the year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Foreign currency translation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Net carrying amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">10,045,294<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_SoftwareMember', window );">Software [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems', window );"><strong>Schedule of&#8203; Intangible Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Net carrying amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,119,494<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,638,752<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">16,222<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">585,313<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets', window );">Loss of control</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(605,341)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AdditionsFromBusinessCombinations', window );">Additions from business combinations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill', window );">Transfers/ Disposals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">146,839<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">276,128<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AmortizationOfTheYear', window );">Amortization of the year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(723,312)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,369,379)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Foreign currency translation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">46,098<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(11,320)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Net carrying amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,119,494<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_SoftwareInProgressMember', window );">Software in progress [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems', window );"><strong>Schedule of&#8203; Intangible Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Net carrying amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">580,728<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">349,171<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">176,064<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">507,685<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets', window );">Loss of control</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(609,953)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AdditionsFromBusinessCombinations', window );">Additions from business combinations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill', window );">Transfers/ Disposals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(146,839)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(276,128)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AmortizationOfTheYear', window );">Amortization of the year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Foreign currency translation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Net carrying amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">580,728<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_CustomerLoyaltyMember', window );">Customer loyalty [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems', window );"><strong>Schedule of&#8203; Intangible Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Net carrying amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">18,934,570<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">23,006,023<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets', window );">Loss of control</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(17,565,911)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AdditionsFromBusinessCombinations', window );">Additions from business combinations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill', window );">Transfers/ Disposals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AmortizationOfTheYear', window );">Amortization of the year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,368,659)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(4,071,453)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Foreign currency translation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Net carrying amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">18,934,570<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_RGRSOXWheatMember', window );">RG/RS/OX Wheat [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems', window );"><strong>Schedule of&#8203; Intangible Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Net carrying amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,528,899<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets', window );">Loss of control</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(10,480,817)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AdditionsFromBusinessCombinations', window );">Additions from business combinations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill', window );">Transfers/ Disposals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AmortizationOfTheYear', window );">Amortization of the year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,048,082)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Foreign currency translation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Net carrying amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_SustainableAgriculturalEquipmentTechnologyMember', window );">Sustainable agricultural equipment technology [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems', window );"><strong>Schedule of&#8203; Intangible Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Net carrying amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets', window );">Loss of control</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AdditionsFromBusinessCombinations', window );">Additions from business combinations</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">10,719,710<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill', window );">Transfers/ Disposals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AmortizationOfTheYear', window );">Amortization of the year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Foreign currency translation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Net carrying amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10,719,710<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_FungalBiomassMember', window );">Fungal Biomass [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems', window );"><strong>Schedule of&#8203; Intangible Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Net carrying amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets', window );">Loss of control</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AdditionsFromBusinessCombinations', window );">Additions from business combinations</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">10,775,940<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill', window );">Transfers/ Disposals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AmortizationOfTheYear', window );">Amortization of the year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Foreign currency translation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Net carrying amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10,775,940<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_PiggysooyMember', window );">Piggysooy [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems', window );"><strong>Schedule of&#8203; Intangible Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Net carrying amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets', window );">Loss of control</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AdditionsFromBusinessCombinations', window );">Additions from business combinations</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">16,813,781<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill', window );">Transfers/ Disposals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AmortizationOfTheYear', window );">Amortization of the year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Foreign currency translation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Net carrying amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">16,813,781<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_SafflowerGLAMember', window );">Safflower GLA [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems', window );"><strong>Schedule of&#8203; Intangible Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Net carrying amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets', window );">Loss of control</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AdditionsFromBusinessCombinations', window );">Additions from business combinations</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">27,857,339<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill', window );">Transfers/ Disposals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AmortizationOfTheYear', window );">Amortization of the year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Foreign currency translation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Net carrying amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">27,857,339<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_SafflowerChimosin20Member', window );">Safflower Chimosin 2.0 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems', window );"><strong>Schedule of&#8203; Intangible Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Net carrying amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets', window );">Loss of control</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AdditionsFromBusinessCombinations', window );">Additions from business combinations</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">2,600,554<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Net carrying amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,600,554<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember', window );">Other Intangibles [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems', window );"><strong>Schedule of&#8203; Intangible Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Net carrying amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets', window );">Loss of control</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AdditionsFromBusinessCombinations', window );">Additions from business combinations</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">6,074,609<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill', window );">Transfers/ Disposals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AmortizationOfTheYear', window );">Amortization of the year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Foreign currency translation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Net carrying amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,074,609<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_BacillusPHAsMember', window );">Bacillus-PHAs [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems', window );"><strong>Schedule of&#8203; Intangible Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Net carrying amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,089,536<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AdditionsFromBusinessCombinations', window );">Additions from business combinations</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,089,536)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill', window );">Transfers/ Disposals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AmortizationOfTheYear', window );">Amortization of the year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Foreign currency translation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Net carrying amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Correspond to the loss of control of BIOX.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Correspond to The Bioceres Group Business Combination Agreement.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">USD 1,089,768 correspond to the loss of control of Inmet
S.A.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Total for all business combinations [member]; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_118_e_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_e_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_e_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in intangible assets other than goodwill resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_118_e_vii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in intangible assets other than goodwill resulting from transfers. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_AdditionsFromBusinessCombinations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of additions from business combinations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_AdditionsFromBusinessCombinations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_AmortizationOfTheYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization of the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_AmortizationOfTheYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>he decrease in intangible assets resulting from the loss of control of a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_AlfalfaGenuityHarXstraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_AlfalfaGenuityHarXstraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_HB4SoyAndBreedingProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_HB4SoyAndBreedingProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_IntegratedSeedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_IntegratedSeedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_MicrobiologicalProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_MicrobiologicalProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_MicrobiologicalProductsInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_MicrobiologicalProductsInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_TrademarksAndPatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_TrademarksAndPatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_TrademarksAndPatentsWithIndefiniteUsefulLifeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_TrademarksAndPatentsWithIndefiniteUsefulLifeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_SoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_SoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_SoftwareInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_SoftwareInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_CustomerLoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_CustomerLoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_RGRSOXWheatMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_RGRSOXWheatMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_SustainableAgriculturalEquipmentTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_SustainableAgriculturalEquipmentTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_FungalBiomassMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_FungalBiomassMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_PiggysooyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_PiggysooyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_SafflowerGLAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_SafflowerGLAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_SafflowerChimosin20Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_SafflowerChimosin20Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_BacillusPHAsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=mlec_BacillusPHAsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Information About Components of Consolidated Statements of Financial Position - Schedule of Intangible Assets and Liabilities Assumed (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfIntangibleAssetsAndLiabilitiesAssumedLineItems', window );"><strong>Schedule of Intangible Assets and Liabilities Assumed [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections', window );">Discount rate</a></td>
<td class="nump">16.39%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PercentageOfWeightedAverageCostOfCapital', window );">Discount rate</a></td>
<td class="nump">11.56%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PercentageOfRiskPremium', window );">Percentage of risk premium</a></td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections', window );">Growth rate used to extrapolate future cash flow projections to terminal period</a></td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_RizobacterUGEMember', window );">Rizobacter UGE [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfIntangibleAssetsAndLiabilitiesAssumedLineItems', window );"><strong>Schedule of Intangible Assets and Liabilities Assumed [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections', window );">Discount rate</a></td>
<td class="nump">14.11%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_ProFarmUGEMember', window );">Pro Farm UGE [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfIntangibleAssetsAndLiabilitiesAssumedLineItems', window );"><strong>Schedule of Intangible Assets and Liabilities Assumed [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections', window );">Discount rate</a></td>
<td class="nump">9.28%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The discount rate applied to cash flow projections for a cash-generating unit (group of units). [Refer: Total for all cash-generating units [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2025-01-01<br> -Paragraph 134<br> -Subparagraph d<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_134_d_v&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2025-01-01<br> -Paragraph 134<br> -Subparagraph e<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_134_e_v&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 254<br> -Subparagraph d<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_254_d_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 254<br> -Subparagraph f<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_254_f_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 254<br> -Subparagraph d<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_254_d_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 254<br> -Subparagraph f<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_254_f_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The growth rate used to extrapolate cash flow projections beyond the period covered by the most recent budgets/forecasts for a cash-generating unit (group of units). [Refer: Total for all cash-generating units [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2025-01-01<br> -Paragraph 134<br> -Subparagraph d<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_134_d_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2025-01-01<br> -Paragraph 134<br> -Subparagraph e<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_134_e_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 254<br> -Subparagraph f<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_254_f_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 254<br> -Subparagraph d<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_254_d_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 254<br> -Subparagraph d<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_254_d_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 254<br> -Subparagraph f<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_254_f_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_PercentageOfRiskPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of risk premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_PercentageOfRiskPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_PercentageOfWeightedAverageCostOfCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of weighted average cost of capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_PercentageOfWeightedAverageCostOfCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ScheduleOfIntangibleAssetsAndLiabilitiesAssumedLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ScheduleOfIntangibleAssetsAndLiabilitiesAssumedLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_RizobacterUGEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_RizobacterUGEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_ProFarmUGEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_ProFarmUGEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Information About Components of Consolidated Statements of Financial Position - Schedule of Goodwill (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems', window );"><strong>Schedule of Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 112,163,432<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=mlec_RizobacterArgentinaSAMember', window );">Rizobacter Argentina S.A. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems', window );"><strong>Schedule of Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">28,080,271<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=mlec_BioceresCropsSAMember', window );">Bioceres Crops S.A. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems', window );"><strong>Schedule of Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">7,523,322<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=mlec_InsumosAgroqumicosSAMember', window );">Insumos Agroqu&#237;micos S.A. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems', window );"><strong>Schedule of Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">470,090<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=mlec_ProFarmGroupMember', window );">Pro Farm Group [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems', window );"><strong>Schedule of Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 76,089,749<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2025-01-01<br> -Paragraph 134<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_134_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2025-01-01<br> -Paragraph 135<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_135_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2025-01-01<br> -Paragraph B67<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B67_d&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 254<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_254_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 255<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_255_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 254<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_254_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 255<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_255_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 37<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 37<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=mlec_RizobacterArgentinaSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=mlec_RizobacterArgentinaSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=mlec_BioceresCropsSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=mlec_BioceresCropsSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=mlec_InsumosAgroqumicosSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=mlec_InsumosAgroqumicosSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=mlec_ProFarmGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=mlec_ProFarmGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Information About Components of Consolidated Statements of Financial Position - Schedule of Investment Properties (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnDisposalsOfInvestmentPropertiesAbstract', window );"><strong>Schedule of Investment Properties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentProperty', window );">Investment properties</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 560,783<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentProperty', window );">Total</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 560,783<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnDisposalsOfInvestmentPropertiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnDisposalsOfInvestmentPropertiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property (land or a building - or part of a building - or both) held (by the owner or by the lessee as a right-of-use asset) to earn rentals or for capital appreciation or both, rather than for: (a) use in the production or supply of goods or services or for administrative purposes; or (b) sale in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 40<br> -IssueDate 2025-01-01<br> -Paragraph 76<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=40&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_76&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 40<br> -IssueDate 2025-01-01<br> -Paragraph 79<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=40&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_79_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 269<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_269&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 271<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_271_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 269<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_269&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 271<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_271_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Information About Components of Consolidated Statements of Financial Position - Schedule of Trade and Other Payables (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesAbstract', window );"><strong>Schedule of Trade and Other Payables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers', window );">Trade creditors</a></td>
<td class="nump">$ 6,490,684<span></span>
</td>
<td class="nump">$ 108,922,112<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_TradeAndOtherPayablesShareholdersAndOtherRelatedParties', window );">Shareholders and other related parties (Note 17)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">37,985<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_TradeCreditorsJointVenturesAndAssociates', window );">Trade creditors - Joint ventures and associates (Note 13)</a></td>
<td class="nump">620,034<span></span>
</td>
<td class="nump">52,778,206<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax', window );">Taxes</a></td>
<td class="nump">12,647<span></span>
</td>
<td class="nump">5,877,930<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentPayables', window );">Miscellaneous</a></td>
<td class="nump">200,568<span></span>
</td>
<td class="nump">1,321,303<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayables', window );">Trade and Other Payable</a></td>
<td class="nump">$ 7,323,933<span></span>
</td>
<td class="nump">$ 168,937,536<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current payables on social security and taxes other than incomes tax. [Refer: Payables on social security and taxes other than income tax]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current payables that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph k<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_k&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current amount of payment due to suppliers for goods and services used in entity's business. [Refer: Current liabilities; Trade payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 70<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_70&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_TradeAndOtherPayablesShareholdersAndOtherRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of trade and other payables in shareholders and other related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_TradeAndOtherPayablesShareholdersAndOtherRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_TradeCreditorsJointVenturesAndAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of trade creditors - Joint ventures and associates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_TradeCreditorsJointVenturesAndAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Information About Components of Consolidated Statements of Financial Position - Schedule of Borrowings (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowingsAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentPortionOfLongtermBorrowings', window );">Current Bank borrowings</a></td>
<td class="nump">$ 227,154,007<span></span>
</td>
<td class="nump">$ 234,510,751<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentPortionOfNoncurrentBorrowingsByTypeAbstract', window );"><strong>Non-current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherBorrowings', window );">Non-current Bank borrowings</a></td>
<td class="nump">1,348,173<span></span>
</td>
<td class="nump">127,248,305<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=mlec_BankBorrowingMember', window );">Bank borrowings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowingsAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentPortionOfLongtermBorrowings', window );">Current Bank borrowings</a></td>
<td class="nump">33,383<span></span>
</td>
<td class="nump">94,711,273<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentPortionOfNoncurrentBorrowingsByTypeAbstract', window );"><strong>Non-current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherBorrowings', window );">Non-current Bank borrowings</a></td>
<td class="nump">1,348,173<span></span>
</td>
<td class="nump">17,033,059<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=mlec_CorporateBondsMember', window );">Corporate bonds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowingsAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentPortionOfLongtermBorrowings', window );">Current Bank borrowings</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">42,035,925<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentPortionOfNoncurrentBorrowingsByTypeAbstract', window );"><strong>Non-current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherBorrowings', window );">Non-current Bank borrowings</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">25,071,823<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=mlec_NetLoansPayablesJointVenturesAndAssociatesMember', window );">Net loans payables- Joint ventures and associates [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowingsAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentPortionOfLongtermBorrowings', window );">Current Bank borrowings</a></td>
<td class="nump">10,303,098<span></span>
</td>
<td class="nump">1,860,058<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=mlec_ConvertiblePreferenceSharesMember', window );">Convertible preference shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowingsAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentPortionOfLongtermBorrowings', window );">Current Bank borrowings</a></td>
<td class="nump">15,739,726<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=mlec_FinancialBorrowingsMember', window );">Financial borrowings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowingsAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentPortionOfLongtermBorrowings', window );">Current Bank borrowings</a></td>
<td class="nump">201,077,800<span></span>
</td>
<td class="nump">95,903,495<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentPortionOfNoncurrentBorrowingsByTypeAbstract', window );"><strong>Non-current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherBorrowings', window );">Non-current Bank borrowings</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 85,143,423<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentPortionOfLongtermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current portion of non-current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentPortionOfLongtermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentPortionOfNoncurrentBorrowingsByTypeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentPortionOfNoncurrentBorrowingsByTypeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of borrowings that the entity does not separately disclose in the same statement or note. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=mlec_BankBorrowingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=mlec_BankBorrowingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=mlec_CorporateBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=mlec_CorporateBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=mlec_NetLoansPayablesJointVenturesAndAssociatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=mlec_NetLoansPayablesJointVenturesAndAssociatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=mlec_ConvertiblePreferenceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=mlec_ConvertiblePreferenceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=mlec_FinancialBorrowingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=mlec_FinancialBorrowingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Information About Components of Consolidated Statements of Financial Position - Schedule of Borrowings, Carrying Amount (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostMember', window );">Amortized cost [Member] | Bank borrowings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowingsAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermBorrowings', window );">Current borrowing</a></td>
<td class="nump">$ 33,383<span></span>
</td>
<td class="nump">$ 94,711,273<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentPortionOfNoncurrentBorrowingsByTypeAbstract', window );"><strong>Non current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Non current borrowing</a></td>
<td class="nump">1,348,173<span></span>
</td>
<td class="nump">17,033,059<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostMember', window );">Amortized cost [Member] | Corporate bonds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowingsAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermBorrowings', window );">Current borrowing</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">42,035,925<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentPortionOfNoncurrentBorrowingsByTypeAbstract', window );"><strong>Non current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Non current borrowing</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">25,071,823<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostMember', window );">Amortized cost [Member] | Convertible preference shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowingsAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermBorrowings', window );">Current borrowing</a></td>
<td class="nump">15,739,726<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostMember', window );">Amortized cost [Member] | Financial borrowings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowingsAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermBorrowings', window );">Current borrowing</a></td>
<td class="nump">211,380,898<span></span>
</td>
<td class="nump">95,903,495<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentPortionOfNoncurrentBorrowingsByTypeAbstract', window );"><strong>Non current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Non current borrowing</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">85,143,423<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostMember', window );">Amortized cost [Member] | Convertible notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentPortionOfNoncurrentBorrowingsByTypeAbstract', window );"><strong>Non current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Non current borrowing</a></td>
<td class="nump">18,260,456<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value [Member] | Bank borrowings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowingsAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermBorrowings', window );">Current borrowing</a></td>
<td class="nump">33,383<span></span>
</td>
<td class="nump">93,301,194<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentPortionOfNoncurrentBorrowingsByTypeAbstract', window );"><strong>Non current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Non current borrowing</a></td>
<td class="nump">1,348,173<span></span>
</td>
<td class="nump">12,206,794<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value [Member] | Corporate bonds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowingsAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermBorrowings', window );">Current borrowing</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">41,492,963<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentPortionOfNoncurrentBorrowingsByTypeAbstract', window );"><strong>Non current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Non current borrowing</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">23,845,583<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value [Member] | Convertible preference shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowingsAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermBorrowings', window );">Current borrowing</a></td>
<td class="nump">14,179,927<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value [Member] | Financial borrowings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowingsAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermBorrowings', window );">Current borrowing</a></td>
<td class="nump">205,082,929<span></span>
</td>
<td class="nump">95,480,681<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentPortionOfNoncurrentBorrowingsByTypeAbstract', window );"><strong>Non current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Non current borrowing</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">81,120,125<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value [Member] | Convertible notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentPortionOfNoncurrentBorrowingsByTypeAbstract', window );"><strong>Non current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Non current borrowing</a></td>
<td class="nump">$ 18,260,456<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LongtermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The non-current portion of non-current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LongtermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentPortionOfNoncurrentBorrowingsByTypeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentPortionOfNoncurrentBorrowingsByTypeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShorttermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShorttermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=mlec_BankBorrowingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=mlec_BankBorrowingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=mlec_CorporateBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=mlec_CorporateBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=mlec_ConvertiblePreferenceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=mlec_ConvertiblePreferenceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=mlec_FinancialBorrowingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=mlec_FinancialBorrowingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=mlec_ConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=mlec_ConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Information About Components of Consolidated Statements of Financial Position - Schedule of Convertible Notes (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofConvertibleNotesDetailsLineItems', window );"><strong>Information About Components of Consolidated Statements of Financial Position - Schedule of Convertible Notes (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SecuredDebtNonCurrent', window );">Convertible notes</a></td>
<td class="nump">$ 18,260,456<span></span>
</td>
<td class="nump">$ 80,809,686<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=mlec_ConvertibleNotesMember', window );">Convertible notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofConvertibleNotesDetailsLineItems', window );"><strong>Information About Components of Consolidated Statements of Financial Position - Schedule of Convertible Notes (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SecuredDebtNonCurrent', window );">Convertible notes</a></td>
<td class="nump">$ 18,260,456<span></span>
</td>
<td class="nump">$ 80,809,686<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofConvertibleNotesDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofConvertibleNotesDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_SecuredDebtNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of secured debt, non-current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_SecuredDebtNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=mlec_ConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=mlec_ConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Information About Components of Consolidated Statements of Financial Position - Schedule of Employee Benefits and Social Security (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_CurrentAbstract2', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SalariesAccruedIncentivesVacationsAndSocialSecurity', window );">Salaries, accrued incentives, vacations and social security</a></td>
<td class="nump">$ 202,014<span></span>
</td>
<td class="nump">$ 7,280,129<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_KeyManagementPersonnelBenefitsLiabilityCurrent', window );">Key management personnel (Note 18)</a></td>
<td class="nump">41,620<span></span>
</td>
<td class="nump">226,702<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentProvisionsForEmployeeBenefits', window );">Total</a></td>
<td class="nump">$ 243,634<span></span>
</td>
<td class="nump">$ 7,506,831<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentProvisionsForEmployeeBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current provisions for employee benefits. [Refer: Provisions for employee benefits]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_e&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentProvisionsForEmployeeBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_CurrentAbstract2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_CurrentAbstract2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_KeyManagementPersonnelBenefitsLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current liability related to key management personnel.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_KeyManagementPersonnelBenefitsLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_SalariesAccruedIncentivesVacationsAndSocialSecurity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current provisions for employee salaries, accrued incentives, vacations and social security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_SalariesAccruedIncentivesVacationsAndSocialSecurity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Information About Components of Consolidated Statements of Financial Position - Schedule of Deferred Revenue and Advances from Customers (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_CurrentAbstract3', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAdvances', window );">Advances from customers</a></td>
<td class="nump">$ 1,260<span></span>
</td>
<td class="nump">$ 3,335,740<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime', window );">Deferred revenue</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">589,061<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities', window );">Total current deferred revenue and advances from customers</a></td>
<td class="nump">1,260<span></span>
</td>
<td class="nump">3,924,801<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NonCurrentAbstract1', window );"><strong>Non current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAdvances', window );">Advances from customers</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">52,511<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime', window );">Deferred revenue</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,872,627<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentDeferredIncomeIncludingNoncurrentContractLiabilities', window );">Total non current deferred revenue and advances from customers</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,925,138<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAdvances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current advances received representing current contract liabilities for performance obligations satisfied at a point in time. [Refer: Advances received, representing contract liabilities for performance obligations satisfied at point in time]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAdvances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current contract liabilities for performance obligations satisfied over time. [Refer: Contract liabilities for performance obligations satisfied over time]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current deferred income including current contract liabilities. [Refer: Deferred income including contract liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAdvances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current advances received representing non-current contract liabilities for performance obligations satisfied at a point in time. [Refer: Advances received, representing contract liabilities for performance obligations satisfied at point in time]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAdvances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current contract liabilities for performance obligations satisfied over time. [Refer: Contract liabilities for performance obligations satisfied over time]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentDeferredIncomeIncludingNoncurrentContractLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current deferred income including non-current contract liabilities. [Refer: Deferred income including contract liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentDeferredIncomeIncludingNoncurrentContractLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_CurrentAbstract3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_CurrentAbstract3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_NonCurrentAbstract1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_NonCurrentAbstract1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Information About Components of Consolidated Statements of Financial Position - Schedule of Changes in Allowances and Provisions (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsLineItems', window );"><strong>Schedule of Changes in Allowances and Provisions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherProvisions', window );">Beginning</a></td>
<td class="nump">$ 27,622,558<span></span>
</td>
<td class="nump">$ 1,993,517<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionalProvisionsOtherProvisions', window );">Additions</a></td>
<td class="nump">9,008,358<span></span>
</td>
<td class="nump">355,898<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions', window );">Additions from business combination</a></td>
<td class="num">(1,467,829)<span></span>
</td>
<td class="num">(1,240,213)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AllowancesAndProvisionsUsedAndReversed', window );">Uses and reversals</a></td>
<td class="num">(111,023)<span></span>
</td>
<td class="num">(306,520)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions', window );">Currency conversion difference</a></td>
<td class="num">(18,897,490)<span></span>
</td>
<td class="nump">27,622,558<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ChangeInAllowanceAndProvisionLossOfControl', window );">Loss of control</a></td>
<td class="nump">16,154,574<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherProvisions', window );">Ending</a></td>
<td class="nump">26,819,876<span></span>
</td>
<td class="nump">27,622,558<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfProvisionsAxis=mlec_AllowanceForImpairmentOfTradeDebtorsMember', window );">Allowance for impairment of trade debtors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsLineItems', window );"><strong>Schedule of Changes in Allowances and Provisions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherProvisions', window );">Beginning</a></td>
<td class="nump">7,050,280<span></span>
</td>
<td class="nump">753,428<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionalProvisionsOtherProvisions', window );">Additions</a></td>
<td class="nump">7,123,716<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions', window );">Additions from business combination</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(777,558)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AllowancesAndProvisionsUsedAndReversed', window );">Uses and reversals</a></td>
<td class="num">(50,533)<span></span>
</td>
<td class="num">(351,194)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions', window );">Currency conversion difference</a></td>
<td class="num">(14,123,463)<span></span>
</td>
<td class="nump">7,050,280<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherProvisions', window );">Ending</a></td>
<td class="nump">7,425,604<span></span>
</td>
<td class="nump">7,050,280<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfProvisionsAxis=mlec_AllowanceForObsolescenceMember', window );">Allowance for obsolescence [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsLineItems', window );"><strong>Schedule of Changes in Allowances and Provisions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherProvisions', window );">Beginning</a></td>
<td class="nump">3,087,563<span></span>
</td>
<td class="nump">586,515<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionalProvisionsOtherProvisions', window );">Additions</a></td>
<td class="nump">1,547,723<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions', window );">Additions from business combination</a></td>
<td class="num">(1,158,036)<span></span>
</td>
<td class="num">(69,582)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AllowancesAndProvisionsUsedAndReversed', window );">Uses and reversals</a></td>
<td class="nump">29,204<span></span>
</td>
<td class="nump">78,131<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions', window );">Currency conversion difference</a></td>
<td class="num">(3,506,454)<span></span>
</td>
<td class="nump">3,087,563<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherProvisions', window );">Ending</a></td>
<td class="nump">2,492,499<span></span>
</td>
<td class="nump">3,087,563<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfProvisionsAxis=mlec_deductedFromAssetsMember', window );">Total deducted from assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsLineItems', window );"><strong>Schedule of Changes in Allowances and Provisions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherProvisions', window );">Beginning</a></td>
<td class="nump">10,137,843<span></span>
</td>
<td class="nump">1,339,943<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionalProvisionsOtherProvisions', window );">Additions</a></td>
<td class="nump">8,671,439<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions', window );">Additions from business combination</a></td>
<td class="num">(1,158,036)<span></span>
</td>
<td class="num">(847,140)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AllowancesAndProvisionsUsedAndReversed', window );">Uses and reversals</a></td>
<td class="num">(21,329)<span></span>
</td>
<td class="num">(273,063)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions', window );">Currency conversion difference</a></td>
<td class="num">(17,629,917)<span></span>
</td>
<td class="nump">10,137,843<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherProvisions', window );">Ending</a></td>
<td class="nump">9,918,103<span></span>
</td>
<td class="nump">10,137,843<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfProvisionsAxis=mlec_ProvisionForContingenciesMember', window );">Provisions for contingencies [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsLineItems', window );"><strong>Schedule of Changes in Allowances and Provisions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherProvisions', window );">Beginning</a></td>
<td class="nump">17,484,715<span></span>
</td>
<td class="nump">653,574<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionalProvisionsOtherProvisions', window );">Additions</a></td>
<td class="nump">336,919<span></span>
</td>
<td class="nump">355,898<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions', window );">Additions from business combination</a></td>
<td class="num">(309,793)<span></span>
</td>
<td class="num">(393,073)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AllowancesAndProvisionsUsedAndReversed', window );">Uses and reversals</a></td>
<td class="num">(89,694)<span></span>
</td>
<td class="num">(33,457)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions', window );">Currency conversion difference</a></td>
<td class="num">(1,267,573)<span></span>
</td>
<td class="nump">17,484,715<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ChangeInAllowanceAndProvisionLossOfControl', window );">Loss of control</a></td>
<td class="nump">16,154,574<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherProvisions', window );">Ending</a></td>
<td class="nump">16,901,773<span></span>
</td>
<td class="nump">17,484,715<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfProvisionsAxis=mlec_LiabilitiesMember', window );">Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsLineItems', window );"><strong>Schedule of Changes in Allowances and Provisions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherProvisions', window );">Beginning</a></td>
<td class="nump">17,484,715<span></span>
</td>
<td class="nump">653,574<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionalProvisionsOtherProvisions', window );">Additions</a></td>
<td class="nump">336,919<span></span>
</td>
<td class="nump">355,898<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions', window );">Additions from business combination</a></td>
<td class="num">(309,793)<span></span>
</td>
<td class="num">(393,073)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AllowancesAndProvisionsUsedAndReversed', window );">Uses and reversals</a></td>
<td class="num">(89,694)<span></span>
</td>
<td class="num">(33,457)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions', window );">Currency conversion difference</a></td>
<td class="num">(1,267,573)<span></span>
</td>
<td class="nump">17,484,715<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ChangeInAllowanceAndProvisionLossOfControl', window );">Loss of control</a></td>
<td class="nump">16,154,574<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherProvisions', window );">Ending</a></td>
<td class="nump">$ 16,901,773<span></span>
</td>
<td class="nump">$ 17,484,715<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in other provisions resulting from acquisitions through business combinations. [Refer: Total for all business combinations [member]; Other provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2025-01-01<br> -Paragraph 84<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_84&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionalProvisionsOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of additional other provisions made. [Refer: Other provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2025-01-01<br> -Paragraph 84<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_84_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 257<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_257_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 257<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_257_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionalProvisionsOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in other provisions resulting from foreign currency exchange rate changes on provisions measured in a currency different from the entity's presentation currency. [Refer: Other provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2025-01-01<br> -Paragraph 84<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_84&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of provisions other than provisions for employee benefits. [Refer: Provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2025-01-01<br> -Paragraph 84<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_84_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_e&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 257<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_257_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 257<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_257_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_AllowancesAndProvisionsUsedAndReversed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount used and reversed (i.e. incurrent and charged against the provision) for allowances and provisions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_AllowancesAndProvisionsUsedAndReversed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ChangeInAllowanceAndProvisionLossOfControl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of change in allowance and provisions of loss of control.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ChangeInAllowanceAndProvisionLossOfControl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfProvisionsAxis=mlec_AllowanceForImpairmentOfTradeDebtorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfProvisionsAxis=mlec_AllowanceForImpairmentOfTradeDebtorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfProvisionsAxis=mlec_AllowanceForObsolescenceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfProvisionsAxis=mlec_AllowanceForObsolescenceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfProvisionsAxis=mlec_deductedFromAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfProvisionsAxis=mlec_deductedFromAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfProvisionsAxis=mlec_ProvisionForContingenciesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfProvisionsAxis=mlec_ProvisionForContingenciesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfProvisionsAxis=mlec_LiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfProvisionsAxis=mlec_LiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Information About Components of Consolidated Statements of Financial Position - Schedule of Provisions (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofProvisionsDetailsLineItems', window );"><strong>Information About Components of Consolidated Statements of Financial Position - Schedule of Provisions (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentProvisions', window );">Provisions</a></td>
<td class="nump">$ 16,154,574<span></span>
</td>
<td class="nump">$ 17,484,715<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfProvisionsAxis=mlec_ConditionalPaymentRizobacterSAMember', window );">Conditional payment Rizobacter SA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofProvisionsDetailsLineItems', window );"><strong>Information About Components of Consolidated Statements of Financial Position - Schedule of Provisions (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentProvisions', window );">Provisions</a></td>
<td class="nump">15,916,116<span></span>
</td>
<td class="nump">15,916,116<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfProvisionsAxis=mlec_ProvisionForContingenciesMember', window );">Provisions for contingencies [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofProvisionsDetailsLineItems', window );"><strong>Information About Components of Consolidated Statements of Financial Position - Schedule of Provisions (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentProvisions', window );">Provisions</a></td>
<td class="nump">$ 238,458<span></span>
</td>
<td class="nump">$ 1,568,599<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current provisions, including provisions for employee benefits. [Refer: Provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph l<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_l&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofProvisionsDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofProvisionsDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfProvisionsAxis=mlec_ConditionalPaymentRizobacterSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfProvisionsAxis=mlec_ConditionalPaymentRizobacterSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfProvisionsAxis=mlec_ProvisionForContingenciesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfProvisionsAxis=mlec_ProvisionForContingenciesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Information About Components of Consolidated Statements of Financial Position - Schedule of Government Grants (Details) - Bioceres Crop Solutions Corp. [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGovernmentGrantsDetailsLineItems', window );"><strong>Information About Components of Consolidated Statements of Financial Position - Schedule of Government Grants (Details) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GovernmentGrants', window );">At the beginning of the year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 4,437<span></span>
</td>
<td class="nump">$ 349,998<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LossesOnDisposalsOfInvestments', window );">Loss of control</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="num">(157,043)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation', window );">Currency conversion difference</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">255<span></span>
</td>
<td class="nump">9,001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity', window );">Released to the statement of profit or loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3,412)<span></span>
</td>
<td class="num">(197,519)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GovernmentGrants', window );">At the end of the year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,280<span></span>
</td>
<td class="nump">$ 4,437<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-size: 10pt">Correspond to the loss of control
of Inmet S.A. in the year 2024</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GovernmentGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assistance by government in the form of transfers of resources to an entity in return for past or future compliance with certain conditions relating to the operating activities of the entity, recognised as deferred income. They exclude those forms of government assistance that cannot reasonably have a value placed upon them and transactions with government that cannot be distinguished from the normal trading transactions of the entity. [Refer: Deferred income other than contract liabilities; Government [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GovernmentGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LossesOnDisposalsOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The losses on the disposal of investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 98<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_98_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LossesOnDisposalsOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, after reclassification adjustments, related to exchange differences when financial statements of foreign operations are translated. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) attributable to ordinary equity holders of the parent entity. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 70<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_70_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGovernmentGrantsDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGovernmentGrantsDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresCropSolutionsCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresCropSolutionsCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Information About Components of Consolidated Statements of Financial Position - Schedule of Warrants (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfWarrantsAbstract', window );"><strong>Schedule of Warrants [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentWarrantLiability', window );">At the beginning of the year</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AdditionsWarrantsForTheYear', window );">Additions for the year</a></td>
<td class="nump">1,030,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AdditionsFromBusinessCombination', window );">Additions from business combination</a></td>
<td class="nump">181,093<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentWarrantLiability', window );">At the end of the year</a></td>
<td class="nump">$ 1,211,093<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentWarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current warrant liabilities. [Refer: Warrant liability]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentWarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_AdditionsFromBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additions from business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_AdditionsFromBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_AdditionsWarrantsForTheYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of additions of warrants for the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_AdditionsWarrantsForTheYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ScheduleOfWarrantsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ScheduleOfWarrantsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Information about Component of Consolidated Statements of Comprehensive Income (Details)<br></strong></div></th>
<th class="th">
<div>Mar. 28, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InformationAboutComponentOfConsolidatedStatementsOfComprehensiveIncomeLineItems', window );"><strong>Information about Component of Consolidated Statements of Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Transfer all rights, licenses, and materials</a></td>
<td class="nump">$ 750,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueOfAcquiree', window );">Royalty payments</a></td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations', window );">Performance benchmark obligations</a></td>
<td class="nump">8,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherTangibleOrIntangibleAssetsTransferred', window );">Gain from exchange of intangible assets</a></td>
<td class="nump">$ 7,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=mlec_NetWheatTechnologyLicensingMember', window );">Net Wheat Technology Licensing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InformationAboutComponentOfConsolidatedStatementsOfComprehensiveIncomeLineItems', window );"><strong>Information about Component of Consolidated Statements of Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfEntitysRevenue', window );">Percentage of revenues</a></td>
<td class="nump">25.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=mlec_NetHB4SoybeanMember', window );">Net HB4 Soybean [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InformationAboutComponentOfConsolidatedStatementsOfComprehensiveIncomeLineItems', window );"><strong>Information about Component of Consolidated Statements of Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfEntitysRevenue', window );">Percentage of revenues</a></td>
<td class="nump">6.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value, at acquisition date, of cash transferred as consideration in a business combination. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2025-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B64_f_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_e_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_e_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherTangibleOrIntangibleAssetsTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value, at acquisition date, of other tangible or intangible assets (including a business or subsidiary of the acquirer) transferred as consideration in a business combination, that the entity does not separately disclose in the same note. [Refer: Intangible assets other than goodwill; Total for all business combinations [member]; Total for all subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2025-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B64_f_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph e<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_e_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph e<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_e_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherTangibleOrIntangibleAssetsTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfEntitysRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 34<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfEntitysRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueOfAcquiree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2025-01-01<br> -Paragraph B64<br> -Subparagraph q<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B64_q_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueOfAcquiree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the transaction price allocated to the performance obligations that are unsatisfied (or partially unsatisfied) as of the end of the reporting period. The transaction price is the amount of consideration to which an entity expects to be entitled in exchange for transferring promised goods or services to a customer, excluding amounts collected on behalf of third parties (for example, some sales taxes). [Refer: Performance obligations [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2025-01-01<br> -Paragraph 120<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_120_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 108<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_108_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 108<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_108_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_InformationAboutComponentOfConsolidatedStatementsOfComprehensiveIncomeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_InformationAboutComponentOfConsolidatedStatementsOfComprehensiveIncomeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=mlec_NetWheatTechnologyLicensingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=mlec_NetWheatTechnologyLicensingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=mlec_NetHB4SoybeanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=mlec_NetHB4SoybeanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Information about Component of Consolidated Statements of Comprehensive Income - Schedule of Revenue from Contracts with Customers (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract', window );"><strong>Schedule of Revenue from Contracts with Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Sale of goods and services</a></td>
<td class="nump">$ 317,924,355<span></span>
</td>
<td class="nump">$ 444,149,141<span></span>
</td>
<td class="nump">$ 385,976,753<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromRoyalties', window );">Royalties</a></td>
<td class="nump">1,414,864<span></span>
</td>
<td class="nump">986,602<span></span>
</td>
<td class="nump">1,247,567<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromRenderingOfServices', window );">Rendering of services with related parties</a></td>
<td class="nump">841,205<span></span>
</td>
<td class="nump">952,742<span></span>
</td>
<td class="nump">739,651<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LicenceFeeIncome', window );">Right of use licenses</a></td>
<td class="nump">13,430,824<span></span>
</td>
<td class="nump">20,287,845<span></span>
</td>
<td class="nump">32,903,458<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from contracts with customers</a></td>
<td class="nump">$ 333,611,248<span></span>
</td>
<td class="nump">$ 466,376,330<span></span>
</td>
<td class="nump">$ 420,867,429<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LicenceFeeIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LicenceFeeIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromContractsWithCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2025-01-01<br> -Paragraph 114<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_114&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2025-01-01<br> -Paragraph 113<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_113_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromContractsWithCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromRenderingOfServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromRenderingOfServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromRoyalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromRoyalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromSaleOfGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromSaleOfGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Information about Component of Consolidated Statements of Comprehensive Income - Schedule of Cost of Sales (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfSalesMember', window );"><strong>Schedule of Cost of Sales [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InventoriesNetOfAgriculturalProducts', window );">Inventories as of the beginning of the year</a></td>
<td class="nump">$ 110,913,884<span></span>
</td>
<td class="nump">$ 112,000,786<span></span>
</td>
<td class="nump">$ 78,775,003<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_LossOfControl', window );">Loss of control</a></td>
<td class="num">(82,999,205)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InventoriesFromBusinessCombination', window );">Additions related to Business combination</a></td>
<td class="nump">2,235,482<span></span>
</td>
<td class="nump">4,020,771<span></span>
</td>
<td class="nump">11,182,602<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PurchaseOfInventory', window );">Purchases of the year</a></td>
<td class="nump">149,950,181<span></span>
</td>
<td class="nump">249,648,267<span></span>
</td>
<td class="nump">233,465,488<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InventoryProductionCosts', window );">Production costs</a></td>
<td class="nump">25,177,920<span></span>
</td>
<td class="nump">25,819,152<span></span>
</td>
<td class="nump">23,234,862<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ForeignCurrencyTranslationOnInventory', window );">Foreign currency translation</a></td>
<td class="nump">382,092<span></span>
</td>
<td class="num">(1,206,764)<span></span>
</td>
<td class="nump">806,903<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InventoriesBeforeClosingInventory', window );">Subtotal</a></td>
<td class="nump">205,660,354<span></span>
</td>
<td class="nump">390,282,212<span></span>
</td>
<td class="nump">347,464,858<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InventoriesTotal', window );">Inventories as of the end of the year</a></td>
<td class="num">(2,235,482)<span></span>
</td>
<td class="num">(110,913,884)<span></span>
</td>
<td class="num">(112,000,786)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of sales</a></td>
<td class="nump">$ 203,424,872<span></span>
</td>
<td class="nump">$ 279,368,328<span></span>
</td>
<td class="nump">$ 235,464,072<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 104<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_104&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:domainItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InventoriesTotal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets: (a) held for sale in the ordinary course of business; (b) in the process of production for such sale; or (c) in the form of materials or supplies to be consumed in the production process or in the rendering of services. Inventories encompass goods purchased and held for resale including, for example, merchandise purchased by a retailer and held for resale, or land and other property held for resale. Inventories also encompass finished goods produced, or work in progress being produced, by the entity and include materials and supplies awaiting use in the production process. [Refer: Current finished goods; Current merchandise; Current work in progress; Land]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_g&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InventoriesTotal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ForeignCurrencyTranslationOnInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation on inventory</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ForeignCurrencyTranslationOnInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_InventoriesBeforeClosingInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of inventory before closing inventory (i.e. Opening inventory plus purchases).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_InventoriesBeforeClosingInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_InventoriesFromBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additions to inventories as results of business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_InventoriesFromBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_InventoriesNetOfAgriculturalProducts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of inventories net of agricultural products.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_InventoriesNetOfAgriculturalProducts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_InventoryProductionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of manufacturing costs capitalized to inventory during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_InventoryProductionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_LossOfControl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of loss of control.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_LossOfControl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_PurchaseOfInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of inventory purchased during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_PurchaseOfInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Information about Component of Consolidated Statements of Comprehensive Income - Schedule of R&amp;D Classified by Nature (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ResearchAndDevelopmentsExpenseAbstract', window );"><strong>Research And Developments Expense Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization of intangible assets</a></td>
<td class="nump">$ 5,079,839<span></span>
</td>
<td class="nump">$ 5,923,389<span></span>
</td>
<td class="nump">$ 4,804,768<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AnalysisAndStorage', window );">Analysis and storage</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">5,302<span></span>
</td>
<td class="nump">52,660<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RoyaltyExpense', window );">Commissions and royalties</a></td>
<td class="nump">14,179<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">16,257<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ImportAndExportExpenses', window );">Import and export expenses</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">855<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Depreciation of leased assets</a></td>
<td class="nump">54,505<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">68,321<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation of property, plant and equipment</a></td>
<td class="nump">767,731<span></span>
</td>
<td class="nump">618,627<span></span>
</td>
<td class="nump">637,734<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TransportationExpense', window );">Freight and haulage</a></td>
<td class="nump">2,025<span></span>
</td>
<td class="nump">30,450<span></span>
</td>
<td class="nump">17,707<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermEmployeeBenefitsExpense', window );">Employee benefits and social securities</a></td>
<td class="nump">4,032,386<span></span>
</td>
<td class="nump">4,727,340<span></span>
</td>
<td class="nump">4,781,678<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InsuranceExpense', window );">Insurance</a></td>
<td class="nump">49,343<span></span>
</td>
<td class="nump">48,872<span></span>
</td>
<td class="nump">78,673<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FuelAndEnergyExpense', window );">Energy and fuel</a></td>
<td class="nump">5,576<span></span>
</td>
<td class="nump">8,101<span></span>
</td>
<td class="nump">111,481<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RepairsAndMaintenanceExpense', window );">Maintenance</a></td>
<td class="nump">236,867<span></span>
</td>
<td class="nump">283,895<span></span>
</td>
<td class="nump">475,868<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SuppliesAndMaterials', window );">Supplies and materials</a></td>
<td class="nump">2,731,604<span></span>
</td>
<td class="nump">2,361,380<span></span>
</td>
<td class="nump">3,078,403<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_LicensesandPatents', window );">Licenses &amp; Patents</a></td>
<td class="nump">516,591<span></span>
</td>
<td class="nump">67,188<span></span>
</td>
<td class="nump">181,264<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TravelExpense', window );">Mobility and travel</a></td>
<td class="nump">141,481<span></span>
</td>
<td class="nump">205,741<span></span>
</td>
<td class="nump">245,875<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdvertisingExpense', window );">Publicity and advertising</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">23,383<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SystemExpenses', window );">Systems expenses</a></td>
<td class="nump">40,286<span></span>
</td>
<td class="nump">29,026<span></span>
</td>
<td class="nump">31,410<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_VehicleExpenses', window );">Vehicles expenses</a></td>
<td class="nump">16,858<span></span>
</td>
<td class="nump">30,883<span></span>
</td>
<td class="nump">8,252<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets', window );">Share-based incentives</a></td>
<td class="nump">217,494<span></span>
</td>
<td class="nump">510,162<span></span>
</td>
<td class="nump">136,754<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SurveillanceExpense', window );">Surveillance expenses</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">11,145<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfessionalFeesExpense', window );">Professional fees and outsourced services</a></td>
<td class="nump">878,973<span></span>
</td>
<td class="nump">1,325,361<span></span>
</td>
<td class="nump">550,585<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ProfessionalFeesExpenseRelatedParties', window );">Professional fees related parties</a></td>
<td class="nump">90,533<span></span>
</td>
<td class="nump">256,877<span></span>
</td>
<td class="nump">542,551<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdministrativeExpense', window );">Office supplies</a></td>
<td class="nump">261,263<span></span>
</td>
<td class="nump">696,760<span></span>
</td>
<td class="nump">111,618<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousOtherOperatingExpense', window );">Miscellaneous</a></td>
<td class="nump">976<span></span>
</td>
<td class="nump">269,750<span></span>
</td>
<td class="nump">128<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">Total</a></td>
<td class="nump">15,138,510<span></span>
</td>
<td class="nump">17,422,487<span></span>
</td>
<td class="nump">15,943,987<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ResearchAndDevelopmentExpenseCapitalized', window );">R&amp;D capitalized (Note 8.3)</a></td>
<td class="nump">8,614,448<span></span>
</td>
<td class="nump">11,856,331<span></span>
</td>
<td class="nump">10,753,047<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">R&amp;D profit and loss</a></td>
<td class="nump">15,138,510<span></span>
</td>
<td class="nump">17,422,487<span></span>
</td>
<td class="nump">15,943,987<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_TotalResearchAndDevelopmentExpenseIncurred', window );">Total</a></td>
<td class="nump">$ 23,752,958<span></span>
</td>
<td class="nump">$ 29,278,818<span></span>
</td>
<td class="nump">$ 26,697,034<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_b_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_118_e_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph e<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_e_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph e<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_e_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_73_e_vii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 75<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_75_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -Subparagraph e<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200_e_vii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -Subparagraph e<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200_e_vii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 53<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_53_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 51<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_51_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 34<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_34_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 34<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_34_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FuelAndEnergyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FuelAndEnergyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InsuranceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InsuranceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MiscellaneousOtherOperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MiscellaneousOtherOperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfessionalFeesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfessionalFeesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RepairsAndMaintenanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RepairsAndMaintenanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 126<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_126&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 266<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_266&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 266<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_266&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RoyaltyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RoyaltyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShorttermEmployeeBenefitsExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShorttermEmployeeBenefitsExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TransportationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TransportationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TravelExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TravelExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_AnalysisAndStorage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of analysis and storage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_AnalysisAndStorage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ImportAndExportExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of import and export expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ImportAndExportExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_LicensesandPatents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Licenses &amp; Patents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_LicensesandPatents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ProfessionalFeesExpenseRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of professional fee expense with related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ProfessionalFeesExpenseRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ResearchAndDevelopmentExpenseCapitalized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of research and development expense capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ResearchAndDevelopmentExpenseCapitalized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ResearchAndDevelopmentsExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ResearchAndDevelopmentsExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_SuppliesAndMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current supplies and materials purchased for production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_SuppliesAndMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_SurveillanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Surveillance expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_SurveillanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_SystemExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Systems expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_SystemExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_TotalResearchAndDevelopmentExpenseIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of research and development costs that an entity incurs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_TotalResearchAndDevelopmentExpenseIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_VehicleExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Vehicles expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_VehicleExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Information about Component of Consolidated Statements of Comprehensive Income - Schedule of Expenses Classified by Nature and Function (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=ifrs-full_CostOfSalesMember', window );">Production and services costs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems', window );"><strong>Schedule of Expenses Classified by Nature and Function [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForAmortisationExpense', window );">Amortization of intangible assets</a></td>
<td class="nump">$ 351,240<span></span>
</td>
<td class="nump">$ 239,545<span></span>
</td>
<td class="nump">$ 173,032<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AnalysisAndStorage', window );">Analysis and storage</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">598<span></span>
</td>
<td class="nump">4,496<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RoyaltyExpense', window );">Commissions and royalties</a></td>
<td class="nump">835,082<span></span>
</td>
<td class="nump">217,000<span></span>
</td>
<td class="nump">127,771<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ImportAndExportExpenses', window );">Import and export expenses</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">147,392<span></span>
</td>
<td class="nump">150,402<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation of property, plant and equipment</a></td>
<td class="nump">2,861,812<span></span>
</td>
<td class="nump">3,018,014<span></span>
</td>
<td class="nump">2,161,236<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables', window );">Impairment of receivables</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TransportationExpense', window );">Freight and haulage</a></td>
<td class="nump">1,003,986<span></span>
</td>
<td class="nump">927,910<span></span>
</td>
<td class="nump">2,427,296<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermEmployeeBenefitsExpense', window );">Employee benefits and social securities</a></td>
<td class="nump">9,899,884<span></span>
</td>
<td class="nump">11,162,207<span></span>
</td>
<td class="nump">10,033,252<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTaxExpenseIncome', window );">Taxes</a></td>
<td class="nump">260,091<span></span>
</td>
<td class="nump">285,791<span></span>
</td>
<td class="nump">255,227<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RepairsAndMaintenanceExpense', window );">Maintenance</a></td>
<td class="nump">2,414,461<span></span>
</td>
<td class="nump">2,074,352<span></span>
</td>
<td class="nump">1,157,887<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FuelAndEnergyExpense', window );">Energy and fuel</a></td>
<td class="nump">658,621<span></span>
</td>
<td class="nump">997,066<span></span>
</td>
<td class="nump">967,412<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SuppliesAndMaterials', window );">Supplies and materials</a></td>
<td class="nump">586,696<span></span>
</td>
<td class="nump">1,031,386<span></span>
</td>
<td class="nump">1,075,909<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TravelExpense', window );">Mobility and travel</a></td>
<td class="nump">339,447<span></span>
</td>
<td class="nump">202,810<span></span>
</td>
<td class="nump">128,072<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AllowanceForObsolescences', window );">Allowance for obsolescence</a></td>
<td class="nump">1,547,723<span></span>
</td>
<td class="nump">581,804<span></span>
</td>
<td class="nump">1,012,788<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdvertisingExpense', window );">Publicity and advertising</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">233<span></span>
</td>
<td class="nump">2,528<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SystemExpenses', window );">Systems expenses</a></td>
<td class="nump">39,583<span></span>
</td>
<td class="nump">35,526<span></span>
</td>
<td class="nump">11,556<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SharebasedIncentivesForEmployees', window );">Share-based incentives for employees</a></td>
<td class="nump">315,965<span></span>
</td>
<td class="nump">1,111,919<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SurveillanceExpense', window );">Surveillance expenses</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">368<span></span>
</td>
<td class="nump">105,988<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfessionalFeesExpense', window );">Professional fees and outsourced services</a></td>
<td class="nump">201,601<span></span>
</td>
<td class="nump">189,090<span></span>
</td>
<td class="nump">100,308<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ProfessionalFeesRelatedParties', window );">Professional fees related parties</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdministrativeExpense', window );">Office supplies</a></td>
<td class="nump">93,967<span></span>
</td>
<td class="nump">242,790<span></span>
</td>
<td class="nump">229,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InsuranceExpense', window );">Insurance</a></td>
<td class="nump">181,595<span></span>
</td>
<td class="nump">199,109<span></span>
</td>
<td class="nump">230,388<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Depreciation of leased assets</a></td>
<td class="nump">2,477,334<span></span>
</td>
<td class="nump">1,312,849<span></span>
</td>
<td class="nump">468,524<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_Contingencies', window );">Contingencies</a></td>
<td class="nump">84,567<span></span>
</td>
<td class="nump">66,682<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_EnvironmentalImpactTreatment', window );">Environmental Impact Treatment</a></td>
<td class="nump">998,303<span></span>
</td>
<td class="nump">1,770,857<span></span>
</td>
<td class="nump">2,369,838<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_LicensesandPatents', window );">Licenses &amp; Patents</a></td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousOtherOperatingExpense', window );">Miscellaneous</a></td>
<td class="nump">25,887<span></span>
</td>
<td class="nump">3,854<span></span>
</td>
<td class="nump">41,452<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherExpenseByFunction', window );">Total</a></td>
<td class="nump">25,177,920<span></span>
</td>
<td class="nump">25,819,152<span></span>
</td>
<td class="nump">23,234,862<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=ifrs-full_SellingGeneralAndAdministrativeExpenseMember', window );">Selling, general and administrative expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems', window );"><strong>Schedule of Expenses Classified by Nature and Function [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForAmortisationExpense', window );">Amortization of intangible assets</a></td>
<td class="nump">5,769,969<span></span>
</td>
<td class="nump">5,950,289<span></span>
</td>
<td class="nump">6,026,784<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AnalysisAndStorage', window );">Analysis and storage</a></td>
<td class="nump">14,744<span></span>
</td>
<td class="nump">160,133<span></span>
</td>
<td class="nump">700,671<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RoyaltyExpense', window );">Commissions and royalties</a></td>
<td class="nump">1,989,880<span></span>
</td>
<td class="nump">1,745,169<span></span>
</td>
<td class="nump">1,396,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ImportAndExportExpenses', window );">Import and export expenses</a></td>
<td class="nump">826,942<span></span>
</td>
<td class="nump">734,026<span></span>
</td>
<td class="nump">794,561<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation of property, plant and equipment</a></td>
<td class="nump">2,386,157<span></span>
</td>
<td class="nump">2,163,357<span></span>
</td>
<td class="nump">2,139,957<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables', window );">Impairment of receivables</a></td>
<td class="nump">7,123,716<span></span>
</td>
<td class="nump">753,428<span></span>
</td>
<td class="nump">1,327,385<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TransportationExpense', window );">Freight and haulage</a></td>
<td class="nump">11,367,271<span></span>
</td>
<td class="nump">11,831,209<span></span>
</td>
<td class="nump">9,646,138<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermEmployeeBenefitsExpense', window );">Employee benefits and social securities</a></td>
<td class="nump">44,971,665<span></span>
</td>
<td class="nump">38,799,972<span></span>
</td>
<td class="nump">39,593,472<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTaxExpenseIncome', window );">Taxes</a></td>
<td class="nump">12,411,799<span></span>
</td>
<td class="nump">14,442,557<span></span>
</td>
<td class="nump">12,001,149<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RepairsAndMaintenanceExpense', window );">Maintenance</a></td>
<td class="nump">2,216,680<span></span>
</td>
<td class="nump">1,666,524<span></span>
</td>
<td class="nump">956,916<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FuelAndEnergyExpense', window );">Energy and fuel</a></td>
<td class="nump">106,846<span></span>
</td>
<td class="nump">514,422<span></span>
</td>
<td class="nump">397,305<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SuppliesAndMaterials', window );">Supplies and materials</a></td>
<td class="nump">2,678,691<span></span>
</td>
<td class="nump">3,520,386<span></span>
</td>
<td class="nump">1,048,056<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TravelExpense', window );">Mobility and travel</a></td>
<td class="nump">4,472,895<span></span>
</td>
<td class="nump">5,317,138<span></span>
</td>
<td class="nump">5,431,323<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AllowanceForObsolescences', window );">Allowance for obsolescence</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">4,711<span></span>
</td>
<td class="nump">53,989<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdvertisingExpense', window );">Publicity and advertising</a></td>
<td class="nump">4,556,518<span></span>
</td>
<td class="nump">5,065,506<span></span>
</td>
<td class="nump">5,775,012<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SystemExpenses', window );">Systems expenses</a></td>
<td class="nump">3,008,347<span></span>
</td>
<td class="nump">3,857,779<span></span>
</td>
<td class="nump">3,158,735<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SharebasedIncentivesForEmployees', window );">Share-based incentives for employees</a></td>
<td class="nump">3,853,229<span></span>
</td>
<td class="nump">12,577,399<span></span>
</td>
<td class="nump">3,393,348<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SurveillanceExpense', window );">Surveillance expenses</a></td>
<td class="nump">583,115<span></span>
</td>
<td class="nump">468,090<span></span>
</td>
<td class="nump">392,631<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfessionalFeesExpense', window );">Professional fees and outsourced services</a></td>
<td class="nump">9,939,339<span></span>
</td>
<td class="nump">9,131,891<span></span>
</td>
<td class="nump">13,807,495<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ProfessionalFeesRelatedParties', window );">Professional fees related parties</a></td>
<td class="nump">16,353<span></span>
</td>
<td class="nump">243,827<span></span>
</td>
<td class="nump">196,101<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdministrativeExpense', window );">Office supplies</a></td>
<td class="nump">1,373,911<span></span>
</td>
<td class="nump">1,743,957<span></span>
</td>
<td class="nump">976,350<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InsuranceExpense', window );">Insurance</a></td>
<td class="nump">2,850,968<span></span>
</td>
<td class="nump">2,133,572<span></span>
</td>
<td class="nump">3,137,598<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Depreciation of leased assets</a></td>
<td class="nump">2,504,864<span></span>
</td>
<td class="nump">2,106,107<span></span>
</td>
<td class="nump">3,029,049<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_Contingencies', window );">Contingencies</a></td>
<td class="nump">252,352<span></span>
</td>
<td class="nump">586,892<span></span>
</td>
<td class="nump">239,292<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_EnvironmentalImpactTreatment', window );">Environmental Impact Treatment</a></td>
<td class="nump">67,510<span></span>
</td>
<td class="nump">14,208<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_LicensesandPatents', window );">Licenses &amp; Patents</a></td>
<td class="nump">193,773<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousOtherOperatingExpense', window );">Miscellaneous</a></td>
<td class="nump">370,706<span></span>
</td>
<td class="nump">808,273<span></span>
</td>
<td class="nump">874,192<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherExpenseByFunction', window );">Total</a></td>
<td class="nump">125,908,240<span></span>
</td>
<td class="nump">126,340,822<span></span>
</td>
<td class="nump">116,531,274<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=mlec_ExpensesClassifiedByNatureAndFunctionMember', window );">Total [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems', window );"><strong>Schedule of Expenses Classified by Nature and Function [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForAmortisationExpense', window );">Amortization of intangible assets</a></td>
<td class="nump">6,121,209<span></span>
</td>
<td class="nump">6,189,834<span></span>
</td>
<td class="nump">6,199,816<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AnalysisAndStorage', window );">Analysis and storage</a></td>
<td class="nump">14,744<span></span>
</td>
<td class="nump">160,731<span></span>
</td>
<td class="nump">705,167<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RoyaltyExpense', window );">Commissions and royalties</a></td>
<td class="nump">2,824,962<span></span>
</td>
<td class="nump">1,962,169<span></span>
</td>
<td class="nump">1,524,521<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ImportAndExportExpenses', window );">Import and export expenses</a></td>
<td class="nump">826,942<span></span>
</td>
<td class="nump">881,418<span></span>
</td>
<td class="nump">944,963<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation of property, plant and equipment</a></td>
<td class="nump">5,247,969<span></span>
</td>
<td class="nump">5,181,371<span></span>
</td>
<td class="nump">4,301,193<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables', window );">Impairment of receivables</a></td>
<td class="nump">7,123,716<span></span>
</td>
<td class="nump">753,428<span></span>
</td>
<td class="nump">1,327,385<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TransportationExpense', window );">Freight and haulage</a></td>
<td class="nump">12,371,257<span></span>
</td>
<td class="nump">12,759,119<span></span>
</td>
<td class="nump">12,073,434<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermEmployeeBenefitsExpense', window );">Employee benefits and social securities</a></td>
<td class="nump">54,871,549<span></span>
</td>
<td class="nump">49,962,179<span></span>
</td>
<td class="nump">49,626,724<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTaxExpenseIncome', window );">Taxes</a></td>
<td class="nump">12,671,890<span></span>
</td>
<td class="nump">14,728,348<span></span>
</td>
<td class="nump">12,256,376<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RepairsAndMaintenanceExpense', window );">Maintenance</a></td>
<td class="nump">4,631,141<span></span>
</td>
<td class="nump">3,740,876<span></span>
</td>
<td class="nump">2,114,803<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FuelAndEnergyExpense', window );">Energy and fuel</a></td>
<td class="nump">765,467<span></span>
</td>
<td class="nump">1,511,488<span></span>
</td>
<td class="nump">1,364,717<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SuppliesAndMaterials', window );">Supplies and materials</a></td>
<td class="nump">3,265,387<span></span>
</td>
<td class="nump">4,551,772<span></span>
</td>
<td class="nump">2,123,965<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TravelExpense', window );">Mobility and travel</a></td>
<td class="nump">4,812,342<span></span>
</td>
<td class="nump">5,519,948<span></span>
</td>
<td class="nump">5,559,395<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AllowanceForObsolescences', window );">Allowance for obsolescence</a></td>
<td class="nump">1,547,723<span></span>
</td>
<td class="nump">586,515<span></span>
</td>
<td class="nump">1,066,777<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdvertisingExpense', window );">Publicity and advertising</a></td>
<td class="nump">4,556,518<span></span>
</td>
<td class="nump">5,065,739<span></span>
</td>
<td class="nump">5,777,540<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SystemExpenses', window );">Systems expenses</a></td>
<td class="nump">3,047,930<span></span>
</td>
<td class="nump">3,893,305<span></span>
</td>
<td class="nump">3,170,291<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SharebasedIncentivesForEmployees', window );">Share-based incentives for employees</a></td>
<td class="nump">4,169,194<span></span>
</td>
<td class="nump">13,689,318<span></span>
</td>
<td class="nump">3,393,348<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SurveillanceExpense', window );">Surveillance expenses</a></td>
<td class="nump">583,115<span></span>
</td>
<td class="nump">468,458<span></span>
</td>
<td class="nump">498,619<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfessionalFeesExpense', window );">Professional fees and outsourced services</a></td>
<td class="nump">10,140,940<span></span>
</td>
<td class="nump">9,320,981<span></span>
</td>
<td class="nump">13,907,803<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ProfessionalFeesRelatedParties', window );">Professional fees related parties</a></td>
<td class="nump">16,353<span></span>
</td>
<td class="nump">243,827<span></span>
</td>
<td class="nump">196,101<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdministrativeExpense', window );">Office supplies</a></td>
<td class="nump">1,467,878<span></span>
</td>
<td class="nump">1,986,747<span></span>
</td>
<td class="nump">1,205,850<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InsuranceExpense', window );">Insurance</a></td>
<td class="nump">3,032,563<span></span>
</td>
<td class="nump">2,332,681<span></span>
</td>
<td class="nump">3,367,986<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Depreciation of leased assets</a></td>
<td class="nump">4,982,198<span></span>
</td>
<td class="nump">3,418,956<span></span>
</td>
<td class="nump">3,497,573<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_Contingencies', window );">Contingencies</a></td>
<td class="nump">336,919<span></span>
</td>
<td class="nump">653,574<span></span>
</td>
<td class="nump">239,292<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_EnvironmentalImpactTreatment', window );">Environmental Impact Treatment</a></td>
<td class="nump">1,065,813<span></span>
</td>
<td class="nump">1,785,065<span></span>
</td>
<td class="nump">2,369,838<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_LicensesandPatents', window );">Licenses &amp; Patents</a></td>
<td class="nump">193,848<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousOtherOperatingExpense', window );">Miscellaneous</a></td>
<td class="nump">396,593<span></span>
</td>
<td class="nump">812,127<span></span>
</td>
<td class="nump">915,644<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherExpenseByFunction', window );">Total</a></td>
<td class="nump">$ 151,086,160<span></span>
</td>
<td class="nump">$ 152,159,974<span></span>
</td>
<td class="nump">$ 139,766,136<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForAmortisationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForAmortisationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_b_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTaxExpenseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 80<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_80_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 193<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_193_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 193<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_193_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTaxExpenseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_73_e_vii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 75<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_75_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -Subparagraph e<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200_e_vii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -Subparagraph e<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200_e_vii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 53<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_53_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FuelAndEnergyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FuelAndEnergyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InsuranceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InsuranceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MiscellaneousOtherOperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MiscellaneousOtherOperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherExpenseByFunction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_b_vii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherExpenseByFunction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfessionalFeesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfessionalFeesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RepairsAndMaintenanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RepairsAndMaintenanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RoyaltyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RoyaltyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShorttermEmployeeBenefitsExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShorttermEmployeeBenefitsExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TransportationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TransportationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TravelExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TravelExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_AllowanceForObsolescences">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Allowance for obsolescence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_AllowanceForObsolescences</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_AnalysisAndStorage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of analysis and storage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_AnalysisAndStorage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_Contingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_Contingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_EnvironmentalImpactTreatment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Environmental Impact Treatment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_EnvironmentalImpactTreatment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ImportAndExportExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of import and export expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ImportAndExportExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_LicensesandPatents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Licenses &amp; Patents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_LicensesandPatents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ProfessionalFeesRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of professional fees related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ProfessionalFeesRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_SharebasedIncentivesForEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based incentives for employees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_SharebasedIncentivesForEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_SuppliesAndMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current supplies and materials purchased for production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_SuppliesAndMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_SurveillanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Surveillance expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_SurveillanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_SystemExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Systems expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_SystemExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=ifrs-full_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=ifrs-full_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=ifrs-full_SellingGeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=ifrs-full_SellingGeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=mlec_ExpensesClassifiedByNatureAndFunctionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=mlec_ExpensesClassifiedByNatureAndFunctionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Information about Component of Consolidated Statements of Comprehensive Income - Schedule of Finance Results (Details) - Bioceres Crop Solutions Corp. [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialCostAbstract', window );"><strong>Financial cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpense', window );">Interest expenses</a></td>
<td class="num">$ (38,077,952)<span></span>
</td>
<td class="num">$ (35,783,901)<span></span>
</td>
<td class="num">$ (30,569,478)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialCommissions', window );">Financial commissions</a></td>
<td class="num">(3,731,493)<span></span>
</td>
<td class="num">(1,850,252)<span></span>
</td>
<td class="num">(3,007,154)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceCosts', window );">Finance Costs</a></td>
<td class="num">(41,809,445)<span></span>
</td>
<td class="num">(37,634,153)<span></span>
</td>
<td class="num">(33,576,632)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_OtherFinancialResultsAbstract', window );"><strong>Other financial results</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementAssets', window );">Exchange differences generated by assets</a></td>
<td class="nump">2,183,367<span></span>
</td>
<td class="num">(7,519,875)<span></span>
</td>
<td class="num">(19,758,444)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementLiabilities', window );">Exchange differences generated by liabilities</a></td>
<td class="num">(14,647,580)<span></span>
</td>
<td class="num">(20,499,620)<span></span>
</td>
<td class="num">(3,886,408)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ChangeInFairValueOfFinancialAssetsOrLiabilitiesOrOtherFinancialResults', window );">Changes in fair value of financial assets or liabilities and other financial results</a></td>
<td class="num">(15,603,088)<span></span>
</td>
<td class="num">(10,455,775)<span></span>
</td>
<td class="num">(341,341)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PrepaymentPremiumFee', window );">Prepayment premium fee</a></td>
<td class="num">(4,870,021)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NetGainOnInflationEffectOnMonetary', window );">Net gain of inflation effect on monetary items</a></td>
<td class="nump">7,949,231<span></span>
</td>
<td class="nump">28,730,804<span></span>
</td>
<td class="nump">10,311,437<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InterestAccruedWithRelatedParties', window );">Interest accrued with related parties</a></td>
<td class="nump">944,186<span></span>
</td>
<td class="nump">135,485<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherFinanceIncomeCost', window );">Other finance results</a></td>
<td class="num">(24,043,905)<span></span>
</td>
<td class="num">(9,608,981)<span></span>
</td>
<td class="num">(13,674,756)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceIncomeCost', window );">Total net financial cost</a></td>
<td class="num">$ (65,853,350)<span></span>
</td>
<td class="num">$ (47,243,134)<span></span>
</td>
<td class="num">$ (47,251,388)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 82<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_82_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncomeCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncomeCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gains (losses) on exchange differences, recognised in profit or loss, on the fair value measurement of assets. [Refer: At fair value [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_e_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gains (losses) on exchange differences, recognised in profit or loss, on the fair value measurement of liabilities. [Refer: At fair value [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_e_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B13<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B13_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherFinanceIncomeCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherFinanceIncomeCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ChangeInFairValueOfFinancialAssetsOrLiabilitiesOrOtherFinancialResults">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Changes in fair value of financial assets or liabilities and other financial results.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ChangeInFairValueOfFinancialAssetsOrLiabilitiesOrOtherFinancialResults</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_FinancialCommissions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financial commissions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_FinancialCommissions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_FinancialCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_FinancialCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_InterestAccruedWithRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest accrued with related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_InterestAccruedWithRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_NetGainOnInflationEffectOnMonetary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net gain of inflation effect on monetary items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_NetGainOnInflationEffectOnMonetary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_OtherFinancialResultsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_OtherFinancialResultsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_PrepaymentPremiumFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepayment Premium Fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_PrepaymentPremiumFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresCropSolutionsCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresCropSolutionsCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Information about Component of Consolidated Statements of Comprehensive Income - Schedule of Other Income or Expenses, Net (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th" colspan="2"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfOtherIncomeOrExpensesNetAbstract', window );"><strong>Schedule of Other Income or Expenses, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfAgriculturalProduce', window );">Loss from subsidiary&#8217;s guarantee recognition</a></td>
<td class="num">$ (61,681,998)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_GainOnBargainPurchase', window );">Gain on bargain purchase</a></td>
<td class="nump">1,473,482<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,032,327<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_RemeasurementToFairValueOfPreexistingInterestInAnAcquiree', window );">Remeasurement to fair value of pre-existing interest in an acquiree</a></td>
<td class="num">(1,666,680)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NetResultFromCommercializationOfAgriculturalProducts', window );">Net result from commercialization of agricultural products</a></td>
<td class="num">(1,890,110)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3,560,703)<span></span>
</td>
<td class="nump">174,122<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets', window );">Result of intangible assets</a></td>
<td class="nump">7,649,848<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">125,464<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_OtherIncomeOrExpensesNet', window );">Others</a></td>
<td class="num">(473,758)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,825,111<span></span>
</td>
<td class="nump">881,177<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherOperatingIncomeExpense', window );">Total</a></td>
<td class="num">$ (56,589,216)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (703,265)<span></span>
</td>
<td class="nump">$ 1,055,299<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">On March 28, 2025, BIOX, a former subsidiary,
agreed to transfer all rights, licenses, and materials containing or pertaining to the Soy ANF trait and pay $750,000&#160;to a Arcadia
Biosciences Inc in exchange for (i) RG and OX Wheat Patents and RS exclusive rights; (ii) the cancellation of all Royalty Payments, which
included&#160;25% of the Net Wheat Technology Licensing Revenues and&#160;6% of the Net HB4 Soybean Revenues up to $10&#160;million;
and (iii) the release from any Performance Benchmark Obligations related to the RG, OX, and RS Varieties which amounted to $8.1&#160;million.
This transaction resulted in the accounting of a gain from the exchange of intangible assets amounting to $7.5&#160;million.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 14<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_14&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherOperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherOperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromSaleOfAgriculturalProduce">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromSaleOfAgriculturalProduce</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_GainOnBargainPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain on bargain purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_GainOnBargainPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_NetResultFromCommercializationOfAgriculturalProducts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net result from commercialization of agricultural products.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_NetResultFromCommercializationOfAgriculturalProducts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_OtherIncomeOrExpensesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other income or expenses net.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_OtherIncomeOrExpensesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_RemeasurementToFairValueOfPreexistingInterestInAnAcquiree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remeasurement to fair value of pre-existing interest in an acquiree.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_RemeasurementToFairValueOfPreexistingInterestInAnAcquiree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ScheduleOfOtherIncomeOrExpensesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ScheduleOfOtherIncomeOrExpensesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Taxation (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2025 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract', window );"><strong>Taxation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense', window );">Unrecognized tax-loss carry</a></td>
<td class="nump">$ 7.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 80<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_80_f&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 193<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_193_f&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 193<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_193_f&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Taxation - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Total deferred tax assets</a></td>
<td class="num">$ (15,767,275)<span></span>
</td>
<td class="num">$ (20,024,215)<span></span>
</td>
<td class="num">$ (24,839,145)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract', window );"><strong>Deferred tax liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax</a></td>
<td class="num">(15,767,275)<span></span>
</td>
<td class="num">(20,024,215)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_CarryForwardOfTaxLossMember', window );">Tax Loss-Carry Forward [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Total deferred tax assets</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">26,988,067<span></span>
</td>
<td class="nump">21,215,789<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_OthersFinancialAssetMember', window );">Others financial assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Total deferred tax assets</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">813,780<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract', window );"><strong>Deferred tax liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(464,404)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_OthersOneMember', window );">Others [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Total deferred tax assets</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,516,719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract', window );"><strong>Deferred tax liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(546,277)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_RoyaltiesMember', window );">Royalties [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Total deferred tax assets</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">764,888<span></span>
</td>
<td class="nump">723,082<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_TradeReceivableMember', window );">Trade receivables [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Total deferred tax assets</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">532,106<span></span>
</td>
<td class="nump">447,449<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_AllowancesMember', window );">Allowances [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Total deferred tax assets</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">942,587<span></span>
</td>
<td class="nump">1,213,899<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_GovernmentGrantsMember', window );">Government grants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Total deferred tax assets</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">15,090<span></span>
</td>
<td class="nump">93,996<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_DeferredTaxAssetMember', window );">Total deferred tax assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Total deferred tax assets</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">32,573,237<span></span>
</td>
<td class="nump">28,433,321<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_IntangiblesTaxLiabilityMember', window );">Intangible assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Total deferred tax assets</a></td>
<td class="num">(15,767,275)<span></span>
</td>
<td class="num">(28,444,095)<span></span>
</td>
<td class="num">(29,117,986)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract', window );"><strong>Deferred tax liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(15,767,275)<span></span>
</td>
<td class="num">(28,444,095)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_PropertyPlantAndEquipmentDepreciationMember', window );">Property, plant and equipment depreciation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Total deferred tax assets</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(14,608,912)<span></span>
</td>
<td class="num">(13,678,341)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract', window );"><strong>Deferred tax liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(14,608,912)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_InventoriesTaxLiabilityMember', window );">Inventories [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Total deferred tax assets</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(8,041,220)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract', window );"><strong>Deferred tax liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(8,041,220)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_RightOfUseLeasedAssetTaxLiabilityMember', window );">Right-of-use leased asset [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Total deferred tax assets</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(190,088)<span></span>
</td>
<td class="num">(120,442)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract', window );"><strong>Deferred tax liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(190,088)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_InflationTaxAdjustmentMember', window );">Inflation tax adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Total deferred tax assets</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(302,456)<span></span>
</td>
<td class="num">(1,131,895)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract', window );"><strong>Deferred tax liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(302,456)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_DeferredTaxLiabilityMember', window );">Total deferred tax liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Total deferred tax assets</a></td>
<td class="num">(15,767,275)<span></span>
</td>
<td class="num">(52,597,452)<span></span>
</td>
<td class="num">$ (53,272,466)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract', window );"><strong>Deferred tax liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">$ (15,767,275)<span></span>
</td>
<td class="num">$ (52,597,452)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred tax liabilities or assets. [Refer: Deferred tax liabilities; Deferred tax assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph f<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_f_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph f<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_f_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred tax assets net of deferred tax liabilities, when the absolute amount of deferred tax assets is greater than the absolute amount of deferred tax liabilities. [Refer: Deferred tax assets; Deferred tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred tax liabilities net of deferred tax assets, when the absolute amount of deferred tax liabilities is greater than the absolute amount of deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_CarryForwardOfTaxLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_CarryForwardOfTaxLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_OthersFinancialAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_OthersFinancialAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_OthersOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_OthersOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_RoyaltiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_RoyaltiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_TradeReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_TradeReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_AllowancesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_AllowancesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_GovernmentGrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_GovernmentGrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_DeferredTaxAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_DeferredTaxAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_IntangiblesTaxLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_IntangiblesTaxLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_PropertyPlantAndEquipmentDepreciationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_PropertyPlantAndEquipmentDepreciationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_InventoriesTaxLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_InventoriesTaxLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_RightOfUseLeasedAssetTaxLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_RightOfUseLeasedAssetTaxLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_InflationTaxAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_InflationTaxAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_DeferredTaxLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_DeferredTaxLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Taxation - Schedule of Roll Forward of Deferred Tax Assets and Liabilities (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Taxation [LIne Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance</a></td>
<td class="num">$ (20,024,215)<span></span>
</td>
<td class="num">$ (24,839,145)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset', window );">Business combination / (loss) of control</a></td>
<td class="nump">10,847,417<span></span>
</td>
<td class="num">(858,661)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Income tax provision</a></td>
<td class="num">(6,636,121)<span></span>
</td>
<td class="nump">7,791,048<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset', window );">Conversion difference</a></td>
<td class="nump">45,644<span></span>
</td>
<td class="num">(894,614)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance</a></td>
<td class="num">(15,767,275)<span></span>
</td>
<td class="num">(20,024,215)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome', window );">Charge to OCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,222,843)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_CarryForwardOfTaxLossMember', window );">Tax Loss-Carry Forward [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Taxation [LIne Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance</a></td>
<td class="nump">26,988,067<span></span>
</td>
<td class="nump">21,215,789<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset', window );">Business combination / (loss) of control</a></td>
<td class="num">(21,525,926)<span></span>
</td>
<td class="num">(62,585)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Income tax provision</a></td>
<td class="num">(5,579,828)<span></span>
</td>
<td class="nump">7,752,424<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset', window );">Conversion difference</a></td>
<td class="nump">117,687<span></span>
</td>
<td class="num">(694,718)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">26,988,067<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome', window );">Charge to OCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,222,843)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_OthersFinancialAssetsMember', window );">Others financial assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Taxation [LIne Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance</a></td>
<td class="nump">813,780<span></span>
</td>
<td class="nump">1,336,260<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset', window );">Business combination / (loss) of control</a></td>
<td class="num">(475,554)<span></span>
</td>
<td class="num">(2,299)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Income tax provision</a></td>
<td class="num">(342,341)<span></span>
</td>
<td class="num">(423,116)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset', window );">Conversion difference</a></td>
<td class="nump">4,115<span></span>
</td>
<td class="num">(97,065)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">813,780<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome', window );">Charge to OCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_TradeReceivableMember', window );">Trade receivables [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Taxation [LIne Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance</a></td>
<td class="nump">532,106<span></span>
</td>
<td class="nump">447,449<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset', window );">Business combination / (loss) of control</a></td>
<td class="num">(1,353,889)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Income tax provision</a></td>
<td class="nump">822,145<span></span>
</td>
<td class="nump">214,734<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset', window );">Conversion difference</a></td>
<td class="num">(362)<span></span>
</td>
<td class="num">(130,077)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">532,106<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome', window );">Charge to OCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_RoyaltiesMember', window );">Royalties [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Taxation [LIne Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance</a></td>
<td class="nump">764,888<span></span>
</td>
<td class="nump">723,082<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset', window );">Business combination / (loss) of control</a></td>
<td class="num">(744,388)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Income tax provision</a></td>
<td class="num">(18,311)<span></span>
</td>
<td class="nump">48,310<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset', window );">Conversion difference</a></td>
<td class="num">(2,189)<span></span>
</td>
<td class="num">(6,504)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">764,888<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome', window );">Charge to OCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_AllowancesMember', window );">Allowances [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Taxation [LIne Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance</a></td>
<td class="nump">942,587<span></span>
</td>
<td class="nump">1,213,899<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset', window );">Business combination / (loss) of control</a></td>
<td class="num">(1,053,605)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Income tax provision</a></td>
<td class="nump">98,032<span></span>
</td>
<td class="num">(221,106)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset', window );">Conversion difference</a></td>
<td class="nump">12,986<span></span>
</td>
<td class="num">(50,206)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">942,587<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome', window );">Charge to OCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_GovernmentGrantsMember', window );">Government grants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Taxation [LIne Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance</a></td>
<td class="nump">15,090<span></span>
</td>
<td class="nump">93,996<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset', window );">Business combination / (loss) of control</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(39,261)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Income tax provision</a></td>
<td class="num">(15,596)<span></span>
</td>
<td class="num">(42,199)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset', window );">Conversion difference</a></td>
<td class="nump">506<span></span>
</td>
<td class="nump">2,554<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">15,090<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome', window );">Charge to OCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_OthersOneMember', window );">Others [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Taxation [LIne Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance</a></td>
<td class="nump">2,516,719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset', window );">Business combination / (loss) of control</a></td>
<td class="nump">227,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Income tax provision</a></td>
<td class="num">(2,744,669)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset', window );">Conversion difference</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,516,719<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_DeferredTaxAssetMember', window );">Total deferred tax assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Taxation [LIne Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance</a></td>
<td class="nump">32,573,237<span></span>
</td>
<td class="nump">28,433,321<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset', window );">Business combination / (loss) of control</a></td>
<td class="num">(24,925,412)<span></span>
</td>
<td class="nump">661,239<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Income tax provision</a></td>
<td class="num">(7,780,568)<span></span>
</td>
<td class="nump">5,677,536<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset', window );">Conversion difference</a></td>
<td class="nump">132,743<span></span>
</td>
<td class="num">(976,016)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">32,573,237<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome', window );">Charge to OCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,222,843)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_IntangiblesTaxLiabilityMember', window );">Intangible assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Taxation [LIne Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance</a></td>
<td class="num">(28,444,095)<span></span>
</td>
<td class="num">(29,117,986)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset', window );">Business combination / (loss) of control</a></td>
<td class="nump">12,428,299<span></span>
</td>
<td class="num">(301,659)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Income tax provision</a></td>
<td class="nump">214,190<span></span>
</td>
<td class="nump">867,636<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset', window );">Conversion difference</a></td>
<td class="nump">34,331<span></span>
</td>
<td class="nump">107,914<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance</a></td>
<td class="num">(15,767,275)<span></span>
</td>
<td class="num">(28,444,095)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome', window );">Charge to OCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_PropertyPlantAndEquipmentDepreciationMember', window );">Property, plant and equipment depreciation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Taxation [LIne Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance</a></td>
<td class="num">(14,608,912)<span></span>
</td>
<td class="num">(13,678,341)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset', window );">Business combination / (loss) of control</a></td>
<td class="nump">15,315,097<span></span>
</td>
<td class="num">(174,228)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Income tax provision</a></td>
<td class="num">(703,102)<span></span>
</td>
<td class="num">(773,812)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset', window );">Conversion difference</a></td>
<td class="num">(3,083)<span></span>
</td>
<td class="nump">17,469<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(14,608,912)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome', window );">Charge to OCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_InventoriesTaxLiabilityMember', window );">Inventories [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Taxation [LIne Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance</a></td>
<td class="num">(8,041,220)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset', window );">Business combination / (loss) of control</a></td>
<td class="nump">6,611,790<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Income tax provision</a></td>
<td class="nump">1,429,430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset', window );">Conversion difference</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(8,041,220)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_BiologicalAssetsMember', window );">Biological assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Taxation [LIne Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset', window );">Business combination / (loss) of control</a></td>
<td class="nump">640,035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Income tax provision</a></td>
<td class="num">(640,035)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset', window );">Conversion difference</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_OthersFinancialAssetsOneMember', window );">Others financial assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Taxation [LIne Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance</a></td>
<td class="num">(464,404)<span></span>
</td>
<td class="num">(2,154,504)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset', window );">Business combination / (loss) of control</a></td>
<td class="nump">28,040<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Income tax provision</a></td>
<td class="nump">436,364<span></span>
</td>
<td class="nump">1,690,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset', window );">Conversion difference</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(464,404)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome', window );">Charge to OCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_RightOfUseLeasedAssetTaxLiabilityMember', window );">Right-of-use leased asset [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Taxation [LIne Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance</a></td>
<td class="num">(190,088)<span></span>
</td>
<td class="num">(120,442)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset', window );">Business combination / (loss) of control</a></td>
<td class="nump">180,967<span></span>
</td>
<td class="num">(115,495)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Income tax provision</a></td>
<td class="nump">10,505<span></span>
</td>
<td class="nump">30,998<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset', window );">Conversion difference</a></td>
<td class="num">(1,384)<span></span>
</td>
<td class="nump">14,851<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(190,088)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome', window );">Charge to OCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_InflationTaxAdjustmentMember', window );">Inflation tax adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Taxation [LIne Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance</a></td>
<td class="num">(302,456)<span></span>
</td>
<td class="num">(1,131,895)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset', window );">Business combination / (loss) of control</a></td>
<td class="nump">26,801<span></span>
</td>
<td class="nump">10,732<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Income tax provision</a></td>
<td class="nump">218,362<span></span>
</td>
<td class="nump">827,211<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset', window );">Conversion difference</a></td>
<td class="nump">57,293<span></span>
</td>
<td class="num">(8,504)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(302,456)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome', window );">Charge to OCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_OthersTaxAssetsTwoMember', window );">Others [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Taxation [LIne Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance</a></td>
<td class="num">(546,277)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset', window );">Business combination / (loss) of control</a></td>
<td class="nump">541,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Income tax provision</a></td>
<td class="nump">178,733<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset', window );">Conversion difference</a></td>
<td class="num">(174,256)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(546,277)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_DeferredTaxLiabilityMember', window );">Total deferred tax liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Taxation [LIne Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance</a></td>
<td class="num">(52,597,452)<span></span>
</td>
<td class="num">(53,272,466)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset', window );">Business combination / (loss) of control</a></td>
<td class="nump">35,772,829<span></span>
</td>
<td class="num">(1,519,900)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Income tax provision</a></td>
<td class="nump">1,144,447<span></span>
</td>
<td class="nump">2,113,512<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset', window );">Conversion difference</a></td>
<td class="num">(87,099)<span></span>
</td>
<td class="nump">81,402<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance</a></td>
<td class="num">(15,767,275)<span></span>
</td>
<td class="num">(52,597,452)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome', window );">Charge to OCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_OtherTaxAssetMember', window );">Others [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Taxation [LIne Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance</a></td>
<td class="nump">2,516,719<span></span>
</td>
<td class="nump">3,402,846<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset', window );">Business combination / (loss) of control</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">765,384<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Income tax provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,651,511)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset', window );">Conversion difference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,516,719<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome', window );">Charge to OCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_InventoryMember', window );">Inventories [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Taxation [LIne Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance</a></td>
<td class="num">(8,041,220)<span></span>
</td>
<td class="num">(6,461,576)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset', window );">Business combination / (loss) of control</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(939,250)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Income tax provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(640,394)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset', window );">Conversion difference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,041,220)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome', window );">Charge to OCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_OtherLiabilitiesOneMember', window );">Others [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Taxation [LIne Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance</a></td>
<td class="num">$ (546,277)<span></span>
</td>
<td class="num">(607,722)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset', window );">Business combination / (loss) of control</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Income tax provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">111,773<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset', window );">Conversion difference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(50,328)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(546,277)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome', window );">Charge to OCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_g_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph f<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_f_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph f<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_f_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax relating to amounts recognised in other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph ab<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_ab&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 90<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_90&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in deferred tax liability (asset) resulting from business combinations. [Refer: Deferred tax liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in deferred tax liability (asset) resulting from the net exchange differences arising when the financial statements are translated from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Deferred tax liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred tax assets net of deferred tax liabilities, when the absolute amount of deferred tax assets is greater than the absolute amount of deferred tax liabilities. [Refer: Deferred tax assets; Deferred tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_CarryForwardOfTaxLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_CarryForwardOfTaxLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_OthersFinancialAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_OthersFinancialAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_TradeReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_TradeReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_RoyaltiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_RoyaltiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_AllowancesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_AllowancesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_GovernmentGrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_GovernmentGrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_OthersOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_OthersOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_DeferredTaxAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_DeferredTaxAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_IntangiblesTaxLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_IntangiblesTaxLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_PropertyPlantAndEquipmentDepreciationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_PropertyPlantAndEquipmentDepreciationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_InventoriesTaxLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_InventoriesTaxLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_BiologicalAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_BiologicalAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_OthersFinancialAssetsOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_OthersFinancialAssetsOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_RightOfUseLeasedAssetTaxLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_RightOfUseLeasedAssetTaxLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_InflationTaxAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_InflationTaxAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_OthersTaxAssetsTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_OthersTaxAssetsTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_DeferredTaxLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_DeferredTaxLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_OtherTaxAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_OtherTaxAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_InventoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_InventoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_OtherLiabilitiesOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=mlec_OtherLiabilitiesOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Taxation - Schedule of Weighted Average Tax Rate (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfWeightedAverageTaxRateAbstract', window );"><strong>Schedule of Weighted Average Tax Rate [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossFromDiscontinuedOperations', window );">(Loss) / earnings before income tax-rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (170,003,479)<span></span>
</td>
<td class="num">$ (27,958,152)<span></span>
</td>
<td class="nump">$ 50,794,242<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate', window );">Income tax expense by applying tax rate in force in the respective countries</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">45,342,071<span></span>
</td>
<td class="nump">7,224,973<span></span>
</td>
<td class="num">(7,628,367)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_TaxEffectOfShareOfProfitOrLossOfSubsidiesJointVenturesAndAssociates', window );">Share of profit or loss of subsidiaries, joint ventures and associates</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(8,232,869)<span></span>
</td>
<td class="num">(5,141,460)<span></span>
</td>
<td class="nump">12,645,224<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PuttableInstrumentsCharge', window );">Puttable instruments charge</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(3,645)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_TaxEffectOfStockOptionCharge', window );">Stock options charge</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(167,601)<span></span>
</td>
<td class="num">(1,366,999)<span></span>
</td>
<td class="num">(586,774)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DerecognitionOfDeferredTaxAssets', window );">Derecognition of deferred tax assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(40,565,962)<span></span>
</td>
<td class="num">(94,189)<span></span>
</td>
<td class="nump">428,530<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_MutualFundsAdjustment', window );">Mutual funds adjustments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">18,471<span></span>
</td>
<td class="nump">27,560<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_TaxEffectOfRevenuesExemptFromTaxationAndExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss', window );">Non-deductible expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(4,027,734)<span></span>
</td>
<td class="num">(1,469,872)<span></span>
</td>
<td class="num">(373,655)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ResultOfInflationEffectOnMonetaryItemsAndOtherFinanceResults', window );">Result of inflation effect on monetary items and other finance results</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">335,680<span></span>
</td>
<td class="num">(5,113,890)<span></span>
</td>
<td class="num">(7,872,801)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_TaxInflationAdjustment', window );">Tax inflation adjustment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,633,659<span></span>
</td>
<td class="nump">4,278,344<span></span>
</td>
<td class="nump">5,916,143<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TaxEffectFromChangeInTaxRate', window );">Rate change adjustment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">118,060<span></span>
</td>
<td class="num">(192,127)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome', window );">Others</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(971,836)<span></span>
</td>
<td class="nump">434,321<span></span>
</td>
<td class="num">(4,162)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income tax expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (6,636,121)<span></span>
</td>
<td class="num">$ (1,103,152)<span></span>
</td>
<td class="nump">$ 2,328,366<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Mainly represent derecognition of deferred tax assets from
Bioceres S.A. because it initiated the voluntary bankruptcy proceeding (Note 21).</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 79<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 192<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_192&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 192<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_192&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that the entity does not separately disclose in the same statement or note. [Refer: Accounting profit; Applicable tax rate]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2025-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_vii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 98<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_98_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 82<br> -Subparagraph ea<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_82_ea&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxEffectFromChangeInTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to changes in the tax rate. [Refer: Accounting profit]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxEffectFromChangeInTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The product of the accounting profit multiplied by the applicable tax rate(s). [Refer: Accounting profit; Applicable tax rate]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxExpenseIncomeAtApplicableTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DerecognitionOfDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derecognition of deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DerecognitionOfDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_MutualFundsAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of mutual funds adjustments.

.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_MutualFundsAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_PuttableInstrumentsCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of puttable instruments charge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_PuttableInstrumentsCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ResultOfInflationEffectOnMonetaryItemsAndOtherFinanceResults">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Result of inflation effect on monetary items and other finance results</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ResultOfInflationEffectOnMonetaryItemsAndOtherFinanceResults</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ScheduleOfWeightedAverageTaxRateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ScheduleOfWeightedAverageTaxRateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_TaxEffectOfRevenuesExemptFromTaxationAndExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to expenses not deductible and revenues that are exempt from taxation in determining taxable profit (tax loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_TaxEffectOfRevenuesExemptFromTaxationAndExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_TaxEffectOfShareOfProfitOrLossOfSubsidiesJointVenturesAndAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to share of profit or loss of subsidies, joint ventures and associates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_TaxEffectOfShareOfProfitOrLossOfSubsidiesJointVenturesAndAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_TaxEffectOfStockOptionCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount representing the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to stock option charge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_TaxEffectOfStockOptionCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_TaxInflationAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax Inflation Adjustment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_TaxInflationAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Taxation - Schedule of Principal Statutory Taxes Rates and Current Tax (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract', window );"><strong>Taxation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTaxExpenseIncome', window );">Current tax expense</a></td>
<td class="text"> <span></span>
</td>
<td class="num">$ (8,894,200)<span></span>
</td>
<td class="num">$ (1,311,506)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncome', window );">Deferred tax</a></td>
<td class="num">(6,636,121)<span></span>
</td>
<td class="nump">7,791,048<span></span>
</td>
<td class="nump">3,639,872<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income tax</a></td>
<td class="num">$ (6,636,121)<span></span>
</td>
<td class="num">$ (1,103,152)<span></span>
</td>
<td class="nump">$ 2,328,366<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTaxExpenseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 80<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_80_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 193<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_193_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 193<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_193_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTaxExpenseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxExpenseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of tax expense (income) relating to changes in deferred tax liabilities and deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_g_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph f<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_f_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph f<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_f_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxExpenseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 79<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 192<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_192&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 192<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_192&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Taxation - Schedule of Income Tax Expense Calculated by Applying Tax Rate in Force (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_TaxationScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceDetailsLineItems', window );"><strong>Taxation - Schedule of Income Tax Expense Calculated by Applying Tax Rate in Force (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AccountingProfit', window );">Earnings before income tax-rate</a></td>
<td class="num">$ (170,003,479)<span></span>
</td>
<td class="num">$ (27,958,152)<span></span>
</td>
<td class="nump">$ 50,794,242<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate', window );">Income tax</a></td>
<td class="nump">45,342,071<span></span>
</td>
<td class="nump">7,224,973<span></span>
</td>
<td class="num">(7,628,367)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_TaxJurisdictionAxis=mlec_LowOrNullTaxationJurisdictionsMember', window );">Low or null taxation jurisdictions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_TaxationScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceDetailsLineItems', window );"><strong>Taxation - Schedule of Income Tax Expense Calculated by Applying Tax Rate in Force (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AccountingProfit', window );">Earnings before income tax-rate</a></td>
<td class="num">$ (7,247,084)<span></span>
</td>
<td class="nump">$ 13,131,953<span></span>
</td>
<td class="nump">$ 30,921,548<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Weight average applicable tax rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate', window );">Income tax</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_TaxJurisdictionAxis=mlec_LossMakingEntitiesMember', window );">Loss-making entities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_TaxationScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceDetailsLineItems', window );"><strong>Taxation - Schedule of Income Tax Expense Calculated by Applying Tax Rate in Force (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AccountingProfit', window );">Earnings before income tax-rate</a></td>
<td class="num">$ (162,756,395)<span></span>
</td>
<td class="num">$ (73,341,811)<span></span>
</td>
<td class="num">$ (54,127,043)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Weight average applicable tax rate</a></td>
<td class="nump">27.90%<span></span>
</td>
<td class="nump">24.00%<span></span>
</td>
<td class="nump">15.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate', window );">Income tax</a></td>
<td class="nump">$ 45,342,071<span></span>
</td>
<td class="nump">$ 17,595,362<span></span>
</td>
<td class="nump">$ 8,271,462<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_TaxJurisdictionAxis=mlec_ProfitMakingEntitiesMember', window );">Profit-making entities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_TaxationScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceDetailsLineItems', window );"><strong>Taxation - Schedule of Income Tax Expense Calculated by Applying Tax Rate in Force (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AccountingProfit', window );">Earnings before income tax-rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,251,706<span></span>
</td>
<td class="nump">$ 73,999,737<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Weight average applicable tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32.20%<span></span>
</td>
<td class="nump">21.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate', window );">Income tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (10,370,389)<span></span>
</td>
<td class="num">$ (15,899,829)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AccountingProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) for a period before deducting tax expense. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AccountingProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ApplicableTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The applicable income tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ApplicableTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The product of the accounting profit multiplied by the applicable tax rate(s). [Refer: Accounting profit; Applicable tax rate]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxExpenseIncomeAtApplicableTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_TaxationScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_TaxationScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_TaxJurisdictionAxis=mlec_LowOrNullTaxationJurisdictionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_TaxJurisdictionAxis=mlec_LowOrNullTaxationJurisdictionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_TaxJurisdictionAxis=mlec_LossMakingEntitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_TaxJurisdictionAxis=mlec_LossMakingEntitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_TaxJurisdictionAxis=mlec_ProfitMakingEntitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_TaxJurisdictionAxis=mlec_ProfitMakingEntitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earning Per Share - Schedule of Earning Per Share (Details) - Bioceres Crop Solutions Corp. [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EarningsPerShareAbstract', window );"><strong>Numerator</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity', window );">Loss/Profit for the year (basic EPS)</a></td>
<td class="num">$ (111,460,708)<span></span>
</td>
<td class="num">$ (32,685,398)<span></span>
</td>
<td class="nump">$ 40,435,923<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects', window );">Loss/Profit for the year (diluted EPS)</a></td>
<td class="num">$ (111,460,708)<span></span>
</td>
<td class="num">$ (32,685,398)<span></span>
</td>
<td class="nump">$ 40,435,923<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract', window );"><strong>Denominator</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageShares', window );">Number of shares (basic EPS)</a></td>
<td class="nump">6,462,960<span></span>
</td>
<td class="nump">5,821,519<span></span>
</td>
<td class="nump">4,593,222<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustedWeightedAverageShares', window );">Number of shares (diluted EPS)</a></td>
<td class="nump">6,462,960<span></span>
</td>
<td class="nump">5,821,519<span></span>
</td>
<td class="nump">4,593,222<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShare', window );">Basic (loss)/profit attributable to ordinary equity holders of the parent</a></td>
<td class="num">$ (17.2461)<span></span>
</td>
<td class="num">$ (5.6146)<span></span>
</td>
<td class="nump">$ 8.8034<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DilutedEarningsLossPerShare', window );">Diluted (loss)/profit attributable to ordinary equity holders of the parent</a></td>
<td class="num">$ (17.2461)<span></span>
</td>
<td class="num">$ (5.6146)<span></span>
</td>
<td class="nump">$ 8.8034<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustedWeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustedWeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutedEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutedEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) attributable to ordinary equity holders of the parent entity. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 70<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_70_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) attributable to ordinary equity holders of the parent entity, adjusted for the effects of all dilutive potential ordinary shares. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 70<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_70_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsAxis=mlec_BioceresCropSolutionsCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsAxis=mlec_BioceresCropSolutionsCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Information about Components of Equity (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2025 </div>
<div>shares</div>
</th>
<th class="th">
<div>May 14, 2025 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InformationaboutComponentsofEquityDetailsLineItems', window );"><strong>Information about Components of Equity (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates', window );">Held own shares</a></td>
<td class="nump">80,370<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">60,083<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember', window );">Ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InformationaboutComponentsofEquityDetailsLineItems', window );"><strong>Information about Components of Equity (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_VotePerShare', window );">Vote per share</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares in the entity held by the entity or by its subsidiaries or associates. [Refer: Total for all associates [member]; Total for all subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 160<br> -Subparagraph a<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_160_a_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph a<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_a_vi&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_79_a_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_InformationaboutComponentsofEquityDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_InformationaboutComponentsofEquityDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_VotePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of vote for each share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_VotePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Information about Components of Equity - Schedule of Number of Shares Issued (Details) - Ordinary [Member] - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfNumberOfSharesIssuedLineItems', window );"><strong>Schedule of Number of Shares Issued [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of Shares</a></td>
<td class="nump">10,891,761<span></span>
</td>
<td class="nump">5,983,687<span></span>
</td>
<td class="nump">5,301,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NumberOfNominalValue', window );">Nominal Value (in Dollars per share)</a></td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SubscribedCapitalOfShares', window );">Subscribed capital</a></td>
<td class="nump">10,891,761<span></span>
</td>
<td class="nump">5,983,687<span></span>
</td>
<td class="nump">5,301,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SubscribedCapital', window );">Subscribed capital amount (in Dollars)</a></td>
<td class="nump">$ 1,089,176<span></span>
</td>
<td class="nump">$ 598,369<span></span>
</td>
<td class="nump">$ 530,170<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_NumberOfNominalValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The per share of nominal value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_NumberOfNominalValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ScheduleOfNumberOfSharesIssuedLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ScheduleOfNumberOfSharesIssuedLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_SubscribedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of subscribed capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_SubscribedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_SubscribedCapitalOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of subscribed capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_SubscribedCapitalOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Information about Components of Equity - Schedule of Subsidiaries Non-Controlling Interest (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Summarized financial information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Bioceres S.A.</a></td>
<td class="nump">10.07%<span></span>
</td>
<td class="nump">26.53%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Bioceres Crop Solutions (*)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">72.67%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Total for all subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17_b_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2025-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_16_b_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 19B<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_19B_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfOwnershipInterestInSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The proportion of ownership interests in a subsidiary held by non-controlling interests. [Refer: Total for all subsidiaries [member]; Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 12<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_12_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Information about Components of Equity - Schedule of Financial Statements (Details) - Bioceres S.A [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems', window );"><strong>Information about Components of Equity - Schedule of Financial Statements (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Current assets</a></td>
<td class="nump">$ 19,390,689<span></span>
</td>
<td class="nump">$ 37,499,373<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NoncurrentAsset', window );">Non-current assets</a></td>
<td class="num">(12,909,646)<span></span>
</td>
<td class="nump">78,742,912<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="nump">6,481,043<span></span>
</td>
<td class="nump">116,242,285<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Current liabilities</a></td>
<td class="nump">97,284,715<span></span>
</td>
<td class="nump">47,526,407<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Non-current liabilities</a></td>
<td class="nump">238,458<span></span>
</td>
<td class="nump">14,689,742<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Liabilities', window );">Total liabilities</a></td>
<td class="nump">97,523,173<span></span>
</td>
<td class="nump">62,216,149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Total equity</a></td>
<td class="num">(91,042,130)<span></span>
</td>
<td class="nump">54,026,136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Total liabilities and equity</a></td>
<td class="nump">6,481,043<span></span>
</td>
<td class="nump">116,242,285<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Revenues</a></td>
<td class="nump">780,952<span></span>
</td>
<td class="nump">1,422,707<span></span>
</td>
<td class="nump">$ 1,074,655<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromGovernmentGrants', window );">Government grants</a></td>
<td class="nump">3,412<span></span>
</td>
<td class="nump">197,519<span></span>
</td>
<td class="nump">49,185<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross margin</a></td>
<td class="nump">784,364<span></span>
</td>
<td class="nump">1,620,226<span></span>
</td>
<td class="nump">1,123,840<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="num">(223,688)<span></span>
</td>
<td class="num">(239,446)<span></span>
</td>
<td class="num">(175,737)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="num">(2,275,441)<span></span>
</td>
<td class="num">(3,248,643)<span></span>
</td>
<td class="num">(3,287,433)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ShareOfProfitOrLossOfSubsidiaries', window );">Share of profit or loss of subsidiaries</a></td>
<td class="num">(33,367,101)<span></span>
</td>
<td class="num">(3,285,724)<span></span>
</td>
<td class="nump">5,287,879<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Share of profit or loss of joint ventures and associates</a></td>
<td class="num">(285)<span></span>
</td>
<td class="num">(2,592)<span></span>
</td>
<td class="num">(3,917)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherOperatingIncomeExpense', window );">Other income / (loss), net</a></td>
<td class="num">(56,484,792)<span></span>
</td>
<td class="nump">11,126<span></span>
</td>
<td class="nump">249,372<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Operating loss</a></td>
<td class="num">(91,566,943)<span></span>
</td>
<td class="num">(5,145,053)<span></span>
</td>
<td class="nump">3,194,004<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceIncomeCost', window );">Financial results</a></td>
<td class="nump">2,891,781<span></span>
</td>
<td class="num">(1,128,752)<span></span>
</td>
<td class="num">(4,327,324)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Loss before taxes</a></td>
<td class="num">(88,675,162)<span></span>
</td>
<td class="num">(6,273,805)<span></span>
</td>
<td class="num">(1,133,320)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income tax</a></td>
<td class="num">(1,653,797)<span></span>
</td>
<td class="nump">471,416<span></span>
</td>
<td class="num">(463,175)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Result for the year</a></td>
<td class="num">(90,328,959)<span></span>
</td>
<td class="num">(5,802,389)<span></span>
</td>
<td class="num">(1,596,495)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation', window );">Revaluation of property, plant and equipment, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(434,390)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax', window );">Foreign exchange differences on translation of foreign operations</a></td>
<td class="num">(5,467,311)<span></span>
</td>
<td class="num">(3,865,328)<span></span>
</td>
<td class="num">(5,182,181)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive result</a></td>
<td class="num">$ (95,796,270)<span></span>
</td>
<td class="num">$ (9,667,717)<span></span>
</td>
<td class="num">$ (7,213,066)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81A<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 69<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncomeCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncomeCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gains (losses) recognised in other comprehensive income on exchange differences on the translation of financial statements of foreign operations, net of tax, before reclassification adjustments. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 79<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 192<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_192&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 192<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_192&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 69<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, related to gains (losses) in relation to changes in the revaluation surplus of property, plant and equipment, right-of-use assets and intangible assets. [Refer: Other comprehensive income; Revaluation surplus]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherOperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherOperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 17<br> -IssueDate 2025-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2025-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2025-01-01<br> -Paragraph IE33<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_IE33&amp;doctype=Illustrative%20Examples<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 126<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_126&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 266<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_266&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 266<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_266&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Revenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 34<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2025-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 82<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_82_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Revenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromGovernmentGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 20<br> -IssueDate 2025-01-01<br> -Paragraph 39<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=20&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_39_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromGovernmentGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23_g&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 82<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_82_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_NoncurrentAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non-current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_NoncurrentAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ShareOfProfitOrLossOfSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the vaue of share of profit or loss of subsidiaries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ShareOfProfitOrLossOfSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=mlec_BioceresSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=mlec_BioceresSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Information about Components of Equity - Schedule of Bioceres SA and Bioceres Crop Solutions (Details) - Bioceres Crop Solutions [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems', window );"><strong>Information about Components of Equity - Schedule of Bioceres SA and Bioceres Crop Solutions (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Current assets</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 408,668,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Non-current assets</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">441,960,310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">850,628,347<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Current liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">329,505,846<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Non-current liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">171,558,140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Liabilities', window );">Total liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">501,063,986<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Total equity</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">349,564,361<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Total liabilities and equity</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">850,628,347<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Revenues</a></td>
<td class="nump">333,343,987<span></span>
</td>
<td class="nump">464,828,548<span></span>
</td>
<td class="nump">$ 419,446,439<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets', window );">Initial recognition and changes in the fair value of biological assets at the point of harvest</a></td>
<td class="nump">1,764,863<span></span>
</td>
<td class="num">(45,746)<span></span>
</td>
<td class="nump">610,554<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of sales</a></td>
<td class="num">(203,424,872)<span></span>
</td>
<td class="num">(278,221,812)<span></span>
</td>
<td class="num">(235,457,053)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ChangeInNetRealizableValueOfAgricultural', window );">Changes in the net realizable value of agricultural products after harvest</a></td>
<td class="num">(1,541,204)<span></span>
</td>
<td class="num">(2,385,069)<span></span>
</td>
<td class="num">(4,351,433)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="num">(14,914,822)<span></span>
</td>
<td class="num">(17,183,041)<span></span>
</td>
<td class="num">(15,345,315)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="num">(123,113,572)<span></span>
</td>
<td class="num">(123,690,910)<span></span>
</td>
<td class="num">(113,002,747)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Share of profit or loss of joint ventures and associates</a></td>
<td class="num">(1,126,312)<span></span>
</td>
<td class="nump">4,049,508<span></span>
</td>
<td class="nump">1,198,628<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherOperatingIncomeExpense', window );">Other income or expenses, net</a></td>
<td class="nump">6,775,970<span></span>
</td>
<td class="num">(1,498,555)<span></span>
</td>
<td class="nump">1,084,892<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Operating (loss) / profit</a></td>
<td class="num">(2,235,962)<span></span>
</td>
<td class="nump">45,852,923<span></span>
</td>
<td class="nump">54,183,965<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceIncomeCost', window );">Financial results</a></td>
<td class="num">(55,335,675)<span></span>
</td>
<td class="num">(34,785,325)<span></span>
</td>
<td class="num">(35,078,018)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">(Loss) / profit before taxes</a></td>
<td class="num">(57,571,637)<span></span>
</td>
<td class="nump">11,067,598<span></span>
</td>
<td class="nump">19,105,947<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income tax</a></td>
<td class="num">(1,273,616)<span></span>
</td>
<td class="num">(3,778,615)<span></span>
</td>
<td class="nump">1,068,652<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Result for the year</a></td>
<td class="num">(58,845,253)<span></span>
</td>
<td class="nump">7,288,983<span></span>
</td>
<td class="nump">20,174,599<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax', window );">Foreign exchange differences on translation of foreign operations</a></td>
<td class="num">(714,251)<span></span>
</td>
<td class="num">(787,354)<span></span>
</td>
<td class="nump">631,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTax', window );">Revaluation of property, plant and equipment, net of tax</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,467,349)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive result</a></td>
<td class="num">$ (59,559,504)<span></span>
</td>
<td class="nump">$ 6,501,629<span></span>
</td>
<td class="nump">$ 19,338,750<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81A<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 69<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncomeCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncomeCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gains (losses) recognised in other comprehensive income on exchange differences on the translation of financial statements of foreign operations, net of tax, before reclassification adjustments. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 41<br> -IssueDate 2025-01-01<br> -Paragraph 50<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=41&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_50_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 273<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_273_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 273<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_273_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 79<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 192<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_192&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 192<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_192&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that do not meet the definition of current assets. [Refer: Current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 69<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherOperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherOperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 17<br> -IssueDate 2025-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2025-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2025-01-01<br> -Paragraph IE33<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_IE33&amp;doctype=Illustrative%20Examples<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 126<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_126&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 266<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_266&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 266<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_266&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Revenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 34<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2025-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 82<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_82_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Revenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23_g&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 82<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_82_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ChangeInNetRealizableValueOfAgricultural">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in the net realizable value of agricultural products after harvest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ChangeInNetRealizableValueOfAgricultural</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revaluation of property, plant and equipment, net of tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=mlec_BioceresCropSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=mlec_BioceresCropSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash Flow Information - Schedule of Significant Non-Cash Transactions Related to Investing and Financing Activities (Details) - Bioceres Crop Solutions Corp. [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract', window );"><strong>Investment activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NetAssetsAcquisitionByBusinessCombination', window );">Net assets acquisition by business combination</a></td>
<td class="nump">$ 43,053,702<span></span>
</td>
<td class="nump">$ 1,297,882<span></span>
</td>
<td class="nump">$ 152,070,313<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InvestmentInKindInOtherRelatedPartiesNonCashTransactionsInvestmentActivities', window );">Investment in-kind in other related parties</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,409,244<span></span>
</td>
<td class="nump">1,163,384<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_IssuanceOfShare', window );">Issuance of shares</a></td>
<td class="nump">457,504<span></span>
</td>
<td class="nump">267,600<span></span>
</td>
<td class="nump">759,236<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_OwnShareHeld', window );">Own shares held</a></td>
<td class="nump">22,327<span></span>
</td>
<td class="num">(437,154)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ExchangeOfIntangibleAssets', window );">Exchange of intangible assets</a></td>
<td class="nump">6,427,436<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestCostsCapitalised', window );">Capitalization of interest on buildings in progress</a></td>
<td class="nump">336,416<span></span>
</td>
<td class="nump">124,098<span></span>
</td>
<td class="nump">74,710<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_RightofuseLeasedAssetAdditionsThroughAnIncreaseInLeaseLiabilities', window );">Right-of-use leased asset additions through an increase in lease liabilities</a></td>
<td class="nump">9,569,819<span></span>
</td>
<td class="nump">2,585,223<span></span>
</td>
<td class="nump">3,154,950<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NonMonetaryContributionsInJointVenturesNonCashTransactionsInvestmentActivities', window );">Reclassification from Investment properties to property, plant and equipment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,589,749<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod', window );">Sale of equity investee</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(900,000)<span></span>
</td>
<td class="num">(133,079)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NonCashInvestingActivities', window );">Total Investment Activities</a></td>
<td class="nump">59,867,204<span></span>
</td>
<td class="nump">5,346,893<span></span>
</td>
<td class="nump">160,679,263<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_CapitalizationOfConvertibleFinancingActivities', window );">Capitalization of convertible notes</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">12,211,638<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AssignmentOfReceivablesWithShareholdersAndOtherRelatedParties', window );">Assignment of receivables with shareholders and other related parties</a></td>
<td class="num">(7,886,442)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_CompensationPaymentFinancedByAcquisitionOfIntangibleAssets', window );">Compensation payment financed by acquisition of intangible assets</a></td>
<td class="num">(1,781,507)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_IncreaseThroughAcquisitionOfNonControllingInterestInSubsidiaries', window );">Acquisition of interest in subsidiaries by financed debts</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">6,417,912<span></span>
</td>
<td class="nump">81,965,022<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NonCashFinancingActivities', window );">Total Financing Activities</a></td>
<td class="num">$ (9,667,949)<span></span>
</td>
<td class="nump">$ 6,417,912<span></span>
</td>
<td class="nump">$ 94,176,660<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestCostsCapitalised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest costs that an entity incurs in connection with the borrowing of funds that are directly attributable to the acquisition, construction or production of a qualifying asset and which form part of the cost of that asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestCostsCapitalised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of investments accounted for using the equity method. [Refer: Investments accounted for using equity method]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 16<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_AssignmentOfReceivablesWithShareholdersAndOtherRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Assignment of receivables with shareholders and other related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_AssignmentOfReceivablesWithShareholdersAndOtherRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_CapitalizationOfConvertibleFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow effect of capitalization of convertible notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_CapitalizationOfConvertibleFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_CompensationPaymentFinancedByAcquisitionOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Compensation payment financed by acquisition of intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_CompensationPaymentFinancedByAcquisitionOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ExchangeOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of exchange of intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ExchangeOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_IncreaseThroughAcquisitionOfNonControllingInterestInSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquisition of interest in subsidiaries by financed debts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_IncreaseThroughAcquisitionOfNonControllingInterestInSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_InvestmentInKindInOtherRelatedPartiesNonCashTransactionsInvestmentActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of investment in kind in other related parties, non cash transactions investment activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_InvestmentInKindInOtherRelatedPartiesNonCashTransactionsInvestmentActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_IssuanceOfShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of issuance of shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_IssuanceOfShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_NetAssetsAcquisitionByBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for net assets acquired or liabilities assumed in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_NetAssetsAcquisitionByBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_NonCashFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non cash financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_NonCashFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_NonCashInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non cash investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_NonCashInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_NonMonetaryContributionsInJointVenturesNonCashTransactionsInvestmentActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-monetary contributions in joint ventures, non cash transactions investment activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_NonMonetaryContributionsInJointVenturesNonCashTransactionsInvestmentActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_OwnShareHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Own shares held.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_OwnShareHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_RightofuseLeasedAssetAdditionsThroughAnIncreaseInLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of right-of-use leased asset additions through an increase in lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_RightofuseLeasedAssetAdditionsThroughAnIncreaseInLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=mlec_BioceresCropSolutionsCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=mlec_BioceresCropSolutionsCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash Flow Information - Schedule of Changes in Liabilities Arising from Financing Activities (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesLineItems', window );"><strong>Schedule of Changes in Liabilities Arising from Financing Activities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Beginning balance</a></td>
<td class="nump">$ 449,145,709<span></span>
</td>
<td class="nump">$ 412,219,376<span></span>
</td>
<td class="nump">$ 236,311,237<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities', window );">Proceeds</a></td>
<td class="nump">403,333,190<span></span>
</td>
<td class="nump">187,994,310<span></span>
</td>
<td class="nump">255,185,822<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancingForAssetsAcquisitions', window );">Financing for assets acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,863,254<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PrepaymentPremiumFee', window );">Prepayment Premium Fee</a></td>
<td class="nump">4,870,021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NoncashActivities', window );">Non-cash activities</a></td>
<td class="num">(9,667,949)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Acquisition from business combination</a></td>
<td class="nump">19,608,629<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DecreaseBecauseOfLossOfControl', window );">Decrease because of loss of control</a></td>
<td class="num">(263,095,494)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities', window );">Payments</a></td>
<td class="num">(380,033,708)<span></span>
</td>
<td class="num">(145,778,896)<span></span>
</td>
<td class="num">(38,457,281)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DecreaseThroughCapitalizationOfDebtLiabilitiesArisingFromFinancingActivities', window );">Conversion of Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,109,516)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestPaidClassifiedAsFinancingActivities', window );">Interest payment</a></td>
<td class="num">(28,088,688)<span></span>
</td>
<td class="num">(36,803,697)<span></span>
</td>
<td class="num">(25,639,013)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities', window );">Exchange differences, currency translation differences and other financial results</a></td>
<td class="nump">50,690,926<span></span>
</td>
<td class="nump">29,651,362<span></span>
</td>
<td class="num">(6,071,873)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Ending balance</a></td>
<td class="nump">246,762,636<span></span>
</td>
<td class="nump">449,145,709<span></span>
</td>
<td class="nump">412,219,376<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=mlec_BorrowingMember', window );">Borrowings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesLineItems', window );"><strong>Schedule of Changes in Liabilities Arising from Financing Activities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Beginning balance</a></td>
<td class="nump">361,759,056<span></span>
</td>
<td class="nump">332,446,307<span></span>
</td>
<td class="nump">211,426,056<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities', window );">Proceeds</a></td>
<td class="nump">403,333,190<span></span>
</td>
<td class="nump">187,994,310<span></span>
</td>
<td class="nump">200,185,822<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancingForAssetsAcquisitions', window );">Financing for assets acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">743,279<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PrepaymentPremiumFee', window );">Prepayment Premium Fee</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NoncashActivities', window );">Non-cash activities</a></td>
<td class="num">(7,886,442)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Acquisition from business combination</a></td>
<td class="nump">1,348,173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DecreaseBecauseOfLossOfControl', window );">Decrease because of loss of control</a></td>
<td class="num">(157,926,152)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities', window );">Payments</a></td>
<td class="num">(376,998,320)<span></span>
</td>
<td class="num">(142,866,725)<span></span>
</td>
<td class="num">(35,308,664)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DecreaseThroughCapitalizationOfDebtLiabilitiesArisingFromFinancingActivities', window );">Conversion of Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestPaidClassifiedAsFinancingActivities', window );">Interest payment</a></td>
<td class="num">(21,772,862)<span></span>
</td>
<td class="num">(32,631,369)<span></span>
</td>
<td class="num">(20,465,271)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities', window );">Exchange differences, currency translation differences and other financial results</a></td>
<td class="nump">26,645,537<span></span>
</td>
<td class="nump">16,073,254<span></span>
</td>
<td class="num">(23,391,636)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Ending balance</a></td>
<td class="nump">228,502,180<span></span>
</td>
<td class="nump">361,759,056<span></span>
</td>
<td class="nump">332,446,307<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=mlec_FinancedPaymentAcquisitionOfBusinessMember', window );">Consideration for acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesLineItems', window );"><strong>Schedule of Changes in Liabilities Arising from Financing Activities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Beginning balance</a></td>
<td class="nump">6,576,967<span></span>
</td>
<td class="nump">4,559,923<span></span>
</td>
<td class="nump">12,326,110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities', window );">Proceeds</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancingForAssetsAcquisitions', window );">Financing for assets acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,119,975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PrepaymentPremiumFee', window );">Prepayment Premium Fee</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NoncashActivities', window );">Non-cash activities</a></td>
<td class="num">(1,781,507)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Acquisition from business combination</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DecreaseBecauseOfLossOfControl', window );">Decrease because of loss of control</a></td>
<td class="num">(2,898,897)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities', window );">Payments</a></td>
<td class="num">(2,035,388)<span></span>
</td>
<td class="num">(2,912,171)<span></span>
</td>
<td class="num">(3,148,617)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DecreaseThroughCapitalizationOfDebtLiabilitiesArisingFromFinancingActivities', window );">Conversion of Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestPaidClassifiedAsFinancingActivities', window );">Interest payment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities', window );">Exchange differences, currency translation differences and other financial results</a></td>
<td class="nump">138,825<span></span>
</td>
<td class="nump">3,809,240<span></span>
</td>
<td class="num">(4,617,570)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Ending balance</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">6,576,967<span></span>
</td>
<td class="nump">4,559,923<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=mlec_IfrsConvertibleNotesPayableMember', window );">Convertible notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesLineItems', window );"><strong>Schedule of Changes in Liabilities Arising from Financing Activities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Beginning balance</a></td>
<td class="nump">80,809,686<span></span>
</td>
<td class="nump">75,213,146<span></span>
</td>
<td class="nump">12,559,071<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities', window );">Proceeds</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">55,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancingForAssetsAcquisitions', window );">Financing for assets acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PrepaymentPremiumFee', window );">Prepayment Premium Fee</a></td>
<td class="nump">4,870,021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NoncashActivities', window );">Non-cash activities</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Acquisition from business combination</a></td>
<td class="nump">18,260,456<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DecreaseBecauseOfLossOfControl', window );">Decrease because of loss of control</a></td>
<td class="num">(102,270,445)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities', window );">Payments</a></td>
<td class="num">(1,000,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DecreaseThroughCapitalizationOfDebtLiabilitiesArisingFromFinancingActivities', window );">Conversion of Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,109,516)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestPaidClassifiedAsFinancingActivities', window );">Interest payment</a></td>
<td class="num">(6,315,826)<span></span>
</td>
<td class="num">(4,172,328)<span></span>
</td>
<td class="num">(5,173,742)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities', window );">Exchange differences, currency translation differences and other financial results</a></td>
<td class="nump">23,906,564<span></span>
</td>
<td class="nump">9,768,868<span></span>
</td>
<td class="nump">21,937,333<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Ending balance</a></td>
<td class="nump">$ 18,260,456<span></span>
</td>
<td class="nump">$ 80,809,686<span></span>
</td>
<td class="nump">$ 75,213,146<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in property, plant and equipment resulting from acquisitions through business combinations. [Refer: Total for all business combinations [member]; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_73_e_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -Subparagraph e<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200_e_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -Subparagraph e<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200_e_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in liabilities arising from financing activities resulting from the effect of changes in foreign exchange rates. [Refer: Liabilities arising from financing activities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 44B<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_44B_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 166<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_166_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 166<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_166_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestPaidClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for interest paid, classified as financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestPaidClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities for which cash flows were, or future cash flows will be, classified in the statement of cash flows as cash flows from financing activities. [Refer: Cash flows from (used in) financing activities; Liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 44D<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_44D&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 166<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_166&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 166<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_166&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DecreaseBecauseOfLossOfControl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease because of loss of control.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DecreaseBecauseOfLossOfControl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DecreaseThroughCapitalizationOfDebtLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease in liabilities arising from financing activities resulting from capitalization of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DecreaseThroughCapitalizationOfDebtLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease in liabilities arising from financing activities resulting from payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_FinancingForAssetsAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase decrease of Financing for assets acquisitions in financing activities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_FinancingForAssetsAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in liabilities arising from financing activities resulting from new borrowings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_NoncashActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non-cash activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_NoncashActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_PrepaymentPremiumFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepayment Premium Fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_PrepaymentPremiumFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=mlec_BorrowingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=mlec_BorrowingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=mlec_FinancedPaymentAcquisitionOfBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=mlec_FinancedPaymentAcquisitionOfBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=mlec_IfrsConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=mlec_IfrsConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Joint Ventures and Associates (Details) - Argentina<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfJointVenturesLineItems', window );"><strong>Joint Ventures and Associates [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PercentageOfProfitForObligationToLegalReserve', window );">Annual legal reserve required, as percent of profit</a></td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_MaximumPercentageOfCapitalForObligationToLegalReserve', window );">Legal reserve required, as percent of capital</a></td>
<td class="nump">20.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfJointVenturesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfJointVenturesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_MaximumPercentageOfCapitalForObligationToLegalReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum percentage of capital establish an obligation to legal reserve on ability of the joint venture to transfer funds to the Group in the form of cash dividends, or to repay loans or advances made by the Group.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_MaximumPercentageOfCapitalForObligationToLegalReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_PercentageOfProfitForObligationToLegalReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of profit to establish an obligation to legal reserve on ability of the joint venture to transfer funds to the Group in the form of cash dividends, or to repay loans or advances made by the Group.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_PercentageOfProfitForObligationToLegalReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_AR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_AR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Joint Ventures and Associates - Schedule of Joint Ventures Assets (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_MeasuredAtEquityValueMethodAbstract', window );"><strong>Measured at equity value method</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates', window );">Assets</a></td>
<td class="nump">$ 94,147,971<span></span>
</td>
<td class="nump">$ 56,260,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_MeasuredAtFairValueAbstract', window );"><strong>Measured at Fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InvestmentsMeasuredAtFairValue', window );">Measured at Fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">36,535,601<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_MeasuredAtEquityValueMethodAbstract0', window );"><strong>Measured at equity value method</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DueToJointVenturesAndAssociatesNonCurrent', window );">Liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">296,455<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_JointVenturesAxis=mlec_SynertechIndustriasSAMember', window );">Synertech Industrias S.A.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_MeasuredAtEquityValueMethodAbstract', window );"><strong>Measured at equity value method</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates', window );">Assets</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">39,749,850<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_JointVenturesAxis=mlec_BioceresCropSolutionsCorpMember', window );">Bioceres Crops Solutions Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_MeasuredAtEquityValueMethodAbstract', window );"><strong>Measured at equity value method</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates', window );">Assets</a></td>
<td class="nump">77,741,970<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_JointVenturesAxis=mlec_AgralityArgentinaSAMember', window );">Agrality Argentina S.A. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_MeasuredAtEquityValueMethodAbstract', window );"><strong>Measured at equity value method</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates', window );">Assets</a></td>
<td class="nump">7,521,996<span></span>
</td>
<td class="nump">7,758,886<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_JointVenturesAxis=mlec_AgralityUSIncMember', window );">Agrality US Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_MeasuredAtEquityValueMethodAbstract', window );"><strong>Measured at equity value method</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates', window );">Assets</a></td>
<td class="nump">3,315,307<span></span>
</td>
<td class="nump">3,521,791<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_JointVenturesAxis=mlec_AgralitySeedsIncMember', window );">Agrality Seeds Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_MeasuredAtEquityValueMethodAbstract', window );"><strong>Measured at equity value method</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates', window );">Assets</a></td>
<td class="nump">5,496,286<span></span>
</td>
<td class="nump">4,812,389<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_JointVenturesAxis=mlec_SWSemillasSAMember', window );">SW Semillas S.A. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_MeasuredAtEquityValueMethodAbstract', window );"><strong>Measured at equity value method</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates', window );">Assets</a></td>
<td class="nump">725<span></span>
</td>
<td class="nump">955<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_JointVenturesAxis=mlec_AlfalfaTechnologiesSRlMember', window );">Alfalfa Technologies S.R.L.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_MeasuredAtEquityValueMethodAbstract', window );"><strong>Measured at equity value method</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates', window );">Assets</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">36,503<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_JointVenturesAxis=mlec_InmetSAMember', window );">Inmet S.A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_MeasuredAtEquityValueMethodAbstract', window );"><strong>Measured at equity value method</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates', window );">Assets</a></td>
<td class="nump">71,687<span></span>
</td>
<td class="nump">379,876<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_JointVenturesAxis=mlec_TheoISCSpMember', window );">Theo I SCSp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_MeasuredAtFairValueAbstract', window );"><strong>Measured at Fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InvestmentsMeasuredAtFairValue', window );">Measured at Fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">36,535,601<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_JointVenturesAxis=mlec_TrigallGeneticsSAMember', window );">Trigall Genetics S.A.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_MeasuredAtEquityValueMethodAbstract0', window );"><strong>Measured at equity value method</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DueToJointVenturesAndAssociatesNonCurrent', window );">Liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 296,455<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of investments in subsidiaries, joint ventures and associates in an entity's separate financial statements. [Refer: Total for all associates [member]; Total for all joint ventures [member]; Total for all subsidiaries [member]; Investments in subsidiaries reported in separate financial statements]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DueToJointVenturesAndAssociatesNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The non-current amount due to joint ventures and associates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DueToJointVenturesAndAssociatesNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_InvestmentsMeasuredAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investments measured at fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_InvestmentsMeasuredAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_MeasuredAtEquityValueMethodAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_MeasuredAtEquityValueMethodAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_MeasuredAtEquityValueMethodAbstract0">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_MeasuredAtEquityValueMethodAbstract0</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_MeasuredAtFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_MeasuredAtFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_JointVenturesAxis=mlec_SynertechIndustriasSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_JointVenturesAxis=mlec_SynertechIndustriasSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_JointVenturesAxis=mlec_BioceresCropSolutionsCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_JointVenturesAxis=mlec_BioceresCropSolutionsCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_JointVenturesAxis=mlec_AgralityArgentinaSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_JointVenturesAxis=mlec_AgralityArgentinaSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_JointVenturesAxis=mlec_AgralityUSIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_JointVenturesAxis=mlec_AgralityUSIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_JointVenturesAxis=mlec_AgralitySeedsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_JointVenturesAxis=mlec_AgralitySeedsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_JointVenturesAxis=mlec_SWSemillasSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_JointVenturesAxis=mlec_SWSemillasSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_JointVenturesAxis=mlec_AlfalfaTechnologiesSRlMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_JointVenturesAxis=mlec_AlfalfaTechnologiesSRlMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_JointVenturesAxis=mlec_InmetSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_JointVenturesAxis=mlec_InmetSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_JointVenturesAxis=mlec_TheoISCSpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_JointVenturesAxis=mlec_TheoISCSpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_JointVenturesAxis=mlec_TrigallGeneticsSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_JointVenturesAxis=mlec_TrigallGeneticsSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Joint Ventures and Associates - Schedule of Changes in Joint Ventures Investments and Affiliates (Details) - Joint Ventures Investments and Affiliates [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsLineItems', window );"><strong>Schedule of Changes in Joint Ventures Investments and Affiliates [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity', window );">As of the beginning</a></td>
<td class="nump">$ 92,499,396<span></span>
</td>
<td class="nump">$ 117,720,140<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LossesOnDisposalsOfInvestments', window );">Loss of control</a></td>
<td class="num">(38,363,585)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ChangesInEquityInterest', window );">Changes in equity interest</a></td>
<td class="nump">77,741,970<span></span>
</td>
<td class="nump">9,958<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SaleOfEquityInvestment', window );">Sale of equity investment</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(900,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_JointVenturesAndAssociatesAccountedForUsingEquityMethodReclassificationChangeInOwnership', window );">Reclassification of Moolec Science S.A.</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(2,560,472)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_EquityMethodInvestmentIncreaseFromShareBasedIncentives', window );">Share-based incentives</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">65,470<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ChangeinJointVenturesDividendsDistribution', window );">Dividends distribution</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(1,790,032)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_GainsLossesOnExchangeDifferencesOnTranslationFromJointVentureNetOfTax', window );">Foreign currency translation</a></td>
<td class="num">(802,200)<span></span>
</td>
<td class="nump">977,482<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Share of profit or loss measured at equity value method</a></td>
<td class="num">(392,009)<span></span>
</td>
<td class="nump">7,747,312<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ShareOfProfitOrLossMeasuredAtFairValue', window );">Share of profit or loss measured at fair value</a></td>
<td class="num">(36,535,601)<span></span>
</td>
<td class="num">(28,770,462)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity', window );">As of the end of the year</a></td>
<td class="nump">$ 94,147,971<span></span>
</td>
<td class="nump">$ 92,499,396<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LossesOnDisposalsOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The losses on the disposal of investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 98<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_98_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LossesOnDisposalsOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23_g&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 82<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_82_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ChangeinJointVenturesDividendsDistribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of Dividends distribution.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ChangeinJointVenturesDividendsDistribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ChangesInEquityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of Changes in equity interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ChangesInEquityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_EquityMethodInvestmentIncreaseFromShareBasedIncentives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in the amount of investment accounted under equity method related to share-based incentives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_EquityMethodInvestmentIncreaseFromShareBasedIncentives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_GainsLossesOnExchangeDifferencesOnTranslationFromJointVentureNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gains (losses) recognised in other comprehensive income on exchange differences on the translation from joint venture of financial statements of foreign operations, net of tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_GainsLossesOnExchangeDifferencesOnTranslationFromJointVentureNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of investments accounted for using the equity method, including an investee with negative equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_JointVenturesAndAssociatesAccountedForUsingEquityMethodReclassificationChangeInOwnership">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of associates and joint ventures accounted for using equity method reclassified from equity method due to change in ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_JointVenturesAndAssociatesAccountedForUsingEquityMethodReclassificationChangeInOwnership</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_SaleOfEquityInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of the equity investment sold during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_SaleOfEquityInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ShareOfProfitOrLossMeasuredAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share of profit or loss measured at fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ShareOfProfitOrLossMeasuredAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_JointVenturesInvestmentsAndAffiliatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_JointVenturesInvestmentsAndAffiliatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Joint Ventures and Associates - Schedule of Share of Profit or Loss of Joint Ventures and Affiliates (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_MeasuredAtEquityValueMethodAbstract1', window );"><strong>Measured at equity value method</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod', window );">Share of profit or loss</a></td>
<td class="num">$ (392,009)<span></span>
</td>
<td class="nump">$ 7,747,312<span></span>
</td>
<td class="num">$ (2,076,234)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_MeasuredAtFairValueAbstract0', window );"><strong>Measured at Fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ShareOfProfitOrLossMeasuredAtFairValue', window );">Share of profit or loss</a></td>
<td class="num">(36,535,601)<span></span>
</td>
<td class="num">(28,770,462)<span></span>
</td>
<td class="nump">49,785,839<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_JointVenturesAxis=mlec_SynertechIndustriasSAMember', window );">Synertech Industrias S.A.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_MeasuredAtEquityValueMethodAbstract1', window );"><strong>Measured at equity value method</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod', window );">Share of profit or loss</a></td>
<td class="num">(415,089)<span></span>
</td>
<td class="nump">3,723,140<span></span>
</td>
<td class="nump">564,598<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_JointVenturesAxis=mlec_AgralityArgentinaSAMember', window );">Agrality Argentina S.A. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_MeasuredAtEquityValueMethodAbstract1', window );"><strong>Measured at equity value method</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod', window );">Share of profit or loss</a></td>
<td class="nump">587,173<span></span>
</td>
<td class="nump">3,519,639<span></span>
</td>
<td class="nump">2,126,492<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_JointVenturesAxis=mlec_AgralityUSIncMember', window );">Agrality US Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_MeasuredAtEquityValueMethodAbstract1', window );"><strong>Measured at equity value method</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod', window );">Share of profit or loss</a></td>
<td class="num">(206,484)<span></span>
</td>
<td class="num">(64,322)<span></span>
</td>
<td class="num">(2,940,435)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_JointVenturesAxis=mlec_AgralitySeedsIncMember', window );">Agrality Seeds Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_MeasuredAtEquityValueMethodAbstract1', window );"><strong>Measured at equity value method</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod', window );">Share of profit or loss</a></td>
<td class="nump">683,897<span></span>
</td>
<td class="num">(124,468)<span></span>
</td>
<td class="nump">2,187,415<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_JointVenturesAxis=mlec_IndrasaBiotecnologaSAMember', window );">Indrasa Biotecnologia S.A.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_MeasuredAtEquityValueMethodAbstract1', window );"><strong>Measured at equity value method</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod', window );">Share of profit or loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">62,613<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_JointVenturesAxis=mlec_MoolecScienceSAMember', window );">Moolec Science SA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_MeasuredAtEquityValueMethodAbstract1', window );"><strong>Measured at equity value method</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod', window );">Share of profit or loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(4,176,703)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_JointVenturesAxis=mlec_SWSemillasSAMember', window );">SW Semillas S.A. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_MeasuredAtEquityValueMethodAbstract1', window );"><strong>Measured at equity value method</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod', window );">Share of profit or loss</a></td>
<td class="num">(285)<span></span>
</td>
<td class="num">(2,592)<span></span>
</td>
<td class="num">(3,917)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_JointVenturesAxis=mlec_TrigallGeneticsSAMember', window );">Trigall Genetics S.A.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_MeasuredAtEquityValueMethodAbstract1', window );"><strong>Measured at equity value method</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod', window );">Share of profit or loss</a></td>
<td class="num">(711,223)<span></span>
</td>
<td class="nump">326,368<span></span>
</td>
<td class="nump">103,703<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_JointVenturesAxis=mlec_InmetSAMember', window );">Inmet S.A. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_MeasuredAtEquityValueMethodAbstract1', window );"><strong>Measured at equity value method</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod', window );">Share of profit or loss</a></td>
<td class="num">(329,998)<span></span>
</td>
<td class="nump">369,547<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_JointVenturesAxis=mlec_TheoISCSpMember', window );">Theo I SCSp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_MeasuredAtFairValueAbstract0', window );"><strong>Measured at Fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ShareOfProfitOrLossMeasuredAtFairValue', window );">Share of profit or loss</a></td>
<td class="num">$ (36,535,601)<span></span>
</td>
<td class="num">$ (28,770,462)<span></span>
</td>
<td class="nump">$ 49,785,839<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_MeasuredAtEquityValueMethodAbstract1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_MeasuredAtEquityValueMethodAbstract1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_MeasuredAtFairValueAbstract0">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_MeasuredAtFairValueAbstract0</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ShareOfProfitOrLossMeasuredAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share of profit or loss measured at fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ShareOfProfitOrLossMeasuredAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_JointVenturesAxis=mlec_SynertechIndustriasSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_JointVenturesAxis=mlec_SynertechIndustriasSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_JointVenturesAxis=mlec_AgralityArgentinaSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_JointVenturesAxis=mlec_AgralityArgentinaSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_JointVenturesAxis=mlec_AgralityUSIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_JointVenturesAxis=mlec_AgralityUSIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_JointVenturesAxis=mlec_AgralitySeedsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_JointVenturesAxis=mlec_AgralitySeedsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_JointVenturesAxis=mlec_IndrasaBiotecnologaSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_JointVenturesAxis=mlec_IndrasaBiotecnologaSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_JointVenturesAxis=mlec_MoolecScienceSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_JointVenturesAxis=mlec_MoolecScienceSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_JointVenturesAxis=mlec_SWSemillasSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_JointVenturesAxis=mlec_SWSemillasSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_JointVenturesAxis=mlec_TrigallGeneticsSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_JointVenturesAxis=mlec_TrigallGeneticsSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_JointVenturesAxis=mlec_InmetSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_JointVenturesAxis=mlec_InmetSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_JointVenturesAxis=mlec_TheoISCSpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_JointVenturesAxis=mlec_TheoISCSpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Joint Ventures and Associates - Schedule of Significant Joint Ventures (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mlec_SynertechIndustriasSAMember', window );">Synertech Industrias S.A.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfJointVenturesLineItems', window );"><strong>Schedule of Significant Joint Ventures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Current assets</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 55,963,591<span></span>
</td>
<td class="nump">$ 50,602,942<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Non-current assets</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">11,195,394<span></span>
</td>
<td class="nump">12,351,672<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Current liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">27,610,517<span></span>
</td>
<td class="nump">30,248,685<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Non- current liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">3,447,008<span></span>
</td>
<td class="nump">3,841,374<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">36,101,460<span></span>
</td>
<td class="nump">28,864,555<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Sales</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">61,815,678<span></span>
</td>
<td class="nump">62,798,136<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">(Loss)/Profit of the year</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">7,236,901<span></span>
</td>
<td class="nump">3,980,995<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mlec_AgralitySAMember', window );">Agrality S.A. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfJointVenturesLineItems', window );"><strong>Schedule of Significant Joint Ventures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Current assets</a></td>
<td class="nump">10,733,702<span></span>
</td>
<td class="nump">22,098,808<span></span>
</td>
<td class="nump">14,203,372<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Non-current assets</a></td>
<td class="nump">17,174,010<span></span>
</td>
<td class="nump">20,002,212<span></span>
</td>
<td class="nump">24,832,433<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Current liabilities</a></td>
<td class="nump">9,749,928<span></span>
</td>
<td class="nump">22,984,897<span></span>
</td>
<td class="nump">14,591,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Non- current liabilities</a></td>
<td class="nump">8,155,954<span></span>
</td>
<td class="nump">8,640,513<span></span>
</td>
<td class="nump">19,382,094<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity</a></td>
<td class="nump">10,001,830<span></span>
</td>
<td class="nump">10,475,610<span></span>
</td>
<td class="nump">5,062,012<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Sales</a></td>
<td class="nump">27,931,724<span></span>
</td>
<td class="nump">22,757,410<span></span>
</td>
<td class="nump">20,540,979<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">(Loss)/Profit of the year</a></td>
<td class="nump">1,409,802<span></span>
</td>
<td class="nump">3,935,787<span></span>
</td>
<td class="nump">2,071,653<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mlec_TheoISCSpMember', window );">Theo I SCSp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfJointVenturesLineItems', window );"><strong>Schedule of Significant Joint Ventures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Current assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Non-current assets</a></td>
<td class="nump">22,755,817<span></span>
</td>
<td class="nump">108,456,044<span></span>
</td>
<td class="nump">135,533,950<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Current liabilities</a></td>
<td class="nump">10,642,112<span></span>
</td>
<td class="nump">13,405,755<span></span>
</td>
<td class="nump">11,998,548<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Non- current liabilities</a></td>
<td class="nump">73,674,157<span></span>
</td>
<td class="nump">57,060,813<span></span>
</td>
<td class="nump">55,630,592<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity</a></td>
<td class="num">(61,560,452)<span></span>
</td>
<td class="nump">37,989,476<span></span>
</td>
<td class="nump">67,904,810<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Sales</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">(Loss)/Profit of the year</a></td>
<td class="num">$ (99,549,928)<span></span>
</td>
<td class="num">$ (32,213,331)<span></span>
</td>
<td class="num">$ (10,632,802)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 69<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfJointVenturesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfJointVenturesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that do not meet the definition of current assets. [Refer: Current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 69<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 17<br> -IssueDate 2025-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mlec_SynertechIndustriasSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mlec_SynertechIndustriasSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mlec_AgralitySAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mlec_AgralitySAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mlec_TheoISCSpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mlec_TheoISCSpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Segment Information (Details)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract', window );"><strong>Segment Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NumberOfComplementaryComponents', window );">Number of complementary components</a></td>
<td class="nump">3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_NumberOfComplementaryComponents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of complementary components of the segments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_NumberOfComplementaryComponents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Schedule of Operating Results Group's Reporting Segments (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=mlec_SeedAndIntegratedProductsMember', window );">Seed and Integrated Products [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_RevenuesFromContractsWithCustomersAbstract', window );"><strong>Revenues from contracts with customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_RevenueFromSaleOfGoodsAndRenderingOfServices', window );">Sale of goods and services</a></td>
<td class="nump">$ 60,535,026<span></span>
</td>
<td class="nump">$ 94,457,404<span></span>
</td>
<td class="nump">$ 55,360,397<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromRoyalties', window );">Royalties</a></td>
<td class="nump">1,414,864<span></span>
</td>
<td class="nump">986,602<span></span>
</td>
<td class="nump">1,247,567<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LicenceFeeIncome', window );">Right of use licenses</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_OthersAbstract', window );"><strong>Others</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets', window );">Initial recognition and changes in the fair value of biological assets at the point of harvest</a></td>
<td class="nump">1,764,863<span></span>
</td>
<td class="num">(45,746)<span></span>
</td>
<td class="nump">319,428<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromGovernmentGrants', window );">Government grants</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Total revenues</a></td>
<td class="nump">63,714,753<span></span>
</td>
<td class="nump">96,398,260<span></span>
</td>
<td class="nump">56,927,392<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of sales</a></td>
<td class="num">(44,727,989)<span></span>
</td>
<td class="num">(66,306,974)<span></span>
</td>
<td class="num">(31,012,687)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross profit per segment</a></td>
<td class="nump">$ 18,986,764<span></span>
</td>
<td class="nump">$ 30,091,286<span></span>
</td>
<td class="nump">$ 25,914,705<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PercentageGrossMargin', window );">% Gross margin</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
<td class="nump">46.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=mlec_CropProtectionMember', window );">Crop Protection [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_RevenuesFromContractsWithCustomersAbstract', window );"><strong>Revenues from contracts with customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_RevenueFromSaleOfGoodsAndRenderingOfServices', window );">Sale of goods and services</a></td>
<td class="nump">$ 181,908,584<span></span>
</td>
<td class="nump">$ 223,538,317<span></span>
</td>
<td class="nump">$ 205,685,451<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromRoyalties', window );">Royalties</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LicenceFeeIncome', window );">Right of use licenses</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_OthersAbstract', window );"><strong>Others</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets', window );">Initial recognition and changes in the fair value of biological assets at the point of harvest</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">153,460<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromGovernmentGrants', window );">Government grants</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Total revenues</a></td>
<td class="nump">181,908,584<span></span>
</td>
<td class="nump">223,538,317<span></span>
</td>
<td class="nump">205,838,911<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of sales</a></td>
<td class="num">(111,888,640)<span></span>
</td>
<td class="num">(143,807,301)<span></span>
</td>
<td class="num">(137,529,299)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross profit per segment</a></td>
<td class="nump">$ 70,019,944<span></span>
</td>
<td class="nump">$ 79,731,016<span></span>
</td>
<td class="nump">$ 68,309,612<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PercentageGrossMargin', window );">% Gross margin</a></td>
<td class="nump">38.00%<span></span>
</td>
<td class="nump">36.00%<span></span>
</td>
<td class="nump">33.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=mlec_CropNutritionMember', window );">Crop Nutrition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_RevenuesFromContractsWithCustomersAbstract', window );"><strong>Revenues from contracts with customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_RevenueFromSaleOfGoodsAndRenderingOfServices', window );">Sale of goods and services</a></td>
<td class="nump">$ 76,054,689<span></span>
</td>
<td class="nump">$ 125,558,380<span></span>
</td>
<td class="nump">$ 157,153,024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromRoyalties', window );">Royalties</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LicenceFeeIncome', window );">Right of use licenses</a></td>
<td class="nump">13,430,824<span></span>
</td>
<td class="nump">19,287,845<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_OthersAbstract', window );"><strong>Others</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets', window );">Initial recognition and changes in the fair value of biological assets at the point of harvest</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">137,666<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromGovernmentGrants', window );">Government grants</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Total revenues</a></td>
<td class="nump">89,485,513<span></span>
</td>
<td class="nump">144,846,225<span></span>
</td>
<td class="nump">157,290,690<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of sales</a></td>
<td class="num">(46,808,243)<span></span>
</td>
<td class="num">(68,107,537)<span></span>
</td>
<td class="num">(66,915,067)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross profit per segment</a></td>
<td class="nump">$ 42,677,270<span></span>
</td>
<td class="nump">$ 76,738,688<span></span>
</td>
<td class="nump">$ 90,375,623<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PercentageGrossMargin', window );">% Gross margin</a></td>
<td class="nump">48.00%<span></span>
</td>
<td class="nump">53.00%<span></span>
</td>
<td class="nump">57.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=mlec_EmergingSolutionsMember', window );">Emerging Solutions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_RevenuesFromContractsWithCustomersAbstract', window );"><strong>Revenues from contracts with customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_RevenueFromSaleOfGoodsAndRenderingOfServices', window );">Sale of goods and services</a></td>
<td class="nump">$ 267,261<span></span>
</td>
<td class="nump">$ 1,547,782<span></span>
</td>
<td class="nump">$ 1,420,990<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromRoyalties', window );">Royalties</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LicenceFeeIncome', window );">Right of use licenses</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_OthersAbstract', window );"><strong>Others</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets', window );">Initial recognition and changes in the fair value of biological assets at the point of harvest</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromGovernmentGrants', window );">Government grants</a></td>
<td class="nump">3,412<span></span>
</td>
<td class="nump">197,519<span></span>
</td>
<td class="nump">93,509<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Total revenues</a></td>
<td class="nump">270,673<span></span>
</td>
<td class="nump">1,745,301<span></span>
</td>
<td class="nump">1,514,499<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of sales</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(1,146,516)<span></span>
</td>
<td class="num">(7,019)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross profit per segment</a></td>
<td class="nump">$ 270,673<span></span>
</td>
<td class="nump">$ 598,785<span></span>
</td>
<td class="nump">$ 1,507,480<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PercentageGrossMargin', window );">% Gross margin</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=mlec_ConsolidatedEntitieMember', window );">Consolidated [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_RevenuesFromContractsWithCustomersAbstract', window );"><strong>Revenues from contracts with customers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_RevenueFromSaleOfGoodsAndRenderingOfServices', window );">Sale of goods and services</a></td>
<td class="nump">$ 318,765,560<span></span>
</td>
<td class="nump">$ 445,101,883<span></span>
</td>
<td class="nump">$ 419,619,862<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromRoyalties', window );">Royalties</a></td>
<td class="nump">1,414,864<span></span>
</td>
<td class="nump">986,602<span></span>
</td>
<td class="nump">1,247,567<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LicenceFeeIncome', window );">Right of use licenses</a></td>
<td class="nump">13,430,824<span></span>
</td>
<td class="nump">20,287,845<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_OthersAbstract', window );"><strong>Others</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets', window );">Initial recognition and changes in the fair value of biological assets at the point of harvest</a></td>
<td class="nump">1,764,863<span></span>
</td>
<td class="num">(45,746)<span></span>
</td>
<td class="nump">610,554<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromGovernmentGrants', window );">Government grants</a></td>
<td class="nump">3,412<span></span>
</td>
<td class="nump">197,519<span></span>
</td>
<td class="nump">93,509<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Total revenues</a></td>
<td class="nump">335,379,523<span></span>
</td>
<td class="nump">466,528,103<span></span>
</td>
<td class="nump">421,571,492<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of sales</a></td>
<td class="num">(203,424,872)<span></span>
</td>
<td class="num">(279,368,328)<span></span>
</td>
<td class="num">(235,464,072)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross profit per segment</a></td>
<td class="nump">$ 131,954,651<span></span>
</td>
<td class="nump">$ 187,159,775<span></span>
</td>
<td class="nump">$ 186,107,420<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PercentageGrossMargin', window );">% Gross margin</a></td>
<td class="nump">39.00%<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="nump">44.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 41<br> -IssueDate 2025-01-01<br> -Paragraph 50<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=41&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_50_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 273<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_273_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 273<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_273_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LicenceFeeIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LicenceFeeIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Revenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 34<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2025-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 82<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_82_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Revenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromGovernmentGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 20<br> -IssueDate 2025-01-01<br> -Paragraph 39<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=20&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_39_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromGovernmentGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromRoyalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromRoyalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_OthersAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_OthersAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_PercentageGrossMargin">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the value of gross margin.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_PercentageGrossMargin</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_RevenueFromSaleOfGoodsAndRenderingOfServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue arising from the sale of goods and rendering of services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_RevenueFromSaleOfGoodsAndRenderingOfServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_RevenuesFromContractsWithCustomersAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_RevenuesFromContractsWithCustomersAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=mlec_SeedAndIntegratedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=mlec_SeedAndIntegratedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=mlec_CropProtectionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=mlec_CropProtectionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=mlec_CropNutritionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=mlec_CropNutritionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=mlec_EmergingSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=mlec_EmergingSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=mlec_ConsolidatedEntitieMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=mlec_ConsolidatedEntitieMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>R107.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Schedule of Revenue by Similar Group of Products or Services (Details) - Bioceres Crop Solutions Corp. [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfProductsAndServicesLineItems', window );"><strong>Schedule of Revenue by Similar Group of Products or Services [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue</a></td>
<td class="nump">$ 333,614,660<span></span>
</td>
<td class="nump">$ 466,573,849<span></span>
</td>
<td class="nump">$ 420,960,938<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresCropSolutionsCorpMember', window );">Seed and Integrated Products [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfProductsAndServicesLineItems', window );"><strong>Schedule of Revenue by Similar Group of Products or Services [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue</a></td>
<td class="nump">61,949,890<span></span>
</td>
<td class="nump">96,444,006<span></span>
</td>
<td class="nump">56,607,954<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresCropSolutionsCorpMember', window );">Seed and Integrated Products [Member] | Seed Treatments Packs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfProductsAndServicesLineItems', window );"><strong>Schedule of Revenue by Similar Group of Products or Services [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue</a></td>
<td class="nump">28,476,396<span></span>
</td>
<td class="nump">29,992,052<span></span>
</td>
<td class="nump">32,563,161<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresCropSolutionsCorpMember', window );">Seed and Integrated Products [Member] | Seed &amp; Royalties Payments &amp; HB4 Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfProductsAndServicesLineItems', window );"><strong>Schedule of Revenue by Similar Group of Products or Services [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue</a></td>
<td class="nump">33,473,494<span></span>
</td>
<td class="nump">66,451,954<span></span>
</td>
<td class="nump">24,044,803<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresCropSolutionsCorpMember', window );">Crop Protection [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfProductsAndServicesLineItems', window );"><strong>Schedule of Revenue by Similar Group of Products or Services [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue</a></td>
<td class="nump">181,908,584<span></span>
</td>
<td class="nump">223,538,317<span></span>
</td>
<td class="nump">205,685,451<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresCropSolutionsCorpMember', window );">Crop Protection [Member] | Adjuvants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfProductsAndServicesLineItems', window );"><strong>Schedule of Revenue by Similar Group of Products or Services [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue</a></td>
<td class="nump">56,028,937<span></span>
</td>
<td class="nump">56,634,128<span></span>
</td>
<td class="nump">52,825,245<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresCropSolutionsCorpMember', window );">Crop Protection [Member] | Seed CP Products and Services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfProductsAndServicesLineItems', window );"><strong>Schedule of Revenue by Similar Group of Products or Services [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue</a></td>
<td class="nump">28,890,840<span></span>
</td>
<td class="nump">34,877,911<span></span>
</td>
<td class="nump">26,080,587<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresCropSolutionsCorpMember', window );">Crop Protection [Member] | Other CP Products and Services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfProductsAndServicesLineItems', window );"><strong>Schedule of Revenue by Similar Group of Products or Services [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue</a></td>
<td class="nump">62,983,430<span></span>
</td>
<td class="nump">103,092,454<span></span>
</td>
<td class="nump">94,277,444<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresCropSolutionsCorpMember', window );">Crop Protection [Member] | Bioprotection [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfProductsAndServicesLineItems', window );"><strong>Schedule of Revenue by Similar Group of Products or Services [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue</a></td>
<td class="nump">34,005,377<span></span>
</td>
<td class="nump">28,933,824<span></span>
</td>
<td class="nump">32,502,175<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresCropSolutionsCorpMember', window );">Crop Nutrition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfProductsAndServicesLineItems', window );"><strong>Schedule of Revenue by Similar Group of Products or Services [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue</a></td>
<td class="nump">89,485,513<span></span>
</td>
<td class="nump">144,846,225<span></span>
</td>
<td class="nump">157,153,024<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresCropSolutionsCorpMember', window );">Crop Nutrition [Member] | Inoculants &amp; Biofertilizers []Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfProductsAndServicesLineItems', window );"><strong>Schedule of Revenue by Similar Group of Products or Services [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue</a></td>
<td class="nump">22,445,093<span></span>
</td>
<td class="nump">18,315,253<span></span>
</td>
<td class="nump">23,621,534<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresCropSolutionsCorpMember', window );">Crop Nutrition [Member] | Micro-Beaded Fertilizers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfProductsAndServicesLineItems', window );"><strong>Schedule of Revenue by Similar Group of Products or Services [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue</a></td>
<td class="nump">56,461,771<span></span>
</td>
<td class="nump">91,786,942<span></span>
</td>
<td class="nump">90,827,714<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresCropSolutionsCorpMember', window );">Crop Nutrition [Member] | Biostimulants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfProductsAndServicesLineItems', window );"><strong>Schedule of Revenue by Similar Group of Products or Services [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue</a></td>
<td class="nump">10,578,649<span></span>
</td>
<td class="nump">15,456,185<span></span>
</td>
<td class="nump">9,800,318<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresCropSolutionsCorpMember', window );">Crop Nutrition [Member] | Syngenta Up-Front Fee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfProductsAndServicesLineItems', window );"><strong>Schedule of Revenue by Similar Group of Products or Services [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">19,287,845<span></span>
</td>
<td class="nump">32,903,458<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresCropSolutionsCorpMember', window );">Emerging Solutions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfProductsAndServicesLineItems', window );"><strong>Schedule of Revenue by Similar Group of Products or Services [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue</a></td>
<td class="nump">270,673<span></span>
</td>
<td class="nump">1,745,301<span></span>
</td>
<td class="nump">1,514,499<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresCropSolutionsCorpMember', window );">Emerging Solutions [Member] | Management Expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfProductsAndServicesLineItems', window );"><strong>Schedule of Revenue by Similar Group of Products or Services [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue</a></td>
<td class="nump">267,261<span></span>
</td>
<td class="nump">1,547,782<span></span>
</td>
<td class="nump">1,420,990<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresCropSolutionsCorpMember', window );">Emerging Solutions [Member] | Government Grants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfProductsAndServicesLineItems', window );"><strong>Schedule of Revenue by Similar Group of Products or Services [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue</a></td>
<td class="nump">$ 3,412<span></span>
</td>
<td class="nump">$ 197,519<span></span>
</td>
<td class="nump">$ 93,509<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfProductsAndServicesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfProductsAndServicesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromContractsWithCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2025-01-01<br> -Paragraph 114<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_114&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2025-01-01<br> -Paragraph 113<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_113_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromContractsWithCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresCropSolutionsCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresCropSolutionsCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=mlec_SeedAndIntegratedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=mlec_SeedAndIntegratedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=mlec_SeedTreatmentsPacksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=mlec_SeedTreatmentsPacksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=mlec_SeedRoyaltiesPaymentsHB4ProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=mlec_SeedRoyaltiesPaymentsHB4ProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=mlec_CropProtectionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=mlec_CropProtectionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=mlec_AdjuvantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=mlec_AdjuvantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=mlec_SeedCpProductsAndServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=mlec_SeedCpProductsAndServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=mlec_OtherCpProductsAndServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=mlec_OtherCpProductsAndServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=mlec_BioprotectionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=mlec_BioprotectionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=mlec_CropNutritionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=mlec_CropNutritionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=mlec_InoculantsBiofertilizersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=mlec_InoculantsBiofertilizersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=mlec_MicroBeadedFertilizersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=mlec_MicroBeadedFertilizersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=mlec_BiostimulantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=mlec_BiostimulantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=mlec_SyngentaUpfrontFeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=mlec_SyngentaUpfrontFeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=mlec_EmergingSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=mlec_EmergingSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=mlec_ManagementExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=mlec_ManagementExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=mlec_GovernmentGrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=mlec_GovernmentGrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>R108.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Schedule of Geographical Information (Details) - Bioceres Crop Solutions Corp. [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfGeographicalInformationLineItems', window );"><strong>Schedule of Geographical Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Total revenues</a></td>
<td class="nump">$ 333,614,660<span></span>
</td>
<td class="nump">$ 466,573,849<span></span>
</td>
<td class="nump">$ 420,960,938<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NonCurrentAssetsAbstract', window );"><strong>Non-current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Total non-current assets</a></td>
<td class="nump">78,603,960<span></span>
</td>
<td class="nump">364,107,146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="nump">3,345,170<span></span>
</td>
<td class="nump">74,612,434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="nump">75,258,790<span></span>
</td>
<td class="nump">177,331,280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">112,163,432<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_TotalReportableAssets', window );">Total reportable assets</a></td>
<td class="nump">78,603,960<span></span>
</td>
<td class="nump">364,107,146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_TotalNonreportableAssets', window );">Total non-reportable assets</a></td>
<td class="nump">126,105,586<span></span>
</td>
<td class="nump">585,729,699<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="nump">204,709,546<span></span>
</td>
<td class="nump">949,836,845<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresCropSolutionsCorpMember', window );">Argentina [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfGeographicalInformationLineItems', window );"><strong>Schedule of Geographical Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Total revenues</a></td>
<td class="nump">231,823,079<span></span>
</td>
<td class="nump">348,366,339<span></span>
</td>
<td class="nump">289,346,766<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NonCurrentAssetsAbstract', window );"><strong>Non-current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Total non-current assets</a></td>
<td class="nump">12,493,920<span></span>
</td>
<td class="nump">139,722,896<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresCropSolutionsCorpMember', window );">Brazil [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfGeographicalInformationLineItems', window );"><strong>Schedule of Geographical Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Total revenues</a></td>
<td class="nump">17,673,809<span></span>
</td>
<td class="nump">24,175,116<span></span>
</td>
<td class="nump">23,690,028<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NonCurrentAssetsAbstract', window );"><strong>Non-current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Total non-current assets</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">7,698,175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresCropSolutionsCorpMember', window );">LATAM [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfGeographicalInformationLineItems', window );"><strong>Schedule of Geographical Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Total revenues</a></td>
<td class="nump">23,900,621<span></span>
</td>
<td class="nump">21,952,339<span></span>
</td>
<td class="nump">21,044,547<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NonCurrentAssetsAbstract', window );"><strong>Non-current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Total non-current assets</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,162,654<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresCropSolutionsCorpMember', window );">North America [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfGeographicalInformationLineItems', window );"><strong>Schedule of Geographical Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Total revenues</a></td>
<td class="nump">30,107,865<span></span>
</td>
<td class="nump">27,543,558<span></span>
</td>
<td class="nump">30,768,912<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NonCurrentAssetsAbstract', window );"><strong>Non-current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Total non-current assets</a></td>
<td class="nump">53,447,180<span></span>
</td>
<td class="nump">189,199,549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresCropSolutionsCorpMember', window );">EMEA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfGeographicalInformationLineItems', window );"><strong>Schedule of Geographical Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Total revenues</a></td>
<td class="nump">7,920,550<span></span>
</td>
<td class="nump">21,320,535<span></span>
</td>
<td class="nump">22,014,855<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NonCurrentAssetsAbstract', window );"><strong>Non-current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Total non-current assets</a></td>
<td class="nump">12,662,860<span></span>
</td>
<td class="nump">44,141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresCropSolutionsCorpMember', window );">Rest of the world [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfGeographicalInformationLineItems', window );"><strong>Schedule of Geographical Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Total revenues</a></td>
<td class="nump">22,188,736<span></span>
</td>
<td class="nump">23,215,962<span></span>
</td>
<td class="nump">$ 34,095,830<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NonCurrentAssetsAbstract', window );"><strong>Non-current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Total non-current assets</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 26,279,731<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2025-01-01<br> -Paragraph 134<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_134_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2025-01-01<br> -Paragraph 135<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_135_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2025-01-01<br> -Paragraph B67<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B67_d&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 254<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_254_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 255<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_255_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 254<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_254_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 255<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_255_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 37<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 37<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that do not meet the definition of current assets. [Refer: Current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Revenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 34<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2025-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 82<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_82_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Revenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_NonCurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_NonCurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ScheduleOfGeographicalInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ScheduleOfGeographicalInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_TotalNonreportableAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total non-reportable assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_TotalNonreportableAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_TotalReportableAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reportable assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_TotalReportableAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresCropSolutionsCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresCropSolutionsCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_AR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_AR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_BR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_BR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=srt_LatinAmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=srt_LatinAmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=srt_NorthAmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=srt_NorthAmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=mlec_EuropeMiddleEastAndAfricaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=mlec_EuropeMiddleEastAndAfricaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=mlec_OtherRegionsOrCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=mlec_OtherRegionsOrCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>R109.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments &#8211; Risk Management (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialInstrumentsRiskManagementAbstract', window );"><strong>Financial Instruments &#8211; Risk Management [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PercentageOfEstimatesThatDevaluationOrAnAppreciation', window );">Percentage of estimates that devaluation or an appreciation</a></td>
<td class="nump">20.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_FinancialInstrumentsRiskManagementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_FinancialInstrumentsRiskManagementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_PercentageOfEstimatesThatDevaluationOrAnAppreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of estimates that devaluation or an appreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_PercentageOfEstimatesThatDevaluationOrAnAppreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>R110.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments &#8211; Risk Management - Schedule of Liquidity Risk (Details) - Liquidity risk [Member] - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_LiquidityRiskMember', window );">Up to 3 months [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Schedule of Liquidity Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total</a></td>
<td class="nump">$ 234,595,403<span></span>
</td>
<td class="nump">$ 196,078,442<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_LiquidityRiskMember', window );">3 to 12 months [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Schedule of Liquidity Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">215,064,447<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_LiquidityRiskMember', window );">Between one and three years [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Schedule of Liquidity Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total</a></td>
<td class="nump">19,608,629<span></span>
</td>
<td class="nump">218,224,493<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=mlec_TradeAndOtherPayablesMember', window );">Trade and other payables [Member] | Up to 3 months [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Schedule of Liquidity Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayables', window );">Trade and other payables</a></td>
<td class="nump">7,323,933<span></span>
</td>
<td class="nump">107,801,065<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=mlec_TradeAndOtherPayablesMember', window );">Trade and other payables [Member] | 3 to 12 months [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Schedule of Liquidity Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayables', window );">Trade and other payables</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">61,136,471<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=mlec_TradeAndOtherPayablesMember', window );">Trade and other payables [Member] | Between one and three years [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Schedule of Liquidity Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayables', window );">Trade and other payables</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=mlec_BorrowingMember', window );">Borrowings [Member] | Up to 3 months [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Schedule of Liquidity Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings</a></td>
<td class="nump">227,154,007<span></span>
</td>
<td class="nump">87,538,816<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=mlec_BorrowingMember', window );">Borrowings [Member] | 3 to 12 months [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Schedule of Liquidity Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">146,971,935<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=mlec_BorrowingMember', window );">Borrowings [Member] | Between one and three years [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Schedule of Liquidity Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings</a></td>
<td class="nump">1,348,173<span></span>
</td>
<td class="nump">127,248,305<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=mlec_IfrsConvertibleNotesPayableMember', window );">Convertible notes [Member] | Up to 3 months [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Schedule of Liquidity Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ConvertibleNotes', window );">Convertible notes</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=mlec_IfrsConvertibleNotesPayableMember', window );">Convertible notes [Member] | 3 to 12 months [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Schedule of Liquidity Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ConvertibleNotes', window );">Convertible notes</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=mlec_IfrsConvertibleNotesPayableMember', window );">Convertible notes [Member] | Between one and three years [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Schedule of Liquidity Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ConvertibleNotes', window );">Convertible notes</a></td>
<td class="nump">18,260,456<span></span>
</td>
<td class="nump">80,809,686<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_LeaseLiabilitiesMember', window );">Lease liability [Member] | Up to 3 months [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Schedule of Liquidity Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_LeasingLiabilities', window );">Leasing liabilities</a></td>
<td class="nump">117,463<span></span>
</td>
<td class="nump">738,561<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_LeaseLiabilitiesMember', window );">Lease liability [Member] | 3 to 12 months [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Schedule of Liquidity Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_LeasingLiabilities', window );">Leasing liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,384,217<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_LeaseLiabilitiesMember', window );">Lease liability [Member] | Between one and three years [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Schedule of Liquidity Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_LeasingLiabilities', window );">Leasing liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">8,161,359<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=mlec_ConsiderationForAcquisitionOfAssetsMember', window );">Consideration for acquisition of assets [Member] | Up to 3 months [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Schedule of Liquidity Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ConsiderationForAcquisitionOfAssets', window );">Consideration for acquisition of assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=mlec_ConsiderationForAcquisitionOfAssetsMember', window );">Consideration for acquisition of assets [Member] | 3 to 12 months [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Schedule of Liquidity Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ConsiderationForAcquisitionOfAssets', window );">Consideration for acquisition of assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,571,824<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=mlec_ConsiderationForAcquisitionOfAssetsMember', window );">Consideration for acquisition of assets [Member] | Between one and three years [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems', window );"><strong>Schedule of Liquidity Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ConsiderationForAcquisitionOfAssets', window );">Consideration for acquisition of assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,005,143<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Borrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of outstanding funds that the entity is obligated to repay.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Borrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity&#8217;s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity&#8217;s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Classes of financial instruments [domain]; Financial assets; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of trade payables and other payables. [Refer: Trade payables; Other payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph k<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_k&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ConsiderationForAcquisitionOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Repersent the amount of consideration for acquisition of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ConsiderationForAcquisitionOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Convertible notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_LeasingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Leasing liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_LeasingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=ifrs-full_LiquidityRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=ifrs-full_LiquidityRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanThreeMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanThreeMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeMonthsAndNotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeMonthsAndNotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=mlec_TradeAndOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=mlec_TradeAndOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=mlec_BorrowingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=mlec_BorrowingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=mlec_IfrsConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=mlec_IfrsConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_LeaseLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_LeaseLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=mlec_ConsiderationForAcquisitionOfAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=mlec_ConsiderationForAcquisitionOfAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>140
<FILENAME>R111.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments &#8211; Risk Management - Schedule of Currency Risk (Details) - Bioceres Crop Solutions Corp. [Member]<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialInstrumentsRiskManagementScheduleofCurrencyRiskDetailsLineItems', window );"><strong>Financial Instruments &#8211; Risk Management - Schedule of Currency Risk (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic', window );">Amount expressed in US$</a></td>
<td class="num">$ (206,837,587)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_OtherCurrencies', window );">Other currencies</a></td>
<td class="num">$ (49,304,636)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of risk exposure associated with financial instruments with a shared characteristic that identifies a concentration of risks. [Refer: Classes of financial instruments [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph B8<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B8_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_FinancialInstrumentsRiskManagementScheduleofCurrencyRiskDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_FinancialInstrumentsRiskManagementScheduleofCurrencyRiskDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_OtherCurrencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the value of other currencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_OtherCurrencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresCropSolutionsCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ConsolidatedStructuredEntitiesAxis=mlec_BioceresCropSolutionsCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>141
<FILENAME>R112.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments &#8211; Risk Management - Schedule of Other Foriegn Currencies with Variables Remaining Constant (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract', window );"><strong>Disclosure of risk management strategy related to hedge accounting [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic', window );">Argentine peso amount expressed</a></td>
<td class="num">$ (51,228,445)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic', window );">Argentine peso amount expressed</a></td>
<td class="nump">$ 51,228,445<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of risk exposure associated with financial instruments with a shared characteristic that identifies a concentration of risks. [Refer: Classes of financial instruments [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph B8<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B8_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>142
<FILENAME>R113.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments &#8211; Risk Management - Schedule of Interest Rate Risk (Details) - Interest Rate Risk [Member] - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember', window );">Fixed-rate instruments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FixedRateInstrumentsAbstract', window );"><strong>Fixed-rate instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentFinancialLiabilities', window );">Current financial liabilities</a></td>
<td class="nump">$ 227,154,007<span></span>
</td>
<td class="nump">$ 187,141,491<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialLiabilities', window );">Non-current financial liabilities</a></td>
<td class="nump">19,608,629<span></span>
</td>
<td class="nump">193,681,929<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities</a></td>
<td class="nump">246,762,636<span></span>
</td>
<td class="nump">380,823,420<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember', window );">Variable-rate instruments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FixedRateInstrumentsAbstract', window );"><strong>Fixed-rate instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentFinancialLiabilities', window );">Current financial liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">47,369,260<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialLiabilities', window );">Non-current financial liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">14,376,062<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 61,745,322<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current financial liabilities. [Refer: Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities for which cash flows were, or future cash flows will be, classified in the statement of cash flows as cash flows from financing activities. [Refer: Cash flows from (used in) financing activities; Liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 44D<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_44D&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 166<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_166&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 166<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_166&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current financial liabilities. [Refer: Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_FixedRateInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_FixedRateInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=mlec_FixedRateBorrowingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=mlec_FixedRateBorrowingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=mlec_VariableRateBorrowingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=mlec_VariableRateBorrowingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>143
<FILENAME>R114.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments &#8211; Risk Management - Schedule of Financial Assets by Category (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostMember', window );">Amortized cost [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsLineItems', window );"><strong>Schedule of Financial Assets by Category [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentFinancialAssetsAtAmortisedCost', window );">Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 29,173,161<span></span>
</td>
<td class="nump">$ 281,560,239<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=mlec_MandatorilyMeasuredAtFairValueThroughProfitOrLossMember', window );">Mandatorily measured at fair value through profit or loss [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsLineItems', window );"><strong>Schedule of Financial Assets by Category [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentFinancialAssetsAtAmortisedCost', window );">Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">19,722<span></span>
</td>
<td class="nump">21,142,697<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=mlec_CashAndEquivalentsMember', window );">Cash and cash equivalents [Member] | Amortized cost [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsLineItems', window );"><strong>Schedule of Financial Assets by Category [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">767,919<span></span>
</td>
<td class="nump">27,210,070<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=mlec_CashAndEquivalentsMember', window );">Cash and cash equivalents [Member] | Mandatorily measured at fair value through profit or loss [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsLineItems', window );"><strong>Schedule of Financial Assets by Category [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">56,284,573<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=mlec_OtherFinancialAssetsMember', window );">Other financial assets [Member] | Amortized cost [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsLineItems', window );"><strong>Schedule of Financial Assets by Category [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherFinancialAssets', window );">Other financial assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,234,539<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=mlec_OtherFinancialAssetsMember', window );">Other financial assets [Member] | Mandatorily measured at fair value through profit or loss [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsLineItems', window );"><strong>Schedule of Financial Assets by Category [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherFinancialAssets', window );">Other financial assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">19,722<span></span>
</td>
<td class="nump">14,858,124<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_TradeReceivablesMember', window );">Trade receivables [Member] | Amortized cost [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsLineItems', window );"><strong>Schedule of Financial Assets by Category [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeReceivables', window );">Trade receivables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,085,400<span></span>
</td>
<td class="nump">209,007,195<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_TradeReceivablesMember', window );">Trade receivables [Member] | Mandatorily measured at fair value through profit or loss [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsLineItems', window );"><strong>Schedule of Financial Assets by Category [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeReceivables', window );">Trade receivables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=mlec_OtherReceivablesMember', window );">Other receivables [Member] | Amortized cost [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsLineItems', window );"><strong>Schedule of Financial Assets by Category [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentReceivables', window );">Other receivables</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">14,085,303<span></span>
</td>
<td class="nump">45,342,974<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=mlec_OtherReceivablesMember', window );">Other receivables [Member] | Mandatorily measured at fair value through profit or loss [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsLineItems', window );"><strong>Schedule of Financial Assets by Category [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentReceivables', window );">Other receivables</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Advances expenses and tax balances are not included.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 169<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_169&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 169<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_169&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentFinancialAssetsAtAmortisedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current financial assets measured at amortised cost. [Refer: Financial assets at amortised cost]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 8<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_8_f&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 44<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_44_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 44<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_44_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentFinancialAssetsAtAmortisedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current other receivables. [Refer: Other receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of financial assets that the entity does not separately disclose in the same statement or note. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount due from customers for goods and services sold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=mlec_MandatorilyMeasuredAtFairValueThroughProfitOrLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=mlec_MandatorilyMeasuredAtFairValueThroughProfitOrLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=mlec_CashAndEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=mlec_CashAndEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=mlec_OtherFinancialAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=mlec_OtherFinancialAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_TradeReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_TradeReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=mlec_OtherReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=mlec_OtherReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>144
<FILENAME>R115.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments &#8211; Risk Management - Schedule of Financial Liabilities by Category (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=mlec_AtAmortizedCostMember', window );">Amortized cost [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Schedule of Financial Liabilities by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liability</a></td>
<td class="nump">$ 254,204,032<span></span>
</td>
<td class="nump">$ 614,653,476<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=mlec_AtAmortizedCostMember', window );">Amortized cost [Member] | Trade and other payables [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Schedule of Financial Liabilities by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liability</a></td>
<td class="nump">7,323,933<span></span>
</td>
<td class="nump">156,947,744<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=mlec_AtAmortizedCostMember', window );">Amortized cost [Member] | Borrowings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Schedule of Financial Liabilities by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liability</a></td>
<td class="nump">228,502,180<span></span>
</td>
<td class="nump">361,759,056<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=mlec_AtAmortizedCostMember', window );">Amortized cost [Member] | Consideration for acquisition of assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Schedule of Financial Liabilities by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liability</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">3,852,853<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=mlec_AtAmortizedCostMember', window );">Amortized cost [Member] | Convertible notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Schedule of Financial Liabilities by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liability</a></td>
<td class="nump">18,260,456<span></span>
</td>
<td class="nump">80,809,686<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=mlec_AtAmortizedCostMember', window );">Amortized cost [Member] | Lease liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Schedule of Financial Liabilities by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liability</a></td>
<td class="nump">117,463<span></span>
</td>
<td class="nump">11,284,137<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=mlec_AtAmortizedCostMember', window );">Amortized cost [Member] | Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Schedule of Financial Liabilities by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liability</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Mandatorily measured at fair value through profit or loss [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Schedule of Financial Liabilities by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liability</a></td>
<td class="nump">1,211,093<span></span>
</td>
<td class="nump">14,713,906<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Mandatorily measured at fair value through profit or loss [Member] | Trade and other payables [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Schedule of Financial Liabilities by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liability</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">11,989,792<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Mandatorily measured at fair value through profit or loss [Member] | Borrowings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Schedule of Financial Liabilities by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liability</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Mandatorily measured at fair value through profit or loss [Member] | Consideration for acquisition of assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Schedule of Financial Liabilities by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liability</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,724,114<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Mandatorily measured at fair value through profit or loss [Member] | Convertible notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Schedule of Financial Liabilities by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liability</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Mandatorily measured at fair value through profit or loss [Member] | Lease liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Schedule of Financial Liabilities by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liability</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Mandatorily measured at fair value through profit or loss [Member] | Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Schedule of Financial Liabilities by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liability</a></td>
<td class="nump">$ 1,211,093<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialLiabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity&#8217;s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity&#8217;s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Classes of financial instruments [domain]; Financial assets; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=mlec_AtAmortizedCostMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=mlec_AtAmortizedCostMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=mlec_TradeAndOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=mlec_TradeAndOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=mlec_BorrowingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=mlec_BorrowingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=mlec_ConsiderationForAcquisitionOfAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=mlec_ConsiderationForAcquisitionOfAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=mlec_ConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=mlec_ConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_LeaseLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_LeaseLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=mlec_WarrantLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=mlec_WarrantLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>145
<FILENAME>R116.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments &#8211; Risk Management - Schedule of Fair Value by Hierarchy (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=mlec_TradeAndOtherPayablesMember', window );">Trade and other payables [Member] | Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialLiabilitiesValuedAtFairValueAbstract', window );"><strong>Financial liabilities valued at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=mlec_TradeAndOtherPayablesMember', window );">Trade and other payables [Member] | Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialLiabilitiesValuedAtFairValueAbstract', window );"><strong>Financial liabilities valued at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,989,792<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=mlec_TradeAndOtherPayablesMember', window );">Trade and other payables [Member] | Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialLiabilitiesValuedAtFairValueAbstract', window );"><strong>Financial liabilities valued at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=mlec_ConsiderationForAcquisitionMember', window );">Consideration for acquisition [Member] | Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialLiabilitiesValuedAtFairValueAbstract', window );"><strong>Financial liabilities valued at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,724,114<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=mlec_ConsiderationForAcquisitionMember', window );">Consideration for acquisition [Member] | Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialLiabilitiesValuedAtFairValueAbstract', window );"><strong>Financial liabilities valued at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=mlec_ConsiderationForAcquisitionMember', window );">Consideration for acquisition [Member] | Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialLiabilitiesValuedAtFairValueAbstract', window );"><strong>Financial liabilities valued at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=mlec_InvestmentsAtFairValueMember', window );">Investments at fair value [Member] | Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialAssetsAtFairValueAbstract', window );"><strong>Financial assets at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets at fair value</a></td>
<td class="nump">$ 19,722<span></span>
</td>
<td class="nump">2,311,604<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=mlec_InvestmentsAtFairValueMember', window );">Investments at fair value [Member] | Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialAssetsAtFairValueAbstract', window );"><strong>Financial assets at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets at fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=mlec_InvestmentsAtFairValueMember', window );">Investments at fair value [Member] | Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialAssetsAtFairValueAbstract', window );"><strong>Financial assets at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets at fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=mlec_WarrantLiabilityMember', window );">Warrant liability [Member] | Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialLiabilitiesValuedAtFairValueAbstract', window );"><strong>Financial liabilities valued at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities at fair value</a></td>
<td class="nump">181,093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=mlec_WarrantLiabilityMember', window );">Warrant liability [Member] | Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialLiabilitiesValuedAtFairValueAbstract', window );"><strong>Financial liabilities valued at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities at fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=mlec_WarrantLiabilityMember', window );">Warrant liability [Member] | Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialLiabilitiesValuedAtFairValueAbstract', window );"><strong>Financial liabilities valued at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities at fair value</a></td>
<td class="nump">$ 1,030,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=mlec_MutualFundsMember', window );">Mutual funds [Member] | Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialAssetsAtFairValueAbstract', window );"><strong>Financial assets at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,943,378<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=mlec_MutualFundsMember', window );">Mutual funds [Member] | Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialAssetsAtFairValueAbstract', window );"><strong>Financial assets at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=mlec_MutualFundsMember', window );">Mutual funds [Member] | Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialAssetsAtFairValueAbstract', window );"><strong>Financial assets at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=mlec_MoolecScienceSASharesMember', window );">Moolec Science SA shares [Member] | Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialAssetsAtFairValueAbstract', window );"><strong>Financial assets at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,191,286<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=mlec_MoolecScienceSASharesMember', window );">Moolec Science SA shares [Member] | Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialAssetsAtFairValueAbstract', window );"><strong>Financial assets at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=mlec_MoolecScienceSASharesMember', window );">Moolec Science SA shares [Member] | Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialAssetsAtFairValueAbstract', window );"><strong>Financial assets at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=mlec_UsTreasuryBillsMember', window );">US Treasury bills [Member] | Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialAssetsAtFairValueAbstract', window );"><strong>Financial assets at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,993,668<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=mlec_UsTreasuryBillsMember', window );">US Treasury bills [Member] | Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialAssetsAtFairValueAbstract', window );"><strong>Financial assets at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=mlec_UsTreasuryBillsMember', window );">US Treasury bills [Member] | Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialAssetsAtFairValueAbstract', window );"><strong>Financial assets at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=mlec_OtherInvestmentMember', window );">Other investments [Member] | Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialAssetsAtFairValueAbstract', window );"><strong>Financial assets at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,702,761<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=mlec_OtherInvestmentMember', window );">Other investments [Member] | Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialAssetsAtFairValueAbstract', window );"><strong>Financial assets at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=mlec_OtherInvestmentMember', window );">Other investments [Member] | Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialAssetsAtFairValueAbstract', window );"><strong>Financial assets at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of financial assets. [Refer: At fair value [member]; Financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilitiesAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of financial liabilities. [Refer: At fair value [member]; Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilitiesAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_FinancialAssetsAtFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_FinancialAssetsAtFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_FinancialLiabilitiesValuedAtFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_FinancialLiabilitiesValuedAtFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=mlec_TradeAndOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=mlec_TradeAndOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level1OfFairValueHierarchyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level1OfFairValueHierarchyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=mlec_ConsiderationForAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=mlec_ConsiderationForAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=mlec_InvestmentsAtFairValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=mlec_InvestmentsAtFairValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=mlec_WarrantLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=mlec_WarrantLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=mlec_MutualFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=mlec_MutualFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=mlec_MoolecScienceSASharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=mlec_MoolecScienceSASharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=mlec_UsTreasuryBillsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=mlec_UsTreasuryBillsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=mlec_OtherInvestmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=mlec_OtherInvestmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>146
<FILENAME>R117.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Schedule of Right-of-Use and Liabilities Related with Lease Assets (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems', window );"><strong>Leases - Schedule of Right-of-Use and Liabilities Related with Lease Assets (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Book value at the beginning of the year</a></td>
<td class="nump">$ 11,601,752<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherPropertyPlantAndEquipment', window );">Total</a></td>
<td class="nump">100,896<span></span>
</td>
<td class="nump">$ 11,601,752<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_LeaseLiabilityBeginningOfTheYearinception', window );">Book value at the beginning of the year/inception</a></td>
<td class="nump">11,284,137<span></span>
</td>
<td class="nump">13,889,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_LeaseLiabiltyAdditionsOfTheYear', window );">Additions of the year</a></td>
<td class="nump">9,569,819<span></span>
</td>
<td class="nump">2,585,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AdditionsToLeaseLiabilityFromBusinessCombination', window );">Additions from business combination</a></td>
<td class="nump">117,463<span></span>
</td>
<td class="nump">168,988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_LeaseLiabilitiesInterestExpenseExchangeDifferencesAndInflationEffects', window );">Interest expenses, exchange differences and inflation effects</a></td>
<td class="nump">1,059,412<span></span>
</td>
<td class="num">(480,189)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PaymentsOfThePeriodLeaseliability', window );">Payments of the year</a></td>
<td class="num">(5,501,387)<span></span>
</td>
<td class="num">(4,879,108)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_LossOfControlLeaseLiability', window );">Loss of control</a></td>
<td class="num">(16,411,981)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_TotalLeaseLiabilities', window );">Total</a></td>
<td class="nump">117,463<span></span>
</td>
<td class="nump">11,284,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilitiesAbstract', window );"><strong>Lease Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLeaseLiabilities', window );">Current</a></td>
<td class="nump">117,463<span></span>
</td>
<td class="nump">3,122,778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Non-current</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">8,161,359<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Total</a></td>
<td class="nump">117,463<span></span>
</td>
<td class="nump">11,284,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Total</a></td>
<td class="nump">75,258,790<span></span>
</td>
<td class="nump">177,331,280<span></span>
</td>
<td class="nump">$ 175,292,219<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsToRightofuseAssets', window );">Additions of the year</a></td>
<td class="nump">100,896<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions', window );">Exchange differences</a></td>
<td class="num">(18,897,490)<span></span>
</td>
<td class="nump">27,622,558<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Book value at the end of the year</a></td>
<td class="nump">100,896<span></span>
</td>
<td class="nump">11,601,752<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems', window );"><strong>Leases - Schedule of Right-of-Use and Liabilities Related with Lease Assets (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Book value at the beginning of the year</a></td>
<td class="nump">20,979,597<span></span>
</td>
<td class="nump">21,163,192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilitiesAbstract', window );"><strong>Lease Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Total</a></td>
<td class="nump">100,896<span></span>
</td>
<td class="nump">20,979,597<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsToRightofuseAssets', window );">Additions of the year</a></td>
<td class="nump">9,569,819<span></span>
</td>
<td class="nump">2,585,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsRightofuseAssets', window );">Additions from business combination</a></td>
<td class="nump">100,896<span></span>
</td>
<td class="nump">168,988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsRightofuseAssets', window );">Disposals</a></td>
<td class="num">(680,110)<span></span>
</td>
<td class="num">(1,284,975)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions', window );">Exchange differences</a></td>
<td class="nump">273,529<span></span>
</td>
<td class="num">(1,652,831)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_RightOfUseAssetLossOfControl', window );">Loss of control</a></td>
<td class="num">(30,142,835)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Book value at the end of the year</a></td>
<td class="nump">100,896<span></span>
</td>
<td class="nump">20,979,597<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member] | Machinery and equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilitiesAbstract', window );"><strong>Lease Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Machinery', window );">Machinery and equipment</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">3,655,741<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member] | Vehicles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilitiesAbstract', window );"><strong>Lease Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Vehicles', window );">Vehicles</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,272,071<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member] | Equipment and computer software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilitiesAbstract', window );"><strong>Lease Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComputerSoftware', window );">Equipment and computer software</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,130,541<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member] | Land and buildings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilitiesAbstract', window );"><strong>Lease Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LandAndBuildings', window );">Land and buildings</a></td>
<td class="nump">100,896<span></span>
</td>
<td class="nump">14,921,244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation and amortisation [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems', window );"><strong>Leases - Schedule of Right-of-Use and Liabilities Related with Lease Assets (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_BookValueAtTheBeginningOfThePeriod', window );">Book value at the beginning of the year/inception</a></td>
<td class="nump">9,377,845<span></span>
</td>
<td class="nump">7,226,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DepreciationOfThePeriod', window );">Depreciation of the year</a></td>
<td class="nump">5,036,703<span></span>
</td>
<td class="nump">3,418,956<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DisposalsDepreciation', window );">Disposals</a></td>
<td class="num">(697,150)<span></span>
</td>
<td class="num">(1,092,167)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ExchangeDifferencesDepreciation', window );">Exchange differences</a></td>
<td class="nump">47,736<span></span>
</td>
<td class="num">(175,561)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_LossOfControlDepreciation', window );">Loss of control</a></td>
<td class="num">(13,765,134)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AccumulatedDepreciationAtTheEndOfThePeriod', window );">Accumulated depreciation at the end of the year</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 9,377,845<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to right-of-use assets other than those acquired through business combinations. [Refer: Total for all business combinations [member]; Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsOtherThanThroughBusinessCombinationsRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsToRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to right-of-use assets. [Refer: Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 53<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_53_h&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115_g&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115_g&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsToRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComputerSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of intangible assets representing computer software. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 119<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_119_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComputerSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisposalsRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease in right-of-use assets resulting from disposals. [Refer: Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisposalsRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in other provisions resulting from foreign currency exchange rate changes on provisions measured in a currency different from the entity's presentation currency. [Refer: Other provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2025-01-01<br> -Paragraph 84<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_84&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LandAndBuildings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant and equipment representing land and depreciable buildings and similar structures for use in operations. [Refer: Buildings; Land; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 37<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_37_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LandAndBuildings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Machinery">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant and equipment representing long-lived, depreciable machinery used in operations. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 37<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_37_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Machinery</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant and equipment that the entity does not separately disclose in the same statement or note. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 37<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 53<br> -Subparagraph j<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Vehicles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant and equipment representing vehicles used in the entity's operations, specifically to include aircraft, motor vehicles and ships. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 37<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Vehicles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_AccumulatedDepreciationAtTheEndOfThePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated depreciation at the end of the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_AccumulatedDepreciationAtTheEndOfThePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_AdditionsToLeaseLiabilityFromBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additions from business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_AdditionsToLeaseLiabilityFromBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_BookValueAtTheBeginningOfThePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Book value at the beginning of the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_BookValueAtTheBeginningOfThePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DepreciationOfThePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Depreciation of the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DepreciationOfThePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DisposalsDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposals.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DisposalsDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ExchangeDifferencesDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exchange differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ExchangeDifferencesDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_LeaseLiabilitiesInterestExpenseExchangeDifferencesAndInflationEffects">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease liabilities additions from interest expense, exchange differences and inflation effects.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_LeaseLiabilitiesInterestExpenseExchangeDifferencesAndInflationEffects</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_LeaseLiabilityBeginningOfTheYearinception">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of lease liability beginning of the year/inception.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_LeaseLiabilityBeginningOfTheYearinception</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_LeaseLiabiltyAdditionsOfTheYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of addition of the lease liablity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_LeaseLiabiltyAdditionsOfTheYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_LossOfControlDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss of control.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_LossOfControlDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_LossOfControlLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss of control.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_LossOfControlLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_PaymentsOfThePeriodLeaseliability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments of the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_PaymentsOfThePeriodLeaseliability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_RightOfUseAssetLossOfControl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of loss of control.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_RightOfUseAssetLossOfControl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_TotalLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_TotalLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_MachineryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_MachineryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_ComputerSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_ComputerSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_LandAndBuildingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_LandAndBuildingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>147
<FILENAME>R118.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Shareholders and Other Related Parties Balances and Transactions - Schedule of Transactions Between the Group and Related Parties (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Schedule of Transactions Between the Group and Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ValueOfTransactionsForThePeriodEnded', window );">Value of transactions for the period ended</a></td>
<td class="num">$ (27,583,730)<span></span>
</td>
<td class="nump">$ 1,536,125<span></span>
</td>
<td class="nump">$ 10,358,989<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherReceivablesDueFromRelatedParties', window );">Amounts receivable from related parties</a></td>
<td class="nump">15,090,994<span></span>
</td>
<td class="nump">39,810,019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Amounts payable to related parties</a></td>
<td class="num">(34,836,506)<span></span>
</td>
<td class="num">(54,902,951)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_SalesOfGoodsAndServicesMember', window );">Sales of goods and services [Member] | Joint ventures and associates [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Schedule of Transactions Between the Group and Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ValueOfTransactionsForThePeriodEnded', window );">Value of transactions for the period ended</a></td>
<td class="nump">4,033,811<span></span>
</td>
<td class="nump">952,742<span></span>
</td>
<td class="nump">739,651<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_SalesOfGoodsAndServicesMember', window );">Sales of goods and services [Member] | Shareholders and other related parties [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Schedule of Transactions Between the Group and Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ValueOfTransactionsForThePeriodEnded', window );">Value of transactions for the period ended</a></td>
<td class="nump">3,714,441<span></span>
</td>
<td class="nump">2,911,723<span></span>
</td>
<td class="nump">6,565,027<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_PurchasesOfGoodsAndServicesMember', window );">Purchases of goods and services [Member] | Joint ventures and associates [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Schedule of Transactions Between the Group and Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ValueOfTransactionsForThePeriodEnded', window );">Value of transactions for the period ended</a></td>
<td class="num">(24,061,563)<span></span>
</td>
<td class="num">(500,704)<span></span>
</td>
<td class="num">(738,652)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_PurchasesOfGoodsAndServicesMember', window );">Purchases of goods and services [Member] | Shareholders and other related parties [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Schedule of Transactions Between the Group and Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ValueOfTransactionsForThePeriodEnded', window );">Value of transactions for the period ended</a></td>
<td class="num">(3,517,528)<span></span>
</td>
<td class="num">(1,998,349)<span></span>
</td>
<td class="num">(2,334,556)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_PurchasesOfGoodsAndServicesMember', window );">Purchases of goods and services [Member] | Key management personnel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Schedule of Transactions Between the Group and Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ValueOfTransactionsForThePeriodEnded', window );">Value of transactions for the period ended</a></td>
<td class="num">(3,079,070)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_NetLoansGrantedMember', window );">Net loans granted [Member] | Joint ventures and associates [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Schedule of Transactions Between the Group and Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ValueOfTransactionsForThePeriodEnded', window );">Value of transactions for the period ended</a></td>
<td class="nump">7,645,504<span></span>
</td>
<td class="nump">13,005,841<span></span>
</td>
<td class="nump">7,141,471<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_InterestGainMember', window );">Interest gain [Member] | Joint ventures and associates [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Schedule of Transactions Between the Group and Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ValueOfTransactionsForThePeriodEnded', window );">Value of transactions for the period ended</a></td>
<td class="nump">944,186<span></span>
</td>
<td class="nump">135,485<span></span>
</td>
<td class="nump">212,407<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_NetLoansReceivedMember', window );">Net loans received [Member] | Joint ventures and associates [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Schedule of Transactions Between the Group and Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ValueOfTransactionsForThePeriodEnded', window );">Value of transactions for the period ended</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(1,860,058)<span></span>
</td>
<td class="num">(1,854,680)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_PuttableInstrumentsMember', window );">Puttable instruments [Member] | Joint ventures and associates [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Schedule of Transactions Between the Group and Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ValueOfTransactionsForThePeriodEnded', window );">Value of transactions for the period ended</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">4,399,631<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_NetLoansGrantedOneMember', window );">Net Loans Granted One [Member] | Joint ventures and associates [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Schedule of Transactions Between the Group and Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ValueOfTransactionsForThePeriodEnded', window );">Value of transactions for the period ended</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">28,299<span></span>
</td>
<td class="nump">19,049<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_PreferenceShareMember', window );">Preference shares [Member] | Joint ventures and associates [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Schedule of Transactions Between the Group and Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ValueOfTransactionsForThePeriodEnded', window );">Value of transactions for the period ended</a></td>
<td class="num">(15,000,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_PreferenceShareMember', window );">Preference shares [Member] | Shareholders and other related parties [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Schedule of Transactions Between the Group and Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Amounts payable to related parties</a></td>
<td class="num">(15,739,726)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_InterestExpensesMember', window );">Interest expenses [Member] | Joint ventures and associates [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Schedule of Transactions Between the Group and Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ValueOfTransactionsForThePeriodEnded', window );">Value of transactions for the period ended</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(2,425,703)<span></span>
</td>
<td class="num">(956,873)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_OwnSharesHeldBySubsidiariesMember', window );">Own shares held by subsidiaries [Member] | Shareholders and other related parties [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Schedule of Transactions Between the Group and Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ValueOfTransactionsForThePeriodEnded', window );">Value of transactions for the period ended</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(444,473)<span></span>
</td>
<td class="num">(133,079)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_InKindContributionsMember', window );">In-kind contributions [Member] | Shareholders and other related parties [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Schedule of Transactions Between the Group and Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ValueOfTransactionsForThePeriodEnded', window );">Value of transactions for the period ended</a></td>
<td class="nump">4,343,549<span></span>
</td>
<td class="nump">2,409,244<span></span>
</td>
<td class="nump">1,163,384<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_SalariesSocialSecurityBenefitsAndOtherBenefitsMember', window );">Salaries, social security benefits and other benefits [Member] | Key management personnel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Schedule of Transactions Between the Group and Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ValueOfTransactionsForThePeriodEnded', window );">Value of transactions for the period ended</a></td>
<td class="num">(2,494,538)<span></span>
</td>
<td class="num">(2,496,073)<span></span>
</td>
<td class="num">(1,995,361)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Amounts payable to related parties</a></td>
<td class="num">(41,620)<span></span>
</td>
<td class="num">(226,702)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_SalesAndServicesMember', window );">Sales and services [Member] | Key management personnel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Schedule of Transactions Between the Group and Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ValueOfTransactionsForThePeriodEnded', window );">Value of transactions for the period ended</a></td>
<td class="nump">367,928<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_StockOptionsAndShareBasedIncentivesMember', window );">Stock options-based incentives [Member] | Key management personnel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Schedule of Transactions Between the Group and Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ValueOfTransactionsForThePeriodEnded', window );">Value of transactions for the period ended</a></td>
<td class="num">(480,450)<span></span>
</td>
<td class="num">(8,181,849)<span></span>
</td>
<td class="num">$ (1,868,430)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_TradeDebtorsMember', window );">Trade debtors [Member] | Joint ventures and associates [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Schedule of Transactions Between the Group and Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherReceivablesDueFromRelatedParties', window );">Amounts receivable from related parties</a></td>
<td class="nump">1,565,913<span></span>
</td>
<td class="nump">2,176,622<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_TradeDebtorsMember', window );">Trade debtors [Member] | Shareholders and other related parties [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Schedule of Transactions Between the Group and Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherReceivablesDueFromRelatedParties', window );">Amounts receivable from related parties</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_OtherReceivablesMember', window );">Other receivables [Member] | Joint ventures and associates [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Schedule of Transactions Between the Group and Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherReceivablesDueFromRelatedParties', window );">Amounts receivable from related parties</a></td>
<td class="nump">11,211,902<span></span>
</td>
<td class="nump">37,586,012<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_OtherReceivablesMember', window );">Other receivables [Member] | Shareholders and other related parties [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Schedule of Transactions Between the Group and Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherReceivablesDueFromRelatedParties', window );">Amounts receivable from related parties</a></td>
<td class="nump">17,405<span></span>
</td>
<td class="nump">47,348<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_LoansReceivablesMember', window );">Loans receivables [Member] | Shareholders and other related parties [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Schedule of Transactions Between the Group and Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherReceivablesDueFromRelatedParties', window );">Amounts receivable from related parties</a></td>
<td class="nump">2,295,774<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_TradeCreditorsMember', window );">Trade creditors [Member] | Joint ventures and associates [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Schedule of Transactions Between the Group and Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Amounts payable to related parties</a></td>
<td class="num">(620,034)<span></span>
</td>
<td class="num">(52,778,206)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_TradeCreditorsMember', window );">Trade creditors [Member] | Shareholders and other related parties [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Schedule of Transactions Between the Group and Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Amounts payable to related parties</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(37,985)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_ConvertibleNotesMember', window );">Convertible notes [Member] | Joint ventures and associates [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Schedule of Transactions Between the Group and Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Amounts payable to related parties</a></td>
<td class="num">(7,102,028)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_NetLoansPayablesMember', window );">Net loans payables [Member] | Joint ventures and associates [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Schedule of Transactions Between the Group and Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Amounts payable to related parties</a></td>
<td class="num">(10,303,098)<span></span>
</td>
<td class="num">(1,860,058)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_WarrantesMember', window );">Warrants [Member] | Shareholders and other related parties [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Schedule of Transactions Between the Group and Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Amounts payable to related parties</a></td>
<td class="num">$ (1,030,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayablesToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of payables due to related parties. [Refer: Total for all related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayablesToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherReceivablesDueFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of receivables due from related parties. [Refer: Total for all related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherReceivablesDueFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ValueOfTransactionsForThePeriodEnded">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of transactions for the period ended.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ValueOfTransactionsForThePeriodEnded</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_SalesOfGoodsAndServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_SalesOfGoodsAndServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_JointVenturesWhereEntityIsVenturerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_JointVenturesWhereEntityIsVenturerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_OtherRelatedPartiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_OtherRelatedPartiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_PurchasesOfGoodsAndServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_PurchasesOfGoodsAndServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_KeyManagementPersonnelOfEntityOrParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_KeyManagementPersonnelOfEntityOrParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_NetLoansGrantedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_NetLoansGrantedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_InterestGainMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_InterestGainMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_NetLoansReceivedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_NetLoansReceivedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_PuttableInstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_PuttableInstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_NetLoansGrantedOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_NetLoansGrantedOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_PreferenceShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_PreferenceShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_InterestExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_InterestExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_OwnSharesHeldBySubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_OwnSharesHeldBySubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_InKindContributionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_InKindContributionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_SalariesSocialSecurityBenefitsAndOtherBenefitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_SalariesSocialSecurityBenefitsAndOtherBenefitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_SalesAndServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_SalesAndServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_StockOptionsAndShareBasedIncentivesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_StockOptionsAndShareBasedIncentivesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_TradeDebtorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_TradeDebtorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_OtherReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_OtherReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_LoansReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_LoansReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_TradeCreditorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_TradeCreditorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_ConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_ConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_NetLoansPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_NetLoansPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_WarrantesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_WarrantesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>148
<FILENAME>R119.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Key Management Personnel Compensation - Schedule of Compensation of Key Management Personnel Compensation (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfCompensationOfKeyManagementPersonnelCompensationAbstract', window );"><strong>Schedule of Compensation of Key Management Personnel Compensation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits', window );">Short-term employee benefits</a></td>
<td class="nump">$ 2,494,538<span></span>
</td>
<td class="nump">$ 2,496,073<span></span>
</td>
<td class="nump">$ 1,995,361<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment', window );">Share based payment</a></td>
<td class="nump">480,450<span></span>
</td>
<td class="nump">8,181,849<span></span>
</td>
<td class="nump">1,868,430<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensation', window );">Total</a></td>
<td class="nump">$ 2,974,988<span></span>
</td>
<td class="nump">$ 10,677,922<span></span>
</td>
<td class="nump">$ 3,863,791<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 227<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_227&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 227<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_227&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ScheduleOfCompensationOfKeyManagementPersonnelCompensationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ScheduleOfCompensationOfKeyManagementPersonnelCompensationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>149
<FILENAME>R120.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Payment (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>May 12, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 26, 2022 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 12, 2022 </div>
<div>$ / shares</div>
</th>
<th class="th"><div>Jan. 31, 2024</div></th>
<th class="th">
<div>Jun. 30, 2025 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-Based Payment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ShareBasedPaymentsIncentiveIncreases', window );">Incentive increases (in Dollars) | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of options, granted during the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ShareBasedPaymentAwardExpirationDate', window );">Expire date</a></td>
<td class="text">Oct. 23,  2030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NumberOfOptionsEstimatedExercisePercent', window );">Estimates of options that will be exercised</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-Based Payment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Options exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-Based Payment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Options exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 204.66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresCropSolutionsCorpMember', window );">Bioceres Crop Solutions Corp. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-Based Payment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of options, granted during the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,560<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mlec_EmployeeStockPurchasePlanMember', window );">Employee Stock Purchase Plan [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-Based Payment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_IfrsDefinedContributionPlanEmployerMatchingContributionPercentOfEmployeesGrossPay', window );">Maximum percentage of employee's monthly compensation</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SharesSubjectToEmployeeStockPurchasePlan', window );">Number of ordinary shares subject to the ESPP (in Shares) | shares</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PercentageOfClosingPriceOnFirstAndLastBusinessDayToDeterminePurchasePrice', window );">Percentage of closing price of the Company's ordinary shares on the first business day and the last business day to determine purchase price</a></td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mlec_StandAloneStockOptionGrantMember', window );">Stand Alone Stock Option Grant [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-Based Payment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of options, granted during the year</a></td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Options exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ShareBasedPaymentAwardExpirationDate', window );">Expire date</a></td>
<td class="text">Oct. 31,  2029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod', window );">Vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ShareBasedPaymentPeriodOfWeightedAveragePriceVwapOfOrdinarySharesForCashlessBasisExercise', window );">Period of weighted average price ("VWAP") of the ordinary shares for cashless basis exercise</a></td>
<td class="text">20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mlec_EmployeeStockOptionPlanMember', window );">Employee Stock Option Plan [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-Based Payment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of options, granted during the year</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Options exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod', window );">Vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ShareBasedPaymentPeriodOfWeightedAveragePriceVwapOfOrdinarySharesForCashlessBasisExercise', window );">Period of weighted average price ("VWAP") of the ordinary shares for cashless basis exercise</a></td>
<td class="text">20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mlec_PastShareOptionPlanMember', window );">Past Share Option plan [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-Based Payment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Options exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mlec_PastShareOptionPlanMember', window );">Past Share Option plan [member] | Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-Based Payment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Options exercise price</a></td>
<td class="nump">$ 11.93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mlec_PastShareOptionPlanMember', window );">Past Share Option plan [member] | Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-Based Payment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Options exercise price</a></td>
<td class="nump">$ 13.24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ifrs-full_ShareOptionsMember', window );">Base Share Option plan [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-Based Payment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Options exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ifrs-full_ShareOptionsMember', window );">Base Share Option plan [member] | Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-Based Payment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Options exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.47<span></span>
</td>
<td class="nump">$ 10.47<span></span>
</td>
<td class="nump">$ 10.47<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ifrs-full_ShareOptionsMember', window );">Base Share Option plan [member] | Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-Based Payment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Options exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.79<span></span>
</td>
<td class="nump">$ 10.79<span></span>
</td>
<td class="nump">$ 10.79<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mlec_PerformanceShareOptionPlanMember', window );">Performance Share Option Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-Based Payment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Options exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ThresholdEarningsBeforeInterestTaxesDepreciationAndAmortization', window );">Threshold earnings before interest (in Dollars) | $</a></td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mlec_PerformanceShareOptionPlanMember', window );">Performance Share Option Plan [Member] | EBITDA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-Based Payment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ThresholdEarningsBeforeInterestTaxesDepreciationAndAmortization', window );">Threshold earnings before interest (in Dollars) | $</a></td>
<td class="nump">$ 120,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mlec_PerformanceShareOptionPlanMember', window );">Performance Share Option Plan [Member] | Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-Based Payment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Options exercise price</a></td>
<td class="nump">$ 10.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mlec_PerformanceShareOptionPlanMember', window );">Performance Share Option Plan [Member] | Bottom of range [member] | EBITDA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-Based Payment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mlec_PerformanceShareOptionPlanMember', window );">Performance Share Option Plan [Member] | Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-Based Payment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Options exercise price</a></td>
<td class="nump">$ 10.79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mlec_PerformanceShareOptionPlanMember', window );">Performance Share Option Plan [Member] | Top of range [member] | EBITDA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-Based Payment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=mlec_ProFarmGroupIncMember', window );">Pro Farm Group Inc [Member] | Stock Incentive Plan 2013 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-Based Payment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ShareBasedPaymentArrangementConversionOfEquityAwardsOutstandingToOptionOrRestrictedStockUnits', window );">Number of total equity awards outstanding converted into option or restricted stock (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,191,362<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_VolumeWeightedAveragePriceMember', window );">Volume Weighted Average Price [Member] | Stand Alone Stock Option Grant [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-Based Payment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Options exercise price</a></td>
<td class="nump">$ 4.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_VolumeWeightedAveragePriceMember', window );">Volume Weighted Average Price [Member] | Employee Stock Option Plan [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Share-Based Payment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Options exercise price</a></td>
<td class="nump">$ 5.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExercisePriceShareOptionsGranted2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exercise price of share options granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExercisePriceShareOptionsGranted2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_IfrsDefinedContributionPlanEmployerMatchingContributionPercentOfEmployeesGrossPay">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum percentage of employee's monthly compensation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_IfrsDefinedContributionPlanEmployerMatchingContributionPercentOfEmployeesGrossPay</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_NumberOfOptionsEstimatedExercisePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimate of share options that will be exercise, as a percent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_NumberOfOptionsEstimatedExercisePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_PercentageOfClosingPriceOnFirstAndLastBusinessDayToDeterminePurchasePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of closing price of the Company's ordinary shares on the first business day and the last business day to determine purchase price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_PercentageOfClosingPriceOnFirstAndLastBusinessDayToDeterminePurchasePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ShareBasedPaymentArrangementConversionOfEquityAwardsOutstandingToOptionOrRestrictedStockUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares converted into options or restricted shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ShareBasedPaymentArrangementConversionOfEquityAwardsOutstandingToOptionOrRestrictedStockUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ShareBasedPaymentAwardExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based payment award expiration date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ShareBasedPaymentAwardExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ShareBasedPaymentPeriodOfWeightedAveragePriceVwapOfOrdinarySharesForCashlessBasisExercise">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of weighted average price ("VWAP") of the ordinary shares during to the date of exercise for cashless basis of exercise options in share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ShareBasedPaymentPeriodOfWeightedAveragePriceVwapOfOrdinarySharesForCashlessBasisExercise</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ShareBasedPaymentsIncentiveIncreases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of share based payments incentive increases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ShareBasedPaymentsIncentiveIncreases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_SharesSubjectToEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares subject to employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_SharesSubjectToEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ThresholdEarningsBeforeInterestTaxesDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exercise price of share options granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ThresholdEarningsBeforeInterestTaxesDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresCropSolutionsCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresCropSolutionsCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mlec_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mlec_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mlec_StandAloneStockOptionGrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mlec_StandAloneStockOptionGrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mlec_EmployeeStockOptionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mlec_EmployeeStockOptionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mlec_PastShareOptionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mlec_PastShareOptionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ifrs-full_ShareOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ifrs-full_ShareOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mlec_PerformanceShareOptionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mlec_PerformanceShareOptionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=mlec_EBITDAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=mlec_EBITDAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=mlec_ProFarmGroupIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=mlec_ProFarmGroupIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mlec_StockIncentivePlan2013Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mlec_StockIncentivePlan2013Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_VolumeWeightedAveragePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=mlec_VolumeWeightedAveragePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>150
<FILENAME>R121.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Payment - Schedule of Fair Value of the Stock Options at the Grant Date (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2025 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mlec_StandAloneStockOptionGrantMember', window );">Stand Alone Stock Option Grant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Schedule of Fair Value of the Stock Options at the Grant Date [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Weighted average fair value of shares (in Dollars per share)</a></td>
<td class="nump">$ 5.42<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Weighted average exercise price (in Dollars per share)</a></td>
<td class="nump">$ 4.55<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Weighted average expected volatility</a></td>
<td class="nump">29.69%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Dividend rate</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Weighted average risk-free interest rate</a></td>
<td class="nump">1.66%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted', window );">Weighted average expected life</a></td>
<td class="nump">9.89<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted', window );">Weighted average fair value of stock options at measurement date (in Dollars) | $</a></td>
<td class="nump">$ 2.47<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mlec_EmployeeStockOptionPlanMember', window );">Employee Stock Option Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Schedule of Fair Value of the Stock Options at the Grant Date [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Weighted average fair value of shares (in Dollars per share)</a></td>
<td class="nump">$ 13.98<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Weighted average exercise price (in Dollars per share)</a></td>
<td class="nump">$ 5.55<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Weighted average expected volatility</a></td>
<td class="nump">42.18%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Dividend rate</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Weighted average risk-free interest rate</a></td>
<td class="nump">1.17%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted', window );">Weighted average expected life</a></td>
<td class="nump">9.22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted', window );">Weighted average fair value of stock options at measurement date (in Dollars) | $</a></td>
<td class="nump">$ 10.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mlec_PastShareOptionPlanMember', window );">Past Share Option plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Schedule of Fair Value of the Stock Options at the Grant Date [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Weighted average fair value of shares (in Dollars per share)</a></td>
<td class="nump">$ 11.45<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Weighted average exercise price (in Dollars per share)</a></td>
<td class="nump">$ 12.48<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Weighted average expected volatility</a></td>
<td class="nump">48.73%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Dividend rate</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Weighted average risk-free interest rate</a></td>
<td class="nump">4.40%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted', window );">Weighted average expected life</a></td>
<td class="nump">4.89<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted', window );">Weighted average fair value of stock options at measurement date (in Dollars) | $</a></td>
<td class="nump">$ 5.01<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ifrs-full_ShareOptionsMember', window );">Base Share Option plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Schedule of Fair Value of the Stock Options at the Grant Date [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Weighted average fair value of shares (in Dollars per share)</a></td>
<td class="nump">$ 10.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Weighted average exercise price (in Dollars per share)</a></td>
<td class="nump">$ 10.52<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Weighted average expected volatility</a></td>
<td class="nump">54.73%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Dividend rate</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Weighted average risk-free interest rate</a></td>
<td class="nump">4.47%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted', window );">Weighted average expected life</a></td>
<td class="nump">2.97<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted', window );">Weighted average fair value of stock options at measurement date (in Dollars) | $</a></td>
<td class="nump">$ 4.46<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mlec_PerformanceShareOptionPlanMember', window );">Performance Share Option plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Schedule of Fair Value of the Stock Options at the Grant Date [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Weighted average fair value of shares (in Dollars per share)</a></td>
<td class="nump">$ 10.79<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Weighted average exercise price (in Dollars per share)</a></td>
<td class="nump">$ 10.52<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Weighted average expected volatility</a></td>
<td class="nump">54.73%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Dividend rate</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Weighted average risk-free interest rate</a></td>
<td class="nump">4.47%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted', window );">Weighted average expected life</a></td>
<td class="nump">2.97<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted', window );">Weighted average fair value of stock options at measurement date (in Dollars) | $</a></td>
<td class="nump">$ 4.45<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The option life of share options granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfOptionLifeShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExercisePriceShareOptionsGranted2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exercise price of share options granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExercisePriceShareOptionsGranted2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of an expected dividend used to calculate the fair value of share options granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value of share options granted during the period at the measurement date. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average share price used as input to the option pricing model to calculate the fair value of share options granted. [Refer: Option pricing model [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mlec_StandAloneStockOptionGrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mlec_StandAloneStockOptionGrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mlec_EmployeeStockOptionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mlec_EmployeeStockOptionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mlec_PastShareOptionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mlec_PastShareOptionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ifrs-full_ShareOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ifrs-full_ShareOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mlec_PerformanceShareOptionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mlec_PerformanceShareOptionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>151
<FILENAME>R122.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Share-Based Payment - Schedule of Range of Assumptions which have Determined (Details)<br></strong></div></th>
<th class="th">
<div>Jul. 12, 2022 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems', window );"><strong>Schedule of Range of Assumptions which have Determined [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk-free interest rate</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Expected dividend yield</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of Range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems', window );"><strong>Schedule of Range of Assumptions which have Determined [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Exercise price (in Dollars per share)</a></td>
<td class="nump">$ 7.16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted', window );">Expected life (years)</a></td>
<td class="nump">0.03<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Estimated volatility factor</a></td>
<td class="nump">34.90%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of Range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems', window );"><strong>Schedule of Range of Assumptions which have Determined [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Exercise price (in Dollars per share)</a></td>
<td class="nump">$ 204.66<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted', window );">Expected life (years)</a></td>
<td class="nump">9.83<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Estimated volatility factor</a></td>
<td class="nump">44.40%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The option life of share options granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfOptionLifeShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExercisePriceShareOptionsGranted2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exercise price of share options granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExercisePriceShareOptionsGranted2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of an expected dividend used to calculate the fair value of share options granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>152
<FILENAME>R123.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Payment - Schedule of Option Activity and Weighted Average Exercise Price (Details) - Options incentive Plan [Member]<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2025 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems', window );"><strong>Schedule of Option Activity and Weighted Average Exercise Price [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of options, At the beginning of the year</a></td>
<td class="nump">7,345,795<span></span>
</td>
<td class="nump">1,791,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">W.A. Exercise price, At the beginning of the year</a></td>
<td class="nump">$ 11.83<span></span>
</td>
<td class="nump">$ 15.79<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of options, Granted during the year</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">5,631,894<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">W.A. Exercise price, Granted during the year</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 10.55<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement', window );">Number of options, Cancelled or expired during the year</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(570)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019', window );">W.A. Exercise price, Cancelled or expired during the year</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 10.07<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Number of options, Exercised during the year</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(76,529)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019', window );">W.A. Exercise price, Exercised during the year</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 10.73<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement', window );">Number of options, Loss of control</a></td>
<td class="num">(7,345,795)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019', window );">W.A. Exercise price, Loss of control</a></td>
<td class="nump">$ 11.83<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of options, Effective at the end of the year</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">7,345,795<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">W.A. Exercise price, Effective at the end of the year</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 11.83<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOutstandingShareOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOutstandingShareOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options exercised in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options expired in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_v&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_v&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_v&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options forfeited in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options expired in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_v&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_v&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_v&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options forfeited in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mlec_OptionsIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mlec_OptionsIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>153
<FILENAME>R124.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Events Occurring After the Reporting Period (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 14, 2024</div></th>
<th class="th"><div>Jul. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 02, 2025</div></th>
<th class="th"><div>Nov. 14, 2025</div></th>
<th class="th"><div>Oct. 02, 2025</div></th>
<th class="th"><div>May 22, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_EventsOccurringAftertheReportingPeriodDetailsLineItems', window );"><strong>Events Occurring After the Reporting Period [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Provisions', window );">Assignment price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AmountOfFinancialDebtUnderRestructuring', window );">Financial debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PledgedOrTransferredSharesQuantity', window );">Pledged shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,062,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_IssuedConvertiblePreferenceShares', window );">Issued convertible preference shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,380,952<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ProceedFromIssuedShares', window );">Total proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PreferenceOfAccruePerAnnum', window );">Perference of accrue per annum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ProceedsFromIssueOfEquityInstrumentsOnConversionOfDebt', window );">Financial liability and increase in equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_WorkingCapital', window );">Working capital amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (204,860,444)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Minimum per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ConsecutiveBusinessDays', window );">Consecutive business days</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss', window );">Estimated gain loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresSAMember', window );">Bioceres S.A. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_EventsOccurringAftertheReportingPeriodDetailsLineItems', window );"><strong>Events Occurring After the Reporting Period [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss', window );">Estimated gain loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresLLCMember', window );">Bioceres LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_EventsOccurringAftertheReportingPeriodDetailsLineItems', window );"><strong>Events Occurring After the Reporting Period [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss', window );">Estimated gain loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=mlec_SubsequentEventsMember', window );">Subsequent Events [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_EventsOccurringAftertheReportingPeriodDetailsLineItems', window );"><strong>Events Occurring After the Reporting Period [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AmountOfFinancialDebtUnderRestructuring', window );">Financial debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=ifrs-full_MajorBusinessCombinationMember', window );">Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_EventsOccurringAftertheReportingPeriodDetailsLineItems', window );"><strong>Events Occurring After the Reporting Period [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_WorkingCapital', window );">Working capital amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 24C<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24C_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 24C<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24C_b_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 62<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_62_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 62<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_62_b_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 62<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_62_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 62<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_62_b_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_a_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 160<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_160_a_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Provisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities of uncertain timing or amount, including provisions for employee benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph l<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_l&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Provisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_AmountOfFinancialDebtUnderRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of financial debt under restructuring.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_AmountOfFinancialDebtUnderRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ConsecutiveBusinessDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Consecutive business days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ConsecutiveBusinessDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_EventsOccurringAftertheReportingPeriodDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_EventsOccurringAftertheReportingPeriodDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_IssuedConvertiblePreferenceShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of issued convertible preference shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_IssuedConvertiblePreferenceShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_PledgedOrTransferredSharesQuantity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of pledged or transferred shares quantity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_PledgedOrTransferredSharesQuantity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_PreferenceOfAccruePerAnnum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of perference of accrue per annum.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_PreferenceOfAccruePerAnnum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ProceedFromIssuedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of issued shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ProceedFromIssuedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ProceedsFromIssueOfEquityInstrumentsOnConversionOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of financial liability and increase in equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ProceedsFromIssueOfEquityInstrumentsOnConversionOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_WorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of working capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_WorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=mlec_SubsequentEventsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=mlec_SubsequentEventsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=ifrs-full_MajorBusinessCombinationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=ifrs-full_MajorBusinessCombinationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>154
<FILENAME>R125.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Reverse Stock Split After the Reporting Period (Details)<br></strong></div></th>
<th class="th"><div>Dec. 20, 2025</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=srt_ScenarioForecastMember', window );">Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ReverseStockSplitAftertheReportingPeriodDetailsLineItems', window );"><strong>Reverse Stock Split After the Reporting Period (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ReverseStockSplit', window );">Reverse stock split.</a></td>
<td class="text">15-for-1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reverse stock split.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ReverseStockSplitAftertheReportingPeriodDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ReverseStockSplitAftertheReportingPeriodDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>155
<FILENAME>R126.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Reverse Stock Split After the Reporting Period - Schedule of Weighted Average Number of Ordinary Shares Outstanding (Details) - Reverse Stock Split [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NumeratorAbstract', window );"><strong>Numerator</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity', window );">Loss/Profit for the year (basic EPS)</a></td>
<td class="num">$ (111,460,708)<span></span>
</td>
<td class="num">$ (32,685,398)<span></span>
</td>
<td class="nump">$ 40,435,923<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects', window );">Loss/Profit for the year (diluted EPS)</a></td>
<td class="num">$ (111,460,708)<span></span>
</td>
<td class="num">$ (32,685,398)<span></span>
</td>
<td class="nump">$ 40,435,923<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DenominatorAbstract', window );"><strong>Denominator</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageShares', window );">Number of shares (basic EPS)</a></td>
<td class="nump">430,864<span></span>
</td>
<td class="nump">388,101<span></span>
</td>
<td class="nump">306,215<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustedWeightedAverageShares', window );">Number of shares (diluted EPS)</a></td>
<td class="nump">430,864<span></span>
</td>
<td class="nump">388,101<span></span>
</td>
<td class="nump">306,215<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShare', window );">Basic (loss)/profit attributable to ordinary equity holders of the parent</a></td>
<td class="num">$ (258.6912)<span></span>
</td>
<td class="num">$ (84.2188)<span></span>
</td>
<td class="nump">$ 132.0508<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DilutedEarningsLossPerShare', window );">Diluted (loss)/profit attributable to ordinary equity holders of the parent</a></td>
<td class="num">$ (258.6912)<span></span>
</td>
<td class="num">$ (84.2188)<span></span>
</td>
<td class="nump">$ 132.0508<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustedWeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustedWeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutedEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutedEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) attributable to ordinary equity holders of the parent entity. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 70<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_70_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) attributable to ordinary equity holders of the parent entity, adjusted for the effects of all dilutive potential ordinary shares. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 70<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_70_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DenominatorAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DenominatorAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_NumeratorAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_NumeratorAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=mlec_ReverseStockSplitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=mlec_ReverseStockSplitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>156
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>157
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>159
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1029</ContextCount>
  <ElementCount>662</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>289</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995100 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/dei/role/document/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995300 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/dei/role/document/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995301 - Statement - Consolidated Statement of Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome</Role>
      <ShortName>Consolidated Statement of Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>995302 - Statement - Consolidated Statement of Financial Position</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ConsolidatedBalanceSheet</Role>
      <ShortName>Consolidated Statement of Financial Position</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>995303 - Statement - Consolidated Statement of Changes in Shareholders??? Deficit / Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ShareholdersEquityType2or3</Role>
      <ShortName>Consolidated Statement of Changes in Shareholders??? Deficit / Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>995304 - Statement - Consolidated Statement of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ConsolidatedCashFlow</Role>
      <ShortName>Consolidated Statement of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>995305 - Disclosure - The Group???s Business Reorganization and General Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformation</Role>
      <ShortName>The Group???s Business Reorganization and General Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>995306 - Disclosure - Accounting Standards and Basis of Preparation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparation</Role>
      <ShortName>Accounting Standards and Basis of Preparation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>995307 - Disclosure - New Standards, Amendments and Interpretations Issued by the IASB</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/NewStandardsAmendmentsandInterpretationsIssuedbytheIASB</Role>
      <ShortName>New Standards, Amendments and Interpretations Issued by the IASB</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>995308 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>995309 - Disclosure - Critical Accounting Judgments and Estimates</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/CriticalAccountingJudgmentsandEstimates</Role>
      <ShortName>Critical Accounting Judgments and Estimates</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>995310 - Disclosure - Acquisitions and Other Significant Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/AcquisitionsandOtherSignificantTransactions</Role>
      <ShortName>Acquisitions and Other Significant Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>995311 - Disclosure - Information About Components of Consolidated Statements of Financial Position</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPosition</Role>
      <ShortName>Information About Components of Consolidated Statements of Financial Position</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>995312 - Disclosure - Information about Component of Consolidated Statements of Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/InformationaboutComponentofConsolidatedStatementsofComprehensiveIncome</Role>
      <ShortName>Information about Component of Consolidated Statements of Comprehensive Income</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>995313 - Disclosure - Taxation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/Taxation</Role>
      <ShortName>Taxation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>995314 - Disclosure - Earning Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/EarningPerShare</Role>
      <ShortName>Earning Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>995315 - Disclosure - Information about Components of Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/InformationaboutComponentsofEquity</Role>
      <ShortName>Information about Components of Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>995316 - Disclosure - Cash Flow Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/CashFlowInformation</Role>
      <ShortName>Cash Flow Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>995317 - Disclosure - Joint Ventures and Associates</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/JointVenturesandAssociates</Role>
      <ShortName>Joint Ventures and Associates</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>995318 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/SegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>995319 - Disclosure - Financial Instruments ??? Risk Management</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/FinancialInstrumentsRiskManagement</Role>
      <ShortName>Financial Instruments ??? Risk Management</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>995320 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>995321 - Disclosure - Shareholders and Other Related Parties Balances and Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ShareholdersandOtherRelatedPartiesBalancesandTransactions</Role>
      <ShortName>Shareholders and Other Related Parties Balances and Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>995322 - Disclosure - Key Management Personnel Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/KeyManagementPersonnelCompensation</Role>
      <ShortName>Key Management Personnel Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>995323 - Disclosure - Share-Based Payment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ShareBasedPayment</Role>
      <ShortName>Share-Based Payment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>995324 - Disclosure - Contingencies, Commitments and Restrictions on the Distribution of Profits</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ContingenciesCommitmentsandRestrictionsontheDistributionofProfits</Role>
      <ShortName>Contingencies, Commitments and Restrictions on the Distribution of Profits</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>995325 - Disclosure - Events Occurring After the Reporting Period</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/EventsOccurringAftertheReportingPeriod</Role>
      <ShortName>Events Occurring After the Reporting Period</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>995326 - Disclosure - Reverse Stock Split After the Reporting Period</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ReverseStockSplitAftertheReportingPeriod</Role>
      <ShortName>Reverse Stock Split After the Reporting Period</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure</Role>
      <ShortName>Cybersecurity Risk Management and Strategy Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>996000 - Disclosure - Accounting Policies, by Policy (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/AccountingPoliciesByPolicy</Role>
      <ShortName>Accounting Policies, by Policy (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparation</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>996001 - Disclosure - Accounting Standards and Basis of Preparation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationTables</Role>
      <ShortName>Accounting Standards and Basis of Preparation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparation</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>996002 - Disclosure - Acquisitions and Other Significant Transactions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/AcquisitionsandOtherSignificantTransactionsTables</Role>
      <ShortName>Acquisitions and Other Significant Transactions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/AcquisitionsandOtherSignificantTransactions</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>996003 - Disclosure - Information About Components of Consolidated Statements of Financial Position (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionTables</Role>
      <ShortName>Information About Components of Consolidated Statements of Financial Position (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPosition</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>996004 - Disclosure - Information about Component of Consolidated Statements of Comprehensive Income (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeTables</Role>
      <ShortName>Information about Component of Consolidated Statements of Comprehensive Income (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/InformationaboutComponentofConsolidatedStatementsofComprehensiveIncome</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>996005 - Disclosure - Taxation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/TaxationTables</Role>
      <ShortName>Taxation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/Taxation</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>996006 - Disclosure - Earning Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/EarningPerShareTables</Role>
      <ShortName>Earning Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/EarningPerShare</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>996007 - Disclosure - Information about Components of Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/InformationaboutComponentsofEquityTables</Role>
      <ShortName>Information about Components of Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/InformationaboutComponentsofEquity</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>996008 - Disclosure - Cash Flow Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/CashFlowInformationTables</Role>
      <ShortName>Cash Flow Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/CashFlowInformation</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>996009 - Disclosure - Joint Ventures and Associates (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/JointVenturesandAssociatesTables</Role>
      <ShortName>Joint Ventures and Associates (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/JointVenturesandAssociates</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>996010 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/SegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/SegmentInformation</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>996011 - Disclosure - Financial Instruments ??? Risk Management (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/FinancialInstrumentsRiskManagementTables</Role>
      <ShortName>Financial Instruments ??? Risk Management (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/FinancialInstrumentsRiskManagement</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>996012 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/Leases</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>996013 - Disclosure - Shareholders and Other Related Parties Balances and Transactions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ShareholdersandOtherRelatedPartiesBalancesandTransactionsTables</Role>
      <ShortName>Shareholders and Other Related Parties Balances and Transactions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/ShareholdersandOtherRelatedPartiesBalancesandTransactions</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>996014 - Disclosure - Key Management Personnel Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/KeyManagementPersonnelCompensationTables</Role>
      <ShortName>Key Management Personnel Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/KeyManagementPersonnelCompensation</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>996015 - Disclosure - Share-Based Payment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ShareBasedPaymentTables</Role>
      <ShortName>Share-Based Payment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/ShareBasedPayment</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>996016 - Disclosure - Reverse Stock Split After the Reporting Period (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ReverseStockSplitAftertheReportingPeriodTables</Role>
      <ShortName>Reverse Stock Split After the Reporting Period (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/ReverseStockSplitAftertheReportingPeriod</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>996017 - Disclosure - The Group???s Business Reorganization and General Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails</Role>
      <ShortName>The Group???s Business Reorganization and General Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformation</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>996018 - Disclosure - Accounting Standards and Basis of Preparation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationDetails</Role>
      <ShortName>Accounting Standards and Basis of Preparation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>996019 - Disclosure - Accounting Standards and Basis of Preparation - Schedule of Information related to Company???s Share of Voting Rights in its Subsidiaries (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofInformationrelatedtoCompanysShareofVotingRightsinitsSubsidiariesTable</Role>
      <ShortName>Accounting Standards and Basis of Preparation - Schedule of Information related to Company???s Share of Voting Rights in its Subsidiaries (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>996020 - Disclosure - New Standards, Amendments and Interpretations Issued by the IASB (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/NewStandardsAmendmentsandInterpretationsIssuedbytheIASBDetails</Role>
      <ShortName>New Standards, Amendments and Interpretations Issued by the IASB (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/NewStandardsAmendmentsandInterpretationsIssuedbytheIASB</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>996021 - Disclosure - Summary of Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>996022 - Disclosure - Acquisitions and Other Significant Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/AcquisitionsandOtherSignificantTransactionsDetails</Role>
      <ShortName>Acquisitions and Other Significant Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/AcquisitionsandOtherSignificantTransactionsTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>996023 - Disclosure - Acquisitions and Other Significant Transactions - Schedule of Fair Value of the Consideration of Payment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofFairValueoftheConsiderationofPaymentTable</Role>
      <ShortName>Acquisitions and Other Significant Transactions - Schedule of Fair Value of the Consideration of Payment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>996024 - Disclosure - Acquisitions and Other Significant Transactions - Schedule of Assets Acquired and Liabilities Assumed (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofAssetsAcquiredandLiabilitiesAssumedTable</Role>
      <ShortName>Acquisitions and Other Significant Transactions - Schedule of Assets Acquired and Liabilities Assumed (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>996025 - Disclosure - Information About Components of Consolidated Statements of Financial Position (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails</Role>
      <ShortName>Information About Components of Consolidated Statements of Financial Position (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>996026 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Cash and Cash Equivalents (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofCashandCashEquivalentsTable</Role>
      <ShortName>Information About Components of Consolidated Statements of Financial Position - Schedule of Cash and Cash Equivalents (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>996027 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Other Financial Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofOtherFinancialAssetsTable</Role>
      <ShortName>Information About Components of Consolidated Statements of Financial Position - Schedule of Other Financial Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>996028 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Trade Receivables (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofTradeReceivablesTable</Role>
      <ShortName>Information About Components of Consolidated Statements of Financial Position - Schedule of Trade Receivables (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>996029 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Other Receivables (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofOtherReceivablesTable</Role>
      <ShortName>Information About Components of Consolidated Statements of Financial Position - Schedule of Other Receivables (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>996030 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofInventoriesTable</Role>
      <ShortName>Information About Components of Consolidated Statements of Financial Position - Schedule of Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>996031 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Changes in Biological Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofChangesinBiologicalAssetsTable</Role>
      <ShortName>Information About Components of Consolidated Statements of Financial Position - Schedule of Changes in Biological Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>996032 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Property, Plant and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofPropertyPlantandEquipmentTable</Role>
      <ShortName>Information About Components of Consolidated Statements of Financial Position - Schedule of Property, Plant and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>996033 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Carrying Amounts that Would Have Been Recognized (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofCarryingAmountsthatWouldHaveBeenRecognizedTable</Role>
      <ShortName>Information About Components of Consolidated Statements of Financial Position - Schedule of Carrying Amounts that Would Have Been Recognized (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>996034 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of??? Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable</Role>
      <ShortName>Information About Components of Consolidated Statements of Financial Position - Schedule of??? Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>996035 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Intangible Assets and Liabilities Assumed (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsScheduleofIntangibleAssetsandLiabilitiesAssumed</Role>
      <ShortName>Information About Components of Consolidated Statements of Financial Position - Schedule of Intangible Assets and Liabilities Assumed (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>996036 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofGoodwillTable</Role>
      <ShortName>Information About Components of Consolidated Statements of Financial Position - Schedule of Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>996037 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Investment Properties (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofInvestmentPropertiesTable</Role>
      <ShortName>Information About Components of Consolidated Statements of Financial Position - Schedule of Investment Properties (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>996038 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Trade and Other Payables (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofTradeandOtherPayablesTable</Role>
      <ShortName>Information About Components of Consolidated Statements of Financial Position - Schedule of Trade and Other Payables (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>996039 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Borrowings (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofBorrowingsTable</Role>
      <ShortName>Information About Components of Consolidated Statements of Financial Position - Schedule of Borrowings (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>996040 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Borrowings, Carrying Amount (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofBorrowingsCarryingAmountTable</Role>
      <ShortName>Information About Components of Consolidated Statements of Financial Position - Schedule of Borrowings, Carrying Amount (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>996041 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Convertible Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofConvertibleNotesTable</Role>
      <ShortName>Information About Components of Consolidated Statements of Financial Position - Schedule of Convertible Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>996042 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Employee Benefits and Social Security (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofEmployeeBenefitsandSocialSecurityTable</Role>
      <ShortName>Information About Components of Consolidated Statements of Financial Position - Schedule of Employee Benefits and Social Security (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>996043 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Deferred Revenue and Advances from Customers (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofDeferredRevenueandAdvancesfromCustomersTable</Role>
      <ShortName>Information About Components of Consolidated Statements of Financial Position - Schedule of Deferred Revenue and Advances from Customers (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>996044 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Changes in Allowances and Provisions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofChangesinAllowancesandProvisionsTable</Role>
      <ShortName>Information About Components of Consolidated Statements of Financial Position - Schedule of Changes in Allowances and Provisions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>996045 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Provisions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofProvisionsTable</Role>
      <ShortName>Information About Components of Consolidated Statements of Financial Position - Schedule of Provisions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>996046 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Government Grants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofGovernmentGrantsTable</Role>
      <ShortName>Information About Components of Consolidated Statements of Financial Position - Schedule of Government Grants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>996047 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofWarrantsTable</Role>
      <ShortName>Information About Components of Consolidated Statements of Financial Position - Schedule of Warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>996048 - Disclosure - Information about Component of Consolidated Statements of Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeDetails</Role>
      <ShortName>Information about Component of Consolidated Statements of Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeTables</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>996049 - Disclosure - Information about Component of Consolidated Statements of Comprehensive Income - Schedule of Revenue from Contracts with Customers (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofRevenuefromContractswithCustomersTable</Role>
      <ShortName>Information about Component of Consolidated Statements of Comprehensive Income - Schedule of Revenue from Contracts with Customers (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>996050 - Disclosure - Information about Component of Consolidated Statements of Comprehensive Income - Schedule of Cost of Sales (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofCostofSalesTable</Role>
      <ShortName>Information about Component of Consolidated Statements of Comprehensive Income - Schedule of Cost of Sales (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>996051 - Disclosure - Information about Component of Consolidated Statements of Comprehensive Income - Schedule of R&amp;D Classified by Nature (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable</Role>
      <ShortName>Information about Component of Consolidated Statements of Comprehensive Income - Schedule of R&amp;D Classified by Nature (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>996052 - Disclosure - Information about Component of Consolidated Statements of Comprehensive Income - Schedule of Expenses Classified by Nature and Function (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofExpensesClassifiedbyNatureandFunctionTable</Role>
      <ShortName>Information about Component of Consolidated Statements of Comprehensive Income - Schedule of Expenses Classified by Nature and Function (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>996053 - Disclosure - Information about Component of Consolidated Statements of Comprehensive Income - Schedule of Finance Results (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofFinanceResultsTable</Role>
      <ShortName>Information about Component of Consolidated Statements of Comprehensive Income - Schedule of Finance Results (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>996054 - Disclosure - Information about Component of Consolidated Statements of Comprehensive Income - Schedule of Other Income or Expenses, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofOtherIncomeorExpensesNetTable</Role>
      <ShortName>Information about Component of Consolidated Statements of Comprehensive Income - Schedule of Other Income or Expenses, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>996055 - Disclosure - Taxation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/TaxationDetails</Role>
      <ShortName>Taxation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/TaxationTables</ParentRole>
      <Position>86</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>996056 - Disclosure - Taxation - Schedule of Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable</Role>
      <ShortName>Taxation - Schedule of Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>996057 - Disclosure - Taxation - Schedule of Roll Forward of Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesTable</Role>
      <ShortName>Taxation - Schedule of Roll Forward of Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>996058 - Disclosure - Taxation - Schedule of Weighted Average Tax Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofWeightedAverageTaxRateTable</Role>
      <ShortName>Taxation - Schedule of Weighted Average Tax Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>996059 - Disclosure - Taxation - Schedule of Principal Statutory Taxes Rates and Current Tax (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofPrincipalStatutoryTaxesRatesandCurrentTaxTable</Role>
      <ShortName>Taxation - Schedule of Principal Statutory Taxes Rates and Current Tax (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>996060 - Disclosure - Taxation - Schedule of Income Tax Expense Calculated by Applying Tax Rate in Force (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceTable</Role>
      <ShortName>Taxation - Schedule of Income Tax Expense Calculated by Applying Tax Rate in Force (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>996061 - Disclosure - Earning Per Share - Schedule of Earning Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofEarningPerShareTable</Role>
      <ShortName>Earning Per Share - Schedule of Earning Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>996062 - Disclosure - Information about Components of Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/InformationaboutComponentsofEquityDetails</Role>
      <ShortName>Information about Components of Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/InformationaboutComponentsofEquityTables</ParentRole>
      <Position>93</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>996063 - Disclosure - Information about Components of Equity - Schedule of Number of Shares Issued (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofNumberofSharesIssuedTable</Role>
      <ShortName>Information about Components of Equity - Schedule of Number of Shares Issued (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>996064 - Disclosure - Information about Components of Equity - Schedule of Subsidiaries Non-Controlling Interest (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofSubsidiariesNonControllingInterestTable</Role>
      <ShortName>Information about Components of Equity - Schedule of Subsidiaries Non-Controlling Interest (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>996065 - Disclosure - Information about Components of Equity - Schedule of Financial Statements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable</Role>
      <ShortName>Information about Components of Equity - Schedule of Financial Statements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>96</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>996066 - Disclosure - Information about Components of Equity - Schedule of Bioceres SA and Bioceres Crop Solutions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable</Role>
      <ShortName>Information about Components of Equity - Schedule of Bioceres SA and Bioceres Crop Solutions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>97</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>996067 - Disclosure - Cash Flow Information - Schedule of Significant Non-Cash Transactions Related to Investing and Financing Activities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesTable</Role>
      <ShortName>Cash Flow Information - Schedule of Significant Non-Cash Transactions Related to Investing and Financing Activities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>98</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>996068 - Disclosure - Cash Flow Information - Schedule of Changes in Liabilities Arising from Financing Activities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable</Role>
      <ShortName>Cash Flow Information - Schedule of Changes in Liabilities Arising from Financing Activities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>99</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>996069 - Disclosure - Joint Ventures and Associates (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/JointVenturesandAssociatesDetails</Role>
      <ShortName>Joint Ventures and Associates (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/JointVenturesandAssociatesTables</ParentRole>
      <Position>100</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>996070 - Disclosure - Joint Ventures and Associates - Schedule of Joint Ventures Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofJointVenturesAssetsTable</Role>
      <ShortName>Joint Ventures and Associates - Schedule of Joint Ventures Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>101</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>996071 - Disclosure - Joint Ventures and Associates - Schedule of Changes in Joint Ventures Investments and Affiliates (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofChangesinJointVenturesInvestmentsandAffiliatesTable</Role>
      <ShortName>Joint Ventures and Associates - Schedule of Changes in Joint Ventures Investments and Affiliates (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>102</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>996072 - Disclosure - Joint Ventures and Associates - Schedule of Share of Profit or Loss of Joint Ventures and Affiliates (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofShareofProfitorLossofJointVenturesandAffiliatesTable</Role>
      <ShortName>Joint Ventures and Associates - Schedule of Share of Profit or Loss of Joint Ventures and Affiliates (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>103</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>996073 - Disclosure - Joint Ventures and Associates - Schedule of Significant Joint Ventures (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofSignificantJointVenturesTable</Role>
      <ShortName>Joint Ventures and Associates - Schedule of Significant Joint Ventures (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>104</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>996074 - Disclosure - Segment Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/SegmentInformationDetails</Role>
      <ShortName>Segment Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/SegmentInformationTables</ParentRole>
      <Position>105</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>996075 - Disclosure - Segment Information - Schedule of Operating Results Group's Reporting Segments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofOperatingResultsGroupsReportingSegmentsTable</Role>
      <ShortName>Segment Information - Schedule of Operating Results Group's Reporting Segments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>106</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R107.htm</HtmlFileName>
      <LongName>996076 - Disclosure - Segment Information - Schedule of Revenue by Similar Group of Products or Services (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofRevenuebySimilarGroupofProductsorServicesTable</Role>
      <ShortName>Segment Information - Schedule of Revenue by Similar Group of Products or Services (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>107</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R108.htm</HtmlFileName>
      <LongName>996077 - Disclosure - Segment Information - Schedule of Geographical Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofGeographicalInformationTable</Role>
      <ShortName>Segment Information - Schedule of Geographical Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>108</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R109.htm</HtmlFileName>
      <LongName>996078 - Disclosure - Financial Instruments ??? Risk Management (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/FinancialInstrumentsRiskManagementDetails</Role>
      <ShortName>Financial Instruments ??? Risk Management (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/FinancialInstrumentsRiskManagementTables</ParentRole>
      <Position>109</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R110.htm</HtmlFileName>
      <LongName>996079 - Disclosure - Financial Instruments ??? Risk Management - Schedule of Liquidity Risk (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofLiquidityRiskTable</Role>
      <ShortName>Financial Instruments ??? Risk Management - Schedule of Liquidity Risk (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>110</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R111.htm</HtmlFileName>
      <LongName>996080 - Disclosure - Financial Instruments ??? Risk Management - Schedule of Currency Risk (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofCurrencyRiskTable</Role>
      <ShortName>Financial Instruments ??? Risk Management - Schedule of Currency Risk (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>111</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R112.htm</HtmlFileName>
      <LongName>996081 - Disclosure - Financial Instruments ??? Risk Management - Schedule of Other Foriegn Currencies with Variables Remaining Constant (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofOtherForiegnCurrencieswithVariablesRemainingConstantTable</Role>
      <ShortName>Financial Instruments ??? Risk Management - Schedule of Other Foriegn Currencies with Variables Remaining Constant (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>112</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R113.htm</HtmlFileName>
      <LongName>996082 - Disclosure - Financial Instruments ??? Risk Management - Schedule of Interest Rate Risk (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofInterestRateRiskTable</Role>
      <ShortName>Financial Instruments ??? Risk Management - Schedule of Interest Rate Risk (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>113</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R114.htm</HtmlFileName>
      <LongName>996083 - Disclosure - Financial Instruments ??? Risk Management - Schedule of Financial Assets by Category (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofFinancialAssetsbyCategoryTable</Role>
      <ShortName>Financial Instruments ??? Risk Management - Schedule of Financial Assets by Category (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>114</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R115.htm</HtmlFileName>
      <LongName>996084 - Disclosure - Financial Instruments ??? Risk Management - Schedule of Financial Liabilities by Category (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofFinancialLiabilitiesbyCategoryTable</Role>
      <ShortName>Financial Instruments ??? Risk Management - Schedule of Financial Liabilities by Category (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>115</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R116.htm</HtmlFileName>
      <LongName>996085 - Disclosure - Financial Instruments ??? Risk Management - Schedule of Fair Value by Hierarchy (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofFairValuebyHierarchyTable</Role>
      <ShortName>Financial Instruments ??? Risk Management - Schedule of Fair Value by Hierarchy (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>116</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R117.htm</HtmlFileName>
      <LongName>996086 - Disclosure - Leases - Schedule of Right-of-Use and Liabilities Related with Lease Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable</Role>
      <ShortName>Leases - Schedule of Right-of-Use and Liabilities Related with Lease Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>117</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R118.htm</HtmlFileName>
      <LongName>996087 - Disclosure - Shareholders and Other Related Parties Balances and Transactions - Schedule of Transactions Between the Group and Related Parties (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofTransactionsBetweentheGroupandRelatedPartiesTable</Role>
      <ShortName>Shareholders and Other Related Parties Balances and Transactions - Schedule of Transactions Between the Group and Related Parties (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>118</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R119.htm</HtmlFileName>
      <LongName>996088 - Disclosure - Key Management Personnel Compensation - Schedule of Compensation of Key Management Personnel Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofCompensationofKeyManagementPersonnelCompensationTable</Role>
      <ShortName>Key Management Personnel Compensation - Schedule of Compensation of Key Management Personnel Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>119</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R120.htm</HtmlFileName>
      <LongName>996089 - Disclosure - Share-Based Payment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ShareBasedPaymentDetails</Role>
      <ShortName>Share-Based Payment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/ShareBasedPaymentTables</ParentRole>
      <Position>120</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R121.htm</HtmlFileName>
      <LongName>996090 - Disclosure - Share-Based Payment - Schedule of Fair Value of the Stock Options at the Grant Date (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofFairValueoftheStockOptionsattheGrantDateTable</Role>
      <ShortName>Share-Based Payment - Schedule of Fair Value of the Stock Options at the Grant Date (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>121</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R122.htm</HtmlFileName>
      <LongName>996091 - Disclosure - Share-Based Payment - Schedule of Range of Assumptions which have Determined (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofRangeofAssumptionswhichhaveDeterminedTable</Role>
      <ShortName>Share-Based Payment - Schedule of Range of Assumptions which have Determined (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>122</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R123.htm</HtmlFileName>
      <LongName>996092 - Disclosure - Share-Based Payment - Schedule of Option Activity and Weighted Average Exercise Price (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofOptionActivityandWeightedAverageExercisePriceTable</Role>
      <ShortName>Share-Based Payment - Schedule of Option Activity and Weighted Average Exercise Price (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>123</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R124.htm</HtmlFileName>
      <LongName>996093 - Disclosure - Events Occurring After the Reporting Period (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/EventsOccurringAftertheReportingPeriodDetails</Role>
      <ShortName>Events Occurring After the Reporting Period (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/EventsOccurringAftertheReportingPeriod</ParentRole>
      <Position>124</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R125.htm</HtmlFileName>
      <LongName>996094 - Disclosure - Reverse Stock Split After the Reporting Period (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ReverseStockSplitAftertheReportingPeriodDetails</Role>
      <ShortName>Reverse Stock Split After the Reporting Period (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/ReverseStockSplitAftertheReportingPeriodTables</ParentRole>
      <Position>125</Position>
    </Report>
    <Report instance="ea0270125-20f_moolec.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R126.htm</HtmlFileName>
      <LongName>996095 - Disclosure - Reverse Stock Split After the Reporting Period - Schedule of Weighted Average Number of Ordinary Shares Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofWeightedAverageNumberofOrdinarySharesOutstandingTable</Role>
      <ShortName>Reverse Stock Split After the Reporting Period - Schedule of Weighted Average Number of Ordinary Shares Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>126</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="20-F" isDefinitelyFs="true" isIfrs="true" isUsgaap="true" original="ea0270125-20f_moolec.htm">ea0270125-20f_moolec.htm</File>
    <File>mlec-20250630.xsd</File>
    <File>mlec-20250630_cal.xml</File>
    <File>mlec-20250630_def.xml</File>
    <File>mlec-20250630_lab.xml</File>
    <File>mlec-20250630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>fin_001.jpg</File>
    <File>fin_002.jpg</File>
    <File>image_001.jpg</File>
    <File>image_002.jpg</File>
    <File>image_003.jpg</File>
    <File>image_004.jpg</File>
    <File>image_005.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="7">http://xbrl.sec.gov/cyd/2025</BaseTaxonomy>
    <BaseTaxonomy items="49">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="1">http://xbrl.sec.gov/ecd/2025</BaseTaxonomy>
    <BaseTaxonomy items="2640">https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>162
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea0270125-20f_moolec.htm": {
   "nsprefix": "mlec",
   "nsuri": "http://www.moolecscience.com/20250630",
   "dts": {
    "inline": {
     "local": [
      "ea0270125-20f_moolec.htm"
     ]
    },
    "schema": {
     "local": [
      "mlec-20250630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/dimensions-ea/rol_ifrs_ea-dim_2025-03-27.xsd",
      "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/dimensions/rol_full_ifrs-dim_2025-03-27.xsd",
      "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd",
      "https://xbrl.sec.gov/cyd/2025/cyd-af-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025_def.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025_lab.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025_pre.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-sub-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-sub-2025.xsd",
      "https://xbrl.sec.gov/sic/2025/sic-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "mlec-20250630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "mlec-20250630_def.xml"
     ],
     "remote": [
      "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/dimensions-ea/dim_ifrs_ea_2025-03-27_role-995000.xml",
      "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/dimensions/dim_full_ifrs_2025-03-27_role-995000.xml"
     ]
    },
    "labelLink": {
     "local": [
      "mlec-20250630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mlec-20250630_pre.xml"
     ]
    }
   },
   "keyStandard": 410,
   "keyCustom": 252,
   "axisStandard": 40,
   "axisCustom": 2,
   "memberStandard": 57,
   "memberCustom": 199,
   "hidden": {
    "total": 697,
    "http://www.moolecscience.com/20250630": 177,
    "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full": 514,
    "http://xbrl.sec.gov/dei/2025": 6
   },
   "contextCount": 1029,
   "entityCount": 1,
   "segmentCount": 289,
   "elementCount": 1461,
   "unitCount": 5,
   "baseTaxonomies": {
    "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full": 2640,
    "http://xbrl.sec.gov/dei/2025": 49,
    "http://xbrl.sec.gov/cyd/2025": 7,
    "http://xbrl.sec.gov/ecd/2025": 1
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/dei/role/document/Cover",
     "longName": "995100 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/dei/role/document/AuditInformation",
     "longName": "995300 - Document - Audit Information",
     "shortName": "Audit Information",
     "isDefault": "false",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome",
     "longName": "995301 - Statement - Consolidated Statement of Comprehensive Income",
     "shortName": "Consolidated Statement of Comprehensive Income",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:RevenueFromContractsWithCustomers",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:RevenueFromGovernmentGrants",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.moolecscience.com/role/ConsolidatedBalanceSheet",
     "longName": "995302 - Statement - Consolidated Statement of Financial Position",
     "shortName": "Consolidated Statement of Financial Position",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c7",
      "name": "ifrs-full:OtherNoncurrentFinancialAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c7",
      "name": "ifrs-full:CurrentTaxAssetsNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.moolecscience.com/role/ShareholdersEquityType2or3",
     "longName": "995303 - Statement - Consolidated Statement of Changes in Shareholders\u2019 Deficit / Equity",
     "shortName": "Consolidated Statement of Changes in Shareholders\u2019 Deficit / Equity",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c57",
      "name": "ifrs-full:Equity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c57",
      "name": "ifrs-full:Equity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.moolecscience.com/role/ConsolidatedCashFlow",
     "longName": "995304 - Statement - Consolidated Statement of Cash Flows",
     "shortName": "Consolidated Statement of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:ProfitLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:AdjustmentsForIncomeTaxExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformation",
     "longName": "995305 - Disclosure - The Group\u2019s Business Reorganization and General Information",
     "shortName": "The Group\u2019s Business Reorganization and General Information",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparation",
     "longName": "995306 - Disclosure - Accounting Standards and Basis of Preparation",
     "shortName": "Accounting Standards and Basis of Preparation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.moolecscience.com/role/NewStandardsAmendmentsandInterpretationsIssuedbytheIASB",
     "longName": "995307 - Disclosure - New Standards, Amendments and Interpretations Issued by the IASB",
     "shortName": "New Standards, Amendments and Interpretations Issued by the IASB",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.moolecscience.com/role/SummaryofSignificantAccountingPolicies",
     "longName": "995308 - Disclosure - Summary of Significant Accounting Policies",
     "shortName": "Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.moolecscience.com/role/CriticalAccountingJudgmentsandEstimates",
     "longName": "995309 - Disclosure - Critical Accounting Judgments and Estimates",
     "shortName": "Critical Accounting Judgments and Estimates",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.moolecscience.com/role/AcquisitionsandOtherSignificantTransactions",
     "longName": "995310 - Disclosure - Acquisitions and Other Significant Transactions",
     "shortName": "Acquisitions and Other Significant Transactions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPosition",
     "longName": "995311 - Disclosure - Information About Components of Consolidated Statements of Financial Position",
     "shortName": "Information About Components of Consolidated Statements of Financial Position",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "mlec:DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "mlec:DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.moolecscience.com/role/InformationaboutComponentofConsolidatedStatementsofComprehensiveIncome",
     "longName": "995312 - Disclosure - Information about Component of Consolidated Statements of Comprehensive Income",
     "shortName": "Information about Component of Consolidated Statements of Comprehensive Income",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "mlec:DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "mlec:DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.moolecscience.com/role/Taxation",
     "longName": "995313 - Disclosure - Taxation",
     "shortName": "Taxation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.moolecscience.com/role/EarningPerShare",
     "longName": "995314 - Disclosure - Earning Per Share",
     "shortName": "Earning Per Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.moolecscience.com/role/InformationaboutComponentsofEquity",
     "longName": "995315 - Disclosure - Information about Components of Equity",
     "shortName": "Information about Components of Equity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.moolecscience.com/role/CashFlowInformation",
     "longName": "995316 - Disclosure - Cash Flow Information",
     "shortName": "Cash Flow Information",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfCashFlowStatementExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfCashFlowStatementExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.moolecscience.com/role/JointVenturesandAssociates",
     "longName": "995317 - Disclosure - Joint Ventures and Associates",
     "shortName": "Joint Ventures and Associates",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfJointVenturesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfJointVenturesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.moolecscience.com/role/SegmentInformation",
     "longName": "995318 - Disclosure - Segment Information",
     "shortName": "Segment Information",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.moolecscience.com/role/FinancialInstrumentsRiskManagement",
     "longName": "995319 - Disclosure - Financial Instruments \u2013 Risk Management",
     "shortName": "Financial Instruments \u2013 Risk Management",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.moolecscience.com/role/Leases",
     "longName": "995320 - Disclosure - Leases",
     "shortName": "Leases",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfLeasesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfLeasesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.moolecscience.com/role/ShareholdersandOtherRelatedPartiesBalancesandTransactions",
     "longName": "995321 - Disclosure - Shareholders and Other Related Parties Balances and Transactions",
     "shortName": "Shareholders and Other Related Parties Balances and Transactions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.moolecscience.com/role/KeyManagementPersonnelCompensation",
     "longName": "995322 - Disclosure - Key Management Personnel Compensation",
     "shortName": "Key Management Personnel Compensation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.moolecscience.com/role/ShareBasedPayment",
     "longName": "995323 - Disclosure - Share-Based Payment",
     "shortName": "Share-Based Payment",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.moolecscience.com/role/ContingenciesCommitmentsandRestrictionsontheDistributionofProfits",
     "longName": "995324 - Disclosure - Contingencies, Commitments and Restrictions on the Distribution of Profits",
     "shortName": "Contingencies, Commitments and Restrictions on the Distribution of Profits",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfCommitmentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfCommitmentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.moolecscience.com/role/EventsOccurringAftertheReportingPeriod",
     "longName": "995325 - Disclosure - Events Occurring After the Reporting Period",
     "shortName": "Events Occurring After the Reporting Period",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.moolecscience.com/role/ReverseStockSplitAftertheReportingPeriod",
     "longName": "995326 - Disclosure - Reverse Stock Split After the Reporting Period",
     "shortName": "Reverse Stock Split After the Reporting Period",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "mlec:DisclosureOfReverseStockSplitAfterTheReportingPeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "mlec:DisclosureOfReverseStockSplitAfterTheReportingPeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure",
     "longName": "995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure",
     "shortName": "Cybersecurity Risk Management and Strategy Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.moolecscience.com/role/AccountingPoliciesByPolicy",
     "longName": "996000 - Disclosure - Accounting Policies, by Policy (Policies)",
     "shortName": "Accounting Policies, by Policy (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationTables",
     "longName": "996001 - Disclosure - Accounting Standards and Basis of Preparation (Tables)",
     "shortName": "Accounting Standards and Basis of Preparation (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfInterestsInSubsidiariesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfInterestsInSubsidiariesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.moolecscience.com/role/AcquisitionsandOtherSignificantTransactionsTables",
     "longName": "996002 - Disclosure - Acquisitions and Other Significant Transactions (Tables)",
     "shortName": "Acquisitions and Other Significant Transactions (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "mlec:ScheduleOfFairValueOfConsiderationOfPaymentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "mlec:ScheduleOfFairValueOfConsiderationOfPaymentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionTables",
     "longName": "996003 - Disclosure - Information About Components of Consolidated Statements of Financial Position (Tables)",
     "shortName": "Information About Components of Consolidated Statements of Financial Position (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "mlec:DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "mlec:DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.moolecscience.com/role/InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeTables",
     "longName": "996004 - Disclosure - Information about Component of Consolidated Statements of Comprehensive Income (Tables)",
     "shortName": "Information about Component of Consolidated Statements of Comprehensive Income (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "mlec:DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "mlec:DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.moolecscience.com/role/TaxationTables",
     "longName": "996005 - Disclosure - Taxation (Tables)",
     "shortName": "Taxation (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfDeferredTaxesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfDeferredTaxesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.moolecscience.com/role/EarningPerShareTables",
     "longName": "996006 - Disclosure - Earning Per Share (Tables)",
     "shortName": "Earning Per Share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:EarningsPerShareExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:EarningsPerShareExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.moolecscience.com/role/InformationaboutComponentsofEquityTables",
     "longName": "996007 - Disclosure - Information about Components of Equity (Tables)",
     "shortName": "Information about Components of Equity (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "mlec:DisclosureOfNumberOfSharesIssuedtextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "mlec:DisclosureOfNumberOfSharesIssuedtextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.moolecscience.com/role/CashFlowInformationTables",
     "longName": "996008 - Disclosure - Cash Flow Information (Tables)",
     "shortName": "Cash Flow Information (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "mlec:ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfCashFlowStatementExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "mlec:ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfCashFlowStatementExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.moolecscience.com/role/JointVenturesandAssociatesTables",
     "longName": "996009 - Disclosure - Joint Ventures and Associates (Tables)",
     "shortName": "Joint Ventures and Associates (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "mlec:DisclosureOfInvestmentsInJointVenturesAndAffiliatesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfJointVenturesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "mlec:DisclosureOfInvestmentsInJointVenturesAndAffiliatesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfJointVenturesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.moolecscience.com/role/SegmentInformationTables",
     "longName": "996010 - Disclosure - Segment Information (Tables)",
     "shortName": "Segment Information (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfOperatingSegmentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfOperatingSegmentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.moolecscience.com/role/FinancialInstrumentsRiskManagementTables",
     "longName": "996011 - Disclosure - Financial Instruments \u2013 Risk Management (Tables)",
     "shortName": "Financial Instruments \u2013 Risk Management (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:MaturityAnalysisForNonderivativeFinancialLiabilities",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:MaturityAnalysisForNonderivativeFinancialLiabilities",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.moolecscience.com/role/LeasesTables",
     "longName": "996012 - Disclosure - Leases (Tables)",
     "shortName": "Leases (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.moolecscience.com/role/ShareholdersandOtherRelatedPartiesBalancesandTransactionsTables",
     "longName": "996013 - Disclosure - Shareholders and Other Related Parties Balances and Transactions (Tables)",
     "shortName": "Shareholders and Other Related Parties Balances and Transactions (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "44",
     "firstAnchor": null,
     "uniqueAnchor": null
    },
    "R45": {
     "role": "http://www.moolecscience.com/role/KeyManagementPersonnelCompensationTables",
     "longName": "996014 - Disclosure - Key Management Personnel Compensation (Tables)",
     "shortName": "Key Management Personnel Compensation (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "mlec:DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "mlec:DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.moolecscience.com/role/ShareBasedPaymentTables",
     "longName": "996015 - Disclosure - Share-Based Payment (Tables)",
     "shortName": "Share-Based Payment (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "mlec:DisclosureOfFairValueOfTheStockOptionsAtTheGrantDateTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "mlec:DisclosureOfFairValueOfTheStockOptionsAtTheGrantDateTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.moolecscience.com/role/ReverseStockSplitAftertheReportingPeriodTables",
     "longName": "996016 - Disclosure - Reverse Stock Split After the Reporting Period (Tables)",
     "shortName": "Reverse Stock Split After the Reporting Period (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "mlec:DisclosureOfReverseStockSplitAfterTheReportingPeriod",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "mlec:DisclosureOfReverseStockSplitAfterTheReportingPeriod",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails",
     "longName": "996017 - Disclosure - The Group\u2019s Business Reorganization and General Information (Details)",
     "shortName": "The Group\u2019s Business Reorganization and General Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c78",
      "name": "ifrs-full:NumberOfSharesIssued",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c78",
      "name": "mlec:NumberOfSharesReverseStockSplit",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationDetails",
     "longName": "996018 - Disclosure - Accounting Standards and Basis of Preparation (Details)",
     "shortName": "Accounting Standards and Basis of Preparation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "mlec:ShorttermPeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ifrs-full:DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "mlec:ShorttermPeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ifrs-full:DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.moolecscience.com/role/ScheduleofInformationrelatedtoCompanysShareofVotingRightsinitsSubsidiariesTable",
     "longName": "996019 - Disclosure - Accounting Standards and Basis of Preparation - Schedule of Information related to Company\u2019s Share of Voting Rights in its Subsidiaries (Details)",
     "shortName": "Accounting Standards and Basis of Preparation - Schedule of Information related to Company\u2019s Share of Voting Rights in its Subsidiaries (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c97",
      "name": "ifrs-full:NameOfSubsidiary",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfInterestsInSubsidiariesExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c97",
      "name": "ifrs-full:NameOfSubsidiary",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfInterestsInSubsidiariesExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.moolecscience.com/role/NewStandardsAmendmentsandInterpretationsIssuedbytheIASBDetails",
     "longName": "996020 - Disclosure - New Standards, Amendments and Interpretations Issued by the IASB (Details)",
     "shortName": "New Standards, Amendments and Interpretations Issued by the IASB (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c123",
      "name": "ifrs-full:DescriptionWhetherChangeInAccountingPolicyIsMadeInAccordanceWithTransitionalProvisionsOfInitiallyAppliedIFRS",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c123",
      "name": "ifrs-full:DescriptionWhetherChangeInAccountingPolicyIsMadeInAccordanceWithTransitionalProvisionsOfInitiallyAppliedIFRS",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails",
     "longName": "996021 - Disclosure - Summary of Significant Accounting Policies (Details)",
     "shortName": "Summary of Significant Accounting Policies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "mlec:ValuationSignificantChangeInAmountNormalWearAndTearVariationImpactOnRevaluationAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "p",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "mlec:ValuationSignificantChangeInAmountNormalWearAndTearVariationImpactOnRevaluationAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "p",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.moolecscience.com/role/AcquisitionsandOtherSignificantTransactionsDetails",
     "longName": "996022 - Disclosure - Acquisitions and Other Significant Transactions (Details)",
     "shortName": "Acquisitions and Other Significant Transactions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c4",
      "name": "ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "b",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "mlec:PercentageOfCustomerRevenues",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.moolecscience.com/role/ScheduleofFairValueoftheConsiderationofPaymentTable",
     "longName": "996023 - Disclosure - Acquisitions and Other Significant Transactions - Schedule of Fair Value of the Consideration of Payment (Details)",
     "shortName": "Acquisitions and Other Significant Transactions - Schedule of Fair Value of the Consideration of Payment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c150",
      "name": "mlec:EquityShares",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:ScheduleOfFairValueOfConsiderationOfPaymentTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c150",
      "name": "mlec:EquityShares",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:ScheduleOfFairValueOfConsiderationOfPaymentTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.moolecscience.com/role/ScheduleofAssetsAcquiredandLiabilitiesAssumedTable",
     "longName": "996024 - Disclosure - Acquisitions and Other Significant Transactions - Schedule of Assets Acquired and Liabilities Assumed (Details)",
     "shortName": "Acquisitions and Other Significant Transactions - Schedule of Assets Acquired and Liabilities Assumed (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c4",
      "name": "ifrs-full:OtherCashAndCashEquivalents",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c4",
      "name": "ifrs-full:OtherCashAndCashEquivalents",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails",
     "longName": "996025 - Disclosure - Information About Components of Consolidated Statements of Financial Position (Details)",
     "shortName": "Information About Components of Consolidated Statements of Financial Position (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryOtherProvisions",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "link:footnote",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryOtherProvisions",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "link:footnote",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.moolecscience.com/role/ScheduleofCashandCashEquivalentsTable",
     "longName": "996026 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Cash and Cash Equivalents (Details)",
     "shortName": "Information About Components of Consolidated Statements of Financial Position - Schedule of Cash and Cash Equivalents (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c4",
      "name": "ifrs-full:Cash",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
       "mlec:DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c4",
      "name": "ifrs-full:Cash",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
       "mlec:DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://www.moolecscience.com/role/ScheduleofOtherFinancialAssetsTable",
     "longName": "996027 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Other Financial Assets (Details)",
     "shortName": "Information About Components of Consolidated Statements of Financial Position - Schedule of Other Financial Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "c4",
      "name": "ifrs-full:OtherCurrentFinancialAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c174",
      "name": "ifrs-full:OtherCurrentFinancialAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:DisclosureOfOtherFinancialAssetsExplanatory",
       "mlec:DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "unique": true
     }
    },
    "R59": {
     "role": "http://www.moolecscience.com/role/ScheduleofTradeReceivablesTable",
     "longName": "996028 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Trade Receivables (Details)",
     "shortName": "Information About Components of Consolidated Statements of Financial Position - Schedule of Trade Receivables (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "c180",
      "name": "ifrs-full:CurrentTradeReceivables",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:DisclosureOfTradeReceivablesTableTextBlock",
       "mlec:DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c180",
      "name": "ifrs-full:CurrentTradeReceivables",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:DisclosureOfTradeReceivablesTableTextBlock",
       "mlec:DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://www.moolecscience.com/role/ScheduleofOtherReceivablesTable",
     "longName": "996029 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Other Receivables (Details)",
     "shortName": "Information About Components of Consolidated Statements of Financial Position - Schedule of Other Receivables (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "c4",
      "name": "ifrs-full:OtherCurrentReceivables",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c182",
      "name": "ifrs-full:OtherCurrentReceivables",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:DisclosureOfOtherReceivablesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "unique": true
     }
    },
    "R61": {
     "role": "http://www.moolecscience.com/role/ScheduleofInventoriesTable",
     "longName": "996030 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Inventories (Details)",
     "shortName": "Information About Components of Consolidated Statements of Financial Position - Schedule of Inventories (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "c4",
      "name": "mlec:InventoriesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfInventoriesExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c4",
      "name": "mlec:InventoriesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfInventoriesExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://www.moolecscience.com/role/ScheduleofChangesinBiologicalAssetsTable",
     "longName": "996031 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Changes in Biological Assets (Details)",
     "shortName": "Information About Components of Consolidated Statements of Financial Position - Schedule of Changes in Biological Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "c7",
      "name": "ifrs-full:BiologicalAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "unique": true
     }
    },
    "R63": {
     "role": "http://www.moolecscience.com/role/ScheduleofPropertyPlantandEquipmentTable",
     "longName": "996032 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Property, Plant and Equipment (Details)",
     "shortName": "Information About Components of Consolidated Statements of Financial Position - Schedule of Property, Plant and Equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "c264",
      "name": "ifrs-full:PropertyPlantAndEquipment",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c284",
      "name": "ifrs-full:PropertyPlantAndEquipment",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "unique": true
     }
    },
    "R64": {
     "role": "http://www.moolecscience.com/role/ScheduleofCarryingAmountsthatWouldHaveBeenRecognizedTable",
     "longName": "996033 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Carrying Amounts that Would Have Been Recognized (Details)",
     "shortName": "Information About Components of Consolidated Statements of Financial Position - Schedule of Carrying Amounts that Would Have Been Recognized (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "c286",
      "name": "ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:DisclosureOfDepreciationIfAssetsHadBeenCarriedUnderCostModelTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c286",
      "name": "ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:DisclosureOfDepreciationIfAssetsHadBeenCarriedUnderCostModelTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R65": {
     "role": "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable",
     "longName": "996034 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of\u200b Intangible Assets (Details)",
     "shortName": "Information About Components of Consolidated Statements of Financial Position - Schedule of\u200b Intangible Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "c7",
      "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "unique": true
     }
    },
    "R66": {
     "role": "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsScheduleofIntangibleAssetsandLiabilitiesAssumed",
     "longName": "996035 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Intangible Assets and Liabilities Assumed (Details)",
     "shortName": "Information About Components of Consolidated Statements of Financial Position - Schedule of Intangible Assets and Liabilities Assumed (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "c4",
      "name": "ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c4",
      "name": "ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R67": {
     "role": "http://www.moolecscience.com/role/ScheduleofGoodwillTable",
     "longName": "996036 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Goodwill (Details)",
     "shortName": "Information About Components of Consolidated Statements of Financial Position - Schedule of Goodwill (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "c7",
      "name": "ifrs-full:Goodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c366",
      "name": "ifrs-full:Goodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfReconciliationOfChangesInGoodwillExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "unique": true
     }
    },
    "R68": {
     "role": "http://www.moolecscience.com/role/ScheduleofInvestmentPropertiesTable",
     "longName": "996037 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Investment Properties (Details)",
     "shortName": "Information About Components of Consolidated Statements of Financial Position - Schedule of Investment Properties (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "c7",
      "name": "ifrs-full:InvestmentProperty",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R69": {
     "role": "http://www.moolecscience.com/role/ScheduleofTradeandOtherPayablesTable",
     "longName": "996038 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Trade and Other Payables (Details)",
     "shortName": "Information About Components of Consolidated Statements of Financial Position - Schedule of Trade and Other Payables (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "c4",
      "name": "ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:DisclosureOfTradeAndOtherPayablesComponentsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c4",
      "name": "ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:DisclosureOfTradeAndOtherPayablesComponentsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R70": {
     "role": "http://www.moolecscience.com/role/ScheduleofBorrowingsTable",
     "longName": "996039 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Borrowings (Details)",
     "shortName": "Information About Components of Consolidated Statements of Financial Position - Schedule of Borrowings (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "c4",
      "name": "ifrs-full:CurrentPortionOfLongtermBorrowings",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c4",
      "name": "ifrs-full:CurrentPortionOfLongtermBorrowings",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R71": {
     "role": "http://www.moolecscience.com/role/ScheduleofBorrowingsCarryingAmountTable",
     "longName": "996040 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Borrowings, Carrying Amount (Details)",
     "shortName": "Information About Components of Consolidated Statements of Financial Position - Schedule of Borrowings, Carrying Amount (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "c383",
      "name": "ifrs-full:ShorttermBorrowings",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c383",
      "name": "ifrs-full:ShorttermBorrowings",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R72": {
     "role": "http://www.moolecscience.com/role/ScheduleofConvertibleNotesTable",
     "longName": "996041 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Convertible Notes (Details)",
     "shortName": "Information About Components of Consolidated Statements of Financial Position - Schedule of Convertible Notes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "c4",
      "name": "mlec:SecuredDebtNonCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c403",
      "name": "mlec:SecuredDebtNonCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDebtSecuritiesExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "unique": true
     }
    },
    "R73": {
     "role": "http://www.moolecscience.com/role/ScheduleofEmployeeBenefitsandSocialSecurityTable",
     "longName": "996042 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Employee Benefits and Social Security (Details)",
     "shortName": "Information About Components of Consolidated Statements of Financial Position - Schedule of Employee Benefits and Social Security (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "c4",
      "name": "mlec:SalariesAccruedIncentivesVacationsAndSocialSecurity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:DisclosureOfBenefitsAndSocialSecurityPayablesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c4",
      "name": "mlec:SalariesAccruedIncentivesVacationsAndSocialSecurity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:DisclosureOfBenefitsAndSocialSecurityPayablesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R74": {
     "role": "http://www.moolecscience.com/role/ScheduleofDeferredRevenueandAdvancesfromCustomersTable",
     "longName": "996043 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Deferred Revenue and Advances from Customers (Details)",
     "shortName": "Information About Components of Consolidated Statements of Financial Position - Schedule of Deferred Revenue and Advances from Customers (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "c4",
      "name": "ifrs-full:CurrentAdvances",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:DisclosuresOfDeferredRevenueAndAdvancesFromCustomersTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c4",
      "name": "ifrs-full:CurrentAdvances",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:DisclosuresOfDeferredRevenueAndAdvancesFromCustomersTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R75": {
     "role": "http://www.moolecscience.com/role/ScheduleofChangesinAllowancesandProvisionsTable",
     "longName": "996044 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Changes in Allowances and Provisions (Details)",
     "shortName": "Information About Components of Consolidated Statements of Financial Position - Schedule of Changes in Allowances and Provisions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "c7",
      "name": "ifrs-full:OtherProvisions",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:DisclosureOfChangesInAllowancesAndProvisionsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c47",
      "name": "ifrs-full:OtherProvisions",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:DisclosureOfChangesInAllowancesAndProvisionsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "unique": true
     }
    },
    "R76": {
     "role": "http://www.moolecscience.com/role/ScheduleofProvisionsTable",
     "longName": "996045 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Provisions (Details)",
     "shortName": "Information About Components of Consolidated Statements of Financial Position - Schedule of Provisions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "c4",
      "name": "ifrs-full:NoncurrentProvisions",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c430",
      "name": "ifrs-full:NoncurrentProvisions",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfProvisionsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "unique": true
     }
    },
    "R77": {
     "role": "http://www.moolecscience.com/role/ScheduleofGovernmentGrantsTable",
     "longName": "996046 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Government Grants (Details)",
     "shortName": "Information About Components of Consolidated Statements of Financial Position - Schedule of Government Grants (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "c432",
      "name": "ifrs-full:GovernmentGrants",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfGovernmentGrantsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c433",
      "name": "ifrs-full:GovernmentGrants",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfGovernmentGrantsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "unique": true
     }
    },
    "R78": {
     "role": "http://www.moolecscience.com/role/ScheduleofWarrantsTable",
     "longName": "996047 - Disclosure - Information About Components of Consolidated Statements of Financial Position - Schedule of Warrants (Details)",
     "shortName": "Information About Components of Consolidated Statements of Financial Position - Schedule of Warrants (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "mlec:AdditionsWarrantsForTheYear",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "mlec:DisclosureOfWarrantsTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "mlec:AdditionsWarrantsForTheYear",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "mlec:DisclosureOfWarrantsTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R79": {
     "role": "http://www.moolecscience.com/role/InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeDetails",
     "longName": "996048 - Disclosure - Information about Component of Consolidated Statements of Comprehensive Income (Details)",
     "shortName": "Information about Component of Consolidated Statements of Comprehensive Income (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "79",
     "firstAnchor": {
      "contextRef": "c437",
      "name": "ifrs-full:CashTransferred",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "link:footnote",
       "p",
       "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c440",
      "name": "ifrs-full:RevenueOfAcquiree",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "link:footnote",
       "p",
       "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "unique": true
     }
    },
    "R80": {
     "role": "http://www.moolecscience.com/role/ScheduleofRevenuefromContractswithCustomersTable",
     "longName": "996049 - Disclosure - Information about Component of Consolidated Statements of Comprehensive Income - Schedule of Revenue from Contracts with Customers (Details)",
     "shortName": "Information about Component of Consolidated Statements of Comprehensive Income - Schedule of Revenue from Contracts with Customers (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "80",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:RevenueFromSaleOfGoods",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory",
       "mlec:DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:RevenueFromSaleOfGoods",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory",
       "mlec:DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R81": {
     "role": "http://www.moolecscience.com/role/ScheduleofCostofSalesTable",
     "longName": "996050 - Disclosure - Information about Component of Consolidated Statements of Comprehensive Income - Schedule of Cost of Sales (Details)",
     "shortName": "Information about Component of Consolidated Statements of Comprehensive Income - Schedule of Cost of Sales (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "81",
     "firstAnchor": {
      "contextRef": "c7",
      "name": "mlec:InventoriesNetOfAgriculturalProducts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfCostOfSalesExplanatory",
       "mlec:DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c7",
      "name": "mlec:InventoriesNetOfAgriculturalProducts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfCostOfSalesExplanatory",
       "mlec:DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R82": {
     "role": "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable",
     "longName": "996051 - Disclosure - Information about Component of Consolidated Statements of Comprehensive Income - Schedule of R&D Classified by Nature (Details)",
     "shortName": "Information about Component of Consolidated Statements of Comprehensive Income - Schedule of R&D Classified by Nature (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "82",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R83": {
     "role": "http://www.moolecscience.com/role/ScheduleofExpensesClassifiedbyNatureandFunctionTable",
     "longName": "996052 - Disclosure - Information about Component of Consolidated Statements of Comprehensive Income - Schedule of Expenses Classified by Nature and Function (Details)",
     "shortName": "Information about Component of Consolidated Statements of Comprehensive Income - Schedule of Expenses Classified by Nature and Function (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "83",
     "firstAnchor": {
      "contextRef": "c441",
      "name": "ifrs-full:AdjustmentsForAmortisationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfExpensesByNatureExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c441",
      "name": "ifrs-full:AdjustmentsForAmortisationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfExpensesByNatureExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R84": {
     "role": "http://www.moolecscience.com/role/ScheduleofFinanceResultsTable",
     "longName": "996053 - Disclosure - Information about Component of Consolidated Statements of Comprehensive Income - Schedule of Finance Results (Details)",
     "shortName": "Information about Component of Consolidated Statements of Comprehensive Income - Schedule of Finance Results (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "84",
     "firstAnchor": {
      "contextRef": "c434",
      "name": "ifrs-full:InterestExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c434",
      "name": "ifrs-full:InterestExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R85": {
     "role": "http://www.moolecscience.com/role/ScheduleofOtherIncomeorExpensesNetTable",
     "longName": "996054 - Disclosure - Information about Component of Consolidated Statements of Comprehensive Income - Schedule of Other Income or Expenses, Net (Details)",
     "shortName": "Information about Component of Consolidated Statements of Comprehensive Income - Schedule of Other Income or Expenses, Net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "85",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:RevenueFromSaleOfAgriculturalProduce",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:RevenueFromSaleOfAgriculturalProduce",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R86": {
     "role": "http://www.moolecscience.com/role/TaxationDetails",
     "longName": "996055 - Disclosure - Taxation (Details)",
     "shortName": "Taxation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "86",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R87": {
     "role": "http://www.moolecscience.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable",
     "longName": "996056 - Disclosure - Taxation - Schedule of Deferred Tax Assets and Liabilities (Details)",
     "shortName": "Taxation - Schedule of Deferred Tax Assets and Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "87",
     "firstAnchor": {
      "contextRef": "c4",
      "name": "ifrs-full:NetDeferredTaxAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:ScheduleOfRollforwardOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c4",
      "name": "ifrs-full:DeferredTaxLiabilityAsset",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDeferredTaxesExplanatory",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "unique": true
     }
    },
    "R88": {
     "role": "http://www.moolecscience.com/role/ScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesTable",
     "longName": "996057 - Disclosure - Taxation - Schedule of Roll Forward of Deferred Tax Assets and Liabilities (Details)",
     "shortName": "Taxation - Schedule of Roll Forward of Deferred Tax Assets and Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "88",
     "firstAnchor": {
      "contextRef": "c7",
      "name": "ifrs-full:NetDeferredTaxAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:ScheduleOfRollforwardOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:ScheduleOfRollforwardOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "unique": true
     }
    },
    "R89": {
     "role": "http://www.moolecscience.com/role/ScheduleofWeightedAverageTaxRateTable",
     "longName": "996058 - Disclosure - Taxation - Schedule of Weighted Average Tax Rate (Details)",
     "shortName": "Taxation - Schedule of Weighted Average Tax Rate (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "89",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:ProfitLossFromDiscontinuedOperations",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:EffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:ProfitLossFromDiscontinuedOperations",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:EffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R90": {
     "role": "http://www.moolecscience.com/role/ScheduleofPrincipalStatutoryTaxesRatesandCurrentTaxTable",
     "longName": "996059 - Disclosure - Taxation - Schedule of Principal Statutory Taxes Rates and Current Tax (Details)",
     "shortName": "Taxation - Schedule of Principal Statutory Taxes Rates and Current Tax (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "90",
     "firstAnchor": {
      "contextRef": "c5",
      "name": "ifrs-full:CurrentTaxExpenseIncome",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c5",
      "name": "ifrs-full:CurrentTaxExpenseIncome",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R91": {
     "role": "http://www.moolecscience.com/role/ScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceTable",
     "longName": "996060 - Disclosure - Taxation - Schedule of Income Tax Expense Calculated by Applying Tax Rate in Force (Details)",
     "shortName": "Taxation - Schedule of Income Tax Expense Calculated by Applying Tax Rate in Force (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "91",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:AccountingProfit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:IncomeTaxExpenseByApplyingApplicableTaxRateInForceInRespectiveJurisdictionsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:AccountingProfit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:IncomeTaxExpenseByApplyingApplicableTaxRateInForceInRespectiveJurisdictionsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R92": {
     "role": "http://www.moolecscience.com/role/ScheduleofEarningPerShareTable",
     "longName": "996061 - Disclosure - Earning Per Share - Schedule of Earning Per Share (Details)",
     "shortName": "Earning Per Share - Schedule of Earning Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "92",
     "firstAnchor": {
      "contextRef": "c547",
      "name": "ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:EarningsPerShareExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c547",
      "name": "ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:EarningsPerShareExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R93": {
     "role": "http://www.moolecscience.com/role/InformationaboutComponentsofEquityDetails",
     "longName": "996062 - Disclosure - Information about Components of Equity (Details)",
     "shortName": "Information about Components of Equity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "93",
     "firstAnchor": {
      "contextRef": "c4",
      "name": "ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c550",
      "name": "mlec:VotePerShare",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "unique": true
     }
    },
    "R94": {
     "role": "http://www.moolecscience.com/role/ScheduleofNumberofSharesIssuedTable",
     "longName": "996063 - Disclosure - Information about Components of Equity - Schedule of Number of Shares Issued (Details)",
     "shortName": "Information about Components of Equity - Schedule of Number of Shares Issued (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "94",
     "firstAnchor": {
      "contextRef": "c550",
      "name": "ifrs-full:NumberOfSharesIssued",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:DisclosureOfNumberOfSharesIssuedtextBlock",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c555",
      "name": "mlec:NumberOfNominalValue",
      "unitRef": "usdPershares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:DisclosureOfNumberOfSharesIssuedtextBlock",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "unique": true
     }
    },
    "R95": {
     "role": "http://www.moolecscience.com/role/ScheduleofSubsidiariesNonControllingInterestTable",
     "longName": "996064 - Disclosure - Information about Components of Equity - Schedule of Subsidiaries Non-Controlling Interest (Details)",
     "shortName": "Information about Components of Equity - Schedule of Subsidiaries Non-Controlling Interest (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "95",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfNoncontrollingInterestsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfNoncontrollingInterestsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R96": {
     "role": "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable",
     "longName": "996065 - Disclosure - Information about Components of Equity - Schedule of Financial Statements (Details)",
     "shortName": "Information about Components of Equity - Schedule of Financial Statements (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "96",
     "firstAnchor": {
      "contextRef": "c86",
      "name": "ifrs-full:CurrentAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:ScheduleOfFinancialStatementsTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c86",
      "name": "ifrs-full:CurrentAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:ScheduleOfFinancialStatementsTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R97": {
     "role": "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable",
     "longName": "996066 - Disclosure - Information about Components of Equity - Schedule of Bioceres SA and Bioceres Crop Solutions (Details)",
     "shortName": "Information about Components of Equity - Schedule of Bioceres SA and Bioceres Crop Solutions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "97",
     "firstAnchor": {
      "contextRef": "c560",
      "name": "ifrs-full:CurrentAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c560",
      "name": "ifrs-full:CurrentAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R98": {
     "role": "http://www.moolecscience.com/role/ScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesTable",
     "longName": "996067 - Disclosure - Cash Flow Information - Schedule of Significant Non-Cash Transactions Related to Investing and Financing Activities (Details)",
     "shortName": "Cash Flow Information - Schedule of Significant Non-Cash Transactions Related to Investing and Financing Activities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "98",
     "firstAnchor": {
      "contextRef": "c564",
      "name": "mlec:NetAssetsAcquisitionByBusinessCombination",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities",
       "ifrs-full:DisclosureOfCashFlowStatementExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c564",
      "name": "mlec:NetAssetsAcquisitionByBusinessCombination",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities",
       "ifrs-full:DisclosureOfCashFlowStatementExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R99": {
     "role": "http://www.moolecscience.com/role/ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable",
     "longName": "996068 - Disclosure - Cash Flow Information - Schedule of Changes in Liabilities Arising from Financing Activities (Details)",
     "shortName": "Cash Flow Information - Schedule of Changes in Liabilities Arising from Financing Activities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "99",
     "firstAnchor": {
      "contextRef": "c7",
      "name": "ifrs-full:LiabilitiesArisingFromFinancingActivities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c65",
      "name": "ifrs-full:LiabilitiesArisingFromFinancingActivities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "unique": true
     }
    },
    "R100": {
     "role": "http://www.moolecscience.com/role/JointVenturesandAssociatesDetails",
     "longName": "996069 - Disclosure - Joint Ventures and Associates (Details)",
     "shortName": "Joint Ventures and Associates (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "100",
     "firstAnchor": {
      "contextRef": "c588",
      "name": "mlec:PercentageOfProfitForObligationToLegalReserve",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c588",
      "name": "mlec:PercentageOfProfitForObligationToLegalReserve",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R101": {
     "role": "http://www.moolecscience.com/role/ScheduleofJointVenturesAssetsTable",
     "longName": "996070 - Disclosure - Joint Ventures and Associates - Schedule of Joint Ventures Assets (Details)",
     "shortName": "Joint Ventures and Associates - Schedule of Joint Ventures Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "101",
     "firstAnchor": {
      "contextRef": "c4",
      "name": "ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "mlec:DisclosureOfInvestmentsInJointVenturesAndAffiliatesTableTextBlock",
       "ifrs-full:DisclosureOfJointVenturesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c4",
      "name": "ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "mlec:DisclosureOfInvestmentsInJointVenturesAndAffiliatesTableTextBlock",
       "ifrs-full:DisclosureOfJointVenturesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R102": {
     "role": "http://www.moolecscience.com/role/ScheduleofChangesinJointVenturesInvestmentsandAffiliatesTable",
     "longName": "996071 - Disclosure - Joint Ventures and Associates - Schedule of Changes in Joint Ventures Investments and Affiliates (Details)",
     "shortName": "Joint Ventures and Associates - Schedule of Changes in Joint Ventures Investments and Affiliates (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "102",
     "firstAnchor": {
      "contextRef": "c609",
      "name": "mlec:InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:DisclosureOfChangesInInvestmentInJointVenturesAndAffiliatesTableTextBlock",
       "ifrs-full:DisclosureOfJointVenturesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c610",
      "name": "mlec:InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:DisclosureOfChangesInInvestmentInJointVenturesAndAffiliatesTableTextBlock",
       "ifrs-full:DisclosureOfJointVenturesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "unique": true
     }
    },
    "R103": {
     "role": "http://www.moolecscience.com/role/ScheduleofShareofProfitorLossofJointVenturesandAffiliatesTable",
     "longName": "996072 - Disclosure - Joint Ventures and Associates - Schedule of Share of Profit or Loss of Joint Ventures and Affiliates (Details)",
     "shortName": "Joint Ventures and Associates - Schedule of Share of Profit or Loss of Joint Ventures and Affiliates (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "103",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R104": {
     "role": "http://www.moolecscience.com/role/ScheduleofSignificantJointVenturesTable",
     "longName": "996073 - Disclosure - Joint Ventures and Associates - Schedule of Significant Joint Ventures (Details)",
     "shortName": "Joint Ventures and Associates - Schedule of Significant Joint Ventures (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "104",
     "firstAnchor": {
      "contextRef": "c646",
      "name": "ifrs-full:CurrentAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "mlec:ScheduleOfSignificantJointVenturesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c646",
      "name": "ifrs-full:CurrentAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "mlec:ScheduleOfSignificantJointVenturesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R105": {
     "role": "http://www.moolecscience.com/role/SegmentInformationDetails",
     "longName": "996074 - Disclosure - Segment Information (Details)",
     "shortName": "Segment Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "105",
     "firstAnchor": {
      "contextRef": "c4",
      "name": "mlec:NumberOfComplementaryComponents",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c4",
      "name": "mlec:NumberOfComplementaryComponents",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R106": {
     "role": "http://www.moolecscience.com/role/ScheduleofOperatingResultsGroupsReportingSegmentsTable",
     "longName": "996075 - Disclosure - Segment Information - Schedule of Operating Results Group's Reporting Segments (Details)",
     "shortName": "Segment Information - Schedule of Operating Results Group's Reporting Segments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "106",
     "firstAnchor": {
      "contextRef": "c662",
      "name": "mlec:RevenueFromSaleOfGoodsAndRenderingOfServices",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfOperatingSegmentsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c662",
      "name": "mlec:RevenueFromSaleOfGoodsAndRenderingOfServices",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfOperatingSegmentsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R107": {
     "role": "http://www.moolecscience.com/role/ScheduleofRevenuebySimilarGroupofProductsorServicesTable",
     "longName": "996076 - Disclosure - Segment Information - Schedule of Revenue by Similar Group of Products or Services (Details)",
     "shortName": "Segment Information - Schedule of Revenue by Similar Group of Products or Services (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "107",
     "firstAnchor": {
      "contextRef": "c434",
      "name": "ifrs-full:RevenueFromContractsWithCustomers",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfProductsAndServicesExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c434",
      "name": "ifrs-full:RevenueFromContractsWithCustomers",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfProductsAndServicesExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R108": {
     "role": "http://www.moolecscience.com/role/ScheduleofGeographicalInformationTable",
     "longName": "996077 - Disclosure - Segment Information - Schedule of Geographical Information (Details)",
     "shortName": "Segment Information - Schedule of Geographical Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "108",
     "firstAnchor": {
      "contextRef": "c434",
      "name": "ifrs-full:Revenue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfGeographicalAreasExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c434",
      "name": "ifrs-full:Revenue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfGeographicalAreasExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R109": {
     "role": "http://www.moolecscience.com/role/FinancialInstrumentsRiskManagementDetails",
     "longName": "996078 - Disclosure - Financial Instruments \u2013 Risk Management (Details)",
     "shortName": "Financial Instruments \u2013 Risk Management (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "109",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "mlec:PercentageOfEstimatesThatDevaluationOrAnAppreciation",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "mlec:DisclosureOfForeignExchangeRiskSensitivityAnalysistextBlock",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "mlec:PercentageOfEstimatesThatDevaluationOrAnAppreciation",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "mlec:DisclosureOfForeignExchangeRiskSensitivityAnalysistextBlock",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R110": {
     "role": "http://www.moolecscience.com/role/ScheduleofLiquidityRiskTable",
     "longName": "996079 - Disclosure - Financial Instruments \u2013 Risk Management - Schedule of Liquidity Risk (Details)",
     "shortName": "Financial Instruments \u2013 Risk Management - Schedule of Liquidity Risk (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "110",
     "firstAnchor": {
      "contextRef": "c782",
      "name": "ifrs-full:FinancialLiabilities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:MaturityAnalysisForNonderivativeFinancialLiabilities",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c782",
      "name": "ifrs-full:FinancialLiabilities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:MaturityAnalysisForNonderivativeFinancialLiabilities",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R111": {
     "role": "http://www.moolecscience.com/role/ScheduleofCurrencyRiskTable",
     "longName": "996080 - Disclosure - Financial Instruments \u2013 Risk Management - Schedule of Currency Risk (Details)",
     "shortName": "Financial Instruments \u2013 Risk Management - Schedule of Currency Risk (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "111",
     "firstAnchor": {
      "contextRef": "c436",
      "name": "ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c436",
      "name": "ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R112": {
     "role": "http://www.moolecscience.com/role/ScheduleofOtherForiegnCurrencieswithVariablesRemainingConstantTable",
     "longName": "996081 - Disclosure - Financial Instruments \u2013 Risk Management - Schedule of Other Foriegn Currencies with Variables Remaining Constant (Details)",
     "shortName": "Financial Instruments \u2013 Risk Management - Schedule of Other Foriegn Currencies with Variables Remaining Constant (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "112",
     "firstAnchor": {
      "contextRef": "c4",
      "name": "ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R113": {
     "role": "http://www.moolecscience.com/role/ScheduleofInterestRateRiskTable",
     "longName": "996082 - Disclosure - Financial Instruments \u2013 Risk Management - Schedule of Interest Rate Risk (Details)",
     "shortName": "Financial Instruments \u2013 Risk Management - Schedule of Interest Rate Risk (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "113",
     "firstAnchor": {
      "contextRef": "c805",
      "name": "ifrs-full:CurrentFinancialLiabilities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c805",
      "name": "ifrs-full:CurrentFinancialLiabilities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R114": {
     "role": "http://www.moolecscience.com/role/ScheduleofFinancialAssetsbyCategoryTable",
     "longName": "996083 - Disclosure - Financial Instruments \u2013 Risk Management - Schedule of Financial Assets by Category (Details)",
     "shortName": "Financial Instruments \u2013 Risk Management - Schedule of Financial Assets by Category (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "114",
     "firstAnchor": {
      "contextRef": "c825",
      "name": "ifrs-full:CurrentFinancialAssetsAtAmortisedCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfFinancialAssetsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c825",
      "name": "ifrs-full:CurrentFinancialAssetsAtAmortisedCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfFinancialAssetsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R115": {
     "role": "http://www.moolecscience.com/role/ScheduleofFinancialLiabilitiesbyCategoryTable",
     "longName": "996084 - Disclosure - Financial Instruments \u2013 Risk Management - Schedule of Financial Liabilities by Category (Details)",
     "shortName": "Financial Instruments \u2013 Risk Management - Schedule of Financial Liabilities by Category (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "115",
     "firstAnchor": {
      "contextRef": "c853",
      "name": "ifrs-full:FinancialLiabilities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c853",
      "name": "ifrs-full:FinancialLiabilities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R116": {
     "role": "http://www.moolecscience.com/role/ScheduleofFairValuebyHierarchyTable",
     "longName": "996085 - Disclosure - Financial Instruments \u2013 Risk Management - Schedule of Fair Value by Hierarchy (Details)",
     "shortName": "Financial Instruments \u2013 Risk Management - Schedule of Fair Value by Hierarchy (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "116",
     "firstAnchor": {
      "contextRef": "c879",
      "name": "ifrs-full:FinancialLiabilitiesAtFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c879",
      "name": "ifrs-full:FinancialLiabilitiesAtFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R117": {
     "role": "http://www.moolecscience.com/role/ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable",
     "longName": "996086 - Disclosure - Leases - Schedule of Right-of-Use and Liabilities Related with Lease Assets (Details)",
     "shortName": "Leases - Schedule of Right-of-Use and Liabilities Related with Lease Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "117",
     "firstAnchor": {
      "contextRef": "c7",
      "name": "ifrs-full:RightofuseAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c4",
      "name": "ifrs-full:OtherPropertyPlantAndEquipment",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
       "ifrs-full:DisclosureOfLeasesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "unique": true
     }
    },
    "R118": {
     "role": "http://www.moolecscience.com/role/ScheduleofTransactionsBetweentheGroupandRelatedPartiesTable",
     "longName": "996087 - Disclosure - Shareholders and Other Related Parties Balances and Transactions - Schedule of Transactions Between the Group and Related Parties (Details)",
     "shortName": "Shareholders and Other Related Parties Balances and Transactions - Schedule of Transactions Between the Group and Related Parties (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "118",
     "firstAnchor": {
      "contextRef": "c4",
      "name": "mlec:ValueOfTransactionsForThePeriodEnded",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c4",
      "name": "mlec:ValueOfTransactionsForThePeriodEnded",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R119": {
     "role": "http://www.moolecscience.com/role/ScheduleofCompensationofKeyManagementPersonnelCompensationTable",
     "longName": "996088 - Disclosure - Key Management Personnel Compensation - Schedule of Compensation of Key Management Personnel Compensation (Details)",
     "shortName": "Key Management Personnel Compensation - Schedule of Compensation of Key Management Personnel Compensation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "119",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock",
       "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock",
       "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R120": {
     "role": "http://www.moolecscience.com/role/ShareBasedPaymentDetails",
     "longName": "996089 - Disclosure - Share-Based Payment (Details)",
     "shortName": "Share-Based Payment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "120",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "mlec:ShareBasedPaymentsIncentiveIncreases",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "mlec:ShareBasedPaymentsIncentiveIncreases",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R121": {
     "role": "http://www.moolecscience.com/role/ScheduleofFairValueoftheStockOptionsattheGrantDateTable",
     "longName": "996090 - Disclosure - Share-Based Payment - Schedule of Fair Value of the Stock Options at the Grant Date (Details)",
     "shortName": "Share-Based Payment - Schedule of Fair Value of the Stock Options at the Grant Date (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "121",
     "firstAnchor": {
      "contextRef": "c999",
      "name": "ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019",
      "unitRef": "usdPershares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:DisclosureOfFairValueOfTheStockOptionsAtTheGrantDateTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c999",
      "name": "ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019",
      "unitRef": "usdPershares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:DisclosureOfFairValueOfTheStockOptionsAtTheGrantDateTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R122": {
     "role": "http://www.moolecscience.com/role/ScheduleofRangeofAssumptionswhichhaveDeterminedTable",
     "longName": "996091 - Disclosure - Share-Based Payment - Schedule of Range of Assumptions which have Determined (Details)",
     "shortName": "Share-Based Payment - Schedule of Range of Assumptions which have Determined (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "122",
     "firstAnchor": {
      "contextRef": "c1011",
      "name": "ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c1011",
      "name": "ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R123": {
     "role": "http://www.moolecscience.com/role/ScheduleofOptionActivityandWeightedAverageExercisePriceTable",
     "longName": "996092 - Disclosure - Share-Based Payment - Schedule of Option Activity and Weighted Average Exercise Price (Details)",
     "shortName": "Share-Based Payment - Schedule of Option Activity and Weighted Average Exercise Price (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "123",
     "firstAnchor": {
      "contextRef": "c1012",
      "name": "ifrs-full:NumberOfOutstandingShareOptions",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c1013",
      "name": "ifrs-full:NumberOfOutstandingShareOptions",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "unique": true
     }
    },
    "R124": {
     "role": "http://www.moolecscience.com/role/EventsOccurringAftertheReportingPeriodDetails",
     "longName": "996093 - Disclosure - Events Occurring After the Reporting Period (Details)",
     "shortName": "Events Occurring After the Reporting Period (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "124",
     "firstAnchor": {
      "contextRef": "c1017",
      "name": "ifrs-full:Provisions",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c1017",
      "name": "ifrs-full:Provisions",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R125": {
     "role": "http://www.moolecscience.com/role/ReverseStockSplitAftertheReportingPeriodDetails",
     "longName": "996094 - Disclosure - Reverse Stock Split After the Reporting Period (Details)",
     "shortName": "Reverse Stock Split After the Reporting Period (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "125",
     "firstAnchor": {
      "contextRef": "c1025",
      "name": "mlec:ReverseStockSplit",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "mlec:DisclosureOfReverseStockSplitAfterTheReportingPeriod",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c1025",
      "name": "mlec:ReverseStockSplit",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "mlec:DisclosureOfReverseStockSplitAfterTheReportingPeriod",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    },
    "R126": {
     "role": "http://www.moolecscience.com/role/ScheduleofWeightedAverageNumberofOrdinarySharesOutstandingTable",
     "longName": "996095 - Disclosure - Reverse Stock Split After the Reporting Period - Schedule of Weighted Average Number of Ordinary Shares Outstanding (Details)",
     "shortName": "Reverse Stock Split After the Reporting Period - Schedule of Weighted Average Number of Ordinary Shares Outstanding (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "126",
     "firstAnchor": {
      "contextRef": "c1026",
      "name": "ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "mlec:DisclosureOfReverseStockSplitAfterTheReportingPeriod",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c1026",
      "name": "ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "mlec:DisclosureOfReverseStockSplitAfterTheReportingPeriod",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0270125-20f_moolec.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "mlec_AGBiomoleculesLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "AGBiomoleculesLLCMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofInformationrelatedtoCompanysShareofVotingRightsinitsSubsidiariesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AG Biomolecules LLC [Member]",
        "label": "AGBiomolecules LLCMember"
       }
      }
     },
     "auth_ref": []
    },
    "country_AR": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2025",
     "localname": "AR",
     "presentation": [
      "http://www.moolecscience.com/role/JointVenturesandAssociatesDetails",
      "http://www.moolecscience.com/role/ScheduleofGeographicalInformationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Argentina [Member]",
        "verboseLabel": "Argentina",
        "label": "ARGENTINA"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Significant Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AccountingProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AccountingProfit",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earnings before income tax-rate",
        "label": "Accounting profit"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) for a period before deducting tax expense. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r4",
      "r5",
      "r267",
      "r268"
     ]
    },
    "mlec_AccountingStandardsAndBasiofPreparationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "AccountingStandardsAndBasiofPreparationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards and Basis of Preparation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_AccountingStandardsandBasisofPreparationDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "AccountingStandardsandBasisofPreparationDetailsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards and Basis of Preparation [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_AccountingStandardsandBasisofPreparationDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "AccountingStandardsandBasisofPreparationDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards and Basis of Preparation (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_AccountingStandardsandBasisofPreparationScheduleofInformationrelatedtoCompanysShareofVotingRightsinitsSubsidiariesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "AccountingStandardsandBasisofPreparationScheduleofInformationrelatedtoCompanysShareofVotingRightsinitsSubsidiariesDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofInformationrelatedtoCompanysShareofVotingRightsinitsSubsidiariesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards and Basis of Preparation - Schedule of Information related to Company\u2019s Share of Voting Rights in its Subsidiaries (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AccumulatedDepreciationAndAmortisationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AccumulatedDepreciationAndAmortisationMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated depreciation and amortisation [member]",
        "label": "Accumulated depreciation and amortisation [member]"
       }
      }
     },
     "auth_ref": [
      "r19",
      "r621",
      "r627",
      "r630",
      "r632"
     ]
    },
    "mlec_AccumulatedDepreciationAtTheEndOfThePeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "AccumulatedDepreciationAtTheEndOfThePeriod",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated depreciation at the end of the year",
        "documentation": "Accumulated depreciation at the end of the year.",
        "label": "Accumulated Depreciation At The End Of The Period"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AcquisitiondateFairValueOfTotalConsiderationTransferred",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/AcquisitionsandOtherSignificantTransactionsDetails",
      "http://www.moolecscience.com/role/ScheduleofAssetsAcquiredandLiabilitiesAssumedTable",
      "http://www.moolecscience.com/role/ScheduleofFairValueoftheConsiderationofPaymentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total consideration",
        "terseLabel": "Total consideration",
        "verboseLabel": "Fair value of consideration",
        "label": "Consideration transferred, acquisition-date fair value"
       }
      },
      "en": {
       "role": {
        "documentation": "The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r180",
      "r332"
     ]
    },
    "ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AcquisitionsThroughBusinessCombinationsOtherProvisions",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinAllowancesandProvisionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Additions from business combination",
        "label": "Acquisitions through business combinations, other provisions"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase in other provisions resulting from acquisitions through business combinations. [Refer: Total for all business combinations [member]; Other provisions]"
       }
      }
     },
     "auth_ref": [
      "r626"
     ]
    },
    "ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable",
      "http://www.moolecscience.com/role/ScheduleofPropertyPlantandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business combination",
        "verboseLabel": "Acquisition from business combination",
        "label": "Acquisitions through business combinations, property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase in property, plant and equipment resulting from acquisitions through business combinations. [Refer: Total for all business combinations [member]; Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r13",
      "r275"
     ]
    },
    "mlec_AcquisitionsandOtherSignificantTransactionsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "AcquisitionsandOtherSignificantTransactionsDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/AcquisitionsandOtherSignificantTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquisitions and Other Significant Transactions (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAssetsAcquiredandLiabilitiesAssumedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of detailed information about business combination [line items]",
        "label": "Acquisitionsand Other Significant Transactions Scheduleof Assets Acquiredand Liabilities Assumed Details Line Items"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "AcquisitionsandOtherSignificantTransactionsScheduleofAssetsAcquiredandLiabilitiesAssumedDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAssetsAcquiredandLiabilitiesAssumedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquisitions and Other Significant Transactions - Schedule of Assets Acquired and Liabilities Assumed (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_AcquisitionsandOtherSignificantTransactionsScheduleofFairValueoftheConsiderationofPaymentDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "AcquisitionsandOtherSignificantTransactionsScheduleofFairValueoftheConsiderationofPaymentDetailsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValueoftheConsiderationofPaymentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about business combination [line items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_AcquisitionsandOtherSignificantTransactionsScheduleofFairValueoftheConsiderationofPaymentDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "AcquisitionsandOtherSignificantTransactionsScheduleofFairValueoftheConsiderationofPaymentDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValueoftheConsiderationofPaymentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquisitions and Other Significant Transactions - Schedule of Fair Value of the Consideration of Payment (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r547"
     ]
    },
    "mlec_AdditionalConvertibleNotesReceivedAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "AdditionalConvertibleNotesReceivedAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional convertible notes received (in Dollars)",
        "documentation": "Additional convertible notes received amount.",
        "label": "Additional Convertible Notes Received Amount"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_AdditionalOrdinarySharesIssue": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "AdditionalOrdinarySharesIssue",
     "presentation": [
      "http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional ordinary shares issue",
        "documentation": "Additional ordinary shares issue.",
        "label": "Additional Ordinary Shares Issue"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdditionalProvisionsOtherProvisions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdditionalProvisionsOtherProvisions",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinAllowancesandProvisionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additions",
        "label": "Additional provisions, other provisions"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of additional other provisions made. [Refer: Other provisions]"
       }
      }
     },
     "auth_ref": [
      "r67",
      "r300"
     ]
    },
    "dei_AdditionalSecurities462b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AdditionalSecurities462b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "auth_ref": [
      "r610"
     ]
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AdditionalSecurities462bFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "auth_ref": [
      "r610"
     ]
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AdditionalSecuritiesEffective413b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "auth_ref": [
      "r608"
     ]
    },
    "mlec_AdditionsFromBusinessCombination": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "AdditionsFromBusinessCombination",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofWarrantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additions from business combination",
        "documentation": "Additions from business combination.",
        "label": "Additions From Business Combination"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_AdditionsFromBusinessCombinations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "AdditionsFromBusinessCombinations",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additions from business combinations",
        "documentation": "The amount of additions from business combinations.",
        "label": "Additions From Business Combinations"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinBiologicalAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Costs incurred during the year",
        "label": "Additions other than through business combinations, biological assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of additions to biological assets, other than those acquired through business combinations. [Refer: Total for all business combinations [member]; Biological assets]"
       }
      }
     },
     "auth_ref": [
      "r631"
     ]
    },
    "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additions",
        "label": "Additions other than through business combinations, intangible assets other than goodwill"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Total for all business combinations [member]; Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r72",
      "r305"
     ]
    },
    "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofPropertyPlantandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additions",
        "label": "Additions other than through business combinations, property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Total for all business combinations [member]; Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r12",
      "r274"
     ]
    },
    "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsRightofuseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdditionsOtherThanThroughBusinessCombinationsRightofuseAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additions from business combination",
        "label": "Additions other than through business combinations, right-of-use assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of additions to right-of-use assets other than those acquired through business combinations. [Refer: Total for all business combinations [member]; Right-of-use assets]"
       }
      }
     },
     "auth_ref": [
      "r622"
     ]
    },
    "mlec_AdditionsToLeaseLiabilityFromBusinessCombination": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "AdditionsToLeaseLiabilityFromBusinessCombination",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additions from business combination",
        "documentation": "Additions from business combination.",
        "label": "Additions To Lease Liability From Business Combination"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdditionsToRightofuseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdditionsToRightofuseAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAssetsAcquiredandLiabilitiesAssumedTable",
      "http://www.moolecscience.com/role/ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right of use assets",
        "verboseLabel": "Additions of the year",
        "label": "Additions to right-of-use assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of additions to right-of-use assets. [Refer: Right-of-use assets]"
       }
      }
     },
     "auth_ref": [
      "r146",
      "r241"
     ]
    },
    "mlec_AdditionsWarrantsForTheYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "AdditionsWarrantsForTheYear",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofWarrantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additions for the year",
        "documentation": "Amount of additions of warrants for the year.",
        "label": "Additions Warrants For The Year"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r560"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "auth_ref": [
      "r560"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r560"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r560"
     ]
    },
    "ifrs-full_AdjustedWeightedAverageShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustedWeightedAverageShares",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofEarningPerShareTable",
      "http://www.moolecscience.com/role/ScheduleofWeightedAverageNumberofOrdinarySharesOutstandingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares (diluted EPS)",
        "label": "Weighted average number of ordinary shares used in calculating diluted earnings per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "ifrs-full_AdjustmentsForAmortisationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForAmortisationExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofExpensesClassifiedbyNatureandFunctionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of intangible assets",
        "label": "Adjustments for amortisation expense"
       }
      }
     },
     "auth_ref": [
      "r639"
     ]
    },
    "mlec_AdjustmentsForDecreaseIncreaseInGovernmentGrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "AdjustmentsForDecreaseIncreaseInGovernmentGrants",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Government grants",
        "documentation": "Adjustments for decrease (increase) in government grants to reconcile profit (loss) to net cash flow from (used in) operating activities.",
        "label": "Adjustments For Decrease Increase In Government Grants"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForDecreaseIncreaseInInventories",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventories and biological assets",
        "label": "Adjustments for decrease (increase) in inventories"
       }
      }
     },
     "auth_ref": [
      "r636"
     ]
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForDecreaseIncreaseInTradeAccountReceivable",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade receivables",
        "label": "Adjustments for decrease (increase) in trade accounts receivable"
       }
      }
     },
     "auth_ref": [
      "r636"
     ]
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other receivables",
        "label": "Adjustments for decrease (increase) in trade and other receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in trade and other receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other receivables; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r639"
     ]
    },
    "ifrs-full_AdjustmentsForDepreciationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForDepreciationExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation of property, plant and equipment",
        "label": "Adjustments for depreciation expense"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for depreciation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r639"
     ]
    },
    "ifrs-full_AdjustmentsForFairValueGainsLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForFairValueGainsLosses",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gain from a bargain purchase",
        "label": "Adjustments for fair value losses (gains)"
       }
      }
     },
     "auth_ref": [
      "r637"
     ]
    },
    "ifrs-full_AdjustmentsForFinanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForFinanceCosts",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial results",
        "label": "Adjustments for finance costs"
       }
      }
     },
     "auth_ref": [
      "r638"
     ]
    },
    "ifrs-full_AdjustmentsForIncomeTaxExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForIncomeTaxExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax",
        "label": "Adjustments for income tax expense"
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 21.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue and advances from customers",
        "label": "Adjustments for increase (decrease) in deferred income including contract liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for the increase (decrease) in deferred income including contract liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Deferred income including contract liabilities; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r636"
     ]
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 19.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee benefits and social security",
        "label": "Adjustments for increase (decrease) in employee benefit liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for increase (decrease) in employee benefit liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r639"
     ]
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade and other payables",
        "label": "Adjustments for increase (decrease) in trade and other payables"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for increase (decrease) in trade and other payables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other payables; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r639"
     ]
    },
    "ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofOtherIncomeorExpensesNetTable": {
       "parentTag": "ifrs-full_OtherOperatingIncomeExpense",
       "weight": -1.0,
       "order": 6.0
      },
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow",
      "http://www.moolecscience.com/role/ScheduleofOtherIncomeorExpensesNetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gain on sale of equipment and intangible assets",
        "negatedLabel": "Result of intangible assets",
        "label": "Adjustments for losses (gains) on disposal of non-current assets"
       }
      }
     },
     "auth_ref": [
      "r633"
     ]
    },
    "ifrs-full_AdjustmentsForSharebasedPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForSharebasedPayments",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based incentive and stock options",
        "label": "Adjustments for share-based payments"
       }
      }
     },
     "auth_ref": [
      "r637"
     ]
    },
    "mlec_AdjuvantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "AdjuvantsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRevenuebySimilarGroupofProductsorServicesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjuvants [Member]",
        "documentation": "This member stands for the adjuvants .",
        "label": "Adjuvants Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable": {
       "parentTag": "ifrs-full_ResearchAndDevelopmentExpense",
       "weight": 1.0,
       "order": 22.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofExpensesClassifiedbyNatureandFunctionTable",
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Office supplies",
        "label": "Administrative expenses"
       }
      }
     },
     "auth_ref": [
      "r38",
      "r419",
      "r475"
     ]
    },
    "ifrs-full_AdvertisingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdvertisingExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable": {
       "parentTag": "ifrs-full_ResearchAndDevelopmentExpense",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofExpensesClassifiedbyNatureandFunctionTable",
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Publicity and advertising",
        "label": "Advertising expense"
       }
      }
     },
     "auth_ref": [
      "r649"
     ]
    },
    "mlec_AggregateAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "AggregateAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate amount (in Dollars)",
        "documentation": "Aggregate amount.",
        "label": "Aggregate Amount"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r601"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r510",
      "r521",
      "r537",
      "r572"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r513",
      "r524",
      "r540",
      "r575"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Pension Adjustments Service Cost [Member]",
        "terseLabel": "Aggregate Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r602"
     ]
    },
    "mlec_AgralityArgentinaSAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "AgralityArgentinaSAMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofJointVenturesAssetsTable",
      "http://www.moolecscience.com/role/ScheduleofShareofProfitorLossofJointVenturesandAffiliatesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Agrality Argentina S.A. [Member]",
        "label": "Agrality Argentina SAMember"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_AgralitySAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "AgralitySAMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofSignificantJointVenturesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Agrality S.A. [Member]",
        "label": "Agrality SAMember"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_AgralitySeedsIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "AgralitySeedsIncMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofJointVenturesAssetsTable",
      "http://www.moolecscience.com/role/ScheduleofShareofProfitorLossofJointVenturesandAffiliatesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Agrality Seeds Inc. [Member]",
        "label": "Agrality Seeds Inc Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_AgralityUSIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "AgralityUSIncMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofJointVenturesAssetsTable",
      "http://www.moolecscience.com/role/ScheduleofShareofProfitorLossofJointVenturesandAffiliatesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Agrality US Inc. [Member]",
        "label": "Agrality USInc Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_AgriculturalProductsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "AgriculturalProductsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofInventoriesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Agricultural products [Member]",
        "label": "Agricultural Products Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_AlfalfaGenuityHarXstraMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "AlfalfaGenuityHarXstraMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Alfalfa Genuity Har Xstra [Member]",
        "label": "Alfalfa Genuity Har Xstra Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_AlfalfaTechnologiesSRlMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "AlfalfaTechnologiesSRlMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofJointVenturesAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Alfalfa Technologies S.R.L.",
        "documentation": "This member stands for Alfalfa Technologies S.R.L.",
        "label": "Alfalfa Technologies SRl Member"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "auth_ref": [
      "r560"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "auth_ref": [
      "r567"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "auth_ref": [
      "r514",
      "r525",
      "r541",
      "r567",
      "r576",
      "r580",
      "r588"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "auth_ref": [
      "r586"
     ]
    },
    "mlec_AllowanceForImpairmentOfTradeDebtors": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "AllowanceForImpairmentOfTradeDebtors",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allowance for impairment of trade debtors",
        "documentation": "Allowance for impairment of trade debtors.",
        "label": "Allowance For Impairment Of Trade Debtors"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_AllowanceForImpairmentOfTradeDebtorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "AllowanceForImpairmentOfTradeDebtorsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinAllowancesandProvisionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allowance for impairment of trade debtors [Member]",
        "documentation": "This member stands for allowance for impairment of trade debtors.",
        "label": "Allowance For Impairment Of Trade Debtors Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_AllowanceForObsolescenceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "AllowanceForObsolescenceMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinAllowancesandProvisionsTable",
      "http://www.moolecscience.com/role/ScheduleofInventoriesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allowance for obsolescence [Member]",
        "documentation": "This member stands for allowance for obsolescence.",
        "label": "Allowance For Obsolescence Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_AllowanceForObsolescences": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "AllowanceForObsolescences",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow",
      "http://www.moolecscience.com/role/ScheduleofExpensesClassifiedbyNatureandFunctionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allowance for obsolescence",
        "documentation": "Allowance for obsolescence.",
        "label": "Allowance For Obsolescences"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_AllowanceForReturnOfGoods": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "AllowanceForReturnOfGoods",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofTradeReceivablesTable": {
       "parentTag": "ifrs-full_TradeAndOtherCurrentReceivables",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTradeReceivablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allowance for credit notes to be issued",
        "documentation": "The amount of allowance for return of goods.",
        "label": "Allowance For Return Of Goods"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_AllowancesAndProvisionsUsedAndReversed": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "AllowancesAndProvisionsUsedAndReversed",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinAllowancesandProvisionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Uses and reversals",
        "documentation": "The amount used and reversed (i.e. incurrent and charged against the provision) for allowances and provisions.",
        "label": "Allowances And Provisions Used And Reversed"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_AllowancesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "AllowancesMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable",
      "http://www.moolecscience.com/role/ScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allowances [Member]",
        "label": "Allowances Member"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AmortisationIntangibleAssetsOtherThanGoodwill",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable": {
       "parentTag": "ifrs-full_ResearchAndDevelopmentExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of intangible assets",
        "label": "Amortisation, intangible assets other than goodwill"
       }
      }
     },
     "auth_ref": [
      "r73",
      "r306"
     ]
    },
    "mlec_AmortizationOfIntangibleAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "AmortizationOfIntangibleAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of intangible assets",
        "documentation": "Amortization of intangible assets.",
        "label": "Amortization Of Intangible Asset"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_AmortizationOfTheYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "AmortizationOfTheYear",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Amortization of the year",
        "documentation": "Amortization of the year.",
        "label": "Amortization Of The Year"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_AmortizationPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "AmortizationPayments",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization payments (in Dollars)",
        "documentation": "The amount of amortization payments.",
        "label": "Amortization Payments"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_AmountOfFinancialDebtUnderRestructuring": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "AmountOfFinancialDebtUnderRestructuring",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/EventsOccurringAftertheReportingPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial debt",
        "documentation": "Represent the amount of financial debt under restructuring.",
        "label": "Amount Of Financial Debt Under Restructuring"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_AnalysisAndStorage": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "AnalysisAndStorage",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable": {
       "parentTag": "ifrs-full_ResearchAndDevelopmentExpense",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofExpensesClassifiedbyNatureandFunctionTable",
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Analysis and storage",
        "documentation": "Amount of analysis and storage.",
        "label": "Analysis And Storage"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r517"
     ]
    },
    "ifrs-full_ApplicableTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ApplicableTaxRate",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weight average applicable tax rate",
        "label": "Applicable tax rate"
       }
      },
      "en": {
       "role": {
        "documentation": "The applicable income tax rate."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r268"
     ]
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "xbrltype": "dateOrAsapItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Approximate Date of Commencement of Proposed Sale to Public",
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings."
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ArgentinePriceIndexShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ArgentinePriceIndexShares",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Argentine price index shares",
        "documentation": "Argentine price index shares.",
        "label": "Argentine Price Index Shares"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet",
      "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable",
      "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable",
      "http://www.moolecscience.com/role/ScheduleofGeographicalInformationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "terseLabel": "Total assets",
        "label": "Assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits."
       }
      }
     },
     "auth_ref": [
      "r132",
      "r133",
      "r134",
      "r220",
      "r223",
      "r352",
      "r353",
      "r390"
     ]
    },
    "mlec_AssignmentOfReceivablesWithShareholdersAndOtherRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "AssignmentOfReceivablesWithShareholdersAndOtherRelatedParties",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesTable": {
       "parentTag": "mlec_NonCashFinancingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Assignment of receivables with shareholders and other related parties",
        "documentation": "Assignment of receivables with shareholders and other related parties.",
        "label": "Assignment Of Receivables With Shareholders And Other Related Parties"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_AtAmortizedCostMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "AtAmortizedCostMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinancialLiabilitiesbyCategoryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortized cost [Member]",
        "documentation": "This member stands for amortized cost.",
        "label": "At Amortized Cost Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AtFairValueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AtFairValueMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofBorrowingsCarryingAmountTable",
      "http://www.moolecscience.com/role/ScheduleofFinancialLiabilitiesbyCategoryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value [Member]",
        "verboseLabel": "Mandatorily measured at fair value through profit or loss [Member]",
        "label": "At fair value [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for measurement based on fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r84",
      "r117",
      "r132",
      "r314",
      "r351",
      "r352"
     ]
    },
    "ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AttributionOfExpensesByNatureToTheirFunctionAxis",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofExpensesClassifiedbyNatureandFunctionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Attribution of expenses by nature to their function [axis]"
       }
      }
     },
     "auth_ref": [
      "r647",
      "r649"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r517"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r495",
      "r498",
      "r517"
     ]
    },
    "dei_AuditorLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorLocation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r495",
      "r498",
      "r517"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r495",
      "r498",
      "r517"
     ]
    },
    "dei_AuditorOpinionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorOpinionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Opinion [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r606"
     ]
    },
    "dei_AuditorTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_AveragePaymentTermBySales": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "AveragePaymentTermBySales",
     "presentation": [
      "http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Average payment terms",
        "documentation": "Average payment terms range at consolidate level from sale of materials.",
        "label": "Average Payment Term By Sales"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r583"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r584"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]",
        "terseLabel": "Award Timing Disclosures"
       }
      }
     },
     "auth_ref": [
      "r579"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r579"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r579"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r579"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r579"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r579"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r582"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r581"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "auth_ref": [
      "r580"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r580"
     ]
    },
    "country_BR": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2025",
     "localname": "BR",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofGeographicalInformationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Brazil [Member]",
        "label": "BRAZIL"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_BacillusPHAsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "BacillusPHAsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bacillus-PHAs [Member]",
        "label": "Bacillus PHAs Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_BankBorrowingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "BankBorrowingMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofBorrowingsCarryingAmountTable",
      "http://www.moolecscience.com/role/ScheduleofBorrowingsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bank borrowings [Member]",
        "label": "Bank Borrowing Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_BasicEarningsLossPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BasicEarningsLossPerShare",
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome",
      "http://www.moolecscience.com/role/ScheduleofEarningPerShareTable",
      "http://www.moolecscience.com/role/ScheduleofWeightedAverageNumberofOrdinarySharesOutstandingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic (loss) / profit attributable to ordinary equity holders of the parent (in Dollars per share)",
        "verboseLabel": "Basic (loss)/profit attributable to ordinary equity holders of the parent",
        "label": "Basic earnings (loss) per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator)."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r52"
     ]
    },
    "mlec_BioceresCropSolutionsBIOXMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "BioceresCropSolutionsBIOXMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofInformationrelatedtoCompanysShareofVotingRightsinitsSubsidiariesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bioceres Crop Solutions (BIOX) [Member]",
        "label": "Bioceres Crop Solutions BIOXMember"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_BioceresCropSolutionsCorpMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "BioceresCropSolutionsCorpMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofCurrencyRiskTable",
      "http://www.moolecscience.com/role/ScheduleofEarningPerShareTable",
      "http://www.moolecscience.com/role/ScheduleofFinanceResultsTable",
      "http://www.moolecscience.com/role/ScheduleofGeographicalInformationTable",
      "http://www.moolecscience.com/role/ScheduleofGovernmentGrantsTable",
      "http://www.moolecscience.com/role/ScheduleofJointVenturesAssetsTable",
      "http://www.moolecscience.com/role/ScheduleofRevenuebySimilarGroupofProductsorServicesTable",
      "http://www.moolecscience.com/role/ScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesTable",
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bioceres Crop Solutions Corp. [Member]",
        "verboseLabel": "Bioceres Crops Solutions Corp [Member]",
        "label": "Bioceres Crop Solutions Corp Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_BioceresCropSolutionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "BioceresCropSolutionsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bioceres Crop Solutions [Member]",
        "label": "Bioceres Crop Solutions Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_BioceresCropsSAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "BioceresCropsSAMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofGoodwillTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bioceres Crops S.A. [Member]",
        "label": "Bioceres Crops SAMember"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_BioceresGroupLimitedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "BioceresGroupLimitedMember",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationDetails",
      "http://www.moolecscience.com/role/AcquisitionsandOtherSignificantTransactionsDetails",
      "http://www.moolecscience.com/role/ScheduleofInformationrelatedtoCompanysShareofVotingRightsinitsSubsidiariesTable",
      "http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bioceres Group Limited [Member]",
        "label": "Bioceres Group Limited Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_BioceresGroupMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "BioceresGroupMember",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bioceres Group [Member]",
        "label": "Bioceres Group Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_BioceresLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "BioceresLLCMember",
     "presentation": [
      "http://www.moolecscience.com/role/EventsOccurringAftertheReportingPeriodDetails",
      "http://www.moolecscience.com/role/ScheduleofInformationrelatedtoCompanysShareofVotingRightsinitsSubsidiariesTable",
      "http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bioceres LLC [Member]",
        "label": "Bioceres LLCMember"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_BioceresSAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "BioceresSAMember",
     "presentation": [
      "http://www.moolecscience.com/role/EventsOccurringAftertheReportingPeriodDetails",
      "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable",
      "http://www.moolecscience.com/role/ScheduleofInformationrelatedtoCompanysShareofVotingRightsinitsSubsidiariesTable",
      "http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bioceres S.A [Member]",
        "verboseLabel": "Bioceres S.A. [Member]",
        "label": "Bioceres SAMember"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_BioceresTechServicesLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "BioceresTechServicesLLCMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofInformationrelatedtoCompanysShareofVotingRightsinitsSubsidiariesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bioceres Tech Services LLC [Member]",
        "label": "Bioceres Tech Services LLCMember"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_BiologicalAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BiologicalAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinBiologicalAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning of the year",
        "periodEndLabel": "Ending of the year",
        "label": "Biological assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of living animals or plants recognised as assets."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r314",
      "r380",
      "r434"
     ]
    },
    "ifrs-full_BiologicalAssetsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BiologicalAssetsAxis",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinBiologicalAssetsTable",
      "http://www.moolecscience.com/role/ScheduleofInventoriesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Biological assets [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r631"
     ]
    },
    "mlec_BiologicalAssetsBarleyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "BiologicalAssetsBarleyMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinBiologicalAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Barley [Member]",
        "documentation": "This member stands for barley biological assets.",
        "label": "Biological Assets Barley Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_BiologicalAssetsCornMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "BiologicalAssetsCornMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinBiologicalAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Corn [Member]",
        "documentation": "This member stands for corn biological assets.",
        "label": "Biological Assets Corn Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_BiologicalAssetsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BiologicalAssetsDomain",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinBiologicalAssetsTable",
      "http://www.moolecscience.com/role/ScheduleofInventoriesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Biological assets [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for living animals or plants. It also represents the standard value for the 'Biological assets' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r631"
     ]
    },
    "mlec_BiologicalAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "BiologicalAssetsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Biological assets [Member]",
        "label": "Biological Assets Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_BiologicalAssetsSoybeanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "BiologicalAssetsSoybeanMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinBiologicalAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soybean [Member]",
        "documentation": "This member stands for soybean biological assets.",
        "label": "Biological Assets Soybean Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_BiologicalAssetsWheatMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "BiologicalAssetsWheatMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinBiologicalAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Wheat [Member]",
        "documentation": "This member stands for wheat biological assets.",
        "label": "Biological Assets Wheat Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_BioprotectionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "BioprotectionMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRevenuebySimilarGroupofProductsorServicesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bioprotection [Member]",
        "documentation": "This member stands for Bioprotection.",
        "label": "Bioprotection Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_BiostimulantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "BiostimulantsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRevenuebySimilarGroupofProductsorServicesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Biostimulants [Member]",
        "documentation": "This member stands for Biostimulants.",
        "label": "Biostimulants Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_BookValueAtTheBeginningOfThePeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "BookValueAtTheBeginningOfThePeriod",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Book value at the beginning of the year/inception",
        "documentation": "Book value at the beginning of the year.",
        "label": "Book Value At The Beginning Of The Period"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_BorrowingInterestRateInCash": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "BorrowingInterestRateInCash",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest payable in cash",
        "documentation": "The interest rate on borrowings payable in cash.",
        "label": "Borrowing Interest Rate In Cash"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_BorrowingInterestRateInKind": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "BorrowingInterestRateInKind",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest payable in kind",
        "documentation": "The interest rate on borrowings payable in kind.",
        "label": "Borrowing Interest Rate In Kind"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_BorrowingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "BorrowingMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable",
      "http://www.moolecscience.com/role/ScheduleofFinancialLiabilitiesbyCategoryTable",
      "http://www.moolecscience.com/role/ScheduleofLiquidityRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings [Member]",
        "documentation": "Represents information pertaining to borrowings.",
        "label": "Borrowing Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_Borrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "Borrowings",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails",
      "http://www.moolecscience.com/role/ScheduleofLiquidityRiskTable",
      "http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings",
        "verboseLabel": "Borrowings (in Dollars)",
        "netLabel": "Principal amount (in Dollars)",
        "label": "Borrowings"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of outstanding funds that the entity is obligated to repay."
       }
      }
     },
     "auth_ref": [
      "r651"
     ]
    },
    "ifrs-full_BorrowingsByNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BorrowingsByNameAxis",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails",
      "http://www.moolecscience.com/role/ScheduleofBorrowingsCarryingAmountTable",
      "http://www.moolecscience.com/role/ScheduleofBorrowingsTable",
      "http://www.moolecscience.com/role/ScheduleofConvertibleNotesTable",
      "http://www.moolecscience.com/role/ScheduleofInterestRateRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Borrowings by name [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r644"
     ]
    },
    "ifrs-full_BorrowingsByNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BorrowingsByNameDomain",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails",
      "http://www.moolecscience.com/role/ScheduleofBorrowingsTable",
      "http://www.moolecscience.com/role/ScheduleofConvertibleNotesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Borrowings by name [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for all borrowings when disaggregated by name. It also represents the standard value for the 'Borrowings by name' axis if no other member is used. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r644"
     ]
    },
    "ifrs-full_BorrowingsInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BorrowingsInterestRate",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest rate",
        "label": "Borrowings, interest rate"
       }
      },
      "en": {
       "role": {
        "documentation": "The interest rate on borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r644"
     ]
    },
    "ifrs-full_BorrowingsMaturity": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BorrowingsMaturity",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maturity date",
        "label": "Borrowings, maturity"
       }
      },
      "en": {
       "role": {
        "documentation": "The maturity of borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r644"
     ]
    },
    "ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BorrowingsRecognisedAsOfAcquisitionDate",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAssetsAcquiredandLiabilitiesAssumedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Borrowings",
        "label": "Borrowings recognised as of acquisition date"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for borrowings assumed in a business combination. [Refer: Borrowings; Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r643"
     ]
    },
    "ifrs-full_BottomOfRangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BottomOfRangeMember",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationDetails",
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails",
      "http://www.moolecscience.com/role/ScheduleofRangeofAssumptionswhichhaveDeterminedTable",
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails",
      "http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bottom of Range [Member]",
        "verboseLabel": "Bottom of range [member]",
        "netLabel": "Bottom of range [Member]",
        "label": "Bottom of range [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the bottom of a range."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r136",
      "r155",
      "r171",
      "r256",
      "r448",
      "r449",
      "r644"
     ]
    },
    "ifrs-full_BrandNamesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BrandNamesMember",
     "presentation": [
      "http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trademarks [Member]",
        "label": "Brand names [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets representing rights to a group of complementary assets such as a trademark (or service mark) and its related trade name, formulas, recipes and technological expertise. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r431"
     ]
    },
    "ifrs-full_BuildingsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BuildingsMember",
     "presentation": [
      "http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Buildings [Member]",
        "label": "Buildings [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of plant, property and equipment representing depreciable buildings and similar structures for use in operations. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r620"
     ]
    },
    "mlec_BusinessCombinationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "BusinessCombinationMember",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Combination [Member]",
        "label": "Business Combination Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_BusinessCombinationsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BusinessCombinationsAxis",
     "presentation": [
      "http://www.moolecscience.com/role/AcquisitionsandOtherSignificantTransactionsDetails",
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails",
      "http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business combinations [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r185",
      "r334"
     ]
    },
    "ifrs-full_BusinessCombinationsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BusinessCombinationsDomain",
     "presentation": [
      "http://www.moolecscience.com/role/AcquisitionsandOtherSignificantTransactionsDetails",
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails",
      "http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business combinations [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Business combinations' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r185",
      "r187",
      "r334"
     ]
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Contact",
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r498",
      "r517"
     ]
    },
    "ifrs-full_CapitalCommitmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CapitalCommitmentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingencies, Commitments and Restrictions on the Distribution of Profits [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_CapitalizationOfConvertibleFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "CapitalizationOfConvertibleFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesTable": {
       "parentTag": "mlec_NonCashFinancingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Capitalization of convertible notes",
        "documentation": "The cash inflow effect of capitalization of convertible notes.",
        "label": "Capitalization Of Convertible Financing Activities"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_CarryForwardOfTaxLossMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "CarryForwardOfTaxLossMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable",
      "http://www.moolecscience.com/role/ScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax Loss-Carry Forward [Member]",
        "documentation": "This member stands for carry forward of tax loses.",
        "label": "Carry Forward Of Tax Loss Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r16",
      "r71",
      "r75",
      "r79",
      "r80",
      "r81",
      "r84",
      "r86",
      "r186",
      "r201",
      "r202",
      "r273",
      "r277",
      "r304",
      "r307",
      "r310",
      "r311",
      "r312",
      "r314",
      "r316",
      "r335",
      "r344",
      "r345"
     ]
    },
    "ifrs-full_CarryingAmountMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CarryingAmountMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carrying amount [member]"
       }
      }
     },
     "auth_ref": [
      "r16",
      "r75",
      "r79",
      "r81",
      "r84",
      "r186",
      "r201",
      "r202",
      "r277",
      "r307",
      "r310",
      "r312",
      "r314",
      "r335",
      "r344",
      "r345"
     ]
    },
    "ifrs-full_Cash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "Cash",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofCashandCashEquivalentsTable": {
       "parentTag": "ifrs-full_CashAndCashEquivalents",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofCashandCashEquivalentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash at bank and on hand",
        "label": "Cash"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of cash on hand and demand deposits. [Refer: Cash on hand]"
       }
      }
     },
     "auth_ref": [
      "r640"
     ]
    },
    "ifrs-full_CashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashAndCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.moolecscience.com/role/ScheduleofCashandCashEquivalentsTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet",
      "http://www.moolecscience.com/role/ScheduleofCashandCashEquivalentsTable",
      "http://www.moolecscience.com/role/ScheduleofFinancialAssetsbyCategoryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Cash and cash equivalents",
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash and cash equivalents"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r95",
      "r125",
      "r257",
      "r383"
     ]
    },
    "ifrs-full_CashAndCashEquivalentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashAndCashEquivalentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Cash and Cash Equivalents [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash and cash equivalents as of beginning of the year",
        "periodEndLabel": "Cash and cash equivalents as of the end of the year",
        "label": "Cash and cash equivalents if different from statement of financial position"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of cash and cash equivalents in the statement of cash flows when different from the amount of cash and cash equivalents in the statement of financial position. [Refer: Cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r640"
     ]
    },
    "mlec_CashAndEquivalentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "CashAndEquivalentsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinancialAssetsbyCategoryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents [Member]",
        "documentation": "This member stands for cash and cash equivalents.",
        "label": "Cash And Equivalents Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_CashFlowInformationScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "CashFlowInformationScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow Information - Schedule of Changes in Liabilities Arising from Financing Activities (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Significant Non-Cash Transactions Related to Investing and Financing Activities [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "CashFlowInformationScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow Information - Schedule of Significant Non-Cash Transactions Related to Investing and Financing Activities (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net cash received from business combination",
        "label": "Cash flows from losing control of subsidiaries or other businesses, classified as investing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The aggregate cash flows arising from losing control of subsidiaries or other businesses, classified as investing activities. [Refer: Total for all subsidiaries [member]]"
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash flows (used in) / generated by financing activities",
        "label": "Cash flows from (used in) financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity, from continuing and discontinued operations."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r97"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow",
      "http://www.moolecscience.com/role/ScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "FINANCING ACTIVITIES",
        "verboseLabel": "Financing activities",
        "label": "Cash flows from (used in) financing activities [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash flows used in investing activities",
        "label": "Cash flows from (used in) investing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents, from continuing and discontinued operations."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r97"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow",
      "http://www.moolecscience.com/role/ScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "INVESTMENT ACTIVITIES",
        "verboseLabel": "Investment activities",
        "label": "Cash flows from (used in) investing activities [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInOperatingActivities",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash flows generated by / (used in) operating activities",
        "label": "Cash flows from (used in) operating activities"
       }
      }
     },
     "auth_ref": [
      "r87",
      "r97"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "OPERATING ACTIVITIES",
        "label": "Cash flows from (used in) operating activities [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Loss of controlling interest",
        "label": "Cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The aggregate cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities. [Refer: Total for all subsidiaries [member]]"
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "ifrs-full_CashTransferred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashTransferred",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/AcquisitionsandOtherSignificantTransactionsDetails",
      "http://www.moolecscience.com/role/InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeDetails",
      "http://www.moolecscience.com/role/ScheduleofFairValueoftheConsiderationofPaymentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash payment",
        "verboseLabel": "Transfer all rights, licenses, and materials",
        "label": "Cash transferred"
       }
      },
      "en": {
       "role": {
        "documentation": "The fair value, at acquisition date, of cash transferred as consideration in a business combination. [Refer: Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r177",
      "r329"
     ]
    },
    "ifrs-full_CategoriesOfRelatedPartiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CategoriesOfRelatedPartiesAxis",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationDetails",
      "http://www.moolecscience.com/role/AcquisitionsandOtherSignificantTransactionsDetails",
      "http://www.moolecscience.com/role/EventsOccurringAftertheReportingPeriodDetails",
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails",
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsScheduleofIntangibleAssetsandLiabilitiesAssumed",
      "http://www.moolecscience.com/role/ScheduleofChangesinJointVenturesInvestmentsandAffiliatesTable",
      "http://www.moolecscience.com/role/ScheduleofTransactionsBetweentheGroupandRelatedPartiesTable",
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails",
      "http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Categories of related parties [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r288"
     ]
    },
    "ifrs-full_CategoriesOfRelatedPartiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CategoriesOfRelatedPartiesDomain",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationDetails",
      "http://www.moolecscience.com/role/AcquisitionsandOtherSignificantTransactionsDetails",
      "http://www.moolecscience.com/role/EventsOccurringAftertheReportingPeriodDetails",
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails",
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsScheduleofIntangibleAssetsandLiabilitiesAssumed",
      "http://www.moolecscience.com/role/ScheduleofTransactionsBetweentheGroupandRelatedPartiesTable",
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails",
      "http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Categories of related parties [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Categories of related parties' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r288"
     ]
    },
    "mlec_ChangeInAllowanceAndProvisionLossOfControl": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ChangeInAllowanceAndProvisionLossOfControl",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinAllowancesandProvisionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Loss of control",
        "documentation": "Represents the amount of change in allowance and provisions of loss of control.",
        "label": "Change In Allowance And Provision Loss Of Control"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ChangeInFairValueOfFinancialAssetsOrLiabilitiesOrOtherFinancialResults": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ChangeInFairValueOfFinancialAssetsOrLiabilitiesOrOtherFinancialResults",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinanceResultsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in fair value of financial assets or liabilities and other financial results",
        "documentation": "Changes in fair value of financial assets or liabilities and other financial results.",
        "label": "Change In Fair Value Of Financial Assets Or Liabilities Or Other Financial Results"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ChangeInNetRealizableValueOfAgricultural": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ChangeInNetRealizableValueOfAgricultural",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome",
      "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in the net realizable value of agricultural products after harvest",
        "documentation": "Change in the net realizable value of agricultural products after harvest.",
        "label": "Change In Net Realizable Value Of Agricultural"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r558"
     ]
    },
    "mlec_ChangeinJointVenturesDividendsDistribution": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ChangeinJointVenturesDividendsDistribution",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinJointVenturesInvestmentsandAffiliatesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends distribution",
        "documentation": "The amount of Dividends distribution.",
        "label": "Changein Joint Ventures Dividends Distribution"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ChangesInEquityInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ChangesInEquityInterest",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinJointVenturesInvestmentsandAffiliatesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in equity interest",
        "documentation": "The amount of Changes in equity interest.",
        "label": "Changes In Equity Interest"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]",
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r555"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]",
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r553"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ClassesOfAssetsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfAssetsAxis",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOtherFinancialAssetsTable",
      "http://www.moolecscience.com/role/ScheduleofOtherReceivablesTable",
      "http://www.moolecscience.com/role/ScheduleofPropertyPlantandEquipmentTable",
      "http://www.moolecscience.com/role/ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of assets [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r57",
      "r135",
      "r148",
      "r243",
      "r291",
      "r354"
     ]
    },
    "ifrs-full_ClassesOfAssetsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfAssetsDomain",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOtherFinancialAssetsTable",
      "http://www.moolecscience.com/role/ScheduleofOtherReceivablesTable",
      "http://www.moolecscience.com/role/ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of assets [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits. It also represents the standard value for the 'Classes of assets' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r135",
      "r148",
      "r243",
      "r291",
      "r354"
     ]
    },
    "ifrs-full_ClassesOfCashPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfCashPaymentsAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile (loss) / profit to net cash flows",
        "label": "Classes of cash payments from operating activities [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ClassesOfFinancialAssetsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfFinancialAssetsAxis",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValuebyHierarchyTable",
      "http://www.moolecscience.com/role/ScheduleofFinancialAssetsbyCategoryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of financial assets [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r162",
      "r209",
      "r210",
      "r232",
      "r233",
      "r367"
     ]
    },
    "ifrs-full_ClassesOfFinancialAssetsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfFinancialAssetsDomain",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValuebyHierarchyTable",
      "http://www.moolecscience.com/role/ScheduleofFinancialAssetsbyCategoryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of financial assets [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregated classes of financial assets. It also represents the standard value for the 'Classes of financial assets' axis if no other member is used. [Refer: Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r162",
      "r209",
      "r210",
      "r232",
      "r233",
      "r367"
     ]
    },
    "ifrs-full_ClassesOfFinancialInstrumentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfFinancialInstrumentsAxis",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTransactionsBetweentheGroupandRelatedPartiesTable",
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of financial instruments [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r201",
      "r203",
      "r205",
      "r206",
      "r344",
      "r347"
     ]
    },
    "ifrs-full_ClassesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTransactionsBetweentheGroupandRelatedPartiesTable",
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of financial instruments [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregated classes of financial instruments. Financial instruments are contracts that give rise to a financial asset of one entity and a financial liability or equity instrument of another entity. It also represents the standard value for the 'Classes of financial instruments' axis if no other member is used. [Refer: Financial assets; Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r201",
      "r203",
      "r205",
      "r206",
      "r344",
      "r347"
     ]
    },
    "ifrs-full_ClassesOfFinancialLiabilitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfFinancialLiabilitiesAxis",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValuebyHierarchyTable",
      "http://www.moolecscience.com/role/ScheduleofFinancialLiabilitiesbyCategoryTable",
      "http://www.moolecscience.com/role/ScheduleofLiquidityRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of financial liabilities [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r209",
      "r210",
      "r232",
      "r233"
     ]
    },
    "ifrs-full_ClassesOfFinancialLiabilitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfFinancialLiabilitiesDomain",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValuebyHierarchyTable",
      "http://www.moolecscience.com/role/ScheduleofFinancialLiabilitiesbyCategoryTable",
      "http://www.moolecscience.com/role/ScheduleofLiquidityRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of financial liabilities [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregated classes financial liabilities. It also represents the standard value for the 'Classes of financial liabilities' axis if no other member is used. [Refer: Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r209",
      "r210",
      "r232",
      "r233"
     ]
    },
    "ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfIntangibleAssetsOtherThanGoodwillAxis",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable",
      "http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of intangible assets other than goodwill [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r308"
     ]
    },
    "ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfIntangibleAssetsOtherThanGoodwillDomain",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable",
      "http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of intangible assets other than goodwill [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Classes of intangible assets other than goodwill' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r308"
     ]
    },
    "ifrs-full_ClassesOfOrdinarySharesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfOrdinarySharesAxis",
     "presentation": [
      "http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of ordinary shares [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "ifrs-full_ClassesOfOrdinarySharesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfOrdinarySharesDomain",
     "presentation": [
      "http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of ordinary shares [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Classes of ordinary shares' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "ifrs-full_ClassesOfOtherProvisionsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfOtherProvisionsDomain",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinAllowancesandProvisionsTable",
      "http://www.moolecscience.com/role/ScheduleofProvisionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of other provisions [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for provisions other than provisions for employee benefits. It also represents the standard value for the 'Classes of other provisions' axis if no other member is used. [Refer: Provisions]"
       }
      }
     },
     "auth_ref": [
      "r68",
      "r301"
     ]
    },
    "ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfPropertyPlantAndEquipmentAxis",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofCarryingAmountsthatWouldHaveBeenRecognizedTable",
      "http://www.moolecscience.com/role/ScheduleofPropertyPlantandEquipmentTable",
      "http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of property, plant and equipment [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r278"
     ]
    },
    "ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfPropertyPlantAndEquipmentDomain",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofPropertyPlantandEquipmentTable",
      "http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of property, plant and equipment [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Classes of property, plant and equipment' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r278"
     ]
    },
    "ifrs-full_ClassesOfProvisionsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfProvisionsAxis",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinAllowancesandProvisionsTable",
      "http://www.moolecscience.com/role/ScheduleofProvisionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of other provisions [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r301"
     ]
    },
    "ifrs-full_ClassesOfShareCapitalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfShareCapitalAxis",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationDetails",
      "http://www.moolecscience.com/role/InformationaboutComponentsofEquityDetails",
      "http://www.moolecscience.com/role/ScheduleofNumberofSharesIssuedTable",
      "http://www.moolecscience.com/role/ScheduleofWeightedAverageNumberofOrdinarySharesOutstandingTable",
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of share capital [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r250",
      "r357",
      "r401"
     ]
    },
    "ifrs-full_ClassesOfShareCapitalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfShareCapitalDomain",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationDetails",
      "http://www.moolecscience.com/role/InformationaboutComponentsofEquityDetails",
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of share capital [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for share capital of the entity. It also represents the standard value for the 'Classes of share capital' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r250",
      "r357",
      "r401"
     ]
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r559"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r559"
     ]
    },
    "mlec_CommonEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "CommonEquity",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common equity (in Dollars)",
        "documentation": "The amoun of common equity.",
        "label": "Common Equity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r564"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r563"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r565"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r562"
     ]
    },
    "mlec_CompensationPaymentFinancedByAcquisitionOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "CompensationPaymentFinancedByAcquisitionOfIntangibleAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesTable": {
       "parentTag": "mlec_NonCashFinancingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Compensation payment financed by acquisition of intangible assets",
        "documentation": "Compensation payment financed by acquisition of intangible assets.",
        "label": "Compensation Payment Financed By Acquisition Of Intangible Assets"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ComponentsOfEquityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ComponentsOfEquityAxis",
     "presentation": [
      "http://www.moolecscience.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of equity [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r372"
     ]
    },
    "ifrs-full_ComponentsOfEquityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ComponentsOfEquityDomain",
     "presentation": [
      "http://www.moolecscience.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of equity [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r372"
     ]
    },
    "mlec_ComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/TaxationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Principal Statutory Taxes Rates and Current Tax",
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Components Of Income Tax Expense Benefit Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ComprehensiveIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ComprehensiveIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncomeAlt0": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome",
      "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable",
      "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total comprehensive (loss) profit",
        "terseLabel": "Total comprehensive (loss)",
        "verboseLabel": "Total comprehensive result",
        "label": "Comprehensive income"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r106",
      "r122",
      "r290",
      "r318",
      "r369",
      "r404",
      "r447"
     ]
    },
    "ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ComprehensiveIncomeAttributableToNoncontrollingInterests",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncomeAlt0": {
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-controlling interests",
        "label": "Comprehensive income, attributable to non-controlling interests"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of comprehensive income attributable to non-controlling interests. [Refer: Comprehensive income; Non-controlling interests]"
       }
      }
     },
     "auth_ref": [
      "r369",
      "r407"
     ]
    },
    "ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ComprehensiveIncomeAttributableToOwnersOfParent",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncomeAlt0": {
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity holders of the parent",
        "label": "Comprehensive income, attributable to owners of parent"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of comprehensive income attributable to owners of the parent. [Refer: Comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r369",
      "r408"
     ]
    },
    "ifrs-full_ComputerEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ComputerEquipmentMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofPropertyPlantandEquipmentTable",
      "http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equipment and computer software [Member]",
        "verboseLabel": "Computer equipment and software [Member]",
        "label": "Computer equipment [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing computer equipment. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r620"
     ]
    },
    "ifrs-full_ComputerSoftware": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ComputerSoftware",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equipment and computer software",
        "label": "Computer software"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of intangible assets representing computer software. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r432"
     ]
    },
    "ifrs-full_ComputerSoftwareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ComputerSoftwareMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable",
      "http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equipment and computer software\t[Member]",
        "verboseLabel": "Software [Member]",
        "label": "Computer software [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets representing computer software. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r432"
     ]
    },
    "mlec_ConditionalPaymentRizobacterSAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ConditionalPaymentRizobacterSAMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofProvisionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conditional payment Rizobacter SA [Member]",
        "label": "Conditional Payment Rizobacter SAMember"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ConsecutiveBusinessDays": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ConsecutiveBusinessDays",
     "presentation": [
      "http://www.moolecscience.com/role/EventsOccurringAftertheReportingPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consecutive business days",
        "documentation": "Consecutive business days.",
        "label": "Consecutive Business Days"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ConsiderationForAcquisitionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ConsiderationForAcquisitionMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValuebyHierarchyTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consideration for acquisition [Member]",
        "documentation": "This member stands for consideration for acquisition.",
        "label": "Consideration For Acquisition Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ConsiderationForAcquisitionOfAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ConsiderationForAcquisitionOfAssets",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofLiquidityRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consideration for acquisition of assets",
        "documentation": "Repersent the amount of consideration for acquisition of assets.",
        "label": "Consideration For Acquisition Of Assets"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ConsiderationForAcquisitionOfAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ConsiderationForAcquisitionOfAssetsCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consideration for acquisition",
        "documentation": "The amount of consideration for acquisition of assets recognised as of balance sheet date, classified as current.",
        "label": "Consideration For Acquisition Of Assets Current"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ConsiderationForAcquisitionOfAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ConsiderationForAcquisitionOfAssetsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinancialLiabilitiesbyCategoryTable",
      "http://www.moolecscience.com/role/ScheduleofLiquidityRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consideration for acquisition of assets [Member]",
        "label": "Consideration For Acquisition Of Assets Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ConsiderationForAcquisitionOfAssetsNonCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ConsiderationForAcquisitionOfAssetsNonCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consideration for acquisition",
        "documentation": "The amount of consideration for acquisition of assets recognised as of balance sheet date, classified as non-current.",
        "label": "Consideration For Acquisition Of Assets Non Current"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ConsiderationForIssuedOrdinaryShareValue": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ConsiderationForIssuedOrdinaryShareValue",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationDetails",
      "http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consideration for issued ordinary shares value",
        "documentation": "The number of shares in consideration for issued ordinary share value.",
        "label": "Consideration For Issued Ordinary Share Value"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ConsolidatedEntitieMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ConsolidatedEntitieMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOperatingResultsGroupsReportingSegmentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidated [Member]",
        "label": "Consolidated Entitie Member"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ConsolidatedEntitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ConsolidatedEntitiesAxis",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesTable",
      "http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ConsolidatedEntitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ConsolidatedEntitiesDomain",
     "presentation": [
      "http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ConsolidatedStatementOfChangesInShareholdersDeficitEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ConsolidatedStatementOfChangesInShareholdersDeficitEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Statement Of Changes In Shareholders Deficit Equity Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ConsolidatedStructuredEntitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ConsolidatedStructuredEntitiesAxis",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofCurrencyRiskTable",
      "http://www.moolecscience.com/role/ScheduleofFinanceResultsTable",
      "http://www.moolecscience.com/role/ScheduleofGeographicalInformationTable",
      "http://www.moolecscience.com/role/ScheduleofGovernmentGrantsTable",
      "http://www.moolecscience.com/role/ScheduleofInformationrelatedtoCompanysShareofVotingRightsinitsSubsidiariesTable",
      "http://www.moolecscience.com/role/ScheduleofRevenuebySimilarGroupofProductsorServicesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated structured entities [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ifrs-full_ConstructionInProgressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ConstructionInProgressMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofPropertyPlantandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Buildings in progress [Member]",
        "label": "Construction in progress [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for expenditure capitalised during the construction of items of property, plant and equipment that are not yet available for use (ie not yet in the location and condition necessary for it to be capable of operating in the manner intended by the management). [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r620"
     ]
    },
    "dei_ContactPersonnelEmailAddress": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContactPersonnelEmailAddress",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Email Address",
        "documentation": "Email address of contact personnel."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelFaxNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContactPersonnelFaxNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Fax Number",
        "documentation": "Fax Number of contact personnel."
       }
      }
     },
     "auth_ref": [
      "r498"
     ]
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContainedFileInformationFileDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Description",
        "documentation": "The description of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContainedFileInformationFileName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Name",
        "documentation": "The name of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContainedFileInformationFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Number",
        "documentation": "The SEC Document Number of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileType": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContainedFileInformationFileType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Type",
        "documentation": "The type or format of the contained file (usually XBRL but may be used for other types such as HTML, Word, PDF, GIF/JPG, etc.)."
       }
      }
     },
     "auth_ref": []
    },
    "mlec_Contingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "Contingencies",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofExpensesClassifiedbyNatureandFunctionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingencies",
        "documentation": "The amount of contingencies.",
        "label": "Contingencies"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ContingentPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ContingentPayment",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent payment (in Dollars)",
        "documentation": "Contingent payment.",
        "label": "Contingent Payment"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ContingentPaymentCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ContingentPaymentCurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent payment current value (in Dollars)",
        "documentation": "Contingent payment current.",
        "label": "Contingent Payment Current"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ContingentPurchasePrice": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ContingentPurchasePrice",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent purchase price (in Dollars)",
        "documentation": "Contingent purchase price.",
        "label": "Contingent Purchase Price"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ConversionOptionStrikePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ConversionOptionStrikePrice",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion option strike price (in Dollars per share)",
        "documentation": "Conversion option strike price.",
        "label": "Conversion Option Strike Price"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ConvertibleNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ConvertibleNotes",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofLiquidityRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible notes",
        "documentation": "Convertible notes.",
        "label": "Convertible Notes"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ConvertibleNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ConvertibleNotesMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofBorrowingsCarryingAmountTable",
      "http://www.moolecscience.com/role/ScheduleofConvertibleNotesTable",
      "http://www.moolecscience.com/role/ScheduleofFinancialLiabilitiesbyCategoryTable",
      "http://www.moolecscience.com/role/ScheduleofTransactionsBetweentheGroupandRelatedPartiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible notes [Member]",
        "label": "Convertible Notes Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ConvertiblePreferenceSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ConvertiblePreferenceSharesMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofBorrowingsCarryingAmountTable",
      "http://www.moolecscience.com/role/ScheduleofBorrowingsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible preference shares [Member]",
        "label": "Convertible Preference Shares Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember",
     "presentation": [
      "http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trademarks and patents [Member]",
        "label": "Copyrights, patents and other industrial property rights, service and operating rights [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets representing copyrights, patents and other industrial property rights, service and operating rights. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r433"
     ]
    },
    "mlec_CorporateBondsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "CorporateBondsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofBorrowingsCarryingAmountTable",
      "http://www.moolecscience.com/role/ScheduleofBorrowingsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Corporate bonds [Member]",
        "label": "Corporate Bonds Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CostOfSales": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CostOfSales",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofOperatingResultsGroupsReportingSegmentsTable": {
       "parentTag": "ifrs-full_GrossProfit",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0,
       "order": 6.0
      },
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome",
      "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable",
      "http://www.moolecscience.com/role/ScheduleofCostofSalesTable",
      "http://www.moolecscience.com/role/ScheduleofOperatingResultsGroupsReportingSegmentsTable",
      "http://www.moolecscience.com/role/ScheduleofSignificantJointVenturesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cost of sales",
        "terseLabel": "Cost of sales",
        "verboseLabel": "Sales",
        "negatedTerseLabel": "Cost of sales",
        "label": "Cost of sales"
       }
      }
     },
     "auth_ref": [
      "r368",
      "r419"
     ]
    },
    "ifrs-full_CostOfSalesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CostOfSalesMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofExpensesClassifiedbyNatureandFunctionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Cost of Sales [Abstract]",
        "terseLabel": "Production and services costs [Member]"
       }
      }
     },
     "auth_ref": [
      "r647",
      "r649"
     ]
    },
    "ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CountryOfIncorporationOrResidenceOfSubsidiary",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofInformationrelatedtoCompanysShareofVotingRightsinitsSubsidiariesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Country of incorporation and principal place of business",
        "label": "Country of incorporation of subsidiary"
       }
      },
      "en": {
       "role": {
        "documentation": "The country in which a subsidiary of the entity is incorporated. [Refer: Total for all subsidiaries [member]]"
       }
      }
     },
     "auth_ref": [
      "r43",
      "r47",
      "r109",
      "r114"
     ]
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "mlec_CreditorsPublicAuctionShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "CreditorsPublicAuctionShares",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Creditor public auction shares (in Shares)",
        "documentation": "Credit public auction shares.",
        "label": "Creditors Public Auction Shares"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_CriticalAccountingJudgmentsAndEstimatesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "CriticalAccountingJudgmentsAndEstimatesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Critical Accounting Judgments and Estimates [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_CropNutritionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "CropNutritionMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOperatingResultsGroupsReportingSegmentsTable",
      "http://www.moolecscience.com/role/ScheduleofRevenuebySimilarGroupofProductsorServicesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Crop Nutrition [Member]",
        "documentation": "This member stands for Crop nutrition.",
        "label": "Crop Nutrition Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_CropProtectionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "CropProtectionMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOperatingResultsGroupsReportingSegmentsTable",
      "http://www.moolecscience.com/role/ScheduleofRevenuebySimilarGroupofProductsorServicesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Crop Protection [Member]",
        "documentation": "This member stands for Crop protection.",
        "label": "Crop Protection Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_CumulativeInflationRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "CumulativeInflationRate",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cumulative inflation rate",
        "documentation": "CumulativeInflation rate.",
        "label": "Cumulative Inflation Rate"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrencyRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrencyRiskMember",
     "presentation": [
      "http://www.moolecscience.com/role/FinancialInstrumentsRiskManagementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Currency Risk",
        "label": "Currency risk [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a type of market risk representing the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rates. [Refer: Classes of financial instruments [domain]]"
       }
      }
     },
     "auth_ref": [
      "r156",
      "r157",
      "r158",
      "r159",
      "r215"
     ]
    },
    "mlec_CurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "CurrentAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOtherFinancialAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current",
        "label": "Current Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_CurrentAbstract0": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "CurrentAbstract0",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTradeReceivablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current",
        "label": "Current Abstract0"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_CurrentAbstract1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "CurrentAbstract1",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOtherReceivablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current",
        "label": "Current Abstract1"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_CurrentAbstract2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "CurrentAbstract2",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofEmployeeBenefitsandSocialSecurityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current",
        "label": "Current Abstract2"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_CurrentAbstract3": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "CurrentAbstract3",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofDeferredRevenueandAdvancesfromCustomersTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current",
        "label": "Current Abstract3"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentAdvances": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentAdvances",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofDeferredRevenueandAdvancesfromCustomersTable": {
       "parentTag": "ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofDeferredRevenueandAdvancesfromCustomersTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Advances from customers",
        "label": "Current advances received, representing current contract liabilities for performance obligations satisfied at point in time"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current advances received representing current contract liabilities for performance obligations satisfied at a point in time. [Refer: Advances received, representing contract liabilities for performance obligations satisfied at point in time]"
       }
      }
     },
     "auth_ref": [
      "r651",
      "r653"
     ]
    },
    "ifrs-full_CurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable": {
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable": {
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet",
      "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable",
      "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable",
      "http://www.moolecscience.com/role/ScheduleofSignificantJointVenturesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "terseLabel": "Current assets",
        "label": "Current assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]"
       }
      }
     },
     "auth_ref": [
      "r118",
      "r393",
      "r447"
     ]
    },
    "ifrs-full_CurrentAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentAssetsAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CURRENT ASSETS",
        "label": "Current assets [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentBiologicalAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentBiologicalAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Biological assets",
        "label": "Current biological assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current biological assets. [Refer: Biological assets]"
       }
      }
     },
     "auth_ref": [
      "r380"
     ]
    },
    "ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowingsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowingsAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofBorrowingsCarryingAmountTable",
      "http://www.moolecscience.com/role/ScheduleofBorrowingsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current",
        "label": "Current borrowings and current portion of non-current borrowings [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofDeferredRevenueandAdvancesfromCustomersTable": {
       "parentTag": "ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofDeferredRevenueandAdvancesfromCustomersTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue",
        "label": "Current contract liabilities for performance obligations satisfied over time"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current contract liabilities for performance obligations satisfied over time. [Refer: Contract liabilities for performance obligations satisfied over time]"
       }
      }
     },
     "auth_ref": [
      "r651",
      "r653"
     ]
    },
    "ifrs-full_CurrentDebtInstrumentsIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentDebtInstrumentsIssued",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails",
      "http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current debt (in Dollars)",
        "verboseLabel": "Current debt amounts (in Dollars)",
        "label": "Current debt instruments issued"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current debt instruments issued. [Refer: Debt instruments issued]"
       }
      }
     },
     "auth_ref": [
      "r651"
     ]
    },
    "ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentDeferredIncomeIncludingCurrentContractLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.moolecscience.com/role/ScheduleofDeferredRevenueandAdvancesfromCustomersTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet",
      "http://www.moolecscience.com/role/ScheduleofDeferredRevenueandAdvancesfromCustomersTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current deferred revenue and advances from customers",
        "terseLabel": "Deferred revenue and advances from customers",
        "label": "Current deferred income including current contract liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current deferred income including current contract liabilities. [Refer: Deferred income including contract liabilities]"
       }
      }
     },
     "auth_ref": [
      "r651",
      "r653"
     ]
    },
    "ifrs-full_CurrentFinancialAssetsAtAmortisedCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentFinancialAssetsAtAmortisedCost",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinancialAssetsbyCategoryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Current financial assets at amortised cost"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current financial assets measured at amortised cost. [Refer: Financial assets at amortised cost]"
       }
      }
     },
     "auth_ref": [
      "r212",
      "r337"
     ]
    },
    "ifrs-full_CurrentFinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentFinancialLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofInterestRateRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current financial liabilities",
        "label": "Current financial liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current financial liabilities. [Refer: Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r196"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentGovernmentGrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentGovernmentGrants",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Government grants",
        "label": "Current government grants"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current government grants recognised in the statement of financial position as deferred income. [Refer: Government [member]; Government grants]"
       }
      }
     },
     "auth_ref": [
      "r651"
     ]
    },
    "ifrs-full_CurrentLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentLeaseLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet",
      "http://www.moolecscience.com/role/ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liabilities",
        "verboseLabel": "Current",
        "label": "Current lease liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current lease liabilities. [Refer: Lease liabilities]"
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "ifrs-full_CurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable": {
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable": {
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet",
      "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable",
      "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable",
      "http://www.moolecscience.com/role/ScheduleofSignificantJointVenturesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "terseLabel": "Current liabilities",
        "label": "Current liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r394",
      "r447"
     ]
    },
    "ifrs-full_CurrentLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentLiabilitiesAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CURRENT LIABILITIES",
        "label": "Current liabilities [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofTradeandOtherPayablesTable": {
       "parentTag": "ifrs-full_TradeAndOtherCurrentPayables",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTradeandOtherPayablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Taxes",
        "label": "Current payables on social security and taxes other than income tax"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current payables on social security and taxes other than incomes tax. [Refer: Payables on social security and taxes other than income tax]"
       }
      }
     },
     "auth_ref": [
      "r653"
     ]
    },
    "ifrs-full_CurrentPortionOfLongtermBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentPortionOfLongtermBorrowings",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofBorrowingsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Bank borrowings",
        "label": "Current portion of non-current borrowings"
       }
      },
      "en": {
       "role": {
        "documentation": "The current portion of non-current borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r651"
     ]
    },
    "ifrs-full_CurrentProvisions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentProvisions",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAssetsAcquiredandLiabilitiesAssumedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Provisions",
        "label": "Current provisions"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current provisions, including provisions for employee benefits. [Refer: Provisions]"
       }
      }
     },
     "auth_ref": [
      "r385"
     ]
    },
    "ifrs-full_CurrentProvisionsForEmployeeBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentProvisionsForEmployeeBenefits",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.moolecscience.com/role/ScheduleofEmployeeBenefitsandSocialSecurityTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet",
      "http://www.moolecscience.com/role/ScheduleofEmployeeBenefitsandSocialSecurityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "terseLabel": "Employee benefits and social security",
        "label": "Current provisions for employee benefits"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current provisions for employee benefits. [Refer: Provisions for employee benefits]"
       }
      }
     },
     "auth_ref": [
      "r362",
      "r397"
     ]
    },
    "ifrs-full_CurrentTaxAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentTaxAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recoverable income tax",
        "label": "Current tax assets, current"
       }
      },
      "en": {
       "role": {
        "documentation": "The current amount of current tax assets. [Refer: Current tax assets]"
       }
      }
     },
     "auth_ref": [
      "r386"
     ]
    },
    "ifrs-full_CurrentTaxAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentTaxAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recoverable income tax",
        "label": "Current tax assets, non-current"
       }
      },
      "en": {
       "role": {
        "documentation": "The non-current amount of current tax assets. [Refer: Current tax assets]"
       }
      }
     },
     "auth_ref": [
      "r386"
     ]
    },
    "ifrs-full_CurrentTaxExpenseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentTaxExpenseIncome",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofPrincipalStatutoryTaxesRatesandCurrentTaxTable": {
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofExpensesClassifiedbyNatureandFunctionTable",
      "http://www.moolecscience.com/role/ScheduleofPrincipalStatutoryTaxesRatesandCurrentTaxTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Taxes",
        "negatedLabel": "Current tax expense",
        "label": "Current tax expense (income)"
       }
      }
     },
     "auth_ref": [
      "r421",
      "r469"
     ]
    },
    "ifrs-full_CurrentTaxLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentTaxLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax payable",
        "label": "Current tax liabilities, current"
       }
      },
      "en": {
       "role": {
        "documentation": "The current amount of current tax liabilities. [Refer: Current tax liabilities]"
       }
      }
     },
     "auth_ref": [
      "r386"
     ]
    },
    "ifrs-full_CurrentTradeReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentTradeReceivables",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofTradeReceivablesTable": {
       "parentTag": "ifrs-full_TradeAndOtherCurrentReceivables",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet",
      "http://www.moolecscience.com/role/ScheduleofTradeReceivablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade receivables",
        "verboseLabel": "Trade debtors",
        "label": "Current trade receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current trade receivables. [Refer: Trade receivables]"
       }
      }
     },
     "auth_ref": [
      "r472",
      "r477",
      "r479"
     ]
    },
    "mlec_CurrentTradeReceivablesAllowanceForImpairmentOfTradeDebtors": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "CurrentTradeReceivablesAllowanceForImpairmentOfTradeDebtors",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofTradeReceivablesTable": {
       "parentTag": "ifrs-full_TradeAndOtherCurrentReceivables",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTradeReceivablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allowance for impairment of trade debtors",
        "documentation": "Represents the amount of current trade receivables of allowance for impairment of trade debtors.",
        "label": "Current Trade Receivables Allowance For Impairment Of Trade Debtors"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_CurrentTradeReceivablesShareholdersAndOtherRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "CurrentTradeReceivablesShareholdersAndOtherRelatedParties",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofTradeReceivablesTable": {
       "parentTag": "ifrs-full_TradeAndOtherCurrentReceivables",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTradeReceivablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shareholders and other related parties",
        "documentation": "Represents the amount of current trade receivables of shareholders and other related parties.",
        "label": "Current Trade Receivables Shareholders And Other Related Parties"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_CurrentTradeReceivablesTradeDebtorsJointVenturesAndAssociates": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "CurrentTradeReceivablesTradeDebtorsJointVenturesAndAssociates",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofTradeReceivablesTable": {
       "parentTag": "ifrs-full_TradeAndOtherCurrentReceivables",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTradeReceivablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade debtors - Joint ventures and associates",
        "documentation": "Represents the amount of trade debtors - joint ventures and associates.",
        "label": "Current Trade Receivables Trade Debtors Joint Ventures And Associates"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentWarrantLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentWarrantLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet",
      "http://www.moolecscience.com/role/ScheduleofWarrantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "At the beginning of the year",
        "periodEndLabel": "At the end of the year",
        "terseLabel": "Warrant liabilities",
        "label": "Current warrant liability"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current warrant liabilities. [Refer: Warrant liability]"
       }
      }
     },
     "auth_ref": [
      "r651"
     ]
    },
    "mlec_CustomerLoyaltyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "CustomerLoyaltyMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer loyalty [Member]",
        "label": "Customer Loyalty Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CustomerrelatedIntangibleAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CustomerrelatedIntangibleAssetsMember",
     "presentation": [
      "http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer loyalty [Member]",
        "label": "Customer-related intangible assets [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets representing assets related to customers. Such assets may include customer lists, order or production backlog, customer contracts and related customer relationships as well as non-contractual customer relationships."
       }
      }
     },
     "auth_ref": [
      "r629"
     ]
    },
    "cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskBoardOfDirectorsOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Board of Directors Oversight [Text Block]",
        "label": "Cybersecurity Risk Board of Directors Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r504",
      "r597"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Management Positions or Committees Responsible [Flag]",
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Flag]"
       }
      }
     },
     "auth_ref": [
      "r505",
      "r598"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]",
        "label": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r501",
      "r594"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r500",
      "r593"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceLineItems",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r500",
      "r593"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceTable",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Table]"
       }
      }
     },
     "auth_ref": [
      "r500",
      "r593"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]",
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r503",
      "r596"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]",
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r503",
      "r596"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]",
        "label": "Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r506",
      "r599"
     ]
    },
    "cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]",
        "label": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]"
       }
      }
     },
     "auth_ref": [
      "r502",
      "r595"
     ]
    },
    "ifrs-full_DebtInstrumentsHeldAtAmortisedCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DebtInstrumentsHeldAtAmortisedCost",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial debt (in Dollars)",
        "label": "Debt instruments held at amortised cost"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of instruments representing indebtedness held by the entity at amortised cost. [Refer: Debt instruments held; Financial assets at amortised cost]"
       }
      }
     },
     "auth_ref": [
      "r651"
     ]
    },
    "mlec_DecreaseBecauseOfLossOfControl": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "DecreaseBecauseOfLossOfControl",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Decrease because of loss of control",
        "documentation": "Decrease because of loss of control.",
        "label": "Decrease Because Of Loss Of Control"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_DecreaseDueToHarvestAndDisposalsBiologicalAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "DecreaseDueToHarvestAndDisposalsBiologicalAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinBiologicalAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Decrease due to harvest/disposals",
        "documentation": "The decrease in biological assets due to the detachment of produce from the assets or the cessation of the assets' life processes and disposals.",
        "label": "Decrease Due To Harvest And Disposals Biological Assets"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_DecreaseThroughCapitalizationOfDebtLiabilitiesArisingFromFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "DecreaseThroughCapitalizationOfDebtLiabilitiesArisingFromFinancingActivities",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Conversion of Convertible Notes",
        "documentation": "The decrease in liabilities arising from financing activities resulting from capitalization of debt.",
        "label": "Decrease Through Capitalization Of Debt Liabilities Arising From Financing Activities"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss of control",
        "documentation": "he decrease in intangible assets resulting from the loss of control of a subsidiary.",
        "label": "Decrease Through Loss Of Control Of Subsidiary Intangible Assets"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryOtherProvisions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DecreaseThroughLossOfControlOfSubsidiaryOtherProvisions",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss of control (in Dollars)",
        "label": "Decrease through loss of control of subsidiary, other provisions"
       }
      },
      "en": {
       "role": {
        "documentation": "The decrease in other provisions resulting from the loss of control of a subsidiary. [Refer: Other provisions]"
       }
      }
     },
     "auth_ref": [
      "r626"
     ]
    },
    "ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofPropertyPlantandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Loss of control",
        "label": "Decrease through loss of control of subsidiary, property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The decrease in property, plant and equipment resulting from the loss of control of a subsidiary. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r622"
     ]
    },
    "mlec_DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments",
        "documentation": "The decrease in liabilities arising from financing activities resulting from payments.",
        "label": "Decrease Through Payments Liabilities Arising From Financing Activities"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_DeferredTaxAssetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "DeferredTaxAssetMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable",
      "http://www.moolecscience.com/role/ScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total deferred tax assets [Member]",
        "documentation": "This member standards for deferred tax assets related differences between the carrying amount of accounts in the statement of financial position and its tax base.",
        "label": "Deferred Tax Asset Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DeferredTaxAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DeferredTaxAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax assets",
        "label": "Deferred tax assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r269",
      "r387",
      "r391"
     ]
    },
    "mlec_DeferredTaxAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "DeferredTaxAssetsAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax assets",
        "label": "Deferred Tax Assets Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DeferredTaxAssetsAndLiabilitiesAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax liabilities",
        "label": "Deferred tax assets and liabilities [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DeferredTaxExpenseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DeferredTaxExpenseIncome",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofPrincipalStatutoryTaxesRatesandCurrentTaxTable": {
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofPrincipalStatutoryTaxesRatesandCurrentTaxTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Deferred tax",
        "label": "Deferred tax expense (income)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of tax expense (income) relating to changes in deferred tax liabilities and deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]"
       }
      }
     },
     "auth_ref": [
      "r7",
      "r270"
     ]
    },
    "ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DeferredTaxExpenseIncomeRecognisedInProfitOrLoss",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAssetsAcquiredandLiabilitiesAssumedTable",
      "http://www.moolecscience.com/role/ScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue and advances from customers",
        "verboseLabel": "Income tax provision",
        "label": "Deferred tax expense (income) recognised in profit or loss"
       }
      }
     },
     "auth_ref": [
      "r7",
      "r270"
     ]
    },
    "ifrs-full_DeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DeferredTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax liabilities",
        "label": "Deferred tax liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r269",
      "r387",
      "r391"
     ]
    },
    "ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAssetsAcquiredandLiabilitiesAssumedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Deferred tax liabilities",
        "label": "Deferred tax liabilities recognised as of acquisition date"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for deferred tax liabilities assumed in a business combination. [Refer: Deferred tax liabilities; Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r643"
     ]
    },
    "ifrs-full_DeferredTaxLiabilityAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DeferredTaxLiabilityAsset",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net deferred tax",
        "label": "Deferred tax liability (asset)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of deferred tax liabilities or assets. [Refer: Deferred tax liabilities; Deferred tax assets]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r269"
     ]
    },
    "mlec_DeferredTaxLiabilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "DeferredTaxLiabilityMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable",
      "http://www.moolecscience.com/role/ScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total deferred tax liabilities [Member]",
        "documentation": "This member standards for deferred tax liability related differences between the carrying amount of accounts in the statement of financial position and its tax base.",
        "label": "Deferred Tax Liability Member"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DelayedOrContinuousOffering": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DelayedOrContinuousOffering",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "auth_ref": [
      "r529",
      "r530",
      "r544"
     ]
    },
    "mlec_DenominatorAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "DenominatorAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofWeightedAverageNumberofOrdinarySharesOutstandingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Denominator",
        "label": "Denominator Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_DepreciationOfLeasedAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "DepreciationOfLeasedAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation of leased assets",
        "documentation": "The amount of depreciation of leased assets.",
        "label": "Depreciation Of Leased Assets"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_DepreciationOfThePeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "DepreciationOfThePeriod",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation of the year",
        "documentation": "Depreciation of the year.",
        "label": "Depreciation Of The Period"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DepreciationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DepreciationPropertyPlantAndEquipment",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable": {
       "parentTag": "ifrs-full_ResearchAndDevelopmentExpense",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofExpensesClassifiedbyNatureandFunctionTable",
      "http://www.moolecscience.com/role/ScheduleofPropertyPlantandEquipmentTable",
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation of property, plant and equipment",
        "negatedLabel": "Depreciation of the year",
        "label": "Depreciation, property, plant and equipment"
       }
      }
     },
     "auth_ref": [
      "r14",
      "r18",
      "r276"
     ]
    },
    "ifrs-full_DepreciationRightofuseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DepreciationRightofuseAssets",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable": {
       "parentTag": "ifrs-full_ResearchAndDevelopmentExpense",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofExpensesClassifiedbyNatureandFunctionTable",
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation of leased assets",
        "label": "Depreciation, right-of-use assets"
       }
      }
     },
     "auth_ref": [
      "r145",
      "r240"
     ]
    },
    "mlec_DerecognitionOfDeferredTaxAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "DerecognitionOfDeferredTaxAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofWeightedAverageTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derecognition of deferred tax assets",
        "documentation": "Derecognition of deferred tax assets.",
        "label": "Derecognition Of Deferred Tax Assets"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_DescriptionOfAccountingPolicyForBasisOfConsolidation": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "DescriptionOfAccountingPolicyForBasisOfConsolidation",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of consolidation",
        "documentation": "The description of accounting policy for basis of consolidation.",
        "label": "Description Of Accounting Policy For Basis Of Consolidation"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Biological assets",
        "label": "Description of accounting policy for biological assets [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for biological assets. [Refer: Biological assets]"
       }
      }
     },
     "auth_ref": [
      "r650"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForBorrowingsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForBorrowingsExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings",
        "label": "Description of accounting policy for borrowings [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r650"
     ]
    },
    "mlec_DescriptionOfAccountingPolicyForConvertibleNotesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "DescriptionOfAccountingPolicyForConvertibleNotesTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertibles notes",
        "documentation": "The description of the entity's accounting policy for convertible notes.",
        "label": "Description Of Accounting Policy For Convertible Notes Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ACCOUNTING STANDARDS AND BASIS OF PREPARATION",
        "label": "Description of accounting policy for derivative financial instruments and hedging [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for derivative financial instruments and hedging. [Refer: Classes of financial instruments [domain]; Derivatives [member]]"
       }
      }
     },
     "auth_ref": [
      "r650"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee benefits",
        "label": "Description of accounting policy for employee benefits [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for employee benefits. Employee benefits are all forms of consideration given by an entity in exchange for services rendered by employees or for the termination of employment."
       }
      }
     },
     "auth_ref": [
      "r650"
     ]
    },
    "mlec_DescriptionOfAccountingPolicyForFinancialAssetsAndLiabilitiesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "DescriptionOfAccountingPolicyForFinancialAssetsAndLiabilitiesPolicyTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial assets and liabilities",
        "documentation": "The description of the entity's material accounting policy information for financial assets and liabilities.",
        "label": "Description Of Accounting Policy For Financial Assets And Liabilities Policy Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForGovernmentGrants",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Government grants",
        "label": "Description of accounting policy for government grants [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for government grants, including the methods of presentation adopted in the financial statements. [Refer: Government [member]; Government grants]"
       }
      }
     },
     "auth_ref": [
      "r25",
      "r280"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment assessment of Goodwill and Intangible assets",
        "label": "Description of accounting policy for impairment of assets [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for the impairment of assets."
       }
      }
     },
     "auth_ref": [
      "r650"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForIncomeTaxExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax",
        "label": "Description of accounting policy for income tax [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for income tax."
       }
      }
     },
     "auth_ref": [
      "r650"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets",
        "label": "Description of accounting policy for intangible assets and goodwill [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for intangible assets and goodwill. [Refer: Intangible assets and goodwill]"
       }
      }
     },
     "auth_ref": [
      "r650"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForInvestmentPropertyExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForInvestmentPropertyExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment properties",
        "label": "Description of accounting policy for investment property [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for investment property. [Refer: Investment property]"
       }
      }
     },
     "auth_ref": [
      "r650"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForLeasesExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leased assets",
        "label": "Description of accounting policy for leases [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time."
       }
      }
     },
     "auth_ref": [
      "r650"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForMeasuringInventories",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventories",
        "label": "Description of accounting policy for measuring inventories [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for measuring inventories. [Refer: Inventories]"
       }
      }
     },
     "auth_ref": [
      "r22",
      "r252"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, plant and equipment",
        "label": "Description of accounting policy for property, plant and equipment [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r650"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForProvisionsExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Provisions",
        "label": "Description of accounting policy for provisions [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for provisions. [Refer: Provisions]"
       }
      }
     },
     "auth_ref": [
      "r650"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForRecognitionOfRevenue",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue recognition",
        "label": "Description of accounting policy for recognition of revenue [text block]"
       }
      }
     },
     "auth_ref": [
      "r650"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based payments",
        "label": "Description of accounting policy for share-based payment transactions [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Types of share-based payment arrangements [domain]]"
       }
      }
     },
     "auth_ref": [
      "r650"
     ]
    },
    "mlec_DescriptionOfAccountingPolicyForWarrantLiabilities": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "DescriptionOfAccountingPolicyForWarrantLiabilities",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant liabilities",
        "documentation": "Description of accounting policy for warrant liabilities.",
        "label": "Description Of Accounting Policy For Warrant Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Description of accounting policy for determining components of cash and cash equivalents [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy used to determine the components of cash and cash equivalents. [Refer: Cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r96",
      "r258"
     ]
    },
    "ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfDiscountRatesAppliedToCashFlowProjections",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsScheduleofIntangibleAssetsandLiabilitiesAssumed"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discount rate",
        "label": "Discount rate applied to cash flow projections"
       }
      },
      "en": {
       "role": {
        "documentation": "The discount rate applied to cash flow projections for a cash-generating unit (group of units). [Refer: Total for all cash-generating units [member]]"
       }
      }
     },
     "auth_ref": [
      "r61",
      "r64",
      "r294",
      "r297"
     ]
    },
    "ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations",
     "presentation": [
      "http://www.moolecscience.com/role/NewStandardsAmendmentsandInterpretationsIssuedbytheIASB"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS ISSUED BY THE IASB",
        "label": "Disclosure of expected impact of initial application of new standards or interpretations [text block]"
       }
      }
     },
     "auth_ref": [
      "r102",
      "r263"
     ]
    },
    "ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfExpectedVolatilityShareOptionsGranted",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValueoftheStockOptionsattheGrantDateTable",
      "http://www.moolecscience.com/role/ScheduleofRangeofAssumptionswhichhaveDeterminedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average expected volatility",
        "verboseLabel": "Estimated volatility factor",
        "label": "Expected volatility, share options granted"
       }
      },
      "en": {
       "role": {
        "documentation": "The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time."
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsScheduleofIntangibleAssetsandLiabilitiesAssumed"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Growth rate used to extrapolate future cash flow projections to terminal period",
        "label": "Growth rate used to extrapolate cash flow projections"
       }
      },
      "en": {
       "role": {
        "documentation": "The growth rate used to extrapolate cash flow projections beyond the period covered by the most recent budgets/forecasts for a cash-generating unit (group of units). [Refer: Total for all cash-generating units [member]]"
       }
      }
     },
     "auth_ref": [
      "r60",
      "r63",
      "r293",
      "r296"
     ]
    },
    "ifrs-full_DescriptionOfOptionLifeShareOptionsGranted": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfOptionLifeShareOptionsGranted",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValueoftheStockOptionsattheGrantDateTable",
      "http://www.moolecscience.com/role/ScheduleofRangeofAssumptionswhichhaveDeterminedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average expected life",
        "verboseLabel": "Expected life (years)",
        "label": "Option life, share options granted"
       }
      },
      "en": {
       "role": {
        "documentation": "The option life of share options granted."
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfRiskFreeInterestRateShareOptionsGranted",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValueoftheStockOptionsattheGrantDateTable",
      "http://www.moolecscience.com/role/ScheduleofRangeofAssumptionswhichhaveDeterminedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average risk-free interest rate",
        "verboseLabel": "Risk-free interest rate",
        "label": "Risk free interest rate, share options granted"
       }
      },
      "en": {
       "role": {
        "documentation": "The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]"
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "ifrs-full_DescriptionWhetherChangeInAccountingPolicyIsMadeInAccordanceWithTransitionalProvisionsOfInitiallyAppliedIFRS": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionWhetherChangeInAccountingPolicyIsMadeInAccordanceWithTransitionalProvisionsOfInitiallyAppliedIFRS",
     "presentation": [
      "http://www.moolecscience.com/role/NewStandardsAmendmentsandInterpretationsIssuedbytheIASBDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Description of nature",
        "label": "Description whether change in accounting policy is made in accordance with transitional provisions of initially applied IFRS"
       }
      }
     },
     "auth_ref": [
      "r100",
      "r261"
     ]
    },
    "ifrs-full_DilutedEarningsLossPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DilutedEarningsLossPerShare",
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome",
      "http://www.moolecscience.com/role/ScheduleofEarningPerShareTable",
      "http://www.moolecscience.com/role/ScheduleofWeightedAverageNumberofOrdinarySharesOutstandingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted (loss) / profit attributable to ordinary equity holders of the parent (in Dollars per share)",
        "verboseLabel": "Diluted (loss)/profit attributable to ordinary equity holders of the parent",
        "label": "Diluted earnings (loss) per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r51",
      "r52"
     ]
    },
    "ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfAccountingJudgementsAndEstimatesExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/CriticalAccountingJudgmentsandEstimates"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CRITICAL ACCOUNTING JUDGMENTS AND ESTIMATES",
        "label": "Disclosure of accounting judgements and estimates [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of judgements that management has made in the process of applying the entity's accounting policies that have the most significant effect on amounts recognised in the financial statements along with information about the assumptions that the entity makes about the future, and other major sources of estimation uncertainty at the end of the reporting period, that have a significant risk of resulting in a material adjustment to the carrying amounts of assets and liabilities within the next year. [Refer: Carrying amount [member]]"
       }
      }
     },
     "auth_ref": [
      "r646"
     ]
    },
    "mlec_DisclosureOfBenefitsAndSocialSecurityPayablesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "DisclosureOfBenefitsAndSocialSecurityPayablesTableTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Employee Benefits and Social Security",
        "documentation": "The tabular disclosure of salaries and social security payables.",
        "label": "Disclosure Of Benefits And Social Security Payables Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfBusinessCombinationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfBusinessCombinationsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquisitions and Other Significant Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfBusinessCombinationsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfBusinessCombinationsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/AcquisitionsandOtherSignificantTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of detailed information about business combination [line items]",
        "label": "Disclosure of detailed information about business combination [line items] [Standard Label]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "mlec_DisclosureOfCarryingValueOfBorrowingsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "DisclosureOfCarryingValueOfBorrowingsExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Borrowings, Carrying Amount",
        "documentation": "The disclosure of detailed information about carrying value of borrowings.",
        "label": "Disclosure Of Carrying Value Of Borrowings Explanatory"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfCashAndCashEquivalentsExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Cash and Cash Equivalents",
        "label": "Disclosure of cash and cash equivalents [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of cash and cash equivalents. [Refer: Cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r646"
     ]
    },
    "ifrs-full_DisclosureOfCashFlowStatementExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfCashFlowStatementExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/CashFlowInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CASH FLOW INFORMATION",
        "label": "Disclosure of cash flow statement [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for a statement of cash flows."
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfChangesInAccountingEstimatesLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Significant Accounting Policies [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "mlec_DisclosureOfChangesInAllowancesAndProvisionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "DisclosureOfChangesInAllowancesAndProvisionsTableTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Changes in Allowances and Provisions",
        "documentation": "The tabular disclosure of changes in allowances and provisions.",
        "label": "Disclosure Of Changes In Allowances And Provisions Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_DisclosureOfChangesInInvestmentInJointVenturesAndAffiliatesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "DisclosureOfChangesInInvestmentInJointVenturesAndAffiliatesTableTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/JointVenturesandAssociatesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Changes in Joint Ventures Investments and Affiliates",
        "documentation": "The disclosure of investments in joint ventures and affiliates.",
        "label": "Disclosure Of Changes In Investment In Joint Ventures And Affiliates Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfCommitmentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfCommitmentsExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/ContingenciesCommitmentsandRestrictionsontheDistributionofProfits"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CONTINGENCIES, COMMITMENTS AND RESTRICTIONS ON THE DISTRIBUTION OF PROFITS",
        "label": "Disclosure of commitments [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of commitments."
       }
      }
     },
     "auth_ref": [
      "r646"
     ]
    },
    "mlec_DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/KeyManagementPersonnelCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Compensation of Key Management Personnel Compensation",
        "documentation": "The tabular disclosure of compensation of directors and other members of key management personnel.",
        "label": "Disclosure Of Compensation Of Directors And Other Members Of Key Management Personnel Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/InformationaboutComponentsofEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Bioceres SA and Bioceres Crop Solutions",
        "label": "Disclosure of information about separate financial statements [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of information about separate financial statements."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r131"
     ]
    },
    "ifrs-full_DisclosureOfCostOfSalesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfCostOfSalesExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of cost of sales",
        "label": "Disclosure of cost of sales [text block]"
       }
      }
     },
     "auth_ref": [
      "r646"
     ]
    },
    "ifrs-full_DisclosureOfDebtSecuritiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfDebtSecuritiesExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Convertible Notes",
        "label": "Disclosure of debt instruments [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of debt instruments. [Refer: Debt instruments issued; Debt instruments held]"
       }
      }
     },
     "auth_ref": [
      "r646"
     ]
    },
    "ifrs-full_DisclosureOfDeferredTaxesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfDeferredTaxesExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/TaxationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities",
        "label": "Disclosure of deferred taxes [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of deferred taxes. [Refer: Deferred tax liabilities; Deferred tax assets]"
       }
      }
     },
     "auth_ref": [
      "r646"
     ]
    },
    "mlec_DisclosureOfDepreciationIfAssetsHadBeenCarriedUnderCostModelTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "DisclosureOfDepreciationIfAssetsHadBeenCarriedUnderCostModelTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Carrying Amounts that Would Have Been Recognized",
        "documentation": "The disclosure of depreciation if the assets had ben carried under the cost model.",
        "label": "Disclosure Of Depreciation If Assets Had Been Carried Under Cost Model Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfDetailedInformationAboutBiologicalAssetsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinBiologicalAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Changes in Biological Assets [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfDetailedInformationAboutBorrowingsExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Borrowings",
        "label": "Disclosure of detailed information about borrowings [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r644"
     ]
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfDetailedInformationAboutBorrowingsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofBorrowingsCarryingAmountTable",
      "http://www.moolecscience.com/role/ScheduleofBorrowingsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Borrowings [Line Items]",
        "terseLabel": "Schedule of Borrowings, Carrying Amount [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/AcquisitionsandOtherSignificantTransactionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Fair Value of the Consideration of Payment",
        "label": "Disclosure of detailed information about business combination [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about business combinations. [Refer: Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r188"
     ]
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of\u200b Intangible Assets",
        "label": "Disclosure of detailed information about intangible assets [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about intangible assets. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r76",
      "r308"
     ]
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutInvestmentPropertyExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfDetailedInformationAboutInvestmentPropertyExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Investment Properties",
        "label": "Disclosure of detailed information about investment property [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about investment property. [Refer: Investment property]"
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Property, Plant and Equipment",
        "label": "Disclosure of detailed information about property, plant and equipment [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r17",
      "r278"
     ]
    },
    "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Revenue from Contracts with Customers [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Revenue from Contracts with Customers",
        "label": "Disclosure of disaggregation of revenue from contracts with customers [text block]"
       }
      }
     },
     "auth_ref": [
      "r139",
      "r236"
     ]
    },
    "ifrs-full_DisclosureOfEarningsPerShareExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfEarningsPerShareExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/EarningPerShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EARNING PER SHARE",
        "label": "Disclosure of earnings per share [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfEntitysReportableSegmentsExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/SegmentInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEGMENT INFORMATION",
        "label": "Disclosure of entity's operating segments [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for operating segments."
       }
      }
     },
     "auth_ref": [
      "r231"
     ]
    },
    "ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfEventsAfterReportingPeriodExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/EventsOccurringAftertheReportingPeriod"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EVENTS OCCURRING AFTER THE REPORTING PERIOD",
        "label": "Disclosure of events after reporting period [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for events after the reporting period."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ifrs-full_DisclosureOfExpensesByNatureExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfExpensesByNatureExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Expenses Classified by Nature and Function",
        "label": "Disclosure of expenses by nature [text block]"
       }
      }
     },
     "auth_ref": [
      "r646"
     ]
    },
    "ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfFairValueMeasurementOfAssetsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValuebyHierarchyTable",
      "http://www.moolecscience.com/role/ScheduleofOtherFinancialAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of fair value measurement of assets [line items]",
        "terseLabel": "Schedule of Fair Value by Hierarchy [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfFairValueOfFinancialInstrumentsExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/FinancialInstrumentsRiskManagementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Fair Value by Hierarchy",
        "label": "Disclosure of fair value of financial instruments [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the fair value of financial instruments. [Refer: Classes of financial instruments [domain]; At fair value [member]]"
       }
      }
     },
     "auth_ref": [
      "r646"
     ]
    },
    "mlec_DisclosureOfFairValueOfTheStockOptionsAtTheGrantDateTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "DisclosureOfFairValueOfTheStockOptionsAtTheGrantDateTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/ShareBasedPaymentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Fair Value of the Stock Options at the Grant Date",
        "documentation": "Disclosure of fair value of the stock options at the grant date.",
        "label": "Disclosure Of Fair Value Of The Stock Options At The Grant Date Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfFinanceIncomeExpenseExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Finance Results",
        "label": "Disclosure of finance income (cost) [text block]"
       }
      }
     },
     "auth_ref": [
      "r646"
     ]
    },
    "ifrs-full_DisclosureOfFinancialAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialAssetsExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/FinancialInstrumentsRiskManagementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Financial Assets by Category",
        "label": "Disclosure of financial assets [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of financial assets. [Refer: Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r211",
      "r336"
     ]
    },
    "ifrs-full_DisclosureOfFinancialAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialAssetsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinancialAssetsbyCategoryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Financial Assets by Category [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialLiabilitiesExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/FinancialInstrumentsRiskManagementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Financial Liabilities by Category",
        "label": "Disclosure of financial liabilities [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of financial liabilities. [Refer: Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r211",
      "r336"
     ]
    },
    "ifrs-full_DisclosureOfFinancialLiabilitiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialLiabilitiesLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinancialLiabilitiesbyCategoryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Financial Liabilities by Category [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfFinancialRiskManagementExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialRiskManagementExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/FinancialInstrumentsRiskManagement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "FINANCIAL INSTRUMENTS \u2013 RISK MANAGEMENT",
        "label": "Disclosure of financial risk management [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the entity's financial risk management practices and policies."
       }
      }
     },
     "auth_ref": [
      "r646"
     ]
    },
    "mlec_DisclosureOfForeignExchangeRiskSensitivityAnalysistextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "DisclosureOfForeignExchangeRiskSensitivityAnalysistextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/FinancialInstrumentsRiskManagementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Other Foriegn Currencies with Variables Remaining Constant",
        "documentation": "Disclosure of foreign exchange risk sensitivity analysis.",
        "label": "Disclosure Of Foreign Exchange Risk Sensitivity Analysistext Block"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "The Group\u2019s Business Reorganization and General Information",
        "label": "Disclosure of general information about financial statements [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for general information about financial statements."
       }
      }
     },
     "auth_ref": [
      "r246",
      "r375"
     ]
    },
    "ifrs-full_DisclosureOfGeographicalAreasExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfGeographicalAreasExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/SegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Geographical Information",
        "label": "Disclosure of geographical areas [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of geographical information."
       }
      }
     },
     "auth_ref": [
      "r229"
     ]
    },
    "ifrs-full_DisclosureOfGovernmentGrantsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfGovernmentGrantsExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Government Grants",
        "label": "Disclosure of government grants [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for government grants."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "ifrs-full_DisclosureOfIncomeTaxExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfIncomeTaxExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/Taxation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "TAXATION",
        "label": "Disclosure of income tax [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for income taxes."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/ShareBasedPaymentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Range of Assumptions which have Determined",
        "label": "Disclosure of indirect measurement of fair value of goods or services received, share options granted during period [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of information about indirect, by reference to the fair value of the equity instruments granted, measurement of the fair value of goods or services received as consideration for the entity's share options."
       }
      }
     },
     "auth_ref": [
      "r174"
     ]
    },
    "mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/InformationaboutComponentofConsolidatedStatementsofComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "INFORMATION ABOUT COMPONENT OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
        "documentation": "The entire disclosure of information about components of consolidated statement of comprehensive income.",
        "label": "Disclosure Of Information About Components Of Consolidated Statements Of Comprehensive Income Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Information About Components of Consolidated Statements of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPosition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION",
        "documentation": "The disclosure of component of consolidated statement of financial positions.",
        "label": "Disclosure Of Information About Components Of Consolidated Statements Of Financial Position Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfInformationAboutKeyManagementPersonnelExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/KeyManagementPersonnelCompensation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "KEY MANAGEMENT PERSONNEL COMPENSATION",
        "label": "Disclosure of information about key management personnel [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of information about key management personnel. [Refer: Key management personnel of entity or parent [member]]"
       }
      }
     },
     "auth_ref": [
      "r646"
     ]
    },
    "ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/NewStandardsAmendmentsandInterpretationsIssuedbytheIASBDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Standards, Amendments and Interpretations Issued by the IASB [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "mlec_DisclosureOfIntangibleAssetsAndLiabilitiesAssumedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "DisclosureOfIntangibleAssetsAndLiabilitiesAssumedTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Intangible Assets and Liabilities Assumed",
        "documentation": "The disclosure of intangible assets and lianilities assumed.",
        "label": "Disclosure Of Intangible Assets And Liabilities Assumed Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of\u200b Intangible Assets [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfInterestsInSubsidiariesExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Information related to Company\u2019s Share of Voting Rights in its Subsidiaries",
        "label": "Disclosure of interests in subsidiaries [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of interests in subsidiaries. [Refer: Total for all subsidiaries [member]]"
       }
      }
     },
     "auth_ref": [
      "r116"
     ]
    },
    "ifrs-full_DisclosureOfInventoriesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfInventoriesExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Inventories",
        "label": "Disclosure of inventories [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for inventories."
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "mlec_DisclosureOfInvestmentsInJointVenturesAndAffiliatesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "DisclosureOfInvestmentsInJointVenturesAndAffiliatesTableTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/JointVenturesandAssociatesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Joint Ventures Assets",
        "documentation": "Information pertains to disclosure of investments in associates and joint ventures.",
        "label": "Disclosure Of Investments In Joint Ventures And Affiliates Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfJointVenturesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfJointVenturesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Joint Ventures and Associates [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfJointVenturesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfJointVenturesExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/JointVenturesandAssociates"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "JOINT VENTURES AND ASSOCIATES",
        "label": "Disclosure of joint ventures [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of joint ventures. [Refer: Total for all joint ventures [member]]"
       }
      }
     },
     "auth_ref": [
      "r45",
      "r49",
      "r129",
      "r350"
     ]
    },
    "ifrs-full_DisclosureOfJointVenturesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfJointVenturesLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/JointVenturesandAssociatesDetails",
      "http://www.moolecscience.com/role/ScheduleofShareofProfitorLossofJointVenturesandAffiliatesTable",
      "http://www.moolecscience.com/role/ScheduleofSignificantJointVenturesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Joint Ventures Assets [Line Items]",
        "terseLabel": "Schedule of Significant Joint Ventures [Line Items]",
        "verboseLabel": "Joint Ventures and Associates [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfJointVenturesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfJointVenturesTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofShareofProfitorLossofJointVenturesandAffiliatesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of joint ventures [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to joint ventures."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r49",
      "r129",
      "r350"
     ]
    },
    "ifrs-full_DisclosureOfLeasesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfLeasesExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LEASES",
        "label": "Disclosure of leases [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for leases."
       }
      }
     },
     "auth_ref": [
      "r151",
      "r152"
     ]
    },
    "ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfMaterialAccountingPolicyInformationExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
        "label": "Disclosure of material accounting policy information [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure of material accounting policy information applied by the entity."
       }
      }
     },
     "auth_ref": [
      "r259",
      "r360",
      "r374"
     ]
    },
    "ifrs-full_DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfMaturityAnalysisForFinancialAssetsHeldForManagingLiquidityRiskLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofLiquidityRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Liquidity Risk [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/FinancialInstrumentsRiskManagementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Interest Rate Risk",
        "label": "Disclosure of nature and extent of risks arising from financial instruments [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of information that enables users of financial statements to evaluate the nature and extent of risks arising from financial instruments to which the entity is exposed. [Refer: Classes of financial instruments [domain]]"
       }
      }
     },
     "auth_ref": [
      "r197"
     ]
    },
    "ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofInterestRateRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Interest Rate Risk [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Events Occurring After the Reporting Period [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfNoncontrollingInterestsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfNoncontrollingInterestsExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/InformationaboutComponentsofEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Subsidiaries Non-Controlling Interest",
        "label": "Disclosure of non-controlling interests [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of non-controlling interests. [Refer: Non-controlling interests]"
       }
      }
     },
     "auth_ref": [
      "r646"
     ]
    },
    "ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/ShareBasedPaymentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Option Activity and Weighted Average Exercise Price",
        "label": "Disclosure of number and weighted average exercise prices of other equity instruments [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the number and weighted average exercise prices of other equity instruments (ie other than share options)."
       }
      }
     },
     "auth_ref": [
      "r642"
     ]
    },
    "ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/ReverseStockSplitAftertheReportingPeriodTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Weighted Average Number of Ordinary Shares Outstanding",
        "label": "Disclosure of number and weighted average exercise prices of share options [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r170",
      "r325"
     ]
    },
    "ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOptionActivityandWeightedAverageExercisePriceTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Option Activity and Weighted Average Exercise Price [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "mlec_DisclosureOfNumberOfSharesIssuedtextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "DisclosureOfNumberOfSharesIssuedtextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/InformationaboutComponentsofEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Number of Shares Issued",
        "documentation": "The Disclosure of number of shares issued.",
        "label": "Disclosure Of Number Of Shares Issuedtext Block"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfOperatingSegmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfOperatingSegmentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfOperatingSegmentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfOperatingSegmentsExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/SegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Operating Results Group's Reporting Segments",
        "label": "Disclosure of operating segments [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of operating segments. [Refer: Operating segments [member]]"
       }
      }
     },
     "auth_ref": [
      "r220"
     ]
    },
    "ifrs-full_DisclosureOfOperatingSegmentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfOperatingSegmentsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOperatingResultsGroupsReportingSegmentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Reporting Segments [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "mlec_DisclosureOfOtherFinancialAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "DisclosureOfOtherFinancialAssetsExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Other Financial Assets",
        "documentation": "The disclosure of other financial assets.",
        "label": "Disclosure Of Other Financial Assets Explanatory"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfOtherOperatingIncomeExpenseExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Other Income or Expenses, Net",
        "label": "Disclosure of other operating income (expense) [text block]"
       }
      }
     },
     "auth_ref": [
      "r646"
     ]
    },
    "mlec_DisclosureOfOtherReceivablesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "DisclosureOfOtherReceivablesTableTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Other Receivables",
        "documentation": "The disclosure of detailed information about other receivables.",
        "label": "Disclosure Of Other Receivables Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfProductsAndServicesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfProductsAndServicesExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/SegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Revenue by Similar Group of Products or Services",
        "label": "Disclosure of products and services [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the entity's products and services. [Refer: Products and services [domain]]"
       }
      }
     },
     "auth_ref": [
      "r227"
     ]
    },
    "ifrs-full_DisclosureOfProductsAndServicesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfProductsAndServicesLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRevenuebySimilarGroupofProductsorServicesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Revenue by Similar Group of Products or Services [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfPropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofCarryingAmountsthatWouldHaveBeenRecognizedTable",
      "http://www.moolecscience.com/role/ScheduleofPropertyPlantandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Property, Plant and Equipment [Line Items]",
        "terseLabel": "Schedule of Carrying Amounts that Would Have Been Recognized [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofCarryingAmountsthatWouldHaveBeenRecognizedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about property, plant and equipment [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of property, plant and equipment."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r278"
     ]
    },
    "ifrs-full_DisclosureOfProvisionsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfProvisionsExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Provisions",
        "label": "Disclosure of provisions [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of provisions. [Refer: Provisions]"
       }
      }
     },
     "auth_ref": [
      "r646"
     ]
    },
    "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Right-of-Use and Liabilities Related with Lease Assets",
        "label": "Disclosure of quantitative information about right-of-use assets [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of quantitative information about right-of-use assets. [Refer: Right-of-use assets]"
       }
      }
     },
     "auth_ref": [
      "r148",
      "r243"
     ]
    },
    "ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRangeofAssumptionswhichhaveDeterminedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Range of Assumptions which have Determined [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Changes in Biological Assets",
        "label": "Disclosure of reconciliation of changes in biological assets [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the reconciliation of changes in biological assets. [Refer: Biological assets]"
       }
      }
     },
     "auth_ref": [
      "r84",
      "r314"
     ]
    },
    "ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfReconciliationOfChangesInGoodwillExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Goodwill",
        "label": "Disclosure of reconciliation of changes in goodwill [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the reconciliation of changes in goodwill. [Refer: Goodwill]"
       }
      }
     },
     "auth_ref": [
      "r186",
      "r335"
     ]
    },
    "ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfReconciliationOfChangesInGoodwillLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofGoodwillTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Goodwill [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/CashFlowInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Changes in Liabilities Arising from Financing Activities",
        "label": "Disclosure of reconciliation of liabilities arising from financing activities [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the reconciliation of liabilities arising from financing activities. [Refer: Liabilities arising from financing activities]"
       }
      }
     },
     "auth_ref": [
      "r255",
      "r445"
     ]
    },
    "ifrs-full_DisclosureOfRelatedPartyExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfRelatedPartyExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/ShareholdersandOtherRelatedPartiesBalancesandTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS",
        "label": "Disclosure of related party [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for related parties."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfResearchAndDevelopmentExpenseExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of R&amp;D Classified by Nature",
        "label": "Disclosure of research and development expense [text block]"
       }
      }
     },
     "auth_ref": [
      "r646"
     ]
    },
    "mlec_DisclosureOfReverseStockSplitAfterTheReportingPeriod": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "DisclosureOfReverseStockSplitAfterTheReportingPeriod",
     "presentation": [
      "http://www.moolecscience.com/role/ReverseStockSplitAftertheReportingPeriod"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "REVERSE STOCK SPLIT AFTER THE REPORTING PERIOD",
        "label": "Disclosure Of Reverse Stock Split After The Reporting Period"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_DisclosureOfReverseStockSplitAfterTheReportingPeriodAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "DisclosureOfReverseStockSplitAfterTheReportingPeriodAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Reverse Stock Split After the Reporting Period [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of risk management strategy related to hedge accounting [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/FinancialInstrumentsRiskManagementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "FINANCIAL INSTRUMENTS - RISK MANAGEMENT"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable",
     "presentation": [
      "http://www.moolecscience.com/role/FinancialInstrumentsRiskManagementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of risk management strategy related to hedge accounting [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the risk management strategy in relation to hedge accounting."
       }
      }
     },
     "auth_ref": [
      "r192",
      "r339",
      "r364"
     ]
    },
    "ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/InformationaboutComponentsofEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "INFORMATION ABOUT COMPONENTS OF EQUITY",
        "label": "Disclosure of share capital, reserves and other equity interest [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for share capital, reserves and other equity interest."
       }
      }
     },
     "auth_ref": [
      "r251",
      "r358",
      "r402"
     ]
    },
    "mlec_DisclosureOfShareOfProfitOrLossInJointVenturesAndAffiliatesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "DisclosureOfShareOfProfitOrLossInJointVenturesAndAffiliatesTableTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/JointVenturesandAssociatesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share of Profit or Loss of Joint Ventures and Affiliates",
        "documentation": "The disclosure of share of profit / (loss) joint ventures and affiliates.",
        "label": "Disclosure Of Share Of Profit Or Loss In Joint Ventures And Affiliates Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfSharebasedPaymentArrangementsExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/ShareBasedPayment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SHARE-BASED PAYMENT",
        "label": "Disclosure of share-based payment arrangements [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangements."
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofInformationrelatedtoCompanysShareofVotingRightsinitsSubsidiariesTable",
      "http://www.moolecscience.com/role/ScheduleofSubsidiariesNonControllingInterestTable",
      "http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Information related to Company\u2019s Share of Voting Rights in its Subsidiaries [Line Items]",
        "terseLabel": "Summarized financial information [Line Items]",
        "verboseLabel": "The Group\u2019s Business Reorganization and General Information [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxation [LIne Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValueoftheStockOptionsattheGrantDateTable",
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Fair Value of the Stock Options at the Grant Date [Line Items]",
        "terseLabel": "Share-Based Payment [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "mlec_DisclosureOfTradeAndOtherPayablesComponentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "DisclosureOfTradeAndOtherPayablesComponentsTableTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Trade and Other Payables",
        "documentation": "Definition: Tabular disclosure of components of trade and other payables.",
        "label": "Disclosure Of Trade And Other Payables Components Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_DisclosureOfTradeReceivablesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "DisclosureOfTradeReceivablesTableTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Trade Receivables",
        "documentation": "The tabular disclosure of current and non-current trade receivables.",
        "label": "Disclosure Of Trade Receivables Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfTransactionsBetweenRelatedPartiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders and Other Related Parties Balances and Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfTransactionsBetweenRelatedPartiesExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/ShareholdersandOtherRelatedPartiesBalancesandTransactionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Transactions Between the Group and Related Parties",
        "label": "Disclosure of transactions between related parties [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of transactions between the entity and its related parties. [Refer: Total for all related parties [member]]"
       }
      }
     },
     "auth_ref": [
      "r32",
      "r284"
     ]
    },
    "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfTransactionsBetweenRelatedPartiesLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTransactionsBetweentheGroupandRelatedPartiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Transactions Between the Group and Related Parties [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/AcquisitionsandOtherSignificantTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ACQUISITIONS AND OTHER SIGNIFICANT TRANSACTIONS",
        "label": "Disclosure of transactions recognised separately from acquisition of assets and assumption of liabilities in business combination [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of transactions recognised separately from acquisition of assets and assumption of liabilities in a business combination. [Refer: Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r181"
     ]
    },
    "mlec_DisclosureOfWarrantsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "DisclosureOfWarrantsTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Warrants",
        "documentation": "The entire disclosure of warrants.",
        "label": "Disclosure Of Warrants Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_DisclosuresOfDeferredRevenueAndAdvancesFromCustomersTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "DisclosuresOfDeferredRevenueAndAdvancesFromCustomersTableTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Deferred Revenue and Advances from Customers",
        "documentation": "The tabular disclosure of deferred revenue and advances from customers.",
        "label": "Disclosures Of Deferred Revenue And Advances From Customers Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_DiscountRateForFairValueOfLiabilityComponent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "DiscountRateForFairValueOfLiabilityComponent",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discount rate for fair value of the liability component",
        "documentation": "The discount rate used to measure the fair value of the liability component of an instrument.",
        "label": "Discount Rate For Fair Value Of Liability Component"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_DisposalsDepreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "DisposalsDepreciation",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposals",
        "documentation": "Disposals.",
        "label": "Disposals Depreciation"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_DisposalsPropertyPlantAndEquipments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "DisposalsPropertyPlantAndEquipments",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofPropertyPlantandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Disposals",
        "documentation": "The decrease in property, plant and equipment resulting from disposals. [Refer: Property, plant and equipment]",
        "label": "Disposals Property Plant And Equipments"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisposalsRightofuseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisposalsRightofuseAssets",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Disposals",
        "label": "Disposals, right-of-use assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The decrease in right-of-use assets resulting from disposals. [Refer: Right-of-use assets]"
       }
      }
     },
     "auth_ref": [
      "r622"
     ]
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "auth_ref": [
      "r529",
      "r530",
      "r544"
     ]
    },
    "ifrs-full_DividendsPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DividendsPaid",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Distribution of dividends",
        "label": "Dividends recognised as distributions to owners"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of dividends recognised as distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r247",
      "r359",
      "r373"
     ]
    },
    "ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cash dividend distributed by non-controlling interest",
        "label": "Dividends paid to non-controlling interests, classified as financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for dividends paid to non-controlling interests, classified as financing activities. [Refer: Non-controlling interests; Dividends paid to non-controlling interests]"
       }
      }
     },
     "auth_ref": [
      "r635"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r498"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r495",
      "r498",
      "r517"
     ]
    },
    "dei_DocumentCopyrightInformation": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentCopyrightInformation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Copyright Information",
        "documentation": "The copyright information for the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentCreationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentCreationDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Creation Date",
        "documentation": "The date the document was made available and submitted, in YYYY-MM-DD format. The date of submission, date of acceptance by the recipient, and the document effective date are all potentially different."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Description",
        "documentation": "The description of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document [Domain]",
        "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentEffectiveDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentEffectiveDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Effective Date",
        "documentation": "The date when a document, upon receipt and acceptance, becomes officially effective, in YYYY-MM-DD format. Usually it is a system-assigned date time value, but it may be declared by the submitter in some cases."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r495",
      "r498",
      "r517",
      "r568"
     ]
    },
    "dei_DocumentFinStmtRestatementRecoveryAnalysisFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFinStmtRestatementRecoveryAnalysisFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Restatement Recovery Analysis [Flag]",
        "documentation": "Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to \u00a7240.10D-1(b)."
       }
      }
     },
     "auth_ref": [
      "r495",
      "r498",
      "r517",
      "r568"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationDocumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationDocumentAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information, Document [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Text Block]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Name",
        "documentation": "Name of the document as assigned by the filer, corresponding to SEC document naming convention standards. Examples appear in the &lt;FILENAME> field of EDGAR filings, such as 'htm_25911.htm', 'exhibit1.htm', 'v105727_8k.txt'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r496"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r484"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r498"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r498"
     ]
    },
    "dei_DocumentSubtitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentSubtitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Subtitle",
        "documentation": "The subtitle given to the document resource by the creator or publisher. An example is 'A New Period of Growth'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentSynopsis": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentSynopsis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Synopsis",
        "documentation": "A synopsis or description of the document provided by the creator or publisher. Examples are 'This is the 2006 annual report for Company. During this period we saw revenue grow by 10% and earnings per share grow by 15% over the prior period'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Title",
        "documentation": "The name or title given to the document resource by the creator or publisher. An example is '2002 Annual Report'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r545"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentVersion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentVersion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Version",
        "documentation": "The version identifier of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r487"
     ]
    },
    "mlec_DueToJointVenturesAndAssociatesNonCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "DueToJointVenturesAndAssociatesNonCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofJointVenturesAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities",
        "documentation": "The non-current amount due to joint ventures and associates.",
        "label": "Due To Joint Ventures And Associates Non Current"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]",
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year"
       }
      }
     },
     "auth_ref": [
      "r557"
     ]
    },
    "mlec_EBITDAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "EBITDAMember",
     "presentation": [
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EBITDA [Member]",
        "label": "EBITDAMember"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_EarningPerShareScheduleofEarningPerShareDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "EarningPerShareScheduleofEarningPerShareDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofEarningPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earning Per Share - Schedule of Earning Per Share (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "EarningsPerShareAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome",
      "http://www.moolecscience.com/role/ScheduleofEarningPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earning Per Share [Abstract]",
        "terseLabel": "(Loss) /Profit per share",
        "verboseLabel": "Numerator"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EarningsPerShareExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "EarningsPerShareExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/EarningPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Earning Per Share",
        "label": "Earnings per share [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of earnings per share."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "ifrs-full_EarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "EarningsPerShareLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofEarningPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Earning Per Share [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "EffectOfExchangeRateChangesOnCashAndCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of exchange rate changes on cash and equivalents",
        "label": "Effect of exchange rate changes on cash and cash equivalents"
       }
      },
      "en": {
       "role": {
        "documentation": "The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r88",
      "r89"
     ]
    },
    "dei_EffectiveAfter60Days486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveAfter60Days486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r614"
     ]
    },
    "mlec_EffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "EffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/TaxationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Weighted Average Tax Rate",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EffectiveOnDate486a": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveOnDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r614"
     ]
    },
    "dei_EffectiveOnDate486b": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveOnDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r615"
     ]
    },
    "dei_EffectiveOnSetDate486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveOnSetDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r614"
     ]
    },
    "dei_EffectiveOnSetDate486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveOnSetDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r615"
     ]
    },
    "dei_EffectiveUponFiling462e": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveUponFiling462e",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "auth_ref": [
      "r613"
     ]
    },
    "dei_EffectiveUponFiling486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveUponFiling486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r615"
     ]
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveWhenDeclaredSection8c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "auth_ref": [
      "r617"
     ]
    },
    "mlec_EmergingSolutionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "EmergingSolutionsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOperatingResultsGroupsReportingSegmentsTable",
      "http://www.moolecscience.com/role/ScheduleofRevenuebySimilarGroupofProductsorServicesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Emerging Solutions [Member]",
        "label": "Emerging Solutions Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_EmployeeStockOptionPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "EmployeeStockOptionPlanMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValueoftheStockOptionsattheGrantDateTable",
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Stock Option Plan [Member]",
        "verboseLabel": "Employee Stock Option Plan [member]",
        "documentation": "This member stands for employee stock option plan.",
        "label": "Employee Stock Option Plan Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_EmployeeStockPurchasePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "EmployeeStockPurchasePlanMember",
     "presentation": [
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Stock Purchase Plan [member]",
        "documentation": "n/a",
        "label": "Employee Stock Purchase Plan Member"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitiesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entities [Table]",
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAccountingStandard": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Accounting Standard",
        "documentation": "The standardized abbreviation of the accounting standard used by the entity. This can either be US GAAP as promulgated by the FASB or IFRS as promulgated by the IASB. Example: 'US GAAP', 'IFRS'. This is distinct from the Document Accounting Standard element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Description",
        "documentation": "Description of the kind of address for the entity, if needed to distinguish more finely among mailing, principal, legal, accounting, contact or other addresses."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressesLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Table]",
        "documentation": "Container of address information for the entity"
       }
      }
     },
     "auth_ref": [
      "r486"
     ]
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r490"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r486"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityContactPersonnelLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityContactPersonnelLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Contact Personnel [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r486"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r616"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r486"
     ]
    },
    "dei_EntityHomeCountryISOCode": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityHomeCountryISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Home Country ISO Code",
        "documentation": "ISO 3166-1 alpha-2 country code for the Entity's home country. If home country is different from country of legal incorporation, then also provide country of legal incorporation in the 'Entity Incorporation, State Country Code' element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationDateOfIncorporation": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationDateOfIncorporation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, Date of Incorporation",
        "documentation": "Date when an entity was incorporated"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information, Former Legal or Registered Name",
        "documentation": "Former Legal or Registered Name of an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r605"
     ]
    },
    "dei_EntityInvCompanyType": {
     "xbrltype": "invCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInvCompanyType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Inv Company Type",
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)."
       }
      }
     },
     "auth_ref": [
      "r604"
     ]
    },
    "dei_EntityLegalForm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityLegalForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Legal Form",
        "documentation": "The details of the entity's legal form. Examples are partnership, limited liability company, trust, etc."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDepositoryReceiptRatio": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingDepositoryReceiptRatio",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Depository Receipt Ratio",
        "documentation": "The number of underlying shares represented by one American Depository Receipt (ADR) or Global Depository Receipt (GDR). A value of '3' means that one ADR represents 3 underlying shares. If one underlying share represents 2 ADR's then the value would be represented as '0.5'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Description",
        "documentation": "Description of the kind of listing the entity has on the exchange, if necessary to further describe different instruments that are already distinguished by Entity, Exchange and Security."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingForeign": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingForeign",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Foreign",
        "documentation": "Yes or No value indicating whether this is a listing that is a foreign listing or depository receipt."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingParValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingParValuePerShare",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Par Value Per Share",
        "documentation": "The par value per share of security quoted in same currency as Trading currency. Example: '0.01'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingPrimary": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingPrimary",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Primary",
        "documentation": "Yes or No value indicating whether a listing of an instrument on an exchange is primary for the entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingSecurityTradingCurrency": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingSecurityTradingCurrency",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Security Trading Currency",
        "documentation": "The three character ISO 4217 code for the currency in which the security is quoted. Example: 'USD'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsExchangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingsExchangeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings, Exchange [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingsLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingsTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Table]",
        "documentation": "Container for exchange listing information for an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityNumberOfEmployees": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityNumberOfEmployees",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Number of Employees",
        "documentation": "Number of persons employed by the Entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPhoneFaxNumbersLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPhoneFaxNumbersLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Phone Fax Numbers [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r517"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r486"
     ]
    },
    "dei_EntityReportingCurrencyISOCode": {
     "xbrltype": "currencyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityReportingCurrencyISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Reporting Currency ISO Code",
        "documentation": "The three character ISO 4217 code for the currency used for reporting purposes. Example: 'USD'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r486"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r486"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r486"
     ]
    },
    "dei_EntityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Text Block]",
        "documentation": "Container to serve as parent of six Entity related Table concepts."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r607"
     ]
    },
    "mlec_EnvironmentalImpactTreatment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "EnvironmentalImpactTreatment",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofExpensesClassifiedbyNatureandFunctionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Environmental Impact Treatment",
        "documentation": "Environmental Impact Treatment.",
        "label": "Environmental Impact Treatment"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote [Text Block]",
        "terseLabel": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r551"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]",
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r600"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments [Member]",
        "terseLabel": "Equity Awards Adjustments"
       }
      }
     },
     "auth_ref": [
      "r600"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r600"
     ]
    },
    "ifrs-full_Equity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "Equity",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable": {
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable": {
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet",
      "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable",
      "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable",
      "http://www.moolecscience.com/role/ScheduleofSignificantJointVenturesTable",
      "http://www.moolecscience.com/role/ShareholdersEquityType2or3",
      "http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance",
        "periodEndLabel": "Balance",
        "totalLabel": "Total equity",
        "terseLabel": "Total shareholders\u2019 deficit / Equity",
        "verboseLabel": "Equity",
        "netLabel": "Shareholders' deficit (in Dollars)",
        "label": "Equity"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r105",
      "r132",
      "r133",
      "r134",
      "r289",
      "r317",
      "r352",
      "r353",
      "r363",
      "r390",
      "r398"
     ]
    },
    "ifrs-full_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "EquityAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SHAREHOLDERS\u2019 DEFICIT / EQUITY",
        "label": "Equity [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EquityAndLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "EquityAndLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet",
      "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable",
      "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total shareholders\u2019 deficit / equity and liabilities",
        "terseLabel": "Total liabilities and equity",
        "label": "Equity and liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]"
       }
      }
     },
     "auth_ref": [
      "r390"
     ]
    },
    "ifrs-full_EquityAttributableToOwnersOfParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "EquityAttributableToOwnersOfParent",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Shareholders\u2019 deficit / Equity attributable to owners of the parent",
        "label": "Equity attributable to owners of parent"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of equity attributable to the owners of the parent. This specifically excludes non-controlling interest."
       }
      }
     },
     "auth_ref": [
      "r389"
     ]
    },
    "ifrs-full_EquityAttributableToOwnersOfParentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "EquityAttributableToOwnersOfParentMember",
     "presentation": [
      "http://www.moolecscience.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Attributable to the equity holders of the parent",
        "label": "Equity attributable to owners of parent [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for equity attributable to the owners of the parent."
       }
      }
     },
     "auth_ref": [
      "r372"
     ]
    },
    "ifrs-full_EquityInterestsOfAcquirer": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "EquityInterestsOfAcquirer",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValueoftheConsiderationofPaymentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Regulatory activities",
        "label": "Equity interests of acquirer"
       }
      },
      "en": {
       "role": {
        "documentation": "The fair value, at the acquisition date, of equity interests of the acquirer transferred as consideration in a business combination. [Refer: Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r179",
      "r331"
     ]
    },
    "mlec_EquityMethodInvestmentIncreaseFromShareBasedIncentives": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "EquityMethodInvestmentIncreaseFromShareBasedIncentives",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinJointVenturesInvestmentsandAffiliatesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based incentives",
        "documentation": "The increase in the amount of investment accounted under equity method related to share-based incentives.",
        "label": "Equity Method Investment Increase From Share Based Incentives"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_EquityShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "EquityShares",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValueoftheConsiderationofPaymentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity shares",
        "documentation": "Equity shares.",
        "label": "Equity Shares"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r561"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r510",
      "r521",
      "r537",
      "r572"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "auth_ref": [
      "r507",
      "r518",
      "r534",
      "r569"
     ]
    },
    "ifrs-full_EstimatedFinancialEffectOfContingentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "EstimatedFinancialEffectOfContingentAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated value (in Dollars)",
        "label": "Estimated financial effect of contingent assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of the estimated financial effect of possible assets that arise from past events and whose existence will be confirmed only by the occurrence or non-occurrence of one or more uncertain future events not wholly within control of the entity."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r302"
     ]
    },
    "mlec_EuropeMiddleEastAndAfricaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "EuropeMiddleEastAndAfricaMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofGeographicalInformationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EMEA [Member]",
        "documentation": "This member stands for regions of Europe, Middle East and Africa.",
        "label": "Europe Middle East And Africa Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_EventsOccurringAftertheReportingPeriodDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "EventsOccurringAftertheReportingPeriodDetailsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/EventsOccurringAftertheReportingPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Events Occurring After the Reporting Period [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_EventsOccurringAftertheReportingPeriodDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "EventsOccurringAftertheReportingPeriodDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/EventsOccurringAftertheReportingPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Events Occurring After the Reporting Period (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ExchangeDifferencesDepreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ExchangeDifferencesDepreciation",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exchange differences",
        "documentation": "Exchange differences.",
        "label": "Exchange Differences Depreciation"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ExchangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ExchangeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange [Domain]",
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383."
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ExchangeOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ExchangeOfIntangibleAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesTable": {
       "parentTag": "mlec_NonCashInvestingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exchange of intangible assets",
        "documentation": "The amount of exchange of intangible assets.",
        "label": "Exchange Of Intangible Assets"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "auth_ref": [
      "r567"
     ]
    },
    "ifrs-full_ExercisePriceShareOptionsGranted2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ExercisePriceShareOptionsGranted2019",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValueoftheStockOptionsattheGrantDateTable",
      "http://www.moolecscience.com/role/ScheduleofRangeofAssumptionswhichhaveDeterminedTable",
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average exercise price (in Dollars per share)",
        "verboseLabel": "Exercise price (in Dollars per share)",
        "netLabel": "Options exercise price",
        "label": "Exercise price, share options granted"
       }
      },
      "en": {
       "role": {
        "documentation": "The exercise price of share options granted."
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "dei_ExhibitsOnly462d": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ExhibitsOnly462d",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "auth_ref": [
      "r612"
     ]
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ExhibitsOnly462dFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "auth_ref": [
      "r612"
     ]
    },
    "ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ExpectedDividendAsPercentageShareOptionsGranted",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValueoftheStockOptionsattheGrantDateTable",
      "http://www.moolecscience.com/role/ScheduleofRangeofAssumptionswhichhaveDeterminedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividend rate",
        "verboseLabel": "Expected dividend yield",
        "label": "Expected dividend as percentage, share options granted"
       }
      },
      "en": {
       "role": {
        "documentation": "The percentage of an expected dividend used to calculate the fair value of share options granted."
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable": {
       "parentTag": "ifrs-full_ResearchAndDevelopmentExpense",
       "weight": 1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based incentives",
        "label": "Expense from share-based payment transactions"
       }
      }
     },
     "auth_ref": [
      "r175",
      "r327"
     ]
    },
    "mlec_ExpensesClassifiedByNatureAndFunctionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ExpensesClassifiedByNatureAndFunctionMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofExpensesClassifiedbyNatureandFunctionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total [Member]",
        "label": "Expenses Classified By Nature And Function Member"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FinanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "FinanceCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinanceResultsTable",
      "http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance Costs",
        "verboseLabel": "Finance debt (in Dollars)",
        "label": "Finance costs"
       }
      }
     },
     "auth_ref": [
      "r410"
     ]
    },
    "ifrs-full_FinanceIncomeCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "FinanceIncomeCost",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome",
      "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable",
      "http://www.moolecscience.com/role/ScheduleofFinanceResultsTable",
      "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total net financial cost",
        "terseLabel": "Financial cost",
        "verboseLabel": "Financial results",
        "label": "Finance income (cost)"
       }
      }
     },
     "auth_ref": [
      "r655"
     ]
    },
    "mlec_FinancedPaymentAcquisitionOfBusinessMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "FinancedPaymentAcquisitionOfBusinessMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consideration for acquisition [Member]",
        "documentation": "Represents information pertaining to financed payment acquisition of business.",
        "label": "Financed Payment Acquisition Of Business Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FinancialAssetsAtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "FinancialAssetsAtFairValue",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAssetsAcquiredandLiabilitiesAssumedTable",
      "http://www.moolecscience.com/role/ScheduleofFairValuebyHierarchyTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Previously held interest - revalued at FV",
        "verboseLabel": "Financial assets at fair value",
        "label": "Financial assets, at fair value"
       }
      },
      "en": {
       "role": {
        "documentation": "The fair value of financial assets. [Refer: At fair value [member]; Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r196"
     ]
    },
    "mlec_FinancialAssetsAtFairValueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "FinancialAssetsAtFairValueAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValuebyHierarchyTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial assets at fair value",
        "label": "Financial Assets At Fair Value Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_FinancialBorrowingsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "FinancialBorrowingsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofBorrowingsCarryingAmountTable",
      "http://www.moolecscience.com/role/ScheduleofBorrowingsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial borrowings [Member]",
        "label": "Financial Borrowings Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_FinancialCommissions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "FinancialCommissions",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinanceResultsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial commissions",
        "documentation": "Financial commissions.",
        "label": "Financial Commissions"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_FinancialCostAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "FinancialCostAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinanceResultsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial cost",
        "label": "Financial Cost Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_FinancialInstrumentsRiskManagementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "FinancialInstrumentsRiskManagementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments \u2013 Risk Management [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_FinancialInstrumentsRiskManagementScheduleofCurrencyRiskDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "FinancialInstrumentsRiskManagementScheduleofCurrencyRiskDetailsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofCurrencyRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments \u2013 Risk Management - Schedule of Currency Risk (Details) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_FinancialInstrumentsRiskManagementScheduleofCurrencyRiskDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "FinancialInstrumentsRiskManagementScheduleofCurrencyRiskDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofCurrencyRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments \u2013 Risk Management - Schedule of Currency Risk (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_FinancialInstrumentsRiskManagementScheduleofFairValuebyHierarchyDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "FinancialInstrumentsRiskManagementScheduleofFairValuebyHierarchyDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValuebyHierarchyTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments \u2013 Risk Management - Schedule of Fair Value by Hierarchy (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_FinancialInstrumentsRiskManagementScheduleofFinancialAssetsbyCategoryDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "FinancialInstrumentsRiskManagementScheduleofFinancialAssetsbyCategoryDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinancialAssetsbyCategoryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments \u2013 Risk Management - Schedule of Financial Assets by Category (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_FinancialInstrumentsRiskManagementScheduleofFinancialLiabilitiesbyCategoryDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "FinancialInstrumentsRiskManagementScheduleofFinancialLiabilitiesbyCategoryDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinancialLiabilitiesbyCategoryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments \u2013 Risk Management - Schedule of Financial Liabilities by Category (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_FinancialInstrumentsRiskManagementScheduleofInterestRateRiskDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "FinancialInstrumentsRiskManagementScheduleofInterestRateRiskDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofInterestRateRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments \u2013 Risk Management - Schedule of Interest Rate Risk (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_FinancialInstrumentsRiskManagementScheduleofLiquidityRiskDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "FinancialInstrumentsRiskManagementScheduleofLiquidityRiskDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofLiquidityRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments \u2013 Risk Management - Schedule of Liquidity Risk (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "FinancialLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinancialLiabilitiesbyCategoryTable",
      "http://www.moolecscience.com/role/ScheduleofLiquidityRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "terseLabel": "Financial liability",
        "label": "Financial liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity\u2019s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity\u2019s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Classes of financial instruments [domain]; Financial assets; Derivatives [member]]"
       }
      }
     },
     "auth_ref": [
      "r196"
     ]
    },
    "ifrs-full_FinancialLiabilitiesAtAmortisedCostMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "FinancialLiabilitiesAtAmortisedCostMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofBorrowingsCarryingAmountTable",
      "http://www.moolecscience.com/role/ScheduleofFinancialAssetsbyCategoryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortized cost [Member]",
        "label": "Financial liabilities at amortised cost, class [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the financial liabilities measured at amortised cost class. [Refer: Financial liabilities at amortised cost]"
       }
      }
     },
     "auth_ref": [
      "r213",
      "r234",
      "r338"
     ]
    },
    "ifrs-full_FinancialLiabilitiesAtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "FinancialLiabilitiesAtFairValue",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValuebyHierarchyTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial liabilities at fair value",
        "label": "Financial liabilities, at fair value"
       }
      },
      "en": {
       "role": {
        "documentation": "The fair value of financial liabilities. [Refer: At fair value [member]; Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r196"
     ]
    },
    "mlec_FinancialLiabilitiesValuedAtFairValueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "FinancialLiabilitiesValuedAtFairValueAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValuebyHierarchyTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial liabilities valued at fair value",
        "label": "Financial Liabilities Valued At Fair Value Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_FinancingForAssetsAcquisitions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "FinancingForAssetsAcquisitions",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing for assets acquisitions",
        "documentation": "Increase decrease of Financing for assets acquisitions in financing activities",
        "label": "Financing For Assets Acquisitions"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_FixedRateBorrowingsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "FixedRateBorrowingsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofInterestRateRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fixed-rate instruments [Member]",
        "documentation": "This member stands for loans that have fixed interest rate.",
        "label": "Fixed Rate Borrowings Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_FixedRateInstrumentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "FixedRateInstrumentsAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofInterestRateRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fixed-rate instruments",
        "label": "Fixed Rate Instruments Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FixturesAndFittingsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "FixturesAndFittingsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofPropertyPlantandEquipmentTable",
      "http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fixtures and fittings [Member]",
        "verboseLabel": "Fixture and fittings [Member]",
        "label": "Fixtures and fittings [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing fixtures and fittings that are not permanently attached to real property. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r425"
     ]
    },
    "mlec_ForeignCurrencyTranslationOnInventory": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ForeignCurrencyTranslationOnInventory",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofCostofSalesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency translation",
        "documentation": "Amount of foreign currency translation on inventory",
        "label": "Foreign Currency Translation On Inventory"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r514",
      "r525",
      "r541",
      "r576"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r514",
      "r525",
      "r541",
      "r576"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r514",
      "r525",
      "r541",
      "r576"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r514",
      "r525",
      "r541",
      "r576"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r514",
      "r525",
      "r541",
      "r576"
     ]
    },
    "dei_FormerAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "FormerAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Address [Member]",
        "documentation": "Former address for entity"
       }
      }
     },
     "auth_ref": [
      "r497",
      "r528"
     ]
    },
    "dei_FormerFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "FormerFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Fiscal Year End Date",
        "documentation": "Former end date of previous fiscal years"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_FortyEightMonthsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "FortyEightMonthsMember",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "48 Months [Member]",
        "label": "Forty Eight Months Member"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]",
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year"
       }
      }
     },
     "auth_ref": [
      "r556"
     ]
    },
    "ifrs-full_FuelAndEnergyExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "FuelAndEnergyExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable": {
       "parentTag": "ifrs-full_ResearchAndDevelopmentExpense",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofExpensesClassifiedbyNatureandFunctionTable",
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Energy and fuel",
        "label": "Fuel and energy expense"
       }
      }
     },
     "auth_ref": [
      "r649"
     ]
    },
    "mlec_FungalBiomassMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "FungalBiomassMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fungal Biomass [Member]",
        "label": "Fungal Biomass Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_GFASMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "GFASMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofInformationrelatedtoCompanysShareofVotingRightsinitsSubsidiariesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "G-FAS [Member]",
        "label": "GFASMember"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/EventsOccurringAftertheReportingPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated gain loss",
        "label": "Gain (loss) on hedge ineffectiveness recognised in profit or loss"
       }
      }
     },
     "auth_ref": [
      "r194",
      "r195",
      "r340",
      "r341"
     ]
    },
    "mlec_GainOnBargainPurchase": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "GainOnBargainPurchase",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofOtherIncomeorExpensesNetTable": {
       "parentTag": "ifrs-full_OtherOperatingIncomeExpense",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOtherIncomeorExpensesNetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gain on bargain purchase",
        "documentation": "Gain on bargain purchase.",
        "label": "Gain On Bargain Purchase"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_GainRecognisedInBargainPurchaseTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GainRecognisedInBargainPurchaseTransaction",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAssetsAcquiredandLiabilitiesAssumedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Gain from a bargain purchase",
        "label": "Gain recognised in bargain purchase transaction"
       }
      }
     },
     "auth_ref": [
      "r182",
      "r333"
     ]
    },
    "mlec_GainlossOfDerecognitionTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "GainlossOfDerecognitionTransactions",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Approximate gain (in Dollars)",
        "documentation": "Amount of gain (loss) on derecognition transactions.",
        "label": "Gainloss Of Derecognition Transactions"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_GainlossOfRecognitionTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "GainlossOfRecognitionTransactions",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated gain (in Dollars)",
        "documentation": "Amount of gain (loss) on recognition transactions.",
        "label": "Gainloss Of Recognition Transactions"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_GainsLossesOnChangeInFairValueEstimatesOfBiologicalAssetsForCurrentPeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GainsLossesOnChangeInFairValueEstimatesOfBiologicalAssetsForCurrentPeriod",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": -1.0,
       "order": 23.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Changes in the net realizable value of agricultural products after harvest",
        "label": "Gains (losses) on change in fair value less costs to sell of biological assets for current period"
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "ifrs-full_GainsLossesOnDisposalsOfInvestmentPropertiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GainsLossesOnDisposalsOfInvestmentPropertiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Investment Properties [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_GainsLossesOnDisposalsOfInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GainsLossesOnDisposalsOfInvestments",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAssetsAcquiredandLiabilitiesAssumedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gain on purchase",
        "label": "Gains (losses) on disposals of investments"
       }
      },
      "en": {
       "role": {
        "documentation": "The gains (losses) on disposals of investments."
       }
      }
     },
     "auth_ref": [
      "r417"
     ]
    },
    "mlec_GainsLossesOnExchangeDifferencesOnTranslationFromJointVentureNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "GainsLossesOnExchangeDifferencesOnTranslationFromJointVentureNetOfTax",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinJointVenturesInvestmentsandAffiliatesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency translation",
        "documentation": "The gains (losses) recognised in other comprehensive income on exchange differences on the translation from joint venture of financial statements of foreign operations, net of tax.",
        "label": "Gains Losses On Exchange Differences On Translation From Joint Venture Net Of Tax"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GainsLossesOnExchangeDifferencesOnTranslationNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome": {
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome",
      "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable",
      "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign exchange differences on translation of foreign operations",
        "label": "Gains (losses) on exchange differences on translation of foreign operations, net of tax"
       }
      },
      "en": {
       "role": {
        "documentation": "The gains (losses) recognised in other comprehensive income on exchange differences on the translation of financial statements of foreign operations, net of tax, before reclassification adjustments. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r415"
     ]
    },
    "ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Initial recognition and changes in the fair value of biological assets",
        "label": "Gains (losses) on fair value adjustment attributable to price changes, biological assets"
       }
      }
     },
     "auth_ref": [
      "r435",
      "r436"
     ]
    },
    "ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GainsLossesOnFairValueAdjustmentBiologicalAssets",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.moolecscience.com/role/ScheduleofOperatingResultsGroupsReportingSegmentsTable": {
       "parentTag": "ifrs-full_Revenue",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome",
      "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable",
      "http://www.moolecscience.com/role/ScheduleofChangesinBiologicalAssetsTable",
      "http://www.moolecscience.com/role/ScheduleofOperatingResultsGroupsReportingSegmentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Initial recognition and changes in the fair value of biological assets at the point of harvest",
        "terseLabel": "Initial recognition and changes in the fair value of biological assets at the point of harvest",
        "negatedTerseLabel": "Initial recognition and changes in the fair value of biological assets at the point of harvest",
        "label": "Gains (losses) on fair value adjustment, biological assets"
       }
      }
     },
     "auth_ref": [
      "r83",
      "r313"
     ]
    },
    "ifrs-full_GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementAssets",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinanceResultsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exchange differences generated by assets",
        "label": "Gains (losses) recognised in profit or loss on exchange differences, fair value measurement, assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The gains (losses) on exchange differences, recognised in profit or loss, on the fair value measurement of assets. [Refer: At fair value [member]]"
       }
      }
     },
     "auth_ref": [
      "r641"
     ]
    },
    "ifrs-full_GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementLiabilities",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinanceResultsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exchange differences generated by liabilities",
        "label": "Gains (losses) recognised in profit or loss on exchange differences, fair value measurement, liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The gains (losses) on exchange differences, recognised in profit or loss, on the fair value measurement of liabilities. [Refer: At fair value [member]]"
       }
      }
     },
     "auth_ref": [
      "r641"
     ]
    },
    "mlec_GentleFarmingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "GentleFarmingMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofInformationrelatedtoCompanysShareofVotingRightsinitsSubsidiariesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gentle Farming [Member]",
        "label": "Gentle Farming Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_GentleTechMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "GentleTechMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofInformationrelatedtoCompanysShareofVotingRightsinitsSubsidiariesTable",
      "http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gentle Tech [Member]",
        "label": "Gentle Tech Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_GeographicalAreasAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GeographicalAreasAxis",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofGeographicalInformationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical areas [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r229",
      "r427",
      "r451",
      "r453",
      "r467"
     ]
    },
    "ifrs-full_GeographicalAreasDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GeographicalAreasDomain",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofGeographicalInformationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical areas [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregated geographical areas. It also represents the standard value for the 'Geographical areas' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r229",
      "r427",
      "r451",
      "r453",
      "r467"
     ]
    },
    "mlec_GoodsInTransitMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "GoodsInTransitMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofInventoriesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goods in transit [Member]",
        "label": "Goods In Transit Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet",
      "http://www.moolecscience.com/role/ScheduleofGeographicalInformationTable",
      "http://www.moolecscience.com/role/ScheduleofGoodwillTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill",
        "label": "Goodwill"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r59",
      "r65",
      "r186",
      "r292",
      "r298",
      "r335",
      "r378"
     ]
    },
    "ifrs-full_GovernmentGrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GovernmentGrants",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofGovernmentGrantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "At the beginning of the year",
        "periodEndLabel": "At the end of the year",
        "label": "Government grants"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assistance by government in the form of transfers of resources to an entity in return for past or future compliance with certain conditions relating to the operating activities of the entity, recognised as deferred income. They exclude those forms of government assistance that cannot reasonably have a value placed upon them and transactions with government that cannot be distinguished from the normal trading transactions of the entity. [Refer: Deferred income other than contract liabilities; Government [member]]"
       }
      }
     },
     "auth_ref": [
      "r651"
     ]
    },
    "mlec_GovernmentGrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "GovernmentGrantsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable",
      "http://www.moolecscience.com/role/ScheduleofRevenuebySimilarGroupofProductsorServicesTable",
      "http://www.moolecscience.com/role/ScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Government grants [Member]",
        "verboseLabel": "Government Grants [Member]",
        "label": "Government Grants Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_GovernmentsGrantsReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "GovernmentsGrantsReceivableMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOtherReceivablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Governments grants receivable [Member]",
        "label": "Governments Grants Receivable Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_GrossCarryingAmountMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GrossCarryingAmountMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross carrying amount [member]",
        "label": "Gross carrying amount [member]"
       }
      }
     },
     "auth_ref": [
      "r11",
      "r71",
      "r80",
      "r86",
      "r186",
      "r202",
      "r205",
      "r273",
      "r304",
      "r311",
      "r316",
      "r345",
      "r347",
      "r458"
     ]
    },
    "ifrs-full_GrossProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GrossProfit",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.moolecscience.com/role/ScheduleofOperatingResultsGroupsReportingSegmentsTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable",
      "http://www.moolecscience.com/role/ScheduleofOperatingResultsGroupsReportingSegmentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Gross profit per segment",
        "terseLabel": "Gross margin",
        "label": "Gross profit"
       }
      }
     },
     "auth_ref": [
      "r475"
     ]
    },
    "mlec_HB4SoyAndBreedingProgramMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "HB4SoyAndBreedingProgramMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "HB4 soy and breeding program [Member]",
        "label": "HB4 Soy And Breeding Program Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_HoldbackMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "HoldbackMember",
     "presentation": [
      "http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Holdback [Member]",
        "label": "Holdback Member"
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r495",
      "r498",
      "r517"
     ]
    },
    "ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IdentifiableAssetsAcquiredLiabilitiesAssumed",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAssetsAcquiredandLiabilitiesAssumedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total net assets identified",
        "label": "Identifiable assets acquired (liabilities assumed)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for net identifiable assets acquired or liabilities assumed in a business combination. [Refer: Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r455",
      "r456",
      "r471"
     ]
    },
    "ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAssetsAcquiredandLiabilitiesAssumedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets",
        "label": "Identifiable intangible assets recognised as of acquisition date"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for identifiable intangible assets acquired in a business combination. [Refer: Intangible assets other than goodwill; Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r455",
      "r456",
      "r471"
     ]
    },
    "mlec_IfrsBalanceSheetLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "IfrsBalanceSheetLocationAxis",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTradeReceivablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "IFRS Balance Sheet Location [Axis]",
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Ifrs Balance Sheet Location Axis"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_IfrsConvertibleNotesPayableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "IfrsConvertibleNotesPayableMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable",
      "http://www.moolecscience.com/role/ScheduleofLiquidityRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible notes [Member]",
        "documentation": "Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder.",
        "label": "Ifrs Convertible Notes Payable Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_IfrsDebtInstrumentTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "IfrsDebtInstrumentTerm",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maturity period",
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Ifrs Debt Instrument Term"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_IfrsDefinedContributionPlanEmployerMatchingContributionPercentOfEmployeesGrossPay": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "IfrsDefinedContributionPlanEmployerMatchingContributionPercentOfEmployeesGrossPay",
     "presentation": [
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum percentage of employee's monthly compensation",
        "documentation": "Maximum percentage of employee's monthly compensation",
        "label": "Ifrs Defined Contribution Plan Employer Matching Contribution Percent Of Employees Gross Pay"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_IfrsFull_machineryAndEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "IfrsFull_machineryAndEquipmentMember",
     "presentation": [
      "http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Machinery and equipment [Member]",
        "documentation": "This member stands for machinery and equipment.",
        "label": "Ifrs Full_machinery And Equipment Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod",
     "presentation": [
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Ifrs Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage",
     "presentation": [
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting percentage",
        "documentation": "Percentage of vesting of award under share-based payment arrangement.",
        "label": "Ifrs Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ImpairmentLossRecognisedInProfitOrLossTradeReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ImpairmentLossRecognisedInProfitOrLossTradeReceivables",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofExpensesClassifiedbyNatureandFunctionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of receivables",
        "label": "Impairment loss recognised in profit or loss, trade receivables"
       }
      }
     },
     "auth_ref": [
      "r649"
     ]
    },
    "mlec_ImportAndExportExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ImportAndExportExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable": {
       "parentTag": "ifrs-full_ResearchAndDevelopmentExpense",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofExpensesClassifiedbyNatureandFunctionTable",
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Import and export expenses",
        "documentation": "Amount of import and export expenses.",
        "label": "Import And Export Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InKindContributionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InKindContributionsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTransactionsBetweentheGroupandRelatedPartiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "In-kind contributions [Member]",
        "label": "In Kind Contributions Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_IncomeAndMinimumPresumedRecoverableIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "IncomeAndMinimumPresumedRecoverableIncomeTaxes",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAssetsAcquiredandLiabilitiesAssumedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income and minimum presumed recoverable income taxes",
        "documentation": "The amount of income and minimum presumed recoverable income taxes.",
        "label": "Income And Minimum Presumed Recoverable Income Taxes"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Profit or loss [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_IncomeTaxExpenseByApplyingApplicableTaxRateInForceInRespectiveJurisdictionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "IncomeTaxExpenseByApplyingApplicableTaxRateInForceInRespectiveJurisdictionsTableTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/TaxationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Income Tax Expense Calculated by Applying Tax Rate in Force",
        "documentation": "Tabular disclosure of income tax expense was calculated by applying the tax rate in force in the respective jurisdictions and entities.",
        "label": "Income Tax Expense By Applying Applicable Tax Rate In Force In Respective Jurisdictions Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncomeTaxExpenseContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncomeTaxExpenseContinuingOperations",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable": {
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable": {
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.moolecscience.com/role/ScheduleofPrincipalStatutoryTaxesRatesandCurrentTaxTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome",
      "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable",
      "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable",
      "http://www.moolecscience.com/role/ScheduleofPrincipalStatutoryTaxesRatesandCurrentTaxTable",
      "http://www.moolecscience.com/role/ScheduleofWeightedAverageTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Income tax",
        "negatedLabel": "Income tax",
        "negatedTerseLabel": "Income tax expenses",
        "negatedNetLabel": "Income tax",
        "label": "Tax expense (income)"
       }
      }
     },
     "auth_ref": [
      "r2",
      "r4",
      "r5",
      "r40",
      "r127",
      "r219",
      "r265",
      "r267",
      "r268",
      "r412"
     ]
    },
    "ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Charge to OCI",
        "label": "Income tax relating to components of other comprehensive income"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of income tax relating to amounts recognised in other comprehensive income. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r3",
      "r266",
      "r414"
     ]
    },
    "ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncomeTaxesPaidRefundClassifiedAsOperatingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": -1.0,
       "order": 24.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Income tax paid",
        "label": "Income taxes paid (refund), classified as operating activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from income taxes paid or refunded, classified as operating activities. [Refer: Income taxes paid (refund)]"
       }
      }
     },
     "auth_ref": [
      "r91",
      "r437"
     ]
    },
    "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncreaseDecreaseInCashAndCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net increase / (decrease) in cash and cash equivalents",
        "label": "Increase (decrease) in cash and cash equivalents after effect of exchange rate changes"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r95",
      "r257"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business combination / (loss) of control",
        "label": "Increase (decrease) through business combinations, deferred tax liability (asset)"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in deferred tax liability (asset) resulting from business combinations. [Refer: Deferred tax liability (asset)]"
       }
      }
     },
     "auth_ref": [
      "r619"
     ]
    },
    "mlec_IncreaseDecreaseThroughChangesInBusinessCombinationEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "IncreaseDecreaseThroughChangesInBusinessCombinationEquity",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business combination",
        "documentation": "The increase (decrease) in equity through changes in business combination, equity.",
        "label": "Increase Decrease Through Changes In Business Combination Equity"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in ownership interests in subsidiaries",
        "label": "Increase (decrease) through changes in ownership interests in subsidiaries that do not result in loss of control, equity"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity through changes in ownership interests in subsidiaries that do not result in loss of control. [Refer: Total for all subsidiaries [member]]"
       }
      }
     },
     "auth_ref": [
      "r371"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exchange differences, currency translation differences and other financial results",
        "label": "Increase (decrease) through effect of changes in foreign exchange rates, liabilities arising from financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in liabilities arising from financing activities resulting from the effect of changes in foreign exchange rates. [Refer: Liabilities arising from financing activities]"
       }
      }
     },
     "auth_ref": [
      "r93",
      "r254"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion difference",
        "label": "Increase (decrease) through net exchange differences, deferred tax liability (asset)"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in deferred tax liability (asset) resulting from the net exchange differences arising when the financial statements are translated from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Deferred tax liability (asset)]"
       }
      }
     },
     "auth_ref": [
      "r619"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency translation",
        "label": "Increase (decrease) through net exchange differences, intangible assets other than goodwill"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in intangible assets other than goodwill resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r74"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinAllowancesandProvisionsTable",
      "http://www.moolecscience.com/role/ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Currency conversion difference",
        "verboseLabel": "Exchange differences",
        "label": "Increase (decrease) through net exchange differences, other provisions"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in other provisions resulting from foreign currency exchange rate changes on provisions measured in a currency different from the entity's presentation currency. [Refer: Other provisions]"
       }
      }
     },
     "auth_ref": [
      "r626"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofPropertyPlantandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency translation",
        "label": "Increase (decrease) through net exchange differences, property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in property, plant and equipment resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughOtherContributionsByOwners",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase in capital",
        "label": "Increase through other contributions by owners, equity"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase in equity through other contributions by owners that the entity does not separately disclose in the same statement or note."
       }
      }
     },
     "auth_ref": [
      "r371"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughOtherDistributionsToOwners": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughOtherDistributionsToOwners",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "BIOX of deconsolidation",
        "label": "Decrease through other distributions to owners, equity"
       }
      },
      "en": {
       "role": {
        "documentation": "The decrease in equity through distributions to owners that the entity does not separately disclose in the same statement or note."
       }
      }
     },
     "auth_ref": [
      "r371"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughSharebasedPaymentTransactions",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based incentives of subsidiaries",
        "label": "Increase (decrease) through share-based payment transactions, equity"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]"
       }
      }
     },
     "auth_ref": [
      "r371"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofPropertyPlantandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification from Investment properties",
        "label": "Increase (decrease) through transfers from (to) investment property, property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in property, plant and equipment resulting from transfers from (to) investment property. [Refer: Property, plant and equipment; Investment property]"
       }
      }
     },
     "auth_ref": [
      "r622"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Transfers/ Disposals",
        "label": "Increase (decrease) through transfers, intangible assets other than goodwill"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in intangible assets other than goodwill resulting from transfers. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r628"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofPropertyPlantandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification within PPE",
        "label": "Increase (decrease) through transfers, property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in property, plant and equipment resulting from transfers. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r622"
     ]
    },
    "mlec_IncreaseThroughAcquisitionOfNonControllingInterestInSubsidiaries": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "IncreaseThroughAcquisitionOfNonControllingInterestInSubsidiaries",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesTable": {
       "parentTag": "mlec_NonCashFinancingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Acquisition of interest in subsidiaries by financed debts",
        "documentation": "Acquisition of interest in subsidiaries by financed debts.",
        "label": "Increase Through Acquisition Of Non Controlling Interest In Subsidiaries"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds",
        "documentation": "The increase in liabilities arising from financing activities resulting from new borrowings.",
        "label": "Increase Through Borrowings Liabilities Arising From Financing Activities"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "auth_ref": [
      "r514",
      "r525",
      "r541",
      "r567",
      "r576",
      "r580",
      "r588"
     ]
    },
    "mlec_IndrasaBiotecnologaSAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "IndrasaBiotecnologaSAMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofShareofProfitorLossofJointVenturesandAffiliatesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Indrasa Biotecnologia S.A.",
        "documentation": "This member stands for Indrasa Biotecnologia S.A.",
        "label": "Indrasa Biotecnologa SAMember"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InflationEffectsOnCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InflationEffectsOnCashAndCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Inflation effects on cash and cash equivalents",
        "documentation": "The effect of inflation effects on cash and cash equivalents.",
        "label": "Inflation Effects On Cash And Cash Equivalents"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InflationOfAccumulatedYears": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InflationOfAccumulatedYears",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inflation of accumulated",
        "documentation": "The years of inflation accumulated.",
        "label": "Inflation Of Accumulated Years"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InflationTaxAdjustmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InflationTaxAdjustmentMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable",
      "http://www.moolecscience.com/role/ScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inflation tax adjustment [Member]",
        "documentation": "This member stands for inflation tax adjustments.",
        "label": "Inflation Tax Adjustment Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InformationAboutComponentOfConsolidatedStatementsOfComprehensiveIncomeLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InformationAboutComponentOfConsolidatedStatementsOfComprehensiveIncomeLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Information about Component of Consolidated Statements of Comprehensive Income [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InformationAboutComponentsOfEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InformationAboutComponentsOfEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Information about Components of Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Information About Components of Consolidated Statements of Financial Position [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Information About Components of Consolidated Statements of Financial Position (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofBorrowingsCarryingAmountDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofBorrowingsCarryingAmountDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofBorrowingsCarryingAmountTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Information About Components of Consolidated Statements of Financial Position - Schedule of Borrowings, Carrying Amount (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofBorrowingsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofBorrowingsDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofBorrowingsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Information About Components of Consolidated Statements of Financial Position - Schedule of Borrowings (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinAllowancesandProvisionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Changes in Allowances and Provisions [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinAllowancesandProvisionsDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinAllowancesandProvisionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Information About Components of Consolidated Statements of Financial Position - Schedule of Changes in Allowances and Provisions (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinBiologicalAssetsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofChangesinBiologicalAssetsDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinBiologicalAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Information About Components of Consolidated Statements of Financial Position - Schedule of Changes in Biological Assets (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofConvertibleNotesDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofConvertibleNotesDetailsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofConvertibleNotesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Information About Components of Consolidated Statements of Financial Position - Schedule of Convertible Notes (Details) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofConvertibleNotesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofConvertibleNotesDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofConvertibleNotesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Information About Components of Consolidated Statements of Financial Position - Schedule of Convertible Notes (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGoodwillDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGoodwillDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofGoodwillTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Information About Components of Consolidated Statements of Financial Position - Schedule of Goodwill (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGovernmentGrantsDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGovernmentGrantsDetailsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofGovernmentGrantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Information About Components of Consolidated Statements of Financial Position - Schedule of Government Grants (Details) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGovernmentGrantsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofGovernmentGrantsDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofGovernmentGrantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Information About Components of Consolidated Statements of Financial Position - Schedule of Government Grants (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofIntangibleAssetsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofIntangibleAssetsDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Information About Components of Consolidated Statements of Financial Position - Schedule of\u200b Intangible Assets (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofIntangibleAssetsandLiabilitiesAssumedDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofIntangibleAssetsandLiabilitiesAssumedDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsScheduleofIntangibleAssetsandLiabilitiesAssumed"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Information About Components of Consolidated Statements of Financial Position - Schedule of Intangible Assets and Liabilities Assumed (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofInventoriesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofInventoriesDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofInventoriesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Information About Components of Consolidated Statements of Financial Position - Schedule of Inventories (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofOtherFinancialAssetsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofOtherFinancialAssetsDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOtherFinancialAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Information About Components of Consolidated Statements of Financial Position - Schedule of Other Financial Assets (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofOtherReceivablesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofOtherReceivablesDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOtherReceivablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Information About Components of Consolidated Statements of Financial Position - Schedule of Other Receivables (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofPropertyPlantandEquipmentDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofPropertyPlantandEquipmentDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofPropertyPlantandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Information About Components of Consolidated Statements of Financial Position - Schedule of Property, Plant and Equipment (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofProvisionsDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofProvisionsDetailsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofProvisionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Information About Components of Consolidated Statements of Financial Position - Schedule of Provisions (Details) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofProvisionsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofProvisionsDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofProvisionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Information About Components of Consolidated Statements of Financial Position - Schedule of Provisions (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofTradeReceivablesDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofTradeReceivablesDetailsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTradeReceivablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Information About Components of Consolidated Statements of Financial Position - Schedule of Trade Receivables (Details) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofTradeReceivablesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InformationAboutComponentsofConsolidatedStatementsofFinancialPositionScheduleofTradeReceivablesDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTradeReceivablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Information About Components of Consolidated Statements of Financial Position - Schedule of Trade Receivables (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Information about Component of Consolidated Statements of Comprehensive Income (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofExpensesClassifiedbyNatureandFunctionDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofExpensesClassifiedbyNatureandFunctionDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofExpensesClassifiedbyNatureandFunctionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Information about Component of Consolidated Statements of Comprehensive Income - Schedule of Expenses Classified by Nature and Function (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofFinanceResultsDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofFinanceResultsDetailsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinanceResultsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Information about Component of Consolidated Statements of Comprehensive Income - Schedule of Finance Results (Details) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofFinanceResultsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeScheduleofFinanceResultsDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinanceResultsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Information about Component of Consolidated Statements of Comprehensive Income - Schedule of Finance Results (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InformationaboutComponentsofEquityDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InformationaboutComponentsofEquityDetailsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/InformationaboutComponentsofEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Information about Components of Equity (Details) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InformationaboutComponentsofEquityDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InformationaboutComponentsofEquityDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/InformationaboutComponentsofEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Information about Components of Equity (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Information about Components of Equity - Schedule of Bioceres SA and Bioceres Crop Solutions (Details) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InformationaboutComponentsofEquityScheduleofBioceresSAandBioceresCropSolutionsDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Information about Components of Equity - Schedule of Bioceres SA and Bioceres Crop Solutions (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Information about Components of Equity - Schedule of Financial Statements (Details) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InformationaboutComponentsofEquityScheduleofFinancialStatementsDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Information about Components of Equity - Schedule of Financial Statements (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InformationaboutComponentsofEquityScheduleofNumberofSharesIssuedDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InformationaboutComponentsofEquityScheduleofNumberofSharesIssuedDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofNumberofSharesIssuedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Information about Components of Equity - Schedule of Number of Shares Issued (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InformationaboutComponentsofEquityScheduleofSubsidiariesNonControllingInterestDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InformationaboutComponentsofEquityScheduleofSubsidiariesNonControllingInterestDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofSubsidiariesNonControllingInterestTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Information about Components of Equity - Schedule of Subsidiaries Non-Controlling Interest (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_InitiallyAppliedIFRSsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "InitiallyAppliedIFRSsAxis",
     "presentation": [
      "http://www.moolecscience.com/role/NewStandardsAmendmentsandInterpretationsIssuedbytheIASBDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Initially applied IFRSs [axis]"
       }
      }
     },
     "auth_ref": [
      "r101",
      "r262"
     ]
    },
    "mlec_InmetSAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InmetSAMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofJointVenturesAssetsTable",
      "http://www.moolecscience.com/role/ScheduleofShareofProfitorLossofJointVenturesandAffiliatesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inmet S.A [Member]",
        "verboseLabel": "Inmet S.A. [Member]",
        "label": "Inmet SAMember"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InoculantsBiofertilizersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InoculantsBiofertilizersMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRevenuebySimilarGroupofProductsorServicesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inoculants &amp; Biofertilizers []Member",
        "documentation": "This member stands for inoculants &amp; biofertilizers.",
        "label": "Inoculants Biofertilizers Member"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]",
        "terseLabel": "Insider Trading Arrangements:"
       }
      }
     },
     "auth_ref": [
      "r586"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]",
        "terseLabel": "Insider Trading Policies and Procedures:"
       }
      }
     },
     "auth_ref": [
      "r499",
      "r592"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r499",
      "r592"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r499",
      "r592"
     ]
    },
    "mlec_InsumosAgroqumicosSAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InsumosAgroqumicosSAMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofGoodwillTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insumos Agroqu\u00edmicos S.A. [Member]",
        "label": "Insumos Agroqumicos SAMember"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_InsuranceExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "InsuranceExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable": {
       "parentTag": "ifrs-full_ResearchAndDevelopmentExpense",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofExpensesClassifiedbyNatureandFunctionTable",
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insurance",
        "label": "Insurance expense"
       }
      }
     },
     "auth_ref": [
      "r649"
     ]
    },
    "mlec_InsuranceToBeAccruedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InsuranceToBeAccruedMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOtherReceivablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insurance to be accrued [Member]",
        "label": "Insurance To Be Accrued Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IntangibleAssetsOtherThanGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet",
      "http://www.moolecscience.com/role/ScheduleofGeographicalInformationTable",
      "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable",
      "http://www.moolecscience.com/role/ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Net carrying amount",
        "periodEndLabel": "Net carrying amount",
        "terseLabel": "Intangible assets",
        "verboseLabel": "Total",
        "label": "Intangible assets other than goodwill"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]"
       }
      }
     },
     "auth_ref": [
      "r75",
      "r307",
      "r378"
     ]
    },
    "mlec_IntangiblesTaxLiabilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "IntangiblesTaxLiabilityMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable",
      "http://www.moolecscience.com/role/ScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets [Member]",
        "documentation": "This member standards for deferred liabilities related differences between the carrying amount of intangibles in the statement of financial position and its tax base.",
        "label": "Intangibles Tax Liability Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_IntegratedSeedProductsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "IntegratedSeedProductsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Integrated seed products [Member]",
        "label": "Integrated Seed Products Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InterestAccruedWithRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InterestAccruedWithRelatedParties",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinanceResultsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest accrued with related parties",
        "documentation": "Interest accrued with related parties.",
        "label": "Interest Accrued With Related Parties"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_InterestCostsCapitalised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "InterestCostsCapitalised",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesTable": {
       "parentTag": "mlec_NonCashInvestingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capitalization of interest on buildings in progress",
        "label": "Interest costs capitalised"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of interest costs that an entity incurs in connection with the borrowing of funds that are directly attributable to the acquisition, construction or production of a qualifying asset and which form part of the cost of that asset."
       }
      }
     },
     "auth_ref": [
      "r649"
     ]
    },
    "ifrs-full_InterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "InterestExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinanceResultsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Interest expenses",
        "label": "Interest expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense arising from interest."
       }
      }
     },
     "auth_ref": [
      "r126",
      "r217",
      "r225"
     ]
    },
    "mlec_InterestExpensesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InterestExpensesMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTransactionsBetweentheGroupandRelatedPartiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest expenses [Member]",
        "label": "Interest Expenses Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InterestGainMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InterestGainMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTransactionsBetweentheGroupandRelatedPartiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest gain [Member]",
        "label": "Interest Gain Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_InterestPaidClassifiedAsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "InterestPaidClassifiedAsFinancingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow",
      "http://www.moolecscience.com/role/ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Interest payments",
        "negatedTerseLabel": "Interest payment",
        "label": "Interest paid, classified as financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for interest paid, classified as financing activities."
       }
      }
     },
     "auth_ref": [
      "r90"
     ]
    },
    "ifrs-full_InterestRateRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "InterestRateRiskMember",
     "presentation": [
      "http://www.moolecscience.com/role/FinancialInstrumentsRiskManagementTables",
      "http://www.moolecscience.com/role/ScheduleofInterestRateRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest Rate Risk",
        "verboseLabel": "Interest Rate Risk [Member]",
        "label": "Interest rate risk [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the type of risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. [Refer: Classes of financial instruments [domain]]"
       }
      }
     },
     "auth_ref": [
      "r156",
      "r157",
      "r158",
      "r159",
      "r215"
     ]
    },
    "ifrs-full_Inventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "Inventories",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventories",
        "label": "Current inventories"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current inventories. [Refer: Inventories]"
       }
      }
     },
     "auth_ref": [
      "r23",
      "r253",
      "r381",
      "r477"
     ]
    },
    "mlec_InventoriesBeforeClosingInventory": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InventoriesBeforeClosingInventory",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofCostofSalesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subtotal",
        "documentation": "Amount of inventory before closing inventory (i.e. Opening inventory plus purchases).",
        "label": "Inventories Before Closing Inventory"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InventoriesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InventoriesCurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofInventoriesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventories",
        "documentation": "Inventories.",
        "label": "Inventories Current"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InventoriesExcludingAgriculturalProduce": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InventoriesExcludingAgriculturalProduce",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofInventoriesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net of agricultural products",
        "documentation": "The amount of current inventories excluding agricultural produce.",
        "label": "Inventories Excluding Agricultural Produce"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InventoriesFromBusinessCombination": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InventoriesFromBusinessCombination",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofCostofSalesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additions related to Business combination",
        "documentation": "Additions to inventories as results of business combination.",
        "label": "Inventories From Business Combination"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InventoriesNetOfAgriculturalProducts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InventoriesNetOfAgriculturalProducts",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofCostofSalesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Inventories as of the beginning of the year",
        "documentation": "Represent the amount of inventories net of agricultural products.",
        "label": "Inventories Net Of Agricultural Products"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InventoriesScheduleOfInventoriesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InventoriesScheduleOfInventoriesLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofInventoriesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "InventoriesSchedule of Inventories [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InventoriesTaxLiabilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InventoriesTaxLiabilityMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable",
      "http://www.moolecscience.com/role/ScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventories [Member]",
        "documentation": "This member standards for deferred liabilities related differences between the carrying amount of inventories in the statement of financial position and its tax base.",
        "label": "Inventories Tax Liability Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_InventoriesTotal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "InventoriesTotal",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAssetsAcquiredandLiabilitiesAssumedTable",
      "http://www.moolecscience.com/role/ScheduleofCostofSalesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedPeriodEndLabel": "Inventories as of the end of the year",
        "terseLabel": "Inventories",
        "label": "Inventories"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets: (a) held for sale in the ordinary course of business; (b) in the process of production for such sale; or (c) in the form of materials or supplies to be consumed in the production process or in the rendering of services. Inventories encompass goods purchased and held for resale including, for example, merchandise purchased by a retailer and held for resale, or land and other property held for resale. Inventories also encompass finished goods produced, or work in progress being produced, by the entity and include materials and supplies awaiting use in the production process. [Refer: Current finished goods; Current merchandise; Current work in progress; Land]"
       }
      }
     },
     "auth_ref": [
      "r381"
     ]
    },
    "mlec_InventoryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InventoryMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventories [Member]",
        "label": "Inventory Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InventoryProductionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InventoryProductionCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofCostofSalesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Production costs",
        "documentation": "The amount of manufacturing costs capitalized to inventory during the period.",
        "label": "Inventory Production Costs"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InventoryRecognizedAsExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InventoryRecognizedAsExpense",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventory recognized as expense (in Dollars)",
        "documentation": "The total amount of inventory recognized as expense.",
        "label": "Inventory Recognized As Expense"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinJointVenturesInvestmentsandAffiliatesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "As of the beginning",
        "periodEndLabel": "As of the end of the year",
        "documentation": "The amount of investments accounted for using the equity method, including an investee with negative equity.",
        "label": "Investment Accounted For Using Equity Method Including Negative Equity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_InvestmentCompanyActFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "InvestmentCompanyActFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "auth_ref": [
      "r530",
      "r531",
      "r532",
      "r533"
     ]
    },
    "dei_InvestmentCompanyActRegistration": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "InvestmentCompanyActRegistration",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "auth_ref": [
      "r546"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "InvestmentCompanyRegistrationAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "auth_ref": [
      "r546"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "auth_ref": [
      "r546"
     ]
    },
    "mlec_InvestmentInKindInOtherRelatedPartiesNonCashTransactionsInvestmentActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InvestmentInKindInOtherRelatedPartiesNonCashTransactionsInvestmentActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesTable": {
       "parentTag": "mlec_NonCashInvestingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment in-kind in other related parties",
        "documentation": "The amount of investment in kind in other related parties, non cash transactions investment activities.",
        "label": "Investment In Kind In Other Related Parties Non Cash Transactions Investment Activities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_InvestmentProperty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "InvestmentProperty",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet",
      "http://www.moolecscience.com/role/ScheduleofInvestmentPropertiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment properties",
        "verboseLabel": "Total",
        "label": "Investment property"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of property (land or a building - or part of a building - or both) held (by the owner or by the lessee as a right-of-use asset) to earn rentals or for capital appreciation or both, rather than for: (a) use in the production or supply of goods or services or for administrative purposes; or (b) sale in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r81",
      "r310",
      "r312",
      "r377"
     ]
    },
    "mlec_InvestmentsAtFairValueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InvestmentsAtFairValueMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValuebyHierarchyTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments at fair value [Member]",
        "label": "Investments At Fair Value Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InvestmentsInJointVenturesAndAssociates": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InvestmentsInJointVenturesAndAssociates",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments in joint ventures and associates",
        "documentation": "The amount of investments accounted for using the equity method, asset position.",
        "label": "Investments In Joint Ventures And Associates"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InvestmentsInSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InvestmentsInSharesMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOtherFinancialAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments at fair value [Member]",
        "documentation": "This member stands for investments in shares.",
        "label": "Investments In Shares Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "InvestmentsInSubsidiariesJointVenturesAndAssociates",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofJointVenturesAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets",
        "label": "Investments in subsidiaries, joint ventures and associates reported in separate financial statements"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of investments in subsidiaries, joint ventures and associates in an entity's separate financial statements. [Refer: Total for all associates [member]; Total for all joint ventures [member]; Total for all subsidiaries [member]; Investments in subsidiaries reported in separate financial statements]"
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "mlec_InvestmentsMeasuredAtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "InvestmentsMeasuredAtFairValue",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofJointVenturesAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measured at Fair value",
        "documentation": "Investments measured at fair value.",
        "label": "Investments Measured At Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_IssuanceOfShare": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "IssuanceOfShare",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesTable": {
       "parentTag": "mlec_NonCashInvestingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of shares",
        "documentation": "The amount of issuance of shares.",
        "label": "Issuance Of Share"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IssuedCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IssuedCapital",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issued capital",
        "label": "Issued capital"
       }
      },
      "en": {
       "role": {
        "documentation": "The nominal value of capital issued."
       }
      }
     },
     "auth_ref": [
      "r473",
      "r480"
     ]
    },
    "ifrs-full_IssuedCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IssuedCapitalMember",
     "presentation": [
      "http://www.moolecscience.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issued capital",
        "label": "Issued capital [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing issued capital."
       }
      }
     },
     "auth_ref": [
      "r372"
     ]
    },
    "ifrs-full_IssuedCapitalOrdinaryShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IssuedCapitalOrdinaryShares",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares (in Dollars)",
        "label": "Issued capital, ordinary shares"
       }
      },
      "en": {
       "role": {
        "documentation": "The nominal value of capital arising from issuing ordinary shares. [Refer: Issued capital]"
       }
      }
     },
     "auth_ref": [
      "r652"
     ]
    },
    "ifrs-full_IssuedCapitalPreferenceShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IssuedCapitalPreferenceShares",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total proceeds (in Dollars)",
        "label": "Issued capital, preference shares"
       }
      },
      "en": {
       "role": {
        "documentation": "The nominal value of capital arising from issuing preference shares. [Refer: Issued capital]"
       }
      }
     },
     "auth_ref": [
      "r652"
     ]
    },
    "mlec_IssuedConvertiblePreferenceShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "IssuedConvertiblePreferenceShares",
     "presentation": [
      "http://www.moolecscience.com/role/EventsOccurringAftertheReportingPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issued convertible preference shares (in Shares)",
        "documentation": "The number of issued convertible preference shares.",
        "label": "Issued Convertible Preference Shares"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ItemsThatWillNotBeSubsequentlyReclassifiedToLossAndProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ItemsThatWillNotBeSubsequentlyReclassifiedToLossAndProfit",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Items that will not be subsequently reclassified to loss and profit",
        "documentation": "Items that will not be subsequently reclassified to loss and profit.",
        "label": "Items That Will Not Be Subsequently Reclassified To Loss And Profit"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_JointVenturesAndAssociatesAccountedForUsingEquityMethodReclassificationChangeInOwnership": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "JointVenturesAndAssociatesAccountedForUsingEquityMethodReclassificationChangeInOwnership",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinJointVenturesInvestmentsandAffiliatesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Reclassification of Moolec Science S.A.",
        "documentation": "The amount of associates and joint ventures accounted for using equity method reclassified from equity method due to change in ownership.",
        "label": "Joint Ventures And Associates Accounted For Using Equity Method Reclassification Change In Ownership"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_JointVenturesAndAssociatesLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "JointVenturesAndAssociatesLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Joint ventures and associates",
        "documentation": "Represent the amount of joint ventures and associates.",
        "label": "Joint Ventures And Associates Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_JointVenturesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "JointVenturesAxis",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofJointVenturesAssetsTable",
      "http://www.moolecscience.com/role/ScheduleofShareofProfitorLossofJointVenturesandAffiliatesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Joint ventures [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r49",
      "r129",
      "r350"
     ]
    },
    "ifrs-full_JointVenturesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "JointVenturesDomain",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofJointVenturesAssetsTable",
      "http://www.moolecscience.com/role/ScheduleofShareofProfitorLossofJointVenturesandAffiliatesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Joint ventures [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Joint ventures' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r49",
      "r129",
      "r350"
     ]
    },
    "mlec_JointVenturesInvestmentsAndAffiliatesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "JointVenturesInvestmentsAndAffiliatesMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinJointVenturesInvestmentsandAffiliatesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Joint Ventures Investments and Affiliates [Member]",
        "label": "Joint Ventures Investments And Affiliates Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_JointVenturesWhereEntityIsVenturerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "JointVenturesWhereEntityIsVenturerMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTransactionsBetweentheGroupandRelatedPartiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Joint ventures and associates [Member]",
        "label": "Joint ventures where entity is venturer [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for joint ventures in which the entity is a joint venturer. A venturer is a party to a joint venture and has joint control over that joint venture. [Refer: Total for all joint ventures [member]]"
       }
      }
     },
     "auth_ref": [
      "r33",
      "r285"
     ]
    },
    "mlec_JointVenturesandAssociatesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "JointVenturesandAssociatesDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/JointVenturesandAssociatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Joint Ventures and Associates (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinJointVenturesInvestmentsandAffiliatesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Changes in Joint Ventures Investments and Affiliates [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "JointVenturesandAssociatesScheduleofChangesinJointVenturesInvestmentsandAffiliatesDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinJointVenturesInvestmentsandAffiliatesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Joint Ventures and Associates - Schedule of Changes in Joint Ventures Investments and Affiliates (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_JointVenturesandAssociatesScheduleofJointVenturesAssetsDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "JointVenturesandAssociatesScheduleofJointVenturesAssetsDetailsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofJointVenturesAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Joint Ventures and Associates - Schedule of Joint Ventures Assets (Details) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_JointVenturesandAssociatesScheduleofJointVenturesAssetsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "JointVenturesandAssociatesScheduleofJointVenturesAssetsDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofJointVenturesAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Joint Ventures and Associates - Schedule of Joint Ventures Assets (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_JointVenturesandAssociatesScheduleofSignificantJointVenturesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "JointVenturesandAssociatesScheduleofSignificantJointVenturesDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofSignificantJointVenturesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Joint Ventures and Associates - Schedule of Significant Joint Ventures (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_KeyManagementPersonnelBenefitsLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "KeyManagementPersonnelBenefitsLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofEmployeeBenefitsandSocialSecurityTable": {
       "parentTag": "ifrs-full_CurrentProvisionsForEmployeeBenefits",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofEmployeeBenefitsandSocialSecurityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Key management personnel (Note 18)",
        "documentation": "The amount of current liability related to key management personnel.",
        "label": "Key Management Personnel Benefits Liability Current"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_KeyManagementPersonnelCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "KeyManagementPersonnelCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofCompensationofKeyManagementPersonnelCompensationTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofCompensationofKeyManagementPersonnelCompensationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Key management personnel compensation"
       }
      }
     },
     "auth_ref": [
      "r31",
      "r283"
     ]
    },
    "mlec_KeyManagementPersonnelCompensationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "KeyManagementPersonnelCompensationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Key Management Personnel Compensation [Abstract]",
        "documentation": "No definition available."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "KeyManagementPersonnelCompensationSharebasedPayment",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofCompensationofKeyManagementPersonnelCompensationTable": {
       "parentTag": "ifrs-full_KeyManagementPersonnelCompensation",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofCompensationofKeyManagementPersonnelCompensationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share based payment",
        "label": "Key management personnel compensation, share-based payment"
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "KeyManagementPersonnelCompensationShorttermEmployeeBenefits",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofCompensationofKeyManagementPersonnelCompensationTable": {
       "parentTag": "ifrs-full_KeyManagementPersonnelCompensation",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofCompensationofKeyManagementPersonnelCompensationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term employee benefits",
        "label": "Key management personnel compensation, short-term employee benefits"
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "ifrs-full_KeyManagementPersonnelOfEntityOrParentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "KeyManagementPersonnelOfEntityOrParentMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTransactionsBetweentheGroupandRelatedPartiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shareholders and other related parties [Member]",
        "verboseLabel": "Key management personnel [Member]",
        "label": "Key management personnel of entity or parent [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for those persons having authority and responsibility for planning, directing and controlling the activities of the entity, directly or indirectly, including any director (whether executive or otherwise) of that entity."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r286"
     ]
    },
    "ifrs-full_LandAndBuildings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LandAndBuildings",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Land and buildings",
        "label": "Land and buildings"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of property, plant and equipment representing land and depreciable buildings and similar structures for use in operations. [Refer: Buildings; Land; Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r423"
     ]
    },
    "ifrs-full_LandAndBuildingsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LandAndBuildingsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofCarryingAmountsthatWouldHaveBeenRecognizedTable",
      "http://www.moolecscience.com/role/ScheduleofPropertyPlantandEquipmentTable",
      "http://www.moolecscience.com/role/ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Land and buildings [Member]",
        "label": "Land and buildings [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing land and depreciable buildings and similar structures for use in operations. [Refer: Buildings; Land; Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r423"
     ]
    },
    "ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LaterThanOneYearAndNotLaterThanThreeYearsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofLiquidityRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Between one and three years [Member]",
        "label": "Later than one year and not later than three years [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than one year and not later than three years."
       }
      }
     },
     "auth_ref": [
      "r460",
      "r461",
      "r463"
     ]
    },
    "ifrs-full_LaterThanThreeMonthsAndNotLaterThanOneYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LaterThanThreeMonthsAndNotLaterThanOneYearMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofLiquidityRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "3 to 12 months [Member]",
        "label": "Later than three months and not later than one year [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than three months and not later than one year."
       }
      }
     },
     "auth_ref": [
      "r459"
     ]
    },
    "ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LaterThanThreeYearsAndNotLaterThanFourYearsMember",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "37 through 48 months [Member]",
        "label": "Later than three years and not later than four years [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than three years and not later than four years."
       }
      }
     },
     "auth_ref": [
      "r149",
      "r150",
      "r161",
      "r460",
      "r463",
      "r649"
     ]
    },
    "ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LaterThanTwoYearsAndNotLaterThanThreeYearsMember",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "25 through 36 months [Member]",
        "label": "Later than two years and not later than three years [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than two years and not later than three years."
       }
      }
     },
     "auth_ref": [
      "r149",
      "r150",
      "r161",
      "r460",
      "r463",
      "r649"
     ]
    },
    "srt_LatinAmericaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "LatinAmericaMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofGeographicalInformationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LATAM [Member]",
        "label": "Latin America [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LeaseLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAssetsAcquiredandLiabilitiesAssumedTable",
      "http://www.moolecscience.com/role/ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total",
        "negatedLabel": "Lease liabilities",
        "label": "Lease liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration."
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "ifrs-full_LeaseLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LeaseLiabilitiesAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease Liabilities",
        "label": "Lease liabilities [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_LeaseLiabilitiesInterestExpenseExchangeDifferencesAndInflationEffects": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "LeaseLiabilitiesInterestExpenseExchangeDifferencesAndInflationEffects",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest expenses, exchange differences and inflation effects",
        "documentation": "Lease liabilities additions from interest expense, exchange differences and inflation effects.",
        "label": "Lease Liabilities Interest Expense Exchange Differences And Inflation Effects"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LeaseLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LeaseLiabilitiesMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinancialLiabilitiesbyCategoryTable",
      "http://www.moolecscience.com/role/ScheduleofLiquidityRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liability [Member]",
        "label": "Lease liabilities [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for lease liabilities. [Refer: Lease liabilities]"
       }
      }
     },
     "auth_ref": [
      "r444",
      "r446"
     ]
    },
    "mlec_LeaseLiabilityBeginningOfTheYearinception": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "LeaseLiabilityBeginningOfTheYearinception",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Book value at the beginning of the year/inception",
        "documentation": "The amount of lease liability beginning of the year/inception.",
        "label": "Lease Liability Beginning Of The Yearinception"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LeaseLiabilityInASaleAndLeasebackMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LeaseLiabilityInASaleAndLeasebackMember",
     "presentation": [
      "http://www.moolecscience.com/role/NewStandardsAmendmentsandInterpretationsIssuedbytheIASBDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease Liability in a Sale and Leaseback [Member]",
        "label": "Lease Liability in a Sale and Leaseback [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for Lease Liability in a Sale and Leaseback (Amendments to IFRS 16) issued in September 2022."
       }
      }
     },
     "auth_ref": [
      "r366"
     ]
    },
    "mlec_LeaseLiabiltyAdditionsOfTheYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "LeaseLiabiltyAdditionsOfTheYear",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additions of the year",
        "documentation": "The amount of addition of the lease liablity.",
        "label": "Lease Liabilty Additions Of The Year"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases - Schedule of Right-of-Use and Liabilities Related with Lease Assets (Details) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "LeasesScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases - Schedule of Right-of-Use and Liabilities Related with Lease Assets (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_LeasingLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "LeasingLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofLiquidityRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leasing liabilities",
        "documentation": "Leasing liabilities.",
        "label": "Leasing Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityIdentifier": {
     "xbrltype": "legalEntityIdentifierItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LegalEntityIdentifier",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity Identifier",
        "documentation": "A globally unique ISO 17442 value to identify entities, commonly abbreviated as LEI."
       }
      }
     },
     "auth_ref": [
      "r483"
     ]
    },
    "ifrs-full_Level1OfFairValueHierarchyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "Level1OfFairValueHierarchyMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValuebyHierarchyTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 1 [Member]",
        "label": "Level 1 of fair value hierarchy [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r58",
      "r62",
      "r133",
      "r295",
      "r353"
     ]
    },
    "ifrs-full_Level2OfFairValueHierarchyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "Level2OfFairValueHierarchyMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValuebyHierarchyTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 2 [Member]",
        "label": "Level 2 of fair value hierarchy [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r62",
      "r133",
      "r295",
      "r353"
     ]
    },
    "ifrs-full_Level3OfFairValueHierarchyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "Level3OfFairValueHierarchyMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValuebyHierarchyTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 3 [Member]",
        "label": "Level 3 of fair value hierarchy [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are unobservable inputs for the asset or liability. Unobservable inputs are inputs for which market data are not available and that are developed using the best information available about the assumptions that the market participants would use when pricing the asset or liability."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r62",
      "r133",
      "r295",
      "r353"
     ]
    },
    "ifrs-full_LevelsOfFairValueHierarchyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LevelsOfFairValueHierarchyAxis",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValuebyHierarchyTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Levels of fair value hierarchy [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r133",
      "r353"
     ]
    },
    "ifrs-full_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable": {
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable": {
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet",
      "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable",
      "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits."
       }
      }
     },
     "auth_ref": [
      "r132",
      "r133",
      "r134",
      "r220",
      "r224",
      "r352",
      "r353",
      "r390"
     ]
    },
    "ifrs-full_LiabilitiesArisingFromFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LiabilitiesArisingFromFinancingActivities",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable",
      "http://www.moolecscience.com/role/ScheduleofInterestRateRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "totalLabel": "Liabilities arising from financing activities",
        "label": "Liabilities arising from financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities for which cash flows were, or future cash flows will be, classified in the statement of cash flows as cash flows from financing activities. [Refer: Cash flows from (used in) financing activities; Liabilities]"
       }
      }
     },
     "auth_ref": [
      "r255",
      "r445"
     ]
    },
    "ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LiabilitiesArisingFromFinancingActivitiesAxis",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities arising from financing activities [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r255",
      "r445"
     ]
    },
    "ifrs-full_LiabilitiesArisingFromFinancingActivitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LiabilitiesArisingFromFinancingActivitiesDomain",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities arising from financing activities [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for liabilities arising from financing activities. It also represents the standard value for the 'Liabilities arising from financing activities' axis if no other member is used. [Refer: Liabilities arising from financing activities]"
       }
      }
     },
     "auth_ref": [
      "r255",
      "r445"
     ]
    },
    "mlec_LiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "LiabilitiesMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinAllowancesandProvisionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities [Member]",
        "label": "Liabilities Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LicenceFeeIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LicenceFeeIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofOperatingResultsGroupsReportingSegmentsTable": {
       "parentTag": "ifrs-full_Revenue",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.moolecscience.com/role/ScheduleofRevenuefromContractswithCustomersTable": {
       "parentTag": "ifrs-full_RevenueFromContractsWithCustomers",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOperatingResultsGroupsReportingSegmentsTable",
      "http://www.moolecscience.com/role/ScheduleofRevenuefromContractswithCustomersTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right of use licenses",
        "label": "Licence fee income"
       }
      }
     },
     "auth_ref": [
      "r649"
     ]
    },
    "ifrs-full_LicencesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LicencesMember",
     "presentation": [
      "http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Certification ISO Standards [Member]",
        "label": "Licences [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets representing the right to use certain intangible assets owned by another entity. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r629"
     ]
    },
    "mlec_LicensesandPatents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "LicensesandPatents",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable": {
       "parentTag": "ifrs-full_ResearchAndDevelopmentExpense",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofExpensesClassifiedbyNatureandFunctionTable",
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Licenses &amp; Patents",
        "documentation": "Licenses &amp; Patents.",
        "label": "Licensesand Patents"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LiquidityRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LiquidityRiskMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofLiquidityRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liquidity risk [Member]",
        "label": "Liquidity risk [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the risk that an entity will encounter difficulty in meeting obligations associated with financial liabilities that are settled by delivering cash or another financial asset. [Refer: Financial assets; Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r156",
      "r157",
      "r158",
      "r457"
     ]
    },
    "mlec_LoansReceivablesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "LoansReceivablesMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOtherReceivablesTable",
      "http://www.moolecscience.com/role/ScheduleofTransactionsBetweentheGroupandRelatedPartiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loans receivables [Member]",
        "label": "Loans Receivables Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LoansReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LoansReceived",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible note received (in Dollars)",
        "label": "Loans received"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of loans received."
       }
      }
     },
     "auth_ref": [
      "r649"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LongtermBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LongtermBorrowings",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet",
      "http://www.moolecscience.com/role/ScheduleofBorrowingsCarryingAmountTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings",
        "verboseLabel": "Non current borrowing",
        "label": "Non-current portion of non-current borrowings"
       }
      },
      "en": {
       "role": {
        "documentation": "The non-current portion of non-current borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r651"
     ]
    },
    "mlec_LossMakingEntitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "LossMakingEntitiesMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss-making entities [Member]",
        "documentation": "This member stands for loss-making entities.",
        "label": "Loss Making Entities Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_LossOfControl": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "LossOfControl",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofCostofSalesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss of control",
        "documentation": "The amount of loss of control.",
        "label": "Loss Of Control"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_LossOfControlDepreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "LossOfControlDepreciation",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss of control",
        "documentation": "Loss of control.",
        "label": "Loss Of Control Depreciation"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_LossOfControlLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "LossOfControlLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss of control",
        "documentation": "Loss of control.",
        "label": "Loss Of Control Lease Liability"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_LossOfControlonBiologicalAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "LossOfControlonBiologicalAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinBiologicalAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Loss of control",
        "documentation": "The amount of loss of control on biological assets.",
        "label": "Loss Of Controlon Biological Assets"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LossesOnDisposalsOfInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LossesOnDisposalsOfInvestments",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinJointVenturesInvestmentsandAffiliatesTable",
      "http://www.moolecscience.com/role/ScheduleofGovernmentGrantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Loss of control",
        "label": "Losses on disposals of investments"
       }
      },
      "en": {
       "role": {
        "documentation": "The losses on the disposal of investments."
       }
      }
     },
     "auth_ref": [
      "r417"
     ]
    },
    "mlec_LowOrNullTaxationJurisdictionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "LowOrNullTaxationJurisdictionsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Low or null taxation jurisdictions [Member]",
        "documentation": "This member stands for low or null taxation jurisdictions.",
        "label": "Low Or Null Taxation Jurisdictions Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_Machinery": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "Machinery",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Machinery and equipment",
        "label": "Machinery"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of property, plant and equipment representing long-lived, depreciable machinery used in operations. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r424"
     ]
    },
    "mlec_MachineryAndEquipmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "MachineryAndEquipmentsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofPropertyPlantandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Machinery and Equipment [Member]",
        "label": "Machinery And Equipments Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_MachineryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "MachineryMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Machinery and equipment [Member]",
        "label": "Machinery [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing long-lived, depreciable machinery used in operations. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r424"
     ]
    },
    "ifrs-full_MajorBusinessCombinationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "MajorBusinessCombinationMember",
     "presentation": [
      "http://www.moolecscience.com/role/EventsOccurringAftertheReportingPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forecast [Member]",
        "label": "Major business combination [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for major business combinations. [Refer: Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r420",
      "r468"
     ]
    },
    "ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "MajorComponentsOfTaxExpenseIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ManagementExpensesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ManagementExpensesMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRevenuebySimilarGroupofProductsorServicesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Management Expenses [Member]",
        "label": "Management Expenses Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_MandatorilyMeasuredAtFairValueThroughProfitOrLossMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "MandatorilyMeasuredAtFairValueThroughProfitOrLossMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinancialAssetsbyCategoryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mandatorily measured at fair value through profit or loss [Member]",
        "label": "Mandatorily Measured At Fair Value Through Profit Or Loss Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_MaturityAnalysisForNonderivativeFinancialLiabilities": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "MaturityAnalysisForNonderivativeFinancialLiabilities",
     "presentation": [
      "http://www.moolecscience.com/role/FinancialInstrumentsRiskManagementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Liquidity Risk",
        "label": "Disclosure of maturity analysis for non-derivative financial liabilities [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of a maturity analysis for non-derivative financial liabilities (including issued financial guarantee contracts) that shows the remaining contractual maturities. [Refer: Derivative financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r207",
      "r348"
     ]
    },
    "ifrs-full_MaturityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "MaturityAxis",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails",
      "http://www.moolecscience.com/role/ScheduleofLiquidityRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maturity [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r142",
      "r149",
      "r150",
      "r153",
      "r154",
      "r155",
      "r161",
      "r193",
      "r208",
      "r235",
      "r239",
      "r244",
      "r245",
      "r342",
      "r392",
      "r429",
      "r460"
     ]
    },
    "ifrs-full_MaturityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "MaturityDomain",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maturity [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregated time bands. It also represents the standard value for the 'Maturity' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r142",
      "r149",
      "r150",
      "r153",
      "r154",
      "r155",
      "r161",
      "r193",
      "r235",
      "r239",
      "r244",
      "r245",
      "r342",
      "r392",
      "r429",
      "r460",
      "r462"
     ]
    },
    "mlec_MaximumPercentageOfCapitalForObligationToLegalReserve": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "MaximumPercentageOfCapitalForObligationToLegalReserve",
     "presentation": [
      "http://www.moolecscience.com/role/JointVenturesandAssociatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Legal reserve required, as percent of capital",
        "documentation": "The maximum percentage of capital establish an obligation to legal reserve on ability of the joint venture to transfer funds to the Group in the form of cash dividends, or to repay loans or advances made by the Group.",
        "label": "Maximum Percentage Of Capital For Obligation To Legal Reserve"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "auth_ref": [
      "r559"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r559"
     ]
    },
    "mlec_MeasuredAtEquityValueMethodAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "MeasuredAtEquityValueMethodAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofJointVenturesAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measured at equity value method",
        "label": "Measured At Equity Value Method Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_MeasuredAtEquityValueMethodAbstract0": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "MeasuredAtEquityValueMethodAbstract0",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofJointVenturesAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measured at equity value method",
        "label": "Measured At Equity Value Method Abstract0"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_MeasuredAtEquityValueMethodAbstract1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "MeasuredAtEquityValueMethodAbstract1",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofShareofProfitorLossofJointVenturesandAffiliatesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measured at equity value method",
        "label": "Measured At Equity Value Method Abstract1"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_MeasuredAtFairValueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "MeasuredAtFairValueAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofJointVenturesAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measured at Fair value",
        "label": "Measured At Fair Value Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_MeasuredAtFairValueAbstract0": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "MeasuredAtFairValueAbstract0",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofShareofProfitorLossofJointVenturesandAffiliatesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measured at Fair value",
        "label": "Measured At Fair Value Abstract0"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_MeasurementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "MeasurementAxis",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofBorrowingsCarryingAmountTable",
      "http://www.moolecscience.com/role/ScheduleofFinancialAssetsbyCategoryTable",
      "http://www.moolecscience.com/role/ScheduleofFinancialLiabilitiesbyCategoryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r84",
      "r132",
      "r314",
      "r352"
     ]
    },
    "mlec_MicroBeadedFertilizersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "MicroBeadedFertilizersMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRevenuebySimilarGroupofProductsorServicesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Micro-Beaded Fertilizers [Member]",
        "documentation": "This member stands for micro-beaded fertilizers.",
        "label": "Micro Beaded Fertilizers Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_MicrobiologicalProductsInProgressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "MicrobiologicalProductsInProgressMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Microbiological products in progress [Member]",
        "label": "Microbiological Products In Progress Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_MicrobiologicalProductsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "MicrobiologicalProductsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Microbiological products [Member]",
        "label": "Microbiological Products Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_MicrobiologicalProductsProducedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "MicrobiologicalProductsProducedMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofInventoriesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Manufactured products [Member]",
        "documentation": "This member stands for information pertaining to microbiological products produced.",
        "label": "Microbiological Products Produced Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_MicrobiologicalResaleProductsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "MicrobiologicalResaleProductsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofInventoriesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Resale products [Member]",
        "documentation": "This member stands for information pertaining to Microbiological resale products.",
        "label": "Microbiological Resale Products Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_MiscellaneousMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "MiscellaneousMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOtherReceivablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Miscellaneous\t[Member]",
        "label": "Miscellaneous Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_MiscellaneousOtherOperatingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "MiscellaneousOtherOperatingExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable": {
       "parentTag": "ifrs-full_ResearchAndDevelopmentExpense",
       "weight": 1.0,
       "order": 23.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofExpensesClassifiedbyNatureandFunctionTable",
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Miscellaneous",
        "label": "Miscellaneous other operating expense"
       }
      }
     },
     "auth_ref": [
      "r649"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r579"
     ]
    },
    "mlec_MoolecScienceCaymanIslandsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "MoolecScienceCaymanIslandsMember",
     "presentation": [
      "http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Moolec Science (Cayman Islands) [Member]",
        "label": "Moolec Science Cayman Islands Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_MoolecScienceLimitedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "MoolecScienceLimitedMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofInformationrelatedtoCompanysShareofVotingRightsinitsSubsidiariesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Moolec Science Limited [Member]",
        "label": "Moolec Science Limited Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_MoolecScienceLuxembourgMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "MoolecScienceLuxembourgMember",
     "presentation": [
      "http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Moolec Science (Luxembourg) [Member[",
        "label": "Moolec Science Luxembourg Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_MoolecScienceSAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "MoolecScienceSAMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAssetsAcquiredandLiabilitiesAssumedTable",
      "http://www.moolecscience.com/role/ScheduleofShareofProfitorLossofJointVenturesandAffiliatesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Moolec Science SA [Member]",
        "label": "Moolec Science SAMember"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_MoolecScienceSASharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "MoolecScienceSASharesMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValuebyHierarchyTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Moolec Science SA shares [Member]",
        "label": "Moolec Science SAShares Member"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r587"
     ]
    },
    "mlec_MutualFunds": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "MutualFunds",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofCashandCashEquivalentsTable": {
       "parentTag": "ifrs-full_CashAndCashEquivalents",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofCashandCashEquivalentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mutual funds",
        "documentation": "Mutual funds.",
        "label": "Mutual Funds"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_MutualFundsAdjustment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "MutualFundsAdjustment",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofWeightedAverageTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mutual funds adjustments",
        "documentation": "Represent the amount of mutual funds adjustments.\r   \n.",
        "label": "Mutual Funds Adjustment"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_MutualFundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "MutualFundsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValuebyHierarchyTable",
      "http://www.moolecscience.com/role/ScheduleofOtherFinancialAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mutual funds [Member]",
        "documentation": "The member stands for mutual funds.",
        "label": "Mutual Funds Member"
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NameChangeEventDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event Date [Axis]",
        "documentation": "For a sequence of name change event related facts, use this typed dimension to distinguish them. The axis members are restricted to be a valid for xml schema 'date' or 'datetime' data type."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NameChangeEventLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Line Items]",
        "documentation": "Line items represent concepts included in a table. Name change event line item concepts are used for information qualified by domain members of axes in the Name Change Event table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NameChangeEventTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Table]",
        "documentation": "For a set of related facts in a sequence of name change events, use this table when the events occurred within a single reporting period."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NameOfSubsidiary": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NameOfSubsidiary",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofInformationrelatedtoCompanysShareofVotingRightsinitsSubsidiariesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Principal activities",
        "label": "Name of subsidiary"
       }
      },
      "en": {
       "role": {
        "documentation": "The name of a subsidiary. [Refer: Total for all subsidiaries [member]]"
       }
      }
     },
     "auth_ref": [
      "r42",
      "r46",
      "r108",
      "r113"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r560"
     ]
    },
    "mlec_NatalAgroSRLMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "NatalAgroSRLMember",
     "presentation": [
      "http://www.moolecscience.com/role/AcquisitionsandOtherSignificantTransactionsDetails",
      "http://www.moolecscience.com/role/ScheduleofFairValueoftheConsiderationofPaymentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Natal Agro S. R. L. [Member]",
        "documentation": "This member stands for Natal Agro S.R.L.",
        "label": "Natal Agro SRLMember"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_NetAssetsAcquisitionByBusinessCombination": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "NetAssetsAcquisitionByBusinessCombination",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesTable": {
       "parentTag": "mlec_NonCashInvestingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Net assets acquisition by business combination",
        "documentation": "The amount recognised as of the acquisition date for net assets acquired or liabilities assumed in a business combination.",
        "label": "Net Assets Acquisition By Business Combination"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NetDeferredTaxAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NetDeferredTaxAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable",
      "http://www.moolecscience.com/role/ScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance",
        "periodEndLabel": "Balance",
        "terseLabel": "Total deferred tax assets",
        "label": "Net deferred tax assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of deferred tax assets net of deferred tax liabilities, when the absolute amount of deferred tax assets is greater than the absolute amount of deferred tax liabilities. [Refer: Deferred tax assets; Deferred tax liabilities]"
       }
      }
     },
     "auth_ref": [
      "r618"
     ]
    },
    "ifrs-full_NetDeferredTaxAssetsAndLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NetDeferredTaxAssetsAndLiabilitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Deferred Tax Assets and Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NetDeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NetDeferredTaxLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total deferred tax liabilities",
        "label": "Net deferred tax liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of deferred tax liabilities net of deferred tax assets, when the absolute amount of deferred tax liabilities is greater than the absolute amount of deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]"
       }
      }
     },
     "auth_ref": [
      "r618"
     ]
    },
    "mlec_NetGainOnInflationEffectOnMonetary": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "NetGainOnInflationEffectOnMonetary",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinanceResultsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net gain of inflation effect on monetary items",
        "documentation": "Net gain of inflation effect on monetary items.",
        "label": "Net Gain On Inflation Effect On Monetary"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_NetHB4SoybeanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "NetHB4SoybeanMember",
     "presentation": [
      "http://www.moolecscience.com/role/InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net HB4 Soybean [Member]",
        "label": "Net HB4 Soybean Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_NetLoansGrantedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "NetLoansGrantedMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTransactionsBetweentheGroupandRelatedPartiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loans granted [Member]",
        "label": "Net Loans Granted Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_NetLoansGrantedOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "NetLoansGrantedOneMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTransactionsBetweentheGroupandRelatedPartiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Loans Granted One [Member]",
        "label": "Net Loans Granted One Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_NetLoansPayablesJointVenturesAndAssociatesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "NetLoansPayablesJointVenturesAndAssociatesMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofBorrowingsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loans payables- Joint ventures and associates [Member]",
        "label": "Net Loans Payables Joint Ventures And Associates Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_NetLoansPayablesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "NetLoansPayablesMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTransactionsBetweentheGroupandRelatedPartiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loans payables [Member]",
        "label": "Net Loans Payables Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_NetLoansReceivedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "NetLoansReceivedMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTransactionsBetweentheGroupandRelatedPartiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loans received [Member]",
        "label": "Net Loans Received Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_NetResultFromCommercializationOfAgriculturalProducts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "NetResultFromCommercializationOfAgriculturalProducts",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofOtherIncomeorExpensesNetTable": {
       "parentTag": "ifrs-full_OtherOperatingIncomeExpense",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOtherIncomeorExpensesNetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Net result from commercialization of agricultural products",
        "documentation": "The amount of net result from commercialization of agricultural products.",
        "label": "Net Result From Commercialization Of Agricultural Products"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_NetWheatTechnologyLicensingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "NetWheatTechnologyLicensingMember",
     "presentation": [
      "http://www.moolecscience.com/role/InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Wheat Technology Licensing [Member]",
        "label": "Net Wheat Technology Licensing Member"
       }
      }
     },
     "auth_ref": []
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NewEffectiveDateForPreviousFiling",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "auth_ref": [
      "r530",
      "r531",
      "r532",
      "r533"
     ]
    },
    "mlec_NewStandardsAmendmentsAndInterpretationsIssuedByTheIASBAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "NewStandardsAmendmentsAndInterpretationsIssuedByTheIASBAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "New Standards, Amendments and Interpretations Issued by the IASB [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_NewStandardsAmendmentsandInterpretationsIssuedbytheIASBDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "NewStandardsAmendmentsandInterpretationsIssuedbytheIASBDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/NewStandardsAmendmentsandInterpretationsIssuedbytheIASBDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Standards, Amendments and Interpretations Issued by the IASB (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoSubstantiveChanges462c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoSubstantiveChanges462c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "auth_ref": [
      "r611"
     ]
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoSubstantiveChanges462cFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "auth_ref": [
      "r611"
     ]
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "mlec_NonCashFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "NonCashFinancingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Financing Activities",
        "documentation": "The amount of non cash financing activities.",
        "label": "Non Cash Financing Activities"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_NonCashInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "NonCashInvestingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Investment Activities",
        "documentation": "The amount of non cash investing activities.",
        "label": "Non Cash Investing Activities"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_NonCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "NonCurrentAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOtherFinancialAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-current",
        "label": "Non Current Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_NonCurrentAbstract0": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "NonCurrentAbstract0",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOtherReceivablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-current",
        "label": "Non Current Abstract0"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_NonCurrentAbstract1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "NonCurrentAbstract1",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofDeferredRevenueandAdvancesfromCustomersTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non current",
        "label": "Non Current Abstract1"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_NonCurrentAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "NonCurrentAssetsAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofGeographicalInformationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-current assets",
        "label": "Non Current Assets Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r559"
     ]
    },
    "mlec_NonMonetaryContributionsInJointVenturesNonCashTransactionsInvestmentActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "NonMonetaryContributionsInJointVenturesNonCashTransactionsInvestmentActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesTable": {
       "parentTag": "mlec_NonCashInvestingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification from Investment properties to property, plant and equipment",
        "documentation": "The amount of non-monetary contributions in joint ventures, non cash transactions investment activities.",
        "label": "Non Monetary Contributions In Joint Ventures Non Cash Transactions Investment Activities"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "auth_ref": [
      "r514",
      "r525",
      "r541",
      "r567",
      "r576"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r550"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r549"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "auth_ref": [
      "r567"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r587"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r587"
     ]
    },
    "ifrs-full_NonadjustingEventsAfterReportingPeriodAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NonadjustingEventsAfterReportingPeriodAxis",
     "presentation": [
      "http://www.moolecscience.com/role/EventsOccurringAftertheReportingPeriodDetails",
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails",
      "http://www.moolecscience.com/role/ReverseStockSplitAftertheReportingPeriodDetails",
      "http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-adjusting events after reporting period [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r264"
     ]
    },
    "ifrs-full_NonadjustingEventsAfterReportingPeriodDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NonadjustingEventsAfterReportingPeriodDomain",
     "presentation": [
      "http://www.moolecscience.com/role/EventsOccurringAftertheReportingPeriodDetails",
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails",
      "http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-adjusting events after reporting period [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for events that occur between the end of the reporting period and the date when the financial statements are authorised for issue and are indicative of conditions that arose after the reporting period. It also represents the standard value for the 'Non-adjusting events after reporting period' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r264"
     ]
    },
    "mlec_NoncashActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "NoncashActivities",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash activities",
        "documentation": "Non-cash activities.",
        "label": "Noncash Activities"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_NoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "NoncontrollingInterest",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAssetsAcquiredandLiabilitiesAssumedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-controlling interest",
        "documentation": "The amount of non-controlling interest information components.",
        "label": "Noncontrolling Interest"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NoncontrollingInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncontrollingInterests",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-controlling interest",
        "label": "Non-controlling interests"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of equity in a subsidiary not attributable, directly or indirectly, to a parent. [Refer: Total for all subsidiaries [member]]"
       }
      }
     },
     "auth_ref": [
      "r107",
      "r112",
      "r388"
     ]
    },
    "ifrs-full_NoncontrollingInterestsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncontrollingInterestsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-controlling Interests",
        "label": "Non-controlling interests [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for equity in a subsidiary not attributable, directly or indirectly, to the parent."
       }
      }
     },
     "auth_ref": [
      "r372"
     ]
    },
    "ifrs-full_NoncurrentAdvances": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentAdvances",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofDeferredRevenueandAdvancesfromCustomersTable": {
       "parentTag": "ifrs-full_NoncurrentDeferredIncomeIncludingNoncurrentContractLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofDeferredRevenueandAdvancesfromCustomersTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Advances from customers",
        "label": "Non-current advances received, representing non-current contract liabilities for performance obligations satisfied at point in time"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current advances received representing non-current contract liabilities for performance obligations satisfied at a point in time. [Refer: Advances received, representing contract liabilities for performance obligations satisfied at point in time]"
       }
      }
     },
     "auth_ref": [
      "r651",
      "r653"
     ]
    },
    "mlec_NoncurrentAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "NoncurrentAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable": {
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-current assets",
        "documentation": "Non-current assets.",
        "label": "Noncurrent Asset"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable": {
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet",
      "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable",
      "http://www.moolecscience.com/role/ScheduleofGeographicalInformationTable",
      "http://www.moolecscience.com/role/ScheduleofSignificantJointVenturesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total non-current assets",
        "terseLabel": "Non-current assets",
        "verboseLabel": "Total non-current assets",
        "label": "Non-current assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets that do not meet the definition of current assets. [Refer: Current assets]"
       }
      }
     },
     "auth_ref": [
      "r119",
      "r393",
      "r447"
     ]
    },
    "ifrs-full_NoncurrentAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentAssetsAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NON-CURRENT ASSETS",
        "label": "Non-current assets [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NoncurrentContractLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentContractLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue and advances from customers",
        "label": "Non-current contract liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current contract liabilities. [Refer: Contract liabilities]"
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "ifrs-full_NoncurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofDeferredRevenueandAdvancesfromCustomersTable": {
       "parentTag": "ifrs-full_NoncurrentDeferredIncomeIncludingNoncurrentContractLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofDeferredRevenueandAdvancesfromCustomersTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue",
        "label": "Non-current contract liabilities for performance obligations satisfied over time"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current contract liabilities for performance obligations satisfied over time. [Refer: Contract liabilities for performance obligations satisfied over time]"
       }
      }
     },
     "auth_ref": [
      "r651",
      "r653"
     ]
    },
    "ifrs-full_NoncurrentDeferredIncomeIncludingNoncurrentContractLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentDeferredIncomeIncludingNoncurrentContractLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofDeferredRevenueandAdvancesfromCustomersTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofDeferredRevenueandAdvancesfromCustomersTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total non current deferred revenue and advances from customers",
        "label": "Non-current deferred income including non-current contract liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current deferred income including non-current contract liabilities. [Refer: Deferred income including contract liabilities]"
       }
      }
     },
     "auth_ref": [
      "r651",
      "r653"
     ]
    },
    "ifrs-full_NoncurrentFinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentFinancialLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofInterestRateRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-current financial liabilities",
        "label": "Non-current financial liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current financial liabilities. [Refer: Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r196"
     ]
    },
    "ifrs-full_NoncurrentGovernmentGrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentGovernmentGrants",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Government grants",
        "label": "Non-current government grants"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current government grants recognised on the statement of financial position as deferred income. [Refer: Government [member]; Government grants]"
       }
      }
     },
     "auth_ref": [
      "r651"
     ]
    },
    "ifrs-full_NoncurrentLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentLeaseLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet",
      "http://www.moolecscience.com/role/ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liabilities",
        "verboseLabel": "Non-current",
        "label": "Non-current lease liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current lease liabilities. [Refer: Lease liabilities]"
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "ifrs-full_NoncurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable": {
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable": {
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet",
      "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable",
      "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable",
      "http://www.moolecscience.com/role/ScheduleofSignificantJointVenturesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total non-current liabilities",
        "terseLabel": "Non-current liabilities",
        "verboseLabel": "Non- current liabilities",
        "label": "Non-current liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]"
       }
      }
     },
     "auth_ref": [
      "r121",
      "r394",
      "r447"
     ]
    },
    "ifrs-full_NoncurrentLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentLiabilitiesAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NON-CURRENT LIABILITIES",
        "label": "Non-current liabilities [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NoncurrentLiabilitiesWithCovenantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentLiabilitiesWithCovenantsMember",
     "presentation": [
      "http://www.moolecscience.com/role/NewStandardsAmendmentsandInterpretationsIssuedbytheIASBDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-current Liabilities with Covenants [member]",
        "label": "Non-current Liabilities with Covenants [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for Noncurrent Liabilities with Covenants (Amendments to IAS 1) issued in October 2022."
       }
      }
     },
     "auth_ref": [
      "r365"
     ]
    },
    "ifrs-full_NoncurrentPortionOfNoncurrentBorrowingsByTypeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentPortionOfNoncurrentBorrowingsByTypeAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofBorrowingsCarryingAmountTable",
      "http://www.moolecscience.com/role/ScheduleofBorrowingsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-current",
        "verboseLabel": "Non current",
        "label": "Non-current portion of non-current borrowings, by type [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NoncurrentProvisions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentProvisions",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet",
      "http://www.moolecscience.com/role/ScheduleofProvisionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Provisions",
        "label": "Non-current provisions"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current provisions, including provisions for employee benefits. [Refer: Provisions]"
       }
      }
     },
     "auth_ref": [
      "r385"
     ]
    },
    "srt_NorthAmericaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "NorthAmericaMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofGeographicalInformationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "North America [Member]",
        "label": "North America [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NotLaterThanThreeMonthsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NotLaterThanThreeMonthsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofLiquidityRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Up to 3 months [Member]",
        "label": "Not later than three months [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of not later than three months."
       }
      }
     },
     "auth_ref": [
      "r649"
     ]
    },
    "ifrs-full_NotesAndOtherExplanatoryInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NotesAndOtherExplanatoryInformationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "The Group\u2019s Business Reorganization and General Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NotionalAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NotionalAmount",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nominal value (in Dollars)",
        "label": "Notional amount"
       }
      },
      "en": {
       "role": {
        "documentation": "The nominal or face amount of a financial instrument, used to calculate payments made on that instrument."
       }
      }
     },
     "auth_ref": [
      "r649"
     ]
    },
    "mlec_NumberOfComplementaryComponents": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "NumberOfComplementaryComponents",
     "presentation": [
      "http://www.moolecscience.com/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of complementary components",
        "documentation": "The number of complementary components of the segments",
        "label": "Number Of Complementary Components"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_NumberOfNominalValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "NumberOfNominalValue",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofNumberofSharesIssuedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nominal Value (in Dollars per share)",
        "documentation": "The per share of nominal value.",
        "label": "Number Of Nominal Value"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_NumberOfOptionsEstimatedExercisePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "NumberOfOptionsEstimatedExercisePercent",
     "presentation": [
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimates of options that will be exercised",
        "documentation": "The estimate of share options that will be exercise, as a percent.",
        "label": "Number Of Options Estimated Exercise Percent"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NumberOfOutstandingShareOptions": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NumberOfOutstandingShareOptions",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOptionActivityandWeightedAverageExercisePriceTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Number of options, At the beginning of the year",
        "periodEndLabel": "Number of options, Effective at the end of the year",
        "label": "Number of share options outstanding in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options outstanding in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r164",
      "r169",
      "r171",
      "r319",
      "r324"
     ]
    },
    "ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NumberOfShareOptionsExercisedInSharebasedPaymentArrangement",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOptionActivityandWeightedAverageExercisePriceTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Number of options, Exercised during the year",
        "label": "Number of share options exercised in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options exercised in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r167",
      "r322"
     ]
    },
    "ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NumberOfShareOptionsExpiredInSharebasedPaymentArrangement",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOptionActivityandWeightedAverageExercisePriceTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Number of options, Cancelled or expired during the year",
        "label": "Number of share options expired in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options expired in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r168",
      "r323"
     ]
    },
    "ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOptionActivityandWeightedAverageExercisePriceTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Number of options, Loss of control",
        "label": "Number of share options forfeited in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options forfeited in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r166",
      "r321"
     ]
    },
    "ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NumberOfShareOptionsGrantedInSharebasedPaymentArrangement",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOptionActivityandWeightedAverageExercisePriceTable",
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of options, Granted during the year",
        "verboseLabel": "Number of options, granted during the year",
        "label": "Number of share options granted in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options granted in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r165",
      "r320"
     ]
    },
    "mlec_NumberOfSharesAcquiredInBusinessCombination": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "NumberOfSharesAcquiredInBusinessCombination",
     "presentation": [
      "http://www.moolecscience.com/role/AcquisitionsandOtherSignificantTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares acquired (in Shares)",
        "documentation": "Represents the number of shares acquired in business combination.",
        "label": "Number Of Shares Acquired In Business Combination"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NumberOfSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NumberOfSharesIssued",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationDetails",
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails",
      "http://www.moolecscience.com/role/ScheduleofNumberofSharesIssuedTable",
      "http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of Shares",
        "verboseLabel": "Shares received",
        "netLabel": "Ordinary shares",
        "label": "Issued convertible preference shares (in Shares)"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of shares issued by the entity."
       }
      }
     },
     "auth_ref": [
      "r648"
     ]
    },
    "mlec_NumberOfSharesOutstandingPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "NumberOfSharesOutstandingPercentage",
     "presentation": [
      "http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares outstanding, percentage",
        "documentation": "Percentage of number of shares outstanding.",
        "label": "Number Of Shares Outstanding Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_NumberOfSharesPledged": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "NumberOfSharesPledged",
     "presentation": [
      "http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares pledged",
        "documentation": "Total number of shares pledged.",
        "label": "Number Of Shares Pledged"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_NumberOfSharesReverseStockSplit": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "NumberOfSharesReverseStockSplit",
     "presentation": [
      "http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares reverse stock split",
        "documentation": "Number of shares under reverse stock split.",
        "label": "Number Of Shares Reverse Stock Split"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_NumeratorAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "NumeratorAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofWeightedAverageNumberofOrdinarySharesOutstandingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Numerator",
        "label": "Numerator Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_NutreconLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "NutreconLLCMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofInformationrelatedtoCompanysShareofVotingRightsinitsSubsidiariesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nutrecon LLC [Member]",
        "label": "Nutrecon LLCMember"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OfficeEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OfficeEquipmentMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofPropertyPlantandEquipmentTable",
      "http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Office equipment [Member]",
        "label": "Office equipment [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing equipment used to support office functions, not specifically used in the production process. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r426"
     ]
    },
    "mlec_OptionsIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "OptionsIncentivePlanMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOptionActivityandWeightedAverageExercisePriceTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options incentive Plan [Member]",
        "documentation": "This member stands for the option incentive plan.",
        "label": "Options Incentive Plan Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OrdinarySharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OrdinarySharesMember",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationDetails",
      "http://www.moolecscience.com/role/InformationaboutComponentsofEquityDetails",
      "http://www.moolecscience.com/role/ScheduleofNumberofSharesIssuedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary [Member]",
        "verboseLabel": "Ordinary shares [member]",
        "netLabel": "Ordinary shares",
        "label": "Ordinary shares [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for equity instruments that are subordinate to all other classes of equity instruments."
       }
      }
     },
     "auth_ref": [
      "r654"
     ]
    },
    "mlec_OrdinarySharesOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "OrdinarySharesOneMember",
     "presentation": [
      "http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary Shares [Member]",
        "label": "Ordinary Shares One Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_OrdinarySharesWithNominalValueOfUS010PerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "OrdinarySharesWithNominalValueOfUS010PerShareMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary Shares, with nominal value of US$0.10 per share",
        "label": "Ordinary Shares With Nominal Value Of US010 Per Share Member"
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Address [Member]",
        "documentation": "Other address for entity"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherBorrowings",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofBorrowingsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-current Bank borrowings",
        "label": "Other borrowings"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of borrowings that the entity does not separately disclose in the same statement or note. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r649"
     ]
    },
    "ifrs-full_OtherCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherCashAndCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAssetsAcquiredandLiabilitiesAssumedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Other cash and cash equivalents"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of cash and cash equivalents that the entity does not separately disclose in the same statement or note. [Refer: Cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r640"
     ]
    },
    "ifrs-full_OtherCashReceiptsFromSalesOfInterestsInJointVenturesClassifiedAsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherCashReceiptsFromSalesOfInterestsInJointVenturesClassifiedAsInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment in joint ventures and associates",
        "label": "Other cash receipts from sales of interests in joint ventures, classified as investing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from sales of interests in joint ventures (other than receipts for those instruments considered to be cash equivalents and those held for dealing or trading purposes), classified as investing activities. [Refer: Total for all joint ventures [member]]"
       }
      }
     },
     "auth_ref": [
      "r440"
     ]
    },
    "ifrs-full_OtherComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherComprehensiveIncomeAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive income",
        "verboseLabel": "Total comprehensive (loss) / income attributable to:",
        "label": "Other comprehensive income [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherComprehensiveIncomeBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherComprehensiveIncomeBeforeTax",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive loss",
        "label": "Other comprehensive income, before tax"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income, before tax. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r416"
     ]
    },
    "ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofGovernmentGrantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Currency conversion difference",
        "label": "Other comprehensive income, net of tax, exchange differences on translation of foreign operations"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income, net of tax, after reclassification adjustments, related to exchange differences when financial statements of foreign operations are translated. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r395",
      "r415"
     ]
    },
    "ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome": {
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign exchange differences on translation of foreign operations from joint ventures",
        "label": "Other comprehensive income, net of tax, exchange differences on translation, other than translation of foreign operations"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income, net of tax, related to exchange differences on translation of the financial statements of a parent company or a stand-alone entity to a different presentation currency. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r415"
     ]
    },
    "ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revaluation of property, plant and equipment, net of tax",
        "label": "Other comprehensive income, net of tax, gains (losses) on revaluation of property, plant and equipment, right-of-use assets and intangible assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income, net of tax, related to gains (losses) in relation to changes in the revaluation surplus of property, plant and equipment, right-of-use assets and intangible assets. [Refer: Other comprehensive income; Revaluation surplus]"
       }
      }
     },
     "auth_ref": [
      "r395",
      "r415"
     ]
    },
    "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome": {
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Items that may be subsequently reclassified to profit and loss",
        "label": "Other comprehensive income that will be reclassified to profit or loss, net of tax"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income that will be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r481",
      "r482"
     ]
    },
    "mlec_OtherCpProductsAndServicesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "OtherCpProductsAndServicesMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRevenuebySimilarGroupofProductsorServicesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other CP Products and Services [Member]",
        "documentation": "This member stands for Other CP products and services.",
        "label": "Other Cp Products And Services Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_OtherCurrencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "OtherCurrencies",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofCurrencyRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other currencies",
        "documentation": "Represents the value of other currencies.",
        "label": "Other Currencies"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherCurrentFinancialAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherCurrentFinancialAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet",
      "http://www.moolecscience.com/role/ScheduleofOtherFinancialAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other financial assets",
        "verboseLabel": "Investments at fair value",
        "label": "Other current financial assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current financial assets that the entity does not separately disclose in the same statement or note. [Refer: Other financial assets; Current financial assets]"
       }
      }
     },
     "auth_ref": [
      "r379"
     ]
    },
    "ifrs-full_OtherCurrentPayables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherCurrentPayables",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofTradeandOtherPayablesTable": {
       "parentTag": "ifrs-full_TradeAndOtherCurrentPayables",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTradeandOtherPayablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Miscellaneous",
        "label": "Other current payables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current payables that the entity does not separately disclose in the same statement or note."
       }
      }
     },
     "auth_ref": [
      "r651"
     ]
    },
    "ifrs-full_OtherCurrentReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherCurrentReceivables",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet",
      "http://www.moolecscience.com/role/ScheduleofFinancialAssetsbyCategoryTable",
      "http://www.moolecscience.com/role/ScheduleofOtherReceivablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other receivables",
        "verboseLabel": "Other receivables, Current",
        "label": "Other current receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current other receivables. [Refer: Other receivables]"
       }
      }
     },
     "auth_ref": [
      "r472",
      "r479"
     ]
    },
    "ifrs-full_OtherExpenseByFunction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherExpenseByFunction",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofExpensesClassifiedbyNatureandFunctionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Other expense, by function"
       }
      }
     },
     "auth_ref": [
      "r39",
      "r419",
      "r475"
     ]
    },
    "ifrs-full_OtherFinanceIncomeCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherFinanceIncomeCost",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome",
      "http://www.moolecscience.com/role/ScheduleofFinanceResultsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other financial results",
        "verboseLabel": "Other finance results",
        "label": "Other finance income (cost)"
       }
      }
     },
     "auth_ref": [
      "r655"
     ]
    },
    "ifrs-full_OtherFinancialAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherFinancialAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAssetsAcquiredandLiabilitiesAssumedTable",
      "http://www.moolecscience.com/role/ScheduleofFinancialAssetsbyCategoryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other financial assets",
        "label": "Other financial assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of financial assets that the entity does not separately disclose in the same statement or note. [Refer: Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r379"
     ]
    },
    "mlec_OtherFinancialAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "OtherFinancialAssetsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinancialAssetsbyCategoryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other financial assets [Member]",
        "documentation": "This member stands for financial assets that the entity does not separately disclose in the same statement or note.",
        "label": "Other Financial Assets Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_OtherFinancialResultsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "OtherFinancialResultsAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinanceResultsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other financial results",
        "label": "Other Financial Results Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_OtherIncomeOrExpensesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "OtherIncomeOrExpensesNet",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofOtherIncomeorExpensesNetTable": {
       "parentTag": "ifrs-full_OtherOperatingIncomeExpense",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOtherIncomeorExpensesNetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Others",
        "documentation": "Other income or expenses net.",
        "label": "Other Income Or Expenses Net"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherIntangibleAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherIntangibleAssetsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable",
      "http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Intangibles [Member]",
        "verboseLabel": "Product development [Member]",
        "label": "Other intangible assets [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets that the entity does not separately disclose in the same statement or note. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r629"
     ]
    },
    "mlec_OtherInvestmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "OtherInvestmentMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValuebyHierarchyTable",
      "http://www.moolecscience.com/role/ScheduleofOtherFinancialAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other investments [Member]",
        "documentation": "This member stands for other investments.",
        "label": "Other Investment Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_OtherLiabilitiesOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "OtherLiabilitiesOneMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Others [Member]",
        "label": "Other Liabilities One Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherNoncurrentFinancialAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherNoncurrentFinancialAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet",
      "http://www.moolecscience.com/role/ScheduleofOtherFinancialAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other financial assets",
        "verboseLabel": "Investments at fair value",
        "label": "Other non-current financial assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current financial assets that the entity does not separately disclose in the same statement or note. [Refer: Other financial assets]"
       }
      }
     },
     "auth_ref": [
      "r379"
     ]
    },
    "ifrs-full_OtherNoncurrentReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherNoncurrentReceivables",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet",
      "http://www.moolecscience.com/role/ScheduleofOtherReceivablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other receivables",
        "verboseLabel": "Other receivables, Non-current",
        "label": "Other non-current receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current other receivables. [Refer: Other receivables]"
       }
      }
     },
     "auth_ref": [
      "r472",
      "r479"
     ]
    },
    "ifrs-full_OtherOperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherOperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      },
      "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      },
      "http://www.moolecscience.com/role/ScheduleofOtherIncomeorExpensesNetTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome",
      "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable",
      "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable",
      "http://www.moolecscience.com/role/ScheduleofOtherIncomeorExpensesNetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "terseLabel": "Other income or expenses, net",
        "verboseLabel": "Other income / (loss), net",
        "label": "Other operating income (expense)"
       }
      }
     },
     "auth_ref": [
      "r655"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r559"
     ]
    },
    "ifrs-full_OtherPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherPropertyPlantAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Other property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of property, plant and equipment that the entity does not separately disclose in the same statement or note. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r620"
     ]
    },
    "ifrs-full_OtherPropertyPlantAndEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherPropertyPlantAndEquipmentMember",
     "presentation": [
      "http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research instruments [Member]",
        "label": "Other property, plant and equipment [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing property, plant and equipment that the entity does not separately disclose in the same statement or note. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r620"
     ]
    },
    "ifrs-full_OtherProvisions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherProvisions",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinAllowancesandProvisionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning",
        "periodEndLabel": "Ending",
        "label": "Other provisions"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of provisions other than provisions for employee benefits. [Refer: Provisions]"
       }
      }
     },
     "auth_ref": [
      "r66",
      "r299",
      "r362",
      "r397"
     ]
    },
    "mlec_OtherReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "OtherReceivableMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOtherReceivablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other receivables [Member]",
        "label": "Other Receivable Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherReceivables",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofTradeReceivablesTable": {
       "parentTag": "ifrs-full_TradeAndOtherCurrentReceivables",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAssetsAcquiredandLiabilitiesAssumedTable",
      "http://www.moolecscience.com/role/ScheduleofTradeReceivablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other receivables",
        "verboseLabel": "Deferred checks",
        "label": "Other receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount receivable by the entity that it does not separately disclose in the same statement or note."
       }
      }
     },
     "auth_ref": [
      "r472",
      "r479"
     ]
    },
    "mlec_OtherReceivablesJointVenturesAndAssociatesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "OtherReceivablesJointVenturesAndAssociatesMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOtherReceivablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other receivables - Joint ventures and associates (Note 13) [Member]",
        "label": "Other Receivables Joint Ventures And Associates Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_OtherReceivablesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "OtherReceivablesMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinancialAssetsbyCategoryTable",
      "http://www.moolecscience.com/role/ScheduleofTransactionsBetweentheGroupandRelatedPartiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other receivables [Member]",
        "documentation": "This member stands for receivables that the entity does not separately disclose in the same statement or note.",
        "label": "Other Receivables Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_OtherRegionsOrCountriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "OtherRegionsOrCountriesMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofGeographicalInformationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rest of the world [Member]",
        "documentation": "This member stands for other countries and region not specifically identified in the note disclosures.",
        "label": "Other Regions Or Countries Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherRelatedPartiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherRelatedPartiesMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTransactionsBetweentheGroupandRelatedPartiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shareholders and other related parties [Member]",
        "label": "Other related parties [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for related parties that the entity does not separately disclose in the same statement or note. [Refer: Total for all related parties [member]]"
       }
      }
     },
     "auth_ref": [
      "r35",
      "r287"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r498"
     ]
    },
    "ifrs-full_OtherTangibleOrIntangibleAssetsTransferred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherTangibleOrIntangibleAssetsTransferred",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gain from exchange of intangible assets",
        "label": "Other tangible or intangible assets transferred"
       }
      },
      "en": {
       "role": {
        "documentation": "The fair value, at acquisition date, of other tangible or intangible assets (including a business or subsidiary of the acquirer) transferred as consideration in a business combination, that the entity does not separately disclose in the same note. [Refer: Intangible assets other than goodwill; Total for all business combinations [member]; Total for all subsidiaries [member]]"
       }
      }
     },
     "auth_ref": [
      "r178",
      "r330"
     ]
    },
    "mlec_OtherTaxAssetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "OtherTaxAssetMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Others [Member]",
        "documentation": "This member standards for deferred tax asset related differences between the carrying amount of certain accounts in the statement of financial position and its tax base, classified as other.",
        "label": "Other Tax Asset Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofWeightedAverageTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Others",
        "label": "Other tax effects for reconciliation between accounting profit and tax expense (income)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that the entity does not separately disclose in the same statement or note. [Refer: Accounting profit; Applicable tax rate]"
       }
      }
     },
     "auth_ref": [
      "r4",
      "r267"
     ]
    },
    "mlec_OthersAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "OthersAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOperatingResultsGroupsReportingSegmentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Others",
        "label": "Others Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_OthersFinancialAssetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "OthersFinancialAssetMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Others financial assets [Member]",
        "label": "Others Financial Asset Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_OthersFinancialAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "OthersFinancialAssetsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Others financial assets [Member]",
        "documentation": "This member stands for others financial assets.",
        "label": "Others Financial Assets Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_OthersFinancialAssetsOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "OthersFinancialAssetsOneMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Others financial assets [Member]",
        "label": "Others Financial Assets One Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_OthersOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "OthersOneMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable",
      "http://www.moolecscience.com/role/ScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Others [Member]",
        "label": "Others One Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_OthersTaxAssetsTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "OthersTaxAssetsTwoMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Others [Member]",
        "label": "Others Tax Assets Two Member"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r512",
      "r523",
      "r539",
      "r574"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r515",
      "r526",
      "r542",
      "r577"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r515",
      "r526",
      "r542",
      "r577"
     ]
    },
    "mlec_OwnShareHeld": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "OwnShareHeld",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesTable": {
       "parentTag": "mlec_NonCashInvestingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Own shares held",
        "documentation": "Own shares held.",
        "label": "Own Share Held"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_OwnSharesHeld": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "OwnSharesHeld",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Own shares held",
        "documentation": "Cost of own shares held.",
        "label": "Own Shares Held"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_OwnSharesHeldBySubsidiariesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "OwnSharesHeldBySubsidiariesMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTransactionsBetweentheGroupandRelatedPartiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Own shares held by subsidiaries [Member]",
        "label": "Own Shares Held By Subsidiaries Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_OwnSharesHeldMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "OwnSharesHeldMember",
     "presentation": [
      "http://www.moolecscience.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Own shares held",
        "label": "Own Shares Held Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ParValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ParValuePerShare",
     "presentation": [
      "http://www.moolecscience.com/role/AcquisitionsandOtherSignificantTransactionsDetails",
      "http://www.moolecscience.com/role/EventsOccurringAftertheReportingPeriodDetails",
      "http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Par value (in Dollars per share)",
        "verboseLabel": "Par value per share (in Pesos per share)",
        "netLabel": "Minimum per share (in Dollars per share)",
        "label": "Par value per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The nominal value per share."
       }
      }
     },
     "auth_ref": [
      "r248",
      "r355",
      "r399"
     ]
    },
    "dei_ParentEntityLegalName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ParentEntityLegalName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Parent Entity Legal Name",
        "documentation": "If the entity which the financial information concerns is a subsidiary of another company, then provide to full legal name of the parent entity"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_PastShareOptionPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "PastShareOptionPlanMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValueoftheStockOptionsattheGrantDateTable",
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Past Share Option plan [Member]",
        "verboseLabel": "Past Share Option plan [member]",
        "documentation": "This member stands for the past share option plan.",
        "label": "Past Share Option Plan Member"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r548"
     ]
    },
    "ifrs-full_PaymentsForDevelopmentProjectExpenditure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PaymentsForDevelopmentProjectExpenditure",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Capitalized development expenditures",
        "label": "Payments for development project expenditure"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for expenditure related to development projects."
       }
      }
     },
     "auth_ref": [
      "r634"
     ]
    },
    "ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Leased assets payments",
        "label": "Payments of lease liabilities, classified as financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]"
       }
      }
     },
     "auth_ref": [
      "r443"
     ]
    },
    "ifrs-full_PaymentsOfOtherEquityInstruments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PaymentsOfOtherEquityInstruments",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other financial payments",
        "label": "Payments of other equity instruments"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for payments for equity instruments that the entity does not separately disclose in the same statement or note."
       }
      }
     },
     "auth_ref": [
      "r635"
     ]
    },
    "mlec_PaymentsOfThePeriodLeaseliability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "PaymentsOfThePeriodLeaseliability",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payments of the year",
        "documentation": "Payments of the year.",
        "label": "Payments Of The Period Leaseliability"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r558"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r558"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r550"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "auth_ref": [
      "r567"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r560"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r549"
     ]
    },
    "mlec_PercentageGrossMargin": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "PercentageGrossMargin",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOperatingResultsGroupsReportingSegmentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "% Gross margin",
        "documentation": "Represents the value of gross margin.",
        "label": "Percentage Gross Margin"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_PercentageOfCapital": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "PercentageOfCapital",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of capital",
        "documentation": "Percentage of capital.",
        "label": "Percentage Of Capital"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_PercentageOfCashPaymentInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "PercentageOfCashPaymentInterestRate",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of cash payment interest rate",
        "documentation": "Percentage of cash payment interest rate.",
        "label": "Percentage Of Cash Payment Interest Rate"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_PercentageOfClosingPriceOnFirstAndLastBusinessDayToDeterminePurchasePrice": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "PercentageOfClosingPriceOnFirstAndLastBusinessDayToDeterminePurchasePrice",
     "presentation": [
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of closing price of the Company's ordinary shares on the first business day and the last business day to determine purchase price",
        "documentation": "Percentage of closing price of the Company's ordinary shares on the first business day and the last business day to determine purchase price.",
        "label": "Percentage Of Closing Price On First And Last Business Day To Determine Purchase Price"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_PercentageOfCustomerRevenues": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "PercentageOfCustomerRevenues",
     "presentation": [
      "http://www.moolecscience.com/role/AcquisitionsandOtherSignificantTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of customer revenues",
        "documentation": "The percentage of customer revenues.",
        "label": "Percentage Of Customer Revenues"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_PercentageOfDividendsTaxedShares": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "PercentageOfDividendsTaxedShares",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of taxed dividend shares",
        "documentation": "Percentage of dividends taxed shares.",
        "label": "Percentage Of Dividends Taxed Shares"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PercentageOfEntitysRevenue": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PercentageOfEntitysRevenue",
     "presentation": [
      "http://www.moolecscience.com/role/InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of revenues",
        "label": "Percentage of entity's revenue"
       }
      }
     },
     "auth_ref": [
      "r645"
     ]
    },
    "mlec_PercentageOfEstimatesThatDevaluationOrAnAppreciation": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "PercentageOfEstimatesThatDevaluationOrAnAppreciation",
     "presentation": [
      "http://www.moolecscience.com/role/FinancialInstrumentsRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of estimates that devaluation or an appreciation",
        "documentation": "Percentage of estimates that devaluation or an appreciation.",
        "label": "Percentage Of Estimates That Devaluation Or An Appreciation"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_PercentageOfInflationAccumulated": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "PercentageOfInflationAccumulated",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of Inflation accumulated",
        "documentation": "Percentage of Inflation accumulated.",
        "label": "Percentage Of Inflation Accumulated"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_PercentageOfIssuedAndOutstandingEquityInterests": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "PercentageOfIssuedAndOutstandingEquityInterests",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationDetails",
      "http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of issued and outstanding equity interests",
        "documentation": "Percentage of issued and outstanding equity interests.",
        "label": "Percentage Of Issued And Outstanding Equity Interests"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_PercentageOfOutstandingAmountInitialInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "PercentageOfOutstandingAmountInitialInterestRate",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Initial interest rate",
        "documentation": "Percentage of outstanding amount initial interest rate.",
        "label": "Percentage Of Outstanding Amount Initial Interest Rate"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_PercentageOfPenalty": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "PercentageOfPenalty",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of penalty",
        "documentation": "Percentage of penalty.",
        "label": "Percentage Of Penalty"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_PercentageOfPenaltyOfPrepayment": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "PercentageOfPenaltyOfPrepayment",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of Penalty of Prepayment",
        "documentation": "Percentage of penalty of prepayment.",
        "label": "Percentage Of Penalty Of Prepayment"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_PercentageOfPreferenceSharesAccrue": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "PercentageOfPreferenceSharesAccrue",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of preference shares accrue",
        "documentation": "Percentage of preference shares accrue.",
        "label": "Percentage Of Preference Shares Accrue"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_PercentageOfPrepaymentPremium": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "PercentageOfPrepaymentPremium",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepayment premium",
        "documentation": "Percentage of prepayment premium.",
        "label": "Percentage Of Prepayment Premium"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_PercentageOfProfitForObligationToLegalReserve": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "PercentageOfProfitForObligationToLegalReserve",
     "presentation": [
      "http://www.moolecscience.com/role/JointVenturesandAssociatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Annual legal reserve required, as percent of profit",
        "documentation": "The percentage of profit to establish an obligation to legal reserve on ability of the joint venture to transfer funds to the Group in the form of cash dividends, or to repay loans or advances made by the Group.",
        "label": "Percentage Of Profit For Obligation To Legal Reserve"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_PercentageOfRiskPremium": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "PercentageOfRiskPremium",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsScheduleofIntangibleAssetsandLiabilitiesAssumed"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of risk premium",
        "documentation": "Percentage of risk premium.",
        "label": "Percentage Of Risk Premium"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_PercentageOfShare": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "PercentageOfShare",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of share",
        "documentation": "Percentage of share.",
        "label": "Percentage Of Share"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PercentageOfVotingEquityInterestsAcquired": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PercentageOfVotingEquityInterestsAcquired",
     "presentation": [
      "http://www.moolecscience.com/role/AcquisitionsandOtherSignificantTransactionsDetails",
      "http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of equity and voting interest acquired",
        "label": "Percentage of voting equity interests acquired"
       }
      },
      "en": {
       "role": {
        "documentation": "The percentage of voting equity interests acquired in a business combination. [Refer: Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r176",
      "r328"
     ]
    },
    "mlec_PercentageOfWeightedAverageCostOfCapital": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "PercentageOfWeightedAverageCostOfCapital",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsScheduleofIntangibleAssetsandLiabilitiesAssumed"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discount rate",
        "documentation": "Percentage of weighted average cost of capital.",
        "label": "Percentage Of Weighted Average Cost Of Capital"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_PerformanceShareOptionPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "PerformanceShareOptionPlanMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValueoftheStockOptionsattheGrantDateTable",
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Performance Share Option plan [Member]",
        "verboseLabel": "Performance Share Option Plan [Member]",
        "documentation": "This member stands for the performance share option plan.",
        "label": "Performance Share Option Plan Member"
       }
      }
     },
     "auth_ref": []
    },
    "dei_PhoneFaxNumberDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PhoneFaxNumberDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Phone Fax Number Description",
        "documentation": "Description of Phone or Fax Number"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_PiggysooyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "PiggysooyMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Piggysooy [Member]",
        "label": "Piggysooy Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_PledgedOrTransferredSharesQuantity": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "PledgedOrTransferredSharesQuantity",
     "presentation": [
      "http://www.moolecscience.com/role/EventsOccurringAftertheReportingPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pledged shares (in Shares)",
        "documentation": "The number of pledged or transferred shares quantity.",
        "label": "Pledged Or Transferred Shares Quantity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Prior Service Cost [Member]",
        "terseLabel": "Pension Adjustments Prior Service Cost"
       }
      }
     },
     "auth_ref": [
      "r551"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Service Cost [Member]",
        "terseLabel": "Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r603"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote [Text Block]",
        "terseLabel": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r550"
     ]
    },
    "dei_PostEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PostEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r484"
     ]
    },
    "dei_PostEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PostEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r484"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r491"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r493"
     ]
    },
    "dei_PreEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r484"
     ]
    },
    "dei_PreEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r484"
     ]
    },
    "mlec_PreferenceOfAccruePerAnnum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "PreferenceOfAccruePerAnnum",
     "presentation": [
      "http://www.moolecscience.com/role/EventsOccurringAftertheReportingPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Perference of accrue per annum",
        "documentation": "The percentage of perference of accrue per annum.",
        "label": "Preference Of Accrue Per Annum"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_PreferenceShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "PreferenceShareMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTransactionsBetweentheGroupandRelatedPartiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preference shares [Member]",
        "label": "Preference Share Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_PrepaidExpensesAndOtherReceivablesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "PrepaidExpensesAndOtherReceivablesMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOtherReceivablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses and other receivables [Member]",
        "label": "Prepaid Expenses And Other Receivables Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_PrepaymentPremiumFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "PrepaymentPremiumFee",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails",
      "http://www.moolecscience.com/role/ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable",
      "http://www.moolecscience.com/role/ScheduleofFinanceResultsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepayment premium fee",
        "verboseLabel": "Prepayment Premium Fee",
        "netLabel": "Prepayment Premium Fee (in Dollars)",
        "documentation": "Prepayment Premium Fee.",
        "label": "Prepayment Premium Fee"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_PrepaymentsToSuppliersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "PrepaymentsToSuppliersMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOtherReceivablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepayments to suppliers [Member]",
        "label": "Prepayments To Suppliers Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PresentationOfLeasesForLesseeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PresentationOfLeasesForLesseeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_PricePerSharesOfStrikePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "PricePerSharesOfStrikePrice",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Price per shares of strike price (in Dollars per share)",
        "documentation": "Price per shares of strike price.",
        "label": "Price Per Shares Of Strike Price"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_PrivateWarrantShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "PrivateWarrantShares",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Private warrant shares",
        "documentation": "Private warrant shares.",
        "label": "Private Warrant Shares"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_PrivateWarrantsExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "PrivateWarrantsExercisePrice",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationDetails",
      "http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Private warrants exercise price (in Dollars per share)",
        "documentation": "Private warrants exercise price.",
        "label": "Private Warrants Exercise Price"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_PrivateWarrantsShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "PrivateWarrantsShares",
     "presentation": [
      "http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Private warrant shares",
        "documentation": "Private warrants shares.",
        "label": "Private Warrants Shares"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ProFarmGroupIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ProFarmGroupIncMember",
     "presentation": [
      "http://www.moolecscience.com/role/AcquisitionsandOtherSignificantTransactionsDetails",
      "http://www.moolecscience.com/role/ScheduleofFairValueoftheConsiderationofPaymentTable",
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pro Farm Group Inc [Member]",
        "documentation": "The member stands for dilutive effect of the future exercise of options of Pro farm group inc.",
        "label": "Pro Farm Group Inc Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ProFarmGroupMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ProFarmGroupMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofGoodwillTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pro Farm Group [Member]",
        "label": "Pro Farm Group Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ProFarmUGEMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ProFarmUGEMember",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsScheduleofIntangibleAssetsandLiabilitiesAssumed"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pro Farm UGE [Member]",
        "label": "Pro Farm UGEMember"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ProceedFromIssuedShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ProceedFromIssuedShares",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/EventsOccurringAftertheReportingPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total proceeds",
        "documentation": "Represent the amount of issued shares.",
        "label": "Proceed From Issued Shares"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProceedsFromBorrowingsClassifiedAsFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from borrowings",
        "label": "Proceeds from borrowings, classified as financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from borrowings obtained. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r441"
     ]
    },
    "mlec_ProceedsFromIssueOfEquityInstrumentsOnConversionOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ProceedsFromIssueOfEquityInstrumentsOnConversionOfDebt",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/EventsOccurringAftertheReportingPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial liability and increase in equity",
        "documentation": "Represent the amount of financial liability and increase in equity.",
        "label": "Proceeds From Issue Of Equity Instruments On Conversion Of Debt"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from financial assets",
        "label": "Proceeds from sales of other long-term assets, classified as investing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from sales of long-term assets that the entity does not separately disclose in the same statement or note, classified as investing activities. [Refer: Assets]"
       }
      }
     },
     "auth_ref": [
      "r439"
     ]
    },
    "ifrs-full_ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesTable": {
       "parentTag": "mlec_NonCashInvestingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Sale of equity investee",
        "label": "Proceeds from sales of investments accounted for using equity method"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from sales of investments accounted for using the equity method. [Refer: Investments accounted for using equity method]"
       }
      }
     },
     "auth_ref": [
      "r634"
     ]
    },
    "ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from sale of property, plant and equipment",
        "label": "Proceeds from sales of property, plant and equipment, classified as investing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from sales of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r439"
     ]
    },
    "ifrs-full_ProductsAndServicesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProductsAndServicesAxis",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRevenuebySimilarGroupofProductsorServicesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Products and services [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r227",
      "r450",
      "r466"
     ]
    },
    "ifrs-full_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRevenuebySimilarGroupofProductsorServicesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Products and services [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the entity's products and services. It also represents the standard value for the 'Products and services' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r227",
      "r450",
      "r466"
     ]
    },
    "ifrs-full_ProfessionalFeesExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProfessionalFeesExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable": {
       "parentTag": "ifrs-full_ResearchAndDevelopmentExpense",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofExpensesClassifiedbyNatureandFunctionTable",
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Professional fees and outsourced services",
        "label": "Professional fees expense"
       }
      }
     },
     "auth_ref": [
      "r649"
     ]
    },
    "mlec_ProfessionalFeesExpenseRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ProfessionalFeesExpenseRelatedParties",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable": {
       "parentTag": "ifrs-full_ResearchAndDevelopmentExpense",
       "weight": 1.0,
       "order": 21.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Professional fees related parties",
        "documentation": "Amount of professional fee expense with related parties.",
        "label": "Professional Fees Expense Related Parties"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ProfessionalFeesRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ProfessionalFeesRelatedParties",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofExpensesClassifiedbyNatureandFunctionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Professional fees related parties",
        "documentation": "Represent the amount of professional fees related parties.",
        "label": "Professional Fees Related Parties"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome": {
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncomeAlt0": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow",
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome",
      "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable",
      "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable",
      "http://www.moolecscience.com/role/ScheduleofSignificantJointVenturesTable",
      "http://www.moolecscience.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "(Loss) Profit for the year",
        "terseLabel": "(Loss) / Profit for the year",
        "verboseLabel": "(Loss) / profit for the year",
        "netLabel": "(Loss)/Profit of the year",
        "label": "Result for the year"
       }
      },
      "en": {
       "role": {
        "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r104",
      "r106",
      "r220",
      "r222",
      "r290",
      "r318",
      "r370",
      "r403",
      "r447",
      "r452"
     ]
    },
    "ifrs-full_ProfitLossAttributableToAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProfitLossAttributableToAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "(Loss) / profit for the year attributable to:",
        "label": "Profit (loss), attributable to [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ProfitLossAttributableToNoncontrollingInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProfitLossAttributableToNoncontrollingInterests",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncomeAlt0": {
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-controlling interests",
        "label": "Profit (loss), attributable to non-controlling interests"
       }
      },
      "en": {
       "role": {
        "documentation": "The profit (loss) from continuing and discontinued operations attributable to non-controlling interests. [Refer: Profit (loss); Non-controlling interests]"
       }
      }
     },
     "auth_ref": [
      "r111",
      "r405"
     ]
    },
    "ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofEarningPerShareTable",
      "http://www.moolecscience.com/role/ScheduleofGovernmentGrantsTable",
      "http://www.moolecscience.com/role/ScheduleofWeightedAverageNumberofOrdinarySharesOutstandingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Released to the statement of profit or loss",
        "verboseLabel": "Loss/Profit for the year (basic EPS)",
        "label": "Profit (loss), attributable to ordinary equity holders of parent entity, used in calculating basic earnings per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The profit (loss) attributable to ordinary equity holders of the parent entity. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofEarningPerShareTable",
      "http://www.moolecscience.com/role/ScheduleofWeightedAverageNumberofOrdinarySharesOutstandingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss/Profit for the year (diluted EPS)",
        "label": "Profit (loss), attributable to ordinary equity holders of parent entity, used in calculating diluted earnings per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The profit (loss) attributable to ordinary equity holders of the parent entity, adjusted for the effects of all dilutive potential ordinary shares. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "ifrs-full_ProfitLossAttributableToOwnersOfParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProfitLossAttributableToOwnersOfParent",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncomeAlt0": {
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity holders of the parent",
        "label": "Profit (loss), attributable to owners of parent"
       }
      },
      "en": {
       "role": {
        "documentation": "The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r406"
     ]
    },
    "ifrs-full_ProfitLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProfitLossBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable": {
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable": {
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome",
      "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable",
      "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "(Loss) Profit before income tax",
        "terseLabel": "Loss before taxes",
        "verboseLabel": "(Loss) / profit before taxes",
        "label": "Profit (loss) before tax"
       }
      }
     },
     "auth_ref": [
      "r190",
      "r464",
      "r465",
      "r474",
      "r475"
     ]
    },
    "ifrs-full_ProfitLossFromDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProfitLossFromDiscontinuedOperations",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofWeightedAverageTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "(Loss) / earnings before income tax-rate",
        "label": "Profit (loss) from discontinued operations"
       }
      }
     },
     "auth_ref": [
      "r124",
      "r189",
      "r413",
      "r418"
     ]
    },
    "ifrs-full_ProfitLossFromOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProfitLossFromOperatingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome",
      "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable",
      "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable",
      "http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Operating (loss) profit",
        "terseLabel": "Operating loss",
        "verboseLabel": "Operating (loss) / profit",
        "netLabel": "Operating loss (in Dollars)",
        "label": "Profit (loss) from operating activities"
       }
      }
     },
     "auth_ref": [
      "r430",
      "r655"
     ]
    },
    "ifrs-full_ProfitLossOfCombinedEntity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProfitLossOfCombinedEntity",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/AcquisitionsandOtherSignificantTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Profit or loss of the combined entity",
        "label": "Profit (loss) of combined entity as if combination occurred at beginning of period"
       }
      },
      "en": {
       "role": {
        "documentation": "The profit (loss) of the combined entity as though the acquisition date for all business combinations that occurred during the year had been as of the beginning of the annual reporting period. [Refer: Total for all business combinations [member]; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r184"
     ]
    },
    "mlec_ProfitMakingEntitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ProfitMakingEntitiesMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Profit-making entities [Member]",
        "documentation": "This member stands for profit-making entities.",
        "label": "Profit Making Entities Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ProjectedPeriodRange": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ProjectedPeriodRange",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Projected period range",
        "documentation": "Represents the projected period range.",
        "label": "Projected Period Range"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet",
      "http://www.moolecscience.com/role/ScheduleofGeographicalInformationTable",
      "http://www.moolecscience.com/role/ScheduleofPropertyPlantandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Net carrying amount beginning",
        "periodEndLabel": "Net carrying amount ending",
        "terseLabel": "Property, plant and equipment",
        "label": "Property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]"
       }
      }
     },
     "auth_ref": [
      "r16",
      "r277",
      "r376"
     ]
    },
    "ifrs-full_PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofCarryingAmountsthatWouldHaveBeenRecognizedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Land and buildings",
        "label": "Property, plant and equipment, revalued assets, at cost"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of property, plant and equipment that would have been recognised had the revalued assets been carried under the cost model. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r20",
      "r279"
     ]
    },
    "mlec_PropertyPlantAndEquipmentDepreciationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "PropertyPlantAndEquipmentDepreciationMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable",
      "http://www.moolecscience.com/role/ScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, plant and equipment depreciation [Member]",
        "label": "Property Plant And Equipment Depreciation Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAssetsAcquiredandLiabilitiesAssumedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, plant and equipment",
        "label": "Property, plant and equipment recognised as of acquisition date"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for plant, property and equipment acquired in a business combination. [Refer: Property, plant and equipment; Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r455",
      "r456",
      "r471"
     ]
    },
    "mlec_PropertyPlantAndEquipmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "PropertyPlantAndEquipmentsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofPropertyPlantandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property Plant And Equipments [Member]",
        "label": "Property Plant And Equipments Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ProportionOfOwnershipInterestInSubsidiary": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProportionOfOwnershipInterestInSubsidiary",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofInformationrelatedtoCompanysShareofVotingRightsinitsSubsidiariesTable",
      "http://www.moolecscience.com/role/ScheduleofSubsidiariesNonControllingInterestTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity interest",
        "verboseLabel": "Bioceres Crop Solutions (*)",
        "label": "Proportion of ownership interest in subsidiary"
       }
      },
      "en": {
       "role": {
        "documentation": "The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Total for all subsidiaries [member]]"
       }
      }
     },
     "auth_ref": [
      "r44",
      "r48",
      "r115"
     ]
    },
    "ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProportionOfOwnershipInterestsHeldByNoncontrollingInterests",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofSubsidiariesNonControllingInterestTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bioceres S.A.",
        "label": "Proportion of ownership interests held by non-controlling interests"
       }
      },
      "en": {
       "role": {
        "documentation": "The proportion of ownership interests in a subsidiary held by non-controlling interests. [Refer: Total for all subsidiaries [member]; Non-controlling interests]"
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "ifrs-full_ProportionOfVotingPowerHeldInSubsidiary": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProportionOfVotingPowerHeldInSubsidiary",
     "presentation": [
      "http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Voting interest percentage",
        "label": "Proportion of voting rights held in subsidiary"
       }
      },
      "en": {
       "role": {
        "documentation": "The proportion of the voting rights in a subsidiary held by the entity. [Refer: Total for all subsidiaries [member]]"
       }
      }
     },
     "auth_ref": [
      "r44",
      "r48",
      "r115"
     ]
    },
    "mlec_ProvisionForContingenciesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ProvisionForContingenciesMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinAllowancesandProvisionsTable",
      "http://www.moolecscience.com/role/ScheduleofProvisionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Provisions for contingencies [Member]",
        "documentation": "This member stands for provision for contingencies.",
        "label": "Provision For Contingencies Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_Provisions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "Provisions",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/EventsOccurringAftertheReportingPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assignment price",
        "label": "Provisions"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities of uncertain timing or amount, including provisions for employee benefits."
       }
      }
     },
     "auth_ref": [
      "r385"
     ]
    },
    "mlec_ProvisionsForContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ProvisionsForContingencies",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Provisions for contingencies",
        "documentation": "Represent the amount of provisions for contingencies.",
        "label": "Provisions For Contingencies"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of intangible assets",
        "label": "Purchase of intangible assets, classified as investing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchases of intangible assets, classified as investing activities. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r438"
     ]
    },
    "ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Investment in financial assets",
        "label": "Purchase of interests in investments accounted for using equity method"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchase of interests in investments accounted for using the equity method. [Refer: Investments accounted for using equity method]"
       }
      }
     },
     "auth_ref": [
      "r634"
     ]
    },
    "mlec_PurchaseOfInventory": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "PurchaseOfInventory",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofCostofSalesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchases of the year",
        "documentation": "Amount of inventory purchased during the year.",
        "label": "Purchase Of Inventory"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_PurchaseOfOwnShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "PurchaseOfOwnShares",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of own shares",
        "documentation": "Represent the payment of own shares.",
        "label": "Purchase Of Own Shares"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of property, plant and equipment",
        "label": "Purchase of property, plant and equipment, classified as investing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r438"
     ]
    },
    "mlec_PurchasesOfGoodsAndServicesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "PurchasesOfGoodsAndServicesMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTransactionsBetweentheGroupandRelatedPartiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchases of goods and services [Member]",
        "label": "Purchases Of Goods And Services Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_PuttableInstrumentsCharge": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "PuttableInstrumentsCharge",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofWeightedAverageTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Puttable instruments charge",
        "documentation": "Represent the amount of puttable instruments charge.",
        "label": "Puttable Instruments Charge"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_PuttableInstrumentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "PuttableInstrumentsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTransactionsBetweentheGroupandRelatedPartiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Puttable instruments [Member]",
        "label": "Puttable Instruments Member"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r548"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r548"
     ]
    },
    "mlec_RGRSOXWheatMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "RGRSOXWheatMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RG/RS/OX Wheat [Member]",
        "label": "RGRSOXWheat Member"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationDetails",
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails",
      "http://www.moolecscience.com/role/ScheduleofRangeofAssumptionswhichhaveDeterminedTable",
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails",
      "http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Range [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r136",
      "r155",
      "r171",
      "r256",
      "r448",
      "r449",
      "r644"
     ]
    },
    "ifrs-full_RangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RangeDomain",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationDetails",
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails",
      "http://www.moolecscience.com/role/ScheduleofRangeofAssumptionswhichhaveDeterminedTable",
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails",
      "http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Range [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregate ranges. It also represents the standard value for the 'Range' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r136",
      "r155",
      "r171",
      "r256",
      "r448",
      "r449",
      "r644"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RangeMember",
     "presentation": [
      "http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ReconciliationOfAccountingProfitMultipliedByApplicableTaxRatesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Reconciliation of accounting profit multiplied by applicable tax rates [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
        "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
       }
      }
     },
     "auth_ref": [
      "r507",
      "r518",
      "r534",
      "r569"
     ]
    },
    "dei_RegistrationStatementAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "RegistrationStatementAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration Statement Amendment Number",
        "documentation": "Amendment number to registration statement under the Investment Company Act of 1940."
       }
      }
     },
     "auth_ref": [
      "r484"
     ]
    },
    "mlec_ReimbursementsOverExportsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ReimbursementsOverExportsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOtherReceivablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reimbursements over exports [Member]",
        "label": "Reimbursements Over Exports Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofSignificantJointVenturesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related and Nonrelated Parties [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_RemeasurementOfPreviouslyHeldInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "RemeasurementOfPreviouslyHeldInterest",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remeasurement of previously held interest",
        "documentation": "Remeasurement of previously held interest.",
        "label": "Remeasurement Of Previously Held Interest"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_RemeasurementToFairValueOfPreexistingInterestInAnAcquiree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "RemeasurementToFairValueOfPreexistingInterestInAnAcquiree",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofOtherIncomeorExpensesNetTable": {
       "parentTag": "ifrs-full_OtherOperatingIncomeExpense",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOtherIncomeorExpensesNetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remeasurement to fair value of pre-existing interest in an acquiree",
        "documentation": "Remeasurement to fair value of pre-existing interest in an acquiree.",
        "label": "Remeasurement To Fair Value Of Preexisting Interest In An Acquiree"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RepairsAndMaintenanceExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RepairsAndMaintenanceExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable": {
       "parentTag": "ifrs-full_ResearchAndDevelopmentExpense",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofExpensesClassifiedbyNatureandFunctionTable",
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maintenance",
        "label": "Repairs and maintenance expense"
       }
      }
     },
     "auth_ref": [
      "r655"
     ]
    },
    "ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RepaymentsOfBorrowingsClassifiedAsFinancingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repayment of borrowings and financed payments",
        "label": "Repayments of borrowings, classified as financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow to settle borrowings, classified as financing activities. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r442"
     ]
    },
    "ifrs-full_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable": {
       "parentTag": "mlec_TotalResearchAndDevelopmentExpenseIncurred",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0,
       "order": 5.0
      },
      "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0,
       "order": 7.0
      },
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome",
      "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable",
      "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable",
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "negatedLabel": "Research and development expenses",
        "terseLabel": "R&amp;D profit and loss",
        "negatedTerseLabel": "Research and development expenses",
        "label": "Research and development expense"
       }
      }
     },
     "auth_ref": [
      "r77",
      "r309"
     ]
    },
    "mlec_ResearchAndDevelopmentExpenseCapitalized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ResearchAndDevelopmentExpenseCapitalized",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable": {
       "parentTag": "mlec_TotalResearchAndDevelopmentExpenseIncurred",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "R&amp;D capitalized (Note 8.3)",
        "documentation": "Amount of research and development expense capitalized.",
        "label": "Research And Development Expense Capitalized"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ResearchAndDevelopmentsExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ResearchAndDevelopmentsExpenseAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Research And Developments Expense Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ResearchInstrumentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ResearchInstrumentsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofPropertyPlantandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research Instruments [Member]",
        "label": "Research Instruments Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ReserveOfExchangeDifferencesOnTranslation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ReserveOfExchangeDifferencesOnTranslation",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency translation reserve",
        "label": "Reserve of exchange differences on translation"
       }
      },
      "en": {
       "role": {
        "documentation": "A component of equity representing exchange differences on translation of financial statements recognised in other comprehensive income and accumulated in equity. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r27",
      "r281"
     ]
    },
    "ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ReserveOfExchangeDifferencesOnTranslationMember",
     "presentation": [
      "http://www.moolecscience.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency translation reserve",
        "label": "Reserve of exchange differences on translation [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing accumulated exchange differences on the translation of financial statements recognised in other comprehensive income. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r27",
      "r281",
      "r476"
     ]
    },
    "ifrs-full_ReserveOfSharebasedPaymentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ReserveOfSharebasedPaymentsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock options and share based incentives",
        "label": "Reserve of share-based payments [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity resulting from share-based payments."
       }
      }
     },
     "auth_ref": [
      "r476"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "auth_ref": [
      "r508",
      "r519",
      "r535",
      "r570"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r509",
      "r520",
      "r536",
      "r571"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r516",
      "r527",
      "r543",
      "r578"
     ]
    },
    "mlec_ResultOfInflationEffectOnMonetaryItemsAndOtherFinanceResults": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ResultOfInflationEffectOnMonetaryItemsAndOtherFinanceResults",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofWeightedAverageTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Result of inflation effect on monetary items and other finance results",
        "documentation": "Result of inflation effect on monetary items and other finance results",
        "label": "Result Of Inflation Effect On Monetary Items And Other Finance Results"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RetainedEarnings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RetainedEarnings",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retained earnings / (deficit)",
        "label": "Retained earnings"
       }
      },
      "en": {
       "role": {
        "documentation": "A component of equity representing the entity's cumulative undistributed earnings or deficit."
       }
      }
     },
     "auth_ref": [
      "r473",
      "r480",
      "r482"
     ]
    },
    "ifrs-full_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retained (deficit) earnings",
        "label": "Retained earnings [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit."
       }
      }
     },
     "auth_ref": [
      "r372",
      "r476"
     ]
    },
    "mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "RevaluationOfPropertyPlantAndEquipmentNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome": {
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome",
      "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revaluation of property, plant and equipment, net of tax",
        "documentation": "Revaluation of property, plant and equipment, net of tax.",
        "label": "Revaluation Of Property Plant And Equipment Net Of Tax"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_RevaluationOfPropertyPlantAndEquipmentNetOfTaxOfJointVenturesAndAssociates": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "RevaluationOfPropertyPlantAndEquipmentNetOfTaxOfJointVenturesAndAssociates",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome": {
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revaluation of property, plant and equipment, net of tax, of joint ventures and associates",
        "documentation": "Revaluation of property, plant and equipment, net of tax, of joint ventures and associates.",
        "label": "Revaluation Of Property Plant And Equipment Net Of Tax Of Joint Ventures And Associates"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_RevaluationOfPropertyPlantAndEquipmentReserve": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "RevaluationOfPropertyPlantAndEquipmentReserve",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revaluation of property, plant and equipment reserve",
        "documentation": "Represent the amount of revaluation of property plant and equipment reserve.",
        "label": "Revaluation Of Property Plant And Equipment Reserve"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_RevaluationOfPropertyPlantEquipmentAndEffectOfTaxRateChangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "RevaluationOfPropertyPlantEquipmentAndEffectOfTaxRateChangeMember",
     "presentation": [
      "http://www.moolecscience.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revaluation of PP&amp;E and effect of tax rate change",
        "label": "Revaluation Of Property Plant Equipment And Effect Of Tax Rate Change Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_Revenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "Revenue",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable": {
       "parentTag": "ifrs-full_GrossProfit",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.moolecscience.com/role/ScheduleofOperatingResultsGroupsReportingSegmentsTable": {
       "parentTag": "ifrs-full_GrossProfit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable",
      "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable",
      "http://www.moolecscience.com/role/ScheduleofGeographicalInformationTable",
      "http://www.moolecscience.com/role/ScheduleofOperatingResultsGroupsReportingSegmentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total revenues",
        "terseLabel": "Revenues",
        "verboseLabel": "Total revenues",
        "label": "Revenue"
       }
      }
     },
     "auth_ref": [
      "r123",
      "r190",
      "r216",
      "r221",
      "r227",
      "r228",
      "r230",
      "r409",
      "r447",
      "r474",
      "r475"
     ]
    },
    "ifrs-full_RevenueFromContractsWithCustomers": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RevenueFromContractsWithCustomers",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.moolecscience.com/role/ScheduleofRevenuefromContractswithCustomersTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome",
      "http://www.moolecscience.com/role/ScheduleofRevenuebySimilarGroupofProductsorServicesTable",
      "http://www.moolecscience.com/role/ScheduleofRevenuefromContractswithCustomersTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Revenue from contracts with customers",
        "terseLabel": "Revenues from contracts with customers",
        "verboseLabel": "Revenue",
        "label": "Revenue from contracts with customers"
       }
      }
     },
     "auth_ref": [
      "r138",
      "r139",
      "r236"
     ]
    },
    "ifrs-full_RevenueFromGovernmentGrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RevenueFromGovernmentGrants",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable": {
       "parentTag": "ifrs-full_GrossProfit",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.moolecscience.com/role/ScheduleofOperatingResultsGroupsReportingSegmentsTable": {
       "parentTag": "ifrs-full_Revenue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome",
      "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable",
      "http://www.moolecscience.com/role/ScheduleofOperatingResultsGroupsReportingSegmentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Government grants",
        "label": "Income from government grants"
       }
      }
     },
     "auth_ref": [
      "r624"
     ]
    },
    "ifrs-full_RevenueFromRenderingOfServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RevenueFromRenderingOfServices",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofRevenuefromContractswithCustomersTable": {
       "parentTag": "ifrs-full_RevenueFromContractsWithCustomers",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRevenuefromContractswithCustomersTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rendering of services with related parties",
        "label": "Revenue from rendering of services"
       }
      }
     },
     "auth_ref": [
      "r649"
     ]
    },
    "ifrs-full_RevenueFromRoyalties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RevenueFromRoyalties",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofRevenuefromContractswithCustomersTable": {
       "parentTag": "ifrs-full_RevenueFromContractsWithCustomers",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.moolecscience.com/role/ScheduleofOperatingResultsGroupsReportingSegmentsTable": {
       "parentTag": "ifrs-full_Revenue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOperatingResultsGroupsReportingSegmentsTable",
      "http://www.moolecscience.com/role/ScheduleofRevenuefromContractswithCustomersTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalties",
        "label": "Royalty income"
       }
      }
     },
     "auth_ref": [
      "r649"
     ]
    },
    "ifrs-full_RevenueFromSaleOfAgriculturalProduce": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RevenueFromSaleOfAgriculturalProduce",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofOtherIncomeorExpensesNetTable": {
       "parentTag": "ifrs-full_OtherOperatingIncomeExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOtherIncomeorExpensesNetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss from subsidiary\u2019s guarantee recognition",
        "label": "Revenue from sale of agricultural produce"
       }
      }
     },
     "auth_ref": [
      "r649"
     ]
    },
    "ifrs-full_RevenueFromSaleOfGoods": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RevenueFromSaleOfGoods",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofRevenuefromContractswithCustomersTable": {
       "parentTag": "ifrs-full_RevenueFromContractsWithCustomers",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRevenuefromContractswithCustomersTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of goods and services",
        "label": "Revenue from sale of goods"
       }
      }
     },
     "auth_ref": [
      "r649"
     ]
    },
    "mlec_RevenueFromSaleOfGoodsAndRenderingOfServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "RevenueFromSaleOfGoodsAndRenderingOfServices",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofOperatingResultsGroupsReportingSegmentsTable": {
       "parentTag": "ifrs-full_Revenue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOperatingResultsGroupsReportingSegmentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of goods and services",
        "documentation": "The amount of revenue arising from the sale of goods and rendering of services.",
        "label": "Revenue From Sale Of Goods And Rendering Of Services"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RevenueOfAcquiree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RevenueOfAcquiree",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalty payments",
        "label": "Revenue of acquiree since acquisition date"
       }
      }
     },
     "auth_ref": [
      "r183"
     ]
    },
    "ifrs-full_RevenueOfCombinedEntity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RevenueOfCombinedEntity",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/AcquisitionsandOtherSignificantTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue of the combined entity",
        "label": "Revenue of combined entity as if combination occurred at beginning of period"
       }
      }
     },
     "auth_ref": [
      "r184"
     ]
    },
    "mlec_RevenuesFromContractsWithCustomersAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "RevenuesFromContractsWithCustomersAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOperatingResultsGroupsReportingSegmentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenues from contracts with customers",
        "label": "Revenues From Contracts With Customers Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ReverseStockSplit": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ReverseStockSplit",
     "presentation": [
      "http://www.moolecscience.com/role/ReverseStockSplitAftertheReportingPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reverse stock split.",
        "documentation": "Reverse stock split.",
        "label": "Reverse Stock Split"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ReverseStockSplitAftertheReportingPeriodDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ReverseStockSplitAftertheReportingPeriodDetailsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ReverseStockSplitAftertheReportingPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reverse Stock Split After the Reporting Period (Details) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ReverseStockSplitAftertheReportingPeriodDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ReverseStockSplitAftertheReportingPeriodDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ReverseStockSplitAftertheReportingPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reverse Stock Split After the Reporting Period (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ReverseStockSplitAftertheReportingPeriodScheduleofWeightedAverageNumberofOrdinarySharesOutstandingDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ReverseStockSplitAftertheReportingPeriodScheduleofWeightedAverageNumberofOrdinarySharesOutstandingDetailsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofWeightedAverageNumberofOrdinarySharesOutstandingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reverse Stock Split After the Reporting Period - Schedule of Weighted Average Number of Ordinary Shares Outstanding (Details) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ReverseStockSplitAftertheReportingPeriodScheduleofWeightedAverageNumberofOrdinarySharesOutstandingDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ReverseStockSplitAftertheReportingPeriodScheduleofWeightedAverageNumberofOrdinarySharesOutstandingDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofWeightedAverageNumberofOrdinarySharesOutstandingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reverse Stock Split After the Reporting Period - Schedule of Weighted Average Number of Ordinary Shares Outstanding (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ReverseStockSplitConsolidationRatio": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ReverseStockSplitConsolidationRatio",
     "presentation": [
      "http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidation ratio",
        "documentation": "Description of reverse stock split consolidation ratio.",
        "label": "Reverse Stock Split Consolidation Ratio"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ReverseStockSplitMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ReverseStockSplitMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofWeightedAverageNumberofOrdinarySharesOutstandingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reverse Stock Split [Member]",
        "label": "Reverse Stock Split Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_RightOfUseAssetLossOfControl": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "RightOfUseAssetLossOfControl",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss of control",
        "documentation": "The amount of loss of control.",
        "label": "Right Of Use Asset Loss Of Control"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_RightOfUseLeasedAssetTaxLiabilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "RightOfUseLeasedAssetTaxLiabilityMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable",
      "http://www.moolecscience.com/role/ScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use leased asset [Member]",
        "documentation": "Right-of-use Leased Asset Tax Liability",
        "label": "Right Of Use Leased Asset Tax Liability Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RightofuseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RightofuseAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet",
      "http://www.moolecscience.com/role/ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Book value at the beginning of the year",
        "periodEndLabel": "Book value at the end of the year",
        "terseLabel": "Right of use asset",
        "label": "Right-of-use assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee."
       }
      }
     },
     "auth_ref": [
      "r143",
      "r147",
      "r242"
     ]
    },
    "mlec_RightofuseLeasedAssetAdditionsThroughAnIncreaseInLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "RightofuseLeasedAssetAdditionsThroughAnIncreaseInLeaseLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesTable": {
       "parentTag": "mlec_NonCashInvestingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofSignificantNonCashTransactionsRelatedtoInvestingandFinancingActivitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Right-of-use leased asset additions through an increase in lease liabilities",
        "documentation": "Represent the amount of right-of-use leased asset additions through an increase in lease liabilities.",
        "label": "Rightofuse Leased Asset Additions Through An Increase In Lease Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RiskExposureAssociatedWithInstrumentsSharingCharacteristic",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofCurrencyRiskTable",
      "http://www.moolecscience.com/role/ScheduleofOtherForiegnCurrencieswithVariablesRemainingConstantTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Argentine peso amount expressed",
        "negatedLabel": "Amount expressed in US$",
        "negatedTerseLabel": "Argentine peso amount expressed",
        "label": "Risk exposure associated with instruments sharing characteristic"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of risk exposure associated with financial instruments with a shared characteristic that identifies a concentration of risks. [Refer: Classes of financial instruments [domain]]"
       }
      }
     },
     "auth_ref": [
      "r214"
     ]
    },
    "mlec_RizobacterArgentinaSAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "RizobacterArgentinaSAMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofGoodwillTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rizobacter Argentina S.A. [Member]",
        "label": "Rizobacter Argentina SAMember"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_RizobacterUGEMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "RizobacterUGEMember",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsScheduleofIntangibleAssetsandLiabilitiesAssumed"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rizobacter UGE [Member]",
        "label": "Rizobacter UGEMember"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_RoyaltiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "RoyaltiesMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable",
      "http://www.moolecscience.com/role/ScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalties [Member]",
        "documentation": "This member stands for royalties.",
        "label": "Royalties Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RoyaltyExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RoyaltyExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable": {
       "parentTag": "ifrs-full_ResearchAndDevelopmentExpense",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofExpensesClassifiedbyNatureandFunctionTable",
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commissions and royalties",
        "label": "Royalty expense"
       }
      }
     },
     "auth_ref": [
      "r655"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r587"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r587"
     ]
    },
    "mlec_SWSemillasSAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "SWSemillasSAMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofJointVenturesAssetsTable",
      "http://www.moolecscience.com/role/ScheduleofShareofProfitorLossofJointVenturesandAffiliatesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SW Semillas S.A. [Member]",
        "label": "SWSemillas SAMember"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SafflowerChimosin20Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "SafflowerChimosin20Member",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Safflower Chimosin 2.0 [Member]",
        "label": "Safflower Chimosin20 Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SafflowerGLAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "SafflowerGLAMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Safflower GLA [Member]",
        "label": "Safflower GLAMember"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SalariesAccruedIncentivesVacationsAndSocialSecurity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "SalariesAccruedIncentivesVacationsAndSocialSecurity",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofEmployeeBenefitsandSocialSecurityTable": {
       "parentTag": "ifrs-full_CurrentProvisionsForEmployeeBenefits",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofEmployeeBenefitsandSocialSecurityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Salaries, accrued incentives, vacations and social security",
        "documentation": "The amount of current provisions for employee salaries, accrued incentives, vacations and social security.",
        "label": "Salaries Accrued Incentives Vacations And Social Security"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SalariesSocialSecurityBenefitsAndOtherBenefitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "SalariesSocialSecurityBenefitsAndOtherBenefitsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTransactionsBetweentheGroupandRelatedPartiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Salaries, social security benefits and other benefits [Member]",
        "label": "Salaries Social Security Benefits And Other Benefits Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SaleOfEquityInvestment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "SaleOfEquityInvestment",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinJointVenturesInvestmentsandAffiliatesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of equity investment",
        "documentation": "The carrying amount of the equity investment sold during the period.",
        "label": "Sale Of Equity Investment"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SalesAndServicesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "SalesAndServicesMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTransactionsBetweentheGroupandRelatedPartiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sales and services [Member]",
        "label": "Sales And Services Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SalesOfGoodsAndServicesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "SalesOfGoodsAndServicesMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTransactionsBetweentheGroupandRelatedPartiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sales of goods and services [Member]",
        "label": "Sales Of Goods And Services Member"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ScenarioForecastMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ScenarioForecastMember",
     "presentation": [
      "http://www.moolecscience.com/role/ReverseStockSplitAftertheReportingPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forecast [Member]",
        "label": "Forecast [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ScenarioUnspecifiedDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ScenarioUnspecifiedDomain",
     "presentation": [
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfAssetsAcquiredAndLiabilitiesAssumedAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfAssetsAcquiredAndLiabilitiesAssumedAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Assets Acquired And Liabilities Assumed Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfBioceresSaAndBioceresCropSolutionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfBioceresSaAndBioceresCropSolutionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Bioceres Sa And Bioceres Crop Solutions Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfBorrowingsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfBorrowingsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Borrowings Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfBorrowingsCarryingAmountAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfBorrowingsCarryingAmountAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Borrowings Carrying Amount Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfCarryingAmountsThatWouldHaveBeenRecognizedAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfCarryingAmountsThatWouldHaveBeenRecognizedAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Carrying Amounts That Would Have Been Recognized Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfChangesInAllowancesAndProvisionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfChangesInAllowancesAndProvisionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Changes In Allowances And Provisions Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfChangesInBiologicalAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfChangesInBiologicalAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Changes In Biological Assets Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfChangesInJointVenturesInvestmentsAndAffiliatesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfChangesInJointVenturesInvestmentsAndAffiliatesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Changes In Joint Ventures Investments And Affiliates Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Changes In Liabilities Arising From Financing Activities Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinLiabilitiesArisingfromFinancingActivitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Changes in Liabilities Arising from Financing Activities [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfCompensationOfKeyManagementPersonnelCompensationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfCompensationOfKeyManagementPersonnelCompensationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Compensation of Key Management Personnel Compensation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfConvertibleNotesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfConvertibleNotesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Convertible Notes Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfDeferredRevenueAndAdvancesFromCustomersAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfDeferredRevenueAndAdvancesFromCustomersAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Deferred Revenue And Advances From Customers Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfEarningPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfEarningPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Earning Per Share Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfEmployeeBenefitsAndSocialSecurityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfEmployeeBenefitsAndSocialSecurityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Employee Benefits And Social Security Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfExpensesClassifiedByNatureAndFunctionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Expenses Classified By Nature And Function Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfExpensesClassifiedByNatureAndFunctionLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofExpensesClassifiedbyNatureandFunctionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Expenses Classified by Nature and Function [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfFairValueByHierarchyAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfFairValueByHierarchyAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Fair Value By Hierarchy Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfFairValueOfConsiderationOfPaymentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfFairValueOfConsiderationOfPaymentTableTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/AcquisitionsandOtherSignificantTransactionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Fair Value of the Consideration of Payment",
        "documentation": "The disclosure of detailed information about the fair value of the consideration of payment.",
        "label": "Schedule Of Fair Value Of Consideration Of Payment Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfFairValueOfTheConsiderationOfPaymentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfFairValueOfTheConsiderationOfPaymentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Fair Value Of The Consideration Of Payment Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfFairValueOfTheStockOptionsAtTheGrantDateAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfFairValueOfTheStockOptionsAtTheGrantDateAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Fair Value Of The Stock Options At The Grant Date Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfFinanceResultsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfFinanceResultsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Finance Results [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfFinancialAssetsByCategoryAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfFinancialAssetsByCategoryAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Financial Assets By Category Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfFinancialLiabilitiesByCategoryAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfFinancialLiabilitiesByCategoryAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Financial Liabilities By Category Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Financial Statements Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfFinancialStatementsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfFinancialStatementsTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/InformationaboutComponentsofEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Financial Statements",
        "documentation": "Disclosure of financial statements.",
        "label": "Schedule Of Financial Statements Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfGeographicalInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfGeographicalInformationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Geographical Information Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfGeographicalInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfGeographicalInformationLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofGeographicalInformationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Geographical Information [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfGoodwillAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfGoodwillAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Goodwill Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfGovernmentGrantsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfGovernmentGrantsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Government Grants Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfInformationRelatedToCompanySShareOfVotingRightsInItsSubsidiariesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfInformationRelatedToCompanySShareOfVotingRightsInItsSubsidiariesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Information Related To Company SShare Of Voting Rights In Its Subsidiaries Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfIntangibleAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfIntangibleAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Intangible Assets Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfIntangibleAssetsAndLiabilitiesAssumedLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfIntangibleAssetsAndLiabilitiesAssumedLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetailsScheduleofIntangibleAssetsandLiabilitiesAssumed"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Intangible Assets and Liabilities Assumed [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfInterestRateRiskAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfInterestRateRiskAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Interest Rate Risk Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfInventoriesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfInventoriesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Inventories Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfJointVenturesAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfJointVenturesAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Joint Ventures Assets Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfLiquidityRiskAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfLiquidityRiskAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Liquidity Risk Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfNumberOfSharesIssuedAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfNumberOfSharesIssuedAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Number Of Shares Issued Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfNumberOfSharesIssuedLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfNumberOfSharesIssuedLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofNumberofSharesIssuedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Number of Shares Issued [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfOperatingResultsGroupsReportingSegmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfOperatingResultsGroupsReportingSegmentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Operating Results Groups Reporting Segments Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfOptionActivityAndWeightedAverageExercisePriceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfOptionActivityAndWeightedAverageExercisePriceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Option Activity And Weighted Average Exercise Price Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfOtherFinancialAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfOtherFinancialAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Other Financial Assets Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfOtherIncomeOrExpensesNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfOtherIncomeOrExpensesNetAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Other Income or Expenses, Net [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfOtherReceivablesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfOtherReceivablesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Other Receivables Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfOtherReceivablesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfOtherReceivablesLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOtherReceivablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Other Receivables [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfPropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfPropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Property Plant And Equipment Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfProvisionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfProvisionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Provisions Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfRangeOfAssumptionsWhichHaveDeterminedAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfRangeOfAssumptionsWhichHaveDeterminedAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Range Of Assumptions Which Have Determined Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfRevenueBySimilarGroupOfProductsOrServicesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfRevenueBySimilarGroupOfProductsOrServicesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Revenue By Similar Group Of Products Or Services Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfRightOfUseAndLiabilitiesRelatedWithLeaseAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfRightOfUseAndLiabilitiesRelatedWithLeaseAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Right Of Use And Liabilities Related With Lease Assets Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfRollForwardOfDeferredTaxAssetsAndLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfRollForwardOfDeferredTaxAssetsAndLiabilitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Roll Forward Of Deferred Tax Assets And Liabilities Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfRollforwardOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfRollforwardOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/TaxationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Roll Forward of Deferred Tax Assets and Liabilities",
        "documentation": "The disclosure of deferred taxes.",
        "label": "Schedule Of Rollforward Of Deferred Tax Assets And Liabilities Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfSignificantJointVenturesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfSignificantJointVenturesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Significant Joint Ventures Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfSignificantJointVenturesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfSignificantJointVenturesTableTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/JointVenturesandAssociatesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Significant Joint Ventures",
        "documentation": "Tabular Disclosure is for schedule of significant joint ventures.",
        "label": "Schedule Of Significant Joint Ventures Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities",
     "presentation": [
      "http://www.moolecscience.com/role/CashFlowInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Significant Non-Cash Transactions Related to Investing and Financing Activities",
        "documentation": "The tabular disclosure of significant non-cash transactions related to investing and financing activities.",
        "label": "Schedule Of Significant Non Cash Transactions Related To Investing And Financing Activities"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Significant Non Cash Transactions Related To Investing And Financing Activities Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfSubsidiariesNonControllingInterestAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfSubsidiariesNonControllingInterestAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Subsidiaries Non Controlling Interest Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfTransactionsBetweenTheGroupAndRelatedPartiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfTransactionsBetweenTheGroupAndRelatedPartiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Transactions Between The Group And Related Parties Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfWarrantsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfWarrantsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Warrants [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfWeightedAverageNumberOfOrdinarySharesOutstandingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfWeightedAverageNumberOfOrdinarySharesOutstandingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Weighted Average Number Of Ordinary Shares Outstanding Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfWeightedAverageTaxRateAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ScheduleOfWeightedAverageTaxRateAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Weighted Average Tax Rate [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SecuredConvertibleGuaranteedNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "SecuredConvertibleGuaranteedNotesMember",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Secured Convertible Guaranteed Notes [Member]",
        "documentation": "This member stands for Secured Convertible Guaranteed Notes.",
        "label": "Secured Convertible Guaranteed Notes Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SecuredDebtNonCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "SecuredDebtNonCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet",
      "http://www.moolecscience.com/role/ScheduleofConvertibleNotesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible and non-convertible notes",
        "verboseLabel": "Convertible notes",
        "documentation": "Amount of secured debt, non-current.",
        "label": "Secured Debt Non Current"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SecuredGuaranteedNotesDue2026Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "SecuredGuaranteedNotesDue2026Member",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Secured Guaranteed Notes due 2026 [Member]",
        "documentation": "This member stands for Secured Guaranteed Notes due 2026.",
        "label": "Secured Guaranteed Notes Due2026 Member"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r485"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r489"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r488"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r494"
     ]
    },
    "mlec_SeedAndIntegratedProductsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "SeedAndIntegratedProductsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOperatingResultsGroupsReportingSegmentsTable",
      "http://www.moolecscience.com/role/ScheduleofRevenuebySimilarGroupofProductsorServicesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Seed and Integrated Products [Member]",
        "documentation": "This member stands for Seed and integrated products.",
        "label": "Seed And Integrated Products Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SeedCpProductsAndServicesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "SeedCpProductsAndServicesMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRevenuebySimilarGroupofProductsorServicesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Seed CP Products and Services [Member]",
        "documentation": "This member stands for Seeds, CP products and services.",
        "label": "Seed Cp Products And Services Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SeedRoyaltiesPaymentsHB4ProgramMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "SeedRoyaltiesPaymentsHB4ProgramMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRevenuebySimilarGroupofProductsorServicesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Seed &amp; Royalties Payments &amp; HB4 Program [Member]",
        "label": "Seed Royalties Payments HB4 Program Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SeedTreatmentsPacksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "SeedTreatmentsPacksMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRevenuebySimilarGroupofProductsorServicesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Seed Treatments Packs [Member]",
        "documentation": "This member stands for seed treatments packs.",
        "label": "Seed Treatments Packs Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SeedsAndGrainsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "SeedsAndGrainsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofInventoriesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Seeds [Member]",
        "documentation": "This member stands for information pertaining to seeds and grains.",
        "label": "Seeds And Grains Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SegmentInformationScheduleofGeographicalInformationDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "SegmentInformationScheduleofGeographicalInformationDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofGeographicalInformationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Information - Schedule of Geographical Information (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SegmentInformationScheduleofOperatingResultsGroupsReportingSegmentsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "SegmentInformationScheduleofOperatingResultsGroupsReportingSegmentsDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOperatingResultsGroupsReportingSegmentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Information - Schedule of Operating Results Group's Reporting Segments (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SegmentInformationScheduleofRevenuebySimilarGroupofProductsorServicesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "SegmentInformationScheduleofRevenuebySimilarGroupofProductsorServicesDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRevenuebySimilarGroupofProductsorServicesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Information - Schedule of Revenue by Similar Group of Products or Services (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_SegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "SegmentsAxis",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOperatingResultsGroupsReportingSegmentsTable",
      "http://www.moolecscience.com/role/ScheduleofRevenuebySimilarGroupofProductsorServicesTable",
      "http://www.moolecscience.com/role/ScheduleofSubsidiariesNonControllingInterestTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segments [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r140",
      "r220",
      "r237",
      "r428",
      "r454"
     ]
    },
    "ifrs-full_SegmentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "SegmentsDomain",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRevenuebySimilarGroupofProductsorServicesTable",
      "http://www.moolecscience.com/role/ScheduleofSubsidiariesNonControllingInterestTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segments [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for all segments of an entity. It also represents the standard value for the 'Segments' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r140",
      "r226",
      "r237",
      "r428",
      "r454"
     ]
    },
    "ifrs-full_SellingGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "SellingGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0,
       "order": 6.0
      },
      "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0,
       "order": 8.0
      },
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome",
      "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable",
      "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Selling, general and administrative expenses",
        "negatedTerseLabel": "Selling, general and administrative expenses",
        "label": "Selling, general and administrative expense"
       }
      }
     },
     "auth_ref": [
      "r655"
     ]
    },
    "ifrs-full_SellingGeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "SellingGeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofExpensesClassifiedbyNatureandFunctionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Selling, general and administrative expenses [Member]",
        "label": "Selling, general and administrative expense [member]"
       }
      }
     },
     "auth_ref": [
      "r647",
      "r649"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "terseLabel": "All Award Types"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ShareBasedPaymentArrangementConversionOfEquityAwardsOutstandingToOptionOrRestrictedStockUnits": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ShareBasedPaymentArrangementConversionOfEquityAwardsOutstandingToOptionOrRestrictedStockUnits",
     "presentation": [
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of total equity awards outstanding converted into option or restricted stock (in Shares)",
        "documentation": "The number of shares converted into options or restricted shares.",
        "label": "Share Based Payment Arrangement Conversion Of Equity Awards Outstanding To Option Or Restricted Stock Units"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ShareBasedPaymentAwardExpirationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ShareBasedPaymentAwardExpirationDate",
     "presentation": [
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expire date",
        "documentation": "Share based payment award expiration date.",
        "label": "Share Based Payment Award Expiration Date"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ShareBasedPaymentDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ShareBasedPaymentDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ShareBasedPaymentPeriodOfWeightedAveragePriceVwapOfOrdinarySharesForCashlessBasisExercise": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ShareBasedPaymentPeriodOfWeightedAveragePriceVwapOfOrdinarySharesForCashlessBasisExercise",
     "presentation": [
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Period of weighted average price (\"VWAP\") of the ordinary shares for cashless basis exercise",
        "documentation": "Period of weighted average price (\"VWAP\") of the ordinary shares during to the date of exercise for cashless basis of exercise options in share-based payment arrangement.",
        "label": "Share Based Payment Period Of Weighted Average Price Vwap Of Ordinary Shares For Cashless Basis Exercise"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ShareBasedPaymentScheduleofFairValueoftheStockOptionsattheGrantDateDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ShareBasedPaymentScheduleofFairValueoftheStockOptionsattheGrantDateDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValueoftheStockOptionsattheGrantDateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment - Schedule of Fair Value of the Stock Options at the Grant Date (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ShareBasedPaymentScheduleofOptionActivityandWeightedAverageExercisePriceDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ShareBasedPaymentScheduleofOptionActivityandWeightedAverageExercisePriceDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOptionActivityandWeightedAverageExercisePriceTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment - Schedule of Option Activity and Weighted Average Exercise Price (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ShareBasedPaymentScheduleofRangeofAssumptionswhichhaveDeterminedDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ShareBasedPaymentScheduleofRangeofAssumptionswhichhaveDeterminedDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRangeofAssumptionswhichhaveDeterminedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment - Schedule of Range of Assumptions which have Determined (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ShareBasedPaymentsIncentiveIncreases": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ShareBasedPaymentsIncentiveIncreases",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Incentive increases (in Dollars)",
        "documentation": "Represents the amount of share based payments incentive increases.",
        "label": "Share Based Payments Incentive Increases"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": -1.0,
       "order": 22.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow",
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome",
      "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable",
      "http://www.moolecscience.com/role/ScheduleofChangesinJointVenturesInvestmentsandAffiliatesTable",
      "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share of profit or loss of joint ventures and associates",
        "negatedLabel": "Share of profit or loss of joint ventures and associates",
        "verboseLabel": "Share of profit or loss measured at equity value method",
        "label": "Share of profit (loss) of associates and joint ventures accounted for using equity method"
       }
      }
     },
     "auth_ref": [
      "r218",
      "r225",
      "r411"
     ]
    },
    "ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofShareofProfitorLossofJointVenturesandAffiliatesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share of profit or loss",
        "label": "Share of profit (loss) of joint ventures accounted for using equity method"
       }
      }
     },
     "auth_ref": [
      "r655"
     ]
    },
    "mlec_ShareOfProfitOrLossMeasuredAtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ShareOfProfitOrLossMeasuredAtFairValue",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinJointVenturesInvestmentsandAffiliatesTable",
      "http://www.moolecscience.com/role/ScheduleofShareofProfitorLossofJointVenturesandAffiliatesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share of profit or loss measured at fair value",
        "verboseLabel": "Share of profit or loss",
        "documentation": "Share of profit or loss measured at fair value.",
        "label": "Share Of Profit Or Loss Measured At Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ShareOfProfitOrLossOfSubsidiaries": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ShareOfProfitOrLossOfSubsidiaries",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share of profit or loss of subsidiaries",
        "documentation": "Represents the vaue of share of profit or loss of subsidiaries.",
        "label": "Share Of Profit Or Loss Of Subsidiaries"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ShareOptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ShareOptionsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValueoftheStockOptionsattheGrantDateTable",
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Base Share Option plan [Member]",
        "verboseLabel": "Base Share Option plan [member]",
        "label": "Share options [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for share options."
       }
      }
     },
     "auth_ref": [
      "r625"
     ]
    },
    "ifrs-full_SharePremiumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "SharePremiumMember",
     "presentation": [
      "http://www.moolecscience.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share premium",
        "label": "Share premium [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the amount received or receivable from issuance of the entity's shares in excess of nominal value."
       }
      }
     },
     "auth_ref": [
      "r372"
     ]
    },
    "mlec_ShareToBeIssuedAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ShareToBeIssuedAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shared to be issued",
        "documentation": "The amount of shares to be issued.",
        "label": "Share To Be Issued Amount"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SharebasedIncentivesForEmployees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "SharebasedIncentivesForEmployees",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofExpensesClassifiedbyNatureandFunctionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based incentives for employees",
        "documentation": "Share-based incentives for employees.",
        "label": "Sharebased Incentives For Employees"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ShareholdersAndOtherRelatedPartiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ShareholdersAndOtherRelatedPartiesMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOtherReceivablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shareholders and other related parties (Note 17) [Member]",
        "label": "Shareholders And Other Related Parties Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ShareholdersandOtherRelatedPartiesBalancesandTransactionsScheduleofTransactionsBetweentheGroupandRelatedPartiesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ShareholdersandOtherRelatedPartiesBalancesandTransactionsScheduleofTransactionsBetweentheGroupandRelatedPartiesDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTransactionsBetweentheGroupandRelatedPartiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders and Other Related Parties Balances and Transactions - Schedule of Transactions Between the Group and Related Parties (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates",
     "presentation": [
      "http://www.moolecscience.com/role/InformationaboutComponentsofEquityDetails",
      "http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares held",
        "verboseLabel": "Held own shares",
        "label": "Number of shares in entity held by entity or by its subsidiaries or associates"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of shares in the entity held by the entity or by its subsidiaries or associates. [Refer: Total for all associates [member]; Total for all subsidiaries [member]]"
       }
      }
     },
     "auth_ref": [
      "r249",
      "r356",
      "r400"
     ]
    },
    "mlec_SharesIssuedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "SharesIssuedMember",
     "presentation": [
      "http://www.moolecscience.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares to be issued",
        "label": "Shares Issued Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SharesPremium": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "SharesPremium",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares premium",
        "documentation": "The amount received or receivable from the issuance of the entity's shares in excess of nominal value.",
        "label": "Shares Premium"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SharesSubjectToEmployeeStockPurchasePlan": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "SharesSubjectToEmployeeStockPurchasePlan",
     "presentation": [
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of ordinary shares subject to the ESPP (in Shares)",
        "documentation": "The number of shares subject to employee stock purchase plan.",
        "label": "Shares Subject To Employee Stock Purchase Plan"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ShorttermBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ShorttermBorrowings",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/AcquisitionsandOtherSignificantTransactionsDetails",
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet",
      "http://www.moolecscience.com/role/ScheduleofBorrowingsCarryingAmountTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings",
        "verboseLabel": "Current borrowing",
        "netLabel": "Working capital loan",
        "label": "Current borrowings"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r651"
     ]
    },
    "ifrs-full_ShorttermEmployeeBenefitsExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ShorttermEmployeeBenefitsExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable": {
       "parentTag": "ifrs-full_ResearchAndDevelopmentExpense",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofExpensesClassifiedbyNatureandFunctionTable",
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee benefits and social securities",
        "label": "Short-term employee benefits expense"
       }
      }
     },
     "auth_ref": [
      "r649"
     ]
    },
    "mlec_ShorttermPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ShorttermPeriod",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term period",
        "documentation": "Short-term period.",
        "label": "Shortterm Period"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_SignificantInvestmentsInSubsidiariesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "SignificantInvestmentsInSubsidiariesAxis",
     "presentation": [
      "http://www.moolecscience.com/role/InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeDetails",
      "http://www.moolecscience.com/role/ScheduleofBioceresSAandBioceresCropSolutionsTable",
      "http://www.moolecscience.com/role/ScheduleofFinancialStatementsTable",
      "http://www.moolecscience.com/role/ScheduleofGoodwillTable",
      "http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiaries [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r49",
      "r128",
      "r349"
     ]
    },
    "ifrs-full_SignificantInvestmentsInSubsidiariesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "SignificantInvestmentsInSubsidiariesDomain",
     "presentation": [
      "http://www.moolecscience.com/role/InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeDetails",
      "http://www.moolecscience.com/role/ScheduleofGoodwillTable",
      "http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiaries [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Subsidiaries' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r49",
      "r128",
      "r349"
     ]
    },
    "ifrs-full_SocialSecurityContributions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "SocialSecurityContributions",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAssetsAcquiredandLiabilitiesAssumedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Employee benefits and social security",
        "label": "Social security contributions"
       }
      }
     },
     "auth_ref": [
      "r623"
     ]
    },
    "mlec_SoftwareInProgressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "SoftwareInProgressMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Software in progress [Member]",
        "label": "Software In Progress Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SoftwareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "SoftwareMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Software [Member]",
        "label": "Software Member"
       }
      }
     },
     "auth_ref": []
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r492"
     ]
    },
    "mlec_StandAloneStockOptionGrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "StandAloneStockOptionGrantMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValueoftheStockOptionsattheGrantDateTable",
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stand Alone Stock Option Grant [Member]",
        "verboseLabel": "Stand Alone Stock Option Grant [member]",
        "documentation": "This member stands for stand alone stock option grant.",
        "label": "Stand Alone Stock Option Grant Member"
       }
      }
     },
     "auth_ref": []
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://www.moolecscience.com/role/JointVenturesandAssociatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of cash flows [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_StatementOfChangesInEquityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "StatementOfChangesInEquityLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_StatementOfChangesInEquityTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "StatementOfChangesInEquityTable",
     "presentation": [
      "http://www.moolecscience.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to changes in equity."
       }
      }
     },
     "auth_ref": [
      "r372"
     ]
    },
    "ifrs-full_StatementOfComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "StatementOfComprehensiveIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Information about Component of Consolidated Statements of Comprehensive Income [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of financial position [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_StatementScenarioAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "StatementScenarioAxis",
     "presentation": [
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r511",
      "r522",
      "r538",
      "r573"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_StockIncentivePlan2013Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "StockIncentivePlan2013Member",
     "presentation": [
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Incentive Plan 2013 [Member]",
        "documentation": "This member stands for stock incentive plan 2013.",
        "label": "Stock Incentive Plan2013 Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_StockOptionsAndShareBasedIncentives": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "StockOptionsAndShareBasedIncentives",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock options and share based incentives",
        "documentation": "Amount of stock options and share based incentives.",
        "label": "Stock Options And Share Based Incentives"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_StockOptionsAndShareBasedIncentivesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "StockOptionsAndShareBasedIncentivesMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTransactionsBetweentheGroupandRelatedPartiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock options-based incentives [Member]",
        "documentation": "This member stands for stock options and share based incentives.",
        "label": "Stock Options And Share Based Incentives Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_StrikePriceForConversionOfDebt": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "StrikePriceForConversionOfDebt",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Strike price (in Dollars per share)",
        "documentation": "The strike price per share for conversion of debt.",
        "label": "Strike Price For Conversion Of Debt"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SubscribedCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "SubscribedCapital",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofNumberofSharesIssuedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subscribed capital amount (in Dollars)",
        "documentation": "Represent the amount of subscribed capital.",
        "label": "Subscribed Capital"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SubscribedCapitalOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "SubscribedCapitalOfShares",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofNumberofSharesIssuedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subscribed capital",
        "documentation": "Number of subscribed capital.",
        "label": "Subscribed Capital Of Shares"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SubsequentEventsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "SubsequentEventsMember",
     "presentation": [
      "http://www.moolecscience.com/role/EventsOccurringAftertheReportingPeriodDetails",
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails",
      "http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Events [Member]",
        "label": "Subsequent Events Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SummaryofSignificantAccountingPoliciesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "SummaryofSignificantAccountingPoliciesDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Significant Accounting Policies (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SunflowerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "SunflowerMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinBiologicalAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sunflower [Member]",
        "documentation": "This member stands for Sunflower biological assets.",
        "label": "Sunflower Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SuppliesAndMaterials": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "SuppliesAndMaterials",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable": {
       "parentTag": "ifrs-full_ResearchAndDevelopmentExpense",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofExpensesClassifiedbyNatureandFunctionTable",
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplies and materials",
        "documentation": "The amount of current supplies and materials purchased for production.",
        "label": "Supplies And Materials"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SuppliesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "SuppliesMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofInventoriesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplies [Member]",
        "label": "Supplies Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SurveillanceExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "SurveillanceExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable": {
       "parentTag": "ifrs-full_ResearchAndDevelopmentExpense",
       "weight": 1.0,
       "order": 19.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofExpensesClassifiedbyNatureandFunctionTable",
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Surveillance expenses",
        "documentation": "Surveillance expenses.",
        "label": "Surveillance Expense"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SustainableAgriculturalEquipmentTechnologyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "SustainableAgriculturalEquipmentTechnologyMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sustainable agricultural equipment technology [Member]",
        "label": "Sustainable Agricultural Equipment Technology Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SynBioPowerlabsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "SynBioPowerlabsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofInformationrelatedtoCompanysShareofVotingRightsinitsSubsidiariesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SynBio Powerlabs [Member]",
        "label": "Syn Bio Powerlabs Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SynertechIndustriasSAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "SynertechIndustriasSAMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofJointVenturesAssetsTable",
      "http://www.moolecscience.com/role/ScheduleofShareofProfitorLossofJointVenturesandAffiliatesTable",
      "http://www.moolecscience.com/role/ScheduleofSignificantJointVenturesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Synertech Industrias S.A.",
        "documentation": "This member stands for Synertech Industrias S.A.",
        "label": "Synertech Industrias SAMember"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SyngentaUpfrontFeeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "SyngentaUpfrontFeeMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRevenuebySimilarGroupofProductsorServicesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Syngenta Up-Front Fee [Member]",
        "label": "Syngenta Upfront Fee Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SystemExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "SystemExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable": {
       "parentTag": "ifrs-full_ResearchAndDevelopmentExpense",
       "weight": 1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofExpensesClassifiedbyNatureandFunctionTable",
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Systems expenses",
        "documentation": "Systems expenses.",
        "label": "System Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r566"
     ]
    },
    "ifrs-full_TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/TaxationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized tax-loss carry",
        "label": "Tax benefit arising from previously unrecognised tax loss, tax credit or temporary difference of prior period used to reduce deferred tax expense"
       }
      }
     },
     "auth_ref": [
      "r422",
      "r470"
     ]
    },
    "ifrs-full_TaxEffectFromChangeInTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TaxEffectFromChangeInTaxRate",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofWeightedAverageTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rate change adjustment",
        "label": "Tax effect from change in tax rate"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to changes in the tax rate. [Refer: Accounting profit]"
       }
      }
     },
     "auth_ref": [
      "r4",
      "r267"
     ]
    },
    "mlec_TaxEffectOfRevenuesExemptFromTaxationAndExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "TaxEffectOfRevenuesExemptFromTaxationAndExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofWeightedAverageTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Non-deductible expenses",
        "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to expenses not deductible and revenues that are exempt from taxation in determining taxable profit (tax loss).",
        "label": "Tax Effect Of Revenues Exempt From Taxation And Expenses Not Deductible In Determining Taxable Profit Tax Loss"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_TaxEffectOfShareOfProfitOrLossOfSubsidiesJointVenturesAndAssociates": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "TaxEffectOfShareOfProfitOrLossOfSubsidiesJointVenturesAndAssociates",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofWeightedAverageTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Share of profit or loss of subsidiaries, joint ventures and associates",
        "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to share of profit or loss of subsidies, joint ventures and associates.",
        "label": "Tax Effect Of Share Of Profit Or Loss Of Subsidies Joint Ventures And Associates"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_TaxEffectOfStockOptionCharge": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "TaxEffectOfStockOptionCharge",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofWeightedAverageTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Stock options charge",
        "documentation": "The amount representing the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to stock option charge.",
        "label": "Tax Effect Of Stock Option Charge"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TaxExpenseIncomeAtApplicableTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TaxExpenseIncomeAtApplicableTaxRate",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceTable",
      "http://www.moolecscience.com/role/ScheduleofWeightedAverageTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income tax expense by applying tax rate in force in the respective countries",
        "terseLabel": "Income tax",
        "label": "Tax expense (income) at applicable tax rate"
       }
      },
      "en": {
       "role": {
        "documentation": "The product of the accounting profit multiplied by the applicable tax rate(s). [Refer: Accounting profit; Applicable tax rate]"
       }
      }
     },
     "auth_ref": [
      "r4",
      "r267"
     ]
    },
    "mlec_TaxInflationAdjustment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "TaxInflationAdjustment",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofWeightedAverageTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Tax inflation adjustment",
        "documentation": "Tax Inflation Adjustment",
        "label": "Tax Inflation Adjustment"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_TaxJurisdictionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "TaxJurisdictionAxis",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax Jurisdiction [Axis]",
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table.",
        "label": "Tax Jurisdiction Axis"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_TaxJurisdictionDomainDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "TaxJurisdictionDomainDomain",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "TaxJurisdictionDomain [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_TaxationScheduleofDeferredTaxAssetsandLiabilitiesDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "TaxationScheduleofDeferredTaxAssetsandLiabilitiesDetailsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxation - Schedule of Deferred Tax Assets and Liabilities (Details) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_TaxationScheduleofDeferredTaxAssetsandLiabilitiesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "TaxationScheduleofDeferredTaxAssetsandLiabilitiesDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxation - Schedule of Deferred Tax Assets and Liabilities (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_TaxationScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "TaxationScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceDetailsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxation - Schedule of Income Tax Expense Calculated by Applying Tax Rate in Force (Details) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_TaxationScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "TaxationScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIncomeTaxExpenseCalculatedbyApplyingTaxRateinForceTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxation - Schedule of Income Tax Expense Calculated by Applying Tax Rate in Force (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_TaxationScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "TaxationScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxation - Schedule of Roll Forward of Deferred Tax Assets and Liabilities (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_TaxesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "TaxesMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOtherReceivablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Taxes [Member]",
        "label": "Taxes Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable",
      "http://www.moolecscience.com/role/ScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary difference, unused tax losses and unused tax credits [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r271"
     ]
    },
    "ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable",
      "http://www.moolecscience.com/role/ScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary difference, unused tax losses and unused tax credits [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for temporary differences, unused tax losses and unused tax credits. It also represents the standard value for the 'Temporary difference, unused tax losses and unused tax credits' axis if no other member is used. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]"
       }
      }
     },
     "auth_ref": [
      "r8",
      "r271"
     ]
    },
    "mlec_TheGroupsBusinessReorganizationandGeneralInformationDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "TheGroupsBusinessReorganizationandGeneralInformationDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "The Group\u2019s Business Reorganization and General Information (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_TheoISCSpMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "TheoISCSpMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofJointVenturesAssetsTable",
      "http://www.moolecscience.com/role/ScheduleofShareofProfitorLossofJointVenturesandAffiliatesTable",
      "http://www.moolecscience.com/role/ScheduleofSignificantJointVenturesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Theo I SCSp [Member]",
        "label": "Theo ISCSp Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ThresholdEarningsBeforeInterestTaxesDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ThresholdEarningsBeforeInterestTaxesDepreciationAndAmortization",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Threshold earnings before interest (in Dollars)",
        "documentation": "The exercise price of share options granted.",
        "label": "Threshold Earnings Before Interest Taxes Depreciation And Amortization"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TitleOfInitiallyAppliedIFRS": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TitleOfInitiallyAppliedIFRS",
     "presentation": [
      "http://www.moolecscience.com/role/NewStandardsAmendmentsandInterpretationsIssuedbytheIASBDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of initially applied",
        "label": "Title of initially applied IFRS"
       }
      }
     },
     "auth_ref": [
      "r99",
      "r260"
     ]
    },
    "ifrs-full_TopOfRangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TopOfRangeMember",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationDetails",
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails",
      "http://www.moolecscience.com/role/ScheduleofRangeofAssumptionswhichhaveDeterminedTable",
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails",
      "http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Top of Range [Member]",
        "verboseLabel": "Top of range [member]",
        "netLabel": "Top of range [Member]",
        "label": "Top of range [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for top of a range."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r136",
      "r155",
      "r171",
      "r256",
      "r448",
      "r449",
      "r644"
     ]
    },
    "mlec_TotalLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "TotalLeaseLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "documentation": "The amount of lease liabilities.",
        "label": "Total Lease Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_TotalNonreportableAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "TotalNonreportableAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofGeographicalInformationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total non-reportable assets",
        "documentation": "Total non-reportable assets.",
        "label": "Total Nonreportable Assets"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_TotalReportableAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "TotalReportableAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofGeographicalInformationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total reportable assets",
        "documentation": "Reportable assets.",
        "label": "Total Reportable Assets"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_TotalResearchAndDevelopmentExpenseIncurred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "TotalResearchAndDevelopmentExpenseIncurred",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "documentation": "The amount of research and development costs that an entity incurs.",
        "label": "Total Research And Development Expense Incurred"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r558"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r565"
     ]
    },
    "ifrs-full_TradeAndOtherCurrentPayables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TradeAndOtherCurrentPayables",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.moolecscience.com/role/ScheduleofTradeandOtherPayablesTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet",
      "http://www.moolecscience.com/role/ScheduleofTradeandOtherPayablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Trade and Other Payable",
        "terseLabel": "Trade and other payables",
        "label": "Trade and other current payables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]"
       }
      }
     },
     "auth_ref": [
      "r384"
     ]
    },
    "ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TradeAndOtherCurrentPayablesToTradeSuppliers",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofTradeandOtherPayablesTable": {
       "parentTag": "ifrs-full_TradeAndOtherCurrentPayables",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTradeandOtherPayablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade creditors",
        "label": "Current trade payables"
       }
      },
      "en": {
       "role": {
        "documentation": "The current amount of payment due to suppliers for goods and services used in entity's business. [Refer: Current liabilities; Trade payables]"
       }
      }
     },
     "auth_ref": [
      "r478",
      "r653"
     ]
    },
    "ifrs-full_TradeAndOtherCurrentReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TradeAndOtherCurrentReceivables",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofTradeReceivablesTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTradeReceivablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Trade and other current receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current trade receivables and current other receivables. [Refer: Current trade receivables; Other current receivables]"
       }
      }
     },
     "auth_ref": [
      "r361",
      "r382",
      "r396"
     ]
    },
    "ifrs-full_TradeAndOtherPayables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TradeAndOtherPayables",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAssetsAcquiredandLiabilitiesAssumedTable",
      "http://www.moolecscience.com/role/ScheduleofLiquidityRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade and other payables",
        "negatedLabel": "Trade and other payables",
        "label": "Trade and other payables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of trade payables and other payables. [Refer: Trade payables; Other payables]"
       }
      }
     },
     "auth_ref": [
      "r384"
     ]
    },
    "ifrs-full_TradeAndOtherPayablesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TradeAndOtherPayablesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Trade and Other Payables [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_TradeAndOtherPayablesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "TradeAndOtherPayablesMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValuebyHierarchyTable",
      "http://www.moolecscience.com/role/ScheduleofFinancialLiabilitiesbyCategoryTable",
      "http://www.moolecscience.com/role/ScheduleofLiquidityRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade and other payables [Member]",
        "documentation": "This member stands for trade and other payables.",
        "label": "Trade And Other Payables Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TradeAndOtherPayablesRecognisedAsOfAcquisitionDate",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAssetsAcquiredandLiabilitiesAssumedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accounts payable",
        "label": "Trade and other payables recognised as of acquisition date"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for trade and other payables assumed in a business combination. [Refer: Trade and other payables; Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r643"
     ]
    },
    "mlec_TradeAndOtherPayablesShareholdersAndOtherRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "TradeAndOtherPayablesShareholdersAndOtherRelatedParties",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofTradeandOtherPayablesTable": {
       "parentTag": "ifrs-full_TradeAndOtherCurrentPayables",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTradeandOtherPayablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shareholders and other related parties (Note 17)",
        "documentation": "Represents the amount of trade and other payables in shareholders and other related parties.",
        "label": "Trade And Other Payables Shareholders And Other Related Parties"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TradeAndOtherPayablesToRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TradeAndOtherPayablesToRelatedParties",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTransactionsBetweentheGroupandRelatedPartiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Amounts payable to related parties",
        "label": "Payables to related parties"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of payables due to related parties. [Refer: Total for all related parties [member]]"
       }
      }
     },
     "auth_ref": [
      "r653"
     ]
    },
    "ifrs-full_TradeAndOtherReceivablesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TradeAndOtherReceivablesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Trade Receivables [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TradeAndOtherReceivablesDueFromRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TradeAndOtherReceivablesDueFromRelatedParties",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTransactionsBetweentheGroupandRelatedPartiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Amounts receivable from related parties",
        "label": "Receivables due from related parties"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of receivables due from related parties. [Refer: Total for all related parties [member]]"
       }
      }
     },
     "auth_ref": [
      "r472",
      "r479"
     ]
    },
    "mlec_TradeCreditorsJointVenturesAndAssociates": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "TradeCreditorsJointVenturesAndAssociates",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofTradeandOtherPayablesTable": {
       "parentTag": "ifrs-full_TradeAndOtherCurrentPayables",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTradeandOtherPayablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade creditors - Joint ventures and associates (Note 13)",
        "documentation": "Represents the amount of trade creditors - Joint ventures and associates.",
        "label": "Trade Creditors Joint Ventures And Associates"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_TradeCreditorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "TradeCreditorsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTransactionsBetweentheGroupandRelatedPartiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade creditors [Member]",
        "label": "Trade Creditors Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_TradeDebtorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "TradeDebtorsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTransactionsBetweentheGroupandRelatedPartiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade debtors [Member]",
        "label": "Trade Debtors Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_TradeReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "TradeReceivableMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable",
      "http://www.moolecscience.com/role/ScheduleofRollForwardofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade receivables [Member]",
        "label": "Trade Receivable Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TradeReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TradeReceivables",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAssetsAcquiredandLiabilitiesAssumedTable",
      "http://www.moolecscience.com/role/ScheduleofFinancialAssetsbyCategoryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade and other receivables",
        "verboseLabel": "Trade receivables",
        "label": "Trade receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount due from customers for goods and services sold."
       }
      }
     },
     "auth_ref": [
      "r472",
      "r479"
     ]
    },
    "ifrs-full_TradeReceivablesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TradeReceivablesMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinancialAssetsbyCategoryTable",
      "http://www.moolecscience.com/role/ScheduleofTradeReceivablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade receivables",
        "verboseLabel": "Trade receivables [Member]",
        "label": "Trade receivables [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for trade receivables. [Refer: Trade receivables]"
       }
      }
     },
     "auth_ref": [
      "r200",
      "r204",
      "r343",
      "r346",
      "r458",
      "r649"
     ]
    },
    "mlec_TrademarksAndPatentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "TrademarksAndPatentsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trademarks and patents [Member]",
        "label": "Trademarks And Patents Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_TrademarksAndPatentsWithIndefiniteUsefulLifeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "TrademarksAndPatentsWithIndefiniteUsefulLifeMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trademarks and patents with indefinite useful life [Member]",
        "label": "Trademarks And Patents With Indefinite Useful Life Member"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "auth_ref": [
      "r586"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "auth_ref": [
      "r588"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TransactionPriceAllocatedToRemainingPerformanceObligations",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/InformationaboutComponentofConsolidatedStatementsofComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Performance benchmark obligations",
        "label": "Transaction price allocated to remaining performance obligations"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of the transaction price allocated to the performance obligations that are unsatisfied (or partially unsatisfied) as of the end of the reporting period. The transaction price is the amount of consideration to which an entity expects to be entitled in exchange for transferring promised goods or services to a customer, excluding amounts collected on behalf of third parties (for example, some sales taxes). [Refer: Performance obligations [domain]]"
       }
      }
     },
     "auth_ref": [
      "r141",
      "r238"
     ]
    },
    "ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAssetsAcquiredandLiabilitiesAssumedTable",
      "http://www.moolecscience.com/role/ScheduleofFairValueoftheConsiderationofPaymentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transactions recognised separately from acquisition of assets and assumption of liabilities in business combination [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r181"
     ]
    },
    "ifrs-full_TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationDomain",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAssetsAcquiredandLiabilitiesAssumedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transactions recognised separately from acquisition of assets and assumption of liabilities in business combination [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for transactions that are recognised separately from the acquisition of assets and assumption of liabilities in business combinations. It also represents the standard value for the 'Transactions recognised separately from acquisition of assets and assumption of liabilities in business combination' axis if no other member is used. [Refer: Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r181"
     ]
    },
    "ifrs-full_TransportationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TransportationExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable": {
       "parentTag": "ifrs-full_ResearchAndDevelopmentExpense",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofExpensesClassifiedbyNatureandFunctionTable",
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Freight and haulage",
        "label": "Transportation expense"
       }
      }
     },
     "auth_ref": [
      "r649"
     ]
    },
    "ifrs-full_TravelExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TravelExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable": {
       "parentTag": "ifrs-full_ResearchAndDevelopmentExpense",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofExpensesClassifiedbyNatureandFunctionTable",
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mobility and travel",
        "label": "Travel expense"
       }
      }
     },
     "auth_ref": [
      "r649"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r589"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r590"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Expiration Date",
        "terseLabel": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r590"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r588"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "auth_ref": [
      "r588"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r591"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r589"
     ]
    },
    "mlec_TrigallGeneticsSAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "TrigallGeneticsSAMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofJointVenturesAssetsTable",
      "http://www.moolecscience.com/role/ScheduleofShareofProfitorLossofJointVenturesandAffiliatesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trigall Genetics S.A.",
        "documentation": "This member stands for Trigall Genetics S.A.",
        "label": "Trigall Genetics SAMember"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TypesOfRisksAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TypesOfRisksAxis",
     "presentation": [
      "http://www.moolecscience.com/role/FinancialInstrumentsRiskManagementTables",
      "http://www.moolecscience.com/role/ScheduleofInterestRateRiskTable",
      "http://www.moolecscience.com/role/ScheduleofLiquidityRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of risks [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r156",
      "r157",
      "r158",
      "r160",
      "r191",
      "r198",
      "r199",
      "r282"
     ]
    },
    "ifrs-full_TypesOfRisksDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TypesOfRisksDomain",
     "presentation": [
      "http://www.moolecscience.com/role/FinancialInstrumentsRiskManagementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of risks [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for all types of risks. It also represents the standard value for the 'Types of risks' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r156",
      "r157",
      "r158",
      "r160",
      "r191",
      "r198",
      "r199",
      "r282"
     ]
    },
    "ifrs-full_TypesOfSharebasedPaymentArrangementsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TypesOfSharebasedPaymentArrangementsAxis",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValueoftheStockOptionsattheGrantDateTable",
      "http://www.moolecscience.com/role/ScheduleofOptionActivityandWeightedAverageExercisePriceTable",
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of share-based payment arrangements [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r172",
      "r326"
     ]
    },
    "ifrs-full_TypesOfSharebasedPaymentArrangementsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TypesOfSharebasedPaymentArrangementsDomain",
     "presentation": [
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of share-based payment arrangements [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for an agreement between the entity or another group entity or any shareholder of the group entity and another party (including an employee) that entitles the other party to receive (a) cash or other assets of the entity for amounts that are based on the price (or value) of equity instruments (including shares or share options) of the entity or another group entity; or (b) equity instruments (including shares or share options) of the entity or another group entity, provided that the specified vesting conditions, if any, are met. It also represents the standard value for the 'Types of share-based payment arrangements' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r172",
      "r326"
     ]
    },
    "ifrs-full_UnderlyingEquityInstrumentAndDepositaryReceiptsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "UnderlyingEquityInstrumentAndDepositaryReceiptsAxis",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofEarningPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying equity instrument and depositary receipts [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r649"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r585"
     ]
    },
    "mlec_UsTreasuryBillsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "UsTreasuryBillsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValuebyHierarchyTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "US Treasury bills [Member]",
        "documentation": "Represents the information pertaining to US Treasury Bills.",
        "label": "Us Treasury Bills Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeBiologicalAssetsAtCost": {
     "xbrltype": "durationItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "UsefulLifeMeasuredAsPeriodOfTimeBiologicalAssetsAtCost",
     "presentation": [
      "http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Period from moment of sowing until the moment of harvest",
        "label": "Useful life measured as period of time, biological assets, at cost"
       }
      },
      "en": {
       "role": {
        "documentation": "The useful life, measured as period of time, used for biological assets. [Refer: Biological assets]"
       }
      }
     },
     "auth_ref": [
      "r85",
      "r315"
     ]
    },
    "ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "durationItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill",
     "presentation": [
      "http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Useful life",
        "label": "Useful life measured as period of time, intangible assets other than goodwill"
       }
      },
      "en": {
       "role": {
        "documentation": "The useful life, measured as period of time, used for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r70",
      "r303"
     ]
    },
    "ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment": {
     "xbrltype": "durationItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment",
     "presentation": [
      "http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Useful lives",
        "label": "Useful life measured as period of time, property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The useful life, measured as period of time, used for property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r10",
      "r272"
     ]
    },
    "mlec_ValoraSoySAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ValoraSoySAMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofInformationrelatedtoCompanysShareofVotingRightsinitsSubsidiariesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ValoraSoy S.A.[Member]",
        "label": "Valora Soy SAMember"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ValuationSignificantChangeInAmountNormalWearAndTearVariationImpactOnRevaluationAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ValuationSignificantChangeInAmountNormalWearAndTearVariationImpactOnRevaluationAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impact on revaluation amount (in Dollars)",
        "documentation": "The amount of increase (decrease) in the amount of normal wear and tear variation impact on revaluation of land.",
        "label": "Valuation Significant Change In Amount Normal Wear And Tear Variation Impact On Revaluation Amount"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ValuationSignificantChangePercentageOfConstructionCosts": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ValuationSignificantChangePercentageOfConstructionCosts",
     "presentation": [
      "http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in construction costs that impacts valuation",
        "documentation": "Percentage of construction costs change that could have significant impact on valuation",
        "label": "Valuation Significant Change Percentage Of Construction Costs"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ValueOfTransactionsForThePeriodEnded": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "ValueOfTransactionsForThePeriodEnded",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTransactionsBetweentheGroupandRelatedPartiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Value of transactions for the period ended",
        "documentation": "Value of transactions for the period ended.",
        "label": "Value Of Transactions For The Period Ended"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_VariableRateBorrowingsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "VariableRateBorrowingsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofInterestRateRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable-rate instruments [Member]",
        "documentation": "This member stands for loans that have variable interest rate.",
        "label": "Variable Rate Borrowings Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_VehicleExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "VehicleExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable": {
       "parentTag": "ifrs-full_ResearchAndDevelopmentExpense",
       "weight": 1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRDClassifiedbyNatureTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vehicles expenses",
        "documentation": "Vehicles expenses.",
        "label": "Vehicle Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_Vehicles": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "Vehicles",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vehicles",
        "label": "Vehicles"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of property, plant and equipment representing vehicles used in the entity's operations, specifically to include aircraft, motor vehicles and ships. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r620"
     ]
    },
    "ifrs-full_VehiclesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "VehiclesMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofPropertyPlantandEquipmentTable",
      "http://www.moolecscience.com/role/ScheduleofRightofUseandLiabilitiesRelatedwithLeaseAssetsTable",
      "http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vehicles [Member]",
        "label": "Vehicles [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing vehicles used in the entity's operations, specifically to include aircraft, motor vehicles and ships. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r620"
     ]
    },
    "mlec_VolumeWeightedAveragePriceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "VolumeWeightedAveragePriceMember",
     "presentation": [
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Volume Weighted Average Price [Member]",
        "label": "Volume Weighted Average Price Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_VoluntaryRepurchaseOfNotesAfterIssueDate": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "VoluntaryRepurchaseOfNotesAfterIssueDate",
     "presentation": [
      "http://www.moolecscience.com/role/InformationAboutComponentsofConsolidatedStatementsofFinancialPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Voluntary repurchase of notes after the issue date",
        "documentation": "The voluntary repurchase of notes after the issue date.",
        "label": "Voluntary Repurchase Of Notes After Issue Date"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_VotePerShare": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "VotePerShare",
     "presentation": [
      "http://www.moolecscience.com/role/InformationaboutComponentsofEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vote per share",
        "documentation": "The number of vote for each share.",
        "label": "Vote Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]",
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r554"
     ]
    },
    "ifrs-full_WarrantLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "WarrantLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAssetsAcquiredandLiabilitiesAssumedTable",
      "http://www.moolecscience.com/role/ScheduleofFairValueoftheConsiderationofPaymentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants",
        "negatedLabel": "Warrant liabilities",
        "label": "Warrant liability"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of warrant liabilities."
       }
      }
     },
     "auth_ref": [
      "r651"
     ]
    },
    "mlec_WarrantLiabilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "WarrantLiabilityMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValuebyHierarchyTable",
      "http://www.moolecscience.com/role/ScheduleofFinancialLiabilitiesbyCategoryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants [Member]",
        "verboseLabel": "Warrant liability [Member]",
        "label": "Warrant Liability Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_WarrantesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "WarrantesMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTransactionsBetweentheGroupandRelatedPartiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants [Member]",
        "label": "Warrantes Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_WarrantsExercisableForOrdinarySharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "WarrantsExercisableForOrdinarySharesMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants, exercisable for ordinary shares",
        "label": "Warrants Exercisable For Ordinary Shares Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOptionActivityandWeightedAverageExercisePriceTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "W.A. Exercise price, Exercised during the year",
        "label": "Weighted average exercise price of share options exercised in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r167",
      "r322"
     ]
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOptionActivityandWeightedAverageExercisePriceTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "W.A. Exercise price, Cancelled or expired during the year",
        "label": "Weighted average exercise price of share options expired in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options expired in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r168",
      "r323"
     ]
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOptionActivityandWeightedAverageExercisePriceTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "W.A. Exercise price, Loss of control",
        "label": "Weighted average exercise price of share options forfeited in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options forfeited in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r166",
      "r321"
     ]
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOptionActivityandWeightedAverageExercisePriceTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "W.A. Exercise price, Granted during the year",
        "label": "Weighted average exercise price of share options granted in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r165",
      "r320"
     ]
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOptionActivityandWeightedAverageExercisePriceTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "W.A. Exercise price, At the beginning of the year",
        "periodEndLabel": "W.A. Exercise price, Effective at the end of the year",
        "label": "Weighted average exercise price of share options outstanding in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r164",
      "r169",
      "r319",
      "r324"
     ]
    },
    "ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "WeightedAverageFairValueAtMeasurementDateShareOptionsGranted",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValueoftheStockOptionsattheGrantDateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average fair value of stock options at measurement date (in Dollars)",
        "label": "Weighted average fair value at measurement date, share options granted"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average fair value of share options granted during the period at the measurement date. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r174"
     ]
    },
    "ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "WeightedAverageSharePriceShareOptionsGranted2019",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValueoftheStockOptionsattheGrantDateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average fair value of shares (in Dollars per share)",
        "label": "Weighted average share price, share options granted"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average share price used as input to the option pricing model to calculate the fair value of share options granted. [Refer: Option pricing model [member]; Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "ifrs-full_WeightedAverageShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "WeightedAverageShares",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofEarningPerShareTable",
      "http://www.moolecscience.com/role/ScheduleofWeightedAverageNumberofOrdinarySharesOutstandingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares (basic EPS)",
        "label": "Weighted average number of ordinary shares used in calculating basic earnings per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor."
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofEarningPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Denominator",
        "label": "Weighted average ordinary shares used in calculating basic and diluted earnings per share [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_WorkingCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "WorkingCapital",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/EventsOccurringAftertheReportingPeriodDetails",
      "http://www.moolecscience.com/role/TheGroupsBusinessReorganizationandGeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Working capital (in Dollars)",
        "verboseLabel": "Working capital amount",
        "documentation": "Amount of working capital.",
        "label": "Working Capital"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_WorkingCapitalAdjustmentsOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "WorkingCapitalAdjustmentsOperatingActivitiesAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Working capital adjustments",
        "documentation": "No definition available.",
        "label": "Working Capital Adjustments Operating Activities Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r609"
     ]
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]",
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r552"
     ]
    },
    "mlec_deductedFromAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20250630",
     "localname": "deductedFromAssetsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofChangesinAllowancesandProvisionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total deducted from assets [Member]",
        "label": "deducted From Assets Member"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "10",
   "IssueDate": "2025-01-01",
   "Paragraph": "21",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2025-en-r&anchor=para_21&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "10",
   "IssueDate": "2025-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS10_g17-22_TI",
   "URIDate": "2025-03-27"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "79",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_79&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "81",
   "Subparagraph": "ab",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_ab&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "81",
   "Subparagraph": "c",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_c_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "81",
   "Subparagraph": "c",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_c_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "81",
   "Subparagraph": "g",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_g_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "81",
   "Subparagraph": "g",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_g_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "81",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_g&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS12_g79-88_TI",
   "URIDate": "2025-03-27"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "73",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "73",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_e_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_e_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "Clause": "vii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_e_vii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "Clause": "viii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_e_viii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "73",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "75",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_75_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "75",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_75_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "77",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_77_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "142",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_142&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "36",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2025-en-r&anchor=para_36_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "36",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2025-en-r&anchor=para_36_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS02_g36-39_TI",
   "URIDate": "2025-03-27"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "20",
   "IssueDate": "2025-01-01",
   "Paragraph": "39",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=20&code=ifrs-tx-2025-en-r&anchor=para_39_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "20",
   "IssueDate": "2025-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=20&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS20_g39-39_TI",
   "URIDate": "2025-03-27"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "21",
   "IssueDate": "2025-01-01",
   "Paragraph": "52",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2025-en-r&anchor=para_52_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "21",
   "IssueDate": "2025-01-01",
   "Paragraph": "A19",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2025-en-r&anchor=para_A19_f&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_17_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_17_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_17&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2025-01-01",
   "Paragraph": "18",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_18&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2025-01-01",
   "Paragraph": "19",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_19_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2025-01-01",
   "Paragraph": "19",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_19_f&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2025-01-01",
   "Paragraph": "19",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_19_g&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2025-01-01",
   "Paragraph": "19",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_19&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2025-01-01",
   "Section": "Disclosures",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS24_g13-24_TI",
   "URIDate": "2025-03-27"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "26",
   "IssueDate": "2025-01-01",
   "Paragraph": "35",
   "Subparagraph": "b",
   "Clause": "vi",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2025-en-r&anchor=para_35_b_vi&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "26",
   "IssueDate": "2025-01-01",
   "Paragraph": "35",
   "Subparagraph": "b",
   "Clause": "vii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2025-en-r&anchor=para_35_b_vii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "26",
   "IssueDate": "2025-01-01",
   "Paragraph": "35",
   "Subparagraph": "b",
   "Clause": "viii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2025-en-r&anchor=para_35_b_viii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2025-01-01",
   "Paragraph": "10",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_10&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2025-01-01",
   "Paragraph": "16",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_16_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2025-01-01",
   "Paragraph": "16",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_16_b_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2025-01-01",
   "Paragraph": "16",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_16_b_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2025-01-01",
   "Paragraph": "16",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_16_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_17_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_17_b_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_17_b_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_17_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2025-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS27_g15-17_TI",
   "URIDate": "2025-03-27"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2025-01-01",
   "Paragraph": "66",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2025-01-01",
   "Paragraph": "67",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_67&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2025-01-01",
   "Paragraph": "70",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_70_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2025-01-01",
   "Paragraph": "70",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_70_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2025-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS33_g70-73A_TI",
   "URIDate": "2025-03-27"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2025-01-01",
   "Paragraph": "126",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_126&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2025-01-01",
   "Paragraph": "130",
   "Subparagraph": "d",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_130_d_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2025-01-01",
   "Paragraph": "130",
   "Subparagraph": "f",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_130_f_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2025-01-01",
   "Paragraph": "134",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_134_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2025-01-01",
   "Paragraph": "134",
   "Subparagraph": "d",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_134_d_iv&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2025-01-01",
   "Paragraph": "134",
   "Subparagraph": "d",
   "Clause": "v",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_134_d_v&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2025-01-01",
   "Paragraph": "134",
   "Subparagraph": "e",
   "Clause": "iiA",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_134_e_iiA&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2025-01-01",
   "Paragraph": "134",
   "Subparagraph": "e",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_134_e_iv&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2025-01-01",
   "Paragraph": "134",
   "Subparagraph": "e",
   "Clause": "v",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_134_e_v&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2025-01-01",
   "Paragraph": "135",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_135_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "37",
   "IssueDate": "2025-01-01",
   "Paragraph": "84",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2025-en-r&anchor=para_84_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "37",
   "IssueDate": "2025-01-01",
   "Paragraph": "84",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2025-en-r&anchor=para_84_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "37",
   "IssueDate": "2025-01-01",
   "Paragraph": "84",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2025-en-r&anchor=para_84&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "37",
   "IssueDate": "2025-01-01",
   "Paragraph": "89",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2025-en-r&anchor=para_89&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "118",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "118",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_e_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "Clause": "vi",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_e_vi&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "Clause": "vii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_e_vii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "118",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "126",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_126&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2025-01-01",
   "Paragraph": "32A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2025-en-r&anchor=para_32A&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2025-01-01",
   "Paragraph": "76",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2025-en-r&anchor=para_76&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2025-01-01",
   "Paragraph": "79",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2025-en-r&anchor=para_79_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2025-01-01",
   "Paragraph": "79",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2025-en-r&anchor=para_79_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "41",
   "IssueDate": "2025-01-01",
   "Paragraph": "40",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2025-en-r&anchor=para_40&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "41",
   "IssueDate": "2025-01-01",
   "Paragraph": "50",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2025-en-r&anchor=para_50_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "41",
   "IssueDate": "2025-01-01",
   "Paragraph": "50",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2025-en-r&anchor=para_50&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "41",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2025-en-r&anchor=para_54_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "41",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2025-en-r&anchor=para_54_f&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "10",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_10&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "25",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_25&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "31",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_31&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "35",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "39",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_39&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "44B",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_44B_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "44H",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_44H_b_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "46",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_46&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "50",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_50_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Section": "Presentation of a statement of cash flows",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS07_g10-17_TI",
   "URIDate": "2025-03-27"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "30",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2025-en-r&anchor=para_30_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "24",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2025-en-r&anchor=para_24_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "24",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2025-en-r&anchor=para_24_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "32",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2025-en-r&anchor=para_32_a_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "32",
   "Subparagraph": "a",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2025-en-r&anchor=para_32_a_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "10",
   "IssueDate": "2025-01-01",
   "Paragraph": "22",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=10&code=ifrs-tx-2025-en-r&anchor=para_22&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "12",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_12_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "12",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_12_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "12",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_12_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "12",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_12_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "12",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_12_f&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "19B",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_19B_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "19B",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_19B_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "19B",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_19B_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "2",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_2_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "21",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_21_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_ii&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_iv&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "ix",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "v",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "vii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_vii&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B13",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B13",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B13_f&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B13",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B4",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B4_a&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B4",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B4_b&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Section": "Nature of the risks associated with an entity's interests in consolidated structured entities",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IFRS12_g14-17_TI",
   "URIDate": "2025-03-27"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Section": "Objective",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IFRS12_g1-4_TI",
   "URIDate": "2025-03-27"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2025-01-01",
   "Paragraph": "93",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_93_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2025-01-01",
   "Paragraph": "93",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_93_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2025-01-01",
   "Paragraph": "93",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_93_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2025-01-01",
   "Paragraph": "93",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_93&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "14",
   "IssueDate": "2025-01-01",
   "Paragraph": "33",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=14&code=ifrs-tx-2025-en-r&anchor=para_33_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2025-01-01",
   "Paragraph": "105",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_105&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2025-01-01",
   "Paragraph": "113",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_113_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2025-01-01",
   "Paragraph": "114",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_114&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2025-01-01",
   "Paragraph": "115",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_115&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2025-01-01",
   "Paragraph": "120",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_120_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2025-01-01",
   "Paragraph": "120",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_120_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "47",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_47_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "47",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_47_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "53",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_53_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "53",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_53_h&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "53",
   "Subparagraph": "j",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_53_j&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "53",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_53&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "94",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_94&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "97",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_97&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IFRS16_g51-60_TI",
   "URIDate": "2025-03-27"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Section": "Presentation",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IFRS16_g47-50_TI",
   "URIDate": "2025-03-27"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "109",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_109&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "109A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_109A&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "120",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_120&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "124",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_124&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "125",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_125&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "127",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_127&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "128",
   "Subparagraph": "a",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_128_a_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "128",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_128_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "132",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_132_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "C32",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_C32&doctype=Appendix&subtype=C",
   "URIDate": "2025-03-27"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "44",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_44&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_iv&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "v",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_v&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "vi",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_vi&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "47",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_47_a_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "47",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_47_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "51",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_51_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2025-01-01",
   "Paragraph": "B64",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B64_c&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2025-01-01",
   "Paragraph": "B64",
   "Subparagraph": "f",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B64_f_i&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2025-01-01",
   "Paragraph": "B64",
   "Subparagraph": "f",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B64_f_ii&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2025-01-01",
   "Paragraph": "B64",
   "Subparagraph": "f",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B64_f_iv&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2025-01-01",
   "Paragraph": "B64",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B64_f&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2025-01-01",
   "Paragraph": "B64",
   "Subparagraph": "l",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B64_l&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2025-01-01",
   "Paragraph": "B64",
   "Subparagraph": "n",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B64_n_i&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2025-01-01",
   "Paragraph": "B64",
   "Subparagraph": "q",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B64_q_i&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2025-01-01",
   "Paragraph": "B64",
   "Subparagraph": "q",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B64_q_ii&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2025-01-01",
   "Paragraph": "B64",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B64&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2025-01-01",
   "Paragraph": "B67",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B67_d&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2025-01-01",
   "Paragraph": "B67",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B67&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2025-01-01",
   "Section": "Disclosures application of paragraphs 59 and 61",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&doctype=Appendix&subtype=B&dita_xref=IFRS03_gB64-B67_TI",
   "URIDate": "2025-03-27"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "5",
   "IssueDate": "2025-01-01",
   "Paragraph": "33",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2025-en-r&anchor=para_33_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "5",
   "IssueDate": "2025-01-01",
   "Paragraph": "33",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2025-en-r&anchor=para_33_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "21C",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_21C&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "22A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_22A&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "23B",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_23B_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "24C",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_24C_a_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "24C",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_24C_b_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "25",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_25&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "31",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_31&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "33",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_33&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "35H",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35H_b_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "35H",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35H&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "35I",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35I&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "35K",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35K&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "35M",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35M_b_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "35M",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35M&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "36",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_36&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "39",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_39_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "42E",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_42E_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "42I",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_42I&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_6&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "7",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "8",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_8_f&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "B2",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_B2_a&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "B8",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_B8_c&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Section": "Defined terms",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&doctype=Appendix&subtype=A&dita_xref=IFRS07_APPA_TI",
   "URIDate": "2025-03-27"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "23",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "23",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "23",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23_g&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "23",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23_h&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "23",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "32",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_32&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "33",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_33_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "33",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_33&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IFRS08_g20-24_TI",
   "URIDate": "2025-03-27"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "9",
   "IssueDate": "2025-01-01",
   "Paragraph": "7.2.34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2025-en-r&anchor=para_7.2.34&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "9",
   "IssueDate": "2025-01-01",
   "Paragraph": "7.2.42",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2025-en-r&anchor=para_7.2.42&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2026-01-01",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "20B",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_20B&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2026-01-01",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "30A",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_30A_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "103",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_103&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "104",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_104&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "108",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_108_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "108",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_108_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "115",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_115_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "115",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_115_g&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "115",
   "Subparagraph": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_115_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "115",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_115&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "122",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_122_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "124",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_124&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "128",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_128&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "138",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_138&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "160",
   "Subparagraph": "a",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_160_a_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "160",
   "Subparagraph": "a",
   "Clause": "vi",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_160_a_vi&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "160",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_160_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "160",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_160&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "164",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_164_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "164",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_164_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "166",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_166_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "166",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_166&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "168",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_168_b_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "169",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_169&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "170",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_170&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "176",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_176&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "178",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_178_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "178",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_178_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "178",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_178&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "180",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_180_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "190",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_190&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "192",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_192&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "194",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_194_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "194",
   "Subparagraph": "c",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_194_c_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "194",
   "Subparagraph": "c",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_194_c_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "194",
   "Subparagraph": "f",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_194_f_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "194",
   "Subparagraph": "f",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_194_f_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "194",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_194_f&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "200",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "200",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "200",
   "Subparagraph": "e",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200_e_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "200",
   "Subparagraph": "e",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200_e_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "200",
   "Subparagraph": "e",
   "Clause": "vii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200_e_vii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "200",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "200",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "202",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_202_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "216",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_216_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "218",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_218_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "223",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_223_f&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "227",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_227&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "230",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_230&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "231",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_231_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "231",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_231_f&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "231",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_231_g&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "231",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_231&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "24",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_24_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "24",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_24_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "250",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_250&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "254",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_254_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "254",
   "Subparagraph": "d",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_254_d_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "254",
   "Subparagraph": "d",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_254_d_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "254",
   "Subparagraph": "e",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_254_e_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "254",
   "Subparagraph": "f",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_254_f_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "254",
   "Subparagraph": "f",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_254_f_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "255",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_255_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "257",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_257_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "257",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_257_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "257",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_257&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "260",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_260&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "263",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_263_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "263",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_263_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "263",
   "Subparagraph": "e",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_263_e_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "263",
   "Subparagraph": "e",
   "Clause": "vi",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_263_e_vi&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "263",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_263_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "263",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_263&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "266",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_266&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "269",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_269&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "271",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_271_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "271",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_271_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "273",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_273_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "273",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_273&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "274",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_274_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "274",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_274_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_28_a_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "Subparagraph": "a",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_28_a_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "31",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "31",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "31",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "31",
   "Subparagraph": "b",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_iv&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "31",
   "Subparagraph": "b",
   "Clause": "v",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_v&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "31",
   "Subparagraph": "b",
   "Clause": "vi",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_vi&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "31",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "31",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "34",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_34_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "35",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_35_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "35",
   "Subparagraph": "e",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_35_e_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "35",
   "Subparagraph": "e",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_35_e_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "35",
   "Subparagraph": "e",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_35_e_iv&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "35",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_35_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "35",
   "Subparagraph": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_35_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "35",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_35&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "37",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_37&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "43",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_43&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "44",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_44_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "56A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_56A&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "58",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_58&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "62",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_62_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "62",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_62_b_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "64A",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_64A_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "66",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_66_b_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "66",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "70",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_70&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "71",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_71_b_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "71",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_71&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "72",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_72_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "75",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_75_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "75",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_75_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "88",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_88_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "95",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_95_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "95",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_95_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "95",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_95&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B10",
   "Subparagraph": "a",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B10_a_iii&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B10",
   "Subparagraph": "a",
   "Clause": "vi",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B10_a_vi&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B10",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B10_a&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B10",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B10&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B12",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B12&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B13",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B13&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B9",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B9_b&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B9",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B9_e&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B9",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B9_f&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expired 2023-01-01",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "22",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_22&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2026-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "139W",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_139W&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2026-01-01",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "C1D",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_C1D&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2026-01-01",
   "Name": "IFRS",
   "Number": "9",
   "IssueDate": "2025-01-01",
   "Paragraph": "7.2.49",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2025-en-r&anchor=para_7.2.49&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "103",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_103&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "106",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_d_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_d_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "106",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "107",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_107&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "117",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_117&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "51",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_51&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_f&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_g&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_h&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "k",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_k&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "l",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_l&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "n",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_n&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "o",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_o&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "q",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_q&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "r",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_r&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "55",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_55&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "56",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_56&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "61",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_61&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "66",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_66&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "69",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_69&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "7",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_7&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "78",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "78",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79_a_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "Clause": "vi",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79_a_vi&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "79",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "81A",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81A_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "81A",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81A_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "81B",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81B_a_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "81B",
   "Subparagraph": "a",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81B_a_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "81B",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81B_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "81B",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81B_b_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "82",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_82_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "82",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_82_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "82",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_82_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "82",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_82_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "82",
   "Subparagraph": "ea",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_82_ea&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "90",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_90&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "91",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_91_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "91",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_91_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "98",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_98_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "98",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_98_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "99",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_99&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "10",
   "IssueDate": "2025-01-01",
   "Paragraph": "22",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2025-en-r&anchor=para_22_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "80",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_80_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "80",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_80_f&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "37",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_37_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "37",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_37_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "37",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_37_g&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "37",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_37_h&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "138",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_138_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "138",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_138_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "147",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_147_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "32",
   "IssueDate": "2025-01-01",
   "Paragraph": "IE33",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=32&code=ifrs-tx-2025-en-r&anchor=para_IE33&doctype=Illustrative%20Examples",
   "URIDate": "2025-03-27"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "119",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_119_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "119",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_119_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "119",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_119_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "41",
   "IssueDate": "2025-01-01",
   "Paragraph": "43",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2025-en-r&anchor=para_43&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "41",
   "IssueDate": "2025-01-01",
   "Paragraph": "51",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2025-en-r&anchor=para_51&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "41",
   "IssueDate": "2025-01-01",
   "Section": "Example 1 XYZ Dairy Ltd",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2025-en-r&doctype=Illustrative%20Examples&dita_xref=IAS41_IE_ex1_TI",
   "URIDate": "2025-03-27"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "14",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_14_f&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "16",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_16_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "16",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_16_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "16",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_16_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_17_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_17_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_17_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "44C",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_44C&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "44D",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_44D&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Section": "C Reconciliation of liabilities arising from financing activities",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_C_TI",
   "URIDate": "2025-03-27"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B10",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2025-01-01",
   "Paragraph": "B6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_B6&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2025-01-01",
   "Paragraph": "IE63",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_IE63&doctype=Illustrative%20Examples",
   "URIDate": "2025-03-27"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2025-01-01",
   "Paragraph": "B89",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_B89_a&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2025-01-01",
   "Paragraph": "B89",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_B89_b&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "113",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_113_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "96",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_96_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "96",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_96_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2025-01-01",
   "Paragraph": "B64",
   "Subparagraph": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B64_i&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2025-01-01",
   "Paragraph": "IE72",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_IE72&doctype=Illustrative%20Examples",
   "URIDate": "2025-03-27"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "32",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_32&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "35N",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35N&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "B11",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_B11_c&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "B11",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_B11&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "B35",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_B35_e&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "B35",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_B35&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "IG31A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_IG31A&doctype=Implementation%20Guidance",
   "URIDate": "2025-03-27"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "23",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "103",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_103_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "103",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_103_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "191",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_191_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "193",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_193_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "193",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_193_f&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "35",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_35_g&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B9",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B9_b&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B9",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B9_f&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "102",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_102&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "103",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_103&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "108",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_108&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "68",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_68&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "70",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_70&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "78",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "82A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_82A&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "IG6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_IG6&doctype=Implementation%20Guidance",
   "URIDate": "2025-03-27"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "Global LEI Foundation"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "249",
   "Section": "308",
   "Subsection": "a"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Number": "249",
   "Section": "308"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form F-3"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-3"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-4"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-6"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form S-3"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Investment Company Act",
   "Number": "270"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "313"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-X",
   "Number": "210",
   "Section": "2",
   "Subsection": "2"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "413",
   "Subsection": "b"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "b"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "c"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "d"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "e"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "a"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "b"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Section": "8",
   "Subsection": "c"
  },
  "r618": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "81",
   "Subparagraph": "g",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_g_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r619": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "81",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r620": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "37",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_37&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r621": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "73",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r622": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r623": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "9",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_9&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r624": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "20",
   "IssueDate": "2025-01-01",
   "Paragraph": "39",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=20&code=ifrs-tx-2025-en-r&anchor=para_39_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r625": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2025-01-01",
   "Paragraph": "70",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_70_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r626": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "37",
   "IssueDate": "2025-01-01",
   "Paragraph": "84",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2025-en-r&anchor=para_84&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r627": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "118",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r628": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r629": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "119",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_119&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r630": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2025-01-01",
   "Paragraph": "79",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2025-en-r&anchor=para_79_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r631": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "41",
   "IssueDate": "2025-01-01",
   "Paragraph": "50",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2025-en-r&anchor=para_50&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r632": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "41",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2025-en-r&anchor=para_54_f&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r633": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "14",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_14&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r634": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "16",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_16&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r635": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_17&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r636": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "20",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_20_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r637": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "20",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_20_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r638": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "20",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_20_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r639": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "20",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_20&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r640": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r641": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2025-01-01",
   "Paragraph": "93",
   "Subparagraph": "e",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_93_e_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r642": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r643": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2025-01-01",
   "Paragraph": "B64",
   "Subparagraph": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B64_i&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r644": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "7",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r645": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r646": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "10",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_10_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r647": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "104",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_104&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r648": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r649": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "112",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_112_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r650": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "117",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_117&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r651": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "55",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_55&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r652": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r653": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "78",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r654": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r655": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "85",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_85&doctype=Standard",
   "URIDate": "2025-03-27"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>163
<FILENAME>0001213900-25-125820-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-25-125820-xbrl.zip
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M6OS;ZP=7&/=<SU0I9#*E2],$Y5WCKG(+0@434CR?49(W-T_TI).T,VHB;H'
MW=/?5 #2-\3Y19.A11<2M>I-',Q';K__;.UJ%[L,LJUZ7$XQ#F=. 74Q3F<I
MXW(>M;!Q;K1 5?M.7=7^I*K:'P"^^(*\+()=B7!TUTK;ON[K;6?)N+5P)V_,
MT2R&O5#D4N (]!1^?H:@<5(,$E2-__CZGZVMI;:$-S^<?KD0%[^T.]5Y)H6?
M(F_.\=@]UUI7<QDWMM#/R5J]_F=)0#/N;8_:6^RP.0Z><^:B#[RD#=Q9Y@:>
M-<\O1/LNV[5]Q\V:M>;7[<,#+_[U6<G*QBP5>Z-]<G%^>O3E\.+T_$]Q<GK1
MHF%T9^>M3NOD@H=9G7X4']LGS9/#-O =_GIZ\4OK7+1/<((:'5+O:V5?E[D]
M%ZW/8 G-RF-/4,7>4JGB"':_??$G[OU1^[R%Y-&!PULG[=-S\;EYTOS$X\V0
M')I'O[<[K?..L,MZ>V+8_TZ)?+^AL>8BZ[^_S#L>:4R?Q$E*J>2.BG2<B,]%
M^OC^E_A68FPEF_!AD4U8*OQ*,[C4*>S!TR/HPT76<JD 1R9IOX*UO)6@?AA=
M<G^:8F>1C5TNIMG'CV +X+S+=N>B?6AGV9Z!RF@=B8OVY]9%\\-Q:U6J8?WD
MUD+*X\U2MZ37PQ(@K(T!^]%_@O)K$5VPO50<JL\J&\0,JM'Z-N+4"YY"3OUZ
MD?63$VJ[FQ/28_Z>+S7H\%OKS^]U<GX$X;6]U$#!_T'/\_SWUM'__4'%UE*]
M^T-&@]+_;<I[07RUHT!U07QA>>F/2-*+V+[;2W6FSPF8@_'@,*'*^AGWX@M#
M<)TEL:]4\ 05]=$BB[U4S_E<IU\1X7W]G(T%]>V34-E[B^S[4IUU1U$+^#\.
M!#5C1._N>NP]=EFWD/I>JI__"[@<,97R!N)(7:HP'KG-#:8$8@6;L9:Z?:F>
M]P<+W'@*"W"IU=6=Q-WN(R?QA=3Y<MWKI"\C8U')$/SL)/>S/+F3%WAPL-9$
MO8CZWEFJGPVFT C>?-P09R'-3D6'^^]<C^X:]K[E"M<*?;9"WU^$$I;J?9^>
MM<Y!G9]\HHABF8 \;_W>;OUALI2G'0PT?D_FZ>#5(Q> B^CXG:6ZZ*<CQ$3
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M8IK;;M(ZEI2^7JK_S:8N6KHS</<.<4UZ7&5:B*L?BCD6J4%]O51'_3!.P*,
M6A>?$.D0+9X[M8>M.ZDO4FOZ>JEN]6<=*=&1/07BI@P[_5#DO$@=ZNO[0O<$
M 0,:ER(5<:+@#<6O(/+30#-^'0A]F8FS1%UB 78[2D?J[L!VZT[]BQ2GOEZJ
MSPH+J@/0IQ>)I#TXBT-]]SS3(Z7_WQ99]J7ZL(?C+M@JI@YX?2AYC7-ZE;U8
MJJ=K"DF66$ER'VU@:[PU2P[?+8(9_'JI[G>)4]:Y:%[0B(O.]Z3Y[KS_L,9X
MOY^?[<S<\">PN;-QZ>X+I^GUZ]F;>Q>8IGI;K]G6U<)OO7[S['WKW[^T/[3O
MNI43(V)K[-W[PM[=JV%V[1<KA-FM<79_$)Q=^H\4.OCY&<C%+0PYD3R\3_[O
MON<6M8M?VE@<=?*%9JV>G9Y?_/2R>^]"[Z\\Q>"C^5)'@<*+;FWN[.MH5:+P
M^F?X$H4X;!N#U3[<#0X1,79L7.E4>0GPHD[P-AA.W=EZ=Z4:]-?V._M-GDY^
M$^?)Y%?.C/19/WT"_3^:_.%S'(?*-U]Z&$&O_" ZX/B#F+!G@;H%'Q4;5JN_
MBTZ3PN\Z2T5J^XFU2C=7IH&ZQ3[?/[TY-^VTCEN'.$3DJ 5&)>$Y=6J2QV>X
M )+K@?2.KS"&!.LU3$6>JL#3$?"!QC0F%94E7+:$@$V!ZNE(!:*KX*R&R)EI
MKH!/9K"-L&SSMEYKP[/,_)@8:_J9Y>FADA%+GLK/XOFYNH1E#%[8BK%#.89G
M$NTT!$Z^?\Y]-*OZDWYO4:U^>JG?3Z_KL J!)1T(+%E"8.%'%IH-^%J >1;A
M*"H\(Z$:/OC R6=X>I2P^&^]"\XN?&B?_MO=@3BQRNJ#CGT<QF+5%.^-_58<
M)O%(=&+&K(2/<3*J%]9=6+M09"),$WGU=W&LAQJI]3F"A:@D'#<FCS@[/GSQ
M,/; HUGV#WD*NBY%:AQV=40B8EJT=.U1?GF4(.L#UE]'("6ZXVE3;'(_&N(D
MSQ(%*E0<'Q_")W260E#!O\.E<N(09(F&^!+A]7D/[6^>W6[<ST_P)7AO%\H?
M1'$8][4]5_"0@>8HT:'8/FB(G:V=_7JWYS*9-VO_1;.?*#/;M^!!48HYO,K"
MI]U 1-*>X\W:N173F!4IWK4T]M [N9;4!(M]C<"&7V>*Z7;D;[YXZ'=9J_4$
MVP),A+'HY*-1./9N8*E?/NR)%(Y.Z>B2F>;Q#=(UW0)(OZ-&F1IV52*V7Q&W
M[=64[>X$CH>>;>;97WDB@1F./D?FV>."8HAZ87_7R^TN=Z=YC?SH;#;KU7I_
MO?KU#L,XI;:>.3I[QN\EH8+"3//AL' 1\;N92GZ4)VF.->#H&LXYJ!1;]:XM
MN&OB",R?F[9NZB#>OU_S2-7&[L(K?@9N>)PB(/LL1AB97^$/E:(:#2REFYAV
M46N<.N,\\!@Y@G,O%1TK@WAT$RN57$)Z&0_+G.FX'&H<CGAZ+H8;51=L)QWY
M84[U</.N6U. 0P'8! DK%&65_3;ZQ?E1=++8_\KCB7'$T[_D</0./L)MBF0&
M;P\-@.K;7;MB(#'S3:W;9^W!T:?#X]DARR,5RBL,N8.SI1+J6>5:<F2=8WE5
M+Z.SC!\E^D\S@K]'L%BGZ:4,@Q@\XG?B.$YQI-^__K&SM_T.T<#0,X]'RL]E
MHB4=4OD"S_\5=#K]<@@N@SGH2(8*O7&TOOB4- ]4FBG\YIWX+!-?A;'7BA+]
M=Z[X$A<@AU2623@^DN(PE""K))9/#[6/7_;Q9=W#D(D^)M@EF?JQ^#5.X;%W
M=]\51]0DX)+ T0PK&1GIRV9G$U8YYO#849+W13,8ZHCZ8VJE0,\P??=KBH/V
MZ^*@AR@.JJN#GE1UT&,3$:6D=:*_TQ)W?OJA3C;=M*[',S187PZ'<B/4L)A*
M^P*X(Z@7S5VTSU.^J@?^AB)9$8[%, YT3ZMZT:J+=CK#5IZU;").^A),I6'-
MJNX"MC^>=V9;FP9B".U*\-EF0 LY: 4R%1K[XH.B2[YRLH,&59[#T?7G>+1Y
MG':S\\$\QXMZD]Q-BL GF]ZE=G2IAZ4W?0F.X>9QO7"3"X<1(+*YP$KR3N)9
MP543'+='B0B.<B@ZI] ?7VPR-$Z'C@S\@Y.<XTSWJ9_%E'W;I\#M[M/>G>LV
MXK.:D=YL1R"JM4HP'/#JG?3@(-G%D,;NNQ#D-P4E&J8HL\@3H4568-)P 4"<
M)W!4C/(^OL*JSL(T&S<$1F]!1(F]U_\4BF$]-&5.TSISX>[1,4Y(^#4?SBC*
M*GX"40XKF&J*W3EQO'HAG84\D6D@_YY>1?[>!*%Y*#N2;[UV[MK%PSR1,]:.
MOG?Q>"HF1H.J3![Z)=9O(0M@HIN*3"C/-4./-8PBDSQEEPNW]EB9-5 WHC/<
M5=F54I%;@,*WKW=D>D<LH!%E!WDJS4U%=8ESBDCX%&>'YB[_=9M7;TUE:[B
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M8*'\W#MR>Q6^*ZX][P,\@J^2R*[)*$Y3*@6!9Y=IF@\Q\,%+#%X.3B#&N\;
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M/K9/FB>'[>8Q_7IZ\4OK7+1//IZ>?Z9#5CBEX'[VZ)X:P'!]HXP[/S$UCD,
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M.^E/!;9:HG@H!@Y+>$LF+-Y.LW)E<RA=4MQX24Q8QGU%]$'FQ">L7E;>A3(
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M/9,T$,'IHI4!UQ':>5U1Y>4:V O\%\^'A0^^3 >BAZ";#:<@K !"M%D)&M&
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M[CJV4G/M.G(M=S(!C:)[%<7H80%;H!U(;I@-UCN0=9.U1';X8D#1=V):X/U
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M)N1Y3S&594JJBXB<L-FTOXZ,.7D^A]RL$5C7.=2<N::<>06.>FPZ0S,<8V2
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M_LRS:V:7F.)W\$_&Y0-N>4)O$DO0M;LP43!*8LR.8FL0;SI004]G)5IH69E
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M)OV@8=(K_J;XC9)QG!XJ[I@C\&EBM@28Z? 1PIG24^M6\?+%_Y@?/_Y/RH>
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M'Y O2$.]RZ6*(TUZ]$7Y1FQ!GIO1TV;]FAF2RRF=JIO:1)N H>^^:,DIIDK
MRX:>)T+H%IQ#_[*K^A6-^W/0*E,+619]WO]$W0_4O(2H&?4#XESV<A\7EZOL
ME.Y:2)N+2Z)'D[M%XEB3KT%/,^0Z@FD L)]W8,P\YZ^@$*J\8RZ$+601W,'2
M*Z7%NV)NWSEUH&.K<#*T?]!5J.FKYWY=H4 =INK+5T^Y^JB)U6^_?29[V-:_
M)]O9':E]#_]*#H=)XNT#,]^@0,G%R3AVK\Z?GE-"*:XKQ5/R&JY7=<5D2BN>
M@7#N=:"]2_ 92L^E@:6BEYPQ%;,?X!^;\(:7$^F%["'@Z29MKXHO-"\!%B)5
M=WA7];?968=O%ES]!Y^=/TS./D8AK(G)*(051"V<Q.%"@+3K5K!C>'T@U"8#
M-LN (4.$;M+#,5'%2AN'?/;XW$0B\'FHVQA]*NOI @<!)(9&;$@5J73<@_*3
MS^Z7P3TMMHU?4;<^,G S>6]Z!EI=_W_7OR9@,*C>GZ7FE&?=BNNR%=HXU 1U
M6]^J'1(C^O#!([KC&0-0B4QKYMZ8<OD!2WS0?]?$ID=+B(\,-;P8IWSZ/C6E
M\[L5J_P$2"X%P6U7@/CQ3!:86S85=Y.UPG@O$S!=<C+N<&9-@7)EC6FV!P_,
M*G/&S8.*G/&3<(M(GC(+,3)52,%4\5HO#7$%=\7?OC[EV[ >GJY)?F$",LES
M'VH\J?.JW9'E6E3M:VHL7^XS^A< VKCOBN8C++40216OGKW:FD3._(KXZQ!N
M9E_[;%V%_;G_R]M>?)+G^],7))P'X-SPE[_^F:YZEYB&X1N8<?_P#L(M\E5^
M:$-D?24N_N>ZUNE 9JY()^<8GR%D^!A3;\8SGM!<A8JAM&!'!*.N'&),61=\
M2"@^\3 4WXYOPB.$SRZF:AJP>, ;->ZE*, 4OKVHZ/#[X:*F3%_Z]<?T0/2L
MQ#'8"F\).0@,66I41$9^F7Y8?/3-R_#C\__ZC_OW'SXY[\\;>3+ L6"/$9O4
MO1..(.8'$L%):@] IM$,2S31*Q\.D:2":NS$(KVC>93G.DC/:)#85SEZ#2<P
M$OJSSV9%O\,GR7;;U51'U<GJR0/CU #USRH0+&&P#5-2! S ^)W.!V3,2)E%
M9$PP<-1NL:MW1";F&)U.^IX7+6-U"'J]DU#VQ=<_O@K/=T[4:#^1?S9)__!V
M2[^%[&5!RJ,;'#D7TI)$Y>+DT^HOZ3FH= ?H=Y1B2^HUT$ZF9Z^2LY@]ZEW+
MBL(<W^R;O4<S?=L.AUA]NO?9NQ\.2/S/Y),FL9TQKIJ,8N)L.%>R]-_J8%7
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M$R]^I$D[G I\)T/T00U1!B8MCH%))R!2S2'8! (C2@D[+,J$O:3,E!Q&L(6
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M849IA#A=)UW0ZI($ICF&80;_$ -KNG&W'2-$*86-ISCD3T>F!J!!,OX]JV1
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M]\,QCX+<7"Q:#&I._W=R&/+2N+(@2E7<S13%#R:BD(G(3KY4[HOS$[9U9YM
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MCW+QC4T4$(UGJ6RCSK!_;KMK0G^..X96Z#.ITT@'>,,G)I(>>H#-=1IK'4/
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MIT>47D&H&5>'B)$9QZ6+ ]['D122F-S+O"XC"JOZV(&LQT-HE/86H@*]H;D
M?7C>&-:N\598@&X'TR5J73/6O(B<KMZ+!"0!Z@9>Q>1MNXI"K-Z/TA&R%IUU
M"?A]TEP3?='I%Y$SUMRQAO;324$R'BVI+3JZ(-U$3VT[$L"=-^?<.1YXZI=T
M_:Y4-L"P\\#$=..EE3X7VVLS=?2Y>TM."13H2LCQ6YP\IC-!P;!$<^+9?599
M),9X'Z]<<7.K!;CH-2P_GCYJFVI6,]NY9E;\4.>J3Z15%0UIM6)@]!"*&(O=
MIB,YCFY6[J2N[VS2XBJPS=<'L,WM@FV^>'  VQS -I]<C*J0;"MY^*1%8,Q$
M6A=%2C=OUUNQ9[FH;IBR*,#*QY%7"+BD#V^O;Q]L0R\XY$$'\/D?F[$6_2U>
MXR&.NCJ.VKLOMJ/9OAT-&[<_%LO'<87_CM%<;]!HU6$NI\0;Z@<B*.;6VL!^
M'**S5>3)1.7S=##* *@2@[1YRH(%7N:D=:7VCA<2;@'^T39G[;@NS641:R=.
MQJ4-.EMQ)(/<\,M#!P'*(!>V^F7#7AK&:=+5EYMZ.D>@.3/:E"6[2[T'DK&?
MQ##M" '-W)&[;G'JLBK$"O?$U9F\E[/M^GEVZB<V#Q 'B=2LCV5ZCT<N;Q*;
M:(H3 6?Y85YO>-:0?D$"QA'J*\F_^@$MV"E=7R7C-,'TM(CZ$X&Q\^MYA!XB
M19T70^$'ESZ0J.&A/_I0U2!T,!PLQ2E.G0 )T7.R8Z41NT=I W8]>>#!#N#$
MUHZCT$TY41_\C S)U:A-[]&K@(!2F!%0T13!>=7--ZL+[GF6/H5S.@D48)!O
MCCA=0L&873-%\_ TQ'+!1PLI'6VF;M> 0#*X!>&]%"!(Z5G!P(EXQ7-B^6CJ
M' P5OM$Q3)XCG,I2.\B+]Z4.AK29MO1338WL/V[.J^&@"W=")%X9:R%;H=M1
M0Z.*&U-Q(.SE-',Q7GN\MH",LE?\C/'"T7%TAF>MM^-^[3A^MX1$_&W?Z1&@
M4UP<%![H>$4T5F:\D3ZJ77B%QW2A?A^7Z+6GDK-RW#]A1%4]+909!ZEO,&(6
MA;Y&F:AK4ET\TX&APU&+"7)*9"GZ\;K'J01MTI],EJB*V&]%QBFH*"EW-)V5
M\[02<?K,383V]KG8D/ JPO W#$SR4;S*#N?22OGJG@R<L6E=*-E,K/C=1DY3
MFIO:FP]]'C*$04JE3*:9PJ1V.&V'D"M:@^0^9ZKUQ<^;!8YJVSD6EDRGME]Q
MMJQE:.YS>M M,C<L)%UW3OG4E<J0;3,*!%H?0=Q)PD;[PW10JL]8>NCC'#7T
MKBJO]S^TH&D;&/9[,G'C?+$A 26F%70PW])&\,XBS\J%P\YZI-*2J?I <1;=
M/\&B1'60;D OL]A9>.>72WK:]&PQN#1VC[PW)$UO41TW?9*>=#?*B=%/K<$P
M-&+SU>':0--CP*_C5.BD-W:IA#H^YY7O0E<9]I.G?MIY@6GM_T9,<K<1@/ \
M"&TYX%GEG' FOXHM1+_AP0Z#Y.V0%X[PN#(T(EAQH2NAW=+QC(FE/<Y.??K6
M,*C(WN\ 4:5W3[C7UGZT@\ '5M*X"$/)^*:C&6-F1U00?11ZQ!7!,/><$XUF
MI +V-KK!V.MU5["I78/I_^Q%3(^KQ0)GI"3!#,$^]ZX#QYTT9  %>$!_-XB&
M=]V$64*F8-+'GYTSG=-+BF;ICV?D02SHS^]Y&/N6'G_-/M"+3CBQ],M_(W%9
MM*O<V7R"U^6':M[FV0E:?^B]Z!)8BO^O+&HNE_VU6&--?@!@XV\MJB*O"PS0
MP ?Q)B/>2Q^-QR%3)C^9? WW? .U&UX@^H@^;'J?7 P2,. LX[S&L[)D_ZP"
M0@UL:.8,:YF;T4!<7V(,?,/L0J'( 0!DN^G=58__$8'WI-$Q9QY4NQ(#)&X[
MXS[EN:>M$1EX+EO1560X(=_,VV76*U,=RSJ74-%DGM9(Q^1&69/D+74\@8HL
M?53I#,SV\+/[9<V6Y$)LNN1^=N7H0J,'F!;GW7V7GXE\%(VC7UI1+ B=[VSS
M#HK5+SER&C&/[(0H8:]C;S#Q22S'* 4P\ &:[\WO@;W]>=-5_0&.YY_AE6BN
M,>3!I2<D[) >1 5E6@[&9U7Z=CE<%EUI!=%01(M<JWY+1VAUS5Y"O7)3_"A?
MDFJ4J4Q<\)VR=QS$^F*]Y-OJG5?.!5C6&#- GM A.-]MT7LL75@&K19.N/+B
M\NG0$^O!" T<Z>2>3 =B@PMBFGW'A827.;5W4WROJBE^<Z@IWG)-\>&AIGBH
M*7Y*ALQJ9$^K-K(IY@;M\=A)AV,B7VGM.HC:Z_*#)0T144DY*:/ST5L/!$P,
MTV_[=&@,PV0;:*9B,N"*<P,V!?!04I3&+-TD6Q8>=39+MA2K5S3>KV/7T7,B
MZ#R,LI8)# &"(RZ_;K-/,*L[(C)@F\\1^@ $>BZ"P%Z+,TF@(*?>]D:NS/,
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MGW>6P=X\G+MV@GM4^\>U!#%1@1!!*G./^&-S7RH,</H9QYC$0Y2JS^!K*V,
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M1=?!CNG'U).4F6>'0ME-&"G6&8AQ>2)WVR4QI$V8\..<PUF- 7?'V3-E)='
M6932B/ 8%XII>]R(('E$7;L<)<B4+T*(2^H#>OUZU^OETA W333.8Y],.CG/
MI7!M1+M\K26!A8\V:YOOL(Y<;X@#/,$%3>C]ZOT'B2UB4'[9A ![KUC)">9M
MM^:A?2,/Z> A2VH\'B5(?BI6RL659.7GT[5/X@Z%R=OA^[DEN<FPF0!*F4^
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MT- HBDXWF0XT*^G29;P'TC?ZA+_WFI2Z^EJT-0+65#R9(?IDR+.8!AZF"G/
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M.6Z;VO-&RO;[BU7R6/HH7JZ7&_$NY.&=6'Q[7N%RV#V9;6Q$R(!/G7!Z4SO
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M< "M^-L^8[(B(6;$*WO^,N(=S]P#(+<P!^^73=$-\*ND%C.>X-W0+HV>VS*
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MMBD>.CV:0_-:&LNZBMO&./M9->^SDD?=1I8!L I0D@Z]A\EDUFLV.BAT''G
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MBG7BFF@]*"W!HKE9)0OP4N(!"="M 543,^$*[A'J8[O]6M_H/;*Y^TS%7:\
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M_RBIAZV-[0UX3Z?PY;10Q-XU%!A"_*&4KL3]#95")KR*;PX]/Y=XL0ZUQ?9
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MG@>8Y,#M;*G;F6B=SL7YKE*GA6@0^<ZZ '0,Z%"A4SUDDG 3%9AM/1V9O!(
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M \JC"7+PSU667Y<4F 4JS<A!^@;2K$/2YX/]*P6;_Y.G1>]O/WWZOXW-YP
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M+P+*)FX,$">XZ'-3=BAD&8+NK44 704=)6B^&L'?,*.S'-'PT1F&:T3]8?1
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M$">S-^4:27?*>0T_?UZ]"0G[=?JR&YI TCHJK=&7#,FAG>R>[NMD=UAO^KH
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M1<76LDX+,FO3VL6?7&'MFPL]LFIT>ZKWP/4F\1\]1N2!2+SI7!DV?_3@4 _
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MBX:R3UF8"8\7)\5=G"'H98(U@^2TS"CC02FB?'? @U9"IXJR#Q.1]/1B=@V
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M%K#O?+OGL2MP:W?5'Y+6,[CH1GOK23'"B7&:C"4)M4(+!'>CGF50UK0"5_8
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MEL3 OTSP %EJ1Z@%2#0W54TJ]&$E7GW:H):GCE-S*,H<-#\35QB]KO"4RM&
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MPH\XYY??^O7&-NJGUXW;X)J\YBBM@BR>Z!;7:0B7PT'"A*=%\E#YSK!I7*O
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M$SVEB*T5M3"V.##:#-XKFFQX^"E^.J<+= R<=B,@NR+C5"Y]:27S+;$D/4&
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M4_U*Y8[X60593 &)-<.+-6"+/2=[C6<>J<]WCZ3I'36QP%^X ??K!ZIIYEU
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M!(D+O6Q'+9L,A^/*M,"E=4E+1&Y2UZIJ1+;02G7/&$-&>S5S3&U2OM"*C1,
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MMP'!N@0-H.=.Q9;YU=T+7S (DF_B&@NRI])]/-QAB]E5P_-S&*@@#S/L=Q*
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M63 N4K$4\,'GG"0G%VJ"8A5RL\60WU$X;/6_ 7ZY$K^A<T^$7G\EL1>D2 4
MZY1+'!,RC]+X;[_@KE=/'W[>ADV$'?U:<9ASG,S/R2N4TE0U5 ".<1P3$Z"R
MBBC\B%11Y'9&6JP3<0J+@^2/X9''1-@F#,Z&N;LG4?-H^3>?WQ\38\>!,ID=
M[CBMJ"]E2ZM'O_#<=_0!9,A^#50!"HI6Z=1CEV-V; 6K4H[:N_1WNM9WND>S
M- BD.Y8E!3JWZ7;YIBS@,B^,J&&&Y*):<B12D0[D>)=:A\?:$)FQ0*V^V2O7
MB 7;'["7)[, 0HUK@1TU".-8%V'3>TZ4WZ &8[S0=2IFK^T(!<<MQM;GH>T]
MN$+M+P3/1-]E7"7>:NFK=Z[\-)4N>_6*YG-87EK+?9M$47*EW:4Q.3)L<7Q(
MDB@8DX4Q]N?2OA@%,]E/6!IC68P^>UDW%_#AN/!;\L/PT/IV6COH56A ',/&
M@T;&$))A&DHH2JVM\HU^SM[DR1]TT&9JT3M5+/"!=",6LZ<.Z>3=!W,F%T'$
MW,$&3F>HF8/K+D>CG_7F)46>Y3Z;8VKGN5V;G:Y<Z%]>(E]U>&#NO,38%ZB>
M7,HR.?!S"04AOV?*]*6.V'VKLK;^> SMQ?53]'F:4%F-L[^82,!I1G:D'[-5
MZ9R^_7+F]I;X]'TX#W'D(1+&Q"\< S@/=!>P?@VKXI2\0''0RT7Q]L.OY0 X
MBM'A'!?S.?O&:AT948D#;]FK;B1Q"?U6\X80E][ZG2)\]4G3W8&F.WUXSIHL
MI(?REN(\"L>&#[GW@SB93@3G&8F-Q-5XY]<K*,*KBEU0'4G3"0<2F/Q!U6>P
M:>@2'EZD"\0UT]&C2PU2DS:5&XF&.!?+A>MI@!ITV&7)91!SCS2O-BHK^2;!
MU+<:W6!L.7O@ AXI%$$;K7I4&D1,F$;66H$<:?;[2(;R^T"%@[Y Q*#W21F7
M/'H$-[(I@D?O^2\J3W'*I[R!$>B;3^:VB8E_+8$@6MA7)!T_$XTDO)Z]\^J3
MW)/7IU_?'.G;3R'G4^9Q1*+.K% 2&^OU1[Z  =YKC09_J#5\X,K.7D=HZ04<
M*R**TK=RY\F$:%'+>F4X3S;<(_H >M/RM<[RM2(#>=3*1#?;^SELX^MF\J!G
M'Q4S8A6]^I&T_I-X2D6^:8)T<4YFQPW!9IZ*S4-*2GU[7[/4NX@<9I^T!ODM
M*<FK$S@L$]\C)9B2(QZX[\E3^I,^85R<![+T?P1XW8?Q.R*K-!:YG0:+B(O4
M;2.AB4NUAG9>)WXZP5+?<!M/(ASS(23? V<5QLDEV1>)?^'^(R&B54;1V3C)
M<SR8/AY.6"*OCY,Y]*%H0'HY.Q?K>*YU@RSQ83Z1$&#22MP(<4!%^]7#D6I=
M6P.RF:$J?]E3TXLC39ME*;W:?)[U98Y\D[NG:5E<0N@WK(J'6""F87VJK(>-
M-=Y\/NH7O.32*U8DX>MVJ>3)1IULDVJ!%M=A7Q73KO9Q5ABI>N+TPQ6TXZGP
M<F"&;.C(]P2=H6-%%Z2*Y,DDUJT2&U4P;BP)CP4='#\M5$)M"*J!DW.RL$EX
MD@GB<+Q>93#$;#$AC#*J@%4Q;:EBG_+EW.NB&Z.FC0$)NG=]P=V>9>ASD7MM
MZ<:R<4]0@7)UP8$]<.\5IRAKE^O-+^,DEG<@,2";R8@S?#Y0J<[E!9B8CM4-
MBGZB-+GV(P2CM8]$\C2'"1C.48?O2[ PIM.60\H-M93:3!VL/D^(/;R26%$,
M7[$*\2QV-ATTU51=/N.KZ&5N*5^NJ[L9[.IN'KGN9K2KN]G5W3P##7W4,-&C
M)G-A?K+4]:#SN),QT84B;,7[N6-LT;/644LT*AF-B/XE5_&*$M?WB-VMB!-
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M"2#;"OS9M:CUL2>*;C3.]"\,M=@P5/;F+"W2EG<8V[L&0V_=:%WKU3<.P=6
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M<C\T]"8,9J0DSY%HN$Y]]WV43-*[,^(# S8]'CV1C5OXT21Q_^FCS/S.I/3
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MX."S4GIC1:ZPT'].0#ZII.W.G^E.5742C#(Z23/\$H:Q_=,":6Z0X(U OXY
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MEKK&$Q#!N3F9J%&$]=V<M=/$">N!KPE ;J_3"1R_, =CK)M/&4*8B7!R#6Y
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M>9)1_.A7NOMGJ*=\&MZA*,'C-S[#$&2NX>"DV[?\8UX]9)S!<P'D8:@#&G/
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MY@F',^9UPSD!;3"&T<C'E!8<9.D,<96"C<0A_ &J,!]%)BD_/ZR6?YK:\6"
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M-W;BXUU5<H:)NY7.-J2)9?;0:'@=>$Q,+GRWQ",L(%<WXDD&-%--F2Y^-D%
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M&4I[9EPP3^?J7!2AJO[I)JBJ:0QS[S"@/2138FXD),8X*=A9J\"VE-)ZC3=
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MD^Q,E5<S548JI%49*1[*N =NKSH<$LK(HG.XU/].!VQK0]ID$MCSFS3D2"0
M?RBQV %'LHI*A'&64!EF5?:&G#6EHBY'X<HX,.)%L3$Z#'1 ^"9E_]&K;(_6
M8D>5HI9H^]R&[A%$;?AT>*VV3F*4<DX4^QLN7@*O-L!&41X88WV0DYBHD@W'
M:D'_/B,$%0TW2=G^R67GZP$']2--,['7G'(.+N(K[OB)E)8;HU$.2RZFE8ZX
M/LE.,V\6\L.&\=T&GU6^I%\\@Z+3'?!F^;ID&*(;/.69^B6OW&\^2N$ E1)U
MQ;4O<R'3,(OR4N=X,?8\QTBEU'CHABL7OS0>*;CL$] <5[H.V;&#=03#'""U
M 48P_"8,,?%*27,7;5@)!ID$I8UW2=R^HCC3VT2@@QR"QAOQOG("]C4;PGNX
MR(P (6+1P<Y7K%#G; IN"FE.)AC>31C%VKF ZR=F9Y76RB1T/%HMD@^S@YO(
MSIOWQXF?XYDP!,U(21:G!SQO.EIH\>9<&E7;]=*S54>N,_:/PR.[9%))2^E(
M28!B@B6Q?>==&]?8%."*.!%IC>&Y3#6&R7U&@/F "1;E:@S4O(8F!:/ABU$"
M)\E$&#! A42QM&:2 .(#]?Y@'"7#:$H6L5&F2>I5C'"-NM*#$FBC>72-)EYP
M!W)VL(X-9NYSDM["<"W81T/C<EDR3S:[ ,;23,^OY&Y&I=?GY=$><&T\'*>P
ME'>MRYTX[5(#FNQT5GAQ!*I-T'&"3YG3'F!7S*_6@^FL>\("-? AKS8+J.=_
MH1<%YTZ:%>,TCE*#UTZ=9.6=-5KJILE G<3;\\P22>-;>H0&[SQP'RU$'$BQ
MZY<H/!)P+)1RK=M[:#_5 U>\-<'BZ>:WM-YBC.AJ?!HGCG*]0=S>"[N:,\]<
M_)7.8RTL*R<,9T7N<0DB+"RMH2.HA<JAG'ONXW!X5!P['"K& C%THX00T^FL
M!\?HKXE]C1991LS [M&,@K8>.'0H'K&I\-%^JTJO,U&*C6,&_58W,;D(YG"Q
M+ZPS^M47TD @I)S S4'H\LH0$6$FP0])+Z./9\H2*K$+OSZ<29?-KP=H:'P4
M.X)JM,@+#,44\FK\?6/EQ5@,,0KO2G_7^THE60Q@0-'5E:*5)9^6#Q&RQ"HJ
M5.>MO0?,2@$ VI@KQIXT>)B(H1V.AMHWSET[_E%"6TKW&\:$ZF+.22V_)QV5
M(:C%6QWJ28R[H/%K"ZQAI%!8''=KN0\S'I_N/4U#3-$!1T2BV*A1C$X1O;@C
M<';+$$>*.%/EM\L]'<2MF,V-"JY+.>CNX[FWEL[#1]9+F ]:45%_<[@[IPXF
MM_82W&8,)B(>RC7@F#6MX>#1<&YZ? 9+4+N*CG7599H15PWQ#)#JY)U1"Q$P
M=O$#1%1@\I%<>26CDX7,-1LHK"*]T.4MYS"E-4'XEG\$DCUC? 3-2<V$F"B-
M0[)3FF5\LNQNJ2K33#]3E93JBO0U=8 +,R4UR,2!PN5-X79D 8)9BAZ*(5?
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M,Z&51=08_(OY'>8&TX'!=+;;0:>[URPT;6U-0H.KBEO);# OGTT9F<4V!^[
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MR<NDA>3D.>$G_<L2Q-$ &ZEE%!5,66;$O'YD^,M&7$E<';ERVGMY(B)^O8C
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MQL:% !,;_6'UQX9&:SI;R*NHD_(6)E88/$;QYT(4DJ3)AFT!6<X;46,_O6'
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M]H$D_OF' 4!1NYO8]CN);;_*2I@:W<1Q9U>VI#6]RWY9+$8N=W((;0Z8L78
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M<E8Z79$GIKY(]CPMC[E?M8:N<+O+#)9*P-(,)*DZDL3=3J*F@55H/\L,ED;
MDA0D$VN*+\)9^_0F7*\:Y Z&'&?RC?_2N.+"-#>?/&L\MX,YU(?./!=J&HEY
M/B7ZI#E&>>E:Y\7&XXL0H9YSC\F-8F2HJ=.?7B5@R6C>Z&"(*[* R/;0.CG+
MH92JQ-(@@H@D74&\FN=8W3J=51V6 L^3LPR2% ')4IX#8F:5M@_OQ"/VL>F-
MGZ-N(J_8=F?4H8I_SK#C%[&LI+;IN*1K*T3ERIG<+#&Y#2%)LR,*T$I04)!
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MK76Z*I($%6D&,UGV%)BO@\XZD6@#Z:* )+%&B6:1^5;Z'1DX#!P&#@.'@</
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M#:Z##,]/PY_;_5-Z$6?"[7_F5O"6IJF@Q O@>^)U PE:;M_3)CZHUG?.N*\
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M64KL=$4D:082]\M2+!#<2@<I X>!P\!AX#!P&#@,' ;.H8+3I$ P7>X/#*#
M8^W)QTBPF.(8QJOG$G\N\I!MO1:UDIZ3\[@GD^/7Q)V/;+SVC2L_ &9X?N%,
M7ZG0")8,(U0-"=)\>21HN7U28GC8JY@DC/=*Y+WM[@BY4'#G(_.E<#K(M%:
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M3;&B4#V8;_3#=$)J@"=,HA..C\;=43*&(K3%EY%@&!N*8)L/8HD^V;P@"O1
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M4AU&@6DY]?(+9%&)2#44Q&OM*W8H1T/N#WV#]H+@C?;5 9:C(O>&O,Z'5J>
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M5S"+'UCMXX9D;S?'8_=E9CIOX+F\=P-R3],C'SNTZ<&31VN%/3C-GA!3P,?
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M[#-?%=C6,BNP+$G>H^[&XZW3_8/=UNYNS1U2G:VSY%E;HM/,UR2X V'YPTO
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MCA^J/EI^I%O_2# ML_A6D&B0'V5=.8X=EEF#^V=1P&6GW7$_DE(&>P_V+M(
MRM>^ C=3PWM\BX8A7B(1R$@?) ;11J!R0K=SI"YLT#-\.5EGM2KB:&+!8E;_
M\O73.<)YA%((=,&5C1X,N<I'@U*PY+$8)B1\-M_Z;"0NA9ZJPV"D>*8E>7V
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MW$PF(R>8KZ*P-W!0]!S0S5Q\1W<?,_&OU&W@$[P4L197:AAG&/8B%-*2:W*
M)2C[K<[!;JO3/:DNRNL_J3>60TY\5$2CI32<0K-+3P!5H%,$0\F !Z)%-4X6
M,_!XC\$2(<G!G:G"QD_=54,K]2_5CH;%)0A>PEV </%JT/X-P=.&,1'&A2E>
M A2SPXBQ?19++OPV'==6*6R3>)BU\S J"T.&02&VD4**F0KIC[R)0\ ?N^VH
M'^<8B0>[C9]@!1#DWQA>FPFXF%2P\NOYV=4[5S<LWG9YX[GQ'*THUPG4D*"
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MI7X=HW[7("#Z7O;(L.*3N&I\^EM4!2YO%X(@8$@92_I3TD8_^Y*K0^L^A>1
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M9" F(LL3AMM9R_66G@Y/J0Q9#]<C5B+K84P)H)XCGTO@=M4V%S'V*<-ID:<
M?3&"]<FN6D'2ST>8.ND3((+O%EUPA.0LW.X+]IZSNNBY18J7!59,+;O5C7,-
MD%3OQ0YA'[4\BI]!RM<R>+"L/5/)W9=9E-U2O"B@@:515ML]*6H%Q$B1@-*J
MX@*'&$E#5;]2EL)_<U]LW1>3HGI)<#O,.#OD"\PL$I;7405#V&ZP9B)VQ8-*
M*J5TNO38I@B)56+TE+QIZ]JU@+H3+-FX8&>AA@6,[988#DY!U%(Q%>2(),^1
ML$B8N\2AH$'$%(@!_(6QP1B6)!%#' 5!PX<Q"6SQB6^;Z6K _UNS1'+^\I<(
MQ,7G[\B%W@C5XX3J6C7FO+,[/19%:"A"C?_6R "G-RF*RT8NUDDNKB32"NX8
MN#9RPF\E:"^0;4"6S6:_UVB__R:KO^$T(UUR1):15 /XFX@"^^UF]GP1>V&I
MGD]!BB7F>4*%KQ(W=!G9WMW#VCDM]5R[4]/!WBI\V5FL]=,8 5MD!,)O& &+
M3 C,/EXNQEH.6M_B"K]4^FOI.E#N+J [E@GY+S:R>HWASE 9K'WH,WYI7%-S
M2F_=^J=,::.%^9BZ1EIR1?1[Z V5(!5\QYV3(UH@!]8[_9J C 9CO'NT6[6R
M4:UFQ:PPW3E&OKC[PU][R6^GIEFQ2N#2K\=Z4J H&!!%OU>IU^=?=E"JCQ\$
MG L,GQ'8YK$#^HO+$%"UKC),13_M'OZVM_L;QOD?->;7,\_]Q\T3;^[YR@4&
M# .\!44?^:CLXN1W-[GMO>GN[K>Z>\>M[L'!=E$!U=HU4B5V42-6]4P)+":!
MV.6I*;5:3&NZU4_L'=>^9281R%$-$@9^OAKH*WU2A+H<;)U>%NI-TD+$N,1C
MN?149JUBY^ O4W3/DC.4B@I-&$M#727?!$:-8"NF3_]PZU1R"_\=Q,V/1X^?
MLOS$X93)];8?_,A.K3S8N?&YHR '6*_P%.#5T3+80E[-?W6Z_\)P7'5SOB8Q
MU6QA-N7J/D)T:C!6MJ9E:DYF !%KV5JF+F/=(OWE)2RZE<1#BIZ=X.?.,/!!
M0G]W^;\4T=WI(/?.CLK8+3'),DIB$;6X@-*KONCL(Z(61ZCM\A!LP4^?SM5
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M]:$Y(K<7O'^'3>_?P9/8/=X/>)A0FXFG,X\0. ;6B<S/.I+"$:^1Q"<RR+X
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M4V_Q0NHM]E97;]%=KMYBH=+P=UX:('FDIA\,L,O]"MCQZAYL8URZNT_.(\K
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M-E)>/,-WK0)N@?C%J,"Z*\/+=1MDJK'WA_F$L-8E$)H2/#2N*E4LMIU+NZ]
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ML$@%3JS<(<POXF2L=>,R&K;%VHYRL^C7JPD%ZD*T9_OKH'^ZC6"?NPUBG]5
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MVT0\T5T%*YX\5L@FQ_+#,*OB?'=F".B/+B>MS8-2.P^B)GY@KQ'&'F\\RD)
MGAE71S[:9#2T3A'K\T!QL*02[KJP 3#Y>KQ:P])&2O<%<J%EDN1[#&9PN02$
M"C*4A;59A6QZX="1\XX^$XXNWX:$$#D.,8'$P/2!?B!B?H$O$ OVF?OE=QS
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M!'C@#=FX'F 20HX*=C?40V"L(,+=I]^&YK]DEC3"[HR*#=G!G*RIB>@CD&
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M9"E<Y0J) IQI'&^RGH#?\!R'03O L*>6=I_"RK)P\82^$/NX+%P"1IDSQ=Z
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M#4>C#3-H/ KS@+10*A7D<-@'&%]$J"61.<JP$Y$-AOC//BMASFO'371;CA7
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MQ))5C9>DW:*S$/R 3.CJVU\.FM3-[9=#75F+9NV^VAY.+W,"Y'[^"NF>W6E
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ML8Q;G7+EUD\A)KK,FVIWK8]5]G2I5:4@A;6A"0>QH)40"DV 1C&UBN 9/>S
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MZ>;VR]VWWZ\>;NYNN:N/=W\\3*[O?O]Z=PM6$G?W)6U*Q084_"HVK+[>W=_
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M=JF96JF*N#=$C%/>8<SO'GYKVZ&\S/([[=Z<S+H_0=IP5749JCWU$LG0M[;
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ML%4Z2IEKS=P>1T>&*S? !]\8.VML/)4VF.[FQ!6UZ6B&@1&J]]CE;@ T@R9
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M^-:O]"F6GRL>998GL_PD]2BS/)GEIZ!&F>7)+#^B-,HL3V;YD98W)[/]AN$
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M,F@IE?0VV=9:E*,8VRP<N&T"TPRB*;O-VG>2 \Q+?SVF!8M9Z!F.6S@?Z,?
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M1N>6WF*:I.HA41H$Z^QEEJ0JX53$8B>FJA&M0*5!Y^VZ;-H$6X0/',4\R%E
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M2)0/-)@N+TP_.5?-5<=VFW"=">G^&;#QS'YE/D1(I\XIPK_;KOOZ!H"N;Q,
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M"M$E] K*B\\;S\GOPU"MPSWMY%S5=:(8\%\.:O&1>ZV;R76XIP/WX*(U=8/
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ML !=_RC\VW9C_+MP>II\DPDW_W*FV8"OY#3R9S\+.G(C^4'*(_:S H.O&XL
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M5WBD2:K5CZ/0CX,Q&"4I[%_O=,C"U<SN\0JV6(K9*LY+MWI\/&I%-VJ1#IQ
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MH9T/U[1*3+V\ODB878.\1_[7OSCJ\!]K."2=:(I$9*.\QCD*0$,"4.OJJ2,
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MQC"I^Y2E1JE*N$'E+]UBZKF_2RM'8P2(X\"?C&1Y@K;!YZRA2BDPSJV<E-Y
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M6XF5MLSMTG'/;#"-5K[M6#ZBA#[>VTX0GWS+O9Z[OO\&3PYJ$3AW'>7V*1=
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M1!AN:?[*!;3\+/"Q3N/ ?:24OC-_9118J3?0=:)JX!>HV=5,%IBL/)":+T
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M+4P*Q_S,[.6Z; =_\R^:X/@!CUAY88N-Z?ONQ#:7+==+N.?1;#LI#(SBS<9
M)/Z!&_\SW/=P,L%J1FMZY7I_^$#JH%SKB[5\<*?9[&<YF'DMJG"Y-5&%5:K!
M*J%Y,JE5=%5X[%GDT_/#-86'*]5S)Z:W1D7;T+'9Z-DD4)A;R'L#6LD9J7U<
MVV]T0!I3T52+868*:6-*N7!&L/,]@,[/= WKO8%*-$TA1H[1&<\=(*A2LY21
M=0PW(\8=B SJ0U'*G_K<8O95>444/7@*+?#@=9GH1KHY4S'&4U%%S]3DNB$6
M]QJ-Y#?<V]!LWM_L\?+7'-WQ&4J&3VU-;TV,*\]]W)!H"&_Z<="KG*X*% %#
M]IA ,]1TJ2IIXDV][*E216?B3C)31%IKI"LB,<3TT'^9%&LT:PKIWY)8@U,H
M91IR-M3TN[-"#):NG*E;3(/J?1-=M4U?7S@1L?W(J97>[P&YPIEF6 R3\3Z7
M03\I1((+7=4ZV_Y4KEE1KE'$+Z+I. .WX]JILA-%N:8"UQ3":SKAA?(G%S?'
M%&#RUQ*AIEY_WG'>N "RA5N:OW+A\CX+ *L3N8@?*:DS#VY6-+A$-*)H E$9
M9BUUXU'+AS KR0N-%8!DONN88B6\"KPWLBNT#K^N).:7Y.=F9#X&A0TB\ HQ
MVCG<I7-GG]MBFF0",3N\@3F)]LVSM[X+F2D!G4 ]A5F0BP#2!P@4!N=<ARTF
MI]+,B*A)1!5R@]J_1.>ID)%1'OL$<*.(!EZ4RE"$^H+85Z65D)5[Z4Z#*M+\
MI IL5%Y"?C+1-+VE8<X=,,&7:N>>R,W-**B8PM&)+BM@%Z1GUSKOMK'>+=OU
M(O<&&A%UG1AZM=SN?-KJ?5HVEF-/,$\$32:*D=Z(>'I7MLO==HNIV[JAWWS'
M(40JHK4?KNW*]4#X'<03IOVMW-2>S2P/,=M]#@[XTC,=?QX@L+HS/-#TX^[&
M?JR8QI4:%SNH-Y<A!3YM"3!R[K;;O[&6HUGF*+NJPL4DP)%7VMBZ6!Y44T74
MU8"ZND:D7 A#SP:P*0]QDVF*M=^20!0^3R-;,Z]*-FV8&.R[M1![8Z,$%QZJ
MO^43X1!6>KD9E$1;<VES G[J.80&V0<@R=WXX,PT4SJ:58S9$3FXM&^+'MNO
M>&B'SO1R?61SWCU!?X4*MX^<W?THKRZD'LT8>K/!U+A=L/J@ O"E>L@5H[)%
M"!U$=[,)K<;W!HI!%/R' 0NI"XLU+"R6(@#)?!>PH0_'0JOBZ6(E'>_+!<W+
MR7N1UGQ(8$EK2O9NSC(G%NY.*$R<65C6%,'D^5N1>6H?3$JLF?^-%W#NS%MS
ML!URLQVQN,M*H'>X<FLZ7.[/OC']AZNY^W,SXR9^Q UG ?,6Z$5YB""^SV[6
M)VYY#5ZPIJ>-OBMY7M'.B)CBT_$VDQ[/(A(9OH.WG=U1P.O?GR<!<0#W!?$\
M8'VRX[J=+LD^'^UB./Z=N_H\^B=W?7,UNOTRO+L>W>R,04/]]2$ZPB\ZJ*<\
M>8:G'A?3."&CMO%X\F!-5W,<I 1DL&? %S"%70=EC<8. OW@WUIS'.)TYUX[
MB"R)W53.-.SWV.VLBLBA;AR.5RIK"&ADN1QLO#^!!0=QRG#%8('2)8-X<?9Z
MT6=T]MMZV9RY63>'8"VF#PIN#B?,?Q=2M?*!J=U<IK0PVGJ63NDS? J/DE_O
M(7E64]P^BLXR:BEM#N8;=;39T$:JCC:GF0<5NXS@IJ 8H%L]>S38_N(G1B40
M=SL:ZEA09H=1O<&-M=S,59G\>V7[P5B6^R?N?N6#^>+[&+&YA[N0_O[UC;NT
M./7 7V_FN!XY9R@0B!*,KAAN2?+QZ6-(D(LM/3(&5*3>0)80E)QH?'I%W+.9
MFJ0TC TRK0XV-*+K+X@+:L.X@&!\BDAXC2>2D%Z'=9()5YDK_?>T:>0R ^?W
M+W@2XO/3P<L;1V-A>M25"%2IH%6>66;.,:F).:::BF8JTBM;+ET[_Q_PZ-JA
M4$RA\_HUX$^,=[O]7D:,$$U%3!V9-X@H%QUO5!>Q\ZJ/TQ,[@$)4)2+IS9XE
ME:!MDG2+[Z^P.9V.#$)TR:K+J2HRKM;["(=RL_$4)Q]@ W*NF1Q-.#ZY=54>
M:AF@;E2-J(6K<EJG;')02^=[ TT!U2SE&>17L>61H M&/YU0!W /UGS:3D4
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MHT@)IKND$IV7B&H4:(3IBM;:4)Q0K;9O2H6*A$$KK$I@,Q=>6H5*^>9](X7
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M46+C='7IF_+;X)3]77;=#%2[- B&6<.F3E$G"B@:0<_>W-UUN##+!+/7FHP
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M4GDRW 0+UY(Z[)YC^M$'\4GC*7/9$HF>(V7;\:ER@R<?GUB*0Y-4HEJ=?=.
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M*D;X_:<3/EW%^+ZY<E((]:5+Q%(M8AZ&/YA7%1= *NP$9X_@5-&45E9PU/[
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MZ]?7F;X5[R(U8EUXLL<X0#.-MIB:';X.)W46N($XJ27&R3\.*.(Q&/YQ?03
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M+2Y%;C/2VFI&GHD#95JE+O.$S_DN!QV=)EW3B*'NS\G4ZC0-_H<^.:-I_7!
M>45-%[>*6AL+C4RKU#R&F/KYQ,9@4S4,F8A&$<B=)HOODIYII@A'WFR^@.L
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M(EHAN+9F$7,LL6C[?PVD-/H#312)(>XOBVD?'0M4HM9%1Q-5F@DJK0CX6:V
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M"YR#FSS' Z)S9KV?=L0QUAM\)K=<UW";.+%-V+"#H<+ KU'C._;>:J;&A:_
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MIF@,#VHF;AWK^AYTSX;+]#<>N#S.=(AI?O#;O_/;^ZW>?SS#SN"Z@Q:4ZW!
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MLQ" >V=!54:VZ)>"SA+7X/OE59%#,SQ2"D#$:$SB"C+Q/H^Q2D#MYOMP@DU
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M-4;GRVHYS7NSM3?&OF&VNM\]2AP:A'9J;.!>*U2L2,Z1,(O4@V#;^6J;K_S
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MGO)!\^PH";;M6;:'# C9NI7RFD]F=+77.C7^E ;U59U_U:2^:O"O6M173>U
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MKYPP'OGR:TB47Y$Q'@6@ HFB:Q84Y5$(*I IO<(#/:I!!3*%60+<)WNH0*8
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M+G[:CL/V<!A-(OTRN_=TM:1L&3$DP:^LP;WTC3)BFH)46=#+_AIEQ(S&!T-
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MUW)EI.=:V3H1#WH)#FZSW5Q6,W.1?40_L"S@,Z S6$*:FV[WFQU#@2\O1;H
M59N ?<9K_@A7837W :]C;?F6:GP%MPK",K2PS/L)B\HT6"",3IW(+(I\1<+1
M'2+D+ T-"<NB^CH8GUS( LSK!6S"#"*/^4/ZYW0"7YT7^4>0IYO*WIF[?!"U
MT8E:_&5ZR>HA%I@5+..-Q:+60+^XBTPG#1$)#M&(':*7-W&(?L]2E!PG%>#A
M)'FD\Z8K3BD7#!3+0B2[TAPH9^05L>,]BQ:J6*%FL_XTQ0'R4RQA;>$2BZK
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MWR%^$A:ZL+X>>G:B*$1VU*N[?^'^@"U)55&3KA_MVNY)<M^3!HA$68J8*.!
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M2<ONW6('Y7J=<MT7Q>:Y1(;ST>K2+1LS?EUJF"HB+4?)'?_\<.DJWE3K%!'
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M$17RH<Q$7%*F!^E0)<^>I(N6\#NBN<2KJ Q?A?!CSRLQW!:\.<>[<M4?Z<K
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MO77$C.]^K]((EN= >T0'(4^P[Z/]XDOR!*>(@BT[CWO7KC;(%1Y%IUT4%W8
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ML=(4J_R9JPP-+L0LU@\TU#!<L3"ISHTA\&C'0B;FAQOCC>AB-E!V4;< 8[R
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M@,/V+9D]80U^ZH,F;G#]RHZ.%"MLKZ0=)/Z -+5I#D=>L%5KR/+R@:OX4]F
M2> RL3*$I;:":R^A\]0,D+5Y$P)_4IU!/V 8,SV"TJY6O,H)_@66RP>%VI]B
M7!5S(U/";=;7IA-)O'HA(!S<2^D;$"J2%I&:XFE#6,@^TON<:*N[>5DDN<3J
M?P*ER<IB<%='(0@]X\RMG46" J,0T!4UX*AT8]7#Z.M.A[VWGS=&_8KHI]R2
MSPT?H+!_S$61&'^::'6\$7J,3+Y:YBE;#C/G6'Y"TC'3.-)!\:^T@^H?>7+<
M'\JE96VX<8Z[P$'4F^"8#7(6;LY ZK:PGC+.P]":P]*,C[3P*D#>N"2__[O
M@11A ,7P!N\&S#T(36MR0_#NE]8Y)I)EY(S>MG\A'SOX3M^ 8-$>>Z2FT7;X
MH0EP6I,D'#HL.O$X.-F]]:'IBOB9:& 60R0<1U,B14G,<W.1?2RJ=1EO6H#$
M!V9$!-[/)@HIOB]MVA<^:G#NYF$53Z-ND#OZ2#93L(.X+WE%!?&1R^=@S]$+
M%?1U0 4U44'?WF-44-#&MU@=X]87-+RLT)#1DY09*-,GSZ/7*4(DWXB-=OAO
M^'RM QN3%9AHS,$G/3*Q^U4NJ0FQ8%VL"P.+=6H;J!\]X_%JRN\Q*J1I$D>
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MZZ(@.+;,X$ZQ]R'#7T,#*+"<3@$2?(9QC9=8>[G.CS9/1; 6YP76$U:P*J?
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MN0.)9,?5@VP.+9O]QDI]V)8!D>I\ER"H!3N'FC9<MI&6#88_[ +_!-'P57Y
M+MC(N[Q?!K1$"RWQS5&@)8(>O#,]V&^LV0<RLDZSL2:<TX#<*V0S)8!P0E/T
MB%@+X6DX] H[*%P2<)G#HU[PH&F.><L(QUF#$H1OK;&9(Y8UG5;-Q&YIS0D@
MW-*YHU>91R]!_88B=4H0VM( +AF\LM27$PG!J(M-V]4E!X</8R@9#[Z7/4O&
MH+LQ:<EI0H3I^N1GAJNS=F2+Z 35.\<Y2KO=IP_^B8&.G7KADDR4\#24BWBG
M!\RZT5 !&,9#5*<TZ7R-[&^@V),\)N8/@B&EZB,!5%;^XWK&Q96,O(?5H6 ]
M"E'L6;">XY"6%#P'@UOIHG,QL_!J7K1@]H<V^_VFCYPOB9:QF4M9")6ZW.MV
M%(V[#G+P]$GT.L7ZR!NQT75]N2Y>QU*M.7^#[5%. <PZ-$*;0OF:#**Y>[FD
MP9RP%TL=B45I1O?2H!U#0 L>J\K[DJT&2;PS2>S'!_+'%AVG12)@E'N14U5-
M_>U<)(IBKV1D=)-<)+?QWB2FFDX6.-(<9#2Z/JC:/@'7'(Z.3"=9<"3>-L28
M\TJK#,ND["XJ] %LPLM,-%W4AXWZ0^V</&Q"E*;NJ4HXIO!)=[F>:Q6.X]#'
ML2<^Y*S9;F\$S@I&E25&XXIY?NE;_B9/"(M.(=5J7A6:VNE44?.OPG&4G]8R
MTT??3?8:+FF.!1^S$>1L[YWD]X.9O'-J<%O!LCS;2)OBJZW>ZQ#9#!W9W* ;
MQTT PC_  2E"RF1LN]F71F8I#<A&>L$"9SL(5'VIBK*"X[N9L5^U7FXT/F:T
M3@4-<@>-7R[#A@^^X3T3$ZIQ4 D6G;O--KP:V'_?M=OLI8"#6D@F_V%R$WPK
M",#@ M!S&M/G!*"\REU$1ENK#:>'DPQ/)3"=0KS,\C2_,/,#47W0 *1*FUD5
M(E8IAJ<RV(A124S/64;>' <<KGQ1B/4R.ED\\)!*A!WF_#:HA1.3@Y \OK2F
M;WSP.89&PA:S6%DG$CY8U3GQ.G+FH4=(22V0:CJDQT<A4HO>2HBFX5B:.J5Y
M5(26IHVKB\Z8E<VGTN4JZPN$!,G@86(_G/>9Z1$P63/.2W)\"&H"$^.FK<KF
M.E NL%,OXT_7$6.DT:*0S@G!X^#GOG?P2&ZE87/ 1"^<_ 9?0UEB-0(M"^5R
MVV]SKK21-@8!^:1H<(+Y-H^VYJ]GNI2BKF[PC8.M&(7,]&X$YU $MGEC"O*9
M!'$PHRVL-!UY*K075/3K !5M046_/0JHZ*$*[6]43 [I^R']LGZ]2*<6M8J
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M]S_Z[D^D2>#%PBU-$!U9+YO'4$._::C8VXPLV?-"NL3C[>0'4(2[:CXKF]5
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M%+I(]AO3\8=V*J0]"_I)J$ $H4Q@.[";IF&$,;SFLY^Z<KH;20*V_"D#6T;
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M,B>F30,MP 3<MH'U,(..BD-8[W"MNZ+"CJX24:B> !95"Z?Y;75GC78$O\4
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M,!H2W0W41E#*XZC>:AE[:W8%0,GA;*YK@4]TC5N3; ]/OO'24#'_@ 6K&.A
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M]9FB78SCI""V"I$3X4Q<=GJMG4KRGY\.C%=[T Z)6]I]5B4Q\DO@OI"=:U-
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M.J<[;Z)OCFS8&;;XY7WL.&G8\7+'IEJS4. (]B45DJDIH,UZOJM7&5X9=:R
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MZAKN)SSE]@RE7%2A:P;S5#\3]N4Z;$:Y%_#,7*_SIYI^ELX\L7E00^5;B&5
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M#0@03869QJL;RI=PV=JU1TB&RSPZUP;:ONB'$7JRIXU[F9>OYZRDJ=N@JW*
M_O,ZZ'I@^<T*6&X"RV]^<&#Y3G+Z&R\-OGP #ZPG[C#_Y52H,YF1%J?)#2)R
MZX%,#0J4N2*9/-2'S>)9WHH7O[;M83/HKM*0/R:R=Z^>K;N1^I/LN2PA0X[\
M,!U,.O3 1RO,]-X[2WH%;UP1'V1$"]!!0AO[8;6Q]]_88TF6FMA_HB6YZ6I+
M_DT;.UAM[/TW]K<H <&BREEF9 CW#$QNV:DA(OON_8^KW;[W;M,:R5,/$S)
M\?*4SFIO'VYO][4:DT8;JBA2LTR*@R@)L]46/ZCA@-=*TH9.D]6V/N"V'IE
M F]XDECM%HOW*B>G.LENOLWWB<"\?-U]^WK>A(_4*)_WM9> ]MY^ 3>IF_RE
M]F[* R25K/Q\VH%?;N[G+ZV2\=X$]_S]T?X7,-_SCX-/!SO_#U!+ P04
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MK(?4.<P4+.SYX'!'?+)=[?& KO)+2<HYXJI>*R9@E&!70B$G)X&I/%/P8*8
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M[MVQ]MXAMM\^UFQT]\W^YNL@;P6KN^7%D[.I% $[7\;Z=2X.GX+PFK'?>,/
MV:=WU?*7U^@=MW\ 4$L#!!0    ( %9!G5M/;K&#NP,  )L,   <    96$P
M,C<P,3(U,#%E>#$S+3%?;6]O;&5C+FAT;>V7WV_:2!#'WR/E?QA9:I1(_#!P
M5 T0)&,[%TX4$':DR^-BK\.VZUUWO6["?W^S-B8T2:^M2G0OQX.-=V9WOCOS
M\=@>W80?9^/3D]&-[WAX!O,;A=-PYH]'[>J,UO;./)HLO#L(PKN9?V4E4N@!
M=.Q,0\A2FL.</L!*ID0TJH$&!%2QQ,*).'59S]/T43<)9_=B (K=;_004J+N
M&5[:UG@T&?N/&[9F&CJ]5F?4GJ"0Y;,E#OS/Q#K/AB]=?E;=07!TM8=P*"^B
M0E-5BG+]53B]GKI..%W,87F["FZ=>0CA8C198>C.![AM!2VW!8'OEBZ=7M]N
M5$8G ,=;+$/?>SFQ=K^TW\/B&L(;'P)G-7'F?M!<_#WS[\!Q0V/IVG;W]6P<
M=:MOFL]/1:Y9LK7&4P&1%()&FDD!#TQO0&\H.$(4A,.*9E)ID E\E)+3"+,4
M,2HBBJF!<^-XQN,OA1RZ,LV(V)ZI\NH"<*UKJ5+,5?,:$JG*1;>4** BIC'\
M50@*/;N!#MU^ T@.">,XOA<0T*A03#/<'Q$Q^(_1AHA["A@H97F.8D]/,(AQ
MC8FFL*&*HLQ#397X6E*C]"TPNLHQ!1C+3%EO,=\*4V$"987*"R(T: D'&.UR
M4V)DE))89AKGU^ZG)^A?>QEZ4$>Y!:+61-"\N7CD= M.5";2T&.TD#*,\5O3
MO+3(0L%G(1\P#_=T\-:%?X97Z$QF/KC^;+9T/&\Z__/*LJWR.E@Z;GV]4_+
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M[-[8R37[2F&1) Q?''XDXJUNT:.]'+RZ:-M\7%1?&^:CY!]02P,$%     @
M5D&=6T6/=U'( P  &@T  !P   !E83 R-S Q,C4P,65X,3,M,E]M;V]L96,N
M:'1MQ5==;Z,X%'VOU/]PA315*^6#))O1-DF1")!I1IDD"G1W^^B :;P#-F/,
MMOGW<PTADW8ZNYUMH\D#Q/:Q[_&]QP<870>?9M;IR>C:LUV\@_Z-@FDP\ZQ1
MN[KC:'LW/!HOW%OP@]N9=V7$@JL!=,Q,0<!2FL.<WL-*I(0WJHX&^%2RV,")
M.'59SU/T035)PN[X "2[VZ@AI$3>,6R:AC4:6][#AJV9@DZOU1VUQTAD^62)
M _P97^?9\'O(2]D=!$>H.81#>B'EBLJ2E..M@NEDZMC!=#&'Y<W*O['G 02+
MT7B%H3N_PTW+;SDM\#VGA'1Z?;-1#=H^V.YB&7CN]Q-K^*7Y'A83"*X]\.W5
MV)Y[?G/QU\R[!=L)]$C7-'^0C3?=ZE'S^7>1*Q9O#6O*(12<TU QP>&>J0VH
M#06;\X(DL**9D I$#)^$2&B(60H9Y2'%U,"Y!IXET9="#!V19H1OSV39N@!<
M:R)DBKEJ3B 6LEQT2XD$RB,:P<>"4^B9#01T^PT@.<0LP?X] 9^&A62*X?X(
MC\!["#>$WU' 0"G+<R1[>H)!-#0BBL*&2HHT#SE5Y&M*C1);8'298PHPEIZR
MWF*^):9"!\H*F1>$*U "#F2TRTTI(\V41")3.+^&GYX@OD9I]2"/<@M$K@FG
M>7/QD- MV&&92*T>S864831N3?-R1!02/G-QCWFXHX-C%_Z)O )[/// \6:S
MI>VZT_F'*\,TRK:_M)VZO6-RSR*UT53,=T/X65I-);*2VKYC+902:=F')SQ8
MU6'^T94)25)SQXG:PD:!^X2(V>KV&3>T4;K6CX<[%T\!SV8FP)KLA!\728(*
M07$G6B![=4KZI6"2IGA4<UVZ;QHY)RA^"9W^>72Q%\(W+>]UC&I  <?0N>S]
M-M02KZBU@Y6^Z&*\3?6K:POW_Y8Z^'/J!M=7AA: \7\)_CH==%^N \;1O%)2
M%A=]4A&FG8-5QE.+A#")*LDDS;4>&GJ8) GN"GV<H8OB0(8"R2L+BADG/-3]
MN&#$5&EEVN,05B25GD1&91DTKS6T,]C6T652*^(U_K 6$FVV&8HD(5E.\9FV
M^_<S;G%@,E6U_TT/C\6=T%@9Y4N4KK&ST!SG5T;7L%RLR0!<&M)T325T+ZLG
M4)G5'7Y_(NI$OR;V8P'VWQF'JS\/ZKT(]=Y\C'HM4VN\'3P7;E?*^FB.$Q)^
MADZKC_7+1<(BPVKG;?B#)%KJ,"$) EDHCI709Q)C_=+@SH;1&";[,[V(8X9O
M%/]%X5AG]\W>&HZRZ,L>06W];5-][.AOHJ]02P,$%     @ 5D&=6U.M8!KJ
M 0  "@<  !P   !E83 R-S Q,C4P,65X,34M,5]M;V]L96,N:'1MU57?:]LP
M$'X/Y'\X_% V2.+$H:-K/$-^.*W!<8SM4OJHN&=;(Y:,I-!V?_W.<3+V-!@D
ML/G!XDYWW_?=2>+<QVP3>OV>^^C/5[1"^[E9D(6^Y]K=2KOV:=M=;%<OD&8O
MH?_-*J0P]S 9-P8R7J.&"-\@D343@\XQ@!05+RQ*I-3X;_-F4#-5<G$/;>AX
M!@;?S9#M>4DNQ<O*6)Z[\/SWBN^X@<GM:.+:"Y(=7Y?P1NQT,[LB58["H#IR
M+;=1ZD<9;-<01"L_]NE'9N(_!&GF)_X*XJ=%&"QAOEQNGZ(LB![ZO760;"XJ
MS_I5\U7J_7[0AA<?EO>,4*'"W0?D4FCJ A@)ID+@(I>JD8H9+@70OL*" D6.
M_1X7QY $2Z[-*2(US&#= I"QEJKN]*?#._@4R1%,I].A<^<X7Z:?01:PD7*/
M.:0Y;R$AG;=.>5!$0Z0&7@GM%5:88[U#U6$Y7P?@C)U;BMD3J2C[O9/85KO<
M\RZIX(*)G+,]Z+,FZLE;Q?,*6-,@4QJ.%7#]FU!G/%R/_KOCL[4-L>+4P6<J
M557RH+%COF%U,X.EA'24C,++5?8'(2GN&)E,P/P'*Q7[=[MI>5?4&C-E!*H+
M(B92,\7E .:JI-M,]_N"X.<W!N?G=;UCL]M9U@VW=@;^!%!+ P04    " !6
M09U;C[#H6(0"  !S"   '    &5A,#(W,#$R-3 Q97@Q-2TR7VUO;VQE8RYH
M=&W%5EUOFS 4?8^4_W"%M&J3$DB3M>H:BD0":2,1@H"JZJ-#'/ $&-E./_Y]
M+Q"D3M.DM4HV'@#['I]SKNUKV;R+5Y[5[YEWKNW@%^K'C)>QYUJFT7XQ:AS"
MYFSM/$(4/WKNC;;CI;J&\U&E(&8%E>#39PAY0<I!VS& B JVTW @#@T^.FX*
M!1$I*Z^AAHZFH.B+&I*<I=@E6)HIS3)GEON2L0U3<'ZACTUCAK:#4P@FM%14
M:-99N9'5],0B\[4?N7X,ZP4L?<<-7'QA,W1OEU'LAJX#P?W,6\[!GL_7]WZ\
M]&_[O<4R7/VGY-]C?^ZE8KO7*7Q26;,>*&14T,TK)+R4* V*@\HHL#+AHN*"
M*,9+P+B@.P2621UJ$"%-F50MH-^+%%&TJ D0ON"B:/U'PROXZG,=)I/)<'PU
M'E].O@'?P8KSG"80):RAC.RZD^\%RJ"H@BVR;<'G3[384(&9#6 \&E]@.$?!
M,NULUJYYSEKXCI6D3!C)^SW9V9$U\8SQ!,U+F M>0<3S?6T:FYBB/H#GC"49
MD*JB1,@V/2:;)%!TN-"/MM*_K6ILSSP7YJ[G!;;CX-:ZT49:TXX">]ZU/RRZ
MX6)+Q3#A>4XJ27%3'?ZF\,RV*JM91E^TYA RX[ 3>*)"L83DW?;:<*5XH1W.
M*C-V.N"!Y'O-84@# L%P$1]PRD7&]Y+"&2FJ*4ZO#I$>ZA[.8.S\D>:RINDF
M!G'X"C]MK2+;+>Z/80O 1/6+2K4N;_<LSZDH.*Q8NJ<YS+AD_%=KI_;QCOYX
MFM8_R<P*B% E%<>F#;DD@O$!V"+%@L4:/K:"0Y/F&&F)QC_:L^1O5(RF0)M:
M/47Y'YW0J"\-[2VBOFR\ 5!+ P04    " !609U;SN?%,P ?   B^0  &@
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MM%<JH5\\4FG==*E*0+DG)R#/FC2A?_[#Z%-)'!FSS1Q5IT9??J&KH(5%6:/
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M<CWGAO-/@;)FL9L2Z>K2*[_17+0I,1G'%<S9H!H0U<M9,-; 6&6260$.:[.
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M[^\Z!K)%$&G KH4,I(_%CURQ[8*XKB_?2/8Z80P H8G@0&J]@SJW:\A*B>!
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MOZ\,R:/;BP?X5>677+]V \]S1A'HP>RG(ZZ^/M[=9 L\L#!VNXZ702V$ ]X
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M-^-4P+5(!;3S5$"]]L4-AUO*6!728QM:Y$[H^D[@A#U$0\\-07,%8<0S6-'
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M/ ) @<?P?;.)J@P[*1'G$4\4V*>I%R6>(!+R1@"8= 339.SR<DI,L0Y\ ]"
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MIJ+8[<2RJ-C3*K3C"87=RYM\N8^5A.G$QTW];](=X.9I?C< SR'PM :X->,
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MC#S'CWEU@/V5N".T[2_6H%;#VCCGTE9+H;8RX^7OBDU,:C5UJAF5 <B@M@X
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MN Q]DZ>A;O,3A<>IP"/*4^E^-T8]GBB;?-OX6&*]EKV%G ;X[_Q50*K\5?W
M\_C5U7P;<PXKX6(1B]$AB<60K(@?= *O>CP/Q6B0-B@<SA>S9]U 28I!S=C$
M[,3\\QCH,3XDF:X?E<'X&,?."+B2]7:MJS8A?FTPP$&8^;)9",Y1F[%<$5/@
M@\U!U<')8RG^$.BIU[A(I@/<UIC>*/)?2J0QMPM!@P4_@[O0C0/TTN&W1?8W
M0/%Y8,,.F&DU7>X0N?DT.Q(]9$Z4A)Q0VV+.K6YW338CB4 A_K9EL1U/D"A.
MC)B>*/%"2%9*>BVILLW=#&Y@>GZ#@I.^/TZ-7,O^UIB=5IOFK5Y62P!\_N]6
MTVI]F*@=+:E8@;4.$V".?&9 P0 ?IUE-5%"%VPH+/8GO&AB6]7@1"QZ?\Q(J
M1E=FMR3TIV:;Y7D%)FIC#L]J=(-[GRLUA\=#3Z)D1OF7R.. \0P,3F*#?_R
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M?X[**B7G1#D #*GP8D4[9-'AC$!O(1]E"CDSQ\#J$?=GT$AD7L!8%?'WX5E
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M8N M(N!T<=/OB;PE+$(QGY@,,1LEXH8,/?RP%G=/'9ZZ8B?(NREV!<,  L(
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M"'!A7L/#??$XOI=7:2-:.-%8Q-J#RPG((4C[3Q[3G"KV$\SJQ5XP9'Q3HFQ
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MDJI ;VX34G+S6N:$NL^Z5]P"W69]:-&DM\B O.,"A9V:L>@_SNJIHC$3-%4
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MAMA<LA>.H^+JB\!-7H?;GXTD8D98)0^Z(2$>\B/)=$#A1\Q\R]P3F]X<W<>
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M#!>2\6+B1K!>2X]Q#QB/4=W/]>-XO)S0VK9"2 2T UVUK&'>@;*^'"?K/5Y
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M8?\>#*1C2@R,0XHIZ[A??+[B\FVJ\?-M+_$Q=0.3Z@._^PLC+USG5J;64-_
M@<)K/SWVDAPE7%Y&:Y#=(7D_YJAM-P@!P4ITD36?FKMW6=59[BK@)8&-V*\H
M9?*:&ZRR#%^K2Y0O:</F(KW-W4#!=L.-F*-H$DS'C"A0Z3<6[+ES%XT&?0?)
M+I=W;!V1!,8"G[-7YG%;KA>R8R4-U8A@>ZJ&6%^(-"@]$E2/7)1I'" _YB_A
M:RQQ09?D-%V]LLZUP5.O;;)X7EMY$I&R9&*Z%6H!&,E6L3I]H&KDS-)X-F20
M*Y;DQ4=-!^.@9 %]'3-0Q'^AGRSM!;0V)+*1V989C;CD%J@$>1#)(2F]CPD
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ME?ASPMZS)3>S#U[-5?58OT>/]7/9:Q1M=2[VFF(Z0H*]Y=[+0C_:?5G,1ZD
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M>&0D@"J-5,W2E7+O=>XG/1)=)45*34&=[4B7+^Q%*O^B93O-K09)'79YGF)
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MF!] ]@G1PZ(DI&Y45:]=K9$40'50;;7ZHMWN*60F_.7LRX\P0;@(YY0?946
M<#$1/P<GV&O]9*!D<& WP=*<>;FL5<9SID&K#"C3>H]Z/OX(&KA=K\WA I.P
ML[$=S73@!+9U[FJ/0=L@P6J)?8F)7"BX]>-4,Q<=76-L#UOU&3QI.( _WG99
M#K#^Y8I)A;@0Y;\RP8S?0EH7?"_&*VS5!1='IJ3-%D8_E:WO@A^^#>W_NIX
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MFF+8?+$KT!H.P,5YR>>?+H*>Z.S85FC'*]PHV*ZJ@0S390]M/LM;.]0I225
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M[M@EWOB5/R&3"BRLA><L'1K3(@S^[6!A[<2Y<;Q@@=,4],ETM5S!:@6K)?S
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M4/#*CMQH-\!<G-0T\7$)\!P_"/]*B0DWJM?2P#D#[27!F_GX.4;R\KOU5]-
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M2]7PXACQ7W. 2_YU3LU-BI^\@'OFM"QU]BUJ-EP0@3&LPV(XQX6337?OC_G
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M]AOR4E/(%9\7PN"C@H1CE1 "38J$,8VCVV"V !%$IY#N]>0>[2A>TO+7%)?
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M)"=ZO]B?N*D-$76"3R\Z4\^99@;A$MR)Y!79D/ZX@^!0X@/G]7P,^&ODJ\_
M5+OP9:$4-D\.O_;&7AR0/EC6J9' H'N'/WOPAFEP)%WA6L6Y 1:H8: B"YCJ
M -/WQREJ?PTTD%4C=!H!L98J2]S::WZ#@ON?/I7WA&@Q964J<4*YYK$RR'/<
ME?30R]O4\O0^RZPR+:W_0PP-!PSK,,._Q5*QO1UXB"J50[\=8M1?5WE@@VZH
MX)H'G9-]'# *9M$)>T_Q=RJQB*F&;NZG\>_1 ^41LH+C(9(33? *D+Y855NY
MPQZ&=*O:<:LZ"#3<$-3O9A_I8I.>$L-MP,4Y&EA6Z8[JD.NC@ZZ;8!OBP\QN
M5"O/K[CNV^QR]+KIV&"H):$4TFOIK1^R4;\=D1^B@ZOIP,KZ\35^2.VHA(W5
M=]3XHA5TV^QM F*GBD5-*TBN6\RTNOA3NB7;VBA3 Y/MB.(JK:;#1SK!T"UP
MMX?->F\],7!LO+@U6]I/;=H.E06RQ_83HQ$4P'09Q]TYCFL5X[A?%B-J9916
M1FEEE+;>J9%'''7=*!=+#<2K:(<1G]CLA\/ WQR1W4W*RM\^G"%5"(/N:5-I
ME@VF_5*-R"L-S7YRS33!5@_.M5K\IQY;HAN$]Z@LT0VBV%%+]/"X&1RX@;<,
M9AV8!'CA42MGJOBYWL=_W5 /X.F)-YH$8<!; (,''_!9HX!*%-/&M6@^.XMN
M\<3-XQE]B=I%^31W#OI-V%+4PNGG3:8+%&KZ0CI!/>^0S%I,EV3@/Q:3V;W3
MDVD\IXHA0@R*(V]X3V/6D=))"L!"C:@^;\3SQAGBB3=Z(% LHO*/11'< K#B
MAGK,\4\PR=HNTQ[8 C89DC<<>\&$4[;\%S6E<A2=K+LU[=9-,9^H 0\W@Q#7
M)E-O.,OQWE>Q,J(I[\H,[ZBG=3ZF!E0.N,:GS0-A-BT[/J=1$O0([0@925W.
MG(%+_L5^,+DA>4A!GW)4GEF4=KDN1*)/J.4QNDETTAXSR*.5A9+LYWW=Z"+:
M/5GW)0&2C7P.<^8E2=JV2F!W&2[H<J-3\,%1D S'$<'S<'90;\FP"'VRIC$:
M"5H>=O[I@.,QK0#"*+<>QW#Z61D$;Y20$ @6*H ?\A21+6^X/3T9^P\^[R,>
M>1-\]J)G_E]S5&ZH#GF+-?YL">"7/H:4+.^CO^&(!WCA#((@A_^+[GCC;MZQ
M3TWFA-6(JL#GG\L^&$U1_1)+"$GM(? ?TZ]X?W$BEZHNP672]Q[>\(,5![R;
M$XE*@DDP]F+^8/P$?6N 'Z)6XY$_3.4M(X+KJ?\O*18->[S+^#YZ)+0_CN>5
M-N*/%G"92\IIS3T1U??S!=  MSH(E(ZZZ_D5])RI0# 6"X[=^., ><)ECF,W
MXN>3^>TMWIJ\,_[F7SYO[T;&H6S2)J5(9 '>M[0E!/V&-V(* X>O(;" 6[Y=
MRQ9P?E_@W<NOC'-<*EG%]SZA4<(SI;D4PD(7/5K)> SS1GH\>N$R#;?HOD_;
M%@B@CX,U*?D-/(P#NN7PT8O[><T%BW;"'?V@)P)1J?_<D/WGU?O/#=E_+OO/
M9?^Y[#^7_>>R_WRGE)E=3)F]N_?"S"3WR+Y/:U122&693-NWCGV?V#+NQR5Z
M82FC-U?)Y%?+AN#W,WG;EI_:C=""1BSFHPY,L-@+SQ&\DR-;]_<,T.W7MSRJ
M2P51<>*-CXT-:>?)\"ECPW)F8/:#%-R83/$C8TPQ*W_HA;\:J>$9N<WFL?>C
M1#ZY\:ZR]Q_>?W_'_:*OG_]0+JZO/Y [)(6D,T\^E)XH6:.O(+O"L^2C&WQT
M0Y5#AKJQ7S-WLWB<@S*=0;P ?8UI8@N!Z$;B=' .;%!-%31GM_;'$CI*B_0S
M30>;E? ]ND%_J86C0YVS*#>FKG=X 0-F<.DQK-U6\:;&"JQ="A)7M4T1@;M2
M':G0'1P#'53'!K.\-96KY7H X31@8!HVV-I1<X$!,QU0]<-@.'69$P/-!;11
MCED84#&8J@6&^6HNM-(J6L427O/]H^OCE=1TA9I:S*!J89V-EE$Z^6M$4W!G
M^:1!*JN;E1RO#BI I@+3;7",HS8*!@Y8-C68NL?,!6D:Y9S0&.C:_K+0%S8,
MF T66HDNV[_W7=I'XM^ZDIJN4-.B??3#;Y=7[SY]?__AO7)YI7RZO'A[^>GR
MV^6'+9DON6N2FNY0(Z\I28VD1LQK:A>??1=XA2[:Y56[K_OLK@XXUJY]U($+
M777!=O=G05\\54J^LL, W':9#8/*T!327^_P]2JIZ0HUXN8S@G XGH_2P?:%
M3N1^Z$!I'$GC2!I'TCB2QM'Q7;F2FJY0(Y1Q9"Q,H^>+J #V^GJLOBUDOPJ^
M;\NS%^J1@>[J8!I;X7*U#<BQE>R(8V&G"ZIJ@[8=KUQR<SLW&1AX=3O;:S*,
MRJQ<3^^1\!.=@PK%3I*9%36G XYK@^%LY>@>9WT=.JH$UEBQ#XX;6$,_,@"!
M8P766*X[19"@0N3LKSFX[P)L8G(3A!Y]^,AX),%')/A(6VA$$GQ$/EE(Q H)
M:R*?+ %3Y*.[^^B&L%@TIT]8+(9F@E7N[^X&ELG -G5<06G083>H[S(2BVW;
M8)J[,5ZL%>@F ^;N)OABK>!U2$JM5U_W&DM& \.E/T?=*CPP'0M,5G6P9B]Y
M4%+R1U=18[E@.G) ^,!V@.FED?7'=!8.A[ E:ZLD-9*:GE$C5*77,<#Z$&8'
M7DKJ4==_#QCH.G+BN+&-I)GJ&#8P0Q; :S9:::^PT/K"AP."GDEK55(CJ>D9
M-1)DJ8N[)JF1U#1^VN45+JF1U(A'3>LIT)X#4#DN ]LZ[A2H;M&\H/W!DGO!
M ],$QRT5BQP3#ZAG5GT%T$9OHBJZ#NXKLL$]$(7#0<](HU12(ZGI&37B9D'[
M"P8F#55IJ$I#51JJTE"5ANK1&1R2&DE-YPU5"<S&5'!4%YSMP)422JP*._'>
MLT'=[A1(;E;@9D7#6O*R"LB=9JB@L:TFNL1EJ\1/37=!=;;VY4AN"H /N@GE
MKC&<NYK>LGC^_S@[4SX&_GCTL_+%NT.N7_O_GE-++$J'^8OR3V\\Q[]JRME9
M+AWO+_^9TY2^Z6P639$RC7B;_23GN$4_V^8*(C5?UAF .=11\2WJFI>H'/CH
MX^>K;RNB?^M-@O'3S]NXQ3^;!/_Q4^;^\-O'LR)3<G;\HGQ[FN)G+F+O)AC^
MHEQY$S]EV55$S$'I*WSKI_QK]*M??R+:.,M__0FYMX:1-['O_7EVX]]&,3YU
MRC>BN&QKS;*)X476%;:]*$4KKRR22+2GV]J\,&_=YO(FXU(O__A=N?[Z[K]^
M\/]RW3/V?U55.__7].X'Y>+3M__Z(17J5[ZCP+?#LJ0 ]G7U^=N':^7;9^7;
M/SXH[SY?77_^=/G^@@,<75Y=7+V[O/B$K\8?_/'ABI".WOY6+ST7"<&%_/<\
M]!5=!453-9.PZN@O!O\+58K,[GWER??B1/%#BLBO?!R6GUT"/]9)\N!B@K[=
M+*'$P/?K'T'Q_QKZ^(T(R8P?@\3'7XS0+YSYHS<U4;-ZM>'C"V?KZWSLG^7G
M:Y/"W*#*5B!)?UCY=J9(^;?7!-2*FJRH ^C\9_\MGO]5(NM@SFLNL;4^^)XW
M05&[/P/(6VCFYY?ZVO?ORILME"I(C'-.A-#??OW^V^75Q\]?_[CX=OGY2KEX
M^_G[-U0/?WSY?$5Z0/G\<559+%5$^JL_OGS]\(\/5]>7__R@7%[AOS_\^M/W
MWW+IK]ML><;7EQ1^O>QD189^]1_\<.ZG7914[!9[0]0:C\'L7ADB&='$)VRD
MYMCT[$+L&(KQ_I[&2[F'-4!<6TST_#K?;EDN@#6K0H*4WOP*]ZKU19>PAHYA
MT54SB5L6O0^T8*78^>' *6O\>D/(=I:Q"=GNVAO[9);>1=&(0R<KB1\_!,-R
M]4=K<%[, </%%98AESH$Z648.IBF 4PM!:0ZM K=,7$?3##8_O!J3=7F__#;
MU^C)&Q<+F>I*LC%B"#A6B2EM9?U<QP*KG-UOBQR*;!,ZD-U@'G*_XH*-]^Q7
M6@DIRCDZO6/4CV'2AP(YIH.AJ^!4-F'Z6Q>D$> BH0+LCVK7%U;H&K@J2D89
M!G0O5M2B\;?E6';XZ.[IF(/E7M8Q7]=!-ZA&K:0NUZ:N]A5#L;E@6'BA:@Z8
MQE89[#,7F N&854>UE7Q'!:2;-U.KWV+O3#QAGPL#EW."7HSR7IWA@>C3D_^
M%07A3'E =W<>I[-BTBA5<N_%_CUZIWZ<_I2'N)78'U-P&ZV"F Q)!3^$/YM&
M\2RMEK^*9K["[/.Z%UHEP5-OO$\KQOO>1<ELP6\9UZL:M]CO4B[&?C<-*-LK
M]O)BP&@[C57?N3Z[5%_$L,.\.'@@L<.\:#J^6%>$[3*DVR:*^?7!+R?*\=[X
MJ.M"7$[^ TKZBA+F84P%%UU#Q^DRBCYC#%Q7!5;VZ#JT"ML!VW3!8KO- F@G
MXO8V&T2X.H*PWN!2">"RK2B7 :I.D4!QPFX,F*/M'@ALI:GGRSP>WGN)GZQ3
MB+5QR'#!-5%%E,M$V]HT#4FR#.3=KM'2&DG2=3!LAN)=:B(51?%\B2,"<D9U
M@ZHGF=4>\==,8+8-KE;2RNW)#5@V'O9=]ZA.L0%-HX#JCFD1D<+^'Z,8+4L4
MJFRB*DW["I/QRL76X3@OW@ZJ*R=X4#^L:H%=3N =4U>P@RQ@ZOXX >UH_NOY
MS:S8'5B;-G,L,%#)JK8P][+NN,!T$RQ7&)VO&S88A+=>;@GKCM)?[['[%!1>
MFJ;*X/_IP9D?X W@NBZJOZ.>Y35X(>)Q9'S8&#-I%!JBEB[R9UF+U>4=21N?
M1GE]O,8J=)/+QLAJ'+7QTM$8..7 C^3HGHV[)A@FS4"MJ15Z?;>IB#G+@Z9R
MG[<\;5;,^)0-BZ$%/(] J^>:&83KF+[&1EK[U"N?*V;O+@Z&\_%L'GMC99J&
M=)+S3([YKO6G=*%29[ E.X.K=P9;LC-XO\(1V1DL.X-E9[#L##[6SF!]I97U
M[]YD^LM[93CVDB2X#?"DW3PIH4?U@H>M=*ND!(^GS"V3V,TU;NNNDPTAEF<R
M]OJ:I@U:\*N?H$8>WG/%._(?_'$TG>"O41M.>8>(4BQS._"2>L,:HYNL6??D
M"I;V3JS1#\^:U@OBT'+ U_V'YU#)[@G"F1?>!3=C?\, YK9*KTQ0;1=<JQ37
MZ5#YF FNIH/N=+IW%AP4.=LJI90$K("["+WQ4Q)DO0>S*$;S[F@JX$S0Q6DZ
M-36PK!W+<UJI?'L7329!D@X+(ZF)&VM;-H#9)<70UGX)(\7,PNUKLE5Y)P5S
M.:'N(RXH:"[07W.KX6@V2!A"'+.4)150O[SWI[$_#!;VUC2.IOC2)U"F8R_,
M1.G?\X#;H'6SS+9LL'5AJFTMYH"E"5/18]K(':=)H=I)]WR,>9*-2\R]-Q\W
M8-MHL*9#K+7J)A4,4YB*7V:#H>UX?;>B@#Y,IN/HR:>FI]"_#6:9<1RA3AHK
MB3^<QT$3Y@[U9VCH"@E3+(<^C6:#;@@C40:8*.*F7DJ[BZ* _O""<.:'7CBL
M7_&8.ICBM(7HC*1%&'(,]*X,HQ/*)_3CNZ<TBS;W:R\3-L&TA5$PSCJXL=:N
M*\; V/5 -5E'/IV.@PP28N+-_!AOI_K[B%#'N*#;PNR2AH?+ KN,NM(>0:YF
M@.N*WT2$UU/$1V>FVF86>P_UZQMF,- $$A^5%* P,4#-T,&QA/6GK@ETYNS&
M2SB8#*5R@H?Z[6"-'(==SU.--R93@95S+*U=4SJJ/[,+VN;+_&8<#'-UXXWX
M&Y,@O#N:^!O/;.WHK C#ED:;HV]]GF! ?_O6SVR<:#Y+HGD\],N0O[6=+= U
M!W2!;%+0+!/L76^(^@BR+!6<,O"?B-JG)%3/L-+J9I6[1Z2BSG"!!8XXK:&F
M@9Z%*:RS]?GV%O6-DF0^5_UF((5*Q3GDC@-N>?YD6^2X.EAEM"T!5<YE>!O%
MDS2/-?.']R$^[NZIL?PG#6<4)WBLN:"61T6V%YX$W106'>8R3.9Q$T%CPR7H
M7E$VQ7#6M7FV18WM@&5W0<T\SY>/?>Z@K]8FUG=Q@UGNQ>^(2U/GE8FN@Z#F
MS,;BVS^"9.B/QU[H1_,>S IPMK?C]AXI2+-<L,LE $?'!_LP\R*$0'WA+?/?
MBAA"F]8D-E@\,\"E,31:-1R"?853<";8P!P=5*/:W.^>,L%$,Q3_L*T@+GM.
M#1 3+$&<SK?BTO*>J.VV3M[+<_CI?]MU_*M1V]<MY+7HY5UESHO9HV-GSHLN
MX.N8TWIKVZ)YV)L&:$\$_T&_<<!GA-CG3@D*I:U^*G3$T4XPRC4>'>H)8PP<
MDU(WI:!3EQ:AHC-!QDHI;R!<9]OFP7B9R$_CZ#9(2\/'4=(#=[>Z.=U[;Z^Z
M4=U_5E0VK:4#W+3;H^E@:BYH]M;X3(]]/\H+H3PXZC%/#]0L4%T']')9F1R;
M5Q5[SI;8<]6QYVR)/5==F+=NL\2>D]AS$GM.8L^MFJV]Q)XSBMAS'W+\IW7@
M<UD+6SA,9\_(F:N[A>3[#T97GH'5152UO9=_[8_'^'I0[OS0)P#IM"MB$H1!
M,HL]:JTIE H>%6NX;U\K%&'KD??.@,KI)@.MW/+?H:BU"78::>GP&BQ0;8*4
MVW\-$E*ND<(_@CW8=8"@6-0<%Z:<HYN@.L(4'3-P'1<<1QB(%0T<:F??M=]5
MXLLU"9NA6> :PLCP7N0(43G?*M(<GC1K[52F]HZ^;E'#J3 M1"9H:,BI=I.C
M&G?21:UV8FA@V#;HNC#&AP8FGDFG/*2V+8+P'G.T3HSZY->:%\0<91T%":7*
M#QZ\F_$1W6HV,#SM-A-&_>Q)4*_A+AFHJH['2IA-8@QO+1OPR E#D49X6:AV
MNH#M+0CT);I KKMNN&UK5X<.ANZ")8YU9NIXU[M@[#I+NY_@EV!1M[LNS.YH
M8+LZ:*XPO=4FRB\%0;L  -XP!*9E$J:V.!@_J@6.(<R%:ELH.I:PXP7:@<$T
M'0NL735OK>J/T I<8618YSA5>B> H=H P60Z[I@PXH-.C;VV1+P]@AR"'-I5
MGAM$J#MZ*$."_7"IRZ+C!+64[0IG*"Q^.&PBPX6<V?7^KO&JHG("51S5IYNH
M_(2='] .X"[>!."*@S&)MP$ZN]JNHT/J5#7,0E73"8AO@;!4F>N"*\[\-H)Q
M-@BM71A!I]@E4;1K[+)-9-Z&052%L7]0G,49';D',:THHV<PJFFECW^7U;M2
M[0_)5-W<<G6\W80QB!B%+2EU*PY!NF:!T6C9F)CHF,QA8+K"7 \:A071>!9F
MU(D.JF:#HW;!Y6H9BU=WP13'5T8;0T?1%N<"0X)L!JJXDR0_WR31V$^&?A-J
M!TS#IIIU479'(*-K+\ZTHG"^>7\U !1OJ:"*$_9G&LUV J<,:-$B12:J.M<2
M-I2\%G3W17:T#2EK[C[Q0^P54<&0:QW6K&I[22Y%S;J0[%_!\=F=I8TAM)C
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M#.I3 ,VVMNU"O=QX?L"D$#0H!+:J@VIH4@*.5@(T,-ASJT'N__'L/S/1IS'
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MPNJ@FL64FJKS7;>PX#739';3\565>6%BS,I U^\E2^'EI1UB)D)%8=GO@Y)
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M1RG_?!M01A9;F3Z"9]PS>;CW<.\?(X5*/.\B B;AY37Y%C[_*J3_?Y86%Z#
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M70TT3O1H,4(&+K@.FA#N5J=%VU!Q5^G@' DW-9U7DFC:5O]'MM%5:[C&:\P
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MIOO#GK=AAY.SRT[6+MN"HC[]#I\$_MIVHU1LN,X4(R(A.UKW_)!&"R> Q^P
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M)OTQS9$0EACD>>DQ.B<[D>S)?8#Z4A0'S/A9KFR/96J ;1H%SEV,%"9\Y^R
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MO[*61-SSC*D*_@JS&=QT!0)R\S1*LF #.HNG-,&"#I/>8>Q[/6'A/0WM"K1
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MF\8CI'#22Y'WN<GET"3[@0GG=S;*$>RCN-D<SNW"S([LH0%'P^D_'[@JPF^
MK=L$?MN?<]'BG(E$#%Q1ED@B.Z]NQ07TB>;R\"H% 9KI1O',Q\^<A<B3G:.U
M"^(1,46Q3J54$!?0#W=LH<M3IBG"/B_72E?WY5I]B*,8R#N'U[8HOTHE>M&5
MT*&,GD)<[BKFWEQ,_(/ONW0JW$X=9C'=3FXF"?9PW1%7"RNBBZK.I0+ A[_8
M]ME<) ^(8[\XW@--8+UK9QO).K[10FOR!EHSD::AV_+H0"^%_^<[Z%4#?@%C
MB'MX,G]8[1S4U2V[+FES'F4W\SL=H^\.ETG;9M.<M#I4,=%[6;"W#* C4O(R
M[;"JI.#5EM6Y+QFJ(SO6FHEPUJE?QK17S@ZS.<0=9^:/PSE_U6(/52,+!1GQ
MM+/V2??RL^>>HGOL"2&4^:HK>]./?[C)M3Y9AM6SM1;"!G46S>Z>LV,]S)5E
M1L=?W%2B;R/QB>%V:MMLAF!,"2%UHFLF,<4NM^\8PC'UF@;?;H6O =/DUL*=
MX[KUE]82RU*(KK?&W!^$WTD>B,O%\22B*2)1C-9$\KKM?F@N)--@T YX1)*)
M/F ]M-V[.41=AMD,49?FMV<_<-$@F%H:=ME;>=V1'6O-1,I*$KM=T9&]_PFH
M?4,<H/8K0^T;X@"U7\)FK[.9-%#8.2#Y#TC^ Y+_@.3?4B3_>@O:WR:EEEA)
M.=\R:2\"WU_3*%^W*LQQI;Q6E)6-AHCXR&J@B;!DX97QB,572.)H9"(D[\!^
MC0YLP0D%, *FL8L'6HC#M)0]*4.U5ZO QPI\_LEVO7:U$NW)>(0S3QYEWTS>
ML"FC+U25+^ @8;5XA@F $\5?8)4!)E'<.<E+)@*\G4FE32TNUM=F!=$P2P8
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M9E/C1!(_=NE'_*G4Q9WS>L_H';[U+L.%AQN-SQOU&7N=R#F<BN\Q[RH*18;
MW1/FQ9V:VD&P3C4#N@^2*;DE]O01FOF4;RX7??E[!O0"!)%!R0)?WSR3F:&H
M+6ZV0'CQ$>@K&!-)[@O>S ?; \.1Z20;_8<)ZZB,_%QXE^]!GOSV5E\KKM?_
MR-Z^3>R>4!*$F:1/DK&^O7K_]N;V[>T__OZM9R8A<^N_].<O40GGD$Z/-MZU
M8 2 2KSIY@47*V<BFWEXT@O<W<9=%U9NG#V=X$ QGL$_,NMK1H04I@M-M%5
M7V;B;XG"$ZYYT/ 3L\'?#,+4@JWYPI2R">>YE?&HBZH!R.AXF5BG,PIC814J
MOIA5I>8^=)8K8&"<14_8]VO)WI1O+%",BP$@3Y@!XFWO;[9#R<TF^ \TR'V.
M=A^![0[9E<AW@4'D 7&1MJ#-.E&J2?)'G+G@H KI@68(&V[/''<]'FU,2&:4
M,<G%7@)?9)A7V7=SUF8._ ]M25@D9S=>,0%\F(E\]JX>[7#.0A;L.S].J+YU
MIG<1]MCA2J#>DKU(W"9@;MCHA7%=_S'\=8 /:Q8^[$M^U]B^S/C&'*RQ: ^8
MU-!9[@R+;BC!WM#W)=B_]OWOF_HRE"AW%(ZSQ[!/YUG$J2VYW[)(+,,BFM7E
M#FVR1"2$@^]$=[,;8&L.95O"#G5EGL .ZQ8Q):LMJ3 RT4R-R'*A"*Z%V52;
M'6,&\L9WYB_OP/IK(J>J-2E,DFX2RSRR***YP_6[$Z[\T*Z_/.2%;HI$DBKD
M;?]2^U1X\RJK2J'!+Q<[1GM5CK<_N(\Z\\9/BVU8.]A^QE"()A?$[=6UX0'F
MU#69F,KIO9G.P;/G;L&3$+ZH[%%T6N]7\YZIB5?>B7/WZSCFY2E>#LA'%7?^
M9'/FK#U0^D+6_0K[N<AZI6G'TI!V7#WM6!K2CJLS\Y 7/.0%#WG!0UYPN_*"
MA[#!?[WZ/1?6[*+3?(@4#)&"IISL%E$,@YAJEU%Z#"++.M&ETX,=#;HR\RD7
M#88*-"(J.C'$(SWS]4U((:ID$DLK=.MH8:B@0?^S91!):XG_6;1D(ND5>@_4
MZ<L;G,ZJ00SE8'_<*_ Y&QK1],MZG,\<);G9FXPW^)UW(I0*,72M2F_XP>]\
M!%GWJG]G=SNW*+[SU8]L]XHW7=+9KAOBR6TLA[-41E:)Z*)$#.WD7IDMCN%<
MO5/I_7;F>!==+(-?:? K->63D7CZDJ1T.0,5E$[3M,KR&5OH61HR4(<,U"$#
MM:;#]0[O'1I& OVQHEZ(F@DM<3:Q\+'CS9-:/<KJ[AN &Q8UBZA2:\ T7ZB8
M1FM6$ HM],E\3@O[GKA5.^@]TX@&QHEB5DTP>\+EW&$JJ,0T+"(5V_WU(6]U
M\&N $$1DX<&O<6:_QAY5_KQ^C7*O1N:K&%P2Y2Z)]YM*YB[:YX-3HL-.B8^^
M]S(!$&R+S0X6J6P02RDHGQWR.YA$TD%7TTY?P\5#\6_*N:)[*J-.3+C\1+6J
M4[^_ 7B%2+),#.-TW;E)V37HTH,NW4*R-J1+;\<(ARAAN4K>F 9YMA[#75*;
MS[_HOJC-'^SIPO%HL&;^8L387"U;I$(K1-<T8J@%T=\A%?KY:V@NN/ ONG"F
M#;3_@KM'4L$T:DT..$S(D(EH%#:IA<&ZM^DI31!IEZLX0JA5?QX]VD'MS?[
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M"M>A;&5)E8A</ &7357NB8/[4S*=5%6HW<&-8+,:=B%NBW^Y98E<W4YJ+Y6
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M5#7(4LNH*'?#)&\H'R_5F?G0<\Y)>>JAB%-@_XE$_[_\4NR75NIR(4<A(7*
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MGA1.=(&5?'TJZM7);LP1+\2@Q+*;(QPNGKYD#,]95IATD,$WE:%DR%*J;*H
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M>F'0:N%8W:FHJ:)<Z50A?__JB2PK33%I&MF8<E&>+(($-::TAAX;5KVQ*S$
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M&0S\* =B^MTXXX3G9]&LA6O_3%2<*^ U3@@?$ +Y[T;S3J4M^Q=5%<V\)OS
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M]$N^;Q@ZH,82M3#H2H&-J,X_>DX=;LWX,/-;L?QT\N9[=8<(KH)(CB]&;)O
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ML;T!>NT;68_?YC*$KR<TT$0"YM&9:E;< 9\',A=26=)ZWK>EI2*K8\-?)7<
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MD& 4$85.QW*EM1Z++1!X0.P.$!N\L@>\#4*B"*7?5H-M\N@:(E>9W$SFK&M
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M*AN"K;<6"2M[R7?R(#42#_B:%#F4,C(]<6U=I"Q$WCT)J_L2N,N([F]88C7
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M=*%R'ZOQJ*=?J5_>2/JK])F?YFD'2INB(O\;>?QG(MAJ1(4TBV<Q#&LHM3B
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MTG[%-3^VPQNN\1"UW&-GI-5#P7OP )'I"4VN-%D&F5MZ>0#B'C$8!?3W0HC
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MQR6'ZKBR.Y@' (QY^-!JRFHYK!#7]@]!(U4E(M7! Q9- G@ ).=)YNCD"?"
M7E7F/)>#GK#YXQ))^T4JS-=.Y=P%QX*9[_]'T P1ZD0C+]NHAXR]M^%I,/K,
M)12STAQ!:W4-*?";5_\!YS#R6Q'-9O3B(0XR!(%B4.^?U\5<Y=_7Q2Z%\@ U
MU+('QT J%CF<N EP1:D&Y(@4_ %I PBY60@C9+:A4U<AL"/EC\LD]'<ZF<.?
M0/ZUF0?44^GW'R*)<$2X_G&L%&E%GG^ &3**=*:W3$>N)'HC#Z"VPH;@'Y?^
M/,#F]_4T94^$LH+<(1ZPH8V!II_!4>'H60P/6//]'X%64&%9QUO@]U0H%(91
M"//_L/J'TT3/$:'SFA)_/, _XKR&Q/H2+\4##J2TDI>9/" )]:>U(MC;"D*"
M<N!/2QX00F[=N?N/A_B/,*>)?V*[WY_7_7#R[PMZNQMX0)K8_]M<DW6,S37Y
M286WSV+F3#A-JXK<*>ZCXBQG",5L68$=:\<]<8Y',AE3/C:98?(6YU)9"SOG
MKN<69W..H"7-Q2T%Z7(Q%RT%EV/R:<N$Q^9[5J] 72W793/HY2+-]3*Y*4]&
MVKV+W4O4+ ,W'KATF_RH3G6WS*K)+3S8:J$R.?+!MXV#B>M^<9^3G<DO:B-Z
M@['APH\SWO?[V]^5E4Q\G:'+6>NMO[C\.4][.2C"9OVD_(8LN7A"ROOBN&(/
M447#B2.9NTH3!W$#ER\]_^7\U<$3&V&,/F\>BYY,Q"S/HEM2MHK]FI#CKCHR
M"6_T(9QC6\J*3#5Z^/?]$%A%BJ4*1P6*+?$ QO2*(ZSAV^*X(O^-#*5,H'^I
MSJ&'/RCS@#PHA:-:"OM.SZ<*<E@),+<8<OJ"'.GO3[7(_K#,K[4\0$P82N4!
M^VMC5G@ ZRK8VA*I!GXLSX?)'$\4R\!"$OS8:<0#VD"%WS1=^=6:M\ #$'K=
M"0'?<R-^(I60NQ.D5B-*\)^XR9O)=#I:$OW=Y2,/P/R^!_)'['_ BNR V7T%
M!AEH9C+A5QZ!= "UT*&_RLZCV_P':-<O<AQS388-=ST%-?W['LE?8+>]_WU]
MS4H9>0,)CN_O8I^>W CV<&Q@":2T#9:6W]R&<>T\(+*?H_6/H#FW>$#,'<XA
MA-H>5EP00JC]1^0/\H31W\]F(UE&)_[N2%P\O><7#T"Z2(LI^5LDZ9<XV"-/
MGJ> 42K_ 1QS%\-DYL6A%K7]0*07(.7W)_!2!G1-[H8K&(X-*P\A,N'A'AZ
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M:URC$3LH^+,+R7ZS_ML765XMJ?5[T^M190-2=TN;'J[S7WJ$/&*1*MG^W#:
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MZ !3F$ D774<O;&=\)NTJ-_,H>C^FSK6\??QJWMH_1 GS)B>Y&TV<P.=+0T
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M1B0"VIL%@T:M!%0+DKX=38]*9\3! =@A"1>&3T(82%%G70G6^;EB928"X0&
MO:[&.KTP@%M%P@/NO *'X=$6Y$0$M T%_;4B7AYWT67E>,63SN4OGS@.7(W4
M"'J([.A!?T_+I6^T;B!I!.UN8+R^&WI7;%\<K5ZVQ6W&1.!5@:.0 G###;\R
M+3N!;OIH&(U8;E\P,(6")^D18"<CJ@!HSR#"A4-P3>W4CE9TJ:+1QDKJ,FI<
M9_TD')":/I 6W;UGY@52"FKL14]_PWP&XE#_]Y"F+^__OXVD_X/=(D39(DKJ
MM:M89T50P.-MJ6GC!M7A/,)K@8?-@M(@I359\"1QL5@SM\ (]8G J^ [EY;4
M^29:7=UDU%97B-#VI?K,V\RQ4,P0@W=LVA8=UBX:GG*R\EA,?<$7D;INVY&A
M@17?H$OZ7BY"UD,?AND[FE'9Q'T!*S)"J=PNJI I5-2L$,_IB).Q']VRL%+M
M"\ 3R//S!F/Y!?:MJ;KMF= B,<((O)NZ"(?(7V(DX-<<&I)X7<5$/+P%#:54
M\?TZ36>GN>E[J"L??/LR>T^X]A.]ZMI)5>.':B@WB'R3@&2<;T7/R*-^P?;>
ML'P""@,NJ6'>"4D!K3BSESTO>T#LG.[K-)BA,;IU"0JXJ>W==:C*Q45\K'2-
MUY9(0"JI&RS4ITXEI"6E#MX1C,>[DGN&]DEU6:LEW]K!G_!$[>&([Z5+S39Y
M-X%*WK:W0W#A+T7%*C@KW[NU,FPU+WC"GY,W[GE;3OW0)87Z:^]Z_NK\V)/K
M<SI":)LJ858O>C65PS3Z[5=:^\7T.U1#PV6?/L\(^=Z/MH1B@F/Q9ICLRZ;]
M<<J&FN*TX8PL"=]B&\DQZ^_Y37YS-YS:8_,?JYM-S%ODRP1:^'&E'LMO.90'
M(/W15 /<T(VIN;EIB$<GAG]169E?Z+)WJ9&FR].CUS[)&6SI([8=/X)P0_ZN
M4^*[:LDV)N**3_LF!YQ= =CC-6O:6R>WU&LDDW+$O5-%WNL9F@33U4LFACQ;
M92J+JU;0T7C6!BE#KR%Y+1H,X?Q"=,;\HZ]UKXX>=*U*+:LY92%T4X9W\LG]
M6X\+V-"?^V?61A?>;_G,:HKU+Y03PY1JCX%!(>, 'YCE021K5'2L<5H,-=Y-
MN3);^MF^Z^K"B4X.KJ<.9\K=G*Y%5C"$C>V>>N[_=-WA5%>30[^&MG&+8;1G
MQ\3DW5?=H;I*:;W%"X.:_6%06,:.^@#UBTBI<1&-UZ6'9AQR[#-E3S3T>:IH
MAV8*%L2;V\<?9[/.<*TN=^OZE</N&Z3ZC0ORE2(Z+PW9G.LME^4&7=;=.B*B
MU>7&6@F[9_A%Q$&\!^%FY>,?9W?WEB@0W]9[*JHL3F2>*M$JBN[:\R.,%"#;
M) N* 8M>--DZ>VYJ9BB5;[3>-\"!A#U-X_&W)'(O^,4I7 TH79CVX#;H3JCG
M>_NP?F[$U>')9.J];Y9Y;8!YN45O@.DN^XQ\,Y*#DZ%KKL@M!?\[Z=[>#>(7
M#3IS D^N/C+1M]D2P'?R/_"-W2TF^36@,%[N$(>=6M+\=0:1H].B6*K2/%<O
M1T0PUSK.;?3[AJU$7YBKH1G53#RO.SHQGWX=:'@!>,IN'JC1@$N. 0PS#F5#
MAW=L>0,=8>0EN@2<V4B 2[DE<C,BD8EHI\- <A^,%E94X51',QK=A9[Q:":"
M0:W$C<_ (0QU!C44 SV210)D4W<FHND47'C.0<.8U:,!07##= PDAQE8Y 'R
M M%T&%4#U)=X%CREF_ZJ,]H4\EZ"1):7(!]4$S]=;<\ZA7603,,H:,9*S-%H
M<@>ZBI^QUUX$QL>OX30?:[D>I(V:$X%A#GH%13^5RX+I3 0/@VH*A0_#PT74
M?& B,B)H87")?L!X1YRY0/T%\<(Y_P8.O(-<)+'.0XD@4O-9)827D=FI\]L4
M50 2.ABF[5E5\)#D)1DF8OHHG4YG8SQBK=3>B6T3X03]*$@.5Z41\2[-8P%+
MF-JRF*O1-QVZ_5YU6QHFNUC5E^GUK7A>WGZ?(S%M@4B.)MZ4W>17(-)9%:AI
M_I=)-'TH"ALOS$92;3I^]JMWC8X1?V1V:+:)BFT#IUYT.#N[$9MN$W?KG*YN
M5RZ_TM32V?*7SU-74Y&@5H.P\F/'C+/W&YW73JON-P_]<MJTD9+7TZC/_C#,
MRC@YL('=4+Z@U]7WR^E'=MDW"]U!&#-PF&_!(.1]#A,Q-HB&E'7H<I:+,,BZ
M,)4*!R@\(_ '=L[8'DG7 \)'5T_#F$+M.GKC^SU8^?N7T1N,IP!9&PU=P?+"
M&(P7VX%9E7$%0%8)C.O\HV],=1(,4+CPY"H&APKL4_N?&D%W]]"U:G 0X(P"
MC6&;):'" "H)4\[/8$_#0)QP:1V_ _S6<?_/'!Z@,1?T@.'5?DG6PQ$8 #Y_
M ,/#I>-PU1J(@'A,6<N.R)@_YX+ZK7._K7QM%$T<$@(Z&EA(;?81;,]K0./9
MS_#_]>NP\\.FWCC_GU:4SF]Z0OU;2_\KM22[Q0-UW(K?$[Y:DWP-3?% F>Q%
M+7\C7M=D"W"WI/K7>R% #";\;(B+%G4R!9]7Q_/0BO+^D<H=7<2V3Y\W[B/Z
M\XTQ+T#_,1B N#R;$B @*;X%8$:K;+B=O6KFF?"323>U^#EN)*MTU5^?%,SL
M8U-5U56Q\QDU'6@)P,A\+NQKO#9W(U=MU9RM8.VH2IY$=(&W<>[NG*_%01\5
MJJZ\C)9<:YC='GWJQ7_F#WDBQH3(5YGN.6T\4;7OT_Z3C^\TO^ A#M[#T:%A
M8-2!+A$+T.9=XS/U_9:V9@$97VV$/=3= TROCT-;*++.>B9L2705ZM=W.)%E
M_Z_YT)+&5UHP!#J04J^,#DNM8WEHTFME2P+Q<ZU_U597)GGWB9/CS_^L@.RK
MF^G\H="^?/<2]_7'4&_MF4M2="W"P%!SC,GQRO(^68]%RI[/**DKVL+NS3^,
M,;,T"K#!$^R>"5"B:!%0=EHR$ M$HB<<:1?A1%5O3@$8:#=%!OO81?/D*6\*
ML"A5M>-ID("39O/\N\N:D@-!EQP"&?BJ7--$?(KZ<.749-R2DU<;_4+3#>KC
M5A%^[LB&]S4Z9[.LBV7<]9Z__YA!;O-,_5AMQ6#1[A6@S@(],U_CQ$0$#P*L
MBD0?I9KC-M66!(!1)3S]!O'(3<*,T9HI7'!F,CX3J=WWF8@IAQ748L8H%!X8
M ?'= #:\-QDP+9^"06H1T-D?T IME,-AQP,T;!#'"E&K?JQKGVH]T" )>PXN
M2/GU,*$P=,2 KI^ E=/ +;C=JOQ7-+4,CO!67/\2C,7HO Y0_(<FS*^VW'_4
M;A2,U';!=#N[A);*6'&%"XWD\NYH=*\A3&]?^AZ# \YP!Q/Q+'3+A;55.I,5
MTD_QD"UVDLZZF64<J#-6MZ$!9'Q81?M@:I-_&CI2W>6EJ_7S/*72]!C)#SG1
M ?Z1^W_,-.[X3B':T;5IW="^5IK8N'^L$!F]V$V)VS%6Q$3P%6/Y9]->WCSH
M9A*@0TJU#GA72UV<+#L4VR>XZ]-#(8933OQ.99K\MONY&Z*,#)CP<NZ@.NR$
MY6+G;[#-Q,.(4030@Q[4*KEC.;IK FD1#8+(^B7PE';S?;H[+<B>6E*$/12P
MW'P9=*(L18F<K.AR[E]05^1V]?#U\"MLN^ZVD.^#XQ^X;_,T^:DRB2:BG43V
MY5!4)XJVW-0KP9BF;9RTM(?3FT>LDW%7L=0)S=)#DAT)&3^SK'F/+PPE:89*
M?)5+IE8X134[Y!ZZ<:VD%/SBAWXT&)UQV#5(65I"\F)_:,STV]27 5OK1%AI
M'X(%P68*+@POB/;"'0XX:T!5;I#>TPR=IFE&C0766(:\GLL\]3&E68M:'/[
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M/13H3L7 AMGGENZ?%K?,_"Y3CMH3O\LEC3OTOH1Y!_ISJ?;GW5NCW.8_SI_
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MF\9T3&(+HS-?A:E&O?B@S+/?K-YI(5U#WJ*A.:^F/.5,=7[:Z^S[K_\K[O%
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MPL70)8&/+95WN>B@U"A5U,J=U?T2!#D7U[-?^2)W;S6BUHO\T6GZK4&AH,7
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M54H)2K6+ N+RW8UH8P2PU&=7*)GO+4!W1^U7MG^W?-AO-,%QD!U9ZE7 <[.
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MTPV0D9$!?I8>0+(,N'Z[_5OV+<F_FT-&\@A0VPU\#R1"9 P 6349B)J,A K
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M6EG:8FSSIYW 3HADZ3\ 4$L#!!0    ( %9!G5M!5UO,& X  "</   -
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M9/\&^Q\N'J"CAE 53\T P  *^8M.JR&CO[$?PD5B):!Q1I[&Y!>2S>HY2H"
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M2!'%,I\:M:2:E>LDL"*"G]LE9S^55C.GZ7L $:F6[FT>"\S2]Q=,4_I8<_Q
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M^(&EQ5OF21=&4306-I1R&:6R@"?I$>( 2XBAW:;H?0&8>!C\&L3A=K>.?Q_
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M_7*S0-_K*KF$O7FK#WMR.=YX>EK(M[NNT?Q]2GGGSRX9?]L\"SK@Z29ZT^T
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M8]MN:-\<(,>764;WB(U:JE1QLKJ?YT2#3'%%[/%]4.L":7?98!\DP0F ( G
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M[1SL?F&.C!9&V6XM-"7_OMZ08I3"F'&3/]!!7!S3/X(0H5AV)%F2P7'Z,K/
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M>>>>&]G$1%AX*)^WEJFO3[LF%JRPP7>3J[F,'CJ$FR^?XU&#'5IQBHG=R>-
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M&SF Y&8*=5'#R((OL<?AV>3H&@^O!8;XM7%WJEN"](M0N"Z'#TF\V!<K/;Z
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M:''Y1$JAF)M/N%&F=,N I(88O/I&=K9YAZSZ8M\7U'M=M0,!(-N)&AE%%>]
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M-E6=!R"W*;O,[!)X_,&!TM:=-FQ#RH^MW=)/@1=-)()48T7O.%XT3I',#OS
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MY[42N!V8R\7[V:\[KJNY%U*&,:YAUN.[*SM3DUX$M2K/".U)B;]3;(!Z:8M
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M_&[31<.19-:EGK*,?C7X8>,$#[?J= 4^(((0[DTEC>@)V2H7-5\(NN#2K-,
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MQ0#4EC@R !7\IP93& #_'L24F#P#8.$GWOQO@LH&_]U*P\ )[,&Z$%-ZP@R
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MUD+CC%][%8;5UMP&.-D+HOTNW%3?-U*[7J8Z<B#*0_F5L]_ 8.-<?\\L[I,
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MBC 4;=,[*WF0S##MQ&(5L2A=\W>4#4-+*P&I>1?7(R#EN(6=E*PH)<3GGT@
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M+*.IF3=!%Z!MAF=81XM!O6@HTD,SB)JV$8(%9,"F$[I2$YQ*H0V@CK":+8?
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M52_%G]&8 ("S:CC>+I5= >M5X1'W(TAV6O3X<^R-U9T61#Y*-%-(48"']*Z
M]:3G;Y9+$:_7OOA2I-?&0W4'K*:"%.J!8R(9+(Z.V'3&0OGWP>B(A8(%OJ=*
MV43ROTE@\P@^X70"F:_NZ7GHLBF]\$,*Q(NGGY5U$V2H3J(92/8(WL1HCD=4
M.F"UJHXS="=2IP9T,"K]$I40V$+5[66_T'FQCJXH%RP,:0#S)L4$F>;O@-64
M"/&AV#?D[[U,?:H*2G)]1*JG]+*Y/[^9T//>L(]G%E8EP!ARG+Z#D+T=TWL:
ML.2Y5_IP%\\<6.(TWN?DZR5YTR#.PU)FJ1[W(=\A6%+I]A..>V[DWZN_(M(
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M$4HKE+"'_&-/4BCDXIT21?+_!U!+ P04    " !609U;AL8]!K4?  "8RP$
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MVU.8J,V>F2U*K>GN+</!31']NF$E#&GJJ?R?4WFP/#9ZQ%1YU[TB^G6#*2E
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MHG9V73 %*&"G\:8S9?$YP@31"HA/=U-OT]5Z02,HZJD7_M5D7T1E!C5<P45
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M41@!6I3[>0NR&_2 :(FO/,[N$]JYGHBCV&M\ZXZI:9R;HAF#=]#P950K.R8
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MU,IT/F"1;T,FQ"P@^ZS.;2USO1%Q,A7=LL'[W+8E*_A5RF:L43EG&_V*TNK
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M$XRIXCRC(D^8/C&3L-0=\G?ZH)1OA66<J&?KG(;J]&SCI@!P=$-KURNH5\'
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M_G6%:#K2%8:0/H]9[@/8*4 R,,14TA%T,1F2D)VZX(1;2*C0JP2AJM':3CC
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ML%U#ZF*H.[;G$&)I),<)T'PD$F/E&L,P(K^0_@V1V?]"5*KLU[Q(4T0;]JB
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M:U\;%W6%@X @15[* :U0^PK37T!0-#?JT)/C7V-<3TMJ!(2UQJL:8I1<-&J
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M6+Q2^*E8,+SVVYFGPW 9#V.1)>^X H$4,TX2RH55!^17F K4"I4%;(+ML)J
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M3>)?0)S+76I[/YQ"4KK:3;5__H/[F?KK*']) QR]P+!<LQ6#<N\A[M?SD[A
M$C)Q82/%KB?N*11J&2EEF?*+3JP1995.0'N /J"$YK62WR"#;>[)JXY,+1NR
M3>A:O4YUN5?1)HG640"2C';\*4H1I?=)G3>.Q<*J34R70\VF@=(ON&',K!I%
M%,D[S!\UJ%Y:QA-58#S%%JZ*4=T&#3:(6GHVFS>6Z"VUYN6Q*6Y;];@J*HZ-
M(RVR;B*QA#:1/NWN!\1*8BJ/C$-;1P\F7JT;JHC82%UM1%7L$2YJ "_?$HC3
M;;2O5G/Z$XS#JP-9ZD%WJ3L-?='FT;>_W,C1:P@N:XTCA%S5YN<TT$Z2(\\A
M,2[UHXF$K%W4^J/KV$B>EK%C5[W4Y"M+^9;3PX]6Z1W3-*T[E/E,V'DZ#=%S
M76O'DI)H/9X&L7!<8:=V.Y'8I=R^I609FH]76G(EMJZ-TL!(^:CM:8?K1YD\
M2YX=V*I+2QU_V^YM>1Y<O@"5%,#W\]"1#EAQC3<2@%8+C;RHXT<^ RW5-[%.
M]M-I\L9+'=4<[D7)7,?MX)M4O7F?+-[6N!(V'9I0N'G)>[U&1L[#W?K&GZO5
M]J6Y(QVC_N]:IH+;151?/>>&6U>HPRD[HS; JB5UY#!-IX?TA]@*&[*6<-OK
MAFH=E[T/</NIG_EBY8C<5J:/#UP_$)I]& JR?30K2#%NG<%7DCMSY"JA#O>$
M' /:(@E]K,!>XKZB8!W"V1:WT4Z-)V)E5TEG<%;T/%6.= +@4:;#S1?'H48[
MUGU!KQ GE+LO&"0.'R0B'CX NOVRE^C_J(?X%TRS<=T6\JW3//,CM"%>TWT-
MZKJ30C+O+2N/] ICM*<\EC5&':Y<$1<>>S,Z6K]"#(:[,NJ&L['HFB\P@1C$
MA/@BI(V9:=<D5F#&L0Y(LG/>%@I93*0:.&KD<]#DA^6ZV':6F-9;6#9"9J4L
MN\.CG.>*EA5A!9[0YJ2[J.OD"^*+-$5D$AFD+;G_AHC ?B$SR3'Y[Z)$/ SO
M$/XY/1;-^P:S+7*756B0Y?/4*SOH5EK(MXII9A33AL1E$ST:NTG+E+L^2T0\
MG/-+0"C["O"A@CFCJA+21\B1@45 #BVWQIEA3L[[ B&!1*4' JN<MB(4?)?-
M":Y1ZNYIV*5\S@N]1\X5K'Q[G('E?07)Y&BG"0\+^D3[W(_Y7GE7^/)M=WK@
M7CH/3PQ]I=;$/YHW[)VTS\,B/V]'2EVT54")\0!6=@FD[&.XI0&;K^4Q\0 S
MUB7["Y$#*Z4(TV7R!%]!G+-IN[V=ZS!XY@M?'[A*E\RW &O0O'T/MB#9P)MH
MO8:8)D.1'SYCD*0Q8Z1BU)T_0(N[\WX!:")6J9"-QH\].NTNR*V']KG?'WOE
M70$LK%1M/5/R%%P.DK"WSX;7Q,EA]JSG46JP8#VM4IHG.UF6BN2GG'2IKV!:
M.9BJP%U2,I49FD]*IMXJOF1H7C(T]41_R="\9&C:SM!L;%]CF]C5*A#/.G.S
M5RB6BF)=$CB=W/RX K=8:KJ9MN@C=6E6*8:F .[*W6PCT!.E2\*H?30O^:-G
M"^TEG?1C+>5+=ND9@WM)-CT3("^YI^>/[B45]5SPM)^9VO"'WX$(LR8T15=?
M:EHAS,=H$P4@=OP<4F;L0UVNU6&3R'35CE](L^5Z!6*7CZL:S8]U@#>D;3KS
ME<WJFL7$W-/HER<(XNAWZN]B^K5<+S8X"O(XR[%D-R/IP3X"BHKB'4YMO:0U
MSULAI"$9SFB]9#F?J6:H)CU?\F9-L_S!MJ)+&JU"H/Y\TVA-J<LEJ_9,LFI-
M*<0ER79.2;:F4+_DW'[()7Y)P9UM"JXI9;ADY'X4I)TDZ%YR*F>N)2-3+ V'
M0M<R@=F;EFQ)V>$Q!DE&GK)4!,S0UJ]'')NVXI!G?PG4DK-,1NTEGW8V.C @
M_FFDU]:2!VAW<Y!NV4X$ C:])TBV)!AFJ$@L(/<7(H@RR[C^?!U*P=7PN!%.
M[F+T5H/+---:B;D^^-+LL>2.5?DD7M<\63IH^M-Z/>KLR97J&G0#"<!JNIWB
MC&RH28KB**3\WI*G53:<[+L&Z0O#DGS/SK/O89RE]+^8FC(5%0YM297DLG8]
MK66J5F)YFPZWX%$;S,X=@V\]S=)ZHF5/KJV,2HN@D,^?-8B%,%76$!H><E[-
M8"&5QVHFA_4:X?W8/-;:&.Z?9G)+7IRS6A>"X550=&2$96[=(B!OA)2)Y>IP
ME:?D($X)]=T+V5"SJ%T3C=?)4GHT3P_E*=QD%$1N _%3*O5]\E]1$MXGS*M;
M3N\18#J)GOF?ON.Y7;GU;0P2_,!Z8Q8XB6($ZJJ5ICEU#"[7+*Y$3CM:W_CS
MITP"X[8$S2;+,AK+MX0-_A.,0RF(&A]X,V]/ 9ZFZ$QGN#(2E1%]N;Y/,O*7
MB+Q:^M(Q.%@)/O_ 6Z=(J,-)J]J^[(Q>YS(:()%>@WV4@3@B(SOT7W,8\&BE
M]JP-,N@,IKRJ^Z6BS39#ZSR%7R$@0S'56X0ADWKZO,4HWVP7R7T28/KO]PG[
M-6Y6)<]5-9K*QSY[#:!D-M.V>"V@Y!M*"._X0(,M</22E[>Z1FRNR0N[89(?
M=[>Q N!@AN^H2+L PI#%<K*L,WI>'@MO32/6?PR/'U<3#6$\F)JLL[W1^1ZG
MIKY5\3[_P-==D5 -=\$MYUQ<GWXO0T+(/O<*<49OV3WL2_I3E8;\P&"K"M]X
M-5K&!;DLD>G2/62Y?H(!C%ZINRW]-<JV[,6\13$A2U.*>HQ64AHQCL('5I"1
MT$AD)NML&6A' XB91![!@7)79A6$5X>:85S3##)B^(][21@-C-G,Y=+H7;RV
MJN=7G0$J!GJC1BQIMGK0-^O#2GHH1A+Q%1@^!849CY!$-K/NO5+W^B'X_ .?
M)"*A#F?_EO&=M@,_BYH;Y.U2L\PL<$0?,U2<3H(\*VZ6%3?W/=S<]7/3$;^X
MP[@12EI+3*B1ZBB8#;D<2=]I>*51;9$+F!P+CXG@R-&U0,62<=HC18TKOXU2
M'*Q;;D%1&<BD'JBVM<=QTQ15OCQW3M%:A)I*8;N'BB(C#ANI:"B%YVXJ[O7"
M8E\5A#%Z(R158E!;WWAQJ([>[4X1J6T1F&ZQP:A4YH72VM!X0%91D0H8* SG
MM[W-6'14Y&8^9/N>S*-F:GY &4P))_06H #6\"A^S''F4)*0DZV&&-*L3^]$
M\QB*8OPUI@6(V=M.GZ'NN+FGFGHB9TS5(>/)Q&;G'6Y"[&;;'C&V;F"#K?(0
M,:P+HXGX,JS;487Q,A\^*G1N8"V^VA[E&_B26=6+<03/:K<P"\5PA/JXT.9'
M$(77,4C3:!W1@$F?=PL5GKPE,5B\7"AA(A'TKE_!C2EP2Y%OUVL89+5IWR$,
MH\VQ9M 3+3@[O0NKF]F<Y677D2*8;5!5>UA3H@AW,C7E#KB!(<X(<"F)#<;%
M*V/TB.&^N#Z1O^VB?'<'Y;R&O1^>&Q[]TC':&ZH*" A NE4/KFA]=3[G,4\L
MUIHZU1=:]<3LII*GW"IMSH[2T8QZ#,RS>$R.QT^FVY/^F_ *!B!/R<R+[@!E
M.)?2*X\SQ+EMND,2D_!KNXB/:K9T8(?U4 "4LO(T:( D//64$/*A5;C.%"V=
M\V\<;?E0)Q-TK)VQ_4%-AE7@N,J,B'Q\^)+>8=UDS&6 4I>RU[)O!A=.\SCM
MD;#I2FX<8HXCAOIH>ZOS)J'A IBD(WR,H>0PB(>'D]<X'7V49.-MU$.F#PFY
MW\)@>Y^$>9KA"*2KA4(D@>A[OW$>@EWB>*H)9V^C"MAY5MQ3$[ILP3V3;M?%
M!H.8]NW&&TA;9P E)>=_[3G23$;<@JD/NC6UY?SSZCX)-"1<_\Z#$UI/LHW)
MRE2GTI?KBM80T!-MZ]/I;\Z\.1NN'%4<!+^NX"Z*8]73K_N9[\ YJ6.O9[;#
M#AT=M8W7@/S?,SEA$]8MG3PTGF(5Y14-, =1BR4P7+A(*^!L!S,E-6Y^,0>Q
MMN8H4YQ'68[/6XCN5]<KE;M9^YL9W \ZTS1?;>891QL0Q[2_<A8%:ELL[]LY
M:"EWWC*^ ]TXD&-1H6:^=_/M63?].(SJ4.?-G[?"@B5U)$Q6TD!JG'R#("5D
MPT5V!R+\"XASR5K"XB'."D(IF=DH\GR3PV?$UPY:(R#'N.-9YOD(I4?S%.9I
M"SH%,<H$_3JMK-!@NZ:#5#SK=12S&0Q65;#C;E-CTIK'<20;NL]S:ZR9]56.
M8,&6,4;?BVE&XY0<G&,@'.W[U.S42#C9('JSH%7(ZB7&G/I!!]CP6YG!S>IM
MM7 <P,6>]Y1/V;$K=9 1S]46Y):.+*RVZRD,47;H>Y4!UK,GU@:V]FHB\/:<
M17W/4;"IJ(SGV\XBNUWU'^1#PK*2[WLJ'RZHZGR?!'$>DA\^P W(HE=8_*/B
M@UN+A+>P;P_7NK%H6"M_4S9OOXG2/4I!W*P'[FRK'F##5QZP6T611\7.]GZ,
MABZ4KLHHE-H*>-]ZC-KWL,JY$I2PX:C[B@$-8:\H51S+^8O[/_U(&S)/>F9S
MIKNS:YCYA&?!$PS*/-Z )8$4 KA/EF\)Q.DVVJO?L4P2_U@KVQZ&-L)(FE>*
M4]_((D.%]?Z@I=^O:)\C\E,:C_4JF;VG.?3'.,%'"=]*Y$LQM];4;J+7*(1)
M2/Z2'CL2*1SS4L-]I,-$1<H6FH1](?)(JSMCE4E_$ZW7Y/9!%(S\D-4#C]D6
M1!6PSN<#S);K9_ NA;\92A]H,S $C>G HM-3@^U%R_4C1NLH*U(6:V=;$C8/
MODGT #/(\H>YQ-@!7"*M7>-=4V=PB2F+NA$ADD-]&"U0DJ]<JS#K80>,752R
MBQB[K9 +A;@#O3V2'.!T[CD56X,R)W# XMXGP<JH"NG<\7LB 'Q,TW$4@(X.
M-+?;(8$::*5P24;6=;NKZKV!9.-+JO$EU?B2:GQ)-;;AHYYDJO$EY560\FJP
M(O\EY=5.=>1+RJM24K%&G$J(00JN(D1V)9:;J+9#B+Z?OJ2%L[?A&OK&WMNK
MXKVM).C^+Z=>Y8$S7PMU8R^YVU;2B"])F_U)FV:3C#]NLK99X_4'3];F&XN-
M>:?FX9!2]D%Y@UO7L#D2&@L1SQ_%<:2+G8[W9\CT8M_]<^IM+K#+CBM:^X$\
M/=).1Y[<K22$2A%S5\%VU (S)UP37;:5E"-//V\ V/^]EM]R8.$I(&#%\:X.
M]7\9\!FM0?K"Q%V.RA;#]S#.TNHG3%F8HF@0MJ8-YG(U598051\=\9MU./5Q
M,.AM&@NT;Y>2OM;S0+/B9N(3$OJ8#*+CP9%D"YN+<TGRKCF\(QCS+(VQS>NX
ME#R:,!6DVIVB%;V=K=U"090\HX6IK*Q:LG!1NZ>H!>3LQ="DZM?WH6M5:$G.
M=*FQ$R':I,D+2AW",[7_= 5HMEYV1R=J/7I<+ZDZZ5FOJX8,)0N+C5I</D#K
MIS[[9=:'G?'6OGW5'RQ"5:\$,3]L6L49!'YZS8T/I=ER33.5'>YX-9HSA:4A
M-K.._A.1D]_#&30UDEX#M'1QJ8M,IB6L==_"<@\QR*)D\P33/,[2+QCE^_0)
M[A&F/UT5YE4'KH8C(Q5)O^X& 3N:I2J*<>Z3-<([ENJH#(*RW\$T3<\Y)\,J
M<C+$F):VIYJ1%3-.DU,:1+TVR;.T:%I>_(:,9:H]:B<:5SRYS5YID9U XDJ?
M6O>#8CE=I4G&8:9*#R9>DU14$;'G/8 P7"0AK1NUP<R<B5&8!YE*4<6A,7P&
M[/;O ;6#:V#Z%H*&:/<W0B:#S*&D(.?>#SV_F ;DVS]7\ZDHE,Y#GN%(0Z3M
M[[R^="3DV9FGG2R4VQW$&WJR5XT*%<3*^]9W]-J =+E3EFEMIZZSA "*HY!N
M.[=)1LUL*IK+_7KB.P)_UH-&+641/\%7F.1%!2Q6?>\+0B$M.?)$W]*80+U<
MKR!^C0+)6F1* T[&9*+PDE.3F#UG68V/)W0 L5-S?B_QF:$Y)$KC!5U/!+\2
MY4@"> ?A?1*@G;L:'AW"$S(GJZ+6%:+1GK4G0HUZ8<=P[$7XC[RH]7,5L>Z-
M 8@=NZV5&9N.GU05;'4,#.?%]NX67] KQ FE_P4#E[6Y13SX?$P:VH6[<K7E
MSBN)N@9N[B#9\^%=_*O:V/3Y6(7./)VS$),]N' :NCOF:C1G#$]#=(,)P\HO
MN4>(:=UBL(&,T#= '^I23[;^+^>U0XE$(-.TV+I?N]PX7PZK:!?% #/O$"NA
MR*RI"%=O1K--&OME6E$EK]:*;$>J3KW;0H;T$D\%GCII+(PZN/6H6EJ&DAYN
M&461\G%KBMQYNEW]-#V9X59DN("&TU0&.<<=$H=9L6@W'N\9'[7>VG><852D
M/.8VE,)UDT099BQ>F&1[)4HO)!6HY7LF6@7;9>M$2;B]NNUM@BWIXK\$-DUW
M^^X/;3*>G7*):[K$-5WBFN0BYMOW>Z<;((^^YTH2CG9#KO0KP,UGP?:0=+Q)
M\CEPL#:%F^7 8AC$3N%*:A@\A_NI&#[/FZL9!*6V7*TXTF<,0=$>YA$$OZE&
MD/9_[=DB/KBA-")).0*P47B.4#L&<SR" R/ZT]6_$GXW&.P413\\DE_7NAH*
M$G*Q$DI-W?6OU)^K4AFD]<ULU+TSV>$@5"TEO][W\*2HWJ(Q?/J!U-1:* D;
M9=*7V1;BL?(?'&0N.\NP-"1JIZN#<!6AO4ZN0-]W7B,8Y27=.^7!@ R-^M,H
MR&.ZA1&":XBS*(Y^AUA%N0>&F,UF/B0*"PUDOT5D)E<0A#"\TY*]< #?>0;R
MHA?+0:;PNM:>DF;1KD!<;4_I?#>?/:4[99G(">5:?+3O#OAY3UA-LCNHDM'!
M_7@F,N9/WFBI]F+9@ 1LF)/\]GU/7L]*=Q+NQS,1-'_R$KYA95&WHU45!,WY
M="Y7/M[,)1P[FMMR #%,:8[?,0/M&F&5 HE#8_A\[JA$%]0W;K%03*<@7;*B
M+UG1EZSH2U;T)2O:>59T;[(,.34R#,C>\VN4;:_S-$.$'2^I2!Q.II-U)AO.
MJB1GV0@TZR'F7R UX>^W- NNYKH>""A7/_I+@DL>P8Y(Q;< ^>',%SKCD#0:
M]RU#P^(&UXGTU@11*LQ;2IXF@KHO,=VCE&)\&(S"RK$1P7T)WQY]>%["MR_A
MVV<3OEW?CA88 K>;>3]U>VO7X_;-$;2,Q<\0LHZW:1Y]>Z\:R8U9J/(#H*EL
MOT9A<[CA"H'S'*@X'CNYW?1B8I^EB9UUZ<6'OR^>!*LEA<&_;-#K]^4O%TWD
MRO\X]8^K#>750#FPC5-9UV=M_%Y8#7YE3J17\Q'IU9-<2*>22%.<_?TK+<VP
MV$%,F.C;(OK['I(O:ST/R7^=A,L9U+.[0D+4/&F8#?ND5!X0SK:F9=XSZ#QD
MWB<-LYUX"AM_3C9_^"T*PQC>@C1;).%BS4. Y]X8&,/GP2@A;3DYF*]1R@)+
MG^"&GKI+?,VVM$@]QI8[PM0W<1DA#)?CNE1(&P)EA&&\1UR6$FD_>(]$(QCI
MM$G47C^/=+_$V>&11E:2W9(V*-N7[@TWR/$Y\+#S&0%0(%-[#13ODPPDF^@E
MAH76L!WY>0L26@#Z+3JYV:P#.LR)#Y>[$60EA&RKS:)S&.>/5@<40_59&7//
M* -QT3X)'/5!ZKK7_^6L+A0B"<C<]33%34Y&K"WQOH_G=<(,"&(XRT=SZW%\
ME9O]!:X%R&#VC_70JZ\1N8&$479XBM+?# 9<]8>Q?0-9C@FQ10+B0QJE=PC?
M10E(@J@J?_X3C$/R4Y8'$26;!GL=V3JM]&F*=[U8L".I^R0E.L*".NFXIX01
M#J;*$6%F*-G:/B7+?QI6M.,6:P@&3STPKV/ ^A"LC].HM0%W&T0VR(GG0DI&
MUULKY&08!6MA9"+2KJ/()'CQ75A)>L$H(&R]V)($=9?18Y(P>XYKL(>T\:),
M)^K/Y+<(;;KMN-V^.X1]1XQ9W*Z[0I9*$AV/J./]N(>T]T@QGH+S$;(?']:E
MYG WY8'D>??4Q<E\+-B)VO$)X')C;!#U6A?9XH[8E*Q,R<^Q&#K>"EMD)U .
MN4^9^T&Q7 ZY2<;ASM>#B=<M3Q41N^60&RMX,+3*+#)]M'WG/?/O4>U6G#UR
MLW=W>$#95Y 5?L%G @S\AI)LVQL09#4@0L2%;^CZ]_QV'(10CA9SL_K(+I*P
MSM R@?\# 7:]"E49\YO<+H.RNJPM;K MBBT^&(?TYZ[7LBI?/B,UE3"7E;-$
MV(RZ1QF#$!+*+(;C$1SH55@E:E/TO=]EIV  /KF51=*P4J/I"F&,WJ)DHY*[
MT_K&<PRXCJ [T[:0)G5/.+Q&R2LM2$EP)&N+%=.FF*I41QT<Q?<M0D?^$K(Q
M7GFHMO-!D,(:DZX/DG[R7E/>U# <%J7IJD9%A2I$WHLA:_6*DCN$%P%Y4J1,
M4LMUX6M6J<\E/=J,D%&5DT2Y;4W;;=]1YLYXVTO=\T%E.6IB4/:6[%3'L]0=
MO#627A-SG"%:E['Q/(1JSVB<QK);:/,CGSNEBZ"DKI0&KRG*2- CE7%TW.:E
ML.CYS/?-T 4B?=(RW,?C-*&^,]C9IM=+_&-L?_UREVD58N62:>IZ>>87$GEQ
MRF8K6(_1OF8I?X%$B+;5L.(Z&Z63N"-A8Y'%0F+V0ZA[R-N)H.82<EY8T[0J
M:,5,\^5^J;TIQXKWVILFE]FE .>E .>E .>E *?Y IR7FG&3J1EWXI<> [?O
M>W;Y)[=P1$X1PCFM6E\[2U9;@,E-_YK\ 8(,XBC-HL#96AS!HK=D>1LW.S.@
M66@V4S3S+&8A:Z5J?^,OO]C:);PC%LE0&>N/6\88>8)'<).<^'LCZO,+41GF
M)'B"5&A4?<A.E($D,_<([C<[M"2>T49)F\,3C*EF/Z.?8+B!BX"5*"1<+5Y2
MUE[#V1YD@-7++CVE7=J&%CK<I%UL$[1A&;F49$^$;XE2!=K*70?@@5H?J<OR
MEHZ<5?DM1"Y$2K2Q3M]NS3&).=H.1K*L:YY6.;;:2%HUKPF)65OJDD4*S.B7
MEIU-#(()6]LEI=6A'4UF3<EFM1JZC,OD8EQR6B\YK9><5@6<3A$W5X<'L(-.
M=\A>XK9<_5/8(_NE/9S];P9;QULEA[Q]L[)PLQ0IO!@L^4W3)%P.MTT^8)XW
MSK&8R6;*ZE?#;>P#CN/L.>1]N@EDDV5YDK-@Q;V+WF%(Z9Q41,$GP__:<VR3
M>(^OO>2XL[>2;U596K4%+AS =\"GI-#%0K!UHRM,WIG7&$X1#U.)G39G*Y&4
MO;7R;*<:_EY!'V!C,B&\-H ?@L!2N;9Z1;D._\EF$631JULED.=H0D'!-C1"
M 1JIMEC6_2&M,.B7PS7U#B%\&'2,C/>+M&C[]7APF=&\"ZF8%+@@6/5IR%&U
M='!+NC:&5$3+:2$I[LD45R[8]%Q7N<;$C$HJ*ZVLH9*L=1PDO!R&\?=>5KG!
MQO0J*G=7B1R>'NHHUPE[+:'<@71RU9/'H6JQ9O(W".@11;<;MY5!6W3GXS@9
ML1=WA"U5.GD\LJ[KA78H>W:;<)2<"XYM9\G_W]ZW-;>-8UO_E?,]=\U)IV\S
MJ3HOLBT[ZCB1VU+L29\Z-453D,2$(M0@:5O]ZS^ %"5*)($-$!=2T4MW8H?
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MD]%J[?G).+I'ST4K^2<MV6_3\PG/C5:$"*\*9C83X<&J,YN*6%*G)B%+NPN
M+ZUWESR-Y3,B5./=>1NVCTT165UL6((<8-+\QJ][KPLXP AO$^92+@Q\>N3(
MTX"P/'39%"DIJRQ)B)?M6G;R+M34.7.<;X$OD6+I(7G8X;D65-MVGG !Q/U^
M/:E"J"';PKD^N;G(B99+0ZU$N8GPJ'.5\G.5<N?$NHYIZU^5\KI=R*IV;A3
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ML[\:>9(5=UN_,AKFC41S[4M!%-6!X^G2H^@\>V&::9 Q&42#]9H@=N\IW9+
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M(QZ 9,6ML+_#<>*%?P9K36JIMMD>;<?UL!0L<./.6RZ"7.UI7 ';!ONF?79
M%*!KO?ANWX/H%3O&483"UL>AV@9[@'D]$ 7FG)AR??OM3T;VVY_Z@#X'DH("
M;NAWVVD_I",)M_UJG?X'#?=AY^4C4Y#!N?M*4\&()\AKO>$>--3]YZS#<1?
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MEA_-HIE'VBDK3K.]6"@\6 H:3#SQEIWJ-.P6!\WUYXAZB$*!-^>F+!VTG^O
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M<9RJJ0;5\,M[7PQ_C6B"8E[5=F93G#S(85_C2OP@>: /H\E<)Y'.[8Q'Y1"
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MB4$XTFG!/2$(BM8HYYT7^A!=]UZ0[LC"O-Y,KFGE?N'\$\9Q)SD1,D=+'3K
M8B+*0,J";VGA]^<D"LA=R1XL[&BCIT[28='JE7_27',"(4TC\98\!TP/QQ9>
M@!,'0R/("MC]U(4$W ?5 4C'$14V(O4F8H=5)OV02TJ$%G..))P?8'*U,Z'
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M-&-P9::#CQ\^S)[^2JUIR_G[A_G=_'KVL$(-V]OCXGY^/;]=3LBB;<9+<J.
M 2;'.13U@G\Y!%M<&NBJDO;0)T('/F#OCP:HLM?@TWQ%N/^^R?Q_^7CSOKYC
M;I>K^8?9JGD6P.X2.RZ2GP5=/)H[<QJ+LO L:@@B=\X3[P.;X6")]QX-Z(F.
M=V3W,Y\\:[*P,'NSHBVTTU26'7;%==<H;C*/ZQ38W3J,)W&_N-\E\)ETOF&I
M)^F_/LZ7<ZX8TH.\(#KA4^O"6SW-'I:S:_8)O*(XA:,A%Q$P9#7)7"\=(XM-
MU2YFL;DF8(<!3LM8.AY"OV)Q1_AS?D7F^U4I0--\=L?IPL: *OB;Z(SHYS*!
MG0:EM29F\9HGU>.<I_W9\D&='6B%2M. 8V[1TZBRTAK@F-N::_=;*+LIYJ[9
M0H36BM(GV[#*A"CRT4NAYTX!.5D8Q*3=A6*@+ &LSUE&J_:-*-P23*56$2@B
M*W/Q'8KJJQ?^)6..;3MK,2UKQS29#4Y3[*X-3G=="-]I&X2^NG]3J?PJH=9I
MCZ;NOD9.W5)R!PG@$!W'\A/D11%*60#.:W(V?=8.^C5S0N\*RQ1\Y613 EQ8
MF,K*BG5%R XU3I"?I,ZS3$00@*65"("1IDUM#Q%[0$THR&:0IJ+<$-F>1S$^
MW=#DUX@V=6M',@O>I. &65-8W2>PC@#U5_#Z/ O'R2TS-HBV>MZP J-4^L_B
M@/Y!C^V+%SDM1=L'@WO^[X&F3]^BE[Y/_X+K[\'O?@7JMGER:/-6O$84C  _
M81^3*=>1PQ+A)PN#/*6[4,@RF.AGC)T25M8XK4? O_ED)&QSD7"G, %>(E D
M*CW!NAC77QBF[5[7TF:%M<-@5FISW$UP0YXZ3B- #<"#R<\U U8:>*_20A-,
M,MCQS6GHH2'>;%A_'M!"4YN0GJ1NK[=I<+\YA.[U*&-8Y3VI))T&86J/VC)+
MIT*I%;:LU+)9$+#9LE7"DLF2S2$K5G;&V'TPN&?='FAD%AOZ&7VTD@]/&V&"
M,*@"6=LL.+3K,]RA2BK< %PB;:X:4AH7CMA+OS:"7!A%5HBK9BCYIB5#'7NI
MQ5 H5CN!3:U1($#EQ>[9II6TKU++B]B>O J'<";L>T  >9C+X9&JXO@E3 Y9
M=&25DRNN0F_("Y+UA B0EZ.[G\$-0,/4;HN< 53 O.'[@1+)_VI$V2204&-#
M+<Z,.+"*X[@DL7OLO_?".+M/R,39(KX)LWV2>5%&\TUH-VNW#<E48 'PW2F
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M[-GT6$SUE!R]Z+3%FQN6JA<'B!04P2&S*):_A[6K]Y%-RCCMO1F[UILSXCC
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M"^.,NB&PU$&QB&\_^\\$I_@FW&PPK6:/LSLO3'_VH@/^@#VJ#-*GBN,TD#.
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M.>CC67=6A%XH8-YXO3 I\YE0?8"Q+:A0NF-G&$2!H9OA8\S^168LI.([)?^
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MJ^68P*\61/6*D^BK,2[+">P((U+'Y'#Q>>E1G<?_&<;!/&9J7+'NHY?2V06
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M:N#<ZFOV#FV ;S%*\]1&VV9M<==\E\ULQ=J3<=CZBY]X[J)D?4CQ'0\D#(7
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MJB9H^>-L$H7--3A3NY!ZACX@+<H*,TY=TF2?&LF%O*7KI$BG$" M4'R+Q,>
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M, []@U.D#,_T>'CJTR,]@Q]R/]2^=#)Q8*G:.SY1*Z ,O3F<PJTAY%GI&_:
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M9U/U+-"WL^ETICE/.P-PEX&GW;$L8KR:.D_K0F?"/AK;.67[B_$$_L*#P%]
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MES@)"#%ITW*@N5H=PF&N&6&K<Q5$J"@$GF?]GW75CTOF2Z>=L_ET2*9&/*?
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M6$/]5)S[3GLA0467TXSL OY8<\,H &O-M4!H<ZF2$;WA6WE+:])7[$@RAM#
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MF_!2:K9KS\KPM -!NBWB:P9)&D3'^?/;?DQZJ0A8VRK)DUS"_"8E4/--GIM
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M+P+GULM9A]/KWL]$)>,B_V@@B*.DIE[FXV+G"&;U)&5N)78TH%5O*.7=09<
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M_O/GG_[CKVF>NY!_GV-%.5A^3F9P41,O^F.!^$_HU^>.M>?Z>FP:ZZ:Z@)N
M\ RIJ]O8J9=D$XM'R7%6U_)-YW&S;[]FI1E";\:D$4S(@W76Y?PK[Q[-)^(
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M7/.3L22T[(5WKQ+\V 8]5L#T%K?7#;]O:_\^UKE/OY=\K?L.A_$CV<[6_*!
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MS:[V6K$)XWW6;;AH%)43;2EH0LVWI*,Z_((=0U\S!6+3[E&RC;+0!%(=C E
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MG,UW=)7 (T'G\OU^Q"-@!P3<I;Y"& M/Q\?ZI7H*+$3"*%.G%/TIY9>]4HS
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MG]9UM5NQR_BMB).X+7LE<V>\6=7PP??5\CW[)"GPF[RF DGD5UD/_"SXK/0
M#6SMJ \?1?''R,T^.X[71/ %S4YA9H7(A,F,C8^USE]H\VN28B<XG!_!X"X>
M:;JK!U("NIDB*VX<O'+2S;:H]A1-'?SPA8@\QV@>\>T+\B*_CD80&OP%,W_X
M &(>L3/D9<R5V3*/<'WF5IJ,0)*%CWQ3($WJ>J]A)XC\1H6-H<I,L1.M]\;*
M0Q+BG=1V5FW:<THDM!WUF*YIMH/Q:"YT,!9R9DS+6Q5_4GV"Q[ G^M9>%<RJ
M\"DPRQL AMOQXB 9;9.\P.79%2U*GJL=/QKZ[Q?PFU3_/%Y@30B ".MVKJ1,
M_1\G\XA31$91/K+6^/+2#,Z'F]Y<Z.(P&T4BJ@$WCCF?"@=E$MZHZT;W4!4%
M6W2O29U!F"=/07M*WD1MWS+3[(?YZULDZP$47$R;[!1L>S1]K"QCSH/'?%7F
MRSQ-RK;G#1VI\^1YQPP.HJWEG!MCC?@"^I:Z;QPXI<]DA8\3@F<&3)'BF6C;
M4GU2A* ^55W1TS*;6)>W%3.BOQ/H,Z"4Y2)[-4)E)&];Z25CF8'NK^I['I/F
M"%F.FU1'*RO\Y0]N%S2#! (8/+^QP5B^]P8Q-+P;.SJ>VPL^57C7J!<S&R^F
MXMP<Q[A<0;3@%;@+A,%X66- -ORH9WCPR\8EG%UZ>::GBM=16]0/%!)8(4 :
M?8:_E/G8"HTB!3;%K[5HYK/5+8O050#<*TF?0Y;F5Y68.5N^OGXB'#0&4S#N
M#V_;G-]>;CQ B=B7/*/;3X;J)M =XI=$?Y+%QD8<P^$(7;O$<@X;!<^#,#!%
M, ?VU]=DNU@N!&X[CTB&X'QV-A6T:1B97"7->J!9(#W$!LO"P>*_^<N_=U7[
MMU]_N[SG/[V3]_]#P'CIX>'X59DH=JDRCS'U00P-9E;>]/XL=Z)<!(._/YA\
MW8*,[%_X6AH:GJBGG0LQWEL-EAKE$Y4.\[&5S3JG8V/N54WG8U9/$U'+H(]A
M?'@".*45:Z>2:&R+&E[)/O-0W^RR50XSEXWY*$L2"T@]MC?@>Z&(%F:;4*MY
M'".ZBD=Q:=?<2.%$,@SZHV/WF]USDV<YOE>,+I&TT^L9&\J$/VE48]X3AS@>
MHT&;C"(I[ZFZH@*L&[?!<2]UXIQF!_0S%7@(D5?6(1]V-=BYC;7GX4'3/>6Q
M0_:#>.ITKIM'S:#I'C][SZ21$T&'.+,K9E 4P=] >$5=/_*FMBAJFE(V\HS?
M?^%G3(5387JP2)*R*YE$$0U.5DP2ZPDP*=Y2RC>\DE>K/XMS2PK"KKR^F")M
M9 W;4B'A^ZF2,P?OS:HP$E/<)/=&P\DA1*\*0,"(L:X:%:,2^R@:P;9#:6/E
M%=[%N*[J%NI:\5N*>RMDS=Y#.R,,(,JVUQNT1>86IL*+%E3,/4P8,**N!=W6
M.YR0QE>!O&5CL(UV;^I.I9A+8YA/4T-C91-!:PJGCR,FC$)&@EU-QRCLX LE
M=H0@PY]TG]N(9XR708NFAN417DG,HD_K_)EF Q#&KCC)1A$PX8N#*^20&5,'
M=G:#FVF'PQ#HULYM[*X[YSWRCG*"N%@9EGV?Z0A3?[LM<LRT^IRP,RY/BI%9
M+3+BLQ$4\#392!H:K@KL6-NZRG;X2!IS89BL6O3CDD<$U=0O-"\*N'J(G&JG
M/:4UE;GE4<]P<^@623O8B^*2WC<MW8AAN&_PV*HY"PGW!FP*U\)/#+D^)6\B
M*7PI:ZE^>&-WLA92PM@?>=' ,I,CO:O:&XH[!6*YR!JY\+K*&K/?<5<<^P_P
MQ8W8J+!X9MWW6&;Y4B*A/]/VE5)>7J5-WA0NPS?,%*XV])VJ<BPV,.D"2-(4
MR/-JRNCNW.R*-H>M(Y/%5A+825)T)0!IJ"'W3?-.CJC@M3TK-9E(64&93\F\
M2 ?D,N.=P/RC*#WAFQ#R ]]#UDD*?P\4Q,B^@:^#*_9=O+WWZ\X#8_J'F':1
MEY//-4V;Z6GM?ZHU,_S6 %DE(Y/M(]B+)]"C;\X?-S="WP/T@7?W>#^.6<][
M*R:J3"PYLZFJ>5PLB&I1I]ZAM+USRJZ:\!YC-J:NW'#V^VX@18FIIBNVW+6/
M9[G9QV\3O9/-X"MTS<BNJR+[D-1P*#97E%WJJ$3L@BKLS0WM*G/#IK*IZC;_
M0RO4;5_$_9($VCNR<%&N 'R^7QH[N,*.X][4["FD&6'=56U2C$TH/D@"]^0"
M1]"GC1%32VYV([PYXVCNJI(==FPFP*'#$UF<\H?V&*O=]>"9VU$#H%QLV*7O
MY#>*Z0TC>A@I_@>?T".)_7#L=IG;.8PUX[T @[<ENB"=CXR'(#P.*$:H.R@O
MV*5XVX>7L%U]'EH;(0&7*D<++[A!42<9E<" ]\D>YANO, /G(JT5:.#$X@2'
M0:$M?$>#8=R*3ZGX8O$YK8FG?$'P"3!/2N9L.$;:P=W>.-IK-C7SMJIG.#(&
M)D,J*9/WY._GZR 8*02[KD=++[AR?Y7P;UHB';M.EBNV(?$HA3M '2A^8SL7
M&^\3^^?7I.9V\.UFFP"ZJ 8B-R7N48'3?)-1_M,[65B[:U3BU\DK^R[W#< /
M+W($),<A -+K 6H?^V[4.\I7D:LQN;ZB]LYH)NI%? 'HH:WYRR54\'47>>O5
M6DVU;L+ 2)$VMS/2:E=D9)V\T%X6;C>[E(C.<DIY!31ATHP0=)1IP8:C9_5^
MK&JVD_#8KP]EYC8X?U6X*'H6-3Q_=W@W!( /L[B&Y1@>K6H<)Y@(EX5?Z3I/
M"SKT?BN:61]P(ZBA/VA3XC:FPB^(JF";=%+OF5VE2I_<5<R$N%RVM,:(?%\.
M*1S"+Y(&..ME!"Z>MN D3X"."K2F!PFEP;4RDE]379,$%4&/K:H?/"Z8^H7U
MX-D)";LVXW4I8L"#/GZ+[ ^9"WVC_:VJO^3E2@NH\X,JO/+V\<,%^P,W)&OC
M*X;[[799-U<)!@L]KBG@<7+LO,NWW+G=WVH09L][4H@N8& ]<U)L5C-:Y!N%
M;]6'O=I6#0(ZOHMZ3OA8-_0U+*<H+W9_W]5YD^7ID,KPRO;&D\(3PCVH&64:
MH?PVC]X9L#W6^;;WNKNAL&TU\D8G?*_B=9>-B(J2'#QZ&N3=2%M\LRUH2[MN
M45T^IJAL+X-V<<98E_ T^0+UH3^C MQZS1NA(X)X&9U=G$@*).HJ.V#$D+J5
MT>"G^&6Q3-C_GFBZ+JNB6N6T>7PH9LE>D"(Z+?+X[<.W/\?5@X=#4RF#X@B_
MVUT61?4*^R^['H'3(Z]YH3/TS$&20U7/6RR))(S_E2O2G6\SX]1C;F#CN;<H
M<YK@0IMX^O@6SPWKTZ00970"958:N7BFH)]!K[Y<\@B_0;8B5H)FX$::IQM)
M 5UW<7TU5GY,5;BYCN"-N<IQ+TZ3@K\A7R5U0?>S5/&,7<FSHFB^IX?6B(\[
M0S'#H@A_0!V.Z;JJRUG*25E'KVJBZZ9C;5 SAU(X@W7S6.V?:3)/-PWOZU=/
M=/WT.!Q4D44>,:X\A\/Z;4V3>0?-*_0<4%%T'6GL#6K($$5H&XT-:%M7+<6;
M\2R=]"C$/68..;&)W\YMI&71M/EF5\SV!O0HQ!7](2<VT=NYC2+ZJJZKU[Q<
M^<6N1<;HU1V@"%\B,L<J\BQI13XI^BR9\K>Q'/RV<0W%3SY*F'F1'C;/E@)*
M1"#6BXJAD-,4-P+-PY^AD4%9A#X+ /52E)5\20HZ=U="7'3P).,/M*,6=7VX
MF+.HQ2>%&+M5KW@*FS!8[)T_M,R\AN@5:/ "WU&,>(P,\FGJ:IQDPE\9K^MJ
M>[=KZ_E* @JDE"2B[FDF+Z8B7/Q&62]L,/?'&;4H?:M9&TD!A_Q8-6!G.O@A
M?U@]9J(& "4>E:"7WA$W/15MWN6L-KUG34MU-9&;JIXZ!]ZN\>C*X;63?15@
MON(JWRY,0_T^F8>V([2QR%2PJ<Y,^QR0"7'[R-,@XAPX$*AO'EAE'\%+UX-<
MY G1 +C8C<H6^./8EP_0*466^ $V9815ZN714-((B<0X-YW8F/[%6_XU.1_9
MF\/V2]_%9HQULF-'./V<9UE!/R1-"^DGRSI/DUD63$U7&$W--C=.^()PT@1H
MX^[&J4?<UP8X-C4W1D(1-,<K5G654;I;R&)YM6L@&&O@*CW*T[04G^FJ>W0?
M CT_BT_%>Q ?+PA#MU-E&-JH^9B_T>R!F0S*D3;/.U)422DBZ3"?90ETH:H4
M8AD@*DK<H\S)J$5E7I$$OW= *"<'2$58*@PE%]F;?E7]QNZM+;,<V85O ] :
M;*VQ)482C+<GK^L\73.+L@3\?_K&\Y(X2F-"FBU-\R6@W/Q[E_!4:%D!#@$0
MR#>,87CO*?80.;EA*Q5-EW<74*L#ZP%MY?I5$?TU$:%^/-TT>C"M5ZC&M!BI
MAO!.&1C8QUU1_,\F2==L0ZGWPL^'>=ZS5K.BA <JE;2B:VR(3:O2QLDFPOEZ
M6V9UTB17.;@W,&XQ>;R<I2]!B6BD\H0\?GL9T0KR<&>J:4@2H8]%!;D$C@>%
MNC1+-[E"G4)_CR(6]4''QY]%.T/"B+#IE:P%/KJR2;.$/;G(_Z S(VIS18S\
M)=EL_P:A&!K->(:GGTN+HH:%$MY\87\K5W!D-B?UG&DP4G/\9GDWK.-=9^'G
MA4>FEFDQJ($HJ5PE(&Y4=7YN$T,-Z\\X,3PRM4R,00W$FACBC+PM.2K^S&U=
MT5% /U$W<P=;5KUX!!!\"\<(C@3R/S_ 73"?J0^ YGV_03H<7RLV J"++T,A
M?@'$6",_5Z^+^H[=;"2*M9X*.%<]KW!!+QG1#E+\=YUL7 _.&)8MFALKIP@7
MP,\YX_R*)AG-/AYIPFZ U/MGI$6LMFMP??FX,_0T+(KP=PP<4Q>5?<^QH1O^
M+\WFW@8=;O!-_VL2BKH1/\2LSCE*$':5CA-?Z.O]P= >:),@MC\.\,1Z/?@6
M % FA4(:C[Y _5(84JI;<L&-E,^[=I<4'W=,(T,:I+8-%+N3)?2/Z9DQV#!5
M8&<T]!JZ2]JDN%S5U>/#S[.6#!(@0.$,TLU-;@RYNQ@.?S")"H>JJ.%P,(,'
M=T$\U*B:CP=A)Z$5X>;-4,B0&")8= B?>KV5&R+4H*3U2Y[.O#$A.7)]WQD#
M6*I3D(QX= SQ:>IJE&!"[V$XJH_2H<-SUV8IJG,*B8!.? GOBD23K!*5G1JZ
M3> UO&"_RYL44CN4FRG9]'Q--3[4QM:R53QV_7HD&6LM=JZ467KE6-":(RFF
M:6!ER*X).]NQE/"@BJG/6UU=,?:OM+#BJ-(0BUV7#NE%V2L?>/C=HKX&=WD]
MUQ/(EU4J:8@:=T":JY)'G_#PDCP#36,LBE GAJ\('>_J^.>@2R@N=?I$&,.7
MB,,Z?5;#G,>7E%^=CXYJOR!IP0;!ITW2\ D7UWUID;)]@CAR'>),B^84UA%*
MOS&,I#/0AYT]NUY\H@B]&=\G3<NK^QV7>(" U! XK5?;BGP#=/)FJ&5 "L%=
M4/>T1B\@@FZ>2#D=29^.8BR@(6Y-=8T23_"E5%<?DWKSJ:YVV]LRG>,[S/)B
MAZX3BD429=#K<@?U-KK2=NS7LIP=^Y%]ERS9A\D*O@S^EXA+SB8#4W]N246X
M6?"JIB=XEN:5/7T/TQ'4X6#-IA.O%.(HYB5O>.;Z=8754YGM=X1V.#69X]_1
MBZPB'Y,V/0T+)8*R'O+5NETL?VDHUCC,T+09'XZ%W=]7R_<[MK]Q"@1)$"BX
MJHC$].R/Y-#0V"3)Q+#/'ZI]4LS>]6K9.^JSRP$/IA)L/ :WZQXA[P4@-57V
MQZ==@@5I:89Y(+,T(*@2C2SIZ!(D'-?"&\FWH;5)\HJQ=,0 #T9ULZ,_?/?#
M_SE*F8<*)-F.$J :\[ :P:Y+A\,BBK :V69<9E G>55CG<)C C> &G<?*7JV
MV(P82O.R:5'8"+%$L#!@7*=[$05JS<4Y/HD.\&G5UY@'T1CZ>JIIPM^[[I/T
MRSQ--;"P6D6(;(%2O"NNDRVK8CP"B++?P?SX5"?YS-!>=W0::(DOH162C[R
M#OFT*L<NC/!Z ?E>%E6I YY\@M-REK</?R0)T.O#P*R 9$R]#/!IZFB48$+[
M^7 LO5BA'[[[_L=Y6QNJIQ\Q18!:5"//PY]%14/""!_5IDT6/ [!17P%-V\U
MSID'D;:8A+6 CO1G]%8H+<8\F\9R;M?C>)G%,"=VY;*H7FD]S]R3O<^J],,!
M3Z96;#R'/Y_V)3OJ:;J^+;-=T]9YTLR$%U"42$>JCRX07 -NWDQM#,DA]$F$
MA8S8:L5790$A,K-N&I9[@BV-1]1L!;%XBO'P9BAF4 [A%9.ODJ+X1$O:YNG<
MU2*H$$GF (<C@DJL7%G4X>$^O#GP2P.7L&97[Z_RHA@/-(9P0\[[SB^/1)(E
M2#?>4K$R:&C%(X88!;83MGVR9?H5$,->!&D7:%AH]?A8-;0T+)?P"^@?=/\Y
M*9,5QLW=T[JIRI(6U]4&ZHCS8K#/[#A,TM:EN;N*%UT5,78O25X<%$8-K93Q
M/!DJFBJ.N)6C.YR=9K%%)/AR=9DR@QY?^/]\BIO#G:'"^2(ZL3)[7.I*O,PR
ME'GSD;$N\1W9''O.2U2\RR>D^A'H2&1/HG6-6WYP@"]#5>,$$4 M^;)NWB\!
M NY&18POEGA1%O/H@<+K 6VD)0KP<.W^5IQ"'][ NY.T5;UWK;:.,((DHG-!
MU'._@'1?I*Y9Z10_T)US_VKI6TN>"W:5_^](+TXGE)(^%4XN_%-?HIT+V7*%
MMZW;SC_!VT5],)SNE>C%R%;],190,;ZJK<))US3;%4R5UX@:VMR6/W>@2Y=U
MSI;["A:^B)CV;>[KFBXYV?<_?/?#?WSW?W[\[MNW)OM?I_O05P@P<$^;$PP8
M%&.;:H(T62R)($YN2Z*1)X(^/T/4%TCW"2*_$=%W=L*YTTWM4XD]V/YR1UN>
M1: A0E_M)U@,C "/M&-*U?"RK_;G9SR,YM70ZT0IG?Y"[+<HNIO> TVK59EC
MF.!BJ8WVAET(779#UQTR'$5_S%9:]C#0,T8CQC5X,J/VHW^2E/J;]9PCZ0$V
M $:]:78;_C#R&R!=_Y2\T!O*S(H-FSO9S%-H&NTPT_&8(8XX:I >_*!1)$B2
M $W2$;4<+C&LH.,F@N5(F2[1H->:T0<=#.T'B[9U"R(1%@0(5.;K08*F(A+]
M?C*:7?MF-%%: 9=PYYQBMQY:-D-/0EU[(CN8EY#@Z$4.)HSEY><VD,G>30MP
M ]9TS0:2O]#;,JTVU+5<>DTA?("UC6).>T=OG_U.-H,+_([QM:MKIG]9VHL/
MA_U_L<O82NP:0+H,;*W:TG7[/<OWHE>7D,Y5!/]PRJ346J6"N(X:'.O\.I5T
M[+H_A<2C^>M@;#"HJF!M5](]U$QVSJ'J.T+*!]?8G7#1/7##? ^[V\;*+N!9
MQX:WK9JD:&[@W3;-O3==U9CHK:.]"UK';IQO'@X#RME7]-DF:FA/6 >B]3@#
MS^9)BEP?%A^<<[?\5+W0N@2K!<-9YSHSG63"N;<'QS+B:MAU);RO]088[P(X
MI"W+7<\KC=#NI<LTW6UVB*&C[R)0'G!3U6W.7ZW]MP2-!K.(.B+X')5H9,B_
M>(C&?T>V9:<P;3_[IHLMN/7+X2^6/'D?P.47R[]7S!;YE4T\0+2ZY/!'-/M8
MU;_ )94_BWVF[;K*7*I^Y/ @2P%H0+X!O/UW\(O?@39Y$<0EN)(H]K;#"[]X
MD]S@%^)<($\D'OND.('$0R__&]JD=8X>)W"6XOC8P.ZK(D_W;)@=QM\]U ^M
MV_T8<[@CJE6/AAFP1;H'A3-@+B%IUR-U' OY&,DX#.;CA1W2?AX8[572Y&R&
MLWM<PWZ5^<UK;4: F[>;$9P<8?0($L271YUDS&-^C@A,*WVV'(/>A,W)YU+F
MK;ERXWLSS.';UZ"+S9.'3KI?9:T0W];G5PV\7+:-=B6=#5X>4K9ZB.QMR<QJ
M#(<<#&64W0CT(UI'VV4C9HRPA2=#"Z-D$-K.N"U3B#"G-Y3_^[2NJ]UJS1&[
MP7&4/^_PV>MJOW@M:>WTODI"I.44%,RK1H,\[TF%5"Z$S1G7V3:9>=?6-4N&
M(4.3N-%[S3V!8_QNT$$<^=#E/+QO3BZ,M3; ;PA7B_;L")-"?WL<V/6P?:^2
MX;\2T>6_XQ_H+FX<3ZY>WH/?O3\!< !,#MHL2AXN=EM^3/+ZUZ38T0]-FV_8
M[LRFSI7*..4Q2(#<QM]'[FF=N^_A^ %^^Z9P_RX)KZT.6,9+]AWR A\B!81H
MI16\/2 .0U' A<Q(<^6P=^*U:HL?CGW].ID$[?/EQ H*9^%\S-]HYLH LNVP
MV($;-EHL6&1CTLF%L<,.\!MBATWWV?]<[]DG&X"K8M;$0]Y\>5KG=7:?L/O#
MXH7]!7#\ !A)X,BG> BP&T9*88I]+)*5:R7W*!,@39 V0>)$44=G:I\^41\@
M_X)/Q KL/XV =-6?4N1A#^$'"HF@-/N0U) .ZK1C93M"1<.X)NKAL.V[IIVY
MX$\674X6VXUUJTN$^3C?*;J.HIR ]E9!>=_8+Q-#O#F>(\:)),@Q95V[6E:D
M6J%5#4=J XYPL8BA4 -;TMB8_<@N.#1IFR?ZUEZ!3WC"%JH%KG6;).A<??*"
M:!^]P-U5?I>(#Y-_P:?)5<RDJ:\GS<']]H0Z"_;F?%_G*666&2]HO5@^LEOQ
M%XJ_=1E(^$?"^A#>":ZCO!O!/\5+8_$P8]A)@XR'RDZ]2LHORE;SOQM#T\XH
MC1]8:AFZ(6<G>\'OF/?)OMOP7VA1;<52_9VF/. UR^'9T25]V5\<A8H"./6!
M!#\1.8W(I^)85NV'XS1!A=NJ&*5UTM#%$MXD2OG&9]VB1%/8FE3CF,#TYM#-
M#<G%7DA_I+H]3G@,T"[,_I> :)?F,:\ PYR'\UD\)D4"-<@NT[3>Z;!QOR;\
MUH:P<A54/7H4]H<S%UJ0(H(6Z8@110VC"SD](@G&0Q&;SKRAS-D"#!HNP .^
MM>H%FA_V.W>LB(B@UVLYZ%G$WT7<YP9XLCSUCY!!0)WP6+0_$AY[\+2F_Z2)
MTU&H-X:#!LH00?N(\K>.WY"ZA\N08=!UM;W;,:N['_AGC8!F38EJ&]_NM0S=
M$+*3O9#'^6W3['HE'^YK*JH^\GN/,V0%._:J8'1=Q;TOWL$^R):AC9&"T(_X
M66G.JCP-.U^T'>V!%]W\+6_7^/ F\N=GYCO/^TB$,/9Y(QV3_XP.?O8#(XW&
MBWX0"NH$R//R1PJ3X= DC9@'?=1,L25$SY=UV!PCC.<#0YM=+]4#XF*I*CA!
M.F15,GO-DWJ$-/B5 P(A@0Q!.C G%"6B2,4TB29P;-I'D\45\G3A@33^:ADV
M!6(_<KTELB>_?XB^QO$>6F-#;!E:&B>'H,&ITH6S6/8 O-3-=M#'!64Q^[AH
MJF_<A[<ASOPN+;\\@JKHKFI_9LNZ?EHG)3P"T,]5V:X'\ 58)P+[.=2A3: *
M-^M'-MC1DBL4*T_:PYA=/2-D$3X9GK;VZZE3-[3M%URW9:_'T8B+%8<V_)P'
M,R152<Y6+%\12.2\)JKV1'0@HD?,NZ*#"?/"Z.4VY+G.E'Y;+@N>H*<>RIV5
M<]A,5\U)USYF'HJ= T/D/D:[LV#.15!5EIU[R;,0B .9: YDQ/VLZW1.=RZW
M4BSW*0??P38_N*RQ[>!@][6&A/.6^ATX*MB7.7)#S"[FPCVQ?,"B\ IPA^T$
M<,<"++PR94/"+>$)LD)Z@1DV\2M*A)-"QSQ>3?O4")(C781,5"5-Y]]0XEP1
MAEM"4,R C8?F+R.JN6!KHC4_ XP-.P?F<O(P&O1.@Y<KA?O.YX464&=#[N+.
M@$KVD<!0WXCPPG>1(RD\'-F-YT$1A(HKNMO!) "DH4U>)@7ZC9R)D]@63F[1
MFGO3XN5.6L9NS'HW@^%<W5,JO5F?Y[$,GJ# W6 (&(%$]+?ZR/D'@8KAA4<+
M[M]UN7/<M549%WR>#'1.=WO.P)AKO<YJL/7RZ>/EH_\4[EI$O+-W@S"F\R$'
MP40G@\*8K7Q%EU5-KXL*HXJ'8N&TCH3W)**K+30N^%/N$%OF4^XX082[2AB+
M:EH,S\';Y)F$[QQP8KY,#3 =\$T17SZKY:ZA^,"9X7A4J1N1]'U9RFSPV_(P
M]]6U<CK"_!DYX[HB75T@09P=W$3EV4/Y!_S!>A\/K=*CA6-H_D3B#A<V3&LP
M-!* "_^-PN#9F%^8?;ZBUU73+I:BZ(TSEECU!_M84B""! $:F)#/J<2\+8[E
MU%#I-!$%T]Q *5*K,QIKKX(=S>^5LE=L^_F$%5C#9:9\N+I]NADHMZJWB;?+
MZ:,P_50&&Z$$>%O^(R^S'M2(7YKL[( >I-<E]MQU<F$QS;S\ADTL_E1737.=
MU#4FW&T@C&;@Z@$=2"IZ  XG!!F=RZNZDQW[96^ ^X ^6 WPI6<)."\LAQ W
M?6LJ7F*"AQ6+1W: [<!0=58@)';0E TSXQN)[';/]- *J.:M? KU@DI]DPF2
M[Q2^5"NI7BBT._834,:<82IIQUY0LX5B7W!'RCCH?#BP\= GAYFO')"5.^L0
M:YEF/WSW_7^ZIH$RAA-A#/,RFUL@=2'^HQ*^S14G%]F=/Y5SNZ[GR2\@8J+P
MC//0]ON"9BN:#?O^13JW:!_1#V$=O]/_;^$R:!H7!'W2#"H6F;'5=N\/[\$K
M0KI"TV-X?UR<6+P_?J8#RO\JKU*HG0'Y-H]5,<;*EET(YA6I3I;WWO 9]6YN
M#"4,<AXXG/7(TD!#17\BU_R94=+'5[$GW/ZD%9U!SX(6)S NP$4KU@-9CNAA
MT<,D/'$M,9(MQC%K;FD3Y12VG*  WE,%;#A(@$ P<D>T((H/%"M5U7JJI08D
M'\<O/98M^_(:(XI@M]L#8U]F&4RJ9VB'?Q?W*_G H/(R)E66CFI,'"<9B\EQ
M"E$'SR+H XT=7A)ORP^;;5'M*;VB)84B&,-GYB$H6VZYB^<EH8(P>>:4'<?J
M&8"V31&*?4\X5LA!;F;CRUJ@OVA4&;TQ=4,*I/:G*A5B","N]IER#&E]B1R.
MP8@ T<X2!1 \7^5@Q,9&;&<I)'!$?P _C)7I#^<BTQ^&9/I#;)E^/U:FWY^+
M3+\?DNGWL67ZXUB9_G@N,OUQ2*8_1L*S;54BO#\:X++5L=W/I9;>X>@=-HV=
MR5!/UU!=*<\PBKTJ <4T_?>.F=<CL'KTCHC.H'6-GML_R)8YY<<)(B X7+5L
M7Y.:F;7W=;5BI >\G;(]!*;)'F>0VN)BPU" G]^0QMQO5?V%V9<B&$J[=*AT
MC^ZZJ?O#;<M$T))A8T2_U2ERVE7^#. 4Y[!O:'.^#(]+R'W,5R6"WI?M755"
M26)\F674P6LN0'*>*NY*X@C-%B?"S&3>$W\\3B+P:9D8D42L?9"P+Q*L@ZU_
M4R$]/55$?1:#_VS.,&L=Y(C9R%]G1EHRF;^"XL)&<AV"]4NWCOR7!TSR^W_G
MM1]?U$#ZSZ0G#?UG+;YS")=*0VI%-VZZSSQ9C'&;39-KR#VH ^]Y6E->10A=
M.\50))GRF@MT3MZ7]#O'A(4>8LQ8U2-%$<X:U4/';]A6D=$R:YZ2-YKY 2;[
M4?6J)\&NAP"3,0/I;4R9:ADEA:!/AE=5VU:;Q?(!2G5U%K,MKY$W!0]RC271
MC(MRE)W.PH!]&W-R&G*/ZN 7M:P8#3UI[[\U]P M>\E&.LSS/C[T[4@^C14R
M23Y!#Y>:'6LM_2VI(5ZO&=BU>&,B6T='PK6.WMR>W#R>25U;%28+K[?2%M6+
M3G^=$&4"HB3?M-4[+2I"#UL>%\!\EO'+DR5IWUV_DL("^N&URCY0C!(QH!M\
M,[RASTX'C5[1"-V874>T6%C7B-NPGR?S,CA"!&'O=+80:L"'X'<2FMG_/A!9
M:\2C5W7&;K+UGL>B-V0'YRJ[W*5)D>X*[F-[3IH\Q96=Y<6NU2H,0F57$<5N
M+_1[-B'LHR5G7^,G4$9O/<]QT/&:LLUM>5D4U6O"! $C.!I';S39D!O2Y-&-
M\)8)4N#E[XBA,\P'QA?5 S95Y1;?UB0!!KU__8/NM7J ;+NMRI(6@-9-RP8?
MDQ[75=VVM-X<A"<Y([\82;+IZC1N)5&2:E0A[X;1?0^$C2"P^ '51XC%OG<=
M+>?@B.FW9<NT"D4H1L*%\%3VKIL;,B0*5+J3'V/=CF$_K!G"=@H("*P:M&,1
M;A]BR'8T$^]1; ]Q8J5C7UY3_AV_260: 8EIQRA$1DP?P:-];8V73LBPFH,'
M>5[:92$L/;1-O%AW9H""*'8C20@(MCX"7OQ0!1>?@Q$+?@&%76_LVOA"BX&R
MT[R166 ZUIG5&[1]I5CXFE=+")17%7D&;W*/+?M_.-8T.P?5MZX*IM_FAIUB
M:=[R8@:3[./COQ)XP1\U6(?UK-,EBO"!+:T3)X(ZX>3/XT'Y9!.FMW\<+^^@
MQK:$GTJ*SO3G\#GJ/]W/P;(K>/M$XPM1_*3[3>R@P6$&76^\(R43]AS0L^T^
M52^T+F&28<K\J,2'+B6Q6I*5(L!1!AS)#G%2'<8Q:E?>)"D%C0I*"JB9_JFJ
M,GNY(VL@(G2"[16[>6L^!?=)^/@QW0_#W ?/,].G2A^"7=NY8<2O>5%,7F%U
M'\F>_2851V1>LN7'J9Y7BM%,>0POQ.G2#6@K?=ZUNZ3XN"NS : \WI!@RS.(
M!C;&;2PZ!V=!S8RAA#.8&JLRYW]_H"^TW#DO.:-R]^J.(%^&2-*QT,XRE<\F
M$L<:FRW<4#D1<&OF'L4NHI*O_MN20ZS=5?4F*7ZC2<W.A2?VSZ])S?>)V\V6
M6<:+D@U<4N%=7 M4?:P7!\L_ATY^#D_'OTC@DWBBPD>)^BKAGR6+DF@?%GVC
MG;9?18[&AO$5M1789Y*\\5(KX(23'(AJ*TX72O)&*';BCDE^7&-<*_M+S7J>
M@5O%PY?#RS(HB7"!CWH1=1F5Z<Q#TRO%R\8QCUO;X(T%Y.8P[/R'B/6/1?6*
M3NA?L'+$0'RZU>T+V0-+("."?D0LP#NR5,D"29<L8'GPC[)(IC%O7S9S!!C0
M9M4 _0<*/.JE#,S*CE&+%[BJ.KJ8"UF>H,0".6P0P\ATJND9Y)M9!FZ(U\E<
M2&\(+_+$;(C/>9EO=IM[1GVWH1E8K! Q\UQT)=+<L:6B>AP8<8(.D82(1DFK
M,A<Q0GX:RY95,5UB 7>DSM?&43RUVFH#$-)=1\)[:DAIT9.?!]DR]#12$.$V
M,TQ)@IC%JA[P-G*<.M$TMG_1'+8A:A=GX62KP:C=EG^O\K+]E?V\$Z& 35.E
M['+DV[]4=[B?(@$B*>"VUM&(N&^-XM%ZC(^637#GK_0\NK<E_O?HT5]R('8[
MM<]&8%"N'IJP@'#^\$;K-$>#&7_]#)DKXBIT66.RE"\%02 K5\L#*&PJR<)]
M'/_T'BF3K:A:GG2TXU_3CQ",7<U'2SKX^L('4P@IK.F:EHTJ>7M'V\42G!)O
MW+]RDR^7E-GX*0!48H8$KRV._9]8$_UWRX]53?-5.1QHQN/_4OW[HDSJ!2EI
M"Q.L3=XNV+P2;IZL&P>@?[;=5^7#=LL:ZK\'&DL^'EO<6IR9%TCL]ED:5.>!
M][HNKN^RY:5:$."V6KR6M&X6R_ND]FQKO;C'"Y)H)$A;D0J)P(3:)@<W],CA
MCSYF[9-@BJ""@TBJ GPB[(S/3_%,@ELI'_ZB!@;<4+-:05,1<H=0"(S6._D
M)<ZJ+=<\@$HRBM&MB:DB<+T[S1%D:&WWT:D5>L<5;5\I+06(!YN.X,F;_+S?
MZJ JSYPD4ST'5]ERHF?UZ#A3&L./^]-E>W3BT\_YOW=YEK?[A[SY,C/+R4XC
MU+OHP#A&)"^I?@0ZGD,QC)'ZL:0DN640^I1/.'S@/:W1IG;!/[!V B%1Y3M&
M/[,/ANXXG:T,ADSDPT3(Q]WS[S1MGRJ97X0ES^_95];L%@/YS\X<8YZ5*@@
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MQK^?LEZ$=4/30'8DHF?\?$\_3X86QH@@F#Z,BL!#!H19Y-L2E!>QELI (-X
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M'3>>:RRW=CU.DU6\!=F+MY^\&'_'C(87F=%P9K!@(]@<7H1^ 06\P/Z#[KO
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M7ZRP$*[)*R3;;P=PTZE&NF--];C_F*ZLSO@=/BH#G^&4F7-<X56Y*7CAA7.
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MA=$29O7]2F)">](J=V8%1^4&VQ(OTLG)1O<D31*&Q9<\7:Z!;ZCN2*EF<J]
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M*/P^24\Q+L[(*LIP^K%(H=Y7W7PH4YQW2C(8,]BEU8Y,H4H>7;1F??(%!)]
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MI+'48_A%1X[1XTW54D2<),NO@-HRG"@25$VOK7B/K8F+P? &FR+4X/<D,^R
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M%0V-Y5A#2U<;M29:"U^A#&CJ/F(*![F0EBVHY5UYB3=)?H-K7#UZ6BUYD"-
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MY[]D@T%/8/YHE.$H\(K,[,U'A!(V) 1CBI]A''(&+"[+X&L@<([S1;&JR%V
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M;V0ON [223RK&_(L@%R%T2E]*]*7%LFD^2*S3=@S,6BY]3T%$U)K[Q>L^_R
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M#,JF+XFN<!I+A*8=[VVQ <19B6,60G==>@M(?2--4=YORCQ_6U9/294NUTI
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M4!^!:9_33QKA$<$13M8"@TB\;S]\@E;MIVF.M1,+?P9@^"\H5?O#X.O-87!
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MFCS%B'>:1<J:C1?]/3K =D#U]O90D <17CU<%.D>KLBD5N')C'J.Z()DGUG
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MV)E*C"$J&1SPAGBS>-%FXZ?=$&@V4H8AC=2G60D&\WT^K/IUFD8W^!D&KLV
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MJAK<"9=)W8@H]_/D<%>>8S)H\LC%P@5!._@![?!/(-J%*$*(?H5B3\-W9/8
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M=0)"ACFT&D*6_(?21??"_KM2*)^PY% KQ'>D+7:4=,R;\ 4$'C+[*R/2NL\
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MJ8S\T 2;1Y2!.P\YHTX+N"H>@ &U.7SQU>&+E_"?8#--'SSG(UUZL0Y8[ /
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M$8U7M-+E48\9QMM]CDPS(BW@#,01E?Q;+PI%[V*2=RT>)VY5;!*7NSC7ZZ4
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M#E<%<_&_"T-8?0HB^*;H+DD#OJF_!%#8GXYJV.PZ4FUX$]&8PRTR #L.@?V
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M$]FS*#G>3L@NK_5N(5W[O[3VU[*QK#: "M*J\E%5+,Y%5,A@1I]3:LI.]N)
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M&6A:2Y.O;;PL-S;,V]%:6M=;LO#_F=(X3SLM:U0K_%4MN-/#LD$&C@M(-!_
ML8%J75-4%#U44V\PY)W=?<HS;)SPL_.,AY/HKH_']!D_6TR.8V^#@V@/5L'"
M<IU7SR^RJ7[I;E]4[)_:L]R'5RDW6$@<<X/FE88YH9WV279W)"3&=BIF&]U]
M'?(+R+70NQA<DQ'AG<S/S35A#4]-]Y?(366=7V[!+!(<8DW9^>(E7K#81.SY
MZ4$G8Z+]&7[N$ Y!NS (W$+ZG(6G0ZT/I%6QUNW*Z[PRGZ6:UEG[ ">LXUP-
M%UQ01Q3^R+%?/5$#F)2RP)V;I+7QF2I1 SZ3-OZ1)L6>0*I@1,1TJD83XR]
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M)H.1EI#%P<I#8TKP)'+XC&Z2JIUOP[\ "1VF7=,3LF'".A$->:O==IVF\ R
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MWB5QX@1W2>@IE;%4OAH*!3CG->8)54-\:K\\9O;+XX3UBE?RA]9]/QABU.$
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MD<8<%VLG?(,Q/6(06&.#9DC&*_PEJ)#KZ7 F62%V I;?6P?#N!QQDGC/V<*
M_=:2*XX\NU@3G*S6G&A:!,\W6E".^$%J2;Z<_<#LS6.2*!AKB2$8;6)2#=)S
MAE")M;W.&")$*P91>_ME&KILA@VZ0=G_#QS]'L6<\&Z>9+7S(\;B%M6=%D".
MEK/:D2YG/HTP%<>9J<)\A<Y9[+1G04^IV&+M N-S;-7C*Z<C8'RI+-G^>FE-
M,GPWBBT/QSGI-;R;60W;;5A^0;IO6KD@3A@Y;JHC7:'X&=%5U^@-%5U;BJT#
MBAX<PA#6T+)2D6%/O?LX,"P.,$S*,&CVK-3:0EFW2V?_K7% ^2!R#O-WSM>^
M<@*'R7_ZMT60].BAW.,2$KY6(JW8>)@#P?FVE:MK=2*Z GCP73/;W#PF$$$9
MWDB'0E,3XPJ##(!'"I8A@7$]]D 4-HV?JY#,3,O+#C@*? 9A%9:^]$EJNH *
M3&!B!N&C$[#EF>^;95\_(K+S7:4IA/4K# GM#;B :@SPD!!JCD<MR=2\2H]Z
M4<E02P(M0*,(WS,CFSX%;]C4>>0I$(G_94_Z#\D017!TD** O-SD#162"C3@
M?#:PF\$[.%!]<\X/<^0B?Z=U%TJ?0B?]:EV'\O'-Y72K/21QS/3- L!*#XCH
M:_!$3L5W0X@%4]E^+1Z+6<AM92CW7IP^'I+:)<: P>P\M8N2[L4\D*E5J'))
MN%\.Z $7'!TD7ZY4+ZHBK 2?#NKQ$!W?6!:;$C%FSV'*$=%;%'A7^\?D*?(]
MWR&^$EV:5QF8KB6!EA;99.W$V#3\S0^]--+G/R6I6TKI"HF^'M9[7X.%%@E=
M+<3:HQ.D_/&(&>2/R$U(6N(;HJ4?,S,V]3WF/ZMY8M07'I1(U$.=P<0I==]:
M"Z>:P$4S(&)QCZ^3MF2$'#%VO\S2HOD4+":VKYP(>5.J[80QM<^4*"2]VH"T
M/P44M<C_::.&+(CCH1OT1/]&A5J<SP:F:/ .#I:[<XB.,:<&,Z65-$#^IX.2
M;*+CMTBH:279"CXF57((/AT4.43'S\EAN[HOO:K7="M?1TJ5/QR6MLT_>TX)
MN_X#JO/O$(E9J<]['"M="\&G@[H6HN/GQ##@0-#R=#XX>U4I)?AT4.00'3\/
M4AH:&RY-CD\.21VN*G0H?S,LV50Y<8YZJ!E4UTZ,5I@9M+-E*7?-[@CC6C!
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M*& G?7!("JO5T%L]&" *(SQG<"-R#00SP$VF.<ER(_]&0&!S#.5NG"S1!4,
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M,!Y)2T$/70T?"-[Y$3O:$15G/&A/'[1YJ#Y5X;=4U$N<;94US*68:*8G^G&
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M@K5^A7'>N0:LY<0TT#M-FY8H=()R_U,9"AZ^^P[HEF,HIY:!AFBZ?2$8W$[
M\U)UVOGA;-O1VKUB1.>4M^SS.K[318UZ&K)&?5+WM>[[D>JSM2C+R=C:"V6
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MA*[CA-[I!,W9L+H#,OS(#7!$-YPMS[:W[M!JAD39QFS$I[QM*;E4*[DCQ(#
MHH0@1MD*A=2"I'F7B1%97K!OED0D/B7<OD%X19SMVG<;C<^E$SVE(- %4F*_
M0$$<L9]2_DTI6K\VC+*@=BL9[1HP!)#KF?9E(?N_)O,: D7(_><*[UX<_G%&
MH\,/)Q(5E@*Q*J38CU&A>.8.\EMZS8%J0EK?:.!I&YIMU_'2C^\P.<6#%_@>
MK9Q@3M%,=CK3YYI6!**FS@-:[;?>B"Z3X09IDKYSOOF;9,.ISFQ+6KV5>_SH
M<VFLB3]S65J=V@N/:)7U,3C:5]U$OXLXGVT1<5AUXF%S6$-!#(UJ<OAAM"RS
M38/T*73(J;N:7"BG:0U8KZX2$=.$\2:4F)*('=Z08]EM8?K8W(^^O'-"*@S8
MCT;CK\W;*<5?%99K562?#U"/%FN'(F3G!$F*\!F9A),M)0%3CNC/RCJ#],(P
MEH@ZN<IZ@SSFAI"MD#K8KIP(>8>^'1)N)P-/"ILB%DU"[QJ'66>U/+#Q5 !E
M0H@3UMTA2R^.-K#*-U1$#7FG5?T*^O&X-OB ]67I0]LOS;?ME4FG+=3S%V@%
M[3' R1/1,$D90DA@WBXIZ2 (U(N1VE^B0V5GU,#2ER2 ICNBP 6"M WE:2D;
M] GYJW6,O,F.FAJKK(&-0M%MXR+0F;-*V&]&"71=V%42T:<NBJA]]T0/E#XI
M5N6L$ "HAU=#P(J1:""-Q!Q=+8O2&A# /<9-;-],7Y'$5.VBC^\<LGE#<+*=
MAJZ"H.1_">MJDL&JX,30<G!!_U6#+FU7+DH#!**-: A)>0SK5R\&16])1UQ@
M68HJ@ 1[^55OD#IW&,@MOMUL [Q'Z#'&[I=CD\5 J2],TQK#(T,C5@S&Q90\
M8:PY^R3 8099UJ'_#3U'K$"NQD6@+0H=BC5C!B@7X8R5,K#:7*_*"L"V=^O;
M546)_FO7LF7,@Q/%Z4&TR"3^&ERYUR%2#3+TZ^ Y!&J3FIZ!9KL.AK/U$"5F
M/2X/--9H>%ZEL6(T-F_@T>(J-BTR1'HU8^9 ,XUVYJU>N%2,4\N5 NWO4BWI
MQY>O?E)22&H6@ \WZ:DC=3@Y$*IU\W+=+G@Q6N&T-&0Y1P'KH?+@D-AV(]\&
M,(9BQ3=A4_^Q;&N[BR&S'4)J @2XRE?J/LA2W8!-?N5CE\UCNB9X^XB#)'V8
MKS'9*LC4IC6&@O)&7 !9XJ>SS-DC8%5RGG8<4$BH@"9]W;)E#"B%P;+P*^X)
M;@A6>)5#(S-QG$(,!,<QWM![SA:W;*KQ]H97*!NHP$68P;I=W5  WL(0L;)Q
MWZ]1%5,&?8^*]#LK:GND]HA#?&RZGO)LW=Z_234HT;>@]93U%)0#!!_":(M<
M?^DCK_&)DJ:0<&T8#T@C-Q[I(T9*Y5U2\L9?31<W$Q7G>_&#'B/M_&"&R[9Z
M>I&-YV%#^&4JIXV.;B/Z!X+HW\@574DMU)_*J];I\MS,;2[RS#72T=.<\OJQ
MHI\]#4TB;QK6G=F:BJ4/X<@8R@C1S.GJ2FTY*>@W:$E/Q5 0$_\IR0,$AX K
M>>?$%)WAZNSOLR*NV3*/RM)3XBBBYY*2.N9W'1E'=4 6<R,4E!\JUEGJ,W+C
M!1:FR,@_5C*+@=MZW;Q94G@T-K1 MQSVFAZ<#55@^?FS\,XG44Q/?^]$<9[8
M>N/L%YCJ9Q0Q]&?UB<;F=H-WZQCG%(.D,#BZ0%,)NOU&3^,? .(\JC^^?/7:
MFKXC!<SX1(\J-30<]<+&J)K6T.39(=[MMZU/LK8>U S6LX9X"XU,U9!#GKZ/
MJXWVP-2@$WRL>08*HP.^CZ>ZVO./D/[G(XKB;,*/CSUIW=3DGL"IEIVHID9I
MT@O_20;,;,DK,OSX[&QGR_,NT'>8L*F% 7U"Z3)^E(M&/3%C;/>Q,5N'=#JP
MW7]LLMV"LD6TQH%WZQ V>"RZ0DM,T)0^GO0OXH7SC?70._4]H>B;;#")_;_E
M&\BTW6.$*G%KM!]XY;5M1=B8K)VSVQ*=3 .[+V%E][&)J0[IE+L%[39.S/V8
M!_T^[]/D'2V #$(I-I)=:VQ,(8W#G,3M V_MC*;3>>BYZ;L:L4Y<^6PBQJ31
M+(DC5C)%.76!LW/-R)RR+GU^TZ&*V/WR(?0E&_YU"\$(W[&.29;S86L7<8<]
MUFYW+%XW<]V$$'JDR9+N'*_1'&W9>YT;%=WW\7R/0\?[G*1".X,I!:4$!VBK
M-440E8US)5+(=UW36%8CHT-ED\I=- ?_:>D>O7YZO)WFDVBP!-C$.LECVLS1
M5@ )P@NI?^-+47(%S(.V5),#U')NN!)0\%J0^C73819^GI^2/IP\1>AK0C?(
M=E$I1>1_"ETOJH=Y$1Z,90?J7<5TU#*G,Y+EM/(&,(!?\;9WK0G)YG)(S)<G
M?O=EJ*9>9\G:U'8S'2_%J?VHE+1<G/JHDD5?^6@H2*V>%B:Y,X?C_OY: ^VG
MKZ 5&77,%TYL_LT:C$S7]7+ =0Y\('CG,R>FO:>\L&7_GVVN6YB//I"!6Y,-
MFW)7Z.I\@Y[B#Z&',I=SXL8).Z24'))=:Z!4DT:5*<-+*9\W0-X*>3.R($X8
M95MF"16_)TXZ,U@N4;=YF8%23P9!IEX>I8R!*$K2F@&J-\0^?0\>THU1WO])
MSH?=O,H@'D1^K+X90\92Z!4-'2J^782\.WK2#$H%DHF^'2ZAA-B 2DL_,<IL
M.7%=DK 0_B0,DXTDA82?]]Z9+R"0&!_ZW5K:Y L?6"8Z\DP>"R\,EYB%Q5 Y
M>W15[I?JTD-]WC01:2I-7(7HGS#YPNK@LL&D4L0L?3)0(I4/KI](;:K;"[7*
M/SI!*@=286W/B"MO#%2&8]28JR!3(V6Y964-O>$1<A-6&E^H&)/32$3?#E<C
M$6(#*C_XQ"QO'#^\QQ$5RF^983(-T7*)7 8I@W*.7+P*_8A5H6>SNF>$_6MK
M]U,3O.&R2GO*&$W\[2H=;XZ8 I"5(3]N S_63,A38_MBLA(?@D4% J7)P:TV
M4,]&4\2B?"Z=UL+*[[_B+I7[8O((]\6$.NMRPP1C,NFAQQ #2)6Z9-.=F*7-
MK8?-I]-M5G>'"7*=B#MVIE6GNM+"@\S"J4.4J5C.X'A<_VFQ/#*R JC>XP84
M:F_[@G-)991M6RFPZ0;4<OOG"N]>>,C/]O"PFSJR7ESCW4D:<513-8%'U_]K
MXGD4K(C-@&A,3"K"E8HZ^H>3E..OIC_%(1^[FWH4#IXCF('@%0A47Q:&FIL#
M#:=A.N6$,0%'.U;$MW!1*'-4YJ2"*=55.A?M2G53A8%RR^*;/N+9(8J8/E\)
M1O8)3Z2,T5<ZX[Z/V^\/U]P87LL+@FA%3<=31O*/>IWE3W#<^ZEB9@S+Y^M!
MBHB:\RFC^2=MZ?#>V:#K-2M+377?]FCF+@C&S'7'4\;RSVW')'#WL)T+70,#
M<,9ND[8C03 #R<_G'6D^^?'Z/=[0WP1I>&>V_/#X\M7+/,JCD*BKL^X "**%
M+J"!/I\<5H$?YVV%F#"@MOOY"10HJK <>$ZV#"E5T&,X3[M+@W&2>'Y1$1?:
MCBT5P8+AUV"C*:N$Y:5UC*\4#9BT?^'/%H*04*+3,!Z6H4O)INJMNP!6\1>P
M<XYD#A;:39-BBYZ*&>FQW6;/<S-Z^2L"Y9NH8UF $.#JWK'YI8K"Y*^71H4C
M$)?Q3Z3O([D8/!>#YV+P7 P>18/GO__?/_[Q7__SZ=W'7_[W?Q8?O:ODZO?G
MIS^>W=O7/[CO7R[P[^NG/SZL7O\T65Y]C)QWT;OYPQOZX_O?;X*$O-S$N_7J
MW__YX>?MZM=_[^>;Z?SEJ\V;VSA^]35XZWV:WU[_]-/^"F_^^.73=>@&GYX>
M_Y[,E]&''U?N[\O-;GUW_?'//W'X]?UOMSA(-JL_O@1?@J\_7K]<_;28>S]_
MG+]W__SXRS-^FM\\O+U[]?E??TS^E<P^O_[Y77RS_GESL]C^/4W>_>=?R_FO
M\U]^>?G+[<_WT>MH]9]7WUX\_O'F-[S[^=4/WH_QK\LU^1J^^OCTUO_UY]=>
M<O-F_O5F%_YK?O]V]6,RO7XU?W5[=7=[_=%Y\>/7]:^[;Z___^3-?/;*^_&'
M)'C\-7GQ]._)]%^3+R^_ODV<GQ]_>_EI]^G/\%L<+[Y.GG9?_,6+5[__%,^<
M^>S7Y><_?MC_$OW[US])_! _/_[V\'+M_?#Y!^?Y=^]#['U]_W9"=G]<>YOU
M#M_.PKMX_?!RZMW__/IQ_XO[VP^?OVY>;/_WOZX?Y__XQ\4@U3!(__L%@XTU
M 60__1]02P$"% ,4    " !609U;ZDC% -C6!0 05#\ &
M@ $     96$P,C<P,3(U+3(P9E]M;V]L96,N:'1M4$L! A0#%     @ 5D&=
M6YU^*W2YOP  ,DL( !L              ( !#M<% &5A,#(W,#$R-3 Q97@Q
M+3%?;6]O;&5C+FAT;5!+ 0(4 Q0    ( %9!G5ON5<LG(QL  '>9   <
M          "  0"7!@!E83 R-S Q,C4P,65X,3$M,5]M;V]L96,N:'1M4$L!
M A0#%     @ 5D&=6TQ;YX!I!P  7B@  !P              ( !7;(& &5A
M,#(W,#$R-3 Q97@Q,BTQ7VUO;VQE8RYH=&U02P$"% ,4    " !609U;HILJ
MSE4'  #J)@  '               @ $ N@8 96$P,C<P,3(U,#%E>#$R+3)?
M;6]O;&5C+FAT;5!+ 0(4 Q0    ( %9!G5M/;K&#NP,  )L,   <
M      "  8_!!@!E83 R-S Q,C4P,65X,3,M,5]M;V]L96,N:'1M4$L! A0#
M%     @ 5D&=6T6/=U'( P  &@T  !P              ( !A,4& &5A,#(W
M,#$R-3 Q97@Q,RTR7VUO;VQE8RYH=&U02P$"% ,4    " !609U;4ZU@&NH!
M   *!P  '               @ &&R08 96$P,C<P,3(U,#%E>#$U+3%?;6]O
M;&5C+FAT;5!+ 0(4 Q0    ( %9!G5N/L.A8A (  ',(   <
M  "  :K+!@!E83 R-S Q,C4P,65X,34M,E]M;V]L96,N:'1M4$L! A0#%
M  @ 5D&=6\[GQ3, 'P  (OD  !H              ( !:,X& &5A,#(W,#$R
M-3 Q97@Y-U]M;V]L96,N:'1M4$L! A0#%     @ 5D&=6S0_Z<:'EP$ EE<6
M !P              ( !H.T& &5A,#(W,#$R-3 Q97@Y.2TQ7VUO;VQE8RYH
M=&U02P$"% ,4    " !609U;9#-?TZM9  #:6P  "P              @ %A
MA0@ 9FEN7S P,2YJ<&=02P$"% ,4    " !609U;"D:'#?@0  #R$0  "P
M            @ $UWP@ 9FEN7S P,BYJ<&=02P$"% ,4    " !609U;_W'O
MCE/H  !_. $ #0              @ %6\ @ :6UA9V5?,# Q+FIP9U!+ 0(4
M Q0    ( %9!G5M4B,X'Q@P  ,(-   -              "  =38"0!I;6%G
M95\P,#(N:G!G4$L! A0#%     @ 5D&=6T%76\P8#@  )P\   T
M     ( !Q>4) &EM86=E7S P,RYJ<&=02P$"% ,4    " !609U;#T_9(^4*
M  #P"P  #0              @ $(] D :6UA9V5?,# T+FIP9U!+ 0(4 Q0
M   ( %9!G5LT0I'H!@P! .,: 0 -              "  1C_"0!I;6%G95\P
M,#4N:G!G4$L! A0#%     @ 5D&=6_-%'M4"1@  EH@# !$
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L &UL96,M,C R-3 V,S!?<')E+GAM;%!+!08     %P 7  L&  #<L X    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>164
<FILENAME>ea0270125-20f_moolec_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2025"
  xmlns:cyd="http://xbrl.sec.gov/cyd/2025"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2025"
  xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:mlec="http://www.moolecscience.com/20250630"
  xmlns:srt="http://fasb.org/srt/2025"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="mlec-20250630.xsd" xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mlec:OrdinarySharesWithNominalValueOfUS010PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mlec:WarrantsExercisableForOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:SharesIssuedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:OwnSharesHeldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:RevaluationOfPropertyPlantEquipmentAndEffectOfTaxRateChangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:SharesIssuedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:OwnSharesHeldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:RevaluationOfPropertyPlantEquipmentAndEffectOfTaxRateChangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:SharesIssuedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:OwnSharesHeldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:RevaluationOfPropertyPlantEquipmentAndEffectOfTaxRateChangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:OwnSharesHeldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:RevaluationOfPropertyPlantEquipmentAndEffectOfTaxRateChangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:OwnSharesHeldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:RevaluationOfPropertyPlantEquipmentAndEffectOfTaxRateChangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:RevaluationOfPropertyPlantEquipmentAndEffectOfTaxRateChangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:RevaluationOfPropertyPlantEquipmentAndEffectOfTaxRateChangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">mlec:MoolecScienceLuxembourgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-14</startDate>
            <endDate>2025-05-14</endDate>
        </period>
    </context>
    <context id="c75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">mlec:MoolecScienceLuxembourgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-05-14</instant>
        </period>
    </context>
    <context id="c76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <instant>2025-05-14</instant>
        </period>
    </context>
    <context id="c77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">mlec:MoolecScienceCaymanIslandsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-05-22</instant>
        </period>
    </context>
    <context id="c78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <instant>2025-05-22</instant>
        </period>
    </context>
    <context id="c79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresGroupLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-05-22</instant>
        </period>
    </context>
    <context id="c80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <startDate>2025-05-22</startDate>
            <endDate>2025-05-22</endDate>
        </period>
    </context>
    <context id="c81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:GentleTechMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-05-22</instant>
        </period>
    </context>
    <context id="c82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">mlec:HoldbackMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-05-22</instant>
        </period>
    </context>
    <context id="c83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresGroupLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">mlec:OrdinarySharesOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-05-22</instant>
        </period>
    </context>
    <context id="c84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:GentleTechMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfOrdinarySharesAxis">mlec:OrdinarySharesOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-05-22</instant>
        </period>
    </context>
    <context id="c85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <startDate>2025-06-16</startDate>
            <endDate>2025-06-16</endDate>
        </period>
    </context>
    <context id="c86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">mlec:BioceresSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">mlec:SubsequentEventsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">mlec:BioceresSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-07-31</endDate>
        </period>
    </context>
    <context id="c88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">mlec:SubsequentEventsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">mlec:BioceresSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-31</instant>
        </period>
    </context>
    <context id="c89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">mlec:BioceresSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">mlec:BioceresLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <startDate>2018-06-30</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="c92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <instant>2025-06-16</instant>
        </period>
    </context>
    <context id="c93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresGroupLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-16</instant>
        </period>
    </context>
    <context id="c94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BusinessCombinationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-16</instant>
        </period>
    </context>
    <context id="c95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-16</instant>
        </period>
    </context>
    <context id="c96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BusinessCombinationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-16</instant>
        </period>
    </context>
    <context id="c97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:MoolecScienceLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:MoolecScienceLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:AGBiomoleculesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:AGBiomoleculesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:ValoraSoySAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:ValoraSoySAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:NutreconLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:NutreconLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:SynBioPowerlabsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:SynBioPowerlabsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:GentleTechMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:GentleTechMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:GentleFarmingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:GentleFarmingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:GFASMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:GFASMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresGroupLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresGroupLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsBIOXMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsBIOXMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresTechServicesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresTechServicesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:InitiallyAppliedIFRSsAxis">ifrs-full:LeaseLiabilityInASaleAndLeasebackMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:InitiallyAppliedIFRSsAxis">ifrs-full:NoncurrentLiabilitiesWithCovenantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:IfrsFull_machineryAndEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:IfrsFull_machineryAndEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresGroupLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">mlec:ProFarmGroupIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">mlec:NatalAgroSRLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-10</instant>
        </period>
    </context>
    <context id="c149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">mlec:NatalAgroSRLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis">mlec:ProFarmGroupIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis">mlec:NatalAgroSRLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis">mlec:MoolecScienceSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis">mlec:MoolecScienceSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">mlec:SubsequentEventsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-01</instant>
        </period>
    </context>
    <context id="c159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:SecuredGuaranteedNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">mlec:FortyEightMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:SecuredGuaranteedNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:SecuredGuaranteedNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:SecuredGuaranteedNotesDue2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:SecuredConvertibleGuaranteedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-18</instant>
        </period>
    </context>
    <context id="c164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:SecuredConvertibleGuaranteedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-18</instant>
        </period>
    </context>
    <context id="c165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:SecuredConvertibleGuaranteedNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-18</instant>
        </period>
    </context>
    <context id="c166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-18</instant>
        </period>
    </context>
    <context id="c167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <startDate>2025-06-18</startDate>
            <endDate>2025-06-18</endDate>
        </period>
    </context>
    <context id="c168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:SecuredConvertibleGuaranteedNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:SecuredConvertibleGuaranteedNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-18</instant>
        </period>
    </context>
    <context id="c171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <instant>2025-06-18</instant>
        </period>
    </context>
    <context id="c172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-18</startDate>
            <endDate>2025-06-18</endDate>
        </period>
    </context>
    <context id="c173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-18</startDate>
            <endDate>2025-06-18</endDate>
        </period>
    </context>
    <context id="c174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:InvestmentsInSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:InvestmentsInSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:MutualFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:MutualFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:OtherInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:OtherInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="mlec:IfrsBalanceSheetLocationAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="mlec:IfrsBalanceSheetLocationAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:TaxesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:TaxesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:InsuranceToBeAccruedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:InsuranceToBeAccruedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:OtherReceivablesJointVenturesAndAssociatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:OtherReceivablesJointVenturesAndAssociatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PrepaymentsToSuppliersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PrepaymentsToSuppliersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:ShareholdersAndOtherRelatedPartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:ShareholdersAndOtherRelatedPartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:GovernmentsGrantsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:GovernmentsGrantsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PrepaidExpensesAndOtherReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PrepaidExpensesAndOtherReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:LoansReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c197">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:LoansReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:MiscellaneousMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:MiscellaneousMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:OtherReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:OtherReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:ReimbursementsOverExportsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:ReimbursementsOverExportsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:SeedsAndGrainsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:SeedsAndGrainsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:MicrobiologicalResaleProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:MicrobiologicalResaleProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:MicrobiologicalProductsProducedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:MicrobiologicalProductsProducedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:GoodsInTransitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:GoodsInTransitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:SuppliesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:SuppliesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:AgriculturalProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:AgriculturalProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:AllowanceForObsolescenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:AllowanceForObsolescenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:BiologicalAssetsSoybeanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:BiologicalAssetsCornMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:BiologicalAssetsWheatMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:BiologicalAssetsBarleyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:SunflowerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:BiologicalAssetsSoybeanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:BiologicalAssetsCornMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:BiologicalAssetsWheatMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:BiologicalAssetsBarleyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:SunflowerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:BiologicalAssetsSoybeanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:BiologicalAssetsCornMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:BiologicalAssetsWheatMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:BiologicalAssetsBarleyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c232">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:SunflowerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c233">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:BiologicalAssetsSoybeanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c234">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:BiologicalAssetsCornMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c235">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:BiologicalAssetsWheatMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c236">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:BiologicalAssetsBarleyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c237">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:SunflowerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c238">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:BiologicalAssetsSoybeanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c239">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:BiologicalAssetsCornMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c240">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:BiologicalAssetsWheatMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c241">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:BiologicalAssetsBarleyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c242">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BiologicalAssetsAxis">mlec:SunflowerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c243">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c244">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c245">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c246">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c247">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c248">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c249">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c250">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c251">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c252">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c253">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c254">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c255">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c256">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c257">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c258">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c259">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c260">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c261">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c262">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c263">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c264">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c265">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c266">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c267">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:ResearchInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c268">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:ResearchInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c269">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:ResearchInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c270">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c271">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c272">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c273">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c274">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c275">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c276">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c277">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c278">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c279">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c280">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c281">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c282">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c283">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c284">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c285">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">mlec:PropertyPlantAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c286">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c287">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:AlfalfaGenuityHarXstraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c288">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:AlfalfaGenuityHarXstraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c289">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:AlfalfaGenuityHarXstraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c290">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:HB4SoyAndBreedingProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c291">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:HB4SoyAndBreedingProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c292">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:HB4SoyAndBreedingProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c293">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:IntegratedSeedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c294">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:IntegratedSeedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c295">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:IntegratedSeedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c296">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:MicrobiologicalProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c297">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:MicrobiologicalProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c298">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:MicrobiologicalProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c299">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:MicrobiologicalProductsInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c300">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:MicrobiologicalProductsInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:MicrobiologicalProductsInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c302">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:TrademarksAndPatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c303">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:TrademarksAndPatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:TrademarksAndPatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c305">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:TrademarksAndPatentsWithIndefiniteUsefulLifeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c306">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:TrademarksAndPatentsWithIndefiniteUsefulLifeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c307">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:TrademarksAndPatentsWithIndefiniteUsefulLifeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:SoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:SoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c310">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:SoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c311">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:SoftwareInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c312">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:SoftwareInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c313">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:SoftwareInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c314">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:CustomerLoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c315">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:CustomerLoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c316">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:CustomerLoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c317">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:RGRSOXWheatMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c318">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:RGRSOXWheatMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c319">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:RGRSOXWheatMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c320">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:SustainableAgriculturalEquipmentTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c321">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:SustainableAgriculturalEquipmentTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c322">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:SustainableAgriculturalEquipmentTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c323">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:FungalBiomassMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c324">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:FungalBiomassMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c325">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:FungalBiomassMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:PiggysooyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:PiggysooyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:PiggysooyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:SafflowerGLAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:SafflowerGLAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:SafflowerGLAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c332">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:SafflowerChimosin20Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c333">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:SafflowerChimosin20Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c334">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:SafflowerChimosin20Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c335">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c336">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c337">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c338">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:AlfalfaGenuityHarXstraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c339">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:AlfalfaGenuityHarXstraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c340">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:BacillusPHAsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c341">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:BacillusPHAsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c342">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:BacillusPHAsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c343">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:HB4SoyAndBreedingProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c344">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:HB4SoyAndBreedingProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c345">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:IntegratedSeedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c346">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:IntegratedSeedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c347">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:MicrobiologicalProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c348">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:MicrobiologicalProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c349">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:MicrobiologicalProductsInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c350">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:MicrobiologicalProductsInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c351">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:TrademarksAndPatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c352">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:TrademarksAndPatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c353">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:TrademarksAndPatentsWithIndefiniteUsefulLifeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c354">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:TrademarksAndPatentsWithIndefiniteUsefulLifeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c355">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:SoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c356">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:SoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c357">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:SoftwareInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c358">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:SoftwareInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c359">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:CustomerLoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c360">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:CustomerLoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c361">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:RGRSOXWheatMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c362">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">mlec:RGRSOXWheatMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c363">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:RizobacterUGEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c364">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:ProFarmUGEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c365">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">mlec:RizobacterArgentinaSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c366">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">mlec:RizobacterArgentinaSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c367">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">mlec:BioceresCropsSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c368">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">mlec:BioceresCropsSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c369">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">mlec:InsumosAgroqumicosSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c370">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">mlec:InsumosAgroqumicosSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c371">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">mlec:ProFarmGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c372">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">mlec:ProFarmGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c373">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BankBorrowingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c374">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BankBorrowingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c375">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:CorporateBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c376">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:CorporateBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c377">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:NetLoansPayablesJointVenturesAndAssociatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c378">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:NetLoansPayablesJointVenturesAndAssociatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c379">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:ConvertiblePreferenceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c380">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:ConvertiblePreferenceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c381">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:FinancialBorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c382">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:FinancialBorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c383">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BankBorrowingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c384">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BankBorrowingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c385">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BankBorrowingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c386">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BankBorrowingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c387">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:CorporateBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c388">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:CorporateBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c389">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:CorporateBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c390">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:CorporateBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c391">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:ConvertiblePreferenceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c392">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:ConvertiblePreferenceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c393">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:ConvertiblePreferenceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c394">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:ConvertiblePreferenceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c395">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:FinancialBorrowingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c396">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:FinancialBorrowingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c397">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:FinancialBorrowingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c398">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:FinancialBorrowingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c399">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c400">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c404">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c405">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:AllowanceForImpairmentOfTradeDebtorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:AllowanceForImpairmentOfTradeDebtorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c407">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:AllowanceForObsolescenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c408">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:AllowanceForObsolescenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c409">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:deductedFromAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c410">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:deductedFromAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c411">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:ProvisionForContingenciesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c412">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:ProvisionForContingenciesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c413">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:LiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c414">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:LiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c415">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:AllowanceForImpairmentOfTradeDebtorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c416">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:AllowanceForImpairmentOfTradeDebtorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c417">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:AllowanceForImpairmentOfTradeDebtorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:AllowanceForObsolescenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c419">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:AllowanceForObsolescenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c420">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:AllowanceForObsolescenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:deductedFromAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c422">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:deductedFromAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c423">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:deductedFromAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:ProvisionForContingenciesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c425">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:ProvisionForContingenciesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c426">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:ProvisionForContingenciesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c427">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:LiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c428">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:LiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:LiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:ConditionalPaymentRizobacterSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c431">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">mlec:ConditionalPaymentRizobacterSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c432">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c433">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c434">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c435">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c436">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c437">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <instant>2025-03-28</instant>
        </period>
    </context>
    <context id="c438">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">mlec:NetWheatTechnologyLicensingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-28</startDate>
            <endDate>2025-03-28</endDate>
        </period>
    </context>
    <context id="c439">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">mlec:NetHB4SoybeanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-28</startDate>
            <endDate>2025-03-28</endDate>
        </period>
    </context>
    <context id="c440">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <startDate>2025-03-28</startDate>
            <endDate>2025-03-28</endDate>
        </period>
    </context>
    <context id="c441">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">ifrs-full:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c442">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">ifrs-full:SellingGeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c443">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">mlec:ExpensesClassifiedByNatureAndFunctionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c444">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">ifrs-full:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c445">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">ifrs-full:SellingGeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c446">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">mlec:ExpensesClassifiedByNatureAndFunctionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c447">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">ifrs-full:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c448">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">ifrs-full:SellingGeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c449">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">mlec:ExpensesClassifiedByNatureAndFunctionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c450">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c451">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:CarryForwardOfTaxLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c452">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:CarryForwardOfTaxLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c453">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:OthersFinancialAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c454">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:OthersFinancialAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c455">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:OthersOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c456">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:OthersOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c457">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:RoyaltiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c458">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:RoyaltiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c459">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:TradeReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c460">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:TradeReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c461">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:AllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c462">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:AllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c463">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:GovernmentGrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c464">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:GovernmentGrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c465">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:DeferredTaxAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c466">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:DeferredTaxAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c467">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:IntangiblesTaxLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c468">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:IntangiblesTaxLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c469">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:PropertyPlantAndEquipmentDepreciationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c470">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:PropertyPlantAndEquipmentDepreciationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c471">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:InventoriesTaxLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c472">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:InventoriesTaxLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c473">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:RightOfUseLeasedAssetTaxLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c474">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:RightOfUseLeasedAssetTaxLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c475">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:InflationTaxAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c476">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:InflationTaxAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c477">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:DeferredTaxLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c478">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:DeferredTaxLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c479">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:CarryForwardOfTaxLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c480">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:OthersFinancialAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c481">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:OthersFinancialAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c482">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:OthersFinancialAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c483">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:TradeReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c484">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:RoyaltiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c485">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:AllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c486">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:GovernmentGrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c487">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:OthersOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c488">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:DeferredTaxAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c489">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:IntangiblesTaxLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c490">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:PropertyPlantAndEquipmentDepreciationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c491">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:InventoriesTaxLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c492">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:BiologicalAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c493">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:BiologicalAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c494">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:BiologicalAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c495">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:OthersFinancialAssetsOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c496">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:OthersFinancialAssetsOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c497">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:OthersFinancialAssetsOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c498">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:RightOfUseLeasedAssetTaxLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c499">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:InflationTaxAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c500">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:OthersTaxAssetsTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c501">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:OthersTaxAssetsTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c502">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:OthersTaxAssetsTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c503">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:DeferredTaxLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c504">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:CarryForwardOfTaxLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c505">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:CarryForwardOfTaxLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c506">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:OthersFinancialAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c507">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:OthersFinancialAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c508">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:TradeReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c509">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:TradeReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c510">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:RoyaltiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c511">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:RoyaltiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c512">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:AllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c513">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:AllowancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c514">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:GovernmentGrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c515">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:GovernmentGrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c516">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:OtherTaxAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c517">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:OtherTaxAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c518">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:OtherTaxAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c519">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:DeferredTaxAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c520">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:DeferredTaxAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c521">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:IntangiblesTaxLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c522">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:IntangiblesTaxLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c523">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:PropertyPlantAndEquipmentDepreciationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c524">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:PropertyPlantAndEquipmentDepreciationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c525">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:InventoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c526">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:InventoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c527">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:InventoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c528">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:OthersFinancialAssetsOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c529">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:OthersFinancialAssetsOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c530">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:RightOfUseLeasedAssetTaxLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:RightOfUseLeasedAssetTaxLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c532">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:InflationTaxAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c533">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:InflationTaxAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c534">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:OtherLiabilitiesOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c535">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:OtherLiabilitiesOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c536">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:OtherLiabilitiesOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c537">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:DeferredTaxLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c538">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">mlec:DeferredTaxLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c539">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="mlec:TaxJurisdictionAxis">mlec:LowOrNullTaxationJurisdictionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c540">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="mlec:TaxJurisdictionAxis">mlec:LossMakingEntitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c541">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="mlec:TaxJurisdictionAxis">mlec:LowOrNullTaxationJurisdictionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c542">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="mlec:TaxJurisdictionAxis">mlec:ProfitMakingEntitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c543">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="mlec:TaxJurisdictionAxis">mlec:LossMakingEntitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c544">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="mlec:TaxJurisdictionAxis">mlec:LowOrNullTaxationJurisdictionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c545">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="mlec:TaxJurisdictionAxis">mlec:ProfitMakingEntitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c546">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="mlec:TaxJurisdictionAxis">mlec:LossMakingEntitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c547">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnderlyingEquityInstrumentAndDepositaryReceiptsAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c548">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnderlyingEquityInstrumentAndDepositaryReceiptsAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c549">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:UnderlyingEquityInstrumentAndDepositaryReceiptsAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c550">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c551">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c552">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-30</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c553">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c554">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-30</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c555">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-30</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c556">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">mlec:BioceresSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c557">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">mlec:BioceresSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c558">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">mlec:BioceresSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c559">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">mlec:BioceresCropSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c560">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">mlec:BioceresCropSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c561">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">mlec:BioceresCropSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c562">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">mlec:BioceresCropSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c563">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">mlec:BioceresCropSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c564">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c565">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c566">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c567">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">mlec:BorrowingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c568">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">mlec:FinancedPaymentAcquisitionOfBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c569">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">mlec:IfrsConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c570">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">mlec:BorrowingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c571">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">mlec:FinancedPaymentAcquisitionOfBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c572">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">mlec:IfrsConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c573">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">mlec:BorrowingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c574">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">mlec:FinancedPaymentAcquisitionOfBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c575">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">mlec:IfrsConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c576">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">mlec:BorrowingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c577">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">mlec:FinancedPaymentAcquisitionOfBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c578">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">mlec:IfrsConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c579">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">mlec:BorrowingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c580">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">mlec:FinancedPaymentAcquisitionOfBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c581">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">mlec:IfrsConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c582">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">mlec:BorrowingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c583">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">mlec:FinancedPaymentAcquisitionOfBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c584">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">mlec:IfrsConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c585">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">mlec:BorrowingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c586">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">mlec:FinancedPaymentAcquisitionOfBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c587">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">mlec:IfrsConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c588">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:AR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c589">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:SynertechIndustriasSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c590">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:SynertechIndustriasSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c591">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c592">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c593">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:AgralityArgentinaSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c594">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:AgralityArgentinaSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c595">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:AgralityUSIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c596">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:AgralityUSIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c597">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:AgralitySeedsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c598">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:AgralitySeedsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c599">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:SWSemillasSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c600">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:SWSemillasSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:AlfalfaTechnologiesSRlMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c602">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:AlfalfaTechnologiesSRlMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c603">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:InmetSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c604">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:InmetSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c605">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:TheoISCSpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c606">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:TheoISCSpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c607">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:TrigallGeneticsSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c608">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:TrigallGeneticsSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c609">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:JointVenturesInvestmentsAndAffiliatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c610">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:JointVenturesInvestmentsAndAffiliatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c611">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:JointVenturesInvestmentsAndAffiliatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c612">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:JointVenturesInvestmentsAndAffiliatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c613">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:JointVenturesInvestmentsAndAffiliatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c614">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:SynertechIndustriasSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c615">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:SynertechIndustriasSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c616">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:SynertechIndustriasSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:AgralityArgentinaSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c618">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:AgralityArgentinaSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c619">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:AgralityArgentinaSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c620">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:AgralityUSIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c621">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:AgralityUSIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c622">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:AgralityUSIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c623">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:AgralitySeedsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c624">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:AgralitySeedsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c625">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:AgralitySeedsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:IndrasaBiotecnologaSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:IndrasaBiotecnologaSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:IndrasaBiotecnologaSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:MoolecScienceSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:MoolecScienceSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c631">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:MoolecScienceSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c632">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:SWSemillasSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c633">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:SWSemillasSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c634">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:SWSemillasSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c635">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:TrigallGeneticsSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c636">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:TrigallGeneticsSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c637">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:TrigallGeneticsSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c638">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:InmetSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c639">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:InmetSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c640">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:InmetSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c641">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:TheoISCSpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c642">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:TheoISCSpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c643">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">mlec:TheoISCSpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c644">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mlec:SynertechIndustriasSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c645">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mlec:SynertechIndustriasSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c646">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mlec:SynertechIndustriasSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c647">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mlec:SynertechIndustriasSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c648">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mlec:SynertechIndustriasSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c649">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mlec:SynertechIndustriasSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c650">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mlec:AgralitySAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c651">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mlec:AgralitySAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c652">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mlec:AgralitySAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c653">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mlec:AgralitySAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c654">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mlec:AgralitySAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c655">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mlec:AgralitySAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c656">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mlec:TheoISCSpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c657">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mlec:TheoISCSpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c658">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mlec:TheoISCSpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c659">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mlec:TheoISCSpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c660">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mlec:TheoISCSpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c661">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">mlec:TheoISCSpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c662">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:SeedAndIntegratedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c663">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropProtectionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c664">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropNutritionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c665">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:EmergingSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c666">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:ConsolidatedEntitieMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c667">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:SeedAndIntegratedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c668">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropProtectionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c669">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropNutritionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c670">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:EmergingSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c671">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:ConsolidatedEntitieMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c672">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:SeedAndIntegratedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c673">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropProtectionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c674">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropNutritionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c675">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:EmergingSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c676">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:ConsolidatedEntitieMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c677">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:SeedAndIntegratedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c678">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropProtectionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c679">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropNutritionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c680">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:EmergingSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c681">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:ConsolidatedEntitieMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c682">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:SeedAndIntegratedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c683">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropProtectionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c684">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropNutritionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c685">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:EmergingSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c686">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:ConsolidatedEntitieMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c687">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:SeedAndIntegratedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c688">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropProtectionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c689">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropNutritionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c690">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:EmergingSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c691">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:ConsolidatedEntitieMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c692">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:SeedAndIntegratedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c693">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:SeedAndIntegratedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c694">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:SeedAndIntegratedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c695">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:SeedTreatmentsPacksMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:SeedAndIntegratedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c696">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:SeedTreatmentsPacksMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:SeedAndIntegratedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c697">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:SeedTreatmentsPacksMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:SeedAndIntegratedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c698">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:SeedRoyaltiesPaymentsHB4ProgramMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:SeedAndIntegratedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c699">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:SeedRoyaltiesPaymentsHB4ProgramMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:SeedAndIntegratedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c700">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:SeedRoyaltiesPaymentsHB4ProgramMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:SeedAndIntegratedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropProtectionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropProtectionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c703">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropProtectionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c704">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:AdjuvantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropProtectionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c705">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:AdjuvantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropProtectionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c706">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:AdjuvantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropProtectionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c707">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:SeedCpProductsAndServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropProtectionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c708">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:SeedCpProductsAndServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropProtectionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c709">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:SeedCpProductsAndServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropProtectionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c710">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:OtherCpProductsAndServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropProtectionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c711">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:OtherCpProductsAndServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropProtectionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c712">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:OtherCpProductsAndServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropProtectionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c713">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:BioprotectionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropProtectionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c714">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:BioprotectionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropProtectionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c715">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:BioprotectionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropProtectionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c716">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropNutritionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c717">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropNutritionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c718">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropNutritionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c719">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:InoculantsBiofertilizersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropNutritionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c720">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:InoculantsBiofertilizersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropNutritionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c721">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:InoculantsBiofertilizersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropNutritionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c722">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:MicroBeadedFertilizersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropNutritionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:MicroBeadedFertilizersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropNutritionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c724">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:MicroBeadedFertilizersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropNutritionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c725">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:BiostimulantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropNutritionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c726">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:BiostimulantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropNutritionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c727">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:BiostimulantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropNutritionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c728">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:SyngentaUpfrontFeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropNutritionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:SyngentaUpfrontFeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropNutritionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c730">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:SyngentaUpfrontFeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:CropNutritionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:EmergingSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c732">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:EmergingSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c733">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:EmergingSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c734">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:ManagementExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:EmergingSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c735">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:ManagementExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:EmergingSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c736">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:ManagementExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:EmergingSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c737">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:GovernmentGrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:EmergingSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c738">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:GovernmentGrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:EmergingSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c739">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">mlec:GovernmentGrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">mlec:EmergingSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c740">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:AR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c741">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:AR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c742">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:AR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c743">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:BR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c744">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:BR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c745">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:BR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c746">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c747">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c748">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c749">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c750">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c751">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c752">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">mlec:EuropeMiddleEastAndAfricaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c753">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">mlec:EuropeMiddleEastAndAfricaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c754">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">mlec:EuropeMiddleEastAndAfricaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c755">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">mlec:OtherRegionsOrCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c756">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">mlec:OtherRegionsOrCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c757">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">mlec:OtherRegionsOrCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c758">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:AR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c759">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:AR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c760">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:BR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c761">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:BR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c762">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c763">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c764">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c765">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c766">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">mlec:EuropeMiddleEastAndAfricaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c767">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">mlec:EuropeMiddleEastAndAfricaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c768">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">mlec:OtherRegionsOrCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c769">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ConsolidatedStructuredEntitiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">mlec:OtherRegionsOrCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c770">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:TradeAndOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanThreeMonthsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c771">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:TradeAndOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c772">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:TradeAndOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c773">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:BorrowingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanThreeMonthsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c774">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:BorrowingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c775">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:BorrowingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c776">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:IfrsConvertibleNotesPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanThreeMonthsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c777">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:IfrsConvertibleNotesPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c778">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:IfrsConvertibleNotesPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c779">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanThreeMonthsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c780">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c781">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c782">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanThreeMonthsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c783">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c784">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c785">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:TradeAndOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanThreeMonthsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c786">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:TradeAndOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c787">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:TradeAndOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c788">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:BorrowingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanThreeMonthsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c789">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:BorrowingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c790">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:BorrowingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c791">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:ConsiderationForAcquisitionOfAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanThreeMonthsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c792">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:ConsiderationForAcquisitionOfAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c793">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:ConsiderationForAcquisitionOfAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c794">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:IfrsConvertibleNotesPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanThreeMonthsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c795">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:IfrsConvertibleNotesPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c796">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:IfrsConvertibleNotesPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c797">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanThreeMonthsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c798">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c799">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c800">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanThreeMonthsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c801">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c802">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c803">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c804">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c805">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:FixedRateBorrowingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c806">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:FixedRateBorrowingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c807">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:VariableRateBorrowingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c808">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:VariableRateBorrowingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c809">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:CashAndEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c810">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:CashAndEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c811">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:CashAndEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">mlec:MandatorilyMeasuredAtFairValueThroughProfitOrLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:CashAndEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">mlec:MandatorilyMeasuredAtFairValueThroughProfitOrLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c813">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:OtherFinancialAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c814">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:OtherFinancialAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c815">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:OtherFinancialAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">mlec:MandatorilyMeasuredAtFairValueThroughProfitOrLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c816">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:OtherFinancialAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">mlec:MandatorilyMeasuredAtFairValueThroughProfitOrLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c817">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c818">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c819">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">mlec:MandatorilyMeasuredAtFairValueThroughProfitOrLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c820">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">mlec:MandatorilyMeasuredAtFairValueThroughProfitOrLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c821">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:OtherReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c822">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:OtherReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:OtherReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">mlec:MandatorilyMeasuredAtFairValueThroughProfitOrLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c824">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:OtherReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">mlec:MandatorilyMeasuredAtFairValueThroughProfitOrLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c825">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c826">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c827">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">mlec:MandatorilyMeasuredAtFairValueThroughProfitOrLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c828">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">mlec:MandatorilyMeasuredAtFairValueThroughProfitOrLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c829">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:TradeAndOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">mlec:AtAmortizedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c830">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:TradeAndOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">mlec:AtAmortizedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:TradeAndOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c832">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:TradeAndOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c833">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:BorrowingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">mlec:AtAmortizedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c834">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:BorrowingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">mlec:AtAmortizedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c835">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:BorrowingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c836">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:BorrowingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c837">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:ConsiderationForAcquisitionOfAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">mlec:AtAmortizedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c838">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:ConsiderationForAcquisitionOfAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">mlec:AtAmortizedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c839">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:ConsiderationForAcquisitionOfAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c840">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:ConsiderationForAcquisitionOfAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c841">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">mlec:AtAmortizedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c842">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">mlec:AtAmortizedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c843">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c844">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c845">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">mlec:AtAmortizedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c846">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">mlec:AtAmortizedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c847">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c848">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c849">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">mlec:AtAmortizedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c850">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">mlec:AtAmortizedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c851">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c852">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c853">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">mlec:AtAmortizedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c854">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">mlec:AtAmortizedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c855">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c856">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c857">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:InvestmentsAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c858">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:InvestmentsAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c859">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:InvestmentsAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c860">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c861">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c862">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c863">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:MutualFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c864">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:MutualFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c865">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:MutualFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c866">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:MoolecScienceSASharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c867">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:MoolecScienceSASharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c868">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:MoolecScienceSASharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c869">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:InvestmentsAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c870">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:InvestmentsAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c871">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:InvestmentsAtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c872">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:UsTreasuryBillsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c873">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:UsTreasuryBillsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c874">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:UsTreasuryBillsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c875">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:OtherInvestmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c876">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:OtherInvestmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c877">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:OtherInvestmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c878">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:TradeAndOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c879">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:TradeAndOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c880">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:TradeAndOtherPayablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c881">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:ConsiderationForAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c882">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:ConsiderationForAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c883">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">mlec:ConsiderationForAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c884">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c885">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c886">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c887">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c888">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c889">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c890">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c891">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c892">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c893">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c894">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c895">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c896">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c897">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c898">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c899">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c900">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LandAndBuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c901">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:SalesOfGoodsAndServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c902">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:SalesOfGoodsAndServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c903">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:SalesOfGoodsAndServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c904">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:PurchasesOfGoodsAndServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c905">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:PurchasesOfGoodsAndServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c906">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:PurchasesOfGoodsAndServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c907">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:NetLoansGrantedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c908">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:NetLoansGrantedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c909">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:NetLoansGrantedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c910">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:InterestGainMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c911">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:InterestGainMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c912">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:InterestGainMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c913">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:NetLoansReceivedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c914">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:NetLoansReceivedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c915">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:NetLoansReceivedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c916">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:PuttableInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c917">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:PuttableInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c918">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:PuttableInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c919">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:NetLoansGrantedOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c920">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:NetLoansGrantedOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c921">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:NetLoansGrantedOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c922">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:PreferenceShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c923">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:PreferenceShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:PreferenceShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:InterestExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:InterestExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:InterestExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:OwnSharesHeldBySubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:OwnSharesHeldBySubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:OwnSharesHeldBySubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c931">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:InKindContributionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c932">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:InKindContributionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c933">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:InKindContributionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c934">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:SalesOfGoodsAndServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c935">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:SalesOfGoodsAndServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c936">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:SalesOfGoodsAndServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c937">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:PurchasesOfGoodsAndServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c938">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:PurchasesOfGoodsAndServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c939">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:PurchasesOfGoodsAndServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c940">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:SalariesSocialSecurityBenefitsAndOtherBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c941">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:SalariesSocialSecurityBenefitsAndOtherBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c942">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:SalariesSocialSecurityBenefitsAndOtherBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c943">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:SalesAndServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c944">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:SalesAndServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c945">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:SalesAndServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c946">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:PurchasesOfGoodsAndServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c947">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:PurchasesOfGoodsAndServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c948">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:PurchasesOfGoodsAndServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c949">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:StockOptionsAndShareBasedIncentivesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c950">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:StockOptionsAndShareBasedIncentivesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c951">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:StockOptionsAndShareBasedIncentivesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c952">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:TradeDebtorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c953">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:TradeDebtorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c954">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:OtherReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c955">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:OtherReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c956">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:TradeDebtorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c957">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:TradeDebtorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c958">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:LoansReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c959">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:LoansReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c960">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:OtherReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c961">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:OtherReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c962">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:TradeCreditorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c963">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:TradeCreditorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c964">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c965">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c966">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:NetLoansPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c967">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:JointVenturesWhereEntityIsVenturerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:NetLoansPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c968">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:TradeCreditorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c969">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:TradeCreditorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c970">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:WarrantesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c971">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:WarrantesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c972">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:PreferenceShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c973">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:PreferenceShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c974">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c975">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-01-31</endDate>
        </period>
    </context>
    <context id="c976">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-12</startDate>
            <endDate>2023-05-12</endDate>
        </period>
    </context>
    <context id="c977">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-12</instant>
        </period>
    </context>
    <context id="c978">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:StandAloneStockOptionGrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-12</startDate>
            <endDate>2023-05-12</endDate>
        </period>
    </context>
    <context id="c979">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:VolumeWeightedAveragePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:StandAloneStockOptionGrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-12</startDate>
            <endDate>2023-05-12</endDate>
        </period>
    </context>
    <context id="c980">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:EmployeeStockOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-12</startDate>
            <endDate>2023-05-12</endDate>
        </period>
    </context>
    <context id="c981">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">mlec:VolumeWeightedAveragePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:EmployeeStockOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-12</startDate>
            <endDate>2023-05-12</endDate>
        </period>
    </context>
    <context id="c982">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <startDate>2023-05-12</startDate>
            <endDate>2023-05-12</endDate>
        </period>
    </context>
    <context id="c983">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:PastShareOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-12</startDate>
            <endDate>2023-05-12</endDate>
        </period>
    </context>
    <context id="c984">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:PastShareOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-12</startDate>
            <endDate>2023-05-12</endDate>
        </period>
    </context>
    <context id="c985">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c986">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c987">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c988">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c989">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c990">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c991">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">mlec:EBITDAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:PerformanceShareOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-12</startDate>
            <endDate>2023-05-12</endDate>
        </period>
    </context>
    <context id="c992">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">mlec:EBITDAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:PerformanceShareOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-12</startDate>
            <endDate>2023-05-12</endDate>
        </period>
    </context>
    <context id="c993">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">mlec:EBITDAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:PerformanceShareOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-12</startDate>
            <endDate>2023-05-12</endDate>
        </period>
    </context>
    <context id="c994">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:PerformanceShareOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-12</startDate>
            <endDate>2023-05-12</endDate>
        </period>
    </context>
    <context id="c995">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:PerformanceShareOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-12</startDate>
            <endDate>2023-05-12</endDate>
        </period>
    </context>
    <context id="c996">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:PerformanceShareOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-12</startDate>
            <endDate>2023-05-12</endDate>
        </period>
    </context>
    <context id="c997">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <instant>2023-05-12</instant>
        </period>
    </context>
    <context id="c998">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">mlec:ProFarmGroupIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:StockIncentivePlan2013Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-26</startDate>
            <endDate>2022-07-26</endDate>
        </period>
    </context>
    <context id="c999">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:StandAloneStockOptionGrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c1000">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:EmployeeStockOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c1001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:PastShareOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c1002">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c1003">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:PerformanceShareOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c1004">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:StandAloneStockOptionGrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c1005">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:EmployeeStockOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c1006">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:PastShareOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c1007">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">ifrs-full:ShareOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c1008">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:PerformanceShareOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c1009">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-12</startDate>
            <endDate>2022-07-12</endDate>
        </period>
    </context>
    <context id="c1010">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-12</startDate>
            <endDate>2022-07-12</endDate>
        </period>
    </context>
    <context id="c1011">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <startDate>2022-07-12</startDate>
            <endDate>2022-07-12</endDate>
        </period>
    </context>
    <context id="c1012">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:OptionsIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c1013">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:OptionsIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c1014">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:OptionsIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c1015">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:OptionsIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c1016">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:OptionsIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c1017">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <instant>2025-10-02</instant>
        </period>
    </context>
    <context id="c1018">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">mlec:SubsequentEventsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-07-31</endDate>
        </period>
    </context>
    <context id="c1019">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c1020">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">ifrs-full:MajorBusinessCombinationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-02</instant>
        </period>
    </context>
    <context id="c1021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <instant>2025-11-14</instant>
        </period>
    </context>
    <context id="c1022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <startDate>2024-11-14</startDate>
            <endDate>2024-11-14</endDate>
        </period>
    </context>
    <context id="c1023">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c1024">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c1025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-20</startDate>
            <endDate>2025-12-20</endDate>
        </period>
    </context>
    <context id="c1026">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mlec:ReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c1027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mlec:ReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c1028">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mlec:ReverseStockSplitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPershares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="arsPershares">
        <divide>
            <unitNumerator>
                <measure>iso4217:ARS</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:DocumentType contextRef="c0" id="ixv-43047">20-F</dei:DocumentType>
    <dei:DocumentRegistrationStatement contextRef="c0" id="ixv-43048">false</dei:DocumentRegistrationStatement>
    <dei:DocumentAnnualReport contextRef="c0" id="ixv-43049">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="c0" id="ixv-43050">2025-06-30</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="c0" id="ixv-43051">--06-30</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="c0" id="ixv-43052">2025</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="c0" id="ixv-43053">false</dei:DocumentTransitionReport>
    <dei:DocumentShellCompanyReport contextRef="c0" id="ixv-43054">false</dei:DocumentShellCompanyReport>
    <dei:EntityFileNumber contextRef="c0" id="ixv-43055">001-41586</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c0" id="ixv-85">Moolec Science SA</dei:EntityRegistrantName>
    <dei:EntityAddressAddressLine1 contextRef="c0" id="ixv-43056">89 Nexus Way, Camana Bay</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c0" id="ixv-43057">Grand Cayman</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode contextRef="c0" id="ixv-43058">KY1-9009</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry contextRef="c0" id="ixv-113">KY</dei:EntityAddressCountry>
    <dei:ContactPersonnelName contextRef="c1" id="ixv-122">Valeria Falottico</dei:ContactPersonnelName>
    <dei:EntityAddressAddressLine1 contextRef="c1" id="ixv-43059">Ocampo Bis 210</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c1" id="ixv-43060">Rosario Sud</dei:EntityAddressCityOrTown>
    <dei:EntityAddressAddressLine2 contextRef="c1" id="ixv-43061">Santa Fe2000</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCountry contextRef="c1" id="ixv-43063">AR</dei:EntityAddressCountry>
    <dei:ContactPersonnelEmailAddress contextRef="c1" id="ixv-135">ir@moolecscience.com</dei:ContactPersonnelEmailAddress>
    <dei:CityAreaCode contextRef="c1" id="ixv-43064">+54</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c1" id="ixv-43065">341 486 1100</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c2" id="ixv-168">Ordinary Shares, with nominal value of US$0.10 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c2" id="ixv-173">MLEC</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c2" id="ixv-177">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c3" id="ixv-181">Warrants, exercisable for ordinary shares</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c3" id="ixv-186">MLECW</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c3" id="ixv-190">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="c4"
      decimals="INF"
      id="ixv-43066"
      unitRef="shares">10891761</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityWellKnownSeasonedIssuer contextRef="c0" id="ixv-43067">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="c0" id="ixv-43068">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="c0" id="ixv-43069">No</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c0" id="ixv-43070">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c0" id="ixv-43071">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityEmergingGrowthCompany contextRef="c0" id="ixv-43072">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="c0" id="ixv-43073">false</dei:EntityExTransitionPeriod>
    <dei:IcfrAuditorAttestationFlag contextRef="c0" id="ixv-43074">false</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="c0" id="ixv-43075">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany contextRef="c0" id="ixv-43076">false</dei:EntityShellCompany>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="c0" id="ixv-43077">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock contextRef="c0" id="ixv-43078">Cybersecurity&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;As of the date of this report
we have not adopted a formal cybersecurity policy, and we have not invested in a comprehensive set of processes for managing cybersecurity
risk due to our relatively small size and limited resources. However, we have taken certain preliminary steps to manage cybersecurity
risks such as utilizing commercially available anti-virus software on company computers, utilizing cloud-based systems and software offered
by major global software and computer systems providers for company records and documents.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;As of the date of this report
we do not believe, or are not aware, of any existing or previous cybersecurity incident that has materially affected or are reasonably
likely to materially affect our business, strategy, operations, or financial condition. However, we may in the future be materially adversely
affected by a cybersecurity incident, such as a computer system failure, a computer system security breach, and as a result may be subject
to ransomware, phishing attacks, or other malicious intrusions.&lt;/p&gt;</cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock contextRef="c0" id="ixv-43079">As of the date of this report
we do not believe, or are not aware, of any existing or previous cybersecurity incident that has materially affected or are reasonably
likely to materially affect our business, strategy, operations, or financial condition.</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag contextRef="c0" id="ixv-43080">true</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag>
    <cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock contextRef="c0" id="ixv-12525">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;b&gt;Cybersecurity Risk Governance&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;Our Compliance Officer is
responsible for assessing and managing material risks from cybersecurity threats. Our Compliance Officer oversees our efforts to monitor
the prevention, detection, mitigation, and remediation of cybersecurity incidents.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;Our Board of Directors has
specific responsibility for overseeing cybersecurity risk management and evaluation and being informed on risks from cybersecurity threats.
Our Compliance Officer reports to the Board of Directors on cybersecurity risk management matters as needed. Any material cybersecurity
incidents would be reported to the Board of Directors by our Compliance Officer. In the case of a material cybersecurity incident, our
board is responsible for ensuring that the proposed action and disclosure of the incident is adequate and that measures are put in place
to prevent further incidents. See Item 3 &#x2013; Risk Factors&lt;i&gt;&#x2014;&#x201c;We rely on information technology systems, and any inadequacy,
failure, interruption or security breaches of those systems may impair our ability to operate our business effectively&lt;/i&gt;&#x201d; in this
Form 20-F.&lt;/p&gt;</cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock>
    <cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock contextRef="c0" id="ixv-43081">Our Board of Directors has
specific responsibility for overseeing cybersecurity risk management and evaluation and being informed on risks from cybersecurity threats.</cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag contextRef="c0" id="ixv-43082">true</cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag contextRef="c0" id="ixv-43083">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag>
    <dei:AuditorFirmId contextRef="c0" id="ixv-43084">1349</dei:AuditorFirmId>
    <dei:AuditorOpinionTextBlock contextRef="c0" id="ixv-13123">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;Opinion on the Financial Statements&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;We have audited the accompanying consolidated statements of financial
position of Moolec Science SA and its subsidiaries (the &#x201c;Company&#x201d;) as of June 30, 2025 and 2024, and the related consolidated
statements of comprehensive income, of changes in shareholders&#x2019; deficit / equity and of cash flows for each of the three years in
the period ended June 30, 2025, including the related notes (collectively referred to as the &#x201c;consolidated financial statements&#x201d;).
In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company
as of June 30, 2025 and 2024, and the results of its operations and its cash flows for each of the three years in the period ended June
30, 2025 in conformity with IFRS Accounting Standards as issued by the International Accounting Standards Board.&lt;/p&gt;</dei:AuditorOpinionTextBlock>
    <dei:AuditorName contextRef="c0" id="ixv-43085">Sebastian Azagra</dei:AuditorName>
    <dei:AuditorLocation contextRef="c0" id="ixv-13219">Rosario, Argentina</dei:AuditorLocation>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c0" decimals="0" id="ixv-43086" unitRef="usd">333611248</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c5" decimals="0" id="ixv-43087" unitRef="usd">466376330</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c6" decimals="0" id="ixv-43088" unitRef="usd">420867429</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromGovernmentGrants contextRef="c0" decimals="0" id="ixv-43089" unitRef="usd">3412</ifrs-full:RevenueFromGovernmentGrants>
    <ifrs-full:RevenueFromGovernmentGrants contextRef="c5" decimals="0" id="ixv-43090" unitRef="usd">197519</ifrs-full:RevenueFromGovernmentGrants>
    <ifrs-full:RevenueFromGovernmentGrants contextRef="c6" decimals="0" id="ixv-43091" unitRef="usd">93509</ifrs-full:RevenueFromGovernmentGrants>
    <ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets contextRef="c0" decimals="0" id="ixv-43092" unitRef="usd">-1764863</ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets>
    <ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets contextRef="c5" decimals="0" id="ixv-43093" unitRef="usd">45746</ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets>
    <ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets contextRef="c6" decimals="0" id="ixv-43094" unitRef="usd">-610554</ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets>
    <ifrs-full:CostOfSales contextRef="c0" decimals="0" id="ixv-43095" unitRef="usd">203424872</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales contextRef="c5" decimals="0" id="ixv-43096" unitRef="usd">279368328</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales contextRef="c6" decimals="0" id="ixv-43097" unitRef="usd">235464072</ifrs-full:CostOfSales>
    <mlec:ChangeInNetRealizableValueOfAgricultural contextRef="c0" decimals="0" id="ixv-43098" unitRef="usd">-1541204</mlec:ChangeInNetRealizableValueOfAgricultural>
    <mlec:ChangeInNetRealizableValueOfAgricultural contextRef="c5" decimals="0" id="ixv-43099" unitRef="usd">-2385069</mlec:ChangeInNetRealizableValueOfAgricultural>
    <mlec:ChangeInNetRealizableValueOfAgricultural contextRef="c6" decimals="0" id="ixv-43100" unitRef="usd">-4351433</mlec:ChangeInNetRealizableValueOfAgricultural>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="c0" decimals="0" id="ixv-43101" unitRef="usd">15138510</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="c5" decimals="0" id="ixv-43102" unitRef="usd">17422487</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="c6" decimals="0" id="ixv-43103" unitRef="usd">15943987</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="c0" decimals="0" id="ixv-43104" unitRef="usd">125908240</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="c5" decimals="0" id="ixv-43105" unitRef="usd">126340822</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="c6" decimals="0" id="ixv-43106" unitRef="usd">116531274</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="c0" decimals="0" id="ixv-43107" unitRef="usd">-36927610</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="c5" decimals="0" id="ixv-43108" unitRef="usd">-21023150</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="c6" decimals="0" id="ixv-43109" unitRef="usd">47709605</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:OtherOperatingIncomeExpense contextRef="c0" decimals="0" id="ixv-43110" unitRef="usd">-56589216</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:OtherOperatingIncomeExpense contextRef="c5" decimals="0" id="ixv-43111" unitRef="usd">-703265</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:OtherOperatingIncomeExpense contextRef="c6" decimals="0" id="ixv-43112" unitRef="usd">1055299</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:ProfitLossFromOperatingActivities contextRef="c0" decimals="0" id="ixv-43113" unitRef="usd">-104150129</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities contextRef="c5" decimals="0" id="ixv-43114" unitRef="usd">19284982</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities contextRef="c6" decimals="0" id="ixv-43115" unitRef="usd">98045630</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:FinanceIncomeCost contextRef="c0" decimals="0" id="ixv-43116" unitRef="usd">-41809445</ifrs-full:FinanceIncomeCost>
    <ifrs-full:FinanceIncomeCost contextRef="c5" decimals="0" id="ixv-43117" unitRef="usd">-37634153</ifrs-full:FinanceIncomeCost>
    <ifrs-full:FinanceIncomeCost contextRef="c6" decimals="0" id="ixv-43118" unitRef="usd">-33576632</ifrs-full:FinanceIncomeCost>
    <ifrs-full:OtherFinanceIncomeCost contextRef="c0" decimals="0" id="ixv-43119" unitRef="usd">-24043905</ifrs-full:OtherFinanceIncomeCost>
    <ifrs-full:OtherFinanceIncomeCost contextRef="c5" decimals="0" id="ixv-43120" unitRef="usd">-9608981</ifrs-full:OtherFinanceIncomeCost>
    <ifrs-full:OtherFinanceIncomeCost contextRef="c6" decimals="0" id="ixv-43121" unitRef="usd">-13674756</ifrs-full:OtherFinanceIncomeCost>
    <ifrs-full:ProfitLossBeforeTax contextRef="c0" decimals="0" id="ixv-43122" unitRef="usd">-170003479</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax contextRef="c5" decimals="0" id="ixv-43123" unitRef="usd">-27958152</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax contextRef="c6" decimals="0" id="ixv-43124" unitRef="usd">50794242</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="c0" decimals="0" id="ixv-43125" unitRef="usd">6636121</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="c5" decimals="0" id="ixv-43126" unitRef="usd">1103152</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="c6" decimals="0" id="ixv-43127" unitRef="usd">-2328366</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:ProfitLoss contextRef="c0" decimals="0" id="ixv-43128" unitRef="usd">-176639600</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c5" decimals="0" id="ixv-43129" unitRef="usd">-29061304</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c6" decimals="0" id="ixv-43130" unitRef="usd">53122608</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax contextRef="c0" decimals="0" id="ixv-43131" unitRef="usd">-3680709</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax contextRef="c5" decimals="0" id="ixv-43132" unitRef="usd">-1092833</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax contextRef="c6" decimals="0" id="ixv-43133" unitRef="usd">-911896</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations contextRef="c0" decimals="0" id="ixv-43134" unitRef="usd">-802200</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations contextRef="c5" decimals="0" id="ixv-43135" unitRef="usd">977482</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations contextRef="c6" decimals="0" id="ixv-43136" unitRef="usd">-46541</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax contextRef="c0" decimals="0" id="ixv-43137" unitRef="usd">-2878509</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax contextRef="c5" decimals="0" id="ixv-43138" unitRef="usd">-2070315</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax contextRef="c6" decimals="0" id="ixv-43139" unitRef="usd">-865355</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax>
    <mlec:ItemsThatWillNotBeSubsequentlyReclassifiedToLossAndProfit contextRef="c6" decimals="0" id="ixv-43140" unitRef="usd">-1467349</mlec:ItemsThatWillNotBeSubsequentlyReclassifiedToLossAndProfit>
    <mlec:RevaluationOfPropertyPlantAndEquipmentNetOfTaxOfJointVenturesAndAssociates contextRef="c6" decimals="0" id="ixv-43141" unitRef="usd">-184630</mlec:RevaluationOfPropertyPlantAndEquipmentNetOfTaxOfJointVenturesAndAssociates>
    <mlec:RevaluationOfPropertyPlantAndEquipmentNetOfTax contextRef="c6" decimals="0" id="ixv-43142" unitRef="usd">-1282719</mlec:RevaluationOfPropertyPlantAndEquipmentNetOfTax>
    <ifrs-full:ComprehensiveIncome contextRef="c0" decimals="0" id="ixv-43143" unitRef="usd">-180320309</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c5" decimals="0" id="ixv-43144" unitRef="usd">-30154137</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c6" decimals="0" id="ixv-43145" unitRef="usd">50743363</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent contextRef="c0" decimals="0" id="ixv-43146" unitRef="usd">-111460708</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent contextRef="c5" decimals="0" id="ixv-43147" unitRef="usd">-32685398</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent contextRef="c6" decimals="0" id="ixv-43148" unitRef="usd">40435923</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests contextRef="c0" decimals="0" id="ixv-43149" unitRef="usd">-65178892</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests contextRef="c5" decimals="0" id="ixv-43150" unitRef="usd">3624094</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests contextRef="c6" decimals="0" id="ixv-43151" unitRef="usd">12686685</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLoss contextRef="c0" decimals="0" id="ixv-43152" unitRef="usd">-176639600</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c5" decimals="0" id="ixv-43153" unitRef="usd">-29061304</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c6" decimals="0" id="ixv-43154" unitRef="usd">53122608</ifrs-full:ProfitLoss>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="c0"
      decimals="4"
      id="ixv-43155"
      unitRef="usdPershares">-17.2461</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="c5"
      decimals="4"
      id="ixv-43156"
      unitRef="usdPershares">-5.6146</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="c6"
      decimals="4"
      id="ixv-43157"
      unitRef="usdPershares">8.8034</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="c0"
      decimals="4"
      id="ixv-43158"
      unitRef="usdPershares">-17.2461</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="c5"
      decimals="4"
      id="ixv-43159"
      unitRef="usdPershares">-5.6146</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="c6"
      decimals="4"
      id="ixv-43160"
      unitRef="usdPershares">8.8034</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent contextRef="c0" decimals="0" id="ixv-43161" unitRef="usd">-114009391</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent contextRef="c5" decimals="0" id="ixv-43162" unitRef="usd">-32875350</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent contextRef="c6" decimals="0" id="ixv-43163" unitRef="usd">39068323</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests contextRef="c0" decimals="0" id="ixv-43164" unitRef="usd">-66310918</ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests>
    <ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests contextRef="c5" decimals="0" id="ixv-43165" unitRef="usd">2721213</ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests>
    <ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests contextRef="c6" decimals="0" id="ixv-43166" unitRef="usd">11675040</ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests>
    <ifrs-full:ComprehensiveIncome contextRef="c0" decimals="0" id="ixv-43167" unitRef="usd">-180320309</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c5" decimals="0" id="ixv-43168" unitRef="usd">-30154137</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c6" decimals="0" id="ixv-43169" unitRef="usd">50743363</ifrs-full:ComprehensiveIncome>
    <ifrs-full:OtherNoncurrentFinancialAssets contextRef="c7" decimals="0" id="ixv-43170" unitRef="usd">190517</ifrs-full:OtherNoncurrentFinancialAssets>
    <ifrs-full:OtherNoncurrentReceivables contextRef="c4" decimals="0" id="ixv-43171" unitRef="usd">664493</ifrs-full:OtherNoncurrentReceivables>
    <ifrs-full:OtherNoncurrentReceivables contextRef="c7" decimals="0" id="ixv-43172" unitRef="usd">27887034</ifrs-full:OtherNoncurrentReceivables>
    <ifrs-full:CurrentTaxAssetsNoncurrent contextRef="c7" decimals="0" id="ixv-43173" unitRef="usd">10889</ifrs-full:CurrentTaxAssetsNoncurrent>
    <ifrs-full:DeferredTaxAssets contextRef="c7" decimals="0" id="ixv-43174" unitRef="usd">14476230</ifrs-full:DeferredTaxAssets>
    <mlec:InvestmentsInJointVenturesAndAssociates contextRef="c4" decimals="0" id="ixv-43175" unitRef="usd">94147971</mlec:InvestmentsInJointVenturesAndAssociates>
    <mlec:InvestmentsInJointVenturesAndAssociates contextRef="c7" decimals="0" id="ixv-43176" unitRef="usd">92795851</mlec:InvestmentsInJointVenturesAndAssociates>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c4" decimals="0" id="ixv-43177" unitRef="usd">3345170</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c7" decimals="0" id="ixv-43178" unitRef="usd">74612434</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:InvestmentProperty contextRef="c7" decimals="0" id="ixv-43179" unitRef="usd">560783</ifrs-full:InvestmentProperty>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c4" decimals="0" id="ixv-43180" unitRef="usd">75258790</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c7" decimals="0" id="ixv-43181" unitRef="usd">177331280</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:Goodwill contextRef="c7" decimals="0" id="ixv-43182" unitRef="usd">112163432</ifrs-full:Goodwill>
    <ifrs-full:RightofuseAssets contextRef="c4" decimals="0" id="ixv-43183" unitRef="usd">100896</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets contextRef="c7" decimals="0" id="ixv-43184" unitRef="usd">11601752</ifrs-full:RightofuseAssets>
    <ifrs-full:NoncurrentAssets contextRef="c4" decimals="0" id="ixv-43185" unitRef="usd">173517320</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets contextRef="c7" decimals="0" id="ixv-43186" unitRef="usd">511630202</ifrs-full:NoncurrentAssets>
    <ifrs-full:CashAndCashEquivalents contextRef="c4" decimals="0" id="ixv-43187" unitRef="usd">767919</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c7" decimals="0" id="ixv-43188" unitRef="usd">52994865</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:OtherCurrentFinancialAssets contextRef="c4" decimals="0" id="ixv-43189" unitRef="usd">8254261</ifrs-full:OtherCurrentFinancialAssets>
    <ifrs-full:OtherCurrentFinancialAssets contextRef="c7" decimals="0" id="ixv-43190" unitRef="usd">14667607</ifrs-full:OtherCurrentFinancialAssets>
    <ifrs-full:CurrentTradeReceivables contextRef="c4" decimals="0" id="ixv-43191" unitRef="usd">6085400</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:CurrentTradeReceivables contextRef="c7" decimals="0" id="ixv-43192" unitRef="usd">209007195</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:OtherCurrentReceivables contextRef="c4" decimals="0" id="ixv-43193" unitRef="usd">13849164</ifrs-full:OtherCurrentReceivables>
    <ifrs-full:OtherCurrentReceivables contextRef="c7" decimals="0" id="ixv-43194" unitRef="usd">34657383</ifrs-full:OtherCurrentReceivables>
    <ifrs-full:CurrentTaxAssetsCurrent contextRef="c7" decimals="0" id="ixv-43195" unitRef="usd">655691</ifrs-full:CurrentTaxAssetsCurrent>
    <ifrs-full:Inventories contextRef="c4" decimals="0" id="ixv-43196" unitRef="usd">2235482</ifrs-full:Inventories>
    <ifrs-full:Inventories contextRef="c7" decimals="0" id="ixv-43197" unitRef="usd">125929768</ifrs-full:Inventories>
    <ifrs-full:CurrentBiologicalAssets contextRef="c7" decimals="0" id="ixv-43198" unitRef="usd">294134</ifrs-full:CurrentBiologicalAssets>
    <ifrs-full:CurrentAssets contextRef="c4" decimals="0" id="ixv-43199" unitRef="usd">31192226</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets contextRef="c7" decimals="0" id="ixv-43200" unitRef="usd">438206643</ifrs-full:CurrentAssets>
    <ifrs-full:Assets contextRef="c4" decimals="0" id="ixv-43201" unitRef="usd">204709546</ifrs-full:Assets>
    <ifrs-full:Assets contextRef="c7" decimals="0" id="ixv-43202" unitRef="usd">949836845</ifrs-full:Assets>
    <ifrs-full:IssuedCapital contextRef="c4" decimals="0" id="ixv-43203" unitRef="usd">1089176</ifrs-full:IssuedCapital>
    <ifrs-full:IssuedCapital contextRef="c7" decimals="0" id="ixv-43204" unitRef="usd">598369</ifrs-full:IssuedCapital>
    <mlec:ShareToBeIssuedAmount contextRef="c4" decimals="0" id="ixv-43205" unitRef="usd">77589</mlec:ShareToBeIssuedAmount>
    <mlec:SharesPremium contextRef="c4" decimals="0" id="ixv-43206" unitRef="usd">39668135</mlec:SharesPremium>
    <mlec:SharesPremium contextRef="c7" decimals="0" id="ixv-43207" unitRef="usd">-5516907</mlec:SharesPremium>
    <mlec:OwnSharesHeld contextRef="c4" decimals="0" id="ixv-43208" unitRef="usd">-422146</mlec:OwnSharesHeld>
    <mlec:OwnSharesHeld contextRef="c7" decimals="0" id="ixv-43209" unitRef="usd">-444473</mlec:OwnSharesHeld>
    <mlec:StockOptionsAndShareBasedIncentives contextRef="c4" decimals="0" id="ixv-43210" unitRef="usd">7271881</mlec:StockOptionsAndShareBasedIncentives>
    <mlec:StockOptionsAndShareBasedIncentives contextRef="c7" decimals="0" id="ixv-43211" unitRef="usd">6222175</mlec:StockOptionsAndShareBasedIncentives>
    <ifrs-full:RetainedEarnings contextRef="c4" decimals="0" id="ixv-43212" unitRef="usd">-110317946</ifrs-full:RetainedEarnings>
    <ifrs-full:RetainedEarnings contextRef="c7" decimals="0" id="ixv-43213" unitRef="usd">1142761</ifrs-full:RetainedEarnings>
    <mlec:RevaluationOfPropertyPlantAndEquipmentReserve contextRef="c4" decimals="0" id="ixv-43214" unitRef="usd">-1323916</mlec:RevaluationOfPropertyPlantAndEquipmentReserve>
    <mlec:RevaluationOfPropertyPlantAndEquipmentReserve contextRef="c7" decimals="0" id="ixv-43215" unitRef="usd">-1323916</mlec:RevaluationOfPropertyPlantAndEquipmentReserve>
    <ifrs-full:ReserveOfExchangeDifferencesOnTranslation contextRef="c4" decimals="0" id="ixv-43216" unitRef="usd">-2013856</ifrs-full:ReserveOfExchangeDifferencesOnTranslation>
    <ifrs-full:ReserveOfExchangeDifferencesOnTranslation contextRef="c7" decimals="0" id="ixv-43217" unitRef="usd">534827</ifrs-full:ReserveOfExchangeDifferencesOnTranslation>
    <ifrs-full:EquityAttributableToOwnersOfParent contextRef="c4" decimals="0" id="ixv-43218" unitRef="usd">-65971083</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent contextRef="c7" decimals="0" id="ixv-43219" unitRef="usd">1212836</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:NoncontrollingInterests contextRef="c4" decimals="0" id="ixv-43220" unitRef="usd">-16902519</ifrs-full:NoncontrollingInterests>
    <ifrs-full:NoncontrollingInterests contextRef="c7" decimals="0" id="ixv-43221" unitRef="usd">248788534</ifrs-full:NoncontrollingInterests>
    <ifrs-full:Equity contextRef="c4" decimals="0" id="ixv-43222" unitRef="usd">-82873602</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c7" decimals="0" id="ixv-43223" unitRef="usd">250001370</ifrs-full:Equity>
    <ifrs-full:LongtermBorrowings contextRef="c4" decimals="0" id="ixv-43224" unitRef="usd">1348173</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings contextRef="c7" decimals="0" id="ixv-43225" unitRef="usd">127248305</ifrs-full:LongtermBorrowings>
    <ifrs-full:NoncurrentContractLiabilities contextRef="c7" decimals="0" id="ixv-43226" unitRef="usd">1925138</ifrs-full:NoncurrentContractLiabilities>
    <ifrs-full:NoncurrentGovernmentGrants contextRef="c7" decimals="0" id="ixv-43227" unitRef="usd">782</ifrs-full:NoncurrentGovernmentGrants>
    <mlec:JointVenturesAndAssociatesLiabilities contextRef="c7" decimals="0" id="ixv-43228" unitRef="usd">296455</mlec:JointVenturesAndAssociatesLiabilities>
    <ifrs-full:DeferredTaxLiabilities contextRef="c4" decimals="0" id="ixv-43229" unitRef="usd">15767275</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities contextRef="c7" decimals="0" id="ixv-43230" unitRef="usd">34500445</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:NoncurrentProvisions contextRef="c4" decimals="0" id="ixv-43231" unitRef="usd">16154574</ifrs-full:NoncurrentProvisions>
    <ifrs-full:NoncurrentProvisions contextRef="c7" decimals="0" id="ixv-43232" unitRef="usd">17484715</ifrs-full:NoncurrentProvisions>
    <mlec:ConsiderationForAcquisitionOfAssetsNonCurrent contextRef="c7" decimals="0" id="ixv-43233" unitRef="usd">2005143</mlec:ConsiderationForAcquisitionOfAssetsNonCurrent>
    <mlec:SecuredDebtNonCurrent contextRef="c4" decimals="0" id="ixv-43234" unitRef="usd">18260456</mlec:SecuredDebtNonCurrent>
    <mlec:SecuredDebtNonCurrent contextRef="c7" decimals="0" id="ixv-43235" unitRef="usd">80809686</mlec:SecuredDebtNonCurrent>
    <ifrs-full:NoncurrentLeaseLiabilities contextRef="c7" decimals="0" id="ixv-43236" unitRef="usd">8161359</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLiabilities contextRef="c4" decimals="0" id="ixv-43237" unitRef="usd">51530478</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities contextRef="c7" decimals="0" id="ixv-43238" unitRef="usd">272432028</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:TradeAndOtherCurrentPayables contextRef="c4" decimals="0" id="ixv-43239" unitRef="usd">7323933</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables contextRef="c7" decimals="0" id="ixv-43240" unitRef="usd">168937536</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:ShorttermBorrowings contextRef="c4" decimals="0" id="ixv-43241" unitRef="usd">227154007</ifrs-full:ShorttermBorrowings>
    <ifrs-full:ShorttermBorrowings contextRef="c7" decimals="0" id="ixv-43242" unitRef="usd">234510751</ifrs-full:ShorttermBorrowings>
    <ifrs-full:CurrentProvisionsForEmployeeBenefits contextRef="c4" decimals="0" id="ixv-43243" unitRef="usd">243634</ifrs-full:CurrentProvisionsForEmployeeBenefits>
    <ifrs-full:CurrentProvisionsForEmployeeBenefits contextRef="c7" decimals="0" id="ixv-43244" unitRef="usd">7506831</ifrs-full:CurrentProvisionsForEmployeeBenefits>
    <ifrs-full:CurrentDeferredIncomeIncludingCurrentContractLiabilities contextRef="c4" decimals="0" id="ixv-43245" unitRef="usd">1260</ifrs-full:CurrentDeferredIncomeIncludingCurrentContractLiabilities>
    <ifrs-full:CurrentDeferredIncomeIncludingCurrentContractLiabilities contextRef="c7" decimals="0" id="ixv-43246" unitRef="usd">3924801</ifrs-full:CurrentDeferredIncomeIncludingCurrentContractLiabilities>
    <ifrs-full:CurrentTaxLiabilitiesCurrent contextRef="c7" decimals="0" id="ixv-43247" unitRef="usd">4825271</ifrs-full:CurrentTaxLiabilitiesCurrent>
    <ifrs-full:CurrentGovernmentGrants contextRef="c4" decimals="0" id="ixv-43248" unitRef="usd">1280</ifrs-full:CurrentGovernmentGrants>
    <ifrs-full:CurrentGovernmentGrants contextRef="c7" decimals="0" id="ixv-43249" unitRef="usd">3655</ifrs-full:CurrentGovernmentGrants>
    <ifrs-full:CurrentWarrantLiability contextRef="c4" decimals="0" id="ixv-43250" unitRef="usd">1211093</ifrs-full:CurrentWarrantLiability>
    <mlec:ConsiderationForAcquisitionOfAssetsCurrent contextRef="c7" decimals="0" id="ixv-43251" unitRef="usd">4571824</mlec:ConsiderationForAcquisitionOfAssetsCurrent>
    <ifrs-full:CurrentLeaseLiabilities contextRef="c4" decimals="0" id="ixv-43252" unitRef="usd">117463</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentLeaseLiabilities contextRef="c7" decimals="0" id="ixv-43253" unitRef="usd">3122778</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentLiabilities contextRef="c4" decimals="0" id="ixv-43254" unitRef="usd">236052670</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities contextRef="c7" decimals="0" id="ixv-43255" unitRef="usd">427403447</ifrs-full:CurrentLiabilities>
    <ifrs-full:Liabilities contextRef="c4" decimals="0" id="ixv-43256" unitRef="usd">287583148</ifrs-full:Liabilities>
    <ifrs-full:Liabilities contextRef="c7" decimals="0" id="ixv-43257" unitRef="usd">699835475</ifrs-full:Liabilities>
    <ifrs-full:EquityAndLiabilities contextRef="c4" decimals="0" id="ixv-43258" unitRef="usd">204709546</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities contextRef="c7" decimals="0" id="ixv-43259" unitRef="usd">949836845</ifrs-full:EquityAndLiabilities>
    <ifrs-full:Equity contextRef="c8" decimals="0" id="ixv-43260" unitRef="usd">598369</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c10" decimals="0" id="ixv-43261" unitRef="usd">-444473</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c11" decimals="0" id="ixv-43262" unitRef="usd">-5516907</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c12" decimals="0" id="ixv-43263" unitRef="usd">6222175</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c13" decimals="0" id="ixv-43264" unitRef="usd">1142761</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c14" decimals="0" id="ixv-43265" unitRef="usd">534827</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c15" decimals="0" id="ixv-43266" unitRef="usd">-1323916</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c16" decimals="0" id="ixv-43267" unitRef="usd">1212836</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c17" decimals="0" id="ixv-43268" unitRef="usd">248788534</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c7" decimals="0" id="ixv-43269" unitRef="usd">250001370</ifrs-full:Equity>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners contextRef="c18" decimals="0" id="ixv-43270" unitRef="usd">111345</ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners contextRef="c21" decimals="0" id="ixv-43271" unitRef="usd">346160</ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners contextRef="c26" decimals="0" id="ixv-43272" unitRef="usd">457505</ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners contextRef="c0" decimals="0" id="ixv-43273" unitRef="usd">457505</ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners>
    <ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl contextRef="c20" decimals="0" id="ixv-43274" unitRef="usd">22327</ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl>
    <ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl contextRef="c21" decimals="0" id="ixv-43275" unitRef="usd">11791403</ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl>
    <ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl contextRef="c26" decimals="0" id="ixv-43276" unitRef="usd">11813730</ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl>
    <ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl contextRef="c27" decimals="0" id="ixv-43277" unitRef="usd">11416836</ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl>
    <ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl contextRef="c0" decimals="0" id="ixv-43278" unitRef="usd">23230566</ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="c22" decimals="0" id="ixv-43279" unitRef="usd">1049706</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="c26" decimals="0" id="ixv-43280" unitRef="usd">1049706</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="c27" decimals="0" id="ixv-43281" unitRef="usd">3326658</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="c0" decimals="0" id="ixv-43282" unitRef="usd">4376364</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity contextRef="c18" decimals="0" id="ixv-43283" unitRef="usd">379462</mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity>
    <mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity contextRef="c19" decimals="0" id="ixv-43284" unitRef="usd">77589</mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity>
    <mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity contextRef="c21" decimals="0" id="ixv-43285" unitRef="usd">33047480</mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity>
    <mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity contextRef="c26" decimals="0" id="ixv-43286" unitRef="usd">33504531</mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity>
    <mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity contextRef="c27" decimals="0" id="ixv-43287" unitRef="usd">6316790</mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity>
    <mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity contextRef="c0" decimals="0" id="ixv-43288" unitRef="usd">39821321</mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity>
    <ifrs-full:IncreaseDecreaseThroughOtherDistributionsToOwners contextRef="c27" decimals="0" id="ixv-43289" unitRef="usd">220368368</ifrs-full:IncreaseDecreaseThroughOtherDistributionsToOwners>
    <ifrs-full:IncreaseDecreaseThroughOtherDistributionsToOwners contextRef="c0" decimals="0" id="ixv-43290" unitRef="usd">220368368</ifrs-full:IncreaseDecreaseThroughOtherDistributionsToOwners>
    <ifrs-full:DividendsPaid contextRef="c27" decimals="0" id="ixv-43291" unitRef="usd">72051</ifrs-full:DividendsPaid>
    <ifrs-full:DividendsPaid contextRef="c0" decimals="0" id="ixv-43292" unitRef="usd">72051</ifrs-full:DividendsPaid>
    <ifrs-full:ProfitLoss contextRef="c23" decimals="0" id="ixv-43293" unitRef="usd">-111460708</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c26" decimals="0" id="ixv-43294" unitRef="usd">-111460708</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c27" decimals="0" id="ixv-43295" unitRef="usd">-65178892</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c0" decimals="0" id="ixv-43296" unitRef="usd">-176639600</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncomeBeforeTax contextRef="c24" decimals="0" id="ixv-43297" unitRef="usd">-2548683</ifrs-full:OtherComprehensiveIncomeBeforeTax>
    <ifrs-full:OtherComprehensiveIncomeBeforeTax contextRef="c26" decimals="0" id="ixv-43298" unitRef="usd">-2548683</ifrs-full:OtherComprehensiveIncomeBeforeTax>
    <ifrs-full:OtherComprehensiveIncomeBeforeTax contextRef="c27" decimals="0" id="ixv-43299" unitRef="usd">-1132026</ifrs-full:OtherComprehensiveIncomeBeforeTax>
    <ifrs-full:OtherComprehensiveIncomeBeforeTax contextRef="c0" decimals="0" id="ixv-43300" unitRef="usd">-3680709</ifrs-full:OtherComprehensiveIncomeBeforeTax>
    <ifrs-full:Equity contextRef="c28" decimals="0" id="ixv-43301" unitRef="usd">1089176</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c29" decimals="0" id="ixv-43302" unitRef="usd">77589</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c30" decimals="0" id="ixv-43303" unitRef="usd">-422146</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c31" decimals="0" id="ixv-43304" unitRef="usd">39668136</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c32" decimals="0" id="ixv-43305" unitRef="usd">7271881</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c33" decimals="0" id="ixv-43306" unitRef="usd">-110317947</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c34" decimals="0" id="ixv-43307" unitRef="usd">-2013856</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c35" decimals="0" id="ixv-43308" unitRef="usd">-1323916</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c36" decimals="0" id="ixv-43309" unitRef="usd">-65971083</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c37" decimals="0" id="ixv-43310" unitRef="usd">-16902519</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c4" decimals="0" id="ixv-43311" unitRef="usd">-82873602</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c38" decimals="0" id="ixv-43312" unitRef="usd">530170</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c40" decimals="0" id="ixv-43313" unitRef="usd">-12021426</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c41" decimals="0" id="ixv-43314" unitRef="usd">1853856</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c42" decimals="0" id="ixv-43315" unitRef="usd">33828159</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c43" decimals="0" id="ixv-43316" unitRef="usd">724779</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c44" decimals="0" id="ixv-43317" unitRef="usd">-1323916</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c45" decimals="0" id="ixv-43318" unitRef="usd">23591622</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c46" decimals="0" id="ixv-43319" unitRef="usd">234978480</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c47" decimals="0" id="ixv-43320" unitRef="usd">258570102</ifrs-full:Equity>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners contextRef="c48" decimals="0" id="ixv-43321" unitRef="usd">68199</ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners contextRef="c49" decimals="0" id="ixv-43322" unitRef="usd">-7319</ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners contextRef="c50" decimals="0" id="ixv-43323" unitRef="usd">206720</ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners contextRef="c55" decimals="0" id="ixv-43324" unitRef="usd">267600</ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners contextRef="c5" decimals="0" id="ixv-43325" unitRef="usd">267600</ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners>
    <ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl contextRef="c49" decimals="0" id="ixv-43326" unitRef="usd">-437154</ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl>
    <ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl contextRef="c50" decimals="0" id="ixv-43327" unitRef="usd">6297799</ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl>
    <ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl contextRef="c55" decimals="0" id="ixv-43328" unitRef="usd">5860645</ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl>
    <ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl contextRef="c56" decimals="0" id="ixv-43329" unitRef="usd">557267</ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl>
    <ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl contextRef="c5" decimals="0" id="ixv-43330" unitRef="usd">6417912</ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="c51" decimals="0" id="ixv-43331" unitRef="usd">4368319</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="c55" decimals="0" id="ixv-43332" unitRef="usd">4368319</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="c56" decimals="0" id="ixv-43333" unitRef="usd">9592291</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="c5" decimals="0" id="ixv-43334" unitRef="usd">13960610</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity contextRef="c56" decimals="0" id="ixv-43335" unitRef="usd">1114083</mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity>
    <mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity contextRef="c5" decimals="0" id="ixv-43336" unitRef="usd">1114083</mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity>
    <ifrs-full:DividendsPaid contextRef="c56" decimals="0" id="ixv-43337" unitRef="usd">174800</ifrs-full:DividendsPaid>
    <ifrs-full:DividendsPaid contextRef="c5" decimals="0" id="ixv-43338" unitRef="usd">174800</ifrs-full:DividendsPaid>
    <ifrs-full:ProfitLoss contextRef="c52" decimals="0" id="ixv-43339" unitRef="usd">-32685398</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c55" decimals="0" id="ixv-43340" unitRef="usd">-32685398</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c56" decimals="0" id="ixv-43341" unitRef="usd">3624094</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c5" decimals="0" id="ixv-43342" unitRef="usd">-29061304</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncomeBeforeTax contextRef="c53" decimals="0" id="ixv-43343" unitRef="usd">-189952</ifrs-full:OtherComprehensiveIncomeBeforeTax>
    <ifrs-full:OtherComprehensiveIncomeBeforeTax contextRef="c55" decimals="0" id="ixv-43344" unitRef="usd">-189952</ifrs-full:OtherComprehensiveIncomeBeforeTax>
    <ifrs-full:OtherComprehensiveIncomeBeforeTax contextRef="c56" decimals="0" id="ixv-43345" unitRef="usd">-902881</ifrs-full:OtherComprehensiveIncomeBeforeTax>
    <ifrs-full:OtherComprehensiveIncomeBeforeTax contextRef="c5" decimals="0" id="ixv-43346" unitRef="usd">-1092833</ifrs-full:OtherComprehensiveIncomeBeforeTax>
    <ifrs-full:Equity contextRef="c8" decimals="0" id="ixv-43347" unitRef="usd">598369</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c10" decimals="0" id="ixv-43348" unitRef="usd">-444473</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c11" decimals="0" id="ixv-43349" unitRef="usd">-5516907</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c12" decimals="0" id="ixv-43350" unitRef="usd">6222175</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c13" decimals="0" id="ixv-43351" unitRef="usd">1142761</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c14" decimals="0" id="ixv-43352" unitRef="usd">534827</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c15" decimals="0" id="ixv-43353" unitRef="usd">-1323916</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c16" decimals="0" id="ixv-43354" unitRef="usd">1212836</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c17" decimals="0" id="ixv-43355" unitRef="usd">248788534</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c7" decimals="0" id="ixv-43356" unitRef="usd">250001370</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c57" decimals="0" id="ixv-43357" unitRef="usd">326694</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c58" decimals="0" id="ixv-43358" unitRef="usd">-7566943</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c59" decimals="0" id="ixv-43359" unitRef="usd">777376</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c60" decimals="0" id="ixv-43360" unitRef="usd">-6607764</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c61" decimals="0" id="ixv-43361" unitRef="usd">1773218</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c62" decimals="0" id="ixv-43362" unitRef="usd">-1004755</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c63" decimals="0" id="ixv-43363" unitRef="usd">-12302174</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c64" decimals="0" id="ixv-43364" unitRef="usd">137171291</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c65" decimals="0" id="ixv-43365" unitRef="usd">124869117</ifrs-full:Equity>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners contextRef="c66" decimals="0" id="ixv-43366" unitRef="usd">203476</ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners contextRef="c67" decimals="0" id="ixv-43367" unitRef="usd">555760</ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners contextRef="c72" decimals="0" id="ixv-43368" unitRef="usd">759236</ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners contextRef="c6" decimals="0" id="ixv-43369" unitRef="usd">759236</ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners>
    <ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl contextRef="c67" decimals="0" id="ixv-43370" unitRef="usd">-29474351</ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl>
    <ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl contextRef="c72" decimals="0" id="ixv-43371" unitRef="usd">-29474351</ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl>
    <ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl contextRef="c73" decimals="0" id="ixv-43372" unitRef="usd">-46940078</ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl>
    <ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl contextRef="c6" decimals="0" id="ixv-43373" unitRef="usd">-76414429</ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl>
    <mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity contextRef="c67" decimals="0" id="ixv-43374" unitRef="usd">24464108</mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity>
    <mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity contextRef="c72" decimals="0" id="ixv-43375" unitRef="usd">24464108</mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity>
    <mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity contextRef="c73" decimals="0" id="ixv-43376" unitRef="usd">130515236</mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity>
    <mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity contextRef="c6" decimals="0" id="ixv-43377" unitRef="usd">154979344</mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="c68" decimals="0" id="ixv-43378" unitRef="usd">1076480</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="c72" decimals="0" id="ixv-43379" unitRef="usd">1076480</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="c73" decimals="0" id="ixv-43380" unitRef="usd">3009120</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="c6" decimals="0" id="ixv-43381" unitRef="usd">4085600</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:DividendsPaid contextRef="c73" decimals="0" id="ixv-43382" unitRef="usd">452129</ifrs-full:DividendsPaid>
    <ifrs-full:DividendsPaid contextRef="c6" decimals="0" id="ixv-43383" unitRef="usd">452129</ifrs-full:DividendsPaid>
    <ifrs-full:ProfitLoss contextRef="c69" decimals="0" id="ixv-43384" unitRef="usd">40435923</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c72" decimals="0" id="ixv-43385" unitRef="usd">40435923</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c73" decimals="0" id="ixv-43386" unitRef="usd">12686685</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c6" decimals="0" id="ixv-43387" unitRef="usd">53122608</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncomeBeforeTax contextRef="c70" decimals="0" id="ixv-43388" unitRef="usd">-1048439</ifrs-full:OtherComprehensiveIncomeBeforeTax>
    <ifrs-full:OtherComprehensiveIncomeBeforeTax contextRef="c71" decimals="0" id="ixv-43389" unitRef="usd">-319161</ifrs-full:OtherComprehensiveIncomeBeforeTax>
    <ifrs-full:OtherComprehensiveIncomeBeforeTax contextRef="c72" decimals="0" id="ixv-43390" unitRef="usd">-1367600</ifrs-full:OtherComprehensiveIncomeBeforeTax>
    <ifrs-full:OtherComprehensiveIncomeBeforeTax contextRef="c73" decimals="0" id="ixv-43391" unitRef="usd">-1011645</ifrs-full:OtherComprehensiveIncomeBeforeTax>
    <ifrs-full:OtherComprehensiveIncomeBeforeTax contextRef="c6" decimals="0" id="ixv-43392" unitRef="usd">-2379245</ifrs-full:OtherComprehensiveIncomeBeforeTax>
    <ifrs-full:Equity contextRef="c38" decimals="0" id="ixv-43393" unitRef="usd">530170</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c40" decimals="0" id="ixv-43394" unitRef="usd">-12021426</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c41" decimals="0" id="ixv-43395" unitRef="usd">1853856</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c42" decimals="0" id="ixv-43396" unitRef="usd">33828159</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c43" decimals="0" id="ixv-43397" unitRef="usd">724779</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c44" decimals="0" id="ixv-43398" unitRef="usd">-1323916</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c45" decimals="0" id="ixv-43399" unitRef="usd">23591622</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c46" decimals="0" id="ixv-43400" unitRef="usd">234978480</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c47" decimals="0" id="ixv-43401" unitRef="usd">258570102</ifrs-full:Equity>
    <ifrs-full:ProfitLoss contextRef="c0" decimals="0" id="ixv-43402" unitRef="usd">-176639600</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c5" decimals="0" id="ixv-43403" unitRef="usd">-29061304</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c6" decimals="0" id="ixv-43404" unitRef="usd">53122608</ifrs-full:ProfitLoss>
    <ifrs-full:AdjustmentsForIncomeTaxExpense contextRef="c0" decimals="0" id="ixv-43405" unitRef="usd">6636121</ifrs-full:AdjustmentsForIncomeTaxExpense>
    <ifrs-full:AdjustmentsForIncomeTaxExpense contextRef="c5" decimals="0" id="ixv-43406" unitRef="usd">1103152</ifrs-full:AdjustmentsForIncomeTaxExpense>
    <ifrs-full:AdjustmentsForIncomeTaxExpense contextRef="c6" decimals="0" id="ixv-43407" unitRef="usd">-2328366</ifrs-full:AdjustmentsForIncomeTaxExpense>
    <ifrs-full:AdjustmentsForDepreciationExpense contextRef="c0" decimals="0" id="ixv-43408" unitRef="usd">6015700</ifrs-full:AdjustmentsForDepreciationExpense>
    <ifrs-full:AdjustmentsForDepreciationExpense contextRef="c5" decimals="0" id="ixv-43409" unitRef="usd">5799998</ifrs-full:AdjustmentsForDepreciationExpense>
    <ifrs-full:AdjustmentsForDepreciationExpense contextRef="c6" decimals="0" id="ixv-43410" unitRef="usd">4938927</ifrs-full:AdjustmentsForDepreciationExpense>
    <mlec:AmortizationOfIntangibleAsset contextRef="c0" decimals="0" id="ixv-43411" unitRef="usd">11201048</mlec:AmortizationOfIntangibleAsset>
    <mlec:AmortizationOfIntangibleAsset contextRef="c5" decimals="0" id="ixv-43412" unitRef="usd">12113223</mlec:AmortizationOfIntangibleAsset>
    <mlec:AmortizationOfIntangibleAsset contextRef="c6" decimals="0" id="ixv-43413" unitRef="usd">11004584</mlec:AmortizationOfIntangibleAsset>
    <mlec:DepreciationOfLeasedAssets contextRef="c0" decimals="0" id="ixv-43414" unitRef="usd">5036703</mlec:DepreciationOfLeasedAssets>
    <mlec:DepreciationOfLeasedAssets contextRef="c5" decimals="0" id="ixv-43415" unitRef="usd">3418956</mlec:DepreciationOfLeasedAssets>
    <mlec:DepreciationOfLeasedAssets contextRef="c6" decimals="0" id="ixv-43416" unitRef="usd">3565894</mlec:DepreciationOfLeasedAssets>
    <ifrs-full:AdjustmentsForFairValueGainsLosses contextRef="c0" decimals="0" id="ixv-43417" unitRef="usd">-1473482</ifrs-full:AdjustmentsForFairValueGainsLosses>
    <mlec:RemeasurementOfPreviouslyHeldInterest contextRef="c0" decimals="0" id="ixv-43418" unitRef="usd">1666680</mlec:RemeasurementOfPreviouslyHeldInterest>
    <ifrs-full:AdjustmentsForSharebasedPayments contextRef="c0" decimals="0" id="ixv-43419" unitRef="usd">4386688</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments contextRef="c5" decimals="0" id="ixv-43420" unitRef="usd">14199480</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments contextRef="c6" decimals="0" id="ixv-43421" unitRef="usd">3480178</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="c0" decimals="0" id="ixv-43422" unitRef="usd">-36927610</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="c5" decimals="0" id="ixv-43423" unitRef="usd">-21023150</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="c6" decimals="0" id="ixv-43424" unitRef="usd">47709605</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <mlec:ProvisionsForContingencies contextRef="c0" decimals="0" id="ixv-43425" unitRef="usd">336919</mlec:ProvisionsForContingencies>
    <mlec:ProvisionsForContingencies contextRef="c5" decimals="0" id="ixv-43426" unitRef="usd">653574</mlec:ProvisionsForContingencies>
    <mlec:ProvisionsForContingencies contextRef="c6" decimals="0" id="ixv-43427" unitRef="usd">239292</mlec:ProvisionsForContingencies>
    <mlec:AllowanceForImpairmentOfTradeDebtors contextRef="c0" decimals="0" id="ixv-43428" unitRef="usd">7123716</mlec:AllowanceForImpairmentOfTradeDebtors>
    <mlec:AllowanceForImpairmentOfTradeDebtors contextRef="c5" decimals="0" id="ixv-43429" unitRef="usd">753428</mlec:AllowanceForImpairmentOfTradeDebtors>
    <mlec:AllowanceForImpairmentOfTradeDebtors contextRef="c6" decimals="0" id="ixv-43430" unitRef="usd">1327385</mlec:AllowanceForImpairmentOfTradeDebtors>
    <mlec:AllowanceForObsolescences contextRef="c0" decimals="0" id="ixv-43431" unitRef="usd">1547723</mlec:AllowanceForObsolescences>
    <mlec:AllowanceForObsolescences contextRef="c5" decimals="0" id="ixv-43432" unitRef="usd">586515</mlec:AllowanceForObsolescences>
    <mlec:AllowanceForObsolescences contextRef="c6" decimals="0" id="ixv-43433" unitRef="usd">1066777</mlec:AllowanceForObsolescences>
    <ifrs-full:GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets contextRef="c0" decimals="0" id="ixv-43434" unitRef="usd">-1764863</ifrs-full:GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets>
    <ifrs-full:GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets contextRef="c5" decimals="0" id="ixv-43435" unitRef="usd">45746</ifrs-full:GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets>
    <ifrs-full:GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets contextRef="c6" decimals="0" id="ixv-43436" unitRef="usd">-610554</ifrs-full:GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets>
    <ifrs-full:GainsLossesOnChangeInFairValueEstimatesOfBiologicalAssetsForCurrentPeriod contextRef="c0" decimals="0" id="ixv-43437" unitRef="usd">-1541204</ifrs-full:GainsLossesOnChangeInFairValueEstimatesOfBiologicalAssetsForCurrentPeriod>
    <ifrs-full:GainsLossesOnChangeInFairValueEstimatesOfBiologicalAssetsForCurrentPeriod contextRef="c5" decimals="0" id="ixv-43438" unitRef="usd">-2385069</ifrs-full:GainsLossesOnChangeInFairValueEstimatesOfBiologicalAssetsForCurrentPeriod>
    <ifrs-full:GainsLossesOnChangeInFairValueEstimatesOfBiologicalAssetsForCurrentPeriod contextRef="c6" decimals="0" id="ixv-43439" unitRef="usd">-4351433</ifrs-full:GainsLossesOnChangeInFairValueEstimatesOfBiologicalAssetsForCurrentPeriod>
    <ifrs-full:AdjustmentsForFinanceCosts contextRef="c0" decimals="0" id="ixv-43440" unitRef="usd">65853350</ifrs-full:AdjustmentsForFinanceCosts>
    <ifrs-full:AdjustmentsForFinanceCosts contextRef="c5" decimals="0" id="ixv-43441" unitRef="usd">47243134</ifrs-full:AdjustmentsForFinanceCosts>
    <ifrs-full:AdjustmentsForFinanceCosts contextRef="c6" decimals="0" id="ixv-43442" unitRef="usd">-47251388</ifrs-full:AdjustmentsForFinanceCosts>
    <ifrs-full:AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets contextRef="c0" decimals="0" id="ixv-43443" unitRef="usd">-7649848</ifrs-full:AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets>
    <ifrs-full:AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets contextRef="c5" decimals="0" id="ixv-43444" unitRef="usd">-125464</ifrs-full:AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable contextRef="c0" decimals="0" id="ixv-43445" unitRef="usd">26040164</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable contextRef="c5" decimals="0" id="ixv-43446" unitRef="usd">-41256269</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable contextRef="c6" decimals="0" id="ixv-43447" unitRef="usd">-14179711</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables contextRef="c0" decimals="0" id="ixv-43448" unitRef="usd">2039034</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables contextRef="c5" decimals="0" id="ixv-43449" unitRef="usd">-6338099</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables contextRef="c6" decimals="0" id="ixv-43450" unitRef="usd">-36705492</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories contextRef="c0" decimals="0" id="ixv-43451" unitRef="usd">34880985</ifrs-full:AdjustmentsForDecreaseIncreaseInInventories>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories contextRef="c5" decimals="0" id="ixv-43452" unitRef="usd">15285866</ifrs-full:AdjustmentsForDecreaseIncreaseInInventories>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories contextRef="c6" decimals="0" id="ixv-43453" unitRef="usd">-8572529</ifrs-full:AdjustmentsForDecreaseIncreaseInInventories>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables contextRef="c0" decimals="0" id="ixv-43454" unitRef="usd">-18847998</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables contextRef="c5" decimals="0" id="ixv-43455" unitRef="usd">16286414</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables contextRef="c6" decimals="0" id="ixv-43456" unitRef="usd">14172818</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities contextRef="c0" decimals="0" id="ixv-43457" unitRef="usd">-1089185</ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities contextRef="c5" decimals="0" id="ixv-43458" unitRef="usd">-2413413</ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities contextRef="c6" decimals="0" id="ixv-43459" unitRef="usd">2074795</ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities>
    <mlec:AdjustmentsForDecreaseIncreaseInGovernmentGrants contextRef="c0" decimals="0" id="ixv-43460" unitRef="usd">-3157</mlec:AdjustmentsForDecreaseIncreaseInGovernmentGrants>
    <mlec:AdjustmentsForDecreaseIncreaseInGovernmentGrants contextRef="c5" decimals="0" id="ixv-43461" unitRef="usd">-188518</mlec:AdjustmentsForDecreaseIncreaseInGovernmentGrants>
    <mlec:AdjustmentsForDecreaseIncreaseInGovernmentGrants contextRef="c6" decimals="0" id="ixv-43462" unitRef="usd">-93091</mlec:AdjustmentsForDecreaseIncreaseInGovernmentGrants>
    <ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities contextRef="c5" decimals="0" id="ixv-43463" unitRef="usd">853299</ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities>
    <ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities contextRef="c6" decimals="0" id="ixv-43464" unitRef="usd">4072347</ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities contextRef="c0" decimals="0" id="ixv-43465" unitRef="usd">-129099</ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities contextRef="c5" decimals="0" id="ixv-43466" unitRef="usd">-21103777</ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities contextRef="c6" decimals="0" id="ixv-43467" unitRef="usd">21019535</ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities contextRef="c0" decimals="0" id="ixv-43468" unitRef="usd">3636413</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities contextRef="c5" decimals="0" id="ixv-43469" unitRef="usd">39557562</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities contextRef="c6" decimals="0" id="ixv-43470" unitRef="usd">-41158857</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="c0" decimals="0" id="ixv-43471" unitRef="usd">390381</ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="c5" decimals="0" id="ixv-43472" unitRef="usd">336726</ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="c6" decimals="0" id="ixv-43473" unitRef="usd">137357</ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:OtherCashReceiptsFromSalesOfInterestsInJointVenturesClassifiedAsInvestingActivities contextRef="c6" decimals="0" id="ixv-43474" unitRef="usd">1085676</ifrs-full:OtherCashReceiptsFromSalesOfInterestsInJointVenturesClassifiedAsInvestingActivities>
    <ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities contextRef="c0" decimals="0" id="ixv-43475" unitRef="usd">554420</ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities>
    <ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities contextRef="c5" decimals="0" id="ixv-43476" unitRef="usd">37508</ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities>
    <ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities contextRef="c6" decimals="0" id="ixv-43477" unitRef="usd">4373265</ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities>
    <ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities contextRef="c0" decimals="0" id="ixv-43478" unitRef="usd">32695079</ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities>
    <ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities contextRef="c5" decimals="0" id="ixv-43479" unitRef="usd">18097</ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities>
    <ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities contextRef="c6" decimals="0" id="ixv-43480" unitRef="usd">1081808</ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities>
    <ifrs-full:ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities contextRef="c0" decimals="0" id="ixv-43481" unitRef="usd">21731347</ifrs-full:ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities>
    <ifrs-full:ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities contextRef="c5" decimals="0" id="ixv-43482" unitRef="usd">62836432</ifrs-full:ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities>
    <ifrs-full:ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities contextRef="c6" decimals="0" id="ixv-43483" unitRef="usd">1316980</ifrs-full:ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod contextRef="c0" decimals="0" id="ixv-43484" unitRef="usd">11351880</ifrs-full:PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod>
    <ifrs-full:PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod contextRef="c5" decimals="0" id="ixv-43485" unitRef="usd">65567062</ifrs-full:PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod>
    <ifrs-full:PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod contextRef="c6" decimals="0" id="ixv-43486" unitRef="usd">8488144</ifrs-full:PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="c0" decimals="0" id="ixv-43487" unitRef="usd">5651506</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="c5" decimals="0" id="ixv-43488" unitRef="usd">9936611</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="c6" decimals="0" id="ixv-43489" unitRef="usd">11491899</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PaymentsForDevelopmentProjectExpenditure contextRef="c0" decimals="0" id="ixv-43490" unitRef="usd">8614448</ifrs-full:PaymentsForDevelopmentProjectExpenditure>
    <ifrs-full:PaymentsForDevelopmentProjectExpenditure contextRef="c5" decimals="0" id="ixv-43491" unitRef="usd">11855766</ifrs-full:PaymentsForDevelopmentProjectExpenditure>
    <ifrs-full:PaymentsForDevelopmentProjectExpenditure contextRef="c6" decimals="0" id="ixv-43492" unitRef="usd">10753047</ifrs-full:PaymentsForDevelopmentProjectExpenditure>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities contextRef="c0" decimals="0" id="ixv-43493" unitRef="usd">350843</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities contextRef="c5" decimals="0" id="ixv-43494" unitRef="usd">3233316</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities contextRef="c6" decimals="0" id="ixv-43495" unitRef="usd">688287</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities contextRef="c0" decimals="0" id="ixv-43496" unitRef="usd">-35987608</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities contextRef="c5" decimals="0" id="ixv-43497" unitRef="usd">-27400186</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities contextRef="c6" decimals="0" id="ixv-43498" unitRef="usd">-25589907</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities contextRef="c0" decimals="0" id="ixv-43499" unitRef="usd">403333190</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities contextRef="c5" decimals="0" id="ixv-43500" unitRef="usd">187994310</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities contextRef="c6" decimals="0" id="ixv-43501" unitRef="usd">150631747</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities contextRef="c0" decimals="0" id="ixv-43502" unitRef="usd">380033708</ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities contextRef="c5" decimals="0" id="ixv-43503" unitRef="usd">145044508</ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities contextRef="c6" decimals="0" id="ixv-43504" unitRef="usd">38457281</ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities contextRef="c0" decimals="0" id="ixv-43505" unitRef="usd">28088688</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities contextRef="c5" decimals="0" id="ixv-43506" unitRef="usd">36803697</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities contextRef="c6" decimals="0" id="ixv-43507" unitRef="usd">25639013</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities contextRef="c0" decimals="0" id="ixv-43508" unitRef="usd">5501387</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities contextRef="c5" decimals="0" id="ixv-43509" unitRef="usd">4879108</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities contextRef="c6" decimals="0" id="ixv-43510" unitRef="usd">3855517</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities contextRef="c0" decimals="0" id="ixv-43511" unitRef="usd">72051</ifrs-full:DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities>
    <ifrs-full:DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities contextRef="c5" decimals="0" id="ixv-43512" unitRef="usd">174800</ifrs-full:DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities>
    <ifrs-full:DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities contextRef="c6" decimals="0" id="ixv-43513" unitRef="usd">452129</ifrs-full:DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfOtherEquityInstruments contextRef="c0" decimals="0" id="ixv-43514" unitRef="usd">3731493</ifrs-full:PaymentsOfOtherEquityInstruments>
    <ifrs-full:PaymentsOfOtherEquityInstruments contextRef="c5" decimals="0" id="ixv-43515" unitRef="usd">1850252</ifrs-full:PaymentsOfOtherEquityInstruments>
    <ifrs-full:PaymentsOfOtherEquityInstruments contextRef="c6" decimals="0" id="ixv-43516" unitRef="usd">3007154</ifrs-full:PaymentsOfOtherEquityInstruments>
    <mlec:PurchaseOfOwnShares contextRef="c0" decimals="0" id="ixv-43517" unitRef="usd">926899</mlec:PurchaseOfOwnShares>
    <mlec:PurchaseOfOwnShares contextRef="c5" decimals="0" id="ixv-43518" unitRef="usd">734388</mlec:PurchaseOfOwnShares>
    <mlec:PurchaseOfOwnShares contextRef="c6" decimals="0" id="ixv-43519" unitRef="usd">2996947</mlec:PurchaseOfOwnShares>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities contextRef="c0" decimals="0" id="ixv-43520" unitRef="usd">-15021036</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities contextRef="c5" decimals="0" id="ixv-43521" unitRef="usd">-1492443</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities contextRef="c6" decimals="0" id="ixv-43522" unitRef="usd">76223706</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents contextRef="c0" decimals="0" id="ixv-43523" unitRef="usd">-47372231</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents contextRef="c5" decimals="0" id="ixv-43524" unitRef="usd">10664933</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents contextRef="c6" decimals="0" id="ixv-43525" unitRef="usd">9474942</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <mlec:InflationEffectsOnCashAndCashEquivalents contextRef="c0" decimals="0" id="ixv-43526" unitRef="usd">-3352</mlec:InflationEffectsOnCashAndCashEquivalents>
    <mlec:InflationEffectsOnCashAndCashEquivalents contextRef="c5" decimals="0" id="ixv-43527" unitRef="usd">-189309</mlec:InflationEffectsOnCashAndCashEquivalents>
    <mlec:InflationEffectsOnCashAndCashEquivalents contextRef="c6" decimals="0" id="ixv-43528" unitRef="usd">-195181</mlec:InflationEffectsOnCashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition contextRef="c7" decimals="0" id="ixv-43529" unitRef="usd">52994865</ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition>
    <ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition contextRef="c47" decimals="0" id="ixv-43530" unitRef="usd">49265020</ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition>
    <ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition contextRef="c65" decimals="0" id="ixv-43531" unitRef="usd">34851505</ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents contextRef="c0" decimals="0" id="ixv-43532" unitRef="usd">-4851363</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents contextRef="c5" decimals="0" id="ixv-43533" unitRef="usd">-6745779</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents contextRef="c6" decimals="0" id="ixv-43534" unitRef="usd">5133754</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition contextRef="c4" decimals="0" id="ixv-43535" unitRef="usd">767919</ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition>
    <ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition contextRef="c7" decimals="0" id="ixv-43536" unitRef="usd">52994865</ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition>
    <ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition contextRef="c47" decimals="0" id="ixv-43537" unitRef="usd">49265020</ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition>
    <ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory contextRef="c0" id="ixv-21107">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;1.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;THE GROUP&#x2019;S BUSINESS REORGANIZATION AND GENERAL
INFORMATION&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Moolec Science SA (the &#x201c;Company&#x201d; or
the &#x201c;Group&#x201d;) is an exempted company incorporated under the laws of the laws of the Cayman Islands.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The company was previously registered with the
Luxembourg Trade and Companies&#x2019; Register (&lt;i&gt;Registre de Commerce et des Soci&#xe9;t&#xe9;s, Luxembourg&lt;/i&gt;) under number B268440.
On May 22, 2025 (the &#x201c;Effective Date&#x201d;), the Company changed its jurisdiction by redomiciling Moolec Science (Luxembourg) from
the Grand Duchy of Luxembourg to the Cayman Islands as Moolec Science (Cayman Islands) by way of continuation pursuant to Part XII of
the Companies Act (Revised) of the Cayman Islands (the &#x201c;Redomiciliation&#x201d;). Following the Redomiciliation, the Company&#x2019;s
address is at c/o Ogier Global (Cayman) -89 Nexus Way, Camana Bay, Grand Cayman KY1-9009.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;The Bioceres Group Business Combination Agreement.&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Before the end of the fiscal year, on June 16,
2025, the Company consummated a business combination (the &#x201c;Business Combination&#x201d;). Prior to such consummation, a series of
previous steps had taken place, as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On May 14, 2025, Moolec Science (Luxembourg) made
effective a reverse stock split of its Ordinary Shares (the &#x201c;Reverse Stock Split&#x201d;) on the consolidation ratio of ten-to-one
(the &#x201c;Consolidation Ratio&#x201d;), pursuant to which holders of Ordinary Shares received one Ordinary Share for every ten Ordinary
Shares held.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On May 22, 2025, the Company changed its jurisdiction
by redomiciling Moolec Science (Luxembourg) from the Grand Duchy of Luxembourg to the Cayman Islands as Moolec Science (Cayman Islands)
by way of continuation pursuant to Part XII of the Companies Act (Revised) of the Cayman Islands. On the Effective Date, all of the shares
of Moolec Science (Luxembourg), par value $0.10 per share by operation of law became shares of Moolec Science (Cayman Islands), par value
$0.10 per share (the &#x201c;Ordinary Shares&#x201d;).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;After completion of the Reverse Stock Split, all
references to the Ordinary Shares, share data, per share data and related information have been adjusted for the Consolidation Ratio to
reflect the Reverse Stock Split. The Reverse Stock Split has consolidated each ten of the Ordinary Shares into one Ordinary Share, with
a new par value of $0.10 per Ordinary Share. Upon completion of the Reverse Stock Split, no fractional Ordinary Shares were issued, and
any fractional Ordinary Shares resulting from the Reverse Stock Split were rounded up to the nearest whole Ordinary Share. Except for
the adjustments that resulted from the treatment of fractional shares, the Reverse Stock Split did not have any dilutive effect on the
shareholders.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Through the consummation of the Business Combination, Moolec Science
SA acquired all the issued and outstanding equity interests of Bioceres Group and Nutrecon and 50% of Gentle Tech, integrating mature
agricultural biologicals and seed businesses, nutritional solutions, and emerging technology ventures. In consideration for the contributed
entities, the Company issued approximately 6.2 million of ordinary shares to the shareholders of Bioceres Group, 450,000 of ordinary shares
and 500,000 private warrants with an exercise price of US$20.00 per share to the shareholders of Nutrecon, and 132,750 ordinary shares
to the shareholders of Gentle Tech. Also, Moolec Science SA committed to issue additional ordinary shares twelve months after the acquisition
date, representing the 10% of the total shares to be issued (the &#x201c;Holdback&#x201d;), representing approximately 0.7 million of ordinary
shares to the shareholders of Bioceres Group, 50,000 of ordinary shares to the shareholders of Nutrecon, and 14,750 ordinary shares to
the shareholders of Gentle Tech.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On June 16, 2025, following the consummation of the Business Combination,
the Company initiated integration processes across organizational, operational, and IT functions to support competitiveness and long-term
sustainability. In parallel, management continued to advance the ongoing operations, which remain crucial to maintaining business continuity
and supporting the successful execution of the integration and growth strategy. The consolidated results as of and for the year ended
June 30, 2025 (&#x201c;FY2025&#x201d;) reflect purchase accounting. The prior periods as of and for the year ended June 30, 2024 (&#x201c;FY2024&#x201d;)
and for the year ended June 30, 2023 reflects the Predecessor on a stand-alone basis and does not include any effects of the Business
Combination. As a result, variances between FY2025 and FY2024 primarily reflect changes in scope and basis of presentation rather than
purely period-over-period operating trends, and therefore the periods are not directly comparable. Effective as of the Closing (i.e.,
June 16, 2025), the Company accounted for the Business Combination under IFRS 3, &lt;i&gt;Business Combinations&lt;/i&gt;, using the acquisition method
of accounting and treating the transaction as a reverse acquisition. Under this approach, Bioceres Group (the legal subsidiary) was considered
the accounting acquirer, and Moolec Science SA (the legal acquirer) was considered the accounting acquiree, together with Gentle Tech
and Nutrecon.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration:underline"&gt;1.1 Going Concern&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Business Combination, initially
announced on April 17, 2025, in which the Company, Bioceres Group (formerly, Bioceres Group PLC, one of the main shareholders of the
Company), Gentle Tech and Nutrecon entered into the Bioceres Group Business Combination Agreement, pursuant to which several parties
transferred their respective holdings in Bioceres Group, Nutrecon and Gentle Tech (together, the &#x201c;Contributed Entities&#x201d;)
to the Company, in exchange of a combination of newly issued Company&#x2019;s shares, and warrants, to the shareholders of the
Contributed Entities. Following the closing, Moolec became the legal parent company of the combined group comprising Bioceres Group,
Gentle Tech, and Nutrecon. The Business Combination was ratified by Moolec shareholders at the Extraordinary General Meeting
(&#x201c;EGM&#x201d;) held on June 16, 2025, with 77% of the outstanding shares present at the meeting, and 98% of the votes cast were
in favor of the transaction. From an accounting perspective and based on the guidance of IFRS 3, Bioceres Group Limited is deemed to
be the accounting acquirer. The transaction was subsequently consummated on the same date, June 16, 2025 (the
&#x201c;Closing&#x201d;).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On June 18, 2025, Bioceres Crop Solutions Corp.
(BIOX), a public company controlled until that date by Bioceres Group Limited, entered into an amendment with the Secured Notes&#x2019;
holders by which the holders of the Secured Notes waived the breach of covenants that led to the default of the debt (specifically, the
breach of covenants related to the Consolidated Total Net Leverage Ratio (determined as the ratio of (a) Consolidated Total Net Debt as
of the last day of such Test Period to (b) Consolidated EBITDA of the Issuer and its Subsidiaries for such Test Period) of 3.75x as of
March 31, 2025), retrospectively modifying the required Consolidated Total Net Leverage Ratio to 5x Consolidated Total Net Leverage Ratio,
and extended the maturity of the Secured Notes to August 31, 2027. In accordance with the terms of the amendments, effective June 24,
2025, Gloria Montaron Estrada, Enrique Lopez Lecube, and Keith McGovern were replaced in Bioceres Crop Solutions Corp.&#x2019;s Board of
Directors by Milen Marinov, Noah Kolatch and Scott Crocco, who were nominated by certain holders of the Secured Notes. Bioceres Crop Solutions
Corp. agreed, for so long as the Secured Notes remain outstanding, to continue to nominate Messrs. Marinov, Kolatch and Crocco (or such
other persons as may be nominated as their replacements) for additional terms as directors.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The effect of the changes in the terms of the Secured Notes of Bioceres
Crop Solutions, resulted in the loss of de facto control of that subsidiary and consequently, its deconsolidation. The equity method was
applied to account for the investment in such former subsidiary, as well as for other investments in joint ventures and associates (the
&#x201c;BIOX deconsolidation&#x201d;). Even when there was a deconsolidation of the business, the Company will continue to be affected by
BIOX business due to the HB4 royalty agreement. It is important to note that the effects of the loss of control in BIOX represents substantially
all of the Company&#x2019;s business.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As a result of the loss of control over BIOX, access to financing that
Bioceres S.A., its wholly owned subsidiary Bioceres LLC, Bioceres Group Limited and Moolec Science SA had until then, was restricted or
limited.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In June 2025, Bioceres S.A., one of the Argentine
subsidiaries of Bioceres Group Limited, defaulted on a portion of its financial debt that was due that month. As a result, Bioceres S.A.
had initiated a debt restructuring process for its financial debt for an aggregate amount of $36.4 million.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In July 2025, Bioceres LLC, a wholly owned subsidiary
of Bioceres S.A., received a notice of default on its financial debt&#160;in the amount of $69.5 million. The creditor conducted a public
auction for 3,062,500 pledged BIOX shares, pursuant to the New York Uniform Commercial Code. Management has responded to the creditor,
reserving all rights, remedies, and defenses. As of June 30, 2025, the current debt amounts to $58.0 million.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The defaults by Bioceres S.A. and Bioceres LLC do not have implications
in other debts as there are no cross-default clauses on the remaining financial debt of the Group. There are no guarantees granted above
Bioceres S.A. and Bioceres LLC.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of June 30, 2025, the Group had a negative working capital amounting
to $204,860,444, and a shareholders&#x2019; deficit of $82,873,602. Additionally, the Group reported recurring operating losses amounting
to $104,150,129.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company had the financial support of its main
shareholders and considering the aforementioned events that derived in the loss of the financial support that was previously provided
by Bioceres Group (and who is also no longer a shareholder of the Company), and, consequently, raise a material uncertainty which may
cast significant doubt (or raise substantial doubt as contemplated by PCAOB standards) &#160;about the ability of Moolec Science SA to
continue as a going concern, currently, the Group lacks sufficient financial resources to meet its obligations or fully implement its
business plan. Without securing additional capital, the Group will not be able to sustain its operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The uncertainty surrounding the ability to secure
additional funding and the potential for continued operational losses contribute to substantial doubt about the Group&#x2019;s ability
to continue as a going concern.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Management has plans to address the Group&#x2019;s
financial situation as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Theo I SCSp&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On November 28, 2025, subsequent to the reporting
date, Theo I SCSp received a conditional payment order from district court of&#160; Luxembourg, and therefore the General Partners engaged
Ogier (Luxembourg) SCS represented by its general partner Ogier Luxembourg (GP) S.&#xe0;.r.l&#160; formally as their legal advisor to
assist with Theo I SCSp&#x2019;s declaration of bankruptcy before the Luxembourg District Court. The declaration of bankruptcy will declare
Theo I SCSp bankrupt and appoint a receiver who will take control over the management of the company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The loss of control constitutes the derecognition
event under IFRS 10.25. Accordingly, the Group will derecognize the assets and liabilities of Theo I SCSp and will remeasure its retained
interest at fair value in accordance with IFRS 9 at the date of the derecognition event. This will result in the recognition of an estimated
gain of $9.5 million in the consolidated statement of profit or loss as of the derecognition date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group will continue to measure its retained
interest in Theo I SCSp at fair value through profit or loss until the liquidation process is formally completed.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Bioceres S.A. and Bioceres LLC&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On December 16, 2025, subsequent to the reporting date, the Board of
Directors of Bioceres S.A. formally approved the initiation of voluntary bankruptcy proceedings and instructed management to seek and
appoint a trustee (&#x201c;&lt;i&gt;s&#xed;ndico&lt;/i&gt;&#x201d;) to oversee the process. The commencement of the voluntary bankruptcy proceedings
and the transfer of decision-making authority to the trustee will result in the Group losing control over Bioceres S.A. in accordance
with the principles of IFRS 10 Consolidated Financial Statements. As Bioceres LLC is a wholly owned subsidiary of Bioceres S.A., the Group
simultaneously will lose control over Bioceres LLC as well.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Under IFRS 10.25, the date on which control is
lost constitutes the derecognition event. Accordingly, after December 16, 2025, the Group will derecognize the assets and liabilities
of Bioceres S.A. and Bioceres LLC and will remeasure any retained interest at fair value in accordance with IFRS 9 Financial Instruments.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The resulting derecognition effects are expected to generate an approximate
gain of $91.0 million related to the loss of control of Bioceres S.A. and an additional approximate gain of $5.3 million related to the
loss of control of Bioceres LLC (including the loss of holding in BIOX, therefore it will no longer be an equity method associate). These
amounts will be recognized in the consolidated statement of profit or loss as of the derecognition date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group will continue to monitor the progress of the voluntary bankruptcy
and liquidation proceedings and will update the accounting treatment as necessary in accordance with IFRS.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Management expects that certain shareholders and/or
investors will continue or commence to provide new financing lines.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;However, there is no assurance that investors
and shareholders will continue to provide financing, or that the Group&#x2019;s future operations will generate profitability. The uncertainty
surrounding the ability to secure additional funding and the potential for continued operational losses contribute to raise a material
uncertainty which may cast significant doubt (or raise substantial doubt as contemplated by PCAOB standards) about the Group&#x2019;s ability
to continue as a going concern.&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The consolidated financial statements of Moolec
Science SA do not include any adjustments that may be required to address the potential impacts on the recoverability and classification
of assets or the amounts and classifications liabilities, should the Group be unable to continue as a going concern.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Accordingly, the financial statements of Moolec
Science SA for periods prior to the Closing reflect the historical financial information of Bioceres Group. The financial information
as of and for the year ended June 30, 2025 reflects the figures corresponding to Bioceres Group and incorporates the effects of applying
the acquisition method to Moolec Science SA, Gentle Tech and Nutrecon, measured at fair value in accordance with IFRS 3.&lt;/p&gt;</ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory>
    <mlec:ReverseStockSplitConsolidationRatio contextRef="c74" id="ixv-43538">ten-to-one</mlec:ReverseStockSplitConsolidationRatio>
    <ifrs-full:NumberOfSharesIssued
      contextRef="c75"
      decimals="0"
      id="ixv-43539"
      unitRef="shares">1</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates
      contextRef="c76"
      decimals="0"
      id="ixv-43540"
      unitRef="shares">10</ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates>
    <ifrs-full:ParValuePerShare
      contextRef="c77"
      decimals="2"
      id="ixv-43541"
      unitRef="usdPershares">0.1</ifrs-full:ParValuePerShare>
    <ifrs-full:ParValuePerShare
      contextRef="c78"
      decimals="2"
      id="ixv-43542"
      unitRef="usdPershares">0.1</ifrs-full:ParValuePerShare>
    <mlec:NumberOfSharesReverseStockSplit
      contextRef="c78"
      decimals="0"
      id="ixv-43543"
      unitRef="shares">10</mlec:NumberOfSharesReverseStockSplit>
    <ifrs-full:NumberOfSharesIssued
      contextRef="c78"
      decimals="0"
      id="ixv-43544"
      unitRef="shares">1</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:ParValuePerShare
      contextRef="c78"
      decimals="2"
      id="ixv-43545"
      unitRef="usdPershares">0.1</ifrs-full:ParValuePerShare>
    <mlec:PercentageOfIssuedAndOutstandingEquityInterests contextRef="c78" decimals="2" id="ixv-43546" unitRef="pure">0.50</mlec:PercentageOfIssuedAndOutstandingEquityInterests>
    <mlec:ConsiderationForIssuedOrdinaryShareValue
      contextRef="c79"
      decimals="-5"
      id="ixv-43547"
      unitRef="shares">6200000</mlec:ConsiderationForIssuedOrdinaryShareValue>
    <ifrs-full:NumberOfSharesIssued
      contextRef="c79"
      decimals="0"
      id="ixv-43548"
      unitRef="shares">450000</ifrs-full:NumberOfSharesIssued>
    <mlec:PrivateWarrantsShares
      contextRef="c78"
      decimals="0"
      id="ixv-43549"
      unitRef="shares">500000</mlec:PrivateWarrantsShares>
    <mlec:PrivateWarrantsExercisePrice
      contextRef="c80"
      decimals="2"
      id="ixv-43550"
      unitRef="usdPershares">20</mlec:PrivateWarrantsExercisePrice>
    <ifrs-full:NumberOfSharesIssued
      contextRef="c81"
      decimals="0"
      id="ixv-43551"
      unitRef="shares">132750</ifrs-full:NumberOfSharesIssued>
    <mlec:AdditionalOrdinarySharesIssue contextRef="c78" id="ixv-43552">P12M</mlec:AdditionalOrdinarySharesIssue>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired contextRef="c82" decimals="2" id="ixv-43553" unitRef="pure">0.10</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <mlec:ConsiderationForIssuedOrdinaryShareValue
      contextRef="c83"
      decimals="-5"
      id="ixv-43554"
      unitRef="shares">700000</mlec:ConsiderationForIssuedOrdinaryShareValue>
    <ifrs-full:NumberOfSharesIssued
      contextRef="c83"
      decimals="0"
      id="ixv-43555"
      unitRef="shares">50000</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="c84"
      decimals="0"
      id="ixv-43556"
      unitRef="shares">14750</ifrs-full:NumberOfSharesIssued>
    <mlec:NumberOfSharesOutstandingPercentage contextRef="c85" decimals="2" id="ixv-43557" unitRef="pure">0.77</mlec:NumberOfSharesOutstandingPercentage>
    <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="c85" decimals="2" id="ixv-43558" unitRef="pure">0.98</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
    <ifrs-full:Borrowings contextRef="c86" decimals="-5" id="ixv-43559" unitRef="usd">36400000</ifrs-full:Borrowings>
    <ifrs-full:FinanceCosts contextRef="c87" decimals="-5" id="ixv-43560" unitRef="usd">69500000</ifrs-full:FinanceCosts>
    <mlec:NumberOfSharesPledged
      contextRef="c88"
      decimals="0"
      id="ixv-43561"
      unitRef="shares">3062500</mlec:NumberOfSharesPledged>
    <ifrs-full:CurrentDebtInstrumentsIssued contextRef="c4" decimals="-5" id="ixv-43562" unitRef="usd">58000000</ifrs-full:CurrentDebtInstrumentsIssued>
    <mlec:WorkingCapital contextRef="c4" decimals="0" id="ixv-43563" unitRef="usd">-204860444</mlec:WorkingCapital>
    <ifrs-full:Equity contextRef="c4" decimals="0" id="ixv-43564" unitRef="usd">-82873602</ifrs-full:Equity>
    <ifrs-full:ProfitLossFromOperatingActivities contextRef="c0" decimals="0" id="ixv-43565" unitRef="usd">-104150129</ifrs-full:ProfitLossFromOperatingActivities>
    <mlec:GainlossOfRecognitionTransactions contextRef="c0" decimals="-5" id="ixv-43566" unitRef="usd">9500000</mlec:GainlossOfRecognitionTransactions>
    <mlec:GainlossOfDerecognitionTransactions contextRef="c89" decimals="-5" id="ixv-43567" unitRef="usd">91000000</mlec:GainlossOfDerecognitionTransactions>
    <mlec:GainlossOfDerecognitionTransactions contextRef="c90" decimals="-5" id="ixv-43568" unitRef="usd">5300000</mlec:GainlossOfDerecognitionTransactions>
    <ifrs-full:DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory contextRef="c0" id="ixv-21324">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;2.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;ACCOUNTING STANDARDS AND BASIS OF PREPARATION&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Statement of compliance with IFRS as issued by IASB&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;These consolidated financial statements of the
Group have been prepared in accordance with IFRS Accounting (&#x201c;IFRS&#x201d;) as issued by International Accounting Standard Board
(&#x201c;IASB&#x201d;), and interpretations issued by the IFRS Interpretations Committee (IFRIC), following the accounting policies as set
forth and summarized in Note 4 &#x2013; &#x201c;Summary of significant accounting policies&#x201d;. All IFRS issued by the IASB, effective
at the time of preparing these consolidated financial statements have been applied.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Authorization for the issue of the Consolidated financial statements&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;These consolidated financial statements of the Group as of June 30,
2025 and 2024 and for the years ended June 30, 2025, and 2024 have been authorized by the Board of Directors of Moolec Science SA on December
29, 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Basis of measurement&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The consolidated financial statements have been
prepared on the historical cost basis, except for items that are required to be accounted for at fair value.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The significant accounting policies set out in
Note 4 &#x2013; Summary of significant accounting policies have been consistently applied in preparing these consolidated financial statements
to all the periods presented, unless otherwise stated.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Due to the activities of the Group, costs and
expenses presented in the statement of operations are classified according to their function. The statement of financial position has
been prepared based on the nature of the transactions, distinguishing: (a) current assets from non-current assets, where current assets
are assets that should be realized, sold or used during the normal operating cycle, or the assets owned with the aim of being sold in
the short-term (within 12 months); (b) current liabilities from non-current liabilities, where current liabilities are liabilities that
should be paid during the normal operating cycle or over the 12-month period subsequent to the reporting date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;All other assets and liabilities are classified
as non-current. Current and deferred tax assets and liabilities (income tax credits / liabilities) are presented separately from each
other and from other assets and liabilities, classified as current and non-current, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The consolidated financial statements of the Group
have been prepared using:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Accrual basis of accounting:&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Accrual basis of accounting (except for cash flows
information). Under this basis of accounting, the effects of transactions and other events are recognized as they occur, even when there
are no cash flows.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Functional currency and presentation currency&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Functional currency&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Items included in the financial statements of
each of the Group&#x2019;s entities are measured using the currency of the primary economic market in which the entity operates (i.e.,
&#x201c;the functional currency&#x201d;).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company and the main subsidiaries of the Group
have United States Dollars as functional currency.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Macroeconomic context &#x2013; in recent years
Argentina&#x2019;s macroeconomic scenario has featured a misalignment between inflation rates and the devaluation of the Argentine peso,
which became more pronounced during the first half of the year ended June 30, 2022. Notwithstanding such misalignment, the Company&#x2019;s
Argentine subsidiaries have been able to continue pricing their products in U.S. dollars as the costs of products and services are set
in U.S. dollars. This has also been achievable as the demand for the type of products the Company commercializes is relatively inelastic
when compared to non-essential goods and services. Further, Argentina&#x2019;s significant economic volatility has caused materials, and
other costs of providing goods that the Company acquires from the Argentine domestic market, to become increasingly indexed to the U.S.
dollar (i.e., denominated in Argentine Pesos but indexed to the U.S. dollar exchange rate).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;For the years ended June 30, 2025, 2024 and 2023, Argentinian subsidiaries,
that have Argentine Pesos as functional currency, had applied IAS 29 &#x201c;Financial reporting in hyperinflationary economies&#x201d;
which requires that the financial statements of an entity whose functional currency is the currency of a hyperinflationary economy, whether
these are based on the historical cost method or the current cost method, be stated in terms of the measuring unit current at the closing
date of the reporting period. For such purpose, the inflation produced since the acquisition date or the revaluation date, as applicable,
must be computed in non-monetary items. The standard details a series of factors to be considered for concluding whether an economy is
hyperinflationary, including, but not limited to, a cumulative inflation rate over a three-year period that approaches or exceeds 100%.
Inflation accumulated in three years, as of June 30, 2018, was over 100%. It was for this reason that, in accordance with IAS 29, the
Argentine economy had to be considered as hyperinflationary since July 1, 2018. Consequently, the Group has applied IAS 29 to these financial
statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;During an inflationary period, any entity that
maintains an excess of monetary assets over monetary liabilities will lose purchasing power, and any entity that maintains an excess of
monetary liabilities over monetary assets will gain purchasing power, provided that such items are not subject to an adjustment mechanism.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Briefly, the restatement mechanism of IAS 29 establishes
that monetary assets and liabilities will not be restated because they are already expressed in a current unit of measurement at the end
of the reporting period. Assets and liabilities subject to adjustments based on specific agreements, will be adjusted according to those
agreements. Non-monetary items measured at their current values at the end of the reporting period, such as the net realizable value or
others, do not need to be restated. The remaining non-monetary assets and liabilities will be restated according to a general price index.
The loss or gain for the net monetary position will be included in the net result of the reporting period, revealing this information
in a separate line item.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The inflation adjustment to the initial balances
was calculated by means of a conversion factor derived from the Argentine price indexes published by the National Institute of Statistics.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Argentine price index as of June 30, 2025,
and 2024 was&#160;8,855.5681&#160;and&#160;6,351.7145, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Presentation currency&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The consolidated financial statements of the Group
are presented in US dollars.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Foreign currency&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Transactions entered into by Group entities in
a currency other than their functional currency are recorded at the relevant exchange rates as of the date upon which such transactions
occur. Foreign currency monetary assets and liabilities are translated at the prevailing exchanges rates as of the final day of each reporting
period. Exchange differences arising on the retranslation of unsettled monetary assets and liabilities are recognized immediately in profit
or loss, except for foreign currency borrowings qualifying as a hedge of a net investment in a foreign operation for which exchange differences
are recognized in other comprehensive income and accumulated in the foreign exchange reserve along with the exchange differences arising
on the retranslation of the foreign operation. Upon the disposal of a foreign operation, the cumulative exchange differences recognized
in the foreign exchange reserve relating to such operation up to the date of disposal are transferred to the Consolidated statement of
profit or loss and other comprehensive income as part of the profit or loss reorganized upon such disposal.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Business combination&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On June 16, 2025, it was completed the business combination with Bioceres
Group Limited, Nutrecon LLC and Gentle Technologies Corp. pursuant to the terms of the Business Combination Agreement approved by Moolec
Science SA&#x2019;s shareholders. Through this transaction, Moolec Science SA acquired all the issued and outstanding equity interests
of Bioceres Group and Nutrecon and 50% of Gentle Tech, integrating mature agricultural biologicals and seed businesses, nutritional solutions,
and emerging technology ventures. In consideration for the contributed entities, the Company issued approximately 6.2 million of ordinary
shares to the shareholders of Bioceres Group, 450,000 of ordinary shares and 500,000 private warrants with an exercise price of US$20.00
per share to the shareholders of Nutrecon, and 132,750 ordinary shares to the shareholders of Gentle Tech. Also, Moolec Science SA committed
to issue additional ordinary shares twelve months after the acquisition date, representing the 10% of the total shares to be issued (the
&#x201c;Holdback&#x201d;), representing approximately 0.7 million of ordinary shares to the shareholders of Bioceres Group, 50,000 of ordinary
shares to the shareholders of Nutrecon, and 14,750 ordinary shares to the shareholders of Gentle Tech. As a result of this combination,
Bioceres Group, Nutrecon and Gentle Tech became subsidiaries of Moolec, and the Company evolved into a diversified life sciences and food-tech
platform, as more fully described below in Note 1 &#x2013; The Group&#x2019;s business reorganization and general information - &#x201c;&lt;i&gt;The
Bioceres Group Business Combination Agreement&#x201d;&lt;/i&gt;. This business combination was accounted as reverse acquisition in accordance
with IFRS 3 &#x2013; &lt;i&gt;Business Combinations&lt;/i&gt;.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Subsidiaries&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Where the Group holds a controlling interest in
an entity, such entity is classified as a subsidiary. The Group exercises control over such an entity if all three of the following elements
are present: (i) the Group has the power to direct or cause the direction of the management and policies of the entity; (ii) the Group
is exposed to the variable returns of such entity; and (iii) the Group has power to affect the variability of such returns. Control is
reassessed whenever facts and circumstances indicate that there may be a change in any of these elements of control.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;De-facto control exists in situations where the
Group has the practical ability to direct the relevant activities of an entity without holding the majority of the voting rights. In determining
whether de facto control exists, the Group considers all relevant facts and circumstances, including:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;The relative share of the Group&#x2019;s voting rights with
respect both the size and dispersion of other parties who hold voting rights;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;Substantive potential voting rights held by the Group and
by other parties;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;Other contractual arrangements; and&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;Historic patterns in voting attendance.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The subsidiaries of the Group, all of which have
been included in the consolidated financial statements of the Group, are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: left"&gt;&lt;b&gt;Name&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt; &lt;td style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Principal activities&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"&gt;&lt;b&gt;Country of &lt;br/&gt;incorporation and &lt;br/&gt;principal place of &lt;br/&gt;business&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt; &lt;td style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Ref&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt; &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;% Equity &lt;br/&gt;interest &lt;br/&gt;06/30/2025&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt; &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;% Equity &lt;br/&gt;interest &lt;br/&gt;06/30/2024&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="vertical-align: top; width: 20%; text-align: left"&gt;Moolec Science Limited&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 38%; text-align: left"&gt;Investment in subsidiaries&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; width: 15%; text-align: center"&gt;United Kingdom&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 6%; text-align: center"&gt;b)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;100&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-171"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="vertical-align: top; text-align: left"&gt;AG Biomolecules LLC&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;Production and commercialization of agricultural products&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: center"&gt;United States&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;b)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-172"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="vertical-align: top; text-align: left"&gt;ValoraSoy S.A.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;Production and commercialization of agricultural products&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: center"&gt;Argentina&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;b)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-173"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="vertical-align: top; text-align: left"&gt;Nutrecon LLC&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;Investment in subsidiaries&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: center"&gt;United States&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;b)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-174"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="vertical-align: top; text-align: left"&gt;SynBio Powerlabs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;Production and commercialization of fermentation products&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: center"&gt;Finland&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;d)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;90&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-175"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="vertical-align: top; text-align: left"&gt;Gentle Tech&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: left"&gt;Investment in subsidiaries&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: center"&gt;British Virgin Islands&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;a),b)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;50&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="vertical-align: top; text-align: left"&gt;Gentle Farming&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: left"&gt;Investment in subsidiaries&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: center"&gt;British Virgin Islands&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;a),b)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;51&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;51&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left; vertical-align: top"&gt;G-FAS&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;Production and commercialization of sustainable agricultural equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: center"&gt;Argentina&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;a),b)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;64&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;64&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="vertical-align: top; text-align: left"&gt;Bioceres Group Limited&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;Investment in subsidiaries&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: center"&gt;United Kingdom&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;b)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;Bioceres Crop Solutions (BIOX)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: left"&gt;Research and development&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: center"&gt;United States&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;c)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;29.30&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28.75&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="vertical-align: top; text-align: left"&gt;Bioceres LLC&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;Investment in subsidiaries&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: center"&gt;United States&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;a)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="vertical-align: top; text-align: left"&gt;Bioceres S.A.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;Investment in subsidiaries&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: center"&gt;Argentina&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;a)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;89.93&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;79.72&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="vertical-align: top; text-align: left"&gt;Bioceres Tech Services LLC&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: left"&gt;Investment in subsidiaries&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: center"&gt;United States&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;a)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; a)&#160;Direct interests held by Bioceres Group Limited.&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;b)&#160;Direct
interest held by Moolec Science SA.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;c)&#160;Since
2023, the Group exercises &#x201c;de facto control&#x201d; over Bioceres Crop Solutions Corp, however, as stated in note Note 1 &#x2013;
The Group&#x2019;s business reorganization and general information - &#x201c;&lt;i&gt;The Bioceres Group Business Combination Agreement&#x201d;&lt;/i&gt;,
Bioceres Group Limited lost the &#x201c;de facto control&#x201d; on June 24, 2025. The subsidiary was deconsolidated as of June 30, 2025,
and the investment in it was measured using the equity method. The Group&#x2019;s consolidated result includes the results of that entity
up to the date of its deconsolidation. No results related to the loss of control have been recognized. Various notes to the financial
statements show the effect it has had on consolidated assets and liabilities, business segments and CGUs.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;d)&#160;Direct
interest held by Nutrecon LLC.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Special purpose and structured entities (&#x201c;SPE&#x201d;)&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;A structured entity is an entity that has been
designed so that voting or similar rights are not the dominant factor in deciding who controls the entity and the relevant activities
are directed by means of contractual arrangements. In these cases, the Company considers the purpose and design of the SPE, including
a consideration of the risks the SPE was expected to be exposed to, the risks it was designed to pass on to the parties involved with
the SPE and whether the Company is exposed to some or all of those risks or potential returns. One then considers which activities have
a significant impact on the SPE&#x2019;s returns and determines which parties have an ability to direct each of those activities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group controls an SPE when is exposed, or
has rights, to variable returns from its involvement with the SPE and has the ability to affect those returns through its power over the
SPE. Following the BIOX deconsolidation, the Group does not control any SPE.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory>
    <mlec:ShorttermPeriod contextRef="c0" id="ixv-43569">P12M</mlec:ShorttermPeriod>
    <mlec:CumulativeInflationRate contextRef="c91" decimals="2" id="ixv-43570" unitRef="pure">1</mlec:CumulativeInflationRate>
    <mlec:InflationOfAccumulatedYears contextRef="c91" id="ixv-43571">P3Y</mlec:InflationOfAccumulatedYears>
    <mlec:PercentageOfInflationAccumulated contextRef="c91" decimals="2" id="ixv-43572" unitRef="pure">1</mlec:PercentageOfInflationAccumulated>
    <mlec:ArgentinePriceIndexShares
      contextRef="c0"
      decimals="4"
      id="ixv-43573"
      unitRef="shares">8855.5681</mlec:ArgentinePriceIndexShares>
    <mlec:ArgentinePriceIndexShares
      contextRef="c5"
      decimals="4"
      id="ixv-43574"
      unitRef="shares">6351.7145</mlec:ArgentinePriceIndexShares>
    <mlec:PercentageOfIssuedAndOutstandingEquityInterests contextRef="c92" decimals="2" id="ixv-43575" unitRef="pure">0.50</mlec:PercentageOfIssuedAndOutstandingEquityInterests>
    <mlec:ConsiderationForIssuedOrdinaryShareValue
      contextRef="c92"
      decimals="-5"
      id="ixv-43576"
      unitRef="shares">6200000</mlec:ConsiderationForIssuedOrdinaryShareValue>
    <mlec:PrivateWarrantShares
      contextRef="c85"
      decimals="0"
      id="ixv-43577"
      unitRef="shares">450000</mlec:PrivateWarrantShares>
    <ifrs-full:NumberOfSharesIssued
      contextRef="c93"
      decimals="0"
      id="ixv-43578"
      unitRef="shares">500000</ifrs-full:NumberOfSharesIssued>
    <mlec:PrivateWarrantsExercisePrice
      contextRef="c85"
      decimals="2"
      id="ixv-43579"
      unitRef="usdPershares">20</mlec:PrivateWarrantsExercisePrice>
    <ifrs-full:NumberOfSharesIssued
      contextRef="c94"
      decimals="0"
      id="ixv-43580"
      unitRef="shares">132750</ifrs-full:NumberOfSharesIssued>
    <mlec:PercentageOfShare contextRef="c85" decimals="2" id="ixv-43581" unitRef="pure">0.10</mlec:PercentageOfShare>
    <ifrs-full:IssuedCapitalOrdinaryShares contextRef="c92" decimals="-5" id="ixv-43582" unitRef="usd">700000</ifrs-full:IssuedCapitalOrdinaryShares>
    <ifrs-full:NumberOfSharesIssued
      contextRef="c95"
      decimals="0"
      id="ixv-43583"
      unitRef="shares">50000</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="c96"
      decimals="0"
      id="ixv-43584"
      unitRef="shares">14750</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:DisclosureOfInterestsInSubsidiariesExplanatory contextRef="c0" id="ixv-21532">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The subsidiaries of the Group, all of which have
been included in the consolidated financial statements of the Group, are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: left"&gt;&lt;b&gt;Name&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt; &lt;td style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Principal activities&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"&gt;&lt;b&gt;Country of &lt;br/&gt;incorporation and &lt;br/&gt;principal place of &lt;br/&gt;business&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt; &lt;td style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Ref&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt; &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;% Equity &lt;br/&gt;interest &lt;br/&gt;06/30/2025&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt; &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;% Equity &lt;br/&gt;interest &lt;br/&gt;06/30/2024&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="vertical-align: top; width: 20%; text-align: left"&gt;Moolec Science Limited&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 38%; text-align: left"&gt;Investment in subsidiaries&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; width: 15%; text-align: center"&gt;United Kingdom&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 6%; text-align: center"&gt;b)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;100&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-171"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="vertical-align: top; text-align: left"&gt;AG Biomolecules LLC&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;Production and commercialization of agricultural products&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: center"&gt;United States&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;b)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-172"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="vertical-align: top; text-align: left"&gt;ValoraSoy S.A.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;Production and commercialization of agricultural products&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: center"&gt;Argentina&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;b)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-173"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="vertical-align: top; text-align: left"&gt;Nutrecon LLC&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;Investment in subsidiaries&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: center"&gt;United States&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;b)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-174"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="vertical-align: top; text-align: left"&gt;SynBio Powerlabs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;Production and commercialization of fermentation products&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: center"&gt;Finland&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;d)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;90&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-175"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="vertical-align: top; text-align: left"&gt;Gentle Tech&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: left"&gt;Investment in subsidiaries&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: center"&gt;British Virgin Islands&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;a),b)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;50&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="vertical-align: top; text-align: left"&gt;Gentle Farming&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: left"&gt;Investment in subsidiaries&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: center"&gt;British Virgin Islands&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;a),b)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;51&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;51&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left; vertical-align: top"&gt;G-FAS&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;Production and commercialization of sustainable agricultural equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: center"&gt;Argentina&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;a),b)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;64&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;64&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="vertical-align: top; text-align: left"&gt;Bioceres Group Limited&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;Investment in subsidiaries&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: center"&gt;United Kingdom&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;b)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;Bioceres Crop Solutions (BIOX)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: left"&gt;Research and development&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: center"&gt;United States&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;c)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;29.30&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28.75&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="vertical-align: top; text-align: left"&gt;Bioceres LLC&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;Investment in subsidiaries&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: center"&gt;United States&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;a)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="vertical-align: top; text-align: left"&gt;Bioceres S.A.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;Investment in subsidiaries&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: center"&gt;Argentina&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;a)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;89.93&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;79.72&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="vertical-align: top; text-align: left"&gt;Bioceres Tech Services LLC&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: left"&gt;Investment in subsidiaries&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="vertical-align: top; text-align: center"&gt;United States&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;a)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; a)&#160;Direct interests held by Bioceres Group Limited.&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;b)&#160;Direct
interest held by Moolec Science SA.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;c)&#160;Since
2023, the Group exercises &#x201c;de facto control&#x201d; over Bioceres Crop Solutions Corp, however, as stated in note Note 1 &#x2013;
The Group&#x2019;s business reorganization and general information - &#x201c;&lt;i&gt;The Bioceres Group Business Combination Agreement&#x201d;&lt;/i&gt;,
Bioceres Group Limited lost the &#x201c;de facto control&#x201d; on June 24, 2025. The subsidiary was deconsolidated as of June 30, 2025,
and the investment in it was measured using the equity method. The Group&#x2019;s consolidated result includes the results of that entity
up to the date of its deconsolidation. No results related to the loss of control have been recognized. Various notes to the financial
statements show the effect it has had on consolidated assets and liabilities, business segments and CGUs.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;d)&#160;Direct
interest held by Nutrecon LLC.&lt;/p&gt;</ifrs-full:DisclosureOfInterestsInSubsidiariesExplanatory>
    <ifrs-full:NameOfSubsidiary contextRef="c97" id="ixv-43585">Investment in subsidiaries</ifrs-full:NameOfSubsidiary>
    <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="c97" id="ixv-43586">United Kingdom</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="c97"
      decimals="2"
      id="ix_12_fact"
      unitRef="pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:NameOfSubsidiary contextRef="c99" id="ixv-43588">Production and commercialization of agricultural products</ifrs-full:NameOfSubsidiary>
    <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="c99" id="ixv-43589">United States</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="c99"
      decimals="2"
      id="ix_13_fact"
      unitRef="pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:NameOfSubsidiary contextRef="c101" id="ixv-43591">Production and commercialization of agricultural products</ifrs-full:NameOfSubsidiary>
    <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="c101" id="ixv-43592">Argentina</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="c101"
      decimals="2"
      id="ix_14_fact"
      unitRef="pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:NameOfSubsidiary contextRef="c103" id="ixv-43594">Investment in subsidiaries</ifrs-full:NameOfSubsidiary>
    <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="c103" id="ixv-43595">United States</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="c103"
      decimals="2"
      id="ix_15_fact"
      unitRef="pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:NameOfSubsidiary contextRef="c105" id="ixv-43597">Production and commercialization of fermentation products</ifrs-full:NameOfSubsidiary>
    <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="c105" id="ixv-43598">Finland</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="c105"
      decimals="2"
      id="ix_20_fact"
      unitRef="pure">0.90</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:NameOfSubsidiary contextRef="c107" id="ixv-43600">Investment in subsidiaries</ifrs-full:NameOfSubsidiary>
    <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="c107" id="ixv-43601">British Virgin Islands</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="c107"
      decimals="2"
      id="ix_0_fact"
      unitRef="pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="c108"
      decimals="2"
      id="ix_1_fact"
      unitRef="pure">0.50</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:NameOfSubsidiary contextRef="c109" id="ixv-43604">Investment in subsidiaries</ifrs-full:NameOfSubsidiary>
    <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="c109" id="ixv-43605">British Virgin Islands</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="c109"
      decimals="2"
      id="ix_2_fact"
      unitRef="pure">0.51</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="c110"
      decimals="2"
      id="ix_3_fact"
      unitRef="pure">0.51</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:NameOfSubsidiary contextRef="c111" id="ixv-43608">Production and commercialization of sustainable agricultural equipment</ifrs-full:NameOfSubsidiary>
    <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="c111" id="ixv-43609">Argentina</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="c111"
      decimals="2"
      id="ix_4_fact"
      unitRef="pure">0.64</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="c112"
      decimals="2"
      id="ix_5_fact"
      unitRef="pure">0.64</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:NameOfSubsidiary contextRef="c113" id="ixv-43612">Investment in subsidiaries</ifrs-full:NameOfSubsidiary>
    <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="c113" id="ixv-43613">United Kingdom</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="c113"
      decimals="2"
      id="ix_16_fact"
      unitRef="pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="c114"
      decimals="2"
      id="ix_17_fact"
      unitRef="pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:NameOfSubsidiary contextRef="c115" id="ixv-43616">Research and development</ifrs-full:NameOfSubsidiary>
    <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="c115" id="ixv-43617">United States</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="c115"
      decimals="4"
      id="ix_18_fact"
      unitRef="pure">0.293</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="c116"
      decimals="4"
      id="ix_19_fact"
      unitRef="pure">0.2875</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:NameOfSubsidiary contextRef="c117" id="ixv-43620">Investment in subsidiaries</ifrs-full:NameOfSubsidiary>
    <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="c117" id="ixv-43621">United States</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="c117"
      decimals="2"
      id="ix_6_fact"
      unitRef="pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="c118"
      decimals="2"
      id="ix_7_fact"
      unitRef="pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:NameOfSubsidiary contextRef="c119" id="ixv-43624">Investment in subsidiaries</ifrs-full:NameOfSubsidiary>
    <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="c119" id="ixv-43625">Argentina</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="c119"
      decimals="4"
      id="ix_8_fact"
      unitRef="pure">0.8993</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="c120"
      decimals="4"
      id="ix_9_fact"
      unitRef="pure">0.7972</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:NameOfSubsidiary contextRef="c121" id="ixv-43628">Investment in subsidiaries</ifrs-full:NameOfSubsidiary>
    <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="c121" id="ixv-43629">United States</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="c121"
      decimals="2"
      id="ix_10_fact"
      unitRef="pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="c122"
      decimals="2"
      id="ix_11_fact"
      unitRef="pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations contextRef="c0" id="ixv-21851">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;3.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS ISSUED
BY THE IASB&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;New standards and interpretations adopted
by the Group&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;a)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;The following new standards became applicable for the current
reporting period and adopted by the Group.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Amendments to IFRS 16 - Lease Liability in a Sale and Leaseback.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.3pt; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Amendments to IAS 1 &#x2013; Non-current liabilities with covenants.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.3pt; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Amendment to IAS 7 and IFRS 7 - Supplier Financing.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.3pt; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Amendments to IAS 7 - Statement of Cash Flows &amp;amp; to IFRS 7- Financial Instruments:
                                                                                                                     Disclosures.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.3pt; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;These new standards and amendments did not have
any material impact on the Group.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-size: 10pt"&gt;b)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;The following new standards are not yet adopted by the Group.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;i&gt;IFRS 19 &#x2013; Subsidiaries without Public Accountability. &lt;/i&gt;The standard is effective for annual
periods beginning on or after January 1, 2027.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.3pt; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;i&gt;Amendments to IFRS 9 and IFRS 7 - Amendments to the Classification and Measurement of Financial Instruments.
&lt;/i&gt;The amendments are effective for reporting periods beginning on or after January 1, 2026.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.3pt; text-align: justify; text-indent: -0.25in"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;i&gt;Amendments to IFRS 9 and IFRS 7 &#x2013; Contracts Referencing Nature-dependent Electricity. &lt;/i&gt;The
amendments are effective for annual periods beginning on or after January 1, 2026.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.3pt; text-align: justify; text-indent: -0.25in"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;i&gt;Annual Improvements to IFRS Accounting Standards&#x2014;Volume 11.&lt;/i&gt; The amendments are effective
for annual periods beginning on or after January 1, 2026.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;i&gt;Amendments to IAS 21- The Effects of Changes in Foreign Exchange Rates titled Lack of Exchangeability&lt;/i&gt;&lt;b&gt;.
&lt;/b&gt;The amendments are effective for annual reporting periods beginning on or after January 1, 2025.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.3pt; text-align: justify; text-indent: -0.25in"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;These amendments are not expected to have material
impact on the Group.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;i&gt;IFRS 18 &#x2013; Presentation and Disclosure in Financial Statements. &lt;/i&gt;This standard introduces new
requirements for the presentation and disclosure of income and expenses in the statement of profit or loss, including the introduction
of new defined subtotals such as Operating Profit and enhanced disaggregation requirements. The standard also includes additional guidance
on aggregation principles and requires disclosures about management-defined performance measures (MPMs) used in public communications
outside the financial statements. It is effective for annual periods beginning on or after January 1, 2027, with retrospective application
in accordance with IAS 8, subject to specific transitional reliefs.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.3pt; text-align: justify; text-indent: -0.25in"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group is analyzing the potential impact of
this standard on our financial statements, which is expected to mainly affect the presentation and structure of the primary financial
statements and related disclosures, but not the recognition or measurement of transactions.&lt;/p&gt;</ifrs-full:DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations>
    <ifrs-full:DescriptionWhetherChangeInAccountingPolicyIsMadeInAccordanceWithTransitionalProvisionsOfInitiallyAppliedIFRS contextRef="c123" id="ixv-43635">IFRS 16 - Lease Liability in a Sale and Leaseback.</ifrs-full:DescriptionWhetherChangeInAccountingPolicyIsMadeInAccordanceWithTransitionalProvisionsOfInitiallyAppliedIFRS>
    <ifrs-full:TitleOfInitiallyAppliedIFRS contextRef="c123" id="ixv-43636">IFRS 16</ifrs-full:TitleOfInitiallyAppliedIFRS>
    <ifrs-full:DescriptionWhetherChangeInAccountingPolicyIsMadeInAccordanceWithTransitionalProvisionsOfInitiallyAppliedIFRS contextRef="c124" id="ixv-43637">IAS 1 &#x2013; Non-current liabilities with covenants.</ifrs-full:DescriptionWhetherChangeInAccountingPolicyIsMadeInAccordanceWithTransitionalProvisionsOfInitiallyAppliedIFRS>
    <ifrs-full:TitleOfInitiallyAppliedIFRS contextRef="c124" id="ixv-43638">IAS 1</ifrs-full:TitleOfInitiallyAppliedIFRS>
    <ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory contextRef="c0" id="ixv-22016">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;4.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;b&gt;4.1.&#160;&lt;span style="text-decoration:underline"&gt;Cash and cash
equivalents&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;For the purposes of the statements of financial
position and statements of cash flows, cash and cash equivalents include cash on hand and in banks and short-term highly liquid investments.
Investments can be readily convertible to known amounts of cash and they are subject to insignificant risk of changes in value. In the
consolidated statements of financial position, bank overdrafts are included in borrowings within current liabilities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;4.2. &#160;&lt;span style="text-decoration:underline"&gt;Financial assets and liabilities&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify; text-indent: -0.3in"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group measures its financial assets at initial
recognition at fair value and subsequently at amortized cost using the effective interest method.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group has not irrevocably designated a financial
asset as measured at fair value through profit or loss to eliminate or significantly reduce a measurement or recognition inconsistency.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Financial assets at fair value through profit
or loss are measured at fair value through profit and loss due to the business model used in their negotiation and/or the contractual
characteristics of their cash flows.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Estimates&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group makes estimates of uncollectability
of its recorded receivables. Management analyzes trade account receivables in accordance with conventional criteria, adjusting the amount
through a charge of an allowance for bad debts upon recognition of the inability of third parties to afford their financial obligations
to the Group. Management specifically analyzes the accounts receivable, the historical bad debts, solvency of customers, current economic
trends and the changes to the payment conditions of customers to assess the adequate allowance for bad debts.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Offsetting of financial assets with financial
liabilities&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Financial assets and liabilities are offset and
presented for their net amount in the statements of financial position only when the Group has the right, legally enforceable, to compensate
the recognized amounts and has the intention to liquidate for the net amount or to settle the asset and cancel the liability simultaneously.&lt;/p&gt;&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;4.3. &lt;span style="text-decoration:underline"&gt;Inventories&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Inventories are recognized at cost initially and
subsequently at the lower of cost and net realizable value. Cost comprises all costs of purchase and conversion as well as other costs
incurred in bringing the inventories to their present location and condition.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Weighted average cost is used to determine the
cost of ordinarily interchangeable items.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Estimates&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group assesses the recoverability of inventories
considering their sale price, whether the inventories are damaged and whether they have become obsolete in whole or in part.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Net realizable value is the sale price estimated
to be attained in the ordinary course of business, less costs of completion and other selling expenses.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group sets up an allowance for obsolescence
or slow-moving inventories in relation to finished and in-process products. The allowance for obsolescence or slow-moving inventories
is recognized for finished products and in-process products based on an analysis by Management of the aging of inventory stocks.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;4.4. &lt;span style="text-decoration:underline"&gt;Biological assets&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify; text-indent: -0.3in"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Within current assets, growing crops are included
as biological assets, from the moment of sowing until the moment of harvest (approximately 5 to 7 months depending on the crop). At harvest
time the biological assets are transformed into agricultural products, including seed varieties for resale, and incorporated into the
inventory.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Costs are capitalized as biological assets if,
and only if, (a) it is probable that future economic benefits will flow to the entity, and (b) the cost can be measured reliably. The
Group capitalizes costs such as: planting, harvesting, weeding, seedlings, irrigation, agrochemicals, fertilizers and a systematic allocation
of fixed and variable production overheads that are directly attributable to the management of biological assets, among others.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Biological assets, both at initial recognition
and at each subsequent reporting date, are measured at fair value less costs to sell, except where fair value cannot be reliably measured.
Cost approximates fair value when little biological transformation has taken place since the costs were originally incurred or the impact
of biological transformation on price is not expected to be material.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Gains and losses that arise from measuring biological
assets at fair value less costs to sell and measuring agricultural produce at the point of harvest at fair value less costs to sell are
recognized in the statement of income in the period in which they arise in the line item &#x201c;Initial recognition and changes in fair
value of biological assets&#x201d;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;From the harvest time, agricultural products are
valued at net realizable value because there is a market asset, and the risk of non-sale is non-significant.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Generally, the estimation of the fair value of
biological assets is based on models or inputs that are not observable in the market and the use of unobservable inputs is significant
to the overall valuation of the assets. Unobservable inputs are determined based on the best information available. Key assumptions include
future market prices, estimated yields at the point of harvest, estimated production cycle, future cash flows, future costs of harvesting
and other costs, and estimated discount rate.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Market prices are generally determined by reference
to observable data in the principal market for the agricultural produce. Harvesting costs and other costs are estimated based on historical
and statistical data. Yields are estimated based on several factors, including the location of the farmland and soil type, environmental
conditions, infrastructure and other restrictions and growth at the time of measurement. Yields are subject to a high degree of uncertainty
and may be affected by several factors out of the Group&#x2019;s control including but not limited to extreme or unusual weather conditions,
plagues and other crop diseases, among other factors.&lt;/p&gt;&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;4.5. &lt;span style="text-decoration:underline"&gt;Basis of consolidation&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Business combinations&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;General&lt;/i&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group applies the acquisition method to account
for business combinations. The acquisition cost is measured as the aggregate of the consideration transferred for the acquisition of a
subsidiary, which is measured at fair value at the acquisition date, and the amount of any non-controlling interest in such subsidiary.
The Group recognizes any non-controlling interest in a subsidiary at the non-controlling interest&#x2019;s proportionate share of the recognized
amounts of subsidiary&#x2019;s identifiable net assets. The acquisition related costs are expensed as incurred.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Any contingent consideration to be transferred
by the Group is recognized at fair value at the acquisition date. The contingent consideration is classified as an asset or liability
that is a financial instrument under IFRS 9 is measured at fair value through profit or loss.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Goodwill is initially measured at cost, which
is the excess of the aggregate of the consideration transferred and the amount of the non-controlling interest and any previous interest
carried over the net identifiable assets acquired, and liabilities assumed.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;After initial recognition, goodwill is measured
at cost less any accumulated impairment losses. For impairment testing, goodwill acquired in a business combination is, as of the acquisition
date, allocated to each of the cash-generating units of the Group that is expected to benefit from the synergies of the combination, without
considering whether other assets or liabilities of the subsidiary are allocated to those units.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Any impairment in the carrying value is recognized
in the consolidated statement of comprehensive income. In the case of acquisitions in stages, prior to the write-off of the previously
held equity interest in the subsidiary, said interest is re-measured at fair value as of the date of acquisition of control over the subsidiary.
The result of the re-measurement at fair value is recognized in profit or loss.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;When a seller in a business combination has contractually
agreed to indemnify the Group for the result of a contingency or uncertainty related to the entirety or a portion of an asset or liability,
the Group recognizes an indemnification asset. The indemnification asset is measured on the same basis as the indemnification item. At
the end of each period, the Group measures the indemnification assets recognized at the acquisition date on the same basis as the indemnified
liability, subject to any contractual limitation on the amount and, for an indemnification asset that is not periodically measured at
fair value, based on Management&#x2019;s assessment of the recoverability of the indemnification asset. The Group derecognizes the indemnification
asset when it collects or sells it, or when it loses the right over it.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Reverse acquisitions&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In a reverse acquisition, the accounting acquirer
usually issues no consideration for the acquiree. Instead, the accounting acquiree usually issues its equity shares to the owners of the
accounting acquirer. Accordingly, the acquisition-date fair value of the consideration transferred by the accounting acquirer for its
interest in the accounting acquiree is based on the number of equity interests the legal subsidiary would have had to issue to give the
owners of the legal parent the same percentage equity interest in the combined entity that results from the reverse acquisition. The fair
value of the number of equity interests calculated in that way can be u sed as the fair value of consideration transferred in exchange
for the acquiree.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Consolidated financial statements prepared following
a reverse acquisition are issued under the name of the legal parent (accounting acquiree) but described in the notes as a continuation
of the financial statements of the legal subsidiary (accounting acquirer), with one adjustment, which is to adjust retroactively the accounting
acquirer&#x2019;s legal capital to reflect the legal capital of the accounting acquiree. That adjustment is required to reflect the capital
of the legal parent (the accounting acquiree). Comparative information presented in those consolidated financial statements also is retroactively
adjusted to reflect the legal capital of the legal parent (accounting acquiree).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Because the consolidated financial statements
represent the continuation of the financial statements of the legal subsidiary except for its capital structure, the consolidated financial
statements reflect:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-size: 10pt"&gt;a.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;the assets and liabilities of the legal subsidiary (the accounting acquirer) recognized and measured at
their pre-combination carrying amounts.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-size: 10pt"&gt;b.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;the assets and liabilities of the legal parent (the accounting acquiree) recognized and measured in accordance
with IFRS 3.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-size: 10pt"&gt;c.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;the retained earnings and other equity balances of the legal subsidiary (accounting acquirer) before the
business combination.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-size: 10pt"&gt;d.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;the amount recognized as issued equity interests in the consolidated financial statements determined by
adding the issued equity interest of the legal subsidiary (the accounting acquirer) outstanding immediately before the business combination
to the fair value of the legal parent (accounting acquiree). However, the equity structure (ie. the number and type of equity interests
issued) reflects the equity structure of the legal parent (the accounting acquiree), including the equity interests the legal parent issued
to effect the combination. Accordingly, the equity structure of the legal subsidiary (the accounting acquirer) is restated using the exchange
ratio established in the acquisition agreement to reflect the number of shares of the legal parent (the accounting acquiree) issued in
the reverse acquisition.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;When a reverse acquisition occurs, in calculating
the weighted average number of ordinary shares outstanding (the denominator of the earnings per share calculation) during the period in
which the reverse acquisition occurs:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-size: 10pt"&gt;a.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;the number of ordinary shares outstanding from the beginning of that period to the acquisition date shall
be computed on the basis of the weighted average number of ordinary shares of the legal acquiree (accounting acquirer) outstanding during
the period multiplied by the exchange ratio established in the merger agreement; and&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-size: 10pt"&gt;b.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;the number of ordinary shares outstanding from the acquisition date to the end of that period shall be
the actual number of ordinary shares of the legal acquirer (the accounting acquiree) outstanding during that period.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The basic earnings per share for each comparative
period before the acquisition date presented in the consolidated financial statements following a reverse acquisition shall be calculated
by dividing:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-size: 10pt"&gt;a.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;the profit or loss of the legal acquiree attributable to ordinary shareholders in each of those periods
by&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-size: 10pt"&gt;b.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;the legal acquiree&#x2019;s historical weighted average number of ordinary shares outstanding multiplied
by the exchange ratio established in the acquisition agreement.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Subsidiaries&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Subsidiaries are entities controlled by the Group.
Information about Group accounting policy is included in Note 2 &#x2013; &#x201c;&lt;i&gt;Accounting standards and Basis of Preparation&lt;/i&gt;&#x201d;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Non controlling interest&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;NCI are measured initially at their proportionate
share of the acquiree&#x2019;s identifiable net assets at the date of acquisition.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Change in ownership interest in subsidiaries
without change of control &lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Transactions with non-controlling interest that
do not result in a loss of control are accounted for as equity transactions - i.e., as transactions with the owners&#160;in their capacity
as owners. The recorded value corresponds to the difference between the fair value of the consideration paid and/or received and the relevant
share acquired and/or transferred of the carrying value of the net assets of the subsidiary.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Loss of control&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;When the Group loses control over a subsidiary,
it derecognizes the assets and liabilities of the subsidiary, and any related NCI and other components of equity. Any resulting gain or
loss is recognized in profit or loss.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Investments for which the Group does not exercise
control, but which are not accounted for under the equity method due to meeting the definition of a financial asset, are measured at fair
value through profit or loss in accordance with IFRS 9 Financial Instruments.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;When an investee (either a subsidiary or other
investment) enters a liquidation process and the Group no longer retains the ability to direct its relevant activities&#x2014;such as through
the formal appointment of a liquidator by the investee&#x2019;s Board of Directors&#x2014;the Group concludes that control has been lost.
In such cases, the date of the liquidator&#x2019;s appointment is considered the derecognition event for purposes of IFRS 10.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Associate and joint arrangements &lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;An associate is an entity over which the Group
exerts significant influence. Significant influence is the power to participate in financial and operating policy decision-making at such
entity, but it does not involve control or joint control over those policies.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group is a party to a joint arrangement when
there is a contractual arrangement that confers joint control over the relevant activities of the arrangement to the Group and at least
one other party. Joint control is assessed under the same principles as control over subsidiaries.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group classifies its interests in joint arrangements
as either:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;i&gt;Joint ventures&lt;/i&gt;: where the group has rights to only
the &lt;i&gt;net assets &lt;/i&gt;of the joint arrangement.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: justify; text-indent: -14.2pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;i&gt;Joint operations&lt;/i&gt;: where the group has both the rights
to the assets and obligations for the liabilities of the joint arrangement.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In assessing the classification of interests in
joint arrangements, the Group considers:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;The structure of the joint arrangement;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;The legal form of joint arrangements structured through a
separate vehicle;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;The contractual terms of the joint arrangement agreement;
and&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;Any other facts and circumstances (including any other contractual
arrangements).&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group accounts for its interests in joint
ventures and associates using the equity method, where the Group&#x2019;s share of post-acquisition profits and losses and other comprehensive
income is recognized in the Consolidated statement of profit and loss and other comprehensive income.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Losses in excess of the Group&#x2019;s investment
in the joint venture and associates are recognized only to the extent that the Group has incurred legal or constructive obligations or
made payments on behalf of the joint venture.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Profits and losses arising on transactions between
the Group and its joint ventures and associates are recognized only to the extent of unrelated investors&#x2019; interests in the joint
venture and/or associates. The Group&#x2019;s share in a joint venture and/or associates&#x2019; profits and losses resulting from a transaction
is eliminated against the carrying amount of investment in the joint venture and/or associates through the line &#x201c;share of profit
(or loss) of joint ventures and associates&#x201d; in the Consolidated statements of profit or loss and other comprehensive income.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Any premium paid for an investment in a joint
venture and/or associates above the fair value of the Group&#x2019;s share of the identifiable assets, liabilities and contingent liabilities
acquired is capitalized and included in the carrying amount of the investment in the joint venture and/or associates. Where there is objective
evidence that the investment in a joint venture and/or associates has been impaired, the carrying amount of the investment is tested for
impairment in the same way as other non-financial assets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;When the Group loses significant influence in
an associate or joint control over a joint venture, it measures and recognizes any investment held at fair value. Any difference between
the carrying amount of the associate or joint venture when losing significant influence or joint control and the fair value of the held
investment and sale revenue are recognized in profit or loss.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group accounts for its interests in joint
operations by recognizing its share of assets, liabilities, revenues and expenses in accordance with its contractually conferred rights
and obligations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;For all joint arrangements structured in separate
vehicles the Group must assess the substance of the joint arrangement in determining whether it is classified as a joint venture or joint
operation. This assessment requires the Group to consider whether it has rights to the joint arrangement&#x2019;s net assets (in which
case it is classified as a joint venture), or rights to and obligations for specific assets, liabilities, expenses, and revenues (in which
case it is classified as a joint operation).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Paragraph 18 of IAS 28 states when an investment
in an associate or a joint venture is held by, or is held indirectly through, an entity that is a venture capital organization, or a mutual
fund, unit trust and similar entities, the entity may elect to measure that investment al fair value through profit or loss in accordance
with IFRS 9.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company has elected to measure the investment
in associates held through Theo I SCSp at fair value through profit or loss in accordance with IFRS 9.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Estimates&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;There is uncertainty regarding Management&#x2019;s
estimates of the Group&#x2019;s ability to recover the carrying amounts of the investments in joint ventures, since such estimates depend
on the joint ventures&#x2019; ability to generate sufficient funds to complete the development projects, the future outcome of the project
deregulation process and the amounts and timing of the cash flows from projects, among other future events.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Management assesses whether there are impairment
indicators and, if any, it performs a recoverability analysis.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Management estimates of the recoverability of
these investments represent the best estimate based on available evidence, the existing facts and circumstances, using reasonable and
provable assumptions in the cash flow projections.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Therefore, the consolidated financial statements
do not include adjustments that would be required if the Group were unable to recover the carrying amount of the above-mentioned assets
by generating sufficient economic benefits in the future.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Transactions eliminated on consolidation&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Intra-group balances and transactions, and any
unrealized income and expenses (except for foreign currency transaction gains and losses) arising from intra-group transactions, are eliminated.
Unrealized gains arising from transactions with equity-accounted investees are eliminated against the investment to the extent of the
Group&#xb4;s interest in the investee. Unrealized losses are eliminated in the same way as unrealized gains, but only to the extent that
there is no evidence of impairment.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;4.6. &lt;span style="text-decoration:underline"&gt;Impairment assessment of Goodwill and Intangible assets&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Impairment tests on goodwill and intangible assets
not yet available for use or with indefinite useful lives, are undertaken annually at the end of the reporting period. Other non-financial
assets are subject to impairment tests whenever events or changes in circumstances indicate that their carrying amount may not be recoverable.
Where the carrying value of an asset exceeds its recoverable amount (i.e. the higher of value in use and fair value less costs to sell),
the asset is written down accordingly.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Where it is not possible to estimate the recoverable
amount of an individual asset, the impairment test is carried out on the smallest group of assets to which it belongs for which there
are separately identifiable cash flows (its Cash Generating Unit or CGU). Goodwill is allocated on initial recognition to each of the
Group&#x2019;s CGUs that are expected to benefit from a business combination that gives rise to the goodwill.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Impairment charges are included in profit or loss,
except to the extent they reverse gains previously recognized in other comprehensive income. An impairment loss recognized for goodwill
is not reversed.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Estimates&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Impairment testing of goodwill and intangible
assets not yet available for use or with indefinite useful lives, requires the use of significant assumptions for the estimation of future
cash flows and the determination of discount rates. The significant assumptions and the determination of discount rates for the impairment
testing of goodwill are further explained in Note 7.9 - Goodwill.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;4.7. &lt;span style="text-decoration:underline"&gt;Property, plant and equipment&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Property, plant and equipment items are initially
recognized at cost. In addition to the purchase price, cost also includes costs directly attributable to such property, plant and equipment
items. There are no unavoidable costs with respect to dismantling and removing items. The cost of property, plant and equipment items
acquired in a business combination is their fair value at the acquisition date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Depreciation is calculated using the straight-line
method to allocate the property, plant or equipment items&#x2019; cost or revalued amounts, net of their residual values, over their estimated
useful lives or, in the case of leasehold improvements and certain leased plant and equipment, the shorter lease term as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Research instruments: 3 to 10 years&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Office equipment: 5 to 10 years&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Vehicles: 5 years&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Computer equipment and software: 3 years&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Fixture and fittings: 10 years&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Machinery and equipment: 5 to 10 years&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Buildings: 50 years&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Useful lives and depreciation methods are reviewed
every year as required by IAS 16.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As a result of the business combination completed
on &lt;span style="font-weight: normal"&gt;June 16, 2025&lt;/span&gt;, and the BIOX deconsolidation, the structure, scale and operations of the Group
changed significantly compared with the former reporting entity. The transaction resulted in a new combined entity whose asset base, operational
model and strategic focus differ materially from those of the pre-combination entity.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Given these changes, management re-assessed the
appropriateness of the accounting policy applied to property, plant and equipment. Prior to the business combination, the former entity
measured certain classes of property, plant and equipment under the &lt;span style="font-weight: normal"&gt;revaluation model&lt;/span&gt;. Following
the acquisition, and considering the characteristics of the combined business, management determined that the &lt;span style="font-weight: normal"&gt;cost
model&lt;/span&gt; provides more reliable and relevant information for users of the financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Accordingly, beginning on &lt;span style="font-weight: normal"&gt;June
16, 2025&lt;/span&gt;, the Group &lt;span style="font-weight: normal"&gt;discontinued the revaluation model&lt;/span&gt; and now measures all property plant
and equipment at &lt;span style="font-weight: normal"&gt;cost less accumulated depreciation and impairment losses&lt;/span&gt;. The change has been
accounted for prospectively in accordance with applicable IFRS requirements, as it results from management&#x2019;s reassessment of the
accounting policies of the newly formed reporting entity rather than from a voluntary change.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The carrying amounts of property, plant and equipment
previously measured under the revaluation model became their deemed cost at the date the new policy was adopted. No restatement of comparative
periods was required.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Prior to The Bioceres Group Business Combination
Agreement and the BIOX deconsolidation, the assets under items Land and Buildings, were accounted for at fair value arising from the last
revaluation performed, applying the revaluation model indicated by IAS 16. Starting with the fiscal year ended on June&#160;30, 2024,
the Group modified its Property, Plant, and Equipment valuation policy by changing the revaluation frequency for items classified under
Buildings and Land. The revaluation must never exceed five years between each occurrence, in compliance with the maximum periods established
by accounting standards, or whenever there are indications that the carrying amount differs significantly from the amount that could be
determined using fair value at the end of the reporting year.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;To obtain fair values, the existence or not of
an active market it was considered for the assets in their current status. For those assets for which an active market in their current
status existed, the fair values were determined based on their market values. For the remaining cases, the market values of comparable
new assets were analyzed, applying a discount based on the status and wear of each asset and considering the characteristics of each of
the revalued assets (for example, improvements made, maintenance status, level of productivity, use, etc.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Estimates&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group used to carry certain classes of property,
plant and equipment under the revaluation model under IAS 16. The revaluation model requires that the Group carry property, plant and
equipment at revalued amounts, being fair value at the date of revaluation less any subsequent accumulated depreciation and any subsequent
accumulated impairment losses. IAS 16 requires that the Group carry out these revaluations with sufficient regularity so that the carrying
amounts of its property, plant and equipment do not differ materially from that which would be determined using fair value at the end
of a reporting period. The determination of fair value at the date of revaluation requires judgments, estimates and assumptions based
on market conditions prevailing at the time of any such revaluation. Changes to any of the Group&#x2019;s judgments, estimates or assumptions
or to the market conditions subsequent to a revaluation will result in changes to the fair value of property, plant and equipment.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group used to prepare the corresponding revaluations
on a regular basis taking into account the work of independent appraisers. The Group uses different valuation techniques depending on
the class of property being valued. Generally, the Group determines the fair value of its industrial buildings and warehouses based on
a depreciated replacement cost approach. The Group determines the fair value of its land based on active market prices adjusted, if necessary,
for differences in the nature, location or condition of the specific asset. If this information is not available, the Group may use alternative
valuation methods, such as recent prices in less active markets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Property valuation is a significant area of estimation
uncertainty. Fair values used to be prepared regularly by Management, taking into account independent valuations. The determination of
fair value for the different classes of property, plant and equipment is sensitive to the selection of various significant assumptions
and estimates. Changes in those significant assumptions and estimates could materially affect the determination of the revalued amounts
of property, plant and equipment. The Group utilizes historical experience, market information and other internal information to determine
and/or review the appropriate revalued amounts.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following were the most significant assumptions
used in the preparation of the revalued amounts for its classes of property, plant and equipment:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;a)&#160;Land:
The Group generally used to use the market price of a square meter of land for the same or similar location as the most significant assumption
to determine the revalued amount. The Group typically used to use comparable land sales in the same location to assess appropriateness
of the value of its land.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;b)&#160;Industrial
buildings and warehouses: The Group generally used to determine the construction cost of a new asset and then the Group adjusts it for
normal wear and tear. Construction prices may include, but are not limited to, construction materials, labor costs, installation and assembly
costs, site preparation, professional fees and applicable taxes. Construction costs may differ significantly from year to year and are
subject to macroeconomic changes in the economy where the Group operates, such as the impact of inflation and foreign exchange rates.
The construction cost of its industrial buildings and warehouses is determined on a US dollar per constructed square meter basis, while
the construction cost of its mills, facilities and grain storage facilities is determined by reference to their total capacity measured
in tons milled or stored, respectively. A 5% increase or decrease in the construction costs or the estimate of normal wear and tear relating
to such assets could have an impact of $1.2 million on their revalued amounts.&lt;/p&gt;&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;4.8. &lt;span style="text-decoration:underline"&gt;Leased assets&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Leases are recognized as a right-of-use asset
and corresponding liability at the date of which the leased asset is available for use by the Group. Each lease payment is allocated between
the liability and finance cost. The finance cost is charged to profit or loss over the lease period so as to produce a constant periodic
rate of interest on the remaining balance of the liability for each period. The right-of-use asset is depreciated over the shorter of
the asset&#x2019;s useful life and the lease term on a straight-line basis.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In determining the lease term, the Company considers
all facts and circumstances that create an economic incentive to exercise an extension option or not exercise a termination option. Extension
options (or periods after termination options) are only included in the lease term if the lease is reasonably certain to be extended (or
not terminated).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Short term leases are recognized on a straight-line
basis as an expense in the income statement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;At initial recognition, the right-of-use asset
is measured considering the value of the initial measurement of the lease liability; any lease payments made at or before the commencement
date, less any lease incentives; and any initial direct costs incurred by the lessee. After initial recognition, the right-of-use assets
are measured at cost, less any accumulated depreciation and/or impairment losses, and adjusted for any re-measurement of the lease liability.
Depreciation of the right-of-use asset is calculated using the straight-line method over the estimated duration of the lease contract.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The lease liability is initially measured at the
present value of the lease payments that are not paid at such date, including variable lease payments that depend on an index or rate,
initially measured using the index or rate as of the commencement date; amounts expected to be payable by the lessee under residual value
guarantees; the exercise price of a purchase option if the lessee is reasonably certain to exercise that option; payments of penalties
for terminating the lease, if the lease term reflects the lessee exercising an option to terminate the lease; and fixed payments, less
any lease incentives receivable. After the commencement date, the Company measures the lease liability by increasing the carrying amount
to reflect interest on the lease liability; reducing the carrying amount to reflect lease payments made; and re-measuring the carrying
amount to reflect any reassessment or lease modifications.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The above-mentioned inputs for the valuation of
the right of use assets and lease liabilities including the determination of the contracts within the scope of the standard, the contract
term ant interest rate used in the discounted cash flow involved a management&#x2019;s estimations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;4.9. &lt;span style="text-decoration:underline"&gt;Intangible assets&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;a) Externally acquired intangible assets&lt;/b&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Externally acquired intangible assets are initially
recognized at acquisition date fair value (which is considered as their cost). After initial recognition, those assets are measured at
cost less accumulated amortization and accumulated impairment losses.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Intangible assets acquired from third parties
have an estimated useful life as follows (in years):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Software: 3 years&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Trademarks and patents: 5 years&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Certification ISO Standards: 3 years&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Useful lives and amortization methods are reviewed
every year as required by IAS 38.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Estimates&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;To value acquired intangible assets, valuation
techniques generally accepted in the market are applied, based mainly on the revenue approach (such as excess earnings, relief from royalty,
and with or without), considering the characteristics of the assets to be valued and available information to estimate their acquisition
date fair value. Application of these valuation techniques requires the use of several assumptions related to future cash flows and the
discount rate.&lt;/p&gt;&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;b) Internally generated intangible assets (development costs)&lt;/b&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Expenditure on internally developed products is
capitalized if it can be demonstrated that:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;It is technically feasible to develop the product for it
to be sold;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;Adequate resources are available to complete the development;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;There is an intention to complete and sell the product;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;The Group is able to sell the product;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;Sale of the product will generate future economic benefits;
and&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;Expenditure on the project can be measured reliably.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Development expenditure not satisfying the above
criteria and expenditure on the research phase of internal projects are recognized in the consolidated statement of profit or loss and
other comprehensive income as incurred (Note 8.3 - R&amp;amp;D classified by nature).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Capitalized development costs are amortized using
the straight-line method over the periods the Group expects to benefit from selling the products developed (Note 7.8 &#x2013; Intangible
assets).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Useful lives and amortization methods are reviewed
every year as required by IAS 38.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The research and development process can be divided
into several discrete steps or phases, which generally begin with discovery, validation and development and end with regulatory approval
and commercial launch. The process for developing seed traits is relatively similar for both GM and non-GM traits. However, the two differ
significantly in later phases of development. For example, obtaining regulatory approval for GM seeds is a far more comprehensive and
lengthy process than for non-GM seeds. Although breeding programs and industrial biotechnology solutions may have shorter or simpler phases
than those described below, the Group has used the industry consensus for seed-trait development phases to characterize its technology
portfolios, which is generally divided into the following six phases:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;i) Discovery: The first phase in the technology
development process is the discovery or identification of candidate genes or genetic systems, metabolites, or microorganisms potentially
capable of enhancing specified plant characteristics or enabling an agro-industrial biotech solution.&lt;/p&gt;

&lt;p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;ii) Proof of concept: Upon successful validation
of the technologies in model systems (&lt;i&gt;in vitro &lt;/i&gt;or &lt;i&gt;in vivo&lt;/i&gt;), promising technologies graduate from discovery and are advanced
to the proof of concept phase. The goal of this phase is to validate a technology within the targeted organism before moving forward with
technology escalation activities or extensive field validation.&lt;/p&gt;

&lt;p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;iii) Early development: In this phase, field tests
commenced in the proof of concept phase are expanded to evaluate various permutations of a technology in multiple geographies and growing
cycles, as well as other characteristics in order to optimize the technology&#x2019;s performance in the targeted organisms. The goal of
the early development phase is to identify the best mode of use of a technology to define its performance concept.&lt;/p&gt;

&lt;p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;iv) Advanced development and deregulation: In
this phase, extensive field tests are used to demonstrate the effectiveness of the technology for its intended purpose. In the case of
GM traits, the process of obtaining regulatory approvals from government authorities is also initiated during this phase, and tests are
performed to evaluate the potential environmental impact of modified plants. For solutions involving microbial fermentation, industrial-scale
runs are conducted.&lt;/p&gt;

&lt;p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;v) Pre-launch: This phase involves finalizing
the regulatory approval process and preparing for the launch and commercialization of the technology. The range of activities in this
phase includes seed increases, pre-commercial production, and product and solution testing with selected customers. Usually, a more detailed
marketing strategy and preparation of marketing materials occur during this phase.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: 0pt; text-align: justify"&gt;vi) Product launch: In general, this phase, which
is the last milestone of the research and development process, is carried out by the Group, the joint ventures and/or the Group&#x2019;s
technology licensees. When technology is commercialized through the joint ventures or technology licensees, a successful product launch
will trigger royalty payments to the Group, which are generally calculated as a percentage of the net sales realized by the technology
and captured upon commercialization.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Demonstrability of technical feasibility generally
occurs when the project reaches the &#x201c;advanced development and deregulation&#x201d; phase because at this stage success is considered
to be probable.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;c)&#160;Intangible
assets acquired in a business combination&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Intangible assets acquired in a business combination
and recognized separately from goodwill are initially recognized at acquisition date fair value (which is considered as their cost). After
initial recognition, those assets are measured at cost less accumulated amortization and accumulated impairment losses in the same manner
as intangible assets acquired separately.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Intangible assets acquired in a business combination
have an estimated useful life as follows (in years):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Product development: 20 &#x2013; 25 years&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Trademarks: 20 years&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Customer loyalty: 14 - 26 years&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Estimates&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;To value intangible assets acquired from a business
combination, valuation techniques generally accepted in the market were applied, based mainly on the revenue approach (such as excess
earnings, relief from royalty, and with or without), considering the characteristics of the assets to be valued and available information
to estimate their acquisition date fair value. Application of these valuation techniques requires the use of several assumptions related
to future cash flows and the discount rate.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;4.10. &lt;span style="text-decoration:underline"&gt;Investment properties&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Investment properties shall be measured initially
at its cost. The cost of a purchased investment property comprises its purchase price and any directly attributable expenditure. Directly
attributable expenditure includes, for example, professional fees for legal services, property transfer taxes and other transaction costs.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In the measurement after initial recognition,
the Group has chosen the cost model for all investment properties.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;4.11. &lt;span style="text-decoration:underline"&gt;Borrowings&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group measures its borrowings at initial recognition
at fair value and, subsequently, are measured at amortized cost using the effective interest rate method.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Borrowing costs, either generic or specific, attributable
to the acquisition, construction or production of assets that necessarily take a substantial period of time to get ready for their intended
use or sale (qualifying assets) are included in the cost of the assets until the moment that they are substantially ready for use or sale.
Income earned on the temporary investments of funds generated in specific borrowings still pending use in the qualifying assets, are deducted
from the total of financing costs potentially eligible for capitalization.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;All other loan costs are recognized under financial
costs, through profit and loss.&lt;/p&gt;&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;4.12. &lt;span style="text-decoration:underline"&gt;Convertibles notes&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Financial liabilities, like convertible notes
that do not meet the &#x201c;fixed for fixed&#x201d; condition, are classified at their inception at fair value through profit or loss or
at amortized cost, using the effective interest amortization method.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;4.13. &lt;span style="text-decoration:underline"&gt;Employee benefits&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Employee benefits are expected to be settled wholly
within 12 months after the end of the reporting period and are presented as current liabilities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The accounting policies related to incentive payments
based on shares, if any, are detailed in Note 19 &#x2013; Share-based payments.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;4.14.&#160;&lt;span style="text-decoration:underline"&gt;Provisions&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group has recognized provisions for liabilities
of uncertain timing or amount. The provision is measured at the best estimate of the expenditure required to settle the obligation at
the end of the reporting period, discounted at a pre-tax rate reflecting current market assessments of the time value of money and risks
specific to the liability.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;4.15.&#160;&lt;span style="text-decoration:underline"&gt;Warrant
liabilities &lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As part of the business combination, the Group
acquired public warrants and private warrants.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Public Warrants: These instruments are initially
recognized at fair value on the date the derivative contract is entered into and are subsequently remeasured to fair value at the end
of each reporting period. Gains and losses arising from changes in fair value are recognized in profit or loss.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;These warrants are measured at Level 1 fair value,
based on their quoted market price.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Private Warrants: These instruments are measured
at fair value using valuation techniques, including the Black-Scholes model.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;These warrants are classified as Level 3 fair
value measurements, as they rely on significant unobservable inputs.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;4.16.&#160;&lt;span style="text-decoration:underline"&gt;Revenue
recognition&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Revenue is recognized when control has been transferred
to the buyer. Transfers of control vary depending on the individual terms of the sales contract. Revenues are recognized when control
of the products has been transferred, which generally means that the products have been delivered to the customer and there is no unfulfilled
obligation that could affect a customer&#x2019;s acceptance of the products. Generally, acceptance occurs upon shipment or delivery but
ultimately depends on the terms of the underlying contracts. The customer is then invoiced at the agreed-upon price with the usual payment
terms for each geographical region. Those payment terms do not contain a significant financing component.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The timing of performance sometimes differs from
the timing that the associated consideration is received from the customer, thus resulting in the recognition of a contract asset or contract
liability. The Company recognizes a contract liability if the customer&#x2019;s payment of consideration is received prior to completion
of the related performance obligation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As a part of the Company&#x2019;s customary business
practices, the Company offers a number of sales incentives to the customers, including volume discounts, retailer incentives, prepayment
options and other product rebates. For all such contracts that include any variable consideration, the Company estimates the amount of
variable consideration that should be included in the transaction price utilizing either the expected value method or the most likely
amount method, depending on the nature of the variable consideration. Variable consideration is included in the transaction price if,
in the judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur. Although determining
the transaction price for consideration requires significant judgment, the Company has meaningful historical experience with incentives
provided to customers and estimate the expected consideration in view of historical patterns of incentive payouts. These estimates are
reassessed each reporting period.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company also offer an assurance warranty,
which gives customers a refund or exchange right in the case the delivered product does not conform to specifications. Replacement products
are accounted for under the warranty guidance if the customer exchanges one product for another of the same type, quality, and price.
The Company has significant experience with historical return patterns and use this experience to include returns in the estimate of transaction
price.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;With respect to services, the Company mainly provides
R&amp;amp;D and seed treatment services. Revenue associated with services is recognized by reference to the stage of completion of the transaction
at the end of the reporting period. Each of the services to be provided has a detailed work plan in which all activities to be rendered
are listed. The stage of completion for services is determined in accordance with the execution of the performed tasks listed in the respective
work plan. The level of execution of such services is provided by the Company&#x2019;s technical experts, who provide information relating
to the transfer of goods or services. The Company has no material revenue for services that cannot be reliably estimated.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Revenue for usage-based royalties relating to
licensed intellectual property rights is recognized at the later of when the performance obligation is satisfied and when a sale or use
occurs.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Typically, the Company&#x2019;s average payment
terms range from 130 to 160 days at a consolidated level. Longer terms may be granted in limited circumstances; however, the effects of
such sales are not material to the consolidated financial statements. Those payment terms do not contain a significant financing component.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;4.17.&#160;&lt;span style="text-decoration:underline"&gt;Government
grants&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Government grants are recognized where there is
reasonable assurance that the grant will be received and all attached conditions will be complied with. When the grant relates to an expense
item, it is recognized as income on a systematic basis over the periods that the related costs, for which it is intended to compensate,
are expensed. When the grant relates to an asset, it is recognized as income in equal amounts over the expected useful life of the related
asset. Management elected this accounting policy because the Group determined it better shows the financial effect of government grants
in the consolidated financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;When the Group receives grants of non-monetary
assets, the asset and the grant are recorded at nominal amounts and released to profit or loss over the expected useful life of the asset.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The difference between the money obtained under
government loans at subsidized rates and the carrying amount of those loans is treated as a government grant, in accordance with IAS 20.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;4.18.&#160;&lt;span style="text-decoration:underline"&gt;Income
tax&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Income tax expense comprises current and deferred
tax. It is recognized in profit or loss except to the extent that it relates to a business combination, or items recognized directly in
equity or in OCI.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group has determined that interest and penalties
related to income taxes, including uncertain tax treatments, do not meet the definition of income taxes, and therefore accounted for them
under IAS 37 &lt;i&gt;Provisions, Contingent Liabilities and Contingent Assets.&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group has determined that the global minimum
top-up tax &#x2013; which it is required to pay under Pillar Two legislation &#x2013; is an income tax in the scope of IAS 12. Pillar Two
legislation is not applicable to Moolec Science SA in accordance with current thresholds.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Current tax&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Current tax comprises the expected tax payable
or receivable on the taxable income or loss for the year and any adjustment to the tax payable or receivable in respect of previous years.
The amount of current tax payable or receivable is the best estimate of the tax amount expected to be paid or received that reflects uncertainty
related to income taxes, if any. It is measured using tax rates enacted or substantively enacted at the reporting date. Current tax also
includes any tax arising from dividends.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Current tax assets and liabilities are offset
only if certain criteria are met.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Deferred tax&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Deferred tax assets and liabilities are recognized
where the carrying amount of an asset or liability in the Consolidated statement of financial position differs from its tax base, except
for differences arising on:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;The initial recognition of goodwill;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;The initial recognition of an asset or liability in a transaction
which is not a business combination and at the time of the transaction affects neither accounting or taxable profit; and&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;Investments in subsidiaries and jointly controlled entities
where the Group is able to control the timing of the reversal of the difference and it is probable that the difference will not reverse
in the foreseeable future.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Recognition of deferred tax assets is restricted
to those instances where it is probable that taxable profit will be available against which the difference can be utilized.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The amount of the asset or liability is determined
using tax rates that have been enacted or substantively enacted by the end of the reporting period and are expected to apply when the
deferred tax liabilities / (assets) are settled / (recovered).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Deferred tax assets and liabilities are offset
when the Group has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities
relate to taxes levied by the same tax authority on either:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;The same taxable entity within the Group, or&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;Different entities within the Group which intend either to
settle current tax assets and liabilities on a net basis, or to realize the assets and settle the liabilities simultaneously, in each
future period in which significant amounts of deferred tax assets or liabilities are expected to be settled or recovered.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;4.19.&#160;&lt;span style="text-decoration:underline"&gt;Share-based
payments&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Prior to the Business Combination and the BIOX
deconsolidation, certain executives and directors of the Group were granted incentives in the form of shares and options to purchase shares
as consideration for services.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The cost of these share-based transactions is
determined based on their fair value at the date upon which such incentives are granted using a valuation model that is appropriate in
the circumstances.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;This cost is recognized as an expense together
with an increase in equity throughout the period in which the service or performance conditions are satisfied (i.e., the vesting period).
The accumulated expense recorded in connection with these transactions at the end of each year until the vesting date reflects the time
elapsed between the vesting period and Management&#x2019;s best estimate of the number of equity instruments that will vest. The charge
to income/loss for the period represents the variation in the accumulated expense recorded between the beginning and the end of the year.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Non-market related service and performance conditions
are not taken into account when determining the grant date fair value of the equity instruments, but the probability that the conditions
are fulfilled is assessed as part of Management&#x2019;s best estimate of the number of equity instruments that will vest. Market-related
performance conditions are reflected in the grant date fair value. Any other conditions related to equity-settled share-based payment
transactions but without a service requirement are considered as non-vesting conditions. Non-vesting conditions are reflected in the fair
value of the equity instruments and are charged to income/loss immediately unless there are service and/or performance conditions as well.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;No amount is recognized for transactions that
will not vest because non-market related performance conditions and/or service conditions were not satisfied. When transactions include
market-related conditions or non-vesting conditions, the transactions are considered to be vested, irrespective of whether a market-related
condition or the non-vesting condition is satisfied, provided that all the other performance and/or service conditions are met.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;When the terms and conditions of an equity-settled
share-based payment transaction are modified, the minimum expense recognized is the grant date fair value, unmodified, provided that the
original terms have been complied with. An additional expense, measured at the date of modification, is recognized for any modification
that increases the total fair value of the share-based payment transaction, or is otherwise beneficial to the employee.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;When the transaction is settled by the Group or
by the counterparty, any remainder of the fair value is charged to income immediately.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The dilutive effect of current options is considered
in the calculation of the diluted earnings per share.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Estimates&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The estimate of the fair value of equity-settled share-based payment
transactions requires a determination to be made of the most adequate option pricing model to apply depending on the terms and conditions
of the arrangement. This estimate also requires a determination of those factors most appropriate to the pricing model, including the
expected life of the option and the expected volatility of the share price upon the basis of which assumptions are made. The Group measures
the fair value of these transactions at the grant date applying the Black-Scholes formula adjusted to consider the possible dilutive effect
of the future exercise of the share options granted on their estimated fair value at grant date, as established in paragraph B41 of IFRS
2. The assumptions used for the estimate of the fair value of these transactions are disclosed in Note 19 &#x2013; Share-based payment
and will not necessarily take place in the future.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of June 30, 2025 no equity awards are outstanding.&lt;/p&gt;</ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents contextRef="c0" id="ixv-22027">&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;b&gt;4.1.&#160;&lt;span style="text-decoration:underline"&gt;Cash and cash
equivalents&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;For the purposes of the statements of financial
position and statements of cash flows, cash and cash equivalents include cash on hand and in banks and short-term highly liquid investments.
Investments can be readily convertible to known amounts of cash and they are subject to insignificant risk of changes in value. In the
consolidated statements of financial position, bank overdrafts are included in borrowings within current liabilities.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents>
    <mlec:DescriptionOfAccountingPolicyForFinancialAssetsAndLiabilitiesPolicyTextBlock contextRef="c0" id="ixv-22036">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;4.2. &#160;&lt;span style="text-decoration:underline"&gt;Financial assets and liabilities&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group measures its financial assets at initial
recognition at fair value and subsequently at amortized cost using the effective interest method.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group has not irrevocably designated a financial
asset as measured at fair value through profit or loss to eliminate or significantly reduce a measurement or recognition inconsistency.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Financial assets at fair value through profit
or loss are measured at fair value through profit and loss due to the business model used in their negotiation and/or the contractual
characteristics of their cash flows.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Estimates&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group makes estimates of uncollectability
of its recorded receivables. Management analyzes trade account receivables in accordance with conventional criteria, adjusting the amount
through a charge of an allowance for bad debts upon recognition of the inability of third parties to afford their financial obligations
to the Group. Management specifically analyzes the accounts receivable, the historical bad debts, solvency of customers, current economic
trends and the changes to the payment conditions of customers to assess the adequate allowance for bad debts.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Offsetting of financial assets with financial
liabilities&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Financial assets and liabilities are offset and
presented for their net amount in the statements of financial position only when the Group has the right, legally enforceable, to compensate
the recognized amounts and has the intention to liquidate for the net amount or to settle the asset and cancel the liability simultaneously.&lt;/p&gt;</mlec:DescriptionOfAccountingPolicyForFinancialAssetsAndLiabilitiesPolicyTextBlock>
    <ifrs-full:DescriptionOfAccountingPolicyForMeasuringInventories contextRef="c0" id="ixv-22110">&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;4.3. &lt;span style="text-decoration:underline"&gt;Inventories&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Inventories are recognized at cost initially and
subsequently at the lower of cost and net realizable value. Cost comprises all costs of purchase and conversion as well as other costs
incurred in bringing the inventories to their present location and condition.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Weighted average cost is used to determine the
cost of ordinarily interchangeable items.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Estimates&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group assesses the recoverability of inventories
considering their sale price, whether the inventories are damaged and whether they have become obsolete in whole or in part.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Net realizable value is the sale price estimated
to be attained in the ordinary course of business, less costs of completion and other selling expenses.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group sets up an allowance for obsolescence
or slow-moving inventories in relation to finished and in-process products. The allowance for obsolescence or slow-moving inventories
is recognized for finished products and in-process products based on an analysis by Management of the aging of inventory stocks.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForMeasuringInventories>
    <ifrs-full:DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory contextRef="c0" id="ixv-22136">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;4.4. &lt;span style="text-decoration:underline"&gt;Biological assets&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Within current assets, growing crops are included
as biological assets, from the moment of sowing until the moment of harvest (approximately 5 to 7 months depending on the crop). At harvest
time the biological assets are transformed into agricultural products, including seed varieties for resale, and incorporated into the
inventory.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Costs are capitalized as biological assets if,
and only if, (a) it is probable that future economic benefits will flow to the entity, and (b) the cost can be measured reliably. The
Group capitalizes costs such as: planting, harvesting, weeding, seedlings, irrigation, agrochemicals, fertilizers and a systematic allocation
of fixed and variable production overheads that are directly attributable to the management of biological assets, among others.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Biological assets, both at initial recognition
and at each subsequent reporting date, are measured at fair value less costs to sell, except where fair value cannot be reliably measured.
Cost approximates fair value when little biological transformation has taken place since the costs were originally incurred or the impact
of biological transformation on price is not expected to be material.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Gains and losses that arise from measuring biological
assets at fair value less costs to sell and measuring agricultural produce at the point of harvest at fair value less costs to sell are
recognized in the statement of income in the period in which they arise in the line item &#x201c;Initial recognition and changes in fair
value of biological assets&#x201d;.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;From the harvest time, agricultural products are
valued at net realizable value because there is a market asset, and the risk of non-sale is non-significant.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Generally, the estimation of the fair value of
biological assets is based on models or inputs that are not observable in the market and the use of unobservable inputs is significant
to the overall valuation of the assets. Unobservable inputs are determined based on the best information available. Key assumptions include
future market prices, estimated yields at the point of harvest, estimated production cycle, future cash flows, future costs of harvesting
and other costs, and estimated discount rate.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Market prices are generally determined by reference
to observable data in the principal market for the agricultural produce. Harvesting costs and other costs are estimated based on historical
and statistical data. Yields are estimated based on several factors, including the location of the farmland and soil type, environmental
conditions, infrastructure and other restrictions and growth at the time of measurement. Yields are subject to a high degree of uncertainty
and may be affected by several factors out of the Group&#x2019;s control including but not limited to extreme or unusual weather conditions,
plagues and other crop diseases, among other factors.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForBiologicalAssetsExplanatory>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeBiologicalAssetsAtCost contextRef="c125" id="ixv-43639">P5M</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeBiologicalAssetsAtCost>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeBiologicalAssetsAtCost contextRef="c126" id="ixv-43640">P7M</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeBiologicalAssetsAtCost>
    <mlec:DescriptionOfAccountingPolicyForBasisOfConsolidation contextRef="c0" id="ixv-22207">&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;4.5. &lt;span style="text-decoration:underline"&gt;Basis of consolidation&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Business combinations&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;General&lt;/i&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group applies the acquisition method to account
for business combinations. The acquisition cost is measured as the aggregate of the consideration transferred for the acquisition of a
subsidiary, which is measured at fair value at the acquisition date, and the amount of any non-controlling interest in such subsidiary.
The Group recognizes any non-controlling interest in a subsidiary at the non-controlling interest&#x2019;s proportionate share of the recognized
amounts of subsidiary&#x2019;s identifiable net assets. The acquisition related costs are expensed as incurred.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Any contingent consideration to be transferred
by the Group is recognized at fair value at the acquisition date. The contingent consideration is classified as an asset or liability
that is a financial instrument under IFRS 9 is measured at fair value through profit or loss.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Goodwill is initially measured at cost, which
is the excess of the aggregate of the consideration transferred and the amount of the non-controlling interest and any previous interest
carried over the net identifiable assets acquired, and liabilities assumed.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;After initial recognition, goodwill is measured
at cost less any accumulated impairment losses. For impairment testing, goodwill acquired in a business combination is, as of the acquisition
date, allocated to each of the cash-generating units of the Group that is expected to benefit from the synergies of the combination, without
considering whether other assets or liabilities of the subsidiary are allocated to those units.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Any impairment in the carrying value is recognized
in the consolidated statement of comprehensive income. In the case of acquisitions in stages, prior to the write-off of the previously
held equity interest in the subsidiary, said interest is re-measured at fair value as of the date of acquisition of control over the subsidiary.
The result of the re-measurement at fair value is recognized in profit or loss.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;When a seller in a business combination has contractually
agreed to indemnify the Group for the result of a contingency or uncertainty related to the entirety or a portion of an asset or liability,
the Group recognizes an indemnification asset. The indemnification asset is measured on the same basis as the indemnification item. At
the end of each period, the Group measures the indemnification assets recognized at the acquisition date on the same basis as the indemnified
liability, subject to any contractual limitation on the amount and, for an indemnification asset that is not periodically measured at
fair value, based on Management&#x2019;s assessment of the recoverability of the indemnification asset. The Group derecognizes the indemnification
asset when it collects or sells it, or when it loses the right over it.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Reverse acquisitions&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In a reverse acquisition, the accounting acquirer
usually issues no consideration for the acquiree. Instead, the accounting acquiree usually issues its equity shares to the owners of the
accounting acquirer. Accordingly, the acquisition-date fair value of the consideration transferred by the accounting acquirer for its
interest in the accounting acquiree is based on the number of equity interests the legal subsidiary would have had to issue to give the
owners of the legal parent the same percentage equity interest in the combined entity that results from the reverse acquisition. The fair
value of the number of equity interests calculated in that way can be u sed as the fair value of consideration transferred in exchange
for the acquiree.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Consolidated financial statements prepared following
a reverse acquisition are issued under the name of the legal parent (accounting acquiree) but described in the notes as a continuation
of the financial statements of the legal subsidiary (accounting acquirer), with one adjustment, which is to adjust retroactively the accounting
acquirer&#x2019;s legal capital to reflect the legal capital of the accounting acquiree. That adjustment is required to reflect the capital
of the legal parent (the accounting acquiree). Comparative information presented in those consolidated financial statements also is retroactively
adjusted to reflect the legal capital of the legal parent (accounting acquiree).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Because the consolidated financial statements
represent the continuation of the financial statements of the legal subsidiary except for its capital structure, the consolidated financial
statements reflect:&lt;/p&gt;&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-size: 10pt"&gt;a.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;the assets and liabilities of the legal subsidiary (the accounting acquirer) recognized and measured at
their pre-combination carrying amounts.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-size: 10pt"&gt;b.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;the assets and liabilities of the legal parent (the accounting acquiree) recognized and measured in accordance
with IFRS 3.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-size: 10pt"&gt;c.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;the retained earnings and other equity balances of the legal subsidiary (accounting acquirer) before the
business combination.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-size: 10pt"&gt;d.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;the amount recognized as issued equity interests in the consolidated financial statements determined by
adding the issued equity interest of the legal subsidiary (the accounting acquirer) outstanding immediately before the business combination
to the fair value of the legal parent (accounting acquiree). However, the equity structure (ie. the number and type of equity interests
issued) reflects the equity structure of the legal parent (the accounting acquiree), including the equity interests the legal parent issued
to effect the combination. Accordingly, the equity structure of the legal subsidiary (the accounting acquirer) is restated using the exchange
ratio established in the acquisition agreement to reflect the number of shares of the legal parent (the accounting acquiree) issued in
the reverse acquisition.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;When a reverse acquisition occurs, in calculating
the weighted average number of ordinary shares outstanding (the denominator of the earnings per share calculation) during the period in
which the reverse acquisition occurs:&lt;/p&gt;&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-size: 10pt"&gt;a.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;the number of ordinary shares outstanding from the beginning of that period to the acquisition date shall
be computed on the basis of the weighted average number of ordinary shares of the legal acquiree (accounting acquirer) outstanding during
the period multiplied by the exchange ratio established in the merger agreement; and&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-size: 10pt"&gt;b.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;the number of ordinary shares outstanding from the acquisition date to the end of that period shall be
the actual number of ordinary shares of the legal acquirer (the accounting acquiree) outstanding during that period.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The basic earnings per share for each comparative
period before the acquisition date presented in the consolidated financial statements following a reverse acquisition shall be calculated
by dividing:&lt;/p&gt;&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-size: 10pt"&gt;a.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;the profit or loss of the legal acquiree attributable to ordinary shareholders in each of those periods
by&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-size: 10pt"&gt;b.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;the legal acquiree&#x2019;s historical weighted average number of ordinary shares outstanding multiplied
by the exchange ratio established in the acquisition agreement.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Subsidiaries&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Subsidiaries are entities controlled by the Group.
Information about Group accounting policy is included in Note 2 &#x2013; &#x201c;&lt;i&gt;Accounting standards and Basis of Preparation&lt;/i&gt;&#x201d;.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Non controlling interest&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;NCI are measured initially at their proportionate
share of the acquiree&#x2019;s identifiable net assets at the date of acquisition.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Change in ownership interest in subsidiaries
without change of control &lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Transactions with non-controlling interest that
do not result in a loss of control are accounted for as equity transactions - i.e., as transactions with the owners&#160;in their capacity
as owners. The recorded value corresponds to the difference between the fair value of the consideration paid and/or received and the relevant
share acquired and/or transferred of the carrying value of the net assets of the subsidiary.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Loss of control&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;When the Group loses control over a subsidiary,
it derecognizes the assets and liabilities of the subsidiary, and any related NCI and other components of equity. Any resulting gain or
loss is recognized in profit or loss.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Investments for which the Group does not exercise
control, but which are not accounted for under the equity method due to meeting the definition of a financial asset, are measured at fair
value through profit or loss in accordance with IFRS 9 Financial Instruments.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;When an investee (either a subsidiary or other
investment) enters a liquidation process and the Group no longer retains the ability to direct its relevant activities&#x2014;such as through
the formal appointment of a liquidator by the investee&#x2019;s Board of Directors&#x2014;the Group concludes that control has been lost.
In such cases, the date of the liquidator&#x2019;s appointment is considered the derecognition event for purposes of IFRS 10.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Associate and joint arrangements &lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;An associate is an entity over which the Group
exerts significant influence. Significant influence is the power to participate in financial and operating policy decision-making at such
entity, but it does not involve control or joint control over those policies.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group is a party to a joint arrangement when
there is a contractual arrangement that confers joint control over the relevant activities of the arrangement to the Group and at least
one other party. Joint control is assessed under the same principles as control over subsidiaries.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group classifies its interests in joint arrangements
as either:&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;i&gt;Joint ventures&lt;/i&gt;: where the group has rights to only
the &lt;i&gt;net assets &lt;/i&gt;of the joint arrangement.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;i&gt;Joint operations&lt;/i&gt;: where the group has both the rights
to the assets and obligations for the liabilities of the joint arrangement.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In assessing the classification of interests in
joint arrangements, the Group considers:&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;The structure of the joint arrangement;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;The legal form of joint arrangements structured through a
separate vehicle;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;The contractual terms of the joint arrangement agreement;
and&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;Any other facts and circumstances (including any other contractual
arrangements).&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group accounts for its interests in joint
ventures and associates using the equity method, where the Group&#x2019;s share of post-acquisition profits and losses and other comprehensive
income is recognized in the Consolidated statement of profit and loss and other comprehensive income.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Losses in excess of the Group&#x2019;s investment
in the joint venture and associates are recognized only to the extent that the Group has incurred legal or constructive obligations or
made payments on behalf of the joint venture.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Profits and losses arising on transactions between
the Group and its joint ventures and associates are recognized only to the extent of unrelated investors&#x2019; interests in the joint
venture and/or associates. The Group&#x2019;s share in a joint venture and/or associates&#x2019; profits and losses resulting from a transaction
is eliminated against the carrying amount of investment in the joint venture and/or associates through the line &#x201c;share of profit
(or loss) of joint ventures and associates&#x201d; in the Consolidated statements of profit or loss and other comprehensive income.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Any premium paid for an investment in a joint
venture and/or associates above the fair value of the Group&#x2019;s share of the identifiable assets, liabilities and contingent liabilities
acquired is capitalized and included in the carrying amount of the investment in the joint venture and/or associates. Where there is objective
evidence that the investment in a joint venture and/or associates has been impaired, the carrying amount of the investment is tested for
impairment in the same way as other non-financial assets.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;When the Group loses significant influence in
an associate or joint control over a joint venture, it measures and recognizes any investment held at fair value. Any difference between
the carrying amount of the associate or joint venture when losing significant influence or joint control and the fair value of the held
investment and sale revenue are recognized in profit or loss.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group accounts for its interests in joint
operations by recognizing its share of assets, liabilities, revenues and expenses in accordance with its contractually conferred rights
and obligations.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;For all joint arrangements structured in separate
vehicles the Group must assess the substance of the joint arrangement in determining whether it is classified as a joint venture or joint
operation. This assessment requires the Group to consider whether it has rights to the joint arrangement&#x2019;s net assets (in which
case it is classified as a joint venture), or rights to and obligations for specific assets, liabilities, expenses, and revenues (in which
case it is classified as a joint operation).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Paragraph 18 of IAS 28 states when an investment
in an associate or a joint venture is held by, or is held indirectly through, an entity that is a venture capital organization, or a mutual
fund, unit trust and similar entities, the entity may elect to measure that investment al fair value through profit or loss in accordance
with IFRS 9.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company has elected to measure the investment
in associates held through Theo I SCSp at fair value through profit or loss in accordance with IFRS 9.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Estimates&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;There is uncertainty regarding Management&#x2019;s
estimates of the Group&#x2019;s ability to recover the carrying amounts of the investments in joint ventures, since such estimates depend
on the joint ventures&#x2019; ability to generate sufficient funds to complete the development projects, the future outcome of the project
deregulation process and the amounts and timing of the cash flows from projects, among other future events.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Management assesses whether there are impairment
indicators and, if any, it performs a recoverability analysis.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Management estimates of the recoverability of
these investments represent the best estimate based on available evidence, the existing facts and circumstances, using reasonable and
provable assumptions in the cash flow projections.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Therefore, the consolidated financial statements
do not include adjustments that would be required if the Group were unable to recover the carrying amount of the above-mentioned assets
by generating sufficient economic benefits in the future.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Transactions eliminated on consolidation&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Intra-group balances and transactions, and any
unrealized income and expenses (except for foreign currency transaction gains and losses) arising from intra-group transactions, are eliminated.
Unrealized gains arising from transactions with equity-accounted investees are eliminated against the investment to the extent of the
Group&#xb4;s interest in the investee. Unrealized losses are eliminated in the same way as unrealized gains, but only to the extent that
there is no evidence of impairment.&lt;/p&gt;</mlec:DescriptionOfAccountingPolicyForBasisOfConsolidation>
    <ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory contextRef="c0" id="ixv-22620">&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;4.6. &lt;span style="text-decoration:underline"&gt;Impairment assessment of Goodwill and Intangible assets&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Impairment tests on goodwill and intangible assets
not yet available for use or with indefinite useful lives, are undertaken annually at the end of the reporting period. Other non-financial
assets are subject to impairment tests whenever events or changes in circumstances indicate that their carrying amount may not be recoverable.
Where the carrying value of an asset exceeds its recoverable amount (i.e. the higher of value in use and fair value less costs to sell),
the asset is written down accordingly.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Where it is not possible to estimate the recoverable
amount of an individual asset, the impairment test is carried out on the smallest group of assets to which it belongs for which there
are separately identifiable cash flows (its Cash Generating Unit or CGU). Goodwill is allocated on initial recognition to each of the
Group&#x2019;s CGUs that are expected to benefit from a business combination that gives rise to the goodwill.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Impairment charges are included in profit or loss,
except to the extent they reverse gains previously recognized in other comprehensive income. An impairment loss recognized for goodwill
is not reversed.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Estimates&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Impairment testing of goodwill and intangible
assets not yet available for use or with indefinite useful lives, requires the use of significant assumptions for the estimation of future
cash flows and the determination of discount rates. The significant assumptions and the determination of discount rates for the impairment
testing of goodwill are further explained in Note 7.9 - Goodwill.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory contextRef="c0" id="ixv-22689">&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;4.7. &lt;span style="text-decoration:underline"&gt;Property, plant and equipment&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Property, plant and equipment items are initially
recognized at cost. In addition to the purchase price, cost also includes costs directly attributable to such property, plant and equipment
items. There are no unavoidable costs with respect to dismantling and removing items. The cost of property, plant and equipment items
acquired in a business combination is their fair value at the acquisition date.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Depreciation is calculated using the straight-line
method to allocate the property, plant or equipment items&#x2019; cost or revalued amounts, net of their residual values, over their estimated
useful lives or, in the case of leasehold improvements and certain leased plant and equipment, the shorter lease term as follows:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Research instruments: 3 to 10 years&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Office equipment: 5 to 10 years&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Vehicles: 5 years&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Computer equipment and software: 3 years&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Fixture and fittings: 10 years&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Machinery and equipment: 5 to 10 years&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Buildings: 50 years&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Useful lives and depreciation methods are reviewed
every year as required by IAS 16.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As a result of the business combination completed
on &lt;span style="font-weight: normal"&gt;June 16, 2025&lt;/span&gt;, and the BIOX deconsolidation, the structure, scale and operations of the Group
changed significantly compared with the former reporting entity. The transaction resulted in a new combined entity whose asset base, operational
model and strategic focus differ materially from those of the pre-combination entity.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Given these changes, management re-assessed the
appropriateness of the accounting policy applied to property, plant and equipment. Prior to the business combination, the former entity
measured certain classes of property, plant and equipment under the &lt;span style="font-weight: normal"&gt;revaluation model&lt;/span&gt;. Following
the acquisition, and considering the characteristics of the combined business, management determined that the &lt;span style="font-weight: normal"&gt;cost
model&lt;/span&gt; provides more reliable and relevant information for users of the financial statements.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Accordingly, beginning on &lt;span style="font-weight: normal"&gt;June
16, 2025&lt;/span&gt;, the Group &lt;span style="font-weight: normal"&gt;discontinued the revaluation model&lt;/span&gt; and now measures all property plant
and equipment at &lt;span style="font-weight: normal"&gt;cost less accumulated depreciation and impairment losses&lt;/span&gt;. The change has been
accounted for prospectively in accordance with applicable IFRS requirements, as it results from management&#x2019;s reassessment of the
accounting policies of the newly formed reporting entity rather than from a voluntary change.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The carrying amounts of property, plant and equipment
previously measured under the revaluation model became their deemed cost at the date the new policy was adopted. No restatement of comparative
periods was required.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Prior to The Bioceres Group Business Combination
Agreement and the BIOX deconsolidation, the assets under items Land and Buildings, were accounted for at fair value arising from the last
revaluation performed, applying the revaluation model indicated by IAS 16. Starting with the fiscal year ended on June&#160;30, 2024,
the Group modified its Property, Plant, and Equipment valuation policy by changing the revaluation frequency for items classified under
Buildings and Land. The revaluation must never exceed five years between each occurrence, in compliance with the maximum periods established
by accounting standards, or whenever there are indications that the carrying amount differs significantly from the amount that could be
determined using fair value at the end of the reporting year.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;To obtain fair values, the existence or not of
an active market it was considered for the assets in their current status. For those assets for which an active market in their current
status existed, the fair values were determined based on their market values. For the remaining cases, the market values of comparable
new assets were analyzed, applying a discount based on the status and wear of each asset and considering the characteristics of each of
the revalued assets (for example, improvements made, maintenance status, level of productivity, use, etc.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Estimates&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group used to carry certain classes of property,
plant and equipment under the revaluation model under IAS 16. The revaluation model requires that the Group carry property, plant and
equipment at revalued amounts, being fair value at the date of revaluation less any subsequent accumulated depreciation and any subsequent
accumulated impairment losses. IAS 16 requires that the Group carry out these revaluations with sufficient regularity so that the carrying
amounts of its property, plant and equipment do not differ materially from that which would be determined using fair value at the end
of a reporting period. The determination of fair value at the date of revaluation requires judgments, estimates and assumptions based
on market conditions prevailing at the time of any such revaluation. Changes to any of the Group&#x2019;s judgments, estimates or assumptions
or to the market conditions subsequent to a revaluation will result in changes to the fair value of property, plant and equipment.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group used to prepare the corresponding revaluations
on a regular basis taking into account the work of independent appraisers. The Group uses different valuation techniques depending on
the class of property being valued. Generally, the Group determines the fair value of its industrial buildings and warehouses based on
a depreciated replacement cost approach. The Group determines the fair value of its land based on active market prices adjusted, if necessary,
for differences in the nature, location or condition of the specific asset. If this information is not available, the Group may use alternative
valuation methods, such as recent prices in less active markets.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Property valuation is a significant area of estimation
uncertainty. Fair values used to be prepared regularly by Management, taking into account independent valuations. The determination of
fair value for the different classes of property, plant and equipment is sensitive to the selection of various significant assumptions
and estimates. Changes in those significant assumptions and estimates could materially affect the determination of the revalued amounts
of property, plant and equipment. The Group utilizes historical experience, market information and other internal information to determine
and/or review the appropriate revalued amounts.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following were the most significant assumptions
used in the preparation of the revalued amounts for its classes of property, plant and equipment:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;a)&#160;Land:
The Group generally used to use the market price of a square meter of land for the same or similar location as the most significant assumption
to determine the revalued amount. The Group typically used to use comparable land sales in the same location to assess appropriateness
of the value of its land.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;b)&#160;Industrial
buildings and warehouses: The Group generally used to determine the construction cost of a new asset and then the Group adjusts it for
normal wear and tear. Construction prices may include, but are not limited to, construction materials, labor costs, installation and assembly
costs, site preparation, professional fees and applicable taxes. Construction costs may differ significantly from year to year and are
subject to macroeconomic changes in the economy where the Group operates, such as the impact of inflation and foreign exchange rates.
The construction cost of its industrial buildings and warehouses is determined on a US dollar per constructed square meter basis, while
the construction cost of its mills, facilities and grain storage facilities is determined by reference to their total capacity measured
in tons milled or stored, respectively. A 5% increase or decrease in the construction costs or the estimate of normal wear and tear relating
to such assets could have an impact of $1.2 million on their revalued amounts.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment contextRef="c127" id="ixv-43641">P3Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment contextRef="c128" id="ixv-43642">P10Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment contextRef="c129" id="ixv-43643">P5Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment contextRef="c130" id="ixv-43644">P10Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment contextRef="c131" id="ixv-43645">P5Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment contextRef="c132" id="ixv-43646">P3Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment contextRef="c133" id="ixv-43647">P10Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment contextRef="c134" id="ixv-43648">P5Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment contextRef="c135" id="ixv-43649">P10Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment contextRef="c136" id="ixv-43650">P50Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <mlec:ValuationSignificantChangePercentageOfConstructionCosts
      contextRef="c137"
      decimals="2"
      id="ixv-43651"
      unitRef="pure">0.05</mlec:ValuationSignificantChangePercentageOfConstructionCosts>
    <mlec:ValuationSignificantChangeInAmountNormalWearAndTearVariationImpactOnRevaluationAmount contextRef="c0" decimals="-5" id="ixv-43652" unitRef="usd">1200000</mlec:ValuationSignificantChangeInAmountNormalWearAndTearVariationImpactOnRevaluationAmount>
    <ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory contextRef="c0" id="ixv-22860">&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;4.8. &lt;span style="text-decoration:underline"&gt;Leased assets&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Leases are recognized as a right-of-use asset
and corresponding liability at the date of which the leased asset is available for use by the Group. Each lease payment is allocated between
the liability and finance cost. The finance cost is charged to profit or loss over the lease period so as to produce a constant periodic
rate of interest on the remaining balance of the liability for each period. The right-of-use asset is depreciated over the shorter of
the asset&#x2019;s useful life and the lease term on a straight-line basis.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In determining the lease term, the Company considers
all facts and circumstances that create an economic incentive to exercise an extension option or not exercise a termination option. Extension
options (or periods after termination options) are only included in the lease term if the lease is reasonably certain to be extended (or
not terminated).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Short term leases are recognized on a straight-line
basis as an expense in the income statement.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;At initial recognition, the right-of-use asset
is measured considering the value of the initial measurement of the lease liability; any lease payments made at or before the commencement
date, less any lease incentives; and any initial direct costs incurred by the lessee. After initial recognition, the right-of-use assets
are measured at cost, less any accumulated depreciation and/or impairment losses, and adjusted for any re-measurement of the lease liability.
Depreciation of the right-of-use asset is calculated using the straight-line method over the estimated duration of the lease contract.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The lease liability is initially measured at the
present value of the lease payments that are not paid at such date, including variable lease payments that depend on an index or rate,
initially measured using the index or rate as of the commencement date; amounts expected to be payable by the lessee under residual value
guarantees; the exercise price of a purchase option if the lessee is reasonably certain to exercise that option; payments of penalties
for terminating the lease, if the lease term reflects the lessee exercising an option to terminate the lease; and fixed payments, less
any lease incentives receivable. After the commencement date, the Company measures the lease liability by increasing the carrying amount
to reflect interest on the lease liability; reducing the carrying amount to reflect lease payments made; and re-measuring the carrying
amount to reflect any reassessment or lease modifications.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The above-mentioned inputs for the valuation of
the right of use assets and lease liabilities including the determination of the contracts within the scope of the standard, the contract
term ant interest rate used in the discounted cash flow involved a management&#x2019;s estimations.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory contextRef="c0" id="ixv-22884">&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;4.9. &lt;span style="text-decoration:underline"&gt;Intangible assets&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;a) Externally acquired intangible assets&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Externally acquired intangible assets are initially
recognized at acquisition date fair value (which is considered as their cost). After initial recognition, those assets are measured at
cost less accumulated amortization and accumulated impairment losses.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Intangible assets acquired from third parties
have an estimated useful life as follows (in years):&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Software: 3 years&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Trademarks and patents: 5 years&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Certification ISO Standards: 3 years&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Useful lives and amortization methods are reviewed
every year as required by IAS 38.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Estimates&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;To value acquired intangible assets, valuation
techniques generally accepted in the market are applied, based mainly on the revenue approach (such as excess earnings, relief from royalty,
and with or without), considering the characteristics of the assets to be valued and available information to estimate their acquisition
date fair value. Application of these valuation techniques requires the use of several assumptions related to future cash flows and the
discount rate.&lt;/p&gt;&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;b) Internally generated intangible assets (development costs)&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Expenditure on internally developed products is
capitalized if it can be demonstrated that:&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;It is technically feasible to develop the product for it
to be sold;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;Adequate resources are available to complete the development;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;There is an intention to complete and sell the product;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;The Group is able to sell the product;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;Sale of the product will generate future economic benefits;
and&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;Expenditure on the project can be measured reliably.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Development expenditure not satisfying the above
criteria and expenditure on the research phase of internal projects are recognized in the consolidated statement of profit or loss and
other comprehensive income as incurred (Note 8.3 - R&amp;amp;D classified by nature).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Capitalized development costs are amortized using
the straight-line method over the periods the Group expects to benefit from selling the products developed (Note 7.8 &#x2013; Intangible
assets).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Useful lives and amortization methods are reviewed
every year as required by IAS 38.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The research and development process can be divided
into several discrete steps or phases, which generally begin with discovery, validation and development and end with regulatory approval
and commercial launch. The process for developing seed traits is relatively similar for both GM and non-GM traits. However, the two differ
significantly in later phases of development. For example, obtaining regulatory approval for GM seeds is a far more comprehensive and
lengthy process than for non-GM seeds. Although breeding programs and industrial biotechnology solutions may have shorter or simpler phases
than those described below, the Group has used the industry consensus for seed-trait development phases to characterize its technology
portfolios, which is generally divided into the following six phases:&lt;/p&gt;&lt;p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;i) Discovery: The first phase in the technology
development process is the discovery or identification of candidate genes or genetic systems, metabolites, or microorganisms potentially
capable of enhancing specified plant characteristics or enabling an agro-industrial biotech solution.&lt;/p&gt;&lt;p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;ii) Proof of concept: Upon successful validation
of the technologies in model systems (&lt;i&gt;in vitro &lt;/i&gt;or &lt;i&gt;in vivo&lt;/i&gt;), promising technologies graduate from discovery and are advanced
to the proof of concept phase. The goal of this phase is to validate a technology within the targeted organism before moving forward with
technology escalation activities or extensive field validation.&lt;/p&gt;&lt;p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;iii) Early development: In this phase, field tests
commenced in the proof of concept phase are expanded to evaluate various permutations of a technology in multiple geographies and growing
cycles, as well as other characteristics in order to optimize the technology&#x2019;s performance in the targeted organisms. The goal of
the early development phase is to identify the best mode of use of a technology to define its performance concept.&lt;/p&gt;&lt;p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;iv) Advanced development and deregulation: In
this phase, extensive field tests are used to demonstrate the effectiveness of the technology for its intended purpose. In the case of
GM traits, the process of obtaining regulatory approvals from government authorities is also initiated during this phase, and tests are
performed to evaluate the potential environmental impact of modified plants. For solutions involving microbial fermentation, industrial-scale
runs are conducted.&lt;/p&gt;&lt;p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;v) Pre-launch: This phase involves finalizing
the regulatory approval process and preparing for the launch and commercialization of the technology. The range of activities in this
phase includes seed increases, pre-commercial production, and product and solution testing with selected customers. Usually, a more detailed
marketing strategy and preparation of marketing materials occur during this phase.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: 0pt; text-align: justify"&gt;vi) Product launch: In general, this phase, which
is the last milestone of the research and development process, is carried out by the Group, the joint ventures and/or the Group&#x2019;s
technology licensees. When technology is commercialized through the joint ventures or technology licensees, a successful product launch
will trigger royalty payments to the Group, which are generally calculated as a percentage of the net sales realized by the technology
and captured upon commercialization.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Demonstrability of technical feasibility generally
occurs when the project reaches the &#x201c;advanced development and deregulation&#x201d; phase because at this stage success is considered
to be probable.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;c)&#160;Intangible
assets acquired in a business combination&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Intangible assets acquired in a business combination
and recognized separately from goodwill are initially recognized at acquisition date fair value (which is considered as their cost). After
initial recognition, those assets are measured at cost less accumulated amortization and accumulated impairment losses in the same manner
as intangible assets acquired separately.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Intangible assets acquired in a business combination
have an estimated useful life as follows (in years):&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Product development: 20 &#x2013; 25 years&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Trademarks: 20 years&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Customer loyalty: 14 - 26 years&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Estimates&lt;/i&gt;&lt;/p&gt;To value intangible assets acquired from a business
combination, valuation techniques generally accepted in the market were applied, based mainly on the revenue approach (such as excess
earnings, relief from royalty, and with or without), considering the characteristics of the assets to be valued and available information
to estimate their acquisition date fair value.</ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill contextRef="c138" id="ixv-43653">P3Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill contextRef="c139" id="ixv-43654">P5Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill contextRef="c140" id="ixv-43655">P3Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill contextRef="c141" id="ixv-43656">P20Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill contextRef="c142" id="ixv-43657">P25Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill contextRef="c143" id="ixv-43658">P20Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill contextRef="c144" id="ixv-43659">P14Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill contextRef="c145" id="ixv-43660">P26Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DescriptionOfAccountingPolicyForInvestmentPropertyExplanatory contextRef="c0" id="ixv-23119">&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;4.10. &lt;span style="text-decoration:underline"&gt;Investment properties&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Investment properties shall be measured initially
at its cost. The cost of a purchased investment property comprises its purchase price and any directly attributable expenditure. Directly
attributable expenditure includes, for example, professional fees for legal services, property transfer taxes and other transaction costs.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In the measurement after initial recognition,
the Group has chosen the cost model for all investment properties.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForInvestmentPropertyExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForBorrowingsExplanatory contextRef="c0" id="ixv-23132">&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;4.11. &lt;span style="text-decoration:underline"&gt;Borrowings&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group measures its borrowings at initial recognition
at fair value and, subsequently, are measured at amortized cost using the effective interest rate method.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Borrowing costs, either generic or specific, attributable
to the acquisition, construction or production of assets that necessarily take a substantial period of time to get ready for their intended
use or sale (qualifying assets) are included in the cost of the assets until the moment that they are substantially ready for use or sale.
Income earned on the temporary investments of funds generated in specific borrowings still pending use in the qualifying assets, are deducted
from the total of financing costs potentially eligible for capitalization.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;All other loan costs are recognized under financial
costs, through profit and loss.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForBorrowingsExplanatory>
    <mlec:DescriptionOfAccountingPolicyForConvertibleNotesTextBlock contextRef="c0" id="ixv-23191">&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;4.12. &lt;span style="text-decoration:underline"&gt;Convertibles notes&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Financial liabilities, like convertible notes
that do not meet the &#x201c;fixed for fixed&#x201d; condition, are classified at their inception at fair value through profit or loss or
at amortized cost, using the effective interest amortization method.&lt;/p&gt;</mlec:DescriptionOfAccountingPolicyForConvertibleNotesTextBlock>
    <ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory contextRef="c0" id="ixv-23200">&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;4.13. &lt;span style="text-decoration:underline"&gt;Employee benefits&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Employee benefits are expected to be settled wholly
within 12 months after the end of the reporting period and are presented as current liabilities.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The accounting policies related to incentive payments
based on shares, if any, are detailed in Note 19 &#x2013; Share-based payments.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory contextRef="c0" id="ixv-23212">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;4.14.&#160;&lt;span style="text-decoration:underline"&gt;Provisions&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group has recognized provisions for liabilities
of uncertain timing or amount. The provision is measured at the best estimate of the expenditure required to settle the obligation at
the end of the reporting period, discounted at a pre-tax rate reflecting current market assessments of the time value of money and risks
specific to the liability.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory>
    <mlec:DescriptionOfAccountingPolicyForWarrantLiabilities contextRef="c0" id="ixv-23221">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;4.15.&#160;&lt;span style="text-decoration:underline"&gt;Warrant
liabilities &lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As part of the business combination, the Group
acquired public warrants and private warrants.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Public Warrants: These instruments are initially
recognized at fair value on the date the derivative contract is entered into and are subsequently remeasured to fair value at the end
of each reporting period. Gains and losses arising from changes in fair value are recognized in profit or loss.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;These warrants are measured at Level 1 fair value,
based on their quoted market price.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Private Warrants: These instruments are measured
at fair value using valuation techniques, including the Black-Scholes model.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;These warrants are classified as Level 3 fair
value measurements, as they rely on significant unobservable inputs.&lt;/p&gt;</mlec:DescriptionOfAccountingPolicyForWarrantLiabilities>
    <ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue contextRef="c0" id="ixv-23242">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;4.16.&#160;&lt;span style="text-decoration:underline"&gt;Revenue
recognition&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Revenue is recognized when control has been transferred
to the buyer. Transfers of control vary depending on the individual terms of the sales contract. Revenues are recognized when control
of the products has been transferred, which generally means that the products have been delivered to the customer and there is no unfulfilled
obligation that could affect a customer&#x2019;s acceptance of the products. Generally, acceptance occurs upon shipment or delivery but
ultimately depends on the terms of the underlying contracts. The customer is then invoiced at the agreed-upon price with the usual payment
terms for each geographical region. Those payment terms do not contain a significant financing component.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The timing of performance sometimes differs from
the timing that the associated consideration is received from the customer, thus resulting in the recognition of a contract asset or contract
liability. The Company recognizes a contract liability if the customer&#x2019;s payment of consideration is received prior to completion
of the related performance obligation.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As a part of the Company&#x2019;s customary business
practices, the Company offers a number of sales incentives to the customers, including volume discounts, retailer incentives, prepayment
options and other product rebates. For all such contracts that include any variable consideration, the Company estimates the amount of
variable consideration that should be included in the transaction price utilizing either the expected value method or the most likely
amount method, depending on the nature of the variable consideration. Variable consideration is included in the transaction price if,
in the judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur. Although determining
the transaction price for consideration requires significant judgment, the Company has meaningful historical experience with incentives
provided to customers and estimate the expected consideration in view of historical patterns of incentive payouts. These estimates are
reassessed each reporting period.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company also offer an assurance warranty,
which gives customers a refund or exchange right in the case the delivered product does not conform to specifications. Replacement products
are accounted for under the warranty guidance if the customer exchanges one product for another of the same type, quality, and price.
The Company has significant experience with historical return patterns and use this experience to include returns in the estimate of transaction
price.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;With respect to services, the Company mainly provides
R&amp;amp;D and seed treatment services. Revenue associated with services is recognized by reference to the stage of completion of the transaction
at the end of the reporting period. Each of the services to be provided has a detailed work plan in which all activities to be rendered
are listed. The stage of completion for services is determined in accordance with the execution of the performed tasks listed in the respective
work plan. The level of execution of such services is provided by the Company&#x2019;s technical experts, who provide information relating
to the transfer of goods or services. The Company has no material revenue for services that cannot be reliably estimated.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Revenue for usage-based royalties relating to
licensed intellectual property rights is recognized at the later of when the performance obligation is satisfied and when a sale or use
occurs.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Typically, the Company&#x2019;s average payment
terms range from 130 to 160 days at a consolidated level. Longer terms may be granted in limited circumstances; however, the effects of
such sales are not material to the consolidated financial statements. Those payment terms do not contain a significant financing component.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue>
    <mlec:AveragePaymentTermBySales contextRef="c125" id="ixv-43662">P130D</mlec:AveragePaymentTermBySales>
    <mlec:AveragePaymentTermBySales contextRef="c126" id="ixv-43663">P160D</mlec:AveragePaymentTermBySales>
    <ifrs-full:DescriptionOfAccountingPolicyForGovernmentGrants contextRef="c0" id="ixv-23313">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;4.17.&#160;&lt;span style="text-decoration:underline"&gt;Government
grants&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Government grants are recognized where there is
reasonable assurance that the grant will be received and all attached conditions will be complied with. When the grant relates to an expense
item, it is recognized as income on a systematic basis over the periods that the related costs, for which it is intended to compensate,
are expensed. When the grant relates to an asset, it is recognized as income in equal amounts over the expected useful life of the related
asset. Management elected this accounting policy because the Group determined it better shows the financial effect of government grants
in the consolidated financial statements.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;When the Group receives grants of non-monetary
assets, the asset and the grant are recorded at nominal amounts and released to profit or loss over the expected useful life of the asset.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The difference between the money obtained under
government loans at subsidized rates and the carrying amount of those loans is treated as a government grant, in accordance with IAS 20.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForGovernmentGrants>
    <ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory contextRef="c0" id="ixv-23328">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;4.18.&#160;&lt;span style="text-decoration:underline"&gt;Income
tax&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Income tax expense comprises current and deferred
tax. It is recognized in profit or loss except to the extent that it relates to a business combination, or items recognized directly in
equity or in OCI.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group has determined that interest and penalties
related to income taxes, including uncertain tax treatments, do not meet the definition of income taxes, and therefore accounted for them
under IAS 37 &lt;i&gt;Provisions, Contingent Liabilities and Contingent Assets.&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group has determined that the global minimum
top-up tax &#x2013; which it is required to pay under Pillar Two legislation &#x2013; is an income tax in the scope of IAS 12. Pillar Two
legislation is not applicable to Moolec Science SA in accordance with current thresholds.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Current tax&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Current tax comprises the expected tax payable
or receivable on the taxable income or loss for the year and any adjustment to the tax payable or receivable in respect of previous years.
The amount of current tax payable or receivable is the best estimate of the tax amount expected to be paid or received that reflects uncertainty
related to income taxes, if any. It is measured using tax rates enacted or substantively enacted at the reporting date. Current tax also
includes any tax arising from dividends.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Current tax assets and liabilities are offset
only if certain criteria are met.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Deferred tax&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Deferred tax assets and liabilities are recognized
where the carrying amount of an asset or liability in the Consolidated statement of financial position differs from its tax base, except
for differences arising on:&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;The initial recognition of goodwill;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;The initial recognition of an asset or liability in a transaction
which is not a business combination and at the time of the transaction affects neither accounting or taxable profit; and&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;Investments in subsidiaries and jointly controlled entities
where the Group is able to control the timing of the reversal of the difference and it is probable that the difference will not reverse
in the foreseeable future.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Recognition of deferred tax assets is restricted
to those instances where it is probable that taxable profit will be available against which the difference can be utilized.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The amount of the asset or liability is determined
using tax rates that have been enacted or substantively enacted by the end of the reporting period and are expected to apply when the
deferred tax liabilities / (assets) are settled / (recovered).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Deferred tax assets and liabilities are offset
when the Group has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities
relate to taxes levied by the same tax authority on either:&lt;/p&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;The same taxable entity within the Group, or&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;Different entities within the Group which intend either to
settle current tax assets and liabilities on a net basis, or to realize the assets and settle the liabilities simultaneously, in each
future period in which significant amounts of deferred tax assets or liabilities are expected to be settled or recovered.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory contextRef="c0" id="ixv-23450">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;4.19.&#160;&lt;span style="text-decoration:underline"&gt;Share-based
payments&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Prior to the Business Combination and the BIOX
deconsolidation, certain executives and directors of the Group were granted incentives in the form of shares and options to purchase shares
as consideration for services.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The cost of these share-based transactions is
determined based on their fair value at the date upon which such incentives are granted using a valuation model that is appropriate in
the circumstances.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;This cost is recognized as an expense together
with an increase in equity throughout the period in which the service or performance conditions are satisfied (i.e., the vesting period).
The accumulated expense recorded in connection with these transactions at the end of each year until the vesting date reflects the time
elapsed between the vesting period and Management&#x2019;s best estimate of the number of equity instruments that will vest. The charge
to income/loss for the period represents the variation in the accumulated expense recorded between the beginning and the end of the year.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Non-market related service and performance conditions
are not taken into account when determining the grant date fair value of the equity instruments, but the probability that the conditions
are fulfilled is assessed as part of Management&#x2019;s best estimate of the number of equity instruments that will vest. Market-related
performance conditions are reflected in the grant date fair value. Any other conditions related to equity-settled share-based payment
transactions but without a service requirement are considered as non-vesting conditions. Non-vesting conditions are reflected in the fair
value of the equity instruments and are charged to income/loss immediately unless there are service and/or performance conditions as well.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;No amount is recognized for transactions that
will not vest because non-market related performance conditions and/or service conditions were not satisfied. When transactions include
market-related conditions or non-vesting conditions, the transactions are considered to be vested, irrespective of whether a market-related
condition or the non-vesting condition is satisfied, provided that all the other performance and/or service conditions are met.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;When the terms and conditions of an equity-settled
share-based payment transaction are modified, the minimum expense recognized is the grant date fair value, unmodified, provided that the
original terms have been complied with. An additional expense, measured at the date of modification, is recognized for any modification
that increases the total fair value of the share-based payment transaction, or is otherwise beneficial to the employee.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;When the transaction is settled by the Group or
by the counterparty, any remainder of the fair value is charged to income immediately.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The dilutive effect of current options is considered
in the calculation of the diluted earnings per share.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Estimates&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The estimate of the fair value of equity-settled share-based payment
transactions requires a determination to be made of the most adequate option pricing model to apply depending on the terms and conditions
of the arrangement. This estimate also requires a determination of those factors most appropriate to the pricing model, including the
expected life of the option and the expected volatility of the share price upon the basis of which assumptions are made. The Group measures
the fair value of these transactions at the grant date applying the Black-Scholes formula adjusted to consider the possible dilutive effect
of the future exercise of the share options granted on their estimated fair value at grant date, as established in paragraph B41 of IFRS
2. The assumptions used for the estimate of the fair value of these transactions are disclosed in Note 19 &#x2013; Share-based payment
and will not necessarily take place in the future.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of June 30, 2025 no equity awards are outstanding.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory>
    <ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory contextRef="c0" id="ixv-23539">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;5.&#160;&lt;span style="text-decoration:underline"&gt;CRITICAL ACCOUNTING
JUDGMENTS AND ESTIMATES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group makes certain estimates and assumptions
regarding the future. Estimates and judgments are continually evaluated based on historical experience and other factors, including expectations
of future events that are believed to be reasonable under the circumstances. In the future, actual experience may differ from these estimates
and assumptions. The estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amounts of
assets and liabilities within the next financial year are listed below.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Critical judgements&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;De facto control over BIOX (Note 1 &#x2013; The Group&#x2019;s
business reorganization and general information and Note 2 &#x2013; Accounting standards an basis of presentation).&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Critical estimates&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;Impairment of goodwill (Notes 4.6 &#x2013; Impairment assessment
of goodwill and intangibles).&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;Impairment testing of intangible assets not yet available
for use or with indefinite useful lives.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;Identification and fair value of identifiable intangible
assets arising in acquisitions.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory>
    <ifrs-full:DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory contextRef="c0" id="ixv-23624">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;6.&#160;&lt;span style="text-decoration:underline"&gt;ACQUISITIONS AND
OTHER SIGNIFICANT TRANSACTIONS&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "&gt;&lt;i&gt;Bioceres Group, Nutrecon,
Gentle Tech and Moolec Science business combination&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "&gt;As stated in Note 1 &#x2013;
The Group&#x2019;s business reorganization and general information - &#x201c;&lt;i&gt;The Bioceres Group Business Combination Agreement&#x201d;,
&lt;/i&gt;on June 16, 2025, it was announced the closing of the Bioceres Group Business Combination.&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The combined group now operates an integrated
platform encompassing R&amp;amp;D, manufacturing, and regulatory capabilities that span from molecular design to validation in both fermenter
and field environments. On one front, the Company advances its molecular farming programs in crops such as soy and safflower to produce
proteins and lipids with animal-like functionality and plant-based cost structures. On the other front, Moolec is developing a precision
fermentation facility in Finland, under the SynBio Powerlabs brand, which will be dedicated to producing target proteins, enzymes, and
other biomolecules using optimized microbial and cellular systems. Once operational, this facility will provide an industrial pathway
to design, ferment, and scale alternative proteins while establishing commercial channels with leading food companies.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "&gt;The combination of these
two complementary approaches, farming and fermentation, will enable the Company to accelerate time-to-market, diversify technology risks,
and anchor production costs in agricultural scalability, without compromising product functionality or organoleptic properties.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "&gt;The Business Combination
under IFRS 3, &lt;i&gt;Business Combinations&lt;/i&gt;, was accounted using the acquisition method of accounting and treating the transaction as a
reverse acquisition. Under this approach, Bioceres Group (the legal subsidiary) was considered the accounting acquirer, and Moolec Science
SA (the legal acquirer) was considered the accounting acquiree, together with Gentle Tech and Nutrecon.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "&gt;As a result, the consolidated
financial statements represent a continuation of the financial statements of Bioceres Group, the predecessor, with the net assets of Moolec
Science SA, Gentle Tech and Nutrecon recognized at fair value on the acquisition date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "&gt;Because the transaction is accounted for as a reverse acquisition,
the consideration transferred is based on the number of equity instruments that Bioceres Group would have had to issue to give the owners
of Moolec Science SA, Nutrecon and Gentle Tech the same percentage ownership in the combined entity that results from the transaction.
The fair value of the consideration amounted to $19,939,162.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "&gt;&lt;span style="text-decoration:underline"&gt;Identifiable Assets
Acquired and Liabilities Assumed (Accounting Acquirees):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "&gt;Provisional Purchase
Price Allocation:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "&gt;The purchase price allocation (&#x201c;PPA&#x201d;) related to the business
combinations have been determined on a provisional basis in accordance with IFRS 3.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "&gt;Under IFRS 3, the Company
is permitted to adjust the provisional amounts recognized at the acquisition date during the measurement period, which may extend up to
twelve months from the acquisition date, as new information becomes available regarding facts and circumstances that existed at that date.
Consequently, the amounts disclosed in this note are subject to change.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Fair value of the consideration of payment&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%"&gt;Equity shares&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;33,504,531&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,030,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total consideration&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;34,534,531&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "&gt;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The consideration of payment was measured at fair value, which was
calculated as the sum of equity shares and warrants. The fair values of the warrants measured were based on Black &amp;amp; Scholes method
and the equity shares measured was determined using the Moolec&#x2019;s share quoted price at the transaction date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;Assets acquired, liabilities assumed, and non-controlling interest
recognized&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-style: normal; border-bottom: Black 1.5pt solid; font-weight: normal; text-align: left"&gt;&lt;b&gt;Net assets incorporated&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-style: normal; width: 88%; font-weight: normal; text-align: justify"&gt;Cash and cash equivalents&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;554,420&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-style: normal; font-weight: normal; text-align: justify"&gt;Trade and other receivables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;4,036,558&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-style: normal; font-weight: normal; text-align: justify"&gt;Property, plant and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;3,319,313&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-style: normal; font-weight: normal; text-align: justify"&gt;Intangible assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;74,841,933&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-style: normal; font-weight: normal; text-align: justify"&gt;Right of use assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;100,896&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-style: normal; font-weight: normal; text-align: justify"&gt;Inventories&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,235,482&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-style: normal; font-weight: normal; text-align: justify"&gt;Borrowings / Financial debt&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(19,608,629&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-style: normal; font-weight: normal; text-align: justify"&gt;Accounts payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(5,806,020&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-style: normal; font-weight: normal; text-align: justify"&gt;Lease liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(117,463&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-style: normal; font-weight: normal; text-align: justify"&gt;Warrant liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(181,093&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-style: normal; padding-bottom: 1.5pt; font-weight: normal; text-align: justify"&gt;Deferred tax liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(15,767,275&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-style: normal; font-weight: normal; text-align: justify"&gt;Total net assets identified&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;43,608,122&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-style: normal; font-weight: normal; text-align: justify"&gt;Non-controlling interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;6,316,790&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-style: normal; font-weight: normal; text-align: left"&gt;Previously held interest - revalued at FV&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,283,319&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-style: normal; padding-bottom: 1.5pt; font-weight: normal; text-align: justify"&gt;Gain on purchase&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;1,473,482&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-style: normal; padding-bottom: 2.5pt; font-weight: normal; text-align: justify"&gt;&lt;b&gt;Total consideration&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;&lt;b&gt;34,534,531&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;Non-controlling
interest (NCI) was measured at the present ownership instruments&#x2019; proportionate share in the recognized amounts of the acquiree&#x2019;s
identifiable net assets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;In one of the three acquired
businesses, the Group held an equity interest in the acquiree prior to obtaining control. In accordance with IFRS 3, the previously held
interest was remeasured at its acquisition-date fair value, and the resulting gain or loss was recognized in profit or loss. This remeasurement
reflects the change in value of the Group&#x2019;s existing investment up to the date control was obtained and forms part of the total
consideration transferred for the business combination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;The fair value of the identifiable
net assets exceeded the consideration transferred (including the fair value of the NCI). As required by IFRS 3, the resulting excess was
recognized as a bargain purchase gain in profit or loss on the acquisition date. The bargain gain primarily reflects overperforming asset
base identified during the purchase price allocation process. The bargain gain on purchase is recognized in the line item &#x201c;Other
income or expenses, net&#x201d; in the Consolidated Statement of Comprehensive Income.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The amounts of revenue and net profit of the acquirees
since the merger date included in the consolidated statement of comprehensive income for the year ended June 30, 2025, were immaterial
considering that the acquisition date was very close to the end of the fiscal year.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Had the reverse acquisition been completed on
&lt;span style="font-weight: normal"&gt;July 1 2024&lt;/span&gt;, the pro forma revenue and net loss of the combined entity for the year ended June
30, 2025 as though the date for the merger had been as of the beginning of the reporting period amount to $339.8&#160;million and $157.4&#160;million,
respectively.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Natal Agro S.R.L.&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On June 10, 2024, the former subsidiary, BIOX,
acquired a controlling interest in Natal Agro S.R.L (&#x201c;Natal&#x201d;), an Argentine company that breeds and develops corn varieties.
The interest acquired is represented by a total of 116,225 shares of AR$ 10 nominal value each, representing 51% of equity and voting
interest.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The consideration for the acquisition was $0.22
million in cash and the commitment to carrying out, at BIOX&#x2019;s own expense, the regulatory activities for HB4 corn to obtain authorization
for its commercialization in Argentina, and the regulatory activities for HB4 corn in Brazil, once the commercialization strategy of HB4
corn in Brazil has been defined by the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Fair value of the consideration of payment&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; width: 88%; text-align: left"&gt;Cash payment&lt;/td&gt;&lt;td style="padding: 0pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; width: 9%; text-align: right"&gt;215,415&lt;/td&gt;&lt;td style="padding: 0pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Regulatory activities&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; border-bottom: Black 1.5pt solid; text-align: right"&gt;727,985&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; font-weight: bold; text-align: left"&gt;Total consideration&lt;/td&gt;&lt;td style="padding: 0pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;943,400&lt;/td&gt;&lt;td style="padding: 0pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The consideration of payment was measured at fair
value, which was calculated as the sum of cash paid and the acquisition-date fair values of the regulatory services to be provided. The
fair values measured were based on discounting future cash flow using market discount rates. The difference between fair value and nominal
value of consideration will be recognized as finance cost over the period the consideration will be paid.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Assets acquired, liabilities assumed, and non-controlling
interest recognized &lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left; padding-left: 0pt"&gt;Cash and cash equivalents&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;252,923&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Other financial assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;73,950&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Trade receivables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;596,463&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Other receivables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;288,861&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Income and minimum presumed recoverable income taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;19,998&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;Inventories&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,031,412&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Property, plant and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;816,576&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Intangible assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,217,985&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Right of use asset&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;168,988&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Trade and other payables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,302,332&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;Borrowings&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(743,279&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Employee benefits and social security&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(23,346&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Deferred revenue and advances from customers&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,515&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;Provisions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(355,898&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Lease liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(168,988&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Deferred tax liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(996,824&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-left: 0pt"&gt;Total net assets identified&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;3,873,974&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Non-controlling interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,898,247&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left; padding-left: 0pt"&gt;Gain from a bargain purchase&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,032,327&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt"&gt;Total consideration&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;943,400&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The business combination was executed in a context
of financial setbacks faced by the acquired company. To address these, in addition to the initial cash payment, BIOX has committed to
providing a working capital loan of up to $3 million to help alleviate the financial strain.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;BIOX will also provide regulatory services related
to its proprietary technologies, which will enable strategic business development for Natal and create a new product pipeline leveraging
BIOX&#x2019; technology. Specifically, BIOX has agreed to grant Natal an exclusive license for certain technologies to be applied to corn, with
Natal committing to pay 15% of the revenues generated from this technology.&lt;/p&gt;</ifrs-full:DisclosureOfTransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationExplanatory>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred contextRef="c146" decimals="0" id="ixv-43664" unitRef="usd">19939162</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <mlec:ScheduleOfFairValueOfConsiderationOfPaymentTableTextBlock contextRef="c0" id="ixv-23700">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Fair value of the consideration of payment&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%"&gt;Equity shares&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;33,504,531&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,030,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total consideration&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;34,534,531&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Fair value of the consideration of payment&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; width: 88%; text-align: left"&gt;Cash payment&lt;/td&gt;&lt;td style="padding: 0pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; width: 9%; text-align: right"&gt;215,415&lt;/td&gt;&lt;td style="padding: 0pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding: 0pt; text-align: left"&gt;Regulatory activities&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; border-bottom: Black 1.5pt solid; text-align: right"&gt;727,985&lt;/td&gt;&lt;td style="padding: 0pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt; font-weight: bold; text-align: left"&gt;Total consideration&lt;/td&gt;&lt;td style="padding: 0pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding: 0pt; border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt; border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;943,400&lt;/td&gt;&lt;td style="padding: 0pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</mlec:ScheduleOfFairValueOfConsiderationOfPaymentTableTextBlock>
    <mlec:EquityShares contextRef="c150" decimals="0" id="ixv-43665" unitRef="usd">33504531</mlec:EquityShares>
    <ifrs-full:WarrantLiability contextRef="c150" decimals="0" id="ixv-43666" unitRef="usd">1030000</ifrs-full:WarrantLiability>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred contextRef="c150" decimals="0" id="ixv-43667" unitRef="usd">34534531</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory contextRef="c0" id="ixv-23726">&lt;p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;Assets acquired, liabilities assumed, and non-controlling interest
recognized&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-style: normal; border-bottom: Black 1.5pt solid; font-weight: normal; text-align: left"&gt;&lt;b&gt;Net assets incorporated&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-style: normal; width: 88%; font-weight: normal; text-align: justify"&gt;Cash and cash equivalents&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;554,420&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-style: normal; font-weight: normal; text-align: justify"&gt;Trade and other receivables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;4,036,558&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-style: normal; font-weight: normal; text-align: justify"&gt;Property, plant and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;3,319,313&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-style: normal; font-weight: normal; text-align: justify"&gt;Intangible assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;74,841,933&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-style: normal; font-weight: normal; text-align: justify"&gt;Right of use assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;100,896&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-style: normal; font-weight: normal; text-align: justify"&gt;Inventories&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,235,482&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-style: normal; font-weight: normal; text-align: justify"&gt;Borrowings / Financial debt&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(19,608,629&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-style: normal; font-weight: normal; text-align: justify"&gt;Accounts payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(5,806,020&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-style: normal; font-weight: normal; text-align: justify"&gt;Lease liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(117,463&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-style: normal; font-weight: normal; text-align: justify"&gt;Warrant liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(181,093&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-style: normal; padding-bottom: 1.5pt; font-weight: normal; text-align: justify"&gt;Deferred tax liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(15,767,275&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-style: normal; font-weight: normal; text-align: justify"&gt;Total net assets identified&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;43,608,122&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-style: normal; font-weight: normal; text-align: justify"&gt;Non-controlling interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;6,316,790&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-style: normal; font-weight: normal; text-align: left"&gt;Previously held interest - revalued at FV&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,283,319&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-style: normal; padding-bottom: 1.5pt; font-weight: normal; text-align: justify"&gt;Gain on purchase&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;1,473,482&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-style: normal; padding-bottom: 2.5pt; font-weight: normal; text-align: justify"&gt;&lt;b&gt;Total consideration&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;&lt;b&gt;34,534,531&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left; padding-left: 0pt"&gt;Cash and cash equivalents&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;252,923&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Other financial assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;73,950&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Trade receivables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;596,463&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Other receivables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;288,861&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Income and minimum presumed recoverable income taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;19,998&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;Inventories&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,031,412&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Property, plant and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;816,576&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Intangible assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,217,985&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Right of use asset&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;168,988&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Trade and other payables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,302,332&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;Borrowings&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(743,279&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Employee benefits and social security&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(23,346&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Deferred revenue and advances from customers&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,515&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;Provisions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(355,898&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Lease liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(168,988&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Deferred tax liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(996,824&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-left: 0pt"&gt;Total net assets identified&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;3,873,974&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Non-controlling interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,898,247&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left; padding-left: 0pt"&gt;Gain from a bargain purchase&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,032,327&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt"&gt;Total consideration&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;943,400&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory>
    <ifrs-full:OtherCashAndCashEquivalents contextRef="c4" decimals="0" id="ixv-43668" unitRef="usd">554420</ifrs-full:OtherCashAndCashEquivalents>
    <ifrs-full:TradeReceivables contextRef="c4" decimals="0" id="ixv-43669" unitRef="usd">4036558</ifrs-full:TradeReceivables>
    <ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate contextRef="c4" decimals="0" id="ixv-43670" unitRef="usd">3319313</ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate contextRef="c4" decimals="0" id="ixv-43671" unitRef="usd">74841933</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:AdditionsToRightofuseAssets contextRef="c0" decimals="0" id="ixv-43672" unitRef="usd">100896</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:InventoriesTotal contextRef="c4" decimals="0" id="ixv-43673" unitRef="usd">2235482</ifrs-full:InventoriesTotal>
    <ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate contextRef="c4" decimals="0" id="ixv-43674" unitRef="usd">19608629</ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate>
    <ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate contextRef="c4" decimals="0" id="ixv-43675" unitRef="usd">5806020</ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate>
    <ifrs-full:LeaseLiabilities contextRef="c4" decimals="0" id="ixv-43676" unitRef="usd">117463</ifrs-full:LeaseLiabilities>
    <ifrs-full:WarrantLiability contextRef="c4" decimals="0" id="ixv-43677" unitRef="usd">181093</ifrs-full:WarrantLiability>
    <ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate contextRef="c4" decimals="0" id="ixv-43678" unitRef="usd">15767275</ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate>
    <ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed contextRef="c4" decimals="0" id="ixv-43679" unitRef="usd">43608122</ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed>
    <mlec:NoncontrollingInterest contextRef="c4" decimals="0" id="ixv-43680" unitRef="usd">6316790</mlec:NoncontrollingInterest>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c4" decimals="0" id="ixv-43681" unitRef="usd">1283319</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:GainsLossesOnDisposalsOfInvestments contextRef="c0" decimals="0" id="ixv-43682" unitRef="usd">1473482</ifrs-full:GainsLossesOnDisposalsOfInvestments>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred contextRef="c4" decimals="0" id="ixv-43683" unitRef="usd">34534531</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:RevenueOfCombinedEntity
      contextRef="c147"
      decimals="-5"
      id="ixv-43684"
      unitRef="usd">339800000</ifrs-full:RevenueOfCombinedEntity>
    <ifrs-full:ProfitLossOfCombinedEntity
      contextRef="c147"
      decimals="-5"
      id="ixv-43685"
      unitRef="usd">157400000</ifrs-full:ProfitLossOfCombinedEntity>
    <mlec:NumberOfSharesAcquiredInBusinessCombination
      contextRef="c148"
      decimals="0"
      id="ixv-43686"
      unitRef="shares">116225</mlec:NumberOfSharesAcquiredInBusinessCombination>
    <ifrs-full:ParValuePerShare
      contextRef="c148"
      decimals="INF"
      id="ixv-43687"
      unitRef="arsPershares">10</ifrs-full:ParValuePerShare>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="c148"
      decimals="2"
      id="ixv-43688"
      unitRef="pure">0.51</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:CashTransferred
      contextRef="c148"
      decimals="-4"
      id="ixv-43689"
      unitRef="usd">220000</ifrs-full:CashTransferred>
    <ifrs-full:CashTransferred contextRef="c151" decimals="0" id="ixv-43690" unitRef="usd">215415</ifrs-full:CashTransferred>
    <ifrs-full:EquityInterestsOfAcquirer contextRef="c151" decimals="0" id="ixv-43691" unitRef="usd">727985</ifrs-full:EquityInterestsOfAcquirer>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred contextRef="c151" decimals="0" id="ixv-43692" unitRef="usd">943400</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:OtherCashAndCashEquivalents contextRef="c152" decimals="0" id="ixv-43693" unitRef="usd">252923</ifrs-full:OtherCashAndCashEquivalents>
    <ifrs-full:OtherFinancialAssets contextRef="c152" decimals="0" id="ixv-43694" unitRef="usd">73950</ifrs-full:OtherFinancialAssets>
    <ifrs-full:TradeReceivables contextRef="c152" decimals="0" id="ixv-43695" unitRef="usd">596463</ifrs-full:TradeReceivables>
    <ifrs-full:OtherReceivables contextRef="c152" decimals="0" id="ixv-43696" unitRef="usd">288861</ifrs-full:OtherReceivables>
    <mlec:IncomeAndMinimumPresumedRecoverableIncomeTaxes contextRef="c152" decimals="0" id="ixv-43697" unitRef="usd">19998</mlec:IncomeAndMinimumPresumedRecoverableIncomeTaxes>
    <ifrs-full:InventoriesTotal contextRef="c152" decimals="0" id="ixv-43698" unitRef="usd">4031412</ifrs-full:InventoriesTotal>
    <ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate contextRef="c152" decimals="0" id="ixv-43699" unitRef="usd">816576</ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate contextRef="c152" decimals="0" id="ixv-43700" unitRef="usd">2217985</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:AdditionsToRightofuseAssets contextRef="c153" decimals="0" id="ixv-43701" unitRef="usd">168988</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:TradeAndOtherPayables contextRef="c152" decimals="0" id="ixv-43702" unitRef="usd">2302332</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate contextRef="c152" decimals="0" id="ixv-43703" unitRef="usd">743279</ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate>
    <ifrs-full:SocialSecurityContributions contextRef="c153" decimals="0" id="ixv-43704" unitRef="usd">23346</ifrs-full:SocialSecurityContributions>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c153" decimals="0" id="ixv-43705" unitRef="usd">-2515</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:CurrentProvisions contextRef="c152" decimals="0" id="ixv-43706" unitRef="usd">355898</ifrs-full:CurrentProvisions>
    <ifrs-full:LeaseLiabilities contextRef="c152" decimals="0" id="ixv-43707" unitRef="usd">168988</ifrs-full:LeaseLiabilities>
    <ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate contextRef="c152" decimals="0" id="ixv-43708" unitRef="usd">996824</ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate>
    <ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed contextRef="c152" decimals="0" id="ixv-43709" unitRef="usd">3873974</ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed>
    <mlec:NoncontrollingInterest contextRef="c152" decimals="0" id="ixv-43710" unitRef="usd">-1898247</mlec:NoncontrollingInterest>
    <ifrs-full:GainRecognisedInBargainPurchaseTransaction contextRef="c153" decimals="0" id="ixv-43711" unitRef="usd">1032327</ifrs-full:GainRecognisedInBargainPurchaseTransaction>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred contextRef="c152" decimals="0" id="ixv-43712" unitRef="usd">943400</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:ShorttermBorrowings
      contextRef="c149"
      decimals="-6"
      id="ixv-43713"
      unitRef="usd">3000000</ifrs-full:ShorttermBorrowings>
    <mlec:PercentageOfCustomerRevenues contextRef="c0" decimals="2" id="ixv-43714" unitRef="pure">0.15</mlec:PercentageOfCustomerRevenues>
    <mlec:DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock contextRef="c0" id="ixv-24132">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;7.&#160;&lt;span style="text-decoration:underline"&gt;INFORMATION ABOUT
COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;7.1 &lt;span style="text-decoration:underline"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;



&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;06/30/2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;06/30/2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 0pt"&gt;Cash at bank and on hand&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;767,919&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;27,210,070&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Mutual funds&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-176"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;25,784,795&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;767,919&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;52,994,865&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;7.2 &lt;span style="text-decoration:underline"&gt;Other financial assets&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt 0pt 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding-top: 0pt; text-align: center; padding-right: 0pt; padding-left: 0pt"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;06/30/2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt 0pt 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt 0pt 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding-top: 0pt; font-weight: bold; text-align: center; padding-right: 0pt; padding-left: 0pt"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;06/30/2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt 0pt 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-top: 0pt; font-weight: bold; padding-right: 0pt; padding-left: 0pt"&gt;Current&lt;/td&gt;&lt;td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-top: 0pt; width: 76%; text-align: left; padding-left: 0pt; padding-right: 0pt"&gt;Investments at fair value&lt;/td&gt;&lt;td style="padding-top: 0pt; width: 1%; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-top: 0pt; width: 1%; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; width: 9%; text-align: right; padding-right: 0pt; padding-left: 0pt"&gt;19,722&lt;/td&gt;&lt;td style="padding-top: 0pt; width: 1%; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; width: 1%; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-top: 0pt; width: 1%; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; width: 9%; text-align: right; padding-right: 0pt; padding-left: 0pt"&gt;2,191,286&lt;/td&gt;&lt;td style="padding-top: 0pt; width: 1%; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-top: 0pt; text-align: left; padding-left: 0pt; padding-right: 0pt"&gt;Mutual funds&lt;/td&gt;&lt;td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; text-align: right; padding-right: 0pt; padding-left: 0pt"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-177"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; text-align: right; padding-right: 0pt; padding-left: 0pt"&gt;6,658,805&lt;/td&gt;&lt;td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 1.5pt; text-align: left"&gt;Other investments&lt;/td&gt;&lt;td style="padding: 0pt 0pt 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-top: 0pt; border-bottom: Black 1.5pt solid; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; border-bottom: Black 1.5pt solid; text-align: right; padding-right: 0pt; padding-left: 0pt"&gt;8,234,539&lt;/td&gt;&lt;td style="padding: 0pt 0pt 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt 0pt 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-top: 0pt; border-bottom: Black 1.5pt solid; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; border-bottom: Black 1.5pt solid; text-align: right; padding-right: 0pt; padding-left: 0pt"&gt;5,817,516&lt;/td&gt;&lt;td style="padding: 0pt 0pt 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding: 0pt 0pt 4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt 0pt 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-top: 0pt; border-bottom: Black 4pt double; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; border-bottom: Black 4pt double; text-align: right; padding-right: 0pt; padding-left: 0pt"&gt;8,254,261&lt;/td&gt;&lt;td style="padding: 0pt 0pt 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt 0pt 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-top: 0pt; border-bottom: Black 4pt double; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; border-bottom: Black 4pt double; text-align: right; padding-right: 0pt; padding-left: 0pt"&gt;14,667,607&lt;/td&gt;&lt;td style="padding: 0pt 0pt 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-top: 0pt; padding-left: 0pt; padding-right: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; text-align: right; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; text-align: right; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-top: 0pt; font-weight: bold; padding-left: 0pt; padding-right: 0pt"&gt;Non-current&lt;/td&gt;&lt;td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; text-align: right; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; text-align: right; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-top: 0pt; text-align: left; padding-left: 0pt; padding-right: 0pt"&gt;Mutual funds&lt;/td&gt;&lt;td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; text-align: right; padding-right: 0pt; padding-left: 0pt"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-178"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; text-align: right; padding-right: 0pt; padding-left: 0pt"&gt;190,080&lt;/td&gt;&lt;td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding: 0pt 0pt 1.5pt; text-align: left"&gt;Investments at fair value&lt;/td&gt;&lt;td style="padding: 0pt 0pt 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-top: 0pt; border-bottom: Black 1.5pt solid; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; border-bottom: Black 1.5pt solid; text-align: right; padding-right: 0pt; padding-left: 0pt"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-179"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0pt 0pt 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt 0pt 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-top: 0pt; border-bottom: Black 1.5pt solid; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; border-bottom: Black 1.5pt solid; text-align: right; padding-right: 0pt; padding-left: 0pt"&gt;437&lt;/td&gt;&lt;td style="padding: 0pt 0pt 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt 0pt 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-top: 0pt; border-bottom: Black 4pt double; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; border-bottom: Black 4pt double; text-align: right; padding-right: 0pt; padding-left: 0pt"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-180"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0pt 0pt 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt 0pt 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-top: 0pt; border-bottom: Black 4pt double; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; border-bottom: Black 4pt double; text-align: right; padding-right: 0pt; padding-left: 0pt"&gt;190,517&lt;/td&gt;&lt;td style="padding: 0pt 0pt 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The book value is reasonably approximate to the
fair value given its short-term nature.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;7.3 &lt;span style="text-decoration:underline"&gt;Trade receivables&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;06/30/2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 0pt"&gt;Trade debtors&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4,519,487&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;205,490,518&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Allowance for impairment of trade debtors (Note 7.16)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-181"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(7,050,280&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Shareholders and other related parties (Note 17)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-182"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;37&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: justify; padding-left: 0pt"&gt;Allowance for credit notes to be issued&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-183"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,905,624&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Trade debtors - Joint ventures and associates (Note 13)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,565,913&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,176,622&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Deferred checks&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-184"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;11,295,922&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;6,085,400&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;209,007,195&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The book value is reasonably approximate to the fair value given its
short-term nature.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;As of June 30, 2025, there is no allowance for impairment of
trade debtors, as the trade debtors mainly was acquired through the Business Combination Agreement consummated in June 16, 2025.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;7.4 &lt;span style="text-decoration:underline"&gt;Other receivables&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;06/30/2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; padding-left: 0pt"&gt;Taxes&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;382,957&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;5,475,685&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Insurance to be accrued&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,835&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,595,319&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Other receivables - Joint ventures and associates (Note 13)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,547,409&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,162,870&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Prepayments to suppliers&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;114&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,236,905&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Shareholders and other related parties (Note 17)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,313,179&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;47,348&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Government grants receivable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-185"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;608&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Prepaid expenses and other receivables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;33,448&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,736,808&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Loans receivables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-186"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,800,572&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 0pt"&gt;Miscellaneous&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;560,222&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,601,268&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;13,849,164&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;34,657,383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; padding-left: 0pt"&gt;Non-current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;Taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-187"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;752,045&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Other receivables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-188"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;230,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Reimbursements over exports&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-189"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,461,042&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Other receivables - Joint ventures and associates (Note 13)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;664,493&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25,423,142&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 0pt"&gt;Miscellaneous&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-190"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;20,805&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;664,493&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;27,887,034&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The book value of financial assets is reasonably approximate to the
fair value given its short-term nature.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;7.5 &lt;span style="text-decoration:underline"&gt;Inventories&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;06/30/2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;06/30/2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; padding-left: 0pt"&gt;Seeds&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;551,290&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;5,967,231&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Resale products&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-191"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;53,788,333&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Manufactured products&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;994,360&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;26,081,250&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Goods in transit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-192"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,618,540&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;Supplies&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-193"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;22,546,093&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Agricultural products&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;689,832&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15,015,884&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Allowance for obsolescence (Note 7.16)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-194"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(3,087,563&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,235,482&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;125,929,768&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0pt"&gt;Net of agricultural products&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,545,650&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;110,913,884&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The roll-forward of allowance for obsolescence
is in Note 7.16.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;7.6 &lt;span style="text-decoration:underline"&gt;Biological assets&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Changes in Biological assets:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Soybean&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Corn&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Wheat&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Barley&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Sunflower&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 28%; text-align: left; padding-left: 0pt"&gt;Beginning of the year&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-195"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-196"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;220,682&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;73,452&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-197"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; text-align: right"&gt;294,134&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Initial recognition and changes in the fair value of biological assets at the point of harvest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;593,001&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;435,725&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;579,313&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;158,080&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,256&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;1,764,863&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Costs incurred during the year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,959,381&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,814,249&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;444,303&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;162,342&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;55,063&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;4,435,338&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Decrease due to harvest/disposals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,275,688&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,148,288&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,244,298&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(393,874&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(53,807&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(4,115,955&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 0pt"&gt;Loss of control&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,276,694&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,101,686&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-198"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-199"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-200"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;(2,378,380&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 0pt"&gt;Year ended June 30, 2025&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-201"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-202"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-203"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-204"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-205"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-206"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Soybean&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Corn&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Wheat&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Barley&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Sunflower&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 28%; text-align: left; padding-left: 0pt"&gt;Beginning of the year&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-207"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-208"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;87,785&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;59,057&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-209"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; text-align: right"&gt;146,842&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Initial recognition and changes in the fair value of biological assets at the point of harvest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(352,199&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(32,674&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;231,526&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;106,605&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;996&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(45,746&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Costs incurred during the year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,423,732&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;792,235&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;220,679&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;73,452&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;137,680&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;2,647,778&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Decrease due to harvest/disposals&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,071,533&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(759,561&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(319,308&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(165,662&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(138,676&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;(2,454,740&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 0pt"&gt;Year ended June 30, 2024&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-210"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-211"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;220,682&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;73,452&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-212"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;294,134&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;7.7 &lt;span style="text-decoration:underline"&gt;Property, plant and equipment&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Property, plant and equipment as of June 30, 2025 and 2024, included
the following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Class&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Net carrying amount 06/30/2024&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Additions&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Reclassification&lt;br/&gt;
within PPE&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Disposals&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Depreciation of the year&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Foreign currency translation&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Loss of control&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Business combination&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Net&#160;carrying&lt;br/&gt;
amount&lt;br/&gt;
06/30/2025&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: 0pt; padding-left: 0pt; width: 19%"&gt;Office&#160;equipment&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;503,950&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;39,611&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-213"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;(4,791&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;(82,495&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;3,947&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;(449,942&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-214"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;10,280&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;Vehicles&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,192,627&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;35,915&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-215"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(17,239&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(882,264&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,023&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,330,062&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-216"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-217"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Equipment and computer software&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;528,816&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;75,297&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-218"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(323&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(273,912&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16,012&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(331,763&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-219"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,127&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Fixtures and fittings&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,805,076&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,084&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;225,338&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(6,789&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(860,822&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,350&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,178,237&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-220"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-221"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Machinery and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16,722,642&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;563,352&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;122,653&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(143,947&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,895,031&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;81,204&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(14,449,423&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-222"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,450&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Land and buildings&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;39,745,067&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-223"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;348,085&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-224"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,021,176&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;71,315&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;(39,143,291&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;982,939&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;982,939&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Buildings in progress&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;12,114,256&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,264,663&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(696,076&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-225"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-226"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;9,753&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(16,692,596&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,336,374&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,336,374&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-indent: 0pt; padding-left: 0pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;74,612,434&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;5,987,922&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-227"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(173,089&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(6,015,700&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;189,604&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(74,575,314&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3,319,313&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3,345,170&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Class&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Net&#160;carrying amount &lt;br/&gt;06/30/2023&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Additions&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Reclassification from Investment properties&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Disposals&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Depreciation of the year&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Foreign currency translation&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Loss of control&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Net&#160;carrying amount 06/30/2024&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; width: 19%; text-align: left; padding-left: 0.125in"&gt;Research&#160;instruments&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;66,131&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-228"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-229"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-230"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-231"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-232"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;(66,131&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-233"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Office&#160;equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;360,575&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;238,679&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-234"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-235"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(81,507&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(13,324&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(473&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;503,950&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Vehicles&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,053,263&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,077,988&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-236"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,677&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(908,040&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(775&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(28,132&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,192,627&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Equipment and computer software&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;198,364&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;725,706&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-237"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(8,184&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(354,379&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(27,650&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(5,041&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;528,816&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Fixtures and fittings&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,925,032&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;731,699&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-238"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,295&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(812,810&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,663&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(43,477&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,805,076&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Machinery and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,586,768&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,460,655&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-239"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(154,492&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,661,097&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(409,769&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(99,423&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16,722,642&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Land and buildings&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;36,211,957&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,835,054&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,222,044&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;53,217&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(982,165&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(595,040&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-240"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;39,745,067&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Buildings in progress&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;11,757,249&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;683,406&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-241"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(106,421&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-242"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(207,757&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(12,221&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;12,114,256&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-indent: -0.125in; font-weight: bold; padding-left: 0.125in"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;68,159,339&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;10,753,187&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;3,222,044&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(211,262&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(5,799,998&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(1,255,978&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(254,898&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;74,612,434&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The depreciation charge is included in Notes 8.3 - R&amp;amp;D classified
by nature and Note 8.4 &#x2013; Expenses classified by nature and function. The Group has no commitments to purchase property, plant and
equipment items.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Revaluation of property, plant and equipment&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group used to frequently update their assessment
of the fair value of its land and buildings taking into account the most recent independent valuations and market data. Last valuations
were performed as of June 30, 2023. Management determined the property, plant and equipment&#x2019;s value within a range of reasonable
fair value estimates.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;All resulting fair value estimates for properties
are included in level 2 or 3 depending on the methodology used.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following are the carrying amounts that would
have been recognized if land and building were stated at cost.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Value at cost&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Class of property&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: justify; padding-left: 0pt"&gt;Land and buildings&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;27,876,636&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;span style="font-size: 10pt"&gt;&lt;b&gt;7.8&lt;/b&gt;&lt;/span&gt; &lt;b&gt;&lt;span style="text-decoration:underline"&gt;Intangible assets&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-size: 6pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Intangible assets as of June 30, 2025 and 2024 included the following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-size: 6pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Class&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Net carrying amount 06/30/2024&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Additions&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Loss of control) &lt;sup&gt;(*)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Additions from business
    combinations &lt;sup&gt;(**)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Transfers/ Disposals&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Amortization of the year&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Foreign currency translation&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Net carrying amount 06/30/2025&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; font-style: italic"&gt;&lt;span style="text-decoration:underline"&gt;Seed and
    integrated products&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; text-indent: -0.125in; padding-left: 0.125in; width: 28%; text-align: left"&gt;Alfalfa Genuity Har Xstra&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;438,029&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-243"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-244"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-245"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-246"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-247"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;(21,172&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;416,857&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;HB4 soy and breeding program&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;35,574,369&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,164,283&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(36,464,169&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-248"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-249"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,274,483&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-250"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-251"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Integrated seed products&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,681,826&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-252"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,526,410&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-253"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-254"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(194,339&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;38,923&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-255"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; font-style: italic; text-decoration: underline; text-align: left"&gt;Crop nutrition&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Microbiological products&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;41,187,249&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;286,665&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(43,570,818&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-256"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,605,198&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,511,420&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,126&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-257"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Microbiological products in progress&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,452,861&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,163,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(11,909,700&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-258"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,706,661&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-259"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-260"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-261"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; font-style: italic; text-decoration: underline; text-align: left"&gt;Other intangible assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Trademarks and patents&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;51,316,860&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;158,557&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(47,394,664&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-262"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-263"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(4,080,753&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-264"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-265"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Trademarks and patents with indefinite useful life&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,045,294&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-266"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(10,045,294&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-267"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-268"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-269"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-270"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-271"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Software&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,119,494&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16,222&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(605,341&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-272"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;146,839&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(723,312&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;46,098&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-273"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Software in progress&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;580,728&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;176,064&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(609,953&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-274"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(146,839&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-275"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-276"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-277"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Customer loyalty&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,934,570&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-278"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(17,565,911&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-279"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-280"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,368,659&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-281"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-282"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;RG/RS/OX Wheat&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,528,899&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(10,480,817&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-283"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-284"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,048,082&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-285"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-286"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Sustainable agricultural equipment technology&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-287"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-288"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-289"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,719,710&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-290"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-291"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-292"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,719,710&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Fungal Biomass&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-293"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-294"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-295"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,775,940&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-296"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-297"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-298"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,775,940&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Piggysooy&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-299"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-300"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-301"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16,813,781&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-302"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-303"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-304"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16,813,781&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Safflower GLA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-305"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-306"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-307"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;27,857,339&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-308"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-309"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-310"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;27,857,339&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Safflower Chimosin 2.0&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-311"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-312"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-313"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,600,554&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,600,554&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Other intangibles&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-314"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-315"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-316"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;6,074,609&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-317"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-318"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-319"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;6,074,609&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;177,331,280&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;15,494,190&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(181,173,077&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;74,841,933&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(101,463&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(11,201,048&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;66,975&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;75,258,790&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-size: 6pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;sup&gt;(*)&lt;/sup&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Correspond to the loss of control of BIOX.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;sup&gt;(**)&lt;/sup&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Correspond to The Bioceres Group Business Combination Agreement.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-size: 6pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left; padding-left: 0in"&gt;&lt;b&gt;Class&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Net carrying amount 06/30/2023&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Additions&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Additions
    from business combinations/ (loss of control)&lt;sup&gt;(*)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Transfers/ Disposals&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Amortization of the year&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Foreign currency translation&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Net carrying amount 06/30/2024&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; font-style: italic"&gt;Seed and integrated products&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; width: 28%; text-align: left"&gt;Alfalfa Genuity Har Xstra&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;419,061&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-320"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-321"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-322"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-323"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;18,968&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;438,029&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Bacillus-PHAs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,089,536&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-324"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,089,536&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-325"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-326"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-327"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-328"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;HB4 soy and breeding program&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;31,679,114&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,987,247&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-329"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-330"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,091,992&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-331"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;35,574,369&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Integrated seed products&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,841,008&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-332"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-333"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-334"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(191,559&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;32,377&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,681,826&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; font-style: italic; text-decoration: underline; text-align: left"&gt;Crop
    nutrition&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Microbiological&#160;products&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;37,295,460&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-335"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-336"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,610,115&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,718,326&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-337"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;41,187,249&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Microbiological products in progress&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,213,341&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,869,084&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-338"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(7,610,115&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-339"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(19,449&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,452,861&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; font-style: italic; text-decoration: underline; text-align: left"&gt;Other
    intangible assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Trademarks and patents&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;51,933,444&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;44,073&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-340"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-341"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(670,514&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,857&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;51,316,860&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Trademarks and patents with indefinite useful life&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,827,309&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-342"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,217,985&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-343"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-344"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-345"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,045,294&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Software&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,638,752&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;585,313&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-346"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;276,128&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,369,379&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(11,320&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,119,494&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Software in progress&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;349,171&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;507,685&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-347"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(276,128&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-348"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-349"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;580,728&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Customer loyalty&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;23,006,023&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-350"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-351"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-352"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;(4,071,453&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-353"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,934,570&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;RG/RS/OX
    Wheat&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,000,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-354"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-355"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-356"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-357"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-358"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,000,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;175,292,219&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;12,993,402&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;1,128,449&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-359"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(12,113,223&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;30,433&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;177,331,280&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-size: 6pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;sup&gt;(*)&lt;/sup&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;USD 1,089,768 correspond to the loss of control of Inmet
S.A.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The amortization charge is included in Notes 8.3 - R&amp;amp;D classified
by nature and Note 8.4 &#x2013; Expenses classified by nature and function.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;There are no intangibles assets whose use has
been restricted or which have been delivered as a guarantee. The Group has not assumed any commitments to acquire new intangibles.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Estimates&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "&gt;There is an inherent
material uncertainty related to management&#x2019;s estimation of the ability of the Group to recover the carrying amounts of internally
generated intangible assets, because it is dependent upon Group&#x2019;s ability to raise sufficient funds to complete the projects development,
the future outcome of the regulatory process, and the timing and amount of the future cash flows generated by the projects, among other
future events.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "&gt;Management&#x2019;s estimations
about the demonstrability of the recognition criteria for these assets and the subsequent recoverability represent the best estimate that
can be made based on all the available evidence, existing facts and circumstances and using reasonable and supportable assumptions in
cash flow projections. Therefore, the consolidated financial statements do not include any adjustments that would result if the Group
were unable to recover the carrying amount of the above-mentioned assets through the generation of enough future economic benefits.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "&gt;The Group is required
to perform an annual impairment test for non-depreciating assets, either because they are not available for use, have indefinite useful
lives, or for other intangible assets when events or changes in circumstances indicate that their carrying amount may not be recoverable.
The recoverable amount is determined based on calculations of value in use. This method requires estimating future cash flows and determining
a discount rate to calculate the present value of those cash flows.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Management has made the estimates considering
the cash flow projections projected by the management. All key assumptions values reflect past experience or, if appropriate, are consistent
with external sources of information.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="border-bottom: Black 1.5pt solid; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; width: 20%"&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;b&gt;Key assumption&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center; border-bottom: Black 1.5pt solid; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; width: 79%"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Management&#x2019;s approach&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td style="padding: 0pt"&gt;&lt;span style="font-size: 10pt"&gt;Discount rate&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="padding: 0pt"&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;The discount rate applied was either&#160;16.39% or&#160;11.56%, depending on the target market.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;The weighted average cost of capital (WACC) was estimated using the market capital structure plus&#160;2% of risk premium which reflect the higher risk associated with intangible assets.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;For the cost of equity, the discount rate is estimated based on the Capital Asset Pricing Model (CAPM).&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td style="text-indent: -0.125in; padding: 0pt 0pt 0pt 0.125in"&gt;&lt;span style="font-size: 10pt"&gt;Market share, product prices and royalties.&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="padding: 0pt"&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; "&gt;The projected revenue from the products and services of the CGUs has been estimated by the management based on market penetration data for comparable products and technologies and on future expectations of foreseen economic and market conditions.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; "&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; "&gt;The prices and royalties estimated in the revenue projections are based on current and projected market prices for the products and services of the CGUs.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "&gt;A projection horizon
longer than&#160;five years&#160;was adopted, as the GGUs are linked to biological products that require extended development and regulatory
approval timelines across multiple target countries. Due to the nature of these products and the maturity level of the markets involved,
a longer time frame is essential to reasonably capture the expected cash flows and the time needed to reach commercial readiness and registration
milestones. Projected range period used:&#160;8-18&#160;years.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "&gt;Management estimates
that any reasonably possible change in any of these key assumptions would not cause the aggregate carrying amount of the CGU to exceed
its recoverable amount.&lt;/p&gt;&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;7.9 &lt;span style="text-decoration:underline"&gt;Goodwill&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;





&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Rizobacter Argentina S.A.&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-360"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;28,080,271&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Bioceres Crops S.A.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-361"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,523,322&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Insumos Agroqu&#xed;micos S.A.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-362"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;470,090&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Pro Farm Group&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-363"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;76,089,749&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-364"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;112,163,432&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group is required to test whether goodwill
has suffered any impairment on an annual basis. The recoverable amount is determined based on value in use calculations. The use of this
method requires the estimation of future cash flows and the determination of a discount rate in order to calculate the present value of
the cash flows.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Prior to the BIOX deconsolidation, the CGUs were
determined as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Rizobacter CGU. This CGU is composed of all revenues
collected through Rizobacter from the production and sale of proprietary and third-party products, both in the domestic and international
markets. Additionally, Rizobacter generates revenue from the formulation, fragmentation and resale of third-party products.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Bioceres Crops CGU. This CGU is composed of the
expected revenues from the commercialization of intensive R&amp;amp;D products that previously were allocated on the equity participation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Insuagro CGU. This CGU is composed of all revenues
collected through Insuagro from the production and sale of proprietary and third-party products, both in the domestic markets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Pro Farm Group Inc CGU. This CGU is composed of
all revenues collected through Pro Farm from the production and sale of proprietary and third-party products, both in the domestic and
international markets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Management has made the estimates considering
the cash flow projections projected by the management and third-party valuation reports on the assets, intangible assets and liabilities
assumed. The key assumptions utilized are the following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="border-bottom: Black 1.5pt solid; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; width: 20%"&gt; &lt;p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;b&gt;Key assumption&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; width: 2%"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center; border-bottom: Black 1.5pt solid; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; width: 78%"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Management&#x2019;s approach&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td style="padding: 0pt"&gt;&lt;span style="font-size: 10pt"&gt;Discount rate&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="padding: 0pt"&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"&gt;The discount rate used ranges was&#160;14.11%&#160;for Rizobacter UGE and for&#160;Bioceres Crops UGE, and&#160;9.28% for Pro Farm UGE due to the target market.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="text-align: justify; text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;The weighted average cost of capital (&#x201c;WACC&#x201d;) rate has been estimated based on the market capital structure.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0pt; margin: 0pt"&gt;&#160;&lt;/p&gt; &lt;p style="text-align: justify; text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;For the cost of equity, the discount rate is estimated based on the Capital Asset Pricing Model (CAPM).&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td style="text-indent: -0.125in; padding: 0pt 0pt 0pt 0.125in; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Market share, product prices and royalties.&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: justify; padding: 0pt"&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"&gt;The projected revenue from the products and services of the CGUs has been estimated by the management based on market penetration data for comparable products and technologies and on future expectations of foreseen economic and market conditions.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"&gt;The prices (Rizobacter CGU and Pro Farm CGU) and royalties (Bioceres Crops CGU) estimated in the revenue projections are based on current and projected market prices for the products and services of the CGUs.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td style="text-align: justify; padding: 0pt"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: justify; padding: 0pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td style="text-align: justify; padding: 0pt"&gt;&lt;span style="font-size: 10pt"&gt;Terminal value&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: justify; padding: 0pt"&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"&gt;Rizobacter CGU and Bioceres Crops CGU: The growth rate used to extrapolate the future cash flow projections to terminal period&#160;is&#160;2%.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;Pro Farm CGU: EBITDA multiple (10x)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;7.10 &lt;span style="text-decoration:underline"&gt;Investment properties&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;



&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Investment properties&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-365"&gt;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;560,783&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-366"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;560,783&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The decrease for the year is attributed to loss
of control in BIOX.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The book value of the investment properties does not differ significantly
from its fair value.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;7.11&#160; &lt;span style="text-decoration:underline"&gt;Trade and other payables&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;





&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 0pt"&gt;Trade creditors&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;6,490,684&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;108,922,112&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Shareholders and other related parties (Note 17)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-367"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;37,985&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Trade creditors - Joint ventures and associates (Note 13)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;620,034&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;52,778,206&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;Taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,647&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,877,930&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 0pt"&gt;Miscellaneous&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;200,568&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,321,303&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;7,323,933&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;168,937,536&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The book value of financial liabilities is reasonably approximate to
the fair value given its short-term nature.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;7.12&#160; &lt;span style="text-decoration:underline"&gt;Borrowings&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;





&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 0pt"&gt;Bank borrowings&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;33,383&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;94,711,273&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Corporate bonds&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-368"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;42,035,925&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Net loans payables- Joint ventures and associates (Note 13)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,303,098&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,860,058&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;Convertible preference shares (Note 17)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15,739,726&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-369"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Financial borrowings&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;201,077,800&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;95,903,495&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;227,154,007&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;234,510,751&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; padding-left: 0pt"&gt;Non-current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Bank borrowings&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,348,173&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,033,059&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Corporate bonds&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-370"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25,071,823&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Financial borrowings&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-371"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;85,143,423&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,348,173&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;127,248,305&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Bioceres S.A. is the guarantor of the stock purchase
agreement signed on October 28, 2022, between Theo I SCSp and DRACO I-LATAM SPC LTD, as well as the subsequent credit line agreement signed
on December 11, 2023, which are included in the investment in Theo I SCSp, as indicated in Note 13 &#x2013; Joint ventures and associates.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As a result of Theo I SCSp&#x2019;s default in July 7, 2025, Bioceres
S.A., a subsidiary of Bioceres Group, as guarantor, recognized the financial debt with DRACO I-LATAM SPC LTD as of June 30, 2025. The
amount recognized of $61.7 million was determined as the difference between the estimated realizable value of Theo I SCSp&#x2019;s assets
and the settlement value of its liabilities. Theo I SCSp is an associate of Bioceres Group, a wholly owned subsidiary of the Company.
As of June 30, 2024 and 2023, the fair value of Theo I SCSp&#x2019;s assets exceeded the value of its liabilities. Accordingly, the value
of the guarantee recognized by Bioceres S.A. as of June 30, 2024 and 2023 was zero. See note 8.6.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In December 2024, the Company issued 2,380,952
convertible preference shares for total proceeds of $15 million. These preference shares accrue a 9% per annum payment-in-kind (PIK) return
and grant the holder specific conversion rights, including the option to convert into ordinary shares at predefined terms, mandatory conversion
provisions, and redemption alternatives contingent on the occurrence of certain events. See Note 21 &#x2013; Events occurring after the
reporting period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The carrying value of some borrowings as of June
30, 2025 and 2024, are measured at amortized cost differ from their fair value. The following fair values measured are based on discounted
cash flows (Level 3) due to the use of unobservable inputs, including own credit risk.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As stated in Note 1 &#x2013; The Group&#x2019;s
business reorganization and general information - &#x201c;&lt;i&gt;The Bioceres Group Business Combination Agreement&#x201d;, &lt;/i&gt;in June 2025,
Bioceres S.A., one of the Argentine subsidiaries of Bioceres Group Limited, defaulted on a portion of its financial debt that was due
that month. The aggregate amount is $36.4 million.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In July 2025, Bioceres LLC, a wholly owned subsidiary
of Bioceres S.A., received a notice of default on its financial debt&#160;in the amount of $69.5 million. The creditor conducted a public
auction for 3,062,500 pledged BIOX shares, pursuant to the New York Uniform Commercial Code. Management has responded to the creditor,
reserving all rights, remedies, and defenses. As of the date of this report, the current debt amounts to $58.0 million.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Amortized Cost&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Fair value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Amortized Cost&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Fair value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; padding-left: 0pt"&gt;Bank borrowings&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;33,383&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;33,383&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;94,711,273&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;93,301,194&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Corporate bonds&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-372"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-373"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;42,035,925&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;41,492,963&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;Convertible preference shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15,739,726&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,179,927&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-374"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-375"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Financial borrowings&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;211,380,898&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;205,082,929&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;95,903,495&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;95,480,681&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-left: 0pt"&gt;Non current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Bank borrowings&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,348,173&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,348,173&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,033,059&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,206,794&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Corporate bonds&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-376"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-377"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25,071,823&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;23,845,583&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Convertible notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,260,456&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,260,456&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-378"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-379"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Financial borrowings&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-380"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-381"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;85,143,423&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;81,120,125&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;7.13&#160; &lt;span style="text-decoration:underline"&gt;Convertible notes&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;





&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="text-decoration:underline"&gt;Convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;Non-current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Convertible notes&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;18,260,456&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;80,809,686&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;18,260,456&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;80,809,686&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Secured Guaranteed Notes &lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Secured Guaranteed Notes due 2026 bore interest
at&#160;9.0%&#160;from the issue date through 24 months after the issue date,&#160;13.0%&#160;from 25 through 36 months after the issue
date, and&#160;14.0%&#160;from 37 through 48 months after the issue date. Interest was payable semi-annually.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On June 18, 2025, BIOX entered into an amendment
to the Secured Guaranteed Notes pursuant to which the aggregate principal amount increases from&#160;$26,437,485&#160;to&#160;$29,081,233,
with an annual interest rate of&#160;19%, of which&#160;14%&#160;is payable in cash and&#160;5%&#160;in kind. BIOX is required to make
scheduled amortization payments of&#160;$1,000,000&#160;on the last business day of each calendar month and may only be repurchased in
full. Had BIOX repurchased it on or before August 5, 2025, a&#160;5%&#160;&#x201c;Prepayment Premium&#x201d; penalty would have applied.
If the repurchase occurred after that date, the penalty increased to&#160;10%. The Prepayment Premium also applied to payments made following
acceleration.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"&gt;The Secured Guaranteed Notes due 2026 had no conversion rights into
BIOX ordinary shares.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Secured Convertible Guaranteed Notes &lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Secured Guaranteed Convertible Notes were
issued for a total principal amount of $55 million. The notes have a 4- year maturity and accrue interest at an annual interest rate of
9%, of which 5% is payable in cash and 4% in-kind. At any time up to maturity the note holders might opt to convert the outstanding principal
amount into common shares of BIOX at a strike price of $18 per share. BIOX can repurchase the notes voluntarily 30 months after the issue
date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On June 18, 2025, BIOX entered into an amendment to the Secured Convertible
Guaranteed Notes pursuant to which the aggregate principal amount increases from&#160;$61,652,927&#160;to&#160;$67,868,227, and the maturity
date is extended to August 31, 2027. The notes carry an annual interest rate of&#160;15%, of which&#160;5%&#160;is payable in cash and&#160;10%&#160;in
kind. Noteholders have now the option to convert the outstanding principal amount of their Convertible Notes into common shares of BIOX
at a reduced strike price of&#160;$6&#160;per share. If BIOX raises more than&#160;$10,000,000&#160;in common equity, the strike price
resets to the lesser of (1) the then-applicable strike price or (2) the price per share at which the new shares are issued (or the weighted
average price per share, if issued at varying prices). BIOX may voluntarily repurchase the Convertible Notes; however, it must pay either
a &#x201c;Prepayment Premium Fee&#x201d; or an &#x201c;Equity Option Fee.&#x201d; If the repurchase occurs on or before August 31, 2025, a&#160;5%&#160;prepayment
penalty applies. If the repurchase had occurred on or before August 31, 2025, a&#160;5%&#160;prepayment penalty would have applied. If
repurchased between September 1 and prior to October 1, 2025, the penalty would have increased to&#160;7%. For repurchases on or after
October 1, 2025, the applicable fee would be the full Equity Option Fee. Additionally, either the Prepayment Premium Fee or the Equity
Option Fee will apply in the event of payments made following acceleration.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;At inception, the fair value of the liability
component of the Secured Convertible Guaranteed Notes was measured using a discount rate of 13.57%. Following the BIOX deconsolidation
and as of June 30, 2025, the Secured Convertible Guaranteed Notes are not included within the line item &#x201c;Convertible Notes&#x201d;
from the Statement of Financial Position.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of June 30, 2025 a total of $4.8&#160;million
was accrued as a Prepayment Premium Fee. (Note 8.5).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="text-align: justify; margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"&gt;Following the BIOX deconsolidation and as of June 30, 2025, the Secured
Guaranteed Notes are not included within the line item &#x201c;Convertible Notes&#x201d; from the Statement of Financial Position&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Convertible Notes&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On October 15, 2023, Moolec Science has entered
into an agreement to issue a convertible note due 2026 to Invim Corporativo S.L. As of June 30, 2025, the Company has received USD 10,000,000
related to such convertible note. Additionally, the Company signed additional convertible notes for USD 940,000 between October 2023 and
June 30, 2024 with local farmers and jointly with the convertible note with Invim Corporativo S.L., are referred to as &#x201c;the Notes&#x201d;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Notes have a term of three years with an early
conversion option with a strike price of US $60.00&#160;per share. If the early conversion option is exercised, Moolec Science will have
the option to pay the outstanding amount at that date using shares, cash or a combination of both. Initial interest rate on the notes
is of 5% per annum payable annually in cash in arrears on anniversary of the date of the notes and on the maturity date, however Moolec
Science will have the option at each payment date to capitalize the interest accrued. After the remaining cash payment made during 2024
the interest rate was increased to 10% per annum. Lastly, as per the convertible note with Invim Corporativo S.L., after the in-kind contribution,
when received, the interest rate will be calculated in accordance with a formula included in the agreement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;At maturity, Moolec Science will hold the option
to deliver ordinary shares, cash, or a combination of cash and ordinary shares. See Note 21 - Events occurring after the reporting period
&#x2013; Notice of Alleged Breach.&lt;/p&gt;&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;7.14&#160; &lt;span style="text-decoration:underline"&gt;Employee benefits and social security&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;





&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 0pt"&gt;Salaries, accrued incentives, vacations&#160;and social security&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;202,014&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;7,280,129&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Key management personnel (Note 18)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;41,620&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;226,702&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;243,634&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;7,506,831&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The book value is reasonably approximate to the fair value given its
short-term nature.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;7.15&#160; &lt;span style="text-decoration:underline"&gt;Deferred revenue and advances from customers&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;





&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 0pt"&gt;Advances from customers&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,260&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3,335,740&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Deferred revenue&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-382"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;589,061&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,260&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3,924,801&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-left: 0pt"&gt;Non current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Advances from customers&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-383"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;52,511&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Deferred revenue&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-384"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,872,627&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-385"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,925,138&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;7.16&#160; &lt;span style="text-decoration:underline"&gt;Changes in allowances and provisions&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Item&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Additions&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;b&gt;Uses and &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;reversals&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Currency &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;b&gt;conversion &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;difference&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;b&gt;Loss of &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;control&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;DEDUCTED FROM ASSETS&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 28%; text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Allowance for impairment of trade debtors&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;7,050,280&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;7,123,716&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-386"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(50,533&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(14,123,463&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"&gt;Allowance for obsolescence&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,087,563&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,547,723&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,158,036&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;29,204&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(3,506,454&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"&gt;Total deducted from assets&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;10,137,843&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;8,671,439&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,158,036&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(21,329&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(17,629,917&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;INCLUDED IN LIABILITIES&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Provisions for contingencies&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;17,484,715&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;336,919&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(309,793&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(89,694&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,267,573&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;16,154,574&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"&gt;Total included in liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;17,484,715&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;336,919&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(309,793&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(89,694&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,267,573&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;16,154,574&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.125in"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;27,622,558&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;9,008,358&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(1,467,829&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(111,023&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(18,897,490&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;16,154,574&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-indent: -0.25in; padding-left: 0.25in; font-weight: bold"&gt;Item&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Additions&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Additions &lt;br/&gt; from &lt;br/&gt; business &lt;br/&gt; combination&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Uses and &lt;br/&gt; reversals&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Currency &lt;br/&gt; conversion &lt;br/&gt; difference&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.25in; padding-left: 0.25in; font-weight: bold"&gt;DEDUCTED FROM ASSETS&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 28%; text-align: left; text-indent: -0.25in; padding-left: 0.25in"&gt;Allowance for impairment of trade debtors&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;7,425,604&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;753,428&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-387"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(777,558&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(351,194&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;7,050,280&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.25in; padding-left: 0.25in"&gt;Allowance for obsolescence&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,492,499&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;586,515&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-388"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(69,582&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;78,131&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,087,563&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -0.25in; padding-left: 0.25in"&gt;Total deducted from assets&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;9,918,103&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,339,943&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-389"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(847,140&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(273,063&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;10,137,843&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.25in; padding-left: 0.25in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; text-indent: -0.25in; padding-left: 0.25in"&gt;INCLUDED IN LIABILITIES&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.25in; padding-left: 0.25in"&gt;Provisions for contingencies&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;16,901,773&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;653,574&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;355,898&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(393,073&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(33,457&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;17,484,715&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -0.25in; padding-left: 0.25in"&gt;Total included in liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;16,901,773&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;653,574&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;355,898&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(393,073&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(33,457&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;17,484,715&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt; text-indent: -0.25in; padding-left: 0.25in"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;26,819,876&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;1,993,517&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;355,898&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(1,240,213&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(306,520&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;27,622,558&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="text-decoration:underline"&gt;Provisions&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 0pt"&gt;Conditional payment Rizobacter SA&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;15,916,116&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;15,916,116&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Provisions for contingencies&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;238,458&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,568,599&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;16,154,574&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;17,484,715&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group has recorded a provision for probable
administrative, judicial and out-of-court proceedings that could arise in the ordinary course of business, based on a prudent criterion
according to its professional advisors and on Management&#x2019;s assessment of the best estimate of the amount of possible claims. These
potential claims are not likely to have a material impact on the results of the Group&#x2019;s operations, its cash flow or financial position.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Management considers that the objective evidence
is not enough to determine the date of the eventual cash outflow due to a lack of experience in any similar cases. However, the provision
was classified under current or non-current liabilities, applying the best prudent criterion based on Management&#x2019;s estimates.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;There are no expected reimbursements related to
the provisions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In order to assess the need for provisions and
disclosures in its consolidated financial statements, Management considers the following factors: (i) nature of the claim and potential
level of damages in the jurisdiction in which the claim has been brought; (ii) the progress of the eventual case; (iii) the opinions or
views of tax and legal advisers; (iv) experience in similar cases; and (v) any decision of the Group&#x2019;s management as to how it will respond
to the eventual claim.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Conditional payment Rizobacter S.A.&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group agreed with certain sellers of Rizobacter,
a contingent payment of $17.3 million (current value of $15.9 million) conditional on obtaining a favorable resolution that totally rejects
the claim of the plaintiff in the nullity trials, file &#x201c;Harnan Miguel, Marcos and Martina c/ac Mullen Jorge and others s/ Annulment
Action&#x201d;, file No. 76,806 and in the injunction (&#x201c;&lt;i&gt;embargo&lt;/i&gt;&#x201d;), file &#x201c;Harnan Miguel, Marcos and Martina c/
Mac Mullen Jorge and others s/ Precautionary Measures&#x201d;, file No. 76,745. In said cause, 44% of the capital of Rizobacter Argentina
S.A. is seized and 30% of the dividends that the taxed shares produce.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;If the injunction is lifted, the Group will be
required to pay within 12 months of notification, a contingent purchase price of $17.3 million to certain selling shareholders of Rizobacter.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of June 30, 2025 there is no allowance for
obsolescence for inventories, as the inventory was acquired through the Business Combination Agreement consummated in June 16, 2025.&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;7.17&#160; &lt;span style="text-decoration:underline"&gt;Government Grants&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;





&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 0pt"&gt;At the beginning of the year&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4,437&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;349,998&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;&lt;span style="font-size: 10pt"&gt;Loss of control &lt;sup&gt;(*)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-390"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(157,043&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Currency conversion difference&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;255&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,001&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Released to the statement of profit or loss&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(3,412&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(197,519&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0pt"&gt;At the end of the year&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,280&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4,437&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;sup&gt;&#160;&lt;/sup&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&lt;sup&gt;(*)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Correspond to the loss of control
of Inmet S.A. in the year 2024&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;7.18&#160; &lt;span style="text-decoration:underline"&gt;Warrants&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;



&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;At the beginning of the year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-391"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-392"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Additions for the year&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"&gt;1,030,000&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;p style="-sec-ix-hidden: hidden-fact-393; margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Additions from business combination&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;181,093&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-394"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0pt"&gt;At the end of the year&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,211,093&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-395"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</mlec:DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTextBlock>
    <ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory contextRef="c0" id="ixv-24141">&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;06/30/2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;06/30/2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 0pt"&gt;Cash at bank and on hand&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;767,919&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;27,210,070&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Mutual funds&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-176"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;25,784,795&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;767,919&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;52,994,865&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory>
    <ifrs-full:Cash contextRef="c4" decimals="0" id="ixv-43715" unitRef="usd">767919</ifrs-full:Cash>
    <ifrs-full:Cash contextRef="c7" decimals="0" id="ixv-43716" unitRef="usd">27210070</ifrs-full:Cash>
    <mlec:MutualFunds contextRef="c7" decimals="0" id="ixv-43717" unitRef="usd">25784795</mlec:MutualFunds>
    <ifrs-full:CashAndCashEquivalents contextRef="c4" decimals="0" id="ixv-43718" unitRef="usd">767919</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c7" decimals="0" id="ixv-43719" unitRef="usd">52994865</ifrs-full:CashAndCashEquivalents>
    <mlec:DisclosureOfOtherFinancialAssetsExplanatory contextRef="c0" id="ixv-24192">&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding: 0pt 0pt 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt 0pt 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding-top: 0pt; text-align: center; padding-right: 0pt; padding-left: 0pt"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;06/30/2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt 0pt 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt 0pt 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; padding-top: 0pt; font-weight: bold; text-align: center; padding-right: 0pt; padding-left: 0pt"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;06/30/2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding: 0pt 0pt 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-top: 0pt; font-weight: bold; padding-right: 0pt; padding-left: 0pt"&gt;Current&lt;/td&gt;&lt;td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-top: 0pt; width: 76%; text-align: left; padding-left: 0pt; padding-right: 0pt"&gt;Investments at fair value&lt;/td&gt;&lt;td style="padding-top: 0pt; width: 1%; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-top: 0pt; width: 1%; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; width: 9%; text-align: right; padding-right: 0pt; padding-left: 0pt"&gt;19,722&lt;/td&gt;&lt;td style="padding-top: 0pt; width: 1%; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; width: 1%; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-top: 0pt; width: 1%; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; width: 9%; text-align: right; padding-right: 0pt; padding-left: 0pt"&gt;2,191,286&lt;/td&gt;&lt;td style="padding-top: 0pt; width: 1%; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-top: 0pt; text-align: left; padding-left: 0pt; padding-right: 0pt"&gt;Mutual funds&lt;/td&gt;&lt;td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; text-align: right; padding-right: 0pt; padding-left: 0pt"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-177"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; text-align: right; padding-right: 0pt; padding-left: 0pt"&gt;6,658,805&lt;/td&gt;&lt;td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 1.5pt; text-align: left"&gt;Other investments&lt;/td&gt;&lt;td style="padding: 0pt 0pt 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-top: 0pt; border-bottom: Black 1.5pt solid; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; border-bottom: Black 1.5pt solid; text-align: right; padding-right: 0pt; padding-left: 0pt"&gt;8,234,539&lt;/td&gt;&lt;td style="padding: 0pt 0pt 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt 0pt 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-top: 0pt; border-bottom: Black 1.5pt solid; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; border-bottom: Black 1.5pt solid; text-align: right; padding-right: 0pt; padding-left: 0pt"&gt;5,817,516&lt;/td&gt;&lt;td style="padding: 0pt 0pt 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding: 0pt 0pt 4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt 0pt 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-top: 0pt; border-bottom: Black 4pt double; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; border-bottom: Black 4pt double; text-align: right; padding-right: 0pt; padding-left: 0pt"&gt;8,254,261&lt;/td&gt;&lt;td style="padding: 0pt 0pt 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt 0pt 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-top: 0pt; border-bottom: Black 4pt double; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; border-bottom: Black 4pt double; text-align: right; padding-right: 0pt; padding-left: 0pt"&gt;14,667,607&lt;/td&gt;&lt;td style="padding: 0pt 0pt 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-top: 0pt; padding-left: 0pt; padding-right: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; text-align: right; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; text-align: right; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-top: 0pt; font-weight: bold; padding-left: 0pt; padding-right: 0pt"&gt;Non-current&lt;/td&gt;&lt;td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; text-align: right; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; text-align: right; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-top: 0pt; text-align: left; padding-left: 0pt; padding-right: 0pt"&gt;Mutual funds&lt;/td&gt;&lt;td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; text-align: right; padding-right: 0pt; padding-left: 0pt"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-178"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; text-align: right; padding-right: 0pt; padding-left: 0pt"&gt;190,080&lt;/td&gt;&lt;td style="padding-top: 0pt; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding: 0pt 0pt 1.5pt; text-align: left"&gt;Investments at fair value&lt;/td&gt;&lt;td style="padding: 0pt 0pt 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-top: 0pt; border-bottom: Black 1.5pt solid; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; border-bottom: Black 1.5pt solid; text-align: right; padding-right: 0pt; padding-left: 0pt"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-179"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0pt 0pt 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt 0pt 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-top: 0pt; border-bottom: Black 1.5pt solid; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; border-bottom: Black 1.5pt solid; text-align: right; padding-right: 0pt; padding-left: 0pt"&gt;437&lt;/td&gt;&lt;td style="padding: 0pt 0pt 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt 0pt 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-top: 0pt; border-bottom: Black 4pt double; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; border-bottom: Black 4pt double; text-align: right; padding-right: 0pt; padding-left: 0pt"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-180"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding: 0pt 0pt 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding: 0pt 0pt 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-top: 0pt; border-bottom: Black 4pt double; text-align: left; padding-right: 0pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-top: 0pt; border-bottom: Black 4pt double; text-align: right; padding-right: 0pt; padding-left: 0pt"&gt;190,517&lt;/td&gt;&lt;td style="padding: 0pt 0pt 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</mlec:DisclosureOfOtherFinancialAssetsExplanatory>
    <ifrs-full:OtherCurrentFinancialAssets contextRef="c174" decimals="0" id="ixv-43720" unitRef="usd">19722</ifrs-full:OtherCurrentFinancialAssets>
    <ifrs-full:OtherCurrentFinancialAssets contextRef="c175" decimals="0" id="ixv-43721" unitRef="usd">2191286</ifrs-full:OtherCurrentFinancialAssets>
    <ifrs-full:OtherCurrentFinancialAssets contextRef="c177" decimals="0" id="ixv-43722" unitRef="usd">6658805</ifrs-full:OtherCurrentFinancialAssets>
    <ifrs-full:OtherCurrentFinancialAssets contextRef="c178" decimals="0" id="ixv-43723" unitRef="usd">8234539</ifrs-full:OtherCurrentFinancialAssets>
    <ifrs-full:OtherCurrentFinancialAssets contextRef="c179" decimals="0" id="ixv-43724" unitRef="usd">5817516</ifrs-full:OtherCurrentFinancialAssets>
    <ifrs-full:OtherCurrentFinancialAssets contextRef="c4" decimals="0" id="ixv-43725" unitRef="usd">8254261</ifrs-full:OtherCurrentFinancialAssets>
    <ifrs-full:OtherCurrentFinancialAssets contextRef="c7" decimals="0" id="ixv-43726" unitRef="usd">14667607</ifrs-full:OtherCurrentFinancialAssets>
    <ifrs-full:OtherNoncurrentFinancialAssets contextRef="c177" decimals="0" id="ixv-43727" unitRef="usd">190080</ifrs-full:OtherNoncurrentFinancialAssets>
    <ifrs-full:OtherNoncurrentFinancialAssets contextRef="c175" decimals="0" id="ixv-43728" unitRef="usd">437</ifrs-full:OtherNoncurrentFinancialAssets>
    <ifrs-full:OtherNoncurrentFinancialAssets contextRef="c7" decimals="0" id="ixv-43729" unitRef="usd">190517</ifrs-full:OtherNoncurrentFinancialAssets>
    <mlec:DisclosureOfTradeReceivablesTableTextBlock contextRef="c0" id="ixv-24315">&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;06/30/2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 0pt"&gt;Trade debtors&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4,519,487&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;205,490,518&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Allowance for impairment of trade debtors (Note 7.16)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-181"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(7,050,280&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Shareholders and other related parties (Note 17)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-182"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;37&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: justify; padding-left: 0pt"&gt;Allowance for credit notes to be issued&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-183"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,905,624&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Trade debtors - Joint ventures and associates (Note 13)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,565,913&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,176,622&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Deferred checks&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-184"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;11,295,922&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;6,085,400&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;209,007,195&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</mlec:DisclosureOfTradeReceivablesTableTextBlock>
    <ifrs-full:CurrentTradeReceivables contextRef="c180" decimals="0" id="ixv-43730" unitRef="usd">4519487</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:CurrentTradeReceivables contextRef="c181" decimals="0" id="ixv-43731" unitRef="usd">205490518</ifrs-full:CurrentTradeReceivables>
    <mlec:CurrentTradeReceivablesAllowanceForImpairmentOfTradeDebtors contextRef="c181" decimals="0" id="ixv-43732" unitRef="usd">-7050280</mlec:CurrentTradeReceivablesAllowanceForImpairmentOfTradeDebtors>
    <mlec:CurrentTradeReceivablesShareholdersAndOtherRelatedParties contextRef="c181" decimals="0" id="ixv-43733" unitRef="usd">37</mlec:CurrentTradeReceivablesShareholdersAndOtherRelatedParties>
    <mlec:AllowanceForReturnOfGoods contextRef="c181" decimals="0" id="ixv-43734" unitRef="usd">-2905624</mlec:AllowanceForReturnOfGoods>
    <mlec:CurrentTradeReceivablesTradeDebtorsJointVenturesAndAssociates contextRef="c180" decimals="0" id="ixv-43735" unitRef="usd">1565913</mlec:CurrentTradeReceivablesTradeDebtorsJointVenturesAndAssociates>
    <mlec:CurrentTradeReceivablesTradeDebtorsJointVenturesAndAssociates contextRef="c181" decimals="0" id="ixv-43736" unitRef="usd">2176622</mlec:CurrentTradeReceivablesTradeDebtorsJointVenturesAndAssociates>
    <ifrs-full:OtherReceivables contextRef="c181" decimals="0" id="ixv-43737" unitRef="usd">11295922</ifrs-full:OtherReceivables>
    <ifrs-full:TradeAndOtherCurrentReceivables contextRef="c180" decimals="0" id="ixv-43738" unitRef="usd">6085400</ifrs-full:TradeAndOtherCurrentReceivables>
    <ifrs-full:TradeAndOtherCurrentReceivables contextRef="c181" decimals="0" id="ixv-43739" unitRef="usd">209007195</ifrs-full:TradeAndOtherCurrentReceivables>
    <mlec:DisclosureOfOtherReceivablesTableTextBlock contextRef="c0" id="ixv-24462">&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;06/30/2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; padding-left: 0pt"&gt;Taxes&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;382,957&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;5,475,685&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Insurance to be accrued&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,835&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,595,319&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Other receivables - Joint ventures and associates (Note 13)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,547,409&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,162,870&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Prepayments to suppliers&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;114&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,236,905&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Shareholders and other related parties (Note 17)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,313,179&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;47,348&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Government grants receivable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-185"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;608&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Prepaid expenses and other receivables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;33,448&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,736,808&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Loans receivables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-186"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,800,572&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 0pt"&gt;Miscellaneous&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;560,222&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,601,268&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;13,849,164&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;34,657,383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; padding-left: 0pt"&gt;Non-current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;Taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-187"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;752,045&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Other receivables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-188"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;230,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Reimbursements over exports&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-189"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,461,042&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Other receivables - Joint ventures and associates (Note 13)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;664,493&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25,423,142&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 0pt"&gt;Miscellaneous&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-190"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;20,805&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;664,493&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;27,887,034&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</mlec:DisclosureOfOtherReceivablesTableTextBlock>
    <ifrs-full:OtherCurrentReceivables contextRef="c182" decimals="0" id="ixv-43740" unitRef="usd">382957</ifrs-full:OtherCurrentReceivables>
    <ifrs-full:OtherCurrentReceivables contextRef="c183" decimals="0" id="ixv-43741" unitRef="usd">5475685</ifrs-full:OtherCurrentReceivables>
    <ifrs-full:OtherCurrentReceivables contextRef="c184" decimals="0" id="ixv-43742" unitRef="usd">11835</ifrs-full:OtherCurrentReceivables>
    <ifrs-full:OtherCurrentReceivables contextRef="c185" decimals="0" id="ixv-43743" unitRef="usd">1595319</ifrs-full:OtherCurrentReceivables>
    <ifrs-full:OtherCurrentReceivables contextRef="c186" decimals="0" id="ixv-43744" unitRef="usd">10547409</ifrs-full:OtherCurrentReceivables>
    <ifrs-full:OtherCurrentReceivables contextRef="c187" decimals="0" id="ixv-43745" unitRef="usd">12162870</ifrs-full:OtherCurrentReceivables>
    <ifrs-full:OtherCurrentReceivables contextRef="c188" decimals="0" id="ixv-43746" unitRef="usd">114</ifrs-full:OtherCurrentReceivables>
    <ifrs-full:OtherCurrentReceivables contextRef="c189" decimals="0" id="ixv-43747" unitRef="usd">7236905</ifrs-full:OtherCurrentReceivables>
    <ifrs-full:OtherCurrentReceivables contextRef="c190" decimals="0" id="ixv-43748" unitRef="usd">2313179</ifrs-full:OtherCurrentReceivables>
    <ifrs-full:OtherCurrentReceivables contextRef="c191" decimals="0" id="ixv-43749" unitRef="usd">47348</ifrs-full:OtherCurrentReceivables>
    <ifrs-full:OtherCurrentReceivables contextRef="c193" decimals="0" id="ixv-43750" unitRef="usd">608</ifrs-full:OtherCurrentReceivables>
    <ifrs-full:OtherCurrentReceivables contextRef="c194" decimals="0" id="ixv-43751" unitRef="usd">33448</ifrs-full:OtherCurrentReceivables>
    <ifrs-full:OtherCurrentReceivables contextRef="c195" decimals="0" id="ixv-43752" unitRef="usd">3736808</ifrs-full:OtherCurrentReceivables>
    <ifrs-full:OtherCurrentReceivables contextRef="c197" decimals="0" id="ixv-43753" unitRef="usd">1800572</ifrs-full:OtherCurrentReceivables>
    <ifrs-full:OtherCurrentReceivables contextRef="c198" decimals="0" id="ixv-43754" unitRef="usd">560222</ifrs-full:OtherCurrentReceivables>
    <ifrs-full:OtherCurrentReceivables contextRef="c199" decimals="0" id="ixv-43755" unitRef="usd">2601268</ifrs-full:OtherCurrentReceivables>
    <ifrs-full:OtherCurrentReceivables contextRef="c4" decimals="0" id="ixv-43756" unitRef="usd">13849164</ifrs-full:OtherCurrentReceivables>
    <ifrs-full:OtherCurrentReceivables contextRef="c7" decimals="0" id="ixv-43757" unitRef="usd">34657383</ifrs-full:OtherCurrentReceivables>
    <ifrs-full:OtherNoncurrentReceivables contextRef="c183" decimals="0" id="ixv-43758" unitRef="usd">752045</ifrs-full:OtherNoncurrentReceivables>
    <ifrs-full:OtherNoncurrentReceivables contextRef="c201" decimals="0" id="ixv-43759" unitRef="usd">230000</ifrs-full:OtherNoncurrentReceivables>
    <ifrs-full:OtherNoncurrentReceivables contextRef="c203" decimals="0" id="ixv-43760" unitRef="usd">1461042</ifrs-full:OtherNoncurrentReceivables>
    <ifrs-full:OtherNoncurrentReceivables contextRef="c186" decimals="0" id="ixv-43761" unitRef="usd">664493</ifrs-full:OtherNoncurrentReceivables>
    <ifrs-full:OtherNoncurrentReceivables contextRef="c187" decimals="0" id="ixv-43762" unitRef="usd">25423142</ifrs-full:OtherNoncurrentReceivables>
    <ifrs-full:OtherNoncurrentReceivables contextRef="c199" decimals="0" id="ixv-43763" unitRef="usd">20805</ifrs-full:OtherNoncurrentReceivables>
    <ifrs-full:OtherNoncurrentReceivables contextRef="c4" decimals="0" id="ixv-43764" unitRef="usd">664493</ifrs-full:OtherNoncurrentReceivables>
    <ifrs-full:OtherNoncurrentReceivables contextRef="c7" decimals="0" id="ixv-43765" unitRef="usd">27887034</ifrs-full:OtherNoncurrentReceivables>
    <ifrs-full:DisclosureOfInventoriesExplanatory contextRef="c0" id="ixv-24676">&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;06/30/2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;06/30/2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; padding-left: 0pt"&gt;Seeds&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;551,290&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;5,967,231&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Resale products&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-191"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;53,788,333&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Manufactured products&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;994,360&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;26,081,250&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Goods in transit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-192"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,618,540&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;Supplies&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-193"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;22,546,093&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Agricultural products&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;689,832&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15,015,884&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Allowance for obsolescence (Note 7.16)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-194"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(3,087,563&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,235,482&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;125,929,768&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0pt"&gt;Net of agricultural products&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,545,650&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;110,913,884&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfInventoriesExplanatory>
    <mlec:InventoriesCurrent contextRef="c204" decimals="0" id="ixv-43766" unitRef="usd">551290</mlec:InventoriesCurrent>
    <mlec:InventoriesCurrent contextRef="c205" decimals="0" id="ixv-43767" unitRef="usd">5967231</mlec:InventoriesCurrent>
    <mlec:InventoriesCurrent contextRef="c207" decimals="0" id="ixv-43768" unitRef="usd">53788333</mlec:InventoriesCurrent>
    <mlec:InventoriesCurrent contextRef="c208" decimals="0" id="ixv-43769" unitRef="usd">994360</mlec:InventoriesCurrent>
    <mlec:InventoriesCurrent contextRef="c209" decimals="0" id="ixv-43770" unitRef="usd">26081250</mlec:InventoriesCurrent>
    <mlec:InventoriesCurrent contextRef="c211" decimals="0" id="ixv-43771" unitRef="usd">5618540</mlec:InventoriesCurrent>
    <mlec:InventoriesCurrent contextRef="c213" decimals="0" id="ixv-43772" unitRef="usd">22546093</mlec:InventoriesCurrent>
    <mlec:InventoriesCurrent contextRef="c214" decimals="0" id="ixv-43773" unitRef="usd">689832</mlec:InventoriesCurrent>
    <mlec:InventoriesCurrent contextRef="c215" decimals="0" id="ixv-43774" unitRef="usd">15015884</mlec:InventoriesCurrent>
    <mlec:InventoriesCurrent contextRef="c217" decimals="0" id="ixv-43775" unitRef="usd">-3087563</mlec:InventoriesCurrent>
    <mlec:InventoriesCurrent contextRef="c4" decimals="0" id="ixv-43776" unitRef="usd">2235482</mlec:InventoriesCurrent>
    <mlec:InventoriesCurrent contextRef="c7" decimals="0" id="ixv-43777" unitRef="usd">125929768</mlec:InventoriesCurrent>
    <mlec:InventoriesExcludingAgriculturalProduce contextRef="c4" decimals="0" id="ixv-43778" unitRef="usd">1545650</mlec:InventoriesExcludingAgriculturalProduce>
    <mlec:InventoriesExcludingAgriculturalProduce contextRef="c7" decimals="0" id="ixv-43779" unitRef="usd">110913884</mlec:InventoriesExcludingAgriculturalProduce>
    <ifrs-full:DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory contextRef="c0" id="ixv-24853">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Changes in Biological assets:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Soybean&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Corn&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Wheat&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Barley&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Sunflower&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 28%; text-align: left; padding-left: 0pt"&gt;Beginning of the year&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-195"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-196"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;220,682&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;73,452&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-197"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; text-align: right"&gt;294,134&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Initial recognition and changes in the fair value of biological assets at the point of harvest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;593,001&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;435,725&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;579,313&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;158,080&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,256&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;1,764,863&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Costs incurred during the year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,959,381&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,814,249&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;444,303&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;162,342&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;55,063&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;4,435,338&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Decrease due to harvest/disposals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,275,688&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,148,288&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,244,298&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(393,874&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(53,807&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(4,115,955&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 0pt"&gt;Loss of control&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,276,694&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,101,686&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-198"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-199"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-200"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;(2,378,380&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 0pt"&gt;Year ended June 30, 2025&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-201"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-202"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-203"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-204"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-205"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-206"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Soybean&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Corn&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Wheat&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Barley&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Sunflower&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 28%; text-align: left; padding-left: 0pt"&gt;Beginning of the year&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-207"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-208"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;87,785&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;59,057&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-209"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; text-align: right"&gt;146,842&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Initial recognition and changes in the fair value of biological assets at the point of harvest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(352,199&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(32,674&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;231,526&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;106,605&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;996&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(45,746&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Costs incurred during the year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,423,732&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;792,235&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;220,679&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;73,452&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;137,680&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;2,647,778&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Decrease due to harvest/disposals&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,071,533&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(759,561&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(319,308&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(165,662&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(138,676&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;(2,454,740&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 0pt"&gt;Year ended June 30, 2024&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-210"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-211"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;220,682&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;73,452&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-212"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;294,134&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory>
    <ifrs-full:BiologicalAssets contextRef="c220" decimals="0" id="ixv-43780" unitRef="usd">220682</ifrs-full:BiologicalAssets>
    <ifrs-full:BiologicalAssets contextRef="c221" decimals="0" id="ixv-43781" unitRef="usd">73452</ifrs-full:BiologicalAssets>
    <ifrs-full:BiologicalAssets contextRef="c7" decimals="0" id="ixv-43782" unitRef="usd">294134</ifrs-full:BiologicalAssets>
    <ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets contextRef="c223" decimals="0" id="ixv-43783" unitRef="usd">-593001</ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets>
    <ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets contextRef="c224" decimals="0" id="ixv-43784" unitRef="usd">-435725</ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets>
    <ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets contextRef="c225" decimals="0" id="ixv-43785" unitRef="usd">-579313</ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets>
    <ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets contextRef="c226" decimals="0" id="ixv-43786" unitRef="usd">-158080</ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets>
    <ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets contextRef="c227" decimals="0" id="ixv-43787" unitRef="usd">1256</ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets>
    <ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets contextRef="c0" decimals="0" id="ixv-43788" unitRef="usd">-1764863</ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets contextRef="c223" decimals="0" id="ixv-43789" unitRef="usd">1959381</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets contextRef="c224" decimals="0" id="ixv-43790" unitRef="usd">1814249</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets contextRef="c225" decimals="0" id="ixv-43791" unitRef="usd">444303</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets contextRef="c226" decimals="0" id="ixv-43792" unitRef="usd">162342</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets contextRef="c227" decimals="0" id="ixv-43793" unitRef="usd">55063</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets contextRef="c0" decimals="0" id="ixv-43794" unitRef="usd">4435338</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets>
    <mlec:DecreaseDueToHarvestAndDisposalsBiologicalAssets contextRef="c223" decimals="0" id="ixv-43795" unitRef="usd">1275688</mlec:DecreaseDueToHarvestAndDisposalsBiologicalAssets>
    <mlec:DecreaseDueToHarvestAndDisposalsBiologicalAssets contextRef="c224" decimals="0" id="ixv-43796" unitRef="usd">1148288</mlec:DecreaseDueToHarvestAndDisposalsBiologicalAssets>
    <mlec:DecreaseDueToHarvestAndDisposalsBiologicalAssets contextRef="c225" decimals="0" id="ixv-43797" unitRef="usd">1244298</mlec:DecreaseDueToHarvestAndDisposalsBiologicalAssets>
    <mlec:DecreaseDueToHarvestAndDisposalsBiologicalAssets contextRef="c226" decimals="0" id="ixv-43798" unitRef="usd">393874</mlec:DecreaseDueToHarvestAndDisposalsBiologicalAssets>
    <mlec:DecreaseDueToHarvestAndDisposalsBiologicalAssets contextRef="c227" decimals="0" id="ixv-43799" unitRef="usd">53807</mlec:DecreaseDueToHarvestAndDisposalsBiologicalAssets>
    <mlec:DecreaseDueToHarvestAndDisposalsBiologicalAssets contextRef="c0" decimals="0" id="ixv-43800" unitRef="usd">4115955</mlec:DecreaseDueToHarvestAndDisposalsBiologicalAssets>
    <mlec:LossOfControlonBiologicalAssets contextRef="c223" decimals="0" id="ixv-43801" unitRef="usd">1276694</mlec:LossOfControlonBiologicalAssets>
    <mlec:LossOfControlonBiologicalAssets contextRef="c224" decimals="0" id="ixv-43802" unitRef="usd">1101686</mlec:LossOfControlonBiologicalAssets>
    <mlec:LossOfControlonBiologicalAssets contextRef="c0" decimals="0" id="ixv-43803" unitRef="usd">2378380</mlec:LossOfControlonBiologicalAssets>
    <ifrs-full:BiologicalAssets contextRef="c235" decimals="0" id="ixv-43804" unitRef="usd">87785</ifrs-full:BiologicalAssets>
    <ifrs-full:BiologicalAssets contextRef="c236" decimals="0" id="ixv-43805" unitRef="usd">59057</ifrs-full:BiologicalAssets>
    <ifrs-full:BiologicalAssets contextRef="c47" decimals="0" id="ixv-43806" unitRef="usd">146842</ifrs-full:BiologicalAssets>
    <ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets contextRef="c238" decimals="0" id="ixv-43807" unitRef="usd">352199</ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets>
    <ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets contextRef="c239" decimals="0" id="ixv-43808" unitRef="usd">32674</ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets>
    <ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets contextRef="c240" decimals="0" id="ixv-43809" unitRef="usd">-231526</ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets>
    <ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets contextRef="c241" decimals="0" id="ixv-43810" unitRef="usd">-106605</ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets>
    <ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets contextRef="c242" decimals="0" id="ixv-43811" unitRef="usd">-996</ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets>
    <ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets contextRef="c5" decimals="0" id="ixv-43812" unitRef="usd">45746</ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets contextRef="c238" decimals="0" id="ixv-43813" unitRef="usd">1423732</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets contextRef="c239" decimals="0" id="ixv-43814" unitRef="usd">792235</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets contextRef="c240" decimals="0" id="ixv-43815" unitRef="usd">220679</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets contextRef="c241" decimals="0" id="ixv-43816" unitRef="usd">73452</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets contextRef="c242" decimals="0" id="ixv-43817" unitRef="usd">137680</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets contextRef="c5" decimals="0" id="ixv-43818" unitRef="usd">2647778</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets>
    <mlec:DecreaseDueToHarvestAndDisposalsBiologicalAssets contextRef="c238" decimals="0" id="ixv-43819" unitRef="usd">1071533</mlec:DecreaseDueToHarvestAndDisposalsBiologicalAssets>
    <mlec:DecreaseDueToHarvestAndDisposalsBiologicalAssets contextRef="c239" decimals="0" id="ixv-43820" unitRef="usd">759561</mlec:DecreaseDueToHarvestAndDisposalsBiologicalAssets>
    <mlec:DecreaseDueToHarvestAndDisposalsBiologicalAssets contextRef="c240" decimals="0" id="ixv-43821" unitRef="usd">319308</mlec:DecreaseDueToHarvestAndDisposalsBiologicalAssets>
    <mlec:DecreaseDueToHarvestAndDisposalsBiologicalAssets contextRef="c241" decimals="0" id="ixv-43822" unitRef="usd">165662</mlec:DecreaseDueToHarvestAndDisposalsBiologicalAssets>
    <mlec:DecreaseDueToHarvestAndDisposalsBiologicalAssets contextRef="c242" decimals="0" id="ixv-43823" unitRef="usd">138676</mlec:DecreaseDueToHarvestAndDisposalsBiologicalAssets>
    <mlec:DecreaseDueToHarvestAndDisposalsBiologicalAssets contextRef="c5" decimals="0" id="ixv-43824" unitRef="usd">2454740</mlec:DecreaseDueToHarvestAndDisposalsBiologicalAssets>
    <ifrs-full:BiologicalAssets contextRef="c220" decimals="0" id="ixv-43825" unitRef="usd">220682</ifrs-full:BiologicalAssets>
    <ifrs-full:BiologicalAssets contextRef="c221" decimals="0" id="ixv-43826" unitRef="usd">73452</ifrs-full:BiologicalAssets>
    <ifrs-full:BiologicalAssets contextRef="c7" decimals="0" id="ixv-43827" unitRef="usd">294134</ifrs-full:BiologicalAssets>
    <ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory contextRef="c0" id="ixv-25208">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Property, plant and equipment as of June 30, 2025 and 2024, included
the following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Class&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Net carrying amount 06/30/2024&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Additions&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Reclassification&lt;br/&gt;
within PPE&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Disposals&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Depreciation of the year&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Foreign currency translation&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Loss of control&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Business combination&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Net&#160;carrying&lt;br/&gt;
amount&lt;br/&gt;
06/30/2025&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: 0pt; padding-left: 0pt; width: 19%"&gt;Office&#160;equipment&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;503,950&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;39,611&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-213"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;(4,791&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;(82,495&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;3,947&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;(449,942&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-214"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;10,280&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: 0pt; padding-left: 0pt"&gt;Vehicles&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,192,627&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;35,915&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-215"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(17,239&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(882,264&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,023&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,330,062&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-216"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-217"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Equipment and computer software&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;528,816&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;75,297&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-218"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(323&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(273,912&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16,012&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(331,763&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-219"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,127&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Fixtures and fittings&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,805,076&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,084&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;225,338&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(6,789&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(860,822&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,350&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,178,237&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-220"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-221"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Machinery and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16,722,642&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;563,352&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;122,653&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(143,947&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,895,031&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;81,204&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(14,449,423&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-222"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,450&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Land and buildings&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;39,745,067&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-223"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;348,085&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-224"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,021,176&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;71,315&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;(39,143,291&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;982,939&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;982,939&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Buildings in progress&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;12,114,256&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,264,663&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(696,076&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-225"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-226"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;9,753&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(16,692,596&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,336,374&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,336,374&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-indent: 0pt; padding-left: 0pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;74,612,434&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;5,987,922&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-227"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(173,089&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(6,015,700&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;189,604&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(74,575,314&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3,319,313&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3,345,170&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Class&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Net&#160;carrying amount &lt;br/&gt;06/30/2023&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Additions&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Reclassification from Investment properties&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Disposals&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Depreciation of the year&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Foreign currency translation&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Loss of control&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Net&#160;carrying amount 06/30/2024&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; width: 19%; text-align: left; padding-left: 0.125in"&gt;Research&#160;instruments&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;66,131&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-228"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-229"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-230"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-231"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-232"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;(66,131&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-233"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Office&#160;equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;360,575&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;238,679&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-234"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-235"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(81,507&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(13,324&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(473&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;503,950&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Vehicles&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,053,263&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,077,988&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-236"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,677&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(908,040&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(775&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(28,132&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,192,627&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Equipment and computer software&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;198,364&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;725,706&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-237"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(8,184&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(354,379&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(27,650&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(5,041&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;528,816&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Fixtures and fittings&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,925,032&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;731,699&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-238"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,295&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(812,810&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,663&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(43,477&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,805,076&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Machinery and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,586,768&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,460,655&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-239"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(154,492&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,661,097&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(409,769&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(99,423&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16,722,642&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Land and buildings&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;36,211,957&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,835,054&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,222,044&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;53,217&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(982,165&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(595,040&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-240"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;39,745,067&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Buildings in progress&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;11,757,249&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;683,406&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-241"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(106,421&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-242"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(207,757&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(12,221&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;12,114,256&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-indent: -0.125in; font-weight: bold; padding-left: 0.125in"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;68,159,339&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;10,753,187&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;3,222,044&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(211,262&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(5,799,998&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(1,255,978&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(254,898&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;74,612,434&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c243" decimals="0" id="ixv-43828" unitRef="usd">503950</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c244" decimals="0" id="ixv-43829" unitRef="usd">39611</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <mlec:DisposalsPropertyPlantAndEquipments contextRef="c244" decimals="0" id="ixv-43830" unitRef="usd">4791</mlec:DisposalsPropertyPlantAndEquipments>
    <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="c244" decimals="0" id="ixv-43831" unitRef="usd">82495</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="c244" decimals="0" id="ixv-43832" unitRef="usd">3947</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment contextRef="c244" decimals="0" id="ixv-43833" unitRef="usd">449942</ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c245" decimals="0" id="ixv-43834" unitRef="usd">10280</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c246" decimals="0" id="ixv-43835" unitRef="usd">2192627</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c247" decimals="0" id="ixv-43836" unitRef="usd">35915</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <mlec:DisposalsPropertyPlantAndEquipments contextRef="c247" decimals="0" id="ixv-43837" unitRef="usd">17239</mlec:DisposalsPropertyPlantAndEquipments>
    <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="c247" decimals="0" id="ixv-43838" unitRef="usd">882264</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="c247" decimals="0" id="ixv-43839" unitRef="usd">1023</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment contextRef="c247" decimals="0" id="ixv-43840" unitRef="usd">1330062</ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c249" decimals="0" id="ixv-43841" unitRef="usd">528816</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c250" decimals="0" id="ixv-43842" unitRef="usd">75297</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <mlec:DisposalsPropertyPlantAndEquipments contextRef="c250" decimals="0" id="ixv-43843" unitRef="usd">323</mlec:DisposalsPropertyPlantAndEquipments>
    <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="c250" decimals="0" id="ixv-43844" unitRef="usd">273912</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="c250" decimals="0" id="ixv-43845" unitRef="usd">16012</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment contextRef="c250" decimals="0" id="ixv-43846" unitRef="usd">331763</ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c251" decimals="0" id="ixv-43847" unitRef="usd">14127</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c252" decimals="0" id="ixv-43848" unitRef="usd">2805076</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c253" decimals="0" id="ixv-43849" unitRef="usd">9084</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment contextRef="c253" decimals="0" id="ixv-43850" unitRef="usd">225338</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <mlec:DisposalsPropertyPlantAndEquipments contextRef="c253" decimals="0" id="ixv-43851" unitRef="usd">6789</mlec:DisposalsPropertyPlantAndEquipments>
    <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="c253" decimals="0" id="ixv-43852" unitRef="usd">860822</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="c253" decimals="0" id="ixv-43853" unitRef="usd">6350</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment contextRef="c253" decimals="0" id="ixv-43854" unitRef="usd">2178237</ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c255" decimals="0" id="ixv-43855" unitRef="usd">16722642</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c256" decimals="0" id="ixv-43856" unitRef="usd">563352</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment contextRef="c256" decimals="0" id="ixv-43857" unitRef="usd">122653</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <mlec:DisposalsPropertyPlantAndEquipments contextRef="c256" decimals="0" id="ixv-43858" unitRef="usd">143947</mlec:DisposalsPropertyPlantAndEquipments>
    <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="c256" decimals="0" id="ixv-43859" unitRef="usd">2895031</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="c256" decimals="0" id="ixv-43860" unitRef="usd">81204</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment contextRef="c256" decimals="0" id="ixv-43861" unitRef="usd">14449423</ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c257" decimals="0" id="ixv-43862" unitRef="usd">1450</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c258" decimals="0" id="ixv-43863" unitRef="usd">39745067</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment contextRef="c259" decimals="0" id="ixv-43864" unitRef="usd">348085</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="c259" decimals="0" id="ixv-43865" unitRef="usd">1021176</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="c259" decimals="0" id="ixv-43866" unitRef="usd">71315</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment contextRef="c259" decimals="0" id="ixv-43867" unitRef="usd">39143291</ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c259" decimals="0" id="ixv-43868" unitRef="usd">982939</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c260" decimals="0" id="ixv-43869" unitRef="usd">982939</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c261" decimals="0" id="ixv-43870" unitRef="usd">12114256</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c262" decimals="0" id="ixv-43871" unitRef="usd">5264663</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment contextRef="c262" decimals="0" id="ixv-43872" unitRef="usd">-696076</ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="c262" decimals="0" id="ixv-43873" unitRef="usd">9753</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment contextRef="c262" decimals="0" id="ixv-43874" unitRef="usd">16692596</ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c262" decimals="0" id="ixv-43875" unitRef="usd">2336374</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c263" decimals="0" id="ixv-43876" unitRef="usd">2336374</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c264" decimals="0" id="ixv-43877" unitRef="usd">74612434</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c265" decimals="0" id="ixv-43878" unitRef="usd">5987922</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <mlec:DisposalsPropertyPlantAndEquipments contextRef="c265" decimals="0" id="ixv-43879" unitRef="usd">173089</mlec:DisposalsPropertyPlantAndEquipments>
    <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="c265" decimals="0" id="ixv-43880" unitRef="usd">6015700</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="c265" decimals="0" id="ixv-43881" unitRef="usd">189604</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment contextRef="c265" decimals="0" id="ixv-43882" unitRef="usd">74575314</ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c265" decimals="0" id="ixv-43883" unitRef="usd">3319313</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c266" decimals="0" id="ixv-43884" unitRef="usd">3345170</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c267" decimals="0" id="ixv-43885" unitRef="usd">66131</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment contextRef="c268" decimals="0" id="ixv-43886" unitRef="usd">66131</ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c270" decimals="0" id="ixv-43887" unitRef="usd">360575</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c271" decimals="0" id="ixv-43888" unitRef="usd">238679</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="c271" decimals="0" id="ixv-43889" unitRef="usd">81507</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="c271" decimals="0" id="ixv-43890" unitRef="usd">-13324</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment contextRef="c271" decimals="0" id="ixv-43891" unitRef="usd">473</ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c243" decimals="0" id="ixv-43892" unitRef="usd">503950</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c272" decimals="0" id="ixv-43893" unitRef="usd">2053263</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c273" decimals="0" id="ixv-43894" unitRef="usd">1077988</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <mlec:DisposalsPropertyPlantAndEquipments contextRef="c273" decimals="0" id="ixv-43895" unitRef="usd">1677</mlec:DisposalsPropertyPlantAndEquipments>
    <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="c273" decimals="0" id="ixv-43896" unitRef="usd">908040</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="c273" decimals="0" id="ixv-43897" unitRef="usd">-775</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment contextRef="c273" decimals="0" id="ixv-43898" unitRef="usd">28132</ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c246" decimals="0" id="ixv-43899" unitRef="usd">2192627</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c274" decimals="0" id="ixv-43900" unitRef="usd">198364</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c275" decimals="0" id="ixv-43901" unitRef="usd">725706</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <mlec:DisposalsPropertyPlantAndEquipments contextRef="c275" decimals="0" id="ixv-43902" unitRef="usd">8184</mlec:DisposalsPropertyPlantAndEquipments>
    <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="c275" decimals="0" id="ixv-43903" unitRef="usd">354379</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="c275" decimals="0" id="ixv-43904" unitRef="usd">-27650</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment contextRef="c275" decimals="0" id="ixv-43905" unitRef="usd">5041</ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c249" decimals="0" id="ixv-43906" unitRef="usd">528816</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c276" decimals="0" id="ixv-43907" unitRef="usd">2925032</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c277" decimals="0" id="ixv-43908" unitRef="usd">731699</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <mlec:DisposalsPropertyPlantAndEquipments contextRef="c277" decimals="0" id="ixv-43909" unitRef="usd">-6295</mlec:DisposalsPropertyPlantAndEquipments>
    <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="c277" decimals="0" id="ixv-43910" unitRef="usd">812810</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="c277" decimals="0" id="ixv-43911" unitRef="usd">-1663</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment contextRef="c277" decimals="0" id="ixv-43912" unitRef="usd">43477</ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c252" decimals="0" id="ixv-43913" unitRef="usd">2805076</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c278" decimals="0" id="ixv-43914" unitRef="usd">14586768</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c279" decimals="0" id="ixv-43915" unitRef="usd">5460655</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <mlec:DisposalsPropertyPlantAndEquipments contextRef="c279" decimals="0" id="ixv-43916" unitRef="usd">154492</mlec:DisposalsPropertyPlantAndEquipments>
    <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="c279" decimals="0" id="ixv-43917" unitRef="usd">2661097</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="c279" decimals="0" id="ixv-43918" unitRef="usd">-409769</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment contextRef="c279" decimals="0" id="ixv-43919" unitRef="usd">99423</ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c255" decimals="0" id="ixv-43920" unitRef="usd">16722642</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c280" decimals="0" id="ixv-43921" unitRef="usd">36211957</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c281" decimals="0" id="ixv-43922" unitRef="usd">1835054</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment contextRef="c281" decimals="0" id="ixv-43923" unitRef="usd">3222044</ifrs-full:IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment>
    <mlec:DisposalsPropertyPlantAndEquipments contextRef="c281" decimals="0" id="ixv-43924" unitRef="usd">-53217</mlec:DisposalsPropertyPlantAndEquipments>
    <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="c281" decimals="0" id="ixv-43925" unitRef="usd">982165</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="c281" decimals="0" id="ixv-43926" unitRef="usd">-595040</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c258" decimals="0" id="ixv-43927" unitRef="usd">39745067</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c282" decimals="0" id="ixv-43928" unitRef="usd">11757249</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c283" decimals="0" id="ixv-43929" unitRef="usd">683406</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <mlec:DisposalsPropertyPlantAndEquipments contextRef="c283" decimals="0" id="ixv-43930" unitRef="usd">106421</mlec:DisposalsPropertyPlantAndEquipments>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="c283" decimals="0" id="ixv-43931" unitRef="usd">-207757</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment contextRef="c283" decimals="0" id="ixv-43932" unitRef="usd">12221</ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c261" decimals="0" id="ixv-43933" unitRef="usd">12114256</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c284" decimals="0" id="ixv-43934" unitRef="usd">68159339</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c285" decimals="0" id="ixv-43935" unitRef="usd">10753187</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment contextRef="c285" decimals="0" id="ixv-43936" unitRef="usd">3222044</ifrs-full:IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment>
    <mlec:DisposalsPropertyPlantAndEquipments contextRef="c285" decimals="0" id="ixv-43937" unitRef="usd">211262</mlec:DisposalsPropertyPlantAndEquipments>
    <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="c285" decimals="0" id="ixv-43938" unitRef="usd">5799998</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="c285" decimals="0" id="ixv-43939" unitRef="usd">-1255978</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment contextRef="c285" decimals="0" id="ixv-43940" unitRef="usd">254898</ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c264" decimals="0" id="ixv-43941" unitRef="usd">74612434</ifrs-full:PropertyPlantAndEquipment>
    <mlec:DisclosureOfDepreciationIfAssetsHadBeenCarriedUnderCostModelTextBlock contextRef="c0" id="ixv-26020">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following are the carrying amounts that would
have been recognized if land and building were stated at cost.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Value at cost&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Class of property&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: justify; padding-left: 0pt"&gt;Land and buildings&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;27,876,636&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</mlec:DisclosureOfDepreciationIfAssetsHadBeenCarriedUnderCostModelTextBlock>
    <ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets contextRef="c286" decimals="0" id="ixv-43942" unitRef="usd">27876636</ifrs-full:PropertyPlantAndEquipmentCarryingAmountAtCostOfRevaluedAssets>
    <ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory contextRef="c0" id="ixv-26095">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Intangible assets as of June 30, 2025 and 2024 included the following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-size: 6pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Class&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Net carrying amount 06/30/2024&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Additions&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Loss of control) &lt;sup&gt;(*)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Additions from business
    combinations &lt;sup&gt;(**)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Transfers/ Disposals&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Amortization of the year&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Foreign currency translation&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Net carrying amount 06/30/2025&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; font-style: italic"&gt;&lt;span style="text-decoration:underline"&gt;Seed and
    integrated products&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="white-space: nowrap; text-indent: -0.125in; padding-left: 0.125in; width: 28%; text-align: left"&gt;Alfalfa Genuity Har Xstra&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;438,029&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-243"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-244"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-245"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-246"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-247"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;(21,172&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;416,857&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;HB4 soy and breeding program&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;35,574,369&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,164,283&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(36,464,169&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-248"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-249"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,274,483&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-250"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-251"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Integrated seed products&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,681,826&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-252"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,526,410&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-253"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-254"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(194,339&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;38,923&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-255"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; font-style: italic; text-decoration: underline; text-align: left"&gt;Crop nutrition&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Microbiological products&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;41,187,249&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;286,665&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(43,570,818&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-256"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,605,198&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,511,420&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,126&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-257"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Microbiological products in progress&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,452,861&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,163,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(11,909,700&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-258"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,706,661&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-259"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-260"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-261"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; font-style: italic; text-decoration: underline; text-align: left"&gt;Other intangible assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Trademarks and patents&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;51,316,860&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;158,557&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(47,394,664&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-262"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-263"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(4,080,753&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-264"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-265"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Trademarks and patents with indefinite useful life&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,045,294&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-266"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(10,045,294&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-267"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-268"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-269"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-270"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-271"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Software&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,119,494&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16,222&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(605,341&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-272"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;146,839&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(723,312&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;46,098&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-273"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Software in progress&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;580,728&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;176,064&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(609,953&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-274"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(146,839&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-275"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-276"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-277"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Customer loyalty&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,934,570&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-278"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(17,565,911&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-279"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-280"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,368,659&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-281"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-282"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;RG/RS/OX Wheat&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,528,899&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(10,480,817&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-283"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-284"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,048,082&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-285"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-286"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Sustainable agricultural equipment technology&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-287"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-288"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-289"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,719,710&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-290"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-291"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-292"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,719,710&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Fungal Biomass&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-293"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-294"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-295"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,775,940&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-296"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-297"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-298"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,775,940&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Piggysooy&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-299"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-300"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-301"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16,813,781&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-302"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-303"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-304"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16,813,781&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Safflower GLA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-305"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-306"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-307"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;27,857,339&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-308"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-309"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-310"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;27,857,339&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Safflower Chimosin 2.0&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-311"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-312"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-313"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,600,554&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,600,554&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Other intangibles&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-314"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-315"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-316"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;6,074,609&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-317"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-318"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-319"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;6,074,609&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;177,331,280&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;15,494,190&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(181,173,077&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;74,841,933&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(101,463&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(11,201,048&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;66,975&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;75,258,790&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-size: 6pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;sup&gt;(*)&lt;/sup&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Correspond to the loss of control of BIOX.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;sup&gt;(**)&lt;/sup&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Correspond to The Bioceres Group Business Combination Agreement.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-size: 6pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left; padding-left: 0in"&gt;&lt;b&gt;Class&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Net carrying amount 06/30/2023&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Additions&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Additions
    from business combinations/ (loss of control)&lt;sup&gt;(*)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Transfers/ Disposals&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Amortization of the year&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Foreign currency translation&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Net carrying amount 06/30/2024&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; font-style: italic"&gt;Seed and integrated products&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; width: 28%; text-align: left"&gt;Alfalfa Genuity Har Xstra&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;419,061&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-320"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-321"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-322"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-323"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;18,968&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;438,029&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Bacillus-PHAs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,089,536&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-324"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,089,536&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-325"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-326"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-327"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-328"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;HB4 soy and breeding program&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;31,679,114&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,987,247&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-329"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-330"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,091,992&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-331"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;35,574,369&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Integrated seed products&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,841,008&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-332"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-333"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-334"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(191,559&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;32,377&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,681,826&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; font-style: italic; text-decoration: underline; text-align: left"&gt;Crop
    nutrition&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Microbiological&#160;products&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;37,295,460&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-335"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-336"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,610,115&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,718,326&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-337"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;41,187,249&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Microbiological products in progress&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,213,341&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,869,084&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-338"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(7,610,115&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-339"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(19,449&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,452,861&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; font-style: italic; text-decoration: underline; text-align: left"&gt;Other
    intangible assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Trademarks and patents&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;51,933,444&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;44,073&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-340"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-341"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(670,514&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,857&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;51,316,860&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Trademarks and patents with indefinite useful life&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,827,309&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-342"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,217,985&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-343"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-344"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-345"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,045,294&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Software&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,638,752&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;585,313&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-346"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;276,128&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,369,379&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(11,320&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,119,494&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Software in progress&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;349,171&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;507,685&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-347"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(276,128&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-348"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-349"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;580,728&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Customer loyalty&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;23,006,023&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-350"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-351"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-352"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;(4,071,453&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-353"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,934,570&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;RG/RS/OX
    Wheat&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,000,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-354"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-355"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-356"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-357"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-358"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;5,000,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;175,292,219&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;12,993,402&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;1,128,449&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-359"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(12,113,223&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;30,433&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;177,331,280&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-size: 6pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;sup&gt;(*)&lt;/sup&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;USD 1,089,768 correspond to the loss of control of Inmet
S.A.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c287" decimals="0" id="ixv-43943" unitRef="usd">438029</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill contextRef="c288" decimals="0" id="ixv-43944" unitRef="usd">-21172</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c289" decimals="0" id="ixv-43945" unitRef="usd">416857</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c290" decimals="0" id="ixv-43946" unitRef="usd">35574369</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="c291" decimals="0" id="ixv-43947" unitRef="usd">3164283</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <mlec:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets
      contextRef="c291"
      decimals="0"
      id="ix_21_fact"
      unitRef="usd">-36464169</mlec:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets>
    <mlec:AmortizationOfTheYear contextRef="c291" decimals="0" id="ixv-43949" unitRef="usd">2274483</mlec:AmortizationOfTheYear>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c293" decimals="0" id="ixv-43950" unitRef="usd">2681826</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <mlec:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets
      contextRef="c294"
      decimals="0"
      id="ix_22_fact"
      unitRef="usd">-2526410</mlec:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets>
    <mlec:AmortizationOfTheYear contextRef="c294" decimals="0" id="ixv-43952" unitRef="usd">194339</mlec:AmortizationOfTheYear>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill contextRef="c294" decimals="0" id="ixv-43953" unitRef="usd">38923</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c296" decimals="0" id="ixv-43954" unitRef="usd">41187249</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="c297" decimals="0" id="ixv-43955" unitRef="usd">286665</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <mlec:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets
      contextRef="c297"
      decimals="0"
      id="ix_23_fact"
      unitRef="usd">-43570818</mlec:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill contextRef="c297" decimals="0" id="ixv-43957" unitRef="usd">-3605198</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill>
    <mlec:AmortizationOfTheYear contextRef="c297" decimals="0" id="ixv-43958" unitRef="usd">1511420</mlec:AmortizationOfTheYear>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill contextRef="c297" decimals="0" id="ixv-43959" unitRef="usd">3126</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c299" decimals="0" id="ixv-43960" unitRef="usd">10452861</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="c300" decimals="0" id="ixv-43961" unitRef="usd">5163500</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <mlec:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets
      contextRef="c300"
      decimals="0"
      id="ix_24_fact"
      unitRef="usd">-11909700</mlec:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill contextRef="c300" decimals="0" id="ixv-43963" unitRef="usd">3706661</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c302" decimals="0" id="ixv-43964" unitRef="usd">51316860</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="c303" decimals="0" id="ixv-43965" unitRef="usd">158557</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <mlec:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets
      contextRef="c303"
      decimals="0"
      id="ix_25_fact"
      unitRef="usd">-47394664</mlec:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets>
    <mlec:AmortizationOfTheYear contextRef="c303" decimals="0" id="ixv-43967" unitRef="usd">4080753</mlec:AmortizationOfTheYear>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c305" decimals="0" id="ixv-43968" unitRef="usd">10045294</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <mlec:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets
      contextRef="c306"
      decimals="0"
      id="ix_26_fact"
      unitRef="usd">-10045294</mlec:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c308" decimals="0" id="ixv-43970" unitRef="usd">1119494</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="c309" decimals="0" id="ixv-43971" unitRef="usd">16222</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <mlec:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets
      contextRef="c309"
      decimals="0"
      id="ix_27_fact"
      unitRef="usd">-605341</mlec:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill contextRef="c309" decimals="0" id="ixv-43973" unitRef="usd">-146839</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill>
    <mlec:AmortizationOfTheYear contextRef="c309" decimals="0" id="ixv-43974" unitRef="usd">723312</mlec:AmortizationOfTheYear>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill contextRef="c309" decimals="0" id="ixv-43975" unitRef="usd">46098</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c311" decimals="0" id="ixv-43976" unitRef="usd">580728</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="c312" decimals="0" id="ixv-43977" unitRef="usd">176064</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <mlec:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets
      contextRef="c312"
      decimals="0"
      id="ix_28_fact"
      unitRef="usd">-609953</mlec:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill contextRef="c312" decimals="0" id="ixv-43979" unitRef="usd">146839</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c314" decimals="0" id="ixv-43980" unitRef="usd">18934570</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <mlec:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets
      contextRef="c315"
      decimals="0"
      id="ix_29_fact"
      unitRef="usd">-17565911</mlec:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets>
    <mlec:AmortizationOfTheYear contextRef="c315" decimals="0" id="ixv-43982" unitRef="usd">1368659</mlec:AmortizationOfTheYear>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c317" decimals="0" id="ixv-43983" unitRef="usd">5000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="c318" decimals="0" id="ixv-43984" unitRef="usd">6528899</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <mlec:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets
      contextRef="c318"
      decimals="0"
      id="ix_30_fact"
      unitRef="usd">-10480817</mlec:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets>
    <mlec:AmortizationOfTheYear contextRef="c318" decimals="0" id="ixv-43986" unitRef="usd">1048082</mlec:AmortizationOfTheYear>
    <mlec:AdditionsFromBusinessCombinations
      contextRef="c321"
      decimals="0"
      id="ix_35_fact"
      unitRef="usd">10719710</mlec:AdditionsFromBusinessCombinations>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c322" decimals="0" id="ixv-43988" unitRef="usd">10719710</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <mlec:AdditionsFromBusinessCombinations
      contextRef="c324"
      decimals="0"
      id="ix_36_fact"
      unitRef="usd">10775940</mlec:AdditionsFromBusinessCombinations>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c325" decimals="0" id="ixv-43990" unitRef="usd">10775940</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <mlec:AdditionsFromBusinessCombinations
      contextRef="c327"
      decimals="0"
      id="ix_37_fact"
      unitRef="usd">16813781</mlec:AdditionsFromBusinessCombinations>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c328" decimals="0" id="ixv-43992" unitRef="usd">16813781</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <mlec:AdditionsFromBusinessCombinations
      contextRef="c330"
      decimals="0"
      id="ix_38_fact"
      unitRef="usd">27857339</mlec:AdditionsFromBusinessCombinations>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c331" decimals="0" id="ixv-43994" unitRef="usd">27857339</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <mlec:AdditionsFromBusinessCombinations
      contextRef="c333"
      decimals="0"
      id="ix_39_fact"
      unitRef="usd">2600554</mlec:AdditionsFromBusinessCombinations>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c334" decimals="0" id="ixv-43996" unitRef="usd">2600554</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <mlec:AdditionsFromBusinessCombinations
      contextRef="c336"
      decimals="0"
      id="ix_40_fact"
      unitRef="usd">6074609</mlec:AdditionsFromBusinessCombinations>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c337" decimals="0" id="ixv-43998" unitRef="usd">6074609</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c7" decimals="0" id="ixv-43999" unitRef="usd">177331280</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="c0" decimals="0" id="ixv-44000" unitRef="usd">15494190</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <mlec:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets contextRef="c0" decimals="0" id="ix_31_fact" unitRef="usd">-181173077</mlec:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets>
    <mlec:AdditionsFromBusinessCombinations contextRef="c0" decimals="0" id="ix_41_fact" unitRef="usd">74841933</mlec:AdditionsFromBusinessCombinations>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill contextRef="c0" decimals="0" id="ixv-44003" unitRef="usd">101463</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill>
    <mlec:AmortizationOfTheYear contextRef="c0" decimals="0" id="ixv-44004" unitRef="usd">11201048</mlec:AmortizationOfTheYear>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill contextRef="c0" decimals="0" id="ixv-44005" unitRef="usd">66975</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c4" decimals="0" id="ixv-44006" unitRef="usd">75258790</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c338" decimals="0" id="ixv-44009" unitRef="usd">419061</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill contextRef="c339" decimals="0" id="ixv-44010" unitRef="usd">18968</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c287" decimals="0" id="ixv-44011" unitRef="usd">438029</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c340" decimals="0" id="ixv-44012" unitRef="usd">1089536</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <mlec:AdditionsFromBusinessCombinations
      contextRef="c341"
      decimals="0"
      id="ix_32_fact"
      unitRef="usd">-1089536</mlec:AdditionsFromBusinessCombinations>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c343" decimals="0" id="ixv-44014" unitRef="usd">31679114</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="c344" decimals="0" id="ixv-44015" unitRef="usd">5987247</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <mlec:AmortizationOfTheYear contextRef="c344" decimals="0" id="ixv-44016" unitRef="usd">2091992</mlec:AmortizationOfTheYear>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c290" decimals="0" id="ixv-44017" unitRef="usd">35574369</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c345" decimals="0" id="ixv-44018" unitRef="usd">2841008</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <mlec:AmortizationOfTheYear contextRef="c346" decimals="0" id="ixv-44019" unitRef="usd">191559</mlec:AmortizationOfTheYear>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill contextRef="c346" decimals="0" id="ixv-44020" unitRef="usd">32377</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c293" decimals="0" id="ixv-44021" unitRef="usd">2681826</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c347" decimals="0" id="ixv-44022" unitRef="usd">37295460</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill contextRef="c348" decimals="0" id="ixv-44023" unitRef="usd">-7610115</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill>
    <mlec:AmortizationOfTheYear contextRef="c348" decimals="0" id="ixv-44024" unitRef="usd">3718326</mlec:AmortizationOfTheYear>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c296" decimals="0" id="ixv-44025" unitRef="usd">41187249</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c349" decimals="0" id="ixv-44026" unitRef="usd">12213341</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="c350" decimals="0" id="ixv-44027" unitRef="usd">5869084</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill contextRef="c350" decimals="0" id="ixv-44028" unitRef="usd">7610115</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill contextRef="c350" decimals="0" id="ixv-44029" unitRef="usd">-19449</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c299" decimals="0" id="ixv-44030" unitRef="usd">10452861</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c351" decimals="0" id="ixv-44031" unitRef="usd">51933444</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="c352" decimals="0" id="ixv-44032" unitRef="usd">44073</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <mlec:AmortizationOfTheYear contextRef="c352" decimals="0" id="ixv-44033" unitRef="usd">670514</mlec:AmortizationOfTheYear>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill contextRef="c352" decimals="0" id="ixv-44034" unitRef="usd">9857</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c302" decimals="0" id="ixv-44035" unitRef="usd">51316860</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c353" decimals="0" id="ixv-44036" unitRef="usd">7827309</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <mlec:AdditionsFromBusinessCombinations
      contextRef="c354"
      decimals="0"
      id="ix_33_fact"
      unitRef="usd">2217985</mlec:AdditionsFromBusinessCombinations>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c305" decimals="0" id="ixv-44038" unitRef="usd">10045294</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c355" decimals="0" id="ixv-44039" unitRef="usd">1638752</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="c356" decimals="0" id="ixv-44040" unitRef="usd">585313</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill contextRef="c356" decimals="0" id="ixv-44041" unitRef="usd">-276128</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill>
    <mlec:AmortizationOfTheYear contextRef="c356" decimals="0" id="ixv-44042" unitRef="usd">1369379</mlec:AmortizationOfTheYear>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill contextRef="c356" decimals="0" id="ixv-44043" unitRef="usd">-11320</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c308" decimals="0" id="ixv-44044" unitRef="usd">1119494</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c357" decimals="0" id="ixv-44045" unitRef="usd">349171</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="c358" decimals="0" id="ixv-44046" unitRef="usd">507685</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill contextRef="c358" decimals="0" id="ixv-44047" unitRef="usd">276128</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c311" decimals="0" id="ixv-44048" unitRef="usd">580728</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c359" decimals="0" id="ixv-44049" unitRef="usd">23006023</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <mlec:AmortizationOfTheYear contextRef="c360" decimals="0" id="ixv-44050" unitRef="usd">4071453</mlec:AmortizationOfTheYear>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c314" decimals="0" id="ixv-44051" unitRef="usd">18934570</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c361" decimals="0" id="ixv-44052" unitRef="usd">5000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c317" decimals="0" id="ixv-44053" unitRef="usd">5000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c47" decimals="0" id="ixv-44054" unitRef="usd">175292219</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="c5" decimals="0" id="ixv-44055" unitRef="usd">12993402</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <mlec:AdditionsFromBusinessCombinations contextRef="c5" decimals="0" id="ix_34_fact" unitRef="usd">1128449</mlec:AdditionsFromBusinessCombinations>
    <mlec:AmortizationOfTheYear contextRef="c5" decimals="0" id="ixv-44057" unitRef="usd">12113223</mlec:AmortizationOfTheYear>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill contextRef="c5" decimals="0" id="ixv-44058" unitRef="usd">30433</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c7" decimals="0" id="ixv-44059" unitRef="usd">177331280</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryOtherProvisions contextRef="c0" decimals="0" id="ixv-44061" unitRef="usd">1089768</ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryOtherProvisions>
    <mlec:DisclosureOfIntangibleAssetsAndLiabilitiesAssumedTextBlock contextRef="c0" id="ixv-44062">All key assumptions values reflect past experience or, if appropriate, are consistent
with external sources of information.&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="border-bottom: Black 1.5pt solid; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; width: 20%"&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;b&gt;Key assumption&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center; border-bottom: Black 1.5pt solid; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; width: 79%"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Management&#x2019;s approach&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td style="padding: 0pt"&gt;&lt;span style="font-size: 10pt"&gt;Discount rate&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="padding: 0pt"&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;The discount rate applied was either&#160;16.39% or&#160;11.56%, depending on the target market.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;The weighted average cost of capital (WACC) was estimated using the market capital structure plus&#160;2% of risk premium which reflect the higher risk associated with intangible assets.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;For the cost of equity, the discount rate is estimated based on the Capital Asset Pricing Model (CAPM).&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td style="text-indent: -0.125in; padding: 0pt 0pt 0pt 0.125in"&gt;&lt;span style="font-size: 10pt"&gt;Market share, product prices and royalties.&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="padding: 0pt"&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; "&gt;The projected revenue from the products and services of the CGUs has been estimated by the management based on market penetration data for comparable products and technologies and on future expectations of foreseen economic and market conditions.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; "&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; "&gt;The prices and royalties estimated in the revenue projections are based on current and projected market prices for the products and services of the CGUs.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;The key assumptions utilized are the following:&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="border-bottom: Black 1.5pt solid; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; width: 20%"&gt; &lt;p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;b&gt;Key assumption&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; width: 2%"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center; border-bottom: Black 1.5pt solid; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; width: 78%"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Management&#x2019;s approach&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td style="padding: 0pt"&gt;&lt;span style="font-size: 10pt"&gt;Discount rate&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="padding: 0pt"&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"&gt;The discount rate used ranges was&#160;14.11%&#160;for Rizobacter UGE and for&#160;Bioceres Crops UGE, and&#160;9.28% for Pro Farm UGE due to the target market.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="text-align: justify; text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;The weighted average cost of capital (&#x201c;WACC&#x201d;) rate has been estimated based on the market capital structure.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0pt; margin: 0pt"&gt;&#160;&lt;/p&gt; &lt;p style="text-align: justify; text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;For the cost of equity, the discount rate is estimated based on the Capital Asset Pricing Model (CAPM).&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="padding: 0pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td style="text-indent: -0.125in; padding: 0pt 0pt 0pt 0.125in; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Market share, product prices and royalties.&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: justify; padding: 0pt"&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"&gt;The projected revenue from the products and services of the CGUs has been estimated by the management based on market penetration data for comparable products and technologies and on future expectations of foreseen economic and market conditions.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"&gt;The prices (Rizobacter CGU and Pro Farm CGU) and royalties (Bioceres Crops CGU) estimated in the revenue projections are based on current and projected market prices for the products and services of the CGUs.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td style="text-align: justify; padding: 0pt"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: justify; padding: 0pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr&gt; &lt;td style="text-align: justify; padding: 0pt"&gt;&lt;span style="font-size: 10pt"&gt;Terminal value&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: justify; padding: 0pt"&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"&gt;Rizobacter CGU and Bioceres Crops CGU: The growth rate used to extrapolate the future cash flow projections to terminal period&#160;is&#160;2%.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;Pro Farm CGU: EBITDA multiple (10x)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;</mlec:DisclosureOfIntangibleAssetsAndLiabilitiesAssumedTextBlock>
    <ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections contextRef="c4" decimals="4" id="ixv-44063" unitRef="pure">0.1639</ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections>
    <mlec:PercentageOfWeightedAverageCostOfCapital contextRef="c4" decimals="4" id="ixv-44064" unitRef="pure">0.1156</mlec:PercentageOfWeightedAverageCostOfCapital>
    <mlec:PercentageOfRiskPremium contextRef="c0" decimals="2" id="ixv-44065" unitRef="pure">0.02</mlec:PercentageOfRiskPremium>
    <mlec:ProjectedPeriodRange contextRef="c154" id="ixv-44066">P8Y</mlec:ProjectedPeriodRange>
    <mlec:ProjectedPeriodRange contextRef="c155" id="ixv-44067">P18Y</mlec:ProjectedPeriodRange>
    <ifrs-full:DisclosureOfReconciliationOfChangesInGoodwillExplanatory contextRef="c0" id="ixv-27676">&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Rizobacter Argentina S.A.&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-360"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;28,080,271&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Bioceres Crops S.A.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-361"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,523,322&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Insumos Agroqu&#xed;micos S.A.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-362"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;470,090&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Pro Farm Group&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-363"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;76,089,749&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-364"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;112,163,432&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfReconciliationOfChangesInGoodwillExplanatory>
    <ifrs-full:Goodwill contextRef="c366" decimals="0" id="ixv-44068" unitRef="usd">28080271</ifrs-full:Goodwill>
    <ifrs-full:Goodwill contextRef="c368" decimals="0" id="ixv-44069" unitRef="usd">7523322</ifrs-full:Goodwill>
    <ifrs-full:Goodwill contextRef="c370" decimals="0" id="ixv-44070" unitRef="usd">470090</ifrs-full:Goodwill>
    <ifrs-full:Goodwill contextRef="c372" decimals="0" id="ixv-44071" unitRef="usd">76089749</ifrs-full:Goodwill>
    <ifrs-full:Goodwill contextRef="c7" decimals="0" id="ixv-44072" unitRef="usd">112163432</ifrs-full:Goodwill>
    <ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections
      contextRef="c363"
      decimals="4"
      id="ixv-44074"
      unitRef="pure">0.1411</ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections>
    <ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections
      contextRef="c364"
      decimals="4"
      id="ixv-44075"
      unitRef="pure">0.0928</ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections>
    <ifrs-full:DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections contextRef="c4" decimals="2" id="ixv-44076" unitRef="pure">0.02</ifrs-full:DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections>
    <ifrs-full:DisclosureOfDetailedInformationAboutInvestmentPropertyExplanatory contextRef="c0" id="ixv-27851">&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Investment properties&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-365"&gt;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;560,783&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-366"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;560,783&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfDetailedInformationAboutInvestmentPropertyExplanatory>
    <ifrs-full:InvestmentProperty contextRef="c7" decimals="0" id="ixv-44077" unitRef="usd">560783</ifrs-full:InvestmentProperty>
    <ifrs-full:InvestmentProperty contextRef="c7" decimals="0" id="ixv-44078" unitRef="usd">560783</ifrs-full:InvestmentProperty>
    <mlec:DisclosureOfTradeAndOtherPayablesComponentsTableTextBlock contextRef="c0" id="ixv-27892">&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 0pt"&gt;Trade creditors&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;6,490,684&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;108,922,112&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Shareholders and other related parties (Note 17)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-367"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;37,985&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Trade creditors - Joint ventures and associates (Note 13)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;620,034&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;52,778,206&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;Taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,647&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,877,930&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 0pt"&gt;Miscellaneous&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;200,568&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,321,303&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;7,323,933&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;168,937,536&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</mlec:DisclosureOfTradeAndOtherPayablesComponentsTableTextBlock>
    <ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers contextRef="c4" decimals="0" id="ixv-44079" unitRef="usd">6490684</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
    <ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers contextRef="c7" decimals="0" id="ixv-44080" unitRef="usd">108922112</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
    <mlec:TradeAndOtherPayablesShareholdersAndOtherRelatedParties contextRef="c7" decimals="0" id="ixv-44081" unitRef="usd">37985</mlec:TradeAndOtherPayablesShareholdersAndOtherRelatedParties>
    <mlec:TradeCreditorsJointVenturesAndAssociates contextRef="c4" decimals="0" id="ixv-44082" unitRef="usd">620034</mlec:TradeCreditorsJointVenturesAndAssociates>
    <mlec:TradeCreditorsJointVenturesAndAssociates contextRef="c7" decimals="0" id="ixv-44083" unitRef="usd">52778206</mlec:TradeCreditorsJointVenturesAndAssociates>
    <ifrs-full:CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax contextRef="c4" decimals="0" id="ixv-44084" unitRef="usd">12647</ifrs-full:CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax>
    <ifrs-full:CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax contextRef="c7" decimals="0" id="ixv-44085" unitRef="usd">5877930</ifrs-full:CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax>
    <ifrs-full:OtherCurrentPayables contextRef="c4" decimals="0" id="ixv-44086" unitRef="usd">200568</ifrs-full:OtherCurrentPayables>
    <ifrs-full:OtherCurrentPayables contextRef="c7" decimals="0" id="ixv-44087" unitRef="usd">1321303</ifrs-full:OtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables contextRef="c4" decimals="0" id="ixv-44088" unitRef="usd">7323933</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables contextRef="c7" decimals="0" id="ixv-44089" unitRef="usd">168937536</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory contextRef="c0" id="ixv-27979">&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 0pt"&gt;Bank borrowings&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;33,383&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;94,711,273&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Corporate bonds&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-368"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;42,035,925&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Net loans payables- Joint ventures and associates (Note 13)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,303,098&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,860,058&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;Convertible preference shares (Note 17)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15,739,726&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-369"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Financial borrowings&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;201,077,800&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;95,903,495&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;227,154,007&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;234,510,751&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; padding-left: 0pt"&gt;Non-current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Bank borrowings&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,348,173&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,033,059&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Corporate bonds&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-370"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25,071,823&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Financial borrowings&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-371"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;85,143,423&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,348,173&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;127,248,305&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory>
    <ifrs-full:CurrentPortionOfLongtermBorrowings contextRef="c373" decimals="0" id="ixv-44090" unitRef="usd">33383</ifrs-full:CurrentPortionOfLongtermBorrowings>
    <ifrs-full:CurrentPortionOfLongtermBorrowings contextRef="c374" decimals="0" id="ixv-44091" unitRef="usd">94711273</ifrs-full:CurrentPortionOfLongtermBorrowings>
    <ifrs-full:CurrentPortionOfLongtermBorrowings contextRef="c376" decimals="0" id="ixv-44092" unitRef="usd">42035925</ifrs-full:CurrentPortionOfLongtermBorrowings>
    <ifrs-full:CurrentPortionOfLongtermBorrowings contextRef="c377" decimals="0" id="ixv-44093" unitRef="usd">10303098</ifrs-full:CurrentPortionOfLongtermBorrowings>
    <ifrs-full:CurrentPortionOfLongtermBorrowings contextRef="c378" decimals="0" id="ixv-44094" unitRef="usd">1860058</ifrs-full:CurrentPortionOfLongtermBorrowings>
    <ifrs-full:CurrentPortionOfLongtermBorrowings contextRef="c379" decimals="0" id="ixv-44095" unitRef="usd">15739726</ifrs-full:CurrentPortionOfLongtermBorrowings>
    <ifrs-full:CurrentPortionOfLongtermBorrowings contextRef="c381" decimals="0" id="ixv-44096" unitRef="usd">201077800</ifrs-full:CurrentPortionOfLongtermBorrowings>
    <ifrs-full:CurrentPortionOfLongtermBorrowings contextRef="c382" decimals="0" id="ixv-44097" unitRef="usd">95903495</ifrs-full:CurrentPortionOfLongtermBorrowings>
    <ifrs-full:CurrentPortionOfLongtermBorrowings contextRef="c4" decimals="0" id="ixv-44098" unitRef="usd">227154007</ifrs-full:CurrentPortionOfLongtermBorrowings>
    <ifrs-full:CurrentPortionOfLongtermBorrowings contextRef="c7" decimals="0" id="ixv-44099" unitRef="usd">234510751</ifrs-full:CurrentPortionOfLongtermBorrowings>
    <ifrs-full:OtherBorrowings contextRef="c373" decimals="0" id="ixv-44100" unitRef="usd">1348173</ifrs-full:OtherBorrowings>
    <ifrs-full:OtherBorrowings contextRef="c374" decimals="0" id="ixv-44101" unitRef="usd">17033059</ifrs-full:OtherBorrowings>
    <ifrs-full:OtherBorrowings contextRef="c376" decimals="0" id="ixv-44102" unitRef="usd">25071823</ifrs-full:OtherBorrowings>
    <ifrs-full:OtherBorrowings contextRef="c382" decimals="0" id="ixv-44103" unitRef="usd">85143423</ifrs-full:OtherBorrowings>
    <ifrs-full:OtherBorrowings contextRef="c4" decimals="0" id="ixv-44104" unitRef="usd">1348173</ifrs-full:OtherBorrowings>
    <ifrs-full:OtherBorrowings contextRef="c7" decimals="0" id="ixv-44105" unitRef="usd">127248305</ifrs-full:OtherBorrowings>
    <ifrs-full:EstimatedFinancialEffectOfContingentAssets contextRef="c4" decimals="-5" id="ixv-44106" unitRef="usd">61700000</ifrs-full:EstimatedFinancialEffectOfContingentAssets>
    <mlec:InventoryRecognizedAsExpense contextRef="c5" decimals="0" id="ixv-44107" unitRef="usd">0</mlec:InventoryRecognizedAsExpense>
    <mlec:InventoryRecognizedAsExpense contextRef="c6" decimals="0" id="ixv-44108" unitRef="usd">0</mlec:InventoryRecognizedAsExpense>
    <ifrs-full:NumberOfSharesIssued
      contextRef="c156"
      decimals="0"
      id="ixv-44109"
      unitRef="shares">2380952</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:IssuedCapitalPreferenceShares
      contextRef="c156"
      decimals="-6"
      id="ixv-44110"
      unitRef="usd">15000000</ifrs-full:IssuedCapitalPreferenceShares>
    <mlec:PercentageOfPreferenceSharesAccrue
      contextRef="c157"
      decimals="2"
      id="ixv-44111"
      unitRef="pure">0.09</mlec:PercentageOfPreferenceSharesAccrue>
    <mlec:AggregateAmount contextRef="c4" decimals="-5" id="ixv-44112" unitRef="usd">36400000</mlec:AggregateAmount>
    <ifrs-full:DebtInstrumentsHeldAtAmortisedCost
      contextRef="c158"
      decimals="-5"
      id="ixv-44113"
      unitRef="usd">69500000</ifrs-full:DebtInstrumentsHeldAtAmortisedCost>
    <mlec:DisclosureOfCarryingValueOfBorrowingsExplanatory contextRef="c0" id="ixv-44114">The creditor conducted a public
auction for 3,062,500 pledged BIOX shares, pursuant to the New York Uniform Commercial Code. Management has responded to the creditor,
reserving all rights, remedies, and defenses. As of the date of this report, the current debt amounts to $58.0 million.&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Amortized Cost&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Fair value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Amortized Cost&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Fair value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; padding-left: 0pt"&gt;Bank borrowings&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;33,383&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;33,383&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;94,711,273&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;93,301,194&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Corporate bonds&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-372"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-373"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;42,035,925&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;41,492,963&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;Convertible preference shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15,739,726&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,179,927&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-374"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-375"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Financial borrowings&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;211,380,898&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;205,082,929&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;95,903,495&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;95,480,681&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-left: 0pt"&gt;Non current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Bank borrowings&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,348,173&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,348,173&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,033,059&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,206,794&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Corporate bonds&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-376"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-377"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25,071,823&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;23,845,583&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Convertible notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,260,456&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,260,456&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-378"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-379"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Financial borrowings&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-380"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-381"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;85,143,423&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;81,120,125&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</mlec:DisclosureOfCarryingValueOfBorrowingsExplanatory>
    <mlec:CreditorsPublicAuctionShares
      contextRef="c158"
      decimals="0"
      id="ixv-44115"
      unitRef="shares">3062500</mlec:CreditorsPublicAuctionShares>
    <ifrs-full:CurrentDebtInstrumentsIssued contextRef="c4" decimals="-5" id="ixv-44116" unitRef="usd">58000000</ifrs-full:CurrentDebtInstrumentsIssued>
    <ifrs-full:ShorttermBorrowings contextRef="c383" decimals="0" id="ixv-44117" unitRef="usd">33383</ifrs-full:ShorttermBorrowings>
    <ifrs-full:ShorttermBorrowings contextRef="c384" decimals="0" id="ixv-44118" unitRef="usd">33383</ifrs-full:ShorttermBorrowings>
    <ifrs-full:ShorttermBorrowings contextRef="c385" decimals="0" id="ixv-44119" unitRef="usd">94711273</ifrs-full:ShorttermBorrowings>
    <ifrs-full:ShorttermBorrowings contextRef="c386" decimals="0" id="ixv-44120" unitRef="usd">93301194</ifrs-full:ShorttermBorrowings>
    <ifrs-full:ShorttermBorrowings contextRef="c389" decimals="0" id="ixv-44121" unitRef="usd">42035925</ifrs-full:ShorttermBorrowings>
    <ifrs-full:ShorttermBorrowings contextRef="c390" decimals="0" id="ixv-44122" unitRef="usd">41492963</ifrs-full:ShorttermBorrowings>
    <ifrs-full:ShorttermBorrowings contextRef="c391" decimals="0" id="ixv-44123" unitRef="usd">15739726</ifrs-full:ShorttermBorrowings>
    <ifrs-full:ShorttermBorrowings contextRef="c392" decimals="0" id="ixv-44124" unitRef="usd">14179927</ifrs-full:ShorttermBorrowings>
    <ifrs-full:ShorttermBorrowings contextRef="c395" decimals="0" id="ixv-44125" unitRef="usd">211380898</ifrs-full:ShorttermBorrowings>
    <ifrs-full:ShorttermBorrowings contextRef="c396" decimals="0" id="ixv-44126" unitRef="usd">205082929</ifrs-full:ShorttermBorrowings>
    <ifrs-full:ShorttermBorrowings contextRef="c397" decimals="0" id="ixv-44127" unitRef="usd">95903495</ifrs-full:ShorttermBorrowings>
    <ifrs-full:ShorttermBorrowings contextRef="c398" decimals="0" id="ixv-44128" unitRef="usd">95480681</ifrs-full:ShorttermBorrowings>
    <ifrs-full:LongtermBorrowings contextRef="c383" decimals="0" id="ixv-44129" unitRef="usd">1348173</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings contextRef="c384" decimals="0" id="ixv-44130" unitRef="usd">1348173</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings contextRef="c385" decimals="0" id="ixv-44131" unitRef="usd">17033059</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings contextRef="c386" decimals="0" id="ixv-44132" unitRef="usd">12206794</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings contextRef="c389" decimals="0" id="ixv-44133" unitRef="usd">25071823</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings contextRef="c390" decimals="0" id="ixv-44134" unitRef="usd">23845583</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings contextRef="c399" decimals="0" id="ixv-44135" unitRef="usd">18260456</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings contextRef="c400" decimals="0" id="ixv-44136" unitRef="usd">18260456</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings contextRef="c397" decimals="0" id="ixv-44137" unitRef="usd">85143423</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings contextRef="c398" decimals="0" id="ixv-44138" unitRef="usd">81120125</ifrs-full:LongtermBorrowings>
    <ifrs-full:DisclosureOfDebtSecuritiesExplanatory contextRef="c0" id="ixv-28413">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="text-decoration:underline"&gt;Convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;Non-current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Convertible notes&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;18,260,456&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;80,809,686&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;18,260,456&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;80,809,686&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfDebtSecuritiesExplanatory>
    <mlec:SecuredDebtNonCurrent contextRef="c403" decimals="0" id="ixv-44139" unitRef="usd">18260456</mlec:SecuredDebtNonCurrent>
    <mlec:SecuredDebtNonCurrent contextRef="c404" decimals="0" id="ixv-44140" unitRef="usd">80809686</mlec:SecuredDebtNonCurrent>
    <mlec:SecuredDebtNonCurrent contextRef="c4" decimals="0" id="ixv-44141" unitRef="usd">18260456</mlec:SecuredDebtNonCurrent>
    <mlec:SecuredDebtNonCurrent contextRef="c7" decimals="0" id="ixv-44142" unitRef="usd">80809686</mlec:SecuredDebtNonCurrent>
    <ifrs-full:BorrowingsInterestRate
      contextRef="c159"
      decimals="3"
      id="ixv-44143"
      unitRef="pure">0.09</ifrs-full:BorrowingsInterestRate>
    <ifrs-full:BorrowingsInterestRate
      contextRef="c160"
      decimals="3"
      id="ixv-44144"
      unitRef="pure">0.13</ifrs-full:BorrowingsInterestRate>
    <ifrs-full:BorrowingsInterestRate
      contextRef="c161"
      decimals="3"
      id="ixv-44145"
      unitRef="pure">0.14</ifrs-full:BorrowingsInterestRate>
    <mlec:IfrsDebtInstrumentTerm contextRef="c162" id="ixv-44146">P48M</mlec:IfrsDebtInstrumentTerm>
    <ifrs-full:Borrowings contextRef="c163" decimals="0" id="ixv-44147" unitRef="usd">26437485</ifrs-full:Borrowings>
    <ifrs-full:Borrowings contextRef="c164" decimals="0" id="ixv-44148" unitRef="usd">29081233</ifrs-full:Borrowings>
    <ifrs-full:BorrowingsInterestRate
      contextRef="c165"
      decimals="2"
      id="ixv-44149"
      unitRef="pure">0.19</ifrs-full:BorrowingsInterestRate>
    <ifrs-full:BorrowingsInterestRate
      contextRef="c164"
      decimals="2"
      id="ixv-44150"
      unitRef="pure">0.14</ifrs-full:BorrowingsInterestRate>
    <ifrs-full:BorrowingsInterestRate
      contextRef="c166"
      decimals="2"
      id="ixv-44151"
      unitRef="pure">0.05</ifrs-full:BorrowingsInterestRate>
    <mlec:AmortizationPayments contextRef="c167" decimals="0" id="ixv-44152" unitRef="usd">1000000</mlec:AmortizationPayments>
    <mlec:PercentageOfPrepaymentPremium
      contextRef="c167"
      decimals="2"
      id="ixv-44153"
      unitRef="pure">0.05</mlec:PercentageOfPrepaymentPremium>
    <mlec:PercentageOfPenalty
      contextRef="c167"
      decimals="2"
      id="ixv-44154"
      unitRef="pure">0.10</mlec:PercentageOfPenalty>
    <ifrs-full:NotionalAmount
      contextRef="c168"
      decimals="-6"
      id="ixv-44155"
      unitRef="usd">55000000</ifrs-full:NotionalAmount>
    <mlec:IfrsDebtInstrumentTerm contextRef="c169" id="ixv-44156">P4Y</mlec:IfrsDebtInstrumentTerm>
    <ifrs-full:BorrowingsInterestRate
      contextRef="c168"
      decimals="2"
      id="ixv-44157"
      unitRef="pure">0.09</ifrs-full:BorrowingsInterestRate>
    <mlec:BorrowingInterestRateInCash
      contextRef="c168"
      decimals="2"
      id="ixv-44158"
      unitRef="pure">0.05</mlec:BorrowingInterestRateInCash>
    <mlec:BorrowingInterestRateInKind
      contextRef="c168"
      decimals="2"
      id="ixv-44159"
      unitRef="pure">0.04</mlec:BorrowingInterestRateInKind>
    <mlec:StrikePriceForConversionOfDebt
      contextRef="c169"
      decimals="0"
      id="ixv-44160"
      unitRef="usdPershares">18</mlec:StrikePriceForConversionOfDebt>
    <mlec:VoluntaryRepurchaseOfNotesAfterIssueDate contextRef="c169" id="ixv-44161">P30M</mlec:VoluntaryRepurchaseOfNotesAfterIssueDate>
    <ifrs-full:Borrowings contextRef="c166" decimals="0" id="ixv-44162" unitRef="usd">61652927</ifrs-full:Borrowings>
    <ifrs-full:Borrowings contextRef="c170" decimals="0" id="ixv-44163" unitRef="usd">67868227</ifrs-full:Borrowings>
    <ifrs-full:BorrowingsMaturity contextRef="c167" id="ixv-44164">August 31, 2027</ifrs-full:BorrowingsMaturity>
    <ifrs-full:BorrowingsInterestRate
      contextRef="c171"
      decimals="2"
      id="ixv-44165"
      unitRef="pure">0.15</ifrs-full:BorrowingsInterestRate>
    <ifrs-full:BorrowingsInterestRate
      contextRef="c166"
      decimals="2"
      id="ixv-44166"
      unitRef="pure">0.05</ifrs-full:BorrowingsInterestRate>
    <ifrs-full:BorrowingsInterestRate
      contextRef="c170"
      decimals="2"
      id="ixv-44167"
      unitRef="pure">0.10</ifrs-full:BorrowingsInterestRate>
    <mlec:PricePerSharesOfStrikePrice
      contextRef="c167"
      decimals="0"
      id="ixv-44168"
      unitRef="usdPershares">6</mlec:PricePerSharesOfStrikePrice>
    <mlec:CommonEquity contextRef="c167" decimals="0" id="ixv-44169" unitRef="usd">10000000</mlec:CommonEquity>
    <mlec:PercentageOfPenaltyOfPrepayment
      contextRef="c167"
      decimals="2"
      id="ixv-44170"
      unitRef="pure">0.05</mlec:PercentageOfPenaltyOfPrepayment>
    <mlec:PercentageOfPenaltyOfPrepayment
      contextRef="c172"
      decimals="2"
      id="ixv-44171"
      unitRef="pure">0.05</mlec:PercentageOfPenaltyOfPrepayment>
    <mlec:PercentageOfPenalty
      contextRef="c173"
      decimals="2"
      id="ixv-44172"
      unitRef="pure">0.07</mlec:PercentageOfPenalty>
    <mlec:DiscountRateForFairValueOfLiabilityComponent
      contextRef="c169"
      decimals="4"
      id="ixv-44173"
      unitRef="pure">0.1357</mlec:DiscountRateForFairValueOfLiabilityComponent>
    <mlec:PrepaymentPremiumFee
      contextRef="c169"
      decimals="-5"
      id="ixv-44174"
      unitRef="usd">4800000</mlec:PrepaymentPremiumFee>
    <ifrs-full:LoansReceived contextRef="c4" decimals="0" id="ixv-44175" unitRef="usd">10000000</ifrs-full:LoansReceived>
    <mlec:AdditionalConvertibleNotesReceivedAmount contextRef="c4" decimals="0" id="ixv-44176" unitRef="usd">940000</mlec:AdditionalConvertibleNotesReceivedAmount>
    <mlec:ConversionOptionStrikePrice
      contextRef="c4"
      decimals="2"
      id="ixv-44177"
      unitRef="usdPershares">60</mlec:ConversionOptionStrikePrice>
    <mlec:PercentageOfOutstandingAmountInitialInterestRate contextRef="c4" decimals="2" id="ixv-44178" unitRef="pure">0.05</mlec:PercentageOfOutstandingAmountInitialInterestRate>
    <mlec:PercentageOfCashPaymentInterestRate contextRef="c4" decimals="2" id="ixv-44179" unitRef="pure">0.10</mlec:PercentageOfCashPaymentInterestRate>
    <mlec:DisclosureOfBenefitsAndSocialSecurityPayablesTableTextBlock contextRef="c0" id="ixv-28581">&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 0pt"&gt;Salaries, accrued incentives, vacations&#160;and social security&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;202,014&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;7,280,129&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Key management personnel (Note 18)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;41,620&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;226,702&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;243,634&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;7,506,831&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</mlec:DisclosureOfBenefitsAndSocialSecurityPayablesTableTextBlock>
    <mlec:SalariesAccruedIncentivesVacationsAndSocialSecurity contextRef="c4" decimals="0" id="ixv-44180" unitRef="usd">202014</mlec:SalariesAccruedIncentivesVacationsAndSocialSecurity>
    <mlec:SalariesAccruedIncentivesVacationsAndSocialSecurity contextRef="c7" decimals="0" id="ixv-44181" unitRef="usd">7280129</mlec:SalariesAccruedIncentivesVacationsAndSocialSecurity>
    <mlec:KeyManagementPersonnelBenefitsLiabilityCurrent contextRef="c4" decimals="0" id="ixv-44182" unitRef="usd">41620</mlec:KeyManagementPersonnelBenefitsLiabilityCurrent>
    <mlec:KeyManagementPersonnelBenefitsLiabilityCurrent contextRef="c7" decimals="0" id="ixv-44183" unitRef="usd">226702</mlec:KeyManagementPersonnelBenefitsLiabilityCurrent>
    <ifrs-full:CurrentProvisionsForEmployeeBenefits contextRef="c4" decimals="0" id="ixv-44184" unitRef="usd">243634</ifrs-full:CurrentProvisionsForEmployeeBenefits>
    <ifrs-full:CurrentProvisionsForEmployeeBenefits contextRef="c7" decimals="0" id="ixv-44185" unitRef="usd">7506831</ifrs-full:CurrentProvisionsForEmployeeBenefits>
    <mlec:DisclosuresOfDeferredRevenueAndAdvancesFromCustomersTableTextBlock contextRef="c0" id="ixv-28636">&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 0pt"&gt;Advances from customers&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,260&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3,335,740&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Deferred revenue&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-382"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;589,061&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,260&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3,924,801&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-left: 0pt"&gt;Non current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Advances from customers&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-383"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;52,511&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Deferred revenue&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-384"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,872,627&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-385"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,925,138&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</mlec:DisclosuresOfDeferredRevenueAndAdvancesFromCustomersTableTextBlock>
    <ifrs-full:CurrentAdvances contextRef="c4" decimals="0" id="ixv-44186" unitRef="usd">1260</ifrs-full:CurrentAdvances>
    <ifrs-full:CurrentAdvances contextRef="c7" decimals="0" id="ixv-44187" unitRef="usd">3335740</ifrs-full:CurrentAdvances>
    <ifrs-full:CurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime contextRef="c7" decimals="0" id="ixv-44188" unitRef="usd">589061</ifrs-full:CurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime>
    <ifrs-full:CurrentDeferredIncomeIncludingCurrentContractLiabilities contextRef="c4" decimals="0" id="ixv-44189" unitRef="usd">1260</ifrs-full:CurrentDeferredIncomeIncludingCurrentContractLiabilities>
    <ifrs-full:CurrentDeferredIncomeIncludingCurrentContractLiabilities contextRef="c7" decimals="0" id="ixv-44190" unitRef="usd">3924801</ifrs-full:CurrentDeferredIncomeIncludingCurrentContractLiabilities>
    <ifrs-full:NoncurrentAdvances contextRef="c7" decimals="0" id="ixv-44191" unitRef="usd">52511</ifrs-full:NoncurrentAdvances>
    <ifrs-full:NoncurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime contextRef="c7" decimals="0" id="ixv-44192" unitRef="usd">1872627</ifrs-full:NoncurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime>
    <ifrs-full:NoncurrentDeferredIncomeIncludingNoncurrentContractLiabilities contextRef="c7" decimals="0" id="ixv-44193" unitRef="usd">1925138</ifrs-full:NoncurrentDeferredIncomeIncludingNoncurrentContractLiabilities>
    <mlec:DisclosureOfChangesInAllowancesAndProvisionsTableTextBlock contextRef="c0" id="ixv-28735">&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Item&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Additions&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;b&gt;Uses and &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;reversals&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Currency &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;b&gt;conversion &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;difference&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;b&gt;Loss of &lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;control&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;DEDUCTED FROM ASSETS&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 28%; text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Allowance for impairment of trade debtors&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;7,050,280&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;7,123,716&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-386"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(50,533&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(14,123,463&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"&gt;Allowance for obsolescence&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,087,563&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,547,723&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,158,036&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;29,204&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(3,506,454&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"&gt;Total deducted from assets&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;10,137,843&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;8,671,439&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,158,036&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(21,329&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(17,629,917&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;INCLUDED IN LIABILITIES&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Provisions for contingencies&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;17,484,715&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;336,919&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(309,793&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(89,694&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,267,573&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;16,154,574&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"&gt;Total included in liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;17,484,715&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;336,919&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(309,793&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(89,694&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,267,573&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;16,154,574&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.125in"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;27,622,558&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;9,008,358&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(1,467,829&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(111,023&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(18,897,490&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;16,154,574&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-indent: -0.25in; padding-left: 0.25in; font-weight: bold"&gt;Item&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Additions&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Additions &lt;br/&gt; from &lt;br/&gt; business &lt;br/&gt; combination&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Uses and &lt;br/&gt; reversals&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Currency &lt;br/&gt; conversion &lt;br/&gt; difference&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.25in; padding-left: 0.25in; font-weight: bold"&gt;DEDUCTED FROM ASSETS&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 28%; text-align: left; text-indent: -0.25in; padding-left: 0.25in"&gt;Allowance for impairment of trade debtors&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;7,425,604&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;753,428&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-387"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(777,558&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(351,194&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;7,050,280&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.25in; padding-left: 0.25in"&gt;Allowance for obsolescence&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,492,499&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;586,515&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-388"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(69,582&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;78,131&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,087,563&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -0.25in; padding-left: 0.25in"&gt;Total deducted from assets&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;9,918,103&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,339,943&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-389"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(847,140&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(273,063&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;10,137,843&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.25in; padding-left: 0.25in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; text-indent: -0.25in; padding-left: 0.25in"&gt;INCLUDED IN LIABILITIES&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.25in; padding-left: 0.25in"&gt;Provisions for contingencies&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;16,901,773&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;653,574&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;355,898&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(393,073&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(33,457&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;17,484,715&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -0.25in; padding-left: 0.25in"&gt;Total included in liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;16,901,773&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;653,574&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;355,898&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(393,073&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(33,457&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;17,484,715&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt; text-indent: -0.25in; padding-left: 0.25in"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;26,819,876&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;1,993,517&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;355,898&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(1,240,213&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(306,520&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;27,622,558&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</mlec:DisclosureOfChangesInAllowancesAndProvisionsTableTextBlock>
    <ifrs-full:OtherProvisions contextRef="c405" decimals="0" id="ixv-44194" unitRef="usd">7050280</ifrs-full:OtherProvisions>
    <ifrs-full:AdditionalProvisionsOtherProvisions contextRef="c406" decimals="0" id="ixv-44195" unitRef="usd">7123716</ifrs-full:AdditionalProvisionsOtherProvisions>
    <mlec:AllowancesAndProvisionsUsedAndReversed contextRef="c406" decimals="0" id="ixv-44196" unitRef="usd">-50533</mlec:AllowancesAndProvisionsUsedAndReversed>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions contextRef="c406" decimals="0" id="ixv-44197" unitRef="usd">-14123463</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
    <ifrs-full:OtherProvisions contextRef="c407" decimals="0" id="ixv-44198" unitRef="usd">3087563</ifrs-full:OtherProvisions>
    <ifrs-full:AdditionalProvisionsOtherProvisions contextRef="c408" decimals="0" id="ixv-44199" unitRef="usd">1547723</ifrs-full:AdditionalProvisionsOtherProvisions>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions contextRef="c408" decimals="0" id="ixv-44200" unitRef="usd">1158036</ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions>
    <mlec:AllowancesAndProvisionsUsedAndReversed contextRef="c408" decimals="0" id="ixv-44201" unitRef="usd">29204</mlec:AllowancesAndProvisionsUsedAndReversed>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions contextRef="c408" decimals="0" id="ixv-44202" unitRef="usd">-3506454</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
    <ifrs-full:OtherProvisions contextRef="c409" decimals="0" id="ixv-44203" unitRef="usd">10137843</ifrs-full:OtherProvisions>
    <ifrs-full:AdditionalProvisionsOtherProvisions contextRef="c410" decimals="0" id="ixv-44204" unitRef="usd">8671439</ifrs-full:AdditionalProvisionsOtherProvisions>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions contextRef="c410" decimals="0" id="ixv-44205" unitRef="usd">1158036</ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions>
    <mlec:AllowancesAndProvisionsUsedAndReversed contextRef="c410" decimals="0" id="ixv-44206" unitRef="usd">-21329</mlec:AllowancesAndProvisionsUsedAndReversed>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions contextRef="c410" decimals="0" id="ixv-44207" unitRef="usd">-17629917</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
    <ifrs-full:OtherProvisions contextRef="c411" decimals="0" id="ixv-44208" unitRef="usd">17484715</ifrs-full:OtherProvisions>
    <ifrs-full:AdditionalProvisionsOtherProvisions contextRef="c412" decimals="0" id="ixv-44209" unitRef="usd">336919</ifrs-full:AdditionalProvisionsOtherProvisions>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions contextRef="c412" decimals="0" id="ixv-44210" unitRef="usd">309793</ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions>
    <mlec:AllowancesAndProvisionsUsedAndReversed contextRef="c412" decimals="0" id="ixv-44211" unitRef="usd">-89694</mlec:AllowancesAndProvisionsUsedAndReversed>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions contextRef="c412" decimals="0" id="ixv-44212" unitRef="usd">-1267573</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
    <mlec:ChangeInAllowanceAndProvisionLossOfControl contextRef="c412" decimals="0" id="ixv-44213" unitRef="usd">-16154574</mlec:ChangeInAllowanceAndProvisionLossOfControl>
    <ifrs-full:OtherProvisions contextRef="c413" decimals="0" id="ixv-44214" unitRef="usd">17484715</ifrs-full:OtherProvisions>
    <ifrs-full:AdditionalProvisionsOtherProvisions contextRef="c414" decimals="0" id="ixv-44215" unitRef="usd">336919</ifrs-full:AdditionalProvisionsOtherProvisions>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions contextRef="c414" decimals="0" id="ixv-44216" unitRef="usd">309793</ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions>
    <mlec:AllowancesAndProvisionsUsedAndReversed contextRef="c414" decimals="0" id="ixv-44217" unitRef="usd">-89694</mlec:AllowancesAndProvisionsUsedAndReversed>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions contextRef="c414" decimals="0" id="ixv-44218" unitRef="usd">-1267573</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
    <mlec:ChangeInAllowanceAndProvisionLossOfControl contextRef="c414" decimals="0" id="ixv-44219" unitRef="usd">-16154574</mlec:ChangeInAllowanceAndProvisionLossOfControl>
    <ifrs-full:OtherProvisions contextRef="c7" decimals="0" id="ixv-44220" unitRef="usd">27622558</ifrs-full:OtherProvisions>
    <ifrs-full:AdditionalProvisionsOtherProvisions contextRef="c0" decimals="0" id="ixv-44221" unitRef="usd">9008358</ifrs-full:AdditionalProvisionsOtherProvisions>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions contextRef="c0" decimals="0" id="ixv-44222" unitRef="usd">1467829</ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions>
    <mlec:AllowancesAndProvisionsUsedAndReversed contextRef="c0" decimals="0" id="ixv-44223" unitRef="usd">-111023</mlec:AllowancesAndProvisionsUsedAndReversed>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions contextRef="c0" decimals="0" id="ixv-44224" unitRef="usd">-18897490</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
    <mlec:ChangeInAllowanceAndProvisionLossOfControl contextRef="c0" decimals="0" id="ixv-44225" unitRef="usd">-16154574</mlec:ChangeInAllowanceAndProvisionLossOfControl>
    <ifrs-full:OtherProvisions contextRef="c415" decimals="0" id="ixv-44226" unitRef="usd">7425604</ifrs-full:OtherProvisions>
    <ifrs-full:OtherProvisions contextRef="c416" decimals="0" id="ixv-44227" unitRef="usd">753428</ifrs-full:OtherProvisions>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions contextRef="c417" decimals="0" id="ixv-44228" unitRef="usd">777558</ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions>
    <mlec:AllowancesAndProvisionsUsedAndReversed contextRef="c417" decimals="0" id="ixv-44229" unitRef="usd">-351194</mlec:AllowancesAndProvisionsUsedAndReversed>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions contextRef="c417" decimals="0" id="ixv-44230" unitRef="usd">7050280</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
    <ifrs-full:OtherProvisions contextRef="c418" decimals="0" id="ixv-44231" unitRef="usd">2492499</ifrs-full:OtherProvisions>
    <ifrs-full:OtherProvisions contextRef="c419" decimals="0" id="ixv-44232" unitRef="usd">586515</ifrs-full:OtherProvisions>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions contextRef="c420" decimals="0" id="ixv-44233" unitRef="usd">69582</ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions>
    <mlec:AllowancesAndProvisionsUsedAndReversed contextRef="c420" decimals="0" id="ixv-44234" unitRef="usd">78131</mlec:AllowancesAndProvisionsUsedAndReversed>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions contextRef="c420" decimals="0" id="ixv-44235" unitRef="usd">3087563</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
    <ifrs-full:OtherProvisions contextRef="c421" decimals="0" id="ixv-44236" unitRef="usd">9918103</ifrs-full:OtherProvisions>
    <ifrs-full:OtherProvisions contextRef="c422" decimals="0" id="ixv-44237" unitRef="usd">1339943</ifrs-full:OtherProvisions>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions contextRef="c423" decimals="0" id="ixv-44238" unitRef="usd">847140</ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions>
    <mlec:AllowancesAndProvisionsUsedAndReversed contextRef="c423" decimals="0" id="ixv-44239" unitRef="usd">-273063</mlec:AllowancesAndProvisionsUsedAndReversed>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions contextRef="c423" decimals="0" id="ixv-44240" unitRef="usd">10137843</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
    <ifrs-full:OtherProvisions contextRef="c424" decimals="0" id="ixv-44241" unitRef="usd">16901773</ifrs-full:OtherProvisions>
    <ifrs-full:OtherProvisions contextRef="c425" decimals="0" id="ixv-44242" unitRef="usd">653574</ifrs-full:OtherProvisions>
    <ifrs-full:AdditionalProvisionsOtherProvisions contextRef="c426" decimals="0" id="ixv-44243" unitRef="usd">355898</ifrs-full:AdditionalProvisionsOtherProvisions>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions contextRef="c426" decimals="0" id="ixv-44244" unitRef="usd">393073</ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions>
    <mlec:AllowancesAndProvisionsUsedAndReversed contextRef="c426" decimals="0" id="ixv-44245" unitRef="usd">-33457</mlec:AllowancesAndProvisionsUsedAndReversed>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions contextRef="c426" decimals="0" id="ixv-44246" unitRef="usd">17484715</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
    <ifrs-full:OtherProvisions contextRef="c427" decimals="0" id="ixv-44247" unitRef="usd">16901773</ifrs-full:OtherProvisions>
    <ifrs-full:OtherProvisions contextRef="c428" decimals="0" id="ixv-44248" unitRef="usd">653574</ifrs-full:OtherProvisions>
    <ifrs-full:AdditionalProvisionsOtherProvisions contextRef="c429" decimals="0" id="ixv-44249" unitRef="usd">355898</ifrs-full:AdditionalProvisionsOtherProvisions>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions contextRef="c429" decimals="0" id="ixv-44250" unitRef="usd">393073</ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions>
    <mlec:AllowancesAndProvisionsUsedAndReversed contextRef="c429" decimals="0" id="ixv-44251" unitRef="usd">-33457</mlec:AllowancesAndProvisionsUsedAndReversed>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions contextRef="c429" decimals="0" id="ixv-44252" unitRef="usd">17484715</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
    <ifrs-full:OtherProvisions contextRef="c4" decimals="0" id="ixv-44253" unitRef="usd">26819876</ifrs-full:OtherProvisions>
    <ifrs-full:OtherProvisions contextRef="c47" decimals="0" id="ixv-44254" unitRef="usd">1993517</ifrs-full:OtherProvisions>
    <ifrs-full:AdditionalProvisionsOtherProvisions contextRef="c5" decimals="0" id="ixv-44255" unitRef="usd">355898</ifrs-full:AdditionalProvisionsOtherProvisions>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions contextRef="c5" decimals="0" id="ixv-44256" unitRef="usd">1240213</ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions>
    <mlec:AllowancesAndProvisionsUsedAndReversed contextRef="c5" decimals="0" id="ixv-44257" unitRef="usd">-306520</mlec:AllowancesAndProvisionsUsedAndReversed>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions contextRef="c5" decimals="0" id="ixv-44258" unitRef="usd">27622558</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
    <ifrs-full:DisclosureOfProvisionsExplanatory contextRef="c0" id="ixv-29305">&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="text-decoration:underline"&gt;Provisions&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 0pt"&gt;Conditional payment Rizobacter SA&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;15,916,116&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;15,916,116&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Provisions for contingencies&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;238,458&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,568,599&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;16,154,574&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;17,484,715&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfProvisionsExplanatory>
    <ifrs-full:NoncurrentProvisions contextRef="c430" decimals="0" id="ixv-44259" unitRef="usd">15916116</ifrs-full:NoncurrentProvisions>
    <ifrs-full:NoncurrentProvisions contextRef="c431" decimals="0" id="ixv-44260" unitRef="usd">15916116</ifrs-full:NoncurrentProvisions>
    <ifrs-full:NoncurrentProvisions contextRef="c424" decimals="0" id="ixv-44261" unitRef="usd">238458</ifrs-full:NoncurrentProvisions>
    <ifrs-full:NoncurrentProvisions contextRef="c411" decimals="0" id="ixv-44262" unitRef="usd">1568599</ifrs-full:NoncurrentProvisions>
    <ifrs-full:NoncurrentProvisions contextRef="c4" decimals="0" id="ixv-44263" unitRef="usd">16154574</ifrs-full:NoncurrentProvisions>
    <ifrs-full:NoncurrentProvisions contextRef="c7" decimals="0" id="ixv-44264" unitRef="usd">17484715</ifrs-full:NoncurrentProvisions>
    <mlec:ContingentPayment contextRef="c4" decimals="-5" id="ixv-44265" unitRef="usd">17300000</mlec:ContingentPayment>
    <mlec:ContingentPaymentCurrent contextRef="c4" decimals="-5" id="ixv-44266" unitRef="usd">15900000</mlec:ContingentPaymentCurrent>
    <mlec:PercentageOfCapital contextRef="c4" decimals="2" id="ixv-44267" unitRef="pure">0.44</mlec:PercentageOfCapital>
    <mlec:PercentageOfDividendsTaxedShares contextRef="c0" decimals="2" id="ixv-44268" unitRef="pure">0.30</mlec:PercentageOfDividendsTaxedShares>
    <mlec:ContingentPurchasePrice contextRef="c4" decimals="-5" id="ixv-44269" unitRef="usd">17300000</mlec:ContingentPurchasePrice>
    <ifrs-full:DisclosureOfGovernmentGrantsExplanatory contextRef="c0" id="ixv-29372">&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 0pt"&gt;At the beginning of the year&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4,437&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;349,998&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;&lt;span style="font-size: 10pt"&gt;Loss of control &lt;sup&gt;(*)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-390"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(157,043&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Currency conversion difference&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;255&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,001&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Released to the statement of profit or loss&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(3,412&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(197,519&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0pt"&gt;At the end of the year&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,280&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4,437&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;sup&gt;&#160;&lt;/sup&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&lt;sup&gt;(*)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Correspond to the loss of control
of Inmet S.A. in the year 2024&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfGovernmentGrantsExplanatory>
    <ifrs-full:GovernmentGrants contextRef="c432" decimals="0" id="ixv-44270" unitRef="usd">4437</ifrs-full:GovernmentGrants>
    <ifrs-full:GovernmentGrants contextRef="c433" decimals="0" id="ixv-44271" unitRef="usd">349998</ifrs-full:GovernmentGrants>
    <ifrs-full:LossesOnDisposalsOfInvestments
      contextRef="c435"
      decimals="0"
      id="ix_42_fact"
      unitRef="usd">157043</ifrs-full:LossesOnDisposalsOfInvestments>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation contextRef="c434" decimals="0" id="ixv-44273" unitRef="usd">255</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation contextRef="c435" decimals="0" id="ixv-44274" unitRef="usd">9001</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
    <ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity contextRef="c434" decimals="0" id="ixv-44275" unitRef="usd">-3412</ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity>
    <ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity contextRef="c435" decimals="0" id="ixv-44276" unitRef="usd">-197519</ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity>
    <ifrs-full:GovernmentGrants contextRef="c436" decimals="0" id="ixv-44277" unitRef="usd">1280</ifrs-full:GovernmentGrants>
    <ifrs-full:GovernmentGrants contextRef="c432" decimals="0" id="ixv-44278" unitRef="usd">4437</ifrs-full:GovernmentGrants>
    <mlec:DisclosureOfWarrantsTextBlock contextRef="c0" id="ixv-29497">&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;At the beginning of the year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-391"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-392"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Additions for the year&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"&gt;1,030,000&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;p style="-sec-ix-hidden: hidden-fact-393; margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Additions from business combination&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;181,093&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-394"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0pt"&gt;At the end of the year&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,211,093&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-395"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</mlec:DisclosureOfWarrantsTextBlock>
    <mlec:AdditionsWarrantsForTheYear contextRef="c0" decimals="0" id="ixv-44279" unitRef="usd">1030000</mlec:AdditionsWarrantsForTheYear>
    <mlec:AdditionsFromBusinessCombination contextRef="c0" decimals="0" id="ixv-44280" unitRef="usd">181093</mlec:AdditionsFromBusinessCombination>
    <ifrs-full:CurrentWarrantLiability contextRef="c4" decimals="0" id="ixv-44281" unitRef="usd">1211093</ifrs-full:CurrentWarrantLiability>
    <mlec:DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock contextRef="c0" id="ixv-29560">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;8.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;INFORMATION ABOUT COMPONENT OF CONSOLIDATED STATEMENTS
OF COMPREHENSIVE INCOME&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;8.1 &lt;span style="text-decoration:underline"&gt;Revenue from contracts with customers&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Sale of goods and services&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;317,924,355&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;444,149,141&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;385,976,753&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Royalties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,414,864&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;986,602&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,247,567&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Rendering of services with related parties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;841,205&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;952,742&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;739,651&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Right of use licenses&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;13,430,824&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;20,287,845&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;32,903,458&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;333,611,248&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;466,376,330&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;420,867,429&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Transactions of sales of goods and services with
joint ventures and with shareholders and other related parties are reported in Note 17.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;8.2 &lt;span style="text-decoration:underline"&gt;Cost of sales&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Item&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; padding-left: 0pt"&gt;Inventories as of the beginning of the year&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;110,913,884&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;112,000,786&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;78,775,003&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;Loss of control&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(82,999,205&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-396"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-397"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Additions related to Business combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,235,482&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,020,771&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,182,602&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Purchases of the year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;149,950,181&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;249,648,267&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;233,465,488&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Production costs (note 8.4)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25,177,920&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25,819,152&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;23,234,862&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Foreign currency translation&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;382,092&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,206,764&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;806,903&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;Subtotal&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;205,660,354&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;390,282,212&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;347,464,858&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;&lt;span style="font-size: 10pt"&gt;Inventories as of the end of
the year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(2,235,482&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(110,913,884&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(112,000,786&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 0pt"&gt;Cost of sales&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;203,424,872&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;279,368,328&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;235,464,072&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;8.3 &lt;span style="text-decoration:underline"&gt;R&amp;amp;D classified by nature&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Research and development expenses&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Item&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;06/30/2025&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;06/30/2024&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;06/30/2023&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Amortization of intangible assets&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;5,079,839&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;5,923,389&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4,804,768&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Analysis and storage&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-398"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,302&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;52,660&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Commissions and royalties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,179&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-399"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16,257&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Import and export expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-400"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-401"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;855&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Depreciation of leased assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;54,505&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-402"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;68,321&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Depreciation of property, plant and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;767,731&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;618,627&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;637,734&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Freight and haulage&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,025&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;30,450&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,707&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Employee benefits and social securities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,032,386&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,727,340&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,781,678&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Insurance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;49,343&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;48,872&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;78,673&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Energy and fuel&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,576&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,101&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;111,481&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Maintenance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;236,867&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;283,895&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;475,868&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Supplies and materials&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,731,604&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,361,380&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,078,403&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Licenses &amp;amp; Patents&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;516,591&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;67,188&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;181,264&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Mobility and travel&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;141,481&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;205,741&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;245,875&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Publicity and advertising&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-403"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;23,383&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-404"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Systems expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;40,286&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;29,026&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;31,410&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Vehicles expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16,858&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;30,883&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,252&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Share-based incentives&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;217,494&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;510,162&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;136,754&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Surveillance expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-405"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-406"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,145&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Professional fees and outsourced services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;878,973&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,325,361&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;550,585&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Professional fees related parties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;90,533&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;256,877&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;542,551&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Office supplies&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;261,263&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;696,760&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;111,618&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Miscellaneous&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;976&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;269,750&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;128&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;15,138,510&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;17,422,487&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;15,943,987&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; padding-left: 0pt"&gt;R&amp;amp;D capitalized (Note 8.3)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;8,614,448&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;11,856,331&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;10,753,047&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;R&amp;amp;D profit and loss&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;15,138,510&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;17,422,487&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;15,943,987&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;23,752,958&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;29,278,818&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;26,697,034&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;8.4 &lt;span style="text-decoration:underline"&gt;Expenses classified by nature and function&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;b&gt;Item&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Production and services costs&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Selling, general and administrative expenses&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;06/30/2025&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; padding-left: 0pt"&gt;Amortization of intangible assets&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;351,240&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;5,769,969&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;6,121,209&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Analysis and storage&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-407"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,744&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,744&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Commissions and royalties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;835,082&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,989,880&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,824,962&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Import and export expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-408"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;826,942&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;826,942&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Depreciation of property, plant and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,861,812&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,386,157&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,247,969&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;Impairment of receivables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-409"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,123,716&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,123,716&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Freight and haulage&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,003,986&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,367,271&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,371,257&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Employee benefits and social securities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,899,884&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;44,971,665&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;54,871,549&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;Taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;260,091&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,411,799&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,671,890&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;Maintenance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,414,461&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,216,680&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,631,141&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Energy and fuel&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;658,621&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;106,846&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;765,467&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Supplies and materials&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;586,696&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,678,691&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,265,387&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Mobility and travel&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;339,447&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,472,895&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,812,342&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Allowance&#160;for obsolescence&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,547,723&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-410"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,547,723&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Publicity and advertising&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-411"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,556,518&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,556,518&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Systems expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;39,583&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,008,347&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,047,930&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Share-based incentives for employees&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;315,965&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,853,229&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,169,194&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Surveillance expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-412"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;583,115&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;583,115&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Professional fees and outsourced services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;201,601&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,939,339&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,140,940&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Professional fees related parties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-413"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16,353&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16,353&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Office supplies&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;93,967&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,373,911&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,467,878&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;Insurance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;181,595&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,850,968&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,032,563&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Depreciation of leased assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,477,334&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,504,864&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,982,198&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;Contingencies&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;84,567&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;252,352&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;336,919&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Environmental Impact Treatment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;998,303&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;67,510&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,065,813&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Licenses &amp;amp; Patents&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;75&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;193,773&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;193,848&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 0pt"&gt;Miscellaneous&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;25,887&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;370,706&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;396,593&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 0pt"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;25,177,920&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;125,908,240&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;151,086,160&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;b&gt;Item&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Production and services costs&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Selling, general and administrative expenses&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;06/30/2024&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; padding-left: 0pt"&gt;Amortization of intangible assets&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;239,545&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;5,950,289&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;6,189,834&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Analysis and storage&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;598&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;160,133&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;160,731&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Commissions and royalties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;217,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,745,169&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,962,169&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Import and export expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;147,392&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;734,026&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;881,418&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Depreciation of property, plant and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,018,014&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,163,357&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,181,371&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;Impairment of receivables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-414"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;753,428&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;753,428&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Freight and haulage&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;927,910&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,831,209&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,759,119&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Employee benefits and social securities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,162,207&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;38,799,972&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;49,962,179&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;Taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;285,791&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,442,557&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,728,348&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;Maintenance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,074,352&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,666,524&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,740,876&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Energy and fuel&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;997,066&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;514,422&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,511,488&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Supplies and materials&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,031,386&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,520,386&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,551,772&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Mobility and travel&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;202,810&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,317,138&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,519,948&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Allowance&#160;for obsolescence&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;581,804&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,711&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;586,515&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Publicity and advertising&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;233&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,065,506&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,065,739&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Systems expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;35,526&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,857,779&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,893,305&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Share-based incentives for employees&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,111,919&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,577,399&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;13,689,318&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Surveillance expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;368&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;468,090&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;468,458&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Professional fees and outsourced services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;189,090&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,131,891&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,320,981&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Professional fees related parties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-415"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;243,827&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;243,827&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Office supplies&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;242,790&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,743,957&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,986,747&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;Insurance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;199,109&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,133,572&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,332,681&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Depreciation of leased assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,312,849&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,106,107&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,418,956&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;Contingencies&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;66,682&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;586,892&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;653,574&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Environmental Impact Treatment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,770,857&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,208&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,785,065&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 0pt"&gt;Miscellaneous&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,854&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;808,273&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;812,127&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 0pt"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;25,819,152&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;126,340,822&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;152,159,974&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;b&gt;Item&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Production and services costs&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Selling, general and administrative expenses&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Total &lt;br/&gt;06/30/2023&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; padding-left: 0pt"&gt;Amortization of intangible assets&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;173,032&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;6,026,784&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;6,199,816&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Analysis and storage&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,496&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;700,671&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;705,167&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Commissions and royalties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;127,771&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,396,750&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,524,521&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Import and export expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;150,402&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;794,561&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;944,963&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Depreciation of property, plant and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,161,236&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,139,957&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,301,193&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;Impairment of receivables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-416"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,327,385&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,327,385&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Freight and haulage&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,427,296&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,646,138&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,073,434&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Employee benefits and social securities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,033,252&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;39,593,472&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;49,626,724&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;Taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;255,227&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,001,149&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,256,376&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;Maintenance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,157,887&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;956,916&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,114,803&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Energy and fuel&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;967,412&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;397,305&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,364,717&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Supplies and materials&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,075,909&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,048,056&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,123,965&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Mobility and travel&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;128,072&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,431,323&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,559,395&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Allowance&#160;for obsolescence&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,012,788&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;53,989&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,066,777&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Publicity and advertising&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,528&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,775,012&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,777,540&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Systems expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,556&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,158,735&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,170,291&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Share-based incentives for employees&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-417"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,393,348&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,393,348&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Surveillance expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;105,988&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;392,631&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;498,619&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Professional fees and outsourced services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100,308&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;13,807,495&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;13,907,803&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Professional fees related parties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-418"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;196,101&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;196,101&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Office supplies&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;229,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;976,350&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,205,850&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;Insurance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;230,388&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,137,598&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,367,986&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Licenses &amp;amp; Patents&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-419"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;37,015&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;37,015&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Depreciation of leased assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;468,524&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,029,049&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,497,573&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;Contingencies&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-420"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;239,292&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;239,292&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Environmental Impact Treatment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,369,838&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-421"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,369,838&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 0pt"&gt;Miscellaneous&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;41,452&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;874,192&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;915,644&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 0pt"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;23,234,862&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;116,531,274&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;139,766,136&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;8.5 &lt;span style="text-decoration:underline"&gt;Finance results&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;



&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="text-decoration:underline"&gt;Financial cost&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; padding-left: 0pt"&gt;Interest expenses&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(38,077,952&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(35,783,901&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(30,569,478&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Financial commissions&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(3,731,493&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,850,252&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(3,007,154&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(41,809,445&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(37,634,153&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(33,576,632&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-decoration: underline; text-align: left; padding-left: 0pt"&gt;Other financial results&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Exchange differences generated by assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,183,367&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(7,519,875&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(19,758,444&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Exchange differences generated by liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(14,647,580&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(20,499,620&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,886,408&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Changes in fair value of financial assets or liabilities and other financial results&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(15,603,088&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(10,455,775&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(341,341&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Prepayment premium fee&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(4,870,021&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-422"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-423"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Net gain of inflation effect on monetary items&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,949,231&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28,730,804&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,311,437&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Interest accrued with related parties&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;944,186&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;135,485&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-424"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(24,043,905&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(9,608,981&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(13,674,756&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-decoration: underline; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt"&gt;Total net financial cost&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(65,853,350&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(47,243,134&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(47,251,388&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;8.6 &lt;span style="text-decoration:underline"&gt;Other income or expenses, net&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;06/30/2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Loss from subsidiary&#x2019;s guarantee recognition (Note 7.12)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(61,681,998&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-425"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-426"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Gain on bargain purchase&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,473,482&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,032,327&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-427"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Remeasurement to fair value of pre-existing interest in an acquiree&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,666,680&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-428"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-429"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Net result from commercialization of agricultural products&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,890,110&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,560,703&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;174,122&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Result of intangible assets (i)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,649,848&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Others&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(473,758&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,825,111&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;881,177&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(56,589,216&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(703,265&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,055,299&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;(i) On March 28, 2025, BIOX, a former subsidiary,
agreed to transfer all rights, licenses, and materials containing or pertaining to the Soy ANF trait and pay $750,000&#160;to a Arcadia
Biosciences Inc in exchange for (i) RG and OX Wheat Patents and RS exclusive rights; (ii) the cancellation of all Royalty Payments, which
included&#160;25% of the Net Wheat Technology Licensing Revenues and&#160;6% of the Net HB4 Soybean Revenues up to $10&#160;million;
and (iii) the release from any Performance Benchmark Obligations related to the RG, OX, and RS Varieties which amounted to $8.1&#160;million.
This transaction resulted in the accounting of a gain from the exchange of intangible assets amounting to $7.5&#160;million.&#160;&lt;/p&gt;</mlec:DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock>
    <ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory contextRef="c0" id="ixv-29575">&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Sale of goods and services&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;317,924,355&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;444,149,141&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;385,976,753&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Royalties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,414,864&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;986,602&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,247,567&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Rendering of services with related parties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;841,205&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;952,742&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;739,651&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Right of use licenses&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;13,430,824&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;20,287,845&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;32,903,458&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;333,611,248&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;466,376,330&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;420,867,429&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory>
    <ifrs-full:RevenueFromSaleOfGoods contextRef="c0" decimals="0" id="ixv-44282" unitRef="usd">317924355</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods contextRef="c5" decimals="0" id="ixv-44283" unitRef="usd">444149141</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods contextRef="c6" decimals="0" id="ixv-44284" unitRef="usd">385976753</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromRoyalties contextRef="c0" decimals="0" id="ixv-44285" unitRef="usd">1414864</ifrs-full:RevenueFromRoyalties>
    <ifrs-full:RevenueFromRoyalties contextRef="c5" decimals="0" id="ixv-44286" unitRef="usd">986602</ifrs-full:RevenueFromRoyalties>
    <ifrs-full:RevenueFromRoyalties contextRef="c6" decimals="0" id="ixv-44287" unitRef="usd">1247567</ifrs-full:RevenueFromRoyalties>
    <ifrs-full:RevenueFromRenderingOfServices contextRef="c0" decimals="0" id="ixv-44288" unitRef="usd">841205</ifrs-full:RevenueFromRenderingOfServices>
    <ifrs-full:RevenueFromRenderingOfServices contextRef="c5" decimals="0" id="ixv-44289" unitRef="usd">952742</ifrs-full:RevenueFromRenderingOfServices>
    <ifrs-full:RevenueFromRenderingOfServices contextRef="c6" decimals="0" id="ixv-44290" unitRef="usd">739651</ifrs-full:RevenueFromRenderingOfServices>
    <ifrs-full:LicenceFeeIncome contextRef="c0" decimals="0" id="ixv-44291" unitRef="usd">13430824</ifrs-full:LicenceFeeIncome>
    <ifrs-full:LicenceFeeIncome contextRef="c5" decimals="0" id="ixv-44292" unitRef="usd">20287845</ifrs-full:LicenceFeeIncome>
    <ifrs-full:LicenceFeeIncome contextRef="c6" decimals="0" id="ixv-44293" unitRef="usd">32903458</ifrs-full:LicenceFeeIncome>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c0" decimals="0" id="ixv-44294" unitRef="usd">333611248</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c5" decimals="0" id="ixv-44295" unitRef="usd">466376330</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c6" decimals="0" id="ixv-44296" unitRef="usd">420867429</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:DisclosureOfCostOfSalesExplanatory contextRef="c0" id="ixv-29665">&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Item&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; padding-left: 0pt"&gt;Inventories as of the beginning of the year&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;110,913,884&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;112,000,786&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;78,775,003&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;Loss of control&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(82,999,205&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-396"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-397"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Additions related to Business combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,235,482&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,020,771&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,182,602&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Purchases of the year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;149,950,181&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;249,648,267&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;233,465,488&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Production costs (note 8.4)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25,177,920&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25,819,152&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;23,234,862&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Foreign currency translation&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;382,092&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,206,764&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;806,903&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;Subtotal&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;205,660,354&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;390,282,212&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;347,464,858&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;&lt;span style="font-size: 10pt"&gt;Inventories as of the end of
the year&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(2,235,482&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(110,913,884&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(112,000,786&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 0pt"&gt;Cost of sales&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;203,424,872&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;279,368,328&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;235,464,072&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfCostOfSalesExplanatory>
    <mlec:InventoriesNetOfAgriculturalProducts contextRef="c7" decimals="0" id="ixv-44297" unitRef="usd">110913884</mlec:InventoriesNetOfAgriculturalProducts>
    <mlec:InventoriesNetOfAgriculturalProducts contextRef="c47" decimals="0" id="ixv-44298" unitRef="usd">112000786</mlec:InventoriesNetOfAgriculturalProducts>
    <mlec:InventoriesNetOfAgriculturalProducts contextRef="c65" decimals="0" id="ixv-44299" unitRef="usd">78775003</mlec:InventoriesNetOfAgriculturalProducts>
    <mlec:LossOfControl contextRef="c0" decimals="0" id="ixv-44300" unitRef="usd">-82999205</mlec:LossOfControl>
    <mlec:InventoriesFromBusinessCombination contextRef="c0" decimals="0" id="ixv-44301" unitRef="usd">2235482</mlec:InventoriesFromBusinessCombination>
    <mlec:InventoriesFromBusinessCombination contextRef="c5" decimals="0" id="ixv-44302" unitRef="usd">4020771</mlec:InventoriesFromBusinessCombination>
    <mlec:InventoriesFromBusinessCombination contextRef="c6" decimals="0" id="ixv-44303" unitRef="usd">11182602</mlec:InventoriesFromBusinessCombination>
    <mlec:PurchaseOfInventory contextRef="c0" decimals="0" id="ixv-44304" unitRef="usd">149950181</mlec:PurchaseOfInventory>
    <mlec:PurchaseOfInventory contextRef="c5" decimals="0" id="ixv-44305" unitRef="usd">249648267</mlec:PurchaseOfInventory>
    <mlec:PurchaseOfInventory contextRef="c6" decimals="0" id="ixv-44306" unitRef="usd">233465488</mlec:PurchaseOfInventory>
    <mlec:InventoryProductionCosts contextRef="c0" decimals="0" id="ixv-44307" unitRef="usd">25177920</mlec:InventoryProductionCosts>
    <mlec:InventoryProductionCosts contextRef="c5" decimals="0" id="ixv-44308" unitRef="usd">25819152</mlec:InventoryProductionCosts>
    <mlec:InventoryProductionCosts contextRef="c6" decimals="0" id="ixv-44309" unitRef="usd">23234862</mlec:InventoryProductionCosts>
    <mlec:ForeignCurrencyTranslationOnInventory contextRef="c0" decimals="0" id="ixv-44310" unitRef="usd">382092</mlec:ForeignCurrencyTranslationOnInventory>
    <mlec:ForeignCurrencyTranslationOnInventory contextRef="c5" decimals="0" id="ixv-44311" unitRef="usd">-1206764</mlec:ForeignCurrencyTranslationOnInventory>
    <mlec:ForeignCurrencyTranslationOnInventory contextRef="c6" decimals="0" id="ixv-44312" unitRef="usd">806903</mlec:ForeignCurrencyTranslationOnInventory>
    <mlec:InventoriesBeforeClosingInventory contextRef="c0" decimals="0" id="ixv-44313" unitRef="usd">205660354</mlec:InventoriesBeforeClosingInventory>
    <mlec:InventoriesBeforeClosingInventory contextRef="c5" decimals="0" id="ixv-44314" unitRef="usd">390282212</mlec:InventoriesBeforeClosingInventory>
    <mlec:InventoriesBeforeClosingInventory contextRef="c6" decimals="0" id="ixv-44315" unitRef="usd">347464858</mlec:InventoriesBeforeClosingInventory>
    <ifrs-full:InventoriesTotal contextRef="c4" decimals="0" id="ixv-44316" unitRef="usd">2235482</ifrs-full:InventoriesTotal>
    <ifrs-full:InventoriesTotal contextRef="c7" decimals="0" id="ixv-44317" unitRef="usd">110913884</ifrs-full:InventoriesTotal>
    <ifrs-full:InventoriesTotal contextRef="c47" decimals="0" id="ixv-44318" unitRef="usd">112000786</ifrs-full:InventoriesTotal>
    <ifrs-full:CostOfSales contextRef="c0" decimals="0" id="ixv-44319" unitRef="usd">203424872</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales contextRef="c5" decimals="0" id="ixv-44320" unitRef="usd">279368328</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales contextRef="c6" decimals="0" id="ixv-44321" unitRef="usd">235464072</ifrs-full:CostOfSales>
    <ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory contextRef="c0" id="ixv-29861">&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Research and development expenses&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Item&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;06/30/2025&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;06/30/2024&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;06/30/2023&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Amortization of intangible assets&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;5,079,839&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;5,923,389&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4,804,768&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Analysis and storage&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-398"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,302&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;52,660&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Commissions and royalties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,179&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-399"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16,257&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Import and export expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-400"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-401"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;855&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Depreciation of leased assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;54,505&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-402"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;68,321&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Depreciation of property, plant and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;767,731&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;618,627&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;637,734&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Freight and haulage&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,025&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;30,450&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,707&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Employee benefits and social securities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,032,386&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,727,340&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,781,678&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Insurance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;49,343&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;48,872&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;78,673&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Energy and fuel&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,576&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,101&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;111,481&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Maintenance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;236,867&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;283,895&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;475,868&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Supplies and materials&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,731,604&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,361,380&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,078,403&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Licenses &amp;amp; Patents&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;516,591&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;67,188&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;181,264&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Mobility and travel&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;141,481&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;205,741&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;245,875&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Publicity and advertising&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-403"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;23,383&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-404"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Systems expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;40,286&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;29,026&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;31,410&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Vehicles expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16,858&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;30,883&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,252&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Share-based incentives&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;217,494&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;510,162&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;136,754&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Surveillance expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-405"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-406"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,145&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Professional fees and outsourced services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;878,973&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,325,361&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;550,585&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Professional fees related parties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;90,533&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;256,877&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;542,551&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Office supplies&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;261,263&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;696,760&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;111,618&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Miscellaneous&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;976&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;269,750&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;128&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;15,138,510&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;17,422,487&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;15,943,987&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; padding-left: 0pt"&gt;R&amp;amp;D capitalized (Note 8.3)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;8,614,448&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;11,856,331&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;10,753,047&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;R&amp;amp;D profit and loss&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;15,138,510&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;17,422,487&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;15,943,987&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;23,752,958&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;29,278,818&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;26,697,034&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill contextRef="c0" decimals="0" id="ixv-44322" unitRef="usd">5079839</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill contextRef="c5" decimals="0" id="ixv-44323" unitRef="usd">5923389</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill contextRef="c6" decimals="0" id="ixv-44324" unitRef="usd">4804768</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <mlec:AnalysisAndStorage contextRef="c5" decimals="0" id="ixv-44325" unitRef="usd">5302</mlec:AnalysisAndStorage>
    <mlec:AnalysisAndStorage contextRef="c6" decimals="0" id="ixv-44326" unitRef="usd">52660</mlec:AnalysisAndStorage>
    <ifrs-full:RoyaltyExpense contextRef="c0" decimals="0" id="ixv-44327" unitRef="usd">14179</ifrs-full:RoyaltyExpense>
    <ifrs-full:RoyaltyExpense contextRef="c6" decimals="0" id="ixv-44328" unitRef="usd">16257</ifrs-full:RoyaltyExpense>
    <mlec:ImportAndExportExpenses contextRef="c6" decimals="0" id="ixv-44329" unitRef="usd">855</mlec:ImportAndExportExpenses>
    <ifrs-full:DepreciationRightofuseAssets contextRef="c0" decimals="0" id="ixv-44330" unitRef="usd">54505</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets contextRef="c6" decimals="0" id="ixv-44331" unitRef="usd">68321</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="c0" decimals="0" id="ixv-44332" unitRef="usd">767731</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="c5" decimals="0" id="ixv-44333" unitRef="usd">618627</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="c6" decimals="0" id="ixv-44334" unitRef="usd">637734</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:TransportationExpense contextRef="c0" decimals="0" id="ixv-44335" unitRef="usd">2025</ifrs-full:TransportationExpense>
    <ifrs-full:TransportationExpense contextRef="c5" decimals="0" id="ixv-44336" unitRef="usd">30450</ifrs-full:TransportationExpense>
    <ifrs-full:TransportationExpense contextRef="c6" decimals="0" id="ixv-44337" unitRef="usd">17707</ifrs-full:TransportationExpense>
    <ifrs-full:ShorttermEmployeeBenefitsExpense contextRef="c0" decimals="0" id="ixv-44338" unitRef="usd">4032386</ifrs-full:ShorttermEmployeeBenefitsExpense>
    <ifrs-full:ShorttermEmployeeBenefitsExpense contextRef="c5" decimals="0" id="ixv-44339" unitRef="usd">4727340</ifrs-full:ShorttermEmployeeBenefitsExpense>
    <ifrs-full:ShorttermEmployeeBenefitsExpense contextRef="c6" decimals="0" id="ixv-44340" unitRef="usd">4781678</ifrs-full:ShorttermEmployeeBenefitsExpense>
    <ifrs-full:InsuranceExpense contextRef="c0" decimals="0" id="ixv-44341" unitRef="usd">49343</ifrs-full:InsuranceExpense>
    <ifrs-full:InsuranceExpense contextRef="c5" decimals="0" id="ixv-44342" unitRef="usd">48872</ifrs-full:InsuranceExpense>
    <ifrs-full:InsuranceExpense contextRef="c6" decimals="0" id="ixv-44343" unitRef="usd">78673</ifrs-full:InsuranceExpense>
    <ifrs-full:FuelAndEnergyExpense contextRef="c0" decimals="0" id="ixv-44344" unitRef="usd">5576</ifrs-full:FuelAndEnergyExpense>
    <ifrs-full:FuelAndEnergyExpense contextRef="c5" decimals="0" id="ixv-44345" unitRef="usd">8101</ifrs-full:FuelAndEnergyExpense>
    <ifrs-full:FuelAndEnergyExpense contextRef="c6" decimals="0" id="ixv-44346" unitRef="usd">111481</ifrs-full:FuelAndEnergyExpense>
    <ifrs-full:RepairsAndMaintenanceExpense contextRef="c0" decimals="0" id="ixv-44347" unitRef="usd">236867</ifrs-full:RepairsAndMaintenanceExpense>
    <ifrs-full:RepairsAndMaintenanceExpense contextRef="c5" decimals="0" id="ixv-44348" unitRef="usd">283895</ifrs-full:RepairsAndMaintenanceExpense>
    <ifrs-full:RepairsAndMaintenanceExpense contextRef="c6" decimals="0" id="ixv-44349" unitRef="usd">475868</ifrs-full:RepairsAndMaintenanceExpense>
    <mlec:SuppliesAndMaterials contextRef="c0" decimals="0" id="ixv-44350" unitRef="usd">2731604</mlec:SuppliesAndMaterials>
    <mlec:SuppliesAndMaterials contextRef="c5" decimals="0" id="ixv-44351" unitRef="usd">2361380</mlec:SuppliesAndMaterials>
    <mlec:SuppliesAndMaterials contextRef="c6" decimals="0" id="ixv-44352" unitRef="usd">3078403</mlec:SuppliesAndMaterials>
    <mlec:LicensesandPatents contextRef="c0" decimals="0" id="ixv-44353" unitRef="usd">516591</mlec:LicensesandPatents>
    <mlec:LicensesandPatents contextRef="c5" decimals="0" id="ixv-44354" unitRef="usd">67188</mlec:LicensesandPatents>
    <mlec:LicensesandPatents contextRef="c6" decimals="0" id="ixv-44355" unitRef="usd">181264</mlec:LicensesandPatents>
    <ifrs-full:TravelExpense contextRef="c0" decimals="0" id="ixv-44356" unitRef="usd">141481</ifrs-full:TravelExpense>
    <ifrs-full:TravelExpense contextRef="c5" decimals="0" id="ixv-44357" unitRef="usd">205741</ifrs-full:TravelExpense>
    <ifrs-full:TravelExpense contextRef="c6" decimals="0" id="ixv-44358" unitRef="usd">245875</ifrs-full:TravelExpense>
    <ifrs-full:AdvertisingExpense contextRef="c5" decimals="0" id="ixv-44359" unitRef="usd">23383</ifrs-full:AdvertisingExpense>
    <mlec:SystemExpenses contextRef="c0" decimals="0" id="ixv-44360" unitRef="usd">40286</mlec:SystemExpenses>
    <mlec:SystemExpenses contextRef="c5" decimals="0" id="ixv-44361" unitRef="usd">29026</mlec:SystemExpenses>
    <mlec:SystemExpenses contextRef="c6" decimals="0" id="ixv-44362" unitRef="usd">31410</mlec:SystemExpenses>
    <mlec:VehicleExpenses contextRef="c0" decimals="0" id="ixv-44363" unitRef="usd">16858</mlec:VehicleExpenses>
    <mlec:VehicleExpenses contextRef="c5" decimals="0" id="ixv-44364" unitRef="usd">30883</mlec:VehicleExpenses>
    <mlec:VehicleExpenses contextRef="c6" decimals="0" id="ixv-44365" unitRef="usd">8252</mlec:VehicleExpenses>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets contextRef="c0" decimals="0" id="ixv-44366" unitRef="usd">217494</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets contextRef="c5" decimals="0" id="ixv-44367" unitRef="usd">510162</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets contextRef="c6" decimals="0" id="ixv-44368" unitRef="usd">136754</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <mlec:SurveillanceExpense contextRef="c6" decimals="0" id="ixv-44369" unitRef="usd">11145</mlec:SurveillanceExpense>
    <ifrs-full:ProfessionalFeesExpense contextRef="c0" decimals="0" id="ixv-44370" unitRef="usd">878973</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense contextRef="c5" decimals="0" id="ixv-44371" unitRef="usd">1325361</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense contextRef="c6" decimals="0" id="ixv-44372" unitRef="usd">550585</ifrs-full:ProfessionalFeesExpense>
    <mlec:ProfessionalFeesExpenseRelatedParties contextRef="c0" decimals="0" id="ixv-44373" unitRef="usd">90533</mlec:ProfessionalFeesExpenseRelatedParties>
    <mlec:ProfessionalFeesExpenseRelatedParties contextRef="c5" decimals="0" id="ixv-44374" unitRef="usd">256877</mlec:ProfessionalFeesExpenseRelatedParties>
    <mlec:ProfessionalFeesExpenseRelatedParties contextRef="c6" decimals="0" id="ixv-44375" unitRef="usd">542551</mlec:ProfessionalFeesExpenseRelatedParties>
    <ifrs-full:AdministrativeExpense contextRef="c0" decimals="0" id="ixv-44376" unitRef="usd">261263</ifrs-full:AdministrativeExpense>
    <ifrs-full:AdministrativeExpense contextRef="c5" decimals="0" id="ixv-44377" unitRef="usd">696760</ifrs-full:AdministrativeExpense>
    <ifrs-full:AdministrativeExpense contextRef="c6" decimals="0" id="ixv-44378" unitRef="usd">111618</ifrs-full:AdministrativeExpense>
    <ifrs-full:MiscellaneousOtherOperatingExpense contextRef="c0" decimals="0" id="ixv-44379" unitRef="usd">976</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:MiscellaneousOtherOperatingExpense contextRef="c5" decimals="0" id="ixv-44380" unitRef="usd">269750</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:MiscellaneousOtherOperatingExpense contextRef="c6" decimals="0" id="ixv-44381" unitRef="usd">128</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="c0" decimals="0" id="ixv-44382" unitRef="usd">15138510</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="c5" decimals="0" id="ixv-44383" unitRef="usd">17422487</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="c6" decimals="0" id="ixv-44384" unitRef="usd">15943987</ifrs-full:ResearchAndDevelopmentExpense>
    <mlec:ResearchAndDevelopmentExpenseCapitalized contextRef="c0" decimals="0" id="ixv-44385" unitRef="usd">8614448</mlec:ResearchAndDevelopmentExpenseCapitalized>
    <mlec:ResearchAndDevelopmentExpenseCapitalized contextRef="c5" decimals="0" id="ixv-44386" unitRef="usd">11856331</mlec:ResearchAndDevelopmentExpenseCapitalized>
    <mlec:ResearchAndDevelopmentExpenseCapitalized contextRef="c6" decimals="0" id="ixv-44387" unitRef="usd">10753047</mlec:ResearchAndDevelopmentExpenseCapitalized>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="c0" decimals="0" id="ixv-44388" unitRef="usd">15138510</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="c5" decimals="0" id="ixv-44389" unitRef="usd">17422487</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="c6" decimals="0" id="ixv-44390" unitRef="usd">15943987</ifrs-full:ResearchAndDevelopmentExpense>
    <mlec:TotalResearchAndDevelopmentExpenseIncurred contextRef="c0" decimals="0" id="ixv-44391" unitRef="usd">23752958</mlec:TotalResearchAndDevelopmentExpenseIncurred>
    <mlec:TotalResearchAndDevelopmentExpenseIncurred contextRef="c5" decimals="0" id="ixv-44392" unitRef="usd">29278818</mlec:TotalResearchAndDevelopmentExpenseIncurred>
    <mlec:TotalResearchAndDevelopmentExpenseIncurred contextRef="c6" decimals="0" id="ixv-44393" unitRef="usd">26697034</mlec:TotalResearchAndDevelopmentExpenseIncurred>
    <ifrs-full:DisclosureOfExpensesByNatureExplanatory contextRef="c0" id="ixv-30345">&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;b&gt;Item&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Production and services costs&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Selling, general and administrative expenses&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;06/30/2025&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; padding-left: 0pt"&gt;Amortization of intangible assets&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;351,240&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;5,769,969&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;6,121,209&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Analysis and storage&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-407"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,744&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,744&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Commissions and royalties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;835,082&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,989,880&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,824,962&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Import and export expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-408"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;826,942&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;826,942&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Depreciation of property, plant and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,861,812&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,386,157&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,247,969&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;Impairment of receivables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-409"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,123,716&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,123,716&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Freight and haulage&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,003,986&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,367,271&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,371,257&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Employee benefits and social securities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,899,884&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;44,971,665&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;54,871,549&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;Taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;260,091&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,411,799&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,671,890&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;Maintenance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,414,461&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,216,680&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,631,141&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Energy and fuel&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;658,621&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;106,846&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;765,467&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Supplies and materials&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;586,696&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,678,691&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,265,387&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Mobility and travel&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;339,447&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,472,895&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,812,342&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Allowance&#160;for obsolescence&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,547,723&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-410"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,547,723&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Publicity and advertising&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-411"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,556,518&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,556,518&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Systems expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;39,583&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,008,347&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,047,930&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Share-based incentives for employees&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;315,965&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,853,229&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,169,194&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Surveillance expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-412"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;583,115&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;583,115&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Professional fees and outsourced services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;201,601&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,939,339&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,140,940&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Professional fees related parties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-413"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16,353&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16,353&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Office supplies&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;93,967&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,373,911&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,467,878&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;Insurance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;181,595&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,850,968&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,032,563&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Depreciation of leased assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,477,334&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,504,864&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,982,198&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;Contingencies&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;84,567&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;252,352&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;336,919&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Environmental Impact Treatment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;998,303&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;67,510&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,065,813&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Licenses &amp;amp; Patents&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;75&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;193,773&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;193,848&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 0pt"&gt;Miscellaneous&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;25,887&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;370,706&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;396,593&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 0pt"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;25,177,920&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;125,908,240&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;151,086,160&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;b&gt;Item&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Production and services costs&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Selling, general and administrative expenses&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;06/30/2024&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; padding-left: 0pt"&gt;Amortization of intangible assets&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;239,545&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;5,950,289&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;6,189,834&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Analysis and storage&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;598&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;160,133&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;160,731&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Commissions and royalties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;217,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,745,169&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,962,169&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Import and export expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;147,392&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;734,026&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;881,418&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Depreciation of property, plant and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,018,014&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,163,357&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,181,371&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;Impairment of receivables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-414"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;753,428&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;753,428&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Freight and haulage&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;927,910&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,831,209&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,759,119&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Employee benefits and social securities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,162,207&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;38,799,972&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;49,962,179&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;Taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;285,791&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,442,557&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,728,348&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;Maintenance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,074,352&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,666,524&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,740,876&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Energy and fuel&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;997,066&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;514,422&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,511,488&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Supplies and materials&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,031,386&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,520,386&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,551,772&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Mobility and travel&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;202,810&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,317,138&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,519,948&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Allowance&#160;for obsolescence&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;581,804&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,711&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;586,515&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Publicity and advertising&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;233&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,065,506&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,065,739&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Systems expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;35,526&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,857,779&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,893,305&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Share-based incentives for employees&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,111,919&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,577,399&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;13,689,318&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Surveillance expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;368&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;468,090&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;468,458&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Professional fees and outsourced services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;189,090&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,131,891&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,320,981&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Professional fees related parties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-415"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;243,827&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;243,827&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Office supplies&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;242,790&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,743,957&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,986,747&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;Insurance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;199,109&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,133,572&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,332,681&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Depreciation of leased assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,312,849&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,106,107&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,418,956&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;Contingencies&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;66,682&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;586,892&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;653,574&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Environmental Impact Treatment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,770,857&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,208&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,785,065&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 0pt"&gt;Miscellaneous&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,854&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;808,273&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;812,127&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 0pt"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;25,819,152&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;126,340,822&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;152,159,974&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;b&gt;Item&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Production and services costs&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Selling, general and administrative expenses&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;Total &lt;br/&gt;06/30/2023&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; padding-left: 0pt"&gt;Amortization of intangible assets&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;173,032&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;6,026,784&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;6,199,816&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Analysis and storage&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,496&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;700,671&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;705,167&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Commissions and royalties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;127,771&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,396,750&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,524,521&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Import and export expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;150,402&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;794,561&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;944,963&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Depreciation of property, plant and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,161,236&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,139,957&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,301,193&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;Impairment of receivables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-416"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,327,385&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,327,385&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Freight and haulage&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,427,296&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,646,138&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,073,434&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Employee benefits and social securities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,033,252&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;39,593,472&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;49,626,724&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;Taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;255,227&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,001,149&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,256,376&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;Maintenance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,157,887&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;956,916&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,114,803&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Energy and fuel&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;967,412&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;397,305&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,364,717&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Supplies and materials&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,075,909&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,048,056&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,123,965&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Mobility and travel&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;128,072&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,431,323&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,559,395&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Allowance&#160;for obsolescence&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,012,788&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;53,989&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,066,777&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Publicity and advertising&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,528&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,775,012&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,777,540&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Systems expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,556&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,158,735&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,170,291&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Share-based incentives for employees&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-417"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,393,348&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,393,348&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Surveillance expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;105,988&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;392,631&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;498,619&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Professional fees and outsourced services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100,308&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;13,807,495&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;13,907,803&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Professional fees related parties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-418"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;196,101&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;196,101&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Office supplies&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;229,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;976,350&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,205,850&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;Insurance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;230,388&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,137,598&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,367,986&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Licenses &amp;amp; Patents&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-419"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;37,015&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;37,015&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Depreciation of leased assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;468,524&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,029,049&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,497,573&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;Contingencies&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-420"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;239,292&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;239,292&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Environmental Impact Treatment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,369,838&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-421"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,369,838&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 0pt"&gt;Miscellaneous&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;41,452&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;874,192&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;915,644&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 0pt"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;23,234,862&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;116,531,274&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;139,766,136&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfExpensesByNatureExplanatory>
    <ifrs-full:AdjustmentsForAmortisationExpense contextRef="c441" decimals="0" id="ixv-44394" unitRef="usd">351240</ifrs-full:AdjustmentsForAmortisationExpense>
    <ifrs-full:AdjustmentsForAmortisationExpense contextRef="c442" decimals="0" id="ixv-44395" unitRef="usd">5769969</ifrs-full:AdjustmentsForAmortisationExpense>
    <ifrs-full:AdjustmentsForAmortisationExpense contextRef="c443" decimals="0" id="ixv-44396" unitRef="usd">6121209</ifrs-full:AdjustmentsForAmortisationExpense>
    <mlec:AnalysisAndStorage contextRef="c442" decimals="0" id="ixv-44397" unitRef="usd">14744</mlec:AnalysisAndStorage>
    <mlec:AnalysisAndStorage contextRef="c443" decimals="0" id="ixv-44398" unitRef="usd">14744</mlec:AnalysisAndStorage>
    <ifrs-full:RoyaltyExpense contextRef="c441" decimals="0" id="ixv-44399" unitRef="usd">835082</ifrs-full:RoyaltyExpense>
    <ifrs-full:RoyaltyExpense contextRef="c442" decimals="0" id="ixv-44400" unitRef="usd">1989880</ifrs-full:RoyaltyExpense>
    <ifrs-full:RoyaltyExpense contextRef="c443" decimals="0" id="ixv-44401" unitRef="usd">2824962</ifrs-full:RoyaltyExpense>
    <mlec:ImportAndExportExpenses contextRef="c442" decimals="0" id="ixv-44402" unitRef="usd">826942</mlec:ImportAndExportExpenses>
    <mlec:ImportAndExportExpenses contextRef="c443" decimals="0" id="ixv-44403" unitRef="usd">826942</mlec:ImportAndExportExpenses>
    <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="c441" decimals="0" id="ixv-44404" unitRef="usd">2861812</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="c442" decimals="0" id="ixv-44405" unitRef="usd">2386157</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="c443" decimals="0" id="ixv-44406" unitRef="usd">5247969</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossTradeReceivables contextRef="c442" decimals="0" id="ixv-44407" unitRef="usd">7123716</ifrs-full:ImpairmentLossRecognisedInProfitOrLossTradeReceivables>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossTradeReceivables contextRef="c443" decimals="0" id="ixv-44408" unitRef="usd">7123716</ifrs-full:ImpairmentLossRecognisedInProfitOrLossTradeReceivables>
    <ifrs-full:TransportationExpense contextRef="c441" decimals="0" id="ixv-44409" unitRef="usd">1003986</ifrs-full:TransportationExpense>
    <ifrs-full:TransportationExpense contextRef="c442" decimals="0" id="ixv-44410" unitRef="usd">11367271</ifrs-full:TransportationExpense>
    <ifrs-full:TransportationExpense contextRef="c443" decimals="0" id="ixv-44411" unitRef="usd">12371257</ifrs-full:TransportationExpense>
    <ifrs-full:ShorttermEmployeeBenefitsExpense contextRef="c441" decimals="0" id="ixv-44412" unitRef="usd">9899884</ifrs-full:ShorttermEmployeeBenefitsExpense>
    <ifrs-full:ShorttermEmployeeBenefitsExpense contextRef="c442" decimals="0" id="ixv-44413" unitRef="usd">44971665</ifrs-full:ShorttermEmployeeBenefitsExpense>
    <ifrs-full:ShorttermEmployeeBenefitsExpense contextRef="c443" decimals="0" id="ixv-44414" unitRef="usd">54871549</ifrs-full:ShorttermEmployeeBenefitsExpense>
    <ifrs-full:CurrentTaxExpenseIncome contextRef="c441" decimals="0" id="ixv-44415" unitRef="usd">260091</ifrs-full:CurrentTaxExpenseIncome>
    <ifrs-full:CurrentTaxExpenseIncome contextRef="c442" decimals="0" id="ixv-44416" unitRef="usd">12411799</ifrs-full:CurrentTaxExpenseIncome>
    <ifrs-full:CurrentTaxExpenseIncome contextRef="c443" decimals="0" id="ixv-44417" unitRef="usd">12671890</ifrs-full:CurrentTaxExpenseIncome>
    <ifrs-full:RepairsAndMaintenanceExpense contextRef="c441" decimals="0" id="ixv-44418" unitRef="usd">2414461</ifrs-full:RepairsAndMaintenanceExpense>
    <ifrs-full:RepairsAndMaintenanceExpense contextRef="c442" decimals="0" id="ixv-44419" unitRef="usd">2216680</ifrs-full:RepairsAndMaintenanceExpense>
    <ifrs-full:RepairsAndMaintenanceExpense contextRef="c443" decimals="0" id="ixv-44420" unitRef="usd">4631141</ifrs-full:RepairsAndMaintenanceExpense>
    <ifrs-full:FuelAndEnergyExpense contextRef="c441" decimals="0" id="ixv-44421" unitRef="usd">658621</ifrs-full:FuelAndEnergyExpense>
    <ifrs-full:FuelAndEnergyExpense contextRef="c442" decimals="0" id="ixv-44422" unitRef="usd">106846</ifrs-full:FuelAndEnergyExpense>
    <ifrs-full:FuelAndEnergyExpense contextRef="c443" decimals="0" id="ixv-44423" unitRef="usd">765467</ifrs-full:FuelAndEnergyExpense>
    <mlec:SuppliesAndMaterials contextRef="c441" decimals="0" id="ixv-44424" unitRef="usd">586696</mlec:SuppliesAndMaterials>
    <mlec:SuppliesAndMaterials contextRef="c442" decimals="0" id="ixv-44425" unitRef="usd">2678691</mlec:SuppliesAndMaterials>
    <mlec:SuppliesAndMaterials contextRef="c443" decimals="0" id="ixv-44426" unitRef="usd">3265387</mlec:SuppliesAndMaterials>
    <ifrs-full:TravelExpense contextRef="c441" decimals="0" id="ixv-44427" unitRef="usd">339447</ifrs-full:TravelExpense>
    <ifrs-full:TravelExpense contextRef="c442" decimals="0" id="ixv-44428" unitRef="usd">4472895</ifrs-full:TravelExpense>
    <ifrs-full:TravelExpense contextRef="c443" decimals="0" id="ixv-44429" unitRef="usd">4812342</ifrs-full:TravelExpense>
    <mlec:AllowanceForObsolescences contextRef="c441" decimals="0" id="ixv-44430" unitRef="usd">1547723</mlec:AllowanceForObsolescences>
    <mlec:AllowanceForObsolescences contextRef="c443" decimals="0" id="ixv-44431" unitRef="usd">1547723</mlec:AllowanceForObsolescences>
    <ifrs-full:AdvertisingExpense contextRef="c442" decimals="0" id="ixv-44432" unitRef="usd">4556518</ifrs-full:AdvertisingExpense>
    <ifrs-full:AdvertisingExpense contextRef="c443" decimals="0" id="ixv-44433" unitRef="usd">4556518</ifrs-full:AdvertisingExpense>
    <mlec:SystemExpenses contextRef="c441" decimals="0" id="ixv-44434" unitRef="usd">39583</mlec:SystemExpenses>
    <mlec:SystemExpenses contextRef="c442" decimals="0" id="ixv-44435" unitRef="usd">3008347</mlec:SystemExpenses>
    <mlec:SystemExpenses contextRef="c443" decimals="0" id="ixv-44436" unitRef="usd">3047930</mlec:SystemExpenses>
    <mlec:SharebasedIncentivesForEmployees contextRef="c441" decimals="0" id="ixv-44437" unitRef="usd">315965</mlec:SharebasedIncentivesForEmployees>
    <mlec:SharebasedIncentivesForEmployees contextRef="c442" decimals="0" id="ixv-44438" unitRef="usd">3853229</mlec:SharebasedIncentivesForEmployees>
    <mlec:SharebasedIncentivesForEmployees contextRef="c443" decimals="0" id="ixv-44439" unitRef="usd">4169194</mlec:SharebasedIncentivesForEmployees>
    <mlec:SurveillanceExpense contextRef="c442" decimals="0" id="ixv-44440" unitRef="usd">583115</mlec:SurveillanceExpense>
    <mlec:SurveillanceExpense contextRef="c443" decimals="0" id="ixv-44441" unitRef="usd">583115</mlec:SurveillanceExpense>
    <ifrs-full:ProfessionalFeesExpense contextRef="c441" decimals="0" id="ixv-44442" unitRef="usd">201601</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense contextRef="c442" decimals="0" id="ixv-44443" unitRef="usd">9939339</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense contextRef="c443" decimals="0" id="ixv-44444" unitRef="usd">10140940</ifrs-full:ProfessionalFeesExpense>
    <mlec:ProfessionalFeesRelatedParties contextRef="c442" decimals="0" id="ixv-44445" unitRef="usd">16353</mlec:ProfessionalFeesRelatedParties>
    <mlec:ProfessionalFeesRelatedParties contextRef="c443" decimals="0" id="ixv-44446" unitRef="usd">16353</mlec:ProfessionalFeesRelatedParties>
    <ifrs-full:AdministrativeExpense contextRef="c441" decimals="0" id="ixv-44447" unitRef="usd">93967</ifrs-full:AdministrativeExpense>
    <ifrs-full:AdministrativeExpense contextRef="c442" decimals="0" id="ixv-44448" unitRef="usd">1373911</ifrs-full:AdministrativeExpense>
    <ifrs-full:AdministrativeExpense contextRef="c443" decimals="0" id="ixv-44449" unitRef="usd">1467878</ifrs-full:AdministrativeExpense>
    <ifrs-full:InsuranceExpense contextRef="c441" decimals="0" id="ixv-44450" unitRef="usd">181595</ifrs-full:InsuranceExpense>
    <ifrs-full:InsuranceExpense contextRef="c442" decimals="0" id="ixv-44451" unitRef="usd">2850968</ifrs-full:InsuranceExpense>
    <ifrs-full:InsuranceExpense contextRef="c443" decimals="0" id="ixv-44452" unitRef="usd">3032563</ifrs-full:InsuranceExpense>
    <ifrs-full:DepreciationRightofuseAssets contextRef="c441" decimals="0" id="ixv-44453" unitRef="usd">2477334</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets contextRef="c442" decimals="0" id="ixv-44454" unitRef="usd">2504864</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets contextRef="c443" decimals="0" id="ixv-44455" unitRef="usd">4982198</ifrs-full:DepreciationRightofuseAssets>
    <mlec:Contingencies contextRef="c441" decimals="0" id="ixv-44456" unitRef="usd">84567</mlec:Contingencies>
    <mlec:Contingencies contextRef="c442" decimals="0" id="ixv-44457" unitRef="usd">252352</mlec:Contingencies>
    <mlec:Contingencies contextRef="c443" decimals="0" id="ixv-44458" unitRef="usd">336919</mlec:Contingencies>
    <mlec:EnvironmentalImpactTreatment contextRef="c441" decimals="0" id="ixv-44459" unitRef="usd">998303</mlec:EnvironmentalImpactTreatment>
    <mlec:EnvironmentalImpactTreatment contextRef="c442" decimals="0" id="ixv-44460" unitRef="usd">67510</mlec:EnvironmentalImpactTreatment>
    <mlec:EnvironmentalImpactTreatment contextRef="c443" decimals="0" id="ixv-44461" unitRef="usd">1065813</mlec:EnvironmentalImpactTreatment>
    <mlec:LicensesandPatents contextRef="c441" decimals="0" id="ixv-44462" unitRef="usd">75</mlec:LicensesandPatents>
    <mlec:LicensesandPatents contextRef="c442" decimals="0" id="ixv-44463" unitRef="usd">193773</mlec:LicensesandPatents>
    <mlec:LicensesandPatents contextRef="c443" decimals="0" id="ixv-44464" unitRef="usd">193848</mlec:LicensesandPatents>
    <ifrs-full:MiscellaneousOtherOperatingExpense contextRef="c441" decimals="0" id="ixv-44465" unitRef="usd">25887</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:MiscellaneousOtherOperatingExpense contextRef="c442" decimals="0" id="ixv-44466" unitRef="usd">370706</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:MiscellaneousOtherOperatingExpense contextRef="c443" decimals="0" id="ixv-44467" unitRef="usd">396593</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:OtherExpenseByFunction contextRef="c441" decimals="0" id="ixv-44468" unitRef="usd">25177920</ifrs-full:OtherExpenseByFunction>
    <ifrs-full:OtherExpenseByFunction contextRef="c442" decimals="0" id="ixv-44469" unitRef="usd">125908240</ifrs-full:OtherExpenseByFunction>
    <ifrs-full:OtherExpenseByFunction contextRef="c443" decimals="0" id="ixv-44470" unitRef="usd">151086160</ifrs-full:OtherExpenseByFunction>
    <ifrs-full:AdjustmentsForAmortisationExpense contextRef="c444" decimals="0" id="ixv-44471" unitRef="usd">239545</ifrs-full:AdjustmentsForAmortisationExpense>
    <ifrs-full:AdjustmentsForAmortisationExpense contextRef="c445" decimals="0" id="ixv-44472" unitRef="usd">5950289</ifrs-full:AdjustmentsForAmortisationExpense>
    <ifrs-full:AdjustmentsForAmortisationExpense contextRef="c446" decimals="0" id="ixv-44473" unitRef="usd">6189834</ifrs-full:AdjustmentsForAmortisationExpense>
    <mlec:AnalysisAndStorage contextRef="c444" decimals="0" id="ixv-44474" unitRef="usd">598</mlec:AnalysisAndStorage>
    <mlec:AnalysisAndStorage contextRef="c445" decimals="0" id="ixv-44475" unitRef="usd">160133</mlec:AnalysisAndStorage>
    <mlec:AnalysisAndStorage contextRef="c446" decimals="0" id="ixv-44476" unitRef="usd">160731</mlec:AnalysisAndStorage>
    <ifrs-full:RoyaltyExpense contextRef="c444" decimals="0" id="ixv-44477" unitRef="usd">217000</ifrs-full:RoyaltyExpense>
    <ifrs-full:RoyaltyExpense contextRef="c445" decimals="0" id="ixv-44478" unitRef="usd">1745169</ifrs-full:RoyaltyExpense>
    <ifrs-full:RoyaltyExpense contextRef="c446" decimals="0" id="ixv-44479" unitRef="usd">1962169</ifrs-full:RoyaltyExpense>
    <mlec:ImportAndExportExpenses contextRef="c444" decimals="0" id="ixv-44480" unitRef="usd">147392</mlec:ImportAndExportExpenses>
    <mlec:ImportAndExportExpenses contextRef="c445" decimals="0" id="ixv-44481" unitRef="usd">734026</mlec:ImportAndExportExpenses>
    <mlec:ImportAndExportExpenses contextRef="c446" decimals="0" id="ixv-44482" unitRef="usd">881418</mlec:ImportAndExportExpenses>
    <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="c444" decimals="0" id="ixv-44483" unitRef="usd">3018014</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="c445" decimals="0" id="ixv-44484" unitRef="usd">2163357</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="c446" decimals="0" id="ixv-44485" unitRef="usd">5181371</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossTradeReceivables contextRef="c445" decimals="0" id="ixv-44486" unitRef="usd">753428</ifrs-full:ImpairmentLossRecognisedInProfitOrLossTradeReceivables>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossTradeReceivables contextRef="c446" decimals="0" id="ixv-44487" unitRef="usd">753428</ifrs-full:ImpairmentLossRecognisedInProfitOrLossTradeReceivables>
    <ifrs-full:TransportationExpense contextRef="c444" decimals="0" id="ixv-44488" unitRef="usd">927910</ifrs-full:TransportationExpense>
    <ifrs-full:TransportationExpense contextRef="c445" decimals="0" id="ixv-44489" unitRef="usd">11831209</ifrs-full:TransportationExpense>
    <ifrs-full:TransportationExpense contextRef="c446" decimals="0" id="ixv-44490" unitRef="usd">12759119</ifrs-full:TransportationExpense>
    <ifrs-full:ShorttermEmployeeBenefitsExpense contextRef="c444" decimals="0" id="ixv-44491" unitRef="usd">11162207</ifrs-full:ShorttermEmployeeBenefitsExpense>
    <ifrs-full:ShorttermEmployeeBenefitsExpense contextRef="c445" decimals="0" id="ixv-44492" unitRef="usd">38799972</ifrs-full:ShorttermEmployeeBenefitsExpense>
    <ifrs-full:ShorttermEmployeeBenefitsExpense contextRef="c446" decimals="0" id="ixv-44493" unitRef="usd">49962179</ifrs-full:ShorttermEmployeeBenefitsExpense>
    <ifrs-full:CurrentTaxExpenseIncome contextRef="c444" decimals="0" id="ixv-44494" unitRef="usd">285791</ifrs-full:CurrentTaxExpenseIncome>
    <ifrs-full:CurrentTaxExpenseIncome contextRef="c445" decimals="0" id="ixv-44495" unitRef="usd">14442557</ifrs-full:CurrentTaxExpenseIncome>
    <ifrs-full:CurrentTaxExpenseIncome contextRef="c446" decimals="0" id="ixv-44496" unitRef="usd">14728348</ifrs-full:CurrentTaxExpenseIncome>
    <ifrs-full:RepairsAndMaintenanceExpense contextRef="c444" decimals="0" id="ixv-44497" unitRef="usd">2074352</ifrs-full:RepairsAndMaintenanceExpense>
    <ifrs-full:RepairsAndMaintenanceExpense contextRef="c445" decimals="0" id="ixv-44498" unitRef="usd">1666524</ifrs-full:RepairsAndMaintenanceExpense>
    <ifrs-full:RepairsAndMaintenanceExpense contextRef="c446" decimals="0" id="ixv-44499" unitRef="usd">3740876</ifrs-full:RepairsAndMaintenanceExpense>
    <ifrs-full:FuelAndEnergyExpense contextRef="c444" decimals="0" id="ixv-44500" unitRef="usd">997066</ifrs-full:FuelAndEnergyExpense>
    <ifrs-full:FuelAndEnergyExpense contextRef="c445" decimals="0" id="ixv-44501" unitRef="usd">514422</ifrs-full:FuelAndEnergyExpense>
    <ifrs-full:FuelAndEnergyExpense contextRef="c446" decimals="0" id="ixv-44502" unitRef="usd">1511488</ifrs-full:FuelAndEnergyExpense>
    <mlec:SuppliesAndMaterials contextRef="c444" decimals="0" id="ixv-44503" unitRef="usd">1031386</mlec:SuppliesAndMaterials>
    <mlec:SuppliesAndMaterials contextRef="c445" decimals="0" id="ixv-44504" unitRef="usd">3520386</mlec:SuppliesAndMaterials>
    <mlec:SuppliesAndMaterials contextRef="c446" decimals="0" id="ixv-44505" unitRef="usd">4551772</mlec:SuppliesAndMaterials>
    <ifrs-full:TravelExpense contextRef="c444" decimals="0" id="ixv-44506" unitRef="usd">202810</ifrs-full:TravelExpense>
    <ifrs-full:TravelExpense contextRef="c445" decimals="0" id="ixv-44507" unitRef="usd">5317138</ifrs-full:TravelExpense>
    <ifrs-full:TravelExpense contextRef="c446" decimals="0" id="ixv-44508" unitRef="usd">5519948</ifrs-full:TravelExpense>
    <mlec:AllowanceForObsolescences contextRef="c444" decimals="0" id="ixv-44509" unitRef="usd">581804</mlec:AllowanceForObsolescences>
    <mlec:AllowanceForObsolescences contextRef="c445" decimals="0" id="ixv-44510" unitRef="usd">4711</mlec:AllowanceForObsolescences>
    <mlec:AllowanceForObsolescences contextRef="c446" decimals="0" id="ixv-44511" unitRef="usd">586515</mlec:AllowanceForObsolescences>
    <ifrs-full:AdvertisingExpense contextRef="c444" decimals="0" id="ixv-44512" unitRef="usd">233</ifrs-full:AdvertisingExpense>
    <ifrs-full:AdvertisingExpense contextRef="c445" decimals="0" id="ixv-44513" unitRef="usd">5065506</ifrs-full:AdvertisingExpense>
    <ifrs-full:AdvertisingExpense contextRef="c446" decimals="0" id="ixv-44514" unitRef="usd">5065739</ifrs-full:AdvertisingExpense>
    <mlec:SystemExpenses contextRef="c444" decimals="0" id="ixv-44515" unitRef="usd">35526</mlec:SystemExpenses>
    <mlec:SystemExpenses contextRef="c445" decimals="0" id="ixv-44516" unitRef="usd">3857779</mlec:SystemExpenses>
    <mlec:SystemExpenses contextRef="c446" decimals="0" id="ixv-44517" unitRef="usd">3893305</mlec:SystemExpenses>
    <mlec:SharebasedIncentivesForEmployees contextRef="c444" decimals="0" id="ixv-44518" unitRef="usd">1111919</mlec:SharebasedIncentivesForEmployees>
    <mlec:SharebasedIncentivesForEmployees contextRef="c445" decimals="0" id="ixv-44519" unitRef="usd">12577399</mlec:SharebasedIncentivesForEmployees>
    <mlec:SharebasedIncentivesForEmployees contextRef="c446" decimals="0" id="ixv-44520" unitRef="usd">13689318</mlec:SharebasedIncentivesForEmployees>
    <mlec:SurveillanceExpense contextRef="c444" decimals="0" id="ixv-44521" unitRef="usd">368</mlec:SurveillanceExpense>
    <mlec:SurveillanceExpense contextRef="c445" decimals="0" id="ixv-44522" unitRef="usd">468090</mlec:SurveillanceExpense>
    <mlec:SurveillanceExpense contextRef="c446" decimals="0" id="ixv-44523" unitRef="usd">468458</mlec:SurveillanceExpense>
    <ifrs-full:ProfessionalFeesExpense contextRef="c444" decimals="0" id="ixv-44524" unitRef="usd">189090</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense contextRef="c445" decimals="0" id="ixv-44525" unitRef="usd">9131891</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense contextRef="c446" decimals="0" id="ixv-44526" unitRef="usd">9320981</ifrs-full:ProfessionalFeesExpense>
    <mlec:ProfessionalFeesRelatedParties contextRef="c445" decimals="0" id="ixv-44527" unitRef="usd">243827</mlec:ProfessionalFeesRelatedParties>
    <mlec:ProfessionalFeesRelatedParties contextRef="c446" decimals="0" id="ixv-44528" unitRef="usd">243827</mlec:ProfessionalFeesRelatedParties>
    <ifrs-full:AdministrativeExpense contextRef="c444" decimals="0" id="ixv-44529" unitRef="usd">242790</ifrs-full:AdministrativeExpense>
    <ifrs-full:AdministrativeExpense contextRef="c445" decimals="0" id="ixv-44530" unitRef="usd">1743957</ifrs-full:AdministrativeExpense>
    <ifrs-full:AdministrativeExpense contextRef="c446" decimals="0" id="ixv-44531" unitRef="usd">1986747</ifrs-full:AdministrativeExpense>
    <ifrs-full:InsuranceExpense contextRef="c444" decimals="0" id="ixv-44532" unitRef="usd">199109</ifrs-full:InsuranceExpense>
    <ifrs-full:InsuranceExpense contextRef="c445" decimals="0" id="ixv-44533" unitRef="usd">2133572</ifrs-full:InsuranceExpense>
    <ifrs-full:InsuranceExpense contextRef="c446" decimals="0" id="ixv-44534" unitRef="usd">2332681</ifrs-full:InsuranceExpense>
    <ifrs-full:DepreciationRightofuseAssets contextRef="c444" decimals="0" id="ixv-44535" unitRef="usd">1312849</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets contextRef="c445" decimals="0" id="ixv-44536" unitRef="usd">2106107</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets contextRef="c446" decimals="0" id="ixv-44537" unitRef="usd">3418956</ifrs-full:DepreciationRightofuseAssets>
    <mlec:Contingencies contextRef="c444" decimals="0" id="ixv-44538" unitRef="usd">66682</mlec:Contingencies>
    <mlec:Contingencies contextRef="c445" decimals="0" id="ixv-44539" unitRef="usd">586892</mlec:Contingencies>
    <mlec:Contingencies contextRef="c446" decimals="0" id="ixv-44540" unitRef="usd">653574</mlec:Contingencies>
    <mlec:EnvironmentalImpactTreatment contextRef="c444" decimals="0" id="ixv-44541" unitRef="usd">1770857</mlec:EnvironmentalImpactTreatment>
    <mlec:EnvironmentalImpactTreatment contextRef="c445" decimals="0" id="ixv-44542" unitRef="usd">14208</mlec:EnvironmentalImpactTreatment>
    <mlec:EnvironmentalImpactTreatment contextRef="c446" decimals="0" id="ixv-44543" unitRef="usd">1785065</mlec:EnvironmentalImpactTreatment>
    <ifrs-full:MiscellaneousOtherOperatingExpense contextRef="c444" decimals="0" id="ixv-44544" unitRef="usd">3854</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:MiscellaneousOtherOperatingExpense contextRef="c445" decimals="0" id="ixv-44545" unitRef="usd">808273</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:MiscellaneousOtherOperatingExpense contextRef="c446" decimals="0" id="ixv-44546" unitRef="usd">812127</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:OtherExpenseByFunction contextRef="c444" decimals="0" id="ixv-44547" unitRef="usd">25819152</ifrs-full:OtherExpenseByFunction>
    <ifrs-full:OtherExpenseByFunction contextRef="c445" decimals="0" id="ixv-44548" unitRef="usd">126340822</ifrs-full:OtherExpenseByFunction>
    <ifrs-full:OtherExpenseByFunction contextRef="c446" decimals="0" id="ixv-44549" unitRef="usd">152159974</ifrs-full:OtherExpenseByFunction>
    <ifrs-full:AdjustmentsForAmortisationExpense contextRef="c447" decimals="0" id="ixv-44550" unitRef="usd">173032</ifrs-full:AdjustmentsForAmortisationExpense>
    <ifrs-full:AdjustmentsForAmortisationExpense contextRef="c448" decimals="0" id="ixv-44551" unitRef="usd">6026784</ifrs-full:AdjustmentsForAmortisationExpense>
    <ifrs-full:AdjustmentsForAmortisationExpense contextRef="c449" decimals="0" id="ixv-44552" unitRef="usd">6199816</ifrs-full:AdjustmentsForAmortisationExpense>
    <mlec:AnalysisAndStorage contextRef="c447" decimals="0" id="ixv-44553" unitRef="usd">4496</mlec:AnalysisAndStorage>
    <mlec:AnalysisAndStorage contextRef="c448" decimals="0" id="ixv-44554" unitRef="usd">700671</mlec:AnalysisAndStorage>
    <mlec:AnalysisAndStorage contextRef="c449" decimals="0" id="ixv-44555" unitRef="usd">705167</mlec:AnalysisAndStorage>
    <ifrs-full:RoyaltyExpense contextRef="c447" decimals="0" id="ixv-44556" unitRef="usd">127771</ifrs-full:RoyaltyExpense>
    <ifrs-full:RoyaltyExpense contextRef="c448" decimals="0" id="ixv-44557" unitRef="usd">1396750</ifrs-full:RoyaltyExpense>
    <ifrs-full:RoyaltyExpense contextRef="c449" decimals="0" id="ixv-44558" unitRef="usd">1524521</ifrs-full:RoyaltyExpense>
    <mlec:ImportAndExportExpenses contextRef="c447" decimals="0" id="ixv-44559" unitRef="usd">150402</mlec:ImportAndExportExpenses>
    <mlec:ImportAndExportExpenses contextRef="c448" decimals="0" id="ixv-44560" unitRef="usd">794561</mlec:ImportAndExportExpenses>
    <mlec:ImportAndExportExpenses contextRef="c449" decimals="0" id="ixv-44561" unitRef="usd">944963</mlec:ImportAndExportExpenses>
    <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="c447" decimals="0" id="ixv-44562" unitRef="usd">2161236</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="c448" decimals="0" id="ixv-44563" unitRef="usd">2139957</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="c449" decimals="0" id="ixv-44564" unitRef="usd">4301193</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossTradeReceivables contextRef="c448" decimals="0" id="ixv-44565" unitRef="usd">1327385</ifrs-full:ImpairmentLossRecognisedInProfitOrLossTradeReceivables>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossTradeReceivables contextRef="c449" decimals="0" id="ixv-44566" unitRef="usd">1327385</ifrs-full:ImpairmentLossRecognisedInProfitOrLossTradeReceivables>
    <ifrs-full:TransportationExpense contextRef="c447" decimals="0" id="ixv-44567" unitRef="usd">2427296</ifrs-full:TransportationExpense>
    <ifrs-full:TransportationExpense contextRef="c448" decimals="0" id="ixv-44568" unitRef="usd">9646138</ifrs-full:TransportationExpense>
    <ifrs-full:TransportationExpense contextRef="c449" decimals="0" id="ixv-44569" unitRef="usd">12073434</ifrs-full:TransportationExpense>
    <ifrs-full:ShorttermEmployeeBenefitsExpense contextRef="c447" decimals="0" id="ixv-44570" unitRef="usd">10033252</ifrs-full:ShorttermEmployeeBenefitsExpense>
    <ifrs-full:ShorttermEmployeeBenefitsExpense contextRef="c448" decimals="0" id="ixv-44571" unitRef="usd">39593472</ifrs-full:ShorttermEmployeeBenefitsExpense>
    <ifrs-full:ShorttermEmployeeBenefitsExpense contextRef="c449" decimals="0" id="ixv-44572" unitRef="usd">49626724</ifrs-full:ShorttermEmployeeBenefitsExpense>
    <ifrs-full:CurrentTaxExpenseIncome contextRef="c447" decimals="0" id="ixv-44573" unitRef="usd">255227</ifrs-full:CurrentTaxExpenseIncome>
    <ifrs-full:CurrentTaxExpenseIncome contextRef="c448" decimals="0" id="ixv-44574" unitRef="usd">12001149</ifrs-full:CurrentTaxExpenseIncome>
    <ifrs-full:CurrentTaxExpenseIncome contextRef="c449" decimals="0" id="ixv-44575" unitRef="usd">12256376</ifrs-full:CurrentTaxExpenseIncome>
    <ifrs-full:RepairsAndMaintenanceExpense contextRef="c447" decimals="0" id="ixv-44576" unitRef="usd">1157887</ifrs-full:RepairsAndMaintenanceExpense>
    <ifrs-full:RepairsAndMaintenanceExpense contextRef="c448" decimals="0" id="ixv-44577" unitRef="usd">956916</ifrs-full:RepairsAndMaintenanceExpense>
    <ifrs-full:RepairsAndMaintenanceExpense contextRef="c449" decimals="0" id="ixv-44578" unitRef="usd">2114803</ifrs-full:RepairsAndMaintenanceExpense>
    <ifrs-full:FuelAndEnergyExpense contextRef="c447" decimals="0" id="ixv-44579" unitRef="usd">967412</ifrs-full:FuelAndEnergyExpense>
    <ifrs-full:FuelAndEnergyExpense contextRef="c448" decimals="0" id="ixv-44580" unitRef="usd">397305</ifrs-full:FuelAndEnergyExpense>
    <ifrs-full:FuelAndEnergyExpense contextRef="c449" decimals="0" id="ixv-44581" unitRef="usd">1364717</ifrs-full:FuelAndEnergyExpense>
    <mlec:SuppliesAndMaterials contextRef="c447" decimals="0" id="ixv-44582" unitRef="usd">1075909</mlec:SuppliesAndMaterials>
    <mlec:SuppliesAndMaterials contextRef="c448" decimals="0" id="ixv-44583" unitRef="usd">1048056</mlec:SuppliesAndMaterials>
    <mlec:SuppliesAndMaterials contextRef="c449" decimals="0" id="ixv-44584" unitRef="usd">2123965</mlec:SuppliesAndMaterials>
    <ifrs-full:TravelExpense contextRef="c447" decimals="0" id="ixv-44585" unitRef="usd">128072</ifrs-full:TravelExpense>
    <ifrs-full:TravelExpense contextRef="c448" decimals="0" id="ixv-44586" unitRef="usd">5431323</ifrs-full:TravelExpense>
    <ifrs-full:TravelExpense contextRef="c449" decimals="0" id="ixv-44587" unitRef="usd">5559395</ifrs-full:TravelExpense>
    <mlec:AllowanceForObsolescences contextRef="c447" decimals="0" id="ixv-44588" unitRef="usd">1012788</mlec:AllowanceForObsolescences>
    <mlec:AllowanceForObsolescences contextRef="c448" decimals="0" id="ixv-44589" unitRef="usd">53989</mlec:AllowanceForObsolescences>
    <mlec:AllowanceForObsolescences contextRef="c449" decimals="0" id="ixv-44590" unitRef="usd">1066777</mlec:AllowanceForObsolescences>
    <ifrs-full:AdvertisingExpense contextRef="c447" decimals="0" id="ixv-44591" unitRef="usd">2528</ifrs-full:AdvertisingExpense>
    <ifrs-full:AdvertisingExpense contextRef="c448" decimals="0" id="ixv-44592" unitRef="usd">5775012</ifrs-full:AdvertisingExpense>
    <ifrs-full:AdvertisingExpense contextRef="c449" decimals="0" id="ixv-44593" unitRef="usd">5777540</ifrs-full:AdvertisingExpense>
    <mlec:SystemExpenses contextRef="c447" decimals="0" id="ixv-44594" unitRef="usd">11556</mlec:SystemExpenses>
    <mlec:SystemExpenses contextRef="c448" decimals="0" id="ixv-44595" unitRef="usd">3158735</mlec:SystemExpenses>
    <mlec:SystemExpenses contextRef="c449" decimals="0" id="ixv-44596" unitRef="usd">3170291</mlec:SystemExpenses>
    <mlec:SharebasedIncentivesForEmployees contextRef="c448" decimals="0" id="ixv-44597" unitRef="usd">3393348</mlec:SharebasedIncentivesForEmployees>
    <mlec:SharebasedIncentivesForEmployees contextRef="c449" decimals="0" id="ixv-44598" unitRef="usd">3393348</mlec:SharebasedIncentivesForEmployees>
    <mlec:SurveillanceExpense contextRef="c447" decimals="0" id="ixv-44599" unitRef="usd">105988</mlec:SurveillanceExpense>
    <mlec:SurveillanceExpense contextRef="c448" decimals="0" id="ixv-44600" unitRef="usd">392631</mlec:SurveillanceExpense>
    <mlec:SurveillanceExpense contextRef="c449" decimals="0" id="ixv-44601" unitRef="usd">498619</mlec:SurveillanceExpense>
    <ifrs-full:ProfessionalFeesExpense contextRef="c447" decimals="0" id="ixv-44602" unitRef="usd">100308</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense contextRef="c448" decimals="0" id="ixv-44603" unitRef="usd">13807495</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense contextRef="c449" decimals="0" id="ixv-44604" unitRef="usd">13907803</ifrs-full:ProfessionalFeesExpense>
    <mlec:ProfessionalFeesRelatedParties contextRef="c448" decimals="0" id="ixv-44605" unitRef="usd">196101</mlec:ProfessionalFeesRelatedParties>
    <mlec:ProfessionalFeesRelatedParties contextRef="c449" decimals="0" id="ixv-44606" unitRef="usd">196101</mlec:ProfessionalFeesRelatedParties>
    <ifrs-full:AdministrativeExpense contextRef="c447" decimals="0" id="ixv-44607" unitRef="usd">229500</ifrs-full:AdministrativeExpense>
    <ifrs-full:AdministrativeExpense contextRef="c448" decimals="0" id="ixv-44608" unitRef="usd">976350</ifrs-full:AdministrativeExpense>
    <ifrs-full:AdministrativeExpense contextRef="c449" decimals="0" id="ixv-44609" unitRef="usd">1205850</ifrs-full:AdministrativeExpense>
    <ifrs-full:InsuranceExpense contextRef="c447" decimals="0" id="ixv-44610" unitRef="usd">230388</ifrs-full:InsuranceExpense>
    <ifrs-full:InsuranceExpense contextRef="c448" decimals="0" id="ixv-44611" unitRef="usd">3137598</ifrs-full:InsuranceExpense>
    <ifrs-full:InsuranceExpense contextRef="c449" decimals="0" id="ixv-44612" unitRef="usd">3367986</ifrs-full:InsuranceExpense>
    <mlec:LicensesandPatents contextRef="c448" decimals="0" id="ixv-44613" unitRef="usd">37015</mlec:LicensesandPatents>
    <mlec:LicensesandPatents contextRef="c449" decimals="0" id="ixv-44614" unitRef="usd">37015</mlec:LicensesandPatents>
    <ifrs-full:DepreciationRightofuseAssets contextRef="c447" decimals="0" id="ixv-44615" unitRef="usd">468524</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets contextRef="c448" decimals="0" id="ixv-44616" unitRef="usd">3029049</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets contextRef="c449" decimals="0" id="ixv-44617" unitRef="usd">3497573</ifrs-full:DepreciationRightofuseAssets>
    <mlec:Contingencies contextRef="c448" decimals="0" id="ixv-44618" unitRef="usd">239292</mlec:Contingencies>
    <mlec:Contingencies contextRef="c449" decimals="0" id="ixv-44619" unitRef="usd">239292</mlec:Contingencies>
    <mlec:EnvironmentalImpactTreatment contextRef="c447" decimals="0" id="ixv-44620" unitRef="usd">2369838</mlec:EnvironmentalImpactTreatment>
    <mlec:EnvironmentalImpactTreatment contextRef="c449" decimals="0" id="ixv-44621" unitRef="usd">2369838</mlec:EnvironmentalImpactTreatment>
    <ifrs-full:MiscellaneousOtherOperatingExpense contextRef="c447" decimals="0" id="ixv-44622" unitRef="usd">41452</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:MiscellaneousOtherOperatingExpense contextRef="c448" decimals="0" id="ixv-44623" unitRef="usd">874192</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:MiscellaneousOtherOperatingExpense contextRef="c449" decimals="0" id="ixv-44624" unitRef="usd">915644</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:OtherExpenseByFunction contextRef="c447" decimals="0" id="ixv-44625" unitRef="usd">23234862</ifrs-full:OtherExpenseByFunction>
    <ifrs-full:OtherExpenseByFunction contextRef="c448" decimals="0" id="ixv-44626" unitRef="usd">116531274</ifrs-full:OtherExpenseByFunction>
    <ifrs-full:OtherExpenseByFunction contextRef="c449" decimals="0" id="ixv-44627" unitRef="usd">139766136</ifrs-full:OtherExpenseByFunction>
    <ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory contextRef="c0" id="ixv-31738">&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="text-decoration:underline"&gt;Financial cost&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; padding-left: 0pt"&gt;Interest expenses&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(38,077,952&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(35,783,901&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(30,569,478&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Financial commissions&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(3,731,493&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,850,252&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(3,007,154&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(41,809,445&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(37,634,153&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(33,576,632&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-decoration: underline; text-align: left; padding-left: 0pt"&gt;Other financial results&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Exchange differences generated by assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,183,367&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(7,519,875&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(19,758,444&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Exchange differences generated by liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(14,647,580&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(20,499,620&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,886,408&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Changes in fair value of financial assets or liabilities and other financial results&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(15,603,088&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(10,455,775&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(341,341&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Prepayment premium fee&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(4,870,021&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-422"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-423"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Net gain of inflation effect on monetary items&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,949,231&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28,730,804&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,311,437&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Interest accrued with related parties&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;944,186&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;135,485&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-424"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(24,043,905&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(9,608,981&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(13,674,756&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-decoration: underline; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt"&gt;Total net financial cost&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(65,853,350&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(47,243,134&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(47,251,388&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory>
    <ifrs-full:InterestExpense contextRef="c434" decimals="0" id="ixv-44628" unitRef="usd">38077952</ifrs-full:InterestExpense>
    <ifrs-full:InterestExpense contextRef="c435" decimals="0" id="ixv-44629" unitRef="usd">35783901</ifrs-full:InterestExpense>
    <ifrs-full:InterestExpense contextRef="c450" decimals="0" id="ixv-44630" unitRef="usd">30569478</ifrs-full:InterestExpense>
    <mlec:FinancialCommissions contextRef="c434" decimals="0" id="ixv-44631" unitRef="usd">-3731493</mlec:FinancialCommissions>
    <mlec:FinancialCommissions contextRef="c435" decimals="0" id="ixv-44632" unitRef="usd">-1850252</mlec:FinancialCommissions>
    <mlec:FinancialCommissions contextRef="c450" decimals="0" id="ixv-44633" unitRef="usd">-3007154</mlec:FinancialCommissions>
    <ifrs-full:FinanceCosts contextRef="c434" decimals="0" id="ixv-44634" unitRef="usd">-41809445</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts contextRef="c435" decimals="0" id="ixv-44635" unitRef="usd">-37634153</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts contextRef="c450" decimals="0" id="ixv-44636" unitRef="usd">-33576632</ifrs-full:FinanceCosts>
    <ifrs-full:GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementAssets contextRef="c434" decimals="0" id="ixv-44637" unitRef="usd">2183367</ifrs-full:GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementAssets>
    <ifrs-full:GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementAssets contextRef="c435" decimals="0" id="ixv-44638" unitRef="usd">-7519875</ifrs-full:GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementAssets>
    <ifrs-full:GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementAssets contextRef="c450" decimals="0" id="ixv-44639" unitRef="usd">-19758444</ifrs-full:GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementAssets>
    <ifrs-full:GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementLiabilities contextRef="c434" decimals="0" id="ixv-44640" unitRef="usd">-14647580</ifrs-full:GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementLiabilities>
    <ifrs-full:GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementLiabilities contextRef="c435" decimals="0" id="ixv-44641" unitRef="usd">-20499620</ifrs-full:GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementLiabilities>
    <ifrs-full:GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementLiabilities contextRef="c450" decimals="0" id="ixv-44642" unitRef="usd">-3886408</ifrs-full:GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementLiabilities>
    <mlec:ChangeInFairValueOfFinancialAssetsOrLiabilitiesOrOtherFinancialResults contextRef="c434" decimals="0" id="ixv-44643" unitRef="usd">-15603088</mlec:ChangeInFairValueOfFinancialAssetsOrLiabilitiesOrOtherFinancialResults>
    <mlec:ChangeInFairValueOfFinancialAssetsOrLiabilitiesOrOtherFinancialResults contextRef="c435" decimals="0" id="ixv-44644" unitRef="usd">-10455775</mlec:ChangeInFairValueOfFinancialAssetsOrLiabilitiesOrOtherFinancialResults>
    <mlec:ChangeInFairValueOfFinancialAssetsOrLiabilitiesOrOtherFinancialResults contextRef="c450" decimals="0" id="ixv-44645" unitRef="usd">-341341</mlec:ChangeInFairValueOfFinancialAssetsOrLiabilitiesOrOtherFinancialResults>
    <mlec:PrepaymentPremiumFee contextRef="c434" decimals="0" id="ixv-44646" unitRef="usd">-4870021</mlec:PrepaymentPremiumFee>
    <mlec:NetGainOnInflationEffectOnMonetary contextRef="c434" decimals="0" id="ixv-44647" unitRef="usd">7949231</mlec:NetGainOnInflationEffectOnMonetary>
    <mlec:NetGainOnInflationEffectOnMonetary contextRef="c435" decimals="0" id="ixv-44648" unitRef="usd">28730804</mlec:NetGainOnInflationEffectOnMonetary>
    <mlec:NetGainOnInflationEffectOnMonetary contextRef="c450" decimals="0" id="ixv-44649" unitRef="usd">10311437</mlec:NetGainOnInflationEffectOnMonetary>
    <mlec:InterestAccruedWithRelatedParties contextRef="c434" decimals="0" id="ixv-44650" unitRef="usd">944186</mlec:InterestAccruedWithRelatedParties>
    <mlec:InterestAccruedWithRelatedParties contextRef="c435" decimals="0" id="ixv-44651" unitRef="usd">135485</mlec:InterestAccruedWithRelatedParties>
    <ifrs-full:OtherFinanceIncomeCost contextRef="c434" decimals="0" id="ixv-44652" unitRef="usd">-24043905</ifrs-full:OtherFinanceIncomeCost>
    <ifrs-full:OtherFinanceIncomeCost contextRef="c435" decimals="0" id="ixv-44653" unitRef="usd">-9608981</ifrs-full:OtherFinanceIncomeCost>
    <ifrs-full:OtherFinanceIncomeCost contextRef="c450" decimals="0" id="ixv-44654" unitRef="usd">-13674756</ifrs-full:OtherFinanceIncomeCost>
    <ifrs-full:FinanceIncomeCost contextRef="c434" decimals="0" id="ixv-44655" unitRef="usd">-65853350</ifrs-full:FinanceIncomeCost>
    <ifrs-full:FinanceIncomeCost contextRef="c435" decimals="0" id="ixv-44656" unitRef="usd">-47243134</ifrs-full:FinanceIncomeCost>
    <ifrs-full:FinanceIncomeCost contextRef="c450" decimals="0" id="ixv-44657" unitRef="usd">-47251388</ifrs-full:FinanceIncomeCost>
    <ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory contextRef="c0" id="ixv-31955">&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;06/30/2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Loss from subsidiary&#x2019;s guarantee recognition (Note 7.12)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(61,681,998&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-425"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-426"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Gain on bargain purchase&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,473,482&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,032,327&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-427"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Remeasurement to fair value of pre-existing interest in an acquiree&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,666,680&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-428"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-429"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Net result from commercialization of agricultural products&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,890,110&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,560,703&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;174,122&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Result of intangible assets (i)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,649,848&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Others&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(473,758&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,825,111&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;881,177&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(56,589,216&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(703,265&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,055,299&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;(i) On March 28, 2025, BIOX, a former subsidiary,
agreed to transfer all rights, licenses, and materials containing or pertaining to the Soy ANF trait and pay $750,000&#160;to a Arcadia
Biosciences Inc in exchange for (i) RG and OX Wheat Patents and RS exclusive rights; (ii) the cancellation of all Royalty Payments, which
included&#160;25% of the Net Wheat Technology Licensing Revenues and&#160;6% of the Net HB4 Soybean Revenues up to $10&#160;million;
and (iii) the release from any Performance Benchmark Obligations related to the RG, OX, and RS Varieties which amounted to $8.1&#160;million.
This transaction resulted in the accounting of a gain from the exchange of intangible assets amounting to $7.5&#160;million.&#160;&lt;/p&gt;</ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory>
    <ifrs-full:RevenueFromSaleOfAgriculturalProduce contextRef="c0" decimals="0" id="ixv-44658" unitRef="usd">-61681998</ifrs-full:RevenueFromSaleOfAgriculturalProduce>
    <mlec:GainOnBargainPurchase contextRef="c0" decimals="0" id="ixv-44659" unitRef="usd">1473482</mlec:GainOnBargainPurchase>
    <mlec:GainOnBargainPurchase contextRef="c5" decimals="0" id="ixv-44660" unitRef="usd">1032327</mlec:GainOnBargainPurchase>
    <mlec:RemeasurementToFairValueOfPreexistingInterestInAnAcquiree contextRef="c0" decimals="0" id="ixv-44661" unitRef="usd">-1666680</mlec:RemeasurementToFairValueOfPreexistingInterestInAnAcquiree>
    <mlec:NetResultFromCommercializationOfAgriculturalProducts contextRef="c0" decimals="0" id="ixv-44662" unitRef="usd">1890110</mlec:NetResultFromCommercializationOfAgriculturalProducts>
    <mlec:NetResultFromCommercializationOfAgriculturalProducts contextRef="c5" decimals="0" id="ixv-44663" unitRef="usd">3560703</mlec:NetResultFromCommercializationOfAgriculturalProducts>
    <mlec:NetResultFromCommercializationOfAgriculturalProducts contextRef="c6" decimals="0" id="ixv-44664" unitRef="usd">-174122</mlec:NetResultFromCommercializationOfAgriculturalProducts>
    <ifrs-full:AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets contextRef="c0" decimals="0" id="ix_43_fact" unitRef="usd">-7649848</ifrs-full:AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets>
    <mlec:OtherIncomeOrExpensesNet contextRef="c0" decimals="0" id="ixv-44666" unitRef="usd">-473758</mlec:OtherIncomeOrExpensesNet>
    <mlec:OtherIncomeOrExpensesNet contextRef="c5" decimals="0" id="ixv-44667" unitRef="usd">1825111</mlec:OtherIncomeOrExpensesNet>
    <mlec:OtherIncomeOrExpensesNet contextRef="c6" decimals="0" id="ixv-44668" unitRef="usd">881177</mlec:OtherIncomeOrExpensesNet>
    <ifrs-full:OtherOperatingIncomeExpense contextRef="c0" decimals="0" id="ixv-44669" unitRef="usd">-56589216</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:OtherOperatingIncomeExpense contextRef="c5" decimals="0" id="ixv-44670" unitRef="usd">-703265</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:OtherOperatingIncomeExpense contextRef="c6" decimals="0" id="ixv-44671" unitRef="usd">1055299</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:CashTransferred contextRef="c437" decimals="0" id="ixv-44673" unitRef="usd">750000</ifrs-full:CashTransferred>
    <ifrs-full:PercentageOfEntitysRevenue
      contextRef="c438"
      decimals="2"
      id="ixv-44674"
      unitRef="pure">0.25</ifrs-full:PercentageOfEntitysRevenue>
    <ifrs-full:PercentageOfEntitysRevenue
      contextRef="c439"
      decimals="2"
      id="ixv-44675"
      unitRef="pure">0.06</ifrs-full:PercentageOfEntitysRevenue>
    <ifrs-full:RevenueOfAcquiree
      contextRef="c440"
      decimals="-6"
      id="ixv-44676"
      unitRef="usd">10000000</ifrs-full:RevenueOfAcquiree>
    <ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations
      contextRef="c437"
      decimals="-5"
      id="ixv-44677"
      unitRef="usd">8100000</ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations>
    <ifrs-full:OtherTangibleOrIntangibleAssetsTransferred
      contextRef="c437"
      decimals="-5"
      id="ixv-44678"
      unitRef="usd">7500000</ifrs-full:OtherTangibleOrIntangibleAssetsTransferred>
    <ifrs-full:DisclosureOfIncomeTaxExplanatory contextRef="c0" id="ixv-32133">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;9.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;TAXATION&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The balances of deferred tax assets and liabilities
are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="text-decoration:underline"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 0pt"&gt;Tax Loss-Carry Forward&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-430"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;26,988,067&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Others financial assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-431"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;813,780&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;Others&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-432"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,516,719&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;Royalties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-433"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;764,888&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Trade receivables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-434"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;532,106&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;Allowances&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-435"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;942,587&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Government grants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-436"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;15,090&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt"&gt;Total deferred tax assets&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-437"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;32,573,237&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-decoration: underline; text-align: left; padding-left: 0pt"&gt;Deferred tax liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Intangible assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(15,767,275&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(28,444,095&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Property, plant and equipment depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-438"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(14,608,912&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;Inventories&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-439"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(8,041,220&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Others financial assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-440"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(464,404&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Right-of-use leased asset&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-441"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(190,088&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Inflation tax adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-442"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(302,456&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 0pt"&gt;Others&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-443"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(546,277&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt"&gt;Total deferred tax liabilities&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(15,767,275&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(52,597,452&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt"&gt;Net deferred tax&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(15,767,275&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(20,024,215&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The roll forward of deferred tax assets and liabilities
as of June 30, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Balance 06/30/2024&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Business combination / (loss) of control&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Income tax provision&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Conversion difference&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Balance 06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="text-decoration:underline"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left; padding-left: 0pt"&gt;Tax Loss-Carry Forward&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;26,988,067&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(21,525,926&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(5,579,828&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;117,687&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-444"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Others financial assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;813,780&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(475,554&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(342,341&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,115&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-445"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Trade receivables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;532,106&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,353,889&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;822,145&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(362&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-446"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;Royalties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;764,888&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(744,388&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(18,311&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,189&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-447"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;Allowances&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;942,587&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,053,605&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;98,032&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,986&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-448"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Government grants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15,090&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-449"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(15,596&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;506&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-450"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 0pt"&gt;Others&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,516,719&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;227,950&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(2,744,669&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-451"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-452"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt"&gt;Total deferred tax assets&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;32,573,237&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(24,925,412&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(7,780,568&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;132,743&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-453"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-decoration: underline; text-align: left; padding-left: 0pt"&gt;Deferred tax liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Intangible assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(28,444,095&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,428,299&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;214,190&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;34,331&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(15,767,275&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Property, plant and equipment depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(14,608,912&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15,315,097&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(703,102&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,083&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-454"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;Inventories&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(8,041,220&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,611,790&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,429,430&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-455"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-456"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Biological assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-457"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;640,035&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(640,035&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-458"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-459"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Others financial assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(464,404&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28,040&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;436,364&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-460"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-461"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Right-of-use leased asset&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(190,088&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;180,967&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,505&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,384&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-462"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Inflation tax adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(302,456&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;26,801&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;218,362&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;57,293&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-463"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 0pt"&gt;Others&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(546,277&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;541,800&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;178,733&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(174,256&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-464"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt"&gt;Total deferred tax liabilities&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(52,597,452&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;35,772,829&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,144,447&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(87,099&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(15,767,275&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt"&gt;Net deferred tax&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(20,024,215&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;10,847,417&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(6,636,121&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;45,644&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(15,767,275&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Deferred tax assets&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Balance 06/30/2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Business combination / (loss) of control&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Income tax provision&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Conversion difference&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Charge to OCI&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Balance 06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; width: 28%; text-align: left; padding-left: 0.125in"&gt;Tax Loss-Carry Forward&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;21,215,789&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(62,585&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;7,752,424&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(694,718&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(1,222,843&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;26,988,067&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Others financial assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,336,260&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,299&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(423,116&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(97,065&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-465"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;813,780&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Trade receivables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;447,449&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-466"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;214,734&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(130,077&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-467"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;532,106&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Royalties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;723,082&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-468"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;48,310&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(6,504&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-469"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;764,888&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Allowances&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,213,899&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-470"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(221,106&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(50,206&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-471"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;942,587&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Government grants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;93,996&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(39,261&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(42,199&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,554&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-472"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15,090&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-bottom: 1.5pt; padding-left: 0.125in"&gt;Others&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,402,846&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;765,384&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,651,511&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-473"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-474"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,516,719&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0.125in"&gt;Total deferred tax assets&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;28,433,321&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;661,239&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;5,677,536&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(976,016&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(1,222,843&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;32,573,237&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-decoration: underline; font-weight: bold; text-align: left; padding-left: 0.125in"&gt;Deferred tax liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Intangible assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(29,117,986&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(301,659&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;867,636&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;107,914&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-475"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(28,444,095&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Property, plant and equipment depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(13,678,341&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(174,228&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(773,812&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,469&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-476"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(14,608,912&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Inventories&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(6,461,576&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(939,250&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(640,394&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-477"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-478"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(8,041,220&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Others financial assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,154,504&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-479"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,690,100&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-480"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-481"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(464,404&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Right-of-use leased asset&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(120,442&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(115,495&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;30,998&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,851&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-482"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(190,088&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Inflation tax adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,131,895&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,732&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;827,211&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(8,504&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-483"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(302,456&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-bottom: 1.5pt; padding-left: 0.125in"&gt;Others&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(607,722&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-484"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;111,773&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(50,328&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-485"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(546,277&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0.125in"&gt;Total deferred tax liabilities&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(53,272,466&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(1,519,900&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,113,512&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;81,402&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-486"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(52,597,452&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0.125in"&gt;Net deferred tax&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(24,839,145&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(858,661&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;7,791,048&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(894,614&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(1,222,843&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(20,024,215&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The tax on the Group&#x2019;s profit before tax differs from the theoretical
amount that would arise using the weighted average tax rate applicable to profits of the consolidated entities as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;(Loss) / earnings before income tax-rate&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;(170,003,479&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;(27,958,152&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;50,794,242&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Income tax expense by applying tax rate in force in the respective countries&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;45,342,071&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7,224,973&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(7,628,367&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Share of profit or loss of subsidiaries, joint ventures and associates&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(8,232,869&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(5,141,460&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,645,224&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Puttable instruments charge&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-487"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-488"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,645&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Stock options charge&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(167,601&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,366,999&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(586,774&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Derecognition of deferred tax assets (i)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(40,565,962&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(94,189&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;428,530&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Mutual funds adjustments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,471&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;27,560&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-489"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Non-deductible expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(4,027,734&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,469,872&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(373,655&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Result of inflation effect on monetary items and other finance results&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;335,680&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(5,113,890&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(7,872,801&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Tax inflation adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,633,659&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,278,344&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,916,143&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Rate change adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-490"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;118,060&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(192,127&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 0pt"&gt;Others&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(971,836&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;434,321&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(4,162&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt"&gt;Income tax expenses&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(6,636,121&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(1,103,152&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;2,328,366&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;(i)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Mainly represent derecognition of deferred tax assets from
Bioceres S.A. because it initiated the voluntary bankruptcy proceeding (Note 21).&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;06/30/2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Current tax expense&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-491"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(8,894,200&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(1,311,506&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Deferred tax&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(6,636,121&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7,791,048&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,639,872&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(6,636,121&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(1,103,152&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,328,366&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The income tax expense was calculated by applying
the tax rate in force in the respective countries, as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;Tax jurisdiction&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Earnings before income tax-rate&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Weight average applicable &lt;br/&gt;
tax rate&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Income &lt;br/&gt;
tax as of &lt;br/&gt;
June 30, &lt;br/&gt;
2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Low or null taxation jurisdictions&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(7,247,084&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;0.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-492"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Loss-making entities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(162,756,395&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;27.9&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;45,342,071&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(170,003,479&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;45,342,071&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;Tax jurisdiction&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Earnings before income tax-rate&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Weight average applicable &lt;br/&gt;
tax rate&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Income &lt;br/&gt;
tax as of &lt;br/&gt;
June 30, &lt;br/&gt;
2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Low or null taxation jurisdictions&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;13,131,953&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;0.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-493"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Profit-making entities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;32,251,706&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;32.2&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(10,370,389&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Loss-making entities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(73,341,811&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;24.0&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;17,595,362&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(27,958,152&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;7,224,973&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;Tax jurisdiction&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Earnings before income tax-rate&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Weight average applicable &lt;br/&gt;
tax rate&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Income &lt;br/&gt;
tax as of &lt;br/&gt;
June 30, &lt;br/&gt;
2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Low or null taxation jurisdictions&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;30,921,548&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;0.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-494"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Profit-making entities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;73,999,737&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;21.5&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(15,899,829&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Loss-making entities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(54,127,043&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;15.3&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;8,271,462&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;50,794,242&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(7,628,367&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Estimates&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;There is an inherent material uncertainty related
to management&#x2019;s estimation of the ability of the Group to use the deferred tax assets (both carryforward of unused tax losses and
deductible temporary differences) and the credit of minimum presumed income tax because their future utilization depends on the generation
of enough future taxable income by the entities within the Group during the periods in which those temporary differences are deductible
or when the unused tax losses can be used.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Based on the projections of future taxable income
for the periods in which the deferred tax assets are deductible, the Group&#x2019;s management estimates that it is not probable that the
entities within the Group can utilize those deferred tax assets. Tax-loss Carry unrecognized as of June 30, 2025 amounting to $7.6 million.&lt;/p&gt;</ifrs-full:DisclosureOfIncomeTaxExplanatory>
    <ifrs-full:DisclosureOfDeferredTaxesExplanatory contextRef="c0" id="ixv-32144">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The balances of deferred tax assets and liabilities
are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="text-decoration:underline"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 0pt"&gt;Tax Loss-Carry Forward&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-430"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;26,988,067&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Others financial assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-431"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;813,780&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;Others&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-432"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,516,719&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;Royalties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-433"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;764,888&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Trade receivables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-434"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;532,106&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;Allowances&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-435"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;942,587&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Government grants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-436"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;15,090&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt"&gt;Total deferred tax assets&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-437"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;32,573,237&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-decoration: underline; text-align: left; padding-left: 0pt"&gt;Deferred tax liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Intangible assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(15,767,275&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(28,444,095&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Property, plant and equipment depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-438"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(14,608,912&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;Inventories&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-439"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(8,041,220&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Others financial assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-440"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(464,404&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Right-of-use leased asset&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-441"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(190,088&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Inflation tax adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-442"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(302,456&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 0pt"&gt;Others&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-443"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(546,277&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt"&gt;Total deferred tax liabilities&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(15,767,275&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(52,597,452&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt"&gt;Net deferred tax&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(15,767,275&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(20,024,215&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfDeferredTaxesExplanatory>
    <ifrs-full:NetDeferredTaxAssets contextRef="c452" decimals="0" id="ixv-44679" unitRef="usd">26988067</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxAssets contextRef="c454" decimals="0" id="ixv-44680" unitRef="usd">813780</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxAssets contextRef="c456" decimals="0" id="ixv-44681" unitRef="usd">2516719</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxAssets contextRef="c458" decimals="0" id="ixv-44682" unitRef="usd">764888</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxAssets contextRef="c460" decimals="0" id="ixv-44683" unitRef="usd">532106</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxAssets contextRef="c462" decimals="0" id="ixv-44684" unitRef="usd">942587</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxAssets contextRef="c464" decimals="0" id="ixv-44685" unitRef="usd">15090</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxAssets contextRef="c466" decimals="0" id="ixv-44686" unitRef="usd">32573237</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxLiabilities contextRef="c467" decimals="0" id="ixv-44687" unitRef="usd">-15767275</ifrs-full:NetDeferredTaxLiabilities>
    <ifrs-full:NetDeferredTaxLiabilities contextRef="c468" decimals="0" id="ixv-44688" unitRef="usd">-28444095</ifrs-full:NetDeferredTaxLiabilities>
    <ifrs-full:NetDeferredTaxLiabilities contextRef="c470" decimals="0" id="ixv-44689" unitRef="usd">-14608912</ifrs-full:NetDeferredTaxLiabilities>
    <ifrs-full:NetDeferredTaxLiabilities contextRef="c472" decimals="0" id="ixv-44690" unitRef="usd">-8041220</ifrs-full:NetDeferredTaxLiabilities>
    <ifrs-full:NetDeferredTaxLiabilities contextRef="c454" decimals="0" id="ixv-44691" unitRef="usd">-464404</ifrs-full:NetDeferredTaxLiabilities>
    <ifrs-full:NetDeferredTaxLiabilities contextRef="c474" decimals="0" id="ixv-44692" unitRef="usd">-190088</ifrs-full:NetDeferredTaxLiabilities>
    <ifrs-full:NetDeferredTaxLiabilities contextRef="c476" decimals="0" id="ixv-44693" unitRef="usd">-302456</ifrs-full:NetDeferredTaxLiabilities>
    <ifrs-full:NetDeferredTaxLiabilities contextRef="c456" decimals="0" id="ixv-44694" unitRef="usd">-546277</ifrs-full:NetDeferredTaxLiabilities>
    <ifrs-full:NetDeferredTaxLiabilities contextRef="c477" decimals="0" id="ixv-44695" unitRef="usd">-15767275</ifrs-full:NetDeferredTaxLiabilities>
    <ifrs-full:NetDeferredTaxLiabilities contextRef="c478" decimals="0" id="ixv-44696" unitRef="usd">-52597452</ifrs-full:NetDeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilityAsset contextRef="c4" decimals="0" id="ixv-44697" unitRef="usd">-15767275</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset contextRef="c7" decimals="0" id="ixv-44698" unitRef="usd">-20024215</ifrs-full:DeferredTaxLiabilityAsset>
    <mlec:ScheduleOfRollforwardOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="c0" id="ixv-32380">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The roll forward of deferred tax assets and liabilities
as of June 30, 2025 and 2024 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Balance 06/30/2024&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Business combination / (loss) of control&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Income tax provision&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Conversion difference&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Balance 06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="text-decoration:underline"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left; padding-left: 0pt"&gt;Tax Loss-Carry Forward&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;26,988,067&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(21,525,926&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(5,579,828&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;117,687&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-444"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Others financial assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;813,780&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(475,554&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(342,341&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,115&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-445"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Trade receivables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;532,106&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,353,889&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;822,145&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(362&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-446"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;Royalties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;764,888&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(744,388&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(18,311&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,189&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-447"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;Allowances&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;942,587&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,053,605&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;98,032&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,986&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-448"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Government grants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15,090&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-449"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(15,596&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;506&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-450"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 0pt"&gt;Others&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,516,719&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;227,950&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(2,744,669&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-451"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-452"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt"&gt;Total deferred tax assets&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;32,573,237&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(24,925,412&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(7,780,568&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;132,743&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-453"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-decoration: underline; text-align: left; padding-left: 0pt"&gt;Deferred tax liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Intangible assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(28,444,095&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,428,299&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;214,190&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;34,331&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(15,767,275&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Property, plant and equipment depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(14,608,912&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15,315,097&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(703,102&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,083&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-454"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;Inventories&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(8,041,220&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,611,790&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,429,430&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-455"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-456"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Biological assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-457"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;640,035&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(640,035&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-458"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-459"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Others financial assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(464,404&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28,040&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;436,364&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-460"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-461"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Right-of-use leased asset&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(190,088&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;180,967&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,505&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,384&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-462"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Inflation tax adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(302,456&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;26,801&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;218,362&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;57,293&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-463"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 0pt"&gt;Others&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(546,277&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;541,800&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;178,733&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(174,256&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-464"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt"&gt;Total deferred tax liabilities&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(52,597,452&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;35,772,829&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;1,144,447&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(87,099&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(15,767,275&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt"&gt;Net deferred tax&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(20,024,215&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;10,847,417&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(6,636,121&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;45,644&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(15,767,275&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Deferred tax assets&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Balance 06/30/2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Business combination / (loss) of control&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Income tax provision&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Conversion difference&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Charge to OCI&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Balance 06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; width: 28%; text-align: left; padding-left: 0.125in"&gt;Tax Loss-Carry Forward&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;21,215,789&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(62,585&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;7,752,424&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(694,718&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(1,222,843&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;26,988,067&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Others financial assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,336,260&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,299&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(423,116&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(97,065&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-465"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;813,780&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Trade receivables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;447,449&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-466"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;214,734&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(130,077&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-467"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;532,106&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Royalties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;723,082&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-468"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;48,310&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(6,504&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-469"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;764,888&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Allowances&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,213,899&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-470"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(221,106&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(50,206&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-471"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;942,587&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Government grants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;93,996&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(39,261&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(42,199&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,554&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-472"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15,090&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-bottom: 1.5pt; padding-left: 0.125in"&gt;Others&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,402,846&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;765,384&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,651,511&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-473"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-474"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,516,719&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0.125in"&gt;Total deferred tax assets&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;28,433,321&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;661,239&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;5,677,536&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(976,016&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(1,222,843&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;32,573,237&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-decoration: underline; font-weight: bold; text-align: left; padding-left: 0.125in"&gt;Deferred tax liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Intangible assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(29,117,986&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(301,659&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;867,636&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;107,914&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-475"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(28,444,095&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Property, plant and equipment depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(13,678,341&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(174,228&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(773,812&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,469&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-476"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(14,608,912&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Inventories&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(6,461,576&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(939,250&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(640,394&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-477"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-478"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(8,041,220&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Others financial assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,154,504&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-479"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,690,100&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-480"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-481"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(464,404&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Right-of-use leased asset&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(120,442&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(115,495&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;30,998&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,851&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-482"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(190,088&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Inflation tax adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,131,895&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,732&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;827,211&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(8,504&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-483"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(302,456&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-bottom: 1.5pt; padding-left: 0.125in"&gt;Others&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(607,722&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-484"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;111,773&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(50,328&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-485"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(546,277&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0.125in"&gt;Total deferred tax liabilities&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(53,272,466&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(1,519,900&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,113,512&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;81,402&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-486"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(52,597,452&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0.125in"&gt;Net deferred tax&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(24,839,145&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(858,661&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;7,791,048&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(894,614&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(1,222,843&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(20,024,215&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</mlec:ScheduleOfRollforwardOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <ifrs-full:NetDeferredTaxAssets contextRef="c452" decimals="0" id="ixv-44699" unitRef="usd">26988067</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset contextRef="c479" decimals="0" id="ixv-44700" unitRef="usd">-21525926</ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c479" decimals="0" id="ixv-44701" unitRef="usd">-5579828</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset contextRef="c479" decimals="0" id="ixv-44702" unitRef="usd">117687</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset>
    <ifrs-full:NetDeferredTaxAssets contextRef="c480" decimals="0" id="ixv-44703" unitRef="usd">813780</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset contextRef="c481" decimals="0" id="ixv-44704" unitRef="usd">-475554</ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c481" decimals="0" id="ixv-44705" unitRef="usd">-342341</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset contextRef="c481" decimals="0" id="ixv-44706" unitRef="usd">4115</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset>
    <ifrs-full:NetDeferredTaxAssets contextRef="c460" decimals="0" id="ixv-44707" unitRef="usd">532106</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset contextRef="c483" decimals="0" id="ixv-44708" unitRef="usd">-1353889</ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c483" decimals="0" id="ixv-44709" unitRef="usd">822145</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset contextRef="c483" decimals="0" id="ixv-44710" unitRef="usd">-362</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset>
    <ifrs-full:NetDeferredTaxAssets contextRef="c458" decimals="0" id="ixv-44711" unitRef="usd">764888</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset contextRef="c484" decimals="0" id="ixv-44712" unitRef="usd">-744388</ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c484" decimals="0" id="ixv-44713" unitRef="usd">-18311</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset contextRef="c484" decimals="0" id="ixv-44714" unitRef="usd">-2189</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset>
    <ifrs-full:NetDeferredTaxAssets contextRef="c462" decimals="0" id="ixv-44715" unitRef="usd">942587</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset contextRef="c485" decimals="0" id="ixv-44716" unitRef="usd">-1053605</ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c485" decimals="0" id="ixv-44717" unitRef="usd">98032</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset contextRef="c485" decimals="0" id="ixv-44718" unitRef="usd">12986</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset>
    <ifrs-full:NetDeferredTaxAssets contextRef="c464" decimals="0" id="ixv-44719" unitRef="usd">15090</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c486" decimals="0" id="ixv-44720" unitRef="usd">-15596</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset contextRef="c486" decimals="0" id="ixv-44721" unitRef="usd">506</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset>
    <ifrs-full:NetDeferredTaxAssets contextRef="c456" decimals="0" id="ixv-44722" unitRef="usd">2516719</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset contextRef="c487" decimals="0" id="ixv-44723" unitRef="usd">227950</ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c487" decimals="0" id="ixv-44724" unitRef="usd">-2744669</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:NetDeferredTaxAssets contextRef="c466" decimals="0" id="ixv-44725" unitRef="usd">32573237</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset contextRef="c488" decimals="0" id="ixv-44726" unitRef="usd">-24925412</ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c488" decimals="0" id="ixv-44727" unitRef="usd">-7780568</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset contextRef="c488" decimals="0" id="ixv-44728" unitRef="usd">132743</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset>
    <ifrs-full:NetDeferredTaxAssets contextRef="c468" decimals="0" id="ixv-44729" unitRef="usd">-28444095</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset contextRef="c489" decimals="0" id="ixv-44730" unitRef="usd">12428299</ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c489" decimals="0" id="ixv-44731" unitRef="usd">214190</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset contextRef="c489" decimals="0" id="ixv-44732" unitRef="usd">34331</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset>
    <ifrs-full:NetDeferredTaxAssets contextRef="c467" decimals="0" id="ixv-44733" unitRef="usd">-15767275</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxAssets contextRef="c470" decimals="0" id="ixv-44734" unitRef="usd">-14608912</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset contextRef="c490" decimals="0" id="ixv-44735" unitRef="usd">15315097</ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c490" decimals="0" id="ixv-44736" unitRef="usd">-703102</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset contextRef="c490" decimals="0" id="ixv-44737" unitRef="usd">-3083</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset>
    <ifrs-full:NetDeferredTaxAssets contextRef="c472" decimals="0" id="ixv-44738" unitRef="usd">-8041220</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset contextRef="c491" decimals="0" id="ixv-44739" unitRef="usd">6611790</ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c491" decimals="0" id="ixv-44740" unitRef="usd">1429430</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset contextRef="c493" decimals="0" id="ixv-44741" unitRef="usd">640035</ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c493" decimals="0" id="ixv-44742" unitRef="usd">-640035</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:NetDeferredTaxAssets contextRef="c495" decimals="0" id="ixv-44743" unitRef="usd">-464404</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset contextRef="c496" decimals="0" id="ixv-44744" unitRef="usd">28040</ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c496" decimals="0" id="ixv-44745" unitRef="usd">436364</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:NetDeferredTaxAssets contextRef="c474" decimals="0" id="ixv-44746" unitRef="usd">-190088</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset contextRef="c498" decimals="0" id="ixv-44747" unitRef="usd">180967</ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c498" decimals="0" id="ixv-44748" unitRef="usd">10505</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset contextRef="c498" decimals="0" id="ixv-44749" unitRef="usd">-1384</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset>
    <ifrs-full:NetDeferredTaxAssets contextRef="c476" decimals="0" id="ixv-44750" unitRef="usd">-302456</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset contextRef="c499" decimals="0" id="ixv-44751" unitRef="usd">26801</ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c499" decimals="0" id="ixv-44752" unitRef="usd">218362</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset contextRef="c499" decimals="0" id="ixv-44753" unitRef="usd">57293</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset>
    <ifrs-full:NetDeferredTaxAssets contextRef="c500" decimals="0" id="ixv-44754" unitRef="usd">-546277</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset contextRef="c501" decimals="0" id="ixv-44755" unitRef="usd">541800</ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c501" decimals="0" id="ixv-44756" unitRef="usd">178733</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset contextRef="c501" decimals="0" id="ixv-44757" unitRef="usd">-174256</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset>
    <ifrs-full:NetDeferredTaxAssets contextRef="c478" decimals="0" id="ixv-44758" unitRef="usd">-52597452</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset contextRef="c503" decimals="0" id="ixv-44759" unitRef="usd">35772829</ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c503" decimals="0" id="ixv-44760" unitRef="usd">1144447</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset contextRef="c503" decimals="0" id="ixv-44761" unitRef="usd">-87099</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset>
    <ifrs-full:NetDeferredTaxAssets contextRef="c477" decimals="0" id="ixv-44762" unitRef="usd">-15767275</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxAssets contextRef="c7" decimals="0" id="ixv-44763" unitRef="usd">-20024215</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset contextRef="c0" decimals="0" id="ixv-44764" unitRef="usd">10847417</ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c0" decimals="0" id="ixv-44765" unitRef="usd">-6636121</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset contextRef="c0" decimals="0" id="ixv-44766" unitRef="usd">45644</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset>
    <ifrs-full:NetDeferredTaxAssets contextRef="c4" decimals="0" id="ixv-44767" unitRef="usd">-15767275</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxAssets contextRef="c504" decimals="0" id="ixv-44768" unitRef="usd">21215789</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset contextRef="c505" decimals="0" id="ixv-44769" unitRef="usd">-62585</ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c505" decimals="0" id="ixv-44770" unitRef="usd">7752424</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset contextRef="c505" decimals="0" id="ixv-44771" unitRef="usd">-694718</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset>
    <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome contextRef="c505" decimals="0" id="ixv-44772" unitRef="usd">-1222843</ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome>
    <ifrs-full:NetDeferredTaxAssets contextRef="c452" decimals="0" id="ixv-44773" unitRef="usd">26988067</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxAssets contextRef="c506" decimals="0" id="ixv-44774" unitRef="usd">1336260</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset contextRef="c507" decimals="0" id="ixv-44775" unitRef="usd">-2299</ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c507" decimals="0" id="ixv-44776" unitRef="usd">-423116</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset contextRef="c507" decimals="0" id="ixv-44777" unitRef="usd">-97065</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset>
    <ifrs-full:NetDeferredTaxAssets contextRef="c480" decimals="0" id="ixv-44778" unitRef="usd">813780</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxAssets contextRef="c508" decimals="0" id="ixv-44779" unitRef="usd">447449</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c509" decimals="0" id="ixv-44780" unitRef="usd">214734</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset contextRef="c509" decimals="0" id="ixv-44781" unitRef="usd">-130077</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset>
    <ifrs-full:NetDeferredTaxAssets contextRef="c460" decimals="0" id="ixv-44782" unitRef="usd">532106</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxAssets contextRef="c510" decimals="0" id="ixv-44783" unitRef="usd">723082</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c511" decimals="0" id="ixv-44784" unitRef="usd">48310</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset contextRef="c511" decimals="0" id="ixv-44785" unitRef="usd">-6504</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset>
    <ifrs-full:NetDeferredTaxAssets contextRef="c458" decimals="0" id="ixv-44786" unitRef="usd">764888</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxAssets contextRef="c512" decimals="0" id="ixv-44787" unitRef="usd">1213899</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c513" decimals="0" id="ixv-44788" unitRef="usd">-221106</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset contextRef="c513" decimals="0" id="ixv-44789" unitRef="usd">-50206</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset>
    <ifrs-full:NetDeferredTaxAssets contextRef="c462" decimals="0" id="ixv-44790" unitRef="usd">942587</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxAssets contextRef="c514" decimals="0" id="ixv-44791" unitRef="usd">93996</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset contextRef="c515" decimals="0" id="ixv-44792" unitRef="usd">-39261</ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c515" decimals="0" id="ixv-44793" unitRef="usd">-42199</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset contextRef="c515" decimals="0" id="ixv-44794" unitRef="usd">2554</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset>
    <ifrs-full:NetDeferredTaxAssets contextRef="c464" decimals="0" id="ixv-44795" unitRef="usd">15090</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxAssets contextRef="c516" decimals="0" id="ixv-44796" unitRef="usd">3402846</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset contextRef="c517" decimals="0" id="ixv-44797" unitRef="usd">765384</ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c517" decimals="0" id="ixv-44798" unitRef="usd">-1651511</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:NetDeferredTaxAssets contextRef="c518" decimals="0" id="ixv-44799" unitRef="usd">2516719</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxAssets contextRef="c519" decimals="0" id="ixv-44800" unitRef="usd">28433321</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset contextRef="c520" decimals="0" id="ixv-44801" unitRef="usd">661239</ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c520" decimals="0" id="ixv-44802" unitRef="usd">5677536</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset contextRef="c520" decimals="0" id="ixv-44803" unitRef="usd">-976016</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset>
    <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome contextRef="c520" decimals="0" id="ixv-44804" unitRef="usd">-1222843</ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome>
    <ifrs-full:NetDeferredTaxAssets contextRef="c466" decimals="0" id="ixv-44805" unitRef="usd">32573237</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxAssets contextRef="c521" decimals="0" id="ixv-44806" unitRef="usd">-29117986</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset contextRef="c522" decimals="0" id="ixv-44807" unitRef="usd">-301659</ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c522" decimals="0" id="ixv-44808" unitRef="usd">867636</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset contextRef="c522" decimals="0" id="ixv-44809" unitRef="usd">107914</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset>
    <ifrs-full:NetDeferredTaxAssets contextRef="c468" decimals="0" id="ixv-44810" unitRef="usd">-28444095</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxAssets contextRef="c523" decimals="0" id="ixv-44811" unitRef="usd">-13678341</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset contextRef="c524" decimals="0" id="ixv-44812" unitRef="usd">-174228</ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c524" decimals="0" id="ixv-44813" unitRef="usd">-773812</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset contextRef="c524" decimals="0" id="ixv-44814" unitRef="usd">17469</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset>
    <ifrs-full:NetDeferredTaxAssets contextRef="c470" decimals="0" id="ixv-44815" unitRef="usd">-14608912</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxAssets contextRef="c525" decimals="0" id="ixv-44816" unitRef="usd">-6461576</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset contextRef="c526" decimals="0" id="ixv-44817" unitRef="usd">-939250</ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c526" decimals="0" id="ixv-44818" unitRef="usd">-640394</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:NetDeferredTaxAssets contextRef="c527" decimals="0" id="ixv-44819" unitRef="usd">-8041220</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxAssets contextRef="c528" decimals="0" id="ixv-44820" unitRef="usd">-2154504</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c529" decimals="0" id="ixv-44821" unitRef="usd">1690100</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:NetDeferredTaxAssets contextRef="c495" decimals="0" id="ixv-44822" unitRef="usd">-464404</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxAssets contextRef="c530" decimals="0" id="ixv-44823" unitRef="usd">-120442</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset contextRef="c531" decimals="0" id="ixv-44824" unitRef="usd">-115495</ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c531" decimals="0" id="ixv-44825" unitRef="usd">30998</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset contextRef="c531" decimals="0" id="ixv-44826" unitRef="usd">14851</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset>
    <ifrs-full:NetDeferredTaxAssets contextRef="c474" decimals="0" id="ixv-44827" unitRef="usd">-190088</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxAssets contextRef="c532" decimals="0" id="ixv-44828" unitRef="usd">-1131895</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset contextRef="c533" decimals="0" id="ixv-44829" unitRef="usd">10732</ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c533" decimals="0" id="ixv-44830" unitRef="usd">827211</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset contextRef="c533" decimals="0" id="ixv-44831" unitRef="usd">-8504</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset>
    <ifrs-full:NetDeferredTaxAssets contextRef="c476" decimals="0" id="ixv-44832" unitRef="usd">-302456</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxAssets contextRef="c534" decimals="0" id="ixv-44833" unitRef="usd">-607722</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c535" decimals="0" id="ixv-44834" unitRef="usd">111773</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset contextRef="c535" decimals="0" id="ixv-44835" unitRef="usd">-50328</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset>
    <ifrs-full:NetDeferredTaxAssets contextRef="c536" decimals="0" id="ixv-44836" unitRef="usd">-546277</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxAssets contextRef="c537" decimals="0" id="ixv-44837" unitRef="usd">-53272466</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset contextRef="c538" decimals="0" id="ixv-44838" unitRef="usd">-1519900</ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c538" decimals="0" id="ixv-44839" unitRef="usd">2113512</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset contextRef="c538" decimals="0" id="ixv-44840" unitRef="usd">81402</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset>
    <ifrs-full:NetDeferredTaxAssets contextRef="c478" decimals="0" id="ixv-44841" unitRef="usd">-52597452</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxAssets contextRef="c47" decimals="0" id="ixv-44842" unitRef="usd">-24839145</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset contextRef="c5" decimals="0" id="ixv-44843" unitRef="usd">-858661</ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c5" decimals="0" id="ixv-44844" unitRef="usd">7791048</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset contextRef="c5" decimals="0" id="ixv-44845" unitRef="usd">-894614</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset>
    <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome contextRef="c5" decimals="0" id="ixv-44846" unitRef="usd">-1222843</ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome>
    <ifrs-full:NetDeferredTaxAssets contextRef="c7" decimals="0" id="ixv-44847" unitRef="usd">-20024215</ifrs-full:NetDeferredTaxAssets>
    <mlec:EffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="c0" id="ixv-33515">&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The tax on the Group&#x2019;s profit before tax differs from the theoretical
amount that would arise using the weighted average tax rate applicable to profits of the consolidated entities as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;(Loss) / earnings before income tax-rate&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;(170,003,479&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;(27,958,152&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;50,794,242&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Income tax expense by applying tax rate in force in the respective countries&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;45,342,071&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7,224,973&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(7,628,367&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Share of profit or loss of subsidiaries, joint ventures and associates&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(8,232,869&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(5,141,460&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,645,224&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Puttable instruments charge&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-487"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-488"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,645&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Stock options charge&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(167,601&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,366,999&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(586,774&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Derecognition of deferred tax assets (i)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(40,565,962&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(94,189&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;428,530&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Mutual funds adjustments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,471&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;27,560&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-489"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Non-deductible expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(4,027,734&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,469,872&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(373,655&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Result of inflation effect on monetary items and other finance results&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;335,680&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(5,113,890&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(7,872,801&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Tax inflation adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,633,659&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,278,344&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,916,143&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Rate change adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-490"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;118,060&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(192,127&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 0pt"&gt;Others&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(971,836&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;434,321&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(4,162&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt"&gt;Income tax expenses&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(6,636,121&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(1,103,152&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;2,328,366&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;(i)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Mainly represent derecognition of deferred tax assets from
Bioceres S.A. because it initiated the voluntary bankruptcy proceeding (Note 21).&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</mlec:EffectiveIncomeTaxRateReconciliationTableTextBlock>
    <ifrs-full:ProfitLossFromDiscontinuedOperations contextRef="c0" decimals="0" id="ixv-44848" unitRef="usd">-170003479</ifrs-full:ProfitLossFromDiscontinuedOperations>
    <ifrs-full:ProfitLossFromDiscontinuedOperations contextRef="c5" decimals="0" id="ixv-44849" unitRef="usd">-27958152</ifrs-full:ProfitLossFromDiscontinuedOperations>
    <ifrs-full:ProfitLossFromDiscontinuedOperations contextRef="c6" decimals="0" id="ixv-44850" unitRef="usd">50794242</ifrs-full:ProfitLossFromDiscontinuedOperations>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate contextRef="c0" decimals="0" id="ixv-44851" unitRef="usd">45342071</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate contextRef="c5" decimals="0" id="ixv-44852" unitRef="usd">7224973</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate contextRef="c6" decimals="0" id="ixv-44853" unitRef="usd">-7628367</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
    <mlec:TaxEffectOfShareOfProfitOrLossOfSubsidiesJointVenturesAndAssociates contextRef="c0" decimals="0" id="ixv-44854" unitRef="usd">8232869</mlec:TaxEffectOfShareOfProfitOrLossOfSubsidiesJointVenturesAndAssociates>
    <mlec:TaxEffectOfShareOfProfitOrLossOfSubsidiesJointVenturesAndAssociates contextRef="c5" decimals="0" id="ixv-44855" unitRef="usd">5141460</mlec:TaxEffectOfShareOfProfitOrLossOfSubsidiesJointVenturesAndAssociates>
    <mlec:TaxEffectOfShareOfProfitOrLossOfSubsidiesJointVenturesAndAssociates contextRef="c6" decimals="0" id="ixv-44856" unitRef="usd">-12645224</mlec:TaxEffectOfShareOfProfitOrLossOfSubsidiesJointVenturesAndAssociates>
    <mlec:PuttableInstrumentsCharge contextRef="c6" decimals="0" id="ixv-44857" unitRef="usd">3645</mlec:PuttableInstrumentsCharge>
    <mlec:TaxEffectOfStockOptionCharge contextRef="c0" decimals="0" id="ixv-44858" unitRef="usd">167601</mlec:TaxEffectOfStockOptionCharge>
    <mlec:TaxEffectOfStockOptionCharge contextRef="c5" decimals="0" id="ixv-44859" unitRef="usd">1366999</mlec:TaxEffectOfStockOptionCharge>
    <mlec:TaxEffectOfStockOptionCharge contextRef="c6" decimals="0" id="ixv-44860" unitRef="usd">586774</mlec:TaxEffectOfStockOptionCharge>
    <mlec:DerecognitionOfDeferredTaxAssets contextRef="c0" decimals="0" id="ix_44_fact" unitRef="usd">-40565962</mlec:DerecognitionOfDeferredTaxAssets>
    <mlec:DerecognitionOfDeferredTaxAssets contextRef="c5" decimals="0" id="ix_45_fact" unitRef="usd">-94189</mlec:DerecognitionOfDeferredTaxAssets>
    <mlec:DerecognitionOfDeferredTaxAssets contextRef="c6" decimals="0" id="ix_46_fact" unitRef="usd">428530</mlec:DerecognitionOfDeferredTaxAssets>
    <mlec:MutualFundsAdjustment contextRef="c0" decimals="0" id="ixv-44864" unitRef="usd">18471</mlec:MutualFundsAdjustment>
    <mlec:MutualFundsAdjustment contextRef="c5" decimals="0" id="ixv-44865" unitRef="usd">27560</mlec:MutualFundsAdjustment>
    <mlec:TaxEffectOfRevenuesExemptFromTaxationAndExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss contextRef="c0" decimals="0" id="ixv-44866" unitRef="usd">4027734</mlec:TaxEffectOfRevenuesExemptFromTaxationAndExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss>
    <mlec:TaxEffectOfRevenuesExemptFromTaxationAndExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss contextRef="c5" decimals="0" id="ixv-44867" unitRef="usd">1469872</mlec:TaxEffectOfRevenuesExemptFromTaxationAndExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss>
    <mlec:TaxEffectOfRevenuesExemptFromTaxationAndExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss contextRef="c6" decimals="0" id="ixv-44868" unitRef="usd">373655</mlec:TaxEffectOfRevenuesExemptFromTaxationAndExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss>
    <mlec:ResultOfInflationEffectOnMonetaryItemsAndOtherFinanceResults contextRef="c0" decimals="0" id="ixv-44869" unitRef="usd">-335680</mlec:ResultOfInflationEffectOnMonetaryItemsAndOtherFinanceResults>
    <mlec:ResultOfInflationEffectOnMonetaryItemsAndOtherFinanceResults contextRef="c5" decimals="0" id="ixv-44870" unitRef="usd">5113890</mlec:ResultOfInflationEffectOnMonetaryItemsAndOtherFinanceResults>
    <mlec:ResultOfInflationEffectOnMonetaryItemsAndOtherFinanceResults contextRef="c6" decimals="0" id="ixv-44871" unitRef="usd">7872801</mlec:ResultOfInflationEffectOnMonetaryItemsAndOtherFinanceResults>
    <mlec:TaxInflationAdjustment contextRef="c0" decimals="0" id="ixv-44872" unitRef="usd">-1633659</mlec:TaxInflationAdjustment>
    <mlec:TaxInflationAdjustment contextRef="c5" decimals="0" id="ixv-44873" unitRef="usd">-4278344</mlec:TaxInflationAdjustment>
    <mlec:TaxInflationAdjustment contextRef="c6" decimals="0" id="ixv-44874" unitRef="usd">-5916143</mlec:TaxInflationAdjustment>
    <ifrs-full:TaxEffectFromChangeInTaxRate contextRef="c5" decimals="0" id="ixv-44875" unitRef="usd">118060</ifrs-full:TaxEffectFromChangeInTaxRate>
    <ifrs-full:TaxEffectFromChangeInTaxRate contextRef="c6" decimals="0" id="ixv-44876" unitRef="usd">-192127</ifrs-full:TaxEffectFromChangeInTaxRate>
    <ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome contextRef="c0" decimals="0" id="ixv-44877" unitRef="usd">971836</ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome>
    <ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome contextRef="c5" decimals="0" id="ixv-44878" unitRef="usd">-434321</ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome>
    <ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome contextRef="c6" decimals="0" id="ixv-44879" unitRef="usd">4162</ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome>
    <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="c0" decimals="0" id="ixv-44880" unitRef="usd">6636121</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="c5" decimals="0" id="ixv-44881" unitRef="usd">1103152</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="c6" decimals="0" id="ixv-44882" unitRef="usd">-2328366</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <mlec:ComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="c0" id="ixv-44883">Mainly represent derecognition of deferred tax assets from
Bioceres S.A. because it initiated the voluntary bankruptcy proceeding (Note 21).&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;06/30/2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Current tax expense&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-491"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(8,894,200&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(1,311,506&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Deferred tax&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(6,636,121&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7,791,048&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,639,872&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(6,636,121&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(1,103,152&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,328,366&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</mlec:ComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <ifrs-full:CurrentTaxExpenseIncome contextRef="c5" decimals="0" id="ixv-44885" unitRef="usd">8894200</ifrs-full:CurrentTaxExpenseIncome>
    <ifrs-full:CurrentTaxExpenseIncome contextRef="c6" decimals="0" id="ixv-44886" unitRef="usd">1311506</ifrs-full:CurrentTaxExpenseIncome>
    <ifrs-full:DeferredTaxExpenseIncome contextRef="c0" decimals="0" id="ixv-44887" unitRef="usd">6636121</ifrs-full:DeferredTaxExpenseIncome>
    <ifrs-full:DeferredTaxExpenseIncome contextRef="c5" decimals="0" id="ixv-44888" unitRef="usd">-7791048</ifrs-full:DeferredTaxExpenseIncome>
    <ifrs-full:DeferredTaxExpenseIncome contextRef="c6" decimals="0" id="ixv-44889" unitRef="usd">-3639872</ifrs-full:DeferredTaxExpenseIncome>
    <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="c0" decimals="0" id="ixv-44890" unitRef="usd">6636121</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="c5" decimals="0" id="ixv-44891" unitRef="usd">1103152</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="c6" decimals="0" id="ixv-44892" unitRef="usd">-2328366</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <mlec:IncomeTaxExpenseByApplyingApplicableTaxRateInForceInRespectiveJurisdictionsTableTextBlock contextRef="c0" id="ixv-33824">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The income tax expense was calculated by applying
the tax rate in force in the respective countries, as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;Tax jurisdiction&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Earnings before income tax-rate&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Weight average applicable &lt;br/&gt;
tax rate&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Income &lt;br/&gt;
tax as of &lt;br/&gt;
June 30, &lt;br/&gt;
2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Low or null taxation jurisdictions&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(7,247,084&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;0.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-492"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Loss-making entities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(162,756,395&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;27.9&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;45,342,071&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(170,003,479&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;45,342,071&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;Tax jurisdiction&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Earnings before income tax-rate&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Weight average applicable &lt;br/&gt;
tax rate&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Income &lt;br/&gt;
tax as of &lt;br/&gt;
June 30, &lt;br/&gt;
2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Low or null taxation jurisdictions&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;13,131,953&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;0.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-493"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Profit-making entities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;32,251,706&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;32.2&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(10,370,389&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Loss-making entities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(73,341,811&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;24.0&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;17,595,362&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(27,958,152&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;7,224,973&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;Tax jurisdiction&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Earnings before income tax-rate&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Weight average applicable &lt;br/&gt;
tax rate&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Income &lt;br/&gt;
tax as of &lt;br/&gt;
June 30, &lt;br/&gt;
2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Low or null taxation jurisdictions&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;30,921,548&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;0.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-494"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Profit-making entities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;73,999,737&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;21.5&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(15,899,829&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Loss-making entities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(54,127,043&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;15.3&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;8,271,462&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;50,794,242&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(7,628,367&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</mlec:IncomeTaxExpenseByApplyingApplicableTaxRateInForceInRespectiveJurisdictionsTableTextBlock>
    <ifrs-full:AccountingProfit contextRef="c539" decimals="0" id="ixv-44893" unitRef="usd">-7247084</ifrs-full:AccountingProfit>
    <ifrs-full:ApplicableTaxRate
      contextRef="c539"
      decimals="3"
      id="ixv-44894"
      unitRef="pure">0</ifrs-full:ApplicableTaxRate>
    <ifrs-full:AccountingProfit contextRef="c540" decimals="0" id="ixv-44895" unitRef="usd">-162756395</ifrs-full:AccountingProfit>
    <ifrs-full:ApplicableTaxRate
      contextRef="c540"
      decimals="3"
      id="ixv-44896"
      unitRef="pure">0.279</ifrs-full:ApplicableTaxRate>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate contextRef="c540" decimals="0" id="ixv-44897" unitRef="usd">45342071</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
    <ifrs-full:AccountingProfit contextRef="c0" decimals="0" id="ixv-44898" unitRef="usd">-170003479</ifrs-full:AccountingProfit>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate contextRef="c0" decimals="0" id="ixv-44899" unitRef="usd">45342071</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
    <ifrs-full:AccountingProfit contextRef="c541" decimals="0" id="ixv-44900" unitRef="usd">13131953</ifrs-full:AccountingProfit>
    <ifrs-full:ApplicableTaxRate
      contextRef="c541"
      decimals="3"
      id="ixv-44901"
      unitRef="pure">0</ifrs-full:ApplicableTaxRate>
    <ifrs-full:AccountingProfit contextRef="c542" decimals="0" id="ixv-44902" unitRef="usd">32251706</ifrs-full:AccountingProfit>
    <ifrs-full:ApplicableTaxRate
      contextRef="c542"
      decimals="3"
      id="ixv-44903"
      unitRef="pure">0.322</ifrs-full:ApplicableTaxRate>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate contextRef="c542" decimals="0" id="ixv-44904" unitRef="usd">-10370389</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
    <ifrs-full:AccountingProfit contextRef="c543" decimals="0" id="ixv-44905" unitRef="usd">-73341811</ifrs-full:AccountingProfit>
    <ifrs-full:ApplicableTaxRate
      contextRef="c543"
      decimals="3"
      id="ixv-44906"
      unitRef="pure">0.24</ifrs-full:ApplicableTaxRate>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate contextRef="c543" decimals="0" id="ixv-44907" unitRef="usd">17595362</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
    <ifrs-full:AccountingProfit contextRef="c5" decimals="0" id="ixv-44908" unitRef="usd">-27958152</ifrs-full:AccountingProfit>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate contextRef="c5" decimals="0" id="ixv-44909" unitRef="usd">7224973</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
    <ifrs-full:AccountingProfit contextRef="c544" decimals="0" id="ixv-44910" unitRef="usd">30921548</ifrs-full:AccountingProfit>
    <ifrs-full:ApplicableTaxRate
      contextRef="c544"
      decimals="3"
      id="ixv-44911"
      unitRef="pure">0</ifrs-full:ApplicableTaxRate>
    <ifrs-full:AccountingProfit contextRef="c545" decimals="0" id="ixv-44912" unitRef="usd">73999737</ifrs-full:AccountingProfit>
    <ifrs-full:ApplicableTaxRate
      contextRef="c545"
      decimals="3"
      id="ixv-44913"
      unitRef="pure">0.215</ifrs-full:ApplicableTaxRate>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate contextRef="c545" decimals="0" id="ixv-44914" unitRef="usd">-15899829</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
    <ifrs-full:AccountingProfit contextRef="c546" decimals="0" id="ixv-44915" unitRef="usd">-54127043</ifrs-full:AccountingProfit>
    <ifrs-full:ApplicableTaxRate
      contextRef="c546"
      decimals="3"
      id="ixv-44916"
      unitRef="pure">0.153</ifrs-full:ApplicableTaxRate>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate contextRef="c546" decimals="0" id="ixv-44917" unitRef="usd">8271462</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
    <ifrs-full:AccountingProfit contextRef="c6" decimals="0" id="ixv-44918" unitRef="usd">50794242</ifrs-full:AccountingProfit>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate contextRef="c6" decimals="0" id="ixv-44919" unitRef="usd">-7628367</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
    <ifrs-full:TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense contextRef="c0" decimals="-5" id="ixv-44920" unitRef="usd">7600000</ifrs-full:TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense>
    <ifrs-full:DisclosureOfEarningsPerShareExplanatory contextRef="c0" id="ixv-34046">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;10.&#160;&lt;span style="text-decoration:underline"&gt;EARNING PER SHARE&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Basic and diluted EPS for the current period is based on the profit
or loss of the accounting acquirer and the weighted average number of ordinary shares of the legal acquirer outstanding during the period
(net of treasury shares). Comparative EPS has been retrospectively restated to reflect exchange ratio of the Business Combination Agreement
and the Reverse Stock Split ratio.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As part of the consideration transferred in the reverse acquisition
stated in Note 1 - The Group&#x2019;s business reorganization and general information &#x2013; &#x201c;&lt;i&gt;The Bioceres Group Business Combination
Agreement&lt;/i&gt;&#x201d;, the Company committed to issue the Holdback additional ordinary shares twelve months after the acquisition date.
As this obligation is unconditional and forms part of the purchase consideration under IFRS 3, such shares are included in basic and diluted
EPS from the acquisition date and retrospectively for all comparative periods, in accordance with IAS 33. The deferred issuance date does
not affect their inclusion in the earnings per share calculation.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group&#x2019;s basic and diluted loss per ordinary
share are the same because the Group has generated net loss to ordinary shareholders.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2025&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2024&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2023&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Numerator&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Loss/Profit for the year (basic EPS)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(111,460,708&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(32,685,398&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;40,435,923&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Loss/Profit for the year (diluted EPS)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(111,460,708&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(32,685,398&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;40,435,923&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Denominator&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Number of shares (basic EPS)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,462,960&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,821,519&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,593,222&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Number of shares (diluted EPS)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,462,960&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,821,519&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,593,222&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Basic (loss)/profit attributable to ordinary equity holders of the parent&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(17.2461&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(5.6146&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;8.8034&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Diluted (loss)/profit attributable to ordinary equity holders of the parent&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(17.2461&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(5.6146&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;8.8034&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfEarningsPerShareExplanatory>
    <ifrs-full:EarningsPerShareExplanatory contextRef="c0" id="ixv-34099">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group&#x2019;s basic and diluted loss per ordinary
share are the same because the Group has generated net loss to ordinary shareholders.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2025&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2024&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2023&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Numerator&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Loss/Profit for the year (basic EPS)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(111,460,708&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(32,685,398&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;40,435,923&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Loss/Profit for the year (diluted EPS)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(111,460,708&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(32,685,398&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;40,435,923&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Denominator&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Number of shares (basic EPS)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,462,960&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,821,519&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,593,222&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Number of shares (diluted EPS)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,462,960&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,821,519&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,593,222&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Basic (loss)/profit attributable to ordinary equity holders of the parent&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(17.2461&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(5.6146&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;8.8034&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Diluted (loss)/profit attributable to ordinary equity holders of the parent&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(17.2461&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(5.6146&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;8.8034&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:EarningsPerShareExplanatory>
    <ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity contextRef="c547" decimals="0" id="ixv-44921" unitRef="usd">-111460708</ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity>
    <ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity contextRef="c548" decimals="0" id="ixv-44922" unitRef="usd">-32685398</ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity>
    <ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity contextRef="c549" decimals="0" id="ixv-44923" unitRef="usd">40435923</ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity>
    <ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects contextRef="c547" decimals="0" id="ixv-44924" unitRef="usd">-111460708</ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects>
    <ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects contextRef="c548" decimals="0" id="ixv-44925" unitRef="usd">-32685398</ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects>
    <ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects contextRef="c549" decimals="0" id="ixv-44926" unitRef="usd">40435923</ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects>
    <ifrs-full:WeightedAverageShares
      contextRef="c547"
      decimals="0"
      id="ixv-44927"
      unitRef="shares">6462960</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="c548"
      decimals="0"
      id="ixv-44928"
      unitRef="shares">5821519</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="c549"
      decimals="0"
      id="ixv-44929"
      unitRef="shares">4593222</ifrs-full:WeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="c547"
      decimals="0"
      id="ixv-44930"
      unitRef="shares">6462960</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="c548"
      decimals="0"
      id="ixv-44931"
      unitRef="shares">5821519</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="c549"
      decimals="0"
      id="ixv-44932"
      unitRef="shares">4593222</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="c547"
      decimals="4"
      id="ixv-44933"
      unitRef="usdPershares">-17.2461</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="c548"
      decimals="4"
      id="ixv-44934"
      unitRef="usdPershares">-5.6146</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="c549"
      decimals="4"
      id="ixv-44935"
      unitRef="usdPershares">8.8034</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="c547"
      decimals="4"
      id="ixv-44936"
      unitRef="usdPershares">-17.2461</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="c548"
      decimals="4"
      id="ixv-44937"
      unitRef="usdPershares">-5.6146</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="c549"
      decimals="4"
      id="ixv-44938"
      unitRef="usdPershares">8.8034</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory contextRef="c0" id="ixv-34244">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;11.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;INFORMATION ABOUT COMPONENTS OF EQUITY&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Capital issued&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As described in Note 1 &#x2013; The Group&#x2019;s
business reorganization and general information &#x2013; &#x201c;&lt;i&gt;The Bioceres Group Business Combination Agreement&lt;/i&gt;&#x201d; and in
note 6 &#x2013; Acquisitions and other significant transactions &#x2013; &#x201c;&lt;i&gt;Bioceres Group, Nutrecon, Gentle Tech and Moolec Science
business combination&lt;/i&gt;&#x201d;, the Company completed a reverse acquisition on June 16, 2025, whereby Moolec Science SA (&#x201c;the Legal
Acquirer&#x201d;) legally acquired Bioceres Group, Nutrecon and Gentle Tech (&#x201c;the Legal Acquirees&#x201d;). For accounting purposes,
however, Bioceres Group was identified as the accounting acquirer in accordance with IFRS 3 Business Combinations. As a result, the consolidated
financial statements represent a continuation of the financial statements of the accounting acquirer, except for the capital structure,
which is that of the legal acquirer. Following the reverse acquisition, &lt;span style="font-weight: normal"&gt;Share Capital&lt;/span&gt; reflects
the share capital of &lt;span style="font-weight: normal"&gt;Moolec Science SA, &lt;/span&gt;including the shares issued to the former shareholders
of the accounting acquirer as consideration for the transaction.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The number of shares issued as of June 30, 2025,
2024 and 2023 is the following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;b&gt;Year ended&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Class&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Number of &lt;br/&gt;
Shares&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Nominal Value&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Subscribed capital&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 23%; text-align: left"&gt;06/30/2023&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 22%; text-align: center"&gt;Ordinary&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;5,301,700&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;0.10&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;5,301,700&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;530,170&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;06/30/2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Ordinary&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,983,687&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.10&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,983,687&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;598,369&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;06/30/2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Ordinary&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,891,761&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.10&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,891,761&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,089,176&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Holders of the ordinary shares are entitled to
one vote for each ordinary share.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Reserves&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Foreign currency translation reserve&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The translation reserve comprises all foreign
currency differences arising from the translation of the financial statements of foreign operations.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Revaluation of PP&amp;amp;E and effect of tax rate
change&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The revaluation reserve relates to the revaluation
of Land and buildings, prior to the BIOX deconsolidation, as mentioned in note 4.8 &#x2013; Property, plant and equipment, net of income
tax effect.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Own shares held&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The reserve of the Company&#xb4;s own shares
held comprises the cost of the Company&#x2019;s shares held by the Group. At June 30, 2025, the Group held 80,370 of the Company&#x2019;s
shares. (2024: 60,083).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Share premium&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Share premium represents the excess of the consideration
received over the par value of shares issued, net of directly attributable transaction costs, and is presented within equity in accordance
with IAS 32.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Non-controlling interests&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The subsidiaries whose non-controlling interest
is significant as of June 30, 2025 and 2024 are:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;b&gt;Name&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;06/30/2025&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;06/30/2024&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Bioceres S.A.&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;10.07&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;26.53&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Bioceres Crop Solutions (*)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-495"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;72.67&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Below is a detail of the summarized financial
information of Bioceres S.A., prepared in accordance with IFRS, and modified due to fair value adjustments at the acquisition date and
differences in accounting policies. The information is presented prior to eliminations between that subsidiary and other Group companies.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Bioceres Crop Solutions ceased to be a subsidiary in June
24, 2025.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Bioceres S.A.&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="text-decoration:underline"&gt;Summary financial statements:&lt;/span&gt; &#160; &#160; &#160; &#160; &#160; &#160;&lt;/p&gt;



&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 0pt"&gt;Current assets&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;19,390,689&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;37,499,373&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Non-current assets&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(12,909,646&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;78,742,912&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt"&gt;Total assets&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;6,481,043&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;116,242,285&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Current liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;97,284,715&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;47,526,407&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Non-current liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;238,458&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;14,689,742&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Total liabilities&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;97,523,173&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;62,216,149&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Total equity&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;(91,042,130&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;54,026,136&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt"&gt;Total liabilities and equity&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;6,481,043&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;116,242,285&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="text-decoration:underline"&gt;Summary statements of comprehensive income or loss&lt;/span&gt;&lt;/p&gt;



&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2025&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2024&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;06/30/2023&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; padding-left: 0pt"&gt;Revenues&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;780,952&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,422,707&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,074,655&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Government grants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,412&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;197,519&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;49,185&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-left: 0pt"&gt;Gross margin&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;784,364&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;1,620,226&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;1,123,840&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Research and development expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(223,688&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(239,446&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(175,737&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Selling, general and administrative expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,275,441&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,248,643&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,287,433&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;Share of profit or loss of subsidiaries&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(33,367,101&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,285,724&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,287,879&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Share of profit or loss of joint ventures and associates&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(285&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,592&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,917&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Other income / (loss), net&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(56,484,792&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;11,126&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;249,372&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-left: 0pt"&gt;Operating loss&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(91,566,943&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(5,145,053&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;3,194,004&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Financial results&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,891,781&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,128,752&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(4,327,324&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt"&gt;Loss before taxes&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(88,675,162&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(6,273,805&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(1,133,320&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Income tax (expense) / benefit&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,653,797&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;471,416&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(463,175&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt"&gt;Result for the year&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(90,328,959&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(5,802,389&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(1,596,495&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-style: italic; text-align: left; padding-left: 0pt"&gt;Revaluation of property, plant and equipment, net of tax&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(434,390&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-style: italic; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Foreign exchange differences on translation of foreign operations&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(5,467,311&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(3,865,328&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(5,182,181&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-style: italic; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt"&gt;Total comprehensive result&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(95,796,270&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(9,667,717&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(7,213,066&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;Bioceres Crop Solutions&lt;/p&gt;

&lt;p style="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="text-decoration:underline"&gt;Summary financial statements:&lt;/span&gt;&lt;/p&gt;



&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 0pt"&gt;Current assets&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-496"&gt;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;408,668,037&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Non-current assets&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-497"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;441,960,310&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt"&gt;Total assets&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-498"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;850,628,347&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Current liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-499"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;329,505,846&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Non-current liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-500"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;171,558,140&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Total liabilities&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-501"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;501,063,986&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Total equity&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-502"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;349,564,361&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt"&gt;Total liabilities and equity&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-503"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;850,628,347&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="text-decoration:underline"&gt;Summary statements of comprehensive income or loss&lt;/span&gt;&lt;/p&gt;



&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 64%"&gt;Revenues&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;333,343,987&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;464,828,548&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;419,446,439&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Initial recognition and changes in the fair value of biological assets at the point of harvest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,764,863&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(45,746&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;610,554&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Cost of sales&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(203,424,872&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(278,221,812&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(235,457,053&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Changes in the net realizable value of agricultural products after harvest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,541,204&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,385,069&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(4,351,433&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Research and development expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(14,914,822&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(17,183,041&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(15,345,315&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Selling, general and administrative expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(123,113,572&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(123,690,910&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(113,002,747&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Share of profit or loss of joint ventures and associates&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,126,312&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,049,508&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,198,628&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Other income or expenses, net&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;6,775,970&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,498,555&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,084,892&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left"&gt;Operating (loss) / profit&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(2,235,962&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;45,852,923&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;54,183,965&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Financial results&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(55,335,675&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(34,785,325&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(35,078,018&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;(Loss) / profit before taxes&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(57,571,637&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;11,067,598&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;19,105,947&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Income tax&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,273,616&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(3,778,615&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,068,652&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Result for the year&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(58,845,253&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;7,288,983&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;20,174,599&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-style: italic; text-align: left"&gt;Foreign exchange differences on translation of foreign operations&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(714,251&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(787,354&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;631,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-style: italic; text-align: left; padding-bottom: 1.5pt"&gt;Revaluation of property, plant and equipment, net of tax&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-504"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-505"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,467,349&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-style: italic; text-align: left; padding-bottom: 2.5pt"&gt;Total comprehensive result&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(59,559,504&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;6,501,629&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;19,338,750&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory>
    <mlec:DisclosureOfNumberOfSharesIssuedtextBlock contextRef="c0" id="ixv-34266">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The number of shares issued as of June 30, 2025,
2024 and 2023 is the following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;b&gt;Year ended&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Class&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Number of &lt;br/&gt;
Shares&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Nominal Value&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;b&gt;Subscribed capital&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 23%; text-align: left"&gt;06/30/2023&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 22%; text-align: center"&gt;Ordinary&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 15%; text-align: right"&gt;5,301,700&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;0.10&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;5,301,700&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;530,170&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;06/30/2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Ordinary&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,983,687&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.10&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,983,687&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;598,369&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;06/30/2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Ordinary&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,891,761&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.10&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,891,761&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,089,176&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</mlec:DisclosureOfNumberOfSharesIssuedtextBlock>
    <ifrs-full:NumberOfSharesIssued
      contextRef="c551"
      decimals="INF"
      id="ixv-44939"
      unitRef="shares">5301700</ifrs-full:NumberOfSharesIssued>
    <mlec:NumberOfNominalValue
      contextRef="c552"
      decimals="2"
      id="ixv-44940"
      unitRef="usdPershares">0.1</mlec:NumberOfNominalValue>
    <mlec:SubscribedCapitalOfShares
      contextRef="c552"
      decimals="0"
      id="ixv-44941"
      unitRef="shares">5301700</mlec:SubscribedCapitalOfShares>
    <mlec:SubscribedCapital contextRef="c551" decimals="0" id="ixv-44942" unitRef="usd">530170</mlec:SubscribedCapital>
    <ifrs-full:NumberOfSharesIssued
      contextRef="c553"
      decimals="INF"
      id="ixv-44943"
      unitRef="shares">5983687</ifrs-full:NumberOfSharesIssued>
    <mlec:NumberOfNominalValue
      contextRef="c554"
      decimals="2"
      id="ixv-44944"
      unitRef="usdPershares">0.1</mlec:NumberOfNominalValue>
    <mlec:SubscribedCapitalOfShares
      contextRef="c554"
      decimals="0"
      id="ixv-44945"
      unitRef="shares">5983687</mlec:SubscribedCapitalOfShares>
    <mlec:SubscribedCapital contextRef="c553" decimals="0" id="ixv-44946" unitRef="usd">598369</mlec:SubscribedCapital>
    <ifrs-full:NumberOfSharesIssued
      contextRef="c550"
      decimals="INF"
      id="ixv-44947"
      unitRef="shares">10891761</ifrs-full:NumberOfSharesIssued>
    <mlec:NumberOfNominalValue
      contextRef="c555"
      decimals="2"
      id="ixv-44948"
      unitRef="usdPershares">0.1</mlec:NumberOfNominalValue>
    <mlec:SubscribedCapitalOfShares
      contextRef="c555"
      decimals="0"
      id="ixv-44949"
      unitRef="shares">10891761</mlec:SubscribedCapitalOfShares>
    <mlec:SubscribedCapital contextRef="c550" decimals="0" id="ixv-44950" unitRef="usd">1089176</mlec:SubscribedCapital>
    <mlec:VotePerShare
      contextRef="c550"
      decimals="INF"
      id="ixv-44951"
      unitRef="pure">1</mlec:VotePerShare>
    <ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates
      contextRef="c4"
      decimals="0"
      id="ixv-44952"
      unitRef="shares">80370</ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates>
    <ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates
      contextRef="c7"
      decimals="0"
      id="ixv-44953"
      unitRef="shares">60083</ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates>
    <ifrs-full:DisclosureOfNoncontrollingInterestsExplanatory contextRef="c0" id="ixv-34436">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The subsidiaries whose non-controlling interest
is significant as of June 30, 2025 and 2024 are:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;b&gt;Name&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;06/30/2025&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;06/30/2024&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Bioceres S.A.&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;10.07&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;26.53&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Bioceres Crop Solutions (*)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-495"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;72.67&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfNoncontrollingInterestsExplanatory>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests contextRef="c0" decimals="4" id="ixv-44954" unitRef="pure">0.1007</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests contextRef="c5" decimals="4" id="ixv-44955" unitRef="pure">0.2653</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="c5" decimals="4" id="ixv-44956" unitRef="pure">0.7267</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <mlec:ScheduleOfFinancialStatementsTextBlock contextRef="c0" id="ixv-34495">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="text-decoration:underline"&gt;Summary financial statements:&lt;/span&gt; &#160; &#160; &#160; &#160; &#160; &#160;&lt;/p&gt;



&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 0pt"&gt;Current assets&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;19,390,689&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;37,499,373&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Non-current assets&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(12,909,646&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;78,742,912&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt"&gt;Total assets&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;6,481,043&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;116,242,285&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Current liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;97,284,715&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;47,526,407&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Non-current liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;238,458&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;14,689,742&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Total liabilities&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;97,523,173&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;62,216,149&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Total equity&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;(91,042,130&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;54,026,136&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt"&gt;Total liabilities and equity&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;6,481,043&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;116,242,285&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="text-decoration:underline"&gt;Summary statements of comprehensive income or loss&lt;/span&gt;&lt;/p&gt;



&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2025&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2024&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;06/30/2023&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; padding-left: 0pt"&gt;Revenues&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;780,952&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,422,707&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,074,655&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Government grants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,412&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;197,519&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;49,185&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-left: 0pt"&gt;Gross margin&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;784,364&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;1,620,226&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;1,123,840&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Research and development expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(223,688&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(239,446&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(175,737&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Selling, general and administrative expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,275,441&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,248,643&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,287,433&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;Share of profit or loss of subsidiaries&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(33,367,101&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,285,724&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,287,879&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Share of profit or loss of joint ventures and associates&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(285&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,592&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,917&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Other income / (loss), net&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(56,484,792&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;11,126&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;249,372&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-left: 0pt"&gt;Operating loss&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(91,566,943&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(5,145,053&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;3,194,004&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Financial results&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,891,781&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,128,752&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(4,327,324&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt"&gt;Loss before taxes&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(88,675,162&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(6,273,805&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(1,133,320&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Income tax (expense) / benefit&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,653,797&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;471,416&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(463,175&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt"&gt;Result for the year&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(90,328,959&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(5,802,389&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(1,596,495&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-style: italic; text-align: left; padding-left: 0pt"&gt;Revaluation of property, plant and equipment, net of tax&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(434,390&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-style: italic; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Foreign exchange differences on translation of foreign operations&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(5,467,311&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(3,865,328&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(5,182,181&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-style: italic; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt"&gt;Total comprehensive result&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(95,796,270&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(9,667,717&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(7,213,066&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</mlec:ScheduleOfFinancialStatementsTextBlock>
    <ifrs-full:CurrentAssets contextRef="c86" decimals="0" id="ixv-44957" unitRef="usd">19390689</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets contextRef="c556" decimals="0" id="ixv-44958" unitRef="usd">37499373</ifrs-full:CurrentAssets>
    <mlec:NoncurrentAsset contextRef="c86" decimals="0" id="ixv-44959" unitRef="usd">-12909646</mlec:NoncurrentAsset>
    <mlec:NoncurrentAsset contextRef="c556" decimals="0" id="ixv-44960" unitRef="usd">78742912</mlec:NoncurrentAsset>
    <ifrs-full:Assets contextRef="c86" decimals="0" id="ixv-44961" unitRef="usd">6481043</ifrs-full:Assets>
    <ifrs-full:Assets contextRef="c556" decimals="0" id="ixv-44962" unitRef="usd">116242285</ifrs-full:Assets>
    <ifrs-full:CurrentLiabilities contextRef="c86" decimals="0" id="ixv-44963" unitRef="usd">97284715</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities contextRef="c556" decimals="0" id="ixv-44964" unitRef="usd">47526407</ifrs-full:CurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities contextRef="c86" decimals="0" id="ixv-44965" unitRef="usd">238458</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities contextRef="c556" decimals="0" id="ixv-44966" unitRef="usd">14689742</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:Liabilities contextRef="c86" decimals="0" id="ixv-44967" unitRef="usd">97523173</ifrs-full:Liabilities>
    <ifrs-full:Liabilities contextRef="c556" decimals="0" id="ixv-44968" unitRef="usd">62216149</ifrs-full:Liabilities>
    <ifrs-full:Equity contextRef="c86" decimals="0" id="ixv-44969" unitRef="usd">-91042130</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c556" decimals="0" id="ixv-44970" unitRef="usd">54026136</ifrs-full:Equity>
    <ifrs-full:EquityAndLiabilities contextRef="c86" decimals="0" id="ixv-44971" unitRef="usd">6481043</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities contextRef="c556" decimals="0" id="ixv-44972" unitRef="usd">116242285</ifrs-full:EquityAndLiabilities>
    <ifrs-full:Revenue contextRef="c89" decimals="0" id="ixv-44973" unitRef="usd">780952</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c557" decimals="0" id="ixv-44974" unitRef="usd">1422707</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c558" decimals="0" id="ixv-44975" unitRef="usd">1074655</ifrs-full:Revenue>
    <ifrs-full:RevenueFromGovernmentGrants contextRef="c89" decimals="0" id="ixv-44976" unitRef="usd">3412</ifrs-full:RevenueFromGovernmentGrants>
    <ifrs-full:RevenueFromGovernmentGrants contextRef="c557" decimals="0" id="ixv-44977" unitRef="usd">197519</ifrs-full:RevenueFromGovernmentGrants>
    <ifrs-full:RevenueFromGovernmentGrants contextRef="c558" decimals="0" id="ixv-44978" unitRef="usd">49185</ifrs-full:RevenueFromGovernmentGrants>
    <ifrs-full:GrossProfit contextRef="c89" decimals="0" id="ixv-44979" unitRef="usd">784364</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit contextRef="c557" decimals="0" id="ixv-44980" unitRef="usd">1620226</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit contextRef="c558" decimals="0" id="ixv-44981" unitRef="usd">1123840</ifrs-full:GrossProfit>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="c89" decimals="0" id="ixv-44982" unitRef="usd">223688</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="c557" decimals="0" id="ixv-44983" unitRef="usd">239446</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="c558" decimals="0" id="ixv-44984" unitRef="usd">175737</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="c89" decimals="0" id="ixv-44985" unitRef="usd">2275441</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="c557" decimals="0" id="ixv-44986" unitRef="usd">3248643</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="c558" decimals="0" id="ixv-44987" unitRef="usd">3287433</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <mlec:ShareOfProfitOrLossOfSubsidiaries contextRef="c89" decimals="0" id="ixv-44988" unitRef="usd">-33367101</mlec:ShareOfProfitOrLossOfSubsidiaries>
    <mlec:ShareOfProfitOrLossOfSubsidiaries contextRef="c557" decimals="0" id="ixv-44989" unitRef="usd">-3285724</mlec:ShareOfProfitOrLossOfSubsidiaries>
    <mlec:ShareOfProfitOrLossOfSubsidiaries contextRef="c558" decimals="0" id="ixv-44990" unitRef="usd">5287879</mlec:ShareOfProfitOrLossOfSubsidiaries>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="c89" decimals="0" id="ixv-44991" unitRef="usd">-285</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="c557" decimals="0" id="ixv-44992" unitRef="usd">-2592</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="c558" decimals="0" id="ixv-44993" unitRef="usd">-3917</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:OtherOperatingIncomeExpense contextRef="c89" decimals="0" id="ixv-44994" unitRef="usd">-56484792</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:OtherOperatingIncomeExpense contextRef="c557" decimals="0" id="ixv-44995" unitRef="usd">11126</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:OtherOperatingIncomeExpense contextRef="c558" decimals="0" id="ixv-44996" unitRef="usd">249372</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:ProfitLossFromOperatingActivities contextRef="c89" decimals="0" id="ixv-44997" unitRef="usd">-91566943</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities contextRef="c557" decimals="0" id="ixv-44998" unitRef="usd">-5145053</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities contextRef="c558" decimals="0" id="ixv-44999" unitRef="usd">3194004</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:FinanceIncomeCost contextRef="c89" decimals="0" id="ixv-45000" unitRef="usd">2891781</ifrs-full:FinanceIncomeCost>
    <ifrs-full:FinanceIncomeCost contextRef="c557" decimals="0" id="ixv-45001" unitRef="usd">-1128752</ifrs-full:FinanceIncomeCost>
    <ifrs-full:FinanceIncomeCost contextRef="c558" decimals="0" id="ixv-45002" unitRef="usd">-4327324</ifrs-full:FinanceIncomeCost>
    <ifrs-full:ProfitLossBeforeTax contextRef="c89" decimals="0" id="ixv-45003" unitRef="usd">-88675162</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax contextRef="c557" decimals="0" id="ixv-45004" unitRef="usd">-6273805</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax contextRef="c558" decimals="0" id="ixv-45005" unitRef="usd">-1133320</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="c89" decimals="0" id="ixv-45006" unitRef="usd">1653797</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="c557" decimals="0" id="ixv-45007" unitRef="usd">-471416</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="c558" decimals="0" id="ixv-45008" unitRef="usd">463175</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:ProfitLoss contextRef="c89" decimals="0" id="ixv-45009" unitRef="usd">-90328959</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c557" decimals="0" id="ixv-45010" unitRef="usd">-5802389</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c558" decimals="0" id="ixv-45011" unitRef="usd">-1596495</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation contextRef="c558" decimals="0" id="ixv-45012" unitRef="usd">-434390</ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax contextRef="c89" decimals="0" id="ixv-45013" unitRef="usd">-5467311</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax contextRef="c557" decimals="0" id="ixv-45014" unitRef="usd">-3865328</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax contextRef="c558" decimals="0" id="ixv-45015" unitRef="usd">-5182181</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax>
    <ifrs-full:ComprehensiveIncome contextRef="c89" decimals="0" id="ixv-45016" unitRef="usd">-95796270</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c557" decimals="0" id="ixv-45017" unitRef="usd">-9667717</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c558" decimals="0" id="ixv-45018" unitRef="usd">-7213066</ifrs-full:ComprehensiveIncome>
    <ifrs-full:DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory contextRef="c0" id="ixv-34980">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="text-decoration:underline"&gt;Summary financial statements:&lt;/span&gt;&lt;/p&gt;



&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 0pt"&gt;Current assets&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-496"&gt;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;408,668,037&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Non-current assets&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-497"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;441,960,310&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt"&gt;Total assets&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-498"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;850,628,347&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Current liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-499"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;329,505,846&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Non-current liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-500"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;171,558,140&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Total liabilities&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-501"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;501,063,986&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Total equity&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-502"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;349,564,361&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 0pt"&gt;Total liabilities and equity&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-503"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;850,628,347&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="text-decoration:underline"&gt;Summary statements of comprehensive income or loss&lt;/span&gt;&lt;/p&gt;



&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 64%"&gt;Revenues&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;333,343,987&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;464,828,548&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;419,446,439&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Initial recognition and changes in the fair value of biological assets at the point of harvest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,764,863&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(45,746&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;610,554&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Cost of sales&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(203,424,872&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(278,221,812&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(235,457,053&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Changes in the net realizable value of agricultural products after harvest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,541,204&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,385,069&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(4,351,433&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Research and development expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(14,914,822&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(17,183,041&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(15,345,315&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Selling, general and administrative expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(123,113,572&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(123,690,910&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(113,002,747&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Share of profit or loss of joint ventures and associates&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,126,312&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,049,508&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,198,628&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Other income or expenses, net&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;6,775,970&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,498,555&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,084,892&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left"&gt;Operating (loss) / profit&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(2,235,962&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;45,852,923&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;54,183,965&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Financial results&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(55,335,675&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(34,785,325&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(35,078,018&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;(Loss) / profit before taxes&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(57,571,637&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;11,067,598&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;19,105,947&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Income tax&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,273,616&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(3,778,615&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,068,652&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Result for the year&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(58,845,253&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;7,288,983&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;20,174,599&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-style: italic; text-align: left"&gt;Foreign exchange differences on translation of foreign operations&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(714,251&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(787,354&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;631,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-style: italic; text-align: left; padding-bottom: 1.5pt"&gt;Revaluation of property, plant and equipment, net of tax&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-504"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-505"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,467,349&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-style: italic; text-align: left; padding-bottom: 2.5pt"&gt;Total comprehensive result&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(59,559,504&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;6,501,629&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;19,338,750&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory>
    <ifrs-full:CurrentAssets contextRef="c560" decimals="0" id="ixv-45019" unitRef="usd">408668037</ifrs-full:CurrentAssets>
    <ifrs-full:NoncurrentAssets contextRef="c560" decimals="0" id="ixv-45020" unitRef="usd">441960310</ifrs-full:NoncurrentAssets>
    <ifrs-full:Assets contextRef="c560" decimals="0" id="ixv-45021" unitRef="usd">850628347</ifrs-full:Assets>
    <ifrs-full:CurrentLiabilities contextRef="c560" decimals="0" id="ixv-45022" unitRef="usd">329505846</ifrs-full:CurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities contextRef="c560" decimals="0" id="ixv-45023" unitRef="usd">171558140</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:Liabilities contextRef="c560" decimals="0" id="ixv-45024" unitRef="usd">501063986</ifrs-full:Liabilities>
    <ifrs-full:Equity contextRef="c560" decimals="0" id="ixv-45025" unitRef="usd">349564361</ifrs-full:Equity>
    <ifrs-full:EquityAndLiabilities contextRef="c560" decimals="0" id="ixv-45026" unitRef="usd">850628347</ifrs-full:EquityAndLiabilities>
    <ifrs-full:Revenue contextRef="c561" decimals="0" id="ixv-45027" unitRef="usd">333343987</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c562" decimals="0" id="ixv-45028" unitRef="usd">464828548</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c563" decimals="0" id="ixv-45029" unitRef="usd">419446439</ifrs-full:Revenue>
    <ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets contextRef="c561" decimals="0" id="ixv-45030" unitRef="usd">1764863</ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets>
    <ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets contextRef="c562" decimals="0" id="ixv-45031" unitRef="usd">-45746</ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets>
    <ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets contextRef="c563" decimals="0" id="ixv-45032" unitRef="usd">610554</ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets>
    <ifrs-full:CostOfSales contextRef="c561" decimals="0" id="ixv-45033" unitRef="usd">203424872</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales contextRef="c562" decimals="0" id="ixv-45034" unitRef="usd">278221812</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales contextRef="c563" decimals="0" id="ixv-45035" unitRef="usd">235457053</ifrs-full:CostOfSales>
    <mlec:ChangeInNetRealizableValueOfAgricultural contextRef="c561" decimals="0" id="ixv-45036" unitRef="usd">-1541204</mlec:ChangeInNetRealizableValueOfAgricultural>
    <mlec:ChangeInNetRealizableValueOfAgricultural contextRef="c562" decimals="0" id="ixv-45037" unitRef="usd">-2385069</mlec:ChangeInNetRealizableValueOfAgricultural>
    <mlec:ChangeInNetRealizableValueOfAgricultural contextRef="c563" decimals="0" id="ixv-45038" unitRef="usd">-4351433</mlec:ChangeInNetRealizableValueOfAgricultural>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="c561" decimals="0" id="ixv-45039" unitRef="usd">14914822</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="c562" decimals="0" id="ixv-45040" unitRef="usd">17183041</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="c563" decimals="0" id="ixv-45041" unitRef="usd">15345315</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="c561" decimals="0" id="ixv-45042" unitRef="usd">123113572</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="c562" decimals="0" id="ixv-45043" unitRef="usd">123690910</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="c563" decimals="0" id="ixv-45044" unitRef="usd">113002747</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="c561" decimals="0" id="ixv-45045" unitRef="usd">-1126312</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="c562" decimals="0" id="ixv-45046" unitRef="usd">4049508</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="c563" decimals="0" id="ixv-45047" unitRef="usd">1198628</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:OtherOperatingIncomeExpense contextRef="c561" decimals="0" id="ixv-45048" unitRef="usd">6775970</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:OtherOperatingIncomeExpense contextRef="c562" decimals="0" id="ixv-45049" unitRef="usd">-1498555</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:OtherOperatingIncomeExpense contextRef="c563" decimals="0" id="ixv-45050" unitRef="usd">1084892</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:ProfitLossFromOperatingActivities contextRef="c561" decimals="0" id="ixv-45051" unitRef="usd">-2235962</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities contextRef="c562" decimals="0" id="ixv-45052" unitRef="usd">45852923</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities contextRef="c563" decimals="0" id="ixv-45053" unitRef="usd">54183965</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:FinanceIncomeCost contextRef="c561" decimals="0" id="ixv-45054" unitRef="usd">-55335675</ifrs-full:FinanceIncomeCost>
    <ifrs-full:FinanceIncomeCost contextRef="c562" decimals="0" id="ixv-45055" unitRef="usd">-34785325</ifrs-full:FinanceIncomeCost>
    <ifrs-full:FinanceIncomeCost contextRef="c563" decimals="0" id="ixv-45056" unitRef="usd">-35078018</ifrs-full:FinanceIncomeCost>
    <ifrs-full:ProfitLossBeforeTax contextRef="c561" decimals="0" id="ixv-45057" unitRef="usd">-57571637</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax contextRef="c562" decimals="0" id="ixv-45058" unitRef="usd">11067598</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax contextRef="c563" decimals="0" id="ixv-45059" unitRef="usd">19105947</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="c561" decimals="0" id="ixv-45060" unitRef="usd">1273616</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="c562" decimals="0" id="ixv-45061" unitRef="usd">3778615</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="c563" decimals="0" id="ixv-45062" unitRef="usd">-1068652</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:ProfitLoss contextRef="c561" decimals="0" id="ixv-45063" unitRef="usd">-58845253</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c562" decimals="0" id="ixv-45064" unitRef="usd">7288983</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c563" decimals="0" id="ixv-45065" unitRef="usd">20174599</ifrs-full:ProfitLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax contextRef="c561" decimals="0" id="ixv-45066" unitRef="usd">-714251</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax contextRef="c562" decimals="0" id="ixv-45067" unitRef="usd">-787354</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax contextRef="c563" decimals="0" id="ixv-45068" unitRef="usd">631500</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax>
    <mlec:RevaluationOfPropertyPlantAndEquipmentNetOfTax contextRef="c563" decimals="0" id="ixv-45069" unitRef="usd">-1467349</mlec:RevaluationOfPropertyPlantAndEquipmentNetOfTax>
    <ifrs-full:ComprehensiveIncome contextRef="c561" decimals="0" id="ixv-45070" unitRef="usd">-59559504</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c562" decimals="0" id="ixv-45071" unitRef="usd">6501629</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c563" decimals="0" id="ixv-45072" unitRef="usd">19338750</ifrs-full:ComprehensiveIncome>
    <ifrs-full:DisclosureOfCashFlowStatementExplanatory contextRef="c0" id="ixv-35478">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;12.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;CASH FLOW INFORMATION&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Significant non-cash transactions related to investing
and financing activities are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2025&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2024&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2023&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold"&gt;Investment activities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; width: 64%; text-align: left; padding-left: 0.125in"&gt;Net assets acquisition by business combination (Note 6)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;43,053,702&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,297,882&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;152,070,313&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Investment in-kind in other related parties (Note 17)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-506"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,409,244&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,163,384&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Issuance of shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;457,504&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;267,600&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;759,236&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Own shares held&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;22,327&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(437,154&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-507"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Exchange of intangible assets (Note 8.6)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,427,436&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-508"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-509"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Capitalization of interest on buildings in progress&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;336,416&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;124,098&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;74,710&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Right-of-use leased asset additions through an increase
    in lease liabilities (Note 16)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,569,819&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,585,223&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,154,950&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Reclassification from Investment properties to property, plant and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-510"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-511"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,589,749&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in"&gt;Sale of equity investee (Note 13)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-512"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(900,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(133,079&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-bottom: 2.5pt; padding-left: 0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;59,867,204&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;5,346,893&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;160,679,263&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Financing activities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="width: 64%; text-align: left; padding-left: 0pt"&gt;Capitalization of convertible notes&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-513"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-514"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;12,211,638&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Assignment of receivables with shareholders and other related parties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(7,886,442&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-515"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-516"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Compensation payment financed by acquisition of intangible assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,781,507&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-517"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-518"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Acquisition of interest in subsidiaries by financed debts&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-519"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,417,912&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;81,965,022&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(9,667,949&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;6,417,912&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;94,176,660&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;During the fiscal year ended on June 30, 2024,
the Group has incorporated the assets and liabilities from Natal Agro S.R.L. mentioned in Note 6 &#x2013; Acquisitions and other significant
transactions.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Disclosure of changes in liabilities arising from
financing activities:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Financing activities&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Borrowings&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Consideration for acquisition&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Convertible notes&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; width: 52%; font-weight: bold; padding-bottom: 2.5pt; padding-left: 0.125in"&gt;As of June 30 2022&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;211,426,056&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;12,326,110&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;12,559,071&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;236,311,237&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Proceeds&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;200,185,822&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-520"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;55,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;255,185,822&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(35,308,664&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,148,617&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-521"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(38,457,281&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Conversion of Convertible Notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-522"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-523"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,109,516&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,109,516&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Interest payment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(20,465,271&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-524"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(5,173,742&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(25,639,013&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in"&gt;Exchange differences, currency translation differences and other financial results&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(23,391,636&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(4,617,570&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;21,937,333&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(6,071,873&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; font-weight: bold; padding-bottom: 2.5pt; padding-left: 0.125in"&gt;As of June 30 2023&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;332,446,307&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;4,559,923&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;75,213,146&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;412,219,376&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Proceeds&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;187,994,310&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-525"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-526"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;187,994,310&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(142,866,725&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,912,171&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-527"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(145,778,896&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Financing for assets acquisitions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;743,279&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,119,975&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-528"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,863,254&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Interest payment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(32,631,369&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-529"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(4,172,328&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(36,803,697&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in"&gt;Exchange differences, currency translation differences and other financial results&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;16,073,254&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,809,240&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;9,768,868&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;29,651,362&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; font-weight: bold; padding-bottom: 2.5pt; padding-left: 0.125in"&gt;As of June 30 2024&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;361,759,056&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;6,576,967&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;80,809,686&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;449,145,709&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Proceeds&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;403,333,190&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-530"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-531"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;403,333,190&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(376,998,320&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,035,388&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(380,033,708&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Prepayment Premium Fee&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-532"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-533"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,870,021&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,870,021&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Non-cash activities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(7,886,442&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,781,507&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-534"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,667,949&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Interest payment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(21,772,862&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-535"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(6,315,826&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(28,088,688&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Exchange differences, currency translation differences and other financial results&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;26,645,537&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;138,825&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;23,906,564&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;50,690,926&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Acquisition from business combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,348,173&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-536"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,260,456&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;19,608,629&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in"&gt;Decrease because of loss of control&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(157,926,152&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(2,898,897&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(102,270,445&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(263,095,494&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; font-weight: bold; padding-bottom: 2.5pt; padding-left: 0.125in"&gt;As of June 30 2025&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;228,502,180&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-537"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;18,260,456&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;246,762,636&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfCashFlowStatementExplanatory>
    <mlec:ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities contextRef="c0" id="ixv-35489">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Significant non-cash transactions related to investing
and financing activities are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2025&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2024&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2023&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold"&gt;Investment activities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; width: 64%; text-align: left; padding-left: 0.125in"&gt;Net assets acquisition by business combination (Note 6)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;43,053,702&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,297,882&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;152,070,313&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Investment in-kind in other related parties (Note 17)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-506"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,409,244&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,163,384&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Issuance of shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;457,504&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;267,600&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;759,236&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Own shares held&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;22,327&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(437,154&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-507"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Exchange of intangible assets (Note 8.6)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,427,436&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-508"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-509"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Capitalization of interest on buildings in progress&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;336,416&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;124,098&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;74,710&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Right-of-use leased asset additions through an increase
    in lease liabilities (Note 16)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,569,819&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,585,223&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,154,950&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Reclassification from Investment properties to property, plant and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-510"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-511"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,589,749&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in"&gt;Sale of equity investee (Note 13)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-512"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(900,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(133,079&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-bottom: 2.5pt; padding-left: 0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;59,867,204&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;5,346,893&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;160,679,263&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Financing activities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="width: 64%; text-align: left; padding-left: 0pt"&gt;Capitalization of convertible notes&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-513"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-514"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;12,211,638&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Assignment of receivables with shareholders and other related parties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(7,886,442&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-515"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-516"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Compensation payment financed by acquisition of intangible assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,781,507&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-517"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-518"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Acquisition of interest in subsidiaries by financed debts&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-519"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,417,912&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;81,965,022&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(9,667,949&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;6,417,912&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;94,176,660&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</mlec:ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities>
    <mlec:NetAssetsAcquisitionByBusinessCombination contextRef="c564" decimals="0" id="ixv-45073" unitRef="usd">-43053702</mlec:NetAssetsAcquisitionByBusinessCombination>
    <mlec:NetAssetsAcquisitionByBusinessCombination contextRef="c565" decimals="0" id="ixv-45074" unitRef="usd">-1297882</mlec:NetAssetsAcquisitionByBusinessCombination>
    <mlec:NetAssetsAcquisitionByBusinessCombination contextRef="c566" decimals="0" id="ixv-45075" unitRef="usd">-152070313</mlec:NetAssetsAcquisitionByBusinessCombination>
    <mlec:InvestmentInKindInOtherRelatedPartiesNonCashTransactionsInvestmentActivities contextRef="c565" decimals="0" id="ixv-45076" unitRef="usd">2409244</mlec:InvestmentInKindInOtherRelatedPartiesNonCashTransactionsInvestmentActivities>
    <mlec:InvestmentInKindInOtherRelatedPartiesNonCashTransactionsInvestmentActivities contextRef="c566" decimals="0" id="ixv-45077" unitRef="usd">1163384</mlec:InvestmentInKindInOtherRelatedPartiesNonCashTransactionsInvestmentActivities>
    <mlec:IssuanceOfShare contextRef="c564" decimals="0" id="ixv-45078" unitRef="usd">457504</mlec:IssuanceOfShare>
    <mlec:IssuanceOfShare contextRef="c565" decimals="0" id="ixv-45079" unitRef="usd">267600</mlec:IssuanceOfShare>
    <mlec:IssuanceOfShare contextRef="c566" decimals="0" id="ixv-45080" unitRef="usd">759236</mlec:IssuanceOfShare>
    <mlec:OwnShareHeld contextRef="c564" decimals="0" id="ixv-45081" unitRef="usd">-22327</mlec:OwnShareHeld>
    <mlec:OwnShareHeld contextRef="c565" decimals="0" id="ixv-45082" unitRef="usd">437154</mlec:OwnShareHeld>
    <mlec:ExchangeOfIntangibleAssets contextRef="c564" decimals="0" id="ixv-45083" unitRef="usd">6427436</mlec:ExchangeOfIntangibleAssets>
    <ifrs-full:InterestCostsCapitalised contextRef="c564" decimals="0" id="ixv-45084" unitRef="usd">336416</ifrs-full:InterestCostsCapitalised>
    <ifrs-full:InterestCostsCapitalised contextRef="c565" decimals="0" id="ixv-45085" unitRef="usd">124098</ifrs-full:InterestCostsCapitalised>
    <ifrs-full:InterestCostsCapitalised contextRef="c566" decimals="0" id="ixv-45086" unitRef="usd">74710</ifrs-full:InterestCostsCapitalised>
    <mlec:RightofuseLeasedAssetAdditionsThroughAnIncreaseInLeaseLiabilities contextRef="c564" decimals="0" id="ixv-45087" unitRef="usd">-9569819</mlec:RightofuseLeasedAssetAdditionsThroughAnIncreaseInLeaseLiabilities>
    <mlec:RightofuseLeasedAssetAdditionsThroughAnIncreaseInLeaseLiabilities contextRef="c565" decimals="0" id="ixv-45088" unitRef="usd">-2585223</mlec:RightofuseLeasedAssetAdditionsThroughAnIncreaseInLeaseLiabilities>
    <mlec:RightofuseLeasedAssetAdditionsThroughAnIncreaseInLeaseLiabilities contextRef="c566" decimals="0" id="ixv-45089" unitRef="usd">-3154950</mlec:RightofuseLeasedAssetAdditionsThroughAnIncreaseInLeaseLiabilities>
    <mlec:NonMonetaryContributionsInJointVenturesNonCashTransactionsInvestmentActivities contextRef="c566" decimals="0" id="ixv-45090" unitRef="usd">3589749</mlec:NonMonetaryContributionsInJointVenturesNonCashTransactionsInvestmentActivities>
    <ifrs-full:ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod contextRef="c565" decimals="0" id="ixv-45091" unitRef="usd">900000</ifrs-full:ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod>
    <ifrs-full:ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod contextRef="c566" decimals="0" id="ixv-45092" unitRef="usd">133079</ifrs-full:ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod>
    <mlec:NonCashInvestingActivities contextRef="c564" decimals="0" id="ixv-45093" unitRef="usd">59867204</mlec:NonCashInvestingActivities>
    <mlec:NonCashInvestingActivities contextRef="c565" decimals="0" id="ixv-45094" unitRef="usd">5346893</mlec:NonCashInvestingActivities>
    <mlec:NonCashInvestingActivities contextRef="c566" decimals="0" id="ixv-45095" unitRef="usd">160679263</mlec:NonCashInvestingActivities>
    <mlec:CapitalizationOfConvertibleFinancingActivities contextRef="c566" decimals="0" id="ixv-45096" unitRef="usd">-12211638</mlec:CapitalizationOfConvertibleFinancingActivities>
    <mlec:AssignmentOfReceivablesWithShareholdersAndOtherRelatedParties contextRef="c564" decimals="0" id="ixv-45097" unitRef="usd">7886442</mlec:AssignmentOfReceivablesWithShareholdersAndOtherRelatedParties>
    <mlec:CompensationPaymentFinancedByAcquisitionOfIntangibleAssets contextRef="c564" decimals="0" id="ixv-45098" unitRef="usd">1781507</mlec:CompensationPaymentFinancedByAcquisitionOfIntangibleAssets>
    <mlec:IncreaseThroughAcquisitionOfNonControllingInterestInSubsidiaries contextRef="c565" decimals="0" id="ixv-45099" unitRef="usd">-6417912</mlec:IncreaseThroughAcquisitionOfNonControllingInterestInSubsidiaries>
    <mlec:IncreaseThroughAcquisitionOfNonControllingInterestInSubsidiaries contextRef="c566" decimals="0" id="ixv-45100" unitRef="usd">-81965022</mlec:IncreaseThroughAcquisitionOfNonControllingInterestInSubsidiaries>
    <mlec:NonCashFinancingActivities contextRef="c564" decimals="0" id="ixv-45101" unitRef="usd">-9667949</mlec:NonCashFinancingActivities>
    <mlec:NonCashFinancingActivities contextRef="c565" decimals="0" id="ixv-45102" unitRef="usd">6417912</mlec:NonCashFinancingActivities>
    <mlec:NonCashFinancingActivities contextRef="c566" decimals="0" id="ixv-45103" unitRef="usd">94176660</mlec:NonCashFinancingActivities>
    <ifrs-full:DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory contextRef="c0" id="ixv-35795">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Disclosure of changes in liabilities arising from
financing activities:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Financing activities&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Borrowings&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Consideration for acquisition&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Convertible notes&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; width: 52%; font-weight: bold; padding-bottom: 2.5pt; padding-left: 0.125in"&gt;As of June 30 2022&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;211,426,056&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;12,326,110&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;12,559,071&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;236,311,237&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Proceeds&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;200,185,822&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-520"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;55,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;255,185,822&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(35,308,664&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,148,617&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-521"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(38,457,281&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Conversion of Convertible Notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-522"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-523"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,109,516&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,109,516&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Interest payment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(20,465,271&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-524"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(5,173,742&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(25,639,013&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in"&gt;Exchange differences, currency translation differences and other financial results&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(23,391,636&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(4,617,570&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;21,937,333&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(6,071,873&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; font-weight: bold; padding-bottom: 2.5pt; padding-left: 0.125in"&gt;As of June 30 2023&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;332,446,307&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;4,559,923&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;75,213,146&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;412,219,376&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Proceeds&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;187,994,310&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-525"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-526"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;187,994,310&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(142,866,725&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,912,171&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-527"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(145,778,896&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Financing for assets acquisitions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;743,279&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,119,975&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-528"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,863,254&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Interest payment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(32,631,369&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-529"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(4,172,328&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(36,803,697&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in"&gt;Exchange differences, currency translation differences and other financial results&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;16,073,254&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,809,240&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;9,768,868&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;29,651,362&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; font-weight: bold; padding-bottom: 2.5pt; padding-left: 0.125in"&gt;As of June 30 2024&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;361,759,056&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;6,576,967&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;80,809,686&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;449,145,709&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Proceeds&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;403,333,190&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-530"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-531"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;403,333,190&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(376,998,320&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,035,388&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(380,033,708&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Prepayment Premium Fee&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-532"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-533"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,870,021&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,870,021&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Non-cash activities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(7,886,442&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,781,507&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-534"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,667,949&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Interest payment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(21,772,862&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-535"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(6,315,826&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(28,088,688&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Exchange differences, currency translation differences and other financial results&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;26,645,537&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;138,825&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;23,906,564&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;50,690,926&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-left: 0.125in"&gt;Acquisition from business combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,348,173&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-536"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,260,456&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;19,608,629&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in"&gt;Decrease because of loss of control&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(157,926,152&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(2,898,897&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(102,270,445&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(263,095,494&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; font-weight: bold; padding-bottom: 2.5pt; padding-left: 0.125in"&gt;As of June 30 2025&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;228,502,180&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-537"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;18,260,456&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;246,762,636&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c567" decimals="0" id="ixv-45104" unitRef="usd">211426056</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c568" decimals="0" id="ixv-45105" unitRef="usd">12326110</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c569" decimals="0" id="ixv-45106" unitRef="usd">12559071</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c65" decimals="0" id="ixv-45107" unitRef="usd">236311237</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <mlec:IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities contextRef="c570" decimals="0" id="ixv-45108" unitRef="usd">200185822</mlec:IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities>
    <mlec:IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities contextRef="c572" decimals="0" id="ixv-45109" unitRef="usd">55000000</mlec:IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities>
    <mlec:IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities contextRef="c6" decimals="0" id="ixv-45110" unitRef="usd">255185822</mlec:IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities>
    <mlec:DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities contextRef="c570" decimals="0" id="ixv-45111" unitRef="usd">35308664</mlec:DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities>
    <mlec:DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities contextRef="c571" decimals="0" id="ixv-45112" unitRef="usd">3148617</mlec:DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities>
    <mlec:DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities contextRef="c6" decimals="0" id="ixv-45113" unitRef="usd">38457281</mlec:DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities>
    <mlec:DecreaseThroughCapitalizationOfDebtLiabilitiesArisingFromFinancingActivities contextRef="c572" decimals="0" id="ixv-45114" unitRef="usd">9109516</mlec:DecreaseThroughCapitalizationOfDebtLiabilitiesArisingFromFinancingActivities>
    <mlec:DecreaseThroughCapitalizationOfDebtLiabilitiesArisingFromFinancingActivities contextRef="c6" decimals="0" id="ixv-45115" unitRef="usd">9109516</mlec:DecreaseThroughCapitalizationOfDebtLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities contextRef="c570" decimals="0" id="ixv-45116" unitRef="usd">20465271</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities contextRef="c572" decimals="0" id="ixv-45117" unitRef="usd">5173742</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities contextRef="c6" decimals="0" id="ixv-45118" unitRef="usd">25639013</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities contextRef="c570" decimals="0" id="ixv-45119" unitRef="usd">-23391636</ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities contextRef="c571" decimals="0" id="ixv-45120" unitRef="usd">-4617570</ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities contextRef="c572" decimals="0" id="ixv-45121" unitRef="usd">21937333</ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities contextRef="c6" decimals="0" id="ixv-45122" unitRef="usd">-6071873</ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c573" decimals="0" id="ixv-45123" unitRef="usd">332446307</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c574" decimals="0" id="ixv-45124" unitRef="usd">4559923</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c575" decimals="0" id="ixv-45125" unitRef="usd">75213146</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c47" decimals="0" id="ixv-45126" unitRef="usd">412219376</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <mlec:IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities contextRef="c576" decimals="0" id="ixv-45127" unitRef="usd">187994310</mlec:IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities>
    <mlec:IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities contextRef="c5" decimals="0" id="ixv-45128" unitRef="usd">187994310</mlec:IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities>
    <mlec:DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities contextRef="c576" decimals="0" id="ixv-45129" unitRef="usd">142866725</mlec:DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities>
    <mlec:DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities contextRef="c577" decimals="0" id="ixv-45130" unitRef="usd">2912171</mlec:DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities>
    <mlec:DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities contextRef="c5" decimals="0" id="ixv-45131" unitRef="usd">145778896</mlec:DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities>
    <mlec:FinancingForAssetsAcquisitions contextRef="c576" decimals="0" id="ixv-45132" unitRef="usd">743279</mlec:FinancingForAssetsAcquisitions>
    <mlec:FinancingForAssetsAcquisitions contextRef="c577" decimals="0" id="ixv-45133" unitRef="usd">1119975</mlec:FinancingForAssetsAcquisitions>
    <mlec:FinancingForAssetsAcquisitions contextRef="c5" decimals="0" id="ixv-45134" unitRef="usd">1863254</mlec:FinancingForAssetsAcquisitions>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities contextRef="c576" decimals="0" id="ixv-45135" unitRef="usd">32631369</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities contextRef="c578" decimals="0" id="ixv-45136" unitRef="usd">4172328</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities contextRef="c5" decimals="0" id="ixv-45137" unitRef="usd">36803697</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities contextRef="c576" decimals="0" id="ixv-45138" unitRef="usd">16073254</ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities contextRef="c577" decimals="0" id="ixv-45139" unitRef="usd">3809240</ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities contextRef="c578" decimals="0" id="ixv-45140" unitRef="usd">9768868</ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities contextRef="c5" decimals="0" id="ixv-45141" unitRef="usd">29651362</ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c579" decimals="0" id="ixv-45142" unitRef="usd">361759056</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c580" decimals="0" id="ixv-45143" unitRef="usd">6576967</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c581" decimals="0" id="ixv-45144" unitRef="usd">80809686</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c7" decimals="0" id="ixv-45145" unitRef="usd">449145709</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <mlec:IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities contextRef="c582" decimals="0" id="ixv-45146" unitRef="usd">403333190</mlec:IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities>
    <mlec:IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities contextRef="c0" decimals="0" id="ixv-45147" unitRef="usd">403333190</mlec:IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities>
    <mlec:DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities contextRef="c582" decimals="0" id="ixv-45148" unitRef="usd">376998320</mlec:DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities>
    <mlec:DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities contextRef="c583" decimals="0" id="ixv-45149" unitRef="usd">2035388</mlec:DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities>
    <mlec:DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities contextRef="c584" decimals="0" id="ixv-45150" unitRef="usd">1000000</mlec:DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities>
    <mlec:DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities contextRef="c0" decimals="0" id="ixv-45151" unitRef="usd">380033708</mlec:DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities>
    <mlec:PrepaymentPremiumFee contextRef="c584" decimals="0" id="ixv-45152" unitRef="usd">4870021</mlec:PrepaymentPremiumFee>
    <mlec:PrepaymentPremiumFee contextRef="c0" decimals="0" id="ixv-45153" unitRef="usd">4870021</mlec:PrepaymentPremiumFee>
    <mlec:NoncashActivities contextRef="c582" decimals="0" id="ixv-45154" unitRef="usd">-7886442</mlec:NoncashActivities>
    <mlec:NoncashActivities contextRef="c583" decimals="0" id="ixv-45155" unitRef="usd">-1781507</mlec:NoncashActivities>
    <mlec:NoncashActivities contextRef="c0" decimals="0" id="ixv-45156" unitRef="usd">-9667949</mlec:NoncashActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities contextRef="c582" decimals="0" id="ixv-45157" unitRef="usd">21772862</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities contextRef="c584" decimals="0" id="ixv-45158" unitRef="usd">6315826</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities contextRef="c0" decimals="0" id="ixv-45159" unitRef="usd">28088688</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities contextRef="c582" decimals="0" id="ixv-45160" unitRef="usd">26645537</ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities contextRef="c583" decimals="0" id="ixv-45161" unitRef="usd">138825</ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities contextRef="c584" decimals="0" id="ixv-45162" unitRef="usd">23906564</ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities contextRef="c0" decimals="0" id="ixv-45163" unitRef="usd">50690926</ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c582" decimals="0" id="ixv-45164" unitRef="usd">1348173</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c584" decimals="0" id="ixv-45165" unitRef="usd">18260456</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c0" decimals="0" id="ixv-45166" unitRef="usd">19608629</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <mlec:DecreaseBecauseOfLossOfControl contextRef="c582" decimals="0" id="ixv-45167" unitRef="usd">-157926152</mlec:DecreaseBecauseOfLossOfControl>
    <mlec:DecreaseBecauseOfLossOfControl contextRef="c583" decimals="0" id="ixv-45168" unitRef="usd">-2898897</mlec:DecreaseBecauseOfLossOfControl>
    <mlec:DecreaseBecauseOfLossOfControl contextRef="c584" decimals="0" id="ixv-45169" unitRef="usd">-102270445</mlec:DecreaseBecauseOfLossOfControl>
    <mlec:DecreaseBecauseOfLossOfControl contextRef="c0" decimals="0" id="ixv-45170" unitRef="usd">-263095494</mlec:DecreaseBecauseOfLossOfControl>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c585" decimals="0" id="ixv-45171" unitRef="usd">228502180</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c587" decimals="0" id="ixv-45172" unitRef="usd">18260456</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c4" decimals="0" id="ixv-45173" unitRef="usd">246762636</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:DisclosureOfJointVenturesExplanatory contextRef="c0" id="ixv-36272">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="padding: 0pt; width: 0"&gt;&lt;/td&gt;&lt;td style="padding: 0pt; width: 0.25in"&gt;&lt;b&gt;13.&lt;/b&gt;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;JOINT VENTURES AND ASSOCIATES&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;06/30/2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;06/30/2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration:underline"&gt;Assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; font-style: italic"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Measured at equity value
    method&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Synertech Industrias
    S.A.&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-538; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;39,749,850&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Bioceres Crops Solutions
    Corp&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;77,741,970&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-539; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Agrality Argentina S.A.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,521,996&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,758,886&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Agrality US Inc.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,315,307&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,521,791&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Agrality Seeds Inc.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,496,286&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,812,389&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;SW Semillas S.A.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;725&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;955&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Alfalfa Technologies S.R.L.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-540; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;36,503&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Inmet
    S.A&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;71,687&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;379,876&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;94,147,971&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;56,260,250&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Measured
    at Fair value&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Theo
    I SCSp&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-541; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;36,535,601&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-542; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;36,535,601&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;06/30/2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;06/30/2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="text-decoration:underline"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left"&gt;Measured at equity value method&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Trigall Genetics S.A.&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-543"&gt;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;296,455&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-544"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;296,455&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Changes in joint ventures investments and affiliates:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; padding-left: 0pt"&gt;As of the beginning&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;92,499,396&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;117,720,140&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;Loss of control&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(38,363,585&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-545"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Changes in equity interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;77,741,970&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,958&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Sale of equity investment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-546"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(900,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Reclassification of Moolec Science S.A.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-547"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,560,472&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Share-based incentives&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-548"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;65,470&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Dividends distribution&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-549"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,790,032&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Foreign currency translation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(802,200&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;977,482&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Share of profit or loss measured at equity value method&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(392,009&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,747,312&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Share of profit or loss measured at fair value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(36,535,601&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(28,770,462&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;As of the end of the year&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;94,147,971&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;92,499,396&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Share of profit or loss of joint ventures and affiliates:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Profit and losses&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; font-style: italic"&gt;Measured at equity value method&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; padding-left: 0pt"&gt;Synertech Industrias S.A.&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(415,089&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3,723,140&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;564,598&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Agrality Argentina S.A.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;587,173&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,519,639&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,126,492&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Agrality US Inc.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(206,484&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(64,322&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,940,435&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Agrality Seeds Inc.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;683,897&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(124,468&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,187,415&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Indrasa Biotecnolog&#xed;a S.A.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-550"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-551"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;62,613&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Moolec Science SA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-552"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-553"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(4,176,703&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;SW Semillas S.A.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(285&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,592&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,917&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Trigall Genetics&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(711,223&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;326,368&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;103,703&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Inmet S.A.&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(329,998&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;369,547&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-554"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(392,009&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;7,747,312&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(2,076,234&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left; padding-left: 0pt"&gt;Measured at Fair value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Theo I SCSp&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(36,535,601&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(28,770,462&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;49,785,839&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(36,535,601&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(28,770,462&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;49,785,839&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Bioceres Group Limited has elected to measure
the investment in associates held through Theo I SCSp at fair value through profit or loss in accordance&#160;with&#160;IFRS&#160;9.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;There are no significant restrictions on the ability
of the joint ventures and affiliates to transfer funds to the Group for cash dividends, or to repay loans or advances made by the Group,
except for the legal obligation to establish a legal reserve for 5% of the profit for the year until reaching 20% of the capital for Argentinian
entities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Summarized financial information prepared in accordance
with International Financial Reporting Standards (&#x201c;IFRS&#x201d;) in relation to the significant joint ventures is presented below:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Name&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Date&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Current&lt;br/&gt;
    assets&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Non-current&lt;br/&gt;
    assets&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Current&lt;br/&gt;
    liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Non-&lt;br/&gt;
    current&lt;br/&gt; liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Equity&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(Loss)/Profit&lt;br/&gt;
    of the year&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Synertech&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;06/30/2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-555; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-556; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-557; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-558; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-559; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-560"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-561"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; width: 16%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Industries&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&lt;/td&gt;
    &lt;td style="width: 10%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;06/30/2024&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;55,963,591&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,195,394&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;27,610,517&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,447,008&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;36,101,460&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;61,815,678&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,236,901&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;S.A.&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;06/30/2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;50,602,942&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12,351,672&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;30,248,685&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,841,374&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;28,864,555&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;62,798,136&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,980,995&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;06/30/2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,733,702&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;17,174,010&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9,749,928&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8,155,954&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,001,830&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;27,931,724&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,409,802&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Agrality S.A.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;06/30/2024&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;22,098,808&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20,002,212&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;22,984,897&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8,640,513&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,475,610&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;22,757,410&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,935,787&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;06/30/2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14,203,372&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;24,832,433&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14,591,700&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;19,382,094&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,062,012&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20,540,979&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,071,653&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Theo I SCSp&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;06/30/2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-562; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;22,755,817&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,642,112&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;73,674,157&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(61,560,452&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-563; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(99,549,928&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;06/30/2024&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-564; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;108,456,044&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,405,755&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;57,060,813&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;37,989,476&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-565; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(32,213,331&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;06/30/2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-566; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;135,533,950&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,998,548&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;55,630,592&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;67,904,810&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-567; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(10,632,802&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfJointVenturesExplanatory>
    <mlec:DisclosureOfInvestmentsInJointVenturesAndAffiliatesTableTextBlock contextRef="c0" id="ixv-36282">&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;06/30/2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;06/30/2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="text-decoration:underline"&gt;Assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; font-style: italic"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Measured at equity value
    method&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Synertech Industrias
    S.A.&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-538; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;39,749,850&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Bioceres Crops Solutions
    Corp&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;77,741,970&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-539; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Agrality Argentina S.A.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,521,996&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,758,886&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Agrality US Inc.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,315,307&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,521,791&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Agrality Seeds Inc.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,496,286&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,812,389&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;SW Semillas S.A.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;725&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;955&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Alfalfa Technologies S.R.L.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-540; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;36,503&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Inmet
    S.A&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;71,687&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;379,876&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;94,147,971&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;56,260,250&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Measured
    at Fair value&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Theo
    I SCSp&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-541; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;36,535,601&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-542; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;36,535,601&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;06/30/2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;06/30/2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;span style="text-decoration:underline"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left"&gt;Measured at equity value method&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Trigall Genetics S.A.&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-543"&gt;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;296,455&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-544"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;296,455&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</mlec:DisclosureOfInvestmentsInJointVenturesAndAffiliatesTableTextBlock>
    <ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates contextRef="c590" decimals="0" id="ixv-45174" unitRef="usd">39749850</ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates>
    <ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates contextRef="c591" decimals="0" id="ixv-45175" unitRef="usd">77741970</ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates>
    <ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates contextRef="c593" decimals="0" id="ixv-45176" unitRef="usd">7521996</ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates>
    <ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates contextRef="c594" decimals="0" id="ixv-45177" unitRef="usd">7758886</ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates>
    <ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates contextRef="c595" decimals="0" id="ixv-45178" unitRef="usd">3315307</ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates>
    <ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates contextRef="c596" decimals="0" id="ixv-45179" unitRef="usd">3521791</ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates>
    <ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates contextRef="c597" decimals="0" id="ixv-45180" unitRef="usd">5496286</ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates>
    <ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates contextRef="c598" decimals="0" id="ixv-45181" unitRef="usd">4812389</ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates>
    <ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates contextRef="c599" decimals="0" id="ixv-45182" unitRef="usd">725</ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates>
    <ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates contextRef="c600" decimals="0" id="ixv-45183" unitRef="usd">955</ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates>
    <ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates contextRef="c602" decimals="0" id="ixv-45184" unitRef="usd">36503</ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates>
    <ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates contextRef="c603" decimals="0" id="ixv-45185" unitRef="usd">71687</ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates>
    <ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates contextRef="c604" decimals="0" id="ixv-45186" unitRef="usd">379876</ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates>
    <ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates contextRef="c4" decimals="0" id="ixv-45187" unitRef="usd">94147971</ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates>
    <ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates contextRef="c7" decimals="0" id="ixv-45188" unitRef="usd">56260250</ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates>
    <mlec:InvestmentsMeasuredAtFairValue contextRef="c606" decimals="0" id="ixv-45189" unitRef="usd">36535601</mlec:InvestmentsMeasuredAtFairValue>
    <mlec:InvestmentsMeasuredAtFairValue contextRef="c7" decimals="0" id="ixv-45190" unitRef="usd">36535601</mlec:InvestmentsMeasuredAtFairValue>
    <mlec:DueToJointVenturesAndAssociatesNonCurrent contextRef="c608" decimals="0" id="ixv-45191" unitRef="usd">296455</mlec:DueToJointVenturesAndAssociatesNonCurrent>
    <mlec:DueToJointVenturesAndAssociatesNonCurrent contextRef="c7" decimals="0" id="ixv-45192" unitRef="usd">296455</mlec:DueToJointVenturesAndAssociatesNonCurrent>
    <mlec:DisclosureOfChangesInInvestmentInJointVenturesAndAffiliatesTableTextBlock contextRef="c0" id="ixv-36611">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Changes in joint ventures investments and affiliates:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; padding-left: 0pt"&gt;As of the beginning&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;92,499,396&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;117,720,140&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;Loss of control&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(38,363,585&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-545"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Changes in equity interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;77,741,970&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,958&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Sale of equity investment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-546"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(900,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Reclassification of Moolec Science S.A.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-547"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,560,472&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Share-based incentives&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-548"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;65,470&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Dividends distribution&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-549"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,790,032&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Foreign currency translation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(802,200&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;977,482&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Share of profit or loss measured at equity value method&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(392,009&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,747,312&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Share of profit or loss measured at fair value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(36,535,601&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(28,770,462&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;As of the end of the year&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;94,147,971&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;92,499,396&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</mlec:DisclosureOfChangesInInvestmentInJointVenturesAndAffiliatesTableTextBlock>
    <mlec:InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity contextRef="c609" decimals="0" id="ixv-45193" unitRef="usd">92499396</mlec:InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity>
    <mlec:InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity contextRef="c610" decimals="0" id="ixv-45194" unitRef="usd">117720140</mlec:InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity>
    <ifrs-full:LossesOnDisposalsOfInvestments contextRef="c611" decimals="0" id="ixv-45195" unitRef="usd">38363585</ifrs-full:LossesOnDisposalsOfInvestments>
    <mlec:ChangesInEquityInterest contextRef="c611" decimals="0" id="ixv-45196" unitRef="usd">77741970</mlec:ChangesInEquityInterest>
    <mlec:ChangesInEquityInterest contextRef="c612" decimals="0" id="ixv-45197" unitRef="usd">9958</mlec:ChangesInEquityInterest>
    <mlec:SaleOfEquityInvestment contextRef="c612" decimals="0" id="ixv-45198" unitRef="usd">-900000</mlec:SaleOfEquityInvestment>
    <mlec:JointVenturesAndAssociatesAccountedForUsingEquityMethodReclassificationChangeInOwnership contextRef="c612" decimals="0" id="ixv-45199" unitRef="usd">2560472</mlec:JointVenturesAndAssociatesAccountedForUsingEquityMethodReclassificationChangeInOwnership>
    <mlec:EquityMethodInvestmentIncreaseFromShareBasedIncentives contextRef="c612" decimals="0" id="ixv-45200" unitRef="usd">65470</mlec:EquityMethodInvestmentIncreaseFromShareBasedIncentives>
    <mlec:ChangeinJointVenturesDividendsDistribution contextRef="c612" decimals="0" id="ixv-45201" unitRef="usd">-1790032</mlec:ChangeinJointVenturesDividendsDistribution>
    <mlec:GainsLossesOnExchangeDifferencesOnTranslationFromJointVentureNetOfTax contextRef="c611" decimals="0" id="ixv-45202" unitRef="usd">-802200</mlec:GainsLossesOnExchangeDifferencesOnTranslationFromJointVentureNetOfTax>
    <mlec:GainsLossesOnExchangeDifferencesOnTranslationFromJointVentureNetOfTax contextRef="c612" decimals="0" id="ixv-45203" unitRef="usd">977482</mlec:GainsLossesOnExchangeDifferencesOnTranslationFromJointVentureNetOfTax>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="c611" decimals="0" id="ixv-45204" unitRef="usd">-392009</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="c612" decimals="0" id="ixv-45205" unitRef="usd">7747312</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <mlec:ShareOfProfitOrLossMeasuredAtFairValue contextRef="c611" decimals="0" id="ixv-45206" unitRef="usd">-36535601</mlec:ShareOfProfitOrLossMeasuredAtFairValue>
    <mlec:ShareOfProfitOrLossMeasuredAtFairValue contextRef="c612" decimals="0" id="ixv-45207" unitRef="usd">-28770462</mlec:ShareOfProfitOrLossMeasuredAtFairValue>
    <mlec:InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity contextRef="c613" decimals="0" id="ixv-45208" unitRef="usd">94147971</mlec:InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity>
    <mlec:InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity contextRef="c609" decimals="0" id="ixv-45209" unitRef="usd">92499396</mlec:InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity>
    <mlec:DisclosureOfShareOfProfitOrLossInJointVenturesAndAffiliatesTableTextBlock contextRef="c0" id="ixv-36780">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Share of profit or loss of joint ventures and affiliates:&lt;/p&gt;&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; font-style: italic"&gt;Measured at equity value method&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; padding-left: 0pt"&gt;Synertech Industrias S.A.&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(415,089&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3,723,140&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;564,598&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Agrality Argentina S.A.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;587,173&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,519,639&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,126,492&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Agrality US Inc.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(206,484&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(64,322&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,940,435&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Agrality Seeds Inc.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;683,897&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(124,468&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,187,415&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Indrasa Biotecnolog&#xed;a S.A.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-550"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-551"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;62,613&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Moolec Science SA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-552"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-553"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(4,176,703&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;SW Semillas S.A.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(285&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,592&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,917&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Trigall Genetics&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(711,223&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;326,368&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;103,703&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Inmet S.A.&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(329,998&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;369,547&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-554"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(392,009&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;7,747,312&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(2,076,234&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left; padding-left: 0pt"&gt;Measured at Fair value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Theo I SCSp&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(36,535,601&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(28,770,462&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;49,785,839&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 2.5pt; padding-left: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(36,535,601&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(28,770,462&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;49,785,839&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</mlec:DisclosureOfShareOfProfitOrLossInJointVenturesAndAffiliatesTableTextBlock>
    <ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod contextRef="c614" decimals="0" id="ixv-45210" unitRef="usd">-415089</ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod contextRef="c615" decimals="0" id="ixv-45211" unitRef="usd">3723140</ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod contextRef="c616" decimals="0" id="ixv-45212" unitRef="usd">564598</ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod contextRef="c617" decimals="0" id="ixv-45213" unitRef="usd">587173</ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod contextRef="c618" decimals="0" id="ixv-45214" unitRef="usd">3519639</ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod contextRef="c619" decimals="0" id="ixv-45215" unitRef="usd">2126492</ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod contextRef="c620" decimals="0" id="ixv-45216" unitRef="usd">-206484</ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod contextRef="c621" decimals="0" id="ixv-45217" unitRef="usd">-64322</ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod contextRef="c622" decimals="0" id="ixv-45218" unitRef="usd">-2940435</ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod contextRef="c623" decimals="0" id="ixv-45219" unitRef="usd">683897</ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod contextRef="c624" decimals="0" id="ixv-45220" unitRef="usd">-124468</ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod contextRef="c625" decimals="0" id="ixv-45221" unitRef="usd">2187415</ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod contextRef="c628" decimals="0" id="ixv-45222" unitRef="usd">62613</ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod contextRef="c631" decimals="0" id="ixv-45223" unitRef="usd">-4176703</ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod contextRef="c632" decimals="0" id="ixv-45224" unitRef="usd">-285</ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod contextRef="c633" decimals="0" id="ixv-45225" unitRef="usd">-2592</ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod contextRef="c634" decimals="0" id="ixv-45226" unitRef="usd">-3917</ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod contextRef="c635" decimals="0" id="ixv-45227" unitRef="usd">-711223</ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod contextRef="c636" decimals="0" id="ixv-45228" unitRef="usd">326368</ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod contextRef="c637" decimals="0" id="ixv-45229" unitRef="usd">103703</ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod contextRef="c638" decimals="0" id="ixv-45230" unitRef="usd">-329998</ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod contextRef="c639" decimals="0" id="ixv-45231" unitRef="usd">369547</ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod contextRef="c0" decimals="0" id="ixv-45232" unitRef="usd">-392009</ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod contextRef="c5" decimals="0" id="ixv-45233" unitRef="usd">7747312</ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod contextRef="c6" decimals="0" id="ixv-45234" unitRef="usd">-2076234</ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod>
    <mlec:ShareOfProfitOrLossMeasuredAtFairValue contextRef="c641" decimals="0" id="ixv-45235" unitRef="usd">-36535601</mlec:ShareOfProfitOrLossMeasuredAtFairValue>
    <mlec:ShareOfProfitOrLossMeasuredAtFairValue contextRef="c642" decimals="0" id="ixv-45236" unitRef="usd">-28770462</mlec:ShareOfProfitOrLossMeasuredAtFairValue>
    <mlec:ShareOfProfitOrLossMeasuredAtFairValue contextRef="c643" decimals="0" id="ixv-45237" unitRef="usd">49785839</mlec:ShareOfProfitOrLossMeasuredAtFairValue>
    <mlec:ShareOfProfitOrLossMeasuredAtFairValue contextRef="c0" decimals="0" id="ixv-45238" unitRef="usd">-36535601</mlec:ShareOfProfitOrLossMeasuredAtFairValue>
    <mlec:ShareOfProfitOrLossMeasuredAtFairValue contextRef="c5" decimals="0" id="ixv-45239" unitRef="usd">-28770462</mlec:ShareOfProfitOrLossMeasuredAtFairValue>
    <mlec:ShareOfProfitOrLossMeasuredAtFairValue contextRef="c6" decimals="0" id="ixv-45240" unitRef="usd">49785839</mlec:ShareOfProfitOrLossMeasuredAtFairValue>
    <mlec:PercentageOfProfitForObligationToLegalReserve
      contextRef="c588"
      decimals="2"
      id="ixv-45241"
      unitRef="pure">0.05</mlec:PercentageOfProfitForObligationToLegalReserve>
    <mlec:MaximumPercentageOfCapitalForObligationToLegalReserve
      contextRef="c588"
      decimals="2"
      id="ixv-45242"
      unitRef="pure">0.20</mlec:MaximumPercentageOfCapitalForObligationToLegalReserve>
    <mlec:ScheduleOfSignificantJointVenturesTableTextBlock contextRef="c0" id="ixv-37028">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Summarized financial information prepared in accordance
with International Financial Reporting Standards (&#x201c;IFRS&#x201d;) in relation to the significant joint ventures is presented below:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Name&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Date&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Current&lt;br/&gt;
    assets&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Non-current&lt;br/&gt;
    assets&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Current&lt;br/&gt;
    liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Non-&lt;br/&gt;
    current&lt;br/&gt; liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Equity&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(Loss)/Profit&lt;br/&gt;
    of the year&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Synertech&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;06/30/2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-555; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-556; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-557; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-558; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-559; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-560"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-561"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; width: 16%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Industries&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&lt;/td&gt;
    &lt;td style="width: 10%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;06/30/2024&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;55,963,591&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,195,394&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;27,610,517&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,447,008&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;36,101,460&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;61,815,678&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,236,901&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 0.5%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;S.A.&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;06/30/2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;50,602,942&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12,351,672&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;30,248,685&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,841,374&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;28,864,555&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;62,798,136&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,980,995&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;06/30/2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,733,702&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;17,174,010&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9,749,928&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8,155,954&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,001,830&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;27,931,724&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,409,802&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Agrality S.A.&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;06/30/2024&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;22,098,808&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20,002,212&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;22,984,897&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8,640,513&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,475,610&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;22,757,410&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,935,787&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;06/30/2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14,203,372&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;24,832,433&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14,591,700&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;19,382,094&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,062,012&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20,540,979&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,071,653&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Theo I SCSp&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;06/30/2025&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-562; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;22,755,817&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10,642,112&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;73,674,157&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(61,560,452&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-563; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(99,549,928&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;06/30/2024&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-564; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;108,456,044&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,405,755&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;57,060,813&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;37,989,476&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-565; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(32,213,331&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;06/30/2023&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-566; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;135,533,950&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,998,548&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;55,630,592&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;67,904,810&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-567; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(10,632,802&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</mlec:ScheduleOfSignificantJointVenturesTableTextBlock>
    <ifrs-full:CurrentAssets contextRef="c646" decimals="0" id="ixv-45243" unitRef="usd">55963591</ifrs-full:CurrentAssets>
    <ifrs-full:NoncurrentAssets contextRef="c646" decimals="0" id="ixv-45244" unitRef="usd">11195394</ifrs-full:NoncurrentAssets>
    <ifrs-full:CurrentLiabilities contextRef="c646" decimals="0" id="ixv-45245" unitRef="usd">27610517</ifrs-full:CurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities contextRef="c646" decimals="0" id="ixv-45246" unitRef="usd">3447008</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:Equity contextRef="c646" decimals="0" id="ixv-45247" unitRef="usd">36101460</ifrs-full:Equity>
    <ifrs-full:CostOfSales contextRef="c647" decimals="0" id="ixv-45248" unitRef="usd">61815678</ifrs-full:CostOfSales>
    <ifrs-full:ProfitLoss contextRef="c647" decimals="0" id="ixv-45249" unitRef="usd">7236901</ifrs-full:ProfitLoss>
    <ifrs-full:CurrentAssets contextRef="c648" decimals="0" id="ixv-45250" unitRef="usd">50602942</ifrs-full:CurrentAssets>
    <ifrs-full:NoncurrentAssets contextRef="c648" decimals="0" id="ixv-45251" unitRef="usd">12351672</ifrs-full:NoncurrentAssets>
    <ifrs-full:CurrentLiabilities contextRef="c648" decimals="0" id="ixv-45252" unitRef="usd">30248685</ifrs-full:CurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities contextRef="c648" decimals="0" id="ixv-45253" unitRef="usd">3841374</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:Equity contextRef="c648" decimals="0" id="ixv-45254" unitRef="usd">28864555</ifrs-full:Equity>
    <ifrs-full:CostOfSales contextRef="c649" decimals="0" id="ixv-45255" unitRef="usd">62798136</ifrs-full:CostOfSales>
    <ifrs-full:ProfitLoss contextRef="c649" decimals="0" id="ixv-45256" unitRef="usd">3980995</ifrs-full:ProfitLoss>
    <ifrs-full:CurrentAssets contextRef="c650" decimals="0" id="ixv-45257" unitRef="usd">10733702</ifrs-full:CurrentAssets>
    <ifrs-full:NoncurrentAssets contextRef="c650" decimals="0" id="ixv-45258" unitRef="usd">17174010</ifrs-full:NoncurrentAssets>
    <ifrs-full:CurrentLiabilities contextRef="c650" decimals="0" id="ixv-45259" unitRef="usd">9749928</ifrs-full:CurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities contextRef="c650" decimals="0" id="ixv-45260" unitRef="usd">8155954</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:Equity contextRef="c650" decimals="0" id="ixv-45261" unitRef="usd">10001830</ifrs-full:Equity>
    <ifrs-full:CostOfSales contextRef="c651" decimals="0" id="ixv-45262" unitRef="usd">27931724</ifrs-full:CostOfSales>
    <ifrs-full:ProfitLoss contextRef="c651" decimals="0" id="ixv-45263" unitRef="usd">1409802</ifrs-full:ProfitLoss>
    <ifrs-full:CurrentAssets contextRef="c652" decimals="0" id="ixv-45264" unitRef="usd">22098808</ifrs-full:CurrentAssets>
    <ifrs-full:NoncurrentAssets contextRef="c652" decimals="0" id="ixv-45265" unitRef="usd">20002212</ifrs-full:NoncurrentAssets>
    <ifrs-full:CurrentLiabilities contextRef="c652" decimals="0" id="ixv-45266" unitRef="usd">22984897</ifrs-full:CurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities contextRef="c652" decimals="0" id="ixv-45267" unitRef="usd">8640513</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:Equity contextRef="c652" decimals="0" id="ixv-45268" unitRef="usd">10475610</ifrs-full:Equity>
    <ifrs-full:CostOfSales contextRef="c653" decimals="0" id="ixv-45269" unitRef="usd">22757410</ifrs-full:CostOfSales>
    <ifrs-full:ProfitLoss contextRef="c653" decimals="0" id="ixv-45270" unitRef="usd">3935787</ifrs-full:ProfitLoss>
    <ifrs-full:CurrentAssets contextRef="c654" decimals="0" id="ixv-45271" unitRef="usd">14203372</ifrs-full:CurrentAssets>
    <ifrs-full:NoncurrentAssets contextRef="c654" decimals="0" id="ixv-45272" unitRef="usd">24832433</ifrs-full:NoncurrentAssets>
    <ifrs-full:CurrentLiabilities contextRef="c654" decimals="0" id="ixv-45273" unitRef="usd">14591700</ifrs-full:CurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities contextRef="c654" decimals="0" id="ixv-45274" unitRef="usd">19382094</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:Equity contextRef="c654" decimals="0" id="ixv-45275" unitRef="usd">5062012</ifrs-full:Equity>
    <ifrs-full:CostOfSales contextRef="c655" decimals="0" id="ixv-45276" unitRef="usd">20540979</ifrs-full:CostOfSales>
    <ifrs-full:ProfitLoss contextRef="c655" decimals="0" id="ixv-45277" unitRef="usd">2071653</ifrs-full:ProfitLoss>
    <ifrs-full:NoncurrentAssets contextRef="c656" decimals="0" id="ixv-45278" unitRef="usd">22755817</ifrs-full:NoncurrentAssets>
    <ifrs-full:CurrentLiabilities contextRef="c656" decimals="0" id="ixv-45279" unitRef="usd">10642112</ifrs-full:CurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities contextRef="c656" decimals="0" id="ixv-45280" unitRef="usd">73674157</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:Equity contextRef="c656" decimals="0" id="ixv-45281" unitRef="usd">-61560452</ifrs-full:Equity>
    <ifrs-full:ProfitLoss contextRef="c657" decimals="0" id="ixv-45282" unitRef="usd">-99549928</ifrs-full:ProfitLoss>
    <ifrs-full:NoncurrentAssets contextRef="c658" decimals="0" id="ixv-45283" unitRef="usd">108456044</ifrs-full:NoncurrentAssets>
    <ifrs-full:CurrentLiabilities contextRef="c658" decimals="0" id="ixv-45284" unitRef="usd">13405755</ifrs-full:CurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities contextRef="c658" decimals="0" id="ixv-45285" unitRef="usd">57060813</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:Equity contextRef="c658" decimals="0" id="ixv-45286" unitRef="usd">37989476</ifrs-full:Equity>
    <ifrs-full:ProfitLoss contextRef="c659" decimals="0" id="ixv-45287" unitRef="usd">-32213331</ifrs-full:ProfitLoss>
    <ifrs-full:NoncurrentAssets contextRef="c660" decimals="0" id="ixv-45288" unitRef="usd">135533950</ifrs-full:NoncurrentAssets>
    <ifrs-full:CurrentLiabilities contextRef="c660" decimals="0" id="ixv-45289" unitRef="usd">11998548</ifrs-full:CurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities contextRef="c660" decimals="0" id="ixv-45290" unitRef="usd">55630592</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:Equity contextRef="c660" decimals="0" id="ixv-45291" unitRef="usd">67904810</ifrs-full:Equity>
    <ifrs-full:ProfitLoss contextRef="c661" decimals="0" id="ixv-45292" unitRef="usd">-10632802</ifrs-full:ProfitLoss>
    <ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory contextRef="c0" id="ixv-37708">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;14.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;SEGMENT INFORMATION&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;After the BIOX deconsolidation, that took place
in June 24, 2025 the Group is organized under &lt;span&gt;a single operating segment, which is &#x201c;science-based
food ingredients&#x201d;. Operating segments are defined as components of an enterprise for which separate financial information is regularly
evaluated by the chief operating decision maker, who in the Group&#x2019;s case is the Executive Team, in deciding how to allocate resources
and assess performance. The Executive Team is composed of the Chief Executive Officer (&#x201c;CEO&#x201d;), the Chief Financial Officer
(&#x201c;CFO&#x201d;) and the Chief Technology Officer (&#x201c;CTO&#x201d;).&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span&gt;Prior to the BIOX deconsolidation,
the Executive Team evaluates the Group&#x2019;s financial information and resources and assess the financial performance of these resources
as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Seed and integrated products&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The seed and integrated products segment focuses
mainly on the development and commercialization of seed technologies and products that increase yield per hectare, with a focus on the
provision of seed technologies integrated with crop protection and crop nutrition products designed to control weeds, insects or diseases,
to increase their quality characteristics, to improve nutritional value and other benefits. The segment focuses on the commercialization
of integrated products that combine three complementary components biotechnological events, germplasm and seed treatments&#x2014;in order
to increase crop productivity and create value for customers. While each component can increase yield independently, through an integrated
technology strategy the segment offers products that complement and integrate with each other to generate higher yields in crops.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Currently the segment generates revenue from ordinary
activities through the sale of seeds, integrated product packs, royalties and licenses charged to third parties, among others.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Crop protection&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The crop protection segment mainly includes the
development, production and marketing of high-tech adjuvants and a full range of pest control molecules and biocontrol products. Adjuvants
are used in mixtures to facilitate the application and effectiveness of active ingredients, such as insecticides, leading to better performance,
reduced usage rates and lower residue levels Insecticides and fungicides are applied to control pests and significantly reduce disease
during the germination period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The segment currently generates revenue from ordinary
activities through the sale of adjuvants, insecticides, fungicides, and baits, among others.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Crop nutrition&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The crop nutrition segment focuses mainly on the
development, production and commercialization of inoculants that allow the biological fixation of nitrogen in the crops, and of fertilizers
including biofertilizers and microgranulated fertilizers that optimize the productivity and yield of the crops.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Currently the segment generates income from ordinary
activities through the sale of inoculants, bio-inductors, biological fertilizers and microgranulated fertilizers, among others.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The measurement principles for the Group&#x2019;s
segment reporting structure are based on the IFRS principles adopted in the Consolidated financial statements. Revenue generated by products
and services exchanged between segments and entities within the Group are calculated based on market prices.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Emerging solutions&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The emerging solution segment is based on providing
R&amp;amp;D services, biotechnology capabilities and specialised expertise to facilitate the integration of technologies and product development
efforts within the Group, as well as R&amp;amp;D services to third parties.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;This segment includes revenue sources primarily
related to agro-industrial biotechnology businesses, such as those generated by the production and commercialization of industrial enzymes
and fermentation technology to convert sugars and oils into high-value molecules or compounds.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The measurement principles for the Group&#x2019;s
segment reporting structure are based on the IFRS principles adopted in the Consolidated financial statements. Revenue generated by products
and services exchanged between segments and entities within the Group are calculated based on market prices.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following tables present information with
respect to the Group&#x2019;s reporting segments:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Year ended June 30, 2025&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Seed and integrated products&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Crop protection&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Crop nutrition&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Emerging solutions&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Consolidated&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Revenues from contracts with customers&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;Sale of goods and services&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;60,535,026&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;181,908,584&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;76,054,689&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;267,261&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;318,765,560&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Royalties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,414,864&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-568"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-569"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-570"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,414,864&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Right of use licenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-571"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-572"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;13,430,824&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-573"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;13,430,824&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold"&gt;Others&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Initial recognition and changes in the fair value of biological assets at the point of harvest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,764,863&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-574"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-575"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-576"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,764,863&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Government grants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-577"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-578"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-579"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,412&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,412&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total revenues&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;63,714,753&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;181,908,584&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;89,485,513&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;270,673&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;335,379,523&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;Cost of sales&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(44,727,989&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(111,888,640&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(46,808,243&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-580"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(203,424,872&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Gross profit per segment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;18,986,764&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;70,019,944&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;42,677,270&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;270,673&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;131,954,651&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;% Gross margin&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;30&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;38&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;48&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;39&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Year ended June 30, 2024&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Seed and integrated products&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Crop protection&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Crop nutrition&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Emerging solutions&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Consolidated&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Revenues from contracts with customers&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;Sale of goods and services&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;94,457,404&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;223,538,317&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;125,558,380&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,547,782&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;445,101,883&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Royalties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;986,602&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-581"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-582"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-583"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;986,602&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Right of use licenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-584"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;19,287,845&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-585"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;20,287,845&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold"&gt;Others&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Initial recognition and changes in the fair value of biological assets at the point of harvest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(45,746&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-586"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-587"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-588"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(45,746&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Government grants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-589"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-590"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-591"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;197,519&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;197,519&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total revenues&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;96,398,260&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;223,538,317&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;144,846,225&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,745,301&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;466,528,103&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;Cost of sales&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(66,306,974&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(143,807,301&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(68,107,537&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,146,516&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(279,368,328&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Gross profit per segment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;30,091,286&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;79,731,016&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;76,738,688&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;598,785&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;187,159,775&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;% Gross margin&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;31&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;36&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;53&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;34&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;40&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Year ended June 30, 2023&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Seed and integrated products&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Crop protection&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Crop nutrition&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Emerging solutions&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Consolidated&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Revenues from contracts with customers&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;Sale of goods and services&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;55,360,397&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;205,685,451&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;157,153,024&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,420,990&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;419,619,862&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Royalties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,247,567&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-592"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-593"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-594"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,247,567&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Others&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Initial recognition and changes in the fair value of biological assets at the point of harvest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;319,428&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;153,460&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;137,666&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-595"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;610,554&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Government grants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-596"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-597"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-598"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;93,509&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;93,509&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total revenues&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;56,927,392&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;205,838,911&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;157,290,690&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,514,499&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;421,571,492&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;Cost of sales&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(31,012,687&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(137,529,299&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(66,915,067&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(7,019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(235,464,072&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Gross profit per segment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;25,914,705&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;68,309,612&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;90,375,623&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,507,480&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;186,107,420&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;% Gross margin&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;46&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;33&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;57&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;44&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;06/30/2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Revenue by similar group of products or services&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; font-weight: bold; font-style: italic; text-decoration: underline; text-align: left; padding-bottom: 1.5pt"&gt;Seed and integrated products&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;61,949,890&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;96,444,006&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;56,607,954&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Seed Treatments Packs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28,476,396&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;29,992,052&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;32,563,161&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Seed &amp;amp; Royalties Payments &amp;amp; HB4 Program&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;33,473,494&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;66,451,954&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;24,044,803&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-decoration: underline; text-align: left; padding-bottom: 1.5pt"&gt;Crop protection&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;181,908,584&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;223,538,317&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;205,685,451&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Adjuvants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;56,028,937&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;56,634,128&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;52,825,245&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Seed CP Products and Services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28,890,840&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;34,877,911&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;26,080,587&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Other CP Products and Services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;62,983,430&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;103,092,454&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;94,277,444&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Bioprotection&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;34,005,377&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28,933,824&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;32,502,175&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-decoration: underline; text-align: left; padding-bottom: 1.5pt"&gt;Crop nutrition&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;89,485,513&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;144,846,225&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;157,153,024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Inoculants &amp;amp; Biofertilizers&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;22,445,093&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,315,253&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;23,621,534&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Micro-beaded Fertilizers&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;56,461,771&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;91,786,942&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;90,827,714&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Biostimulants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,578,649&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15,456,185&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,800,318&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Syngenta up-front fee&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-599"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;19,287,845&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;32,903,458&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-decoration: underline; text-align: left; padding-bottom: 1.5pt"&gt;Emerging solutions&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;270,673&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;1,745,301&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;1,514,499&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Management expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;267,261&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,547,782&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,420,990&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Government grants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,412&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;197,519&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;93,509&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-decoration: underline; text-align: left; padding-bottom: 1.5pt"&gt;Total revenues&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;333,614,660&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;466,573,849&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;420,960,938&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of the current period, geographical information
is reported by main countries and regions. LATAM refers to Latin America countries, excluding Argentina and Brazil which are reported
separately. North America includes United States of America and Canada. The EMEA region covers Europe, the Middle East and Africa. The
Group has recast the comparative figures accordingly.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Geographical information&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;Argentina&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;231,823,079&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;348,366,339&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;289,346,766&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Brazil&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,673,809&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;24,175,116&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;23,690,028&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;LATAM&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;23,900,621&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;21,952,339&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;21,044,547&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;North America&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;30,107,865&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;27,543,558&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;30,768,912&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;EMEA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,920,550&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;21,320,535&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;22,014,855&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Rest of the world&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;22,188,736&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;23,215,962&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;34,095,830&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Total revenues&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;333,614,660&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;466,573,849&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;420,960,938&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold"&gt;Non-current assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; width: 76%"&gt;Argentina&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;12,493,920&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;139,722,896&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Brazil&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-600"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,698,175&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;LATAM&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-601"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,162,654&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;North America&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;53,447,180&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;189,199,549&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;EMEA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,662,860&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;44,141&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Rest of the world&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-602"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;26,279,731&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; padding-bottom: 4pt"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;78,603,960&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;364,107,146&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Property, plant and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,345,170&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;74,612,434&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Intangible assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;75,258,790&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;177,331,280&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1.5pt"&gt;Goodwill&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-603"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;112,163,432&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;Total reportable assets&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;78,603,960&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;364,107,146&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Total non-reportable assets&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;126,105,586&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;585,729,699&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 4pt"&gt;Total assets&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;204,709,546&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;949,836,845&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Following the Business Combination and the BIOX
deconsolidation, the Executive team will evaluate &lt;span&gt;the Group&#x2019;s financial information and resources
and assess the financial performance of these resources on a consolidated basis on the basis of Net revenue/loss for the period.&lt;/span&gt;&#160;&lt;/p&gt;</ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory>
    <mlec:NumberOfComplementaryComponents
      contextRef="c4"
      decimals="INF"
      id="ixv-45293"
      unitRef="pure">3</mlec:NumberOfComplementaryComponents>
    <ifrs-full:DisclosureOfOperatingSegmentsExplanatory contextRef="c0" id="ixv-37845">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following tables present information with
respect to the Group&#x2019;s reporting segments:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Year ended June 30, 2025&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Seed and integrated products&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Crop protection&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Crop nutrition&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Emerging solutions&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Consolidated&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Revenues from contracts with customers&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;Sale of goods and services&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;60,535,026&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;181,908,584&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;76,054,689&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;267,261&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;318,765,560&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Royalties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,414,864&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-568"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-569"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-570"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,414,864&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Right of use licenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-571"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-572"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;13,430,824&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-573"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;13,430,824&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold"&gt;Others&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Initial recognition and changes in the fair value of biological assets at the point of harvest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,764,863&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-574"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-575"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-576"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,764,863&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Government grants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-577"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-578"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-579"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,412&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,412&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total revenues&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;63,714,753&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;181,908,584&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;89,485,513&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;270,673&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;335,379,523&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;Cost of sales&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(44,727,989&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(111,888,640&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(46,808,243&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-580"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(203,424,872&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Gross profit per segment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;18,986,764&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;70,019,944&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;42,677,270&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;270,673&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;131,954,651&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;% Gross margin&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;30&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;38&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;48&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;39&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Year ended June 30, 2024&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Seed and integrated products&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Crop protection&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Crop nutrition&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Emerging solutions&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Consolidated&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Revenues from contracts with customers&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;Sale of goods and services&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;94,457,404&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;223,538,317&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;125,558,380&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,547,782&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;445,101,883&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Royalties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;986,602&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-581"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-582"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-583"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;986,602&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Right of use licenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-584"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;19,287,845&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-585"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;20,287,845&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold"&gt;Others&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Initial recognition and changes in the fair value of biological assets at the point of harvest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(45,746&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-586"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-587"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-588"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(45,746&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Government grants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-589"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-590"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-591"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;197,519&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;197,519&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total revenues&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;96,398,260&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;223,538,317&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;144,846,225&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,745,301&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;466,528,103&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;Cost of sales&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(66,306,974&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(143,807,301&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(68,107,537&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,146,516&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(279,368,328&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Gross profit per segment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;30,091,286&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;79,731,016&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;76,738,688&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;598,785&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;187,159,775&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;% Gross margin&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;31&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;36&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;53&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;34&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;40&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Year ended June 30, 2023&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Seed and integrated products&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Crop protection&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Crop nutrition&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Emerging solutions&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Consolidated&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Revenues from contracts with customers&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;Sale of goods and services&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;55,360,397&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;205,685,451&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;157,153,024&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,420,990&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;419,619,862&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Royalties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,247,567&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-592"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-593"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-594"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,247,567&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Others&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Initial recognition and changes in the fair value of biological assets at the point of harvest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;319,428&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;153,460&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;137,666&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-595"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;610,554&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Government grants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-596"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-597"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-598"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;93,509&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;93,509&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total revenues&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;56,927,392&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;205,838,911&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;157,290,690&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,514,499&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;421,571,492&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;Cost of sales&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(31,012,687&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(137,529,299&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(66,915,067&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(7,019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(235,464,072&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Gross profit per segment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;25,914,705&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;68,309,612&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;90,375,623&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,507,480&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;186,107,420&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;% Gross margin&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;46&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;33&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;57&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;44&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfOperatingSegmentsExplanatory>
    <mlec:RevenueFromSaleOfGoodsAndRenderingOfServices contextRef="c662" decimals="0" id="ixv-45294" unitRef="usd">60535026</mlec:RevenueFromSaleOfGoodsAndRenderingOfServices>
    <mlec:RevenueFromSaleOfGoodsAndRenderingOfServices contextRef="c663" decimals="0" id="ixv-45295" unitRef="usd">181908584</mlec:RevenueFromSaleOfGoodsAndRenderingOfServices>
    <mlec:RevenueFromSaleOfGoodsAndRenderingOfServices contextRef="c664" decimals="0" id="ixv-45296" unitRef="usd">76054689</mlec:RevenueFromSaleOfGoodsAndRenderingOfServices>
    <mlec:RevenueFromSaleOfGoodsAndRenderingOfServices contextRef="c665" decimals="0" id="ixv-45297" unitRef="usd">267261</mlec:RevenueFromSaleOfGoodsAndRenderingOfServices>
    <mlec:RevenueFromSaleOfGoodsAndRenderingOfServices contextRef="c666" decimals="0" id="ixv-45298" unitRef="usd">318765560</mlec:RevenueFromSaleOfGoodsAndRenderingOfServices>
    <ifrs-full:RevenueFromRoyalties contextRef="c662" decimals="0" id="ixv-45299" unitRef="usd">1414864</ifrs-full:RevenueFromRoyalties>
    <ifrs-full:RevenueFromRoyalties contextRef="c666" decimals="0" id="ixv-45300" unitRef="usd">1414864</ifrs-full:RevenueFromRoyalties>
    <ifrs-full:LicenceFeeIncome contextRef="c664" decimals="0" id="ixv-45301" unitRef="usd">13430824</ifrs-full:LicenceFeeIncome>
    <ifrs-full:LicenceFeeIncome contextRef="c666" decimals="0" id="ixv-45302" unitRef="usd">13430824</ifrs-full:LicenceFeeIncome>
    <ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets contextRef="c662" decimals="0" id="ixv-45303" unitRef="usd">1764863</ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets>
    <ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets contextRef="c666" decimals="0" id="ixv-45304" unitRef="usd">1764863</ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets>
    <ifrs-full:RevenueFromGovernmentGrants contextRef="c665" decimals="0" id="ixv-45305" unitRef="usd">3412</ifrs-full:RevenueFromGovernmentGrants>
    <ifrs-full:RevenueFromGovernmentGrants contextRef="c666" decimals="0" id="ixv-45306" unitRef="usd">3412</ifrs-full:RevenueFromGovernmentGrants>
    <ifrs-full:Revenue contextRef="c662" decimals="0" id="ixv-45307" unitRef="usd">63714753</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c663" decimals="0" id="ixv-45308" unitRef="usd">181908584</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c664" decimals="0" id="ixv-45309" unitRef="usd">89485513</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c665" decimals="0" id="ixv-45310" unitRef="usd">270673</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c666" decimals="0" id="ixv-45311" unitRef="usd">335379523</ifrs-full:Revenue>
    <ifrs-full:CostOfSales contextRef="c662" decimals="0" id="ixv-45312" unitRef="usd">44727989</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales contextRef="c663" decimals="0" id="ixv-45313" unitRef="usd">111888640</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales contextRef="c664" decimals="0" id="ixv-45314" unitRef="usd">46808243</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales contextRef="c666" decimals="0" id="ixv-45315" unitRef="usd">203424872</ifrs-full:CostOfSales>
    <ifrs-full:GrossProfit contextRef="c662" decimals="0" id="ixv-45316" unitRef="usd">18986764</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit contextRef="c663" decimals="0" id="ixv-45317" unitRef="usd">70019944</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit contextRef="c664" decimals="0" id="ixv-45318" unitRef="usd">42677270</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit contextRef="c665" decimals="0" id="ixv-45319" unitRef="usd">270673</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit contextRef="c666" decimals="0" id="ixv-45320" unitRef="usd">131954651</ifrs-full:GrossProfit>
    <mlec:PercentageGrossMargin
      contextRef="c667"
      decimals="2"
      id="ixv-45321"
      unitRef="pure">0.30</mlec:PercentageGrossMargin>
    <mlec:PercentageGrossMargin
      contextRef="c668"
      decimals="2"
      id="ixv-45322"
      unitRef="pure">0.38</mlec:PercentageGrossMargin>
    <mlec:PercentageGrossMargin
      contextRef="c669"
      decimals="2"
      id="ixv-45323"
      unitRef="pure">0.48</mlec:PercentageGrossMargin>
    <mlec:PercentageGrossMargin
      contextRef="c670"
      decimals="2"
      id="ixv-45324"
      unitRef="pure">1</mlec:PercentageGrossMargin>
    <mlec:PercentageGrossMargin
      contextRef="c671"
      decimals="2"
      id="ixv-45325"
      unitRef="pure">0.39</mlec:PercentageGrossMargin>
    <mlec:RevenueFromSaleOfGoodsAndRenderingOfServices contextRef="c672" decimals="0" id="ixv-45326" unitRef="usd">94457404</mlec:RevenueFromSaleOfGoodsAndRenderingOfServices>
    <mlec:RevenueFromSaleOfGoodsAndRenderingOfServices contextRef="c673" decimals="0" id="ixv-45327" unitRef="usd">223538317</mlec:RevenueFromSaleOfGoodsAndRenderingOfServices>
    <mlec:RevenueFromSaleOfGoodsAndRenderingOfServices contextRef="c674" decimals="0" id="ixv-45328" unitRef="usd">125558380</mlec:RevenueFromSaleOfGoodsAndRenderingOfServices>
    <mlec:RevenueFromSaleOfGoodsAndRenderingOfServices contextRef="c675" decimals="0" id="ixv-45329" unitRef="usd">1547782</mlec:RevenueFromSaleOfGoodsAndRenderingOfServices>
    <mlec:RevenueFromSaleOfGoodsAndRenderingOfServices contextRef="c676" decimals="0" id="ixv-45330" unitRef="usd">445101883</mlec:RevenueFromSaleOfGoodsAndRenderingOfServices>
    <ifrs-full:RevenueFromRoyalties contextRef="c672" decimals="0" id="ixv-45331" unitRef="usd">986602</ifrs-full:RevenueFromRoyalties>
    <ifrs-full:RevenueFromRoyalties contextRef="c676" decimals="0" id="ixv-45332" unitRef="usd">986602</ifrs-full:RevenueFromRoyalties>
    <ifrs-full:LicenceFeeIncome contextRef="c672" decimals="0" id="ixv-45333" unitRef="usd">1000000</ifrs-full:LicenceFeeIncome>
    <ifrs-full:LicenceFeeIncome contextRef="c674" decimals="0" id="ixv-45334" unitRef="usd">19287845</ifrs-full:LicenceFeeIncome>
    <ifrs-full:LicenceFeeIncome contextRef="c676" decimals="0" id="ixv-45335" unitRef="usd">20287845</ifrs-full:LicenceFeeIncome>
    <ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets contextRef="c672" decimals="0" id="ixv-45336" unitRef="usd">-45746</ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets>
    <ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets contextRef="c676" decimals="0" id="ixv-45337" unitRef="usd">-45746</ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets>
    <ifrs-full:RevenueFromGovernmentGrants contextRef="c675" decimals="0" id="ixv-45338" unitRef="usd">197519</ifrs-full:RevenueFromGovernmentGrants>
    <ifrs-full:RevenueFromGovernmentGrants contextRef="c676" decimals="0" id="ixv-45339" unitRef="usd">197519</ifrs-full:RevenueFromGovernmentGrants>
    <ifrs-full:Revenue contextRef="c672" decimals="0" id="ixv-45340" unitRef="usd">96398260</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c673" decimals="0" id="ixv-45341" unitRef="usd">223538317</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c674" decimals="0" id="ixv-45342" unitRef="usd">144846225</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c675" decimals="0" id="ixv-45343" unitRef="usd">1745301</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c676" decimals="0" id="ixv-45344" unitRef="usd">466528103</ifrs-full:Revenue>
    <ifrs-full:CostOfSales contextRef="c672" decimals="0" id="ixv-45345" unitRef="usd">66306974</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales contextRef="c673" decimals="0" id="ixv-45346" unitRef="usd">143807301</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales contextRef="c674" decimals="0" id="ixv-45347" unitRef="usd">68107537</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales contextRef="c675" decimals="0" id="ixv-45348" unitRef="usd">1146516</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales contextRef="c676" decimals="0" id="ixv-45349" unitRef="usd">279368328</ifrs-full:CostOfSales>
    <ifrs-full:GrossProfit contextRef="c672" decimals="0" id="ixv-45350" unitRef="usd">30091286</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit contextRef="c673" decimals="0" id="ixv-45351" unitRef="usd">79731016</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit contextRef="c674" decimals="0" id="ixv-45352" unitRef="usd">76738688</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit contextRef="c675" decimals="0" id="ixv-45353" unitRef="usd">598785</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit contextRef="c676" decimals="0" id="ixv-45354" unitRef="usd">187159775</ifrs-full:GrossProfit>
    <mlec:PercentageGrossMargin
      contextRef="c677"
      decimals="2"
      id="ixv-45355"
      unitRef="pure">0.31</mlec:PercentageGrossMargin>
    <mlec:PercentageGrossMargin
      contextRef="c678"
      decimals="2"
      id="ixv-45356"
      unitRef="pure">0.36</mlec:PercentageGrossMargin>
    <mlec:PercentageGrossMargin
      contextRef="c679"
      decimals="2"
      id="ixv-45357"
      unitRef="pure">0.53</mlec:PercentageGrossMargin>
    <mlec:PercentageGrossMargin
      contextRef="c680"
      decimals="2"
      id="ixv-45358"
      unitRef="pure">0.34</mlec:PercentageGrossMargin>
    <mlec:PercentageGrossMargin
      contextRef="c681"
      decimals="2"
      id="ixv-45359"
      unitRef="pure">0.40</mlec:PercentageGrossMargin>
    <mlec:RevenueFromSaleOfGoodsAndRenderingOfServices contextRef="c682" decimals="0" id="ixv-45360" unitRef="usd">55360397</mlec:RevenueFromSaleOfGoodsAndRenderingOfServices>
    <mlec:RevenueFromSaleOfGoodsAndRenderingOfServices contextRef="c683" decimals="0" id="ixv-45361" unitRef="usd">205685451</mlec:RevenueFromSaleOfGoodsAndRenderingOfServices>
    <mlec:RevenueFromSaleOfGoodsAndRenderingOfServices contextRef="c684" decimals="0" id="ixv-45362" unitRef="usd">157153024</mlec:RevenueFromSaleOfGoodsAndRenderingOfServices>
    <mlec:RevenueFromSaleOfGoodsAndRenderingOfServices contextRef="c685" decimals="0" id="ixv-45363" unitRef="usd">1420990</mlec:RevenueFromSaleOfGoodsAndRenderingOfServices>
    <mlec:RevenueFromSaleOfGoodsAndRenderingOfServices contextRef="c686" decimals="0" id="ixv-45364" unitRef="usd">419619862</mlec:RevenueFromSaleOfGoodsAndRenderingOfServices>
    <ifrs-full:RevenueFromRoyalties contextRef="c682" decimals="0" id="ixv-45365" unitRef="usd">1247567</ifrs-full:RevenueFromRoyalties>
    <ifrs-full:RevenueFromRoyalties contextRef="c686" decimals="0" id="ixv-45366" unitRef="usd">1247567</ifrs-full:RevenueFromRoyalties>
    <ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets contextRef="c682" decimals="0" id="ixv-45367" unitRef="usd">319428</ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets>
    <ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets contextRef="c683" decimals="0" id="ixv-45368" unitRef="usd">153460</ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets>
    <ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets contextRef="c684" decimals="0" id="ixv-45369" unitRef="usd">137666</ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets>
    <ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets contextRef="c686" decimals="0" id="ixv-45370" unitRef="usd">610554</ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets>
    <ifrs-full:RevenueFromGovernmentGrants contextRef="c685" decimals="0" id="ixv-45371" unitRef="usd">93509</ifrs-full:RevenueFromGovernmentGrants>
    <ifrs-full:RevenueFromGovernmentGrants contextRef="c686" decimals="0" id="ixv-45372" unitRef="usd">93509</ifrs-full:RevenueFromGovernmentGrants>
    <ifrs-full:Revenue contextRef="c682" decimals="0" id="ixv-45373" unitRef="usd">56927392</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c683" decimals="0" id="ixv-45374" unitRef="usd">205838911</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c684" decimals="0" id="ixv-45375" unitRef="usd">157290690</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c685" decimals="0" id="ixv-45376" unitRef="usd">1514499</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c686" decimals="0" id="ixv-45377" unitRef="usd">421571492</ifrs-full:Revenue>
    <ifrs-full:CostOfSales contextRef="c682" decimals="0" id="ixv-45378" unitRef="usd">31012687</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales contextRef="c683" decimals="0" id="ixv-45379" unitRef="usd">137529299</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales contextRef="c684" decimals="0" id="ixv-45380" unitRef="usd">66915067</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales contextRef="c685" decimals="0" id="ixv-45381" unitRef="usd">7019</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales contextRef="c686" decimals="0" id="ixv-45382" unitRef="usd">235464072</ifrs-full:CostOfSales>
    <ifrs-full:GrossProfit contextRef="c682" decimals="0" id="ixv-45383" unitRef="usd">25914705</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit contextRef="c683" decimals="0" id="ixv-45384" unitRef="usd">68309612</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit contextRef="c684" decimals="0" id="ixv-45385" unitRef="usd">90375623</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit contextRef="c685" decimals="0" id="ixv-45386" unitRef="usd">1507480</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit contextRef="c686" decimals="0" id="ixv-45387" unitRef="usd">186107420</ifrs-full:GrossProfit>
    <mlec:PercentageGrossMargin
      contextRef="c687"
      decimals="2"
      id="ixv-45388"
      unitRef="pure">0.46</mlec:PercentageGrossMargin>
    <mlec:PercentageGrossMargin
      contextRef="c688"
      decimals="2"
      id="ixv-45389"
      unitRef="pure">0.33</mlec:PercentageGrossMargin>
    <mlec:PercentageGrossMargin
      contextRef="c689"
      decimals="2"
      id="ixv-45390"
      unitRef="pure">0.57</mlec:PercentageGrossMargin>
    <mlec:PercentageGrossMargin
      contextRef="c690"
      decimals="2"
      id="ixv-45391"
      unitRef="pure">1</mlec:PercentageGrossMargin>
    <mlec:PercentageGrossMargin
      contextRef="c691"
      decimals="2"
      id="ixv-45392"
      unitRef="pure">0.44</mlec:PercentageGrossMargin>
    <ifrs-full:DisclosureOfProductsAndServicesExplanatory contextRef="c0" id="ixv-38740">&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;06/30/2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Revenue by similar group of products or services&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; font-weight: bold; font-style: italic; text-decoration: underline; text-align: left; padding-bottom: 1.5pt"&gt;Seed and integrated products&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;61,949,890&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;96,444,006&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;56,607,954&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Seed Treatments Packs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28,476,396&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;29,992,052&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;32,563,161&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Seed &amp;amp; Royalties Payments &amp;amp; HB4 Program&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;33,473,494&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;66,451,954&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;24,044,803&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-decoration: underline; text-align: left; padding-bottom: 1.5pt"&gt;Crop protection&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;181,908,584&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;223,538,317&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;205,685,451&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Adjuvants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;56,028,937&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;56,634,128&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;52,825,245&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Seed CP Products and Services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28,890,840&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;34,877,911&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;26,080,587&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Other CP Products and Services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;62,983,430&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;103,092,454&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;94,277,444&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Bioprotection&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;34,005,377&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28,933,824&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;32,502,175&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-decoration: underline; text-align: left; padding-bottom: 1.5pt"&gt;Crop nutrition&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;89,485,513&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;144,846,225&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;157,153,024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Inoculants &amp;amp; Biofertilizers&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;22,445,093&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,315,253&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;23,621,534&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Micro-beaded Fertilizers&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;56,461,771&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;91,786,942&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;90,827,714&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Biostimulants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,578,649&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15,456,185&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,800,318&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Syngenta up-front fee&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-599"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;19,287,845&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;32,903,458&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-decoration: underline; text-align: left; padding-bottom: 1.5pt"&gt;Emerging solutions&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;270,673&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;1,745,301&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;1,514,499&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Management expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;267,261&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,547,782&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,420,990&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Government grants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,412&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;197,519&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;93,509&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-decoration: underline; text-align: left; padding-bottom: 1.5pt"&gt;Total revenues&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;333,614,660&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;466,573,849&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;420,960,938&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfProductsAndServicesExplanatory>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c692" decimals="0" id="ixv-45393" unitRef="usd">61949890</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c693" decimals="0" id="ixv-45394" unitRef="usd">96444006</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c694" decimals="0" id="ixv-45395" unitRef="usd">56607954</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c695" decimals="0" id="ixv-45396" unitRef="usd">28476396</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c696" decimals="0" id="ixv-45397" unitRef="usd">29992052</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c697" decimals="0" id="ixv-45398" unitRef="usd">32563161</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c698" decimals="0" id="ixv-45399" unitRef="usd">33473494</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c699" decimals="0" id="ixv-45400" unitRef="usd">66451954</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c700" decimals="0" id="ixv-45401" unitRef="usd">24044803</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c701" decimals="0" id="ixv-45402" unitRef="usd">181908584</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c702" decimals="0" id="ixv-45403" unitRef="usd">223538317</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c703" decimals="0" id="ixv-45404" unitRef="usd">205685451</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c704" decimals="0" id="ixv-45405" unitRef="usd">56028937</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c705" decimals="0" id="ixv-45406" unitRef="usd">56634128</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c706" decimals="0" id="ixv-45407" unitRef="usd">52825245</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c707" decimals="0" id="ixv-45408" unitRef="usd">28890840</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c708" decimals="0" id="ixv-45409" unitRef="usd">34877911</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c709" decimals="0" id="ixv-45410" unitRef="usd">26080587</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c710" decimals="0" id="ixv-45411" unitRef="usd">62983430</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c711" decimals="0" id="ixv-45412" unitRef="usd">103092454</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c712" decimals="0" id="ixv-45413" unitRef="usd">94277444</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c713" decimals="0" id="ixv-45414" unitRef="usd">34005377</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c714" decimals="0" id="ixv-45415" unitRef="usd">28933824</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c715" decimals="0" id="ixv-45416" unitRef="usd">32502175</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c716" decimals="0" id="ixv-45417" unitRef="usd">89485513</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c717" decimals="0" id="ixv-45418" unitRef="usd">144846225</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c718" decimals="0" id="ixv-45419" unitRef="usd">157153024</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c719" decimals="0" id="ixv-45420" unitRef="usd">22445093</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c720" decimals="0" id="ixv-45421" unitRef="usd">18315253</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c721" decimals="0" id="ixv-45422" unitRef="usd">23621534</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c722" decimals="0" id="ixv-45423" unitRef="usd">56461771</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c723" decimals="0" id="ixv-45424" unitRef="usd">91786942</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c724" decimals="0" id="ixv-45425" unitRef="usd">90827714</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c725" decimals="0" id="ixv-45426" unitRef="usd">10578649</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c726" decimals="0" id="ixv-45427" unitRef="usd">15456185</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c727" decimals="0" id="ixv-45428" unitRef="usd">9800318</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c729" decimals="0" id="ixv-45429" unitRef="usd">19287845</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c730" decimals="0" id="ixv-45430" unitRef="usd">32903458</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c731" decimals="0" id="ixv-45431" unitRef="usd">270673</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c732" decimals="0" id="ixv-45432" unitRef="usd">1745301</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c733" decimals="0" id="ixv-45433" unitRef="usd">1514499</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c734" decimals="0" id="ixv-45434" unitRef="usd">267261</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c735" decimals="0" id="ixv-45435" unitRef="usd">1547782</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c736" decimals="0" id="ixv-45436" unitRef="usd">1420990</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c737" decimals="0" id="ixv-45437" unitRef="usd">3412</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c738" decimals="0" id="ixv-45438" unitRef="usd">197519</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c739" decimals="0" id="ixv-45439" unitRef="usd">93509</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c434" decimals="0" id="ixv-45440" unitRef="usd">333614660</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c435" decimals="0" id="ixv-45441" unitRef="usd">466573849</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c450" decimals="0" id="ixv-45442" unitRef="usd">420960938</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:DisclosureOfGeographicalAreasExplanatory contextRef="c0" id="ixv-39066">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Geographical information&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;Argentina&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;231,823,079&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;348,366,339&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;289,346,766&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Brazil&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,673,809&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;24,175,116&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;23,690,028&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;LATAM&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;23,900,621&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;21,952,339&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;21,044,547&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;North America&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;30,107,865&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;27,543,558&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;30,768,912&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;EMEA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,920,550&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;21,320,535&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;22,014,855&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Rest of the world&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;22,188,736&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;23,215,962&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;34,095,830&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Total revenues&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;333,614,660&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;466,573,849&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;420,960,938&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold"&gt;Non-current assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; width: 76%"&gt;Argentina&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;12,493,920&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;139,722,896&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;Brazil&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-600"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,698,175&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;LATAM&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-601"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,162,654&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;North America&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;53,447,180&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;189,199,549&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;EMEA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,662,860&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;44,141&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Rest of the world&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-602"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;26,279,731&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; padding-bottom: 4pt"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;78,603,960&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;364,107,146&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Property, plant and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,345,170&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;74,612,434&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Intangible assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;75,258,790&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;177,331,280&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1.5pt"&gt;Goodwill&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-603"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;112,163,432&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"&gt;Total reportable assets&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;78,603,960&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;364,107,146&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Total non-reportable assets&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;126,105,586&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;585,729,699&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 4pt"&gt;Total assets&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;204,709,546&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;949,836,845&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfGeographicalAreasExplanatory>
    <ifrs-full:Revenue contextRef="c740" decimals="0" id="ixv-45443" unitRef="usd">231823079</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c741" decimals="0" id="ixv-45444" unitRef="usd">348366339</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c742" decimals="0" id="ixv-45445" unitRef="usd">289346766</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c743" decimals="0" id="ixv-45446" unitRef="usd">17673809</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c744" decimals="0" id="ixv-45447" unitRef="usd">24175116</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c745" decimals="0" id="ixv-45448" unitRef="usd">23690028</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c746" decimals="0" id="ixv-45449" unitRef="usd">23900621</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c747" decimals="0" id="ixv-45450" unitRef="usd">21952339</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c748" decimals="0" id="ixv-45451" unitRef="usd">21044547</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c749" decimals="0" id="ixv-45452" unitRef="usd">30107865</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c750" decimals="0" id="ixv-45453" unitRef="usd">27543558</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c751" decimals="0" id="ixv-45454" unitRef="usd">30768912</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c752" decimals="0" id="ixv-45455" unitRef="usd">7920550</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c753" decimals="0" id="ixv-45456" unitRef="usd">21320535</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c754" decimals="0" id="ixv-45457" unitRef="usd">22014855</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c755" decimals="0" id="ixv-45458" unitRef="usd">22188736</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c756" decimals="0" id="ixv-45459" unitRef="usd">23215962</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c757" decimals="0" id="ixv-45460" unitRef="usd">34095830</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c434" decimals="0" id="ixv-45461" unitRef="usd">333614660</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c435" decimals="0" id="ixv-45462" unitRef="usd">466573849</ifrs-full:Revenue>
    <ifrs-full:Revenue contextRef="c450" decimals="0" id="ixv-45463" unitRef="usd">420960938</ifrs-full:Revenue>
    <ifrs-full:NoncurrentAssets contextRef="c758" decimals="0" id="ixv-45464" unitRef="usd">12493920</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets contextRef="c759" decimals="0" id="ixv-45465" unitRef="usd">139722896</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets contextRef="c761" decimals="0" id="ixv-45466" unitRef="usd">7698175</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets contextRef="c763" decimals="0" id="ixv-45467" unitRef="usd">1162654</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets contextRef="c764" decimals="0" id="ixv-45468" unitRef="usd">53447180</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets contextRef="c765" decimals="0" id="ixv-45469" unitRef="usd">189199549</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets contextRef="c766" decimals="0" id="ixv-45470" unitRef="usd">12662860</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets contextRef="c767" decimals="0" id="ixv-45471" unitRef="usd">44141</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets contextRef="c769" decimals="0" id="ixv-45472" unitRef="usd">26279731</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets contextRef="c436" decimals="0" id="ixv-45473" unitRef="usd">78603960</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets contextRef="c432" decimals="0" id="ixv-45474" unitRef="usd">364107146</ifrs-full:NoncurrentAssets>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c436" decimals="0" id="ixv-45475" unitRef="usd">3345170</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c432" decimals="0" id="ixv-45476" unitRef="usd">74612434</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c436" decimals="0" id="ixv-45477" unitRef="usd">75258790</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c432" decimals="0" id="ixv-45478" unitRef="usd">177331280</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:Goodwill contextRef="c432" decimals="0" id="ixv-45479" unitRef="usd">112163432</ifrs-full:Goodwill>
    <mlec:TotalReportableAssets contextRef="c436" decimals="0" id="ixv-45480" unitRef="usd">78603960</mlec:TotalReportableAssets>
    <mlec:TotalReportableAssets contextRef="c432" decimals="0" id="ixv-45481" unitRef="usd">364107146</mlec:TotalReportableAssets>
    <mlec:TotalNonreportableAssets contextRef="c436" decimals="0" id="ixv-45482" unitRef="usd">126105586</mlec:TotalNonreportableAssets>
    <mlec:TotalNonreportableAssets contextRef="c432" decimals="0" id="ixv-45483" unitRef="usd">585729699</mlec:TotalNonreportableAssets>
    <ifrs-full:Assets contextRef="c436" decimals="0" id="ixv-45484" unitRef="usd">204709546</ifrs-full:Assets>
    <ifrs-full:Assets contextRef="c432" decimals="0" id="ixv-45485" unitRef="usd">949836845</ifrs-full:Assets>
    <ifrs-full:DisclosureOfFinancialRiskManagementExplanatory contextRef="c0" id="ixv-39406">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="padding: 0pt; width: 0"&gt;&lt;/td&gt;&lt;td style="padding: 0pt; width: 0.25in"&gt;&lt;b&gt;15.&lt;/b&gt;&lt;/td&gt;&lt;td style="padding: 0pt"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;FINANCIAL INSTRUMENTS &#x2013; RISK MANAGEMENT&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group is exposed to a variety of financial
risks that arise from its activities and from its use of financial instruments. This Note provides information on the Group&#x2019;s exposure
to certain main risks, the Group&#x2019;s objectives, policies and processes regarding the measurement and management of each risk.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group does not use derivative financial instruments
to hedge any of the above risks.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;General objectives, policies, and processes&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Board of Directors has overall responsibility
for establishing and monitoring the Group&#x2019;s risk management objectives and policies and, whilst retaining ultimate responsibility
for them, it has delegated the function to design and operate processes that ensure the effective implementation of the objectives and
policies to the management that periodically reports to the Board of Directors on the evolution of the risk management activities and
results. The overall objective of the Board of Directors is to set policies that seek to reduce risk as much as possible without unduly
affecting the Group&#x2019;s competitiveness and flexibility.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group&#x2019;s risk management policy is established
to identify and analyze the risks facing the Group, to set appropriate risk limits and controls and to monitor risks and adherence to
limits. The risks and methods for managing the risks are reviewed regularly in order to reflect changes in market conditions and the Group&#x2019;s
activities. The Group, through training and management standards and procedures, aims to develop a disciplined and constructive control
environment in which all the employees understand their roles and obligations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group seeks to use suitable means of financing
to minimize the Group&#x2019;s capital costs and to manage and control the Group&#x2019;s financial risks effectively. There have been no
substantive changes in the Group&#x2019;s exposure to financial instrument risks, its objectives, policies and processes for managing those risks
or the methods used to measure them from previous periods unless otherwise stated in this Note.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group adopted a code of ethics applicable
to its principal executive, financial and accounting officers and all employees.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The principal risks and uncertainties facing the
business, set out below, do not appear in any particular order of potential materiality or probability of occurrence.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Credit risk&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Credit risk is the risk of financial loss to the
Group if a customer or counterparty fails to meet its contractual obligations, which derives mainly from trade and other receivables,
as well as from cash and deposits in financial institutions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The credit risk to which the Group is exposed
is mainly defined in the Group&#x2019;s accounts receivable followed by cash and cash equivalents, with the logical importance of being
able to satisfy the Group&#x2019;s needs in the short term.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Trade and other receivables&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Credit risk is the risk of financial loss to the
Group if a customer or counterparty fails to meet its contractual obligations and derives mainly from trade receivables and other receivables
generated by services and product sales. The Group is also exposed to political and economic risk events, which may cause nonpayment of
local and foreign currency obligations to the Group owed by customers, partners, contractors and suppliers.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group sells its products to a diverse base
of customers. Customers include multi-national and local agricultural companies, distributors, and farmers who purchase the Group&#x2019;s
products. Type and class of customers may differ depending on the Group&#x2019;s business segments.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group&#x2019;s management determines concentrations
of credit risk by periodically monitoring the credit worthiness rating of existing customers and through a monthly review of the trade
receivables&#x2019; aging analysis. In monitoring the customers&#x2019; credit risk, customers are grouped according to their credit characteristics.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group&#x2019;s policy is to manage credit exposure
to counterparties through a process of credit rating. The Group performs credit evaluations of existing and new customers, and every new
customer is examined thoroughly regarding the quality of its credit before offering the customer transaction terms. The examination made
by the Group includes outside credit rating information, if available. Additionally, and even if there is no independent outside rating,
the Group assesses the credit quality of the customer taking into account its financial position, past experience, bank references and
other factors. A credit limit is prescribed for each customer. These limits are examined periodically. Customers that do not meet the
Group&#x2019;s criteria for credit quality may do business with the Group on a prepayment basis or by furnishing collateral satisfactory
to the Group. The Group may still seek collateral and guarantees as it may consider appropriate regardless the credit profile of any customer.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Cash and deposits in banks &lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group is exposed to counterparty credit risk
on cash and cash equivalent balances. The Group holds cash on deposit with a number of financial institutions. The Group manages its credit
risk exposure by limiting individual deposits to clearly defined limits. The Group only deposits with high quality banks and financial
institutions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The maximum exposure to credit risk is represented
by the carrying amount of cash and cash equivalents in the statement of financial position.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Liquidity risk&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Liquidity risk is the risk that the Group will
encounter difficulty in meeting its financial obligations when they come due.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group&#x2019;s approach to managing its liquidity
risk is to manage the profile of debt maturities and funding sources, maintaining sufficient cash, and ensuring the availability of funding
from an adequate amount of credit facilities. The Group&#x2019;s ability to fund its existing and prospective debt requirements is managed
by maintaining diversified funding sources.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The cash flow forecast is determined at both an
entity level and consolidated level. The forecasts are reviewed by the Board of Directors in advance, enabling the Group&#x2019;s cash
requirements to be anticipated. The Group examines the forecasts of its liquidity requirements in order to ascertain that there is sufficient
cash for the operating needs, including the amounts required in order to settle financial liabilities.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As explained in Note 1 &#x2013; The Group&#x2019;s
business reorganization and general information, in the near term, management plans to continue to focus on raising the funds necessary
to fully implement the Group&#x2019;s business plan. Management believes that certain shareholders and/or investors will continue to advance
the capital required to meet the Group&#x2019;s financial obligations. There is no assurance, however, that these investors and shareholders
will continue to advance capital to the Group or that the business operations will be profitable. The possibility of failure in obtaining
additional funding and the potential inability to achieve profitability raise substantial doubts about the Group&#x2019;s ability to continue
as a going concern.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The following table sets out the contractual maturities of financial
liabilities:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid"&gt;As of June 30, 2025&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Up to&lt;br/&gt; 3 months&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;3 to 12 months&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Between one and three years&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Trade and other payables&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;7,323,933&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-604"&gt;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-605"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Borrowings&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;227,154,007&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-606"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,348,173&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Convertible notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-607"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-608"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,260,456&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Lease liability&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;117,463&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-609"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-610"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;234,595,403&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-611"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;19,608,629&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid"&gt;As of June 30, 2024&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Up to &lt;br/&gt;
3 months&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;3 to 12 months&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Between one and three years&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Trade and other payables&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;107,801,065&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;61,136,471&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-612"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Borrowings&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;87,538,816&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;146,971,935&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;127,248,305&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Consideration for acquisition of assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-613"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,571,824&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,005,143&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Convertible notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-614"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-615"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;80,809,686&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Lease liability&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;738,561&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,384,217&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;8,161,359&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;196,078,442&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;215,064,447&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;218,224,493&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of June 30, 2025 and 2024, the Group had no
exposure to derivative liabilities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Currency risk&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Foreign currency risk is the risk that the fair
value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rate. Currency on foreign exchange
risk arises when the Group enters into transactions denominated in a currency other than its functional currency.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Part of the Company&#x2019;s business activities
is conducted in Argentine pesos. However, some of the subsidiaries using the Argentine peso as their functional currency also have significant
transactions denominated in U.S. dollars, mainly with respect to sales and financing activities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The table below sets forth the net exposure to
currency risk as of June 30, 2025:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Net foreign currency position&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;Amount expressed in US$&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(206,837,587&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Other currencies&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(49,304,636&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The main Argentinian subsidiaries of the Group
have changed their functional currency from Argentine Pesos to US Dollar (Note 2 &#x2013; Accounting standards and basis of preparation).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Considering only this net currency exposure as
of June 30, 2025, if an Argentine peso/US dollar revaluation or depreciation in relation to other foreign currencies with the remaining
variables remaining constant, would have a positive or a negative impact on comprehensive income as a result of foreign exchange gains
or losses. The Company estimates that a devaluation or an appreciation of the Argentine peso against the U.S. dollar of 20% during the
year ended June 30, 2025, would have resulted in the following results:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Estimated&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Exchange rate variation&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(-)
    20%&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(+)
    20%&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Argentine peso amount expressed
    in US$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(51,228,445&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;51,228,445&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Interest rate risk&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group&#x2019;s financing costs may be affected
by interest rate volatility. Borrowings under the Group&#x2019;s interest rate management policy may be fixed or floating rate. The Group
maintains adequate committed borrowing facilities and holds most of its financial assets primarily in cash or checks collected from customers
that are readily convertible into known amounts of cash.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group&#x2019;s interest rate risk arises from
long-term borrowings. Borrowings issued at floating rates expose the Group to cash flow interest rate risk. Borrowings issued at fixed
rates expose the Group to fair value interest rate risk. The Group has not entered into derivative contracts to hedge this exposure.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group does not use derivative financial instruments
to hedge its interest rate risk exposure.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group&#x2019;s debt composition is set out
below.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;b&gt;&lt;i&gt;&lt;span style="text-decoration:underline"&gt;Carrying amount&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Fixed-rate instruments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Current financial liabilities&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;227,154,007&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;187,141,491&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Non-current financial liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;19,608,629&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;193,681,929&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;246,762,636&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;380,823,420&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Variable-rate instruments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Current financial liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-616"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;47,369,260&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Non-current financial liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-617"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;14,376,062&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-618"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;61,745,322&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group does not use derivative financial instruments
to hedge its interest rate risk exposure.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Capital risk&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group&#x2019;s objectives when managing capital
are to safeguard the Group&#x2019;s ability to continue as a going concern, in order to provide returns for shareholders and benefits for
other stakeholders, and to maintain an optimal capital structure to reduce the cost of capital.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group manages its capital structure and makes
adjustments to it in the light of changes in economic conditions and the risk characteristics of the underlying assets. In order to maintain
or adjust the capital structure, the Group may adjust the amount of any dividends it could pay to shareholders, return capital to shareholders,
issue new shares, or sell assets to reduce debt.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Financial instruments by category&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following tables show additional information
required under IFRS 7 on the financial assets and liabilities recorded as of June 30, 2025 and 2024.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Financial assets by category&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Amortized cost&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Mandatorily measured at fair value through profit or loss&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;b&gt;Financial asset&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Cash and cash equivalents&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;767,919&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;27,210,070&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-619"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;56,284,573&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Other financial assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,234,539&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-620"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;19,722&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,858,124&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Trade receivables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,085,400&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;209,007,195&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-621"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-622"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;Other receivables (*)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;14,085,303&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;45,342,974&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-623"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-624"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;29,173,161&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;281,560,239&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;19,722&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;21,142,697&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;sup&gt;&#160;&lt;/sup&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;sup&gt;(*)&lt;/sup&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Advances expenses and tax balances are not included.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Financial liabilities by category&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Amortized cost&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Mandatorily measured at fair value through profit or loss&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Financial liability&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Trade and other payables&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;7,323,933&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;156,947,744&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-625"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;11,989,792&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Borrowings&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;228,502,180&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;361,759,056&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-626"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-627"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Consideration for acquisition of assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-628"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,852,853&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-629"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,724,114&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Convertible notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,260,456&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;80,809,686&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-630"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-631"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Lease liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;117,463&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,284,137&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-632"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-633"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-634"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-635"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,211,093&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-636"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;254,204,032&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;614,653,476&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;1,211,093&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;14,713,906&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Financial instruments measured at fair value&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Measurement of fair values&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;A number of the Group&#x2019;s accounting policies
and disclosures require the measurement of fair values, for both financial and non-financial assets, and financial and non-financial liabilities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group has an established control framework
with respect to the measurement of fair values. This includes a valuation team that has overall responsibility for overseeing all significant
fair value measurements, including Level 3 fair values, and reports directly to the chief financial officer.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The valuation team regularly reviews significant
unobservable inputs and valuation adjustments. If third party information, such as broker quotes or pricing services, is used to measure
fair values, then the valuation team assesses the evidence obtained from the third parties to support the conclusion that these valuations
meet the requirements of the Accounting Standards, including the level in the fair value hierarchy in which the valuations should be classified.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Significant valuation issues are reported to the
Group&#x2019;s audit committee.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Fair value by hierarchy&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;According to the requirements of IFRS 7, the Group
classifies each class of financial instrument valued at fair value into three levels, depending on the relevance of the judgment associated
to the assumptions used for measuring the fair value.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Level 1 comprises financial assets and liabilities
with fair values determined by reference to quoted prices (unadjusted) in active markets for identical assets or liabilities;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Level 2 comprises inputs other than quoted prices
included within Level 1 that are observable for the asset or liability, either directly (i.e. as prices) or indirectly (i.e. derived from
prices);&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Level 3 comprises financial instruments with inputs
for estimating fair value that are not based on observable market data.&lt;/p&gt;&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level
    1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level
    2&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level
    3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Measurement at fair value at 06/30/2025&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; font-style: italic"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Financial assets at fair
    value&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Investments at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;19,722&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-637; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-638; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Financial
    liabilities valued at fair value&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Warrant liability&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;181,093&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-639; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,030,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Measurement at fair value at 06/30/2024&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; font-style: italic"&gt;Financial assets at fair value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Mutual funds&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;12,943,378&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-640"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-641"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Moolec Science SA shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,191,286&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-642"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-643"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Investments at fair value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,311,604&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-644"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-645"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;US Treasury bills&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,993,668&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-646"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-647"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Other investments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,702,761&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-648"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-649"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left"&gt;Financial liabilities valued at fair value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Trade and other payables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-650"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,989,792&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-651"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Consideration for acquisition&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,724,114&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-652"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-653"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;Estimation of fair value&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The fair value of marketable securities, mutual
funds and US Treasury Bills is calculated using the market approach using quoted prices in active markets for identical assets. The quoted
marked price used for financial assets held by the Group is the current bid price. These instruments are included in level 1.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group&#x2019;s financial liabilities, which
were not traded in an active market, were determined using valuation techniques that maximize the use of available market information
and thus rely as little as possible on specific estimates of the entity specific estimates. If all significant inputs required to fair
value an instrument are observable, the instruments are included in level 2.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;If one or more of the significant inputs is not
based on observable market data, the instruments are included in level 3.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group&#x2019;s policy is to recognize transfers
between different categories of the fair value hierarchy at the time they occur or when there are changes in the circumstances that cause
the transfer. There were no transfers between levels of the fair value hierarchy. There were no changes in economic or business circumstances
affecting fair value.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Financial instruments not measured at fair
value&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The financial instruments not measured at fair
value include cash and cash equivalents, trade accounts receivable, other accounts receivable, trade payables and other debts, borrowings,
financed payments and convertible notes.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The carrying value of financial instruments not
measured at fair value does not differ significantly from their fair value, except for borrowings (Note 7.12).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Management estimates that the carrying value of
the financial instruments measured at amortized cost approximates their fair value.&lt;/p&gt;</ifrs-full:DisclosureOfFinancialRiskManagementExplanatory>
    <ifrs-full:MaturityAnalysisForNonderivativeFinancialLiabilities contextRef="c0" id="ixv-39560">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The following table sets out the contractual maturities of financial
liabilities:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid"&gt;As of June 30, 2025&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Up to&lt;br/&gt; 3 months&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;3 to 12 months&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Between one and three years&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Trade and other payables&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;7,323,933&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-604"&gt;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-605"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Borrowings&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;227,154,007&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-606"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,348,173&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Convertible notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-607"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-608"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,260,456&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Lease liability&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;117,463&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-609"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-610"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;234,595,403&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-611"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;19,608,629&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid"&gt;As of June 30, 2024&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Up to &lt;br/&gt;
3 months&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;3 to 12 months&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Between one and three years&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Trade and other payables&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;107,801,065&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;61,136,471&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-612"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Borrowings&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;87,538,816&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;146,971,935&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;127,248,305&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Consideration for acquisition of assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-613"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,571,824&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,005,143&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Convertible notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-614"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-615"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;80,809,686&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Lease liability&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;738,561&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,384,217&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;8,161,359&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;196,078,442&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;215,064,447&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;218,224,493&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:MaturityAnalysisForNonderivativeFinancialLiabilities>
    <ifrs-full:TradeAndOtherPayables contextRef="c770" decimals="0" id="ixv-45486" unitRef="usd">7323933</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:Borrowings contextRef="c773" decimals="0" id="ixv-45487" unitRef="usd">227154007</ifrs-full:Borrowings>
    <ifrs-full:Borrowings contextRef="c775" decimals="0" id="ixv-45488" unitRef="usd">1348173</ifrs-full:Borrowings>
    <mlec:ConvertibleNotes contextRef="c778" decimals="0" id="ixv-45489" unitRef="usd">18260456</mlec:ConvertibleNotes>
    <mlec:LeasingLiabilities contextRef="c779" decimals="0" id="ixv-45490" unitRef="usd">117463</mlec:LeasingLiabilities>
    <ifrs-full:FinancialLiabilities contextRef="c782" decimals="0" id="ixv-45491" unitRef="usd">234595403</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities contextRef="c784" decimals="0" id="ixv-45492" unitRef="usd">19608629</ifrs-full:FinancialLiabilities>
    <ifrs-full:TradeAndOtherPayables contextRef="c785" decimals="0" id="ixv-45493" unitRef="usd">107801065</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables contextRef="c786" decimals="0" id="ixv-45494" unitRef="usd">61136471</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:Borrowings contextRef="c788" decimals="0" id="ixv-45495" unitRef="usd">87538816</ifrs-full:Borrowings>
    <ifrs-full:Borrowings contextRef="c789" decimals="0" id="ixv-45496" unitRef="usd">146971935</ifrs-full:Borrowings>
    <ifrs-full:Borrowings contextRef="c790" decimals="0" id="ixv-45497" unitRef="usd">127248305</ifrs-full:Borrowings>
    <mlec:ConsiderationForAcquisitionOfAssets contextRef="c792" decimals="0" id="ixv-45498" unitRef="usd">4571824</mlec:ConsiderationForAcquisitionOfAssets>
    <mlec:ConsiderationForAcquisitionOfAssets contextRef="c793" decimals="0" id="ixv-45499" unitRef="usd">2005143</mlec:ConsiderationForAcquisitionOfAssets>
    <mlec:ConvertibleNotes contextRef="c796" decimals="0" id="ixv-45500" unitRef="usd">80809686</mlec:ConvertibleNotes>
    <mlec:LeasingLiabilities contextRef="c797" decimals="0" id="ixv-45501" unitRef="usd">738561</mlec:LeasingLiabilities>
    <mlec:LeasingLiabilities contextRef="c798" decimals="0" id="ixv-45502" unitRef="usd">2384217</mlec:LeasingLiabilities>
    <mlec:LeasingLiabilities contextRef="c799" decimals="0" id="ixv-45503" unitRef="usd">8161359</mlec:LeasingLiabilities>
    <ifrs-full:FinancialLiabilities contextRef="c800" decimals="0" id="ixv-45504" unitRef="usd">196078442</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities contextRef="c801" decimals="0" id="ixv-45505" unitRef="usd">215064447</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities contextRef="c802" decimals="0" id="ixv-45506" unitRef="usd">218224493</ifrs-full:FinancialLiabilities>
    <ifrs-full:DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory contextRef="c803" id="ixv-39767">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The table below sets forth the net exposure to
currency risk as of June 30, 2025:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Net foreign currency position&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;Amount expressed in US$&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(206,837,587&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Other currencies&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(49,304,636&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory>
    <ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic contextRef="c436" decimals="0" id="ixv-45507" unitRef="usd">206837587</ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic>
    <mlec:OtherCurrencies contextRef="c436" decimals="0" id="ixv-45508" unitRef="usd">49304636</mlec:OtherCurrencies>
    <mlec:DisclosureOfForeignExchangeRiskSensitivityAnalysistextBlock contextRef="c0" id="ixv-45509">The Company estimates that a devaluation or an appreciation of the Argentine peso against the U.S. dollar of 20% during the
year ended June 30, 2025, would have resulted in the following results:&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Estimated&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Exchange rate variation&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(-)
    20%&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(+)
    20%&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Argentine peso amount expressed
    in US$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(51,228,445&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;51,228,445&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</mlec:DisclosureOfForeignExchangeRiskSensitivityAnalysistextBlock>
    <mlec:PercentageOfEstimatesThatDevaluationOrAnAppreciation contextRef="c0" decimals="2" id="ixv-45510" unitRef="pure">0.20</mlec:PercentageOfEstimatesThatDevaluationOrAnAppreciation>
    <ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic contextRef="c4" decimals="0" id="ixv-45511" unitRef="usd">51228445</ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic>
    <ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic contextRef="c4" decimals="0" id="ixv-45512" unitRef="usd">51228445</ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic>
    <ifrs-full:DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory contextRef="c804" id="ixv-39895">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group&#x2019;s debt composition is set out
below.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&lt;b&gt;&lt;i&gt;&lt;span style="text-decoration:underline"&gt;Carrying amount&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Fixed-rate instruments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Current financial liabilities&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;227,154,007&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;187,141,491&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Non-current financial liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;19,608,629&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;193,681,929&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;246,762,636&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;380,823,420&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Variable-rate instruments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Current financial liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-616"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;47,369,260&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Non-current financial liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-617"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;14,376,062&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-618"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;61,745,322&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory>
    <ifrs-full:CurrentFinancialLiabilities contextRef="c805" decimals="0" id="ixv-45513" unitRef="usd">227154007</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:CurrentFinancialLiabilities contextRef="c806" decimals="0" id="ixv-45514" unitRef="usd">187141491</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities contextRef="c805" decimals="0" id="ixv-45515" unitRef="usd">19608629</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities contextRef="c806" decimals="0" id="ixv-45516" unitRef="usd">193681929</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c805" decimals="0" id="ixv-45517" unitRef="usd">246762636</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c806" decimals="0" id="ixv-45518" unitRef="usd">380823420</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:CurrentFinancialLiabilities contextRef="c808" decimals="0" id="ixv-45519" unitRef="usd">47369260</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities contextRef="c808" decimals="0" id="ixv-45520" unitRef="usd">14376062</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="c808" decimals="0" id="ixv-45521" unitRef="usd">61745322</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:DisclosureOfFinancialAssetsExplanatory contextRef="c0" id="ixv-40059">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Financial assets by category&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Amortized cost&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Mandatorily measured at fair value through profit or loss&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;b&gt;Financial asset&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Cash and cash equivalents&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;767,919&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;27,210,070&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-619"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;56,284,573&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Other financial assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,234,539&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-620"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;19,722&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,858,124&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Trade receivables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,085,400&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;209,007,195&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-621"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-622"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;Other receivables (*)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;14,085,303&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;45,342,974&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-623"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-624"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;29,173,161&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;281,560,239&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;19,722&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;21,142,697&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;sup&gt;&#160;&lt;/sup&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;sup&gt;(*)&lt;/sup&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Advances expenses and tax balances are not included.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfFinancialAssetsExplanatory>
    <ifrs-full:CashAndCashEquivalents contextRef="c809" decimals="0" id="ixv-45522" unitRef="usd">767919</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c810" decimals="0" id="ixv-45523" unitRef="usd">27210070</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c812" decimals="0" id="ixv-45524" unitRef="usd">56284573</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:OtherFinancialAssets contextRef="c813" decimals="0" id="ixv-45525" unitRef="usd">8234539</ifrs-full:OtherFinancialAssets>
    <ifrs-full:OtherFinancialAssets contextRef="c815" decimals="0" id="ixv-45526" unitRef="usd">19722</ifrs-full:OtherFinancialAssets>
    <ifrs-full:OtherFinancialAssets contextRef="c816" decimals="0" id="ixv-45527" unitRef="usd">14858124</ifrs-full:OtherFinancialAssets>
    <ifrs-full:TradeReceivables contextRef="c817" decimals="0" id="ixv-45528" unitRef="usd">6085400</ifrs-full:TradeReceivables>
    <ifrs-full:TradeReceivables contextRef="c818" decimals="0" id="ixv-45529" unitRef="usd">209007195</ifrs-full:TradeReceivables>
    <ifrs-full:OtherCurrentReceivables
      contextRef="c821"
      decimals="0"
      id="ix_47_fact"
      unitRef="usd">14085303</ifrs-full:OtherCurrentReceivables>
    <ifrs-full:OtherCurrentReceivables
      contextRef="c822"
      decimals="0"
      id="ix_48_fact"
      unitRef="usd">45342974</ifrs-full:OtherCurrentReceivables>
    <ifrs-full:CurrentFinancialAssetsAtAmortisedCost contextRef="c825" decimals="0" id="ixv-45532" unitRef="usd">29173161</ifrs-full:CurrentFinancialAssetsAtAmortisedCost>
    <ifrs-full:CurrentFinancialAssetsAtAmortisedCost contextRef="c826" decimals="0" id="ixv-45533" unitRef="usd">281560239</ifrs-full:CurrentFinancialAssetsAtAmortisedCost>
    <ifrs-full:CurrentFinancialAssetsAtAmortisedCost contextRef="c827" decimals="0" id="ixv-45534" unitRef="usd">19722</ifrs-full:CurrentFinancialAssetsAtAmortisedCost>
    <ifrs-full:CurrentFinancialAssetsAtAmortisedCost contextRef="c828" decimals="0" id="ixv-45535" unitRef="usd">21142697</ifrs-full:CurrentFinancialAssetsAtAmortisedCost>
    <ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory contextRef="c0" id="ixv-40196">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Financial liabilities by category&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Amortized cost&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Mandatorily measured at fair value through profit or loss&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Financial liability&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Trade and other payables&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;7,323,933&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;156,947,744&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-625"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;11,989,792&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Borrowings&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;228,502,180&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;361,759,056&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-626"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-627"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Consideration for acquisition of assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-628"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,852,853&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-629"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,724,114&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Convertible notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,260,456&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;80,809,686&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-630"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-631"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Lease liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;117,463&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,284,137&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-632"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-633"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-634"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-635"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1,211,093&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-636"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;254,204,032&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;614,653,476&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;1,211,093&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;14,713,906&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory>
    <ifrs-full:FinancialLiabilities contextRef="c829" decimals="0" id="ixv-45537" unitRef="usd">7323933</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities contextRef="c830" decimals="0" id="ixv-45538" unitRef="usd">156947744</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities contextRef="c832" decimals="0" id="ixv-45539" unitRef="usd">11989792</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities contextRef="c833" decimals="0" id="ixv-45540" unitRef="usd">228502180</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities contextRef="c834" decimals="0" id="ixv-45541" unitRef="usd">361759056</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities contextRef="c838" decimals="0" id="ixv-45542" unitRef="usd">3852853</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities contextRef="c840" decimals="0" id="ixv-45543" unitRef="usd">2724114</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities contextRef="c841" decimals="0" id="ixv-45544" unitRef="usd">18260456</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities contextRef="c842" decimals="0" id="ixv-45545" unitRef="usd">80809686</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities contextRef="c845" decimals="0" id="ixv-45546" unitRef="usd">117463</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities contextRef="c846" decimals="0" id="ixv-45547" unitRef="usd">11284137</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities contextRef="c851" decimals="0" id="ixv-45548" unitRef="usd">1211093</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities contextRef="c853" decimals="0" id="ixv-45549" unitRef="usd">254204032</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities contextRef="c854" decimals="0" id="ixv-45550" unitRef="usd">614653476</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities contextRef="c855" decimals="0" id="ixv-45551" unitRef="usd">1211093</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities contextRef="c856" decimals="0" id="ixv-45552" unitRef="usd">14713906</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c857" decimals="0" id="ixv-45553" unitRef="usd">19722</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c860" decimals="0" id="ixv-45554" unitRef="usd">181093</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c862" decimals="0" id="ixv-45555" unitRef="usd">1030000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c863" decimals="0" id="ixv-45556" unitRef="usd">12943378</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c866" decimals="0" id="ixv-45557" unitRef="usd">2191286</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c869" decimals="0" id="ixv-45558" unitRef="usd">2311604</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c872" decimals="0" id="ixv-45559" unitRef="usd">1993668</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c875" decimals="0" id="ixv-45560" unitRef="usd">1702761</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c879" decimals="0" id="ixv-45561" unitRef="usd">11989792</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c881" decimals="0" id="ixv-45562" unitRef="usd">2724114</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:DisclosureOfLeasesExplanatory contextRef="c0" id="ixv-40862">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;16.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;LEASES&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The right-of-use asset was initially measured
at the amount of the lease liability plus initial direct costs incurred, adjusted by pre-payments made in relation to the lease. The right-of-use
asset was measured at cost less accumulated depreciation and accumulated impairment.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The lease liability was initially measured at
the present value of the lease payments payable over the lease term, discounted at the rate implicit in the lease if it can be readily
determined. If that rate cannot be readily determined, the Group uses its incremental borrowing rate.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The information about the right-of-use and liabilities
related with lease assets is as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2025&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2024&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Right-of-use leased asset&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 0pt"&gt;Book value at the beginning of the year&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;20,979,597&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;21,163,192&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Additions of the year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,569,819&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,585,223&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Additions from business combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100,896&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;168,988&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;Disposals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(680,110&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,284,975&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Exchange differences&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;273,529&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,652,831&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 0pt"&gt;Loss of control&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(30,142,835&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-654"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Book value at the end of the year&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;100,896&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;20,979,597&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2025&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2024&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 0pt"&gt;Book value at the beginning of the year/inception&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;9,377,845&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;7,226,617&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Depreciation of the year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,036,703&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,418,956&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;Disposals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(697,150&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,092,167&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Exchange differences&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;47,736&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(175,561&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 0pt"&gt;Loss of control&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(13,765,134&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-655"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Accumulated depreciation at the end of the year&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-656"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;9,377,845&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 0pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;100,896&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;11,601,752&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Lease Liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Book value at the beginning of the year/inception&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;11,284,137&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;13,889,223&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Additions of the year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,569,819&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,585,223&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Additions from business combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;117,463&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;168,988&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Interest expenses, exchange differences and inflation effects&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,059,412&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(480,189&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Payments of the year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(5,501,387&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(4,879,108&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Loss of control&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(16,411,981&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-657"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;117,463&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;11,284,137&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Lease Liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%"&gt;Current&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;117,463&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3,122,778&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Non-current&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-658"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;8,161,359&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;117,463&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;11,284,137&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Machinery and equipment&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-659"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3,655,741&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Vehicles&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-660"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,272,071&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Equipment and computer software&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-661"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,130,541&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Land and buildings&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;100,896&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;14,921,244&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;100,896&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;20,979,597&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfLeasesExplanatory>
    <ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory contextRef="c0" id="ixv-40876">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The information about the right-of-use and liabilities
related with lease assets is as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2025&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2024&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Right-of-use leased asset&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 0pt"&gt;Book value at the beginning of the year&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;20,979,597&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;21,163,192&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Additions of the year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,569,819&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,585,223&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Additions from business combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100,896&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;168,988&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt"&gt;Disposals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(680,110&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,284,975&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Exchange differences&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;273,529&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,652,831&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 0pt"&gt;Loss of control&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(30,142,835&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-654"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Book value at the end of the year&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;100,896&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;20,979,597&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2025&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2024&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-left: 0pt"&gt;Book value at the beginning of the year/inception&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;9,377,845&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;7,226,617&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Depreciation of the year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,036,703&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,418,956&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0pt"&gt;Disposals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(697,150&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,092,167&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 0pt"&gt;Exchange differences&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;47,736&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(175,561&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 0pt"&gt;Loss of control&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(13,765,134&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-655"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt"&gt;Accumulated depreciation at the end of the year&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-656"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;9,377,845&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt; padding-left: 0pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;100,896&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;11,601,752&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Lease Liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Book value at the beginning of the year/inception&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;11,284,137&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;13,889,223&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Additions of the year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,569,819&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,585,223&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Additions from business combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;117,463&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;168,988&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Interest expenses, exchange differences and inflation effects&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,059,412&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(480,189&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Payments of the year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(5,501,387&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(4,879,108&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Loss of control&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(16,411,981&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-657"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;117,463&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;11,284,137&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Lease Liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%"&gt;Current&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;117,463&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3,122,778&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Non-current&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-658"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;8,161,359&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;117,463&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;11,284,137&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Machinery and equipment&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-659"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3,655,741&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Vehicles&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-660"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,272,071&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Equipment and computer software&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-661"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,130,541&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Land and buildings&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;100,896&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;14,921,244&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;100,896&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;20,979,597&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory>
    <ifrs-full:RightofuseAssets contextRef="c884" decimals="0" id="ixv-45563" unitRef="usd">20979597</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets contextRef="c885" decimals="0" id="ixv-45564" unitRef="usd">21163192</ifrs-full:RightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets contextRef="c886" decimals="0" id="ixv-45565" unitRef="usd">9569819</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets contextRef="c887" decimals="0" id="ixv-45566" unitRef="usd">2585223</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsRightofuseAssets contextRef="c886" decimals="0" id="ixv-45567" unitRef="usd">100896</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsRightofuseAssets>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsRightofuseAssets contextRef="c887" decimals="0" id="ixv-45568" unitRef="usd">168988</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsRightofuseAssets>
    <ifrs-full:DisposalsRightofuseAssets contextRef="c886" decimals="0" id="ixv-45569" unitRef="usd">680110</ifrs-full:DisposalsRightofuseAssets>
    <ifrs-full:DisposalsRightofuseAssets contextRef="c887" decimals="0" id="ixv-45570" unitRef="usd">1284975</ifrs-full:DisposalsRightofuseAssets>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions contextRef="c886" decimals="0" id="ixv-45571" unitRef="usd">273529</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions contextRef="c887" decimals="0" id="ixv-45572" unitRef="usd">-1652831</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
    <mlec:RightOfUseAssetLossOfControl contextRef="c886" decimals="0" id="ixv-45573" unitRef="usd">-30142835</mlec:RightOfUseAssetLossOfControl>
    <ifrs-full:RightofuseAssets contextRef="c888" decimals="0" id="ixv-45574" unitRef="usd">100896</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets contextRef="c884" decimals="0" id="ixv-45575" unitRef="usd">20979597</ifrs-full:RightofuseAssets>
    <mlec:BookValueAtTheBeginningOfThePeriod contextRef="c889" decimals="0" id="ixv-45576" unitRef="usd">9377845</mlec:BookValueAtTheBeginningOfThePeriod>
    <mlec:BookValueAtTheBeginningOfThePeriod contextRef="c890" decimals="0" id="ixv-45577" unitRef="usd">7226617</mlec:BookValueAtTheBeginningOfThePeriod>
    <mlec:DepreciationOfThePeriod contextRef="c889" decimals="0" id="ixv-45578" unitRef="usd">5036703</mlec:DepreciationOfThePeriod>
    <mlec:DepreciationOfThePeriod contextRef="c890" decimals="0" id="ixv-45579" unitRef="usd">3418956</mlec:DepreciationOfThePeriod>
    <mlec:DisposalsDepreciation contextRef="c889" decimals="0" id="ixv-45580" unitRef="usd">-697150</mlec:DisposalsDepreciation>
    <mlec:DisposalsDepreciation contextRef="c890" decimals="0" id="ixv-45581" unitRef="usd">-1092167</mlec:DisposalsDepreciation>
    <mlec:ExchangeDifferencesDepreciation contextRef="c889" decimals="0" id="ixv-45582" unitRef="usd">47736</mlec:ExchangeDifferencesDepreciation>
    <mlec:ExchangeDifferencesDepreciation contextRef="c890" decimals="0" id="ixv-45583" unitRef="usd">-175561</mlec:ExchangeDifferencesDepreciation>
    <mlec:LossOfControlDepreciation contextRef="c891" decimals="0" id="ixv-45584" unitRef="usd">-13765134</mlec:LossOfControlDepreciation>
    <mlec:AccumulatedDepreciationAtTheEndOfThePeriod contextRef="c890" decimals="0" id="ixv-45585" unitRef="usd">9377845</mlec:AccumulatedDepreciationAtTheEndOfThePeriod>
    <ifrs-full:OtherPropertyPlantAndEquipment contextRef="c4" decimals="0" id="ixv-45586" unitRef="usd">100896</ifrs-full:OtherPropertyPlantAndEquipment>
    <ifrs-full:OtherPropertyPlantAndEquipment contextRef="c7" decimals="0" id="ixv-45587" unitRef="usd">11601752</ifrs-full:OtherPropertyPlantAndEquipment>
    <mlec:LeaseLiabilityBeginningOfTheYearinception contextRef="c4" decimals="0" id="ixv-45588" unitRef="usd">11284137</mlec:LeaseLiabilityBeginningOfTheYearinception>
    <mlec:LeaseLiabilityBeginningOfTheYearinception contextRef="c7" decimals="0" id="ixv-45589" unitRef="usd">13889223</mlec:LeaseLiabilityBeginningOfTheYearinception>
    <mlec:LeaseLiabiltyAdditionsOfTheYear contextRef="c4" decimals="0" id="ixv-45590" unitRef="usd">9569819</mlec:LeaseLiabiltyAdditionsOfTheYear>
    <mlec:LeaseLiabiltyAdditionsOfTheYear contextRef="c7" decimals="0" id="ixv-45591" unitRef="usd">2585223</mlec:LeaseLiabiltyAdditionsOfTheYear>
    <mlec:AdditionsToLeaseLiabilityFromBusinessCombination contextRef="c0" decimals="0" id="ixv-45592" unitRef="usd">117463</mlec:AdditionsToLeaseLiabilityFromBusinessCombination>
    <mlec:AdditionsToLeaseLiabilityFromBusinessCombination contextRef="c5" decimals="0" id="ixv-45593" unitRef="usd">168988</mlec:AdditionsToLeaseLiabilityFromBusinessCombination>
    <mlec:LeaseLiabilitiesInterestExpenseExchangeDifferencesAndInflationEffects contextRef="c0" decimals="0" id="ixv-45594" unitRef="usd">1059412</mlec:LeaseLiabilitiesInterestExpenseExchangeDifferencesAndInflationEffects>
    <mlec:LeaseLiabilitiesInterestExpenseExchangeDifferencesAndInflationEffects contextRef="c5" decimals="0" id="ixv-45595" unitRef="usd">-480189</mlec:LeaseLiabilitiesInterestExpenseExchangeDifferencesAndInflationEffects>
    <mlec:PaymentsOfThePeriodLeaseliability contextRef="c4" decimals="0" id="ixv-45596" unitRef="usd">-5501387</mlec:PaymentsOfThePeriodLeaseliability>
    <mlec:PaymentsOfThePeriodLeaseliability contextRef="c7" decimals="0" id="ixv-45597" unitRef="usd">-4879108</mlec:PaymentsOfThePeriodLeaseliability>
    <mlec:LossOfControlLeaseLiability contextRef="c0" decimals="0" id="ixv-45598" unitRef="usd">-16411981</mlec:LossOfControlLeaseLiability>
    <mlec:TotalLeaseLiabilities contextRef="c0" decimals="0" id="ixv-45599" unitRef="usd">117463</mlec:TotalLeaseLiabilities>
    <mlec:TotalLeaseLiabilities contextRef="c5" decimals="0" id="ixv-45600" unitRef="usd">11284137</mlec:TotalLeaseLiabilities>
    <ifrs-full:CurrentLeaseLiabilities contextRef="c4" decimals="0" id="ixv-45601" unitRef="usd">117463</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentLeaseLiabilities contextRef="c7" decimals="0" id="ixv-45602" unitRef="usd">3122778</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities contextRef="c7" decimals="0" id="ixv-45603" unitRef="usd">8161359</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:LeaseLiabilities contextRef="c4" decimals="0" id="ixv-45604" unitRef="usd">117463</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities contextRef="c7" decimals="0" id="ixv-45605" unitRef="usd">11284137</ifrs-full:LeaseLiabilities>
    <ifrs-full:Machinery contextRef="c894" decimals="0" id="ixv-45606" unitRef="usd">3655741</ifrs-full:Machinery>
    <ifrs-full:Vehicles contextRef="c896" decimals="0" id="ixv-45607" unitRef="usd">1272071</ifrs-full:Vehicles>
    <ifrs-full:ComputerSoftware contextRef="c898" decimals="0" id="ixv-45608" unitRef="usd">1130541</ifrs-full:ComputerSoftware>
    <ifrs-full:LandAndBuildings contextRef="c899" decimals="0" id="ixv-45609" unitRef="usd">100896</ifrs-full:LandAndBuildings>
    <ifrs-full:LandAndBuildings contextRef="c900" decimals="0" id="ixv-45610" unitRef="usd">14921244</ifrs-full:LandAndBuildings>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c888" decimals="0" id="ixv-45611" unitRef="usd">100896</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c884" decimals="0" id="ixv-45612" unitRef="usd">20979597</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DisclosureOfRelatedPartyExplanatory contextRef="c0" id="ixv-41347">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;17.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND
TRANSACTIONS&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;During the year ended June 30, 2025, the transactions
between the Group and related parties, and the related balances owed by and to them for the year ended June 30, 2025, 2024 and 2023 are
as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Value of transactions for the year ended&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid"&gt;Party&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;Transaction type&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 30%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 33%; text-align: left"&gt;Sales of goods and services&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4,033,811&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;952,742&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;739,651&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Joint ventures and associates&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Purchases of goods and services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(24,061,563&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(500,704&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(738,652&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Net loans granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,645,504&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;13,005,841&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,141,471&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Interest gain&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;944,186&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;135,485&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;212,407&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Net loans received&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-662"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,860,058&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,854,680&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Puttable instruments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-663"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-664"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,399,631&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Net loans granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-665"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28,299&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;19,049&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Preference shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(15,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-666"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-667"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Interest expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-668"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,425,703&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(956,873&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Shareholders and other related parties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Own shares held by subsidiaries&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-669"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(444,473&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(133,079&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;In-kind contributions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,343,549&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,409,244&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,163,384&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Sales of goods and services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,714,441&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,911,723&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,565,027&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Purchases of goods and services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,517,528&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,998,349&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,334,556&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Salaries, social security benefits and other benefits&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,494,538&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,496,073&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,995,361&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Key management personnel&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Sales and services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;367,928&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-670"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-671"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Purchases of goods and services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,079,070&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-672"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-673"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Stock options-based incentives&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(480,450&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(8,181,849&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,868,430&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;(27,583,730&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;1,536,125&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;10,358,989&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Amounts receivable from&lt;br/&gt;
 related parties&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Party&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Transaction type&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 30%; text-align: left"&gt;Joint ventures and associates&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 45%; text-align: left"&gt;Trade debtors&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,565,913&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2,176,622&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Other receivables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,211,902&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;37,586,012&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Shareholders and other related parties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Trade debtors&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-674"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;37&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Loans receivables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,295,774&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-675"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Other receivables&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;17,405&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;47,348&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;15,090,994&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;39,810,019&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 52.5pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Amounts payable to&lt;br/&gt;
 related parties&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Party&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Transaction type&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 30%; text-align: left"&gt;Joint ventures and associates&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 45%; text-align: left"&gt;Trade creditors&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(620,034&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(52,778,206&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Convertible notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(7,102,028&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-676"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Net loans payables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(10,303,098&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,860,058&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Shareholders and other related parties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Trade creditors&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-677"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(37,985&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,030,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-678"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Preference shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(15,739,726&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-679"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Key management personnel&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Salaries, social security benefits and other benefits&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(41,620&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(226,702&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(34,836,506&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(54,902,951&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfRelatedPartyExplanatory>
    <mlec:ValueOfTransactionsForThePeriodEnded contextRef="c901" decimals="0" id="ixv-45613" unitRef="usd">4033811</mlec:ValueOfTransactionsForThePeriodEnded>
    <mlec:ValueOfTransactionsForThePeriodEnded contextRef="c902" decimals="0" id="ixv-45614" unitRef="usd">952742</mlec:ValueOfTransactionsForThePeriodEnded>
    <mlec:ValueOfTransactionsForThePeriodEnded contextRef="c903" decimals="0" id="ixv-45615" unitRef="usd">739651</mlec:ValueOfTransactionsForThePeriodEnded>
    <mlec:ValueOfTransactionsForThePeriodEnded contextRef="c904" decimals="0" id="ixv-45616" unitRef="usd">-24061563</mlec:ValueOfTransactionsForThePeriodEnded>
    <mlec:ValueOfTransactionsForThePeriodEnded contextRef="c905" decimals="0" id="ixv-45617" unitRef="usd">-500704</mlec:ValueOfTransactionsForThePeriodEnded>
    <mlec:ValueOfTransactionsForThePeriodEnded contextRef="c906" decimals="0" id="ixv-45618" unitRef="usd">-738652</mlec:ValueOfTransactionsForThePeriodEnded>
    <mlec:ValueOfTransactionsForThePeriodEnded contextRef="c907" decimals="0" id="ixv-45619" unitRef="usd">7645504</mlec:ValueOfTransactionsForThePeriodEnded>
    <mlec:ValueOfTransactionsForThePeriodEnded contextRef="c908" decimals="0" id="ixv-45620" unitRef="usd">13005841</mlec:ValueOfTransactionsForThePeriodEnded>
    <mlec:ValueOfTransactionsForThePeriodEnded contextRef="c909" decimals="0" id="ixv-45621" unitRef="usd">7141471</mlec:ValueOfTransactionsForThePeriodEnded>
    <mlec:ValueOfTransactionsForThePeriodEnded contextRef="c910" decimals="0" id="ixv-45622" unitRef="usd">944186</mlec:ValueOfTransactionsForThePeriodEnded>
    <mlec:ValueOfTransactionsForThePeriodEnded contextRef="c911" decimals="0" id="ixv-45623" unitRef="usd">135485</mlec:ValueOfTransactionsForThePeriodEnded>
    <mlec:ValueOfTransactionsForThePeriodEnded contextRef="c912" decimals="0" id="ixv-45624" unitRef="usd">212407</mlec:ValueOfTransactionsForThePeriodEnded>
    <mlec:ValueOfTransactionsForThePeriodEnded contextRef="c914" decimals="0" id="ixv-45625" unitRef="usd">-1860058</mlec:ValueOfTransactionsForThePeriodEnded>
    <mlec:ValueOfTransactionsForThePeriodEnded contextRef="c915" decimals="0" id="ixv-45626" unitRef="usd">-1854680</mlec:ValueOfTransactionsForThePeriodEnded>
    <mlec:ValueOfTransactionsForThePeriodEnded contextRef="c918" decimals="0" id="ixv-45627" unitRef="usd">4399631</mlec:ValueOfTransactionsForThePeriodEnded>
    <mlec:ValueOfTransactionsForThePeriodEnded contextRef="c920" decimals="0" id="ixv-45628" unitRef="usd">28299</mlec:ValueOfTransactionsForThePeriodEnded>
    <mlec:ValueOfTransactionsForThePeriodEnded contextRef="c921" decimals="0" id="ixv-45629" unitRef="usd">19049</mlec:ValueOfTransactionsForThePeriodEnded>
    <mlec:ValueOfTransactionsForThePeriodEnded contextRef="c922" decimals="0" id="ixv-45630" unitRef="usd">-15000000</mlec:ValueOfTransactionsForThePeriodEnded>
    <mlec:ValueOfTransactionsForThePeriodEnded contextRef="c926" decimals="0" id="ixv-45631" unitRef="usd">-2425703</mlec:ValueOfTransactionsForThePeriodEnded>
    <mlec:ValueOfTransactionsForThePeriodEnded contextRef="c927" decimals="0" id="ixv-45632" unitRef="usd">-956873</mlec:ValueOfTransactionsForThePeriodEnded>
    <mlec:ValueOfTransactionsForThePeriodEnded contextRef="c929" decimals="0" id="ixv-45633" unitRef="usd">-444473</mlec:ValueOfTransactionsForThePeriodEnded>
    <mlec:ValueOfTransactionsForThePeriodEnded contextRef="c930" decimals="0" id="ixv-45634" unitRef="usd">-133079</mlec:ValueOfTransactionsForThePeriodEnded>
    <mlec:ValueOfTransactionsForThePeriodEnded contextRef="c931" decimals="0" id="ixv-45635" unitRef="usd">4343549</mlec:ValueOfTransactionsForThePeriodEnded>
    <mlec:ValueOfTransactionsForThePeriodEnded contextRef="c932" decimals="0" id="ixv-45636" unitRef="usd">2409244</mlec:ValueOfTransactionsForThePeriodEnded>
    <mlec:ValueOfTransactionsForThePeriodEnded contextRef="c933" decimals="0" id="ixv-45637" unitRef="usd">1163384</mlec:ValueOfTransactionsForThePeriodEnded>
    <mlec:ValueOfTransactionsForThePeriodEnded contextRef="c934" decimals="0" id="ixv-45638" unitRef="usd">3714441</mlec:ValueOfTransactionsForThePeriodEnded>
    <mlec:ValueOfTransactionsForThePeriodEnded contextRef="c935" decimals="0" id="ixv-45639" unitRef="usd">2911723</mlec:ValueOfTransactionsForThePeriodEnded>
    <mlec:ValueOfTransactionsForThePeriodEnded contextRef="c936" decimals="0" id="ixv-45640" unitRef="usd">6565027</mlec:ValueOfTransactionsForThePeriodEnded>
    <mlec:ValueOfTransactionsForThePeriodEnded contextRef="c937" decimals="0" id="ixv-45641" unitRef="usd">-3517528</mlec:ValueOfTransactionsForThePeriodEnded>
    <mlec:ValueOfTransactionsForThePeriodEnded contextRef="c938" decimals="0" id="ixv-45642" unitRef="usd">-1998349</mlec:ValueOfTransactionsForThePeriodEnded>
    <mlec:ValueOfTransactionsForThePeriodEnded contextRef="c939" decimals="0" id="ixv-45643" unitRef="usd">-2334556</mlec:ValueOfTransactionsForThePeriodEnded>
    <mlec:ValueOfTransactionsForThePeriodEnded contextRef="c940" decimals="0" id="ixv-45644" unitRef="usd">-2494538</mlec:ValueOfTransactionsForThePeriodEnded>
    <mlec:ValueOfTransactionsForThePeriodEnded contextRef="c941" decimals="0" id="ixv-45645" unitRef="usd">-2496073</mlec:ValueOfTransactionsForThePeriodEnded>
    <mlec:ValueOfTransactionsForThePeriodEnded contextRef="c942" decimals="0" id="ixv-45646" unitRef="usd">-1995361</mlec:ValueOfTransactionsForThePeriodEnded>
    <mlec:ValueOfTransactionsForThePeriodEnded contextRef="c943" decimals="0" id="ixv-45647" unitRef="usd">367928</mlec:ValueOfTransactionsForThePeriodEnded>
    <mlec:ValueOfTransactionsForThePeriodEnded contextRef="c946" decimals="0" id="ixv-45648" unitRef="usd">-3079070</mlec:ValueOfTransactionsForThePeriodEnded>
    <mlec:ValueOfTransactionsForThePeriodEnded contextRef="c949" decimals="0" id="ixv-45649" unitRef="usd">-480450</mlec:ValueOfTransactionsForThePeriodEnded>
    <mlec:ValueOfTransactionsForThePeriodEnded contextRef="c950" decimals="0" id="ixv-45650" unitRef="usd">-8181849</mlec:ValueOfTransactionsForThePeriodEnded>
    <mlec:ValueOfTransactionsForThePeriodEnded contextRef="c951" decimals="0" id="ixv-45651" unitRef="usd">-1868430</mlec:ValueOfTransactionsForThePeriodEnded>
    <mlec:ValueOfTransactionsForThePeriodEnded contextRef="c4" decimals="0" id="ixv-45652" unitRef="usd">-27583730</mlec:ValueOfTransactionsForThePeriodEnded>
    <mlec:ValueOfTransactionsForThePeriodEnded contextRef="c7" decimals="0" id="ixv-45653" unitRef="usd">1536125</mlec:ValueOfTransactionsForThePeriodEnded>
    <mlec:ValueOfTransactionsForThePeriodEnded contextRef="c47" decimals="0" id="ixv-45654" unitRef="usd">10358989</mlec:ValueOfTransactionsForThePeriodEnded>
    <ifrs-full:TradeAndOtherReceivablesDueFromRelatedParties contextRef="c952" decimals="0" id="ixv-45655" unitRef="usd">1565913</ifrs-full:TradeAndOtherReceivablesDueFromRelatedParties>
    <ifrs-full:TradeAndOtherReceivablesDueFromRelatedParties contextRef="c953" decimals="0" id="ixv-45656" unitRef="usd">2176622</ifrs-full:TradeAndOtherReceivablesDueFromRelatedParties>
    <ifrs-full:TradeAndOtherReceivablesDueFromRelatedParties contextRef="c954" decimals="0" id="ixv-45657" unitRef="usd">11211902</ifrs-full:TradeAndOtherReceivablesDueFromRelatedParties>
    <ifrs-full:TradeAndOtherReceivablesDueFromRelatedParties contextRef="c955" decimals="0" id="ixv-45658" unitRef="usd">37586012</ifrs-full:TradeAndOtherReceivablesDueFromRelatedParties>
    <ifrs-full:TradeAndOtherReceivablesDueFromRelatedParties contextRef="c957" decimals="0" id="ixv-45659" unitRef="usd">37</ifrs-full:TradeAndOtherReceivablesDueFromRelatedParties>
    <ifrs-full:TradeAndOtherReceivablesDueFromRelatedParties contextRef="c958" decimals="0" id="ixv-45660" unitRef="usd">2295774</ifrs-full:TradeAndOtherReceivablesDueFromRelatedParties>
    <ifrs-full:TradeAndOtherReceivablesDueFromRelatedParties contextRef="c960" decimals="0" id="ixv-45661" unitRef="usd">17405</ifrs-full:TradeAndOtherReceivablesDueFromRelatedParties>
    <ifrs-full:TradeAndOtherReceivablesDueFromRelatedParties contextRef="c961" decimals="0" id="ixv-45662" unitRef="usd">47348</ifrs-full:TradeAndOtherReceivablesDueFromRelatedParties>
    <ifrs-full:TradeAndOtherReceivablesDueFromRelatedParties contextRef="c4" decimals="0" id="ixv-45663" unitRef="usd">15090994</ifrs-full:TradeAndOtherReceivablesDueFromRelatedParties>
    <ifrs-full:TradeAndOtherReceivablesDueFromRelatedParties contextRef="c7" decimals="0" id="ixv-45664" unitRef="usd">39810019</ifrs-full:TradeAndOtherReceivablesDueFromRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties contextRef="c962" decimals="0" id="ixv-45665" unitRef="usd">620034</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties contextRef="c963" decimals="0" id="ixv-45666" unitRef="usd">52778206</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties contextRef="c964" decimals="0" id="ixv-45667" unitRef="usd">7102028</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties contextRef="c966" decimals="0" id="ixv-45668" unitRef="usd">10303098</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties contextRef="c967" decimals="0" id="ixv-45669" unitRef="usd">1860058</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties contextRef="c969" decimals="0" id="ixv-45670" unitRef="usd">37985</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties contextRef="c970" decimals="0" id="ixv-45671" unitRef="usd">1030000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties contextRef="c972" decimals="0" id="ixv-45672" unitRef="usd">15739726</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties contextRef="c940" decimals="0" id="ixv-45673" unitRef="usd">41620</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties contextRef="c941" decimals="0" id="ixv-45674" unitRef="usd">226702</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties contextRef="c4" decimals="0" id="ixv-45675" unitRef="usd">34836506</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties contextRef="c7" decimals="0" id="ixv-45676" unitRef="usd">54902951</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory contextRef="c0" id="ixv-41943">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;18.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;KEY MANAGEMENT PERSONNEL COMPENSATION&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Key management personnel are those persons having
authority and responsibility for planning, directing and controlling the activities of the Group.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The compensation of directors and other members
of key management personnel, including social contributions and other benefits, were as follows for the year ended June 30, 2025, 2024
and 2023.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Short-term employee benefits&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2,494,538&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2,496,073&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,995,361&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Share based payment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;480,450&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;8,181,849&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,868,430&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,974,988&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;10,677,922&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3,863,791&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group entered into indemnification agreements
with each of its directors and executive officers. These agreements generally provide that the relevant director or officer will be indemnified
by the Group to the fullest extent permitted by law against liability and against all expenses reasonably incurred or paid by him or her
in connection with any claim, action, suit or proceeding which he or she becomes involved as a party or otherwise by virtue of his or
her being or having been such a director or officer of the Group and against amounts paid or incurred by him or her in the settlement
thereof.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The agreements are subject to certain exceptions,
including that no indemnification will be provided to any director or officer against any liability to the Group or its shareholder (i)
by reason of intentional fraudulent conduct, dishonesty, willful misconduct, or gross negligence on the part of the director or officer;
or (ii) by reason of payment made under an insurance policy or any third party that has no recourse against the indemnitee director or
officer.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The compensation of key executives is determined
by the Board of Directors of Moolec Science SA, Bioceres Group Limited, Bioceres S.A. and Bioceres Crop Solutions Corp., based on the
performance of individuals and market trends.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Moolec Science SA currently does not pay any compensation
to any of its executive board members.&lt;/p&gt;</ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory>
    <mlec:DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock contextRef="c0" id="ixv-41956">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The compensation of directors and other members
of key management personnel, including social contributions and other benefits, were as follows for the year ended June 30, 2025, 2024
and 2023.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Short-term employee benefits&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2,494,538&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2,496,073&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,995,361&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Share based payment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;480,450&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;8,181,849&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,868,430&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;2,974,988&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;10,677,922&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3,863,791&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</mlec:DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits contextRef="c0" decimals="0" id="ixv-45677" unitRef="usd">2494538</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits contextRef="c5" decimals="0" id="ixv-45678" unitRef="usd">2496073</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits contextRef="c6" decimals="0" id="ixv-45679" unitRef="usd">1995361</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment contextRef="c0" decimals="0" id="ixv-45680" unitRef="usd">480450</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment contextRef="c5" decimals="0" id="ixv-45681" unitRef="usd">8181849</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment contextRef="c6" decimals="0" id="ixv-45682" unitRef="usd">1868430</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensation contextRef="c0" decimals="0" id="ixv-45683" unitRef="usd">2974988</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:KeyManagementPersonnelCompensation contextRef="c5" decimals="0" id="ixv-45684" unitRef="usd">10677922</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:KeyManagementPersonnelCompensation contextRef="c6" decimals="0" id="ixv-45685" unitRef="usd">3863791</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory contextRef="c0" id="ixv-42026">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;19.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;SHARE-BASED PAYMENT&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;19.1 &lt;span style="text-decoration:underline"&gt;Bioceres S.A share based payments&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Prior to the Business Combination and the BIOX
deconsolidation, and in accordance with the compensation policy defined previously by the Bioceres Group Limited and its subsidiaries,
certain directors of Bioceres S.A. had the option of choosing to collect the annual incentive in cash or in shares of BIOX. The incentive
was for up to five times the monthly salary of each one and increases by $30,000 in the event that they choose to receive the incentive
in the form of shares.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of June 30, 2023 8,560 of Bioceres Crop Solutions Corp, were assigned
to the beneficiaries, which were granted immediately in recognition of the professional performance demonstrated during the year.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Additionally, in January 2024, in compliance with
the resolution in Minute No. 256 of the Board Meeting held in December 2021, it was decided to grant the Bioceres 2021 Award. It consists
of 10,000 shares of Bioceres Crops Solutions Corp for Dr. L&#xed;a Raquel Chan, a researcher at CONICET, in recognition of her leadership
in the early development of HB4 technology.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;After the latest grant in January 2024, no incentives were awarded.
As of June 30, 2025 there is no outstanding annual incentive pending to be granted.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;b&gt;19.2 &lt;span style="text-decoration:underline"&gt;Bioceres Crop Solutions Corp share based payments&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;2023 Omnibus Equity Incentive Plan&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On May 12, 2023, the board of directors of Bioceres
Crop Solutions Corp approved the 2023 Omnibus Equity Incentive Plan to attract and retain the best available personnel, provide additional
incentives to employees, directors and consultants and to promote the success of the Company&#x2019;s business. In addition to introducing
new incentive plans, it comprehensively amends and restates in entirety (i) the Employee Stock Purchase Plan, (ii) the Equity Compensation
Plan, (iii) the Stand-Alone Stock Option Grant, and (iv) the Employee Stock Option Plan.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Employee Stock Purchase Plan (&#x201c;ESPP&#x201d;): incentive
plan for eligible employees with no stock compensation to purchase ordinary shares of BIOX up to a maximum of 15% percent of such employee&#x2019;s
monthly compensation. The number of ordinary shares subject to the ESPP shall be 200,000 ordinary shares. The purchase price will be
equal to 85% of the lower of the closing price of BIOX&#x2019;s ordinary shares on the first business day and the last business day of
the relevant offering period. As of the date of these consolidated financial statements the ESSP is not yet implemented.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Equity Compensation Plan: annual incentive plan based on
certain financial and operational targets defined by the Board of Directors upon approval of the annual budget.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Stand Alone Stock Option Grant: plan granted up to 1,200,000
underlying ordinary shares. The options have an exercise price of $4.55 and expire on October 31, 2029. Options can be exercised for
a period of up to three years, with 1/3 vesting every 12 months, and on a cashless basis at their volume weighted average price (&#x201c;VWAP&#x201d;)
of the ordinary shares during a twenty-day period to the date of exercise.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Employee Stock Option Plan: plan granted up to 100,000 underlying
ordinary shares to certain key employees. The options have an exercise price of $5.55 and expire on October 23, 2030. Options can be
exercised for a period of up to three years, with 1/3 vesting every 12 months, and on a cashless basis at their volume weighted average
price (&#x201c;VWAP&#x201d;) of the ordinary shares during a twenty-day period to the date of exercise.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Past Share Option plan: immediately
vested options with a strike price between $11.93 and $13.24.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Base Share Option plan: to
vest and become exercisable in equal installments on June 30, 2023, June 30, 2024, and June 30, 2025, with a strike price between $10.47
and $10.79.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Performance Share Option plan:
to vest and become exercisable if the Group&#x2019;s fiscal year 2025 EBITDA reaches at least US$120 million, at 0% of the award, and
linearly thereafter up to 100% of the awarded options when reaching at least US$150 million. These options have also a strike price of
between $10.47 and $10.79.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The fair value of the stock options at the grant
date was estimated using the &#x201c;Black-Scholes&#x201d; model, considering the terms and conditions under which the options on shares were
granted and adjusted to consider the possible dilutive effect of the future exercise of options.&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid"&gt;Factor&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Stand Alone Stock Option Grant&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Employee Stock Option Plan&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Past Share Option plan&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Base Share Option plan&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Performance Share Option plan&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: justify; padding-left: 0pt"&gt;Weighted average fair value of shares&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;5.42&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;13.98&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;11.45&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;10.80&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;10.79&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: justify; padding-left: 0pt"&gt;Weighted average exercise price&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;4.55&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;5.55&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;12.48&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;10.52&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;10.52&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-left: 0pt"&gt;Weighted average expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;29.69&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;42.18&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;48.73&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;54.73&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;54.73&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: justify; padding-left: 0pt"&gt;Dividend rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-left: 0pt"&gt;Weighted average risk-free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1.66&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1.17&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.40&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.47&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.47&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: justify; padding-left: 0pt"&gt;Weighted average expected life&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;9.89 years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;9.22 years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;4.89 years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;2.97 year&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;2.97 year&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: justify; padding-left: 0.125in"&gt;Weighted average fair value of stock options at measurement date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2.47&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;10.10&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;5.01&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;4.46&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;4.45&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;There are no market-related performance conditions
or non-vesting conditions that should be considered for determining the fair value of options.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group estimated that nearly 100% of the share
options will be exercised, based on historical trends of executive retention and option exercise behavior. This estimate is reviewed at
the end of each annual or interim period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;2013 Stock Incentive Plan &#x2013; Pro Farm
Group&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As part of the acquisition of Pro Farm Group,
Bioceres Group Limited, through its former subsidiary, BIOX, have incorporated the outstanding &#x201c;2013 Stock Incentive Plan&#x201d;
from Pro Farm Group. On the merger date the total equity awards outstanding was converted consistent with the terms of the merger agreement
into an aggregate of 1,191,362 option and or restricted stock units which was fully registered with the Securities and Exchange Commission
on July 26, 2022. All equity awards retained their original granted terms. BIOX has not granted any additional awards under this plan
during the year.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Bioceres Crop Solutions&#x2019;s fair value of
the grants was estimated utilizing a Black Scholes option pricing model based on the following range of assumptions which have determined
consistent with BIOX&#x2019;s historical methodology for such assumptions:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;July
    12, &lt;br/&gt;
    2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercise price&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7.16 - 204.66&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expected life (years)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.03 - 9.83&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Estimated volatility factor&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;34.9% - 44.4&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="vertical-align: top; width: 88%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Risk-free
    interest rate&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-680; font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table shows the evolution of stock
option and weighted average exercise price for the years ended June 30, 2025, and 2024:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Number of options&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;W.A. Exercise price&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Number of options&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;W.A. Exercise price&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; font-weight: bold; text-align: left"&gt;At the beginning of the year&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; text-align: right"&gt;7,345,795&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; text-align: right"&gt;11.83&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; text-align: right"&gt;1,791,000&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; text-align: right"&gt;15.79&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Granted during the year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-681"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-682"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,631,894&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10.55&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Cancelled or expired during the year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-683"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-684"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(570&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10.07&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Exercised during the year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-685"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-686"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(76,529&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10.73&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Loss of control&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(7,345,795&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;11.83&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-687"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-688"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Effective at the end of the year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-689"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-690"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;7,345,795&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;11.83&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory>
    <mlec:ShareBasedPaymentsIncentiveIncreases contextRef="c0" decimals="0" id="ixv-45686" unitRef="usd">30000</mlec:ShareBasedPaymentsIncentiveIncreases>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="c974"
      decimals="0"
      id="ixv-45687"
      unitRef="pure">8560</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="c975"
      decimals="0"
      id="ixv-45688"
      unitRef="pure">10000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <mlec:IfrsDefinedContributionPlanEmployerMatchingContributionPercentOfEmployeesGrossPay
      contextRef="c976"
      decimals="2"
      id="ixv-45689"
      unitRef="pure">0.15</mlec:IfrsDefinedContributionPlanEmployerMatchingContributionPercentOfEmployeesGrossPay>
    <mlec:SharesSubjectToEmployeeStockPurchasePlan
      contextRef="c977"
      decimals="INF"
      id="ixv-45690"
      unitRef="shares">200000</mlec:SharesSubjectToEmployeeStockPurchasePlan>
    <mlec:PercentageOfClosingPriceOnFirstAndLastBusinessDayToDeterminePurchasePrice
      contextRef="c976"
      decimals="2"
      id="ixv-45691"
      unitRef="pure">0.85</mlec:PercentageOfClosingPriceOnFirstAndLastBusinessDayToDeterminePurchasePrice>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="c978"
      decimals="INF"
      id="ixv-45692"
      unitRef="pure">1200000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="c979"
      decimals="2"
      id="ixv-45693"
      unitRef="usdPershares">4.55</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <mlec:ShareBasedPaymentAwardExpirationDate contextRef="c978" id="ixv-45694">2029-10-31</mlec:ShareBasedPaymentAwardExpirationDate>
    <mlec:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod contextRef="c978" id="ixv-45695">P3Y</mlec:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod>
    <mlec:ShareBasedPaymentPeriodOfWeightedAveragePriceVwapOfOrdinarySharesForCashlessBasisExercise contextRef="c978" id="ixv-45696">P20D</mlec:ShareBasedPaymentPeriodOfWeightedAveragePriceVwapOfOrdinarySharesForCashlessBasisExercise>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="c980"
      decimals="INF"
      id="ixv-45697"
      unitRef="pure">100000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="c981"
      decimals="2"
      id="ixv-45698"
      unitRef="usdPershares">5.55</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <mlec:ShareBasedPaymentAwardExpirationDate contextRef="c982" id="ixv-45699">2030-10-23</mlec:ShareBasedPaymentAwardExpirationDate>
    <mlec:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod contextRef="c980" id="ixv-45700">P3Y</mlec:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod>
    <mlec:ShareBasedPaymentPeriodOfWeightedAveragePriceVwapOfOrdinarySharesForCashlessBasisExercise contextRef="c980" id="ixv-45701">P20D</mlec:ShareBasedPaymentPeriodOfWeightedAveragePriceVwapOfOrdinarySharesForCashlessBasisExercise>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="c983"
      decimals="2"
      id="ixv-45702"
      unitRef="usdPershares">11.93</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="c984"
      decimals="2"
      id="ixv-45703"
      unitRef="usdPershares">13.24</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="c985"
      decimals="2"
      id="ixv-45704"
      unitRef="usdPershares">10.47</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="c986"
      decimals="2"
      id="ixv-45705"
      unitRef="usdPershares">10.47</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="c987"
      decimals="2"
      id="ixv-45706"
      unitRef="usdPershares">10.47</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="c988"
      decimals="2"
      id="ixv-45707"
      unitRef="usdPershares">10.79</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="c989"
      decimals="2"
      id="ixv-45708"
      unitRef="usdPershares">10.79</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="c990"
      decimals="2"
      id="ixv-45709"
      unitRef="usdPershares">10.79</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <mlec:ThresholdEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="c991"
      decimals="-6"
      id="ixv-45710"
      unitRef="usd">120000000</mlec:ThresholdEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <mlec:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage
      contextRef="c992"
      decimals="2"
      id="ixv-45711"
      unitRef="pure">0</mlec:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage>
    <mlec:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage
      contextRef="c993"
      decimals="2"
      id="ixv-45712"
      unitRef="pure">1</mlec:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage>
    <mlec:ThresholdEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="c994"
      decimals="-6"
      id="ixv-45713"
      unitRef="usd">150000000</mlec:ThresholdEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="c995"
      decimals="2"
      id="ixv-45714"
      unitRef="usdPershares">10.47</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="c996"
      decimals="2"
      id="ixv-45715"
      unitRef="usdPershares">10.79</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <mlec:DisclosureOfFairValueOfTheStockOptionsAtTheGrantDateTextBlock contextRef="c0" id="ixv-42195">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The fair value of the stock options at the grant
date was estimated using the &#x201c;Black-Scholes&#x201d; model, considering the terms and conditions under which the options on shares were
granted and adjusted to consider the possible dilutive effect of the future exercise of options.&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid"&gt;Factor&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Stand Alone Stock Option Grant&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Employee Stock Option Plan&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Past Share Option plan&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Base Share Option plan&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Performance Share Option plan&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: justify; padding-left: 0pt"&gt;Weighted average fair value of shares&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;5.42&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;13.98&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;11.45&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;10.80&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;10.79&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: justify; padding-left: 0pt"&gt;Weighted average exercise price&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;4.55&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;5.55&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;12.48&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;10.52&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;10.52&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-left: 0pt"&gt;Weighted average expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;29.69&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;42.18&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;48.73&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;54.73&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;54.73&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: justify; padding-left: 0pt"&gt;Dividend rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-left: 0pt"&gt;Weighted average risk-free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1.66&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1.17&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.40&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.47&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.47&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: justify; padding-left: 0pt"&gt;Weighted average expected life&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;9.89 years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;9.22 years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;4.89 years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;2.97 year&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;2.97 year&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -0.125in; text-align: justify; padding-left: 0.125in"&gt;Weighted average fair value of stock options at measurement date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2.47&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;10.10&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;5.01&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;4.46&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;4.45&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</mlec:DisclosureOfFairValueOfTheStockOptionsAtTheGrantDateTextBlock>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="c999"
      decimals="2"
      id="ixv-45716"
      unitRef="usdPershares">5.42</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="c1000"
      decimals="2"
      id="ixv-45717"
      unitRef="usdPershares">13.98</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="c1001"
      decimals="2"
      id="ixv-45718"
      unitRef="usdPershares">11.45</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="c1002"
      decimals="2"
      id="ixv-45719"
      unitRef="usdPershares">10.8</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="c1003"
      decimals="2"
      id="ixv-45720"
      unitRef="usdPershares">10.79</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="c999"
      decimals="2"
      id="ixv-45721"
      unitRef="usdPershares">4.55</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="c1000"
      decimals="2"
      id="ixv-45722"
      unitRef="usdPershares">5.55</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="c1001"
      decimals="2"
      id="ixv-45723"
      unitRef="usdPershares">12.48</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="c1002"
      decimals="2"
      id="ixv-45724"
      unitRef="usdPershares">10.52</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="c1003"
      decimals="2"
      id="ixv-45725"
      unitRef="usdPershares">10.52</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="c999"
      decimals="4"
      id="ixv-45726"
      unitRef="pure">0.2969</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="c1000"
      decimals="4"
      id="ixv-45727"
      unitRef="pure">0.4218</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="c1001"
      decimals="4"
      id="ixv-45728"
      unitRef="pure">0.4873</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="c1002"
      decimals="4"
      id="ixv-45729"
      unitRef="pure">0.5473</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="c1003"
      decimals="4"
      id="ixv-45730"
      unitRef="pure">0.5473</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="c999"
      decimals="2"
      id="ixv-45731"
      unitRef="pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="c1000"
      decimals="2"
      id="ixv-45732"
      unitRef="pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="c1001"
      decimals="2"
      id="ixv-45733"
      unitRef="pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="c1002"
      decimals="2"
      id="ixv-45734"
      unitRef="pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="c1003"
      decimals="2"
      id="ixv-45735"
      unitRef="pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="c999"
      decimals="4"
      id="ixv-45736"
      unitRef="pure">0.0166</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="c1000"
      decimals="4"
      id="ixv-45737"
      unitRef="pure">0.0117</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="c1001"
      decimals="4"
      id="ixv-45738"
      unitRef="pure">0.044</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="c1002"
      decimals="4"
      id="ixv-45739"
      unitRef="pure">0.0447</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="c1003"
      decimals="4"
      id="ixv-45740"
      unitRef="pure">0.0447</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="c999"
      decimals="2"
      id="ixv-45741"
      unitRef="pure">9.89</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="c1000"
      decimals="2"
      id="ixv-45742"
      unitRef="pure">9.22</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="c1001"
      decimals="2"
      id="ixv-45743"
      unitRef="pure">4.89</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="c1002"
      decimals="2"
      id="ixv-45744"
      unitRef="pure">2.97</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="c1003"
      decimals="2"
      id="ixv-45745"
      unitRef="pure">2.97</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted
      contextRef="c1004"
      decimals="2"
      id="ixv-45746"
      unitRef="usd">2.47</ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted>
    <ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted
      contextRef="c1005"
      decimals="2"
      id="ixv-45747"
      unitRef="usd">10.1</ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted>
    <ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted
      contextRef="c1006"
      decimals="2"
      id="ixv-45748"
      unitRef="usd">5.01</ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted>
    <ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted
      contextRef="c1007"
      decimals="2"
      id="ixv-45749"
      unitRef="usd">4.46</ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted>
    <ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted
      contextRef="c1008"
      decimals="2"
      id="ixv-45750"
      unitRef="usd">4.45</ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted>
    <mlec:NumberOfOptionsEstimatedExercisePercent
      contextRef="c997"
      decimals="2"
      id="ixv-45751"
      unitRef="pure">1</mlec:NumberOfOptionsEstimatedExercisePercent>
    <mlec:ShareBasedPaymentArrangementConversionOfEquityAwardsOutstandingToOptionOrRestrictedStockUnits
      contextRef="c998"
      decimals="INF"
      id="ixv-45752"
      unitRef="shares">1191362</mlec:ShareBasedPaymentArrangementConversionOfEquityAwardsOutstandingToOptionOrRestrictedStockUnits>
    <ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory contextRef="c0" id="ixv-42386">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Bioceres Crop Solutions&#x2019;s fair value of
the grants was estimated utilizing a Black Scholes option pricing model based on the following range of assumptions which have determined
consistent with BIOX&#x2019;s historical methodology for such assumptions:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;July
    12, &lt;br/&gt;
    2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercise price&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7.16 - 204.66&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expected life (years)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;0.03 - 9.83&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Estimated volatility factor&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;34.9% - 44.4&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="vertical-align: top; width: 88%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Risk-free
    interest rate&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-680; font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="c1009"
      decimals="2"
      id="ixv-45753"
      unitRef="usdPershares">7.16</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:ExercisePriceShareOptionsGranted2019
      contextRef="c1010"
      decimals="2"
      id="ixv-45754"
      unitRef="usdPershares">204.66</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="c1009"
      decimals="2"
      id="ixv-45755"
      unitRef="pure">0.03</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="c1010"
      decimals="2"
      id="ixv-45756"
      unitRef="pure">9.83</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="c1009"
      decimals="3"
      id="ixv-45757"
      unitRef="pure">0.349</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="c1010"
      decimals="3"
      id="ixv-45758"
      unitRef="pure">0.444</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="c1011"
      decimals="3"
      id="ixv-45759"
      unitRef="pure">0</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory contextRef="c0" id="ixv-42456">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table shows the evolution of stock
option and weighted average exercise price for the years ended June 30, 2025, and 2024:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Number of options&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;W.A. Exercise price&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Number of options&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;W.A. Exercise price&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; font-weight: bold; text-align: left"&gt;At the beginning of the year&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; text-align: right"&gt;7,345,795&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; text-align: right"&gt;11.83&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; text-align: right"&gt;1,791,000&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; text-align: right"&gt;15.79&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Granted during the year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-681"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-682"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,631,894&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10.55&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Cancelled or expired during the year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-683"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-684"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(570&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10.07&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Exercised during the year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-685"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-686"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(76,529&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10.73&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Loss of control&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(7,345,795&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;11.83&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-687"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-688"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Effective at the end of the year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-689"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-690"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;7,345,795&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;11.83&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="c1012"
      decimals="INF"
      id="ixv-45760"
      unitRef="pure">7345795</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="c1012"
      decimals="2"
      id="ixv-45761"
      unitRef="usdPershares">11.83</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="c1013"
      decimals="INF"
      id="ixv-45762"
      unitRef="pure">1791000</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="c1013"
      decimals="2"
      id="ixv-45763"
      unitRef="usdPershares">15.79</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="c1015"
      decimals="INF"
      id="ixv-45764"
      unitRef="pure">5631894</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="c1015"
      decimals="2"
      id="ixv-45765"
      unitRef="usdPershares">10.55</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="c1015"
      decimals="INF"
      id="ixv-45766"
      unitRef="pure">570</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019
      contextRef="c1015"
      decimals="2"
      id="ixv-45767"
      unitRef="usdPershares">10.07</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="c1015"
      decimals="INF"
      id="ixv-45768"
      unitRef="pure">76529</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="c1015"
      decimals="2"
      id="ixv-45769"
      unitRef="usdPershares">10.73</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="c1014"
      decimals="INF"
      id="ixv-45770"
      unitRef="pure">7345795</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019
      contextRef="c1014"
      decimals="2"
      id="ixv-45771"
      unitRef="usdPershares">11.83</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="c1012"
      decimals="INF"
      id="ixv-45772"
      unitRef="pure">7345795</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="c1012"
      decimals="2"
      id="ixv-45773"
      unitRef="usdPershares">11.83</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:DisclosureOfCommitmentsExplanatory contextRef="c0" id="ixv-42660">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;20.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;CONTINGENCIES, COMMITMENTS AND RESTRICTIONS ON THE
DISTRIBUTION OF PROFITS&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Prior to the BIOX deconsolidation, the Group had
secured guaranteed notes and the convertibles notes which are referenced in Note 7.13 &#x2013; Convertible Notes. Such instruments were
secured by substantially all of the assets located in the United States of Pro Farm Group, Inc. and its U.S. subsidiaries and are guaranteed
by BCS Holding Inc., Bioceres Crops do Brasil Ltda., Bioceres Crops S.A., Bioceres Semillas S.A.U., Verdeca LLC, Rasa Holding LLC, Rizobacter
Argentina S.A., Rizobacter del Paraguay S.A., Rizobacter do Brasil Ltda., Rizobacter South Africa, Rizobacter Uruguay, Rizobacter USA,
LLC, Pro Farm Group, Inc., Pro Farm Michigan Manufacturing LLC, Pro Farm, Inc., Pro Farm Technologies Com&#xe9;rcio de Insumo Agr&#xed;colas
do Brasil Ltda., Glinatur S.A. and Pro Farm OU.&lt;/p&gt;</ifrs-full:DisclosureOfCommitmentsExplanatory>
    <ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory contextRef="c0" id="ixv-42677">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;21.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;EVENTS OCCURRING AFTER THE REPORTING PERIOD&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Management has considered subsequent events through
the date these consolidated financial statements were issued.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Notice of Alleged breach&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On October 2, 2025, the Company received a notice
of alleged breach from INVIM Corporativo S.L., a private limited company incorporated under the laws of Spain (&#x201c;INVIM&#x201d;), regarding
the alleged failure to pay the assignment price of $13 million in connection with a certain Assignment and Assumption Agreement dated
May 27, 2025 (the &#x201c;Agreement&#x201d;). The Agreement, in turn, references related instruments, including a Note Purchase Agreement
and a Binding Contribution Memorandum of Understanding, both dated October 15, 2023.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In response, the Company rejected INVIM&#x2019;s
assertion that any payment is due or owing, on the grounds that, among other reasons, under the express terms of the Agreement and related
transaction instruments, INVIM failed to satisfy certain conditions precedent, including the valid transfer of relevant securities and
the execution of a required services agreement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company intends to vigorously defend its position
and enforce its rights under the Agreement, the related transaction instruments, and applicable law. While the Company believes that INVIM&#x2019;s
assertions are without merit, if INVIM were ultimately to prevail in any proceedings, such an adverse outcome could have a material adverse
effect on the Company&#x2019;s business, results of operations, financial condition, or liquidity.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Bioceres S.A. and Bioceres LLC&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As stated in Note 1 &#x2013; The Group&#x2019;s
business reorganization and general information - &#x201c;&lt;i&gt;The Bioceres Group Business Combination Agreement&#x201d;, &lt;/i&gt;in June 2025,
Bioceres S.A., one of the Argentine subsidiaries of Bioceres Group Limited, defaulted on a portion of its financial debt that was due
that month. As a result, Bioceres S.A. had initiated a debt restructuring process for its financial debt for an aggregate amount of $36.4
million.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In July 2025, Bioceres LLC, a wholly owned subsidiary
of Bioceres S.A., received a notice of default on its financial debt in the amount of $69.5 million. The creditor conducted a public auction
to wit 3,062,500 pledged BIOX shares, pursuant to the New York Uniform Commercial Code. Management has responded to said creditor, reserving
all rights, remedies, and defenses.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The defaults by Bioceres S.A. and Bioceres LLC
do not have implications in other debts as there are no cross-default clauses on the remaining financial debt of the Group. There are no guarantees granted above Bioceres S.A. and Bioceres LLC.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company had the financial support of its main
shareholders and considering the aforementioned events that derived in the loss of the financial support that was previously provided
by Bioceres Group (and who is also no longer a shareholder of the Company), and, consequently, raise a material uncertainty which may
cast significant doubt (or raise substantial doubt as contemplated by PCAOB standards) about the ability of Moolec Science SA to continue
as a going concern. The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Currently, the Group lacks sufficient financial resources to meet its obligations or fully implement its business plan. Without securing
additional capital, or achieving a successful financial restructuring process, the Group will not be able to sustain its operations. See
below &#x201c;&lt;i&gt;Exercise of convertible preference shares&#x201d;&lt;/i&gt; and &lt;i&gt;&#x201c;Summary of the liquidation and loss of control&#x201d;.&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;However, there is no assurance the Group&#x2019;s
future operations will generate profitability. The uncertainty surrounding the ability to secure additional funding and the potential
for continued operational losses contribute to raise a material uncertainty which may cast significant doubt (or raise substantial doubt
as contemplated by PCAOB standards) about the Group&#x2019;s ability to continue as a going concern.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Exercise of convertible preference shares&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In December 2024, Bioceres Group issued 2,380,952
convertible preference shares for total proceeds of $15 million. These preference shares accrue a 9% per annum payment-in-kind (PIK) return
and grant the holder specific conversion rights, including the option to convert into ordinary shares or into Moolec Scicence shares if
the business combination closed before September 12, 2025. Upon the consummation of the Business Combination, and subsequent to the reporting
date, on December 10, 2025, the holder undertook to exercise the conversion of all or part of the subscription shares into a number of
Moolec Science shares, at the Company&#x2019;s request. If total convertible shares are exercised, it will result in the derecognition
of a financial liability and an increase in equity of approximately $15 million plus the accumulated PIK up to the moment of exercise.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Financing proceeds&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Subsequent to the closing date of the financial
statements, on December 2, 2025, the Company successfully obtained and received financing proceeds for working capital purposes in the
amount of $2.5 million.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Financial support&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of the date of issuance of these financial statements, the Company&#x2019;s
principal minority shareholder has committed to provide financial support to the Company for a period of twelve months.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Nasdaq delist letter received &amp;amp; 20-F
delinquency letter&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-align: justify; text-indent: -0.5pt"&gt;On November 14,
2025, the Company received a determination letter (the &#x201c;Nasdaq Determination Letter&#x201d;) from the Nasdaq Stock Market LLC (&#x201c;Nasdaq&#x201d;)
indicating that the closing bid price of the Company&#x2019;s ordinary shares had been below the minimum $1.00 per share requirement for
the last 30 consecutive business days, as set forth in Nasdaq Listing Rule 5550(a)(2), and informing the Company of their view that the
Company would not be afforded an automatic 180-day period to regain compliance with such rule.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-align: justify; text-indent: -0.5pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-align: justify; text-indent: -0.5pt"&gt;The Company has
submitted a timely appeal to a Nasdaq Hearings Panel, through which it will request the granting of a 180- day period to submit and effect
a compliance plan, which includes a potential implementation of a reverse stock split, if determined to be in the best interest of shareholders.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-align: justify; text-indent: -0.5pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-align: justify; text-indent: -0.5pt"&gt;The submission of the appeal automatically stays the effect of the
Nasdaq Determination Letter until the appeal has been considered, which took place on December 18, 2025. Accordingly, the Company&#x2019;s
ordinary shares will continue to trade on The Nasdaq Capital Market under the symbol &#x201c;MLEC&#x201d; without interruption during the
time period when the panel decision is pending.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-align: justify; text-indent: -0.5pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-align: justify; text-indent: -0.5pt"&gt;The Company intends
to continue closely monitoring the closing bid price for its ordinary shares and remains committed to evaluating and executing all appropriate
actions to cure the deficiency and regain compliance with Nasdaq Listing Rule 5550(a)(2). The receipt of the Nasdaq Determination Letter
does not affect the Company&#x2019;s business, operations or reporting requirements with the Securities and Exchange Commission.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-align: justify; text-indent: -0.5pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On November 24, 2025, the Company received a letter
(the &#x201c;Letter&#x201d;) from the Listing Qualifications Department of Nasdaq stating that the Company is not in compliance with Nasdaq
Listing Rule 5250(c)(1) because it has not yet filed its Annual Report on Form 20-F for the year ended June 30, 2025 (the &#x201c;Form
20-F&#x201d;) with the Securities and Exchange Commission (the &#x201c;SEC&#x201d;).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As the Company stated in the form 12b-25 filed
with the SEC on October 31, 2025, it was unable to file the Form 20-F in a timely manner due to complexities that arose immediately after
the closing of the business combination in mid-June 2025, two weeks prior to Moolec&#x2019;s fiscal year end of June 30. The business combination
involves complex accounting, including the imposition of reverse acquisition accounting and valuation of acquired assets and liabilities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company has requested a stay of suspension
to the Nasdaq Hearings Panel, which automatically stayed the effect of the Letter until the panel hearing, which took
place on December 18, 2025. Accordingly, the Company&#x2019;s ordinary shares will continue to trade on The Nasdaq Capital Market under
the symbol &#x201c;MLEC&#x201d; without interruption during the time period when the panel decision is pending.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Summary of the liquidation and loss of control&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Theo I SCSp&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On November 28, 2025, subsequent to the reporting
date, Theo I SCSp received a conditional payment order from district court of&#160; Luxembourg, and therefore the General Partners engaged
Ogier (Luxembourg) SCS represented by its general partner Ogier Luxembourg (GP) S.&#xe0;.r.l&#160; formally as their legal advisor to
assist with Theo I SCSp&#x2019;s declaration of bankruptcy before the Luxembourg District Court. The declaration of bankruptcy will declare
Theo I SCSp bankrupt and appoint a receiver who will take control over the management of the company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The loss of control constitutes the derecognition
event under IFRS 10.25. Accordingly, the Group will derecognize the assets and liabilities of Theo I SCSp and will remeasure its retained
interest at fair value in accordance with IFRS 9 at the date of the derecognition event. This will result in the recognition of an estimated
gain of $9.5 million in the consolidated statement of profit or loss as of the derecognition date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group will continue to measure its retained
interest in Theo I SCSp at fair value through profit or loss until the liquidation process is formally completed.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Bioceres S.A. and Bioceres LLC&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On December 16, 2025, subsequent to the
reporting date, the Board of Directors of Bioceres S.A. formally approved the initiation of voluntary bankruptcy proceedings and
instructed management to seek and appoint a trustee (&#x201c;&lt;i&gt;s&#xed;ndico&lt;/i&gt;&#x201d;) to oversee the process. The commencement
of the voluntary bankruptcy proceedings and the transfer of decision-making authority to the trustee will result in the Group losing
control over Bioceres S.A. in accordance with the principles of IFRS 10 Consolidated Financial Statements. As Bioceres LLC is a
wholly owned subsidiary of Bioceres S.A., the Group simultaneously will lose control over Bioceres LLC as well.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Under IFRS 10.25, the date on which control is
lost constitutes the derecognition event. Accordingly, after December 16, 2025, the Group will derecognize the assets and liabilities
of Bioceres S.A. and Bioceres LLC and will remeasure any retained interest at fair value in accordance with IFRS 9 Financial Instruments.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The resulting derecognition effects are expected to generate an approximate
gain of $91.0 million related to the loss of control of Bioceres S.A. and an additional approximate gain of $5.3 million related to the
loss of control of Bioceres LLC (including the loss of holding in BIOX, therefore it will no longer be an equity method associate). These
amounts will be recognized in the consolidated statement of profit or loss as of the derecognition date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Group will continue to monitor the
progress of the voluntary bankruptcy and liquidation proceedings and will update the accounting treatment as necessary in accordance
with IFRS.&lt;/p&gt;</ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory>
    <ifrs-full:Provisions
      contextRef="c1017"
      decimals="-6"
      id="ixv-45774"
      unitRef="usd">13000000</ifrs-full:Provisions>
    <mlec:AmountOfFinancialDebtUnderRestructuring contextRef="c0" decimals="-5" id="ixv-45775" unitRef="usd">36400000</mlec:AmountOfFinancialDebtUnderRestructuring>
    <mlec:AmountOfFinancialDebtUnderRestructuring
      contextRef="c1018"
      decimals="-5"
      id="ixv-45776"
      unitRef="usd">69500000</mlec:AmountOfFinancialDebtUnderRestructuring>
    <mlec:PledgedOrTransferredSharesQuantity
      contextRef="c0"
      decimals="0"
      id="ixv-45777"
      unitRef="shares">3062500</mlec:PledgedOrTransferredSharesQuantity>
    <mlec:IssuedConvertiblePreferenceShares
      contextRef="c1019"
      decimals="0"
      id="ixv-45778"
      unitRef="shares">2380952</mlec:IssuedConvertiblePreferenceShares>
    <mlec:ProceedFromIssuedShares
      contextRef="c1019"
      decimals="-6"
      id="ixv-45779"
      unitRef="usd">15000000</mlec:ProceedFromIssuedShares>
    <mlec:PreferenceOfAccruePerAnnum
      contextRef="c1019"
      decimals="2"
      id="ixv-45780"
      unitRef="pure">0.09</mlec:PreferenceOfAccruePerAnnum>
    <mlec:ProceedsFromIssueOfEquityInstrumentsOnConversionOfDebt
      contextRef="c1019"
      decimals="-6"
      id="ixv-45781"
      unitRef="usd">15000000</mlec:ProceedsFromIssueOfEquityInstrumentsOnConversionOfDebt>
    <mlec:WorkingCapital
      contextRef="c1020"
      decimals="-5"
      id="ixv-45782"
      unitRef="usd">2500000</mlec:WorkingCapital>
    <ifrs-full:ParValuePerShare
      contextRef="c1021"
      decimals="2"
      id="ixv-45783"
      unitRef="usdPershares">1</ifrs-full:ParValuePerShare>
    <mlec:ConsecutiveBusinessDays contextRef="c1022" id="ixv-45784">P30D</mlec:ConsecutiveBusinessDays>
    <ifrs-full:GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss contextRef="c0" decimals="-5" id="ixv-45785" unitRef="usd">9500000</ifrs-full:GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss>
    <ifrs-full:GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss
      contextRef="c1023"
      decimals="-5"
      id="ixv-45786"
      unitRef="usd">91000000</ifrs-full:GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss>
    <ifrs-full:GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss
      contextRef="c1024"
      decimals="-5"
      id="ixv-45787"
      unitRef="usd">5300000</ifrs-full:GainLossOnHedgeIneffectivenessRecognisedInProfitOrLoss>
    <mlec:DisclosureOfReverseStockSplitAfterTheReportingPeriod contextRef="c0" id="ixv-42880">&lt;table border="0" cellpadding="0" style="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: top"&gt;
  &lt;td style="width: 0.25in"&gt;&lt;b&gt;22.&lt;/b&gt;&lt;/td&gt;
  &lt;td&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;REVERSE STOCK SPLIT AFTER THE REPORTING PERIOD&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Subsequent to the period end,
the Company&#x2019;s shareholders approved a reverse stock split of the Company&#x2019;s ordinary shares at a ratio to be determined by
the Board of Directors.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;On December 20, 2025, the Board of Directors approved a reverse stock
split at a ratio of&#160;15-for-1, which will be effective on or around January 5, 2026.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;For purposes of comparability, earnings per share (&#x201c;EPS&#x201d;)
information presented in this note has been retrospectively adjusted to reflect the reverse stock split, as if it had been effective for
all periods presented. The reverse stock split did not impact the Company&#x2019;s consolidated statements of operations, financial position
or cash flows, other than the recast of the weighted average number of ordinary shares outstanding used in the calculation of basic and
diluted EPS.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2025&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2024&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; font-weight: bold; text-indent: -0.125in"&gt;Numerator&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; width: 64%; text-align: left; text-indent: -0.125in"&gt;Loss/Profit for the year (basic EPS)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(111,460,708&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(32,685,398&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;40,435,923&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-align: left; text-indent: -0.125in"&gt;Loss/Profit for the year (diluted EPS)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(111,460,708&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(32,685,398&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;40,435,923&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; font-weight: bold; text-indent: -0.125in"&gt;Denominator&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Number of shares (basic EPS)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;430,864&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;388,101&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;306,215&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Number of shares (diluted EPS)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;430,864&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;388,101&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;306,215&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; font-weight: bold; text-align: left; text-indent: -0.125in"&gt;Basic (loss)/profit attributable to ordinary equity holders of the parent&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(258.6912&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(84.2188&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;132.0508&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; font-weight: bold; text-align: left; text-indent: -0.125in"&gt;Diluted (loss)/profit attributable to ordinary equity holders of the parent&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(258.6912&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(84.2188&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;132.0508&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</mlec:DisclosureOfReverseStockSplitAfterTheReportingPeriod>
    <mlec:ReverseStockSplit contextRef="c1025" id="ixv-45788">15-for-1</mlec:ReverseStockSplit>
    <ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory contextRef="c0" id="ixv-45789">The reverse stock split did not impact the Company&#x2019;s consolidated statements of operations, financial position
or cash flows, other than the recast of the weighted average number of ordinary shares outstanding used in the calculation of basic and
diluted EPS.&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2025&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2024&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; font-weight: bold; text-indent: -0.125in"&gt;Numerator&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; width: 64%; text-align: left; text-indent: -0.125in"&gt;Loss/Profit for the year (basic EPS)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(111,460,708&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(32,685,398&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;40,435,923&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-align: left; text-indent: -0.125in"&gt;Loss/Profit for the year (diluted EPS)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(111,460,708&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(32,685,398&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;40,435,923&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; font-weight: bold; text-indent: -0.125in"&gt;Denominator&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Number of shares (basic EPS)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;430,864&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;388,101&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;306,215&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Number of shares (diluted EPS)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;430,864&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;388,101&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;306,215&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; font-weight: bold; text-align: left; text-indent: -0.125in"&gt;Basic (loss)/profit attributable to ordinary equity holders of the parent&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(258.6912&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(84.2188&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;132.0508&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0.125in; font-weight: bold; text-align: left; text-indent: -0.125in"&gt;Diluted (loss)/profit attributable to ordinary equity holders of the parent&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(258.6912&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(84.2188&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;132.0508&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory>
    <ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity
      contextRef="c1026"
      decimals="0"
      id="ixv-45790"
      unitRef="usd">-111460708</ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity>
    <ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity
      contextRef="c1027"
      decimals="0"
      id="ixv-45791"
      unitRef="usd">-32685398</ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity>
    <ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity
      contextRef="c1028"
      decimals="0"
      id="ixv-45792"
      unitRef="usd">40435923</ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity>
    <ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects
      contextRef="c1026"
      decimals="0"
      id="ixv-45793"
      unitRef="usd">-111460708</ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects>
    <ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects
      contextRef="c1027"
      decimals="0"
      id="ixv-45794"
      unitRef="usd">-32685398</ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects>
    <ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects
      contextRef="c1028"
      decimals="0"
      id="ixv-45795"
      unitRef="usd">40435923</ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects>
    <ifrs-full:WeightedAverageShares
      contextRef="c1026"
      decimals="INF"
      id="ixv-45796"
      unitRef="shares">430864</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="c1027"
      decimals="INF"
      id="ixv-45797"
      unitRef="shares">388101</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="c1028"
      decimals="INF"
      id="ixv-45798"
      unitRef="shares">306215</ifrs-full:WeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="c1026"
      decimals="INF"
      id="ixv-45799"
      unitRef="shares">430864</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="c1027"
      decimals="INF"
      id="ixv-45800"
      unitRef="shares">388101</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="c1028"
      decimals="INF"
      id="ixv-45801"
      unitRef="shares">306215</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="c1026"
      decimals="4"
      id="ixv-45802"
      unitRef="usdPershares">-258.6912</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="c1027"
      decimals="4"
      id="ixv-45803"
      unitRef="usdPershares">-84.2188</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="c1028"
      decimals="4"
      id="ixv-45804"
      unitRef="usdPershares">132.0508</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="c1026"
      decimals="4"
      id="ixv-45805"
      unitRef="usdPershares">-258.6912</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="c1027"
      decimals="4"
      id="ixv-45806"
      unitRef="usdPershares">-84.2188</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="c1028"
      decimals="4"
      id="ixv-45807"
      unitRef="usdPershares">132.0508</ifrs-full:DilutedEarningsLossPerShare>
    <dei:EntityIncorporationStateCountryCode contextRef="c0" id="hidden-fact-0">E9</dei:EntityIncorporationStateCountryCode>
    <dei:DocumentAccountingStandard contextRef="c0" id="hidden-fact-1">International Financial Reporting Standards</dei:DocumentAccountingStandard>
    <mlec:ItemsThatWillNotBeSubsequentlyReclassifiedToLossAndProfit
      contextRef="c0"
      id="hidden-fact-2"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ItemsThatWillNotBeSubsequentlyReclassifiedToLossAndProfit
      contextRef="c5"
      id="hidden-fact-3"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:RevaluationOfPropertyPlantAndEquipmentNetOfTaxOfJointVenturesAndAssociates
      contextRef="c0"
      id="hidden-fact-4"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:RevaluationOfPropertyPlantAndEquipmentNetOfTaxOfJointVenturesAndAssociates
      contextRef="c5"
      id="hidden-fact-5"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:RevaluationOfPropertyPlantAndEquipmentNetOfTax
      contextRef="c0"
      id="hidden-fact-6"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:RevaluationOfPropertyPlantAndEquipmentNetOfTax
      contextRef="c5"
      id="hidden-fact-7"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherNoncurrentFinancialAssets
      contextRef="c4"
      id="hidden-fact-8"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CurrentTaxAssetsNoncurrent
      contextRef="c4"
      id="hidden-fact-9"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DeferredTaxAssets
      contextRef="c4"
      id="hidden-fact-10"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:InvestmentProperty
      contextRef="c4"
      id="hidden-fact-11"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Goodwill
      contextRef="c4"
      id="hidden-fact-12"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CurrentTaxAssetsCurrent
      contextRef="c4"
      id="hidden-fact-13"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CurrentBiologicalAssets
      contextRef="c4"
      id="hidden-fact-14"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ShareToBeIssuedAmount
      contextRef="c7"
      id="hidden-fact-15"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentContractLiabilities
      contextRef="c4"
      id="hidden-fact-16"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentGovernmentGrants
      contextRef="c4"
      id="hidden-fact-17"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:JointVenturesAndAssociatesLiabilities
      contextRef="c4"
      id="hidden-fact-18"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ConsiderationForAcquisitionOfAssetsNonCurrent
      contextRef="c4"
      id="hidden-fact-19"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="c4"
      id="hidden-fact-20"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CurrentTaxLiabilitiesCurrent
      contextRef="c4"
      id="hidden-fact-21"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CurrentWarrantLiability
      contextRef="c7"
      id="hidden-fact-22"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ConsiderationForAcquisitionOfAssetsCurrent
      contextRef="c4"
      id="hidden-fact-23"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="c9"
      id="hidden-fact-24"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners
      contextRef="c19"
      id="hidden-fact-25"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners
      contextRef="c20"
      id="hidden-fact-26"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners
      contextRef="c22"
      id="hidden-fact-27"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners
      contextRef="c23"
      id="hidden-fact-28"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners
      contextRef="c24"
      id="hidden-fact-29"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners
      contextRef="c25"
      id="hidden-fact-30"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners
      contextRef="c27"
      id="hidden-fact-31"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl
      contextRef="c18"
      id="hidden-fact-32"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl
      contextRef="c19"
      id="hidden-fact-33"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl
      contextRef="c22"
      id="hidden-fact-34"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl
      contextRef="c23"
      id="hidden-fact-35"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl
      contextRef="c24"
      id="hidden-fact-36"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl
      contextRef="c25"
      id="hidden-fact-37"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="c18"
      id="hidden-fact-38"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="c19"
      id="hidden-fact-39"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="c20"
      id="hidden-fact-40"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="c21"
      id="hidden-fact-41"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="c23"
      id="hidden-fact-42"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="c24"
      id="hidden-fact-43"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="c25"
      id="hidden-fact-44"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity
      contextRef="c20"
      id="hidden-fact-45"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity
      contextRef="c22"
      id="hidden-fact-46"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity
      contextRef="c23"
      id="hidden-fact-47"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity
      contextRef="c24"
      id="hidden-fact-48"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity
      contextRef="c25"
      id="hidden-fact-49"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughOtherDistributionsToOwners
      contextRef="c18"
      id="hidden-fact-50"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughOtherDistributionsToOwners
      contextRef="c19"
      id="hidden-fact-51"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughOtherDistributionsToOwners
      contextRef="c20"
      id="hidden-fact-52"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughOtherDistributionsToOwners
      contextRef="c21"
      id="hidden-fact-53"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughOtherDistributionsToOwners
      contextRef="c22"
      id="hidden-fact-54"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughOtherDistributionsToOwners
      contextRef="c23"
      id="hidden-fact-55"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughOtherDistributionsToOwners
      contextRef="c24"
      id="hidden-fact-56"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughOtherDistributionsToOwners
      contextRef="c25"
      id="hidden-fact-57"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughOtherDistributionsToOwners
      contextRef="c26"
      id="hidden-fact-58"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="c18"
      id="hidden-fact-59"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="c19"
      id="hidden-fact-60"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="c20"
      id="hidden-fact-61"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="c21"
      id="hidden-fact-62"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="c22"
      id="hidden-fact-63"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="c23"
      id="hidden-fact-64"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="c24"
      id="hidden-fact-65"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="c25"
      id="hidden-fact-66"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="c26"
      id="hidden-fact-67"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c18"
      id="hidden-fact-68"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c19"
      id="hidden-fact-69"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c20"
      id="hidden-fact-70"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c21"
      id="hidden-fact-71"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c22"
      id="hidden-fact-72"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c24"
      id="hidden-fact-73"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c25"
      id="hidden-fact-74"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeBeforeTax
      contextRef="c18"
      id="hidden-fact-75"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeBeforeTax
      contextRef="c19"
      id="hidden-fact-76"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeBeforeTax
      contextRef="c20"
      id="hidden-fact-77"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeBeforeTax
      contextRef="c21"
      id="hidden-fact-78"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeBeforeTax
      contextRef="c22"
      id="hidden-fact-79"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeBeforeTax
      contextRef="c23"
      id="hidden-fact-80"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeBeforeTax
      contextRef="c25"
      id="hidden-fact-81"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="c39"
      id="hidden-fact-82"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners
      contextRef="c51"
      id="hidden-fact-83"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners
      contextRef="c52"
      id="hidden-fact-84"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners
      contextRef="c53"
      id="hidden-fact-85"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners
      contextRef="c54"
      id="hidden-fact-86"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners
      contextRef="c56"
      id="hidden-fact-87"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl
      contextRef="c48"
      id="hidden-fact-88"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl
      contextRef="c51"
      id="hidden-fact-89"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl
      contextRef="c52"
      id="hidden-fact-90"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl
      contextRef="c53"
      id="hidden-fact-91"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl
      contextRef="c54"
      id="hidden-fact-92"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="c48"
      id="hidden-fact-93"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="c49"
      id="hidden-fact-94"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="c50"
      id="hidden-fact-95"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="c52"
      id="hidden-fact-96"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="c53"
      id="hidden-fact-97"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="c54"
      id="hidden-fact-98"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity
      contextRef="c48"
      id="hidden-fact-99"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity
      contextRef="c49"
      id="hidden-fact-100"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity
      contextRef="c50"
      id="hidden-fact-101"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity
      contextRef="c51"
      id="hidden-fact-102"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity
      contextRef="c52"
      id="hidden-fact-103"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity
      contextRef="c53"
      id="hidden-fact-104"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity
      contextRef="c54"
      id="hidden-fact-105"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity
      contextRef="c55"
      id="hidden-fact-106"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="c48"
      id="hidden-fact-107"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="c49"
      id="hidden-fact-108"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="c50"
      id="hidden-fact-109"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="c51"
      id="hidden-fact-110"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="c52"
      id="hidden-fact-111"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="c53"
      id="hidden-fact-112"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="c54"
      id="hidden-fact-113"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="c55"
      id="hidden-fact-114"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c48"
      id="hidden-fact-115"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c49"
      id="hidden-fact-116"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c50"
      id="hidden-fact-117"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c51"
      id="hidden-fact-118"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c53"
      id="hidden-fact-119"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c54"
      id="hidden-fact-120"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeBeforeTax
      contextRef="c48"
      id="hidden-fact-121"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeBeforeTax
      contextRef="c49"
      id="hidden-fact-122"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeBeforeTax
      contextRef="c50"
      id="hidden-fact-123"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeBeforeTax
      contextRef="c51"
      id="hidden-fact-124"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeBeforeTax
      contextRef="c52"
      id="hidden-fact-125"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeBeforeTax
      contextRef="c54"
      id="hidden-fact-126"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners
      contextRef="c68"
      id="hidden-fact-127"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners
      contextRef="c69"
      id="hidden-fact-128"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners
      contextRef="c70"
      id="hidden-fact-129"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners
      contextRef="c71"
      id="hidden-fact-130"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners
      contextRef="c73"
      id="hidden-fact-131"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl
      contextRef="c66"
      id="hidden-fact-132"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl
      contextRef="c68"
      id="hidden-fact-133"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl
      contextRef="c69"
      id="hidden-fact-134"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl
      contextRef="c70"
      id="hidden-fact-135"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl
      contextRef="c71"
      id="hidden-fact-136"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity
      contextRef="c66"
      id="hidden-fact-137"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity
      contextRef="c68"
      id="hidden-fact-138"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity
      contextRef="c69"
      id="hidden-fact-139"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity
      contextRef="c70"
      id="hidden-fact-140"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IncreaseDecreaseThroughChangesInBusinessCombinationEquity
      contextRef="c71"
      id="hidden-fact-141"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="c66"
      id="hidden-fact-142"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="c67"
      id="hidden-fact-143"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="c69"
      id="hidden-fact-144"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="c70"
      id="hidden-fact-145"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="c71"
      id="hidden-fact-146"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="c66"
      id="hidden-fact-147"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="c67"
      id="hidden-fact-148"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="c68"
      id="hidden-fact-149"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="c69"
      id="hidden-fact-150"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="c70"
      id="hidden-fact-151"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="c71"
      id="hidden-fact-152"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="c72"
      id="hidden-fact-153"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c66"
      id="hidden-fact-154"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c67"
      id="hidden-fact-155"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c68"
      id="hidden-fact-156"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c70"
      id="hidden-fact-157"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c71"
      id="hidden-fact-158"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeBeforeTax
      contextRef="c66"
      id="hidden-fact-159"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeBeforeTax
      contextRef="c67"
      id="hidden-fact-160"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeBeforeTax
      contextRef="c68"
      id="hidden-fact-161"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeBeforeTax
      contextRef="c69"
      id="hidden-fact-162"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForFairValueGainsLosses
      contextRef="c5"
      id="hidden-fact-163"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForFairValueGainsLosses
      contextRef="c6"
      id="hidden-fact-164"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:RemeasurementOfPreviouslyHeldInterest
      contextRef="c5"
      id="hidden-fact-165"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:RemeasurementOfPreviouslyHeldInterest
      contextRef="c6"
      id="hidden-fact-166"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets
      contextRef="c6"
      id="hidden-fact-167"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities
      contextRef="c0"
      id="hidden-fact-168"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherCashReceiptsFromSalesOfInterestsInJointVenturesClassifiedAsInvestingActivities
      contextRef="c0"
      id="hidden-fact-169"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherCashReceiptsFromSalesOfInterestsInJointVenturesClassifiedAsInvestingActivities
      contextRef="c5"
      id="hidden-fact-170"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="c98"
      id="hidden-fact-171"
      unitRef="pure"
      xsi:nil="true"/>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="c100"
      id="hidden-fact-172"
      unitRef="pure"
      xsi:nil="true"/>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="c102"
      id="hidden-fact-173"
      unitRef="pure"
      xsi:nil="true"/>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="c104"
      id="hidden-fact-174"
      unitRef="pure"
      xsi:nil="true"/>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="c106"
      id="hidden-fact-175"
      unitRef="pure"
      xsi:nil="true"/>
    <mlec:MutualFunds
      contextRef="c4"
      id="hidden-fact-176"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherCurrentFinancialAssets
      contextRef="c176"
      id="hidden-fact-177"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherNoncurrentFinancialAssets
      contextRef="c176"
      id="hidden-fact-178"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherNoncurrentFinancialAssets
      contextRef="c174"
      id="hidden-fact-179"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherNoncurrentFinancialAssets
      contextRef="c4"
      id="hidden-fact-180"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:CurrentTradeReceivablesAllowanceForImpairmentOfTradeDebtors
      contextRef="c180"
      id="hidden-fact-181"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:CurrentTradeReceivablesShareholdersAndOtherRelatedParties
      contextRef="c180"
      id="hidden-fact-182"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AllowanceForReturnOfGoods
      contextRef="c180"
      id="hidden-fact-183"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherReceivables
      contextRef="c180"
      id="hidden-fact-184"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherCurrentReceivables
      contextRef="c192"
      id="hidden-fact-185"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherCurrentReceivables
      contextRef="c196"
      id="hidden-fact-186"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherNoncurrentReceivables
      contextRef="c182"
      id="hidden-fact-187"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherNoncurrentReceivables
      contextRef="c200"
      id="hidden-fact-188"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherNoncurrentReceivables
      contextRef="c202"
      id="hidden-fact-189"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherNoncurrentReceivables
      contextRef="c198"
      id="hidden-fact-190"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:InventoriesCurrent
      contextRef="c206"
      id="hidden-fact-191"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:InventoriesCurrent
      contextRef="c210"
      id="hidden-fact-192"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:InventoriesCurrent
      contextRef="c212"
      id="hidden-fact-193"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:InventoriesCurrent
      contextRef="c216"
      id="hidden-fact-194"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:BiologicalAssets
      contextRef="c218"
      id="hidden-fact-195"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:BiologicalAssets
      contextRef="c219"
      id="hidden-fact-196"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:BiologicalAssets
      contextRef="c222"
      id="hidden-fact-197"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:LossOfControlonBiologicalAssets
      contextRef="c225"
      id="hidden-fact-198"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:LossOfControlonBiologicalAssets
      contextRef="c226"
      id="hidden-fact-199"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:LossOfControlonBiologicalAssets
      contextRef="c227"
      id="hidden-fact-200"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:BiologicalAssets
      contextRef="c228"
      id="hidden-fact-201"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:BiologicalAssets
      contextRef="c229"
      id="hidden-fact-202"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:BiologicalAssets
      contextRef="c230"
      id="hidden-fact-203"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:BiologicalAssets
      contextRef="c231"
      id="hidden-fact-204"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:BiologicalAssets
      contextRef="c232"
      id="hidden-fact-205"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:BiologicalAssets
      contextRef="c4"
      id="hidden-fact-206"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:BiologicalAssets
      contextRef="c233"
      id="hidden-fact-207"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:BiologicalAssets
      contextRef="c234"
      id="hidden-fact-208"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:BiologicalAssets
      contextRef="c237"
      id="hidden-fact-209"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:BiologicalAssets
      contextRef="c218"
      id="hidden-fact-210"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:BiologicalAssets
      contextRef="c219"
      id="hidden-fact-211"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:BiologicalAssets
      contextRef="c222"
      id="hidden-fact-212"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="c244"
      id="hidden-fact-213"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="c244"
      id="hidden-fact-214"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="c247"
      id="hidden-fact-215"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="c247"
      id="hidden-fact-216"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c248"
      id="hidden-fact-217"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="c250"
      id="hidden-fact-218"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="c250"
      id="hidden-fact-219"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="c253"
      id="hidden-fact-220"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c254"
      id="hidden-fact-221"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="c256"
      id="hidden-fact-222"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="c259"
      id="hidden-fact-223"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:DisposalsPropertyPlantAndEquipments
      contextRef="c259"
      id="hidden-fact-224"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:DisposalsPropertyPlantAndEquipments
      contextRef="c262"
      id="hidden-fact-225"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="c262"
      id="hidden-fact-226"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment
      contextRef="c265"
      id="hidden-fact-227"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="c268"
      id="hidden-fact-228"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment
      contextRef="c268"
      id="hidden-fact-229"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:DisposalsPropertyPlantAndEquipments
      contextRef="c268"
      id="hidden-fact-230"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="c268"
      id="hidden-fact-231"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="c268"
      id="hidden-fact-232"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c269"
      id="hidden-fact-233"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment
      contextRef="c271"
      id="hidden-fact-234"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:DisposalsPropertyPlantAndEquipments
      contextRef="c271"
      id="hidden-fact-235"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment
      contextRef="c273"
      id="hidden-fact-236"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment
      contextRef="c275"
      id="hidden-fact-237"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment
      contextRef="c277"
      id="hidden-fact-238"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment
      contextRef="c279"
      id="hidden-fact-239"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryPropertyPlantAndEquipment
      contextRef="c281"
      id="hidden-fact-240"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersFromToInvestmentPropertyPropertyPlantAndEquipment
      contextRef="c283"
      id="hidden-fact-241"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="c283"
      id="hidden-fact-242"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="c288"
      id="hidden-fact-243"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets
      contextRef="c288"
      id="hidden-fact-244"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AdditionsFromBusinessCombinations
      contextRef="c288"
      id="hidden-fact-245"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="c288"
      id="hidden-fact-246"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AmortizationOfTheYear
      contextRef="c288"
      id="hidden-fact-247"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AdditionsFromBusinessCombinations
      contextRef="c291"
      id="hidden-fact-248"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="c291"
      id="hidden-fact-249"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="c291"
      id="hidden-fact-250"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c292"
      id="hidden-fact-251"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="c294"
      id="hidden-fact-252"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AdditionsFromBusinessCombinations
      contextRef="c294"
      id="hidden-fact-253"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="c294"
      id="hidden-fact-254"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c295"
      id="hidden-fact-255"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AdditionsFromBusinessCombinations
      contextRef="c297"
      id="hidden-fact-256"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c298"
      id="hidden-fact-257"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AdditionsFromBusinessCombinations
      contextRef="c300"
      id="hidden-fact-258"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AmortizationOfTheYear
      contextRef="c300"
      id="hidden-fact-259"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="c300"
      id="hidden-fact-260"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c301"
      id="hidden-fact-261"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AdditionsFromBusinessCombinations
      contextRef="c303"
      id="hidden-fact-262"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="c303"
      id="hidden-fact-263"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="c303"
      id="hidden-fact-264"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c304"
      id="hidden-fact-265"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="c306"
      id="hidden-fact-266"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AdditionsFromBusinessCombinations
      contextRef="c306"
      id="hidden-fact-267"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="c306"
      id="hidden-fact-268"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AmortizationOfTheYear
      contextRef="c306"
      id="hidden-fact-269"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="c306"
      id="hidden-fact-270"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c307"
      id="hidden-fact-271"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AdditionsFromBusinessCombinations
      contextRef="c309"
      id="hidden-fact-272"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c310"
      id="hidden-fact-273"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AdditionsFromBusinessCombinations
      contextRef="c312"
      id="hidden-fact-274"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AmortizationOfTheYear
      contextRef="c312"
      id="hidden-fact-275"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="c312"
      id="hidden-fact-276"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c313"
      id="hidden-fact-277"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="c315"
      id="hidden-fact-278"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AdditionsFromBusinessCombinations
      contextRef="c315"
      id="hidden-fact-279"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="c315"
      id="hidden-fact-280"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="c315"
      id="hidden-fact-281"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c316"
      id="hidden-fact-282"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AdditionsFromBusinessCombinations
      contextRef="c318"
      id="hidden-fact-283"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="c318"
      id="hidden-fact-284"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="c318"
      id="hidden-fact-285"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c319"
      id="hidden-fact-286"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c320"
      id="hidden-fact-287"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="c321"
      id="hidden-fact-288"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets
      contextRef="c321"
      id="hidden-fact-289"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="c321"
      id="hidden-fact-290"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AmortizationOfTheYear
      contextRef="c321"
      id="hidden-fact-291"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="c321"
      id="hidden-fact-292"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c323"
      id="hidden-fact-293"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="c324"
      id="hidden-fact-294"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets
      contextRef="c324"
      id="hidden-fact-295"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="c324"
      id="hidden-fact-296"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AmortizationOfTheYear
      contextRef="c324"
      id="hidden-fact-297"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="c324"
      id="hidden-fact-298"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c326"
      id="hidden-fact-299"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="c327"
      id="hidden-fact-300"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets
      contextRef="c327"
      id="hidden-fact-301"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="c327"
      id="hidden-fact-302"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AmortizationOfTheYear
      contextRef="c327"
      id="hidden-fact-303"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="c327"
      id="hidden-fact-304"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c329"
      id="hidden-fact-305"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="c330"
      id="hidden-fact-306"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets
      contextRef="c330"
      id="hidden-fact-307"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="c330"
      id="hidden-fact-308"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AmortizationOfTheYear
      contextRef="c330"
      id="hidden-fact-309"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="c330"
      id="hidden-fact-310"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c332"
      id="hidden-fact-311"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="c333"
      id="hidden-fact-312"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets
      contextRef="c333"
      id="hidden-fact-313"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c335"
      id="hidden-fact-314"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="c336"
      id="hidden-fact-315"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:DecreaseThroughLossOfControlOfSubsidiaryIntangibleAssets
      contextRef="c336"
      id="hidden-fact-316"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="c336"
      id="hidden-fact-317"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AmortizationOfTheYear
      contextRef="c336"
      id="hidden-fact-318"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="c336"
      id="hidden-fact-319"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="c339"
      id="hidden-fact-320"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AdditionsFromBusinessCombinations
      contextRef="c339"
      id="hidden-fact-321"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="c339"
      id="hidden-fact-322"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AmortizationOfTheYear
      contextRef="c339"
      id="hidden-fact-323"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="c341"
      id="hidden-fact-324"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="c341"
      id="hidden-fact-325"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AmortizationOfTheYear
      contextRef="c341"
      id="hidden-fact-326"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="c341"
      id="hidden-fact-327"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c342"
      id="hidden-fact-328"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AdditionsFromBusinessCombinations
      contextRef="c344"
      id="hidden-fact-329"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="c344"
      id="hidden-fact-330"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="c344"
      id="hidden-fact-331"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="c346"
      id="hidden-fact-332"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AdditionsFromBusinessCombinations
      contextRef="c346"
      id="hidden-fact-333"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="c346"
      id="hidden-fact-334"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="c348"
      id="hidden-fact-335"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AdditionsFromBusinessCombinations
      contextRef="c348"
      id="hidden-fact-336"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="c348"
      id="hidden-fact-337"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AdditionsFromBusinessCombinations
      contextRef="c350"
      id="hidden-fact-338"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AmortizationOfTheYear
      contextRef="c350"
      id="hidden-fact-339"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AdditionsFromBusinessCombinations
      contextRef="c352"
      id="hidden-fact-340"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="c352"
      id="hidden-fact-341"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="c354"
      id="hidden-fact-342"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="c354"
      id="hidden-fact-343"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AmortizationOfTheYear
      contextRef="c354"
      id="hidden-fact-344"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="c354"
      id="hidden-fact-345"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AdditionsFromBusinessCombinations
      contextRef="c356"
      id="hidden-fact-346"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AdditionsFromBusinessCombinations
      contextRef="c358"
      id="hidden-fact-347"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AmortizationOfTheYear
      contextRef="c358"
      id="hidden-fact-348"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="c358"
      id="hidden-fact-349"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="c360"
      id="hidden-fact-350"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AdditionsFromBusinessCombinations
      contextRef="c360"
      id="hidden-fact-351"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="c360"
      id="hidden-fact-352"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="c360"
      id="hidden-fact-353"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="c362"
      id="hidden-fact-354"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AdditionsFromBusinessCombinations
      contextRef="c362"
      id="hidden-fact-355"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="c362"
      id="hidden-fact-356"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AmortizationOfTheYear
      contextRef="c362"
      id="hidden-fact-357"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="c362"
      id="hidden-fact-358"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="c5"
      id="hidden-fact-359"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Goodwill
      contextRef="c365"
      id="hidden-fact-360"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Goodwill
      contextRef="c367"
      id="hidden-fact-361"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Goodwill
      contextRef="c369"
      id="hidden-fact-362"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Goodwill
      contextRef="c371"
      id="hidden-fact-363"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Goodwill
      contextRef="c4"
      id="hidden-fact-364"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:InvestmentProperty
      contextRef="c4"
      id="hidden-fact-365"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:InvestmentProperty
      contextRef="c4"
      id="hidden-fact-366"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:TradeAndOtherPayablesShareholdersAndOtherRelatedParties
      contextRef="c4"
      id="hidden-fact-367"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CurrentPortionOfLongtermBorrowings
      contextRef="c375"
      id="hidden-fact-368"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CurrentPortionOfLongtermBorrowings
      contextRef="c380"
      id="hidden-fact-369"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherBorrowings
      contextRef="c375"
      id="hidden-fact-370"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherBorrowings
      contextRef="c381"
      id="hidden-fact-371"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ShorttermBorrowings
      contextRef="c387"
      id="hidden-fact-372"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ShorttermBorrowings
      contextRef="c388"
      id="hidden-fact-373"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ShorttermBorrowings
      contextRef="c393"
      id="hidden-fact-374"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ShorttermBorrowings
      contextRef="c394"
      id="hidden-fact-375"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:LongtermBorrowings
      contextRef="c387"
      id="hidden-fact-376"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:LongtermBorrowings
      contextRef="c388"
      id="hidden-fact-377"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:LongtermBorrowings
      contextRef="c401"
      id="hidden-fact-378"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:LongtermBorrowings
      contextRef="c402"
      id="hidden-fact-379"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:LongtermBorrowings
      contextRef="c395"
      id="hidden-fact-380"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:LongtermBorrowings
      contextRef="c396"
      id="hidden-fact-381"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime
      contextRef="c4"
      id="hidden-fact-382"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentAdvances
      contextRef="c4"
      id="hidden-fact-383"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime
      contextRef="c4"
      id="hidden-fact-384"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentDeferredIncomeIncludingNoncurrentContractLiabilities
      contextRef="c4"
      id="hidden-fact-385"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions
      contextRef="c406"
      id="hidden-fact-386"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdditionalProvisionsOtherProvisions
      contextRef="c417"
      id="hidden-fact-387"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdditionalProvisionsOtherProvisions
      contextRef="c420"
      id="hidden-fact-388"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdditionalProvisionsOtherProvisions
      contextRef="c423"
      id="hidden-fact-389"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:LossesOnDisposalsOfInvestments
      contextRef="c434"
      id="hidden-fact-390"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CurrentWarrantLiability
      contextRef="c7"
      id="hidden-fact-391"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CurrentWarrantLiability
      contextRef="c47"
      id="hidden-fact-392"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AdditionsWarrantsForTheYear
      contextRef="c5"
      id="hidden-fact-393"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AdditionsFromBusinessCombination
      contextRef="c5"
      id="hidden-fact-394"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CurrentWarrantLiability
      contextRef="c7"
      id="hidden-fact-395"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:LossOfControl
      contextRef="c5"
      id="hidden-fact-396"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:LossOfControl
      contextRef="c6"
      id="hidden-fact-397"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AnalysisAndStorage
      contextRef="c0"
      id="hidden-fact-398"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:RoyaltyExpense
      contextRef="c5"
      id="hidden-fact-399"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ImportAndExportExpenses
      contextRef="c0"
      id="hidden-fact-400"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ImportAndExportExpenses
      contextRef="c5"
      id="hidden-fact-401"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="c5"
      id="hidden-fact-402"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdvertisingExpense
      contextRef="c0"
      id="hidden-fact-403"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdvertisingExpense
      contextRef="c6"
      id="hidden-fact-404"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:SurveillanceExpense
      contextRef="c0"
      id="hidden-fact-405"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:SurveillanceExpense
      contextRef="c5"
      id="hidden-fact-406"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AnalysisAndStorage
      contextRef="c441"
      id="hidden-fact-407"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ImportAndExportExpenses
      contextRef="c441"
      id="hidden-fact-408"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossTradeReceivables
      contextRef="c441"
      id="hidden-fact-409"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AllowanceForObsolescences
      contextRef="c442"
      id="hidden-fact-410"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdvertisingExpense
      contextRef="c441"
      id="hidden-fact-411"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:SurveillanceExpense
      contextRef="c441"
      id="hidden-fact-412"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ProfessionalFeesRelatedParties
      contextRef="c441"
      id="hidden-fact-413"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossTradeReceivables
      contextRef="c444"
      id="hidden-fact-414"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ProfessionalFeesRelatedParties
      contextRef="c444"
      id="hidden-fact-415"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossTradeReceivables
      contextRef="c447"
      id="hidden-fact-416"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:SharebasedIncentivesForEmployees
      contextRef="c447"
      id="hidden-fact-417"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ProfessionalFeesRelatedParties
      contextRef="c447"
      id="hidden-fact-418"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:LicensesandPatents
      contextRef="c447"
      id="hidden-fact-419"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:Contingencies
      contextRef="c447"
      id="hidden-fact-420"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:EnvironmentalImpactTreatment
      contextRef="c448"
      id="hidden-fact-421"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:PrepaymentPremiumFee
      contextRef="c435"
      id="hidden-fact-422"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:PrepaymentPremiumFee
      contextRef="c450"
      id="hidden-fact-423"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:InterestAccruedWithRelatedParties
      contextRef="c450"
      id="hidden-fact-424"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:RevenueFromSaleOfAgriculturalProduce
      contextRef="c5"
      id="hidden-fact-425"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:RevenueFromSaleOfAgriculturalProduce
      contextRef="c6"
      id="hidden-fact-426"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:GainOnBargainPurchase
      contextRef="c6"
      id="hidden-fact-427"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:RemeasurementToFairValueOfPreexistingInterestInAnAcquiree
      contextRef="c5"
      id="hidden-fact-428"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:RemeasurementToFairValueOfPreexistingInterestInAnAcquiree
      contextRef="c6"
      id="hidden-fact-429"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="c451"
      id="hidden-fact-430"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="c453"
      id="hidden-fact-431"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="c455"
      id="hidden-fact-432"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="c457"
      id="hidden-fact-433"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="c459"
      id="hidden-fact-434"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="c461"
      id="hidden-fact-435"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="c463"
      id="hidden-fact-436"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="c465"
      id="hidden-fact-437"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NetDeferredTaxLiabilities
      contextRef="c469"
      id="hidden-fact-438"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NetDeferredTaxLiabilities
      contextRef="c471"
      id="hidden-fact-439"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NetDeferredTaxLiabilities
      contextRef="c453"
      id="hidden-fact-440"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NetDeferredTaxLiabilities
      contextRef="c473"
      id="hidden-fact-441"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NetDeferredTaxLiabilities
      contextRef="c475"
      id="hidden-fact-442"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NetDeferredTaxLiabilities
      contextRef="c455"
      id="hidden-fact-443"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="c451"
      id="hidden-fact-444"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="c482"
      id="hidden-fact-445"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="c459"
      id="hidden-fact-446"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="c457"
      id="hidden-fact-447"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="c461"
      id="hidden-fact-448"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset
      contextRef="c486"
      id="hidden-fact-449"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="c463"
      id="hidden-fact-450"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset
      contextRef="c487"
      id="hidden-fact-451"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="c455"
      id="hidden-fact-452"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="c465"
      id="hidden-fact-453"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="c469"
      id="hidden-fact-454"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset
      contextRef="c491"
      id="hidden-fact-455"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="c471"
      id="hidden-fact-456"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="c492"
      id="hidden-fact-457"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset
      contextRef="c493"
      id="hidden-fact-458"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="c494"
      id="hidden-fact-459"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset
      contextRef="c496"
      id="hidden-fact-460"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="c497"
      id="hidden-fact-461"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="c473"
      id="hidden-fact-462"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="c475"
      id="hidden-fact-463"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NetDeferredTaxAssets
      contextRef="c502"
      id="hidden-fact-464"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome
      contextRef="c507"
      id="hidden-fact-465"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset
      contextRef="c509"
      id="hidden-fact-466"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome
      contextRef="c509"
      id="hidden-fact-467"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset
      contextRef="c511"
      id="hidden-fact-468"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome
      contextRef="c511"
      id="hidden-fact-469"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset
      contextRef="c513"
      id="hidden-fact-470"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome
      contextRef="c513"
      id="hidden-fact-471"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome
      contextRef="c515"
      id="hidden-fact-472"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset
      contextRef="c517"
      id="hidden-fact-473"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome
      contextRef="c517"
      id="hidden-fact-474"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome
      contextRef="c522"
      id="hidden-fact-475"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome
      contextRef="c524"
      id="hidden-fact-476"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset
      contextRef="c526"
      id="hidden-fact-477"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome
      contextRef="c526"
      id="hidden-fact-478"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset
      contextRef="c529"
      id="hidden-fact-479"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset
      contextRef="c529"
      id="hidden-fact-480"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome
      contextRef="c529"
      id="hidden-fact-481"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome
      contextRef="c531"
      id="hidden-fact-482"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome
      contextRef="c533"
      id="hidden-fact-483"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset
      contextRef="c535"
      id="hidden-fact-484"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome
      contextRef="c535"
      id="hidden-fact-485"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome
      contextRef="c538"
      id="hidden-fact-486"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:PuttableInstrumentsCharge
      contextRef="c0"
      id="hidden-fact-487"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:PuttableInstrumentsCharge
      contextRef="c5"
      id="hidden-fact-488"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:MutualFundsAdjustment
      contextRef="c6"
      id="hidden-fact-489"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:TaxEffectFromChangeInTaxRate
      contextRef="c0"
      id="hidden-fact-490"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CurrentTaxExpenseIncome
      contextRef="c0"
      id="hidden-fact-491"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate
      contextRef="c539"
      id="hidden-fact-492"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate
      contextRef="c541"
      id="hidden-fact-493"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate
      contextRef="c544"
      id="hidden-fact-494"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="c0"
      id="hidden-fact-495"
      unitRef="pure"
      xsi:nil="true"/>
    <ifrs-full:CurrentAssets
      contextRef="c559"
      id="hidden-fact-496"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentAssets
      contextRef="c559"
      id="hidden-fact-497"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Assets
      contextRef="c559"
      id="hidden-fact-498"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CurrentLiabilities
      contextRef="c559"
      id="hidden-fact-499"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentLiabilities
      contextRef="c559"
      id="hidden-fact-500"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Liabilities
      contextRef="c559"
      id="hidden-fact-501"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="c559"
      id="hidden-fact-502"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:EquityAndLiabilities
      contextRef="c559"
      id="hidden-fact-503"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:RevaluationOfPropertyPlantAndEquipmentNetOfTax
      contextRef="c561"
      id="hidden-fact-504"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:RevaluationOfPropertyPlantAndEquipmentNetOfTax
      contextRef="c562"
      id="hidden-fact-505"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:InvestmentInKindInOtherRelatedPartiesNonCashTransactionsInvestmentActivities
      contextRef="c564"
      id="hidden-fact-506"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:OwnShareHeld
      contextRef="c566"
      id="hidden-fact-507"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ExchangeOfIntangibleAssets
      contextRef="c565"
      id="hidden-fact-508"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ExchangeOfIntangibleAssets
      contextRef="c566"
      id="hidden-fact-509"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:NonMonetaryContributionsInJointVenturesNonCashTransactionsInvestmentActivities
      contextRef="c564"
      id="hidden-fact-510"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:NonMonetaryContributionsInJointVenturesNonCashTransactionsInvestmentActivities
      contextRef="c565"
      id="hidden-fact-511"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod
      contextRef="c564"
      id="hidden-fact-512"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:CapitalizationOfConvertibleFinancingActivities
      contextRef="c564"
      id="hidden-fact-513"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:CapitalizationOfConvertibleFinancingActivities
      contextRef="c565"
      id="hidden-fact-514"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AssignmentOfReceivablesWithShareholdersAndOtherRelatedParties
      contextRef="c565"
      id="hidden-fact-515"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AssignmentOfReceivablesWithShareholdersAndOtherRelatedParties
      contextRef="c566"
      id="hidden-fact-516"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:CompensationPaymentFinancedByAcquisitionOfIntangibleAssets
      contextRef="c565"
      id="hidden-fact-517"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:CompensationPaymentFinancedByAcquisitionOfIntangibleAssets
      contextRef="c566"
      id="hidden-fact-518"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IncreaseThroughAcquisitionOfNonControllingInterestInSubsidiaries
      contextRef="c564"
      id="hidden-fact-519"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities
      contextRef="c571"
      id="hidden-fact-520"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities
      contextRef="c572"
      id="hidden-fact-521"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:DecreaseThroughCapitalizationOfDebtLiabilitiesArisingFromFinancingActivities
      contextRef="c570"
      id="hidden-fact-522"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:DecreaseThroughCapitalizationOfDebtLiabilitiesArisingFromFinancingActivities
      contextRef="c571"
      id="hidden-fact-523"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="c571"
      id="hidden-fact-524"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities
      contextRef="c577"
      id="hidden-fact-525"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities
      contextRef="c578"
      id="hidden-fact-526"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:DecreaseThroughPaymentsLiabilitiesArisingFromFinancingActivities
      contextRef="c578"
      id="hidden-fact-527"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:FinancingForAssetsAcquisitions
      contextRef="c578"
      id="hidden-fact-528"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="c577"
      id="hidden-fact-529"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities
      contextRef="c583"
      id="hidden-fact-530"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IncreaseThroughBorrowingsLiabilitiesArisingFromFinancingActivities
      contextRef="c584"
      id="hidden-fact-531"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:PrepaymentPremiumFee
      contextRef="c582"
      id="hidden-fact-532"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:PrepaymentPremiumFee
      contextRef="c583"
      id="hidden-fact-533"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:NoncashActivities
      contextRef="c584"
      id="hidden-fact-534"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="c583"
      id="hidden-fact-535"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="c583"
      id="hidden-fact-536"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="c586"
      id="hidden-fact-537"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates
      contextRef="c589"
      id="hidden-fact-538"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates
      contextRef="c592"
      id="hidden-fact-539"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates
      contextRef="c601"
      id="hidden-fact-540"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:InvestmentsMeasuredAtFairValue
      contextRef="c605"
      id="hidden-fact-541"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:InvestmentsMeasuredAtFairValue
      contextRef="c4"
      id="hidden-fact-542"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:DueToJointVenturesAndAssociatesNonCurrent
      contextRef="c607"
      id="hidden-fact-543"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:DueToJointVenturesAndAssociatesNonCurrent
      contextRef="c4"
      id="hidden-fact-544"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:LossesOnDisposalsOfInvestments
      contextRef="c612"
      id="hidden-fact-545"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:SaleOfEquityInvestment
      contextRef="c611"
      id="hidden-fact-546"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:JointVenturesAndAssociatesAccountedForUsingEquityMethodReclassificationChangeInOwnership
      contextRef="c611"
      id="hidden-fact-547"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:EquityMethodInvestmentIncreaseFromShareBasedIncentives
      contextRef="c611"
      id="hidden-fact-548"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ChangeinJointVenturesDividendsDistribution
      contextRef="c611"
      id="hidden-fact-549"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod
      contextRef="c626"
      id="hidden-fact-550"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod
      contextRef="c627"
      id="hidden-fact-551"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod
      contextRef="c629"
      id="hidden-fact-552"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod
      contextRef="c630"
      id="hidden-fact-553"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod
      contextRef="c640"
      id="hidden-fact-554"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CurrentAssets
      contextRef="c644"
      id="hidden-fact-555"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentAssets
      contextRef="c644"
      id="hidden-fact-556"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CurrentLiabilities
      contextRef="c644"
      id="hidden-fact-557"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentLiabilities
      contextRef="c644"
      id="hidden-fact-558"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="c644"
      id="hidden-fact-559"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CostOfSales
      contextRef="c645"
      id="hidden-fact-560"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c645"
      id="hidden-fact-561"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CurrentAssets
      contextRef="c656"
      id="hidden-fact-562"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CostOfSales
      contextRef="c657"
      id="hidden-fact-563"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CurrentAssets
      contextRef="c658"
      id="hidden-fact-564"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CostOfSales
      contextRef="c659"
      id="hidden-fact-565"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CurrentAssets
      contextRef="c660"
      id="hidden-fact-566"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CostOfSales
      contextRef="c661"
      id="hidden-fact-567"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:RevenueFromRoyalties
      contextRef="c663"
      id="hidden-fact-568"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:RevenueFromRoyalties
      contextRef="c664"
      id="hidden-fact-569"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:RevenueFromRoyalties
      contextRef="c665"
      id="hidden-fact-570"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:LicenceFeeIncome
      contextRef="c662"
      id="hidden-fact-571"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:LicenceFeeIncome
      contextRef="c663"
      id="hidden-fact-572"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:LicenceFeeIncome
      contextRef="c665"
      id="hidden-fact-573"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets
      contextRef="c663"
      id="hidden-fact-574"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets
      contextRef="c664"
      id="hidden-fact-575"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets
      contextRef="c665"
      id="hidden-fact-576"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:RevenueFromGovernmentGrants
      contextRef="c662"
      id="hidden-fact-577"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:RevenueFromGovernmentGrants
      contextRef="c663"
      id="hidden-fact-578"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:RevenueFromGovernmentGrants
      contextRef="c664"
      id="hidden-fact-579"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CostOfSales
      contextRef="c665"
      id="hidden-fact-580"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:RevenueFromRoyalties
      contextRef="c673"
      id="hidden-fact-581"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:RevenueFromRoyalties
      contextRef="c674"
      id="hidden-fact-582"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:RevenueFromRoyalties
      contextRef="c675"
      id="hidden-fact-583"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:LicenceFeeIncome
      contextRef="c673"
      id="hidden-fact-584"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:LicenceFeeIncome
      contextRef="c675"
      id="hidden-fact-585"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets
      contextRef="c673"
      id="hidden-fact-586"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets
      contextRef="c674"
      id="hidden-fact-587"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets
      contextRef="c675"
      id="hidden-fact-588"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:RevenueFromGovernmentGrants
      contextRef="c672"
      id="hidden-fact-589"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:RevenueFromGovernmentGrants
      contextRef="c673"
      id="hidden-fact-590"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:RevenueFromGovernmentGrants
      contextRef="c674"
      id="hidden-fact-591"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:RevenueFromRoyalties
      contextRef="c683"
      id="hidden-fact-592"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:RevenueFromRoyalties
      contextRef="c684"
      id="hidden-fact-593"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:RevenueFromRoyalties
      contextRef="c685"
      id="hidden-fact-594"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets
      contextRef="c685"
      id="hidden-fact-595"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:RevenueFromGovernmentGrants
      contextRef="c682"
      id="hidden-fact-596"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:RevenueFromGovernmentGrants
      contextRef="c683"
      id="hidden-fact-597"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:RevenueFromGovernmentGrants
      contextRef="c684"
      id="hidden-fact-598"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="c728"
      id="hidden-fact-599"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentAssets
      contextRef="c760"
      id="hidden-fact-600"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentAssets
      contextRef="c762"
      id="hidden-fact-601"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentAssets
      contextRef="c768"
      id="hidden-fact-602"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Goodwill
      contextRef="c436"
      id="hidden-fact-603"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayables
      contextRef="c771"
      id="hidden-fact-604"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayables
      contextRef="c772"
      id="hidden-fact-605"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Borrowings
      contextRef="c774"
      id="hidden-fact-606"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ConvertibleNotes
      contextRef="c776"
      id="hidden-fact-607"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ConvertibleNotes
      contextRef="c777"
      id="hidden-fact-608"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:LeasingLiabilities
      contextRef="c780"
      id="hidden-fact-609"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:LeasingLiabilities
      contextRef="c781"
      id="hidden-fact-610"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="c783"
      id="hidden-fact-611"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayables
      contextRef="c787"
      id="hidden-fact-612"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ConsiderationForAcquisitionOfAssets
      contextRef="c791"
      id="hidden-fact-613"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ConvertibleNotes
      contextRef="c794"
      id="hidden-fact-614"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ConvertibleNotes
      contextRef="c795"
      id="hidden-fact-615"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CurrentFinancialLiabilities
      contextRef="c807"
      id="hidden-fact-616"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentFinancialLiabilities
      contextRef="c807"
      id="hidden-fact-617"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="c807"
      id="hidden-fact-618"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CashAndCashEquivalents
      contextRef="c811"
      id="hidden-fact-619"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherFinancialAssets
      contextRef="c814"
      id="hidden-fact-620"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:TradeReceivables
      contextRef="c819"
      id="hidden-fact-621"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:TradeReceivables
      contextRef="c820"
      id="hidden-fact-622"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherCurrentReceivables
      contextRef="c823"
      id="hidden-fact-623"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherCurrentReceivables
      contextRef="c824"
      id="hidden-fact-624"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="c831"
      id="hidden-fact-625"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="c835"
      id="hidden-fact-626"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="c836"
      id="hidden-fact-627"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="c837"
      id="hidden-fact-628"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="c839"
      id="hidden-fact-629"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="c843"
      id="hidden-fact-630"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="c844"
      id="hidden-fact-631"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="c847"
      id="hidden-fact-632"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="c848"
      id="hidden-fact-633"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="c849"
      id="hidden-fact-634"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="c850"
      id="hidden-fact-635"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="c852"
      id="hidden-fact-636"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DisclosureOfFairValueOfFinancialInstrumentsExplanatory contextRef="c0" id="ixv-46447">Level 3 comprises financial instruments with inputs for estimating fair value that are not based on observable market data.&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level
    1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level
    2&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level
    3&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Measurement at fair value at 06/30/2025&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; font-style: italic"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Financial assets at fair
    value&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Investments at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;19,722&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-637; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-638; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Financial
    liabilities valued at fair value&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Warrant liability&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;181,093&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-639; font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,030,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;Measurement at fair value at 06/30/2024&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; font-style: italic"&gt;Financial assets at fair value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Mutual funds&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;12,943,378&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-640"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-641"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Moolec Science SA shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,191,286&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-642"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-643"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Investments at fair value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,311,604&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-644"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-645"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;US Treasury bills&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,993,668&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-646"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-647"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Other investments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,702,761&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-648"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-649"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left"&gt;Financial liabilities valued at fair value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Trade and other payables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-650"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,989,792&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-651"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Consideration for acquisition&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,724,114&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-652"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-653"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfFairValueOfFinancialInstrumentsExplanatory>
    <ifrs-full:FinancialAssetsAtFairValue
      contextRef="c858"
      id="hidden-fact-637"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:FinancialAssetsAtFairValue
      contextRef="c859"
      id="hidden-fact-638"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilitiesAtFairValue
      contextRef="c861"
      id="hidden-fact-639"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:FinancialAssetsAtFairValue
      contextRef="c864"
      id="hidden-fact-640"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:FinancialAssetsAtFairValue
      contextRef="c865"
      id="hidden-fact-641"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:FinancialAssetsAtFairValue
      contextRef="c867"
      id="hidden-fact-642"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:FinancialAssetsAtFairValue
      contextRef="c868"
      id="hidden-fact-643"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:FinancialAssetsAtFairValue
      contextRef="c870"
      id="hidden-fact-644"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:FinancialAssetsAtFairValue
      contextRef="c871"
      id="hidden-fact-645"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:FinancialAssetsAtFairValue
      contextRef="c873"
      id="hidden-fact-646"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:FinancialAssetsAtFairValue
      contextRef="c874"
      id="hidden-fact-647"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:FinancialAssetsAtFairValue
      contextRef="c876"
      id="hidden-fact-648"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:FinancialAssetsAtFairValue
      contextRef="c877"
      id="hidden-fact-649"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilitiesAtFairValue
      contextRef="c878"
      id="hidden-fact-650"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilitiesAtFairValue
      contextRef="c880"
      id="hidden-fact-651"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilitiesAtFairValue
      contextRef="c882"
      id="hidden-fact-652"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilitiesAtFairValue
      contextRef="c883"
      id="hidden-fact-653"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:RightOfUseAssetLossOfControl
      contextRef="c887"
      id="hidden-fact-654"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:LossOfControlDepreciation
      contextRef="c892"
      id="hidden-fact-655"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AccumulatedDepreciationAtTheEndOfThePeriod
      contextRef="c889"
      id="hidden-fact-656"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:LossOfControlLeaseLiability
      contextRef="c5"
      id="hidden-fact-657"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="c4"
      id="hidden-fact-658"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Machinery
      contextRef="c893"
      id="hidden-fact-659"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Vehicles
      contextRef="c895"
      id="hidden-fact-660"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ComputerSoftware
      contextRef="c897"
      id="hidden-fact-661"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory contextRef="c0" id="ixv-46473">During the year ended June 30, 2025, the transactions between the Group and related parties, and the related balances owed by and to them for the year ended June 30, 2025, 2024 and 2023 are as follows:&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;17.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND
TRANSACTIONS&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Value of transactions for the year ended&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid"&gt;Party&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;Transaction type&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 30%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 33%; text-align: left"&gt;Sales of goods and services&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4,033,811&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;952,742&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;739,651&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Joint ventures and associates&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Purchases of goods and services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(24,061,563&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(500,704&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(738,652&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Net loans granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,645,504&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;13,005,841&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,141,471&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Interest gain&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;944,186&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;135,485&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;212,407&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Net loans received&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-662"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,860,058&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,854,680&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Puttable instruments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-663"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-664"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,399,631&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Net loans granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-665"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28,299&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;19,049&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Preference shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(15,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-666"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-667"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Interest expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-668"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,425,703&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(956,873&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Shareholders and other related parties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Own shares held by subsidiaries&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-669"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(444,473&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(133,079&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;In-kind contributions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,343,549&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,409,244&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,163,384&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Sales of goods and services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,714,441&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,911,723&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,565,027&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Purchases of goods and services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,517,528&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,998,349&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,334,556&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Salaries, social security benefits and other benefits&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,494,538&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,496,073&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,995,361&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Key management personnel&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Sales and services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;367,928&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-670"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-671"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Purchases of goods and services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,079,070&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-672"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-673"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Stock options-based incentives&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(480,450&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(8,181,849&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,868,430&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;(27,583,730&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;1,536,125&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;10,358,989&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Amounts receivable from&lt;br/&gt;
 related parties&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Party&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Transaction type&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 30%; text-align: left"&gt;Joint ventures and associates&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 45%; text-align: left"&gt;Trade debtors&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,565,913&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2,176,622&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Other receivables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,211,902&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;37,586,012&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Shareholders and other related parties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Trade debtors&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-674"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;37&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Loans receivables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,295,774&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-675"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Other receivables&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;17,405&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;47,348&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;15,090,994&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;39,810,019&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 52.5pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Amounts payable to&lt;br/&gt;
 related parties&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Party&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Transaction type&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;06/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 30%; text-align: left"&gt;Joint ventures and associates&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 45%; text-align: left"&gt;Trade creditors&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(620,034&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(52,778,206&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Convertible notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(7,102,028&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-676"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Net loans payables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(10,303,098&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,860,058&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Shareholders and other related parties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Trade creditors&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-677"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(37,985&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,030,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-678"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;Preference shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(15,739,726&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-679"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Key management personnel&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Salaries, social security benefits and other benefits&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(41,620&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(226,702&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(34,836,506&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(54,902,951&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory>
    <mlec:ValueOfTransactionsForThePeriodEnded
      contextRef="c913"
      id="hidden-fact-662"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ValueOfTransactionsForThePeriodEnded
      contextRef="c916"
      id="hidden-fact-663"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ValueOfTransactionsForThePeriodEnded
      contextRef="c917"
      id="hidden-fact-664"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ValueOfTransactionsForThePeriodEnded
      contextRef="c919"
      id="hidden-fact-665"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ValueOfTransactionsForThePeriodEnded
      contextRef="c923"
      id="hidden-fact-666"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ValueOfTransactionsForThePeriodEnded
      contextRef="c924"
      id="hidden-fact-667"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ValueOfTransactionsForThePeriodEnded
      contextRef="c925"
      id="hidden-fact-668"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ValueOfTransactionsForThePeriodEnded
      contextRef="c928"
      id="hidden-fact-669"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ValueOfTransactionsForThePeriodEnded
      contextRef="c944"
      id="hidden-fact-670"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ValueOfTransactionsForThePeriodEnded
      contextRef="c945"
      id="hidden-fact-671"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ValueOfTransactionsForThePeriodEnded
      contextRef="c947"
      id="hidden-fact-672"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ValueOfTransactionsForThePeriodEnded
      contextRef="c948"
      id="hidden-fact-673"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherReceivablesDueFromRelatedParties
      contextRef="c956"
      id="hidden-fact-674"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherReceivablesDueFromRelatedParties
      contextRef="c959"
      id="hidden-fact-675"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="c965"
      id="hidden-fact-676"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="c968"
      id="hidden-fact-677"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="c971"
      id="hidden-fact-678"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="c973"
      id="hidden-fact-679"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="c1011"
      id="hidden-fact-680"
      unitRef="pure"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="c1014"
      id="hidden-fact-681"
      unitRef="pure"
      xsi:nil="true"/>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="c1014"
      id="hidden-fact-682"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="c1014"
      id="hidden-fact-683"
      unitRef="pure"
      xsi:nil="true"/>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019
      contextRef="c1014"
      id="hidden-fact-684"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="c1014"
      id="hidden-fact-685"
      unitRef="pure"
      xsi:nil="true"/>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="c1014"
      id="hidden-fact-686"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="c1015"
      id="hidden-fact-687"
      unitRef="pure"
      xsi:nil="true"/>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019
      contextRef="c1015"
      id="hidden-fact-688"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="c1016"
      id="hidden-fact-689"
      unitRef="pure"
      xsi:nil="true"/>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="c1016"
      id="hidden-fact-690"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <dei:EntityCentralIndexKey contextRef="c0" id="ixv-46503">0001937737</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c0" id="ixv-46504">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="c0" id="ixv-46505">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityAddressPostalZipCode contextRef="c1" id="ixv-46506">KY1-9009</dei:EntityAddressPostalZipCode>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#ix_8_fact"
          xlink:label="ix_8_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_9_fact"
          xlink:label="ix_9_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_10_fact"
          xlink:label="ix_10_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_7_fact"
          xlink:label="ix_7_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_2_fact"
          xlink:label="ix_2_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_6_fact"
          xlink:label="ix_6_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_5_fact"
          xlink:label="ix_5_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_11_fact"
          xlink:label="ix_11_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_0_fact"
          xlink:label="ix_0_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_4_fact"
          xlink:label="ix_4_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_1_fact"
          xlink:label="ix_1_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_3_fact"
          xlink:label="ix_3_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_0_footnote" xlink:label="ix_0_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Direct interests held by Bioceres Group Limited.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_8_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_9_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_10_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_7_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_2_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_6_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_5_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_11_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_0_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_4_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_1_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_3_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_13_fact"
          xlink:label="ix_13_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-173"
          xlink:label="hidden-fact-173"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-171"
          xlink:label="hidden-fact-171"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_16_fact"
          xlink:label="ix_16_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-172"
          xlink:label="hidden-fact-172"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-174"
          xlink:label="hidden-fact-174"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_14_fact"
          xlink:label="ix_14_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_15_fact"
          xlink:label="ix_15_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_12_fact"
          xlink:label="ix_12_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_17_fact"
          xlink:label="ix_17_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_1_footnote" xlink:label="ix_1_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Direct
interest held by Moolec Science SA.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_13_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-173"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-171"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_2_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_3_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_5_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_16_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_0_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-172"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-174"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_14_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_15_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_1_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_4_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_12_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_17_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_18_fact"
          xlink:label="ix_18_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_19_fact"
          xlink:label="ix_19_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_2_footnote" xlink:label="ix_2_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Since
2023, the Group exercises &#x201c;de facto control&#x201d; over Bioceres Crop Solutions Corp, however, as stated in note Note 1 &#x2013;
The Group&#x2019;s business reorganization and general information - &#x201c;<xhtml:i>The Bioceres Group Business Combination Agreement&#x201d;</xhtml:i>,
Bioceres Group Limited lost the &#x201c;de facto control&#x201d; on June 24, 2025. The subsidiary was deconsolidated as of June 30, 2025,
and the investment in it was measured using the equity method. The Group&#x2019;s consolidated result includes the results of that entity
up to the date of its deconsolidation. No results related to the loss of control have been recognized. Various notes to the financial
statements show the effect it has had on consolidated assets and liabilities, business segments and CGUs.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_18_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_19_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_20_fact"
          xlink:label="ix_20_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-175"
          xlink:label="hidden-fact-175"
          xlink:type="locator"/>
        <link:footnote id="ix_3_footnote" xlink:label="ix_3_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Direct
interest held by Nutrecon LLC.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_20_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-175"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#hidden-fact-244"
          xlink:label="hidden-fact-244"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-307"
          xlink:label="hidden-fact-307"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-295"
          xlink:label="hidden-fact-295"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-313"
          xlink:label="hidden-fact-313"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_30_fact"
          xlink:label="ix_30_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_21_fact"
          xlink:label="ix_21_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_27_fact"
          xlink:label="ix_27_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-316"
          xlink:label="hidden-fact-316"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_29_fact"
          xlink:label="ix_29_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_23_fact"
          xlink:label="ix_23_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_24_fact"
          xlink:label="ix_24_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_28_fact"
          xlink:label="ix_28_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_25_fact"
          xlink:label="ix_25_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_26_fact"
          xlink:label="ix_26_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_22_fact"
          xlink:label="ix_22_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-289"
          xlink:label="hidden-fact-289"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-301"
          xlink:label="hidden-fact-301"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_31_fact"
          xlink:label="ix_31_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_4_footnote" xlink:label="ix_4_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Correspond to the loss of control of BIOX.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-244"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-307"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-295"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-313"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_30_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_21_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_27_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-316"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_29_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_23_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_24_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_28_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_25_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_26_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_22_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-289"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-301"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_31_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#hidden-fact-340"
          xlink:label="hidden-fact-340"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_34_fact"
          xlink:label="ix_34_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_32_fact"
          xlink:label="ix_32_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-351"
          xlink:label="hidden-fact-351"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-321"
          xlink:label="hidden-fact-321"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-336"
          xlink:label="hidden-fact-336"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-355"
          xlink:label="hidden-fact-355"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_33_fact"
          xlink:label="ix_33_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-329"
          xlink:label="hidden-fact-329"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-346"
          xlink:label="hidden-fact-346"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-338"
          xlink:label="hidden-fact-338"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-333"
          xlink:label="hidden-fact-333"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-347"
          xlink:label="hidden-fact-347"
          xlink:type="locator"/>
        <link:footnote id="ix_5_footnote" xlink:label="ix_5_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">USD 1,089,768 correspond to the loss of control of Inmet
S.A.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-340"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_34_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_32_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-351"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-321"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-336"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-355"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_33_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-329"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-346"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-338"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-333"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-347"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_37_fact"
          xlink:label="ix_37_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_39_fact"
          xlink:label="ix_39_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_41_fact"
          xlink:label="ix_41_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-262"
          xlink:label="hidden-fact-262"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_35_fact"
          xlink:label="ix_35_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-279"
          xlink:label="hidden-fact-279"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_40_fact"
          xlink:label="ix_40_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-253"
          xlink:label="hidden-fact-253"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-272"
          xlink:label="hidden-fact-272"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_36_fact"
          xlink:label="ix_36_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-274"
          xlink:label="hidden-fact-274"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-245"
          xlink:label="hidden-fact-245"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-248"
          xlink:label="hidden-fact-248"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_38_fact"
          xlink:label="ix_38_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-267"
          xlink:label="hidden-fact-267"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-256"
          xlink:label="hidden-fact-256"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-283"
          xlink:label="hidden-fact-283"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-258"
          xlink:label="hidden-fact-258"
          xlink:type="locator"/>
        <link:footnote id="ix_6_footnote" xlink:label="ix_6_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Correspond to The Bioceres Group Business Combination Agreement.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_37_fact"
          xlink:to="ix_6_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_39_fact"
          xlink:to="ix_6_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_41_fact"
          xlink:to="ix_6_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-262"
          xlink:to="ix_6_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_35_fact"
          xlink:to="ix_6_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-279"
          xlink:to="ix_6_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_40_fact"
          xlink:to="ix_6_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-253"
          xlink:to="ix_6_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-272"
          xlink:to="ix_6_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_36_fact"
          xlink:to="ix_6_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-274"
          xlink:to="ix_6_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-245"
          xlink:to="ix_6_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-248"
          xlink:to="ix_6_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_38_fact"
          xlink:to="ix_6_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-267"
          xlink:to="ix_6_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-256"
          xlink:to="ix_6_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-283"
          xlink:to="ix_6_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-258"
          xlink:to="ix_6_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_42_fact"
          xlink:label="ix_42_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-390"
          xlink:label="hidden-fact-390"
          xlink:type="locator"/>
        <link:footnote id="ix_7_footnote" xlink:label="ix_7_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-size: 10pt">Correspond to the loss of control
of Inmet S.A. in the year 2024</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_42_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-390"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_43_fact"
          xlink:label="ix_43_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_8_footnote" xlink:label="ix_8_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">On March 28, 2025, BIOX, a former subsidiary,
agreed to transfer all rights, licenses, and materials containing or pertaining to the Soy ANF trait and pay $750,000&#160;to a Arcadia
Biosciences Inc in exchange for (i) RG and OX Wheat Patents and RS exclusive rights; (ii) the cancellation of all Royalty Payments, which
included&#160;25% of the Net Wheat Technology Licensing Revenues and&#160;6% of the Net HB4 Soybean Revenues up to $10&#160;million;
and (iii) the release from any Performance Benchmark Obligations related to the RG, OX, and RS Varieties which amounted to $8.1&#160;million.
This transaction resulted in the accounting of a gain from the exchange of intangible assets amounting to $7.5&#160;million.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_43_fact"
          xlink:to="ix_8_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_46_fact"
          xlink:label="ix_46_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_45_fact"
          xlink:label="ix_45_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_44_fact"
          xlink:label="ix_44_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_9_footnote" xlink:label="ix_9_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Mainly represent derecognition of deferred tax assets from
Bioceres S.A. because it initiated the voluntary bankruptcy proceeding (Note 21).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_46_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_45_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_44_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#hidden-fact-624"
          xlink:label="hidden-fact-624"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_48_fact"
          xlink:label="ix_48_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-623"
          xlink:label="hidden-fact-623"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_47_fact"
          xlink:label="ix_47_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_10_footnote" xlink:label="ix_10_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Advances expenses and tax balances are not included.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-624"
          xlink:to="ix_10_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_48_fact"
          xlink:to="ix_10_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-623"
          xlink:to="ix_10_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_47_fact"
          xlink:to="ix_10_footnote"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
